PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Liu, W; Guo, TF; Jing, ZT; Yang, Z; Liu, L; Yang, YP; Lin, X; Tong, QY				Liu, Wei; Guo, Teng-Fei; Jing, Zhen-Tang; Yang, Zhi; Liu, Lei; Yang, Yuan-Ping; Lin, Xu; Tong, Qiao-Yun			Hepatitis B virus core protein promotes hepatocarcinogenesis by enhancing Src expression and activating the Src/PI3K/Akt pathway	FASEB JOURNAL			English	Article						proliferation; cell cycle; Csk; Sp1; survival signaling	HEPATOCELLULAR-CARCINOMA; C-SRC; NUCLEAR-LOCALIZATION; BINDING PROTEIN; FAMILY KINASES; HBX PROTEIN; ANTIGEN; TRANSCRIPTION; GENE; MECHANISMS	Hepatitis B virus core protein (HBc) is expressed preferentially in hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC). HBc can function as an oncogene arising from its gene regulatory properties, but how it contributes functionally to hepatocarcinogenesis remains unclear. In this study, we determined the molecular and functional roles of HBc during HBV-associated hepatocellular tumorigenesis. HBc increased tumor formation of hepatoma cells. Moreover, expression of HBc specifically promoted proliferation of hepatoma cells in vitro. Mechanistic investigations revealed that these effects were caused by activation of the Src/PI3K/Akt pathway through proximal switch from inactive Src to the active form of the kinase by HBc. HBc-mediated sarcoma (Src) kinase activation was associated with down-regulation of C-terminal Src kinase (Csk). In addition, HBc enhances Src expression by activation of alternative Src 1A promoter in an Sp1 transcription factor-dependent manner. Proliferation induced by stable HBc expression was associated with increased G(1) -S cell cycle progression mediated by Src kinase activation. HBc-induced cellular proliferation and tumor formation were reversed by administration of the Src inhibitor saracatinib. Together, our findings suggest that HBc promotes tumorigenesis of hepatoma cells by enhancing the expression of total Src and the active form of the kinase and subsequently activates Src/PI3K/Akt signaling pathway, revealing novel insights into the underlying mechanisms of HBV-associated hepatocarcinogenesis.				liuwei@ctgu.edu.cn	Liu, Wei/ABX-2014-2022	Liu, Wei/0000-0001-7118-815X	National Natural Science Foundation of China [31600134]; Key Laboratory of Tumor Microbiology, Fujian Medical University [FMUTM-201704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Tumor Microbiology, Fujian Medical University	This work was supported by National Natural Science Foundation of China Grant 31600134, Key Laboratory of Tumor Microbiology, Fujian Medical University (Open Research Fund, Grant FMUTM-201704). The authors declare no conflicts of interest.	Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Bonham K, 2000, J BIOL CHEM, V275, P37604, DOI 10.1074/jbc.M004882200; Bouchard M, 2001, J VIROL, V75, P4247, DOI 10.1128/JVI.75.9.4247-4257.2001; Brechot C, 2004, GASTROENTEROLOGY, V127, pS56, DOI 10.1053/j.gastro.2004.09.016; Chen JY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-282; Chen ML, 2011, DIS MARKERS, V30, P325, DOI [10.1155/2011/946295, 10.3233/DMA-2011-0792]; Chen XC, 2004, VACCINE, V22, P439, DOI 10.1016/j.vaccine.2003.07.014; Du J, 2009, CELL DEATH DIFFER, V16, P219, DOI 10.1038/cdd.2008.144; ECKHARDT SG, 1991, J VIROL, V65, P575, DOI 10.1128/JVI.65.2.575-582.1991; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Gai XX, 2013, INT J BIOCHEM CELL B, V45, P1174, DOI 10.1016/j.biocel.2013.03.015; Guo YH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-563; HATTON T, 1992, J VIROL, V66, P5232, DOI 10.1128/JVI.66.9.5232-5241.1992; Ito Y, 2001, J HEPATOL, V35, P68, DOI 10.1016/S0168-8278(01)00077-0; Jeong H, 2014, FEBS LETT, V588, P851, DOI 10.1016/j.febslet.2014.01.020; Kew MC, 2010, PATHOL BIOL, V58, P273, DOI 10.1016/j.patbio.2010.01.005; Klein NP, 1997, MOL CELL BIOL, V17, P6427, DOI 10.1128/MCB.17.11.6427; Kwon JA, 2003, BIOL CHEM, V384, P203, DOI 10.1515/BC.2003.022; Lau GM, 2009, DIGEST DIS SCI, V54, P1465, DOI 10.1007/s10620-008-0519-0; Levinson NM, 2008, CELL, V134, P124, DOI 10.1016/j.cell.2008.05.051; Li HC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001162; LIAO W, 1995, J VIROL, V69, P1025, DOI 10.1128/JVI.69.2.1025-1029.1995; Lin YJ, 2010, P NATL ACAD SCI USA, V107, P9340, DOI 10.1073/pnas.1004762107; Liu HO, 2011, CANCER RES, V71, P7547, DOI 10.1158/0008-5472.CAN-11-2260; Liu W, 2015, FASEB J, V29, P1113, DOI 10.1096/fj.14-263822; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; Masaki T, 1999, HEPATOLOGY, V29, P379, DOI 10.1002/hep.510290239; Masaki T, 1998, HEPATOLOGY, V27, P1257, DOI 10.1002/hep.510270511; MILICH DR, 1986, SCIENCE, V234, P1398, DOI 10.1126/science.3491425; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Nicolas M, 2001, J BIOL CHEM, V276, P22126, DOI 10.1074/jbc.M010740200; Ritchie S, 2000, J BIOL CHEM, V275, P847, DOI 10.1074/jbc.275.2.847; Ritchie SA, 2003, NUCLEIC ACIDS RES, V31, P1502, DOI 10.1093/nar/gkg246; Shim HY, 2011, VIROLOGY, V410, P161, DOI 10.1016/j.virol.2010.11.005; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Wu YL, 2016, J VIROL, V90, P1729, DOI 10.1128/JVI.02604-15; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022524; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002	40	18	20	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3033	3046		10.1096/fj.201701144R	http://dx.doi.org/10.1096/fj.201701144R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401603				2022-12-26	WOS:000432546000012
J	Coppens, V; Leuckx, G; Heremans, Y; Staels, W; Verdonck, Y; Baeyens, L; De Leu, N; Heimberg, H				Coppens, Violette; Leuckx, Gunter; Heremans, Yves; Staels, Willem; Verdonck, Yannick; Baeyens, Luc; De Leu, Nico; Heimberg, Harry			Semi-automated digital measurement as the method of choice for beta cell mass analysis	PLOS ONE			English	Article							IMAGE-ANALYSIS; SOFTWARE	Pancreas injury by partial duct ligation (PDL) activates beta cell differentiation and proliferation in adult mouse pancreas but remains controversial regarding the anticipated increase in beta cell volume. Several reports unable to show beta cell volume augmentation in PDL pancreas used automated digital image analysis software. We hypothesized that fully automatic beta cell morphometry without manual micrograph artifact remediation introduces bias and therefore might be responsible for reported discrepancies and controversy. However, our present results prove that standard digital image processing with automatic thresholding is sufficiently robust albeit less sensitive and less adequate to demonstrate a significant increase in beta cell volume in PDL versus Sham-operated pancreas. We therefore conclude that other confounding factors such as quality of surgery, selection of samples based on relative abundance of the transcription factor Neurogenin 3 (Ngn3) and tissue processing give rise to inter-laboratory inconsistencies in beta cell volume quantification in PDL pancreas.	[Coppens, Violette; Leuckx, Gunter; Heremans, Yves; Staels, Willem; Verdonck, Yannick; Baeyens, Luc; De Leu, Nico; Heimberg, Harry] Vrije Univ Brussel, Beta Cell Neogenesis, Brussels, Belgium; [Coppens, Violette] Univ Antwerp, Fac Med & Hlth Sci, Collaborat Antwerp Psychiat Res Inst, Campus Drie Eiken, Antwerp, Belgium; [Coppens, Violette] Univ Dept Psychiat, Campus Duffel, Duffel, Belgium; [Staels, Willem] Univ Ghent, Div Pediat Endocrinol, Dept Pediat, Hosp & Dept Pediat & Genet, Ghent, Belgium; [De Leu, Nico] Univ Ziekenhuis Brussel, Dept Endocrinol, Brussels, Belgium; [De Leu, Nico] Algemeen Stedelijk Ziekenhuis Aalst, Dept Endocrinol, Aalst, Belgium	Vrije Universiteit Brussel; University of Antwerp; Ghent University; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University Hospital Brussels	Heimberg, H (corresponding author), Vrije Univ Brussel, Beta Cell Neogenesis, Brussels, Belgium.	Harry.Heimberg@vub.ac.be	Staels, Willem/I-4985-2013; Coppens, Violette/AAH-6649-2020	Staels, Willem/0000-0001-8259-3329; Coppens, Violette/0000-0001-6247-551X; Heimberg, Harry/0000-0003-1954-7375; De Leu, Nico/0000-0002-0542-5708	Instituut voor Innovatie door Wetenschap en Technologie (IWT) [91113]; Research Council, Vrije Universiteit Brussel [SRP35, P7/07]; Fund for Scientific Research Flanders (FWO) [G024512N]; FWO-Odysseus [GOF9116N]; DON Foundation; European Research Council [ERC DLV-677555]	Instituut voor Innovatie door Wetenschap en Technologie (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Council, Vrije Universiteit Brussel; Fund for Scientific Research Flanders (FWO)(FWO); FWO-Odysseus; DON Foundation; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Instituut voor Innovatie door Wetenschap en Technologie (IWT) (project nr: 91113; URL: http://www.iwt.be/) provided a PhD scholarship for the first author (VC); Research Council, Vrije Universiteit Brussel (Strategic Research Project SRP35) to HH" "Belgian Science Policy (Interuniversity Attraction Pole phase VI, project P7/07 to HH; Fund for Scientific Research Flanders (FWO) (Research Grant G024512N) to HH; FWO-Odysseus GOF9116N) to LB; DON Foundation (www.scion.nI) to HH and the European Research Council (ERC DLV-677555) to LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Chintinne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043959; De Groef S, 2015, JOVE-J VIS EXP, DOI 10.3791/52765; de Jonge GJ, 2011, INT J CARDIOVAS IMAG, V27, P787, DOI 10.1007/s10554-010-9727-8; HALLY AD, 1964, Q J MICROSC SCI, V105, P503; Inuwa IM, 2005, INT J DIABETES METAB, V13; KIEKENS R, 1992, J CLIN INVEST, V89, P117, DOI 10.1172/JCI115551; Marks Peter C, 2013, Open Med Imaging J, V7, P19; McGrath JC, 2015, BRIT J PHARMACOL, V172, P2427, DOI 10.1111/bph.12956; Molinari F, 2012, INT ANGIOL, V31, P42; Olerud J, 2009, DIABETOLOGIA, V52, P2594, DOI 10.1007/s00125-009-1544-z; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Picut CA, 2008, TOXICOL PATHOL, V36, P674, DOI 10.1177/0192623308317428; Rankin MM, 2013, DIABETES, V62, P1634, DOI 10.2337/db12-0848; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Van de Casteele M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.52; Wu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041976; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015	19	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191249	10.1371/journal.pone.0191249	http://dx.doi.org/10.1371/journal.pone.0191249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408875	Green Submitted, Green Published, gold			2022-12-26	WOS:000424302800013
J	Tang, XH; Li, YZ; Ao, JY; Ding, L; Liu, Y; Yuan, Y; Wang, ZF; Wang, GL				Tang, XiaoHong; Li, YiZe; Ao, JiYing; Ding, Ling; Liu, Yang; Yuan, Yuan; Wang, ZhiFen; Wang, GuoLin			Role of alpha 7nAChR-NMDAR in sevoflurane-induced memory deficits in the developing rat hippocampus	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; LONG-TERM DEPRESSION; NMDA-RECEPTOR; GENERAL-ANESTHESIA; NEONATAL EXPOSURE; DENDRITIC SPINES; AMYLOID-BETA; MICE; PROTEIN; EXPRESSION	Detrimental effects of volatile anaesthetics, including sevoflurane, on the structure and function of the developing brain have been reported. The internalization of N-methyl-D-aspartate receptors (NMDARs) contributes to anaesthetic neurotoxicity. Both nicotinic acetylcholine receptors (nAChRs) and NMDAR play a critical role in the development of the nervous system. Moreover, nAChR can interact with NMDAR, and previous studies have demonstrated modulation of NMDAR by nAChR. In our study, we used an alpha 7 nicotinic acetylcholine receptor (alpha 7nAChR) agonist and alpha 7nAChR antagonist to explore the role of alpha 7nAChR and NMDAR in sevoflurane-induced long-term effects on memory and dendritic spine both in vivo and in vitro. The results revealed that the activation of alpha 7nAChR attenuated the development of sevoflurane-induced memory deficit and dendritic spine changes, which might be by regulating NR2B-containing NMDAR trafficking from the intracellular pool to the cell surface pool in the hippocampus. Moreover, we demonstrated that alpha 7nAChR could regulate NR2B-containing NMDAR via Src-family tyrosine kinase (SFK). Thus, our current study indicates that the trafficking of NR2B-containing NMDAR is regulated by alpha 7nAChR via SFK in neonatal rat hippocampus, which may be secondary to sevoflurane-induced cognitive deficits in the developing hippocampus.	[Tang, XiaoHong; Li, YiZe; Ao, JiYing; Ding, Ling; Yuan, Yuan; Wang, ZhiFen; Wang, GuoLin] Tianjin Med Univ Gen Hosp, Dept Anesthesiol, Tianjin, Peoples R China; [Tang, XiaoHong; Li, YiZe; Ao, JiYing; Ding, Ling; Yuan, Yuan; Wang, ZhiFen; Wang, GuoLin] Tianjin Res Inst Anesthesiol, Tianjin, Peoples R China; [Liu, Yang] Tianjin Med Univ, Sch Biomed Engn, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Wang, GL (corresponding author), Tianjin Med Univ Gen Hosp, Dept Anesthesiol, Tianjin, Peoples R China.; Wang, GL (corresponding author), Tianjin Res Inst Anesthesiol, Tianjin, Peoples R China.	wangguolinemail@126.com			National Natural Science Foundation of China [NSFC 81300960, 81371245, 81400908]; Key Projects in the Tianjin Science & Technology Pillar Program [12ZCZDSY03000]; Tianjin Research Program of Application Foundation and Advanced Technology [14JCQNJC12800]; Scientific Grant from Tianjin Health Bureau [2013KZ124]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the Tianjin Science & Technology Pillar Program; Tianjin Research Program of Application Foundation and Advanced Technology; Scientific Grant from Tianjin Health Bureau	Our study is supported by National Natural Science Foundation of China(NSFC 81300960, 81371245, and 81400908), Key Projects in the Tianjin Science & Technology Pillar Program (12ZCZDSY03000), Tianjin Research Program of Application Foundation and Advanced Technology (14JCQNJC12800), Scientific Grant from Tianjin Health Bureau (2013KZ124). The funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, P NATL ACAD SCI USA, V105, P1722, DOI 10.1073/pnas.0711651105; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; DiMaggio C, 2009, J NEUROSURG ANESTH, V21, P286, DOI 10.1097/ANA.0b013e3181a71f11; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Dong Y, 2013, CURR MOL MED, V13, P488; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Franks NP, 1998, TOXICOL LETT, V101, P1, DOI 10.1016/S0378-4274(98)00158-1; Gambrill AC, 2011, P NATL ACAD SCI USA, V108, P5855, DOI 10.1073/pnas.1012676108; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Goebel-Goody SM, 2009, NEUROSCIENCE, V158, P1446, DOI 10.1016/j.neuroscience.2008.11.006; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Han XD, 2015, MOL MED REP, V11, P226, DOI 10.3892/mmr.2014.2751; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Head BP, 2009, ANESTHESIOLOGY, V110, P813, DOI 10.1097/ALN.0b013e31819b602b; Kim DH, 2007, J PHARMACOL SCI, V105, P82, DOI 10.1254/jphs.FP0061565; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; Lee S, 2008, BIOCHEM BIOPH RES CO, V377, P930, DOI 10.1016/j.bbrc.2008.10.082; LERMAN J, 1994, ANESTHESIOLOGY, V80, P814, DOI 10.1097/00000542-199404000-00014; Li SP, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-58; Li SP, 2012, J EXP MED, V209, P2141, DOI 10.1084/jem.20121270; Lin CS, 2009, NEUROSCIENCE, V158, P1326, DOI 10.1016/j.neuroscience.2008.11.007; Lozada AF, 2012, J NEUROSCI, V32, P7651, DOI 10.1523/JNEUROSCI.6246-11.2012; Lu Y, 2010, ANESTHESIOLOGY, V112, P1404, DOI 10.1097/ALN.0b013e3181d94de1; Luo JH, 2002, NEUROPHARMACOLOGY, V42, P306, DOI 10.1016/S0028-3908(01)00188-5; Morley BJ, 2013, NEUROSCIENCE, V233, P54, DOI 10.1016/j.neuroscience.2012.12.025; Newcomer JW, 2001, HIPPOCAMPUS, V11, P529, DOI 10.1002/hipo.1069.abs; Packard MG, 1997, NEUROBIOL LEARN MEM, V68, P42, DOI 10.1006/nlme.1996.3762; Rada EM, 2003, ANESTH ANALG, V96, P108, DOI 10.1097/00000539-200301000-00023; Ramage TM, 2013, BRIT J ANAESTH, V110, P39, DOI 10.1093/bja/aet103; Roberts M, 2002, BEHAV NEUROSCI, V116, P1059, DOI 10.1037//0735-7044.116.6.1059; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shen L, 2016, ACTA PHARMACOL SIN, V37, P312, DOI 10.1038/aps.2015.106; Shen XF, 2013, NEUROTOXICOLOGY, V39, P45, DOI 10.1016/j.neuro.2013.08.007; Shi Y, 2006, J NEUROSCI, V26, P1813, DOI 10.1523/JNEUROSCI.4091-05.2006; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Takaenoki Y, 2014, ANESTHESIOLOGY, V120, P403, DOI 10.1097/ALN.0000435846.28299.e7; Wang WY, 2016, MOL NEUROBIOL, V53, P216, DOI 10.1007/s12035-014-9005-1; Yamazaki Y, 2006, EUR J NEUROSCI, V23, P1819, DOI 10.1111/j.1460-9568.2006.04714.x; Yang Y, 2013, P NATL ACAD SCI USA, V110, P12078, DOI 10.1073/pnas.1307849110; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Zhang HL, 2016, J PROTEOMICS, V131, P113, DOI 10.1016/j.jprot.2015.10.018; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	48	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192498	10.1371/journal.pone.0192498	http://dx.doi.org/10.1371/journal.pone.0192498			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401517	gold, Green Published, Green Submitted			2022-12-26	WOS:000424101400063
J	Li, L; Liao, ZB; Yang, Y; Lv, L; Cao, YY; Zhu, ZY				Li, Ling; Liao, ZeBin; Yang, Yu; Lv, Lei; Cao, YingYing; Zhu, ZhenYu			Metabolomic profiling for the identification of potential biomarkers involved in a laboratory azole resistance in Candida albicans	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; PROTEIN; EXTRACTION; EXPRESSION; TREHALOSE; GLYCEROL; STRESS; YEAST	Candida albicans, one of the most common fungal pathogens, is responsible for several yeast infections in human hosts, being resistant to classically used antifungal drugs, such as azole drugs. Multifactorial and multistep alterations are involved in the azole resistance in Candida albicans. In this study, a FCZ-resistant C. albicans strain was obtained by serial cultures of a FCZ-susceptible C. albicans strain in incrementally increasing concentrations of FCZ. We performed an integrated profile of different classes of molecules related to azole resistance in C. albicans by combining several mass-spectrometry based methodologies. The comparative metabolomic study was performed with the sensitive and resistant strains of C. albicans to identify metabolites altered during the development of resistance to fluconazole, while the intervention strains and non-intervention strains of C. albicans to identify metabolites altered involved in cross-resistant to azole drugs. Our analysis of the different metabolites identified molecules mainly involved in metabolic processes such as amino acid metabolism, tricarboxylic acid cycle and phospholipid metabolism. We also compared the phospholipid composition of each group, revealing that the relative content of phospholipids significantly changed during the development of resistance to azole drugs. According with these results, we hypothesized that the metabolism shift might contribute to azole drugs resistance in C. albicans from multifactorial alterations. Our result paves the way to understand processes underlying the resistance to azole drugs in C. albicans, providing the basis for developing new antifungal drugs.	[Li, Ling; Yang, Yu; Cao, YingYing; Zhu, ZhenYu] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Liao, ZeBin] Second Mil Med Univ, Fac Naval Med, Dept Radiat Med, Shanghai, Peoples R China; [Lv, Lei] Shanghai Eastern Hepatobiliary Surg Hosp, Dept Pharm, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Cao, YY; Zhu, ZY (corresponding author), Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China.	caoyingying608@163.com; zzyzyfzhu@126.com	Liao, Zebin/AAC-8303-2022		National Nature Science Foundation of China [81273474, 81671991]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by two National Nature Science Foundation of China (81273474 and 81671991). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Professor William A. Fonzi for kindly providing the C. albicans strains SC5314. This work was financially supported by two National Nature Science Foundation of China (81273474 and 81671991). In addition, the authors would like to thank the referees and editor for their useful comments and suggestions, which have helped us to improve our manuscript.	Bari VK, 2015, SCI REP-UK, V5, DOI 10.1038/srep09685; Bilski P, 2000, PHOTOCHEM PHOTOBIOL, V71, P129, DOI 10.1562/0031-8655(2000)071&lt;0129:SIPVBP&gt;2.0.CO;2; Bolten CJ, 2008, BIOTECHNOL LETT, V30, P1993, DOI 10.1007/s10529-008-9789-z; Bona E, 2016, J APPL MICROBIOL, V121, P1530, DOI 10.1111/jam.13282; Canelas AB, 2009, ANAL CHEM, V81, P7379, DOI 10.1021/ac900999t; Chauhan N, 2015, MITOCHONDRION, V22, P60, DOI 10.1016/j.mito.2015.03.003; Ferrari S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000268; Flis VV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135084; Fuentes M, 2014, REV CHIL INFECTOL, V31, P511, DOI 10.4067/S0716-10182014000500001; Gromski PS, 2015, ANAL CHIM ACTA, V879, P10, DOI 10.1016/j.aca.2015.02.012; Hounoum BM, 2015, ANAL BIOANAL CHEM, V407, P8861, DOI 10.1007/s00216-015-9047-x; Howe AG, 2001, BBA-MOL CELL BIOL L, V1534, P65, DOI 10.1016/S1388-1981(01)00181-0; Ito T, 2013, J BACTERIOL, V195, P5439, DOI 10.1128/JB.00593-13; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Li LL, 2009, BIOCHEM BIOPH RES CO, V387, P778, DOI 10.1016/j.bbrc.2009.07.113; Liebeke M, 2014, INT J MED MICROBIOL, V304, P222, DOI 10.1016/j.ijmm.2013.11.017; Luevano-Martinez LA, 2015, BBA-BIOENERGETICS, V1847, P587, DOI 10.1016/j.bbabio.2015.03.007; Luo LL, 2011, CHEMOTHERAPY, V57, P77, DOI 10.1159/000323620; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Min J, 2001, BBA-MOL CELL BIOL L, V1531, P77, DOI 10.1016/S1388-1981(01)00088-9; Mukherjee T, 2011, BBA-PROTEINS PROTEOM, V1814, P1585, DOI 10.1016/j.bbapap.2011.06.018; Nakamura K, 2001, ANTIMICROB AGENTS CH, V45, P3366, DOI 10.1128/AAC.45.12.3366-3374.2001; Natarajan SK, 2012, FREE RADICAL BIO MED, V53, P1181, DOI 10.1016/j.freeradbiomed.2012.07.002; Peetla C, 2013, ADV DRUG DELIVER REV, V65, P1686, DOI 10.1016/j.addr.2013.09.004; Pokorna L, 2016, BBA-BIOENERGETICS, V1857, P34, DOI 10.1016/j.bbabio.2015.10.004; Romantsov T, 2009, BBA-BIOMEMBRANES, V1788, P2092, DOI 10.1016/j.bbamem.2009.06.010; Sanchez-Fresneda R, 2013, BIOCHEM BIOPH RES CO, V430, P1334, DOI 10.1016/j.bbrc.2012.10.118; Saye M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092028; Sharma S, 2014, ANTIMICROB AGENTS CH, V58, P2409, DOI 10.1128/AAC.02130-13; Shingu-Vazquez M, 2011, EUKARYOT CELL, V10, P1376, DOI 10.1128/EC.05184-11; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0039812, 10.1371/journal.pone.0044931]; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; Tagliaferri E, 2015, EXPERT REV ANTI-INFE, V13, P685, DOI 10.1586/14787210.2015.1029916; Teoh ST, 2016, J BIOSCI BIOENG, V122, P168, DOI 10.1016/j.jbiosc.2016.01.007; Theiss S, 2006, INT J MED MICROBIOL, V296, P405, DOI 10.1016/j.ijmm.2006.03.003; VanEldere J, 1996, J CLIN MICROBIOL, V34, P842, DOI 10.1128/JCM.34.4.842-847.1996; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Zhang L, 2015, J BACTERIOL, V197, P431, DOI 10.1128/JB.02282-14	39	11	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192328	10.1371/journal.pone.0192328	http://dx.doi.org/10.1371/journal.pone.0192328			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394282	Green Submitted, gold, Green Published			2022-12-26	WOS:000424060400035
J	Srinivasan, L; Kilpatrick, L; Shah, SS; Abbasi, S; Harris, MC				Srinivasan, Lakshmi; Kilpatrick, Laurie; Shah, Samir S.; Abbasi, Soraya; Harris, Mary C.			Elevations of novel cytokines in bacterial meningitis in infants	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; CEREBROSPINAL-FLUID PARAMETERS; NEONATAL MENINGITIS; LUMBAR PUNCTURE; SEPSIS; INFLAMMATION; INFECTION; IL-23; EXPRESSION; CELLS	Background Bacterial meningitis is challenging to diagnose in infants, especially in the common setting of antibiotic pre-treatment, which diminishes yield of cerebrospinal fluid (CSF) cultures. Prior studies of diagnostic markers have not demonstrated sufficient accuracy. Interleukin-23 (IL-23), interleukin-18 (IL-18) and soluble receptor for advanced glycation end products (sRAGE) possess biologic plausibility, and may be useful as diagnostic markers in bacterial meningitis. Methods In a prospective cohort study, we measured IL-23, IL-18 and sRAGE levels in CSF. We compared differences between infected and non-infected infants, and conducted receiver operating characteristic (ROC) analyses to identify individual markers and combinations of markers with the best diagnostic accuracy. Results 189 infants <6 months, including 8 with bacterial meningitis, 30 without meningitis, and 151 with indeterminate diagnosis (due to antibiotic pretreatment) were included. CSF IL-23, IL-18 and sRAGE levels were significantly elevated in infants with culture proven meningitis. Among individual markers, IL-23 possessed the greatest accuracy for diagnosis of bacterial meningitis (area under the curve (AUC) 0.9698). The combination of all three markers had an AUC of 1. Conclusions IL-23, alone and in combination with IL-18 and sRAGE, identified bacterial meningitis with excellent accuracy. Following validation, these markers could aid clinicians in diagnosis of bacterial meningitis and decision-making regarding prolongation of antibiotic therapy.	[Srinivasan, Lakshmi; Harris, Mary C.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Srinivasan, Lakshmi; Harris, Mary C.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kilpatrick, Laurie] Temple Univ, Lewis Katz Sch Med, Ctr Inflammat Translat & Clin Lung Res, Philadelphia, PA 19122 USA; [Shah, Samir S.] Cincinnati Childrens Hosp Med Ctr, Div Hosp Med, Cincinnati, OH 45229 USA; [Shah, Samir S.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Abbasi, Soraya] Penn Hosp, Div Newborn Pediat, Philadelphia, PA 19107 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Pennsylvania; Pennsylvania Medicine	Srinivasan, L (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA.; Srinivasan, L (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	srinivasanl@email.chop.edu		Harris, Mary Catherine/0000-0001-6287-0026	Foerderer Murray Award (The Children's Hospital of Philadelphia); University Research Foundation grant (University of Pennsylvania); National Center for Research Resources [UL1-RR-024134]; Clinical and Translational Research Centers at the Hospital of the University of Pennsylvania; Children's Hospital of Philadelphia	Foerderer Murray Award (The Children's Hospital of Philadelphia); University Research Foundation grant (University of Pennsylvania); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical and Translational Research Centers at the Hospital of the University of Pennsylvania; Children's Hospital of Philadelphia	This study was supported by the Foerderer Murray Award (The Childrens Hospital of Philadelphia) and the University Research Foundation grant (University of Pennsylvania). The project described was supported by grant number UL1-RR-024134 from the National Center for Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health.; We would like to thank Caitlin La Russa, Kaitilin Mahoney, Lavanya Madhusudan, Sharon Zirin, Linda Corcoran and Toni Mancini for their help with subject enrollment and data collection. We would also like to acknowledge the Clinical and Translational Research Centers at the Hospital of the University of Pennsylvania and the Childrens Hospital of Philadelphia for providing support with sample collection and storage for this study. A special thanks to Dr. Ting Zhang for her assistance in performance of ELISA testing of the biomarkers.	Baker MD, 1999, ARCH PEDIAT ADOL MED, V153, P508; BAKER MD, 1990, PEDIATRICS, V85, P1040; Bassler D, 2009, PEDIATRICS, V123, P313, DOI 10.1542/peds.2008-0377; Bopp C, 2008, CRIT CARE, V12, DOI 10.1186/cc6164; Bopp C, 2008, J SURG RES, V147, P79, DOI 10.1016/j.jss.2007.07.014; Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; Chi W, 2008, INVEST OPHTH VIS SCI, V49, P3058, DOI 10.1167/iovs.07-1390; Christaki E, 2011, SHOCK, V35, P492, DOI 10.1097/SHK.0b013e31820b2e1c; Comim CM, 2009, CURR NEUROVASC RES, V6, P194, DOI 10.2174/156720209788970045; Endo Shigeatsu, 2000, Journal of Medicine (Westbury), V31, P15; FRANCO SM, 1992, AM J DIS CHILD, V146, P567, DOI 10.1001/archpedi.1992.02160170047014; Garges HP, 2006, PEDIATRICS, V117, P1094, DOI 10.1542/peds.2005-1132; Garofalo RP, 2004, J MED VIROL, V73, P289, DOI 10.1002/jmv.20089; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Heath PT, 2003, ARCH DIS CHILD-FETAL, V88, P173; Hofer S, 2016, J SURG RES, V202, P315, DOI 10.1016/j.jss.2016.01.019; Holt DE, 2001, ARCH DIS CHILD-FETAL, V84, pF85, DOI 10.1136/fn.84.2.F85; HRISTEVA L, 1993, ARCH DIS CHILD-FETAL, V69, P14, DOI 10.1136/adc.69.1_Spec_No.14; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Lee JK, 2004, P NATL ACAD SCI USA, V101, P8815, DOI 10.1073/pnas.0402800101; Lutterloh EC, 2007, CRIT CARE, V11, DOI 10.1186/cc6184; Ng PC, 2010, CLIN PERINATOL, V37, P599, DOI 10.1016/j.clp.2010.05.005; Oberholzer A, 2001, SHOCK, V16, P411, DOI 10.1097/00024382-200116060-00001; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Schwalm MT, 2014, MOL NEUROBIOL, V49, P380, DOI 10.1007/s12035-013-8526-3; Smith PB, 2008, AM J PERINAT, V25, P421, DOI 10.1055/s-0028-1083839; Smits HH, 2004, EUR J IMMUNOL, V34, P1371, DOI 10.1002/eji.200324815; Srinivasan L, 2016, PEDIATR RES, V80, P566, DOI 10.1038/pr.2016.117; Srinivasan L, 2013, PEDIATR INFECT DIS J, V32, P1150, DOI 10.1097/INF.0b013e31829862b7; Srinivasan L, 2012, SEMIN PERINATOL, V36, P445, DOI 10.1053/j.semperi.2012.06.007; Srinivasan L, 2012, CURR OPIN PEDIATR, V24, P165, DOI 10.1097/MOP.0b013e3283504df3; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2004, PEDIATRICS, V113, P1181, DOI 10.1542/peds.113.5.1181; Sugitharini V, 2013, INFLAMM RES, V62, P1025, DOI 10.1007/s00011-013-0661-9; Wei TT, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003079; WISWELL TE, 1995, PEDIATRICS, V95, P803; Xu DM, 2000, EUR J IMMUNOL, V30, P3147, DOI 10.1002/1521-4141(200011)30:11<3147::AID-IMMU3147>3.0.CO;2-J; Ye Q, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003222	40	9	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0181449	10.1371/journal.pone.0181449	http://dx.doi.org/10.1371/journal.pone.0181449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394248	Green Published, gold, Green Submitted			2022-12-26	WOS:000424060400001
J	Noden, BH; Martin, J; Carrillo, Y; Talley, JL; Ochoa-Corona, FM				Noden, Bruce H.; Martin, Jaclyn; Carrillo, Yisel; Talley, Justin L.; Ochoa-Corona, Francisco M.			Development of a loop-mediated isothermal amplification (LAMP) assay for rapid screening of ticks and fleas for spotted fever group rickettsia	PLOS ONE			English	Article							SENSITIVE DETECTION; FIELD-EVALUATION; DIAGNOSIS; TYPHUS; SPECIMENS; NORTH; STATE; AREA; DNA	Background The importance of tick and flea-borne rickettsia infections is increasingly recognized worldwide. While increased focus has shifted in recent years to the development of point-of-care diagnostics for various vector-borne diseases in humans and animals, little research effort has been devoted to their integration into vector surveillance and control programs, particularly in resource-challenged countries. One technology which may be helpful for large scale vector surveillance initiatives is loop-mediated isothermal amplification (LAMP). The aim of this study was to develop a LAMP assay to detect spotted fever group (SFG) rickettsia DNA from field-collected ticks and fleas and compare with published end-point PCR results. Methodology/Principal findings A Spotted Fever Group rickettsia-specific loop-mediated isothermal amplification (SFGRLAMP) assay was developed using primers based on a region of the R. rickettsii 17kDa protein gene. The sensitivity, specificity, and reproducibility of the assay were evaluated. The assay was then compared with the results of end-point PCR assays for pooled tick and flea samples obtained from field-based surveillance studies. The sensitivity of the SFGR-LAMP assay was 0.00001 ng/mu l (25 mu l volume) which was 10 times more sensitive than the 17kDa protein gene end-point PCR used as the reference method. The assay only recognized gDNA from SFG and transitional group (TRG) rickettsia species tested but did not detect gDNA from typhus group (TG) rickettsia species or closely or distantly related bacterial species. The SFGRLAMP assay detected the same positives from a set of pooled tick and flea samples detected by end-point PCR in addition to two pooled flea samples not detected by end-point PCR. Conclusions/significance To our knowledge, this is the first study to develop a functional LAMP assay to initially screen for SFG and TRG rickettsia pathogens in field-collected ticks and fleas. With a high sensitivity and specificity, the results indicate the potential use as a field-based surveillance tool for tick and flea-borne rickettsial pathogens in resource-challenged countries.	[Noden, Bruce H.; Martin, Jaclyn; Carrillo, Yisel; Talley, Justin L.; Ochoa-Corona, Francisco M.] Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Noden, BH (corresponding author), Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA.	bruce.noden@okstate.edu		Noden, Bruce/0000-0002-0096-370X; Ochoa-Corona, Francisco/0000-0002-4112-8209	NIFA/USDA Hatch Grant funds through the Oklahoma Agricultural Experiment Station [OKL-02909]	NIFA/USDA Hatch Grant funds through the Oklahoma Agricultural Experiment Station	Funding for this project was provided by NIFA/USDA Hatch Grant funds through the Oklahoma Agricultural Experiment Station (OKL-02909) to BHN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acestor N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044269; Beier-Sexton M, 2015, PRACTICAL HDB MICROB, P54; Brown Lisa D, 2016, Curr Trop Med Rep, V3, P27; Chikeka I, 2015, CLIN MICROBIOL INFEC, V21, P404, DOI 10.1016/j.cmi.2015.04.022; Cunningham LJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004441; Dittrich S, 2014, J CLIN MICROBIOL, V52, P832, DOI 10.1128/JCM.02786-13; Gillespie JJ, 2009, VET RES, V40, DOI 10.1051/vetres:2008050; Gomes J, 2017, MOL CELL PROBE, V31, P61, DOI 10.1016/j.mcp.2016.12.006; Jiang J, 2012, VECTOR-BORNE ZOONOT, V12, P175, DOI 10.1089/vbz.2011.0614; Karpathy SE, 2016, INT J SYST EVOL MICR, V66, P5236, DOI 10.1099/ijsem.0.001502; Labruna MB, 2004, J CLIN MICROBIOL, V42, P90, DOI 10.1128/JCM.42.1.90-98.2004; Laohasinnarong D, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1112-y; Lucchi NW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151437; Luce-Fedrow A, 2015, FUTURE MICROBIOL, V10, P537, DOI [10.2217/fmb.14.141, 10.2217/FMB.14.141]; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; Martin A.N., 2016, CORRECTIVE CHURCH DI; Mitashi P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002504; Mori Y, 2013, J INFECT CHEMOTHER, V19, P404, DOI 10.1007/s10156-013-0590-0; Nakao R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-296; Njiru ZK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001572; Noden BH, 2017, J MED ENTOMOL, V54, P1093, DOI 10.1093/jme/tjx069; Noden BH, 2017, TICKS TICK-BORNE DIS, V8, P119, DOI 10.1016/j.ttbdis.2016.10.007; Noden BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108674; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Nzelu CO, 2014, ACTA TROP, V132, P1, DOI 10.1016/j.actatropica.2013.12.016; Pan L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002231; Pan L, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-254; Pan L, 2011, J CLIN MICROBIOL, V49, P4117, DOI 10.1128/JCM.01085-11; Paris DH, 2016, CURR OPIN INFECT DIS, V29, P433, DOI 10.1097/QCO.0000000000000298; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Patel JC, 2014, J INFECT DIS, V210, P1180, DOI 10.1093/infdis/jiu252; Prabhu M, 2011, CLIN INFECT DIS, V53, pe8, DOI 10.1093/cid/cir411; Richards AL, 2012, FEMS IMMUNOL MED MIC, V64, P107, DOI 10.1111/j.1574-695X.2011.00875.x; Salazar J. L., 2015, THESIS; Sokhna C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001999; TZIANABOS T, 1989, J CLIN MICROBIOL, V27, P2866, DOI 10.1128/JCM.27.12.2866-2868.1989; Wheeler SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147962; Yang J, 2013, TRANSBOUND EMERG DIS, V60, P238, DOI 10.1111/j.1865-1682.2012.01335.x; Yang YM, 2016, VET PARASITOL, V219, P71, DOI 10.1016/j.vetpar.2016.02.004	39	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192331	10.1371/journal.pone.0192331	http://dx.doi.org/10.1371/journal.pone.0192331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390021	Green Submitted, gold, Green Published			2022-12-26	WOS:000423793400088
J	Zheng, QQ; Shen, JW; Wang, ZJ				Zheng, Qianqian; Shen, Jianwei; Wang, Zhijie			Pattern dynamics of the reaction-diffusion immune system	PLOS ONE			English	Article							CROSS-DIFFUSION; INSTABILITY; STABILITY; ALGORITHM; NETWORK; MODEL	In this paper, we will investigate the effect of diffusion, which is ubiquitous in nature, on the immune system using a reaction-diffusion model in order to understand the dynamical behavior of complex patterns and control the dynamics of different patterns. Through control theory and linear stability analysis of local equilibrium, we obtain the optimal condition under which the system loses stability and a Turing pattern occurs. By combining mathematical analysis and numerical simulation, we show the possible patterns and how these patterns evolve. In addition, we establish a bridge between the complex patterns and the biological mechanism using the results from a previous study in Nature Cell Biology. The results in this paper can help us better understand the biological significance of the immune system.	[Zheng, Qianqian; Wang, Zhijie] Donghua Univ, Coll Informat Sci & Technol, Shanghai, Peoples R China; [Shen, Jianwei] Xuchang Univ, Inst Appl Math, Xuchang, Henan, Peoples R China	Donghua University; Xuchang University	Wang, ZJ (corresponding author), Donghua Univ, Coll Informat Sci & Technol, Shanghai, Peoples R China.; Shen, JW (corresponding author), Xuchang Univ, Inst Appl Math, Xuchang, Henan, Peoples R China.	phdshen@126.com; wangzj@dhu.edu.cn	zheng, qianqian/HHR-8375-2022; Shen, Jianwei/A-8727-2011	Shen, Jianwei/0000-0003-1289-8674	National Natural Science Foundation of China [11772291, 11572278, 11572084]; Innovation Scientists and Technicians Troop Construction Projects of Henan Province [2017JR0013]; Program for Innovative Research Team in University of Henan Province [13IRTSTHN019]; China Scholarship Council; Fundamental Research Funds for the Central Universities [CUSF-DH-2017079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Scientists and Technicians Troop Construction Projects of Henan Province; Program for Innovative Research Team in University of Henan Province; China Scholarship Council(China Scholarship Council); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the National Natural Science Foundation of China (11772291 and 11572278, 11572084 to QZ and ZW), Innovation Scientists and Technicians Troop Construction Projects of Henan Province (2017JR0013 to JS), the Program for Innovative Research Team in University of Henan Province (13IRTSTHN019), China Scholarship Council and the Fundamental Research Funds for the Central Universities (CUSF-DH-2017079 to QZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the National Natural Science Foundation of China(11772291 and 11572278,11572084), Innovation Scientists and Technicians Troop Construction Projects of Henan Province (2017JR0013), the Program for Innovative Research Team in University of Henan Province (13IRTSTHN019), China Scholarship Council and the Fundamental Research Funds for the Central Universities(CUSF-DH-2017079).	Avron JE, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/4/043009; BATHER JA, 1969, J R STAT SOC SER A-G, V132, P335, DOI 10.2307/2344117; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Cho J, 2015, NAT BIOTECHNOL, V33, P608, DOI 10.1038/nbt.3256; Chrobak JM, 2011, J BIOL SYST, V19, P521, DOI 10.1142/S0218339011004111; Coron J.-M., 2007, CONTROL NONLINEARITY; Cota AM, 2015, ANAESTH INTENSIV CA, V16, P353, DOI 10.1016/j.mpaic.2015.04.006; Dutt AK, 2012, AIP ADV, V2, DOI 10.1063/1.4765650; Fanelli D, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-30649-7; Gain J, 2015, COMPUT GRAPH FORUM, V34, P105, DOI 10.1111/cgf.12545; Ghorai S, 2016, CHAOS SOLITON FRACT, V85, P57, DOI 10.1016/j.chaos.2016.01.013; Giles H, 2012, ARXIV12103739; Grasso P., 2002, ESSENTIALS PATHOLOGY; Han Z.X, 2014, MODERN CONTROL THEOR; Hata S, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/64004; Jordehi AR, 2015, NEURAL COMPUT APPL, V26, P827, DOI 10.1007/s00521-014-1751-5; Karafyllis I, 1999, PHYS REV E, V59, P372, DOI 10.1103/PhysRevE.59.372; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kourtidis A, 2015, NAT CELL BIOL, V17, P1145, DOI 10.1038/ncb3227; Kuo RJ, 2014, APPL ARTIF INTELL, V28, P577, DOI 10.1080/08839514.2014.923167; Lee IH, 2000, B KOR CHEM SOC, V21, P1213; Li L, 2016, APPL MATH MODEL, V40, P4765, DOI 10.1016/j.apm.2015.12.003; Li L, 2015, APPL MATH COMPUT, V258, P342, DOI 10.1016/j.amc.2015.02.006; Liu H., 2010, SCI TECHNOLOGY ENG, V10, P1929; Liu K, 2015, IEEE T AUTOMAT CONTR, V60, P3071, DOI 10.1109/TAC.2015.2414812; Maidi A, 2015, CAN J CHEM ENG, V93, P427, DOI 10.1002/cjce.22030; Maini PK, 2012, INTERFACE FOCUS, V2, P487, DOI 10.1098/rsfs.2011.0113; McCoy DF, 1997, IEEE SYS MAN CYBERN, P867, DOI 10.1109/ICSMC.1997.626211; Morton R, 1974, J OPTIMIZ THEORY APP, V14, P151, DOI 10.1007/BF00932937; Murray J. D., 2002, MATH BIOL; Nakao H, 2008, ARXIV08071230V1NLINP; Nakao H, 2010, NAT PHYS, V6, P544, DOI 10.1038/NPHYS1651; OTHMER HG, 1971, J THEOR BIOL, V32, P507, DOI 10.1016/0022-5193(71)90154-8; Popescu M, 2011, COMMUN NONLINEAR SCI, V16, P2319, DOI 10.1016/j.cnsns.2010.04.054; Saldi N, 2016, J MATH ANAL APPL, V435, P321, DOI 10.1016/j.jmaa.2015.10.008; Shi JP, 2011, J APPL ANAL COMPUT, V1, P95; Skandari MHN, 2015, NONLINEAR DYNAM, V80, P1245, DOI 10.1007/s11071-015-1940-5; Soh S, 2010, ANGEW CHEM INT EDIT, V49, P4170, DOI 10.1002/anie.200905513; Sun GQ, 2017, NONLINEAR DYNAM, V88, P1385, DOI 10.1007/s11071-016-3317-9; Sun GQ, 2016, PHYS LIFE REV, V19, P43, DOI 10.1016/j.plrev.2016.08.002; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tolerance MP, 1994, ANNU REV IMMUNOL, V12, P991, DOI DOI 10.1146/ANNUREV.IY.12.040194.005015; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Udwadia FE, 2015, NONLINEAR DYNAM, V82, P547, DOI 10.1007/s11071-015-2175-1; Vanag VK, 2009, PHYS CHEM CHEM PHYS, V11, P897, DOI 10.1039/b813825g; Viney M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1104; Vladimir KV, 2008, CHAOS, V18; Wang JM, 2013, 2013 AM CONTR C WASH; Wood PJ, 2015, ANAESTH INTENSIV CA, V16, P349, DOI 10.1016/j.mpaic.2015.04.003; Zheng QQ, 2015, COMMUN NONLINEAR SCI, V27, P93, DOI 10.1016/j.cnsns.2015.02.023	51	6	6	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0190176	10.1371/journal.pone.0190176	http://dx.doi.org/10.1371/journal.pone.0190176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385145	gold, Green Submitted, Green Published			2022-12-26	WOS:000423668400015
J	Song, C; Tan, P; Zhang, Z; Wu, W; Dong, YH; Zhao, LM; Liu, HY; Guan, HF; Li, F				Song, Chao; Tan, Peng; Zhang, Zheng; Wu, Wei; Dong, Yonghui; Zhao, Liming; Liu, Huiyong; Guan, Hanfeng; Li, Feng			REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation	FASEB JOURNAL			English	Article						transcription factors; osteoclasts; osteoporosis	NUCLEAR-FACTOR; GENE-EXPRESSION; NADPH OXIDASE; RANK LIGAND; OSTEOPOROSIS; ALPHA; HOMEOSTASIS; MICE; DIFFERENTIATION; TRANSCRIPTION	REV-ERBs (REV-ERB alpha and REV-ERB beta) are transcription repressors and circadian regulators. Previous investigations have shown that REV-ERB s repress the expression of target genes, including MMP9 and CX3CR1, in macrophages. Because MMP9 and CX3CR1 reportedly participate in receptor activator of nuclear factor-kappa B ligand (RANKL)-induced osteoclastogenesis, we inferred that REV-ERBs might play a role in osteoclastogenesis. In the present study, we found that the REV-ERBa level decreased significantly during RANKL-induced osteoclast differentiation from primary bone marrow-derived macrophages (BMMs). REV-ERB alpha knockdown by small interfering RNA in BMMs resulted in the enhanced formation of osteoclasts, whereas REV-ERB beta knockdown showed no effect on osteoclast differentiation. Moreover, the REV-ERB agonist SR9009 inhibited osteoclast differentiation and bone resorption. Intraperitoneal SR9009 administration prevented ovariectomy-induced bone loss; this effect was accompanied by decreased serum RANKL and C-terminal telopeptide of type I collagen levels and increased osteoprotegerin levels. Further investigation revealed that NF-kappa B and MAPK activation and nuclear factor of activated T cells, cytoplasmic 1, and c-fos expression were suppressed by SR9009. The level of reactive oxygen species was also decreased by SR9009, with NADPH oxidase subunits also being down-regulated. In addition, an expression microarray showed that FABP4, an intracellular lipid-binding protein, was up-regulated by REV-ERB agonism. BMS309403, an inhibitor of FABP4, partially prevented the suppression of osteoclastogenesis by SR9009 through stabilizing phosphorylation of p65. To summarize, our results proved that the REV-ERB agonism inhibited osteoclastogenesis partially via FABP4 up-regulation.	[Song, Chao; Tan, Peng; Zhang, Zheng; Wu, Wei; Dong, Yonghui; Zhao, Liming; Liu, Huiyong; Guan, Hanfeng; Li, Feng] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Orthopaed Surg, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China; [Guan, Hanfeng; Li, Feng] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Biol Engn & Regenerat Med Ctr, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Guan, HF; Li, F (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Orthopaed Surg, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.	hguan@hust.edu.cn; lifengmd@hust.edu.cn	Tan, Peng/HGD-6812-2022	Li, Feng/0000-0002-7961-3728; Zhang, Zheng/0000-0002-3242-5738; CHAO, SONG/0000-0002-1209-1056	National Natural Science Foundation of China [81401762, 81101788, 81572857, 81271934, 81472133]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Dr. Yuting Wang (Huazhong University of Science and Technology) for preparation of the graphical abstract (Fig. 9D). This work was supported by the National Natural Science Foundation of China (81401762 to W.W., 81101788 and 81572857 to H.G., and 81271934 and 81472133 to F.L.). The authors declare no conflicts of interest.	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Balkan W, 2009, GENE, V446, P90, DOI 10.1016/j.gene.2009.06.013; Carrier Y, 2011, J INVEST DERMATOL, V131, P2428, DOI 10.1038/jid.2011.234; Chen Y, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0295; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Duarte Joao H, 2016, Nat Rev Rheumatol, V12, P69, DOI 10.1038/nrrheum.2015.177; Guan HF, 2015, FASEB J, V29, P1092, DOI 10.1096/fj.14-262055; Hawse JR, 2008, BONE, V42, P1025, DOI 10.1016/j.bone.2008.02.004; Hofbauer L. C., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P268; Hoo RLC, 2013, J HEPATOL, V58, P358, DOI 10.1016/j.jhep.2012.10.022; Hoshino A, 2013, J CELL SCI, V126, P1032, DOI 10.1242/jcs.113910; Joo JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22389; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Karsenty G, 2016, CELL, V164, P1248, DOI 10.1016/j.cell.2016.02.043; Kim JY, 2014, J BONE MINER RES, V29, P1541, DOI 10.1002/jbmr.2183; Kurinna S, 2016, J IMMUNOL, V196, P4663, DOI 10.4049/jimmunol.1501447; Kwak HB, 2005, BLOOD, V105, P2963, DOI 10.1182/blood-2004-07-2534; Lakkakorpi PT, 1996, MICROSC RES TECHNIQ, V33, P171, DOI 10.1002/(SICI)1097-0029(19960201)33:2<171::AID-JEMT7>3.0.CO;2-W; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Lee JH, 2012, CANCER RES, V72, P3175, DOI 10.1158/0008-5472.CAN-12-0481; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Medina-Contreras O, 2016, J IMMUNOL, V196, P34, DOI 10.4049/jimmunol.1501312; Mercer KE, 2014, ALCOHOL CLIN EXP RES, V38, P672, DOI 10.1111/acer.12305; Muxel SM, 2016, J PINEAL RES, V60, P394, DOI 10.1111/jpi.12321; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Roscher Anne, 2016, Bone Rep, V5, P214, DOI 10.1016/j.bonr.2016.07.002; Sato S., 2014, THESCIENTIFICWORLDJO, V2014, P685854, DOI [10.1155/2014/685854, DOI 10.1155/2014/685854]; Schroder K, 2015, CELL MOL LIFE SCI, V72, P25, DOI 10.1007/s00018-014-1712-2; Sengupta S, 2016, FREE RADICAL BIO MED, V93, P177, DOI 10.1016/j.freeradbiomed.2016.02.004; Sitaula S, 2015, BIOCHEM BIOPH RES CO, V460, P566, DOI 10.1016/j.bbrc.2015.03.070; Sundaram K, 2007, EXP CELL RES, V313, P168, DOI 10.1016/j.yexcr.2006.10.001; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takeya R, 2006, ANTIOXID REDOX SIGN, V8, P1523, DOI 10.1089/ars.2006.8.1523; Van Raemdonck K, 2015, CYTOKINE GROWTH F R, V26, P311, DOI 10.1016/j.cytogfr.2014.11.009; Wang L, 2015, CELL DEATH DIFFER, V22, P1654, DOI 10.1038/cdd.2015.14; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Xu HL, 2016, MOL ENDOCRINOL, V30, P325, DOI 10.1210/me.2015-1301; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Zhang CC, 2014, J CELL PHYSIOL, V229, P1330, DOI 10.1002/jcp.24553; Zhang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13575	42	25	27	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3215	3228		10.1096/fj.201600825RRR	http://dx.doi.org/10.1096/fj.201600825RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401617				2022-12-26	WOS:000432546000026
J	Takahashi, M; Takahashi, E; Joudeh, LI; Marini, M; Das, G; Elshenawy, MM; Akal, A; Sakashita, K; Alam, I; Tehseen, M; Sobhy, MA; Stingl, U; Merzaban, JS; Di Fabrizio, E; Hamdan, SM				Takahashi, Masateru; Takahashi, Etsuko; Joudeh, Luay I.; Marini, Monica; Das, Gobind; Elshenawy, Mohamed M.; Akal, Anastassja; Sakashita, Kosuke; Alam, Intikhab; Tehseen, Muhammad; Sobhy, Mohamed A.; Stingl, Ulrich; Merzaban, Jasmeen S.; Di Fabrizio, Enzo; Hamdan, Samir M.			Dynamic structure mediates halophilic adaptation of a DNA polymerase from the deep-sea brines of the Red Sea	FASEB JOURNAL			English	Article						DNA polymerase engineering; halophilic enzymes; thermophilic enzymes; structure dynamism; structural adaptation	CRYSTAL-STRUCTURE; REPLICATION TERMINATION; MALATE-DEHYDROGENASE; PROTEINS; SALTS; AMINOACYLATION; ENVIRONMENT; MECHANISMS; STABILITY; INSIGHTS	The deep-sea brines of the Red Sea are remote and unexplored environments characterized by high temperatures, anoxic water, and elevated concentrations of salt and heavy metals. This environment provides a rare system to study the interplay between halophilic and thermophilic adaptation in biologic macromolecules. The present article reports the first DNA polymerase with halophilic and thermophilic features. Biochemical and structural analysis by Raman and circular dichroism spectroscopy showed that the charge distribution on the protein's surface mediates the structural balance between stability for thermal adaptation and flexibility for counteracting the salt-induced rigid and nonfunctional hydrophobic packing. Salt bridge interactions via increased negative and positive charges contribute to structural stability. Salt tolerance, conversely, is mediated by a dynamic structure that becomes more fixed and functional with increasing salt concentration. We propose that repulsive forces among excess negative charges, in addition to a high percentage of negatively charged random coils, mediate this structural dynamism. This knowledge enabled us to engineer a halophilic version of Thermococcus kodakarensis DNA polymerase.	[Takahashi, Masateru; Takahashi, Etsuko; Joudeh, Luay I.; Elshenawy, Mohamed M.; Sakashita, Kosuke; Tehseen, Muhammad; Sobhy, Mohamed A.; Stingl, Ulrich; Merzaban, Jasmeen S.; Hamdan, Samir M.] King Abdullah Univ Sci & Technol, Biol & Environm Sci & Engn Div, Bldg 2-4221, Jeddah, Saudi Arabia; [Marini, Monica; Das, Gobind; Akal, Anastassja; Di Fabrizio, Enzo] King Abdullah Univ Sci & Technol, Phys Sci & Engn Div, Jeddah, Saudi Arabia; [Akal, Anastassja] King Abdullah Univ Sci & Technol, KAUST Catalysis Ctr, Jeddah, Saudi Arabia; [Alam, Intikhab] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Jeddah, Saudi Arabia; [Stingl, Ulrich] Univ Florida, Ft Lauderdale Res & Educ Ctr, Davie, FL USA	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; State University System of Florida; University of Florida	Hamdan, SM (corresponding author), King Abdullah Univ Sci & Technol, Biol & Environm Sci & Engn Div, Bldg 2-4221, Jeddah, Saudi Arabia.	samir.hamdan@kaust.edu.sa	Merzaban, Jasmeen/V-3147-2018; Das, Gobind/N-7405-2013; Joudeh, Luay/O-8929-2018; Elshenawy, Mohamed/AAA-6812-2020; Marini, Monica/AAX-1145-2020; Stingl, Uli/H-1191-2014	Merzaban, Jasmeen/0000-0002-7276-2907; Das, Gobind/0000-0003-0942-681X; Joudeh, Luay/0000-0001-9338-205X; Elshenawy, Mohamed/0000-0002-8599-8388; Gespers, Anastassja/0000-0002-7172-3199; Hamdan, Samir/0000-0001-5192-1852; Marini, Monica/0000-0001-8182-5239; Stingl, Uli/0000-0002-0684-2597; Tehseen, Muhammad/0000-0001-9834-2372; Alam, Intikhab/0000-0001-5306-847X	Saudi Economic and Development Company (SEDCO) Research Excellence Project; baseline funding from KAUST	Saudi Economic and Development Company (SEDCO) Research Excellence Project; baseline funding from KAUST	The authors thank the King Abdullah University of Science and Technology (KAUST) BioScience Core Laboratory for providing Pfu polymerase. This research was funded by the Saudi Economic and Development Company (SEDCO) Research Excellence Project and baseline funding from KAUST to S.M.H. The authors declare no conflicts of interest.	Alam I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082210; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Antunes A, 2011, ENV MICROBIOL REP, V3, P416, DOI 10.1111/j.1758-2229.2011.00264.x; Antunes A, 2011, J BACTERIOL, V193, P4553, DOI 10.1128/JB.05462-11; ARAKAWA T, 1984, BIOCHEMISTRY-US, V23, P5912, DOI 10.1021/bi00320a004; ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6545, DOI 10.1021/bi00268a034; BACKER H, 1972, NATURE-PHYS SCI, V240, P153, DOI 10.1038/physci240153a0; Bergen K, 2013, CHEMBIOCHEM, V14, P1058, DOI 10.1002/cbic.201300175; Bergqvist S, 2003, BIOCHEM SOC T, V31, P677, DOI 10.1042/bst0310677; Bredenberg JH, 2008, BIOPHYS J, V94, P4634, DOI 10.1529/biophysj.107.125609; Cacciapuoti G, 2012, BBA-PROTEINS PROTEOM, V1824, P1136, DOI 10.1016/j.bbapap.2012.06.014; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Costantini S, 2006, BIOCHEM BIOPH RES CO, V342, P441, DOI 10.1016/j.bbrc.2006.01.159; Das G, 2011, J MOL STRUCT, V993, P500, DOI 10.1016/j.molstruc.2010.12.044; Das G, 2009, BIOSENS BIOELECTRON, V24, P1693, DOI 10.1016/j.bios.2008.08.050; DYM O, 1995, SCIENCE, V267, P1344, DOI 10.1126/science.267.5202.1344; Elcock AH, 1998, J MOL BIOL, V280, P731, DOI 10.1006/jmbi.1998.1904; Elshenawy MM, 2015, NATURE, V525, P394, DOI 10.1038/nature14866; Evilia C, 2003, RNA, V9, P794, DOI 10.1261/rna.5320603; Evilia C, 2006, BIOCHEMISTRY-US, V45, P6835, DOI 10.1021/bi0521386; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; Frege Telma, 2015, Biochem Biophys Rep, V1, P33, DOI 10.1016/j.bbrep.2015.03.003; Frolow F, 1996, NAT STRUCT BIOL, V3, P452, DOI 10.1038/nsb0596-452; Fukuchi S, 2003, J MOL BIOL, V327, P347, DOI 10.1016/S0022-2836(03)00150-5; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Grotzinger SW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00134; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Hartmann M, 1998, MAR GEOL, V144, P311, DOI 10.1016/S0025-3227(97)00055-8; Hashimoto H, 2001, J MOL BIOL, V306, P469, DOI 10.1006/jmbi.2000.4403; HECHT K, 1989, EUR J BIOCHEM, V183, P69, DOI 10.1111/j.1432-1033.1989.tb14897.x; HUYGHUESDESPOINTES BMP, 1993, PROTEIN SCI, V2, P1604, DOI 10.1002/pro.5560021006; Jergic S, 2013, EMBO J, V32, P1322, DOI 10.1038/emboj.2012.347; Karan Ram, 2012, Aquat Biosyst, V8, P4, DOI 10.1186/2046-9063-8-4; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Karshikoff A, 2001, TRENDS BIOCHEM SCI, V26, P550, DOI 10.1016/S0968-0004(01)01918-1; Kastritis PL, 2007, INT J BIOL MACROMOL, V41, P447, DOI 10.1016/j.ijbiomac.2007.06.005; Kennedy SP, 2001, GENOME RES, V11, P1641, DOI 10.1101/gr.190201; Kim SW, 2008, INT J BIOL MACROMOL, V42, P356, DOI 10.1016/j.ijbiomac.2008.01.010; LANYI JK, 1974, BACTERIOL REV, V38, P272, DOI 10.1128/MMBR.38.3.272-290.1974; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Li-Chan E., 1994, RAMAN SPECTROSCOPY P; Lieutaud P, 2016, METHODS MOL BIOL, V1415, P265, DOI 10.1007/978-1-4939-3572-7_14; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Madern D, 2004, EXTREMOPHILES, V8, P377, DOI 10.1007/s00792-004-0398-z; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; Mevarech M, 2000, BIOPHYS CHEM, V86, P155, DOI 10.1016/S0301-4622(00)00126-5; MORIKAWA M, 1994, APPL ENVIRON MICROB, V60, P4559, DOI 10.1128/AEM.60.12.4559-4566.1994; Nayek A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093862; Pandey M, 2015, NUCLEIC ACIDS RES, V43, P5924, DOI 10.1093/nar/gkv527; Reed CJ, 2013, ARCHAEA, V2013, DOI 10.1155/2013/373275; Ruckenstein E, 2006, ADV COLLOID INTERFAC, V123, P97, DOI 10.1016/j.cis.2006.05.018; Santos H, 2002, ENVIRON MICROBIOL, V4, P501, DOI 10.1046/j.1462-2920.2002.00335.x; SIAMWIZA MN, 1975, BIOCHEMISTRY-US, V14, P4870, DOI 10.1021/bi00693a014; Sinha R, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00165; TABOR S, 1989, P NATL ACAD SCI USA, V86, P4076, DOI 10.1073/pnas.86.11.4076; Tadeo X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000257; Taupin CMJ, 1997, EUR J BIOCHEM, V243, P141, DOI 10.1111/j.1432-1033.1997.0141a.x; Terpe K, 2013, APPL MICROBIOL BIOT, V97, P10243, DOI 10.1007/s00253-013-5290-2; TUMA R, 1995, BIOCHEMISTRY-US, V34, P15150, DOI 10.1021/bi00046a022; van Oijen AM, 2003, SCIENCE, V301, P1235, DOI 10.1126/science.1084387; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; WU FYH, 1987, ANNU REV NUTR, V7, P251, DOI 10.1146/annurev.nu.07.070187.001343; Xue B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S1; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	66	12	12	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3346	3360		10.1096/fj.201700862RR	http://dx.doi.org/10.1096/fj.201700862RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401622	Green Published			2022-12-26	WOS:000432546000036
J	Nikonova, AS; Deneka, AY; Kiseleva, AA; Korobeynikov, V; Gaponova, A; Serebriiskii, IG; Kopp, MC; Hensley, HH; Seeger-Nukpezah, TN; Somlo, S; Proia, DA; Golemis, EA				Nikonova, Anna S.; Deneka, Alexander Y.; Kiseleva, Anna A.; Korobeynikov, Vladislav; Gaponova, Anna; Serebriiskii, Ilya G.; Kopp, Meghan C.; Hensley, Harvey H.; Seeger-Nukpezah, Tamina N.; Somlo, Stefan; Proia, David A.; Golemis, Erica A.			Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD)	FASEB JOURNAL			English	Article						PKD1; heat shock protein 90; polycystins; renal cyst; cilia	CYST GROWTH; RENAL CYSTOGENESIS; PROTEIN-KINASE; MOUSE MODEL; CELL-CYCLE; AURORA-A; CILIOGENESIS; INHIBITION; ACTIVATION; CANCER	Autosomal-dominant polycystic kidney disease (ADPKD) is associated with progressive formation of renal cysts, kidney enlargement, hypertension, and typically end-stage renal disease. In ADPKD, inherited mutations disrupt function of the polycystins (encoded by PKD1 and PKD2), thus causing loss of a cyst-repressive signal emanating from the renal cilium. Genetic studies have suggested ciliary maintenance is essential for ADPKD pathogenesis. Heat shock protein 90 (HSP90) clients include multiple proteins linked to ciliary maintenance. We determined that ganetespib, a clinical HSP90 inhibitor, inhibited proteasomal repression of NEK8 and the Aurora-A activator trichoplein, rapidly activating Aurora-A kinase and causing ciliary loss in vitro. Using conditional mouse models for ADPKD, we performed long-term (10 or 50 wk) dosing experiments that demonstrated HSP90 inhibition caused durable in vivo loss of cilia, controlled cystic growth, and ameliorated symptoms induced by loss of Pkd1 or Pkd2. Ganetespib efficacy was not increased by combination with 2-deoxy-n-glucose, a glycolysis inhibitor showing some promise for ADPKD. These studies identify a new biologic activity for HSP90 and support a cilia-based mechanism for cyst repression.	[Nikonova, Anna S.; Deneka, Alexander Y.; Kiseleva, Anna A.; Korobeynikov, Vladislav; Gaponova, Anna; Serebriiskii, Ilya G.; Kopp, Meghan C.; Hensley, Harvey H.; Seeger-Nukpezah, Tamina N.; Golemis, Erica A.] Fox Chase Canc Ctr, Inst Canc Res, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Deneka, Alexander Y.; Kiseleva, Anna A.; Serebriiskii, Ilya G.] Kazan Fed Univ, Kazan, Russia; [Korobeynikov, Vladislav] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Gaponova, Anna] Moscow Inst Phys & Technol, Lab Genome Engn, Dolgoprudnyi, Russia; [Gaponova, Anna] Immanuel Kant Balt Fed Univ, Konigsberg, Russia; [Kopp, Meghan C.] Drexel Univ, Coll Med, Canc Biol, Philadelphia, PA 19104 USA; [Seeger-Nukpezah, Tamina N.] Univ Cologne, Dept Internal Med 1, Cologne, Germany; [Seeger-Nukpezah, Tamina N.] Univ Cologne, Ctr Integrated Oncol, Cologne, Germany; [Somlo, Stefan] Yale Sch Med, Dept Internal Med, New Haven, CT USA; [Somlo, Stefan] Yale Sch Med, Dept Genet, New Haven, CT USA; [Proia, David A.] Synta Pharmaceut Corp, Lexington, MA USA	Fox Chase Cancer Center; Kazan Federal University; Columbia University; Moscow Institute of Physics & Technology; Immanuel Kant Baltic Federal University; Drexel University; University of Cologne; University of Cologne; Yale University; Yale University	Golemis, EA (corresponding author), Fox Chase Canc Ctr, W406,333 Cottman Ave, Philadelphia, PA 19111 USA.	erica.golemis@fccc.edu	Kiseleva, Anna/C-3046-2019; Deneka, Alexander/AAE-9202-2020; Kiseleva, Anna/AAE-9747-2020; Korobeynikov, Vlad/H-9541-2019	Kiseleva, Anna/0000-0002-8720-5062; Korobeynikov, Vlad/0000-0002-9127-292X; Golemis, Erica/0000-0003-3618-3673	NIH [NIDDK R01 DK108195]; DOD PRMRP [W81XWH-12-1-0437/PR110518]; PKD Foundation; Russian Government Program for Competitive Growth of Kazan Federal University; NIH National Cancer Institute Core Grant [CA006927]; NATIONAL CANCER INSTITUTE [T32CA009035, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK108195, P30DK079310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD PRMRP; PKD Foundation; Russian Government Program for Competitive Growth of Kazan Federal University; NIH National Cancer Institute Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors express sincere gratitude to J. Calvet (University of Kansas Cancer Center, Kansas City, KS, USA) and J. Grantham (Kansas University Medical Center, Kansas City, KS, USA) for helpful conversations and encouragement. The authors thank G. Germino [National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)] for providing the Pkd1 mutant mouse strains, S. Tarpinian and A. Lerro (Fox Chase Laboratory Animal Facility, Institute for Cancer Research, Fox Chase Cancer Center) for help with mice, and B. Egleston (Fox Chase Cancer Center Biostatistics Facility) for consultation on analysis. This work was supported by NIH, NIDDK R01 DK108195, by DOD PRMRP W81XWH-12-1-0437/PR110518, and by an award from the PKD Foundation (to E.A.G.); the Russian Government Program for Competitive Growth of Kazan Federal University (to A.Y.D. and A.A.K.); and by NIH National Cancer Institute Core Grant CA006927 (to Fox Chase Cancer Center). The authors declare no conflicts of interest.	Chang MY, 2012, NEPHRON CLIN PRACT, V120, pC25, DOI 10.1159/000334166; Chapman AB, 2010, CLIN J AM SOC NEPHRO, V5, P102, DOI 10.2215/CJN.04310709; Chiaravalli M, 2016, J AM SOC NEPHROL, V27, P1958, DOI 10.1681/ASN.2015030231; Cizmecioglu O, 2012, J CELL SCI, V125, P981, DOI 10.1242/jcs.095075; Ding XF, 2015, J BIOL CHEM, V290, P1389, DOI 10.1074/jbc.M114.589226; Echeverria PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044; Erickson KF, 2013, ANN INTERN MED, V159, P382, DOI 10.7326/0003-4819-159-6-201309170-00004; Grantham JJ, 2016, NAT REV NEPHROL, V12, P667, DOI 10.1038/nrneph.2016.135; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Inoko A, 2012, J CELL BIOL, V197, P391, DOI 10.1083/jcb.201106101; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jhaveri K, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S65804; Kasahara K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6081; Kim JH, 2016, BBA-MOL CELL RES, V1863, P1307, DOI 10.1016/j.bbamcr.2016.03.021; Kim S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9087; Lee JE, 2011, GENOME MED, V3, DOI 10.1186/gm275; Lee YR, 2006, NEPHRON CLIN PRACT, V103, pC173, DOI 10.1159/000092915; Lilja A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114975; Ma M, 2013, NAT GENET, V45, P1004, DOI 10.1038/ng.2715; Majumder S, 2013, CELL CYCLE, V12, P849, DOI 10.4161/cc.23824; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Nikonova AS, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00228; Nikonova AS, 2014, P NATL ACAD SCI USA, V111, P12859, DOI 10.1073/pnas.1405362111; Nikonova AS, 2013, CELL MOL LIFE SCI, V70, P661, DOI 10.1007/s00018-012-1073-7; Outeda P, 2014, CELL REP, V7, P634, DOI 10.1016/j.celrep.2014.03.064; Pan JM, 2013, CELL MOL LIFE SCI, V70, P1849, DOI 10.1007/s00018-012-1052-z; Perrone RD, 2015, NAT REV NEPHROL, V11, P589, DOI 10.1038/nrneph.2015.128; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Plotnikova OV, 2012, MOL BIOL CELL, V23, P2658, DOI 10.1091/mbc.E11-12-1056; Plotnikova OV, 2011, J CELL BIOL, V193, P1021, DOI 10.1083/jcb.201012061; Plotnikova OV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1061; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Rasband W., 2006, IMAGEJ; Reichardt W, 2009, MAGN RESON MATER PHY, V22, P143, DOI 10.1007/s10334-008-0158-7; Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092; Schrier RW, 2014, NEW ENGL J MED, V371, P2255, DOI 10.1056/NEJMoa1402685; Seeger-Nukpezah T, 2015, NAT REV NEPHROL, V11, P515, DOI 10.1038/nrneph.2015.46; Seeger-Nukpezah T, 2013, P NATL ACAD SCI USA, V110, P12786, DOI 10.1073/pnas.1301904110; Seeger-Nukpezah T, 2012, CURR OPIN CELL BIOL, V24, P652, DOI 10.1016/j.ceb.2012.06.002; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Shaheen R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1099-5; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Shults J, 2007, STATA J, V7, P147, DOI 10.1177/1536867X0700700201; Smithline ZB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114403; Socinski MA, 2013, CLIN CANCER RES, V19, P3068, DOI 10.1158/1078-0432.CCR-12-3381; Spirli C, 2010, HEPATOLOGY, V51, P1778, DOI 10.1002/hep.23511; Spirli C, 2010, GASTROENTEROLOGY, V138, P360, DOI 10.1053/j.gastro.2009.09.005; Sweeney WE, 2008, J AM SOC NEPHROL, V19, P1331, DOI 10.1681/ASN.2007060665; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Takiar V, 2011, P NATL ACAD SCI USA, V108, P2462, DOI 10.1073/pnas.1011498108; Torres VE, 2003, KIDNEY INT, V64, P1573, DOI 10.1046/j.1523-1755.2003.00256.x; Torres VE, 2014, NEW ENGL J MED, V371, P2267, DOI 10.1056/NEJMoa1402686; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; van Dam Teunis Jp, 2013, Cilia, V2, P7, DOI 10.1186/2046-2530-2-7; WATSON ML, 1992, KIDNEY INT, V41, P206, DOI 10.1038/ki.1992.28; Wheway G, 2015, NAT CELL BIOL, V17, P1074, DOI 10.1038/ncb3201; Wu ZX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016675; Wuthrich RP, 2014, EXPERT OPIN PHARMACO, V15, P1085, DOI 10.1517/14656566.2014.903923; Zalli D, 2012, HUM MOL GENET, V21, P1155, DOI 10.1093/hmg/ddr544	61	23	23	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2735	2746		10.1096/fj.201700909R	http://dx.doi.org/10.1096/fj.201700909R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401581	Green Published			2022-12-26	WOS:000432528000033
J	Ladanyi, A; Mukherjee, A; Kenny, HA; Johnson, A; Mitra, AK; Sundaresan, S; Nieman, KM; Pascual, G; Benitah, SA; Montag, A; Yamada, SD; Abumrad, NA; Lengyel, E				Ladanyi, Andras; Mukherjee, Abir; Kenny, Hilary A.; Johnson, Alyssa; Mitra, Anirban K.; Sundaresan, Sinju; Nieman, Kristin M.; Pascual, Gloria; Aznar Benitah, Salvador; Montag, Anthony; Yamada, S. Diane; Abumrad, Nada A.; Lengyel, Ernst			Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis	ONCOGENE			English	Article							FATTY-ACID UPTAKE; MONOCYTE-DERIVED MACROPHAGES; B SCAVENGER RECEPTOR; MESOTHELIAL CELLS; TRANSPORT; MEMBRANE; ACTIVATION; OXIDATION; PROTEINS; ADHESION	Ovarian cancer (OvCa) is characterized by widespread and rapid metastasis in the peritoneal cavity. Visceral adipocytes promote this process by providing fatty acids (FAs) for tumour growth. However, the exact mechanism of FA transfer from adipocytes to cancer cells remains unknown. This study shows that OvCa cells co-cultured with primary human omental adipocytes express high levels of the FA receptor, CD36, in the plasma membrane, thereby facilitating exogenous FA uptake. Depriving OvCa cells of adipocyte-derived FAs using CD36 inhibitors and short hairpin RNA knockdown prevented development of the adipocyte-induced malignant phenotype. Specifically, inhibition of CD36 attenuated adipocyte-induced cholesterol and lipid droplet accumulation and reduced intracellular reactive oxygen species (ROS) content. Metabolic analysis suggested that CD36 plays an essential role in the bioenergetic adaptation of OvCa cells in the adipocyte-rich microenvironment and governs their metabolic plasticity. Furthermore, the absence of CD36 affected cellular processes that play a causal role in peritoneal dissemination, including adhesion, invasion, migration and anchorage independent growth. Intraperitoneal injection of CD36-deficient cells or treatment with an anti-CD36 monoclonal antibody reduced tumour burden in mouse xenografts. Moreover, a matched cohort of primary and metastatic human ovarian tumours showed upregulation of CD36 in the metastatic tissues, a finding confirmed in three public gene expression data sets. These results suggest that omental adipocytes reprogram tumour metabolism through the upregulation of CD36 in OvCa cells. Targeting the stromal-tumour metabolic interface via CD36 inhibition may prove to be an effective treatment strategy against OvCa metastasis.	[Ladanyi, Andras; Mukherjee, Abir; Kenny, Hilary A.; Johnson, Alyssa; Mitra, Anirban K.; Nieman, Kristin M.; Yamada, S. Diane; Lengyel, Ernst] Univ Chicago, Dept Obstet, Gynecol Oncol Sect, Chicago, IL 60637 USA; [Ladanyi, Andras; Mukherjee, Abir; Kenny, Hilary A.; Johnson, Alyssa; Mitra, Anirban K.; Nieman, Kristin M.; Yamada, S. Diane; Lengyel, Ernst] Univ Chicago, Dept Gynecol, Gynecol Oncol Sect, Chicago, IL 60637 USA; [Ladanyi, Andras] Univ Illinois, Dept Obstet, Gynecol Oncol Sect, Chicago, IL USA; [Ladanyi, Andras] Univ Illinois, Dept Gynecol, Gynecol Oncol Sect, Chicago, IL USA; [Sundaresan, Sinju; Abumrad, Nada A.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Sundaresan, Sinju; Abumrad, Nada A.] Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA; [Pascual, Gloria; Aznar Benitah, Salvador] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Aznar Benitah, Salvador] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain; [Montag, Anthony] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Washington University (WUSTL); Washington University (WUSTL); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA; University of Chicago	Lengyel, E (corresponding author), Univ Chicago, Dept Obstet, Gynecol Oncol Sect, Chicago, IL 60637 USA.; Lengyel, E (corresponding author), Univ Chicago, Dept Gynecol, Gynecol Oncol Sect, Chicago, IL 60637 USA.	elengyel@uchicago.edu	Aznar-Benitah, Salvador/F-4761-2016; Angulo, Gloria Pascual/AAA-7668-2019; Lengyel, Ernst/D-9220-2014	Aznar-Benitah, Salvador/0000-0002-9059-5049; Angulo, Gloria Pascual/0000-0003-3810-6647; Lengyel, Ernst/0000-0001-8624-1507; Nieman, Kristin/0000-0001-7529-0872	Bears Care, the charitable beneficiary of the Chicago Bears Football Club; National Cancer Institute [DK033301]; Foundation for Women's Cancer, Amgen Ovarian Cancer Research Grant;  [CA 169604]; NATIONAL CANCER INSTITUTE [R01CA169604, R01CA211916, R01CA111882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033301, R01DK060022, R01DK111175, P30DK056341] Funding Source: NIH RePORTER	Bears Care, the charitable beneficiary of the Chicago Bears Football Club; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Foundation for Women's Cancer, Amgen Ovarian Cancer Research Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from Bears Care, the charitable beneficiary of the Chicago Bears Football Club (SD Yamada and E Lengyel) by National Cancer Institute grant DK033301 (NA Abumrad) and by CA 169604 (E Lengyel) and the Foundation for Women's Cancer, Amgen Ovarian Cancer Research Grant (A Ladanyi). We thank Chunling Zhang and the Center for Research Informatics at the University of Chicago for their bioinformatics support on the microarray data. We are grateful to Gail Isenberg for editing this manuscript.	Abumrad N A, 2000, Curr Opin Clin Nutr Metab Care, V3, P255, DOI 10.1097/00075197-200007000-00003; Accioly MT, 2008, CANCER RES, V68, P1732, DOI 10.1158/0008-5472.CAN-07-1999; Adib TR, 2004, BRIT J CANCER, V90, P686, DOI 10.1038/sj.bjc.6601603; Agrawal S, 2007, CIRCULATION, V115, P2939, DOI 10.1161/CIRCULATIONAHA.107.696922; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; ASCH AS, 1987, J CLIN INVEST, V79, P1054, DOI 10.1172/JCI112918; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; Bastie CC, 2005, J BIOL CHEM, V280, P14222, DOI 10.1074/jbc.M413625200; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Cheng JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21808; Cho S, 2005, J NEUROSCI, V25, P2504, DOI 10.1523/JNEUROSCI.0035-05.2005; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Coscia F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12645; de Gonzalo-Calvo D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1469-5; Dobrzyn P, 2008, AM J PHYSIOL-ENDOC M, V294, pE357, DOI 10.1152/ajpendo.00471.2007; Eckert MA, 2016, CANCER DISCOV, V6, P1342, DOI 10.1158/2159-8290.CD-16-0607; Ehehalt R, 2006, MOL CELL BIOCHEM, V284, P135, DOI 10.1007/s11010-005-9034-1; Guillaumond F, 2015, P NATL ACAD SCI USA, V112, P2473, DOI 10.1073/pnas.1421601112; HARMON CM, 1993, J MEMBRANE BIOL, V133, P43; Janabi M, 2001, BIOCHEM BIOPH RES CO, V283, P26, DOI 10.1006/bbrc.2001.4718; Janabi M, 2000, ARTERIOSCL THROM VAS, V20, P1953, DOI 10.1161/01.ATV.20.8.1953; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Kazantzis M, 2012, BBA-MOL CELL BIOL L, V1821, P852, DOI 10.1016/j.bbalip.2011.09.010; Kenny HA, 2007, INT J CANCER, V121, P1463, DOI 10.1002/ijc.22874; Kenny HA, 2014, J CLIN INVEST, V124, P4614, DOI 10.1172/JCI74778; Kenny HA, 2011, CLIN CANCER RES, V17, P459, DOI 10.1158/1078-0432.CCR-10-2258; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lee SH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7364; Li W, 2010, J CLIN INVEST, V120, P3996, DOI 10.1172/JCI42823; Liu YY, 2015, CANCER RES, V75, P5046, DOI 10.1158/0008-5472.CAN-15-0706; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Mwaikambo BR, 2009, J BIOL CHEM, V284, P26695, DOI 10.1074/jbc.M109.033480; Nath A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14752; Naville D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030686; Nergiz-Unal R., 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P42, DOI 10.2174/187152511794182855; Nieman KM, 2013, BBA-MOL CELL BIOL L, V1831, P1533, DOI 10.1016/j.bbalip.2013.02.010; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Parrales A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122074; Pascual G, 2017, NATURE, V541, P41, DOI 10.1038/nature20791; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pepino MY, 2014, ANNU REV NUTR, V34, P281, DOI 10.1146/annurev-nutr-071812-161220; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RANDLE PJ, 1963, LANCET, V1, P785; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rodrigue-Way A, 2014, FASEB J, V28, P1910, DOI 10.1096/fj.13-240168; Romero IL, 2015, CLIN CANCER RES, V21, P680, DOI 10.1158/1078-0432.CCR-14-2198; Samovski D, 2015, DIABETES, V64, P353, DOI 10.2337/db14-0582; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Sehouli J, 2009, J SURG ONCOL, V99, P424, DOI 10.1002/jso.21288; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Tan DSP, 2006, LANCET ONCOL, V7, P925, DOI 10.1016/S1470-2045(06)70939-1; TANDON NN, 1989, J BIOL CHEM, V264, P7570; Thompson BR, 2010, MOL CELL ENDOCRINOL, V318, P24, DOI 10.1016/j.mce.2009.08.015; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Witz CA, 2001, J SOC GYNECOL INVEST, V8, P299, DOI 10.1016/S1071-5576(01)00122-8	58	215	224	7	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	17					2285	2301		10.1038/s41388-017-0093-z	http://dx.doi.org/10.1038/s41388-017-0093-z			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GE3FW	29398710	Green Accepted			2022-12-26	WOS:000431100200006
J	Crickard, JB; Kaniecki, K; Kwon, Y; Sung, P; Greene, EC				Crickard, J. Brooks; Kaniecki, Kyle; Kwon, YoungHo; Sung, Patrick; Greene, Eric C.			Spontaneous self-segregation of Rad51 and Dmc1 DNA recombinases within mixed recombinase filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; MEIOTIC RECOMBINATION; STRAND EXCHANGE; RECA PROTEIN; DYNAMICS; ATTRIBUTES; COMPLEXES; CURTAINS; MEIOSIS; BINDING	During meiosis, the two DNA recombinases Rad51 and Dmc1 form specialized presynaptic filaments that are adapted for performing recombination between homologous chromosomes. There is currently a limited understanding of how these two recombinases are organized within the meiotic presynaptic filament. Here, we used single molecule imaging to examine the properties of presynaptic complexes composed of both Rad51 and Dmc1. We demonstrate that Rad51 and Dmc1 have an intrinsic ability to self-segregate, even in the absence of any other recombination accessory proteins. Moreover, we found that the presence of Dmc1 stabilizes the adjacent Rad51 filaments, suggesting that cross-talk between these two recombinases may affect their biochemical properties. Based upon these findings, we describe a model for the organization of Rad51 and Dmc1 within the meiotic presynaptic complex, which is also consistent with in vivo observations, genetic findings, and biochemical expectations. This model argues against the existence of extensively intermixed filaments, and we propose that Rad51 and Dmc1 have intrinsic capacities to form spatially distinct filaments, suggesting that additional recombination cofactors are not required to segregate the Rad51 and Dmc1 filaments.	[Crickard, J. Brooks; Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Kaniecki, Kyle] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Kwon, YoungHo; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Columbia University; Columbia University; Yale University	Greene, EC (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	ecg2108@cumc.columbia.edu			National Institutes of Health [R35 GM118026, R01ES007061, RO1ES015632]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015632, R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by National Institutes of Health Grants R35 GM118026 (to E.C.G.) and R01ES007061 and RO1ES015632 (to P.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; Bell JC, 2012, NATURE, V491, P274, DOI 10.1038/nature11598; Bianco P R, 1998, Front Biosci, V3, pD570; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Brown MS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005653; Brown MS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016659; Busygina V, 2008, GENE DEV, V22, P786, DOI 10.1101/gad.1638708; Busygina V, 2013, DNA REPAIR, V12, P707, DOI 10.1016/j.dnarep.2013.05.004; Busygina V, 2012, J BIOL CHEM, V287, P1566, DOI 10.1074/jbc.M111.297309; Callender TL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006226; Candelli A, 2014, P NATL ACAD SCI USA, V111, P15090, DOI 10.1073/pnas.1307824111; CAZENAVE C, 1983, EMBO J, V2, P2247, DOI 10.1002/j.1460-2075.1983.tb01730.x; Cloud V, 2012, SCIENCE, V337, P1222, DOI 10.1126/science.1219379; Crickard JB, 2018, EMBO J, V37, DOI 10.15252/embj.201798728; De Tullio L., 2018, METHODS ENZ IN PRESS; De Tullio L, 2017, CELL REP, V21, P570, DOI 10.1016/j.celrep.2017.09.073; Dresser ME, 1997, GENETICS, V147, P533; Ferrari SR, 2009, J BIOL CHEM, V284, P11766, DOI 10.1074/jbc.C900023200; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Gibb B, 2014, NAT STRUCT MOL BIOL, V21, P893, DOI 10.1038/nsmb.2886; Gibb B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087922; Greene EC, 2010, METHOD ENZYMOL, V472, P293, DOI 10.1016/S0076-6879(10)72006-1; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kaniecki K, 2017, CELL REP, V21, P3166, DOI 10.1016/j.celrep.2017.11.047; Keeney S, 2014, ANNU REV GENET, V48, P187, DOI 10.1146/annurev-genet-120213-092304; Kowalczykowski SC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016410; Kurzbauer MT, 2012, PLANT CELL, V24, P2058, DOI 10.1105/tpc.112.098459; Lee JY, 2015, SCIENCE, V349, P977, DOI 10.1126/science.aab2666; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Liu Yang, 2014, ScientificWorldJournal, V2014, P476219, DOI 10.1155/2014/476219; Ma CJ, 2017, METHOD ENZYMOL, V582, P193, DOI 10.1016/bs.mie.2016.08.005; Ma CJ, 2017, J BIOL CHEM, V292, P11702, DOI 10.1074/jbc.M117.794545; Ma CJ, 2017, NUCLEIC ACIDS RES, V45, P749, DOI 10.1093/nar/gkw1125; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; PUGH BF, 1987, J BIOL CHEM, V262, P1326; Qi Z, 2015, CELL, V160, P856, DOI 10.1016/j.cell.2015.01.029; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sehorn MG, 2004, NATURE, V429, P433, DOI 10.1038/nature02563; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; STORY RM, 1993, SCIENCE, V259, P1892, DOI 10.1126/science.8456313; Sung P, 1996, J BIOL CHEM, V271, P27983, DOI 10.1074/jbc.271.45.27983; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Taylor MRG, 2016, MOL CELL, V64, P926, DOI 10.1016/j.molcel.2016.10.020; Tsubouchi H, 2006, GENE DEV, V20, P1766, DOI 10.1101/gad.1422506; van der Heijden T, 2007, NUCLEIC ACIDS RES, V35, P5646, DOI 10.1093/nar/gkm629; van Mameren J, 2009, NATURE, V457, P745, DOI 10.1038/nature07581; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D., 2015, COLD SPRING HARB PER, V7, DOI DOI 10.1101/CSHPERSPECT.A016626	56	16	17	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4191	4200		10.1074/jbc.RA117.001143	http://dx.doi.org/10.1074/jbc.RA117.001143			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29382724	Green Published, hybrid			2022-12-26	WOS:000427587500029
J	Forson, AO; Arthur, I; Ayeh-Kumi, PF				Forson, Akua Obeng; Arthur, Isaac; Ayeh-Kumi, Patrick F.			The role of family size, employment and education of parents in the prevalence of intestinal parasitic infections in school children in Accra	PLOS ONE			English	Article							RISK-FACTORS; KNOWLEDGE	Introduction Intestinal parasitic infections (IPIs) in school children are a public health problem in most developing countries. Methods and principal findings A cross sectional survey was conducted from May to July 2016 with school children living in overcrowded urban slums in Accra, Ghana. A simple random sample of 300 children aged 2-9 years was collected. The study used structured pre-tested questionnaire and stool tests to obtain information on epidemiological, sanitation habits, employment and education status of parents and children. Data were analysed using appropriate descriptive, univariate and multivariable logistic tools of analyses. The mean age of participants was 6.9 years and 49% were males and 51.3% were females. Giardia lamblia was found in males (10.95%) and females (7.79%). Very low prevalences for Schistosoma mansoni, Ascaris lumbricoides, Taenia species, and Entamoeba coli were detected. Whilst children from mothers (62.2%) and fathers (55.6%) with no education were often infected, a few children from fathers (22.2%) and mothers (6.7%) with no jobs were infected. Most of the infected children's (93.7%) parents did not have any knowledge of IPIs. The educational and employment status of the mothers [p = 1.0 and p = 0.422] was not significant, however, the family size was a predisposing factor (p = 0.031) for parasitic infections. Conclusions Intestinal parasites were prevalent in children from overcrowded families and with no knowledge of IPIs. Educative programmes on IPIs, improving hygiene, and application of supportive programmes to elevate socioeconomic conditions may help reduce the burden of intestinal parasite carriage in children.	[Forson, Akua Obeng; Arthur, Isaac; Ayeh-Kumi, Patrick F.] Univ Ghana, Dept Med Lab Sci, Sch Biomed & Allied Hlth Sci, Coll Hlth Sci, Legon, Accra, Ghana; [Ayeh-Kumi, Patrick F.] Univ Ghana, Dept Med Microbiol, Sch Biomed & Allied Hlth Sci, Coll Hlth Sci, Legon, Accra, Ghana	University of Ghana; University of Ghana	Forson, AO (corresponding author), Univ Ghana, Dept Med Lab Sci, Sch Biomed & Allied Hlth Sci, Coll Hlth Sci, Legon, Accra, Ghana.	obeng.akua@yahoo.com		Forson, akua obeng/0000-0002-6398-3118; Ayeh-Kumi, Patrick Ferdinand/0000-0001-8764-4463	University of Ghana- Building a New Generation of Academics in Africa (BANGA-Africa) Project; Carnegie Corporation of New York at a Writing workshop; Carnegie Corporation of New York	University of Ghana- Building a New Generation of Academics in Africa (BANGA-Africa) Project; Carnegie Corporation of New York at a Writing workshop; Carnegie Corporation of New York	No specific grant from any funding agency in the public, commercial, or not for-profit sectors was received for the project work. However, the writing of this research paper was supported by the University of Ghana- Building a New Generation of Academics in Africa (BANGA-Africa) Project with funding from the Carnegie Corporation of New York at a Writing workshop.; The authors would like to express their gratitude to all staff of Ghana Education Service, the various communities, teachers, parents and pupils for their cooperation and support during the various aspects of the study. The research paper was also supported by the University of Ghana- Building a New Generation of Academics in Africa (BANGA-Africa) Project with funding from the Carnegie Corporation of New York.	Abossie A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-166; Ahmed A, 2010, ASIAN PAC J TROP MED, P92; Ahmed Akbar K, 2003, J Ayub Med Coll Abbottabad, V15, P28; Alamir M., 2013, Health, V5, P1697, DOI 10.4236/health.2013.510228; Amuta EU, 2010, ASIAN PAC J TROP MED, V3, P993, DOI 10.1016/S1995-7645(11)60016-3; Anim-Baidoo I, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.217.8012; [Anonymous], [No title captured]; Ayalew A., 2011, J PARASITOL VECTOR B, V3, P75; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brannan M, 2012, VOLUNTEER PARTNERSHI; Brooker S, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-42; CDC, 2006, LAB ID PAR PUBL HTLH; Cheesbrough M, 2005, DISTRICT LAB PRACTIC; Contreras CF, 1993, ASIAN PARASITE CONTR, VV, P335; Curtale F, 1998, HEALTH POLICY PLANN, V13, P423, DOI 10.1093/heapol/13.4.423; Erismann S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1835-4; Gelaw A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-304; Ghana Statistical Service, 2010, DISTR AN REP; Hailegebriel T, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2466-x; Maia MMM, 2009, ANN TROP MED PARASIT, V103, P583, DOI 10.1179/000349809X12459740922417; Mehraj V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003680; Mineno T, 2003, CURR PHARM DESIGN, V9, P841, DOI 10.2174/1381612033455260; Modern Ghana, 2002, UNTOLD STORY SODOM G; Nematian J, 2004, ACTA TROP, V92, P179, DOI 10.1016/j.actatropica.2004.06.010; Osman M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004496; Payapvipapong P., 1993, ASIAN PARASITE CONTR, VV, P318; Quihui L, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-225; Raso G, 2004, INT J EPIDEMIOL, V33, P1092, DOI 10.1093/ije/dyh241; Reither K, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-104; Shakya B, 2012, J Nepal Health Res Counc, V10, P20; Wamani H., 2004, INT, V3, P9, DOI [10.1186/1475-9276-3-9, DOI 10.1186/1475-9276-3-9]; Wordemann M, 2006, TROP MED INT HEALTH, V11, P1813, DOI 10.1111/j.1365-3156.2006.01745.x	32	21	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192303	10.1371/journal.pone.0192303	http://dx.doi.org/10.1371/journal.pone.0192303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415040	gold, Green Submitted, Green Published			2022-12-26	WOS:000424325300070
J	Coulibaly, A; Haas, A; Steinmann, S; Jakobs, A; Schmidt, TJ; Klempnauer, KH				Coulibaly, Anna; Haas, Astrid; Steinmann, Simone; Jakobs, Anke; Schmidt, Thomas J.; Klempnauer, Karl-Heinz			The natural anti-tumor compound Celastrol targets a Myb-C/EBP beta-p300 transcriptional module implicated in myeloid gene expression	PLOS ONE			English	Article							BINDING-PROTEIN-BETA; C/EBP-BETA; SYNERGISTIC ACTIVATION; SESQUITERPENE LACTONE; SUPER-ENHANCERS; CELL IDENTITY; V-MYB; NF-M; LEUKEMIA; PHOSPHORYLATION	Myb is a key regulator of hematopoietic progenitor cell proliferation and differentiation and has emerged as a potential target for the treatment of acute leukemia. Using a myeloid cell line with a stably integrated Myb-inducible reporter gene as a screening tool we have previously identified Celastrol, a natural compound with anti-tumor activity, as a potent Myb inhibitor that disrupts the interaction of Myb with the co-activator p300. We showed that Celastrol inhibits the proliferation of acute myeloid leukemia (AML) cells and prolongs the survival of mice in an in vivo model of AML, demonstrating that targeting Myb with a small-molecule inhibitor is feasible and might have potential as a therapeutic approach against AML. Recently we became aware that the reporter system used for Myb inhibitor screening also responds to inhibition of C/EBP beta, a transcription factor known to cooperate with Myb in myeloid cells. By re-investigating the inhibitory potential of Celastrol we have found that Celastrol also strongly inhibits the activity of C/EBP beta by disrupting its interaction with the Taz2 domain of p300. Together with previous studies our work reveals that Celastrol independently targets Myb and C/EBP beta by disrupting the interaction of both transcription factors with p300. Myb, C/EBP beta and p300 cooperate in myeloid-specific gene expression and, as shown recently, are associated with so-called super-enhancers in AML cells that have been implicated in the maintenance of the leukemia. We hypothesize that the ability of Celastrol to disrupt the activity of a transcriptional Myb-C/EBP beta-p300 module might explain its promising anti-leukemic activity.	[Coulibaly, Anna; Haas, Astrid; Steinmann, Simone; Jakobs, Anke; Klempnauer, Karl-Heinz] Westfal Wilhelms Univ, Inst Biochem, D-48149 Munster, Germany; [Schmidt, Thomas J.] Westfal Wilhelms Univ, Inst Pharmaceut Biol & Phytochem, D-48149 Munster, Germany; [Coulibaly, Anna] Heidelberg Univ, Univ Med Mannheim, Med Fak Mannheim, Klin Anasthesiol & Operat Intens Med, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany	University of Munster; University of Munster; Ruprecht Karls University Heidelberg	Klempnauer, KH (corresponding author), Westfal Wilhelms Univ, Inst Biochem, D-48149 Munster, Germany.	klempna@uni-muenster.de	Schmidt, Thomas J/M-1678-2016	Schmidt, Thomas J/0000-0003-2634-9705; Coulibaly, Anna/0000-0001-5746-4496; Klempnauer, Karl-Heinz/0000-0002-5239-7690	Deutsche Krebshilfe [109269]; Deutsche Forschungsgemeinschaft [KL461/17-1]; Open Access Publication Fund of the University of Munster	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of the University of Munster	This work was supported by the Deutsche Krebshilfe (www.krebshilfe.de), grant number 109269, Deutsche Forschungsgemeinschaft (www.dfg.de), grant number KL461/17-1, and the Open Access Publication Fund of the University of Munster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Morante D, 2015, ONCOTARGET, V6, P4369, DOI 10.18632/oncotarget.2976; Bhaumik P, 2014, ACTA CRYSTALLOGR D, V70, P1914, DOI 10.1107/S1399004714009262; Bujnicki T, 2012, LEUKEMIA, V26, P615, DOI 10.1038/leu.2011.275; BURK O, 1993, EMBO J, V12, P2027, DOI 10.1002/j.1460-2075.1993.tb05852.x; CALABRETTA B, 1991, P NATL ACAD SCI USA, V88, P2351, DOI 10.1073/pnas.88.6.2351; Calkhoven CF, 2000, GENE DEV, V14, P1920; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cesena TI, 2008, MOL CELL ENDOCRINOL, V289, P94, DOI 10.1016/j.mce.2008.03.009; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; De Guzman RN, 2000, J MOL BIOL, V303, P243, DOI 10.1006/jmbi.2000.4141; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Erickson RL, 2001, J BIOL CHEM, V276, P16348, DOI 10.1074/jbc.M100128200; Falkenberg KD, 2017, BBA-MOL CELL RES, V1864, P1349, DOI 10.1016/j.bbamcr.2017.05.003; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jakobs A, 2016, LEUKEMIA, V30, P1612, DOI 10.1038/leu.2016.16; Jakobs A, 2016, J BIOL CHEM, V291, P26098, DOI 10.1074/jbc.M116.748129; Kim MH, 2009, PROSTATE, V69, P1435, DOI 10.1002/pros.20993; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Mink S, 1996, MOL CELL BIOL, V16, P1316; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; Pal R, 2009, BLOOD, V114, P3890, DOI 10.1182/blood-2009-01-201111; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Piva R, 2006, J CLIN INVEST, V116, P3171, DOI 10.1172/JCI29401; Plachetka A, 2008, MOL CELL BIOL, V28, P2102, DOI 10.1128/MCB.01943-07; Pless O, 2008, J BIOL CHEM, V283, P26357, DOI 10.1074/jbc.M802132200; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rask K, 2000, INT J CANCER, V86, P337, DOI 10.1002/(SICI)1097-0215(20000501)86:3<337::AID-IJC6>3.3.CO;2-V; Regalo G, 2016, J MOL MED, V94, P1385, DOI 10.1007/s00109-016-1447-7; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Salminen A, 2010, BIOCHEM BIOPH RES CO, V394, P439, DOI 10.1016/j.bbrc.2010.03.050; Schwartz C, 2003, EMBO J, V22, P882, DOI 10.1093/emboj/cdg076; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Steinmann S, 2009, ONCOGENE, V28, P2446, DOI 10.1038/onc.2009.90; Steinmann S, 2013, J BIOL CHEM, V288, P22257, DOI 10.1074/jbc.M113.487769; Uttarkar S, 2016, MOL CANCER THER, V15, P2905, DOI 10.1158/1535-7163.MCT-16-0185; Uttarkar S, 2016, BLOOD, V127, P1173, DOI 10.1182/blood-2015-09-668632; Uttarkar S, 2015, MOL CANCER THER, V14, P1276, DOI 10.1158/1535-7163.MCT-14-0662; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Zuber J, 2011, GENE DEV, V25, P1628, DOI 10.1101/gad.17269211	49	17	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0190934	10.1371/journal.pone.0190934	http://dx.doi.org/10.1371/journal.pone.0190934			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394256	Green Published, gold, Green Submitted			2022-12-26	WOS:000424060400007
J	Tang, JC; Cheng, RM; Shi, ZM; Xu, GX; Liu, SR; Centritto, M				Tang, Jingchao; Cheng, Ruimei; Shi, Zuomin; Xu, Gexi; Liu, Shirong; Centritto, Mauro			Fagaceae tree species allocate higher fraction of nitrogen to photosynthetic apparatus than Leguminosae in Jianfengling tropical montane rain forest, China	PLOS ONE			English	Article							MESOPHYLL DIFFUSION CONDUCTANCE; CO2 TRANSFER CONDUCTANCE; WATER-USE EFFICIENCY; CELL-WALLS; INTERNAL CONDUCTANCE; TEMPERATURE RESPONSE; LEAF; LEAVES; LIGHT; EVERGREEN	Variation in photosynthetic-nitrogen use efficiency (PNUE) is generally affected by several factors such as leaf nitrogen allocation and leaf diffusional conductances to CO2, although it is still unclear which factors significantly affect PNUE in tropical montane rain forest trees. In this study, comparison of PNUE, photosynthetic capacity, leaf nitrogen allocation, and diffusional conductances to CO2 between five Fagaceae tree species and five Leguminosae tree species were analyzed in Jianfengling tropical montane rain forest, Hainan Island, China. The result showed that PNUE of Fagaceae was significantly higher than that of Leguminosae (+35.5%), attributed to lower leaf nitrogen content per area (N-area, -29.4%). The difference in nitrogen allocation was the main biochemical factor that influenced interspecific variation in PNUE of these tree species. Fagaceae species allocated a higher fraction of leaf nitrogen to the photosynthetic apparatus (P-P, +43.8%), especially to Rubisco (P-R, +50.0%) and bioenergetics (P-B +33.3%) in comparison with Leguminosae species. Leaf mass per area (LMA) of Leguminosae species was lower than that of Fagaceae species (-15.4%). While there was no significant difference shown for mesophyll conductance (g(m)), Fagaceae tree species may have greater chloroplast to total leaf surface area ratios and that offset the action of thicker cell walls on g(m). Furthermore, weak negative relationship between nitrogen allocation in cell walls and in Rubisco was found for Castanopsis hystrix, Cyclobalanopsis phanera and Cy. patelliformis, which might imply that nitrogen in the leaves was insufficient for both Rubisco and cell walls. In summary, our study concluded that higher PNUE might contribute to the dominance of most Fagaceae tree species in Jianfengling tropical montane rain forest.	[Tang, Jingchao; Cheng, Ruimei; Shi, Zuomin; Xu, Gexi; Liu, Shirong] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, State Forestry Adm, Key Lab Forest Ecol & Environm Sci, Beijing, Peoples R China; [Cheng, Ruimei; Shi, Zuomin] Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China; [Shi, Zuomin; Centritto, Mauro] Natl Res Council Italy Sesto, Tree & Timber Inst, Fiorentino, Italy	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Nanjing Forestry University; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Valorizzazione del Legno e delle Specie Arboree (IVALSA-CNR)	Shi, ZM (corresponding author), Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, State Forestry Adm, Key Lab Forest Ecol & Environm Sci, Beijing, Peoples R China.; Shi, ZM (corresponding author), Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China.; Shi, ZM (corresponding author), Natl Res Council Italy Sesto, Tree & Timber Inst, Fiorentino, Italy.	shizm@caf.ac.cn			National Natural Science Foundation of China (Ministry of National Science and Technology, China) [31290223, 31570240]	National Natural Science Foundation of China (Ministry of National Science and Technology, China)	This research was supported by projects of the National Natural Science Foundation of China, http://www.nsfc.gov.cn/ (funder: Ministry of National Science and Technology, China, no. 31290223 and 31570240, received by ZS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Bahar N. H. A., 2016, NEW PHYTOL; Bernacchi CJ, 2001, PLANT CELL ENVIRON, V24, P253, DOI 10.1111/j.1365-3040.2001.00668.x; Bloomfield KJ, 2014, FUNCT PLANT BIOL, V41, P820, DOI 10.1071/FP13278; Broeckx LS, 2014, TREE PHYSIOL, V34, P701, DOI 10.1093/treephys/tpu057; Buckley TN, 2014, PHOTOSYNTH RES, V119, P77, DOI 10.1007/s11120-013-9825-2; Burns AE, 2002, OECOLOGIA, V133, P288, DOI 10.1007/s00442-002-1055-9; Chen LH, 2014, TREES-STRUCT FUNCT, V28, P793, DOI 10.1007/s00468-014-0992-3; Dusenge ME, 2015, OECOLOGIA, V177, P1183, DOI 10.1007/s00442-015-3260-3; Ethier GJ, 2006, PLANT CELL ENVIRON, V29, P2168, DOI 10.1111/j.1365-3040.2006.01590.x; Ethier GJ, 2004, PLANT CELL ENVIRON, V27, P137, DOI 10.1111/j.1365-3040.2004.01140.x; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Fang JY, 2004, BIODIVERSITY SCI, V12, P29, DOI DOI 10.3321/J.ISSN:1005-0094.2004.01.005; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Feng Qiu-Hong, 2013, Chinese Journal of Plant Ecology, V37, P591, DOI 10.3724/SP.J.1258.2013.00061; Feng YL, 2007, OECOLOGIA, V153, P501, DOI 10.1007/s00442-007-0759-2; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Feng YL, 2007, ACTA OECOL, V31, P40, DOI 10.1016/j.actao.2006.03.009; Field C. H., 1986, EC FORM FUNCTION, P25; Flexas J, 2012, PLANT SCI, V193, P70, DOI 10.1016/j.plantsci.2012.05.009; Funk JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064502; Gu LH, 2010, PLANT CELL ENVIRON, V33, P1852, DOI 10.1111/j.1365-3040.2010.02192.x; HARLEY PC, 1992, PLANT PHYSIOL, V98, P1429, DOI 10.1104/pp.98.4.1429; Harrison MT, 2009, PLANT CELL ENVIRON, V32, P259, DOI 10.1111/j.1365-3040.2008.01918.x; Hassiotou F, 2009, J EXP BOT, V60, P2303, DOI 10.1093/jxb/erp021; Hikosaka K, 2004, J PLANT RES, V117, P481, DOI 10.1007/s10265-004-0174-2; Hikosaka K, 2010, PLANT BIOTECHNOL, V27, P223, DOI 10.5511/plantbiotechnology.27.223; Hikosaka K, 2009, OECOLOGIA, V160, P443, DOI 10.1007/s00442-009-1315-z; Imanishi L, 2011, MOL PLANT MICROBE IN, V24, P1317, DOI 10.1094/MPMI-03-11-0078; Jang YX, 1991, TROPICAL FOREST ECOS, P47; Peguero-Pina JJ, 2012, PLANT CELL ENVIRON, V35, P2121, DOI 10.1111/j.1365-3040.2012.02540.x; Jin SH, 2011, TREE PHYSIOL, V31, P1142, DOI 10.1093/treephys/tpr095; Kositsup B, 2009, TREES-STRUCT FUNCT, V23, P357, DOI 10.1007/s00468-008-0284-x; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057130; Li Y, 2009, J EXP BOT, V60, P2351, DOI 10.1093/jxb/erp127; LORETO F, 1994, PHOTOSYNTH RES, V41, P397, DOI 10.1007/BF02183042; Loreto F, 2009, J EXP BOT, V60, P2283, DOI 10.1093/jxb/erp112; Loustau D, 1999, TREE PHYSIOL, V19, P707; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Momayyezi M, 2017, J PLANT PHYSIOL, V213, P122, DOI 10.1016/j.jplph.2017.03.006; Moon M, 2015, J KOREAN SOC APPL BI, V58, P511, DOI 10.1007/s13765-015-0074-2; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; Niinemets U, 2005, PLANT CELL ENVIRON, V28, P1552, DOI 10.1111/j.1365-3040.2005.01392.x; Niinemets U, 1997, PLANT CELL ENVIRON, V20, P845, DOI 10.1046/j.1365-3040.1997.d01-133.x; Niinemets U, 2010, ECOL RES, V25, P693, DOI 10.1007/s11284-010-0712-4; Niinemets U, 2009, J EXP BOT, V60, P2433, DOI 10.1093/jxb/erp045; Novriyanti E, 2012, PHOTOSYNTHETICA, V50, P273, DOI 10.1007/s11099-012-0033-7; Onoda Y, 2004, FUNCT ECOL, V18, P419, DOI 10.1111/j.0269-8463.2004.00847.x; Pegueropina JJ, 2017, NEW PHYTOL; Piel C, 2002, J EXP BOT, V53, P2423, DOI 10.1093/jxb/erf095; Poorter H, 1998, OECOLOGIA, V116, P26, DOI 10.1007/s004420050560; Qin RM, 2013, NEW PHYTOL, V197, P979, DOI 10.1111/nph.12071; Qing H, 2012, BIOL INVASIONS, V14, P2039, DOI 10.1007/s10530-012-0210-4; Raim O, 2012, PLANT BIOLOGY, V14, P306, DOI 10.1111/j.1438-8677.2011.00503.x; Robinson DE, 2001, CAN J FOREST RES, V31, P2014, DOI 10.1139/cjfr-31-11-2014; Ruan J, 2010, PLANT BIOLOGY, V12, P724, DOI 10.1111/j.1438-8677.2009.00288.x; Scafaro AP, 2011, PLANT CELL ENVIRON, V34, P1999, DOI 10.1111/j.1365-3040.2011.02398.x; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; Shi ZM, 2006, PHYSIOL PLANTARUM, V128, P722, DOI 10.1111/j.1399-3054.2006.00805.x; Sorrentino G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148554; Takashima T, 2004, PLANT CELL ENVIRON, V27, P1047, DOI 10.1111/j.1365-3040.2004.01209.x; Tenhaken R., 2015, FRONT PLANT SCI, DOI [10.1105/tpc.16.00891, DOI 10.3389/FPLS.2014.00771, 10.3389/fpls.2014.00771.eCollection2014]; Terashima I, 2005, ANN BOT-LONDON, V95, P507, DOI 10.1093/aob/mci049; Tosens T, 2012, PLANT CELL ENVIRON, V35, P839, DOI 10.1111/j.1365-3040.2011.02457.x; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Warren CR, 2008, J EXP BOT, V59, P1475, DOI 10.1093/jxb/erm245; Warren CR, 2004, TRENDS PLANT SCI, V9, P270, DOI 10.1016/j.tplants.2004.04.004; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Xu G, 2013, PHOTOSYNTHETICA, V51, P438, DOI 10.1007/s11099-013-0043-0; Xu H, 2015, J ECOL, V103, P1325, DOI 10.1111/1365-2745.12442; Xu Han, 2015, Biodiversity Science, V23, P192, DOI 10.17520/biods.2014157; Yamori W, 2010, PLANT CELL ENVIRON, V33, P332, DOI 10.1111/j.1365-3040.2009.02067.x; Zhang LL, 2016, BIOL INVASIONS, V18, P1391, DOI 10.1007/s10530-016-1089-2; [周璋 ZHOU Zhang], 2009, [生态学报, Acta Ecologica Sinica], V29, P1112; Zhou Zhang, 2009, Shengtaixue Zazhi, V28, P1006; Zhu JT, 2012, AUST J BOT, V60, P61, DOI 10.1071/BT11181	76	4	7	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192040	10.1371/journal.pone.0192040	http://dx.doi.org/10.1371/journal.pone.0192040			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390007	gold, Green Published, Green Submitted			2022-12-26	WOS:000423793400056
J	Lesilau, F; Fonck, M; Gatta, M; Musyoki, C; van't Zelfde, M; Persoon, GA; Musters, KCJM; de Snoo, GR; de Iongh, HH				Lesilau, Francis; Fonck, Myrthe; Gatta, Maria; Musyoki, Charles; van't Zelfde, Maarten; Persoon, Gerard A.; Musters, Kees C. J. M.; de Snoo, Geert R.; de Iongh, Hans H.			Effectiveness of a LED flashlight technique in reducing livestock depredation by lions (Panthera leo) around Nairobi National Park, Kenya	PLOS ONE			English	Article							LARGE CARNIVORES; CENTRAL-AFRICA; PREDATION; CONSERVATION; HUSBANDRY; CAMEROON; WEST	The global lion (Panthera leo) population decline is partly a result of retaliatory killing in response to livestock depredation. Nairobi National Park (NNP) is a small protected area in Kenya surrounded by a human-dominated landscape. Communities around the park use flashlights to deter lions from their livestock bomas. We investigated the response by lions to the installation of a LED flashlight technique during 2007-2016. We interviewed 80 owners of livestock bomas with flashlights (n = 43) and without (n = 37) flashlights in the surroundings of NNP and verified reported attacks on bomas against predation data over10 years. The frequency of attacks on bomas equipped with flashlights was significantly lower compared to bomas without flashlights. We also found that after flashlight installation at livestock bomas, lion attacks took place further away from the park edge, towards areas where bomas without flashlights were still present. With increased numbers of flashlight installations at bomas in recent years, we further noticed a shift from nocturnal to more diurnal predation incidences. Our study shows that the LED flashlight technique is effective in reducing nocturnal livestock predation at bomas by lions. Long term studies on the effects as well as expansion of this technique into other communities around NNP are recommended.	[Lesilau, Francis; Fonck, Myrthe; Gatta, Maria; van't Zelfde, Maarten; Musters, Kees C. J. M.; de Snoo, Geert R.; de Iongh, Hans H.] Leiden Univ, Inst Environm Sci, Ra Leiden, Netherlands; [Lesilau, Francis; Musyoki, Charles] Kenya Wildlife Serv, Nairobi, Kenya; [Persoon, Gerard A.] Leiden Univ, Inst Cultural Anthropol & Dev Sociol, Ra Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Lesilau, F (corresponding author), Leiden Univ, Inst Environm Sci, Ra Leiden, Netherlands.; Lesilau, F (corresponding author), Kenya Wildlife Serv, Nairobi, Kenya.	lesilau004@yahoo.com	van 't Zelfde, Maarten/K-6708-2013	Musters, C.J.M./0000-0003-1321-6786; Lesilau, Francis/0000-0002-4719-3503	Louwes Fund for Water to FL and Food through Leiden University (CML); Leo Foundation; Louwes Fund for Water and Food through Leiden University (CML)	Louwes Fund for Water to FL and Food through Leiden University (CML); Leo Foundation(LEO Pharma); Louwes Fund for Water and Food through Leiden University (CML)	This study was part of the PhD project of the first author, FL. The scholarship costs were covered by Louwes Fund for Water to FL and Food through Leiden University (CML) as well as Leo Foundation. Field data collection costs for the present paper is covered within the scholarship as part of PhD program. Therefore, the sponsor had no interest and role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kenya Wildlife Service (KWS), Friends of Nairobi National Park (FoNNaP) and The Wildlife Foundation (TWF) for permission to use their database on human-wildlife conflict reports. The Louwes Fund for Water and Food through Leiden University (CML) as well as Leo Foundation are acknowledged for their financial support. This research would not have been possible without assistance of KWS Rangers, Atif Chunghtai, Chief Nickson Parmisa and MSc students enrolled in the NNP lion project. We finally thank our respondents for their cooperation during two years of interviews and Mr. Isaacc Tarayia who helped with the translation of the interviews.	Abade L, 2014, BIOL CONSERV, V180, P241, DOI 10.1016/j.biocon.2014.10.005; Bauer H, 2005, AFR J ECOL, V43, P208, DOI 10.1111/j.1365-2028.2005.00570.x; Bauer H, 2004, ORYX, V38, P26, DOI 10.1017/S0030605304000055; Bauer H, 2008, MAMM BIOL, V73, P70, DOI 10.1016/j.mambio.2006.11.006; Bauer H, 2010, MAMMALIA, V74, P363, DOI 10.1515/MAMM.2010.048; Bertola LD, 2011, J BIOGEOGR, V38, P1356, DOI 10.1111/j.1365-2699.2011.02500.x; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; de Iongh Hans, 2009, Cat News, V50, P26; Eklund A, 2017, SCI REP, V7, P1; Gichohi H., 2003, 5 WORLD PARKS C, P1; GICHOHI H., 1996, ECOLOGY TRUNCATED EC; Henschel P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083500; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Khorozyan I, 2015, BIOL CONSERV, P192; Kissui BM, 2008, ANIM CONSERV, V11, P422, DOI 10.1111/j.1469-1795.2008.00199.x; Kolowski JM, 2006, BIOL CONSERV, V128, P529, DOI 10.1016/j.biocon.2005.10.021; Kuiper TR, 2015, BIOL CONSERV, V191, P546, DOI 10.1016/j.biocon.2015.08.012; Lichtenfeld LL, 2015, BIODIVERS CONSERV, V24, P483, DOI 10.1007/s10531-014-0828-x; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; Manoa D. O., 2016, NATURAL RESOURCES, V7, P28, DOI [10.4236/nr.2016.71003, DOI 10.4236/NR.2016.71003]; Matiko D., 2014, J ECOSYST ECOGRAPHY, V4, P2; Miller JRB, 2016, WILDLIFE SOC B, V40, P806, DOI 10.1002/wsb.720; Musyoki C, 2012, G WRIGHT FORUM, V29, P81; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Ogutu Joseph O., 2013, Open Conservation Biology Journal, V7, P11, DOI 10.2174/1874839201307010011; Oriol-Cotterill A, 2015, OIKOS, V124, P1263, DOI 10.1111/oik.02224; Owino A. O., 2011, Journal of Environmental Protection, V2, P855, DOI 10.4236/jep.2011.26097; Patterson BD, 2004, BIOL CONSERV, V119, P507, DOI 10.1016/j.biocon.2004.01.013; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Rudnai, 1974, AFR J ECOL; Schiess-Meier M, 2007, J WILDLIFE MANAGE, V71, P1267, DOI 10.2193/2006-177; Sogbohossou EA, 2011, ORYX, V45, P569, DOI 10.1017/S0030605310001109; Steinhart E., 1994, NATL PARKS ANTIPOACH, P27; Tomas Holmerna, 2007, BIOL CONSERV, V135, P518; Treves A, 2016, FRONT ECOL ENVIRON, V14, P380, DOI 10.1002/fee.1312; Tumenta PN, 2010, AFR J ECOL, V48, P888, DOI 10.1111/j.1365-2028.2009.01181.x; Tumenta PN, 2013, MAMMALIA, V77, P247, DOI 10.1515/mammalia-2012-0063; Tuqa, 2015, IMPACT CLIMATE VARIA; Van Bommel L, 2007, AFR J ECOL, V45, P490, DOI 10.1111/j.1365-2028.2007.00759.x; van Eeden LM, 2017, CONSERV BIOL; Woodroffe R, 2007, BIODIVERS CONSERV, V16, P1245, DOI 10.1007/s10531-006-9124-8	42	24	25	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0190898	10.1371/journal.pone.0190898	http://dx.doi.org/10.1371/journal.pone.0190898			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385146	Green Published, gold			2022-12-26	WOS:000423668400028
J	Kaushik, M; Pejchar, L; Crampton, LH				Kaushik, Monica; Pejchar, Liba; Crampton, Lisa H.			Potential disruption of seed dispersal in the absence of a native Kauai thrush	PLOS ONE			English	Article							INTRODUCED BIRDS; BODY-SIZE; FOREST; FRUGIVORES; PATTERNS; PUAIOHI; POPULATION; SURVIVAL; DISTANCE; ECOLOGY	Hawaii has experienced a catastrophic decline in frugivorous native birds coupled with the introduction of non-native species. Puaiohi (Myadestes palmeri), a critically endangered thrush, is the sole extant native songbird capable of dispersing fleshy fruited plants in the rainforest of Kauai island, Hawaii. As this species has declined to occupy a small proportion of its original range, a suite of largely omnivorous non-native birds have been introduced to this region, including the common and widespread Japanese White-eye (Zosterops japonicus). This reshuffling of the bird community could have long-term implications for plant community composition if introduced birds incompletely replace the ecological role of native species. The objective of this study was to evaluate the potential consequences of the local extirpation of Puaiohi for seed dispersal. Specifically, we compared the diet of Puaiohi and Japanese White-eye, vegetation characteristics, and seed rain at sites with and without Puaiohi in the Na Pali-Kona Forest Reserve on the island of Kauai. We found high overlap in the composition of seeds consumed by the two bird species, but differences in the characteristics of seeds consumed; Japanese White-eye appeared more likely to consume smaller seeded species compared with Puaiohi. Sites with Puaiohi received substantially higher seed rain during the study period, despite no significant differences in overall fruit abundance. Our results suggest that non-native birds are unlikely to completely replace the seed dispersal services provided by Puaiohi. If Puaohi continue to be rare and range restricted, we predict a shift in plant community composition through an increase in non-native and small-seeded plants, and possible dispersal failure of other native species. Our findings lend further support to efforts to conserve Puaiohi across its current and former range, and to consider introductions to other suitable areas to ensure the persistence not only of the species and but also its functional role in Hawaii's montane ecosystems.	[Kaushik, Monica] Wildlife Inst India, Dehra Dun, Uttar Pradesh, India; [Pejchar, Liba] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Crampton, Lisa H.] Hawaii Dept Land & Nat Resources, Hanapepe, HI USA; [Crampton, Lisa H.] Univ Hawaii Manoa, Kauai Forest Bird Recovery Project, Hanapepe, HI USA	Wildlife Institute of India; Colorado State University; University of Hawaii System; University of Hawaii Manoa	Kaushik, M (corresponding author), Wildlife Inst India, Dehra Dun, Uttar Pradesh, India.	monikakaushik05@gmail.com	Kaushik, Monica/L-8246-2019	Kaushik, Monica/0000-0002-2020-1278; Pejchar, Liba/0000-0002-9253-9884	U.S. Fish and Wildlife Service, Pacific Cooperative Studies Unit; Hawaii Department of Land Natural Resources Division of Forestry and Wildlife; Fulbright-Nehru Doctoral and Professional research fellowship (USIEF) [15130904]; Sigma Xi, The Scientific Research Society [A-6494090995]	U.S. Fish and Wildlife Service, Pacific Cooperative Studies Unit; Hawaii Department of Land Natural Resources Division of Forestry and Wildlife; Fulbright-Nehru Doctoral and Professional research fellowship (USIEF); Sigma Xi, The Scientific Research Society	This work was supported by U.S. Fish and Wildlife Service, Pacific Cooperative Studies Unit, and Hawaii Department of Land Natural Resources Division of Forestry and Wildlife. MK received funding from a Fulbright-Nehru Doctoral and Professional research fellowship (USIEF) (HE Grantee ID:15130904) and Sigma Xi, The Scientific Research Society (Grant ID#: A-6494090995). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, SINGLE-POLLEN GENOTYPING, P47, DOI 10.1007/978-4-431-53901-8_5; [Anonymous], 2011, ISLAND INVASIVES ERA; Atkinson CT, 2014, GLOBAL CHANGE BIOL, V20, P2426, DOI 10.1111/gcb.12535; Baker J, 2014, EMU, V114, P1, DOI 10.1071/MU12122; Baker JR, 1939, P ZOOL SOC LOND A-GE, V108, P557; Barton K., 2014, PACKAGE MUMLN MULTI; Behnke LAH, 2016, CONDOR, V118, P148, DOI 10.1650/CONDOR-15-80.1; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Caves EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065618; Chimera CG, 2010, BIOTROPICA, V42, P493, DOI 10.1111/j.1744-7429.2009.00610.x; Clark CJ, 2005, ECOLOGY, V86, P2684, DOI 10.1890/04-1325; COLLAR N, 2017, HDB BIRDS WORLD ALIV; Corlett Richard T., 1998, Forktail, V13, P23; Crampton LH, 2017, BIODIVERS CONSERV, P1; Culliney S, 2012, ECOL APPL, V22, P1718, DOI 10.1890/11-1613.1; FLEMING TH, 1991, J MAMMAL, V72, P493, DOI 10.2307/1382132; Fortini LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140389; Foster JT, 2007, CONSERV BIOL, V21, P1248, DOI 10.1111/j.1523-1739.2007.00781.x; Foster JT, 2004, CONSERV BIOL, V18, P716, DOI 10.1111/j.1523-1739.2004.00030.x; Giambelluca TW, 2013, B AM METEOROL SOC, V94, P313, DOI 10.1175/BAMS-D-11-00228.1; Gleditsch JM, 2011, DIVERS DISTRIB, V17, P244, DOI 10.1111/j.1472-4642.2010.00733.x; Godinez-Alvarez H., 2007, Seed dispersal: theory and its application in a changing world, P391, DOI 10.1079/9781845931650.0391; GUEVARA S, 1993, VEGETATIO, V108, P319; Hamann A, 1999, CONSERV BIOL, V13, P766, DOI 10.1046/j.1523-1739.1999.97420.x; Hammond RL, 2015, J AVIAN BIOL; HERRERA CM, 1984, ECOLOGY, V65, P609, DOI 10.2307/1941423; Howe HF, 2000, TRENDS ECOL EVOL, V15, P434, DOI 10.1016/S0169-5347(00)01965-0; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; IUCN. Invasive Species Specialist Group (ISSG), 2016, GLOBAL INVASIVE SPEC; James HF, 1991, ORNITHOL MONOGR, P1; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Jr Engilis A, 1989, HAWAII WILDLIFE NEWS, V4, P1; Kueffer C, 2009, PREVENTION EARLY DET; Link A, 2006, J TROP ECOL, V22, P235, DOI 10.1017/S0266467405003081; Lord JM, 2002, SEED DISPERSAL FRUGI, P55; Medellin RA, 1999, BIOTROPICA, V31, P478, DOI 10.1111/j.1744-7429.1999.tb00390.x; Paxton EH, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600029; Pejchar L, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv072; Pitt W. C., 2012, Outlooks on Pest Management, V23, P166, DOI 10.1564/23aug05; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Pratt HD, 1994, STUD AVIAN BIOL, V15, P103; PRATT TK, 1983, AM NAT, V122, P797, DOI 10.1086/284172; Pyle Robert L., 2002, Elepaio, V62, P137; R Core Team, 2021, R LANGUAGE ENV STAT; RALPH CJ, 1994, CONDOR, V96, P151, DOI 10.2307/1369072; Reynolds Michelle H., 1997, T W SECT WILDL SOC, P33; ROBINSON GR, 1993, CONSERV BIOL, V7, P271, DOI 10.1046/j.1523-1739.1993.07020271.x; Rutz C, 2016, NATURE, V537, P403, DOI 10.1038/nature19103; SCHUPP EW, 1993, VEGETATIO, V108, P15; Scott JM, 1986, STUD AVIAN BIOL; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Shiels AB, 2011, BIOL INVASIONS, V13, P883, DOI 10.1007/s10530-010-9876-7; Sincock JL, 1984, KAUAI FOREST BIRD RE; Snetsinger TJ, 2005, WILSON BULL, V117, P72, DOI 10.1676/04-049; Snetsinger TJ, 1999, BIRDS N AM, V20; Takanose Yoichiro, 2003, Ornithological Science, V2, P25, DOI 10.2326/osj.2.25; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Traveset A, 2014, ANNU REV ECOL EVOL S, V45, P89, DOI 10.1146/annurev-ecolsys-120213-091857; Tweed EJ, 2003, BIOL CONSERV, V111, P1, DOI 10.1016/S0006-3207(02)00175-1; Tweed EJ, 2006, AUK, V123, P753, DOI 10.1642/0004-8038(2006)123[753:BBASOA]2.0.CO;2; U. S. Fish and Wildlife Service (USFWS), 2006, PUAIOH MYD PALM REV; USDA, 2016, HAW STAT LIST NOX WE; Valenta K, 2015, J TROP ECOL, V31, P491, DOI 10.1017/S0266467415000413; vanBalen B, 2017, HDB BIRDS WORLD ALIV; VanderWerf EA, 2014, CONDOR, V116, P609, DOI 10.1650/CONDOR-14-18.1; Vanderwerf EA, 2012, CONSERV BIOL, V26, P905, DOI 10.1111/j.1523-1739.2012.01877.x; Wenny DG, 2011, AUK, V128, P1, DOI 10.1525/auk.2011.10248; Werf EAV, 2008, WILSON J ORNITHOL, V120, P195, DOI 10.1676/07-022.1; Westcott DA, 2005, OECOLOGIA, V146, P57, DOI 10.1007/s00442-005-0178-1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Wotton DM, 2012, J BIOGEOGR, V39, P1973, DOI 10.1111/jbi.12000; Wotton DM, 2011, P ROY SOC LOND B BIO; Wu JX, 2014, BIOTROPICA, V46, P175, DOI 10.1111/btp.12087; Wu JX, 2012, MOVEMENT PATTERNS OM; Wunderle JM, 1997, FOREST ECOL MANAG, V99, P223, DOI 10.1016/S0378-1127(97)00208-9	77	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191992	10.1371/journal.pone.0191992	http://dx.doi.org/10.1371/journal.pone.0191992			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381764	Green Published, gold			2022-12-26	WOS:000423617800050
J	Sprague, TA; Bateman, HL				Sprague, Tiffany A.; Bateman, Heather L.			Influence of seasonality and gestation on habitat selection by northern Mexican gartersnakes (Thamnophis eques megalops)	PLOS ONE			English	Article							SEMIAQUATIC SNAKES; HOME-RANGE; LOGISTIC-REGRESSION; MOVEMENT PATTERNS; BODY-SIZE; THERMOREGULATION; REPRODUCTION; WETLAND; MICROHABITAT; CONSERVATION	Species conservation requires a thorough understanding of habitat requirements. The northern Mexican gartersnake (Thamnophis eques megalops) was listed as threatened under the U.S. Endangered Species Act in 2014. Natural resource managers are interested in understanding the ecology of this subspecies to guide management decisions and to determine what features are necessary for habitat creation and restoration. Our objective was to identify habitat selection of northern Mexican gartersnakes in a highly managed, constructed wetland hatchery. We deployed transmitters on 42 individual gartersnakes and documented use of habitat types and selection of specific habitat features. Habitat selection was similar between males and females and varied seasonally. During the active season (March-October), gartersnakes primarily selected wetland edge habitat with abundant cover. Gestating females selected similar locations but with less dense cover. During the inactive season (November-February), gartersnakes selected upland habitats, including rocky slopes with abundant vegetation. These results of this study can help inform management of the subspecies, particularly in human-influenced habitats. Conservation of this subspecies should incorporate a landscape-level approach that includes abundant wetland edge habitat with a mosaic of dense cover for protection and sparsely vegetated areas for basking connected to terrestrial uplands for overwintering.	[Sprague, Tiffany A.; Bateman, Heather L.] Arizona State Univ, Coll Integrat Sci & Arts, Mesa, AZ 85212 USA	Arizona State University	Bateman, HL (corresponding author), Arizona State Univ, Coll Integrat Sci & Arts, Mesa, AZ 85212 USA.	heather.bateman@gmail.com		Bateman, Heather/0000-0002-3573-3824	Arizona Game and Fish Department from the Heritage Fund [IIAPM 115001]; CAMP Fund (Conservation and Mitigation Program)	Arizona Game and Fish Department from the Heritage Fund; CAMP Fund (Conservation and Mitigation Program)	Funding was provided by Arizona Game and Fish Department from the Heritage Fund, IIAPM 115001, and the CAMP Fund (Conservation and Mitigation Program) (to HLB), www.azgfd.com/wildlife/heritagefund/program/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P. D., 2004, NUMERICAL ISSUES STA, DOI [DOI 10.1002/0471475769.CH10, 10.1002/0471475769.ch10]; [Anonymous], 2012, AR STAT WILDL ACT PL; [Anonymous], 2014, FED REGISTER, V79, P38677; [Anonymous], 2016, THREAT END SPEC NEW; Blouin-Demers G, 2001, ECOLOGY, V82, P2882, DOI 10.1890/0012-9658(2001)082[2882:HUBBRS]2.0.CO;2; Boyarski VL, 2015, 291 US FISH WILDL SE; Brito JC, 2003, J HERPETOL, V37, P155, DOI 10.1670/0022-1511(2003)037[0155:SVIMHR]2.0.CO;2; Brode J.M., 1984, CALIFORNIA RIPARIAN, P30; Brown D.E, 1994, BIOTIC COMMUNITIES S; BURGER J, 1988, J HERPETOL, V22, P425, DOI 10.2307/1564337; Burger Joanna, 2004, Urban Ecosystems, V7, P17, DOI 10.1023/B:UECO.0000020169.86700.76; Burgman MA, 2003, ANIM CONSERV, V6, P19, DOI 10.1017/S1367943003003044; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Camper JD, 2009, COPEIA, P556, DOI 10.1643/CE-07-245; CHARLAND MB, 1995, J ZOOL, V236, P543, DOI 10.1111/j.1469-7998.1995.tb02731.x; CIOFI C, 1991, J HERPETOL, V25, P37, DOI 10.2307/1564792; Ciucci P, 1997, J ZOOL, V243, P803, DOI 10.1111/j.1469-7998.1997.tb01977.x; Compton BW, 2002, ECOLOGY, V83, P833, DOI 10.1890/0012-9658(2002)083[0833:HSBWTC]2.0.CO;2; Cooke Steven J., 2008, Endangered Species Research, V4, P165, DOI 10.3354/esr00063; Dodd C.K. Jr, 1987, P478; Duchesne T, 2010, J ANIM ECOL, V79, P548, DOI 10.1111/j.1365-2656.2010.01670.x; Emmons I, 2016, 112028 NO AR U COL P; Fagan WF, 2002, ECOLOGY, V83, P3250, DOI 10.1890/0012-9658(2002)083[3250:RFAERI]2.0.CO;2; FELLERS GM, 1994, MEASURING MONITORING, P146; GIBBONS J W, 1987, P396; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Gibbons JW, 2004, BIOSCIENCE, V54, P447, DOI 10.1641/0006-3568(2004)054[0447:PTSTAI]2.0.CO;2; GIER PJ, 1989, J EXP BIOL, V145, P465; Gorman TA, 2011, J HERPETOL, V45, P313; Grantz K, 2007, J CLIMATE, V20, P1923, DOI 10.1175/JCLI4091.1; Gregory PT, 1999, J ZOOL, V248, P231, DOI 10.1111/j.1469-7998.1999.tb01199.x; Gregory PT, 1998, AM NAT, V151, P477, DOI 10.1086/286134; Hale VL, 2017, J WILDLIFE DIS, V53, P591, DOI 10.7589/2016-08-186; Halstead BJ, 2016, J FISH WILDL MANAG, V7, P397, DOI 10.3996/042016-JFWM-029; Halstead BJ, 2010, COPEIA, P591, DOI 10.1643/CE-09-199; Harvey DS, 2010, ECOSCIENCE, V17, P411, DOI 10.2980/17-4-3363; HATTON TJ, 1986, J RANGE MANAGE, V39, P91, DOI 10.2307/3899697; Heisler LM, 2017, LANDSCAPE ECOL, V32, P1531, DOI 10.1007/s10980-017-0543-6; Hendrickson D.A., 1985, DESERT PLANTS, V6, P131; Holycross AT, 2006, SURVEYS THAMNOPHIS E; Hosmer D. W., 2013, APPL LOGISTIC REGRES; HUEY RB, 1989, ECOLOGY, V70, P931, DOI 10.2307/1941360; HUEY RB, 1991, AM NAT, V137, pS91, DOI 10.1086/285141; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Keating KA, 2004, J WILDLIFE MANAGE, V68, P774, DOI 10.2193/0022-541X(2004)068[0774:UAIOLR]2.0.CO;2; Keck MB, 1998, SOUTHWEST NAT, V43, P13; KECK MB, 1994, COPEIA, P226; Kinlaw A, 1999, J ARID ENVIRON, V41, P127, DOI 10.1006/jare.1998.0476; Langkilde T, 2006, J EXP BIOL, V209, P1035, DOI 10.1242/jeb.02112; Latterell JJ, 2006, FRESHWATER BIOL, V51, P523, DOI 10.1111/j.1365-2427.2006.01513.x; Lee HJ, 2011, ZOOL SCI, V28, P593, DOI 10.2108/zsj.28.593; Lentini AM, 2011, J WILDLIFE DIS, V47, P107, DOI 10.7589/0090-3558-47.1.107; Marshall RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011687; Matthews KR, 2002, J HERPETOL, V36, P16, DOI 10.2307/1565796; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Miller JR, 2007, RESTOR ECOL, V15, P382, DOI 10.1111/j.1526-100X.2007.00234.x; Minckley WL., 1991, BATTLE EXTINCTION NA; Morrison ML, 2001, J WILDLIFE MANAGE, V65, P613, DOI 10.2307/3803012; Mosher KR, 2016, RESTOR ECOL, V24, P71, DOI 10.1111/rec.12273; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; Nelson KJ, 2000, J HERPETOL, V34, P32, DOI 10.2307/1565235; Nowak E, 2016, 2015 SURVEYS WINTER; OSGOOD DW, 1970, COPEIA, P568, DOI 10.2307/1442288; PANUSKA J. A., 1956, JOUR MAMMAL, V37, P23, DOI 10.2307/1375522; Powell RA, 2000, METH C CONS, P65; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Reeder DM, 2015, ILAR J, V56, P275, DOI 10.1093/ilar/ilv035; REINERT HK, 1988, COPEIA, P964, DOI 10.2307/1445720; Reinert Howard K., 1993, P201; Roe JH, 2003, WETLANDS, V23, P1003, DOI 10.1672/0277-5212(2003)023[1003:WAUUPI]2.0.CO;2; Rogers Kevin B., 2007, P625; Rosen PC, 1988, STATUS MEXICAN UNPUB; Rossman DA, 1996, THE GARTER SNAKES; Row JR, 2006, ECOSCIENCE, V13, P443, DOI 10.2980/1195-6860(2006)13[443:TQIHSA]2.0.CO;2; Rudolph DC, 2007, J HERPETOL, V41, P560, DOI 10.1670/06-235.1; Santos X, 2006, BIOL CONSERV, V130, P416, DOI 10.1016/j.biocon.2006.01.003; SEIGEL RA, 1987, OECOLOGIA, V73, P481, DOI 10.1007/BF00379404; Semlitsch RD, 2003, CONSERV BIOL, V17, P1219, DOI 10.1046/j.1523-1739.2003.02177.x; Shine R, 2000, BEHAV ECOL, V11, P239, DOI 10.1093/beheco/11.3.239; SHINE R, 1977, AUST J ZOOL, V25, P655, DOI 10.1071/ZO9770655; Shine R, 1998, WILDLIFE RES, V25, P285, DOI 10.1071/WR97022; SHINE R, 1987, J HERPETOL, V21, P165, DOI 10.2307/1564479; SLIP DJ, 1988, AUST WILDLIFE RES, V15, P515; STEVENSON RD, 1985, AM NAT, V125, P102, DOI 10.1086/284330; Tuttle K., 2007, THESIS; Ward JV, 1999, REGUL RIVER, V15, P125, DOI 10.1002/(SICI)1099-1646(199901/06)15:1/3&lt;125::AID-RRR523&gt;3.0.CO;2-E; Watson JW, 2003, J HERPETOL, V37, P292, DOI 10.1670/0022-1511(2003)037[0292:HRMAHS]2.0.CO;2; Weatherhead PJ, 2004, WILDLIFE SOC B, V32, P900, DOI 10.2193/0091-7648(2004)032[0900:LEOROB]2.0.CO;2; White G.C., 1990, ANAL WILDLIFE RADIO; Willson JD, 2006, WETLANDS, V26, P1071, DOI 10.1672/0277-5212(2006)26[1071:PROSSI]2.0.CO;2; Wilson RP, 2006, FRONT ECOL ENVIRON, V4, P147, DOI 10.1890/1540-9295(2006)004[0147:MDOWAW]2.0.CO;2; Winne Christopher T., 2006, Herpetological Review, V37, P52; Wylie Glenn D., 2011, Herpetological Review, V42, P187; Zar JH, 1999, BIOSTATISTICAL ANAL; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; Zedler JB, 2001, BIOSCIENCE, V51, P1005, DOI 10.1641/0006-3568(2001)051[1005:DBWSMA]2.0.CO;2	98	3	3	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191829	10.1371/journal.pone.0191829	http://dx.doi.org/10.1371/journal.pone.0191829			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381753	Green Submitted, gold, Green Published			2022-12-26	WOS:000423617800039
J	Tan, T; Zhang, Y; Luo, WH; Lv, JH; Han, CS; Hamlin, JNR; Luo, HJ; Li, H; Wan, Y; Yang, X; Song, WH; Tong, ZQ				Tan, Tao; Zhang, Yun; Luo, Wenhong; Lv, Jihui; Han, Chanshuai; Hamlin, Jason N. R.; Luo, Hongjun; Li, Hui; Wan, You; Yang, Xu; Song, Weihong; Tong, Zhiqian			Formaldehyde induces diabetes-associated cognitive impairments	FASEB JOURNAL			English	Article						ALDH2; hyperglycemia; dementia; Alzheimer	MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; OXIDATIVE STRESS; MEMORY DECLINE; IN-VITRO; MELLITUS; MICE; DEFICIENCY; RATS	Patients with type 2 diabetes mellitus (T2DM) often develop cognitive impairments and have an increased risk of developing Alzheimer's disease. Hyperglycemia is a major characteristic of T2DM, but how elevated glucose levels lead to cognitive decline remains elusive. Here, we report that patients with T2DM and mutations in the formaldehyde (FA)-degrading enzyme aldehyde dehydrogenase 2 (ALDH2) gene had higher levels of FA and more severe dementia. Injection of FA induced hyperglycemia and cognitive deficits in rats. Ablation of gene expression of ALDH2, the main enzyme to oxidize FA, resulted in abnormally high levels of hippocampal FA, leading to hyperglycemia and cognitive impairments as well as potentiating streptozotocin-induced diabetes development in ALDH2 knockout mice. We found that FA interacts with insulin to form FA-insulin adducts, and these FA-insulin adducts caused insulin deficiency, contributing to memory decline in diabetic rodent models. Reduction of FA by transgenic overexpression of human ALDH2 attenuates hyperglycemia and alleviates cognitive deficits in diabetic mouse models. These findings suggest that excess FA plays a critical role in mediating diabetes-related dementia. Targeting FA and its metabolizing enzyme ALDH2 may be a valid approach for preventing and treating dementia in diabetes mellitus.Tan, T., Zhang, Y., Luo, W., Lv, J., Han, C., Hamlin, J. N. R., Luo, H., Li, H., Wan, Y., Yang, X., Song, W., Tong, Z. Formaldehyde induces diabetes-associated cognitive impairments.	[Tan, Tao; Tong, Zhiqian] Capital Med Univ, Beijing Inst Brain Disorders, Alzheimers Dis Ctr, Beijing 100069, Peoples R China; [Tan, Tao] Sichuan Prov Hosp Women & Children, Chengdu, Sichuan, Peoples R China; [Zhang, Yun; Song, Weihong] Univ British Columbia, Dept Psychiat, Townsend Family Labs, Vancouver, BC, Canada; [Luo, Wenhong; Luo, Hongjun; Li, Hui] Shantou Univ, Cent Lab, Med Coll, Shantou, Guangdong, Peoples R China; [Lv, Jihui] Beijing Geriatr Hosp, Beijing, Peoples R China; [Han, Chanshuai; Hamlin, Jason N. R.] McGill Univ, Montreal Neurol Inst, Quebec City, PQ, Canada; [Wan, You] Peking Univ, Neurosci Res Inst, Sch Basic Med Sci, Dept Neurobiol, Beijing, Peoples R China; [Yang, Xu] Cent China Normal Univ, Sect Environm Biomed, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Hubei, Peoples R China	Capital Medical University; University of British Columbia; Shantou University; McGill University; Peking University; Central China Normal University	Tong, ZQ (corresponding author), Capital Med Univ, Beijing Inst Brain Disorders, Alzheimers Dis Ctr, Beijing 100069, Peoples R China.; Song, WH (corresponding author), Univ British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	weihong@mail.ubc.ca; tzqbeida@163.com	Wan, You/M-5279-2019; han, chanshuai/GXG-6801-2022; Tan, Tao/F-5535-2010; Song, Weihong/O-7623-2017	Wan, You/0000-0001-6110-7192; Tan, Tao/0000-0002-4571-3296; Song, Weihong/0000-0001-9928-889X; /0000-0003-1035-6943	Natural Science Foundation of China (NSFC) [81400874, 31171080, 51136002]; Scientific Research Common Program of the Beijing Municipal Commission of Education [KM201510025014]; Natural Scientific Foundation of Capital Medical University (CCMU) [2015ZR31]; Beijing Institute for Brain Disorders [0000040103, ZD2015-08]; Michael Smith Foundation for Health Research/The Pacific Alzheimer Research Foundation Post-Doctoral Fellowship Award	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Scientific Research Common Program of the Beijing Municipal Commission of Education; Natural Scientific Foundation of Capital Medical University (CCMU); Beijing Institute for Brain Disorders; Michael Smith Foundation for Health Research/The Pacific Alzheimer Research Foundation Post-Doctoral Fellowship Award	This work was supported by grants from the Natural Science Foundation of China (NSFC; 81400874, 31171080, and 51136002), the Scientific Research Common Program of the Beijing Municipal Commission of Education (KM201510025014), the Natural Scientific Foundation of Capital Medical University (CCMU; 2015ZR31), and the Beijing Institute for Brain Disorders (0000040103 and ZD2015-08). W.S. is the holder of the Tier 1 Canada Research Chair in Alzheimer's Disease. Y.Z. is the recipient of the Michael Smith Foundation for Health Research/The Pacific Alzheimer Research Foundation Post-Doctoral Fellowship Award. The authors declare no conflicts of interest.	Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chen YX, 2014, EXP NEUROL, V261, P610, DOI 10.1016/j.expneurol.2014.06.004; D'Souza Y, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0117-y; de la Monte SM, 2012, CURR ALZHEIMER RES, V9, P35; DICKER E, 1986, BIOCHEM J, V240, P821, DOI 10.1042/bj2400821; Duarte AI, 2006, DIABETES, V55, P2863, DOI 10.2337/db06-0030; Frolich L, 1999, ANN NY ACAD SCI, V893, P290, DOI 10.1111/j.1749-6632.1999.tb07839.x; Grinan-Ferre C, 2016, EXP GERONTOL, V80, P57, DOI 10.1016/j.exger.2016.03.014; Grinan-Ferre C, 2016, AGING-US, V8, P664, DOI 10.18632/aging.100906; Harris C, 2003, REPROD TOXICOL, V17, P349, DOI 10.1016/S0890-6238(03)00013-3; Hong M, 1997, J BIOL CHEM, V272, P19547, DOI 10.1074/jbc.272.31.19547; Ito M, 1999, BIOL PHARM BULL, V22, P988; Izumi Y, 2003, DIABETOLOGIA, V46, P1007, DOI 10.1007/s00125-003-1144-2; Jaganjac M, 2013, FREE RADICAL RES, V47, P39, DOI 10.3109/10715762.2013.789136; Kamino K, 2000, BIOCHEM BIOPH RES CO, V273, P192, DOI 10.1006/bbrc.2000.2923; Kang Y, 2017, CURR ALZHEIMER RES, V14, P841, DOI 10.2174/1567205014666170425112331; Kim TE, 2015, INT J GERIATR PSYCH, V30, P551, DOI 10.1002/gps.4181; Koekkoek PS, 2015, LANCET NEUROL, V14, P329, DOI 10.1016/S1474-4422(14)70249-2; Lu J, 2013, BBA-GEN SUBJECTS, V1830, P4102, DOI 10.1016/j.bbagen.2013.04.028; Lu Z, 2008, INDOOR AIR, V18, P77, DOI 10.1111/j.1600-0668.2008.00524.x; Ly PTT, 2013, J CLIN INVEST, V123, P224, DOI 10.1172/JCI64516; Malek FA, 2003, ANN ANAT, V185, P277, DOI 10.1016/S0940-9602(03)80040-7; Mei YF, 2015, AGING CELL, V14, P659, DOI 10.1111/acel.12345; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Patra SK, 2008, CANCER METAST REV, V27, P315, DOI 10.1007/s10555-008-9118-y; Pitcher H, 2006, LANCET NEUROL, V5, P388, DOI 10.1016/S1474-4422(06)70434-3; Pitten FA, 2000, PATHOL RES PRACT, V196, P193, DOI 10.1016/S0344-0338(00)80100-4; Qiang M, 2014, J ALZHEIMERS DIS, V40, P1039, DOI 10.3233/JAD-131595; Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588; Quillen EE, 2014, AM J MED GENET B, V165, P103, DOI 10.1002/ajmg.b.32213; Roberts RO, 2008, ARCH NEUROL-CHICAGO, V65, P1066, DOI 10.1001/archneur.65.8.1066; Ryan CM, 2006, DIABETES CARE, V29, P345, DOI 10.2337/diacare.29.02.06.dc05-1626; Sim YB, 2012, ANIM CELLS SYST, V16, P385, DOI 10.1080/19768354.2012.696554; Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096; STRUBELT O, 1989, J TOXICOL ENV HEALTH, V27, P351, DOI 10.1080/15287398909531306; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Teng S, 2001, CHEM-BIOL INTERACT, V130, P285, DOI 10.1016/S0009-2797(00)00272-6; Tong ZQ, 2015, NEUROBIOL AGING, V36, P100, DOI 10.1016/j.neurobiolaging.2014.07.018; Tong ZQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01807; Tong ZQ, 2013, AGE, V35, P583, DOI 10.1007/s11357-012-9388-8; Tong ZQ, 2011, NEUROBIOL AGING, V32, P31, DOI 10.1016/j.neurobiolaging.2009.07.013; Tulpule K, 2013, J NEUROCHEM, V127, P7, DOI 10.1111/jnc.12356; Uemura E, 2006, EXP NEUROL, V198, P48, DOI 10.1016/j.expneurol.2005.10.035; Wang JL, 2011, MOL MED, V17, P172, DOI 10.2119/molmed.2010.00114; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xu F, 2010, HYPERTENS RES, V33, P49, DOI 10.1038/hr.2009.178; Xu WL, 2010, DIABETES, V59, P2928, DOI 10.2337/db10-0539; Yang HY, 2013, MOL MED REP, V7, P431, DOI 10.3892/mmr.2012.1227; Yang Y, 2013, NEUROSCIENCE, V250, P140, DOI 10.1016/j.neuroscience.2013.07.009; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069824; Yu PH, 2003, BBA-PROTEINS PROTEOM, V1647, P193, DOI 10.1016/S1570-9639(03)00101-8; Zeng JY, 2017, ACTA NEUROPATHOL, V133, P967, DOI 10.1007/s00401-017-1669-y; Zhang Y, 2017, PROG NEUROBIOL, V153, P100, DOI 10.1016/j.pneurobio.2017.03.001	54	20	23	4	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3669	3679		10.1096/fj.201701239R	http://dx.doi.org/10.1096/fj.201701239R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29401634				2022-12-26	WOS:000435104500015
J	Tomasi, ML; Ramani, K; Ryoo, M; Cossu, C; Floris, A; Murray, B; Iglesias-Ara, A; Spissu, Y; Mavila, N				Tomasi, Maria Lauda; Ramani, Komal; Ryoo, Minjung; Cossu, Carla; Floris, Andrea; Murray, Ben J.; Iglesias-Ara, Ainhoa; Spissu, Ylenia; Mavila, Nirmala			SUMOylation regulates cytochrome P450 2E1 expression and activity in alcoholic liver disease	FASEB JOURNAL			English	Article						alcohol; CYP2E1; small ubiquitin-like modifier	OXIDATIVE STRESS; CANCER CELLS; S-ADENOSYLMETHIONINE; OXIDANT STRESS; FATTY LIVER; HUMAN COLON; PROTEIN; ETHANOL; UBIQUITIN; SUMO	Alcohol acts through numerous pathways leading to alcoholic liver disease (ALD). Cytochrome P450 (CYP2E1), an ethanol-inducible enzyme, metabolizes ethanol-producing toxic reactive oxygen species (ROS) and is regulated at the posttranslational level. Small ubiquitin-like modifier (SUMO)ylation is a posttranslational modification that involves the addition of SUMOs, which modulate protein stability, activity, and localization. We demonstrated that ubiquitin-conjugation enzyme 9, the SUMO-conjugating enzyme, is induced in the livers of an intragastric ethanol mouse model. Our aim is to examine whether SUMOylation could regulate ethanol-induced CYP2E1 expression in ALD and to elucidate the molecular mechanism(s). CYP2E1 and UBC9 expression in vitro and in vivo was detected by real-time PCR and immunoblotting/immunostaining. SUMOylation was assayed by mass spectrometry and coimmunoprecipitation. Ubc9 expression was induced in ethanol-fed mouse livers, and silencing inhibited ethanol-mediated CYP2E1 microsomal retention and enzymatic activity. CYP2E1 SUMOylation was found to be induced by ethanol in vitro and in vivo. Ubc9 silencing prevents ethanol-induced lipid accumulation and ROS production. UBC9 was highly expressed in human ALD livers. Finally, we found that lysine 410 is a key SUMOylated residue contributing to CYP2E1 protein stability and activity preventing CYP2E1 SUMOylation. Ethanol-mediated up-regulation of CYP2E1 via SUMOylation enhancing its protein stability and activity and may have important implications in ALD.	[Tomasi, Maria Lauda; Ramani, Komal; Ryoo, Minjung; Cossu, Carla; Floris, Andrea; Murray, Ben J.; Spissu, Ylenia; Mavila, Nirmala] Cedars Sinai Med Ctr, Dept Med, DAVIS Res Bldg 3096A,8700 Beverly Blvd, Los Angeles, CA 90048 USA; [Cossu, Carla; Spissu, Ylenia] Univ Sassari, Dept Clin & Expt Med, Sassari, Italy; [Floris, Andrea] Univ Cagliari, Dept Med Sci, Cagliari, Italy; [Iglesias-Ara, Ainhoa] Univ Basque Country, UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Bilbao, Spain	Cedars Sinai Medical Center; University of Sassari; University of Cagliari; University of Basque Country	Tomasi, ML; Ramani, K (corresponding author), Cedars Sinai Med Ctr, Dept Med, DAVIS Res Bldg 3096A,8700 Beverly Blvd, Los Angeles, CA 90048 USA.	marialauda.tomasi@cshs.org; komal.ramani@cshs.org	Ramani, Komal/AAH-5913-2021; Iglesias, Ainhoa/H-3021-2015; Spissu, Ylenia/AGQ-3624-2022; tomasi, maria lauda/AAI-1819-2021; Mavila, Nirmala/AAH-6140-2021; Spissu, Ylenia/AAY-3011-2020; Iglesias, Ainhoa/AAB-8731-2022	Iglesias, Ainhoa/0000-0002-2056-8213; Spissu, Ylenia/0000-0003-1551-8817; Iglesias, Ainhoa/0000-0002-2056-8213	Dr. Bin Gao [U.S. National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism]; NIH/NIAAA [K01AA022372]; NIH/NIAAA Grant [K01AA022372]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA022372] Funding Source: NIH RePORTER	Dr. Bin Gao [U.S. National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism]; NIH/NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIH/NIAAA Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors thank Dr. Shelly Lu (Cedars-Sinai Medical Center) for mentoring support, Dr. Bin Gao [U.S. National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism (NIH/NIAAA)] for material support, and all current and previous laboratory members for technical support and helpful discussions. This work was supported by NIH/NIAAA Grant K01AA022372 (to M.L.T.). The authors declare no conflicts of interest.	Bardag-Gorce F, 2000, BIOCHEM BIOPH RES CO, V279, P23, DOI 10.1006/bbrc.2000.3889; Becker J, 2013, NAT STRUCT MOL BIOL, V20, P525, DOI 10.1038/nsmb.2526; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Carter S, 2008, CELL CYCLE, V7, P2519, DOI 10.4161/cc.7.16.6422; Cederbaum AI, 2001, FREE RADICAL BIO MED, V31, P1539, DOI 10.1016/S0891-5849(01)00743-2; Cederbaum AI, 2014, REDOX BIOL, V2, P1048, DOI 10.1016/j.redox.2014.09.007; Chen H, 2007, GASTROENTEROLOGY, V133, P207, DOI 10.1053/j.gastro.2007.03.114; Chen JY, 1997, DRUG METAB DISPOS, V25, P1165; Dasso M, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-5; Davis RL, 2004, ALCOHOL, V32, P195, DOI 10.1016/j.alcohol.2004.01.006; Elmore ZC, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-74; Garcia-Trevijano ER, 2000, FASEB J, V14, P2511, DOI 10.1096/fj.00-0121com; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; GUENGERICH FP, 1987, J BIOL CHEM, V262, P8459; He L, 2002, J BIOL CHEM, V277, P43572, DOI 10.1074/jbc.M204535200; Ingelman-Sundberg M, 1994, Alcohol Alcohol Suppl, V2, P131; Ingelman-Sundberg M, 2004, N-S ARCH PHARMACOL, V369, P89, DOI 10.1007/s00210-003-0819-z; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Leung TM, 2013, J HEPATOL, V58, P395, DOI 10.1016/j.jhep.2012.08.018; Lieber CS, 1999, ALCOHOL CLIN EXP RES, V23, P991, DOI 10.1111/j.1530-0277.1999.tb04217.x; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222; Lu YK, 2010, FREE RADICAL BIO MED, V49, P1406, DOI 10.1016/j.freeradbiomed.2010.07.026; Macauley MS, 2006, J BIOL CHEM, V281, P4164, DOI 10.1074/jbc.M510488200; MURRAY M, 1986, BIOCHEM PHARMACOL, V35, P1817, DOI 10.1016/0006-2952(86)90298-4; Pandey D, 2011, ARTERIOSCL THROM VAS, V31, P1634, DOI 10.1161/ATVBAHA.111.226621; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pascale RM, 2002, HEPATOLOGY, V35, P1341, DOI 10.1053/jhep.2002.33682; Pichler A, 2005, NAT STRUCT MOL BIOL, V12, P264, DOI 10.1038/nsmb903; Porubsky PR, 2010, J BIOL CHEM, V285, P22282, DOI 10.1074/jbc.M110.109017; Ramani K, 2008, HEPATOLOGY, V47, P521, DOI 10.1002/hep.22064; Romanenko AM, 2006, J UROLOGY, V175, P739, DOI 10.1016/S0022-5347(05)00172-2; Sahin U, 2014, NUCLEUS-PHILA, V5, P499, DOI 10.4161/19491034.2014.970104; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Schattenberg JM, 2014, REDOX BIOL, V3, P7, DOI 10.1016/j.redox.2014.09.004; SONG BJ, 1989, J BIOL CHEM, V264, P3568; Stielow C, 2014, NUCLEIC ACIDS RES, V42, P3044, DOI 10.1093/nar/gkt1317; Tomasi ML, 2015, ONCOTARGET, V6, P37706, DOI 10.18632/oncotarget.5342; Tomasi ML, 2012, HEPATOLOGY, V56, P982, DOI 10.1002/hep.25701; Tsukamoto H, 2001, FASEB J, V15, P1335, DOI 10.1096/fj.00-0650rev; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Yang HP, 2008, GASTROENTEROLOGY, V134, P281, DOI 10.1053/j.gastro.2007.10.027; Zanelli U, 2000, TOXICOL IN VITRO, V14, P69, DOI 10.1016/S0887-2333(99)00085-5; Zhao Q, 2014, NUCLEIC ACIDS RES, V42, pW325, DOI 10.1093/nar/gku383	46	9	9	0	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3278	3288		10.1096/fj.201701124R	http://dx.doi.org/10.1096/fj.201701124R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401608	Green Published			2022-12-26	WOS:000432546000031
J	Tsai, CY; Chi, HC; Chi, LM; Yang, HY; Tsai, MM; Lee, KF; Huang, HW; Chou, LF; Cheng, AJ; Yang, CW; Wang, CS; Lin, KH				Tsai, Chung-Ying; Chi, Hsiang-Cheng; Chi, Lang-Ming; Yang, Huang-Yu; Tsai, Ming-Ming; Lee, Kam-Fai; Huang, Hsiang-Wei; Chou, Li-Fang; Cheng, Ann-Joy; Yang, Chih-Wei; Wang, Chia-Siu; Lin, Kwang-Huei			Argininosuccinate synthetase 1 contributes to gastric cancer invasion and progression by modulating autophagy	FASEB JOURNAL			English	Article						autolysosome; iTRAQ; pMTOR	GENE-EXPRESSION; OVARIAN-CANCER; ARGININE; PROTEIN; METASTASIS; BIOMARKERS; MIGRATION; CELLS; LC3	Argininosuccinate synthetase 1 (ASS1) is a rate-limited enzyme in arginine biosynthesis. The oncogenic potential of ASS1 in terms of prognosis and cancer metastasis in arginine prototrophic gastric cancer (GC) remains unclear at present. We identify differentially expressed proteins in microdissected GC tumor cells relative to adjacent nontumor epithelia by isobaric mass tag for relative and absolute quantitation proteomics analysis. GC cells with stable expression or depletion of ASS1 were further analyzed to identify downstream molecules. We investigated their effects on chemoresistance and cell invasion in the presence or absence of arginine. ASS1 was highly expressed in GC and positively correlated with GC aggressiveness and poor outcome. Depletion of ASS1 led to inhibition of tumor growth and decreased cell invasion via induction of autophagy-lysosome machinery, resulting in degradation of active beta-catenin, Snail, and Twist. Ectopic expression of ASS1 in GC cells reversed these effects and protected cancer cells from chemotherapy drug-induced apoptosis via activation of the AKT-mammalian target of rapamycin signaling pathway. ASS1 contributes to GC progression by enhancing aggressive potential resulting from active beta-catenin, Snail, and Twist accumulation. Our results propose that ASS1 might contribute to GC metastasis and support its utility as a prognostic predictor of GC.	[Tsai, Chung-Ying; Chi, Hsiang-Cheng; Huang, Hsiang-Wei; Lin, Kwang-Huei] Chang Gung Univ, Dept Biochem, 259 Wen Hwa 1st Rd,Kwei San 333, Taoyuan, Taiwan; [Tsai, Chung-Ying; Yang, Huang-Yu; Chou, Li-Fang; Yang, Chih-Wei] Chang Gung Univ, Kidney Res Ctr, Dept Nephrol, Taoyuan, Taiwan; [Cheng, Ann-Joy] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Chi, Lang-Ming] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan; [Chi, Hsiang-Cheng] Chang Gung Mem Hosp, Radiat Biol Res Ctr, Inst Radiol Res, Taoyuan, Taiwan; [Chi, Lang-Ming; Tsai, Ming-Ming] Chang Gung Mem Hosp, Clin Prote Core Lab, Taoyuan, Taiwan; [Cheng, Ann-Joy] Chang Gung Mem Hosp, Dept Radiat Oncol, Taoyuan, Taiwan; [Lin, Kwang-Huei] Chang Gung Mem Hosp, Liver Res Ctr, Taoyuan, Taiwan; [Tsai, Ming-Ming] Chang Gung Univ Sci & Technol, Dept Nursing, Taoyuan, Taiwan; [Lin, Kwang-Huei] Chang Gung Univ Sci & Technol, Coll Human Ecol, Res Ctr Chinese Herbal Med, Taoyuan, Taiwan; [Lee, Kam-Fai] Chang Gung Mem Hosp, Dept Pathol, Chiayi, Taiwan; [Wang, Chia-Siu] Chang Gung Mem Hosp, Dept Gen Surg, Chiayi, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Lin, KH (corresponding author), Chang Gung Univ, Dept Biochem, 259 Wen Hwa 1st Rd,Kwei San 333, Taoyuan, Taiwan.; Wang, CS (corresponding author), Chang Gung Mem Hosp, Dept Gen Surg, Chiayi, Taiwan.	wangcs@adm.cgmh.org.tw; khlin@mail.cgu.edu.tw	Cheng, Ann-Joy/AAI-4374-2020	Tsai, Chung-Ying/0000-0002-1444-5647; YANG, HUANG-YU/0000-0001-6826-9717; Cheng, Ann-Joy/0000-0002-1317-0725	Chang Gung Memorial Hospital [CMRPG6D0011, CMRPG6D0012, CMRPG6D0013, CIRPG3D0142-3, CORPG3F0131-2, CLRPD190017]; Ministry of Science and Technology of the Republic of China [MOST 100-2314-B-182A-074, 101-2314-B-182A-030, 102-2314-B-182A-074, 101-2623-B-182-001-MY3, 105-2321-B-182-002-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	The authors thank Dr. Ying Liang (Chang Gung University) for immunohistochemistry and pathological comments. This work was supported by grants from Chang Gung Memorial Hospital (CMRPG6D0011, CMRPG6D0012, CMRPG6D0013, CIRPG3D0142-3, CORPG3F0131-2, and CLRPD190017) and the Ministry of Science and Technology of the Republic of China (MOST 100-2314-B-182A-074, 101-2314-B-182A-030, 102-2314-B-182A-074, 101-2623-B-182-001-MY3, 105-2321-B-182-002-MY3). The authors declare no conflicts of interest.	Allen MD, 2014, CANCER RES, V74, P896, DOI 10.1158/0008-5472.CAN-13-1702; Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Brasse-Lagnel C, 2007, FEBS J, V274, P5250, DOI 10.1111/j.1742-4658.2007.06047.x; Catalano M, 2015, MOL ONCOL, V9, P1612, DOI 10.1016/j.molonc.2015.04.016; Chen YT, 2010, J PROTEOME RES, V9, P5803, DOI 10.1021/pr100576x; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Delage B, 2010, INT J CANCER, V126, P2762, DOI 10.1002/ijc.25202; Huang HY, 2013, CLIN CANCER RES, V19, P2861, DOI 10.1158/1078-0432.CCR-12-2641; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI [DOI 10.1007/PL00011681, DOI 10.1007/S101209800016]]; Kim RH, 2009, AUTOPHAGY, V5, P567, DOI 10.4161/auto.5.4.8252; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kobayashi E, 2010, MOL CANCER THER, V9, P535, DOI 10.1158/1535-7163.MCT-09-0774; Liang Y, 2006, EXP MOL PATHOL, V81, P176, DOI 10.1016/j.yexmp.2006.04.008; Lin YH, 2015, J HEPATOL, V62, P1328, DOI 10.1016/j.jhep.2014.12.035; Marrelli D, 1999, ONCOLOGY-BASEL, V57, P55, DOI 10.1159/000012001; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; McAlpine JA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-621; Monari M, 2007, BIOMARK MED, V1, P209, DOI 10.2217/17520363.1.1.209; Morris SM, 2006, AM J CLIN NUTR, V83, p508S; Nagini S, 2012, WORLD J GASTRO ONCOL, V4, P156, DOI 10.4251/wjgo.v4.i7.156; Nicholson LJ, 2009, INT J CANCER, V125, P1454, DOI 10.1002/ijc.24546; Nikolsky Y, 2005, TOXICOL LETT, V158, P20, DOI 10.1016/j.toxlet.2005.02.004; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Qiang L, 2014, AUTOPHAGY, V10, P1864, DOI 10.4161/auto.32171; Qiu FM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004761; Ren H, 2006, WORLD J GASTROENTERO, V12, P2789, DOI 10.3748/wjg.v12.i17.2789; Rho JH, 2008, J PROTEOME RES, V7, P2959, DOI 10.1021/pr8000892; Shan YS, 2015, ONCOL REP, V33, P49, DOI 10.3892/or.2014.3556; Shih CH, 2004, ENDOCRINOLOGY, V145, P2804, DOI 10.1210/en.2003-1372; Syed N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.197; Szlosarek PW, 2007, INT J CANCER, V121, P6, DOI 10.1002/ijc.22666; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tsai CY, 2014, CLIN CANCER RES, V20, P2276, DOI 10.1158/1078-0432.CCR-13-1221; Tsai MM, 2014, CANCER LETT, V351, P222, DOI 10.1016/j.canlet.2014.06.004; Tuloup-Minguez V, 2013, CELL CYCLE, V12, P3317, DOI 10.4161/cc.26298; Wang Chia-Siu, 2002, Chang Gung Med J, V25, P216; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60; Zois CE, 2009, AUTOPHAGY, V5, P442, DOI 10.4161/auto.5.4.7667	39	34	34	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2601	2614		10.1096/fj.201700094R	http://dx.doi.org/10.1096/fj.201700094R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401583				2022-12-26	WOS:000432528000024
J	Monro, AK; Bystriakova, N; Fu, LF; Wen, F; Wei, YG				Monro, Alexandre K.; Bystriakova, Nadia; Fu, Longfei; Wen, Fang; Wei, Yigang			Discovery of a diverse cave flora in China	PLOS ONE			English	Article							LIMESTONE KARSTS; CONSERVATION; URTICACEAE; ECOLOGY; QUALITY	Few studies document plants in caves. Our field observations of a widespread and seemingly angiosperm-rich cave flora in SW China lead us to test the following hypotheses, 1) SW China caves contain a diverse vascular plant flora, 2) that this is a relic of a largely absent forest type lacking endemic species, and 3) that the light environment plants occupy in caves is not distinct from non-cave habitats. To do so we surveyed 61 caves and used species accumulation curves (SAC) to estimate the total diversity of this flora and used a subsample of 14 caves to characterise the light environment. We used regional floras and existing conservation assessments to evaluate the conservation value of this flora. We used observations on human disturbance within caves to evaluate anthropogenic activities. Four-hundred-and-eighteen vascular plant species were documented with SACs predicting a total diversity of 529-846. Ninety-three percent of the species documented are known karst forest species, 7% are endemic to caves and 81% of the species are angiosperms. We demonstrate that the light environment in caves is distinct to that of terrestrial habitats and that a subset of the flora likely grow in the lowest light levels documented for vascularised plants. Our results suggest that the proportion of species threatened with extinction is like that for the terrestrial habitat and that almost half of the entrance caverns sampled showed signs of human disturbance. We believe that this is the first time that such an extensive sample of cave flora has been undertaken and that such a diverse vascular plant flora has been observed in caves which we predict occurs elsewhere in SE Asia. We argue that the cave flora is an extension of the karst forest understory present prior to catastrophic deforestation in the 20thC. We suggest that within SW China caves serve as both refuges and a valuable source of germplasm for the restoration of karst forest. We also propose that caves represent a distinct habitat for plants that is most similar to that of the forest understory, but distinct with respect to the absence of trees, leaf litter, root mats, higher levels of atmospheric CO2, and lower diurnal and annual variation in temperature and humidity. We highlight tourism, agriculture and the absence of legislated protection of caves as the main current threats to this flora.	[Monro, Alexandre K.; Wen, Fang] Royal Bot Gardens, Herbarium, London, England; [Monro, Alexandre K.] IUCN Cave Invertebrate Specialist Grp, Gland, Switzerland; [Bystriakova, Nadia] Nat Hist Museum, Core Res Labs, London, England; [Fu, Longfei; Wei, Yigang] Guangxi Zhuang Autonomous Reg & Chinese Acad Sci, Guangxi Inst Bot, Guangxi Key Lab Plant Conservat & Restorat Ecol K, Guilin, Guangxi, Peoples R China	Royal Botanic Gardens, Kew; Natural History Museum London	Wei, YG (corresponding author), Guangxi Zhuang Autonomous Reg & Chinese Acad Sci, Guangxi Inst Bot, Guangxi Key Lab Plant Conservat & Restorat Ecol K, Guilin, Guangxi, Peoples R China.	weiyigang@aliyun.com			Conservation of the Covering Native Plant: The Inventory and Conservation of Native Plant in South China, a pilot project [KFJ-1W-NO1-13]; National Natural Science Foundation of China [31160039, 31260038, 31460159, 31570307]; Fund of Guangxi Key Laboratory of Plant Conservation and Restoration Ecology in Karst Terrain [16-380-32, GKB15-B-11, GKB15-A-11]; Bentham Moxon Trust for the conservation of species, a Royal Society; Special Funds of the Natural History Museum, London	Conservation of the Covering Native Plant: The Inventory and Conservation of Native Plant in South China, a pilot project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of Guangxi Key Laboratory of Plant Conservation and Restoration Ecology in Karst Terrain; Bentham Moxon Trust for the conservation of species, a Royal Society; Special Funds of the Natural History Museum, London	This work was supported by 'The Conservation of the Covering Native Plant: The Inventory and Conservation of Native Plant in South China, a pilot project' (KFJ-1W-NO1-13); the National Natural Science Foundation of China (No. 31160039, 31260038, 31460159 and 31570307); the Fund of Guangxi Key Laboratory of Plant Conservation and Restoration Ecology in Karst Terrain (16-380-32 (GKB15-A-11, GKB15-B-11)); the Bentham Moxon Trust for the conservation of species, a Royal Society travel award and Special Funds of the Natural History Museum, London.; This work was supported by 'The Conservation of the Covering Native Plant: The Inventory and Conservation of Native Plant in South China, a pilot project' (KFJ-1W-NO1-13); the National Natural Science Foundation of China (No. 31160039, 31260038, 31460159 and 31570307); the Fund of Guangxi Key Laboratory of Plant Conservation and Restoration Ecology in Karst Terrain (16-380-32 (GKB15-A-11, GKB15-B-11)); the Bentham Moxon Trust for the conservation of species, a Royal Society travel award and Special Funds of the Natural History Museum, London.	[Anonymous], 2014, R LANG ENV STAT COMP; Auler AS, 2014, ENVIRON EARTH SCI, V1, P487, DOI DOI 10.1007/978-3-642-17435-3_; Bichuette ME, 2010, BIOLOGY OF SUBTERRANEAN FISHES, P65; Brummitt N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0015; Cain M, 2014, ECOLOGY, P51; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Clements R, 2006, BIOSCIENCE, V56, P733, DOI 10.1641/0006-3568(2006)56[733:LKOSAI]2.0.CO;2; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Cooper SJB, 2007, MOL ECOL, V16, P1533, DOI 10.1111/j.1365-294X.2007.03261.x; Culver David C., 1992, NSS (National Speleological Society) Bulletin, V54, P79; Culver DC, 2009, BIOL CAVES OTHER SUB, P40; DENSLOW JS, 1990, ECOLOGY, V71, P165, DOI 10.2307/1940257; Fang D, 1993, B BOT RES, V13, P330; Flore Dobat C., 1998, ENCY BIOSPELEOLOGICA, V2; Fu LF, 2017, NORD J BOT, V35, P251, DOI 10.1111/njb.01281; Gabriel R, 2004, AMCS B, V7, P114; Gillieson D, 2005, PHYS GEOGRAPHY SE AS, P157; Glime J.M., 2017, PHYSL ECOLOGY, V1; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Holsinger JR, 1976, GEOLOGY BIOL PENNSYL, P72; HOWARTH FG, 1983, ANNU REV ENTOMOL, V28, P365, DOI 10.1146/annurev.en.28.010183.002053; Humphreys WF, 2000, ECOSY WORLD, V30, P3; HUNTOON PW, 1992, GROUND WATER, V30, P167, DOI 10.1111/j.1745-6584.1992.tb01788.x; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Jiang ZC, 2014, EARTH-SCI REV, V132, P1, DOI 10.1016/j.earscirev.2014.01.005; Juan C, 2010, MOL ECOL, V19, P3865, DOI 10.1111/j.1365-294X.2010.04759.x; Juberthie C., 2000, WORLD SUBTERRANEAN E, P17; Karanovic T, 2013, INVERTEBR SYST, V27, P540, DOI 10.1071/IS12084; Letts MG, 2005, J TROP ECOL, V21, P549, DOI 10.1017/S0266467405002488; Liu JR, 2004, STUDY TROPICAL KARST, P15; Liu LF, 2011, EURASIP J WIREL COMM, DOI 10.1155/2011/362521; LUNING K, 1979, MAR ECOL PROG SER, V1, P195, DOI 10.3354/meps001195; Mason-Williams A, 1967, INT J SPELEOL, V2, P397; Ministry of Environmental Protection of the People's Republic of China, CHIN RED LIST BIOD H; Monro AK, 2012, PHYTOKEYS, V19, P51, DOI 10.3897/phytokeys.19.3968; Moseley Max, 2010, Cave and Karst Science, V36, P53; Neill H, 2004, ENVIRON GEOL, V45, P550, DOI 10.1007/s00254-003-0910-2; Niemiller ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064177; Onac BP, 2011, INT J SPELEOL, V40, P79, DOI 10.5038/1827-806X.40.2.1; PALMER AN, 1991, GEOL SOC AM BULL, V103, P1, DOI 10.1130/0016-7606(1991)103<0001:OAMOLC>2.3.CO;2; Parise M, 2009, ENVIRON GEOL, V58, P235, DOI 10.1007/s00254-008-1608-2; Pentecost A, 2001, INT J SPELEOL, V30, P27, DOI DOI 10.5038/1827-806X.30.1.3; Prous X, 2015, INT J SPELEOL, V44, P177, DOI 10.5038/1827-806X.44.2.7; Qin H.N., 2010, CHECKLIST VASCULAR P; Romero A., 2012, POLYMATH INTERDISCIP, V2, P1; Romero A, 2009, ECOL BIODIVERS CONS, P62, DOI 10.1017/CBO9780511596841.003; Scopoli JA, 1772, DISS SCI NAT, V1, P84; Serena Fabrizio, 1997, Memoires de Biospeologie, V24, P183; Sheue CR, 2007, AM J BOT, V94, P1922, DOI 10.3732/ajb.94.12.1922; Shu SS, 2013, SCIENCE, V340, P272, DOI 10.1126/science.340.6130.272-a; Shui YM, 2006, SEED PLANTS KARST RE, V1; Simoes MH, 2014, ACTA CARSOLOGICA, V43, P159; Sutherland WJ, 2012, TRENDS ECOL EVOL, V27, P12, DOI 10.1016/j.tree.2011.10.011; Tao JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127821; Tuttle M.D., 1978, 1977 NATL CAVE MANAG, P108; Von Humboldt A, 1793, FLORAE FRIBERGENSIS, P108; Wang W, 2011, INT FOREST REV, V13, P416, DOI 10.1505/146554811798811290; Wei Y.-G., 2010, GESNERIACEAE S CHINA; Whitten T., 2012, INT CEMENT REV   JUN, P116; Whitten T, 2009, J APPL ECOL, V46, P520, DOI 10.1111/j.1365-2664.2009.01630.x; Williams P., 2008, WORLD HERITAGE CAVES, P5; Wonnacott TH, 1990, INTRO STAT, P103; Wu Z.Y., 1994, FLORA CHINA, V1; [曾馥平 ZENG FuPing], 2007, [生态学报, Acta Ecologica Sinica], V27, P5110, DOI 10.1016/S1872-2032(08)60016-5; Zhang LB, 2011, SYST BOT, V36, P854, DOI 10.1600/036364411X604877; Zhang YH, 2012, J GUILIN U TECHNOL, V32, P20, DOI [10.3969/j.issn.1674-9057.2012.01.003, DOI 10.19694/J.CNKI.ISSN2095-2457.2018.02.008]; Zhang ZH, 2012, J TROP FOR SCI, V24, P498; Zhou H.-G., 1996, GUIHAIA, V16; Zou T. C., 2001, GUIZHOU ENDEMIC RARE	70	38	41	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0190801	10.1371/journal.pone.0190801	http://dx.doi.org/10.1371/journal.pone.0190801			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415039	Green Published, Green Submitted, gold			2022-12-26	WOS:000424325300010
J	Schroder, C; Steimer, W				Schroeder, Charlotte; Steimer, Werner			gDNA extraction yield and methylation status of blood samples are affected by long-term storage conditions	PLOS ONE			English	Article							DNA METHYLATION; PREANALYTICAL PROCEDURES; HUMAN-DISEASE; INTEGRITY; STABILITY; TEMPERATURE; EPIGENETICS; EXPERIENCE; QUALITY	Epigenetics is believed to provide great chances for a better understanding of the development and treatment of many diseases where the analysis of genomic DNA has so far failed to provide conclusive answers. Methylcytosine is a frequently used quantitative marker of epigenetic studies. Since immediate analysis of sampled material is in most cases not possible, storage time and conditions are critical aspects regarding the quality of genomic DNA and reliability of analysis. Blood is frequently used for such analyses. We, therefore, collected blood samples of ten volunteers and stored them under various conditions for ten months: -70 degrees C, -20 degrees C, 2-8 degrees C and room temperature. An additional aliquot was frozen at -70 degrees C and thawed once a week at room temperature. We then compared the DNA extraction yields and methylation status in relation to storage time and conditions. We found significantly lower DNA extraction yields (up to -97.45%; p <= 0.001) as well as significantly higher methylation levels after ten months of storage (up to +42.0%; p <= 0.001). These results suggest that storage time has an important influence on DNA analyses of blood samples for all storage conditions. This might be due to differences in stability of methylated and non-methylated DNA. Our study indicates that storage conditions and time may be a critical factor for epigenetic methylation studies and require rigorous validation. For reliable analyses we, therefore, recommend to perform epigenetic analysis directly after sample collection.	[Schroeder, Charlotte; Steimer, Werner] Tech Univ Munich, Inst Klin Chem & Pathobiochem, Klinikum Rechts Isar, Munich, Germany	Technical University of Munich	Steimer, W (corresponding author), Tech Univ Munich, Inst Klin Chem & Pathobiochem, Klinikum Rechts Isar, Munich, Germany.	AK.Steimer-TUM@web.de			German Research Foundation (DFG); Technical University of Munich (TUM)	German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich (TUM)	This work was supported by the German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalsteinsson BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046705; Austin MA, 1996, AM J EPIDEMIOL, V144, P437; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Bulla A, 2016, BIOPRESERV BIOBANK, V14, P29, DOI 10.1089/bio.2015.0045; CUSHWA WT, 1993, BIOTECHNIQUES, V14, P204; de Oliveira RA, 2017, THERIOGENOLOGY, V89, P289, DOI 10.1016/j.theriogenology.2016.11.009; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Grouven U, 2007, Dtsch Med Wochenschr, V132 Suppl 1, pe69, DOI 10.1055/s-2007-959047; Malentacchi F, 2015, CLIN CHIM ACTA, V440, P205, DOI 10.1016/j.cca.2014.12.004; Nederhand RJ, 2003, J THROMB HAEMOST, V1, P987, DOI 10.1046/j.1538-7836.2003.00216.x; Palmirotta R, 2011, BIOPRESERV BIOBANK, V9, P35, DOI 10.1089/bio.2010.0027; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Quillien V, 2012, CANCER-AM CANCER SOC, V118, P4201, DOI 10.1002/cncr.27392; Redshaw N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1174; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; ROSS KS, 1990, J MED GENET, V27, P569, DOI 10.1136/jmg.27.9.569; Shao W, 2012, BIOPRESERV BIOBANK, V10, P4, DOI 10.1089/bio.2011.0016; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; Thalhammer A, 2011, CHEM COMMUN, V47, P5325, DOI 10.1039/c0cc05671e; Udtha M, 2014, BIOPRESERV BIOBANK, V12, P332, DOI 10.1089/bio.2014.0026; Vilahur N, 2013, EPIGENOMICS-UK, V5, P341, DOI [10.2217/EPI.13.29, 10.2217/epi.13.29]; Zini G, 2014, INT J LAB HEMATOL, V36, P111, DOI 10.1111/ijlh.12181	24	13	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192414	10.1371/journal.pone.0192414	http://dx.doi.org/10.1371/journal.pone.0192414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415017	gold, Green Published, Green Submitted			2022-12-26	WOS:000424325300076
J	Yang, SH; Wang, LL; Shi, ZY; Ou, XQ; Wang, W; Chen, X; Liu, GQ				Yang, Shaohua; Wang, Lu Lu; Shi, Zhaoyuan; Ou, Xiaoqian; Wang, Wei; Chen, Xue; Liu, Guoqing			Transcriptional profiling of liver tissues in chicken embryo at day 16 and 20 using RNA sequencing reveals differential antioxidant enzyme activity	PLOS ONE			English	Article							APOLIPOPROTEIN A-IV; OXIDATIVE STRESS; VITAMIN-E; EXPRESSION; SEQ; POLYMORPHISM; INDUCTION; PROTEINS; GENES	Considering the high proportion of polyunsaturated fatty acids, the antioxidant defense of chick embryo tissues is vital during the oxidative stress experienced at hatching. In order to better understand the mechanisms of the defense system during chicken embryo development, we detected the activity of antioxidant enzymes during the incubation of chicken embryo. Results showed that the activity of superoxide dismutase (SOD) and (GSH-PX) in livers were higher than those in hearts. Based on these results, liver tissues were used as the follow-up study materials, which were obtained from chicken embryo at day 16 and day 20. Thus, we used RNA sequencing (RNA-Seq) analysis to identify the transcriptome from 6 liver tissues. In total, we obtained 45,552,777-45,462,856 uniquely mapped reads and 18,837 mRNA transcripts, across the 6 liver samples. Among these, 1,154 differentially expressed genes (p<0.05, foldchange >= 1) were identified between the high and low groups, and 1,069 GO terms were significantly enriched (p<0.05). Of these, 10 GO terms were related to active oxygen defense and antioxidant enzyme activity. GO enrichment and KEGG pathway analysis indicated that GSTA2, GSTA4, MGST1, GPX3, and HAO2 participated in glutathione metabolism, and were considered as the most promising candidate genes affecting the antioxidant enzyme activity of chicken embryo at day 16 and day 20. Using RNA-Seq and differential gene expression, our study here investigated the complexity of the liver transcriptome in chick embryos and analyzed the key genes associated with the antioxidant enzyme.	[Yang, Shaohua; Wang, Lu Lu; Shi, Zhaoyuan; Ou, Xiaoqian; Chen, Xue; Liu, Guoqing] Hefei Univ Technol, Coll Food Sci & Engn, Hefei, Anhui, Peoples R China; [Wang, Wei] Agr Prod Qual & Safety Supervis & Management Bur, Xuancheng, Anhui, Peoples R China	Hefei University of Technology	Liu, GQ (corresponding author), Hefei Univ Technol, Coll Food Sci & Engn, Hefei, Anhui, Peoples R China.	13675512000@163.com			Fundamental Research Funds for Industry University-Research in Hefei University of Technology [XC2016JZBZ03]; Fundamental Research Funds for the Central Universities [JZ2017HGTA0228]; innovation Project for College Students [2017CXCYS235]; Wanjiang Institute of Poultry Technology [XC2015AKKG002]; Science and Technology Bureau of AnHui [XC2015XKKJ02, XC2015AKKG003]	Fundamental Research Funds for Industry University-Research in Hefei University of Technology; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); innovation Project for College Students; Wanjiang Institute of Poultry Technology; Science and Technology Bureau of AnHui	This work was supported by the Fundamental Research Funds for Industry University-Research in Hefei University of Technology (XC2016JZBZ03), the Fundamental Research Funds for the Central Universities (JZ2017HGTA0228), the innovation Project for College Students (2017CXCYS235), Wanjiang Institute of Poultry Technology (XC2015AKKG002), and the Science and Technology Bureau of AnHui (XC2015XKKJ02; XC2015AKKG003).	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Ahmad A, 2016, J TIME SER ANAL, V37, P291, DOI 10.1111/jtsa.12167; Ahn JY, 2006, CARCINOGENESIS, V27, P1876, DOI 10.1093/carcin/bgl038; Baez-Duarte BG, 2014, ARCH MED RES, V45, P375, DOI 10.1016/j.arcmed.2014.05.001; Barrett CW, 2013, CANCER RES, V73, P1245, DOI 10.1158/0008-5472.CAN-12-3150; Cheng X, 2016, COMP ANAL LIVER TISS, P15; Coles BF, 2005, METHOD ENZYMOL, V401, P9, DOI 10.1016/S0076-6879(05)01002-5; Covarrubias L, 2008, DEV BIOL, V320, P1, DOI 10.1016/j.ydbio.2008.04.041; Cui XG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-226; Dhage PA, 2017, INT J DEV NEUROSCI, V56, P1, DOI 10.1016/j.ijdevneu.2016.10.004; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Han ZJ, 2011, INT J DEV NEUROSCI, V29, P673, DOI 10.1016/j.ijdevneu.2011.06.006; He RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057732; Huang W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-711; Kumar P, 2015, ONCOTARGET, V6, P13539, DOI 10.18632/oncotarget.3841; Li Y, 2014, INT J CARDIOL, V176, P62, DOI 10.1016/j.ijcard.2014.06.044; Magnanou E, 2014, GENE, V544, P56, DOI 10.1016/j.gene.2014.04.032; Mattu S, 2016, J HEPATOL, V64, P891, DOI 10.1016/j.jhep.2015.11.029; Monson MS, 2016, TOXINS, V8, DOI 10.3390/toxins8010016; Tran NTL, 2014, GENE REGUL SYST BIO, V8, P33, DOI 10.4137/GRSB.S13612; Niu ZY, 2017, J APPL ANIMAL RES; Olson GE, 2010, AM J PHYSIOL-RENAL, V298, pF1244, DOI 10.1152/ajprenal.00662.2009; Opalinski L, 2011, INT J BIOCHEM CELL B, V43, P847, DOI 10.1016/j.biocel.2011.03.006; Ostos MA, 2001, ARTERIOSCL THROM VAS, V21, P1023, DOI 10.1161/01.ATV.21.6.1023; Reed MC, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-8; Rodriguez-Serrano M, 2016, PLANT PHYSIOL, V171, P1665, DOI 10.1104/pp.16.00648; Schaffert CS, 2011, WORLD J GASTROENTERO, V17, P2552, DOI 10.3748/wjg.v17.i20.2552; Shearn CT, 2016, REDOX BIOL, V7, P68, DOI 10.1016/j.redox.2015.11.013; Sodhi SS, 2014, GENE, V546, P233, DOI 10.1016/j.gene.2014.06.005; Sporer KRB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-143; Starrs AP, 2001, J EXP BIOL, V204, P3973; Surai PF, 1999, POULT AVIAN BIOL REV, V10, P1; Tetlow N, 2004, PHARMACOGENETICS, V14, P111, DOI 10.1097/00008571-200402000-00005; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; van Golde JC, 1998, J PHYSIOL-LONDON, V509, P289, DOI 10.1111/j.1469-7793.1998.289bo.x; Wang YX, 2011, BIOL TRACE ELEM RES, V143, P261, DOI 10.1007/s12011-010-8839-2; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wells PG, 2009, TOXICOL SCI, V108, P4, DOI 10.1093/toxsci/kfn263; Weng H, 2013, AM J PHYSIOL-ENDOC M, V304, P187; WILSON JX, 1992, MECH AGEING DEV, V65, P51, DOI 10.1016/0047-6374(92)90125-W; Wong WMR, 2007, ATHEROSCLEROSIS, V192, P266, DOI 10.1016/j.atherosclerosis.2006.07.017; Xu CC, 2016, GENE, V579, P47, DOI 10.1016/j.gene.2015.12.045; Yang DH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-319; Yang N, 2016, FRONT PLANT SCI, P7; Yang YS, 2003, ACTA BIOCHIM POL, V50, P319; Yigit AA, 2014, WORLD POULTRY SCI J, V70, P563, DOI 10.1017/S0043933914000610; Zhang W, 2015, J BIOL CHEM, V290, P5015, DOI 10.1074/jbc.M114.625822; Zhang WY, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0485-6; Zhuo Z, 2015, PLOS ONE, P10	49	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192253	10.1371/journal.pone.0192253	http://dx.doi.org/10.1371/journal.pone.0192253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408927	Green Submitted, Green Published, gold			2022-12-26	WOS:000424302800053
J	Huang, TS; Lee, CC; Tu, HZ; Lee, SSJ				Huang, Tsi-Shu; Lee, Chia-Chien; Tu, Hui-Zin; Lee, Susan Shin-Jung			Rapid identification of mycobacteria from positive MGIT broths of primary cultures by MALDI-TOF mass spectrometry	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; RESTRICTION ENZYME ANALYSIS; 16S RIBOSOMAL-RNA; NONTUBERCULOUS MYCOBACTERIA; ROUTINE IDENTIFICATION; TUBERCULOSIS COMPLEX; LIQUID; GENE; DIAGNOSIS; HSP65	Background Rapid identification of mycobacteria is important for timely treatment and the implementation of public health measures. The MGIT system ensures rapid detection of mycobacteria, but identification is usually delayed by days to weeks due to further subculture on solid medium. Matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF MS) was demonstrated to effectively identify mycobacteria isolates subcultured from solid or liquid media. Reports of identification directly from MGIT broths of both sterile and non-sterile clinical specimens, omitting the subculture step, were limited and not satisfactory before. Our identification method dramatically shortened delay from detection to identification of mycobacteria. Methodology We assessed the performance of the Vitek MS IVD version 3.0 for direct identification of NTM and M.tuberculosis from primary MGIT cultures, and assessed two sample preparation methods. Results Direct identification of NTM from positive MGIT broths, using MALDI-TOF VITEK MS with IVD v.3.0, generated high rates of acceptable results reaching 96.4% (80/83), and up to 100% (83/83) for sample preparations including a 0.1% SDS washing step. The sensitivity of VITEK MS to identify M.tuberculosis from MGIT tubes was 58/72 (80.6%), when using immunochromatography (ICA) test as gold standard. A characteristic colony clumping, wool-like appearance was observed in 48, and all 58 (100%) were correctly identified as M.tuberculosis using MALDI-TOF. The detection rate of M.tuberculosis complex was low (10/24, 41.6%) in the 24 MGIT tubes that was polymicrobial. Our method significantly reduced both the reagent cost and turnaround time. Conclusions Based on a simplified protocol, we showed that MALDI-TOF MS can be used for rapid identification of NTM directly from primary MGIT cultures within the routine clinical laboratory workflow. However, we recommend an initial ICA test to screen for M.tuberculosis complex, due to a low identification rate of M.tuberculosis in the presence of polymicrobial cultures using MALDI-TOF.	[Huang, Tsi-Shu; Lee, Chia-Chien; Tu, Hui-Zin; Lee, Susan Shin-Jung] Kaohsiung Vet Gen Hosp, Dept Pathol & Lab Med, Div Microbiol, Kaohsiung, Taiwan; [Lee, Susan Shin-Jung] Kaohsiung Vet Gen Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Lee, Susan Shin-Jung] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan	Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University	Lee, SSJ (corresponding author), Kaohsiung Vet Gen Hosp, Dept Pathol & Lab Med, Div Microbiol, Kaohsiung, Taiwan.; Lee, SSJ (corresponding author), Kaohsiung Vet Gen Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan.; Lee, SSJ (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan.	ssjlee28@yahoo.com.tw			Kaohsiung Veterans General Hospital [VGHKS105-G02-2]	Kaohsiung Veterans General Hospital	This work was financially supported by Kaohsiung Veterans General Hospital (VGHKS105-G02-2 to TSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2004, INT J SYST EVOL MICR, V54, P2095, DOI 10.1099/ijs.0.63094-0; Balada-Llasat JM, 2013, J CLIN MICROBIOL, V51, P2875, DOI 10.1128/JCM.00819-13; BESSESEN MT, 1993, AIDS, V7, P1357, DOI 10.1097/00002030-199310000-00009; Bizzini A, 2010, J CLIN MICROBIOL, V48, P1549, DOI 10.1128/JCM.01794-09; Bodle EE, 2008, EMERG INFECT DIS, V14, P390, DOI 10.3201/eid1403.061143; Brent AJ, 2011, J CLIN MICROBIOL, V49, P4343, DOI 10.1128/JCM.05995-11; Brunello F, 2001, J CLIN MICROBIOL, V39, P2799, DOI 10.1128/JCM.39.8.2799-2806.2001; Buchan BW, 2014, AM J CLIN PATHOL, V141, P25, DOI 10.1309/AJCPBPUBUDEW2OAG; Buckwalter SP., 2015, J CLIN MICROBIOLOGY; Butler WR, 2001, CLIN MICROBIOL REV, V14, P704, DOI 10.1128/CMR.14.4.704-726.2001; Carbonnelle E, 2011, CLIN BIOCHEM, V44, P104, DOI 10.1016/j.clinbiochem.2010.06.017; Chen JHK, 2013, J CLIN MICROBIOL, V51, P3981, DOI 10.1128/JCM.01437-13; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; Dunne WM, 2014, J CLIN MICROBIOL, V52, P3654, DOI 10.1128/JCM.01728-14; El Khechine A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024720; Euzeby J., 2013, GENUS MYCOBACTER; Gaillard T, 2011, DIAGN MICR INFEC DIS, V70, P154, DOI 10.1016/j.diagmicrobio.2010.12.011; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Henry MT, 2004, EUR RESPIR J, V23, P741, DOI 10.1183/09031936.04.00114004; HOFFNER SE, 1994, EUR J CLIN MICROBIOL, V13, P937, DOI 10.1007/BF02111495; Huang TS, 1996, J FORMOS MED ASSOC, V95, P530; Huang TS, 2001, ANN CLIN LAB SCI, V31, P279; Huang TS, 2007, ANN CLIN LAB SCI, V37, P323; Kodana M, 2016, J INFECT CHEMOTHER, V22, P32, DOI 10.1016/j.jiac.2015.09.006; Lai CC, 2010, EMERG INFECT DIS, V16, P294, DOI 10.3201/eid1602.090675; Lee AS, 2009, J MED MICROBIOL, V58, P900, DOI 10.1099/jmm.0.007484-0; Leyer C, 2017, J CLIN MICROBIOLOGY; Lotz A, 2010, J CLIN MICROBIOL, V48, P4481, DOI 10.1128/JCM.01397-10; Lu JJ, 2000, J CLIN MICROBIOL, V38, P2076; Makinen J, 2006, CLIN MICROBIOL INFEC, V12, P481, DOI 10.1111/j.1469-0691.2006.01380.x; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Mather CA, 2014, J CLIN MICROBIOL, V52, P130, DOI 10.1128/JCM.01996-13; Mediavilla-Gradolph M, 2015, BIOMED RES INT, V2015, P6; Mijs W, 2002, EUR J CLIN MICROBIOL, V21, P794, DOI 10.1007/s10096-002-0825-y; Muchwa Christopher, 2012, BMC Res Notes, V5, P44, DOI 10.1186/1756-0500-5-44; Muyoyeta M, 2010, J CLIN MICROBIOL, V48, P3773, DOI 10.1128/JCM.01688-09; Ngeow YF, 2011, J CLIN MICROBIOL, V49, P2776, DOI 10.1128/JCM.00711-11; Porte L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177929; Pourahmad F, 2009, J MICROBIOL METH, V76, P128, DOI 10.1016/j.mimet.2008.09.021; Prevots DR, 2015, CLIN CHEST MED, V36, P13, DOI 10.1016/j.ccm.2014.10.002; Roth A, 1998, J CLIN MICROBIOL, V36, P139, DOI 10.1128/JCM.36.1.139-147.1998; SALFINGER M, 1994, EUR J CLIN MICROBIOL, V13, P961, DOI 10.1007/BF02111498; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Shen GH, 2009, INT J TUBERC LUNG D, V13, P472; Shrestha NK, 2003, J CLIN MICROBIOL, V41, P5121, DOI 10.1128/JCM.41.11.5121-5126.2003; Singh Amresh Kumar, 2013, J Lab Physicians, V5, P83, DOI 10.4103/0974-2727.119847; Springer B, 1996, J CLIN MICROBIOL, V34, P296, DOI 10.1128/JCM.34.2.296-303.1996; Tortoli E, 2003, CLIN MICROBIOL REV, V16, P319, DOI 10.1128/CMR.16.2.319-354.2003; Tortoli E, 2006, FEMS IMMUNOL MED MIC, V48, P159, DOI 10.1111/j.1574-695X.2006.00123.x; van Eck K, 2016, J CLIN MICROBIOL, V54, P1915, DOI 10.1128/JCM.00304-16; WALLACE RJ, 1990, AM REV RESPIR DIS, V142, P940, DOI 10.1164/ajrccm/142.4.940; Wilen CB, 2015, J CLIN MICROBIOL, V53, P2308, DOI 10.1128/JCM.00567-15; WOLINSKY E, 1994, CLIN INFECT DIS, V19, P396, DOI 10.1093/clinids/19.3.396; Yu MC, 2011, J CLIN MICROBIOL, V49, P802, DOI 10.1128/JCM.02243-10	54	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192291	10.1371/journal.pone.0192291	http://dx.doi.org/10.1371/journal.pone.0192291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394275	Green Published, Green Submitted, gold			2022-12-26	WOS:000424060400033
J	Patel, N; Garikapati, KR; Makani, VKK; Nair, AD; Vangara, N; Bhadra, U; Bhadra, MP				Patel, Nibedita; Garikapati, Koteswara Rao; Makani, Venkata Krishna Kanth; Nair, Ayikkara Drishya; Vangara, Namratha; Bhadra, Utpal; Bhadra, Manika Pal			Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug	PLOS ONE			English	Article							SELF-RENEWAL; HISTONE DEACETYLASES; MIR-200 FAMILY; PROLIFERATION; MICRORNAS; GENE; TUMORIGENESIS; DIFFERENTIATION; DOWNSTREAM; PHENOTYPE	Polycomb group (PcG) proteinB lymphoma Mo-MLV insertion region 1 homolog (BMI1) is a transcriptional repressor that plays an important role in human carcinogenesis. MicroRNAs (miRNAs) are endogenous small non-coding RNAs that implicate a negative regulation on gene expression. Deregulation of the expression of miRNAs has been implicated in tumorigenesis. Here, we have shown that knock-down of BMI1 increases the expression of tumor-suppressive miRNAs. Elevated levels of expression of miR-200a, miR-200b, miR-15a, miR429, miR-203were observed upon knock-down of BMI1. Up-regulation of these miRNA-sleads to down-regulation of PRC1 group of proteins i.e. BMI1, RING1A, RING1B and Ub-H2A. Interestingly, overexpression of miR-200a, miR-200b and miR-15 a also produced decreased BMI1 and Ub-H2A protein expression in the CD44+ Cancer Stem Cellpopulation of MDAMB-231cells. Also, elevating the levels of BMI1 regulated miRNAspromoted Mesenchymal to Epithelial transition by regulating the expression of N-Cadherin, Vimentin, beta-Catenin, Zeb, Snail thereby resulting in decreased invasion, migration and proliferation. Here, we also report that miR-200a, miR-200b, miR-203 accretes the sensitivity of MDAMB-231 cells to the histone deacetylase inhibitor (HDACi) SAHA and miR-15a sensitized breast cancer cells to the chemotherapeutic drug cisplatin leading to apoptosis. These findings suggest that modulatingspecific miRNAs may serve as a therapeutic approach for the treatment of breast cancer	[Patel, Nibedita; Garikapati, Koteswara Rao; Makani, Venkata Krishna Kanth; Nair, Ayikkara Drishya; Vangara, Namratha; Bhadra, Manika Pal] Indian Inst Chem Technol, CSIR, Ctr Chem Biol, Hyderabad, Telangana State, India; [Garikapati, Koteswara Rao] Acad Sci & Innovat Res AcSIR, Training & Dev Complex,CSIR Campus, Chennai, Tamil Nadu, India; [Bhadra, Utpal] Ctr Cellular & Mol Biol, Gene Silencing Grp, Hyderabad, Telangana State, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Bhadra, MP (corresponding author), Indian Inst Chem Technol, CSIR, Ctr Chem Biol, Hyderabad, Telangana State, India.	manikapb@gmail.com	GARIKAPATI, KOTESWARA RAO/L-4416-2014	GARIKAPATI, KOTESWARA RAO/0000-0002-1189-3356; bhadra, manika pal/0000-0002-3740-5031; Makani, Venkata Krishna Kanth/0000-0002-5454-1406	ICMR; UGC	ICMR(Indian Council of Medical Research (ICMR)); UGC(University Grants Commission, India)	NP thanks ICMR and GKR thanks UGC for their fellowship.	Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chen DH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004177; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dang Z, 2014, INT J BIOL SCI, V10, P733, DOI 10.7150/ijbs.8097; Dimri M, 2013, CELL CYCLE, V12, P3537, DOI 10.4161/cc.26592; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Grant S., 2010, CELL CYCLE GEORGETOW, V9, P2722; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hoenerhoff MJ, 2009, ONCOGENE, V28, P3022, DOI 10.1038/onc.2009.165; Humphries B, 2015, ONCOTARGET, V6, P6472, DOI 10.18632/oncotarget.3052; Jene-Sanz A, 2013, MOL CELL BIOL, V33, P3951, DOI 10.1128/MCB.00426-13; Jiao LY, 2015, SCIENCE, V350, DOI 10.1126/science.aac4383; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Komatsu N, 2006, ONCOL REP, V15, P187; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Li LY, 2014, BIOMEDICINE-TAIWAN, V4, DOI [10.7603/s40681-014-0001-6, 10.1136/bmjopen-2014-004897]; Lopez-Arribillaga E, 2015, DEVELOPMENT, V142, P41, DOI 10.1242/dev.107714; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Maynard MA, 2014, ONCOGENE, V33, P3742, DOI 10.1038/onc.2013.333; Mielcarek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027746; Ni ZL, 2010, CURR DRUG METAB, V11, P603, DOI 10.2174/138920010792927325; Ochiai H, 2010, ONCOGENE, V29, P2681, DOI 10.1038/onc.2010.22; Paranjape AN, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-785; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Patel N, 2016, LIFE SCI, V164, P60, DOI 10.1016/j.lfs.2016.08.028; Pietersen AM, 2008, CURR BIOL, V18, P1094, DOI 10.1016/j.cub.2008.06.070; Prabhakaran P, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00134; Reid G, 2016, EPIGENOMICS-UK, V8, P1079, DOI 10.2217/epi-2016-0035; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; SLEDGE GW, 1988, J CLIN ONCOL, V6, P1811, DOI 10.1200/JCO.1988.6.12.1811; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wang D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013067; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang MC, 2015, ONCOL LETT, V10, P583, DOI 10.3892/ol.2015.3361; Xiang XJ, 2015, CELL PHYSIOL BIOCHEM, V36, P1382, DOI 10.1159/000430304; Yamamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029722; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; YU HD, 2012, PLOS GENET, V8, DOI DOI 10.1371/JOURNAL.PONE.0051239; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	54	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0190245	10.1371/journal.pone.0190245	http://dx.doi.org/10.1371/journal.pone.0190245			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394261	Green Published, gold			2022-12-26	WOS:000424060400005
J	Cordoba, M; Rodriguez-Quiroga, SA; Vega, PA; Salinas, V; Perez-Maturo, J; Amartino, H; Vasquez-Dusefante, C; Medina, N; Gonzalez-Moron, D; Kauffman, MA				Cordoba, Marta; Alejandro Rodriguez-Quiroga, Sergio; Analia Vega, Patricia; Salinas, Valeria; Perez-Maturo, Josefina; Amartino, Hernan; Vasquez-Dusefante, Cecilia; Medina, Nancy; Gonzalez-Moron, Dolores; Andres Kauffman, Marcelo			Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach	PLOS ONE			English	Article							CHILDREN; RECOMMENDATIONS; STANDARDS; MUTATIONS; SPECTRUM; GENETICS; IMPACT; GRIK2	Background Diagnostic trajectories for neurogenetic disorders frequently require the use of considerable time and resources, exposing patients and families to so-called "diagnostic odysseys". Previous studies have provided strong evidence for increased diagnostic and clinical utility of whole-exome sequencing in medical genetics. However, specific reports assessing its utility in a setting such as ours-a neurogeneticist led academic group serving in a low-income country-are rare. Objectives To assess the diagnostic yield of WES in patients suspected of having a neurogenetic condition and explore the cost-effectiveness of its implementation in a research group located in an Argentinean public hospital. Methods This is a prospective study of the clinical utility of WES in a series of 40 consecutive patients selected from a Neurogenetic Clinic of a tertiary Hospital in Argentina. We evaluated patients retrospectively for previous diagnostic trajectories. Diagnostic yield, clinical impact on management and economic diagnostic burden were evaluated. Results We demonstrated the clinical utility of Whole Exome Sequencing in our patient cohort, obtaining a diagnostic yield of 40% (95% CI, 24.8%-55.2%) among a diverse group of neurological disorders. The average age at the time of WES was 23 (range 3-70). The mean time elapsed from symptom onset to WES was 11 years (range 3-42). The mean cost of the diagnostic workup prior to WES was USD 1646 (USD 1439 to 1853), which is 60% higher than WES cost in our center. Conclusions WES for neurogenetics proved to be an effective, cost- and time-saving approach for the molecular diagnosis of this heterogeneous and complex group of patients.	[Cordoba, Marta; Alejandro Rodriguez-Quiroga, Sergio; Analia Vega, Patricia; Salinas, Valeria; Perez-Maturo, Josefina; Vasquez-Dusefante, Cecilia; Medina, Nancy; Gonzalez-Moron, Dolores; Andres Kauffman, Marcelo] UBA, Fac Med, Ctr Univ Neurol, Consultorio Neurogenet,Hosp JM Ramos Mejia, Buenos Aires, DF, Argentina; [Cordoba, Marta; Alejandro Rodriguez-Quiroga, Sergio; Analia Vega, Patricia; Salinas, Valeria; Perez-Maturo, Josefina; Vasquez-Dusefante, Cecilia; Medina, Nancy; Gonzalez-Moron, Dolores; Andres Kauffman, Marcelo] UBA, Fac Med, Div Neurol, Consultorio Neurogenet,Hosp JM Ramos Mejia, Buenos Aires, DF, Argentina; [Cordoba, Marta; Salinas, Valeria; Perez-Maturo, Josefina; Andres Kauffman, Marcelo] Univ Austral, CONICET, Fac Ciencias Biomed, Programa Med Precis & Genomica Clin,Inst Invest M, Buenos Aires, DF, Argentina; [Amartino, Hernan] Hosp Univ Austral, Serv Neurol Infantil, Buenos Aires, DF, Argentina	Hospital Ramos Mejia; University of Buenos Aires; Hospital Ramos Mejia; University of Buenos Aires; Austral University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Austral University; Hospital Universitario Austral	Kauffman, MA (corresponding author), UBA, Fac Med, Ctr Univ Neurol, Consultorio Neurogenet,Hosp JM Ramos Mejia, Buenos Aires, DF, Argentina.; Kauffman, MA (corresponding author), UBA, Fac Med, Div Neurol, Consultorio Neurogenet,Hosp JM Ramos Mejia, Buenos Aires, DF, Argentina.; Kauffman, MA (corresponding author), Univ Austral, CONICET, Fac Ciencias Biomed, Programa Med Precis & Genomica Clin,Inst Invest M, Buenos Aires, DF, Argentina.	marcelokauffman@gmail.com		Cordoba, Marta/0000-0002-2814-1636; Kauffman, Marcelo/0000-0003-1680-5092	National Research Council Argentina (CONICET); Ministry of Science and Technology, Argentina	National Research Council Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Ministry of Science and Technology, Argentina	This study was supported by the National Research Council Argentina (CONICET) and the Ministry of Science and Technology, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan A, 2003, NAT REV GENET, V4, P61, DOI 10.1038/nrg978; Bettencourt C, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0721-2; Carmichael N, 2015, J GENET COUNS, V24, P325, DOI 10.1007/s10897-014-9773-9; Cordoba M, 2015, CLIN GENET, V87, P293, DOI 10.1111/cge.12423; Fogel BL, 2016, NEUROL-CLIN PRACT, V6, P164, DOI 10.1212/CPJ.0000000000000239; Fogel BL, 2014, JAMA NEUROL, V71, P1237, DOI 10.1001/jamaneurol.2014.1944; Kingsmore SF, 2012, GENOME MED, V4, DOI 10.1186/gm324; Kozarewa I, 2011, METHODS MOL BIOL, V733, P257, DOI 10.1007/978-1-61779-089-8_18; Li H, 2013, ARXIV13033997V1; Lionel AC, 2017, GENET MED; Margraf Rebecca L, 2011, J Biomol Tech, V22, P74; Monroe GR, 2016, GENET MED, V18, P949, DOI 10.1038/gim.2015.200; Motazacker MM, 2007, AM J HUM GENET, V81, P792, DOI 10.1086/521275; Nambot S, 2017, GENET MED; Posey JE, 2016, GENET MED, V18, P678, DOI 10.1038/gim.2015.142; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Shashi V, 2014, GENET MED, V16, P176, DOI 10.1038/gim.2013.99; Srivastava S, 2014, ANN NEUROL, V76, P473, DOI 10.1002/ana.24251; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Sun Y, 2015, HUM MUTAT, V36, P648, DOI 10.1002/humu.22783; Syrbe S, 2015, NAT GENET, V47, P393, DOI 10.1038/ng.3239; Tan TY, 2017, JAMA PEDIATR, V171, P855, DOI 10.1001/jamapediatrics.2017.1755; Valencia CA, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00067; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wenger AM, 2017, GENET MED, V19, P209, DOI 10.1038/gim.2016.88; Wolf NI, 2014, NEUROLOGY, V83, P1898, DOI 10.1212/WNL.0000000000001002; Wright FA, 2015, J BIOL CHEM, V290, P13948, DOI 10.1074/jbc.M115.655043; Xue Y, 2015, GENET MED, V17, P444, DOI 10.1038/gim.2014.122; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601	31	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191228	10.1371/journal.pone.0191228	http://dx.doi.org/10.1371/journal.pone.0191228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389947	gold, Green Submitted, Green Published			2022-12-26	WOS:000423793400014
J	Grainger, MJ; Aramyan, L; Piras, S; Quested, TE; Righi, S; Setti, M; Vittuari, M; Stewart, GB				Grainger, Matthew James; Aramyan, Lusine; Piras, Simone; Quested, Thomas Edward; Righi, Simone; Setti, Marco; Vittuari, Matteo; Stewart, Gavin Bruce			Model selection and averaging in the assessment of the drivers of household food waste to reduce the probability of false positives	PLOS ONE			English	Article							BEHAVIOR; ATTITUDES; SECURITY; UNCERTAINTY; COUNTRIES; DYNAMICS; BARRIERS; ECOLOGY; INCOME	Food waste from households contributes the greatest proportion to total food waste in developed countries. Therefore, food waste reduction requires an understanding of the socioeconomic (contextual and behavioural) factors that lead to its generation within the household. Addressing such a complex subject calls for sound methodological approaches that until now have been conditioned by the large number of factors involved in waste generation, by the lack of a recognised definition, and by limited available data. This work contributes to food waste generation literature by using one of the largest available datasets that includes data on the objective amount of avoidable household food waste, along with information on a series of socio-economic factors. In order to address one aspect of the complexity of the problem, machine learning algorithms (random forests and boruta) for variable selection integrated with linear modelling, model selection and averaging are implemented. Model selection addresses model structural uncertainty, which is not routinely considered in assessments of food waste in literature. The main drivers of food waste in the home selected in the most parsimonious models include household size, the presence of fussy eaters, employment status, home ownership status, and the local authority. Results, regardless of which variable set the models are run on, point toward large households as being a key target element for food waste reduction interventions.	[Grainger, Matthew James; Stewart, Gavin Bruce] Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Aramyan, Lusine] Wageningen Econ Res, Wageningen, Netherlands; [Piras, Simone; Righi, Simone; Setti, Marco; Vittuari, Matteo] Univ Bologna, Dept Agr & Food Sci, Alma Mater Studiorum, Bologna, Italy; [Quested, Thomas Edward] WRAP, Second Floor, Banbury, Oxon, England	Newcastle University - UK; Wageningen University & Research; University of Bologna	Grainger, MJ (corresponding author), Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England.	matthew.grainger@newcastle.ac.uk	Piras, Simone/AAY-6693-2020; Grainger, Matthew/K-6539-2019; Righi, Simone/B-3388-2013; Vittuari, Matteo/P-5274-2014	Piras, Simone/0000-0003-0334-6800; Grainger, Matthew/0000-0001-8426-6495; Righi, Simone/0000-0001-9821-8451; Aramyan, Lusine/0000-0002-7653-4768; Vittuari, Matteo/0000-0003-4327-1575	Horizon Framework Programme of the European Union [641933]	Horizon Framework Programme of the European Union	This work was carried out under the H2020 project REFRESH - Resource Efficient Food and dRink for the Entire Supply cHain. REFRESH is funded by the Horizon 2020 Framework Programme of the European Union under grant agreement no. 641933.; This work was carried out under the H2020 project REFRESH Resource Efficient Food and dRink for the Entire Supply cHain. REFRESH is funded by the Horizon 2020 Framework Programme of the European Union under Grant Agreement no. 641933. The views reflected in this article represent the professional views of the authors and do not necessarily reflect the views of the European Commission or other REFRESH project partners. We thank Toine Timmermans, Hilke Bos-Brouwers, Hans van Trijp, Erica van Herpen, Graham Moates and Keith Waldron for comments on an earlier draft of this paper.	Abeliotis K, 2014, WASTE MANAGE RES, V32, P237, DOI 10.1177/0734242X14521681; ALTMAN DG, 1989, STAT MED, V8, P771, DOI 10.1002/sim.4780080702; Aschemann-Witzel J, 2015, SUSTAINABILITY-BASEL, V7, P6457, DOI 10.3390/su7066457; Barilla Centre for Food and Nutrition, 2012, FOOD WAST CAUS IMP P; Barr S, 2007, ENVIRON BEHAV, V39, P435, DOI 10.1177/0013916505283421; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Buzby JC, 2009, USDA EC INFORM B, V44; Calcagno V, 2010, J STAT SOFTW, V34, P1; Canali M, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9010037; CHATFIELD C, 1995, J ROY STAT SOC A STA, V158, P419, DOI 10.2307/2983440; Evans D, 2012, SOCIOLOGY, V46, P41, DOI 10.1177/0038038511416150; Glanz R., 2008, THESIS; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Graham-Rowe E, 2014, RESOUR CONSERV RECY, V84, P15, DOI 10.1016/j.resconrec.2013.12.005; Grainger MJ, 2018, GLOB FOOD S IN PRESS; Gunders D., 2012, AM IS LOSING UPTO 40; Gustavsson J., 2011, Global food losses and food waste: extent, causes and prevention; Hamilton C., 2005, 77 AUSTR I; IGD, 2007, PACK FOOD WAST HOM; Jorissen J, 2015, SUSTAINABILITY-BASEL, V7, P2695, DOI 10.3390/su7032695; Koivupuro HK, 2012, INT J CONSUM STUD, V36, P183, DOI 10.1111/j.1470-6431.2011.01080.x; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; LEAMER EE, 1983, AM ECON REV, V73, P31; Lorenz BA, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9050807; Luke DA, 2012, ANNU REV PUBL HEALTH, V33, P357, DOI 10.1146/annurev-publhealth-031210-101222; Mariani J.F., 2014, ENCY AM FOOD DRINK; Midgley G., SYSTEMIC INTERVENTIO, V1; Moates G., 2016, FUSIONS ESTIMATES EU; Monier V, 2010, TECHNICAL REPORT; Osner R., 1982, NUTR FOOD SCI, V82, P13, DOI [DOI 10.1108/EB058904, 10.1108/eb058904]; Ostergren K., 2014, FUSIONS DEFINITIONAL; Parfitt J, 2010, PHILOS T R SOC B, V365, P3065, DOI 10.1098/rstb.2010.0126; Parizeau K, 2015, WASTE MANAGE, V35, P207, DOI 10.1016/j.wasman.2014.09.019; Qi DY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159250; Quested TE, 2013, RESOUR CONSERV RECY, V79, P43, DOI 10.1016/j.resconrec.2013.04.011; R Core Team, 2021, R LANGUAGE ENV STAT; Renzaho AMN, 2017, RENEW SUST ENERG REV, V78, P503, DOI 10.1016/j.rser.2017.04.072; Secondi L, 2015, FOOD POLICY, V56, P25, DOI 10.1016/j.foodpol.2015.07.007; Setti M, 2016, BRIT FOOD J, V118, P1731, DOI 10.1108/BFJ-11-2015-0427; Sibrian R, 2006, STAT DIVISION WORKIN; Silvennoinen K, 2014, BRIT FOOD J, V116, P1058, DOI 10.1108/BFJ-12-2012-0311; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Sonesson U, 2005, AMBIO, V34, P371, DOI 10.1639/0044-7447(2005)034[0371:HTAWER]2.0.CO;2; Stancu V, 2016, APPETITE, V96, P7, DOI 10.1016/j.appet.2015.08.025; Stefan V, 2013, FOOD QUAL PREFER, V28, P375, DOI 10.1016/j.foodqual.2012.11.001; Stewart GB, 2015, RES SYNTH METHODS, V6, P109, DOI 10.1002/jrsm.1152; Thyberg KL, 2016, RESOUR CONSERV RECY, V106, P110, DOI 10.1016/j.resconrec.2015.11.016; Tostivint C., 2016, FOOD WASTE QUANTIFIC; Van Herpen E, 2016, EU HORIZON 2020 REFR; VANGARDE SJ, 1987, J AM DIET ASSOC, V87, P322; Visschers VHM, 2016, J ENVIRON PSYCHOL, V45, P66, DOI 10.1016/j.jenvp.2015.11.007; Vittuari M, 2015, REV EU LEGISLATION P; Wassermann G, 2005, P 10 INT WAST MAN LA, P913; WENLOCK RW, 1980, BRIT J NUTR, V43, P53, DOI 10.1079/BJN19800064; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wilson A, 2012, J HUNGER ENVIRON NUT, V7, P239, DOI 10.1080/19320248.2012.704663; WRAP, 2013, HOUS FOOD DRINK WAST; WRAP, 2010, WHAT IS THROWN HOUS; WRAP, 2012, RED SUPPL CHAIN CONS; WRAP, 2009, HELP CONS RED FRUIT; WRAP, 2007, FOOD BEH CONS RES QU; WRAP, 2011, CONS INS DAT LAB STO; Wrap, 2014, EC MOD HOUS FOOD WAS; WRAP, 2010, RED FOOD WAST CHIL 1; Young C, 2009, AM SOCIOL REV, V74, P380, DOI 10.1177/000312240907400303; ZHANG P, 1992, BIOMETRIKA, V79, P741, DOI 10.1093/biomet/79.4.741	67	20	20	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192075	10.1371/journal.pone.0192075	http://dx.doi.org/10.1371/journal.pone.0192075			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389949	Green Published, gold, Green Submitted			2022-12-26	WOS:000423793400062
J	Pometti, C; Bessega, C; Cialdella, A; Ewens, M; Saidman, B; Vilardi, J				Pometti, Carolina; Bessega, Cecilia; Cialdella, Ana; Ewens, Mauricio; Saidman, Beatriz; Vilardi, Juan			Spatial genetic structure within populations and management implications of the South American species Acacia aroma (Fabaceae)	PLOS ONE			English	Article							NATURAL-POPULATIONS; PLANT-POPULATIONS; MATING SYSTEM; DNA MARKERS; INDIVIDUALS; DIVERSITY; DOMINANT; PROGRAM; PERSPECTIVE; ARGENTINA	The identification of factors that structure intraspecific diversity is of particular interest for biological conservation and restoration ecology. All rangelands in Argentina are currently experiencing some form of deterioration or desertification. Acacia aroma is a multipurpose species widely distributed throughout this country. In this study, we used the AFLP technique to study genetic diversity, population genetic structure, and fine-scale spatial genetic structure in 170 individuals belonging to 6 natural Argentinean populations. With 401 loci, the mean heterozygosity (H-E = 0.2) and the mean percentage of polymorphic loci (PPL = 62.1%) coefficients indicated that the genetic variation is relatively high in A. aroma. The analysis with STRUCTURE showed that the number of clusters (K) was 3. With Geneland analysis, the number of clusters was K = 4, sharing the same grouping as STRUCTURE but dividing one population into two groups. When studying SGS, significant structure was detected in 3 of 6 populations. The neighbourhood size in these populations ranged from 15.2 to 64.3 individuals. The estimated gene dispersal distance depended on the effective population density and disturbance level and ranged from 45 to 864 m. The combined results suggest that a sampling strategy, which aims to maintain a considerable part of the variability contained in natural populations sampled here, would include at least 3 units defined by the clusters analyses that exhibit particular genetic properties. Moreover, the current SGS analysis suggests that within the wider management units/provinces, seed collection from A. aroma should target trees separated by a minimum distance of 50 m but preferably 150 m to reduce genetic relatedness among seeds from different trees.	[Pometti, Carolina; Bessega, Cecilia; Saidman, Beatriz; Vilardi, Juan] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Genet Especies Lenosas GEEL, Buenos Aires, DF, Argentina; [Pometti, Carolina; Bessega, Cecilia; Saidman, Beatriz; Vilardi, Juan] Univ Buenos Aires, CONICET, Inst Ecol Genet & Evoluc IEGEBA, Buenos Aires, DF, Argentina; [Cialdella, Ana] Consejo Nacl Invest Cient & Tecn, IBODA, Buenos Aires, DF, Argentina; [Ewens, Mauricio] Univ Catolica Sgo del Est, Estn Expt Fernandez, UCSE Convenio Prov Sgo del Estero, Dept Robles, Santiago Del Estero, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Pometti, C (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Genet Especies Lenosas GEEL, Buenos Aires, DF, Argentina.; Pometti, C (corresponding author), Univ Buenos Aires, CONICET, Inst Ecol Genet & Evoluc IEGEBA, Buenos Aires, DF, Argentina.	cpometti@ege.fcen.uba.ar	; Vilardi, Juan/O-6547-2014	Bessega, Cecilia/0000-0002-8575-1828; Vilardi, Juan/0000-0002-7247-7911	Universidad de Buenos Aires [UBA 20020130100043BA]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICTO 2011-0081 OTNA, PICT-2013-0478, PICT-2013-1039]	Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by the Universidad de Buenos Aires (UBA 20020130100043BA to B. O. S. (http.//www.uba.ar/secyt/contenido.php?id=42&s=378) and the Agencia Nacional de Promocion Cientifica y Tecnologica (PICTO 2011-0081 OTNA to B. O. S., PICT-2013-0478 to J. C. V. and PICT-2013-1039 to C. L. P (http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors of this work want to thank the SERVICIO DE SECUENCIACION Y GENOTIPIFICADO from the Departamento de Ecologia Genetica y Evolucion, FCEyN, UBA. This work was supported by the Universidad de Buenos Aires (UBA 20020130100043BA to B.O.S.) and the Agencia Nacional de Promocion Cientifica y Tecnologica (PICTO 2011-0081 OTNA to B.O.S., PICT-2013-0478 to J.C.V. and PICT-2013-1039 to C.L.P). We wish to thank the AJE editors for the revisions to the language of our manuscript. Additionally, we acknowledge the contributions of the three reviewers and the Associate Editor of PLOS ONE, who helped improve the quality of our work.	Kalin A. M. T., 1981, Advances in legume systematics. Part 2 [Polhill, R.M.; Raven, P.H. (Editors)], P723; Bessega C, 2016, EUR J FOREST RES, V135, P495, DOI 10.1007/s10342-016-0948-9; Casiva PV, 2004, AM J BOT, V91, P58, DOI 10.3732/ajb.91.1.58; Curtu AL, 2015, IFOREST, V8, P324, DOI 10.3832/ifor1150-007; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dyer RJ, 2004, HEREDITY, V92, P204, DOI 10.1038/sj.hdy.6800397; DYER RJ, 2008, GENETICSTUDIO POPULA; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fernandez OA, 1997, 200 RAL, P20; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Francisco-Ortega J, 2000, AM J BOT, V87, P909, DOI 10.2307/2656988; Goudet J, 2014, HIERFSTAT ESTIMATION; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Gutierrez J., 1981, CIENC INVEST, V10, P3; Hamrick J.L., 1983, GENETICS CONSERVATIO, P335, DOI DOI 10.1111/J.1471-8286.2004.00845.X; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; Hardy OJ, 2006, MOL ECOL, V15, P559, DOI 10.1111/j.1365-294X.2005.02785.x; Hardy OJ, 2003, MOL ECOL, V12, P1577, DOI 10.1046/j.1365-294X.2003.01835.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hedrick PW., 2005, GENETIC POPULATIONS, V3, P505, DOI DOI 10.1038/S41421-021-00322-W; Huang CL, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0862-1; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Josiah CC, 2008, AFR J BIOTECHNOL, V7, P2333; Lemos RPM, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0885-7; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Lowe AJ, 2005, HEREDITY, V95, P255, DOI 10.1038/sj.hdy.6800725; Pometti CL, 2015, BOT J LINN SOC, V177, P593, DOI 10.1111/boj.12262; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Moran EV, 2011, MOL ECOL, V20, P1248, DOI 10.1111/j.1365-294X.2011.05019.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1978, GENETICS, V89, P583; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Omondi S. F., 2010, Tropical Plant Biology, V3, P59, DOI 10.1007/s12042-009-9037-2; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Pometti CL, 2016, PLANT SYST EVOL, V302, P901, DOI 10.1007/s00606-016-1306-6; Pometti CL, 2013, PLANT SYST EVOL, V299, P761, DOI 10.1007/s00606-013-0759-0; Pometti CL, 2012, TREE GENET GENOMES, V8, P911, DOI 10.1007/s11295-012-0479-6; Pometti CL, 2011, PLANT SYST EVOL, V292, P25, DOI 10.1007/s00606-010-0389-8; Pritchard J.K., 2009, STRUCTURE VER 2 3; R Development Core Team, 2016, R LANG ENV STAT COMP; Rico-Arce ML., 2007, AM SPECIES ACACIA LE; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; VEKEMANS X, 2002, AFLP SURV VERSION 1; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wright S., 1978, EVOLUTION GENETIC PO; Young A, TREE, V10, P413; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	52	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192107	10.1371/journal.pone.0192107	http://dx.doi.org/10.1371/journal.pone.0192107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389969	Green Published, gold, Green Submitted			2022-12-26	WOS:000423793400067
J	Reyes-Velasco, J; Manthey, JD; Bourgeois, Y; Freilich, X; Boissinot, S				Reyes-Velasco, Jacobo; Manthey, Joseph D.; Bourgeois, Yann; Freilich, Xenia; Boissinot, Stephane			Revisiting the phylogeography, demography and taxonomy of the frog genus Ptychadena in the Ethiopian highlands with the use of genome-wide SNP data	PLOS ONE			English	Article							SPECIES DELIMITATION; POPULATION-GENETICS; RIFT-VALLEY; EVOLUTION; CONSERVATION; DISPERSAL; INFERENCE; AMPHIBIA; RADIATIONS; DIVERSITY	Understanding the diversification of biological lineages is central to evolutionary studies. To properly study the process of speciation, it is necessary to link micro-evolutionary studies with macro-evolutionary mechanisms. Micro-evolutionary studies require proper sampling across a taxon's range to adequately infer genetic diversity. Here we use the grass frogs of the genus Ptychadena from the Ethiopian highlands as a model to study the process of lineage diversification in this unique biodiversity hotspot. We used thousands of genome-wide SNPs obtained from double digest restriction site associated DNA sequencing (ddRAD-seq) in populations of the Ptychadena neumanni species complex from the Ethiopian highlands in order to infer their phylogenetic relationships and genetic structure, as well as to study their demographic history. Our genome-wide phylogenetic study supports the existence of approximately 13 lineages clustered into 3 species groups. Our phylogenetic and phylogeographic reconstructions suggest that those endemic lineages diversified in allopatry, and subsequently specialized to different habitats and elevations. Demographic analyses point to a continuous decrease in the population size across the majority of lineages and populations during the Pleistocene, which is consistent with a continuous period of aridification that East Africa experienced since the Pliocene. We discuss the taxonomic implications of our analyses and, in particular, we warn against the recent practice to solely use Bayesian species delimitation methods when proposing taxonomic changes.	[Reyes-Velasco, Jacobo; Manthey, Joseph D.; Bourgeois, Yann; Boissinot, Stephane] New York Univ Abu Dhabi, Abu Dhabi, U Arab Emirates; [Freilich, Xenia] CUNY Queens Coll, Dept Biol, Flushing, NY 11367 USA	City University of New York (CUNY) System; Queens College NY (CUNY)	Boissinot, S (corresponding author), New York Univ Abu Dhabi, Abu Dhabi, U Arab Emirates.	stephane.boissinot@nyu.edu	; Bourgeois, Yann/D-9938-2012	Boissinot, Stephane/0000-0002-8760-1284; Bourgeois, Yann/0000-0002-1809-387X	New York University Abu Dhabi Research Funds [AD180]	New York University Abu Dhabi Research Funds	This work was supported by New York University Abu Dhabi Research Funds AD180 to SB.	Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; Bauer AM, 2010, P ROY SOC LOND B BIO; Belay G, 2006, BIOCHEM SYST ECOL, V34, P554, DOI 10.1016/j.bse.2006.01.004; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bohme W, 2011, NORTH-WEST J ZOOL, V7, P322; Bossuyt F, 2000, P NATL ACAD SCI USA, V97, P6585, DOI 10.1073/pnas.97.12.6585; Bowie RCK, 2006, MOL PHYLOGENET EVOL, V38, P171, DOI 10.1016/j.ympev.2005.06.001; Bryja J, 2018, MOL PHYLOGENET EVOL, V118, P75, DOI 10.1016/j.ympev.2017.09.020; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Chifman J, 2014, BIOINFORMATICS, V30, P3317, DOI 10.1093/bioinformatics/btu530; Cutter AD, 2013, MOL PHYLOGENET EVOL, V69, P1172, DOI 10.1016/j.ympev.2013.06.006; de la Harpe M, 2017, MOL ECOL, V26, P2608, DOI 10.1111/mec.14110; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Eaton DA, 2017, OVERCAST IPYRAD INTE; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans BJ, 2011, MOL ECOL, V20, P4216, DOI 10.1111/j.1365-294X.2011.05262.x; Excoffier L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003905; Excoffier L, 2011, BIOINFORMATICS, V27, P1332, DOI 10.1093/bioinformatics/btr124; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Freilich X, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0774-1; Freilich X, 2014, MOL PHYLOGENET EVOL, V71, P157, DOI 10.1016/j.ympev.2013.11.015; Fujita MK, 2011, P ROY SOC B-BIOL SCI, V278, P493, DOI 10.1098/rspb.2010.1864; Glor RE, 2010, ANNU REV ECOL EVOL S, V41, P251, DOI 10.1146/annurev.ecolsys.39.110707.173447; Gordon A, 2010, FASTX TOOLKIT UNPUB; Gottelli D, 2004, MOL ECOL, V13, P2275, DOI 10.1111/j.1365-294X.2004.02226.x; Gould Stephen J., 1996, MISMEASURE MAN REVIS; Gratton P, 2016, SYST BIOL, V65, P292, DOI 10.1093/sysbio/syv087; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson DH, 2005, UNPUB, V4; Jackson ND, 2017, SYST BIOL; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kebede M, 2007, MOL ECOL, V16, P1233, DOI 10.1111/j.1365-294X.2007.03232.x; Kozak KH, 2010, ECOL LETT, V13, P1378, DOI 10.1111/j.1461-0248.2010.01530.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Largen M., 2010, AMPHIBIANS REPTILES; Largen MJ, 1997, TROP ZOOL, V10, P223, DOI 10.1080/03946975.1997.10539339; Leache A AD, 2010, P ROY SOC LOND B BIO; Leache AD, 2014, SYST BIOL, V63, P534, DOI 10.1093/sysbio/syu018; Lexer C, 2013, J BIOGEOGR, V40, P1013, DOI 10.1111/jbi.12076; Liu XM, 2015, NAT GENET, V47, P555, DOI 10.1038/ng.3254; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Manthey JD, 2017, BIOL J LINN SOC; Mark BG, 2008, J QUATERNARY SCI, V23, P589, DOI 10.1002/jqs.1222; Mayr E, 1942, SYSTEMATICS ORIGIN S; Measey GJ, 2007, J BIOGEOGR, V34, P7, DOI 10.1111/j.1365-2699.2006.01589.x; Meirmans PG, 2015, MOL ECOL, V24, P3223, DOI 10.1111/mec.13243; Mengistu AA, 2012, AMPHIBIAN DIVERSITY; Miller MA, 2010, GATEWAY COMPUTING EN, V2010; Mohammed MU, 1998, GLOBAL PLANET CHANGE, V17, P121; Nomenclature ICoZ, 1999, INT TRUST ZOOLOGICAL; Pante E, 2015, SYST BIOL, V64, P152, DOI 10.1093/sysbio/syu083; Perret Jean-Luc, 1994, Bulletin de la Societe Neuchateloise des Sciences Naturelles, V117, P67; PERRET JL, 1980, MONIT ZOOL ITAL, V13, P151, DOI 10.1080/00269786.1980.11758552; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Pritchard JK, 2000, GENETICS, V155, P945; Radwan J, 2012, P ROY SOC B-BIOL SCI, V279, P5024, DOI 10.1098/rspb.2012.2322; Renner SS, 2016, SYST BIOL, V65, P1085, DOI 10.1093/sysbio/syw032; Reyes-Velasco J, EVOLUTION FOSSORIAL; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Rolland J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001775; Romiguier J, 2014, NATURE, V515, P261, DOI 10.1038/nature13685; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Samadi S, 2006, BIOL J LINN SOC, V89, P509, DOI 10.1111/j.1095-8312.2006.00689.x; Schick S., 2005, AMPHIBIA, V4, P31; Seehausen O, 2014, NAT REV GENET, V15, P176, DOI 10.1038/nrg3644; Smith ML, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170021; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sukumaran J, 2017, P NATL ACAD SCI USA, V114, P1607, DOI 10.1073/pnas.1607921114; Taylor PJ, 2011, SPECIFIC LIMITS EMER; Vences M, 2004, J BIOGEOGR, V31, P593, DOI 10.1046/j.1365-2699.2003.01031.x; Whittaker R.J., 2011, CONSERVATION BIOGEOG, P1; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang P, 2013, MOL BIOL EVOL, V30, P1899, DOI 10.1093/molbev/mst091	78	17	17	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0190440	10.1371/journal.pone.0190440	http://dx.doi.org/10.1371/journal.pone.0190440			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389966	Green Submitted, Green Published, gold			2022-12-26	WOS:000423793400006
J	Fuchs, F; Monet, B; Ducruet, T; Chaillet, N; Audibert, F				Fuchs, Florent; Monet, Barbara; Ducruet, Thierry; Chaillet, Nils; Audibert, Francois			Effect of maternal age on the risk of preterm birth: A large cohort study	PLOS ONE			English	Article							DELAYED CHILDBEARING; OUTCOMES; DELIVERY; ASSOCIATION; WEIGHT	Background Maternal age at pregnancy is increasing worldwide as well as preterm birth. However, the association between prematurity and advanced maternal age remains controversial. Objective To evaluate the impact of maternal age on the occurrence of preterm birth after controlling for multiple known confounders in a large birth cohort. Study design Retrospective cohort study using data from the QUARISMA study, a large Canadian randomized controlled trial, which collected data from 184,000 births in 32 hospitals. Inclusion criteria were maternal age over 20 years. Exclusion criteria were multiple pregnancy, fetal malformation and intra-uterine fetal death. Five maternal age categories were defined and compared for maternal characteristics, gestational and obstetric complications, and risk factors for prematurity. Risk factors for preterm birth <37 weeks, either spontaneous or iatrogenic, were evaluated for different age groups using multivariate logistic regression. Results 165,282 births were included in the study. Chronic hypertension, assisted reproduction techniques, pre-gestational diabetes, invasive procedure in pregnancy, gestational diabetes and placenta praevia were linearly associated with increasing maternal age whereas hypertensive disorders of pregnancy followed a "U" shaped distribution according to maternal age. Crude rates of preterm birth before 37 weeks followed a "U" shaped curve with a nadir at 5.7% for the group of 30-34 years. In multivariate analysis, the adjusted odds ratio (aOR) of prematurity stratified by age group followed a "U" shaped distribution with an aOR of 1.08 (95%CI; 1.01-1.15) for 20-24 years, and 1.20 ( 95%CI; 1.06-1.36) for 40 years and older. Confounders found to have the greatest impact were placenta praevia, hypertensive complications, and maternal medical history. Conclusion Even after adjustment for confounders, advanced maternal age (40 years and over) was associated with preterm birth. A maternal age of 30-34 years was associated with the lowest risk of prematurity.	[Fuchs, Florent; Monet, Barbara; Audibert, Francois] CHU St Justine, Dept Obstet & Gynecol, Div Obstet Med, Montreal, PQ, Canada; [Fuchs, Florent] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Reprod & Child Dev, Villejuif, France; [Fuchs, Florent] CHU Montpellier, Dept Obstet & Gynecol, 371 Ave Doyen Gaston Giraud, Montpellier, France; [Ducruet, Thierry] Univ Montreal, CHU St Justine, Res Ctr, Montreal, PQ, Canada; [Chaillet, Nils] CHU Sherbrooke, Clin Res Ctr Etienne Le Bel, Sherbrooke, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Montpellier; CHU de Montpellier; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Sherbrooke	Fuchs, F (corresponding author), CHU St Justine, Dept Obstet & Gynecol, Div Obstet Med, Montreal, PQ, Canada.; Fuchs, F (corresponding author), INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Reprod & Child Dev, Villejuif, France.; Fuchs, F (corresponding author), CHU Montpellier, Dept Obstet & Gynecol, 371 Ave Doyen Gaston Giraud, Montpellier, France.	f-fuchs@chu-montpellier.fr	Audibert, François/AAL-1265-2020; FUCHS, Florent/AAA-5460-2019	FUCHS, Florent/0000-0003-3530-6328				ALDOUS MB, 1993, JAMA-J AM MED ASSOC, V270, P2574, DOI 10.1001/jama.270.21.2574; American College of Obstetricians and Gynecologists, 2012, LAT CHILDB 2012; Berkowitz GS, 1998, EPIDEMIOLOGY, V9, P279, DOI 10.1097/00001648-199805000-00011; Canadian Institute for Health Information, 2012, DUE TIM WHY MAT AG M; Chaillet N, 2015, NEW ENGL J MED, V372, P1710, DOI 10.1056/NEJMoa1407120; Chan BCP, 2008, INT J GYNECOL OBSTET, V102, P237, DOI 10.1016/j.ijgo.2008.05.004; CNATTINGIUS S, 1992, JAMA-J AM MED ASSOC, V268, P886; Fitzpatrick KE, 2016, BJOG; FRASER AM, 1995, NEW ENGL J MED, V332, P1113, DOI 10.1056/NEJM199504273321701; Jacobsson B, 2004, OBSTET GYNECOL, V104, P727, DOI 10.1097/01.AOG.0000140682.63746.be; Johnson JA, 2012, J OBSTET GYNAECOL CA, V34, P80, DOI 10.1016/S1701-2163(16)35138-6; Joseph KS, 2005, OBSTET GYNECOL, V105, P1410, DOI 10.1097/01.AOG.0000163256.83313.36; Kenny LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056583; Khalil A, 2013, ULTRASOUND OBST GYN, V42, P634, DOI 10.1002/uog.12494; Klemetti R, 2016, ACTA OBSTET GYN SCAN, V95, P1368, DOI 10.1111/aogs.13020; Koo YJ, 2012, TAIWAN J OBSTET GYNE, V51, P60, DOI 10.1016/j.tjog.2012.01.012; Lawlor DA, 2011, INT J EPIDEMIOL, V40, P1205, DOI 10.1093/ije/dyr084; Matthews T J, 2009, NCHS Data Brief, P1; McDonald SD, 2009, EUR J OBSTET GYN R B, V146, P138, DOI 10.1016/j.ejogrb.2009.05.035; McIntyre SH, 2009, HEALTH CARE WOMEN IN, V30, P670, DOI 10.1080/07399330802596473; Newburn-Cook Christine V, 2005, Health Care Women Int, V26, P852, DOI 10.1080/07399330500230912; Royal College of Obstetricians and Gynaecologists (RCOG), 2009, RCOG STAT LAT MAT AG; Tough SC, 2002, PEDIATRICS, V109, P399, DOI 10.1542/peds.109.3.399; Yaniv SS, 2011, ARCH GYNECOL OBSTET, V283, P755, DOI 10.1007/s00404-010-1459-4	24	119	124	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191002	10.1371/journal.pone.0191002	http://dx.doi.org/10.1371/journal.pone.0191002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385154	Green Published, gold			2022-12-26	WOS:000423668400031
J	Hazel, A; Jones, JH				Hazel, Ashley; Jones, James Holland			Remoteness influences access to sexual partners and drives patterns of viral sexually transmitted infection prevalence among nomadic pastoralists	PLOS ONE			English	Article							DISTANCE TRUCK-DRIVERS; SIMPLEX-VIRUS TYPE-2; CONCURRENT PARTNERSHIPS; UNITED-STATES; SOUTH-AFRICA; EAST-AFRICA; DISEASES; HEALTH; HIV; WOMEN	Sexually transmitted infections (STIs) comprise a significant portion of the infectious-disease burden among rural people in the Global South. Particular characteristics of ruralness-low-density settlements and poor infrastructure-make healthcare provision difficult, and remoteness, typically a characteristic of ruralness, often compounds the difficultly. Remoteness may also accelerate STI transmission, particularly that of viral STIs, through formation of small, highly connected sexual networks through which pathogens can spread rapidly, especially when partner concurrency is broadly accepted. Herein, we explored the effect of remoteness on herpes simplex virus type-2 (HSV-2) epidemiology among semi-nomadic pastoralists in northwestern (Kaokoveld) Namibia, where, in 2009 we collected HSV-2-specific antibody status, demographic, sexual network, and travel data from 446 subjects (women = 213, men = 233) in a cross-sectional study design. HSV-2 prevalence was high overall in Kaokoveld (>35%), but was heterogeneously distributed across locally defined residential regions: some regions had significantly higher HSV-2 prevalence (39 +/- 48%) than others (21 +/- 33%). Using log-linear models, we asked the following questions: 1) Are sexual contacts among people in high HSV-2-prevalence regions more likely to be homophilous (i.e., from the same region) than those among people from low-prevalence regions? 2) Are high-prevalence regions more "functionally" remote, in that people from those regions are more likely to travel within their own region than outside, compared to people from other regions? We found that high-prevalence regions were more sexually homophilous than low-prevalence regions and that those regions also had higher rates of within-region travel than the other regions. These findings indicate that remoteness can create contact structures for accelerated STI transmission among people who are already disproportionately vulnerable to consequences of untreated STIs.	[Hazel, Ashley; Jones, James Holland] Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA; [Hazel, Ashley; Jones, James Holland] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Jones, James Holland] Imperial Coll London, Div Biol Sci, London, England	Stanford University; Stanford University; Imperial College London	Hazel, A (corresponding author), Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA.; Hazel, A (corresponding author), Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA.	mahazel@stanford.edu		Jones, James/0000-0003-1680-6757; Hazel, Ashley/0000-0001-7680-5460	International Research Award, University of Michigan Rackham Graduate School; Complex Systems Approaches to Population Health & Health Inequalities, University of Michigan Center for the Study of Complex Systems; University of Michigan Rackham Graduate School; University of Michigan School of Natural Resources and Environment; Dissertation Fieldwork Grant, Wenner-Gren Foundation for Anthropological Research; Health & Society Small Grant Program, Robert Wood Johnson Foundation; Lewis & Clark Fund for Exploration and Field Research, The American Philosophical Society; NIH training grant [T32 A1049816]; Center for Social Epidemiology and Public Health	International Research Award, University of Michigan Rackham Graduate School; Complex Systems Approaches to Population Health & Health Inequalities, University of Michigan Center for the Study of Complex Systems; University of Michigan Rackham Graduate School(University of Michigan System); University of Michigan School of Natural Resources and Environment(University of Michigan System); Dissertation Fieldwork Grant, Wenner-Gren Foundation for Anthropological Research; Health & Society Small Grant Program, Robert Wood Johnson Foundation; Lewis & Clark Fund for Exploration and Field Research, The American Philosophical Society; NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Social Epidemiology and Public Health	All grants listed below were received by Ashley Hazel and contributed to supporting fieldwork for data collection. GRANTS FROM THE UNIVERSITY OF MICHIGAN: 1) International Research Award, University of Michigan Rackham Graduate School, P.I., $7,500; 2) Complex Systems Approaches to Population Health & Health Inequalities, University of Michigan Center for the Study of Complex Systems and The Center for Social Epidemiology and Public Health, P.I., $7,620; 3) Graduate Student Research Grant (candidate level), University of Michigan Rackham Graduate School, P.1., $3000; 4) Thesis and Dissertation Research Funding (candidate level), University of Michigan School of Natural Resources and Environment, P.I., $1,500. GRANTS FROM EXTERNAL FOUNDATIONS: 5) Dissertation Fieldwork Grant, Wenner-Gren Foundation for Anthropological Research, P.I., $19,420; 6) Health & Society Small Grant Program, Robert Wood Johnson Foundation, P.I., $20, 565; 7) Lewis & Clark Fund for Exploration and Field Research, The American Philosophical Society, P.I., $5,000. GOVERNMENT SUPPORT: 8) NIH training grant (NIH training grant T32 A1049816): Interdisciplinary Program in Infectious Diseases (PI: Prof. Betsy Foxman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; Adimora AA, 2002, EPIDEMIOLOGY, V13, P320, DOI 10.1097/00001648-200205000-00013; [Anonymous], 2017, R 3 4 0; Bharti N, 2011, SCIENCE, V334, P1424, DOI 10.1126/science.1210554; Bhutta ZA, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-21; Bonds MH, 2010, P ROY SOC B-BIOL SCI, V277, P1185, DOI 10.1098/rspb.2009.1778; Burke M, 2014, ECON J, V125, P1157, DOI DOI 10.1111/EC0J.12149; BWAYO J, 1994, ARCH INTERN MED, V154, P1391, DOI 10.1001/archinte.154.12.1391; BWAYO JJ, 1991, E AFR MED J, V68, P714; BWAYO JJ, 1991, E AFR MED J, V68, P425; Cameron AS, 2013, INFLUENCE MEDIA HIMB; Carnegie NB, 2012, PLOS ONE, V7, P1; CARSWELL JW, 1989, AIDS, V3, P759, DOI 10.1097/00002030-198911000-00013; Cooper HLF, 2015, AIDS BEHAV, V19, P1016, DOI 10.1007/s10461-014-0883-z; Detels R, 2011, SEX TRANSM DIS, V38, P503, DOI 10.1097/OLQ.0b013e318206c288; Finer LB, 1999, FAM PLANN PERSPECT, V31, P228, DOI 10.2307/2991570; Funk S, 2010, J ROYAL SOC INTERFAC, P1; Gottlieb SL, 2014, VACCINE, V32, P1527, DOI 10.1016/j.vaccine.2013.07.087; Hazel A, 2015, ANN HUM BIOL, V42, P543, DOI 10.3109/03014460.2014.970575; HUDSON CP, 1993, INT J STD AIDS, V4, P249, DOI 10.1177/095646249300400501; JACQUEZ JA, 1988, MATH BIOSCI, V92, P119, DOI 10.1016/0025-5564(88)90031-4; Kim JY, 2013, LANCET, V382, P1060, DOI 10.1016/S0140-6736(13)61047-8; Kirakoya-Samadoulougou F, 2011, SEX TRANSM DIS, V38, P117, DOI 10.1097/OLQ.0b013e3181f0bef7; Kostelanetz R, 1993, DICT AVANT GARDES; KREISS JK, 1986, NEW ENGL J MED, V314, P414, DOI 10.1056/NEJM198602133140704; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Lingappa J, 2010, INT J STD AIDS, V21, P611, DOI 10.1258/ijsa.2009.008477; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Low BS, 2005, EVOL HUM BEHAV, V26, P64, DOI 10.1016/j.evolhumbehav.2004.08.011; MERTZ GJ, 1993, INFECT DIS CLIN N AM, V7, P825; MORRIS M, 1991, MATH BIOSCI, V107, P349, DOI 10.1016/0025-5564(91)90014-A; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Mulder MB, 2009, SCIENCE, V326, P682, DOI 10.1126/science.1178336; Ng'ayo MO, 2010, J VIROL METHODS, V163, P276, DOI 10.1016/j.jviromet.2009.10.009; PLUMMER FA, 1989, J CLIN INVEST, V83, P1472, DOI 10.1172/JCI114040; Ramjee G, 2002, AIDS BEHAV, V15, P687; Scelza BA, 2013, EVOL ANTHROPOL, V22, P259, DOI 10.1002/evan.21373; Schiffer JT, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0160; SIMON CP, 1992, SIAM J APPL MATH, V52, P541, DOI 10.1137/0152030; Singh S., 2014, ADD COSTS BEN INV SE; Strasser R, 2003, FAM PRACT, V20, P457, DOI 10.1093/fampra/cmg422; Talavera P., 2002, CHALLENGING NAMIBIAN; Tanser F, 2006, J EPIDEMIOL COMMUN H, V60, P846, DOI 10.1136/jech.2005.043265; Tanser F, 2006, SOC SCI MED, V63, P691, DOI 10.1016/j.socscimed.2006.01.015; The Namibian Ministry of Health and Social Services (MoHSS) International ICF, 2014, NAMB DEM HLTH SURV 2; Wakerman John, 2004, Aust J Rural Health, V12, P210, DOI 10.1111/j.1440-1854.2004.00607.x; Wald A., 2004, HERPES S3, V11; Watson-Jones D, 2007, JAIDS-J ACQ IMM DEF, V46, P631, DOI 10.1097/QAI.0b013e31815b2d9c; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; WHO World Health Organisation STD Statistics, 2001, GLOB PREV INC SEL CU; Wilkinson D, 1999, B WORLD HEALTH ORGAN, V77, P22; Zinsstag J, 2006, TROP MED INT HEALTH, V11, P565, DOI 10.1111/j.1365-3156.2006.01615.x	54	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191168	10.1371/journal.pone.0191168	http://dx.doi.org/10.1371/journal.pone.0191168			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU2GT	29385170	Green Submitted, gold, Green Published			2022-12-26	WOS:000423668400036
J	Leclaire, C; Lecointe, K; Gunning, PA; Tribolo, S; Kavanaugh, DW; Wittmann, A; Latousakis, D; MacKenzie, DA; Kawasaki, N; Juge, N				Leclaire, Charlotte; Lecointe, Karine; Gunning, Patrick A.; Tribolo, Sandra; Kavanaugh, Devon W.; Wittmann, Alexandra; Latousakis, Dimitrios; MacKenzie, Donald A.; Kawasaki, Norihito; Juge, Nathalie			Molecular basis for intestinal mucin recognition by galectin-3 and C-type lectins	FASEB JOURNAL			English	Article						mucus; O-glycosylation; N-glycosylation; immune system	N-LINKED OLIGOSACCHARIDES; BETA-GLUCAN RECEPTOR; 3-DERIVED O-GLYCANS; HUMAN DC-SIGN; GOBLET CELL; DENDRITIC CELLS; SPONTANEOUS COLITIS; EPITHELIAL BARRIER; ENDOTHELIAL-CELLS; IMMUNE-RESPONSES	Intestinal mucins trigger immune responses upon recognition by dendritic cells via protein-carbohydrate interactions. We used a combination of structural, biochemical, biophysical, and cell-based approaches to decipher the specificity of the interaction between mucin glycans and mammalian lectins expressed in the gut, including galectin (Gal)-3 and C-type lectin receptors. Gal-3 differentially recognized intestinal mucins with different O-glycosylation profiles, as determined by mass spectrometry (MS). Modification of mucin glycosylation, via chemical treatment leading to a loss of terminal glycans, promoted the interaction of Gal-3 to poly-N-acetyllactosamine. Specific interactions were observed between mucins and mouse dendritic cell-associated lectin (mDectin)-2 or specific intercellular adhesion molecule-grabbing nonintegrin-related-1 (SIGN-R1), but not mDectin-1, using a cell-reporter assay, as also confirmed by atomic force spectroscopy. We characterized the N-glycosylation profile of mouse colonic mucin (Muc)-2 by MS and showed that the interaction with mDectin-2 was mediated by high-mannose N-glycans. Furthermore, we observed Gal-3 binding to the 3 C-type lectins by force spectroscopy. We showed that mDectin-1, mDectin-2, and SIGN-R1 are decorated by N-glycan structures that can be recognized by the carbohydrate recognition domain of Gal-3. These findings provide a structural basis for the role of mucins in mediating immune responses and new insights into the structure and function of major mammalian lectins.	[Leclaire, Charlotte; Lecointe, Karine; Gunning, Patrick A.; Tribolo, Sandra; Kavanaugh, Devon W.; Wittmann, Alexandra; Latousakis, Dimitrios; MacKenzie, Donald A.; Kawasaki, Norihito; Juge, Nathalie] Quadram Inst Biosci, Norwich Res Pk, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute	Juge, N (corresponding author), Quadram Inst Biosci, Gut Hlth & Food Safety Inst, Strateg Programme, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England.	nathalie.juge@quadram.ac.uk	Latousakis, Dimitrios M/K-6269-2017	Latousakis, Dimitrios M/0000-0002-2472-9328; Juge, Nathalie/0000-0001-8515-1315; Lecointe, Karine/0000-0002-9916-5088; Kavanaugh, Devon/0000-0001-8831-8248; TRIBOLO, Sandra/0000-0002-2664-7553	Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC Institute Strategic Programme for The Gut Health and Food Safety [BB/J004529/1]; Institute of Food Research (IFR) Strategy Fund Grant; BBSRC Responsive Mode Grant [BB/K019554/1]; BBSRC [BBS/E/F/00044452, BBS/E/F/000PR10353, BB/K019554/1, BBS/E/F/000PR10355, BBS/E/F/000PR10356, BBS/E/F/00044504, BBS/E/F/00042548] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/000PR10353, BBS/E/F/000PR10356, BBS/E/F/00042548, BBS/E/F/00044452, BBS/E/F/000PR10355, BB/K019554/1, BBS/E/F/00044504] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Institute Strategic Programme for The Gut Health and Food Safety(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute of Food Research (IFR) Strategy Fund Grant; BBSRC Responsive Mode Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Dimitra Lamprinaki [Quadram Institute Bioscience (QIB, Norwich, United Kingdom)] for help with manuscript revisions. The work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) and was funded in part by a grant from the BBSRC Institute Strategic Programme for The Gut Health and Food Safety (BB/J004529/1) and the BB/K019554/1 BBSRC Responsive Mode Grant (to N.J.), and the Institute of Food Research (IFR) Strategy Fund Grant (to N.J. and N.K.). C.L. and K.L. are joint first authors. The authors declare no conflicts of interest.	An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; Ariizumi K, 2000, J BIOL CHEM, V275, P11957, DOI 10.1074/jbc.275.16.11957; Asker N, 1998, J BIOL CHEM, V273, P18857, DOI 10.1074/jbc.273.30.18857; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Bell SL, 2003, BIOCHEM J, V373, P893, DOI 10.1042/BJ20030096; Bene KP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00321; Bergstrom JH, 2016, P NATL ACAD SCI USA, V113, P13833, DOI 10.1073/pnas.1611400113; Bergstrom K, 2017, MUCOSAL IMMUNOL, V10, P91, DOI 10.1038/mi.2016.45; Bergstrom K, 2016, GASTROENTEROLOGY, V151, P152, DOI 10.1053/j.gastro.2016.03.039; Bergstrom KSB, 2013, GLYCOBIOLOGY, V23, P1026, DOI 10.1093/glycob/cwt045; Bian CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025007; Birchenough GMH, 2015, MUCOSAL IMMUNOL, V8, P712, DOI 10.1038/mi.2015.32; Birchenough GMH, 2016, SCIENCE, V352, P1535, DOI 10.1126/science.aaf7419; Bresalier RS, 1996, CANCER RES, V56, P4354; Capon C, 1997, J BIOL CHEM, V272, P31957, DOI 10.1074/jbc.272.51.31957; Chik JHL, 2014, J PROTEOMICS, V108, P146, DOI 10.1016/j.jprot.2014.05.002; Crost EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076341; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; Davies JR, 2012, METHODS MOL BIOL, V842, P27, DOI 10.1007/978-1-61779-513-8_2; Ermund A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083688; Garcia-Vallejo JJ, 2008, MOL IMMUNOL, V45, P2359, DOI 10.1016/j.molimm.2007.11.001; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geijtenbeek TBH, 2016, NAT REV IMMUNOL, V16, P433, DOI 10.1038/nri.2016.55; Gunning AP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111854; Gunning AP, 2013, FASEB J, V27, P2342, DOI 10.1096/fj.12-221416; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Hanisch FG, 2009, PROTEOMICS, V9, P710, DOI 10.1002/pmic.200800492; Herre J, 2004, MOL IMMUNOL, V40, P869, DOI 10.1016/j.molimm.2003.10.007; Hinterdorfer P, 2002, COLLOID SURFACE B, V23, P115, DOI 10.1016/S0927-7765(01)00256-9; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hollmig ST, 2009, GLYCOBIOLOGY, V19, P568, DOI 10.1093/glycob/cwp032; Larsson JMH, 2013, AM J PHYSIOL-GASTR L, V305, pG357, DOI 10.1152/ajpgi.00048.2013; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ismail MN, 2011, GLYCOBIOLOGY, V21, P82, DOI 10.1093/glycob/cwq134; Jensen PH, 2010, FEBS J, V277, P81, DOI 10.1111/j.1742-4658.2009.07429.x; Johansson MEV, 2014, CELL HOST MICROBE, V15, P251, DOI 10.1016/j.chom.2014.02.014; Johansson MEV, 2013, DIGEST DIS, V31, P305, DOI 10.1159/000354683; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Karlsson NG, 1997, BIOCHEM J, V326, P911, DOI 10.1042/bj3260911; Kataoka H, 2000, J BIOL CHEM, V275, P6573, DOI 10.1074/jbc.275.9.6573; Kato Y, 2006, BIOL PHARM BULL, V29, P1580, DOI 10.1248/bpb.29.1580; Kerscher B, 2013, INT IMMUNOL, V25, P271, DOI 10.1093/intimm/dxt006; Knoop KA, 2015, MUCOSAL IMMUNOL, V8, P198, DOI 10.1038/mi.2014.58; Koning N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00112; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; Lee RT, 2011, GLYCOBIOLOGY, V21, P512, DOI 10.1093/glycob/cwq193; Mason LH, 2003, J IMMUNOL, V171, P4235, DOI 10.4049/jimmunol.171.8.4235; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Miller MJ, 2014, MUCOSAL IMMUNOL, V7, P452, DOI 10.1038/mi.2014.4; Noll AJ, 2016, BIOCHEM J, V473, P1343, DOI 10.1042/BCJ20160046; Noll AJ, 2016, GLYCOBIOLOGY, V26, P655, DOI 10.1093/glycob/cww002; PAHLSSON P, 1995, EUR J IMMUNOL, V25, P2452, DOI 10.1002/eji.1830250907; Parent SA, 2002, GENE, V293, P33, DOI 10.1016/S0378-1119(02)00722-9; Pelaseyed T, 2014, IMMUNOL REV, V260, P8, DOI 10.1111/imr.12182; Plato A, 2013, INT REV IMMUNOL, V32, P134, DOI 10.3109/08830185.2013.777065; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; Robbe C, 2003, J BIOL CHEM, V278, P46337, DOI 10.1074/jbc.M302529200; Rodriguez-Pineiro AM, 2013, AM J PHYSIOL-GASTR L, V305, pG348, DOI 10.1152/ajpgi.00047.2013; Saijo S, 2011, INT IMMUNOL, V23, P467, DOI 10.1093/intimm/dxr046; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Ng SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052785; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Silva-Martin N, 2014, STRUCTURE, V22, P1595, DOI 10.1016/j.str.2014.09.001; Soilleux EJ, 2003, CLIN SCI, V104, P437, DOI 10.1042/CS20020092; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2004, J IMMUNOL, V172, P1157, DOI 10.4049/jimmunol.172.2.1157; Thomsson KA, 2012, GLYCOBIOLOGY, V22, P1128, DOI 10.1093/glycob/cws083; Tsuboi S, 2011, EMBO J, V30, P3173, DOI 10.1038/emboj.2011.215; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; van der Post S, 2014, J PROTEOME RES, V13, P6013, DOI 10.1021/pr500874f; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392; Wittmann A, 2016, J BIOL CHEM, V291, P17629, DOI 10.1074/jbc.M116.741256; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200	81	15	15	2	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3301	3320		10.1096/fj.201700619R	http://dx.doi.org/10.1096/fj.201700619R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401627	Green Published, Green Accepted			2022-12-26	WOS:000432546000033
J	Garwain, O; Valla, K; Scarlata, S				Garwain, Osama; Valla, Kaitlyn; Scarlata, Suzanne			Phospholipase C beta 1 regulates proliferation of neuronal cells	FASEB JOURNAL			English	Article						G protein signaling; cell proliferation; cyclin-dependent kinases	RNA INTERFERENCE; PC12 CELL; SIGNALING PATHWAY; NERVOUS-SYSTEM; LIVING CELLS; C ISOZYMES; CYCLIN Y; FACTOR-X; DIFFERENTIATION; ASSOCIATION	Cells have developed lineage-specific mechanisms to control proliferation and drive morphologic changes upon differentiation. A hallmark of differentiation is the assembly of signaling molecules that transduce extracellular signals, such as the production of the G protein-regulated enzyme phospholipase C beta 1 (PLC beta), which generates calcium signals from sensory stimuli. We found that in most cancerous cell lines there is positive correlation between PLC beta 1 levels and cell proliferation. In cells of neuronal lineage, however, reducing PLC beta 1 levels increases the rate of proliferation. Using a combination of biochemical and biophysical methods, we find that, in the G(1) phase, a cytosolic population of PLC beta 1 associates with cyclin-dependent kinase 16 (CDK16), a neuron-specific enzyme that is activated by cyclin Y to inactivate the antioncogenic protein p27(Ki)(p1). Binding of PLC beta 1 directly inhibits CDK16 activity and in turn reduces the ability of cells to enter the S phase. Activation of G alpha(q) by carbachol causes movement of PLC beta from the cytosol to the plasma membrane, reducing its association with CDK16. Similarly, the overexpression of activated G alpha(q) moves PLC beta 1 to the membrane, reverses G(1) arrest, and promotes proliferation, thereby connecting external stimuli with cell proliferation. Our results present a model in which the transient high expression of PLC beta 1 that occurs at the onset of differentiation arrests cells in the G(1) phase through its association with CDK16 and allows CDK16 to transition to its postmitotic function of neurite outgrowth and trafficking of synaptic vesicles. The novel role of PLC beta 1 in neuronal cell proliferation offers a unique interaction that can be manipulated to guide cells into a neuronal phenotype or to develop therapies for neuroblastomas.	[Garwain, Osama; Valla, Kaitlyn; Scarlata, Suzanne] Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA; [Scarlata, Suzanne] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	Worcester Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Scarlata, S (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	sfscarlata@wpi.edu			U.S. National Institutes of Health [GM116187]; Richard Whitcomb Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116178] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard Whitcomb Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Elizabeth Bavaro (Worcester Polytechnic Institute) for her help in cloning mCherry-CDK16. The authors are grateful for the support of U.S. National Institutes of Health Grant GM116187. O.G. is supported by a Richard Whitcomb Fellowship (to S.S.). The authors declare no conflicts of interest.	Aisiku OR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015001; Albasanz JL, 2005, NEUROBIOL DIS, V20, P685, DOI 10.1016/j.nbd.2005.05.001; AOKI K, 1995, NAT GENET, V10, P167, DOI 10.1038/ng0695-167; Cwiek P, 2015, ONCOTARGET, V6, P116; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Dwivedi Y, 2002, NEUROPHARMACOLOGY, V43, P1269, DOI 10.1016/S0028-3908(02)00253-8; Follo MY, 2009, J CLIN ONCOL, V27, P782, DOI 10.1200/JCO.2008.19.3748; Garwain O, 2016, J BIOL CHEM, V291, P22970, DOI 10.1074/jbc.M116.744953; Graeser R, 2002, J CELL SCI, V115, P3479; Han W., 2004, ANTIOXID REDOX SIGN, V3, P1065; Hannan AJ, 1998, NEUROPHARMACOLOGY, V37, P593, DOI 10.1016/S0028-3908(98)00056-2; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Jaendling A, 2010, BIOCHEM J, V429, P225, DOI 10.1042/BJ20100273; Li Z, 2008, BBA-GENE REGUL MECH, V1779, P479, DOI 10.1016/j.bbagrm.2008.03.008; Liu DM, 2010, FLY, V4, P278, DOI 10.4161/fly.4.4.12881; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Manning EE, 2012, HIPPOCAMPUS, V22, P309, DOI 10.1002/hipo.20900; Mikolcevic P, 2012, MOL CELL BIOL, V32, P868, DOI 10.1128/MCB.06261-11; Narayanan V, 2005, BIOCHEMISTRY-US, V44, P462, DOI 10.1021/bi0487140; OKUDA T, 1992, ONCOGENE, V7, P2249; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Palmer KJ, 2005, J CELL SCI, V118, P3839, DOI 10.1242/jcs.02496; Philip F, 2016, FASEB J, V30, P1958, DOI 10.1096/fj.201500140; Philip F, 2012, FASEB J, V26, P4903, DOI 10.1096/fj.12-213934; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Scarlata Suzanne, 2016, Advances in Biological Regulation, V61, P51, DOI 10.1016/j.jbior.2015.11.006; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Wang XS, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-30; Westerink RHS, 2008, ACTA PHYSIOL, V192, P273, DOI 10.1111/j.1748-1716.2007.01805.x; YAMADA M, 1991, DEV BRAIN RES, V59, P7, DOI 10.1016/0165-3806(91)90023-C; Yanagi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119404; Yanagi T, 2015, CELL CYCLE, V14, P463, DOI 10.1080/15384101.2015.1006539	35	9	10	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2891	2898		10.1096/fj.201701284R	http://dx.doi.org/10.1096/fj.201701284R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401590	Green Published			2022-12-26	WOS:000432528000046
J	Jena, PK; Sheng, L; Di Lucente, J; Jin, LW; Maezawa, I; Wan, YJY				Jena, Prasant Kumar; Sheng, Lili; Di Lucente, Jacopo; Jin, Lee-Way; Maezawa, Izumi; Wan, Yu-Jui Yvonne			Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet-induced systemic inflammation, microglial activation, and reduced neuroplasticity	FASEB JOURNAL			English	Article						gut microbiota; FXR; TGR5; cognition; Alzheimer's disease	RETINOIC ACID; ALZHEIMERS-DISEASE; LIPID-METABOLISM; CHOLESTEROL ACCUMULATION; HEPATIC INFLAMMATION; FECAL MICROBIOTA; GUT MICROBIOTA; ADIPOSE-TISSUE; RECEPTOR TGR5; PEPTIDE-YY	The goal of this study was to identify the intrinsic links that explain the effect of a Western diet (WD) on cognitive dysfunction. Specific pathogen-free, wild-type mice were fed either a control diet (CD) or a high-fat, high-sucrose WD after weaning and were euthanized at 10 mo of age to study the pathways that affect cognitive health. The results showed that long-term WD intake reduced hippocampal synaptic plasticity and the level of brain-derived neurotrophic factor mRNA in the brain and isolated microglia. A WD also activated ERK1/2 and reduced postsynaptic density-95 in the brain, suggesting postsynaptic damage. Moreover, WD-fed mice had increased inflammatory signaling in the brain, ileum, liver, adipose tissue, and spleen, which was accompanied by microglia activation. In the brain, as well as in the digestive tract, a WD reduced signaling regulated by retinoic acid and bile acids (BAs), whose receptors form heterodimers to control metabolism and inflammation. Furthermore, a WD intake caused dysbiosis and dysregulated BA synthesis with reduced endogenous ligands for BA receptors, i.e., farnesoid X receptor and G-protein-coupled bile acid receptor in the liver and brain. Together, dysregulated BA synthesis and dysbiosis were accompanied by systemic inflammation, microglial activation, and reduced neuroplasticity induced by WD.	[Jena, Prasant Kumar; Sheng, Lili; Di Lucente, Jacopo; Jin, Lee-Way; Maezawa, Izumi; Wan, Yu-Jui Yvonne] Univ Calif Davis, Dept Med Pathol & Lab Med, Sacramento, CA 95817 USA; [Di Lucente, Jacopo; Jin, Lee-Way; Maezawa, Izumi] Univ Calif Davis, Med Invest Neurodev Disorders Inst, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Wan, YJY (corresponding author), Univ Calif Davis, Davis Hlth Syst, Dept Med Pathol & Lab Med, Room 3400B,Res Bldg 3,4645 2nd Ave 3400STE, Sacramento, CA 95817 USA.	yjywan@ucdavis.edu	Jena, Prasant Kumar/L-4339-2017	Jena, Prasant Kumar/0000-0002-6729-5881	U.S. National Institutes of Health (NIH) National Cancer Institute [U01CA179582]; NIH National Institute on Aging [P30AG010129, R01AG043788]; NATIONAL CANCER INSTITUTE [U01CA179582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010129, R01AG043788] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Betty P. Guo for extensive review and editing of this manuscript, and Niki Taylor DeGeorge for editing (both from the University of California, Davis). This study was supported by U.S. National Institutes of Health (NIH) National Cancer Institute Grant U01CA179582, and NIH National Institute on Aging Grants P30AG010129 and R01AG043788. The authors declare no conflicts of interest.	Ali AH, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2014.12.06; Allen K, 2011, AM J PATHOL, V178, P175, DOI 10.1016/j.ajpath.2010.11.026; Attene-Ramos MS, 2006, MOL CANCER RES, V4, P9, DOI 10.1158/1541-7786.MCR-05-0126; Ayciriex S, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00211; Bala V, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00420; Barger SW, 2001, J NEUROCHEM, V76, P846, DOI 10.1046/j.1471-4159.2001.00075.x; Berti V, 2015, J NUTR HEALTH AGING, V19, P413, DOI 10.1007/s12603-014-0534-0; Bettcher BM, 2014, CLIN PHARMACOL THER, V96, P464, DOI 10.1038/clpt.2014.147; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Bonfili L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02587-2; Brown J, 2004, J BIOL CHEM, V279, P34674, DOI 10.1074/jbc.M402324200; CALI JJ, 1991, J BIOL CHEM, V266, P7779; Cassiman D, 2001, HEPATOLOGY, V33, P148, DOI 10.1053/jhep.2001.20793; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; CHRISTOPHERHENNING, 1995, IN VIVO, V9, P415; Cyphert HA, 2012, J BIOL CHEM, V287, P25123, DOI 10.1074/jbc.M112.375907; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; De Silva A, 2012, GUT LIVER, V6, P10, DOI 10.5009/gnl.2012.6.1.10; DELAFUENTE M, 1993, IMMUNOLOGY, V80, P259; Ding Y, 2008, J NEUROSCI, V28, P11622, DOI 10.1523/JNEUROSCI.3153-08.2008; Djelti F, 2015, BRAIN, V138, P2383, DOI 10.1093/brain/awv166; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Duboc H, 2014, DIGEST LIVER DIS, V46, P302, DOI 10.1016/j.dld.2013.10.021; Fader KA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05656-8; Friedland RP, 2015, J ALZHEIMERS DIS, V45, P349, DOI 10.3233/JAD-142841; Garcia-Canaveras JC, 2012, J LIPID RES, V53, P2231, DOI 10.1194/jlr.D028803; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Glinghammar B, 2002, CARCINOGENESIS, V23, P839, DOI 10.1093/carcin/23.5.839; Gong YS, 2010, AM J ALZHEIMERS DIS, V25, P547, DOI 10.1177/1533317510382893; Guay V, 2012, METABOLISM, V61, P76, DOI 10.1016/j.metabol.2011.06.002; Guo CS, 2016, IMMUNITY, V45, P944, DOI 10.1016/j.immuni.2016.10.009; HE YH, 2013, MATH PROBL ENG, V2013, P14, DOI DOI 10.1186/1471-2164-14-575; He YQ, 2014, AM J PHYSIOL-GASTR L, V307, pG205, DOI 10.1152/ajpgi.00105.2014; HEUMAN DM, 1989, J LIPID RES, V30, P719; Holland AM, 2016, AM J PHYSIOL-REG I, V311, pR337, DOI 10.1152/ajpregu.00156.2016; Hu N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/524820; Huang F, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00070; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Jayaraman A, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0476-2; Jeffery IB, 2012, GUT, V61, P997, DOI 10.1136/gutjnl-2011-301501; Jena PK, 2017, AM J PATHOL, V187, P1800, DOI 10.1016/j.ajpath.2017.04.019; Jiang CM, 2017, J ALZHEIMERS DIS, V58, P1, DOI 10.3233/JAD-161141; Jiang HY, 2015, BRAIN BEHAV IMMUN, V48, P186, DOI 10.1016/j.bbi.2015.03.016; Jin LW, 2015, J NEUROSCI, V35, P2516, DOI 10.1523/JNEUROSCI.2778-14.2015; Jolly AJ, 2009, FREE RADICAL RES, V43, P234, DOI 10.1080/10715760802684211; Kappe C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-276; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2010, GLIA, V58, P1794, DOI 10.1002/glia.21049; Keshava HB, 2017, MED HYPOTHESES, V104, P4, DOI 10.1016/j.mehy.2017.05.002; Kindy Mark S., 1999, J Alzheimers Dis, V1, P155; Kinzig KP, 2010, ENDOCRINOLOGY, V151, P3105, DOI 10.1210/en.2010-0175; Lavrnja I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02638-8; Li TG, 2012, J BIOL CHEM, V287, P1861, DOI 10.1074/jbc.M111.305789; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Lorbek G, 2012, FEBS J, V279, P1516, DOI 10.1111/j.1742-4658.2011.08432.x; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Bonet ML, 2012, BBA-MOL CELL BIOL L, V1821, P177, DOI 10.1016/j.bbalip.2011.06.001; Maezawa Izumi, 2012, Int J Alzheimers Dis, V2012, P868972, DOI 10.1155/2012/868972; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Mahony S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r2; Mamoon A, 2014, GENE, V550, P165, DOI 10.1016/j.gene.2014.07.017; Matsuzaki T, 2011, NEUROLOGY, V77, P1068, DOI 10.1212/WNL.0b013e31822e145d; McMillin M, 2015, J NEUROCHEM, V135, P565, DOI 10.1111/jnc.13243; Naseribafrouei A, 2014, NEUROGASTROENT MOTIL, V26, P1155, DOI 10.1111/nmo.12378; Nguyen HM, 2017, GLIA, V65, P106, DOI 10.1002/glia.23078; O'Brien KM, 2013, AM J PATHOL, V183, P1498, DOI 10.1016/j.ajpath.2013.07.019; Olazaran J, 2015, J ALZHEIMERS DIS, V45, P1157, DOI 10.3233/JAD-142925; Olson CR, 2010, MOL NUTR FOOD RES, V54, P489, DOI 10.1002/mnfr.200900246; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; Pathak P, 2017, J BIOL CHEM, V292, P11055, DOI 10.1074/jbc.M117.784322; Pinto-Sanchez MI, 2017, GASTROENTEROLOGY, V153, P448, DOI 10.1053/j.gastro.2017.05.003; Pistollato F, 2016, NUTR REV, V74, P624, DOI 10.1093/nutrit/nuw023; Posa M, 2017, MOL PHARMACEUT, V14, P3343, DOI 10.1021/acs.molpharmaceut.7b00375; Puig KL, 2017, SCI REP-UK, V7, DOI 10.1038/srep43725; Ramirez DMO, 2008, J COMP NEUROL, V507, P1676, DOI 10.1002/cne.21605; Sa-nguanmoo P, 2016, HORM BEHAV, V85, P86, DOI 10.1016/j.yhbeh.2016.08.006; Salehi M, 2010, DIABETES, V59, P1330, DOI 10.2337/db09-1253; Schilderink R, 2016, AM J PHYSIOL-GASTR L, V310, pG1138, DOI 10.1152/ajpgi.00411.2015; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schubring SR, 2012, NEUROSCI LETT, V506, P322, DOI 10.1016/j.neulet.2011.11.036; Shao CY, 2011, ACTA NEUROPATHOL, V122, P285, DOI 10.1007/s00401-011-0843-x; Sheng LL, 2017, J PATHOL, V243, P431, DOI 10.1002/path.4983; Sheng LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01576-9; Shihabudeen MS, 2015, MOL CELL ENDOCRINOL, V414, P19, DOI 10.1016/j.mce.2015.07.012; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; Swerdlow RH, 2011, BBA-MOL BASIS DIS, V1812, P1630, DOI 10.1016/j.bbadis.2011.08.012; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Trapp S, 2013, CURR OPIN PHARMACOL, V13, P964, DOI 10.1016/j.coph.2013.09.006; Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002; Tsuei J, 2014, EXP BIOL MED, V239, P1489, DOI 10.1177/1535370214538743; Ukropec Jozef, 2008, Archives of Physiology and Biochemistry, V114, P357, DOI 10.1080/13813450802535812 ; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Wang K, 2008, EXP BIOL MED, V233, P496, DOI 10.3181/0708-MR-231; Wang Q, 2017, MOL NEUROBIOL; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; Waszkielewicz AM, 2013, CURR MED CHEM, V20, P1241; Williams JE, 2017, J NUTR, V147, P1739, DOI 10.3945/jn.117.248864; Xie GX, 2016, INT J CANCER, V139, P1764, DOI 10.1002/ijc.30219; Xu HH, 2006, J NEUROIMMUNOL, V171, P135, DOI 10.1016/j.jneuroim.2005.10.004; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Yang F, 2014, BIOCHEM PHARMACOL, V91, P483, DOI 10.1016/j.bcp.2014.08.018; Yanguas-Casas N, 2017, J CELL PHYSIOL, V232, P2231, DOI 10.1002/jcp.25742; Yanovsky Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042512; Yau JLW, 2003, NEUROSCIENCE, V121, P307, DOI 10.1016/S0306-4522(03)00438-X; Yu Y, 2014, J ALZHEIMERS DIS, V38, P133, DOI 10.3233/JAD-130818; Yui S, 2009, NUTR CANCER, V61, P374, DOI 10.1080/01635580802582744; Zhan L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105930; Zhou J, 2006, OBESITY, V14, P683, DOI 10.1038/oby.2006.77	111	57	59	0	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2866	2877		10.1096/fj.201700984RR	http://dx.doi.org/10.1096/fj.201700984RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401580	Green Published			2022-12-26	WOS:000432528000044
J	Aira, LE; Villa, E; Colosetti, P; Gamas, P; Signetti, L; Obba, S; Proics, E; Gautier, F; Bailly-Maitre, B; Lacquel, A; Robert, G; Luciano, F; Juin, PP; Ricci, JE; Auberger, P; Marchetti, S				Aira, Lazaro E.; Villa, Elodie; Colosetti, Pascal; Gamas, Parvati; Signetti, Laurie; Obba, Sandrine; Proics, Emma; Gautier, Fabien; Bailly-Maitre, Beatrice; Lacquel, Arnaud; Robert, Guillaume; Luciano, Frederic; Juin, Philippe P.; Ricci, Jean-Ehrland; Auberger, Patrick; Marchetti, Sandrine			The oncogenic tyrosine kinase Lyn impairs the pro-apoptotic function of Bim	ONCOGENE			English	Article							FAMILY-MEMBER BIM; BCL-2 FAMILY; CELL-DEATH; B-CELLS; PHOSPHORYLATION; PROTEIN; HOMEOSTASIS; RESISTANCE; IMATINIB; PATHWAY	Phosphorylation of Ser/Thr residues is a well-established modulating mechanism of the pro-apoptotic function of the BH3-only protein Bim. However, nothing is known about the putative tyrosine phosphorylation of this Bcl-2 family member and its potential impact on Bim function and subsequent Bax/Bak-mediated cytochrome c release and apoptosis. As we have previously shown that the tyrosine kinase Lyn could behave as an anti-apoptotic molecule, we investigated whether this Src family member could directly regulate the pro-apoptotic function of Bim. In the present study, we show that Bim is phosphorylated onto tyrosine residues 92 and 161 by Lyn, which results in an inhibition of its pro-apoptotic function. Mechanistically, we show that Lyn-dependent tyrosine phosphorylation of Bim increases its interaction with anti-apoptotic members such as Bcl-xL, therefore limiting mitochondrial outer membrane permeabilization and subsequent apoptosis. Collectively, our data uncover one molecular mechanism through which the oncogenic tyrosine kinase Lyn negatively regulates the mitochondrial apoptotic pathway, which may contribute to the transformation and/or the chemotherapeutic resistance of cancer cells.	[Aira, Lazaro E.; Villa, Elodie; Colosetti, Pascal; Gamas, Parvati; Signetti, Laurie; Obba, Sandrine; Proics, Emma; Bailly-Maitre, Beatrice; Lacquel, Arnaud; Robert, Guillaume; Luciano, Frederic; Ricci, Jean-Ehrland; Auberger, Patrick; Marchetti, Sandrine] Univ Cote dAzur, INSERM, C3M, Nice, France; [Gautier, Fabien; Juin, Philippe P.] Univ Nantes, Univ Angers, Inst Rech Sante, INSERM,CRCINA,UMR 1232, 8 Quai Moncousu,BP 70721, F-44007 Nantes 1, France; [Gautier, Fabien; Juin, Philippe P.] Inst Cancerol Ouest, Bvd J Monod,Site Rene Gauducheau, F-44805 St Herblain, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Universite d'Angers; UNICANCER; Institut de Cancerologie de l'Ouest (ICO)	Marchetti, S (corresponding author), Univ Cote dAzur, INSERM, C3M, Nice, France.	marchett@unice.fr	AUBERGER, Patrick/G-1491-2013; Ricci, Jean Ehrland/I-7117-2016; robert, guillaume/O-1935-2017; Jacquel, Arnaud/O-1928-2017; Colosetti, Pascal/ABH-4585-2020; Jacquel, Arnaud/AAJ-4760-2021; Marchetti, Sandrine/P-6479-2016; luciano, frederic/P-6264-2016; RICCI, Jean Ehrland/AAS-4379-2020; JUIN, Philippe/Q-1338-2019; JUIN, Philippe P/H-3636-2014; Carmen, Team2/Y-7383-2019	AUBERGER, Patrick/0000-0002-2481-8275; Ricci, Jean Ehrland/0000-0003-1585-8117; robert, guillaume/0000-0002-6350-2222; Jacquel, Arnaud/0000-0001-5062-8048; Jacquel, Arnaud/0000-0001-5062-8048; Marchetti, Sandrine/0000-0001-8326-5730; luciano, frederic/0000-0001-9253-4998; RICCI, Jean Ehrland/0000-0003-1585-8117; JUIN, Philippe/0000-0002-4997-3888; JUIN, Philippe P/0000-0002-4997-3888; Carmen, Team2/0000-0001-9867-5724; Lab, Carmen/0000-0002-5935-3236; Colosetti, Pascal/0000-0002-5848-6053; Bailly-Maitre, Beatrice/0000-0002-8389-8498	Fondation ARC pour la Recherche sur le Cancer [PJA 20131200392, PGA1RF201702053889]; Fondation pour la Recherche Medicale [DMP20101120387]; INSERM; Ministere de la Recherche; University of Nice-Sophia-Antipolis; French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE [ANR-11-LABX-0028-01]; Conseil general des AM et de la region PACA et Corse	Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); University of Nice-Sophia-Antipolis; French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE(French National Research Agency (ANR)); Conseil general des AM et de la region PACA et Corse	This work was supported by grants from the Fondation ARC pour la Recherche sur le Cancer (#PJA 20131200392 and #PGA1RF201702053889), the Fondation pour la Recherche Medicale (DMP20101120387), the INSERM, the Ministere de la Recherche, and the University of Nice-Sophia-Antipolis. This work and LEA were funded by the French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE: program reference #ANR-11-LABX-0028-01. We thank Frederic Larbret for technical support for FACS sorting. We thank Dr. Simon Cook for GST-Bim constructs, Dr. Andreas Villunger for kindly providing the WEHI-231 cell line, Dr. David Rubinsztein for the plasmid encoding human BimEL, and Drs. Doug Green and Stephen Tait for HeLa cells stably expressing Smac-GFP. We thank Drs. Eric Eldering and Fabio Brocco for insights and helpful discussion. We thank the Conseil general des AM et de la region PACA et Corse for its financial support.	Ban T, 2016, IMMUNITY, V45, P319, DOI 10.1016/j.immuni.2016.07.015; Belloc F, 2007, CANCER BIOL THER, V6, P912, DOI 10.4161/cbt.6.6.4101; Bian YY, 2016, NAT CHEM BIOL, V12, P959, DOI [10.1038/NCHEMBIO.2178, 10.1038/nchembio.2178]; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Carpenter RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078836; Chen WS, 1999, INT J CANCER, V83, P579, DOI 10.1002/(SICI)1097-0215(19991126)83:5<579::AID-IJC1>3.0.CO;2-R; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Clybouw C, 2012, CELL DEATH DIFFER, V19, P1060, DOI 10.1038/cdd.2011.198; Contri A, 2005, J CLIN INVEST, V115, P369, DOI 10.1172/JC1200522094; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; Fox JL, 2010, EMBO J, V29, P3853, DOI 10.1038/emboj.2010.244; Gamas P, 2009, LEUKEMIA, V23, P1500, DOI 10.1038/leu.2009.60; Gogada R, 2013, J BIOL CHEM, V288, P368, DOI 10.1074/jbc.M112.386102; Goldenberg-Furmanov M, 2004, CANCER RES, V64, P1058, DOI 10.1158/0008-5472.CAN-03-2420; GREEN DR, 2015, COLD SPRING HARB PER, V7, DOI DOI 10.1101/CSHPERSPECT.A006080; Gross AJ, 2011, EUR J IMMUNOL, V41, P3645, DOI 10.1002/eji.201141708; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harder KW, 2001, IMMUNITY, V15, P603, DOI 10.1016/S1074-7613(01)00208-4; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Ingley E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-21; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Leonard JT, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5309; Ley R, 2004, J BIOL CHEM, V279, P8837, DOI 10.1074/jbc.M311578200; Lopez J, 2012, CELL DEATH DIFFER, V19, P1459, DOI 10.1038/cdd.2012.21; Luciano F, 2003, FASEB J, V17, P711, DOI 10.1096/fj.02-0716fje; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Luciano F, 2001, ONCOGENE, V20, P4935, DOI 10.1038/sj.onc.1204661; Luo SQ, 2012, MOL CELL, V47, P359, DOI 10.1016/j.molcel.2012.05.040; Mahon FX, 2008, CANCER RES, V68, P9809, DOI 10.1158/0008-5472.CAN-08-1008; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pecot J, 2016, CELL REP, V17, P3347, DOI 10.1016/j.celrep.2016.11.064; Pinon JD, 2008, ONCOGENE, V27, pS41, DOI 10.1038/onc.2009.42; Ptasznik A, 2004, NAT MED, V10, P1187, DOI 10.1038/nm1127; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ricci JE, 2001, FASEB J, V15, P1777, DOI 10.1096/fj.00-0665fje; Rooswinkel RW, 2014, BLOOD, V123, P2806, DOI 10.1182/blood-2013-08-519470; Scapini P, 2009, IMMUNOL REV, V228, P23, DOI 10.1111/j.1600-065X.2008.00758.x; Sionov RV, 2015, ONCOTARGET, V6, P23058, DOI 10.18632/oncotarget.5492; Tait SWG, 2010, DEV CELL, V18, P802, DOI [10.1016/j.devcel.2010.03.014, 10.1016/j.devce1.2010.03.014]; Tauzin S, 2008, BLOOD, V111, P2310, DOI 10.1182/blood-2007-05-090985; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Zonta F, 2014, BLOOD, V123, P875, DOI 10.1182/blood-2013-02-485540	52	5	5	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	16					2122	2136		10.1038/s41388-017-0112-0	http://dx.doi.org/10.1038/s41388-017-0112-0			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GD5ZV	29391601				2022-12-26	WOS:000430589000004
J	Ulaganathan, T; Helbert, W; Kopel, M; Banin, E; Cygler, M				Ulaganathan, ThirumalaiSelvi; Helbert, William; Kopel, Moran; Banin, Ehud; Cygler, Miroslaw			Structure-function analyses of a PL24 family ulvan lyase reveal key features and suggest its catalytic mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROMOLECULAR CRYSTALLOGRAPHY; PERSICIVIRGA-ULVANIVORANS; POLYSACCHARIDE; ENZYMES; HYDROGELS	Ulvan is a major cell wall component of green algae of the genus Ulva, and some marine bacteria encode enzymes that can degrade this polysaccharide. The first ulvan-degrading lyases have been recently characterized, and several putative ulvan lyases have been recombinantly expressed, confirmed as ulvan lyases, and partially characterized. Two families of ulvan-degrading lyases, PL24 and PL25, have recently been established. The PL24 lyase LOR_107 from the bacterial Alteromonadales sp. strain LOR degrades ulvan endolytically, cleaving the bond at the C4 of a glucuronic acid. However, the mechanism and LOR_107 structural features involved are unknown. We present here the crystal structure of LOR_107, representing the first PL24 family structure. We found that LOR_107 adopts a seven-bladed beta-propeller fold with a deep canyon on one side of the protein. Comparative sequence analysis revealed a cluster of conserved residues within this canyon, and site-directed mutagenesis disclosed several residues essential for catalysis. We also found that LOR_107 uses the His/Tyr catalytic mechanism, common to several PL families. We captured a tetrasaccharide substrate in the structures of two inactive mutants, which indicated a two-step binding event, with the first substrate interaction near the top of the canyon coordinated by Arg(320), followed by sliding of the substrate into the canyon toward the active-site residues. Surprisingly, the LOR_107 structure was very similar to that of the PL25 family PLSV_3936, despite only similar to 14% sequence identity between the two enzymes. On the basis of our structural and mutational analyses, we propose a catalytic mechanism for LOR_107 that differs from the typical His/Tyr mechanism.	[Ulaganathan, ThirumalaiSelvi; Cygler, Miroslaw] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Helbert, William] Univ Grenoble Alpes, Rue Chim, F-38000 Grenoble, France; [Helbert, William] CERMAV, CNRS, UPR 5301 601, Rue Chim, F-38000 Grenoble, France; [Helbert, William] FR CNRS 2607, Inst Chim Mol Grenoble, ICMG, Grenoble, France; [Kopel, Moran; Banin, Ehud] Bar Ilan Univ, Inst Nanotechnol & Adv Mat & Mina & Everard Goodm, Fac Life Sci, IL-52900 Ramat Gan, Israel; [Cygler, Miroslaw] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada	University of Saskatchewan; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Bar Ilan University; McGill University	Cygler, M (corresponding author), Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada.	miroslaw.cygler@usask.ca			Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank Drs. Jeremy Lee and David R. Palmer for helpful discussions. We acknowledge the Protein Characterization and Crystallization Facility, College of Medicine, University of Saskatchewan, for access to the crystallization robot. Research described in this paper was performed using beamline 08ID-1 at the Canadian Light Source, which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research.	Abbott DW, 2010, J BIOL CHEM, V285, P39029, DOI 10.1074/jbc.M110.153981; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Alves A, 2013, J BIOMED MATER RES A, V101, P998, DOI 10.1002/jbm.a.34403; Barbeyron T, 2011, INT J SYST EVOL MICR, V61, P1899, DOI 10.1099/ijs.0.024489-0; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collen PN, 2011, J BIOL CHEM, V286, P42063, DOI 10.1074/jbc.M111.271825; Cunha L, 2016, MAR DRUGS, V14, DOI 10.3390/md14030042; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Delattre C, 2006, APPL MICROBIOL BIOT, V70, P437, DOI 10.1007/s00253-005-0077-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foran E, 2017, ALGAL RES, V25, P39, DOI 10.1016/j.algal.2017.04.036; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; Garron ML, 2014, CURR OPIN STRUC BIOL, V28, P87, DOI 10.1016/j.sbi.2014.07.012; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Grochulski P, 2011, J SYNCHROTRON RADIAT, V18, P681, DOI 10.1107/S0909049511019431; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kopel M., 2014, GENOME ANNOUNC, V2; Kopel M., 2014, GENOME ANNOUNC, V2; Kopel M., 2014, GENOME ANNOUNC, V2; Kopel M, 2016, J BIOL CHEM, V291, P5871, DOI 10.1074/jbc.M115.673947; Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Manivasagan P, 2016, INT J BIOL MACROMOL, V82, P315, DOI 10.1016/j.ijbiomac.2015.10.081; Morelli A, 2016, CARBOHYD POLYM, V136, P1108, DOI 10.1016/j.carbpol.2015.09.068; Popa EG, 2015, CRIT REV BIOTECHNOL, V35, P410, DOI 10.3109/07388551.2014.889079; Skubak P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3777; Ulaganathan T, 2017, ACS CHEM BIOL, V12, P1269, DOI 10.1021/acschembio.7b00126; Walden H, 2010, ACTA CRYSTALLOGR D, V66, P352, DOI 10.1107/S0907444909038207	31	19	20	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4026	4036		10.1074/jbc.RA117.001642	http://dx.doi.org/10.1074/jbc.RA117.001642			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29382716	Green Published, hybrid			2022-12-26	WOS:000427587500015
J	Takahashi, H; Kozhuharova, A; Sharma, H; Hirose, M; Ohyama, T; Fasolo, F; Yamazaki, T; Cotella, D; Santoro, C; Zucchelli, S; Gustincich, S; Carninci, P				Takahashi, Hazuki; Kozhuharova, Ana; Sharma, Harshita; Hirose, Masakazu; Ohyama, Takako; Fasolo, Francesca; Yamazaki, Toshio; Cotella, Diego; Santoro, Claudio; Zucchelli, Silvia; Gustincich, Stefano; Carninci, Piero			Identification of functional features of synthetic SINEUPs, antisense lncRNAs that specifically enhance protein translation	PLOS ONE			English	Article							RNA-POLYMERASE-II; LONG NONCODING RNAS; DOUBLE-STRANDED-RNA; ANALYSIS GENE-EXPRESSION; IN-VIVO; B2 RNA; REPETITIVE ELEMENTS; SECONDARY STRUCTURE; TRANSCRIPTION; GENOME	SINEUPs are antisense long noncoding RNAs, in which an embedded SINE B2 element UP-regulates translation of partially overlapping target sense mRNAs. SINEUPs contain two functional domains. First, the binding domain (BD) is located in the region antisense to the target, providing specific targeting to the overlapping mRNA. Second, the inverted SINE B2 represents the effector domain (ED) and enhances translation. To adapt SINEUP technology to a broader number of targets, we took advantage of a high-throughput, semi-automated imaging system to optimize synthetic SINEUP BD and ED design in HEK293T cell lines. Using SINEUP-GFP as a model SINEUP, we extensively screened variants of the BD to map features needed for optimal design. We found that most active SINEUPs overlap an AUG-Kozak sequence. Moreover, we report our screening of the inverted SINE B2 sequence to identify active sub-domains and map the length of the minimal active ED. Our synthetic SINEUP-GFP screening of both BDs and EDs constitutes a broad test with flexible applications to any target gene of interest.	[Takahashi, Hazuki; Kozhuharova, Ana; Sharma, Harshita; Hirose, Masakazu; Carninci, Piero] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan; [Ohyama, Takako; Yamazaki, Toshio] RIKEN Ctr Life Sci Technol, Div Struct & Synthet Biol, Yokohama, Kanagawa, Japan; [Fasolo, Francesca; Zucchelli, Silvia; Gustincich, Stefano] Scuola Int Super Studi Avanzati, Area Neurosci, Trieste, Italy; [Cotella, Diego; Santoro, Claudio; Zucchelli, Silvia] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Santoro, Claudio] Univ Piemonte Orientale, IRCAD, Novara, Italy; [Gustincich, Stefano] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy; [Carninci, Piero] TransSINE Technol, Yokohama, Kanagawa, Japan	RIKEN; RIKEN; International School for Advanced Studies (SISSA); University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Istituto Italiano di Tecnologia - IIT	Carninci, P (corresponding author), RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan.; Carninci, P (corresponding author), TransSINE Technol, Yokohama, Kanagawa, Japan.	carninci@riken.jp	Carninci, Piero/K-1568-2014; cotella, diego/J-8422-2019; Takahashi, Hazuki/F-9007-2017	Carninci, Piero/0000-0001-7202-7243; cotella, diego/0000-0003-2714-4744; Gustincich, Stefano/0000-0002-2749-2514; Zucchelli, Silvia/0000-0003-4556-2990; Takahashi, Hazuki/0000-0001-7315-7349; Fasolo, Francesca/0000-0002-2491-4822	MEXT; AMED; Telethon grant [GGP15004]; Italian Ministry of Education, University and Research (FIRB) [RBAP11FRE9]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED; Telethon grant(Fondazione Telethon); Italian Ministry of Education, University and Research (FIRB)(Ministry of Education, Universities and Research (MIUR))	This work was founded by a Research Grant from MEXT to the RIKEN Center for Life Science Technologies (grant number N/A, http://www.mext.go.jp/en/) and Grant from AMED to Basic Science and Platform Technology Program for Innovative Biological Medicine (grant number N/A, http://www.i-biomed.jp/en/) to Piero Carninci in Japan. This work was also supported by Telethon grant (GGP15004, http://www.telethon.it/en) and Italian Ministry of Education, University and Research (FIRB grant RBAP11FRE9, http://www.istruzione.it/) to Stefano Gustincich in Italy. TransSINE Technologies has not provided actual funding to this research, nor direct salaries or any direct benefits to any of the members participating in this study. TransSINE Technologies has only provided information that was necessary to the design and the execution of the project. PC, who is also affiliated to TransSINE Technologies, has a key role in the design of the study.	Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; BENNETT KL, 1984, MOL CELL BIOL, V4, P1561, DOI 10.1128/MCB.4.8.1561; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carrieri C, 2015, FRONTIERS CELLULAR N, P9; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Chu WM, 1998, MOL CELL BIOL, V18, P58, DOI 10.1128/MCB.18.1.58; DAVIES MV, 1989, P NATL ACAD SCI USA, V86, P9163, DOI 10.1073/pnas.86.23.9163; Espinoza CA, 2004, NAT STRUCT MOL BIOL, V11, P822, DOI 10.1038/nsmb812; Espinoza CA, 2007, RNA, V13, P583, DOI 10.1261/rna.310307; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Ferrigno O, 2001, NAT GENET, V28, P77, DOI 10.1038/ng0501-77; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fort A, 2014, NAT GENET, V46, P558, DOI 10.1038/ng.2965; Gustincich S, 2016, PROG NEUROBIOL; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P2374, DOI 10.1093/nar/gkl246; Indrieri A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27315; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; JANG KL, 1992, J ACQ IMMUN DEF SYND, V5, P1142; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kim Y, 2014, GENE DEV, V28, P1310, DOI 10.1101/gad.242644.114; Kramerov DA, 2005, INT REV CYTOL, V247, P165, DOI 10.1016/S0074-7696(05)47004-7; Lam JKW, 2015, MOL THERAPY NUCL ACI, P4; Long H, 2016, BIOTECHNOL LETT; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Ohnuki M, 2014, P NATL ACAD SCI USA, V111, P12426, DOI 10.1073/pnas.1413299111; PANNING B, 1993, MOL CELL BIOL, V13, P3231, DOI 10.1128/MCB.13.6.3231; Patrucco L, 2015, GENE, V569, P287, DOI 10.1016/j.gene.2015.05.070; Piskurek O, 2003, MOL BIOL EVOL, V20, P1659, DOI 10.1093/molbev/msg187; Schein A, 2016, SCI REP, P6; Schroer A, 1999, GENOMICS, V56, P340, DOI 10.1006/geno.1998.5712; Shedlock AM, 2000, BIOESSAYS, V22, P148, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;148::AID-BIES6&gt;3.0.CO;2-Z; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Spitale RC, 2015, NATURE, V519, P486, DOI 10.1038/nature14263; Takahashi H, 2014, BIOCHEM BIOPH RES CO, V452, P294, DOI 10.1016/j.bbrc.2014.08.139; Takahashi H, 2012, NAT PROTOC, V7, P542, DOI 10.1038/nprot.2012.005; Upton KR, 2015, CELL, V161, P228, DOI 10.1016/j.cell.2015.03.026; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Williams WP, 2004, VIROLOGY, V327, P233, DOI 10.1016/j.virol.2004.06.040; Wittrup A, 2015, NAT REV GENET, V16, P543, DOI 10.1038/nrg3978; Yakovchuk P, 2009, P NATL ACAD SCI USA, V106, P5569, DOI 10.1073/pnas.0810738106; Yao Y, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv125; Zhao HW, 2005, MOL BIOL CELL, V16, P5857, DOI 10.1091/mbc.E05-08-0705; Zucchelli S, 2015, RNA BIOL, V12, P771, DOI 10.1080/15476286.2015.1060395; Zucchelli S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00174	48	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0183229	10.1371/journal.pone.0183229	http://dx.doi.org/10.1371/journal.pone.0183229			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414979	Green Published, gold, Green Submitted			2022-12-26	WOS:000424325300002
J	Arendt, E; Singh, NS; Campbell, OMR				Arendt, Esther; Singh, Neha S.; Campbell, Oona M. R.			Effect of maternal height on caesarean section and neonatal mortality rates in sub-Saharan Africa: An analysis of 34 national datasets	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; FOR-GESTATIONAL-AGE; SYSTEMATIC ANALYSIS; RISK; INTERVENTIONS; NUTRITION; PRETERM; LIFE; PREVENTION; TRENDS	Rationale The lifecycle perspective reminds us that the roots of adult ill-health may start in-utero or in early childhood. Nutritional and infectious disease insults in early life, the critical first 1000 days, are associated with stunting in childhood, and subsequent short adult stature. There is limited or no opportunity for stunted children above 2 years of age to experience catch-up growth. Some previous research has shown short maternal height to lead to adverse birth outcomes. In this paper, we document the association between maternal height and caesarean section, and between maternal height and neonatal mortality in 34 sub-Saharan African countries. We also explore the appropriate height cut-offs to use. Our paper contributes arguments to support a focus on preventing non-communicable risk factors, namely early childhood under-nutrition, as part of the fight to reduce caesarean section rates and other adverse maternal and newborn health outcomes, particularly neonatal mortality. We focus on the Sub-Saharan Africa region because it carries the highest burden of maternal and neonatal ill-health. Methods We used the most recent Demographic and Health Survey for 34 sub-Saharan African countries. The distribution of heights of women who had given birth in the 5 years before the survey was explored. We adopted the following cut-offs: Very Short (<145.0cm), Short (145.0-149.9cm), Short-average (150.0-154.9cm), Average (155.0-159.9cm), Average-tall (160.0-169.9cm) and Tall (>= 170.0cm). Multivariate logistic regression was used to assess the contribution of maternal stature to the odds ratio of caesarean section delivery, adjusting for other exposures, such as age at index birth, residence, maternal BMI, maternal education, wealth index quintile, previous caesarean section, multiple birth, birth order and country of survey. We also look at its contribution to neonatal mortality adjusting for age at index birth, residence, maternal BMI, maternal education, wealth index quintile, multiple birth, birth order and country of survey. Results There was a gradual increase in the rate of caesarean section with decreasing maternal height. Compared to women of Average height (155.0-159.9cm), taller women were protected. The adjusted odds ratio (aOR) for Tall women was 0.67 (95% CI:0.52-0.87) and for Average-tall women was 0.78 (95% CI:0.69-0.89). Compared to women of Average height, shorter women were at increased risk. The aOR for Short-average women was 1.19 (95% CI:1.03-1.37), for Short women was 2.06 (95% CI:1.71-2.48), and for Very Short women was 2.50 (95% CI:1.85-3.38). There was evidence that compared to Average height women, Very Short and Short women had increased odds of experiencing a neonatal death aOR = 1.95 (95% CI 1.17-3.25) and aOR = 1.66 (95% CI 1.20-2.28) respectively. When we focused on the period of highest risk, the day of delivery and first postnatal day, these aORs increased to 2.36 (95% CI 1.57-3.55) and 2.34 (95% CI 1.19-4.60) respectively. The aORs for the first week of life (early neonatal mortality) were 1.90 (95% CI 1.07-3.36) and 1.83 (95% CI 1.30-2.59) respectively. Conclusions Short stature is associated with an increased prevalence of caesarean section and neonatal mortality, particularly on the newborn's first days. These results are even more striking because we know that caesarean section rates tend to be higher among wealthier and more educated women, who are often taller and that the same patterns may hold for neonatal survival; in such cases, adjusting for wealth, education and urban residence would attenuate these associations. Caesarean sections can be lifesaving operations; however, they cost the health system and families more, and are associated with worse health outcomes. We suggest that our findings be used to argue for policies targeting stunting in infant girls and potential catch-up growth in adolescence and early adulthood, aiming to increase their adult height and thus decrease their subsequent risk of experiencing caesarean section and adverse birth outcomes.	[Arendt, Esther; Campbell, Oona M. R.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Singh, Neha S.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Arendt, E (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.	arendtesther@gmail.com		Singh, Neha/0000-0003-0057-121X				Akinola OI, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-217; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; [Anonymous], 1985, LANCET, V2, P436; [Anonymous], 1995, Bull World Health Organ, V73 Suppl, P1; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Benjamin SJ, 2012, ACTA OBSTET GYNECOL, P91; Bentham J, 2016, ELIFE, V5, DOI 10.7554/eLife.13410.001; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Bonita R., 2006, BASIC EPIDEMIOLOGY, V2nd ed.; CAMILLERI AP, 1981, EUR J OBSTET GYN R B, V12, P347, DOI 10.1016/0028-2243(81)90080-0; Cavallaro FL, 2013, B WORLD HEALTH ORGAN, P91; Chalumeau M, 2002, INT J EPIDEMIOL, V31, P661, DOI 10.1093/ije/31.3.661; Christian P, 2013, INT J EPIDEMIOL; Crenshaw JT, 2014, J PERINAT EDUC, V23, P211, DOI 10.1891/1058-1243.23.4.211; Cresswell JA, 2012, LANCET, V380, P1325, DOI 10.1016/S0140-6736(12)60869-1; Darnton-Hill I, 2004, PUBLIC HEALTH NUTR, V7, P101, DOI 10.1079/PHN2003584; Derraik JGB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154304; Enwerem NY, 2014, AFR J REPROD HEALTH, V18, P54; Gebremedhin S, 2014, REPROD HLTH, P11; Gudmundsson S, 2005, BJOG-INT J OBSTET GY, V112, P764, DOI 10.1111/j.1471-0528.2004.00545.x; Harrison MS, 2016, MATERNAL HLTH NEONAT, V2, P1, DOI DOI 10.1186/s40748-016-0033-x; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Kozuki N, 2015, J NUTR, V145, P2542, DOI 10.3945/jn.115.216374; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Marshall N, 2014, AM J OBSTET GYNECOL, V210, pS252, DOI 10.1016/j.ajog.2013.10.541; MARTORELL R, 1989, HUM ORGAN, V48, P15, DOI 10.17730/humo.48.1.x20u5450x51h5211; Munabi Ian G, 2015, BMC Res Notes, V8, P54, DOI 10.1186/s13104-015-1013-3; Okewole IA, 2011, J OBSTET GYNAECOL, P31; Ozaltin E, 2010, JAMA-J AM MED ASSOC, P303; Perkins JM, 2016, NUTR REV, V74, P149, DOI 10.1093/nutrit/nuv105; Perry GH, 2009, TRENDS ECOL EVOL, V24, P218, DOI 10.1016/j.tree.2008.11.008; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Program D.a.H.S., DHS FIN REP; Ramakrishnan U, 1999, J NUTR, V129, p544S, DOI 10.1093/jn/129.2.544S; Rey H, 1995, Bull World Health Organ, V73 Suppl, P70; Robson MS, 2001, FETAL MATERN MED REV, V12, P23, DOI [DOI 10.1017/S0965539501000122, 10.1017/S0965539501000122]; Rowe-Murray HJ, 2002, BIRTH-ISS PERINAT C, V29, P124, DOI 10.1046/j.1523-536X.2002.00172.x; Sear R, SOCIOECONOMIC ASPECT, P203; Sheinera E, 2005, EUR J OBSTET GYN R B, P120; Stein AD, 2004, PEDIATRICS, V113, pE270, DOI 10.1542/peds.113.3.e270; Stulp G, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0211; Stulp G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028991, 10.1371/journal.pone.0020497]; Subramanian SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018962; Sutan R, 2010, J PERINATOL, V30, P311, DOI 10.1038/jp.2009.158; United Nations Department of Economic and Social Affairs Population Division, 2015, WORLD POP PROSP 2015; Wall LL, 2004, AM J OBSTET GYNECOL, V190, P1011, DOI 10.1016/j.ajog.2004.02.007; Watson-Jones D, 2007, B WORLD HEALTH ORGAN, V85, P9, DOI 10.2471/BLT.06.033258	51	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192167	10.1371/journal.pone.0192167	http://dx.doi.org/10.1371/journal.pone.0192167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408912	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000424302800047
J	Ronque, ERV; Werneck, AO; Bueno, MRO; Cyrino, ES; Stanganelli, LCR; Arruda, M				Ronque, Enio R. V.; Werneck, Andre O.; Bueno, Maria R. O.; Cyrino, Edilson S.; Stanganelli, Luiz C. R.; Arruda, Miguel			Tracking of body adiposity indicators from childhood to adolescence: Mediation by BMI	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; PHYSICAL-ACTIVITY; YOUNG ADULTHOOD; CARDIORESPIRATORY FITNESS; MASS INDEX; OBESITY; CHILDREN; FATNESS; ASSOCIATIONS; WEIGHT	Our aim was to verify the tracking of body adiposity indicators from childhood to adolescence and analyze the mediation effects of BMI on the stability of body adiposity. Our sample was composed by 375 children (197 boys). The children were followed-up over 3 years. Body mass and stature were measured as anthropometric indicators. Body adiposity was estimated through the subcutaneous skinfold method, with measures of triceps (TRSF) and subscapular skinfolds (SSSF). Skinfolds were analyzed singly and agglutinated through the sum of skinfolds (Sigma SF). The sample was categorized into tertiles, and thereafter, the kappa coefficient and McNemar test were adopted to verify stability. For continuous measures, the Intra-Class Correlation coefficient (ICC) was used. Moreover, mediation analyzes were used according to Baron and Kenny with the Sobel test to verify mediation effects. The significance level adopted was 5%. Adiposity indicators increased during the 3 years of follow-up in both sexes (p<0.05). ICCs in all indicators of adiposity were between 0.84 and 0.94 for boys and 0.86 and 0.94 for girls, indicating high tracking. Moreover, 70% of subjects remained in the highest tertile of body adiposity. However, no differences were observed in tertile changes (p>0.05). BMI at the age of adiposity rebound partially mediated all indicators of adiposity from childhood (baseline) to adolescence (3 years later) in both sexes (p<0.001). Thus, moderate to high tracking of body adiposity indicators between childhood and adolescence was verified. Moreover, BMI at the age of adiposity rebound partially mediated the relationship between adiposity in childhood (baseline) and in adolescence (3 years of follow-up).	[Ronque, Enio R. V.; Werneck, Andre O.; Bueno, Maria R. O.; Cyrino, Edilson S.; Arruda, Miguel] State Univ Londrina UEL, Study & Res Grp Phys Activ & Exercise GEPAFE, Londrina, Brazil; [Ronque, Enio R. V.; Werneck, Andre O.; Cyrino, Edilson S.] State Univ Londrina UEL, Study & Res Grp Metab Nutr & Exercise GEPEMENE, Londrina, Brazil; [Stanganelli, Luiz C. R.] Univ Estadual Londrina, Ctr Phys Educ & Sport, Londrina, Brazil; [Arruda, Miguel] Univ Estadual Campinas, Fac Phys Educ, Sao Paulo, Brazil	Universidade Estadual de Londrina; Universidade Estadual de Londrina; Universidade Estadual de Londrina; Universidade Estadual de Campinas	Ronque, ERV (corresponding author), State Univ Londrina UEL, Study & Res Grp Phys Activ & Exercise GEPAFE, Londrina, Brazil.; Ronque, ERV (corresponding author), State Univ Londrina UEL, Study & Res Grp Metab Nutr & Exercise GEPEMENE, Londrina, Brazil.	enioronque@uel.br	Ronque, Enio Ricardo Vaz/AAP-5530-2020; CYRINO, EDILSON S/GQB-5068-2022; de Oliveira Werneck, André/N-5006-2016; CYRINO, EDILSON S/F-7196-2012	Ronque, Enio Ricardo Vaz/0000-0003-3430-3993; CYRINO, EDILSON S/0000-0001-9016-8779; de Oliveira Werneck, André/0000-0002-9166-4376; CYRINO, EDILSON S/0000-0001-9016-8779				Altman D., 1991, PRACTICAL STUDIES FO; [Anonymous], 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19430; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Basterfield L, 2015, J SCI MED SPORT, V18, P178, DOI 10.1016/j.jsams.2014.03.005; Bergmann GG, 2014, J PHYS ACT HEALTH, V11, P375, DOI 10.1123/jpah.2011-0342; Carrel AL, 2009, J PEDIATR ENDOCR MET, V22, P409; Casonatto J, 2016, J CHILD HEALTH CARE, V20, P294, DOI 10.1177/1367493515598645; Cole T J, 2004, BMC Pediatr, V4, P6; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; Da Silva SP, 2013, J SPORT SCI, V31, P104, DOI 10.1080/02640414.2012.723817; Deshmukh-Taskar P, 2006, EUR J CLIN NUTR, V60, P48, DOI 10.1038/sj.ejcn.1602266; Dietz WH, 1997, J NUTR, V127, pS1884, DOI 10.1093/jn/127.9.1884S; Dobbins M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651.pub2; Efrat M, 2013, J PEDIATR ENDOCR MET, V26, P197, DOI 10.1515/jpem-2012-0379; Falaschetti E, 2010, EUR HEART J, V31, P3063, DOI 10.1093/eurheartj/ehq355; Freitas D, 2012, ANN HUM BIOL, V39, P59, DOI 10.3109/03014460.2011.638322; Going SB, 2011, AM J PREV MED, V41, pS77, DOI 10.1016/j.amepre.2011.07.006; Harrison GG, 1988, ANTHROPOMETRIC STAND, P55; Hughes AR, 2014, PEDIATRICS, V134, pE1354, DOI 10.1542/peds.2014-1908; Ip EH, 2017, J PEDIATR-US, V184, P151, DOI 10.1016/j.jpeds.2017.01.051; Johnson W, 2014, ARTERIOSCL THROM VAS, V34, P654, DOI 10.1161/ATVBAHA.113.302572; Kristiansen AL, 2014, PUBLIC HEALTH NUTR, V18, P1; Liao Duanping, 2014, Curr Treat Options Cardiovasc Med, V16, P342, DOI 10.1007/s11936-014-0342-1; Lloyd LJ, 2012, INT J OBESITY, V36, P1, DOI 10.1038/ijo.2011.186; Malina RM, 2001, AM J HUM BIOL, V13, P162, DOI 10.1002/1520-6300(200102/03)13:2<162::AID-AJHB1025>3.0.CO;2-T; Malina RM., 2004, GROWTH MATURATION, P300; Matton L, 2006, MED SCI SPORT EXER, V38, P1114, DOI 10.1249/01.mss.0000222840.58767.40; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Remmers T, 2014, MED SCI SPORT EXER, V46, P177, DOI 10.1249/MSS.0b013e3182a36709; Roberto CA, 2015, LANCET, V385, P2400, DOI 10.1016/S0140-6736(14)61744-X; Rolland-Cachera MF, 2006, INT J OBESITY, V30, pS11, DOI 10.1038/sj.ijo.0803514; ROLLANDCACHERA MF, 1984, AM J CLIN NUTR, V39, P129, DOI 10.1093/ajcn/39.1.129; Soric M, 2014, ANN HUM BIOL, V41, P238, DOI 10.3109/03014460.2013.851739; Starc G, 2011, PUBLIC HEALTH NUTR, V14, P49, DOI 10.1017/S1368980010000741; Taylor RW, 2005, CURR OPIN CLIN NUTR, V8, P607, DOI 10.1097/01.mco.0000168391.60884.93; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Toselli S, 2013, EAT WEIGHT DISORD-ST, V18, P383, DOI 10.1007/s40519-013-0074-3; Twisk JWR, 2000, MED SCI SPORT EXER, V32, P1455, DOI 10.1097/00005768-200008000-00014; TWISK JWR, 1994, EPIDEMIOL REV, V16, P165, DOI 10.1093/oxfordjournals.epirev.a036149; Wang YF, 2003, EUR J EPIDEMIOL, V18, P1037, DOI 10.1023/A:1026196310041; Werneck AO, 2016, CHILD OBES, V12, P377, DOI 10.1089/chi.2016.0042; Wheaton N, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006963; WHO, 2015, REPORT OF THE COMMIS	43	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191908	10.1371/journal.pone.0191908	http://dx.doi.org/10.1371/journal.pone.0191908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408914	Green Submitted, gold, Green Published			2022-12-26	WOS:000424302800029
J	Sun, KF; Ji, FZ; Yan, XY; Jiang, K; Yang, SC				Sun, Kangfeng; Ji, Fenzhu; Yan, Xiaoyu; Jiang, Kai; Yang, Shichun			A particle filter for ammonia coverage ratio and input simultaneous estimations in Diesel-engine SCR system	PLOS ONE			English	Article							STATE-OF-CHARGE; ION BATTERIES; UREA-SCR; REDUCTION; EMISSIONS	As NOx emissions legislation for Diesel-engines is becoming more stringent than ever before, an aftertreatment system has been widely used in many countries. Specifically, to reduce the NOx emissions, a selective catalytic reduction(SCR) system has become one of the most promising techniques for Diesel-engine vehicle applications. In the SCR system, input ammonia concentration and ammonia coverage ratio are regarded as essential states in the control-oriental model. Currently, an ammonia sensor placed before the SCR Can is a good strategy for the input ammonia concentration value. However, physical sensor would increase the SCR system cost and the ammonia coverage ratio information cannot be directly measured by physical sensor. Aiming to tackle this problem, an observer based on particle filter(PF) is investigated to estimate the input ammonia concentration and ammonia coverage ratio. Simulation results through the experimentally-validated full vehicle simulator cX-Emission show that the performance of observer based on PF is outstanding, and the estimation error is very small.	[Sun, Kangfeng; Ji, Fenzhu; Yan, Xiaoyu; Jiang, Kai; Yang, Shichun] Beihang Univ, Sch Transportat Sci & Engn, Beijing, Peoples R China	Beihang University	Yang, SC (corresponding author), Beihang Univ, Sch Transportat Sci & Engn, Beijing, Peoples R China.	yangshichun@buaa.edu.cn	JIANG, KAI/AAT-7171-2021	JIANG, KAI/0000-0001-9006-0514; yang, shichun/0000-0003-3426-7988	National Natural Science Foundation of China [51576011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China, (http://www.nsfc.gov.co), grant number: 51576011 to SCY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J DYNAMIC SYSTEMS ME; [Anonymous], 2005, SAE TECHNICAL PAPER, DOI DOI 10.4271/2005-01-0966; Arnett M, 2008, CLEANER DIESEL USING; Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374; Bidarvatan M, 2013, J ENG GAS TURB POWER, V136; Cao EM, 2016, NEUROCOMPUTING, V205, P329, DOI 10.1016/j.neucom.2016.03.065; Chen P, 2013, AM CONTR C; Devarakonda M, 2008, SAE WORLD C EXH; Dong HC, 2014, J POWER SOURCES, V271, P114, DOI 10.1016/j.jpowsour.2014.07.176; Gyorgy K, 2014, PROC TECH, V12, P65, DOI 10.1016/j.protcy.2013.12.457; Hsieh MF, 2012, J DYN SYST-T ASME, V134, DOI 10.1115/1.4005372; Hsieh MF, 2011, J DYN SYST-T ASME, V133, DOI 10.1115/1.4003380; Hsieh MF, 2011, IEEE T CONTR SYST T, V19, P1504, DOI 10.1109/TCST.2010.2098477; Jiang K, 2016, FUEL, V165, P185, DOI 10.1016/j.fuel.2015.10.019; Jiang K, 2016, NEUROCOMPUTING, V171, P569, DOI 10.1016/j.neucom.2015.06.072; Johnson TV, 2009, INT J ENGINE RES, V10, P275, DOI 10.1243/14680874JER04009; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Koebel M, 2000, CATAL TODAY, V59, P335, DOI 10.1016/S0920-5861(00)00299-6; Luenberger DG, 2007, MILITARY ELECT IEEE, V8, P74; Mallick M, 2003, INF FUS 2003 P 6 INT; Meisami-Azad M, 2012, INT J CONTROL, V85, P114, DOI 10.1080/00207179.2011.639090; Ming FH, 2010, AM CONTR C; Pournazeri M, 2017, MECHATRONICS, V46, P1, DOI 10.1016/j.mechatronics.2017.06.010; Shah S.L., 2010, IFAC P, V43, P159; Shao S, 2014, TRANSPORT RES D-TR E, V32, P207, DOI 10.1016/j.trd.2014.07.013; Song Q., 2002, ELECT CONTROL SYSTEM; Tronconi E, 1996, CHEM ENG SCI, V51, P2965, DOI 10.1016/0009-2509(96)00182-0; Tulsyan A, 2016, J POWER SOURCES, V331, P208, DOI 10.1016/j.jpowsour.2016.08.113; Upadhyay D, 2006, J DYN SYST-T ASME, V128, P737, DOI 10.1115/1.2234494; Wang J., 2010, CONTROL DIESEL ENGIN; Wang JM, 2008, IEEE T CONTR SYST T, V16, P1138, DOI 10.1109/TCST.2008.917227; Wang Y., 2015, CHINESE U TECHNOLOGY, V2015, P4, DOI DOI 10.1016/J.EXPNEUR0L.2015.04.009; Wang Y., 2015, APPL ENERG, V185, P2026; Willems F., 2007, IS CLOSED LOOP SCR C; Won SHP, 2010, IEEE T IND ELECTRON, V57, P1787, DOI 10.1109/TIE.2009.2032431; Yim SD, 2004, IND ENG CHEM RES, V43, P4856, DOI 10.1021/ie034052j; Zhang H, 2015, IEEE-ASME T MECH, V20, P2222, DOI 10.1109/TMECH.2014.2370043; Zhang H, 2015, IEEE-ASME T MECH, V20, P1585, DOI 10.1109/TMECH.2014.2355039; Zhang H, 2015, J FRANKLIN I, V352, P708, DOI 10.1016/j.jfranklin.2014.06.009; Zhang H, 2015, FUEL, V141, P200, DOI 10.1016/j.fuel.2014.10.051	40	2	2	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192217	10.1371/journal.pone.0192217	http://dx.doi.org/10.1371/journal.pone.0192217			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408924	gold, Green Published, Green Submitted			2022-12-26	WOS:000424302800049
J	Terato, K; Waritani, T; Fukai, R; Shionoya, H; Itoh, H; Katayama, K				Terato, Kuniaki; Waritani, Takaki; Fukai, Richio; Shionoya, Hiroshi; Itoh, Hiroshi; Katayama, Kou			Contribution of bacterial pathogens to evoking serological disease markers and aggravating disease activity in rheumatoid arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; ESCHERICHIA-COLI LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY COMPLEX; RAPID RADIOGRAPHIC PROGRESSION; CELL-WALL POLYMERS; PORPHYROMONAS-GINGIVALIS; AUTOIMMUNE ARTHRITIS; II COLLAGEN; ARTHROPATHIC PROPERTIES; SYSTEMIC INJECTION	Commensal bacteria and their pathogenic components in the gastrointestinal tract and oral cavity may play pathological roles in autoimmune diseases. To study the possible involvement of bacterial pathogens in autoimmune diseases, IgG and IgA antibodies against pathogenic components produced by three strains of commensal bacteria, Escherichia coli-lipopolysaccharide (E. coli-LPS), Porphyromonas gingivalis-LPS (Pg-LPS) and peptidoglycan polysaccharide (PG-PS) from Streptococcus pyogenes, were determined by an improved ELISA system for sera from two groups of patients with rheumatoid arthritis (RA), who met rapid radiographic progression (RRP) criteria and non-RRP, and compared to normal (NL) controls. Antibody responses to these bacterial pathogens are unique and consistent in individuals, and no fundamental difference was observed between RA and NL controls. Despite the similar antibody responses to pathogens, lower IgG or higher IgA and consequent higher IgA/IgG antibody ratio among the patients with RA related to disease marker levels and disease activity. Peculiarly, the IgA/IgG anti-Pg-LPS antibody ratio resulted from lower IgG and higher IgA antibody responses to Pg-LPS strongly correlated not only with rheumatoid factor (RF), but also correlated with erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and disease activity score of 28 joints with ESR (DAS28-ESR) in the RRP group. In contrast, the IgA/IgG anti-E. coli-LPS and anti-PG-PS antibody ratio correlated or tended to correlate with RF, ESR, CRP, and DAS28-ESR in the non-RRP group, whereas either the IgG or IgA anti-Pg-LPS antibody levels and consequent IgA/IgG anti-Pg-LPS antibody ratio did not correlate with any clinical marker levels in this group. Notably, anti-circular-citrullinated peptide (CCP) antibody levels, which did not correlate with either IgG or IgA antibody levels to any pathogens, did not correlate with severity of arthritis in both RRP and non-RRP. Taken together, we propose that multiple environmental pathogens, which overwhelm the host antibody defense function, contribute independently or concomitantly to evoking disease makers and aggravating disease activity, and affect disease outcomes.	[Terato, Kuniaki; Waritani, Takaki] Chondrex Inc, Dept Res & Dev, Redmond, WA 98052 USA; [Fukai, Richio] Fukai Pharm, Asahikawa, Hokkaido, Japan; [Shionoya, Hiroshi] Asama Chem Inc, Res Lab, Chiyoda Ku, Sect 5, Tokyo, Japan; [Itoh, Hiroshi] Asahikawa Med Univ, Dept Orthoped Surg, Asahikawa, Hokkaido, Japan; [Katayama, Kou] Katayama Orthoped Rheumatol Clin, Asahikawa, Hokkaido, Japan	Asahikawa Medical College	Terato, K (corresponding author), Chondrex Inc, Dept Res & Dev, Redmond, WA 98052 USA.	terato@chondrex.com		Terato, Kuniaki/0000-0001-8259-1729	Chondrex Inc.; Asama Chemicals; Fukai Pharmacy; Katayama Orthopedic Rheumatology Clinic; Asahikawa Medical University	Chondrex Inc.; Asama Chemicals; Fukai Pharmacy; Katayama Orthopedic Rheumatology Clinic; Asahikawa Medical University	The authors received no specific funding for this work. KT and TW declare that they received salary support from Chondrex Inc., and HS from Asama Chemicals, respectively. RF and KK declare that they were supported by Fukai Pharmacy and Katayama Orthopedic Rheumatology Clinic, respectively. HI declares that he received salary from Asahikawa Medical University. The organizations provided support in the form of salaries for the authors (KT, TW, HS, RF, KK and HI) but did not play any roles in this study design, data collection and analysis, decision to publish or preparation of manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aoki S, 1996, ANN RHEUM DIS, V55, P363, DOI 10.1136/ard.55.6.363; Arabski M, 2012, CLIN BIOCHEM, V45, P1374, DOI 10.1016/j.clinbiochem.2012.06.021; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Carmona-Rivera C, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag3358; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Chou YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139693; Chukkapalli S, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1056-4; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; COLE BC, 1993, ARTHRITIS RHEUM-US, V36, P994, DOI 10.1002/art.1780360717; COULIE PG, 1985, J EXP MED, V161, P88, DOI 10.1084/jem.161.1.88; CROMARTIE WJ, 1977, J EXP MED, V146, P1585, DOI 10.1084/jem.146.6.1585; de Pablo P, 2008, J RHEUMATOL, V35, P70; DEVRIES DD, 1992, ANN RHEUM DIS, V51, P783, DOI 10.1136/ard.51.6.783; Edwards CJ, 2008, J RHEUMATOL, V35, P1477; FOX A, 1982, INFECT IMMUN, V35, P1003, DOI 10.1128/IAI.35.3.1003-1010.1982; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; FUJII K, 1989, J IMMUNOL METHODS, V124, P63; Gomez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036095; Granger B, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2016-000245; Guilherme L, 2006, AUTOIMMUNITY, V39, P31, DOI 10.1080/08916930500484674; Hetland ML, 2009, ANN RHEUM DIS, V68, P384, DOI 10.1136/ard.2008.088245; Hitchon CA, 2010, J RHEUMATOL, V37, P1105, DOI 10.3899/jrheum.091323; Kang Y, 2016, Z RHEUMATOL; Katayama K, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-2; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kjeldsen-Kragh J, 1999, AM J CLIN NUTR, V70, p594S, DOI 10.1093/ajcn/70.3.594s; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Konig MF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaj1921; Konig MF, 2015, ANN RHEUM DIS, V74, P2054, DOI 10.1136/annrheumdis-2014-205385; Li MC, 2009, CURR MOL MED, V9, P365, DOI 10.2174/156652409787847137; Liao F, 2009, MED HYPOTHESES, V72, P732, DOI 10.1016/j.mehy.2008.12.040; Marchesan JT, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4376; Mathis D, 2011, CELL HOST MICROBE, V10, P297, DOI 10.1016/j.chom.2011.09.007; Mestecky J, 1999, GUT, V44, P2, DOI 10.1136/gut.44.1.2; Midwood KS, 2009, CURR DRUG TARGETS, V10, P1139, DOI 10.2174/138945009789735101; Mikuls TR, 2012, ARTHRITIS RHEUM-US, V64, P3522, DOI 10.1002/art.34595; Mikuls TR, 2009, INT IMMUNOPHARMACOL, V9, P38, DOI 10.1016/j.intimp.2008.09.008; Nakajima M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134234; Nakashima Y, 2016, J RHEUMATOL, V43, P1278, DOI 10.3899/jrheum.150988; Okada M, 2011, J PERIODONTOL, V82, P1433, DOI 10.1902/jop.2011.110020; Ostergaard M, 2005, ANN RHEUM DIS, V64, P3, DOI 10.1136/ard.2004.031773; Peltonen R, 1997, BRIT J RHEUMATOL, V36, P64; Peltonen R, 1994, BR J RHEUMATOL, V33, P56; Rashid T, 2004, CLIN RHEUMATOL, V23, P134, DOI 10.1007/s10067-003-0847-6; Rashid T, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/539282; Rosenstein ED, 2004, INFLAMMATION, V28, P311, DOI 10.1007/s10753-004-6641-z; Sandal I, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1143-6; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; SARTOR RB, 1989, BAILLIERE CLIN RHEUM, V3, P223, DOI 10.1016/S0950-3579(89)80019-6; Scheinecker C, 2011, NAT REV RHEUMATOL, V7, P73, DOI 10.1038/nrrheum.2010.226; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Scher JU, 2011, NAT REV RHEUMATOL, V7, P569, DOI 10.1038/nrrheum.2011.121; Schmidt WP, 2004, MED SCI MONITOR, V10, pHY5; Stewart JA, 2005, J MED MICROBIOL, V54, P1239, DOI 10.1099/jmm.0.46189-0; STIMPSON SA, 1986, INFECT IMMUN, V51, P240, DOI 10.1128/IAI.51.1.240-249.1986; Terato K, 1995, AUTOIMMUNITY, V22, P137, DOI 10.3109/08916939508995311; Terato K, 1996, BRIT J RHEUMATOL, V35, P828; Terato K, 2004, P 11 AS PAC LEAG ASS; Terato K, 2016, VACCINE, V34, P4643, DOI 10.1016/j.vaccine.2016.08.007; Terato K, 2015, AUTOIMMUN DIS, V2015, DOI 10.1155/2015/636207; Terato K, 2014, J IMMUNOL METHODS, V407, P15, DOI 10.1016/j.jim.2014.03.013; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Toivanen P, 2003, ANN RHEUM DIS, V62, P807, DOI 10.1136/ard.62.9.807; Toivanen P, 2001, INFECT IMMUN, V69, P2372, DOI 10.1128/IAI.69.4.2372-2377.2001; Totaro MC, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4243; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500; van den Broek M, 2012, ANN RHEUM DIS, V71, P1530, DOI 10.1136/annrheumdis-2011-201212; van der Post S, 2013, J BIOL CHEM, V288, P14636, DOI 10.1074/jbc.M113.459479; VANDERHEIJDE DM, 1989, LANCET, V1, P1036, DOI 10.1016/S0140-6736(89)92442-2; Vastesaeger N, 2009, RHEUMATOLOGY, V48, P1114, DOI 10.1093/rheumatology/kep155; Waritani T, 2017, METHODSX, V4, P153, DOI 10.1016/j.mex.2017.03.002; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; WELLS AF, 1989, INFECT IMMUN, V57, P351, DOI 10.1128/IAI.57.2.351-358.1989; WILSON C, 1995, ANN RHEUM DIS, V54, P216, DOI 10.1136/ard.54.3.216; WOOLEY PH, 1995, ANN RHEUM DIS, V54, P298, DOI 10.1136/ard.54.4.298; Wu XH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030431; Yoshida A, 2001, J DENT RES, V80, P346, DOI 10.1177/00220345010800010901; Yoshino S, 1999, J IMMUNOL, V163, P3417	82	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0190588	10.1371/journal.pone.0190588	http://dx.doi.org/10.1371/journal.pone.0190588			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408886	Green Submitted, gold, Green Published			2022-12-26	WOS:000424302800008
J	Busse, A; Antiqueira, PAP; Neutzling, AS; Wolf, AM; Romero, GQ; Petermann, JS				Busse, Annika; Antiqueira, Pablo A. P.; Neutzling, Alexandre S.; Wolf, Anna M.; Romero, Gustavo Q.; Petermann, Jana S.			Different in the dark: The effect of habitat characteristics on community composition and beta diversity in bromeliad microfauna	PLOS ONE			English	Article							STOCHASTIC-PROCESSES; NESTEDNESS ANALYSIS; PASSIVE DISPERSAL; SPECIES-DIVERSITY; TROPICAL FOREST; CONSERVATION; DRIVERS; MICROORGANISMS; HETEROGENEITY; SCALE	The mechanisms which structure communities have been the focus of a large body of research. Here, we address the question if habitat characteristics describing habitat quality may drive changes in community composition and beta diversity of bromeliad-inhabiting microfauna. In our system, changes in canopy cover along an environmental gradient may affect resource availability, disturbance in form of daily water temperature fluctuations and predation, and thus may lead to changes in community structure of bromeliad microfauna through differences in habitat quality along this gradient. Indeed, we observed distinct changes in microfauna community composition along the environmental gradient explained by changes in the extent of daily water temperature fluctuations. We found beta diversity to be higher under low habitat quality (low canopy cover) than under high habitat quality (high canopy cover), which could potentially be explained by a higher relative importance of stochastic processes under low habitat quality. We also partitioned beta diversity into turnover and nestedness components and we found a nested pattern of beta diversity along the environmental gradient, with communities from the lower-quality habitat being nested subsets of communities from the higher-quality habitat. However, this pattern resulted from an increase in microfauna alpha diversity with an increase in habitat quality. By providing insights into microfauna-environment relationships our results contribute to the mechanistic understanding of community dynamics in small freshwater bodies. Here, we highlight the importance of habitat characteristics representing habitat quality in structuring communities, and suggest that this information may help to improve conservation practices of small freshwater ecosystems.	[Busse, Annika; Petermann, Jana S.] Univ Salzburg, Dept Biosci, Salzburg, Austria; [Busse, Annika; Petermann, Jana S.] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany; [Antiqueira, Pablo A. P.; Neutzling, Alexandre S.] Univ Campinas UNICAMP, Inst Biol, Grad Program Ecol, Campinas, SP, Brazil; [Antiqueira, Pablo A. P.; Romero, Gustavo Q.] Univ Campinas UNICAMP, Inst Biol, Dept Anim Biol, Multitroph Interact & Biodivers Lab, Campinas, SP, Brazil; [Wolf, Anna M.] Free Univ Berlin, Inst Biol, Berlin, Germany	Salzburg University; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Free University of Berlin	Busse, A; Petermann, JS (corresponding author), Univ Salzburg, Dept Biosci, Salzburg, Austria.; Busse, A; Petermann, JS (corresponding author), Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany.	annika.busse@sbg.ac.at; jana.petermann@sbg.ac.at	Romero, Gustavo Q/N-1896-2019; Romero, Gustavo Q/H-8974-2012; Petermann, Jana/AAK-9787-2020; Petermann, Jana/E-2130-2013; Busse, Annika/AFM-6382-2022	Romero, Gustavo Q/0000-0003-3736-4759; Romero, Gustavo Q/0000-0003-3736-4759; Petermann, Jana/0000-0002-3898-5656; Petermann, Jana/0000-0002-3898-5656; Busse, Annika/0000-0001-5948-2698	Deutsche Forschungsgemeinschaft (DFG); DAAD PROMOS; Sao Paulo Research Foundation (FAPESP); CNPq-Brazil; FAPESP [2014/04603-4]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DAAD PROMOS; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funding was provided for AB through a grant to JSP by the Deutsche Forschungsgemeinschaft (DFG) and for AMW by DAAD PROMOS. Field work was supported by a research grant from Sao Paulo Research Foundation (FAPESP), coordinated by GQR. GQR received a CNPq-Brazil grant of productivity in research. During the study, PAPA received a PhD scholarship from the FAPESP (Proc. No 2014/04603-4). The authors also acknowledge the Open Access Publication Fund of the University of Salzburg to Annika Busse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shami SA, 2013, FRESHWATER BIOL, V58, P1126, DOI 10.1111/fwb.12113; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; [Anonymous], 1995, GLOBAL BIODIVERSITY; Arellano Lucrecia, 2003, Acta Zool. Mex, P27; Astorga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P365, DOI 10.1111/j.1466-8238.2011.00681.x; Baselga A, 2013, BETAPART PARTITIONIN; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; BICCAMARQUES JC, 1992, FOLIA PRIMATOL, V58, P107, DOI 10.1159/000156616; Blaustein L, 2001, ISR J ZOOL, V47, P303, DOI 10.1560/CKMU-Q2PM-HTGC-P9C8; Bloch CP, 2007, OIKOS, V116, P395, DOI 10.1111/j.0030-1299.2007.15391.x; Brendonck L, 2015, OIKOS, V124, P741, DOI 10.1111/oik.01710; Cestari C, 2008, ORNITOL NEOTROP, V19, P97; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Chase JM, 2009, ECOL LETT, V12, P1210, DOI 10.1111/j.1461-0248.2009.01362.x; Cotterill FPD, 2008, BIODIVERS CONSERV, V17, P427, DOI 10.1007/s10531-007-9261-8; COWELL BC, 1987, FLA ENTOMOL, V70, P1, DOI 10.2307/3495085; De Omena P. M., 2014, THESIS; Dormann C.F., 2008, R NEWS, V8, P8; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dunthorn M, 2012, SYST BIODIVERS, V10, P195, DOI 10.1080/14772000.2012.685195; Esteban GF, 2010, NATURE, V463, P293, DOI 10.1038/463293c; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Farjalla VF, 2016, ECOLOGY, V97, P2147, DOI 10.1002/ecy.1432; Farjalla VF, 2012, ECOLOGY, V93, P1752, DOI 10.1890/11-1144.1; Fernandez-Juricic E, 2002, OECOLOGIA, V131, P269, DOI 10.1007/s00442-002-0883-y; Finlay BJ, 2004, PROTIST, V155, P15, DOI 10.1078/1434461000160; Foissner W, 2003, EUR J PROTISTOL, V39, P365, DOI 10.1078/0932-4739-00005; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; FRYER G, 1980, FRESHWATER BIOL, V10, P41, DOI 10.1111/j.1365-2427.1980.tb01178.x; Goncalves-Souza T, 2011, AUSTRAL ECOL, V36, P476, DOI 10.1111/j.1442-9993.2010.02177.x; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Hanazato T, 1998, ENVIRON POLLUT, V101, P361, DOI 10.1016/S0269-7491(98)00053-0; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; Horvath Z, 2016, ECOGRAPHY, V39, P726, DOI 10.1111/ecog.01685; Hylander K, 2005, OIKOS, V108, P351, DOI 10.1111/j.0030-1299.2005.13400.x; Jackson DA, 2001, CAN J FISH AQUAT SCI, V58, P157, DOI 10.1139/f00-239; Jacobsen D, 2012, GLOBAL ECOL BIOGEOGR, V21, P647, DOI 10.1111/j.1466-8238.2011.00699.x; Jiang L, 2007, J ANIM ECOL, V76, P660, DOI 10.1111/j.1365-2656.2007.01252.x; Johnston NK, 2016, J ANIM ECOL, V85, P1161, DOI 10.1111/1365-2656.12551; Kalinkat G, 2017, CONSERV BIOL, V31, P481, DOI 10.1111/cobi.12813; Kitching R.L., 2000, FOOD WEBS CONTAINER, DOI [10.1017/CBO9780511542107, DOI 10.1017/CBO9780511542107]; Kratina P, 2017, ECOL EVOL, V7, P1627, DOI 10.1002/ece3.2797; LAESSLE AM, 1961, ECOLOGY, V42, P499, DOI 10.2307/1932236; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Lopez LCS, 1999, BIOTROPICA, V31, P705, DOI 10.1111/j.1744-7429.1999.tb00421.x; Lopez Luiz Carlos Serramo, 2001, Selbyana, V22, P219; MAGUIRE B, 1963, ECOL MONOGR, V33, P161, DOI 10.2307/1948560; Manoel MC, 2012, REV GEONORTE; Marino NAC, 2011, HYDROBIOLOGIA, V678, P191, DOI 10.1007/s10750-011-0848-4; Marks CO, 2016, ECOL LETT, V19, P743, DOI 10.1111/ele.12608; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; Mestre LAM, 2001, BRAZ ARCH BIOL TECHN, V44, P89, DOI 10.1590/S1516-89132001000100012; Minchin P.R., 2015, R PACKAGE VERSION, V2, P1; Montagnes DJS, 2000, AQUAT MICROB ECOL, V21, P97, DOI 10.3354/ame021097; NADKARNI NM, 1989, CONDOR, V91, P891, DOI 10.2307/1368074; NAEEM S, 1990, OECOLOGIA, V84, P29, DOI 10.1007/BF00665591; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Peckarsky B.L., 1983, P303; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Petermann JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118952; Poos MS, 2012, ECOL INDIC, V18, P82, DOI 10.1016/j.ecolind.2011.10.008; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; R Core Team, 2021, R LANGUAGE ENV STAT; Rangel JV, 2016, J LIMNOL; REVILL DL, 1967, ECOLOGY, V48, P1023, DOI 10.2307/1934558; Richardson BA, 2000, J TROP ECOL, V16, P167, DOI 10.1017/S0266467400001346; Ricotta C, 2010, ECOLOGY, V91, P1981, DOI 10.1890/09-0126.1; Rizzini CT, 1997, TRATADO FITOGEOGRAFI; Rogerson A, 1999, ATMOS RES, V51, P35, DOI 10.1016/S0169-8095(98)00109-4; Pessenda LCR, 2012, PALAEOGEOGR PALAEOCL, V363, P57, DOI 10.1016/j.palaeo.2012.08.014; Sanders Robert W., 1993, Marine Microbial Food Webs, V7, P197; SCHLICHTING HE, 1969, J ECOL, V57, P759, DOI 10.2307/2258497; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segre H, 2014, ECOL LETT, V17, P1400, DOI 10.1111/ele.12343; Shade A, 2008, ENVIRON MICROBIOL, V10, P1057, DOI 10.1111/j.1462-2920.2007.01527.x; Socolar JB, 2016, TRENDS ECOL EVOL, V31, P67, DOI 10.1016/j.tree.2015.11.005; Srivastava DS, 2006, OECOLOGIA, V149, P493, DOI 10.1007/s00442-006-0467-3; Srivastava DS, 2004, TRENDS ECOL EVOL, V19, P379, DOI 10.1016/j.tree.2004.04.010; Staddon WJ, 1998, BIODIVERS CONSERV, V7, P1081, DOI 10.1023/A:1008813232395; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tonkin JD, 2016, OIKOS, V125, P686, DOI 10.1111/oik.02717; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Ulrich Werner, 2009, Ecological Questions, V11, P27, DOI 10.2478/v10090-009-0015-y; Vanschoenwinkel B, 2011, FRESHWATER BIOL, V56, P1606, DOI 10.1111/j.1365-2427.2011.02600.x; Wang XG, 2016, ECOL RES, V31, P57, DOI 10.1007/s11284-015-1313-z; Weisse T, 2013, J EUKARYOT MICROBIOL, V60, P578, DOI 10.1111/jeu.12063; Weisse T, 2013, EUR J PROTISTOL, V49, P406, DOI 10.1016/j.ejop.2013.02.001; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Williams D. D., 1987, ECOLOGY TEMPORARY WA; Williams DD., 2006, BIOL TEMPORARY WATER; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055	100	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191426	10.1371/journal.pone.0191426	http://dx.doi.org/10.1371/journal.pone.0191426			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401522	Green Submitted, Green Published, gold			2022-12-26	WOS:000424101400013
J	Li, KL; Vorkas, CK; Chaudhry, A; Bell, DL; Willis, RA; Rudensky, A; Altman, JD; Glickman, MS; Aube, J				Li, Kelin; Vorkas, Charles K.; Chaudhry, Ashutosh; Bell, Donielle L.; Willis, Richard A.; Rudensky, Alexander; Altman, John D.; Glickman, Michael S.; Aube, Jeffrey			Synthesis, stabilization, and characterization of the MR1 ligand precursor 5-amino-6-D-ribitylaminouracil (5-A-RU)	PLOS ONE			English	Article							INVARIANT T-CELLS; GROUP B GALACTOSYLTRANSFERASE; MAIT CELLS; RIBOFLAVIN SYNTHASE; RECEPTOR HETEROGENEITY; IMMUNE-RESPONSE; BIOSYNTHESIS; TUBERCULOSIS; SUBSTRATE; ENZYME	Mucosal-associated invariant T (MAIT) cells are an abundant class of innate T cells restricted by the MHC I-related molecule MR1. MAIT cells can recognize bacterially-derived metabolic intermediates from the riboflavin pathway presented by MR1 and are postulated to play a role in innate antibacterial immunity through production of cytokines and direct bacterial killing. MR1 tetramers, typically stabilized by the adduct of 5-amino-6-D-ribitylaminouracil (5-A-RU) and methylglyoxal (MeG), are important tools for the study of MAIT cells. A long-standing problem with 5-A-RU is that it is unstable upon storage. Herein we report an efficient synthetic approach to the HCl salt of this ligand, which has improved stability during storage. We also show that synthetic 5-A-RU center dot HCl produced by this method may be used in protocols for the stimulation of human MAIT cells and production of both human and mouse MR1 tetramers for MAIT cell identification.	[Li, Kelin; Aube, Jeffrey] Univ N Carolina, UNC Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Vorkas, Charles K.; Glickman, Michael S.] Weill Cornell Med, Div Infect Dis, New York, NY USA; [Vorkas, Charles K.; Chaudhry, Ashutosh; Rudensky, Alexander; Glickman, Michael S.] Sloan Kettering Inst, Immunol Program, New York, NY USA; [Bell, Donielle L.; Altman, John D.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Willis, Richard A.; Glickman, Michael S.] Mem Sloan Kettering Canc Ctr, Div Infect Dis, 1275 York Ave, New York, NY 10021 USA	University of North Carolina; University of North Carolina Chapel Hill; Cornell University; Memorial Sloan Kettering Cancer Center; Emory University; Memorial Sloan Kettering Cancer Center	Aube, J (corresponding author), Univ N Carolina, UNC Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA.	jaube@unc.edu	Ehrmann, Mass Spectrometry Core/GLQ-5891-2022; Vorkas, Charles/HII-6376-2022	Ehrmann, Mass Spectrometry Core/0000-0002-6741-7914; Aube, Jeffrey/0000-0003-1049-5767; WILLIS, RICHARD/0000-0001-6890-1268; Li, Kelin/0000-0002-8630-2928	National Institute of Allergy and Infectious Disease [U19 AI11143, U19 AI111211]; HHSN [272201300006C, T32AI007613-18]; National Cancer Institute [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007613, U19AI111143, U19AI111211] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); HHSN; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support from the National Institute of Allergy and Infectious Disease (niaid.nih.gov) is gratefully acknowledged: U19 AI11143, Carl Nathan, PI (supported work by KL, CKV, MSG, and JA); U19 AI111211, Henry M. Blumberg, PI (supported work by DLB, RAW, JDA); HHSN 272201300006C (supported work by DLB, RAW, JDA); and T32AI007613-18, Roy M. Gulick, PI (supported CKV). In addition support from the National Cancer Institute (nci.nih.gov) is acknowledged, through P30 CA008748 (supported AC and AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHASSAN SS, 1980, J CHEM SOC PERK T 1, P2645, DOI 10.1039/p19800002645; Altman JD, 2001, CURRENT PROTOCOLS IM; Bacher A, 2001, VITAM HORM, V61, P1; Birkinshaw RW, 2014, CURR OPIN IMMUNOL, V26, P7, DOI 10.1016/j.coi.2013.09.007; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; CRESSWELL RM, 1960, J CHEM SOC, P4768, DOI 10.1039/jr9600004768; Cushman M, 2001, J ORG CHEM, V66, P8320, DOI 10.1021/jo010706r; CUSHMAN M, 1991, J ORG CHEM, V56, P4603, DOI 10.1021/jo00015a009; Decamps L, 2012, J AM CHEM SOC, V134, P18173, DOI 10.1021/ja307762b; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Eckle SBG, 2014, J EXP MED, V211, P1585, DOI 10.1084/jem.20140484; Edholm ES, 2014, CELL MOL LIFE SCI, V71, P4763, DOI 10.1007/s00018-014-1701-5; Gallegos AM, 2016, NAT IMMUNOL, V17, P379, DOI 10.1038/ni.3386; Gapin L, 2014, J IMMUNOL, V192, P4475, DOI 10.4049/jimmunol.1400119; Gapin L, 2009, PLOS BIOL, V7, P435, DOI 10.1371/journal.pbio.1000070; Gerart S, 2013, BLOOD, V121, P614, DOI 10.1182/blood-2012-09-456095; Gerhardt S, 2002, J MOL BIOL, V318, P1317, DOI 10.1016/S0022-2836(02)00116-X; Gold MC, 2015, IMMUNOL REV, V264, P154, DOI 10.1111/imr.12271; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Jiang J, 2016, J INFECTION, V72, P338, DOI 10.1016/j.jinf.2015.11.010; Jiang J, 2014, AM J RESP CRIT CARE, V190, P329, DOI 10.1164/rccm.201401-0106OC; KATAGIRI H, 1959, J Vitaminol (Kyoto), V5, P287; Keller AN, 2017, CURR OPIN IMMUNOL, V46, P66, DOI 10.1016/j.coi.2017.04.002; Keller AN, 2017, NAT IMMUNOL, V18, P402, DOI 10.1038/ni.3679; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Kurioka A, 2015, MUCOSAL IMMUNOL, V8, P429, DOI 10.1038/mi.2014.81; Kurioka A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01031; Kwon YS, 2015, TUBERCULOSIS, V95, P267, DOI 10.1016/j.tube.2015.03.004; Lamichhane R, 2017, IMMUNOLOGY, V151, P270, DOI 10.1111/imm.12744; Le Bourhis L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003681; Le Bourhis L, 2013, CURR OPIN IMMUNOL, V25, P174, DOI 10.1016/j.coi.2013.01.005; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Lepore M, 2017, ELIFE, V6, DOI 10.7554/eLife.24476; Mak JYW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14599; MALEY GF, 1959, J BIOL CHEM, V234, P641; Masuda T, 1959, B CHEM PHARM SCI, P361; Meermeier EW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12506; Nerdal PT, 2016, J IMMUNOL, V197, P3059, DOI 10.4049/jimmunol.1600913; NIELSEN P, 1988, Z NATURFORSCH B, V43, P1358; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Plaut GWE, 1971, METHODS ENZYMOL B, V18, P515; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; ROWAN T, 1968, J CHEM SOC C, P452, DOI 10.1039/j39680000452; Schaefer K, 2013, J MED CHEM, V56, P2150, DOI 10.1021/jm300642a; Schaefer K, 2012, CHEMBIOCHEM, V13, P443, DOI 10.1002/cbic.201100642; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Sharma PK, 2015, IMMUNOLOGY, V145, P443, DOI 10.1111/imm.12461; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Treiner E, 2005, MICROBES INFECT, V7, P552, DOI 10.1016/j.micinf.2004.12.013; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Treiner E, 2006, CURR OPIN IMMUNOL, V18, P519, DOI 10.1016/j.coi.2006.07.001; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; WEINSTOCK C, 1961, J ORG CHEM, V26, P4456; ZEECHANG KY, 1968, J MED CHEM, V11, P1107, DOI 10.1021/jm00311a063	54	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191837	10.1371/journal.pone.0191837	http://dx.doi.org/10.1371/journal.pone.0191837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401462	Green Published, gold, Green Submitted			2022-12-26	WOS:000424101400023
J	Shrestha, M; Moles, R; Ranjit, E; Chaar, B				Shrestha, Mina; Moles, Rebekah; Ranjit, Eurek; Chaar, Betty			Medicine procurement in hospital pharmacies of Nepal: A qualitative study based on the Basel Statements	PLOS ONE			English	Article							LOW-INCOME; HEALTH; CONSEQUENCES; GUIDELINES; COMMITTEES; SHORTAGES; DRUGS; CARE	Background Accessibility and affordability of evidence-based medicines are issues of global concern. For low-income countries like Nepal, it is crucial to have easy and reliable access to affordable, good-quality, evidence-based medicines, especially in the aftermath of natural or man-made disasters. Availability of affordable and evidence-based high quality medicines depends on the medicine procurement procedure, which makes it an important aspect of healthcare delivery. In this study, we aimed to investigate medicine procurement practices in hospital pharmacies of Nepal within the framework of International Pharmaceutical Federation [FIP] hospital pharmacy guidelines "the Basel Statements". Method We conducted semi-structured interviews with hospital pharmacists or procurement officers in hospital pharmacies of four major regions in Nepal to explore procurement practices. Data were collected until saturation of themes, analysed using the framework approach, and organised around the statements within the procurement theme of the Basel Statements. Results Interviews conducted with 53 participants revealed that the procurement guidelines of the Basel Statements were adopted to a certain extent in hospital pharmacies of Nepal. It was found that the majority of hospital pharmacies in Nepal reported using an expensive direct-procurement model for purchasing medicines. Most had no formulary and procured medicines solely based on doctors' prescriptions, which were heavily influenced by pharmaceutical companies' marketing strategies. Whilst most procured only registered medicines, a minority reported purchasing unregistered medicines through unauthorised supply-chains. And although the majority of hospital pharmacies had some contingency plans for managing medicine shortages, a few had none. Conclusions Procurement guidelines of the Basel Statements were thus found to be partially adopted; however, there is room for improvement in current procurement practices in hospital pharmacies of Nepal. Adoption and regulation of national and international policies is recommended for enhancing medicine accessibility, as well as improving preparedness for health emergencies during natural disasters and health epidemics.	[Shrestha, Mina; Moles, Rebekah; Chaar, Betty] Univ Sydney, Fac Pharm, Sydney, NSW, Australia; [Shrestha, Mina; Moles, Rebekah; Ranjit, Eurek; Chaar, Betty] World Hosp Pharm Res Consortium WHoPReC, Kathmandu, Bagmati, Nepal; [Ranjit, Eurek] Kathmandu Med Coll, Dept Pharmacol, Kathmandu, Bagmati, Nepal	University of Sydney	Shrestha, M (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW, Australia.; Shrestha, M (corresponding author), World Hosp Pharm Res Consortium WHoPReC, Kathmandu, Bagmati, Nepal.	shresthamina@gmail.com						American Medical Association, 2015, AMAS COD MED ETH; American Society of Health System Pharmacists International Pharmaceutical Federation, 2009, AM J HLTH SYST PH S3, V66, pS1; [Anonymous], 2009, AM J HEALTH-SYST PH, V66, pS61, DOI 10.2146/ajhp080666; [Anonymous], 2014, MY REPUBLICA; Arney L, 2014, GLOB HEALTH-SCI PRAC, V2, P295, DOI 10.9745/GHSP-D-14-00068; Baghdadi-Sabeti G, 2010, GOOD GOVERNANCE FOR; Baghdadi-Sabeti G., 2009, MEASURING TRANSPAREN; Barraclough A, 2012, MANAGEMENT SCIENCE F; Bigdeli M, 2013, HEALTH POLICY PLANN, V28, P692, DOI 10.1093/heapol/czs108; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cameron A., 2011, WORLD MED SITUATION; Condie CK, 2008, AM J HEALTH-SYST PH, V65, P454, DOI 10.2146/ajhp070322; Department of Drug Administration, 2017, GUID SPEC REC MED; Department of Drug Administration, 2007, GUID ETH PROM MED; Dickens T., 2011, WORLD MED SITUATION; Dill S, 2014, EUR J CLIN PHARMACOL, V70, P1405, DOI 10.1007/s00228-014-1747-1; Doloresco F, 2009, AM J HEALTH-SYST PH, V66, pS13, DOI 10.2146/ajhp080674; European Association of Hospital Pharmacists, 2012, WHAT IS HOSPITAL PHA; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Government of Nepal, 2007, NAT MED POL 2007; Government of Nepal, 2014, NAT HLTH POL 2071; Government of Nepal Ministry of Health and Population, 2009, PUBL PROC GUID; Government of Nepal Ministry of Health and Population., 2013, HOSPITAL PHARMACY DI; Government of Nepal Ministry of Health and Population, 2011, NEPAL PHARMACEUTICAL; Hall C, 2012, PATHOG GLOB HEALTH, V106, P73, DOI 10.1179/204777312X13419245939485; Harper I, 2007, DRUG PROCUREMENT NEP; Hatton RC, 2008, PHARMACOTHERAPY, V28, P410, DOI 10.1592/phco.28.3.410; Health Sector Programme Ministry of Health and Population Deutsche Gesellschaft fur Technische Zusammenarbeit., 2009, ESS DRUG PROC SUPPL; Hogerzeil HV, 2006, B WORLD HEALTH ORGAN, V84, P371, DOI 10.2471/BLT.06.031153; Holloway K, 2003, DRUG THERAPEUTIC COM; Hussain Z, 2012, WORKSHOP ON FRAMEWOR; International Council of Nurses International Pharmaceutical Federation World Dental Federation World Medical Association, 2016, BE AWARE HELP FIGHT; Kafle KK, 2010, NEPALESE NATL FORMUL; Levison L., 2003, ESSENT DRUGS MONIT, P31; Lewis J, 2003, QUALITATIVE RES PRAC; Manolakis M, 2012, AM J HEALTH-SYST PH, V69, P17, DOI 10.2146/ajhp110640; Mark SM, 2001, AM J HEALTH-SYST PH, V58, P1445, DOI 10.1093/ajhp/58.15.1445; Mason M., 2010, FORUM QUAL SOC RES, V11; Medical Board of Australia, 2014, COD GOOD SCI PRACT; Medicines Australia, 2015, COD COND; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Milovanovic DR, 2004, EUR J CLIN PHARMACOL, V60, P149, DOI 10.1007/s00228-004-0736-1; Mostert S, 2012, PEDIATR BLOOD CANCER, V58, P325, DOI 10.1002/pbc.23408; Nepal Medical Council, 2016, NMC COD ETH; Nepal Pharmacy Council, 2005, NAT GOOD PHARM PRACT; Nguyen NY, 2013, JAMA INTERN MED, V173, P338, DOI 10.1001/jamainternmed.2013.2522; Noy C, 2008, INT J SOC RES METHOD, V11, P327, DOI 10.1080/13645570701401305; Ombaka E, 2009, AM J HEALTH-SYST PH, V66, pS20, DOI 10.2146/ajhp080604; Penm J, 2014, HEALTH POLICY PLANN, V29, P849, DOI 10.1093/heapol/czt067; Penm J, 2013, AM J HEALTH-SYST PH, V70, P967, DOI 10.2146/ajhp120396; QSR International, 2014, NVIVO 10 WIND GETT S; Rankin J, 1999, OPERATIONAL PRINCIPL; Roy Nobhojit, 2007, Indian J Med Ethics, V4, P57; Sanyal D, 2015, THE RISING NEPAL; Seiter A, 2009, CLIN PHARMACOL THER, V85, P576, DOI 10.1038/clpt.2009.47; Smith Joanna, 2011, Nurse Res, V18, P52; Spencer L., 2014, QUALITATIVE RESEACH; Thapa BB, 2007, DRUG B NEPAL, V19, P3; The White House Office of Press Secretary, 2011, FACT SHEET OBAMA ADM; Tordoff JM, 2005, VALUE HEALTH, V8, P201, DOI 10.1111/j.1524-4733.2005.04040.x; Transparency International, 2014, CORR COUNTR TERR; Nguyen TA, 2015, HEALTH POLICY PLANN, V30, P267, DOI 10.1093/heapol/czt105; United Nations Development Programme, 2015, 2014 HUMAN DEVELOPME; United States Pharmacopeia Drug Quality and Information Program, 2007, ENS QUAL MED RES LTD; Vermeulen LC, 2009, AM J HEALTH-SYST PH, V66, pS7, DOI 10.2146/ajhp080690; Ward DJ, 2013, J ADV NURS, V69, P2423, DOI 10.1111/jan.12127; Wertheimer Albert I, 2005, Expert Opin Drug Saf, V4, P619, DOI 10.1517/14740338.4.4.619; Wertheimer AI, 2009, RES SOC ADMIN PHARM, V5, P4, DOI 10.1016/j.sapharm.2008.05.002; WHO, 2007, MOD QUAL ASS SYST PR; WHO Prequalification of Medicines Programme, 2012, WHO DRUG INFORM, V26, P99; World Health Organization, 2014, GOOD GOV MED MOD FRA; World Health Organization, 2014, WHO MOD FORM; World Health Organization, 2016, GUID DEV MEAS COMB C; World Health Organization, 2002, ANTITB OTHER MED PRE; World Health Organization, 2014, NEPAL WHO STATISTICA	75	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191778	10.1371/journal.pone.0191778	http://dx.doi.org/10.1371/journal.pone.0191778			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401474	Green Published, gold, Green Submitted			2022-12-26	WOS:000424101400019
J	Oo, AZ; Sudo, S; Akiyama, H; Win, KT; Shibata, A; Yamamoto, A; Sano, T; Hirono, Y				Oo, Aung Zaw; Sudo, Shigeto; Akiyama, Hiroko; Win, Khin Thuzar; Shibata, Akira; Yamamoto, Akinori; Sano, Tomohito; Hirono, Yuhei			Effect of dolomite and biochar addition on N2O and CO2 emissions from acidic tea field soil	PLOS ONE			English	Article							NITROUS-OXIDE EMISSIONS; ORGANIC-CARBON MINERALIZATION; CHEMICAL-PROPERTIES; DENITRIFICATION; MOISTURE; DIOXIDE; TEMPERATURE; LIME; FLUX; PH	A laboratory study was conducted to study the effects of liming and different biochar amendments on N2O and CO2 emissions from acidic tea field soil. The first experiment was done with three different rates of N treatment; N 300 (300 kg N ha(-1)), N 600 (600 kg N ha(-1)) and N 900 (900 kg N ha(-1)) and four different rates of bamboo biochar amendment; 0%, 0.5%, 1% and 2% biochar. The second experiment was done with three different biochars at a rate of 2% (rice husk, sawdust, and bamboo) and a control and lime treatment (dolomite) and control at two moisture levels (50% and 90% water filled pore space (WFPS)). The results showed that dolomite and biochar amendment significantly increased soil pH. However, only biochar amendment showed a significant increase in total carbon (C), C/N (the ratio of total carbon and total nitrogen), and C/IN ratio (the ratio of total carbon and inorganic nitrogen) at the end of incubation. Reduction in soil NO3--N concentration was observed under different biochar amendments. Bamboo biochar with the rates of 0.5, 1 and 2% reduced cumulative N2O emission by 38%, 48% and 61%, respectively, compare to the control soil in experiment 1. Dolomite and biochar, either alone or combined significantly reduced cumulative N2O emission by 4.6% to 32.7% in experiment 2. Reduction in N2O production under biochar amendment was due to increases in soil pH and decreases in the magnitude of mineral-N in soil. Although, both dolomite and biochar increased cumulative CO2 emission, only biochar amendment had a significant effect. The present study suggests that application of dolomite and biochar to acidic tea field soil can mitigate N2O emissions.	[Oo, Aung Zaw; Sudo, Shigeto; Akiyama, Hiroko] Natl Agr & Food Res Org NARO, Inst Agroenvironm Sci NIAES, 3-1-3 Kannondai, Tsukuba, Ibaraki, Japan; [Win, Khin Thuzar] Natl Agr & Food Res Org NARO, Cent Reg Agr Res Ctr, Kannondai 2-1-18, Tsukuba, Ibaraki, Japan; [Shibata, Akira] Ritsumeikan Univ, Kyoto, Japan; [Yamamoto, Akinori] Tokyo Gakugei Univ, Koganei, Tokyo, Japan; [Sano, Tomohito; Hirono, Yuhei] Natl Agr & Food Res Org NARO, Inst Fruit Tree & Tea Sci, 2769 Kanaya Shishidoi, Shimada, Shizuoka, Japan	National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; Ritsumeikan University; Tokyo Gakugei University	Oo, AZ; Sudo, S (corresponding author), Natl Agr & Food Res Org NARO, Inst Agroenvironm Sci NIAES, 3-1-3 Kannondai, Tsukuba, Ibaraki, Japan.	aungzawoo@affrc.go.jp; ssudo@affrc.go.jp	Sano, Tomohito/ABI-2664-2020; , 0000-0002-2689-7560/ABB-2870-2020; Hiroko, Akiyama/T-8715-2017	Sano, Tomohito/0000-0002-1101-2117; , 0000-0002-2689-7560/0000-0002-2689-7560; Hiroko, Akiyama/0000-0001-8821-5185; Win, Khin Thuzar/0000-0002-4834-078X; Oo, Aung Zaw/0000-0002-0571-0613	Research Institute for Humanity and Nature (RIHN), Kyoto, Japan, under the project "Life Worlds of Sustainable food Consumption and Production: Agri-food Systems in Transition (FEAST Project)"	Research Institute for Humanity and Nature (RIHN), Kyoto, Japan, under the project "Life Worlds of Sustainable food Consumption and Production: Agri-food Systems in Transition (FEAST Project)"	This work was supported by the Research Institute for Humanity and Nature (RIHN), Kyoto, Japan, under the project "Life Worlds of Sustainable food Consumption and Production: Agri-food Systems in Transition (FEAST Project)."	Akiyama H, 2006, SOIL SCI PLANT NUTR, V52, P774, DOI 10.1111/j.1747-0765.2006.00097.x; Ameloot N, 2013, SOIL BIOL BIOCHEM, V57, P401, DOI 10.1016/j.soilbio.2012.10.025; Baggs EM, 2010, BIOL FERT SOILS, V46, P793, DOI 10.1007/s00374-010-0484-6; Bakken LR, 2012, PHILOS T R SOC B, V367, P1226, DOI 10.1098/rstb.2011.0321; Bolan NS, 2011, ADV AGRON, V110, P1, DOI 10.1016/B978-0-12-385531-2.00001-3; Bowden RD, 1998, SOIL BIOL BIOCHEM, V30, P1591, DOI 10.1016/S0038-0717(97)00228-9; Cayuela ML, 2014, AGR ECOSYST ENVIRON, V191, P5, DOI 10.1016/j.agee.2013.10.009; Chia CH, 2014, J ANAL APPL PYROL, V108, P26, DOI 10.1016/j.jaap.2014.05.021; Ciais P, 2013, COMP GEOM-THEOR APPL; Cross A, 2011, SOIL BIOL BIOCHEM, V43, P2127, DOI 10.1016/j.soilbio.2011.06.016; Dong YJ, 2014, J ARID LAND, V6, P37, DOI 10.1007/s40333-013-0195-6; Downie A., 2009, BIOCHAR ENV MANAGEME, P13; Ernfors M, 2007, BIOGEOCHEMISTRY, V84, P219, DOI 10.1007/s10533-007-9123-1; Erntors M, 2007, BIOGEOCHEM, V84, P219; Feng K, 2003, NUTR CYCL AGROECOSYS, V67, P283, DOI 10.1023/B:FRES.0000003664.51048.0e; Feng Z, 2017, SCI TOTAL ENV; Fuentes JP, 2006, SOIL TILL RES, V88, P123, DOI 10.1016/j.still.2005.05.001; Geisseler D, 2010, SOIL BIOL BIOCHEM, V42, P2058, DOI 10.1016/j.soilbio.2010.08.021; Glaser B, 2002, BIOL FERT SOILS, V35, P219, DOI 10.1007/s00374-002-0466-4; Higgins S, 2013, NUTR CYCL AGROECOSYS, V95, P219, DOI 10.1007/s10705-013-9559-8; Hirono Y, 2012, SOIL SCI PLANT NUTR, V58, P384, DOI 10.1080/00380768.2012.686434; IPCC, 2014, IPCC CLIM CHANG 2014; Kemmitt SJ, 2006, SOIL BIOL BIOCHEM, V38, P898, DOI 10.1016/j.soilbio.2005.08.006; Kong YH, 2013, SOIL SCI PLANT NUTR, V59, P790, DOI 10.1080/00380768.2013.817938; Li X, 2002, BIOL FERT SOILS, V35, P108, DOI 10.1007/s00374-002-0447-7; Liu BB, 2010, FEMS MICROBIOL ECOL, V72, P407, DOI 10.1111/j.1574-6941.2010.00856.x; Cayuela ML, 2013, SCI REP-UK, V3, DOI 10.1038/srep01732; Major J, 2009, BIOCHAR ENV MANAGEME, P271; NIES (National Institute for Environmental Studies), 2012, NATIONAL GREENHOUSE; Nishimura S, 2005, SOIL SCI SOC AM J, V69, P1977, DOI 10.2136/sssaj2005.0035; Obia A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138781; Page K, 2010, SOIL RES, V47, P747; Qu Z, 2014, GLOBAL CHANGE BIOL, V20, P1685, DOI 10.1111/gcb.12461; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Rochette P, 2006, SOIL SCI SOC AM J, V70, P744, DOI 10.2136/sssaj2005.0242; Ruan JY, 2007, ANN BOT-LONDON, V99, P301, DOI 10.1093/aob/mcl258; Saarnio S, 2013, SOIL BIOL BIOCHEM, V58, P99, DOI 10.1016/j.soilbio.2012.10.035; Shaaban M, 2017, ENVIRON SCI POLLUT R, V24, P9241, DOI 10.1007/s11356-017-8602-8; Shaaban M, 2015, ENVIRON SCI POLLUT R, V22, P19961, DOI 10.1007/s11356-015-5238-4; Shaaban M, 2014, J CHEM SOC PAKISTAN, V36, P875; Singla A, 2014, BIOL FERT SOILS, V50, P1201, DOI 10.1007/s00374-014-0950-7; Smith JL, 2010, SOIL BIOL BIOCHEM, V42, P2345, DOI 10.1016/j.soilbio.2010.09.013; Smith Keith, 2010, NITROUS OXIDE CLIMAT; Sohi SP, 2010, ADV AGRON, V105, P47, DOI 10.1016/S0065-2113(10)05002-9; Taghizadeh-Toosi A, 2011, J ENVIRON QUAL, V40, P468, DOI 10.2134/jeq2010.0419; Thammasom Nipa, 2016, Agriculture and Natural Resources, V50, P192, DOI 10.1016/j.anres.2016.01.003; Tokuda S, 2004, SOIL SCI PLANT NUTR, V50, P365, DOI 10.1080/00380768.2004.10408490; Troy SM, 2013, SOIL BIOL BIOCHEM, V60, P173, DOI 10.1016/j.soilbio.2013.01.019; Valzano FP, 2001, AUST J SOIL RES, V39, P1307, DOI 10.1071/SR99086; van Zwieten L, 2010, AUST J SOIL RES, V48, P555, DOI 10.1071/SR10004; Van Zwieten L, 2009, BIOCHAR ENV MANAGEME, P227, DOI DOI 10.4324/9781849770552; Wang JY, 2012, PLANT SOIL, V360, P287, DOI 10.1007/s11104-012-1250-3; Wang XW, 2010, J ENVIRON SCI-CHINA, V22, P1057, DOI 10.1016/S1001-0742(09)60217-5; WEIER KL, 1993, SOIL SCI SOC AM J, V57, P66, DOI 10.2136/sssaj1993.03615995005700010013x; Weslien P, 2009, EUR J SOIL SCI, V60, P311, DOI 10.1111/j.1365-2389.2009.01123.x; Yanai Y, 2007, SOIL SCI PLANT NUTR, V53, P181, DOI 10.1111/j.1747-0765.2007.00123.x; Yu YX, 2016, APPL SOIL ECOL, V100, P75, DOI 10.1016/j.apsoil.2015.12.009; Zhang XH, 2007, J ENVIRON SCI, V19, P319, DOI 10.1016/S1001-0742(07)60052-7; Zimmerman AR, 2011, SOIL BIOL BIOCHEM, V43, P1169, DOI 10.1016/j.soilbio.2011.02.005	60	33	35	8	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192235	10.1371/journal.pone.0192235	http://dx.doi.org/10.1371/journal.pone.0192235			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394272	Green Submitted, Green Published, gold			2022-12-26	WOS:000424060400030
J	Wu, YH; Chen, YH; Chang, MH; Lin, CH				Wu, Yu-Hsuan; Chen, Yi-Huei; Chang, Ming-Hong; Lin, Ching-Heng			Depression in Parkinson's disease: A case-control study	PLOS ONE			English	Article							NONMOTOR FEATURES; RISK	Background To evaluate the association between Parkinson's disease (PD) prognosis and the patient's onset of depression. Methods A total of 353 patients with newly-diagnosed PD and a history of depression were enrolled. On the basis of the onset of depression before or after PD diagnosis, we divided participants into PD patients with pre- or post-diagnostic depression. Cox's regression analysis was used to detect risks between the onset of depression and outcomes (including death, accidental injury, dementia, and aspiration pneumonia). The association between the onset of depression and levodopa equivalent dosage (LED) and cumulative equivalent dosage of antidepressants were assessed. Results PD patients with post-diagnostic depression were associated with significantly higher risks of dementia (adjusted HR = 2.01, p = 0.015), and were older (58.5 +/- 17.7 vs. 53.7 +/- 18.6, p = 0.020) at the time of PD diagnosis than PD patients with pre-diagnostic depression. The higher incident rate of accidental injury was also noted in PD patients with post-diagnostic depression (48.1 vs. 31.3/1000 person-years, HR = 1.60, p = 0.041), but no statistical significance was observed in the adjusted hazard ratio (HR) (HR = 1.52, p = 0.069). Otherwise, mortality, motor condition and severity of depression revealed no significant difference between PD patients with pre-diagnostic and post-diagnostic depression. Conclusion PD patients with post-diagnostic depression had higher incidence of dementia, implying different onset time of depression could be associated with different subtypes and spreading routes which should be examined in follow-up studies.	[Wu, Yu-Hsuan; Chang, Ming-Hong] Taichung Vet Gen Hosp, Sect Neurol, Taichung, Taiwan; [Chen, Yi-Huei; Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan; [Chang, Ming-Hong] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Chang, MH (corresponding author), Taichung Vet Gen Hosp, Sect Neurol, Taichung, Taiwan.; Lin, CH (corresponding author), Taichung Vet Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan.; Chang, MH (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei, Taiwan.	cmh50@ms10.hinet.net; joelin99@gmail.com		Chang, Ming-Hong/0000-0002-7699-334X				Alzahrani H, 2015, J NEUROL SCI, V356, P32, DOI 10.1016/j.jns.2015.06.037; Beach TG, 2009, ACTA NEUROPATHOL, V117, P169, DOI 10.1007/s00401-008-0450-7; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; de Lau LML, 2014, PARKINSONISM RELAT D, V20, P613, DOI 10.1016/j.parkreldis.2014.02.030; Guo YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107465; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; Jellinger KA, 2012, MOVEMENT DISORD, V27, P8, DOI 10.1002/mds.23795; Lin CH, 2014, PARKINSONISM RELAT D, V20, P1371, DOI 10.1016/j.parkreldis.2014.09.026; Marras C, 2016, MOVEMENT DISORD, V31, P1095, DOI 10.1002/mds.26510; Morgan JC, 2014, PARKINSONS DIS-US, V2014, DOI 10.1155/2014/426976; Shen CC, 2013, NEUROLOGY, V81, P1538, DOI 10.1212/WNL.0b013e3182a956ad; Walker Z, 2015, LANCET, V386, P1683, DOI 10.1016/S0140-6736(15)00462-6; Wu YM, 2015, 4TH INTERNATIONAL CONFERENCE ON MECHANICAL AUTOMATION AND MATERIALS ENGINEERING (ICMAME 2015), P6; Wu YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161271	14	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192050	10.1371/journal.pone.0192050	http://dx.doi.org/10.1371/journal.pone.0192050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390032	gold, Green Submitted, Green Published			2022-12-26	WOS:000423793400058
J	Chen, TK; Cong, Q; Qi, YC; Jin, JF; Choy, KL				Chen, Tingkun; Cong, Qian; Qi, Yingchun; Jin, Jingfu; Choy, Kwang-Leong			Hydrophobic durability characteristics of butterfly wing surface after freezing cycles towards the design of nature inspired antiicing surfaces	PLOS ONE			English	Article							SUPERHYDROPHOBIC SURFACES; FROST FORMATION; ICE-ADHESION; GROWTH-RATE; ROUGHNESS; REPELLENCY; CONVECTION	The hydrophobicity and anti-icing performance of the surfaces of some artificial hydrophobic coatings degraded after several icing and de-icing cycles. In this paper, the frost formation on the surfaces of butterfly wings from ten different species was observed, and the contact angles were measured after 0 to 6 frosting/defrosting cycles. The results show that no obvious changes in contact angle for the butterfly wing specimens were not obvious during the frosting/defrosting process. Further, the conclusion was inferred that the topography of the butterfly wing surface forms a special space structure which has a larger space inside that can accommodate more frozen droplets; this behavior prevents destruction of the structure. The findings of this study may provide a basis and new concepts for the design of novel industrially important surfaces to inhibit frost/ice growth, such as durable anti-icing coatings, which may decrease or prevent the socio-economic loss.	[Chen, Tingkun; Cong, Qian] Jilin Univ, Key Lab Bion Engn, Minist Educ, Changchun, Jilin, Peoples R China; [Cong, Qian] Jilin Univ, State Key Lab Automot Simulat & Control, Changchun, Jilin, Peoples R China; [Qi, Yingchun; Jin, Jingfu] Jilin Univ, Coll Biol & Agr Engn, Changchun, Jilin, Peoples R China; [Choy, Kwang-Leong] UCL, Inst Mat Discovery, London, England	Jilin University; Jilin University; Jilin University; University of London; University College London	Jin, JF (corresponding author), Jilin Univ, Coll Biol & Agr Engn, Changchun, Jilin, Peoples R China.	jinjingfu@jlu.edu.cn		Choy, Kwang-Leong/0000-0002-5596-4427	National Natural Science Foundation of China [51711530236]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by National Natural Science Foundation of China (Grant No.51711530236 to QC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengol JM, 2016, INT J THERM SCI, V104, P245, DOI 10.1016/j.ijthermalsci.2016.01.017; Bharathidasan T, 2014, APPL SURF SCI, V314, P241, DOI 10.1016/j.apsusc.2014.06.101; Callies M, 2005, SOFT MATTER, V1, P55, DOI 10.1039/b501657f; Chou Io, 1999, PRIMARY COLORS OF PI; Chou Io, 1998, CLASSIFICATION AND I; Dorrer C, 2009, SOFT MATTER, V5, P51, DOI 10.1039/b811945g; Farhadi S, 2011, APPL SURF SCI, V257, P6264, DOI 10.1016/j.apsusc.2011.02.057; Farzaneh M, 2011, COLD REG SCI TECHNOL, V65, P1, DOI 10.1016/j.coldregions.2010.08.012; Fossa M, 2010, INT J MULTIPHAS FLOW, V36, P210, DOI 10.1016/j.ijmultiphaseflow.2009.11.002; HAYASHI Y, 1977, J HEAT TRANS-T ASME, V99, P239, DOI 10.1115/1.3450675; Huang LY, 2010, J MECH SCI TECHNOL, V24, P1523, DOI 10.1007/s12206-010-0410-8; Kandula M, 2011, INT J HEAT MASS TRAN, V54, P3719, DOI 10.1016/j.ijheatmasstransfer.2011.02.056; Koch K, 2009, SOFT MATTER, V5, P1386, DOI 10.1039/b818940d; Kulinich SA, 2015, SOFT MATTER, V11, P856, DOI 10.1039/c4sm02204a; Kulinich SA, 2011, LANGMUIR, V27, P25, DOI 10.1021/la104277q; Kulinich SA, 2011, COLD REG SCI TECHNOL, V65, P60, DOI 10.1016/j.coldregions.2010.01.001; Makkonen L, 2012, J ADHES SCI TECHNOL, V26, P413, DOI 10.1163/016942411X574583; Max Kandula, 2011, INT J HEAT MASS TRAN, V54, P3719; Miwa M, 2000, LANGMUIR, V16, P5754, DOI 10.1021/1a991660o; Momen G, 2015, APPL SURF SCI, V349, P211, DOI 10.1016/j.apsusc.2015.04.180; Na B, 2003, INT J HEAT MASS TRAN, V46, P3797, DOI 10.1016/S0017-9310(03)00194-7; Na BC, 2004, INT J HEAT MASS TRAN, V47, P925, DOI 10.1016/j.ijheatmasstransfer.2003.09.001; Rykaczewski K, 2011, ACS NANO, V5, P5962, DOI 10.1021/nn201738n; SEKI N, 1985, WARME STOFFUBERTRAG, V19, P9, DOI 10.1007/BF01682542; Shou JX, 2006, SYSTEMATIC BUTTERFLY; Stavenga DG, 2014, J EXP BIOL, V217, P2171, DOI 10.1242/jeb.098673; Sun G, 2009, J BIONIC ENG, V6, P71, DOI 10.1016/S1672-6529(08)60094-3; Tourkine P, 2009, LANGMUIR, V25, P7214, DOI 10.1021/la900929u; Varanasi Kraipa K., 2009, APPL PHYS LETT, V95; Varanasi KK, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3524513; Yue XF, 2016, SURF COAT TECH, V307, P278, DOI 10.1016/j.surfcoat.2016.09.004; Zou M, 2011, APPL SURF SCI, V257, P3786, DOI 10.1016/j.apsusc.2010.11.149	32	10	10	8	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0188775	10.1371/journal.pone.0188775	http://dx.doi.org/10.1371/journal.pone.0188775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385390	Green Submitted, Green Published, gold			2022-12-26	WOS:000423668400005
J	Henriques, M; Granadeiro, JP; Monteiro, H; Nuno, A; Lecoq, M; Cardoso, P; Regalla, A; Catry, P				Henriques, Mohamed; Pedro Granadeiro, Jose; Monteiro, Hamilton; Nuno, Ana; Lecoq, Miguel; Cardoso, Paulo; Regalla, Aissa; Catry, Paulo			Not in wilderness: African vulture strongholds remain in areas with high human density	PLOS ONE			English	Article							MAMMAL POPULATION DECLINES; NECROSYRTES-MONACHUS; GYPS-AFRICANUS; WEST-AFRICA; SCAVENGERS; HEALTH; POISON; BIRDS; CONSEQUENCES; CONSERVATION	Vultures constitute an important functional group in many ecosystems, providing crucial ecosystem services both in natural and humanized environments. These scavengers are facing massive declines worldwide, but in several African countries virtually nothing is known on populations' status and threats, hampering the development of adequate conservation strategies. In Guinea-Bissau, globally important populations of Hooded Necrosyrtes monachus and African white-backed vultures Gyps africanus were recently reported. Using the country as a study area, we aim to characterize human-vulture interactions in West Africa applying a multidisciplinary approach. We assessed the status and distribution of vulture populations using data from 1711 km of roadside transects, examined predictors of their distribution, and produced a nationwide population estimate for the Hooded Vulture, using an innovative method based on the relationship between the size of human population in settlements and vulture numbers. We conducted 47 stakeholder interviews to assess perceived roles played by vultures, and to investigate potential anthropogenic threats. Hooded vultures were strongly associated with high human population densities, whereas no relation was found between African white-backed and Ruppell's vultures and any of the tested predictors, which included cattle density, precipitation and Normalized Difference Vegetation Index, among others. We estimate a national population of 43347 Hooded vultures, the largest population reported in the species range. Respondents were generally aware of the services provided by vultures, especially waste and carcass removal, including in urban areas. Hunting for witchcraft and traditional medicine was the most frequently recognised threat, while poisoning was ranked as having the highest impact. We hypothesise that poisoning-related mortality may be affecting African white-backed and Ruppell's vultures' distribution and explain their scarcity in apparently highly suitable habitats. Our results suggest a mutualistic rather than a commensalistic relationship between vultures and humans, with important implications for designing and implementing conservation strategies.	[Henriques, Mohamed; Catry, Paulo] ISPA Inst Univ, MARE Marine & Environm Sci Ctr, Rua Jardim Tabaco, Lisbon, Portugal; [Henriques, Mohamed; Regalla, Aissa] BAP Inst Biodiversidade & Areas Protegidas, Ave Dom Settimio Arturo Ferrazzetta, Bissau, Guinea Bissau; [Pedro Granadeiro, Jose] Univ Lisbon, Fac Ciencias, CESAM, Dept Biol Anim, Lisbon, Portugal; [Monteiro, Hamilton] Coastal Planning Off, Bissau, Guinea Bissau; [Nuno, Ana] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Lecoq, Miguel] BirdLife Int, Africa Partnership Secretariat, Dakar, Senegal; [Cardoso, Paulo] Bioinsight, Rua Antero de Quental, Odivelas, Portugal	Instituto Superior Psicologia Aplicada (ISPA); Universidade de Lisboa; University of Exeter; BirdLife International	Henriques, M (corresponding author), ISPA Inst Univ, MARE Marine & Environm Sci Ctr, Rua Jardim Tabaco, Lisbon, Portugal.; Henriques, M (corresponding author), BAP Inst Biodiversidade & Areas Protegidas, Ave Dom Settimio Arturo Ferrazzetta, Bissau, Guinea Bissau.	mhenriquesbalde@gmail.com	Granadeiro, José Pedro/E-8060-2011; Nuno, Ana/H-9497-2019; Henriques, Mohamed F/V-3811-2018; Catry, Paulo/I-5408-2013	Granadeiro, José Pedro/0000-0002-7207-3474; Henriques, Mohamed F/0000-0002-3061-5423; Nuno, Ana/0000-0003-4680-2378; Catry, Paulo/0000-0003-3000-0522; Regalla de Barros, Aissa/0000-0003-1522-8211	Institute of Biodiversity and Protected Areas of Guinea-Bissau - IBAP; Rufford Foundation, through the Rufford Small Grants [18298-1]; Fondation MAYA, through the project "La recherche participative au service the la conservation de la biodiversite du Parc National Marin Joao Vieira/Poilao"; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) through MARE [UID/MAR/04292/2013]; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) through CESAM [UID/AMB/50017/2013]; Darwin Initiative. P. Cardoso	Institute of Biodiversity and Protected Areas of Guinea-Bissau - IBAP; Rufford Foundation, through the Rufford Small Grants; Fondation MAYA, through the project "La recherche participative au service the la conservation de la biodiversite du Parc National Marin Joao Vieira/Poilao"; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) through MARE; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) through CESAM; Darwin Initiative. P. Cardoso	This study benefited from logistical, institutional and financial support of the Institute of Biodiversity and Protected Areas of Guinea-Bissau - IBAP granted to MH. Additional funding was received from the Rufford Foundation, through the Rufford Small Grants (attributed to MH, Ref: 18298-1), from the Fondation MAYA, through the project "La recherche participative au service the la conservation de la biodiversite du Parc National Marin Joao Vieira/Poilao" granted to IBAP, and from Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) through the strategic project UID/MAR/04292/2013 granted through MARE to P. Catry and UID/AMB/50017/2013 through CESAM to JPG. AN was supported by the Darwin Initiative. P. Cardoso is affiliated to Bioinsight Lda., a commercial company, but this company did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, and did not provide any kind of funding except in the form of salary for author P. Cardoso, who's participation in this study was unrelated to his work at Bioinsight. The specific roles of P. Cardoso are articulated in the 'author contributions' section.	Alcamo J, 2003, ECOSYSTEMS; Annorbah Nathaniel N. D., 2012, Malimbus, V34, P1; [Anonymous], 2015, R SOC CHEM ENV CHEM; [Anonymous], 2021, LANG ENV STAT COMP; Atuo FA, 2015, BIOL CONSERV, V191, P614, DOI 10.1016/j.biocon.2015.08.013; Barton PS, 2013, OECOLOGIA, V171, P761, DOI 10.1007/s00442-012-2460-3; Biai J., 2015, STRATEGY NATL ACTION; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Botha A., 2012, PAN AFRICAN VULTURE, P1; Bridgeford Peter, 2001, Vulture News, V44, P22; Buij R, 2016, ORYX, V50, P606, DOI 10.1017/S0030605315000514; Buij R, 2015, ORYX, V50, P1; Campbell M. O., 2016, VULTURES THEIR EVOLU; Campbell M, 2009, AREA, V41, P341, DOI 10.1111/j.1475-4762.2008.00870.x; Carrascal L. M., 2008, Animal Biodiversity and Conservation, V31, P45; Chung O, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0780-4; CONNER R N, 1980, Wildlife Society Bulletin, V8, P4; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; DGA DGP, 2013, GUIN BISS REC NAC GA; EBERHARDT LL, 1978, J WILDLIFE MANAGE, V42, P1, DOI 10.2307/3800685; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Faye M., 2010, LETTRE POLITIQUE DEV; Gangoso L, 2013, CONSERV LETT, V6, P172, DOI 10.1111/j.1755-263X.2012.00289.x; Garcia-del-Rey Eduardo, 2005, Vieraea, V33, P193; Gbogbo F., 2008, Vulture News, V58, P16; Gbogbo F., 2016, INT J ZOOL, P1; Green RE, 2004, J APPL ECOL, V41, P793, DOI 10.1111/j.0021-8901.2004.00954.x; Harris Richard J., 2013, Journal of Threatened Taxa, V5, P3603, DOI 10.11609/JoTT.o2816.3603-19; Henriques M, 2017, OSTRICH, V88, P101, DOI 10.2989/00306525.2017.1312584; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hla H, 2011, BIRD CONSERV INT, V21, P376, DOI 10.1017/S0959270910000560; HOUSTON DC, 1974, J ZOOL, V172, P35; INE, 2013, PROJ DEM GUIN BISS 2; Instituto Nacional de Estatistica, 2009, POP SEC LOC SEX CENS; IUCN, 2021, WIKIPEDIA; IUCN & ICCN, 2012, BON PAN PAN CONS STR; Jallow M, 2016, MALIMBUS, V38, P23; Kendall CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083470; Margalida A, 2014, SCIENCE, V346, P1296, DOI 10.1126/science.1260260; Margalida A., 2011, PLOS ONE, V6, P1; Margalida A, 2017, NAT ECOL EVOL, V1, P1050, DOI 10.1038/s41559-017-0255-y; Margalida A, 2014, ECOL APPL, V24, P436, DOI 10.1890/13-0414.1; Margalida A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00753; Margalida A, 2012, SCIENCE, V338, P192, DOI 10.1126/science.338.6104.192-a; Markandya A, 2008, ECOL ECON, V67, P194, DOI 10.1016/j.ecolecon.2008.04.020; MDRARNA PNUD, 2000, ESTR PLAN ACC NAC BI; Moleon M, 2014, BIOSCIENCE, V64, P394, DOI 10.1093/biosci/biu034; Morales-Reyes Z, 2017, CONSERV LETT, P1; Morelli F, 2015, ANTHROZOOS, V28, P449, DOI 10.1080/08927936.2015.1052279; Murn C., 2017, ORYX, P1; Murn C, 2008, OSTRICH, V79, P191, DOI 10.2989/OSTRICH.2008.79.2.9.583; Naidoo V, 2017, ENVIRON RES, V152, P150, DOI 10.1016/j.envres.2016.10.013; Newing H, 2011, CONDUCTING RESEARCH IN CONSERVATION: SOCIAL SCIENCE METHODS AND PRACTICE, P1; Odino Martin, 2014, Vulture News, V67, P3; Ogada D, 2015, ORYX IN PRESS, P1; Ogada DL, 2012, CONSERV BIOL, V26, P453, DOI 10.1111/j.1523-1739.2012.01827.x; Ogada DL, 2011, OSTRICH, V82, P101, DOI 10.2989/00306525.2011.603464; Ogada D, 2016, ORYX, V50, P593, DOI 10.1017/S0030605315001209; Ogada D, 2016, CONSERV LETT, V9, P89, DOI 10.1111/conl.12182; Ogada DL, 2014, ANN NY ACAD SCI, V1322, P1, DOI 10.1111/nyas.12405; Ogada DL, 2012, ANN NY ACAD SCI, V1249, P57, DOI 10.1111/j.1749-6632.2011.06293.x; Pain DJ, 2008, BIRD CONSERV INT, V18, pS30, DOI 10.1017/S0959270908000324; Parmenter RR, 2009, ECOL MONOGR, V79, P637, DOI 10.1890/08-0972.1; Plaza PI, 2017, GLOB ECOL CONSERV, V12, P9, DOI 10.1016/j.gecco.2017.08.002; POMEROY DE, 1975, IBIS, V117, P69, DOI 10.1111/j.1474-919X.1975.tb04188.x; Pomeroy D, 2015, BIRD CONSERV INT, V25, P399, DOI 10.1017/S095927091400029X; Roberts JST, 2013, ESTIMATING POPULATIO; Rondeau G, 2008, JOINT NATURE CONSERV; Roxburgh Lizanne, 2012, Vulture News, V62, P33; Rutina L, 2017, BOTSW NOTES REC, V49, P106; Ruxton GD, 2004, J THEOR BIOL, V228, P431, DOI 10.1016/j.jtbi.2004.02.005; Santangeli A, 2017, OSTRICH, V88, P147, DOI 10.2989/00306525.2017.1321051; Santangeli A, 2016, BIOL CONSERV, V204, P205, DOI 10.1016/j.biocon.2016.10.018; Scholte P, 2011, TROP CONSERV SCI, V4, P1, DOI 10.1177/194008291100400102; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Sodeinde O.A., 1999, Traffic Bulletin, V18, P35; Ssemmanda Richard, 2005, Vulture News, V53, P10; Thiollay JM, 2007, OSTRICH, V78, P405, DOI 10.2989/OSTRICH.2007.78.2.46.126; Thiollay JM, 2006, BIRD CONSERV INT, V16, P353, DOI 10.1017/S0959270906000487; Thiollay JM, 2006, BIODIVERS CONSERV, V15, P2085, DOI 10.1007/s10531-004-6684-3; Thiollay JM, 2006, IBIS, V148, P240, DOI 10.1111/j.1474-919X.2006.00531.x; Virani MZ, 2016, AFRICAS VULTURES ENT, P73; Whytock C.R., 2010, GABAR, V21, P1; Whytock R.C., 2014, ORYX, P1; Williamson VJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086170; Woodford M.H., 2008, WORLD ORG ANIMAL WEL, V2, P11; World Bank, 2016, WORLD DEV IND 2016	88	26	29	7	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0190594	10.1371/journal.pone.0190594	http://dx.doi.org/10.1371/journal.pone.0190594			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385172	gold, Green Published			2022-12-26	WOS:000423668400021
J	Klein, ES; Hill, SL; Hinke, JT; Phillips, T; Watters, GM				Klein, Emily S.; Hill, Simeon L.; Hinke, Jefferson T.; Phillips, Tony; Watters, George M.			Impacts of rising sea temperature on krill increase risks for predators in the Scotia Sea	PLOS ONE			English	Article							CLIMATE-CHANGE; CONCEPTUAL-MODEL; MARINE FISH; ECOSYSTEM; MANAGEMENT; FISHERIES; DYNAMICS; SCALE; IMPLEMENTATION; POPULATIONS	Climate change is a threat to marine ecosystems and the services they provide, and reducing fishing pressure is one option for mitigating the overall consequences for marine biota. We used a minimally realistic ecosystem model to examine how projected effects of ocean warming on the growth of Antarctic krill, Euphausia superba, might affect populations of krill and dependent predators (whales, penguins, seals, and fish) in the Scotia Sea. We also investigated the potential to mitigate depletion risk for predators by curtailing krill fishing at different points in the 21st century. The projected effects of ocean warming on krill biomass were strongest in the northern Scotia Sea, with a >= 40% decline in the mass of individual krill. Projections also suggest a 25% chance that krill biomass will fall below an established depletion threshold (75% of its unimpacted level), with consequent risks for some predator populations, especially penguins. Average penguin abundance declined by up to 30% of its unimpacted level, with up to a 50% chance of falling below the depletion threshold. Simulated krill fishing at currently permitted harvest rates further increased risks for depletion, and stopping fishing offset the increased risks associated with ocean warming in our model to some extent. These results varied by location and species group. Risk reductions at smaller spatial scales also differed from those at the regional level, which suggests that some predator populations may be more vulnerable than others to future changes in krill biomass. However, impacts on predators did not always map directly to those for krill. Our findings indicate the importance of identifying vulnerable marine populations and targeting protection measures at appropriate spatial scales, and the potential for spatially-structured management to avoid aggravating risks associated with rising ocean temperatures. This may help balance tradeoffs among marine ecosystem services in an uncertain future.	[Klein, Emily S.; Hinke, Jefferson T.; Watters, George M.] Natl Marine Fisheries Serv, NOAA, Southwest Fisheries Sci Ctr, Antarctic Ecosyst Res Div, La Jolla, CA 92038 USA; [Klein, Emily S.] Farallon Inst, Petaluma, CA 94952 USA; [Hill, Simeon L.; Phillips, Tony] British Antarctic Survey, Nat Environm Res Council, Cambridge, England	National Oceanic Atmospheric Admin (NOAA) - USA; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Klein, ES (corresponding author), Natl Marine Fisheries Serv, NOAA, Southwest Fisheries Sci Ctr, Antarctic Ecosyst Res Div, La Jolla, CA 92038 USA.; Klein, ES (corresponding author), Farallon Inst, Petaluma, CA 94952 USA.	emily.klein04@gmail.com	, Jefferson/AAG-1702-2021; BITOUN, RACHEL Elisabeth/AAC-9538-2021; Simeon, Hill L/B-2307-2008	, Jefferson/0000-0002-3600-1414; BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Klein, Emily S./0000-0001-9514-7344	Pew Charitable Trusts [29068]; NERC [bas0100035] Funding Source: UKRI	Pew Charitable Trusts; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by funding from the Pew Charitable Trusts, contract ID #29068. This funder had no role in study design, data collection and analysis, or preparation of the manuscript, Publication under peer review was a requirement of this funding source, although the funder had no say in where this manuscript would be submitted.	Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Atkinson A, 2014, TRENDS ECOL EVOL, V29, P309, DOI 10.1016/j.tree.2014.03.011; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Brander K, 2010, J MARINE SYST, V79, P389, DOI 10.1016/j.jmarsys.2008.12.015; Brooks CM, 2016, SCIENCE, V354, P185, DOI 10.1126/science.aah4119; Cash DW, 2006, ECOL SOC, V11; Chapman EW, 2011, MAR ECOL PROG SER, V436, P273, DOI 10.3354/meps09242; Cimino MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep28785; Constable AJ, 2000, ICES J MAR SCI, V57, P778, DOI 10.1006/jmsc.2000.0725; Constable AJ, 2014, GLOBAL CHANGE BIOL, V20, P3004, DOI 10.1111/gcb.12623; Constable AJ, 2011, FISH FISH, V12, P138, DOI 10.1111/j.1467-2979.2011.00410.x; Costa D.P., 1991, P300; Costa DP, 2007, AQUAT CONSERV, V17, pS44, DOI 10.1002/aqc.917; Costa Daniel P., 2012, P225; Flores H, 2012, MAR ECOL PROG SER, V458, P1, DOI 10.3354/meps09831; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; Grant SM, 2013, ANTARCT SCI, V25, P603, DOI 10.1017/S0954102013000308; Hewitt RP, 2004, CCAMLR SCI, V11, P81; Hill SL, 2016, CCAMLR SCI, V23, P31; Hill SL, 2013, CCAMLR SCI, V20, P97; Hill SL, 2013, ENVIRON CONSERV, V40, P394, DOI 10.1017/S0376892913000088; Hill SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072246; Hinke JT, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1666; Hinke JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170132; Hollowed AB, 2013, ICES J MAR SCI, V70, P1023, DOI 10.1093/icesjms/fst081; Kawaguchi S, 2007, POLAR BIOL, V30, P689, DOI 10.1007/s00300-006-0226-2; Kawaguchi S, 2011, BIOL LETTERS, V7, P288, DOI 10.1098/rsbl.2010.0777; Koenigstein S, 2016, FISH FISH, V17, P972, DOI 10.1111/faf.12155; Lockyer C, 2007, J MAR BIOL ASSOC UK, V87, P1035, DOI 10.1017/S0025315407054720; Melbourne-Thomas J, 2016, GEOPHYS RES LETT, V43, P10322, DOI 10.1002/2016GL070846; Murphy EJ, 2007, PHILOS T R SOC B, V362, P113, DOI 10.1098/rstb.2006.1957; NASA Goddard Space Flight Center Ocean Biology Processing Group (NASA), 2010, MOD HES IM SPEC AQ M; Nicol S, 2006, BIOSCIENCE, V56, P111, DOI 10.1641/0006-3568(2006)056[0111:KCASIE]2.0.CO;2; Nilsson JA, 2016, MAR POLICY, V73, P172, DOI 10.1016/j.marpol.2016.08.005; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Plaganyi EE, 2014, FISH FISH, V15, P1, DOI 10.1111/j.1467-2979.2012.00488.x; Plaganyi EE, 2012, ECOL APPL, V22, P748, DOI 10.1890/11-0441.1; Portner HO, 2010, J FISH BIOL, V77, P1745, DOI 10.1111/j.1095-8649.2010.02783.x; R Core Team, 2021, R LANGUAGE ENV STAT; Steneck RS, 2010, B MAR SCI, V86, P387; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Trathan PN, 2007, PHILOS T R SOC B, V362, P2351, DOI 10.1098/rstb.2006.1953; Trathan PN, 2016, ADV POL ECO, P321, DOI 10.1007/978-3-319-29279-3_9; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Tulloch VJD, 2017, FISH FISH, P1; Watters GM, 2013, ECOL APPL, V23, P710, DOI 10.1890/12-1371.1	46	51	51	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191011	10.1371/journal.pone.0191011	http://dx.doi.org/10.1371/journal.pone.0191011			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385153	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000423668400032
J	Koelsch, S; Skouras, S; Lohmann, G				Koelsch, Stefan; Skouras, Stavros; Lohmann, Gabriele			The auditory cortex hosts network nodes influential for emotion processing: An fMRI study on music-evoked fear and joy	PLOS ONE			English	Article							SUPERIOR TEMPORAL REGION; MULTISENSORY CONVERGENCE; CORTICAL CONNECTIONS; ORBITOFRONTAL CORTEX; LANGUAGE PATHWAYS; OPTIMIZED EPI; COMPENSATION; SUBDIVISIONS; ASSOCIATION; PROJECTIONS	Sound is a potent elicitor of emotions. Auditory core, belt and parabelt regions have anatomical connections to a large array of limbic and paralimbic structures which are involved in the generation of affective activity. However, little is known about the functional role of auditory cortical regions in emotion processing. Using functional magnetic resonance imaging and music stimuli that evoke joy or fear, our study reveals that anterior and posterior regions of auditory association cortex have emotion-characteristic functional connectivity with limbic/paralimbic (insula, cingulate cortex, and striatum), somatosensory, visual, motor-related, and attentional structures. We found that these regions have remarkably high emotion-characteristic eigenvector centrality, revealing that they have influential positions within emotion-processing brain networks with "small-world" properties. By contrast, primary auditory fields showed surprisingly strong emotion-characteristic functional connectivity with intra-auditory regions. Our findings demonstrate that the auditory cortex hosts regions that are influential within networks underlying the affective processing of auditory information. We anticipate our results to incite research specifying the role of the auditory cortex D and sensory systems in general D in emotion processing, beyond the traditional view that sensory cortices have merely perceptual functions.	[Koelsch, Stefan] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Skouras, Stavros] Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany; [Lohmann, Gabriele] Univ Clin Tubingen, Dept Biomed Magnet Resonance, Tubingen, Germany; [Lohmann, Gabriele] Max Planck Inst Biol Cybernet, Magnet Resonance Ctr, Tubingen, Germany	University of Bergen; Free University of Berlin; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society	Koelsch, S (corresponding author), Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway.	stefan.koelsch@uib.no	Koelsch, Stefan/AAV-1556-2020; Lohmann, Gabriele/C-3590-2008; Lohmann, Gabriele/AGE-9413-2022	Lohmann, Gabriele/0000-0002-5922-9016; Koelsch, Stefan/0000-0002-8714-3404; Skouras, Stavros/0000-0003-2288-7821	Cluster of Excellence "Languages of Emotion" of the Freie Universitat Berlin	Cluster of Excellence "Languages of Emotion" of the Freie Universitat Berlin	The study was funded by the Cluster of Excellence "Languages of Emotion" of the Freie Universitat Berlin.	AMARAL DG, 1983, BRAIN RES, V275, P263, DOI 10.1016/0006-8993(83)90987-3; [Anonymous], GLOT INT; Anwander A, 2007, CEREB CORTEX, V17, P816, DOI 10.1093/cercor/bhk034; Aube A W, 2014, SOCIAL COGNITIVE AND; Barnes CL, 2004, J COMP NEUROL, V318, p222 ; Baumgartner T, 2006, BRAIN RES, V1075, P151, DOI 10.1016/j.brainres.2005.12.065; Beck A., 1993, BECK DEPRESSION INVE; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Budinger E, 2008, BRAIN RES, V1220, P2, DOI 10.1016/j.brainres.2007.07.084; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cappe C, 2005, EUR J NEUROSCI, V22, P2886, DOI 10.1111/j.1460-9568.2005.04462.x; Caria A, 2011, CEREB CORTEX, V21, P2838, DOI 10.1093/cercor/bhr084; Chapin H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013812; Deichmann R, 2002, NEUROIMAGE, V15, P120, DOI 10.1006/nimg.2001.0985; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Eerola T., 2004, P INT C MUS INF RETR, P22; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Escoffier N, 2013, HUM BRAIN MAPP, V34, P1796, DOI 10.1002/hbm.22029; Falchier A, 2002, J NEUROSCI, V22, P5749; Fecteau S, 2007, NEUROIMAGE, V36, P480, DOI 10.1016/j.neuroimage.2007.02.043; Fishman YI, 2001, J NEUROPHYSIOL, V86, P2761, DOI 10.1152/jn.2001.86.6.2761; Frey S, 2008, J NEUROSCI, V28, P11435, DOI 10.1523/JNEUROSCI.2388-08.2008; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Fritz T, 2009, CURR BIOL, V19, P573, DOI 10.1016/j.cub.2009.02.058; Fruhholz S, 2016, NEUROSCI BIOBEHAV R, V68, P96, DOI 10.1016/j.neubiorev.2016.05.002; GALABURDA AM, 1983, J COMP NEUROL, V221, P169, DOI 10.1002/cne.902210206; Gosselin N, 2006, BRAIN, V129, P2585, DOI 10.1093/brain/awl240; Hackett TA, 1998, J COMP NEUROL, V394, P475, DOI 10.1002/(SICI)1096-9861(19980518)394:4<475::AID-CNE6>3.0.CO;2-Z; Hackett TA, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P215; Hackett TA, 2007, J COMP NEUROL, V502, P924, DOI 10.1002/cne.21326; Hackett TA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00072; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Juslin PN, 2013, PHYS LIFE REV, V10, P235, DOI 10.1016/j.plrev.2013.05.008; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koelsch S, 2015, PHYS LIFE REV, V13, P1, DOI 10.1016/j.plrev.2015.03.001; Koelsch S, 2015, ANN NY ACAD SCI, V1337, P193, DOI 10.1111/nyas.12684; Koelsch S, 2014, HUM BRAIN MAPP, V35, P3485, DOI 10.1002/hbm.22416; Koelsch S, 2014, NAT REV NEUROSCI, V15, P170, DOI 10.1038/nrn3666; Koelsch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077196; Kotz SA, 2013, HUM BRAIN MAPP, V34, P1971, DOI 10.1002/hbm.22041; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lehne M, 2014, SOC COGN AFFECT NEUR, V9, P1515, DOI 10.1093/scan/nst141; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; Mitterschiffthaler MT, 2007, HUM BRAIN MAPP, V28, P1150, DOI 10.1002/hbm.20337; PANDYA DN, 1969, BRAIN RES, V14, P49, DOI 10.1016/0006-8993(69)90030-4; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; PERETZ I, 1994, BRAIN, V117, P1283, DOI 10.1093/brain/117.6.1283; Petkov CI, 2006, PLOS BIOL, V4, P1213, DOI 10.1371/journal.pbio.0040215; PETRIDES M, 1988, J COMP NEUROL, V273, P52, DOI 10.1002/cne.902730106; Romanski LM, 1999, J COMP NEUROL, V403, P141, DOI 10.1002/(SICI)1096-9861(19990111)403:2<141::AID-CNE1>3.0.CO;2-V; Salimpoor VN, 2013, SCIENCE, V340, P216, DOI 10.1126/science.1231059; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Sammler D, 2007, PSYCHOPHYSIOLOGY, V44, P293, DOI 10.1111/j.1469-8986.2007.00497.x; SELTZER B, 1991, J COMP NEUROL, V312, P625, DOI 10.1002/cne.903120412; Smiley JF, 2007, J COMP NEUROL, V502, P894, DOI 10.1002/cne.21325; Sporns O, 2006, P NATL ACAD SCI USA, V103, P19219, DOI 10.1073/pnas.0609523103; Talairach J., 1988, COPLANAR STEREOTAXIC; Tomasi D, 2011, CEREB CORTEX, V21, P2003, DOI 10.1093/cercor/bhq268; Tramo MJ, 2001, ANN NY ACAD SCI, V930, P92, DOI 10.1111/j.1749-6632.2001.tb05727.x; van Albada SJ, 2007, J NEUROSCI METH, V161, P205, DOI 10.1016/j.jneumeth.2006.11.004; Weiskopf N, 2007, MAGN RESON MATER PHY, V20, P39, DOI 10.1007/s10334-006-0067-6; Wildgruber D, 2005, NEUROIMAGE, V24, P1233, DOI 10.1016/j.neuroimage.2004.10.034; Wink AM, 2012, BRAIN CONNECT, V2, P265, DOI 10.1089/brain.2012.0087; Yeterian EH, 1998, J COMP NEUROL, V399, P384	67	31	31	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0190057	10.1371/journal.pone.0190057	http://dx.doi.org/10.1371/journal.pone.0190057			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385142	Green Submitted, Green Published, gold			2022-12-26	WOS:000423668400014
J	Metlaine, A; Sauvet, F; Gomez-Merino, D; Boucher, T; Elbaz, M; Delafosse, JY; Leger, D; Chennaoui, M				Metlaine, Arnaud; Sauvet, Fabien; Gomez-Merino, Danielle; Boucher, Thierry; Elbaz, Maxime; Delafosse, Jean Yves; Leger, Damien; Chennaoui, Mounir			Sleep and biological parameters in professional burnout: A psychophysiological characterization	PLOS ONE			English	Article							JOB STRAIN; RISK-FACTOR; INSULIN-RESISTANCE; DIABETES-MELLITUS; VITAMIN-D; STRESS; WORK; MEN; DISORDERS; COHORT	Professional burnout syndrome has been described in association with insomnia and metabolic, inflammatory and immune correlates. We investigated the interest of exploring biological parameters and sleep disturbances in relation to burnout symptoms among white-collar workers. Fifty-four participants with burnout were compared to 86 healthy control participants in terms of professional rank level, sleep, job strain (Karasek questionnaire), social support, anxiety and depression (HAD scale). Fasting concentrations of glycaemia, glycosylated hemoglobin (HbA1C), total-cholesterol, triglycerides, C-reactive protein (CRP), thyroid stimulating hormone (TSH), 25-hydroxyvitamin D (25[ OH] D), and white blood cell (WBC) counts were assessed. Analysis of variance and a forward Stepwise Multiple Logistic Regression were made to identify predictive factors of burnout. Besides reporting more job strain (in particular job control p = 0.02), higher levels of anxiety (p<0.001), and sleep disorders related to insomnia (OR = 21.5, 95% CI = 8.8-52.3), participants with burnout presented higher levels of HbA1C, glycaemia, CRP, lower levels of 25(OH) D, higher number of leukocytes, neutrophils and monocytes (P<0.001 for all) and higher total-cholesterol (P = 0.01). In particular, when HbA1c is > 3.5%, the prevalence of burnout increases from 16.6% to 60.0% (OR = 4.3, 95% CI = 2.8-6.9). Strong significant positive correlation existed between HbA1C and the two dimensions (emotional exhaustion and depersonalization (r = 0.79 and r = 0.71, p<0.01)) of burnout. Models including job strain, job satisfaction, anxiety and insomnia did not predict burnout (p = 0.30 and p = 0.50). However, when HbA1C levels is included, the prediction of burnout became significant (P = 0.03). Our findings demonstrated the interest of sleep and biological parameters, in particular HbA1C levels, in the characterization of professional burnout.	[Metlaine, Arnaud; Sauvet, Fabien; Gomez-Merino, Danielle; Elbaz, Maxime; Leger, Damien; Chennaoui, Mounir] Univ Paris 05, Sorbonne Paris Cite, Hotel Dieu, Paris, France; [Metlaine, Arnaud; Elbaz, Maxime; Delafosse, Jean Yves; Leger, Damien] AP HP, Ctr Sommeil & Vigilance, Hotel Dieu, Paris, France; [Sauvet, Fabien; Gomez-Merino, Danielle; Chennaoui, Mounir] IRBA, Unite Fatigue & Vigilance, Bretigny Sur Orge, France; [Boucher, Thierry] Bio Paris Ouest, Courbevoie, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Metlaine, A (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Hotel Dieu, Paris, France.; Metlaine, A (corresponding author), AP HP, Ctr Sommeil & Vigilance, Hotel Dieu, Paris, France.	arnaud.metlaine@aphp.fr		chennaoui, mounir/0000-0002-4409-813X	occupational health and safety programs of the subject's employers	occupational health and safety programs of the subject's employers	This study was supported by the occupational health and safety programs of the subject's employers. It did not receive specific founds. Indeed, in France, according to the regulatory framework for occupational health and safety, employers are required to take measures to ensure workers' safety and protect their physical and mental health. In regards of French Labour Legislation, the occupational health and safety is exclusively financed by employers' contributions in every company and the system is managed by the social partners. Occupational medical services are provided by occupational health officers whose exclusively preventive role lies in ensuring there is no deterioration in the health of workers owing to their work. The data collection including clinical examinations and biological analysis were done during the required occupational health survey of workers' company. So, no additional financial support was necessary. The biological analyses were done by a private laboratory which usually collaborates with the company from which participants of the study were selected. Doctor Thierry Boucher (TB) is employed in this private laboratory which belongs to a commercial company Bio Paris Ouest. We declare this commercial affiliation. But this company was not a funder but provided support in the form of salaries for author Doctor Thierry Boucher (TB). He did not have any additional role in the study design, data collection and analysis, decision to publish or preparation manuscript. The specific roles of this author are articulated in the author contribution section.	Ahola K, 2013, J OCCUP HEALTH, V55, P450, DOI 10.1539/joh.13-0021-OA; Arnal PJ, 2015, SLEEP, V38, P1935, DOI 10.5665/sleep.5244; Asensio C, 2004, INT J OBESITY, V28, pS45, DOI 10.1038/sj.ijo.0802856; Beydoun MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103490; Bianchi R, 2015, FRONT PUBLIC HLTH, P3; Carod-Artal F. J., 2013, BURNOUT SYNDROME INT, P15; Danhof-Pont MB, 2011, J PSYCHOSOM RES, V70, P505, DOI 10.1016/j.jpsychores.2010.10.012; Costa EFD, 2012, CLINICS, V67, P573, DOI 10.6061/clinics/2012(06)05; Finney C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-82; Gominak SC, 2012, MED HYPOTHESES, V79, P132, DOI 10.1016/j.mehy.2012.03.031; Grossi G, 2003, J PSYCHOSOM RES, V55, P309, DOI 10.1016/S0022-3999(02)00633-5; Higgins T, 2013, ENDOCRINE, V43, P266, DOI 10.1007/s12020-012-9768-y; Hirotsu C, 2015, SLEEP SCI, V8, P143, DOI 10.1016/j.slsci.2015.09.002; Huth C, 2014, PSYCHOSOM MED, V76, P562, DOI 10.1097/PSY.0000000000000084; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Kachi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021420; Kalimo R, 1999, SCAND J WORK ENV HEA, V25, P605, DOI 10.5271/sjweh.487; Karasek R., 1992, HLTH WORK STRESS PRO; Kawakami N, 2000, OCCUP ENVIRON MED, V57, P805, DOI 10.1136/oem.57.12.805; Kim H. J., 2007, International Journal of Hospitality Management, V26, P421, DOI 10.1016/j.ijhm.2006.03.006; Leger D, 2000, J SLEEP RES, V9, P35, DOI 10.1046/j.1365-2869.2000.00178.x; Li J, 2013, INT J BEHAV MED, V20, P495, DOI 10.1007/s12529-012-9255-0; Li YP, 2016, DIABETOLOGIA, V59, P719, DOI 10.1007/s00125-015-3860-9; Licht CMM, 2010, J CLIN ENDOCR METAB, V95, P2458, DOI 10.1210/jc.2009-2801; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Maslach C, 2001, PSYCHOL HEALTH, V16, P607, DOI 10.1080/08870440108405530; Massa J, 2015, SLEEP, V38, P251, DOI 10.5665/sleep.4408; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Melamed S, 2006, PSYCHOL BULL, V132, P327, DOI 10.1037/0033-2909.132.3.327; Metlaine A, 2005, IND HEALTH, V43, P11, DOI 10.2486/indhealth.43.11; Metlaine A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012816; Mojsa-Kaja J, 2015, INT J OCCUP MED ENV, V28, P102, DOI 10.13075/ijomeh.1896.00238; NETTERSTROM B, 1991, BRIT J IND MED, V48, P684; Nieuwenhuijsen K, 2010, OCCUP MED-OXFORD, V60, P277, DOI 10.1093/occmed/kqq081; Nyberg ST, 2014, DIABETES CARE, V37, P2268, DOI 10.2337/dc13-2936; Nyberg ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067323; Papandreou D, 2015, DIS MARKERS, V2015; Schaufeli WB, 2003, HDB WORK HLTH PSYCHO, V2, P282, DOI DOI 10.1002/0470013400.CH1; Schonfeld IS, 2016, J CLIN PSYCHOL, V72, P22, DOI 10.1002/jclp.22229; Seidler A, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-10; Soderstrom M, 2012, J OCCUP HEALTH PSYCH, V17, P175, DOI 10.1037/a0027518; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Steptoe A, 2014, P NATL ACAD SCI USA, V111, P15693, DOI 10.1073/pnas.1410401111; Filha MMT, 2013, REV LAT-AM ENFERM, V21, P475, DOI 10.1590/S0104-11692013000200002; Toker S, 2012, J OCCUP HEALTH PSYCH, V17, P259, DOI 10.1037/a0028401; von Bonsdorff MB, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000860; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	49	29	30	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0190607	10.1371/journal.pone.0190607	http://dx.doi.org/10.1371/journal.pone.0190607			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU2GT	29385150	gold, Green Published, Green Submitted			2022-12-26	WOS:000423668400022
J	Rout, ED; Burnett, RC; Labadie, JD; Yoshimoto, JA; Avery, AC				Rout, Emily D.; Burnett, Robert C.; Labadie, Julia D.; Yoshimoto, Janna A.; Avery, Anne C.			Preferential use of unmutated immunoglobulin heavy variable region genes in Boxer dogs with chronic lymphocytic leukemia	PLOS ONE			English	Article							SEQUENCE-ANALYSIS; MUTATIONAL STATUS; IGHV GENE; CANINE; CLASSIFICATION; ORGANIZATION; REARRANGEMENTS; GUIDELINES; DIAGNOSIS; DISEASE	Human chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease, and immunoglobulin heavy variable region (IGHV) gene mutational status is an important prognostic marker. IGHV mutational status has not been previously examined in canine CLL. We sequenced the IGHV-D-J rearrangements from 55 canine patients with CLL, including 36 non-Boxer and 19 Boxer dogs. The majority of non-Boxers (75%) had mutated IGHV genes, whereas the majority of Boxers (79%) had unmutated IGHV genes. IGHV3-41 and IGHV3-67 gene usage was significantly higher in Boxers with CLL compared to non-Boxers. Additionally, 11 Boxers with large B-cell lymphoma and the normal IGHV repertoire of six control dogs (three Boxers and three non-Boxers) were sequenced. IGHV3-41 was preferentially used in Boxers with other forms of lymphoma and without lymphoproliferative disease. However, preferential use of unmutated IGHV genes was unique to Boxers with CLL, suggesting Boxers may be a valuable model to investigate unmutated CLL.	[Rout, Emily D.; Burnett, Robert C.; Labadie, Julia D.; Yoshimoto, Janna A.; Avery, Anne C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Rout, ED (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Emily.Rout@colostate.edu		Rout, Emily/0000-0003-1435-8532				Adam F, 2009, VET COMP ONCOL, V7, P181, DOI 10.1111/j.1476-5829.2009.00189.x; Agathangelidis A, 2012, BLOOD, V119, P4467, DOI 10.1182/blood-2011-11-393694; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bao YH, 2010, VET IMMUNOL IMMUNOP, V137, P64, DOI 10.1016/j.vetimm.2010.04.011; Braganza A, 2011, VET IMMUNOL IMMUNOP, V139, P27, DOI 10.1016/j.vetimm.2010.07.026; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Bromberek JL, 2016, J VET INTERN MED, V30, P215, DOI 10.1111/jvim.13814; Burnett RC, 2003, VET PATHOL, V40, P32, DOI 10.1354/vp.40-1-32; Cahill N, 2012, CL LYMPH MYELOM LEUK, V12, P201, DOI 10.1016/j.clml.2012.01.009; Chen HW, 2014, VET IMMUNOL IMMUNOP, V157, P125, DOI 10.1016/j.vetimm.2013.10.020; Comazzi S, 2011, J VET INTERN MED, V25, P100, DOI 10.1111/j.1939-1676.2010.0640.x; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Ghia P, 2007, LEUKEMIA, V21, P1, DOI 10.1038/sj.leu.2404457; Ghia P, 2005, BLOOD, V105, P1678, DOI 10.1182/blood-2004-07-2606; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hallek M, 2016, LANCET ONCOL, V17, P779, DOI 10.1016/S1470-2045(16)30029-8; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Langerak AW, 2011, LEUKEMIA, V25, P979, DOI 10.1038/leu.2011.49; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Lefranc MP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00022; Lefranc MP, 2005, DEV COMP IMMUNOL, V29, P185, DOI 10.1016/j.dci.2004.07.003; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Martin J, 2017, IMMUNOGENETICS; Nabhan C, 2014, JAMA-J AM MED ASSOC, V312, P2265, DOI 10.1001/jama.2014.14553; Rai KR, 2016, AM J HEMATOL, V91, P330, DOI 10.1002/ajh.24282; Rao S, 2011, J VET INTERN MED, V25, P1097, DOI 10.1111/j.1939-1676.2011.0767.x; Richards KL, 2013, CANCER RES, V73, P5029, DOI 10.1158/0008-5472.CAN-12-3546; Rosenquist R, 2017, LEUKEMIA, V31, P1477, DOI 10.1038/leu.2017.125; Rout ED, 2017, VET CLIN PATH, V46, P77, DOI 10.1111/vcp.12463; Seelig DM, 2014, J VET INTERN MED, V28, P878, DOI 10.1111/jvim.12343; Stanganelli C, 2013, CL LYMPH MYELOM LEUK, V13, P447, DOI 10.1016/j.clml.2013.02.019; Steiniger SCJ, 2014, MOL IMMUNOL, V59, P71, DOI 10.1016/j.molimm.2014.01.010; Sutton LA, 2017, HAEMATOLOGICA, V102, P968, DOI 10.3324/haematol.2017.165605; Swerdlow SH, 2008, WHO CLASSIFICATION T; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Tasca S, 2009, VET CLIN PATH, V38, P2, DOI 10.1111/j.1939-165X.2008.00099.x; Tobin G, 2005, HAEMATOLOGICA, V90, P465; Valli VE, 2011, VET PATHOL, V48, P198, DOI 10.1177/0300985810379428; Valli VE, 2006, VET PATHOL, V43, P241, DOI 10.1354/vp.43-3-241; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Vezzali E, 2010, VET COMP ONCOL, V8, P38, DOI 10.1111/j.1476-5829.2009.00201.x; Williams MJ, 2008, J VET INTERN MED, V22, P596, DOI 10.1111/j.1939-1676.2008.0041.x; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382	47	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191205	10.1371/journal.pone.0191205	http://dx.doi.org/10.1371/journal.pone.0191205			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385200	Green Published, Green Submitted, gold			2022-12-26	WOS:000423668400037
J	Schaefer, C; Mallela, N; Seggewiss, J; Lechtape, B; Omran, H; Dirksen, U; Korsching, E; Potratz, J				Schaefer, Christiane; Mallela, Nikhil; Seggewiss, Jochen; Lechtape, Birgit; Omran, Heymut; Dirksen, Uta; Korsching, Eberhard; Potratz, Jenny			Target discovery screens using pooled shRNA libraries and next-generation sequencing: A model workflow and analytical algorithm	PLOS ONE			English	Article							RNAI SCREEN; GENE; IDENTIFICATION; SENSITIVITY; SARCOMA; CELLS; TUMOR	In the search for novel therapeutic targets, RNA interference screening has become a valuable tool. High-throughput technologies are now broadly accessible but their assay development from baseline remains resource-intensive and challenging. Focusing on this assay development process, we here describe a target discovery screen using pooled shRNA libraries and next-generation sequencing (NGS) deconvolution in a cell line model of Ewing sarcoma. In a strategy designed for comparative and synthetic lethal studies, we screened for targets specific to the A673 Ewing sarcoma cell line. Methods, results and pitfalls are described for the entire multi-step screening procedure, from lentiviral shRNA delivery to bioinformatics analysis, illustrating a complete model workflow. We demonstrate that successful studies are feasible from the first assay performance and independent of specialized screening units. Furthermore, we show that a resource-saving screen depth of 100-fold average shRNA representation can suffice to generate reproducible target hits despite heterogeneity in the derived datasets. Because statistical analysis methods are debatable for such datasets, we created ProFED, an analysis package designed to facilitate descriptive data analysis and hit calling using an aim-oriented profile filtering approach. In its versatile design, this open-source online tool provides fast and easy analysis of shRNA and other count-based datasets to complement other analytical algorithms.	[Schaefer, Christiane; Lechtape, Birgit; Potratz, Jenny] Univ Hosp Munster, Pediat Hematol & Oncol, Munster, Germany; [Mallela, Nikhil; Korsching, Eberhard] Westfal Wilhelms Univ Munster, Inst Bioinformat, Munster, Germany; [Seggewiss, Jochen] Univ Hosp Munster, Inst Human Genet, Munster, Germany; [Omran, Heymut; Potratz, Jenny] Univ Hosp Munster, Gen Pediat, Munster, Germany; [Schaefer, Christiane; Dirksen, Uta] Univ Hosp Essen, German Canc Consortium DKTK Ctr Essen, West German Canc Ctr, Dept Hematol & Oncol,Pediat 3, Essen, Germany	University of Munster; University of Munster; University of Munster; University of Munster; University of Duisburg Essen	Potratz, J (corresponding author), Univ Hosp Munster, Pediat Hematol & Oncol, Munster, Germany.; Potratz, J (corresponding author), Univ Hosp Munster, Gen Pediat, Munster, Germany.	jenny.potratz@ukmuenster.de	Dirksen, Uta/AGX-8472-2022	Omran, Heymut/0000-0003-0282-6765	Bundesministerium fur Bildung und Forschung [01GM0869]; ERA-Net-TRANSCAN consortium under the European Commission Seventh Framework Program [01KT1310]; Euro Ewing Consortium EEC under the European Commission Seventh Framework Program [EU-FP7 602856]; Deutsche Krebshilfe (German Cancer Aid) [DKH-108128]; Medical Faculty of the Westfalische Wilhelms-Universitat Munster [16-002]; Innovative Medizinische Forschung at the Medical Faculty of the Westfalische Wilhelms-Universitat [PO 2 2 16 12]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); ERA-Net-TRANSCAN consortium under the European Commission Seventh Framework Program; Euro Ewing Consortium EEC under the European Commission Seventh Framework Program; Deutsche Krebshilfe (German Cancer Aid)(Deutsche Krebshilfe); Medical Faculty of the Westfalische Wilhelms-Universitat Munster; Innovative Medizinische Forschung at the Medical Faculty of the Westfalische Wilhelms-Universitat	This work was supported by grants from the Bundesministerium fur Bildung und Forschung (https://www.bmbf.de/de/seltene-erkrankungen-379.html), project number 01GM0869 (UD EK JP). The ERA-Net-TRANSCAN consortium, project number 01KT1310 (EK UD), and the Euro Ewing Consortium EEC, project number EU-FP7 602856 (UD), both funded under the European Commission Seventh Framework Program FP7-HEALTH (http://cordis.europa.eu/). Deutsche Krebshilfe (German Cancer Aid) (https://www.krebshilfe.de), project number DKH-108128 (UD). The Medical Faculty of the Westfalische Wilhelms-Universitat Munster (https://campus.uni-muenster.de/fakultaet/forschung), project number 16-002 (JP). Innovative Medizinische Forschung at the Medical Faculty of the Westfalische Wilhelms-Universitat (https://campus.uni-muenster.de/imf/das-imf), project number PO 2 2 16 12 (JP). The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-218; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Fennell M, 2014, J BIOMOL SCREEN, V19, P1327, DOI 10.1177/1087057114548414; Haney SA, 2007, EXPERT OPIN THER TAR, V11, P1429, DOI 10.1517/14728222.11.11.1429; Head SR, 2014, BIOTECHNIQUES, V56, P61, DOI 10.2144/000114133; Hoshiyama H, 2012, J BIOMOL SCREEN, V17, P258, DOI 10.1177/1087057111423101; Hu G, 2012, ACTA BIOCH BIOPH SIN, V44, P103, DOI 10.1093/abbs/gmr116; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang XD, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-49; Hwang GW, 2010, J TOXICOL SCI, V35, P601, DOI 10.2131/jts.35.601; Kennedy AL, 2015, ONCOTARGET, V6, P30178, DOI 10.18632/oncotarget.4903; Ketela T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-213; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Martinez-Ramirez A, 2003, CANCER GENET CYTOGEN, V141, P138, DOI 10.1016/S0165-4608(02)00670-2; Mendes-Pereira AM, 2012, P NATL ACAD SCI USA, V109, P2730, DOI 10.1073/pnas.1018872108; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Niedan S, 2014, ONCOGENE, V33, P3927, DOI 10.1038/onc.2013.361; Potratz JC, 2010, CANCER RES, V70, P8770, DOI 10.1158/0008-5472.CAN-10-1093; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROBINSON MD, 2010, GENOME BIOL, V11; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Shukla N, 2016, CANCER RES, V76, P4525, DOI 10.1158/0008-5472.CAN-16-1040; Sims D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r104; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Strezoska Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042341; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Taylor J, 2015, J BIOMOL SCREEN, V20, P1040, DOI 10.1177/1087057115590069; Wade M, 2015, J BIOMOL SCREEN, V20, P1027, DOI 10.1177/1087057115587916; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Yuan YX, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2745-8; Zhang ZZ, 2014, DNA CELL BIOL, V33, P136, DOI 10.1089/dna.2013.2179	38	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191570	10.1371/journal.pone.0191570	http://dx.doi.org/10.1371/journal.pone.0191570			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385199	Green Published, gold, Green Submitted			2022-12-26	WOS:000423668400049
J	Song, HS; Shin, JS; Lee, J; Lee, YJ; Kim, MR; Cho, JH; Kim, KW; Park, Y; Song, HJ; Park, SY; Kim, S; Kim, M; Ha, IH				Song, Hyun-Seop; Shin, Joon-Shik; Lee, Jinho; Lee, Yoon Jae; Kim, Me-riong; Cho, Jae-Heung; Kim, Koh-Woon; Park, Yeoncheol; Song, Hyun Jin; Park, Sun-Young; Kim, Seoyoun; Kim, Mia; Ha, In-Hyuk			Association between temporomandibular disorders, chronic diseases, and ophthalmologic and otolaryngologic disorders in Korean adults: A cross-sectional study	PLOS ONE			English	Article							PAIN; HEADACHE; JOINT; PREVALENCE; TINNITUS; DEPRESSION; MODULATION; SYMPTOMS; MIGRAINE; VERTIGO	Introduction Temporomandibular disorders (TMDs) are common musculoskeletal conditions in the maxillofacial area. Although strong relationships between TMDs and other pain and diseases exist, few studies have comprehensively assessed the association between chronic diseases, ophthalmologic and otolaryngologic disorders and TMD. Methods Of 25,534 individuals included in the fifth Korea National Health and Nutrition Examination Survey (2010 +/- 2012), 17,575 aged >= 20 years who completed survey items on TMD symptoms were included for cross-sectional analysis. Logistic regression analysis was performed to assess the association between chronic diseases, ophthalmologic and otolaryngologic disorders and examination findings, and TMD symptoms after adjusting for various confounding variables. Results Out of 17,575 participants, 2,059 (11.75%) reported experience of >= 1 TMD symptom(s). Compared to individuals without chronic disease, those with asthma (odds ratio (OR) 1.46; 95% confidence interval (CI) 1.09 +/- 1.96), migraine (1.44; 1.26 +/- 1.65), osteoarthritis (1.51; 1.20 +/- 1.89), thyroid dysfunction (1.49; 1.13 +/- 1.96), and depressive symptoms (1.51; 1.29 +/- 1.77) had higher ORs for TMD prevalence. Participants with tinnitus (1.97; 1.70 +/- 2.27), hearing difficulties (1.55; 1.29 +/- 1.87), dizziness (1.52; 1.27 +/- 1.82), rhinitis (1.46; 1.28 +/- 1.65), and xerophthalmia (1.82; 1.57 +/- 2.12) also displayed higher ORs for TMD prevalence. Patients diagnosed with chronic rhinosinusitis upon otolaryngologic examination exhibited an OR of 1.44 (95% CI 1.11 +/- 1.87) for TMD prevalence, while that for individuals with abnormal laryngoscopic results was 0.57 (95% CI 0.36 +/- 0.90). Conclusions These findings imply that TMDs, chronic diseases, and ophthalmologic and otolaryngologic disorders hold various correlations, suggesting the need for multitarget approaches to effectively address this phenomenon.	[Song, Hyun-Seop; Shin, Joon-Shik; Lee, Jinho; Lee, Yoon Jae; Kim, Me-riong; Ha, In-Hyuk] Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea; [Cho, Jae-Heung; Kim, Koh-Woon] Kyung Hee Univ, Coll Korean Med, Dept Korean Rehabil Med, Seoul, South Korea; [Park, Yeoncheol] Kyung Hee Univ Hosp Gangdong, Dept Acupuncture & Moxibust, Seoul, South Korea; [Song, Hyun Jin] Univ Florida, Coll Pharm, Gainesville, FL USA; [Park, Sun-Young] VIAplus, Shihung, South Korea; [Kim, Seoyoun] Korea Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Kim, Mia] Kyung Hee Univ, Coll Korean Med, Stroke Ctr, Dept Cardiovasc & Neurol Dis, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University Hospital; State University System of Florida; University of Florida; Korea University; Korea University Medicine (KU Medicine); Kyung Hee University	Ha, IH (corresponding author), Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea.	hanihata@gmail.com	Park, Sun/GSD-9620-2022; Park, Yeon cheol/AAI-3061-2020; Kim, Koh-Woon/A-2234-2017; Kim, Mia/A-4060-2013; Lee, Yoon Jae/ABA-8808-2020; Song, Hyun Jin/AAI-9148-2020	Park, Yeon cheol/0000-0002-8805-9212; Lee, Yoon Jae/0000-0002-1532-0942; Song, Hyun Jin/0000-0003-4779-6555; Kim, Koh-Woon/0000-0002-0353-6041	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HB16C0059]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HB16C0059). The funder did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial company VIAplus did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of co-author S-YP's salaries.	Aggarwal V, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008456.pub2; Al-Ekrish AA, 2015, OR SURG OR MED OR PA, V120, P78, DOI 10.1016/j.oooo.2015.04.008; Auerbach SM, 2001, J ORAL MAXIL SURG, V59, P628, DOI 10.1053/joms.2001.23371; Bakke M, 2014, J ORAL FACIAL PAIN H, V28, P331, DOI 10.11607/ofph.1255; Blakley BW, 2001, OTOLARYNG HEAD NECK, V125, P147, DOI 10.1067/mhn.2001.117869; Bo-Hee C, 2006, J PHARMACOPUNCT, V9, P69; BUSH FM, 1987, J PROSTHET DENT, V58, P495, DOI 10.1016/0022-3913(87)90282-4; Cakur B, 2011, ACTA RADIOL, V52, P562, DOI 10.1258/ar.2011.100409; Charleston L IV, 2014, CURR PAIN HEADACHE R, V18, p1 ; CHOLE RA, 1992, ARCH OTOLARYNGOL, V118, P817; Clark G.T., 1987, PERSPECTIVES TEMPORO; Marchiori LLD, 2014, INT ARCH OTORHINOLAR, V18, P49, DOI 10.1055/s-0033-1358583; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Fernandes G, 2014, BRAZ ORAL RES, V28, P95, DOI 10.1590/1807-3107BOR-2014.vol28.0003; Fernandes G, 2013, ARQ NEURO-PSIQUIAT, V71, P943, DOI 10.1590/0004-282X20130191; Fillingim RB, 2013, J PAIN, V14; Gatchel RJ, 2006, J AM DENT ASSOC, V137, P339, DOI 10.14219/jada.archive.2006.0183; Giannakopoulos NN, 2010, J DENT, V38, P369, DOI 10.1016/j.jdent.2010.01.003; Goadsby PJ, 2009, NEUROSCIENCE, V161, P327, DOI 10.1016/j.neuroscience.2009.03.019; Goncalves DAG, 2010, HEADACHE, V50, P231, DOI 10.1111/j.1526-4610.2009.01511.x; Graff-Radford SB, 2005, CHRONIC DAILY HEADAC, P199; Gynther GW, 1996, ORAL SURG ORAL MED O, V81, P613, DOI 10.1016/S1079-2104(96)80058-8; 심수현, 2013, [Journal of Korean society of Dental Hygiene, 한국치위생학회지], V13, P739, DOI 10.13065/jksdh.2013.13.05.739; HALEY D, 1993, HEADACHE, V33, P210, DOI 10.1111/j.1526-4610.1993.hed33040210.x; Houle T, 2008, HEADACHE, V48, P40, DOI 10.1111/j.1526-4610.2007.00973.x; Janwantanakul P, 2008, OCCUP MED-OXFORD, V58, P436, DOI 10.1093/occmed/kqn072; Jeon YD, 2005, ORAL SURG ORAL MED O, V99, P677, DOI 10.1016/j.tripleo.2004.10.007; Katsarava Z, 2002, NEUROLOGY, V59, P1450, DOI 10.1212/WNL.59.9.1450; Keersmaekers K, 1996, J PROSTHET DENT, V75, P72, DOI 10.1016/S0022-3913(96)90421-7; Kernick D, 2009, CEPHALALGIA, V29, P3, DOI 10.1111/j.1468-2982.2008.01693.x; Kim TY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145002; Klasser GD, 2014, QUINTESSENCE INT, V45, P157, DOI 10.3290/j.qi.a30999; Korea Environmental Institute, 2017, MAIN PAG, P1; Lacout A, 2005, AM J NEURORADIOL, V26, P1317; McLean RM, 1995, SEMINARS ARTHRITIS R; Meldolesi GN, 2000, PSYCHOTHER PSYCHOSOM, V69, P322, DOI 10.1159/000012415; National Institute of Dental and Craniofascial Research, 2017, FAC PAIN, V3, P1; Nilsson IM, 2006, J OROFAC PAIN, V20, P138; Nilsson IM, 2007, J OROFAC PAIN, V21, P127; Nishioka M, 2008, ANGLE ORTHOD, V78, P793, DOI 10.2319/091407-438; Oral K, 2009, AGRI, P21; PARKER WS, 1995, AM J ORTHOD DENTOFAC, V107, P153, DOI 10.1016/S0889-5406(95)70130-3; Peck CC, 2014, J ORAL REHABIL, V41, P2, DOI 10.1111/joor.12132; Pekkan G, 2010, J CRANIO MAXILL SURG, V38, P231, DOI 10.1016/j.jcms.2009.07.001; Lopes SLPD, 2015, IMAGNG SCI DENT, V45, P1, DOI 10.5624/isd.2015.45.1.1; Pinchoff RJ, 1998, AM J OTOL, V19, P785; Plesh O, 2012, J OROFAC PAIN, V26, P91; Ramirez Aristeguieta Luis Miguel, 2005, Int. J. Morphol., V23, P141, DOI 10.4067/S0717-95022005000200009; Riga M, 2010, OTOL NEUROTOL, V31, P1359, DOI 10.1097/MAO.0b013e3181edb703; Sanchez TG, 2002, AUDIOL NEURO-OTOL, V7, P370, DOI 10.1159/000066155; Sanders AE, 2013, J PAIN, V14, pT51, DOI 10.1016/j.jpain.2013.06.001; Schokker RP, 1990, J CRANIOMANDIB DISOR, V4; Sharma Shalender, 2011, Natl J Maxillofac Surg, V2, P116, DOI 10.4103/0975-5950.94463; Sherman J J, 2001, Curr Pain Headache Rep, V5, P421, DOI 10.1007/s11916-001-0053-7; Shigeishi H, 2016, BIOMED REP, V5, P7, DOI 10.3892/br.2016.669; Sipila K, 2001, CRANIO, V19, P183, DOI 10.1080/08869634.2001.11746168; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Sugisaki M., 2008, J JPN SOC TMJ, V20, P127; The American Academy of Orofacial Pain, 2008, OROFACIAL PAIN GUIDE, V4; TOLLER MO, 1993, J CRANIO MAXILL SURG, V21, P2, DOI 10.1016/S1010-5182(05)80523-2; Uchino M, 2013, AM J OPHTHALMOL, V156, P759, DOI 10.1016/j.ajo.2013.05.040; Yap AUJ, 2002, J PROSTHET DENT, V88, P479, DOI 10.1067/mpr.2002.129375; Zhang X, 2016, INT DENT J	63	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191336	10.1371/journal.pone.0191336	http://dx.doi.org/10.1371/journal.pone.0191336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385182	Green Submitted, Green Published, gold			2022-12-26	WOS:000423668400045
J	Louis, FJ; Buteau, J; Francois, K; Hulland, E; Domercant, JW; Yang, CF; Boncy, J; Burris, R; Pelletier, V; Wagar, N; Deyde, V; Lowrance, DW; Charles, M				Louis, Frantz Jean; Buteau, Josiane; Francois, Kesner; Hulland, Erin; Domercant, Jean Wysler; Yang, Chunfu; Boncy, Jacques; Burris, Robert; Pelletier, Valerie; Wagar, Nicholas; Deyde, Varough; Lowrance, David W.; Charles, Macarthur			Virologic outcome among patients receiving antiretroviral therapy at five hospitals in Haiti	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; VIRAL LOAD; CELL COUNT; FAILURE; ADULTS; PREDICTORS; ADHERENCE; CRITERIA	Introduction Viral load (VL) assessment is the preferred method for diagnosing and confirming virologic failure for patients on antiretroviral therapy (ART). We conducted a retrospective cross-sectional study to evaluate the virologic suppression rate among patients on ART for >= 6 months in five hospitals around Port-au-Prince, Haiti. Methods Plasma VL was measured and patients with VL <1,000 copies/mL were defined as virologically suppressed. A second VL test was performed within at least six months of the first test. Factors associated with virologic suppression were analyzed using logistic regression models accounting for site-level clustering using complex survey procedures. Results Data were analyzed for 2,313 patients on ART for six months or longer between July 2013 and February 2015. Among them, 1,563 (67.6%) achieved virologic suppression at the first VL test. A second VL test was performed within at least six months for 718 (31.0%) of the patients. Of the 459 patients with an initial HIV-1 RNA <1,000 copies/mL who had a second VL performed, 394 (85.8%) maintained virologic suppression. Virologic suppression was negatively associated with male gender (adjusted odds ratio [aOR]: 0.80, 95% Cl: 0.74- 0.0.86), 23 to 35 months on ART (aOR:0.72[0.54-0.96]), baseline CD4 counts of 201-500 cells/mm(3) and 200 cells/mm(3) or lower (aORs: 0.77 [0.62-0.95] and 0.80 [0.66-0.98], respectively), poor adherence (aOR: 0.69 [0.59-0.81 ]), and TB co-infection (aOR: 0.73 [0.55-0.97]). Conclusions This study showed that over two-thirds of the patients in this evaluation achieved virologic suppression after >= six months on ART and the majority of them remained suppressed. These results reinforce the importance of expanding access to HIV-1 viral load testing in Haiti for monitoring ART outcomes.	[Louis, Frantz Jean; Domercant, Jean Wysler; Burris, Robert; Pelletier, Valerie; Deyde, Varough; Lowrance, David W.; Charles, Macarthur] Ctr Dis Control & Prevent, Port Au Prince, Haiti; [Buteau, Josiane; Boncy, Jacques] Minist Sante Publ & Populat, Lab Natl Sante Publ, Port Au Prince, Haiti; [Francois, Kesner] Minist Sante Publ & Populat, Programme Natl Lutte SIDA, Port Au Prince, Haiti; [Hulland, Erin; Yang, Chunfu; Wagar, Nicholas] Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Charles, M (corresponding author), Ctr Dis Control & Prevent, Port Au Prince, Haiti.	xzk9@cdc.gov	Jean Louis, Frantz/GYE-3218-2022	Jean Louis, Frantz/0000-0001-7073-3603; Hulland, Erin/0000-0003-0525-1856	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention [PS003183-04]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This evaluation was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention under the terms of PS003183-04 and in part by an appointment to the Research Participation Program at the Centers for Disease Control and Prevention (CDC) administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and CDC. The findings and conclusions of this report are those of the authors and do not necessarily represent the official position of the CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; Aghokeng AF, 2014, CLIN INFECT DIS, V58, P99, DOI 10.1093/cid/cit627; Ahoua L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-81; [Anonymous], 2017, PAPFAR HAIT COUNTR O; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Billioux A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127235; Charles M, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17375; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Dowshen N, 2011, PEDIATRICS, V128, P762, DOI 10.1542/peds.2011-0068; European AIDS Clinical Society, 2015, GUID VERS 8 0; Gulick RM, 2006, CLIN INFECT DIS, V43, P942, DOI 10.1086/507549; Hassan AS, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-9; Kassa D, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-18; Leger P, 2009, NEW ENGL J MED, V361, P828, DOI 10.1056/NEJMc0809485; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Meriki HD, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-5; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Ministere de la Sante et de la Lutte contre le Sida [Cote d'Ivoire], 2016, ET BIOL COMP IST VIH; Ministere de la Sante. Publique et de la Population, 2012, PROGR NAT LUTT IST V; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Moore DM, 2008, JAIDS-J ACQ IMM DEF, V49, P477, DOI 10.1097/QAI.0b013e318186eb18; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Phillips AN, 2011, AIDS, V25, P843, DOI 10.1097/QAD.0b013e328344037a; Puttkammer N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112261; Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729; Rouet F, 2010, J VIROL METHODS, V163, P253, DOI 10.1016/j.jviromet.2009.10.005; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; Ugbena R, 2012, CLIN INFECT DIS, V54, pS375, DOI 10.1093/cid/cir1064; WHO, CONGUID UANT DRU	30	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0192077	10.1371/journal.pone.0192077	http://dx.doi.org/10.1371/journal.pone.0192077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381736	Green Submitted, gold, Green Published			2022-12-26	WOS:000423617800056
J	Fajuyigbe, D; Lwin, SM; Diffey, BL; Baker, R; Tobin, DJ; Sarkany, RPE; Young, AR				Fajuyigbe, Damilola; Lwin, Su M.; Diffey, Brian L.; Baker, Richard; Tobin, Desmond J.; Sarkany, Robert P. E.; Young, Antony R.			Melanin distribution in human epidermis affords localized protection against DNA photodamage and concurs with skin cancer incidence difference in extreme phototypes	FASEB JOURNAL			English	Article						skin phototype; solar-simulated radiation; cyclobutane pyrimidine dimer; minimal erythema dose	SQUAMOUS-CELL CARCINOMA; ULTRAVIOLET-RADIATION; UV EXPOSURE; STEM-CELLS; DAMAGE; COLOR; SUNSCREEN; RESPONSES; ERYTHEMA; SUNLIGHT	Epidermal DNA damage, especially to the basal layer, is an established cause of keratinocyte cancers (KCs). Large differences in KC incidence (20- to 60-fold) between white and black populations are largely attributable to epidermal melanin photoprotection in the latter. The cyclobutane pyrimidine dimer (CPD) is the most mutagenic DNA photolesion; however, most studies suggest that melanin photoprotection against CPD is modest and cannot explain the considerable skin color-based differences in KC incidence. Along with melanin quantity, solar-simulated radiation-induced CPD assessed immediately postexposure in the overall epidermis and within 3 epidermal zones was compared in black West Africans and fair Europeans. Melanin in black skin protected against CPD by 8.0-fold in the overall epidermis and by 59.0-, 16.5-, and 5.0-fold in the basal, middle, and upper epidermis, respectively. Protection was related to the distribution of melanin, which was most concentrated in the basal layer of black skin. These results may explain, at least in part, the considerable skin color differences in KC incidence. These data suggest that a DNA protection factor of at least 60 is necessary in sunscreens to reduce white skin KC incidence to a level that is comparable with that of black skin.Fajuyigbe, D., Lwin, S. M., Diffey, B. L., Baker, R., Tobin, D. J., Sarkany, R. P. E., Young, A. R. Melanin distribution in human epidermis affords localized protection against DNA photodamage and concurs with skin cancer incidence difference in extreme phototypes.	[Fajuyigbe, Damilola; Lwin, Su M.; Sarkany, Robert P. E.; Young, Antony R.] Kings Coll London, St Johns Inst Dermatol, London, England; [Diffey, Brian L.] Newcastle Univ, Inst Cellular Med, Dermatol Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Baker, Richard; Tobin, Desmond J.] Univ Bradford, Ctr Skin Sci, Fac Life Sci, Bradford, W Yorkshire, England	University of London; King's College London; Newcastle University - UK; University of Bradford	Fajuyigbe, D (corresponding author), Kings Coll London, Guys Hosp, 9th Floor,Tower Wing, London SE1 9RT, England.	damilola.fajuyigbe@kcl.ac.uk	Young, Antony/AAI-6723-2020; Tobin, Desmond/A-5228-2009	Young, Antony/0000-0002-4163-6772; Tobin, Desmond/0000-0003-4566-9392	Walgreens Boots Alliance (Weybridge, United Kingdom); National Institute for Health Research (NIHR) Clinical Research Facility at Guy's and St. Thomas' National Health Service (NHS) Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St. Thomas' NHS Foundation Trust and King's College London	Walgreens Boots Alliance (Weybridge, United Kingdom); National Institute for Health Research (NIHR) Clinical Research Facility at Guy's and St. Thomas' National Health Service (NHS) Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St. Thomas' NHS Foundation Trust and King's College London	The authors thank the volunteers for their participation. D.F. is supported by a Ph.D. Studentship from Walgreens Boots Alliance (Weybridge, United Kingdom). This work was also supported by the National Institute for Health Research (NIHR) Clinical Research Facility at Guy's and St. Thomas' National Health Service (NHS) Foundation Trust, and the NIHR Biomedical Research Centre based at Guy's and St. Thomas' NHS Foundation Trust and King's College London. The views expressed here are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. The authors declare no conflicts of interest.	Blanpain C, 2013, NAT CELL BIOL, V15, P126, DOI 10.1038/ncb2657; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Cestari T, 2017, J AM ACAD DERMATOL, V76, pS110, DOI 10.1016/j.jaad.2016.09.039; Coelho SG, 2013, EXP DERMATOL, V22, P266, DOI 10.1111/exd.12116; Cole C, 2014, PHOTODERMATOL PHOTO, V30, P212, DOI 10.1111/phpp.12124; Dadzie OE, 2013, BRIT J DERMATOL, V169, pIII, DOI 10.1111/bjd.12528; Del Bino S, 2006, PIGM CELL RES, V19, P606, DOI 10.1111/j.1600-0749.2006.00338.x; Del Bino S, 2013, BRIT J DERMATOL, V169, P33, DOI 10.1111/bjd.12529; Del Bino S, 2015, PIGM CELL MELANOMA R, V28, P707, DOI 10.1111/pcmr.12410; Douki T., 2016, SKIN STRESS RESPONSE, P49, DOI [DOI 10.1007/978-3-319-43157-4_3, 10.1007/978-3-319-43157-4_3]; Droste M. S., 2006, THESIS; Fajuyigbe D, 2016, PIGM CELL MELANOMA R, V29, P607, DOI 10.1111/pcmr.12511; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; FREEMAN SE, 1986, J INVEST DERMATOL, V86, P34, DOI 10.1111/1523-1747.ep12283768; Ghiasvand R, 2016, J CLIN ONCOL, V34, P3976, DOI 10.1200/JCO.2016.67.5934; Gloster HM, 2006, J AM ACAD DERMATOL, V55, P741, DOI 10.1016/j.jaad.2005.08.063; Green AC, 2011, J CLIN ONCOL, V29, P257, DOI 10.1200/JCO.2010.28.7078; Harrison GI, 2002, METHODS, V28, P14, DOI 10.1016/S1046-2023(02)00205-0; Hu W., 2015, ENV SYST RES, V4, P4, DOI [10.1186/s40068-015-0031-4, DOI 10.1186/S40068-015-0031-4]; Joly-Tonetti N, 2016, EXP DERMATOL, V25, P501, DOI 10.1111/exd.13016; KAIDBEY KH, 1979, J AM ACAD DERMATOL, V1, P249, DOI 10.1016/S0190-9622(79)70018-1; Khavari PA, 2006, NAT REV CANCER, V6, P270, DOI 10.1038/nrc1838; Leiter U, 2008, ADV EXP MED BIOL, V624, P89, DOI 10.1007/978-0-387-77574-6_8; Martin MT, 2016, MUTAT RES-REV MUTAT, V770, P349, DOI 10.1016/j.mrrev.2016.08.004; MOAN J, 1989, CANCER RES, V49, P4247; Norval M, 2014, PHOTODERMATOL PHOTO, V30, P262, DOI 10.1111/phpp.12106; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Petersen B, 2014, PHOTODERMATOL PHOTO, V30, P96, DOI 10.1111/phpp.12099; Pfeifer GP, 2012, PHOTOCH PHOTOBIO SCI, V11, P90, DOI 10.1039/c1pp05144j; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Premi S, 2015, SCIENCE, V347, P842, DOI 10.1126/science.1256022; Rijken F, 2004, J INVEST DERMATOL, V122, P1448, DOI 10.1111/j.0022-202X.2004.22609.x; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Sheehan JM, 2002, J INVEST DERMATOL, V118, P825, DOI 10.1046/j.1523-1747.2002.01681.x; Tadokoro T, 2003, FASEB J, V17, P1177, DOI 10.1096/fj.02-0865fje; Tewari A, 2012, J INVEST DERMATOL, V132, P394, DOI 10.1038/jid.2011.283; van der Pols JC, 2006, CANCER EPIDEM BIOMAR, V15, P2546, DOI 10.1158/1055-9965.EPI-06-0352; Yamaguchi Y, 2006, FASEB J, V20, P1486, DOI 10.1096/fj.06-5725fje; Young AR, 2017, J AM ACAD DERMATOL, V76, pS100, DOI 10.1016/j.jaad.2016.09.038; Young AR, 1998, J INVEST DERMATOL, V111, P982, DOI 10.1046/j.1523-1747.1998.00436.x; Young AR, 2000, J INVEST DERMATOL, V115, P37, DOI 10.1046/j.1523-1747.2000.00012.x	42	60	60	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3700	3706		10.1096/fj.201701472R	http://dx.doi.org/10.1096/fj.201701472R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29394104				2022-12-26	WOS:000435104500018
J	Thomas, ME; Grinshpon, R; Swartz, P; Clark, AC				Thomas, Melvin E., III; Grinshpon, Robert; Swartz, Paul; Clark, A. Clay			Modifications to a common phosphorylation network provide individualized control in caspases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; SEQUENCE; DIFFERENTIATION; INHIBITION; STABILITY; APOPTOSIS; DYNAMICS; MUSCLE; MODELS; PH	Caspase-3 activation and function have been well-defined during programmed cell death, but caspase activity, at low levels, is also required for developmental processes such as lymphoid proliferation and erythroid differentiation. Post-translational modification of caspase-3 is one method used by cells to fine-tune activity below the threshold required for apoptosis, but the allosteric mechanism that reduces activity is unknown. Phosphorylation of caspase-3 at a conserved allosteric site by p38-MAPK (mitogen-activated protein kinase) promotes survival in human neutrophils, and the modification of the loop is thought to be a key regulator in many developmental processes. We utilized phylogenetic, structural, and biophysical studies to define the interaction networks that facilitate the allosteric mechanism in caspase-3. We show that, within the modified loop, Ser(150) evolved with the apoptotic caspases, whereas Thr(152) is a more recent evolutionary event in mammalian caspase-3. Substitutions at Ser150 result in a pH-dependent decrease in dimer stability, and localized changes in the modified loop propagate to the active site of the same protomer through a connecting surface helix. Likewise, a cluster of hydrophobic amino acids connects the conserved loop to the active site of the second protomer. The presence of Thr152 in the conserved loop introduces a "kill switch" in mammalian caspase-3, whereas the more ancient Ser150 reduces without abolishing enzyme activity. These data reveal how evolutionary changes in a conserved allosteric site result in a common pathway for lowering activity during development or a more recent cluster-specific switch to abolish activity.	[Thomas, Melvin E., III; Grinshpon, Robert; Swartz, Paul] North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27608 USA; [Clark, A. Clay] Univ Texas Arlington, Dept Biol, Box 19498,501 S Nedderman Dr,337 Life Sci Bldg, Arlington, TX 76019 USA	University of North Carolina; North Carolina State University; University of Texas System; University of Texas Arlington	Clark, AC (corresponding author), Univ Texas Arlington, Dept Biol, Box 19498,501 S Nedderman Dr,337 Life Sci Bldg, Arlington, TX 76019 USA.	clay.clark@uta.edu		Swartz, Paul/0000-0002-2064-9443	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-ENG-38]	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank Drs. Jeanne Hardy and Guy Salvesen for the donation of caspase-6 and caspase-7 plasmids, respectively. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-ENG-38.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarado-Kristensson M, 2004, J EXP MED, V199, P449, DOI 10.1084/jem.20031771; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boehm D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062303; Bortner CD, 1998, BIOCHEM PHARMACOL, V56, P1549, DOI 10.1016/S0006-2952(98)00225-1; Bose K, 2005, PROTEIN SCI, V14, P24; Bose K, 2003, BIOCHEMISTRY-US, V42, P12298, DOI 10.1021/bi034998x; Bose K, 2001, BIOCHEMISTRY-US, V40, P14236, DOI 10.1021/bi0110387; Cade C, 2014, BIOCHEMISTRY-US, V53, P7582, DOI 10.1021/bi500874k; Carlile GW, 2004, BLOOD, V103, P4310, DOI 10.1182/blood-2003-09-3362; Chen AA, 2007, J PHYS CHEM B, V111, P11884, DOI 10.1021/jp0765392; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Clark AC, 2016, CHEM REV, V116, P6666, DOI 10.1021/acs.chemrev.5b00540; Crawford ED, 2011, ANNU REV BIOCHEM, V80, P1055, DOI 10.1146/annurev-biochem-061809-121639; Creagh EM, 2003, IMMUNOL REV, V193, P10, DOI 10.1034/j.1600-065X.2003.00048.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dagbay K, 2014, METHOD ENZYMOL, V544, P215, DOI 10.1016/B978-0-12-417158-9.00009-1; Denault JB, 2003, J BIOL CHEM, V278, P34042, DOI 10.1074/jbc.M305110200; Duncan JS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001682; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eron SJ, 2017, STRUCTURE, V25, P27, DOI 10.1016/j.str.2016.11.001; Feeney B, 2005, J BIOL CHEM, V280, P39772, DOI 10.1074/jbc.M505834200; Feeney B, 2004, BIOCHEM J, V384, P515, DOI 10.1042/BJ20040693; Feeney B, 2006, BIOCHEMISTRY-US, V45, P13249, DOI 10.1021/bi0611964; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Huang Z, 2008, BIOCHEM PHARMACOL, V75, P2234, DOI 10.1016/j.bcp.2008.02.026; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lee AY, 2004, PROTEOMICS, V4, P3429, DOI 10.1002/pmic.200400979; Li X, 2011, J BIOL CHEM, V286, P22291, DOI 10.1074/jbc.M111.236596; Maciag JJ, 2016, P NATL ACAD SCI USA, V113, pE6080, DOI 10.1073/pnas.1603549113; MacKenzie SH, 2012, ADV EXP MED BIOL, V747, P55, DOI 10.1007/978-1-4614-3229-6_4; Makishima T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-102; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parrish Amanda B, 2013, Cold Spring Harb Perspect Biol, V5, DOI 10.1101/cshperspect.a008672; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Peng C, 2011, J BIOL CHEM, V286, P6946, DOI 10.1074/jbc.M110.172338; Pop C, 2003, BIOCHEMISTRY-US, V42, P12311, DOI 10.1021/bi034999p; Pop C, 2001, BIOCHEMISTRY-US, V40, P14224, DOI 10.1021/bi011037e; Porollo AA, 2004, BIOINFORMATICS, V20, P2460, DOI 10.1093/bioinformatics/bth248; ROYER CA, 1993, PROTEIN SCI, V2, P1844, DOI 10.1002/pro.5560021106; Sahara S, 1999, NATURE, V401, P168, DOI 10.1038/43678; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Vaidya S, 2011, J MOL BIOL, V406, P75, DOI 10.1016/j.jmb.2010.11.031; Velazquez-Delgado EM, 2012, J BIOL CHEM, V287, P36000, DOI 10.1074/jbc.M112.397752; Walters J, 2012, BIOSCIENCE REP, V32, P401, DOI 10.1042/BSR20120037; Walters J, 2011, ARCH BIOCHEM BIOPHYS, V508, P31, DOI 10.1016/j.abb.2011.01.011; Yang XH, 1998, J BIOL CHEM, V273, P34278, DOI 10.1074/jbc.273.51.34278; Zandy AJ, 2005, J BIOL CHEM, V280, P30263, DOI 10.1074/jbc.M504007200; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	68	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5447	5461		10.1074/jbc.RA117.000728	http://dx.doi.org/10.1074/jbc.RA117.000728			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29414778	Green Published, hybrid			2022-12-26	WOS:000430044100009
J	Han, J; Lachance, C; Ricketts, MD; McCullough, CE; Gerace, M; Black, BE; Cote, J; Marmorstein, R				Han, Joseph; Lachance, Catherine; Ricketts, M. Daniel; McCullough, Cheryl E.; Gerace, Morgan; Black, Ben E.; Cote, Jacques; Marmorstein, Ronen			The scaffolding protein JADE1 physically links the acetyltransferase subunit HBO1 with its histone H3-H4 substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAT HBO1; CHROMATIN; ACETYLATION; NUCLEOSOME; MECHANISM; PARTICLE; COMPLEX; CANCER; TAIL; CODE	The human enzyme histone acetyltransferase binding to ORC1 (HBO1) regulates DNA replication, cell proliferation, and development. HBO1 is part of a multiprotein histone acetyltransferase (HAT) complex that also contains inhibitor of growth family member (ING) 4/5, MYST/Esa1-associated factor (MEAF) 6, and the scaffolding proteins Jade family PHD finger (JADE) 1/2/3 or bromodomain and PHD finger-containing protein (BRPF) 2/3 to acetylate histone H4 H4K5/8/12 or H3K14, respectively. Within this four-protein complex, JADE1 determines histone H4 substrate specificity of the HBO1-HAT complex. However, the mechanism by which JADE1 controls the H4-specific acetyltransferase activity of HBO1 is unknown. Here we used recombinant proteins in vitro to dissect the specific regions and activities of HBO1 and JADE1 that mediate histone H3-H4 acetylation via the HBO1-HAT domain. We found that JADE1 increases the catalytic efficiency of HBO1 acetylation of an H3-H4 substrate by about 5-fold through an N-terminal, 21-residue HBO1-and histone-binding domain and a nearby second histone core-binding domain. We also demonstrate that HBO1 contains an N-terminal histone-binding domain (HBD) that makes additional contacts with H3-H4 independent of JADE1 interactions with histones and that the HBO1 HBD does not significantly contribute to HBO1's overall HAT activity. Experiments with JADE1 deletions in vivo recapitulated these in vitro interactions and their roles in HBO1 histone acetylation activity. Together, these results indicate that the N-terminal region of JADE1 functions as a platform that brings together the catalytic HBO1 subunit with its cognate H3-H4 substrate for histone acetylation.	[Han, Joseph; Ricketts, M. Daniel; McCullough, Cheryl E.; Gerace, Morgan; Black, Ben E.; Marmorstein, Ronen] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Han, Joseph; Ricketts, M. Daniel; McCullough, Cheryl E.; Marmorstein, Ronen] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ricketts, M. Daniel] Univ Penn, Grad Grp Biochem & Mol Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Han, Joseph; McCullough, Cheryl E.; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Lachance, Catherine; Cote, Jacques] Laval Univ, Canc Res Ctr, CHU Quebec, Res Ctr,Oncol Axis, Quebec City, PQ G1R 3S3, Canada	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Laval University	Marmorstein, R (corresponding author), Univ Penn, Dept Biochem & Biophys, Abramson Family Canc Res Inst, Perelman Sch Med, 421 Curie Blvd, Philadelphia, PA 19104 USA.	marmor@upenn.edu	Cote, Jacques/I-8901-2014	Cote, Jacques/0000-0001-6751-555X	National Institutes of Health [R01 GM060293, R35 GM118090, R01 GM082989]; Ovarian Cancer Research Fund Alliance; Canadian Institutes of Health Research [FDN-143314]; DNA Sequencing Facility at the Perelman School of Medicine, University of Pennsylvania [NIH P30 CA016520]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118090, R01GM082989, R01GM060293] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Fund Alliance; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); DNA Sequencing Facility at the Perelman School of Medicine, University of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM060293 and R35 GM118090 and the Ovarian Cancer Research Fund Alliance (to R.M.), Canadian Institutes of Health Research Grant FDN-143314 (to J. C.), National Institutes of Health Grant R01 GM082989 (to B. E. B.), and the DNA Sequencing Facility at the Perelman School of Medicine, University of Pennsylvania (NIH P30 CA016520). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Avvakumov N, 2012, MOL CELL BIOL, V32, P689, DOI 10.1128/MCB.06455-11; Berndsen CE, 2005, METHODS, V36, P321, DOI 10.1016/j.ymeth.2005.03.002; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Duong MT, 2013, CANCER RES, V73, P5556, DOI 10.1158/0008-5472.CAN-13-0013; Feng YP, 2016, EMBO J, V35, P176, DOI 10.15252/embj.201591293; Foy RL, 2008, J BIOL CHEM, V283, P28817, DOI 10.1074/jbc.M801407200; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Havasi A, 2013, AM J PATHOL, V182, P152, DOI 10.1016/j.ajpath.2012.09.017; Iizuka M, 2009, GENE, V436, P108, DOI 10.1016/j.gene.2009.01.020; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kueh AJ, 2011, MOL CELL BIOL, V31, P845, DOI 10.1128/MCB.00159-10; Lalonde ME, 2014, GENE DEV, V28, P1029, DOI 10.1101/gad.236331.113; Lalonde ME, 2013, GENE DEV, V27, P2009, DOI 10.1101/gad.223396.113; Luger K, 1999, METHOD ENZYMOL, V304, P3; Miotto B, 2008, GENE DEV, V22, P2633, DOI 10.1101/gad.1674108; Miotto B, 2010, MOL CELL, V37, P57, DOI 10.1016/j.molcel.2009.12.012; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Piche B, 2010, CELL MOL LIFE SCI, V67, P1987, DOI 10.1007/s00018-010-0312-z; Ricketts MD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8711; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007; Sapountzi V, 2011, CELL MOL LIFE SCI, V68, P1147, DOI 10.1007/s00018-010-0599-9; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tao Y, 2017, NUCLEIC ACIDS RES, V45, P5707, DOI 10.1093/nar/gkx142; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thomas T, 2007, CELL CYCLE, V6, P696, DOI 10.4161/cc.6.6.4013; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Xu P, 2016, MOL CELL, V63, P965, DOI 10.1016/j.molcel.2016.07.024; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849; Ythier D, 2008, INT J CANCER, V123, P1483, DOI 10.1002/ijc.23790; Zhou MI, 2002, J BIOL CHEM, V277, P39887, DOI 10.1074/jbc.M205040200	34	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4498	4509		10.1074/jbc.RA117.000677	http://dx.doi.org/10.1074/jbc.RA117.000677			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29382722	hybrid, Green Published			2022-12-26	WOS:000428204300021
J	Wang, P; Li, JZ; Tao, JH; Sha, BD				Wang, Peng; Li, Jingzhi; Tao, Jiahui; Sha, Bingdong			The luminal domain of the ER stress sensor protein PERK binds misfolded proteins and thereby triggers PERK oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED-PROTEIN; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; SUBSTRATE-BINDING; IRE1; DIMERIZATION; ACTIVATION; MECHANISM; FRAGMENT; KINASE	PRKR-like endoplasmic reticulum kinase (PERK) is one of the major sensor proteins that detect protein folding imbalances during endoplasmic reticulum (ER) stress. However, it remains unclear how ER stress activates PERK to initiate a downstream unfolded protein response (UPR). Here, we found that PERK's luminal domain can recognize and selectively interact with mis-folded proteins but not with native proteins. Screening a phage-display library, we identified a peptide substrate, P16, of the PERK luminal domain and confirmed that P16 efficiently competes with misfolded proteins for binding this domain. To unravel the mechanism by which the PERK luminal domain interacts with misfolded proteins, we determined the crystal structure of the bovine PERK luminal domain complexed with P16 to 2.8-angstrom resolution. The structure revealed that PERK's luminal domain binds the peptide through a conserved hydrophobic groove. Substitutions within hydrophobic regions of the PERK luminal domain abolished the binding between PERK and misfolded proteins. We also noted that peptide binding results in major conformational changes in the PERK luminal domain that may favor PERK oligomerization. The structure of the PERK luminal domain-P16 complex suggested stacking of the luminal domain that leads to PERK oligomerization and activation via autophosphorylation after ligand binding. Collectively, our structural and biochemical results strongly support a ligand-driven model in which the PERK luminal domain interacts directly with misfolded proteins to induce PERK oligomerization and activation, resulting in ER stress signaling and the UPR.	[Wang, Peng; Li, Jingzhi; Tao, Jiahui; Sha, Bingdong] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol CDIB, MCLM 364,1918 Univ Blvd, Birmingham, AL 35294 USA; [Wang, Peng] Anhui Normal Univ, Inst Mol Biol & Biotechnol, Coll Life, Wuhu 241000, Peoples R China	University of Alabama System; University of Alabama Birmingham; Anhui Normal University	Sha, BD (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol CDIB, MCLM 364,1918 Univ Blvd, Birmingham, AL 35294 USA.	bdsha@uab.edu	Wang, Peng/AAW-9052-2020; Wang, Peng/I-8770-2018	Wang, Peng/0000-0002-5598-0996; Wang, Peng/0000-0002-5598-0996	National Institutes of Health NIGMS [R01 GM080261]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080261] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NIGMS Grant R01 GM080261. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amin-Wetzel N, 2017, CELL, V171, P1625, DOI 10.1016/j.cell.2017.10.040; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Carrara M, 2015, EMBO J, V34, P1589, DOI 10.15252/embj.201489183; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Cui WJ, 2011, ACTA CRYSTALLOGR D, V67, P423, DOI 10.1107/S0907444911006445; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Karagoz GE, 2017, ELIFE, V6, DOI 10.7554/eLife.30700; Lakshmipathy SK, 2010, J BIOL CHEM, V285, P27911, DOI 10.1074/jbc.M110.134163; Li JZ, 2005, BIOCHEM J, V386, P453, DOI 10.1042/BJ20041050; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tao JH, 2010, J MOL BIOL, V397, P1307, DOI 10.1016/j.jmb.2010.02.028; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wang P, 2016, ACTA CRYSTALLOGR D, V72, P1290, DOI 10.1107/S2059798316018064; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	35	72	76	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4110	4121		10.1074/jbc.RA117.001294	http://dx.doi.org/10.1074/jbc.RA117.001294			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29386355	hybrid, Green Published			2022-12-26	WOS:000427587500022
J	Belcher, DA; Ju, JA; Baek, JH; Yalamanoglu, A; Buehler, PW; Gilkes, DM; Palmer, AF				Belcher, Donald A.; Ju, Julia A.; Baek, Jin Hyen; Yalamanoglu, Ayla; Buehler, Paul W.; Gilkes, Daniele M.; Palmer, Andre F.			The quaternary state of polymerized human hemoglobin regulates oxygenation of breast cancer solid tumors: A theoretical and experimental study	PLOS ONE			English	Article							PEG-CONJUGATED HEMOGLOBIN; CELL-FREE HEMOGLOBIN; BOVINE HEMOGLOBINS; TISSUE OXYGENATION; NITRIC-OXIDE; BLOOD-FLOW; BIOPHYSICAL PROPERTIES; ORTHOPEDIC-SURGERY; SOLUTION HBOC-201; 9L GLIOSARCOMA	A major constraint in the treatment of cancer is inadequate oxygenation of the tumor mass, which can reduce chemotherapeutic efficacy. We hypothesize that polymerized human hemoglobin (PolyhHb) can be transfused into the systemic circulation to increase solid tumor oxygenation, and improve chemotherapeutic outcomes. By locking PolyhHb in the relaxed (R) quaternary state, oxygen (O-2) offloading at low O-2 tensions (< 20mm Hg) may be increased, while O-2 offloading at high O-2 tensions (> 20 mm Hg) is facilitated with tense (T) state PolyhHb. Therefore, R-state PolyhHb may deliver significantly more O-2 to hypoxic tissues. Biophysical parameters of T and R-state PolyhHb were used to populate a modified Krogh tissue cylinder model to assess O-2 transport in a tumor. In general, we found that increasing the volume of transfused PolyhHb decreased the apparent viscosity of blood in the arteriole. In addition, we found that PolyhHb transfusion decreased the wall shear stress at large arteriole diameters (> 20 mu m), but increased wall shear stress for small arteriole diameters (< 10 mu m). Therefore, transfusion of PolyhHb may lead to elevated O-2 delivery at low pO(2). In addition, transfusion of R-state PolyhHb may be more effective than T-state PolyhHb for O-2 delivery at similar transfusion volumes. Reduction in the apparent viscosity resulting from PolyhHb transfusion may result in significant changes in flow distributions throughout the tumor microcirculatory network. The difference in wall shear stress implies that PolyhHb may have a more significant effect in capillary beds through mechano-transduction. Periodic top-load transfusions of PolyhHb into mice bearing breast tumors confirmed the oxygenation potential of both PolyhHbs via reduced hypoxic volume, vascular density, tumor growth, and increased expression of hypoxia inducible genes. Tissue section analysis demonstrated primary PolyhHb clearance occurred in the liver and spleen indicating a minimal risk for renal damage.	[Belcher, Donald A.; Palmer, Andre F.] Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA; [Ju, Julia A.; Gilkes, Daniele M.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Baek, Jin Hyen; Yalamanoglu, Ayla; Buehler, Paul W.] US FDA, Div Blood Components & Devices, Lab Biochem & Vasc Biol, CBER, Silver Spring, MD USA; [Gilkes, Daniele M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	University System of Ohio; Ohio State University; Johns Hopkins University; US Food & Drug Administration (FDA); Johns Hopkins University	Palmer, AF (corresponding author), Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA.	palmer.351@osu.edu	Gilkes, Daniele M/AAI-8133-2020; Ju, Julia A/Y-5717-2018; Yalamanoglu, Ayla/GYJ-1306-2022; Belcher, Donald/ABC-7359-2020	Gilkes, Daniele M/0000-0003-3984-9338; Yalamanoglu, Ayla/0000-0002-0203-9297; Belcher, Donald/0000-0002-7633-6219	National Institutes of Health [R56HL123015, R01HL126945, R01EB021926, R00CA181352]; Susan G. Komen Foundation [CCR17483484]; V Scholar Foundation [V2016-024]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138116, R01HL126945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB021926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); V Scholar Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health grants R56HL123015, R01HL126945, R01EB021926, R00CA181352, Susan G. Komen Foundation grant CCR17483484, and V Scholar Foundation grant V2016-024.	Baek JH, 2012, TOXICOL SCI, V127, P567, DOI 10.1093/toxsci/kfs109; Batchelor TT, 2014, NEURO-ONCOLOGY, V16, DOI 10.1093/neuonc/nou206.42; Belcher DA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185988; Blanco E, 2015, NAT BIOTECHNOL, V33, P941, DOI 10.1038/nbt.3330; Bouchet A, 2014, TUMOR BIOL, V35, P6221, DOI 10.1007/s13277-014-1783-6; BROOKS JJ, 1982, CANCER, V50, P1757, DOI 10.1002/1097-0142(19821101)50:9<1757::AID-CNCR2820500919>3.0.CO;2-5; Buehler PW, 2010, ANTIOXID REDOX SIGN, V12, P275, DOI 10.1089/ars.2009.2799; Butt OI, 2011, AM J PATHOL, V178, P1316, DOI 10.1016/j.ajpath.2010.12.006; Butt OI, 2010, ANTIOXID REDOX SIGN, V12, P199, DOI 10.1089/ars.2009.2798; Cabrales P, 2010, AM J PHYSIOL-HEART C, V298, pH1062, DOI 10.1152/ajpheart.01022.2009; Camporesi EM., UNDERSEA HYPERB MED, V41, P253; Castro C, 2014, MINERVA ANESTESIOL, V80, P537; Chaturvedi P, 2012, J CLIN INVEST; CHIANCONE E, 1968, J BIOL CHEM, V243, P1212; Deuel JW, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.392; DEWHIRST MW, 1992, RADIAT RES, V130, P171, DOI 10.2307/3578274; Dewhirst MW, 1996, BRIT J CANCER, V74, pS247; Dong XL, 2012, BIOMED PHARMACOTHER, V66, P70, DOI 10.1016/j.biopha.2011.11.016; Fedosov DA, 2010, MICROCIRCULATION, V17, P615, DOI 10.1111/j.1549-8719.2010.00056.x; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Freilich D, 2009, J TRAUMA, V66, P365, DOI 10.1097/TA.0b013e3181820d5c; Galie PA, 2014, P NATL ACAD SCI USA, V111, P7968, DOI 10.1073/pnas.1310842111; Goldman D, 2008, MICROCIRCULATION, V15, P795, DOI 10.1080/10739680801938289; GOLDSMITH HL, 1989, AM J PHYSIOL, V257, pH1005, DOI 10.1152/ajpheart.1989.257.3.H1005; Gottschalk A, 2005, ARTIF CELL BLOOD SUB, V33, P379, DOI 10.1080/10731190500289750; Gundersen SI, 2008, BIOTECHNOL PROGR, V24, P1353, DOI 10.1002/btpr.56; Han JQ, 2012, ARTIF CELL BLOOD SUB, V40, P239, DOI 10.3109/10731199.2012.663385; Handrigan MT, CHOICE FLUID INFLUEN; Heijmen L, 2014, CONTRAST MEDIA MOL I, V9, P237, DOI 10.1002/cmmi.1564; Hendriksen EM, 2009, MICROVASC RES, V77, P96, DOI 10.1016/j.mvr.2008.11.002; Jahr JS, 2008, J TRAUMA, V64, P1484, DOI 10.1097/TA.0b013e318173a93f; Kanapathipillai M, 2014, ADV DRUG DELIVER REV, V79-80, P107, DOI 10.1016/j.addr.2014.05.005; Karakashev SV, 2015, CANCER MANAG RES, V7, P253, DOI 10.2147/CMAR.S58285; Linberg R, IN VIVO, V12, P167; Liu XP, 1998, J BIOL CHEM, V273, P18709, DOI 10.1074/jbc.273.30.18709; Marchiq I, 2016, J MOL MED, V94, P155, DOI 10.1007/s00109-015-1307-x; Marcinkowska-Gapinska A, 2007, MED BIOL ENG COMPUT, V45, P837, DOI 10.1007/s11517-007-0236-4; Montero AJ, 2012, CURR ONCOL REP, V14, P1, DOI 10.1007/s11912-011-0202-z; Murayama C, 2014, ARTIF ORGANS, V38, P656, DOI 10.1111/aor.12354; Napolitano LM, 2009, CRIT CARE CLIN, V25, P279, DOI 10.1016/j.ccc.2009.01.003; Nozue M, 1996, J SURG ONCOL, V62, P109; Palmer AF, 2014, ANNU REV BIOMED ENG, V16, P77, DOI 10.1146/annurev-bioeng-071813-104950; Palmer AF, 2009, BIOTECHNOL PROGR, V25, P1803, DOI 10.1002/btpr.265; Raabe A, 2005, STRAHLENTHER ONKOL, V181, P730, DOI 10.1007/s00066-005-1418-3; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; Schito L, 2012, P NATL ACAD SCI USA, V109, pE2707, DOI 10.1073/pnas.1214019109; SCOTT MD, 1991, J LAB CLIN MED, V118, P7; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; SIEMANN DW, 1992, INT J RADIAT ONCOL, V22, P393, DOI 10.1016/0360-3016(92)90839-A; Song JW, 2014, VASC MORPHOG METHODS, V1214, P243; Sriram K, 2014, MICROCIRCULATION, V21, P628, DOI 10.1111/micc.12141; Strese S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-331; TEICHER BA, 1993, CANCER CHEMOTH PHARM, V33, P57, DOI 10.1007/BF00686024; TEICHER BA, 1995, INT J CANCER, V61, P732, DOI 10.1002/ijc.2910610523; TEICHER BA, 1993, J CANCER RES CLIN, V120, P85, DOI 10.1007/BF01200729; TEICHER BA, 1994, ARTIF CELL BLOOD SUB, V22, P827, DOI 10.3109/10731199409117917; Thews O, 1998, INT J ONCOL, V13, P205; Tolaney SM, 2015, P NATL ACAD SCI USA, V112, P14325, DOI 10.1073/pnas.1518808112; Tsai AG, 2006, BLOOD, V108, P3603, DOI 10.1182/blood-2006-02-005272; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Waliszewski P, 2015, PROSTATE, V75, P399, DOI 10.1002/pros.22926; Ward C, 2013, CANCER TREAT REV, V39, P171, DOI 10.1016/j.ctrv.2012.08.004; Wong CCL, 2012, J MOL MED, V90, P803, DOI 10.1007/s00109-011-0855-y; Yamamoto M, 2009, J SURG RES, V151, P48, DOI 10.1016/j.jss.2007.12.770; Yokoi K, 2004, CLIN CANCER RES, V10, P2299, DOI 10.1158/1078-0432.CCR-03-0488; Yu BL, 2010, ANESTHESIOLOGY, V112, P586, DOI 10.1097/ALN.0b013e3181cd7838; Yu MH, 2008, ARTIF CELL BLOOD SUB, V36, P551, DOI 10.1080/10731190802556674; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zhang N, 2011, TISSUE ENG PT A, V17, P927, DOI [10.1089/ten.TEA.2010.0353, 10.1089/ten.tea.2010.0353]; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60; Zhou YP, 2012, BIOPHYS CHEM, V162, P45, DOI 10.1016/j.bpc.2011.12.006; Zhou YP, 2011, BIOTECHNOL PROGR, V27, P1172, DOI 10.1002/btpr.624	74	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191275	10.1371/journal.pone.0191275	http://dx.doi.org/10.1371/journal.pone.0191275			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414985	gold, Green Submitted, Green Published			2022-12-26	WOS:000424325300021
J	Soliman, S; Mohammad, MG; El-Keblawy, AA; Omar, H; Abouleish, M; Madkour, M; Elnaggar, A; Hosni, RM				Soliman, Sameh; Mohammad, Mohammad G.; El-Keblawy, Ali A.; Omar, Hany; Abouleish, Mohamed; Madkour, Mohamed; Elnaggar, Attiat; Hosni, Racha M.			Mechanical and phytochemical protection mechanisms of Calligonum comosum in arid deserts	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; ESSENTIAL OILS; SECONDARY METABOLITES; CALCIUM-OXALATE; PLANT DEFENSE; MANAGEMENT; MORPHOLOGY; SCLEREIDS; PATHOGENS; MITES	Unlike animals, plants are sessile organisms, lacking circulating antibodies and specialized immune cells and are exposed to various harsh environmental conditions that make them at risk of being attacked by different pathogens and herbivores. Plants produce chemo-signals to respond to the surroundings and be able to distinguish between harmless and harmful signals. In this study, the production of phytochemicals as plant signaling mechanisms and their defensive roles in disease resistance and repelling herbivores are examined in Calligonum comosum. C. comosum is a leafless standalone perennial shrub widespread in sand dunes. The plant has the ability to survive the drastic environmental conditions of the arid/hyperarid deserts of the Arabia. Structural anatomy and phytochemicals analyses were used to identify both mechanical and chemical defensive mechanisms in C. comosum. Microscopy-based investigations indicated that stems of this species developed hard structures in its outer layers including sclerenchyma and cluster crystals of calcium oxalate (CaOx). Sclerenchyma and CaOx are difficult to be eaten by herbivores and insects and can harm their mouthparts. On the other hand, the plant developed both short-distance (local) and long-distance (systematic over limited sphere) phytochemicals-producing cells located at its outer regions that is surrounding the inner nutrient-rich vascular system (VS). Local chemical was represented by phenolic idioblasts that were released in response to plant cutting. Systematic chemical was represented by toxic volatile oil containing similar to 50% benzaldehyde derivative (cuminaldehyde). The oil caused strong killing effect on both mammalian cells and microbial pathogens via either direct addition or indirect exposure to its vapor. The plants lost the oil content and allowed fungal growth once cut and dried. The localization of both defensive mechanisms to the outer region of the plant seemed to protect the inner nutrient-rich VS and hence maintained the plant survival. Surprisingly, in relation to traditional folklore use as medicine, local people use only green parts of the plant and only during the winter, where the plant found devoid of volatile oil and phenolic idioblasts. Moreover, it turns into recommendations for local people to avoid any health problems caused by the plant supply.	[Soliman, Sameh; Mohammad, Mohammad G.; Omar, Hany; Madkour, Mohamed] Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates; [Soliman, Sameh; Omar, Hany] Univ Sharjah, Coll Pharm, Sharjah, U Arab Emirates; [Soliman, Sameh] Zagazig Univ, Fac Pharm, Zagazig, Egypt; [Mohammad, Mohammad G.; Madkour, Mohamed; Hosni, Racha M.] Univ Sharjah, Collage Hlth Sci, Dept Med Lab Sci, Sharjah, U Arab Emirates; [El-Keblawy, Ali A.] Univ Sharjah, Dept Appl Biol, Sharjah, U Arab Emirates; [El-Keblawy, Ali A.; Elnaggar, Attiat] Univ Sharjah, Res Inst Sci & Engn, Sharjah, U Arab Emirates; [Abouleish, Mohamed] Amer Univ Sharjah, Coll Arts & Sci, Dept Biol Chem & Environm Sci, Sharjah, U Arab Emirates	University of Sharjah; University of Sharjah; Egyptian Knowledge Bank (EKB); Zagazig University; University of Sharjah; University of Sharjah; University of Sharjah; American University of Sharjah	Soliman, S (corresponding author), Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates.; Soliman, S (corresponding author), Univ Sharjah, Coll Pharm, Sharjah, U Arab Emirates.; Soliman, S (corresponding author), Zagazig Univ, Fac Pharm, Zagazig, Egypt.	ssoliman@sharjah.ac.ae	Abouleish, Mohamed/ABA-9060-2020; Omar, Hany/B-7440-2013	Abouleish, Mohamed/0000-0003-3234-9795; Omar, Hany/0000-0002-4670-8149; Mohammad, Mohammad/0000-0002-6775-1955; Soliman, Sameh/0000-0002-7691-615X; El-Keblawy, Ali/0000-0003-4448-6236; Madkour, Mohamed I./0000-0002-9130-4928	University of Sharjah, U.A.E. [1601110215-P]	University of Sharjah, U.A.E.	This work was supported by grants from University of Sharjah, U.A.E. (1601110215-P) to SS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from University of Sharjah, U.A.E. (1601110215-P) to S.S.	Ahmed HS, 2016, PLANTA MED, V82, pPC49; Al-Khalifah NS, 2006, IAWA J, V27, P299, DOI 10.1163/22941932-90000156; AlShebly MM, 2017, ECOTOXICOL ENV SA SC, V137, P149; Bannour M, 2016, CHEM BIODIVERS, V13, P1527, DOI 10.1002/cbdv.201600086; Baratto LC, 2010, BRAZ J PHARM SCI, V46, P555, DOI 10.1590/S1984-82502010000300020; Ben Hassine D, 2012, MOLECULES, V17, P9540, DOI 10.3390/molecules17089540; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Bhattacharya A, 2010, MOL PLANT PATHOL, V11, P705, DOI [10.1111/J.1364-3703.2010.00625.X, 10.1111/j.1364-3703.2010.00625.x]; Bresca P., 2009, BIOTEK APPL NOTE; Brown SL, 2013, PLANT PHYSIOL BIOCH, V73, P219, DOI 10.1016/j.plaphy.2013.10.006; Danin A., 2012, PLANTS DESERT DUNES; Dhief A, 2011, J ESSENT OIL BEAR PL, V14, P11, DOI 10.1080/0972060X.2011.10643896; Di Pietro A, 2003, MOL PLANT PATHOL, V4, P315, DOI [10.1046/j.1364-3703.2003.00180.x, 10.1046/J.1364-3703.2003.00180.X]; Diseases, 2008, CLIN MICROBIOL INFEC, V14, P982; Doty RL, 2001, ANNU REV PSYCHOL, V52, P423, DOI 10.1146/annurev.psych.52.1.423; Doughari J. H., 2015, Journal of Plant Pathology and Microbiology, V6, P322; El-Keblawy A, 2016, J ARID LAND, V8, P254, DOI 10.1007/s40333-015-0023-2; Essam AA-S, 2012, TOXICOL IND HEALTH, V30, P147; Farid A Badria, Z NATURFORSCHUNG C20, P656; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; Genin S, 2010, NEW PHYTOL, V187, P920, DOI 10.1111/j.1469-8137.2010.03397.x; Ghazanfar S.A., 1994, HDB ARABIAN MED PLAN; Harwood TD, 2011, PLANT PATHOL, V60, P545, DOI 10.1111/j.1365-3059.2010.02391.x; Hasselmann C, 2003, CLIN MICROBIOL INFEC, V9; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Karban R, 1997, ECOL APPL, V7, P183, DOI 10.1890/1051-0761(1997)007[0183:MVFSMO]2.0.CO;2; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kirkpatrick WR, 1998, J CLIN MICROBIOL, V36, P1330, DOI 10.1128/JCM.36.5.1330-1332.1998; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Kokoska L, 2008, J FOOD PROTECT, V71, P2475, DOI 10.4315/0362-028X-71.12.2475; LevYadun S, 1997, ANN BOT-LONDON, V80, P125, DOI 10.1006/anbo.1997.0419; Liu XM, 2001, FITOTERAPIA, V72, P487, DOI 10.1016/S0367-326X(01)00271-4; Mandal SM, 2010, PLANT SIGNAL BEHAV, V5, P359, DOI 10.4161/psb.5.4.10871; Manual R. M. A, 1912, FLORA EGYPT; Masaoka Y, 2010, NEUROSCI LETT, V473, P92, DOI 10.1016/j.neulet.2010.02.024; Masoum S, 2013, ANAL METHODS-UK, V5, P4639, DOI 10.1039/c3ay40451j; Mithofer A, 2009, ANNU PLANT REV, V34, P261, DOI 10.1111/b.9781405175326.2009.00009.x; Moser JC, 2010, NATURWISSENSCHAFTEN, V97, P219, DOI 10.1007/s00114-009-0630-x; Nakata P. A., 2012, FRONT BIOL, V7, P254, DOI DOI 10.1007/S11515-012-1224-0; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Nitoda T, 2008, PHYTOTHER RES, V22, P809, DOI 10.1002/ptr.2374; Okasaka M, 2004, J NAT PROD, V67, P1044, DOI 10.1021/np0304823; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Patten AM, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 3: DEVELOPMENT & MODIFICATION OF BIOACTIVITY, P1173; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; Serafino A, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-17; Shepherd GM, NEUROGASTRONOMY BRAI; Singhi M, 2010, STUD ETHNO-MED, V4, P121, DOI 10.1080/09735070.2010.11886369; Singla N, 2014, SCI WORLD J, V2014, P7; Taia Wafaa K., 2006, Asian Journal of Plant Sciences, V5, P570; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7; Tjamos E. C., 1989, VASCULAR WILT DIS PL; Uddin K., 2014, INT J ADV RES, V2, P459; Veronese P, 2003, PLANT PHYSIOL, V131, P1580, DOI 10.1104/pp.102.013417; War AR, 2012, PLANT SIGNAL BEHAV, V7, P1306, DOI 10.4161/psb.21663; Yadav K, 2001, CELL PROLIFERATION A; Yap Polly Soo Xi, 2014, Open Microbiol J, V8, P6, DOI 10.2174/1874285801408010006; Zhang W, 2011, PLANT BIOLOGY, V13, P688, DOI 10.1111/j.1438-8677.2010.00434.x; Zouari S, 2012, J ESSENT OIL BEAR PL, V15, P320, DOI 10.1080/0972060X.2012.10644054	60	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192576	10.1371/journal.pone.0192576	http://dx.doi.org/10.1371/journal.pone.0192576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415032	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000424325300089
J	Bonato, M; Meloni, A; Merati, G; La Torre, A; Agnello, L; Vernillo, G				Bonato, Matteo; Meloni, Andrea; Merati, Giampiero; La Torre, Antonio; Agnello, Luca; Vernillo, Gianluca			Effect of repeated-sprints on the reliability of short-term parasympathetic reactivation	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RATE RECOVERY; AUTONOMIC FUNCTION; SPORTS-MEDICINE; PERFORMANCE; FATIGUE; VALIDITY; MONITOR; ABILITY; WORK	This study determined the reliability of post-exercise heart rate recovery (HRR) and vagal-related HR variability (HRV) after repeated-sprints (RSs), and contrasted it with the smallest worthwhile change (SWC) of these indices. Fourteen healthy male participants performed on four occasions, separated by 7 days, five 30-m sprints interspersed by 25-s of recovery. Post-exercise HR during 10 min of seated rest was measured. HRR during the first 60-s of recovery was computed (HRR60s). HRV indices were calculated in time and frequency domains during the last 5-min of the recovery. Absolute and relative reliability were assessed by typical error of measurement expressed as coefficient of variation (CV) and intraclass correlation coefficients (ICCs), respectively. Sensitivity was assessed comparing SWC to the typical error of measurement. CV ranged from 3.6% to 13.5% and from 6.3% to 109.2% for the HRR and HRV indices, respectively. ICCs were from 0.78 to 0.96 and from 0.76 to 0.92, respectively. HRR and HRV indices showed large discrepancies reliability. HRR60s and the square root of the mean sum of the squared differences between R-R intervals presented the highest levels of both absolute and relative reliability. However, SWC was lower than the typical error of measurement, indicating insufficient sensitivity to confidently detect small, but meaningful, changes in HRR and HRV indices.	[Bonato, Matteo; Meloni, Andrea; Merati, Giampiero; La Torre, Antonio; Agnello, Luca; Vernillo, Gianluca] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Merati, Giampiero] IRCCS, Fdn Don Carlo Gnocchi, Milan, Italy; [La Torre, Antonio] IRCCS, Ist Ortoped Galeazzi, Milan, Italy; [Vernillo, Gianluca] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada	University of Milan; IRCCS Fondazione Don Carlo Gnocchi Onlus; IRCCS Istituto Ortopedico Galeazzi; University of Calgary	Vernillo, G (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.; Vernillo, G (corresponding author), Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada.	gianluca.vernillo@unimi.it	Meloni, Andrea/GVS-7802-2022; Bonato, Matteo/R-1917-2019; Merati, Giampiero/AAT-3854-2021; Merati, Giampiero/J-9713-2018; VERNILLO, GIANLUCA/L-1571-2016	Meloni, Andrea/0000-0001-9891-406X; Bonato, Matteo/0000-0002-5589-7957; Merati, Giampiero/0000-0002-1389-7596; VERNILLO, GIANLUCA/0000-0003-2580-4470	Universita degli Studi di Milano	Universita degli Studi di Milano	This study was partly funded by an intramural grant of the Universita degli Studi di Milano for the support of research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the participants involved in the present study. We would also like to express our gratitude to Lupo Guiati for his logistical support during the investigation. This study was partly funded by an intramural grant of the Universita degli Studi di Milano for the support of research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Haddad H, 2011, INT J SPORTS MED, V32, P598, DOI 10.1055/s-0031-1275356; Arduini A, 2011, J SCI MED SPORT, V14, P352, DOI 10.1016/j.jsams.2011.02.012; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Aubert AE, 2003, SPORTS MED, V33, P889, DOI 10.2165/00007256-200333120-00003; Bishop D, 2011, SPORTS MED, V41, P741, DOI 10.2165/11590560-000000000-00000; Bloomfield DM, 2001, AM J PHYSIOL-HEART C, V280, pH1145, DOI 10.1152/ajpheart.2001.280.3.H1145; Bonato M, 2017, J SPORT SCI MED, V16, P286; Bosquet L, 2008, INT J SPORTS MED, V29, P238, DOI 10.1055/s-2007-965162; Bravo DF, 2008, INT J SPORTS MED, V29, P668, DOI 10.1055/s-2007-989371; Buchheit M, 2012, EUR J APPL PHYSIOL, V112, P711, DOI 10.1007/s00421-011-2014-0; BUCHHEIT M, 2014, FRONT PHYSIOL, V5; Buchheit M, 2006, AM J PHYSIOL-HEART C, V291, pH451, DOI 10.1152/ajpheart.00008.2006; Buchheit M, 2007, AM J PHYSIOL-HEART C, V293, pH133, DOI 10.1152/ajpheart.00062.2007; Buchheit M, 2007, AM J PHYSIOL-HEART C, V293, pH8, DOI 10.1152/ajpheart.00335.2007; Cronin JB, 2008, J STRENGTH COND RES, V22, P318, DOI 10.1519/JSC.0b013e31815fa3d3; Dupuy O, 2012, CLIN PHYSIOL FUNCT I, V32, P296, DOI 10.1111/j.1475-097X.2012.01125.x; Gamelin FX, 2006, MED SCI SPORT EXER, V38, P887, DOI 10.1249/01.mss.0000218135.79476.9c; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; Glaister M, 2005, SPORTS MED, V35, P757, DOI 10.2165/00007256-200535090-00003; Glaister M, 2008, J STRENGTH COND RES, V22, P1597, DOI 10.1519/JSC.0b013e318181ab80; Haugen T, 2016, SPORTS MED, V46, P641, DOI 10.1007/s40279-015-0446-0; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Impellizzeri FM, 2009, INT J SPORT PHYSIOL, V4, P269, DOI 10.1123/ijspp.4.2.269; Kiviniemi AM, 2007, EUR J APPL PHYSIOL, V101, P743, DOI 10.1007/s00421-007-0552-2; Kobayashi Hiromitsu, 2009, Journal of Physiological Anthropology, V28, P225, DOI 10.2114/jpa2.28.225; Lamberts RP, 2010, SCAND J MED SCI SPOR, V20, P449, DOI 10.1111/j.1600-0838.2009.00977.x; Le Meur Y, 2013, MED SCI SPORT EXER, V45, P2061, DOI 10.1249/MSS.0b013e3182980125; Mietus JE, 2002, HEART, V88, P378, DOI 10.1136/heart.88.4.378; Millar PJ, 2009, APPL PHYSIOL NUTR ME, V34, P875, DOI 10.1139/H09-086; Nakamura FY, 2009, INT J SPORTS MED, V30, P808, DOI 10.1055/s-0029-1234055; Niewiadomski W, 2007, CLIN PHYSIOL FUNCT I, V27, P309, DOI 10.1111/j.1475-097X.2007.00753.x; Pinna GD, 2007, CLIN SCI, V113, P131, DOI 10.1042/CS20070055; Sandercock G, 2007, CLIN SCI, V113, P129, DOI 10.1042/CS20070137; Sandercock GRH, 2005, INT J CARDIOL, V103, P238, DOI 10.1016/j.ijcard.2004.09.013; Stuckey MI, 2012, SCAND J MED SCI SPOR, V22, P756, DOI 10.1111/j.1600-0838.2011.01320.x; Takahashi T, 2000, EUR J APPL PHYSIOL, V81, P233, DOI 10.1007/s004210050036; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Vernillo G, 2015, EUR J APPL PHYSIOL, V115, P2445, DOI 10.1007/s00421-015-3226-5; Vianna LC, 2008, EUR J APPL PHYSIOL, V102, P283, DOI 10.1007/s00421-007-0584-7; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	41	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192231	10.1371/journal.pone.0192231	http://dx.doi.org/10.1371/journal.pone.0192231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408911	Green Published, gold			2022-12-26	WOS:000424302800051
J	Catalano, C; da Silva, MI; Frank, C; Jiraskova, K; Vymetalkova, V; Levy, M; Liska, V; Vycital, O; Naccarati, A; Vodickova, L; Hemminki, K; Vodicka, P; Weber, ANR; Forsti, A				Catalano, Calogerina; da Silva Filho, Miguel Inacio; Frank, Christoph; Jiraskova, Katerina; Vymetalkova, Veronika; Levy, Miroslav; Liska, Vaclav; Vycital, Ondrej; Naccarati, Alessio; Vodickova, Ludmila; Hemminki, Kari; Vodicka, Pavel; Weber, Alexander N. R.; Foersti, Asta			Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer	PLOS ONE			English	Article							CLASS-I TRANSACTIVATOR; IMMUNE EVASION; T-CELLS; EXPRESSION; COLON; INFLAMMATION; SURVIVAL; PATHWAY	Constitutive activation of interferon signaling pathways has been reported in colorectal cancer (CRC), leading to a strong CD8(+) T cell response through stimulation of NLRC5 expression. Primed CD8(+) T cell expansion, however, may be negatively regulated by PD-L1 expression. Additionally, aberrant PD-L1 expression enables cancer cells to escape the immune attack. Our study aimed to select potential regulatory variants in the NLRC5 and PD-L1 genes by using several online in silico tools, such as UCSC browser, HaploReg, Regulome DB, Gtex Portal, microRNA and transcription factor binding site prediction tools and to investigate their influence on CRC risk in a Czech cohort of 1424 CRC patients and 1114 healthy controls. Logistic regression analysis adjusted for age and gender reported a moderate association between rectal cancer risk and two NLRC5 SNPs, rs1684575 T>G (OR: 1.60, 95% CI: 1.13-2.27, recessive model) and rs3751710 (OR: 0.70, 95% CI: 0.51-0.96, dominant model). Given that a combination of genetic variants, rather than a single polymorphism, may explain better the genetic etiology of CRC, we studied the interplay between the variants within NLRC5, PD-L1 and the previously genotyped IFNGR1 and IFNGR2variants, to evaluate their involvement in the risk of CRC development. Overall we obtained 18 pair wise interactions within and between the NLRC5ad PD-L1 genes and 6 more when IFNGR variants were added. Thirteen out of the 24 interactions were below the threshold for the FDR calculated and controlled at an arbitrary level q*<0.10. Furthermore, the interaction IFNGR2rs1059293 C>T NLRC5 rs289747 G>A (P<0.0001) remained statistically significant even after Bonferroni correction. Our data suggest that not only a single genetic variant but also an interaction between two or more variants within genes involved in immune regulation may play important roles in the onset of CRC, providing therefore novel biological information, which could eventually improve CRC risk management but also PD-1-based immunotherapy in CRC.	[Catalano, Calogerina; da Silva Filho, Miguel Inacio; Frank, Christoph; Hemminki, Kari; Foersti, Asta] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Jiraskova, Katerina; Vymetalkova, Veronika; Naccarati, Alessio; Vodickova, Ludmila; Vodicka, Pavel] Czech Acad Sci, Inst Expt Med, Dept Mol Biol Canc, Prague, Czech Republic; [Jiraskova, Katerina; Vymetalkova, Veronika; Vodickova, Ludmila; Vodicka, Pavel] Charles Univ Prague, Med Fac 1, Inst Biol & Med Genet, Prague, Czech Republic; [Levy, Miroslav; Liska, Vaclav; Vycital, Ondrej] Charles Univ Prague, Med Fac 1, Dept Surg, Prague, Czech Republic; [Levy, Miroslav; Liska, Vaclav; Vycital, Ondrej] Thomayer Hosp, Prague, Czech Republic; [Liska, Vaclav; Vycital, Ondrej; Vodickova, Ludmila; Vodicka, Pavel] Charles Univ Prague, Fac Med Pilsen, Biomed Ctr, Plzen, Czech Republic; [Naccarati, Alessio] IIGM, Mol & Genet Epidemiol, Turin, Italy; [Hemminki, Kari; Foersti, Asta] Lund Univ, Clin Res Ctr, Ctr Primary Hlth Care Res, Malmo, Sweden; [Weber, Alexander N. R.] Univ Tubingen, Interfac Inst Cell Biol, Dept Immunol, Tubingen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; Charles University Prague; Thomayer Hospital; Charles University Prague; Italian Institute for Genomic Medicine (IIGM); Lund University; Eberhard Karls University of Tubingen	Catalano, C (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany.	c.catalano@dkfz.de	Jiraskova, Katerina/C-8232-2017	Jiraskova, Katerina/0000-0001-8462-6358; Naccarati, Alessio/0000-0001-5774-0905; Vodicka, Pavel/0000-0003-2376-1243; Catalano, Calogerina/0000-0002-4047-8485	Internal Grant Agency of the Ministry of Health of the Czech Republic [AZV 15-27580A, AZV 15-26535A]; Grant Agency of the Charles University [GAUK 112515]; University of Tubingen; Federal State Baden-Wurttemberg Junior Professor Program	Internal Grant Agency of the Ministry of Health of the Czech Republic; Grant Agency of the Charles University; University of Tubingen; Federal State Baden-Wurttemberg Junior Professor Program	The work was supported by Internal Grant Agency of the Ministry of Health of the Czech Republic AZV 15-27580A (PI: PV) and AZV 15-26535A (PI: W) (http://www.azvcr.cz/o-azv-cr) and the Grant Agency of the Charles University (GAUK 112515) (PI: KJ) (http://www.cuni.cz/ukeng-33.html). AW was supported by the University of Tubingen, the Federal State Baden-Wurttemberg Junior Professor Program (https://www.medizin.uni-tuebingen.de/en/Research/Research+Funding/Gender+Equality+Prize.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida R, 2005, J PATHOL, V207, P396, DOI 10.1002/path.1861; Angelova M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0620-6; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Beatty GL, 2015, CLIN CANCER RES, V21, P687, DOI 10.1158/1078-0432.CCR-14-1860; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Carrai M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08946-3; Cheon H, 2014, SEMIN ONCOL, V41, P156, DOI 10.1053/j.seminoncol.2014.02.002; Hassanzadeh Parichehr, 2011, Gastroenterol Hepatol Bed Bench, V4, P127; Hendricks AE, 2014, EUR J HUM GENET, V22, P414, DOI 10.1038/ejhg.2013.144; Janakiram NB, 2014, ADV EXP MED BIOL, V816, P25, DOI 10.1007/978-3-0348-0837-8_2; Jin TR, 1999, INT J CANCER, V81, P104, DOI 10.1002/(SICI)1097-0215(19990331)81:1<104::AID-IJC18>3.0.CO;2-Q; Juliger S, 2003, IMMUNOGENETICS, V54, P675, DOI 10.1007/s00251-002-0516-y; Karwacz K, 2011, EMBO MOL MED, V3, P581, DOI 10.1002/emmm.201100165; Kataoka K, 2016, NATURE, V534, P402, DOI 10.1038/nature18294; Khurana E, 2016, NAT REV GENET, V17, P93, DOI 10.1038/nrg.2015.17; Kuenzel S, 2010, J IMMUNOL, V184, P1990, DOI 10.4049/jimmunol.0900557; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; LIEBERMAN PM, 1994, GENE DEV, V8, P995, DOI 10.1101/gad.8.9.995; Lu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111061; Lynch D, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.29; Meissner TB, 2012, MICROBES INFECT, V14, P477, DOI 10.1016/j.micinf.2011.12.007; Mlecnik B, 2016, IMMUNITY, V44, P698, DOI 10.1016/j.immuni.2016.02.025; Mueller K, 2013, NUCLEIC ACIDS RES, V41, P2138, DOI 10.1093/nar/gks1349; Pandiyan P, 2007, J IMMUNOL, P178; Passardi A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061324; Riella LV, 2012, AM J TRANSPLANT, V12, P2575, DOI 10.1111/j.1600-6143.2012.04224.x; Rodriguez GM, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1151593; Seliger B, 2005, BIODRUGS, V19, P347, DOI 10.2165/00063030-200519060-00002; Slattery ML, 2011, CARCINOGENESIS, V32, P1660, DOI 10.1093/carcin/bgr189; Van L, 2016, J IMMUNOTHER CANC, V4; Wang X, 2016, ONCOTARGETS THER, V9, P5023, DOI 10.2147/OTT.S105862; Wang YP, 2016, TUMOR BIOL, V37, P3247, DOI 10.1007/s13277-015-4080-0; Weber ANR, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27763; Welsh RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002352; Wu HJ, 2012, GUT MICROBES, V3, P4, DOI 10.4161/gmic.19320; Yoshihama S, 2016, P NATL ACAD SCI USA, V113, P5999, DOI 10.1073/pnas.1602069113; Zhang XL, 2014, J PHYS CHEM B, V118, P2009, DOI 10.1021/jp409778e	37	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192385	10.1371/journal.pone.0192385	http://dx.doi.org/10.1371/journal.pone.0192385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408916	Green Published, Green Submitted, gold			2022-12-26	WOS:000424302800061
J	Sasaki, E; Momose, H; Hiradate, Y; Furuhata, K; Takai, M; Asanuma, H; Ishii, KJ; Mizukami, T; Hamaguchi, I				Sasaki, Eita; Momose, Haruka; Hiradate, Yuki; Furuhata, Keiko; Takai, Mamiko; Asanuma, Hideki; Ishii, Ken J.; Mizukami, Takuo; Hamaguchi, Isao			Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; IMMUNE-RESPONSE; NEEDLE LENGTH; WHOLE VIRION; VACCINATION; RISK; FORMULATION; THICKNESS; PATTERNS; VIRUSES	Historically, vaccine safety assessments have been conducted by animal testing (e.g., quality control tests and adjuvant development). However, classical evaluation methods do not provide sufficient information to make treatment decisions. We previously identified bio-marker genes as novel safety markers. Here, we developed a practical safety assessment system used to evaluate the intramuscular, intraperitoneal, and nasal inoculation routes to provide robust and comprehensive safety data. Influenza vaccines were used as model vaccines. A toxicity reference vaccine (RE) and poly I: C-adjuvanted hemagglutinin split vaccine were used as toxicity controls, while a non-adjuvanted hemagglutinin split vaccine and AddaVax (squalene-based oil-in-water nano-emulsion with a formulation similar to MF59)-adjuvanted hemagglutinin split vaccine were used as safety controls. Body weight changes, number of white blood cells, and lung biomarker gene expression profiles were determined in mice. In addition, vaccines were inoculated into mice by three different administration routes. Logistic regression analyses were carried out to determine the expression changes of each biomarker. The results showed that the regression equations clearly classified each vaccine according to its toxic potential and inoculation amount by biomarker expression levels. Interestingly, lung biomarker expression was nearly equivalent for the various inoculation routes. The results of the present safety evaluation were confirmed by the approximation rate for the toxicity control. This method may contribute to toxicity evaluation such as quality control tests and adjuvant development.	[Sasaki, Eita; Momose, Haruka; Hiradate, Yuki; Furuhata, Keiko; Takai, Mamiko; Mizukami, Takuo; Hamaguchi, Isao] Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Musashimurayama, Tokyo, Japan; [Asanuma, Hideki] Natl Inst Infect Dis, Influenza Virus Res Ctr, Musashimurayama, Tokyo, Japan; [Ishii, Ken J.] Natl Inst Biomed Innovat Hlth & Nutr, Lab Adjuvant Innovat, Ibaraki, Osaka, Japan; [Ishii, Ken J.] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Vaccine Sci, Suita, Osaka, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Osaka University	Mizukami, T; Hamaguchi, I (corresponding author), Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Musashimurayama, Tokyo, Japan.	tmiz@nih.go.jp; 130hama@nih.go.jp	Ishii, Ken J/B-1685-2012; Mizukami, Takuo/F-9248-2016	Ishii, Ken J/0000-0002-6728-3872; Mizukami, Takuo/0000-0001-6105-6049; Sasaki, Eita/0000-0002-3384-7414	Ministry of Health, Labour and Welfare; Research on Development of New Drugs, the Japan Agency for Medical Research and Development [16ak0101010j0105, 17fk0108124j0101]	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Research on Development of New Drugs, the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study (Adjuvant Data Base Project) was supported by Grants from The Ministry of Health, Labour and Welfare and Research on Development of New Drugs, the Japan Agency for Medical Research and Development (16ak0101010j0105 and 17fk0108124j0101).	ABSHER M, 1969, NATURE, V223, P715, DOI 10.1038/223715a0; Adler M, 2011, J GEN VIROL, V92, P1532, DOI 10.1099/vir.0.030981-0; Ato M, 2013, VACCINE, V31, P2184, DOI 10.1016/j.vaccine.2013.02.016; Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Carlow DA, 1998, J IMMUNOL, V161, P2348; Cook IF, 2008, HUM VACCINES, V4, P67, DOI 10.4161/hv.4.1.4747; Delafuente JC, 1998, PHARMACOTHERAPY, V18, P631; Diez-Domingo J, 2015, VACCINE, V33, P789, DOI 10.1016/j.vaccine.2014.12.024; Durando P, 2010, EXPERT OPIN BIOL TH, V10, P639, DOI 10.1517/14712591003724662; Fruh K, 1999, CURR OPIN IMMUNOL, V11, P76, DOI 10.1016/S0952-7915(99)80014-4; Ghimire TR, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0972-0; GOLDENTHAL KL, 1993, AIDS RES HUM RETROV, V9, pS47; Groswasser J, 1997, PEDIATRICS, V100, P400, DOI 10.1542/peds.100.3.400; Hamaguchi I, 2008, VACCINE, V26, P4686, DOI 10.1016/j.vaccine.2008.06.086; Hamaguchi I, 2007, VACCINE, V25, P3355, DOI 10.1016/j.vaccine.2006.12.059; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; KUROKAWA M, 1975, JPN J MED SCI BIOL, V28, P37, DOI 10.7883/yoken1952.28.37; KUROKAWA M, 1974, JPN J MED SCI BIOL, V27, P173, DOI 10.7883/yoken1952.27.173; Lago-Deibe FI, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-147; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Mizukami T, 2017, PLOS ONE, V9; Mizukami T, 2008, VACCINE, V26, P2270, DOI 10.1016/j.vaccine.2008.02.031; Mizukami T, 2009, BIOLOGICALS, V37, P8, DOI 10.1016/j.biologicals.2008.07.007; Momose H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124392; Momose H, 2010, JPN J INFECT DIS, V63, P25; National Institute of Infectious Diseases, 2006, GEN TESTS 272 336 IN, P10; Neter J, 1974, APPLIED LINEAR STATI, P214; O'Hagan DT, 2012, VACCINE, V30, P4341, DOI 10.1016/j.vaccine.2011.09.061; ORTBALS DW, 1978, J CLIN MICROBIOL, V8, P431; Petrovsky N, 2015, VACCINE, V33, P5920, DOI 10.1016/j.vaccine.2015.09.030; Philips FS, 1971, BIOL EFFECTS POLYNUC, P45, DOI [10.1007/978-3-642-85772-0_18, DOI 10.1007/978-3-642-85772-0_18]; Poland GA, 1997, JAMA-J AM MED ASSOC, V277, P1709, DOI 10.1001/jama.277.21.1709; Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007; ROBINSON RA, 1976, JNCI-J NATL CANCER I, V57, P599, DOI 10.1093/jnci/57.3.599; Sasaki E, 2017, VACCINE, V35, P821, DOI 10.1016/j.vaccine.2016.12.036; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schultze V, 2008, VACCINE, V26, P3209, DOI 10.1016/j.vaccine.2008.03.093; SHAW FE, 1989, VACCINE, V7, P425, DOI 10.1016/0264-410X(89)90157-6; Soema PC, 2015, EUR J PHARM BIOPHARM, V94, P251, DOI 10.1016/j.ejpb.2015.05.023; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	42	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191896	10.1371/journal.pone.0191896	http://dx.doi.org/10.1371/journal.pone.0191896			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408882	gold, Green Submitted, Green Published			2022-12-26	WOS:000424302800027
J	Christensen, MHE; Fadnes, DJ; Rost, TH; Pedersen, ER; Andersen, JR; Vage, V; Ulvik, A; Midttun, O; Ueland, PM; Nygard, OK; Mellgren, G				Christensen, Monika H. E.; Fadnes, Dag J.; Rost, Therese H.; Pedersen, Eva R.; Andersen, John R.; Vage, Villy; Ulvik, Arve; Midttun, Oivind; Ueland, Per M.; Nygard, Ottar K.; Mellgren, Gunnar			Inflammatory markers, the tryptophan-kynurenine pathway, and vitamin B status after bariatric surgery	PLOS ONE			English	Article							INTERFERON-GAMMA; IMMUNE-RESPONSE; OBESITY; MACROPHAGES; ACTIVATION; DISEASE; ASSOCIATION; EXPRESSION; NEOPTERIN; BALANCE	Objective Obesity is associated with increased inflammation and insulin resistance. In conditions with chronic immune activation, low plasma vitamin B6-levels are described, as well as an increased kynurenine: tryptophan-ratio (KTR). We investigated circulating tryptophan, kynurenine and its metabolites, neopterin, B-vitamins, CRP, and HbA1c in individuals with obesity before and after bariatric surgery. Methods This longitudinal study included 37 patients with severe obesity, scheduled for bariatric surgery. Blood samples were taken at inclusion and at three months and one year postoperatively. Results We observed significant positive correlations between HbA1c and both 3-hydroxy-kynurenine and 3-hydroxyanthranilic acid at inclusion. After surgery, fasting glucose, HbA1C and triglycerides decreased, whereas HDL-cholesterol increased. Tryptophan, kynurenine and its metabolites, except for anthranilic acid, decreased during weight loss. The KTR and CRP decreased while vitamin B6 increased during the year following operation, indicating reduced inflammation (all p<0.05). Conclusions In patients with obesity subjected to bariatric surgery, levels of 3-hydroxykynurenine and 3-hydroxyanthranilic acid seemed to be positively correlated to impaired glucose tolerance. One year following surgery, plasma levels of the kynurenine metabolites were substantially decreased, along with a metabolic improvement. The relation of circulating kynurenine pathway metabolites with biomarkers of metabolic impairment in patients with obesity needs further evaluation.	[Christensen, Monika H. E.; Rost, Therese H.; Pedersen, Eva R.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Christensen, Monika H. E.] Haukeland Hosp, Dept Med, Bergen, Norway; [Fadnes, Dag J.] Forde Hosp Trust, Med Dept, Forde, Norway; [Pedersen, Eva R.; Nygard, Ottar K.] Haukeland Hosp, Dept Heart Dis, Bergen, Norway; [Andersen, John R.] Sogn og Fjordane Univ Coll, Forde, Norway; [Pedersen, Eva R.; Andersen, John R.] Forde Hosp Trust, Ctr Hlth Res, Forde, Norway; [Vage, Villy] Bergen Hlth Trust, Voss Hosp, Dept Surg, Voss, Norway; [Ulvik, Arve; Midttun, Oivind] Bevital AS, Bergen, Norway; [Ueland, Per M.] Haukeland Hosp, Lab Clin Biochem, Bergen, Norway; [Nygard, Ottar K.; Mellgren, Gunnar] Univ Bergen, KG Jebsen Ctr Diabet Res, Dept Clin Sci, Bergen, Norway; [Mellgren, Gunnar] Haukeland Hosp, Hormone Lab, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Western Norway University of Applied Sciences; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital	Mellgren, G (corresponding author), Univ Bergen, KG Jebsen Ctr Diabet Res, Dept Clin Sci, Bergen, Norway.; Mellgren, G (corresponding author), Haukeland Hosp, Hormone Lab, Bergen, Norway.	gunnar.mellgren@med.uib.no	Ueland, Per M/C-7340-2013; Mellgren, Gunnar/AAG-6573-2020	Mellgren, Gunnar/0000-0001-6282-4986; Ueland, Per Magne/0000-0002-1903-0571; Andersen, John Roger/0000-0001-6300-9086	West Norway Regional Health Authority	West Norway Regional Health Authority	West Norway Regional Health Authority funded costs for the analysis. The funder, Bevital, provided support in the form of salaries for authors, OM and AU. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.; The study was supported by the West Norway Regional Health Authority.	Aasheim ET, 2009, AM J CLIN NUTR, V90, P15, DOI 10.3945/ajcn.2009.27583; AlberatiGiani D, 1996, J NEUROCHEM, V66, P996; Brandacher G, 2006, OBES SURG, V16, P541, DOI 10.1381/096089206776945066; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Cheng CH, 2008, NUTRITION, V24, P239, DOI 10.1016/j.nut.2007.12.003; Constantinopoulos P, 2015, EUR J ENDOCRINOL, V172, DOI 10.1530/EJE-14-0626; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Favennec M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158051; Favennec M, 2015, OBESITY, V23, P2066, DOI 10.1002/oby.21199; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gloy VL, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5934; Grant RW, 2015, AM J PHYSIOL ENDOCRI; Havel PJ, 2004, DIABETES, V53, pS143, DOI 10.2337/diabetes.53.2007.S143; Hegyi J, 2004, INT J DERMATOL, V43, P1, DOI 10.1111/j.1365-4632.2004.01959.x; HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levy P, 2007, OBES SURG, V17, P1248, DOI 10.1007/BF02802098; Lotto V, 2011, BR J NUTR, V13, P1; LUI A, 1985, J LAB CLIN MED, V106, P491; Mahuren JD, 1999, J NUTR, V129, P1905, DOI 10.1093/jn/129.10.1905; Mandi Y, 2012, J NEURAL TRANSM, V119, P197, DOI 10.1007/s00702-011-0681-y; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Midttun O, 2013, ANAL BIOANAL CHEM, V405, P2009, DOI 10.1007/s00216-012-6602-6; Midttun O, 2011, J NUTR, V141, P611, DOI 10.3945/jn.110.133082; Moffett JR, 2003, IMMUNOL CELL BIOL, V81, P247, DOI 10.1046/j.1440-1711.2003.t01-1-01177.x; Munipally PK, 2011, ARCH PHYSIOL BIOCHEM, V117, P254, DOI 10.3109/13813455.2011.623705; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; Oxenkrug GF, 2011, J NEURAL TRANSM, V118, P75, DOI 10.1007/s00702-010-0475-7; Paul L, 2013, NUTR REV, V71, P239, DOI 10.1111/nure.12014; Rojano-Rodriguez ME, 2014, REV GASTROENTEROL ME, V79, P90, DOI 10.1016/j.rgmx.2013.11.002; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Shen J, 2010, AM J CLIN NUTR, V91, P337, DOI 10.3945/ajcn.2009.28571; Sjostrom L, 2014, JAMA-J AM MED ASSOC, V311, P2297, DOI 10.1001/jama.2014.5988; Theofylaktopoulou D, 2013, CLIN EXP IMMUNOL, V173, P121, DOI 10.1111/cei.12092; Ueland PM, 2016, MOL ASPECTS MED; Ulvik A, 2012, AM J CLIN NUTR; Vage V, 2014, BMC SURG, V14, DOI 10.1186/1471-2482-14-8; Vage V, 2011, OBES SURG, V21, P1864, DOI 10.1007/s11695-011-0496-9; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	40	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192169	10.1371/journal.pone.0192169	http://dx.doi.org/10.1371/journal.pone.0192169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401505	Green Published, Green Submitted, gold			2022-12-26	WOS:000424101400040
J	da Silva, RL; Labrecque, D; Caromano, FA; Higgins, J; Frak, V				da Silva, Ronaldo Luis; Labrecque, David; Caromano, Fatima Aparecida; Higgins, Johanne; Frak, Victor			Manual action verbs modulate the grip force of each hand in unimanual or symmetrical bimanual tasks	PLOS ONE			English	Article							SUPPLEMENTARY MOTOR AREA; INTERHEMISPHERIC-TRANSFER TIME; INFERIOR FRONTAL GYRUS; CONNECTIVITY; COORDINATION; LANGUAGE; BRAIN; CORTEX; FMRI	Manual action verbs modulate the right-hand grip force in right-handed subjects. However, to our knowledge, no studies demonstrate the ability to accomplish this modulation during bimanual tasks nor describe their effect on left-hand behavior in unimanual and bimanual tasks. Using load cells and word playlists, we evaluated the occurrence of grip force modulation by manual action verbs in unimanual and symmetrical bimanual tasks across the three auditory processing phases. We found a significant grip force increase for all conditions compared to baseline, indicating the occurrence of modulation. When compared to each other, the grip force variation from baseline for the three phases of both hands in the symmetrical bimanual task was not different from the right-hand in the unimanual task. The left-hand grip force showed a lower amplitude for auditory phases 1 and 2 when compared to the other conditions. The right-hand grip force modulation became significant from baseline at 220 ms after the word onset in the unimanual task. This moment occurred earlier for both hands in bimanual task (160 ms for the right-hand and 180 for the left-hand). It occurred later for the left-hand in unimanual task (320 ms). We discuss the hypothesis that Broca's area and Broca's homologue area likely control the left-hand modulation in a unilateral or a bilateral fashion. These results provide new evidence for understanding the linguistic function processing in both hemispheres.	[da Silva, Ronaldo Luis; Labrecque, David; Frak, Victor] Univ Quebec Montre, Fac Sci, Montreal, PQ, Canada; [da Silva, Ronaldo Luis; Higgins, Johanne; Frak, Victor] CRIR, CIUSSS Ctr Sud De Ile De Montreal, CRIR, Site Inst Readaptat Gingras Lindsay Montreal, Montreal, PQ, Canada; [Caromano, Fatima Aparecida] Univ Sao Paulo, Med Sch, Dept Phys Therapy Speech & Occupat Therapy, Lab Phys Therapy & Behav, Sao Paulo, Brazil; [Higgins, Johanne] Univ Montreal, Fac Med, Ecole Readapt, Montreal, PQ, Canada	Universite de Montreal; Universidade de Sao Paulo; Universite de Montreal	da Silva, RL (corresponding author), Univ Quebec Montre, Fac Sci, Montreal, PQ, Canada.; da Silva, RL (corresponding author), CRIR, CIUSSS Ctr Sud De Ile De Montreal, CRIR, Site Inst Readaptat Gingras Lindsay Montreal, Montreal, PQ, Canada.	da_silva.ronaldo_luis@courrier.uqam.ca	da Silva, Ronaldo Luis/Q-3704-2019; da Silva, Ronaldo Luis/ABC-3801-2020; Higgins, Johanne/AAF-3672-2019	da Silva, Ronaldo Luis/0000-0003-0254-2017; Higgins, Johanne/0000-0003-1513-6587; Frak, Victor/0000-0002-3311-777X	National Council for Scientific and Technological Development (CNPq) [202464/2014-8]; Fondation de l'Institut de Readaptation de Montreal, Canada	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fondation de l'Institut de Readaptation de Montreal, Canada	RLS was supported by the National Council for Scientific and Technological Development (CNPq), by means of the Brazilian Governments Science Without Borders Program (https://fondationrea.ca/en/foundation/-Grant number: 202464/2014-8). This work was aided by a grant from Fondation de lInstitut de Readaptation de Montreal, Canada (http://www.fondationirglm.org/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramaki Y, 2006, NEUROSCIENCE, V141, P2147, DOI 10.1016/j.neuroscience.2006.05.030; Aramaki Y, 2010, EXP BRAIN RES, V203, P407, DOI 10.1007/s00221-010-2244-0; Aravena P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050287; Beaule V, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/627816; Begliomini C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003388; Bernal B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00687; Catani M, 2012, CORTEX, V48, P273, DOI 10.1016/j.cortex.2011.12.001; Cattaneo L, 2011, SOC COGN AFFECT NEUR, V6, P301, DOI 10.1093/scan/nsq099; Flinker A, 2015, P NATL ACAD SCI USA, V112, P2871, DOI 10.1073/pnas.1414491112; Frak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009728; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Genon S, 2016, CEREB CORTEX; Haberling IS, 2016, NEUROPSYCHOLOGIA, V80, P17, DOI 10.1016/j.neuropsychologia.2015.11.002; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hickok G, 2012, NAT REV NEUROSCI, V13, P135, DOI 10.1038/nrn3158; INDEFREY P, 2011, FRONT PSYCHOL, V2; Jancke L, 2001, BRAIN LANG, V78, P349, DOI 10.1006/brln.2000.2476; Jung-Beeman M, 2005, TRENDS COGN SCI, V9, P512, DOI 10.1016/j.tics.2005.09.009; KELSO JAS, 1979, J EXP PSYCHOL HUMAN, V5, P229, DOI 10.1037/0096-1523.5.2.229; Maki Y, 2008, NEUROIMAGE, V42, P1295, DOI 10.1016/j.neuroimage.2008.06.045; Moes PE, 2007, NEUROPSYCHOLOGIA, V45, P2626, DOI 10.1016/j.neuropsychologia.2007.03.017; Nazir TA, 2017, BEHAV RES METHODS, V49, P61, DOI 10.3758/s13428-015-0696-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prichard E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00009; Rapp B, 2014, LANG COGN NEUROSCI, V29, P24, DOI 10.1080/01690965.2013.848991; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2016, NAT REV NEUROSCI, V17, P757, DOI 10.1038/nrn.2016.135; Rogers BP, 2004, NEUROIMAGE, V22, P855, DOI 10.1016/j.neuroimage.2004.02.027; Rosso C, 2014, BRAIN STIMUL, V7, P122, DOI 10.1016/j.brs.2013.08.007; Rota G, 2009, HUM BRAIN MAPP, V30, P1605, DOI 10.1002/hbm.20621; Rowan A, 2004, NEUROIMAGE, V22, P665, DOI 10.1016/j.neuroimage.2004.01.034; Sadato N, 1997, J NEUROSCI, V17, P9667; Sollmann N, 2014, NEUROIMAGE, V102, P776, DOI 10.1016/j.neuroimage.2014.09.002; Stout D, 2012, PHILOS T R SOC B, V367, P75, DOI 10.1098/rstb.2011.0099; Westerhausen R, 2006, NEUROSCI LETT, V409, P140, DOI 10.1016/j.neulet.2006.09.028	35	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192320	10.1371/journal.pone.0192320	http://dx.doi.org/10.1371/journal.pone.0192320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401468	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000424101400048
J	Diaz, GJ; Parade, MS; Barton, SL; Fajen, BR				Diaz, Gabriel J.; Parade, Melissa S.; Barton, Sean L.; Fajen, Brett R.			The pickup of visual information about size and location during approach to an obstacle	PLOS ONE			English	Article							LONG-LASTING MEMORIES; FOOT PLACEMENT; APPROACH PHASE; WALKING; LOCOMOTION; GAIT; VISION; PATTERNS; TERRAIN; STEP	The present study investigated differences in the pickup of information about the size and location of an obstacle in the path of locomotion. The main hypothesis was that information about obstacle location is most useful when it is sampled at a specific time during the approach phase, whereas information about obstacle size can be sampled at any point during the last few steps. Subjects approached and stepped over obstacles in a virtual environment viewed through a head-mounted display. In Experiment 1, a horizontal line on the ground indicating obstacle location was visible throughout the trial while information about obstacle height and depth was available only while the subject was passing through a viewing window located at one of four locations along the subject's path. Subjects exhibited more cautious behavior when the obstacle did not become visible until they were within one step length, but walking behavior was at most weakly affected in the other viewing window conditions. In Experiment 2, the horizontal line indicating obstacle location was removed, such that no information about the obstacle (size or location) was available outside of the viewing window. Subjects adopted a more cautious strategy compared to Experiment 1 and differences between the viewing window conditions and the full vision control condition were observed across several measures. The differences in walking behavior and performance across the two experiments support the hypothesis that walkers have greater flexibility in when they can sample information about obstacle size compared to location. Such flexibility may impact gaze and locomotor control strategies, especially in more complex environments with multiple objects and obstacles.	[Diaz, Gabriel J.] Rochester Inst Technol, Chester F Carlson Ctr Imaging Sci, Rochester, NY 14623 USA; [Parade, Melissa S.; Barton, Sean L.; Fajen, Brett R.] Rensselaer Polytech Inst, Cognit Sci Dept, Troy, NY 12181 USA	Rochester Institute of Technology; Rensselaer Polytechnic Institute	Diaz, GJ (corresponding author), Rochester Inst Technol, Chester F Carlson Ctr Imaging Sci, Rochester, NY 14623 USA.; Fajen, BR (corresponding author), Rensselaer Polytech Inst, Cognit Sci Dept, Troy, NY 12181 USA.	gabriel.diaz@rit.edu; fajenb@rpi.edu			NSF BCS [1431078]	NSF BCS(National Science Foundation (NSF))	Supported by NSF BCS 1431078. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardy BG, 1999, PERCEPT PSYCHOPHYS, V61, P1356, DOI 10.3758/BF03206186; Buckley JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019079; CHEN HC, 1991, J GERONTOL, V46, pM196, DOI 10.1093/geronj/46.6.M196; Chou LS, 2001, GAIT POSTURE, V13, P17, DOI 10.1016/S0966-6362(00)00087-4; Chou LS, 1998, J BIOMECH, V31, P685, DOI 10.1016/S0021-9290(98)00081-5; Creem-Regehr SH, 2015, PSYCHOL LEARN MOTIV, V62, P195, DOI 10.1016/bs.plm.2014.09.006; Franchak JM, 2010, VISION RES, V50, P2766, DOI 10.1016/j.visres.2010.09.024; Heijnen MJH, 2014, EXP BRAIN RES, V232, P2131, DOI 10.1007/s00221-014-3903-3; Hesse C, 2016, NEUROPSYCHOLOGIA, V91, P531, DOI 10.1016/j.neuropsychologia.2016.09.016; Krigolson A, 2004, HUM MOVEMENT SCI, V23, P861, DOI 10.1016/j.humov.2004.10.011; Kuo AD, 2001, J BIOMECH ENG-T ASME, V123, P264, DOI 10.1115/1.1372322; Lajoie K, 2012, J NEUROPHYSIOL, V107, P2283, DOI 10.1152/jn.00756.2011; Marigold DS, 2007, NEUROSCIENCE, V144, P302, DOI 10.1016/j.neuroscience.2006.09.006; Marigold DS, 2008, EXP BRAIN RES, V188, P23, DOI 10.1007/s00221-008-1335-7; Marigold DS, 2007, EXP BRAIN RES, V176, P32, DOI 10.1007/s00221-006-0598-0; Matthis JS, 2014, J EXP PSYCHOL HUMAN, V40, P106, DOI 10.1037/a0033101; Matthis JS, 2015, J VISION, V15, DOI 10.1167/15.3.10; Matthis JS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0700; McVea DA, 2006, J NEUROSCI, V26, P1175, DOI 10.1523/JNEUROSCI.4458-05.2006; Mcvea DA, 2007, CURR BIOL, V17, pR621, DOI 10.1016/j.cub.2007.06.026; Mohagheghi AA, 2004, EXP BRAIN RES, V155, P459, DOI 10.1007/s00221-003-1751-7; Muir BC, 2015, GAIT POSTURE, V41, P233, DOI 10.1016/j.gaitpost.2014.10.005; Parade M, 2014, J VISION, V14, P1353; Patla AE, 1997, NEUROREPORT, V8, P3661, DOI 10.1097/00001756-199712010-00002; Patla AE, 1996, J MOTOR BEHAV, V28, P35, DOI 10.1080/00222895.1996.9941731; Patla AE, 1998, ECOL PSYCHOL, V10, P287, DOI 10.1207/s15326969eco103&4_7; Patla AE, 2006, NEUROSCI LETT, V397, P110, DOI 10.1016/j.neulet.2005.12.016; PATLA AE, 1993, GAIT POSTURE, V1, P45, DOI 10.1016/0966-6362(93)90042-Y; Renner RS, 2013, ACM COMPUT SURV, V46, DOI 10.1145/2543581.2543590; Rhea CK, 2007, NEUROSCI LETT, V418, P60, DOI 10.1016/j.neulet.2007.02.063; Rietdyk S, 2006, EXP BRAIN RES, V169, P272, DOI 10.1007/s00221-005-0345-y; Timmis MA, 2016, GAIT POSTURE, V44, P55, DOI 10.1016/j.gaitpost.2015.11.008; Timmis MA, 2012, GAIT POSTURE, V36, P160, DOI 10.1016/j.gaitpost.2012.02.008; Watt SJ, 2005, J VISION, V5, P834, DOI 10.1167/5.10.7; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	35	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192044	10.1371/journal.pone.0192044	http://dx.doi.org/10.1371/journal.pone.0192044			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401511	Green Published, Green Submitted, gold			2022-12-26	WOS:000424101400032
J	Eggimann, L; Blum, S; Aeschbacher, S; Reusser, A; Ammann, P; Erne, P; Moschovitis, G; Di Valentino, M; Shah, D; Schlapfer, J; Mondet, N; Kuhne, M; Sticherling, C; Osswald, S; Conen, D				Eggimann, Lucien; Blum, Steffen; Aeschbacher, Stefanie; Reusser, Andreas; Ammann, Peter; Erne, Paul; Moschovitis, Giorgio; Di Valentino, Marcello; Shah, Dipen; Schlapfer, Jurg; Mondet, Nadine; Kuhne, Michael; Sticherling, Christian; Osswald, Stefan; Conen, David			Risk factors for heart failure hospitalizations among patients with atrial fibrillation	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; DIASTOLIC BLOOD-PRESSURE; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; PROGNOSTIC IMPLICATIONS; DIABETES-MELLITUS; JAPANESE PATIENTS; OBESITY PARADOX; SERUM CHLORIDE; MORTALITY	Background Patients with atrial fibrillation (AF) have an increased risk for the development of heart failure (HF). In this study, we aimed to detect predictors of HF hospitalizations in an unselected AF population. Methods The Basel Atrial Fibrillation Cohort Study is an ongoing observational multicenter cohort study in Switzerland. For this analysis, 1193 patients with documented AF underwent clinical examination, venous blood sampling and resting 12-lead ECG at baseline. Questionnaires about lifestyle and medical history were obtained in person at baseline and during yearly follow-up phone calls. HF hospitalizations were validated by two independent physicians. Cox regression analyses were performed using a forward selection strategy. Results Overall, 29.8% of all patients were female and mean age was 69 +/- 12 years. Mean follow-up time was 3.7 +/- 1.5 years. Hospitalization for HF occurred in 110 patients, corresponding to an incidence of 2.5 events per 100 person years of follow-up. Independent predictors for HF were body mass index (HR 1.40 [95% CI 1.17; 1.66], p = 0.0002), chronic kidney disease (2.27 [1.49; 3.45], p = 0.0001), diabetes mellitus (2.13 [1.41; 3.24], p = 0.0004), QTc interval (1.25 [1.04; 1.49], p = 0.02), brain natriuretic peptide (2.19 [1.73; 2.77], p< 0.0001), diastolic blood pressure (0.79 [0.65; 0.96], p = 0.02), history of pulmonary vein isolation or electrical cardioversion (0.54 [0.36; 0.80], p = 0.003) and serum chloride (0.82 [0.70; 0.96], p = 0.02). Conclusions In this unselected AF population, several traditional cardiovascular risk factors and arrhythmia interventions predicted HF hospitalizations, providing potential opportunities for the implementation of strategies to reduce HF among AF patients.	[Eggimann, Lucien; Blum, Steffen; Aeschbacher, Stefanie; Reusser, Andreas; Kuhne, Michael; Sticherling, Christian; Osswald, Stefan; Conen, David] Univ Basel, Univ Hosp Basel, Dept Med, Div Cardiol, Basel, Switzerland; [Eggimann, Lucien; Blum, Steffen; Aeschbacher, Stefanie; Reusser, Andreas; Mondet, Nadine; Kuhne, Michael; Sticherling, Christian; Osswald, Stefan; Conen, David] Univ Basel, Univ Hosp Basel, Cardiovasc Res Inst Basel, Basel, Switzerland; [Blum, Steffen] Univ Basel, Univ Hosp Basel, Dept Med, Div Internal Med, Basel, Switzerland; [Ammann, Peter] Kantonsspital, Div Cardiol, St Gallen, Switzerland; [Erne, Paul] Univ Hosp Basel, Dept Biomed, Lab Signal Transduct, Basel, Switzerland; [Moschovitis, Giorgio] Osped Reg Lugano, Div Cardiol, Ticino, Switzerland; [Di Valentino, Marcello] Osped San Giovanni Bellinzona, Div Cardiol, Ticino, Switzerland; [Shah, Dipen] Univ Hosp Geneva, Div Cardiol, Geneva, Switzerland; [Schlapfer, Jurg] Univ Hosp Lausanne, Serv Cardiol, Lausanne, Switzerland; [Conen, David] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada	University of Basel; University of Basel; University of Basel; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; University of Basel; Regional Hospital of Bellinzona & Valleys, San Giovanni; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); McMaster University; Population Health Research Institute	Conen, D (corresponding author), Univ Basel, Univ Hosp Basel, Dept Med, Div Cardiol, Basel, Switzerland.; Conen, D (corresponding author), Univ Basel, Univ Hosp Basel, Cardiovasc Res Inst Basel, Basel, Switzerland.; Conen, D (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.	conend@mcmaster.ca	Kühne, Michael/AAB-5202-2022; Aeschbacher, Stefanie/E-4935-2017; Osswald, Stefan/A-6904-2018; Sticherling, Christian/AAY-4435-2021	Kühne, Michael/0000-0002-2937-3711; Osswald, Stefan/0000-0002-9240-6731; Sticherling, Christian/0000-0001-8428-7050; /0000-0001-8134-2421	Swiss National Science Foundation; Swiss Heart Foundation; University of Basel; Boehringer Ingelheim; Sanofi-Aventis; Merck Sharp Dome; Bayer; Daiichi-Sankyo; Pfizer/Bristol-Myers Squibb	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Heart Foundation; University of Basel; Boehringer Ingelheim(Boehringer Ingelheim); Sanofi-Aventis(Sanofi-Aventis); Merck Sharp Dome; Bayer(Bayer AG); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Pfizer/Bristol-Myers Squibb(Bristol-Myers SquibbPfizer)	This study was supported by the Swiss National Science Foundation, the Swiss Heart Foundation, the University of Basel, Boehringer Ingelheim, Sanofi-Aventis, Merck Sharp & Dome, Bayer, Daiichi-Sankyo and Pfizer/Bristol-Myers Squibb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardestani A, 2010, AM J CARDIOL, V106, P369, DOI 10.1016/j.amjcard.2010.03.036; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Beinart R, 2014, J AM COLL CARDIOL, V64, P2111, DOI 10.1016/j.jacc.2014.08.039; Berger R, 2002, CIRCULATION, V105, P2392, DOI 10.1161/01.CIR.0000016642.15031.34; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; Bunch TJ, 2010, HEART RHYTHM, V7, P433, DOI 10.1016/j.hrthm.2009.12.004; Burger M, 2004, PREV MED, V39, P111, DOI 10.1016/j.ypmed.2003.11.011; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Cavender MA, 2015, CIRCULATION, V132, P923, DOI 10.1161/CIRCULATIONAHA.114.014796; Chen CY, 2012, CIRC J, V76, P2372, DOI 10.1253/circj.CJ-12-0040; Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659; Cox DR, 1972, J ROY STAT SOC B; De Bacquer D, 1998, J Cardiovasc Risk, V5, P177; Dunlay SM, 2009, J AM COLL CARDIOL, V54, P1695, DOI 10.1016/j.jacc.2009.08.019; Ellinor PT, 2005, J AM COLL CARDIOL, V45, P82, DOI 10.1016/j.jacc.2004.09.045; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fukuda T, 2007, CIRC J, V71, P308, DOI 10.1253/circj.71.308; Grodin JL, 2015, J AM COLL CARDIOL, V66, P659, DOI 10.1016/j.jacc.2015.06.007; Heo S, 2007, HEART LUNG, V36, P16, DOI 10.1016/j.hrtlng.2006.06.003; Hillege HL, 2006, CIRCULATION, V113, P671, DOI 10.1161/CIRCULATIONAHA.105.580506; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Imai K, 2014, INTERNAL MED, V53, P7, DOI 10.2169/internalmedicine.53.0962; Javaheri S, 2007, J AM COLL CARDIOL, V49, P2028, DOI 10.1016/j.jacc.2007.01.084; Krijthe BP, 2013, EUR HEART J, V34, P2746, DOI 10.1093/eurheartj/eht280; Lee DS, 2007, HYPERTENSION, V50, P869, DOI 10.1161/HYPERTENSIONAHA.107.095380; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin ER, 1998, NEW ENGL J MED, V339, P321; Lip GYH, 2015, EUR J HEART FAIL, V17, P570, DOI 10.1002/ejhf.254; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; McCallum L, 2013, HYPERTENSION, V62, P836, DOI 10.1161/HYPERTENSIONAHA.113.01793; Nieuwlaat R, 2007, AM HEART J, V153, P1006, DOI 10.1016/j.ahj.2007.03.008; Pandey A, 2017, JACC-HEART FAIL, V5, P44, DOI 10.1016/j.jchf.2016.09.016; Potpara TS, 2013, EUR J HEART FAIL, V15, P415, DOI 10.1093/eurjhf/hft004; Sandhu RK, 2016, EUR HEART J, V37, P2869, DOI 10.1093/eurheartj/ehw124; Santhanakrishnan R, 2016, CIRCULATION, V133, P484, DOI 10.1161/CIRCULATIONAHA.115.018614; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schnabel RB, 2013, EUR J HEART FAIL, V15, P843, DOI 10.1093/eurjhf/hft041; Schoen T, 2012, J AM COLL CARDIOL, V60, P1421, DOI 10.1016/j.jacc.2012.06.030; Steinberg BA, 2014, AM HEART J, V167, P735, DOI 10.1016/j.ahj.2014.02.003; Suzuki S, 2012, AM J CARDIOL, V110, P678, DOI 10.1016/j.amjcard.2012.04.049; Tedrow UB, 2010, J AM COLL CARDIOL, V55, P2319, DOI 10.1016/j.jacc.2010.02.029; Testani JM, 2016, EUR J HEART FAIL, V18, P660, DOI 10.1002/ejhf.477; Thihalolipavan S, 2015, PROG CARDIOVASC DIS, V58, P126, DOI 10.1016/j.pcad.2015.07.004; Wang J, 2014, INT J CARDIOL, V176, P1356, DOI 10.1016/j.ijcard.2014.07.264; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wozakowska-Kaplon B, 2004, AM J CARDIOL, V93, P1555, DOI 10.1016/j.amjcard.2004.03.013; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	49	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191736	10.1371/journal.pone.0191736	http://dx.doi.org/10.1371/journal.pone.0191736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394253	Green Submitted, Green Published, gold			2022-12-26	WOS:000424060400018
J	Calocer, F; Dejardin, O; Droulon, K; Launoy, G; Defer, G				Calocer, Floriane; Dejardin, Olivier; Droulon, Karine; Launoy, Guy; Defer, Gilles			Socio-economic status influences access to second-line disease modifying treatment in Relapsing Remitting Multiple Sclerosis patients	PLOS ONE			English	Article							DEPRIVATION INDEX; HEALTH; RISK; DIAGNOSIS; PEOPLE; CANCER; VALIDATION; CHILDHOOD; POSITION; OUTCOMES	Objective In MS, Socio-Economic status (SES) may influence healthcare and access to disease-modifying treatments (DMTs). Optimising delays to switch patients to a second-line DMT may hamper disease progression most effectively and achieve long term disease control. The objective of this study is to identify the influence of SES on the delay between first and second line DMT in RRMS patients, in Western-Normandy, France. Methods The association between SES and the delay to access a second-line DMT were studied using data from the MS registry of Western-Normandy including 733 patients with a diagnosis of RRMS during the period in question [1982 +/- 2011]. We used the European Deprivation Index (EDI), a score with a rank level inversely related to SES. We performed multivariate adjusted Cox models for studying EDI effect on the delay between first and second line DMT. Results No significant influence of SES was observed on delay to access a second-line DMT if firstline DMT exposure time was less than 5 years. After 5 years from initiation of first-line treatment the risk of accessing a second-line DMT is 3 times higher for patients with lower deprivation indices (1 st quintile of EDI) ([HR] 3.14 95% CI [1.72 +/- 5.72], p-value<0.001) compared to patients with higher values (EDI quintiles 2 to 5). Interpretation In RRMS, a high SES may facilitate access to a second-line DMT a few years after first-line DMT exposure. Greater consideration should also be given to the SES of MS patients as a risk factor in therapeutic healthcare issues throughout medical follow-up.	[Calocer, Floriane; Defer, Gilles] CHU Caen, Dept Neurol, Caen, France; [Calocer, Floriane; Defer, Gilles] Normandie Univ, UNICAEN, INSERM 1237, Physiopathol & Imaging Neurol Disorders, Caen, France; [Dejardin, Olivier; Launoy, Guy] CHU Caen, Pole Rech, Caen, France; [Dejardin, Olivier; Launoy, Guy] Normandie Univ, UNICAEN, INSERM 1086, ANTICIPE Canc & Prevent, Caen, France; [Droulon, Karine] Reseau Bas Normand SEP, Caen, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie	Calocer, F (corresponding author), CHU Caen, Dept Neurol, Caen, France.; Calocer, F (corresponding author), Normandie Univ, UNICAEN, INSERM 1237, Physiopathol & Imaging Neurol Disorders, Caen, France.	floriane.calocer@inserm.fr	Launoy, Guy/K-7372-2015; dejardin, olivier/L-9879-2015; DEFER, Gilles/AAM-4393-2020	dejardin, olivier/0000-0002-6561-1430; Calocer, Floriane/0000-0001-6021-7197	French State; Agence Nationale de la Recherche [ANR-10-COHO-002]; Reseau Bas-Normand pour la SEP; Regional Council of Normandy	French State; Agence Nationale de la Recherche(French National Research Agency (ANR)); Reseau Bas-Normand pour la SEP; Regional Council of Normandy(Region Normandie)	Floriane Calocer received a fellowship from the "Reseau Bas-Normand pour la SEP" and from the Regional Council of Normandy for carrying out this study. The Regional Council of Normandy had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The "Reseau BasNormand pour la SEP" had only a role in data collection.	Agardh EE, 2007, INT J EPIDEMIOL, V36, P84, DOI 10.1093/ije/dyl269; Allgar VL, 2005, BRIT J CANCER, V92, P1959, DOI 10.1038/sj.bjc.6602587; Beltran VM, 2011, PUBLIC HEALTH REP, V126, P41, DOI 10.1177/00333549111260S309; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Bjornevik K, 2016, MULT SCLER J, V22, P104, DOI 10.1177/1352458515579444; Buchanan RJ, 2006, NEUROREHABILITATION, V21, P177; Buchanan Robert J, 2006, J Health Hum Serv Adm, V29, P360; Burks J, 1998, J Spinal Cord Med, V21, P113; Cotton F, 2015, J NEURORADIOLOGY, V42, P133, DOI 10.1016/j.neurad.2014.12.001; Creange A, 2009, MULT SCLER, V15, P1085, DOI 10.1177/1352458509106710; De Saint Pol T, 2007, INSEE PREM, P4; Frier A, 2016, DISABIL REHABIL, P1; Goulden R, 2015, EUR J NEUROL, V22, P899, DOI 10.1111/ene.12586; GREENLAND S, 1989, INT J EPIDEMIOL, V18, P269, DOI 10.1093/ije/18.1.269; Halper J, 1994, NeuroRehabilitation, V4, P67, DOI 10.3233/NRE-1994-4203; IRDES, 2013, COUV COMPL SANT FRAN; KAMPF C, 2012, BMC PUBLIC HLTH, V10; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Marshall IJ, 2015, LANCET NEUROL, V14, P1206, DOI 10.1016/S1474-4422(15)00200-8; Minden SL, 2008, NEUROLOGY, V70, P1141, DOI 10.1212/01.wnl.0000306411.46934.ef; Minden SL, 2007, MULT SCLER J, V13, P547, DOI 10.1177/1352458506071306; Mustard CA, 1999, HEALTH PLACE, V5, P157, DOI 10.1016/S1353-8292(99)00008-8; Neal RD, 2015, BRIT J CANCER, V112, pS92, DOI 10.1038/bjc.2015.48; Nielsen NM, 2013, AM J EPIDEMIOL, V177, P1289, DOI 10.1093/aje/kws350; Noyes K, 2013, AM J MANAG CARE, V19, pS321; Owens T, 2013, EUR J HEALTH ECON, V14, P315, DOI 10.1007/s10198-012-0378-7; Pampalon R, 2014, CHRON DIS INJ CAN, V34, P12; Pornet C, 2012, J EPIDEMIOL COMMUN H, V66, P982, DOI 10.1136/jech-2011-200311; Qian WN, 2014, INT PSYCHOGERIATR, V26, P597, DOI 10.1017/S1041610213002299; Riise T, 2011, MULT SCLER J, V17, P780, DOI 10.1177/1352458510397686; Szaflarski M, 2014, EPILEPSY BEHAV, V41, P283, DOI 10.1016/j.yebeh.2014.06.013; Vohra J, 2016, J EPIDEMIOL COMMUN H, V70, P629, DOI 10.1136/jech-2015-206274; Willems S, 2005, PATIENT EDUC COUNS, V56, P139, DOI 10.1016/j.pec.2004.02.011; Ziemssen T, 2015, MULT SCLER RELAT DIS, V4, P460, DOI 10.1016/j.msard.2015.07.007	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191646	10.1371/journal.pone.0191646	http://dx.doi.org/10.1371/journal.pone.0191646			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29390025	Green Published, gold, Green Submitted			2022-12-26	WOS:000423793400025
J	Chen, CH; Xin, Y; Lee, KW; Lin, MJ; Lin, JJ				Chen, Che Hsiu; Xin, Ye; Lee, Kuang Wu; Lin, Ming Ju; Lin, Jiu Jenq			Acute effects of different dynamic exercises on hamstring strain risk factors	PLOS ONE			English	Article							PROPRIOCEPTIVE NEUROMUSCULAR FACILITATION; KNEE PROPRIOCEPTION; ISOKINETIC STRENGTH; PASSIVE PROPERTIES; SPINAL CURVATURES; MUSCLE; QUADRICEPS; POSITION; FLEXIBILITY; PERFORMANCE	The purpose of the study was to examine the acute effects of different dynamic exercise interventions on hamstring muscle performance. Thirty-six young men with poor hamstring flexibility were randomly assigned to three intervention groups: jogging combined with dynamic open kinetic chain stretching (DS), jogging combined with dynamic closed kinetic chain stretching (lunge with eccentric hamstring windmills, LEC), and jogging only (CON) groups. Hamstring flexibility, muscle stiffness (area under the curve, AUC), joint position sense (JPS), maximal eccentric strength (ECC), and angle of peak torque (APT) were recorded before and immediately after the exercise interventions. The results showed that the hamstring flexibility increased in DS (p < 0.001); muscle stiffness decreased in DS and was lower than jogging (p < 0.001). Moreover, ECC increased in LEC and was higher than jogging and DS (p < 0.001). APT was different among 3 groups (p < 0.001). Decreased accuracy of JPS was found in DS and jogging (p < 0.001). In conclusion, the dynamic closed kinetic chain stretching (LEC) as compared to open kinetic chain stretching (DS) or jogging group, may be an effective technique to enhance muscle performance during the pre-competition warm-up routine.	[Chen, Che Hsiu] Natl Taiwan Univ Sport, Dept Sport Performance, Taichung, Taiwan; [Chen, Che Hsiu; Lee, Kuang Wu] Univ Taipei, Grad Inst Sports Training, Taipei, Taiwan; [Xin, Ye] Univ Mississippi, Dept Hlth Exercise Sci & Recreat Management, University, MS 38677 USA; [Lin, Ming Ju] Natl Chiayi Univ, Dept Phys Educ, 85 Wenlong Village, Minsyong Township, Chiayi, Taiwan; [Lin, Jiu Jenq] Natl Taiwan Univ, Coll Med, Sch & Grad Inst Phys Therapy, Taipei, Taiwan	National Taiwan University of Sport; University of Taipei; University of Mississippi; National Chiayi University; National Taiwan University	Lin, JJ (corresponding author), Natl Taiwan Univ, Coll Med, Sch & Grad Inst Phys Therapy, Taipei, Taiwan.	jiujlin@ntu.edu.tw	lin, jiu jenq/H-4604-2014; Lin, Jiu/GRJ-5213-2022	lin, jiu jenq/0000-0001-9070-7939; 	Ministry of Science and Technology in Taiwan [101-2410-H-259-082]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	Funded by Ministry of Science and Technology in Taiwan (101-2410-H-259-082) to Che Hsiu Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarrestad DD, 2004, J CHILD NEUROL, V19, P894, DOI 10.1177/08830738040190110801; [Anonymous], 1988, J C STAT POWER ANAL; Avela J, 1999, J APPL PHYSIOL, V86, P1283, DOI 10.1152/jappl.1999.86.4.1283; Ayala F, 2013, J SPORT SCI, V31, P831, DOI 10.1080/02640414.2012.751119; Bartlett MJ, 2002, BRIT J SPORT MED, V36, P132, DOI 10.1136/bjsm.36.2.132; Batista LH, 2009, AM J PHYS MED REHAB, V88, P815, DOI 10.1097/PHM.0b013e3181b72149; Behm DG, 2011, APPL PHYSIOL NUTR ME, V36, P790, DOI [10.1139/h11-107, 10.1139/H11-107]; Behm DG, 2011, EUR J APPL PHYSIOL, V111, P2633, DOI 10.1007/s00421-011-1879-2; Bjorklund M, 2006, J ATHL TRAINING, V41, P270; Chen CH, 2013, J SPORT REHABIL, V22, P59, DOI 10.1123/jsr.22.1.59; Chen CH, 2011, MED SCI SPORT EXER, V43, P491, DOI 10.1249/MSS.0b013e3181f315ad; Costa PB, 2014, MED SCI SPORT EXER, V46, P586, DOI 10.1249/MSS.0000000000000138; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fletcher IM, 2007, J STRENGTH COND RES, V21, P784; Fletcher IM, 2010, EUR J APPL PHYSIOL, V109, P491, DOI 10.1007/s00421-010-1386-x; Gleim GW, 1997, SPORTS MED, V24, P291; Herda TJ, 2013, J SPORT SCI, V31, P479, DOI 10.1080/02640414.2012.736632; Larsen R, 2005, BRIT J SPORT MED, V39, P43, DOI 10.1136/bjsm.2003.011056; Lopez-Minarro PA, 2012, J HUM KINET, V31, P69, DOI 10.2478/v10078-012-0007-7; Magnusson SP, 1998, SCAND J MED SCI SPOR, V8, P65; Manoel ME, 2008, J STRENGTH COND RES, V22, P1528, DOI 10.1519/JSC.0b013e31817b0433; Muyor JM, 2016, J HUM KINET, V53, P23, DOI 10.1515/hukin-2016-0007; Muyor JM, 2011, J HUM KINET, V29, P15, DOI 10.2478/v10078-011-0035-8; Pacheco L, 2011, J STRENGTH COND RES, V25, P2991, DOI 10.1519/JSC.0b013e318212dac0; Sekir U, 2010, SCAND J MED SCI SPOR, V20, P268, DOI 10.1111/j.1600-0838.2009.00923.x; Streepey JW, 2010, J STRENGTH COND RES, V24, P1037, DOI 10.1519/JSC.0b013e3181d09e87; SULLIVAN MK, 1992, MED SCI SPORT EXER, V24, P1383; Thacker SB, 2004, MED SCI SPORT EXER, V36, P371, DOI 10.1249/01.MSS.0000117134.83018.F7; Thompsen AG, 2007, J STRENGTH COND RES, V21, P52, DOI 10.1519/00124278-200702000-00010; Torres R, 2010, INT J SPORTS MED, V31, P410, DOI 10.1055/s-0030-1248285; Watsford ML, 2010, AM J SPORT MED, V38, P2058, DOI 10.1177/0363546510370197; Witvrouw E, 2003, AM J SPORT MED, V31, P41, DOI 10.1177/03635465030310011801	32	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191801	10.1371/journal.pone.0191801	http://dx.doi.org/10.1371/journal.pone.0191801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390001	Green Published, gold, Green Submitted			2022-12-26	WOS:000423793400036
J	Suzuki, K; Nakashima, A; Igarashi, M; Saito, K; Konno, M; Yamazaki, N; Takimoto, H				Suzuki, Kengo; Nakashima, Ayaka; Igarashi, Masaharu; Saito, Keita; Konno, Makoto; Yamazaki, Noriyuki; Takimoto, Hiroaki			Euglena gracilis Z and its carbohydrate storage substance relieve arthritis symptoms by modulating Th17 immunity	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; COLLAGEN-INDUCED ARTHRITIS; IFN-GAMMA; II COLLAGEN; GM-CSF; RHEUMATOID-ARTHRITIS; INTERFERON-GAMMA; BETA-GLUCAN; MICE; PARAMYLON	Euglena gracilis Z is a microorganism classified as a microalga and is used as a food or nutritional supplement. Paramylon, the carbohydrate storage substance of E. gracilis Z, is reported to affect the immunological system. This study evaluated the symptom-relieving effects of E. gracilis Z and paramylon in rheumatoid arthritis in a collagen-induced arthritis mouse model. The efficacy of both substances was assessed based on clinical arthritis signs, as well as cytokine (interleukin [IL]-17, IL-6, and interferon [IFN]-gamma) levels in lymphoid tissues. Additionally, the knee joints were harvested and histopathologically examined. The results showed that both substances reduced the transitional changes in the visual assessment score of arthritis symptoms compared with those in the control group, indicating their symptom-relieving effects on rheumatoid arthritis. Furthermore, E. gracilis Z and paramylon significantly reduced the secretion of the cytokines, IL-17, IL-6, and IFN-gamma. The histopathological examination of the control group revealed edema, inflammation, cell hyperplasia, granulation tissue formation, fibrosis, and exudate in the synovial membrane, as well as pannus formation and articular cartilage destruction in the femoral trochlear groove. These changes were suppressed in both treatment groups. Particularly, the E. gracilis Z group showed no edema, inflammation, and fibrosis of the synovial membrane, or pannus formation and destruction of articular cartilage in the femoral trochlear groove. Furthermore, E. gracilis Z and paramylon exhibited symptom-relieving effects on rheumatoid arthritis and suppressed the secretion of cytokines IL-17, IL-6, and IFN-gamma. These effects were likely mediated by the regulatory activities of E. gracilis Z and paramylon on Th17 immunity. In addition, the symptom-relieving effects of both substances were comparable, which suggests that paramylon is the active component of Euglena gracilis Z.	[Suzuki, Kengo; Nakashima, Ayaka] Euglena Co Ltd, Minato Ku, Tokyo, Japan; [Igarashi, Masaharu; Saito, Keita; Konno, Makoto; Yamazaki, Noriyuki] New Drug Res Ctr Inc, Eniwa, Hokkaido, Japan; [Takimoto, Hiroaki] Kitasato Univ, Sch Sci, Dept Biosci, Minami Ku, Sagamihara, Kanagawa, Japan	Kitasato University	Takimoto, H (corresponding author), Kitasato Univ, Sch Sci, Dept Biosci, Minami Ku, Sagamihara, Kanagawa, Japan.	takimoto@sci.kitasato-u.ac.jp		Nakashima, Ayaka/0000-0001-7474-406X				[Anonymous], 2007, TRENDS GLYCOSCI GLYC, DOI DOI 10.4052/TIGG.19.195; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; BILLIAU A, 1988, J IMMUNOL, V140, P1506; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Chen JZ, 2013, ANTI-CANCER AGENT ME, V13, P725, DOI 10.2174/1871520611313050007; Chu CQ, 2003, ANN RHEUM DIS, V62, P983, DOI 10.1136/ard.62.10.983; CHUAH CT, 1983, MACROMOLECULES, V16, P1375, DOI 10.1021/ma00242a020; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; Criscione LG, 2002, CURR OPIN RHEUMATOL, V14, P204, DOI 10.1097/00002281-200205000-00002; Farooq SM, 2014, J CELL MOL MED, V18, P2512, DOI 10.1111/jcmm.12376; Farooq SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048635; Ferber IA, 1996, J IMMUNOL, V156, P5; Gathungu G, 2013, INFLAMM BOWEL DIS, V19, P1671, DOI 10.1097/MIB.0b013e318281f506; Haddad CS, 2016, AUTOIMMUNITY, V49, P298, DOI 10.1080/08916934.2016.1183657; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; KISS JZ, 1988, PROTOPLASMA, V146, P150, DOI 10.1007/BF01405924; KOIZUMI N, 1993, ANTIVIR RES, V21, P1, DOI 10.1016/0166-3542(93)90063-O; KONDO Y, 1992, J PHARMACOBIO-DYNAM, V15, P617, DOI 10.1248/bpb1978.15.617; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; ManourySchwartz B, 1997, J IMMUNOL, V158, P5501; Mansour MK, 2013, J BIOL CHEM, V288, P16043, DOI 10.1074/jbc.M113.473223; Masuda Y, 2013, INT J CANCER, V133, P108, DOI 10.1002/ijc.27999; Masuda Y, 2012, J LEUKOCYTE BIOL, V91, P547, DOI 10.1189/jlb.0711386; Nowak B, 2012, ARCH IMMUNOL THER EX, V60, P211, DOI 10.1007/s00005-012-0170-5; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024; Rossini M, 2013, ANN RHEUM DIS, V72, P409; Rowin J, 2012, MUSCLE NERVE, V46, P449, DOI 10.1002/mus.23488; Sakagami H, 1991, N DIMETHYLAMINO ETHY, V5, P101; Sato K., 2008, ALLERGOL INT, V27, P109; SEKI N, 1988, J IMMUNOL, V140, P1477; Shimada R, 2016, FOOD FUNCT, V7, P4655, DOI [10.1039/c6fo00606j, 10.1039/C6FO00606J]; Shinobe R, 2008, JPN J CLIN CHEM, V37, P53; Sugiyama A, 2010, J VET MED SCI, V72, P755, DOI 10.1292/jvms.09-0526; Tada R, 2009, IMMUNOL LETT, V123, P144, DOI 10.1016/j.imlet.2009.03.005; TAGUCHI T, 1983, ADV EXP MED BIOL, V166, P181; Taylor PC, 2003, CURR PHARM DESIGN, V9, P1095, DOI 10.2174/1381612033454991; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; Vermeire K, 1997, J IMMUNOL, V158, P5507; VOORTHUIS JAC, 1990, CLIN EXP IMMUNOL, V81, P183; Watanabe T, 2013, FOOD FUNCT, V4, P1685, DOI 10.1039/c3fo60256g; Widdifield J, 2013, ANN RHEUM DIS, V72, P549; Willenborg DO, 1996, J IMMUNOL, V157, P3223	47	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191462	10.1371/journal.pone.0191462	http://dx.doi.org/10.1371/journal.pone.0191462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389956	Green Published, Green Submitted, gold			2022-12-26	WOS:000423793400021
J	Wang, KH; Wang, YM; Chiu, LH; Chen, TC; Tsai, YH; Zuo, CS; Chen, KC; Changou, CA; Lai, WFT				Wang, Kuo-Hwa; Wang, Yung-Ming; Chiu, Li-Hsuan; Chen, Tze-Chien; Tsai, Yu-Hui; Zuo, Chun S.; Chen, Kuan-Chou; Changou, Chun Austin; Lai, Wen-Fu T.			Optical imaging of ovarian cancer using a matrix metalloproteinase-3-sensitive near-infrared fluorescent probe	PLOS ONE			English	Article							CELL INVASION; STROMELYSIN-1; PROGRESSION; EXPRESSION; GROWTH	Epithelial ovarian cancer (EOC) is the seventh most common cancer among women worldwide. The 5-year survival rate for women with EOC is only 30%-50%, which is largely due to the typically late diagnosis of this condition. EOC is difficult to detect in its early stage because of its asymptomatic nature. Recently, near-infrared fluorescent (NIRF) imaging has been developed as a potential tool for detecting EOC at the molecular level. In this study, a NIRF-sensitive probe was designed to detect matrix metalloproteinase (MMP) activity in ovarian cancer cells. A cyanine fluorochrome was conjugated to the amino terminus of a peptide substrate with enzymatic specificity for MMP-3. To analyze the novel MMP-3 probe, an in vivo EOC model was established by subcutaneously implanting SKOV3 cells, a serous-type EOC cell line, in mice. This novel MMP-3-sensitive probe specifically reacted with only the active MMP-3 enzyme, resulting in a significantly enhanced NIRF emission intensity. Histological analysis demonstrated that MMP-3 expression and activity were enhanced in the stromal cells surrounding the ovarian cancer cells. These studies establish a molecular imaging reporter for diagnosing early-stage EOC. Additional studies are required to confirm the early-stage activity of MMP-3 in EOC and its diagnostic and prognostic significance.	[Wang, Kuo-Hwa; Chen, Kuan-Chou] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Wang, Kuo-Hwa] Cheng Ching Hosp, Chung Kang Branch, Dept Obstet & Gynecol, Taichung, Taiwan; [Wang, Yung-Ming] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Chiu, Li-Hsuan; Zuo, Chun S.; Lai, Wen-Fu T.] Harvard Med Sch, McLean Hosp, McLean Imaging Ctr, Belmont, MA USA; [Chen, Tze-Chien] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Tsai, Yu-Hui; Lai, Wen-Fu T.] Taipei Med Univ, Shuang Ho Hosp, Dept Res, New Taipei, Taiwan; [Chen, Kuan-Chou] Taipei Med Univ, Shuang Ho Hosp, Dept Urol, New Taipei, Taiwan; [Changou, Chun Austin] Taipei Med Univ, Ctr Translat Med, PhD Program Canc Biol & Drug Discovery, Taipei, Taiwan; [Lai, Wen-Fu T.] Taipei Med Univ, Shuang Ho Hosp, Dept Dent, New Taipei, Taiwan	Taipei Medical University; National Yang Ming Chiao Tung University; Harvard University; McLean Hospital; Mackay Memorial Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital	Lai, WFT (corresponding author), Harvard Med Sch, McLean Hosp, McLean Imaging Ctr, Belmont, MA USA.; Lai, WFT (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Res, New Taipei, Taiwan.; Lai, WFT (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Dent, New Taipei, Taiwan.	laitw@tmu.edu.tw			Ministry of Science and Technology, Taiwan [MOST-103-2314-B-038-053, 104-2917-1-564-006]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by the Ministry of Science and Technology, Taiwan (MOST-103-2314-B-038-053 and 104-2917-1-564-006).	Banik D, 2015, ONCOTARGET, V6, P15164, DOI 10.18632/oncotarget.3897; Baruch A, 2004, TRENDS CELL BIOL, V14, P29, DOI 10.1016/j.tcb.2003.11.002; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Blum G, 2008, CURR OPIN DRUG DISC, V11, P708; Cao J, 2012, CONTRAST MEDIA MOL I, V7, P390, DOI 10.1002/cmmi.1464; Chakravarty D, 2011, CLIN CANCER RES, V17, P2250, DOI 10.1158/1078-0432.CCR-10-2718; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Choi JW, 2011, ONCOL LETT, V2, P1047, DOI 10.3892/ol.2011.391; Correia AL, 2013, GENE DEV, V27, P805, DOI 10.1101/gad.211383.112; Davidson B, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00104; Doufekas K, 2014, INT J WOMENS HEALTH, V6, P537, DOI 10.2147/IJWH.S40894; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fields GB, 2000, METH MOL B, V151, P495, DOI 10.1385/1-59259-046-2:495; Funovics M, 2003, ANAL BIOANAL CHEM, V377, P956, DOI 10.1007/s00216-003-2199-0; Hu XX, 2012, ARCH GYNECOL OBSTET, V286, P1537, DOI 10.1007/s00404-012-2456-6; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Kwon M, 2014, INT J CANCER, V135, P48, DOI 10.1002/ijc.28662; Lai WFT, 2004, OSTEOARTHR CARTILAGE, V12, P239, DOI 10.1016/j.joca.2003.11.005; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee S, 2008, ANGEW CHEM INT EDIT, V47, P2804, DOI 10.1002/anie.200705240; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; McCawley LJ, 2004, CANCER RES, V64, P6965, DOI 10.1158/0008-5472.CAN-04-0910; Mehner Christine, 2015, Genes Cancer, V6, P480; Nagase H, 1998, BIOL EXTRAC, P43; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Owen Jennifer L, 2004, Breast Dis, V20, P145; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Shimizu Y, 2014, NANOMED-NANOTECHNOL, V10, P187, DOI 10.1016/j.nano.2013.06.009; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Sun NX, 2014, TUMOR BIOL, V35, P11359, DOI 10.1007/s13277-014-2434-7; Weissleder R, 2002, NAT REV CANCER, V2, P11, DOI 10.1038/nrc701; Weissleder R, 2001, RADIOLOGY, V219, P316, DOI 10.1148/radiology.219.2.r01ma19316; WITTY JP, 1995, CANCER RES, V55, P1401; Yao DF, 2016, ACS APPL MATER INTER, V8, P5847, DOI 10.1021/acsami.5b11826; Yi XM, 2014, INT J NANOMED, V9, P1347, DOI 10.2147/IJN.S60206; Zhao HX, 2012, EXP MOL MED, V44, P633, DOI 10.3858/emm.2012.44.11.072	39	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192047	10.1371/journal.pone.0192047	http://dx.doi.org/10.1371/journal.pone.0192047			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390034	gold, Green Published, Green Submitted			2022-12-26	WOS:000423793400057
J	Just, S; Chenard, BL; Ceci, A; Strassmaier, T; Chong, JA; Blair, NT; Gallaschun, RJ; del Camino, D; Cantin, S; D'Amours, M; Eickmeier, C; Fanger, CM; Hecker, C; Hessler, DP; Hengerer, B; Kroker, KS; Malekiani, S; Mihalek, R; McLaughlin, J; Rast, G; Witek, J; Sauer, A; Pryce, CR; Moran, MM				Just, Stefan; Chenard, Bertrand L.; Ceci, Angelo; Strassmaier, Timothy; Chong, Jayhong A.; Blair, Nathaniel T.; Gallaschun, Randall J.; del Camino, Donato; Cantin, Susan; D'Amours, Marc; Eickmeier, Christian; Fanger, Christopher M.; Hecker, Carsten; Hessler, David P.; Hengerer, Bastian; Kroker, Katja S.; Malekiani, Sam; Mihalek, Robert; McLaughlin, Joseph; Rast, Georg; Witek, JoAnn; Sauer, Achim; Pryce, Christopher R.; Moran, Magdalene M.			Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice	PLOS ONE			English	Article							CHANNELS; BEHAVIOR; DEPRESSION; AMYGDALA; STRESS; BRAIN; HELPLESSNESS; SENSITIVITY; RESPONSES; SUBTYPE	Background Forty million adults in the US suffer from anxiety disorders, making these the most common forms of mental illness. Transient receptor potential channel canonical subfamily (TRPC) members 4 and 5 are non-selective cation channels highly expressed in regions of the cortex and amygdala, areas thought to be important in regulating anxiety. Previous work with null mice suggests that inhibition of TRPC4 and TRPC5 may have anxiolytic effects. HC-070 in vitro To assess the potential of TRPC4/5 inhibitors as an avenue for treatment, we invented a highly potent, small molecule antagonist of TRPC4 and TRPC5 which we call HC-070. HC-070 inhibits recombinant TRPC4 and TRPC5 homomultimers in heterologous expression systems with nanomolar potency. It also inhibits TRPC1/5 and TRPC1/4 heteromultimers with similar potency and reduces responses evoked by cholecystokinin tetrapeptide (CCK4) in the amygdala. The compound is >400-fold selective over a wide range of molecular targets including ion channels, receptors, and kinases. HC-070 in vivo Upon oral dosing in mice, HC-070 achieves exposure levels in the brain and plasma deemed sufficient to test behavioral activity. Treatment with HC-070 attenuates the anxiogenic effect of CCK-4 in the elevated plus maze (EPM). The compound recapitulates the phenotype observed in both null TRPC4 and TRPC5 mice in a standard EPM. Anxiolytic and anti-depressant effects of HC-070 are also observed in pharmacological in vivo tests including marble burying, tail suspension and forced swim. Furthermore, HC-070 ameliorates the increased fear memory induced by chronic social stress. A careful evaluation of the pharmacokinetic-pharmacodynamic relationship reveals that substantial efficacy is observed at unbound brain levels similar to, or even lower than, the 50% inhibitory concentration (IC50) recorded in vitro, increasing confidence that the observed effects are indeed mediated by TRPC4 and/or TRPC5 inhibition. Together, this experimental data set introduces a novel, high quality, small molecule antagonist of TRPC4 and TRPC5 containing channels and supports the targeting of TRPC4 and TRPC5 channels as a new mechanism of action for the treatment of psychiatric symptoms.	[Just, Stefan; Ceci, Angelo; Eickmeier, Christian; Hecker, Carsten; Hengerer, Bastian; Kroker, Katja S.; Rast, Georg; Sauer, Achim] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; [Chenard, Bertrand L.; Strassmaier, Timothy; Chong, Jayhong A.; Blair, Nathaniel T.; Gallaschun, Randall J.; del Camino, Donato; Cantin, Susan; D'Amours, Marc; Fanger, Christopher M.; Hessler, David P.; Malekiani, Sam; Mihalek, Robert; McLaughlin, Joseph; Witek, JoAnn; Moran, Magdalene M.] Hydra Biosci, Cambridge, MA 02138 USA; [Pryce, Christopher R.] Univ Zurich, Psychiat Hosp, Dept Psychiat Psychotherapy & Psychosomat, Preclin Lab Translat Res Affect Disorders, Zurich, Switzerland	Boehringer Ingelheim; University of Zurich	Moran, MM (corresponding author), Hydra Biosci, Cambridge, MA 02138 USA.	mmoran@hydrabiosciences.com	Sauer, Achim/ABG-6258-2020	Fanger, Christopher/0000-0002-8268-9053	Hydra Biosciences and Boehringer Ingelheim	Hydra Biosciences and Boehringer Ingelheim	The work presented here was funded by Hydra Biosciences and Boehringer Ingelheim. All authors performed work under the sponsorship of the companies or as full time employees for the companies.	Arnone D, 2012, AM J PSYCHIAT, V169, P841, DOI 10.1176/appi.ajp.2012.11121774; Azzinnari D, 2014, NEUROPHARMACOLOGY, V85, P328, DOI 10.1016/j.neuropharm.2014.05.039; Blair NT, 2009, J GEN PHYSIOL, V133, P525, DOI 10.1085/jgp.200810153; Chenard B., 2016, U.S. Patent, Patent No. [9,359,359, 9359359]; Chenard B. L., 2014, International patent, Patent No. [WO/2014/ 143799, 143799]; Di L, 2011, DRUG METAB DISPOS, V39, P1270, DOI 10.1124/dmd.111.038778; Dietrich Alexander, 2014, Cells, V3, P939, DOI 10.3390/cells3040939; Fowler MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000573; Fuertig R, 2016, BRAIN BEHAV IMMUN, V54, P59, DOI 10.1016/j.bbi.2015.12.020; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Harmer AR, 2011, BRIT J PHARMACOL, V164, P260, DOI 10.1111/j.1476-5381.2011.01415.x; HARRO J, 1991, EUR J PHARMACOL, V193, P379, DOI 10.1016/0014-2999(91)90156-K; Jeon JP, 2008, BIOCHEM BIOPH RES CO, V377, P538, DOI 10.1016/j.bbrc.2008.10.012; Kisselbach J, 2014, BRIT J PHARMACOL, V171, P5182, DOI 10.1111/bph.12596; Koenigsberg HW, 2014, AM J PSYCHIAT, V171, P82, DOI 10.1176/appi.ajp.2013.13070852; Lehto SG, 2008, J PHARMACOL EXP THER, V326, P218, DOI 10.1124/jpet.107.132233; Lehto SG, 2016, MOL PAIN, V12, DOI 10.1177/1744806916677761; Lucki I, 2001, PSYCHOPHARMACOLOGY, V155, P315, DOI 10.1007/s002130100694; Mandell D, 2014, J ABNORM PSYCHOL, V123, P35, DOI 10.1037/a0035834; Mazzone CM, 2016, MOL PSYCHIAT; McClintock SM, 2011, J CLIN PSYCHOPHARM, V31, P180, DOI 10.1097/JCP.0b013e31820ebd2c; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Miller M, 2011, J BIOL CHEM, V286, P33436, DOI 10.1074/jbc.M111.274167; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; Pryce CR, 2012, NEUROPHARMACOLOGY, V62, P358, DOI 10.1016/j.neuropharm.2011.08.012; Riccio A, 2014, J NEUROSCI, V34, P3653, DOI 10.1523/JNEUROSCI.2274-13.2014; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Rubaiy HN, 2017, J BIOL CHEM, V292, P8158, DOI 10.1074/jbc.M116.773556; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Smith DA, 2010, NAT REV DRUG DISCOV, V9, P929, DOI 10.1038/nrd3287; Storch U, 2012, J BIOL CHEM, V287, P3530, DOI 10.1074/jbc.M111.283218; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Thakur DP, 2016, P NATL ACAD SCI USA, V113, P1092, DOI 10.1073/pnas.1522294113; Woody ML, 2015, CURR OPIN PSYCHOL, V4, P6, DOI 10.1016/j.copsyc.2015.01.004; World Health Organization, 2014, PREV SUIC PREV SUIC; Yang LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136255	38	65	68	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191225	10.1371/journal.pone.0191225	http://dx.doi.org/10.1371/journal.pone.0191225			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385160	Green Published, gold, Green Accepted			2022-12-26	WOS:000423668400038
J	Petersson, F; Kilsgard, O; Shannon, O; Lood, R				Petersson, Frida; Kilsgard, Ola; Shannon, Oonagh; Lood, Rolf			Platelet activation and aggregation by the opportunistic pathogen Cutibacterium (Propionibacterium) acnes	PLOS ONE			English	Article							BIOFILM FORMATION; BACTERIA; PROTEINS; LOCALIZATION; ENDOCARDITIS; MECHANISMS; INFECTION; ADHESION; BINDING; PARVUM	Cutibacterium (Propionibacterium) acnes, considered a part of the skin microbiota, is one of the most commonly isolated anaerobic bacteria from medical implants in contact with plasma. However, the precise interaction of C. acnes with blood cells and plasma proteins has not been fully elucidated. Herein, we have investigated the molecular interaction of C. acnes with platelets and plasma proteins. We report that the ability of C. acnes to aggregate platelets is dependent on phylotype, with a significantly lower ability amongst type IB isolates, and the interaction of specific donor-dependent plasma proteins (or concentrations thereof) with C. acnes. Pretreatment of C. acnes with plasma reduces the lag time before aggregation demonstrating that pre-deposition of plasma proteins on C. acnes is an important step in platelet aggregation. Using mass spectrometry we identified several plasma proteins deposited on C. acnes, including IgG, fibrinogen and complement factors. Inhibition of IgG, fibrinogen or complement decreased C. acnes-mediated platelet aggregation, demonstrating the importance of these plasma proteins for aggregation. The interaction of C. acnes and platelets was visualized using fluorescence microscopy, verifying the presence of IgG and fibrinogen as components of the aggregates, and co-localization of C. acnes and platelets in the aggregates. Here, we have demonstrated the ability of C. acnes to activate and aggregate platelets in a bacterium and donor-specific fashion, as well as added mechanistic insights into this interaction.	[Petersson, Frida; Kilsgard, Ola; Shannon, Oonagh; Lood, Rolf] Lund Univ, Div Infect Med, Dept Clin Sci Lund, Lund, Sweden; [Kilsgard, Ola] Lund Univ, Fac Engn Lund, Dept Immunotechnol, Lund, Sweden	Lund University; Lund University	Lood, R (corresponding author), Lund Univ, Div Infect Med, Dept Clin Sci Lund, Lund, Sweden.	Rolf.Lood@med.lu.se		Shannon, Oonagh/0000-0001-8291-8189	Crafoord Foundation; Royal Physiographic Society in Lund; Swedish Society for Medicine; foundation of Thelma Zoega; foundation of Langmanska Kulturfonden; foundation of Sven and Dagmar Salen; foundation of Sigurd and Elsa Golje; foundation of Nanna Svartz; foundation of Lars Hierta	Crafoord Foundation; Royal Physiographic Society in Lund; Swedish Society for Medicine; foundation of Thelma Zoega; foundation of Langmanska Kulturfonden; foundation of Sven and Dagmar Salen; foundation of Sigurd and Elsa Golje; foundation of Nanna Svartz; foundation of Lars Hierta	This work was supported by funding from Crafoord Foundation (OS), The Royal Physiographic Society in Lund (OS, RL), the Swedish Society for Medicine (RL), and the foundations of Thelma Zoega, Langmanska Kulturfonden, Sven and Dagmar Salen, Sigurd and Elsa Golje, Nanna Svartz, and Lars Hierta (RL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann Y, 2014, CLIN MICROBIOL REV, V27, P419, DOI 10.1128/CMR.00092-13; Alexeyev OA, 2007, J CLIN MICROBIOL, V45, P3721, DOI 10.1128/JCM.01543-07; Allhorn M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36412; Alt E, 2004, CLIN HEMORHEOL MICRO, V30, P107; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; Aubin GG, 2014, MED MALADIES INFECT, V44, P241, DOI 10.1016/j.medmal.2014.02.004; Aubin GG, 2017, ANAEROBE, V47, P73, DOI 10.1016/j.anaerobe.2017.04.009; Aubin GG, 2017, SCI REP-UK, V7, DOI 10.1038/srep42918; Bensing BA, 2001, INFECT IMMUN, V69, P6186, DOI 10.1128/IAI.69.10.6186-6192.2001; Beynon RP, 2006, BMJ-BRIT MED J, V333, P334, DOI 10.1136/bmj.333.7563.334; Bhate K, 2013, BRIT J DERMATOL, V168, P474, DOI 10.1111/bjd.12149; Brennan MP, 2009, J THROMB HAEMOST, V7, P1364, DOI 10.1111/j.1538-7836.2009.03495.x; Brennan MP, 2004, BLOOD; Cederblad G, 2009, PATHOPHYSIOL HAEMO T, V6, P294; Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005; CLAWSON CC, 1975, AM J PATHOL, V81, P411; CLAWSON CC, 1973, AM J PATHOL, V70, P449; CLAWSON CC, 1971, AM J PATHOL, V65, P381; CLAWSON CC, 1971, AM J PATHOL, V65, P367; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Damgaard C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120826; Davies EV, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw015; Dekio I, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/151797; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Fischer N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/603046; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Florschutz AV, 2015, J SHOULDER ELB SURG, V24, P1296, DOI 10.1016/j.jse.2014.12.036; Furusawa H, 2012, RESPIR INVESTIG, V50, P104, DOI 10.1016/j.resinv.2012.07.001; Grange PA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06940-3; Holmberg A, 2009, CLIN MICROBIOL INFEC, V15, P787, DOI 10.1111/j.1469-0691.2009.02747.x; Johansson BP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001692; Johansson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026928; JONES PDE, 1977, BRIT J CANCER, V36, P777, DOI 10.1038/bjc.1977.261; Kerrigan SW, 2010, CELL MOL LIFE SCI, V67, P513, DOI 10.1007/s00018-009-0207-z; Kumaran D, 2014, VOX SANG, V107, P188, DOI 10.1111/vox.12141; Lheure C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167237; Lomholt HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012277; Lood R, 2015, FUTURE MICROBIOL, V10, P1659, DOI 10.2217/fmb.15.89; Lood R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-198; Lood R, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-139; McDowell A, 2005, J CLIN MICROBIOL, V43, P326, DOI 10.1128/JCM.43.1.326-334.2005; McDowell A, 2016, INT J SYST EVOL MICR, V66, P5358, DOI 10.1099/ijsem.0.001521; MITCHESON HD, 1980, BRIT J CANCER, V41, P117, DOI 10.1038/bjc.1980.13; Murphy WG, 2008, VOX SANG, V95, P13, DOI 10.1111/j.1423-0410.2008.01051.x; OBrien L, 2002, MOL MICROBIOL, V44, P1033, DOI 10.1046/j.1365-2958.2002.02935.x; Paugam C, 2017, J EUR ACAD DERMATOL, V31, pE406, DOI 10.1111/jdv.14206; Perry AL, 2006, LETT APPL MICROBIOL, V42, P185, DOI 10.1111/j.1472-765X.2006.01866.x; Rasmussen M, 2010, MICROBES INFECT, V12, P295, DOI 10.1016/j.micinf.2010.01.005; Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200; Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551; Sampedro MF, 2009, DIAGN MICR INFEC DIS, V64, P138, DOI 10.1016/j.diagmicrobio.2009.01.024; Scholz CFP, 2016, INT J SYST EVOL MICR, V66, P4422, DOI 10.1099/ijsem.0.001367; Scholz CFP, 2016, SCI REP-UK, V6, DOI 10.1038/srep20662; Scholz CFP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104199; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Seo HS, 2011, INFECT IMMUN, V79, P3518, DOI 10.1128/IAI.05088-11; Severi G, 2010, BRIT J CANCER, V103, P411, DOI 10.1038/sj.bjc.6605757; Shannon BA, 2008, BJU INT, V101, P429, DOI 10.1111/j.1464-410X.2007.07214.x; Shannon O, 2010, INFECT IMMUN, V78, P4268, DOI 10.1128/IAI.00469-10; Svensson L, 2014, INFECT IMMUN, V82, P4307, DOI 10.1128/IAI.02020-14; Talib WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124384; Tomida S, 2013, MBIO, V4, DOI 10.1128/mBio.00003-13; Tsuda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029020; Valanne S, 2005, MICROBIOL-SGM, V151, P1369, DOI 10.1099/mic.0.27788-0; van Valen R, 2016, INTERACT CARDIOV TH, V23, P150, DOI 10.1093/icvts/ivw087; von Pawel-Rammingen U, 2003, CURR OPIN MICROBIOL, V6, P50, DOI 10.1016/S1369-5274(03)00003-1; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; WEBSTER GF, 1985, INFECT IMMUN, V49, P116, DOI 10.1128/IAI.49.1.116-121.1985; Yeaman MR, 2010, CELL MOL LIFE SCI, V67, P525, DOI 10.1007/s00018-009-0210-4; Yeaman MR, 1997, CLIN INFECT DIS, V25, P951, DOI 10.1086/516120; Yu Y, 2016, J INVEST DERMATOL; Zeller V, 2007, J INFECTION, V55, P119, DOI 10.1016/j.jinf.2007.02.006	74	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0192051	10.1371/journal.pone.0192051	http://dx.doi.org/10.1371/journal.pone.0192051			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385206	Green Published, Green Submitted, gold			2022-12-26	WOS:000423668400073
J	Prechtel, H; Hartmann, S; Mingecurrency, D; Bahring, R				Prechtel, Helena; Hartmann, Sven; Mingecurrency, Daniel; Baehring, Robert			Somatodendritic surface expression of epitope-tagged and KChIP binding-deficient Kv4.2 channels in hippocampal neurons	PLOS ONE			English	Article							CA1 PYRAMIDAL NEURONS; TEMPORAL-LOBE EPILEPSY; LONG-TERM POTENTIATION; POTASSIUM CHANNELS; K+ CHANNELS; DOWN-REGULATION; ALPHA-SUBUNITS; DENDRITIC EXCITABILITY; ALTERED EXPRESSION; STATUS EPILEPTICUS	Kv4.2 channels mediate a subthreshold-activating somatodendritic A-type current (I-SA) in hippocampal neurons. We examined the role of accessory Kv channel interacting protein (KChIP) binding in somatodendritic surface expression and activity-dependent decrease in the availability of Kv4.2 channels. For this purpose we transfected cultured hippocampal neurons with cDNA coding for Kv4.2 wild-type (wt) or KChIP binding-deficient Kv4.2 mutants. All channels were equipped with an externally accessible hemagglutinin (HA)-tag and an EGFP-tag, which was attached to the C-terminal end. Combined analyses of EGFP self-fluorescence, surface HA immunostaining and patch-clamp recordings demonstrated similar dendritic trafficking and functional surface expression for Kv4.2[wt (HA, EGFP) and the KChIP binding-deficient Kv4.2[A14K](HA, EGFP). Coexpression of exogenous KChIP2 augmented the surface expression of Kv4.2[wt](HA, EGFP) but not Kv4.2[A14K](HA, EGFP). Notably, activity-dependent decrease in availability was more pronounced in Kv4.2[wt] HA, EGFP + KChIP2 coexpressing than in Kv4.2[A14K](HA, EGFP) + KChIP2 coexpressing neurons. Our results do not support the notion that accessory KChIP binding is a prerequisite for dendritic trafficking and functional surface expression of Kv4.2 channels, however, accessory KChIP binding may play a potential role in Kv4.2 modulation during intrinsic plasticity processes.	[Prechtel, Helena; Hartmann, Sven; Mingecurrency, Daniel; Baehring, Robert] Univ Klinikum Hamburg Eppendorf, Inst Zellulare & Integrat Physiol, Zentrum Expt Med, Hamburg, Germany; [Mingecurrency, Daniel] Rhein Friedrich Wilhelms Univ, Inst Zellulare Neurowissensch, Bonn, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn	Bahring, R (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Zellulare & Integrat Physiol, Zentrum Expt Med, Hamburg, Germany.	r.baehring@uke.de		Bahring, Robert/0000-0002-0406-5958	Deutsche Forschungsgemeinschaft [SFB444-A8, BA2055/4-1]; Deutsche Forschungsgemeinschaft (DFG) [SFB444-A8, BA2055/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants SFB444-A8 and BA2055/4-1 from the Deutsche Forschungsgemeinschaft (http://www.dfg.de/) to RB.; We thank Michaela Schweizer and Frank Heisler (Zentrum fur Molekulare Neurobiologie Hamburg) for preparing hippocampal primary cultures. This work was supported by grants SFB444-A8 and BA2055/4-1 from the Deutsche Forschungsgemeinschaft (DFG).	Alonso G, 1997, NEUROSCIENCE, V77, P617; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; BANKER GA, 1979, J COMP NEUROL, V187, P469, DOI 10.1002/cne.901870302; Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Callsen B, 2005, J PHYSIOL-LONDON, V568, P397, DOI 10.1113/jphysiol.2005.094359; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Chu PJ, 2006, J BIOL CHEM, V281, P365, DOI 10.1074/jbc.M508897200; Cui YY, 2008, NEUROCHEM RES, V33, P2078, DOI 10.1007/s11064-008-9688-7; Foeger NC, 2012, J BIOL CHEM, V287, P9640, DOI 10.1074/jbc.M111.324574; Foeger NC, 2010, J BIOL CHEM, V285, P33413, DOI 10.1074/jbc.M110.145185; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Groen C, 2017, PFLUG ARCH EUR J PHY, V469, P1457, DOI 10.1007/s00424-017-2039-2; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Hammond RS, 2008, J NEUROSCI, V28, P7513, DOI 10.1523/JNEUROSCI.1951-08.2008; Hasdemir B, 2005, J CELL BIOL, V171, P459, DOI 10.1083/jcb.200506005; Hatano N, 2002, PFLUG ARCH EUR J PHY, V444, P80, DOI 10.1007/s00424-002-0798-9; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1999, J NEUROPHYSIOL, V81, P408, DOI 10.1152/jn.1999.81.1.408; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Holmqvist MH, 2002, P NATL ACAD SCI USA, V99, P1035, DOI 10.1073/pnas.022509299; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; Jensen CS, 2014, J BIOL CHEM, V289, P10566, DOI 10.1074/jbc.M113.534495; Jinno S, 2005, NEUROSCIENCE, V134, P483, DOI 10.1016/j.neuroscience.2005.04.065; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Kunjilwar K, 2004, J BIOL CHEM, V279, P54542, DOI 10.1074/jbc.M409721200; Lei ZG, 2008, J NEUROCHEM, V106, P182, DOI 10.1111/j.1471-4159.2008.05356.x; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Lin L, 2011, J NEUROSCI, V31, P1323, DOI 10.1523/JNEUROSCI.5383-10.2011; Lugo JN, 2008, J NEUROCHEM, V106, P1929, DOI 10.1111/j.1471-4159.2008.05508.x; Maffie J, 2008, J PHYSIOL-LONDON, V586, P5609, DOI 10.1113/jphysiol.2008.161620; Maue RA, 2007, J CELL PHYSIOL, V213, P618, DOI 10.1002/jcp.21259; Menegola M, 2006, J NEUROSCI, V26, P12137, DOI 10.1523/JNEUROSCI.2783-06.2006; Moise L, 2010, CHANNELS, V4, P115, DOI 10.4161/chan.4.2.10878; Monaghan MM, 2008, NEUROSCIENCE, V156, P550, DOI 10.1016/j.neuroscience.2008.07.057; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Nestor MW, 2012, HIPPOCAMPUS, V22, P969, DOI 10.1002/hipo.20899; Norris AJ, 2010, J NEUROSCI, V30, P13644, DOI 10.1523/JNEUROSCI.2487-10.2010; Norris AJ, 2010, J NEUROSCI, V30, P5092, DOI 10.1523/JNEUROSCI.5890-09.2010; Patel SP, 2005, J PHYSIOL-LONDON, V569, P7, DOI 10.1113/jphysiol.2005.086223; Petrecca K, 2000, J NEUROSCI, V20, P8736; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; Ren XM, 2005, MOL CELL NEUROSCI, V29, P320, DOI 10.1016/j.mcn.2005.02.003; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Rizwan AP, 2016, J NEUROSCI, V36, P11196, DOI 10.1523/JNEUROSCI.2051-16.2016; Rosati B, 2001, J PHYSIOL-LONDON, V533, P119, DOI 10.1111/j.1469-7793.2001.0119b.x; Schrader LA, 2002, J NEUROSCI, V22, P10123; Seikel E, 2009, BIOCHEMISTRY-US, V48, P5721, DOI 10.1021/bi802316m; SERODIO P, 1994, J NEUROPHYSIOL, V72, P1516, DOI 10.1152/jn.1994.72.4.1516; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; STORM JF, 1990, PROG BRAIN RES, V83, P161; Su T, 2008, NEUROSCIENCE, V157, P566, DOI 10.1016/j.neuroscience.2008.09.027; Sun W, 2011, NEURON, V71, P1102, DOI 10.1016/j.neuron.2011.08.008; TSAUR ML, 1992, NEURON, V8, P1055, DOI 10.1016/0896-6273(92)90127-Y; Wang HG, 2013, J BIOL CHEM, V288, P13258, DOI 10.1074/jbc.M112.434548; Witzel K, 2012, NEUROPHARMACOLOGY, V63, P1389, DOI 10.1016/j.neuropharm.2012.08.017; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002; Yuste R, 1997, NATURE, V387, P851, DOI 10.1038/43063; Zagha E, 2005, J BIOL CHEM, V280, P18853, DOI 10.1074/jbc.M410613200	63	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191911	10.1371/journal.pone.0191911	http://dx.doi.org/10.1371/journal.pone.0191911			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385176	gold, Green Published, Green Submitted			2022-12-26	WOS:000423668400061
J	Li, FH; Liu, ZW; Tang, CY; Cai, J; Dong, Z				Li, Fanghua; Liu, Zhiwen; Tang, Chengyuan; Cai, Juan; Dong, Zheng			FGF21 is induced in cisplatin nephrotoxicity to protect against kidney tubular cell injury	FASEB JOURNAL			English	Article						acute kidney injury; apoptosis; P53	CHEMICALLY-INDUCED HEPATOCARCINOGENESIS; FIBROBLAST GROWTH FACTOR-21; SERUM-LEVELS; P53; APOPTOSIS; MICE; ACTIVATION; AKI; MECHANISMS; SIGNAL	Cisplatin, a widely used cancer therapy drug, induces nephrotoxicity or acute kidney injury (AKI), but the underlying mechanism remains unclear, and renal protective approaches are not available. Fibroblast growth factor (FGF)21 is an endocrine factor that regulates glucose uptake, metabolism, and energy expenditure. However, recent work has also implicated FGF21 in cellular stress response under pathogenic conditions. The role and regulation of FGF21 in AKI are unclear. Here, we show that FGF21 was dramatically induced during cisplatin treatment of renal tubular cells in vitro and mouse kidneys in vivo. The inductive response was suppressed by pifithrin (a pharmacological inhibitor of P53), suggesting a role of P53 in FGF21 induction. In cultured renal tubular cells, knockdown of FGF21 aggravated cisplatin-induced apoptosis, whereas supplementation of recombinant FGF21 was protective. Consistently, recombinant FGF21 alleviated cisplatin-induced kidney dysfunction, tissue damage, and tubular apoptosis in mice. Mechanistically, FGF21 suppressed P53 induction and activation during cisplatin treatment. Together, these results indicate that FGF21 is induced during cisplatin nephrotoxicity to protect renal tubules, and recombinant FGF21 may have therapeutic potential.	[Li, Fanghua; Liu, Zhiwen; Tang, Chengyuan; Cai, Juan; Dong, Zheng] Cent S Univ, Xiangya Hosp 2, Dept Nephrol, Changsha 410011, Hunan, Peoples R China; [Dong, Zheng] Augusta Univ, Med Coll Georgia, Dept Cellular Biol & Anat, 1459 Laney Walker Blvd, Augusta, GA 30912 USA; [Dong, Zheng] Charlie Norwood Vet Affairs Med Ctr, 1459 Laney Walker Blvd, Augusta, GA 30912 USA	Central South University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Tang, CY (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Nephrol, Changsha 410011, Hunan, Peoples R China.; Dong, Z (corresponding author), Augusta Univ, Med Coll Georgia, Dept Cellular Biol & Anat, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.; Dong, Z (corresponding author), Charlie Norwood Vet Affairs Med Ctr, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	tangchengyuan@csu.edu.cn; zdong@augusta.edu			National Natural Science Foundation of China [81720108008, 81430017]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK58831, DK87843]; U.S. Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058831, R01DK087843] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Jinke Cheng (Shanghai Jiao Tong University School of Medicine, Shanghai, China) for providing the FGF21 shRNA plasmids. This work was supported by the National Natural Science Foundation of China (Grants 81720108008 and 81430017), by the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Grants DK58831, DK87843), and by the U.S. Department of Veterans Affairs. The authors declare no conflicts of interest.	Adams AC, 2012, CURR DIABETES REV, V8, P285, DOI 10.2174/157339912800840505; Agarwal A, 2016, J AM SOC NEPHROL, V27, P1288, DOI 10.1681/ASN.2015070740; Basile DP, 2016, J AM SOC NEPHROL, V27, P687, DOI 10.1681/ASN.2015030309; Bhatt K, 2010, MOL MED, V16, P409, DOI 10.2119/molmed.2010.00002; Chen JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep38868; Feingold KR, 2012, ENDOCRINOLOGY, V153, P2689, DOI 10.1210/en.2011-1496; Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339; Han SH, 2010, METABOLISM, V59, P1656, DOI 10.1016/j.metabol.2010.03.018; Hao JL, 2017, KIDNEY INT, V91, P106, DOI 10.1016/j.kint.2016.07.017; Hindricks J, 2014, CLIN ENDOCRINOL, V80, P918, DOI 10.1111/cen.12380; Huang XQ, 2006, MOL CARCINOGEN, V45, P934, DOI 10.1002/mc.20241; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Jiang M, 2004, AM J PHYSIOL-RENAL, V287, pF1140, DOI 10.1152/ajprenal.00262.2004; Jiang M, 2008, J PHARMACOL EXP THER, V327, P300, DOI 10.1124/jpet.108.139162; Kim HW, 2013, ENDOCRINOLOGY, V154, P3366, DOI 10.1210/en.2012-2276; Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915; Lin ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018398; Linkermann A, 2014, J AM SOC NEPHROL, V25, P2689, DOI 10.1681/ASN.2014030262; Livingston MJ, 2016, AUTOPHAGY, V12, P976, DOI 10.1080/15548627.2016.1166317; Loeffler I, 2011, J AM SOC NEPHROL, V22, P649, DOI 10.1681/ASN.2010010098; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Pabla N, 2011, J CLIN INVEST, V121, P2709, DOI 10.1172/JCI45586; Planavila A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3019; Rusu CC, 2017, INT UROL NEPHROL, V49, P517, DOI 10.1007/s11255-016-1474-x; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; Sharp CN, 2016, AM J PHYSIOL-RENAL, V310, pF560, DOI 10.1152/ajprenal.00512.2015; Stein S, 2009, DIABETES CARE, V32, P126, DOI 10.2337/dc08-1054; Torres R, 2016, J AM SOC NEPHROL, V27, P1102, DOI 10.1681/ASN.2015010079; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wei QQ, 2007, AM J PHYSIOL-RENAL, V293, pF1282, DOI 10.1152/ajprenal.00230.2007; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Xu PF, 2015, DIGEST DIS SCI, V60, P3032, DOI 10.1007/s10620-015-3711-z; Yan MJ, 2016, TOXICOL APPL PHARM, V313, P104, DOI 10.1016/j.taap.2016.10.022; Yang CF, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-67; Ye DW, 2014, HEPATOLOGY, V60, P977, DOI 10.1002/hep.27060; Yu YH, 2015, MOL CELL BIOCHEM, V403, P287, DOI 10.1007/s11010-015-2358-6; Zhang C, 2015, DIABETOLOGIA, V58, P1937, DOI 10.1007/s00125-015-3630-8; Zhang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082275; Zhang DS, 2014, J AM SOC NEPHROL, V25, P2278, DOI 10.1681/ASN.2013080902	40	21	22	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3423	3433		10.1096/fj.201701316R	http://dx.doi.org/10.1096/fj.201701316R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401620	Green Published			2022-12-26	WOS:000432546000042
J	Li, Y; Cui, T; Kong, XD; Yi, XL; Kong, DX; Zhang, JN; Liu, CX; Gong, M				Li, Ying; Cui, Tao; Kong, Xiaodong; Yi, Xiulin; Kong, Dexin; Zhang, Jianning; Liu, Changxiao; Gong, Min			Nanoparticles induced by embedding self-assembling cassette into glucagon-like peptide 1 for improving in vivo stability	FASEB JOURNAL			English	Article						GLP-1; self-assembling peptide; type 2 diabetes mellitus; self-assembling GLP-1	AMINO-ACID-SEQUENCE; SIRNA DELIVERY; MECHANICAL-PROPERTIES; SYSTEMATIC VARIATION; OLIGOPEPTIDE MATRIX; CELL-PROLIFERATION; INSULIN-SECRETION; 7-36 AMIDE; GLP-1; PANCREAS	The multiple physiologic characteristics of glucagon-like peptide 1 (GLP-1) make it a promising drug candidate for treating type 2 diabetes mellitus. However, the half-life of GLP-1 is short as a result of degradation by dipeptidyl peptidase IV and renal clearance. Stabilizing GLP-1 is therefore critical for its use in drug development. Self-assembling peptides are a class of peptides that undergo spontaneous assembly into ordered nanostructures. Recently, studies of self-assembling peptides as drug carriers have increased because of their enhanced stability. In the present study, GLP-1 was modified to incorporate the structural characteristics of self-assembling peptides aiming to generate a self-assembling GLP-1 derivative. Receptor binding capacity and insulinotropic effects were measured to investigate the physiologic functions of GLP-1, along with morphologic approaches to observe supramolecular formation on self-assembly at the nano scale. Finally, blood glucose regulation and body weight were monitored after administration of selected derivatives. Our findings revealed that cadyglple and cadyglp1m both exhibited improved stability even though different nanoshapes were observed for these two self-assembling peptides. Both cadyglple and cadyglp1m retained glucoregulatory activity after insulin stimulation and were potent drug candidates for long-acting GLP-1 derivatives to treat type 2 diabetes mellitus. Our findings support the feasibility of introducing self-assembly functions into peptides with poor stabilities, such as GLP-1.	[Li, Ying; Kong, Xiaodong; Zhang, Jianning] Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Tianjin, Peoples R China; [Cui, Tao; Liu, Changxiao] Tianjin Univ Tradit Chinese Med, Tianjin, Peoples R China; [Yi, Xiulin] Tianjin Inst Pharmaceut Res, State Key Lab Drug Delivery Technol & Pharmacokin, Tianjin, Peoples R China; [Kong, Dexin; Gong, Min] Tianjin Med Univ, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin, Peoples R China	Tianjin Medical University; Tianjin University of Traditional Chinese Medicine; Tianjin Medical University	Zhang, JN (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Tianjin, Peoples R China.; Gong, M (corresponding author), Tianjin Med Univ, Tianjin Inst Pharmaceut Res, 22 Qixiangtai Rd, Tianjin 300060, Peoples R China.	kahongmg@163.com; gongmin@tmu.edu.cn			National Science and Technology Major Project of the Ministry of Science and Technology of China [2014ZX09507005-003]; National Natural Science Funding [81400932, 81771221]; Major Project of Science and Technology of Tianjin [13RCGFSY19700]; Natural Science Foundation of Tianjin [12JCYBJC31500]; Science and Technology of Tianjin [15JCBJC50500]	National Science and Technology Major Project of the Ministry of Science and Technology of China; National Natural Science Funding(National Natural Science Foundation of China (NSFC)); Major Project of Science and Technology of Tianjin; Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Science and Technology of Tianjin	The authors thank Newman Gong (Tianjun Medical University) for his kind support in the data storage. This study was supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China (2014ZX09507005-003), the National Natural Science Funding (81400932 and 81771221), the Major Project of Science and Technology of Tianjin (13RCGFSY19700), the Natural Science Foundation of Tianjin (12JCYBJC31500), and Science and Technology of Tianjin (15JCBJC50500). The authors declare no conflicts of interest.	ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Al-Sabah S, 2003, BRIT J PHARMACOL, V140, P339, DOI 10.1038/sj.bjp.0705453; Brubaker PL, 2004, ENDOCRINOLOGY, V145, P2653, DOI 10.1210/en.2004-0015; Caplan MR, 2002, J BIOMAT SCI-POLYM E, V13, P225, DOI 10.1163/156856202320176493; Caplan MR, 2002, BIOMATERIALS, V23, P219, DOI 10.1016/S0142-9612(01)00099-0; Crombez L, 2011, METHODS MOL BIOL, V683, P349, DOI [10.1007/978-1-60751-919-2_25, 10.1007/978-1-60761-919-2_25]; Crombez L, 2009, MOL THER, V17, P95, DOI 10.1038/mt.2008.215; Davidson Jaime A, 2009, Cleve Clin J Med, V76 Suppl 5, pS28, DOI 10.3949/ccjm.76.s5.05; Deshayes S, 2012, SMALL, V8, P2184, DOI 10.1002/smll.201102413; Dhadwar SS, 2003, BIOTECHNOL ADV, V21, P395, DOI 10.1016/S0734-9750(03)00056-9; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; Fernandez-Carneado J, 2004, BIOPOLYMERS, V76, P196, DOI 10.1002/bip.10585; Galdiero M, 2012, CURR DRUG METAB, V13, P2, DOI 10.2174/138920012798356925; GALLWITZ B, 1994, EUR J BIOCHEM, V225, P1151, DOI 10.1111/j.1432-1033.1994.1151b.x; Graziano MP, 1996, RECEPTOR CHANNEL, V4, P9; Hui HX, 2005, DIABETES-METAB RES, V21, P313, DOI 10.1002/dmrr.553; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; KREYMANN B, 1987, LANCET, V2, P1300; Kurzawa L, 2010, BBA-BIOMEMBRANES, V1798, P2274, DOI 10.1016/j.bbamem.2010.02.027; Leon EJ, 1998, J BIOMAT SCI-POLYM E, V9, P297, DOI 10.1163/156856298X00668; Li Y, 2012, INT J PHARMACEUT, V434, P209, DOI 10.1016/j.ijpharm.2012.06.003; Liang J, 2014, COLLOID SURFACE B, V114, P398, DOI 10.1016/j.colsurfb.2013.10.037; Lugari R, 2000, HORM METAB RES, V32, P424, DOI 10.1055/s-2007-978665; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Nauck MA, 1997, EXP CLIN ENDOCR DIAB, V105, P187, DOI 10.1055/s-0029-1211750; OHNEDA A, 1991, TOHOKU J EXP MED, V165, P209, DOI 10.1620/tjem.165.209; Okerson T, 2012, CARDIOVASC THER, V30, pe146, DOI 10.1111/j.1755-5922.2010.00256.x; Parhofer Klaus G, 2007, MMW Fortschr Med, V149, P41; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; RUIZGRANDE C, 1990, CAN J PHYSIOL PHARM, V68, P1568, DOI 10.1139/y90-239; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g; SHIMA K, 1988, REGUL PEPTIDES, V22, P245, DOI 10.1016/0167-0115(88)90037-7; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Villanueva-Penacarrillo ML, 2001, ENDOCRINE, V15, P241, DOI 10.1385/ENDO:15:2:241; Wassenaar TA, 2014, J CHEM THEORY COMPUT, V10, P676, DOI 10.1021/ct400617g; WEIR GC, 1989, DIABETES, V38, P338, DOI 10.2337/diabetes.38.3.338; YAMATO E, 1990, BIOCHEM BIOPH RES CO, V167, P431, DOI 10.1016/0006-291X(90)92041-W; Yang X, 2014, MOL PHARMACEUT, V11, P4092, DOI 10.1021/mp5002685; Zhang SG, 1997, P NATL ACAD SCI USA, V94, P23, DOI 10.1073/pnas.94.1.23	41	9	10	5	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					2992	3004		10.1096/fj.201701033RRR	http://dx.doi.org/10.1096/fj.201701033RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401602				2022-12-26	WOS:000432546000009
J	Yang, YX; Qi, Q; Wang, Y; Shi, YR; Yang, WL; Cen, YZ; Zhu, ED; Li, XX; Chen, D; Wang, BL				Yang, Yongxu; Qi, Qi; Wang, Yi; Shi, Yaru; Yang, Weili; Cen, Yunzhu; Zhu, Endong; Li, Xiaoxia; Chen, Di; Wang, Baoli			Cysteine-rich protein 61 regulates adipocyte differentiation from mesenchymal stem cells through mammalian target of rapamycin complex 1 and canonical Wnt signaling	FASEB JOURNAL			English	Article						adipogenesis; Wnt/beta-catenin; ribosomal protein S6	IMMEDIATE-EARLY GENE; ADIPOGENIC DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; WNT/BETA-CATENIN; ADIPOSE-TISSUE; CCN FAMILY; IN-VITRO; EXPRESSION; CYR61; GROWTH	Emerging evidence suggests that cysteine-rich protein 61 (CYR61) plays a role in the differentiation and development of chondrocytes, osteoblasts, and osteoclasts; however, little is known about its role in adipogenesis. The current study indicates that the expression level of Cyr61 was altered in primary cultured marrow stromal cells and the established mesenchymal cell line, C3H10T1/2, after adipogenic treatment. Overexpressing Cyr61 repressed C3H10T1/2 and primary marrow stromal cells to differentiate into mature adipocytes. Conversely, inhibition of endogenous Cyr61 induced C3H10T1/2 and primary marrow stromal cells to fully differentiate. Mechanism investigations reveal that knockdown of Cyr61 inhibited the nuclear translocation of beta-catenin and decreased nuclear protein levels of beta-catenin and transcription factor 7-like 2. Moreover, the silencing of Cyr61 increased protein levels of phosphorylated ribosomal protein S6 kinase B1, mammalian target of rapamycin, eukaryotic translation initiation factor 4E-binding protein 1, and ribosomal protein S6-the major components of mammalian target of rapamycin complex 1 (mTORC1) signaling-in C3H10T1/2 cells. Additional investigations demonstrated that treatment with rapamycin significantly attenuated adipocyte formation that was induced by Cyr61 small interfering RNA (siRNA) transfection. Moreover, Cyr61 siRNA also lost its ability to stimulate adipocyte formation under the background of beta-catenin overexpression. Taken together, our study provides evidence that CYR61 regulates adipocyte differentiation via multiple signaling pathways that involve at least the inactivation of mTORC1 signaling and the activation of canonical Wnt signaling.				blwang@tmu.edu.cn			Natural Science Foundation of China [81672116, 81472040, 81772297, 81501846]; Tianjin Municipal Natural Science Foundation [14JCZDJC33700]; Science and Technology Development Fund of the Tianjin Education Commission for Higher Education [2017KJ213]; Key Laboratory of Hormones and Development, Ministry of Health [2015DX03]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Natural Science Foundation(Natural Science Foundation of Tianjin); Science and Technology Development Fund of the Tianjin Education Commission for Higher Education; Key Laboratory of Hormones and Development, Ministry of Health	This work was supported by the Natural Science Foundation of China Grants 81672116 and 81472040 (to B.W.), Grant 81772297 (to X.L.), and Grant 81501846 (to E.Z.). This work was also supported, in part, by Grant 14JCZDJC33700 from the Tianjin Municipal Natural Science Foundation, Grant 2017KJ213 from the Science and Technology Development Fund of the Tianjin Education Commission for Higher Education, and Grant 2015DX03 from the Key Laboratory of Hormones and Development, Ministry of Health. The authors declare no conflicts of interest.	Carnevalli LS, 2010, DEV CELL, V18, P763, DOI 10.1016/j.devcel.2010.02.018; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chang GR, 2009, BASIC CLIN PHARMACOL, V105, P188, DOI 10.1111/j.1742-7843.2009.00427.x; Chang GR, 2009, J PHARMACOL SCI, V109, P496, DOI 10.1254/jphs.08215FP; Croci S, 2004, CANCER RES, V64, P1730, DOI 10.1158/0008-5472.CAN-3502-02; Crockett JC, 2007, ENDOCRINOLOGY, V148, P5761, DOI 10.1210/en.2007-0473; French DM, 2004, AM J PATHOL, V165, P855, DOI 10.1016/S0002-9440(10)63348-2; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Gagnon A, 2001, J CELL PHYSIOL, V189, P14, DOI 10.1002/jcp.1132; Ge CX, 2016, J CELL PHYSIOL, V231, P587, DOI 10.1002/jcp.25102; Grafe I., 2017, COLD SPRING HARB PER; Han Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35655; Hirasaki S, 2001, HEPATOL RES, V19, P294, DOI 10.1016/S1386-6346(00)00101-7; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Laudes M, 2011, J MOL ENDOCRINOL, V46, pR65, DOI 10.1530/JME-10-0169; Lechner A, 2000, BONE, V27, P53, DOI 10.1016/S8756-3282(00)00294-5; Leng E, 2002, J BIOMED SCI, V9, P59, DOI 10.1007/BF02256579; Li J, 2015, INT J MOL MED, V36, P1451, DOI 10.3892/ijmm.2015.2390; Li ZY, 2012, COMPUT ENG APPL, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0040132; Liu H, 2017, INT J ONCOL, V50, P631, DOI 10.3892/ijo.2016.3815; Liu WZ, 2012, J BIOL CHEM, V287, P7213, DOI 10.1074/jbc.M111.286724; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu WY, 2014, J CELL BIOCHEM, V115, P1799, DOI 10.1002/jcb.24850; Luo LP, 2016, J ENDOCRINOL, V231, pR77, DOI 10.1530/JOE-16-0211; Malik AR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00237; Matsushita K, 2017, LAB INVEST, V97, P1158, DOI 10.1038/labinvest.2017.42; Menendez JA, 2003, ENDOCR-RELAT CANCER, V10, P141, DOI 10.1677/erc.0.0100141; Moseti D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010124; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Rendina-Ruedy E, 2017, ENDOCRIN METAB CLIN, V46, P41, DOI 10.1016/j.ecl.2016.09.004; Ricoult SJH, 2013, EMBO REP, V14, P242, DOI 10.1038/embor.2013.5; Schutze N, 2005, PROTEIN EXPRES PURIF, V42, P219, DOI 10.1016/j.pep.2005.03.031; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Sisakhtnezhad S, 2017, EUR J CELL BIOL, V96, P13, DOI 10.1016/j.ejcb.2016.11.003; Song HI, 2016, SCI REP-UK, V6, DOI 10.1038/srep36968; Su JL, 2010, J BIOL CHEM, V285, P31325, DOI 10.1074/jbc.M109.087122; Wang J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.356; Wong M, 1997, DEV BIOL, V192, P492, DOI 10.1006/dbio.1997.8766; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]; Zhang YC, 2016, J BONE MINER RES, V31, P549, DOI 10.1002/jbmr.2712; Zhang YY, 2012, MOL ENDOCRINOL, V26, P798, DOI 10.1210/me.2011-1287	46	11	11	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3096	3107		10.1096/fj.201700830RR	http://dx.doi.org/10.1096/fj.201700830RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401606				2022-12-26	WOS:000432546000017
J	Trogden, KP; Battaglia, RA; Kabiraj, P; Madden, VJ; Herrmann, H; Snider, NT				Trogden, Kathryn P.; Battaglia, Rachel A.; Kabiraj, Parijat; Madden, Victoria J.; Herrmann, Harald; Snider, Natasha T.			An image-based small-molecule screen identifies vimentin as a pharmacologically relevant target of simvastatin in cancer cells	FASEB JOURNAL			English	Article						statin; intermediate filaments; cytoskeleton; drug screen	INTERMEDIATE-FILAMENT PROTEIN; STATIN THERAPY; MUSCLE INJURY; LUNG-CANCER; IN-VITRO; DYNAMICS; EXPRESSION; MANAGEMENT; WITHAFERIN; INHIBITOR	Vimentin is a cytoskeletal intermediate filament protein that is expressed in mesenchymal cells and cancer cells during the epithelial-mesenchymal transition. The goal of this study was to identify vimentin-targeting small molecules by using the Tocriscreen library of 1120 biochemically active compounds. We monitored vimentin filament reorganization and bundling in adrenal carcinoma SW13 vimentin-positive (SW13-vim(+) cells via indirect immunofluorescence. The screen identified 18 pharmacologically diverse hits that included 2 statins-simvastatin and mevastatin. Simvastatin induced vimentin reorganization within 15-30 min and significant perinuclear bundling within 60 min (IC50 = 6.7 nM). Early filament reorganization coincided with increased vimentin solubility. Mevastatin produced similar effects at >1 mu M, whereas the structurally related pravastatin and lovastatin did not affect vimentin. In vitro vimentin filament assembly assays revealed a direct targeting mechanism, as determined biochemically and by electron microscopy. In SW13-vim(+) cells, simvastatin, but not pravastatin, reduced total cell numbers (IC50 = 48.1 nM) and promoted apoptosis after 24 h. In contrast, SW13-vim(-) cell viability was unaffected by simvastatin, unless vimentin was ectopically expressed. Simvastatin similarly targeted vimentin filaments and induced cell death in MDA-MB-231 (vim(+)), but lacked effect in MCF7 (vim(-)) breast cancer cells. In conclusion, this study identified vimentin as a direct molecular target that mediates simvastatin-induced cell death in 2 different cancer cell lines.	[Trogden, Kathryn P.; Battaglia, Rachel A.; Kabiraj, Parijat; Snider, Natasha T.] Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, 5340C MBRB,111 Mason Farm Rd, Chapel Hill, NC 27516 USA; [Madden, Victoria J.] Univ North Carolina Chapel Hill, Dept Pathol & Lab Med, Chapel Hill, NC 27516 USA; [Herrmann, Harald] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany; [Herrmann, Harald] Univ Hosp Erlangen, Inst Neuropathol, Erlangen, Germany	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Helmholtz Association; German Cancer Research Center (DKFZ); University of Erlangen Nuremberg	Snider, NT (corresponding author), Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, 5340C MBRB,111 Mason Farm Rd, Chapel Hill, NC 27516 USA.	ntsnider@med.unc.edu	Ariel, Pablo/AGJ-4118-2022; Kabiraj, Parijat/AAE-9797-2020	, Parijat/0000-0003-3936-3143; Battaglia, Rachel/0000-0003-3187-6964; Trogden, Kathryn/0000-0003-3288-3859	Department of Cell Biology and Physiology at the University of North Carolina-Chapel Hill; National Science Foundation Graduate Research Fellowship; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant [R01-DK110355]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110355] Funding Source: NIH RePORTER	Department of Cell Biology and Physiology at the University of North Carolina-Chapel Hill; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Helen Willcockson and Deekshita Ramanarayanan (University of North Carolina-Chapel Hill) for technical assistance, and Dr. Susan J. Henning (University of North Carolina-Chapel Hill) for critical reading and helpful discussions of the manuscript. This work was supported by the Department of Cell Biology and Physiology at the University of North Carolina-Chapel Hill, The National Science Foundation Graduate Research Fellowship (to R.A.B), and by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK110355 (to N.T.S.). The authors declare no conflicts of interest.	Ahern TP, 2014, LANCET ONCOL, V15, pE461, DOI 10.1016/S1470-2045(14)70119-6; Alexander JP, 2006, J AM CHEM SOC, V128, P9699, DOI 10.1021/ja062999h; Atilano-Roque A, 2017, TOXICOL IN VITRO, V45, P158, DOI 10.1016/j.tiv.2017.09.002; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Battaglia R. A., 2017, JOVE-J VIS EXP, V123, P1; Bjorkhem-Bergman L, 2011, BRIT J CLIN PHARMACO, V72, P164, DOI 10.1111/j.1365-2125.2011.03907.x; Brown J.H., 2001, GOODMAN GILMANS PHAR, V10th ed., P10; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Bryant AE, 2006, J INFECT DIS, V193, P1685, DOI 10.1086/504261; Cardwell CR, 2015, CANCER EPIDEM BIOMAR, V24, P833, DOI 10.1158/1055-9965.EPI-15-0052; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Chernoivanenko IS, 2015, FASEB J, V29, P820, DOI 10.1096/fj.14-259903; Chernyatina AA, 2015, CURR OPIN CELL BIOL, V32, P65, DOI 10.1016/j.ceb.2014.12.007; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Fitchett DH, 2015, CIRCULATION, V131, pE389, DOI 10.1161/CIRCULATIONAHA.114.013189; Gan Z, 2016, CELL SYST, V3, P252, DOI 10.1016/j.cels.2016.08.007; Gao X, 2009, CHEM BIOL, V16, P1064, DOI 10.1016/j.chembiol.2009.09.017; Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994; Gluba-Brzozka A, 2016, ARCH MED SCI, V12, P645, DOI 10.5114/aoms.2016.59938; GOLDMAN RD, 1971, J CELL BIOL, V51, P752, DOI 10.1083/jcb.51.3.752; Goldman RD, 2008, CURR OPIN CELL BIOL, V20, P28, DOI 10.1016/j.ceb.2007.11.003; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Hamilton SM, 2008, J INFECT DIS, V198, P1692, DOI 10.1086/593016; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; Herrmann H, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018242; Hookway C, 2015, MOL BIOL CELL, V26, P1675, DOI 10.1091/mbc.E14-09-1398; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; Jiang P, 2014, BRIT J CANCER, V111, P1562, DOI 10.1038/bjc.2014.431; Jimenez-Oses G, 2014, NAT CHEM BIOL, V10, P431, DOI 10.1038/nchembio.1503; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kidd ME, 2014, AM J RESP CELL MOL, V50, P1, DOI 10.1165/rcmb.2013-0314TR; Kou R, 2009, J BIOL CHEM, V284, P14734, DOI 10.1074/jbc.M808664200; Kreplak L, 2008, METHOD CELL BIOL, V88, P273, DOI 10.1016/S0091-679X(08)00415-9; Lowery J, 2015, J BIOL CHEM, V290, P17145, DOI 10.1074/jbc.R115.640359; Matveeva EA, 2015, BIOL OPEN, V4, P1290, DOI 10.1242/bio.011874; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; SARRIA AJ, 1994, J CELL SCI, V107, P1593; Saxon DR, 2016, PROG CARDIOVASC DIS, V59, P153, DOI 10.1016/j.pcad.2016.07.009; Schick BA, 2007, CLIN PHARMACOL THER, V81, P650, DOI 10.1038/sj.clpt.6100124; Schwarz N, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030030; Seckl MJ, 2017, J CLIN ONCOL, V35, P1506, DOI 10.1200/JCO.2016.69.7391; Snider NT, 2013, J CELL BIOL, V200, P241, DOI 10.1083/jcb.201209028; SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929; Stroes ES, 2015, EUR HEART J, V36, P1012, DOI 10.1093/eurheartj/ehv043; Tang HL, 2008, BIOCHEM J, V410, P141, DOI 10.1042/BJ20071072; TRAUB P, 1985, FEBS LETT, V193, P217, DOI 10.1016/0014-5793(85)80155-1; Vanden Berghe W, 2012, BIOCHEM PHARMACOL, V84, P1282, DOI 10.1016/j.bcp.2012.08.027; Warita K, 2014, SCI REP-UK, V4, DOI 10.1038/srep07593; Zhu Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.103	52	27	27	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2841	2854		10.1096/fj.201700663R	http://dx.doi.org/10.1096/fj.201700663R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401610	Green Published			2022-12-26	WOS:000432528000042
J	Garg, A; Sanchez, AM; Shuman, S; Schwer, B				Garg, Angad; Sanchez, Ana M.; Shuman, Stewart; Schwer, Beate			A long noncoding (lnc)RNA governs expression of the phosphate transporter Pho84 in fission yeast and has cascading effects on the flanking prt lncRNA and pho1 genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CTD CODE; TRANSCRIPTION; SITES; TERMINATION; PROTEOME; PATHWAY; EXOSOME	The expression of the phosphate transporter Pho84 in fission yeast Schizosaccharomyces pombe is repressed in phosphate-rich medium and induced during phosphate starvation. Two other phosphate-responsive genes in S. pombe (pho1 and tgp1) had been shown to be repressed in cis by transcription of a long noncoding (lnc) RNA from the upstream flanking gene, but whether pho84 expression is regulated in this manner is unclear. Here, we show that repression of pho84 is enforced by transcription of the SPBC8E4.02c locus upstream of pho84 to produce a lncRNA that we name prt2 (pho-repressive transcript 2). We identify two essential elements of the prt2 promoter, a HomolD box and a TATA box, mutations of which inactivate the prt2 promoter and de-repress the downstream pho84 promoter under phosphate-replete conditions. We find that prt2 promoter inactivation also elicits a cascade effect on the adjacent downstream prt (lncRNA) and pho1 (acid phosphatase) genes, whereby increased pho84 transcription down-regulates prt lncRNA transcription and thereby de-represses pho1. Our results establish a unified model for the repressive arm of fission yeast phosphate homeostasis, in which transcription of prt2, prt, and nc-tgp1 lncRNAs interferes with the promoters of the flanking pho84, pho1, and tgp1 genes, respectively.	[Garg, Angad; Shuman, Stewart] Sloan Kettering Inst, Mol Biol Program, New York, NY 10065 USA; [Sanchez, Ana M.; Schwer, Beate] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Shuman, S (corresponding author), Sloan Kettering Inst, Mol Biol Program, New York, NY 10065 USA.; Schwer, B (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA.	s-shuman@ski.mskcc.org; bschwer@med.cornell.edu	Garg, Angad/ABI-4903-2020	Garg, Angad/0000-0003-4494-6386; Sanchez, Ana/0000-0002-9119-7624; Schwer, Beate/0000-0002-3824-9819	National Institutes of Health [GM52470]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM52470 (to S.S. and B.S.).	Ard R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6576; Carpy A, 2014, MOL CELL PROTEOMICS, V13, P1925, DOI 10.1074/mcp.M113.035824; Carter-O'Connell I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-697; Chalamcharla VR, 2015, P NATL ACAD SCI USA, V112, P15548, DOI 10.1073/pnas.1522127112; Chatterjee D, 2016, RNA, V22, P1011, DOI 10.1261/rna.056515.116; Estill M, 2015, CURR GENET, V61, P175, DOI 10.1007/s00294-014-0466-6; Gross T, 1998, NUCLEIC ACIDS RES, V26, P3319, DOI 10.1093/nar/26.14.3319; Gunaratne J, 2013, MOL CELL PROTEOMICS, V12, P1741, DOI 10.1074/mcp.M112.023754; Henry TC, 2011, EUKARYOT CELL, V10, P198, DOI 10.1128/EC.00216-10; HERRICK D, 1990, MOL CELL BIOL, V10, P2269, DOI 10.1128/MCB.10.5.2269; Lee NN, 2013, CELL, V155, P1061, DOI 10.1016/j.cell.2013.10.027; Lemay JF, 2014, NAT STRUCT MOL BIOL, V21, P919, DOI 10.1038/nsmb.2893; Loya T. J., 2016, F1000RES, V5, P25; Mata J, 2013, RNA BIOL, V10, P1407, DOI 10.4161/rna.25758; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Sanchez AM, 2018, RNA, V24, P237, DOI 10.1261/rna.063966.117; Schwer B, 1998, NUCLEIC ACIDS RES, V26, P2050, DOI 10.1093/nar/26.9.2050; Schwer B, 2017, MBIO, V8, DOI 10.1128/mBio.01218-17; Schwer B, 2015, RNA, V21, P1770, DOI 10.1261/rna.052555.115; Schwer B, 2014, P NATL ACAD SCI USA, V111, P4185, DOI 10.1073/pnas.1321842111; Schwer B, 2012, P NATL ACAD SCI USA, V109, P18024, DOI 10.1073/pnas.1208995109; Schwer B, 2011, MOL CELL, V43, P311, DOI 10.1016/j.molcel.2011.05.024; Shah S, 2014, GENE DEV, V28, P231, DOI 10.1101/gad.230177.113; Tomar P, 2014, J BIOSCIENCES, V39, P525, DOI 10.1007/s12038-014-9435-y; Touat-Todeschini L, 2017, EMBO J, V36, P2626, DOI 10.15252/embj.201796571; WITT I, 1993, EMBO J, V12, P1201, DOI 10.1002/j.1460-2075.1993.tb05761.x; WITT I, 1995, NUCLEIC ACIDS RES, V23, P4296, DOI 10.1093/nar/23.21.4296	27	18	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4456	4467		10.1074/jbc.RA117.001352	http://dx.doi.org/10.1074/jbc.RA117.001352			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29414789	Green Published, hybrid			2022-12-26	WOS:000428204300017
J	Munoz, SS; Li, HY; Ruberu, K; Chu, Q; Saghatelian, A; Ooi, L; Garner, B				Munoz, Sonia Sanz; Li, Hongyun; Ruberu, Kalani; Chu, Qian; Saghatelian, Alan; Ooi, Lezanne; Garner, Brett			The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; THROMBIN-CLEAVAGE FRAGMENT; HUMAN NEUROBLASTOMA-CELLS; NEURO-BLASTOMA CELLS; ALZHEIMERS-DISEASE; A-BETA; INFLAMMATORY RESPONSE; LIPOPROTEIN RECEPTORS; TERMINAL FRAGMENT; MIMETIC PEPTIDES	Apolipoprotein-E (apoE) is a glycoprotein highly expressed in the brain, where it appears to play a role in lipid transport, beta-amyloid clearance, and neuronal signaling. ApoE proteolytic fragments are also present in the brain, but the enzymes responsible for apoE fragmentation are unknown, and the biological activity of specific apoE fragments remains to be determined. Here we utilized SK-N-SH neuroblastoma cells differentiated into neurons with all-trans-retinoic acid (ATRA) to study extracellular apoE proteolysis. ApoE fragments were detectable in culture supernatants after 3 days, and their levels were increased for up to 9 days in the presence of ATRA. The concentration of apoE fragments was positively correlated with levels of the neuronal maturation markers (PSD95 and SMI32). The most abundant apoE fragments were 25-and 28-kDa N-terminal fragments that both contained sialylated glycosylation and bound to heparin. We detected apoE fragments only in the extracellular milieu and not in cell lysates, suggesting that an extracellular protease contributes to apoE fragmentation. Of note, siRNA-mediated knockdown of high-temperature requirement serine peptidase A1 (HtrA1) and a specific HtrA1 inhibitor reduced apoE 25-kDa fragment formation by 41 and 86%, respectively. Recombinant 25-kDa fragment apoE and full-length apoE both stimulated neuritogenesis in vitro, increasing neuroblastoma neurite growth by more than 2-fold over a 6-day period. This study provides a cellular model for assessing apoE proteolysis, indicates that HtrA1 regulates apoE 25-kDa fragment formation under physiological conditions, and reveals a new neurotrophic function for the apoE 25-kDa fragment.	[Munoz, Sonia Sanz; Li, Hongyun; Ruberu, Kalani; Ooi, Lezanne; Garner, Brett] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Munoz, Sonia Sanz; Li, Hongyun; Ruberu, Kalani; Ooi, Lezanne; Garner, Brett] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Chu, Qian; Saghatelian, Alan] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	University of Wollongong; University of Wollongong; Salk Institute	Garner, B (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia.	brettg@uow.edu.au	; Li, Hongyun/G-2301-2011	Chu, Qian/0000-0001-6550-6975; Ooi, Lezanne/0000-0001-9241-8268; Li, Hongyun/0000-0003-3332-3132; Ruberu, Kalani/0000-0003-2575-5242; Sanz Munoz, Sonia/0000-0003-0970-3637	National Health and Medical Research Council (NHMRC) of Australia [1079995]; Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals; NHMRC Dementia Research Leadership Fellowship [1135720]; NHMRC Senior Research Fellowship [1109831]; George E. Hewitt Foundation for medical research	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals(Ferring Pharmaceuticals); NHMRC Dementia Research Leadership Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); George E. Hewitt Foundation for medical research	This research was supported by National Health and Medical Research Council (NHMRC) of Australia Grant 1079995. The authors declare that they have no conflicts of interest with the contents of this article.; A postdoctoral fellow supported by the George E. Hewitt Foundation for medical research.; Supported by the Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals.; Supported by an NHMRC Dementia Research Leadership Fellowship (Grant 1135720).; Supported by an NHMRC Senior Research Fellowship (Grant 1109831).	Achariyar TM, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0138-8; Aizawa Y, 1997, BRAIN RES, V768, P208, DOI 10.1016/S0006-8993(97)00640-9; Aono M, 2003, NEUROSCIENCE, V116, P437, DOI 10.1016/S0306-4522(02)00709-1; BANAYSCHWARTZ M, 1992, AGE, V15, P51, DOI 10.1007/BF02435024; Beffert U, 2004, J LIPID RES, V45, P403, DOI 10.1194/jlr.R300017-JLR200; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; Caillet-Boudin ML, 1998, NEUROSCI LETT, V250, P83, DOI 10.1016/S0304-3940(98)00448-0; Cao F, 2016, J NEUROTRAUM, V33, P175, DOI 10.1089/neu.2015.3887; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Cho HS, 2001, J NEUROPATH EXP NEUR, V60, P342, DOI 10.1093/jnen/60.4.342; Chu Q, 2016, J AM CHEM SOC, V138, P9473, DOI 10.1021/jacs.6b03463; CICCARONE V, 1989, CANCER RES, V49, P219; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; CLAY MA, 1995, BIOCHEMISTRY-US, V34, P11142, DOI 10.1021/bi00035a020; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CRUTCHER KA, 1994, EXP NEUROL, V130, P120, DOI 10.1006/exnr.1994.1191; D'Angelo V, 2014, J NEURO-ONCOL, V117, P287, DOI 10.1007/s11060-014-1387-4; Dafnis I, 2012, NEUROSCIENCE, V210, P21, DOI 10.1016/j.neuroscience.2012.03.013; De Luca A, 2004, J HISTOCHEM CYTOCHEM, V52, P1609, DOI 10.1369/jhc.4A6330.2004; De Luca A, 2003, J HISTOCHEM CYTOCHEM, V51, P1279, DOI 10.1177/002215540305101004; Dupont-Wallois L, 1997, NEUROBIOL DIS, V4, P356, DOI 10.1006/nbdi.1997.0155; Elliott DA, 2007, NEUROSCI LETT, V416, P206, DOI 10.1016/j.neulet.2007.02.014; Elliott DA, 2010, CLIN LIPIDOL, V5, P555, DOI 10.2217/CLP.10.37; Elliott DA, 2011, NEUROBIOL AGING, V32, P257, DOI 10.1016/j.neurobiolaging.2009.02.006; Fisher CA, 2000, J BIOL CHEM, V275, P33601, DOI 10.1074/jbc.M002643200; Gay EA, 2007, MOL PHARMACOL, V72, P838, DOI 10.1124/mol.107.035527; Glanz S, 2016, STEM CELLS DEV, V25, P687, DOI 10.1089/scd.2015.0368; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Heeren J, 2001, J BIOL CHEM, V276, P42333, DOI 10.1074/jbc.M107461200; Herz J, 2000, NAT REV NEUROSCI, V1, P51, DOI 10.1038/35036221; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hoe HS, 2005, J NEUROCHEM, V93, P145, DOI 10.1111/j.1471-4159.2004.03007.x; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; HOLTZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480, DOI 10.1073/pnas.92.21.9480; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Huang YWA, 2017, CELL, V168, P427, DOI 10.1016/j.cell.2016.12.044; Hussain A, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-49; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kim WS, 2009, J NEUROCHEM, V109, P1053, DOI 10.1111/j.1471-4159.2009.06031.x; Koch S, 2001, J LIPID RES, V42, P1143; LaDu MJ, 1998, J NEUROCHEM, V70, P2070; Lane-Donovan C, 2016, J NEUROSCI, V36, P10141, DOI 10.1523/JNEUROSCI.1054-16.2016; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Launay S, 2008, CELL DEATH DIFFER, V15, P1408, DOI 10.1038/cdd.2008.82; Li FQ, 2006, J PHARMACOL EXP THER, V318, P956, DOI 10.1124/jpet.106.103671; Li HY, 2012, CLIN SCI, V122, P409, DOI 10.1042/CS20110257; Li HY, 2010, BBA-MOL CELL BIOL L, V1801, P887, DOI 10.1016/j.bbalip.2010.05.012; Lorenzi T, 2013, INT J CANCER, V133, P2650, DOI 10.1002/ijc.28280; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Marques MA, 1996, NEUROREPORT, V7, P2529, DOI 10.1097/00001756-199611040-00025; Marques MA, 2004, J MOL NEUROSCI, V24, P73, DOI 10.1385/JMN:24:1:073; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Mulder M, 2001, LAB INVEST, V81, P953, DOI 10.1038/labinvest.3780307; Nathan BP, 2002, BRAIN RES, V928, P96, DOI 10.1016/S0006-8993(01)03367-4; Nilsson J, 2009, NAT METHODS, V6, P809, DOI [10.1038/NMETH.1392, 10.1038/nmeth.1392]; Pirttila T, 1996, BRAIN RES, V722, P71, DOI 10.1016/0006-8993(96)00183-7; Poepsel S, 2015, NAT CHEM BIOL, V11, P862, DOI [10.1038/NCHEMBIO.1931, 10.1038/nchembio.1931]; PREIS PN, 1988, CANCER RES, V48, P6530; Puttfarcken PS, 1997, J NEUROCHEM, V68, P760; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; RALL SC, 1982, P NATL ACAD SCI-BIOL, V79, P4696, DOI 10.1073/pnas.79.15.4696; Raussens V, 1998, J BIOL CHEM, V273, P25825, DOI 10.1074/jbc.273.40.25825; Rohn TT, 2012, BRAIN RES, V1475, P106, DOI 10.1016/j.brainres.2012.08.003; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; Saito H, 2003, J BIOL CHEM, V278, P14782, DOI 10.1074/jbc.M213207200; Sakamoto T, 2008, BIOCHEMISTRY-US, V47, P2968, DOI 10.1021/bi701923h; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singh K, 2008, J BIOL CHEM, V283, P16752, DOI 10.1074/jbc.M710530200; Tai LM, 2013, J BIOL CHEM, V288, P5914, DOI 10.1074/jbc.M112.442103; Tamboli IY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093120; Tennstaedt A, 2012, J BIOL CHEM, V287, P20931, DOI 10.1074/jbc.M111.316232; Tolar M, 1997, J NEUROSCI, V17, P5678; Tolar M, 1999, J NEUROSCI, V19, P7100, DOI 10.1523/JNEUROSCI.19-16-07100.1999; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Wahrle SE, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-7; Wellnitz S, 2005, J NEUROCHEM, V94, P1351, DOI 10.1111/j.1471-4159.2005.03295.x; WESTERLUND JA, 1993, J BIOL CHEM, V268, P15745; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Wu Y, 2016, NEUROSCI LETT, V627, P92, DOI 10.1016/j.neulet.2016.05.058; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; ZANNIS VI, 1984, J BIOL CHEM, V259, P5495; Zhao N, 2018, BIOL PSYCHIAT, V83, P347, DOI 10.1016/j.biopsych.2017.03.003	87	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4071	4084		10.1074/jbc.RA117.001278	http://dx.doi.org/10.1074/jbc.RA117.001278			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29414786	Green Published, hybrid			2022-12-26	WOS:000427587500019
J	Owens, ACS; Meyer-Rochow, VB; Yang, EC				Owens, Avalon Celeste Stevahn; Meyer-Rochow, Victor Benno; Yang, En-Cheng			Short-and mid-wavelength artificial light influences the flash signals of Aquatica ficta fireflies (Coleoptera: Lampyridae)	PLOS ONE			English	Article							PHOTINUS-PYRALIS COLEOPTERA; SPECTRAL SENSITIVITY; OPSIN GENES; SCINTILLANS COLEOPTERA; COURTSHIP FLASHES; L. COLEOPTERA; COMPOUND EYE; NOCTILUCA L.; GLOW-WORMS; EVOLUTION	Urbanization can radically disrupt natural ecosystems through alteration of the sensory environment. Habitat disturbances are predicted to favor behaviorally flexible species capable of adapting to altered environments. When artificial light at night (ALAN) is introduced into urban areas, it has the potential to impede reproduction of local firefly populations by obscuring their bioluminescent courtship signals. Whether individual fireflies can brighten their signals to maintain visibility against an illuminated background remains unknown. In this study, we exposed male Aquatica ficta fireflies to diffused light of varying wavelength and intensity, and recorded their alarm flash signals. When exposed to wavelengths at or below 533 nm, males emitted brighter signals with decreased frequency. This is the first evidence of individual-level light signal plasticity in fireflies. In contrast, long wavelength ambient light (>= 597 nm) did not affect signal morphology, likely because A. ficta cannot perceive these wavelengths. These results suggest long wavelength lighting is less likely to impact firefly courtship, and its use in place of broad spectrum white lighting could augment firefly conservation efforts. More generally, this study demonstrates benefits of bioluminescent signal plasticity in a "noisy" signaling environment, and sheds light on an important yet understudied consequence of urbanization.	[Owens, Avalon Celeste Stevahn] Tufts Univ, Dept Biol, Medford, MA USA; [Meyer-Rochow, Victor Benno] Oulu Univ, Dept Genet & Physiol, Oulu, Finland; [Meyer-Rochow, Victor Benno] Res Inst Luminous Organisms, Tokyo, Japan; [Yang, En-Cheng] Natl Taiwan Univ, Dept Entomol, Taipei, Taiwan	Tufts University; University of Oulu; National Taiwan University	Yang, EC (corresponding author), Natl Taiwan Univ, Dept Entomol, Taipei, Taiwan.	ecyang@ntu.edu.tw	MEYER-ROCHOW, Victor Benno/AAJ-7258-2020	Owens, Avalon/0000-0001-7212-2275	Friends of Da'an Forest Park Foundation [FD97011]; Friends of Da'an Forest Park Foundation	Friends of Da'an Forest Park Foundation; Friends of Da'an Forest Park Foundation	Funding for firefly research provided to National Taiwan University by the Friends of Da'an Forest Park Foundation (http://www.daanforestpark.org.tw/ - grant number: FD97011). Some funding was allocated to ECY's laboratory, and used by ECY and ACSO to purchase experimental equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Leo Jeng and Phil Suslow for technical support, Duncan Wright for assistance with data collection, and Dr. Sara Lewis (Tufts University), Dr. Christian Wegener, and one anonymous reviewer for valuable comments on the manuscript. This study was supported by a grant from the Friends of Da'an Forest Park Foundation to ACSO and ECY.	Adams C.E., 2016, URBAN WILDLIFE MANAG, Vthird; Alberti M, 2015, TRENDS ECOL EVOL, V30, P114, DOI 10.1016/j.tree.2014.11.007; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bird S, 2014, J INSECT CONSERV, V18, P737, DOI 10.1007/s10841-014-9664-2; Booth D, 2004, J EXP BIOL, V207, P2373, DOI 10.1242/jeb.01044; Branham MA, 1996, NATURE, V381, P745, DOI 10.1038/381745b0; BUCK JOHN BONNER, 1937, PHYSIOL ZOOL, V10, P45; Case JF, 2004, INTEGR COMP BIOL, V44, P250, DOI 10.1093/icb/44.3.250; Cook LM, 2013, HEREDITY, V110, P207, DOI 10.1038/hdy.2012.92; Cratsley CK, 2003, BEHAV ECOL, V14, P135, DOI 10.1093/beheco/14.1.135; Cratsley CK, 2000, SEXUAL SELECTION PHO; Cronin TW, 2000, J COMP PHYSIOL A, V186, P1, DOI 10.1007/s003590050001; Czech B, 2000, BIOSCIENCE, V50, P593, DOI 10.1641/0006-3568(2000)050[0593:EAACOS]2.0.CO;2; Demary K, 2005, FIREFLY COURTSHIP BE, V112, P485; Douglas I, 2015, URBAN ECOLOGY: AN INTRODUCTION, P1; DREISIG H, 1975, OECOLOGIA, V18, P85, DOI 10.1007/BF00348090; EGUCHI E, 1984, J INSECT PHYSIOL, V30, P607, DOI 10.1016/0022-1910(84)90044-1; Elvidge CD, 2010, SENSORS-BASEL, V10, P3961, DOI 10.3390/s100403961; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Falchi F, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600377; Firebaugh A, 2016, OECOLOGIA, V182, P1203, DOI 10.1007/s00442-016-3723-1; Fu X, 2010, ZOOTAXA, V2530; Gillham O., 2002, LIMITLESS CITY PRIME; Goh KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029576; Hagen O., 2015, ADV ENTOMOLOGY, V03, P24, DOI [10.4236/ae.2015.31004, DOI 10.4236/AE.2015.31004]; Hall DW, 2016, EVOLUTION, V70, P2033, DOI 10.1111/evo.13002; Ho JZ, 2010, J ASIA-PAC ENTOMOL, V13, P189, DOI 10.1016/j.aspen.2010.03.007; Hu Y, 2010, ANIM BEHAV, V79, P863, DOI 10.1016/j.anbehav.2009.12.036; Ineichen S, 2012, IMPACT ARTIFICIAL LI; Isaksson C, 2010, ECOHEALTH, V7, P342, DOI 10.1007/s10393-010-0345-7; Jeng ML., 2013, SCI DEV, P18; Kegel B., 2013, TIERE STADT NATURGES, P21; KIRSCHFELD K, 1978, J COMP PHYSIOL, V125, P275, DOI 10.1007/BF00656606; Kundrata R, 2014, MOL PHYLOGENET EVOL, V76, P162, DOI 10.1016/j.ympev.2014.03.012; Kupfer JA, 2009, GEOGR COMPASS, V3, P1331, DOI 10.1111/j.1749-8198.2009.00245.x; LALL AB, 1988, J COMP PHYSIOL A, V162, P23, DOI 10.1007/BF01342700; LALL AB, 1982, J COMP PHYSIOL, V147, P195, DOI 10.1007/BF00609844; LALL AB, 1980, J COMP PHYSIOL, V135, P21, DOI 10.1007/BF00660178; Lall AB, 2000, J INSECT PHYSIOL, V46, P965, DOI 10.1016/S0022-1910(99)00206-1; LALL AB, 1994, J INSECT PHYSIOL, V40, P359, DOI 10.1016/0022-1910(94)90077-9; LALL AB, 1993, J INSECT PHYSIOL, V39, P123, DOI 10.1016/0022-1910(93)90103-X; Lau T. F. S., 2007, Journal of Asia-Pacific Entomology, V10, P27; Lewis SM, 2008, ANNU REV ENTOMOL, V53, P293, DOI 10.1146/annurev.ento.53.103106.093346; LEWIS SM, 2009, BIOLUMINESCENCE FOCU, P147, DOI DOI 10.1002/BIO.1170100602/; LLOYD JE, 1971, ANNU REV ENTOMOL, V16, P97, DOI 10.1146/annurev.en.16.010171.000525; Long SM, 2012, ANIM BEHAV, V83, P81, DOI 10.1016/j.anbehav.2011.10.008; Longcore T, 2015, PHILOS T R SOC LON B, P370; Macgregor CJ, 2015, ECOL ENTOMOL, V40, P187, DOI 10.1111/een.12174; Martin GJ, 2015, ORG DIVERS EVOL, V15, P513, DOI 10.1007/s13127-015-0212-z; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Merritt DJ, 2013, J INSECT CONSERV, V17, P147, DOI 10.1007/s10841-012-9493-0; Meyer-Rochow VB, 2007, LUMINESCENCE, V22, P251, DOI 10.1002/bio.955; Michaelidis CI, 2006, BEHAV ECOL, V17, P329, DOI 10.1093/beheco/arj035; Mills R, 2016, J COMP PHYSIOL A, V202, P313, DOI 10.1007/s00359-016-1077-0; Moosman PR, 2009, ANIM BEHAV, V78, P1019, DOI 10.1016/j.anbehav.2009.07.028; Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; Niemela J, 2011, URBAN ECOLOGY: PATTERNS, PROCESSES, AND APPLICATIONS, P1; Oba Y, 2014, ADV BIOCHEM ENG BIOT, V144, P3, DOI 10.1007/978-3-662-43385-0_1; Oba Y, 2009, GENE, V436, P66, DOI 10.1016/j.gene.2009.02.001; Picchi MS, 2013, J INSECT CONSERV, V17, P797, DOI 10.1007/s10841-013-9562-z; R Core Team, 2021, R LANGUAGE ENV STAT; Rich C., 2006, ECOLOGICAL CONSEQUEN; Sander SE, 2015, MOL ECOL, V24, P4679, DOI 10.1111/mec.13346; Schuster S, 2012, BIOL LETTERS, V8, P913, DOI 10.1098/rsbl.2012.0676; SELIGER HH, 1982, PHOTOCHEM PHOTOBIOL, V36, P673, DOI 10.1111/j.1751-1097.1982.tb09488.x; Sharkey EK, 2010, J INSECT BEHAV, V23, P215, DOI 10.1007/s10905-010-9208-x; Stanger-Hall KF, 2015, EVOLUTION, V69, P666, DOI 10.1111/evo.12606; Vencl FV, 1998, J INSECT BEHAV, V11, P191, DOI 10.1023/A:1021091806472; Viviani VR, 2010, BIOTA NEOTROP, V10, P103, DOI 10.1590/S1676-06032010000200013; Woods WA, 2007, AM NAT, V170, P702, DOI 10.1086/521964; Wu C, 2014, INT FIR S; Zvereva EL, 2010, ENVIRON SCI POLLUT R, V17, P297, DOI 10.1007/s11356-009-0138-0	73	27	27	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191576	10.1371/journal.pone.0191576	http://dx.doi.org/10.1371/journal.pone.0191576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415023	gold, Green Published, Green Submitted			2022-12-26	WOS:000424325300033
J	Schmoeckel, K; Mrochen, DM; Huhn, J; Potschke, C; Broker, BM				Schmoeckel, Katrin; Mrochen, Daniel M.; Huehn, Jochen; Poetschke, Christian; Broeker, Barbara M.			Polymicrobial sepsis and non-specific immunization induce adaptive immunosuppression to a similar degree	PLOS ONE			English	Article							REGULATORY T-CELLS; HUMORAL IMMUNE-RESPONSES; DOWN-REGULATION; B-CELLS; INDUCED IMPAIRMENT; GAMMA-INTERFERON; CECAL LIGATION; MURINE MODEL; WHOLE-BLOOD; EXPRESSION	Sepsis is frequently complicated by a state of profound immunosuppression, in its extreme form known as immunoparalysis. We have studied the role of the adaptive immune system in the murine acute peritonitis model. To read out adaptive immunosuppression, we primed post-septic and control animals by immunization with the model antigen TNP-ovalbumin in alum, and measured the specific antibody-responses via ELISA and ELISpot assay as well as T-cell responses in a proliferation assay after restimulation. Specific antibody titers, antibody affinity and plasma cell counts in the bone marrow were reduced in post-septic animals. The antigen-induced splenic proliferation was also impaired. The adaptive immunosuppression was positively correlated with an overwhelming general antibody response to the septic insult. Remarkably, antigen "overload" by non-specific immunization induced a similar degree of adaptive immunosuppression in the absence of sepsis. In both settings, depletion of regulatory T cells before priming reversed some parameters of the immunosuppression. In conclusion, our data show that adaptive immunosuppression occurs independent of profound systemic inflammation and life-threatening illness.	[Schmoeckel, Katrin; Mrochen, Daniel M.; Poetschke, Christian; Broeker, Barbara M.] Univ Med, Inst Immunol & Transfus Med, Dept Immunol, Greifswald, Germany; [Huehn, Jochen] Helmholtz Ctr Infect Res, Expt Immunol, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Broker, BM (corresponding author), Univ Med, Inst Immunol & Transfus Med, Dept Immunol, Greifswald, Germany.	broeker@uni-greifswald.de	Bröker, Barbara M/O-4850-2015	Bröker, Barbara M/0000-0002-5020-8542; Mrochen, Daniel Michael/0000-0002-5893-1778	Deutsche Forschungsgemeinschaft [Graduiertenkolleg 840]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Katrin Schmoeckel received a grant from Deutsche Forschungsgemeinschaft: Graduiertenkolleg 840 - Host pathogen interaction, http://gepris.dfg.de/gepris/projekt/273551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Acharya UH, 2013, CLIN PHARMACOL-ADV A, V5, P21, DOI 10.2147/CPAA.S45884; Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Barrera G, 2011, INFECT IMMUN, V79, P1280, DOI 10.1128/IAI.01127-10; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Boomer JS, 2012, CRIT CARE, V16, DOI 10.1186/cc11404; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037; Brune IB, 1999, AM J SURG, V177, P55, DOI 10.1016/S0002-9610(98)00299-2; Brunner M, 2004, INTENS CARE MED, V30, P1468, DOI 10.1007/s00134-004-2184-x; Busse M, 2008, GUT, V57, P188, DOI 10.1136/gut.2007.121616; Carlei F, 1999, WORLD J SURG, V23, P18, DOI 10.1007/s002689900559; Cavassani KA, 2010, BLOOD, V115, P4403, DOI 10.1182/blood-2009-09-241083; Chang KC, 2013, CRIT CARE, V17, DOI 10.1186/cc12711; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Corthay A, 2009, SCAND J IMMUNOL, V70, P326, DOI 10.1111/j.1365-3083.2009.02308.x; Davis CG, 2011, BIOCHEM BIOPH RES CO, V414, P37, DOI 10.1016/j.bbrc.2011.09.017; Decker D, 1996, SURGERY, V119, P316, DOI 10.1016/S0039-6060(96)80118-8; Delano MJ, 2011, J IMMUNOL, V186, P195, DOI 10.4049/jimmunol.1002104; Devaud C, 2014, CANCER IMMUNOL IMMUN, V63, P869, DOI 10.1007/s00262-014-1581-4; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Eddahri F, 2006, EUR J IMMUNOL, V36, P855, DOI 10.1002/eji.200535500; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; Guignant C, 2011, CRIT CARE, V15, DOI 10.1186/cc10112; Hensler T, 1997, INFECT IMMUN, V65, P2283, DOI 10.1128/IAI.65.6.2283-2291.1997; HERZENBERG LA, 1980, J EXP MED, V151, P1071, DOI 10.1084/jem.151.5.1071; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hotchkiss RS, 2005, CLIN INFECT DIS S7, V41, P9; Huehn J, 2015, SEMIN IMMUNOL, V27, P10, DOI 10.1016/j.smim.2015.02.002; Inoue S, 1950, J IMMUNOLOGY BALTIM, V184, P1401; Inoue S, 2011, SHOCK, V36, P38, DOI 10.1097/SHK.0b013e3182168cce; Kalechman Y, 2002, J IMMUNOL, V169, P384, DOI 10.4049/jimmunol.169.1.384; Kalff JC, 1998, ANN SURG, V228, P652, DOI 10.1097/00000658-199811000-00004; Kelly-Scumpia KM, 2011, J EXP MED, V208, P1673, DOI 10.1084/jem.20101715; Kuhlhorn F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065109; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lahl K, 2011, METHODS MOL BIOL, V707, P157, DOI 10.1007/978-1-61737-979-6_10; LeMessurier K, 2010, INFECT IMMUN, V78, P5287, DOI 10.1128/IAI.00431-10; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Mohr A, 2012, EUR J IMMUNOL, V42, P341, DOI 10.1002/eji.201141692; Monaghan SF, 2012, SHOCK, V38, P117, DOI 10.1097/SHK.0b013e31825de6a3; Monneret G, 2003, CRIT CARE MED, V31, P2068, DOI 10.1097/01.CCM.0000069345.78884.0F; Muenzer JT, 2006, SHOCK, V26, P565, DOI 10.1097/01.shk.0000235130.82363.ed; Muenzer JT, 2010, INFECT IMMUN, V78, P1582, DOI 10.1128/IAI.01213-09; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Murphey ED, 2012, MICROBES INFECT, V14, P35, DOI 10.1016/j.micinf.2011.08.002; Murphey ED, 2004, INFECT IMMUN, V72, P6892, DOI 10.1128/IAI.72.12.6892-6901.2004; Murphy TJ, 2005, J IMMUNOL, V174, P2957, DOI 10.4049/jimmunol.174.5.2957; Nascimento DC, 2010, CRIT CARE MED, V38, P1718, DOI 10.1097/CCM.0b013e3181e78ad0; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332; Passerini L, 2014, INT REV IMMUNOL, V33, P129, DOI 10.3109/08830185.2013.863303; Reddy RC, 2001, IMMUNOL RES, V24, P273, DOI 10.1385/IR:24:3:273; Rigato O, 2003, SHOCK, V19, P113, DOI 10.1097/00024382-200302000-00004; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schmoeckel K, 2015, SHOCK, V43, P192, DOI 10.1097/SHK.0000000000000267; Scumpia PO, 2006, J IMMUNOL, V177, P7943, DOI 10.4049/jimmunol.177.11.7943; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Sinistro A, 2008, CLIN VACCINE IMMUNOL, V15, P1851, DOI 10.1128/CVI.00184-08; Skrupky LP, 2011, ANESTHESIOLOGY, V115, P1349, DOI 10.1097/ALN.0b013e31823422e8; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Sundar KM, 2013, INDIAN J CRIT CARE M, V17, P162, DOI 10.4103/0972-5229.117054; van Dissel JT, 1998, LANCET, V351, P950, DOI 10.1016/S0140-6736(05)60606-X; Venet F, 2004, CRIT CARE MED, V32, P2329, DOI 10.1097/01.CCM.0000145999.42971.4B; Venet F, 2008, J LEUKOCYTE BIOL, V83, P523, DOI 10.1189/jlb.0607371; Venet F, 2009, INTENS CARE MED, V35, P678, DOI 10.1007/s00134-008-1337-8; Vignali DAAA, 2008, EUR J IMMUNOL, V38, P908, DOI 10.1002/eji.200738114; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vuddamalay Y, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00031; Walker LSK, 2009, IMMUNOLOGY, V126, P466, DOI 10.1111/j.1365-2567.2009.03053.x; Ward NS, 2008, CLIN CHEST MED, V29, P617, DOI 10.1016/j.ccm.2008.06.010; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Wing JB, 2014, INT IMMUNOL, V26, P61, DOI 10.1093/intimm/dxt060; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Wingender G, 2006, EUR J IMMUNOL, V36, P12, DOI 10.1002/eji.200535602; Wisnoski N, 2007, SHOCK, V27, P251, DOI 10.1097/01.shk.0000239780.33398.e4; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Wolniak KL, 2006, J IMMUNOL, V177, P2072, DOI 10.4049/jimmunol.177.4.2072; Workman CJ, 2009, CELL MOL LIFE SCI, V66, P2603, DOI 10.1007/s00018-009-0026-2; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440; Yoon SJ, 2017, J INFECT DIS, V215, P1608, DOI 10.1093/infdis/jix142; Zantl N, 1998, INFECT IMMUN, V66, P2300, DOI 10.1128/IAI.66.5.2300-2309.1998	95	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192197	10.1371/journal.pone.0192197	http://dx.doi.org/10.1371/journal.pone.0192197			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415028	gold, Green Submitted, Green Published			2022-12-26	WOS:000424325300057
J	Hoshino, J; Furuichi, K; Yamanouchi, M; Mise, K; Sekine, A; Kawada, M; Sumida, K; Hiramatsu, R; Hasegawa, E; Hayami, N; Suwabe, T; Sawa, N; Hara, S; Fujii, T; Ohashi, K; Kitagawa, K; Toyama, T; Shimizu, M; Takaichi, K; Ubara, Y; Wada, T				Hoshino, Junichi; Furuichi, Kengo; Yamanouchi, Masayuki; Mise, Koki; Sekine, Akinari; Kawada, Masahiro; Sumida, Keiichi; Hiramatsu, Rikako; Hasegawa, Eiko; Hayami, Noriko; Suwabe, Tatsuya; Sawa, Naoki; Hara, Shigeko; Fujii, Takeshi; Ohashi, Kenichi; Kitagawa, Kiyoki; Toyama, Tadashi; Shimizu, Miho; Takaichi, Kenmei; Ubara, Yoshifumi; Wada, Takashi			A new pathological scoring system by the Japanese classification to predict renal outcome in diabetic nephropathy	PLOS ONE			English	Article							TUBULOINTERSTITIAL LESIONS; KIDNEY-DISEASE; BIOPSY; OVERT; RISK; MICROALBUMINURIA; REDUCTION; PROGNOSIS	Background and objectives The impact of the newly proposed pathological classification by the Japan Renal Pathology Society (JRPS) on renal outcome is unclear. So we evaluated that impact and created a new pathological scoring to predict outcome using this classification. Design, setting, participants, & measurements A multicenter cohort of 493 biopsy-proven Japanese patients with diabetic nephropathy (DN) were analyzed. The association between each pathological factor-Tervaert' and JRPS classifications-and renal outcome (dialysis initiation or 50% eGFR decline) was estimated by adjusted Cox regression. The overall pathological risk score (J-score) was calculated, whereupon its predictive ability for 10-year risk of renal outcome was evaluated. Results The J-scores of diffuse lesion classes 2 or 3, GBM doubling class 3, presence of mesangiolysis, polar vasculosis, and arteriolar hyalinosis were, respectively, 1, 2, 4, 1, and 2. The scores of IFTA classes 1, 2, and 3 were, respectively, 3, 4, and 4, and those of interstitial inflammation classes 1, 2, and 3 were 5, 5, and 4 (J-score range, 0-19). Renal survival curves, when dividing into four J-score grades (0-5, 6-10, 11-15, and 16-19), were significantly different from each other (p<0.01, log-rank test). After adjusting clinical factors, the J-score was a significant predictor of renal outcome. Ability to predict 10-year renal outcome was improved when the J-score was added to the basic model: c-statistics from 0.661 to 0.685; category-free net reclassification improvement, 0.154 (-0.040, 0.349, p = 0.12); and integrated discrimination improvement, 0.015 (0.003, 0.028, p = 0.02). Conclusions Mesangiolysis, polar vasculosis, and doubling of GBM-features of the JRPS system-were significantly associated with renal outcome. Prediction of DN patients' renal outcome was better with the J-score than without it.	[Hoshino, Junichi; Sekine, Akinari; Kawada, Masahiro; Hasegawa, Eiko; Hara, Shigeko; Takaichi, Kenmei] Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan; [Hoshino, Junichi; Takaichi, Kenmei; Ubara, Yoshifumi] Okinaka Mem Inst Med Res, Tokyo, Japan; [Furuichi, Kengo; Toyama, Tadashi; Shimizu, Miho; Wada, Takashi] Kanazawa Univ Hosp, Dept Nephrol, Kanazawa, Ishikawa, Japan; [Yamanouchi, Masayuki; Sumida, Keiichi; Hiramatsu, Rikako; Hayami, Noriko; Suwabe, Tatsuya; Sawa, Naoki; Ubara, Yoshifumi] Toranomon Hosp Kajigaya, Nephrol Ctr, Kanagawa, Japan; [Mise, Koki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan; [Fujii, Takeshi] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan; [Ohashi, Kenichi] Yokohama City Univ, Sch Med, Dept Pathol, Kanagawa, Japan; [Kitagawa, Kiyoki] Kanazawa Med Ctr, Dept Nephrol, Kanazawa, Ishikawa, Japan; [Wada, Takashi] Kanazawa Univ, Dept Nephrol & Lab Med, Kanazawa, Ishikawa, Japan	Toranomon Hospital; Kanazawa University; Okayama University; Toranomon Hospital; Yokohama City University; Kanazawa University	Hoshino, J (corresponding author), Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan.; Hoshino, J (corresponding author), Okinaka Mem Inst Med Res, Tokyo, Japan.	hoshino@toranomon.gr.jp	FURUICHI, Kengo/AAA-5685-2019; Fujii, Takeshi/D-5877-2014	Fujii, Takeshi/0000-0001-7237-1183; Hoshino, Junichi/0000-0002-0444-101X; Mise, Koki/0000-0003-0296-7429	Japan Agency for Medical Research and Development; JSPS KAKENHI [15K08719]; Kidney Foundation, Japan [JKFB 14-13]; Okinaka Memorial Institute for Medical Research	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kidney Foundation, Japan(Kidney Foundation, Japan); Okinaka Memorial Institute for Medical Research	This study was supported in part by TW's Grant-in-Aid for Practical Research Project for Renal Diseases, from the Japan Agency for Medical Research and Development, in part by JH's research grants from Grants-in-Aid for Scientific Research (JSPS KAKENHI) Grant Number 15K08719, in part by a grant from the Kidney Foundation, Japan (JKFB 14-13), and in part by a grant from the Okinaka Memorial Institute for Medical Research.	Advani A, 2012, SEMIN NEPHROL, V32, P199, DOI 10.1016/j.semnephrol.2012.02.006; An Y, 2014, NEPHROL DIAL TRANSPL; Araki S, 2007, DIABETES, V56, P1727, DOI 10.2337/db06-1646; Araki S, 2013, DIABETES CARE, V36, P1248, DOI 10.2337/dc12-1298; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Ekinci EI, 2013, DIABETES CARE, V36, P3620, DOI 10.2337/dc12-2572; Fioretto P, 1996, DIABETOLOGIA, V39, P1569, DOI 10.1007/s001250050616; Fioretto P, 1998, NEW ENGL J MED, V339, P69, DOI 10.1056/NEJM199807093390202; Fioretto P, 2014, DIABETES RES CLIN PR, V104, P323, DOI 10.1016/j.diabres.2014.01.017; Furuichi K, 2018, NEPHROL DIAL TRANSPL, V33, P138, DOI 10.1093/ndt/gfw417; Hong D, 2007, DIABETES RES CLIN PR, V78, P189, DOI 10.1016/j.diabres.2007.03.024; Hoshino J, 2015, AM J NEPHROL, V41, P337, DOI 10.1159/000431333; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Makino H, 2008, HYPERTENS RES, V31, P657, DOI 10.1291/hypres.31.657; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; MIN W, 1993, VIRCHOWS ARCH A, V423, P201, DOI 10.1007/BF01614771; Mise K, 2015, DIABETIC MED, V32, P546, DOI 10.1111/dme.12633; Mise K, 2016, CLIN J AM SOC NEPHRO, V11, P593, DOI 10.2215/CJN.04980515; Mise K, 2014, NEPHROL DIAL TRANSPL, V29, P109, DOI 10.1093/ndt/gft349; Morita T, 1998, AM J KIDNEY DIS, V31, P559, DOI 10.1053/ajkd.1998.v31.pm9531171; Nakamura A, 2005, DIABETES CARE, V28, P2890, DOI 10.2337/diacare.28.12.2890; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Nyumura I, 2012, TRANSPLANTATION, V94, P612, DOI 10.1097/TP.0b013e31825e4a5f; Okada T, 2012, NEPHROLOGY, V17, P68, DOI 10.1111/j.1440-1797.2011.01525.x; Royston P, 2009, STATA J, V9, P547, DOI 10.1177/1536867X0900900403; Shimizu M, 2014, CLIN EXP NEPHROL, V18, P305, DOI 10.1007/s10157-013-0870-0; Shimizu M, 2013, DIABETES CARE, V36, P3655, DOI 10.2337/dc13-0298; Steyerberg E., 2010, CLIN PREDICTION MODE; Tangri N, 2016, JAMA-J AM MED ASSOC, V315, P164, DOI 10.1001/jama.2015.18202; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Wolf G, 2003, J AM SOC NEPHROL, V14, P1396, DOI 10.1097/01.ASN.0000065639.19190.CF; Yokoyama H, 2013, DIABETES CARE, V36, P3227, DOI 10.2337/dc13-0281; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	35	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0190923	10.1371/journal.pone.0190923	http://dx.doi.org/10.1371/journal.pone.0190923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408865	Green Published, gold, Green Submitted			2022-12-26	WOS:000424302800011
J	Zhang, JH; Yang, J; Zhang, X; Xu, J; Sun, YY; Zhang, PR				Zhang, Jianhui; Yang, Jing; Zhang, Xin; Xu, Jia; Sun, Yiyi; Zhang, Purong			MicroRNA-10b expression in breast cancer and its clinical association	PLOS ONE			English	Article							METASTASIS; INVASION	MicroRNAs (miRNAs) are short non-coding RNA molecules that play a significant role in many types of cancers including breast cancer. In the current study, we evaluated the expression levels of microR-10b (miR-10b) in 115 breast cancer patients from Sichuan Cancer Center. Real time reverse transcription-PCR was used to assess miR-10b expression. Clinical data including disease stage, survival status, age, ER/PR/HER2 status, molecular subtypes, tumor size, lymph node status and Ki-67 expression levels were correlated with miR-10b expression levels. Our data showed that the miR-10b expression is correlated with disease stage, living status and tumor sizes. We also found that miR-10b expression levels are higher in the lymph node positive group and the Ki-67 higher scoring group (score > 20). No statistically significant differences were observed based on age or molecular sub-type grouping. In conclusion, miR-10b may be a biomarker for breast cancer and is a potential treatment target.	[Zhang, Jianhui; Yang, Jing; Zhang, Xin; Xu, Jia; Zhang, Purong] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med, Chengdu, Sichuan, Peoples R China; [Sun, Yiyi] Chengdu Med Coll, Chengdu, Sichuan, Peoples R China	University of Electronic Science & Technology of China; Chengdu Medical College	Zhang, PR (corresponding author), Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med, Chengdu, Sichuan, Peoples R China.	zprjournal@hotmail.com			Program for provincial universities innovative research team in Sichuan province [13TD0028]	Program for provincial universities innovative research team in Sichuan province	The work was supported by the Program for provincial universities innovative research team in Sichuan province (NO. 13TD0028. Awarded to Yiyi Sun). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Andorfer CA, 2011, TRENDS MOL MED, V17, P313, DOI 10.1016/j.molmed.2011.01.006; Biagioni F, 2012, EMBO MOL MED, V4, P1214, DOI 10.1002/emmm.201201483; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chia SK, 2012, CLIN CANCER RES, V18, P4465, DOI 10.1158/1078-0432.CCR-12-0286; Fassan M, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2348; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li Ma J T-F, 2008, NATURE, V455; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Milioli HH, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0250-9; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh R, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-256; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang Fei, 2015, Chronic Dis Transl Med, V1, P2, DOI 10.1016/j.cdtm.2015.02.003; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	30	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192509	10.1371/journal.pone.0192509	http://dx.doi.org/10.1371/journal.pone.0192509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408861	Green Submitted, Green Published, gold			2022-12-26	WOS:000424302800076
J	Seglias, AE; Williams, E; Bilge, A; Kramer, AT				Seglias, Alexandra E.; Williams, Evelyn; Bilge, Arman; Kramer, Andrea T.			Phylogeny and source climate impact seed dormancy and germination of restoration-relevant forb species	PLOS ONE			English	Article							HABITAT-CORRELATED VARIATION; LIFE-HISTORY; EVOLUTIONARY SIGNIFICANCE; PLANT-REGENERATION; LOCAL ADAPTATION; ALPINE MEADOW; GREAT-BASIN; DIFFERENTIATION; RECRUITMENT; PATTERNS	For many species and seed sources used in restoration activities, specific seed germination requirements are often unknown. Because seed dormancy and germination traits can be constrained by phylogenetic history, related species are often assumed to have similar traits. However, significant variation in these traits is also present within species as a result of adaptation to local climatic conditions. A growing number of studies have attempted to disentangle how phylogeny and climate influence seed dormancy and germination traits, but they have focused primarily on species-level effects, ignoring potential population-level variation. We examined the relationships between phylogeny, climate, and seed dormancy and germination traits for 24 populations of eight native, restoration-relevant forb species found in a wide range of climatic conditions in the Southwest United States. The seeds were exposed to eight temperature and stratification length regimes designed to mimic regional climatic conditions. Phylogenetic relatedness, overall climatic conditions, and temperature conditions at the site were all significantly correlated with final germination response, with significant among-population variation in germination response across incubation treatments for seven of our eight study species. Notably, germination during stratification was significantly predicted by precipitation seasonality and differed significantly among populations for seven species. While previous studies have not examined germination during stratification as a potential trait influencing overall germination response, our results suggest that this trait should be included in germination studies as well as seed sourcing decisions. Results of this study deepen our understanding of the relationships between source climate, species identity, and germination, leading to improved seed sourcing decisions for restorations.	[Seglias, Alexandra E.] Northwestern Univ, Program Plant Biol & Conservat, Evanston, IL USA; [Seglias, Alexandra E.; Williams, Evelyn; Kramer, Andrea T.] Chicago Bot Garden, Dept Plant Sci & Conservat, Glencoe, IL 60022 USA; [Bilge, Arman] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Bilge, Arman] Fred Hutchinson Canc Res Ctr, Computat Biol Program, 1124 Columbia St, Seattle, WA 98104 USA	Northwestern University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Seglias, AE (corresponding author), Northwestern Univ, Program Plant Biol & Conservat, Evanston, IL USA.; Seglias, AE (corresponding author), Chicago Bot Garden, Dept Plant Sci & Conservat, Glencoe, IL 60022 USA.	alexandra.seglias@botanicgardens.org	Kramer, Andrea T/K-8427-2017	Kramer, Andrea T/0000-0002-0956-0157; Seglias, Alexandra/0000-0002-2756-7088	Northwestern University; Native Plant Society of New Mexico; Bureau of Land Management's Plant Conservation Program [DBI-0521245]; NSF MRI [DBI-1125997]	Northwestern University; Native Plant Society of New Mexico; Bureau of Land Management's Plant Conservation Program; NSF MRI(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was supported by Northwestern University Graduate Program in Plant Biology and Conservation (www.plantbiology.northwestern.edu) and the Native Plant Society of New Mexico (www.npsnm.org) through grants awarded to AES. Funding was also provided by the Bureau of Land Management's Plant Conservation Program (grant DBI-0521245; www.greatbasinnpp.org/usdi-blm/) and NSF MRI (grant DBI-1125997; www.nsf.gov/mri/) through grants awarded to Chicago Botanic Garden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Aronson J, 2013, RESTOR ECOL, V21, P293, DOI 10.1111/rec.12011; Baskin C.C, 2001, SEEDS ECOLOGY BIOGEO; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Baskin Jerry M., 2000, Plant Species Biology, V15, P139, DOI 10.1046/j.1442-1984.2000.00034.x; BASKIN JM, 1971, AM MIDL NAT, V85, P22, DOI 10.2307/2423908; Blanquart F, 2013, ECOL LETT, V16, P1195, DOI 10.1111/ele.12150; Bower AD, 2014, ECOL APPL, V24, P913, DOI 10.1890/13-0285.1; Bu HY, 2008, PLANT ECOL, V195, P87, DOI 10.1007/s11258-007-9301-1; Bu HY, 2009, ARCT ANTARCT ALP RES, V41, P97, DOI [10.1657/1938-4246(08-014)[DU]2.0.CO;2, 10.1657/1523-0430-41.1.97]; Bureau of Land Managment, 2012, TECHN PROT COLL STUD; Bureau of Land Managment, 2014, COL PLAT NAT PLANT P; Burns JH, 2011, P NATL ACAD SCI USA, V108, P5302, DOI 10.1073/pnas.1013003108; Butterfield BJ, 2015, PLANT ECOL, V216, P1341, DOI 10.1007/s11258-015-0510-8; Butterfield BJ, 2015, OIKOS, V124, P1374, DOI 10.1111/oik.02311; Carta A, 2016, ECOL EVOL, V6, P4166, DOI 10.1002/ece3.2150; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Clausen J, 1941, AM NAT, V75, P231, DOI 10.1086/280955; COMSTOCK JP, 1992, GREAT BASIN NAT, V52, P195; Donohue K, 2010, ANNU REV ECOL EVOL S, V41, P293, DOI 10.1146/annurev-ecolsys-102209-144715; Faxitron X-Ray Corporation, SPEC RAD SYST; Fenner M., 2005, ECOLOGY SEEDS; Fernandez-Pascual E, 2017, PLANT BIOLOGY, V19, P32, DOI 10.1111/plb.12472; Fernandez-Pascual E, 2013, ANN BOT-LONDON, V112, P937, DOI 10.1093/aob/mct154; Figueroa JA, 2003, PLANT ECOL, V166, P227, DOI 10.1023/A:1023286521721; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Hadfield JD, 2010, J EVOLUTION BIOL, V23, P494, DOI 10.1111/j.1420-9101.2009.01915.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Hereford R, 2002, PRECIPITATION HIST C; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hintz L, 2016, WEST N AM NATURALIST, V76, P6, DOI 10.3398/064.076.0103; James JJ, 2011, J APPL ECOL, V48, P961, DOI 10.1111/j.1365-2664.2011.02009.x; Johnson R., 2010, Native Plants Journal, V11, P117, DOI 10.2979/NPJ.2010.11.2.117; Jurado E, 2005, J VEG SCI, V16, P559, DOI 10.1111/j.1654-1103.2005.tb02396.x; Kimball S, 2010, GLOBAL CHANGE BIOL, V16, P1555, DOI 10.1111/j.1365-2486.2009.02106.x; Kramer AT, 2015, NAT AREA J, V35, P174, DOI 10.3375/043.035.0119; Kramer AT, 2009, TRENDS PLANT SCI, V14, P599, DOI 10.1016/j.tplants.2009.08.005; Kramer AT, 2016, PROPAGATION PROTOCOL; Larson JE, 2015, J APPL ECOL, V52, P199, DOI 10.1111/1365-2664.12350; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; MEYER SE, 1992, B TORREY BOT CLUB, V119, P268, DOI 10.2307/2996758; MEYER SE, 1995, AM J BOT, V82, P377, DOI 10.2307/2445584; MEYER SE, 1994, AM MIDL NAT, V132, P349, DOI 10.2307/2426591; Morgan David R., 2003, SIDA Contributions to Botany, V20, P1387; Nikolaeva MG, 1999, RUSS J PLANT PHYSL+, V46, P369; Pendleton RL, 2014, NATIV PLANTS, V15, P17, DOI DOI 10.3368/npj.15.1.17; Percival Scientific Inc, INT ENV CONTR; Plant Conservation Alliance, 2015, NAT SEED STRAT REH R; Plummer M., 2003, P 3 INT WORKSH DISTR; Probert R. J., 2000, Seeds: the ecology of regeneration in plant communities, P261, DOI 10.1079/9780851994321.0261; RATCLIFFE D, 1961, J ECOL, V49, P187, DOI 10.2307/2257433; Riebkes JL., 2015, NATIV PLANTS J, V16, P96, DOI [DOI 10.3368/NPJ.16.2.96, 10.3368/npj.16.2.96]; Schwinning S, 2008, ECOL SOC, P13; THOMPSON PA, 1979, GARTENBAUWISSENSCHAF, V44, P97; Turesson G, 1922, HEREDITAS, V3, P100, DOI 10.1111/j.1601-5223.1922.tb02727.x; Vleeshouwers LM, 1995, J ECOL, V83, P1031, DOI 10.2307/2261184; Wagmann K, 2012, ANN BOT-LONDON, V110, P1205, DOI 10.1093/aob/mcs194; Walck JL, 2011, GLOBAL CHANGE BIOL, V17, P2145, DOI 10.1111/j.1365-2486.2010.02368.x; Walder T, 2015, PLANT ECOL, V216, P1297, DOI 10.1007/s11258-015-0509-1; Wang JH, 2009, EVOL ECOL, V23, P827, DOI 10.1007/s10682-008-9273-1; Wang ZQ, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9875298; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Willis CG, 2014, NEW PHYTOL, V203, P300, DOI 10.1111/nph.12782; Wood TE, 2015, NAT AREA J, V35, P134, DOI 10.3375/043.035.0117; Xu JP, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-188; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872	69	16	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191931	10.1371/journal.pone.0191931	http://dx.doi.org/10.1371/journal.pone.0191931			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401470	Green Submitted, gold, Green Published			2022-12-26	WOS:000424101400026
J	Li, BY; Yang, HX; Zhang, WY; Shi, YD; Qin, ST; Wei, YM; He, YD; Yang, WS; Jiang, SJ; Jin, HY				Li, Boya; Yang, Huixia; Zhang, Wanyi; Shi, Yundi; Qin, Shengtang; Wei, Yumei; He, Yingdong; Yang, Wenshuang; Jiang, Shiju; Jin, Hongyan			Fatty acid-binding protein 4 predicts gestational hypertension and preeclampsia in women with gestational diabetes mellitus	PLOS ONE			English	Article							PREGNANCY-INDUCED HYPERTENSION; NULLIPAROUS WOMEN; BLOOD-PRESSURE; GLUCOSE; AP2; ATHEROSCLEROSIS; INTOLERANCE; DISORDERS; DISEASE; FABP4	Objective Fatty acid-binding protein 4 (FABP4) has been proposed to be a potential predictive factor of gestational hypertension or preeclampsia (GH/PE) because of its integrating metabolic and inflammatory responses. Women with gestational diabetes mellitus (GDM) are more likely to develop both GH/PE, than the normal population. The aim of our study was to examine the relationship between plasma FABP4 in the second trimester of pregnancy and the risk of GH/PE in women with GDM. Methods This was a nested case-control study conducted within a large on-going prospective cohort study conducted at Peking University First Hospital. A total of 1344 women, who were diagnosed with GDM, according to a 75 g oral glucose tolerance test, participated in the GDM One-Day Clinic at Peking University First Hospital from February 24, 2016 to February 9, 2017. Of the 748 GDM women who agreed to the blood sample collection, 637 were followed until their delivery. The cases included GDM patients who developed gestational hypertension or preeclampsia (GDM-GH/PE group, n = 41). Another 41 matched GDM women without major complications were selected as the control group (GDM group). Results The incidence of GH/PE was 6.44% and 3.30% for preeclampsia. The level of the second trimester plasma FABP4 in the GDM-GH/PE group was significantly higher than the GDM group (17.53 +/- 11.35 vs. 12.79 +/- 6.04 ng/ml, P = 0.020). The AUC ROC for the second trimester plasma FABP4 predicted GH/PE in the GDM patients alone was 0.647 (95% CI 0.529-0.766). Multivariate analysis showed that the elevated second trimester FABP4 level was independently associated with GH/PE in the GDM patients (OR 1.136 [95% CI 1.003-1.286], P = 0.045). Conclusions Increased second trimester plasma FABP4 independently predicted GH/PE in GDM patients.	[Li, Boya; Yang, Huixia; Zhang, Wanyi; Qin, Shengtang; Wei, Yumei; He, Yingdong; Yang, Wenshuang; Jiang, Shiju; Jin, Hongyan] Peking Univ, Hosp 1, Beijing, Peoples R China; [Shi, Yundi] Peking Univ, Hlth Sci Ctr, Sch Basic Med, Dept Pharmacol, Beijing, Peoples R China	Peking University; Peking University	Yang, HX (corresponding author), Peking Univ, Hosp 1, Beijing, Peoples R China.	yanghuixia@bjmu.edu.cn		Yang, Huixia/0000-0001-8954-2102; Zhang, Wanyi/0000-0002-3523-6713; YANG, HUIXIA/0000-0001-9913-2721; Boya, Li/0000-0002-9402-1608	National Natural Science Foundation of China [81490745]; Major National Scientific Research Program of China [2015CB943304]; Beijing Science and Technology Project [Z151100001615051]; National Science and Technology Support Program of China [2015BAI13B06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major National Scientific Research Program of China; Beijing Science and Technology Project; National Science and Technology Support Program of China	This study was supported by the National Natural Science Foundation of China (Grant No. 81490745 to HY), the Major National Scientific Research Program of China (Grant No. 2015CB943304 to HY), the Beijing Science and Technology Project (Grant No. Z151100001615051 to HY), and the National Science and Technology Support Program of China (Grant No. 2015BAI13B06 to HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Fu YC, 2002, ATHEROSCLEROSIS, V165, P259, DOI 10.1016/S0021-9150(02)00305-2; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Hypertensive Disorders in Pregnancy Subgroup Chinese Society of Obstetrics and Gynecology Chinese Medical Association, 2015, Zhonghua Fu Chan Ke Za Zhi, V50, P721; Joffe GM, 1998, AM J OBSTET GYNECOL, V179, P1032, DOI 10.1016/S0002-9378(98)70210-8; Kralisch S, 2013, DIABETOLOGIA, V56, P10, DOI 10.1007/s00125-012-2737-4; Kralisch S, 2009, EUR J ENDOCRINOL, V160, P33, DOI 10.1530/EJE-08-0540; Li Yuan-yuan, 2015, Med Sci Monit, V21, P426, DOI 10.12659/MSM.892431; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Miyakoshi K, 2004, DIABETES RES CLIN PR, V64, P201, DOI 10.1016/j.diabres.2003.11.002; Obstetrics Subgroup Chinese Society of Obstetrics and Gynecology Chinese Medical Association, 2014, Zhonghua Fu Chan Ke Za Zhi, V49, P561; Ortega-Senovilla H, 2011, DIABETES CARE, V34, P2061, DOI 10.2337/dc11-0715; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Salzer L, 2015, BEST PRACT RES CL OB, V29, P328, DOI 10.1016/j.bpobgyn.2014.09.008; Scifres CM, 2012, J CLIN ENDOCR METAB, V97, pE349, DOI 10.1210/jc.2011-2276; Scifres CM, 2011, J CLIN ENDOCR METAB, V96, pE1083, DOI 10.1210/jc.2010-2084; Stejskal D, 2006, EUR J CLIN INVEST, V36, P621, DOI 10.1111/j.1365-2362.2006.01696.x; Sun Wei-Jie, 2007, Zhonghua Fu Chan Ke Za Zhi, V42, P377; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Tuuri AL, 2014, PLACENTA, V35, P797, DOI 10.1016/j.placenta.2014.07.016; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; Vambergue A, 2002, EUR J OBSTET GYN R B, V102, P31, DOI 10.1016/S0301-2115(01)00556-5; Wotherspoon AC, 2016, DIABETES CARE, V39, P1827, DOI 10.2337/dc16-0803; Yamada M, 2015, J NUTR SCI VITAMINOL, V61, P291, DOI 10.3177/jnsv.61.291; Yang Hui-xia, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P577; Yeung DCY, 2007, ARTERIOSCL THROM VAS, V27, P1796, DOI 10.1161/ATVBAHA.107.146274; Zhang Y, 2016, J DIABETES INVEST, V7, P797, DOI 10.1111/jdi.12484; Zhu Yuchun ZW, 2016, CHINESE J DIABETES M, V8	29	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192347	10.1371/journal.pone.0192347	http://dx.doi.org/10.1371/journal.pone.0192347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394285	gold, Green Published, Green Submitted			2022-12-26	WOS:000424060400036
J	Shelus, V; Taylor, J; Greene, E; Stanton, J; Pack, A; Tolley, EE; Branson, BM; El-Sadr, WM; Pollydore, J; Gamble, T				Shelus, Victoria; Taylor, Jamilah; Greene, Elizabeth; Stanton, Jill; Pack, Allison; Tolley, Elizabeth E.; Branson, Bernard M.; El-Sadr, Wafaa M.; Pollydore, June; Gamble, Theresa			It's all in the timing: Acceptability of a financial incentive intervention for linkage to HIV care in the HPTN 065 (TLC-Plus) study	PLOS ONE			English	Article							CONTINGENCY MANAGEMENT; MEDICATION ADHERENCE; METHADONE PATIENTS; UNITED-STATES; REINFORCEMENT; INFECTION; PROGRAM; TRIAL	The HPTN 065 (TLC-Plus) study tested the feasibility and effectiveness of using financial incentives (FIs) to increase linkage to care (L2C) among individuals with newly diagnosed HIV and those out of care in the Bronx, NY and Washington, DC. Qualitative data collection with a subset of participating patients and staff focused on experiences with and attitudes about the FI intervention. Semi-structured interviews were conducted with 15 patients and 14 site investigators. Four focus group discussions were conducted with a total of 15 staff members. The use of FIs for L2C was generally viewed favorably. Patients were grateful and benefited financially, but sites had some challenges implementing the program. Challenges included the timing and sensitive introduction of the intervention immediately after an HIV diagnosis, negative attitudes towards paying people for health behaviors, and the existence and strength of existing linkage programs. Future programs should consider optimal timing and presentation of FIs.	[Shelus, Victoria; Greene, Elizabeth; Stanton, Jill; Pack, Allison; Gamble, Theresa] FHI 360, HPTN Leadership & Operat Ctr, Sci Facilitat, Durham, NC 27701 USA; [Taylor, Jamilah; Tolley, Elizabeth E.] FHI 360, Behav Epidemiol & Clin Sci, Durham, NC USA; [Branson, Bernard M.] Sci Affairs LLC, Atlanta, GA USA; [El-Sadr, Wafaa M.] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA; [Pollydore, June] Womens Collect, Washington, DC USA; [Shelus, Victoria] Univ N Carolina, Gillings Sch Publ Hlth, Hlth Behav Dept, Chapel Hill, NC USA	FHI 360; FHI 360; Columbia University; University of North Carolina; University of North Carolina Chapel Hill	Gamble, T (corresponding author), FHI 360, HPTN Leadership & Operat Ctr, Sci Facilitat, Durham, NC 27701 USA.	tgamble@fhi360.org		Shelus, Victoria/0000-0001-7418-6002	National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Mental Health (NIMH); National Institute on Drug Abuse (NIDA), of the U.S. National Institutes of Health (NIH) [UM1 AI 068619]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse (NIDA), of the U.S. National Institutes of Health (NIH)	The HIV Prevention Trials Network (HPTN) 065 qualitative substudy was sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Mental Health (NIMH), and the National Institute on Drug Abuse (NIDA), of the U.S. National Institutes of Health (NIH), under Cooperative Agreements #UM1 AI 068619. The funder provided support in the form of salaries for authors [VS, JT, EG, JS, AP, ET and WME], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID, NIMH, NIDA or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, HIV SURV REP; Ashcroft RE, 2011, HEALTH EXPECT, V14, P191, DOI 10.1111/j.1369-7625.2011.00664.x; Barnett PG, 2009, DRUG ALCOHOL DEPEN, V100, P115, DOI 10.1016/j.drugalcdep.2008.09.017; Bradley H, 2014, MMWR-MORBID MORTAL W, V63, P1113; Centers for Disease Control and Prevention, 2016, HIV SURV SUPPL REP 2, V21; DECI EL, 1994, J PERS, V62, P119, DOI 10.1111/j.1467-6494.1994.tb00797.x; El-Sadr WM, 2017, JAMA INTERN MED, V177, P1083, DOI 10.1001/jamainternmed.2017.2158; Farber S, 2013, AIDS BEHAV, V17, P2293, DOI 10.1007/s10461-013-0416-1; Foster C, 2014, AIDS PATIENT CARE ST, V28, P28, DOI 10.1089/apc.2013.0262; Giles EL, 2015, PREV MED, V73, P145, DOI 10.1016/j.ypmed.2014.12.029; Giles EL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1409-y; Giles EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090347; Gneezy U, 2011, J ECON PERSPECT, V25, P191, DOI 10.1257/jep.25.4.191; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Haukoos JS, 2005, ACAD EMERG MED, V12, P617, DOI 10.1111/j.1553-2712.2005.tb00916.x; Javanbakht Marjan, 2006, J Int Assoc Physicians AIDS Care (Chic), V5, P143, DOI 10.1177/1545109706291706; Krawczyk CS, 2006, AIDS CARE, V18, pS35, DOI 10.1080/09540120600839280; Loewenstein G, 2012, JAMA-J AM MED ASSOC, V307, P1375, DOI 10.1001/jama.2012.387; Marteau TM, 2009, BMJ, V338; McCoy SI, 2013, JAIDS-J ACQ IMM DEF, V63, pE56, DOI 10.1097/QAI.0b013e31828a7629; Mehrotra A, 2010, AM J MANAG CARE, V16, P497; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Nglazi MD, 2012, JAIDS-J ACQ IMM DEF, V59, pE28, DOI 10.1097/QAI.0b013e31824445f0; Oliver A, 2012, J HEALTH POLIT POLIC, V37, P201, DOI 10.1215/03616878-1538602; Petry NM, 2010, ADDICTION, V105, P1507, DOI 10.1111/j.1360-0443.2009.02879.x; Promberger M, 2011, J MED ETHICS, V37, P682, DOI 10.1136/jme.2010.039347; Rigsby MO, 2000, J GEN INTERN MED, V15, P841, DOI 10.1046/j.1525-1497.2000.00127.x; Rosen MI, 2007, AIDS PATIENT CARE ST, V21, P30, DOI 10.1089/apc.2006.0028; Skinner BF., 1953, SCI HUMAN BEHAV SIM; Solomon SS, 2014, CLIN INFECT DIS, V59, P589, DOI 10.1093/cid/ciu324; Sorensen JL, 2007, DRUG ALCOHOL DEPEN, V88, P54, DOI 10.1016/j.drugalcdep.2006.09.019; Thornton RL, 2008, AM ECON REV, V98, P1829, DOI 10.1257/aer.98.5.1829; Tolley E, 2016, QUALITATIVE METHODS, P85; Weihs M, 2014, SAHARA J-J SOC ASP H, V11, P116, DOI 10.1080/17290376.2014.937739; Zou HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051919	35	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191638	10.1371/journal.pone.0191638	http://dx.doi.org/10.1371/journal.pone.0191638			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU7VI	29394259	gold, Green Published, Green Submitted			2022-12-26	WOS:000424060400016
J	Gaglio, D; Cook, TR; McInnes, A; Sherley, RB; Ryan, PG				Gaglio, Davide; Cook, Timothee R.; McInnes, Alistair; Sherley, Richard B.; Ryan, Peter G.			Foraging plasticity in seabirds: A non-invasive study of the diet of greater crested terns breeding in the Benguela region	PLOS ONE			English	Article							PENGUINS SPHENISCUS-DEMERSUS; ANCHOVY ENGRAULIS-CAPENSIS; SOUTHERN BENGUELA; MORUS-CAPENSIS; PREY DEPLETION; BIRD ISLAND; CHICK; ROSEATE; FOOD; AVAILABILITY	Marine predators, such as seabirds, are useful indicators of marine ecosystem functioning. In particular, seabird diet may reflect variability in food-web composition due to natural or human-induced environmental change. Diet monitoring programmes, which sample diet non-invasively, are valuable aids to conservation and management decision-making. We investigated the diet of an increasing population of greater crested terns Thalasseus bergii in the Western Cape, South Africa, during three successive breeding seasons (2013 to 2015), when populations of other seabirds feeding on small pelagic schooling fish in the region were decreasing. Breeding greater crested terns carry prey in their bills, so we used an intensive photo-sampling method to record their diet with little disturbance. We identified 24,607 prey items from at least 47 different families, with 34 new prey species recorded. Fish dominated the diet, constituting 94% of prey by number, followed by cephalopods (3%), crustaceans (2%) and insects (1%). The terns mainly targeted surface-schooling Clupeiformes, with anchovy Engraulis encrasicolus the most abundant prey in all three breeding seasons (65% overall). Prey composition differed significantly between breeding stages and years, with anchovy most abundant at the start of the breeding season, becoming less frequent as the season progressed. The proportion of anchovy in the diet also was influenced by environmental factors; anchovy occurred more frequently with increasing wind speeds and was scarce on foggy days, presumably because terns rely in part on social facilitation to locate anchovy schools. The application of this intensive and non-invasive photo-sampling method revealed an important degree of foraging plasticity for this seabird within a context of locally reduced food availability, suggesting that, unlike species that specialise on a few high-quality prey, opportunistic seabirds may be better able to cope with reductions in the abundance of their preferred prey.	[Gaglio, Davide; Cook, Timothee R.; Sherley, Richard B.; Ryan, Peter G.] Univ Cape Town, DST NRF Ctr Excellence, FitzPatrick Inst African Ornithol, Rondebosch, South Africa; [Cook, Timothee R.] Univ Paris 06, Evolutionary Ecophysiol Team, Inst Ecol & Environm Sci, Batiment Paris, Paris, France; [McInnes, Alistair] Nelson Mandela Univ, Dept Zool, FitzPatrick Inst African Ornithol, DST NRF Ctr Excellence, Summerstrand, South Africa; [Sherley, Richard B.] Univ Exeter, Environm & Sustainabil Inst, Penryn Campus, Penryn, Cornwall, England	National Research Foundation - South Africa; University of Cape Town; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); National Research Foundation - South Africa; Nelson Mandela University; University of Exeter	Gaglio, D (corresponding author), Univ Cape Town, DST NRF Ctr Excellence, FitzPatrick Inst African Ornithol, Rondebosch, South Africa.	swift.terns@gmail.com	Sherley, Richard B/D-7507-2012	Sherley, Richard B/0000-0001-7367-9315	Department of Science and Technology-Centre of Excellence grant; Leiden Conservation Foundation	Department of Science and Technology-Centre of Excellence grant; Leiden Conservation Foundation	This work was supported by a Department of Science and Technology-Centre of Excellence grant to the FitrPatrick Institute of African Ornithology. RBS was supported by a fellowship from the Leiden Conservation Foundation.; Our research was supported by a Department of Science and Technology-Centre of Excellence grant to the FitzPatrick Institute of African Ornithology and the Leiden Conservation Foundation (RBS). Robben Island Museum provided logistical support and access to the tern colony. The South African Weather Service kindly provided weather data from Robben Island. We thank the late Barrie Rose, Bruce Dyer, Carl van der Lingen, Rob Leslie, Bryan Maritz, Charles Griffiths, Mike Picker and Jean-Paul Roux for assistance with prey identification. This research was approved by SANParks (CONM1182), the Department of Environmental Affairs (RES2013/24, RES2014/83, RES2015/65) and the animal ethics committee of the University of Cape Town (2013/V3/TC) and Nelson Mandela University (A14-SCI-ZOO-003).	ABELLO P, 1990, S AFR J MARINE SCI, V9, P169; Arthur KE, 2008, PAC SCI, V62, P205, DOI 10.2984/1534-6188(2008)62[205:ACOIGT]2.0.CO;2; Barrett RT, 2007, ICES J MAR SCI, V64, P1675, DOI 10.1093/icesjms/fsm152; BATCHELOR AL, 1984, OSTRICH, V55, P45, DOI 10.1080/00306525.1984.9634757; BERRUTI A, 1993, COLON WATERBIRD, V16, P158, DOI 10.2307/1521434; BirdLife International, 2017, IUCN RED LIST BIRDS; BIRT VL, 1987, MAR ECOL PROG SER, V40, P205, DOI 10.3354/meps040205; Blamey LK, 2015, J MARINE SYST, V144, P9, DOI 10.1016/j.jmarsys.2014.11.006; Blamey LK, 2012, PROG OCEANOGR, V106, P80, DOI 10.1016/j.pocean.2012.07.001; Bocard D., 2011, NUMERICAL ECOLOGY R; Braby J., 2011, THESIS; Branch GM., 2010, 2 OCEANS GUIDE MARIN, DOI DOI 10.1038/NMETH.3869; Campbell K., 2016, THESIS; Cherel Y, 2008, MAR ECOL PROG SER, V366, P281, DOI 10.3354/meps07587; Chiaradia A, 2002, EMU, V102, P367, DOI 10.1071/MU02004; CRAM DL, 1974, J CONSEIL, V35, P272; Crawford RJ, 2016, CLIMATE CHANGE MARIN, V3, P1; CRAWFORD RJM, 1995, IBIS, V137, P329, DOI 10.1111/j.1474-919X.1995.tb08029.x; Crawford RJM, 2005, ROBERTS BIRDS SO AFR, P453; Crawford RJM, 2014, OSTRICH, V85, P111, DOI 10.2989/00306525.2014.955141; Crawford RJM, 2009, PROG OCEANOGR, V83, P398, DOI 10.1016/j.pocean.2009.07.021; Cury P, 2004, PROG OCEANOGR, V60, P223, DOI 10.1016/j.pocean.2004.02.007; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Davoren GK, 1999, ANIM BEHAV, V58, P853, DOI 10.1006/anbe.1999.1209; DRENT RH, 1980, ARDEA, V68, P225; Duffy D.C., 1987, Cormorant, V14, P46; DUNN EK, 1973, NATURE, V244, P520, DOI 10.1038/244520a0; Elliott KH, 2015, MAR BIOL, V162, P1739, DOI 10.1007/s00227-015-2701-1; Fauchald P, 2009, MAR ECOL PROG SER, V391, P139, DOI 10.3354/meps07818; Fijn Ruben C., 2012, Marine Ornithology, V40, P81; Furness RW, 2000, MAR ECOL PROG SER, V202, P253, DOI 10.3354/meps202253; Gaglio D., 2017, THESIS; Gaglio D, 2017, METHODS ECOL EVOL, V8, P214, DOI 10.1111/2041-210X.12643; Gaglio Davide, 2015, Marine Ornithology, V43, P131; Gaston AJ, 2014, MAR ECOL PROG SER, V513, P211, DOI 10.3354/meps10945; Green DB, 2015, ICES J MAR SCI, V72, P771, DOI 10.1093/icesjms/fsu203; Gremillet D, 2008, P R SOC B, V275, P1149, DOI 10.1098/rspb.2007.1763; Gremillet D, 2012, MAR ECOL PROG SER, V454, P197, DOI 10.3354/meps09590; Griffiths CL, 2004, OCEANOGR MAR BIOL, V42, P303; Hutchings L, 1998, S AFR J MARINE SCI, V19, P211; Hutchings L, 2014, COMMENTS RIVER MODEL; JACKSON S, 1986, AUK, V103, P617; JAMES AG, 1987, S AFR J MARINE SCI, V5, P673, DOI 10.2989/025776187784522784; Karnovsky NJ, 2012, MAR ECOL PROG SER, V451, P263, DOI 10.3354/meps09713; KLAGES NTW, 1992, S AFR J MARINE SCI, V12, P761; Labbe AMT, 2013, MAR FRESHWATER RES, V64, P1184, DOI 10.1071/MF12334; Lack D., 1968, pvii; Lescroel A, 2016, MAR POLICY, V68, P212, DOI 10.1016/j.marpol.2016.02.015; Ludynia K, 2010, AFR J MAR SCI, V32, P563, DOI 10.2989/1814232X.2010.538151; Lyons DE, 2005, WATERBIRDS, V28, P280, DOI 10.1675/1524-4695(2005)028[0280:FEOCTI]2.0.CO;2; Makhado AB, 2013, INTERNAL REPORT, P1; Martins I, 2004, ECOL MODEL, V177, P95, DOI 10.1016/j.ecolmodel.2004.02.002; McLeay LJ, 2009, ICES J MAR SCI, V66, P237, DOI 10.1093/icesjms/fsn195; McLeay LJ, 2009, MAR BIOL, V156, P1765, DOI 10.1007/s00227-009-1211-4; Minich L., 2001, THESIS; MONAGHAN P, 1992, ARDEA, V80, P70; Nicholson L., 2002, THESIS; Orians G.H., 1979, P155; Paiva VH, 2006, BIRD STUDY, V53, P1; Passuni G, 2016, ECOLOGY, V97, P182, DOI 10.1890/14-1134.1; Piatt JF, 2007, MAR ECOL PROG SER, V352, P221, DOI 10.3354/meps07078; Pichegru L, 2007, MAR ECOL PROG SER, V350, P127, DOI 10.3354/meps07128; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2017, R LANG ENV STAT COMP; Ramos JA, 2002, MAR ECOL PROG SER, V243, P271, DOI 10.3354/meps243271; ROEL BA, 1991, S AFR J MARINE SCI, V11, P267, DOI 10.2989/025776191784287655; Ryan Peter, 2017, Promerops, V307, P19; Ryan PG, 2012, ARDEA, V100, P89, DOI 10.5253/078.100.0113; SAFINA C, 1990, J FIELD ORNITHOL, V61, P331; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Shannon V, 2006, LAR MAR ECOSYST, V14, P3; Shealer DA, 1998, CONDOR, V100, P131, DOI 10.2307/1369904; Sherley RB, 2017, CURR BIOL, V27, P563, DOI 10.1016/j.cub.2016.12.054; Sorensen MC, 2009, J ANIM ECOL, V78, P460, DOI 10.1111/j.1365-2656.2008.01492.x; TAYLOR IR, 1983, ORNIS SCAND, V14, P90, DOI 10.2307/3676011; Thorpe W. H., 1956, British Birds, V49, P389; Tremblay Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088424; van der Lingen CD, 2003, BIG FISH BANG, P303; Van der Lingen CD, 2002, S AFR J MARINE SCI, V24, P301, DOI 10.2989/025776102784528691; Votier SC, 2003, POLAR BIOL, V26, P20, DOI 10.1007/s00300-002-0446-z; WALTER CB, 1987, OSTRICH, V58, P49, DOI 10.1080/00306525.1987.9634141; Watermeyer KE, 2008, AFR J MAR SCI, V30, P383, DOI 10.2989/AJMS.2008.30.2.12.562; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur Alain F., 2009, P1	85	17	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0190444	10.1371/journal.pone.0190444	http://dx.doi.org/10.1371/journal.pone.0190444			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385167	Green Published, Green Submitted, gold			2022-12-26	WOS:000423668400017
J	Kumeta, M; Takahashi, D; Takeyasu, K; Yoshimura, SH				Kumeta, Masahiro; Takahashi, Daiji; Takeyasu, Kunio; Yoshimura, Shige H.			Cell type-specific suppression of mechanosensitive genes by audible sound stimulation	PLOS ONE			English	Article							INTENSITY PULSED ULTRASOUND; TISSUE GROWTH-FACTOR; AU-RICH ELEMENTS; MESSENGER-RNA; MECHANICAL-STRESS; ANABOLIC RESPONSE; FRACTURE MODEL; TENASCIN-C; MECHANOTRANSDUCTION; ACTIVATION	Audible sound is a ubiquitous environmental factor in nature that transmits oscillatory compressional pressure through the substances. To investigate the property of the sound as a mechanical stimulus for cells, an experimental system was set up using 94.0 dB sound which transmits approximately 10 mPa pressure to the cultured cells. Based on research on mechanotransduction and ultrasound effects on cells, gene responses to the audible sound stimulation were analyzed by varying several sound parameters: frequency, wave form, composition, and exposure time. Real-time quantitative PCR analyses revealed a distinct suppressive effect for several mechanosensitive and ultrasound-sensitive genes that were triggered by sounds. The effect was clearly observed in a wave form-and pressure level-specific manner, rather than the frequency, and persisted for several hours. At least two mechanisms are likely to be involved in this sound response: transcriptional control and RNA degradation. ST2 stromal cells and C2C12 myoblasts exhibited a robust response, whereas NIH3T3 cells were partially and NB2a neuroblastoma cells were completely insensitive, suggesting a cell type-specific response to sound. These findings reveal a cell-level systematic response to audible sound and uncover novel relationships between life and sound.	[Kumeta, Masahiro; Takeyasu, Kunio; Yoshimura, Shige H.] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Takahashi, Daiji] Kyoto Univ, Grad Sch Engn, Kyoto, Japan; [Takeyasu, Kunio] Natl Taiwan Univ, Ctr Biotechnol, Taipei, Taiwan	Kyoto University; Kyoto University; National Taiwan University	Kumeta, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan.	kumeta@lif.kyoto-u.ac.jp	Yoshimura, Shige H./AAF-5463-2019	Yoshimura, Shige H./0000-0001-6033-1301	SPIRITS: Supporting Program for Interaction-based Initiative Team Studies from Kyoto University; KAKENHI Challenging Research: Exploratory from Japan Society for the Promotion of Science [JP17K19394]; JSPS KAKENHI [JP17K19394]; Advanced Research & Development Programs for Medical Innovation Grant from the Japan Agency for Medical Research and Development [16gm5810018h0001]	SPIRITS: Supporting Program for Interaction-based Initiative Team Studies from Kyoto University; KAKENHI Challenging Research: Exploratory from Japan Society for the Promotion of Science; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Advanced Research & Development Programs for Medical Innovation Grant from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by SPIRITS: Supporting Program for Interaction-based Initiative Team Studies (to M.K.) from Kyoto University (http://research.kyoto-u.ac.jp/service/topic/spirits/lists/h26list/sprits_h26ja_kumeta/), the Advanced Research & Development Programs for Medical Innovation from the Japan Agency for Medical Research and Development (No. 16gm5810018h0001 to S.H.Y.) (http://www.amed.go.jp/koubo//010720160323_kettei_kadai02.html), and KAKENHI Challenging Research: Exploratory (No. JP17K19394 to M.K.) from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. A. Ichimura (Kyoto University) and Dr. M. Otani (Kyoto University) for technical supports and discussions. This work was supported by SPIRITS: Supporting Program for Interaction-based Initiative Team Studies (to M.K.) from Kyoto University, JSPS KAKENHI Grant number JP17K19394 (Challenging Research: Exploratory) (to M.K.), and the Advanced Research & Development Programs for Medical Innovation Grant number 16gm5810018h0001 from the Japan Agency for Medical Research and Development (to SH. Y.).	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Asparuhova MB, 2011, FASEB J, V25, P3477, DOI 10.1096/fj.11-187310; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Box MS, 2015, CURR BIOL, V25, P194, DOI 10.1016/j.cub.2014.10.076; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Chiquet M, 2004, BBA-MOL CELL RES, V1693, P193, DOI 10.1016/j.bbamcr.2004.08.001; Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012; Chowdhury I, 2004, EUR J BIOCHEM, V271, P4436, DOI 10.1111/j.1432-1033.2004.04382.x; Chowdhury TT, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2389; Cok SJ, 2003, J BIOL CHEM, V278, P36157, DOI 10.1074/jbc.M302547200; Dalla-Bona DA, 2008, ARCH ORAL BIOL, V53, P318, DOI 10.1016/j.archoralbio.2007.11.006; Davies PF, 1997, ANNU REV PHYSIOL, V59, P527, DOI 10.1146/annurev.physiol.59.1.527; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Heo SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16895; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Honjo T, 2012, J CELL COMMUN SIGNAL, V6, P225, DOI 10.1007/s12079-012-0177-z; Iyer KV, 2012, BIOPHYS J, V103, P1416, DOI 10.1016/j.bpj.2012.08.041; Karshafian R, 2009, ULTRASOUND MED BIOL, V35, P847, DOI 10.1016/j.ultrasmedbio.2008.10.013; Katiyar A, 2014, J THER ULTRASOUND, V2, DOI 10.1186/2050-5736-2-1; Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200; Kokubu T, 1999, BIOCHEM BIOPH RES CO, V256, P284, DOI 10.1006/bbrc.1999.0318; Krasovitski B, 2011, P NATL ACAD SCI USA, V108, P3258, DOI 10.1073/pnas.1015771108; Louw TM, 2013, ULTRASOUND MED BIOL, V39, P1303, DOI 10.1016/j.ultrasmedbio.2013.01.015; Maki K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24878; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.E06-12-1079; Mizrahi N, 2012, SOFT MATTER, V8, P2438, DOI 10.1039/c2sm07246g; Naruse K, 2000, BIOCHEM BIOPH RES CO, V268, P216, DOI 10.1006/bbrc.2000.2094; Naruse K, 2003, J BONE MINER RES, V18, P360, DOI 10.1359/jbmr.2003.18.2.360; OGAWA M, 1988, EMBO J, V7, P1337, DOI 10.1002/j.1460-2075.1988.tb02949.x; Or M, 2009, ULTRASOUND MED BIOL, V35, P1015, DOI 10.1016/j.ultrasmedbio.2008.11.011; Padilla F, 2014, ULTRASONICS, V54, P1125, DOI 10.1016/j.ultras.2014.01.004; Park D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09846; Rauch C, 2002, AM J PHYSIOL-CELL PH, V283, pC235, DOI 10.1152/ajpcell.00234.2001; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; SACKIN H, 1995, ANNU REV PHYSIOL, V57, P333, DOI 10.1146/annurev.ph.57.030195.002001; Schild C, 2002, EXP CELL RES, V274, P83, DOI 10.1006/excr.2001.5458; Shivashankar GV, 2011, ANNU REV BIOPHYS, V40, P361, DOI 10.1146/annurev-biophys-042910-155319; Stoecklin G, 2007, GENE DEV, V21, P627, DOI 10.1101/gad.1538807; Takikawa S, 2001, J ULTRAS MED, V20, P197, DOI 10.7863/jum.2001.20.3.197; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; Thorpe SD, 2017, NUCLEUS-PHILA, V8, P287, DOI 10.1080/19491034.2017.1285988; Tsukamoto A, 2013, APPL ACOUST, V74, P1117, DOI 10.1016/j.apacoust.2013.04.001; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Yang KH, 1996, J ORTHOP RES, V14, P802, DOI 10.1002/jor.1100140518; Yoshida M, 2015, P NATL ACAD SCI USA, V112, P2764, DOI 10.1073/pnas.1415525112; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	52	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0188764	10.1371/journal.pone.0188764	http://dx.doi.org/10.1371/journal.pone.0188764			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385174	Green Submitted, Green Published, gold			2022-12-26	WOS:000423668400004
J	Lee, TH; Sung, MS; Heo, H; Park, SW				Lee, Tae Hee; Sung, Mi Sun; Heo, Hwan; Park, Sang Woo			Association between meibomian gland dysfunction and compliance of topical prostaglandin analogs in patients with normal tension glaucoma	PLOS ONE			English	Article							OCULAR SURFACE DISEASE; DRY EYE SYNDROME; LONG-TERM; BENZALKONIUM CHLORIDE; INTERNATIONAL WORKSHOP; INTRAOCULAR-PRESSURE; CONJUNCTIVAL CHANGES; IMPRESSION CYTOLOGY; MEDICATION; PREVALENCE	Purpose The aim of this study was to investigate the association between tear film and meibomian gland parameters in patients with normal tension glaucoma (NTG), who underwent topical prostaglandin analog (PGA) monotherapy, and medication compliance. Methods Ocular surface disease index (OSDI), Schirmer's test, tear film break-up time (TBUT), keratoepitheliopathy (KEP) score with fluorescein, and meibomian gland parameters were assessed in 45 eyes of 45 patients with NTG (NTG group), who received topical PGA monotherapy for more than 1 year. The results were compared to those of 40 eyes of 40 normal subjects (control group). Medication compliance was assessed by an 8-item Morisky Medication Adherence Scale (MMAS-8). Multiple logistic regression analysis was used to identify the factors associated with medication compliance. Results There was a significant difference in OSDI (P = 0.043), Schirmer's test (P < 0.001), TBUT (P < 0.001), KEP score (P = 0.015) and all meibomian gland parameters (all P < 0.001) between two groups. When the NTG group was divided into compliant and non-compliant groups based on the scores of MMAS-8, 30 (75%) patients were classified into the compliant group. Multiple logistic regression analysis revealed that the lid margin score (OR, 0.256; 95% CI, 0.072-0.908, P = 0.035), meibum score (OR, 0.144; 95% CI, 0.023-0.915, P = 0.04), and meibo score (OR, 0.344; 95% CI, 0.140-0.845, P = 0.02) were significant factors associated with compliance in patients with NTG. The meibomian gland parameters showed a negative correlation with medication compliance (all P < 0.005). Conclusions Malfunction of the meibomian glands can be an important clinical finding associated with compliance of PGA monotherapy in patients with NTG.	[Lee, Tae Hee; Sung, Mi Sun; Heo, Hwan; Park, Sang Woo] Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Gwangju, South Korea	Chonnam National University	Park, SW (corresponding author), Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Gwangju, South Korea.	exo70@naver.com			National Research Foundation of Korea - Ministry of Education, Seoul, Korea [NRF-2015R1D1A1A01059630]	National Research Foundation of Korea - Ministry of Education, Seoul, Korea	This research was supported by the Basic Science Research program through the National Research Foundation of Korea funded by the Ministry of Education (NRF-2015R1D1A1A01059630), Seoul, Korea. The funding organizations had no role in the design or conduct of this research.	Alm A, 2008, SURV OPHTHALMOL, V53, pS93, DOI 10.1016/j.survophthal.2008.08.004; Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI 10.1016/j.ophtha.2007.06.031; Arita R, 2012, CORNEA, V31, P1229, DOI 10.1097/ICO.0b013e31823f8e7d; BAUDOUIN C, 1994, OPHTHALMOLOGY, V101, P454; Baudouin C, 1998, BRIT J OPHTHALMOL, V82, P39, DOI 10.1136/bjo.82.1.39; Baudouin C, 2008, OPHTHALMOLOGY, V115, P109, DOI 10.1016/j.ophtha.2007.01.036; Baudouin C, 2007, INVEST OPHTH VIS SCI, V48, P4123, DOI 10.1167/iovs.07-0266; Baudouin C, 2013, EUR J OPHTHALMOL, V23, P47, DOI 10.5301/ejo.5000181; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; Bengtsson B, 2007, OPHTHALMOLOGY, V114, P205, DOI 10.1016/j.ophtha.2006.07.060; BRANDT JD, 1991, AM J OPHTHALMOL, V112, P297, DOI 10.1016/S0002-9394(14)76730-3; BROADWAY DC, 1994, ARCH OPHTHALMOL-CHIC, V112, P1437, DOI 10.1001/archopht.1994.01090230051020; Bron A J, 2004, Ocul Surf, V2, P149; Chawla A, 2007, ACTA OPHTHALMOL SCAN, V85, P464, DOI 10.1111/j.1600-0420.2007.00882.x; Ciancaglini M, 2008, EUR J OPHTHALMOL, V18, P400, DOI 10.1177/112067210801800314; Cvenkel B, 2015, CLIN OPHTHALMOL, V9, P625, DOI 10.2147/OPTH.S81247; de Oliveira AD, 2014, RES SOC ADMIN PHARM, V10, P554, DOI 10.1016/j.sapharm.2013.10.006; Fechtner RD, 2010, CORNEA, V29, P618, DOI 10.1097/ICO.0b013e3181c325b2; Foulks GN, 2012, OPHTHALMOLOGY, V119, pS1, DOI 10.1016/j.ophtha.2012.06.064; Garcia-Feijoo J, 2012, CLIN OPHTHALMOL, V6, P441, DOI 10.2147/OPTH.S29158; Ghosh S, 2012, CLIN EXP OPHTHALMOL, V40, P675, DOI 10.1111/j.1442-9071.2012.02781.x; HERRERAS JM, 1992, OPHTHALMOLOGY, V99, P1082; Hong JX, 2013, CORNEA, V32, P716, DOI 10.1097/ICO.0b013e3182714425; Jean MD, 1999, INVEST OPHTH VIS SCI, V40, P619; JESTER JV, 1981, INVEST OPHTH VIS SCI, V20, P537; Jung Hyun Ho, 2015, Chonnam Med J, V51, P26, DOI 10.4068/cmj.2015.51.1.26; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kekale M, 2014, PATIENT PREFER ADHER, V8, P1619, DOI 10.2147/PPA.S70712; Kim Jee Hyun, 2015, Korean J Ophthalmol, V29, P270, DOI 10.3341/kjo.2015.29.4.270; Knop E, 2011, INVEST OPHTH VIS SCI, V52, P1938, DOI 10.1167/iovs.10-6997c; Krousel-Wood M, 2009, AM J MANAG CARE, V15, P59; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Martone G, 2009, AM J OPHTHALMOL, V147, P725, DOI 10.1016/j.ajo.2008.10.019; Mocan MC, 2016, J GLAUCOMA, V25, P770, DOI 10.1097/IJG.0000000000000495; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Nelson JD, 2011, INVEST OPHTH VIS SCI, V52, P1930, DOI 10.1167/iovs.10-6997b; Newman-Casey PA, 2015, OPHTHALMOLOGY, V122, P1308, DOI 10.1016/j.ophtha.2015.03.026; Nichols KK, 2011, INVEST OPHTH VIS SCI, V52, P1922, DOI 10.1167/iovs.10-6997a; NICOLAIDES N, 1989, INVEST OPHTH VIS SCI, V30, P946; Noecker R, 2001, ADV THER, V18, P205, DOI 10.1007/BF02853166; Noecker RJ, 2004, CORNEA, V23, P490, DOI 10.1097/01.ico.0000116526.57227.82; Rosin LM, 2013, CLIN OPHTHALMOL, V7, P2131, DOI 10.2147/OPTH.S41358; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; SHERWOOD MB, 1989, OPHTHALMOLOGY, V96, P327, DOI 10.1016/S0161-6420(89)32888-0; Shimazaki J, 1998, OPHTHALMOLOGY, V105, P1485, DOI 10.1016/S0161-6420(98)98033-2; Shin J, 2014, J OCUL PHARMACOL TH, V30, P803, DOI 10.1089/jop.2014.0034; Srinivasan S, 2012, OPTOMETRY VISION SCI, V89, P788, DOI 10.1097/OPX.0b013e318253de93; Tsai JH, 2006, CORNEA, V25, P530, DOI 10.1097/01.ico.0000220776.93852.d9; Yee RW, 2007, CURR OPIN OPHTHALMOL, V18, P134, DOI 10.1097/ICU.0b013e328089f1c8; Yoon KC, 2006, CORNEA, V25, P268, DOI 10.1097/01.ico.0000183484.85636.b6; Yoon KC, 2011, CORNEA, V30, P972, DOI 10.1097/ICO.0b013e31820687dd; 최정한, 2013, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V54, P745	53	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191398	10.1371/journal.pone.0191398	http://dx.doi.org/10.1371/journal.pone.0191398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385185	Green Submitted, Green Published, gold			2022-12-26	WOS:000423668400047
J	Wu, SH; Lu, IC; Lee, SS; Kwan, AL; Chai, CY; Huang, SH				Wu, Sheng-Hua; Lu, I-Cheng; Lee, Su-Shin; Kwan, Aij-Lie; Chai, Chee-Yin; Huang, Shu-Hung			Erythropoietin attenuates motor neuron programmed cell death in a burn animal model	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; TRAUMATIC BRAIN-INJURY; SKELETAL-MUSCLE APOPTOSIS; ALZHEIMERS-DISEASE; RAT MODEL; NEUROINFLAMMATION; ACTIVATION; IMPROVES; INFLAMMATION; MICROGLIA	Burn-induced neuromuscular dysfunction may contribute to long-term morbidity; therefore, it is imperative to develop novel treatments. The present study investigated whether erythropoietin (EPO) administration attenuates burn-induced motor neuron apoptosis and neuro-inflammatory response. To validate our hypothesis, a third-degree hind paw burn rat model was developed by bringing the paw into contact with a metal surface at 75 degrees C for 10 s. A total of 24 male Sprague-Dawley rats were randomly assigned to four groups: Group A, sham-control; Group B, burn-induced; Group C, burn + single EPO dose (5000 IU/kg i.p. at D0); and Group D, burn + daily EPO dosage (3000 IU/kg/day i.p. at D0-D6). Two treatment regimens were used to evaluate single versus multiple doses treatment effects. Before sacrifice, blood samples were collected for hematological parameter examination. The histological analyses of microglia activation, iNOS, and COX-2 in the spinal cord ventral horn were performed at week 1 post-burn. In addition, we examined autophagy changes by biomarkers of LC3B and ATG5. The expression of BCL-2, BAX, cleaved caspase-3, phospho-AKT, and mTOR was assessed simultaneously through Western blotting. EPO administration after burn injury attenuated neuroinflammation through various mechanisms, including the reduction of microglia activity as well as iNOS and COX-2 expression in the spinal cord ventral horn. In addition, the expression of phospho-AKT, mTOR and apoptotic indicators, such as BAX, BCL-2, and cleaved caspase-3, was modulated. Furthermore, the activity of burn-induced autophagy in the spinal cord ventral horn characterized by the expression of autophagic biomarkers, LC3B and ATG5, was reduced after EPO administration. The present results indicate that EPO inhibits the AKT-mTOR pathway to attenuate burn-induced motor neuron programmed cell death and microglia activation. EPO can modulate neuroinflammation and programmed cell death and may be a therapeutic candidate for neuroprotection.	[Wu, Sheng-Hua; Lu, I-Cheng] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Kaohsiung, Taiwan; [Wu, Sheng-Hua; Lu, I-Cheng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Anesthesiol, Kaohsiung, Taiwan; [Wu, Sheng-Hua; Lu, I-Cheng] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Anesthesiol, Kaohsiung, Taiwan; [Lee, Su-Shin; Kwan, Aij-Lie; Huang, Shu-Hung] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Surg, Kaohsiung, Taiwan; [Lee, Su-Shin; Huang, Shu-Hung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Plast Surg, Kaohsiung, Taiwan; [Huang, Shu-Hung] Kaohsiung Med Univ, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Huang, Shu-Hung] Kaohsiung Med Univ, Ctr Stem Cell Res, Kaohsiung, Taiwan; [Kwan, Aij-Lie] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Neurosurg, Kaohsiung, Taiwan; [Chai, Chee-Yin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan; [Chai, Chee-Yin] Kaohsiung Med Univ, Sch Med, Dept Pathol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Huang, SH (corresponding author), Kaohsiung Med Univ, Coll Med, Sch Med, Dept Surg, Kaohsiung, Taiwan.; Huang, SH (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Plast Surg, Kaohsiung, Taiwan.; Huang, SH (corresponding author), Kaohsiung Med Univ, Orthopaed Res Ctr, Kaohsiung, Taiwan.; Huang, SH (corresponding author), Kaohsiung Med Univ, Ctr Stem Cell Res, Kaohsiung, Taiwan.	huangsh63@gmail.com	Lee, Su-Shin/D-4722-2009; Huang, Shu-Hung/AAA-3445-2021	Lee, Su-Shin/0000-0001-8675-0870; Huang, Shu-Hung/0000-0002-2903-1703; Chai, Chee-Yin/0000-0003-0486-9742	Ministry of Science and Technology of Taiwan [MOST 104-2314-B-037-061-MY3, MOST106-2314-B-037-028]; Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University [Kmhk-105-022]; Center for Stem Cell Research, Kaohsiung Medical University [KMU-TP105G00, KMU-TP105G02]; Aim for the Top Universities Grant [KMU-TP105B07]; Kaohsiung Medical University Hospital [KMUH105-5R69, 106-6R81]; Childhood Burn Foundation of the Republic Of China	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University; Center for Stem Cell Research, Kaohsiung Medical University; Aim for the Top Universities Grant; Kaohsiung Medical University Hospital; Childhood Burn Foundation of the Republic Of China	This work was supported by grants from the Ministry of Science and Technology of Taiwan (MOST 104-2314-B-037-061-MY3, MOST106-2314-B-037-028); Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University (Kmhk-105-022), Center for Stem Cell Research, Kaohsiung Medical University (KMU-TP105G00, KMU-TP105G02), Aim for the Top Universities Grant (KMU-TP105B07), Kaohsiung Medical University Hospital (KMUH105-5R69, 106-6R81), and Childhood Burn Foundation of the Republic Of China. The funders had no role in the study design, data collection and analysis, publication decision, or manuscript preparation.	Alnaeeli Mawadda, 2012, Anat Res Int, V2012, P953264, DOI 10.1155/2012/953264; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Bagyinszky E, 2017, J NEUROL SCI, V376, P242, DOI 10.1016/j.jns.2017.03.031; Bahcekapili N, 2014, INT J NEUROSCI, V124, P762, DOI 10.3109/00207454.2013.878935; Bakan V, 2016, ULUS TRAVMA ACIL CER, V22, P322, DOI 10.5505/tjtes.2015.09483; Barranco Caroline, 2015, Nat Rev Rheumatol, V11, P127, DOI 10.1038/nrrheum.2015.12; Basrai HS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153418; Bianchi R, 2007, EUR J CANCER, V43, P710, DOI 10.1016/j.ejca.2006.09.028; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bond WS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00523; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Brown MS, 2009, PEDIATRICS, V124, pE681, DOI 10.1542/peds.2008-2701; Byts N, 2008, CELL DEATH DIFFER, V15, P783, DOI 10.1038/cdd.2008.1; Carelli S, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/453179; Carraway MS, 2010, CIRC RES, V106, P1722, DOI 10.1161/CIRCRESAHA.109.214353; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chan KY, 2017, DEV NEUROSCI; Chauhan AK, 2017, MOL NEUROBIOL, V287; Chung H, 2009, J NEUROSCI RES, V87, P2365, DOI 10.1002/jnr.22046; Ciardiello F, 2002, ANN ONCOL, V13, P501, DOI 10.1093/annonc/mdf191; Dauber A, 2002, PAIN MED, V3, P6, DOI 10.1046/j.1526-4637.2002.02004.x; Duan HJ, 2009, APOPTOSIS, V14, P52, DOI 10.1007/s10495-008-0277-7; Ebid AA, 2014, BURNS, V40, P97, DOI 10.1016/j.burns.2013.05.022; Ehrenreich H, 2007, BRAIN, V130, P2577, DOI 10.1093/brain/awm203; Fry CS, 2016, J PHYSIOL-LONDON, V594, P5223, DOI 10.1113/JP272520; Frymoyer A, 2017, PEDIAT RES; Gantner DC, 2017, ANN SURG; Gonzalez FF, 2013, STROKE, V44, P753, DOI 10.1161/STROKEAHA.111.000104; Gunst J, 2013, CRIT CARE MED, V41, P182, DOI 10.1097/CCM.0b013e3182676657; Hart DW, 2000, SURGERY, V128, P312, DOI 10.1067/msy.2000.108059; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Holavanahalli RK, 2016, J BURN CARE RES, V37, P243, DOI 10.1097/BCR.0000000000000257; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Jiang CJ, 2016, NEURAL REGEN RES, V11, P1450, DOI 10.4103/1673-5374.191219; Kao SJ, 2005, IMMUNOLOGY, V115, P366, DOI 10.1111/j.1365-2567.2005.02160.x; Kim KW, 2009, CLIN CANCER RES, V15, P6096, DOI 10.1158/1078-0432.CCR-09-0589; Kohman RA, 2013, BRAIN BEHAV IMMUN, V27, P22, DOI 10.1016/j.bbi.2012.09.003; Kraft AD, 2011, INT J ENV RES PUB HE, V8, P2980, DOI 10.3390/ijerph8072980; Kristal B, 2008, ISR MED ASSOC J, V10, P266; Li XQ, 2005, GLIA, V51, P254, DOI 10.1002/glia.20202; Li ZM, 2016, CLIN NEUROL NEUROSUR, V150, P80, DOI 10.1016/j.clineuro.2016.09.001; Liu Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.69; Lopez E, 2015, ARCH PEDIATRIE, V22, P1092, DOI 10.1016/j.arcped.2015.07.001; Maggioni D, 2010, J NEUROSCI RES, V88, P3171, DOI 10.1002/jnr.22465; McPherson RJ, 2010, CURR OPIN PEDIATR, V22, P139, DOI 10.1097/MOP.0b013e328336eb57; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Merelli A, 2015, INT J NEUROSCI, V125, P793, DOI 10.3109/00207454.2014.989321; Merritt EK, 2012, J BURN CARE RES, V33, P291, DOI 10.1097/BCR.0b013e3182331e4b; Messier AM, 2014, CURR OPIN PEDIATR, V26, P139, DOI 10.1097/MOP.0000000000000077; Mowat FM, 2012, AM J PATHOL, V180, P1726, DOI 10.1016/j.ajpath.2011.12.033; Nakazawa H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170391; Neelakantan S, 2009, PEDIATR INT, V51, P25, DOI 10.1111/j.1442-200X.2008.02648.x; Ning B, 2011, NEUROSCI LETT, V490, P57, DOI 10.1016/j.neulet.2010.12.025; Ogunshola Omolara O, 2013, Methods Mol Biol, V982, P13, DOI 10.1007/978-1-62703-308-4_2; Ojha S, 2016, NEUROTOX RES, V29, P275, DOI 10.1007/s12640-015-9579-z; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Porter C, 2013, J TRAUMA ACUTE CARE, V74, P1480, DOI 10.1097/TA.0b013e3182921651; Punnonen J, 2015, CURR TOP MED CHEM, V15, P955, DOI 10.2174/156802661510150328224527; Rao JS, 2012, NEUROCHEM RES, V37, P903, DOI 10.1007/s11064-012-0708-2; Robinson S, 2016, J NEUROSURG-PEDIATR, V17, P739, DOI 10.3171/2015.10.PEDS15554; Sawikr Y, 2017, ADV PROTEIN CHEM STR, V108, P33, DOI 10.1016/bs.apcsb.2017.02.001; Shapiro IM, 2014, AUTOPHAGY, V10, P7, DOI 10.4161/auto.26679; Shefa U, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1689341; Song JQ, 2014, J SURG RES, V187, P128, DOI 10.1016/j.jss.2013.09.042; STREAT SJ, 1987, J TRAUMA, V27, P262, DOI 10.1097/00005373-198703000-00006; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Tahamtan M, 2016, FUND CLIN PHARMACOL, V30, P502, DOI 10.1111/fcp.12226; Tamura T, 2017, BRAIN RES; Teng RF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1526; Tsai TH, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0761-8; Vairano M, 2002, EUR J NEUROSCI, V16, P584, DOI 10.1046/j.1460-9568.2002.02125.x; Vesey DA, 2004, NEPHROL DIAL TRANSPL, V19, P348, DOI 10.1093/ndt/gfg547; Vetrichevvel TP, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012668; Wang L, 2015, TRANSL STROKE RES, V6, P50, DOI 10.1007/s12975-014-0362-x; White JPM, 2011, EUR J PAIN, V15, P683, DOI 10.1016/j.ejpain.2010.12.006; Williams PA, 2017, EXP EYE RES, V157, P20, DOI 10.1016/j.exer.2017.02.014; Wu SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/372819; Wu YW, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0191; Wustenberg T, 2011, MOL PSYCHIATR, V16, P26, DOI 10.1038/mp.2010.51; Wymann MP, 2003, BIOCHEM SOC T, V31, P275, DOI 10.1042/bst0310275; Xiao R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039488; Xie Z, 2012, EYE, V26, P144, DOI 10.1038/eye.2011.254; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Yasuhara S, 1999, J BURN CARE REHABIL, V20, P462, DOI 10.1097/00004630-199920060-00007; Yasuhara S, 2000, AM J PHYSIOL-ENDOC M, V279, pE1114, DOI 10.1152/ajpendo.2000.279.5.E1114; Yoshimura, 1996, Oncologist, V1, P337; Zhang DX, 2017, BIOMED PHARMACOTHER, V87, P332, DOI 10.1016/j.biopha.2016.12.115; Zheng HH, 2013, NEUROREPORT, V24, P335, DOI 10.1097/WNR.0b013e32835ffe03	88	11	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0190039	10.1371/journal.pone.0190039	http://dx.doi.org/10.1371/journal.pone.0190039			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385149	Green Published, Green Submitted, gold			2022-12-26	WOS:000423668400013
J	Sassa, T; Tadaki, M; Kiyonari, H; Kihara, A				Sassa, Takayuki; Tadaki, Masato; Kiyonari, Hiroshi; Kihara, Akio			Very long-chain tear film lipids produced by fatty acid elongase ELOVL1 prevent dry eye disease in mice	FASEB JOURNAL			English	Article						meibomian gland; wax ester; cholesteryl ester	LIQUID-CHROMATOGRAPHY; PERMEABILITY BARRIER; MASS-SPECTROMETRY; MEIBOMIAN GLAND; WAX ESTERS; SKIN; PATHOPHYSIOLOGY; ACYLCERAMIDES; EXPRESSION; PHYSIOLOGY	Lipids secreted from the meibomian gland (meibum) form the superficial layer of the tear film and prevent water evaporation from the ocular surface and infection. Here, we identified the fatty acid (FA) elongases responsible for the synthesis of very long-chain FAs (VLCFAs) that constitute the meibum lipids. Elongation of VLCFAs (ELOVL)1 is primarily responsible for the production of saturated VLCFAs, whereas ELOVL1, ELOVL3, and ELOVL4 redundantly participate in the synthesis of monounsaturated VLCFAs. Gene disruption of Elov11 in mice shortened acyl moieties in the 2 major meibum lipids: cholesteryl esters and wax esters. These changes were associated with dry eye phenotypes, including increases in eye blink frequency and water evaporation from the ocular surface at younger ages. Aged Elov11 mutant mice developed corneal opacity with vascular invasion, accompanied by epidermalization of the cornea. Thus, in addition to the well-known VLC ceramides (acylceramides) in the epidermis, VLC meibum lipids are barrier-forming lipids.	[Sassa, Takayuki; Tadaki, Masato; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biochem, Sapporo, Hokkaido, Japan; [Kiyonari, Hiroshi] RIKEN, Ctr Life Sci Technol, Kobe, Hyogo, Japan	Hokkaido University; RIKEN	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Biochem, Kita Ku, Kita 12-Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	KIHARA, AKIO/A-3802-2012; SASSA, Takayuki/B-2519-2012	KIHARA, AKIO/0000-0001-5889-0788; SASSA, Takayuki/0000-0003-3145-9829	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan under the Support Program for Implementation of a New Equipment Sharing System; Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from MEXT; Advanced Research and Development Programs for Medical Innovation (AMED-CREST) from AMED [JP17gm0910002]; Japan Society for the Promotion of Science (JSPS) [26251010]; JSPS [16K08220]; Grants-in-Aid for Scientific Research [26251010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan under the Support Program for Implementation of a New Equipment Sharing System; Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from MEXT; Advanced Research and Development Programs for Medical Innovation (AMED-CREST) from AMED; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Dr. S. Ghazizadeh (State University of New York at Stony Brook, Stony Brook, NY, USA) for providing the human IVL promoter. The authors also thank T. Kashiwagi and T. Hirayama (both from Hokkaido University) for assistance with animal preparation. The authors acknowledge assistance received from Hokkaido University; Global Facility Center (GFC); Pharma Science Open Unit (PSOU), which is funded by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan under the Support Program for Implementation of a New Equipment Sharing System; and Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from MEXT; and Japan Agency for Medical Research and Development (AMED) for use of mass spectrometer. This work was supported by funding from the Advanced Research and Development Programs for Medical Innovation (AMED-CREST; Grant JP17gm0910002 to A.K.) from AMED, by a Grant-in-Aid for Scientific Research (A) (Grant 26251010 to A.K.) from the Japan Society for the Promotion of Science (JSPS), and by a Grant-in-Aid for Scientific Research (C) (Grant 16K08220 to T.S.) from JSPS. The authors declare no conflicts of interest.	Adhikary G, 2005, INVEST OPHTH VIS SCI, V46, P3109, DOI 10.1167/iovs.05-0053; BANKSSCHLEGEL S, 1981, J CELL BIOL, V90, P732, DOI 10.1083/jcb.90.3.732; Bron A J, 2004, Ocul Surf, V2, P149; Bron AJ, 2014, OCUL SURF, V12, pS1, DOI 10.1016/j.jtos.2014.02.002; Butovich IA, 2013, EXP EYE RES, V117, P4, DOI 10.1016/j.exer.2013.05.010; Butovich IA, 2012, INVEST OPHTH VIS SCI, V53, P3766, DOI 10.1167/iovs.11-9333; Camera E, 2010, J LIPID RES, V51, P3377, DOI 10.1194/jlr.D008391; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; CARROLL JM, 1993, P NATL ACAD SCI USA, V90, P10270, DOI 10.1073/pnas.90.21.10270; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Cwiklik L, 2016, BBA-BIOMEMBRANES, V1858, P2421, DOI 10.1016/j.bbamem.2016.02.020; Gayton JL, 2009, CLIN OPHTHALMOL, V3, P405; Gipson IK, 2004, EXP EYE RES, V78, P379, DOI 10.1016/S0014-4835(03)00204-5; IYENGAR BTR, 1969, LIPIDS, V4, P28, DOI 10.1007/BF02531790; Kashima T, 2014, CLIN OPHTHALMOL, V8, P1003, DOI 10.2147/OPTH.S40798; Keating GM, 2015, DRUGS, V75, P911, DOI 10.1007/s40265-015-0409-7; Kihara A, 2016, PROG LIPID RES, V63, P50, DOI 10.1016/j.plipres.2016.04.001; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kitamura T, 2015, BIOCHEM J, V465, P79, DOI 10.1042/BJ20140624; Knop E, 2011, INVEST OPHTH VIS SCI, V52, P1938, DOI 10.1167/iovs.10-6997c; Lam SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024339; Lee HS, 2014, CORNEA, V33, P946, DOI 10.1097/ICO.0000000000000165; MAHADEVAN V, 1962, J LIPID RES, V3, P106; McMahon A, 2014, INVEST OPHTH VIS SCI, V55, P2832, DOI 10.1167/iovs.13-13335; Nien CJ, 2010, MOL VIS, V16, P1132; Ohashi Y, 2006, CLIN CHIM ACTA, V369, P17, DOI 10.1016/j.cca.2005.12.035; Ohno Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14610; Ohno Y, 2015, P NATL ACAD SCI USA, V112, P7707, DOI 10.1073/pnas.1503491112; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Okuda A, 2010, MOL VIS, V16, P2438; Poli M, 2011, INVEST OPHTH VIS SCI, V52, P9411, DOI 10.1167/iovs.10-7049; Sassa T, 2014, BIOMOL THER, V22, P83, DOI 10.4062/biomolther.2014.017; Sassa T, 2013, MOL CELL BIOL, V33, P2787, DOI 10.1128/MCB.00192-13; Vasireddy V, 2007, HUM MOL GENET, V16, P471, DOI 10.1093/hmg/ddl480	34	37	40	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					2966	2978		10.1096/fj.201700947R	http://dx.doi.org/10.1096/fj.201700947R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401594				2022-12-26	WOS:000432546000007
J	de Jong, NWM; Vrieling, M; Garcia, BL; Koop, G; Brettmann, M; Aerts, PC; Ruyken, M; van Strijp, JAG; Holmes, M; Harrison, EM; Geisbrecht, BV; Rooijakkers, SHM				de Jong, Nienke W. M.; Vrieling, Manouk; Garcia, Brandon L.; Koop, Gerrit; Brettmann, Matt; Aerts, Piet C.; Ruyken, Maartje; van Strijp, Jos A. G.; Holmes, Mark; Harrison, Ewan M.; Geisbrecht, Brian V.; Rooijakkers, Suzan H. M.			Identification of a staphylococcal complement inhibitor with broad host specificity in equid Staphylococcus aureus strains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE EVASION; PROTEIN FAMILY; SCIN PROTEINS; INFECTIONS; ADAPTATION; CONVERTASE; NEUTROPHILS; EVOLUTION; GENOMICS; RUMINANT	Staphylococcus aureus is a versatile pathogen capable of causing a broad range of diseases in many different hosts. S. aureus can adapt to its host through modification of its genome (e.g. by acquisition and exchange of mobile genetic elements that encode host-specific virulence factors). Recently, the prophage phi Saeq1 was discovered in S. aureus strains from six different clonal lineages almost exclusively isolated from equids. Within this phage, we discovered a novel variant of staphylococcal complement inhibitor (SCIN), a secreted protein that interferes with activation of the human complement system, an important line of host defense. We here show that this equine variant of SCIN, eqSCIN, is a potent blocker of equine complement system activation and subsequent phagocytosis of bacteria by phagocytes. Mechanistic studies indicate that eqSCIN blocks equine complement activation by specific inhibition of the C3 convertase enzyme (C3bBb). Whereas SCIN-A from human S. aureus isolates exclusively inhibits human complement, eqSCIN represents the first animal-adapted SCIN variant that functions in a broader range of hosts (horses, humans, and pigs). Binding analyses suggest that the human-specific activity of SCIN-A is related to amino acid differences on both sides of the SCIN-C3b interface. These data suggest that modification of this phage-encoded complement inhibitor plays a role in the host adaptation of S. aureus and are important to understand how this pathogen transfers between different hosts.	[de Jong, Nienke W. M.; Vrieling, Manouk; Aerts, Piet C.; Ruyken, Maartje; van Strijp, Jos A. G.; Rooijakkers, Suzan H. M.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3584 CX Utrecht, Netherlands; [Vrieling, Manouk] Univ Edinburgh, Roslin Inst, Easter Bush Campus, Roslin EH25 9RG, Midlothian, Scotland; [Garcia, Brandon L.; Brettmann, Matt; Geisbrecht, Brian V.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Koop, Gerrit] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, NL-3584 CL Utrecht, Netherlands; [Holmes, Mark] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Harrison, Ewan M.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England	Utrecht University; Utrecht University Medical Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Kansas State University; Utrecht University; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Rooijakkers, SHM (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.; Rooijakkers, SHM (corresponding author), Univ Utrecht, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	s.h.m.rooijakkers@umcutrecht.nl	van Strijp, Jos A.G./J-9549-2014; Harrison, Ewan/I-5003-2013	van Strijp, Jos A.G./0000-0001-6253-0830; Vrieling, Manouk/0000-0002-5465-4515; Harrison, Ewan/0000-0003-2720-0507	National Institutes of Health [AI113552, GM121511]; ERC [639209]; Health Innovation Challenge Fund [WT098600, HICF-T5-342]; Department of Health; Wellcome Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI113552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121511] Funding Source: NIH RePORTER; MRC [G1001787, MR/P007201/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); Health Innovation Challenge Fund; Department of Health; Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by National Institutes of Health Grants AI113552 and GM121511 (to B.V.G.) and by ERC Starting Grant 639209 (to S.H.M.R.), and this publication presents independent research supported by the Health Innovation Challenge Fund (WT098600, HICF-T5-342), a parallel funding partnership between the Department of Health and Wellcome Trust.	Abdelbary MMH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088083; Aires-De-Sousa M, 2007, APPL ENVIRON MICROB, V73, P3845, DOI 10.1128/AEM.00019-07; Bradley AJ, 2002, VET J, V164, P116, DOI 10.1053/tvjl.2002.0724; Cuny C, 2008, MICROB DRUG RESIST, V14, P307, DOI 10.1089/mdr.2008.0845; Cuny C, 2015, VET MICROBIOL, V177, P219, DOI 10.1016/j.vetmic.2015.02.031; Fitzgerald JR, 2012, TRENDS MICROBIOL, V20, P192, DOI 10.1016/j.tim.2012.01.006; Garcia BL, 2013, J BIOL CHEM, V288, P2870, DOI 10.1074/jbc.M112.426858; Garcia BL, 2012, J BIOL CHEM, V287, P628, DOI 10.1074/jbc.M111.298984; Garcia BL, 2010, J MOL BIOL, V402, P17, DOI 10.1016/j.jmb.2010.07.029; Garcia BL, 2009, ACTA CRYSTALLOGR F, V65, P482, DOI 10.1107/S174430910901207X; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Gharsa H, 2015, VECTOR-BORNE ZOONOT, V15, P109, DOI 10.1089/vbz.2014.1655; Gharsa H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-203; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Islam MZ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00543; JOISEL F, 1983, J IMMUNOL METHODS, V59, P229, DOI 10.1016/0022-1759(83)90035-2; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Koop G, 2017, SCI REP-UK, V7, DOI 10.1038/srep40660; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McCarthy AJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00006; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Ricklin D, 2009, J IMMUNOL, V183, P2565, DOI 10.4049/jimmunol.0901443; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Rooijakkers SHM, 2007, J IMMUNOL, V179, P2989, DOI 10.4049/jimmunol.179.5.2989; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Sieber S, 2011, MICROB DRUG RESIST, V17, P471, DOI 10.1089/mdr.2010.0188; Siemsen Daniel W., 2007, V412, P21, DOI 10.1007/978-1-59745-467-4_3; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Summers BJ, 2015, MOL IMMUNOL, V67, P193, DOI 10.1016/j.molimm.2015.05.012; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; van Duijkeren E, 2010, VET MICROBIOL, V141, P96, DOI 10.1016/j.vetmic.2009.08.009; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Viana D, 2010, MOL MICROBIOL, V77, P1583, DOI 10.1111/j.1365-2958.2010.07312.x; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Xu YY, 2001, IMMUNOL REV, V180, P123, DOI 10.1034/j.1600-065X.2001.1800111.x	38	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4468	4477		10.1074/jbc.RA117.000599	http://dx.doi.org/10.1074/jbc.RA117.000599			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29414776	Green Published, hybrid			2022-12-26	WOS:000428204300018
J	Streit, BR; Celis, AI; Moraski, GC; Shisler, KA; Shepard, EM; Rodgers, KR; Lukat-Rodgers, GS; DuBois, JL				Streit, Bennett R.; Celis, Arianna I.; Moraski, Garrett C.; Shisler, Krista A.; Shepard, Eric M.; Rodgers, Kenton R.; Lukat-Rodgers, Gudrun S.; DuBois, Jennifer L.			Decarboxylation involving a ferryl, propionate, and a tyrosyl group in a radical relay yields heme b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED ELECTRON-TRANSFER; CYTOCHROME-P450 COMPOUND I; RIBONUCLEOTIDE REDUCTASE; ESCHERICHIA-COLI; PEROXIDASE; MECHANISM; EPR; PROTEINS; ACIDS; IRON	The H2O2-dependent oxidative decarboxylation of coproheme III is the final step in the biosynthesis of heme b in many microbes. However, the coproheme decarboxylase reaction mechanism is unclear. The structure of the decarboxylase in complex with coproheme III suggested that the substrate iron, reactive propionates, and an active-site tyrosine convey a net 2e(-) /2H(+) from each propionate to an activated form of H2O2. Time-resolved EPR spectroscopy revealed that Tyr-145 formed a radical species within 30 s of the reaction of the enzyme-coproheme complex with H2O2. This radical disappeared over the next 270 s, consistent with a catalytic intermediate. Use of the harderoheme III intermediate as substrate or substitutions of redox-active side chains (W198F, W157F, or Y113S) did not strongly affect the appearance or intensity of the radical spectrum measured 30 s after initiating the reaction with H2O2, nor did it change the similar to 270 s required for the radical signal to recede to <= 10% of its initial intensity. These results suggested Tyr-145 as the site of a catalytic radical involved in decarboxylating both propionates. Tyr-145(center dot) was accompanied by partial loss of the initially present Fe(III) EPR signal intensity, consistent with the possible formation of Fe(IV) = O. Site-specifically deuterated coproheme gave rise to a kinetic isotope effect of similar to 2 on the decarboxylation rate constant, indicating that cleavage of the propionate C beta-H bond was partly rate-limiting. The inferred mechanism requires two consecutive hydrogen atom transfers, first from Tyr-145 to the substrate Fe/H2O2 intermediate and then from the propionate C beta-H to Tyr-145(center dot).	[Streit, Bennett R.; Celis, Arianna I.; Moraski, Garrett C.; Shisler, Krista A.; Shepard, Eric M.; DuBois, Jennifer L.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Rodgers, Kenton R.; Lukat-Rodgers, Gudrun S.] North Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA	Montana State University System; Montana State University Bozeman; North Dakota State University Fargo	DuBois, JL (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	jennifer.dubois1@montana.edu	Moraski, Garrett/AAH-3616-2021	Celis, Arianna/0000-0002-5116-9768	NIGMS, National Institutes of Health [R01GM090260, R15GM114787]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090260, R15GM114787] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health, Grants R01GM090260 (to J.L.D.) and R15GM114787 (to G.S.L.-R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BARRY BA, 1990, J BIOL CHEM, V265, P20139; BENDER CJ, 1989, J AM CHEM SOC, V111, P8076, DOI 10.1021/ja00203a002; Brown KR, 2004, BIOCHEMISTRY-US, V43, P8616, DOI 10.1021/bi049056m; Celis AI, 2017, J AM CHEM SOC, V139, P1900, DOI 10.1021/jacs.6b11324; Celis AI, 2015, BIOCHEMISTRY-US, V54, P4022, DOI 10.1021/acs.biochem.5b00492; Colas C, 2003, CHEM REV, V103, P2305, DOI 10.1021/cr0204303; Dailey HA, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00048-16; Dailey HA, 2015, P NATL ACAD SCI USA, V112, P2210, DOI 10.1073/pnas.1416285112; Di Bilio AJ, 2001, J AM CHEM SOC, V123, P3181, DOI 10.1021/ja0043183; Doyle WA, 1998, BIOCHEMISTRY-US, V37, P15097, DOI 10.1021/bi981633h; Efimov I, 2011, J AM CHEM SOC, V133, P15376, DOI 10.1021/ja2007017; Frey P. A., 2007, ENZYMATIC REACTION M, P91; Fujii H, 1996, INORG CHEM, V35, P2373, DOI 10.1021/ic9513752; Gorchein A, 2005, BIOMED CHROMATOGR, V19, P565, DOI 10.1002/bmc.480; Grant JL, 2015, J AM CHEM SOC, V137, P4940, DOI 10.1021/jacs.5b01965; Gumiero A, 2011, J BIOL CHEM, V286, P1260, DOI 10.1074/jbc.M110.183483; Hofbauer S, 2016, BIOCHEMISTRY-US, V55, P5398, DOI 10.1021/acs.biochem.6b00701; Khindaria A, 1996, BIOCHEMISTRY-US, V35, P13107, DOI 10.1021/bi961297+; Lash TD, 2010, J ORG CHEM, V75, P3183, DOI 10.1021/jo100083t; Layer G, 2006, J BIOL CHEM, V281, P15727, DOI 10.1074/jbc.M512628200; Lin MT, 2011, METHODS, V55, P370, DOI 10.1016/j.ymeth.2011.08.019; Macdonald IK, 2006, BIOCHEMISTRY-US, V45, P7808, DOI 10.1021/bi0606849; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Roston D, 2014, ARCH BIOCHEM BIOPHYS, V544, P96, DOI 10.1016/j.abb.2013.10.010; SCHULZ CE, 1979, FEBS LETT, V103, P102, DOI 10.1016/0014-5793(79)81259-4; Schunemann V, 2004, J BIOL CHEM, V279, P10919, DOI 10.1074/jbc.M307884200; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Streit BR, 2017, BIOCHEMISTRY-US, V56, P189, DOI 10.1021/acs.biochem.6b00958; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Svistunenko DA, 2004, BIOPHYS J, V87, P582, DOI 10.1529/biophysj.104.041046; TSAI AL, 1995, J BIOL CHEM, V270, P10503, DOI 10.1074/jbc.270.18.10503; Unno M, 2007, NAT PROD REP, V24, P553, DOI 10.1039/b604180a; Warren JJ, 2011, J AM CHEM SOC, V133, P8544, DOI 10.1021/ja201663p; Warren JJ, 2010, CHEM REV, V110, P6961, DOI 10.1021/cr100085k; Westerlund K, 2005, BBA-BIOENERGETICS, V1707, P103, DOI 10.1016/j.bbabio.2004.02.013; Wilks A, 2014, ARCH BIOCHEM BIOPHYS, V544, P87, DOI 10.1016/j.abb.2013.10.013; Yeh HC, 2009, BIOCHEMISTRY-US, V48, P917, DOI 10.1021/bi801382v	37	18	16	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3989	3999		10.1074/jbc.RA117.000830	http://dx.doi.org/10.1074/jbc.RA117.000830			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29414780	Green Published, hybrid			2022-12-26	WOS:000427587500012
J	Sonenblum, SE; Sprigle, SH				Sonenblum, Sharon Eve; Sprigle, Stephen H.			Buttock tissue response to loading in men with spinal cord injury	PLOS ONE			English	Article							SKIN BLOOD-FLOW; SUB-DERMAL TISSUES; PRESSURE ULCERS; RISK-FACTORS; HOSPITALIZED-PATIENTS; EXTERNAL-PRESSURE; DEEP; SORES; DEFORMATION; INDIVIDUALS	Objective/Background Despite the fact that most people with a spinal cord injury who use a wheelchair for mobility are considered at-risk for pressure ulcer (PrU) development, there still exists a spectrum of risk amongst this group. Efforts to differentiate risk level would benefit from clinical tools that can measure or predict the buttocks response to loading. Therefore, the goal of this study was to identify how tissue compliance and blood flow were impacted by clinically-measurable risk factors in young men with SCI. Methods Blood flow at the ischial tuberosity was measured using laser Doppler flowmetry while the seated buttock was unloaded, and loaded at lower (40-60 mmHg) and high (>200 mmHg) loads. Tissue compliance of the buttock was measured using the Myotonometer while subject were lifted in a Guldmann Net. Results Across 28 participants, blood flow was significantly reduced at high loads, while no consistent, significant changes were found at lower loads. At 40-60 mmHg, blood flow decreased in participants with a pressure ulcer history and lower BMI, but stayed the same or increased in most other participants. The buttock displaced an average of 9.3 mm (2.7 mm) at 4.2 N, which represented 82% (7%) of maximum displacement. BMI was related to the amount of buttock tissue displacement while smoking status explained some of the variation in the percent of max displacement. Conclusion Wide variability in tissue compliance and blood flow responses across a relatively homogeneous population indicate that differences in biomechanical risk may provide an explanation for the spectrum of PrU risk among persons with SCI.	[Sonenblum, Sharon Eve; Sprigle, Stephen H.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Sprigle, Stephen H.] Georgia Inst Technol, Sch Ind Design, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Sonenblum, SE (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.	ss427@gatech.edu	Sonenblum, Sharon/S-9573-2019	Sonenblum, Sharon/0000-0001-9747-5683	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR); RERC on Wheeled Mobility [H133E080003]	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)(United States Department of Health & Human Services); RERC on Wheeled Mobility	This work was supported by National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), https://www.acl.gov/about-acl/about-national-institute-disabiliy-independent-living-and-rehabilitation-research; and RERC on Wheeled Mobility, Grant H133E080003, PI SHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMAN RM, 1986, ANN INTERN MED, V105, P337, DOI 10.7326/0003-4819-105-3-337; ALLMAN RM, 1995, JAMA-J AM MED ASSOC, V273, P865, DOI 10.1001/jama.273.11.865; [Anonymous], 2014, PRESS ULC PREV TREAT; BADER D L, 1990, Journal of Rehabilitation Research and Development, V27, P141, DOI 10.1682/JRRD.1990.04.0141; Bar C, 1988, RESPONSE TISSUE APPL; BENNETT L, 1979, ARCH PHYS MED REHAB, V60, P309; Bolton L, 2007, J WOUND OSTOMY CONT, V34, P368, DOI 10.1097/01.WON.0000281653.32955.9b; Bouten CV, 2003, ARCH PHYS MED REHAB, V84, P616, DOI 10.1053/apmr.2003.50038; Byrne DW, 1996, SPINAL CORD, V34, P255, DOI 10.1038/sc.1996.46; EK AC, 1987, SCAND J REHABIL MED, V19, P121; Elsner JJ, 2008, J BIOMECH, V41, P3322, DOI 10.1016/j.jbiomech.2008.09.036; Gawlitta D, 2007, ANN BIOMED ENG, V35, P273, DOI 10.1007/s10439-006-9222-5; Gefen Amit, 2008, Technol Health Care, V16, P141; Gefen A, 2007, MED BIOL ENG COMPUT, V45, P563, DOI 10.1007/s11517-007-0187-9; Gould LJ, 2014, MED HYPOTHESES, V83, P552, DOI 10.1016/j.mehy.2014.08.027; Haesler E, 2014, PREV TREATM PRESS UL; HOLLOWAY GA, 1976, J APPL PHYSIOL, V40, P597, DOI 10.1152/jappl.1976.40.4.597; Just M, 2007, BRIT J DERMATOL, V156, P85, DOI 10.1111/j.1365-2133.2006.07575.x; KOSIAK M, 1959, Arch Phys Med Rehabil, V40, P62; Krause JS, 2004, ARCH PHYS MED REHAB, V85, P1257, DOI 10.1016/j.apmr.2003.08.108; KROUSKOP TA, 1983, MED HYPOTHESES, V11, P255, DOI 10.1016/0306-9877(83)90067-1; LASSEN NA, 1974, SURG CLIN N AM, V54, P39; Linder-Ganz E, 2008, J BIOMECH, V41, P567, DOI 10.1016/j.jbiomech.2007.10.011; Linder-Ganz E, 2007, J BIOMECH, V40, P1443, DOI 10.1016/j.jbiomech.2006.06.020; Loerakker S, 2011, J APPL PHYSIOL, V111, P1168, DOI 10.1152/japplphysiol.00389.2011; Loerakker S, 2012, COMPUT METHODS BIOME; Luboz V, 2014, J BIOMECH, V47, P2231, DOI 10.1016/j.jbiomech.2014.05.004; Makhsous M, 2008, J SPINAL CORD MED, V31, P88, DOI 10.1080/10790268.2008.11753987; Mortenson WB, 2008, SPINAL CORD, V46, P168, DOI 10.1038/sj.sc.3102129; Oomens C. W. J., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P171, DOI 10.1080/1025584031000121034; Oomens CWJ, 2015, ANN BIOMED ENG, V43, P297, DOI 10.1007/s10439-014-1202-6; Oomens CW, 2009, J TISSUE VIABILITY; Raghavan P, 2003, CLIN REHABIL, V17, P879, DOI 10.1191/0269215503cr692oa; Reswick J., 1976, BED SORE BIOMECHANIC, P301, DOI [10.1007/978-1-349-02492-6_38, DOI 10.1007/978-1-349-02492-6_38]; Salzberg C A, 1998, Adv Wound Care, V11, P237; Salzberg CA, 1996, AM J PHYS MED REHAB, V75, P96, DOI 10.1097/00002060-199603000-00004; Sanada H, 1997, Adv Wound Care, V10, P29; Saunders LL, 2012, ARCH PHYS MED REHAB, V93, P972, DOI 10.1016/j.apmr.2012.02.004; Smalls LK, 2006, SKIN RES TECHNOL, V12, P43, DOI 10.1111/j.0909-725X.2006.00135.x; Sonenbium SE, 2015, J TISSUE VIABILITY, V24, P51, DOI 10.1016/j.jtv.2015.03.003; Sonenblum SE, 2014, RESNA ANN M ATL GA; Sonenblum SE, 2012, 28 INT SEAT S VANC C; Sonenblum SE, 2011, J TISSUE VIABILITY; Sonenblum SE, 2014, ARCH PHYS MED REHAB, V95, P1350, DOI 10.1016/j.apmr.2014.01.007; Sopher R, 2010, J BIOMECH, V43, P280, DOI 10.1016/j.jbiomech.2009.08.021; Sprigle S, 2002, MED ENG PHYS, V24, P651, DOI 10.1016/S1350-4533(02)00149-2; Sprigle S, 2011, J REHABIL RES DEV, V48, P203, DOI 10.1682/JRRD.2010.05.0102; Stekelenburg A, 2006, J APPL PHYSIOL, V100, P1946, DOI 10.1152/japplphysiol.00889.2005; Then C, 2008, Technol Health Care, V16, P61; van Marum RJ, 2002, ARCH PHYS MED REHAB, V83, P40, DOI 10.1053/apmr.2002.26827; Verver M. M., 2004, Computer Methods in Biomechanics and Biomedical Engineering, V7, P193, DOI 10.1080/10255840410001727832; VIDAL J, 1991, PARAPLEGIA, V29, P261, DOI 10.1038/sc.1991.37	52	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191868	10.1371/journal.pone.0191868	http://dx.doi.org/10.1371/journal.pone.0191868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415014	gold, Green Published, Green Submitted			2022-12-26	WOS:000424325300044
J	Tensen, L; Groom, RJ; Khuzwayo, J; van Vuuren, BJ				Tensen, Laura; Groom, Rosemary J.; Khuzwayo, Joy; van Vuuren, Bettine Jansen			The genetic tale of a recovering lion population (Panthera leo) in the Save Valley region (Zimbabwe): A better understanding of the history and managing the future	PLOS ONE			English	Article							SELOUS-GAME-RESERVE; AFRICAN LION; CONSERVATION UNITS; COMPUTER-PROGRAM; DIVERSITY; MICROSATELLITES; RELATEDNESS; BOTTLENECK; EVOLUTION; PATERNITY	The rapid decline of the African lion (Panthera leo) has raised conservation concerns. In the Save A Valley Conservancy (SVC), in the Lowveld of Zimbabwe, lions were presumably reduced to approximately 5 to 10 individuals. After ten lions were reintroduced in 2005, the population has recovered to over 200 lions in 2016. Although the increase of lions in the SVC seems promising, a question remains whether the population is genetically viable, considering their small founding population. In this study, we document the genetic diversity in the SVC lion population using both mitochondrial and nuclear genetic markers, and compare our results to literature from other lion populations across Africa. We also tested whether genetic diversity is spatially structured between lion populations residing on several reserves in the Lowveld of Zimbabwe. A total of 42 lions were genotyped successfully for 11 microsatellite loci. We confirmed that the loss of allelic richness (probably resulting from genetic drift and small number of founders) has resulted in low genetic diversity and inbreeding. The SVC lion population was also found to be genetically differentiated from surrounding population, as a result of genetic drift and restricted natural dispersal due to anthropogenic barriers. From a conservation perspective, it is important to avoid further loss of genetic variability in the SVC lion population and maintain evolutionary potential required for future survival. Genetic restoration through the introduction of unrelated individuals is recommended, as this will increase genetic heterozygosity and improve survival and reproductive fitness in populations.	[Tensen, Laura; Groom, Rosemary J.; Khuzwayo, Joy; van Vuuren, Bettine Jansen] Univ Johannesburg, Dept Zool, Ctr Ecol Genom & Wildlife Conservat, Johannesburg, South Africa; [Groom, Rosemary J.] African Wildlife Conservat Fund, Chishakwe Ranch, Save Valley Con, Zimbabwe	University of Johannesburg	van Vuuren, BJ (corresponding author), Univ Johannesburg, Dept Zool, Ctr Ecol Genom & Wildlife Conservat, Johannesburg, South Africa.	bettinevv@uj.ac.za	Jansen van Vuuren, Bettine/E-6227-2013	Jansen van Vuuren, Bettine/0000-0002-5334-5358; Tensen, Laura/0000-0001-9333-4955	Faculty (FRC), University of Johannesburg; University (URC) Funding, University of Johannesburg	Faculty (FRC), University of Johannesburg; University (URC) Funding, University of Johannesburg	The study was financed through Faculty (FRC) and University (URC) Funding, University of Johannesburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; [Anonymous], 2002, FSTAT VERSION 2 9 3; Antunes A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000251; Baker PJ, 2004, BEHAV ECOL, V15, P766, DOI 10.1093/beheco/arh077; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bauer D, 2014, CAN J ZOOL, V92, P97, DOI 10.1139/cjz-2013-0176; Bauer H., 2016, PANTHERA LEO ERRATA, DOI [10.2305/IUCN.UK.2016-3.RLTS.T15951A107265605.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T15951A107265605.EN, 10.2305/IUCN.UK.2016-3.RLTS.T20522A71739753.en]; Bauer H, 2015, P NATL ACAD SCI USA, V112, P14894, DOI 10.1073/pnas.1500664112; Bertola LD, 2016, SCI REP-UK, V6, DOI 10.1038/srep30807; Bertola LD, 2011, J BIOGEOGR, V38, P1356, DOI 10.1111/j.1365-2699.2011.02500.x; Bertola LD, 2015, THESIS; Bijlsma R, 2000, J EVOLUTION BIOL, V13, P502, DOI 10.1046/j.1420-9101.2000.00177.x; Bjorklund M, 2003, CONSERV GENET, V4, P515, DOI 10.1023/A:1024737317695; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Cohas A, 2006, BEHAV ECOL SOCIOBIOL, V59, P597, DOI 10.1007/s00265-005-0086-8; Collen B, 2011, BIOL SCI, P366; Cozzi G, 2013, J ANIM ECOL, V82, P707, DOI 10.1111/1365-2656.12039; Creel S, 1997, AFR J ECOL, V35, P83, DOI 10.1111/j.1365-2028.1997.062-89062.x; Driscoll CA, 2002, GENOME RES, V12, P414, DOI 10.1101/gr.185702; Dubach J, 2005, CONSERV GENET, V6, P15, DOI 10.1007/s10592-004-7729-6; Dubach JM, 2013, CONSERV GENET, V14, P741, DOI 10.1007/s10592-013-0453-3; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ernest HB, 2003, CONSERV GENET, V4, P353, DOI 10.1023/A:1024069014911; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R., 2009, REINTRODUCTION TOP O, P1; Frankham R., 2004, PRIMER CONSERVATION, DOI [10.1017/CBO9780511817359, DOI 10.1017/CBO9780511817359]; Glaubitz JC, 2003, MOL ECOL, V12, P1039, DOI 10.1046/j.1365-294X.2003.01790.x; Greenbaum G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119663; Groom RJ, 2014, ORYX, V48, P385, DOI 10.1017/S0030605312001457; Holderegger R, 2006, LANDSCAPE ECOL, V21, P793, DOI 10.1007/s10980-005-6058-6; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kremer A, 2002, FOREST ECOL MANAG, V156, P75, DOI 10.1016/S0378-1127(01)00635-1; Lindsey P., 2008, EVOLUTION INNOVATION, P163; Lindsey PA, 2006, ANIM CONSERV, V9, P283, DOI 10.1111/j.1469-1795.2006.00034.x; Lindsey PA, 2011, ORYX, V45, P84, DOI 10.1017/S0030605310001274; Lindsey PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073808; Lindsey PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029332; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Lyke MM, 2013, MOL ECOL, V22, P2787, DOI 10.1111/mec.12279; Menotti-Raymond M, 2003, J HERED, V94, P95, DOI 10.1093/jhered/esg008; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Moritz C, 1999, HEREDITAS, V130, P217, DOI 10.1111/j.1601-5223.1999.00217.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; OBRIEN SJ, 1987, NATL GEOGR RES, V3, P114; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; PACKER C, 1991, CONSERV BIOL, V5, P219, DOI 10.1111/j.1523-1739.1991.tb00127.x; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Spong G, 2002, J EVOLUTION BIOL, V15, P945, DOI 10.1046/j.1420-9101.2002.00473.x; Stein B., 1999, THESIS; Tensen L, 2016, CONSERV GENET, V17, P785, DOI 10.1007/s10592-016-0821-x; Trinkel M, 2008, ANIM CONSERV, V11, P138, DOI 10.1111/j.1469-1795.2008.00163.x; Trinkel M, 2010, ANIM CONSERV, V13, P374, DOI 10.1111/j.1469-1795.2009.00344.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vila C, 2003, P ROY SOC B-BIOL SCI, V270, P91, DOI 10.1098/rspb.2002.2184; Watermeyer J, 2016, CARNIVORE DENSITIES; Williams ST, 2016, PEERJ, V4, DOI 10.7717/peerj.1537; WITTING L, 1995, BIOL CONSERV, V71, P205, DOI 10.1016/0006-3207(94)00041-N	69	9	9	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0190369	10.1371/journal.pone.0190369	http://dx.doi.org/10.1371/journal.pone.0190369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415031	gold, Green Published, Green Submitted			2022-12-26	WOS:000424325300006
J	Tremblay, JA; Boulanger, Y; Cyr, D; Taylor, AR; Price, DT; St-Laurent, MH				Tremblay, Junior A.; Boulanger, Yan; Cyr, Dominic; Taylor, Anthony R.; Price, David T.; St-Laurent, Martin-Hugues			Harvesting interacts with climate change to affect future habitat quality of a focal species in eastern Canada's boreal forest	PLOS ONE			English	Article							SPRUCE BUDWORM OUTBREAKS; LANDSCAPE SIMULATION-MODEL; LAND-USE CHANGE; FIRE REGIMES; POPULATION TRENDS; BIRD COMMUNITIES; CHANGE IMPACTS; NORTH-AMERICA; DISTURBANCES; SUCCESSION	Many studies project future bird ranges by relying on correlative species distribution models. Such models do not usually represent important processes explicitly related to climate change and harvesting, which limits their potential for predicting and understanding the future of boreal bird assemblages at the landscape scale. In this study, we attempted to assess the cumulative and specific impacts of both harvesting and climate-induced changes on wildfires and standlevel processes (e.g., reproduction, growth) in the boreal forest of eastern Canada. The projected changes in these landscape-and stand-scale processes (referred to as "drivers of change") were then assessed for their impacts on future habitats and potential productivity of black-backed woodpecker (BBWO; Picoides arcticus), a focal species representative of deadwood and old-growth biodiversity in eastern Canada. Forest attributes were simulated using a forest landscape model, LANDIS-II, and were used to infer future landscape suitability to BBWO under three anthropogenic climate forcing scenarios (RCP 2.6, RCP 4.5 and RCP 8.5), compared to the historical baseline. We found climate change is likely to be detrimental for BBWO, with up to 92% decline in potential productivity under the worst-case climate forcing scenario (RCP 8.5). However, large declines were also projected under baseline climate, underlining the importance of harvest in determining future BBWO productivity. Present-day harvesting practices were the single most important cause of declining areas of old-growth coniferous forest, and hence appeared as the single most important driver of future BBWO productivity, regardless of the climate scenario. Climate-induced increases in fire activity would further promote young, deciduous stands at the expense of old-growth coniferous stands. This suggests that the biodiversity associated with deadwood and old-growth boreal forests may be greatly altered by the cumulative impacts of natural and anthropogenic disturbances under a changing climate. Management adaptations, including reduced harvesting levels and strategies to promote coniferous species content, may help mitigate these cumulative impacts.	[Tremblay, Junior A.] Environm & Climate Change Canada, Sci & Technol Branch, Quebec City, PQ, Canada; [Boulanger, Yan; Cyr, Dominic] Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, Stn Sainte Foy, Quebec City, PQ, Canada; [Taylor, Anthony R.] Nat Resources Canada, Atlantic Forestry Ctr, Canadian Forest Serv, Fredericton, NB, Canada; [Price, David T.] Nat Resources Canada, Northern Forestry Ctr, Canadian Forest Serv, Edmonton, AB, Canada; [St-Laurent, Martin-Hugues] Univ Quebec, Ctr Northern Studies, Allee Ursulines, Rimouski, PQ, Canada; [St-Laurent, Martin-Hugues] Univ Quebec, Dept Biol Chim & Geog, Ctr Forest Res, Allee Ursulines, Rimouski, PQ, Canada	Environment & Climate Change Canada; Natural Resources Canada; Canadian Forest Service; Natural Resources Canada; Canadian Forest Service; Natural Resources Canada; Canadian Forest Service; University of Quebec; University of Quebec	Tremblay, JA (corresponding author), Environm & Climate Change Canada, Sci & Technol Branch, Quebec City, PQ, Canada.	junior.tremblay@canada.ca	Tremblay, Junior A./AAX-7353-2020	Tremblay, Junior A./0000-0003-4930-0939; Cyr, Dominic/0000-0001-5247-8274	Environment and Climate change Canada; Natural Resource Canada; Natural Resources Canada	Environment and Climate change Canada; Natural Resource Canada(Natural Resources Canada); Natural Resources Canada(Natural Resources CanadaCanadian Forest Service)	This study was funded by the Environment and Climate change Canada, and Natural Resource Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by Environment and Climate Change Canada and Natural Resources Canada. We are thankful to A. Beaudoin and L. Guindon for providing data to initialize simulations. Anonymous reviewers provided useful comments on earlier versions of this manuscript.	Arora VK, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046270; Bayne E, 2016, CONDOR, V118, P376, DOI 10.1650/CONDOR-15-126.1; Beaudoin A, 2014, CAN J FOREST RES, V44, P521, DOI 10.1139/cjfr-2013-0401; Belisle AC, 2011, SILVA FENN, V45, P889, DOI 10.14214/sf.77; Bonnot TW, 2009, FOREST ECOL MANAG, V259, P220, DOI 10.1016/j.foreco.2009.10.021; Boucher Y, 2017, LANDSCAPE ECOL, V32, P361, DOI 10.1007/s10980-016-0448-9; Boulanger Y, 2018, J ECOL, V106, P977, DOI 10.1111/1365-2745.12892; Boulanger Y, 2017, LANDSCAPE ECOL, V32, P1415, DOI 10.1007/s10980-016-0421-7; Boulanger Y, 2014, CAN J FOREST RES, V44, P365, DOI 10.1139/cjfr-2013-0372; Boulanger Y, 2012, CAN J FOREST RES, V42, P1264, DOI [10.1139/X2012-069, 10.1139/x2012-069]; Brandt JP, 2009, ENVIRON REV, V17, P101, DOI 10.1139/A09-004; Brown CD, 2012, FOREST ECOL MANAG, V266, P34, DOI 10.1016/j.foreco.2011.11.006; Bujold F., 2013, GUIDE INTEGRATION BE; Burns R. M., 1990, AGR HDB, V2, P877, DOI DOI 10.1093/JHERED/ESP102; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Cumming SG, 2014, ECOGRAPHY, V37, P137, DOI 10.1111/j.1600-0587.2013.00299.x; De Caceres M, 2013, J BIOGEOGR, V40, P1535, DOI 10.1111/jbi.12111; de Groot WJ, 2003, J VEG SCI, V14, P355, DOI 10.1658/1100-9233(2003)014[0355:STEOFF]2.0.CO;2; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Drever MC, 2008, BIOL CONSERV, V141, P624, DOI 10.1016/j.biocon.2007.12.004; Dukes JS, 2009, CAN J FOREST RES, V39, P231, DOI 10.1139/X08-171; Ecological Stratification Working Group, 1996, NATL ECOLOGICAL FRAM; Farrar J.L., 1995, TREES CANADA NATURAL; Fisichelli NA, 2014, ECOGRAPHY, V37, P152, DOI 10.1111/j.1600-0587.2013.00197.x; Gauthier S, 2015, CAN J FOREST RES, V45, P1439, DOI 10.1139/cjfr-2015-0079; Gauthier S, 2015, SCIENCE, V349, P819, DOI 10.1126/science.aaa9092; Gillett NP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020876; Girardin MP, 2016, GLOBAL CHANGE BIOL, V22, P627, DOI 10.1111/gcb.13072; Guindon L, 2014, CAN J FOREST RES, V44, P1545, DOI 10.1139/cjfr-2014-0229; Gustafson EJ, 2000, CAN J FOREST RES, V30, P32, DOI 10.1139/cjfr-30-1-32; Hauer G, 2010, ECOL MODEL, V221, P2590, DOI 10.1016/j.ecolmodel.2010.07.013; Hennigar CR, 2008, FOREST SCI, V54, P158; Hitch AT, 2007, CONSERV BIOL, V21, P534, DOI 10.1111/j.1523-1739.2006.00609.x; Jardon Y, 2003, CAN J FOREST RES, V33, P1947, DOI 10.1139/X03-108; Jenouvrier S, 2013, GLOBAL CHANGE BIOL, V19, P2036, DOI 10.1111/gcb.12195; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jiguet F, 2013, BIRD STUDY, V60, P60, DOI 10.1080/00063657.2012.733337; Keane RE, 2013, ECOL MODEL, V266, P172, DOI 10.1016/j.ecolmodel.2013.06.020; Klein E, 2005, CAN J FOREST RES, V35, P1931, DOI 10.1139/x05-129; La Sorte Frank A, 2010, Proc Biol Sci, V277, P3401, DOI 10.1098/rspb.2010.0612; Langham GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135350; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; LeBrun JJ, 2016, LANDSCAPE ECOL; Leduc A, 2015, CAN J FOREST RES, V45, P480, DOI 10.1139/cjfr-2014-0434; Lexer MJ, 2001, FOREST ECOL MANAG, V144, P43, DOI 10.1016/S0378-1127(00)00386-8; Lovejoy T.E., 2005, CLIMATE CHANGE BIODI; MACLEAN DA, 1980, FOREST CHRON, V56, P213, DOI 10.5558/tfc56213-5; Mahon CL, 2016, FOREST ECOL MANAG, V361, P99, DOI 10.1016/j.foreco.2015.11.007; Mahon CL, 2014, FOREST ECOL MANAG, V312, P28, DOI 10.1016/j.foreco.2013.10.025; Mansuy N, 2014, GEODERMA, V235, P59, DOI 10.1016/j.geoderma.2014.06.032; McGarigal K., 2002, FRAGSTATS SPATIAL PA, DOI DOI 10.1016/S0022-3913(12)00047-9; McKenney D, 2013, FOREST CHRON, V89, P659, DOI 10.5558/tfc2013-118; Mckenney DW, 2007, BIOSCIENCE, V57, P939, DOI 10.1641/B571106; McKenney DW, 2011, GLOBAL CHANGE BIOL, V17, P2720, DOI 10.1111/j.1365-2486.2011.02413.x; Michaelian M, 2011, GLOBAL CHANGE BIOL, V17, P2084, DOI 10.1111/j.1365-2486.2010.02357.x; Mikusinski G, 2001, CONSERV BIOL, V15, P208, DOI 10.1046/j.1523-1739.2001.99236.x; MORIN H, 1990, CAN J FOREST RES, V20, P1, DOI 10.1139/x90-001; Nappi A, 2011, CAN J FOREST RES, V41, P994, DOI [10.1139/X11-028, 10.1139/x11-028]; Nappi A, 2009, BIOL CONSERV, V142, P1381, DOI 10.1016/j.biocon.2009.01.022; OMNR, 2000, SILV GUID MAN SO ONT; Ordonez A, 2014, NAT CLIM CHANGE, V4, P811, DOI [10.1038/nclimate2337, 10.1038/NCLIMATE2337]; Pasher J., 2013, CANADIAN J REMOTE SE, V39, P42, DOI DOI 10.5589/M13-007; Pearce-Higgins JW, 2015, J ANIM ECOL, V84, P943, DOI 10.1111/1365-2656.12364; Peng CH, 2011, NAT CLIM CHANGE, V1, P467, DOI 10.1038/NCLIMATE1293; Portier J, 2016, ANN STAT, V9, P93; Price DT, 2013, ENVIRON REV, V21, P322, DOI 10.1139/er-2013-0042; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; R Core Team, 2015, R LANG ENV STAT COMP; Racey GD, 1996, TERRESTRIAL WETLAND; Regniere J, 2012, BIOL INVASIONS, V14, P1571, DOI 10.1007/s10530-010-9918-1; Rehfeldt GE, 2012, ECOL APPL, V22, P119, DOI 10.1890/11-0495.1; Robitaille A., 1998, PAYSAGES REGIONAUX Q; Scheller R.M., 2005, LANDIS 2 BASE FIRE E; Scheller RM, 2005, GLOBAL CHANGE BIOL, V11, P307, DOI 10.1111/j.1365-2486.2005.00906.x; Scheller RM, 2004, ECOL MODEL, V180, P211, DOI 10.1016/j.ecolmodel.2004.01.022; Scheller RM, 2007, ECOL MODEL, V201, P409, DOI 10.1016/j.ecolmodel.2006.10.009; Schieck J, 2006, CAN J FOREST RES, V36, P1299, DOI 10.1139/X06-017; Schneider RR, 2003, CONSERV ECOL, V7; Seidl R, 2014, ENVIRON MODELL SOFTW, V51, P1, DOI 10.1016/j.envsoft.2013.09.018; Silva LCR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011543; Soja AJ, 2007, GLOBAL PLANET CHANGE, V56, P274, DOI 10.1016/j.gloplacha.2006.07.028; Stralberg D, 2015, ECOL APPL, V25, P52, DOI 10.1890/13-2289.1; Stralberg D, 2015, DIVERS DISTRIB, V21, P1112, DOI 10.1111/ddi.12356; Sturtevant BR, 2004, ECOL MODEL, V180, P153, DOI 10.1016/j.ecolmodel.2004.01.021; Sturtevant BR, 2012, ECOL APPL, V22, P1278, DOI 10.1890/11-0590.1; Taylor AR, 2017, FOREST ECOL MANAG, V405, P284, DOI 10.1016/j.foreco.2017.07.033; Terrier A, 2013, ECOL APPL, V23, P21, DOI 10.1890/12-0425.1; Thom D, 2017, GLOBAL CHANGE BIOL, V23, P269, DOI 10.1111/gcb.13506; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Tremblay JA, 2016, BLACK BACKED WOODPEC, P509; Tremblay JA, 2015, ECOSCIENCE, V22, P145, DOI 10.1080/11956860.2016.1169386; Tremblay JA, 2015, FOREST ECOL MANAG, V357, P220, DOI 10.1016/j.foreco.2015.08.024; Tremblay JA, 2010, CAN J FOREST RES, V40, P991, DOI 10.1139/X10-044; Tremblay JA, 2009, AVIAN CONSERV ECOL, V4; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Vedder O, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001605; Virkkala R, 2016, BIODIVERS CONSERV, V25, P151, DOI 10.1007/s10531-015-1043-0; Virkkala R, 2014, GLOBAL CHANGE BIOL, V20, P2995, DOI [10.1111/gcb.12573, 10.1111/gcb.1]; Volney WJA, 2005, FOREST CHRON, V81, P662, DOI 10.5558/tfc81662-5; Wang WJ, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00238.1; Ward BC, 2004, TECHNICAL DOCUMENT D; Wretenberg J, 2007, J APPL ECOL, V44, P933, DOI 10.1111/j.1365-2664.2007.01349.x	102	28	28	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191645	10.1371/journal.pone.0191645	http://dx.doi.org/10.1371/journal.pone.0191645			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414989	Green Published, Green Submitted, gold			2022-12-26	WOS:000424325300037
J	Benedetti, S; Catalani, S; Peda, F; Luchetti, F; Citarella, R; Battistelli, S				Benedetti, Serena; Catalani, Simona; Peda, Federica; Luchetti, Francesca; Citarella, Roberto; Battistelli, Serafina			Impact of the 24-h ultramarathon race on homocysteine, oxidized low-density lipoprotein, and paraoxonase 1 levels in professional runners	PLOS ONE			English	Article							ULTRA-ENDURANCE EXERCISE; MARATHON; INFLAMMATION; MUSCLE; DAMAGE	The impact of the 24-h ultramarathon race on homocysteine (Hcy) and oxidized low-density lipoprotein (oxLDL) levels, two well-recognized cardiovascular risk factors, has not been deeply investigated. Similarly, no information exists on paraoxonase 1 (PON1), an antioxidant enzyme associated with high-density lipoproteins, which may detoxify oxLDL and Hcy-thiolactone, hence preventing their proatherogenic action. Taking this into account, a competitive 24-h ultramarathon race was organized in Reggio-Emilia (Italy) recruiting professional runners (n = 14) from the Italian Ultramarathon and Trail Association. Blood samples were collected from each participant before, during (14 h), and immediately after (24 h) the competition, thus to monitor the serum changes in Hcy, oxLDL, and PON1 levels, as well as other oxidative stress-related parameters, namely reactive oxygen metabolites (ROM) and total antioxidant capacity (PAT). As a result, a significant PON1 increase was recorded after 14 h of racing that persisted until the end of the performance. The same trend was observed for PAT values, which positively correlated to PON1 levels (R = 0.643, P< 0.001). Hcy, oxLDL, and ROM remained almost unchanged throughout the competition. In conclusion, the present study suggested a protective role of PON1 in sustaining the antioxidant defense system and contrasting lipoprotein oxidative modifications over the 24-h race, and did not specifically evidence either Hcy or oxLDL accumulation in such challenging sporting events.	[Benedetti, Serena; Catalani, Simona; Peda, Federica; Battistelli, Serafina] Univ Urbino Carlo Bo, Sect Clin Biochem & Mol Genet, Dept Biomol Sci, Urbino, Italy; [Luchetti, Francesca] Univ Urbino Carlo Bo, Sect Pharmacol & Pharmacognosy, Dept Biomol Sci, Urbino, Italy; [Citarella, Roberto] Ctr Rehabil Therapy, Reggio Emilia, Italy	University of Urbino; University of Urbino	Benedetti, S (corresponding author), Univ Urbino Carlo Bo, Sect Clin Biochem & Mol Genet, Dept Biomol Sci, Urbino, Italy.	serena.benedetti@uniurb.it		Benedetti, Serena/0000-0002-9719-2381	Centro di Terapia Riabilitativa "C.T.R." (Reggio Emiiia, Italy)	Centro di Terapia Riabilitativa "C.T.R." (Reggio Emiiia, Italy)	This study was partially sustained by Centro di Terapia Riabilitativa "C.T.R." (Reggio Emiiia, Italy). The funder had no role in data collection and analysis. There was no additional external funding received for this study. Other sources of support were internal to our organization	Chernyavskiy I, 2016, ANN NY ACAD SCI, V1363, P138, DOI 10.1111/nyas.13009; Chistiakov DA, 2017, BIOCHIMIE, V132, P19, DOI 10.1016/j.biochi.2016.10.010; Emed LGM, 2016, J SPORT SCI, V34, P1657, DOI 10.1080/02640414.2015.1130237; Gill SK, 2015, INT J SPORTS MED, V36, P688, DOI 10.1055/s-0034-1398535; Gresslien T, 2016, INT J CARDIOL, V221, P609, DOI 10.1016/j.ijcard.2016.06.243; He F, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00486; Jee H, 2012, J SPORT SCI MED, V11, P719; Kerschan-Schindl K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132478; Khodaee M, 2015, INT J SPORTS MED, V36, P867, DOI 10.1055/s-0035-1550045; Kim HJ, 2007, EUR J APPL PHYSIOL, V99, P443, DOI 10.1007/s00421-006-0362-y; Knez WL, 2006, SPORTS MED, V36, P429, DOI 10.2165/00007256-200636050-00005; Kupchak BR, 2014, WILD ENVIRON MED, V25, P278, DOI 10.1016/j.wem.2014.03.013; Mackness M, 2015, GENE, V567, P12, DOI 10.1016/j.gene.2015.04.088; Marklund P, 2013, J APPL PHYSIOL, V114, P66, DOI 10.1152/japplphysiol.01538.2011; Maroto-Sanchez B, 2016, CLIN CHEM LAB MED, V54, P1561, DOI 10.1515/cclm-2015-1040; Millet GY, 2011, SCAND J MED SCI SPOR, V21, P54, DOI 10.1111/j.1600-0838.2009.01001.x; Morillas-Ruiz J. M., 2015, BASIC PRINCIPLES CLI, P221; Nieman DC, 2003, INT J SPORTS MED, V24, P541; Otocka-Kmiecik A., 2014, THESCIENTIFICWORLDJO, V2014, DOI DOI 10.1155/2014/230271; Passaglia DG, 2013, ARQ BRAS CARDIOL, V100, P21, DOI 10.1590/S0066-782X2012005000118; Scott JM, 2009, MED SCI SPORT EXER, V41, P25, DOI 10.1249/MSS.0b013e31818313ff; Seidl J, 2014, CURR SPORT MED REP, V13, P361, DOI 10.1249/JSR.0000000000000097; Skenderi KP, 2008, EUR J CLIN INVEST, V38, P159, DOI 10.1111/j.1365-2362.2007.01917.x; Skovierova H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101733; Trpkovic A, 2015, CRIT REV CL LAB SCI, V52, P70, DOI 10.3109/10408363.2014.992063; Turner JE, 2014, BIOCHEM SOC T, V42, P989, DOI 10.1042/BST20140120; Vezzoli A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6439037; Waskiewicz Z, 2012, EUR J APPL PHYSIOL, V112, P1679, DOI 10.1007/s00421-011-2135-5; Wu HJ, 2004, WORLD J GASTROENTERO, V10, P2711, DOI 10.3748/wjg.v10.i18.2711	29	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192392	10.1371/journal.pone.0192392	http://dx.doi.org/10.1371/journal.pone.0192392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394290	Green Published, Green Submitted, gold			2022-12-26	WOS:000424060400042
J	He, YJ; Penney, ME; Negandhi, AA; Parfrey, PS; Savas, S; Yilmaz, YE				He, Yanjing; Penney, Michelle E.; Negandhi, Amit A.; Parfrey, Patrick S.; Savas, Sevtap; Yilmaz, Yildiz E.			XRCC3 Thr241Met and TYMS variable number tandem repeat polymorphisms are associated with time-to-metastasis in colorectal cancer	PLOS ONE			English	Article							THYMIDYLATE SYNTHASE GENE; BREAST-CANCER; SURVIVAL-DATA; COLON-CANCER; 5-FLUOROURACIL; POPULATION; EXPRESSION; PROGNOSIS; MODELS; CHEMOTHERAPY	Background Metastasis is a major cause of mortality in cancer. Identifying prognostic factors that distinguish patients who will experience metastasis in the short-term and those that will be free of metastasis in the long-term is of particular interest in current medical research. The objective of this study was to examine if select genetic polymorphisms can differentiate colorectal cancer patients based on timing and long-term risk of metastasis. Methods The patient cohort consisted of 402 stage I-III colorectal cancer patients with microsatellite instability (MSI)-low (MSI-L) or microsatellite stable (MSS) tumors. We applied multivariable mixture cure model, which is the proper model when there is a substantial group of patients who remain free of metastasis in the long-term, to 26 polymorphisms. Time-dependent receiver operator characteristic (ROC) curve analysis was performed to determine the change in discriminatory accuracy of the models when the significant SNPs were included. Results After adjusting for significant baseline characteristics, two polymorphisms were significantly associated with time-to-metastasis: TT and TC genotypes of the XRCC3 Thr241Met (p = 0.042) and the 3R/3R genotype of TYMS 5'-UTR variable number tandem repeat (VNTR) (p = 0.009) were associated with decreased time-to-metastasis. ROC curves showed that the discriminatory accuracy of the model is increased slightly when these polymorphisms were added to the significant baseline characteristics. Conclusions Our results indicate XRCC3 Thr241Met and TYMS 5'-UTR VNTR polymorphisms are associated with time-to-metastasis, and may have potential biological roles in expediting the metastatic process. Once replicated, these associations could contribute to the development of precision medicine for colorectal cancer patients.	[He, Yanjing; Yilmaz, Yildiz E.] Mem Univ Newfoundland, Fac Sci, Dept Math & Stat, St John, NF, Canada; [He, Yanjing; Penney, Michelle E.; Negandhi, Amit A.; Savas, Sevtap; Yilmaz, Yildiz E.] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada; [Parfrey, Patrick S.; Yilmaz, Yildiz E.] Mem Univ Newfoundland, Fac Med, Discipline Med, St John, NF, Canada; [Savas, Sevtap] Mem Univ Newfoundland, Fac Med, Discipline Oncol, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland	Yilmaz, YE (corresponding author), Mem Univ Newfoundland, Fac Sci, Dept Math & Stat, St John, NF, Canada.; Yilmaz, YE (corresponding author), Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada.; Yilmaz, YE (corresponding author), Mem Univ Newfoundland, Fac Med, Discipline Med, St John, NF, Canada.	yyilmaz@mun.ca			Research and Development Corporation (RDC) of Newfoundland and Labrador (NL) [5404.1723.101]; Newfoundland Colorectal Cancer Registry (NFCCR); Faculty of Medicine of Memorial University Cox Award; Canadian Institute of Health Research (CIHR) fund for the Colorectal Cancer Interdisciplinary Health Research Team at the University of Toronto; Memorial University of Newfoundland; National Cancer Institute of Canada [18223, 18226]; Atlantic Innovation Fund for the Interdisciplinary Research Team in Human Genetics; Translational and Personalized Medicine Initiative (TPMI)/NL SUPPORT fellowship; CIHR Interdisciplinary Health Research Team Fellowship	Research and Development Corporation (RDC) of Newfoundland and Labrador (NL); Newfoundland Colorectal Cancer Registry (NFCCR); Faculty of Medicine of Memorial University Cox Award; Canadian Institute of Health Research (CIHR) fund for the Colorectal Cancer Interdisciplinary Health Research Team at the University of Toronto(Canadian Institutes of Health Research (CIHR)); Memorial University of Newfoundland; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Atlantic Innovation Fund for the Interdisciplinary Research Team in Human Genetics; Translational and Personalized Medicine Initiative (TPMI)/NL SUPPORT fellowship; CIHR Interdisciplinary Health Research Team Fellowship(Canadian Institutes of Health Research (CIHR))	This work was primarily funded by the Research and Development Corporation (RDC) of Newfoundland and Labrador (NL) [5404.1723.101] and the Faculty of Medicine of Memorial University of Newfoundland awarded to Y.E. Yilmaz. Other funds that supported the Newfoundland Colorectal Cancer Registry (NFCCR) and helped collect the data used in this study are: Medical Research fund at Faculty of Medicine of Memorial University Cox Award 2010, Canadian Institute of Health Research (CIHR) fund for the Colorectal Cancer Interdisciplinary Health Research Team at the University of Toronto and Memorial University of Newfoundland, the National Cancer Institute of Canada [18223 and 18226] and the Atlantic Innovation Fund for the Interdisciplinary Research Team in Human Genetics. M.E. Penney is partly supported by a Translational and Personalized Medicine Initiative (TPMI)/NL SUPPORT fellowship. A.A. Negandhi was supported by a CIHR Interdisciplinary Health Research Team Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejan-Angoulvant T, 2008, EUR J EPIDEMIOL, V23, P251, DOI 10.1007/s10654-008-9226-6; Boige V, 2010, J CLIN ONCOL, V28, P2556, DOI 10.1200/JCO.2009.25.2106; Buckowitz A, 2005, BRIT J CANCER, V92, P1746, DOI 10.1038/sj.bjc.6602534; Canadian Cancer Society's Advisory Committee on Cancer Statistics, 2016, CAN CANC STAT 2016; Cui YH, 2009, J DIGEST DIS, V10, P118, DOI 10.1111/j.1751-2980.2009.00373.x; Cvancarova M, 2013, INT J CANCER, V132, P1700, DOI 10.1002/ijc.27802; FAREWELL VT, 1982, BIOMETRICS, V38, P1041, DOI 10.2307/2529885; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Forse CL, 2013, BREAST CANCER RES TR, V137, P709, DOI 10.1007/s10549-012-2392-y; Gosens MI, 2008, INT J CANCER, V123, P1941, DOI 10.1002/ijc.23740; Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071; Green RC, 2007, FAM CANCER, V6, P53, DOI 10.1007/s10689-006-9104-x; Grimminger PP, 2010, J SURG RES, V164, pE61, DOI 10.1016/j.jss.2010.08.002; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hitre E, 2005, PHARMACOGENET GENOM, V15, P723, DOI 10.1097/01.fpc.0000175598.42141.59; Hosmer DW, 2008, APPL SURVIVAL ANAL; Howlader N, 2011, SEER CANC STAT REV 1; Kawakami K, 2001, CLIN CANCER RES, V7, P4096; Kawakami K, 1999, ANTICANCER RES, V19, P3249; Lambert PC, 2010, J R STAT SOC C-APPL, V59, P35, DOI 10.1111/j.1467-9876.2009.00677.x; Lawless J. F., 2003, STAT MODELS METHODS; Lawless JF, 2011, BIOMETRICAL J, V53, P779, DOI 10.1002/bimj.201000131; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; Liu Y, 2012, HEPATO-GASTROENTEROL, V59, P977, DOI 10.5754/hge12187; Malesci A, 2007, CLIN CANCER RES, V13, P3831, DOI 10.1158/1078-0432.CCR-07-0366; Martinez-Balibrea E, 2008, EUR J CANCER, V44, P1229, DOI 10.1016/j.ejca.2008.03.025; Martinez-Balibrea E, 2007, ONCOL REP, V17, P637; Matullo G, 2001, CARCINOGENESIS, V22, P1437, DOI 10.1093/carcin/22.9.1437; Moreno V, 2006, CLIN CANCER RES, V12, P2101, DOI 10.1158/1078-0432.CCR-05-1363; Negandhi AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061469; Paez D, 2017, INT J RADIAT ONCOL, V81, P1319; PINEDO HM, 1988, J CLIN ONCOL, V6, P1653, DOI 10.1200/JCO.1988.6.10.1653; Popat S, 2004, J CLIN ONCOL, V22, P529, DOI 10.1200/JCO.2004.05.064; Ruzzo A, 2008, PHARMACOGENOMICS J, V8, P278, DOI 10.1038/sj.tpj.6500463; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Wish TA, 2010, CANCER EPIDEM BIOMAR, V19, P1831, DOI 10.1158/1055-9965.EPI-10-0055; Woods MO, 2010, GUT, V59, P1369, DOI 10.1136/gut.2010.208462; Yilmaz YE, 2013, J CLIN ONCOL, V31, P2047, DOI 10.1200/JCO.2012.46.6615; Yoshihara T, 2004, EMBO J, V23, P670, DOI 10.1038/sj.emboj.7600087	40	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192316	10.1371/journal.pone.0192316	http://dx.doi.org/10.1371/journal.pone.0192316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394274	Green Submitted, Green Published, gold			2022-12-26	WOS:000424060400034
J	Abuyassin, B; Badran, M; Ayas, NT; Laher, I				Abuyassin, Bisher; Badran, Mohammad; Ayas, Najib T.; Laher, Ismail			Intermittent hypoxia causes histological kidney damage and increases growth factor expression in a mouse model of obstructive sleep apnea	PLOS ONE			English	Article							ANGIOTENSIN SYSTEM ACTIVITY; MESANGIAL MATRIX EXPANSION; AIRWAY PRESSURE THERAPY; GLOMERULAR-DISEASE; TGF-BETA; DIABETIC-NEPHROPATHY; CARDIOVASCULAR CONSEQUENCES; OXIDATIVE STRESS; BLOOD-PRESSURE; RENAL-DISEASE	Epidemiological studies demonstrate an association between obstructive sleep apnea (OSA) and accelerated loss of kidney function. It is unclear whether the decline in function is due to OSA per se or to other confounding factors such as obesity. In addition, the structural kidney abnormalities associated with OSA are unclear. The objective of this study was to determine whether intermittent hypoxia (IH), a key pathological feature of OSA, induces renal histopathological damage using a mouse model. Ten 8-week old wild-type male CB57BL/6 mice were randomly assigned to receive either IH or intermittent air (IA) for 60 days. After euthanasia, one kidney per animal was paraformaldehyde-fixed and then sectioned for histopathological and immunohistochemical analysis. Measurements of glomerular hypertrophy and mesangial matrix expansion were made in periodic acid-Schiff stained kidney sections, while glomerular transforming growth factor-beta 1 (TGF-beta 1), connective tissue growth factor (CTGF) and vascular endothelial growth factor-A (VEGF-A) proteins were semi-quantified by immunohistochemistry. The antigen-antibody reaction was detected by 3,3'-diaminobenzidine chromogen where the color intensity semi-quantified glomerular protein expression. To enhance the accuracy of protein semi-quantification, the percentage of only highly-positive staining was used for analysis. Levels of TGF-beta, CTGF and VEGF-A proteins in the kidney cortex were further quantified by western blotting. Cellular apoptosis was also investigated by measuring cortical antiapoptotic B-cell lymphoma 2 (Bcl-2) and apoptotic Bcl-2-associated X (Bax) proteins by western blotting. Further investigation of cellular apoptosis was carried out by fluorometric terminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling (TUNEL) staining. Finally, the levels of serum creatinine and 24-hour urinary albumin were measured as a general index of renal function. Our results indicate that mice exposed to IH have an increased glomerular area (by 1.13 fold, p< 0.001) and expansion of mesangial matrix (by 1.8 fold, p< 0.01). Moreover, the glomerular expressions of TGF-beta 1, CTGF and VEGF-A proteins were 2.7, 2.2 and 3.8-fold higher in mice exposed to IH (p< 0.05 for all). Furthermore, western blotting protein analysis demonstrates that IH-exposed mice express higher levels of TGF-beta 1, CTGF and VEGF-A proteins by 1.9, 4.0 and 1.6-fold (p< 0.05 for all) respectively. Renal cellular apoptosis was greater in the IH group as shown by an increased cortical Bax/Bcl-2 protein ratio (p< 0.01) and higher fluorometric TUNEL staining (p< 0.001). Finally, 24-hr urinary albumin levels were higher in mice exposed to IH (43.4 mu g vs 9.7 mu g, p< 0.01), while there were no differences in serum creatinine levels between the two groups. We conclude that IH causes kidney injury that is accompanied by glomerular hypertrophy, mesangial matrix expansion, increased expression of glomerular growth factors and an increased cellular apoptosis.	[Abuyassin, Bisher; Ayas, Najib T.] Univ British Columbia, Dept Med, Fac Med, Vancouver, BC, Canada; [Badran, Mohammad; Laher, Ismail] Univ British Columbia, Fac Med, Dept Pharmacol, Vancouver, BC, Canada; [Badran, Mohammad; Laher, Ismail] Univ British Columbia, Fac Med, Dept Therapeut, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Laher, I (corresponding author), Univ British Columbia, Fac Med, Dept Pharmacol, Vancouver, BC, Canada.; Laher, I (corresponding author), Univ British Columbia, Fac Med, Dept Therapeut, Vancouver, BC, Canada.	ilaher@mail.ubc.ca	Badran, Mohammad/AAX-6962-2021; Laher, Ismail/X-3323-2019	Badran, Mohammad/0000-0001-7073-741X; Laher, Ismail/0000-0002-3917-4417	CIHR Sleep Team Grant; Saudi Arabian Cultural Bureau in Canada	CIHR Sleep Team Grant(Canadian Institutes of Health Research (CIHR)); Saudi Arabian Cultural Bureau in Canada	This work received project funding from CIHR Sleep Team Grant. Individual Acknowledgment: The support of the Saudi Arabian Cultural Bureau in Canada (to BA) is gratefully acknowledged.; The support of the Saudi Arabian Cultural Bureau in Canada (to BA) is gratefully acknowledged.	ABRASS CK, 1995, WESTERN J MED, V162, P318; Abuyassin B, 2015, J CLIN SLEEP MED, V11, P915, DOI 10.5664/jcsm.4946; Adeseun GA, 2010, CURR HYPERTENS REP, V12, P378, DOI 10.1007/s11906-010-0135-1; Ahmed SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019029; Almendros I, 2014, AM J RESP CRIT CARE, V189, P593, DOI 10.1164/rccm.201310-1830OC; Almendros I, 2013, RESP PHYSIOL NEUROBI, V186, P303, DOI 10.1016/j.resp.2013.03.001; Badran M, 2015, CAN J CARDIOL, V31, P873, DOI 10.1016/j.cjca.2015.03.011; Badran M, 2014, SLEEP MED, V15, P596, DOI 10.1016/j.sleep.2014.01.013; Calvin AD, 2009, METAB SYNDR RELAT D, V7, P271, DOI 10.1089/met.2008.0093; Carpagnano GE, 2003, CHEST, V124, P1386, DOI 10.1378/chest.124.4.1386; Chou YT, 2011, NEPHROL DIAL TRANSPL, V26, P2244, DOI 10.1093/ndt/gfq821; Cravedi P, 2013, BRIT J CLIN PHARMACO, V76, P516, DOI 10.1111/bcp.12104; Daehn I, 2014, J CLIN INVEST, V124, P1608, DOI 10.1172/JCI71195; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Dewan NA, 2015, CHEST, V147, P266, DOI 10.1378/chest.14-0500; Fine LG, 1998, KIDNEY INT, pS74; FLETCHER EC, 1992, HYPERTENSION, V19, P555, DOI 10.1161/01.HYP.19.6.555; Fogo AB, 2000, KIDNEY INT, V57, pS15, DOI 10.1046/j.1523-1755.2000.07505.x; Fogo AB, 1999, EXP NEPHROL, V7, P147; Friederich-Persson M, 2013, HYPERTENSION, V62, P914, DOI 10.1161/HYPERTENSIONAHA.113.01425; Ghayur A, 2013, KIDNEY RES CLIN PRAC, V32, P3, DOI 10.1016/j.krcp.2013.01.003; Golbidi S, 2012, LUNG, V190, P113, DOI 10.1007/s00408-011-9340-1; Goldschmeding R, 2000, NEPHROL DIAL TRANSPL, V15, P296, DOI 10.1093/ndt/15.3.296; Goumenos DS, 2002, NEPHROL DIAL TRANSPL, V17, P2145, DOI 10.1093/ndt/17.12.2145; Goumenos DS, 2001, NEPHRON, V87, P240, DOI 10.1159/000045921; Griffin KA, 2004, KIDNEY INT, V65, P209, DOI 10.1111/j.1523-1755.2004.00356.x; Gupta S, 2000, KIDNEY INT, V58, P1389, DOI 10.1046/j.1523-1755.2000.00301.x; Hughson MD, 2014, NEPHROL DIAL TRANSPL, V29, P1399, DOI 10.1093/ndt/gft480; Iiyori N, 2007, AM J RESP CRIT CARE, V175, P851, DOI 10.1164/rccm.200610-1527OC; Iseki K, 2008, HYPERTENS RES, V31, P249, DOI 10.1291/hypres.31.249; Kanbay A, 2012, INT UROL NEPHROL, V44, P535, DOI 10.1007/s11255-011-9927-8; Lee HS, 2012, HISTOL HISTOPATHOL, V27, P1131, DOI 10.14670/HH-27.1131; Lee HS, 2009, HISTOL HISTOPATHOL, V24, P901, DOI 10.14670/HH-24.901; Nakagawa T, 2003, AM J NEPHROL, V23, P2, DOI 10.1159/000066303; Nicholl DDM, 2014, AM J RESP CRIT CARE, V190, P572, DOI 10.1164/rccm.201403-0526OC; Nicholl DDM, 2012, CHEST, V141, P1422, DOI 10.1378/chest.11-1809; Palm F, 2011, CLIN EXP PHARMACOL P, V38, P424, DOI 10.1111/j.1440-1681.2011.05532.x; Parati G, 2014, HYPERTENS RES, V37, P601, DOI 10.1038/hr.2014.80; Petrosino T, 2014, CRIT REV FOOD SCI, V54, P1202, DOI 10.1080/10408398.2011.630153; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Rajan P, 2015, NAT SCI SLEEP, V7, P113, DOI 10.2147/NSS.S90835; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Sun WX, 2013, DOSE-RESPONSE, V11, P385, DOI 10.2203/dose-response.12-027.Cai; Tagaito Y, 2001, J APPL PHYSIOL, V91, P2758, DOI 10.1152/jappl.2001.91.6.2758; Thomson SE, 2008, J DIABETES COMPLICAT, V22, P284, DOI 10.1016/j.jdiacomp.2007.07.001; Tobar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075547; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Vilaseca A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179444; Wang X, 2013, INT J CARDIOL, V169, P207, DOI 10.1016/j.ijcard.2013.08.088; Wang X, 2013, RESPIROLOGY, V18, P140, DOI 10.1111/j.1440-1843.2012.02267.x; Weston BS, 2003, J AM SOC NEPHROL, V14, P601, DOI 10.1097/01.ASN.0000051600.53134.B9; Wu H, 2015, TOXICOL LETT, V232, P340, DOI 10.1016/j.toxlet.2014.11.015; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705; Zalucky AA, 2015, AM J RESP CRIT CARE, V192, P873, DOI 10.1164/rccm.201502-0383OC; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B	55	31	31	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192084	10.1371/journal.pone.0192084	http://dx.doi.org/10.1371/journal.pone.0192084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389945	Green Published, gold, Green Submitted			2022-12-26	WOS:000423793400065
J	Bergman, P				Bergman, Patrick			The number of repeated observations needed to estimate the habitual physical activity of an individual to a given level of precision	PLOS ONE			English	Article							OUTCOME VARIABLES; ACCELEROMETER; VARIABILITY; ADULTS; CHILDREN	Physical activity behavior varies naturally from day to day, from week to week and even across seasons. In order to assess the habitual level of physical activity of a person, the person must be monitored for long enough so that the level can be identified, taking into account this natural within-person variation. An important question, and one whose answer has implications for study-and survey design, epidemiological research and population surveillance, is, for how long does an individual need to be monitored before such a habitual level or pattern can be identified to a desired level of precision? The aim of this study was to estimate the number of repeated observations needed to identify the habitual physical activity behaviour of an individual to a given degree of precision. A convenience sample of 50 Swedish adults wore accelerometers during four consecutive weeks. The number of days needed to come within 5-50% of an individual's usual physical activity 95% of the time was calculated. To get an idea of the uncertainty of the estimates all statistical estimates were bootstrapped 2000 times. The mean number of days of measurement needed for the observation to, with 95% confidence, be within 20% of the habitual physical activity of an individual is highest for vigorous physical activity, for which 182 days are needed. For sedentary behaviour the equivalent number of days is 2.4. To capture 80% of the sample to within +/- 20% of their habitual level of physical activity, 3.4 days is needed if sedentary behavior is the outcome of interest, and 34.8 days for MVPA. The present study shows that for analyses requiring accurate data at the individual level a longer measurement collection period than the traditional 7-day protocol should be used. In addition, the amount of MVPA was negatively associated with the number of days required to identify the habitual physical activity level indicating that the least active are also those whose habitual physical activity level is the most difficult to identify. These results could have important implications for researchers whose aim is to analyse data on an individual level. Before recommendations regarding an appropriate monitoring protocol are updated, the present study should be replicated in different populations.	[Bergman, Patrick] Linnaeus Univ, Dept Sport Sci, Kalmar, Sweden	Linnaeus University	Bergman, P (corresponding author), Linnaeus Univ, Dept Sport Sci, Kalmar, Sweden.	Patrick.bergman@lnu.se	Bergman, Patrick/B-5906-2012	Bergman, Patrick/0000-0003-4934-8684				Aadland E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133296; Aadland E, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-172; Augustin NH, 2015, STAT METHODS MED RES; Coleman KJ, 1998, RES Q EXERCISE SPORT, V69, P58, DOI 10.1080/02701367.1998.10607667; Dillon CB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0109913; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gibson R, 2005, PRINCIPLES NUTR ASSE; GRETEBECK RJ, 1992, MED SCI SPORT EXER, V24, P1167; Hallal PC, 2012, LANCET, V380, P190, DOI 10.1016/S0140-6736(12)61027-7; Hart TL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-62; Holliday KM, 2017, MED SCI SPORT EXER, V49, P939, DOI 10.1249/MSS.0000000000001190; Hutcheon JA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2289; Levin S, 1999, ANN EPIDEMIOL, V9, P481, DOI 10.1016/S1047-2797(99)00022-8; LIU K, 1978, J CHRON DIS, V31, P399, DOI 10.1016/0021-9681(78)90004-8; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1376, DOI 10.1097/00005768-200208000-00021; Mattocks C, 2008, J PHYS ACT HEALTH, V5, pS98, DOI 10.1123/jpah.5.s1.s98; Melin M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153036; NELSON M, 1989, AM J CLIN NUTR, V50, P155, DOI 10.1093/ajcn/50.1.155; Ojiambo R, 2011, INT J OBESITY, V35, pS98, DOI 10.1038/ijo.2011.40; Patrick K, 2004, ARCH PEDIAT ADOL MED, V158, P385, DOI 10.1001/archpedi.158.4.385; Ridgers ND, 2016, J SCI MED SPORT; Santos-Lozano A, 2013, INT J SPORTS MED, V34, P975, DOI 10.1055/s-0033-1337945; Shephard RJ, 2009, EUR J APPL PHYSIOL, V107, P251, DOI 10.1007/s00421-009-1127-1; Team RC, 2016, R LANG ENV STAT COMP; Togo F, 2008, MED SCI SPORT EXER, V40, P1058, DOI 10.1249/MSS.0b013e318167469a; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Vanhelst Jeremy, 2012, BMC Res Notes, V5, P187, DOI 10.1186/1756-0500-5-187; Wickel EE, 2006, EUR J CLIN NUTR, V60, P538, DOI 10.1038/sj.ejcn.1602348; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wright D.B., 2011, J EXPER PSYCHOPATHOL, V2, P252, DOI [10.5127/jep.013611, DOI 10.5127/JEP.013611]; Wu YT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177767	34	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192117	10.1371/journal.pone.0192117	http://dx.doi.org/10.1371/journal.pone.0192117			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390010	gold, Green Submitted, Green Published			2022-12-26	WOS:000423793400069
J	Wan, Z; Ostendorff, HP; Liu, ZY; Schneider, LC; Rothschild, KJ; Lim, MJ				Wan, Zhi; Ostendorff, Heather P.; Liu, Ziying; Schneider, Lynda C.; Rothschild, Kenneth J.; Lim, Mark J.			Photocleavage-based affinity purification of biomarkers from serum: Application to multiplex allergy testing	PLOS ONE			English	Article							FOOD ALLERGY; HETEROPHILE ANTIBODY; IGE CONCENTRATIONS; INTERFERENCE; PEANUT; IMMUNOASSAY; BINDING; RISK; AUTOANTIBODIES; PARAMETER	Multiplex serological immunoassays, such as implemented on microarray or microsphere-based platforms, provide greater information content and higher throughput, while lowering the cost and blood volume required. These features are particularly attractive in pediatric food allergy testing to facilitate high throughput multi-allergen analysis from finger-or heel-stick collected blood. However, the miniaturization and microfluidics necessary for creating multiplex assays make them highly susceptible to the "matrix effect" caused by interference from non-target agents in serum and other biofluids. Such interference can result in lower sensitivity, specificity, reproducibility and quantitative accuracy. These problems have in large part prevented wide-spread implementation of multiplex immunoassays in clinical laboratories. We report the development of a novel method to eliminate the matrix effect by utilizing photocleavable capture antibodies to purify and concentrate blood-based biomarkers (a process termed PC-PURE) prior to detection in a multiplex immunoassay. To evaluate this approach, it was applied to blood-based allergy testing. Patient total IgE was purified and enriched using PC-PURE followed by multiplex microsphere-based detection of allergen-specific IgEs (termed the AllerBead assay). AllerBead was formatted to detect the eight most common pediatric food allergens: milk, soy, wheat, egg, peanuts, tree nuts, fin fish and shellfish, which account for >90% of all pediatric food allergies. 205 serum samples obtained from Boston Children's Hospital were evaluated. When PC-PURE was employed with AllerBead, excellent agreement was obtained with the standard, non-multiplex, ImmunoCAP (R) assay (average sensitivity above published negative predictive cutoffs = 96% and average Pearson r = 0.90; average specificity = 97%). In contrast, poor ImmunoCAP (R)-correlation was observed when PC-PURE was not utilized (average sensitivity above published negative predictive cutoffs = 59% and average Pearson r = 0.61; average specificity = 97%). This approach should be adaptable to improve a wide range of multiplex immunoassays such as in cancer, infectious disease and autoimmune disease.	[Wan, Zhi; Ostendorff, Heather P.; Liu, Ziying; Rothschild, Kenneth J.; Lim, Mark J.] AmberGen Inc, Watertown, MA 02472 USA; [Schneider, Lynda C.] Boston Childrens Hosp, Dept Pediat, Boston, MA USA; [Rothschild, Kenneth J.] Boston Univ, Dept Phys, Mol Biophys Lab, 590 Commonwealth Ave, Boston, MA 02215 USA; [Rothschild, Kenneth J.] Boston Univ, Photon Ctr, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Boston University; Boston University	Rothschild, KJ; Lim, MJ (corresponding author), AmberGen Inc, Watertown, MA 02472 USA.; Rothschild, KJ (corresponding author), Boston Univ, Dept Phys, Mol Biophys Lab, 590 Commonwealth Ave, Boston, MA 02215 USA.; Rothschild, KJ (corresponding author), Boston Univ, Photon Ctr, Boston, MA 02215 USA.	krothschild@amberen.com; mlim@ambergen.com	Rothschild, Kenneth J/P-6177-2018; Schneider, Lynda C/AAY-6545-2021	Rothschild, Kenneth J/0000-0002-2847-6671; Schneider, Lynda C/0000-0002-5633-0178; Lim, Mark/0000-0002-5784-7195	National Institute of Allergy and Infectious Diseases of the National Institutes of Health, United States of America [R43/R44 AI100424]	National Institute of Allergy and Infectious Diseases of the National Institutes of Health, United States of America	This work was supported by the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/) of the National Institutes of Health, United States of America, grant R43/R44 AI100424 to AmberGen Incorporated with MJL as the Principle Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann F, 2016, ALLERGO J, V25, P18, DOI 10.1007/s40629-016-0112-6; Anderson KS, 2015, J PROTEOME RES, V14, P578, DOI 10.1021/pr500908n; Anderson KS, 2011, J PROTEOME RES, V10, P85, DOI 10.1021/pr100686b; Barker DP, 1996, ARCH DIS CHILD-FETAL, V74, pF139, DOI 10.1136/fn.74.2.F139; Branum AM, 2009, PEDIATRICS, V124, P1549, DOI 10.1542/peds.2009-1210; Branum Amy M, 2008, NCHS Data Brief, P1; Carey BS, 2016, TRANSPL IMMUNOL, V37, P23, DOI 10.1016/j.trim.2016.04.002; Carosso A, 2007, INT ARCH ALLERGY IMM, V142, P230, DOI 10.1159/000097025; Chacko M P, 2016, Indian J Nephrol, V26, P134, DOI 10.4103/0971-4065.159305; Chiu ML, 2010, JALA-J LAB AUTOM, V15, P233, DOI 10.1016/j.jala.2010.02.001; Churchman SM, 2012, CLIN EXP RHEUMATOL, V30, P534; Copple SS, 2007, ANN NY ACAD SCI, V1109, P464, DOI 10.1196/annals.1398.052; de Jager W, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-52; Deinhofer K, 2004, METHODS, V32, P249, DOI 10.1016/j.ymeth.2003.08.018; Dias D, 2005, CLIN DIAGN LAB IMMUN, V12, P959, DOI 10.1128/CDLI.12.8.959-969.2005; Du Toit G, 2016, NEW ENGL J MED, V374, P1435, DOI 10.1056/NEJMoa1514209; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Du Toit G, 2013, J ALLERGY CLIN IMMUN, V131, P135, DOI 10.1016/j.jaci.2012.09.015; Fulton RJ, 1997, CLIN CHEM, V43, P1749; Fung KYC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120425; Guhsl EE, 2015, ALLERGY, V70, P59, DOI 10.1111/all.12534; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Hofman T, 1995, Rocz Akad Med Bialymst, V40, P468; Jarvinen KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143855; Janes Marianne, 2002, J Perinatol, V22, P154, DOI 10.1038/sj.jp.7210583; Jarvinen KM, 2001, INT ARCH ALLERGY IMM, V126, P111, DOI 10.1159/000049501; Jia J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095444; Kadooka Y, 2000, INT ARCH ALLERGY IMM, V122, P264, DOI 10.1159/000024408; Kaplan IV, 1999, CLIN CHEM, V45, P616; Kenten JH, 2005, METHOD ENZYMOL, V399, P682, DOI 10.1016/S0076-6879(05)99045-9; Kim YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044960; King EM, 2007, J ALLERGY CLIN IMMUN, V120, P1126, DOI 10.1016/j.jaci.2007.06.043; Kukkonen AK, 2015, ALLERGY; LAURENT J, 1985, ANN MED INTERNE, V136, P419; Lieberman JA, 2011, CURR ALLERGY ASTHM R, V11, P58, DOI 10.1007/s11882-010-0149-4; Lim M, 2008, ANAL BIOCHEM, V383, P103, DOI 10.1016/j.ab.2008.07.038; Martins TB, 2004, CLIN DIAGN LAB IMMUN, V11, P325, DOI 10.1128/CDLI.11.2.325-329.2004; Norman GL, 2015, LIVER INT, V35, P642, DOI 10.1111/liv.12690; Ostendorff HP, 2013, J IMMUNOL METHODS, V400, P58, DOI 10.1016/j.jim.2013.09.013; Ott H, 2009, ACTA DERM-VENEREOL, V89, P257, DOI 10.2340/00015555-0627; Peng Z, 2015, INT J LAB HEMATOL, V37, P56, DOI 10.1111/ijlh.12231; Perkin MR, 2016, NEW ENGL J MED, V374, P1733, DOI 10.1056/NEJMoa1514210; Perry TT, 2004, J ALLERGY CLIN IMMUN, V114, P144, DOI 10.1016/j.jaci.2004.04.009; Pickering JW, 2010, CLIN VACCINE IMMUNOL, V17, P185, DOI 10.1128/CVI.00329-09; Pomponi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035697; Rispens T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055566; Rosenberg-Hasson Y, 2014, IMMUNOL RES, V58, P224, DOI 10.1007/s12026-014-8491-6; Sampson HA, 1997, J ALLERGY CLIN IMMUN, V100, P444, DOI 10.1016/S0091-6749(97)70133-7; Sampson HA, 2001, J ALLERGY CLIN IMMUN, V107, P891, DOI 10.1067/mai.2001.114708; Sampson HA, 2014, J ALLERGY CLIN IMMUN, V134, P1016, DOI 10.1016/j.jaci.2014.05.013; Shreffler WG, 2011, J ALLERGY CLIN IMMUN, V127, P843, DOI 10.1016/j.jaci.2011.02.011; Shreffler WG, 2005, J ALLERGY CLIN IMMUN, V116, P893, DOI 10.1016/j.jaci.2005.06.033; Sicherer SH, 2008, J ALLERGY CLIN IMMUN, V122, P413, DOI 10.1016/j.jaci.2008.05.012; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Sicherer SH, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e6; Stern E, 2010, NAT NANOTECHNOL, V5, P138, DOI [10.1038/nnano.2009.353, 10.1038/NNANO.2009.353]; Tighe PJ, 2015, PROTEOM CLIN APPL, V9, P406, DOI 10.1002/prca.201400130; Togias A, 2017, ALLERGY ASTHMA CL IM, V13, DOI 10.1186/s13223-016-0175-4; Treudler R, 2013, CURR ALLERGY ASTHM R, V13, P110, DOI 10.1007/s11882-012-0318-8; Visco V, 1996, J IMMUNOL, V157, P956; Waterboer T, 2006, J IMMUNOL METHODS, V309, P200, DOI 10.1016/j.jim.2005.11.008; Zachary AA, 2009, HUM IMMUNOL, V70, P496, DOI 10.1016/j.humimm.2009.04.001; Zerrouki A, 2016, TRANSPL IMMUNOL, V36, P20, DOI 10.1016/j.trim.2016.03.001	63	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191987	10.1371/journal.pone.0191987	http://dx.doi.org/10.1371/journal.pone.0191987			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389948	Green Submitted, Green Published, gold			2022-12-26	WOS:000423793400047
J	Aguayo, A; Martin, CS; Huddy, TF; Ogawa-Okada, M; Adkins, JL; Steele, AD				Aguayo, Antonio; Martin, Camille S.; Huddy, Timothy F.; Ogawa-Okada, Maya; Adkins, Jamie L.; Steele, Andrew D.			Sex differences in circadian food anticipatory activity are not altered by individual manipulations of sex hormones or sex chromosome copy number in mice	PLOS ONE			English	Article							RHYTHMS; RESTRICTION; CLOCKS; SYSTEM; BRAIN	Recent studies in mice have demonstrated a sexual dimorphism in circadian entrainment to scheduled feeding. On a time restricted diet, males tend to develop food anticipatory activity (FAA) sooner than females and with a higher amplitude of activity. The underlying cause of this sex difference remains unknown. One study suggests that sex hormones, both androgens and estrogens, modulate food anticipatory activity in mice. Here we present results suggesting that the sex difference in FAA is unrelated to gonadal sex hormones. While a sex difference between males and females in FAA on a timed, calorie restricted diet was observed there were no differences between intact and gonadectomized mice in the onset or magnitude of FAA. To test other sources of the sex difference in circadian entrainment to scheduled feeding, we used sex chromosome copy number mutants, but there was no difference in FAA when comparing XX, XY-, XY-; Sry Tg, and XX; Sry Tg mice, demonstrating that gene dosage of sex chromosomes does not mediate the sex difference in FAA. Next, we masculinized female mice by treating them with 17-beta estradiol during the neonatal period; yet again, we saw no difference in FAA between control and masculinized females. Finally, we observed that there was no longer a sex difference in FAA for older mice, suggesting that the sex difference in FAA is age-dependent. Thus, our study demonstrates that singular manipulations of gonadal hormones, sex chromosomes, or developmental patterning are not able to explain the difference in FAA between young male and female mice.	[Aguayo, Antonio; Martin, Camille S.; Huddy, Timothy F.; Ogawa-Okada, Maya; Adkins, Jamie L.; Steele, Andrew D.] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA	California State University System; California State Polytechnic University Pomona	Steele, AD (corresponding author), Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA.	adsteele@cpp.edu			California State Polytechnic University of Pomona; CSU Program for Education and Research in Biotechnology (New Investigator Award); Kellogg Undergraduate Scholars Program; Science Educational Enhancement Services; CSU-Louis Stokes Alliance for Minority Participation; Hearst and California Wellness Foundation	California State Polytechnic University of Pomona; CSU Program for Education and Research in Biotechnology (New Investigator Award); Kellogg Undergraduate Scholars Program; Science Educational Enhancement Services; CSU-Louis Stokes Alliance for Minority Participation; Hearst and California Wellness Foundation	The authors received no specific funding for this work but did receive the following awards, which were used, in part, to fund this study: the California State Polytechnic University of Pomona to AS, CSU Program for Education and Research in Biotechnology (New Investigator Award) to AS, Kellogg Undergraduate Scholars Program to CM and JA, Science Educational Enhancement Services to AA, CSU-Louis Stokes Alliance for Minority Participation to AA, and the Hearst and California Wellness Foundation to AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AP, 2017, J NEUROSCI RES, V95, P291, DOI 10.1002/jnr.23884; DAAN S, 1975, P NATL ACAD SCI USA, V72, P3744, DOI 10.1073/pnas.72.9.3744; DAVIS FC, 1983, AM J PHYSIOL, V244, pR93, DOI 10.1152/ajpregu.1983.244.1.R93; Gallardo CM, 2014, ELIFE, V3, DOI 10.7554/eLife.03781; Gallardo CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095990; Gunapala KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018377; Honma K, 2009, EUR J NEUROSCI, V30, P1707, DOI 10.1111/j.1460-9568.2009.06976.x; Hsu CT, 2010, PLOS ONE, V9; Iwahana E, 2008, HORM BEHAV, V53, P422, DOI 10.1016/j.yhbeh.2007.11.014; Karatsoreos IN, 2011, ENDOCRINOLOGY, V152, P1970, DOI 10.1210/en.2010-1398; KRIEGER DT, 1974, ENDOCRINOLOGY, V95, P1195, DOI 10.1210/endo-95-5-1195; Kuljis DA, 2013, ENDOCRINOLOGY, V154, P1501, DOI 10.1210/en.2012-1921; Li ZG, 2015, HORM BEHAV, V70, P38, DOI 10.1016/j.yhbeh.2015.02.004; Luby MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037992; McCarthy MM, 2012, J NEUROSCI, V32, P2241, DOI 10.1523/JNEUROSCI.5372-11.2012; Michalik M, 2015, BEHAV NEUROSCI, V129, P351, DOI 10.1037/bne0000058; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger Ralph E, 2009, J Circadian Rhythms, V7, P11, DOI 10.1186/1740-3391-7-11; Mistlberger RE, 2009, J BIOL RHYTHM, V24, P95, DOI 10.1177/0748730408329573; MISTLBERGER RE, 1990, NEUROBIOL AGING, V11, P619, DOI 10.1016/0197-4580(90)90027-W; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; Valle A, 2005, AM J PHYSIOL-ENDOC M, V289, pE15, DOI 10.1152/ajpendo.00553.2004; Wu MV, 2009, CELL, V139, P61, DOI 10.1016/j.cell.2009.07.036	25	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191373	10.1371/journal.pone.0191373	http://dx.doi.org/10.1371/journal.pone.0191373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385171	gold, Green Published, Green Submitted			2022-12-26	WOS:000423668400046
J	Eckmann, TC; Wright, SG; Simpson, LK; Walker, JL; Kolmes, SA; Houck, JE; Velasquez, SC				Eckmann, Ted C.; Wright, Samantha G.; Simpson, Logan K.; Walker, Joe L.; Kolmes, Steven A.; Houck, James E.; Velasquez, Sandra C.			Combining Ordinary Kriging with wind directions to identify sources of industrial odors in Portland, Oregon	PLOS ONE			English	Article							FIELD INSPECTION; AIR-QUALITY; DISPERSION; MODELS; ENVIRONMENT; GUIDELINES; INTENSITY; ANNOYANCE; CALPUFF; IMPACTS	This study combines Ordinary Kriging, odor monitoring, and wind direction data to demonstrate how these elements can be applied to identify the source of an industrial odor. The specific case study used as an example of how to address this issue was the University Park neighborhood of Portland, Oregon (USA) where residents frequently complain about industrial odors, and suspect the main source to be a nearby Daimler Trucks North America LLC manufacturing plant. We collected 19,665 odor observations plus 105,120 wind measurements, using an automated weather station to measure winds in the area at five-minute intervals, logging continuously from December 2014 through November 2015, while we also measured odors at 19 locations, three times per day, using methods from the American Society of the International Association for Testing and Materials. Our results quantify how winds vary with season and time of day when industrial odors were observed versus when they were not observed, while also mapping spatiotemporal patterns in these odors using Ordinary Kriging. Our analyses show that industrial odors were detected most frequently to the northwest of the Daimler plant, mostly when winds blew from the southeast, suggesting Daimler's facility is a likely source for much of this odor.	[Eckmann, Ted C.; Wright, Samantha G.; Simpson, Logan K.; Walker, Joe L.; Kolmes, Steven A.; Houck, James E.; Velasquez, Sandra C.] Univ Portland, Dept Environm Studies, Portland, OR 97203 USA	University of Portland	Eckmann, TC (corresponding author), Univ Portland, Dept Environm Studies, Portland, OR 97203 USA.	eckmann@up.edu		Kolmes, Steven/0000-0002-7782-5241; Eckmann, Ted/0000-0002-7083-7856	University of Portland; Vigor Industrial, LLC	University of Portland; Vigor Industrial, LLC	This research was funded by the University of Portland (TE, SW, LS, JW, SK) and Vigor Industrial, LLC (JH, SV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the following University of Portland undergraduate students for their roles in collecting odor data: Gabe Ablin, Blake Arellano, Tony Aguilar, Kelsey Keeler, Luke Kemp, Dalton Kuhn, Kelsie Orikasa, Chloe Ryan, and Darren Suto. We would also like to thank the following undergraduate and high school students who participated in weather station installation and maintenance: Amanda Adams, Mike Allen, Debra Baker, Maggie Bruckner, Carla Cerda, Junjie Chen, Leo Deng, Georgia Hastie, Brooke Holmes, Zoe Shaw, Diana Swanson, Hector Uriel Gonzalez-Montiel, and Calli VanderWilde. In addition, we would like to thank Speaker Tina Kotek of the Oregon House of Representatives for responding to this research by asking the Nuisance Odor Panel of the Northwest Region of the Oregon DEQ to reconsider its conclusion that Daimler was not causing a nuisance odor: as of November 2017, the Oregon DEQ is using our data to reevaluate this issue. Finally, we would like to thank the University of Portland for supporting this research, plus the manuscript's editors and reviewers for their very helpful comments that substantially improved this paper.	(AFNOR) AF de N, 1993, 1043103 AFNOR AF N N; [Anonymous], 2006, 3940B1 VDI; [Anonymous], 1992, 3882 VDI 1; ARMSTRONG M, 1988, MATH GEOL, V20, P447, DOI 10.1007/BF00892988; (ASTM) AS of the IA for T and M, 2010, E544 ASTM INT AS IA; Bartier PM, 1996, COMPUT GEOSCI, V22, P795, DOI 10.1016/0098-3004(96)00021-0; Boeker P, 2014, SENSOR ACTUAT B-CHEM, V204, P2, DOI 10.1016/j.snb.2014.07.087; Brancher M, 2017, CHEMOSPHERE, V168, P1531, DOI 10.1016/j.chemosphere.2016.11.160; Capelli L, 2013, ATMOS ENVIRON, V79, P731, DOI 10.1016/j.atmosenv.2013.07.029; CARPENTER CP, 1975, TOXICOL APPL PHARM, V32, P282, DOI 10.1016/0041-008X(75)90219-7; Curran TP, 2007, ANN INT M MINN MN, P17; Cusano G, 2010, CHEM ENGINEER TRANS, V23, P19, DOI 10.3303/CET1023004; Danuso F, 2015, ENVIRON MODELL SOFTW, V69, P175, DOI 10.1016/j.envsoft.2015.03.016; (DEQ) OD of EQ, 2016, NUIS OD PAN REV REP; Dincer F, 2007, CLEAN-SOIL AIR WATER, V35, P565, DOI 10.1002/clen.200700057; EKMAN G, 1967, SCAND J PSYCHOL, V8, P177, DOI 10.1111/j.1467-9450.1967.tb01392.x; Elbir T, 2007, ENVIRON ENG SCI, V24, P313, DOI 10.1089/ees.2005.0105; Guillot JM, 2012, WATER SCI TECHNOL, V66, P1691, DOI 10.2166/wst.2012.375; Guo H, 2005, CANADIAN BIOSYSTEMS, V47, P57; Henry CG, 2011, T ASABE, V54, P1865, DOI 10.13031/2013.39828; Jernigan RW, 1986, A PRIMER ON KRIGING; Krige DG., 1966, J S AFR I MIN MET, V66, P13; Kwak KH, 2016, ENVIRON POLLUT, V208, P185, DOI 10.1016/j.envpol.2015.07.030; Lloyd CD, 2001, COMPUT GEOSCI-UK, V27, P929, DOI 10.1016/S0098-3004(00)00132-1; Matsubasa T, 2016, CHEMOSENS PERCEPT, V9, P14, DOI 10.1007/s12078-015-9200-0; Morgan B, 2015, J AIR WASTE MANAGE, V65, P1127, DOI 10.1080/10962247.2015.1064833; Nicell JA, 2009, ATMOS ENVIRON, V43, P196, DOI 10.1016/j.atmosenv.2008.09.033; Nicolas J., 2008, CHEM ENG TRANS, V15, P29; Oleniacz Robert, 2014, Geoinformatica Polonica, V13, P57, DOI 10.2478/gein-2014-0006; Piringer M, 2015, ATMOS ENVIRON, V116, P22, DOI 10.1016/j.atmosenv.2015.06.006; Poustchi R, 1991, T RECENT DEV CURRENT, P150; Ranzato L, 2012, ATMOS ENVIRON, V61, P570, DOI 10.1016/j.atmosenv.2012.08.009; Sharp J, 2004, WEATHER FORECAST, V19, P970, DOI 10.1175/826.1; Shusterman D, 2001, CHEM SENSES, V26, P339, DOI 10.1093/chemse/26.3.339; Shusterman D., 1999, J ENV MED, V1, P249, DOI [10.1002/jem.38, DOI 10.1002/JEM.38]; Sowka Izabela, 2017, Environmental Protection and Natural Resources, V28, P16, DOI 10.1515/OSZN-2017-0007; Sowka I, 2010, ENVIRON PROT ENG, V36, P133; Sucker K, 2008, INT ARCH OCC ENV HEA, V81, P671, DOI 10.1007/s00420-007-0259-z; Wang LJ, 2006, ATMOS ENVIRON, V40, P4663, DOI 10.1016/j.atmosenv.2006.04.043; WASCH HH, 1989, ARCH NEUROL-CHICAGO, V46, P902, DOI 10.1001/archneur.1989.00520440096025; Yamamoto JK, 2005, MATH GEOL, V37, P69, DOI 10.1007/s11004-005-8748-7; Yuter SE, 2011, J HYDROMETEOROL, V12, P329, DOI 10.1175/2010JHM1239.1; Zhou CB, 2014, ENERG BUILDINGS, V82, P457, DOI 10.1016/j.enbuild.2014.06.036; Zimmerman D, 1999, MATH GEOL, V31, P375, DOI 10.1023/A:1007586507433; ZIMMERMAN DL, 1991, TECHNOMETRICS, V33, P77, DOI 10.2307/1269009	45	2	2	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0189175	10.1371/journal.pone.0189175	http://dx.doi.org/10.1371/journal.pone.0189175			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385136	gold, Green Published, Green Submitted			2022-12-26	WOS:000423668400006
J	Marques, ACR; Raimundo, MM; Cavalheiro, EMB; Salles, LFP; Lyra, C; Von Zuben, FJ				Marques, Alan Caio R.; Raimundo, Marcos M.; Cavalheiro, Ellen Marianne B.; Salles, Luis F. P.; Lyra, Christiano; Von Zuben, Fernando J.			Ant genera identification using an ensemble of convolutional neural networks	PLOS ONE			English	Article							CLASSIFICATION; IMAGES	Works requiring taxonomic knowledge face several challenges, such as arduous identification of many taxa and an insufficient number of taxonomists to identify a great deal of collected organisms. Machine learning tools, particularly convolutional neural networks (CNNs), are then welcome to automatically generate high-performance classifiers from available data. Supported by the image datasets available at the largest online database on ant biology, the AntWeb (www.antweb.org), we propose here an ensemble of CNNs to identify ant genera directly from the head, profile and dorsal perspectives of ant images. Transfer learning is also considered to improve the individual performance of the CNN classifiers. The performance achieved by the classifiers is diverse enough to promote a reduction in the overall classification error when they are combined in an ensemble, achieving an accuracy rate of over 80% on top-1 classification and an accuracy of over 90% on top-3 classification.	[Marques, Alan Caio R.; Raimundo, Marcos M.; Cavalheiro, Ellen Marianne B.; Lyra, Christiano; Von Zuben, Fernando J.] Univ Estadual Campinas, UNICAMP, Sch Elect & Comp Engn, Av Albert Einstein 400, BR-13083852 Campinas, SP, Brazil; [Salles, Luis F. P.] Univ Estadual Campinas, UNICAMP, Inst Biol, Grad Program Ecol, R Monteiro Lobato 255, BR-13083862 Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Marques, ACR (corresponding author), Univ Estadual Campinas, UNICAMP, Sch Elect & Comp Engn, Av Albert Einstein 400, BR-13083852 Campinas, SP, Brazil.	alancaiorm@gmail.com	Lyra, Christiano/A-5920-2010	Lyra, Christiano/0000-0002-5263-1977; Salles, Luis/0000-0002-5326-4603; Marques, Alan Caio/0000-0001-7233-7444; Cavalheiro, Ellen/0000-0001-6586-2101	Brazilian National Council for Scientific and Technological Development [141308/2014-1, 131488/2015-5, 311751/2013-0, 309115/2014-0]; Coordination for the Improvement of Higher Education Personnel [23038.002884/2013-38]; Sao Paulo Research Foundation [2014/13533-0]	Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors kindly acknowledge support from the: Brazilian National Council for Scientific and Technological Development (http://cnpq.br/), grants #141308/2014-1 (ACRM), #131488/2015-5 (LFPS) #311751/2013-0 (CL) and #309115/2014-0 (FJVZ); Coordination for the Improvement of Higher Education Personnel (http://www.capes.gov.br/) grants #23038.002884/2013-38 (EMBC); and Sao Paulo Research Foundation (http://www.fapesp.br/) grant 2014/13533-0 (MMR).; The authors kindly acknowledge support from the Brazilian National Council for Scientific and Technological Development (grants #141308/2014-1, #131488/2015-5, #311751/2013-0 and #309115/2014-0), Coordination for the Improvement of Higher Education Personnel (grants #23038.002884/2013-38) and Sao Paulo Research Foundation (grant 2014/13533-0).	Carneiro G, 2015, LECT NOTES COMPUT SC, V9351, P652, DOI 10.1007/978-3-319-24574-4_78; Chen G, 2014 IEEE INT C IM P; Ding WG, 2016, COMPUT ELECTRON AGR, V123, P17, DOI 10.1016/j.compag.2016.02.003; Drew LW, 2011, BIOSCIENCE, V61, P942, DOI 10.1525/bio.2011.61.12.4; Dyrmann M, 2016, BIOSYST ENG, V151, P72, DOI 10.1016/j.biosystemseng.2016.08.024; Favret C, 2016, SYST ENTOMOL, V41, P133, DOI 10.1111/syen.12146; Fratello M, 2017, NEUROINFORMATICS, V15, P199, DOI 10.1007/s12021-017-9324-2; Gaston KJ, 2004, PHILOS T R SOC B, V359, P655, DOI 10.1098/rstb.2003.1442; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Hopkins GW, 2002, ANIM CONSERV, V5, P245, DOI 10.1017/S1367943002002299; Jia Y., 2014, 22 ACM INT C MULTIME, P675, DOI 10.1145/2647868.2654889; Kan MN, 2016, PROC CVPR IEEE, P4847, DOI 10.1109/CVPR.2016.524; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kuncheva LI, 2003, MACH LEARN, V51, P181, DOI 10.1023/A:1022859003006; Liu K, 2017, INT J IMAG SYST TECH, V27, P12, DOI 10.1002/ima.22206; Liu Z, 2016, SCI REPORTS, V6, P11; MacLeod N, 2010, NATURE, V467, P154, DOI 10.1038/467154a; Mitchell T.M, 2003, MACH LEARN; Raitoharju J, 2016, 2016 ICPR 2ND WORKSHOP ON COMPUTER VISION FOR ANALYSIS OF UNDERWATER IMAGERY (CVAUI 2016), P43, DOI [10.1109/CVAUI.2016.020, 10.1109/CVAUI.2016.20]; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Silva RR, 2010, ECOL MONOGR, V80, P107, DOI 10.1890/08-1298.1; Weeks PJD, 1997, B ENTOMOL RES, V87, P203, DOI 10.1017/S000748530002736X; Weiser MD, 2006, ECOL ENTOMOL, V31, P131, DOI 10.1111/j.0307-6946.2006.00759.x; Wilson EO, 2004, PHILOS T R SOC B, V359, P739, DOI 10.1098/rstb.2003.1440; Xu C., 2013, ARXIV13045634, P1; Zhou Z.-H, 2012, ENSEMBLE METHODS FDN, DOI DOI 10.1201/B12207; Zhu L-Q., 2016, ORIENT INSECTS, V51, P1	27	17	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0192011	10.1371/journal.pone.0192011	http://dx.doi.org/10.1371/journal.pone.0192011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385214	Green Published, Green Submitted, gold			2022-12-26	WOS:000423668400069
J	Caetano, JM; Tessarolo, G; de Oliveira, G; Souza, KDE; Diniz, JAF; Nabout, JC				Caetano, Jordana Moura; Tessarolo, Geiziane; de Oliveira, Guilherme; da Silva e Souza, Kelly; Felizola Diniz-Filho, Jose Alexandre; Nabout, Joao Carlos			Geographical patterns in climate and agricultural technology drive soybean productivity in Brazil	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; ECOSYSTEM-BASED ADAPTATION; ENVIRONMENTAL SUITABILITY; SPATIAL AUTOCORRELATION; ENVELOPE MODELS; NICHE MODELS; IMPACTS; DISTRIBUTIONS; CROP; FUTURE	The impacts of global climate change have been a worldwide concern for several research areas, including those dealing with resources essential to human well being, such as agriculture, which directly impact economic activities and food security. Here we evaluate the relative effect of climate (as indicated by the Ecological Niche Model-ENM) and agricultural technology on actual soybean productivity in Brazilian municipalities and estimate the future geographic distribution of soybeans using a novel statistical approach allowing the evaluation of partial coefficients in a non-stationary (Geographically Weighted Regression; GWR) model. We found that technology was more important than climate in explaining soybean productivity in Brazil. However, some municipalities are more dependent on environmental suitability (mainly in Southern Brazil). The future environmental suitability for soybean cultivation tends to decrease by up 50% in the central region of Brazil. Meanwhile, southern-most Brazil will have more favourable conditions, with an increase of ca. 25% in environmental suitability. Considering that opening new areas for cultivation can degrade environmental quality, we suggest that, in the face of climate change impacts on soybean cultivation, the Brazilian government and producers must invest in breeding programmes and more general ecosystem-based strategies for adaptation to climate change, including the development of varieties tolerant to climate stress, and strategies to increase productivity and reduce costs (social and environmental).	[Caetano, Jordana Moura; Tessarolo, Geiziane; Nabout, Joao Carlos] Univ Estadual Goias, CCET, Anapolis, Go, Brazil; [de Oliveira, Guilherme] Univ Fed Reconcavo Bahia, Setor Biol, Ctr Ciencias Agr Ambientais & Biol, Cruz das Almas, BA, Brazil; [da Silva e Souza, Kelly; Felizola Diniz-Filho, Jose Alexandre] Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Campus Samambaia, Goiania, Go, Brazil	Universidade Estadual de Goias; Universidade Federal do Reconcavo da Bahia; Universidade Federal de Goias	Nabout, JC (corresponding author), Univ Estadual Goias, CCET, Anapolis, Go, Brazil.	joao.nabout@ueg.br	Nabout, João/I-2828-2014; de Oliveira, Guilherme/S-1531-2019; Diniz-Filho, José Alexandre Felizola/D-9405-2013	Nabout, João/0000-0001-9102-3627; Diniz-Filho, José Alexandre Felizola/0000-0002-0967-9684; Moura Caetano, Jordana/0000-0001-5777-2974; Tessarolo, Geiziane/0000-0003-1361-0062; Souza, Kelly/0000-0002-5672-4556	CAPES [Auxpe 2036/2013]; CNPq; National Institutes for Science and Technology (INCT) in Ecology, Evolution and Biodiversity Conservation; MCTIC/CNPq; FAPEG [465610/2014-5]; PNPD/CAPES-Postdoctoral fellowship; CAPES; GENPAC ('Geographical Genetics and Regional Planning for Natural Resources in the Brazilian Cerrado') from CNPq/MCT/CAPES/FAPEG	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes for Science and Technology (INCT) in Ecology, Evolution and Biodiversity Conservation; MCTIC/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEG(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG)); PNPD/CAPES-Postdoctoral fellowship; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); GENPAC ('Geographical Genetics and Regional Planning for Natural Resources in the Brazilian Cerrado') from CNPq/MCT/CAPES/FAPEG	This work was supported by CAPES (grant no. Auxpe 2036/2013) to JCN, CNPq/scholarship to JMC, the National Institutes for Science and Technology (INCT) in Ecology, Evolution and Biodiversity Conservation, supported by MCTIC/CNPq and FAPEG (grant no. 465610/2014-5) to JAFDF, Productivity grants/CNPq to JAFDF and JCN, PNPD/CAPES-Postdoctoral fellowship to GT, CAPES/Scholarship to KdSS, and GENPAC ('Geographical Genetics and Regional Planning for Natural Resources in the Brazilian Cerrado') from CNPq/MCT/CAPES/FAPEG to JAFDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abberton M, 2016, PLANT BIOTECHNOL J, V14, P1095, DOI 10.1111/pbi.12467; Akbari H, 2016, J CIV ENG MANAG, V22, P1, DOI 10.3846/13923730.2015.1111934; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2016, ECOGRAPHY; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Assad E., 2008, AQUECIMENTO GLOBAL N; Assad ED, 2013, CONTRIBUICAO GRUPO 2; Asseng S, 2015, NAT CLIM CHANGE, V5, P143, DOI [10.1038/nclimate2470, 10.1038/NCLIMATE2470]; Asseng S, 2013, NAT CLIM CHANGE, V3, P827, DOI [10.1038/nclimate1916, 10.1038/NCLIMATE1916]; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Beck J, 2013, CLIMATIC CHANGE, V116, P177, DOI 10.1007/s10584-012-0481-x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bianco S, 2012, PLANTA DANINHA, V30, P87, DOI 10.1590/S0100-83582012000100010; BONATO E. R., 1987, SOJA BRASIL HIST EST; Bradley BA, 2012, DIVERS DISTRIB, V18, P425, DOI 10.1111/j.1472-4642.2011.00875.x; Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/NCLIMATE2153, 10.1038/nclimate2153]; Collevatti RG, 2013, J BIOGEOGR, V40, P345, DOI 10.1111/jbi.12005; Collevatti RG, 2012, MOL ECOL, V21, P5845, DOI 10.1111/mec.12071; Companhia Nacional de Abastecimento, 2016, AC SAFR BRAS GRAOS Q; Connor D.J., 2011, CROP ECOLOGY PRODUCT; Craufurd PQ, 2009, J EXP BOT, V60, P2529, DOI 10.1093/jxb/erp196; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; De Oliveira G, J PLANT ECOL; de Oliveira G, 2015, AM J BOT, V102, P870, DOI 10.3732/ajb.1400352; de Oliveira G, 2014, ECOGRAPHY, V37, P637, DOI 10.1111/j.1600-0587.2013.00564.x; Diniz JAF, 2015, MOL ECOL RESOUR, V15, P1059, DOI 10.1111/1755-0998.12374; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Dobrovolski R, 2011, BIODIVERS CONSERV, V20, P2445, DOI 10.1007/s10531-011-9997-z; Eme D, 2015, ECOGRAPHY, V38, P531, DOI 10.1111/ecog.01092; Empresa Brasileira de Pesquisa Agropecuaria, EMPR BRAS PROD SOJ R; Estes LD, 2013, GLOBAL CHANGE BIOL, V19, P3762, DOI 10.1111/gcb.12325; Fageria NK, 2013, COMMUN SOIL SCI PLAN, V44, P2941, DOI 10.1080/00103624.2013.829484; Filz KJ, 2013, EUR J ENTOMOL, V110, P311, DOI 10.14411/eje.2013.044; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Food and Agriculture Organization, TECHN PROD ED FLOUS; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; Franklin J, 2009, MAPPING SPECIES DIST; Gaston A, 2011, ECOL MODEL, V222, P2037, DOI 10.1016/j.ecolmodel.2011.04.015; Goberville E, 2015, ECOL EVOL, V5, P1100, DOI 10.1002/ece3.1411; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Hannah L, 2013, P NATL ACAD SCI USA, V110, P6907, DOI 10.1073/pnas.1210127110; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Instituto Brasileiro de Geografia e Estatistica - IBGE, 2016, SIST IBGE REC AUT SI; Instituto Nacional de Pesquisas Espaciais, 2015, NOV DAD ATL MAT ATL; Jarvis A, 2012, TROP PLANT BIOL, V5, P9, DOI 10.1007/s12042-012-9096-7; Jimenez-Valverde A, 2009, ANN ZOOL FENN, V46, P451, DOI 10.5735/086.046.0606; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Kang YH, 2009, PROG NAT SCI-MATER, V19, P1665, DOI 10.1016/j.pnsc.2009.08.001; Laderach P, 2013, CLIMATIC CHANGE, V119, P841, DOI 10.1007/s10584-013-0774-8; Lane A, 2007, OPEN ACCESS J PUBLIS, V4, P1, DOI DOI 10.3914/ICRISAT.0094; Legendre P., 2012, NUMERICAL ECOLOGY, V24; Leitao PJ, 2011, INT J GEOGR INF SCI, V25, P439, DOI 10.1080/13658816.2010.531020; Lesk C, 2016, NATURE, V529, P84, DOI 10.1038/nature16467; LIMARIBEIRO MS, 2015, BIODIVERS INFORM, V10, DOI 10.17161/bi.v10i0.4955; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Ludwig Marcos Paulo, 2011, Rev. Ceres, V58, P305, DOI 10.1590/S0034-737X2011000300010; Matthews RB, 1997, AGR SYST, V54, P399, DOI 10.1016/S0308-521X(95)00060-I; Mesgaran MB, 2014, DIVERS DISTRIB, V20, P1147, DOI 10.1111/ddi.12209; Miller JA, 2012, PROG PHYS GEOG, V36, P681, DOI 10.1177/0309133312442522; Mourtzinis S, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2014.26, 10.1038/nplants.2014.26]; Munang R, 2014, ENVIRONMENT, V56, P18, DOI 10.1080/00139157.2014.861676; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nabout JC, 2016, ENVIRON MANAGE, V57, P814, DOI 10.1007/s00267-016-0659-5; Nabout JC, 2012, NAT CONSERVACAO, V10, P177, DOI 10.4322/natcon.2012.034; Nabout JC, 2012, NAT CONSERVACAO, V10, P45, DOI 10.4322/natcon.2012.008; Nabout JC, 2011, NAT CONSERVACAO, V9, P55, DOI 10.4322/natcon.2011.006; Nelson GC, 2014, P NATL ACAD SCI USA, V111, P3274, DOI 10.1073/pnas.1222465110; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Ramirez-Villegas J, 2012, AGR FOREST METEOROL, V161, P26, DOI 10.1016/j.agrformet.2012.03.015; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Ranjitkar S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163916; Refsgaard JC, 2014, CLIMATIC CHANGE, V122, P271, DOI 10.1007/s10584-013-0990-2; Romero-Alvarez D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180930; Rose G, 2016, CLIMATIC CHANGE, V134, P417, DOI 10.1007/s10584-016-1601-9; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Sawyer D, 2008, PHILOS T R SOC B, V363, P1747, DOI 10.1098/rstb.2007.0030; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Srivastava A, 2010, AGR ECOSYST ENVIRON, V138, P160, DOI 10.1016/j.agee.2010.04.012; Terribile LC, 2012, NAT CONSERVACAO, V10, P152, DOI 10.4322/natcon.2012.025; Terribile LC, 2009, ACTA OECOL, V35, P163, DOI 10.1016/j.actao.2008.09.006; Tessarolo G, 2014, DIVERS DISTRIB, V20, P1258, DOI 10.1111/ddi.12236; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Torres NM, 2012, DIVERS DISTRIB, V18, P615, DOI 10.1111/j.1472-4642.2012.00892.x; Vaz UL, 2015, BRAZ J BIOL, V75, pS17, DOI 10.1590/1519-6984.22713; Vera-Diaz MD, 2008, ECOL ECON, V65, P420, DOI 10.1016/j.ecolecon.2007.07.015; Vignola R, 2015, AGR ECOSYST ENVIRON, V211, P126, DOI 10.1016/j.agee.2015.05.013; von Schneidemesser E, 2015, CHEM REV, V115, P3856, DOI 10.1021/acs.chemrev.5b00089; Wamsler C, 2016, ECOL SOC, V21, DOI 10.5751/ES-08266-210131; Weber MM, 2017, ECOGRAPHY, V40, P817, DOI 10.1111/ecog.02125; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402	95	14	14	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191273	10.1371/journal.pone.0191273	http://dx.doi.org/10.1371/journal.pone.0191273			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0QJ	29381755	gold, Green Published, Green Submitted			2022-12-26	WOS:000433106800001
J	Moradi, N; Fadaei, R; Emamgholipour, S; Kazemian, E; Panahi, G; Vahedi, S; Saed, L; Fallah, S				Moradi, Nariman; Fadaei, Reza; Emamgholipour, Solaleh; Kazemian, Elham; Panahi, Ghodratollah; Vahedi, Siamak; Saed, Lotfolah; Fallah, Soudabeh			Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery disease	PLOS ONE			English	Article							ADIPOSE-TISSUE; PROTEIN 9; FAMILY; ADIPOKINES; CYTOKINE	C1q/TNF-related protein 9 (CTRP9) is a paralogue of adiponectin with known favorable effects on lipid and glucose metabolism. A potential role of CTRP9 for regulation of endothelium function has been suggested by previous studies. However, no studies have examined the relation between serum CTRP9 levels and adhesion molecules in patients with type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD). The present study was conducted on 337 subjects who underwent coronary angiography and were categorized into four groups according to the presence of CAD and T2DM (control, CAD, T2DM and CAD +T2DM). Serum levels of CTRP9, adiponectin, slCAM-1, sVCAM-1, sE-Selectin, IL-6 and TNF-alpha were measured. It was found that the circulating CTRP9 levels were independently associated with increased risk of CAD and T2DM in addition to elevated levels of serum CTRP9 in CAD, T2DM and CAD+T2DM groups. A significant association of serum CTRP9 levels with adhesion molecules in CAD and T2DM patients as well as serum TNF-alpha levels in CAD individuals was noted. A significant relation between the circulating levels of CTRP9 and HOMA-IR in T2DM subjects was also observed. The results revealed increased circulating levels of CTRP9 in T2DM and CAD individuals which suggests a compensatory response to insulin resistance, inflammatory milieu and endothelial dysfunction; however, more studies are needed to confirm this.	[Moradi, Nariman; Fallah, Soudabeh] Iran Univ Med Sci, Fac Med, Dept Clin Biochem, Tehran, Iran; [Fadaei, Reza] Kermanshah Univ Med Sci, Fac Med, Dept Clin Biochem, Kermanshah, Iran; [Fadaei, Reza; Emamgholipour, Solaleh; Panahi, Ghodratollah] Univ Tehran Med Sci, Fac Med, Dept Clin Biochem, Tehran, Iran; [Kazemian, Elham] Shahid Beheshti Univ Med Sci, Fac Nutr Sci, Dept Basic Sci & Cellular & Mol Nutr, Tehran, Iran; [Vahedi, Siamak] Kurdistan Univ Med Sci, Fac Med, Dept Cardiol, Sanandaj, Iran; [Saed, Lotfolah] Kurdistan Univ Med Sci, Fac Med, Dept Internal Med, Sanandaj, Iran; [Fallah, Soudabeh] Iran Univ Med Sci, Rasool Akram Hosp, Res Ctr Pediat Infect Dis, Tehran, Iran	Iran University of Medical Sciences; Kermanshah University of Medical Sciences; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences; Kurdistan University of Medical Sciences; Kurdistan University of Medical Sciences; Iran University of Medical Sciences	Fallah, S (corresponding author), Iran Univ Med Sci, Fac Med, Dept Clin Biochem, Tehran, Iran.; Fallah, S (corresponding author), Iran Univ Med Sci, Rasool Akram Hosp, Res Ctr Pediat Infect Dis, Tehran, Iran.	fallah.s@iums.ac.ir	panahi, shahriyar/W-3772-2019; Fadaei, Reza/M-9456-2016; Emamgholipour, Solaleh/T-6035-2017; Kazemian, Elham/CAG-0678-2022	panahi, shahriyar/0000-0001-8338-4633; Moradi, Nariman/0000-0001-7760-4804; Fadaei, Reza/0000-0002-4989-1137; Emamgholipour, Solaleh/0000-0002-9949-5773	Iran University of Medical Science [94-04-30-26498]	Iran University of Medical Science	This work was supported by a grant (94-04-30-26498) from Iran University of Medical Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Asada M, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8624313; Bai B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172271; Fadaei R, 2016, HORM METAB RES, V48, P269, DOI 10.1055/s-0035-1564133; Fadaei R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168773; Forouhi N, 2016, DIABETES METAB SYND, V10, pS131, DOI 10.1016/j.dsx.2016.03.012; Hwang YC, 2014, INT J OBESITY, V38, P1207, DOI 10.1038/ijo.2013.242; Jia YJ, 2017, DIABETES RES CLIN PR, V131, P116, DOI 10.1016/j.diabres.2017.07.003; Jung CH, 2016, MOL CELL ENDOCRINOL, V419, P235, DOI 10.1016/j.mce.2015.10.023; Jung CH, 2014, J CLIN ENDOCR METAB, V99, pE2477, DOI 10.1210/jc.2014-2524; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Li J, 2015, BIOCHEM BIOPH RES CO, V458, P890, DOI 10.1016/j.bbrc.2015.02.054; Li YX, 2016, J CARDIOVASC PHARM, V67, P394, DOI 10.1097/FJC.0000000000000364; Mahmoudi M, 2017, INT J RHEUM DIS, V20, P287, DOI 10.1111/1756-185X.12999; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pan X, 2014, PLOS ONE, V9; Peterson JM, 2013, AM J PHYSIOL-REG I, V305; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; Seldin MM, 2014, REV ENDOCR METAB DIS, V15, P111, DOI 10.1007/s11154-013-9255-7; Seldin MM, 2014, REV ENDOCR METAB DIS, V15; Shanaki M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168082; Su H, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0315-z; Sun Y, 2013, CIRCULATION, V128, pS113, DOI 10.1161/CIRCULATIONAHA.112.000010; Uemura Y, 2013, FASEB J, V27, P25, DOI 10.1096/fj.12-213744; Wang J, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, P6, DOI 10.1109/ICMA.2015.7237447; Wei ZK, 2014, AM J PHYSIOL-ENDOC M, V306, pE779, DOI 10.1152/ajpendo.00593.2013; Wolf RM, 2016, J CLIN ENDOCR METAB, V101, P2211, DOI 10.1210/jc.2016-1027; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Zhang P, 2016, MOL CELL BIOCHEM, V417, P67, DOI 10.1007/s11010-016-2714-1; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050	31	38	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0192159	10.1371/journal.pone.0192159	http://dx.doi.org/10.1371/journal.pone.0192159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381773	Green Submitted, gold, Green Published			2022-12-26	WOS:000423617800061
J	Yatabe, T; More, SJ; Geoghegan, F; McManus, C; Hill, AE; Martinez-Lopez, B				Yatabe, Tadaishi; More, Simon J.; Geoghegan, Fiona; McManus, Catherine; Hill, Ashley E.; Martinez-Lopez, Beatriz			Can biosecurity and local network properties predict pathogen species richness in the salmonid industry?	PLOS ONE			English	Article							INFECTIOUS PANCREATIC NECROSIS; FARMED ATLANTIC SALMON; FISH MOVEMENTS; UNITED-STATES; GILL DISEASE; RISK-FACTORS; SALAR L.; ANEMIA; SPREAD; IRELAND	Salmonid farming in Ireland is mostly organic, which implies limited disease treatment options. This highlights the importance of biosecurity for preventing the introduction and spread of infectious agents. Similarly, the effect of local network properties on infection spread processes has rarely been evaluated. In this paper, we characterized the biosecurity of salmonid farms in Ireland using a survey, and then developed a score for benchmarking the disease risk of salmonid farms. The usefulness and validity of this score, together with farm indegree (dichotomized as <= 1 or > 1), were assessed through generalized Poisson regression models, in which the modeled outcome was pathogen richness, defined here as the number of different diseases affecting a farm during a year. Seawater salmon (SW salmon) farms had the highest biosecurity scores with a median (interquartile range) of 82.3 (5.4), followed by freshwater salmon (FW salmon) with 75.2 (8.2), and freshwater trout (FW trout) farms with 74.8 (4.5). For FW salmon and trout farms, the top ranked model (in terms of leave-one-out information criteria, looic) was the null model (looic = 46.1). For SW salmon farms, the best ranking model was the full model with both predictors and their interaction (looic = 33.3). Farms with a higher biosecurity score were associated with lower pathogen richness, and farms with indegree > 1 (i.e. more than one fish supplier) were associated with increased pathogen richness. The effect of the interaction between these variables was also important, showing an antagonistic effect. This would indicate that biosecurity effectiveness is achieved through a broader perspective on the subject, which includes a minimization in the number of suppliers and hence in the possibilities for infection to enter a farm. The work presented here could be used to elaborate indicators of a farm's disease risk based on its biosecurity score and indegree, to inform risk-based disease surveillance and control strategies for private and public stakeholders.	[Yatabe, Tadaishi; Martinez-Lopez, Beatriz] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, CADMS, Davis, CA 95616 USA; [More, Simon J.] Univ Coll Dublin, UCD Sch Vet Med, CVERA, Dublin, Ireland; [Geoghegan, Fiona] Marine Inst, Oranmore, County Galway, Ireland; [McManus, Catherine] Marine Harvest Ireland, Letterkenny, County Donegal, Ireland; [Hill, Ashley E.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Calif Anim Hlth & Food Safety Labs CAHFS, Davis, CA USA	University of California System; University of California Davis; University College Dublin; Marine Institute Ireland; University of California System; University of California Davis	Yatabe, T (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, CADMS, Davis, CA 95616 USA.	tyatabe@ucdavis.edu	Lopez, Beatriz Martinez/AAE-6692-2021	More, Simon/0000-0002-4270-0385; Yatabe, Tadaishi/0000-0002-4287-9282	Consejo Nacional de Inovacion, Ciencia y Tecnologia; University of California Davis; Marine Harvest Ireland	Consejo Nacional de Inovacion, Ciencia y Tecnologia; University of California Davis(University of California System); Marine Harvest Ireland	This study was funded by the Consejo Nacional de Inovacion, Ciencia y Tecnologia (Becas Chile scholarship to TY), http://www.conicyt.cl/; the University of California Davis (School of Vet Med GSSP award to TY), http://www.vetmed.ucdavis.edu/research/grad_education/gssp/; and Marine Harvest Ireland (TY), http://marineharvestireland.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrin M, 2011, MODELLING SPREAD INF, P1346; [Anonymous], 2015, DOMESTIC LIVE FISH M; [Anonymous], 2013, EPIDEMIOLOGY; [Anonymous], 2017, SURVEILLANCE PROGRAM; [Anonymous], 2006, CODE GOOD PRACTICE S; Arneberg P, 2002, ECOGRAPHY, V25, P88, DOI 10.1034/j.1600-0587.2002.250110.x; Bernoth E.M, 1997, FURUNCULOSIS MULTIDI; Fat M, 2016, ANN AQ SURV 2015, P16; Cipriano R.C., 2005, FLAVOBACTERIUM PSYCH; CONSUL PC, 1992, COMMUN STAT THEORY, V21, P89, DOI 10.1080/03610929208830766; CONSUL PC, 1973, TECHNOMETRICS, V15, P791, DOI 10.2307/1267389; Consul PC, 1989, GEN POISSON DISTRIBU; Delabbio J, 2004, AQUACULTURE, V242, P165, DOI 10.1016/j.aquaculture.2004.03.005; Delabbio J, 2003, INT J RECIRCULATING, V4, P5; Delabbio JL, 2005, J AQUAT ANIM HEALTH, V17, P153, DOI 10.1577/H04-005.1; Delgado AH, 2012, PREV VET MED, V103, P120, DOI 10.1016/j.prevetmed.2011.09.012; Downes JK, 2015, AQUACULT ENV INTERAC, V7, P239, DOI 10.3354/aei00150; Dunn Robert R, 2010, Proc Biol Sci, V277, P2587, DOI 10.1098/rspb.2010.0340; Farmer Bradley D., 2014, Journal of Applied Aquaculture, V26, P71, DOI 10.1080/10454438.2014.882213; Gabry J., 2017, BAYESPLOT PLOTTING B; Gelman A., 2014, BAYESIAN DATA ANAL, VThird; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Graham DA, 2010, J FISH DIS, V33, P123, DOI 10.1111/j.1365-2761.2009.01096.x; Green DM, 2012, J FISH DIS, V35, P29, DOI 10.1111/j.1365-2761.2011.01321.x; Green DM, 2011, PREV VET MED, V99, P225, DOI 10.1016/j.prevetmed.2011.01.008; Green DM, 2009, PREV VET MED, V91, P261, DOI 10.1016/j.prevetmed.2009.05.031; Gunn GJ, 2008, PREV VET MED, V84, P310, DOI 10.1016/j.prevetmed.2007.12.003; JARP J, 1995, J FISH DIS, V18, P67, DOI 10.1111/j.1365-2761.1995.tb01267.x; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kilburn R, 2012, AQUACULTURE, V368, P89, DOI 10.1016/j.aquaculture.2012.09.004; Kirkpatrick R, 2014, RMKDISCRETE VERSION; Kleiber C, 2016, AM STAT, V70, P296, DOI 10.1080/00031305.2016.1173590; Kristoffersen AB, 2009, PREV VET MED, V90, P127, DOI 10.1016/j.prevetmed.2009.04.003; Mardones FO, 2014, PREV VET MED, V114, P37, DOI 10.1016/j.prevetmed.2014.01.012; McClure CA, 2005, PREV VET MED, V72, P263, DOI 10.1016/j.prevetmed.2005.07.010; McElreath R, 2016, TEXT STAT SCI, pXI; Mitchell CE, 2010, ECOL LETT, V13, P1525, DOI 10.1111/j.1461-0248.2010.01543.x; Mitchell SO, 2011, J FISH DIS, V34, P411, DOI 10.1111/j.1365-2761.2011.01251.x; Munro LA, 2009, J FISH DIS, V32, P641, DOI 10.1111/j.1365-2761.2009.01076.x; Murray AG, 2002, EMERG INFECT DIS, V8, P1, DOI 10.3201/eid0801.010144; Oidtmann BC, 2011, PREV VET MED, V102, P329, DOI 10.1016/j.prevetmed.2011.07.016; Oidtmann BC, 2011, AQUACULTURE, V320, P22, DOI 10.1016/j.aquaculture.2011.07.032; Oidtmann B, 2013, PREV VET MED, V112, P13, DOI 10.1016/j.prevetmed.2013.07.008; Plumb J. A., 1994, Health maintenance of cultured fishes: principal microbial diseases.; Pruder GD, 2004, AQUACULT ENG, V32, P3, DOI 10.1016/j.aquaeng.2004.05.002; R Core Team, 2021, R LANGUAGE ENV STAT; Roberts RJ, 2005, J FISH DIS, V28, P383, DOI 10.1111/j.1365-2761.2005.00642.x; Rodger H, 2007, J FISH DIS, V30, P157, DOI 10.1111/j.1365-2761.2007.00799.x; Ruane N., 2013, GILPAT INVESTIGATION; Ruane N, 2007, INFECT PANCREATIC NE; Ruane NM, 2009, J FISH DIS, V32, P979, DOI 10.1111/j.1365-2761.2009.01080.x; Ruane NM, 2009, ECOL MODEL, V220, P1369, DOI 10.1016/j.ecolmodel.2009.02.016; Scollnik D. P. M., 1998, ASTIN BULL, V28, P135; Stan Development Team, 2016, RSTAN R INT STAN 2 1; Stan Development Team, 2016, STAN MOD LANG US GUI; Tavornpanich S, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-172; Tuenter HJH, 2000, STAT NEERL, V54, P374, DOI 10.1111/1467-9574.00147; Vehtari A., 2016, LOO EFFICIENT LEAVE; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4; Viljugrein H, 2009, DIS AQUAT ORGAN, V88, P35, DOI 10.3354/dao02151; Yanong R.P.E, 2012, BIOSECURITY AQUACU 2, V4708, P12; Yanong RP, 2012, BIOSECURITY AQUACU 1, P4707; Yanong RP., 2013, BIOSECURITY AQUACU 3; Yatabe T, 2015, PREV VET MED, V122, P195, DOI 10.1016/j.prevetmed.2015.09.005	65	2	2	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191680	10.1371/journal.pone.0191680	http://dx.doi.org/10.1371/journal.pone.0191680			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381760	Green Published, Green Submitted, gold			2022-12-26	WOS:000423617800029
J	Adam, M; Heikela, H; Sobolewski, C; Portius, D; Maki-Jouppila, J; Mehmood, A; Adhikari, P; Esposito, I; Elo, LL; Zhang, FP; Ruohonen, ST; Strauss, L; Foti, M; Poutanen, M				Adam, Marion; Heikelae, Hanna; Sobolewski, Cyril; Portius, Dorothea; Maki-Jouppila, Jenni; Mehmood, Arfa; Adhikari, Prem; Esposito, Irene; Elo, Laura L.; Zhang, Fu-Ping; Ruohonen, Suvi T.; Strauss, Leena; Foti, Michelangelo; Poutanen, Matti			Hydroxysteroid (17 beta) dehydrogenase 13 deficiency triggers hepatic steatosis and inflammation in mice	FASEB JOURNAL			English	Article						liver; steatohepatitis; lipid droplet	FATTY LIVER-DISEASE; GENOME-WIDE ASSOCIATION; LIPID DROPLET PROTEINS; MICROVESICULAR STEATOSIS; EXPRESSION ANALYSIS; GENE; BIOLOGY; BIOCONDUCTOR; DIVERSITY; HORMONE	Hydroxysteroid (17(3) dehydrogenases (HSD17Bs) form an enzyme family characterized by their ability to catalyze reactions in steroid and lipid metabolism. In the present study, we characterized the phenotype of HSD17B13-knockout (HSD17B13KO) mice deficient in Hsd1 7b13. In these studies, hepatic steatosis was detected in HSD17B13KO male mice, indicated by histologic analysis and by the increased triglyceride concentration in the liver, whereas reproductive performance and serum steroid concentrations were normal in HSD17B13KO mice. In line with these changes, the expression of key proteins in fatty acid synthesis, such as FAS, acetyl-CoA carboxylase 1, and SCD1, was increased in the HSD17B13KO liver. Furthermore, the knockout liver showed an increase in 2 acylcamitines, suggesting impaired mitochondrial beta-oxidation in the presence of unaltered malonyl CoA and AMPK expression. The glucose tolerance did not differ between wild-type and HSD17B13KO mice in the presence of lower levels of glucose 6-phosphatase in HSD17B13KO liver compared with wild-type liver. Furthermore, microgranulomas and increased portal inflammation together with up-regulation of immune response genes were observed in HSD17B13KO mice. Our data indicate that disruption of Hsdl7b13 impairs hepatic-lipid metabolism in mice, resulting in liver steatosis and inflammation, but the enzyme does not play a major role in the regulation of reproductive functions.	[Adam, Marion; Heikelae, Hanna; Maki-Jouppila, Jenni; Mehmood, Arfa; Adhikari, Prem; Zhang, Fu-Ping; Ruohonen, Suvi T.; Strauss, Leena; Poutanen, Matti] Univ Turku, Inst Biomed, Res Ctr Integrat Physiol & Pharmacol, Turku Ctr Dis Modeling, Turku, Finland; [Sobolewski, Cyril; Portius, Dorothea; Foti, Michelangelo] Ctr Med Univ Geneva, Dept Cell Physiol & Metab, Fac Med, Off C05-2138-A,Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland; [Mehmood, Arfa; Elo, Laura L.] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Mehmood, Arfa; Elo, Laura L.] Abo Akad Univ, Turku, Finland; [Esposito, Irene] Tech Univ Munich, Inst Pathol, Munich, Germany; [Poutanen, Matti] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Internal Med, Gothenburg, Sweden	University of Turku; University of Geneva; University of Turku; Abo Akademi University; Technical University of Munich; University of Gothenburg	Foti, M (corresponding author), Ctr Med Univ Geneva, Dept Cell Physiol & Metab, Fac Med, Off C05-2138-A,Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.; Poutanen, M (corresponding author), Univ Turku, Res Ctr Integrat Physiol & Pharmacol, Inst Biomed, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.	michelangevlo.foti@unige.ch; matti.poutanen@utu.fi	Poutanen, Matti/I-1700-2018; Strauss, Leena/AAY-8824-2021; Sobolewski, Cyril/ABA-8197-2021; Elo, Laura/A-9449-2015	Poutanen, Matti/0000-0002-8953-1734; Sobolewski, Cyril/0000-0002-9404-6290; Elo, Laura/0000-0001-5648-4532; Foti, Michelangelo/0000-0001-7199-4135	German Academic Exchange Service; Academy of Finland; Novo Nordisk Foundation; Sigrid Juselius Foundation; Swiss National Science Foundation [310030_172862]	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Academy of Finland(Academy of Finland); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank Gilles Mithieux and Fabienne Rajas (University of Lyon, INSERM U1213 Lyon, France) for providing G6pase antibody for this study and N. Messner, H. Niittymaki, K. Hovirinta, H. Liljenback, A. Junnila, A. Hakkarainen, T. Kirjonen, J. Palmu, M. Niiranen, E. Nyman, M.-R. Kajaala, K. Asp, and M. Leppiaho (all from the University of Turku) for technical assistance. The study was supported by a fellowship within the Postdoctoral-Programme of the German Academic Exchange Service (to M. A.); the Academy of Finland, Novo Nordisk Foundation, and the Sigrid Juselius Foundation (to M.P.); and Swiss National Science Foundation Grant 310030_172862 (to M.F.). The authors declare no conflicts of interest.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Cao JS, 2014, AM J PHYSIOL-ENDOC M, V306, pE1176, DOI 10.1152/ajpendo.00666.2013; Carr RM, 2016, EXP CELL RES, V340, P187, DOI 10.1016/j.yexcr.2015.10.021; Carter-Kent C, 2011, J PEDIATR GASTR NUTR, V52, P190, DOI 10.1097/MPG.0b013e3181fb47d3; Chai ZL, 2003, ENDOCRINOLOGY, V144, P2084, DOI 10.1210/en.2002-221030; Crunk AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067631; DiStefano MT, 2015, J BIOL CHEM, V290, P15175, DOI 10.1074/jbc.M115.650184; Edelman D, 2015, MOL GENET GENOM MED, V3, P558, DOI 10.1002/mgg3.168; Ellis PJI, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-49; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fotbolcu H, 2016, WORLD J GASTROENTERO, V22, P4079, DOI 10.3748/wjg.v22.i16.4079; Gai ZB, 2016, J BIOL CHEM, V291, P2397, DOI 10.1074/jbc.M115.694323; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goh GBB, 2015, BBA CLIN, V3, P141, DOI 10.1016/j.bbacli.2014.09.001; HAAVISTO AM, 1993, ENDOCRINOLOGY, V132, P1687, DOI 10.1210/en.132.4.1687; Hijmans BS, 2017, HEPATOLOGY, V66, P2042, DOI 10.1002/hep.29389; Horiguchi Y, 2008, BIOCHEM BIOPH RES CO, V370, P235, DOI 10.1016/j.bbrc.2008.03.063; HUHTANIEMI I, 1985, J CLIN ENDOCR METAB, V61, P698, DOI 10.1210/jcem-61-4-698; Ibrahim SH, 2016, DIGEST DIS SCI, V61, P1325, DOI 10.1007/s10620-015-3977-1; Jokela H, 2010, ENDOCRINOLOGY, V151, P1884, DOI 10.1210/en.2009-0928; Jolly Robert A, 2004, Toxicol Pathol, V32 Suppl 2, P19, DOI 10.1080/01926230490451699; Kahali B, 2015, SEMIN LIVER DIS, V35, P375, DOI 10.1055/s-0035-1567870; Kainuma M, 2006, J GASTROENTEROL, V41, P971, DOI 10.1007/s00535-006-1883-1; Kanth VVR, 2016, WORLD J HEPATOL, V8, P827, DOI 10.4254/wjh.v8.i20.827; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Liu S, 2007, ACTA BIOCHIM POL, V54, P213, DOI 10.18388/abp.2007_3289; Ma SZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07633; Mashek DG, 2015, HEPATOLOGY, V62, P964, DOI 10.1002/hep.27839; Meli R, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00177; Mikolasevic I, 2016, WORLD J GASTROENTERO, V22, P9488, DOI 10.3748/wjg.v22.i43.9488; Mindnich J, 2009, MOL CELL ENDOCRINOL, V301, P20, DOI 10.1016/j.mce.2008.12.002; Mindnich R, 2004, MOL CELL ENDOCRINOL, V218, P7, DOI 10.1016/j.mce.2003.12.006; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Mutel E, 2011, J HEPATOL, V54, P529, DOI 10.1016/j.jhep.2010.08.014; Natarajan SK, 2006, J GASTROEN HEPATOL, V21, P1240, DOI 10.1111/j.1440-1746.2006.04313.x; Neuschwander-Tetri BA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0806-8; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Park Tae-Joon, 2013, Genomics & Informatics, V11, P149, DOI 10.5808/GI.2013.11.3.149; R Development Core Team, 2016, R LANG ENV STAT COMP; Rantakari P, 2010, ENDOCRINOLOGY, V151, P1893, DOI 10.1210/en.2009-0929; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saloniemi T, 2012, J ENDOCRINOL, V212, P27, DOI 10.1530/JOE-11-0315; Schleicher J, 2015, BBA-MOL CELL BIOL L, V1851, P641, DOI 10.1016/j.bbalip.2015.02.004; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sookoian S, 2015, WORLD J GASTROENTERO, V21, P711, DOI 10.3748/wjg.v21.i3.711; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Su W, 2017, AM J PHYSIOL-ENDOC M, V312, DOI 10.1152/ajpendo.00310.2016; Su W, 2014, P NATL ACAD SCI USA, V111, P11437, DOI 10.1073/pnas.1410741111; Tan JSY, 2014, J GENET GENOMICS, V41, P251, DOI 10.1016/j.jgg.2014.03.003; Tandra S, 2011, J HEPATOL, V55, P654, DOI 10.1016/j.jhep.2010.11.021; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; van Casteren JIJ, 2000, BIOL REPROD, V62, P886, DOI 10.1095/biolreprod62.4.886; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Zhang XL, 2017, PROTEIN CELL, V8, P4, DOI 10.1007/s13238-016-0327-9	58	31	32	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3434	3447		10.1096/fj.201700914R	http://dx.doi.org/10.1096/fj.201700914R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401633				2022-12-26	WOS:000432546000043
J	Nishida, J; Miyazono, K; Ehata, S				Nishida, Jun; Miyazono, Kohei; Ehata, Shogo			Decreased TGFBR3/betaglycan expression enhances the metastatic abilities of renal cell carcinoma cells through TGF-beta-dependent and-independent mechanisms	ONCOGENE			English	Article							GROWTH-FACTOR-BETA; ALDEHYDE DEHYDROGENASE; RECEPTOR EXPRESSION; FUNCTIONAL-ANALYSIS; INITIATING CELLS; PROTEIN; TARGET; PROGRESSION; POPULATION; BETAGLYCAN	TGF-beta regulates both the tumor-forming and migratory abilities of various types of cancer cells. However, it is unclear how the loss of TGF-beta signaling components affects these abilities in clear-cell renal cell carcinoma (ccRCC). In this study, we investigated the role of TGFBR3 (TGF-beta type III receptor, also known as betaglycan) in ccRCC. Database analysis revealed decreased expression of TGFBR3 in ccRCC tissues, which correlated with poor prognosis in patients. Orthotopic inoculation experiments using immunocompromised mice indicated that low TGFBR3 expression in ccRCC cells enhanced primary tumor formation and lung metastasis. In the presence of TGFBR3, TGF-beta 2 decreased the aldehyde dehydrogenase (ALDH)-positive ccRCC cell population, in which renal cancer-initiating cells are enriched. Loss of TGFBR3 also enhanced cell migration in cell culture and induced expression of several mesenchymal markers in a TGF-beta-independent manner. Increased lamellipodium formation by FAK-PI3K signaling was observed with TGFBR3 downregulation, and this contributed to TGF-beta-independent cell migration in ccRCC cells. Taken together, our findings reveal that loss of TGFBR3 endows ccRCC cells with multiple metastatic abilities through TGF-beta-dependent and independent pathways.	[Nishida, Jun; Miyazono, Kohei; Ehata, Shogo] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan	University of Tokyo	Miyazono, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp	Nishida, Jun/C-4892-2018	Nishida, Jun/0000-0001-5098-9361; Ehata, Shogo/0000-0002-6740-9391	KAKENHI from the Japan Society for the Promotion of Science (JSPS) [15H05774, 15K08393]; Japan Society for the Promotion of Science (JSPS) [16J05993]; Yasuda Medical Foundation; Grants-in-Aid for Scientific Research [16J05993, 15H05774] Funding Source: KAKEN	KAKENHI from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yasuda Medical Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr. Yoko Katsuno, Dr. Anna Mizutani, Dr. Yukari Hoshino, Dr. Fumihiko Murai, Dr. Kei Takahashi, and Dr. Luna Taguchi (The University of Tokyo) for technical help; and Dr. Hiroyuki Miyoshi (Keio University) for providing the lentiviral vectors. This work was supported by KAKENHI Grants-in-Aid for Scientific Research (S) (15H05774) (KM) and Scientific Research (C) (15K08393) (SE), and Grant-in-Aid for JSPS Research Fellow (16J05993) (JN) from the Japan Society for the Promotion of Science (JSPS), and the Yasuda Medical Foundation (KM).	Ananth S, 1999, CANCER RES, V59, P2210; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Bilandzic M, 2011, MOL CELL ENDOCRINOL, V339, P180, DOI 10.1016/j.mce.2011.04.014; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; Capitanio U, 2016, LANCET, V387, P894, DOI 10.1016/S0140-6736(15)00046-X; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Copland JA, 2003, ONCOGENE, V22, P8053, DOI 10.1038/sj.onc.1206835; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Ehata S, 2011, ONCOGENE, V30, P1693, DOI 10.1038/onc.2010.546; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Heldin CH, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022053; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hoshino Y, 2015, AM J PATHOL, V185, P1457, DOI 10.1016/j.ajpath.2015.01.011; Hoshino Y, 2011, J BIOCHEM, V149, P55, DOI 10.1093/jb/mvq114; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Katsuno Y, 2012, J PATHOL, V228, P391, DOI 10.1002/path.4020; Katsura A, 2017, MOL ONCOL, V11, P1241, DOI 10.1002/1878-0261.12098; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kubota SI, 2017, CELL REP, V20, P236, DOI 10.1016/j.celrep.2017.06.010; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Marcato P, 2011, CELL CYCLE, V10, P1378, DOI 10.4161/cc.10.9.15486; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; Miyazono K, 2012, UPSALA J MED SCI, V117, P143, DOI 10.3109/03009734.2011.638729; Mizutani A, 2016, ONCOGENE, V35, P3514, DOI 10.1038/onc.2015.412; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Murai F, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.26; Mythreye K, 2009, P NATL ACAD SCI USA, V106, P8221, DOI 10.1073/pnas.0812879106; Nagata M, 2006, GENES CELLS, V11, P1267, DOI 10.1111/j.1365-2443.2006.01018.x; NAITO S, 1986, CANCER RES, V46, P4109; Namwanje M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021881; Peired AJ, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/8342625; Riazalhosseini Y, 2016, NAT REV NEPHROL, V12, P655, DOI 10.1038/nrneph.2016.133; Scelo G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6135; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Ueda K., 2013, PLOS ONE, V8, P1; Vanharanta S, 2013, NAT MED, V19, P50, DOI 10.1038/nm.3029; Yokoyama Y, 2017, CANCER RES, V77, P4026, DOI 10.1158/0008-5472.CAN-17-0112	49	39	39	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	16					2197	2212		10.1038/s41388-017-0084-0	http://dx.doi.org/10.1038/s41388-017-0084-0			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GD5ZV	29391598	Green Published, hybrid			2022-12-26	WOS:000430589000009
J	Loughran, G; Jungreis, I; Tzani, I; Power, M; Dmitriev, RI; Ivanov, IP; Kellis, M; Atkins, JF				Loughran, Gary; Jungreis, Irwin; Tzani, Ioanna; Power, Michael; Dmitriev, Ruslan I.; Ivanov, Ivaylo P.; Kellis, Manolis; Atkins, John F.			Stop codon readthrough generates a C-terminally extended variant of the human vitamin D receptor with reduced calcitriol response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSOR TRANSFER-RNAS; COGNATE TRANSFER-RNAS; TRANSLATION TERMINATION; READ-THROUGH; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; RECODING SIGNALS; GENOME BROWSER; VEGF-AX; SEQUENCES	Although stop codon readthrough is used extensively by viruses to expand their gene expression, verified instances of mammalian readthrough have only recently been uncovered by systems biology and comparative genomics approaches. Previously, our analysis of conserved protein coding signatures that extend beyond annotated stop codons predicted stop codon readthrough of several mammalian genes, all of which have been validated experimentally. Four mRNAs display highly efficient stop codon readthrough, and these mRNAs have a UGA stop codon immediately followed by CUAG (UGA_CUAG) that is conserved throughout vertebrates. Extending on the identification of this readthrough motif, we here investigated stop codon readthrough, using tissue culture reporter assays, for all previously untested human genes containing UGA_CUAG. The readthrough efficiency of the annotated stop codon for the sequence encoding vitamin D receptor (VDR) was 6.7%. It was the highest of those tested but all showed notable levels of readthrough. The VDR is a member of the nuclear receptor superfamily of ligand-inducible transcription factors, and it binds its major ligand, calcitriol, via its C-terminal ligand-binding domain. Readthrough of the annotated VDR mRNA results in a 67 amino acid-long C-terminal extension that generates a VDR proteoform named VDRx. VDRx may form homodimers and heterodimers with VDR but, compared with VDR, VDRx displayed a reduced transcriptional response to calcitriol even in the presence of its partner retinoid X receptor.	[Loughran, Gary; Tzani, Ioanna; Power, Michael; Dmitriev, Ruslan I.; Ivanov, Ivaylo P.; Atkins, John F.] Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland; [Jungreis, Irwin; Kellis, Manolis] MIT, CSAIL, Cambridge, MA 02139 USA; [Atkins, John F.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Tzani, Ioanna] Natl Inst Bioproc Res & Training, Dublin A94 X099, Ireland; [Power, Michael] Univ Tubingen, Inst Ophthalm Res, D-72076 Tubingen, Germany; [Ivanov, Ivaylo P.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	University College Cork; Massachusetts Institute of Technology (MIT); Utah System of Higher Education; University of Utah; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Loughran, G; Atkins, JF (corresponding author), Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland.; Atkins, JF (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	g.loughran@ucc.ie; j.atkins@ucc.ie	Kellis, Manolis/ABE-7385-2020; Dmitriev, Ruslan/F-8741-2017; Loughran, Gary/AAQ-8791-2020	Kellis, Manolis/0000-0001-7113-9630; Loughran, Gary/0000-0002-2683-5597; Ivanov, Ivaylo/0000-0002-6008-3261; Dmitriev, Ruslan/0000-0002-0347-8718; Power, Michael/0000-0003-3750-6454	Science Foundation Ireland [12/IP/1492, 13/1A/1853, 13/SIRG/2144]; National Institutes of Health [R01 HG004037]; GENCODE Wellcome Trust [U41 HG007234]; Health Research Board Award [PhD/2007/04]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, U41HG007234] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GENCODE Wellcome Trust; Health Research Board Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by Science Foundation Ireland Grants 12/IP/1492 and 13/1A/1853 (to J.F.A.) and 13/SIRG/2144 (to R.I.D.). I. J. was supported by National Institutes of Health Grant R01 HG004037 and GENCODE Wellcome Trust Grant U41 HG007234. This work was also supported by a Health Research Board Award (PhD/2007/04) (to I.T.).	Andreev DE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0651-z; Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Beier H, 2001, NUCLEIC ACIDS RES, V29, P4767, DOI 10.1093/nar/29.23.4767; Betney R, 2010, RNA, V16, P655, DOI 10.1261/rna.1796210; Beznoskova P, 2016, RNA, V22, P456, DOI 10.1261/rna.054452.115; Beznoskova P, 2015, NUCLEIC ACIDS RES, V43, P5099, DOI 10.1093/nar/gkv421; Blanchet S, 2014, NUCLEIC ACIDS RES, V42, P10061, DOI 10.1093/nar/gku663; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; BONETTI B, 1995, J MOL BIOL, V251, P334, DOI 10.1006/jmbi.1995.0438; BOSSI L, 1980, NATURE, V286, P123, DOI 10.1038/286123a0; Brown A, 2015, NATURE, V524, P493, DOI 10.1038/nature14896; BROWN CM, 1990, NUCLEIC ACIDS RES, V18, P6339, DOI 10.1093/nar/18.21.6339; BROWN CM, 1990, NUCLEIC ACIDS RES, V18, P2079, DOI 10.1093/nar/18.8.2079; Brown CM, 1996, J VIROL, V70, P5884, DOI 10.1128/JVI.70.9.5884-5892.1996; CAVENER DR, 1991, NUCLEIC ACIDS RES, V19, P3185, DOI 10.1093/nar/19.12.3185; Chan CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059450; Chung BYW, 2010, J MOL BIOL, V397, P448, DOI 10.1016/j.jmb.2010.01.044; Coldwell MJ, 2004, J CELL SCI, V117, P2545, DOI 10.1242/jcs.01106; Cridge A. G., 2018, NUCLEIC ACIDS RES; Cridge AG, 2006, NUCLEIC ACIDS RES, V34, P1959, DOI 10.1093/nar/gkl074; Crofts LA, 1998, P NATL ACAD SCI USA, V95, P10529, DOI 10.1073/pnas.95.18.10529; De Bellis M, 2017, GLIA, V65, P790, DOI 10.1002/glia.23126; Dmitriev RI, 2013, BIOMATERIALS, V34, P9307, DOI 10.1016/j.biomaterials.2013.08.065; Dunn JG, 2013, ELIFE, V2, DOI 10.7554/eLife.01179; Eswarappa SM, 2014, CELL, V157, P1605, DOI 10.1016/j.cell.2014.04.033; Feng T, 2014, MOL CELL, V53, P645, DOI 10.1016/j.molcel.2013.12.028; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Firth AE, 2011, NUCLEIC ACIDS RES, V39, P6679, DOI 10.1093/nar/gkr224; Fixsen SM, 2010, J MOL BIOL, V399, P385, DOI 10.1016/j.jmb.2010.04.033; Freitag J, 2012, NATURE, V485, P522, DOI 10.1038/nature11051; Gardiner EM, 2004, J STEROID BIOCHEM, V89-90, P233, DOI 10.1016/j.jsbmb.2004.03.078; Grentzmann G, 1998, RNA, V4, P479; Harrell L, 2002, NUCLEIC ACIDS RES, V30, P2011, DOI 10.1093/nar/30.9.2011; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heaphy SM, 2016, MOL BIOL EVOL, V33, P2885, DOI 10.1093/molbev/msw166; Houck-Loomis B, 2011, NATURE, V480, P561, DOI 10.1038/nature10657; Iakoucheva LM, 2001, PROTEIN SCI, V10, P560, DOI 10.1110/ps.29401; Jeudy S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003122; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Jungreis I, 2016, MOL BIOL EVOL, V33, P3108, DOI 10.1093/molbev/msw189; Jungreis I, 2011, GENOME RES, V21, P2096, DOI 10.1101/gr.119974.110; Jurutka PW, 2000, MOL ENDOCRINOL, V14, P401, DOI 10.1210/me.14.3.401; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kobayashi Y, 2010, J BIOL CHEM, V285, P19776, DOI 10.1074/jbc.M109.085621; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liscovitch-Brauer N, 2017, CELL, V169, P191, DOI 10.1016/j.cell.2017.03.025; Lobanov AV, 2017, NAT STRUCT MOL BIOL, V24, P61, DOI 10.1038/nsmb.3330; Loenarz C, 2014, P NATL ACAD SCI USA, V111, P4019, DOI 10.1073/pnas.1311750111; Loughran G, 2017, RNA, V23, P1285, DOI 10.1261/rna.061051.117; Loughran G, 2014, NUCLEIC ACIDS RES, V42, P8928, DOI 10.1093/nar/gku608; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Matheisl S, 2015, NUCLEIC ACIDS RES, V43, P8615, DOI 10.1093/nar/gkv909; MCCAUGHAN KK, 1995, P NATL ACAD SCI USA, V92, P5431, DOI 10.1073/pnas.92.12.5431; Michel AM, 2014, NUCLEIC ACIDS RES, V42, pD859, DOI 10.1093/nar/gkt1035; Namy O, 2001, EMBO REP, V2, P787, DOI 10.1093/embo-reports/kve176; Nyiko T, 2017, NUCLEIC ACIDS RES, V45, P4174, DOI 10.1093/nar/gkw1303; Pelechano V, 2017, NUCLEIC ACIDS RES, V45, P7326, DOI 10.1093/nar/gkx479; PIKE JW, 1979, P NATL ACAD SCI USA, V76, P5485, DOI 10.1073/pnas.76.11.5485; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; Prufer K, 2002, MOL ENDOCRINOL, V16, P1738, DOI 10.1210/me.2001-0345; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Roy B, 2015, P NATL ACAD SCI USA, V112, P3038, DOI 10.1073/pnas.1424127112; SAIJO T, 1991, AM J HUM GENET, V49, P668; Schueren F, 2014, ELIFE, V3, DOI 10.7554/eLife.03640; Schuller AP, 2017, MOL CELL, V66, P194, DOI 10.1016/j.molcel.2017.03.003; SKUZESKI JM, 1991, J MOL BIOL, V218, P365, DOI 10.1016/0022-2836(91)90718-L; Steneberg P, 2001, EMBO REP, V2, P593, DOI 10.1093/embo-reports/kve128; Stiebler AC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004685; Sunn KL, 2001, MOL ENDOCRINOL, V15, P1599, DOI 10.1210/me.15.9.1599; Swart EC, 2016, CELL, V166, P691, DOI 10.1016/j.cell.2016.06.020; Urakov VN, 2017, FEBS J, V284, P1914, DOI 10.1111/febs.14099; von der Haar T, 2007, TRENDS MICROBIOL, V15, P78, DOI 10.1016/j.tim.2006.12.002; WILLS NM, 1991, P NATL ACAD SCI USA, V88, P6991, DOI 10.1073/pnas.88.16.6991; WILLS NM, 1994, EMBO J, V13, P4137, DOI 10.1002/j.1460-2075.1994.tb06731.x; Xin H, 2016, CELL, V167, P275, DOI 10.1016/j.cell.2016.08.054; Yamaguchi Y, 2012, J BIOL CHEM, V287, P17765, DOI 10.1074/jbc.M111.314468; Yordanova MM, 2018, NATURE, V553, P356, DOI 10.1038/nature25174	79	32	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4434	4444		10.1074/jbc.M117.818526	http://dx.doi.org/10.1074/jbc.M117.818526			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29386352	Green Published, hybrid			2022-12-26	WOS:000428204300015
J	Maity, G; Haque, I; Ghosh, A; Dhar, G; Gupta, V; Sarkar, S; Azeem, I; McGregor, D; Choudhary, A; Campbell, DR; Kambhampati, S; Banerjee, SK; Banerjee, S				Maity, Gargi; Haque, Inamul; Ghosh, Arnab; Dhar, Gopal; Gupta, Vijayalaxmi; Sarkar, Sandipto; Azeem, Imaan; McGregor, Douglas; Choudhary, Abhishek; Campbell, Donald R.; Kambhampati, Suman; Banerjee, Sushanta K.; Banerjee, Snigdha			The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; K-RAS MUTATIONS; EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-TUMOR CELLS; DUCTAL ADENOCARCINOMA; KRAS; MYC; EXPRESSION; PHOSPHORYLATION; ANGIOGENESIS	Myc-associated zinc-finger protein (MAZ) is a transcription factor with dual roles in transcription initiation and termination. Deregulation of MAZ expression is associated with the progression of pancreatic ductal adenocarcinoma (PDAC). However, the mechanism of action of MAZ in PDAC progression is largely unknown. Here, we present evidence that MAZ mRNA expression and protein levels are increased in human PDAC cell lines, tissue samples, a subcutaneous tumor xenograft in a nude mouse model, and spontaneous cancer in the genetically engineered PDAC mouse model. We also found that MAZ is predominantly expressed in pancreatic cancer stem cells. Functional analysis indicated that MAZ depletion in PDAC cells inhibits invasive phenotypes such as the epithelial-to-mesenchymal transition, migration, invasion, and the sphere-forming ability of PDAC cells. Mechanistically, we detected no direct effects of MAZ on the expression of K-Ras mutants, but MAZ increased the activity of CRAF-ERK signaling, a downstream signaling target of K-Ras. The MAZ-induced activation of CRAF-ERK signaling was mediated via p21-activated protein kinase (PAK) and protein kinase B (AKT/PKB) signaling cascades and promoted PDAC cell invasiveness. Moreover, we found that the matricellular oncoprotein cysteine-rich angiogenic inducer 61 (Cyr61/CCN1) regulates MAZ expression via Notch-1-sonic hedgehog signaling in PDAC cells. We propose that Cyr61/CCN1-induced expression of MAZ promotes invasive phenotypes of PDAC cells not through direct K-Ras activation but instead through the activation of CRAF-ERK signaling. Collectively, these results highlight key molecular players in PDAC invasiveness and may help inform therapeutic strategies to improve clinical management and outcomes of PDAC.	[Maity, Gargi; Haque, Inamul; Ghosh, Arnab; Dhar, Gopal; Gupta, Vijayalaxmi; Sarkar, Sandipto; Azeem, Imaan; McGregor, Douglas; Campbell, Donald R.; Kambhampati, Suman; Banerjee, Sushanta K.; Banerjee, Snigdha] Univ Kansas, Med Ctr, Vet Affairs Med Ctr, Canc Res Unit, Kansas City, KS 66103 USA; [Maity, Gargi; Haque, Inamul; McGregor, Douglas; Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Ghosh, Arnab; Sarkar, Sandipto; Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [McGregor, Douglas] Vet Affairs Med Ctr, Dept Pathol, Kansas City, MO 64128 USA; [Choudhary, Abhishek] Vet Affairs Med Ctr, Dept Gastroenterol, Kansas City, MO 64128 USA; [Campbell, Donald R.] Univ Missouri, Kansas City, MO 64110 USA; [Campbell, Donald R.] St Lukes Hosp, Kansas City, MO USA; [Kambhampati, Suman; Banerjee, Snigdha] HCA Midwest Hlth, Sarah Cannon Canc Ctr, Kansas City, MO 64131 USA; [Dhar, Gopal] Syngene Int Ltd, Biocon Bristol Myers Squibb R&D Ctr, Bangalore 56099, Karnataka, India	University of Kansas; University of Kansas Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Missouri System; University of Missouri Kansas City; Saint Luke's Hospital - Missouri; Sarah Cannon Research Institute; Bristol-Myers Squibb; Syngene International Limited	Banerjee, SK; Banerjee, S (corresponding author), Vet Affairs Med Ctr, Canc Res Unit, Res Div 151,4801 E Linwood Blvd, Kansas City, MO 64128 USA.	sbanerjee2@kumc.edu; sbanerjee@kumc.edu	Banerjee, Sushanta/AAG-6534-2021; Haque, Inamul/I-2482-2019; Gupta, Viju/AAI-1017-2019; Ghosh, Arnab/ABE-6292-2020	Gupta, Viju/0000-0001-8915-3393; Banerjee, Sushanta/0000-0002-7698-0717; Ghosh, Arnab/0000-0003-0355-7763	Veterans Affairs Merit Award grants; Grace Hortense Greenley Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103326] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001002] Funding Source: NIH RePORTER	Veterans Affairs Merit Award grants; Grace Hortense Greenley Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs Merit Award grants (to S. K. B. and S. B.) and by the Grace Hortense Greenley Trust (to S. K. B., S. B., and S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Abramson Michael A, 2007, Gastrointest Cancer Res, V1, pS7; Banerjee J, 2016, ONCOTARGET, V7, P44430, DOI 10.18632/oncotarget.9790; Banerjee S, 2005, MOL CANCER RES, V3, P151, DOI 10.1158/1541-7786.MCR-04-0130; Banerjee SK, 1997, PANCREAS, V15, P16, DOI 10.1097/00006676-199707000-00003; Banerjee SK, 2000, PANCREAS, V20, P248, DOI 10.1097/00006676-200004000-00005; Banerjee SK, 2016, J CELL COMMUN SIGNAL, V10, P207, DOI 10.1007/s12079-016-0343-9; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; CALDAS C, 1994, CANCER RES, V54, P3568; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cogoi S, 2013, NUCLEIC ACIDS RES, V41, P4049, DOI 10.1093/nar/gkt127; Cogoi S, 2010, CHEM COMMUN, V46, P7364, DOI 10.1039/c0cc01912g; Cogoi S, 2010, J BIOL CHEM, V285, P22003, DOI 10.1074/jbc.M110.101923; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Dhar G, 2007, CANCER LETT, V254, P63, DOI 10.1016/j.canlet.2007.02.012; di Magliano MP, 2013, GASTROENTEROLOGY, V144, P1220, DOI 10.1053/j.gastro.2013.01.071; Dudas J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-92; Eser S., 2014, BR J CANC; Feygenzon V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179862; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Ghosh P, 2017, METHODS MOL BIOL, V1489, P495, DOI 10.1007/978-1-4939-6430-7_41; Han S, 2017, ONCOTARGET, V8, P54054, DOI 10.18632/oncotarget.10722; Haque I, 2012, J BIOL CHEM, V287, P38569, DOI 10.1074/jbc.M112.389064; Haque I, 2011, J BIOL CHEM, V286, P43475, DOI 10.1074/jbc.M111.284158; Haque I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-8; Hesler RA, 2016, CARCINOGENESIS, V37, P1041, DOI 10.1093/carcin/bgw093; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042513; Jiao L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0570-3; Jonckheere N, 2017, CRIT REV ONCOL HEMAT, V111, P7, DOI 10.1016/j.critrevonc.2017.01.002; Jun JI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8386; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Lau LF, 2012, J CELL COMMUN SIGNAL, V6, P121, DOI 10.1007/s12079-012-0169-z; Leask A, 2013, J CELL COMMUN SIGNAL, V7, P61, DOI 10.1007/s12079-012-0187-x; Leask A, 2011, J CELL COMMUN SIGNAL, V5, P123, DOI 10.1007/s12079-011-0127-1; Lee WP, 2016, CANCER LETT, V375, P9, DOI 10.1016/j.canlet.2016.02.023; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; Maity G, 2015, LAB INVEST, V95, P702, DOI 10.1038/labinvest.2015.49; Maity G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04995; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mueller S, 2018, NATURE, V554, P62, DOI 10.1038/nature25459; Nakagomi S, 2003, J NEUROSCI, V23, P5187; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; Nussinov R, 2013, TRENDS MOL MED, V19, P695, DOI 10.1016/j.molmed.2013.07.009; Ogura T, 2013, J GASTROENTEROL, V48, P640, DOI 10.1007/s00535-012-0664-2; Okada M, 2014, ONCOTARGET, V5, P5100, DOI 10.18632/oncotarget.2087; Pecot CV, 2014, MOL CANCER THER, V13, P2876, DOI 10.1158/1535-7163.MCT-14-0074; Poulin EJ, 2017, GENE DEV, V31, P333, DOI 10.1101/gad.297630.117; Rajalingam K, 2005, CELL CYCLE, V4, P1503, DOI 10.4161/cc.4.11.2142; Ray A, 1998, MOL CELL BIOL, V18, P7327, DOI 10.1128/MCB.18.12.7327; Ray A, 2015, CANCER MED-US, V4, P224, DOI 10.1002/cam4.362; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sarkar S, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.43; Shi WD, 2016, ONCOTARGET, V7, P73160, DOI 10.18632/oncotarget.12248; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Smits M, 2012, FASEB J, V26, P2639, DOI 10.1096/fj.11-202820; Son H, 2010, TOX RESEARCH, V26, P245, DOI 10.5487/TR.2010.26.4.245; Song J, 1998, J BIOL CHEM, V273, P20603, DOI 10.1074/jbc.273.32.20603; Song J, 2003, INT J MOL MED, V11, P547; Stephenson JM, 2002, INT J CANCER, V101, P409, DOI 10.1002/ijc.10611; Tao LY, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0888-3; Thomas A, 2000, ONCOGENE, V19, P5259, DOI 10.1038/sj.onc.1203895; Tsutsui H, 1996, BIOCHEM BIOPH RES CO, V226, P801, DOI 10.1006/bbrc.1996.1432; Wang P, 2015, ONCOTARGET, V6, P21148, DOI 10.18632/oncotarget.4125; Wang X, 2008, BREAST CANCER RES TR, V111, P103, DOI 10.1007/s10549-007-9765-7; Wang YM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153312; Wu JG, 2016, ELIFE, V5, DOI 10.7554/eLife.10734; Xia LG, 2016, SCI REP-UK, V6, DOI 10.1038/srep22005; Xu X, 2014, J CHEM-NY, V2014, DOI 10.1155/2014/640757; Yan L, 2005, GASTROENTEROLOGY, V128, P2124, DOI 10.1053/j.gastro.2005.03.006; Yip-Schneider MT, 2000, BIOCHEM J, V351, P151, DOI 10.1042/0264-6021:3510151; Zhu XN, 2016, ONCOTARGETS THER, V9, P7493, DOI 10.2147/OTT.S124118; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	77	24	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4334	4349		10.1074/jbc.RA117.000333	http://dx.doi.org/10.1074/jbc.RA117.000333			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29414775	Green Published, hybrid			2022-12-26	WOS:000428204300008
J	Beauvais, W; Gart, EV; Bean, M; Blanco, A; Wilsey, J; McWhinney, K; Bryan, L; Krath, M; Yang, CY; Alvarez, DM; Paudyal, S; Bryan, K; Stewart, S; Cook, PW; Lahodny, G; Baumgarten, K; Gautam, R; Nightingale, K; Lawhon, SD; Pinedo, P; Ivanek, R				Beauvais, Wendy; Gart, Elena V.; Bean, Melissa; Blanco, Anthony; Wilsey, Jennifer; McWhinney, Kallie; Bryan, Laura; Krath, Mary; Yang, Ching-Yuan; Alvarez, Diego Manriquez; Paudyal, Sushil; Bryan, Kelsey; Stewart, Samantha; Cook, Peter W.; Lahodny, Glenn, Jr.; Baumgarten, Karina; Gautam, Raju; Nightingale, Kendra; Lawhon, Sara D.; Pinedo, Pablo; Ivanek, Renata			The prevalence of Escherichia coli O157:H7 fecal shedding in feedlot pens is affected by the water-to-cattle ratio: A randomized controlled trial	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; UNITED-STATES; BOVINE FECES; MIDWESTERN USA; BEEF-CATTLE; FOOD SAFETY; DAIRY-HERD; O157-H7; INFECTIONS; DYNAMICS	Escherichia coli O157:H7 fecal shedding in feedlot cattle is common and is a public health concern due to the risk of foodborne transmission that can result in severe, or even fatal, disease in people. Despite a large body of research, few practical and cost-effective farm-level interventions have been identified. In this study, a randomized controlled trial was conducted to assess the effect of reducing the level of water in automatically refilling watertroughs on fecal shedding of E. coli O157:H7 in feedlot cattle. Pens in a feedlot in the Texas Panhandle were randomly allocated as control (total number:17) or intervention (total number: 18) pens. Fecal samples (2,759 in total) were collected both at baseline and three weeks after the intervention, and tested for the presence of E. coli O157:H7 using immunomagnetic bead separation and selective culture. There was a strong statistical association between sampling date and the likelihood of a fecal sample testing positive for E. coli O157: H7. Pen was also a strong predictor of fecal prevalence. Despite accounting for this high level of clustering, a statistically significant association between reduced water levels in the trough and increased prevalence of E. coli O157:H7 in the feces was observed (Odds Ratio = 1.6; 95% Confidence Interval:1.2-2.0; Likelihood Ratio Test: p = 0.02). This is the first time that such an association has been reported, and suggests that increasing watertrough levels may be effective in reducing shedding of E. coli O157:H7 in cattle feces, although further work would be needed to test this hypothesis. Controlling E. coli O157:H7 fecal shedding at the pre-harvest level may lead to a reduced burden of human foodborne illness attributed to this pathogen in beef.	[Beauvais, Wendy; Ivanek, Renata] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; [Gart, Elena V.; Bean, Melissa; Blanco, Anthony; Wilsey, Jennifer; McWhinney, Kallie; Bryan, Laura; Krath, Mary; Yang, Ching-Yuan; Alvarez, Diego Manriquez; Lahodny, Glenn, Jr.; Baumgarten, Karina; Gautam, Raju; Lawhon, Sara D.; Ivanek, Renata] Texas A&M Univ, Coll Vet Med & Biomed Sci, College Stn, TX USA; [Paudyal, Sushil] West Texas A&M Univ, Canyon, TX USA; [Bryan, Kelsey; Pinedo, Pablo] Texas A&M Agrilife Res, Amarillo, TX USA; [Stewart, Samantha; Cook, Peter W.; Nightingale, Kendra] Texas Tech Univ, Anim & Food Sci, Lubbock, TX 79409 USA	Cornell University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; West Texas A&M University; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Texas Tech University System; Texas Tech University	Beauvais, W (corresponding author), Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA.	wab223@Cornell.edu	Manriquez, Diego/ADS-4204-2022; Bryan, Laura/ABD-5741-2020; Paudyal, Sushil/O-1899-2019; Ivanek, Renata/B-9005-2009; Lawhon, Sara D./G-5147-2011	Manriquez, Diego/0000-0003-0899-2457; Ivanek, Renata/0000-0001-6348-4709; Lawhon, Sara D./0000-0001-9154-8909; Beauvais, Wendy/0000-0001-7634-3331; Paudyal, Sushil/0000-0002-6388-921X; Bryan, Laura/0000-0002-9422-2338; Bryan, Laura K/0000-0003-0746-9461	United States Department of Agriculture [1002529, TEX09586]; National Institutes of Health (NIH) [5T35OD010991]; Texas Veterinary Medical Foundation; Merial NIH Veterinary Scholars Program; NIH [5 T32 0D 011083-8]	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Veterinary Medical Foundation; Merial NIH Veterinary Scholars Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Formula Animal Health Fund from the United States Department of Agriculture (Accession No. 1002529; Project No. TEX09586). Additionally, MB and AB were funded by the National Institutes of Health (NIH) (5T35OD010991), Texas Veterinary Medical Foundation and Merial NIH Veterinary Scholars Program. LB was supported by the NIH T32 grant (5 T32 0D 011083-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Arthur TM, 2009, APPL ENVIRON MICROB, V75, P6515, DOI 10.1128/AEM.00081-09; Ayscue P, 2009, FOODBORNE PATHOG DIS, V6, P461, DOI 10.1089/fpd.2008.0235; Banatvala N, 2001, J INFECT DIS, V183, P1063, DOI 10.1086/319269; Barkocy-Gallagher GA, 2003, J FOOD PROTECT, V66, P1978, DOI 10.4315/0362-028X-66.11.1978; BRUHN CM, 1992, J FOOD SAFETY, V12, P253, DOI 10.1111/j.1745-4565.1991.tb00082.x; Callaway T R, 2004, J Anim Sci, V82 E-Suppl, pE93; CDC, 2006, MMWR-MORBID MORTAL W, V57, P625; Champely S, PWR BASIC FUNCTIONS; CHAPMAN PA, 1993, EPIDEMIOL INFECT, V111, P439, DOI 10.1017/S0950268800057162; Dohoo I.R., 2010, VET EPIDEMIOLOGIC RE, P257; Doyle M. E., 2006, HUMAN ILLNESS CAUSED; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; Fox JT, 2007, APPL ENVIRON MICROB, V73, P5253, DOI 10.1128/AEM.00554-07; Frenzen PD, 2005, J FOOD PROTECT, V68, P2623, DOI 10.4315/0362-028X-68.12.2623; Friedman MS, 1999, CLIN INFECT DIS, V29, P298, DOI 10.1086/520204; Gautam R, 2012, J BIOL DYNAM, V6, P1052, DOI 10.1080/17513758.2012.722232; Gautam R, 2013, AGR SCI, V4; Gautam R, 2011, PREV VET MED, V102, P10, DOI 10.1016/j.prevetmed.2011.06.008; HANCOCK DD, 1994, EPIDEMIOL INFECT, V113, P199, DOI 10.1017/S0950268800051633; HAYES DJ, 1995, AM J AGR ECON, V77, P40, DOI 10.2307/1243887; Hughes KJ., 2013, THESIS, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Jacob ME, 2012, FOODBORNE PATHOG DIS, V9, P79, DOI 10.1089/fpd.2011.0947; Khaitsa ML, 2003, J FOOD PROTECT, V66, P1972, DOI 10.4315/0362-028X-66.11.1972; Kim NH, 2017, ADV APPL MICROBIOL, V100, P1, DOI 10.1016/bs.aambs.2017.02.001; KOHLI HS, 1994, J PUBLIC HEALTH MED, V16, P11, DOI 10.1093/oxfordjournals.pubmed.a042911; LeJeune JT, 2006, J CLIN MICROBIOL, V44, P872, DOI 10.1128/JCM.44.3.872-875.2006; Lumley T., 2016, SURVEY ANAL COMPLEX, V3, P31; Machado LCP, 2004, APPL ANIM BEHAV SCI, V89, P185, DOI 10.1016/j.applanim.2004.07.002; Marsh TL, 2004, APPL ECON, V36, P897, DOI 10.1080/0003684042000233113; Mechie SC, 1997, EPIDEMIOL INFECT, V118, P17, DOI 10.1017/S0950268896007194; Mukhejee A, 2007, INT J FOOD MICROBIOL, V120, P296, DOI 10.1016/j.ijfoodmicro.2007.09.007; Ochieng BJ, 2016, FOOD POLICY, V59, P78, DOI 10.1016/j.foodpol.2015.12.004; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Sargeant JA, 2004, PREV VET MED, V66, P175, DOI 10.1016/j.prevetmed.2004.09.007; Sargeant JM, 2004, PREV VET MED, V66, P207, DOI 10.1016/j.prevetmed.2004.09.006; SATO S, 1991, APPL ANIM BEHAV SCI, V32, P3, DOI 10.1016/S0168-1591(05)80158-3; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schroeder TC, 2000, J ANIM SCI, V77, P1; SIEGLER RL, 1994, PEDIATRICS, V94, P35; SU CY, 1995, ANN INTERN MED, V123, P698, DOI 10.7326/0003-4819-123-9-199511010-00009; Trevena W B, 1999, Commun Dis Public Health, V2, P263; Tuttle J, 1999, EPIDEMIOL INFECT, V122, P185, DOI 10.1017/S0950268898001976; Ungkuraphinunt P., 2003, THESIS; University of Nebraska-Lincoln Extension, 2011, WAT REQ BEEF CATTL; van Elsas JD, 2011, ISME J, V5, P173, DOI 10.1038/ismej.2010.80; Vital M, 2008, ENVIRON MICROBIOL, V10, P2387, DOI 10.1111/j.1462-2920.2008.01664.x; Wang GD, 1996, APPL ENVIRON MICROB, V62, P2567, DOI 10.1128/AEM.62.7.2567-2570.1996	49	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192149	10.1371/journal.pone.0192149	http://dx.doi.org/10.1371/journal.pone.0192149			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1MC	29414986	gold, Green Published, Green Submitted			2022-12-26	WOS:000424325300053
J	Yang, C; Yang, SJ; Feng, CH; Zhang, C; Xu, WW; Zhang, LY; Yan, YX; Deng, JQ; Ohore, OE; Li, J				Yang, Chao; Yang, Shujuan; Feng, Chunhong; Zhang, Chuan; Xu, Weiwei; Zhang, Liyun; Yan, Yixin; Deng, Jiaqi; Ohore, Okugbe Ebiotubo; Li, Jing			Associations of hyperuricemia and obesity with remission of nonalcoholic fatty liver disease among Chinese men: A retrospective cohort study	PLOS ONE			English	Article							SERUM URIC-ACID; INSULIN-RESISTANCE; METABOLIC SYNDROME; HEPATIC STEATOSIS; PREDICTOR; RISK; DYSFUNCTION; POPULATION; PREVALENCE; MORTALITY	Nonalcoholic fatty liver disease (NAFLD) is a common chronic disease that is associated with high serum uric acid (SUA) levels, although the effects of high SUA levels on NAFLD remission remain unclear. In addition, it is unclear whether obesity and high SUA levels have a combined effect on NAFLD remission. This retrospective cohort study evaluated male employees of seven Chinese companies and investigated the association between high SUA levels and NAFLD remission, as well as the potential combined effect of high SUA levels and obesity on NAFLD remission. The study followed 826 men with NAFLD for 4 years, and the NAFLD remission rate was 23.2% (192/826). Comparing to obese and non-obese individuals with normouricemia, individuals with hyperuricemia had significant higher values for total cholesterol, triglycerides, creatinine, and aspartate transaminase (all P < 0.05). Among non-obese individuals, hyperuricemia was associated with a lower NAFLD remission rate, compared to normouricemia (P < 0.001). However, no significant difference was observed between hyperuricemia and normouricemia among obese subjects (P > 0.05). Similar results were observed in the multivariate cox proportional hazard regression analyses. Compared to the normouricemia subjects, individuals with hyperuricemia had a significant lower likelihood of NAFLD remission (RR = 0.535, 95% CI: 0.312-0.916); and obese subjects had a significant lower likelihood of NAFLD remission than the non-obese individuals (RR = 0.635, 95% CI: 0.439-0.918). In addition, the interaction between hyperuricemia and obesity had a statistically significant effect on NAFLD remission (P = 0.048). In conclusion, hyperuricemia and obesity may be involved in NAFLD development and remission, with similar pathogenic mechanisms. Further studies are needed to confirm our findings and determine how to improve these individuals' conditions.	[Yang, Chao] Southwest Med Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Luzhou, Peoples R China; [Yang, Shujuan] Sichuan Univ, Dept Hlth Related Social & Behav Sci, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China; [Feng, Chunhong; Xu, Weiwei; Zhang, Liyun; Yan, Yixin] Southwest Med Univ, Hlth Management Dept, Affiliated Hosp 1, Coll Med, Luzhou, Peoples R China; [Zhang, Chuan] Sichuan Univ, Dept Palliat Med, West China Teaching Hosp 1, Chengdu, Sichuan, Peoples R China; [Deng, Jiaqi] Southwest Med Univ, Dept Ultrasonog, Affiliated Hosp 1, Coll Med, Luzhou, Peoples R China; [Ohore, Okugbe Ebiotubo] Southeast Univ, Dept Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Li, Jing] Southwest Med Univ, Dept Educ Affairs, Luzhou, Peoples R China	Southwest Medical University; Sichuan University; Southwest Medical University; Sichuan University; Southwest Medical University; Southeast University - China; Southwest Medical University	Li, J (corresponding author), Southwest Med Univ, Dept Educ Affairs, Luzhou, Peoples R China.	jingl2017@tom.com	Ohore, Okugbe/GQP-8720-2022; Ohore, Okugbe/AAK-1994-2021	Ohore, Okugbe/0000-0002-0784-480X; 				Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Cardoso AS, 2013, J PEDIAT-BRAZIL, V89, P412, DOI 10.1016/j.jped.2012.12.008; Chen CH, 2006, J CLIN GASTROENTEROL, V40, P745, DOI 10.1097/00004836-200609000-00016; Cho HC, 2016, GUT LIVER, V10, P117, DOI 10.5009/gnl14444; Choi YJ, 2014, LAB INVEST, V94, P1114, DOI 10.1038/labinvest.2014.98; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Fan JG, 2013, J GASTROEN HEPATOL, V28, P11, DOI 10.1111/jgh.12036; FANG J, 1971, NATIONAL HEALTH AND, V2000, P283; Fang J, 2000, PUBMED, V283, P2404; Garcia-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Jian-gao F, 2010, MEDICINE, V18, P163; Jian-gao Fan, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P163; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Lee JW, 2010, GUT LIVER, V4, P378, DOI 10.5009/gnl.2010.4.3.378; Li CG, 2013, CURR OPIN RHEUMATOL, V25, P210, DOI 10.1097/BOR.0b013e32835d951e; Liu CR, 2016, SCI REP-UK, V6, DOI 10.1038/srep33472; LIU J, 2016, HEPATOLOGY RESEARCH; Liu L, 2013, CLIN RHEUMATOL, V32, P233, DOI 10.1007/s10067-012-2108-z; Liu PJ, 2014, CLIMACTERIC, V17, P692, DOI 10.3109/13697137.2014.926323; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Miyake T, 2013, J GASTROENTEROL, V48, P413, DOI 10.1007/s00535-012-0650-8; Mount DB, 2006, RHEUM DIS CLIN N AM, V32, P313, DOI 10.1016/j.rdc.2006.02.006; PMID, 2010, PUBMED; PMID, 2008, PUBMED; PMID, 2014, PUBMED; PMID, PUBMED, P3681; PMID, 2015, PUBMED; PMID, 2004, PUBMED; PMID, 1929, PUBMED; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Sartorio A, 2007, EUR J CLIN NUTR, V61, P877, DOI 10.1038/sj.ejcn.1602588; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; SUN D, 2016, EXPERT OPIN THER TAR; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Tulloch-Reid MK, 2004, OBES RES, V12, P1352, DOI 10.1038/oby.2004.170; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wan XY, 2016, J HEPATOL, V64, P925, DOI 10.1016/j.jhep.2015.11.022; Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406; WIJARNPREECHA K, 2016, LIVER INTERNATIONAL; Xie Y, 2013, PLOS ONE, V8; Xu C, 2010, PUBMED, V5; YANG C, 2017, PUBMED; Ye JP, 2013, FRONT MED-PRC, V7, P14, DOI 10.1007/s11684-013-0262-6; Yu TY, 2016, METABOLISM, V65, P432, DOI 10.1016/j.metabol.2015.11.003; Yu TY, 2016, INT J MOL SCI, V65, P432; Zelber-Sagi S, 2012, J HEPATOL, V56, P1145, DOI 10.1016/j.jhep.2011.12.011; Zhang JP, 2016, CLIN RHEUMATOL, V35, P143, DOI 10.1007/s10067-015-2867-4; Zhou YJ, 2016, CLIN BIOCHEM, V49, P636, DOI 10.1016/j.clinbiochem.2015.12.010; ZHOU Z, 2016, PUBMED; Zhu YZ, 2014, BIOCHEM BIOPH RES CO, V447, P707, DOI 10.1016/j.bbrc.2014.04.080; Zoppini G, 2014, AM J GASTROENTEROL, V109, P1020, DOI 10.1038/ajg.2014.132	54	14	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192396	10.1371/journal.pone.0192396	http://dx.doi.org/10.1371/journal.pone.0192396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415050	Green Published, Green Submitted, gold			2022-12-26	WOS:000424325300074
J	Dettmer, S; Ringshausen, F; Vogel-Claussen, J; Fuge, J; Faschkami, A; Shin, HO; Schwerk, N; Welte, T; Wacker, F; Rademacher, J				Dettmer, Sabine; Ringshausen, Felix; Vogel-Claussen, Jens; Fuge, Jan; Faschkami, Amir; Shin, Hoen-oh; Schwerk, Nicolaus; Welte, Tobias; Wacker, Frank; Rademacher, Jessica			Computed tomography in adult patients with primary ciliary dyskinesia: Typical imaging findings	PLOS ONE			English	Article							HIGH-RESOLUTION CT; CYSTIC FIBROSIS BRONCHIECTASIS; NON-CF BRONCHIECTASIS; THIN-SECTION CT; DIAGNOSIS; ACCURACY; DISEASES; REGISTRY; SOCIETY; AGE	Objectives Among patients with non-cystic fibrosis bronchiectasis, 1-18% have an underlying diagnosis of primary ciliary dyskinesia (PCD) and it is suspected that there is under-recognition of this disease. Our intention was to evaluate the specific features of PCD seen on computed tomography (CT) in the cohort of bronchiectasis in order to facilitate the diagnosis. Materials and methods One hundred and twenty-one CTs performed in patients with bronchiectasis were scored for the involvement, type, and lobar distribution of bronchiectasis, bronchial dilatation, and bronchial wall thickening. Later, associated findings such as mucus plugging, tree in bud, consolidations, ground glass opacities, interlobular thickening, intralobular lines, situs inversus, emphysema, mosaic attenuation, and atelectasis were registered. Patients with PCD (n = 46) were compared to patients with other underlying diseases (n = 75). Results In patients with PCD, the extent and severity of the bronchiectasis and bronchial wall thickness were significantly lower in the upper lung lobes (p<0.001-p = 0.011). The lobar distribution differed significantly with a predominance in the middle and lower lobes in patients with PCD (<0.001). Significantly more common in patients with PCD were mucous plugging (p = 0.001), tree in bud (p < 0.001), atelectasis (p = 0.009), and a history of resection of a middle or lower lobe (p = 0.047). Less common were emphysematous (p = 0.003) and fibrotic (p<0.001) changes. A situs inversus (Kartagener's Syndrome) was only seen in patients with PCD (17%, p < 0.001). Conclusion Typical imaging features in PCD include a predominance of bronchiectasis in the middle and lower lobes, severe tree in bud pattern, mucous plugging, and atelectasis. These findings may help practitioners to identify patients with bronchiectasis in whom further work-up for PCD is called for.	[Dettmer, Sabine; Vogel-Claussen, Jens; Faschkami, Amir; Shin, Hoen-oh; Wacker, Frank] Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany; [Ringshausen, Felix; Fuge, Jan; Welte, Tobias; Rademacher, Jessica] Hannover Med Sch, Dept Resp Med, Hannover, Germany; [Ringshausen, Felix; Vogel-Claussen, Jens; Fuge, Jan; Shin, Hoen-oh; Welte, Tobias; Wacker, Frank] German Ctr Lung Res DZL, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Schwerk, Nicolaus] Hannover Med Sch, Dept Pediat Pneumol & Neonatol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Dettmer, S (corresponding author), Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany.	dettmer.sabine@mh-hannover.de	Rademacher, Jessica/ABG-1898-2020; schwerk, nicolaus/AAU-5676-2020; Vogel-Claussen, Jens/Q-3374-2019; Ringshausen, Felix C./AAA-9154-2021	Ringshausen, Felix C./0000-0001-9084-4968; Vogel-Claussen, Jens/0000-0001-5595-6948; Fuge, Jan/0000-0003-2926-3608				Altenburg J, 2015, NETH J MED, V73, P147; American Association of Physicists in Medicine, 2016, AD ROUT CHEST CT PRO; Barker AF, 2002, NEW ENGL J MED, V346, P1383, DOI 10.1056/NEJMra012519; BHALLA M, 1991, RADIOLOGY, V179, P783, DOI 10.1148/radiology.179.3.2027992; Cartier Y, 1999, AM J ROENTGENOL, V173, P47, DOI 10.2214/ajr.173.1.10397098; Chalmers JD, 2016, ERJ OPEN RES, V2; Coren ME, 2002, ACTA PAEDIATR, V91, P667, DOI 10.1080/080352502760069089; GRENIER P, 1986, RADIOLOGY, V161, P95, DOI 10.1148/radiology.161.1.3763889; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Kennedy MP, 2007, AM J ROENTGENOL, V188, P1232, DOI 10.2214/AJR.06.0965; Kuehni CE, 2010, EUR RESPIR J, V36, P1248, DOI 10.1183/09031936.00001010; LEE PH, 1995, CLIN RADIOL, V50, P839, DOI 10.1016/S0009-9260(05)83104-6; Lonni S, 2015, ANN AM THORAC SOC, V12, P1764, DOI 10.1513/AnnalsATS.201507-472OC; Lucas JS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01090-2016; Lucas JS, 2014, ARCH DIS CHILD, V99, P850, DOI 10.1136/archdischild-2013-304831; Milliron B, 2015, RADIOGRAPHICS, V35, P1011, DOI 10.1148/rg.2015140214; NAIDICH DP, 1982, J COMPUT ASSIST TOMO, V6, P437, DOI 10.1097/00004728-198206000-00001; Noone PG, 2004, AM J RESP CRIT CARE, V169, P459, DOI 10.1164/rccm.200303-365OC; Ooi GC, 2002, RADIOLOGY, V225, P663, DOI 10.1148/radiol.2253011575; Pasteur MC, 2010, THORAX, V65, P577, DOI 10.1136/thx.2010.142778; Rademacher J, 2015, PNEUMOLOGIE, V69, P391, DOI 10.1055/s-0034-1392254; REID LM, 1950, THORAX, V5, P233, DOI 10.1136/thx.5.3.233; REIFF DB, 1995, AM J ROENTGENOL, V165, P261, DOI 10.2214/ajr.165.2.7618537; Shah A, 2016, EUR RESPIR J, V48, P441, DOI 10.1183/13993003.00209-2016; Shah RM, 1997, AM J ROENTGENOL, V169, P375, DOI 10.2214/ajr.169.2.9242738; Shapiro AJ, 2016, PEDIATR PULM, V51, P115, DOI 10.1002/ppul.23304; Webb W. Richard, 2011, THORACIC IMAGING PUL; Werner C, 2016, EUR RESPIR J, V47, P849, DOI 10.1183/13993003.00776-2015	28	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191457	10.1371/journal.pone.0191457	http://dx.doi.org/10.1371/journal.pone.0191457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408869	Green Submitted, Green Published, gold			2022-12-26	WOS:000424302800018
J	Foshtomi, MY; Leliaert, F; Derycke, S; Willems, A; Vincx, M; Vanaverbeke, J				Foshtomi, Maryam Yazdani; Leliaert, Frederik; Derycke, Sofie; Willems, Anne; Vincx, Magda; Vanaverbeke, Jan			The effect of bio-irrigation by the polychaete Lanice conchilega on active denitrifiers: Distribution, diversity and composition of nosZ gene	PLOS ONE			English	Article							CONTINENTAL-MARGIN SEDIMENTS; BACTERIAL COMMUNITIES; MARINE-SEDIMENTS; AEROBIC DENITRIFICATION; CALLIANASSA-SUBTERRANEA; MICROBIAL COMMUNITIES; BENTHIC METABOLISM; NUTRIENT FLUXES; IMPACT; BIOTURBATION	The presence of large densities of the piston-pumping polychaete Lanice conchilega can have important consequences for the functioning of marine sediments. It is considered both an allogenic and an autogenic ecosystem engineer, affecting spatial and temporal biogeochemical gradients (oxygen concentrations, oxygen penetration depth and nutrient concentrations) and physical properties (grain size) of marine sediments, which could affect functional properties of sediment-inhabiting microbial communities. Here we investigated whether density-dependent effects of L. conchilega affected horizontal (m-scale) and vertical (cm-scale) patterns in the distribution, diversity and composition of the typical nosZgene in the active denitrifying organisms. This gene plays a major role in N2O reduction in coastal ecosystems as the last step completing the denitrification pathway. We showed that both vertical and horizontal composition and richness of nosZgene were indeed significantly affected when large densities of the bio-irrigator were present. This could be directly related to allogenic ecosystem engineering effects on the environment, reflected in increased oxygen penetration depth and oxygen concentrations in the upper cm of the sediment in high densities of L. conchilega. A higher diversity (Shannon diversity and inverse Simpson) of nosZobserved in patches with high L. conchilega densities (3,185-3,440 ind. m(-2)) at deeper sediment layers could suggest a downward transport of NO3- to deeper layers resulting from bio-irrigation as well. Hence, our results show the effect of L. conchilega bio-irrigation activity on denitrifying organisms in L. conchilega reefs.	[Foshtomi, Maryam Yazdani; Leliaert, Frederik; Derycke, Sofie; Vincx, Magda; Vanaverbeke, Jan] Univ Ghent, Biol Dept, Marine Biol Res Grp, Ghent, Belgium; [Foshtomi, Maryam Yazdani; Willems, Anne] Univ Ghent, CeMoFE, Ghent, Belgium; [Leliaert, Frederik] Bot Garden Meise, Meise, Belgium; [Derycke, Sofie] Inst Agr & Fisheries Res ILVO, Aquat Environm & Qual, Oostende, Belgium; [Willems, Anne] Univ Ghent, Dept Biochem & Microbiol, Lab Microbiol, Ghent, Belgium; [Vanaverbeke, Jan] Royal Belgian Inst Nat Sci, Operat Directorate Nat Environm OD Nat, Marine Ecol & Management, Brussels, Belgium; [Foshtomi, Maryam Yazdani] Kharazmi Univ, Fac Biol Sci, Tehran, Iran	Ghent University; Ghent University; Institute For Agricultural & Fisheries Research; Ghent University; Royal Belgian Institute of Natural Sciences; Kharazmi University	Vanaverbeke, J (corresponding author), Univ Ghent, Biol Dept, Marine Biol Res Grp, Ghent, Belgium.; Vanaverbeke, J (corresponding author), Royal Belgian Inst Nat Sci, Operat Directorate Nat Environm OD Nat, Marine Ecol & Management, Brussels, Belgium.	jvanaverbeke@naturalsciences.be	Leliaert, Frederik/A-9162-2009; Willems, Anne/B-2872-2010	Leliaert, Frederik/0000-0002-4627-7318; Willems, Anne/0000-0002-8421-2881; Vanaverbeke, Jan/0000-0003-2488-8609	Fonds voor Wetenschappelijk Onderzoek Vlaanderen [G0033.11]; Special Research Fund of Ghent University [01G01911]; Ministry of Science, Research and Technology, Iran [24-88200022]	Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); Special Research Fund of Ghent University(Ghent University); Ministry of Science, Research and Technology, Iran	Funded by Fonds voor Wetenschappelijk Onderzoek Vlaanderen. http://www.fwo.be/. Grant number G0033.11 to MV, JV, AW. Special Research Fund of Ghent University. https://www.ugent.be/nl/onderzoek/financiering/bof. Grant number 01G01911 to MV and AW. Ministry of Science, Research and Technology, Iran. https://www.msrt.ir/en. Grant number 24-88200022 to MYF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alves RMS, 2017, ESTUAR COAST SHELF S, V188, P88, DOI 10.1016/j.ecss.2017.02.012; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Bai YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037796; Bakken L., 2008, ENVIRON MICROBIOL, V10, P3070; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Bertics VJ, 2012, APPL ENVIRON MICROB, V78, P3864, DOI 10.1128/AEM.00114-12; Bertics VJ, 2009, ISME J, V3, P1269, DOI 10.1038/ismej.2009.62; Birchenough SNR, 2012, ECOL INDIC, V12, P8, DOI 10.1016/j.ecolind.2011.03.015; Bokulich NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036357; Braeckman U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018078; Braeckman U, 2010, MAR ECOL PROG SER, V399, P173, DOI 10.3354/meps08336; Braker G, 2001, APPL ENVIRON MICROB, V67, P1893, DOI 10.1128/AEM.67.4.1893-1901.2001; Callaway R, 2006, MAR ECOL PROG SER, V308, P49, DOI 10.3354/meps308049; Canfield DE, 2005, ADV MAR BIOL, V48, P65; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; De Smet B, 2016, J EXP MAR BIOL ECOL, V475, P31, DOI 10.1016/j.jembe.2015.11.005; De Smet B, 2015, ESTUAR COAST SHELF S, V152, P44, DOI 10.1016/j.ecss.2014.11.002; Decleyre H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126583; Degraer S, 2006, THE MACROBENTHOS ATL; Deutsch B, 2010, BIOGEOSCIENCES, V7, P3259, DOI 10.5194/bg-7-3259-2010; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Falk S, 2007, BIOGEOSCIENCES, V4, P255, DOI 10.5194/bg-4-255-2007; Fernandes SO, 2012, MAR ENVIRON RES, V74, P9, DOI 10.1016/j.marenvres.2011.11.008; Fish JA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00291; FORSTER S, 1995, MAR BIOL, V123, P335, DOI 10.1007/BF00353625; Foshtomi MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130116; Franco MA, 2007, AQUAT MICROB ECOL, V48, P241, DOI 10.3354/ame048241; Fulthorpe RR, 2008, ISME J, V2, P901, DOI 10.1038/ismej.2008.55; Gao H, 2010, ISME J, V4, P417, DOI 10.1038/ismej.2009.127; Gao Z, 2011, CHIN J OCEANOL LIMN, V29, P1209, DOI 10.1007/s00343-011-0316-z; Gihring TM, 2009, LIMNOL OCEANOGR, V54, P1073, DOI 10.4319/lo.2009.54.4.1073; Gilbert F, 1997, HYDROBIOLOGIA, V345, P67, DOI 10.1023/A:1002931432250; Godet L, 2008, AMBIO, V37, P347, DOI 10.1579/07-A-317.1; Graf DRH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114118; Heuers J., 1998, VERH GES OKOL, V28, P207; Howe RL, 2004, J MAR BIOL ASSOC UK, V84, P629, DOI 10.1017/S002531540400966Xh; Huang S, 2011, BIOGEOSCIENCES, V8, P3041, DOI 10.5194/bg-8-3041-2011; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Hunter EM, 2006, APPL ENVIRON MICROB, V72, P5689, DOI 10.1128/AEM.03007-05; Jantti H, 2012, AMBIO, V41, P161, DOI 10.1007/s13280-011-0233-6; Jayakumar A, 2009, MICROB ECOL, V58, P350, DOI 10.1007/s00248-009-9487-y; Jenkins BD, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1303, DOI 10.1016/B978-0-12-372522-6.00030-X; JOYE SB, 1995, SCIENCE, V270, P623, DOI 10.1126/science.270.5236.623; Kampschreur MJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00370; Kartzinel TR, 2015, P NATL ACAD SCI USA, V112, P8019, DOI 10.1073/pnas.1503283112; KNOWLES R, 1982, MICROBIOL REV, V46, P43, DOI 10.1128/MMBR.46.1.43-70.1982; Kohn RA, 2015, CABI CLIM CHANGE SER, V6, P61, DOI 10.1079/9781780644325.0061; Kristensen E, 2005, COAST ESTUAR STUD, V60, P125; Kristensen E, 2000, HYDROBIOLOGIA, V426, P1, DOI 10.1023/A:1003980226194; Laverock B, 2014, ENV MICROBIOL REP, V6, P113, DOI 10.1111/1758-2229.12115; Laverock B, 2011, BIOCHEM SOC T, V39, P315, DOI 10.1042/BST0390315; Li FY, 2010, SOIL SCI PLANT NUTR, V56, P66, DOI 10.1111/j.1747-0765.2010.00450.x; Liu BB, 2013, ENVIRON MICROBIOL, V15, P2816, DOI 10.1111/1462-2920.12142; Liu XD, 2003, APPL ENVIRON MICROB, V69, P3549, DOI 10.1128/AEM.69.6.3549-3560.2003; Marconi M., 2014, FUNGAL RNA BIOLOGY, V15, P371; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Middelburg JJ, 2009, BIOGEOSCIENCES, V6, P1273, DOI 10.5194/bg-6-1273-2009; Miller M.A., 2010, P GAT COMP ENV WORKS; Mills HJ, 2008, APPL ENVIRON MICROB, V74, P4440, DOI 10.1128/AEM.02692-07; Nizzoli D, 2006, MAR ECOL PROG SER, V315, P151, DOI 10.3354/meps315151; Papaspyrou S, 2006, MAR BIOL, V148, P541, DOI 10.1007/s00227-005-0105-3; Philippot L, 2005, CURR OPIN MICROBIOL, V8, P234, DOI 10.1016/j.mib.2005.04.003; Poulsen M, 2014, SYST APPL MICROBIOL, V37, P51, DOI 10.1016/j.syapm.2013.07.006; Props R, 2017, ISME J, V11, P584, DOI 10.1038/ismej.2016.117; Queiros AM, 2013, ECOL EVOL, V3, P3958, DOI 10.1002/ece3.769; Rabaut M, 2007, ESTUAR COAST SHELF S, V75, P525, DOI 10.1016/j.ecss.2007.05.041; Rabaut M, 2008, FISH RES, V90, P209, DOI 10.1016/j.fishres.2007.10.009; Rabaut M, 2009, HELGOLAND MAR RES, V63, P37, DOI 10.1007/s10152-008-0137-4; Read G., 2017, WORLD POLYCHAETA DAT; Sanford RA, 2012, P NATL ACAD SCI USA, V109, P19709, DOI [10.1073/pnas., 10.1073/pnas.1211238109]; Scala DJ, 1999, APPL ENVIRON MICROB, V65, P1681; Scala DJ, 2000, APPL ENVIRON MICROB, V66, P1980, DOI 10.1128/AEM.66.5.1980-1986.2000; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P6773, DOI 10.1128/AEM.00474-06; Su JJ, 2001, J APPL MICROBIOL, V90, P457, DOI 10.1046/j.1365-2672.2001.01265.x; Team RDC, 2008, R A LANGUAGE AND ENV; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tiquia SM, 2006, FEMS MICROBIOL ECOL, V58, P464, DOI 10.1111/j.1574-6941.2006.00173.x; Van Hoey G, 2008, MAR BIOL, V154, P1009, DOI 10.1007/s00227-008-0992-1; Van Hoey G, 2006, HELGOLAND MAR RES, V60, P317, DOI 10.1007/s10152-006-0041-8; Wang YF, 2013, APPL MICROBIOL BIOT, V97, P7015, DOI 10.1007/s00253-012-4430-4; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; Webb AP, 2004, MAR ECOL PROG SER, V268, P205, DOI 10.3354/meps268205; Widdicombe S, 2013, MAR POLLUT BULL, V73, P416, DOI 10.1016/j.marpolbul.2012.11.008; Wittorf L, 2016, ENV MICROBIOL REP, V8, P486, DOI 10.1111/1758-2229.12393; Wright S., 1997, PHYTOPLANKTON PIGMEN, P327; Zehr JP, 2002, APPL ENVIRON MICROB, V68, P1015, DOI 10.1128/AEM.68.3.1015-1024.2002; Zhang Y, 2014, BIOGEOSCIENCES, V11, P2131, DOI 10.5194/bg-11-2131-2014; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	92	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192391	10.1371/journal.pone.0192391	http://dx.doi.org/10.1371/journal.pone.0192391			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408934	Green Published, gold			2022-12-26	WOS:000424302800062
J	Hsiao, PJ; Lin, HC; Chang, ST; Hsu, JT; Lin, WS; Chung, CM; Chang, JJ; Hung, KC; Shih, YW; Chen, FC; Hu, FK; Wu, YS; Chang, CW; Su, SL; Chu, CM				Hsiao, Po-Jen; Lin, Hung-Che; Chang, Shih-Tai; Hsu, Jen-Te; Lin, Wei-Shiang; Chung, Chang-Min; Chang, Jung-Jung; Hung, Kuo-Chun; Shih, Yun-Wen; Chen, Fu-Chi; Hu, Fu-Kang; Wu, Yi-Syuan; Chang, Chi-Wen; Su, Sui-Lung; Chu, Chi-Ming			Albuminuria and neck circumference are determinate factors of successful accurate estimation of glomerular filtration rate in high cardiovascular risk patients	PLOS ONE			English	Article							SERUM CYSTATIN-C; METABOLIC SYNDROME; DIABETES-MELLITUS; KIDNEY-FUNCTION; GFR ESTIMATION; CREATININE; FORMULAS; COHORT; IMPACT	Background Estimated glomerular filtration rate (eGFR) is used for diagnosis of chronic kidney disease (CKD). The eGFR models based on serum creatinine or cystatin C are used more in clinical practice. Albuminuria and neck circumference are associated with CKD and may have correlations with eGFR. Aim We explored the correlations and modelling formulates among various indicators such as serum creatinine, cystatin C, albuminuria, and neck circumference for eGFR. Design Cross-sectional study. Methods We reviewed the records of patients with high cardiovascular risk from 2010 to 2011 in Taiwan. 24-hour urine creatinine clearance was used as the standard. We utilized a decision tree to select for variables and adopted a stepwise regression method to generate five models. Model 1 was based on only serum creatinine and was adjusted for age and gender. Model 2 added serum cystatin C, models 3 and 4 added albuminuria and neck circumference, respectively. Model 5 simultaneously added both albuminuria and neck circumference. Results Total 177 patients were recruited in this study. In model 1, the bias was 2.01 and its precision was 14.04. In model 2, the bias was reduced to 1.86 with a precision of 13.48. The bias of model 3 was 1.49 with a precision of 12.89, and the bias for model 4 was 1.74 with a precision of 12.97. In model 5, the bias could be lower to 1.40 with a precision of 12.53. Conclusions In this study, the predicting ability of eGFR was improved after the addition of serum cystatin C compared to serum creatinine alone. The bias was more significantly reduced by the calculation of albuminuria. Furthermore, the model generated by combined albuminuria and neck circumference could provide the best eGFR predictions among these five eGFR models. Neck circumference can be investigated potentially in the further studies.	[Hsiao, Po-Jen] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Hsiao, Po-Jen] Taoyuan Armed Forces Gen Hosp, Dept Internal Med, Div Nephrol, Taoyuan, Taiwan; [Hsiao, Po-Jen; Chu, Chi-Ming] Fu Jen Catholic Univ, Big Data Res Ctr, New Taipei, Taiwan; [Lin, Hung-Che] Triserv Gen Hosp, Natl Def Med Ctr, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Chang, Shih-Tai; Hsu, Jen-Te; Chung, Chang-Min; Chang, Jung-Jung; Hung, Kuo-Chun] Chang Gung Univ, Chang Gung Mem Hosp Linkou, Div Cardiol, Coll Med, Taoyuan, Taiwan; [Lin, Wei-Shiang] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Shih, Yun-Wen; Hu, Fu-Kang; Wu, Yi-Syuan; Su, Sui-Lung; Chu, Chi-Ming] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chen, Fu-Chi] Natl Def Med Ctr, Dept Biomed Engn, Taipei, Taiwan; [Chang, Chi-Wen] Chang Gung Univ, Coll Med, Sch Nursing, Taoyuan, Taiwan; [Chang, Chi-Wen] Linkou Chang Gung Mem Hosp, Dept Pediat, Div Endocrinol, Taoyuan, Taiwan; [Su, Sui-Lung; Chu, Chi-Ming] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chu, Chi-Ming] China Med Univ, Dept Publ Hlth, Taichung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; Fu Jen Catholic University; National Defense Medical Center; Tri-Service General Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Chang Gung University; Chang Gung Memorial Hospital; National Defense Medical Center; China Medical University Taiwan	Chu, CM (corresponding author), Fu Jen Catholic Univ, Big Data Res Ctr, New Taipei, Taiwan.; Chu, CM (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.; Chu, CM (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.; Chu, CM (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.	chuchiming@web.de	Lin, Wei-Shiang/ABA-7928-2020	Wu, Yi-Syuan/0000-0001-9609-6489				Artunc FH, 2005, INT J CARDIOL, V102, P173, DOI 10.1016/j.ijcard.2004.04.009; Baumeister SE, 2010, AM J NEPHROL, V31, P222, DOI 10.1159/000272937; Bevc S, 2012, KIDNEY BLOOD PRESS R, V35, P649, DOI 10.1159/000341918; Canales MT, 2016, AM J NEPHROL, V43, P325, DOI 10.1159/000445757; Chehade H, 2014, CLIN J AM SOC NEPHRO, V9, P54, DOI 10.2215/CJN.00940113; Cho Nam H, 2015, Sci Rep, V5, P18565, DOI 10.1038/srep18565; Delanaye P, 2008, CLIN CHIM ACTA, V398, P118, DOI 10.1016/j.cca.2008.09.001; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Ebert N, 2016, CLIN CHIM ACTA, V456, P115, DOI 10.1016/j.cca.2016.03.002; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ferraro S, 2016, CLIN CHEM LAB MED, V54, P1629, DOI 10.1515/cclm-2015-1272; Go AS, 2007, NEW ENGL J MED, V351, P1296; Hoebel S, 2012, ENDOCRINE, V42, P335, DOI 10.1007/s12020-012-9642-y; Hofstra JM, 2009, KIDNEY INT, V76, P462, DOI 10.1038/ki.2009.167; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liang J, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0107-x; Lin MY, 2010, NEPHROL DIAL TRANSPL, V25, P3230, DOI 10.1093/ndt/gfq158; Liu YF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/745410; Ma YC, 2007, KIDNEY INT, V72, P1535, DOI 10.1038/sj.ki.5002566; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Peralta CA, 2015, AM J NEPHROL, V42, P141, DOI 10.1159/000439231; Pontillo C, 2016, NEPHROL DIAL TRANSPL; Rule AD, 2009, AM J KIDNEY DIS, V53, P932, DOI 10.1053/j.ajkd.2009.02.011; Stabe C, 2013, CLIN ENDOCRINOL, V78, P874, DOI 10.1111/j.1365-2265.2012.04487.x; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Tidman M, 2008, NEPHROL DIAL TRANSPL, V23, P154, DOI 10.1093/ndt/gfm661; White C, 2005, J AM SOC NEPHROL, V16, P3763, DOI 10.1681/ASN.2005050512	27	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0185693	10.1371/journal.pone.0185693	http://dx.doi.org/10.1371/journal.pone.0185693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394255	gold, Green Submitted, Green Published			2022-12-26	WOS:000424060400003
J	Liu, JC; Yu, Y; Zhu, SY; Yang, JK; Song, J; Fan, W; Yu, HB; Bian, DJ; Huo, MX				Liu, Jiancong; Yu, Yang; Zhu, Suiyi; Yang, Jiakuan; Song, Jian; Fan, Wei; Yu, Hongbin; Bian, Dejun; Huo, Mingxin			Synthesis and characterization of a magnetic adsorbent from negatively-valued iron mud for methylene blue adsorption	PLOS ONE			English	Article							ASCORBIC-ACID; RED MUD; FE3O4 NANOPARTICLES; PHASE-TRANSFORMATION; OXIDE NANOPARTICLES; TREATMENT SLUDGE; FERRIC-OXIDE; ONE-POT; REDUCTION; WASTE	With increasing awareness of reduction of energy and CO2 footprint, more waste is considered recyclable for generating value-added products. Here we reported the negatively-valued iron mud, a waste from groundwater treatment plant, was successfully converted into magnetic adsorbent. Comparing with the conventional calcination method under the high temperature and pressure, the synthesis of the magnetic particles (MPs) by Fe2+/Fe3+ coprecipitation was conducted at environment-friendly condition using ascorbic acid (H(2)A) as reduction reagent and nitric acid (or acid wastewater) as leaching solution. The MPs with major component of Fe3O4 were synthesized at the molar ratio (called ratio subsequently) of H(2)A to Fe3+ of iron mud >= 0.1; while amorphous ferrihydrite phase was formed at the ratio <= 0.05, which were confirmed by vibrating sample magnetometer (VSM), X-ray diffraction (XRD) and X-ray photoelectron spectroscopy (XPS). With the ratio increased, the crystalline size and the crystallization degree of MPs increased, and thus the Brunauer-Emmett-Teller (BET) surface and the cation-exchange capacity (CEC) decreased. MPs-3 prepared with H(2)A to Fe3+ ratio of 0.1 demonstrated the highest methylene blue (MB) adsorption of 87.3 mg/g and good magnetic response. The adsorption of MB onto MPs agreed well with the non-linear Langmuir isotherm model and the pseudo-second-order model. Pilot-scale experiment showed that 99% of MB was removed by adding 10 g/L of MPs-3. After five adsorption-desorption cycles, MPs-3 still showed 62% removal efficiency for MB adsorption. When nitric acid was replaced by acid wastewater from a propylene plant, the synthesized MPs-3w showed 3.7 emu/g of saturation magnetization (Ms) and 56.7 mg/g of MB adsorption capacity, 2.8 times of the widely used commercial adsorbent of granular active carbon (GAC). The major mechanism of MPs adsorption for MB was electrostatic attraction and cation exchange. This study synthesized a magnetic adsorbent from the negatively-valued iron mud waste by using an environment-friendly coprecipitation method, which had a potential for treatment of dye wastewater.	[Liu, Jiancong; Yu, Yang; Zhu, Suiyi; Fan, Wei; Yu, Hongbin; Bian, Dejun; Huo, Mingxin] Northeast Normal Univ, Sci & Technol Innovat Ctr Municipal Wastewater Tr, Changchun, Jilin, Peoples R China; [Yu, Yang] Jilin Jianzu Univ, Minist Educ, Key Lab Songliao Aquat Environm, Changchun, Jilin, Peoples R China; [Zhu, Suiyi; Yu, Hongbin; Huo, Mingxin] Northeast Normal Univ, Engn Lab Water Pollut Control & Resources Recover, Changchun, Jilin, Peoples R China; [Yang, Jiakuan; Song, Jian] Huazhong Univ Sci & Technol, Sch Environm Sci & Engn, Wuhan, Hubei, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Huazhong University of Science & Technology	Huo, MX (corresponding author), Northeast Normal Univ, Sci & Technol Innovat Ctr Municipal Wastewater Tr, Changchun, Jilin, Peoples R China.; Huo, MX (corresponding author), Northeast Normal Univ, Engn Lab Water Pollut Control & Resources Recover, Changchun, Jilin, Peoples R China.	papermanuscript@126.com; huomx097@nenu.edu.cn	yu, yang/W-5426-2019; Zhu, Suiyi/AAD-7613-2021	yu, yang/0000-0001-8342-9299; Yang, Jiakuan/0000-0002-1553-5679; Fan, Wei/0000-0001-7232-7668; Suiyi, Zhu/0000-0002-9784-2698	National Natural Science Foundation of China [51578118, 51238001, 51408110, 51378098]; Major Science and Technology Program for Water Pollution Control and Treatment of China [2014ZX07201-011-004-2]; Jilin Provincial Natural Science Foundation [20150101072JC]; Long-term Program in "1000 Talent Plan for High-Level Foreign Experts" [WQ20142200209]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Program for Water Pollution Control and Treatment of China; Jilin Provincial Natural Science Foundation; Long-term Program in "1000 Talent Plan for High-Level Foreign Experts"	This work was supported by the National Natural Science Foundation of China (Granted No.51578118, 51238001, 51408110 and 51378098), the Major Science and Technology Program for Water Pollution Control and Treatment of China (Granted No. 2014ZX07201-011-004-2), the Jilin Provincial Natural Science Foundation (Granted No. 20150101072JC) and the Long-term Program in 1000 Talent Plan for High-Level Foreign Experts (Granted No. WQ20142200209).	Akin I, 2012, J HAZARD MATER, V235, P62, DOI [10.1016/j.jhazmat2012.06.024, 10.1016/j.jhazmat.2012.06.024]; Alibeigi S, 2008, CHEM ENG TECHNOL, V31, P1591, DOI 10.1002/ceat.200800093; Allen SJ, 2004, J COLLOID INTERF SCI, V280, P322, DOI 10.1016/j.jcis.2004.08.078; Bai LJ, 1997, ACTA BIOCH BIOPH SIN, V29, P527; BLANCHARD JM, 1981, RESOUR CONSERV, V6, P21, DOI 10.1016/0166-3097(81)90004-3; BODE AM, 1990, CLIN CHEM, V36, P1807; Chang Z, 2001, CHIN J INORG CHEM, V17, P366; Chen FX, 2013, MATER LETT, V112, P177, DOI 10.1016/j.matlet.2013.09.022; Costa RCC, 2010, CHEMOSPHERE, V78, P1116, DOI 10.1016/j.chemosphere.2009.12.032; Elovich SY, 1962, B ACAD SCI USSR DIV, V11, P198, DOI [10.1007/BF00908017, DOI 10.1007/BF00908017]; Fredrickson JK, 2001, ENVIRON SCI TECHNOL, V35, P703, DOI 10.1021/es001500v; GHOSH SK, 1989, INORG CHEM, V28, P1538, DOI 10.1021/ic00307a023; Gong XM, 2014, CHINESE SCI BULL, V59, P3904, DOI 10.1007/s11434-014-0520-2; Gupta H, 2014, J COLLOID INTERF SCI, V430, P221, DOI 10.1016/j.jcis.2014.05.043; HILLS CD, 1992, CEMENT CONCRETE RES, V22, P822, DOI 10.1016/0008-8846(92)90106-6; Hou XJ, 2016, J HAZARD MATER, V310, P170, DOI 10.1016/j.jhazmat.2016.01.020; Iida H, 2007, J COLLOID INTERF SCI, V314, P274, DOI 10.1016/j.jcis.2007.05.047; Jia YF, 2006, ENVIRON SCI TECHNOL, V40, P3248, DOI 10.1021/es051872+; Khorasani-Motlagh M, 2010, J IRAN CHEM SOC, V7, pS113, DOI 10.1007/BF03246190; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Li F. W., 2009, J WATER RESOURCE PRO, V1, P35; Li XB, 2015, T NONFERR METAL SOC, V25, P3467, DOI 10.1016/S1003-6326(15)63984-X; Liu YY, 2014, THERMOCHIM ACTA, V588, P11, DOI 10.1016/j.tca.2014.04.027; Man Y, 2016, POWDER TECHNOL, V301, P674, DOI 10.1016/j.powtec.2016.06.013; Mayes WM, 2016, J SUSTAIN METALL, V2, P332, DOI 10.1007/s40831-016-0050-z; Nene AG, 2016, J NANO RES-SW, V40, P8, DOI 10.4028/www.scientific.net/JNanoR.40.8; Ngatenah SNI, 2010, INT C ENV ICENV PEN; Ovchinnikov OV, 2016, VIB SPECTROSC, V86, P181, DOI 10.1016/j.vibspec.2016.06.016; Tran PHL, 2012, ARCH PHARM RES, V35, P2045, DOI 10.1007/s12272-012-1203-7; Ramasamy V, 2008, SPECTROCHIM ACTA A, V70, P25, DOI 10.1016/j.saa.2007.07.008; Sajih M, 2014, GEOCHIM COSMOCHIM AC, V146, P150, DOI 10.1016/j.gca.2014.10.008; Sales A, 2009, CONSTR BUILD MATER, V23, P2362, DOI 10.1016/j.conbuildmat.2008.11.001; Shao Z., 1984, Acta Pedologica Sinica, V21, P153; Simpson GLW, 2000, BBA-MOL BASIS DIS, V1501, P12, DOI 10.1016/S0925-4439(00)00009-0; Snehalatha T, 1997, J CHEM EDUC, V74, P228, DOI 10.1021/ed074p228; Sushil S, 2010, J HAZARD MATER, V180, P409, DOI 10.1016/j.jhazmat.2010.04.046; TAKAMURA K, 1977, CHEM PHARM BULL, V25, P3218; Wu S, 2011, MATER LETT, V65, P1882, DOI 10.1016/j.matlet.2011.03.065; Wu SP, 2007, MATER LETT, V61, P1125, DOI 10.1016/j.matlet.2006.06.068; Yan H, 2011, COLLOID SURFACE A, V380, P143, DOI 10.1016/j.colsurfa.2011.02.045; Yang K, 2010, APPL SURF SCI, V256, P3093, DOI 10.1016/j.apsusc.2009.11.079; Yang WB, 1996, CHINESE J ANAL CHEM, V24, P828; Yu Y, 2017, FUEL, V203, P187, DOI 10.1016/j.fuel.2017.04.118; Yukselen-Aksoy Y, 2008, ENG GEOL, V102, P38, DOI 10.1016/j.enggeo.2008.07.002; Zhang C, 2016, CHEM ENG J, V284, P247, DOI 10.1016/j.cej.2015.08.096; Zhu SY, 2015, J HAZARD MATER, V292, P173, DOI 10.1016/j.jhazmat.2015.03.028; Zong Y, 2017, J MAGN MAGN MATER, V423, P321, DOI 10.1016/j.jmmm.2016.09.132; Zuhaimi NAS, 2015, APPL CATAL A-GEN, V502, P312, DOI 10.1016/j.apcata.2015.06.024	48	22	22	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191229	10.1371/journal.pone.0191229	http://dx.doi.org/10.1371/journal.pone.0191229			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394262	gold, Green Submitted, Green Published			2022-12-26	WOS:000424060400010
J	Matsuguma, S; Kawashima, M; Negishi, K; Sano, F; Mimura, M; Tsubota, K				Matsuguma, Shinichiro; Kawashima, Motoko; Negishi, Kazuno; Sano, Fumiya; Mimura, Masaru; Tsubota, Kazuo			Strengths use as a secret of happiness: Another dimension of visually impaired individuals' psychological state	PLOS ONE			English	Article							QUALITY-OF-LIFE; MENTAL-HEALTH; IMPACT; POPULATION; RELIABILITY; ASSOCIATION; PREVALENCE	It is well recognized that visual impairments (VI) worsen individuals' mental condition. However, little is known about the positive aspects including subjective happiness, positive emotions, and strengths. Therefore, the purpose of this study was to investigate the positive aspects of persons with VI including their subjective happiness, positive emotions, and strengths use. Positive aspects of persons with VI were measured using the Subjective Happiness Scale (SHS), the Scale of Positive and Negative Experience-Balance (SPANE-B), and the Strengths Use Scale (SUS). A cross-sectional analysis was utilized to examine personal information in a Tokyo sample (N = 44). We used a simple regression analysis and found significant relationships between the SHS or SPANE-B and SUS; on the contrary, VI-related variables were not correlated with them. A multiple regression analysis confirmed that SUS was a significant factor associated with both the SHS and SPANE-B. Strengths use might be a possible protective factor from the negative effects of VI.	[Matsuguma, Shinichiro; Kawashima, Motoko; Negishi, Kazuno; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo, Japan; [Sano, Fumiya] Keio Univ Hosp, Clin & Translat Res Ctr, Shinjuku Ku, Tokyo, Japan; [Mimura, Masaru] Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, Tokyo, Japan	Keio University; Keio University; Keio University	Kawashima, M (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo, Japan.	motoko-k@a3.keio.jp	Negishi, Kazuno/AAG-3260-2021; Tsubota, Kazuo/M-1915-2013	Negishi, Kazuno/0000-0002-2892-9810; Tsubota, Kazuo/0000-0002-8874-7111; Kawashima, Motoko/0000-0001-7650-7180				[Anonymous], JPN J RES EMOT; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Biswas-Diener R, 2011, J POSIT PSYCHOL, V6, P106, DOI 10.1080/17439760.2010.545429; Broman AT, 2002, INVEST OPHTH VIS SCI, V43, P3393; Cho GE, 2015, INVEST OPHTH VIS SCI, V56, P4375, DOI 10.1167/iovs.15-16462; Diener E, 2010, SOC INDIC RES, V97, P143, DOI 10.1007/s11205-009-9493-y; Douglass RP, 2015, J HAPPINESS STUD, V16, P619, DOI 10.1007/s10902-014-9525-4; Dunn D.S., 2013, OXFORD HDB POSITIVE, P427, DOI [DOI 10.1093/OXFORDHB/9780195398786.013.013.0026, 10.1093/oxfordhb/9780195398786.013.013.0026]; Gander F, 2013, J HAPPINESS STUD, V14, P1241, DOI 10.1007/s10902-012-9380-0; Ghielen STS, 2018, J POSIT PSYCHOL, V13, P573, DOI 10.1080/17439760.2017.1365164; Govindji R., 2007, INT COACHING PSYCHOL, V2, p143?153, DOI DOI 10.1037/T01038-000; Hodges T.D., 2004, POSITIVE PSYCHOL PRA, V1, P256, DOI [10.1002/9780470939338.ch16, DOI 10.1002/9780470939338.CH16]; Huppert FA, 2003, BRIT J HEALTH PSYCH, V8, P107, DOI 10.1348/135910703762879246; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Kawashima M, 2016, JPN J OPHTHALMOL, V60, P219, DOI 10.1007/s10384-016-0437-1; Keyes CLM, 2005, J CONSULT CLIN PSYCH, V73, P539, DOI 10.1037/0022-006X.73.3.539; Keyes CLM, 2002, J HEALTH SOC BEHAV, V43, P207, DOI 10.2307/3090197; Lam BL, 2008, ARCH OPHTHALMOL-CHIC, V126, P975, DOI 10.1001/archopht.126.7.975; Layous K., 2014, POSITIVE EMOTION INT, P472, DOI [10.1093/acprof:oso/9780199926725.003.0025, DOI 10.1093/ACPROF:OSO/9780199926725.003.0025]; Li FZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054801, 10.1371/journal.pone.0056303, 10.1371/journal.pone.0061137]; Linley PA, 2006, PSYCHOLOGIST, V19, P86; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; Mangione CM, 1999, AM J OPHTHALMOL, V128, P45, DOI 10.1016/S0002-9394(99)00169-5; Ribeiro MVMR, 2015, ARQ BRAS OFTALMOL, V78, P197, DOI 10.5935/0004-2749.20150051; Nakae K MK, 2006, GERIATR MED, V44, P1221; Papadopoulos K, 2015, REHABIL COUNS BULL, V58, P240, DOI 10.1177/0034355214535471; Papadopoulos K, 2013, RES DEV DISABIL, V34, P4565, DOI 10.1016/j.ridd.2013.09.036; Peters ML, 2017, CLIN J PAIN, V33, P962, DOI 10.1097/AJP.0000000000000494; PETERSON CHRISTOPHER, 2004, CHARACTER STRENGTHS; Scott IU, 1999, AM J OPHTHALMOL, V128, P54, DOI 10.1016/S0002-9394(99)00108-7; Seligman MEP, 2006, AM PSYCHOL, V61, P774, DOI 10.1037/0003-066X.61.8.774; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Shimai Satoshi, 2004, Nihon Koshu Eisei Zasshi, V51, P845; STEINBERG EP, 1994, ARCH OPHTHALMOL-CHIC, V112, P630, DOI 10.1001/archopht.1994.01090170074026; Sumi K, 2014, SOC INDIC RES, V118, P601, DOI 10.1007/s11205-013-0432-6; Swanson MW, 2004, OPHTHAL EPIDEMIOL, V11, P227, DOI 10.1080/09286580490514540; Wang JJ, 1999, INVEST OPHTH VIS SCI, V40, P12; Wood AM, 2011, PERS INDIV DIFFER, V50, P15, DOI 10.1016/j.paid.2010.08.004; Yamada M, 2010, OPHTHAL EPIDEMIOL, V17, P50, DOI 10.3109/09286580903450346	39	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192323	10.1371/journal.pone.0192323	http://dx.doi.org/10.1371/journal.pone.0192323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389991	Green Published, gold, Green Submitted			2022-12-26	WOS:000423793400087
J	Belkhiria, J; Hijmans, RJ; Boyce, W; Crossley, BM; Martinez-Lopez, B				Belkhiria, Jaber; Hijmans, Robert J.; Boyce, Walter; Crossley, Beate M.; Martinez-Lopez, Beatriz			Identification of high risk areas for avian influenza outbreaks in California using disease distribution models	PLOS ONE			English	Article							EURASIAN H5N8; POULTRY; VIRUS; SURVEILLANCE; SUITABILITY; BIRDS	The coexistence of different types of poultry operations such as free range and backyard flocks, large commercial indoor farms and live bird markets, as well as the presence of many areas where wild and domestic birds co-exist, make California susceptible to avian influenza outbreaks. The 2014-2015 highly pathogenic Avian Influenza (HPAI) outbreaks affecting California and other states in the United States have underscored the need for solutions to protect the US poultry industry against this devastating disease. We applied disease distribution models to predict where Avian influenza is likely to occur and the risk for HPAI outbreaks is highest. We used observations on the presence of Low Pathogenic Avian influenza virus (LPAI) in waterfowl or water samples at 355 locations throughout the state and environmental variables relevant to the disease epidemiology. We used two algorithms, Random Forest and MaxEnt, and two data-sets Presence-Background and Presence-Absence data. The models performed well (AUCc > 0.7 for testing data), particularly those using Presence-Background data (AUCc > 0.85). Spatial predictions were similar between algorithms, but there were large differences between the predictions with PresenceAbsence and Presence-Background data. Overall, predictors that contributed most to the models included land cover, distance to coast, and broiler farm density. Models successfully identified several counties as high-to-intermediate risk out of the 8 counties with observed outbreaks during the 2014-2015 HPAI epizootics. This study provides further insights into the spatial epidemiology of AI in California, and the high spatial resolution maps may be useful to guide risk-based surveillance and outreach efforts.	[Belkhiria, Jaber; Martinez-Lopez, Beatriz] Univ Calif Davis, Ctr Anim Dis Modeling & Surveillance, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA; [Hijmans, Robert J.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Boyce, Walter] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Crossley, Beate M.] Univ Calif Davis, Sch Vet Med, Calif Anim Hlth & Food Safety Lab, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Belkhiria, J (corresponding author), Univ Calif Davis, Ctr Anim Dis Modeling & Surveillance, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA.	Jabelkhiria@ucdavis.edu	Lopez, Beatriz Martinez/AAE-6692-2021; Belkhiria, jaber/HII-5497-2022	Belkhiria, jaber/0000-0002-8522-8754	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture [2015-09118]; UC Davis Academic Senate Faculty Research Grant;  [NIH: CEIRS-HHSN272201400008C];  [HHSN266200700010C]	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture; UC Davis Academic Senate Faculty Research Grant; ; 	The proposed project was funded by the Agriculture and Food Research Initiative Competitive Grant no. 2015-09118 from the USDA National Institute of Food and Agriculture and a UC Davis Academic Senate Faculty Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to specially thank Dr. Zin Htway for providing the water sampling data used in this study. We would like to thank all researchers that helped collecting analyzing and making AIV data free and available online (project supported in part by funding from NIH: CEIRS-HHSN272201400008C and HHSN266200700010C.)	AlKhamis MA, 2016, USE SPATIAL SPATIO T; Alkhamis M, 2016, AVIAN DIS, V60, P146, DOI 10.1637/11106-042115-Reg; [Anonymous], 2012, CROSS VALIDATION SPE; Artois J, 2017, STOCH ENV RES RISK A, V31, P393, DOI 10.1007/s00477-016-1362-z; Audubon, IMPORTANT BIRD AREAS; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Belkhiria J, 2016, SCI REP-UK, V6, DOI 10.1038/srep33161; Bevins SN, 2016, SCI REPORTS, V6, P152; Bouwstra R, 2017, EMERG INFECT DIS, V23, P1510, DOI 10.3201/eid2309.170276; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Calfire-Frap, CALF LAND COV DAT; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; DeLiberto TJ, 2009, INTEGR ZOOL, V4, P426, DOI 10.1111/j.1749-4877.2009.00180.x; ELITH J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI [DOI 10.1146/ANNUREV.EC0LSYS.110308.120159, 10.1146/annurev.ecolsys.110308.120159, DOI 10.1146/ANNUREV.ECOLSYS.110308.120159]; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; ESRI E, 2009, ARCGIS DESKT REL 10; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Gilbert M, 2012, SPAT SPATIO-TEMPORAL, V3, P173, DOI 10.1016/j.sste.2012.01.002; Greene J.L., 2015, R44114 C RES SERV; Herrick KA, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-42; Hijmans R.J., 2021, DISMO SPECIES DISTRI; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill NJ, 2010, AVIAN DIS, V54, P426, DOI 10.1637/8912-043009-Reg.1; Htway ZM, 2016, J NATURAL SCI; Htway ZM, 2014, THESIS; Lee YJ, 2014, EMERG INFECT DIS, V20, P1087, DOI 10.3201/eid2006.140233; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; Mete A, 2013, AVIAN DIS, V57, P311, DOI 10.1637/10382-092312-Case.1; Moriguchi S, 2013, DIVERS DISTRIB, V19, P78, DOI 10.1111/ddi.12006; Pasick J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09484; Paul M, 2010, VET RES, V41, DOI 10.1051/vetres/2009076; Paul MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101958; Pearce JM, 2011, MOL ECOL, V20, P1015, DOI 10.1111/j.1365-294X.2010.04908.x; Peterson A. Townsend, 2004, Rev. Soc. Bras. Med. Trop., V37, P10, DOI 10.1590/S0037-86822004000100003; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Ramey Am, SURVEILLANCE HIGHLY; Russell CA, 2016, SCIENCE, V354, P174, DOI 10.1126/science.aaj1646; Sanchez-Mercado AY, 2010, MAPPING SPECIES DIST; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; State of California DOC, CAL IMP FARML FIND; Stevens KB, 2013, SPAT SPATIO-TEMPORAL, V4, P1, DOI 10.1016/j.sste.2012.11.002; Stoute S, 2016, AVIAN DIS, V60, P688, DOI 10.1637/11314-110615-Case.1; United States Department of Agriculture, 2015, AV INFL REP TECHN RE; United States Geological Survey, NAT MAP SMALL SCAL; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Veits J, 2012, P NATL ACAD SCI USA, V109, P2579, DOI 10.1073/pnas.1109397109; Wells SJ, 2015, EPIDEMIOLOGIC INVEST	50	17	17	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0190824	10.1371/journal.pone.0190824	http://dx.doi.org/10.1371/journal.pone.0190824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385158	Green Published, Green Submitted, gold			2022-12-26	WOS:000423668400026
J	Yang, XY; Wang, J; Zhou, ZW; Jiang, R; Huang, J; Chen, LL; Cao, ZL; Chu, H; Han, B; Cheng, YS; Chao, J				Yang, Xiyue; Wang, Jing; Zhou, Zewei; Jiang, Rong; Huang, Jie; Chen, Lulu; Cao, Zhouli; Chu, Han; Han, Bing; Cheng, Yusi; Chao, Jie			Silica-induced initiation of circular ZC3H4 RNA/ZC3H4 pathway promotes the pulmonary macrophage activation	FASEB JOURNAL			English	Article						miR-212; migration; silicosis; inflammation; circRNA	ZINC-FINGER PROTEIN; FIBROSIS; MCPIP1; RNAS; TRANSPLANTATION; INHIBITION; REVEALS; CANCER	Phagocytosis of silicon dioxide (SiO2) into lung cells causes an inflammatory cascade that results in fibroblast proliferation and migration, followed by fibrosis. Circular RNAs (circRNAs) are a subclass of noncoding RNAs that are present within mammalian cells; however, researchers have not determined whether circRNAs are involved in the pathophysiologic process of silicosis. To elucidate the role of these RNAs in SiO2 induced inflammation in pulmonary macrophages, we investigated the upstream molecular mechanisms and functional effects of circRNAs on cell apoptosis, proliferation, and migration. Primary cultures of alveolar macrophages from healthy donors and from patients and the RAW264.7 macrophage cell line were used to explore the functions of circZC3H4 RNA in macrophage activation. The experimental results indicated the following: 1) SiO2 concomitantly increased circZC3H4 RNA expression and increased ZC3H4 protein levels; 2) circular ZC3H4 (circZC3H4) RNA and ZC3H4 protein participated in SiO2 -induced macrophage activation; and 3) SiO2-activated macrophages promoted fibroblast proliferation and migration via the circZC3H4 RNA/ZC3H4 pathway. The up-regulation of the ZC3H4 protein was confirmed in tissue samples from patients with silicosis. Our study elucidates a link between SiO2 -induced macrophage activation and the circZC3H4 RNA/ZC3H4 pathway, thereby providing novel insight into the potential use of ZC3H4 to develop novel therapeutic strategies for silicosis.	[Yang, Xiyue; Wang, Jing; Zhou, Zewei; Jiang, Rong; Huang, Jie; Chen, Lulu; Cao, Zhouli; Chu, Han; Cheng, Yusi; Chao, Jie] Southeast Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China; [Yang, Xiyue; Zhou, Zewei; Jiang, Rong; Chao, Jie] Southeast Univ, Zhongda Hosp, Dept Respirat, Nanjing, Jiangsu, Peoples R China; [Yang, Xiyue; Zhou, Zewei; Han, Bing] Southeast Univ, Sch Med, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Yang, Xiyue; Zhou, Zewei; Jiang, Rong; Chen, Lulu; Chu, Han; Chao, Jie] Southeast Univ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China; Southeast University - China	Chao, J (corresponding author), Southeast Univ, Sch Med, Dept Physiol, 87 Dingjiaqiao Rd, Nanjing 210009, Jiangsu, Peoples R China.	chaojie@seu.edu.cn	Jie, Chao/J-1004-2019	Jie, Chao/0000-0002-7800-3557	National Natural Science Foundation of China [81773796]; National Key R&D Program of China [2017YFA0104303]; Natural Science Foundation of Jiangsu Province [BK20141347]; Postgraduate Research and Practice Innovation Program of Jiangsu Province [KYCX17-0165]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Postgraduate Research and Practice Innovation Program of Jiangsu Province	This work was supported by the National Natural Science Foundation of China (Grant 81773796) and the National Key R&D Program of China (Grant 2017YFA0104303), the Natural Science Foundation of Jiangsu Province (Grant BK20141347), and the Postgraduate Research and Practice Innovation Program of Jiangsu Province (Grant KYCX17-0165). The authors declare no conflicts of interest.	Adegunsoye A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/510105; Armakola M, 2012, NAT GENET, V44, P1302, DOI 10.1038/ng.2434; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Boeckel JN, 2015, CIRC RES, V117, P884, DOI 10.1161/CIRCRESAHA.115.306319; Cao ZL, 2017, CELL DEATH DIS, V8, DOI 10.1038/s41419-017-0017-4; Carneiro PJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00159; Chao J, 2015, J INVEST DERMATOL, V135, P2944, DOI 10.1038/jid.2015.334; Cortes-Lopez Mariela, 2016, Yale Journal of Biology and Medicine, V89, P527; Cui XL, 2016, BIOMARK MED, V10, P943, DOI 10.2217/bmm-2016-0130; Daskalova E, 2006, EVOL BIOINFORM, V2, P103; Dong R, 2017, RNA BIOL, V14, P1064, DOI 10.1080/15476286.2016.1269999; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Gordon S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0392-4; Guarnerio J, 2016, CELL, V165, P289, DOI 10.1016/j.cell.2016.03.020; Gungen AC, 2016, RESPIR MED CASE REP, V18, P93, DOI 10.1016/j.rmcr.2016.04.011; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Impellizzeri D, 2015, BRIT J NUTR, V114, P853, DOI 10.1017/S0007114515002597; Jin X, 2016, ONCOTARGET, V7, P66455, DOI 10.18632/oncotarget.12186; Jura J, 2012, BBA-MOL CELL RES, V1823, P1905, DOI 10.1016/j.bbamcr.2012.06.029; Lasda E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148407; Li ZY, 2017, NAT STRUCT MOL BIOL, V24, P194, DOI 10.1038/nsmb0217-194a; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Liu H, 2016, J BIORESOURCES BIOPR, V1, P55; Liu Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep22572; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Miao RM, 2016, J THORAC DIS, V8, P329, DOI 10.21037/jtd.2016.02.46; Mosser D. M., 2008, CURR PROTOC IMMUNOL, V83; Murthy S, 2015, FASEB J, V29, P3527, DOI 10.1096/fj.15-271304; Pollard KM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00097; Rosengarten D, 2017, AM J IND MED, V60, P248, DOI 10.1002/ajim.22687; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Sziksz E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/764641; Talhouarne GJS, 2014, RNA, V20, P1476, DOI 10.1261/rna.045781.114; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wang K, 2016, EUR HEART J, V37, P2602, DOI 10.1093/eurheartj/ehv713; Wang XG, 2016, TOXICOL SCI, V151, P126, DOI 10.1093/toxsci/kfw029; Westholm JO, 2014, CELL REP, V9, P1966, DOI 10.1016/j.celrep.2014.10.062; Xie HJ, 2016, ONCOTARGET, V7, P26680, DOI 10.18632/oncotarget.8589; Yang CB, 2015, CRIT REV EUKAR GENE, V25, P77, DOI 10.1615/CritRevEukaryotGeneExpr.2015013022; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017; Zhao MM, 2013, MOL MED REP, V8, P741, DOI 10.3892/mmr.2013.1580; Zheng QP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11215; Zhou ZW, 2018, THERANOSTICS, V8, P575, DOI 10.7150/thno.21648	46	64	68	2	45	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3264	3277		10.1096/fj.201701118R	http://dx.doi.org/10.1096/fj.201701118R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401612				2022-12-26	WOS:000432546000030
J	Zhao, LL; Wang, XB; Yu, Y; Deng, L; Chen, L; Peng, XP; Jiao, CC; Gao, GL; Tan, X; Pan, WJ; Ge, X; Wang, P				Zhao, Linlin; Wang, Xinbo; Yu, Yue; Deng, Lu; Chen, Lei; Peng, Xiaoping; Jiao, Chenchen; Gao, Guoli; Tan, Xiao; Pan, Weijuan; Ge, Xin; Wang, Ping			OTUB1 protein suppresses mTOR complex 1 (mTORC1) activity by deubiquitinating the mTORC1 inhibitor DEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-TRCP; CELL-PROLIFERATION; SIGNALING PATHWAYS; COLORECTAL-CANCER; UBIQUITIN CODE; POOR-PROGNOSIS; ER-ALPHA; ENZYMES; DEGRADATION; GROWTH	Mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) integrates various environmental signals to regulate cell growth and metabolism. DEPTOR, also termed DEPDC6, is an endogenous inhibitor of mTORC1 and mTORC2 activities. The abundance of DEPTOR centrally orchestrates the mTOR signaling network. However, the mechanisms by which DEPTOR stability is regulated are still elusive. Here, we report that OTU domain-containing ubiquitin aldehyde-binding protein 1 (OTUB1) specifically deubiquitinates DEPTOR in a deubiquitination assay. We found that OTUB1 directly interacted with DEPTOR via its N-terminal domain, deubiquitinated DEPTOR, and there by stabilized DEPTOR in a Cys-91-independent but Asp-88-dependent manner, suggesting that OTUB1 targets DEPTOR for deubiquitination via a deubiquitinase activity-independent non-canonical mechanism. The interaction between OTUB1 and DEPTOR was enhanced when the cells were treated with amino acids. Moreover, OTUB1 suppressed amino acid-induced activation of mTORC1 in a DEPTOR-dependent manner and thereby ultimately controlled cellular autophagy, cell proliferation, and size. Our findings reveal a mechanism that stabilizes the mTORC1 inhibitor DEPTOR via OTUB1's deubiquitinase activity. Our insights may inform research into various mTOR activity-related diseases, such as cancer, and may contribute to the identification of new diagnostic markers and therapeutic strategies for cancer treatments.	[Zhao, Linlin; Wang, Xinbo; Yu, Yue; Pan, Weijuan] East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [Zhao, Linlin; Wang, Xinbo; Yu, Yue; Pan, Weijuan] East China Normal Univ, Sch Life Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [Deng, Lu; Chen, Lei; Peng, Xiaoping; Jiao, Chenchen; Tan, Xiao; Wang, Ping] Tongji Univ, Sch Life Sci & Technol, Sch Med, Dept Cent Lab,Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China; [Ge, Xin] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Clin Lab Med, Shanghai 200072, Peoples R China; [Gao, Guoli] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	East China Normal University; East China Normal University; Tongji University; Tongji University; Tongji University	Wang, P (corresponding author), Tongji Univ, Sch Life Sci & Technol, Sch Med, Dept Cent Lab,Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China.; Ge, X (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Clin Lab Med, Shanghai 200072, Peoples R China.	xin.ge@tongji.edu.cn; wangp@tongji.edu.cn			National Key Research and Development Program of China [2016YFC0902102]; National Natural Science Foundation of China [81625019, 91440104, 91519322, 81402417]; Science Technology Commission of Shanghai Municipality [16JC1404500]; Fundamental Research Funds for the Central Universities [1501219106, 1500219121, 1500219133]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Key Research and Development Program of China Grant 2016YFC0902102; National Natural Science Foundation of China Grants 81625019, 91440104, 91519322, and 81402417; Science Technology Commission of Shanghai Municipality Grant 16JC1404500; and Fundamental Research Funds for the Central Universities Grants 1501219106, 1500219121, and 1500219133. The authors declare that they have no conflicts of interest with the contents of this article.	Chen L, 2016, ONCOL REP, V35, P1049, DOI 10.3892/or.2015.4442; Deng L, 2015, MOL CELL, V58, P804, DOI 10.1016/j.molcel.2015.03.033; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030; Goncharov T, 2013, EMBO J, V32, P1103, DOI 10.1038/emboj.2013.62; Herhaus L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3519; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Iglesias-Gato D, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0280-2; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jin GX, 2015, MOL CELL, V58, P989, DOI 10.1016/j.molcel.2015.05.010; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim JH, 2003, J BIOCHEM, V134, P9, DOI 10.1093/jb/mvg107; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; Millour J, 2010, ONCOGENE, V29, P2983, DOI 10.1038/onc.2010.47; Millour J, 2011, MOL CANCER THER, V10, P1046, DOI 10.1158/1535-7163.MCT-11-0024; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Rajalingam K, 2016, CELL, V164, DOI 10.1016/j.cell.2016.02.019; Ramanathan HN, 2012, CRIT REV BIOCHEM MOL, V47, P17, DOI 10.3109/10409238.2011.620943; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Song WJ, 2018, GYNECOL OBSTET INVES, V83, P124, DOI 10.1159/000464351; Stanisic V, 2009, J BIOL CHEM, V284, P16135, DOI 10.1074/jbc.M109.007484; Sun XX, 2012, EMBO J, V31, P576, DOI 10.1038/emboj.2011.434; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wang YQ, 2016, ONCOTARGET, V7, P36681, DOI 10.18632/oncotarget.9160; Wiener R, 2013, NAT STRUCT MOL BIOL, V20, P1033, DOI 10.1038/nsmb.2655; Wing SS, 2003, INT J BIOCHEM CELL B, V35, P590, DOI 10.1016/S1357-2725(02)00392-8; Xue JF, 2014, J CLIN INVEST, V124, P564, DOI 10.1172/JCI71104; Yang Z, 2012, OBES REV, V13, P58, DOI 10.1111/j.1467-789X.2012.01038.x; Yuan L, 2017, AM J CANCER RES, V7, P159; Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029; Zhou Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-258	49	37	40	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4883	4892		10.1074/jbc.M117.809533	http://dx.doi.org/10.1074/jbc.M117.809533			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29382726	hybrid, Green Published			2022-12-26	WOS:000428848300027
J	Reyna-Beltran, E; Iranzo, M; Calderon-Gonzalez, KG; Mondragon-Flores, R; Labra-Barrios, ML; Mormeneo, S; Luna-Arias, JP				Reyna-Beltran, Elizabeth; Iranzo, Maria; Grisel Calderon-Gonzalez, Karla; Mondragon-Flores, Ricardo; Luisa Labra-Barrios, Maria; Mormeneo, Salvador; Pedro Luna-Arias, Juan			The Candida albicans ENO1 gene encodes a transglutaminase involved in growth, cell division, morphogenesis, and osmotic protection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIFUNGAL DRUG DISCOVERY; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; TISSUE TRANSGLUTAMINASE; WALL PROTEINS; CROSS-LINKING; ENOLASE; PATHOGENICITY; INHIBITORS; INFECTION	Candida albicans is an opportunistic fungus that is part of the normal microflora commonly found in the human digestive tract and the normal mucosa or skin of healthy individuals. However, in immunocompromised individuals, it becomes a serious health concern and a threat to their lives and is ranked as the leading fungal infection in humans worldwide. As existing treatments for this infection are non-specific or under threat of developing resistance, there is a dire necessity to find new targets for designing specific drugs to defeat this fungus. Some authors reported the presence of the transglutaminase activity in Candida and Saccharomyces, but its identity remains unknown. We report here the phenotypic effects produced by the inhibition of transglutaminase enzymatic activity with cystamine, including growth inhibition of yeast cells, induction of autophagy in response to damage caused by cystamine, alteration of the normal yeast division pattern, changes in cell wall, and inhibition of the yeast-to-mycelium transition. The latter phenomenon was also observed in the C. albicans ATCC 26555 strain. Growth inhibition by cystamine was also determined in other Candida strains, demonstrating the importance of transglutaminase in these species. Finally, we identified enolase 1 as the cell wall protein responsible for TGase activity. After studying the inhibition of enzymatic activities with anti-CaEno1 antibodies and through bioinformatics studies, we suggest that the enolase and transglutaminase catalytic sites are localized in different domains of the protein. The aforementioned data indicate that TGase/Eno1 is a putative target for designing new drugs to control C. albicans infection.	[Reyna-Beltran, Elizabeth; Grisel Calderon-Gonzalez, Karla; Luisa Labra-Barrios, Maria; Pedro Luna-Arias, Juan] IPN, CINVESTAV, Ctr Invest & Estud Avanzados, Dept Biol Celular, Av IPN 2508, Ciudad De Mexico 07360, Mexico; [Mondragon-Flores, Ricardo] IPN, CINVESTAV, Ctr Invest & Estud Avanzados, Dept Bioquim, Ciudad De Mexico 07360, Mexico; [Iranzo, Maria; Mormeneo, Salvador] Univ Valencia, Dept Microbiol & Ecol, Fac Farm, Unidad Microbiol, E-46100 Valencia, Spain	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; University of Valencia	Luna-Arias, JP (corresponding author), IPN, CINVESTAV, Ctr Invest & Estud Avanzados, Dept Biol Celular, Av IPN 2508, Ciudad De Mexico 07360, Mexico.	jpluna@cinvestav.mx	Luna-Arias, Juan Pedro/D-4395-2019	Luna-Arias, Juan Pedro/0000-0002-3602-8000; Reyna Beltran, Elizabeth/0000-0001-7896-0560	National Council of Science and Technology (Conacyt) of Mexico; Department of Cell Biology at Cinvestav-IPN; Spanish Ministry of Innovation and Science [AGL 2011-29382]	National Council of Science and Technology (Conacyt) of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Department of Cell Biology at Cinvestav-IPN; Spanish Ministry of Innovation and Science(Spanish Government)	This work was supported in part by the National Council of Science and Technology (Conacyt) of Mexico and the Department of Cell Biology at Cinvestav-IPN (to J.P.L.-A.) and Spanish Ministry of Innovation and Science Grant AGL 2011-29382 (to S.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Amberg DC., 2005, METHODS YEAST GENETI; Bharucha N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002058; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Calderone R, 2014, FUTURE MICROBIOL, V9, P791, DOI [10.2217/FMB.14.32, 10.2217/fmb.14.32]; Chaffin WL, 2008, MICROBIOL MOL BIOL R, V72, P495, DOI 10.1128/MMBR.00032-07; Chin VK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101643; Decker BL, 2006, J BIOL CHEM, V281, P14523, DOI 10.1074/jbc.M600911200; Del Duca S, 2014, AMINO ACIDS, V46, P777, DOI 10.1007/s00726-013-1605-y; Diaz-Ramos A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/156795; Ecker M, 2006, J BIOL CHEM, V281, P11523, DOI 10.1074/jbc.M600314200; Eckert RL, 2014, PHYSIOL REV, V94, P383, DOI 10.1152/physrev.00019.2013; Edwards SR, 1999, FEMS MICROBIOL LETT, V177, P211, DOI 10.1111/j.1574-6968.1999.tb13734.x; Entelis N, 2006, GENE DEV, V20, P1609, DOI 10.1101/gad.385706; Escalona-Montano AR, 2016, PARASITOLOGY, V143, P1409, DOI 10.1017/S0031182016000949; Herrera-Aguirre ME, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/734898; FALLER LD, 1977, BIOCHEMISTRY-US, V16, P3864, DOI 10.1021/bi00636a023; Fernandes C, 2014, ANTIMICROB AGENTS CH, V58, P2894, DOI 10.1128/AAC.02647-13; FONZI WA, 1993, GENETICS, V134, P717; Free SJ, 2013, ADV GENET, V81, P33, DOI 10.1016/B978-0-12-407677-8.00002-6; Furlaneto MC, 2012, SCANNING ELECTRON MICROSCOPY, P295; Gil-Bona A, 2015, J PROTEOME RES, V14, P142, DOI 10.1021/pr5007944; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Gutierrez-Escribano P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002683; Gutierrez-Escribano P, 2011, MOL BIOL CELL, V22, P2458, DOI 10.1091/mbc.E11-03-0205; Hani Umme, 2015, Infectious Disorders - Drug Targets, V15, P42; Hofs S, 2016, J MICROBIOL, V54, P149, DOI 10.1007/s12275-016-5514-0; Iranzo M, 2002, MICROBIOL-SGM, V148, P1329, DOI 10.1099/00221287-148-5-1329; Iversen R, 2014, P NATL ACAD SCI USA, V111, P17146, DOI 10.1073/pnas.1407457111; JOHNSTONE SA, 1992, EXP CELL RES, V202, P458, DOI 10.1016/0014-4827(92)90099-T; Jong AY, 2003, J MED MICROBIOL, V52, P615, DOI 10.1099/jmm.0.05060-0; Keillor JW, 2016, EXPERT OPIN THER PAT, V26, P49, DOI 10.1517/13543776.2016.1115836; Keillor JW, 2015, TRENDS PHARMACOL SCI, V36, P32, DOI 10.1016/j.tips.2014.10.014; Keillor JW, 2014, BIOORG CHEM, V57, P186, DOI 10.1016/j.bioorg.2014.06.003; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; KIRSCH DR, 1991, INFECT IMMUN, V59, P3297, DOI 10.1128/IAI.59.9.3297-3300.1991; Klingspor L, 1997, ACTA PAEDIATR, V86, P30, DOI 10.1111/j.1651-2227.1997.tb08827.x; Ko HC, 2013, J MICROBIOL, V51, P345, DOI 10.1007/s12275-013-2577-z; Kustrzeba-Wojcicka I, 2000, COMP BIOCHEM PHYS B, V126, P109, DOI 10.1016/S0305-0491(00)00169-3; Lai TS, 1998, J BIOL CHEM, V273, P1776, DOI 10.1074/jbc.273.3.1776; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Li W., 2015, NUCLEIC ACIDS RES, V43, pW58, DOI DOI 10.1093/nar/gkv316; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Maecker HT, 2004, CYTOM PART A, V62A, P169, DOI 10.1002/cyto.a.20092; McNemar MD, 2002, J BACTERIOL, V184, P2058, DOI 10.1128/JB.184.7.2058-2061.2002; Morgan J, 2005, INFECT CONT HOSP EP, V26, P540, DOI 10.1086/502581; MORMENEO S, 1994, FEMS MICROBIOL LETT, V123, P131, DOI 10.1111/j.1574-6968.1994.tb07212.x; Munro CA, 2013, ADV APPL MICROBIOL, V83, P145, DOI 10.1016/B978-0-12-407678-5.00004-0; Poulain D, 2015, CRIT REV MICROBIOL, V41, P208, DOI 10.3109/1040841X.2013.813904; Ruiz-Herrera J, 2006, FEMS YEAST RES, V6, P14, DOI 10.1111/j.1567-1364.2005.00017.x; RUIZHERRERA J, 1995, ARCH MICROBIOL, V164, P186, DOI 10.1007/BF02529970; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; Sillitoe I, 2015, NUCLEIC ACIDS RES, V43, pD376, DOI 10.1093/nar/gku947; Song Y, 2008, MOL BIOL CELL, V19, P5456, DOI 10.1091/mbc.E08-03-0272; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; US Department of Health and Human Services. Centers for Disease Control and Prevention (CDC), 2013, ANTIBIOTIC RESISTANC; Waffenschmidt S, 1999, PLANT PHYSIOL, V121, P1003, DOI 10.1104/pp.121.3.1003; Wang Y, 2015, VIRULENCE, V6, P307, DOI 10.1080/21505594.2014.1000752	61	23	25	5	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4304	4323		10.1074/jbc.M117.810440	http://dx.doi.org/10.1074/jbc.M117.810440			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29386353	Green Published, hybrid			2022-12-26	WOS:000428204300006
J	Abbott, P; Banerjee, T; Yujra, ACA; Xie, BQ; Piette, J				Abbott, Patricia; Banerjee, Tanima; Yujra, Amparo Clara Aruquipa; Xie, Boqin; Piette, John			Exploring chronic disease in Bolivia: A cross-sectional study in La Paz	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; HEALTH-CARE; PATIENT ASSESSMENT; ILLNESS; INTERVENTIONS; ADHERENCE; SYMPTOMS; VALIDITY; OUTCOMES; QUALITY	Purpose This study seeks to develop an understanding that can guide development of programs to improve health and care for individuals with Non-Communicable Diseases (NCDs) in La Paz, Bolivia, where NCDs are prevalent and primary care systems are weak. This exploratory investigation examines the characteristics of chronic disease patients in the region, key health related behaviors, and their perceptions of the care that they receive. The longer-term goal is to lay groundwork for interventional studies based on the principles of the Chronic Care Model (CCM). Subjects and methods The study is based on two surveys of adults (> 18 years old) administered in 2014 in La Paz, Bolivia. A total of 1165 adult patients participated in the first screening survey. A post-screening second survey, administered only on those who qualified based on Survey 1, collected more detailed information about the subjects' general health and health related personal circumstances, several health behaviors, health literacy, and their perceptions of care received. A final data set of 651 merged records were used for analysis. Results Characteristic of a low-income country, the majority of participants had low levels of education, income, health literacy and high rates of under/unemployment. Nearly 50% of participants reported 2 or more NCDs. Seventy-four percent (74%) of respondents reported low levels of medication adherence and 26% of the population was found to have an undiagnosed depressive disorder. Overall, the perception of care quality was low (60%), particularly in those under the age of 45. Significant relationships emerged between several sociodemographic characteristics, health behaviors, and perceptions that have major implications for improving NCD care in this population. Conclusions These findings illustrate some of the challenges facing low-income countries where reversing the tide of NCDs is of great importance. The prevalence of NCDs coupled with challenging social determinants of health, poor medication adherence, low health literacy, and perceptions of low quality of healthcare highlight several areas of opportunity for intervention.	[Abbott, Patricia] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Banerjee, Tanima] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Yujra, Amparo Clara Aruquipa] Univ Catolica Boliviana, La Paz, Bolivia; [Xie, Boqin] Fudan Univ, Sch Nursing, Shanghai, Peoples R China; [Piette, John] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Fudan University; University of Michigan System; University of Michigan	Abbott, P (corresponding author), Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA.	pabbott@med.umich.edu		Abbott, Patricia/0000-0002-4955-6996	NIH [P30DK092926]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors received no specific funding for this work. however John Piette is a Department of Veterans Affairs Senior Career Scientist and also receives support from grant number P30DK092926 from NIH.; John Piette is a Department of Veterans Affairs Senior Career Scientist and also received support from grant number P30DK092926 from NIH.	Abbott P A, 2013, Yearb Med Inform, V8, P51; Abbott PA, 2008, NURS OUTLOOK, V56, P238, DOI 10.1016/j.outlook.2008.06.009; Abbott PA, 2013, STUD HEALTH TECHNOL, V192, P1262; Ahlstrom SK, 2004, ALCOHOL RES HEALTH, V28, P258; Alvarez FN, 2016, HEALTH POLICY PLANN, V31, P114, DOI 10.1093/heapol/czv013; [Anonymous], 2014, LANCET DIABETES ENDO, V2, P263, DOI [10.1016/S2213-8587(13)70173-6, 10.1016/S2213-8587(14)70079-8]; Aragones Abraham, 2008, Prev Chronic Dis, V5, pA113; Arena R, 2015, EUR HEART J, V36, P2097, DOI 10.1093/eurheartj/ehv207; Babor TF., 2001, AUDIT ALCOHOL USE DI; Boyd CM, 2010, J GEN INTERN MED, V25, P235, DOI 10.1007/s11606-009-1192-5; Brown MT, 2011, MAYO CLIN PROC, V86, P304, DOI 10.4065/mcp.2010.0575; Christiani Y, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.32505; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Danish Trade Union, 2014, BOL LAB MARK PROF; Davitte J., 2012, RESUMEN ANALISIS IND; Fuertes C., 2016, UNIVERSAL HLTH COVER; Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c; Hampshire K, 2015, SOC SCI MED, V142, P90, DOI 10.1016/j.socscimed.2015.07.033; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Jaen-Varas D, 2014, INT J MENT HEALTH SY, V8, DOI 10.1186/1752-4458-8-18; Janevic MR, 2016, INT J MENT HEALTH SY, V10, DOI 10.1186/s13033-016-0093-3; Kamis K, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0115-y; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Legetic B, 2016, EC DIMENSIONS NONCOM, V3, P172; Martinez YV, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-164; Morales D., 2017, MIDDLE CLASSES LATIN; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Moser DK, 2009, NURS RES, V58, P42, DOI 10.1097/NNR.0b013e3181900ca0; Organization WH, 2009, GLOB HLTH RISKS MORT; PAHO, 2013, HLTH AM; Pan American Health O, 2013, INN CAR CHRON COND O; Paradis G, 2011, J AM COLL CARDIOL, V57, P1775, DOI 10.1016/j.jacc.2010.11.047; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; Piette JD, 2016, TELEMED E-HEALTH, V22, P261, DOI 10.1089/tmj.2015.0099; Piette JD, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00095; Romans SE, 2007, J NERV MENT DIS, V195, P905, DOI 10.1097/NMD.0b013e3181594cb7; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Schmittdiel J, 2008, J GEN INTERN MED, V23, P77, DOI 10.1007/s11606-007-0452-5; Stieglitz J, 2014, J GERONTOL B-PSYCHOL, V70, P948; Tejerina H, 2014, INT J HEALTH PLAN M, V29, P90, DOI 10.1002/hpm.2149; Tran DN, 2017, CARDIOL CLIN, V35, P125, DOI 10.1016/j.ccl.2016.08.008; Twagirumukiza M, 2011, J HUM HYPERTENS, V25, P47, DOI 10.1038/jhh.2010.32; United Nations Development Project, 1980, HUM DEV DAT 1980 201; Vanek Joann., 2014, 2 WIEGO; Wallace LS, 2006, J GEN INTERN MED, V21, P874, DOI 10.1111/j.1525-1497.2006.00532.x; World Health Organisation, 2003, ADHERENCE LONG TERM	48	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0189218	10.1371/journal.pone.0189218	http://dx.doi.org/10.1371/journal.pone.0189218			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1MC	29415037	Green Published, Green Submitted, gold			2022-12-26	WOS:000424325300004
J	Russo-Abrahao, T; Lacerda-Abreu, MA; Gomes, T; Cosentino-Gomes, D; Carvalho-De-Araujo, AD; Rodrigues, MF; de Oliveira, ACL; Rumjanek, FD; Monteiro, RQ; Meyer-Fernandes, JAR				Russo-Abrahao, Thais; Lacerda-Abreu, Marco Antonio; Gomes, Taina; Cosentino-Gomes, Daniela; Carvalho-de-Araujo, Ayra Diandra; Rodrigues, Mariana Figueiredo; Leal de Oliveira, Ana Carolina; Rumjanek, Franklin David; Monteiro, Robson de Queiroz; Meyer-Fernandes, Jose Roberto			Characterization of inorganic phosphate transport in the triple-negative breast cancer cell line, MDA-MB-231	PLOS ONE			English	Article							ENERGY-METABOLISM; SLC34A2; MIGRATION; SLC20	Background Recent studies demonstrate that interstitial inorganic phosphate is significantly elevated in the breast cancer microenvironment as compared to normal tissue. In addition it has been shown that breast cancer cells express high levels of the NaPi-IIb carrier (SLC34A2), suggesting that this carrier may play a role in breast cancer progression. However, the biochemical behavior of inorganic phosphate (P-i) transporter in this cancer type remains elusive. Methods In this work, we characterize the kinetic parameters of Pi transport in the aggressive human breast cancer cell line, MDA-MB-231, and correlated P-i transport with cell migration and adhesion. Results We determined the influence of sodium concentration, pH, metabolic inhibitors, as well as the affinity for inorganic phosphate in P-i transport. We observed that the inorganic phosphate is dependent on sodium transport (K-0,K-5 value = 21.98 mM for NaCl). Furthermore, the transport is modulated by different pH values and increasing concentrations of P-i, following the Michaelis-Menten kinetics (K-0,K-5 = 0.08 mM P-i). PFA, monensin, furosemide and ouabain inhibited P-i transport, cell migration and adhesion. Conclusions Taken together, these results showed that the uptake of P-i in MDA-MB-231 cells is modulated by sodium and by regulatory mechanisms of intracellular sodium gradient. General Significance: Pi transport might be regarded as a potential target for therapy against tumor progression.	[Russo-Abrahao, Thais; Lacerda-Abreu, Marco Antonio; Gomes, Taina; Cosentino-Gomes, Daniela; Carvalho-de-Araujo, Ayra Diandra; Rodrigues, Mariana Figueiredo; Leal de Oliveira, Ana Carolina; Rumjanek, Franklin David; Monteiro, Robson de Queiroz; Meyer-Fernandes, Jose Roberto] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioqum Med Leopoldo Meis, Rio De Janeiro, RJ, Brazil; [Russo-Abrahao, Thais; Lacerda-Abreu, Marco Antonio; Cosentino-Gomes, Daniela; Carvalho-de-Araujo, Ayra Diandra; Meyer-Fernandes, Jose Roberto] Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Meyer-Fernandes, JAR (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioqum Med Leopoldo Meis, Rio De Janeiro, RJ, Brazil.; Meyer-Fernandes, JAR (corresponding author), Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, RJ, Brazil.	meyer@bioqmed.ufrj.br	de Queiroz Monteiro, Robson/M-7097-2019; Monteiro, Robson/GRX-0672-2022; DE QUEIROZ MONTEIRO, ROBSON/B-8007-2014; Cosentino-Gomes, Daniela/F-9374-2013	Monteiro, Robson/0000-0002-5260-2332; Cosentino-Gomes, Daniela/0000-0001-5690-5413	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [401134/2014-8]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [e-26/201.300/2014]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [23038.002352/2017-24]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - http://cnpq.br/ - 401134/2014-8 to TR-A; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) - http:// www.faperj.br/ - e-26/201.300/2014 to JRM-F; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - 23038.002352/2017-24 to JRM-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoedo ND, 2011, RECENT PAT ANTI-CANC, V6, P15; Andrini O, 2008, CHANNELS, V2, P346, DOI 10.4161/chan.2.5.6900; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Biber J, 2013, ANNU REV PHYSIOL, V75, P535, DOI 10.1146/annurev-physiol-030212-183748; Bobko AA, 2017, SCI REP-UK, V7, DOI 10.1038/srep41233; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castello A, 2015, TRENDS ENDOCRIN MET, V26, P746, DOI 10.1016/j.tem.2015.09.012; Chen DR, 2010, ANTICANCER RES, V30, P4135; Dick CF, 2013, BBA-GEN SUBJECTS, V1830, P4265, DOI 10.1016/j.bbagen.2013.04.034; Dick CF, 2014, BBA-GEN SUBJECTS, V1840, P2123, DOI 10.1016/j.bbagen.2014.03.014; Elser JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001028; Forster I, 2011, ADV CHRONIC KIDNEY D, V18, P63, DOI 10.1053/j.ackd.2011.01.006; Forster IC, 2013, MOL ASPECTS MED, V34, P386, DOI 10.1016/j.mam.2012.07.007; Forster IC, 2012, CURR TOP MEMBR, V70, P313, DOI 10.1016/B978-0-12-394316-3.00010-7; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Ito M, 2007, AM J PHYSIOL-CELL PH, V292, pC526, DOI 10.1152/ajpcell.00357.2006; Jiang ZX, 2016, TUMOR BIOL, V37, P10383, DOI 10.1007/s13277-016-4928-y; Jin H, 2009, AM J RESP CRIT CARE, V179, P59, DOI 10.1164/rccm.200802-306OC; Kwiatkowska E, 2016, J BIOENERG BIOMEMBR, V48, P23, DOI 10.1007/s10863-015-9637-5; Li YY, 2016, PROCEEDINGS OF THE 2016 IEEE 41ST CONFERENCE ON LOCAL COMPUTER NETWORKS - LCN WORKSHOPS 2016, P34, DOI [10.1109/LCNW.2016.21, 10.1109/LCN.2016.026]; Lin YM, 2015, MOL CARCINOGEN, V54, P926, DOI 10.1002/mc.22153; Liu LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117058; Mariano-Oliveira A, 2008, INT J BIOCHEM CELL B, V40, P517, DOI 10.1016/j.biocel.2007.09.002; Milani A, 2014, WORLD J CLIN ONCOL, V5, P990, DOI 10.5306/wjco.v5.i5.990; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Park JH, 2009, INT J BIOCHEM CELL B, V41, P659, DOI 10.1016/j.biocel.2008.07.010; Rodrigues MF, 2015, J CELL BIOCHEM, V116, P797, DOI 10.1002/jcb.25036; Ross CR, 2015, BIOORG MED CHEM LETT, V25, P1715, DOI 10.1016/j.bmcl.2015.02.071; Russo-Abrahao T, 2013, BBA-GEN SUBJECTS, V1830, P2683, DOI 10.1016/j.bbagen.2012.11.017; Russo-Abrahao T, 2017, J BIOENERG BIOMEMBR, V49, P183, DOI 10.1007/s10863-017-9695-y; Shyian M., 2011, Experimental Oncology, V33, P94; Takeda E, 2004, J CELL MOL MED, V8, P191, DOI 10.1111/j.1582-4934.2004.tb00274.x; Villa-Bellosta R, 2009, AM J PHYSIOL-CELL PH, V297, pC516, DOI 10.1152/ajpcell.00186.2009; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang L, 2008, J CANCER RES CLIN, V134, P365, DOI 10.1007/s00432-007-0292-z	36	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191270	10.1371/journal.pone.0191270	http://dx.doi.org/10.1371/journal.pone.0191270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415049	Green Published, gold, Green Submitted			2022-12-26	WOS:000424325300020
J	Belyhun, Y; Liebert, UG; Maier, M				Belyhun, Yeshambel; Liebert, Uwe Gerd; Maier, Melanie			Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; RECEIVING LAMIVUDINE THERAPY; ANTIGEN-NEGATIVE PATIENTS; CLINICAL-SIGNIFICANCE; INFECTED PATIENTS; PRECORE REGION; IN-VITRO; MUTATIONS; REPLICATION; GENOTYPE	Background We recently reported complex hepatitis B virus (HBV) drug resistant and concomitant vaccine escape hepatitis B surface antigen (HBsAg) variants during human immunodeficiency virus (HIV) co-infection and antiretroviral therapy (ART) exposure in Ethiopia. As a continuation of this report using the HBV positive sera from the same study participants, the current study further analyzed the HBV basal core promoter (BCP)/precore (PC) genes variability in patients with HBV drug resistance (at tyrosine-methionine-aspartate-aspartate (YMDD) reverse transcriptase (RT) motifs) and HIV co-infection in comparison with HBV monoinfected counterparts with no HBV drug resistant gene variants. Materials and methods A total of 143 participants of HBV-HIV co-infected (n = 48), HBV mono-infected blood donors (n = 43) and chronic liver disease (CLD) patients (n = 52) were included in the study. The BCP/PC genome regions responsible for HBeAg expression from the EcoRI site (nucleotides 1653-1959) were sequenced and analyzed for the BCP/PC mutant variants. Results Among the major mutant variants detected, double BCP mutations (A1762T/G1764A) (25.9%), Kozak sequences mutations (nt1809-1812) (51.7%) and the classical PC mutations such as A1814C/C1816T (15.4%), G1896A (25.2%) and G1862T (44.8%) were predominant mutant variants. The prevalence of the double BCP mutations was significantly lower in HIV co-infected patients (8.3%) compared with HBV mono-infected blood donors (32.6%) and CLD patients (36.5%). However, the Kozak sequences BCP mutations and the majority of PC mutations showed no significant differences among the study groups. Moreover, except for the overall BCP/PC mutant variants, co-prevalence rates of each major BCP/PC mutations and YMDDRT motif associated lamivudine (3TC)/entecavir (ETV) resistance mutations showed no significant differences when compared with the rates of BCP/PC PC mutations without YMDD RT motif drug resistance gene mutations. Unlike HIV coinfected group, no similar comparison made among HBV mono-infected blood donors and CLD patients since none of them developed the YMDD RT motif associated 3TC/ETV resistance mutations. However, HBV mono-infected blood donors and CLD patients who had no any drug resistance gene variants developed comparable G1862T (60.6% vs. 65.1%) and G1896A (24.2% vs. 11.6%) PC gene mutations. Conclusion No correlation observed between the BCP/PC genome variability and the YMDD RT motif associated HBV drug resistance gene variants during HIV co-infection. Nevertheless, irrespective of HIV co-infection status, the higher records of the BCP/PC gene variability in this study setting indicate a high risk of potential HBeAg negative chronic HBV infection in Northwest Ethiopia.	[Belyhun, Yeshambel; Liebert, Uwe Gerd; Maier, Melanie] Univ Leipzig, Med Fac, Inst Virol, Leipzig, Germany; [Belyhun, Yeshambel] Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Gondar, Ethiopia	Leipzig University; University of Gondar	Belyhun, Y (corresponding author), Univ Leipzig, Med Fac, Inst Virol, Leipzig, Germany.; Belyhun, Y (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Gondar, Ethiopia.	belyhun@gmail.com		Belyhun, Yeshambel/0000-0002-5747-4034				Ahn SH, 2003, GASTROENTEROLOGY, V125, P1370, DOI 10.1016/j.gastro.2003.07.016; Alexopoulou A, 2014, WORLD J GASTROENTERO, V20, P7644, DOI 10.3748/wjg.v20.i24.7644; Amini-Bavil-Olyaee S, 2009, AIDS, V23, P268, DOI 10.1097/QAD.0b013e3283224316; Ayari R, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.6191; Ayed K, 2007, J INFECTION, V54, P291, DOI 10.1016/j.jinf.2006.05.013; Belyhun Y, 2017, ANTIVIR THER, V22, P97, DOI 10.3851/IMP3060; Buckwold VE, 1997, J GEN VIROL, V78, P2055, DOI 10.1099/0022-1317-78-8-2055; Chauhan R, 2006, J MED VIROL, V78, P1047, DOI 10.1002/jmv.20661; Chen CH, 2006, J HEPATOL, V44, P76, DOI 10.1016/j.jhep.2005.08.022; Chen CH, 2005, J CLIN MICROBIOL, V43, P6000, DOI 10.1128/JCM.43.12.6000-6006.2005; Chen CY, 2008, HEPATOL RES, V38, P580, DOI 10.1111/j.1872-034X.2007.00315.x; Chen RYM, 2003, HEPATOLOGY, V37, P27, DOI 10.1053/jhep.2003.50012; Cho SW, 2000, HEPATOLOGY, V32, P1163, DOI 10.1053/jhep.2000.19618; Datta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110012; Gatanaga H, 2000, EUR J CLIN MICROBIOL, V19, P237, DOI 10.1007/s100960050468; Ghosh S, 2012, CLIN MICROBIOL INFEC, V18, pE412, DOI 10.1111/j.1469-0691.2012.03975.x; Herbers U, 2013, J VIRAL HEPATITIS, V20, P141, DOI 10.1111/j.1365-2893.2012.01639.x; Hou JL, 2002, J GEN VIROL, V83, P2291, DOI 10.1099/0022-1317-83-9-2291; Juniastuti, 2013, BIOMED REP, V1, P522, DOI 10.3892/br.2013.106; Kamijo N, 2015, WORLD J GASTROENTERO, V21, P541, DOI 10.3748/wjg.v21.i2.541; Kato H, 2001, J VIROL METHODS, V98, P153, DOI 10.1016/S0166-0934(01)00374-3; Khan A, 2013, INT J CANCER, V133, P2864, DOI 10.1002/ijc.28307; Kuwahara R, 2004, J MED VIROL, V72, P26, DOI 10.1002/jmv.10558; Laras A, 1998, J VIRAL HEPATITIS, V5, P241, DOI 10.1046/j.1365-2893.1998.00109.x; Lim Chee Kent, 2006, Int J Med Sci, V3, P14; Lin CL, 2004, LIVER INT, V24, P9, DOI 10.1111/j.1478-3231.2004.00893.x; Lok ASF, 2000, HEPATOLOGY, V32, P1145; Makondo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046345; de Mello FMMA, 2014, REV SOC BRAS MED TRO, V47, P701, DOI 10.1590/0037-8682-0158-2014; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; Sun HY, 2014, WORLD J GASTROENTERO, V20, P14598, DOI 10.3748/wjg.v20.i40.14598; Suzuki F, 2002, J HEPATOL, V37, P824, DOI 10.1016/S0168-8278(02)00281-7; Tacke F, 2004, CURR MED CHEM, V11, P2667, DOI 10.2174/0929867043364333; Tacke F, 2004, J VIROL, V78, P8524, DOI 10.1128/JVI.78.16.8524-8535.2004; Tacke F, 2012, HEPAT MON, V12, P357, DOI 10.5812/hepatmon.6131; Taffon S, 2014, INFECTION, V42, P675, DOI 10.1007/s15010-014-0616-2; Vermeulen M, 2012, TRANSFUSION, V52, P880, DOI 10.1111/j.1537-2995.2011.03355.x; Vutien P, 2013, ALIMENT PHARM THER, V37, P464, DOI 10.1111/apt.12193; Yuen MF, 2002, J INFECT DIS, V186, P1335, DOI 10.1086/344327; Zhu Yuao, 2011, Antiviral Chemistry & Chemotherapy, V22, P13, DOI 10.3851/IMP1791	40	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191970	10.1371/journal.pone.0191970	http://dx.doi.org/10.1371/journal.pone.0191970			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408943	gold, Green Submitted, Green Published			2022-12-26	WOS:000424302800036
J	Falconer, DJ; Barb, AW				Falconer, Daniel J.; Barb, Adam W.			Mouse IgG2c Fc loop residues promote greater receptor-binding affinity than mouse IgG2b or human IgG1	PLOS ONE			English	Article							GAMMA-RIII; THERAPEUTIC ANTIBODIES; IMMUNOGLOBULIN-G; N-GLYCOSYLATION; CARBOHYDRATE; FUCOSE; SITE	The structures of non-human antibodies are largely unstudied despite the potential for the identification of alternative structural motifs and physical properties that will benefit a basic understanding of protein and immune system evolution as well as highlight unexplored motifs to improve therapeutic monoclonal antibody. Here we probe the structure and receptor-binding properties of the mouse IgG2c crystallizable fragment (Fc) to compare to mouse IgG2b and human IgG1 Fcs. Models of mIgG2c Fc determined by x-ray crystallography with a complex-type biantennary (to 2.05 angstrom) or a truncated (1) GlcNAc asparagine-linked (N)-glycan attached (to 2.04 angstrom) show differences in key regions related to mouse Fc gamma receptor IV (mFc gamma RIV) binding. Mouse IgG2c forms different non-bonded interactions between the BC, DE and FG loops than the highly-conserved mIgG2b and binds to Fc gamma RIV with 4.7-fold greater affinity in the complex-type glycoform. Secondary structural elements surrounding the Asn297 site of glycosylation form longer beta strands in the truncated mIgG2c Fc glycoform when compared to mIgG2c with the complex-type N-glycan. Solution NMR spectroscopy of the N-linked (1) GlcNAc residues show differences between mIgG2b, 2c and hIgG1 Fc that correlate to receptor binding affinity. Mutations targeting differences in mIgG2 DE and FG loops decreased affinity of mIgG2c for Fc gamma RIV and increased affinity of mIgG2b. Changes in NMR spectra of the mutant Fc proteins mirrored these changes in affinity. Our studies identified structural and functional differences in highly conserved molecules that were not predicted from primary sequence comparison.	[Falconer, Daniel J.; Barb, Adam W.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Barb, AW (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	abarb@iastate.edu		Barb, Adam/0000-0003-3290-8649	National Institutes of Health [R01 GM115489]; Department of Energy [GUP-48455]; Roy J. Carver Department of Biochemistry, Biophysics & Molecular Biology at Iowa State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); Roy J. Carver Department of Biochemistry, Biophysics & Molecular Biology at Iowa State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This material is based upon work supported by the National Institutes of Health under Award No. R01 GM115489 (NIGMS) to AWB, a grant for synchrotron time at the Argonne National Laboratory Advanced Photon Source by the Department of Energy (GUP-48455), and by funds from the Roy J. Carver Department of Biochemistry, Biophysics & Molecular Biology at Iowa State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. D. Bruce Fulton of the Iowa State University Biomolecular NMR Facility for assistance running the NMR experiments and Mr. Joel Nott of the ISU Protein Facility for mass spectrometric analyses. We also thank Ms. Emily Knuth for assistance cloning the Fc constructs and Prof. Falk Nimmerjahn (University of Erlangen-Nuremberg) for providing the mIgG2 expression constructs. This material is based upon work supported by the National Institutes of Health under Award No. R01 GM115489 (NIGMS), a grant for synchrotron time at the Argonne National Laboratory Advanced Photon Source by the Department of Energy (GUP-48455), and by funds from the Roy J. Carver Department of Biochemistry, Biophysics & Molecular Biology at Iowa State University. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Institutes of Health or the Department of Energy.	Ackerman ME, 2013, J CLIN INVEST, V123, P2183, DOI 10.1172/JCI65708; Ahmed AA, 2016, J STRUCT BIOL, V194, P78, DOI 10.1016/j.jsb.2016.02.001; Barb AW, 2015, BIOCHEMISTRY-US, V54, P313, DOI 10.1021/bi501380t; Barb AW, 2012, BIOCHEMISTRY-US, V51, P4618, DOI 10.1021/bi300319q; Barb AW, 2011, NAT CHEM BIOL, V7, P147, DOI 10.1038/NCHEMBIO.511; Baruah K, 2012, J MOL BIOL, V420, P1, DOI 10.1016/j.jmb.2012.04.002; Bruhns P, 2015, IMMUNOL REV, V268, P25, DOI 10.1111/imr.12350; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; de Haan N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00608; Dekkers G, 2018, MOL IMMUNOL, V94, P54, DOI 10.1016/j.molimm.2017.12.006; Dekkers G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00877; Ferrara C, 2006, J BIOL CHEM, V281, P5032, DOI 10.1074/jbc.M510171200; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Fridman C, 2000, J MOL BIOL, V295, P213; Gardinassi LG, 2014, MBIO, V5, DOI 10.1128/mBio.01844-14; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Isoda Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140120; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Kemna MJ, 2017, EBIOMEDICINE, V17, P108, DOI 10.1016/j.ebiom.2017.01.033; Kolenko P, 2009, IMMUNOLOGY, V126, P378, DOI 10.1111/j.1365-2567.2008.02904.x; Labrijn AF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02823-9; Lux A, 2013, J IMMUNOL, V190, P4315, DOI 10.4049/jimmunol.1200501; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; MICHAELSEN TE, 1992, MOL IMMUNOL, V29, P319, DOI 10.1016/0161-5890(92)90018-S; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Ruhaak LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012566; Selman MHJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014563; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Stavenhagen JB, 2007, CANCER RES, V67, P8882, DOI 10.1158/0008-5472.CAN-07-0696; Subedi GP, 2017, BIOCHEMISTRY-US, V56, P3174, DOI 10.1021/acs.biochem.7b00392; Subedi GP, 2016, MABS-AUSTIN, V8, P1512, DOI 10.1080/19420862.2016.1218586; Subedi GP, 2015, JOVE-J VIS EXP, DOI 10.3791/53568; Subedi GP, 2015, STRUCTURE, V23, P1573, DOI 10.1016/j.str.2015.06.015; Subedi GP, 2014, STRUCTURE, V22, P1478, DOI 10.1016/j.str.2014.08.002; Varki A., 2017, ESSENTIALS GLYCOBIOL, Vxxix; Wuhrer M, 2009, J PROTEOME RES, V8, P450, DOI 10.1021/pr800651j; Yamaguchi Y, 1998, J BIOMOL NMR, V12, P385, DOI 10.1023/A:1008392229694; Yu XW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004112; Zhang ZP, 2012, MOL IMMUNOL, V50, P169, DOI 10.1016/j.molimm.2011.11.006; Zwolak A, 2017, MABS-AUSTIN, V9, P1306, DOI 10.1080/19420862.2017.1375639	44	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192123	10.1371/journal.pone.0192123	http://dx.doi.org/10.1371/journal.pone.0192123			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408873	gold, Green Submitted, Green Published			2022-12-26	WOS:000424302800046
J	Lee, SY; Bae, HW; Kwon, HJ; Seong, GJ; Kim, CY				Lee, Sang Yeop; Bae, Hyoung Won; Kwon, Hee Jung; Seong, Gong Je; Kim, Chan Yun			Utility of Goldmann applanation tonometry for monitoring intraocular pressure in glaucoma patients with a history of laser refractory surgery	PLOS ONE			English	Article							DYNAMIC CONTOUR TONOMETRY; IN-SITU KERATOMILEUSIS; CORNEAL THICKNESS; BIOMECHANICAL PROPERTIES; PROGRESSION; FLUCTUATION; ASSOCIATION; CURVATURE; IMPACT	The utility of Goldmann applanation tonometry (GAT) for monitoring intraocular pressure (IOP) in open-angle glaucoma (OAG) patients with a history of laser refractive surgery was investigated by comparing IOP fluctuations measured using GAT and dynamic contour tonometry (DCT) on the same day. In this retrospective study, patients were divided into one of two subgroups according to IOP fluctuation values using GAT: 43 eyes in the low IOP fluctuation group (LIFG [GAT fluctuation <= 1.7 mmHg]); and 55 eyes in the high IOP fluctuation group (HIFG [GAT fluctuation >1.7 mmHg]). IOP fluctuation was defined as the standard deviation of all IOP values during follow-up. IOP parameters using GAT were compared with those of DCT. Correlation analyses were performed among IOP parameters, and between IOP fluctuation and associated factors including central corneal thickness, corneal curvature, and axial length. All IOP parameters demonstrated significantly high values in the HIFG compared with those in the LIFG. Mean and peak IOP using DCT were significantly higher than those using GAT in both groups. However, there were no significant differences in IOP fluctuation and reduction using both tonometry methods in the HIFG (p = 0.946 and p = 0.986, respectively). Bland-Altman analysis revealed similar fluctuations using GAT and DCT. In multivariate analyses, there was a significant correlation between fluctuations using GAT and DCT in the HIFG (p = 0.043). These results suggest that IOP monitoring using GAT is a reliable method of monitoring IOP change in glaucoma patients with a history of laser refractive surgery, especially those exhibiting high IOP fluctuation. Nevertheless, several factors, including central corneal thickness, corneal curvature, and axial length, should be considered when using GAT for IOP monitoring.	[Lee, Sang Yeop; Bae, Hyoung Won; Seong, Gong Je; Kim, Chan Yun] Yonsei Univ, Severance Hosp, Coll Med, Inst Vis Res,Dept Ophthalmol, Seoul, South Korea; [Kwon, Hee Jung] CHA Univ, CHA Bundang Med Ctr, Dept Ophthalmol, Seongnam, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University	Kim, CY (corresponding author), Yonsei Univ, Severance Hosp, Coll Med, Inst Vis Res,Dept Ophthalmol, Seoul, South Korea.	kcyeye@yuhs.ac	Lee, Sang Yeop/M-4685-2015	Lee, Sang Yeop/0000-0002-3834-7953; Seong, Gong Je/0000-0002-5456-4296; Bae, Hyoung Won/0000-0002-8421-5636; Kim, Chan Yun/0000-0002-8373-9999	National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2017R1A2B4012212]	National Research Foundation of Korea (NRF) - Ministry of Education	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. NRF-2017R1A2B4012212). The funding organization played no role in study design or conduct.	Aristeidou AP, 2011, GRAEF ARCH CLIN EXP, V249, P767, DOI 10.1007/s00417-010-1431-9; Asrani S, 2000, J GLAUCOMA, V9, P134; Bengtsson B, 2007, OPHTHALMOLOGY, V114, P205, DOI 10.1016/j.ophtha.2006.07.060; Boehm AG, 2008, INVEST OPHTH VIS SCI, V49, P2472, DOI 10.1167/iovs.07-1366; Budenz DL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1136; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; Firat PG, 2013, CLIN EXP OPTOM, V96, P233, DOI 10.1111/cxo.12016; Francis BA, 2007, OPHTHALMOLOGY, V114, P20, DOI 10.1016/j.ophtha.2006.06.047; Fukuchi T, 2013, J GLAUCOMA, V22, P689, DOI 10.1097/IJG.0b013e318264b779; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Halkiadakis I, 2009, ACTA OPHTHALMOL, V87, P323, DOI 10.1111/j.1755-3768.2008.01239.x; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Hong S, 2007, ARCH OPHTHALMOL-CHIC, V125, P1010, DOI 10.1001/archopht.125.8.1010; Jonas Jost B, 2010, J Ophthalmic Vis Res, V5, P92; Kaufmann C, 2004, INVEST OPHTH VIS SCI, V45, P3118, DOI 10.1167/iovs.04-0018; Kniestedt C, 2004, ARCH OPHTHALMOL-CHIC, V122, P1287, DOI 10.1001/archopht.122.9.1287; Lee PP, 2007, AM J OPHTHALMOL, V144, P901, DOI 10.1016/j.ajo.2007.07.040; Leidl MC, 2014, BRIT J OPHTHALMOL, V98, P1315, DOI 10.1136/bjophthalmol-2013-303980; Liu J, 2005, J CATARACT REFR SURG, V31, P146, DOI 10.1016/j.jcrs.2004.09.031; Loewen NA, 2010, INVEST OPHTH VIS SCI, V51, P933, DOI 10.1167/iovs.09-4218; Meyenberg A, 2008, CORNEA, V27, P305, DOI 10.1097/ICO.0b013e31815dcf97; Ozcura F, 2008, JPN J OPHTHALMOL, V52, P353, DOI 10.1007/s10384-008-0535-9; Ozbek Z, 2006, CORNEA, V25, P890, DOI 10.1097/01.ico.0000224649.12214.33; Qazi MA, 2009, J CATARACT REFR SURG, V35, P1774, DOI 10.1016/j.jcrs.2009.05.041; Regev G, 2011, J GLAUCOMA, V20, P282, DOI 10.1097/IJG.0b013e3181e66498; Shemesh G, 2012, CLIN OPHTHALMOL, V6, P1967, DOI 10.2147/OPTH.S38094; Shin J, 2015, J GLAUCOMA, V24, P195, DOI 10.1097/IJG.0b013e31829da1ec; Sung KR, 2013, SURGERY, V27, P103, DOI DOI 10.3341/KJ0.2013.27.2.103; Svedberg H, 2005, GRAEF ARCH CLIN EXP, V243, P1218, DOI 10.1007/s00417-005-0072-x; Tzamalis A, 2013, J OCUL PHARMACOL TH, V29, P41, DOI 10.1089/jop.2012.0115; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Wang J, 2011, J GLAUCOMA, V20, P482, DOI 10.1097/IJG.0b013e3181efbe8f	32	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192344	10.1371/journal.pone.0192344	http://dx.doi.org/10.1371/journal.pone.0192344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401477	Green Published, gold			2022-12-26	WOS:000424101400050
J	Toliczenko-Bernatowicz, D; Matuszczak, E; Tylicka, M; Szymanska, B; Komarowska, M; Gorodkiewicz, E; Debek, W; Hermanowicz, A				Toliczenko-Bernatowicz, Dorota; Matuszczak, Ewa; Tylicka, Marzena; Szymanska, Beata; Komarowska, Marta; Gorodkiewicz, Ewa; Debek, Wojciech; Hermanowicz, Adam			Overexpression of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in boys with cryptorchidism	PLOS ONE			English	Article							GERM-CELL APOPTOSIS; SPERM QUALITY-CONTROL; GENE-PRODUCT 9.5; RECIPROCAL MODULATORS; FUNCTIONAL-ANALYSIS; THERMAL-INJURY; SPERMATOGENESIS; TESTIS; MOUSE; SERUM	Background The ubiquitin-proteasome system regulate p53, caspase and Bcl-2 family proteins, and is crucial for the degradation of the defective germ cells in testes. Purpose: to evaluate the concentration of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in the blood plasma of boys with cryptorchidism and if there is any correlation with patient age. Methods Patients-50 boys aged 1-4 years (median = 2,4y.) with unilateral cryptorchidism. Exclusion criteria were: previous human chorionic gonadotropin treatment, an abnormal karyotype, endocrine or immunological disorders or any long-term medication. The control group-50 healthy, age matched boys (aged 1-4 years, median = 2,1y.), admitted to the Pediatric Surgery Department for planned herniotomy. To investigate UCHL1 in blood plasma of boys with cryptorchidism, we used a novel technique Surface PLASMON RESONANCE Imaging (SPRI). Results The median concentration of UCHL1 in the blood plasma of boys with cryptorchidism, was 5-folds higher than in boys with inguinal hernia, whose testicles were located in the scrotum. We also noticed statistically significant difference between UCHL1 levels in boys with cryptorchidism up to 2 years old, and above 2 years old. Older boys, whose testicles since birth were located in the inguinal pouch or in the abdominal cavity, had higher concentration of UCHL1 in their blood plasma, than boys from younger group. In the group of cryptorchid boys, we also found slightly lower concentrations of INSL3, without statistical significance and no correlation with UCHL1 levels. Conclusions Uchl1 concentrations in the blood plasma of boys with cryptorchidism, may reflect the heat-induced apoptosis of germ cells. Higher UCHL1 concentrations in older boys with undescended testicles, probably express intensity of germ cell apoptosis, more extensive when testicles are subjected to heat-stress for longer period. Further analyses of UCHL1 may help to elucidate its role in mechanisms influencing spermatogenesis.	[Toliczenko-Bernatowicz, Dorota; Matuszczak, Ewa; Komarowska, Marta; Debek, Wojciech; Hermanowicz, Adam] Med Univ Bialystok, Paediat Surg Dept, Bialystok, Poland; [Tylicka, Marzena] Med Univ Bialystok, Biophys Dept, Bialystok, Poland; [Szymanska, Beata; Gorodkiewicz, Ewa] Univ Bialystok, Electrochem Dept, Bialystok, Poland	Medical University of Bialystok; Medical University of Bialystok; University of Bialystok	Matuszczak, E (corresponding author), Med Univ Bialystok, Paediat Surg Dept, Bialystok, Poland.	ewamat@tlen.pl	Tylicka, Marzena/AAV-7088-2020; Matuszczak, Ewa/T-3497-2018; Hermanowicz, ahermanowicz/T-3500-2018; Dębek, Wojciech/S-8168-2018; Komarowska, Marta/R-6010-2018	Tylicka, Marzena/0000-0002-9594-8173; Matuszczak, Ewa/0000-0003-2425-9589; Hermanowicz, ahermanowicz/0000-0002-5723-6941; Dębek, Wojciech/0000-0001-6023-8510; Komarowska, Marta/0000-0002-9671-6542				Agarwal A, 2012, STUDIES ON MENS HEAL; Albin AK, 2013, HORM RES PAEDIAT, V80, P100, DOI 10.1159/000353761; Berger R. P., 2012, J NEUROTRAUMA, V29; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Chung E, 2011, CUAJ-CAN UROL ASSOC, V5, P210, DOI 10.5489/cuaj.10106; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Du Ping, 2014, Shengli Xuebao, V66, P528; Ferguson I, 2011, ANN EMERG MED, V58, pS213, DOI 10.1016/j.annemergmed.2011.06.133; FORMAN D, 1994, BRIT MED J, V308, P1393, DOI 10.1136/bmj.308.6941.1393; Hermanowicz A, 2012, MED SCI MONITOR, V18, pCR630, DOI 10.12659/MSM.883490; Kocak I, 2002, ASIAN J ANDROL, V4, P183; Komarowska MD, 2016, ADV MED SCI-POLAND, V61, P288, DOI 10.1016/j.advms.2016.03.004; Komarowska MD, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/973154; Komarowska MD, 2012, J PEDIATR ENDOCR MET, V25, P1073, DOI 10.1515/jpem-2012-0210; Kon Y, 1999, MOL REPROD DEV, V54, P333, DOI 10.1002/(SICI)1098-2795(199912)54:4&lt;333::AID-MRD3&gt;3.0.CO;2-8; Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200; Kurihara LJ, 2000, MOL CELL BIOL, V20, P2498, DOI 10.1128/MCB.20.7.2498-2504.2000; Kwon J, 2005, BIOL REPROD, V73, P29, DOI 10.1095/biolreprod.104.037077; Kwon J, 2004, AM J PATHOL, V165, P1367, DOI 10.1016/S0002-9440(10)63394-9; Kwon J, 2007, EXP ANIM TOKYO, V56, P71, DOI 10.1538/expanim.56.71; Marshansky V, 2001, J IMMUNOL, V166, P3130, DOI 10.4049/jimmunol.166.5.3130; Matuszczak E, 2017, J INVEST SURG, V27, P1; Matuszczak E, 2017, ADV MED SCI-POLAND, V62, P83, DOI 10.1016/j.advms.2016.07.004; Matuszczak E, 2016, ANN CLIN LAB SCI, V46, P407; Matuszczak E, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/128907; Matuszczak E, 2012, ENDOCRINE, V41, P334, DOI 10.1007/s12020-011-9551-5; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Niedzielski JK, 2016, ARCH MED SCI, V12, P667, DOI 10.5114/aoms.2016.59940; Ohta H, 2003, BIOL REPROD, V68, P2249, DOI 10.1095/biolreprod.102.014779; Oldereid NB, 2001, MOL HUM REPROD, V7, P403, DOI 10.1093/molehr/7.5.403; Print CG, 2000, BIOESSAYS, V22, P423, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;423::AID-BIES4&gt;3.0.CO;2-0; Sankiewicz A, 2015, ANAL BIOCHEM, V469, P4, DOI 10.1016/j.ab.2014.09.021; Sekiguchi S, 2003, EXP ANIM TOKYO, V52, P365, DOI 10.1538/expanim.52.365; Sutovsky P, 2003, MICROSC RES TECHNIQ, V61, P88, DOI 10.1002/jemt.10319; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tasian GE, 2009, J UROLOGY, V182, P704, DOI 10.1016/j.juro.2009.04.032; Tokarzewicz A, 2017, ANAL METHODS-UK, V9, P2407, DOI 10.1039/c7ay00786h; Wang YL, 2006, MOL REPROD DEV, V73, P40, DOI 10.1002/mrd.20364; Wilkerson ML, 2001, HORM RES, V136, P274; Yang YL, 2003, FASEB J, V17, P790, DOI 10.1096/fj.02-0654rev	40	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191806	10.1371/journal.pone.0191806	http://dx.doi.org/10.1371/journal.pone.0191806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401475	gold, Green Published, Green Submitted			2022-12-26	WOS:000424101400021
J	Heintz, BD; Keenan, KG				Heintz, Brittany D.; Keenan, Kevin G.			Spiral tracing on a touchscreen is influenced by age, hand, implement, and friction	PLOS ONE			English	Article							OLDER-ADULTS; FORCE FLUCTUATIONS; NEURAL-CONTROL; REACTION-TIME; PERFORMANCE; FINGERTIP; INTERNET; HANDEDNESS; SCALES; TREMOR	Dexterity impairments are well documented in older adults, though it is unclear how these influence touchscreen manipulation. This study examined age-related differences while tracing on high-and low-friction touchscreens using the finger or stylus. 26 young and 24 older adults completed an Archimedes spiral tracing task on a touchscreen mounted on a force sensor. Root mean square error was calculated to quantify performance. Root mean square error increased by 29.9% for older vs. young adults using the fingertip, but was similar to young adults when using the stylus. Although other variables (e.g., touchscreen usage, sensation, and reaction time) differed between age groups, these variables were not related to increased error in older adults while using their fingertip. Root mean square error also increased on the low-friction surface for all subjects. These findings suggest that utilizing a stylus and increasing surface friction may improve touchscreen use in older adults.	[Heintz, Brittany D.; Keenan, Kevin G.] Univ Wisconsin, Dept Kinesiol, Milwaukee, WI 53201 USA; [Heintz, Brittany D.; Keenan, Kevin G.] Univ Wisconsin, Ctr Aging & Translat Res, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee	Keenan, KG (corresponding author), Univ Wisconsin, Dept Kinesiol, Milwaukee, WI 53201 USA.; Keenan, KG (corresponding author), Univ Wisconsin, Ctr Aging & Translat Res, Milwaukee, WI 53201 USA.	keenan@uwm.edu		Heintz Walters, Brittany/0000-0002-5418-7072	University of Wisconsin Research Growth Initiative; Helen Bader Age & Community Scholarship	University of Wisconsin Research Growth Initiative; Helen Bader Age & Community Scholarship	B. Heintz was supported by the University of Wisconsin Research Growth Initiative and the Helen Bader Age & Community Scholarship.; The authors would like to thank the University of Wisconsin Research Growth Initiative and the Helen Bader Age & Community Scholarship for support.	Albinsson PA, 2003, HIGH PRECISION TOUCH; Arif AS, 2013, IDC 13; Benko H, 2006, CHI 06; Charness N, 2004, HUM FACTORS, V46, P373, DOI 10.1518/hfes.46.3.373.3800; Chib VS, 2009, J NEUROSCI, V29, P3939, DOI 10.1523/JNEUROSCI.5856-08.2009; Cody MJ, 1999, COMMUN EDUC, V48, P269, DOI 10.1080/03634529909379178; Cole KJ, 2006, EXP BRAIN RES, V175, P285, DOI 10.1007/s00221-006-0553-0; COLE KJ, 1993, EXP BRAIN RES, V95, P523; COLE KJ, 1991, J MOTOR BEHAV, V23, P251, DOI 10.1080/00222895.1991.9942036; Cole KJ, 1999, J NEUROSCI, V19, P3238; Cousineau D, 2010, INT J PSYCHOL RES, V3, P58; Czaja SJ, 2006, PSYCHOL AGING, V21, P333, DOI 10.1037/0882-7974.21.2.333; Deary IJ, 2005, AGING NEUROPSYCHOL C, V12, P187, DOI 10.1080/13825580590969235; Elble RJ, 2006, BRAIN, V129, P2660, DOI 10.1093/brain/awl190; Genaro LM, 2014, IHM 14; Harada S, 2013, IFIP C HUM COMP INT; Heenan M, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-170; Holzinger A, 2007, LECT NOTES COMPUT SC, V4554, P923; Hoogendam YY, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00259; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; JOHANSSON RS, 1980, BRAIN RES, V184, P343, DOI 10.1016/0006-8993(80)90803-3; Joshi MN, 2016, EXP BRAIN RES, V234, P1893, DOI 10.1007/s00221-016-4581-0; Kapur S, 2010, J APPL PHYSIOL, V109, P1827, DOI 10.1152/japplphysiol.00430.2010; Keenan KG, 2017, J NEUROPHYSIOL, V118, P2537, DOI 10.1152/jn.00928.2016; Keenan KG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048193; Lagana L, 2008, EDUC GERONTOL, V34, P831, DOI 10.1080/03601270802243713; Laidlaw DH, 2000, MUSCLE NERVE, V23, P600, DOI 10.1002/(SICI)1097-4598(200004)23:4<600::AID-MUS20>3.3.CO;2-4; Leonardi C, 2010, EXPLORATORY STUDY TO; Louis ED, 2011, NEUROEPIDEMIOLOGY, V37, P90, DOI 10.1159/000330352; Marmon AR, 2011, MED SCI SPORT EXER, V43, P560, DOI 10.1249/MSS.0b013e3181f3f3ab; Marquie JC, 2002, BEHAV INFORM TECHNOL, V21, P273, DOI 10.1080/0144929021000020998; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Matulic F, 2012, ITS 12; McMellon CA, 2002, J APPL GERONTOL, V21, P157, DOI 10.1177/07364802021002002; Mynatt ED, 2011, AGING INT, V27, P24; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prattichizzo D, 2015, IEEE T HAPTICS, V8, P356, DOI 10.1109/TOH.2015.2434812; Sainburg RL, 2002, EXP BRAIN RES, V145, P437, DOI 10.1007/s00221-002-1140-7; Seo Na Jin, 2012, J Hand Ther, V25, P397, DOI 10.1016/j.jht.2012.04.004; Seo NJ, 2011, ARCH PHYS MED REHAB, V92, P24, DOI 10.1016/j.apmr.2010.08.016; Shapira N, 2007, AGING MENT HEALTH, V11, P477, DOI 10.1080/13607860601086546; Shinohara M, 2003, J APPL PHYSIOL, V94, P259, DOI 10.1152/japplphysiol.00643.2002; Slavin MJ, 1996, PSYCHOL AGING, V11, P521, DOI 10.1037/0882-7974.11.3.521; Stanley K, 2010, PARKINSONISM RELAT D, V16, P233, DOI 10.1016/j.parkreldis.2009.12.007; STEVENS JC, 1995, SOMATOSENS MOT RES, V12, P29, DOI 10.3109/08990229509063140; Stirling LA, 2013, J GERONTOL A-BIOL, V68, P938, DOI 10.1093/gerona/glt003; Tu H, 2012, CHI 12; Venkadesan M, 2008, J NEUROSCI, V28, P1366, DOI 10.1523/JNEUROSCI.4993-07.2008; Vogel D, 2007, CHI 07; Wang F, 2009, CHI 09; Wang JS, 2011, EXP BRAIN RES, V210, P283, DOI 10.1007/s00221-011-2631-1; Westin J, 2010, J NEUROSCI METH, V190, P143, DOI 10.1016/j.jneumeth.2010.04.027; Wright K, 2000, J COMMUN, V50, P100, DOI 10.1111/j.1460-2466.2000.tb02855.x; Zhai S, 2003, CHI 03	54	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191309	10.1371/journal.pone.0191309	http://dx.doi.org/10.1371/journal.pone.0191309			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389940	gold, Green Published, Green Submitted			2022-12-26	WOS:000423793400015
J	Pachikian, BD; Druart, C; Catry, E; Bindels, LB; Neyrinck, AM; Larondelle, Y; Cani, PD; Delzenne, NM				Pachikian, Barbara D.; Druart, Celine; Catry, Emilie; Bindels, Laure B.; Neyrinck, Audrey M.; Larondelle, Yvan; Cani, Patrice D.; Delzenne, Nathalie M.			Implication of trans-11, trans-13 conjugated linoleic acid in the development of hepatic steatosis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; GUT MICROBIOTA; ADIPOSE-TISSUE; BIOHYDROGENATION; METABOLISM; MODULATION; MECHANISMS; EXPRESSION; RECEPTOR; HEALTH	Scope Conjugated linoleic acids are linoleic acid isomers found in the diet that can also be produced through bacterial metabolism of polyunsaturated fatty acids. Our objective was to evaluate the contribution of fatty acid metabolites produced from polyunsaturated fatty acids by the gut microbiota in vivo to regulation of hepatic lipid metabolism and steatosis. Methods and results In mice with depleted n-3 polyunsaturated fatty acids, we observed an accumulation of trans-11, trans-13 CLA and cis-9, cis-11 conjugated linoleic acids in the liver tissue that were associated with an increased triglyceride content and expression of lipogenic genes. We used an in vitro model to evaluate the impact of these two conjugated linoleic acids on hepatic lipid metabolism. In HepG2 cells, we observed that only trans-11, trans-13 conjugated linoleic acids recapitulated triglyceride accumulation and increased lipogenic gene expression, which is a phenomenon that may implicate the nuclear factors sterol regulatory element binding protein 1c (SREBP-1c) and carbohydrate-responsive element-binding protein (ChREBP). Conclusion The trans-11, trans-13 conjugated linoleic acids can stimulate hepatic lipogenesis, which supports the conclusion that gut microbiota and related metabolites should be considered in the treatment of non-alcoholic liver disease.	[Pachikian, Barbara D.; Druart, Celine; Catry, Emilie; Bindels, Laure B.; Neyrinck, Audrey M.; Cani, Patrice D.; Delzenne, Nathalie M.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, Brussels, Belgium; [Larondelle, Yvan] Catholic Univ Louvain, Inst Sci Vie, Louvain La Neuve, Belgium; [Cani, Patrice D.] Catholic Univ Louvain, WELBIO, WELBIO Walloon Excellence Life Sci & BIOtechnol, Metab & Nutr Res Grp,Louvain Drug Res Inst, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; WELBIO	Delzenne, NM (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, Brussels, Belgium.	nathalie.delzenne@uclouvain.be	Neyrinck, Audrey/AAE-7929-2019; Delzenne, Nathalie/AAC-4628-2019; Bindels, Laure/T-7846-2019; D., Cani Patrice/M-8055-2016	Neyrinck, Audrey/0000-0002-9435-3338; Delzenne, Nathalie/0000-0003-2115-6082; Bindels, Laure/0000-0003-3747-3234; D., Cani Patrice/0000-0003-2040-2448; Druart, Celine/0000-0002-7786-9172	FRS-FNRS (Fonds de la recherche scientifique) [FRSM 3.4574.07, FRFC 2.4555.08]; competitive cluster Wagralim (Walnut20); European Union's Seventh Framework Program (Mynewgut grant) [613979]; FNRS; FRFS-WELBIO [WELBIO-CR-2012S-02R]; Funds Baillet Latour (Grant for Medical Research); ERC Starting Grant [336452-ENIGMO]	FRS-FNRS (Fonds de la recherche scientifique)(Fonds de la Recherche Scientifique - FNRS); competitive cluster Wagralim (Walnut20); European Union's Seventh Framework Program (Mynewgut grant); FNRS(Fonds de la Recherche Scientifique - FNRS); FRFS-WELBIO(WELBIO); Funds Baillet Latour (Grant for Medical Research); ERC Starting Grant(European Research Council (ERC))	NMD is a recipient of grants from FRS-FNRS (Fonds de la recherche scientifique) (convention FRSM 3.4574.07 and FRFC 2.4555.08), from Wallonia supported by the competitive cluster Wagralim (Walnut20) and from the European Union's Seventh Framework Program (Mynewgut grant agreement no 613979). PDC is senior research associate from the FRS-FNRS Belgium and the recipient of grants from FNRS, FRFS-WELBIO under grant: WELBIO-CR-2012S-02R, the Funds Baillet Latour (Grant for Medical Research 2015), and ERC Starting Grant 2013 (Starting grant 336452-ENIGMO). LBB is a postdoctoral fellow from the FRS-FNRS Belgium.	Abdul-Wahed A, 2017, CELL METAB, V26, P324, DOI 10.1016/j.cmet.2017.07.004; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Berlanga A, 2014, CLIN EXP GASTROENTER, V7, P221, DOI 10.2147/CEG.S62831; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Choi JS, 2007, BRIT J NUTR, V98, P264, DOI 10.1017/S000711450770497X; Clarke G, 2014, MOL ENDOCRINOL, V28, P1221, DOI 10.1210/me.2014-1108; Clement L, 2002, J LIPID RES, V43, P1400, DOI 10.1194/jlr.M20008-JLR200; Cui W, 2010, AM J TRANSL RES, V2, P95; Delarue J, 2016, MOL NUTR FOOD RES, V60, P147, DOI 10.1002/mnfr.201500346; Della Casa L, 2016, GENES NUTR, V11, DOI 10.1186/s12263-016-0542-2; Delzenne NM, 2015, DIABETOLOGIA, V58, P2206, DOI 10.1007/s00125-015-3712-7; Druart C, 2015, MOL NUTR FOOD RES, V59, P1603, DOI 10.1002/mnfr.201500014; Druart C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087560; Ducheix S, 2013, BIOCHEM PHARMACOL, V86, P96, DOI 10.1016/j.bcp.2013.03.016; Ducheix S, 2013, J HEPATOL, V58, P984, DOI 10.1016/j.jhep.2013.01.006; Ferramosca A, 2014, WORLD J GASTROENTERO, V20, P1746, DOI 10.3748/wjg.v20.i7.1746; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gwang-woong G, 2013, J MICROBIOL BIOTECHN, V23, P1569, DOI 10.4014/jmb.1308.08008; Honkanen AM, 2016, BRIT J NUTR, V115, P2093, DOI 10.1017/S0007114516001446; Jenkins TC, 2008, J ANIM SCI, V86, P397, DOI 10.2527/jas.2007-0588; Kelley DS, 2009, BRIT J NUTR, V101, P701, DOI 10.1017/S0007114508027451; Kim JH, 2016, ANNU REV FOOD SCI T, V7, P221, DOI 10.1146/annurev-food-041715-033028; Lee YJ, 2011, J NUTR, V141, P1445, DOI 10.3945/jn.111.138396; Lee Y, 2010, J NUTR BIOCHEM, V21, P490, DOI 10.1016/j.jnutbio.2009.02.005; Liu WS, 2016, CELL MOL LIFE SCI, V73, P1969, DOI 10.1007/s00018-016-2161-x; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Marques TM, 2015, BRIT J NUTR, V113, P728, DOI 10.1017/S0007114514004206; McIntosh FM, 2009, MICROBIOL-SGM, V155, P285, DOI 10.1099/mic.0.022921-0; Mitchell PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052634; Moya-Camarena SY, 1999, J LIPID RES, V40, P1426; Nagao K, 2005, J NUTR, V135, P9, DOI 10.1093/jn/135.1.9; O'Shea EF, 2012, INT J FOOD MICROBIOL, V152, P189, DOI 10.1016/j.ijfoodmicro.2011.05.025; Pachikian B. D., 2008, BMC Physiology, V8, P21, DOI 10.1186/1472-6793-8-21; Pachikian BD, 2013, MOL NUTR FOOD RES, V57, P347, DOI 10.1002/mnfr.201200364; Pachikian BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023365; Pini M, 2016, FASEB J, V30, P241, DOI 10.1096/fj.15-276675; Raimondi S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8654317; Russell DA, 2011, INT J FOOD MICROBIOL, V149, P88, DOI 10.1016/j.ijfoodmicro.2011.06.003; SATTAR N, 2014, BMJ-BRIT MED J, V349, DOI DOI 10.1136/BMJ.G4596; Shen W, 2013, J LIPID RES, V54, P909, DOI 10.1194/jlr.M030924; Tan NS, 2016, PROG LIPID RES, V64, P98, DOI 10.1016/j.plipres.2016.09.001; Tilg H, 2016, GUT, V65, P2035, DOI 10.1136/gutjnl-2016-312729; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025	44	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192447	10.1371/journal.pone.0192447	http://dx.doi.org/10.1371/journal.pone.0192447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389988	Green Submitted, Green Published, gold			2022-12-26	WOS:000423793400092
J	Ndjoyi-Mbiguino, A; Kombe, AJK; Bivigou-Mboumba, B; Zoa-Assoumou, S; Akombi, FL; Nzengui, FN; Kamdem, HM; Francois-Souquiere, S				Ndjoyi-Mbiguino, Angelique; Kombe, Arnaud John Kombe; Bivigou-Mboumba, Berthold; Zoa-Assoumou, Samira; Akombi, Falone Larissa; Nzengui, Francis Nzengui; Kamdem, Herve M'boyis; Francois-Souquiere, Sandrine			Low prevalence of HCV infection with predominance of genotype 4 among HIV patients living in Libreville, Gabon	PLOS ONE			English	Article							HEPATITIS-C VIRUS; BLOOD-DONORS; TRANSMISSION; EPIDEMIOLOGY; COINFECTION; CAMEROON; AFRICA; BURDEN; RISK; RNA	Background Gabon is an endemic area for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) and the risk of co-infection is high. Method Between November 2015 and April 2016, we conducted retrospective study on HCV infection among people living with HIV/AIDS (PLHA). A total of 491 PLHA were included in this study and tested for the presence of HCV infection. HIV viral loads were obtained using the Generic HIV viral Load (R) assay and the CD4+ T cells count was performed using BD FACS-Count (TM) T CD4 reagents. HCV screening was performed using the MP Diagnostics HCV ELISA 4.0 kit. HCV genotypes were determined by sequence analysis of NS5B and Core regions. The Mann-Whitney test was used to compare the groups. Chi-2 test and Fisher's Exact Test were used to compare prevalence. Results HCV seroprevalence was 2.9% (14/491), (95% confidence interval (CI): 1.4 +/- 4.3%). The percentage of HCV viremic patients, defined by the detection of HCV RNA in plasma, was 57% (8/14), representing 1.6% of the total population. HCV seroprevalence and replicative infection were not statistically differ with gender. The percentage of co-infection increased with age. No correlation with CD4+ T cells count and HIV viral load level was registered in this study. Identified HCV strains were predominantly of genotype 4 (87.5%) including 4k, 4e, 4g, 4p, 4f and 4c subtypes. Only one strain belonged to genotype 2 (subtype 2q). Analysis of the NS5B region did not reveal the presence of resistance-associated substitutions for sofosbuvir. Conclusion A systematic screening of hepatitis C is therefore strongly recommended as well as genotyping of HCV strains in order to adapt treatments for the specific case of people living with HIV/AIDS in Central Africa.	[Ndjoyi-Mbiguino, Angelique; Kombe, Arnaud John Kombe; Bivigou-Mboumba, Berthold; Zoa-Assoumou, Samira; Akombi, Falone Larissa; Nzengui, Francis Nzengui; Kamdem, Herve M'boyis; Francois-Souquiere, Sandrine] Univ Sci Sante, Fac Med & Sci Sante, Dept Bacteriol Virol, Lab Natl Reference IST Sida, Owendo, Gabon; [Kombe, Arnaud John Kombe; Bivigou-Mboumba, Berthold; Akombi, Falone Larissa; Francois-Souquiere, Sandrine] Ctr Int Rech Med CIRM, Unite Mixte Recherches VIH, Libreville, Gabon; [Kombe, Arnaud John Kombe; Bivigou-Mboumba, Berthold; Akombi, Falone Larissa; Francois-Souquiere, Sandrine] Ctr Int Rech Med CIRM, Malad Infect Associees UMR VIH MIA, Libreville, Gabon		Francois-Souquiere, S (corresponding author), Univ Sci Sante, Fac Med & Sci Sante, Dept Bacteriol Virol, Lab Natl Reference IST Sida, Owendo, Gabon.; Francois-Souquiere, S (corresponding author), Ctr Int Rech Med CIRM, Unite Mixte Recherches VIH, Libreville, Gabon.; Francois-Souquiere, S (corresponding author), Ctr Int Rech Med CIRM, Malad Infect Associees UMR VIH MIA, Libreville, Gabon.	sandsouquiere@yahoo.fr	KOMBE, ARNAUD KOMBE/AAF-4919-2019	KOMBE, ARNAUD KOMBE/0000-0003-1533-1913	Centre International de Recherches Medicales de Franceville; Gabonese Government; Total Gabon; French Foreign Ministry	Centre International de Recherches Medicales de Franceville; Gabonese Government; Total Gabon(Total SA); French Foreign Ministry	The study was funded by the Centre International de Recherches Medicales de Franceville, which is funded by the Gabonese Government, Total Gabon and the French Foreign Ministry. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to all patients who participated to this study. We also especially thank the clinicians. We thank Mrs. Leonie NGOUANGA for blood sampling. We thank Dr Katharine Abernethy for reading the manuscript. The Centre International de Recherches Medicales de Franceville (CIRMF), Gabon, is funded by the Gabonese Government, Total Gabon and the French Foreign Ministry.	Alidjinou EK, 2014, J INFECT DEV COUNTR, V8, P1068, DOI 10.3855/jidc.4767; Bruggmann P, 2014, J VIRAL HEPATITIS, V21, P5, DOI 10.1111/jvh.12247; BUKH J, 1992, P NATL ACAD SCI USA, V89, P187, DOI 10.1073/pnas.89.1.187; Cacoub P, 2015, LIVER INT, V35, P65, DOI 10.1111/liv.12639; Cantaloube JF, 2010, J MED VIROL, V82, P562, DOI 10.1002/jmv.21724; Cuypers L, 2015, VIRUSES-BASEL, V7, P5018, DOI 10.3390/v7092857; El-Sherif O, 2015, CURR OPIN HIV AIDS, V10, P348, DOI 10.1097/COH.0000000000000185; Fabbri G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2287-y; Galani BRT, 2016, J TRANSL INTERN MED, V4, P162, DOI 10.1515/jtim-2016-0037; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Guerra J, 2012, J VIRAL HEPATITIS, V19, P560, DOI 10.1111/j.1365-2893.2011.01576.x; Iles JC, 2015, J CLIN MICROBIOL, V53, P3155, DOI 10.1128/JCM.00483-15; Iles JC, 2013, INFECT GENET EVOL, V19, P386, DOI 10.1016/j.meegid.2013.01.021; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Luma Henry Namme, 2016, Open AIDS J, V10, P199, DOI 10.2174/1874613601610010199; Modi AA, 2007, AIDS REV, V9, P25; Murphy DG, 2015, J CLIN MICROBIOL, V53, P967, DOI 10.1128/JCM.02831-14; Muzembo BA, 2016, PUBLIC HEALTH, V139, P13, DOI 10.1016/j.puhe.2016.06.017; Nambei WS, 2016, MED SANTE TROP, V26, P192, DOI 10.1684/mst.2016.0553; Ndong-Atome GR, 2008, J MED VIROL, V80, P1581, DOI 10.1002/jmv.21252; Ndong-Atome GR, 2009, J CLIN VIROL, V45, P349, DOI 10.1016/j.jcv.2009.04.017; Ndong-Atome GR, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-82; Njouom R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042002; Njouom R, 2009, J GEN VIROL, V90, P2452, DOI 10.1099/vir.0.011981-0; Noubiap JJN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137375; Pasquier C, 2005, J MED VIROL, V77, P390, DOI 10.1002/jmv.20468; Pei RJ, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-9; Pepin J, 2010, CLIN INFECT DIS, V51, P768, DOI 10.1086/656233; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Rao VB, 2015, LANCET INFECT DIS, V15, P819, DOI 10.1016/S1473-3099(15)00006-7; Riou J, 2016, J VIRAL HEPATITIS, V23, P244, DOI 10.1111/jvh.12481; Rouet F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116975; Ruta S, 2015, WORLD J GASTROENTERO, V21, P10811, DOI 10.3748/wjg.v21.i38.10811; Sereno S, 2009, J CLIN VIROL, V45, P354, DOI 10.1016/j.jcv.2009.04.022; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; World Health Organization, 2016, HIV AIDS FACT SHEET; Xie DD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139947	37	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0190529	10.1371/journal.pone.0190529	http://dx.doi.org/10.1371/journal.pone.0190529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385148	Green Submitted, Green Published, gold			2022-12-26	WOS:000423668400018
J	Schmid, D; Behrens, G; Arem, H; Hart, C; Herr, W; Jochem, C; Matthews, CE; Leitzmann, MF				Schmid, Daniela; Behrens, Gundula; Arem, Hannah; Hart, Christina; Herr, Wolfgang; Jochem, Carmen; Matthews, Charles E.; Leitzmann, Michael F.			Pre- and post-diagnosis physical activity, television viewing, and mortality among hematologic cancer survivors	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; COLORECTAL-CANCER; NATIONAL INSTITUTES; BREAST-CANCER; AARP DIET; HEALTH; ASSOCIATION; INACTIVITY; EXERCISE; TIME	Purpose The associations of physical activity and television (TV) viewing with mortality risk among individuals with hematologic malignancies remain unclear. Methods We examined the relations of physical activity and TV viewing time before and after diagnosis with mortality among 5182 U.S. adults aged 50-71 years from the NIH-AARP Diet and Health Study cohort who survived a first primary hematologic cancer between 1995-1996 and 2011. Results For the pre- and post-diagnosis analyses, we confirmed 2606 and 613 deaths respectively. In multivariable-adjusted Cox proportional hazard regression models, comparing high (>= 4 hrs/wk) versus low (<1 hr/wk) activity levels, pre-diagnosis physical activity was associated with 18%-22% reduced risks of all-cause mortality among all hematologic cancer survivors, and survivors of non-Hodgkin lymphoma, myeloma, and leukemia, respectively. Additional control for BMI had little impact on the results, expect for myeloma survivors, for whom the association was no longer significant. Post-diagnosis physical activity was related to risk reductions in mortality ranging from 36%-47%. The associations for TV viewing did not show a clear pattern. Conclusion Our study suggests that pre- and post-diagnosis physical activity is associated with lower risk of all-cause mortality among hematologic cancer survivors. Further research is required to confirm this observation.	[Schmid, Daniela; Behrens, Gundula; Jochem, Carmen; Leitzmann, Michael F.] Univ Regensburg, Dept Epidemiol & Prevent Med, Regensburg, Germany; [Arem, Hannah] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Epidemiol & Biostat, Washington, DC USA; [Hart, Christina; Herr, Wolfgang] Univ Hosp Regensburg, Dept Internal Med Haematol & Oncol 3, Regensburg, Germany; [Matthews, Charles E.] NCI, Div Canc Epidemiol & Genet, Metab Epidemiol Branch, Bethesda, MD 20892 USA	University of Regensburg; George Washington University; University of Regensburg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schmid, D (corresponding author), Univ Regensburg, Dept Epidemiol & Prevent Med, Regensburg, Germany.	daniela.schmid@ukr.de	Schmid, Daniela/GPG-1151-2022; matthews, Charles e/E-8073-2015	matthews, Charles e/0000-0001-8037-3103; Behrens, Gundula/0000-0002-9355-6491	NATIONAL CANCER INSTITUTE [ZIACP010196] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arem H, 2016, CANCER CAUSE CONTROL, V27, P1403, DOI 10.1007/s10552-016-0813-7; Arem H, 2015, J CLIN ONCOL, V33, P180, DOI 10.1200/JCO.2014.58.1355; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Bjordal K, 1995, ORAL ONCOL, V31B, P340, DOI 10.1016/0964-1955(95)00039-9; Bouillet T, 2015, CRIT REV ONCOL HEMAT, V94, P74, DOI 10.1016/j.critrevonc.2014.12.012; Boyle T, 2017, BRIT J HAEMATOL, V178, P442, DOI 10.1111/bjh.14702; Campbell PT, 2013, J CLIN ONCOL, V31, P876, DOI 10.1200/JCO.2012.45.9735; Cao Y, 2015, CANCER CAUSE CONTROL, V26, P1467, DOI 10.1007/s10552-015-0645-x; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Courneya KS, 2015, RES Q EXERCISE SPORT, V86, P107, DOI 10.1080/02701367.2015.991265; Courneya KS, 2015, CANCER CAUSE CONTROL, V26, P269, DOI 10.1007/s10552-014-0508-x; Demark-Wahnefried W, 2006, J CLIN ONCOL, V24, P5125, DOI 10.1200/JCO.2006.06.6175; Dores GM, 2002, J CLIN ONCOL, V20, P3484, DOI 10.1200/JCO.2002.09.038; Fong DYT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e70; Fritz A, INT CLASSIFICATION D, V3; Ganz PA, 2004, JNCI-J NATL CANCER I, V96, P376, DOI 10.1093/jnci/djh060; George SM, 2013, J CANCER SURVIV, V7, P247, DOI 10.1007/s11764-013-0265-y; Gutschoven K, 2004, PREV MED, V39, P1093, DOI 10.1016/j.ypmed.2004.04.019; Hamilton MT, 2004, EXERC SPORT SCI REV, V32, P161; Hill ME, 2001, SOC SECUR BULL, V64, P45; Hobbs M, 2015, BRIT J SPORT MED, V49, P1179, DOI 10.1136/bjsports-2014-093754; Keats MR, 2017, J CANCER SURVIV, V11, P264, DOI 10.1007/s11764-016-0584-x; Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602; Laufs U, 2005, ARTERIOSCL THROM VAS, V25, P809, DOI 10.1161/01.ATV.0000158311.24443.af; Lynch BM, 2010, CANCER EPIDEM BIOMAR, V19, P2691, DOI 10.1158/1055-9965.EPI-10-0815; Maass SWMC, 2015, MATURITAS, V82, P100, DOI 10.1016/j.maturitas.2015.04.010; Marshall AL, 2010, MED SCI SPORT EXER, V42, P1094, DOI 10.1249/MSS.0b013e3181c5ec18; Matthews CE, 2018, MED SCI SPORT EXER, V50, P266, DOI 10.1249/MSS.0000000000001428; McCabe MS, 2013, SEMIN ONCOL, V40, P804, DOI 10.1053/j.seminoncol.2013.09.004; Michael YL, 2000, CANCER-AM CANCER SOC, V89, P2176, DOI 10.1002/1097-0142(20001201)89:11<2176::AID-CNCR5>3.0.CO;2-6; Otten JJ, 2010, OBESITY, V18, P1273, DOI 10.1038/oby.2009.371; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Roberts CK, 2005, J APPL PHYSIOL, V98, P3, DOI 10.1152/japplphysiol.00852.2004; Rock Cheryl L, 2012, CA Cancer J Clin, V62, P243, DOI 10.3322/caac.21142; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Schmidt ME, 2013, INT J CANCER, V133, P1431, DOI 10.1002/ijc.28130; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Servaes P, 2002, EUR J CANCER, V38, P27, DOI 10.1016/S0959-8049(01)00332-X; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sweeney C, 2006, JNCI-J NATL CANCER I, V98, P521, DOI 10.1093/jnci/djj130; Thomas RJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-096343; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Wiskemann J, 2015, INT J CANCER, V137, P2749, DOI 10.1002/ijc.29633; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	44	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0192078	10.1371/journal.pone.0192078	http://dx.doi.org/10.1371/journal.pone.0192078			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU2GT	29385194	Green Published, gold, Green Submitted			2022-12-26	WOS:000423668400075
J	Wan, Y; Jin, HJ; Zhu, YY; Fang, Z; Mao, L; He, QW; Xia, YP; Li, M; Li, YN; Chen, XQ; Hu, B				Wan, Yan; Jin, Hui-Juan; Zhu, Yi-Yi; Fang, Zhi; Mao, Ling; He, Quanwei; Xia, Yuan-Peng; Li, Man; Li, Yanan; Chen, Xiaoqian; Hu, Bo			MicroRNA-149-5p regulates blood-brain barrier permeability after transient middle cerebral artery occlusion in rats by targeting S1PR2 of pericytes	FASEB JOURNAL			English	Article						pericyte migration; N-cadherin; NF-kappa B p65; stroke	SPHINGOSINE 1-PHOSPHATE; ISCHEMIC-STROKE; TIGHT JUNCTION; MIGRATION; SPHINGOSINE-1-PHOSPHATE; RECEPTOR; MIR-149; EXPRESSION; PROTEINS; CELLS	Blood-brain barrier (BBB) disruption caused by reperfusion injury after ischemic stroke is an intractable event conducive to further injury. Brain pericytes play a vital role in maintaining BBB integrity by interacting with other components of the BBB. In this study, we found that sphingosine-1-phosphate receptor (S1PR)2 expressed in pericytes was significantly up-regulated after ischemia in vivo and in vitro. By using a S1PR2 antagonist (JTE-013), we showed that S1PR2 plays a critical role in the induction of BBB permeability of transient middle cerebral artery occlusion (tMCAO) rats and the in vitro BBB model. Furthermore, we discovered that S1PR2 may decrease N-cadherin expression and increase pericyte migration via NF-kappa B p65 signal and found that S1PR2 could be regulated by miR-149-5p negatively, which was decreased in the ischemic boundary zone and cultured pericytes after ischemia. Overexpression of miR-149-5p in cultured pericytes substantially increased N-cadherin expression and decreased pericyte migration, which decreased BBB leakage in the in vitro model. Up-regulating miR-149-5p by intracerebroventricular injection of agomir-149-5p attenuated BBB permeability and improved the outcomes of tMCAO rats significantly. Thus, our data suggest that miR-149-5p may serve as a potential target for treatment of BBB disruption after ischemic stroke.				hubo@mail.hust.edu.cn	Fang, Zhi/AGE-7582-2022; xia, yuanpeng/S-7988-2019	Fang, Zhi/0000-0002-9495-4467	National Natural Science Foundation of China [81571119, 81371311, 81671147]; National Key Research and Development Program of China [2016YFC1300600]; New Century Excellent Talents in University [NCET-10-0406]; Integrated Innovative Team for Major Human Disease Program of Tongji Medical College (HUST) [5001530026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Integrated Innovative Team for Major Human Disease Program of Tongji Medical College (HUST)	This work was supported by the National Natural Science Foundation of China (Grants 81571119 and 81371311 to B.H.; Grant 81671147 to H.J.), the National Key Research and Development Program of China Grant 2016YFC1300600), the New Century Excellent Talents in University Grant NCET-10-0406 to B.H.), and Integrated Innovative Team for Major Human Disease Program of Tongji Medical College (HUST) (Grant 5001530026). The authors declare no conflicts of interest.	[Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Brait VH, 2016, STROKE, V47, P3053, DOI 10.1161/STROKEAHA.116.015371; Braun A, 2007, J NEUROSCI, V27, P12012, DOI 10.1523/JNEUROSCI.3281-07.2007; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Duan HY, 2014, CANCER RES, V74, P5782, DOI 10.1158/0008-5472.CAN-14-0650; Dusaban SS, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0882-x; Duz B, 2007, CRYOBIOLOGY, V55, P279, DOI 10.1016/j.cryobiol.2007.08.009; Fang Z, 2016, FASEB J, V30, P2097, DOI 10.1096/fj.201500126; Fayyaz S, 2014, DIABETOLOGIA, V57, P373, DOI 10.1007/s00125-013-3123-6; Gaire B. P., 2017, MOL NEUROBIOL; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gonul E, 2002, MICROVASC RES, V64, P116, DOI 10.1006/mvre.2002.2413; He QW, 2013, MOL NEUROBIOL, V47, P976, DOI 10.1007/s12035-013-8396-8; Hsieh MJ, 2014, BRIT J PHARMACOL, V171, P3037, DOI 10.1111/bph.12626; Jeon YJ, 2013, ARTERIOSCL THROM VAS, V33, P420, DOI 10.1161/ATVBAHA.112.300251; Jin L, 2016, MOL MED REP, V13, P5386, DOI 10.3892/mmr.2016.5205; Kim GS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8893; Kim JH, 2009, J NEUROSCI RES, V87, P653, DOI 10.1002/jnr.21884; Kimura A, 2008, STROKE, V39, P3411, DOI 10.1161/STROKEAHA.108.514612; Li L, 2015, INT J CLIN EXP MED, V8, P15351; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Luo G, 2015, ONCOTARGET, V6, P37808, DOI 10.18632/oncotarget.5676; McGuire PG, 2011, ARTERIOSCL THROM VAS, V31, pE107, DOI 10.1161/ATVBAHA.111.235408; Molina CA, 2009, CEREBROVASC DIS, V27, P162, DOI 10.1159/000200455; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Ozen I, 2014, ACTA NEUROPATHOL, V128, P381, DOI 10.1007/s00401-014-1295-x; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Pfister F, 2008, DIABETES, V57, pA234, DOI 10.2337/db08-0325; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rosen H, 2013, ANNU REV BIOCHEM, V82, P637, DOI 10.1146/annurev-biochem-062411-130916; Sa-Pereira I, 2012, MOL NEUROBIOL, V45, P327, DOI 10.1007/s12035-012-8244-2; Sanchez T, 2007, ARTERIOSCL THROM VAS, V27, P1312, DOI 10.1161/ATVBAHA.107.143735; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Santini P, 2014, RHEUMATOL INT, V34, P711, DOI 10.1007/s00296-013-2754-8; Saver JL, 2011, J THROMB HAEMOST, V9, P333, DOI 10.1111/j.1538-7836.2011.04371.x; Sayed ASM, 2015, CLINICS, V70, P257, DOI 10.6061/clinics/2015(04)07; Sheikh MSA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/740301; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Song L, 2007, BLOOD, V109, P1515, DOI 10.1182/blood-2006-07-034009; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; Testai FD, 2014, J NEUROCHEM, V131, P530, DOI 10.1111/jnc.12836; Thomsen LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134765; Underly RG, 2017, J NEUROSCI, V37, P129, DOI 10.1523/JNEUROSCI.2891-16.2016; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Wang MD, 2016, MOL NEUROBIOL, V53, P1310, DOI 10.1007/s12035-015-9099-0; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Xu GX, 2014, J CELL BIOCHEM, V115, P919, DOI 10.1002/jcb.24734; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222; Zhang WL, 2013, PROSTAG OTH LIPID M, V106, P62, DOI 10.1016/j.prostaglandins.2013.06.001; Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386; Zhu JL, 2017, NEOPLASIA, V19, P672, DOI 10.1016/j.neo.2017.06.002	56	50	56	2	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3133	3148		10.1096/fj.201701121R	http://dx.doi.org/10.1096/fj.201701121R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401609				2022-12-26	WOS:000432546000020
J	Serrano-Perez, MC; Tilley, FC; Nevo, F; Arrondel, C; Sbissa, S; Martin, G; Tory, K; Antignac, C; Mollet, G				Serrano-Perez, Maria-Carmen; Tilley, Frances C.; Nevo, Fabien; Arrondel, Christelle; Sbissa, Selim; Martin, Gaelle; Tory, Kalman; Antignac, Corinne; Mollet, Geraldine			Endoplasmic reticulum-retained podocin mutants are massively degraded by the proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT NEPHROTIC SYNDROME; QUALITY-CONTROL; MEMBRANE TOPOLOGY; PROTEIN PODOCIN; SLIT DIAPHRAGM; N-GLYCANASE; CALNEXIN; DEGRADATION; NEPHRIN; NPHS2	Podocin is a key component of the slit diaphragm in the glomerular filtration barrier, and mutations in the podocin-encoding gene NPHS2 are a common cause of hereditary steroid-resistant nephrotic syndrome. A mutant allele encoding podocin with a p. R138Q amino acid substitution is the most frequent pathogenic variant in European and North American children, and the corresponding mutant protein is poorly expressed and retained in the endoplasmic reticulum both in vitro and in vivo. To better understand the defective trafficking and degradation of this mutant, we generated human podocyte cell lines stably expressing podocin(wt) or podocin(R138Q). Although it has been proposed that podocin has a hairpin topology, we present evidence for podocin(R138Q) N-glycosylation, suggesting that most of the protein has a transmembrane topology. We find that N-glycosylated podocin(R138Q) has a longer half-life than non-glycosylated podocin(R138Q) and that the latter is far more rapidly degraded than podocinwt. Consistent with its rapid degradation, podocin(R138Q) is exclusively degraded by the proteasome, whereas podocinwt is degraded by both the proteasomal and the lysosomal proteolytic machineries. In addition, we demonstrate an enhanced interaction of podocin(R138Q) with calnexin as the mechanism of endoplasmic reticulum retention. Calnexin knockdown enriches the podocin(R138Q) non-glycosylated fraction, whereas preventing exit from the calnexin cycle increases the glycosylated fraction. Altogether, we propose a model in which hairpin podocin(R138Q) is rapidly degraded by the proteasome, whereas transmembrane podocin(R138Q) degradation is delayed due to entry into the calnexin cycle.	[Serrano-Perez, Maria-Carmen; Tilley, Frances C.; Nevo, Fabien; Arrondel, Christelle; Sbissa, Selim; Martin, Gaelle; Antignac, Corinne; Mollet, Geraldine] INSERM, UMR 1163, Imagine Inst, Lab Hereditary Kidney Dis, F-75015 Paris, France; [Serrano-Perez, Maria-Carmen; Tilley, Frances C.; Nevo, Fabien; Arrondel, Christelle; Sbissa, Selim; Martin, Gaelle; Antignac, Corinne; Mollet, Geraldine] Univ Paris 05, Sorbonne Paris Cite, Imagine Inst, F-75015 Paris, France; [Tory, Kalman] Semmelweis Univ, Hungarian Acad Sci, MTA SE Lendulet Nephrogenet Lab, H-1083 Budapest, Hungary; [Tory, Kalman] Semmelweis Univ, Dept Pediat 1, H-1083 Budapest, Hungary; [Antignac, Corinne] Hop Necker Enfants Malad, AP HP, Dept Genet, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Hungarian Academy of Sciences; Semmelweis University; Semmelweis University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Mollet, G (corresponding author), INSERM, UMR1163, Imagine Inst, 24 Blvd Montparnasse, F-75015 Paris, France.	geraldine.mollet@inserm.fr	ANTIGNAC, Corinne/H-8945-2017; Mollet, Geraldine/E-8049-2017	ANTIGNAC, Corinne/0000-0002-9934-4940; Mollet, Geraldine/0000-0003-4685-5736	European Union [305608]; Agence Nationale de la Recherche under "Investissements d'avenir" program [ANR-10-IAHU-01]; Association des Malades d'un Syndrome Nephrotique (AMSN) (Programme Ambition Recherche)	European Union(European Commission); Agence Nationale de la Recherche under "Investissements d'avenir" program(French National Research Agency (ANR)); Association des Malades d'un Syndrome Nephrotique (AMSN) (Programme Ambition Recherche)	This work was supported by European Union's Seventh Framework Programme Grant FP7/2007-2013/no305608-EURenOmics (to C. Antignac), State funding from the Agence Nationale de la Recherche under "Investissements d'avenir" program Grant ANR-10-IAHU-01 (to C. Antignac), and Association des Malades d'un Syndrome Nephrotique (AMSN) (Programme Ambition Recherche 2008 - 2011 (to G. Mollet). The authors declare that they have no conflicts of interest with the contents of this article.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; ARUNACHALAM B, 1995, J BIOL CHEM, V270, P2784, DOI 10.1074/jbc.270.6.2784; Bonuccelli G, 2007, CELL CYCLE, V6, P1242, DOI 10.4161/cc.6.10.4182; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Buac D, 2013, CURR PHARM DESIGN, V19, P4025, DOI 10.2174/1381612811319220012; Bubeck A, 2002, J BIOL CHEM, V277, P2216, DOI 10.1074/jbc.M104178200; Cannon KS, 1996, J BIOL CHEM, V271, P14280, DOI 10.1074/jbc.271.24.14280; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; Drozdova T, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.86; FAY D.S., 2013, BIOL GUIDE STAT THIN, P1; Fontanini A, 2005, J BIOL CHEM, V280, P2378, DOI 10.1074/jbc.M405104200; Frenkel Z, 2003, J BIOL CHEM, V278, P34119, DOI 10.1074/jbc.M305929200; Godel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057078; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hideshima Teru, 2003, Rev Clin Exp Hematol, V7, P191; Hinkes BG, 2007, PEDIATRICS, V119, pE907, DOI 10.1542/peds.2006-2164; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Kadurin I, 2009, BIOCHEM J, V418, P587, DOI 10.1042/BJ20081662; Kamhi-Nesher S, 2001, MOL BIOL CELL, V12, P1711, DOI 10.1091/mbc.12.6.1711; Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Lederkremer GZ, 2005, TRENDS BIOCHEM SCI, V30, P297, DOI 10.1016/j.tibs.2005.04.010; LI WW, 1994, MOL CELL BIOL, V14, P5533, DOI 10.1128/MCB.14.8.5533; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mekahli D, 2009, PEDIATR NEPHROL, V24, P1525, DOI 10.1007/s00467-009-1138-5; Ohashi T, 2003, HISTOCHEM CELL BIOL, V119, P257, DOI 10.1007/s00418-003-0511-x; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Philippe A, 2008, KIDNEY INT, V73, P1038, DOI 10.1038/ki.2008.27; Rinschen MM, 2016, HUM MOL GENET, V25, P1328, DOI 10.1093/hmg/ddw016; Roselli S, 2004, TRAFFIC, V5, P37, DOI 10.1046/j.1600-0854.2003.00148.x; Roselli S, 2002, AM J PATHOL, V160, P131, DOI 10.1016/S0002-9440(10)64357-X; Sadowski CE, 2015, J AM SOC NEPHROL, V26, P1279, DOI 10.1681/ASN.2014050489; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schurek EM, 2014, J BIOL CHEM, V289, P11262, DOI 10.1074/jbc.M113.521773; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Tory K, 2014, NAT GENET, V46, P299, DOI 10.1038/ng.2898; Tune BM, 1997, J AM SOC NEPHROL, V8, P824; Volker LA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-102; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; WOODEN SK, 1991, MOL CELL BIOL, V11, P5612, DOI 10.1128/MCB.11.11.5612; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	47	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4122	4133		10.1074/jbc.RA117.001159	http://dx.doi.org/10.1074/jbc.RA117.001159			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29382718	hybrid, Green Published			2022-12-26	WOS:000427587500023
J	Villalobos, G				Villalobos, Gabriel			Brownian orientational lath model (BOLD): A computational model relating the self-assembly in a fluid of lath like particles with its rheology and gelation	PLOS ONE			English	Article							THIOPHENE DIMER; POLY(3-HEXYLTHIOPHENE); SIMULATIONS; STACKING; FORCE; GELS	By means of a computational model, we study the relation between two complementary views of gelation, rheological tests against the characterization of a network of consecutive particles. The model we propose consists of slender, plane, colloidal sized particles, which we name laths, which self-assemble into long ordered aggregates of several particles; called whiskers in the literature. Within a whisker, the interaction potential is a minimum when: the planes of two consecutive laths are aligned, thus favoring their alignment; when the center of three consecutive laths lie in a straight line, thus favoring stacking; and when the center of two consecutive laths are located at a certain distance, which mimics excluded volume. A threshold value of the potential gives a condition for sticking free laths into whiskers, and for the breaking of whiskers. The simplicity of the model allows the simulation to reach large enough times, of the order of minutes, needed to simulate numerical rheology tests. We are able to characterize the whisker formation, as well as to simulate the gel transition, by means of an oscillatory shear numerical experiment. We conclude that according to the usual rheological definition a gel transition occurs at about 250K, even though there is no branching and less than 10% of whiskers are long enough as to percolate the system.	[Villalobos, Gabriel] Univ Twente, Computat Biophys, POB 217, NL-7500 AE Enschede, Netherlands; [Villalobos, Gabriel] Univ Bogota Jorge Tadeo Lozano, Dept Ciencias Basicas, Carrera 4 22-61 Modulo 6, Bogota 110311, Colombia	University of Twente	Villalobos, G (corresponding author), Univ Twente, Computat Biophys, POB 217, NL-7500 AE Enschede, Netherlands.; Villalobos, G (corresponding author), Univ Bogota Jorge Tadeo Lozano, Dept Ciencias Basicas, Carrera 4 22-61 Modulo 6, Bogota 110311, Colombia.	gabriel.villalobosc@utadeo.edu.co		Villalobos, Gabriel/0000-0003-4582-265X	Ozofab [EOST-10023-OZOFAB]; ESMI [262348]	Ozofab; ESMI	Some of the simulations for this paper used computational time from the "Centro de Informatica y Biologia Computacional BIOS," and ran through the "Red Nacional Academica de Tecnologia Avanzada, RENATA." This work was partially funded by Ozofab, EOST-10023-OZOFAB; and ESMI, Grant Agreement No. 262348 "ESMI."	Abrams CF, 2003, MACROMOLECULES, V36, P260, DOI 10.1021/ma0213495; Allen M. P., 1989, COMPUTER SIMULATION, DOI DOI 10.1093/OSO/9780198803195.001.0001; Bhatta RS, 2013, J PHYS CHEM B, V117, P10035, DOI 10.1021/jp404629a; Briels WJ, 2009, SOFT MATTER, V5, P4401, DOI 10.1039/b911310j; CATES ME, 1990, J PHYS-CONDENS MAT, V2, P6869, DOI 10.1088/0953-8984/2/33/001; Cobb PD, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1997149; Dag S, 2010, J PHYS CHEM B, V114, P5997, DOI 10.1021/jp1008219; de Oliveira ISS, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3633701; Doi M., 1986, THEORY POLYM DYNAMIC; Hayashi N, 2009, X PI INTERACTIONS AR, P103; Hore MJA, 2014, MACROMOLECULES, V47, P875, DOI 10.1021/ma402179w; Kazem N, 2015, SOFT MATTER, V11, P7877, DOI 10.1039/c5sm01845e; Keller A, 1995, FARADAY DISCUSS, V101, P1, DOI 10.1039/fd9950100001; Koppe M, 2009, MACROMOLECULES, V42, P4661, DOI 10.1021/ma9005445; Larson R. G., 1999, STRUCTURE RHEOLOGY C, V150; Lee CK, 2013, MACROMOLECULES, V46, P1932, DOI 10.1021/ma302343e; Lee CK, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3687241; Lee CK, 2009, J PHYS CHEM B, V113, P15937, DOI 10.1021/jp907338j; Lim JA, 2010, MATER TODAY, V13, P14, DOI 10.1016/S1369-7021(10)70080-8; MCCULLOUGH RD, 1993, J AM CHEM SOC, V115, P4910, DOI 10.1021/ja00064a070; Newbloom GM, 2012, MACROMOLECULES, V45, P3452, DOI 10.1021/ma202564k; Newbloom GM, 2011, MACROMOLECULES, V44, P3801, DOI 10.1021/ma2000515; Ngo T. T., 2012, ADV NAT SCI NANOSCI, V3; Padding JT, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/23/233101; Rodriguez-Ropero F, 2008, J COMPUT CHEM, V29, P69, DOI 10.1002/jcc.20763; Scherlis DA, 2005, J AM CHEM SOC, V127, P3207, DOI 10.1021/ja043557d; Schwarz KN, 2013, NANOSCALE, V5, P2017, DOI 10.1039/c3nr33324h; Tao YG, 2006, KAYAKING WAGGING RIG; Tschop W, 1998, ACTA POLYM, V49, P61, DOI 10.1002/(SICI)1521-4044(199802)49:2/3<61::AID-APOL61>3.0.CO;2-V; Tsuzuki S, 2002, J AM CHEM SOC, V124, P12200, DOI 10.1021/ja0204877; Villalobos G, DATA SET BROWNIAN OR; Zhao J, 2009, J PHYS CHEM B, V113, P1587, DOI 10.1021/jp804151a	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191785	10.1371/journal.pone.0191785	http://dx.doi.org/10.1371/journal.pone.0191785			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414981	Green Submitted, Green Published, gold			2022-12-26	WOS:000424325300041
J	Ben-Abu, Y; Beiles, A; Flom, D; Nevo, E				Ben-Abu, Yuval; Beiles, Avigdor; Flom, Dvir; Nevo, Eviatar			Adaptive evolution of benzoxazinoids in wild emmer wheat, Triticum dicoccoides, at "Evolution Canyon", Mount Carmel, Israel	PLOS ONE			English	Article							MOLECULAR EVOLUTION; HORDEUM-SPONTANEUM; ECOLOGICAL STRESS; BARLEY; DIMBOA; MAIZE; FUNGI; ADAPTATION; DIVERGENCE; DIVERSITY	Background "Evolution Canyon" (ECI) at Lower Nahal Oren, Mount Carmel, Israel, is an optimal natural microscale model for unraveling evolution-in-action, highlighting the evolutionary processes of biodiversity evolution, adaptation, and incipient sympatric speciation. A major model organism in ECI is the tetraploid wild emmer wheat, Triticum dicoccoides (TD), the progenitor of cultivated emmer and durum wheat. TD displays dramatic interslope adaptive evolutionary divergence on the tropical, savannoid-hot and dry south-facing, "African" slope (AS), and on the temperate, forested, cool and humid, north-facing, "European" slope (ES), separated on average by 250 m. From the perspective of chemical evolution and metabolomics, it is important to unravel interslope divergence in biologically relevant secondary metabolites between the abutting slope populations. Here, in TD we examined hydroxamic acid (Hx), which is a family of secondary cereal metabolites, and plays a major role in defending the plant against fungi, insects and weeds. Results Our examination revealed that higher concentrations of DIBOA and DIMBOA were found in seedlings growing in the same greenhouse from seeds collected from the cool and humid forested ES, whereas the seedlings of seeds collected from the savannoid AS (both in root and shoot tissues), showed no DIMBOA. Remarkably, only DIBOA appears in both shoots and roots of the AS seedlings. It rises to a peak and then decreases in both organs and in seedlings from both slopes. The DIMBOA, which appears only in the ES seedlings, rises to a peak and decreases in the shoot, but increased and remained in a plateau in the root, till the end of the experiment. Conculsions/Significance The results suggest stronger genetic resistance of defense compounds DIBOA and DIMBOA against biotic stresses (fungi and other pathogens) by ES seedlings. However, AS seedlings responded earlier but were to the same biotic stresses. The genetic difference found in AS seedlings was caused by the main adaptive selection in AS, which was against climatic, abiotic stresses, and was weaker, or not at all, against biotic stresses. The distinct genetic interslope differences appear important and is very significant and are elaborated in the discussion.	[Ben-Abu, Yuval] Sapir Acad Coll, DN Hof Ashkelon, Projects & Phys Sect, Ashqelon, Israel; [Beiles, Avigdor; Nevo, Eviatar] Univ Haifa, Inst Evolut, Haifa, Israel; [Flom, Dvir] Ben Gurion Univ Negev, Dept Phys, Beer Sheva, Israel	University of Haifa; Ben Gurion University	Ben-Abu, Y (corresponding author), Sapir Acad Coll, DN Hof Ashkelon, Projects & Phys Sect, Ashqelon, Israel.; Nevo, E (corresponding author), Univ Haifa, Inst Evolut, Haifa, Israel.	yuvalb@sapir.ac.il; nevo@research.haifa.ac.il	Abu, Yuval Ben/AAD-1402-2020					Ahmad S, 2011, PLANT PHYSIOL, V157, P317, DOI 10.1104/pp.111.180224; Cambier V, 2000, PHYTOCHEMISTRY, V53, P223, DOI 10.1016/S0031-9422(99)00498-7; Carlsen SCK, 2009, NAT PROD COMMUN, V4, P199; Chen KJ, 2010, J AGR FOOD CHEM, V58, P12710, DOI 10.1021/jf1032608; Cronin JK, 2007, P NATL ACAD SCI USA, V104, P2773, DOI 10.1073/pnas.0611226104; Dick R, 2012, PLANT CELL, V24, P915, DOI 10.1105/tpc.112.096461; Ebisui K, 1998, Z NATURFORSCH C, V53, P793; Erb M, 2009, PLANT SIGNAL BEHAV, V4, P636, DOI 10.1111/j.1365-313X.2009.03868.x; Flors V, 2007, PLANT J, V52, P1027, DOI 10.1111/j.1365-313X.2007.03299.x; GIVOVICH A, 1992, J CHEM ECOL, V18, P841, DOI 10.1007/BF00988324; Gupta PK, 2002, THEOR APPL GENET, V104, P473, DOI 10.1007/s001220100690; Kalendar R, 2000, P NATL ACAD SCI USA, V97, P6603, DOI 10.1073/pnas.110587497; Korol A, 2006, ISR J ECOL EVOL, V52, P507, DOI 10.1560/IJEE_52_3-4_507; Li YC, 1998, BARLEY GENETICS NEWS, V28, P58; Macias FA, 2005, J AGR FOOD CHEM, V53, P538, DOI 10.1021/jf0484071; Maresh J, 2006, ACS CHEM BIOL, V1, P165, DOI 10.1021/cb600051w; MARTOS A, 1992, J CHEM ECOL, V18, P469, DOI 10.1007/BF00994245; Martyniuk S, 2006, J AGR FOOD CHEM, V54, P1036, DOI 10.1021/jf050901x; McMillan VE, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0212-8; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Neal AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035498; Nevo E, 1998, J EXP ZOOL, V282, P95, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2&lt;95::AID-JEZ12&gt;3.0.CO;2-F; Nevo E, 2005, BIOL J LINN SOC, V84, P205, DOI 10.1111/j.1095-8312.2005.00425.x; NEVO E, 1995, P ROY SOC B-BIOL SCI, V262, P149, DOI 10.1098/rspb.1995.0189; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Nevo E, 1998, CATENA, V33, P241, DOI 10.1016/S0341-8162(98)00071-X; Nevo E., 2004, DYNAMICAL GENETICS, V81, P7231; Nevo E., 2009, TRENDS EVOL BIOL, V1, P3; Nevo E, 2014, ISR J ECOL EVOL, V60, P85, DOI 10.1080/15659801.2014.986879; Nevo E, 2012, P NATL ACAD SCI USA, V109, P2960, DOI 10.1073/pnas.1120633109; NIEMEYER HM, 1988, PHYTOCHEMISTRY, V27, P3349, DOI 10.1016/0031-9422(88)80731-3; Owuor ED, 1997, MOL ECOL, V6, P1177, DOI 10.1046/j.1365-294X.1997.00296.x; Pavlicek Tomas, 2003, Israel Journal of Earth Sciences, V52, P1, DOI 10.1560/QD0A-9T22-4FGL-FGH6; PEREZ FJ, 1990, PHYTOCHEMISTRY, V29, P773, DOI 10.1016/0031-9422(90)80016-A; Sikorski J, 2007, ENVIRON MICROBIOL, V9, P716, DOI 10.1111/j.1462-2920.2006.01193.x; Urban K., 2011, ADV GENETIC RES, P67; WEIBULL J, 1995, PHYSIOL MOL PLANT P, V47, P201, DOI 10.1006/pmpp.1995.1052; Wilkes MA, 1999, SOIL BIOL BIOCHEM, V31, P1831, DOI 10.1016/S0038-0717(99)00104-2; Yin HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122344; ZDERO C, 1990, PHYTOCHEMISTRY, V29, P2611, DOI 10.1016/0031-9422(90)85198-O; ZDERO C, 1988, J NAT PROD, V51, P509, DOI 10.1021/np50057a009	41	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0190424	10.1371/journal.pone.0190424	http://dx.doi.org/10.1371/journal.pone.0190424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408917	Green Submitted, Green Published, gold			2022-12-26	WOS:000424302800007
J	Pansch, C; Hattich, GSI; Heinrichs, ME; Pansch, A; Zagrodzka, Z; Havenhand, JN				Pansch, Christian; Hattich, Giannina S. I.; Heinrichs, Mara E.; Pansch, Andreas; Zagrodzka, Zuzanna; Havenhand, Jonathan N.			Long-term exposure to acidification disrupts reproduction in a marine invertebrate	PLOS ONE			English	Article							BARNACLE SEMIBALANUS-BALANOIDES; OCEAN ACIDIFICATION; CLIMATE-CHANGE; SELF-FERTILIZATION; CO2 CONCENTRATIONS; LARVAL DEVELOPMENT; CARBONIC-ACID; SEA-URCHIN; IMPACTS; TEMPERATURE	Climate change research is advancing to more complex and more comprehensive studies that include long-term experiments, multiple life-history stages, multi-population, and multi-trait approaches. We used a population of the barnacle Balanus improvisus known to be sensitive to short-term acidification to determine its potential for long-term acclimation to acidification. We reared laboratory-bred individuals (as singles or pairs), and field-collected assemblages of barnacles, at pH 8.1 and 7.5 (approximate to 400 and 1600 mu atm pCO(2) respectively) for up to 16 months. Acidification caused strong mortality and reduced growth rates. Acidification suppressed respiration rates and induced a higher feeding activity of barnacles after 6 months, but this suppression of respiration rate was absent after 15 months. Laboratory-bred barnacles developed mature gonads only when they were held in pairs, but nonetheless failed to produce fertilized embryos. Field-collected barnacles reared in the laboratory for 8 months at the same pH's developed mature gonads, but only those in pH 8.1 produced viable embryos and larvae. Because survivors of long-term acidification were not capable of reproducing, this demonstrates that B. improvisus can only partially acclimate to long-term acidification. This represents a clear and significant bottleneck in the ontogeny of this barnacle population that may limit its potential to persist in a future ocean.	[Pansch, Christian; Hattich, Giannina S. I.; Heinrichs, Mara E.; Zagrodzka, Zuzanna; Havenhand, Jonathan N.] Univ Gothenburg, Dept Marine Sci Tjarno, Tjarno, Stromstad, Sweden; [Pansch, Andreas] Alfred Wegener Inst, Helmholtz Zentrum Polar & Meeresforschung, Wattenmeerstation Sylt, List Auf Sylt, Germany; [Pansch, Christian; Hattich, Giannina S. I.] GEOMAR Helmholtz Ctr Ocean Res Kiel, Dept Marine Ecol, Kiel, Germany; [Heinrichs, Mara E.] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Oldenburg, Germany; [Zagrodzka, Zuzanna] Univ Sheffield, Dept Anim & Plant Sci, Sheffield, S Yorkshire, England	University of Gothenburg; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Carl von Ossietzky Universitat Oldenburg; University of Sheffield	Pansch, C (corresponding author), Univ Gothenburg, Dept Marine Sci Tjarno, Tjarno, Stromstad, Sweden.	ch.pansch@gmail.com	Zagrodzka, Zuzanna/AAE-4541-2021; Pansch, Christian/I-9170-2012	Pansch, Christian/0000-0001-8442-4502; Havenhand, Jonathan/0000-0001-6721-7763; Hattich, Giannina Saskia Isabelle/0000-0003-4660-7759	Royal Swedish Academy of Sciences; Royal Society of Arts and Sciences in Gothenburg; Swedish Research Council VR; Swedish Research Council FORMAS	Royal Swedish Academy of Sciences; Royal Society of Arts and Sciences in Gothenburg; Swedish Research Council VR(Swedish Research Council); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	This project was financed by The Royal Swedish Academy of Sciences, partly supported by The Royal Society of Arts and Sciences in Gothenburg to CP and a Linnaeus-grant from the Swedish Research Councils VR and FORMAS to JNH (http://www.cemeb.science.gu.se).	Alsterberg C, 2013, PHYCOLOGIA, V52, P2; Anderson D.T., 1994, BARNACLES STRUCTURE; Andersson AJ, 2015, OCEANOGRAPHY, V28, P16; Barazandeh M, 2013, P ROY SOC LOND B BIO, P280; BARNES H, 1977, J EXP MAR BIOL ECOL, V27, P219, DOI 10.1016/0022-0981(77)90125-3; BARNES H, 1956, J MAR BIOL ASSOC UK, V35, P631, DOI 10.1017/S002531540001047X; Berntsson KM, 2003, BIOFOULING, V19, P187, DOI 10.1080/0892701031000072091; Berntsson KM, 2000, J EXP MAR BIOL ECOL, V251, P59, DOI 10.1016/S0022-0981(00)00210-0; Bishop JDD, 2006, INTEGR COMP BIOL, V46, P398, DOI 10.1093/icb/icj037; Bishop JDD, 2000, P ROY SOC B-BIOL SCI, V267, P1165, DOI 10.1098/rspb.2000.1124; Boyd PW, 2012, MAR ECOL PROG SER, V470, P125, DOI 10.3354/meps10121; Byrne M, 2009, P ROY SOC B-BIOL SCI, V276, P1883, DOI 10.1098/rspb.2008.1935; Calosi P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0444; Carey N, 2016, J EXP BIOL, V219, P1178, DOI 10.1242/jeb.136101; CRISP D. J., 1959, OIKOS, V10, P275, DOI 10.2307/3565151; Darwin C., 1854, MONOGRAPH SUBCLASS C; Dickson A., 2007, PICES SPEC PUBL; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dupont S, 2013, MAR BIOL, V160, P1835, DOI 10.1007/s00227-012-1921-x; Eriander L, 2016, ICES J MAR SCI, V73, P596, DOI 10.1093/icesjms/fsv214; Findlay HS, 2010, ECOLOGY, V91, P2931, DOI 10.1890/09-1987.1; Findlay HS, 2010, MAR BIOL, V157, P725, DOI 10.1007/s00227-009-1356-1; Findlay HS, 2010, ESTUAR COAST SHELF S, V86, P675, DOI 10.1016/j.ecss.2009.11.036; Findlay HS, 2009, MAR ECOL PROG SER, V389, P193, DOI 10.3354/meps08141; Foo SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042497; Form AU, 2012, GLOBAL CHANGE BIOL, V18, P843, DOI 10.1111/j.1365-2486.2011.02583.x; FURMAN ER, 1990, J EXP MAR BIOL ECOL, V144, P235, DOI 10.1016/0022-0981(90)90030-G; Gaonkar CA, 2010, J MAR BIOL ASSOC UK, V90, P1241, DOI 10.1017/S0025315409991238; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Gunderson AR, 2016, ANNU REV MAR SCI, V8, P357, DOI 10.1146/annurev-marine-122414-033953; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; HANSSON I, 1973, DEEP-SEA RES, V20, P461, DOI 10.1016/0011-7471(73)90100-9; Harvey BP, 2013, ECOL EVOL, V3, P1016, DOI 10.1002/ece3.516; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; JONES LWG, 1954, P ZOOL SOC LOND, V123, P765; Kelly MW, 2012, MOL ECOL, V21, P5088, DOI 10.1111/mec.12009; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kurihara H, 2004, MAR POLLUT BULL, V49, P721, DOI 10.1016/j.marpolbul.2004.05.005; Lannig G, 2010, MAR DRUGS, V8, P2318, DOI 10.3390/md8082318; Leppakoski Erkki, 2000, Biological Invasions, V2, P151, DOI 10.1023/A:1010052809567; Mayor DJ, 2007, MAR ECOL PROG SER, V350, P91, DOI 10.3354/meps07142; McDonald MR, 2009, MAR ECOL PROG SER, V385, P179, DOI 10.3354/meps08099; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Melzner F, 2013, MAR BIOL, V160, P1875, DOI 10.1007/s00227-012-1954-1; Michaelidis B, 2005, MAR ECOL PROG SER, V293, P109, DOI 10.3354/meps293109; Morley Simon A., 2016, BIODIVERSITY-OTTAWA, V17, P34, DOI 10.1080/14888386.2016.1174956; Munday PL, 2014, NAT CLIM CHANGE, V4, P487, DOI [10.1038/nclimate2195, 10.1038/NCLIMATE2195]; Nakamura M, 2012, AQUAT BIOL, V15, P299, DOI 10.3354/ab00436; Nasrolahi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32263; Nasrolahi A, 2013, MAR BIOL, V160, P1109, DOI 10.1007/s00227-012-2162-8; Niehoff B, 2013, BIOGEOSCIENCES, V10, P1391, DOI 10.5194/bg-10-1391-2013; Oney B, 2013, ECOL EVOL, V3, P437, DOI 10.1002/ece3.426; Pansch C, 2017, BIOFOULING, V33, P613, DOI 10.1080/08927014.2017.1349897; Pansch C, 2014, GLOBAL CHANGE BIOL, V20, P765, DOI 10.1111/gcb.12478; Pansch C, 2013, ICES J MAR SCI, V70, P805, DOI 10.1093/icesjms/fst092; Pansch C, 2013, MAR BIOL, V160, P2023, DOI 10.1007/s00227-012-2069-4; Pansch C, 2012, J EXP MAR BIOL ECOL, V420, P48, DOI 10.1016/j.jembe.2012.03.023; Perez-Losada M, 2014, MOL PHYLOGENET EVOL, V81, P147, DOI 10.1016/j.ympev.2014.09.013; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Quinn GP, 2003, EXPT DESIGN DATA ANA; Riebesell U, 2015, NAT CLIM CHANGE, V5, P12; Robbins L. L., 2010, USGS NUMBERED SERIES; Saderne V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062689; Schlegel P, 2015, J EXP BIOL, V218, P1084, DOI 10.1242/jeb.114900; Stumpp M, 2013, NAT CLIM CHANGE, V3, P1044, DOI 10.1038/NCLIMATE2028; Suckling CC, 2015, J ANIM ECOL, V84, P773, DOI 10.1111/1365-2656.12316; Sunday JM, 2014, TRENDS ECOL EVOL, V29, P117, DOI 10.1016/j.tree.2013.11.001; Thiyagarajan V, 2010, J EXP MAR BIOL ECOL, V392, P22, DOI 10.1016/j.jembe.2010.04.030; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; Valladares F, 2014, ECOL LETT, V17, P1351, DOI 10.1111/ele.12348; Wahl M, 2016, MAR FRESHWATER RES, V67, P25, DOI 10.1071/MF14154; Waldbusser GG, 2014, ANNU REV MAR SCI, V6, P221, DOI 10.1146/annurev-marine-121211-172238; Werner FJ, 2016, OECOLOGIA, V180, P889, DOI 10.1007/s00442-015-3489-x; Whiteley NM, 2011, MAR ECOL PROG SER, V430, P257, DOI 10.3354/meps09185; Wrange AL, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-156; Zittier ZMC, 2015, J EXP MAR BIOL ECOL, V473, P16, DOI 10.1016/j.jembe.2015.08.001	81	8	8	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192036	10.1371/journal.pone.0192036	http://dx.doi.org/10.1371/journal.pone.0192036			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408893	Green Accepted, Green Published, gold			2022-12-26	WOS:000424302800041
J	Sugi, K; Hsieh, PN; Ilkayeva, O; Shelkay, S; Moroney, B; Baadh, P; Haynes, B; Pophal, M; Fan, L; Newgard, CB; Prosdocimo, DA; Jain, MK				Sugi, Keiki; Hsieh, Paishiun N.; Ilkayeva, Olga; Shelkay, Shamanthika; Moroney, Bridget; Baadh, Palvir; Haynes, Browning; Pophal, Megan; Fan, Liyan; Newgard, Christopher B.; Prosdocimo, Domenick A.; Jain, Mukesh K.			Kruppel-like factor 15 is required for the cardiac adaptive response to fasting	PLOS ONE			English	Article							COA DEHYDROGENASE-DEFICIENCY; ACID OXIDATION DISORDERS; INSULIN-RESISTANCE; LIPID-ACCUMULATION; HEART-FAILURE; RAT-HEART; METABOLISM; CARDIOMYOPATHY; MECHANISMS; EXPRESSION	Cardiac metabolism is highly adaptive in response to changes in substrate availability, as occur during fasting. This metabolic flexibility is essential to the maintenance of contractile function and is under the control of a group of select transcriptional regulators, notably the nuclear receptor family of factors member PPARa. However, the diversity of physiologic and pathologic states through which the heart must sustain function suggests the possible existence of additional transcriptional regulators that play a role in matching cardiac metabolism to energetic demand. Here we show that cardiac KLF15 is required for the normal cardiac response to fasting. Specifically, we find that cardiac function is impaired upon fasting in systemic and cardiac specific K/f/5-null mice. Further, cardiac specific K/f/5-null mice display a fasting-dependent accumulation of long chain acylcarnitine species along with a decrease in expression of the carnitine translocase Slc25a20. Treatment with a diet high in short chain fatty acids relieves the KLF15-dependent long chain acylcarnitine accumulation and impaired cardiac function in response to fasting. Our observations establish KLF15 as a critical mediator of the cardiac adaptive response to fasting through its regulation of myocardial lipid utilization.	[Sugi, Keiki; Hsieh, Paishiun N.; Shelkay, Shamanthika; Moroney, Bridget; Baadh, Palvir; Haynes, Browning; Pophal, Megan; Fan, Liyan; Prosdocimo, Domenick A.; Jain, Mukesh K.] Case Cardiovasc Res Inst, Cleveland, OH USA; [Sugi, Keiki; Hsieh, Paishiun N.; Shelkay, Shamanthika; Moroney, Bridget; Baadh, Palvir; Haynes, Browning; Pophal, Megan; Fan, Liyan; Prosdocimo, Domenick A.; Jain, Mukesh K.] Univ Hosp Case Med Ctr, Harrington Heart & Vasc Inst, Cleveland, OH USA; [Sugi, Keiki; Hsieh, Paishiun N.; Shelkay, Shamanthika; Moroney, Bridget; Baadh, Palvir; Haynes, Browning; Pophal, Megan; Fan, Liyan; Prosdocimo, Domenick A.; Jain, Mukesh K.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Sugi, Keiki; Hsieh, Paishiun N.; Shelkay, Shamanthika; Moroney, Bridget; Baadh, Palvir; Haynes, Browning; Pophal, Megan; Fan, Liyan; Prosdocimo, Domenick A.; Jain, Mukesh K.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Sugi, Keiki; Hsieh, Paishiun N.; Shelkay, Shamanthika; Moroney, Bridget; Baadh, Palvir; Haynes, Browning; Pophal, Megan; Fan, Liyan; Prosdocimo, Domenick A.; Jain, Mukesh K.] Univ Hosp Case Med Ctr, Dept Med, Cleveland, OH USA; [Fan, Liyan] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Ilkayeva, Olga] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Sch Med, Dept Med & Pharmacol & Canc Biol, Durham, NC USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Duke University	Sugi, K; Jain, MK (corresponding author), Case Cardiovasc Res Inst, Cleveland, OH USA.; Sugi, K; Jain, MK (corresponding author), Univ Hosp Case Med Ctr, Harrington Heart & Vasc Inst, Cleveland, OH USA.	mxj84@case.edu		Sugi, Keiki/0000-0002-7608-4541	National Institutes of Health [F32HL110538, K01DK104922, R01HL112486, R01HL119195, R01HL123098, F30AG054237]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL134622, R35HL135789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG054237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants F32HL110538 and K01DK104922 (to D.A.P.), R01HL112486, R01HL119195, and R01HL123098 (to M.J.K.), F30AG054237 (to P.N.H), along with generous gifts by Tom F. Peterson (TFP Lab). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2012, ARTERIOSCL THROM VAS, V32, P2068, DOI 10.1161/ATVBAHA.111.241984; Abel ED, 2011, CARDIOVASC RES, V90, P234, DOI 10.1093/cvr/cvr015; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Beer M, 2002, J AM COLL CARDIOL, V40, P1267, DOI 10.1016/S0735-1097(02)02160-5; Bonnet D, 1999, CIRCULATION, V100, P2248, DOI 10.1161/01.CIR.100.22.2248; BrownHarrison MC, 1996, BIOCHEM MOL MED, V58, P59, DOI 10.1006/bmme.1996.0033; Cox GF, 1998, J PEDIATR-US, V133, P247, DOI 10.1016/S0022-3476(98)70228-8; DENTON RM, 1967, BIOCHEM J, V104, P416, DOI 10.1042/bj1040416; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Gillingham MB, 2006, MOL GENET METAB, V89, P58, DOI 10.1016/j.ymgme.2006.06.004; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Haldar SM, 2007, J MOL CELL CARDIOL, V43, P1, DOI 10.1016/j.yjmcc.2007.04.005; Haldar SM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000502; HALE DE, 1992, J PEDIATR-US, V121, P1, DOI 10.1016/S0022-3476(05)82532-6; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; KELLY DP, 1994, NEW ENGL J MED, V330, P913; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kuang M, 2004, CIRCULATION, V109, P1550, DOI 10.1161/01.CIR.0000121730.41801.12; Leone TC, 2011, COLD SH Q B, V76, P175, DOI 10.1101/sqb.2011.76.011965; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Miki T, 2013, HEART FAIL REV, V18, P149, DOI 10.1007/s10741-012-9313-3; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Nickel A, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0358-9; Prosdocimo DA, 2014, TRENDS IN CAR DIOVAS; Prosdocimo DA, 2015, PPAR RES, V2015, DOI 10.1155/2015/201625; Prosdocimo DA, 2014, J BIOL CHEM, V289, P5914, DOI 10.1074/jbc.M113.531384; Ramsay RR, 2000, BIOCHEM SOC T, V28, P182, DOI 10.1042/bst0280182; Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Suzuki J, 2002, AM J PHYSIOL-ENDOC M, V283, pE94, DOI 10.1152/ajpendo.00017.2002; Touma EH, 2001, ARCH DIS CHILD, V84, P58, DOI 10.1136/adc.84.1.58; Wende AR, 2010, BBA-MOL CELL BIOL L, V1801, P311, DOI 10.1016/j.bbalip.2009.09.023; York B, 2012, CELL METAB, V15, P752, DOI 10.1016/j.cmet.2012.03.020; Zhang LL, 2015, CELL REP, V13, P2368, DOI 10.1016/j.celrep.2015.11.038	37	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192376	10.1371/journal.pone.0192376	http://dx.doi.org/10.1371/journal.pone.0192376			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408889	Green Published, gold, Green Submitted			2022-12-26	WOS:000424302800058
J	Bhise, MD; Patra, S				Bhise, Mahadev D.; Patra, Shraboni			Prevalence and correlates of hypertension in Maharashtra, India: A multilevel analysis	PLOS ONE			English	Article							AWARENESS	Background and aim In the last few decades, the prevalence of hypertension has been drastically increased in India. The present study estimates the current prevalence of hypertension and its correlates in the state of Maharashtra. The variation in the prevalence of hypertension associated with individual-level characteristics is explained at the community and district level. Methods Data is used from the recent round of District Level Household & Facility Survey (DLHS-4), 2012-13. The DLHS-4 has used the nationally representative sample, collected through multistage stratified sampling procedure. A similar sampling frame, used in NSSO-2007-08, has been followed. The chi-square test is used to show the significance level of the association between the estimated prevalence of hypertension and its correlates. Multilevel regression analysis is carried out to investigate the effects of individual and community level factors on the prevalence of hypertension. Results The overall prevalence of hypertension is 25% in Maharashtra, and a huge variation in the prevalence of hypertension is found across the districts. Dhule, Gadchiroli (with a low HDI rank), Mumbai and Satara (with higher HDI rank) are the districts with the higher (above 30%) prevalence of high blood pressure. The prevalence also significantly varies according to different correlates. The prevalence of high blood pressure is higher among elderly population (40%), among males (28%), in the urban areas (27%) and in the richest wealth quintile (28%). The prevalence is also higher among cigarette smokers (31%), alcohol consumers (30%) and people with obesity (38%) as compared to their counterparts. The results of the multilevel analysis show that the older and obese persons are at four-time higher risk of hypertension. Again, age, sex, marital status, place of residence, wealth status, unhealthy habits (i.e. smoking and alcohol consumption) and BMI are significantly associated with hypertension. The results of VPC statistics show that 14% of hypertension prevalence could be attributed to differences at the community level. Conclusion The prevalence of hypertension largely varies in the districts of Maharashtra irrespective of their level of socio-economic development (i.e. HDI rank). The variation in the rate of prevalence of hypertension is higher in the community (PSU) level as compared to the variation in the prevalence rate at the district level. Hypertension is attributable to the modifiable factors like risky lifestyle practices.	[Bhise, Mahadev D.; Patra, Shraboni] Int Inst Populat Sci, Populat Studies, Govandi Stn Rd, Bombay, Maharashtra, India	International Institute for Population Sciences	Patra, S (corresponding author), Int Inst Populat Sci, Populat Studies, Govandi Stn Rd, Bombay, Maharashtra, India.	shrageo@gmail.com		Bhise, Mahadev/0000-0002-9477-3498				Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Anchala R, 2014, J HYPERTENS, V32, P1170, DOI 10.1097/HJH.0000000000000146; [Anonymous], 2012, MAH HUM DEV REP; Banerji Monali, 2003, Journal of Human Ecology, V14, P377; Bonsa F, 2014, ETHIOP J HEALTH SCI, V24, P21, DOI 10.4314/ejhs.v24i1.3; Cai L, 2011, PUBLIC HEALTH REP, V126, P420; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Geleijnse JM, 2005, J HUM HYPERTENS, V19, pS1, DOI 10.1038/sj.jhh.1001953; Gorman BK, 2011, POPUL RES POLICY REV, V30, P885, DOI 10.1007/s11113-011-9215-4; Gupta R, 2014, INDIAN J MED RES, V139, P657; International Institute for Population Sciences (IIPS), 2014, DISTR LEV HOUS FAC S; Kanagarajan P, 2015, INDIAN J FORENSIC CO, V2, P100; Kashyap V, 2015, PREVALENCE HYPERTENS, V14, P1; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Khan HR., 2011, J DATA SCI, V9, P93; Kini S, 2016, PLOS ONE, P20; Laxmaiah A., 2014, INT J HLTH SCI RES, V4, P130; Merlo J, 2004, AM J EPIDEMIOL, V159, P1168, DOI 10.1093/aje/kwh160; Merlo J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153778; Midha T, 2009, INDIAN J PREV SOC ME, V40, P5; Mittal P, 2013, RECENT RES SCI TECHN, V5, P21; MOHFW, 2017, NATL FAMILY HLTH SUR; Nagammanavar R, 2015, J SCI-ADV MATER DEV, V5, P459; Poulter NR, 2015, LANCET, V386, P801, DOI 10.1016/S0140-6736(14)61468-9; Quasem I, 2001, B WORLD HEALTH ORGAN, V79, P490; Rahman MM, 2015, J CLEAN PROD, V105, P406, DOI 10.1016/j.jclepro.2014.04.068; Sathish Kumar K., 2015, INT J INTERDISCIPLIN, V2, P61; SIMONSON DC, 1988, DIABETES CARE, V11, P821, DOI 10.2337/diacare.11.10.821; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Tiwaskar Mangesh, 2016, J Assoc Physicians India, V64, P11; Undhad A. M., 2011, National Journal of Community Medicine, V2, P123; WHO, 2013, GLOB BIREF HYP; World Health Organization, 2012, WORLD HLTH STAT SNAP	33	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191948	10.1371/journal.pone.0191948	http://dx.doi.org/10.1371/journal.pone.0191948			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401464	Green Published, gold, Green Submitted			2022-12-26	WOS:000424101400027
J	Ufimtseva, E; Eremeeva, N; Petrunina, E; Umpeleva, T; Karskanova, S; Bayborodin, S; Vakhrusheva, D; Kravchenko, M; Skornyakov, S				Ufimtseva, Elena; Eremeeva, Natalya; Petrunina, Ekaterina; Umpeleva, Tatiana; Karskanova, Svetlana; Bayborodin, Sergey; Vakhrusheva, Diana; Kravchenko, Marionella; Skornyakov, Sergey			Ex vivo expansion of alveolar macrophages with Mycobacterium tuberculosis from the resected lungs of patients with pulmonary tuberculosis	PLOS ONE			English	Article							IMMUNE-RESPONSE; DENDRITIC CELLS; INFLAMMATION; NEUTROPHILS; GRANULOMAS; MECHANISMS; PATHOLOGY; MICE	Tuberculosis (TB), with the Mycobacterium tuberculosis (Mtb) as the causative agent, remains to be a serious world health problem. Traditional methods used for the study of Mtb in the lungs of TB patients do not provide information about the number and functional status of Mtb, especially if Mtb are located in alveolar macrophages. We have developed a technique to produce ex vivo cultures of cells from different parts of lung tissues surgically removed from patients with pulmonary TB and compared data on the number of cells with Mtb inferred by the proposed technique to the results of bacteriological and histological analyses used for examination of the resected lungs. The ex vivo cultures of cells obtained from the resected lungs of all patients were largely composed of CD14-positive alveolar macrophages, foamy or not, with or without Mtb. Lymphocytes, fibroblasts, neutrophils, and multinucleate Langhans giant cells were also observed. We found alveolar macrophages with Mtb in the ex vivo cultures of cells from the resected lungs of even those TB patients, whose sputum smears and lung tissues did not contain acid-fast Mtb or reveal growing Mtb colonies on dense medium. The detection of alveolar macrophages with Mtb in ex vivo culture as soon as 16-18 h after isolation of cells from the resected lungs of all TB patients suggests that the technique proposed for assessing the level of infection in alveolar macrophages of TB patients has higher sensitivity than do prolonged bacteriological or pathomorphological methods. The proposed technique allowed us to rapidly (in two days after surgery) determine the level of infection with Mtb in the cells of the resected lungs of TB patients and, by the presence or absence of Mtb colonies, including those with cording morphology, the functional status of the TB agent at the time of surgery.	[Ufimtseva, Elena] Res Inst Biochem, Lab Med Biotechnol, Novosibirsk, Russia; [Ufimtseva, Elena; Eremeeva, Natalya; Petrunina, Ekaterina; Umpeleva, Tatiana; Karskanova, Svetlana; Vakhrusheva, Diana; Kravchenko, Marionella; Skornyakov, Sergey] Minist Hlth Russian Federat, Natl Med Res Ctr TB & Infect Dis, Ural Res Inst Phthisiopulmonol, Sci Dept, Ekaterinburg, Russia; [Bayborodin, Sergey] Fed Res Ctr, Inst Cytol & Genet, Shared Ctr Microscop Anal Biol Objects, Novosibirsk, Russia	Ministry of Health of the Russian Federation; National Medical Research Center of Phthisiopulmonology & Infectious Diseases; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Ufimtseva, E (corresponding author), Res Inst Biochem, Lab Med Biotechnol, Novosibirsk, Russia.; Ufimtseva, E (corresponding author), Minist Hlth Russian Federat, Natl Med Res Ctr TB & Infect Dis, Ural Res Inst Phthisiopulmonol, Sci Dept, Ekaterinburg, Russia.	ufim1@ngs.ru	Skornyakov, Sergey/AAB-4703-2020; Vakhrusheva, Diana/R-4409-2017; Ufimtseva, Elena/E-5277-2017; Umpeleva, Tatiana/N-8878-2016	Skornyakov, Sergey/0000-0002-9942-3008; Vakhrusheva, Diana/0000-0001-6085-6466; Umpeleva, Tatiana/0000-0001-8014-1230				Arnett E, 2016, DRUG DELIVERY SYSTEM, P11; Barry C, 2015, SCIENCE, V348, P633, DOI 10.1126/science.aaa2886; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bates JH., 1994, CURRENT CONCEPTS TRE, P81; Belousova KV, 2014, FUNDAMENTAL RES RUSS, V9, P2452; Berg RD, 2016, CELL, V165, P139, DOI 10.1016/j.cell.2016.02.034; Brown RE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00078; Cardona PJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00612; Cole ST, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0506; Dallenga T, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw012; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Donoghue HD, 2009, MICROBES INFECT, V11, P1156, DOI 10.1016/j.micinf.2009.08.008; Erokhin VV, 2008, CULTURAL METHODS TUB; Espitia C, 2012, UNDERSTANDING TUBERCULOSIS - ANALYZING THE ORIGIN OF MYCOBACTERIUM TUBERCULOSIS PATHOGENICITY, P43; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Fenhalls G, 2002, INFECT IMMUN, V70, P6330, DOI 10.1128/IAI.70.11.6330-6338.2002; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; Fu LM, 2013, SCI J CLIN MED, V2, P92; Halse TA, 2011, J CLIN MICROBIOL, V49, P2562, DOI 10.1128/JCM.00467-11; Hmama Z, 2015, IMMUNOL REV, V264, P220, DOI 10.1111/imr.12268; Hunter RL, 2007, TUBERCULOSIS, V87, P267, DOI 10.1016/j.tube.2006.11.003; Hunter RL, 2016, TUBERCULOSIS, V97, P8, DOI 10.1016/j.tube.2015.11.010; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lenaerts A, 2015, IMMUNOL REV, V264, P288, DOI 10.1111/imr.12252; Lerner TR, 2015, CELL MICROBIOL, V17, P1277, DOI 10.1111/cmi.12480; Lienhardt C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001965; Lowe DM, 2012, TRENDS IMMUNOL, V33, P14, DOI 10.1016/j.it.2011.10.003; Lyadova I, 2012, UNDERSTANDING TUBERCULOSIS - ANALYZING THE ORIGIN OF MYCOBACTERIUM TUBERCULOSIS PATHOGENICITY, P19; Melo RCN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002729; Mortellaro A, 2009, EMBO MOL MED, V1, P19, DOI 10.1002/emmm.200900008; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Ndlovu H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00434; Ni Cheallaigh C., 2012, HDB MACROPHAGES LIFE, P1; Parida SK, 2015, J INTERN MED, V277, P388, DOI 10.1111/joim.12264; Parihar SP, 2014, J INFECT DIS, V209, P754, DOI 10.1093/infdis/jit550; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Santucci P, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00122; Sasindran SJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00002; Schneberger D, 2011, CELL TISSUE RES, V343, P97, DOI 10.1007/s00441-010-1032-2; Schreiber HA, 2010, IMMUNOL LETT, V130, P26, DOI 10.1016/j.imlet.2009.12.009; Singh Ananya, 2014, Recent Pat Antiinfect Drug Discov, V9, P25; Srivastava S, 2014, IMMUNOL REV, V262, P179, DOI 10.1111/imr.12217; Subbian S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132249; Ufimtseva E., ISOLATION EX VIVO CU; Ufimtseva EG, 2016, B IZOBRET, V22, P1; Ufimtseva E, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4325646; Ufimtseva E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/948131; Ufimtseva E, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/371249; Ulrichs T, 2005, J INFECT DIS, V192, P89, DOI 10.1086/430621; Weiss G, 2015, IMMUNOL REV, V264, P182, DOI 10.1111/imr.12266; World Health Organization, GLOB TUB REP 2016; Zumla A, 2015, J INTERN MED, V277, P373, DOI 10.1111/joim.12256	56	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191918	10.1371/journal.pone.0191918	http://dx.doi.org/10.1371/journal.pone.0191918			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401466	gold, Green Published			2022-12-26	WOS:000424101400025
J	Usongo, V; Berry, C; Yousfi, K; Doualla-Bell, F; Labbe, G; Johnson, R; Fournier, E; Nadon, C; Goodridge, L; Bekal, S				Usongo, Valentine; Berry, Chrystal; Yousfi, Khadidja; Doualla-Bell, Florence; Labbe, Genevieve; Johnson, Roger; Fournier, Eric; Nadon, Celine; Goodridge, Lawrence; Bekal, Sadjia			Impact of the choice of reference genome on the ability of the core genome SNV methodology to distinguish strains of Salmonella enterica serovar Heidelberg	PLOS ONE			English	Article							PHYLOGENETIC TREES	Salmonella enterica serovar Heidelberg (S. Heidelberg) is one of the top serovars causing human salmonellosis. The core genome single nucleotide variant pipeline (cgSNV) is one of several whole genome based sequence typing methods used for the laboratory investigation of foodborne pathogens. SNV detection using this method requires a reference genome. The purpose of this study was to investigate the impact of the choice of the reference genome on the cgSNV-informed phylogenetic clustering and inferred isolate relationships. We found that using a draft or closed genome of S. Heidelberg as reference did not impact the ability of the cgSNV methodology to differentiate among 145 S. Heidelberg isolates involved in foodborne outbreaks. We also found that using a distantly related genome such as S. Dublin as choice of reference led to a loss in resolution since some sporadic isolates were found to cluster together with outbreak isolates. In addition, the genetic distances between outbreak isolates as well as between outbreak and sporadic isolates were overall reduced when S. Dublin was used as the reference genome as opposed to S. Heidelberg.	[Usongo, Valentine; Yousfi, Khadidja; Doualla-Bell, Florence; Fournier, Eric; Bekal, Sadjia] Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada; [Usongo, Valentine; Goodridge, Lawrence] McGill Univ, Dept Food Sci & Agr Chem, Food Safety & Qual Program, Ste Anne De Bellevue, PQ, Canada; [Berry, Chrystal; Nadon, Celine] Publ Hlth Agcy Canada, Natl Microbiol Lab, Div Enter Dis, Winnipeg, MB, Canada; [Labbe, Genevieve; Johnson, Roger] Publ Hlth Agcy Canada, Natl Microbiol Lab Guelph, Guelph, ON, Canada; [Bekal, Sadjia] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada	McGill University; Public Health Agency of Canada; Public Health Agency of Canada; Universite de Montreal	Bekal, S (corresponding author), Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada.; Bekal, S (corresponding author), Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada.	sadjia.bekal@inspq.qc.ca	Usongo, Valentine/CAG-1903-2022; Labbé, Geneviève/N-4531-2017	Labbé, Geneviève/0000-0001-9720-7574; Bekal, Sadjia/0000-0001-9840-0114	Genome Canada; Genome Quebec provincial genome center	Genome Canada(Genome Canada); Genome Quebec provincial genome center	We express our gratitude to members of the genomics analysis and bioinformatics platforms at the National Microbiology Laboratory and the Bacteriology Unit staff at the Laboratoire de Sante Publique du Quebec. Lawrence Goodridge, Celine Nadon and Sadjia Bekal are funded by Genome Canada and by the Genome Quebec provincial genome center.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Alix B, 2012, NUCLEIC ACIDS RES, V40, pW573, DOI 10.1093/nar/gks485; Allard MW, 2016, J CLIN MICROBIOL, V54, P1975, DOI 10.1128/JCM.00081-16; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bekal S, 2016, J CLIN MICROBIOL, V54, P289, DOI 10.1128/JCM.02200-15; Bertels F, 2014, MOL BIOL EVOL, V31, P1077, DOI 10.1093/molbev/msu088; Croxen MA, 2017, PLOSCURR, V1; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Kwong JC, 2016, J CLIN MICROBIOL, V54, P333, DOI 10.1128/JCM.02344-15; Labbe G, 2016, COMPLETE GENOME SEQU, V15; Land M, 2014, STAND GENOMIC SCI, P9; Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4; Leekitcharoenphon P., 2014, PLOS ONE, V9; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Moura A., 2016, NAT MICROBIOL; Nadon C, 2017, EUROSURVEILLANCE, V22, P13, DOI 10.2807/1560-7917.ES.2017.22.23.30544; Olson ND, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00235; Petkau A., 2016, SNVPHYL SINGLE NUCLE; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; The National Microbiology Laboratory (NML), 2014, NAT ENT SURV PROGR N	22	6	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192233	10.1371/journal.pone.0192233	http://dx.doi.org/10.1371/journal.pone.0192233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401524	Green Published, gold, Green Submitted			2022-12-26	WOS:000424101400044
J	Abadia, B; Sunen, I; Calvo, P; Bartol, F; Verdes, G; Ferreras, A				Abadia, Beatriz; Sunen, Ines; Calvo, Pilar; Bartol, Francisco; Verdes, Guayente; Ferreras, Antonio			Choroidal thickness measured using swept-source optical coherence tomography is reduced in patients with type 2 diabetes	PLOS ONE			English	Article							SPECTRAL-DOMAIN; RETINAL THICKNESS; DIURNAL-VARIATION; HEALTHY-SUBJECTS; MACULAR EDEMA; AXIAL LENGTH; RETINOPATHY; PREDICTOR; SEVERITY; ADULTS	Objective To compare choroidal thickness between patients with type 2 diabetes (T2D) and healthy controls measured using swept-source optical coherence tomography (SS-OCT). Methods The sample comprised 157 eyes of 94 T2D patients, 48 eyes of which had diabetic macular edema (DME), and 71 normal eyes of 38 healthy patients. Subfoveal (SF) choroidal thickness, and choroidal thickness at 500-mu m intervals up to 2500 mu m nasal and temporal from the fovea were measured using the SS-OCT. Choroidal thicknesses were compared between groups using Student's t-test. Additionally, Pearson correlations were calculated between diabetes duration, glycosylated hemoglobin (HbA1c) levels, and choroidal thickness. Results Mean diabetes duration was 16.6 +/- 9.5 years, while mean glycosylated hemoglobin was 7.7 +/- 1.3%. Overall, the choroid was significantly thinner in T2D patients. Individuals with DME had reduced choroidal thickness in all measurements, except at 2000 and 2500-mu m nasal positions, compared to healthy controls. There was a moderate correlation between choroidal thickness and HbA1c levels in DME patients (SF: r = 0.342; p = 0.017). Diabetes duration did not correlate significantly with choroidal thickness. Conclusion SS-OCT measurements revealed that the choroid was significantly thinner in T2D patients, moderate non-proliferative diabetic retinopathy patients, and DME patients than in healthy individuals. Further studies are needed to clarify the effect of diabetes on this layer and the relationship between choroidal thickness and DME.	[Abadia, Beatriz; Calvo, Pilar; Bartol, Francisco; Ferreras, Antonio] Miguel Servet Univ Hosp, Dept Ophthalmol, IIS Aragon, Zaragoza, Spain; [Sunen, Ines; Calvo, Pilar; Ferreras, Antonio] Univ Zaragoza, Dept Surg Gynecol & Obstet, Zaragoza, Spain; [Verdes, Guayente] Hosp Alcaniz, Dept Endocrinol, Teruel, Spain	Miguel Servet University Hospital; University of Zaragoza	Ferreras, A (corresponding author), Miguel Servet Univ Hosp, Dept Ophthalmol, IIS Aragon, Zaragoza, Spain.; Ferreras, A (corresponding author), Univ Zaragoza, Dept Surg Gynecol & Obstet, Zaragoza, Spain.	aferreras@msn.com	Ferreras, Antonio/AAF-4220-2020; de Asís Bartol-Puyal, Francisco/AAF-8095-2020	de Asís Bartol-Puyal, Francisco/0000-0002-4476-6003; Ferreras, Antonio/0000-0002-2914-2593; Sunen, Ines/0000-0001-6335-797X				Adhi M, 2013, JAMA OPHTHALMOL, V131, P1267, DOI 10.1001/jamaophthalmol.2013.4321; Barteselli G, 2016, RETINA-J RET VIT DIS, V36, P1153, DOI 10.1097/IAE.0000000000000842; Barteselli G, 2012, OPHTHALMOLOGY, V119, P2572, DOI 10.1016/j.ophtha.2012.06.065; Chhablani J, 2014, SAUDI J OPHTHALMOL, V28, P123, DOI 10.1016/j.sjopt.2014.03.004; Copete S, 2014, BRIT J OPHTHALMOL, V98, P334, DOI 10.1136/bjophthalmol-2013-303904; Esmaeelpour M, 2011, INVEST OPHTH VIS SCI, V52, P5311, DOI 10.1167/iovs.10-6875; Ferrara D, 2015, PROG RETIN EYE RES, V23, P82; Gupta P, 2016, ACTA OPHTHALMOL, V94, pE142, DOI 10.1111/aos.12777; Han YS, 2015, OPHTHALMOLOGICA, V233, P192, DOI 10.1159/000375538; International Diabetes Federation, 2015, IDF DIAB ATL, V7; Kang HM, 2014, AM J OPHTHALMOL, V157, P1013, DOI 10.1016/j.ajo.2014.01.019; Kim JT, 2013, INVEST OPHTH VIS SCI, V54, P3378, DOI 10.1167/iovs.12-11503; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Melancia D, 2016, GRAEF ARCH CLIN EXP, V254, P1453, DOI 10.1007/s00417-016-3360-8; Michalewski J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/639160; Mrejen S, 2013, SURV OPHTHALMOL, V58, P387, DOI 10.1016/j.survophthal.2012.12.001; Querques G, 2012, INVEST OPHTH VIS SCI, V53, P6017, DOI 10.1167/iovs.12-9692; Rayess N, 2015, AM J OPHTHALMOL, V159, P85, DOI 10.1016/j.ajo.2014.09.033; Regatieri CV, 2012, RETINA-J RET VIT DIS, V32, P563, DOI [10.1097/IAE.0B013E31822F5678, 10.1097/IAE.0b013e31822f5678]; Ruiz-Medrano J, 2014, INVEST OPHTH VIS SCI, V55, P3532, DOI 10.1167/iovs.14-13868; Sanchez-Cano A, 2014, AM J OPHTHALMOL, V158, P574, DOI 10.1016/j.ajo.2014.05.035; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Tan CSH, 2014, INVEST OPHTH VIS SCI, V55, P6452, DOI 10.1167/iovs.13-13771; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Zhang L, 2015, INVEST OPHTH VIS SCI, V56, P3202, DOI 10.1167/iovs.14-15669	26	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191977	10.1371/journal.pone.0191977	http://dx.doi.org/10.1371/journal.pone.0191977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394291	Green Submitted, gold, Green Published			2022-12-26	WOS:000424060400021
J	Limbu, R; Cottrell, GS; McNeish, AJ				Limbu, Roshan; Cottrell, Graeme S.; McNeish, Alister J.			Characterisation of the vasodilation effects of DHA and EPA, n-3 PUFAs (fish oils), in rat aorta and mesenteric resistance arteries	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; CA2+-ACTIVATED K+ CHANNELS; POSTPRANDIAL VASCULAR REACTIVITY; ACTIVATED POTASSIUM CHANNELS; AGED HUMAN SKIN; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; FATTY-ACIDS; EPOXYGENASE METABOLITES	Background and purpose Increasing evidence suggests that the omega-3 polyunsaturated acids (n-3 PUFA), docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), are beneficial to cardiovascular health, promoting relaxation of vascular smooth muscle cells and vasodilation. Numerous studies have attempted to study these responses, but to date there has not been a systematic characterisation of both DHA and EPA mediated vasodilation in conduit and resistance arteries. Therefore, we aimed to fully characterise the n-3 PUFA-induced vasodilation pathways in rat aorta and mesenteric artery. Methods Wire myography was used to measure the vasomotor responses of freshly dissected rat mesenteric artery and aorta. Arteries were pre-constricted with U46619 and cumulative concentrations of either DHA or EPA (10 nM-30 mu M) were added. The mechanisms by which n-3 PUFA relaxed arteries were investigated using inhibitors of vasodilator pathways, which include: nitric oxide synthase (NOS; L-NAME), cycloxygenase (COX; indomethacin), cytochrome P450 epoxygenase (CYP450; clotrimazole); and calcium-activated potassium channels (K-Ca), SKCa (apamin), IKCa (TRAM-34) and BKCa (paxilline). Results Both DHA-and EPA-induced relaxations were partially inhibited following endothelium removal in rat mesenteric arteries. Similarly, in aorta EPA-induced relaxation was partially suppressed due to endothelium removal. CYP450 also contributed to EPA-induced relaxation in mesenteric artery. Inhibition of IKCa partially attenuated DHA-induced relaxation in aorta and mesenteric artery along with EPA-induced relaxation in mesenteric artery. Furthermore, this inhibition of DHA-and EPA-induced relaxation was increased following the additional blockade of BKCa in these arteries. Conclusions This study provides evidence of heterogeneity in the vasodilation mechanisms of DHA and EPA in different vascular beds. Our data also demonstrates that endothelium removal has little effect on relaxations produced by either PUFA. We demonstrate IKCa and BKCa are involved in DHA-induced relaxation in rat aorta and mesenteric artery; and EPA-induced relaxation in rat mesenteric artery only. CYP450 derived metabolites of EPA may also be involved in BKCa dependent relaxation. To our knowledge this is the first study indicating the involvement of IKCa in n-3 PUFA mediated relaxation.	[McNeish, Alister J.] Univ Reading, Reading Sch Pharm, Reading, Berks, England; Univ Reading, ICMR, Reading, Berks, England	University of Reading; University of Reading	McNeish, AJ (corresponding author), Univ Reading, Reading Sch Pharm, Reading, Berks, England.	a.mcneish@reading.ac.uk	; McNeish, Alister James/K-4521-2017	Cottrell, Graeme/0000-0001-9098-7627; McNeish, Alister James/0000-0002-3466-8442	British Heart Foundation PhD studentship [FS/14/33/30799]; British Heart Foundation [FS/14/33/30799] Funding Source: researchfish	British Heart Foundation PhD studentship; British Heart Foundation(British Heart Foundation)	Roshan Limbu was supported by British Heart Foundation PhD studentship FS/14/33/30799 with Alister J McNeish as the Principal investigator and Graeme S Cottrell as Co-investigator, www.bhf.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armah CK, 2008, CLIN SCI, V114, P679, DOI 10.1042/CS20070277; Arnold C, 2010, PHARMACOL REP, V62, P536, DOI 10.1016/S1734-1140(10)70311-X; BANG HO, 1980, AM J CLIN NUTR, V33, P2657, DOI 10.1093/ajcn/33.12.2657; Birch EE, 2007, EARLY HUM DEV, V83, P279, DOI 10.1016/j.earlhumdev.2006.11.003; Bruno RS, 2016, MED CHEM, V12, P1; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; Chen JH, 2011, ARTERIOSCL THROM VAS, V31, P590, DOI 10.1161/ATVBAHA.110.220061; Chin JP, 1993, J HYPERTENS, V11; Crane GJ, 2004, BRIT J PHARMACOL, V142, P43, DOI 10.1038/sj.bjp.0705756; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; DAVIS MJ, 1986, AM J PHYSIOL, V250, pH291, DOI 10.1152/ajpheart.1986.250.2.H291; Dong L, 2016, J BIOL CHEM, V291, P4069, DOI 10.1074/jbc.M115.698001; Dora KA, 2008, CIRC RES, V102, P1247, DOI 10.1161/CIRCRESAHA.108.172379; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Eguchi S, 2007, J CARDIOVASC PHARM, V50, P686, DOI 10.1097/FJC.0b013e3181583d9b; Engler M B, 2000, Biol Res Nurs, V2, P85, DOI 10.1177/109980040000200202; Engler MB, 2000, BRIT J PHARMACOL, V131, P1793, DOI 10.1038/sj.bjp.0703754; Fleming I, 2016, VASC PHARMACOL, V86, P31, DOI 10.1016/j.vph.2016.03.001; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Fukao M, 1999, J BIOL CHEM, V274, P10927, DOI 10.1074/jbc.274.16.10927; Garland CJ, 2017, ACTA PHYSIOL, V219, P152, DOI 10.1111/apha.12649; Hercule HC, 2007, EXP PHYSIOL, V92, P1067, DOI 10.1113/expphysiol.2007.038166; Hirafuji M, 2002, BRIT J PHARMACOL, V136, P613, DOI 10.1038/sj.bjp.0704768; Holowatz LA, 2007, EXERC SPORT SCI REV, V35, P119; Holowatz LA, 2006, J PHYSIOL-LONDON, V574, P573, DOI 10.1113/jphysiol.2006.108993; Jackson KG, 2009, BRIT J NUTR, V102, P1414, DOI 10.1017/S0007114509990742; Jiang JH, 1999, BRIT J PHARMACOL, V128, P637, DOI 10.1038/sj.bjp.0702855; Kacik M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112081; KAGAWA Y, 1982, J NUTR SCI VITAMINOL, V28, P441, DOI 10.3177/jnsv.28.441; Kemse NG, 2016, PROSTAG LEUKOTR ESS, V104, P25, DOI 10.1016/j.plefa.2015.11.003; Khan F, 2003, CARDIOVASC RES, V59, P955, DOI 10.1016/S0008-6363(03)00395-X; KUKOVETZ WR, 1979, J CYCLIC NUCL PROT, V5, P469; Kwan HY, 2009, CIRC RES, V104, P670, DOI 10.1161/CIRCRESAHA.108.188748; Lai LH, 2009, ACTA PHARMACOL SIN, V30, P314, DOI 10.1038/aps.2009.7; Li XA, 2011, J PHARMACOL EXP THER, V336, P891, DOI 10.1124/jpet.110.176461; Li ZY, 2001, J CARDIOVASC PHARM, V37, P41, DOI 10.1097/00005344-200101000-00005; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; London G M, 1997, Blood Press Suppl, V2, P48; Lopez D, 2004, AM J PHYSIOL-HEART C, V287, pH567, DOI 10.1152/ajpheart.01145.2003; Maroon JC, 2006, SURG NEUROL, V65, P326, DOI 10.1016/j.surneu.2005.10.023; McNeish AJ, 2007, BRIT J PHARMACOL, V151, P441, DOI 10.1038/sj.bjp.0707240; Mies F, 2004, AM J PHYSIOL-RENAL, V287, pF850, DOI 10.1152/ajprenal.00078.2004; Mori TA, 2000, CIRCULATION, V102, P1264, DOI 10.1161/01.CIR.102.11.1264; Morin C, 2009, AM J PHYSIOL-LUNG C, V296, pL130, DOI 10.1152/ajplung.90436.2008; MORRIS MC, 1993, CIRCULATION, V88, P523, DOI 10.1161/01.CIR.88.2.523; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Newens KJ, 2011, AM J CLIN NUTR, V94, P742, DOI 10.3945/ajcn.110.009233; Nicholson WT, 2009, HYPERTENSION, V53, P973, DOI 10.1161/HYPERTENSIONAHA.108.121483; Omura M, 2001, FEBS LETT, V487, P361, DOI 10.1016/S0014-5793(00)02351-6; Ozkor MA, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/156146; Parkington HC, 2004, PHARMACOL RES, V49, P509, DOI 10.1016/j.phrs.2003.11.012; Peter Soumia, 2013, Indian J Endocrinol Metab, V17, P422, DOI 10.4103/2230-8210.111630; ROBERTSON BE, 1993, AM J PHYSIOL, V265, pC299; Sandow SL, 2006, J ANAT, V209, P689, DOI 10.1111/j.1469-7580.2006.00647.x; Sansom SC, 1996, CLIN EXP PHARMACOL P, V23, P76; Sato K, 2014, BIOL PHARM BULL, V37, P394, DOI 10.1248/bpb.b13-00746; Sato Kyosuke, 2013, J Smooth Muscle Res, V49, P63; Sawada T, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0437-y; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; SCHIFFRIN EL, 1992, HYPERTENSION, V19, P1; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Seals DR, 2011, CLIN SCI, V120, P357, DOI 10.1042/CS20100476; Shimokawa H, 1996, J CARDIOVASC PHARM, V28, P703, DOI 10.1097/00005344-199611000-00014; Shimokawa H, 2016, J CARDIOVASC PHARM, V67, P361, DOI 10.1097/FJC.0000000000000348; Singh TU, 2010, EUR J PHARMACOL, V636, P108, DOI 10.1016/j.ejphar.2010.02.041; Sirot V, 2008, J FOOD COMPOS ANAL, V21, P8, DOI 10.1016/j.jfca.2007.05.006; Strokin M, 2004, INT J DEV NEUROSCI, V22, P551, DOI 10.1016/j.ijdevneu.2004.07.002; Strokin M, 2003, BRIT J PHARMACOL, V139, P1014, DOI 10.1038/sj.bjp.0705326; Taddei S, 2001, HYPERTENSION, V38, P274, DOI 10.1161/01.HYP.38.2.274; Tagawa H, 1999, J CARDIOVASC PHARM, V33, P633, DOI 10.1097/00005344-199904000-00017; Tai CC, 2009, J BIOL CHEM, V284, P32239, DOI 10.1074/jbc.M109.024661; Thomson SJ, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/605101; Villalpando DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142039; Wang RX, 2011, CARDIOVASC RES, V90, P344, DOI 10.1093/cvr/cvq411; Yang Y, 2008, BBA-BIOMEMBRANES, V1778, P88, DOI 10.1016/j.bbamem.2007.08.030; Ye D, 2002, J PHARMACOL EXP THER, V303, P768, DOI 10.1124/jpet.303.2.768; ZEIHER AM, 1993, J CLIN INVEST, V92, P652, DOI 10.1172/JCI116634; Zheng JS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3706	78	26	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192484	10.1371/journal.pone.0192484	http://dx.doi.org/10.1371/journal.pone.0192484			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394279	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000424060400045
J	McGrath, DS; Meitner, A; Sears, CR				McGrath, Daniel S.; Meitner, Amadeus; Sears, Christopher R.			The specificity of attentional biases by type of gambling: An eye-tracking study	PLOS ONE			English	Article							INCENTIVE-SENSITIZATION THEORY; ADDICTIVE BEHAVIORS; AUTOMATICITY	A growing body of research indicates that gamblers develop an attentional bias for gambling-related stimuli. Compared to research on substance use, however, few studies have examined attentional biases in gamblers using eye-gaze tracking, which has many advantages over other measures of attention. In addition, previous studies of attentional biases in gamblers have not directly matched type of gambler with personally-relevant gambling cues. The present study investigated the specificity of attentional biases for individual types of gambling using an eye-gaze tracking paradigm. Three groups of participants (poker players, video lottery terminal/slot machine players, and non-gambling controls) took part in one test session in which they viewed 25 sets of four images (poker, VLTs/slot machines, bingo, and board games). Participants' eye fixations were recorded throughout each 8-second presentation of the four images. The results indicated that, as predicted, the two gambling groups preferentially attended to their primary form of gambling, whereas control participants attended to board games more than gambling images. The findings have clinical implications for the treatment of individuals with gambling disorder. Understanding the importance of personally-salient gambling cues will inform the development of effective attentional bias modification treatments for problem gamblers.	[McGrath, Daniel S.; Meitner, Amadeus; Sears, Christopher R.] Univ Calgary, Dept Psychol, Calgary, AB, Canada	University of Calgary	McGrath, DS (corresponding author), Univ Calgary, Dept Psychol, Calgary, AB, Canada.	daniel.mcgrath@ucalgary.ca		Sears, Christopher/0000-0003-4036-0265; McGrath, Daniel/0000-0002-2772-942X	Alberta Gambling Research Institute (AGRI)	Alberta Gambling Research Institute (AGRI)	This work was funded through a small grant from the Alberta Gambling Research Institute (AGRI), http://www.abgamblinginstitute.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Babor TF, 2001, PRIMARY CARE; Berridge KC, 2016, AM PSYCHOL, V71, P670, DOI 10.1037/amp0000059; Bjerg O., 2010, INT GAMBL STUD, V10, P239, DOI DOI 10.1080/14459795.2010.520330; Boffo M, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2190-2; Boyer M, 2003, ADDICTION, V98, P61, DOI 10.1046/j.1360-0443.2003.00219.x; Brevers D, 2013, SOCIOAFFECTIVE NEURO, V3, DOI 10.3402/snp.v3i0.21592; Brevers D, 2011, PSYCHOL ADDICT BEHAV, V25, P675, DOI 10.1037/a0024201; Brevers D, 2011, J BEHAV THER EXP PSY, V42, P265, DOI 10.1016/j.jbtep.2011.01.005; Ciccarelli M, 2016, J AFFECT DISORDERS, V206, P9, DOI 10.1016/j.jad.2016.07.017; Ciccarelli M, 2016, J AFFECT DISORDERS, V198, P135, DOI 10.1016/j.jad.2016.03.009; Cox W Miles, 2017, Addict Behav Rep, V5, P94, DOI 10.1016/j.abrep.2017.03.001; Cox WM, 2014, CNS SPECTRUMS, V19, P215, DOI 10.1017/S1092852914000091; Currie SR, 2013, J GAMBL STUD, V29, P311, DOI 10.1007/s10899-012-9300-6; Diskin Katherine M., 1999, J Gambl Stud, V15, P17, DOI 10.1023/A:1023062912062; Diskin KM, 2001, CAN J BEHAV SCI, V33, P58, DOI 10.1037/h0087128; Ferris J., 2001, CANADIAN PROBLEM GAM; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; Field M, 2012, DRUG ALCOHOL DEPEN, V124, P189, DOI 10.1016/j.drugalcdep.2012.02.009; Field M, 2009, PSYCHOL BULL, V135, P589, DOI 10.1037/a0015843; Gladwin TE, 2017, ADDICT RES THEORY, V25, P32, DOI 10.1080/16066359.2016.1196674; Goudriaan AE, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00141; Grant JE, 2012, PROG NEURO-PSYCHOPH, V38, P336, DOI 10.1016/j.pnpbp.2012.05.006; Grant LD, 2015, J GAMBL STUD, V31, P1487, DOI 10.1007/s10899-014-9468-z; Honsi A, 2013, J GAMBL STUD, V29, P359, DOI 10.1007/s10899-012-9315-z; Ladouceur R, 1994, J Gambl Stud, V10, P399, DOI 10.1007/BF02104905; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Linnet J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00100; Lorains FK, 2014, ADDICTION, V109, P1128, DOI 10.1111/add.12494; McCusker CG, 1997, BRIT J CLIN PSYCHOL, V36, P543, DOI 10.1111/j.2044-8260.1997.tb01259.x; Moragas L, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0459-0; Newman KR, 2015, COGNITIVE THER RES, V39, P292, DOI 10.1007/s10608-014-9669-x; Nowak DE, 2014, J GAMBL STUD, V30, P819, DOI 10.1007/s10899-013-9399-0; Orford J., 2010, INT GAMBL STUD, V10, P31, DOI [10.1080/14459790903567132, DOI 10.1080/14459790903567132, https://doi.org/10.1080/14459790903567132]; Petry N., 2005, PATHOLOGICAL GAMBLIN; Petry NM, 2003, ADDICTION, V98, P645, DOI 10.1046/j.1360-0443.2003.00336.x; Rash CL, 2017, J GAMBL STUD, V33, P825, DOI 10.1007/s10899-016-9656-0; Robinson MJF, 2016, CURR TOP BEHAV NEURO, V27, P105, DOI 10.1007/7854_2015_387; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Roy-Charland A, 2017, AM J DRUG ALCOHOL AB, V43, P332, DOI 10.1080/00952990.2016.1209511; Sharpe L., 2003, GAMBL RES J NATL ASS, V15, P35; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Stacy AW, 2010, ANNU REV CLIN PSYCHO, V6, P551, DOI 10.1146/annurev.clinpsy.121208.131444; Thomas CL, 2013, J ANXIETY DISORD, V27, P447, DOI 10.1016/j.janxdis.2013.05.005; Vizcaino EJV, 2013, PSYCHOL ADDICT BEHAV, V27, P861, DOI 10.1037/a0032656; Welte JW, 2015, J GAMBL STUD, V31, P695, DOI 10.1007/s10899-014-9471-4; Zack M, 2004, NEUROPSYCHOPHARMACOL, V29, P195, DOI 10.1038/sj.npp.1300333; Zack M, 2007, NEUROPSYCHOPHARMACOL, V32, P1678, DOI 10.1038/sj.npp.1301295	48	22	22	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0190614	10.1371/journal.pone.0190614	http://dx.doi.org/10.1371/journal.pone.0190614			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU2GT	29385164	Green Published, gold, Green Submitted			2022-12-26	WOS:000423668400023
J	Milanese, C; Cavedon, V; Sandri, M; Tam, E; Piscitelli, F; Boschi, F; Zancanaro, C				Milanese, Chiara; Cavedon, Valentina; Sandri, Marco; Tam, Enrico; Piscitelli, Francesco; Boschi, Federico; Zancanaro, Carlo			Metabolic effect of bodyweight whole-body vibration in a 20-min exercise session: A crossover study using verified vibration stimulus	PLOS ONE			English	Article							ENERGY-EXPENDITURE; MUSCLE STRENGTH; VOLUNTARY CONTRACTIONS; PERCEIVED EXERTION; POSTURAL CONTROL; GROWTH-HORMONE; OXYGEN-UPTAKE; RESPONSES; INDIVIDUALS; PERFORMANCE	The ability of whole body vibration (WBV) to increase energy expenditure (EE) has been investigated to some extent in the past using short-term single exercises or sets of single exercises. However, the current practice in WBV training for fitness is based on the execution of multiple exercises during a WBV training session for a period of at least 20 min; nevertheless, very limited and inconsistent data are available on EE during long term WBV training session. This crossover study was designed to demonstrate, in an adequately powered sample of participants, the ability of WBV to increase the metabolic cost of exercise vs. no vibration over the time span of a typical WBV session for fitness (20 min). Twenty-two physically active young males exercised on a vibration platform (three identical sets of six different exercises) using an accelerometer-verified vibration stimulus in both the WBV and no vibration condition. Oxygen consumption was measured with indirect calorimetry and expressed as area under the curve (O-2(AUC)). Results showed that, in the overall 20-min training session, WBV increased both the O-2(AUC) and the estimated EE vs. no vibration by about 22% and 20%, respectively (P<0.001 for both, partial eta squared [eta(2)] >= 0.35) as well as the metabolic equivalent of task (+5.5%, P = 0.043; eta(2) = 0.02) and the rate of perceived exertion (+13%, P<0.001; eta(2) = 0.16). Results demonstrated that vibration is able to significantly increase the metabolic cost of exercise in a 20-min WBV training session.	[Milanese, Chiara; Cavedon, Valentina; Sandri, Marco; Tam, Enrico; Piscitelli, Francesco; Zancanaro, Carlo] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Boschi, Federico] Univ Verona, Dept Comp Sci, Verona, Italy	University of Verona; University of Verona	Milanese, C (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy.	chiara.milanese@univr.it	TAM, ENRICO/F-8669-2013; TAM, Enrico/AAU-5413-2020; Cavedon, Valentina/AAL-3002-2020; Sandri, Marco/L-2875-2013	TAM, Enrico/0000-0002-1392-0717; Sandri, Marco/0000-0002-1422-5695; Cavedon, Valentina/0000-0002-2464-1019; Zancanaro, Carlo/0000-0003-1117-296X; Milanese, Chiara/0000-0002-8011-4379	FUR	FUR	This work was supported in part by departmental intramural funds (FUR) to CZ and CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abercromby AFJ, 2007, MED SCI SPORT EXER, V39, P1642, DOI 10.1249/mss.0b013e318093f551; ACSM, 2010, ACSMS GUID EX TEST P; Adams JB, 2009, J STRENGTH COND RES, V23, P237, DOI 10.1519/JSC.0b013e3181876830; Alizadeh-Meghrazi M, 2014, J REHABIL MED, V46, P937, DOI 10.2340/16501977-1868; Beijer A, 2015, CLIN PHYSIOL FUNCT I, V35, P425, DOI 10.1111/cpf.12180; Bertucci WM, 2015, ACTA BIOENG BIOMECH, V17, P87, DOI 10.5277/ABB-00095-2014-01; Bogaerts A, 2007, GAIT POSTURE, V26, P309, DOI 10.1016/j.gaitpost.2006.09.078; BONGIOVANNI LG, 1990, J PHYSIOL-LONDON, V423, P1; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Borne R, 2017, INT J SPORT PHYSIOL, V12, P152, DOI 10.1123/ijspp.2015-0779; Bosco C, 2000, EUR J APPL PHYSIOL, V81, P449, DOI 10.1007/s004210050067; Brown H., 2014, APPL MIXED MODELS ME; Cardinale M, 2008, INT J SPORT PHYSIOL, V3, P232, DOI 10.1123/ijspp.3.2.232; Chen MJ, 2002, J SPORT SCI, V20, P873, DOI 10.1080/026404102320761787; Chow SC., 2007, SAMPLE SIZE CALCULAT, V2nd; Cochrane DI, 2008, ARCH PHYS MED REHAB, V89, P815, DOI 10.1016/j.apmr.2007.09.055; Cochrane DJ, 2010, EUR J APPL PHYSIOL, V108, P311, DOI 10.1007/s00421-009-1215-2; Cochrane DJ, 2004, J STRENGTH COND RES, V18, P828; Cohen J.E., 1988, STAT POWER ANAL BEHA; Da Silva ME, 2007, J STRENGTH COND RES, V21, P470, DOI 10.1519/R-19025.1; Davis P. J., 1984, METHODS NUMERICAL IN; De Hoyo M, 2013, EUR J SPORT SCI, V13, P666, DOI 10.1080/17461391.2013.774052; Eston RG, 2001, KINANTHROPOMETRY EXE, V2, P211; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Games KE, 2013, SCAND J MED SCI SPOR, V23, P516, DOI 10.1111/j.1600-0838.2011.01419.x; Garatachea N, 2007, J STRENGTH COND RES, V21, P594, DOI 10.1519/R-20566.1; Giunta M, 2012, OBESITY FACTS, V5, P567, DOI 10.1159/000342066; Gojanovic B, 2014, PHYSIOL RES, V63, P779, DOI 10.33549/physiolres.932628; Gojanovic B, 2012, J SPORT SCI, V30, P1397, DOI 10.1080/02640414.2012.710756; Goto K, 2005, JPN J PHYSIOL, V55, P279, DOI 10.2170/jjphysiol.RP000305; Hazell TJ, 2007, APPL PHYSIOL NUTR ME, V32, P1156, DOI 10.1139/H07-116; Hazell TJ, 2012, EUR J APPL PHYSIOL, V112, P413, DOI 10.1007/s00421-011-1984-2; Jones B, 2015, DESIGN ANAL CROSS OV; Justo ACG, 2015, IEEE ENG MED BIO, P4528, DOI 10.1109/EMBC.2015.7319401; Kang J, 2015, J SPORTS MED PHYS FI, V56; Kang J, 2016, EUR J APPL PHYSIOL, V116, P1829, DOI 10.1007/s00421-016-3440-9; Kerschan-Schindl K, 2001, CLIN PHYSIOL, V21, P377, DOI 10.1046/j.1365-2281.2001.00335.x; Kvorning T, 2006, EUR J APPL PHYSIOL, V96, P615, DOI 10.1007/s00421-006-0139-3; Liao LR, 2015, PHYS THER, V95, P966, DOI 10.2522/ptj.20140295; Milanese C, 2013, INT J MED SCI, V10, P307, DOI 10.7150/ijms.5161; Milanese C, 2012, J ALTERN COMPLEM MED, V18, P69, DOI 10.1089/acm.2010.0324; Milleliri E, 2012, SCI SPORT, V27, P184, DOI 10.1016/j.scispo.2011.06.005; Montani JP, 2016, PLOS ONE, V11; Pel JJM, 2009, MED ENG PHYS, V31, P937, DOI 10.1016/j.medengphy.2009.05.005; Pollock RD, 2012, J APPL PHYSIOL, V112, P388, DOI 10.1152/japplphysiol.01223.2010; Preatoni E, 2012, J STRENGTH COND RES, V26, P2495, DOI 10.1519/JSC.0b013e31823f299d; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Rauch F, 2010, J MUSCULOSKEL NEURON, V10, P193; Rittweger J, 2000, CLIN PHYSIOL, V20, P134; Rittweger J, 2002, INT J SPORTS MED, V23, P428, DOI 10.1055/s-2002-33739; Rittweger J, 2001, EUR J APPL PHYSIOL, V86, P169, DOI 10.1007/s004210100511; Rittweger J, 2010, EUR J APPL PHYSIOL, V108, P877, DOI 10.1007/s00421-009-1303-3; Rittweger J, 2010, CLIN PHYSIOL FUNCT I, V30, P269, DOI 10.1111/j.1475-097X.2010.00937.x; Roelants M, 2004, INT J SPORTS MED, V25, P1, DOI 10.1055/s-2003-45238; Rosenberger W.F., 2016, RANDOMIZATION CLIN T, V2nd ed; Sartorio A, 2011, J ENDOCRINOL INVEST, V34, P216, DOI [10.1007/BF03347069, 10.3275/7255]; Serravite DH, 2013, J SPORT SCI MED, V12, P475; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Torvinen S, 2002, MED SCI SPORT EXER, V34, P1523, DOI 10.1097/00005768-200209000-00020; Verschueren SMP, 2004, J BONE MINER RES, V19, P352, DOI 10.1359/JBMR.0301245; Vissers D, 2010, OBESITY FACTS, V3, P93, DOI 10.1159/000301785; Wakeling JM, 2001, J APPL PHYSIOL, V90, P412, DOI 10.1152/jappl.2001.90.2.412; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Westerterp KR, 1997, INT J OBESITY, V21, P184, DOI 10.1038/sj.ijo.0800385; Yamada E, 2005, CLIN PHYSIOL FUNCT I, V25, P203, DOI 10.1111/j.1475-097X.2005.00614.x; Yarar-Fisher C, 2014, MUSCLE NERVE, V50, P599, DOI 10.1002/mus.24248; Zange J, 2009, EUR J APPL PHYSIOL, V105, P265, DOI 10.1007/s00421-008-0898-0	68	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0192046	10.1371/journal.pone.0192046	http://dx.doi.org/10.1371/journal.pone.0192046			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385196	gold, Green Published, Green Submitted			2022-12-26	WOS:000423668400072
J	Park, S; Ha, S; Lee, SH; Paeng, JC; Keam, B; Kim, TM; Kim, DW; Heo, DS				Park, Sehhoon; Ha, Seunggyun; Lee, Se-Hoon; Paeng, Jin Chul; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog			Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; FACTOR-RECEPTOR GENE; CT TEXTURE ANALYSIS; TUMOR HETEROGENEITY; METABOLIC HETEROGENEITY; F-18-FDG PET/CT; T790M MUTATION; EVOLUTION; CHEMOTHERAPY; GEFITINIB	Intratumoral heterogeneity has been suggested to be an important resistance mechanism leading to treatment failure. We hypothesized that radiologic images could be an alternative method for identification of tumor heterogeneity. We tested heterogeneity textural parameters on pretreatment FDG-PET/CT in order to assess the predictive value of target therapy. Recurred or metastatic non-small cell lung cancer (NSCLC) subjects with an activating EGFR mutation treated with either gefitinib or erlotinib were reviewed. An exploratory data set (n = 161) and a validation data set (n = 21) were evaluated, and eight parameters were selected for survival analysis. The optimal cutoff value was determined by the recursive partitioning method, and the predictive value was calculated using Harrell's C-index. Univariate analysis revealed that all eight parameters showed an increased hazard ratio (HR) for progression- free survival (PFS). The highest HR was 6.41 (P< 0.01) with co-occurrence (Co) entropy. Increased risk remained present after adjusting for initial stage, performance status (PS), and metabolic volume (MV) (aHR: 4.86, P< 0.01). Textural parameters were found to have an incremental predictive value of early EGFR tyrosine kinase inhibitor (TKI) failure compared to that of the base model of the stage and PS (C-index 0.596 vs. 0.662, P = 0.02, by Co entropy). Heterogeneity textural parameters acquired from pretreatment FDG-PET/CT are highly predictive factors for PFS of EGFR TKI in EGFR-mutated NSCLC patients. These parameters are easily applicable to the identification of a subpopulation at increased risk of early EGFR TKI failure. Correlation to genomic alteration should be determined in future studies.	[Park, Sehhoon; Lee, Se-Hoon; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Ha, Seunggyun; Paeng, Jin Chul] Seoul Natl Univ Hosp, Dept Nucl Med, Seoul, South Korea; [Lee, Se-Hoon] Sungkyunkwan Univ, Div Hematol Oncol, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, SH (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.; Paeng, JC (corresponding author), Seoul Natl Univ Hosp, Dept Nucl Med, Seoul, South Korea.; Lee, SH (corresponding author), Sungkyunkwan Univ, Div Hematol Oncol, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea.	sehoon.lee119@gmail.com; paengjc@snu.ac.kr	Kim, Dong-Wan/J-5391-2012		Ministry for Health, Welfare Family Affairs [HI13C0015]; Innovative Research Institute for Cell Therapy, Republic of Korea [A062260]	Ministry for Health, Welfare Family Affairs; Innovative Research Institute for Cell Therapy, Republic of Korea	This study was supported by a grant from the Ministry for Health, Welfare & Family Affairs (HI13C0015) and the Innovative Research Institute for Cell Therapy (A062260), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the Ministry of Health, Welfare & Family Affairs (HI13C0015) and the Innovative Research Institute for Cell Therapy (A062260), Republic of Korea.	Brooks FJ, 2014, J NUCL MED, V55, P37, DOI 10.2967/jnumed.112.116715; Chicklore S, 2013, EUR J NUCL MED MOL I, V40, P133, DOI 10.1007/s00259-012-2247-0; Cook GJR, 2014, CLIN TRANSL IMAGING, V2, P269, DOI 10.1007/s40336-014-0064-0; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Ganeshan B, 2012, CLIN RADIOL, V67, P157, DOI 10.1016/j.crad.2011.08.012; Ganeshan B, 2012, EUR RADIOL, V22, P796, DOI 10.1007/s00330-011-2319-8; Gatenby RA, 2013, RADIOLOGY, V269, P8, DOI 10.1148/radiol.13122697; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hatt M, 2015, J NUCL MED, V56, P38, DOI 10.2967/jnumed.114.144055; Hatt M, 2013, EUR J NUCL MED MOL I, V40, P1662, DOI 10.1007/s00259-013-2486-8; Inukai M, 2006, CANCER RES, V66, P7854, DOI 10.1158/0008-5472.CAN-06-1951; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kang L, 2015, STAT MED, V34, P685, DOI 10.1002/sim.6370; Kang SR, 2014, NUCL MED MOLEC IMAG, V48, P16, DOI 10.1007/s13139-013-0231-7; Kim DH, 2015, CLIN NUCL MED, V40, P708, DOI 10.1097/RLU.0000000000000867; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Lee JW, 2006, METHOD INFORM MED, V45, P37; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nair VS, 2012, CANCER RES, V72, P3725, DOI 10.1158/0008-5472.CAN-11-3943; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Nelson DA, 2004, GENE DEV, V18, P2095, DOI 10.1101/gad.1204904; Nickel GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035262; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Paesmans M, 2010, J THORAC ONCOL, V5, P612, DOI 10.1097/JTO.0b013e3181d0a4f5; Rajendran JG, 2006, CLIN CANCER RES, V12, P5435, DOI 10.1158/1078-0432.CCR-05-1773; Reck M, 2014, ANN ONCOL, V25, P27, DOI 10.1093/annonc/mdu199; Russnes HG, 2011, J CLIN INVEST, V121, P3810, DOI 10.1172/JCI57088; Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Tixier F, 2012, J NUCL MED, V53, P693, DOI 10.2967/jnumed.111.099127; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Vaidya M, 2012, RADIOTHER ONCOL, V102, P239, DOI 10.1016/j.radonc.2011.10.014; van Gool MH, 2016, J THORAC DIS, V8, pE200, DOI 10.21037/jtd.2016.02.10; Vesselle H, 2000, CLIN CANCER RES, V6, P3837; Win T, 2013, CLIN CANCER RES, V19, P3591, DOI 10.1158/1078-0432.CCR-12-1307; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	42	34	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0189766	10.1371/journal.pone.0189766	http://dx.doi.org/10.1371/journal.pone.0189766			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385152	gold, Green Published, Green Submitted			2022-12-26	WOS:000423668400009
J	Koyama, K; Katayama, S; Muronoi, T; Tonai, K; Goto, Y; Koinuma, T; Shima, J; Nunomiya, S				Koyama, Kansuke; Katayama, Shinshu; Muronoi, Tomohiro; Tonai, Ken; Goto, Yuya; Koinuma, Toshitaka; Shima, Jun; Nunomiya, Shin			Time course of immature platelet count and its relation to thrombocytopenia and mortality in patients with sepsis	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; CRITICALLY-ILL PATIENTS; SEPTIC SHOCK; CIRCULATING THROMBOPOIETIN; FRACTION; SEVERITY; COAGULOPATHY; ENDOTOXEMIA; DEFINITION; MANAGEMENT	Introduction The pathogenesis of thrombocytopenia in patients with sepsis is not fully understood. The aims of this study were to investigate changes in thrombopoietic activity over time by using absolute immature platelet counts (AIPC) and to examine the impact of platelet production on thrombocytopenia and mortality in patients with sepsis. Methods This retrospective observational study included adult patients with sepsis admitted to the intensive care unit at a university hospital. Two hundred five consecutive sepsis patients were stratified into four groups according to nadir platelet count: severe (nadir <= 40x10(3)/mu L), moderate (41-80x10(3)/mu L), or mild thrombocytopenia (81-120x10(3)/mu L), or normal- increased platelet count (>120x10(3)/mu L). The development of thrombocytopenia was assessed during the first week; mortality was assessed at day 28. Result Of the 205 patients included, 61 (29.8%) developed severe thrombocytopenia. On admission, AIPC did not differ among the four groups. In patients with severe thrombocytopenia, AIPC decreased significantly from days 2 to 7, but remained within or above the normal range in the other three groups (overall group comparison, P<0.0001). Multivariate analysis including coagulation biomarkers revealed that AIPC was independently associated with the development of severe thrombocytopenia (day 3 AIPC, odds ratio 0.49 [95% confidence interval (Cl) 0.35-0.66], P<0.0001; day 5 AIPC, 0.59 [95% Cl 0.45-0.75], P<0.0001). AIPC was a significant predictor of 28-day mortality in Cox hazard models adjusted for Acute Physiology and Chronic Health Evaluation II and Sequential Organ Failure Assessment scores (day 3 AIPC, hazard ratio 0.70 [95% Cl 0.52-0.89], P = 0.0029; day 5 AIPC, 0.68 [95% Cl 0.49-0.87], P = 0.0012). Conclusions Thrombopoietic activity was generally maintained in the acute phase of sepsis. However, a decrease in AIPC after admission was independently associated with the development of severe thrombocytopenia and mortality, suggesting the importance of suppressed thrombopoiesis in the pathophysiology of sepsis-induced thrombocytopenia.	[Koyama, Kansuke; Katayama, Shinshu; Muronoi, Tomohiro; Tonai, Ken; Goto, Yuya; Koinuma, Toshitaka; Shima, Jun; Nunomiya, Shin] Jichi Med Univ, Sch Med, Dept Anesthesiol & Intens Care Med, Div Intens Care, Shimotsuke, Tochigi, Japan; [Muronoi, Tomohiro] Jichi Med Univ, Sch Med, Dept Emergency Med, Shimotsuke, Tochigi, Japan	Jichi Medical University; Jichi Medical University	Koyama, K (corresponding author), Jichi Med Univ, Sch Med, Dept Anesthesiol & Intens Care Med, Div Intens Care, Shimotsuke, Tochigi, Japan.	k_koyama@jichi.ac.jp	Muronoi, Tomohiro/AAW-2204-2021; Katayama, Shinshu/AHD-2024-2022	Muronoi, Tomohiro/0000-0001-7127-7187; Katayama, Shinshu/0000-0002-6078-5052				Abe Y, 2006, THROMB RES, V118, P463, DOI 10.1016/j.thromres.2005.09.007; Barsam SJ, 2011, BLOOD, V117, P5723, DOI 10.1182/blood-2010-11-321398; Bat T, 2013, TRANSFUSION, V53, P1201, DOI 10.1111/j.1537-2995.2012.03918.x; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Briggs C, 2004, BRIT J HAEMATOL, V126, P93, DOI 10.1111/j.1365-2141.2004.04987.x; Buyse S, 2010, INTENS CARE MED, V36, P1695, DOI 10.1007/s00134-010-1936-z; Cerutti A, 1999, CLIN LAB HAEMATOL, V21, P271, DOI 10.1046/j.1365-2257.1999.00226.x; Cremer M, 2013, J PERINATOL, V33, P622, DOI 10.1038/jp.2013.21; De Blasi RA, 2013, INTENS CARE MED, V39, P636, DOI 10.1007/s00134-012-2725-7; de Stoppelaar SF, 2014, THROMB HAEMOSTASIS, V112, P666, DOI 10.1160/TH14-02-0126; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Deutsch VR, 2013, BRIT J HAEMATOL, V161, P778, DOI 10.1111/bjh.12328; Dhainaut JF, 2005, CRIT CARE MED, V33, P341, DOI 10.1097/01.CCM.0000153520.31562.48; Di Mario A, 2009, J INFECTION, V59, P201, DOI 10.1016/j.jinf.2009.07.007; Eissa DS, 2013, PLATELETS, V24, P122, DOI 10.3109/09537104.2012.696748; Gando S, 2006, CRIT CARE MED, V34, P625, DOI 10.1097/01.CCM.0000202209.42491.38; Hoffmann JJML, 2014, CLIN CHEM LAB MED, V52, P1107, DOI 10.1515/cclm-2014-0165; Inai K, 2014, VIRCHOWS ARCH, V465, P109, DOI 10.1007/s00428-014-1592-8; Ishiguro A, 2002, BRIT J HAEMATOL, V116, P612, DOI 10.1046/j.0007-1048.2001.03304.x; Kaser A, 2001, BLOOD, V98, P2720, DOI 10.1182/blood.V98.9.2720; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; Kinasewitz GT, 2004, CRIT CARE, V8, pR82, DOI 10.1186/cc2459; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koyama K, 2013, J CRIT CARE, V28, P556, DOI 10.1016/j.jcrc.2012.10.069; Kulshrestha M, 2015, AM J PHYSIOL-HEART C, V308, pH68, DOI 10.1152/ajpheart.00528.2013; Larkin CM, 2016, THROMB RES, V141, P11, DOI 10.1016/j.thromres.2016.02.022; Martin CM, 2009, CRIT CARE MED, V37, P81, DOI 10.1097/CCM.0b013e31819285f0; Moreau D, 2007, CHEST, V131, P1735, DOI 10.1378/chest.06-2233; Muronoi T, 2016, THROMB RES, V144, P169, DOI 10.1016/j.thromres.2016.06.002; Pons I, 2010, EUR J HAEMATOL, V85, P158, DOI 10.1111/j.1600-0609.2010.01468.x; Segre E, 2014, CLIN CHEM LAB MED, V52, P1479, DOI 10.1515/cclm-2014-0219; Semeraro N, 2012, THROMB RES, V129, P290, DOI 10.1016/j.thromres.2011.10.013; Sharma B, 2007, ANAESTH INTENS CARE, V35, P874, DOI 10.1177/0310057X0703500604; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stohlawetz P, 1999, THROMB HAEMOSTASIS, V81, P613; Takami A, 2007, BONE MARROW TRANSPL, V39, P501, DOI 10.1038/sj.bmt.1705623; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Taylor FB, 2000, CRIT CARE MED, V28, pS12, DOI 10.1097/00003246-200009001-00004; Thiery-Antier N, 2016, CRIT CARE MED, V44, P764, DOI 10.1097/CCM.0000000000001520; Thiolliere F, 2013, INTENS CARE MED, V39, P1460, DOI 10.1007/s00134-013-2963-3; Vanderschueren S, 2000, CRIT CARE MED, V28, P1871, DOI 10.1097/00003246-200006000-00031; Vandijck DM, 2010, HEART LUNG, V39, P21, DOI 10.1016/j.hrtlng.2009.07.005; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vincent JL, 2002, CRIT CARE MED, V30, pS313, DOI 10.1097/00003246-200205001-00022; Zakynthinos SG, 2004, CRIT CARE MED, V32, P1004, DOI 10.1097/01.CCM.0000121433.61546.A0	45	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0192064	10.1371/journal.pone.0192064	http://dx.doi.org/10.1371/journal.pone.0192064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381746	Green Published, gold, Green Submitted			2022-12-26	WOS:000423617800055
J	Chen, KH; Zuo, DC; Wang, SY; Chen, HJ				Chen, Kuihao; Zuo, Dongchuan; Wang, Sho-Ya; Chen, Haijun			Kir2 inward rectification-controlled precise and dynamic balances between Kir2 and HCN currents initiate pacemaking activity	FASEB JOURNAL			English	Article						pacemaker cells; Kir2.1 channels; HCN channels; spontaneous rhythmic action potential	PACE-MAKER CURRENT; FUNNY CURRENT; SODIUM-CHANNELS; BIOLOGICAL PACEMAKER; CARDIAC PACEMAKING; K+ CURRENT; SINOATRIAL; NODE; CELLS; HEART	Spontaneous rhythmic action potential or pacemaking activity of pacemaker cells controls rhythmic signaling such as heartbeat. The mechanism underlying the origin of pacemaking activity is not well understood. In this study, we created human embryonic kidney (HEK) 293 cells that show pacemaking activity through heterologous expression of strong inward rectifier IC subfamily 2 isoform 1 (Kir2.1) channels, hyperpolarization-activated cyclic nucleotide-gated isoform 2 (HCN2) nonselective cation channels, and voltage-gated Na + subfamily 1 isoform 5 or Ca2+ subfamily 3 isoform 1 (Na(v)1.5 or Ca(v)3.1) channels. A range of relative levels of Kir2.1 and HCN2 currents dynamically counterbalance, generating spontaneous rhythmic oscillation of resting membrane potential between -64 and -34 mV and determining oscillation rates. Each oscillation cycle begins with an autodepolarization phase, which slowly proceeds to the threshold potential that activates Na(v)1.5 or Ca(v)3.1 channels and triggers action potential, causing engineered HEK293 cells to exhibit pacemaking activity at a rate of <= 67 beats/min. Engineered HEK293 cells with Kir2.1 and either HCN3 or HCN4 also show the oscillation. Engineered HEK293 cells expressing HCN2 and other Kir2 channels, which lack Kir2.1-like complete inward rectification, do not show the oscillation. Therefore, Kir2.1-like inward rectification-controlled precise and dynamic balances between Kir2 and HCN currents initiate spontaneous rhythmic action potential and form an origin of pacemaking activity; Kir2 and HCN channels play essential roles in pacemaking activity.				hchen01@albany.edu			U.S. National Institutes of Health, National Institute of General Medical Sciences Award [R01GM102943]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102943] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Toshinori Hoshi (Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA) for providing Ca<INF>v</INF>1 and Ca<INF>v</INF>3 plasmids and sharing information of functional expression of Ca<INF>v</INF>1 and Ca<INF>v</INF>3 channels, Edward Perez-Reyes (University of Virginia School of Medicine, Charlottesville, VA, USA) for providing HEK293-Ca<INF>v</INF>3.1 cells, and Steven A. Siegelbaum (Columbia University Medical Center, New York, NY, USA), Juliane Stieber (University of Erlangen-Nuremberg, Erlangen, Germany), and Catherine Proenza (University of Colorado School of Medicine, Denver, CO, USA) for providing HCN plasmids. H.C. was supported by the U.S. National Institutes of Health, National Institute of General Medical Sciences Award R01GM102943. The authors declare no conflicts of interest.	Accorsi-Mendonca D, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00424; Anumonwo JMB, 2010, J MOL CELL CARDIOL, V48, P45, DOI 10.1016/j.yjmcc.2009.08.013; Baruscotti M, 2005, PHARMACOL THERAPEUT, V107, P59, DOI 10.1016/j.pharmthera.2005.01.005; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343, DOI 10.1111/j.1476-5381.1993.tb13815.x; Capel RA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00080; Chan YC, 2009, J CARDIOVASC ELECTR, V20, P1048, DOI 10.1111/j.1540-8167.2009.01475.x; Cho HS, 2003, J PHYSIOL-LONDON, V550, P169, DOI 10.1113/jphysiol.2003.040501; DENYER JC, 1990, J PHYSIOL-LONDON, V428, P405, DOI 10.1113/jphysiol.1990.sp018219; DIFRANCESCO D, 1981, J PHYSIOL-LONDON, V314, P377, DOI 10.1113/jphysiol.1981.sp013714; DIFRANCESCO D, 1981, J PHYSIOL-LONDON, V314, P359, DOI 10.1113/jphysiol.1981.sp013713; DiFrancesco D, 2012, HEART RHYTHM, V9, P299, DOI 10.1016/j.hrthm.2011.09.021; DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041; Findeisen F, 2010, CHANNELS, V4, P459, DOI 10.4161/chan.4.6.12867; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; IRISAWA H, 1993, PHYSIOL REV, V73, P197, DOI 10.1152/physrev.1993.73.1.197; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; Kuhlman SJ, 2006, J BIOL RHYTHM, V21, P470, DOI 10.1177/0748730406294316; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Lakatta EG, 2009, J MOL CELL CARDIOL, V47, P157, DOI 10.1016/j.yjmcc.2009.03.022; Lee JH, 1999, J NEUROSCI, V19, P1912; Lei M, 2004, J PHYSIOL-LONDON, V559, P835, DOI 10.1113/jphysiol.2004.068643; Lopatin AN, 2001, J MOL CELL CARDIOL, V33, P625, DOI 10.1006/jmcc.2001.1344; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Ma LQ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001726; Maier SKG, 2003, P NATL ACAD SCI USA, V100, P3507, DOI 10.1073/pnas.2627986100; Maltsev VA, 2012, HEART RHYTHM, V9, P302, DOI 10.1016/j.hrthm.2011.09.022; Maltsev VA, 2010, J MOL CELL CARDIOL, V48, P804, DOI 10.1016/j.yjmcc.2009.12.009; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49; Mesirca P, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00019; Mesirca P, 2014, PFLUG ARCH EUR J PHY, V466, P791, DOI 10.1007/s00424-014-1482-6; Miake J, 2002, NATURE, V419, P132, DOI 10.1038/419132b; Miake J, 2003, J CLIN INVEST, V111, P1529, DOI 10.1172/JCI200317959; NOBLE D, 1968, J PHYSIOL-LONDON, V195, P185, DOI 10.1113/jphysiol.1968.sp008454; Noble D, 2010, CIRC RES, V106, P1791, DOI 10.1161/CIRCRESAHA.110.218875; Qu JH, 2003, CIRCULATION, V107, P1106, DOI 10.1161/01.CIR.0000059939.97249.2C; Rosen MR, 2011, NAT REV CARDIOL, V8, P656, DOI 10.1038/nrcardio.2011.120; SHAH AK, 1987, BIOPHYS J, V52, P519, DOI 10.1016/S0006-3495(87)83241-1; Shinagawa Y, 2000, J PHYSIOL-LONDON, V523, P593, DOI 10.1111/j.1469-7793.2000.t01-2-00593.x; Sun Y, 2017, STEM CELL REV REP, V13, P631, DOI 10.1007/s12015-017-9745-1; Tse HF, 2006, CIRCULATION, V114, P1000, DOI 10.1161/CIRCULATIONAHA.106.615385; Verkerk AO, 2007, EUR HEART J, V28, P2472, DOI 10.1093/eurheartj/ehm339; Verkerk AO, 2009, INT J BIOL SCI, V5, P201; Wang GK, 2014, MOL PHARMACOL, V85, P692, DOI 10.1124/mol.113.091173; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; Xie LH, 2003, J PHYSIOL-LONDON, V550, P67, DOI 10.1113/jphysiol.2003.043117; Xie LH, 2002, J GEN PHYSIOL, V120, P53, DOI 10.1085/jgp.20028576; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yuill KH, 2002, PFLUG ARCH EUR J PHY, V445, P311, DOI 10.1007/s00424-002-0932-8; Zuo DC, 2017, J PHYSIOL-LONDON, V595, P5129, DOI 10.1113/JP274268	52	8	8	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3047	3057		10.1096/fj.201701260R	http://dx.doi.org/10.1096/fj.201701260R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401592	Green Published			2022-12-26	WOS:000432546000013
J	Woodman, AG; Mah, R; Keddie, D; Noble, RMN; Panahi, S; Gragasin, FS; Lemieux, H; Bourque, SL				Woodman, Andrew G.; Mah, Richard; Keddie, Danae; Noble, Ronan M. N.; Panahi, Sareh; Gragasin, Ferrante S.; Lemieux, Helene; Bourque, Stephane L.			Prenatal iron deficiency causes sex-dependent mitochondria! dysfunction and oxidative stress in fetal rat kidneys and liver	FASEB JOURNAL			English	Article						pregnancy; development; nutrition; metabolism; programming	CYTOCHROME-C-OXIDASE; RENAL DEVELOPMENT; PREGNANT RATS; WISTAR RATS; COMPLEX-II; ANEMIA; HYPOXIA; TESTOSTERONE; HYPERTENSION; RESTRICTION	Prenatal iron deficiency alters fetal developmental trajectories, which results in persistent changes in organ function. Here, we studied the effects of prenatal iron deficiency on fetal kidney and liver mitochondrial function. Pregnant Sprague-Dawley rats were fed partially or fully iron-restricted diets to induce a state of moderate or severe iron deficiency alongside iron-replete control rats. We assessed mitochondrial function via high-resolution respirometry and reactive oxygen species generation via fluorescence microscopy on gestational d 21. Hemoglobin levels were reduced in dams in the moderate (-31%) and severe groups (-54%) compared with controls, which was accompanied by 55% reductions in fetal hemoglobin levels in both moderate and severe groups versus controls. Male iron-deficient kidneys exhibited globally reduced mitochondrial content and respiration, as well as increased cytosolic superoxide and decreased NO. Female iron-deficient kidneys exhibited complex II down-regulation and increased mitochondrial oxidative stress. Male iron-deficient livers exhibited reduced complex IV respiration and increased cytosolic superoxide, whereas female liver tissues exhibited no alteration in oxidant levels or mitochondrial function. These findings indicate that prenatal iron deficiency causes changes in mitochondrial content and function as well as oxidant status in a sex- and organ-dependent manner, which may be an important mechanism that underlies the programming of cardiovascular disease.	[Woodman, Andrew G.; Bourque, Stephane L.] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada; [Woodman, Andrew G.; Mah, Richard; Keddie, Danae; Noble, Ronan M. N.; Panahi, Sareh; Gragasin, Ferrante S.; Bourque, Stephane L.] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Mah, Richard; Keddie, Danae; Noble, Ronan M. N.; Panahi, Sareh; Gragasin, Ferrante S.; Bourque, Stephane L.] Univ Alberta, Dept Anesthesiol & Pain Med, Edmonton, AB, Canada; [Lemieux, Helene] Univ Alberta, Fac St Jean, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Bourque, SL (corresponding author), Univ Alberta, Katz Grp Ctr, 3-020H, Edmonton, AB T6G 2E1, Canada.	sbourque@ualberta.ca		Mah, Richard/0000-0002-1172-5088; lemieux, Helene/0000-0002-8864-6062; Woodman, Andrew/0000-0002-1476-1850	Canadian Institutes of Health Research (CIHR) [MOP142396]; Women and Children's Health Research Institute; Discovery Grant from the National Sciences and Engineering Research Council [RGPIN 402636]; CIHR; Alberta Innovates-Health Solutions; CIHR New Investigator Salary Award; Alberta Innovates [201600255] Funding Source: researchfish	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Women and Children's Health Research Institute; Discovery Grant from the National Sciences and Engineering Research Council; CIHR(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; CIHR New Investigator Salary Award(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	This work was supported by grants from the Canadian Institutes of Health Research (CIHR; MOP142396) and the Women and Children's Health Research Institute (to S.L.B.), and a Discovery Grant from the National Sciences and Engineering Research Council (RGPIN 402636; to H.L.). A.G.W. holds studentships from CIHR and Alberta Innovates-Health Solutions. S.L.B. holds a CIHR New Investigator Salary Award. The authors declare no conflicts of interest.	Bourque SL, 2008, J NUTR, V138, P931, DOI 10.1093/jn/138.5.931; Bourque SL, 2008, HYPERTENSION, V51, P154, DOI 10.1161/HYPERTENSIONAHA.107.100446; Bourque SL, 2012, ENDOCRINOLOGY, V153, P1174, DOI 10.1210/en.2011-1700; Breymann C, 2015, SEMIN HEMATOL, V52, P339, DOI 10.1053/j.seminhematol.2015.07.003; DALLMAN PR, 1986, ANNU REV NUTR, V6, P13, DOI 10.1146/annurev.nu.06.070186.000305; Danson MJ, 2001, METHOD ENZYMOL, V331, P3; DAVIS LE, 1991, AM J PHYSIOL, V261, pR1542, DOI 10.1152/ajpregu.1991.261.6.R1542; Drake KA, 2009, PEDIATR RES, V66, P619, DOI 10.1203/PDR.0b013e3181be79c2; Gnaiger E, 1998, J EXP BIOL, V201, P1129; Gnaiger E., 2014, MITOCHONDRIAL PATHWA, V4th ed., P81, DOI DOI 10.26124/BEC:2020-0002; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Haase VH, 2010, AM J PHYSIOL-RENAL, V299, pF1, DOI 10.1152/ajprenal.00174.2010; HABERT R, 1984, J STEROID BIOCHEM, V21, P193, DOI 10.1016/0022-4731(84)90383-2; Iverson TM, 2012, J BIOL CHEM, V287, P35430, DOI 10.1074/jbc.R112.408419; Komolova M, 2008, INT J OBESITY, V32, P1441, DOI 10.1038/ijo.2008.97; Lewis RM, 2002, BRIT J NUTR, V88, P283, DOI 10.1079/BJN2002656; Lisle SJM, 2003, BRIT J NUTR, V90, P33, DOI 10.1079/BJN2003881; Lopez A, 2016, LANCET, V387, P907, DOI 10.1016/S0140-6736(15)60865-0; Luo SX, 2014, CURR PHARM DESIGN, V20, P3548, DOI 10.2174/13816128113196660746; MACKLER B, 1983, TERATOLOGY, V28, P103, DOI 10.1002/tera.1420280113; Maduwegedera D, 2007, AM J PHYSIOL-REG I, V292, pR706, DOI 10.1152/ajpregu.00458.2006; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Ortiz LA, 2003, HYPERTENSION, V41, P328, DOI 10.1161/01.HYP.0000049763.51269.51; Ozcay F, 2003, PEDIATR NEPHROL, V18, P254, DOI 10.1007/s00467-002-1054-4; Paddenberg R, 2003, AM J PHYSIOL-LUNG C, V284, pL710, DOI 10.1152/ajplung.00149.2002; Pereira SP, 2015, AM J PHYSIOL-RENAL, V308, pF1217, DOI 10.1152/ajprenal.00419.2014; Pesta D, 2011, AM J PHYSIOL-REG I, V301, pR1078, DOI 10.1152/ajpregu.00285.2011; Ralph SJ, 2011, PHARM RES-DORDR, V28, P2695, DOI 10.1007/s11095-011-0566-7; Rensvold JW, 2016, J BIOL CHEM, V291, P20827, DOI 10.1074/jbc.M116.727701; Rensvold JW, 2013, CELL REP, V3, P237, DOI 10.1016/j.celrep.2012.11.029; Srinivasan S, 2012, FREE RADICAL BIO MED, V53, P1252, DOI 10.1016/j.freeradbiomed.2012.07.021; Stangenberg S, 2015, INT J BIOCHEM CELL B, V64, P81, DOI 10.1016/j.biocel.2015.03.017; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Toblli JE, 2012, PLACENTA, V33, P81, DOI 10.1016/j.placenta.2011.11.017; Tower J, 2006, MECH AGEING DEV, V127, P705, DOI 10.1016/j.mad.2006.05.001; Unger EL, 2012, J NUTR, V142, P2040, DOI 10.3945/jn.112.162198; Ventura-Clapier R, 2017, CLIN SCI, V131, P803, DOI 10.1042/CS20160485; Vieyra-Reyes P, 2017, J PHYSIOL BIOCHEM, V73, P99, DOI 10.1007/s13105-016-0529-x; WEISZ J, 1980, ENDOCRINOLOGY, V106, P306, DOI 10.1210/endo-106-1-306; Woodman AG, 2017, SCI REP-UK, V7, DOI 10.1038/srep46573	40	22	22	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3254	3263		10.1096/fj.201701080R	http://dx.doi.org/10.1096/fj.201701080R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401611				2022-12-26	WOS:000432546000029
J	Yan, MS; Turgeon, PJ; Man, HSJ; Dubinsky, MK; Ho, JJD; El-Rass, S; Wang, YD; Wen, XY; Marsden, PA				Yan, Matthew S.; Turgeon, Paul J.; Man, Hon-Sum Jeffrey; Dubinsky, Michelle K.; Ho, J. J. David; El-Rass, Suzan; Wang, You-Dong; Wen, Xiao-Yan; Marsden, Philip A.			Histone acetyltransferase 7 (KAT7)-dependent intragenic histone acetylation regulates endothelial cell gene regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; EMBRYONIC STEM-CELLS; GROWTH-FACTOR; HBO1 ACETYLTRANSFERASE; DNA-REPLICATION; CODING REGIONS; ANGIOGENIC FACTOR; ZEBRAFISH EMBRYO; METHYLATION; CHROMATIN	Although the functional role of chromatin marks at promoters in mediating cell-restricted gene expression has been well characterized, the role of intragenic chromatin marks is not well understood, especially in endothelial cell (EC) gene expression. Here, we characterized the histone H3 and H4 acetylation profiles of 19 genes with EC-enriched expression via locus-wide chromatin immunoprecipitation followed by ultra-high-resolution (5 bp) tiling array analysis in ECs versus non-ECs throughout their genomic loci. Importantly, these genes exhibit differential EC enrichment of H3 and H4 acetylation in their promoter in ECs versus non-ECs. Interestingly, VEGFR-2 and VEGFR-1 show EC-enriched acetylation across broad intragenic regions and are up-regulated in non-ECs by histone deacetylase inhibition. It is unclear which histone acetyltransferases (KATs) are key to EC physiology. Depletion of KAT7 reduced VEGFR-2 expression and disrupted angiogenic potential. Microarray analysis of KAT7-depleted ECs identified 263 differentially regulated genes, many of which are key for growth and angiogenic potential. KAT7 inhibition in zebrafish embryos disrupted vessel formation and caused loss of circulatory integrity, especially hemorrhage, all of which were rescued with human KAT7. Notably, perturbed EC-enriched gene expression, especially the VEGFR-2 homologs, contributed to these vascular defects. Mechanistically, KAT7participates in VEGFR-2 transcription by mediating RNA polymerase II binding, H3 lysine 14, and H4 acetylation in its intragenic region. Collectively, our findings support the importance of differential histone acetylation at both promoter and intragenic regions of EC genes and reveal a previously underappreciated role of KAT7 and intragenic histone acetylation in regulating VEGFR-2 and endothelial function.	[Yan, Matthew S.; Marsden, Philip A.] Univ Toronto, Dept Med Biophys, Toronto, ON M5B 1T8, Canada; [Turgeon, Paul J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5B 1T8, Canada; [Man, Hon-Sum Jeffrey; Dubinsky, Michelle K.; El-Rass, Suzan; Wang, You-Dong; Wen, Xiao-Yan; Marsden, Philip A.] Univ Toronto, Inst Med Sci, Toronto, ON M5B 1T8, Canada; [Yan, Matthew S.; Turgeon, Paul J.; Man, Hon-Sum Jeffrey; Dubinsky, Michelle K.; El-Rass, Suzan; Wang, You-Dong; Wen, Xiao-Yan; Marsden, Philip A.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1T8, Canada; [Marsden, Philip A.] Univ Toronto, Dept Med, Toronto, ON M5B 1T8, Canada; [Ho, J. J. David] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Ho, J. J. David] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Toronto; University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Miami; University of Miami	Marsden, PA (corresponding author), St Michaels Hosp, 209 Victoria St, Toronto, ON M5B 1T8, Canada.	p.marsden@utoronto.ca		Wen, Xiao-Yan/0000-0001-6728-0025; , Jeffrey/0000-0001-6628-0007	Canadian Institutes of Health Research [MOP-142307]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Grant MOP-142307 from Canadian Institutes of Health Research (to P.A.M.).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Albig AR, 2005, MOL BIOL CELL, V16, P609, DOI 10.1091/mbc.e04-06-0479; Avvakumov N, 2012, MOL CELL BIOL, V32, P689, DOI 10.1128/MCB.06455-11; Bastiaansen AJNM, 2013, ARTERIOSCL THROM VAS, V33, P1902, DOI 10.1161/ATVBAHA.113.301579; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Bussmann J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000064; Carpentier G., 2012, IMAGEJ NEWS; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chan Y, 2004, J BIOL CHEM, V279, P35087, DOI 10.1074/jbc.M405063200; Charpentier MS, 2013, DEV CELL, V25, P132, DOI 10.1016/j.devcel.2013.03.003; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Contzler R, 2006, BIOCHEM BIOPH RES CO, V350, P208, DOI 10.1016/j.bbrc.2006.09.030; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; Ergun S, 2000, MOL CELL, V5, P311, DOI 10.1016/S1097-2765(00)80426-8; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feng YP, 2016, EMBO J, V35, P176, DOI 10.15252/embj.201591293; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fish JE, 2010, J BIOL CHEM, V285, P810, DOI 10.1074/jbc.M109.067868; Fish JE, 2005, J BIOL CHEM, V280, P24824, DOI 10.1074/jbc.M502115200; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Gunderson FQ, 2011, P NATL ACAD SCI USA, V108, P2004, DOI 10.1073/pnas.1011982108; Gunderson FQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000682; Habeck H, 2002, CURR BIOL, V12, P1405, DOI 10.1016/S0960-9822(02)01044-8; Hannus M, 2014, NUCLEIC ACIDS RES, V42, P8049, DOI 10.1093/nar/gku480; Ho JJD, 2012, J BIOL CHEM, V287, P29003, DOI 10.1074/jbc.M112.373365; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Hu M, 2010, P NATL ACAD SCI USA, V107, P2956, DOI 10.1073/pnas.0915033107; Huang HT, 2013, NAT CELL BIOL, V15, P1516, DOI 10.1038/ncb2870; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Johmura Y, 2008, J BIOL CHEM, V283, P2265, DOI 10.1074/jbc.M707880200; Kim MS, 2001, NAT MED, V7, P437, DOI 10.1038/86507; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kristjuhan A, 2002, MOL CELL, V10, P925, DOI 10.1016/S1097-2765(02)00647-0; Krueger J, 2011, DEVELOPMENT, V138, P2111, DOI 10.1242/dev.063933; Kueh AJ, 2011, MOL CELL BIOL, V31, P845, DOI 10.1128/MCB.00159-10; Lalonde ME, 2013, GENE DEV, V27, P2009, DOI 10.1101/gad.223396.113; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Li RF, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0209-0; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Miotto B, 2010, MOL CELL, V37, P57, DOI 10.1016/j.molcel.2009.12.012; Mishima Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6872; Mishima Y, 2011, BLOOD, V118, P2443, DOI 10.1182/blood-2011-01-331892; Mun GI, 2011, J BIOL CHEM, V286, P2536, DOI 10.1074/jbc.M110.180489; Nag A, 2013, ELIFE, V2, DOI 10.7554/eLife.01256; Newman DM, 2017, J LEUKOCYTE BIOL, V101, P887, DOI 10.1189/jlb.1MA0816-338R; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Pober JS, 2001, ANN NY ACAD SCI, V941, P12; Rush JWE, 2008, APPL PHYSIOL NUTR ME, V33, P162, DOI 10.1139/H07-147; Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007; Sharma M, 2000, J BIOL CHEM, V275, P35200, DOI 10.1074/jbc.M004838200; Shirodkar AV, 2013, BLOOD, V121, P3531, DOI 10.1182/blood-2013-01-479170; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; Thisse B, 2004, ZFIN DIRECT DATA SUB; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yan KZ, 2016, J BIOL CHEM, V291, P2647, DOI 10.1074/jbc.M115.703041; Yan MS, 2015, ARTERIOSCL THROM VAS, V35, P2297, DOI 10.1161/ATVBAHA.115.305043; Zhuge X, 2005, BIOCHEM BIOPH RES CO, V331, P1295, DOI 10.1016/j.bbrc.2005.03.200	63	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4381	4402		10.1074/jbc.RA117.001383	http://dx.doi.org/10.1074/jbc.RA117.001383			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29414790	Green Published, hybrid			2022-12-26	WOS:000428204300011
J	Dumas, SE; Kassa, L; Young, SL; Travis, AJ				Dumas, Sarah E.; Kassa, Lea; Young, Sera L.; Travis, Alexander J.			Examining the association between livestock ownership typologies and child nutrition in the Luangwa Valley, Zambia	PLOS ONE			English	Article							ANIMAL SOURCE FOODS; WILDLIFE CONSUMPTION; DEVELOPING-COUNTRIES; ADULT HEALTH; IMPACT; GROWTH; COMMUNITY; POULTRY; MILK; UNDERNUTRITION	Objective To investigate the association between livestock ownership and dietary diversity, animal-source food consumption, height-for-age z-score, and stunting among children living in wild-life "buffer zones" of Zambia's Luangwa Valley using a novel livestock typology approach. Methods We conducted a cross-sectional study of 838 children aged 6-36 months. Households were categorized into typologies based on the types and numbers of animals owned, ranging from no livestock to large numbers of mixed livestock. We used multilevel mixed-effects linear and logistic regression to examine the association between livestock typologies and four nutrition-related outcomes of interest. Results were compared with analyses using more common binary and count measures of livestock ownership. Results No measure of livestock ownership was significantly associated with children's odds of animal-source food consumption, child height-for-age z-score, or stunting odds. Livestock ownership Type 2 (having a small number of poultry) was surprisingly associated with decreased child dietary diversity (beta = -0.477; p<0.01) relative to owning no livestock. Similarly, in comparison models, chicken ownership was negatively associated with dietary diversity (beta = -0.320; p<0.01), but increasing numbers of chickens were positively associated with dietary diversity (beta = 0.022; p<0.01). Notably, neither child dietary diversity nor animal-source food consumption was significantly associated with height, perhaps due to unusually high prevalences of morbidities. Conclusions Our novel typologies methodology allowed for an efficient and a more in-depth examination of the differential impact of livestock ownership patterns compared to typical binary or count measures of livestock ownership. We found that these patterns were not positively associated with child nutrition outcomes in this context. Development and conservation programs focusing on livestock must carefully consider the complex, context-specific relationship between livestock ownership and nutrition outcomes-including how livestock are utilized by the target population-when attempting to use livestock as a means of improving child nutrition.	[Dumas, Sarah E.; Travis, Alexander J.] Cornell Univ, Master Publ Hlth Program, Ithaca, NY USA; [Dumas, Sarah E.; Travis, Alexander J.] Cornell Univ, Atkinson Ctr Sustainable Future, Ithaca, NY USA; [Dumas, Sarah E.; Travis, Alexander J.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Kassa, Lea] Cornell Univ, Coll Arts & Sci, Ithaca, NY USA; [Young, Sera L.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Young, Sera L.] Cornell Univ, Program Int Nutr, Ithaca, NY USA; [Young, Sera L.] Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Northwestern University	Travis, AJ (corresponding author), Cornell Univ, Master Publ Hlth Program, Ithaca, NY USA.; Travis, AJ (corresponding author), Cornell Univ, Atkinson Ctr Sustainable Future, Ithaca, NY USA.; Travis, AJ (corresponding author), Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA.	atj32@cornell.edu		Young, Sera/0000-0002-1763-1218	Atkinson Center for a Sustainable Future [K01 M H098902]; Cornell University Master of Public Health program; Richard P. Henry '65, DVM '68 Award	Atkinson Center for a Sustainable Future; Cornell University Master of Public Health program; Richard P. Henry '65, DVM '68 Award	This work was supported by the Atkinson Center for a Sustainable Future A.J.T.); and S.L.Y., award number K01 M H098902); the Cornell University Master of Public Health program (A.J.T.); and the Richard P. Henry '65, DVM '68 Award (S.E.D.). No funder had any role in the design, analysis, or writing of this paper. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources, the National Institutes of Health, the Atkinson Center for a Sustainable Future, or Cornell University.	Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Ahmed Mohamed M., 2000, Food and Nutrition Bulletin, V21, P460; [Anonymous], 2011, NAT HLTH STRAT PLAN; [Anonymous], 2014, REV 6 NAT DEV PLAN 2; Azzarri C, 2015, J DEV STUD, V51, P1034, DOI 10.1080/00220388.2015.1018905; Barrett M.A., 2013, JEKELS EPIDEMIOLOGY, P364; Bengis RG, 2002, REV SCI TECH OIE, V21, P53; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Cogill B, 2003, ANTHROPOMETRIC INDIC; CSO MOH and ICF International, 2015, ZAMB DEM HLTH SURV 2; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; Distefano E, 2005, HUMAN WILDLIFE CONFL; Dumas SE, 2016, FOOD SECUR, V8, P507, DOI 10.1007/s12571-016-0579-5; Fierstein JL, 2017, AM J TROP MED HYG, V96, P74, DOI 10.4269/ajtmh.16-0646; Food and Agricultural Organisation of the United Nations (FAO), FAOSTAT DAT; George CM, 2015, AM J TROP MED HYG, V93, P269, DOI 10.4269/ajtmh.14-0694; Golden CD, 2011, P NATL ACAD SCI USA, V108, P19653, DOI 10.1073/pnas.1112586108; Good S., 2008, ANIMAL SOURCE FOODS, P1; Grosse SD, 1998, S HUM NUTR LIV DEV W, P190; Headey D, 2016, PLOONE PUBLIC LIB, V11; Herrero M, 2013, ANIMAL, V7, P3, DOI 10.1017/S1751731112001954; Hoddinott J, 2015, J DEV STUD, V51, P958, DOI 10.1080/00220388.2015.1018903; Iannotti L, 2014, AM J PHYS ANTHROPOL, V155, P66, DOI 10.1002/ajpa.22547; Jin MC, 2014, SOC SCI MED, V105, P16, DOI 10.1016/j.socscimed.2014.01.001; Knueppel D, 2010, FOOD NUTR BULL, V31, P436, DOI 10.1177/156482651003100306; Lewis D, 2011, P NATL ACAD SCI USA, V108, P13957, DOI 10.1073/pnas.1011538108; MARQUIS GS, 1990, AM J PUBLIC HEALTH, V80, P146, DOI 10.2105/AJPH.80.2.146; Miller LC, 2014, FOOD NUTR BULL, V35, P312, DOI 10.1177/156482651403500304; Mosites E, 2016, J NUTR, V146, P1118, DOI 10.3945/jn.115.225961; Mosites EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136686; Mullins G, 1996, HUM ECOL, V24, P231, DOI 10.1007/BF02169128; Ngure FM, 2013, AM J TROP MED HYG, V89, P709, DOI 10.4269/ajtmh.12-0568; Nicholson C.F., 2003, DAIRY COW OWNERSHIP; Nielsen H, 2003, J NUTR, V133, p4027S, DOI 10.1093/jn/133.11.4027S; Njuki J., 2013, WOMEN LIVESTOCK OWNE, P21; Njuki J., 2011, ILRI ADD AB 2 MAY; Njuki JM, 2016, EUR J DEV RES, V28, P722, DOI 10.1057/ejdr.2015.22; Okike I, 2005, ECOL FOOD NUTR, V44, P167, DOI 10.1080/03670240590952990; Olney DK, 2009, FOOD NUTR BULL, V30, P355, DOI 10.1177/156482650903000407; Randolph TF, 2007, J ANIM SCI, V85, P2788, DOI 10.2527/jas.2007-0467; Rawlins R, 2014, FOOD POLICY, V44, P202, DOI 10.1016/j.foodpol.2013.12.003; Schipani Steven, 2002, Food and Nutrition Bulletin, V23, P175; Thumbi SM, 2015, PLOS ONE, V10; United Nations Children's Fund (UNICEF), 2013, IMPR CHILD NUTR ACH; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Walton C, 2012, PUBLIC HEALTH NUTR, V17, P307; WHO, 2006, WHO CHILD GROWTH STA; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Wyatt AJ, 2015, MATERN CHILD NUTR, V11, P88, DOI 10.1111/mcn.12074; Zambrano LD, 2014, T ROY SOC TROP MED H, V108, P313, DOI 10.1093/trstmh/tru056	53	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191339	10.1371/journal.pone.0191339	http://dx.doi.org/10.1371/journal.pone.0191339			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	29408920	Green Published, Green Submitted, gold			2022-12-26	WOS:000424302800016
J	Ericsson, A; Glah, D; Lorenzi, M; Jansen, JP; Fridhammar, A				Ericsson, Asa; Glah, Divina; Lorenzi, Maria; Jansen, Jeroen P.; Fridhammar, Adam			Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes	PLOS ONE			English	Article							LIFETIME HEALTH OUTCOMES; GLYCEMIC CONTROL; GLUCOSE CONTROL; COMPLICATIONS; MODEL; METFORMIN; ASSOCIATION; ADHERENCE; DEGLUDEC; DEGLUDEC/LIRAGLUTIDE	Background We assessed the cost-effectiveness of the glucagon-like peptide 1 receptor agonists liraglutide 1.8 mg and lixisenatide 20 mu g (both added to basal insulin) in patients with type 2 diabetes (T2D) in Sweden. Methods The Swedish Institute for Health Economics cohort model for T2D was used to compare liraglutide and lixisenatide (both added to basal insulin), with a societal perspective and with comparative treatment effects derived by indirect treatment comparison (ITC). Drug prices were 2016 values, and all other costs 2015 values. The cost-effectiveness of IDegLira (fixed-ratio combination of insulin degludec and liraglutide) versus lixisenatide plus basal insulin was also assessed, under different sets of assumptions. Results From the ITC, decreases in HbA1c were -1.32% and -0.43% with liraglutide and lixisenatide, respectively; decreases in BMI were -1.29 and -0.65 kg/m(2), respectively. An estimated 2348 cases of retinopathy, 265 of neuropathy and 991 of nephropathy would be avoided with liraglutide compared with lixisenatide in a cohort of 10,000 patients aged over 40 years. In the base-case analysis, total direct costs were higher with liraglutide than lixisenatide, but costs associated with complications were lower. The cost/quality-adjusted life-year (QALY) for liraglutide added to basal insulin was SEK30,802. Base-case findings were robust in sensitivity analyses, except when glycated haemoglobin (HbA1c) differences for liraglutide added to basal insulin were abolished, suggesting these benefits were driving the cost/QALY. With liraglutide 1.2 mg instead of liraglutide 1.8 mg (adjusted for efficacy and cost), liraglutide added to basal insulin was dominant over lixisenatide 20 mu g. IDegLira was dominant versus lixisenatide plus basal insulin when a defined daily dose was used in the model. Conclusions The costs/QALY for liraglutide, 1.8 or 1.2 mg, added to basal insulin, and for IDegLira (all compared with lixisenatide 20 mu g added to basal insulin) were below the threshold considered low by Swedish authorities. In some scenarios, liraglutide and IDegLira were costsaving.	[Ericsson, Asa] Novo Nordisk Scandinavia AB, Diabet Mkt, Malmo, Sweden; [Glah, Divina] Novo Nordisk Ltd, Hlth Econ & Outcomes Res, Gatwick, England; [Lorenzi, Maria; Jansen, Jeroen P.] Precis Hlth Econ, Evidence Synth & Decis Modelling, San Francisco, CA USA; [Fridhammar, Adam] Swedish Inst Hlth Econ, Res Manager, Lund, Sweden	Novo Nordisk; Novo Nordisk	Ericsson, A (corresponding author), Novo Nordisk Scandinavia AB, Diabet Mkt, Malmo, Sweden.	ASAE@novonordisk.com		Jansen, Jeroen Paul/0000-0003-2686-9217; Fridhammar, Adam/0000-0003-3715-003X	Novo Nordisk Scandinavia AB; Novo Nordisk Ltd.; Precision Health Economics; Novo Nordisk	Novo Nordisk Scandinavia AB(Novo Nordisk); Novo Nordisk Ltd.(Novo Nordisk); Precision Health Economics; Novo Nordisk(Novo Nordisk)	The study was funded and supported by Novo Nordisk Scandinavia AB. Novo Nordisk Scandinavia AB provided support in the form of salary for author AE, Novo Nordisk Ltd. provided support in the form of salary for author DG, Precision Health Economics provided support in the form of salaries for authors ML and JPJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Medical writing and submission support were provided by Nathan Ley PhD of Watermeadow Medical, an Ashfield company, part of UDG Healthcare plc, funded by Novo Nordisk.	Ahmann A, 2015, DIABETES OBES METAB, V17, P1056, DOI 10.1111/dom.12539; Bagust A, 2005, HEALTH ECON, V14, P217, DOI 10.1002/hec.910; Bagust A, 2001, DIABETOLOGIA, V44, P2140, DOI 10.1007/s001250100023; Blonde L, 2009, DIABETES OBES METAB, V11, P26, DOI 10.1111/j.1463-1326.2009.01075.x; Bolin K, 2009, DIABETIC MED, V26, P928, DOI 10.1111/j.1464-5491.2009.02786.x; Brod M, 2011, VALUE HEALTH, V14, P665, DOI 10.1016/j.jval.2011.02.001; Brown JB, 2000, DIABETES RES CLIN PR, V50, pS15, DOI 10.1016/S0168-8227(00)00215-1; Buse JB, 2014, DIABETES CARE, V37, P2926, DOI 10.2337/dc14-0785; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Donnelly LA, 2007, QJM-INT J MED, V100, P345, DOI 10.1093/qjmed/hcm031; Eastman RC, 1997, DIABETES CARE, V20, P725, DOI 10.2337/diacare.20.5.725; Eng C, 2014, LANCET, V384, P2228, DOI 10.1016/S0140-6736(14)61335-0; Evans M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-90; Freemantle N, 2015, DIABETES THER, V6, P573, DOI 10.1007/s13300-015-0142-y; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Geelhoed-Duijvestijn Petronella H, 2013, J Med Econ, V16, P1453, DOI 10.3111/13696998.2013.852098; Gough SCL, 2016, EXPERT REV ENDOCRINO, V11, P7, DOI 10.1586/17446651.2016.1113129; Hayes AJ, 2013, DIABETOLOGIA, V56, P1925, DOI 10.1007/s00125-013-2940-y; Heise T, 2012, DIABETES OBES METAB, V14, P944, DOI 10.1111/j.1463-1326.2012.01638.x; Heise T, 2012, DIABETES OBES METAB, V14, P859, DOI 10.1111/j.1463-1326.2012.01627.x; Henriksson F, 2000, J INTERN MED, V248, P387, DOI 10.1046/j.1365-2796.2000.00749.x; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; International Diabetes Federation Clinical Guidelines Task Force, 2012, GLOB GUID TYP 2 DIAB; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Jendle J, 2010, CURR MED RES OPIN, V26, P917, DOI 10.1185/03007991003657867; Jonsson L, 2006, VALUE HEALTH, V9, P193, DOI 10.1111/j.1524-4733.2006.00100.x; Kiadaliri AA, 2014, DIABETES THER, V5, P591, DOI 10.1007/s13300-014-0080-0; Kiadaliri AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062650; Lind M, 2016, DIABETES THER, V7, P321, DOI 10.1007/s13300-016-0173-z; Lingvay I, 2016, JAMA-J AM MED ASSOC, V315, P898, DOI 10.1001/jama.2016.1252; Lundqvist A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110235; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Nauck M, 2016, DIABETES CARE, V39, P1501, DOI 10.2337/dc15-2479; Novo Nordisk A/S, XULT SUMM PROD CHAR; Peyrot M, 2012, DIABETIC MED, V29, P682, DOI 10.1111/j.1464-5491.2012.03605.x; Pfeffer MA, 2015, NEW ENGL J MED, V373, P2247, DOI 10.1056/NEJMoa1509225; Riddle MC, 2013, DIABETES CARE, V36, P2489, DOI 10.2337/dc12-2454; Ringborg A, 2008, INT J CLIN PRACT, V62, P708, DOI 10.1111/j.1742-1241.2008.01716.x; Saini SD, 2009, AM J MANAG CARE, V15, pE22; Sanofi-aventis, 2016, LYX SUMM PROD CHAR 2; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shetty Sharashchandra, 2005, J Manag Care Pharm, V11, P559; Socialstyrelsen, 2014, NAT RIKTL STOD STYRN; Socialstyrelsen, 2015, NAT RIKTL MET BIL; Socialstyrelsen, NAT GUID DIAB CAR SU; Sorensen J., 2013, EC RES INT, V2013, P1, DOI DOI 10.1155/2013/618039; Steen Carlsson Katarina, 2014, J Med Econ, V17, P658, DOI 10.3111/13696998.2014.933110; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turner R, 1996, ANN INTERN MED, V124, P136, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00011; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UPDS Group, 1998, LANCET, V12, P352; Ward Alexandra J, 2004, Cost Eff Resour Alloc, V2, P2, DOI 10.1186/1478-7547-2-2; World Health Organization Collaborating Centre for Drug Statistics Methodology, DEF GEN CONS 2016	55	9	9	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191953	10.1371/journal.pone.0191953	http://dx.doi.org/10.1371/journal.pone.0191953			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408938	Green Published, gold, Green Submitted			2022-12-26	WOS:000424302800035
J	Stockdale, L; Nash, S; Nalwoga, A; Painter, H; Asiki, G; Fletcher, H; Newton, R				Stockdale, Lisa; Nash, Stephen; Nalwoga, Angela; Painter, Hannah; Asiki, Gershim; Fletcher, Helen; Newton, Robert			Human cytomegalovirus epidemiology and relationship to tuberculosis and cardiovascular disease risk factors in a rural Ugandan cohort	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; INFECTION; HIV; POPULATION; ANTIBODIES; HYPERTENSION; MORTALITY; ASSOCIATION; PREVENTION; MALARIA	Human cytomegalovirus (HCMV) infection has been associated with increased mortality, specifically cardiovascular disease (CVD), in high-income countries (HICs). There is a paucity of data in low-and middle-income countries (LMICs) where HCMV seropositivity is higher. Serum samples from 2,174 Ugandan individuals were investigated for HCMV antibodies and data linked to demographic information, co-infections and a variety of CVD measurements. HCMV seropositivity was 83% by one year of age, increasing to 95% by five years. Female sex, HIV positivity and active pulmonary tuberculosis (TB) were associated with an increase in HCMV IgG levels in adjusted analyses. There was no evidence of any associations with risk factors for CVD after adjusting for age and sex. HCMV infection is ubiquitous in this rural Ugandan cohort from a young age. The association between TB disease and high HCMV IgG levels merits further research. Known CVD risk factors do not appear to be associated with higher HCMV antibody levels in this Ugandan cohort.	[Stockdale, Lisa; Nalwoga, Angela; Painter, Hannah; Fletcher, Helen] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Nash, Stephen] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Nalwoga, Angela; Asiki, Gershim; Newton, Robert] Uganda Virus Res Inst, Med Res Council, Entebbe, Uganda; [Newton, Robert] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Newton, Robert] Int Agcy Res Canc, Lyon, France	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Uganda Virus Research Institute; University of York - UK; World Health Organization; International Agency for Research on Cancer (IARC)	Stockdale, L (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.	lisa.stockdale@lshtm.ac.uk		Nash, Stephen/0000-0003-2086-1740; Asiki, Gershim/0000-0002-9966-1153; Nalwoga, Angela/0000-0001-8259-4735; Painter, Hannah/0000-0003-0445-7473	UK Medical Research Council [MR/J003999/1]; Medical Research Council [MR/K012126/1]; Medical Research Council [MC_UP_1204/17, 1487357] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a UK Medical Research Council studentship for LS [MR/J003999/1] and Medical Research Council funding for SN [MR/K012126/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank participants from the GPC and their families. None of the authors have a commercial or other association that might pose a conflict of interest (e.g., pharmaceutical stock ownership, consultancy, advisory board membership, relevant patents, or research funding). This work was supported by a UK Medical Research Council studentship for LS [MR/J003999/1] and SN receives support from the Medical Research Council and Department for International Development (MR/K012126/1).	Aguilar R, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01284; Asiki G, 2015, TROP MED INT HEALTH, V20, P1306, DOI 10.1111/tmi.12556; Asiki G, 2013, INT J EPIDEMIOL, V42, P129, DOI 10.1093/ije/dys234; Bbaale E, 2014, J HEALTH POPUL NUTR, V32, P249; BOS P, 1995, E AFR MED J, V72, P113; Cannon MJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0569-1; Cannon MJ, 2011, REV MED VIROL, V21, P240, DOI 10.1002/rmv.695; Cappuccio FP, 2016, INTERN EMERG MED, V11, P299, DOI 10.1007/s11739-016-1423-9; Carpenter LM, 2008, INT J CANCER, V122, P1319, DOI 10.1002/ijc.23254; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; Dollard Sheila C, 2014, BMC Res Notes, V7, P776, DOI 10.1186/1756-0500-7-776; Dowd JB, 2009, EPIDEMIOL INFECT, V137, P58, DOI 10.1017/S0950268808000551; Durand M, 2011, JAIDS-J ACQ IMM DEF, V57, P245, DOI 10.1097/QAI.0b013e31821d33a5; Fielding K, 2011, PLOS ONE, V6; Firth C, 2016, QJM, P1; Fletcher HA, 2016, NAT COMMUN, P1; Gompels UA, 2012, CLIN INFECT DIS, V54, P434, DOI 10.1093/cid/cir837; Goodier MR, 2014, BLOOD, V124, P2213, DOI 10.1182/blood-2014-05-576124; Hamdan HZ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-217; HO M, 1990, REV INFECT DIS, V12, pS701; Hui J, 2016, WIEN KLIN WOCHENSCHR, V128, P586, DOI 10.1007/s00508-016-0977-x; Hummel M, 2002, J CLIN VIROL, V25, pS123; Jarvis MA, 2007, J VIROL, V81, P2095, DOI 10.1128/JVI.01422-06; Joosten SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073230; Kamel N, 2014, MED PRIN PRACT, V23, P29, DOI 10.1159/000354758; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Leuridan E, 2007, VACCINE, V25, P6296, DOI 10.1016/j.vaccine.2007.06.020; Li C, 2012, PLOS ONE, V7, P1999; Lichtner M, 2014, J INFECT DIS; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Marsico C, 2017, ITAL J PEDIATR, V43, DOI 10.1186/s13052-017-0358-8; Mugisha Joseph O, 2016, BMC Res Notes, V9, P433, DOI 10.1186/s13104-016-2217-x; Murphy GAV, 2013, INT J EPIDEMIOL, V42, P1740, DOI 10.1093/ije/dyt184; Mutalima N, 2008, PLOS ONE, P3; Nagu T, 2017, INT J INFECT DIS, V56, P136, DOI 10.1016/j.ijid.2017.01.022; Nsagha Dickson Shey, 2015, Open AIDS J, V9, P51, DOI 10.2174/1874613601509010051; Pembrey L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081881; Pletcher MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154288; Popovic M, 2012, J THROMB THROMBOLYS, V33, P160, DOI 10.1007/s11239-011-0662-x; RICE GPA, 1984, P NATL ACAD SCI-BIOL, V81, P6134, DOI 10.1073/pnas.81.19.6134; Roberts ET, 2010, AM J EPIDEMIOL, V172, P363, DOI 10.1093/aje/kwq177; RODIER MH, 1995, ACTA TROP, V59, P271, DOI 10.1016/0001-706X(95)00087-U; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Savva GM, 2013, AGING CELL, V12, P381, DOI 10.1111/acel.12059; Simanek AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016103; Slaymaker E, 2009, SEX TRANSM INFECT, V85, pI12, DOI 10.1136/sti.2008.034009; Sobngwi E, 2004, INT J EPIDEMIOL, V33, P769, DOI 10.1093/ije/dyh044; Tang YJ, 2016, SCI REP-UK, V6, P1, DOI 10.1038/srep34607; Wakeham K, 2015, INT J CANCER, V136, P2822, DOI 10.1002/ijc.29329; Wall NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055686; WHO, 2014, GLOB TUB REP 2014; Wittkop L, 2013, J INFECT DIS, V207, P622, DOI 10.1093/infdis/jis732; World Health Organization, 2014, NONC DIS NCD COUNTR; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2000, WHO TECHN REP SER, V894; Yalew Aregawi, 2016, BMC Res Notes, V9, P483; Zanni MV, 2014, NAT REV CARDIOL, V11, P728, DOI 10.1038/nrcardio.2014.167	58	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192086	10.1371/journal.pone.0192086	http://dx.doi.org/10.1371/journal.pone.0192086			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408860	Green Published, Green Accepted, gold			2022-12-26	WOS:000424302800044
J	Harmon, AW; Moitra, R; Xu, ZL; Byrnes, AP				Harmon, Andrew W.; Moitra, Rituparna; Xu, Zhili; Byrnes, Andrew P.			Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum	PLOS ONE			English	Article							NATURAL IGM; ANTIBODIES TARGET; FACTOR-BINDING; GENE-THERAPY; IDENTIFICATION; ACTIVATION; TOXICITY; IMPACT	Adenovirus vectors are widely used in gene therapy clinical trials, and preclinical studies with these vectors are often conducted in mice. It is therefore critical to understand whether mouse studies adequately predict the behavior of adenovirus vectors in humans. The most commonly-used adenovirus vectors are derived from adenovirus serotype 5 (Ad5). The Ad5 hexon protein can bind coagulation factor X (FX), and binding of FX has a major impact on vector interactions with other blood proteins. In mouse serum, FX protects Ad5 vectors from neutralization by natural antibodies and complement. In the current study, we similarly find that human FX inhibits neutralization of Ad5 vectors by human serum, and this finding is consistent among individual human sera. We show that human IgM and human IgG can each induce complement-mediated neutralization when Ad5 vectors are not protected by FX. Although mouse and human serum had similar effects on Ad5 vectors, we found that this was not true for a chimeric Ad5 vector that incorporated hexon regions from adenovirus serotype 48. Interestingly, this hexon-chimeric vector was neutralized by human serum, but not by mouse serum. These findings indicate that studies in mouse serum accurately predict the behavior of Ad5 vectors in human serum, but mouse serum is not an accurate model system for all adenovirus vectors.	[Harmon, Andrew W.; Moitra, Rituparna; Xu, Zhili; Byrnes, Andrew P.] US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Byrnes, AP (corresponding author), US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Andrew.Byrnes@fda.hhs.gov	Byrnes, Andrew/D-2808-2013	Byrnes, Andrew/0000-0003-1135-2629	U.S. Food and Drug Administration (FDA); FDA's Critical Path program; Oak Ridge Institute for Science and Education	U.S. Food and Drug Administration (FDA); FDA's Critical Path program; Oak Ridge Institute for Science and Education(General Electric)	Funding was provided by the U.S. Food and Drug Administration (FDA) to APB, including funding from the FDAs Critical Path program. This project was supported in part by fellowships administered by the Oak Ridge Institute for Science and Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2010, ENCY RES DESIGN, V3, P1, DOI DOI 10.4135/9781412961288.N178; Alba R, 2012, GENE THER, V19, P109, DOI 10.1038/gt.2011.87; [Anonymous], 2017, J GENE MED GENE THER; Atoda H, 1998, BIOCHEMISTRY-US, V37, P17361, DOI 10.1021/bi981177x; Baden LR, 2014, J INFECT DIS, V210, P1052, DOI 10.1093/infdis/jiu217; Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025; BEEBE DP, 1981, J IMMUNOL, V126, P1562; Bradley RR, 2012, J VIROL, V86, P1267, DOI 10.1128/JVI.06165-11; Bradley RR, 2012, J VIROL, V86, P625, DOI 10.1128/JVI.06254-11; Bruder JT, 2013, J VIROL, V87, P9661, DOI 10.1128/JVI.00462-13; Byrnes AP, 2016, ADENOVIRUS VECTORS G, P367; Carlisle RC, 2009, BLOOD, V113, P1909, DOI 10.1182/blood-2008-09-178459; Casali P, 1996, CURR TOP MICROBIOL, V210, P167; Cichon G, 2001, GENE THER, V8, P1794, DOI 10.1038/sj.gt.3301611; COOPER NR, 1985, ADV IMMUNOL, V37, P151, DOI 10.1016/S0065-2776(08)60340-5; Coughlan L, 2012, MOL THER, V20, P2268, DOI 10.1038/mt.2012.162; Czajkowsky DM, 2009, P NATL ACAD SCI USA, V106, P14960, DOI 10.1073/pnas.0903805106; Di Paolo NC, 2009, MOL THER, V17, P675, DOI 10.1038/mt.2008.307; Di Y, 2014, GENE THER, V21, P440, DOI 10.1038/gt.2014.2; Duffy MR, 2016, GENE THER, V23, P592, DOI 10.1038/gt.2016.32; Farrow AL, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030078; FEINSTEIN A, 1986, IMMUNOL TODAY, V7, P169, DOI 10.1016/0167-5699(86)90168-4; Harmon A. W., 2017, SAFETY EFFICACY GENE, P37; Irons EE, 2013, J VIROL, V87, P9610, DOI 10.1128/JVI.01070-13; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Khare R, 2013, J VIROL, V87, P3678, DOI 10.1128/JVI.01392-12; Khare R, 2012, J VIROL, V86, P2293, DOI 10.1128/JVI.05760-11; Lachmann PJ, 2010, J IMMUNOL METHODS, V352, P195, DOI 10.1016/j.jim.2009.11.003; Lopez-Gordo E, 2014, EXPERT OPIN DRUG DEL, P1; Ma JT, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004673; Mallery DL, 2010, P NATL ACAD SCI USA, V107, P19985, DOI 10.1073/pnas.1014074107; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Notkins AL, 2004, TRENDS IMMUNOL, V25, P174, DOI 10.1016/j.it.2004.02.004; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Qiu Q, 2015, J VIROL, V89, P3412, DOI 10.1128/JVI.03217-14; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; Seiradake E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000277; SIGOUNAS G, 1994, J CLIN IMMUNOL, V14, P134, DOI 10.1007/BF01541346; Teigler JE, 2014, CLIN VACCINE IMMUNOL, V21, P1137, DOI 10.1128/CVI.00207-14; Unzu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085432; Vigant F, 2008, MOL THER, V16, P1474, DOI 10.1038/mt.2008.132; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Xu WD, 2014, MOL THER, V22, P1504, DOI 10.1038/mt.2014.80; Xu ZL, 2017, METHODS MOL BIOL, V1643, P187, DOI 10.1007/978-1-4939-7180-0_15; Xu ZL, 2013, NAT MED, V19, P452, DOI 10.1038/nm.3107; Xu ZL, 2008, J VIROL, V82, P11705, DOI 10.1128/JVI.01320-08; Xu ZL, 2002, J CONTROL RELEASE, V81, P155, DOI 10.1016/S0168-3659(02)00059-7; Zaiss AK, 2016, J VIROL, V90, P412, DOI 10.1128/JVI.01939-15; Zhang ZW, 2011, HUM GENE THER, V22, P1137, DOI 10.1089/hum.2011.003; Zhou ZH, 2007, J AUTOIMMUN, V29, P219, DOI 10.1016/j.jaut.2007.07.015	50	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192353	10.1371/journal.pone.0192353	http://dx.doi.org/10.1371/journal.pone.0192353			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401488	Green Submitted, Green Published, gold			2022-12-26	WOS:000424101400051
J	Sabalza, M; Yasmin, R; Barber, CA; Castro, T; Malamud, D; Kim, BJ; Zhu, H; Montagna, RA; Abrams, WR				Sabalza, Maite; Yasmin, Rubina; Barber, Cheryl A.; Castro, Talita; Malamud, Daniel; Kim, Beum Jun; Zhu, Hui; Montagna, Richard A.; Abrams, William R.			Detection of Zika virus using reverse-transcription LAMP coupled with reverse dot blot analysis in saliva	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; INFECTIOUS-DISEASES; MOLECULAR-DETECTION; IDENTIFICATION; EMERGENCE; SPREAD; STATES; DNA	In recent years, there have been increasing numbers of infectious disease outbreaks that spread rapidly to population centers resulting from global travel, population vulnerabilities, environmental factors, and ecological disasters such as floods and earthquakes. Some examples of the recent outbreaks are the Ebola epidemic in West Africa, Middle East respiratory syndrome coronavirus (MERS-Co) in the Middle East, and the Zika outbreak through the Americas. We have created a generic protocol for detection of pathogen RNA and/or DNA using loop-mediated isothermal amplification (LAMP) and reverse dot-blot for detection (RDB) and processed automatically in a microfluidic device. In particular, we describe how a microfluidic assay to detect HIV viral RNA was converted to detect Zika virus (ZIKV) RNA. We first optimized the RT-LAMP assay to detect ZIKV RNA using a benchtop isothermal amplification device. Then we implemented the assay in a microfluidic device that will allow analyzing 24 samples simultaneously and automatically from sample introduction to detection by RDB technique. Preliminary data using saliva samples spiked with ZIKV showed that our diagnostic system detects ZIKV RNA in saliva. These results will be validated in further experiments with well-characterized ZIKV human specimens of saliva. The described strategy and methodology to convert the HIV diagnostic assay and platform to a ZIKV RNA detection assay provides a model that can be readily utilized for detection of the next emerging or re-emerging infectious disease.	[Sabalza, Maite; Barber, Cheryl A.; Castro, Talita; Malamud, Daniel; Abrams, William R.] NYU, Coll Dent, Dept Basic Sci, New York, NY 10003 USA; [Yasmin, Rubina; Kim, Beum Jun; Zhu, Hui; Montagna, Richard A.] Rheonix Inc, Ithaca, NY USA; [Castro, Talita] Univ Sao Paulo, Sch Dent, Stomatol Dept, Sao Paulo, SP, Brazil; [Malamud, Daniel] NYU, Sch Med, Dept Med, New York, NY USA	New York University; Universidade de Sao Paulo; New York University	Sabalza, M (corresponding author), NYU, Coll Dent, Dept Basic Sci, New York, NY 10003 USA.	ms10129@nyu.edu	KIM, BEUM JUN/G-6829-2011; Abrams, William R/A-5782-2008	KIM, BEUM JUN/0000-0003-1797-5026; Malamud, Daniel/0000-0002-9094-4122	National Institute of Dental and Craniofacial Research of the National Institutes of Health [R44DE024456, 3R44DE024456-03S1]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R44DE024456] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Research reported in this publication was supported by the National Institute of Dental and Craniofacial Research of the National Institutes of Health under Award Numbers R44DE024456 and 3R44DE024456-03S1. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Four of the authors (Richard Montagna, Rubina Yasmin, Beum Jun Kim and Hui Zhu) are employees of Rheonix, Inc. Rheonix, Inc. provided support in the form of salaries for authors RM, RY, BJK and HZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159; Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816; Brierley L, 2016, AM NAT, V187, pE53, DOI 10.1086/684391; Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309; Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340; CDC, 2017, WORLD MAP AR RISK ZI; CDC, 2016, CAS COUNTS US 2016; Chen Zongyuan, 2016, J AIDS Clin Res, V7; Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538; Cone EJ, 2002, J ANAL TOXICOL, V26, P541, DOI 10.1093/jat/26.8.541; Corstjens Paul L A M, 2012, J Am Dent Assoc, V143, p12S; de Souza M, 2017, MYCOPATHOLOGIA, V182, P625, DOI 10.1007/s11046-017-0129-5; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; DeSantis AS, 2015, PSYCHOSOM MED, V77, P6, DOI 10.1097/PSY.0000000000000131; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Duz MB, 2016, CELL ONCOL, V39, P187, DOI 10.1007/s13402-015-0259-z; FDA, EM US AUTH 2017; Fernandez-Soto P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094664; Finger F, 2016, P NATL ACAD SCI USA, V113, P6421, DOI 10.1073/pnas.1522305113; Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9; Hajosi-Kalcakosz S, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0392-z; Hutchins SS, 2009, AM J PUBLIC HEALTH, V99, pS243, DOI 10.2105/AJPH.2009.164814; Javaid Mohammad A, 2016, J Oral Biol Craniofac Res, V6, P66, DOI 10.1016/j.jobcr.2015.08.006; Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003; Lau Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0142861, 10.1371/journal.pone.0138694]; Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689; Maffert P, 2017, EUR J CLIN MICROBIOL, V36, P1717, DOI 10.1007/s10096-017-3013-9; Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004; Mangili A, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.IOL5-0009-2015; MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411; Martins D, 2015, BIOSENS BIOELECTRON, V72, P87, DOI 10.1016/j.bios.2015.04.063; MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4; Miocevic O, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00133; Modak Sayli S, 2016, Infect Dis (Auckl), V9, P1, DOI [10.4137/IDRT.S32162, 10.4137/idrt.s32162]; Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394; Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Nakata Y, 2015, J MATH BIOL, V70, P1411, DOI 10.1007/s00285-014-0801-z; Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z; Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; PAHO, 2017, COUNTR TERR AUT TRAN; Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778; Sabalza M, 2017, JOVE-J VIS EXP, DOI 10.3791/56784; SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262; Septfons A, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.32.30315; Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68; Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821; Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632; Spizz G, 2015, ARCH PATHOL LAB MED, V139, P805, DOI 10.5858/arpa.2014-0059-OA; Spizz G, 2012, POINT CARE, V11, P42, DOI 10.1097/POC.0b013e318222e184; Tang HK, 2013, MOL MED REP, V7, P761, DOI 10.3892/mmr.2012.1254; Triunfol M, 2016, LANCET INFECT DIS, V16, P527, DOI 10.1016/S1473-3099(16)30015-9; WILSON ME, 1995, EMERG INFECT DIS, V1, P39, DOI 10.3201/eid0102.950201; Wilson ME, 2003, J APPL MICROBIOL, V94, p1S; Yadav S, 2016, J CLIN DIAGN RES, V10, pDM1, DOI 10.7860/JCDR/2016/19170.8133; Zanoli LM, 2013, BIOSENSORS-BASEL, V3, P18, DOI 10.3390/bios3010018; Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114	59	31	35	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192398	10.1371/journal.pone.0192398	http://dx.doi.org/10.1371/journal.pone.0192398			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401479	Green Published, gold, Green Submitted			2022-12-26	WOS:000424101400058
J	Kaneko, C; Kobayashi, T; Ito, S; Sugita, N; Murasawa, A; Nakazono, K; Yoshie, H				Kaneko, Chihiro; Kobayashi, Tetsuo; Ito, Satoshi; Sugita, Noriko; Murasawa, Akira; Nakazono, Kiyoshi; Yoshie, Hiromasa			Circulating levels of carbamylated protein and neutrophil extracellular traps are associated with periodontitis severity in patients with rheumatoid arthritis: A pilot case-control study	PLOS ONE			English	Article							DISEASE-ACTIVITY; PORPHYROMONAS-GINGIVALIS; SEDIMENTATION-RATE; JAPANESE PATIENTS; EPIDEMIOLOGY; CITRULLINE; CRITERIA	Objectives An interrelationship between rheumatoid arthritis (RA) and periodontitis has been suggested due to their common pathogenic mechanisms. Protein carbamylation and neutrophil extracellular traps (NETs) formation have been shown to be related to autoimmune conditions, including RA, but their association with periodontitis has not been elucidated. Therefore, we assessed whether or not circulating levels of carbamylated protein (CarP) and NETs are associated with periodontitis severity and influenced by periodontal treatment. Methods We conducted a retrospective case-control study that included 40 patients with RA and periodontitis, 30 patients with periodontitis, and 43 systemically and periodontally healthy controls to assess the circulating levels of CarP and NETs and rheumatologic and periodontal conditions. The same assessments were also performed in 22 patients with RA and periodontitis after 2 months of periodontal treatment, including oral hygiene instruction and full-mouth supragingival scaling. Results Patients with RA and periodontitis showed significantly higher serum levels of CarP and NETs than the control group (P = 0.04 and P < 0.001, respectively). The serum levels of CarP and NETs were significantly correlated positively with the mean values of probing depth (P = 0.01 and P = 0.007, respectively) and clinical attachment level (P = 0.007 and P = 0.001, respectively) in the 40 patients with RA and periodontitis. Multiple logistic regression analyses also revealed significantly positive associations between the serum levels of CarP and NETs and moderate to severe periodontitis (P = 0.03 and P = 0.001, respectively). Furthermore, periodontal treatment significantly decreased the serum levels of CarP and NETs in patients with RA and periodontitis (P = 0.03 and P = 0.02). Conclusion The circulating levels of CarP and NETs are associated with periodontitis severity and influenced by periodontal treatment in patients with RA.	[Kaneko, Chihiro; Kobayashi, Tetsuo; Sugita, Noriko; Yoshie, Hiromasa] Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Biol Sci, Div Periodontol, Niigata, Japan; [Kobayashi, Tetsuo] Niigata Univ, Med & Dent Hosp, Gen Dent & Clin Educ Unit, Niigata, Japan; [Ito, Satoshi; Murasawa, Akira; Nakazono, Kiyoshi] Niigata Rheumat Ctr, Dept Rheumatol, Shibata, Japan	Niigata University; Niigata University	Kobayashi, T (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Biol Sci, Div Periodontol, Niigata, Japan.; Kobayashi, T (corresponding author), Niigata Univ, Med & Dent Hosp, Gen Dent & Clin Educ Unit, Niigata, Japan.	kotetsuo@dent.niigata-u.ac.jp	Ito, Satoshi/AAL-9615-2020		KAKENHI from the Japan Society for the Promotion of Science [26463130, 17K11983]	KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The present study was supported by KAKENHI Grant-in Aid for Scientific Research (26463130 and 17K11983 to Tetsuo Kobayashi) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/j-grantsinaid/). The funding source had no involvement in the study design, data collection and analysis, writing of the report, or decision to submit the article for publication.	Alamanos Y, 2005, AUTOIMMUN REV, V4, P130, DOI 10.1016/j.autrev.2004.09.002; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bright R, 2015, MED HYPOTHESES, V84, P570, DOI 10.1016/j.mehy.2015.03.006; Bright R, 2017, J PERIODONTAL RES; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; Dias IHK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066407; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; Hirschfeld J, 2015, INT J MED MICROBIOL, V305, P453, DOI 10.1016/j.ijmm.2015.04.002; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Kaur S, 2014, SEMIN ARTHRITIS RHEU, V44, P113, DOI 10.1016/j.semarthrit.2014.04.009; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kobayashi T, 2007, J PERIODONTOL, V78, P2311, DOI 10.1902/jop.2007.070136; Kobayashi Tetsuo, 2015, Curr Oral Health Rep, V2, P1; Kojima A, 2016, J PERIODONTAL RES, V51, P350, DOI 10.1111/jre.12314; Leech MT, 2015, BEST PRACT RES CL RH, V29, P189, DOI 10.1016/j.berh.2015.03.001; Leppilahti JM, 2014, J CLIN PERIODONTOL, V41, P348, DOI 10.1111/jcpe.12223; Li LB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159000; Matsui T, 2007, ANN RHEUM DIS, V66, P1221, DOI 10.1136/ard.2006.063834; Montes A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161141; Nizam N, 2014, INFLAMMATION, V37, P1771, DOI 10.1007/s10753-014-9907-0; Okada M, 2013, J PERIODONTOL, V84, pE74, DOI 10.1902/jop.2013.130079; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Perez-Sanchez C, 2017, J AUTOIMMUN, V82, P31, DOI 10.1016/j.jaut.2017.04.007; Petersen PE, 2012, PERIODONTOL 2000, V60, P15, DOI 10.1111/j.1600-0757.2011.00425.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Potempa J, 2017, NAT REV RHEUMATOL, V13, P606, DOI 10.1038/nrrheum.2017.132; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Shi J, 2011, P NATL ACAD SCI USA, V108, P17372, DOI 10.1073/pnas.1114465108; Shidara K, 2011, RHEUMATOL INT, V31, P617, DOI 10.1007/s00296-009-1336-2; Shimada A, 2016, J PERIODONTAL RES, V51, P103, DOI 10.1111/jre.12288; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Stoop JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102163; Sun JT, 2016, AM J PHYSIOL-RENAL, V310, pF511, DOI 10.1152/ajprenal.00508.2015; Sur Chowdhury Chanchal, 2014, Arthritis Res Ther, V16, pR122, DOI 10.1186/ar4579; Verheul MK, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1455-1; Vitkov L, 2009, J PERIODONTAL RES, V44, P664, DOI 10.1111/j.1600-0765.2008.01175.x; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wang H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148197; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; White PC, 2016, J DENT RES, V95, P26, DOI 10.1177/0022034515609097; White P, 2016, J CLIN PERIODONTOL, V43, P1041, DOI 10.1111/jcpe.12628	44	23	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192365	10.1371/journal.pone.0192365	http://dx.doi.org/10.1371/journal.pone.0192365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394286	Green Published, Green Submitted, gold			2022-12-26	WOS:000424060400040
J	Horii, N; Uchida, M; Hasegawa, N; Fujie, S; Oyanagi, E; Yano, H; Hashimoto, T; Iemitsu, M				Horii, Naoki; Uchida, Masataka; Hasegawa, Natsuki; Fujie, Shumpei; Oyanagi, Eri; Yano, Hiromi; Hashimoto, Takeshi; Iemitsu, Motoyuki			Resistance training prevents muscle fibrosis and atrophy via down-regulation of C1q-induced Wnt signaling in senescent mice	FASEB JOURNAL			English	Article						aging; sarcopenia; muscle regeneration	DIFFERENT FIBER TYPES; STEM-CELL FATE; SKELETAL-MUSCLE; BODY-COMPOSITION; EXERCISE; SARCOPENIA; HYPERTROPHY; RATS; C1Q; ACTIVATION	Increased complement component 1q (C1q) secretion with aging leads to muscle fibrosis and atrophy whereas resistance training attenuates circulating C1q levels. This study aimed to clarify whether resistance exercise-induced reduction of C1q secretion contributes to the inhibition of fibrosis and atrophy in aged muscles. Young (13-wk-old) and aged (38-wk-old) senescence-accelerated mouse prone 1 mice were randomly assigned to one of 4 groups: a young or aged sedentary control group, or a young or aged resistance training (climbing a ladder 3 d/wk for 12 wk) group. We found that resistance training ameliorated muscle fibrosis and atrophy in aged mice, concomitant with decreased circulating and muscle C1q levels and attenuated activation of muscle Wnt signaling (glycogen synthase kinase beta/beta-catenin), including beta-catenin in satellite (Pax7(+)/DAPI(+)) and fibroblast (vimentin(+)/DAPI(+)) cells. Furthermore, during muscle regeneration after mice were injured by cardiotoxin injection, we observed a reduction in circulating C1q levels, the inhibition of muscle fibrosis and repair, and decreased in the activation of muscle cytoplasmic and nuclear beta-catenin in aged mice from the resistance training group, but these effects were cancelled by a single preadministration of exogenous recombinant C1q. In addition, resistance training attenuated aging-related muscle loss concomitant with decreased expression of both muscle ring-finger protein 1 and muscle atrophy F-box in the muscle. Thus, resistance training-induced changes in circulating C1q levels may contribute to the prevention of muscle fibrosis and atrophy via muscle Wnt signaling in senescent mice.-Horii, N., Uchida, M., Hasegawa, N., Fujie, S., Oyanagi, E., Yano, H., Hashimoto, T., Iemitsu, M. Resistance training prevents muscle fibrosis and atrophy via down-regulation of C1q-induced Wnt signaling in senescent mice.	[Horii, Naoki; Uchida, Masataka; Hasegawa, Natsuki; Fujie, Shumpei; Hashimoto, Takeshi; Iemitsu, Motoyuki] Ritsumeikan Univ, Fac Sport & Hlth Sci, 1-1-1 Nojihigashi, Shiga 5258577, Japan; [Hasegawa, Natsuki; Fujie, Shumpei] Japan Soc Promot Sci, Tokyo, Japan; [Oyanagi, Eri; Yano, Hiromi] Kawasaki Univ Med Welf, Dept Hlth & Sports Sci, Okayama, Japan	Ritsumeikan University; Japan Society for the Promotion of Science	Iemitsu, M (corresponding author), Ritsumeikan Univ, Fac Sport & Hlth Sci, 1-1-1 Nojihigashi, Shiga 5258577, Japan.	iemitsu@fc.ritsumei.ac.jp			Japan Science Society [29-628]; Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI) [16K13059, 17H02182]; Grants-in-Aid for Scientific Research [15H03091, 17H02182] Funding Source: KAKEN	Japan Science Society; Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI; 17H02182 and 16K13059 to M.I.), and the Sasakawa Scientific Research Grant from the Japan Science Society (29-628 to N.H.). The authors declare no conflicts of interest.	Armstrong DD, 2005, AM J PHYSIOL-CELL PH, V289, pC853, DOI 10.1152/ajpcell.00093.2005; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bazgir B, 2017, CELL J, V18, P473; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; EVANS WJ, 1993, J NUTR, V123, P465, DOI 10.1093/jn/123.suppl_2.465; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Gasier HG, 2011, ACTA PHYSIOL, V201, P381, DOI 10.1111/j.1748-1716.2010.02183.x; Haramizu S, 2011, J APPL PHYSIOL, V111, P1654, DOI 10.1152/japplphysiol.01434.2010; Horii N, 2016, HORM METAB RES, V48, P207, DOI 10.1055/s-0035-1564132; Horii N, 2017, AM J PHYSIOL-REG I, V312, pR520, DOI 10.1152/ajpregu.00383.2016; Hornberger TA, 2004, CAN J APPL PHYSIOL, V29, P16, DOI 10.1139/h04-002; Iemitsu M, 2002, AM J PHYSIOL-HEART C, V283, pH1750, DOI 10.1152/ajpheart.01051.2001; Iemitsu M, 2006, J APPL PHYSIOL, V101, P151, DOI 10.1152/japplphysiol.00392.2005; Kim JM, 2012, AGE, V34, P11, DOI 10.1007/s11357-011-9207-7; LEXELL J, 1983, MUSCLE NERVE, V6, P588, DOI 10.1002/mus.880060809; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Matheny W, 2009, EXP BIOL MED, V234, P164, DOI 10.3181/0808-RM-251; Montero-Fernandez N, 2013, EUR J PHYS REHAB MED, V49, P131; Naito AT, 2012, CELL, V149, P1298, DOI 10.1016/j.cell.2012.03.047; Okada K, 2015, CIRC-HEART FAIL, V8, P799, DOI 10.1161/CIRCHEARTFAILURE.114.001958; Ono Y, 2015, CELL REP, V10, P1135, DOI 10.1016/j.celrep.2015.01.045; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Roubenoff R, 2000, J GERONTOL A-BIOL, V55, pM716, DOI 10.1093/gerona/55.12.M716; Sakakima H, 2004, J GERONTOL A-BIOL, V59, P1015; Sato K, 2017, FASEB J, V31, P793, DOI 10.1096/fj.201600874R; Sayer AA, 2005, DIABETES CARE, V28, P2541, DOI 10.2337/diacare.28.10.2541; Uchida M, 2014, IMMUNOL LETT, V158, P151, DOI 10.1016/j.imlet.2013.12.021; Verschueren S, 2013, OSTEOPOROSIS INT, V24, P87, DOI 10.1007/s00198-012-2057-z; Watanabe S, 2015, FASEB J, V29, P1003, DOI 10.1096/fj.14-262154; Yabumoto C, 2015, SCI REP-UK, V5, DOI 10.1038/srep14453; Zanchi NE, 2009, EUR J APPL PHYSIOL, V106, P415, DOI 10.1007/s00421-009-1033-6	31	30	31	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3547	3559		10.1096/fj.201700772RRR	http://dx.doi.org/10.1096/fj.201700772RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29401629				2022-12-26	WOS:000435104500006
J	Tian, HY; Huang, JJ; Golzio, C; Gao, X; Hector-Greene, M; Katsanis, N; Blobe, GC				Tian, Hongyu; Huang, Jennifer J.; Golzio, Christelle; Gao, Xia; Hector-Greene, Melissa; Katsanis, Nicholas; Blobe, Gerard C.			Endoglin interacts with VEGFR2 to promote angiogenesis	FASEB JOURNAL			English	Article						endothelial; sprouting; VEGF; signaling cancer	HEREDITARY HEMORRHAGIC TELANGIECTASIA; ENDOTHELIAL-CELLS; KINASE-ACTIVITY; PHASE-I; SU5416; TRC105; GROWTH; INHIBITOR; ANTIBODY; TRAFFICKING	Endoglin, a TGF-beta coreceptor predominantly expressed in endothelial cells, plays an important role in vascular development and tumor-associated angiogenesis. However, the mechanism by which endoglin regulates angiogenesis, especially during tip cell formation, remains largely unknown. In this study, we report that endoglin promoted VEGF-induced tip cell formation. Mechanistically, endoglin interacted with VEGF receptor (VEGFR)-2 in a VEGF-dependent manner, which sustained VEGFR2 on the cell surface and prevented its degradation. Endoglin mutants deficient in the ability to interact with VEGFR2 failed to sustain VEGFR2 on the cell surface and to promote VEGF-induced tip cell formation. Further, an endoglin-targeting monoclonal antibody (mAb), TRC105, cooperated with a VEGF-A targeting mAb, bevacizumab, to inhibit VEGF signaling and tip cell formation in vitro and to inhibit tumor growth, metastasis, and tumor-associated angiogenesis in a murine tumor model. This study demonstrate a novel mechanism by which endoglin initiates and regulates VEGF-driven angiogenesis while providing a rationale for combining anti-VEGF and anti-endoglin therapy in patients with cancer.	[Tian, Hongyu; Blobe, Gerard C.] Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Durham, NC 27708 USA; [Huang, Jennifer J.; Hector-Greene, Melissa; Blobe, Gerard C.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Golzio, Christelle; Katsanis, Nicholas] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27708 USA; [Gao, Xia] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Duke University	Tian, HY; Blobe, GC (corresponding author), Duke Univ, Med Ctr, Dept Med, B354 LSRC,Box 91004 DUMC,Res Dr, Durham, NC 27708 USA.	hongyu.tian@duke.edu; gerard.blobe@duke.edu	Blobe, Gerard/AAJ-5945-2020	Blobe, Gerard/0000-0002-4274-8901; Golzio, Christelle/0000-0002-4420-3921; Hector-Greene, Melissa/0000-0001-7263-1440	Susan G. Komen for the Cure [CCR15333124, SAC10002]; HHT Young Scholar Award	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); HHT Young Scholar Award	The authors thank Dr. Elisabetta Dejana [Italian Foundation for Cancer Research (FIRC) Institute of Molecular Oncology, European Institute of Oncology, Milan, Italy] for providing mouse embryonic endothelial cells; Dr. Christopher D. Kontos (Duke University) for providing the VEGFR2 construct; Tracon Pharma, Inc. (San Diego, CA, USA) for providing TRC105 antibody; and Genentech, Inc. for providing bevacizumab and B20-4.1 antibodies. This work was supported, in part, by Susan G. Komen for the Cure Grants CCR15333124 (to H.T.) and SAC10002 (to G.C.B.), and an HHT Young Scholar Award (to H.T.). The authors declare no conflicts of interest.	Alajati A, 2008, NAT METHODS, V5, P439, DOI [10.1038/nmeth.1198, 10.1038/NMETH.1198]; Anderberg C, 2013, J EXP MED, V210, P563, DOI 10.1084/jem.20120662; Apolo AB, 2017, CLIN GENITOURIN CANC, V15, P77, DOI 10.1016/j.clgc.2016.05.010; Ardelean DS, 2014, ANGIOGENESIS, V17, P129, DOI 10.1007/s10456-013-9383-4; Ballmer-Hofer K, 2011, BLOOD, V118, P816, DOI 10.1182/blood-2011-01-328773; Bruns AF, 2010, TRAFFIC, V11, P161, DOI 10.1111/j.1600-0854.2009.01001.x; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Deng T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0752-z; Dorff TB, 2017, CANCER-AM CANCER SOC, V123, P4566, DOI 10.1002/cncr.30942; Duffy AG, 2015, UNITED EUR GASTROENT, V3, P453, DOI 10.1177/2050640615583587; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Fong TAT, 1999, CANCER RES, V59, P99; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gordon MS, 2014, CLIN CANCER RES, V20, P5918, DOI 10.1158/1078-0432.CCR-14-1143; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hendriksen EM, 2009, MICROVASC RES, V77, P96, DOI 10.1016/j.mvr.2008.11.002; Jin Y, 2017, NAT CELL BIOL, V19, P639, DOI 10.1038/ncb3534; Karzai FH, 2015, BJU INT, V116, P546, DOI 10.1111/bju.12986; Keskin U, 2012, OPHTHALMIC RES, V47, P13, DOI 10.1159/000324994; Koleva RI, 2006, J BIOL CHEM, V281, P25110, DOI 10.1074/jbc.M601288200; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee NY, 2012, MOL BIOL CELL, V23, P2412, DOI 10.1091/mbc.E11-12-0993; Li CG, 2003, J CELL SCI, V116, P2677, DOI 10.1242/jcs.00470; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Liu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086273; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Mahmoud M, 2010, CIRC RES, V106, P1425, DOI 10.1161/CIRCRESAHA.109.211037; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; McDonald J, 2011, GENET MED, V13, P607, DOI 10.1097/GIM.0b013e3182136d32; Mendel DB, 2000, ANTI-CANCER DRUG DES, V15, P29; Minhajat R, 2006, VIRCHOWS ARCH, V448, P127, DOI 10.1007/s00428-005-0062-8; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Paauwe M, 2016, ONCOGENE, V35, P4069, DOI 10.1038/onc.2015.509; Pardali E, 2009, FRONT BIOSCI-LANDMRK, V14, P4848, DOI 10.2741/3573; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Ray BN, 2010, CARCINOGENESIS, V31, P435, DOI 10.1093/carcin/bgp327; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Rosen LS, 2012, CLIN CANCER RES, V18, P4820, DOI 10.1158/1078-0432.CCR-12-0098; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Simonds J, 2009, LARYNGOSCOPE, V119, P988, DOI 10.1002/lary.20159; Smolich BD, 2001, BLOOD, V97, P1413, DOI 10.1182/blood.V97.5.1413; Sugden WW, 2017, NAT CELL BIOL, V19, P653, DOI 10.1038/ncb3528; Tian H, 2015, ONCOGENE, V34, P5635, DOI 10.1038/onc.2015.13; Tian HY, 2017, ARTERIOSCL THROM VAS, V37, P1115, DOI 10.1161/ATVBAHA.116.308859; Tian HY, 2012, EMBO J, V31, P3885, DOI 10.1038/emboj.2012.246; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; Yee KWH, 2002, BLOOD, V100, P2941, DOI 10.1182/blood-2002-02-0531; Zhu YH, 2003, STROKE, V34, P2483, DOI 10.1161/01.STR.0000088644.60368.ED	58	39	42	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					2934	2949		10.1096/fj.201700867RR	http://dx.doi.org/10.1096/fj.201700867RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401587				2022-12-26	WOS:000432546000005
J	Yang, XX; Ren, HL; Wood, K; Li, MS; Qiu, SF; Shi, FD; Ma, CG; Liu, Q				Yang, Xiaoxia; Ren, Honglei; Wood, Kristofer; Li, Minshu; Qiu, Shenfeng; Shi, Fu-Dong; Ma, Cungen; Liu, Qiang			Depletion of microglia augments the dopaminergic neurotoxicity of MPTP	FASEB JOURNAL			English	Article						MPTP; Parkinson's disease; neuroprotection	PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASE; MOUSE MODEL; NEUROTROPHIC FACTOR; PROGENITOR-CELL; BRAIN-INJURY; IN-VIVO; INFLAMMATION; ACTIVATION; NEURONS	The activation of microglia and the various substances they produce have been linked to the pathologic development of Parkinson's disease (PD), but the precise role of microglia in PD remains to be defined. The survival of microglia depends on colony-stimulating factor 1 receptor (CSF1R) signaling, and CSF1R inhibition results in rapid elimination of microglia in the central nervous system. Using a mouse PD model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment, we showed that the depletion of microglia via the CSF1R inhibitor PLX3397 exacerbated the impairment of locomotor activities and the loss of dopaminergic neurons. Further, depletion of microglia augmented the production of inflammatory mediators and infiltration of leukocytes in the brain after MPTP exposure. Microglia depletion-induced aggravation of MPTP neurotoxicity was also seen in lymphocyte-deficient mice. In addition, the depletion of microglia did not affect the production of brain-derived neurotrophic factor, but it dramatically augmented the production of inflammatory mediators by astrocytes after MPTP treatment. Our findings suggest microglia play a protective role against MPTP-induced neuroinflammation and dopaminergic neurotoxicity.	[Yang, Xiaoxia; Ren, Honglei; Li, Minshu; Shi, Fu-Dong; Liu, Qiang] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China; [Yang, Xiaoxia; Wood, Kristofer; Shi, Fu-Dong; Liu, Qiang] St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ USA; [Qiu, Shenfeng] Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, Phoenix, AZ USA; [Ma, Cungen] Shanxi Datong Univ, Sch Med, Inst Brain Sci, Datong, Peoples R China	Tianjin Medical University; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of Arizona; Shanxi Datong University	Liu, Q (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China.	qliu.asu@gmail.com	Liu, Qiang/HHZ-3181-2022		U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grant [R01NS092713]; American Heart Association [16SDG27250236]; National Multiple Sclerosis Society Grant [RG-1507-05318]; Arizona Alzheimer's Research Consortium grant; Valley Research Partnership grant; National Science Foundation of China Grant [81471535]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092713] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grant; American Heart Association(American Heart Association); National Multiple Sclerosis Society Grant(National Multiple Sclerosis Society); Arizona Alzheimer's Research Consortium grant; Valley Research Partnership grant; National Science Foundation of China Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by the U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grant R01NS092713; American Heart Association Grant 16SDG27250236; National Multiple Sclerosis Society Grant RG-1507-05318; an Arizona Alzheimer's Research Consortium grant; a Valley Research Partnership grant; and National Science Foundation of China Grant 81471535. The authors declare no conflicts of interest.	Athauda D, 2015, NAT REV NEUROL, V11, P25, DOI 10.1038/nrneurol.2014.226; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Cheng YX, 2008, NEUROSCI LETT, V441, P16, DOI 10.1016/j.neulet.2008.05.116; Colombo E, 2014, ANN NEUROL, V76, P325, DOI 10.1002/ana.24217; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; De I, 2014, GLIA, V62, P1955, DOI 10.1002/glia.22717; Depboylu C, 2012, EXP NEUROL, V238, P183, DOI 10.1016/j.expneurol.2012.08.020; Ding YM, 2004, J NEUROCHEM, V89, P776, DOI 10.1111/j.1471-4159.2004.02415.x; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Erblich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026317; Gomes C, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-16; Gonzalez H, 2013, J IMMUNOL, V190, P5048, DOI 10.4049/jimmunol.1203121; Hauser DN, 2011, J NEUROCHEM, V117, P357, DOI 10.1111/j.1471-4159.2011.07217.x; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Hirsch EC, 1998, ANN NEUROL, V44, pS115, DOI 10.1002/ana.410440717; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Jin WN, 2017, J CEREBR BLOOD F MET, V37, P2224, DOI 10.1177/0271678X17694185; Kordower JH, 2003, ANN NEUROL, V53, pS120, DOI 10.1002/ana.10485; Li MS, 2017, J CEREBR BLOOD F MET, V37, P2383, DOI 10.1177/0271678X16666551; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liu L, 2015, BEHAV BRAIN RES, V281, P215, DOI 10.1016/j.bbr.2014.12.035; Liu Q, 2017, IMMUNITY, V46, P474, DOI 10.1016/j.immuni.2017.02.015; Liu Q, 2016, NAT NEUROSCI, V19, P243, DOI 10.1038/nn.4211; Liu Z, 2017, MOL NEUROBIOL, V54, P7762, DOI 10.1007/s12035-016-0249-9; Moriguchi S, 2012, J NEUROCHEM, V120, P541, DOI 10.1111/j.1471-4159.2011.07608.x; Nam JH, 2015, MOL NEUROBIOL, V51, P487, DOI 10.1007/s12035-014-8729-2; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Olanow CW, 2013, ANN NEUROL, V74, P337, DOI 10.1002/ana.24011; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Patterson SL, 2015, NEUROPHARMACOLOGY, V96, P11, DOI 10.1016/j.neuropharm.2014.12.020; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Rice RA, 2017, GLIA, V65, P931, DOI 10.1002/glia.23135; Schapira AHV, 2014, LANCET, V384, P545, DOI 10.1016/S0140-6736(14)61010-2; Schapira AHV, 2010, NAT REV NEUROL, V6, P309, DOI 10.1038/nrneurol.2010.52; Schwartz M, 2004, TRENDS PHARMACOL SCI, V25, P407, DOI 10.1016/j.tips.2004.06.010; Shao W, 2013, NATURE, V494, P90, DOI 10.1038/nature11748; Szalay G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11499; Zhang C, 2013, P NATL ACAD SCI USA, V110, P5689, DOI 10.1073/pnas.1219457110; Zhao P, 2017, FASEB J, V31, P172, DOI 10.1096/fj.201600751R	42	54	55	2	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3336	3345		10.1096/fj.201700833RR	http://dx.doi.org/10.1096/fj.201700833RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401614	Green Published			2022-12-26	WOS:000432546000035
J	Park, J; Kim, J; Park, B; Yang, KM; Sun, EJ; Tognon, CE; Sorensen, PH; Kim, SJ				Park, Jinah; Kim, Junil; Park, Bora; Yang, Kyung-Min; Sun, Eun Jin; Tognon, Cristina E.; Sorensen, Poul H.; Kim, Seong-Jin			Novel identification of STAT1 as a crucial mediator of ETV6-NTRK3-induced tumorigenesis	ONCOGENE			English	Article							PROTEIN-TYROSINE KINASE; PHOSPHORYLATION-ACETYLATION SWITCH; GENE FUSION; RNA-SEQ; CONGENITAL FIBROSARCOMA; MYELOGENOUS LEUKEMIA; REGULATORY NETWORK; BREAST-CANCER; TRANSFORMATION; TRANSCRIPTION	Chromosomal rearrangements that facilitate tumor formation and progression through activation of oncogenic tyrosine kinases are frequently observed in cancer. The ETV6-NTRK3 (EN) fusion has been implicated in various cancers, including infantile fibrosarcoma, secretory breast carcinoma, and acute myeloblastic leukemia, and has exhibited in vivo and in vitro transforming ability. In the present study, we analyzed transcriptome alterations using DNA microarray and RNA-Seq in EN-transduced NIH3T3 fibroblasts to identify the mechanisms that are involved in EN-mediated tumorigenesis. Through functional profile assessment of EN-regulated transcriptome alterations, we found that upregulated genes by EN were mainly associated with cell motion, membrane invagination, and cell proliferation, while downregulated genes were involved in cell adhesion, which correlated with the transforming potential and increased proliferation in EN-transduced cells. KEGG pathway analysis identified the JAK-STAT signaling pathway with the highest statistical significance. Moreover, Ingenuity Pathway Analysis and gene regulatory network analysis identified the STAT1 transcription factor and its target genes as top EN-regulated molecules. We further demonstrated that EN enhanced STAT1 phosphorylation but attenuated STAT1 acetylation, eventually inhibiting the interaction between the NF-kappa B p65 subunit and acetylated STAT1. Consequently, nuclear translocation of NF-kappa B p65 and subsequent NF-kappa B activity were increased by EN. Notably, inhibition of STAT1 phosphorylation attenuated tumorigenic ability of EN in vitro and in vivo. Taken together, here we report, for the first time, STAT1 as a significant EN-regulated transcription factor and a crucial mediator of EN-induced tumorigenesis.	[Park, Jinah; Park, Bora; Yang, Kyung-Min; Sun, Eun Jin; Kim, Seong-Jin] Seoul Natl Univ, Precis Med Res Ctr, Adv Inst Convergence Technol, Suwon 16229, Gyeonggi Do, South Korea; [Kim, Junil] Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Kim, Junil] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Tognon, Cristina E.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97239 USA; [Sorensen, Poul H.] British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Kim, Seong-Jin] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Transdisciplinary Studies, Suwon 16229, Gyeonggi Do, South Korea	Seoul National University (SNU); University of Pennsylvania; Pennsylvania Medicine; Oregon Health & Science University; British Columbia Cancer Agency; Seoul National University (SNU)	Kim, SJ (corresponding author), Seoul Natl Univ, Precis Med Res Ctr, Adv Inst Convergence Technol, Suwon 16229, Gyeonggi Do, South Korea.; Kim, SJ (corresponding author), Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Transdisciplinary Studies, Suwon 16229, Gyeonggi Do, South Korea.	jasonsjkim@snu.ac.kr		kim, junil/0000-0002-1202-1808	National Research Foundation grant of Korea [NRF-2014M3A9B5073918]; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea - Korean government [1520120]; British Columbia Cancer Foundation	National Research Foundation grant of Korea(National Research Foundation of Korea); National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea - Korean government; British Columbia Cancer Foundation	This work was supported by a National Research Foundation grant of Korea (NRF-2014M3A9B5073918), a National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (1520120) funded by the Korean government, and the British Columbia Cancer Foundation through generous donations from Team Finn and the Ride to Conquer Cancer (to PHS).	Adamaki M, 2015, LEUKEMIA RES, V39, P1285, DOI 10.1016/j.leukres.2015.09.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop JA, 2017, AM J SURG PATHOL, V41, P62, DOI 10.1097/PAS.0000000000000734; Blake J. A., 2008, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0702S23; Brenca M, 2016, J PATHOL, V238, P543, DOI 10.1002/path.4677; Cetinbas N, 2013, J BIOL CHEM, V288, P27940, DOI 10.1074/jbc.M113.475301; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Eguchi M, 1999, BLOOD, V93, P1355, DOI 10.1182/blood.V93.4.1355; Fazekas D, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-7; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Gridelli C, 2014, CANCER TREAT REV, V40, P300, DOI 10.1016/j.ctrv.2013.07.002; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Hix LM, 2013, J BIOL CHEM, V288, P11676, DOI 10.1074/jbc.M112.441402; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim J, 2012, NUCLEIC ACIDS RES, V40, P8849, DOI 10.1093/nar/gks664; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kramer OH, 2010, MOL CELL ENDOCRINOL, V315, P40, DOI 10.1016/j.mce.2009.10.007; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Kramer OH, 2006, GENE DEV, V20, P473, DOI 10.1101/gad.364306; Lannon CL, 2005, SEMIN CANCER BIOL, V15, P215, DOI 10.1016/j.semcancer.2005.01.003; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li Z, 2007, CANCER CELL, V12, P542, DOI 10.1016/j.ccr.2007.11.012; Liu Q, 2000, EMBO J, V19, P1827, DOI 10.1093/emboj/19.8.1827; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Rubin BP, 1998, AM J PATHOL, V153, P1451, DOI 10.1016/S0002-9440(10)65732-X; Shaw AT, 2013, NAT REV CANCER, V13, P772, DOI 10.1038/nrc3612; Skalova A, 2010, AM J SURG PATHOL, V34, P599, DOI 10.1097/PAS.0b013e3181d9efcc; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Tognon C, 2001, CANCER RES, V61, P8909; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Tognon CE, 2011, CANCER RES, V71, P1060, DOI 10.1158/0008-5472.CAN-10-3096; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tymoszuk P, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-257; Vlahopoulos SA, 2015, CYTOKINE GROWTH F R, V26, P389, DOI 10.1016/j.cytogfr.2015.06.001; Wada R, 2016, PATHOL INT, V66, P431, DOI 10.1111/pin.12431; Wai DH, 2000, ONCOGENE, V19, P906, DOI 10.1038/sj.onc.1203396; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Zaidi MR, 2011, CLIN CANCER RES, V17, P6118, DOI 10.1158/1078-0432.CCR-11-0482	46	6	6	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	17					2270	2284		10.1038/s41388-017-0102-2	http://dx.doi.org/10.1038/s41388-017-0102-2			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GE3FW	29391602				2022-12-26	WOS:000431100200005
J	Riedinger, C; Mendler, M; Schlotterer, A; Fleming, T; Okun, J; Hammes, HP; Herzig, S; Nawroth, PP				Riedinger, Christin; Mendler, Michael; Schlotterer, Andrea; Fleming, Thomas; Okun, Juergen; Hammes, Hans-Peter; Herzig, Stephan; Nawroth, Peter P.			High-glucose toxicity is mediated by AICAR-transformylase/IMP cyclohydrolase and mitigated by AMP-activated protein kinase in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; LIFE-SPAN; DNA-DAMAGE; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE; REACTIVE METABOLITES; GENE-TRANSFER; INSULIN; NEMATODE; HYPERGLYCEMIA; RESTRICTION	The enzyme AICAR-transformylase/IMP cyclohydrolase (ATIC) catalyzes the last two steps of purine de novo synthesis. It metabolizes 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR), which is an AMP analogue, leading to activation of AMP-activated kinase (AMPK). We investigated whether the AICAR-ATIC pathway plays a role in the high glucose (HG)mediated DNA damage response and AICAR-mediated AMPK activation, explaining the detrimental effects of glucose on neuronal damage and shortening of the lifespan. HG up-regulated the expression and activity of the Caenorhabditis elegans homologue of ATIC, C55F2.1 (atic-1), and increased the levels of reactive oxygen species and methylglyoxal-derived advanced glycation end products. Overexpression of atic-1 decreased the lifespan and head motility and increased neuronal damage under both standard and HG conditions. Inhibition of atic-1 expression, by RNAi, under HG was associated with increased lifespan and head motility and reduced neuronal damage, reactive oxygen species, and methylglyoxal-derived advanced glycation end product accumulation. This effect was independent of an effect on DNA damage or antioxidant defense pathways, such as superoxide dismutase (sod-3) or glyoxalase-1 (glod-4), but was dependent on AMPK and accumulation of AICAR. Through AMPK, AICAR treatment also reduced the negative effects of HG. The mitochondrial inhibitor rotenone abolished the AICAR/AMPK-induced amelioration of HG effects, pointing to mitochondria as a prime target of the glucotoxic effects in C. elegans. We conclude that atic-1 is involved in glucotoxic effects under HG conditions, either by blocked atic-1 expression or via AICAR and AMPK induction.	[Riedinger, Christin; Mendler, Michael; Schlotterer, Andrea; Fleming, Thomas; Nawroth, Peter P.] Heidelberg Univ, Dept Med & Clin Chem 1, Neuenheimer Feld 410, D-69120 Heidelberg, Germany; [Okun, Juergen] Dietmar Hopp Metab Ctr, Dept Pediat, D-69120 Heidelberg, Germany; [Hammes, Hans-Peter] Univ Hosp Mannheim, V Med Hosp, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany; [Herzig, Stephan] Helmholtz Ctr Munich, Inst Diabet & Canc, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Herzig, Stephan; Nawroth, Peter P.] Heidelberg Univ Hosp, Joint Heidelberg Inst Diabet & Canc Translat Diab, Neuenheimer Feld 410, D-69120 Heidelberg, Germany; [Herzig, Stephan; Nawroth, Peter P.] German Ctr Diabet Res, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg	Nawroth, PP (corresponding author), Heidelberg Univ, Dept Med & Clin Chem 1, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.; Nawroth, PP (corresponding author), Heidelberg Univ Hosp, Joint Heidelberg Inst Diabet & Canc Translat Diab, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.; Nawroth, PP (corresponding author), German Ctr Diabet Res, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	peter.nawroth@med.uni-heidelberg.de	Hammes, Hans-Peter/S-3719-2019; Schlotterer, Andrea/GWC-7442-2022		German Research Foundation (DFG) [SFB1118, TP C06, SFB1158, TP A03]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by the German Research Foundation (DFG, "SFB1118, TP C06 Reactive metabolites as cause of diabetic complications") (to M. M., C. R., T. F., S. H., and P. P. N.) and "SFB1158', TP A03" (to P. P. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Bhatt S, 2015, CELL METAB, V22, P239, DOI 10.1016/j.cmet.2015.07.015; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; BLACK SL, 1978, ANAL BIOCHEM, V90, P397, DOI 10.1016/0003-2697(78)90042-8; Blasiak J, 2004, MUTAT RES-FUND MOL M, V554, P297, DOI 10.1016/j.mrfmmm.2004.05.011; Brenner T, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0683-x; Buhl ES, 2001, DIABETES, V50, P12, DOI 10.2337/diabetes.50.1.12; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; CycLex Co. Ltd., 2016, CYCL AMPK KIN ASS KI; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Dhawan A, 2003, SIGMA, V1077, P1; Dmitrieva NI, 2011, P NATL ACAD SCI USA, V108, P20796, DOI 10.1073/pnas.1114677108; Dugan LL, 2013, J CLIN INVEST, V123, P4888, DOI 10.1172/JCI66218; Fleming T, 2014, BIOCHEM SOC T, V42, P439, DOI 10.1042/BST20130265; Ghiraldini FG, 2013, MOL BIOL CELL, V24, P2467, DOI 10.1091/mbc.E13-04-0186; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Habib SL, 2016, CELL CYCLE, V15, P3048, DOI 10.1080/15384101.2016.1231259; Hartmann S, 2006, CLIN CHEM, V52, P1127, DOI 10.1373/clinchem.2005.058842; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Iglesias MA, 2002, DIABETES, V51, P2886, DOI 10.2337/diabetes.51.10.2886; Imanikia S, 2016, ENVIRON TOXICOL PHAR, V45, P356, DOI 10.1016/j.etap.2016.06.020; Kasznicki J, 2009, POL ARCH MED WEWN, V119, P128, DOI 10.20452/pamw.626; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mendler M, 2012, EXP CLIN ENDOCR DIAB, V120, P182, DOI 10.1055/s-0032-1304570; Mendler M, 2017, J DIABETES COMPLICAT, V31, P304, DOI 10.1016/j.jdiacomp.2016.09.014; Mendler M, 2015, DIABETOLOGIA, V58, P393, DOI 10.1007/s00125-014-3415-5; Morcos M, 2008, AGING CELL, V7, P260, DOI 10.1111/j.1474-9726.2008.00371.x; Mungai PT, 2011, MOL CELL BIOL, V31, P3531, DOI 10.1128/MCB.05124-11; O'Neil N., 2006, WORMBOOK, DOI [10.1895/wormbook.1.7.1, DOI 10.1895/WORMBOOK.1.7.1]; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Park S, 2016, MOL CELLS, V39, P204, DOI 10.14348/molcells.2016.2206; Rani V, 2016, LIFE SCI, V148, P183, DOI 10.1016/j.lfs.2016.02.002; Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Schlernitzauer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078788; Schlotterer A, 2010, AGING CELL, V9, P420, DOI 10.1111/j.1474-9726.2010.00572.x; Schlotterer A, 2009, DIABETES, V58, P2450, DOI 10.2337/db09-0567; Schmeisser S, 2013, MOL METAB, V2, P92, DOI 10.1016/j.molmet.2013.02.002; SCHNABEL H, 1990, SCIENCE, V250, P686, DOI 10.1126/science.250.4981.686; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Schumacher B, 2005, CELL DEATH DIFFER, V12, P153, DOI 10.1038/sj.cdd.4401539; Sliwinska A, 2008, CHEM-BIOL INTERACT, V173, P159, DOI 10.1016/j.cbi.2008.03.017; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tewari S, 2012, ANTIOXID REDOX SIGN, V17, P492, DOI 10.1089/ars.2011.4333; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tornovsky-Babeay S, 2014, CELL METAB, V19, P109, DOI 10.1016/j.cmet.2013.11.007; Totemeyer S, 1998, MOL MICROBIOL, V27, P553, DOI 10.1046/j.1365-2958.1998.00700.x; Vazquez-Manrique RP, 2016, HUM MOL GENET, V25, P1043, DOI 10.1093/hmg/ddv513; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; Winder WW, 2008, DIABETOLOGIA, V51, P1761, DOI 10.1007/s00125-008-1115-8; Xavier DJ, 2015, MUTAT RES-FUND MOL M, V776, P98, DOI 10.1016/j.mrfmmm.2015.01.016; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013	57	5	6	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4845	4859		10.1074/jbc.M117.805879	http://dx.doi.org/10.1074/jbc.M117.805879			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29414769	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000428848300024
J	Taylor, IR; Dunyak, BM; Komiyama, T; Shao, H; Ran, X; Assimon, VA; Kalyanaraman, C; Rauch, JN; Jacobson, MP; Zuiderweg, ERP; Gestwicki, JE				Taylor, Isabelle R.; Dunyak, Bryan M.; Komiyama, Tomoko; Shao, Hao; Ran, Xu; Assimon, Victoria A.; Kalyanaraman, Chakrapani; Rauch, Jennifer N.; Jacobson, Matthew P.; Zuiderweg, Erik R. P.; Gestwicki, Jason E.			High-throughput screen for inhibitors of protein-protein interactions in a reconstituted heat shock protein 70 (Hsp70) complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE; SMALL MOLECULES; ATPASE; BINDING; DNAK; CHAPERONES; DOMAIN; SITE; KDA	Protein-protein interactions (PPIs) are an important category of putative drug targets. Improvements in high-throughput screening (HTS) have significantly accelerated the discovery of inhibitors for some categories of PPIs. However, methods suitable for screening multiprotein complexes (e.g. those composed of three or more different components) have been slower to emerge. Here, we explored an approach that uses reconstituted multiprotein complexes (RMPCs). As a model system, we chose heat shock protein 70 (Hsp70), which is an ATP-dependent molecular chaperone that interacts with co-chaperones, including DnaJA2 and BAG2. The PPIs between Hsp70 and its co-chaperones stimulate nucleotide cycling. Thus, to re-create this ternary protein system, we combined purified human Hsp70 with DnaJA2 and BAG2 and then screened 100,000 diverse compounds for those that inhibited co-chaperone-stimulated ATPase activity. This HTS campaign yielded two compounds with promising inhibitory activity. Interestingly, one inhibited the PPI between Hsp70 and DnaJA2, whereas the other seemed to inhibit the Hsp70-BAG2 complex. Using secondary assays, we found that both compounds inhibited the PPIs through binding to allosteric sites on Hsp70, but neither affected Hsp70's intrinsic ATPase activity. Our RMPC approach expands the toolbox of biochemical HTS methods available for studying difficult-to-target PPIs in multiprotein complexes. The results may also provide a starting point for new chemical probes of the Hsp70 system.	[Taylor, Isabelle R.; Dunyak, Bryan M.; Shao, Hao; Ran, Xu; Assimon, Victoria A.; Kalyanaraman, Chakrapani; Rauch, Jennifer N.; Jacobson, Matthew P.; Gestwicki, Jason E.] Univ Calif San Francisco, Dept Pharmaceut Chem, Sandler Neurosc Bldg,675 Nelson Rising Lane, San Francisco, CA 94158 USA; [Komiyama, Tomoko; Zuiderweg, Erik R. P.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; University of Michigan System; University of Michigan	Gestwicki, JE (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, Sandler Neurosc Bldg,675 Nelson Rising Lane, San Francisco, CA 94158 USA.	jason.gestwicki@ucsf.edu	Ran, Xu/A-5841-2016; Rauch, Jennifer/AGI-2683-2022; Jacobson, Matthew/Y-5161-2018	Rauch, Jennifer/0000-0001-6853-5915; Jacobson, Matthew/0000-0001-6262-655X; Taylor, Isabelle/0000-0003-1053-5677	National Institutes of Health [R01NS059690]; Stand Up 2 Cancer; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM064337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up 2 Cancer; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01NS059690 (to J. E. G. and E. R. P. Z.) and Stand Up 2 Cancer (to J. E. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad A, 2011, P NATL ACAD SCI USA, V108, P18966, DOI 10.1073/pnas.1111220108; Andreasson C, 2008, P NATL ACAD SCI USA, V105, P16519, DOI 10.1073/pnas.0804187105; Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001; Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bonomo J, 2010, BIOPHYS CHEM, V149, P58, DOI 10.1016/j.bpc.2010.04.001; Cesa LC, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00119; Cesa LC, 2013, ACS CHEM BIOL, V8, P1988, DOI 10.1021/cb400356m; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Chang L, 2011, CHEM BIOL, V18, P210, DOI 10.1016/j.chembiol.2010.12.010; Chang L, 2010, J BIOL CHEM, V285, P21282, DOI 10.1074/jbc.M110.124149; Chiappori F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23474; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Erlanson DA, 2000, P NATL ACAD SCI USA, V97, P9367, DOI 10.1073/pnas.97.17.9367; Gallardo-Godoy A, 2011, J MED CHEM, V54, P1010, DOI 10.1021/jm101250y; Gillis EP, 2015, J MED CHEM, V58, P8315, DOI 10.1021/acs.jmedchem.5b00258; Goddard TD., 2000, SPARKY 3; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Kang YL, 2014, J MED CHEM, V57, P1188, DOI 10.1021/jm401551n; Kiang JG, 2000, MOL CELL BIOCHEM, V204, P169, DOI 10.1023/A:1007016822939; LEVY EJ, 1995, FEBS LETT, V368, P435, DOI 10.1016/0014-5793(95)00704-D; Li X., 2013, ACS MED CHEM LETT, V4; Li XK, 2016, CURR TOP MED CHEM, V16, P2729, DOI 10.2174/1568026616666160413140911; Li XK, 2015, MOL CANCER THER, V14, P642, DOI 10.1158/1535-7163.MCT-14-0650; Mally A, 2001, NAT STRUCT BIOL, V8, P254, DOI 10.1038/85002; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Miyata Y, 2012, CHEM BIOL, V19, P1391, DOI 10.1016/j.chembiol.2012.07.026; Miyata Y, 2010, J BIOMOL SCREEN, V15, P1211, DOI 10.1177/1087057110380571; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Rauch JN, 2014, J BIOL CHEM, V289, P1402, DOI 10.1074/jbc.M113.521997; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Scott DE, 2016, NAT REV DRUG DISCOV, V15, P533, DOI 10.1038/nrd.2016.29; Thompson AD, 2012, ACS CHEM BIOL, V7, P1311, DOI 10.1021/cb300255p; Whitmore A, 2017, FASEB J, V31; Wisen S, 2008, ANAL BIOCHEM, V374, P371, DOI 10.1016/j.ab.2007.12.009; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P1309, DOI 10.1038/nsmb.1518; Young ZT, 2016, CELL CHEM BIOL, V23, P992, DOI 10.1016/j.chembiol.2016.04.014; Yue XT, 2015, ELIFE, V4, DOI 10.7554/eLife.08401	39	19	19	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4014	4025		10.1074/jbc.RA117.001575	http://dx.doi.org/10.1074/jbc.RA117.001575			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29414793	hybrid, Green Published			2022-12-26	WOS:000427587500014
J	Garvey, M; Suarez, NM; Kerr, K; Hector, R; Moloney-Quinn, L; Arkins, S; Davison, AJ; Cullinane, A				Garvey, Marie; Suarez, Nicolas M.; Kerr, Karen; Hector, Ralph; Moloney-Quinn, Laura; Arkins, Sean; Davison, Andrew J.; Cullinane, Ann			Equid herpesvirus 8: Complete genome sequence and association with abortion in mares	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; DNA-SEQUENCE; ASININE HERPESVIRUS-3; GAZELLE HERPESVIRUS-1; THOMSONS GAZELLE; VIRUS; EHV-1; HOSTS; ZEBRA; DIFFERENTIATION	Equid herpesvirus 8 (EHV-8), formerly known as asinine herpesvirus 3, is an alphaherpes-virus that is closely related to equid herpesviruses 1 and 9 (EHV-1 and EHV-9). The pathogenesis of EHV-8 is relatively little studied and to date has only been associated with respiratory disease in donkeys in Australia and horses in China. A single EHV-8 genome sequence has been generated for strain Wh in China, but is apparently incomplete and contains frameshifts in two genes. In this study, the complete genome sequences of four EHV-8 strains isolated in Ireland between 2003 and 2015 were determined by Illumina sequencing. Two of these strains were isolated from cases of abortion in horses, and were misdiagnosed initially as EHV-1, and two were isolated from donkeys, one with neurological disease. The four genome sequences are very similar to each other, exhibiting greater than 98.4% nucleotide identity, and their phylogenetic clustering together demonstrated that genomic diversity is not dependent on the host. Comparative genomic analysis revealed 24 of the 76 predicted protein sequences are completely conserved among the Irish EHV-8 strains. Evolutionary comparisons indicate that EHV-8 is phylogenetically closer to EHV-9 than it is to EHV-1. In summary, the first complete genome sequences of EHV-8 isolates from two host species over a twelve year period are reported. The current study suggests that EHV-8 can cause abortion in horses. The potential threat of EHV-8 to the horse industry and the possibility that donkeys may act as reservoirs of infection warrant further investigation.	[Garvey, Marie; Moloney-Quinn, Laura; Cullinane, Ann] Irish Equine Ctr, Virol Unit, Naas, Kildare, Ireland; [Suarez, Nicolas M.; Kerr, Karen; Hector, Ralph; Davison, Andrew J.] Univ Glasgow, Ctr Virus Res, MRC, Glasgow, Lanark, Scotland; [Arkins, Sean] Univ Limerick, Dept Life Sci, Limerick, Ireland; [Hector, Ralph] Univ Glasgow, Inst Neurosci & Psychol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of Limerick; University of Glasgow	Cullinane, A (corresponding author), Irish Equine Ctr, Virol Unit, Naas, Kildare, Ireland.; Davison, AJ (corresponding author), Univ Glasgow, Ctr Virus Res, MRC, Glasgow, Lanark, Scotland.	andrew.davison@glasgow.ac.uk; ACullinane@irishequinecentre.ie	Hector, Ralph D/AAB-5455-2019	Hector, Ralph D/0000-0002-3778-1483	Irish Research Council [EBPPG/2014/62]; Medical Research Council [MC_UU_12014/3]; Medical Research Council [MC_UU_12014/12] Funding Source: researchfish; MRC [MC_UU_12014/3, MC_UU_12014/12] Funding Source: UKRI	Irish Research Council(Irish Research Council for Science, Engineering and Technology); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Irish Research Council (grant number EBPPG/2014/62 to MG; http://research.ie) and the Medical Research Council (grant number MC_UU_12014/3 to AD; http://www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgawad A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090262; Abdelgawad A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138370; Abdelgawad A, 2014, VET MICROBIOL, V169, P102, DOI 10.1016/j.vetmic.2013.12.011; Allen GP, 2008, EQUINE VET J, V40, P105, DOI 10.2746/042516408X253127; Allen G. P., 2004, Infectious diseases of livestock. Volume Two, P829; Allen GP, 2007, J VET DIAGN INVEST, V19, P69, DOI 10.1177/104063870701900110; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Balasuriya UBR, 2015, J VET DIAGN INVEST, V27, P673, DOI 10.1177/1040638715605558; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BAUMANN RP, 1989, J VIROL, V63, P1275, DOI 10.1128/JVI.63.3.1275-1283.1989; Bazanow BA, 2014, EQUINE VET EDUC, V26, P48, DOI 10.1111/eve.12084; Bloom DC, 2016, ADV VIRUS RES, V94, P53, DOI 10.1016/bs.aivir.2015.10.001; BROWNING GF, 1988, ARCH VIROL, V101, P183, DOI 10.1007/BF01310999; CHOWDHURY SI, 1988, VIRUS RES, V11, P127, DOI 10.1016/0168-1702(88)90038-X; CHOWDHURY SI, 1990, J VIROL, V64, P873, DOI 10.1128/JVI.64.2.873-880.1990; CRABB BS, 1990, J GEN VIROL, V71, P2033, DOI 10.1099/0022-1317-71-9-2033; CRANDELL RA, 1988, AM J VET RES, V49, P1807; CULLINANE AA, 1988, J GEN VIROL, V69, P1575, DOI 10.1099/0022-1317-69-7-1575; Cuxson JL, 2014, VET MICROBIOL, V169, P50, DOI 10.1016/j.vetmic.2013.12.007; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; Dayaram A, 2017, SCI REP-UK, V7, DOI 10.1038/srep46559; Donovan TA, 2009, VET PATHOL, V46, P1138, DOI 10.1354/vp.09-VP-0007-D-CR; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FICORILLI N, 1995, ARCH VIROL, V140, P1653, DOI 10.1007/BF01322539; Fukushi H, 1997, VIROLOGY, V227, P34, DOI 10.1006/viro.1996.8296; Ghanem Y, 2008, ARCH VIROL, V153, P2297, DOI 10.1007/s00705-008-0247-y; Greenwood AD, 2012, CURR BIOL, V22, P1727, DOI 10.1016/j.cub.2012.07.035; Guo XQ, 2014, J VET MED SCI, V76, P1309, DOI 10.1292/jvms.14-0183; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kasem S, 2008, EMERG INFECT DIS, V14, P1948, DOI 10.3201/eid1412.080801; KINYILI JH, 1979, J WILDLIFE DIS, V15, P339, DOI 10.7589/0090-3558-15.2.339; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAWRENCE GL, 1994, J VIROL METHODS, V47, P59, DOI 10.1016/0166-0934(94)90066-3; Liu CY, 2012, J VIROL, V86, P5407, DOI 10.1128/JVI.00445-12; Lunn DP, 2009, J VET INTERN MED, V23, P450, DOI 10.1111/j.1939-1676.2009.0304.x; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Narita M, 2000, VET PATHOL, V37, P476, DOI 10.1354/vp.37-5-476; Nugent J, 2006, J VIROL, V80, P4047, DOI 10.1128/JVI.80.8.4047-4060.2006; Patel JR, 2005, VET J, V170, P14, DOI 10.1016/j.tvjl.2004.04.018; REBHUN WC, 1988, J AM VET MED ASSOC, V192, P953; Rozen S, 2000, Methods Mol Biol, V132, P365; Schrenzel MD, 2008, EMERG INFECT DIS, V14, P1616, DOI 10.3201/eid1410.080703; Smith KL, 2012, J CLIN MICROBIOL, V50, P1981, DOI 10.1128/JCM.00135-12; Smith KL, 2010, VET MICROBIOL, V141, P5, DOI 10.1016/j.vetmic.2009.07.030; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Taniguchi A, 2000, J VET MED SCI, V62, P215, DOI 10.1292/jvms.62.215; Taniguchi A, 2000, ARCH VIROL, V145, P2619, DOI 10.1007/s007050070011; Telford EAR, 1998, J GEN VIROL, V79, P1197, DOI 10.1099/0022-1317-79-5-1197; TELFORD EAR, 1992, VIROLOGY, V189, P304, DOI 10.1016/0042-6822(92)90706-U; Virus taxonomy, 1995, ARCH VIROL, V10, P1; Wagner LM, 2012, J VIROL, V86, P6862, DOI 10.1128/JVI.00651-12; Wilkie GS, 2014, SCI REP-UK, V4, DOI 10.1038/srep06299; Wohlsein P, 2011, VET MICROBIOL, V149, P456, DOI 10.1016/j.vetmic.2010.11.024	56	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192301	10.1371/journal.pone.0192301	http://dx.doi.org/10.1371/journal.pone.0192301			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414990	Green Published, gold, Green Accepted			2022-12-26	WOS:000424325300069
J	Higaki, A; Mogi, M; Iwanami, J; Min, LJ; Bai, HY; Shan, BS; Kukida, M; Kan-no, H; Ikeda, S; Higaki, J; Horiuchi, M				Higaki, Akinori; Mogi, Masaki; Iwanami, Jun; Min, Li-Juan; Bai, Hui-Yu; Shan, Bao-Shuai; Kukida, Masayoshi; Kan-no, Harumi; Ikeda, Shuntaro; Higaki, Jitsuo; Horiuchi, Masatsugu			Predicting outcome of Morris water maze test in vascular dementia mouse model with deep learning	PLOS ONE			English	Article							MEMORY	The Morris water maze test (MWM) is one of the most popular and established behavioral tests to evaluate rodents' spatial learning ability. The conventional training period is around 5 days, but there is no clear evidence or guidelines about the appropriate duration. In many cases, the final outcome of the MWM seems predicable from previous data and their trend. So, we assumed that if we can predict the final result with high accuracy, the experimental period could be shortened and the burden on testers reduced. An artificial neural network (ANN) is a useful modeling method for datasets that enables us to obtain an accurate mathematical model. Therefore, we constructed an ANN system to estimate the final outcome in MWM from the previously obtained 4 days of data in both normal mice and vascular dementia model mice. Ten-week-old male C57B1/6 mice (wild type, WT) were subjected to bilateral common carotid artery stenosis (WT-BCAS) or sham-operation (WT-sham). At 6 weeks after surgery, we evaluated their cognitive function with MWM. Mean escape latency was significantly longer in WT-BCAS than in WT-sham. All data were collected and used as training data and test data for the ANN system. We defined a multiple layer perceptron (MLP) as a prediction model using an open source framework for deep learning, Chainer. After a certain number of updates, we compared the predicted values and actual measured values with test data. A significant correlation coefficient was derived form the updated ANN model in both WT-sham and WT-BCAS. Next, we analyzed the predictive capability of human testers with the same datasets. There was no significant difference in the prediction accuracy between human testers and ANN models in both WT-sham and WT-BCAS. In conclusion, deep learning method with ANN could predict the final outcome in MWM from 4 days of data with high predictive accuracy in a vascular dementia model.	[Higaki, Akinori; Iwanami, Jun; Min, Li-Juan; Bai, Hui-Yu; Shan, Bao-Shuai; Kukida, Masayoshi; Kan-no, Harumi; Horiuchi, Masatsugu] Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan; [Higaki, Akinori; Kukida, Masayoshi; Ikeda, Shuntaro; Higaki, Jitsuo] Ehime Univ, Grad Sch Med, Dept Cardiol Pulmonol Hypertens & Nephrol, Tohon, Ehime, Japan; [Mogi, Masaki] Ehime Univ, Grad Sch Med, Dept Pharmacol, Tohon, Ehime, Japan	Ehime University; Ehime University; Ehime University	Higaki, A (corresponding author), Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan.; Higaki, A (corresponding author), Ehime Univ, Grad Sch Med, Dept Cardiol Pulmonol Hypertens & Nephrol, Tohon, Ehime, Japan.	keroplant83@gmail.com	Higaki, Akinori/AAA-2551-2019	Higaki, Akinori/0000-0002-0827-874X				Agatonovic-Kustrin S, 2000, J PHARMACEUT BIOMED, V22, P717, DOI 10.1016/S0731-7085(99)00272-1; Araghinejad S, 2013, CHAINER A NEXT GENER; Bromley-Brits K, 2011, JOVE-J VIS EXP, DOI 10.3791/2920; Coltman R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.09.005; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Deng L., 2014, SIGNAL PROCESS, V7, P3, DOI DOI 10.1561/2000000039; Deng L., 2014, DATA DRIVEN MODELING, V7, P3; Enrique AM, 2009, MATH COMPUT MODEL, V49, P207; Hosseini-Sharifabad A, 2011, DARU, V19, P166; Iwanami J, 2015, J AM SOC HYPERTENS, V9, P250, DOI 10.1016/j.jash.2015.01.010; Lakhani P, 2017, RADIOLOGY, V284, P574, DOI 10.1148/radiol.2017162326; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Nishio K, 2010, STROKE, V41, P1278, DOI 10.1161/STROKEAHA.110.581686; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Sakata A, 2009, BRAIN RES, V1300, P14, DOI 10.1016/j.brainres.2009.08.068; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Shibata M, 2007, STROKE, V38, P2826, DOI 10.1161/STROKEAHA.107.490151; STR, 2007, STR; STR, 1960, STR; Tachibana K, 2011, BRAIN RES, V1388, P69, DOI 10.1016/j.brainres.2011.02.086; Timic T, 2013, BEHAV BRAIN RES, V241, P198, DOI 10.1016/j.bbr.2012.12.014; Xiao HG, 2017, J HYPERTENS, V35, P1577, DOI 10.1097/HJH.0000000000001337; Yaslan Y, 2017, MEASUREMENT, V103, P52, DOI 10.1016/j.measurement.2017.02.007	24	14	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191708	10.1371/journal.pone.0191708	http://dx.doi.org/10.1371/journal.pone.0191708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415035	Green Submitted, Green Published, gold			2022-12-26	WOS:000424325300038
J	Levy, BR; Slade, MD; Pietrzak, RH; Ferrucci, L				Levy, Becca R.; Slade, Martin D.; Pietrzak, Robert H.; Ferrucci, Luigi			Positive age beliefs protect against dementia even among elders with high-risk gene	PLOS ONE			English	Article							CENTER MORALE SCALE; COGNITIVE IMPAIRMENT; NEGATIVE STEREOTYPES; TELEPHONE INTERVIEW; SELF-STEREOTYPES; APOLIPOPROTEIN-E; METAANALYSIS; STRESS; MEMORY; ASSOCIATION	One of the strongest risk factors for dementia is the epsilon 4 variant of the APOE gene. Yet, many who carry it never develop dementia. The current study examined for the first time whether positive age beliefs that are acquired from the culture may reduce the risk of developing dementia among older individuals, including those who are APOE epsilon 4 carriers. The cohort consisted of 4,765 Health and Retirement Study participants who were aged 60 or older and dementia-free at baseline. As predicted, in the total sample those with positive age beliefs at baseline were significantly less likely to develop dementia, after adjusting for relevant covariates. Among those with APOE epsilon 4, those with positive age beliefs were 49.8% less likely to develop dementia than those with negative age beliefs. The results of this study suggest that positive age beliefs, which are modifiable and have been found to reduce stress, can act as a protective factor, even for older individuals at high risk of dementia.	[Levy, Becca R.] Yale Sch Publ Hlth, Social & Behav Sci Dept, New Haven, CT 06510 USA; [Slade, Martin D.] Yale Sch Med, Dept Internal Med, New Haven, CT USA; [Pietrzak, Robert H.] Yale Sch Med, Dept Psychiat, New Haven, CT USA; [Pietrzak, Robert H.] US Dept Vet Affairs, Natl Ctr Posttraumat Stress Disorder, West Haven, CT USA; [Ferrucci, Luigi] NIA, Longitudinal Studies Sect, Baltimore, MD 21224 USA	Yale University; Yale University; Yale University; US Department of Veterans Affairs; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Levy, BR (corresponding author), Yale Sch Publ Hlth, Social & Behav Sci Dept, New Haven, CT 06510 USA.	Becca.Levy@yale.edu			National Institute on Aging grant [`U01AG032284-05A1]; NATIONAL INSTITUTE ON AGING [U01AG032284] Funding Source: NIH RePORTER	National Institute on Aging grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a National Institute on Aging grant (U01AG032284-05A1) to BL, MS RP and LF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Beydoun MA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.017; Castanho TC, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00016; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P162, DOI 10.1093/geronb/gbr048; Faul J, 2014, HLTH RETIREMENT STUD; Ferrucci I, 1998, AGING CLIN EXP RES, V10, P332; Fisher GG, 2017, HLTH RETIREMENT STUD; Fong TG, 2009, ALZHEIMERS DEMENT, V5, P492, DOI 10.1016/j.jalz.2009.02.007; Gilsanz P, 2017, JAMA NEUROL, V74, P1056, DOI 10.1001/jamaneurol.2017.1553; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Horton S, 2008, J APPL GERONTOL, V27, P446, DOI 10.1177/0733464808315291; Lamont RA, 2015, PSYCHOL AGING, V30, P180, DOI 10.1037/a0038586; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; LAWTON MP, 1975, J GERONTOL, V30, P85, DOI 10.1093/geronj/30.1.85; Levy B, 1996, J PERS SOC PSYCHOL, V71, P1092, DOI 10.1037/0022-3514.71.6.1092; LEVY B, 1994, J PERS SOC PSYCHOL, V66, P989, DOI 10.1037/0022-3514.66.6.989; Levy B, 2009, CURR DIR PSYCHOL SCI, V18, P332, DOI 10.1111/j.1467-8721.2009.01662.x; Levy BR, 2016, GEROPSYCH, V29, P141, DOI 10.1024/1662-9647/a000149; Levy BR, 2016, PSYCHOL AGING, V31, P82, DOI 10.1037/pag0000062; Levy BR, 2015, J GERONTOL B-PSYCHOL, V70, P886, DOI 10.1093/geronb/gbu082; Levy BR, 2014, PSYCHOL SCI, V25, P2127, DOI 10.1177/0956797614551970; Levy BR, 2012, J GERONTOL B-PSYCHOL, V67, P432, DOI 10.1093/geronb/gbr120; Levy BR, 2000, J GERONTOL B-PSYCHOL, V55, pP205, DOI 10.1093/geronb/55.4.P205; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; LIANG J, 1983, J GERONTOL, V38, P181, DOI 10.1093/geronj/38.2.181; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; McEwen B. S., 2017, CHRONIC STRESS, V1; Meisner BA, 2012, J GERONTOL B-PSYCHOL, V67, P13, DOI 10.1093/geronb/gbr062; National Institute of Aging, 2007, GROW OLD AM HLTH RET; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Robertson DA, 2016, PSYCHOL AGING, V31, P71, DOI 10.1037/pag0000061; Seidler AL, 2017, GEROPSYCH, V30, P49, DOI 10.1024/1662-9647/a000165; Seo EH, 2011, ARCH GERONTOL GERIAT, V52, pE26, DOI 10.1016/j.archger.2010.04.008; Smith J., 2017, PSYCHOSOCIAL LIFESTY; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61	36	42	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191004	10.1371/journal.pone.0191004	http://dx.doi.org/10.1371/journal.pone.0191004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414991	gold, Green Published, Green Submitted			2022-12-26	WOS:000424325300013
J	Silva, AF; Escada-Rebelo, S; Amaral, S; Tavares, RS; Schlatt, S; Ramalho-Santos, J; Mota, PC				Silva, Andreia F.; Escada-Rebelo, Sara; Amaral, Sandra; Tavares, Renata S.; Schlatt, Stefan; Ramalho-Santos, Joao; Mota, Paula C.			Can we induce spermatogenesis in the domestic cat using an in vitro tissue culture approach?	PLOS ONE			English	Article							GERM-CELL SURVIVAL; ORGAN-CULTURE; SEMINIFEROUS EPITHELIUM; TESTICULAR TISSUE; SPERM PRODUCTION; TESTIS TISSUE; IMMATURE RAT; FELIS-CATUS; DIFFERENTIATION; SPERMATOGONIA	The reduced number of animals in most wild felid populations implies a loss of genetic diversity. The death of juveniles, prior to the production of mature sperm, represents a loss of potential genetic contribution to future populations. Since 2011 mouse testicular organ culture has introduced an alternative mechanism to produce sperm in vitro from immature tissue. However, extension of this technology to other species has remained limited. We have used the domestic cat (Felis catus) as a model for wild felids to investigate spermatogenesis initiation and regulation, with the mouse serving as a control species. Testicular tissue fragments were cultured in control medium or medium supplemented with knockout serum replacement (KSR), AlbuMax, beta-estradiol or AlbuMax plus beta-estradiol. Contrary to expectations, and unlike results obtained in mouse controls, no germ cell differentiation could be detected. The only germ cells observed after six weeks of culture were spermatogonia regardless of the initial stage of tubule development in the donor tissue. Moreover, the number of spermatogonia decreased with time in culture in all media tested, especially in the medium supplemented with KSR, while AlbuMax had a slight protective effect. The combination of AlbuMax and beta-estradiol led to an increase in the area occupied by seminiferous tubules, and thus to an increase in total number of spermatogonial cells. Considering all the media combinations tested the stimulus for felid germ cell differentiation in this type of system seems to be different from the mouse. Studies using other triggers of differentiation and tissue survival factors should be performed to pursue this technology for the genetic diversity preservation in wild felids.	[Silva, Andreia F.; Escada-Rebelo, Sara; Amaral, Sandra; Tavares, Renata S.; Ramalho-Santos, Joao; Mota, Paula C.] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, Biol Reprod & Stem Cell Grp, Coimbra, Portugal; [Amaral, Sandra; Mota, Paula C.] Univ Coimbra, Inst Interdisciplinary Res IIIUC, Coimbra, Portugal; [Schlatt, Stefan] Univ Munster, Inst Reprod & Regenerat Biol, Ctr Reprod Med & Androl, Munster, Germany; [Ramalho-Santos, Joao] Univ Coimbra, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; University of Munster; Universidade de Coimbra	Mota, PC (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol CNC, Biol Reprod & Stem Cell Grp, Coimbra, Portugal.; Mota, PC (corresponding author), Univ Coimbra, Inst Interdisciplinary Res IIIUC, Coimbra, Portugal.	pccrmota@cnc.uc.pt	Santos, João/HHZ-5595-2022; Ramalho-Santos, João/F-8641-2012	Ramalho-Santos, João/0000-0002-1172-4018; Amaral, Sandra/0000-0001-5542-7763; Mota, Paula/0000-0001-9374-3476; Rebelo, Sara/0000-0001-8895-7867; Neves Silva, Andreia Filipa/0000-0002-8157-0819	Programa Operacional Factores de Competitividade-COMPETE through the Portuguese Foundation for Science and Technology (FCT) [PTDC/CVT/119477/2010]; FCT fellowships [SFRH/BPD/74252/2010, SFRH/BPD/110160/2015]; FEDER (QREN) through Programa Operacional Factores de Competitividade COMPETE; FCT [UID/NEU/04539/2013]	Programa Operacional Factores de Competitividade-COMPETE through the Portuguese Foundation for Science and Technology (FCT); FCT fellowships(Portuguese Foundation for Science and Technology); FEDER (QREN) through Programa Operacional Factores de Competitividade COMPETE; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was supported by Programa Operacional Factores de Competitividade-COMPETE through the Portuguese Foundation for Science and Technology (FCT), research grant PTDC/CVT/119477/2010 to PC Mota. PC Mota and Amaral S were recipients of FCT fellowships (SFRH/BPD/74252/2010 and SFRH/BPD/110160/2015), and CNC was funded by FEDER (QREN) through Programa Operacional Factores de Competitividade COMPETE, and by national funds via the FCT under the project UID/NEU/04539/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri JM, 2008, LIPIDS, V43, P19, DOI 10.1007/s11745-007-3117-6; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Arregui L, 2014, REPROD FERT DEVELOP, V26, P817, DOI 10.1071/RD12411; Belkaid A, 2017, CARCINOGENESIS, V38, P402, DOI 10.1093/carcin/bgx020; BOITANI C, 1993, BIOL REPROD, V48, P761, DOI 10.1095/biolreprod48.4.761; CHEN YDI, 1976, P SOC EXP BIOL MED, V153, P473; Chishti YZ, 2014, GEN COMP ENDOCR, V199, P16, DOI 10.1016/j.ygcen.2014.01.004; D'Souza R, 2005, MOL CELL ENDOCRINOL, V241, P41, DOI 10.1016/j.mce.2005.04.011; Deng SL, 2017, THERIOGENOLOGY, V90, P120, DOI 10.1016/j.theriogenology.2016.12.002; Escada-Rebelo S, 2016, ANDROLOGY-US, V4, P1159, DOI 10.1111/andr.12223; Franca LR, 2003, BIOL REPROD, V68, P1554, DOI 10.1095/biolreprod.102.010652; Gohbara A, 2010, BIOL REPROD, V83, P261, DOI 10.1095/biolreprod.110.083899; Goldschmidt R, 1915, P NATL ACAD SCI USA, V1, P220, DOI 10.1073/pnas.1.4.220; He ZP, 2010, BIOL REPROD, V82, P363, DOI 10.1095/biolreprod.109.078550; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hogg K, 2015, STEM CELLS DEV, V24, P2899, DOI 10.1089/scd.2015.0196; Holdcraft RW, 2004, INT J ANDROL, V27, P335, DOI 10.1111/j.1365-2605.2004.00502.x; Iizuka-Hishikawa Y, 2017, J BIOL CHEM, V292, P12065, DOI [10.1074/jbc.M117.791277, 10.1074/jbc.m117.791277]; Jewgenow K, 2009, J ANDROL, V30, P460, DOI 10.2164/jandrol.108.006726; Kang JX, 2014, STEM CELLS, V32, P1092, DOI 10.1002/stem.1620; Kwon J, 2004, BIOL REPROD, V71, P515, DOI 10.1095/biolreprod.104.027565; Laurentino S, 2011, FERTIL STERIL, V96, P745, DOI 10.1016/j.fertnstert.2011.06.009; Lo KC, 2011, ASIAN J ANDROL, V13, P677, DOI 10.1038/aja.2011.88; LUCAS DR, 1958, J EMBRYOL EXP MORPH, V6, P178; Luo JP, 2006, MOL REPROD DEV, V73, P1531, DOI 10.1002/mrd.20529; Maganty Avinash, 2015, FUTURE PERSPECTIVES; Mota PC, 2012, THERIOGENOLOGY, V77, P299, DOI 10.1016/j.theriogenology.2011.07.042; Muller G, 2012, THERIOGENOLOGY, V78, P1224, DOI 10.1016/j.theriogenology.2012.05.018; Neubauer K, 2004, BIOL REPROD, V71, P1517, DOI 10.1095/biolreprod.104.031062; Pentikainen V, 2000, J CLIN ENDOCR METAB, V85, P2057, DOI 10.1210/jc.85.5.2057; Perrard MH, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.142802; Reda A, 2016, MOL HUM REPROD, V22, P601, DOI 10.1093/molehr/gaw047; Reuter Karin, 2012, Spermatogenesis, V2, P245; Roulet V, 2006, HUM REPROD, V21, P1564, DOI 10.1093/humrep/del018; Sato T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130171; Sato T, 2013, NAT PROTOC, V8, P2098, DOI 10.1038/nprot.2013.138; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Schoen J, 2012, REPROD DOMEST ANIM, V47, P30, DOI 10.1111/rda.12065; STEINBER.A, 1966, EXP CELL RES, V44, P429, DOI 10.1016/0014-4827(66)90449-6; STEINBERGER A, 1964, EXP CELL RES, V36, P19, DOI 10.1016/0014-4827(64)90156-9; Steinberger A, 1970, In Vitro, V5, P17, DOI 10.1007/BF02618371; STEINBERGER A, 1965, J REPROD FERTIL, V9, P243; STEINBERGER E, 1964, ENDOCRINOLOGY, V74, P788, DOI 10.1210/endo-74-5-788; STEINBERGER E, 1964, ANAT REC, V148, P581, DOI 10.1002/ar.1091480409; Stukenborg JB, 2008, J ANDROL, V29, P312, DOI 10.2164/jandrol.107.002857; Tokunaga Y, 1999, ENDOCRINOLOGY, V140, P1875, DOI 10.1210/en.140.4.1875; Vansandt LM, 2012, REPROD DOMEST ANIM, V47, P256, DOI 10.1111/rda.12079; Wrobel KH, 2000, ANAT EMBRYOL, V202, P209, DOI 10.1007/s004290000111; Zhou Q, 2016, CELL STEM CELL, V18, P330, DOI 10.1016/j.stem.2016.01.017	49	7	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191912	10.1371/journal.pone.0191912	http://dx.doi.org/10.1371/journal.pone.0191912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414992	Green Submitted, Green Published, gold			2022-12-26	WOS:000424325300045
J	Biru, M; Hallstrom, I; Lundqvist, P; Jerene, D				Biru, Mulatu; Hallstrom, Inger; Lundqvist, Pia; Jerene, Degu			Rates and predictors of attrition among children on antiretroviral therapy in Ethiopia: A prospective cohort study	PLOS ONE			English	Article							CARE	Introduction Attrition from antiretroviral therapy (ART) programmes is a critical challenge among children receiving care in resource-limited settings. Our objective was to determine the rates and predictors of attrition among children on ART in Ethiopia. Methods Between December 2014 and September 2016, we conducted a prospective cohort study in eight health facilities in Ethiopia. Eligibility criteria included age 3 months-14 years; being on ART for not more than a month. Outcome was attrition due to death and/or loss to follow-up. Predictor variables were child clinical and socio-demographic characteristics, and caregiver socio-demographic characteristics. We used Cox Regression analyses to examine the association between predictors and outcome. Results Of 309 children, 304 were included, 52% were male. Their median age was 9 years (Inter-quartile range, IQR, 6-12). At ART initiation, their median CD4 was 362 cells/mm 3 (IQR 231-499); and 74.3% had WHO stage 1 or 2 disease. During 287.7 person-years of observation (PYO), 24 attritions were recorded, yielding an attrition rate of 8.3 per 100 PYO (95% CI 5.4-12.1). Of these, six children were reported dead, leading to a mortality rate of 2.1 per 100 PYO (95% CI 0.8-4.3). Eighteen were lost to follow-up (LTFU) leading to LTFU rate of 6.26 per 100 PYO (95% CI: 3.83-9.70). The majority, 14 (58%) of attrition occurred during the first six months of treatment. Age below three years [aHR] = 5.14 (95% CI: 2.07-12.96), rural residence (aHR = 3.97, 95% CI: 1.34-11.78) and baseline Hgb in g/dl < 10 g/dl [aHR] = 5.68 (95% CI: 2.03-6.23) predicted higher risk of attrition. Baseline Hgb < 10 g/dl (aHR = 16.63, 95% CI: 1.64-168.4) and WHO stage III or IV (aHR = 12.25, 95% CI: 1.26-119.05) predicted the death of the child. Higher attrition was documented among children of both biological parents alive and biologically related close family caregivers. Conclusion Younger children, those from rural areas, and children with anaemia were at higher risk of attrition, especially during the early months of treatment, and therefore should be prioritized during treatment follow-up. Further studies should examine underlying reasons for higher attrition.	[Biru, Mulatu; Hallstrom, Inger; Lundqvist, Pia] Lund Univ, Fac Med, Dept Hlth Sci, Lund, Sweden; [Jerene, Degu] Management Sci Hlth, Addis Ababa, Ethiopia	Lund University	Biru, M (corresponding author), Lund Univ, Fac Med, Dept Hlth Sci, Lund, Sweden.	mulatu.biru@med.lu.se		Biru, Mulatu/0000-0002-8370-2571; Kristensson Hallstrom, Inger/0000-0002-9402-6230	Swedish Research Council [521-2013-2633]; Swedish Research Council for Health, Working Life and Welfare [2013-2094]; SIDA [348-2011-7394]; Swedish Research Council; Swedish Research Council for Health, Working Life and Welfare; SIDA	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); SIDA; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); SIDA	This study was supported by the Swedish Research Council [grant number 521-2013-2633], The Swedish Research Council for Health, Working Life and Welfare [grant number 2013-2094] and SIDA [grant number 348-2011-7394]. The support was received by I. Hallstrom.; This study was supported by the Swedish Research Council, The Swedish Research Council for Health, Working Life and Welfare, and SIDA	Abuogi LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156506; Alvarez-Uria Gerardo, 2014, Germs, V4, P9, DOI 10.11599/germs.2014.1049; Asfawesen GY, 2011, ACTA PAEDIATR, V100, P1164, DOI 10.1111/j.1651-2227.2011.02243.x; Biru M, 2016, CAREGIVER REPORTED A, P1360; CSA E, 2013, POP PROJ ETH ALL REG; Federal Ministry of Health E, 2016, 2014 NAT COMPR HIV S; Federal Ministry of Health E, 2013, ACC ACT PLAN IMPR PE; Federal Ministry of Health E, 2007, GUID PAED HIV AIDS C; Federal Ministry of Health (FMOH), 2017, UNPUB; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Hagstromer O, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.22274; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Koye DN, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-161; Melaku Z, 2017, TROPICAL MED INT HLT; office F.H.A.p.a.c. The Federal Democratic Republic of Ethiopia Ministry of Health, 2014, HIV AIDS STRAT PLAN; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; UNAIDS, 2016, END AIDS; UNICEF, 2016, 7 UNICEF; WHO, 2016, CONGUID UANT DRU; Wilhelmson S, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.29943; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 2016, PREV HIV TEST TREAT; World Health Organization (WHO), 2007, WHO CAS DET HIV SURV	23	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0189777	10.1371/journal.pone.0189777	http://dx.doi.org/10.1371/journal.pone.0189777			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408897	Green Published, Green Submitted, gold			2022-12-26	WOS:000424302800006
J	Garcia-Villaescusa, A; Morales-Tatay, JM; Monleon-Salvado, D; Gonzalez-Darder, JM; Bellot-Arcis, C; Montiel-Company, JM; Almerich-Silla, JAM				Garcia-Villaescusa, Alberto; Manuel Morales-Tatay, Jose; Monleon-Salvado, Daniel; Manuel Gonzalez-Darder, Jose; Bellot-Arcis, Carlos; Maria Montiel-Company, Jose; Manuel Almerich-Silla, Jose			Using NMR in saliva to identify possible biomarkers of glioblastoma and chronic periodontitis	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; DISEASE; GLIOMA; H-1; EPIDEMIOLOGY; PROFILES; INVASION; CELLS	Nowadays there is increasing interest in identifying-and using-metabolites that can be employed as biomarkers for diagnosing, treating and monitoring diseases. Saliva and NMR have been widely used for this purpose as they are fast and inexpensive methods. This case-control study aimed to find biomarkers that could be related to glioblastoma (GBL) and periodontal disease (PD) and studied a possible association between GBL and periodontal status. The participants numbered 130, of whom 10 were diagnosed with GBL and were assigned to the cases group, while the remaining 120 did not present any pathology and were assigned to the control group. On one hand, significantly increased (p < 0.05) metabolites were found in GBL group: leucine, valine, isoleucine, propionate, alanine, acetate, ethanolamine and sucrose. Moreover, a good tendency to separation between the two groups was observed on the scatterplot of the NMR. On the other hand, the distribution of the groups attending to the periodontal status was very similar and we didn't find any association between GBL and periodontal status (Chi-Square 0.1968, p = 0.91). Subsequently, the sample as a whole (130 individuals) was divided into three groups by periodontal status in order to identify biomarkers for PD. Group 1 was composed of periodontally healthy individuals, group 2 had gingivitis or early periodontitis and group 3 had moderate to advanced periodontitis. On comparing periodontal status, a significant increase (p < 0.05) in certain metabolites was observed. These findings along with previous reports suggest that these could be used as biomarkers of a PD: caproate, isocaproate+butyrate, isovalerate, isopropanol+methanol, 4 aminobutyrate, choline, sucrose, sucrose-glucose-lysine, lactate-proline, lactate and proline. The scatter plot showed a good tendency to wards separation between group 1 and 3.	[Garcia-Villaescusa, Alberto; Bellot-Arcis, Carlos; Maria Montiel-Company, Jose; Manuel Almerich-Silla, Jose] Univ Valencia, Fac Med & Odontol, Dept Estomatol, Valencia, Spain; [Manuel Morales-Tatay, Jose] Univ Valencia, Fac Med & Odontol, Unidad Cent Invest & Med, Valencia, Spain; [Monleon-Salvado, Daniel] Univ Valencia, Hosp Clin, Inst Invest Sanitaria Clin Valencia, Fdn Invest, Valencia, Spain; [Manuel Gonzalez-Darder, Jose] Clin Hosp, Dept Neurosurg, Valencia, Spain	University of Valencia; University of Valencia; University of Valencia	Garcia-Villaescusa, A (corresponding author), Univ Valencia, Fac Med & Odontol, Dept Estomatol, Valencia, Spain.	garvial@alumni.uv.es	BELLOT-ARCIS, CARLOS/AGP-0731-2022; Monleon, Daniel/A-5078-2010; Montiel-Company, José María/S-1836-2018; Monleon, Daniel/GNP-4083-2022; tatay, jose manuel morales/L-7972-2014	BELLOT-ARCIS, CARLOS/0000-0003-4363-2713; Monleon, Daniel/0000-0002-4803-1573; Montiel-Company, José María/0000-0002-3952-7681; Monleon, Daniel/0000-0002-4803-1573; tatay, jose manuel morales/0000-0002-4404-6735	Conselleria de Sanitat Universal i Salut Publica; Ministry of Economy and Competitiveness of Spain [SAF2014-52875R]; Institute de Salud Carlos III [PIE15/00013]; FEDER [PIE15/00013]	Conselleria de Sanitat Universal i Salut Publica; Ministry of Economy and Competitiveness of Spain(Spanish Government); Institute de Salud Carlos III(Instituto de Salud Carlos III); FEDER(European Commission)	This work was supported by Conselleria de Sanitat Universal i Salut Publica, Ministry of Economy and Competitiveness of Spain (SAF2014-52875R) and Institute de Salud Carlos III and FEDER [grant number PIE15/00013]. Almerich-Silla JM is the principal researcher, http://www.san.gva.es/inicio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2012, CARCINOGENESIS, V33, P1055, DOI 10.1093/carcin/bgs112; Aimetti M, 2012, METABOLOMICS, V8, P465, DOI 10.1007/s11306-011-0331-2; Albert DA, 2012, ANN NY ACAD SCI, V1255, P1, DOI 10.1111/j.1749-6632.2011.06460.x; Araujo MWB, 2003, J PERIODONTOL, V74, P1736, DOI 10.1902/jop.2003.74.12.1736; Arora M, 2010, AM J EPIDEMIOL, V171, P253, DOI 10.1093/aje/kwp340; Borgnakke WS, 2013, J CLIN PERIODONTOL, V40, pS135, DOI [10.1111/jcpe.12080, 10.1902/jop.2013.1340013]; Bulakbasi N, 2003, AM J NEURORADIOL, V24, P225; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cuperlovic-Culf M, 2012, J BIOL CHEM, V287, P20164, DOI 10.1074/jbc.M111.337196; De La Pena VA, 2007, ARCH ORAL BIOL, V52, P911, DOI 10.1016/j.archoralbio.2007.04.008; Dietrich Thomas, 2013, J Periodontol, V84, pS70, DOI [10.1111/jcpe.12062, 10.1902/jop.2013.134008]; Eke P. I., 2015, J PERIODONTOL, V86, P611, DOI DOI 10.1902/J0P.2015.140520; Eriksson L., 2006, MULTI MEGAVARIATE 1; Galbis-Estrada C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/542549; Gil-Gil MJ, 2013, CLIN MED INSIGHTS-ON, V7, P123, DOI 10.4137/CMO.S8503; Herrera D, 2008, J CLIN PERIODONTOL, V35, P106, DOI 10.1111/j.1600-051X.2007.01170.x; Howe FA, 2003, MAGNET RESON MED, V49, P223, DOI 10.1002/mrm.10367; Ide M, 2013, J CLIN PERIODONTOL, V40, pS181, DOI [10.1111/jcpe.12063, 10.1902/jop.2013.134009]; Inagaki S, 2006, INFECT IMMUN, V74, P5023, DOI 10.1128/IAI.00062-06; Kim EH, 2005, ONCOGENE, V24, P6877, DOI 10.1038/sj.onc.1208851; Linden GJ, 2013, J CLIN PERIODONTOL, V40, pS8, DOI [10.1902/jop.2013.1340010, 10.1111/jcpe.12064]; Lindon JC, 2004, BIOMARKERS, V9, P1, DOI 10.1080/13547500410001668379; Lu R, 2014, J PERIODONTAL RES, V49, P574, DOI 10.1111/jre.12137; Tieu MT, 2015, J NEURO-ONCOL, V124, P119, DOI 10.1007/s11060-015-1815-0; Mohammad AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113740; NAVAZESH M, 1982, J DENT RES, V61, P1158, DOI 10.1177/00220345820610100901; Nicolaidis S, 2015, METABOLISM, V64, pS22, DOI 10.1016/j.metabol.2014.10.031; Nomura Y, 2012, ARCH ORAL BIOL, V57, P413, DOI 10.1016/j.archoralbio.2011.09.011; Norska A, 2010, NEUROIMAG CLIN N AM, V20, P293, DOI 10.1016/j.nic.2010.04.003; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Piao YJ, 2009, NEURO-ONCOLOGY, V11, P260, DOI 10.1215/15228517-2008-094; Qiqiang L, 2012, J PERIODONTAL RES, V47, P740, DOI 10.1111/j.1600-0765.2012.01489.x; Rzeznik M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182767; Shao W, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-197; Silwood CJL, 2002, J DENT RES, V81, P422, DOI 10.1177/154405910208100613; Takeda I, 2009, NMR BIOMED, V22, P577, DOI 10.1002/nbm.1369; Tanaka S, 2014, BRAIN TUMOR PATHOL, V31, P172, DOI 10.1007/s10014-014-0192-2; Tezal M, 2001, J PERIODONTOL, V72, P183, DOI 10.1902/jop.2001.72.2.183; Yaiw Koon-Chu, 2013, Herpesviridae, V4, P3, DOI 10.1186/2042-4280-4-3; Yilmaz A, 2017, J ALZHEIMERS DIS, V58, P355, DOI 10.3233/JAD-161226; Zappacosta B, 2007, CLIN BIOCHEM, V40, P661, DOI 10.1016/j.clinbiochem.2007.01.011; Zhu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144319	42	14	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0188710	10.1371/journal.pone.0188710	http://dx.doi.org/10.1371/journal.pone.0188710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408884	Green Published, gold, Green Submitted			2022-12-26	WOS:000424302800002
J	Lasser, KE; Lunze, K; Cheng, DM; Blokhina, E; Walley, AY; Tindle, HA; Quinn, E; Gnatienko, N; Krupitsky, E; Samet, JH				Lasser, Karen E.; Lunze, Karsten; Cheng, Debbie M.; Blokhina, Elena; Walley, Alexander Y.; Tindle, Hilary A.; Quinn, Emily; Gnatienko, Natalia; Krupitsky, Evgeny; Samet, Jeffrey H.			Depression and smoking characteristics among HIV-positive smokers in Russia: A cross-sectional study	PLOS ONE			English	Article							CIGARETTE-SMOKING; NICOTINE DEPENDENCE; FAGERSTROM TEST; HEALTH; CESSATION; SUBSTANCE; PATTERNS; WOMEN	Introduction Globally, persons with HIV infection, depression and substance use disorders have a higher smoking prevalence and smoke more heavily than other populations. These associations have not been explored among Russian smokers with HIV infection and substance use disorders. The purpose of this study was to examine the relationship between the presence of depressive symptoms and smoking outcomes in an HIV-positive cohort of Russian smokers with a history of substance use disorders (alcohol and/or drug use disorders). Methods We performed a cross-sectional secondary data analysis of a cohort of HIV-positive regular smokers with a history of substance use disorders recruited in St. Petersburg, Russia in 2012-2015. The primary outcome was heavy smoking, defined as smoking > 20 cigarettes per day. Nicotine dependence (moderate-very high) was a secondary outcome. The main independent variable was a high level of depressive symptoms in the past 7 days (defined as CES-D > = 24). We used multivariable logistic regression to examine associations between depressive symptoms and the outcomes, controlling for age, sex, education, income, running out of money for housing/food, injection drug use, and alcohol use measured by the AUDIT. Results Among 309 regular smokers, 79 participants (25.6%) had high levels of depressive symptoms, and 65 participants (21.0%) were heavy smokers. High levels of depressive symptoms were not significantly associated with heavy smoking (adjusted odds ratio [aOR] 1.50, 95% CI 0.78-2.89) or with moderate-very high levels of nicotine dependence (aOR 1.35, 95% CI 0.75-2.41). Conclusions This study did not detect an association between depressive symptoms and smoking outcomes among HIV-positive regular smokers in Russia.	[Lasser, Karen E.] Boston Univ, Boston Med Ctr, Sch Med, Dept Med,Sect Gen Internal Med, Boston, MA 02215 USA; [Lasser, Karen E.] Boston Univ, Boston Med Ctr, Sch Publ Hlth, Dept Med,Sect Gen Internal Med, Boston, MA 02215 USA; [Lunze, Karsten; Walley, Alexander Y.; Samet, Jeffrey H.] Boston Univ, Boston Med Ctr, Sch Med, Dept Med,Sect Gen Internal Med,Clin Addict Res &, Boston, MA 02215 USA; [Cheng, Debbie M.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Blokhina, Elena; Krupitsky, Evgeny] First St Petersburg Pavlov State Med Univ, St Petersburg, Russia; [Tindle, Hilary A.] Vanderbilt Univ, Vanderbilt Ctr Tobacco Addict & Lifestyle, Sch Med, Nashville, TN 37235 USA; [Quinn, Emily] Boston Univ, Data Coordinating Ctr, Sch Publ Hlth, Boston, MA 02215 USA; [Gnatienko, Natalia] Boston Med Ctr, Dept Med, Sect Gen Internal Med, Clin Addict & Res Educ Unit, Boston, MA USA; [Krupitsky, Evgeny] St Petersburg Bekhterev Res Psychoneurol Inst, St Petersburg, Russia; [Samet, Jeffrey H.] Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA 02215 USA	Boston Medical Center; Boston University; Boston Medical Center; Boston University; Boston Medical Center; Boston University; Boston University; Pavlov First Saint Petersburg State Medical University; Vanderbilt University; Boston University; Boston Medical Center; V.M. Bekhterev National Research Medical Center Psychiatry & Neurology; Boston University	Lasser, KE (corresponding author), Boston Univ, Boston Med Ctr, Sch Med, Dept Med,Sect Gen Internal Med, Boston, MA 02215 USA.; Lasser, KE (corresponding author), Boston Univ, Boston Med Ctr, Sch Publ Hlth, Dept Med,Sect Gen Internal Med, Boston, MA 02215 USA.	Karen.lasser@bmc.org	Lunze, Karsten/AAL-7240-2021; Blokhina, Elena A/V-6040-2018; Krupitsky, Evgeny/M-5935-2016	Lunze, Karsten/0000-0001-8495-0350; Blokhina, Elena A/0000-0001-5811-9897; Samet, Jeffrey/0000-0002-0897-3400; Krupitsky, Evgeny/0000-0002-0529-4525	National Institute on Drug Abuse [R01DA032082]; National Institute on Alcohol Abuse and Alcoholism [U01AA020780, U01AA021989, U24AA020778, U24AA020779]; American Cancer Society [RSG-14-034-01-CPPB]; CFAR; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA020780, U24AA020778, U24AA020779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032082] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); American Cancer Society(American Cancer Society); CFAR; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The project described was supported by grants R01DA032082 from the National Institute on Drug Abuse, U01AA020780, U01AA021989, U24AA020778, U24AA020779 from the National Institute on Alcohol Abuse and Alcoholism, and RSG-14-034-01-CPPB from the American Cancer Society. The work was facilitated by the Providence/Boston Center for AIDS Research (P30A1042853, PI: Susan Cu-Vin). Efforts of three co-authors, Drs. Walley, Lunze, and Samet were partially supported by the CFAR, as Drs. Walley and Lunze are faculty members of the Substance Use Research Core (SURC) and Dr. Samet is a codirector of the SURC. The funding source had no role in the study design, the data collection, analysis and interpretation of the data; in the writing of this manuscript or decision to submit this article for publication.	Abdullah ASM, 2002, AM J ADDICTION, V11, P235, DOI 10.1080/10550490290088018; Babor TF., 2001, AUDIT ALCOHOL USE DI; Benard A, 2007, AIDS PATIENT CARE ST, V21, P458, DOI 10.1089/apc.2006.0142; BOYD JH, 1982, ARCH GEN PSYCHIAT, V39, P1195; Brown JL, AIDS CARE; Burkhalter JE, 2005, NICOTINE TOB RES, V7, P511, DOI 10.1080/14622200500186064; Caponnetto P, 2008, RESP MED, V102, P1182, DOI 10.1016/j.rmed.2008.02.017; Chishinga N, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-75; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Cropsey KL, J ADDICTION MED JID; de Meneses-Gaya IC, 2009, J BRAS PNEUMOL, V35, P73, DOI 10.1590/S1806-37132009000100011; Feldman JG, 2006, AM J PUBLIC HEALTH, V96, P1060, DOI 10.2105/AJPH.2005.062745; Fleishman JA, 2000, AM J COMMUN PSYCHOL, V28, P421, DOI 10.1023/A:1005132430171; Gfroerer J, 2013, MORB MORTAL WEEKLY R, V62; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; Hymowitz N, 1997, Tob Control, V6 Suppl 2, pS57, DOI 10.1136/tc.6.suppl_2.S57; Institute for Health Metrics and Evaluation, 2016, TOB BURD VIS; Janus E, 1996, HONG KONG CARDIOVASC; Kaleta D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2537-0; Khaled SM, 2011, NICOTINE TOB RES, V13, P1059, DOI 10.1093/ntr/ntr157; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Le Cook B, 2014, JAMA-J AM MED ASSOC, V311, P172, DOI 10.1001/jama.2013.284985; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Lunze K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-64; Ministry of Health, FED RES CTR HIV AIDS; Munafo MR, 2010, BRIT J PSYCHIAT, V196, P425, DOI 10.1192/bjp.bp.109.074880; National Institute on Drug Abuse, 2013, HIV HCV STI TEST STA; National Institute on Drug Abuse, FAG SCOR; National Institute on Drug Abuse, WHY DO DRUG US DIS O; NEEDLE R, 1995, PSYCHOL ADDICT BEHAV, V9, P242, DOI 10.1037/0893-164X.9.4.242; OECD, 2016, EC ENV SOC STAT; Ompad DC, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-375; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X; Reynolds NR, 2009, AIDS EDUC PREV, V21, P106, DOI 10.1521/aeap.2009.21.3_supp.106; Roberts B, 2013, NICOTINE TOB RES, V15, P271, DOI 10.1093/ntr/nts100; Ross H, 2008, EC TOBACCO TAXATION, P4; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350; So-Armah K, 2017, 2017 C RETR OPP INF; Tyndale RF, 2001, DRUG METAB DISPOS, V29, P548; UNAIDS, 2008, REP GLOB AIDS EP; WEATHERBY NL, 1994, EVAL PROGRAM PLANN, V17, P347, DOI 10.1016/0149-7189(94)90035-3; Webb MS, 2007, J BEHAV MED, V30, P371, DOI 10.1007/s10865-007-9112-9; WHO, 2016, TOB FREE IN TAX; World Health Organization (WHO), 2005, WHO FRAM CONV TOB CO; Zhou J., 2007, PREV CHRONIC DIS, V7, pA15; ZICH JM, 1990, INT J PSYCHIAT MED, V20, P259, DOI 10.2190/LYKR-7VHP-YJEM-MKM2	49	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0189207	10.1371/journal.pone.0189207	http://dx.doi.org/10.1371/journal.pone.0189207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	29408935	gold, Green Published, Green Submitted			2022-12-26	WOS:000424302800003
J	Bougaret, L; Delort, L; Billard, H; Le Huede, C; Boby, C; De la Foye, A; Rossary, A; Mojallal, A; Damour, O; Auxenfans, C; Vasson, MP; Caldefie-Chezet, F				Bougaret, Lauriane; Delort, Laetitia; Billard, Hermine; Le Huede, Camille; Boby, Celine; De la Foye, Anne; Rossary, Adrien; Mojallal, Ali; Damour, Odile; Auxenfans, Celine; Vasson, Marie Paule; Caldefie-Chezet, Florence			Adipocyte/breast cancer cell crosstalk in obesity interferes with the anti-proliferative efficacy of tamoxifen	PLOS ONE			English	Article							BODY-MASS-INDEX; NECROSIS-FACTOR-ALPHA; BREAST-CANCER; ADIPOSE-TISSUE; WOMEN; DIFFERENTIATION; PREADIPOCYTES; MORTALITY; MIGRATION; PROMOTE	Background Obesity is a well-known risk factor of breast cancer in post-menopausal women that also correlates with a diminished therapeutic response. The influence of adipocytes and their secretome, i.e. adipokines, on the efficacy of hormone therapy has yet to be elucidated. Methods We investigated, ex vivo, whether mature adipocytes, differentiated from adipose stem cells of normal-weight (MA20) or obese (MA30) women, and their secretions, were able to counteract the effects of tamoxifen (Tx) which is known to decrease neoplastic cell proliferation. Results In a tridimensional model and in a model of co-culture, the anti-proliferative effect of Tx on MCF-7 cancer cells was counteracted by MA30. These two models highlighted two different specific gene expression profiles for genes encoding cytokines or involved in angiogenesis based on the adipocyte microenvironment and the treatment. Thus it notably showed altered expression of genes such as TNF alpha that correlated with IL-6. In addition, leptin, IL-6 and TNF alpha, at concentrations reflecting plasma concentrations in obese patients, decreased the anti-proliferative efficacy of 4-hydroxytamoxifen (a major active metabolite of Tx). Conclusions These findings bring insights on adipocytes and mammary cancer cell interactions in Tx therapy, particularly in overweight/obese people. Indeed, patient' adipokine status would give valuable information for developing individual strategies and avoid resistance to treatment.	[Bougaret, Lauriane; Delort, Laetitia; Billard, Hermine; Rossary, Adrien; Vasson, Marie Paule; Caldefie-Chezet, Florence] Univ Clermont Auvergne, INRA, UNH, CRNH Auvergne, F-63000 Clermont Ferrand, France; [Le Huede, Camille; Damour, Odile; Auxenfans, Celine] Hop Edouard Herriot, Banque Tissus & Cellules, Lyon, France; [Boby, Celine; De la Foye, Anne] Plate Forme Explorat Metab Composante Transcripto, Site Theix, St Genes Champanelle, France; [Mojallal, Ali] Hop Edouard Herriot, Serv Chirurg Plast Reconstruct & Esthet, Lyon, France; [Vasson, Marie Paule] Ctr Anticanc Jean Perrin, Clermont Ferrand, France; [Vasson, Marie Paule; Caldefie-Chezet, Florence] CLARA, Lyon, France	INRAE; Universite Clermont Auvergne (UCA); CHU Lyon; CHU Lyon; UNICANCER; Centre Jean Perrin	Delort, L (corresponding author), Univ Clermont Auvergne, INRA, UNH, CRNH Auvergne, F-63000 Clermont Ferrand, France.	laetitia.delort@uca.fr	FLORENCE, CALDEFIE-CHEZET FCC/U-3378-2018; vasson, marie-paule/ABA-2486-2021	rossary, adrien/0000-0001-8311-2419; BOBY, Celine/0000-0002-4420-7033	Canceropole Lyon Auvergne Rhone-Alpes (Oncostarter); Institut National du Cancer (Mammadipo, INCA) [6666]; league of cancer research [CD63]; Ministry of Research and Technology	Canceropole Lyon Auvergne Rhone-Alpes (Oncostarter); Institut National du Cancer (Mammadipo, INCA)(Institut National du Cancer (INCA) France); league of cancer research; Ministry of Research and Technology(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	This study received financial support from the Canceropole Lyon Auvergne Rhone-Alpes (Oncostarter 2012), from the Institut National du Cancer (Mammadipo 2013, INCA no 6666) and from the league of cancer research (CD63). Lauriane Bougaret is supported by a fellowship from the Ministry of Research and Technology.	Biglia N, 2013, GYNECOL ENDOCRINOL, V29, P263, DOI 10.3109/09513590.2012.736559; BJORNTORP P, 1991, INT J OBESITY, V15, P67; Bochet L, 2011, BIOCHEM BIOPH RES CO, V411, P102, DOI 10.1016/j.bbrc.2011.06.101; Bougoulia Maria, 2006, Hormones (Athens), V5, P192; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Carter JC, 2012, EXP MOL PATHOL, V92, P312, DOI 10.1016/j.yexmp.2012.03.005; Chen DR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/532161; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Dandona P, 1998, J CLIN ENDOCR METAB, V83, P2907, DOI 10.1210/jc.83.8.2907; Delort L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066284; Dubois V, 2010, ANTICANCER RES, V30, P2919; Dubois V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058541; Ewertz M, 2011, J CLIN ONCOL, V29, P25, DOI 10.1200/JCO.2010.29.7614; FARGIN A, 1988, CHEM-BIOL INTERACT, V66, P101, DOI 10.1016/0009-2797(88)90044-0; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; Gundimeda U, 1996, J BIOL CHEM, V271, P13504, DOI 10.1074/jbc.271.23.13504; Harvie M, 2003, Obes Rev, V4, P157, DOI 10.1046/j.1467-789X.2003.00108.x; Jarde T, 2008, HISTOPATHOLOGY, V53, P484, DOI 10.1111/j.1365-2559.2008.03121.x; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Kyselova Z, 2008, CLIN CHEM, V54, P1166, DOI 10.1373/clinchem.2007.087148; Lahmann PH, 2004, INT J CANCER, V111, P762, DOI 10.1002/ijc.20315; Lequeux C, 2009, BIO-MED MATER ENG, V19, P283, DOI 10.3233/BME-2009-0593; Litton JK, 2008, J CLIN ONCOL, V26, P4072, DOI 10.1200/JCO.2007.14.4527; Lorincz AM, 2006, ENDOCR-RELAT CANCER, V13, P279, DOI 10.1677/erc.1.00729; Maehle BO, 1996, BREAST CANCER RES TR, V41, P123, DOI 10.1007/BF01807157; Manabe Y, 2003, J PATHOL, V201, P221, DOI 10.1002/path.1430; Marttunen MB, 2000, MATURITAS, V35, P175, DOI 10.1016/S0378-5122(00)00121-3; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Melen-Mucha Gabriela, 2007, Endokrynol Pol, V58, P2; Mojallal A, 2008, BIO-MED MATER ENG, V18, P193, DOI 10.3233/BME-2008-0524; Ozet A, 2001, JPN J CLIN ONCOL, V31, P424, DOI 10.1093/jjco/hye097; Petrelli JM, 2002, CANCER CAUSE CONTROL, V13, P325, DOI 10.1023/A:1015288615472; Creydt VP, 2010, MOL MED REP, V3, P433, DOI 10.3892/mmr_00000276; Salameh TS, 2013, INT J CANCER, V132, P288, DOI 10.1002/ijc.27672; Schonherr A, 2012, BREAST CARE, V7, P289, DOI 10.1159/000341384; Stephenson GD, 2003, NUTR CANCER, V45, P1, DOI 10.1207/S15327914NC4501_1; Strong AL, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3569; Thivat E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-648; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130	39	40	41	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191571	10.1371/journal.pone.0191571	http://dx.doi.org/10.1371/journal.pone.0191571			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389973	Green Published, gold, Green Submitted			2022-12-26	WOS:000423793400023
J	Cai, T; Qi, YJ; Jergens, A; Wannemuehler, M; Barrett, TA; Wang, Q				Cai, Tenson; Qi, Yijun; Jergens, Albert; Wannemuehler, Michael; Barrett, Terrence A.; Wang, Qun			Effects of six common dietary nutrients on murine intestinal organoid growth	PLOS ONE			English	Article							CRYPT-VILLUS AXIS; EPITHELIAL-CELLS; CHLOROGENIC ACID; CAFFEIC ACID; STEM-CELLS; EXPRESSION; CURCUMIN; PROLIFERATION; BIOSYNTHESIS; MECHANISM	The intestinal epithelium of the gastrointestinal (GI) tract constantly renews itself to absorb nutrients and provide protection for the body from the outside world. Since the intestinal epithelium is constantly exposed to various chemicals and dietary components, it is critical to determine which constituents promote or inhibit intestinal epithelium health and growth rate. Intestinal organoids, three-dimensional miniature models of the intestines, represent an ex vivo tool to investigate intestinal physiology and growth patterns. In this study, we measured the growth rates of murine intestinal organoids exposed to various concentrations of different dietary constituents. Results indicate that caffeic acid inhibited organoid growth in a concentration-dependent manner, curcumin exhibited variable effectiveness, and vitamin C had no effect on organoid growth.	[Cai, Tenson; Qi, Yijun; Wang, Qun] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA; [Cai, Tenson] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Jergens, Albert] Iowa State Univ, Dept Vet Clin Sci, Ames, IA USA; [Wannemuehler, Michael] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA USA; [Barrett, Terrence A.] Univ Kentucky, Dept Internal Med, Div Gastroenterol, Lexington, KY USA	Iowa State University; Case Western Reserve University; Iowa State University; Iowa State University; University of Kentucky	Wang, Q (corresponding author), Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA.	qunwang@iastate.edu	Qi, Yijun/M-7651-2019	Barrett, Terrence/0000-0001-6428-3271; Wang, Qun/0000-0002-5660-5602	Crohn's & Colitis Foundation of America (CCFA) Career Award [348137]; National Science Foundation [EEC 1560012]; PhRMA Foundation Research Starter Award [RSGTMT17]; McGee-Wagner Interdisciplinary Research Foundation; NIH grant [R01DK095662]; VA Merit grant [I01CX001353]	Crohn's & Colitis Foundation of America (CCFA) Career Award; National Science Foundation(National Science Foundation (NSF)); PhRMA Foundation Research Starter Award; McGee-Wagner Interdisciplinary Research Foundation; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit grant	Dr. Wang is grateful for the support from Crohn's & Colitis Foundation of America (CCFA) Career Award (No. 348137), National Science Foundation (No. EEC 1560012), PhRMA Foundation Research Starter Award (No. RSGTMT17), and McGee-Wagner Interdisciplinary Research Foundation. The research was also supported (TAB) by NIH (R01DK095662) and VA Merit (I01CX001353) grants.	Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x; Dhandapani KM, 2007, J NEUROCHEM, V102, P522, DOI 10.1111/j.1471-4159.2007.04633.x; Duda-Chodak A, 2009, ACTA SCI POLON-TECHN, V8, P63; Feng ZM, 2015, APPL PHYSIOL NUTR ME, V40, DOI 10.1139/apnm-2014-0434; Fong D, 2010, CANCER LETT, V293, P65, DOI 10.1016/j.canlet.2009.12.018; HULSE JD, 1978, J BIOL CHEM, V253, P1654; Hynds RE, 2013, STEM CELLS, V31, P417, DOI 10.1002/stem.1290; Kakarala M, 2010, BREAST CANCER RES TR, V122, P777, DOI 10.1007/s10549-009-0612-x; Konishi Y, 2004, J AGR FOOD CHEM, V52, P6418, DOI 10.1021/jf049560y; Leushacke M, 2014, GUT, V63, P1345, DOI 10.1136/gutjnl-2014-307204; Liu DW, 2013, J BREAST CANCER, V16, P133, DOI 10.4048/jbc.2013.16.2.133; Lu R, 2017, ALCOHOL CLIN EXP RES, V41, P727, DOI 10.1111/acer.13351; MacDonald L, 2002, BRIT J NUTR, V87, P97, DOI 10.1079/BJN2001492; Naidu K., 2003, J NUTR, V2, P1; Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66; Peng HS, 2015, ACS BIOMATER SCI ENG, V1, P37, DOI 10.1021/ab500041d; Peng HS, 2015, NANOSCALE, V7, P4354, DOI 10.1039/c4nr06377e; Prasad NR, 2011, MOL CELL BIOCHEM, V349, P11, DOI 10.1007/s11010-010-0655-7; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Seib PA, 1982, 180 ACS NAT M LAS VE; Shibata H, 1999, BIOSCI BIOTECH BIOCH, V63, P1295, DOI 10.1271/bbb.63.1295; Syng-ai C, 2004, MOL CANCER THER, V3, P1101; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; Tang YL, 2015, FREE RADICAL BIO MED, V89, P944, DOI 10.1016/j.freeradbiomed.2015.09.012; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wang Q, 2015, ADV DRUG DELIVER REV, V91, P125, DOI 10.1016/j.addr.2014.12.003; Xiong X, 2016, FRONT BIOSCI-LANDMRK, V21, P343, DOI 10.2741/4392; Xiong X, 2015, AM J PHYSIOL-GASTR L, V309, pG229, DOI 10.1152/ajpgi.00095.2015; Yang HS, 2016, SCI REP-UK, V6, DOI 10.1038/srep36939	30	15	16	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191517	10.1371/journal.pone.0191517	http://dx.doi.org/10.1371/journal.pone.0191517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389993	Green Published, Green Submitted, gold			2022-12-26	WOS:000423793400022
J	Mork-Jansson, AE; Eichacker, LA				Mork-Jansson, Astrid Elisabeth; Eichacker, Lutz Andreas			Characterization of chlorophyll binding to LIL3	PLOS ONE			English	Article							DYNAMIC LIGHT-SCATTERING; HARVESTING COMPLEXES; MEMBRANE-PROTEIN; RECONSTITUTION; AGGREGATION; SURFACTANTS	The light harvesting like protein 3 (LIL 3) from higher plants, has been linked to functions in chlorophyll and tocopherol biosynthesis, photo-protection and chlorophyll transfer. However, the binding of chlorophyll to LIL3 is unclear. We present a reconstitution protocol for chlorophyll binding to LIL3 in DDM micelles. It is shown in the absence of lipids and carotenoids that reconstitution of chlorophyll binding to in vitro expressed LIL3 requires pre-incubation of reaction partners at room temperature. We show chlorophyll a but not chlorophyll b binding to LIL3 at a molar ratio of 1:1. Neither dynamic light scattering nor native PAGE, enabled a discrimination between binding of chlorophyll a and/or b to LIL3.	[Mork-Jansson, Astrid Elisabeth; Eichacker, Lutz Andreas] Univ Stavanger, Fac Sci & Technol, Ctr Organelle Res, Stavanger, Norway	Universitetet i Stavanger	Eichacker, LA (corresponding author), Univ Stavanger, Fac Sci & Technol, Ctr Organelle Res, Stavanger, Norway.	lutz.eichacker@uis.no		Mork-Jansson, Astrid Elisabeth/0000-0003-1525-2270	Norwegian research council [NFR 240770]	Norwegian research council(Research Council of NorwayEuropean Commission)	We are grateful for research funding received from the Norwegian research council NFR 240770. NFR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We like to thank H. Paulsen for the Lhcb_pXLHCP plasmid. Financial Disclosure: We are grateful for research funding received from the Norwegian research council NFR 240770. NFR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aivaliotis M, 2003, BBA-BIOMEMBRANES, V1615, P69, DOI 10.1016/S0005-2736(03)00208-6; Ballottari M, 2012, BBA-BIOENERGETICS, V1817, P143, DOI 10.1016/j.bbabio.2011.06.005; CAMMARATA KV, 1992, BIOCHEMISTRY-US, V31, P2779, DOI 10.1021/bi00125a019; Chidgey JW, 2014, PLANT CELL, V26, P1267, DOI 10.1105/tpc.114.124495; Dahani M, 2015, ACTA CRYSTALLOGR F, V71, P838, DOI 10.1107/S2053230X15009516; Engelken J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-233; Ghosh S, 2013, LANGMUIR, V29, P10066, DOI 10.1021/la402053a; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; HANSEN PC, 1993, SIAM J SCI COMPUT, V14, P1487, DOI 10.1137/0914086; Hassan PA, 2015, LANGMUIR, V31, P3, DOI 10.1021/la501789z; Hey D, 2017, PLANT PHYSIOL, V174, P1037, DOI 10.1104/pp.17.00505; Hoober JK, 2007, PHOTOSYNTH RES, V94, P387, DOI 10.1007/s11120-007-9181-1; Hoober JK, 1999, PHOTOSYNTH RES, V61, P197; Hutchison JM, 2017, BIOCHEMISTRY-US, V56, P5481, DOI 10.1021/acs.biochem.7b00810; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; JANSSON S, 1994, BBA-BIOENERGETICS, V1184, P1, DOI 10.1016/0005-2728(94)90148-1; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Lawson CL, 1995, APPL MATH; Lewis EN, 2014, MOLECULES, V19, P20888, DOI 10.3390/molecules191220888; Martins AF, 2015, CHEM-EUR J, V21, P5413, DOI 10.1002/chem.201406152; MICHEL H, 1986, EMBO J, V5, P2445, DOI 10.1002/j.1460-2075.1986.tb04520.x; Mork-Jansson A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133145; Mork-Jansson AE, 2015, FEBS LETT, V589, P3064, DOI 10.1016/j.febslet.2015.08.023; Neves P, 2009, J PHARMACEUT BIOMED, V49, P276, DOI 10.1016/j.jpba.2008.11.026; Niedzwiedzki DM, 2016, BBA-BIOENERGETICS, V1857, P1430, DOI 10.1016/j.bbabio.2016.04.280; Ouameur AA, 2005, BIOPOLYMERS, V77, P129, DOI 10.1002/bip.20173; PAULSEN H, 1990, PLANTA, V181, P204, DOI 10.1007/BF02411539; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; Reisinger V, 2008, FEBS LETT, V582, P1547, DOI 10.1016/j.febslet.2008.03.042; Ruf H, 2000, PROG COLL POL SCI S, V115, P255; Standardization IO, 2017, INT ORGAN, P34; Stromland O, 2017, DATA BRIEF, V12, P113, DOI 10.1016/j.dib.2017.03.014; Takahashi K, 2014, J BIOL CHEM, V289, P987, DOI 10.1074/jbc.M113.525428; Tanaka R, 2010, P NATL ACAD SCI USA, V107, P16721, DOI 10.1073/pnas.1004699107; Twomey S., 1977, INTRODUCTION TO THE; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; WU MX, 1990, ARCH BIOCHEM BIOPHYS, V281, P324, DOI 10.1016/0003-9861(90)90451-4; Zhou YC, 2013, P IEEE INT C E-SCI, P9, DOI 10.1109/eScience.2013.12	39	9	9	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192228	10.1371/journal.pone.0192228	http://dx.doi.org/10.1371/journal.pone.0192228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390011	Green Published, Green Submitted, gold			2022-12-26	WOS:000423793400077
J	Yebra, G; Frampton, D; Cassarino, TG; Raffle, J; Hubb, J; Ferns, RB; Waters, L; Tong, CYW; Kozlakidis, Z; Hayward, A; Kellam, P; Pillay, D; Clark, D; Nastouli, E; Brown, AJL				Yebra, Gonzalo; Frampton, Dan; Cassarino, Tiziano Gallo; Raffle, Jade; Hubb, Jonathan; Ferns, R. Bridget; Waters, Laura; Tong, C. Y. William; Kozlakidis, Zisis; Hayward, Andrew; Kellam, Paul; Pillay, Deenan; Clark, Duncan; Nastouli, Eleni; Brown, Andrew J. Leigh		ICONIC Consortium	A high HIV-1 strain variability in London, UK, revealed by full-genome analysis: Results from the ICONIC project	PLOS ONE			English	Article							NON-B SUBTYPES; GENETIC DIVERSITY; RECOMBINANT FORM; DRUG-RESISTANCE; TYPE-1; IDENTIFICATION; RELIABILITY; COMPLEX; COHORT; SPAIN	Background & methods The ICONIC project has developed an automated high-throughput pipeline to generate HIV nearly full-length genomes (NFLG, i.e. from gag to nef) from next-generation sequencing (NGS) data. The pipeline was applied to 420 HIV samples collected at University College London Hospitals NHS Trust and Barts Health NHS Trust (London) and sequenced using an Illumina MiSeq at the Wellcome Trust Sanger Institute (Cambridge). Consensus genomes were generated and subtyped using COMET, and unique recombinants were studied with jpHMM and SimPlot. Maximum-likelihood phylogenetic trees were constructed using RAxML to identify transmission networks using the Cluster Picker. Results The pipeline generated sequences of at least 1Kb of length (median = 7.46Kb, IQR = 4.01Kb) for 375 out of the 420 samples (89%), with 174 (46.4%) being NFLG. A total of 365 sequences (169 of them NFLG) corresponded to unique subjects and were included in the down-stream analyses. The most frequent HIV subtypes were B (n = 149, 40.8%) and C (n = 77, 21.1%) and the circulating recombinant form CRF02_AG (n = 32, 8.8%). We found 14 different CRFs (n = 66, 18.1%) and multiple URFs (n = 32, 8.8%) that involved recombination between 12 different subtypes/CRFs. The most frequent URFs were B/CRF01_AE (4 cases) and A1/D, B/C, and B/CRF02_AG (3 cases each). Most URFs (19/26, 73%) lacked breakpoints in the PR+RT pol region, rendering them undetectable if only that was sequenced. Twelve (37.5%) of the URFs could have emerged within the UK, whereas the rest were probably imported from sub-Saharan Africa, South East Asia and South America. For 2 URFs we found highly similar pol sequences circulating in the UK. We detected 31 phylogenetic clusters using the full dataset: 25 pairs (mostly subtypes B and C), 4 triplets and 2 quadruplets. Some of these were not consistent across different genes due to interand intra-subtype recombination. Clusters involved 70 sequences, 19.2% of the dataset. Conclusions The initial analysis of genome sequences detected substantial hidden variability in the London HIV epidemic. Analysing full genome sequences, as opposed to only PR+RT, identified previously undetected recombinants. It provided a more reliable description of CRFs (that would be otherwise misclassified) and transmission clusters.	[Yebra, Gonzalo; Brown, Andrew J. Leigh] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Frampton, Dan; Cassarino, Tiziano Gallo; Raffle, Jade; Kozlakidis, Zisis; Pillay, Deenan] Fac Med Sci, UCL Div Infect & Immun, London, England; [Raffle, Jade; Ferns, R. Bridget; Nastouli, Eleni] UCL Hosp NHS Fdn Trust, Dept Clin Virol, London, England; [Hubb, Jonathan; Tong, C. Y. William; Clark, Duncan] Barts Hlth NHS Trust, Dept Virol, London, England; [Ferns, R. Bridget] NIHR UCLH UCL Biomed Res Ctr, London, England; [Waters, Laura] Cent & North West London NHS Trust, Dept HIV Med, Mortimer Market Ctr, London, England; [Tong, C. Y. William] Queen Mary Univ, London, England; [Kozlakidis, Zisis] Farr Inst Hlth Informat Res, UCL Inst Dis Informat, London, England; [Hayward, Andrew] UCL Inst Epidemiol & Hlth Care, London, England; [Kellam, Paul] Imperial Coll London, Div Infect Dis, Dept Med, London, England; [Clark, Duncan] Univ Glasgow, Sch Life Sci, Glasgow, Lanark, Scotland; [Nastouli, Eleni] UCL GOS Inst Child Hlth, Dept Populat Policy & Practice, London, England	University of Edinburgh; University of London; University College London; University of London; University College London; Barts Health NHS Trust; University of London; University College London; University of London; Queen Mary University London; University of London; University College London; University of London; University College London; Imperial College London; University of Glasgow; University of London; University College London	Yebra, G (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	Gonzalo.Yebra@ed.ac.uk	Cassarino, Tiziano Gallo/AAM-2845-2020; Leigh Brown, Andrew/F-3802-2010; Tong, Cheuk Yan William/C-1312-2012; Kozlakidis, Zisis/AAX-8081-2020; Brown, Andrew Leigh/ABF-8269-2020	Cassarino, Tiziano Gallo/0000-0001-9220-2360; Leigh Brown, Andrew/0000-0002-5700-3128; Tong, Cheuk Yan William/0000-0001-8401-6832; Kozlakidis, Zisis/0000-0002-3836-7209; Brown, Andrew Leigh/0000-0002-5700-3128; Yebra, Gonzalo/0000-0002-3472-3667; Kellam, Paul/0000-0003-3166-4734	ICONIC project (Department of Health) [T5-344]; ICONIC project (Wellcome Trust) [T5-344]	ICONIC project (Department of Health); ICONIC project (Wellcome Trust)	This work was supported by the ICONIC project (supported by the Health Innovation Challenge Fund T5-344, a parallel funding partnership between the Department of Health and Wellcome Trust).; We would like to thank the clinicians and scientists at University College London Hospital and Barts Health NHS Trust. We would also like to thank Dr Anna Tostevin (UCL Research Department of Infection and Population Health) for her help with the analysis of the UK HIV Drug Resistance Database sequences and Dr Astrid Gall (University of Cambridge) for her initial guidance on the HIV whole genome sequencing methods. This work was supported by the ICONIC project (supported by the Health Innovation Challenge Fund T5-344, a parallel funding partnership between the Department of Health and Wellcome Trust). The views expressed in this publication are those of the authors and not necessarily those of their funders and employees. The members of the ICONIC Consortium are Dr A. Oliver, Dr C.Y.W. Tong, Dr D. Clark (Barts Health NHS Trust), Dr E. Nastouli (UCL Hospital NHS Foundation Trust), Prof A. Johnson, Prof D. Dunn, Prof A. Hayward, Prof D. Pillay, Prof S. Morris, Dr Z. Kozlakidis (UCL), Prof P. Kellam (Imperial College London), Prof J. Edgeworth (Guy's and St. Thomas' NHS foundation Trust) and Prof A.J. Leigh Brown (University of Edinburgh).	Beloukas A, 2016, INFECT GENET EVOL, V46, P180, DOI 10.1016/j.meegid.2016.06.033; Brenner BG, 2011, J MED VIROL, V83, P751, DOI 10.1002/jmv.22047; De Candia C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-259; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Dunn D, 2014, AIDS, V28, P773, DOI 10.1097/QAD.0000000000000119; Fernandez-Garcia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148549; Fernandez-Garcia A, 2010, AIDS RES HUM RETROV, V26, P827, DOI 10.1089/aid.2009.0311; Foster GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083337; Galimand J, 2010, AIDS RES HUM RETROV, V26, P645, DOI 10.1089/aid.2009.0201; Gall A., 2014, GENOME ANNOUNC, V2; Gall A, 2012, J CLIN MICROBIOL, V50, P3838, DOI 10.1128/JCM.01516-12; Gallo Cassarino T, 2016, BIORXIV; Hemelaar J, 2013, J INFECTION, V66, P391, DOI 10.1016/j.jinf.2012.10.026; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Holguin A, 2008, J MED VIROL, V80, P383, DOI 10.1002/jmv.21105; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Kaleebu P, 2007, JAIDS-J ACQ IMM DEF, V45, P28, DOI 10.1097/QAI.0b013e3180385aa0; Kiwelu IE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071131; LANL, 2017, LOS AL HIV DAT; LANL, 2017, HIV CIRC REC FORMS C; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mackie NE, 2013, AIDS, V27, P2245, DOI 10.1097/QAD.0b013e3283636179; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Martinez-Cajas JL, 2008, AIDS REV, V10, P212; Moradigaravand D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004439; Moutouh L, 1996, P NATL ACAD SCI USA, V93, P6106, DOI 10.1073/pnas.93.12.6106; Pai NP, 2012, JAIDS-J ACQ IMM DEF, V59, P382, DOI 10.1097/QAI.0b013e31824a0628; Peeters M, 2010, CLIN MICROBIOL INFEC, V16, P1525, DOI 10.1111/j.1469-0691.2010.03300.x; Public Health England (PHE), 2017, HIV UK DECL NEW HIV; Ramirez BC, 2008, VIRUS RES, V134, P64, DOI 10.1016/j.virusres.2008.01.007; Ratmann O, 2017, AIDS RES HUM RETROVI; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Simonetti FR, 2014, INFECT GENET EVOL, V23, P176, DOI 10.1016/j.meegid.2014.02.007; Streeck H, 2008, J EXP MED, V205, P1789, DOI 10.1084/jem.20080281; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Zhao JQ, 2010, AIDS RES HUM RETROV, V26, P1033, DOI 10.1089/aid.2009.0197; Zhuang JL, 2002, J VIROL, V76, P11273, DOI 10.1128/JVI.76.22.11273-11282.2002; 2013, AIDS, V27, P2309, DOI DOI 10.1097/QAD.0B013E3283632E0C	40	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192081	10.1371/journal.pone.0192081	http://dx.doi.org/10.1371/journal.pone.0192081			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389981	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000423793400064
J	Mondal, T; Bag, I; Pushpavalli, SNCVL; Garikapati, KR; Bhadra, U; Bhadra, MP				Mondal, Tanmoy; Bag, Indira; Pushpavalli, S. N. C. V. L.; Garikapati, Koteswara Rao; Bhadra, Utpal; Bhadra, Manika Pal			Two way controls of apoptotic regulators consign DmArgonaute-1 a better clasp on it	PLOS ONE			English	Article							N-TERMINAL KINASE; DROSOPHILA CASPASE DRONC; CELL-DEATH; SIGNAL-TRANSDUCTION; JNK ACTIVATION; MICRORNAS; HID; DIAP1; GENE; ARGONAUTE1	Argonaute family proteins are well conserved among all organisms. Its role in mitotic cell cycle progression and apoptotic cell elimination is poorly understood. Earlier we have established the contribution of Ago-1 in cell cycle control related to G2/M cyclin in Drosophila. Here we have extended our study in understanding the relationship of Ago-1 in regulating apoptosis during Drosophila development. Apoptosis play a critical role in controlling organ shape and size during development of multi cellular organism. Multifarious regulatory pathways control apoptosis during development among which highly conserved JNK (c-Jun N-terminal kinase) pathway play a crucial role. Here we have over expressed Ago-1 in Drosophila eye and brain by employing UAS (upstream activation sequence)-GAL4 system under the expression of eye and brain specific driver. Over expression of Ago-1 resulted in reduced number of ommatidia in the eye and produced smaller size brain in adult and larval Drosophila. A drastic reversal of the phenotype towards normal was observed upon introduction of a single copy of the dominant negative mutation of basket (bsk, Drosophila homolog of JNK) indicating an active and physical involvement of the bsk with Ago-1 in inducing developmental apoptotic process. Further study showed that Ago-1 stimulates phosphorylation of JNK through transforming growth factor-beta activated kinase 1-hemipterous (Tak1-hep) axis of JNK pathway. JNK phosphorylation results in up regulation of pro-apoptotic genes head involution defective (hid), grim & reaper (rpr) and induces activation of Drosophila caspases (cysteinyl aspartate proteinases); DRONC (Death regulator Nedd2-like caspase), ICE (alternatively Drice, Death related ICE-like caspase) and DCP1 (Death caspase1) by inhibiting apoptotic inhibitor protein DIAP1 (Death-associated inhibitor of apoptosis 1). Further, Ago-1 also inhibits miR-14 expression to trigger apoptosis. Our findings propose that Ago-1 acts as a key regulator in controlling cell death, tumor regression and stress response in metazoan providing a constructive bridge between RNAi machinery and cell death.	[Mondal, Tanmoy; Bag, Indira; Pushpavalli, S. N. C. V. L.; Garikapati, Koteswara Rao; Bhadra, Manika Pal] Indian Inst Chem Technol, CSIR, Dept Biol Chem, Hyderabad, Telangana State, India; [Mondal, Tanmoy; Bhadra, Manika Pal] Acad Sci & Innovat Res AcSIR, CSIR IICT Campus, Hyderabad, Andhra Pradesh, India; [Bhadra, Utpal] Ctr Cellular & Mol Biol, CSIR, Gene Silencing & Funct Genom Grp, Uppal Rd, Hyderabad, Telangana State, India; [Pushpavalli, S. N. C. V. L.] ARS Tandur, Ranga Reddy, Telangana State, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Bhadra, MP (corresponding author), Indian Inst Chem Technol, CSIR, Dept Biol Chem, Hyderabad, Telangana State, India.; Bhadra, MP (corresponding author), Acad Sci & Innovat Res AcSIR, CSIR IICT Campus, Hyderabad, Andhra Pradesh, India.	manikapb@gmail.com	GARIKAPATI, KOTESWARA RAO/L-4416-2014; MONDAL, TANMOY/Q-3302-2018	GARIKAPATI, KOTESWARA RAO/0000-0002-1189-3356; MONDAL, TANMOY/0000-0003-1996-1226; bhadra, manika pal/0000-0002-3740-5031	Department of Biotechnology, Ministry of Science & Technology, India [GAP 0362]; Council of Scientific and Industrial Research (CSIR), India	Department of Biotechnology, Ministry of Science & Technology, India; Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	The work was supported by grants from Department of Biotechnology, Ministry of Science & Technology, India (GAP 0362 to MPB). T.M. thanks Council of Scientific and Industrial Research (CSIR), India for granting him fellowship during the course of study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Nicolas Tapon and Dr. Monika Hediger for UAS-puc fly stock, Dr. Julian Ng for anti hep antibody, Dr. Eric Lai for Ago-1<SUP>k08121</SUP>fly stock, Dr. T. Uemura for P{hs-Ago1} fly. We acknowledge Genotypic Technology Private Limited, Bangalore for the help in microarray processing and data analysis. T.M. thanks Council of Scientific and Industrial Research (CSIR), India for granting him fellowship during the course of study. All the authors thank P. Devender and Narasimha for maintaining the Drosophila facility and Y. Suresh for FAGS.	Adams BD, 2014, CURR BIOL, V24, pR762, DOI 10.1016/j.cub.2014.06.043; Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Berthelet Jean, 2013, Cells, V2, P163, DOI 10.3390/cells2010163; Catalanotto C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101712; Cha GH, 2003, MOL CELL BIOL, V23, P7982, DOI 10.1128/MCB.23.22.7982-7991.2003; D'Brot A, 2013, GENE DEV, V27, P1650, DOI 10.1101/gad.219287.113; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Fan Y, 2010, CELL DEATH DIFFER, V17, P534, DOI 10.1038/cdd.2009.185; Fraser AG, 1997, EMBO J, V16, P6192, DOI 10.1093/emboj/16.20.6192; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hawkins CJ, 2000, J BIOL CHEM, V275, P27084; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Igaki T, 2009, APOPTOSIS, V14, P1021, DOI 10.1007/s10495-009-0361-7; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Kuranaga E, 2002, NAT CELL BIOL, V4, P705, DOI 10.1038/ncb842; Lin AN, 2002, AGING CELL, V1, P112, DOI 10.1046/j.1474-9728.2002.00014.x; Lin RJ, 2010, CANCER RES, V70, P7841, DOI 10.1158/0008-5472.CAN-10-0970; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Ma X, 2014, CELL DEATH DIFFER, V21, P407, DOI 10.1038/cdd.2013.154; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Nelson C, 2014, MOL CELL, V56, P376, DOI 10.1016/j.molcel.2014.09.011; NUSSLEINVOLHARD C, 1994, SCIENCE, V266, P572, DOI 10.1126/science.7939708; Perez-Garijo A, 2015, DEVELOPMENT, V142, P3253, DOI 10.1242/dev.127878; Pushpavalli SNCVL, 2014, FASEB J, V28, P655, DOI 10.1096/fj.13-231167; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Shin JH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01561; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Takatsu Y, 2000, MOL CELL BIOL, V20, P3015, DOI 10.1128/MCB.20.9.3015-3026.2000; Teng DHF, 1997, CANCER RES, V57, P4177; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; Xu DB, 2009, FLY, V3, P78, DOI 10.4161/fly.3.1.7800; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Xue L, 2007, DEV CELL, V13, P446, DOI 10.1016/j.devcel.2007.07.012; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Yoshida S, 2001, J HUM GENET, V46, P182, DOI 10.1007/s100380170086	50	4	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0190548	10.1371/journal.pone.0190548	http://dx.doi.org/10.1371/journal.pone.0190548			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385168	Green Published, Green Submitted, gold			2022-12-26	WOS:000423668400019
J	Zhou, ZY; Liu, FR; Zhang, XY; Zhou, XX; Zhong, ZJ; Su, HY; Li, J; Li, HZ; Feng, F; Lan, JC; Zhang, ZH; Fu, HL; Hu, YC; Cao, SZ; Chen, WG; Deng, JB; Yu, JQ; Zhang, WP; Peng, GN				Zhou, Ziyao; Liu, Furui; Zhang, Xinyue; Zhou, Xiaoxiao; Zhong, Zhijun; Su, Huaiyi; Li, Jin; Li, Haozhou; Feng, Fan; Lan, Jingchao; Zhang, Zhihe; Fu, Hualin; Hu, Yanchun; Cao, Suizhong; Chen, Weigang; Deng, Jiabo; Yu, Jianqiu; Zhang, Wenping; Peng, Guangneng			Cellulose-dependent expression and antibacterial characteristics of surfactin from Bacillus subtilis HH2 isolated from the giant panda	PLOS ONE			English	Article							PROBIOTICS; LIPOPEPTIDES; FENGYCIN; ITURINS	Surfactin secreted by Bacillus subtilis can confer strong, diverse antipathogenic effects, thereby benefitting the host. Carbon source is an important factor for surfactin production. However, the mechanism that bacteria utilize cellulose, the most abundant substance in the intestines of herbivores, to produce surfactin remains unclear. Here, we used B. subtilis HH2, isolated from the feces of a giant panda, as a model to determine changes in surfactin expression in the presence of different concentrations of cellulose by quantitative polymerase chain reaction and high-performance liquid chromatography. We further investigated the antimicrobial effects of surfactin against three common intestinal pathogens (Escherichia coli, Staphylococcus aureus, and Salmonella enterica) and its resistance to high temperature (60 +/- 121 degrees C), pH (1 +/- 12), trypsin (100 +/- 300 mu g/mL, pH 8), and pepsin (100 +/- 300 mu g/mL, pH 2). The results showed that the surfactin expressed lowest in bacteria cultured in the presence of 1% glucose medium as the carbon source, whereas increased in an appropriate cellulose concentration (0.67% glucose and 0.33% cellulose). The surfactin could inhibit E. coli and Staphylococcus aureus, but did not affect efficiently for Salmonella enterica. The antibacterial ability of surfactin did not differ according to temperature (60 +/- 100 degrees C), pH (2 +/- 11), trypsin (100 +/- 300 mu g/mL), and pepsin (100 +/- 300 mu g/mL; P > 0.05), but decreased significantly at extreme environments (121 degrees C, pH 1 or 12; P < 0.05) compared with that in the control group (37 degrees C, pH = 7, without any protease). In conclusion, our findings indicated that B. subtilis HH2 could increase surfactin expression in an appropriate cellulose environment and thus provide benefits to improve the intestinal health of herbivores.	[Zhou, Ziyao; Liu, Furui; Zhang, Xinyue; Zhou, Xiaoxiao; Zhong, Zhijun; Su, Huaiyi; Li, Jin; Li, Haozhou; Feng, Fan; Fu, Hualin; Hu, Yanchun; Cao, Suizhong; Peng, Guangneng] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Zhou, Xiaoxiao] Chengdu Ctr Anim Dis Prevent & Control, Chengdu, Sichuan, Peoples R China; [Lan, Jingchao; Zhang, Zhihe; Zhang, Wenping] Chengdu Res Base Giant Panda Breeding, Key Lab Conservat Biol Endangered Wildlife Sichua, Chengdu, Sichuan, Peoples R China; [Chen, Weigang; Deng, Jiabo; Yu, Jianqiu] Inst Wild Anim, Chengdu, Sichuan, Peoples R China	Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University	Peng, GN (corresponding author), Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Sichuan, Peoples R China.; Zhang, WP (corresponding author), Chengdu Res Base Giant Panda Breeding, Key Lab Conservat Biol Endangered Wildlife Sichua, Chengdu, Sichuan, Peoples R China.	zhang_zoology@163.com; pgn.sicau@163.com	Li, Haozhou/GXF-3701-2022; Zhang, Wenping/H-5125-2015		Chengdu giant panda breeding research foundation [CPF2015-07, CPF2015-09]	Chengdu giant panda breeding research foundation	The study was financially supported by the Chengdu giant panda breeding research foundation (CPF2015-07, CPF2015-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The study was financially supported by the Chengdu giant panda breeding research foundation (CPF2015-07, CPF2015-09).	Abriouel H, 2011, FEMS MICROBIOL REV, V35, P201, DOI 10.1111/j.1574-6976.2010.00244.x; Arutchelvi J, 2014, COLLOID SURFACE B, V116, P396, DOI 10.1016/j.colsurfb.2013.12.034; Casacuberta E, 2013, MOL ECOL, V22, P1503, DOI 10.1111/mec.12170; Chen WS, 2011, CELLULOSE, V18, P433, DOI 10.1007/s10570-011-9497-z; Chun J, 2000, ANTON LEEUW INT J G, V78, P123, DOI 10.1023/A:1026555830014; de Araujo LV, 2016, FOOD CONTROL, V63, P171, DOI 10.1016/j.foodcont.2015.11.036; Deleu M, 2008, BIOPHYS J, V94, P2667, DOI 10.1529/biophysj.107.114090; Dunne C, 1999, ANTON LEEUW INT J G, V76, P279, DOI 10.1023/A:1002065931997; Han Q, 2015, ENVIRON MICROBIOL, V17, P1166, DOI 10.1111/1462-2920.12538; Heerklotz H, 2007, EUR BIOPHYS J BIOPHY, V36, P305, DOI 10.1007/s00249-006-0091-5; Ho BT, 2014, CELL HOST MICROBE, V15, P9, DOI 10.1016/j.chom.2013.11.008; Irnov I, 2010, NUCLEIC ACIDS RES; Jin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022602; Liu X, 2012, 2012 7TH INTERNATIONAL ICST CONFERENCE ON COMMUNICATIONS AND NETWORKING IN CHINA (CHINACOM), P7, DOI 10.1109/ChinaCom.2012.6417439; Loiseau C, 2015, APPL MICROBIOL BIOT, V99, P5083, DOI 10.1007/s00253-014-6317-z; MAGETDANA R, 1994, TOXICOLOGY, V87, P151, DOI 10.1016/0300-483X(94)90159-7; Manninen TJK, 2006, APPL ENVIRON MICROB, V72, P6539, DOI 10.1128/AEM.02977-05; Mireles JR, 2001, J BACTERIOL, V183, P5848, DOI 10.1128/JB.183.20.5848-5854.2001; Nitschke M, 2009, LETT APPL MICROBIOL, V49, P241, DOI 10.1111/j.1472-765X.2009.02646.x; Ouwehand AC, 2002, ANTON LEEUW INT J G, V82, P279, DOI 10.1023/A:1020620607611; Pabinger Stephan, 2014, Biomol Detect Quantif, V1, P23; Romero D, 2007, MOL PLANT MICROBE IN, V20, P430, DOI 10.1094/MPMI-20-4-0430; Sabate DC, 2013, MICROBIOL RES, V168, P125, DOI 10.1016/j.micres.2012.11.004; Soccol CR, 2010, FOOD TECHNOL BIOTECH, V48, P413; Wang M, 2015, BIOMASS BIOENERG, V80, P30, DOI 10.1016/j.biombioe.2015.04.028; Wang XQ, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170082; Wheat PF, 2001, J ANTIMICROB CHEMOTH, V48, P1, DOI 10.1093/jac/48.suppl_1.1; Zhang R, 2016, J ANIM PHYSIOL AN N, V100, P33, DOI 10.1111/jpn.12338; Zhang W, 2016, APPL ENVIRON MICROB; Zhang YY, 2015, INFLAMMATION, V38, P756, DOI 10.1007/s10753-014-9986-y; Zhao X, 2013, MICROBIOL RES, V168, P598, DOI 10.1016/j.micres.2013.03.001; Zhou ZY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116935; Zhou ZY, 2014, WORLD J MICROB BIOT, V30, P3129, DOI 10.1007/s11274-014-1740-y	33	9	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191991	10.1371/journal.pone.0191991	http://dx.doi.org/10.1371/journal.pone.0191991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385201	Green Published, Green Submitted, gold			2022-12-26	WOS:000423668400066
J	Boyd, M; Rosenzweig, F; Herron, MD				Boyd, Margrethe; Rosenzweig, Frank; Herron, Matthew D.			Analysis of motility in multicellular Chlamydomonas reinhardtii evolved under predation	PLOS ONE			English	Article							ORIGIN; ALGAE; PHOTOTAXIS; EVOLUTION; GROWTH	The advent of multicellularity was a watershed event in the history of life, yet the transition from unicellularity to multicellularity is not well understood. Multicellularity opens up opportunities for innovations in intercellular communication, cooperation, and specialization, which can provide selective advantages under certain ecological conditions. The unicellular alga Chlamydomonas reinhardtii has never had a multicellular ancestor yet it is closely related to the volvocine algae, a clade containing taxa that range from simple unicells to large, specialized multicellular colonies. Simple multicellular structures have been observed to evolve in C. reinhardtii in response to predation or to settling rate-based selection. Structures formed in response to predation consist of individual cells confined within a shared transparent extracellular matrix. Evolved isolates form such structures obligately under culture conditions in which their wild type ancestors do not, indicating that newly-evolved multicellularity is heritable. C. reinhardtii is capable of photosynthesis, and possesses an eyespot and two flagella with which it moves towards or away from light in order to optimize input of radiant energy. Motility contributes to C. reinhardtii fitness because it allows cells or colonies to achieve this optimum. Utilizing phototaxis to assay motility, we determined that newly evolved multicellular strains do not exhibit significant directional movement, even though the flagellae of their constituent unicells are present and active. In C. reinhardtii the first steps towards multicellularity in response to predation appear to result in a trade-off between motility and differential survivorship, a trade-off that must be overcome by further genetic change to ensure long-term success of the new multicellular organism.	[Boyd, Margrethe; Rosenzweig, Frank; Herron, Matthew D.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Boyd, Margrethe] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Rosenzweig, Frank; Herron, Matthew D.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA	University of Montana System; University of Montana; Northwestern University; University System of Georgia; Georgia Institute of Technology	Boyd, M (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.; Boyd, M (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.	MargretheBoyd2023@u.northwestern.edu	Herron, Matthew/C-8603-2009	Herron, Matthew/0000-0002-9578-0972; Boyd, Margrethe/0000-0001-5084-666X	National Aeronautics and Space Administration Astrobiology Institute [NNA17BB05A]; National Science Foundation [DEB-1457701]; John Templeton Foundation [43285]; Division Of Environmental Biology [1723293] Funding Source: National Science Foundation	National Aeronautics and Space Administration Astrobiology Institute; National Science Foundation(National Science Foundation (NSF)); John Templeton Foundation; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this work was provided by the National Aeronautics and Space Administration Astrobiology Institute (NNA17BB05A) FR, the National Science Foundation (DEB-1457701) MDH & FR, and the John Templeton Foundation (43285) MDH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell G., 1985, ORIGIN EVOLUTION SEX; Bonner JT, 2003, J BIOSCIENCES, V28, P523, DOI 10.1007/BF02705126; Boraas ME, 1998, EVOL ECOL, V12, P153, DOI 10.1023/A:1006527528063; Burke MK, 2014, GENOME BIOL EVOL, V6, P1, DOI 10.1093/gbe/evt180; Chla,ydomonas Resource Center, 2017, TAP AND TRIS MIN; Fischer BB, 2006, PLANT CELL PHYSIOL, V47, P1135, DOI 10.1093/pcp/pcj085; Goldstein RE, 2015, ANNU REV FLUID MECH, V47, P343, DOI 10.1146/annurev-fluid-010313-141426; Grosberg RK, 2007, ANNU REV ECOL EVOL S, V38, P621, DOI 10.1146/annurev.ecolsys.36.102403.114735; Hallmann A, 2011, SEX PLANT REPROD, V24, P97, DOI 10.1007/s00497-010-0158-4; Herron MD, 2009, P NATL ACAD SCI USA, V106, P3254, DOI 10.1073/pnas.0811205106; Herron MD, 2018, BIORXIV; HOOBER JK, 1989, SCIENCE, V246, P1503, DOI 10.1126/science.246.4936.1503-a; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; LALIBERTE G, 1993, J PHYCOL, V29, P612, DOI 10.1111/j.0022-3646.1993.00612.x; Leiby N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001789; Lurling M, 2006, ANN LIMNOL-INT J LIM, V42, P65, DOI 10.1051/limn/2006010; Rasband WS, 2012, ASCL; Ratcliff WC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3742; Rosenzweig F, 2014, GENOMICS, V104, pV, DOI 10.1016/j.ygeno.2014.11.008; Sharma OP., 1986, TXB OF ALGAE; Solari CA, 2007, GENET PROGRAM EVOL M, V8, P115, DOI 10.1007/s10710-007-9029-7; STAVIS RL, 1973, J CELL BIOL, V59, P367, DOI 10.1083/jcb.59.2.367; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; UTEX Culture Collection of Algae, 2017, WC MED; Wakabayashi K, 2011, P NATL ACAD SCI USA, V108, P11280, DOI 10.1073/pnas.1100592108	25	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0192184	10.1371/journal.pone.0192184	http://dx.doi.org/10.1371/journal.pone.0192184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381766	Green Published, Green Submitted, gold			2022-12-26	WOS:000423617800062
J	Paine, A; Woeller, CF; Zhang, HW; Garcia-Hernandez, MD; Huertas, N; Xing, LP; Phipps, RP; Ritchlin, CT				Paine, Ananta; Woeller, Collynn F.; Zhang, Hengwei; de la Luz Garcia-Hernandez, Maria; Huertas, Nelson; Xing, Lianping; Phipps, Richard P.; Ritchlin, Christopher T.			Thyl is a positive regulator of osteoblast differentiation and modulates bone homeostasis in obese mice	FASEB JOURNAL			English	Article						adipocytes; CD90; mesenchymal stem cells; osteoblastogenesis; trabecular bone volume	STEM-CELLS; IN-VITRO; MARROW; OSTEOPOROSIS; EXPRESSION; TISSUE; ADIPOGENESIS; FIBROBLASTS; ADHESION; WOMEN	Thy1 (CD90), a glycosylated, glycophosphatidylinositol-anchored membrane protein highly expressed by subsets of mesenchymal stem cells and fibroblasts, inhibits adipogenesis. The role of Thy1 on bone structure and function has been poorly studied and represents a major knowledge gap. Therefore, we analyzed the long bones of wild-type (WT) and Thy1 knockout (KO) mice with micro-computed tomography (micro-CT) and histomorphometry to compare changes in bone architecture and overall bone structure. micro-CT analysis of long bones revealed Thy1 KO and WT mice fed a high-fat diet demonstrated bone structural parameters at 4 mo that differed significantly between WT and KO mice. A significant reduction in trabecular bone volume was noted in Thy1 KO mice. The most prominent differences were observed in trabecular bone volume ratio and trabecular bone connectivity density. Consistent with micro-CT measurements, histomorphometric analysis also showed decreased bone volume in the obese Thy1 KO mice compared to obese WT mice. In vitro assays revealed that osteogenic conditions increased Thy1 expression during OB differentiation and absence of Thy1 attenuated osteoblastogenesis. Together, these findings support the concept that Thy1 serves as a major mechanistic link to regulate bone formation and negatively regulate adipogenesis.	[Paine, Ananta; de la Luz Garcia-Hernandez, Maria; Huertas, Nelson; Ritchlin, Christopher T.] Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, 601 Elmwood Ave,Room 56216,Box 695, Rochester, NY 14642 USA; [Woeller, Collynn F.; Phipps, Richard P.] Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY USA; [Zhang, Hengwei; Xing, Lianping] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY USA; [Zhang, Hengwei; Xing, Lianping] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Paine, A (corresponding author), Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, 601 Elmwood Ave,Room 56216,Box 695, Rochester, NY 14642 USA.	ananta_paine@urmc.rochester.edu		ritchlin, christopher/0000-0002-2602-1219; Garcia-Hernandez, Maria de la luz/0000-0001-9268-2464; Woeller, Collynn/0000-0001-7197-5057	Lung Biology Strategic Plan High Risk Project Pilot Research Award; Health Sciences Research Using High Performance Computational Resources (HSCCI) Pilot Grant; Department of Medicine Research Pilot Projects Award from University of Rochester; U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR0169000, AR063650, P30AR069655]; National Institute for Translational Sciences [5UL1TR000042-09]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069000, R01AR063650, P30AR069655] Funding Source: NIH RePORTER	Lung Biology Strategic Plan High Risk Project Pilot Research Award; Health Sciences Research Using High Performance Computational Resources (HSCCI) Pilot Grant; Department of Medicine Research Pilot Projects Award from University of Rochester; U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute for Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Michael Thullen, Sarah Mack, and Christopher Dean (all from the University of Rochester) for excellent technical assistance with micro-CT and histological analysis; and Cheryl Ackert-Bicknell, Edward M. Schwarz, Michael John Zuscik, Jennifer Jonason, and Thomas J. Mariani (all from the University of Rochester) for assistance and helpful scientific discussions. This study was supported by funds from the Lung Biology Strategic Plan High Risk Project Pilot Research Award, a Health Sciences Research Using High Performance Computational Resources (HSCCI) Pilot Grant and a Department of Medicine Research Pilot Projects Award from University of Rochester; and from U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants AR0169000, AR063650, and P30AR069655, and National Institute for Translational Sciences Grant 5UL1TR000042-09. The authors declare no conflicts of interest.	Albala C, 1996, INT J OBESITY, V20, P1027; Bar-Shavit Z, 2007, J CELL BIOCHEM, V102, P1130, DOI 10.1002/jcb.21553; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chen HY, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/213234; Chen Q, 2016, CELL DEATH DIFFER, V23, P1128, DOI 10.1038/cdd.2015.168; Chen XD, 1999, J BONE MINER RES, V14, P362, DOI 10.1359/jbmr.1999.14.3.362; Chung MT, 2013, TISSUE ENG PT A, V19, P989, DOI [10.1089/ten.tea.2012.0370, 10.1089/ten.TEA.2012.0370]; Compston JE, 2014, J BONE MINER RES, V29, P487, DOI 10.1002/jbmr.2051; Doucette CR, 2015, J CELL PHYSIOL, V230, P2032, DOI 10.1002/jcp.24954; Garreta E, 2006, TISSUE ENG, V12, P2215, DOI 10.1089/ten.2006.12.2215; Genant HK, 2006, ANN NY ACAD SCI, V1068, P410, DOI 10.1196/annals.1346.038; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Hosoya A, 2012, HISTOCHEM CELL BIOL, V137, P733, DOI 10.1007/s00418-012-0928-1; Issever AS, 2009, J BONE MINER RES, V24, P1628, DOI [10.1359/JBMR.090311, 10.1359/jbmr.090311]; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Kim YK, 2016, STEM CELL TRANSL MED, V5, P227, DOI 10.5966/sctm.2015-0013; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Koumas L, 2003, AM J PATHOL, V163, P1291, DOI 10.1016/S0002-9440(10)63488-8; Lehmann GM, 2010, AM J PHYSIOL-CELL PH, V299, pC672, DOI 10.1152/ajpcell.00451.2009; Pino AM, 2012, BIOL RES, V45, P279, DOI 10.4067/S0716-97602012000300009; McNiece I, 2000, EXP HEMATOL, V28, P1312, DOI 10.1016/S0301-472X(00)00609-3; MEUNIER P, 1971, CLIN ORTHOP RELAT R, P147, DOI 10.1097/00003086-197110000-00021; Paine A, 2012, J IMMUNOL, V188, P1620, DOI 10.4049/jimmunol.1100181; PHIPPS RP, 1989, AM J RESP CELL MOL, V1, P65, DOI 10.1165/ajrcmb/1.1.65; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Rege TA, 2006, BBA-MOL CELL RES, V1763, P991, DOI 10.1016/j.bbamcr.2006.08.008; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; REIF AE, 1964, NATURE, V203, P886, DOI 10.1038/203886a0; RIBOT C, 1994, ADV NUTR RES, V9, P257; Rodan GA, 1998, P NATL ACAD SCI USA, V95, P13361, DOI 10.1073/pnas.95.23.13361; Shi JX, 2014, ARTHRITIS RHEUMATOL, V66, P657, DOI 10.1002/art.38278; Sogaard AJ, 2015, J INTERN MED, V277, P306, DOI 10.1111/joim.12230; Takahashi T, 2011, CALCIFIED TISSUE INT, V88, P336, DOI 10.1007/s00223-011-9461-9; Watts NB, 2014, NAT REV ENDOCRINOL, V10, P412, DOI 10.1038/nrendo.2014.55; Woeller CF, 2017, TOXICOL SCI, V157, P305, DOI 10.1093/toxsci/kfx046; Woeller CF, 2015, FASEB J, V29, P920, DOI 10.1096/fj.14-257121; Yeung DKW, 2005, J MAGN RESON IMAGING, V22, P279, DOI 10.1002/jmri.20367; Zhang LZ, 2016, BONE RES, V4, DOI 10.1038/boneres.2015.37	39	20	21	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3174	3183		10.1096/fj.201701379R	http://dx.doi.org/10.1096/fj.201701379R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401595	Green Published			2022-12-26	WOS:000432546000023
J	Banta, KL; Wang, XY; Das, P; Winoto, A				Banta, Karl L.; Wang, Xinyue; Das, Phani; Winoto, Astar			B cell lymphoma 2 (Bcl-2) residues essential for Bcl-2 ' s apoptosis-inducing interaction with Nur77/Nor-1 orphan steroid receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PERMEABILIZATION; CANCER-THERAPY; BH3 DOMAIN; BH3-ONLY PROTEINS; FAMILY PROTEINS; IMMUNE-SYSTEM; DEATH; NUR77; INHIBITION; BAX	Apoptosis is mediated through the extrinsic or intrinsic pathway. Key regulators of the intrinsic apoptotic pathway are the family of B cell lymphoma 2 (Bcl-2) proteins. The activity of the prototypical Bcl-2 protein is usually considered antiapoptotic. However, under some conditions, Bcl-2 associates with the orphan nuclear hormone receptors Nur77 and Nor-1, converting Bcl-2 into a proapoptotic molecule. Expression of Nur77 and Nor-1 is induced by a variety of signals, including those leading to apoptosis. Translocation of Nur77/Nor-1 to mitochondria results in their association with Bcl-2, exposing the Bcl-2 homology (BH) 3 domain and causing apoptosis. However, the molecular details of this interaction are incompletely understood. Here, through extensive Bcl-2 mutagenesis and functional assays, we identified residues within Bcl-2 that are essential for its interaction with Nur77/Nor-1. Although an initial report has suggested that an unstructured loop region between the Bcl-2 BH4 and BH3 domains is required for Bcl-2's interaction with Nur77/Nor-1, we found that it is dispensable for this interaction. Instead, we found important interacting residues at the BH4 domain and crucial interacting residues between the BH1 and BH2 domains. Bcl-2 alanine mutants at this region could no longer interact with Nur77/Nor-1 and could not initiate Nur77/Bcl-2-mediated cell death. However, they still retained their anti-apoptotic capability in two different death assays. These results establish crucial residues in Bcl-2 required for Nur77/Nor-1-mediated apoptosis and point to potential new strategies for manipulating Bcl-2 function.	[Winoto, Astar] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Winoto, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	winoto@berkeley.edu		Wang, Xinyue/0000-0002-9187-5472	National Institutes of Health [CA66236]; NATIONAL CANCER INSTITUTE [R01CA066236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA66236 (to A. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Bouillet P, 2002, J CELL SCI, V115, P1567; Burger ML, 2014, ELIFE, V3, DOI 10.7554/eLife.03468; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Delbridge ARD, 2016, NAT REV CANCER, V16, P99, DOI 10.1038/nrc.2015.17; Ferlini C, 2009, CANCER RES, V69, P6906, DOI 10.1158/0008-5472.CAN-09-0540; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Godoi PHC, 2016, J BIOL CHEM, V291, P14072, DOI 10.1074/jbc.M116.715235; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang DCS, 1998, EMBO J, V17, P1029, DOI 10.1093/emboj/17.4.1029; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kawatani M, 2003, J BIOL CHEM, V278, P19732, DOI 10.1074/jbc.M213038200; Ke N, 2001, J BIOL CHEM, V276, P12481, DOI 10.1074/jbc.C000871200; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; KINASHI T, 1988, P NATL ACAD SCI USA, V85, P4473, DOI 10.1073/pnas.85.12.4473; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Lee LC, 1996, J BIOL CHEM, V271, P23284, DOI 10.1074/jbc.271.38.23284; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Luciano F, 2007, BLOOD, V109, P3849, DOI 10.1182/blood-2006-11-056879; Merino D, 2009, APOPTOSIS, V14, P570, DOI 10.1007/s10495-008-0308-4; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Nagata S, 2017, NAT REV IMMUNOL, V17, P333, DOI 10.1038/nri.2016.153; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Rautureau GJP, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.178; Ruefli-Brasse A, 2017, BIOCHEM J, V474, P3643, DOI 10.1042/BCJ20170080; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Sprick MR, 2004, BBA-MOL CELL RES, V1644, P125, DOI 10.1016/j.bbamcr.2003.11.002; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; Thompson J, 2010, EUR J IMMUNOL, V40, P2041, DOI 10.1002/eji.200940231; Tischner D, 2010, Cell Death Dis, V1, pe48, DOI 10.1038/cddis.2010.27; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Walczak H, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008698; Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhou T, 1996, J EXP MED, V183, P1879, DOI 10.1084/jem.183.4.1879	61	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4724	4734		10.1074/jbc.RA117.001101	http://dx.doi.org/10.1074/jbc.RA117.001101			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29414782	Green Published, hybrid			2022-12-26	WOS:000428848300015
J	Cox, D; Whiten, DR; Brown, JWP; Horrocks, MH; San Gil, R; Dobson, CM; Klenerman, D; van Oijen, AM; Ecroyd, H				Cox, Dezerae; Whiten, Daniel R.; Brown, James W. P.; Horrocks, Mathew H.; San Gil, Rebecca; Dobson, Christopher M.; Klenerman, David; van Oijen, Antoine M.; Ecroyd, Heath			The small heat shock protein Hsp27 binds alpha-synuclein fibrils, preventing elongation and cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN C-II; B-CRYSTALLIN; PARKINSONS-DISEASE; AMYLOID FIBRILS; MOLECULAR CHAPERONE; LEWY BODIES; AGGREGATION; DEMENTIA; OLIGOMERS; MUTATION	Proteostasis, or protein homeostasis, encompasses the maintenance of the conformational and functional integrity of the proteome and involves an integrated network of cellular pathways. Molecular chaperones, such as the small heat shock proteins (sHsps), are key elements of the proteostasis network that have crucial roles in inhibiting the aggregation of misfolded proteins. Failure of the proteostasis network can lead to the accumulation of misfolded proteins into intracellular and extracellular deposits. Deposits containing fibrillar forms of alpha-synuclein (alpha-syn) are characteristic of neurodegenerative disorders including Parkinson's disease and dementia with Lewy bodies. Here we show that the sHsp Hsp27 (HSPB1) binds to alpha-syn fibrils, inhibiting fibril growth by preventing elongation. Using total internal reflection fluorescence (TIRF)-based imaging methods, we show that Hsp27 binds along the surface of alpha-syn fibrils, decreasing their hydrophobicity. Binding of Hsp27 also inhibits cytotoxicity of alpha-syn fibrils. Our results demonstrate that the ability of sHsps, such as Hsp27, to bind fibrils represents an important mechanism through which they may mitigate cellular toxicity associated with aberrant protein aggregation. Fibril binding may represent a generic mechanism by which chaperone-active sHsps interact with aggregation-prone proteins, highlighting the potential to target sHsp activity to prevent or disrupt the onset and progression of alpha-syn aggregation associated with alpha-synucleinopathies.	[Cox, Dezerae; Whiten, Daniel R.; Horrocks, Mathew H.; San Gil, Rebecca; van Oijen, Antoine M.; Ecroyd, Heath] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Cox, Dezerae; Whiten, Daniel R.; San Gil, Rebecca; Ecroyd, Heath] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Whiten, Daniel R.; Brown, James W. P.; Horrocks, Mathew H.; Dobson, Christopher M.; Klenerman, David] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England; [van Oijen, Antoine M.] Univ Wollongong, Sch Chem, Wollongong, NSW 2522, Australia; [Horrocks, Mathew H.] Univ Edinburgh, Sch Chem, David Brewster Rd, Edinburgh EH9 3FJ, Midlothian, Scotland	University of Wollongong; University of Wollongong; University of Cambridge; University of Wollongong; University of Edinburgh	Ecroyd, H (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia.; Ecroyd, H (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia.	heath_ecroyd@uow.edu.au	Cox, Dezerae/I-7265-2019; van Oijen, Antoine/I-3167-2014; San Gil, Rebecca/S-5661-2019	Cox, Dezerae/0000-0002-5345-8360; van Oijen, Antoine/0000-0002-1794-5161; San Gil, Rebecca/0000-0001-5725-5512; Whiten, Daniel/0000-0002-7853-3566; Klenerman, David/0000-0001-7116-6954; Brown, James/0000-0002-2731-8882; Horrocks, Mathew/0000-0001-5495-5492; Ecroyd, Heath/0000-0001-7574-0044	Faculty of Science, Medicine and Health of the University of Wollongong; Cambridge Centre for Mis-folding Diseases; Australian Postgraduate Award; Australian Research Council Future Fellowship [FT110100586]; Australian Research Council Laureate Fellowship [FL1401000027]; MRC [UKDRI-2003] Funding Source: UKRI	Faculty of Science, Medicine and Health of the University of Wollongong; Cambridge Centre for Mis-folding Diseases; Australian Postgraduate Award(Australian Government); Australian Research Council Future Fellowship(Australian Research Council); Australian Research Council Laureate Fellowship(Australian Research Council); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Faculty of Science, Medicine and Health of the University of Wollongong and the Cambridge Centre for Mis-folding Diseases (to J.B. and C.M.D.). This work was also supported by an Australian Postgraduate Award (to D.C.), Australian Research Council Future Fellowship FT110100586 (to H.E.), and Australian Research Council Laureate Fellowship FL1401000027 (to. A.O.).	Baba M, 1998, AM J PATHOL, V152, P879; Benesch JLP, 2008, J BIOL CHEM, V283, P28513, DOI 10.1074/jbc.M804729200; Binger KJ, 2013, FASEB J, V27, P1214, DOI 10.1096/fj.12-220657; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Bongiovanni MN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13544; Bruinsma IB, 2011, PROTEINS, V79, P2956, DOI 10.1002/prot.23152; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Campbell BCV, 2001, J NEUROCHEM, V76, P87, DOI 10.1046/j.1471-4159.2001.00021.x; Carver JA, 2003, IUBMB LIFE, V55, P661, DOI 10.1080/15216540310001640498; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Cohen SIA, 2015, NAT STRUCT MOL BIOL, V22, P207, DOI 10.1038/nsmb.2971; Cox D, 2016, J BIOL CHEM, V291, P22618, DOI 10.1074/jbc.M116.739250; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Devlin GL, 2003, J BIOL CHEM, V278, P48644, DOI 10.1074/jbc.M308376200; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Glabe C., 2009, OPEN BIOL J, V2, P222; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; GREENSPAN P, 1985, J LIPID RES, V26, P781; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hatters DM, 2001, J BIOL CHEM, V276, P33755, DOI 10.1074/jbc.M105285200; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; Horrocks MH, 2016, ACS CHEM NEUROSCI, V7, P399, DOI 10.1021/acschemneuro.5b00324; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; IWAKI T, 1992, AM J PATHOL, V140, P345; Jakhria T, 2014, J BIOL CHEM, V289, P35781, DOI 10.1074/jbc.M114.586222; Jehle S, 2011, P NATL ACAD SCI USA, V108, P6409, DOI 10.1073/pnas.1014656108; Jehle S, 2010, NAT STRUCT MOL BIOL, V17, P1037, DOI 10.1038/nsmb.1891; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Jovcevski B, 2015, CHEM BIOL, V22, P186, DOI 10.1016/j.chembiol.2015.01.001; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kulig M, 2012, BIOCHEM J, V448, P343, DOI 10.1042/BJ20121187; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lelj-Garolla B, 2006, J BIOL CHEM, V281, P8169, DOI 10.1074/jbc.M512553200; Leverenz JB, 2007, BRAIN PATHOL, V17, P139, DOI 10.1111/j.1750-3639.2007.00048.x; LOWE J, 1990, LANCET, V336, P515, DOI 10.1016/0140-6736(90)92075-S; Marti MJ, 2003, MOVEMENT DISORD, V18, pS21, DOI 10.1002/mds.10560; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Mizutani T, 1998, ACTA NEUROPATHOL, V95, P15, DOI 10.1007/s004010050761; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rekas A, 2007, FEBS J, V274, P6290, DOI 10.1111/j.1742-4658.2007.06144.x; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shammas SL, 2011, BIOPHYS J, V101, P1681, DOI 10.1016/j.bpj.2011.07.056; Shvadchak VV, 2015, J PHYS CHEM B, V119, P1912, DOI 10.1021/jp5111604; Sot B, 2017, SCI REP-UK, V7, DOI 10.1038/srep40859; Stamler R, 2005, J MOL BIOL, V353, P68, DOI 10.1016/j.jmb.2005.08.025; Tabner Brian J., 2001, Current Topics in Medicinal Chemistry, V1, P507, DOI 10.2174/1568026013394822; Treweek TM, 2015, CELL MOL LIFE SCI, V72, P429, DOI 10.1007/s00018-014-1754-5; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Walker J. M, 2005, PROTEOMICS PROTOCOLS; Wang XH, 2013, J MOL MED, V91, P917, DOI 10.1007/s00109-013-1067-4; Waudby CA, 2010, BIOPHYS J, V98, P843, DOI 10.1016/j.bpj.2009.10.056; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Yerbury JJ, 2016, J NEUROCHEM, V137, P489, DOI 10.1111/jnc.13575; Yerbury JJ, 2013, CELL STRESS CHAPERON, V18, P251, DOI 10.1007/s12192-012-0371-1; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang X., 2013, JOVE-J VIS EXP, V81; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	71	69	71	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4486	4497		10.1074/jbc.M117.813865	http://dx.doi.org/10.1074/jbc.M117.813865			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29382725	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000428204300020
J	Haque, MM; Tejero, J; Bayachou, M; Kenney, CT; Stuehr, DJ				Haque, Mohammad Mahfuzul; Tejero, Jesus; Bayachou, Mekki; Kenney, Claire T.; Stuehr, Dennis J.			A cross-domain charge interaction governs the activity of NO synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ELECTRON-TRANSFER; REDUCTASE DOMAIN; CONFORMATIONAL EQUILIBRIUM; CYTOCHROME-P450 REDUCTASE; BILIVERDIN-REDUCTASE; FLAVOPROTEIN DOMAIN; SURFACE-CHARGE; CALMODULIN; FMN	NO synthase (NOS) enzymes perform interdomain electron transfer reactions during catalysis that may rely on complementary charge interactions at domain-domain interfaces. Guided by our previous results and a computer-generated domain-docking model, we assessed the importance of cross-domain charge interactions in the FMN-to-heme electron transfer in neuronal NOS(nNOS). We reversed the charge of three residues (Glu-762, Glu-816, and Glu-819) that form an electronegative triad on the FMN domain and then individually reversed the charges of three electropositive residues (Lys-423, Lys-620, and Lys-660) on the oxygenase domain (NOSoxy), to potentially restore a cross-domain charge interaction with the triad, but in reversed polarity. Charge reversal of the triad completely eliminated heme reduction and NO synthesis in nNOS. These functions were partly restored by the charge reversal at oxygenase residue Lys-423, but not at Lys-620 or Lys-660. Full recovery of heme reduction was probably muted by an accompanying change in FMN midpoint potential that made electron transfer to the heme thermodynamically unfavorable. Our results provide direct evidence that cross-domain charge pairing is required for the FMN-to-heme electron transfer in nNOS. The unique ability of charge reversal at position 423 to rescue function indicates that it participates in an essential cross-domain charge interaction with the FMN domain triad. This supports our domain-docking model and suggests that it may depict a productive electron transfer complex formed during nNOS catalysis.	[Haque, Mohammad Mahfuzul; Kenney, Claire T.; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, NC-22,9500 Euclid Ave, Cleveland, OH 44195 USA; [Tejero, Jesus] Univ Pittsburgh, Pittsburgh Heart Lung Blood & Vasc Med Inst, Pittsburgh, PA 15213 USA; [Bayachou, Mekki] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA	Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Cleveland State University	Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, NC-22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Tejero, Jesus/G-3953-2017	Tejero, Jesus/0000-0003-3245-9978; Kenney, Claire/0000-0003-0883-5494; HAQUE, MOHAMMAD/0000-0003-0852-6368	National Institutes of Health [R15 EB019739, R01 GM051491]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R15EB019739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R15 EB019739 (to M. B.) and R01 GM051491 (to D. J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adak S, 1999, J BIOL CHEM, V274, P26907, DOI 10.1074/jbc.274.38.26907; Adak S, 2001, J BIOL CHEM, V276, P23246, DOI 10.1074/jbc.M102509200; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Arnett DC, 2015, FEBS LETT, V589, P1173, DOI 10.1016/j.febslet.2015.03.035; Astashkin AV, 2010, J AM CHEM SOC, V132, P12059, DOI 10.1021/ja104461p; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dunford AJ, 2007, BIOCHEMISTRY-US, V46, P5018, DOI 10.1021/bi7001339; Dutton P L, 1978, Methods Enzymol, V54, P411; Feng CJ, 2012, COORDIN CHEM REV, V256, P393, DOI 10.1016/j.ccr.2011.10.011; Fields JB, 2015, BIOCHEMISTRY-US, V54, P7272, DOI 10.1021/acs.biochem.5b00569; Gachhui R, 1996, J BIOL CHEM, V271, P20594, DOI 10.1074/jbc.271.34.20594; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Haque MM, 2011, FEBS J, V278, P4055, DOI 10.1111/j.1742-4658.2011.08310.x; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; Haque MM, 2013, BIOCHEM J, V450, P607, DOI 10.1042/BJ20121488; Haque MM, 2012, J BIOL CHEM, V287, P30105, DOI 10.1074/jbc.M112.339697; Haque MM, 2009, J BIOL CHEM, V284, P19237, DOI 10.1074/jbc.M109.013144; Hedison TM, 2017, NITRIC OXIDE-BIOL CH, V63, P61, DOI 10.1016/j.niox.2016.09.002; Hollingsworth SA, 2016, PROTEIN SCI, V25, P374, DOI 10.1002/pro.2824; Ilagan RP, 2009, BIOCHEMISTRY-US, V48, P3864, DOI 10.1021/bi8021087; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; Im SC, 2011, ARCH BIOCHEM BIOPHYS, V507, P144, DOI 10.1016/j.abb.2010.10.023; KLATT P, 1992, J BIOL CHEM, V267, P11374; Kobayashi K, 2001, J BIOL CHEM, V276, P39864, DOI 10.1074/jbc.M102537200; Konas DW, 2004, J BIOL CHEM, V279, P35412, DOI 10.1074/jbc.M400872200; Masters BSS, 1996, FASEB J, V10, P552, DOI 10.1096/fasebj.10.5.8621055; Newman E, 2004, J BIOL CHEM, V279, P33547, DOI 10.1074/jbc.M403892200; Noble MA, 1999, BIOCHEMISTRY-US, V38, P16413, DOI 10.1021/bi992150w; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Sagami I, 2001, J BIOL CHEM, V276, P30036, DOI 10.1074/jbc.M104123200; Sheng YH, 2015, J INORG BIOCHEM, V153, P186, DOI 10.1016/j.jinorgbio.2015.08.006; Shimanuki T, 1999, J BIOL CHEM, V274, P26956, DOI 10.1074/jbc.274.38.26956; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Smith BC, 2013, P NATL ACAD SCI USA, V110, pE3577, DOI 10.1073/pnas.1313331110; Spencer ALM, 2014, J BIOL CHEM, V289, P29836, DOI 10.1074/jbc.M114.582783; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Tejero JS, 2008, J BIOL CHEM, V283, P33498, DOI 10.1074/jbc.M806122200; Tejero J, 2011, BIOCHEM J, V433, P163, DOI 10.1042/BJ20101353; Tejero J, 2010, J BIOL CHEM, V285, P27232, DOI 10.1074/jbc.M110.138842; Tejero J, 2010, J BIOL CHEM, V285, P25941, DOI 10.1074/jbc.M110.126797; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Wang JL, 2003, J BIOL CHEM, V278, P20069, DOI 10.1074/jbc.M300989200; Wei CC, 2003, CHEM REV, V103, P2365, DOI 10.1021/cr0204350; Welland A, 2008, BIOCHEMISTRY-US, V47, P9771, DOI 10.1021/bi800787m; Xia CW, 2009, J BIOL CHEM, V284, P30708, DOI 10.1074/jbc.M109.031682	51	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4545	4554		10.1074/jbc.RA117.000635	http://dx.doi.org/10.1074/jbc.RA117.000635			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29414777	hybrid, Green Published			2022-12-26	WOS:000428204300025
J	Mann, D; Guldenhaupt, J; Schartner, J; Gerwert, K; Kotting, C				Mann, Daniel; Gueldenhaupt, Joern; Schartner, Jonas; Gerwert, Klaus; Koetting, Carsten			The protonation states of GTP and GppNHp in Ras proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-ENERGY RELATIONSHIPS; P-31 NMR-SPECTROSCOPY; CONFORMATIONAL STATES; GAMMA-PHOSPHATE; MOLECULAR SIMULATION; PERTURBATION-THEORY; QM/MM SIMULATIONS; CRYSTAL-STRUCTURE; AQUEOUS-SOLUTION; HYDROGEN-BONDS	The small GTPase Ras transmits signals in a variety of cellular signaling pathways, most prominently in cell proliferation. GTP hydrolysis in the active center of Ras acts as a prototype for many GTPases and is the key to the understanding of several diseases, including cancer. Therefore, Ras has been the focus of intense research over the last decades. A recent neutron diffraction crystal structure of Ras indicated a protonated gamma-guanylyl imidodiphosphate (gamma-GppNHp) group, which has put the protonation state of GTP in question. A possible protonation of GTP was not considered in previously published mechanistic studies. To determine the detailed prehydrolysis state of Ras, we calculated infrared and NMR spectra from quantum mechanics/molecular mechanics (QM/MM) simulations and compared them with those from previous studies. Furthermore, we measured infrared spectra of GTP and several GTP analogs bound to lipidated Ras on a membrane system under near-native conditions. Our findings unify results from previous studies and indicate a structural model confirming the hypothesis that gamma-GTP is fully deprotonated in the prehydrolysis state of Ras.	[Mann, Daniel; Gueldenhaupt, Joern; Schartner, Jonas; Gerwert, Klaus; Koetting, Carsten] Ruhr Univ Bochum, Dept Biophys, D-44780 Bochum, Germany; [Gerwert, Klaus] Chinese Acad Sci, Max Planck Gesell, PICB, Shanghai 200031, Peoples R China	Ruhr University Bochum; Chinese Academy of Sciences; Max Planck Society	Gerwert, K; Kotting, C (corresponding author), Univ Str 150, D-44780 Bochum, Germany.	gerwert@bph.rub.de; carsten.koetting@rub.de	Gerwert, Klaus/G-7311-2015; Kötting, Carsten/A-8266-2008	Kötting, Carsten/0000-0002-3599-9657; Mann, Daniel/0000-0002-9106-9358	Deutsche Forschungsgemeinschaft [SFB 642]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grant SFB 642, TP A1. The authors declare that they have no conflicts of interest with the contents of this article.	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Allin C, 2001, BIOCHEMISTRY-US, V40, P3037, DOI 10.1021/bi0017024; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Broyden C. G., 1970, J I MATH ITS APPL, V6, P76, DOI [10.1093/imamat/6.1.76, DOI 10.1093/IMAMAT/6.1.76]; Brunsveld L, 2006, ANGEW CHEM INT EDIT, V45, P6622, DOI 10.1002/anie.200600855; Case DA, 2014, AMBER 14; Cheeseman JR, 1996, J CHEM PHYS, V104, P5497, DOI 10.1063/1.471789; Cheng H, 2001, J BIOL CHEM, V276, P9931, DOI 10.1074/jbc.M009295200; Dapprich S, 1999, J MOL STRUC-THEOCHEM, V461, P1, DOI 10.1016/S0166-1280(98)00475-8; Deng H, 1998, J PHYS CHEM B, V102, P3617, DOI 10.1021/jp973314q; DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; DITCHFIELD R, 1974, MOL PHYS, V27, P789, DOI 10.1080/00268977400100711; Fetics SK, 2015, STRUCTURE, V23, P505, DOI 10.1016/j.str.2014.12.017; FLETCHER R, 1970, COMPUT J, V13, P317, DOI 10.1093/comjnl/13.3.317; Frisch M.J., 2009, GAUSSIAN 09 REVISION; Glennon TM, 2000, BIOCHEMISTRY-US, V39, P9641, DOI 10.1021/bi000640e; Grigorenko BL, 2007, PROTEINS, V66, P456, DOI 10.1002/prot.21228; Guldenhaupt J, 2008, FEBS J, V275, P5910, DOI 10.1111/j.1742-4658.2008.06720.x; Guldenhaupt J, 2012, BIOPHYS J, V103, P1585, DOI 10.1016/j.bpj.2012.08.043; He HT, 2011, ANNU REV PHYS CHEM, V62, P417, DOI 10.1146/annurev-physchem-032210-103402; Howeler U., 2007, MAXIMOBY 11 1; Iuga A, 2004, J MOL BIOL, V342, P1033, DOI 10.1016/j.jmb.2004.07.077; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Klahn M, 2006, J AM CHEM SOC, V128, P15310, DOI 10.1021/ja065470t; Knihtila R, 2015, J BIOL CHEM, V290, P31025, DOI 10.1074/jbc.M115.679860; Kotting C, 2015, BIOL CHEM, V396, P131, DOI 10.1515/hsz-2014-0219; Kotting C, 2012, CHEM PHYS, V396, P72, DOI 10.1016/j.chemphys.2011.08.007; Kuhn K, 2001, J AM CHEM SOC, V123, P1023, DOI 10.1021/ja002723o; Li ZL, 2016, BIOPHYS J, V110, P1033, DOI 10.1016/j.bpj.2016.01.020; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; London F, 1937, J PHYS-PARIS, V8, P397, DOI 10.1051/jphysrad:01937008010039700; Lu SY, 2016, CHEM REV, V116, P6607, DOI 10.1021/acs.chemrev.5b00542; Mann D, 2017, BIOPHYS J, V112, P66, DOI 10.1016/j.bpj.2016.11.3195; Maurer T, 1996, J MAGN RESON SER B, V113, P177, DOI 10.1006/jmrb.1996.0172; MCWEENY R, 1962, PHYS REV, V126, P1028, DOI 10.1103/PhysRev.126.1028; Nagele E, 1998, J AM CHEM SOC, V120, P6889, DOI 10.1021/ja9805627; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rudack T, 2015, J BIOL CHEM, V290, P24079, DOI 10.1074/jbc.M115.648071; Rudack T, 2012, P NATL ACAD SCI USA, V109, P15295, DOI 10.1073/pnas.1204333109; Rudolph MG, 2001, J BIOL CHEM, V276, P23914, DOI 10.1074/jbc.M011600200; Scheidig AJ, 1999, STRUCTURE, V7, P1311, DOI 10.1016/S0969-2126(00)80021-0; Schweins T, 1996, BIOCHEMISTRY-US, V35, P14232, DOI 10.1021/bi961119g; Schweins T, 1996, BIOCHEMISTRY-US, V35, P14225, DOI 10.1021/bi961118o; SCHWEINS T, 1995, NAT STRUCT BIOL, V2, P36, DOI 10.1038/nsb0195-36; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Spoerner M, 2005, MAGN RESON CHEM, V43, pS74, DOI 10.1002/mrc.1693; Spoerner M, 2005, BIOCHEMISTRY-US, V44, P2225, DOI 10.1021/bi0488000; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Spoerner M, 2010, J BIOL CHEM, V285, P39768, DOI 10.1074/jbc.M110.145235; Topol IA, 2004, BBA-PROTEINS PROTEOM, V1700, P125, DOI 10.1016/j.bbapap.2004.04.007; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VEDANI A, 1991, J AM CHEM SOC, V113, P5860, DOI 10.1021/ja00015a049; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vreven T, 2003, J COMPUT CHEM, V24, P760, DOI 10.1002/jcc.10156; Vreven T, 2006, ANN REP COMP CHEM, V2, P35, DOI 10.1016/S1574-1400(06)02003-2; WALKER JW, 1988, J AM CHEM SOC, V110, P7170, DOI 10.1021/ja00229a036; Wang JH, 1998, BIOSPECTROSCOPY, V4, P219, DOI 10.1002/(SICI)1520-6343(1998)4:4<219::AID-BSPY1>3.3.CO;2-K; WOLINSKI K, 1990, J AM CHEM SOC, V112, P8251, DOI 10.1021/ja00179a005; Xia F, 2011, PHYS CHEM CHEM PHYS, V13, P21451, DOI 10.1039/c1cp22741f; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	61	6	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3871	3879		10.1074/jbc.RA117.001110	http://dx.doi.org/10.1074/jbc.RA117.001110			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29382720	Green Published, hybrid			2022-12-26	WOS:000427587500001
J	Veesa, KS; John, KR; Moonan, PK; Kaliappan, SP; Manjunath, K; Sagili, KD; Ravichandra, C; Menon, PA; Dolla, C; Luke, N; Munshi, K; George, K; Minz, S				Veesa, Karun Sandeep; John, Kamalabhai Russell; Moonan, Patrick K.; Kaliappan, Saravanakumar Puthupalayam; Manjunath, Krishna; Sagili, Karuna D.; Ravichandra, Chinnappareddy; Menon, Pradeep Aravindan; Dolla, Chandrakumar; Luke, Nancy; Munshi, Kaivan; George, Kuryan; Minz, Shantidani			Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India	PLOS ONE			English	Article							PUBLIC-PRIVATE MIX; SEEKING BEHAVIOR; SOUTH-INDIA; DELAYS; CARE; NORTHWEST; ETHIOPIA; PROGRAM; BURDEN; DOTS	Background Tuberculosis (TB) patients face substantial delays prior to treatment initiation, and out of pocket (OOP) expenditures often surpass the economic productivity of the household. We evaluated the pre-diagnostic cost and health seeking behaviour of new adult pulmonary TB patients registered at Primary Health Centres (PHCs) in Vellore district, Tamil Nadu, India. Methods This descriptive study, part of a randomised controlled trial conducted in three rural Tuberculosis Units from Dec 2012 to Dec 2015, collected data on number of health facilities, dates of visits prior to the initiation of anti-tuberculosis treatment, and direct OOP medical costs associated with TB diagnosis. Logistic regression analysis examined the factors associated with delays in treatment initiation and OOP expenditures. Results Of 880 TB patients interviewed, 34.7% presented to public health facilities and 65% patients sought private health facilities as their first point of care. The average monthly individual income was $77.79 (SD 57.14). About 69% incurred some pre-treatment costs at an average of $39.74. Overall, patients experienced a median of 6 days (3-11 IQR) of time to treatment initiation and 21 days (10-30 IQR) of health systems delay. Age <= 40 years (aOR: 1.73; CI: 1.22-2.44), diabetes (aOR: 1.63; CI: 1.08-2.44) and first visit to a private health facility (aOR: 17.2; CI: 11.1-26.4) were associated with higher direct OOP medical costs, while age <= 40 years (aOR: 0.64; CI: 0.48-0.85) and first visit to private health facility (aOR: 1.79, CI: 1.34-2.39) were associated with health systems delay. Conclusion The majority of rural TB patients registering at PHCs visited private health facilities first and incurred substantial direct OOP medical costs and delays prior to diagnosis and anti-tuberculosis treatment initiation. This study highlights the need for PHCs to be made as the preferred choice for first point of contact, to combat TB more efficiently.	[Veesa, Karun Sandeep; Kaliappan, Saravanakumar Puthupalayam; Manjunath, Krishna; George, Kuryan; Minz, Shantidani] Christian Med Coll & Hosp, Dept Community Hlth, Vellore, Tamil Nadu, India; [John, Kamalabhai Russell] Apollo Inst Med Sci, Dept Community Med, Chittoor, Andhra Pradesh, India; [Moonan, Patrick K.] US Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA USA; [Sagili, Karuna D.] Union South East Asia Off, Int Union TB & Lung Dis, New Delhi, India; [Ravichandra, Chinnappareddy] Natl TB Inst, Bangalore, Karnataka, India; [Menon, Pradeep Aravindan; Dolla, Chandrakumar] Natl Inst Res TB, Madras, Tamil Nadu, India; [Luke, Nancy] Penn State Univ, Populat Res Inst, Dept Sociol & Criminol, University Pk, PA 16802 USA; [Munshi, Kaivan] Univ Cambridge, Dept Econ, Cambridge, England	Christian Medical College & Hospital (CMCH) Vellore; Centers for Disease Control & Prevention - USA; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Cambridge	Minz, S (corresponding author), Christian Med Coll & Hosp, Dept Community Hlth, Vellore, Tamil Nadu, India.	shantidani@cmcvellore.ac.in	SOUNDRARAJAN, JOYSON/I-1779-2019; Moonan, Patrick/AAD-2169-2021	Moonan, Patrick/0000-0002-3550-2065; KALIAPPAN, SARAVANAKUMAR/0000-0002-1904-6880; Veesa, Karun Sandeep/0000-0002-6777-5885	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01 HD058831-01]; Population Research Institute at Penn State University; NICHD [P2CHD041025]; Newton Trust at the University of Cambridge; Population Studies and Training Center at Brown University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD041025] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Population Research Institute at Penn State University; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Newton Trust at the University of Cambridge; Population Studies and Training Center at Brown University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The data used in this paper are from a project directed by Kaivan Munshi, University of Cambridge, Nancy Luke, Pennsylvania State University, Soumya Swaminathan, Indian Council of Medical Research, and Shantidani Minz, Christian Medical College, Vellore. The project was supported by a grant (R01 HD058831-01) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Support was also provided by the Population Research Institute at Penn State University, which is supported by an infrastructure grant from NICHD (P2CHD041025); the Newton Trust at the University of Cambridge; and the Population Studies and Training Center at Brown University. The study was conducted as a part of the 'TB Operations Research Training Project' aimed to build operational research capacity within the Government of India's RNTCP. This training project was conceived and implemented jointly by Central TB Division (Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India), the National TB Institute (Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, Bangalore, India), The International Union Against Tuberculosis and Lung Diseases (The Union, South-East Asia Regional Office, New Delhi, India) and U.S. Centers for Disease Control and Prevention (Division of TB Elimination, Atlanta, USA).; The project was supported by a grant (R01 HD058831-01) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Support was also provided by the Population Research Institute at Penn State University, which is supported by an infrastructure grant from NICHD (P2CHD041025); the Newton Trust at the University of Cambridge; and the Population Studies and Training Center at Brown University.	Adenager Getinet Shewaseged, 2017, Tuberc Res Treat, V2017, P5120841, DOI 10.1155/2017/5120841; [Anonymous], 2016, NAT STRAT PLAN TUB C, V7, P19; Arinaminpathy N, 2016, LANCET INFECT DIS, V16, P1255, DOI 10.1016/S1473-3099(16)30259-6; Aspler A, 2008, INT J TUBERC LUNG D, V12, P928; Bawankule S, 2010, ONLINE J HLTH ALLIED; Bogale S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2240-0; Central Tuberculosis Division Ministry of Health and Family Welfare Government of India, TECHN OP GUID TUB CO; Charles N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012379; Dhanvij P, DELAY DIAGNOSIS TUBE; Foster N, 2015, SOC SCI MED, V130, P42, DOI 10.1016/j.socscimed.2015.01.046; Gebreegziabher SB, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1995-z; Goal K, 2011, INDAN J COMMUNITY HE, V23, P87; John KR, 2009, INT J TUBERC LUNG D, V13, P1281; Kelkar-Khambete A, 2008, INT J TUBERC LUNG D, V12, P87; Krishnan N, 2009, INT J TUBERC LUNG D, V13, P112; Lal SS, 2011, INT J TUBERC LUNG D, V15, P97; Laokri S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096912; Mesfin MM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-173; Moghaddam HT, 2016, INT J PEDIATR-MASSHA, V4, P1243; Pantoja A, 2009, INT J TUBERC LUNG D, V13, P705; Pinto LM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-357; Rajeswari R, 2002, INT J TUBERC LUNG D, V6, P789; Satyanarayana S, 2015, INT J TUBERC LUNG D, V19, P751, DOI 10.5588/ijtld.15.0186; Selvam JM, 2007, INT J TUBERC LUNG D, V11, P161; Sreeramareddy CT, 2014, INT J TUBERC LUNG D, V18, P255, DOI 10.5588/ijtld.13.0585; Sudha G, 2003, TROP MED INT HEALTH, V8, P336, DOI 10.1046/j.1365-3156.2003.01010.x; Tanimura T, 2014, EUR RESPIR J, V43, P1763, DOI 10.1183/09031936.00193413; Tegegn A, 2009, ETHIOP J HLTH SCI, V19; Thakur Rajesh, 2013, Indian J Tuberc, V60, P37; Uplekar MW, 2003, INT J TUBERC LUNG D, V7, P1113; World Health Organisation, 2017, TUB FACT SHEET, V6, P30; World Health Organisation, 2017, GLOB TUB REP 2016, V6, P30; World Health Organisation. WHO-EM, 2017, DIAGN TREATM DEL TUB, V6, P30	33	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191591	10.1371/journal.pone.0191591	http://dx.doi.org/10.1371/journal.pone.0191591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414980	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000424325300034
J	Freundt-Revilla, J; Heinrich, F; Zoerner, A; Gesell, F; Beyerbach, M; Shamir, M; Oevermann, A; Baumgartner, W; Tipold, A				Freundt-Revilla, Jessica; Heinrich, Franciska; Zoerner, Alexander; Gesell, Felix; Beyerbach, Martin; Shamir, Merav; Oevermann, Anna; Baumgaertner, Wolfgang; Tipold, Andrea			The endocannabinoid system in canine Steroid-Responsive Meningitis-Arteritis and Intraspinal Spirocercosis	PLOS ONE			English	Article							CANNABINOID CB2 RECEPTOR; PERIPHERAL-BLOOD EOSINOPHILS; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; MICROGLIAL CELLS; ENDOGENOUS CANNABINOIDS; MULTIPLE-SCLEROSIS; DISTEMPER VIRUS; LUPI INFECTION; HUMAN BRAIN	Endocannabinoids (ECs) are involved in immunomodulation, neuroprotection and control of inflammation in the central nervous system (CNS). Activation of cannabinoid type 2 receptors (CB2) is known to diminish the release of pro-inflammatory factors and enhance the secretion of anti-inflammatory cytokines. Furthermore, the endocannabinoid 2-arachidonoyl glycerol (2-AG) has been proved to induce the migration of eosinophils in a CB2 receptor-dependent manner in peripheral blood and activate neutrophils independent of CB activation in humans. The aim of the current study was to investigate the influence of the endocannabinoid system in two different CNS inflammatory diseases of the dog, i.e. Steroid-Responsive Meningitis-Arteritis (SRMA) and Intraspinal Spirocercosis (IS). The two main endocannabinoids, anandamide (AEA) and 2-AG, were quantified by mass spectrometry in CSF and serum samples of dogs affected with Steroid-Responsive Meningitis-Arteritis in the acute phase (SRMA A), SRMA under treatment with prednisolone (SRMA Tr), intraspinal Spirocercosis and healthy dogs. Moreover, expression of the CB2 receptor was evaluated in inflammatory lesions of SRMA and IS and compared to healthy controls using immunohistochemistry (IHC). Dogs with SRMA A showed significantly higher concentrations of total AG and AEA in serum in comparison to healthy controls and in CSF compared to SRMA Tr (p<0.05). Furthermore, dogs with IS displayed the highest ECs concentrations in CSF, being significantly higher than in CSF samples of dogs with SRMA A (p<0.05). CSF samples that demonstrated an eosinophilic pleocytosis had the highest levels of ECs, exceeding those with neutrophilic pleocytosis, suggesting that ECs have a major effect on migration of eosinophils in the CSF. Furthermore, CB2 receptor expression was found in glial cells in the spinal cord of healthy dogs, whereas in dogs with SRMA and IS, CB2 was strongly expressed not only in glial cells but also on the cellular surface of infiltrating leukocytes (i.e. neutrophils, eosinophils, lymphocytes, plasma cells, and macrophages) at lesion sites. The present study revealed an upregulated endocannabinoid system in dogs with inflammatory CNS diseases, highlighting the endocannabinoid system as a potential target for treatment of inflammatory CNS diseases.	[Freundt-Revilla, Jessica; Gesell, Felix; Tipold, Andrea] Univ Vet Med Hannover, Dept Small Anim Med & Surg, Hannover, Germany; [Freundt-Revilla, Jessica; Heinrich, Franciska; Baumgaertner, Wolfgang; Tipold, Andrea] Ctr Syst Neurosci, Hannover, Germany; [Heinrich, Franciska; Baumgaertner, Wolfgang] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany; [Zoerner, Alexander] Hannover Med Sch, Inst Clin Pharmacol, Hannover, Germany; [Beyerbach, Martin] Univ Vet Med Hannover, Inst Biometry Epidemiol & Informat Proc, Hannover, Germany; [Shamir, Merav] Hebrew Univ Jerusalem, Koret Sch Vet Med, Jerusalem, Israel; [Oevermann, Anna] Univ Bern, Vetsuisse Fac, Dept Clin Res & Vet Publ Hlth, Bern, Switzerland	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; Hebrew University of Jerusalem; University of Bern	Freundt-Revilla, J (corresponding author), Univ Vet Med Hannover, Dept Small Anim Med & Surg, Hannover, Germany.; Freundt-Revilla, J (corresponding author), Ctr Syst Neurosci, Hannover, Germany.	Jessica.Freundt.Revilla@tiho-hannover.de			Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover, Foundation; Deutscher Akademischer Austauschdienst (DAAD) [PKZ/12/92958]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover, Foundation; Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This publication was supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing. JFR recieved funding from the Deutscher Akademischer Austauschdienst (DAAD), Grant number: PKZ/12/92958 (http://www.daad.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo-Martin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049057; Arevalo-Martin A, 2010, NEUROBIOL DIS, V38, P304, DOI 10.1016/j.nbd.2010.02.002; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Baker D, 2001, FASEB J, V15, P300, DOI 10.1096/fj.00-0399fje; Battista N, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00009; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Cabral GA, 2005, J LEUKOCYTE BIOL, V78, P1192, DOI 10.1189/jlb.0405216; Cabral GA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000957; Campora L, 2012, AM J VET RES, V73, P988, DOI 10.2460/ajvr.73.7.988; Carlisle SJ, 2002, INT IMMUNOPHARMACOL, V2, P69, DOI 10.1016/S1567-5769(01)00147-3; Carrier EJ, 2004, MOL PHARMACOL, V65, P999, DOI 10.1124/mol.65.4.999; Chai O, 2008, VET RADIOL ULTRASOUN, V49, P456, DOI 10.1111/j.1740-8261.2008.00407.x; Chiarlone A, 2014, P NATL ACAD SCI USA, V111, P8257, DOI 10.1073/pnas.1400988111; Chiurchiu V, 2016, CANNABIS CANNABINOID, V1, P59, DOI 10.1089/can.2016.0002; Chouinard F, 2013, J LEUKOCYTE BIOL, V93, P267, DOI 10.1189/jlb.0412200; Comelli F, 2007, BRIT J PHARMACOL, V152, P787, DOI 10.1038/sj.bjp.0707425; De Lahunta A., 2014, VET NEUROANATOMY CLI, P243; De Lahunta A., 2021, LAHUNTAS VET NEUROAN, V5th, P6; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Di Marzo V, 1999, EUR J BIOCHEM, V264, P258, DOI 10.1046/j.1432-1327.1999.00631.x; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Di Marzo V, 2007, CURR OPIN LIPIDOL, V18, P129, DOI 10.1097/MOL.0b013e32803dbdec; Di Marzo V, 2015, NAT REV NEUROSCI, V16, P30, DOI 10.1038/nrn3876; Du Plessis CJ, 2007, J SMALL ANIM PRACT, V48, P275, DOI 10.1111/j.1748-5827.2006.00262.x; Dvir E, 2007, J VET INTERN MED, V21, P860, DOI 10.1892/0891-6640(2007)21[860:SIASLM]2.0.CO;2; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Fernandez-Ruiz J, 2007, TRENDS PHARMACOL SCI, V28, P39, DOI 10.1016/j.tips.2006.11.001; Gal A, 2005, VET PARASITOL, V130, P331, DOI 10.1016/j.vetpar.2005.03.037; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Galve-Roperh I, 2013, PROG LIPID RES, V52, P633, DOI 10.1016/j.plipres.2013.05.004; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Gauthier KM, 2005, AM J PHYSIOL-HEART C, V288, pH1344, DOI 10.1152/ajpheart.00537.2004; Gesell FK, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-262; Glass M, 1999, MOL PHARMACOL, V56, P1362, DOI 10.1124/mol.56.6.1362; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Gonsiorek W, 2000, MOL PHARMACOL, V57, P1045; Gonthier MP, 2007, OBESITY, V15, P837, DOI 10.1038/oby.2007.581; Grundy RI, 2002, EXPERT OPIN INV DRUG, V11, P1365, DOI 10.1517/13543784.11.10.1365; Gui H, 2015, INT IMMUNOPHARMACOL, V26, P86, DOI 10.1016/j.intimp.2015.03.006; Hansen HH, 2001, J NEUROCHEM, V78, P1415, DOI 10.1046/j.1471-4159.2001.00542.x; HARCOURT RA, 1978, VET REC, V102, P519, DOI 10.1136/vr.102.24.519; Harrus S, 1996, J AM ANIM HOSP ASSOC, V32, P125, DOI 10.5326/15473317-32-2-125; Hegde VL, 2008, MOL PHARMACOL, V74, P20, DOI 10.1124/mol.108.047035; Imbschweiler I, 2012, GLIA, V60, P358, DOI 10.1002/glia.22270; Jacobsen EA, 2012, BLOOD, V120, P3882, DOI 10.1182/blood-2012-06-330845; Karsak M, 2007, SCIENCE, V316, P1494, DOI 10.1126/science.1142265; Kegler K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133916; Kishimoto S, 2004, J BIOCHEM, V135, P517, DOI 10.1093/jb/mvh063; Kishimoto S, 2006, INT ARCH ALLERGY IMM, V140, P3, DOI 10.1159/000092704; Krishnan G, 2012, GLIA, V60, P1629, DOI 10.1002/glia.22380; Louvet A, 2011, HEPATOLOGY, V54, P1217, DOI 10.1002/hep.24524; Luongo L, 2010, NEUROBIOL DIS, V37, P177, DOI 10.1016/j.nbd.2009.09.021; Mackie K, 2005, HANDB EXP PHARMACOL, V168, P299; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mestre L, 2005, J NEUROCHEM, V92, P1327, DOI 10.1111/j.1471-4159.2004.02979.x; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; Molina-Holgado E, 2002, J NEUROSCI, V22, P9742, DOI 10.1523/jneurosci.22-22-09742.2002; Muccioli GG, 2010, DRUG DISCOV TODAY, V15, P474, DOI 10.1016/j.drudis.2010.03.007; Mylonakis ME, 2008, COMPENDIUM, V30, P111; Nagarkatti P, 2009, FUTURE MED CHEM, V1, P1333, DOI 10.4155/FMC.09.93; Ndong C, 2011, EUR J PHARMACOL, V669, P24, DOI 10.1016/j.ejphar.2011.08.002; Nunez E, 2004, SYNAPSE, V53, P208, DOI 10.1002/syn.20050; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Oka S, 2004, J LEUKOCYTE BIOL, V76, P1002, DOI 10.1189/jlb.0404252; Onaivi ES, 2012, J PSYCHOPHARMACOL, V26, P92, DOI 10.1177/0269881111400652; Pacher P, 2011, PROG LIPID RES, V50, P193, DOI 10.1016/j.plipres.2011.01.001; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Pertwee RG, 2006, INT J OBESITY, V30, pS13, DOI 10.1038/sj.ijo.0803272; Rayman N, 2004, J IMMUNOL, V172, P2111, DOI 10.4049/jimmunol.172.4.2111; Rom S, 2013, J NEUROIMMUNE PHARM, V8, P608, DOI 10.1007/s11481-013-9445-9; Romigi A, 2010, EPILEPSIA, V51, P768, DOI 10.1111/j.1528-1167.2009.02334.x; Savinainen JR, 2001, BRIT J PHARMACOL, V134, P664, DOI 10.1038/sj.bjp.0704297; Seehusen F, 2007, ACTA NEUROPATHOL, V114, P597, DOI 10.1007/s00401-007-0307-5; Skaper SD, 1996, P NATL ACAD SCI USA, V93, P3984, DOI 10.1073/pnas.93.9.3984; Spitzbarth I, 2012, VET IMMUNOL IMMUNOP, V147, P6, DOI 10.1016/j.vetimm.2012.04.005; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; Storr MA, 2009, INFLAMM BOWEL DIS, V15, P1678, DOI 10.1002/ibd.20960; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sugiura T, 1998, BIOCHEM BIOPH RES CO, V243, P838, DOI 10.1006/bbrc.1998.8187; TIPOLD A, 1994, J SMALL ANIM PRACT, V35, P311, DOI 10.1111/j.1748-5827.1994.tb03293.x; Tipold A, 2010, J SMALL ANIM PRACT, V51, P150, DOI 10.1111/j.1748-5827.2009.00848.x; TIPOLD A, 1995, J VET INTERN MED, V9, P304, DOI 10.1111/j.1939-1676.1995.tb01089.x; Tipold A, 2003, CLIN NEUROLOGY SMALL; Tudury EA, 1995, RELATO CASO, V32, P5; Turcotte C, 2015, J LEUKOCYTE BIOL, V97, P1049, DOI 10.1189/jlb.3RU0115-021R; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Varga K, 1998, FASEB J, V12, P1035, DOI 10.1096/fasebj.12.11.1035; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Witting A, 2004, J NEUROCHEM, V89, P1555, DOI 10.1111/j.1471-4159.2004.02544.x; Yu XJ, 2010, DECIS ENG, P11, DOI 10.1109/IECON.2010.5675382; Zoerner AA, 2012, J CHROMATOGR B, V883, P161, DOI 10.1016/j.jchromb.2011.06.025; Zoerner AA, 2011, BBA-MOL CELL BIOL L, V1811, P706, DOI 10.1016/j.bbalip.2011.08.004	98	14	14	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0187197	10.1371/journal.pone.0187197	http://dx.doi.org/10.1371/journal.pone.0187197			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408878	gold, Green Published, Green Submitted			2022-12-26	WOS:000424302800001
J	Oliver, SV; Brooke, BD				Oliver, Shune V.; Brooke, Basil D.			The effect of metal pollution on the life history and insecticide resistance phenotype of the major malaria vector Anopheles arabiensis (Diptera: Culicidae)	PLOS ONE			English	Article							MOSQUITO AEDES-AEGYPTI; SOUTH-AFRICA; PLASMODIUM-FALCIPARUM; PYRETHROID RESISTANCE; DETOXIFICATION GENES; LARVAL NUTRITION; HEAVY-METALS; BODY-SIZE; GAMBIAE; SELECTION	Metal exposure is one of the commonest anthropogenic pollutants mosquito larvae are exposed to, both in agricultural and urban settings. As members of the Anopheles gambiae complex, which contains several major malaria vector species including An. arabiensis, are increasingly adapting to polluted environments, this study examined the effects of larval metal exposure on various life history traits of epidemiological importance. Two laboratory strains of An. arabiensis, SENN (insecticide susceptible) and SENN DDT (insecticide resistant), were reared in maximum acceptable toxicity concentrations, (MATC the highest legally accepted concentration) of cadmium chloride, lead nitrate and copper nitrate. Following these exposures, time to pupation, adult size and longevity were determined. Larvae reared in double the MATC were assessed for changes in malathion and deltamethrin tolerance, measured by lethal time bottle bioassay, as well as changes in detoxification enzyme activity. As defence against oxidative stress has previously been demonstrated to affect the expression of insecticide resistance, catalase, glutathione peroxidase and superoxide dismutase activity was assessed. The relative metal toxicity to metal naive larvae was also assessed. SENN DDT larvae were more tolerant of metal pollution than SENN larvae. Pupation in SENN larvae was significantly reduced by metal exposure, while adult longevity was not affected. SENN DDT showed decreased adult size after larval metal exposure. Adult insecticide tolerance was increased after larval metal exposure, and this effect appeared to be mediated by increased (3-esterase, cytochrome P450 and superoxide dismutase activity. These data suggest an enzyme-mediated positive link between tolerance to metal pollutants and insecticide resistance in adult mosquitoes. Furthermore, exposure of larvae to metal pollutants may have operational consequences under an insecticide-based vector control scenario by increasing the expression of insecticide resistance in adults.	[Oliver, Shune V.; Brooke, Basil D.] Natl Inst Communicable Dis, Ctr Emerging Zoonot & Parasit Dis, Johannesburg, South Africa; [Oliver, Shune V.; Brooke, Basil D.] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Wits Res Inst Malaria, Johannesburg, South Africa	National Institute for Communicable Diseases (NICD); University of Witwatersrand	Oliver, SV (corresponding author), Natl Inst Communicable Dis, Ctr Emerging Zoonot & Parasit Dis, Johannesburg, South Africa.; Oliver, SV (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Wits Res Inst Malaria, Johannesburg, South Africa.	shuneo@nicd.ac.za	Oliver, Shune/AAH-4961-2019	Oliver, Shune/0000-0003-0658-6658; Brooke, Basil/0000-0002-8857-1304	National Research Foundation Thuthuka post-PhD track grant [TTK160622173523]; National Health Laboratory Service development grant [2014-DEV31-SOLIVER]	National Research Foundation Thuthuka post-PhD track grant; National Health Laboratory Service development grant	This study was funded by a National Research Foundation Thuthuka post-PhD track grant (TTK160622173523) and a National Health Laboratory Service development grant (2014-DEV31-SOLIVER) to SVO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, WORLD HLTH ORG TECHN, DOI [10.1021/jp052915b, DOI 10.1021/JP052915B]; Antonio-Nkondjio C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-154; Awolola T. S., 2007, Journal of Vector Borne Diseases, V44, P241; Chambers GM, 2001, J VECTOR ECOL, V26, P196; CHIN TA, 1993, TOXICOLOGY, V77, P145, DOI 10.1016/0300-483X(93)90145-I; COOGAN TP, 1994, J TOXICOL ENV HEALTH, V41, P233, DOI 10.1080/15287399409531839; Dandalo LC, 2017, J MED ENTOMOL, V54, P1758, DOI 10.1093/jme/tjx169; DJOUAKA RF, 2007, MALARIA J, V6; Eisler R, 2004, REV ENVIRON CONTAM T, V181, P139, DOI 10.1007/0-387-21733-9_4; Finney D.J, 1952, STAT METHOD BIOL ASS; Huber M, 2016, SCI TOTAL ENVIRON, V541, P895, DOI 10.1016/j.scitotenv.2015.09.033; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Jiao WT, 2012, ENVIRON POLLUT, V168, P44, DOI 10.1016/j.envpol.2012.03.052; Jones CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045995; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Kitau J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031481; Lehmann T, 2006, INFECT GENET EVOL, V6, P410, DOI 10.1016/j.meegid.2006.01.007; LYIMO EO, 1992, PARASITOLOGY, V104, P233, DOI 10.1017/S0031182000061667; Matambo TS, 2007, MED VET ENTOMOL, V21, P97, DOI 10.1111/j.1365-2915.2007.00671.x; Mattingly KS, 2001, AQUAT TOXICOL, V54, P249, DOI 10.1016/S0166-445X(00)00181-8; Mireji PO, 2010, MED VET ENTOMOL, V24, P101, DOI 10.1111/j.1365-2915.2010.00863.x; Mireji PO, 2010, ECOTOX ENVIRON SAFE, V73, P46, DOI 10.1016/j.ecoenv.2009.08.004; Mireji Paul Odhiambo, 2006, International Journal of Tropical Insect Science, V26, P214, DOI 10.1017/S1742758406658955; Monserrat JM, 2007, COMP BIOCHEM PHYS C, V146, P221, DOI 10.1016/j.cbpc.2006.08.012; Musasia Fauzia K, 2013, Malar J, V12, P97, DOI 10.1186/1475-2875-12-97; Nkya TE, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0480-z; Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006; Oliver SV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151049; Oliver SV, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-390; Oliver SV, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-44; Oliver SV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180909; Oliver SV, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1720-4; Padmanabha H, 2011, MED VET ENTOMOL, V25, P445, DOI 10.1111/j.1365-2915.2011.00950.x; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Poupardin R, 2012, AQUAT TOXICOL, V114, P49, DOI 10.1016/j.aquatox.2012.02.001; Rayms-Keller A, 1998, ECOTOX ENVIRON SAFE, V39, P41, DOI 10.1006/eesa.1997.1605; Riaz MA, 2009, AQUAT TOXICOL, V93, P61, DOI 10.1016/j.aquatox.2009.03.005; Sawadogo SP, 2013, J MED ENTOMOL, V50, P285, DOI 10.1603/ME12041; SHARP BL, 1990, J AM MOSQUITO CONTR, V6, P197; Shiao SH, 2008, J INSECT PHYSIOL, V54, P231, DOI 10.1016/j.jinsphys.2007.09.007; SINKA ME, 2010, PARASITE VECTOR, V0003; Suwanchaichinda C, 1998, J MED ENTOMOL, V35, P157, DOI 10.1093/jmedent/35.2.157; TAKKEN W, 2013, PARASITE VECTOR, V6; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Walters CR, 2011, J ENVIRON SCI HEAL A, V46, P1129, DOI 10.1080/10934529.2011.590729; Zhang L, 2015, INT J ENV RES PUB HE, V12, P14115, DOI 10.3390/ijerph121114115	46	24	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192551	10.1371/journal.pone.0192551	http://dx.doi.org/10.1371/journal.pone.0192551			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408922	Green Published, gold, Green Submitted			2022-12-26	WOS:000424302800080
J	Tao, SY; Jiao, ZL; Wen, GG; Zhang, LH; Wang, GX				Tao, Siying; Jiao, Zhenlong; Wen, Guigui; Zhang, Lihong; Wang, Guoxiu			Cloning and expression analysis of the DEAD-box/RNA helicase Oslaf-1 in Ovomermis sinensis	PLOS ONE			English	Article							BOX RNA HELICASE; PROTEIN; TRANSLATION; GENE; HYDROLYSIS; NEMATODES; ELEGANS; BINDING; FAMILY; VBH-1	Ovomermis sinensis is a potentially-valuable nematode for controlling insect pests. The parasitic stage of the nematode absorbs nutrients in its host's hemolymph to maintain its growth development and then kills the host when it emerges. At present, little known about its reproductive development, particularly the responsible molecular mechanism. More detailed research on the genes of reproductive development will not only help us understand the mechanisms underlying sex differentiation in the nematode, but would also be valuable for successfully cultivating them in vitro and using them for biocontrol. In this study, we used the homology cloning method to clone the full-length cDNA of a DEAD-box family gene (Oslaf-1) from O. sinensis. Then, using qRT-PCR technology to detect the expression pattern of the Oslaf-1 gene at different development stages and tissues, the gene was found to be highly expressed in the post-parasitic stage (P < 0.01) and ovarian (P < 0.05) of O. sinensis. Western blot analysis showed the same result that the gene is associated with gonadal development and function, but is not gonad-specific. In situ hybridization further demonstrated that the gene is widely expressed in early embryos and is mainly distributed in the gonadal area. However, the signal was mainly concentrated in the reproductive primordia in pre-parasitic juveniles. RNA interference (RNAi) studies revealed that the sex ratio of O. sinensis soaked in dsRNA of Oslaf-1 was not statistically different than the gfp dsRNA treated groups. Our results suggest that Oslaf-1 may play a vital role in the reproductive systems of the nematode. In addition, we speculate that the Oslaf-1 gene plays an important role during embryonic development and that it occurs and develops in the gonads of pre-parasitic juveniles of O. sinensis.	[Tao, Siying; Jiao, Zhenlong; Wen, Guigui; Zhang, Lihong; Wang, Guoxiu] Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Hubei, Peoples R China	Central China Normal University	Wang, GX (corresponding author), Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Hubei, Peoples R China.	wanggx@mail.ccnu.edu.cn			National Natural Science Foundation of China [31572279]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31572279) to GW.; This work was supported by the National Natural Science Foundation of China (Grant No. 31572279).	Aubourg S, 1999, NUCLEIC ACIDS RES, V27, P628, DOI 10.1093/nar/27.2.628; CHAUDHARY BR, 1988, ARCH PROTISTENKD, V136, P389, DOI 10.1016/S0003-9365(88)80019-8; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; Duan MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163127; Goodwin EB, 1997, DEVELOPMENT, V124, P749; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; GURURAJAN R, 1991, NATURE, V349, P717, DOI 10.1038/349717a0; Gustafson EA, 2010, BIOCHEM BIOPH RES CO, V395, P1, DOI 10.1016/j.bbrc.2010.02.172; Hubert A, 2009, DEV BIOL, V330, P358, DOI 10.1016/j.ydbio.2009.04.003; Jiao Z, 2016, BIOCONTROL SCI TECHN, V26, P1; LEROY P, 1989, CELL, V57, P549, DOI 10.1016/0092-8674(89)90125-6; [李俊莉 LI Junli], 2006, [华中师范大学学报. 自然科学版, Journal of Central China Normal University. Natural Sciences edition], V40, P265; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malygin AA, 2007, NUCLEIC ACIDS RES, V35, P6414, DOI 10.1093/nar/gkm701; Marracci S, 2007, DEV GENES EVOL, V217, P395, DOI 10.1007/s00427-007-0143-6; Olsen LC, 1997, MECH DEVELOP, V66, P95, DOI 10.1016/S0925-4773(97)00099-3; PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; PETERSEN JJ, 1981, J NEMATOL, V13, P228; Edward EG, 2007, J AM MOSQUITO CONTR, V23, P58, DOI 10.2987/8756-971X(2007)23[58:MN]2.0.CO;2; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Salinas LS, 2007, GENESIS, V45, P533, DOI 10.1002/dvg.20323; Salinas LS, 2012, GENESIS, V50, P801, DOI 10.1002/dvg.22043; Stuart RJ, 1998, J INVERTEBR PATHOL, V72, P288, DOI 10.1006/jipa.1998.4789; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thompson RC, 2006, DEV DYNAM, V235, P2538; Tuteja N, 2014, PLANT MOL BIOL, V85, P639, DOI 10.1007/s11103-014-0209-6; Wang Guo-Xiu, 2001, Acta Zoologica Sinica, V47, P235; Wang W. H., 2009, THESIS; Wei YA, 2012, ONCOL REP, V27, P504, DOI 10.3892/or.2011.1536; Zhao N. L., 2010, THESIS	35	1	1	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192101	10.1371/journal.pone.0192101	http://dx.doi.org/10.1371/journal.pone.0192101			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408876	Green Submitted, Green Published, gold			2022-12-26	WOS:000424302800045
J	Babu, MS; Mahanta, S; Lakhter, AJ; Hato, T; Paul, S; Naidu, SR				Babu, Mani Shankar; Mahanta, Sailendra; Lakhter, Alexander J.; Hato, Takashi; Paul, Subhankar; Naidu, Samisubbu R.			Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2	PLOS ONE			English	Article							BRAF INHIBITION; TUMOR-GROWTH; MELANOMA; METABOLISM; IDENTIFICATION; VEMURAFENIB; PGC1-ALPHA; EXPRESSION; RESISTANCE; SHIKONIN	Reliance on aerobic glycolysis is one of the hallmarks of cancer. Although pyruvate kinase M2 (PKM2) is a key mediator of glycolysis in cancer cells, lack of selective agents that target PKM2 remains a challenge in exploiting metabolic pathways for cancer therapy. We report that unlike its structural analog shikonin, a known inhibitor of PKM2, lapachol failed to induce non-apoptotic cell death ferroxitosis in hypoxia. However, melanoma cells treated with lapachol showed a dose-dependent inhibition of glycolysis and a corresponding increase in oxygen consumption. Accordingly, in silico studies revealed a high affinity-binding pocket for lapachol on PKM2 structure. Lapachol inhibited PKM2 activity of purified enzyme as well as in melanoma cell extracts. Blockade of glycolysis by lapachol in melanoma cells led to decreased ATP levels and inhibition of cell proliferation. Furthermore, perturbation of glycolysis in melanoma cells with lapachol sensitized cells to mitochondrial protonophore and promoted apoptosis. These results present lapachol as an inhibitor of PKM2 to interrogate metabolic plasticity in tumor cells.	[Babu, Mani Shankar; Lakhter, Alexander J.; Naidu, Samisubbu R.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Mahanta, Sailendra; Paul, Subhankar] Natl Inst Technol, Dept Biotechnol & Med Engn, Struct Biol & Nanomed Lab, Rourkela, Odisha, India; [Hato, Takashi] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; National Institute of Technology (NIT System); National Institute of Technology Rourkela; Indiana University System; Indiana University Bloomington	Naidu, SR (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	naidus@iu.edu	Mahanta, Sailendra Kumar/U-8237-2019; MAHANTA, SAILENDRA/GQQ-8093-2022	Mahanta, Sailendra Kumar/0000-0003-1254-2264; Naidu, Samisubbu/0000-0001-9411-660X; Shankar Babu, Mani/0000-0002-2693-1634; Hato, Takashi/0000-0002-0446-6575	Indiana CTSI; Showalter Award; Indiana University School of Medicine; Government of India	Indiana CTSI; Showalter Award; Indiana University School of Medicine; Government of India	This work was in part supported by grants from Indiana CTSI, Showalter Award and Biomedical Research Grant from Indiana University School of Medicine (to SRN). MSB is a recipient of Raman Postdoctoral Fellowship from the Government of India. Hal E Broxmeyer contributed significant financial support for the study and the authors thank him for reading the manuscript.; This work was in part supported by grants from Indiana CTSI, Showalter Award and Biomedical Research Grant from Indiana University School of Medicine (to S.R.N). MSB is a recipient of Raman Postdoctoral Fellowship from the Government of India. Hal E Broxmeyer contributed significant financial support for the study and the authors thank him for reading the manuscript.	ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; BLOCK JB, 1974, CANCER CHEMOTH REP 2, V4, P27; Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen J, 2011, ONCOGENE, V30, P4297, DOI 10.1038/onc.2011.137; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; DEALMEIDA ER, 1990, J ETHNOPHARMACOL, V29, P239, DOI 10.1016/0378-8741(90)90061-W; Deshmukh A, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0555-x; Felicio AC, 2002, CONTRACEPTION, V66, P289, DOI 10.1016/S0010-7824(02)00356-6; FIESER L F, 1946, Rec Chem Prog, V7, P26; Filipp Fabian V, 2013, J Carcinog, V12, P14, DOI 10.4103/1477-3163.115423; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Hussain H, 2017, EXPERT OPIN THER PAT, V27, P1111, DOI 10.1080/13543776.2017.1339792; Lakhter AJ, 2014, ONCOTARGET, V5, P12694, DOI 10.18632/oncotarget.3031; Li WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094079; Li WJ, 2014, MOL CARCINOGEN, V53, P403, DOI 10.1002/mc.21988; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Luo WB, 2012, TRENDS ENDOCRIN MET, V23, P560, DOI 10.1016/j.tem.2012.06.010; Macintyre AN, 2011, MOL CELL, V42, P713, DOI 10.1016/j.molcel.2011.06.003; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Ning XL, 2017, EUR J MED CHEM, V138, P343, DOI 10.1016/j.ejmech.2017.06.064; Olson KA, 2016, TRENDS BIOCHEM SCI, V41, P219, DOI 10.1016/j.tibs.2016.01.002; OTTEN S, 1978, APPL ENVIRON MICROB, V35, P554, DOI 10.1128/AEM.35.3.554-557.1978; Parmenter TJ, 2014, CANCER DISCOV, V4, P423, DOI 10.1158/2159-8290.CD-13-0440; Pinho BR, 2013, BRIT J PHARMACOL, V169, P1072, DOI 10.1111/bph.12186; PINTO A V, 1987, Revista Latinoamericana de Microbiologia, V29, P15; Pollak M, 2013, CANCER CELL, V23, P263, DOI 10.1016/j.ccr.2013.02.015; Potter M, 2016, BIOCHEM SOC T, V44, P1499, DOI 10.1042/BST20160094; RAO KV, 1968, CANCER RES, V28, P1952; RAO KV, 1974, CANCER CHEMOTH REP 3, V4, P11; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; SIEBER SM, 1976, CANCER TREAT REP, V60, P1127; Theodosakis N, 2015, MOL CANCER THER, V14, P1680, DOI 10.1158/1535-7163.MCT-15-0080; Vander Heiden MG, 2010, BIOCHEM PHARMACOL, V79, P1118, DOI 10.1016/j.bcp.2009.12.003; VANVEELEN CWM, 1978, CANCER RES, V38, P4681; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Viale A, 2016, RECENT RESULTS CANC, V207, P135, DOI 10.1007/978-3-319-42118-6_6; Wang YW, 2014, BIOCHEM PHARMACOL, V88, P322, DOI 10.1016/j.bcp.2014.01.041; Yang LC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5436; Yuan P, 2013, P NATL ACAD SCI USA, V110, P18226, DOI 10.1073/pnas.1317577110; Zhao YZ, 2015, CELL METAB, V21, P777, DOI 10.1016/j.cmet.2015.04.009	45	40	40	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191419	10.1371/journal.pone.0191419	http://dx.doi.org/10.1371/journal.pone.0191419			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394289	Green Published, gold, Green Submitted			2022-12-26	WOS:000424060400011
J	Guest, JF; Ingram, A; Ayoub, N; Hendriksz, CJ; Murphy, E; Rahman, Y; McKiernan, P; Mundy, H; Deegan, P				Guest, Julian F.; Ingram, Andy; Ayoub, Nadia; Hendriksz, Christian J.; Murphy, Elaine; Rahman, Yusof; McKiernan, Patrick; Mundy, Helen; Deegan, Patrick			Healthcare resource use and costs of managing children and adults with lysosomal acid lipase deficiency at a tertiary referral centre in the United Kingdom	PLOS ONE			English	Article							ESTER STORAGE DISEASE	Objective To estimate clinical progression and resource utilisation together with the associated costs of managing children and adults with LAL Deficiency, at a tertiary referral centre in the UK. Methods A retrospective chart review was undertaken of patients in the UK with a confirmed diagnosis of LAL Deficiency who were managed at a LAL Deficiency tertiary referral treatment centre. Patients' pathways, treatment patterns, health outcomes and resource use were quantified over differing lengths of time for each patient enabling the NHS cost of patient management in tertiary care to be estimated. Results The study population comprised 19 patients of whom 58% were male. Mean age at the time of initial presentation was 15.5 years and the mean age at diagnosis was 18.0 years. 63%, 53% and 42% of patients had hepatomegaly, abnormal lipid storage and splenomegaly at a mean age of presentation of 17.8, 17.1 and 20.9 years, respectively. Over a period of 50 years there were a mean of 48.5 clinician visits and 3.4 hospital admissions per patient. The mean NHS cost of patient management at a LAL Deficiency tertiary referral treatment centre, spanning a period of over 50 years was 61,454 pound per patient. Conclusion This study provides important insights into a number of aspects of the disease that are difficult to ascertain from published case reports. Additionally, it provides the best estimate available of NHS resource use and costs with which to inform policy and budgetary decisions pertaining to managing this ultra-orphan disease.	[Guest, Julian F.; Ingram, Andy; Ayoub, Nadia] Catalyst Hlth Econ Consultants, Rickmansworth, Herts, England; [Guest, Julian F.] Kings Coll London, Fac Life Sci & Med, London, England; [Hendriksz, Christian J.] Salford Royal NHS Fdn Trust, Adult Inherited Metab Disorders, Salford, Lancs, England; [Hendriksz, Christian J.] Univ Pretoria, Paediat & Child Hlth, Pretoria, South Africa; [Murphy, Elaine] Natl Hosp Neurol & Neurosurg, Charles Dent Metab Unit, London, England; [Rahman, Yusof] Guys & St Thomas Hosp, Adult Inherited Metab Dis, London, England; [McKiernan, Patrick] Birmingham Childrens Hosp, Liver Unit, Birmingham, W Midlands, England; [Mundy, Helen] Guys & St Thomas Hosp, Evelina Childrens Hosp, London, England; [Deegan, Patrick] Addenbrookes Hosp, Lysosomal Disorders Unit, Cambridge, England	University of London; King's College London; Salford Royal NHS Foundation Trust; University of Pretoria; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of Birmingham; Guy's & St Thomas' NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Guest, JF (corresponding author), Catalyst Hlth Econ Consultants, Rickmansworth, Herts, England.; Guest, JF (corresponding author), Kings Coll London, Fac Life Sci & Med, London, England.	julian.guest@catalyst-health.com	; Hendriksz, Christian/E-7377-2013	Guest, Julian F./0000-0003-0162-2007; Deegan, Patrick/0000-0001-9427-9900; Hendriksz, Christian/0000-0003-2179-3639	Synageva Biopharma Corp, Lexington, MA, US	Synageva Biopharma Corp, Lexington, MA, US	This study was part funded by Synageva Biopharma Corp, Lexington, MA, US, now part of Alexion Pharmaceuticals Inc., Cheshire, CT, US. However, the funders had no role in study design, data collection and analysis or preparation of the manuscript. The funders commissioned Catalyst Health Economics Consultants (Catalyst) to conduct the study. However, the funders did not provide support in the form of salaries for Catalyst employees.	Bernstein DL, 2013, J HEPATOL, V58, P1230, DOI 10.1016/j.jhep.2013.02.014; Burton BK, 2015, NEW ENGL J MED, V373, P1010, DOI 10.1056/NEJMoa1501365; Burton BK, 2015, J PEDIATR GASTR NUTR, V61, P619, DOI 10.1097/MPG.0000000000000935; Department of Health, NHS REF COSTS 2014 2; Department of Health, UK STRAT RAR DIS; Grabowski GA, ONLINE METABOLIC MOL; Guest JF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009283; Muntoni S, 2007, ARTERIOSCL THROM VAS, V27, P1866, DOI 10.1161/ATVBAHA.107.146639; Orphanet, WOLM DIS; Rombach SM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-29; Tapper EB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147237; Unit A. L. D., 2014, LYSOSOMAL ACID LIPAS; van Dussen L, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-51	13	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191945	10.1371/journal.pone.0191945	http://dx.doi.org/10.1371/journal.pone.0191945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394260	Green Published, Green Submitted, gold			2022-12-26	WOS:000424060400020
J	Jiang, H; Liu, Y; Wei, YT; Shi, YY; Wright, CB; Sun, XY; Rundek, T; Baumel, BS; Landman, J; Wang, JH				Jiang, Hong; Liu, Yi; Wei, Yantao; Shi, Yingying; Wright, Clinton B.; Sun, Xiaoyan; Rundek, Tatjana; Baumel, Bernard S.; Landman, Jonathan; Wang, Jianhua			Impaired retinal microcirculation in patients with Alzheimer's disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; BLOOD-FLOW-VELOCITY; OPTICAL COHERENCE TOMOGRAPHY; CEREBRAL AMYLOID ANGIOPATHY; A-BETA-DEPOSITION; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; FUNCTION IMAGER; HYPOPERFUSION	The goal of this study was to determine the retinal blood flow rate (BFR) and blood flow velocity (BFV) of pre-capillary arterioles and post-capillary venules in patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD). Forty patients (20 AD and 20 MCI) and 21 cognitively normal (CN) controls with a similar age range (+/- 5 yrs) were recruited. A retinal function imager (RFI) was used to measure BFRs and BFVs of arterioles and venules in the macular region. The thickness of the ganglion cell-inner plexiform layer (GCIPL) was measured using Zeiss Cirrus optical coherence tomography. Macular BFRs in AD group were 2.64 +/- 0.20 nl/s (mean +/- standard deviation) in arterioles and 2.23 +/- 0.19 nl/s in venules, which were significantly lower than in MCI and CN groups (P < 0.05). In addition, BFRs in MCI were lower than in CN in both arterioles and venules (P < 0.05). The BFV of the arterioles was 3.20 +/- 1.07 mm/s in AD patients, which was significantly lower than in CN controls (3.91 +/- 0.77 mm/s, P = 0.01). The thicknesses of GCIPL in patients with AD and MCI were significantly lower than in CN controls (P < 0.05). Neither BFV nor BFR in arterioles and venules was related to age, GCIPL thickness, mini mental state examination (MMSE) score and disease duration in patients with AD and MCI (P > 0.05). The lower BFR in both arterioles and venules in AD and MCI patients together with the loss of GCIPL were evident, indicating the impairment of the two components in the neurovascular-hemodynamic system, which may play a role in disease progression.	[Jiang, Hong; Liu, Yi; Wei, Yantao; Shi, Yingying; Wang, Jianhua] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA; [Jiang, Hong; Sun, Xiaoyan; Rundek, Tatjana; Baumel, Bernard S.; Landman, Jonathan] Univ Miami, Miller Sch Med, Evelyn F McKnight Brain Inst, Dept Neurol, Miami, FL 33136 USA; [Liu, Yi] Nanjing Univ Chinese Med, Affiliated Hosp 3, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China; [Wei, Yantao] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou, Guangdong, Peoples R China; [Wright, Clinton B.] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	Bascom Palmer Eye Institute; University of Miami; University of Miami; Nanjing University of Chinese Medicine; Sun Yat Sen University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Jiang, H (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA.; Jiang, H (corresponding author), Univ Miami, Miller Sch Med, Evelyn F McKnight Brain Inst, Dept Neurol, Miami, FL 33136 USA.	hjiang@med.miami.edu			North American Neuro-ophthalmology Society; McKnight Brain Institute, NIH Center [P30 EY014801]; Research to Prevent Blindness (RPB)	North American Neuro-ophthalmology Society; McKnight Brain Institute, NIH Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB))	This study was supported by the North American Neuro-ophthalmology Society, McKnight Brain Institute, NIH Center Grant P30 EY014801, and a grant from Research to Prevent Blindness (RPB).	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Aliev G, 2003, NEUROTOX RES, V5, P491, DOI 10.1007/BF03033159; Austin BP, 2011, J ALZHEIMERS DIS, V26, P123, DOI 10.3233/JAD-2011-0010; Berisha F, 2007, INVEST OPHTH VIS SCI, V48, P2285, DOI 10.1167/iovs.06-1029; Blaise R, 2012, AGING CELL, V11, P384, DOI 10.1111/j.1474-9726.2012.00797.x; Brown WR, 2000, ANN NY ACAD SCI, V903, P39, DOI 10.1111/j.1749-6632.2000.tb06348.x; Burgansky-Eliash Z, 2013, OSLI RETINA, V44, P51, DOI 10.3928/23258160-20121221-13; Cheung CYL, 2015, J ALZHEIMERS DIS, V45, P45, DOI 10.3233/JAD-141659; Cheung CYL, 2014, ALZHEIMERS DEMENT, V10, P135, DOI 10.1016/j.jalz.2013.06.009; Choi SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162202; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Feke Gilbert T, 2015, Alzheimers Dement (Amst), V1, P144, DOI 10.1016/j.dadm.2015.01.004; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Iseri PK, 2006, J NEURO-OPHTHALMOL, V26, P18, DOI 10.1097/01.wno.0000204645.56873.26; Jiang H, 2016, MULT SCLER J, V22, P1812, DOI 10.1177/1352458516631035; Jiang H, 2013, MICROVASC RES, V89, P172, DOI 10.1016/j.mvr.2013.06.008; Kalaria RN, 1995, BRAIN RES, V705, P349, DOI 10.1016/0006-8993(95)01250-8; Kalaria RN, 1996, MOL BRAIN RES, V35, P58, DOI 10.1016/0169-328X(95)00180-Z; Kesler A, 2011, CLIN NEUROL NEUROSUR, V113, P523, DOI 10.1016/j.clineuro.2011.02.014; Knight MJ, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00139; Koronyo Y, 2012, NEURODEGENER DIS, V10, P285, DOI 10.1159/000335154; Koutsiaris AG, 2007, BIORHEOLOGY, V44, P375; Landa G, 2010, BRIT J OPHTHALMOL, V94, P54, DOI 10.1136/bjo.2009.161257; Landa Gennady, 2012, International Ophthalmology, V32, P211, DOI 10.1007/s10792-012-9547-z; Landa G, 2009, OPHTHALMOLOGICA, V223, P155, DOI 10.1159/000189819; de Faria JML, 2014, BRIT J OPHTHALMOL, V98, P726, DOI 10.1136/bjophthalmol-2013-304100; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Ong YT, 2015, NEUROSCI LETT, V584, P12, DOI 10.1016/j.neulet.2014.10.010; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Poels MMF, 2008, J CEREBR BLOOD F MET, V28, P1652, DOI 10.1038/jcbfm.2008.62; Pournaras CJ, 2008, PROG RETIN EYE RES, V27, P284, DOI 10.1016/j.preteyeres.2008.02.002; Protogerou AD, 2007, HYPERTENSION, V50, P172, DOI 10.1161/HYPERTENSIONAHA.107.089797; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Snyder Peter J, 2016, Alzheimers Dement (Amst), V4, P169; Thal DR, 2008, J CELL MOL MED, V12, P1848, DOI 10.1111/j.1582-4934.2008.00411.x; Tian J, 2006, NEUROPATH APPL NEURO, V32, P332, DOI 10.1111/j.1365-2990.2006.00732.x; Vinters HV, 1996, BRAIN PATHOL, V6, P179, DOI 10.1111/j.1750-3639.1996.tb00799.x; Wei YT, 2017, INVEST OPHTH VIS SCI, V58, P3804, DOI 10.1167/iovs.17-21460; Weller RO, 2009, ACTA NEUROPATHOL, V118, P87, DOI 10.1007/s00401-009-0498-z; Williams Michael A, 2015, Alzheimers Dement (Amst), V1, P229; Zhou J, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/2895982	42	32	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192154	10.1371/journal.pone.0192154	http://dx.doi.org/10.1371/journal.pone.0192154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394263	Green Published, gold, Green Submitted			2022-12-26	WOS:000424060400027
J	Laktabai, J; Platt, A; Menya, D; Turner, EL; Menya, D; Turner, EL; Aswa, D; Kinoti, S; O'Meara, WP				Laktabai, Jeremiah; Platt, Alyssa; Menya, Diana; Turner, Elizabeth L.; Menya, Diana; Turner, Elizabeth L.; Aswa, Daniel; Kinoti, Stephen; O'Meara, Wendy Prudhomme			A mobile health technology platform for quality assurance and quality improvement of malaria diagnosis by community health workers	PLOS ONE			English	Article							CASE-MANAGEMENT; CLUSTERED DATA; TESTS; SIZE	Background Community health workers (CHWs) play an important role in improving access to services in areas with limited health infrastructure or workforce. Supervision of CHWs by qualified health professionals is the main link between this lay workforce and the formal health system. The quality of services provided by lay health workers is dependent on adequate supportive supervision. It is however one of the weakest links in CHW programs due to logistical and resource constraints, especially in large scale programs. Interventions such as point of care testing using malaria rapid diagnostic tests (RDTs) require real time monitoring to ensure diagnostic accuracy. In this study, we evaluated the utility of a mobile health technology platform to remotely monitor malaria RDT (mRDT) testing by CHWs for quality improvement. Methods As part of a large implementation trial involving mRDT testing by CHWs, we introduced the Fionet system composed of a mobile device (Deki Reader, DR) to assist in processing and automated interpretation of mRDTs, which connects to a cloud-based database which captures reports from the field in real time, displaying results in a custom dashboard of key performance indicators. A random sample of 100 CHWs were trained and provided with the Deki Readers and instructed to use it on 10 successive patients. The CHWs interpretation was compared with the Deki Reader's automatic interpretation, with the errors in processing and interpreting the RDTs recorded. After the CHW entered their interpretation on the DR, the DR provided immediate, automated feedback and interpretation based on its reading of the same cassette. The study team monitored the CHW performance remotely and provided additional support. Results A total of 1251 primary and 113 repeat tests were performed by the 97 CHWs who used the DR. 91.6% of the tests had agreement between the DR and the CHWs. There were 61 (4.9%) processing and 52 (4.2%) interpretation errors among the primary tests. There was a tendency towards lower odds of errors with increasing number and frequency of tests, though not statistically significant. Of the 62 tests that were repeated due to errors, 79% achieved concordance between the CHW and the DR. Satisfaction with the use of the DR by the CHWs was high. Conclusions Use of innovative mHealth strategies for monitoring and quality control can ensure quality within a large scale implementation of community level testing by lay health workers.	[Laktabai, Jeremiah] Moi Univ, Sch Med, Dept Family Med, Eldoret, Kenya; [Laktabai, Jeremiah; Aswa, Daniel; O'Meara, Wendy Prudhomme] AMPATH, Eldoret, Kenya; [Platt, Alyssa; Turner, Elizabeth L.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Platt, Alyssa; Turner, Elizabeth L.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [O'Meara, Wendy Prudhomme] Moi Univ, Sch Publ Hlth, Coll Hlth Sci, Dept Epidemiol & Biostat, Eldoret, Kenya; [Kinoti, Stephen] Fio Corp, Toronto, ON, Canada; [O'Meara, Wendy Prudhomme] Duke Univ, Med Ctr, Div Infect Dis & Int Hlth, Durham, NC USA	Moi University; Duke University; Duke University; Moi University; Duke University	Laktabai, J (corresponding author), Moi Univ, Sch Med, Dept Family Med, Eldoret, Kenya.; Laktabai, J (corresponding author), AMPATH, Eldoret, Kenya.	jklaktabai@gmail.com	Laktabai, Jeremiah/AAE-8952-2021; Urzua, Andrea Silva/AAS-7284-2020	Laktabai, Jeremiah/0000-0003-2198-6414; Platt, Alyssa/0000-0001-6396-0170	CTSA grant [UL1TR001117]; National Institutes of Health-National Institute of Allergy and Infectious Diseases (NIH-NIAID) [R01AI110478]; Fio Corporation	CTSA grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health-National Institute of Allergy and Infectious Diseases (NIH-NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fio Corporation	This study was supported by CTSA grant (UL1TR001117) and by the National Institutes of Health-National Institute of Allergy and Infectious Diseases (NIH-NIAID) grant number R01AI110478. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The study sponsor had no influence on the study design; data collection, analysis or interpretation; content of the manuscript, nor the authors decision to submit this manuscript. The researchers operated independently from the funder in these matters. All authors had full access to all data and take responsibility for the integrity and accurate analysis of the data. Fio Corporation provided support in the form of salaries for author [SK], but did provide any additional funding and did not have any additional role in the data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section. The project rented the DRs from Fio for use during the study. As part of the rental service, the Fio team conducted trainings for the study team on the use of the devices, and provided technical support including device repairs and/or replacement. They created and maintained the electronic portal for aggregation of the data transmitted from the DRs.	[Anonymous], ROLL BACK MAL STRAT; [Anonymous], PUBLIC HLTH IMPACT R; [Anonymous], 2015, MALARIA J, V14, P26; [Anonymous], PEDIAT HLTH, V25; Bosch-Capblanch X, 2008, TROP MED INT HEALTH, V13, P369, DOI 10.1111/j.1365-3156.2008.02012.x; Braun R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065772; Chanda P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-158; Counihan H, 2012, AM J TROP MED HYG, V87, P57, DOI 10.4269/ajtmh.2012.11-0800; Crigler L., 2013, SUPERVISION COMMUNIT; Degefie T, 2010, ETHIOPIAN J HLTH DEV, V23; Hamer DH, 2012, PATHOG GLOB HEALTH, V106, P32, DOI 10.1179/1364859411Y.0000000042; Herrera S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-87; Hill Z, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24085; Jaskiewicz W, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-38; Laktabai J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013972; Lewin S., 2006, LAY HLTH WORKERS PRI; Mathauer Inke, 2006, Hum Resour Health, V4, P24, DOI 10.1186/1478-4491-4-24; Seaman S, 2014, STAT MED, V33, P5371, DOI 10.1002/sim.6277; Shekalaghe S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-141; USAID, 2010, COMM HLTH WORK PROGR; WHO, 2006, WORLD HLTH REP; Williamson JM, 2003, BIOMETRICS, V59, P36, DOI 10.1111/1541-0420.00005; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340; Young M, 2012, AM J TROP MED HYG, V87, P6, DOI 10.4269/ajtmh.2012.12-0221	24	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191968	10.1371/journal.pone.0191968	http://dx.doi.org/10.1371/journal.pone.0191968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389958	gold, Green Published, Green Submitted			2022-12-26	WOS:000423793400046
J	Thibault, M; Vidal, E; Potter, MA; Sanchez, T; Brescia, F				Thibault, Martin; Vidal, Eric; Potter, Murray Alan; Sanchez, Thierry; Brescia, Fabrice			The invasive Red-vented bulbul (Pycnonotus cafer) outcompetes native birds in a tropical biodiversity hotspot	PLOS ONE			English	Article							ACRIDOTHERES-TRISTIS; COMMON MYNA; RISK-ASSESSMENT; NEW-CALEDONIA; IMPACT; ECOLOGY; ISLAND; URBAN; ERADICATION; POPULATION	Invasive alien species are a major cause of biodiversity loss globally, but especially on islands where high species richness and levels of endemism accentuate their impacts. The Red vented bulbul (Pycnonotus cafer), a tropical passerine bird that has been introduced widely across locations of high conservation value, is considered an extreme pest. It is currently expanding its range in New Caledonia, one of the world's biodiversity hotspots. Decisive recommendations on management strategies are required urgently to inform local managers and policy makers, but they should be based on quantitative local evidence, not just on expert opinion. The Red-vented bulbul is widely blamed for its impacts on biodiversity, especially through competition. We used data from 2,472 point counts to explore the abundance relationships between the Red-vented bulbul and 14 other species of bird. Our results revealed a negative relationship between the occurrence of the bulbul and the mean abundance of nine species, all native (or endemic, n = 3) to the New Caledonia archipelago. In contrast, the abundance of other introduced species such as Acridotheres tristis (Common myna), Passer domesticus (House sparrow) and Spilopelia chinensis (Spotted dove) were not affected by the Red-vented bulbul. Moreover, temporal trends in the abundance of impacted species suggest that the Red-vented bulbul may cause niche contractions rather than mortality for native species in man-modified habitats. Monitoring and control of the Red-vented bulbul is recommended to prevent on-going impacts on native bird communities throughout New Caledonia, and its impact on native bird communities elsewhere should be quantified.	[Thibault, Martin; Brescia, Fabrice] Inst Agron Neocaledonien IAC, Equipe ARBOREAL Agr BiOdiversite & VAlorisat, Paita, New Caledonia; [Thibault, Martin; Potter, Murray Alan] Massey Univ, Sch Agr & Environm, Wildlife & Ecol Grp, Palmerston North, New Zealand; [Vidal, Eric] Aix Marseille Univ, Inst Mediterraneen Biodiversite & Ecol Marine & C, CNRS, IRD,Avignon Univ,Ctr IRD Noumea, Noumea, New Caledonia; [Sanchez, Thierry] Soc Caledonienne Ornithol, Noumea, New Caledonia	Massey University; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Thibault, M (corresponding author), Inst Agron Neocaledonien IAC, Equipe ARBOREAL Agr BiOdiversite & VAlorisat, Paita, New Caledonia.; Thibault, M (corresponding author), Massey Univ, Sch Agr & Environm, Wildlife & Ecol Grp, Palmerston North, New Zealand.	thibault@iac.nc	THIBAULT, Martin/J-5856-2019	THIBAULT, Martin/0000-0002-2386-4501; Potter, Murray/0000-0002-0246-8294				[Anonymous], 2016, DIRECTION DE L ENVIR; [Anonymous], 2008, DIRECTION DEV EC ENV; Barnagaud JY, 2014, ECOLOGY, V95, P78, DOI 10.1890/13-0791.1; Barre Nicolas, 2009, Alauda, V77, P287; Barton K., 2016, MULTIMODEL INFERENCE; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bates JH, 2014, NOTORNIS, V61, P35; Bellard C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0623; Bellard C, 2014, GLOBAL ECOL BIOGEOGR, V23, P1376, DOI 10.1111/geb.12228; Bivand R, 2017, RGEOS INTERFACE GEOM; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Blackburn TM, 2005, ECOLOGY, V86, P2916, DOI 10.1890/04-1847; Blanvillain C, 2003, BIOL CONSERV, V109, P197, DOI 10.1016/S0006-3207(02)00147-7; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brooks DM, 2013, WILSON J ORNITHOL, V125, P800, DOI 10.1676/13-037.1; Byers JE, 2002, OIKOS, V97, P449, DOI 10.1034/j.1600-0706.2002.970316.x; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Canning Gregory, 2011, Phelsuma, V19, P43; Corlett Richard T., 2005, Urban Ecosystems, V8, P275, DOI 10.1007/s11252-005-3260-x; David P, 2017, ADV ECOL RES, V56, P1, DOI 10.1016/bs.aecr.2016.10.001; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; Davis MA, 2017, TRENDS ECOL EVOL, V32, P229, DOI 10.1016/j.tree.2017.02.008; del Hoyo J, 2017, HDB BIRDS WORLD ALIV; Delorme Q, 2016, ZOOTAXA, V4092, P301, DOI 10.11646/zootaxa.4092.3.1; Dutson G., 2011, BIRDS MELANESIA BISM, P446; Early R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12485; Evans T, 2014, ECOL EVOL, V4, P2957, DOI 10.1002/ece3.1144; Feare CJ, 2017, PEST MANAG SCI, V73, P295, DOI 10.1002/ps.4263; Firake DM, 2016, FIELD CROP RES, V188, P74, DOI 10.1016/j.fcr.2016.01.008; Geraghty AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161206; Gill B. J., 1995, Notornis, V42, P214; GORMAN M L, 1972, Fiji Agricultural Journal, V34, P35; Grandcolas P, 2008, PHILOS T R SOC B, V363, P3309, DOI 10.1098/rstb.2008.0122; Gren IM, 2016, REG ENVIRON CHANGE, V16, P445, DOI 10.1007/s10113-015-0754-9; Grey Merilyn J., 1998, Pacific Conservation Biology, V4, P55; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Islam K, 2000, BIRDS N AM LIFE HIST; Jiguet F, 2012, ACTA OECOL, V44, P58, DOI 10.1016/j.actao.2011.05.003; Kumschick S, 2016, BIRD CONSERV INT, V26, P154, DOI 10.1017/S0959270915000167; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; Martin LB, 2005, BEHAV ECOL, V16, P702, DOI 10.1093/beheco/ari044; Martin-Albarracin VL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143070; Moller AP, 2015, OECOLOGIA, V178, P943, DOI 10.1007/s00442-015-3268-8; Moller AP, 2012, OECOLOGIA, V170, P867, DOI 10.1007/s00442-012-2355-3; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Old JM, 2014, EMU, V114, P241, DOI 10.1071/MU13029; Peacock DS, 2007, S AFR J SCI, V103, P465; POWLESLAND M H, 1982, Notornis, V29, P181; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; R Core Team, 2021, R LANGUAGE ENV STAT; RALPH C. J., 1995, MONITORING BIRD POPU; Rogers HS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14557; Russell JC, 2017, TRENDS ECOL EVOL, V32, P3, DOI 10.1016/j.tree.2016.10.012; Saavedra S., 2013, 2 CONTROL CAMPAIGN C; Saxena A, 2015, INT J MED PHARM RES, V3, P1246; Scheele BC, 2017, TRENDS ECOL EVOL, V32, P346, DOI 10.1016/j.tree.2017.02.013; Seebens H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14435; Sherman JA, 2010, TERRA AUSTRALIS, V32, P101; Shukuroglou P, 2006, AUSTRAL ECOL, V31, P240, DOI 10.1111/j.1442-9993.2006.01588.x; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Simberloff D, 2011, NATURE, V475, P36, DOI 10.1038/475036a; Smith SA, 2007, MOL PHYLOGENET EVOL, V43, P1151, DOI 10.1016/j.ympev.2007.02.007; Soh MCK, 2006, BIOL CONSERV, V129, P149, DOI 10.1016/j.biocon.2005.10.030; Spotswood EN, 2013, BIOL INVASIONS, V15, P2147, DOI 10.1007/s10530-013-0441-z; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Strubbe D, 2011, BIOL CONSERV, V144, P2112, DOI 10.1016/j.biocon.2011.05.001; Summers-Smith J. Denis, 2003, British Birds, V96, P439; Tershy BR, 2015, BIOSCIENCE, V65, P592, DOI 10.1093/biosci/biv031; Thibault JC, 2002, BIOL CONSERV, V108, P161, DOI 10.1016/S0006-3207(02)00102-7; Thibault M, 2017, BIOL INVASI IN PRESS; Vijayan VS, 1975, ECOLOGICAL ISOLATION; von der Lippe M, 2008, DIVERS DISTRIB, V14, P18, DOI 10.1111/j.1472-4642.2007.00401.x; Walker R, 2008, ELEPAIO, V68, P71; Walsh JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P841, DOI 10.1111/j.1466-8238.2011.00724.x; WATLING D, 1979, NEW SCI, V81, P963; WATLING D, 1978, Notornis, V25, P109; Young HS, 2017, TRENDS ECOL EVOL, V32, P41, DOI 10.1016/j.tree.2016.09.008; Zuur Alain F., 2009, P1	79	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192249	10.1371/journal.pone.0192249	http://dx.doi.org/10.1371/journal.pone.0192249			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390027	Green Published, gold			2022-12-26	WOS:000423793400081
J	Zhan, XY; Zhu, QY				Zhan, Xiao-Yong; Zhu, Qing-Yi			Molecular typing of Legionella pneumophila isolates from environmental water samples and clinical samples using a five-gene sequence typing and standard Sequence-Based Typing	PLOS ONE			English	Article							LEGIONNAIRES-DISEASE; DISCRIMINATORY ABILITY; POPULATION-STRUCTURE; RECOMBINATION; SEROGROUP-1; SCHEME; SECRETION; EVOLUTION; NETWORKS; STRAINS	Inadequate discriminatory power to distinguish between L. pneumophila isolates, especially those belonging to disease-related prevalent sequence types (STs) such as ST1, ST36 and ST47, is an issue of SBT scheme. In this study, we developed a multilocus sequence typing (MLST) scheme based on two non-virulence loci (trpA, cca) and three virulence loci (icmK, lspE, lssD), to genotype 110 L. pneumophila isolates from various natural and artificial water sources in Guangdong province of China, and compared with the SBT. The isolates were assigned to 33 STs of the SBT and 91 new sequence types (nSTs) of the MLST. The indices of discrimination (IODs) of SBT and MLST were 0.920 and 0.985, respectively. Maximum likelihood trees of the concatenated SBT and MLST sequences both showed distinct phylogenetic relationships between the isolates from the two environments. More intragenic recombinations were detected in nSTs than in STs, and they were both more abundant in natural water isolates. We found out the MLST had a high discriminatory ability for the disease-associated ST1 isolates: 22 ST1 isolates were assigned to 19 nSTs. Furthermore, we assayed the discrimination of the MLST for 29 reference strains (19 clinical and 10 environmental). The clinical strains were assigned to eight STs and ten nSTs. The MLST could also subtype the prevalent clinical ST36 or ST47 strains: eight ST36 strains were subtyped into three nSTs and two ST47 strains were subtyped into two nSTs. We found different distribution patterns of nSTs between the environmental and clinical ST36 isolates, and between the outbreak clinical ST36 isolates and the sporadic clinical ST36 isolates. These results together revealed the MLST scheme could be used as part of a typing scheme that increased discrimination when necessary.	[Zhan, Xiao-Yong; Zhu, Qing-Yi] Guangzhou KingMed Ctr Clin Lab, Guangzhou, Guangdong, Peoples R China; [Zhan, Xiao-Yong; Zhu, Qing-Yi] Guangzhou Med Univ, KingMed Sch Lab Med, Guangzhou, Guangdong, Peoples R China; [Zhan, Xiao-Yong] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Sun Yat Sen University	Zhan, XY (corresponding author), Guangzhou KingMed Ctr Clin Lab, Guangzhou, Guangdong, Peoples R China.; Zhan, XY (corresponding author), Guangzhou Med Univ, KingMed Sch Lab Med, Guangzhou, Guangdong, Peoples R China.; Zhan, XY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	tsinghan@126.com	zhan, xiao yong/C-9449-2016	zhan, xiao yong/0000-0002-5809-7904	National Natural Science Foundation of China [31500002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (grant number 31500002) to Xiao-Yong Zhan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by National Natural Science Foundation of China (grant number 31500002).	Borges V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26261; Bosch T, 2015, J CLIN MICROBIOL, V53, P3234, DOI 10.1128/JCM.01369-15; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Campese C, 2011, INT J INFECT DIS, V15, pE30, DOI 10.1016/j.ijid.2010.09.007; Coscolla M, 2007, ENVIRON MICROBIOL, V9, P643, DOI 10.1111/j.1462-2920.2006.01184.x; Coscolla M, 2009, INFECT GENET EVOL, V9, P882, DOI 10.1016/j.meegid.2009.05.013; Costa J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109840; Costa J, 2012, ENVIRON MICROBIOL, V14, P2017, DOI 10.1111/j.1462-2920.2011.02646.x; David S, 2016, J CLIN MICROBIOL, V54, P2135, DOI 10.1128/JCM.00432-16; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; Den Boer JW, 2015, EMERG INFECT DIS, V21, P1167, DOI 10.3201/eid2107.141130; Escoll P, 2014, CURR TOP MICROBIOL, V376, P1, DOI 10.1007/82_2013_351; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; FLIERMANS CB, 1981, APPL ENVIRON MICROB, V41, P9, DOI 10.1128/AEM.41.1.9-16.1981; Furuhata K, 2014, BIOCONTROL SCI, V19, P33, DOI 10.4265/bio.19.33; Gaia V, 2003, J CLIN MICROBIOL, V41, P2932, DOI 10.1128/JCM.41.7.2932-2939.2003; Gaia V, 2005, J CLIN MICROBIOL, V43, P2047, DOI 10.1128/JCM.43.5.2047-2052.2005; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Ginevra C., 2013, LEGIONELLA PNEUMOPHI; Ginevra C, 2008, EMERG INFECT DIS, V14, P673, DOI 10.3201/eid1404.070961; Gomez-Valero L, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0505-0; Gomez-Valero L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-536; Graham RMA, 2014, EPIDEMIOL INFECT, V142, P2347, DOI 10.1017/S0950268814000375; Guo JY, 2015, INFECT GENET EVOL, V29, P35, DOI 10.1016/j.meegid.2014.10.023; [郭玉梅 Guo Yumei], 2014, [微生物学杂志, Journal of Mirobiology], V34, P72; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jolley KA, 2012, MICROBIOL-SGM, V158, P1005, DOI 10.1099/mic.0.055459-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kozak-Muiznieks NA, 2014, J CLIN MICROBIOL, V52, P201, DOI 10.1128/JCM.01973-13; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lau HY, 2009, J APPL MICROBIOL, V107, P368, DOI 10.1111/j.1365-2672.2009.04208.x; Lepeuple AS, 2004, WATER SCI TECHNOL, V50, P281, DOI 10.2166/wst.2004.0068; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2017, METHODS MOL BIOL, V1525, P433, DOI 10.1007/978-1-4939-6622-6_17; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McAdam PR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0504-1; Mercante JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164074; Moran-Gilad J, 2015, EUROSURVEILLANCE, V20; Morrison DA, 2005, INT J PARASITOL, V35, P567, DOI 10.1016/j.ijpara.2005.02.007; Pancer K, 2013, ANN AGR ENV MED, V20, P436; Posada D, 2002, MOL BIOL EVOL, V19, P708, DOI 10.1093/oxfordjournals.molbev.a004129; Qin T, 2016, SCI REP-UK, V6, DOI 10.1038/srep21356; Qin T, 2012, J MED MICROBIOL, V61, P1023, DOI 10.1099/jmm.0.040170-0; Ratzow S, 2007, J CLIN MICROBIOL, V45, P1965, DOI 10.1128/JCM.00261-07; Reimer AR, 2010, EUR J CLIN MICROBIOL, V29, P191, DOI 10.1007/s10096-009-0840-3; Reuter S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002175; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Sanchez-Buso L, 2014, NAT GENET, V46, P1205, DOI 10.1038/ng.3114; SMITH JM, 1992, J MOL EVOL, V34, P126; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; Visca P, 2011, MICROBIOL-SGM, V157, P2582, DOI 10.1099/mic.0.047258-0; Yuan M, 2010, CHINESE J PUBLIC HLT; Zhan XY, 2017, PEERJ, V5, DOI 10.7717/peerj.4114; Zhan XY, 2016, ARCH MICROBIOL, V198, P241, DOI 10.1007/s00203-015-1186-0; Zhang LY, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030222	58	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0190986	10.1371/journal.pone.0190986	http://dx.doi.org/10.1371/journal.pone.0190986			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389983	gold, Green Submitted, Green Published			2022-12-26	WOS:000423793400012
J	Martinez-Chacon, G; Brown, KA; Docanto, MM; Kumar, H; Salminen, S; Saarinen, N; Makela, S				Martinez-Chacon, Gabriela; Brown, Kristy A.; Docanto, Maria M.; Kumar, Himanshu; Salminen, Seppo; Saarinen, Niina; Makela, Sari			IL-10 suppresses TNF-alpha-induced expression of human aromatase gene in mammary adipose tissue	FASEB JOURNAL			English	Article						weight gain; anti-inflammatory cytokine; ovariectomy; CYP19A1 regulation	NECROSIS-FACTOR-ALPHA; STROMAL CELLS; METABOLIC SYNDROME; BREAST AROMATASE; GUT MICROBIOTA; HUMAN OBESITY; BODY-WEIGHT; INFLAMMATION; INTERLEUKIN-10; WOMEN	White adipose tissue inflammation is linked with increased aromatase gene expression and estrogen production, a major risk factor for breast cancer in obese postmenopausal women. TNF-alpha, a proinflammatory cytokine, is a key driver of aromatase promoter I.4-mediated expression in adipose tissue. In this study, we have shown that IL-10, an anti-inflammatory cytokine, suppressed both TNF-alpha-stimulated human aromatase reporter-luciferase (hARO-Luc) expression in mouse bone marrow mesenchymal stromal cells and aromatase gene expression in human breast adipose stromal cells (ASCs). IL-10 blocked TNF-alpha-stimulated ERK 1 / 2 activation in ASCs, suggesting an inhibitory effect through the MAPK signaling pathway. The links among obesity, IL-10, and aromatase were confirmed in ovariectomized (OVX) hARO-Luc mice, where increased adiposity was associated with upregulation of aromatase reporter activity and reduced IL-10 level in the mammary fat pad. OVX mice also exhibited changes in gut microbiota, similar to that in obese women, indicating altered immune function. In summary, our results suggest that increased adiposity, induced by the lack of ovarian hormones, results in enhanced expression of aromatase in mammary adipose tissue, mediated by reduction in local IL-10. These findings may bring new insights into the mechanisms involved in the development of postmenopausal breast cancer, as well as novel approaches for prevention.	[Martinez-Chacon, Gabriela; Kumar, Himanshu; Salminen, Seppo; Makela, Sari] Univ Turku, Funct Foods Forum, Turku, Finland; [Martinez-Chacon, Gabriela; Saarinen, Niina; Makela, Sari] Univ Turku, Inst Biomed, Turku 20014, Finland; [Saarinen, Niina; Makela, Sari] Univ Turku, Turku Ctr Dis Modeling, Turku, Finland; [Brown, Kristy A.; Docanto, Maria M.] Hudson Inst Med Res, Ctr Canc Res, Metab & Canc Lab, Clayton, Vic, Australia; [Brown, Kristy A.; Docanto, Maria M.] Monash Univ, Dept Physiol, Clayton, Vic, Australia	University of Turku; University of Turku; University of Turku; Hudson Institute of Medical Research; Monash University	Makela, S (corresponding author), Univ Turku, Inst Biomed, Turku 20014, Finland.	sari.makela@utu.fi	kumar, Himanshu/ABE-7982-2020	kumar, Himanshu/0000-0002-9749-8620; Makela, Sari/0000-0002-8698-4076; Martinez-Chacon, Gabriela/0000-0002-1387-8715; Saarinen, Niina/0000-0003-3531-378X	University of Turku Graduate School; Academy of Finland [264153]; Finnish Cultural Foundation [0116947-3]; Victorian Government Operational Infrastructure Support Program; Mavis Robertson Fellowship from the National Breast Cancer Foundation [ECF-16-004]; National Health and Medical Research Council [GNT1061800]	University of Turku Graduate School; Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Victorian Government Operational Infrastructure Support Program; Mavis Robertson Fellowship from the National Breast Cancer Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by the University of Turku Graduate School, and by grants from the Academy of Finland (264153) and the Finnish Cultural Foundation (0116947-3; to G.M.-C., N.S., and S.M.). K.A.B. was supported by the Victorian Government Operational Infrastructure Support Program, and by the Mavis Robertson Fellowship from the National Breast Cancer Foundation (ECF-16-004), and the National Health and Medical Research Council Project Grant GNT1061800. The authors declare no conflicts of interest.	ACKERMAN GE, 1981, J CLIN ENDOCR METAB, V53, P412, DOI 10.1210/jcem-53-2-412; Agarwal VR, 1996, J CLIN ENDOCR METAB, V81, P3843, DOI 10.1210/jc.81.11.3843; Asarian L, 2002, HORM BEHAV, V42, P461, DOI 10.1006/hbeh.2002.1835; Avdiushko R, 2001, J LEUKOCYTE BIOL, V70, P624; Brown KA, 2017, J CLIN ENDOCR METAB, V102, P1692, DOI 10.1210/jc.2016-3606; BULUN SE, 1994, BREAST CANCER RES TR, V30, P19, DOI 10.1007/BF00682738; BULUN SE, 1994, J CLIN ENDOCR METAB, V78, P428, DOI 10.1210/jc.78.2.428; Chen D, 2012, MOL CELL ENDOCRINOL, V355, P114, DOI 10.1016/j.mce.2012.01.027; Chen Z, 2005, AM J CLIN NUTR, V82, P651, DOI 10.1093/ajcn/82.3.651; Cox AJ, 2015, LANCET DIABETES ENDO, V3, P207, DOI 10.1016/S2213-8587(14)70134-2; Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155; Docanto MM, 2014, BREAST CANCER RES TR, V147, P193, DOI 10.1007/s10549-014-3060-1; Esposito K, 2003, J CLIN ENDOCR METAB, V88, P1055, DOI 10.1210/jc.2002-021437; GRODIN JM, 1973, J CLIN ENDOCR METAB, V36, P207, DOI 10.1210/jcem-36-2-207; Hamidullah, 2012, BREAST CANCER RES TR, V133, P11, DOI 10.1007/s10549-011-1855-x; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Iyengar NM, 2017, CANCER PREV RES, V10, P235, DOI 10.1158/1940-6207.CAPR-16-0314; Iyengar NM, 2016, CLIN CANCER RES, V22, P2283, DOI 10.1158/1078-0432.CCR-15-2239; Iyengar NM, 2015, CANCER PREV RES, V8, P349, DOI 10.1158/1940-6207.CAPR-14-0243; Juge-Aubry CE, 2005, CYTOKINE, V29, P270, DOI 10.1016/j.cyto.2004.10.017; Jung SH, 2008, J NUTR BIOCHEM, V19, P371, DOI 10.1016/j.jnutbio.2007.05.007; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Leon-Cabrera S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/493409; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lira FS, 2011, METABOLISM, V60, P359, DOI 10.1016/j.metabol.2010.02.017; Liu TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136150; Lizcano F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/757461; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; MINELLI EB, 1993, MICROB ECOL HEALTH D, V6, P43, DOI 10.3109/08910609309141561; Mocellin S, 2003, TRENDS IMMUNOL, V24, P36, DOI 10.1016/S1471-4906(02)00009-1; Morris PG, 2011, CANCER PREV RES, V4, P1021, DOI 10.1158/1940-6207.CAPR-11-0110; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Nishida M, 2007, CIRC J, V71, P1234, DOI 10.1253/circj.71.1234; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Schmidt FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121971; Simpson ER, 2001, ENDOCRINOLOGY, V142, P4589, DOI 10.1210/endo.142.11.8547; Simpson ER, 2013, J MOL ENDOCRINOL, V51, pT51, DOI 10.1530/JME-13-0217; Strauss L, 2013, FASEB J, V27, P1342, DOI 10.1096/fj.12-219048; Subbaramaiah K, 2012, CANCER DISCOV, V2, P356, DOI 10.1158/2159-8290.CD-11-0241; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; To SQ, 2013, BIOCHEM BIOPH RES CO, V433, P96, DOI 10.1016/j.bbrc.2013.02.058; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van Exel E, 2002, DIABETES, V51, P1088, DOI 10.2337/diabetes.51.4.1088; WADE GN, 1975, J COMP PHYSIOL PSYCH, V88, P183, DOI 10.1037/h0076186; Wang XY, 2015, J STEROID BIOCHEM, V153, P35, DOI 10.1016/j.jsbmb.2015.07.008; Williams LM, 2004, IMMUNOLOGY, V113, P281, DOI 10.1111/j.1365-2567.2004.01988.x; ZHAO Y, 1995, J BIOL CHEM, V270, P16449, DOI 10.1074/jbc.270.27.16449; Zhao Y, 1996, MOL ENDOCRINOL, V10, P1350, DOI 10.1210/me.10.11.1350	52	18	19	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3361	3370		10.1096/fj.201700938RRR	http://dx.doi.org/10.1096/fj.201700938RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401621				2022-12-26	WOS:000432546000037
J	Wang, Q; Delcorde, J; Tang, T; Downey, GP; McCulloch, CA				Wang, Qin; Delcorde, Julie; Tang, Tracy; Downey, Gregory P.; McCulloch, Christopher A.			Regulation of IL-1 signaling through control of focal adhesion assembly	FASEB JOURNAL			English	Article						fibroblasts; cell spreading; integrins; cytokine signaling	TYROSINE PHOSPHATASE-ALPHA; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; ACTIN DYNAMICS; CELL-ADHESION; KINASE IRAK; KAPPA-B; INTERLEUKIN-1; INTEGRIN; ACTIVATION	IL-1 signaling is adhesion-restricted in many cell types, but the mechanism that drives it is not defined. We screened for proteins recruited to nascent adhesions in IL-1-treated human fibroblasts with tandem mass tag-mass spectrometry. We used fibronectin bead preparations to enrich 10 actin-associated proteins. There was a 1.2 times log 2-fold enrichment of actin capping protein (ACP) at 30 min after IL-1 stimulation. Knockdown (KD) of ACP by siRNA reduced IL-1-induced ERK activation(by 56%, matrix metalloproteinase-3 (MMP-3) expression by 48%, and MMP-9 expression by 62% (in all reductions, P < 0.01). Confocal or structured illumination microscopy showed that ACP was diffused throughout the cytosol but strongly accumulated at the ruffled border of spreading cells. ACP colocalized with nascent paxillin- and vinculin-containing adhesions at the ruffled border, but not with mature adhesions in the center. ACP KD promoted the formation of large, stable adhesions. Immunoprecipitation and proximity ligation analysis showed that ACP was associated with the IL-1 signal transduction proteins myeloid differentiation factor 88 (MyD88) and IL-1 receptor-associated kinase (IRAK) at the ruffled border of the leading edge. IL-1-induced phospho-ERK and MyD88 or IRAK colocalized at the leading edge. We concluded that ACP is required for recruitment and function of IL-1 signaling complexes in nascent adhesions at the leading edge of the cell.				christopher.mcculloch@utoronto.ca		Downey, Gregory P/0000-0003-3253-5862	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant [HL132950]; Canadian Institutes of Health Research (CIHR) [MOP-483461]; Canada Research Chair (Tier 1) in Matrix Dynamics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132950] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair (Tier 1) in Matrix Dynamics(Canada Research Chairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Jonathan Krieger (SPARC BioCentre, Hospital for Sick Children Toronto, ON, Canada) for performing MS. This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant HL132950, and by Canadian Institutes of Health Research (CIHR) Grant MOP-483461. C.A.M. is supported by a Canada Research Chair (Tier 1) in Matrix Dynamics. The authors declare no conflicts of interest.	Abreu MTH, 2006, J CELL PHYSIOL, V207, P132, DOI 10.1002/jcp.20544; ARORA PD, 1995, J BIOL CHEM, V270, P6042, DOI 10.1074/jbc.270.11.6042; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Chiu CL, 2013, MICROSC RES TECHNIQ, V76, P1070, DOI 10.1002/jemt.22267; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; CURTIS BM, 1989, P NATL ACAD SCI USA, V86, P3045, DOI 10.1073/pnas.86.9.3045; Dolat L, 2014, J CELL BIOL, V207, P225, DOI 10.1083/jcb.201405050; Edwards M, 2014, NAT REV MOL CELL BIO, V15, P677, DOI 10.1038/nrm3869; Franz CM, 2005, J CELL SCI, V118, P5315, DOI 10.1242/jcs.02653; Gallegos L, 2011, NAT CELL BIOL, V13, P344, DOI [10.1038/ncb0411-344, 10.1038/ncb2230]; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Geiger T, 2012, CURR OPIN CELL BIOL, V24, P562, DOI 10.1016/j.ceb.2012.05.004; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; HONIG J, 1989, J PERIODONTAL RES, V24, P362, DOI 10.1111/j.1600-0765.1989.tb00883.x; Horton ER, 2015, NAT CELL BIOL, V17, P1577, DOI 10.1038/ncb3257; Iskratsch T, 2013, DEV CELL, V27, P545, DOI 10.1016/j.devcel.2013.11.003; Kai F, 2015, ONCOTARGET, V6, P11162, DOI 10.18632/oncotarget.3578; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lanier MH, 2016, J BIOL CHEM, V291, P1076, DOI 10.1074/jbc.M115.676882; Livne A, 2016, J CELL SCI, V129, P1293, DOI 10.1242/jcs.180927; Lo YYC, 1998, J BIOL CHEM, V273, P7059, DOI 10.1074/jbc.273.12.7059; Luo L, 1997, BIOCHEM J, V324, P653, DOI 10.1042/bj3240653; MacGillivray MK, 2000, J BIOL CHEM, V275, P23509, DOI 10.1074/jbc.M003186200; Manninen A, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600022; McCulloch CA, 2006, NAT REV DRUG DISCOV, V5, P864, DOI 10.1038/nrd2109; McDermott EP, 2002, J BIOL CHEM, V277, P7808, DOI 10.1074/jbc.M108133200; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Morimatsu M, 2015, NANO LETT, V15, P2220, DOI 10.1021/nl5047335; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; QWARNSTROM EE, 1991, P NATL ACAD SCI USA, V88, P1232, DOI 10.1073/pnas.88.4.1232; Rajshankar D, 2012, FASEB J, V26, P4429, DOI 10.1096/fj.12-207381; Reunanen N, 1998, J BIOL CHEM, V273, P5137, DOI 10.1074/jbc.273.9.5137; Shekhar S, 2016, J CELL SCI, V129, P1085, DOI 10.1242/jcs.179994; SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155; SLACK J, 1993, J BIOL CHEM, V268, P2513; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sun ZQ, 2016, J CELL BIOL, V215, P445, DOI 10.1083/jcb.201609037; Wang Q, 2016, MOB INF SYST, V2016, DOI [10.1155/2016/8765874, 10.1155/2016/2159703]; Wang Q, 2006, J BIOL CHEM, V281, P31093, DOI 10.1074/jbc.M606392200; Wang Qin, 2003, FASEB Journal, V17, P1898; Wang Q, 2014, J BIOL CHEM, V289, P18427, DOI 10.1074/jbc.M113.540294; Wang Q, 2013, BIOCHEM J, V449, P771, DOI 10.1042/BJ20121170; Wang Q, 2010, J BIOL CHEM, V285, P22308, DOI 10.1074/jbc.M110.102426; Wang Q, 2009, J BIOL CHEM, V284, P20763, DOI 10.1074/jbc.M808828200; Wang Yu-li, 2007, Sci STKE, V2007, ppe10; Wehrle-Haller B, 2002, TRENDS CELL BIOL, V12, P382, DOI 10.1016/S0962-8924(02)02321-8; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1997, J BIOL CHEM, V272, P7727, DOI 10.1074/jbc.272.12.7727; Zamir E, 2001, J CELL SCI, V114, P3577; Zhu P, 1998, BIOCHEM J, V330, P975, DOI 10.1042/bj3300975	59	9	9	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3119	3132		10.1096/fj.201700966R	http://dx.doi.org/10.1096/fj.201700966R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401618	Green Published			2022-12-26	WOS:000432546000019
J	Zhao, SS; Adebiyi, MG; Zhang, YJ; Couturier, JP; Fan, XG; Zhang, HQ; Kellems, RE; Lewis, DE; Xia, Y				Zhao, Shushan; Adebiyi, Morayo G.; Zhang, Yujin; Couturier, Jacob P.; Fan, Xuegong; Zhang, Hongqi; Kellems, Rodney E.; Lewis, Dorothy E.; Xia, Yang			Sphingosine-1-phosphate receptor 1 mediates elevated IL-6 signaling to promote chronic inflammation and multitissue damage in sickle cell disease	FASEB JOURNAL			English	Article						S1PR1; JAK2; macrophage	PERSISTENT STAT3 ACTIVATION; SPHINGOSINE 1-PHOSPHATE; ERYTHROCYTES; ADENOSINE; KINASE; ARTHRITIS; EFFICACY; FTY720; EGRESS; CANCER	Sphingosine-1-phosphate (S1P) is a biolipid involved in chronic inflammation in several inflammatory disorders. Recent studies revealed that elevated S1P contributes to sickling in sickle cell disease (SCD), a devastating hemolytic, genetic disorder associated with severe chronic inflammation and tissue damage. We evaluated the effect of elevated S1P in chronic inflammation and tissue damage in SCD and underlying mechanisms. First, we demonstrated that interfering with S1P receptor signaling by FTY720, a U.S. Food and Drug Administration-approved drug, significantly reduced systemic, local inflammation and tissue damage without antisickling effects. These findings led us to discover that S1P receptor activation leads to substantial elevated local and systemic IL-6 levels in SCD mice. Genetic deletion of IL-6 in SCD mice significantly reduced local and systemic inflammation, tissue damage, and kidney dysfunction. At the cellular level, we determined that elevated IL-6 is a key cytokine functioning downstream of elevated S1P, which contributes to increased S1P receptor 1 (S1pr1) gene expression in the macrophages of several tissues in SCD mice. Mechanistically, we revealed that S1P-S1PR1 signaling reciprocally upregulated IL-6 gene expression in primary mouse macrophages in a JAK2-dependent manner. Altogether, we revealed that elevated S1P, coupled with macrophage S1PR1 reciprocally inducing IL-6 expression, is a key signaling network functioning as a malicious, positive, feed-forward loop to sustain inflammation and promote tissue damage in SCD. Our findings immediately highlight novel therapeutic possibilities.	[Zhao, Shushan; Fan, Xuegong; Zhang, Hongqi] Cent S Univ, Xiangya Hosp, Dept Orthoped, Changsha, Hunan, Peoples R China; [Xia, Yang] Cent S Univ, Xiangya Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China; [Zhao, Shushan; Adebiyi, Morayo G.; Zhang, Yujin; Kellems, Rodney E.; Xia, Yang] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, 6431 Fannin St,MSB 6-200, Houston, TX 77030 USA; [Couturier, Jacob P.; Lewis, Dorothy E.] Univ Texas Houston, Sch Med, Dept Internal Med, Houston, TX 77030 USA; [Adebiyi, Morayo G.; Kellems, Rodney E.; Xia, Yang] MD Anderson Univ Texas Hlth Grad Sch UTHlth, Houston, TX USA	Central South University; Central South University; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Xia, Y (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, 6431 Fannin St,MSB 6-200, Houston, TX 77030 USA.	yang.xia@uth.tmc.edu	赵, 树山/F-1536-2011		U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL113574, HL114457, HL136969, HL137990]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL137990, P01HL114457, R01HL136969, R01HL113574] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL113574, HL114457, HL136969, and HL137990 (to Y.X.). The authors declare no conflicts of interest.	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Amenabar Jose M, 2006, J Oral Sci, V48, P139, DOI 10.2334/josnusd.48.139; An SZ, 2000, J BIOL CHEM, V275, P288, DOI 10.1074/jbc.275.1.288; Awojoodu AO, 2014, BLOOD, V124, P1941, DOI 10.1182/blood-2014-01-543652; Bode C, 2010, J CELL BIOCHEM, V109, P1232, DOI 10.1002/jcb.22507; Florey O, 2009, J IMMUNOL, V183, P2330, DOI 10.4049/jimmunol.0901019; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Goyal P, 2013, MOL HUM REPROD, V19, P528, DOI 10.1093/molehr/gat023; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hu X, 2016, CELL REP, V16, P106, DOI 10.1016/j.celrep.2016.05.080; Ito K, 2007, BIOCHEM BIOPH RES CO, V357, P212, DOI 10.1016/j.bbrc.2007.03.123; Jin BR, 2017, SCI REP-UK, V7, DOI 10.1038/srep46252; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kaul DK, 2000, J CLIN INVEST, V106, P411, DOI 10.1172/JCI9225; Keikhaei B, 2013, EUR CYTOKINE NETW, V24, P45, DOI 10.1684/ecn.2013.0328; Keul P, 2011, CIRC RES, V108, P314, DOI 10.1161/CIRCRESAHA.110.235028; Kikuta J, 2011, RHEUMATOL INT, V31, P967, DOI 10.1007/s00296-010-1634-8; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Lai Wen-Qi, 2010, World J Biol Chem, V1, P321, DOI 10.4331/wjbc.v1.i11.321; Lan YY, 2005, AM J TRANSPLANT, V5, P2649, DOI 10.1111/j.1600-6143.2005.01085.x; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Lewis ND, 2013, J IMMUNOL, V190, P3533, DOI 10.4049/jimmunol.1201810; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Madigan Catherine, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010659; Maines Lynn W., 2010, Inflammopharmacology, V18, P73, DOI 10.1007/s10787-010-0032-x; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Pathare A, 2004, AM J HEMATOL, V77, P323, DOI 10.1002/ajh.20196; Platt OS, 2000, J CLIN INVEST, V106, P337, DOI 10.1172/JCI10726; Ranjbaran Mina, 2017, J Nephropathol, V6, P69, DOI 10.15171/jnp.2017.12; Ratajczak MZ, 2010, LEUKEMIA, V24, P976, DOI 10.1038/leu.2010.53; Sun KQ, 2015, BLOOD, V125, P1643, DOI 10.1182/blood-2014-08-595751; Takasugi N, 2011, J NEUROSCI, V31, P6850, DOI 10.1523/JNEUROSCI.6467-10.2011; Weinblatt ME, 2015, ARTHRITIS RHEUMATOL, V67, P2591, DOI 10.1002/art.39249; Weischenfeldt J, 2008, CSH PROTOC, V2008, P5080; Xiang YQ, 2014, J CLIN INVEST, V124, P4823, DOI 10.1172/JCI77685; Yokota S, 2014, J RHEUMATOL, V41, P759, DOI 10.3899/jrheum.130690; Zhang YJ, 2014, J CLIN INVEST, V124, P2750, DOI 10.1172/JCI74604; Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280	41	25	26	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2855	2865		10.1096/fj.201600788RR	http://dx.doi.org/10.1096/fj.201600788RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401601	Green Published			2022-12-26	WOS:000432528000043
J	Li, B; Tunc-Ozdemir, M; Urano, D; Jia, HY; Werth, EG; Mowrey, DD; Hicks, LM; Dokholyan, NV; Torres, MP; Jones, AM				Li, Bo; Tunc-Ozdemir, Meral; Urano, Daisuke; Jia, Haiyan; Werth, Emily G.; Mowrey, David D.; Hicks, Leslie M.; Dokholyan, Nikolay V.; Torres, Matthew P.; Jones, Alan M.			Tyrosine phosphorylation switching of a G protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEIN; RECEPTOR-LIKE KINASES; DISCRETE MOLECULAR-DYNAMICS; LARGE GENE LISTS; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; REGULATORY ELEMENTS; STRUCTURAL-ANALYSIS; FUNCTIONAL-ANALYSIS; ALPHA-SUBUNITS	Heterotrimeric G protein complexes are molecular switches relaying extracellular signals sensed by G protein-coupled receptors (GPCRs) to downstream targets in the cytoplasm, which effect cellular responses. In the plant heterotrimeric GTPase cycle, GTP hydrolysis, rather than nucleotide exchange, is the rate-limiting reaction and is accelerated by a receptor-like regulator of G signaling (RGS) protein. We hypothesized that post-translational modification of the G alpha subunit in the G protein complex regulates the RGS-dependent GTPase cycle. Our structural analyses identified an invariant phosphorylated tyrosine residue (Tyr(166) in the Arabidopsis G alpha subunit AtGPA1) located in the intramolecular domain interface where nucleotide binding and hydrolysis occur. We also identified a receptor-like kinase that phosphorylates AtGPA1 in a Tyr(166)-dependent manner. Discrete molecular dynamics simulations predicted that phosphorylated Tyr(166) forms a salt bridge in this interface and potentially affects the RGS protein-accelerated GTPase cycle. Using a Tyr(166) phosphomimetic substitution, we found that the cognate RGS protein binds more tightly to the GDP-bound G alpha substrate, consequently reducing its ability to accelerate GTPase activity. In conclusion, we propose that phosphorylation of Tyr(166) in AtGPA1 changes the binding pattern with AtRGS1 and thereby attenuates the steady-state rate of the GTPase cycle. We coin this newly identified mechanism "substrate phosphoswitching."	[Li, Bo; Tunc-Ozdemir, Meral; Urano, Daisuke; Jia, Haiyan; Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Werth, Emily G.; Hicks, Leslie M.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Mowrey, David D.; Dokholyan, Nikolay V.] Univ N Carolina, Dept Biochem Biophys, Chapel Hill, NC 27599 USA; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Urano, Daisuke] Natl Univ Singapore, Temasek Life Sci Lab, 1 Res Link, Singapore 117604, Singapore; [Torres, Matthew P.] Georgia Inst Technol, Dept Biol Sci, Atlanta, GA 30332 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National University of Singapore; University System of Georgia; Georgia Institute of Technology	Jones, AM (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	alan_jones@unc.edu	Dokholyan, Nikolay/D-8081-2018; Hicks, Leslie M/E-8015-2010	Dokholyan, Nikolay/0000-0002-8225-4025; Hicks, Leslie M/0000-0002-8008-3998; Werth, Emily/0000-0001-8953-0611; Torres, Matthew/0000-0001-7296-4536; Urano, Daisuke/0000-0003-4541-1076; Jia, Haiyan/0000-0003-4788-6534	NCI, National Institutes of Health [CA016086]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114015, R01GM065989, R01GM080742, R01GM123247, R01GM117400, R01GM064803] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. Stephen R. Sprang (University of Montana) for insightful comments; Dr. Henrik Dohlman (University of North Carolina, Chapel Hill, NC) for sharing equipment; and Kevin Knight, Jing Yang, and Catherine Jones for valuable technical assistance. This research is based in part upon work conducted using the UNC Michael Hooker Proteomics Center, which is supported in part by NCI, National Institutes of Health, Grant CA016086 (to the Lineberger Comprehensive Cancer Center).	Becraft PW, 2002, ANNU REV CELL DEV BI, V18, P163, DOI 10.1146/annurev.cellbio.18.012502.083431; Berardini TZ, 2004, PLANT PHYSIOL, V135, P745, DOI 10.1104/pp.104.040071; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Chen JG, 2004, METHOD ENZYMOL, V389, P338; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chen Y, 2010, PLANT J, V63, P1, DOI 10.1111/j.1365-313X.2010.04218.x; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Chen Z, 2008, STRUCTURE, V16, P1532, DOI 10.1016/j.str.2008.07.009; Coleman DE, 1998, BIOCHEMISTRY-US, V37, P14376, DOI 10.1021/bi9810306; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Lorenzo L, 2009, PLANT CELL, V21, P668, DOI 10.1105/tpc.108.059576; Dewhurst HM, 2015, MOL CELL PROTEOMICS, V14, P2285, DOI 10.1074/mcp.M115.051177; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Frisch M. J., 2016, GAUSSIAN 16 REV C01; Glick JL, 1998, J BIOL CHEM, V273, P26008, DOI 10.1074/jbc.273.40.26008; Greeff C, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00209; HAUSDORFF WP, 1992, P NATL ACAD SCI USA, V89, P5720, DOI 10.1073/pnas.89.13.5720; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Isom DG, 2011, PROTEINS, V79, P1034, DOI 10.1002/prot.22932; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Jones JC, 2011, J BIOL CHEM, V286, P13143, DOI 10.1074/jbc.M110.190355; Jones JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001446; Kim DJ, 2015, FEBS LETT, V589, P3321, DOI 10.1016/j.febslet.2015.09.025; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Li B, 2016, PROTEIN EXPRES PURIF, V126, P33, DOI 10.1016/j.pep.2016.04.016; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Lin WW, 2014, P NATL ACAD SCI USA, V111, P3632, DOI 10.1073/pnas.1318817111; Liu JM, 2013, PLANT PHYSIOL, V161, P2146, DOI 10.1104/pp.112.212431; Luan S, 2003, ANNU REV PLANT BIOL, V54, P63, DOI 10.1146/annurev.arplant.54.031902.134743; Mitra SK, 2015, PLANT J, V82, P1042, DOI 10.1111/tpj.12863; MOYERS JS, 1995, BIOCHEM J, V305, P411, DOI 10.1042/bj3050411; Nance MR, 2013, STRUCTURE, V21, P438, DOI 10.1016/j.str.2012.12.016; Aranda-Sicilia MN, 2015, J PLANT PHYSIOL, V188, P44, DOI 10.1016/j.jplph.2015.09.005; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Oh MH, 2012, FEBS LETT, V586, P4070, DOI 10.1016/j.febslet.2012.09.040; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Poppleton H, 1996, J BIOL CHEM, V271, P6947, DOI 10.1074/jbc.271.12.6947; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Rudrabhatla P, 2006, PLANT MOL BIOL, V60, P293, DOI 10.1007/s11103-005-4109-7; Shah K, 2001, J BIOL CHEM, V276, P41263, DOI 10.1074/jbc.M102381200; Shirvanyants D, 2012, J PHYS CHEM B, V116, P8375, DOI 10.1021/jp2114576; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Slep KC, 2008, P NATL ACAD SCI USA, V105, P6243, DOI 10.1073/pnas.0801569105; Sprang SR, 2016, BIOPOLYMERS, V105, P449, DOI 10.1002/bip.22836; Stahl Y., 2012, RECEPTOR LIKE KINASE, P23, DOI DOI 10.1007/978-3-642-23044-8_2; Stratmann JW, 1997, P NATL ACAD SCI USA, V94, P11085, DOI 10.1073/pnas.94.20.11085; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; SUZUKI K, 1995, PLANT CELL, V7, P639, DOI 10.1105/tpc.7.5.639; Taylor VG, 2016, J BIOL CHEM, V291, P5138, DOI 10.1074/jbc.M115.712075; Tor M, 2009, J EXP BOT, V60, P3645, DOI 10.1093/jxb/erp233; Torres MP, 2016, MOL CELL PROTEOMICS, V15, P3513, DOI 10.1074/mcp.M116.062331; Tunc-Ozdemir M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171854; Tunc-Ozdemir M, 2016, J BIOL CHEM, V291, P13918, DOI 10.1074/jbc.C116.736702; Tweedie-Cullen RY, 2009, J PROTEOME RES, V8, P4966, DOI 10.1021/pr9003739; Urano D, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf9558; Urano D, 2016, PLANT CELL PHYSIOL, V57, P437, DOI 10.1093/pcp/pcw002; Urano D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120186; Urano D, 2012, NAT CELL BIOL, V14, P1079, DOI 10.1038/ncb2568; Urano D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002756; Wang J, 1999, J BIOL CHEM, V274, P31641, DOI 10.1074/jbc.274.44.31641; Wang J, 1998, J BIOL CHEM, V273, P26014, DOI 10.1074/jbc.273.40.26014; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Xu Q, 1998, PLANT CELL, V10, P849, DOI 10.1105/tpc.10.5.849; Yeh YH, 2016, PLANT CELL, V28, P1701, DOI 10.1105/tpc.16.00313; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Yin SY, 2010, METHODS MOL BIOL, V634, P189, DOI 10.1007/978-1-60761-652-8_14; Zhang SQ, 1997, PLANT CELL, V9, P809, DOI 10.1105/tpc.9.5.809	73	16	16	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4752	4766		10.1074/jbc.RA117.000163	http://dx.doi.org/10.1074/jbc.RA117.000163			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29382719	hybrid, Green Published			2022-12-26	WOS:000428848300017
J	Sheikh, T; Gupta, P; Gowda, P; Patrick, S; Sen, E				Sheikh, Touseef; Gupta, Piyushi; Gowda, Pruthvi; Patrick, Shruti; Sen, Ellora			Hexokinase 2 and nuclear factor erythroid 2-related factor 2 transcriptionally coactivate xanthine oxidoreductase expression in stressed glioma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; OXIDATIVE STRESS; CANCER-CELLS; SACCHAROMYCES-CEREVISIAE; GLUCOSE-HOMEOSTASIS; NLRP3 INFLAMMASOME; GLIOBLASTOMA CELLS; SIGNALING PATHWAY; ROS PRODUCTION; NRF2	A dynamic network of metabolic adaptations, inflammatory responses, and redox homeostasis is known to drive tumor progression. A considerable overlap among these processes exists, but several of their key regulators remain unknown. To this end, here we investigated the role of the proinflammatory cytokine IL-1 beta in connecting these processes in glioma cells. We found that glucose starvation sensitizes glioma cells to IL-1 beta-induced apoptosis in a manner that depended on reactive oxygen species (ROS). Although IL-1 beta-induced JNK had no effect on cell viability under glucose deprivation, it mediated nuclear translocation of hexokinase 2 (HK2). This event was accompanied by increases in the levels of sirtuin 6 (SIRT6), nuclear factor erythroid 2-related factor 2 (Nrf2), and xanthine oxidoreductase (XOR). SIRT6 not only induced ROS-mediated cell death but also facilitated nuclear Nrf2-HK2 interaction. Recruitment of the Nrf2-HK2 complex to the ARE site on XOR promoter regulated its expression. Importantly, HK2 served as transcriptional coactivator of Nrf2 to regulate XOR expression, indicated by decreased XOR levels in siRNA-mediated Nrf2 and HK2 knockdown experiments. Our results highlight a non-metabolic role of HK2 as transcriptional coactivator of Nrf2 to regulate XOR expression under conditions of proinflammatory and metabolic stresses. Our insights also underscore the importance of nuclear activities of HK2 in the regulation of genes involved in redox homeostasis.	[Sheikh, Touseef; Gupta, Piyushi; Gowda, Pruthvi; Patrick, Shruti; Sen, Ellora] Natl Brain Res Ctr, Manesar 122051, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Sen, E (corresponding author), Natl Brain Res Ctr, Manesar 122051, Haryana, India.	ellora@nbrc.ac.in		Sen, Ellora/0000-0001-6842-7850; Sheikh, Dr Touseef Ahmad/0000-0002-5608-8705; Gowda, Pruthvi/0000-0002-3928-2442	Department of Biotechnology (Government of India) [BT/MED/30/SP11016/2015]	Department of Biotechnology (Government of India)(Department of Biotechnology (DBT) India)	The work was supported by Department of Biotechnology (Government of India) Research Grant BT/MED/30/SP11016/2015 (to E. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad F, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.117; Ahuatzi D, 2004, J BIOL CHEM, V279, P14440, DOI 10.1074/jbc.M313431200; Bauer I, 2012, J BIOL CHEM, V287, P40924, DOI 10.1074/jbc.M112.405837; del Rey A, 2006, P NATL ACAD SCI USA, V103, P16039, DOI 10.1073/pnas.0607076103; Dixit D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.179; Dixit D, 2009, FREE RADICAL BIO MED, V47, P364, DOI 10.1016/j.freeradbiomed.2009.04.031; Ghosh S, 2016, EXP CELL RES, V340, P116, DOI 10.1016/j.yexcr.2015.11.016; Ghosh S, 2013, MOL CELL BIOL, V33, P2718, DOI 10.1128/MCB.01254-12; Graham NA, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.20; Griguer CE, 2006, CANCER RES, V66, P2257, DOI 10.1158/0008-5472.CAN-05-3364; Gupta P, 2017, EXP CELL RES, V357, P98, DOI 10.1016/j.yexcr.2017.05.005; Herrero P, 1998, FEBS LETT, V434, P71, DOI 10.1016/S0014-5793(98)00872-2; Huber HJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.2; Ives A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7555; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; John S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017674; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Kovac S, 2015, BBA-GEN SUBJECTS, V1850, P794, DOI 10.1016/j.bbagen.2014.11.021; Maksin-Matveev A, 2015, EXP CELL RES, V330, P81, DOI 10.1016/j.yexcr.2014.07.013; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Martinez-Outschoorn UE, 2013, CELL CYCLE, V12, P2580, DOI 10.4161/cc.25510; Mathupala SP, 2001, J BIOL CHEM, V276, P43407, DOI 10.1074/jbc.M108181200; Mergenthaler P, 2012, P NATL ACAD SCI USA, V109, P1518, DOI 10.1073/pnas.1108225109; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Neary CL, 2010, BIOCHEM BIOPH RES CO, V394, P1075, DOI 10.1016/j.bbrc.2010.03.129; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Pan HZ, 2016, CELL RES, V26, P190, DOI 10.1038/cr.2016.4; Pelaez R, 2009, J BIOL CHEM, V284, P20548, DOI 10.1074/jbc.M109.013730; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Sanman LE, 2016, ELIFE, V5, DOI 10.7554/eLife.13663; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Sharma V, 2007, MOL CANCER THER, V6, P2544, DOI 10.1158/1535-7163.MCT-06-0788; Sharma V, 2011, J MOL MED, V89, P123, DOI 10.1007/s00109-010-0683-5; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Vega M, 2016, J BIOL CHEM, V291, P7267, DOI 10.1074/jbc.M115.711408; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Wolf AJ, 2016, CELL, V166, P624, DOI 10.1016/j.cell.2016.05.076; Wu RX, 2012, EMBO MOL MED, V4, P633, DOI 10.1002/emmm.201200240; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou YF, 2011, J BIOL CHEM, V286, P32843, DOI 10.1074/jbc.M111.260935	44	17	18	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4767	4777		10.1074/jbc.M117.816785	http://dx.doi.org/10.1074/jbc.M117.816785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29414774	Green Published, hybrid			2022-12-26	WOS:000428848300018
J	Eguchi, T; Sogawa, C; Okusha, Y; Uchibe, K; Iinuma, R; Ono, K; Nakano, K; Murakami, J; Itoh, M; Arai, K; Fujiwara, T; Namba, Y; Murata, Y; Ohyama, K; Shimomura, M; Okamura, H; Takigawa, M; Nakatsura, T; Kozaki, K; Okamoto, K; Calderwood, SK				Eguchi, Takanori; Sogawa, Chiharu; Okusha, Yuka; Uchibe, Kenta; Iinuma, Ryosuke; Ono, Kisho; Nakano, Keisuke; Murakami, Jun; Itoh, Manabu; Arai, Kazuya; Fujiwara, Toshifumi; Namba, Yuri; Murata, Yoshiki; Ohyama, Kazumi; Shimomura, Manami; Okamura, Hirohiko; Takigawa, Masaharu; Nakatsura, Tetsuya; Kozaki, Ken-ichi; Okamoto, Kuniaki; Calderwood, Stuart K.			Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HEAT-SHOCK PROTEINS; FATE DETERMINATION FACTOR; PROSTATE-CANCER; CLONAL EVOLUTION; BREAST-CANCER; PANCREATIC-CANCER; NEUROENDOCRINE DIFFERENTIATION; EXTRACELLULAR VESICLES; TUMOR-DEVELOPMENT	Ability to form cellular aggregations such as tumorspheres and spheroids have been used as a morphological marker of malignant cancer cells and in particular cancer stem cells (CSC). However, the common definition of the types of cellular aggregation formed by cancer cells has not been available. We examined morphologies of 67 cell lines cultured on three dimensional morphology enhancing NanoCulture Plates (NCP) and classified the types of cellular aggregates that form. Among the 67 cell lines, 49 cell lines formed spheres or spheroids, 8 cell lines formed grape-like aggregation (GLA), 8 cell lines formed other types of aggregation, and 3 cell lines formed monolayer sheets. Seven GLA-forming cell lines were derived from adenocarcinoma among the 8 lines. A neuroendocrine adenocarcinoma cell line PC-3 formed asymmetric GLA with ductal structures on the NCPs and rapidly growing asymmetric tumors that metastasized to lymph nodes in immunocompromised mice. In contrast, another adenocarcinoma cell line DU-145 formed spheroids in vitro and spheroid-like tumors in vivo that did not metastasize to lymph nodes until day 50 after transplantation. Culture in the 3D nanoenvironment and in a defined stem cell medium enabled the neuroendocrine adenocarcinoma cells to form slowly growing large organoids that expressed multiple stem cell markers, neuroendocrine markers, intercellular adhesion molecules, and oncogenes in vitro. In contrast, the more commonly used 2D serum-contained environment reduced intercellular adhesion and induced mesenchymal transition and promoted rapid growth of the cells. In addition, the 3D stemness nanoenvironment promoted secretion of HSP90 and EpCAM-exosomes, a marker of CSC phenotype, from the neuroendocrine organoids. These findings indicate that the NCP-based 3D environment enables cells to form stem cell tumoroids with multipotency and model more accurately the in vivo tumor status at the levels of morphology and gene expression.	[Eguchi, Takanori; Sogawa, Chiharu; Okusha, Yuka; Ono, Kisho; Fujiwara, Toshifumi; Namba, Yuri; Murata, Yoshiki; Kozaki, Ken-ichi; Okamoto, Kuniaki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dent Pharmacol, Okayama, Japan; [Eguchi, Takanori; Nakano, Keisuke; Murakami, Jun; Takigawa, Masaharu] Okayama Univ, Adv Res Ctr Oral & Craniofacial Sci, Dent Sch, Okayama, Japan; [Uchibe, Kenta; Okamura, Hirohiko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Morphol, Okayama, Japan; [Iinuma, Ryosuke; Itoh, Manabu; Arai, Kazuya] JSR Life Sci Corp, Tsukuba, Ibaraki, Japan; [Nakano, Keisuke] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Pathol & Med, Okayama, Japan; [Murakami, Jun] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Diag & Dent Maxillofacial Radiol, Okayama, Japan; [Ohyama, Kazumi] Okayama Univ, Radio Isotope Res Ctr, Dent Sch, Okayama, Japan; [Shimomura, Manami; Nakatsura, Tetsuya] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Canc Immunotherapy, Kashiwa, Chiba, Japan; [Calderwood, Stuart K.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA USA	Okayama University; Okayama University; Okayama University; Okayama University; Okayama University; Okayama University; National Cancer Center - Japan; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Eguchi, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dent Pharmacol, Okayama, Japan.; Eguchi, T (corresponding author), Okayama Univ, Adv Res Ctr Oral & Craniofacial Sci, Dent Sch, Okayama, Japan.	eguchi@okayama-u.ac.jp	SOGAWA, Chiharu/B-1994-2011; Okamura, Hirohiko/I-5917-2019	Okamura, Hirohiko/0000-0002-3254-5238; Okusha, Yuka/0000-0002-1399-2294; Eguchi, Takanori/0000-0002-3297-6126	JSR Life Sciences Corporation; JSPS KAKENHI [JP17K11642, JP16K11722, JP17K11669]; JSR joint research program; Ryobi Teien Memorial Foundation Grant	JSR Life Sciences Corporation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSR joint research program; Ryobi Teien Memorial Foundation Grant	JSR Life Sciences Corporation provided support in the form of salaries for authors RI, MI, and KA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by JSPS KAKENHI, grant numbers JP17K11642 (to TE), JP16K11722 (to JM TE), JP17K11669 (to CS TE), and JP17K11669 (to KO CS TE), a JSR joint research program (to TE), and a Ryobi Teien Memorial Foundation Grant (to TE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal B, 1998, NAT MED, V4, P43, DOI 10.1038/nm0198-043; Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Arai K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162394; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921; Barker HE, 2015, NAT REV CANCER, V15, P409, DOI 10.1038/nrc3958; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Braicu C, 2015, CELL DEATH DIFFER, V22, P34, DOI 10.1038/cdd.2014.130; Brockmann M, 2013, CANCER CELL, V24, P75, DOI 10.1016/j.ccr.2013.05.005; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calderwood SK, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00159; Calderwood Stuart K, 2015, Subcell Biochem, V78, P103, DOI 10.1007/978-3-319-11731-7_5; Carnero A, 2016, BIOESSAYS, V38, pS65, DOI 10.1002/bies.201670911; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Chou SD, 2015, ONCOGENE, V34, P2178, DOI 10.1038/onc.2014.177; Chou SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039679; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Cioffi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10357; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Daley D, 2016, CELL, V166, P1485, DOI 10.1016/j.cell.2016.07.046; Day KC, 2017, CANCER RES, V77, P74, DOI 10.1158/0008-5472.CAN-16-1656; Desiderio V, 2014, ONCOTARGET, V6; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dong PX, 2014, CARCINOGENESIS, V35, P760, DOI 10.1093/carcin/bgt369; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Eguchi T, 2008, MOL CELL BIOL, V28, P2391, DOI 10.1128/MCB.01288-07; Eguchi T, 2017, J CELL BIOCHEM, V118, P43, DOI 10.1002/jcb.25607; Eguchi T, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/7530942; Eguchi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058796; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; Fujita Y, 2016, CANCER SCI, V107, P385, DOI 10.1111/cas.12896; Gimmi CD, 1996, NAT MED, V2, P1367, DOI 10.1038/nm1296-1367; Gong J, 2015, ONCOGENE, V34, P5460, DOI 10.1038/onc.2015.1; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hance MW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.389015; Hara ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083545; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; Hida K, 2017, CANC LETT; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ishiguro T, 2017, CANCER SCI, V108, P283, DOI 10.1111/cas.13155; Ishii H, 2014, J BIOL CHEM, V289, P27386, DOI 10.1074/jbc.M114.589432; Jayaprakash P, 2015, J CELL SCI, V128, P1475, DOI 10.1242/jcs.166363; Jeter CR, 2015, STEM CELLS, V33, P2381, DOI 10.1002/stem.2007; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kharmate G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154967; King CE, 2011, ONCOGENE, V30, P4185, DOI 10.1038/onc.2011.131; Komohara Y, 2017, CANCER SCI, V108, P290, DOI 10.1111/cas.13137; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kufe DW, 2013, ONCOGENE, V32, P1073, DOI 10.1038/onc.2012.158; Kugel S, 2016, CELL, V165, P1401, DOI 10.1016/j.cell.2016.04.033; Kumar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068597; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Li W, 2013, INT REV CEL MOL BIO, V303, P203, DOI 10.1016/B978-0-12-407697-6.00005-2; Li ZH, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-79; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Lv LH, 2012, J BIOL CHEM, V287, P15874, DOI 10.1074/jbc.M112.340588; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Madhavan B, 2015, INT J CANCER, V136, P2616, DOI 10.1002/ijc.29324; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mathiyalagan P, 2017, CIRC RES, V120, P1466, DOI 10.1161/CIRCRESAHA.116.310557; Matsuo Y, 2009, INT J CANCER, V124, P853, DOI 10.1002/ijc.24040; MAYER B, 1993, LANCET, V342, P1019, DOI 10.1016/0140-6736(93)92879-X; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mizushima H, 2009, J CELL SCI, V122, P4277, DOI 10.1242/jcs.054551; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Murshid A, 2013, INT J HYPERTHER, V29, P442, DOI 10.3109/02656736.2013.798873; Nagano O, 2013, ONCOGENE, V32, P5191, DOI 10.1038/onc.2012.638; Nakase I, 2015, SCI REP-UK, V5, DOI 10.1038/srep10300; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Omara-Opyene AL, 2004, LAB INVEST, V84, P894, DOI 10.1038/labinvest.3700112; Palmgren JS, 2007, SEMIN ONCOL, V34, P22, DOI 10.1053/j.seminoncol.2006.10.026; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park SJ, 2016, ONCOGENE, V35, P1292, DOI 10.1038/onc.2015.187; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; PERROTTI D, 1995, MOL CELL BIOL, V15, P6075; Petreaca ML, 2007, MOL BIOL CELL, V18, P5014, DOI 10.1091/mbc.E07-01-0004; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Popov VM, 2009, CANCER RES, V69, P5752, DOI 10.1158/0008-5472.CAN-08-3992; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Raj D, 2015, STEM CELLS, V33, P2893, DOI 10.1002/stem.2114; Ramteke A, 2015, MOL CARCINOGEN, V54, P554, DOI 10.1002/mc.22124; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sakata K, 1996, JPN J CANCER RES, V87, P78, DOI 10.1111/j.1349-7006.1996.tb00203.x; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Shimada K, 2008, CANCER SCI, V99, P39, DOI 10.1111/j.1349-7006.2007.00655.x; Sowell RT, 2016, CELL, V166, P1362, DOI 10.1016/j.cell.2016.08.058; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Spiotto MT, 2000, PROSTATE, V42, P186, DOI 10.1002/(SICI)1097-0045(20000215)42:3<186::AID-PROS4>3.0.CO;2-E; Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106; Sun Z, 2013, MOL ONCOL, V7, P884, DOI 10.1016/j.molonc.2013.04.007; Sunde JS, 2006, CANCER RES, V66, P8404, DOI 10.1158/0008-5472.CAN-06-0683; Swartling FJ, 2012, CANCER CELL, V21, P601, DOI 10.1016/j.ccr.2012.04.012; Tai S, 2011, PROSTATE, V71, P1668, DOI 10.1002/pros.21383; Takahashi Kazutoshi, 2006, V329, P449; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TANABE KK, 1993, LANCET, V341, P725, DOI 10.1016/0140-6736(93)90490-8; Tirino V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.144; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Weber CE, 2015, ONCOGENE, V34, P4821, DOI 10.1038/onc.2014.410; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461; Wu KM, 2008, P NATL ACAD SCI USA, V105, P6924, DOI 10.1073/pnas.0802085105; Wu KM, 2006, MOL CELL BIOL, V26, P7116, DOI 10.1128/MCB.00268-06; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Yan T, 2014, J CANCER, V5, P572, DOI 10.7150/jca.8865; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yoshida GJ, 2016, CANCER SCI, V107, P5, DOI 10.1111/cas.12817; Yoshii Y, 2011, BIOMATERIALS, V32, P6052, DOI 10.1016/j.biomaterials.2011.04.076; Zeng Y, 2013, CANCER RES, V73, P4123, DOI 10.1158/0008-5472.CAN-12-1343; Zhuang JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep11924	141	71	72	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191109	10.1371/journal.pone.0191109	http://dx.doi.org/10.1371/journal.pone.0191109			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415026	Green Published, Green Submitted, gold			2022-12-26	WOS:000424325300015
J	Jung, SY; Kwon, J; Park, S; Jhee, JH; Yun, HR; Kim, H; Kee, YK; Yoon, CY; Chang, TI; Kang, EW; Park, JT; Yoo, TH; Kang, SW; Han, SH				Jung, Su-Young; Kwon, Jaeyeol; Park, Seohyun; Jhee, Jong Hyun; Yun, Hae-Ryong; Kim, HyoungNae; Kee, Youn Kyung; Yoon, Chang-Yun; Chang, Tae-Ik; Kang, Ea Wha; Park, Jung Tak; Yoo, Tae-Hyun; Kang, Shin-Wook; Han, Seung Hyeok			Phosphate is a potential biomarker of disease severity and predicts adverse outcomes in acute kidney injury patients undergoing continuous renal replacement therapy	PLOS ONE			English	Article							CHRONIC-HEMODIALYSIS PATIENTS; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; GROWTH-FACTOR 23; MORTALITY RISK; PARATHYROID-HORMONE; FAILURE; HYPERPHOSPHATEMIA; ASSOCIATION; PHOSPHORUS	Hyperphosphatemia is associated with mortality in patients with chronic kidney disease, and is common in critically ill patients with acute kidney injury (AKI); however, its clinical implication in these patients is unknown. We conducted an observational study in 1144 patients (mean age, 63.2 years; male, 705 [61.6%]) with AKI who received continuous renal replacement therapy (CRRT) between January 2009 and September 2016. Phosphate levels were measured before (0 h) and 24 h after CRRT initiation. We assessed disease severity using various clinical parameters. Phosphate at 0 h positively correlated with the Acute Physiology and Chronic Health Evaluation II (APACHE II; P < 0.001) and Sequential Organ Failure Assessment (SOFA; P < 0.001) scores, and inversely with mean arterial pressure (MAP; P = 0.02) and urine output (UO; P = 0.01). In a fully adjusted linear regression analysis for age, sex, Charlson comorbidity index (CCI), MAP, and estimated glomerular filtration rate (eGFR), higher 0 h phosphate level was significantly associated with high APACHE II (P < 0.001) and SOFA (P = 0.04) scores, suggesting that phosphate represents disease severity. A multivariable Cox model also showed that hyperphosphatemia was significantly associated with increased 28-day (HR 1.05, 95% CI 1.02 +/- 1.08, P = 0.001) and 90-day (HR 1.05, 95% CI 1.02 +/- 1.08, P = 0.001) mortality. Furthermore, patients with increased phosphate level during 24 h were at higher risk of death than those with stable or decreased phosphate levels. Finally, c-statistics significantly increased when phosphate was added to a model that included age, sex, CCI, body mass index, eGFR, MAP, hemoglobin, serum albumin, C-reactive protein, and APACHE II score. This study shows that phosphate is a potential biomarker that can reflect disease severity and predict mortality in critically ill patients receiving CRRT.	[Jung, Su-Young; Kwon, Jaeyeol; Park, Seohyun; Jhee, Jong Hyun; Yun, Hae-Ryong; Kim, HyoungNae; Kee, Youn Kyung; Yoon, Chang-Yun; Park, Jung Tak; Yoo, Tae-Hyun; Kang, Shin-Wook; Han, Seung Hyeok] Yonsei Univ, Inst Kidney Dis Res, Coll Med, Dept Internal Med, Seoul, South Korea; [Chang, Tae-Ik; Kang, Ea Wha] Ilsan Hosp, NHIS Med Ctr, Dept Internal Med, Ilsan, South Korea	Yonsei University; Yonsei University Health System; NHIS Ilsan Hospital	Han, SH (corresponding author), Yonsei Univ, Inst Kidney Dis Res, Coll Med, Dept Internal Med, Seoul, South Korea.	hansh@yuhs.ac	Han, Seung Hyeok/K-4559-2018; Han, Seung Hyeok/W-8825-2019	Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Park, Jung Tak/0000-0002-2325-8982; Yun, Hae-Ryong/0000-0002-7038-0251; Yoo, Tae-Hyun/0000-0002-9183-4507; Kang, Shin-Wook/0000-0002-5677-4756				Ali FN, 2013, PEDIATR NEPHROL, V28, P959, DOI 10.1007/s00467-012-2395-2; Badve SV, 2016, AM J KIDNEY DIS, V68, P554, DOI 10.1053/j.ajkd.2016.03.418; Baker SG, 2014, STAT MED, V33, P3946, DOI 10.1002/sim.6195; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Buckley MS, 2010, CRIT CARE MED, V38, pS253, DOI 10.1097/CCM.0b013e3181dda0be; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Demirjian S, 2011, CLIN J AM SOC NEPHRO, V6, P2114, DOI 10.2215/CJN.02900311; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Foley RN, 2009, CLIN J AM SOC NEPHRO, V4, P1136, DOI 10.2215/CJN.01660309; Gail MH, 2008, J NATL CANCER I, V100, P1037, DOI 10.1093/jnci/djn180; Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131; Gaudry S, 2016, NEW ENGL J MED, V375, P122, DOI 10.1056/NEJMoa1603017; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Isakova T, 2009, J AM SOC NEPHROL, V20, P388, DOI 10.1681/ASN.2008060609; Jimbo R, 2014, KIDNEY INT, V85, P1103, DOI 10.1038/ki.2013.332; Jung SY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004542; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Leaf DE, 2012, CLIN J AM SOC NEPHRO, V7, P1217, DOI 10.2215/CJN.00550112; Leaf DE, 2016, J AM SOC NEPHROL; Liangos O, 2007, J AM SOC NEPHROL, V18, P904, DOI 10.1681/ASN.2006030221; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Ozmen S, 2007, RENAL FAILURE, V29, P509, DOI 10.1080/08860220701275006; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; PEPPERS MP, 1991, CRIT CARE CLIN, V7, P201, DOI 10.1016/S0749-0704(18)30332-4; Sanjeevani Scienthia, 2014, Int J Crit Illn Inj Sci, V4, P223, DOI 10.4103/2229-5151.141420; Sullivan C, 2009, JAMA-J AM MED ASSOC, V301, P629, DOI 10.1001/jama.2009.96; Titan SM, 2011, CLIN J AM SOC NEPHRO, V6, P241, DOI 10.2215/CJN.04250510; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Zhang M, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-21	33	31	34	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191290	10.1371/journal.pone.0191290	http://dx.doi.org/10.1371/journal.pone.0191290			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415048	gold, Green Published, Green Submitted			2022-12-26	WOS:000424325300022
J	dos Santos, EA; de Almeida, AAF; Branco, MCD; dos Santos, IC; Ahnert, D; Baligar, VC; Valle, RR				dos Santos, Emerson Alves; de Almeida, Alex-Alan Furtado; da Silva Branco, Marcia Christina; dos Santos, Ivanildes Conceicao; Ahnert, Dario; Baligar, Virupax C.; Valle, Raul Rene			Path analysis of phenotypic traits in young cacao plants under drought conditions	PLOS ONE			English	Article							COCOA THEOBROMA-CACAO; WATER-STRESS; IRRIGATION; RESPONSES; YIELD; TOLERANCE; SALINITY; QUALITY; ROOTS	Drought is worldwide considered one of the most limiting factors of Theobroma cacao production, which can be intensified by global climate changes. In this study, we aimed to investigate the phenotypic correlation among morphological characteristics of cacao progenies submitted to irrigation and drought conditions and their partitions into direct and indirect effects. Path analysis with phenotypic plasticity index was used as criteria for estimation of basic and explanatory variables. The experiment was conducted in a greenhouse at the Cacao Research Center (CEPEC), Ilheus, Bahia, Brazil, in a randomized block 21 x 2 factorial arrangement [21 cacao progenies obtained from complete diallel crosses and two water regimes (control and drought)] and six replications. In general, drought conditions influenced biomass production in most progenies, causing significant reductions in total leaf area, leaf number, leaf biomass, fine-roots length (diameter <1 mm), root volume and root area for considered drought intolerant. All progenies showed alterations in growth due to drought. Phenotypic plasticity was most strongly pronounced in root volume. Stem and root diameters, as well as stem dry biomass were the growth variables with the greatest direct effects on root volume under drought conditions, these characters being indicated in screening of cacao progenies drought tolerant.	[dos Santos, Emerson Alves; de Almeida, Alex-Alan Furtado; da Silva Branco, Marcia Christina; dos Santos, Ivanildes Conceicao; Ahnert, Dario] Univ Estadual Santa Cruz, Dept Ciencias Biol, Campus Soane Nazare Andrade, Ilhe Aeus, BA, Brazil; [Baligar, Virupax C.] USDA, Agr Res Serv, Beltsville, MD 20705 USA; [Valle, Raul Rene] CEPLAC, CEPEC, Ctr Pesquisas Cacau Comissao Executiva Plano Lavo, Ilhe Aeus, BA, Brazil	Universidade Estadual de Santa Cruz; United States Department of Agriculture (USDA)	de Almeida, AAF (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Campus Soane Nazare Andrade, Ilhe Aeus, BA, Brazil.	alexalan@uesc.br		da Silva Branco, Marcia Christina/0000-0001-9998-713X; Baligar, Virupax/0000-0002-6441-4638				Albacete AA, 2014, BIOTECHNOL ADV, V32, P12, DOI 10.1016/j.biotechadv.2013.10.005; Alvim P., 1977, ECOPHYSIOLOGY TROPIC, P279, DOI DOI 10.1016/C2013-0-07134-4; Anjum SA, 2011, AFR J AGR RES, V6, P2026; Arvalo AR, 1975, P 5 INT COC RES C IB, P78; Bae H, 2008, PLANT PHYSIOL BIOCH, V46, P174, DOI 10.1016/j.plaphy.2007.10.014; BALASIMHA D, 1988, INDIAN J AGR SCI, V58, P213; Belsky JM, 2003, AGR HUM VALUES, V20, P277, DOI 10.1023/A:1026100714149; Bizeti HS, 2004, BRAZ ARCH BIOL TECHN, V47, P669, DOI 10.1590/S1516-89132004000500001; Carr MKV, 2011, EXP AGR, V47, P653, DOI 10.1017/S0014479711000421; Carvalho S P, 1999, GENET MOL BIOL, V22, P109; Coimbra JLM, 2005, MULTICOLINEARIDADE A; CRUZ C. D., 2006, MODELOS BIOMETRICOS, V2; Cruz C.D., 2006, PROGRAMA GENES ESTAT; DaMatta Fábio Murilo, 2004, Braz. J. Plant Physiol., V16, P1, DOI 10.1590/S1677-04202004000100001; DaMatta FM, 2003, PLANT SCI, V164, P111, DOI 10.1016/S0168-9452(02)00342-4; de Araujo EC, 2007, CROP BREED APPL BIOT, V7, P148; Junior JOD, 2008, REV BRAS CIENC SOLO, V32, P2367, DOI 10.1590/S0100-06832008000600015; DEALMEIDA CMVC, 1994, REV BRAS GENET, V17, P181; dos Santos A, 2014, CROP BREED APPL BIOT, V14, P82, DOI 10.1590/1984-70332014v14n2a15; Falconer D. S., 1996, INTRO QUANTITATIVE G; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Gao HJ, 2009, SCI HORTIC-AMSTERDAM, V119, P147, DOI 10.1016/j.scienta.2008.07.034; Garcia-Sanchez F, 2003, EUR J AGRON, V19, P427, DOI 10.1016/S1161-0301(02)00138-7; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hutcheon W. V., 1977, Proceedings, V International Cocoa Research Conference., P222; KHAN MN, 1988, 10TH INTERNATIONAL COCOA RESEARCH CONFERENCE, P185; Kramer P.J., 1995, WATER RELATIONS PLAN, P377; Kummerow J., 1981, Revista Theobroma, V11, P77; Li CC, 1975, PATH ANAL APRIMER; Maurel C, 2010, J EXP BOT, V61, P3191, DOI 10.1093/jxb/erq150; MCCREE KJ, 1989, CROP SCI, V29, P353, DOI 10.2135/cropsci1989.0011183X002900020025x; Moser G, 2010, AGROFOREST SYST, V79, P171, DOI 10.1007/s10457-010-9303-1; ORCHARD JE, 1988, 10TH INTERNATIONAL COCOA RESEARCH CONFERENCE, P193; Ortuno MF, 2004, PLANT SCI, V167, P275, DOI 10.1016/j.plantsci.2004.03.023; Padi FK, 2013, PLANT BREEDING, V132, P229, DOI 10.1111/pbr.12039; Pinto EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105127; Quinones A, 2007, AGR ECOSYST ENVIRON, V122, P399, DOI 10.1016/j.agee.2007.02.004; Rada F., 2005, Rev. Fac. Agron., V22, P112; RAZI IM, 1992, ASIAN JOURNAL OF PLA, V6, P709; SALE PJM, 1970, J HORTIC SCI BIOTECH, V45, P99, DOI 10.1080/00221589.1970.11514337; Santos R. F., 1998, Revista Brasileira de Engenharia Agricola e Ambiental, V2, P287; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; Schuppler U, 1998, PLANT PHYSIOL, V117, P667, DOI 10.1104/pp.117.2.667; Silva W. S. da, 1998, Agrotropica, V10, P31; Turner NC, 1997, ADV AGRON, V58, P293; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P525, DOI 10.4161/psb.3.8.6186; Valladares F, 1997, PLANT CELL ENVIRON, V20, P25, DOI 10.1046/j.1365-3040.1997.d01-8.x; VALLADARES F, 2000, ECOLOGY, V81, P1925; Vencovsky R, 1992, REV BRAS GENET; Wright S, 1920, J AGRIC RES, V20, P0557; Yagdi K, 2009, PAK J BOT, V41, P753	51	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191847	10.1371/journal.pone.0191847	http://dx.doi.org/10.1371/journal.pone.0191847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408854	gold, Green Submitted, Green Published			2022-12-26	WOS:000424302800025
J	Azar, D; Ohadi, D; Rachev, A; Eberth, JF; Uline, MJ; Shazly, T				Azar, Dara; Ohadi, Donya; Rachev, Alexander; Eberth, John F.; Uline, Mark J.; Shazly, Tarek			Mechanical and geometrical determinants of wall stress in abdominal aortic aneurysms: A computational study	PLOS ONE			English	Article							QUALITY-OF-LIFE; DAMAGE EXPERIMENTS; RUPTURE RISK; REPAIR; PATHOPHYSIOLOGY; SURVEILLANCE; TORTUOSITY; THICKNESS; DIAMETER; SURVIVAL	An aortic aneurysm (AA) is a focal dilatation of the aortic wall. Occurrence of AA rupture is an all too common event that is associated with high levels of patient morbidity and mortality. The decision to surgically intervene prior to AA rupture is made with recognition of significant procedural risks, and is primarily based on the maximal diameter and/or growth rate of the AA. Despite established thresholds for intervention, rupture occurs in a notable subset of patients exhibiting sub-critical maximal diameters and/or growth rates. Therefore, a pressing need remains to identify better predictors of rupture risk and ultimately integrate their measurement into clinical decision making. In this study, we use a series of finite element-based computational models that represent a range of plausible AA scenarios, and evaluate the relative sensitivity of wall stress to geometrical and mechanical properties of the aneurysmal tissue. Taken together, our findings encourage an expansion of geometrical parameters considered for rupture risk assessment, and provide perspective on the degree to which tissue mechanical properties may modulate peak stress values within aneurysmal tissue.	[Azar, Dara; Rachev, Alexander; Eberth, John F.; Uline, Mark J.; Shazly, Tarek] Univ South Carolina, Coll Engn & Comp, Biomed Engn Program, Columbia, SC 29208 USA; [Ohadi, Donya; Uline, Mark J.] Univ South Carolina, Coll Engn & Comp, Dept Chem Engn, Columbia, SC 29208 USA; [Rachev, Alexander] Bulgarian Acad Sci, Inst Mech, Sofia, Bulgaria; [Eberth, John F.] Univ South Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA; [Shazly, Tarek] Univ South Carolina, Dept Mech Engn, Coll Engn & Comp, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia; Bulgarian Academy of Sciences; University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia	Uline, MJ; Shazly, T (corresponding author), Univ South Carolina, Coll Engn & Comp, Biomed Engn Program, Columbia, SC 29208 USA.; Uline, MJ (corresponding author), Univ South Carolina, Coll Engn & Comp, Dept Chem Engn, Columbia, SC 29208 USA.; Shazly, T (corresponding author), Univ South Carolina, Dept Mech Engn, Coll Engn & Comp, Columbia, SC 29208 USA.	uline@cec.sc.edu; shazly@mailbox.sc.edu	Uline, Mark Jacob/GZL-2712-2022; Azar, Dara/AAE-6353-2019	Azar, Dara/0000-0002-4670-3997	NIH INBRE [P20GM103499, R01HL133662]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103499] Funding Source: NIH RePORTER	NIH INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the NIH INBRE Grant for South Carolina (P20GM103499) to Mark J Uline and Tarek Shazly and R01HL133662 to John F Eberth.; This research was supported by the NIH INBRE Grant for South Carolina (P20GM103499) and (R01HL133662).	Aljabri B, 2006, J VASC SURG, V44, P1182, DOI 10.1016/j.jvs.2006.08.015; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Bottasso CL, 2002, ENG COMPUT-GERMANY, V18, P66, DOI 10.1007/s003660200006; Brady AR, 2002, NEW ENGL J MED, V346, P1445; Celi S, 2010, EUR HEART J, V31, P284; Chauhan SS, 2017, ANN BIOMED ENG, V45, P1908, DOI 10.1007/s10439-017-1837-1; Danyi P, 2012, TRENDS CARDIOVAS MED, V22, P180, DOI 10.1016/j.tcm.2012.07.017; Del Corso L, 1998, ANGIOLOGY, V49, P361, DOI 10.1177/000331979804900505; Di Martino ES, 2006, J VASC SURG, V43, P570, DOI 10.1016/j.jvs.2005.10.072; DOBRIN PB, 1989, SURG CLIN N AM, V69, P687; Dorfmann A, 2010, BIOMECH MODEL MECHAN, V9, P127, DOI 10.1007/s10237-009-0163-4; Doyle BJ, 2009, J VASC SURG, V49, P443, DOI 10.1016/j.jvs.2008.08.064; Fillinger M, 2007, SEMIN VASC SURG, V20, P121, DOI 10.1053/j.semvascsurg.2007.04.001; Fillinger MF, 2003, J VASC SURG, V37, P724, DOI 10.1067/mva.2003.213; Fillinger MF, 2002, J VASC SURG, V36, P589, DOI 10.1067/mva.2002.125478; Fujikura K, 2007, ULTRASONIC IMAGING, V29, P137, DOI 10.1177/016173460702900301; Gasser TC, 2010, EUR J VASC ENDOVASC, V40, P176, DOI 10.1016/j.ejvs.2010.04.003; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Geest JPV, 2008, ANN BIOMED ENG, V36, P921, DOI 10.1007/s10439-008-9490-3; Georgakarakos E, 2010, EUR J VASC ENDOVASC, V39, P42, DOI 10.1016/j.ejvs.2009.09.026; Giannakoulas G, 2005, MED HYPOTHESES, V65, P1191, DOI 10.1016/j.mehy.2005.06.017; Giannoglou G, 2006, ANGIOLOGY, V57, P487, DOI 10.1177/0003319706290741; Hinterseher I, 2013, ANN VASC SURG, V27, P553, DOI 10.1016/j.avsg.2012.05.028; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Humphrey J.D., 2013, CARDIOVASCULAR SOLID; Kent KC, 2004, J VASC SURG, V39, P267, DOI 10.1016/j.jvs.2003.08.019; Koskas F, 1997, ANN VASC SURG, V11, P473, DOI 10.1007/s100169900078; LUND GB, 1995, AM J KIDNEY DIS, V25, P732, DOI 10.1016/0272-6386(95)90549-9; Maas SA, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005694; Meijer CA, 2013, ANN INTERN MED, V159, P815, DOI 10.7326/0003-4819-159-12-201312170-00007; Nanayakkara BG, 2007, GALLE MED J, V12, P8; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Papaharilaou Y, 2007, J BIOMECH, V40, P367, DOI 10.1016/j.jbiomech.2005.12.013; Pappu S, 2008, ANN VASC SURG, V22, P88, DOI 10.1016/j.avsg.2007.09.004; Pierce DM, 2015, J MECH BEHAV BIOMED, V41, P92, DOI 10.1016/j.jmbbm.2014.10.003; Raghavan ML, 2006, J BIOMECH, V39, P3010, DOI 10.1016/j.jbiomech.2005.10.021; Raghavan ML, 1996, ANN BIOMED ENG, V24, P573, DOI 10.1007/BF02684226; Raghavan ML, 2000, J VASC SURG, V31, P760, DOI 10.1067/mva.2000.103971; Raghavan ML, 2000, J BIOMECH, V33, P475, DOI 10.1016/S0021-9290(99)00201-8; Rissland P, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005200; Rodriguez JF, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2898830; Roy D, 2014, IMA J APPL MATH, V79, P1011, DOI 10.1093/imamat/hxu037; Ruddy JM, 2013, PROG CARDIOVASC DIS, V56, P68, DOI 10.1016/j.pcad.2013.04.002; Sacks MS, 1999, ANN BIOMED ENG, V27, P469, DOI 10.1114/1.202; Scotti CM, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-64; Sharma AK, 2012, CIRCULATION, V126, pS38, DOI 10.1161/CIRCULATIONAHA.111.083451; Stevens RRF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187421; Stroupe KT, 2012, J VASC SURG, V56, P901, DOI 10.1016/j.jvs.2012.01.086; Timaran CH, 2007, ARCH SURG-CHICAGO, V142, P520, DOI 10.1001/archsurg.142.6.520; Tran AP, 2000, FAST AND HIGH QUALIT, P1; Uchida N, 2013, GEN THORAC CARDIOVAS, V61, P118, DOI 10.1007/s11748-012-0151-y; Vande Geest JP, 2006, ANN BIOMED ENG, V34, P1098, DOI 10.1007/s10439-006-9132-6; Vandy F, 2012, CIRC-CARDIOVASC INTE, V5, P871, DOI 10.1161/CIRCINTERVENTIONS.111.966184; Venkatasubramaniam AK, 2004, EUR J VASC ENDOVASC, V28, P168, DOI 10.1016/j.ejvs.2004.03.029; Vorp DA, 2005, ARTERIOSCL THROM VAS, V25, P1558, DOI 10.1161/01.ATV.0000174129.77391.55; Vorp DA, 1998, J VASC SURG, V27, P632, DOI 10.1016/S0741-5214(98)70227-7; Vorp DA, 2007, J BIOMECH, V40, P1887, DOI 10.1016/j.jbiomech.2006.09.003; Weiford BC, 2005, BRAUNWALDS HEART DIS; Weisbecker H, 2012, J MECH BEHAV BIOMED, V12, P93, DOI 10.1016/j.jmbbm.2012.03.012; Zarins CK, 2001, ATHEROSCLEROSIS, V155, P157, DOI 10.1016/S0021-9150(00)00527-X	60	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192032	10.1371/journal.pone.0192032	http://dx.doi.org/10.1371/journal.pone.0192032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401512	Green Published, gold, Green Submitted			2022-12-26	WOS:000424101400031
J	Bayerl, C; Lorbeer, R; Heier, M; Meisinger, C; Rospleszcz, S; Schafnitzel, A; Patscheider, H; Auweter, S; Peters, A; Ertl-Wagner, B; Reiser, M; Bamberg, F; Hetterich, H				Bayerl, Christian; Lorbeer, Roberto; Heier, Margit; Meisinger, Christa; Rospleszcz, Susanne; Schafnitzel, Anina; Patscheider, Hannah; Auweter, Sigrid; Peters, Annette; Ertl-Wagner, Birgit; Reiser, Maximilian; Bamberg, Fabian; Hetterich, Holger			Alcohol consumption, but not smoking is associated with higher MR-derived liver fat in an asymptomatic study population	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; HEPATIC STEATOSIS; BODY-FAT; CIGARETTE-SMOKING; TRIGLYCERIDE CONTENT; METABOLIC SYNDROME; TOBACCO SMOKING; RISK-FACTORS; PREVALENCE	Background The aim of our study was to determine the relation of alcohol consumption and cigarette smoking on continuous-measured hepatic fat fraction (HFF) in a population free of cardiovascular disease. We suggested a direct correlation of alcohol consumption with HFF and increased HFF in former smokers compared to current smokers. Methods Data from 384 subjects (mean age: 56 years, 58% men) of a population-based cohort study (KORA) were included in a cross-sectional design. Liver fat was assessed by 3 Tesla magnetic resonance imaging (MRI) using a multi-echo Dixon sequence and T2-corrected single voxel multi-echo spectroscopy (H-1-MRS). Smoking status was classified as never, former or current smoker and alcohol consumption as non-, moderate (0.1-39.9 g/day for men and 0.1-19.9 g/day for women), or heavy drinker (>= 40 g/day for men and >= 20 g/day for women). Fatty liver disease was defined as HFF >= 5.56%. Results Average HFF was 8.8% by H-1-MRS and 8.5% by MRI. Former smokers showed a higher HFF (MRI: beta = 2.64; p = 0.006) and a higher FLD prevalence (MRI: OR = 1.91; p = 0.006) compared to never smokers. Current smokers showed decreased odds for FLD measured by H-1-MRS after multivariable adjustment (OR = 0.37; p = 0.007) with never smoker as reference. Heavy drinking was positively associated with HFF (H-1-MRS: beta = 2.99; p = 0.003) and showed highest odds for FLD (H-1-MRS: OR = 3.05; p = 0.008) with non-drinker as reference. Moderate drinking showed a positive association with HFF (H-1-MRS: beta = 1.54; p = 0.061 and MRI: beta = 1.75; p = 0.050). Conclusions Our data revealed lowest odds for FLD in current smokers, moderate drinkers showing higher HFF than non-drinkers and heavy drinkers showing highest HFF and odds for FLD. These findings partly conflict with former literature and underline the importance of further studies to investigate the complex effects on liver metabolism.	[Bayerl, Christian; Lorbeer, Roberto; Schafnitzel, Anina; Patscheider, Hannah; Auweter, Sigrid; Ertl-Wagner, Birgit; Reiser, Maximilian; Bamberg, Fabian; Hetterich, Holger] Ludwig Maximilian Univ Hosp, Inst Clin Radiol, Munich, Germany; [Heier, Margit; Meisinger, Christa; Rospleszcz, Susanne; Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Heier, Margit] Cent Hosp Augsburg, KORA Myocardial Infarct Regis, Augsburg, Germany; [Meisinger, Christa] Ludwig Maximilians Univ Munchen, UNIKA T, Augsburg, Germany; [Peters, Annette] German Ctr Diabet Res DZD eV, Neuherberg, Germany; [Peters, Annette] German Ctr Cardiovasc Dis Res DZHK eV, Munich, Germany; [Bamberg, Fabian] Eberhard Karls Univ Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; German Centre for Cardiovascular Research; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Bayerl, C (corresponding author), Ludwig Maximilian Univ Hosp, Inst Clin Radiol, Munich, Germany.	christian.bayerl@med.uni-muenchen.de	Heier, Margit/AAT-5280-2020; Meisinger, Christine/B-5358-2014; Rospleszcz, Susanne/AGF-1630-2022; Peters, Annette/A-6117-2011; Ertl-Wagner, Birgit/AAD-5708-2020	Rospleszcz, Susanne/0000-0002-4788-2341; Peters, Annette/0000-0001-6645-0985; Ertl-Wagner, Birgit/0000-0002-7896-7049	Helmholtz Zentrum Munchen German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF); State of Bavaria; Munich Center of Health Sciences (MC-Health); Ludwig-Maximilian University, as part of LMUinnovativ; German Research Foundation (DFG, Deutsche Forschungsgemeinschaft) [BA 4233/4-1]; Siemens Healthcare	Helmholtz Zentrum Munchen German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Munich Center of Health Sciences (MC-Health); Ludwig-Maximilian University, as part of LMUinnovativ; German Research Foundation (DFG, Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Siemens Healthcare(Siemens AG)	The KORA study was initiated and financed by the Helmholtz Zentrum Munchen German Research Center for Environmental Health (https://www.helmholtz-muenchen.de), which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC-Health, http://www.en.mc-health.uni-muenchen.de/index.html), Ludwig-Maximilian University, as part of LMUinnovativ. The KORA-MRI sub-study received funding by the German Research Foundation (DFG, Deutsche Forschungsgemeinschaft, BA 4233/4-1, http://www.dfg.de). The KORA-MRI sub-study was supported by an unrestricted grant from Siemens Healthcare (https://www.healthcare.siemens.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Asvold BO, 2014, INT J EPIDEMIOL, V43, P1458, DOI 10.1093/ije/dyu113; Bamia C, 2004, INT J OBESITY, V28, P1091, DOI 10.1038/sj.ijo.0802697; BARRETTCONNOR E, 1989, ANN INTERN MED, V111, P783, DOI 10.7326/0003-4819-111-10-783; Bashir MR, 2015, AM J ROENTGENOL, V204, P297, DOI 10.2214/AJR.14.12457; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Bellentani S, 1997, GUT, V41, P845, DOI 10.1136/gut.41.6.845; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Bohte AE, 2011, EUR RADIOL, V21, P87, DOI 10.1007/s00330-010-1905-5; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; CAAN B, 1994, INT J OBESITY, V18, P397; Canoy D, 2005, OBES RES, V13, P1466, DOI 10.1038/oby.2005.177; Chavez-Tapia NC, 2006, WORLD J GASTROENTERO, V12, P5196; d'Assignies G, 2009, EUR RADIOL, V19, P2033, DOI 10.1007/s00330-009-1351-4; Dare S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123579; DAY CP, 1994, BBA-LIPID LIPID MET, V1215, P33, DOI 10.1016/0005-2760(94)90089-2; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Du SS, 2016, DIABETES RES CLIN PR, V116, P183, DOI 10.1016/j.diabres.2016.04.047; Dunn W, 2008, HEPATOLOGY, V47, P1947, DOI 10.1002/hep.22292; Ekstedt M, 2009, SCAND J GASTROENTERO, V44, P366, DOI 10.1080/00365520802555991; Eliasson B, 1999, EUR J CLIN INVEST, V29, P145, DOI 10.1046/j.1365-2362.1999.00420.x; Ely M, 1999, ALCOHOL ALCOHOLISM, V34, P894, DOI 10.1093/alcalc/34.6.894; Fishbein M, 2005, J CLIN GASTROENTEROL, V39, P619, DOI 10.1097/00004836-200508000-00012; Gunji T, 2009, AM J GASTROENTEROL, V104, P2189, DOI 10.1038/ajg.2009.361; Hamabe A, 2011, J GASTROENTEROL, V46, P769, DOI 10.1007/s00535-011-0376-z; Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P156, DOI 10.3748/wjg.v18.i2.156; HOFSTETTER A, 1986, NEW ENGL J MED, V314, P79, DOI 10.1056/NEJM198601093140204; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Keil U, 1997, EPIDEMIOLOGY, V8, P150, DOI 10.1097/00001648-199703000-00005; Koopmann A, 2011, HORM BEHAV, V60, P58, DOI 10.1016/j.yhbeh.2011.02.013; Liu Y, 2013, J EPIDEMIOL, V23, P115, DOI 10.2188/jea.JE20120067; Moriya A, 2011, ALIMENT PHARM THER, V33, P378, DOI 10.1111/j.1365-2036.2010.04520.x; Moriya A, 2015, J HEPATOL, V62, P921, DOI 10.1016/j.jhep.2014.11.025; Peres W, 2000, J HEPATOL, V33, P742, DOI 10.1016/S0168-8278(00)80305-0; Pineda N, 2009, RADIOLOGY, V252, P568, DOI [10.1148/radiol.2523082084, 10.1148/radiol.25230820B4]; Pozzato C, 2008, J PEDIATR GASTR NUTR, V47, P493, DOI 10.1097/MPG.0b013e31817b6e10; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Runge JH, 2014, MAGN RESON MATER PHY, V27, P317, DOI 10.1007/s10334-013-0414-3; Schwenzer NF, 2009, J HEPATOL, V51, P433, DOI 10.1016/j.jhep.2009.05.023; SEIDELL JC, 1991, AM J EPIDEMIOL, V133, P257, DOI 10.1093/oxfordjournals.aje.a115870; Seissler J, 2012, EUR J ENDOCRINOL, V167, P847, DOI 10.1530/EJE-12-0472; SHIMOKATA H, 1989, JAMA-J AM MED ASSOC, V261, P1169, DOI 10.1001/jama.261.8.1169; Stadler M, 2014, EUR J ENDOCRINOL, V170, P219, DOI 10.1530/EJE-13-0590; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Wellmann J, 2004, EUR J CARDIOV PREV R, V11, P48, DOI 10.1097/01.hjr.0000118174.70522.20; Yilmaz Y, 2010, HEPATOLOGY, V52, P391, DOI 10.1002/hep.23718; Zhong XD, 2014, MAGN RESON MED, V72, P1353, DOI 10.1002/mrm.25054	50	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192448	10.1371/journal.pone.0192448	http://dx.doi.org/10.1371/journal.pone.0192448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401483	Green Submitted, Green Published, gold			2022-12-26	WOS:000424101400061
J	Lee, HS; Chung, MJ; Park, JY; Bang, S; Park, SW; Song, SY; Chung, JB				Lee, Hee Seung; Chung, Moon Jae; Park, Jeong Youp; Bang, Seungmin; Park, Seung Woo; Song, Si Young; Chung, Jae Bock			Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis	PLOS ONE			English	Article							GALLSTONE PANCREATITIS; CONSERVATIVE MANAGEMENT; INTERVENTION; METAANALYSIS; PAPILLOTOMY; TRIAL	Acute pancreatitis is a common diagnosis worldwide, with gallstone disease being the most prevalent cause (50%). The American College of Gastroenterology recommends urgent endoscopic retrograde cholangiopancreatography (ERCP) (within 24 h) for patients with biliary pancreatitis accompanied by cholangitis. Most international guidelines recommend that ERCP be performed within 72 h in patients with biliary pancreatitis and a bile duct obstruction without cholangitis, but the optimal timing for endoscopy is controversial. We investigated the optimal timing for ERCP in patients with biliary pancreatitis and a bile duct obstruction without cholangitis, and whether performing endoscopy within 24 h is superior to performing it after 24 h. We analyzed the clinical data of 505 patients with newly diagnosed acute pancreatitis, from January 1, 2005 to December 31, 2014. We divided the patients into two groups according to the timing of ERCP: <24 h (urgent) and 24-72 h (early). Among the 505 patients, 73 were diagnosed with biliary pancreatitis and a bile duct obstruction without cholangitis. The mean age of the patients was 55 years (range: 26-90 years). Bile duct stones and biliary sludge were identified on endoscopy in 45 (61.6%) and 11 (15.0%) patients, respectively. The timing of ERCP within 72 h was not associated with ERCP-related complications (P = 0.113), and the total length of hospital stay was not different between urgent and early ERCP (5.9 vs. 5.7 days, P = 0.174). No significant differences were found in total length of hospitalization or procedural-related complications, in patients with biliary pancreatitis and a bile duct obstruction without cholangitis, according to the timing of ERCP (<24 h vs. 24-72 h).	[Lee, Hee Seung; Chung, Moon Jae; Park, Jeong Youp; Bang, Seungmin; Park, Seung Woo; Song, Si Young; Chung, Jae Bock] Yonsei Univ, Inst Gastroenterol, Coll Med, Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System	Chung, MJ (corresponding author), Yonsei Univ, Inst Gastroenterol, Coll Med, Dept Internal Med, Seoul, South Korea.	mjchung@yuhs.ac	Song, SY/E-2891-2012	Park, Seung Woo/0000-0001-8230-964X; Song, Si Young/0000-0002-1417-4314; Bang, Seungmin/0000-0001-5209-8351; Lee, HEE SEUNG/0000-0002-2825-3160; Park, Jeong Youp/0000-0003-0110-8606; Chung, Moon Jae/0000-0002-5920-8549				Acosta JM, 1997, J AM COLL SURGEONS, V184, P499; Ammori B J, 2003, Pancreas, V26, pe32, DOI 10.1097/00006676-200303000-00023; Bae SH, 2013, WORKPLACE HEALTH SAF, V61, P203, DOI 10.3928/21650799-20130418-73; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Bradley EL, 1992, ARCH SURG, V257; Cavdar F, 2014, PANCREATOLOGY, V14, P411, DOI 10.1016/j.pan.2014.08.002; Chen P, 2010, PANCREAS, V39, P398, DOI 10.1097/MPA.0b013e3181bd6821; FAN ST, 1993, NEW ENGL J MED, V328, P228, DOI 10.1056/NEJM199301283280402; Fogel EL, 2014, NEW ENGL J MED, V370, P150, DOI 10.1056/NEJMct1208450; Folsch UR, 1997, NEW ENGL J MED, V336, P237, DOI 10.1056/NEJM199701233360401; Frakes JT, 1999, J CLIN GASTROENTEROL, V28, P97, DOI 10.1097/00004836-199903000-00004; Kapetanos DJ, 2010, WORLD J GASTRO ENDOS, V2, P25, DOI 10.4253/wjge.v2.i1.25; Liu CL, 2005, ALIMENT PHARM THERAP, V22, P423, DOI 10.1111/j.1365-2036.2005.02580.x; NEOPTOLEMOS JP, 1988, LANCET, V2, P979, DOI 10.1016/S0140-6736(88)90740-4; Oria A, 2007, ANN SURG, V245, P10, DOI 10.1097/01.sla.0000232539.88254.80; Papachristou GI, 2010, AM J GASTROENTEROL, V105, P435, DOI 10.1038/ajg.2009.622; Petrov MS, 2008, ANN SURG, V247, P250, DOI 10.1097/SLA.0b013e31815edddd; Rondonotti E, 2013, DIGEST LIVER DIS, V45, P179, DOI 10.1016/j.dld.2012.07.012; RUNZI M, 1993, GASTROENTEROLOGY, V105, P157; TENNER S, 1994, AM J GASTROENTEROL, V89, P1863; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; Tse F, 2012, COCHRANE DATABASE SY; van Santvoort HC, 2009, ANN SURG, V250, P68, DOI 10.1097/SLA.0b013e3181a77bb4; Zhou Ming-Qing, 2002, Hepatobiliary Pancreat Dis Int, V1, P608	25	12	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0190835	10.1371/journal.pone.0190835	http://dx.doi.org/10.1371/journal.pone.0190835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401491	Green Published, Green Submitted, gold			2022-12-26	WOS:000424101400005
J	Nascimento, MS; Carminati, JA; Morishita, KN; Neto, DPA; Pinheiro, HP; Maia, RP				Nascimento, Maristela S.; Carminati, Joyce A.; Morishita, Karen N.; Amorim Neto, Dionisio P.; Pinheiro, Hildete P.; Maia, Rafael P.			Long-term kinetics of Salmonella Typhimurium ATCC 14028 survival on peanuts and peanut confectionery products	PLOS ONE			English	Article							ESCHERICHIA-COLI O157/H7; WATER ACTIVITY FOODS; LISTERIA-MONOCYTOGENES; HEAT-RESISTANCE; ENTERICA; OUTBREAK; BUTTER; INACTIVATION; TEMPERATURE; TENNESSEE	Due to recent large outbreaks, peanuts have been considered a product of potential risk for Salmonella. Usually, peanut products show a low water activity (a(w)) and high fat content, which contribute to increasing the thermal resistance and survival of Salmonella. This study evaluated the long-term kinetics of Salmonella survival on different peanut products under storage at 28 degrees C for 420 days. Samples of raw in-shell peanuts (a(w) = 0.29), roasted peanuts (a(w) = 0.39), unblanched peanut kernel (a(w) = 0.54), peanut brittle (a(w) = 0.30), pacoca (a(w) = 0.40) and pe-de-moca (a(w) = 0.68) were inoculated with Salmonella Typhimurium ATCC 14028 at two inoculum levels (3 and 6 log cfu/g). The Salmonella behavior was influenced (p<0.05) by a(w), lipid, carbohydrate and protein content. In most cases for both inoculum levels, the greatest reductions were seen after the first two weeks of storage, followed by a slower decline phase. The lowest reductions were verified in pacoca and roasted peanuts, with counts of 1.01 and 0.87 log cfu/g at low inoculum level and 2.53 and 3.82 log cfu/g at high inoculum level at the end of the storage time. The highest loss of viability was observed in pe-de-moca, with absence of Salmonella in 10-g after 180 days at low inoculum level. The Weibull model provided a suitable fit to the data (R-2 >= 0.81), with delta value ranging from 0.06 to 49.75 days. Therefore, the results demonstrated that Salmonella survives longer in peanut products, beyond the shelf life (>420 days), especially in products with aw around 0.40.	[Nascimento, Maristela S.; Carminati, Joyce A.; Morishita, Karen N.; Amorim Neto, Dionisio P.] Univ Estadual Campinas, Sch Food Engn, Dept Food Technol, Campinas, SP, Brazil; [Pinheiro, Hildete P.; Maia, Rafael P.] Univ Estadual Campinas, Dept Stat, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Nascimento, MS (corresponding author), Univ Estadual Campinas, Sch Food Engn, Dept Food Technol, Campinas, SP, Brazil.	mnasci@unicamp.br	Nascimento, Maristela da Silva do/J-3054-2015; Maia, Rafael Pimentel/F-6942-2012; Amorim Neto, Dionisio Pedro/AAA-8444-2022	Nascimento, Maristela da Silva do/0000-0003-1791-0361; Maia, Rafael Pimentel/0000-0001-5736-8269; Amorim Neto, Dionisio Pedro/0000-0001-6763-273X; Noda Morishita, Karen/0000-0002-1951-7996	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/13942-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Process 2013/13942-4), www.fapesp.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; To the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo for financial support (Process 2013/13942-4).	Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P521; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P85; [Anonymous], 2007, 657912007 ISSO INT O; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beuchat LR, 2013, J FOOD PROTECT, V76, P150, DOI 10.4315/0362-028X.JFP-12-211; Beuchat LR, 2010, J FOOD PROTECT, V73, P1257, DOI 10.4315/0362-028X-73.7.1257; Blessington T, 2012, J FOOD PROTECT, V75, P245, DOI 10.4315/0362-028X.JFP-11-278; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brar PK, 2015, J FOOD PROTECT, V78, P323, DOI 10.4315/0362-028X.JFP-14-327; Burnett SL, 2000, J APPL MICROBIOL, V89, P472, DOI 10.1046/j.1365-2672.2000.01138.x; Canovas D, 2001, J BACTERIOL, V183, P3365, DOI 10.1128/JB.183.11.3365-3371.2001; Carminati JD, 2016, J APPL MICROBIOL, V121, P1071, DOI 10.1111/jam.13235; Centers for Disease Control Prevention [CDC], 2014, MULT OUTBR SALM BRAE; Centre for Disease Control and Prevention (CDC), 2012, MULT OUTBR SALM BRED; CORRY JEL, 1974, J APPL BACTERIOL, V37, P31, DOI 10.1111/j.1365-2672.1974.tb00412.x; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Danyluk MD, 2007, J FOOD PROTECT, V70, P820, DOI 10.4315/0362-028X-70.4.820; do Nascimento MD, 2012, INT J FOOD MICROBIOL, V159, P225, DOI 10.1016/j.ijfoodmicro.2012.08.017; Farakos SMS, 2013, INT J FOOD MICROBIOL, V166, P280, DOI 10.1016/j.ijfoodmicro.2013.07.007; Farakos SMS, 2014, J FOOD PROTECT, V77, P1448, DOI 10.4315/0362-028X.JFP-14-013; He YS, 2011, APPL ENVIRON MICROB, V77, P8434, DOI 10.1128/AEM.06270-11; Horwitz W., 2006, OFFICIAL METHODS ANA, P72; Instituto Adolfo Lutz, 2005, MET FIS QUIM AN AL N; JUVEN BJ, 1984, J FOOD PROTECT, V47, P445, DOI 10.4315/0362-028X-47.6.445; Kataoka AI, 2014, J FOOD PROTECT, V77, P1252, DOI 10.4315/0362-028X.JFP-13-553; Keller SE, 2012, J FOOD PROTECT, V75, P1125, DOI 10.4315/0362-028X.JFP-11-477; Killalea D, 1996, BMJ-BRIT MED J, V313, P1105, DOI 10.1136/bmj.313.7065.1105; Kimber MA, 2012, J FOOD PROTECT, V75, P1394, DOI 10.4315/0362-028X.JFP-12-023; Kirk MD, 2004, EPIDEMIOL INFECT, V132, P571, DOI 10.1017/S095026880400216X; Li HP, 2014, J FOOD PROTECT, V77, P67, DOI 10.4315/0362-028X.JFP-13-277; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; Mafart P, 2002, INT J FOOD MICROBIOL, V72, P107, DOI 10.1016/S0168-1605(01)00624-9; Mattick KL, 2000, APPL ENVIRON MICROB, V66, P4921, DOI 10.1128/AEM.66.11.4921-4925.2000; MOSSEL DAA, 1965, POULTRY SCI, V44, P890, DOI 10.3382/ps.0440890; Park EJ, 2008, J FOOD SCI, V73, pM82, DOI 10.1111/j.1750-3841.2007.00638.x; Scheil W, 1998, AUST NZ J PUBL HEAL, V22, P536, DOI 10.1111/j.1467-842X.1998.tb01434.x; TAMMINGA SK, 1976, J HYG-CAMBRIDGE, V76, P41, DOI 10.1017/S0022172400054929; Uesugi AR, 2006, J FOOD PROTECT, V69, P1851, DOI 10.4315/0362-028X-69.8.1851; [No title captured]	39	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							0192457	10.1371/journal.pone.0192457	http://dx.doi.org/10.1371/journal.pone.0192457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401480	Green Submitted, Green Published, gold			2022-12-26	WOS:000424101400062
J	Marques, LH; Santos, AC; Castro, BA; Storer, NP; Babcock, JM; Lepping, MD; Sa, V; Moscardini, VF; Rule, DM; Fernandes, OA				Marques, Luiz H.; Santos, Antonio C.; Castro, Boris A.; Storer, Nicholas P.; Babcock, Jonathan M.; Lepping, Miles D.; Sa, Verissimo; Moscardini, Valeria F.; Rule, Dwain M.; Fernandes, Odair A.			Impact of transgenic soybean expressing Cry1Ac and Cry1F proteins on the non-target arthropod community associated with soybean in Brazil	PLOS ONE			English	Article							ENVIRONMENTAL RISK-ASSESSMENT; INTEGRATED PEST-MANAGEMENT; GENETICALLY-MODIFIED CROPS; BT COTTON; NO-TILLAGE; HELIOTHIS-VIRESCENS; PROBLEM FORMULATION; LEPIDOPTERAN PESTS; CARABID BEETLES; TERM ASSESSMENT	Field-scale studies that examine the potential for adverse effects of Bt crop technology on non-target arthropods may supplement data from laboratory studies to support an environmental risk assessment. A three year field study was conducted in Brazil to evaluate potential for adverse effects of cultivating soybean event DAS-81419-2 that produces the Cry1Ac and Cry1F proteins. To do so, we examined the diversity and abundance of non-target arthropods (NTAs) in Bt soybean in comparison with its non-Bt near isoline, with and without conventional insecticide applications, in three Brazilian soybean producing regions. Non-target arthropod abundance was surveyed using Moericke traps (yellow pan) and pitfall trapping. Total abundance (N), richness (S), Shannon-Wiener (H'), Simpson's (D) and Pielou's evenness (J) values for arthropod samples were calculated for each treatment and sampling period (soybean growth stages). A faunistic analysis was used to select the most representative NTAs which were used to describe the NTA community structure associated with soybean, and to test for effects due to the treatments effects via application of the Principal Response Curve (PRC) method. Across all years and sites, a total of 254,054 individuals from 190 taxa were collected by Moericke traps, while 29,813 individuals from 100 taxa were collected using pitfall traps. Across sites and sampling dates, the abundance and diversity measurements of representative NTAs were not significantly affected by Bt soybean as compared with non-sprayed non-Bt soybean. Similarly, community analyses and repeated measures ANOVA, when applicable, indicated that neither Bt soybean nor insecticide sprays altered the structure of the NTA communities under study. These results support the conclusion that transgenic soybean event DAS-81419-2 producing Cry1Ac and Cry1F toxins does not adversely affect the NTA community associated with soybean.	[Marques, Luiz H.; Santos, Antonio C.; Sa, Verissimo; Moscardini, Valeria F.] Dow AgroSci Ind Ltda, Sao Paulo, SP, Brazil; [Castro, Boris A.; Storer, Nicholas P.; Babcock, Jonathan M.; Lepping, Miles D.; Rule, Dwain M.] Dow AgroSci LLC, Indianapolis, IN USA; [Fernandes, Odair A.] Univ Estadual Paulista, UNESP, FCAV, Jaboticabal, SP, Brazil	Dow Chemical Company; Universidade Estadual Paulista	Marques, LH (corresponding author), Dow AgroSci Ind Ltda, Sao Paulo, SP, Brazil.	ldmarques@dow.com	Fernandes, Odair A/C-1345-2013	Fernandes, Odair A/0000-0003-3489-4754	Dow AgroSciences	Dow AgroSciences	No independent third party funding was used in the research for this article. Dow AgroSciences provided salary to the authors who are employees of Dow AgroSciences. Dow AgroSciences authors participated in the study design which must be submitted for approval by the Brazilian government authority. Also, authors participated in the decision to publish, and the preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Ali I, 2016, J APPL ENTOMOL  0309; [Anonymous], 2008, SAS WIND VERS 9 0; [Anonymous], 2016, TECNICA NACL BIOSSEG, P1; Araujo RA, 2004, NEOTROP ENTOMOL, V33, P379, DOI 10.1590/S1519-566X2004000300017; Aronson AI, 2001, FEMS MICROBIOL LETT, V195, P1, DOI 10.1111/j.1574-6968.2001.tb10489.x; Badji CA, 2007, J APPL ENTOMOL, V131, P50, DOI 10.1111/j.1439-0418.2006.01118.x; Badji CA, 2004, CROP PROT, V23, P1031, DOI 10.1016/j.cropro.2004.03.003; Badji CA, 2006, SOCIOBIOLOGY, V48, P701; Bernardi O, 2014, PEST MANAG SCI, V70, P588, DOI 10.1002/ps.3581; Bernardi O, 2012, PEST MANAG SCI, V68, P1083, DOI 10.1002/ps.3271; Burkness Eric C, 2010, GM Crops, V1, P337, DOI 10.4161/gmcr.1.5.14765; Carstens Keri, 2014, GM Crops Food, V5, P11, DOI 10.4161/gmcr.26560; Center for Environmental Risk Assessment ILSI Research Foundation, 2011, Environ Biosafety Res, V10, P27, DOI 10.1051/ebr:2012002; Chong CS, 2007, ENVIRON ENTOMOL, V36, P1374, DOI 10.1603/0046-225X(2007)36[1374:CAAIVD]2.0.CO;2; Cutler GC, 2017, ACS SYM SER, V1249, P101; Dively GP, 2005, ENVIRON ENTOMOL, V34, P1267, DOI 10.1603/0046-225X(2005)034[1267:IOTVCL]2.0.CO;2; Duan JJ, 2010, BIOL LETTERS, V6, P74, DOI 10.1098/rsbl.2009.0612; Dutton A, 2003, BIOCONTROL, V48, P611, DOI 10.1023/A:1026313719424; Fast BJ, 2015, J AGR FOOD CHEM, V63, P2063, DOI 10.1021/jf505015y; Fernandes OA, 2007, SCI AGR, V64, P249, DOI 10.1590/S0103-90162007000300006; Ferreira BS, 2000, PRAGAS SOJA BRASIL S, P22102; Garcia-Alonso Monica, 2006, Environmental Biosafety Research, V5, P57, DOI 10.1051/ebr:2006018; Gonzalez E, 2015, INSECT CONSERV DIVER, V8, P359, DOI 10.1111/icad.12117; Gonzalez-Zamora JE, 2007, ENVIRON ENTOMOL, V36, P1246, DOI 10.1603/0046-225X(2007)36[1246:EOBTCT]2.0.CO;2; Gouffon C, 2011, APPL ENVIRON MICROB, V77, P3182, DOI 10.1128/AEM.02791-10; Guedes RNC, 2016, ANNU REV ENTOMOL, V61, P43, DOI 10.1146/annurev-ento-010715-023646; Guedes RNC, 2017, CURR OPIN INSECT SCI, V21, P47, DOI 10.1016/j.cois.2017.04.010; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; Guo J, 2016, MICROSYST TECHNOL, V2016, P1, DOI [10.1007/s00542-016-2961-9, DOI 10.1007/S00542-016-2961-9]; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Han P, 2016, J PEST SCI, V89, P859, DOI 10.1007/s10340-016-0791-2; Hatten TD, 2007, ENVIRON ENTOMOL, V36, P356, DOI 10.1603/0046-225X(2007)36[356:EOTOTA]2.0.CO;2; ILSI Research Foundation, 2016, REV ENV SAF CRY1F PR; Kromp B, 1999, AGR ECOSYST ENVIRON, V74, P187, DOI 10.1016/S0167-8809(99)00037-7; Lara R.I.R., 2009, Arq. Inst. Biol., V76, P55, DOI 10.1590/1808-1657v76p0552009; Lee MK, 2006, BIOCHEM BIOPH RES CO, V339, P1043, DOI 10.1016/j.bbrc.2005.11.112; Leps J, 2003, MULTIVARIATE ANAL EC; Li YC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022185, 10.1371/journal.pone.0026302]; Li YH, 2014, INSECT SCI, V21, P125, DOI 10.1111/1744-7917.12044; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Marques LH, 2016, J ECON ENTOMOL, V109, P1922, DOI 10.1093/jee/tow153; Marques LH, 2017, CROP PROT, V96, P109, DOI 10.1016/j.cropro.2017.02.014; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; MCCLINTOCK JT, 1995, PESTIC SCI, V45, P95, DOI 10.1002/ps.2780450202; Monzo C, 2014, B ENTOMOL RES, V104, P576, DOI 10.1017/S0007485314000315; MORAES R. C. B., 2003, S CONTROLE BIOL, V8, P195; Mumm R, 2010, CAN J ZOOL, V88, P628, DOI 10.1139/Z10-032; Nakai S, 2015, TRANSGENIC RES, V24, P929, DOI 10.1007/s11248-015-9892-6; Naranjo S. E., 2009, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V4, P1, DOI 10.1079/PAVSNNR20094011; Naranjo SE, 2005, ENVIRON ENTOMOL, V34, P1193, DOI 10.1603/0046-225X(2005)034[1193:LAOTEO]2.0.CO;2; Nash MA, 2010, ECOL APPL, V20, P1693, DOI 10.1890/09-1065.1; Panizzi AR, 2013, NEOTROP ENTOMOL, V42, P119, DOI 10.1007/s13744-013-0111-y; Paula DP, 2016, ECOTOXICOLOGY, V25, P601, DOI 10.1007/s10646-016-1619-9; Pekar S, 1999, AGR ECOSYST ENVIRON, V73, P155, DOI 10.1016/S0167-8809(99)00024-9; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rang C, 2004, CURR MICROBIOL, V49, P22, DOI 10.1007/s00284-003-4258-3; Raybould Alan, 2006, Environmental Biosafety Research, V5, P119, DOI 10.1051/ebr:2007004; Ritchie S.W., 1982, SPECIAL REPORT; Rodrigo-Simon A, 2006, APPL ENVIRON MICROB, V72, P1595, DOI 10.1128/AEM.72.2.1595-1603.2006; Roger-Estrade J, 2010, SOIL TILL RES, V111, P33, DOI 10.1016/j.still.2010.08.010; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Romeis J, 2014, TRANSGENIC RES, V23, P995, DOI 10.1007/s11248-014-9791-2; Romeis J, 2013, CHEMOSPHERE, V90, P901, DOI 10.1016/j.chemosphere.2012.09.035; Romeis J, 2011, TRANSGENIC RES, V20, P1, DOI 10.1007/s11248-010-9446-x; Rose RI, 2007, WHITEPAPER TIER BASE; Rusch A, 2010, ADV AGRON, V109, P219, DOI 10.1016/S0065-2113(10)09006-1; Sanvido O, 2007, ADV BIOCHEM ENG BIOT, V107, P235, DOI 10.1007/10_2007_048; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Siebert MW, 2012, J ECON ENTOMOL, V105, P1825, DOI 10.1603/EC12155; Silveira-Neto S., 1976, MANUAL ECOLOGIA INSE; Slade NA, 2000, J MAMMAL, V81, P1035, DOI 10.1644/1545-1542(2000)081<1035:AETOUC>2.0.CO;2; Sleper DA, 1998, CROP SCI, V38, P549, DOI 10.2135/cropsci1998.0011183X003800020072x; Storer Nicholas P., 2008, V5, P273, DOI 10.1007/978-1-4020-8373-0_10; Su HH, 2015, J APPL ENTOMOL, V139, P23, DOI 10.1111/jen.12184; Szenasi A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05315; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Tian JC, 2014, ENVIRON ENTOMOL, V43, P242, DOI 10.1603/EN13184; Tian JC, 2012, TRANSGENIC RES, V21, P1303, DOI 10.1007/s11248-012-9604-4; Torres JB, 2005, ENVIRON ENTOMOL, V34, P1242, DOI 10.1603/0046-225X(2005)034[1242:CAGPAI]2.0.CO;2; Triplehorn C. A., 2005, BORROR DELONGS INTRO, V7th; US EPA, 2005, BIOP REG ACT DOC BAC, P1; USDA, 2012, POULTR SLAUGHT, P1; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; Wach M, 2016, TRANSGENIC RES, V25, P499, DOI 10.1007/s11248-016-9945-5; Wang ZX, 2016, INSECT SCI; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; Wolt JD, 2010, TRANSGENIC RES, V19, P425, DOI 10.1007/s11248-009-9321-9; Yao YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166771; Yu HL, 2014, ENVIRON ENTOMOL, V43, P1124, DOI 10.1603/EN13337	92	17	22	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191567	10.1371/journal.pone.0191567	http://dx.doi.org/10.1371/journal.pone.0191567			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394266	Green Submitted, Green Published, gold			2022-12-26	WOS:000424060400014
J	Schaub, P; Rodriguez-Franco, M; Cazzonelli, CI; Alvarez, D; Wuest, F; Welsch, R				Schaub, Patrick; Rodriguez-Franco, Marta; Cazzonelli, Christopher Ian; Alvarez, Daniel; Wuest, Florian; Welsch, Ralf			Establishment of an Arabidopsis callus system to study the interrelations of biosynthesis, degradation and accumulation of carotenoids	PLOS ONE			English	Article							INCREASES BETA-CAROTENE; PHYTOENE SYNTHASE; CLEAVAGE DIOXYGENASE; GOLDEN RICE; FUNCTIONAL-CHARACTERIZATION; ANTIOXIDANT ACTIVITY; LIPOXYGENASE GENE; PROVIDES INSIGHT; SINGLET OXYGEN; ABIOTIC STRESS	The net amounts of carotenoids accumulating in plant tissues are determined by the rates of biosynthesis and degradation. While biosynthesis is rate-limited by the activity of PHYTOENE SYNTHASE (PSY), carotenoid losses are caused by catabolic enzymatic and nonenzymatic degradation. We established a system based on non-green Arabidopsis callus which allowed investigating major determinants for high steady-state levels of beta-carotene. Wild-type callus development was characterized by strong carotenoid degradation which was only marginally caused by the activity of carotenoid cleavage oxygenases. In contrast, carotenoid degradation occurred mostly non-enzymatically and selectively affected carotenoids in a molecule-dependent manner. Using carotenogenic pathway mutants, we found that linear carotenes such as phytoene, phytofluene and pro-lycopene resisted degradation and accumulated while beta-carotene was highly susceptible towards degradation. Moderately increased pathway activity through PSY overexpression was compensated by degradation revealing no net increase in beta-carotene. However, higher pathway activities outcompeted carotenoid degradation and efficiently increased steady-state beta-carotene amounts to up to 500 mu g g(-1) dry mass. Furthermore, we identified oxidative beta-carotene degradation products which correlated with pathway activities, yielding beta-apocarotenals of different chain length and various apocarotene-dialdehydes. The latter included methylglyoxal and glyoxal as putative oxidative end products suggesting a potential recovery of carotenoid-derived carbon for primary metabolic pathways. Moreover, we investigated the site of beta-carotene sequestration by co-localization experiments which revealed that beta-carotene accumulated as intra-plastid crystals which was confirmed by electron microscopy with carotenoid-accumulating roots. The results are discussed in the context of using the non-green calli carotenoid assay system for approaches targeting high steady-state beta-carotene levels prior to their application in crops.	[Schaub, Patrick; Rodriguez-Franco, Marta; Alvarez, Daniel; Wuest, Florian; Welsch, Ralf] Univ Freiburg, Fac Biol, Inst Biol 2, Freiburg, Germany; [Cazzonelli, Christopher Ian] Univ Western Sydney, Hawkesbury Inst Environm, Hawkesbury Campus, Richmond, NSW, Australia	University of Freiburg; Western Sydney University	Welsch, R (corresponding author), Univ Freiburg, Fac Biol, Inst Biol 2, Freiburg, Germany.	ralf.welsch@biologie.uni-freiburg.de	Welsch, Ralf/H-3157-2019; Cazzonelli, Christopher I/A-5347-2010	Welsch, Ralf/0000-0002-2865-2743; Cazzonelli, Christopher I/0000-0003-3096-3193; Rodriguez Franco, Marta/0000-0003-1183-2075; Wust, Florian/0000-0002-9941-5550; Alvarez, Daniel/0000-0002-5930-2295	HarvestPlus [2014H6320.FRE]; German Research Foundation (DFG); Albert Ludwigs University Freiburg	HarvestPlus; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This research was supported by funds from the HarvestPlus (http://www.harvestplus.org/) research consortium (grant 2014H6320.FRE) to PS, FW and RW. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to Prof. Peter Beyer for his suggestions to improve the manuscript. We thank Jamie van Norman for nced and max mutants, Li-Jia Qu for the pds mutant, Dean Della-Penna for lutl, lut5 and ccd1-4 mutants and Barry Pogson for ccr2.1. We gratefully acknowledge the excellent technical supports from Roland Nitschke, Carmen Schubert and Rosula Hinnenberg. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding program Open Access Publishing.	Ahrazem O, 2015, J AGR FOOD CHEM, V63, P8751, DOI 10.1021/acs.jafc.5b03194; Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Alvarez D, 2016, PLANT PHYSIOL, V172, P2314, DOI 10.1104/pp.16.01262; Arango J, 2014, PLANT CELL, V26, P2223, DOI 10.1105/tpc.113.122127; Auldridge ME, 2006, CURR OPIN PLANT BIOL, V9, P315, DOI 10.1016/j.pbi.2006.03.005; Bai C, 2014, PLANT J, V77, P464, DOI 10.1111/tpj.12384; Baranski R, 2016, CAROTENOID BIOSYNTHE, P159; Barr J, 2004, PLANT CELL ENVIRON, V27, P840, DOI 10.1111/j.1365-3040.2004.01190.x; Beisel KG, 2010, PLANT PHYSIOL, V152, P2188, DOI 10.1104/pp.109.151647; Biacs PA, 2000, BIOCHEM SOC T, V28, P839, DOI 10.1042/BST0280839; BISWAL B, 1995, J PHOTOCH PHOTOBIO B, V30, P3, DOI 10.1016/1011-1344(95)07197-A; Boon CS, 2010, CRIT REV FOOD SCI, V50, P515, DOI 10.1080/10408390802565889; Bradbury LMT, 2012, P NATL ACAD SCI USA, V109, pE1888, DOI 10.1073/pnas.1206002109; Brandi F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-24; Brausemann A, 2017, STRUCTURE, V25, P1222, DOI 10.1016/j.str.2017.06.002; Britton G, 1995, FASEB J, V9, P1551, DOI 10.1096/fasebj.9.15.8529834; Bruno M, 2016, J EXP BOT, V67, P5993, DOI 10.1093/jxb/erw356; Burton GW, 2016, J AGR FOOD CHEM, V64, P3767, DOI 10.1021/acs.jafc.6b00503; Cao HB, 2012, J EXP BOT, V63, P4403, DOI 10.1093/jxb/ers115; Carrera A, 2007, J CEREAL SCI, V45, P67, DOI 10.1016/j.jcs.2006.07.001; Cazzonelli CI, 2010, MOL PLANT, V3, P174, DOI 10.1093/mp/ssp092; Cazzonelli CI, 2009, PLANT CELL, V21, P39, DOI 10.1105/tpc.108.063131; Chayut N, 2016, PLANT PHYSIOL, V2016; Che P, 2016, P NATL ACAD SCI USA, P113; Chen Y, 2010, PLANT PHYSIOL, V153, P66, DOI 10.1104/pp.110.153916; Cooperstone JL, 2015, MOL NUTR FOOD RES, V59, P658, DOI 10.1002/mnfr.201400658; Benevides CMD, 2011, FOOD CHEM, V126, P927, DOI 10.1016/j.foodchem.2010.11.082; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; Diretto G, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-11; Engelmann NJ, 2011, ADV NUTR, V2, P51, DOI 10.3945/an.110.000075; Farmer EE, 2013, ANNU REV PLANT BIOL, V64, P429, DOI 10.1146/annurev-arplant-050312-120132; Fiore A, 2006, FEBS LETT, V580, P4718, DOI 10.1016/j.febslet.2006.07.055; Fraser PD, 1999, PLANT MOL BIOL, V40, P687, DOI 10.1023/A:1006256302570; Galpaz N, 2013, ARCH BIOCHEM BIOPHYS, V539, P117, DOI 10.1016/j.abb.2013.08.006; Gayen D, 2015, PLANTA, V242, P353, DOI 10.1007/s00425-015-2314-4; Gayen D, 2014, PLANT CELL TISS ORG, V118, P229, DOI 10.1007/s11240-014-0476-6; Gemmecker S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131717; Giuliano G, 2002, TRENDS PLANT SCI, V7, P427, DOI 10.1016/S1360-1385(02)02329-4; Giuliano G, 2017, CURR OPIN BIOTECH, V44, P169, DOI 10.1016/j.copbio.2017.02.001; Gonzalez-Jorge S, 2013, PLANT CELL, V113; Granchi C, 2017, J AGR FOOD CHEM, V65, P5639, DOI 10.1021/acs.jafc.7b01668; HARRIS WM, 1969, AM J BOT, V56, P380, DOI 10.2307/2440813; Havaux M, 2014, PLANT J, V79, P597, DOI 10.1111/tpj.12386; Hoque TS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01341; Hou X, 2016, TRENDS PLANT SCI, V21, P792, DOI 10.1016/j.tplants.2016.06.001; Huang FC, 2009, PHYTOCHEMISTRY, V70, P457, DOI 10.1016/j.phytochem.2009.01.020; Ibdah M, 2006, PHYTOCHEMISTRY, V67, P1579, DOI 10.1016/j.phytochem.2006.02.009; Ilg A, 2014, FEBS OPEN BIO, V4, P584, DOI 10.1016/j.fob.2014.06.005; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Iskandar AR, 2016, CANCER PREV RES, V9, P875, DOI 10.1158/1940-6207.CAPR-16-0161; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jeffery J, 2012, J SCI FOOD AGR, V92, P2594, DOI 10.1002/jsfa.5767; Kachanovsky DE, 2012, P NATL ACAD SCI USA, V109, P19021, DOI 10.1073/pnas.1214808109; Kang L, 2017, PLANT PHYSIOL BIOCH, V117, P24, DOI 10.1016/j.plaphy.2017.05.017; Karuppusamy S, 2009, J MED PLANTS RES, V3, P1222; Kim JE, 2010, PHYTOCHEMISTRY, V71, P168, DOI 10.1016/j.phytochem.2009.10.011; Kim J, 2009, PLANT CELL PHYSIOL, V50, P463, DOI 10.1093/pcp/pcp005; Kloer DP, 2006, BIOCHEMISTRY-US, V45, P15197, DOI 10.1021/bi061572k; Kobayashi N, 2008, PLANT J, V55, P607, DOI 10.1111/j.1365-313X.2008.03539.x; Koch TC, 2005, J AGR FOOD CHEM, V53, P325, DOI 10.1021/jf048272z; Latari K, 2015, PLANT PHYSIOL, V168, P1550, DOI 10.1104/pp.15.00243; Lewinsohn E, 2005, J AGR FOOD CHEM, V53, P3142, DOI 10.1021/jf047927t; Li L, 2013, ARCH BIOCHEM BIOPHYS, V539, P102, DOI 10.1016/j.abb.2013.07.002; Maass D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006373; Mapelli-Brahm P, 2017, FOOD CHEM, V229, P304, DOI 10.1016/j.foodchem.2017.02.074; Melendez-Martinez AJ, 2015, ARCH BIOCHEM BIOPHYS; Mor A, 2014, PLANT PHYSIOL, V165, P249, DOI 10.1104/pp.114.236380; Muller L, 2011, J AGR FOOD CHEM, V59, P4504, DOI 10.1021/jf1045969; Mueller L, 2011, MOLECULES, V16, P1055, DOI 10.3390/molecules16021055; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Nogueira M, 2013, PLANT CELL, V25, P4560, DOI 10.1105/tpc.113.116210; Ohmiya A, 2006, PLANT PHYSIOL, V142, P1193, DOI 10.1104/pp.106.087130; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Palozza P, 1998, NUTR REV, V56, P257, DOI 10.1111/j.1753-4887.1998.tb01762.x; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; Park SY, 2016, FOOD SCI BIOTECHNOL, V25, P283, DOI 10.1007/s10068-016-0041-7; Pogson B, 1996, PLANT CELL, V8, P1627, DOI 10.1105/tpc.8.9.1627; Qin GJ, 2007, CELL RES, V17, P471, DOI 10.1038/cr.2007.40; RABOURN WJ, 1954, ARCH BIOCHEM BIOPHYS, V48, P267, DOI 10.1016/0003-9861(54)90341-0; Ramel F, 2013, J EXP BOT, V64, P799, DOI 10.1093/jxb/ers223; Ramel F, 2012, PLANT PHYSIOL, V158, P1267, DOI 10.1104/pp.111.182394; Rao SR, 2002, BIOTECHNOL ADV, V20, P101, DOI 10.1016/S0734-9750(02)00007-1; Rischer H, 2013, CURR PHARM DESIGN, V19, P5640, DOI 10.2174/1381612811319310017; Rodrigo MJ, 2013, J EXP BOT, V64, P4461, DOI 10.1093/jxb/ert260; Rodriguez-Villalon A, 2009, PLANT SIGNAL BEHAV, V4, P965, DOI 10.4161/psb.4.10.9672; Rottet S, 2015, BBA-BIOENERGETICS, V1847, P889, DOI 10.1016/j.bbabio.2015.02.002; Rubio A, 2008, J BIOL CHEM, V283, P24816, DOI 10.1074/jbc.M804000200; Schaub P, 2005, PLANT PHYSIOL, V138, P441, DOI 10.1104/pp.104.057927; Schaub P, 2017, J AGR FOOD CHEM, V65, P6588, DOI 10.1021/acs.jafc.7b01693; Schaub P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039550; Schuessele C, 2016, NEW PHYTOL, V209, P1014, DOI 10.1111/nph.13656; Schweiggert RM, 2017, CRIT REV FOOD SCI, V57, P1807, DOI 10.1080/10408398.2015.1012756; Sestak Z., 2004, CAROTENOIDS, V42, DOI 10.1023/b:phot.0000040641.40049.19,2; Simkin AJ, 2004, PLANT J, V40, P882, DOI 10.1111/j.1365-313X.2004.02263.x; Simkin AJ, 2004, PLANT PHYSIOL, V136, P3504, DOI 10.1104/pp.104.049718; Simkin AJ, 2003, J PLANT PHYSIOL, V160, P439, DOI 10.1078/0176-1617-00871; Sitte P, 1980, PIGMENTS PLANTS, P117; Stinco CM, 2016, LWT-FOOD SCI TECHNOL, V65, P718, DOI 10.1016/j.lwt.2015.08.068; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; TEVINI M, 1985, PLANTA, V163, P91, DOI 10.1007/BF00395902; Vazquez A-O, 2014, PLANT CELL, V26, P2524; von Lintig J, 2012, AM J CLIN NUTR, V96, p1234S, DOI 10.3945/ajcn.112.034629; Welsch R, 2000, PLANTA, V211, P846, DOI 10.1007/s004250000352; Welsch R, 2008, PLANT PHYSIOL, V147, P367, DOI 10.1104/pp.108.117028; Yadav Sudesh Kumar, 2008, Drug Metabolism and Drug Interactions, V23, P51; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yue W, 2016, CRIT REV BIOTECHNOL, V36, P215, DOI 10.3109/07388551.2014.923986; Zhang MK, 2014, PLANTA, V240, P1063, DOI 10.1007/s00425-014-2147-6; Zhou XJ, 2015, P NATL ACAD SCI USA, V112, P3558, DOI 10.1073/pnas.1420831112	112	37	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192158	10.1371/journal.pone.0192158	http://dx.doi.org/10.1371/journal.pone.0192158			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394270	Green Submitted, Green Published, gold			2022-12-26	WOS:000424060400028
J	Glaesener, S; Jaenke, C; Habener, A; Geffers, R; Hagendorff, P; Witzlau, K; Imelmann, E; Krueger, A; Meyer-Bahlburg, A				Glaesener, Stephanie; Jaenke, Christine; Habener, Anika; Geffers, Robert; Hagendorff, Petra; Witzlau, Katrin; Imelmann, Esther; Krueger, Andreas; Meyer-Bahlburg, Almut			Decreased production of class-switched antibodies in neonatal B cells is associated with increased expression of miR-181b	PLOS ONE			English	Article							T-CELLS; COSTIMULATOR MOLECULES; MONONUCLEAR-CELLS; IMMUNE-RESPONSES; REFERENCE VALUES; LYMPHOCYTES; CORD; BAFF; ACTIVATION; FAMILY	The increased susceptibility to infections of neonates is caused by an immaturity of the immune system as a result of both qualitative and quantitative differences between neonatal and adult immune cells. With respect to B cells, neonatal antibody responses are known to be decreased. Accountable for this is an altered composition of the neonatal B cell compartment towards more immature B cells. However, it remains unclear whether the functionality of individual neonatal B cell subsets is altered as well. In the current study we therefore compared phenotypical and functional characteristics of corresponding neonatal and adult B cell subpopulations. No phenotypic differences could be identified with the exception of higher IgM expression in neonatal B cells. Functional analysis revealed differences in proliferation, survival, and B cell receptor signaling. Most importantly, neonatal B cells showed severely impaired class-switch recombination (CSR) to IgG and IgA. This was associated with increased expression of miR-181b in neonatal B cells. Deficiency of miR-181b resulted in increased CSR. With this, our results highlight intrinsic differences that contribute to weaker B cell antibody responses in newborns.	[Glaesener, Stephanie; Jaenke, Christine; Habener, Anika; Meyer-Bahlburg, Almut] Hannover Med Sch, Dept Pediat Pneumol Allergy & Neonatol, Hannover, Germany; [Habener, Anika; Meyer-Bahlburg, Almut] German Ctr Lung Res DZL, Biomed Res Endstage & Obstruct Lung Dis BREATH, Hannover, Germany; [Geffers, Robert; Hagendorff, Petra] Helmholtz Ctr Infect Res, Genome Analyt, Braunschweig, Germany; [Witzlau, Katrin; Krueger, Andreas] Hannover Med Sch, Inst Immunol, Hannover, Germany; [Imelmann, Esther] Goethe Univ, Inst Mol Med, Frankfurt, Germany; [Meyer-Bahlburg, Almut] Univ Med Greifswald, Dept Pediat, Greifswald, Germany	Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Goethe University Frankfurt; Greifswald Medical School	Meyer-Bahlburg, A (corresponding author), Hannover Med Sch, Dept Pediat Pneumol Allergy & Neonatol, Hannover, Germany.; Meyer-Bahlburg, A (corresponding author), German Ctr Lung Res DZL, Biomed Res Endstage & Obstruct Lung Dis BREATH, Hannover, Germany.; Meyer-Bahlburg, A (corresponding author), Univ Med Greifswald, Dept Pediat, Greifswald, Germany.	almut.meyer-bahlburg@uni-greifswald.de	Krueger, Andreas/M-9769-2019; von Kaisenberg, Constantin/AAR-2756-2021	Krueger, Andreas/0000-0001-7873-7334; Glaesener, Stephanie/0000-0002-3971-7282	German Research Foundation [ME2709/2-3, KR2320/5-1, SFB902-B15]; European Union Marie-Curie International Re-integration Grant [IRG 256372]; Braukmann-Wittenberg-Herz-Stiftung; Deutsche Forschungsgemeinschaft	German Research Foundation(German Research Foundation (DFG)); European Union Marie-Curie International Re-integration Grant; Braukmann-Wittenberg-Herz-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work has been supported by grants from the German Research Foundation (http://www.dfg.de/) (ME2709/2-3 (AMB); KR2320/5-1 and SFB902-B15 (AK)), and a European Union Marie-Curie International Re-integration Grant IRG 256372 (https://ec.europa.eu/research/mariecurieactions/about/individual-fellowships_en) (AMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the assistance of the Cell Sorting Core Facility at Hannover Medical School supported by Braukmann-Wittenberg-Herz-Stiftung and Deutsche Forschungsgemeinschaft; and Prof. Dr. von Kaisenberg and Marion Haidukiewicz of the Clinic for Gynaecology and Obstetrics, Medical School Hannover, Germany for their help in providing us with cord blood. We also thank Christin Albrecht and Anika Dreier for the assistance in performing additional mice experiments.	Adderson EE, 2001, SPRINGER SEMIN IMMUN, V23, P387, DOI 10.1007/s281-001-8166-x; Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Adkins B, 2003, J IMMUNOL, V170, P4548, DOI 10.4049/jimmunol.170.9.4548; Adkins B, 2013, IMMUNOL RES, V57, P246, DOI 10.1007/s12026-013-8439-2; Aranburu A, 2010, J IMMUNOL, V185, P7293, DOI 10.4049/jimmunol.1002722; Avanzini MA, 2010, INT J IMMUNOPATH PH, V23, P247, DOI 10.1177/039463201002300122; Bao Y, 2016, CLIN REV ALLERG IMMU, V50, P301, DOI 10.1007/s12016-015-8494-7; Basha S, 2014, EXPERT REV CLIN IMMU, V10, P1171, DOI 10.1586/1744666X.2014.942288; Becker-Herman S, 2011, J EXP MED, V208, P2033, DOI 10.1084/jem.20110200; Belderbos ME, 2013, PEDIAT ALLERG IMM-UK, V24, P102, DOI 10.1111/pai.12023; Capolunghi F, 2008, J IMMUNOL, V180, P800, DOI 10.4049/jimmunol.180.2.800; Capolunghi F, 2013, IMMUNOL LETT, V152, P114, DOI 10.1016/j.imlet.2013.04.007; Chalmers IMH, 1998, BLOOD, V92, P11, DOI 10.1182/blood.V92.1.11.413a39_11_18; Chassin C, 2010, CELL HOST MICROBE, V8, P358, DOI 10.1016/j.chom.2010.09.005; Chen ZS, 2015, NATURE, V521, P357, DOI 10.1038/nature14231; Concepcion CP, 2012, CANCER J, V18, P262, DOI 10.1097/PPO.0b013e318258b60a; de Candia P, 2016, EUR J IMMUNOL, V46, P725, DOI 10.1002/eji.201545787; de Yebenes VG, 2008, J EXP MED, V205, P2199, DOI 10.1084/jem.20080579; Debock I, 2013, J IMMUNOL, V191, P1231, DOI 10.4049/jimmunol.1203288; Drohan L, 2004, HUM IMMUNOL, V65, P1356, DOI 10.1016/j.humimm.2004.09.011; Duchamp M, 2014, IMMUN INFLAMM DIS, V2, P131, DOI 10.1002/iid3.26; DURANDY A, 1995, J IMMUNOL, V154, P1560; Durandy A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3904; Elliott SR, 2000, HUM IMMUNOL, V61, P378, DOI 10.1016/S0198-8859(99)00189-5; Elliott SR, 1999, HUM IMMUNOL, V60, P1039, DOI 10.1016/S0198-8859(99)00090-7; Feng C, 2017, J CELL MOL MED, V21, P278, DOI 10.1111/jcmm.12963; Gicquel C, 2008, BEST PRACT RES CL EN, V22, P1, DOI 10.1016/j.beem.2007.07.009; Glaesener S, 2014, ARTHRITIS RHEUMATOL, V66, P2590, DOI 10.1002/art.38736; HAYWARD AR, 1977, J IMMUNOL, V119, P1213; Hori D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174108; Jiang S, 2011, BLOOD, V118, P5487, DOI 10.1182/blood-2011-05-355644; Jin HY, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006623; Kaminski BA, 2003, BLOOD, V102, P4608, DOI 10.1182/blood-2003-05-1732; Kanswal S, 2008, J IMMUNOL, V181, P976, DOI 10.4049/jimmunol.181.2.976; Kaur K, 2007, BLOOD, V110, P2948, DOI 10.1182/blood-2007-01-069245; Khuu C, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/1379643; Klouwenberg PK, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/628963; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; Lai MY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12207; Landers CD, 2005, CLIN IMMUNOL, V116, P236, DOI 10.1016/j.clim.2005.04.013; Lanzavecchia A, 2007, CURR OPIN IMMUNOL, V19, P268, DOI 10.1016/j.coi.2007.04.002; Li JY, 2013, CELL MOL IMMUNOL, V10, P107, DOI 10.1038/cmi.2012.62; Li TJ, 2015, INT J CLIN EXP PATHO, V8, P10375; Lou Z, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00537; Macardle PJ, 1997, IMMUNOLOGY, V90, P376, DOI 10.1111/j.1365-2567.1997.00376.x; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Marie-Cardine A, 2008, CLIN IMMUNOL, V127, P14, DOI 10.1016/j.clim.2007.11.013; Martino DJ, 2011, EPIGENETICS-US, V6, P1085, DOI 10.4161/epi.6.9.16401; Merkerova M, 2010, STEM CELLS DEV, V19, P17, DOI 10.1089/scd.2009.0071; Meyer-Bahlburg A, 2008, J EXP MED, V205, P155, DOI 10.1084/jem.20071088; Meyer-Bahlburg A, 2009, J IMMUNOL, V182, P4065, DOI 10.4049/jimmunol.0802961; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Morbach H, 2010, CLIN EXP IMMUNOL, V162, P271, DOI 10.1111/j.1365-2249.2010.04206.x; Muthukkumar S, 2000, J IMMUNOL, V165, P4803, DOI 10.4049/jimmunol.165.9.4803; Palanichamy A, 2009, J IMMUNOL, V182, P5982, DOI 10.4049/jimmunol.0801859; Palin AC, 2013, J IMMUNOL, V190, P2682, DOI 10.4049/jimmunol.1202534; Pettengill MA, 2016, INNATE IMMUNITY; Piatosa B, 2010, CYTOM PART B-CLIN CY, V78B, P372, DOI 10.1002/cyto.b.20536; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Roth A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152215; Rowland SL, 2010, J IMMUNOL, V185, P4570, DOI 10.4049/jimmunol.1001708; Sater RA, 1998, INT IMMUNOL, V10, P1673, DOI 10.1093/intimm/10.11.1673; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Stadanlick JE, 2008, CURR OPIN IMMUNOL, V20, P158, DOI 10.1016/j.coi.2008.03.015; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Tasker L, 1997, INT IMMUNOL, V9, P475, DOI 10.1093/intimm/9.4.475; Tasker L, 2003, CLIN EXP IMMUNOL, V134, P409, DOI 10.1111/j.1365-2249.2003.02318.x; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tsai DY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17957; TSUJI T, 1994, J IMMUNOL, V152, P4417; van Zelm MC, 2007, J EXP MED, V204, P645, DOI 10.1084/jem.20060964; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Viemann D, 2000, EUR J IMMUNOL, V30, P550, DOI 10.1002/1521-4141(200002)30:2<550::AID-IMMU550>3.0.CO;2-X; Wang XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17618; White CA, 2014, J IMMUNOL, V193, P5933, DOI 10.4049/jimmunol.1401702; Xu DD, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0521-7; Xu XF, 2015, ONCOL REP, V33, P2789, DOI 10.3892/or.2015.3900; Zan H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00631; Zhang JM, 2015, IMMUNOLOGY, V144, P56, DOI 10.1111/imm.12347; Zheng YB, 2016, ONCOL REP, V35, P683, DOI 10.3892/or.2015.4417; Zietara N, 2013, P NATL ACAD SCI USA, V110, P7407, DOI 10.1073/pnas.1221984110	83	17	18	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192230	10.1371/journal.pone.0192230	http://dx.doi.org/10.1371/journal.pone.0192230			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389970	Green Submitted, Green Published, gold			2022-12-26	WOS:000423793400078
J	Jazaeri, SZ; Azad, A; Mehdizadeh, H; Habibi, SA; Najafabadi, MM; Saberi, ZS; Rahimzadegan, H; Moradi, S; Behzadipour, S; Parnianpour, M; Taghizadeh, G; Khalaf, K				Jazaeri, Seyede Zohreh; Azad, Akram; Mehdizadeh, Hajar; Habibi, Seyed Amirhassan; Najafabadi, Mahbubeh Mandehgary; Saberi, Zakieh Sadat; Rahimzadegan, Hawre; Moradi, Saeed; Behzadipour, Saeed; Parnianpour, Mohamad; Taghizadeh, Ghorban; Khalaf, Kinda			The effects of anxiety and external attentional focus on postural control in patients with Parkinson's disease	PLOS ONE			English	Article							BALANCE; INSTABILITY; DEPRESSION; AUTOMATICITY; LEVODOPA; WALKING; SCALE; DOPA; GAIT; CUES	Background Although anxiety is a common non-motor outcome of Parkinson's disease (PD) affecting 40% of patients, little attention has been paid so far to its effects on balance impairment and postural control. Improvement of postural control through focusing on the environment (i.e. external focus) has been reported, but the role of anxiety, as a confounding variable, remains unclear. Objectives This study aimed to investigate the influence of anxiety and attentional focus instruction on the standing postural control of PD patients. Methods Thirty-four patients with PD (17 with high anxiety (HA-PD) and 17 with low anxiety (LA-PD)), as well as 17 gender-and age-matched healthy control subjects (HC) participated in the study. Postural control was evaluated using a combination of two levels of postural difficulty (standing on a rigid force plate surface with open eyes (RO) and standing on a foam surface with open eyes (FO)), as well as three attentional focus instructions (internal, external and no focus). Results Only the HA-PD group demonstrated significant postural control impairment as compared to the control, as indicated by significantly greater postural sway measures. Moreover, external focus significantly reduced postural sway in all participants especially during the FO condition. Conclusion The results of the current study provide evidence that anxiety influences balance control and postural stability in patients with PD, particularly those with high levels of anxiety. The results also confirmed that external focus is a potential strategy that significantly improves the postural control of these patients. Further investigation of clinical applicability is warranted towards developing effective therapeutic and rehabilitative treatment plans.	[Jazaeri, Seyede Zohreh; Azad, Akram; Najafabadi, Mahbubeh Mandehgary; Saberi, Zakieh Sadat; Rahimzadegan, Hawre; Taghizadeh, Ghorban] Iran Univ Med Sci, Sch Rehabil Sci, Dept Occupat Therapy, Tehran, Iran; [Mehdizadeh, Hajar] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Neurosci, Tehran, Iran; [Mehdizadeh, Hajar] Univ Tehran Med Sci, Sch Rehabil, Dept Occupat Therapy, Tehran, Iran; [Habibi, Seyed Amirhassan] Iran Univ Med Sci, Rasool Akram Hosp, Dept Neurol, Movement Disorder Clin, Tehran, Iran; [Moradi, Saeed] Iran Univ Med Sci, Rasool Akram Hosp, Tehran, Iran; [Behzadipour, Saeed; Parnianpour, Mohamad] Sharif Univ Technol, Dept Mech Engn, Tehran, Iran; [Behzadipour, Saeed] Mowafaghian Res Ctr Neurorehabil Technol, Tehran, Iran; [Taghizadeh, Ghorban] Iran Univ Med Sci, Sch Rehabil Sci, Rehabil Res Ctr, Tehran, Iran; [Khalaf, Kinda] Khalifa Univ Sci Technol & Res, Dept Biomed Engn, Abu Dhabi, U Arab Emirates	Iran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Sharif University of Technology; Iran University of Medical Sciences; Khalifa University of Science & Technology	Taghizadeh, G (corresponding author), Iran Univ Med Sci, Sch Rehabil Sci, Dept Occupat Therapy, Tehran, Iran.; Taghizadeh, G (corresponding author), Iran Univ Med Sci, Sch Rehabil Sci, Rehabil Res Ctr, Tehran, Iran.	taghizadeh.gh@iums.ac.ir	Azad, Akram/M-6351-2018; Taghizadeh, Ghorban/AAD-7167-2022; Behzadipour, Saeed/ABC-6740-2020; Mehdizadeh, Hajar/HCI-6580-2022; Taghizadeh, Ghorban/L-8609-2018	Azad, Akram/0000-0001-7544-4878; Taghizadeh, Ghorban/0000-0002-0145-9599; Taghizadeh, Ghorban/0000-0002-0145-9599; Behzadipour, Saeed/0000-0001-9313-315X; Khalaf, Kinda/0000-0002-3878-2621	Iran University of Medical Sciences, Tehran, Iran	Iran University of Medical Sciences, Tehran, Iran	This study was supported by Iran University of Medical Sciences, Tehran, Iran. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Iran University of Medical Sciences, Tehran, Iran.	Baker K, 2008, PARKINSONISM RELAT D, V14, P314, DOI 10.1016/j.parkreldis.2007.09.008; Balaban CD, 2001, J ANXIETY DISORD, V15, P53, DOI 10.1016/S0887-6185(00)00042-6; Beck EN, 2016, PHYS THERAPY; Bekkers EMJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00939; Benke T, 1998, BRAIN COGNITION, V38, P36, DOI 10.1006/brcg.1998.1013; Blaszczyk JW, 2007, EXP BRAIN RES, V183, P107, DOI 10.1007/s00221-007-1024-y; Bohnen NI, 2006, CLIN GERIATR MED, V22, P797, DOI 10.1016/j.cger.2006.06.009; Cunnington R, 1999, MOVEMENT DISORD, V14, P63; DAMASIO AR, 1971, J NEUROL NEUROSUR PS, V34, P502, DOI 10.1136/jnnp.34.5.502; de Kam D, 2014, J NEUROL, V261, P2330, DOI 10.1007/s00415-014-7496-3; ELLGRING H, 1990, ADV NEUROL, V53, P349; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Fergus TA, 2014, BEHAV RES THER, V61, P150, DOI 10.1016/j.brat.2014.08.007; Funkiewiez A, 2006, MOVEMENT DISORD, V21, P1656, DOI 10.1002/mds.21029; HORAK FB, 1992, J NEUROL SCI, V111, P46, DOI 10.1016/0022-510X(92)90111-W; Jankowski J, 2009, NEUROIMAGE, V44, P1369, DOI 10.1016/j.neuroimage.2008.10.059; Kim SD, 2013, CNS DRUGS, V27, P97, DOI 10.1007/s40263-012-0012-3; Landers M, 2005, PHYSIOTHERAPY, V91, P152, DOI 10.1016/j.physio.2004.11.010; Leentjens AFG, 2000, MOVEMENT DISORD, V15, P1221, DOI 10.1002/1531-8257(200011)15:6<1221::AID-MDS1024>3.0.CO;2-H; MARICLE RA, 1995, NEUROLOGY, V45, P1757, DOI 10.1212/WNL.45.9.1757; Martens KAE, 2017, NEUROSCIENCE, V340, P436, DOI 10.1016/j.neuroscience.2016.11.011; Martens KAE, 2015, NEUROPSYCHOLOGIA, V79, P322, DOI 10.1016/j.neuropsychologia.2015.05.015; Mehdizadeh H, 2017, EXP BRAIN RES; Mehdizadeh Maryam, 2016, Med J Islam Repub Iran, V30, P453; Prediger RDS, 2012, NEUROPHARMACOLOGY, V62, P115, DOI 10.1016/j.neuropharm.2011.08.039; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Redfern MS, 2001, J ANXIETY DISORD, V15, P81, DOI 10.1016/S0887-6185(00)00043-8; Richard IH, 1996, J NEUROPSYCH CLIN N, V8, P383; Richer N, 2017, GAIT POSTURE, V54, P45, DOI 10.1016/j.gaitpost.2017.02.022; Riedel O, 2013, J GERIATR PSYCH NEUR, V26, P151, DOI 10.1177/0891988713490994; Rodriguez-Blazquez C, 2009, MOVEMENT DISORD, V24, P519, DOI 10.1002/mds.22321; Schiehser DM, 2013, PARKINSONISM RELAT D, V19, P335, DOI 10.1016/j.parkreldis.2012.11.013; Smania N, 2010, NEUROREHAB NEURAL RE, V24, P826, DOI 10.1177/1545968310376057; Termoz N, 2008, GAIT POSTURE, V27, P463, DOI 10.1016/j.gaitpost.2007.05.015; Weisskopf MG, 2003, MOVEMENT DISORD, V18, P646, DOI 10.1002/mds.10425; Wulf G, 2001, Q J EXP PSYCHOL-A, V54, P1143, DOI 10.1080/02724980143000118; Wulf G, 2007, RES Q EXERCISE SPORT, V78, P384, DOI 10.5641/193250307X13082505158336; Wulf G, 2009, PHYS THER, V89, P162, DOI 10.2522/ptj.20080045; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	39	12	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192168	10.1371/journal.pone.0192168	http://dx.doi.org/10.1371/journal.pone.0192168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29390029	Green Submitted, Green Published, gold			2022-12-26	WOS:000423793400074
J	Mayfield, AB; Chen, YJ; Lu, CY; Chen, CS				Mayfield, Anderson B.; Chen, Yi-Jyun; Lu, Chi-Yu; Chen, Chii-Shiarng			The proteomic response of the reef coral Pocillopora acuta to experimentally elevated temperatures	PLOS ONE			English	Article							GENE-EXPRESSION; BUILDING CORAL; PHYSIOLOGICAL-RESPONSE; CLIMATE-CHANGE; STRESS; RESILIENCE; MECHANISMS; DAMICORNIS; RUBISCO; KINASE	Although most reef-building corals live near the upper threshold of their thermotolerance, some scleractinians are resilient to temperature increases. For instance, Pocillopora acuta specimens from an upwelling habitat in Southern Taiwan survived a nine-month experimental exposure to 30 degrees C, a temperature hypothesized to induce stress. To gain a greater understanding of the molecular pathways underlying such high-temperature acclimation, the protein profiles of experimental controls incubated at 27 degrees C were compared to those of conspecific P. acuta specimens exposed to 30 degrees C for two, four, or eight weeks, and differentially concentrated proteins (DCPs) were removed from the gels and sequenced with mass spectrometry. Sixty unique DCPs were uncovered across both eukaryotic compartments of the P. acuta-dinoflagellate (genus Symbiodinium) mutualism, and Symbiodinium were more responsive to high temperature at the protein-level than the coral hosts in which they resided at the two-week sampling time. Furthermore, proteins involved in the stress response were more likely to be documented at different cellular concentrations across temperature treatments in Symbiodinium, whereas the temperature-sensitive host coral proteome featured numerous proteins involved in cytoskeletal structure, immunity, and metabolism. These proteome-scale data suggest that the coral host and its intracellular dinoflagellates have differing strategies for acclimating to elevated temperatures.	[Mayfield, Anderson B.] Khaled bin Sultan Living Oceans Fdn, Annapolis, MD 21403 USA; [Mayfield, Anderson B.; Chen, Yi-Jyun; Chen, Chii-Shiarng] Taiwan Coral Res Ctr, Pingtung, Taiwan; [Lu, Chi-Yu] Kaohsiung Med Univ, Dept Biochem, Coll Med, Kaohsiung, Taiwan; [Lu, Chi-Yu] Kaohsiung Med Univ, Ctr Res Resources & Dev, Kaohsiung, Taiwan; [Chen, Chii-Shiarng] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan; [Chen, Chii-Shiarng] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Pingtung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; National Dong Hwa University	Mayfield, AB (corresponding author), Khaled bin Sultan Living Oceans Fdn, Annapolis, MD 21403 USA.; Mayfield, AB (corresponding author), Taiwan Coral Res Ctr, Pingtung, Taiwan.	andersonblairmayfield@gmail.com		Mayfield, Anderson/0000-0003-0138-7844	United States National Science Foundation [OISE-0852960]; Khaled bin Sultan Living Oceans Foundation	United States National Science Foundation(National Science Foundation (NSF)); Khaled bin Sultan Living Oceans Foundation	This work was funded by the United States National Science Foundation (postdoctoral research fellowship to ABM; OISE-0852960) and the Khaled bin Sultan Living Oceans Foundation (postdoctoral research fellowship to ABM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Chen HK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02722-z; Chen HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132519; Chen WNU, 2012, CORAL REEFS, V31, P521, DOI 10.1007/s00338-011-0868-6; Chen WNU, 2016, PEERJ, V4, DOI 10.7717/peerj.2358; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Doo SS, 2013, APPROACHES STUDY LIV; Doo SS, 2012, J EXP MAR BIOL ECOL, V430, P63, DOI 10.1016/j.jembe.2012.06.025; Du Clos TW, 2013, ISRN INFLAMM; Gates RD, 1999, AM ZOOL, V39, P30; Hochachka P. W., 2002, BIOCH ADAPTATION; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kim S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6277; Krueger T, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170038; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Lin SJ, 2015, SCIENCE, V350, P691, DOI 10.1126/science.aad0408; Lundgren P, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-9; Mayfield AB, 2013, CORAL REEFS, V32, P909, DOI 10.1007/s00338-013-1067-4; Mayfield A. B., 2017, PLOS ONE, DOI [10.1371/journal.pone.0185857, DOI 10.1371/JOURNAL.PONE.0185857]; Mayfield AB, 2014, INT J MARINE SCI, V4, P1, DOI DOI 10.5376/IJMS.2014.04.0050; MAYFIELD AB, 2013, J MAR BIOL, V2013, P69369, DOI DOI 10.1155/2013/569361; Mayfield AR, 2018, CHILD NEUROPSYCHOL, V24, P166, DOI 10.1080/09297049.2016.1236186; Mayfield AB, 2007, COMP BIOCHEM PHYS A, V147, P1, DOI 10.1016/j.cbpa.2006.12.042; Mayfield AB, 2016, J MAR SCI ENG, V4, DOI 10.3390/jmse4030063; Mayfield Anderson B., 2016, Platax, V13, P1; Mayfield AB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177267; Mayfield AB, 2016, MOL ECOL, V25, P5944, DOI 10.1111/mec.13896; Mayfield Anderson B., 2014, Platax, V11, P1; Mayfield Anderson B., 2013, Platax, V10, P1; Mayfield AB, 2014, MOL ECOL, V23, P5816, DOI 10.1111/mec.12982; Mayfield AB, 2014, MAR BIOTECHNOL, V16, P371, DOI 10.1007/s10126-014-9558-z; Mayfield Anderson B., 2012, Platax, V9, P1; Mayfield AB, 2013, MAR ENVIRON RES, V86, P1, DOI 10.1016/j.marenvres.2013.01.004; Mayfield AB, 2012, J EXP BIOL, V215, P4183, DOI 10.1242/jeb.071688; Mayfield AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026529; Mayfield AB, 2010, J EXP MAR BIOL ECOL, V395, P215, DOI 10.1016/j.jembe.2010.09.007; Mayfield AB, 2009, MOL ECOL RESOUR, V9, P462, DOI 10.1111/j.1755-0998.2008.02349.x; Mente Eleni, 2017, Biochem Biophys Rep, V9, P79, DOI 10.1016/j.bbrep.2016.10.012; Oakley CA, 2016, CELL MICROBIOL, V18, P1009, DOI 10.1111/cmi.12564; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Palmer CV, 2012, P ROY SOC B-BIOL SCI, V279, P4106, DOI 10.1098/rspb.2012.1477; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Peng SE, 2011, PROTEOMICS, V11, P3540, DOI 10.1002/pmic.201000552; Pinzon JH, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140214; Putnam HM, 2013, MAR BIOL, V160, P2157, DOI 10.1007/s00227-012-2129-9; Putnam HM, 2017, CURR BIOL, V27, pR528, DOI 10.1016/j.cub.2017.04.047; Putnam HM, 2012, P ROY SOC B-BIOL SCI, V279, P4352, DOI 10.1098/rspb.2012.1454; Putnam HM, 2011, J EXP MAR BIOL ECOL, V396, P216, DOI 10.1016/j.jembe.2010.10.026; Ruiz-Jones LJ, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601298; Shalit T, 2015, J PROTEOME RES, V14, P1979, DOI 10.1021/pr501045t; Takeuichi T, 2017, PLOS ONE; Thirone ACP, 2009, AM J PHYSIOL-CELL PH, V296, pC463, DOI 10.1152/ajpcell.00467.2008; Wang LH, 2013, PLOS ONE; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Weston AJ, 2015, MOL CELL PROTEOMICS, V14, P585, DOI 10.1074/mcp.M114.043125; Weston AJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015487	60	35	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0192001	10.1371/journal.pone.0192001	http://dx.doi.org/10.1371/journal.pone.0192001			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385204	gold, Green Published, Green Submitted			2022-12-26	WOS:000423668400067
J	Song, N; Lin, AL; Zhao, XC				Song, Nan; Lin, Aili; Zhao, Xincheng			Insight into higher-level phylogeny of Neuropterida: Evidence from secondary structures of mitochondrial rRNA genes and mitogenomic data	PLOS ONE			English	Article							16S RDNA; MOLECULAR PHYLOGENY; GENITAL SCLERITES; SOFTWARE PACKAGE; CYTOCHROME-B; DNA-SEQUENCE; IQ-TREE; INSECTA; GENOME; 18S	It is well known that the rRNA structure information is important to assist phylogenetic analysis through identifying homologous positions to improve alignment accuracy. In addition, the secondary structure of some conserved motifs is highly stable among distantly related taxa, which can provide potentially informative characters for estimating phylogeny. In this paper, we applied the high-throughput pooled sequencing approach to the determination of neu-ropteran mitogenomes. Four complete mitogenome sequences were obtained: Micromus angulatus (Hemerobiidae), Chrysoperla nipponensis (Chrysopidae), Rapisma sp. (Ithonidae), and Thaumatosmylussp. (Osmylidae). This allowed us to sample more complete mitochondrial RNA gene sequences. Secondary structure diagrams for the complete mitochondrial small and large ribosomal subunit RNA genes of eleven neuropterid species were predicted. Comparative analysis of the secondary structures indicated a closer relationship of Megaloptera and Neuroptera. This result was congruent with the resulting phylogeny inferred from sequence alignments of all 37 mitochondrial genes, namely the hypothesis of (Raphidioptera + (Megaloptera + Neuroptera)).	[Song, Nan; Lin, Aili; Zhao, Xincheng] Henan Agr Univ, Coll Plant Protect, Zhengzhou, Henan, Peoples R China	Henan Agricultural University	Song, N (corresponding author), Henan Agr Univ, Coll Plant Protect, Zhengzhou, Henan, Peoples R China.	songnan@henau.edu.cn			National Natural Science Foundation of China [31402002]; Key Scientific Research Projects of Henan Province [16A210029]; Henan Academician Workstation of Pest Green Prevention and Control for Plants in Southern Henan [YZ201601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Scientific Research Projects of Henan Province; Henan Academician Workstation of Pest Green Prevention and Control for Plants in Southern Henan	This research is supported by grants from the National Natural Science Foundation of China (no. 31402002), Key Scientific Research Projects of Henan Province (grant no. 16A210029), and Henan Academician Workstation of Pest Green Prevention and Control for Plants in Southern Henan (YZ201601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspock H, 1991, MONOGRAPHISCHE DARST, V2; Aspock U, 2002, ZOOL SCR, V31, P51, DOI 10.1046/j.0300-3256.2001.00087.x; Aspock U, 2001, SYST ENTOMOL, V26, P73, DOI 10.1046/j.1365-3113.2001.00136.x; Aspock U, 2008, SYST ENTOMOL, V33, P97, DOI 10.1111/j.1365-3113.2007.00396.x; Aspock U, 2012, ARTHROPOD SYST PHYLO, V70, P119; Badano D, 2017, SYST ENTOMOL, V42, P94, DOI 10.1111/syen.12200; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; BLACK WC, 1994, P NATL ACAD SCI USA, V91, P10034, DOI 10.1073/pnas.91.21.10034; Boudreaux H. B., 1979, ARTHROPOD PHYLOGENY; Buckley TR, 2000, INSECT MOL BIOL, V9, P565, DOI 10.1046/j.1365-2583.2000.00220.x; Caetano-Anolles G, 2002, NUCLEIC ACIDS RES, V30, P2575, DOI 10.1093/nar/30.11.2575; Cameron SL, 2014, SYST ENTOMOL, V39, P400, DOI 10.1111/syen.12071; Cameron SL, 2009, ZOOL SCR, V38, P575, DOI 10.1111/j.1463-6409.2009.00392.x; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; Caterino MS, 2002, ZOOL SCR, V31, P41, DOI 10.1046/j.0300-3256.2001.00092.x; Coates BS, 2014, GENE, V542, P190, DOI 10.1016/j.gene.2014.03.035; Colgan D. J., 2002, Journal of Mammalian Evolution, V9, P3, DOI 10.1023/A:1021379627037; Crampton-Platt A, 2015, MOL BIOL EVOL, V32, P2302, DOI 10.1093/molbev/msv111; Daane K.M., 2001, P398, DOI 10.1017/CBO9780511666117.024; Dalevi D, 2001, INT J SYST EVOL MICR, V51, P385, DOI 10.1099/00207713-51-2-385; DERIJK P, 1993, COMPUT APPL BIOSCI, V9, P735; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FastQC Andrews S., 2010, A QUALITY CONTROL TO; Friedrich F, 2010, CLADISTICS, V26, P579, DOI 10.1111/j.1096-0031.2010.00305.x; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Gillett CPDT, 2014, MOL BIOL EVOL, V31, P2223, DOI 10.1093/molbev/msu154; GUTELL RR, 1988, NUCLEIC ACIDS RES, V16, pR175, DOI 10.1093/nar/16.suppl.r175; Halanych KM, 1999, J MOL EVOL, V48, P369, DOI 10.1007/PL00006481; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Haring E, 2004, SYST ENTOMOL, V29, P415, DOI 10.1111/j.0307-6970.2004.00263.x; Hasegawa E, 2006, ENTOMOL SCI, V9, P55, DOI 10.1111/j.1479-8298.2006.00154.x; Jeyaprakash A, 2007, GENE, V391, P264, DOI 10.1016/j.gene.2007.01.012; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kjer Karl M., 2006, Arthropod Systematics & Phylogeny, V64, P35; KJER KM, 1995, MOL PHYLOGENET EVOL, V4, P314, DOI 10.1006/mpev.1995.1028; Kristensen N.P., 1991, P125; Kristensen NP, 1999, EUR J ENTOMOL, V96, P237; Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024; Kuck P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-10; Kuznetsova VG, 2014, ZOOKEYS, V538, P47; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lavrov DV, 2000, MOL BIOL EVOL, V17, P813, DOI 10.1093/oxfordjournals.molbev.a026360; LEE IM, 1993, PHYTOPATHOLOGY, V83, P834, DOI 10.1094/Phyto-83-834; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu X.Y., 2010, FAUNA SINICA INSECTA, V51; Liu XY, 2016, SYST ENTOMOL, V41, P256, DOI 10.1111/syen.12154; Michel B, 2017, MOL PHYLOGENET EVOL, V107, P103, DOI 10.1016/j.ympev.2016.10.014; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Misof B, 2003, INSECT MOL BIOL, V12, P535, DOI 10.1046/j.1365-2583.2003.00432.x; Misof B, 2007, ZOOLOGY, V110, P409, DOI 10.1016/j.zool.2007.08.003; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Moller PR, 2003, MOL PHYLOGENET EVOL, V26, P369, DOI 10.1016/S1055-7903(02)00362-7; Murrell A, 1999, MOL PHYLOGENET EVOL, V12, P83, DOI 10.1006/mpev.1998.0595; Negrisolo E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-221; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Oswald J.D, 2022, NEUROPTERIDA SPECIES, V1; Ouvrard D, 2000, MOL PHYLOGENET EVOL, V16, P403, DOI 10.1006/mpev.2000.0797; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Ramakodi MP, 2015, GENOMICS, V105, P53, DOI 10.1016/j.ygeno.2014.10.014; Senior L.J., 2001, P296, DOI 10.1017/CBO9780511666117.014; Song F, 2016, GENOME BIOL EVOL, V8, P1411, DOI 10.1093/gbe/evw086; Song N, 2016, SCI REP-UK, V6, DOI 10.1038/srep36175; Song N, 2016, J SYST EVOL, V54, P545, DOI 10.1111/jse.12214; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stange Lionel A., 1994, Insecta Mundi, V8, P67; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timmermans MJTN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq807; Titus TA, 1996, MOL PHYLOGENET EVOL, V6, P49, DOI 10.1006/mpev.1996.0057; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Tsagkogeorga G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-187; Wang YY, 2017, CLADISTICS, V33, P617, DOI 10.1111/cla.12186; Wang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047302; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1111/j.1096-0031.2001.tb00115.x, 10.1006/clad.2000.0147]; Whiting MF, 2002, ZOOL SCR, V31, P3, DOI 10.1046/j.0300-3256.2001.00093.x; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Winterton SL, 2010, ANN ENTOMOL SOC AM, V103, P511, DOI 10.1603/AN10026; Winterton SL, 2010, SYST ENTOMOL, V35, P349, DOI 10.1111/j.1365-3113.2010.00521.x; Winterton SL, 2017, SYST ENTOMOL; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xie Q, 2008, MOL PHYLOGENET EVOL, V47, P463, DOI 10.1016/j.ympev.2008.01.024; Yang QQ, 2013, J ECON ENTOMOL, V106, P419, DOI 10.1603/EC12163; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang LL, 2017, BIOCHEM SYST ECOL, V71, P230, DOI 10.1016/j.bse.2017.02.009; Zhao CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114695; Zhao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062943	94	8	8	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191826	10.1371/journal.pone.0191826	http://dx.doi.org/10.1371/journal.pone.0191826			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381758	gold, Green Submitted, Green Published			2022-12-26	WOS:000423617800038
J	Bai, RL; Kusama, K; Nakamura, K; Sakurai, T; Kimura, K; Ideta, A; Aoyagi, Y; Imakawa, K				Bai, Rulan; Kusama, Kazuya; Nakamura, Keigo; Sakurai, Toshihiro; Kimura, Koji; Ideta, Atsushi; Aoyagi, Yoshito; Imakawa, Kazuhiko			Down-regulation of transcription factor OVOL2 contributes to epithelial-mesenchymal transition in a noninvasive type of trophoblast implantation to the maternal endometrium	FASEB JOURNAL			English	Article						bovine; TEAD; YAP; NOTCH	NOTCH SIGNALING PATHWAY; HIPPO PATHWAY; CONCEPTUS ATTACHMENT; BOVINE CONCEPTUSES; CELL FATE; EXPRESSION; GENE; TROPHECTODERM; MECHANISMS; PROTEIN	Embryo implantation into the uterine endometrium is required for pregnancy establishment in most mammals. By using global expression analysis, we investigated the molecules that are related to epithelial- mesenchymal transition (EMT) in noninvasive bovine trophoblasts and found that the transcription factor, ovo-like zinc finger 2 (OVOL2), which is essential for mesenchymal-epithelial transition in various cancers, was down-regulated after trophoblast attachment to the endometrial epithelium in utero. In cultured bovine trophoblast cells, OVOL2 down-regulation occurred only when cells were allowed to attach to bovine endometrial epithelial cells via the TEAD3/YAP signaling pathway. This resulted in the up-regulation of the EMT-associated transcription factors, ZEB1 and SNAI2, and the mesenchymal cell markers, N-cadherin (CDH2) and vimentin (VIM), whereas epithelial cell marker, E-cadherin (CDH1), was down-regulated. In contrast, OVOL2 overexpression in bovine trophoblast cells exhibited a decrease in ZEB1 transcripts and an increase in E-cadherin. These observations revealed that ovo-like protein (OVOL)2 down-regulation occurred concurrently with conceptus implantation into the uterine endometrium via the YAP/TEAD3 signaling pathway, and suggest that the down-regulation of OVOL2 expression contributes to the up-regulation of EMT-related transcription factor expression, which enables EMT progression in the noninvasive bovine trophectoderm postimplantation.	[Bai, Rulan; Kusama, Kazuya; Nakamura, Keigo; Imakawa, Kazuhiko] Univ Tokyo, Anim Resource Sci Ctr, Grad Sch Agr & Life Sci, 3145 Ago, Kasama, Ibaraki 3190206, Japan; [Sakurai, Toshihiro] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Occupat & Environm Hlth, Noda, Chiba, Japan; [Kimura, Koji] Okayama Univ, Grad Sch Environm & Life Sci, Okayama, Japan; [Ideta, Atsushi; Aoyagi, Yoshito] Zennoh Embryo Transfer Ctr, Kamishihoro, Hokkaido, Japan	University of Tokyo; Tokyo University of Science; Okayama University	Imakawa, K (corresponding author), Univ Tokyo, Anim Resource Sci Ctr, Grad Sch Agr & Life Sci, 3145 Ago, Kasama, Ibaraki 3190206, Japan.	akaz@mail.ecc.u-tokyo.ac.jp	Imakawa, Kazuhiko/AAD-3211-2022; Kusama, Kazuya/K-9716-2018	Kusama, Kazuya/0000-0002-9120-0475; Imakawa, Kazuhiko/0000-0002-3798-3560	Livestock Promotional Funds of Japan Racing Association; Japan Society for the Promotion of Science [16H02584, 16F16403, 15K18767]	Livestock Promotional Funds of Japan Racing Association; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank Dr. Alan Ealy (Virginia Polytechnic Institute and State University, Blacksburg, VA, USA) for the generous gift of bovine trophoblast CT-1 cells, and Prof. Christiane Pfarrer (University of Veterinary Medicine Hannover, Hannover, Germany) for kindly providing us with bovine trophoblast F3 cells. The authors also thank Robert Moriarty (Berlitz Japan, Tokyo, Japan) for his editorial assistance throughout the manuscript preparation. This work was supported by Livestock Promotional Funds of Japan Racing Association (to K.I.), a Grant-in-Aid for Scientific Research (16H02584) from the Japan Society for the Promotion of Science (to K.I.), a Grant-in-Aid for International Research Fellow (16F16403) from the Japan Society for the Promotion of Science (to R.B.), and a Grant-in-Aid for Young Scientists (B) (15K18767) from the Japan Society for the Promotion of Science (to K.K.). The authors declare no conflicts of interest.	Ayyanathan K, 2007, CANCER RES, V67, P9097, DOI 10.1158/0008-5472.CAN-07-2987; Bai H, 2009, MOL REPROD DEV, V76, P1143, DOI 10.1002/mrd.21082; Bai RL, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.128652; Bai R, 2014, REPRODUCTION, V148, P119, DOI 10.1530/REP-13-0655; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cuman C, 2014, REPRODUCTION, V147, pR75, DOI 10.1530/REP-13-0474; Dufraine J, 2008, ONCOGENE, V27, P5132, DOI 10.1038/onc.2008.227; Hambruch N, 2010, PLACENTA, V31, P67, DOI 10.1016/j.placenta.2009.10.011; Hong AW, 2016, NAT REV GASTRO HEPAT, V13, P324, DOI 10.1038/nrgastro.2016.59; Ideta A, 2007, CLONING STEM CELLS, V9, P571, DOI 10.1089/clo.2007.0017; IMAKAWA K, 1987, NATURE, V330, P377, DOI 10.1038/330377a0; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kumar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039399; Kusama K, 2016, DOMEST ANIM ENDOCRIN, V57, P21, DOI 10.1016/j.domaniend.2016.05.002; Kusama K, 2016, MOL CELL ENDOCRINOL, V434, P81, DOI 10.1016/j.mce.2016.06.017; Langer EM, 2008, DEV CELL, V14, P424, DOI 10.1016/j.devcel.2008.01.005; Lee B, 2014, DEV CELL, V29, P47, DOI 10.1016/j.devcel.2014.03.005; Li B, 2002, GENOMICS, V80, P319, DOI 10.1006/geno.2002.6831; Li S, 2014, DEV CELL, V29, P1, DOI 10.1016/j.devcel.2014.04.002; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; Mitoma Chikage, 2014, Fukuoka Acta Medica, V105, P166; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Renaud SJ, 2015, P NATL ACAD SCI USA, V112, pE6175, DOI 10.1073/pnas.1507397112; Roca H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076773; Sakurai T, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100180; Sakurai T, 2010, ENDOCRINOLOGY, V151, P5873, DOI 10.1210/en.2010-0458; Senfter Daniel, 2016, BioMolecular Concepts, V7, P311, DOI 10.1515/bmc-2016-0020; Shin SH, 2014, J INVEST DERMATOL, V134, P838, DOI 10.1038/jid.2013.421; Skarzynski DJ, 2000, BIOL REPROD, V62, P1116, DOI 10.1095/biolreprod62.5.1116; Talbot NC, 2000, BIOL REPROD, V62, P235, DOI 10.1095/biolreprod62.2.235; Wang ZW, 2010, CURR DRUG TARGETS, V11, P745, DOI 10.2174/138945010791170860; Watanabe K, 2014, DEV CELL, V29, P59, DOI 10.1016/j.devcel.2014.03.006; Wu CL, 2016, ONCOTARGET, V7, P26593, DOI 10.18632/oncotarget.8557; Yamakoshi S, 2012, REPRODUCTION, V143, P377, DOI 10.1530/REP-11-0364; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Yu OM, 2016, MOL CELL BIOL, V36, P39, DOI 10.1128/MCB.00772-15; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11459	39	23	24	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3371	3384		10.1096/fj.201701131RR	http://dx.doi.org/10.1096/fj.201701131RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29394105				2022-12-26	WOS:000432546000038
J	Soudahome, AG; Catan, A; Giraud, P; Kouao, SA; Guerin-Dubourg, A; Debussche, X; Le Moullec, N; Bourdon, E; Bravo, SB; Paradela-Dobarro, B; Alvarez, E; Meilhac, O; Rondeau, P; Couprie, J				Soudahome, Angelique Gajahi; Catan, Aurelie; Giraud, Pierre; Kouao, Sandrine Assouan; Guerin-Dubourg, Alexis; Debussche, Xavier; Le Moullec, Nathalie; Bourdon, Emmanuel; Bravo, Susana B.; Paradela-Dobarro, Beatriz; Alvarez, Ezequiel; Meilhac, Olivier; Rondeau, Philippe; Couprie, Joel			Glycation of human serum albumin impairs binding to the glucagon-like peptide-1 analogue liraglutide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC BINDING; FATTY-ACIDS; NONENZYMATIC GLYCOSYLATION; CRYSTAL-STRUCTURE; FLUORINE-NMR; CO-BINDING; INSULIN; METHYLGLYOXAL; CONFORMATION; PANCREATITIS	The long-acting glucagon-like peptide-1 analogue liraglutide has proven efficiency in the management of type 2 diabetes and also has beneficial effects on cardiovascular diseases. Liraglutide's protracted action highly depends on its capacity to bind to albumin via its palmitic acid part. However, in diabetes, albumin can undergo glycation, resulting in impaired drug binding. Our objective in this study was to assess the impact of human serum albumin (HSA) glycation on liraglutide affinity. Using fluorine labeling of the drug and F-19 NMR, we determined HSA affinity for liraglutide in two glycated albumin models. We either glycated HSA in vitro by incubation with glucose (G25- or G100-HSA) or methylglyoxal (MGO-HSA) or purified in vivo glycated HSA from the plasma of diabetic patients with poor glycemic control. Nonglycated commercial HSA (G0-HSA) and HSA purified from plasma of healthy individuals served as controls. We found that glycation decreases affinity for liraglutide by 7-fold for G100-HSA and by 5-fold for MGO-HSA compared with G0-HSA. A similarly reduced affinity was observed for HSA purified from diabetic individuals compared with HSA from healthy individuals. Our results reveal that glycation significantly impairs HSA affinity to liraglutide and confirm that glycation contributes to liraglutide's variable therapeutic efficiency, depending on diabetes stage. Because diabetes is a progressive disease, the effect of glycated albumin on liraglutide affinity found here is important to consider when diabetes is managed with this drug.	[Soudahome, Angelique Gajahi; Catan, Aurelie; Giraud, Pierre; Kouao, Sandrine Assouan; Bourdon, Emmanuel; Meilhac, Olivier; Rondeau, Philippe; Couprie, Joel] Univ La Reunion, INSERM, UMR Diabet Atherothrombose Therapie Reun Ocean In, F-97490 St Denis, La Reunion, France; [Guerin-Dubourg, Alexis] Ctr Hosp Gabriel Martin, Serv Cardiol & Biol, F-97866 St Paul, France; [Debussche, Xavier; Le Moullec, Nathalie] CHU La Reunion, Serv Endocrinol Nutr & Diabetol, F-97400 St Denis, La Reunion, France; [Debussche, Xavier; Le Moullec, Nathalie] CIC1410 INSERM, F-97448 St Pierre, Reunion, France; [Bravo, Susana B.; Paradela-Dobarro, Beatriz; Alvarez, Ezequiel] Hosp Clin Univ Santiago, Prote Unit, Santiago De Compostela 15706, Spain; [Bravo, Susana B.; Paradela-Dobarro, Beatriz; Alvarez, Ezequiel] Hosp Clin Univ Santiago, Inst Invest Sanitaria Santiago de Compostela IDIS, Santiago De Compostela 15706, Spain; [Paradela-Dobarro, Beatriz; Alvarez, Ezequiel] CIBERCV, Av Monforte de Lemos,3-5,Pabellon 11,Planta 0, Madrid 28029, Spain; [Meilhac, Olivier] CHU La Reunion, Ctr Invest Clin, F-97448 St Pierre, Reunion, France	Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion; CHU Reunion; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm)	Rondeau, P; Couprie, J (corresponding author), Univ La Reunion Plateforme CYROI, UMR DeTROI INSERM 1188, 2 Rue Maxime Riviere, F-97490 St Clotilde, France.	rophil@univ-reunion.fr; joel.couprie@univ-reunion.fr	rondeau, philippe/Q-1967-2019; Meilhac, Olivier/N-4385-2017; Bourdon, Emmanuel/P-8455-2019; Debussche, Xavier/S-8185-2016; Alvarez, Ezequiel/D-8822-2011; Lopez, Susana Belén Bravo/F-8487-2016	rondeau, philippe/0000-0002-4652-1376; Debussche, Xavier/0000-0003-3087-4297; Alvarez, Ezequiel/0000-0002-2381-8425; Lopez, Susana Belén Bravo/0000-0001-7615-3079; Bourdon, Emmanuel/0000-0003-3731-150X; Meilhac, Olivier/0000-0002-3740-7539; COUPRIE, Joel/0000-0002-1212-6773	Ministere de l'Enseignement Superieur et de la Recherche; Ministere de l'Outre-Mer; Conseil Regional de La Reunion; Universite de La Reunion; Federation Environnement Biodiversite Sante [FED4126]; regional council of La Reunion et l'Europe	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Ministere de l'Outre-Mer; Conseil Regional de La Reunion; Universite de La Reunion; Federation Environnement Biodiversite Sante; regional council of La Reunion et l'Europe	This work was supported by the Ministere de l'Enseignement Superieur et de la Recherche, the Ministere de l'Outre-Mer, the Conseil Regional de La Reunion and Europe, the Universite de La Reunion, and the Federation Environnement Biodiversite Sante-FED4126. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a fellowship from the regional council of La Reunion et l'Europe.	Abou-Zied OK, 2015, CURR PHARM DESIGN, V21, P1800, DOI 10.2174/1381612821666150304163447; Alves C, 2012, DIABETES RES CLIN PR, V98, P271, DOI 10.1016/j.diabres.2012.09.008; Anguizola J, 2016, J CHROMATOGR B, V1021, P175, DOI 10.1016/j.jchromb.2015.09.041; Anguizola J, 2013, CLIN CHIM ACTA, V425, P64, DOI 10.1016/j.cca.2013.07.013; Anguizola JA, 2013, CURR METABOL, V1, P241, DOI 10.2174/2213235X1130100005; Arntson KE, 2016, J MED CHEM, V59, P5158, DOI 10.1021/acs.jmedchem.5b01447; Bai X, 2012, MOLECULES, V17, P8782, DOI 10.3390/molecules17088782; Baraka-Vidot J., 2015, INT J DIABETES CLIN, V2, P109, DOI DOI 10.15344/2394-1499/2015/109; Baraka-Vidot J, 2012, BIOCHIMIE, V94, P1960, DOI 10.1016/j.biochi.2012.05.017; BERDE CB, 1979, J BIOL CHEM, V254, P391; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Bisgaard LS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168396; Bode B, 2012, DIABETES RES CLIN PR, V97, P27, DOI 10.1016/j.diabres.2011.12.015; Bouchi R, 2017, ENDOCR J, V64, P269, DOI 10.1507/endocrj.EJ16-0449; Cantero AV, 2007, FASEB J, V21, P3096, DOI 10.1096/fj.06-7536com; Cao BL, 2003, BIOORGAN MED CHEM, V11, P69, DOI 10.1016/S0968-0896(02)00324-3; Chalmer T, 2015, EXPERT OPIN DRUG SAF, V14, P171, DOI 10.1517/14740338.2015.975205; Cho HJ, 2007, PHARMACOGENOMICS, V8, P329, DOI 10.2217/14622416.8.4.329; Dalvit C, 2003, J AM CHEM SOC, V125, P7696, DOI 10.1021/ja034646d; Digilio G, 2014, EUR J MED CHEM, V79, P13, DOI 10.1016/j.ejmech.2014.03.064; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Fielding L, 2003, CURR TOP MED CHEM, V3, P39, DOI 10.2174/1568026033392705; Frederiksen TM, 2015, BIOPHYS J, V109, P1202, DOI 10.1016/j.bpj.2015.07.051; GARLICK RL, 1983, J BIOL CHEM, V258, P6142; Gerig J. T., 2001, FLUORINE NMR; Gupta Vishal, 2013, Indian J Endocrinol Metab, V17, P413, DOI 10.4103/2230-8210.111625; Iacobellis G, 2017, OBESITY, V25, P311, DOI 10.1002/oby.21718; International Diabetes Federation, 2015, INT DIAB FED DIAB AT; JENKINS BG, 1991, LIFE SCI, V48, P1227, DOI 10.1016/0024-3205(91)90517-F; JENKINS BG, 1990, MOL PHARMACOL, V37, P111; JOHNSON RN, 1983, CLIN CHIM ACTA, V127, P87, DOI 10.1016/0009-8981(83)90078-5; Jonas DE, 2009, TRENDS PHARMACOL SCI, V30, P375, DOI 10.1016/j.tips.2009.05.001; Jovanovic VB, 2013, ANAL BIOCHEM, V439, P17, DOI 10.1016/j.ab.2013.03.033; Kitamura K, 2007, ANAL BIOANAL CHEM, V387, P2843, DOI 10.1007/s00216-007-1162-x; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; Knudsen LB, 2010, ENDOCRINOLOGY, V151, P1473, DOI 10.1210/en.2009-1272; Kong X, 2014, J DIABETES, V6, P535, DOI 10.1111/1753-0407.12160; Kurtzhals P, 1995, BIOCHEM J, V312, P725, DOI 10.1042/bj3120725; Lau J, 2015, J MED CHEM, V58, P7370, DOI 10.1021/acs.jmedchem.5b00726; Li Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep18039; Madsen K, 2007, J MED CHEM, V50, P6126, DOI 10.1021/jm070861j; Maessen DEM, 2015, CLIN SCI, V128, P839, DOI 10.1042/CS20140683; Mera K, 2008, ANN NY ACAD SCI, V1126, P155, DOI 10.1196/annals.1433.000; Raya PM, 2014, ENDOCRINOL NUTR, V61, P202, DOI 10.1016/j.endonu.2013.09.001; Paradela-Dobarro B, 2016, J MOL ENDOCRINOL, V56, P23, DOI 10.1530/JME-15-0031; Patche J, 2017, FREE RADICAL BIO MED, V102, P133, DOI 10.1016/j.freeradbiomed.2016.11.026; Peters Jr. T., 1995, ALL ALBUMIN BIOCH GE; Peters KR, 2013, AM J THER, V20, P178, DOI 10.1097/MJT.0b013e3182204c16; Peterson GE, 2010, INT J CLIN PRACT, V64, P35, DOI 10.1111/j.1742-1241.2010.02498.x; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; Rehman MT, 2014, MOL PHARMACEUT, V11, P1785, DOI 10.1021/mp500116c; Rondeau P, 2008, FREE RADICAL BIO MED, V45, P799, DOI 10.1016/j.freeradbiomed.2008.06.004; Rondeau P, 2011, BIOCHIMIE, V93, P645, DOI 10.1016/j.biochi.2010.12.003; Ryan GJ, 2011, CLIN THER, V33, P793, DOI 10.1016/j.clinthera.2011.06.004; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; SHAKLAI N, 1984, J BIOL CHEM, V259, P3812; Shikii K, 2004, ANAL SCI, V20, P1475, DOI 10.2116/analsci.20.1475; Simard JR, 2005, P NATL ACAD SCI USA, V102, P17958, DOI 10.1073/pnas.0506440102; Sonderby P., 2016, THESIS; Song SO, 2015, DIABETES THER, V6, P547, DOI 10.1007/s13300-015-0140-0; Steensgaard DB, 2008, DIABETES, V57, pA164; Suji G, 2008, PROTEIN J, V27, P205, DOI 10.1007/s10930-008-9126-3; Thornalley PJ, 2005, ANN NY ACAD SCI, V1043, P111, DOI 10.1196/annals.1333.014; Verdier L, 2000, J CHEM SOC PERK T 2, P2363, DOI 10.1039/b007666j; Vlassara H, 1996, DIABETES, V45, pS65, DOI 10.2337/diab.45.3.S65; Wang Y, 2015, MOL PHARMACEUT, V12, P411, DOI 10.1021/mp500519s; Whittingham JL, 1997, BIOCHEMISTRY-US, V36, P2826, DOI 10.1021/bi9625105; Wu D, 2016, J PHARMACEUT BIOMED, V129, P15, DOI 10.1016/j.jpba.2016.06.034; Yamazaki E, 2005, J BIOSCIENCES, V30, P475, DOI 10.1007/BF02703721; Zhuang JQ, 2013, AAPS J, V15, P477, DOI 10.1208/s12248-013-9455-9	70	14	14	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4778	4791		10.1074/jbc.M117.815274	http://dx.doi.org/10.1074/jbc.M117.815274			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29414771	Green Published, hybrid			2022-12-26	WOS:000428848300019
J	Rickert, C; Luer, K; Vef, O; Technau, GM				Rickert, Christof; Lueer, Karin; Vef, Olaf; Technau, Gerhard M.			Progressive derivation of serially homologous neuroblast lineages in the gnathal CNS of Drosophila	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GANGLION MOTHER CELLS; EMBRYONIC CNS; GENE-EXPRESSION; IDENTIFIED NEUROBLASTS; MOLECULAR MARKERS; BRAIN-DEVELOPMENT; HOMEOBOX GENES; INSECT BRAIN; MELANOGASTER	Along the anterior-posterior axis the central nervous system is subdivided into segmental units (neuromeres) the composition of which is adapted to their region-specific functional requirements. In Drosophila melanogaster each neuromere is formed by a specific set of identified neural stem cells (neuroblasts, NBs). In the thoracic and anterior abdominal region of the embryonic ventral nerve cord segmental sets of NBs resemble the ground state (2nd thoracic segment, which does not require input of homeotic genes), and serial (segmental) homologs generate similar types of lineages. The three gnathal head segments form a transitional zone between the brain and the ventral nerve cord. It has been shown recently that although all NBs of this zone are serial homologs of NBs in more posterior segments, they progressively differ from the ground state in anterior direction (labial > maxillary > mandibular segment) with regard to numbers and expression profiles. To study the consequences of their derived characters we traced the embryonic lineages of gnathal NBs using the Flybow and Dil-labelling techniques. For a number of clonal types serial homology is rather clearly reflected by their morphology (location and projection patterns) and cell specific markers, despite of reproducible segment-specific differences. However, many lineages, particularly in the mandibular segment, show a degree of derivation that impedes their assignment to ground state serial homologs. These findings demonstrate that differences in gene expression profiles of gnathal NBs go along with anteriorly directed progressive derivation in the composition of their lineages. Furthermore, lineage sizes decrease from labial to mandibular segments, which in concert with decreasing NB-numbers lead to reduced volumes of gnathal neuromeres, most significantly in the mandibular segment.	[Rickert, Christof; Lueer, Karin; Vef, Olaf; Technau, Gerhard M.] Johannes Gutenberg Univ Mainz, Inst Dev Biol & Neurobiol, JJ Becherweg 32, Mainz, Germany	Johannes Gutenberg University of Mainz	Rickert, C; Technau, GM (corresponding author), Johannes Gutenberg Univ Mainz, Inst Dev Biol & Neurobiol, JJ Becherweg 32, Mainz, Germany.	rickert@uni-mainz.de; technau@uni-mainz.de			German Research Foundation (DFG) [TE 130/10-2]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (DFG) to GMT (Grant TE 130/10-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgardt M, 2014, DEV CELL, V30, P192, DOI 10.1016/j.devcel.2014.06.021; Baumgardt M, 2009, CELL, V139, P969, DOI 10.1016/j.cell.2009.10.032; Becker H, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005961; Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372; Birkholz O, 2015, BIOL OPEN, V4, P420, DOI 10.1242/bio.201411072; Birkholz O, 2013, DEVELOPMENT, V140, P1830, DOI 10.1242/dev.090043; Bivik C, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005984; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; BOSSING T, 1994, DEVELOPMENT, V120, P1895; Boyan G, 2003, ARTHROPOD STRUCT DEV, V32, P61, DOI 10.1016/S1467-8039(03)00037-9; BROADUS J, 1995, MECH DEVELOP, V53, P393, DOI 10.1016/0925-4773(95)00454-8; Cobeta IM, 2017, CURR BIOL, V27, P1161, DOI 10.1016/j.cub.2017.03.023; De Graeve F, 2004, DEV BIOL, V270, P122, DOI 10.1016/j.ydbio.2004.02.014; Dittrich R, 1997, DEVELOPMENT, V124, P2515; DOE CQ, 1992, DEVELOPMENT, V116, P855; Flood TF, 2013, NATURE, V499, P83, DOI 10.1038/nature12208; FRASCH M, 1987, GENE DEV, V1, P981, DOI 10.1101/gad.1.9.981; Friedrich J, 2016, CELL REP, V14, P850, DOI 10.1016/j.celrep.2015.12.077; Fujioka M, 2003, DEVELOPMENT, V130, P5385, DOI 10.1242/dev.00770; Gendre N, 2004, DEVELOPMENT, V131, P83, DOI 10.1242/dev.00879; Gunnar E, 2016, DEVELOPMENT, V143, P3774, DOI 10.1242/dev.139998; Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI 10.1038/NMETH.1567; HARTENSTEIN V, 1985, ROUX ARCH DEV BIOL, V194, P213; HARTENSTEIN V, 1984, ROUX ARCH DEV BIOL, V193, P308, DOI 10.1007/BF00848159; Hartenstein V, 2017, J COMP NEUROL; Higashijima S, 1996, DEVELOPMENT, V122, P527; Hirth F, 1998, DEVELOPMENT, V125, P1579; Huckesfeld S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135011; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Jagla K, 1997, DEVELOPMENT, V124, P91; Karlsson D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000368; Kendroud S, 2017, J COMP NEUROL; Kuert PA, 2014, DEV BIOL, V390, P102, DOI 10.1016/j.ydbio.2014.03.021; Lacin H, 2016, ELIFE, V5, DOI 10.7554/eLife.13399; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Nassif C, 1998, J COMP NEUROL, V402, P10; Page DT, 2004, EVOL DEV, V6, P25, DOI 10.1111/j.1525-142X.2004.04003.x; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Peterson C, 2002, DEVELOPMENT, V129, P1467; PROKOP A, 1991, DEVELOPMENT, V111, P79; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; Rogulja-Ortmann A, 2007, DEVELOPMENT, V134, P105, DOI 10.1242/dev.02707; Ruiz S, 2010, GENE EXPR PATTERNS, V10, P274, DOI 10.1016/j.gep.2010.06.001; Schmid A, 1999, DEVELOPMENT, V126, P4653; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Shimosako N, 2014, METHODS MOL BIOL, V1082, P57, DOI 10.1007/978-1-62703-655-9_4; SKEATH JB, 1995, NATURE, V376, P427, DOI 10.1038/376427a0; Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2; Technau GM, 2014, J NEUROGENET, V28, P171, DOI 10.3109/01677063.2013.868459; TECHNAU GM, 1985, ROUX ARCH DEV BIOL, V194, P196; Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; UDOLPH G, 1993, DEVELOPMENT, V118, P765; Urbach R, 2003, DEVELOPMENT, V130, P3589, DOI 10.1242/dev.00528; Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533; Urbach R, 2003, DEVELOPMENT, V130, P3607, DOI 10.1242/dev.00532; Urbach R, 2016, DEVELOPMENT, V143, P1290, DOI 10.1242/dev.133546; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Wreden CC, 2017, CURR BIOL, V27, P1521, DOI 10.1016/j.cub.2017.04.024; YounossiHartenstein A, 1996, J COMP NEUROL, V370, P313, DOI 10.1002/(SICI)1096-9861(19960701)370:3<313::AID-CNE3>3.0.CO;2-7	65	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191453	10.1371/journal.pone.0191453	http://dx.doi.org/10.1371/journal.pone.0191453			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415052	gold, Green Published, Green Submitted			2022-12-26	WOS:000424325300028
J	Saavedra, I; Amo, L				Saavedra, Irene; Amo, Luisa			Insectivorous birds eavesdrop on the pheromones of their prey	PLOS ONE			English	Article							VOLE SCENT MARKS; DIMETHYL SULFIDE; OLFACTORY NAVIGATION; OPEROPHTERA-BRUMATA; ODOR RECOGNITION; KIN RECOGNITION; SEX-PHEROMONE; WINTER MOTH; PREDATION; TITS	Chemical cues play a fundamental role in mate attraction and mate choice. Lepidopteran females, such as the winter moth (Operophtera brumata), emit pheromones to attract males in the reproductive period. However, these chemical cues could also be eavesdropped by predators. To our knowledge, no studies have examined whether birds can detect pheromones of their prey. O. brumata adults are part of the winter diet of some insectivorous tit species, such as the great tit (Parus major) and blue tit (Cyanistes caeruleus). We performed a field experiment aimed to disentangle whether insectivorous birds can exploit the pheromones emitted by their prey for prey location. We placed artificial larvae and a dispenser on branches of Pyrenean oak trees (Quercus pyrenaica). In half of the trees we placed an O. brumata pheromone dispenser and in the other half we placed a control dispenser. We measured the predation rate of birds on artificial larvae. Our results show that more trees had larvae with signs of avian predation when they contained an O. brumata pheromone than when they contained a control dispenser. Furthermore, the proportion of artificial larvae with signs of avian predation was greater in trees that contained the pheromone than in control trees. Our results indicate that insectivorous birds can exploit the pheromones emitted by moth females to attract males, as a method of prey detection. These results highlight the potential use of insectivorous birds in the biological control of insect pests.	[Saavedra, Irene; Amo, Luisa] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Saavedra, I (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, Madrid, Spain.	irene.saavedra.garces@gmail.com	Amo, Luisa/K-5960-2014; Saavedra, Irene/AAA-4640-2021	Amo, Luisa/0000-0003-4621-3493; 	Ministry of Economy and Competitiveness [CGL2014-58890-P]; FPI grant from Spanish Ministry of Economy and Competitiveness; Ramon y Cajal programme	Ministry of Economy and Competitiveness; FPI grant from Spanish Ministry of Economy and Competitiveness; Ramon y Cajal programme(Spanish Government)	This work was supported by the Ministry of Economy and Competitiveness (CGL2014-58890-P).; We especially thank L.M. Carrascal for statistical advice and I. Lopez Rull for spectral measurements. We also thank Jose Luis Viejo Montesinos for entomological information and the Oficina Comarcal Agroambiental-Comarca del Jiloca for their help with O. brumata phenology. I. Saavedra was supported by a FPI grant from Spanish Ministry of Economy and Competitiveness. L. Amo was supported by Ramon y Cajal programme.	Alma P. J., 1970, Entomologist's mon. Mag., V105, P258; Amo L, 2008, FUNCT ECOL, V22, P289, DOI 10.1111/j.1365-2435.2007.01361.x; Amo L, 2004, J HERPETOL, V38, P451, DOI 10.1670/177-03N; Amo L, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2281-9; Amo L, 2013, ECOL LETT, V16, P1348, DOI 10.1111/ele.12177; Amo L, 2013, MAR ECOL PROG SER, V474, P277, DOI 10.3354/meps10081; Amo L, 2012, ANIM BEHAV, V84, P1483, DOI 10.1016/j.anbehav.2012.09.021; Amo L, 2012, J ANIM ECOL, V81, P605, DOI 10.1111/j.1365-2656.2011.01940.x; Amo L, 2011, ARDEA, V99, P177, DOI 10.5253/078.099.0207; [Anonymous], 2014, PHEROMONES ANIMAL BE; ASKENMO C, 1977, OIKOS, V28, P90, DOI 10.2307/3543327; BESTMANN HJ, 1982, TETRAHEDRON LETT, V23, P4007, DOI 10.1016/S0040-4039(00)88681-5; BETTS MM, 1955, J ANIM ECOL, V24, P282, DOI 10.2307/1715; Bonadonna F, 2004, ANIM BEHAV, V67, P893, DOI 10.1016/j.anbehav.2003.08.013; Bonadonna F, 2004, SCIENCE, V306, P835, DOI 10.1126/science.1103001; Bonadonna F, 2012, ANIM BEHAV, V84, P509, DOI 10.1016/j.anbehav.2012.06.014; Bradbury Jack W., 1998, pi; Carde R. T., 1984, CHEM ECOLOGY INSECTS, P355, DOI DOI 10.1007/978-1-4899-3368-3_13; Caro SP, 2015, HORM BEHAV, V68, P25, DOI 10.1016/j.yhbeh.2014.06.001; Coffin HR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025002; COWIE RJ, 1988, J ANIM ECOL, V57, P611, DOI 10.2307/4928; Cross JV, 1999, BIOCONTROL SCI TECHN, V9, P125, DOI 10.1080/09583159929721; Cunningham GB, 2008, J EXP BIOL, V211, P3123, DOI 10.1242/jeb.018325; Cunningham SJ, 2009, ANIM BEHAV, V78, P899, DOI 10.1016/j.anbehav.2009.07.015; CUSHING BS, 1984, ANIM BEHAV, V32, P1263, DOI 10.1016/S0003-3472(84)80250-X; Darwin Charles, 1871, DESCENT MAN; Eichholz MW, 2012, AUK, V129, P638, DOI 10.1525/auk.2012.12040; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; GRAVES GR, 1992, J RAPTOR RES, V26, P38; Gunnarsson B, 1996, J ANIM ECOL, V65, P389, DOI 10.2307/5885; Gwinner H, 2008, ANIM BEHAV, V75, P971, DOI 10.1016/j.anbehav.2007.08.008; Hagelin JC, 2004, IBIS, V146, P161, DOI 10.1111/j.1474-919X.2004.00212.x; Harari AR, 2011, EVOLUTION, V65, P1572, DOI 10.1111/j.1558-5646.2011.01252.x; HEPPNER J B, 1991, Tropical Lepidoptera, V2, P11; HOUSTON DC, 1986, CONDOR, V88, P318, DOI 10.2307/1368878; Hughes NK, 2012, ECOL LETT, V15, P1326, DOI 10.1111/j.1461-0248.2012.01856.x; Hughes NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013114; JAIN SC, 1983, J ORG CHEM, V48, P2274, DOI 10.1021/jo00161a026; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; Koivula M, 1999, J AVIAN BIOL, V30, P329, DOI 10.2307/3677362; Koski TM, 2015, ETHOLOGY, V121, P1131, DOI 10.1111/eth.12426; Krause ET, 2012, BIOL LETTERS, V8, P327, DOI 10.1098/rsbl.2011.1093; Krebs JR, 1983, BEHAV ECOLOGY EVOLUT, P380; Mantyla E, 2004, ECOL LETT, V7, P915, DOI 10.1111/j.1461-0248.2004.00653.x; Mantyla E, 2017, J ORNITHOL, V158, P479, DOI 10.1007/s10336-016-1412-9; Mantyla E, 2014, ARTHROPOD-PLANT INTE, V8, P143, DOI 10.1007/s11829-014-9296-1; Mantyla E, 2011, OECOLOGIA, V165, P143, DOI 10.1007/s00442-010-1774-2; Mantyla E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002832; MARQUIS RJ, 1994, ECOLOGY, V75, P2007, DOI 10.2307/1941605; MCNEIL JN, 1991, ANNU REV ENTOMOL, V36, P407, DOI 10.1146/annurev.en.36.010191.002203; Mennerat A, 2008, BEHAV PROCESS, V79, P189, DOI 10.1016/j.beproc.2008.07.003; Mihailova M, 2014, ANIM BEHAV, V95, P155, DOI 10.1016/j.anbehav.2014.07.012; Minguez E, 1997, ANIM BEHAV, V53, P701, DOI 10.1006/anbe.1996.0308; Mols CMM, 2002, J APPL ECOL, V39, P888, DOI 10.1046/j.1365-2664.2002.00761.x; Mooney KA, 2010, P NATL ACAD SCI USA, V107, P7335, DOI 10.1073/pnas.1001934107; Mrazova A, 2018, ARTHROPOD-PLANT INTE, V12, P1, DOI 10.1007/s11829-017-9558-9; Muiruri EW, 2016, OECOLOGIA, V180, P619, DOI 10.1007/s00442-015-3391-6; Naef-Daenzer B, 1999, J ANIM ECOL, V68, P708, DOI 10.1046/j.1365-2656.1999.00318.x; NEVITT GA, 1995, NATURE, V376, P680, DOI 10.1038/376680ao; Nevitt GA, 2005, BIOL LETT-UK, V1, P303, DOI 10.1098/rsbl.2005.0350; Petit C, 2002, ECOL LETT, V5, P585, DOI 10.1046/j.1461-0248.2002.00361.x; Posa MRC, 2007, J TROP ECOL, V23, P27, DOI 10.1017/S0266467406003671; Probst R, 2002, J AVIAN BIOL, V33, P437, DOI 10.1034/j.1600-048X.2002.02760.x; R Core Team, 2013, R LANG ENV STAT COMP; Remmel T, 2011, BIOL J LINN SOC, V104, P1, DOI 10.1111/j.1095-8312.2011.01721.x; Richards LA, 2007, OIKOS, V116, P31, DOI 10.1111/j.2006.0030-1299.15043.x; ROELOFS WL, 1982, SCIENCE, V217, P657, DOI 10.1126/science.217.4560.657; Roth TC, 2008, ANIM BEHAV, V76, P2021, DOI 10.1016/j.anbehav.2008.08.022; Sam K, 2015, ECOGRAPHY, V38, P293, DOI 10.1111/ecog.00979; Sipura M, 1999, OECOLOGIA, V121, P537, DOI 10.1007/s004420050960; Soria S., 1987, LEPIDOPTEROS DEFOLIA, P79; STAGER KE, 1967, AM ZOOL, V7, P415; Stauss MJ, 2005, J AVIAN BIOL, V36, P47, DOI 10.1111/j.0908-8857.2005.02855.x; Sundell J, 2003, OIKOS, V101, P615, DOI 10.1034/j.1600-0706.2003.12264.x; Tvardikova K, 2012, J TROP ECOL, V28, P331, DOI 10.1017/S0266467412000235; Van Bael SA, 2003, P NATL ACAD SCI USA, V100, P8304, DOI 10.1073/pnas.1431621100; Vel'ky M, 2011, FOLIA ZOOL, V60, P228, DOI 10.25225/fozo.v60.i3.a7.2011; VIITALA J, 1995, NATURE, V373, P425, DOI 10.1038/373425a0; Wallraff HG, 2004, ANIM BEHAV, V67, P189, DOI 10.1016/j.anbehav.2003.06.007; WENZEL BM, 1968, NATURE, V220, P1133, DOI 10.1038/2201133a0; Whittaker DJ, 2011, BEHAV ECOL, V22, P1256, DOI 10.1093/beheco/arr122; WOOD DL, 1982, ANNU REV ENTOMOL, V27, P411, DOI 10.1146/annurev.en.27.010182.002211; Yang SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116168; Yew JY, 2015, PROG LIPID RES, V59, P88, DOI 10.1016/j.plipres.2015.06.001; Ylonen H, 2003, ECOLOGY, V84, P1447, DOI 10.1890/0012-9658(2003)084[1447:WMNNPF]2.0.CO;2; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zahavi A, 1997, HANDICAP PRINCIPLE M; Zampiga E, 2006, J AVIAN BIOL, V37, P318, DOI 10.1111/j.2006.0908-8857.03825.x; Zidar J, 2012, ANIM BEHAV, V84, P547, DOI 10.1016/j.anbehav.2012.06.006; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	90	18	19	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0190415	10.1371/journal.pone.0190415	http://dx.doi.org/10.1371/journal.pone.0190415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414994	Green Published, Green Submitted, gold			2022-12-26	WOS:000424325300008
J	Wu, CY; Hu, HY; Li, CP; Chou, YJ; Chang, YT				Wu, Chen-Yi; Hu, Hsiao-Yun; Li, Chung-Pin; Chou, Yiing-Jeng; Chang, Yun-Ting			Comorbidity profiles of psoriasis in Taiwan: A latent class analysis	PLOS ONE			English	Article							NUTRITION-EXAMINATION-SURVEY; POPULATION-BASED COHORT; FATTY LIVER-DISEASE; METABOLIC SYNDROME; NATIONAL-HEALTH; RISK; PREVALENCE; ASSOCIATION; DEPRESSION; ARTHRITIS	Background Psoriasis is associated with many comorbidities. An understanding of these comorbidity patterns can help foster better care of patients with psoriasis. Objective To identify the heterogeneity of psoriasis comorbidities using latent class analysis (LCA). Methods LCA was used to empirically identify psoriasis comorbidity patterns in a nationwide sample of 110,729 incident cases of psoriasis (2002-2012) from the National Health Insurance database in Taiwan. Results The mean age of incident psoriasis was 46.1 years. Hypertension (28.8%), dyslipidemia (18.9%), and chronic liver disease/cirrhosis/hepatitis (18.1%) were the top three comorbidities in patients with psoriasis. LCA identified four distinct comorbidity classes among these patients, including 9.9% of patients in the "multi-comorbidity" class, 17.9% in the "metabolic syndrome" class, 11.3% in the "hypertension and chronic obstructive pulmonary disease (COPD)" class, and 60.9% in the "relatively healthy" class. Psoriatic arthritis was evenly distributed among each class. Relative to membership in the "relative healthy" class, an increase of one year of age had a higher probability of membership in the "multi-comorbidity" (odds ratio [OR], 1.25), "metabolic syndrome" (OR, 1.11), or "hypertension and COPD" (OR, 1.34) classes. Relative to membership in the "relative healthy" class, compared to women, men had a higher probability of membership in the "multi-comorbidity" (OR, 1.39), "metabolic syndrome" (OR, 1.77), or "hypertension and COPD" (OR, 1.22) classes. Conclusion We observed four distinct classes of psoriasis comorbidities, including the "multi-comorbidity", "metabolic syndrome", "hypertension and COPD", and "relatively healthy" classes, as well as the clustering of liver diseases with metabolic syndrome and clustering of COPD with hypertension.	[Wu, Chen-Yi; Chang, Yun-Ting] Taipei Vet Gen Hosp, Dept Dermatol, Taipei, Taiwan; [Wu, Chen-Yi; Hu, Hsiao-Yun; Chou, Yiing-Jeng] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Wu, Chen-Yi; Hu, Hsiao-Yun; Chou, Yiing-Jeng] Natl Yang Ming Univ, Dept Publ Hlth, Taipei, Taiwan; [Wu, Chen-Yi; Chang, Yun-Ting] Natl Yang Ming Univ, Dept Dermatol, Taipei, Taiwan; [Hu, Hsiao-Yun] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Li, Chung-Pin] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Li, Chung-Pin] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Wu, CY (corresponding author), Taipei Vet Gen Hosp, Dept Dermatol, Taipei, Taiwan.; Wu, CY (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.; Wu, CY (corresponding author), Natl Yang Ming Univ, Dept Publ Hlth, Taipei, Taiwan.; Wu, CY (corresponding author), Natl Yang Ming Univ, Dept Dermatol, Taipei, Taiwan.	chenyiok@gmail.com			Ministry of Science and Technology [MOST 104-2314-6-075-044-MY2]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by a grant from Ministry of Science and Technology (MOST 104-2314-6-075-044-MY2).	Armstrong AW, 2013, J HYPERTENS, V31, P433, DOI 10.1097/HJH.0b013e32835bcce1; Boehncke S, 2007, BRIT J DERMATOL, V157, P1249, DOI 10.1111/j.1365-2133.2007.08190.x; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chiu HY, 2015, BRIT J DERMATOL, V173, P146, DOI 10.1111/bjd.13599; Cohen BE, 2016, JAMA DERMATOL, V152, P73, DOI 10.1001/jamadermatol.2015.3605; Collins LM, 2010, LATEN CLASS LATENT T; Eder L, 2013, ANN RHEUM DIS, V72, P715, DOI 10.1136/annrheumdis-2012-201497; Evans-Polce R, 2016, ADDICT BEHAV, V53, P80, DOI 10.1016/j.addbeh.2015.10.010; Fitzpatrick KE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153447; Ganzetti G, 2016, WORLD J CARDIOL, V8, P120, DOI 10.4330/wjc.v8.i2.120; Gelfand JM, 2009, J INVEST DERMATOL, V129, P2411, DOI 10.1038/jid.2009.112; Husted JA, 2011, ARTHRIT CARE RES, V63, P1729, DOI 10.1002/acr.20627; Kim Y, 2016, J EPIDEMIOL, V26, P137, DOI 10.2188/jea.JE20150068; Kulkarni NM, 2015, PHARM BIOL, V53, P1110, DOI 10.3109/13880209.2014.960944; Lamb RC, 2016, BR J DERMATOL; Lanza ST DJ, LCA STATA PLUGIN USE; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Love TJ, 2011, ARCH DERMATOL, V147, P419, DOI 10.1001/archdermatol.2010.370; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Prodanovich S, 2009, ARCH DERMATOL, V145, P700, DOI 10.1001/archdermatol.2009.94; Raychaudhuri SP, 2001, J EUR ACAD DERMATOL, V15, P16, DOI 10.1046/j.1468-3083.2001.00192.x; Sommer DM, 2006, ARCH DERMATOL RES, V298, P321, DOI 10.1007/s00403-006-0703-z; Starfield B, 2006, ANN FAM MED, V4, P101, DOI 10.1370/afm.524; Tee SI, 2016, J EUR ACAD DERMATOL, V30, P1159, DOI 10.1111/jdv.13615; Tsai TF, 2011, J DERMATOL SCI, V63, P40, DOI 10.1016/j.jdermsci.2011.03.002; Ungprasert P, 2016, J DERMATOL TREAT, V27, P316, DOI 10.3109/09546634.2015.1107180; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; Wang JP, 2015, CANCER-AM CANCER SOC, V121, P1446, DOI 10.1002/cncr.29159; Wu CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130993; Yang YW, 2011, BRIT J DERMATOL, V165, P1037, DOI 10.1111/j.1365-2133.2011.10494.x	30	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192537	10.1371/journal.pone.0192537	http://dx.doi.org/10.1371/journal.pone.0192537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408915	Green Submitted, Green Published, gold			2022-12-26	WOS:000424302800079
J	Zhang, C; Ward, J; Dauch, JR; Tanzi, RE; Cheng, HT				Zhang, Can; Ward, Joseph; Dauch, Jacqueline R.; Tanzi, Rudolph E.; Cheng, Hsinlin T.			Cytokine-mediated inflammation mediates painful neuropathy from metabolic syndrome	PLOS ONE			English	Article							DIET-INDUCED OBESITY; INSULIN-RESISTANCE; MOUSE MODEL; IDIOPATHIC NEUROPATHY; PERIPHERAL-NERVE; INTERLEUKIN-10; INCREASES; MICE; PREVALENCE; EXPRESSION	Painful neuropathy (PN) is a prevalent condition in patients with metabolic syndrome (MetS). However, the pathogenic mechanisms of metabolic syndrome-associated painful neuropathy (MetSPN) remain unclear. In the current study, high-fat-fed mice (HF mice) were used to study MetSPN. HF mice developed MetS phenotypes, including increased body weight, elevated plasma cholesterol levels, and insulin resistance in comparison with control-fat-fed (CF) mice. Subsequently, HF mice developed mechanical allodynia and thermal hyperalgesia in hind paws after 8 wk of diet treatment. These pain behaviors coincided with increased densities of nociceptive epidermal nerve fibers and inflammatory cells such as Langerhans cells and macrophages in hind paw skin. To study the effect of MetS on profiles of cytokine expression in HF mice, we used a multiplex cytokine assay to study the protein expression of 12 pro-inflammatory and anti-inflammatory cytokines in dorsal root ganglion and serum samples. This method detected the elevated levels of proinflammatory cytokines, including tumor necrosis factor (TNF)-alpha, and interleukin (IL)-6, IL-1 beta as well as reduced anti-inflammatory IL-10 in lumbar dorsal root ganglia (LDRG) of HF mice. Intraperitoneal administration of IL-10 reduced the upregulation of pro-inflammatory cytokines and alleviated pain behaviors in HF mice without affecting MetS phenotypes. Our findings suggested targeting HF-induced cytokine dysregulation could be an effective strategy for treating MetSPN.	[Zhang, Can; Ward, Joseph; Tanzi, Rudolph E.; Cheng, Hsinlin T.] Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Dis, Dept Neurol, Genet & Aging Res Unit, Boston, MA 02114 USA; [Dauch, Jacqueline R.] Univ Michigan, Med Ctr, Dept Neurol, Ann Arbor, MI 48109 USA	Harvard University; Massachusetts General Hospital; University of Michigan System; University of Michigan	Cheng, HT (corresponding author), Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Dis, Dept Neurol, Genet & Aging Res Unit, Boston, MA 02114 USA.	htcheng@mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Cheng, Hsinlin/0000-0002-6309-7298	National Institute of Health [1K08NS061039]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HC received a K award (1K08NS061039) from National Institute of Health: https://www.nih.govt. The funder supported the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260; Burguillos Miguel A, 2013, Methods Mol Biol, V1041, P93, DOI 10.1007/978-1-62703-520-0_11; Callaghan BC, 2016, DIABETES CARE; Callaghan BC, 2012, THE COCHRANE DATABAS, V6; Callaghan B, 2015, NEUROLOGY, V85, P71, DOI 10.1212/WNL.0000000000001714; Callaghan B, 2013, ANN NEUROL, V74, P397, DOI 10.1002/ana.23986; Callaghan BC, 2016, DIABETES CARE, V39, P801, DOI 10.2337/dc16-0081; Casanova-Molla J, 2012, PAIN, V153, P982, DOI 10.1016/j.pain.2012.01.021; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cheng HT, 2012, NEUROBIOL DIS, V45, P280, DOI 10.1016/j.nbd.2011.08.011; Cheng HT, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-28; Cheng HT, 2009, J NEUROPATH EXP NEUR, V68, P1229, DOI 10.1097/NEN.0b013e3181bef710; Choi S.H., 2014, NATURE; Clausen BE, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23186; Cooper MA, 2016, JOURNAL OF THE PERIP; Dauch JR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-64; DeBoer MD, 2013, NUTRITION, V29, P379, DOI 10.1016/j.nut.2012.07.003; Della Vedova MC, 2016, NUTR METAB INSIGHTS, V9, P93, DOI 10.4137/NMI.S32907; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Dominguez LJ, 2016, CURR OPIN CLIN NUTR, V19, P5, DOI 10.1097/MCO.0000000000000243; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Fernandes MR, 2016, ACTA CIR BRAS, V31, P840, DOI [10.1590/S0102-865020160120000010, 10.1590/s0102-865020160120000010]; FEUGEAS JP, 1993, CR ACAD SCI III-VIE, V316, P1255; Galloway C, 2013, CYTOKINE, V63, P1, DOI 10.1016/j.cyto.2013.04.009; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Groover AL, 2013, PAIN; Guilford BL, 2013, EXP NEUROL, V248, P504, DOI 10.1016/j.expneurol.2013.07.016; Haase J, 2013, DIABETOLOGIA; Han L, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0010-y; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hofmann SR, 2012, CLIN IMMUNOL, V143, P116, DOI 10.1016/j.clim.2012.02.005; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Jin CC, 2013, J ALLERGY CLIN IMMUN, V132, P287, DOI 10.1016/j.jaci.2013.06.022; Jones Nick, 2010, Nat Rev Neurol, V6, P416, DOI 10.1038/nrneurol.2010.100; Kabashi E, 2008, J NEUROCHEM; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Lagrelius M, 2006, CYTOKINE, V33, P156, DOI 10.1016/j.cyto.2006.01.005; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Makker PGS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170814; McMillen TS, 2005, CIRCULATION, V111, P2798, DOI 10.1161/CIRCULATIONAHA.104.516278; Mietto BS, 2015, J NEUROSCI, V35, P16431, DOI 10.1523/JNEUROSCI.2119-15.2015; Milligan ED, 2005, EUR J NEUROSCI, V21, P2136, DOI 10.1111/j.1460-9568.2005.04057.x; Moalem G, 2005, NEUROSCIENCE, V134, P1399, DOI 10.1016/j.neuroscience.2005.05.046; Moalem G, 2006, BRAIN RES REV, V51, P240, DOI 10.1016/j.brainresrev.2005.11.004; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Nishimura Satoshi, 2009, Discov Med, V8, P55; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Oh SS, 2010, NEUROSCI LETT, V483, P127, DOI 10.1016/j.neulet.2010.07.076; Ozkul A, 2013, NEUROENDOCRINOL LETT, V34, P52; Padhi Tanmay, 2013, Indian J Dermatol, V58, P299, DOI 10.4103/0019-5154.113950; Paris MM, 1997, J INFECT DIS, V176, P1239, DOI 10.1086/514118; Richardson VR, 2013, IMMUNOBIOLOGY; Samson SL, 2014, ENDOCRIN METAB CLIN, V43, P1, DOI 10.1016/j.ecl.2013.09.009; Satoh-Asahara N, 2012, DIABETES CARE, V35, P2631, DOI 10.2337/dc12-0269; Shen KF, 2013, EXPERIMENTAL NEUROLO; Siau C, 2006, EXP NEUROL, V201, P507, DOI 10.1016/j.expneurol.2006.05.007; Singh AK, 2013, CURR OPIN NEPHROL HY, V22, P198, DOI 10.1097/MNH.0b013e32835dda78; Smith AG, 2008, J NEUROL SCI, V273, P25, DOI 10.1016/j.jns.2008.06.005; Smith AG, 2012, J PERIPHER NERV SYST, V17, P15, DOI 10.1111/j.1529-8027.2012.00390.x; Smith AG, 2006, J NEUROL SCI, V242, P9, DOI 10.1016/j.jns.2005.11.020; Srikanthan K, 2016, INT J MED SCI, V13, P25, DOI 10.7150/ijms.13800; Sullivan KA, 2007, NEUROBIOL DIS, V28, P276, DOI 10.1016/j.nbd.2007.07.022; Uski OJ, 2012, INHAL TOXICOL, V24, P952, DOI 10.3109/08958378.2012.742172; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Veresiu AI, 2015, J DIABETES COMPLICAT, V29, P644, DOI 10.1016/j.jdiacomp.2015.04.001; Vincent AM, 2009, DIABETES, V58, P2376, DOI 10.2337/db09-0047; Volz T, 2013, THE JOURNAL OF INVES; Wagner SL, 2014, BIOCHEMISTRY; WANG X, 2012, EXP DIABETES RES, V2012, DOI DOI 10.1155/2012/847246; Wang YP, 2012, J BIOMED RES, V26, P219, DOI 10.7555/JBR.26.20120013; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246	72	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192333	10.1371/journal.pone.0192333	http://dx.doi.org/10.1371/journal.pone.0192333			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408929	gold, Green Published, Green Submitted			2022-12-26	WOS:000424302800056
J	Laterza, C; Uoshima, N; Tornero, D; Wilhelmsson, U; Stokowska, A; Ge, RM; Pekny, M; Lindvall, O; Kokaia, Z				Laterza, Cecilia; Uoshima, Naomi; Tornero, Daniel; Wilhelmsson, Ulrika; Stokowska, Anna; Ge, Ruimin; Pekny, Milos; Lindvall, Olle; Kokaia, Zaal			Attenuation of reactive gliosis in stroke-injured mouse brain does not affect neurogenesis from grafted human iPSC-derived neural progenitors	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; ASTROCYTE ACTIVATION; ISCHEMIC-STROKE; CORTICAL-NEURONS; MICE DEFICIENT; DENTATE GYRUS; HUMAN CNS; VIMENTIN	Induced pluripotent stem cells (iPSCs) or their progeny, derived from human somatic cells, can give rise to functional improvements after intracerebral transplantation in animal models of stroke. Previous studies have indicated that reactive gliosis, which is associated with stroke, inhibits neurogenesis from both endogenous and grafted neural stem/progenitor cells (NSPCs) of rodent origin. Here we have assessed whether reactive astrocytes affect the fate of human iPSC-derived NSPCs transplanted into stroke-injured brain. Mice with genetically attenuated reactive gliosis (deficient for GFAP and vimentin) were subjected to cortical stroke and cells were implanted adjacent to the ischemic lesion one week later. At 8 weeks after transplantation, immunohistochemical analysis showed that attenuated reactive gliosis did not affect neurogenesis or commitment towards glial lineage of the grafted NSPCs. Our findings, obtained in a human-to-mouse xenograft experiment, provide evidence that the reactive gliosis in stroke-injured brain does not affect the formation of new neurons from intracortically grafted human iPSC-derived NSPCs. However, for a potential clinical translation of these cells in stroke, it will be important to clarify whether the lack of effect of reactive gliosis on neurogenesis is observed also in a human-to-human experimental setting.	[Laterza, Cecilia; Uoshima, Naomi; Tornero, Daniel; Ge, Ruimin; Lindvall, Olle; Kokaia, Zaal] Univ Hosp, Lund Stem Cell Ctr, Dept Clin Sci, Lab Stem Cells & Restorat Neurol, Lund, Sweden; [Uoshima, Naomi] Tokyo Med Univ, Dept Anesthesiol, Shinjuku Ku, Tokyo, Japan; [Wilhelmsson, Ulrika; Pekny, Milos] Univ Gothenburg, Sahlgrenska Acad, Ctr Brain Repair, Inst Neurosci & Physiol,Dept Clin Neurosci,Lab As, Gothenburg, Sweden; [Stokowska, Anna] Univ Gothenburg, Sahlgrenska Acad, Ctr Brain Repair, Inst Neurosci & Physiol,Dept Clin Neurosci,Lab Re, Gothenburg, Sweden	Lund University; Skane University Hospital; Tokyo Medical University; University of Gothenburg; University of Gothenburg	Kokaia, Z (corresponding author), Univ Hosp, Lund Stem Cell Ctr, Dept Clin Sci, Lab Stem Cells & Restorat Neurol, Lund, Sweden.	zaal.kokaia@med.lu.se	Laterza, Cecilia/ABG-6504-2021; Kokaia, Zaal/AAL-6009-2020; Tornero, Daniel/N-2049-2014; Laterza, Cecilia/AAP-7932-2020	Kokaia, Zaal/0000-0003-2296-2449; Tornero, Daniel/0000-0002-4812-4091; Wilhelmsson, Ulrika/0000-0003-3227-2687	Swedish Research Council; European Union project TargetBrain; AFA Foundation; Swedish Brain Foundation; Torsten Foundation; Ragnar Soderberg Foundation; Region Skane; Sparbanksstiftelsen Fars Frosta; Swedish Government Initiative for Strategic Research Areas (StemTherapy); Sten A. Olsson Foundation for Research and Culture; Hagstromer's Foundation Millennium; Amlov's Foundation; E. Jacobson's Donation Fund; Swedish Stroke Foundation; EuroCellNet COST Action [CM15214]	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union project TargetBrain; AFA Foundation; Swedish Brain Foundation; Torsten Foundation; Ragnar Soderberg Foundation; Region Skane; Sparbanksstiftelsen Fars Frosta; Swedish Government Initiative for Strategic Research Areas (StemTherapy); Sten A. Olsson Foundation for Research and Culture; Hagstromer's Foundation Millennium; Amlov's Foundation; E. Jacobson's Donation Fund; Swedish Stroke Foundation; EuroCellNet COST Action(European Cooperation in Science and Technology (COST))	This work was supported by the Swedish Research Council, European Union FP7 project TargetBrain, AFA Foundation, Swedish Brain Foundation, Torsten and Ragnar Soderberg Foundations, Region Skane, Sparbanksstiftelsen Fars & Frosta, Swedish Government Initiative for Strategic Research Areas (StemTherapy), Sten A. Olsson Foundation for Research and Culture, Hagstromer's Foundation Millennium, Amlov's Foundation, E. Jacobson's Donation Fund, Swedish Stroke Foundation, and EuroCellNet COST Action (CM15214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; BASS NH, 1971, J COMP NEUROL, V143, P481, DOI 10.1002/cne.901430405; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cavazzin C, 2006, GLIA, V53, P167, DOI 10.1002/glia.20256; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; Choudhury GR, 2016, NEUROBIOL DIS, V85, P234, DOI 10.1016/j.nbd.2015.05.003; Chow A, 2016, STEM CELL RES, V16, P79, DOI 10.1016/j.scr.2015.12.007; Culbreth ME, 2012, NEUROTOXICOLOGY, V33, P1499, DOI 10.1016/j.neuro.2012.05.012; Dallerac G, 2016, PROG NEUROBIOL, V144, P48, DOI 10.1016/j.pneurobio.2016.01.003; de Pablo Y, 2013, HISTOCHEM CELL BIOL, V140, P81, DOI 10.1007/s00418-013-1110-0; Ding M, 1998, MOL BRAIN RES, V62, P77, DOI 10.1016/S0169-328X(98)00240-X; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Galli R, 2000, DEV NEUROSCI-BASEL, V22, P86, DOI 10.1159/000017430; Gao ZW, 2013, MOL NEUROBIOL, V48, P690, DOI 10.1007/s12035-013-8460-4; George PM, 2015, NEURON, V87, P297, DOI 10.1016/j.neuron.2015.05.041; Gliem M, 2015, GLIA, V63, P2198, DOI 10.1002/glia.22885; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Igarashi Y, 1999, BIOCHEM BIOPH RES CO, V261, P108, DOI 10.1006/bbrc.1999.0992; Jarlestedt K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010397; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kokaia Z, 2017, PROG BRAIN RES, V231, P245, DOI 10.1016/bs.pbr.2016.11.013; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Larsson A, 2004, NEUROCHEM RES, V29, P2069, DOI 10.1007/s11064-004-6880-2; Laterza C, 2017, EXP NEUROL, V297, P129, DOI 10.1016/j.expneurol.2017.07.012; Lebkuechner I, 2015, J NEUROCHEM, V135, P234, DOI 10.1111/jnc.13213; LEUBA G, 1989, EXP BRAIN RES, V77, P31; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu ZW, 2016, PROG NEUROBIOL, V144, P103, DOI 10.1016/j.pneurobio.2015.09.008; Liu ZW, 2014, GLIA, V62, P2022, DOI 10.1002/glia.22723; Lu YB, 2011, FASEB J, V25, P624, DOI 10.1096/fj.10-163790; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Malik N, 2014, NEUROTOXICOLOGY, V45, P192, DOI 10.1016/j.neuro.2014.10.007; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Miller DW, 2004, NEURON GLIA BIOL, V1, P13, DOI 10.1017/s1740925x04000043; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Oki K, 2012, STEM CELLS, V30, P1120, DOI 10.1002/stem.1104; Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Perez-de Puig I, 2013, J CEREBR BLOOD F MET, V33, P1955, DOI 10.1038/jcbfm.2013.155; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Tornero D, 2017, BRAIN, V140, P692, DOI 10.1093/brain/aww347; Tornero D, 2013, BRAIN, V136, P3561, DOI 10.1093/brain/awt278; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; Verkhratsky A, 2012, ASN NEURO, V4, DOI 10.1042/AN20120010; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Widestrand A, 2007, STEM CELLS, V25, P2619, DOI 10.1634/stemcells.2007-0122; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Wilhelmsson U, 2012, STEM CELLS, V30, P2320, DOI 10.1002/stem.1196; Wunderlich KA, 2015, FASEB J, V29, P4815, DOI 10.1096/fj.15-272963; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	66	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192118	10.1371/journal.pone.0192118	http://dx.doi.org/10.1371/journal.pone.0192118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401502	Green Published, Green Submitted, gold			2022-12-26	WOS:000424101400037
J	Lei, CL; Dancause, KN; Elgbeili, G; Laplante, DP; Szyf, M; King, S				Lei Cao-Lei; Dancause, Kelsey N.; Elgbeili, Guillaume; Laplante, David P.; Szyf, Moshe; King, Suzanne			DNA methylation mediates the effect of maternal cognitive appraisal of a disaster in pregnancy on the child's C-peptide secretion in adolescence: Project Ice Storm	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR EXPRESSION; PRENATAL STRESS; NATURAL DISASTER; 51/2-YEAR-OLD CHILDREN; GLUCOSE-INTOLERANCE; GROWTH RESTRICTION; CENTRAL ADIPOSITY; HEALTH OUTCOMES; BIRTH OUTCOMES; ADULT DISEASE	Animal and human studies suggest that prenatal exposure to stress is associated with adverse health outcomes such as type 2 diabetes. Epigenetic modification, such as DNA methylation, is considered one possible underlying mechanism. The 1998 Quebec ice storm provides a unique opportunity to study an independent prenatal stressor on child outcomes. C-peptide is the best measure of endogenous insulin secretion and is widely used in the clinical management of patients with diabetes. The objectives of this study are to determine 1) the extent to which prenatal exposure to disaster-related stress (maternal objective hardship and maternal cognitive appraisal) influences children's C-peptide secretion, and 2) whether DNA methylation of diabetes-related genes mediates the effects of prenatal stress on C-peptide secretion. Children's (n = 30) C-peptide secretion in response to an oral glucose tolerance test were assessed in blood at 13 1/2 years. DNA methylation levels of selected type 1 and 2 diabetes-related genes were chosen based upon the genes associated with prenatal maternal objective hardship and/or cognitive appraisal levels. Bootstrapping analyses were performed to determine the mediation effect of DNA methylation. We found that children whose mothers experienced higher objective hardship exhibited higher C-peptide secretion. Cognitive appraisal was not directly associated with C-peptide secretion. DNA methylation of diabetes-related genes had a positive mediation effect of objective hardship on C-peptide secretion: higher objective hardship predicted higher C-peptide secretion through DNA methylation. Negative mediation effects of cognitive appraisal were observed: negative cognitive appraisal predicted higher C-peptide secretion through DNA methylation. However, only one gene, LTA, remained a significant mediator of cognitive appraisal on C-peptide secretion after the conservative Bonferroni multiple corrections. Our findings suggest that DNA methylation could act as an intervening variable between prenatal stress and metabolic outcomes, highlighting the importance of epigenetic mechanisms in response to environmental factors.	[Lei Cao-Lei; King, Suzanne] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Lei Cao-Lei; Elgbeili, Guillaume; Laplante, David P.; King, Suzanne] Douglas Hosp, Res Ctr, Montreal, PQ, Canada; [Dancause, Kelsey N.] Univ Quebec Montreal, Dept Phys Act Sci, Montreal, PQ, Canada; [Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Szyf, Moshe] McGill Univ, Sackler Program Epigenet & Dev Psychobiol, Montreal, PQ, Canada	McGill University; McGill University; University of Quebec; University of Quebec Montreal; McGill University; McGill University	King, S (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.; King, S (corresponding author), Douglas Hosp, Res Ctr, Montreal, PQ, Canada.	suzanne.king@mcgill.ca	King, Suzanne/AAM-8541-2020	King, Suzanne/0000-0003-3055-6846; Dancause, Kelsey/0000-0002-8677-9953; Laplante, David P./0000-0002-9723-1141	Canadian Institutes of Health Research (CIHR) [MOP-1150067]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant Number: MOP-1150067, Canadian Institutes of Health Research (CIHR):http://www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DIAB PUBL HLTH RES C; Balasubramanian P, 2015, AM J PHYSIOL-ENDOC M, V309, pE582, DOI 10.1152/ajpendo.00167.2015; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x; Braun J, 1998, EUR J CLIN INVEST, V28, P538; BROMET E, 1995, EPIDEMIOL REV, V17, P113, DOI 10.1093/oxfordjournals.epirev.a036166; Cao XJ, 2014, DEV PSYCHOBIOL, V56, P117, DOI 10.1002/dev.21085; Cao-Lei L, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.13; Cao-Lei L, 2016, CLIN EPIGENETICS, V8, P1; Cao-Lei L, 2016, EARLY HUM DEV, V103, P189, DOI 10.1016/j.earlhumdev.2016.09.013; Cao-Lei L, 2015, EPIGENETICS-US, V10, P749, DOI 10.1080/15592294.2015.1063771; CAOLEI L, 2014, PLOS ONE, V0009; Cleasby ME, 2003, EUR J ENDOCRINOL, V148, P129, DOI 10.1530/eje.0.1480129; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; Dancause KN, 2013, EARLY HUM DEV, V89, P773, DOI 10.1016/j.earlhumdev.2013.06.006; Dancause KN, 2011, EARLY HUM DEV, V87, P813, DOI 10.1016/j.earlhumdev.2011.06.007; Dancause KN, 2012, PEDIATR RES, V71, P126, DOI 10.1038/pr.2011.18; DiPietro JA, 2012, J ADOLESCENT HEALTH, V51, pS3, DOI 10.1016/j.jadohealth.2012.04.008; Drake AJ, 2007, CLIN SCI, V113, P219, DOI 10.1042/CS20070107; Entringer S, 2010, CURR OPIN ENDOCRINOL, V17, P507, DOI 10.1097/MED.0b013e3283405921; Entringer S, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.006; Eriksson JG, 2005, MATERN CHILD NUTR, V1, P149, DOI 10.1111/j.1740-8709.2005.00017.x; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Hayakawa T, 2000, METABOLISM, V49, P1506, DOI 10.1053/meta.2000.17710; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hollingshead A. B., 1973, 4 FACTOR INDEX SOCIA; Jones AG, 2013, DIABETIC MED, V30, P803, DOI 10.1111/dme.12159; King S, 2005, STRESS, V8, P35, DOI 10.1080/10253890500108391; King S., 2009, ANN BEHAV MED, V37, ps212; Laplante DP, 2008, J AM ACAD CHILD PSY, V47, P1063, DOI 10.1097/CHI.0b013e31817eec80; Laplante DP, 2003, STRESS PREGNANCY AFF; Laplante DP, 2002, BIENN INT C INF STUD; Lazinski M, 2008, ARCH WOMEN MENT HLTH, V11, P363, DOI 10.1007/s00737-008-0035-4; Lei CL, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0219-0; Lesage J, 2004, J ENDOCRINOL, V181, P291, DOI 10.1677/joe.0.1810291; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lindsay RS, 1996, DIABETOLOGIA, V39, P1299, DOI 10.1007/s001250050573; Liu GT, 2016, ENVIRON RES, V150, P1, DOI 10.1016/j.envres.2016.04.039; MCFARLANE AC, 1988, PSYCHOL MED, V18, P129, DOI 10.1017/S0033291700001963; Monk C, 2012, DEV PSYCHOPATHOL, V24, P1361, DOI 10.1017/S0954579412000764; Moss TJM, 2001, AM J PHYSIOL-REG I, V281, pR960, DOI 10.1152/ajpregu.2001.281.3.R960; Nieuwenhuizen AG, 2008, PHYSIOL BEHAV, V94, P169, DOI 10.1016/j.physbeh.2007.12.011; Nyirenda MJ, 1998, J CLIN INVEST, V101, P2174, DOI 10.1172/JCI1567; Risk Management Solutions Inc, 1998 IC STORM 10 YEA; Rondo PHC, 2003, EUR J CLIN NUTR, V57, P266, DOI 10.1038/sj.ejcn.1601526; SANDMAN CA, 1994, ANN NY ACAD SCI, V739, P198, DOI 10.1111/j.1749-6632.1994.tb19822.x; SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932; Statistics Canada, 1998, ST LAWR RIV VALL 199; Turcotte-Tremblay AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/201717; VENDRELL J, 1995, METABOLISM, V44, P691, DOI 10.1016/0026-0495(95)90177-9; Veru F, 2014, STRESS, V17, P133, DOI 10.3109/10253890.2013.876404; WADHWA PD, 1993, AM J OBSTET GYNECOL, V169, P858, DOI 10.1016/0002-9378(93)90016-C; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Zhu P, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.023	54	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192199	10.1371/journal.pone.0192199	http://dx.doi.org/10.1371/journal.pone.0192199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401509	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000424101400041
J	Joffe, M; Ayeni, O; Norris, SA; McCormack, VA; Ruff, P; Das, I; Neugut, AI; Jacobson, JS; Cubasch, H				Joffe, Maureen; Ayeni, Oluwatosin; Norris, Shane Anthony; McCormack, Valerie Ann; Ruff, Paul; Das, Ishani; Neugut, Alfred I.; Jacobson, Judith S.; Cubasch, Herbert			Barriers to early presentation of breast cancer among women in Soweto, South Africa	PLOS ONE			English	Article							DISPARITIES; CHALLENGES; HEALTH; BLACK; RISK; OPPORTUNITIES; EXPERIENCES; MORTALITY; KNOWLEDGE; FATALISM	Purpose Reported breast cancer incidence is rising in South Africa, where some women are diagnosed late and have poor outcomes. We studied patient and provider factors associated with clinical stage at diagnosis among women diagnosed at the Chris Hani Baragwanath Academic Hospital in Soweto, Johannesburg in 2015 +/- 2016. Methods From face-to-face interviewer-administered questionnaires we compared self-reported socioeconomics, demographics, comorbidities, risk factors, personal and health system barriers, and from patient clinical records, clinical staging, receptor subtype, and tumor grade among 499 consecutive women newly diagnosed with advanced stage (III/IV) breast cancer versus those diagnosed early (stage 0/I/II). Logistic regression models were used to identify factors associated with advanced stage at diagnosis. Results Among the women, 243 (49%) were diagnosed at early and 256 (51%) at advanced stages. In the multiple logistic regression adjusted model, completion of high school or beyond (odds ratio (OR) 0.59, and greater breast cancer knowledge and awareness (OR 0.86) were associated with lower stage of breast cancer at presentation. Advanced stage was associated with Luminal B (OR 2.25) and triple-negative subtypes (OR 3.17) compared to luminal A, with delays > 3 months from first breast symptoms to accessing the health system (OR 2.79) and with having more than 1 visit within the referral health system (OR 3.19) for 2 visits; OR 2.73 for >= 3 visits). Conclusions Limited patient education, breast cancer knowledge and awareness, and health system inefficiencies were associated with advanced stage at diagnosis. Sustained community and healthcare worker education may down-stage disease and improve cancer outcomes.	[Joffe, Maureen; Ayeni, Oluwatosin; Norris, Shane Anthony; Ruff, Paul; Cubasch, Herbert] Wits Hlth Consortium PTY Ltd, Noncommunicable Dis Res Div, Johannesburg, South Africa; [Joffe, Maureen; Norris, Shane Anthony] Univ Witwatersrand, Fac Hlth Sci, Dept Pediat, MRC Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [McCormack, Valerie Ann] Int Agcy Res Canc, Sect Environm & Radiat, Lyon, France; [Ruff, Paul] Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Div Med Oncol, Johannesburg, South Africa; [Das, Ishani; Neugut, Alfred I.] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Neugut, Alfred I.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY USA; [Neugut, Alfred I.; Jacobson, Judith S.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Cubasch, Herbert] Univ Witwatersrand, Fac Hlth Sci, Dept Surg, Johannesburg, South Africa	University of Witwatersrand; World Health Organization; International Agency for Research on Cancer (IARC); University of Witwatersrand; Columbia University; Columbia University; Columbia University; University of Witwatersrand	Joffe, M (corresponding author), Wits Hlth Consortium PTY Ltd, Noncommunicable Dis Res Div, Johannesburg, South Africa.; Joffe, M (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Pediat, MRC Dev Pathways Hlth Res Unit, Johannesburg, South Africa.	mjoffe@witshealth.co.za	Norris, Shane/C-4664-2014	Norris, Shane/0000-0001-7124-3788; McCormack, Valerie/0000-0001-7397-3442; Joffe, Maureen/0000-0001-8616-9672	NIH [NCI 1R01CA192627]; South African Medical Research Council /University of the Witwatersrand Common Epithelial Cancer Research Centre (MRC/WITS CECRC); Cancer Association of South Africa (CANSA); DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg, South Africa; Wits Health Consortium (PTY) Ltd; NATIONAL CANCER INSTITUTE [R01CA192627] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South African Medical Research Council /University of the Witwatersrand Common Epithelial Cancer Research Centre (MRC/WITS CECRC); Cancer Association of South Africa (CANSA); DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg, South Africa; Wits Health Consortium (PTY) Ltd; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant (NCI 1R01CA192627) http://grantome.com/grant/NIH/R01-CA192627-01 to Drs. Jacobson, Joffe, Neugut and Ruff; (ii) the South African Medical Research Council /University of the Witwatersrand Common Epithelial Cancer Research Centre (MRC/WITS CECRC) http://www.mrc.ac.za/epithelial/Epithelial.htm led by Dr. Ruff; and (iii) the Cancer Association of South Africa (CANSA) grant Down-staging and improving survival of breast cancer in South Africa http://www.cansa.org.za/down-staging-and-improving-survival-of-breast-cancer-in-sa-dr-herbert-cubasch(Dr Cubasch). Dr Norris is supported by the DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg, South Africa https://www.wits.ac.za/coe-human. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Wits Health Consortium (PTY) Ltd provided support in the form of payroll administration of salaries from grant funds for authors M Joffe, O Ayeni and S Norris, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	ADAY LA, 1974, EALTH SERV RES; AKUOKO CP, 2017, PLOS ONE, DOI DOI 10.1634/THEONCOLOGIST.2014-0493; Al-Naggar RA, 2011, ASIAN PAC J CANCER P, V12, P1173; [Anonymous], 2012, CANCER, V23, pvi7; [Anonymous], 2016, ONCOLOGIST; Arora NK, 2002, PATIENT EDUC COUNS, V47, P37, DOI 10.1016/S0738-3991(01)00170-7; Banegas MP, 2012, J WOMENS HEALTH, V21, P101, DOI 10.1089/jwh.2010.2638; Bird Y, 2011, J IMMIGR MINOR HEALT, V13, P867, DOI 10.1007/s10903-010-9418-5; Blackman DJ, 2006, J CLIN ONCOL, V24, P2170, DOI 10.1200/JCO.2005.05.4734; Brewster AM, 2014, LANCET ONCOL, V15, pE625, DOI 10.1016/S1470-2045(14)70364-X; Brinton LA, 2014, BREAST CANCER RES TR, V144, P467, DOI 10.1007/s10549-014-2868-z; BUSOLO DS, 2015, GLOB HEALTH PROMOT, DOI DOI 10.1089/JWH.2010.2638; CACALA SR, JOURNAL OF GLOBAL ON, P2; Cacala SR, 2017, CANCER EPIDEMIOL, V3, P497; *CANC S AFR, 2012, FULL REPORT, V2011, P1, DOI DOI 10.1111/TBJ.12369; Caplan L., 2014, BMC FAM PRACT, V2, P87; Caplan L, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00087; Champion VL, 2004, J HEALTH PSYCHOL, V9, P753, DOI 10.1177/1359105304045383; Champion VL, 1999, RES NURS HEALTH, V22, P341, DOI 10.1002/(SICI)1098-240X(199908)22:4<341::AID-NUR8>3.0.CO;2-P; Dietze EC, 2015, NAT REV CANCER, V15, P248, DOI 10.1038/nrc3896; Edge J, 2014, SAMJ S AFR MED J, V104, P377, DOI 10.7196/SAMJ.8249; Elzawawy A, 2015, WORLD J SURG, V39, P693, DOI 10.1007/s00268-014-2913-4; Eng A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001720; Facione NC, 2000, CANCER NURS, V23, P258, DOI 10.1097/00002820-200008000-00002; Ferlay J., 2015, INT J CANCER, V136, pE359; Forbes LJL, 2011, BRIT J CANCER, V105, P1474, DOI 10.1038/bjc.2011.406; Gerend MA, 2008, CANCER EPIDEM BIOMAR, V17, P2913, DOI 10.1158/1055-9965.EPI-07-0633; Grunfeld EA, 2002, BRIT J CANCER, V86, P1373, DOI 10.1038/sj.bjc.6600260; Guidry JJ, 2003, CANCER, V97, P318; HARFORD JB, 2011, BREAST S2, V20, pS2, DOI DOI 10.1016/S1470-2045(09)70335-3; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; JONES CE, 2014, BMJ OPEN, V4, P2, DOI DOI 10.1038/SJ.BJC.6605385; K, MIRANDA, DOI DOI 10.1002/CNCR.29331; Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006; Krok-Schoen JL, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00002; LAA Z, 2006, CANCER, V12, pS1; LAA Z, 2013, CANCER, DOI DOI 10.1007/S10903-010-9418-5; LAA Z, 2015, CANCER; LAA Z, 2011, CANCER; LAA Z, 1968, CANCER; LAA Z, CANCER; LAA Z, 1920, CANCER, DOI DOI 10.1186/1471-2296-14-197; LAA Z, 2003, CANCER, DOI DOI 10.7196/SAMJ.8249; Loerzel VW, 2005, FAM COMMUNITY HEALTH, V28, P79, DOI 10.1097/00003727-200501000-00010; McCormack VA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3478; Micklesfield LK, 2010, OBESITY, V18, P619, DOI 10.1038/oby.2009.292; Mousa SM, 2011, BREAST, V20, P555, DOI 10.1016/j.breast.2011.07.001; Murugan N, 2014, SAMJ S AFR MED J, V104, P380, DOI 10.7196/SAMJ.8243; Newman LA, 2015, BREAST J, V21, P133, DOI 10.1111/tbj.12369; Newman LA, 2014, SURG ONCOL CLIN N AM, V23, P579, DOI 10.1016/j.soc.2014.03.014; Ngo-Metzger Q, 2003, J GEN INTERN MED, V18, P44, DOI 10.1046/j.1525-1497.2003.20205.x; Pace LE, 2016, ONCOLOGIST, V21, P739, DOI 10.1634/theoncologist.2015-0429; Pace LE, 2015, ONCOLOGIST, V20, P780, DOI 10.1634/theoncologist.2014-0493; POWE BD, 1995, CANCER NURS, V18, P385; Remennick L, 2006, BREAST J, V12, pS103, DOI 10.1111/j.1075-122X.2006.00204.x; RoyakSchaler R, 1996, J CLIN PSYCHOL MED S, V3, P185, DOI 10.1007/BF01993905; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Shen LJ, 2009, PSYCHOL HEALTH, V24, P597, DOI 10.1080/08870440801902535; STORY H, 2011, INTERNATIONAL JOURNA, P2012; STUBBINGS S, 2009, BRITISH JOURNAL OF C, V2, P17, DOI DOI 10.1177/135910304045383; Talbert P. Y., 2008, J SOCIAL BEHAV HLTH, V2, P96, DOI DOI 10.5590/JSBHS.2008.02.1.07; Thomas VN, 2005, INT J PALLIAT NURS, V11, P562, DOI 10.12968/ijpn.2005.11.11.20096; WU TY, 2012, INTERNATIONAL JOURNA, P2012, DOI DOI 10.1200/JCO.2005.05.4734; Yedjou CG, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14050486; YIP CH, 2015, WORLD J SURG; Yip CH, 2012, FUTURE ONCOL, V8, P1575, DOI [10.2217/FON.12.141, 10.2217/fon.12.141]; 2012, ANNALS OF ONCOLOGY O, V6, pV17, DOI DOI 10.7196/SAMJ.8243	67	39	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192071	10.1371/journal.pone.0192071	http://dx.doi.org/10.1371/journal.pone.0192071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU7VI	29394271	gold, Green Published, Green Submitted			2022-12-26	WOS:000424060400024
J	Earwaker, P; Anderson, C; Willenbrock, F; Harris, AL; Protheroe, AS; Macaulay, VM				Earwaker, Philip; Anderson, Caroline; Willenbrock, Frances; Harris, Adrian L.; Protheroe, Andrew S.; Macaulay, Valentine M.			RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition	PLOS ONE			English	Article							ADVANCED SOLID TUMORS; GROWTH-FACTOR RECEPTOR; HISTONE DEACETYLASE INHIBITOR; MTOR KINASE INHIBITORS; PHASE-II TRIAL; MAMMALIAN TARGET; TYROSINE KINASE; DUAL INHIBITOR; PROTEIN-KINASE; BREAST-CANCER	The outlook for patients with advanced renal cell cancer (RCC) has been improved by targeted agents including inhibitors of the PI3 kinase (PI3K)-AKT-mTOR axis, although treatment resistance is a major problem. Here, we aimed to understand how RCC cells acquire resistance to PI3K-mTOR inhibition. We used the RCC4 cell line to generate a model of in vitro resistance by continuous culture in PI3K-mTOR kinase inhibitor NVP-BEZ235 (BEZ235, Dactolisib). Resistant cells were cross-resistant to mTOR inhibitor AZD2014. Sensitivity was regained after 4 months drug withdrawal, and resistance was partially suppressed by HDAC inhibition, supporting an epigenetic mechanism. BEZ235-resistant cells up-regulated and/or activated numerous proteins including MET, ABL, Notch, IGF-1R, INSR and MEK/ERK. However, resistance was not reversed by inhibiting or depleting these pathways, suggesting that many induced changes were passengers not drivers of resistance. BEZ235 blocked phosphorylation of mTOR targets S6 and 4E-BP1 in parental cells, but 4E-BP1 remained phosphorylated in resistant cells, suggesting BEZ235-refractory mTORC1 activity. Consistent with this, resistant cells over-expressed mTORC1 component RAPTOR at the mRNA and protein level. Furthermore, BEZ235 resistance was suppressed by RAPTOR depletion, or allosteric mTORC1 inhibitor rapamycin. These data reveal that RAPTOR up-regulation contributes to PI3K-mTOR inhibitor resistance, and suggest that RAPTOR expression should be included in the pharmacodynamic assessment of mTOR kinase inhibitor trials.	[Earwaker, Philip; Anderson, Caroline; Willenbrock, Frances; Macaulay, Valentine M.] Dept Oncol, Oxford, England; [Harris, Adrian L.; Protheroe, Andrew S.; Macaulay, Valentine M.] Churchill Hosp, Oxford Univ Hosp NHS Trust, Oxford Canc & Haematol Ctr, Oxford, England; [Earwaker, Philip] Univ Hosp Birmingham NHS Fdn Trust, Ctr Canc, Birmingham, W Midlands, England	Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Birmingham	Macaulay, VM (corresponding author), Dept Oncol, Oxford, England.; Macaulay, VM (corresponding author), Churchill Hosp, Oxford Univ Hosp NHS Trust, Oxford Canc & Haematol Ctr, Oxford, England.	valentine.macaulay@oncology.ox.ac.uk	Harris, Adrian L/ABA-3343-2020	Harris, Adrian L/0000-0003-1376-8409	Cancer Research UK [C602/A6292]; Oxford University Clinical Academic Graduate School; Cancer Research UK award [C5255/A20758]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre [A93024]; Cancer Research UK program grant; Oxford University Clinical Academic Graduate School grant; Cancer Research UK Oxford Cancer Research Centre; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; Cancer Research UK [18974, 16466, 11359] Funding Source: researchfish; Medical Research Council [G0300648, G0601061] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish; MRC [G0601061] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Oxford University Clinical Academic Graduate School; Cancer Research UK award(Cancer Research UK); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK program grant(Cancer Research UK); Oxford University Clinical Academic Graduate School grant; Cancer Research UK Oxford Cancer Research Centre; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the award to PE of a Clinical Research Fellowship supported by Cancer Research UK (www.cancerresearchuk.org) program grant C602/A6292 to ALH, Oxford University Clinical Academic Graduate School (www.oucags.ox.ac.uk) grant to CA, support to FW from the Cancer Research UK award to the Oxford Cancer Research Centre (C5255/A20758) and to VMM from the National Institute for Health Research (NIHR; www.nihr.ac.uk) Oxford Biomedical Research Centre (award A93024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the award to PE of a Clinical Research Fellowship supported by Cancer Research UK program grant to ALH, Oxford University Clinical Academic Graduate School grant to CA, support to FW from the Cancer Research UK Oxford Cancer Research Centre and to VMM from the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. We are grateful to Tamara Aleksic and Guillaume Rieunier for comments on the manuscript.	Alain T, 2012, CANCER RES, V72, P6468, DOI 10.1158/0008-5472.CAN-12-2395; Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; Alhamdani MSS, 2009, GENOME MED, V1, DOI 10.1186/gm68; Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Bailey ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104413; Basu B, 2015, CLIN CANCER RES, V21, P3412, DOI 10.1158/1078-0432.CCR-14-2422; Behbahani TE, 2012, WORLD J UROL, V30, P559, DOI 10.1007/s00345-011-0767-z; Bendell JC, 2015, INVEST NEW DRUG, V33, P187, DOI 10.1007/s10637-014-0177-3; Bhola NE, 2016, CANCER RES, V76, P440, DOI 10.1158/0008-5472.CAN-15-1640-T; Bianchi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121567; Boulay A, 2004, CANCER RES, V64, P252, DOI 10.1158/0008-5472.CAN-3554-2; Calvo E, 2016, CANCER TREAT REV, V50, P109, DOI 10.1016/j.ctrv.2016.09.002; Carlo MI, 2016, ONCOLOGIST, V21, P787, DOI 10.1634/theoncologist.2016-0145; Chen JZ, 2015, CLIN EXP PHARMACOL P, V42, P1317, DOI 10.1111/1440-1681.12493; Chen L, 2017, ONCOTARGET; Chia S, 2015, CURR ONCOL, V22, P33, DOI 10.3747/co.22.2393; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Cope CL, 2014, J CELL SCI, V127, P788, DOI 10.1242/jcs.137588; Darwish OM, 2013, UROLOGY, V81, P581, DOI 10.1016/j.urology.2012.11.030; Dolly SO, 2016, CLIN CANCER RES, V22, P2874, DOI 10.1158/1078-0432.CCR-15-2225; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Ducker GS, 2014, ONCOGENE, V33, P1590, DOI 10.1038/onc.2013.92; Ducker GS, 2013, ONCOGENE; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Fazio N, 2016, ANTICANCER RES, V36, P713; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; Gibney GT, 2013, ANN ONCOL, V24, P343, DOI 10.1093/annonc/mds463; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Greef B, 2016, BRIT J CANCER, V115, P505, DOI 10.1038/bjc.2016.230; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Hainsworth JD, 2011, CANCER INVEST, V29, P451, DOI 10.3109/07357907.2011.590568; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Heikkinen T, 2013, BREAST CANCER RES TR, V141, P79, DOI 10.1007/s10549-013-2671-2; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Juengel E, 2016, ONCOTARGET, V7, P85208, DOI 10.18632/oncotarget.13421; Juengel E, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-152; Juengel E, 2012, CANCER LETT, V324, P83, DOI 10.1016/j.canlet.2012.05.003; Kim ST, 2016, ANN ONCOL; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu JY, 2013, J BIOL CHEM, V288, P23225, DOI 10.1074/jbc.M113.492371; Liu XD, 2011, CLIN CANCER RES, V17, P7127, DOI 10.1158/1078-0432.CCR-11-1157; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Markman B, 2012, ANN ONCOL, V23, P2399, DOI 10.1093/annonc/mds011; Maroun CR, 2014, PHARMACOL THERAPEUT, V142, P316, DOI 10.1016/j.pharmthera.2013.12.014; Mateo F, 2017, ONCOGENE, V36, P2737, DOI 10.1038/onc.2016.427; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Mohan S, 2015, CLIN CANCER RES, V21, P3946, DOI 10.1158/1078-0432.CCR-14-3377; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Naing A, 2012, BRIT J CANCER, V107, P1093, DOI 10.1038/bjc.2012.368; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Nyfeler B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048548; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; Piao JJ, 2016, ONCOTARGET, V7, P60169, DOI 10.18632/oncotarget.11109; Pike KG, 2013, BIOORG MED CHEM LETT, V23, P1212, DOI 10.1016/j.bmcl.2013.01.019; Powles T, 2016, EUR UROL, V69, P450, DOI 10.1016/j.eururo.2015.08.035; Ramcharan R, 2015, ONCOTARGET, V6, P39877, DOI 10.18632/oncotarget.5631; Ricci C, 2002, CANCER RES, V62, P5995; Rodrik-Outmezguine VS, 2016, NATURE, V534, P272, DOI 10.1038/nature17963; Ryan CW, 2011, INVEST NEW DRUG, V29, P374, DOI 10.1007/s10637-009-9365-y; Sakre N, 2016, ONCOTARGET; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Shapiro GI, 2015, CLIN CANCER RES, V21, P1888, DOI 10.1158/1078-0432.CCR-14-1306; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sjolund J, 2008, J CLIN INVEST, V118, P217, DOI 10.1172/JCI32086; Thomas HE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003923; Venkannagari S, 2012, ONCOTARGET, V3, P1416; Vo K, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-138; Vuky J, 2006, INVEST NEW DRUG, V24, P85, DOI 10.1007/s10637-005-4543-z; Wise-Draper TM, 2017, TARGET ONCOL, V12, P323, DOI 10.1007/s11523-017-0482-9; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yuen JSP, 2009, MOL CANCER THER, V8, P1448, DOI 10.1158/1535-7163.MCT-09-0101; Zhang YJ, 2012, CELL CYCLE, V11, P594, DOI 10.4161/cc.11.3.19096; Zibelman M, 2015, INVEST NEW DRUG, V33, P1040, DOI 10.1007/s10637-015-0261-3	82	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191890	10.1371/journal.pone.0191890	http://dx.doi.org/10.1371/journal.pone.0191890			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389967	Green Published, Green Submitted, gold			2022-12-26	WOS:000423793400040
J	Ladle, A; Steenweg, R; Shepherd, B; Boyce, MS				Ladle, Andrew; Steenweg, Robin; Shepherd, Brenda; Boyce, Mark S.			The role of human outdoor recreation in shaping patterns of grizzly bear-black bear co-occurrence	PLOS ONE			English	Article							HABITAT SELECTION; WILDLIFE; LANDSCAPE; PREDATION; RESPONSES; MODELS; RISK; PARAMETERIZATION; DISTURBANCE; COMPETITION	Species' distributions are influenced by a combination of landscape variables and biotic interactions with other species, including people. Grizzly bears and black bears are sympatric, competing omnivores that also share habitats with human recreationists. By adapting models for multi-species occupancy analysis, we analyzed trail camera data from 192 trail camera locations in and around Jasper National Park, Canada to estimate grizzly bear and black bear occurrence and intensity of trail use. We documented (a) occurrence of grizzly bears and black bears relative to habitat variables (b) occurrence and intensity of use relative to competing bear species and motorised and non-motorised recreational activity, and (c) temporal overlap in activity patterns among the two bear species and recreationists. Grizzly bears were spatially separated from black bears, selecting higher elevations and locations farther from roads. Both species co-occurred with motorised and non-motorised recreation, however, grizzly bears reduced their intensity of use of sites with motorised recreation present. Black bears showed higher temporal activity overlap with recreational activity than grizzly bears, however differences in bear daily activity patterns between sites with and without motorised and non-motorised recreation were not significant. Reduced intensity of use by grizzly bears of sites where motorised recreation was present is a concern given off-road recreation is becoming increasingly popular in North America, and can negatively influence grizzly bear recovery by reducing foraging opportunities near or on trails. Camera traps and multi-species occurrence models offer non-invasive methods for identifying how habitat use by animals changes relative to sympatric species, including humans. These conclusions emphasise the need for integrated land-use planning, access management, and grizzly bear conservation efforts to consider the implications of continued access for motorised recreation in areas occupied by grizzly bears.	[Ladle, Andrew; Boyce, Mark S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Steenweg, Robin] Univ Montana, Wildlife Biol Program, Coll Forestry & Conservat, Missoula, MT 59812 USA; [Shepherd, Brenda] Pk Canada, Jasper, AB, Canada	University of Alberta; University of Montana System; University of Montana	Ladle, A (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	ladle@ualberta.ca		Shepherd, Brenda/0000-0003-0165-7795	Alberta Conservation Association [RES0021375]; Alberta Environment and Parks [RES0021375]; International Bear Association [RES0021389]; Safari Club International: Northern Alberta Chapter [RES0021611]; Alberta Biodiversity Monitoring Institute; Mountain Equipment Co-op; Friends of the Environment	Alberta Conservation Association; Alberta Environment and Parks; International Bear Association; Safari Club International: Northern Alberta Chapter; Alberta Biodiversity Monitoring Institute; Mountain Equipment Co-op; Friends of the Environment	This research was supported by Alberta Conservation Association RES0021375 to MSB and AL, Alberta Environment and Parks RES0021375 to MSB and AL, International Bear Association RES0021389 to AL, Safari Club International: Northern Alberta Chapter RES0021611 to MSB and AL, Alberta Biodiversity Monitoring Institute to AL, Mountain Equipment Co-op to MSB, and TD: Friends of the Environment to MSB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberta Grizzly Bear Recovery Team, 2008, ALB GRIZZL BEAR ALB; Amarasekare P, 2002, P ROY SOC B-BIOL SCI, V269, P2541, DOI 10.1098/rspb.2002.2181; [Anonymous], 1990, URSUS; [Anonymous], 2014, R LANG ENV STAT COMP; Apps CD, 2006, ECOGRAPHY, V29, P561, DOI 10.1111/j.0906-7590.2006.04564.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Bailey LL, 2009, BIOL CONSERV, V142, P2983, DOI 10.1016/j.biocon.2009.07.028; Baldwin RA, 2010, WEST N AM NATURALIST, V70, P48, DOI 10.3398/064.070.0106; Beale CM, 2004, J APPL ECOL, V41, P335, DOI 10.1111/j.0021-8901.2004.00900.x; Berger J, 2007, BIOL LETTERS, V3, P620, DOI 10.1098/rsbl.2007.0415; Bourbonnais ML, 2013, PLOS ONE, V8, DOI [10.1371/journal.po, 10.1371/journal.pone.0083768]; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Burton AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038007; Carter NH, 2012, P NATL ACAD SCI USA, V109, P15360, DOI 10.1073/pnas.1210490109; Ciuti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050611; Ciuti S, 2012, P ROY SOC B-BIOL SCI, V279, P4407, DOI 10.1098/rspb.2012.1483; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Cusack J. J., 2016, OIKOS; DEFRIES RS, 1994, INT J REMOTE SENS, V15, P3567, DOI 10.1080/01431169408954345; Dickie M, 2017, J APPL ECOL, V54, P253, DOI 10.1111/1365-2664.12732; Efford MG, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00308.1; Elfstrom M, 2014, MAMMAL REV, V44, P5, DOI 10.1111/j.1365-2907.2012.00223.x; Farris ZJ, 2015, ANIM CONSERV, P189; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Frid A, 2002, CONSERV ECOL, V6; Gelman A., 2021, BAYESIAN DATA ANAL; Gibeau ML, 2002, BIOL CONSERV, V103, P227, DOI 10.1016/S0006-3207(01)00131-8; Gomes C. B., 2016, INDIVIDUAL BEHAV POP, P247; Hammitt W. E., 2015, WILDLAND RECREATION, V2nd; Hines J., 2006, PRESENCE2 SOFTWARE E; HOLCROFT AC, 1991, CAN FIELD NAT, V105, P335; Holm Greg W., 1999, Ursus, V11, P99; Hutchinson G. E., 1965, ECOLOGICAL THEATER E; Jacoby ME, 1999, J WILDLIFE MANAGE, V63, P921, DOI 10.2307/3802806; KASWORM WF, 1990, INT C BEAR, V8, P79; Ladle A, 2017, METHODS ECOL EVOL, V8, P329, DOI 10.1111/2041-210X.12660; Latif QS, 2016, J WILDLIFE MANAGE, V80, P192, DOI 10.1002/jwmg.1022; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J ANIM ECOL, V73, P546, DOI 10.1111/j.0021-8790.2004.00828.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mattson DJ, 2005, URSUS, V16, P11, DOI 10.2192/1537-6176(2005)016[0011:ABBAFI]2.0.CO;2; McLoughlin PD, 2010, J ANIM ECOL, V79, P4, DOI 10.1111/j.1365-2656.2009.01613.x; Meredith M, 2016, ESTIMATES COEFFICIEN, V18; Morehouse AT, 2016, J WILDLIFE MANAGE, V80, P1152, DOI 10.1002/jwmg.21104; Moreira-Arce D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137854; Mowat G, 2005, WILDLIFE BIOL, V11, P31, DOI 10.2981/0909-6396(2005)11[31:GUAABB]2.0.CO;2; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; Northrup JM, 2012, J APPL ECOL, V49, P1159, DOI 10.1111/j.1365-2664.2012.02180.x; Ordiz A, 2014, BIOL CONSERV, V173, P1, DOI 10.1016/j.biocon.2014.03.006; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pigeon KE, 2016, OECOLOGIA, V181, P1101, DOI 10.1007/s00442-016-3630-5; Richmond OMW, 2010, ECOL APPL, V20, P2036, DOI 10.1890/09-0470.1; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; Roever CL, 2008, FOREST ECOL MANAG, V256, P1253, DOI 10.1016/j.foreco.2008.06.040; Roever CL, 2010, ECOGRAPHY, V33, P1113, DOI 10.1111/j.1600-0587.2010.06077.x; Rogala JK, 2011, ECOL SOC, V16, DOI 10.5751/ES-04251-160316; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Rota CT, 2016, METHODS ECOL EVOL, V7, P1164, DOI 10.1111/2041-210X.12587; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Sahlen V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121576; Schwartz CC, 2014, J WILDLIFE MANAGE, V78, P68, DOI 10.1002/jwmg.633; Schwartz CC, 2010, J WILDLIFE MANAGE, V74, P1628, DOI 10.2193/2009-571; Steenweg R, 2016, BIOL CONSERV, V201, P192, DOI 10.1016/j.biocon.2016.06.020; Waddle JH, 2010, ECOL APPL, V20, P1467, DOI 10.1890/09-0850.1; Weaver JL, 1996, CONSERV BIOL, V10, P964, DOI 10.1046/j.1523-1739.1996.10040964.x; Whittington J, 2005, ECOL APPL, V15, P543, DOI 10.1890/03-5317; WIENS JA, 1987, OIKOS, V48, P132, DOI 10.2307/3565849	69	30	31	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191730	10.1371/journal.pone.0191730	http://dx.doi.org/10.1371/journal.pone.0191730			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389939	gold, Green Submitted, Green Published			2022-12-26	WOS:000423793400030
J	Noll, LW; Worley, JN; Yang, X; Shridhar, PB; Ludwig, JB; Shi, XR; Bai, JF; Caragea, D; Meng, JH; Nagaraja, TG				Noll, Lance W.; Worley, Jay N.; Yang, Xun; Shridhar, Pragathi B.; Ludwig, Justin B.; Shi, Xiaorong; Bai, Jianfa; Caragea, Doina; Meng, Jianghong; Nagaraja, T. G.			Comparative genomics reveals differences in mobile virulence genes of Escherichia coli O103 pathotypes of bovine fecal origin	PLOS ONE			English	Article							III EFFECTOR PROTEIN; LARGE PLASMID; SERINE-PROTEASE; FEEDLOT CATTLE; O157; SEQUENCE; IDENTIFICATION; PREVALENCE; LOCUS; TOXB	Escherichia coli O103, harbored in the hindgut and shed in the feces of cattle, can be enterohemorrhagic (EHEC), enteropathogenic (EPEC), or putative non-pathotype. The genetic diversity particularly that of virulence gene profiles within O103 serogroup is likely to be broad, considering the wide range in severity of illness. However, virulence descriptions of the E. coli O103 strains isolated from cattle feces have been primarily limited to major genes, such as Shiga toxin and intimin genes. Less is known about the frequency at which other virulence genes exist or about genes associated with the mobile genetic elements of E. coli O103 pathotypes. Our objective was to utilize whole genome sequencing (WGS) to identify and compare major and putative virulence genes of EHEC O103 (positive for Shiga toxin gene, stx1, and intimin gene, eae; n = 43), EPEC O103 (negative for stx1 and positive for eae; n = 13) and putative non-pathotype O103 strains (negative for stx and eae; n = 13) isolated from cattle feces. Six strains of EHEC O103 from human clinical cases were also included. All bovine EHEC strains (43/43) and a majority of EPEC (12/13) and putative nonpathotype strains (12/13) were O103: H2 serotype. Both bovine and human EHEC strains had significantly larger average genome sizes (P < 0.0001) and were positive for a higher number of adherence and toxin-based virulence genes and genes on mobile elements (prophages, transposable elements, and plasmids) than EPEC or putative non-pathotype strains. The genome size of the three pathotypes positively correlated (R-2 = 0.7) with the number of genes carried on mobile genetic elements. Bovine strains clustered phylogenetically by pathotypes, which differed in several key virulence genes. The diversity of E. coli O103 pathotypes shed in cattle feces is likely reflective of the acquisition or loss of virulence genes carried on mobile genetic elements.	[Noll, Lance W.; Shridhar, Pragathi B.; Ludwig, Justin B.; Shi, Xiaorong; Nagaraja, T. G.] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Worley, Jay N.; Yang, Xun; Meng, Jianghong] Univ Maryland, Joint Inst Food Safety & Appl Nutr, College Pk, MD 20742 USA; [Worley, Jay N.; Yang, Xun; Meng, Jianghong] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Bai, Jianfa] Kansas State Univ, Vet Diagnost Lab, Manhattan, KS 66506 USA; [Caragea, Doina] Kansas State Univ, Dept Comp & Informat Sci, Manhattan, KS 66506 USA	Kansas State University; University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA); University System of Maryland; University of Maryland College Park; Kansas State University; Kansas State University	Nagaraja, TG (corresponding author), Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	tnagaraj@vet.k-state.edu	Bai, Jianfa/M-7830-2019	Bai, Jianfa/0000-0002-0021-3036; Nagaraja, T. G./0000-0002-0899-878X; Caragea, Doina/0000-0002-6440-0914	Agriculture and Food Research Initiative Competitive from the United States Department of Agriculture National Institute of Food and Agriculture [2012-68003-30155]; FOOD AND DRUG ADMINISTRATION [U01FD001418] Funding Source: NIH RePORTER	Agriculture and Food Research Initiative Competitive from the United States Department of Agriculture National Institute of Food and Agriculture; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	This research was supported in part by the Agriculture and Food Research Initiative Competitive Grant no. 2012-68003-30155 from the United States Department of Agriculture National Institute of Food and Agriculture (to TGN). The funders had no role in the study design, data collection and analyses, preparation of manuscript or decision to publish.	Abdullah UY, 2014, CLONING TRANSGENESIS, V3, P1; Abe A, 1998, J EXP MED, V188, P1907, DOI 10.1084/jem.188.10.1907; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bai JF, 2012, FOODBORNE PATHOG DIS, V9, P541, DOI 10.1089/fpd.2011.1082; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bielaszewska M, 2008, CLIN INFECT DIS, V47, P208, DOI 10.1086/589245; Blanco A, 2004, J CLIN MICROBIOL, V42, P645, DOI 10.1128/JCM.42.2.645-651.2004; Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Brunder W, 1996, MICROBIOL-SGM, V142, P3305, DOI 10.1099/13500872-142-11-3305; Brunder W, 1997, MOL MICROBIOL, V24, P767, DOI 10.1046/j.1365-2958.1997.3871751.x; Bugarel M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-151; Carattoli A, 2014, ANTIMICROB AGENTS CH; Carter MQ, 2016, APPL ENVIRON MICROB, V82, P1090, DOI 10.1128/AEM.03172-15; Centers for Disease Control and Prevention (CDC), 2012, SHIG TOX PROD ESCH C; Cull CA, 2017, FOODBORNE PATHOG DIS, V14, P309, DOI 10.1089/fpd.2016.2227; Dahan S, 2005, INFECT IMMUN, V73, P679, DOI 10.1128/IAI.73.2.679-686.2005; Dautin N, 2010, TOXINS, V2, P1179, DOI 10.3390/toxins2061179; Dewsbury DM, 2015, FOODBORNE PATHOG DIS, V12, P726, DOI 10.1089/fpd.2015.1987; Donnenberg MS, 2013, TRENDS MICROBIOL, V21, P317, DOI 10.1016/j.tim.2013.05.003; Ewers C, 2002, BERLINER MUNCHENER T, V116, P381; Ferdous M, 2015, J CLIN MICROBIOL, V53, P3530, DOI 10.1128/JCM.01899-15; Garmendia J, 2004, CELL MICROBIOL, V6, P1167, DOI 10.1111/j.1462-5822.2004.00459.x; Gonzalez-Escalona N, 2016, APPL ENVIRON MICROB, V82, P3900, DOI 10.1128/AEM.00498-16; Gruenheid S, 2004, MOL MICROBIOL, V51, P1233, DOI 10.1046/j.1365-2958.2003.03911.x; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Iguchi A, 2012, J CLIN MICROBIOL, V50, P2894, DOI 10.1128/JCM.00789-12; Ison SA, 2015, APPL ENVIRON MICROB, V81, P3671, DOI 10.1128/AEM.00397-15; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P2360, DOI 10.1128/AEM.02634-07; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Jordan DM, 2004, INFECT IMMUN, V72, P6168, DOI 10.1128/IAI.72.10.6168-6171.2004; KARMALI MA, 1989, CLIN MICROBIOL REV, V2, P15, DOI 10.1128/CMR.2.1.15-38.1989; Kruger A, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00074; Kwon T, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0096-2; Makino K, 1998, DNA Res, V5, P1, DOI 10.1093/dnares/5.1.1; Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x; McDaniel TK, 1997, MOL MICROBIOL, V23, P399, DOI 10.1046/j.1365-2958.1997.2311591.x; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; McNamara BP, 2001, J CLIN INVEST, V107, P621, DOI 10.1172/JCI11138; Mellmann A, 2008, APPL ENVIRON MICROB, V74, P67, DOI 10.1128/AEM.01906-07; Nadya S, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00036; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Noll LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135446; Norman KN, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00021; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Paddock ZD, 2014, FOODBORNE PATHOG DIS, V11, P186, DOI 10.1089/fpd.2013.1659; Padola NL, 2004, VET MICROBIOL, V100, P3, DOI 10.1016/S0378-1135(03)00127-5; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Rambaut A., 2014, FIGTREE TREE FIGURE; Sandhu KS, 1999, CAN J VET RES, V63, P177; Schmidt H, 1997, FEMS MICROBIOL LETT, V148, P265, DOI 10.1016/S0378-1097(97)00047-5; Schmidt H, 2001, INFECT IMMUN, V69, P6863, DOI 10.1128/IAI.69.11.6863-6873.2001; Schmidt H, 1996, MICROBIOL-UK, V142, P907, DOI 10.1099/00221287-142-4-907; Sekse C, 2013, APPL ENVIRON MICROB, V79, P7502, DOI 10.1128/AEM.01825-13; Shaikh N, 2003, J BACTERIOL, V185, P3596, DOI 10.1128/JB.185.12.3596-3605.2003; Soderlund Robert, 2016, Infection Ecology & Epidemiology, V6, P30246, DOI 10.3402/iee.v6.30246; Stevens MP, 2004, INFECT IMMUN, V72, P5402, DOI 10.1128/IAI.72.9.5402-5411.2004; Taneike I, 2002, FEBS LETT, V524, P219, DOI 10.1016/S0014-5793(02)03027-2; Tatsuno I, 2001, INFECT IMMUN, V69, P6660, DOI 10.1128/IAI.69.11.6660-6669.2001; Tozzoli R, 2005, J CLIN MICROBIOL, V43, P4052, DOI 10.1128/JCM.43.8.4052-4056.2005; Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508, DOI 10.3201/eid0805.010385; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Wickham ME, 2006, J INFECT DIS, V194, P819, DOI 10.1086/506620; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	71	3	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191362	10.1371/journal.pone.0191362	http://dx.doi.org/10.1371/journal.pone.0191362			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389941	Green Published, gold, Green Submitted			2022-12-26	WOS:000423793400018
J	Firdaus-Raih, M; Hashim, NHF; Bharudin, I; Abu Bakar, MF; Huang, KK; Alias, H; Lee, BKB; Isa, MNM; Mat-Sharani, S; Sulaiman, S; Tay, LJ; Zolkefli, R; Noor, YM; Law, DSN; Rahman, SHA; Md-Illias, R; Abu Bakar, FD; Najimudin, N; Murad, AMA; Mahadi, NM				Firdaus-Raih, Mohd; Hashim, Noor Haza Fazlin; Bharudin, Izwan; Abu Bakar, Mohd Faizal; Huang, Kie Kyon; Alias, Halimah; Lee, Bernard K. B.; Isa, Mohd Noor Mat; Mat-Sharani, Shuhaila; Sulaiman, Suhaila; Tay, Lih Jinq; Zolkefli, Radziah; Noor, Yusuf Muhammad; Law, Douglas Sie Nguong; Rahman, Siti Hamidah Abdul; Md-Illias, Rosli; Abu Bakar, Farah Diba; Najimudin, Nazalan; Murad, Abdul Munir Abdul; Mahadi, Nor Muhammad			The Glaciozyma antarctica genome reveals an array of systems that provide sustained responses towards temperature variations in a persistently cold habitat	PLOS ONE			English	Article							ICE-BINDING PROTEIN; BOX C/D SNORNA; ANTIFREEZE PROTEIN; DROSOPHILA-MELANOGASTER; FATTY-ACIDS; EXPRESSION; GENES; YEAST; DESATURASE; ADAPTATION	Extremely low temperatures present various challenges to life that include ice formation and effects on metabolic capacity. Psyhcrophilic microorganisms typically have an array of mechanisms to enable survival in cold temperatures. In this study, we sequenced and analysed the genome of a psychrophilic yeast isolated in the Antarctic region, Glaciozyma antarctica. The genome annotation identified 7857 protein coding sequences. From the genome sequence analysis we were able to identify genes that encoded for proteins known to be associated with cold survival, in addition to annotating genes that are unique to G. antarctica. For genes that are known to be involved in cold adaptation such as anti-freeze proteins (AFPs), our gene expression analysis revealed that they were differentially transcribed over time and in response to different temperatures. This indicated the presence of an array of adaptation systems that can respond to a changing but persistent cold environment. We were also able to validate the activity of all the AFPs annotated where the recombinant AFPs demonstrated anti- freeze capacity. This work is an important foundation for further collective exploration into psychrophilic microbiology where among other potential, the genes unique to this species may represent a pool of novel mechanisms for cold survival.	[Firdaus-Raih, Mohd; Hashim, Noor Haza Fazlin; Bharudin, Izwan; Abu Bakar, Mohd Faizal; Huang, Kie Kyon; Lee, Bernard K. B.; Mat-Sharani, Shuhaila; Sulaiman, Suhaila; Tay, Lih Jinq; Zolkefli, Radziah; Law, Douglas Sie Nguong; Rahman, Siti Hamidah Abdul; Abu Bakar, Farah Diba; Murad, Abdul Munir Abdul] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi, Selangor, Malaysia; [Firdaus-Raih, Mohd] Univ Kebangsaan Malaysia, Inst Syst Biol, Bangi, Selangor, Malaysia; [Alias, Halimah; Isa, Mohd Noor Mat; Mat-Sharani, Shuhaila; Noor, Yusuf Muhammad; Mahadi, Nor Muhammad] Malaysia Genome Inst, Jalan Bangi Lama, Kajang, Selangor, Malaysia; [Noor, Yusuf Muhammad; Md-Illias, Rosli] Univ Teknol Malaysia, Fac Chem & Nat Resources Engn, Dept Biosci Engn, Skudai, Johor, Malaysia; [Najimudin, Nazalan] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia; [Hashim, Noor Haza Fazlin] Minist Nat Resources & Environm, Natl Hydraul Res Inst Malaysia, Water Qual Lab, Seri Kembangan, Selangor, Malaysia; [Sulaiman, Suhaila] FGV Innovat Ctr Biotechnol, Felda Global Ventures Res & Dev Sdn Bhd, Bandar Enstek, Negeri Sembilan, Malaysia; [Tay, Lih Jinq] Infrastruct Univ Kuala Lumpur, Fac Appl Sci & Fdn Studies, Dept Agr & Biotechnol, Kajang, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Teknologi Malaysia; Universiti Sains Malaysia; Infrastructure University Kuala Lumpur (IUKL)	Firdaus-Raih, M (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi, Selangor, Malaysia.; Firdaus-Raih, M (corresponding author), Univ Kebangsaan Malaysia, Inst Syst Biol, Bangi, Selangor, Malaysia.	firdaus@mfrlab.org	Munir, Abdul/L-8575-2017; Najimudin, Nazalan/B-2952-2011; Law, Douglas/E-2449-2019; Firdaus-Raih, Mohd/H-3286-2019; Firdaus-Raih, Mohd/A-9217-2011; Isa, Mohd Noor Mat/AAL-6458-2021; MSR, shuhaila/AAF-2196-2021; Mat-Sharani, Shuhaila/AAV-7690-2020; Sulaiman, Suhaila/J-4350-2019; Sulaiman, Suhaila/AAK-1612-2020; Murad, Abdul/CAG-9324-2022; Mat-Sharani, Shuhaila/GWC-1971-2022	Munir, Abdul/0000-0001-6402-7198; Law, Douglas/0000-0002-7824-3542; Firdaus-Raih, Mohd/0000-0003-4275-4663; Firdaus-Raih, Mohd/0000-0003-4275-4663; Sulaiman, Suhaila/0000-0002-6781-4493; Lee, Bernard Kok Bang/0000-0003-4169-0178; Mat-Sharani, Shuhaila/0000-0001-8088-4042; Hashim, Noor Haza Fazlin/0000-0002-6385-6469; Bharudin, Izwan/0000-0002-8908-4786	Ministry of Science, Technology and Innovation, Malaysia [07-05-MGI-GMB014, BT/BI/04/055-2001, 02-05-20-SF0007]; Universiti Kebangsaan Malaysia [ICONIC-2013-007 / GP-K011849]; Australian Antarctic Division of the Academy of Science, Malaysia; Malaysian Antarctic Research Programme (MARP) of the Academy of Science, Malaysia	Ministry of Science, Technology and Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Universiti Kebangsaan Malaysia; Australian Antarctic Division of the Academy of Science, Malaysia; Malaysian Antarctic Research Programme (MARP) of the Academy of Science, Malaysia	This work was supported by grants from the Ministry of Science, Technology and Innovation (grant numbers 07-05-MGI-GMB014, BT/BI/04/055-2001, 02-05-20-SF0007), Malaysia and Universiti Kebangsaan Malaysia (grant numbers ICONIC-2013-007 / GP-K011849). We acknowledge support given by the Australian Antarctic Division and the Malaysian Antarctic Research Programme (MARP) of the Academy of Science, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Ministry of Science, Technology and Innovation (grant numbers 07-05-MGI-GMB014, BT/BI/04/055-2001, 02-05-20-SF0007), Malaysia and Universiti Kebangsaan Malaysia (grant numbers ICONIC-2013-007 / GP-K011849). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge support given by the Australian Antarctic Division and the Malaysian Antarctic Research Programme (MARP) of the Academy of Science, Malaysia. We thank Synamatix Sdn Bhd., Vivian Junker, Alexandre Dionne-Laporte and the late Maqsudul Alam for technical assistance with an initial draft of the genome sequence.	Accardo MC, 2004, BIOINFORMATICS, V20, P3293, DOI 10.1093/bioinformatics/bth394; Allen MA, 2009, ISME J, V3, P1012, DOI 10.1038/ismej.2009.45; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson KL, 2006, J BACTERIOL, V188, P6739, DOI 10.1128/JB.00609-06; Angelaccio S, 2012, INT J MOL SCI, V13, P1314, DOI 10.3390/ijms13021314; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Blanc G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r39; Boutet Emmanuel, 2007, V406, P89; Cacace G, 2010, J PROTEOMICS, V73, P2021, DOI 10.1016/j.jprot.2010.06.011; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Casanueva A, 2010, TRENDS MICROBIOL, V18, P374, DOI 10.1016/j.tim.2010.05.002; Cavicchioli R, 2006, NAT REV MICROBIOL, V4, P331, DOI 10.1038/nrmicro1390; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; De Maayer P, 2014, EMBO REP, V15, P508, DOI 10.1002/embr.201338170; Duncker BP, 1995, FEBS LETT, V377, P185, DOI 10.1016/0014-5793(95)01340-7; Feller G, 2017, LIFE-BASEL, V7, DOI 10.3390/life7020025; Giaquinto L, 2007, J BACTERIOL, V189, P5738, DOI 10.1128/JB.00395-07; Hashim NHF, 2013, EXTREMOPHILES, V17, P63, DOI 10.1007/s00792-012-0494-4; Hebraud Michel, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P211; Hew C, 1999, TRANSGENIC RES, V8, P405, DOI 10.1023/A:1008900812864; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hsieh SL, 2005, COMP BIOCHEM PHYS B, V141, P95, DOI 10.1016/j.cbpc.2005.02.001; Huang ZP, 2005, RNA, V11, P1303, DOI 10.1261/rna.2380905; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jia ZC, 2002, TRENDS BIOCHEM SCI, V27, P101, DOI 10.1016/S0968-0004(01)02028-X; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kandror O, 2002, P NATL ACAD SCI USA, V99, P9727, DOI 10.1073/pnas.142314099; Kargiotidou A, 2008, J EXP BOT, V59, P2043, DOI 10.1093/jxb/ern065; Kawahara H, 2007, CRYOLETTERS, V28, P39; Kayukawa T, 2007, INSECT BIOCHEM MOLEC, V37, P1160, DOI 10.1016/j.ibmb.2007.07.007; Lee JH, 2012, J BIOL CHEM, V287, P11460, DOI 10.1074/jbc.M111.331835; Lee SJ, 2015, PROCESS BIOCHEM, V50, P2099, DOI 10.1016/j.procbio.2015.09.014; Liu W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123281; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Los DA, 1998, BBA-LIPID LIPID MET, V1394, P3, DOI 10.1016/S0005-2760(98)00091-5; Mavromatis K, 2002, EUR J BIOCHEM, V269, P2330, DOI 10.1046/j.1432-1033.2002.02895.x; MAXWELL ES, 1995, ANNU REV BIOCHEM, V64, P897, DOI 10.1146/annurev.bi.64.070195.004341; Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Michaux C, 2008, FEBS J, V275, P1687, DOI 10.1111/j.1742-4658.2008.06324.x; Mulder Nicola, 2007, V396, P59; Nichols CAM, 2005, MAR BIOTECHNOL, V7, P253, DOI 10.1007/s10126-004-5118-2; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ooi SL, 1998, RNA, V4, P1096, DOI 10.1017/S1355838298980785; Preti M, 2006, BIOCHEM BIOPH RES CO, V351, P468, DOI 10.1016/j.bbrc.2006.10.053; Rabus R, 2004, ENVIRON MICROBIOL, V6, P887, DOI 10.1111/j.1462-2920.2004.00665.x; Reed CJ, 2013, ARCHAEA, V2013, DOI 10.1155/2013/373275; Ribeiro ED, 2005, GENET MOL RES, V4, P590; Riley M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-210; Rodrigues Edson, 2011, Oecologia Australis, V15, P124; Sakamoto T, 2002, CURR OPIN MICROBIOL, V5, P206, DOI 10.1016/S1369-5274(02)00306-5; Sakamoto T, 1997, FEMS MICROBIOL LETT, V152, P313, DOI 10.1016/S0378-1097(97)00217-6; Schattner P, 2004, NUCLEIC ACIDS RES, V32, P4281, DOI 10.1093/nar/gkh768; Schneider M, 2009, J PROTEOMICS, V72, P567, DOI 10.1016/j.jprot.2008.11.010; Scott MS, 2011, BIOCHIMIE, V93, P1987, DOI 10.1016/j.biochi.2011.05.026; Shivaji S, 2010, ARCH MICROBIOL, V192, P85, DOI 10.1007/s00203-009-0539-y; Siddiqui KS, 2006, PROTEINS, V64, P486, DOI 10.1002/prot.20989; White CR, 2011, P ROYAL SOC B, P1; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Xu Y, 2003, J BACTERIOL, V185, P2161, DOI 10.1128/JB.185.7.2161-2168.2003; Yu Y, 2009, POLAR BIOL, V32, P1539, DOI 10.1007/s00300-009-0654-x	62	30	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0189947	10.1371/journal.pone.0189947	http://dx.doi.org/10.1371/journal.pone.0189947			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385175	gold, Green Published, Green Submitted			2022-12-26	WOS:000423668400012
J	Chea, C; Miyauchi, M; Inubushi, T; Ayuningtyas, NF; Subarnbhesaj, A; Nguyen, PT; Shrestha, M; Haing, S; Ohta, K; Takata, T				Chea, Chanbora; Miyauchi, Mutsumi; Inubushi, Toshihiro; Ayuningtyas, Nurina Febriyanti; Subarnbhesaj, Ajiravudh; Phuong Thao Nguyen; Shrestha, Madhu; Haing, Sivmeng; Ohta, Kouji; Takata, Takashi			Molecular mechanism of inhibitory effects of bovine lactoferrin on the growth of oral squamous cell carcinoma	PLOS ONE			English	Article							SOCS PROTEINS; CYCLE ARREST; APOPTOSIS; EXPRESSION; HEAD; LACTOTRANSFERRIN; PROLIFERATION; ACTIVATION; STAT3; MTOR	Background Lactoferrin (LF), a member of the transferrin family, recently has been demonstrated to have anticancer effects on various cancers including oral squamous cell carcinoma (OSCC). However, little is known about the underlying mechanisms of its effects on OSCC. Therefore, we aimed to investigate the mechanism of the suppressive effects of bovine LF (bLF) on the growth of OSCC cells. Methods In the current study, HSC2, HSC3, HSC4 and normal human oral keratinocytes (RT7) cell lines were tested with bLF 1, 10, and 100 mu g/ml. The effects and detail mechanisms of bLF on proliferation and apoptosis of cells were investigated using flow cytometry and western blotting. Results We found that bLF (1, 10, and 100 mu g/ml) induced activation of p53, a tumor suppressor gene, is associated with the induction of cell cycle arrest in G1/S phase and apoptosis in OSCC. Moreover, bLF downregulated the phosphorylation of Akt and activated suppressor of cytokine signaling 3 (SOCS3), thereby attenuating multiple signaling pathways including mTOR/S6K and JAK/STAT3. Interestingly, we revealed that bLF exerted its effect selectively against HSC3 but not on RT7 via different effects on the phosphorylation status of NF-kappa B and Akt. Conclusion This is the first report showing that bLF selectively suppresses proliferation through mTOR/S6K and JAK/STAT3 pathways and induction of apoptosis in OSCC. This study provides important new findings, which might be useful in the prevention and treatment of OSCC.	[Chea, Chanbora; Miyauchi, Mutsumi; Ayuningtyas, Nurina Febriyanti; Shrestha, Madhu; Haing, Sivmeng; Takata, Takashi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima, Japan; [Inubushi, Toshihiro] Sanford Burnham Prebys Med Res Inst, San Diego, CA USA; [Subarnbhesaj, Ajiravudh] Khon Kaen Univ, Dept Oral Diagnost Sci, Fac Dent, Khon Kaen, Thailand; [Phuong Thao Nguyen] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Global Dent Med & Mol Oncol, Hiroshima, Japan; [Ohta, Kouji] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Div Cervicognathostomatol, Dept Oral & Maxillofacial Surg, Hiroshima, Japan	Hiroshima University; Sanford Burnham Prebys Medical Discovery Institute; Khon Kaen University; Hiroshima University; Hiroshima University	Miyauchi, M; Takata, T (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima, Japan.	mmiya@hiroshima-u.ac.jp; ttakata@hiroshima-u.ac.jp	Miyauchi, Mutsumi/G-5268-2019; Shrestha, Madhu/HHC-3819-2022; Nguyen, Thao/AAH-7394-2019	Nguyen, Thao/0000-0003-4651-5168; Ayuningtyas, Nurina Febriyanti/0000-0003-4403-6542	JSPS KAKENHI [25293373]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI for Prof. Takashi Takata, Grants-in-Aid for Scientific Research (B), project number: 25293373.	Baker EN, 2005, CELL MOL LIFE SCI, V62, P2531, DOI 10.1007/s00018-005-5368-9; BELLAMY W, 1992, BIOCHIM BIOPHYS ACTA, V1121, P130, DOI 10.1016/0167-4838(92)90346-F; Boulay A, 2004, CANCER RES, V64, P252, DOI 10.1158/0008-5472.CAN-3554-2; Cox ML, 2010, CELL SIGNAL, V22, P564, DOI 10.1016/j.cellsig.2009.11.014; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Damiens E, 1999, J CELL BIOCHEM, V74, P486, DOI 10.1002/(SICI)1097-4644(19990901)74:3<486::AID-JCB16>3.3.CO;2-Y; Dancey JE, 2006, CANCER BIOL THER, V5, P1065, DOI 10.4161/cbt.5.9.3175; Diao YR, 2009, MOL CELL BIOL, V29, P5084, DOI 10.1128/MCB.00267-09; Duarte DC, 2011, J DAIRY SCI, V94, P66, DOI 10.3168/jds.2010-3629; Ebrahim F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106568; EFSA Panel on Dietetic Products Nutrition and Allergies, 2012, EFSA Journal, V10, P2701; Furlong SJ, 2006, ONCOL REP, V15, P1385; Gibbons JA, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1441-4; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Guillen C, 2000, ARTHRITIS RHEUM, V43, P2073, DOI 10.1002/1529-0131(200009)43:9<2073::AID-ANR19>3.0.CO;2-U; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; Hirashima K, 2010, ANN SURG ONCOL, V17, P2486, DOI 10.1245/s10434-010-1040-1; Hirata I, 2007, WORLD J GASTROENTERO, V13, P1569, DOI 10.3748/wjg.v13.i10.1569; Ikebe T, 2012, ORAL SCI INT, V9, P33, DOI 10.1016/S1348-8643(12)00008-0; Inubushi T, 2012, J BIOL CHEM, V287, P23527, DOI 10.1074/jbc.M111.324673; Iwahori K, 2011, INT J CANCER, V129, P1005, DOI 10.1002/ijc.25716; Jiang RL, 2011, J CELL PHYSIOL, V226, P3022, DOI 10.1002/jcp.22650; Kijima T, 2002, CELL GROWTH DIFFER, V13, P355; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Lai PBS, 2007, APOPTOSIS, V12, P387, DOI 10.1007/s10495-006-0571-1; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Li ZP, 2016, ONCOTARGET, V7, P31892, DOI 10.18632/oncotarget.7441; Lin ML, 2014, MOL CARCINOGEN, V53, P360, DOI 10.1002/mc.21984; Mader JS, 2005, MOL CANCER THER, V4, P612, DOI 10.1158/1535-7163.MCT-04-0077; METZBOUTIGUE MH, 1984, EUR J BIOCHEM, V145, P659, DOI 10.1111/j.1432-1033.1984.tb08607.x; MONTREUIL J, 1960, BIOCHIM BIOPHYS ACTA, V45, P413, DOI 10.1016/0006-3002(60)91478-5; Naruse T, 2015, PATHOL ONCOL RES, V21, P765, DOI 10.1007/s12253-014-9888-1; Onishi J, 2008, J PEPT SCI, V14, P1032, DOI 10.1002/psc.1039; Peng HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158440; Rodrigues L, 2009, CRIT REV FOOD SCI, V49, P203, DOI 10.1080/10408390701856157; Roy MK, 2002, J DAIRY SCI, V85, P2065, DOI 10.3168/jds.S0022-0302(02)74284-7; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Sakai T, 2005, J PHARMACOL SCI, V98, P41, DOI 10.1254/jphs.FPJ04047X; Shaheduzzaman S, 2007, CANCER BIOL THER, V6, P1088, DOI 10.4161/cbt.6.7.4327; Siavash H, 2004, CRIT REV ORAL BIOL M, V15, P298, DOI 10.1177/154411130401500505; Song JI, 2000, ONCOGENE, V19, P2489, DOI 10.1038/sj.onc.1203483; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Takayama Y, 2017, BIOCHEM CELL BIOL, V95, P57, DOI 10.1139/bcb-2016-0039; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Tomita M, 2002, BIOCHEM CELL BIOL, V80, P109, DOI 10.1139/o01-230; Trengove MC, 2013, AM J CLIN EXP IMMUNO, V2, P1; Tsuda H, 2010, BIOMETALS, V23, P399, DOI 10.1007/s10534-010-9331-3; US FDA, 2001, AG RESP LETT GRAS NO; van der Strate BWA, 2001, ANTIVIR RES, V52, P225, DOI 10.1016/S0166-3542(01)00195-4; Vinothkumar S, 2013, BIOTECHNOL ADV, V31, P1826, DOI 10.1016/j.biotechadv.2013.02.006; Weber A, 2005, ONCOGENE, V24, P6699, DOI 10.1038/sj.onc.1208818; Wolf JS, 2007, CLIN CANCER RES, V13, P1601, DOI 10.1158/1078-0432.CCR-06-2008; Worster DT, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001986; Xiao Y, 2004, CLIN CANCER RES, V10, P8683, DOI 10.1158/1078-0432.CCR-04-0988; Xu XX, 2010, J DAIRY SCI, V93, P2344, DOI 10.3168/jds.2009-2926; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Yu T, 2014, ONCOGENE, V33, P5017, DOI 10.1038/onc.2013.448; Zhao Y, 2012, CELL BIOCHEM FUNCT, V30, P340, DOI 10.1002/cbf.2810; Zhou YH, 2008, INT J CANCER, V123, P2065, DOI 10.1002/ijc.23727	60	20	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191683	10.1371/journal.pone.0191683	http://dx.doi.org/10.1371/journal.pone.0191683			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381751	gold, Green Published, Green Submitted			2022-12-26	WOS:000423617800030
J	Smith, EE; Muzikansky, A; McCreary, CR; Batool, S; Viswanathan, A; Dickerson, BC; Johnson, K; Greenberg, SM; Blacker, D				Smith, Eric E.; Muzikansky, Alona; McCreary, Cheryl R.; Batool, Saima; Viswanathan, Anand; Dickerson, Bradford C.; Johnson, Keith; Greenberg, Steven M.; Blacker, Deborah			Impaired memory is more closely associated with brain beta-amyloid than leukoaraiosis in hypertensive patients with cognitive symptoms	PLOS ONE			English	Article							WHITE-MATTER HYPERINTENSITIES; SMALL VESSEL DISEASE; VASCULAR RISK-FACTORS; ALZHEIMERS-DISEASE; BLOOD-PRESSURE; DEMENTIA; BURDEN; PREDICTORS; DECLINE; LIFE	Background Hypertension is the strongest modifiable risk factor for subcortical ischemic changes and is also a risk factor for Alzheimer's dementia. We used neuroimaging to investigate the patho-logical basis of early cognitive symptoms in patients with hypertension. Methods In this cross-sectional cohort study 67 patients age >60 years with hypertension and Clinical Dementia Rating scale score of 0.5 without dementia, and without history of symptomatic stroke, underwent MRI for measurement of subcortical vascular changes and positron emission tomography (PET) scan with Pittsburgh Compound B (PiB-PET) to detect beta-amyloid deposition. These imaging measures were related to neuropsychological tests of memory, executive function and processing speed. Results Mean age was 75.0 (standard deviation, SD, 7.3). Mean neuropsychological Z scores were: episodic memory -0.63 (SD 1.23), executive function -0.40 (SD 1.10), processing speed -0.24 (SD 0.88); 22 of the 67 subjects met criteria for mild cognitive impairment (MCI) and the remaining 45 subjects had subjective cognitive concerns only. In multivariable models adjusting for age and years of education, each 0.1 unit increase in mean cortical PiB-PET binding was associated with 0.14 lower mean Z score for episodic memory (95% Cl -0.28 to -0.01). This means that for every 0.1 unit increase in mean cortical PiB-PET, episodic memory was 0.14 standard deviations lower. White matter hyperintensity volume, silent brain infarcts and microbleeds were not associated with neuropsychological test scores. Conclusions Episodic memory was prominently affected in hypertensive participants with MCI or subjective cognitive concerns, and was associated with PiB-PET binding. This suggests a prominent role for Alzheimer pathology in cognitive impairment even in hypertensive participants at elevated risk for vascular cognitive impairment.	[Smith, Eric E.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Smith, Eric E.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Muzikansky, Alona] Massachusetts Gen Hosp, Dept Biostat, Boston, MA 02114 USA; [McCreary, Cheryl R.; Batool, Saima] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Viswanathan, Anand; Dickerson, Bradford C.; Johnson, Keith; Greenberg, Steven M.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA; [Blacker, Deborah] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA USA; [Blacker, Deborah] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	University of Calgary; University of Calgary; Harvard University; Massachusetts General Hospital; University of Calgary; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Smith, EE (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada.; Smith, EE (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	eesmith@ucalgary.ca	Smith, Eric E/C-5443-2012; Demchuk, Andrew M/E-1103-2012	Smith, Eric E/0000-0003-3956-1668; Demchuk, Andrew M/0000-0002-4930-7789	U.S. National Institute of Neurological Disorders and Stroke [R01 NS062028]; U.S. National Institute of Aging [U01 AG016976]; Alberta Innovates [201300690] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [U01AG016976] Funding Source: NIH RePORTER	U.S. National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); U.S. National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alberta Innovates; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by a grant from the U.S. National Institute of Neurological Disorders and Stroke (R01 NS062028). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The U.S. National Institute of Aging (U01 AG016976) supports the Massachusetts General Hospital Alzheimer's Disease Research Center, without which this study could not have been conducted.	Albert M, 2007, NEUROPSYCHOLOGY, V21, P158, DOI 10.1037/0894-4105.21.2.158; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Amariglio RE, 2015, NEUROLOGY, V85, P56, DOI 10.1212/WNL.0000000000001712; Becker JA, 2011, ANN NEUROL, V69, P1032, DOI 10.1002/ana.22333; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004; Dickerson BC, 2007, ARCH GEN PSYCHIAT, V64, P1443, DOI 10.1001/archpsyc.64.12.1443; Donovan NJ, 2014, AM J GERIAT PSYCHIAT, V22, P1642, DOI 10.1016/j.jagp.2014.02.007; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Grimmer T, 2012, NEUROBIOL AGING, V33, P2766, DOI 10.1016/j.neurobiolaging.2012.01.016; Gurol ME, 2013, ANN NEUROL, V73, P529, DOI 10.1002/ana.23830; Hedden T, 2012, J NEUROSCI, V32, P16233, DOI 10.1523/JNEUROSCI.2462-12.2012; Jansen WJ, 2015, JAMA-J AM MED ASSOC, V313, P1924, DOI 10.1001/jama.2015.4668; Johnson KA, 2013, ALZHEIMERS DEMENT, V9, pE1, DOI [10.1016/j.jalz.2013.01.002, 10.1016/j.jalz.2012.10.007, 10.1016/j.jalz.2013.06.001]; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Launer LJ, 2000, NEUROBIOL AGING, V21, P49, DOI 10.1016/S0197-4580(00)00096-8; Lee JH, 2011, NEUROLOGY, V77, P18, DOI 10.1212/WNL.0b013e318221acee; Lee MJ, 2014, JAMA PSYCHIAT, V71, P412, DOI 10.1001/jamapsychiatry.2013.4506; Lee PH, 2014, J EPIDEMIOL, V24, P161, DOI 10.2188/jea.JE20130062; Li J, 2011, NEUROLOGY; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Noh Y, 2014, J ALZHEIMERS DIS, V40, P877, DOI 10.3233/JAD-130461; Okereke OI, 2011, ARCH NEUROL-CHICAGO, V68, P343, DOI 10.1001/archneurol.2010.375; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Peca S, 2013, NEUROLOGY, V81, P1659, DOI 10.1212/01.wnl.0000435291.49598.54; Power MC, 2011, EPIDEMIOLOGY, V22, P646, DOI 10.1097/EDE.0b013e31822708b5; PRINS ND, 2015, NATURE REV NEUROLOGY; Rentz DM, 2010, ANN NEUROL, V67, P353, DOI 10.1002/ana.21904; Smith EE, 2015, ANN NEUROL, V77, P251, DOI 10.1002/ana.24320; Vemuri P, 2015, BRAIN, V138, P761, DOI 10.1093/brain/awu393; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd	35	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191345	10.1371/journal.pone.0191345	http://dx.doi.org/10.1371/journal.pone.0191345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381739	Green Published, gold, Green Submitted			2022-12-26	WOS:000423617800018
J	Hakkarainen, J; Zhang, FP; Jokela, H; Mayerhofer, A; Behr, R; Cisneros-Montalvo, S; Nurmio, M; Toppari, J; Ohlsson, C; Kotaja, N; Sipila, P; Poutanen, M				Hakkarainen, Janne; Zhang, Fu-Ping; Jokela, Heli; Mayerhofer, Artur; Behr, Ruediger; Cisneros-Montalvo, Sheyla; Nurmio, Mirja; Toppari, Jorma; Ohlsson, Claes; Kotaja, Noora; Sipilae, Petra; Poutanen, Matti			Hydroxysteroid (17 beta) dehydrogenase 1 expressed by Sertoli cells contributes to steroid synthesis and is required for male fertility	FASEB JOURNAL			English	Article						HSD17B1; infertility; spermatogenesis; cell junctions	MULLERIAN-INHIBITING SUBSTANCE; FOLLICLE-STIMULATING-HORMONE; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-1; LUTEINIZING-HORMONE; ECTOPLASMIC SPECIALIZATION; MALE-INFERTILITY; SPERMATOGENESIS; AROMATASE; KNOCKOUT; PROLIFERATION	The pituitary gonadotrophins and testosterone are the main hormonal regulators of spermatogenesis, but estradiol is also known to play a role in the process. The hormonal responses in the testis are partially mediated by somatic Sertoli cells that provide nutritional and physical support for differentiating male germ cells. Hydroxysteroid (17 beta) dehydrogenase 1 (HSD17B1) is a steroidogenic enzyme that especially catalyzes the conversion of low potent 17keto-steroids to highly potent 17 beta-hydroxysteroids. In this study, we show that Hsd17b1 is highly expressed in Sertoli cells of fetal and newborn mice, and HSD17B1 knockout males present with disrupted spermatogenesis with major defects, particularly in the head shape of elongating spermatids. The cell-cell junctions between Sertoli cells and germ cells were disrupted in the HSD17B1 knockout mice. This resulted in complications in the orientation of elongating spermatids in the seminiferous epithelium, reduced sperm production, and morphologically abnormal spermatozoa. We also showed that the Sertoli cell-expressed HSD17B1 participates in testicular steroid synthesis, evidenced by a compensatory up-regulation of HSD17B3 in Leydig cells. These results revealed a novel role for HSD17B1 in the control of spermatogenesis and male fertility, and that Sertoli cells significantly contribute to steroid synthesis in the testis.	[Hakkarainen, Janne; Zhang, Fu-Ping; Jokela, Heli; Cisneros-Montalvo, Sheyla; Nurmio, Mirja; Toppari, Jorma; Kotaja, Noora; Sipilae, Petra; Poutanen, Matti] Univ Turku, Res Ctr Integrat Physiol & Pharmacol, Inst Biomed, Turku, Finland; [Zhang, Fu-Ping; Poutanen, Matti] Univ Turku, Turku Ctr Dis Modeling, Turku, Finland; [Mayerhofer, Artur] Ludwig Maximilians Univ Munchen, Biomed Ctr BMC, Cell Biol Anat 3, Martinsried, Germany; [Behr, Ruediger] German Primate Ctr, Leibniz Inst Primate Res, Platform Degenerat Dis, Gottingen, Germany; [Behr, Ruediger] German Ctr Cardiovasc Res DZHK, Partner Site Gottingen, Gottingen, Germany; [Nurmio, Mirja; Toppari, Jorma] Turku Univ Hosp, Dept Pediat, Turku, Finland; [Ohlsson, Claes; Poutanen, Matti] Gothenburg Univ, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden	University of Turku; University of Turku; University of Munich; Deutsches Primatenzentrum (DPZ); German Centre for Cardiovascular Research; University of Turku; University of Gothenburg	Poutanen, M (corresponding author), Univ Turku, Turku Ctr Dis Modeling, Res Ctr Integrat Physiol & Pharmacol, Inst Biomed, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.	matti.poutanen@utu.fi	Poutanen, Matti/I-1700-2018; Sipilä, Petra/GYE-3323-2022; Ohlsson, Claes/AGP-3544-2022	Poutanen, Matti/0000-0002-8953-1734; Ohlsson, Claes/0000-0002-9633-2805; Kotaja, Noora/0000-0003-1503-9170; Cisneros Montalvo, Sheyla/0000-0001-5667-4846; Nurmio, Mirja/0000-0002-3278-639X; Mayerhofer, Artur/0000-0002-9388-4639; Jokela, Heli/0000-0003-1839-7870; Sipila, Petra/0000-0001-8187-7143	Academy of Finland; Sigrid Juselius Foundation; Swedish Research Council; IngaBritt and Arne Lundberg Foundation (LUA-ALF) research grant from the Salhgrenska University Hospital; Novo Nordisk Foundation; Deutscher Akademischer Austauschdienst (DAAD)	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); IngaBritt and Arne Lundberg Foundation (LUA-ALF) research grant from the Salhgrenska University Hospital; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The authors thank N. Messner, H. Niittymaki, K. Hovirinta, A. Mantyla, A. Hakkarainen, T. Kirjonen, J. Jarvi, J. Palmu, M. Niiranen, E. Nyman, M.-R. Kaajala, K. Asp (all from the University of Turku), and A. Tiefenbacher (Ludwig-Maximilians-Universitat Munchen) for technical assistance, and the Electron Microscopy Core Unit of the University of Turku for services regarding electron microscopy. The authors are grateful to F.-M. Kohn (Andrologicum Munchen, Munchen, Germany) and J. U. Schwarzer (Andrologie Centrum Munchen, Munchen, Germany) for providing human samples. For funding, the authors thank the Academy of Finland, the Sigrid Juselius Foundation, the Swedish Research Council, the IngaBritt and Arne Lundberg Foundation (LUA-ALF) research grant from the Salhgrenska University Hospital, and the Novo Nordisk Foundation, as well as Deutscher Akademischer Austauschdienst (DAAD). The authors declare no conflicts of interest.	Aka JA, 2010, MOL ENDOCRINOL, V24, P832, DOI 10.1210/me.2009-0468; AlAttar L, 1997, J CLIN INVEST, V100, P1335, DOI 10.1172/JCI119653; Allan CM, 2004, ENDOCRINOLOGY, V145, P1587, DOI 10.1210/en.2003-1164; Andersson S, 1997, STEROIDS, V62, P143, DOI 10.1016/S0039-128X(96)00173-0; Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Bartles JR, 1996, J CELL SCI, V109, P1229; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; FOURNETDULGUEROV N, 1987, J CLIN ENDOCR METAB, V65, P757, DOI 10.1210/jcem-65-4-757; GEISSLER WM, 1994, NAT GENET, V7, P34, DOI 10.1038/ng0594-34; GHERSEVICH SA, 1994, J ENDOCRINOL, V143, P139, DOI 10.1677/joe.0.1430139; Giuili G, 1997, DEVELOPMENT, V124, P1799; HAAVISTO AM, 1993, ENDOCRINOLOGY, V132, P1687, DOI 10.1210/en.132.4.1687; Hakkarainen J, 2015, FASEB J, V29, P3806, DOI 10.1096/fj.14-269035; Hara K, 2014, CELL STEM CELL, V14, P658, DOI 10.1016/j.stem.2014.01.019; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Jokela H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16618-5; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Lasala C, 2011, AM J PHYSIOL-ENDOC M, V301, pE539, DOI 10.1152/ajpendo.00187.2011; Lin SX, 2006, MOL CELL ENDOCRINOL, V248, P38, DOI 10.1016/j.mce.2005.11.035; Manno FAM, 2008, PHYSIOL BEHAV, V93, P364, DOI 10.1016/j.physbeh.2007.09.011; Mayer C, 2016, SCI REP-UK, V6, DOI 10.1038/srep37128; McLachlan RI, 2002, RECENT PROG HORM RES, V57, P149, DOI 10.1210/rp.57.1.149; Miettinen MM, 1996, BIOCHEM J, V314, P839, DOI 10.1042/bj3140839; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Mruk DD, 2004, TRENDS ENDOCRIN MET, V15, P439, DOI 10.1016/j.tem.2004.09.009; Mruk DD, 2008, PHARMACOL REV, V60, P146, DOI 10.1124/pr.107.07105; Mueller S, 2003, BIOL REPROD, V69, P1330, DOI 10.1095/biolreprod.102.014670; Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890; Nokelainen P, 1996, EUR J BIOCHEM, V236, P482, DOI 10.1111/j.1432-1033.1996.00482.x; O'Donnell L, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1017; O'Shaughnessy PJ, 2000, ENDOCRINOLOGY, V141, P2631, DOI 10.1210/en.141.7.2631; ODonnell L, 1996, BIOL REPROD, V55, P895, DOI 10.1095/biolreprod55.4.895; Pakarainen T, 2005, ENDOCRINOLOGY, V146, P596, DOI 10.1210/en.2004-0913; Pelletier G, 2004, J MOL ENDOCRINOL, V33, P459, DOI 10.1677/jme.1.01567; POUTANEN M, 1993, ENDOCRINOLOGY, V133, P2639, DOI 10.1210/en.133.6.2639; Puranen T, 1997, ENDOCRINOLOGY, V138, P3532, DOI 10.1210/en.138.8.3532; Robertson KM, 1999, P NATL ACAD SCI USA, V96, P7986, DOI 10.1073/pnas.96.14.7986; Rotgers E, 2015, ANDROLOGY-US, V3, P947, DOI 10.1111/andr.12066; Saloniemi T, 2012, J ENDOCRINOL, V212, P27, DOI 10.1530/JOE-11-0315; Schimenti KJ, 2013, GENETICS, V194, P447, DOI 10.1534/genetics.113.150789; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Shima Y, 2013, MOL ENDOCRINOL, V27, P63, DOI 10.1210/me.2012-1256; Sinkevicius KW, 2009, ENDOCRINOLOGY, V150, P2898, DOI 10.1210/en.2008-1016; Sridharan S, 2007, BIOL REPROD, V76, P804, DOI 10.1095/biolreprod.106.059212; Toyama Y, 2001, MOL CELL ENDOCRINOL, V178, P161, DOI 10.1016/S0303-7207(01)00419-1; van Casteren JIJ, 2000, BIOL REPROD, V62, P886, DOI 10.1095/biolreprod62.4.886; Viger RS, 1998, DEVELOPMENT, V125, P2665; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; Walker William H, 2011, Spermatogenesis, V1, P116; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wong EWP, 2008, BBA-BIOMEMBRANES, V1778, P692, DOI 10.1016/j.bbamem.2007.11.006; Yan HHN, 2007, BIOESSAYS, V29, P36, DOI 10.1002/bies.20513; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172; Zhu SJ, 2002, J ENDOCRINOL, V172, P31, DOI 10.1677/joe.0.1720031	55	10	10	3	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3229	3241		10.1096/fj.201700921R	http://dx.doi.org/10.1096/fj.201700921R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401623				2022-12-26	WOS:000432546000027
J	Sparkes, A; De Baetselier, P; Brys, L; Cabrito, I; Sterckx, YGJ; Schoonooghe, S; Muyldermans, S; Raes, G; Bucala, R; Vanlandschoot, P; Van Ginderachter, JA; Stijlemans, B				Sparkes, Amanda; De Baetselier, Patrick; Brys, Lea; Cabrito, Ines; Sterckx, Yann G. -J.; Schoonooghe, Steve; Muyldermans, Serge; Raes, Geert; Bucala, Richard; Vanlandschoot, Peter; Van Ginderachter, Jo A.; Stijlemans, Benoit			Novel half-life extended anti-MIF nanobodies protect against endotoxic shock	FASEB JOURNAL			English	Article						Nbs; MIF antagonist; LPS	MIGRATION-INHIBITORY-FACTOR; SINGLE-DOMAIN ANTIBODIES; TOLL-LIKE RECEPTOR-4; SEVERE SEPSIS; SEPTIC SHOCK; MONOCLONAL-ANTIBODIES; TAUTOMERASE ACTIVITY; LETHAL ENDOTOXEMIA; CYTOKINE; BINDING	Sepsis-leading to septic shock-is the leading cause of death in intensive care units. The systemic inflammatory response to infection, which is initiated by activated myeloid cells, plays a key role in the lethal outcome. Macrophage migration inhibitory factor (MIF) is an upstream immunoregulatory mediator, released by myeloid cells, that underlies a common genetic susceptibility to different infections and septic shock. Accordingly, strategies that are aimed at inhibiting the action of MIF have therapeutic potential. Here, we report the isolation and characterization of tailorable, small, affinity-matured nanobodies (Nbs; single-domain antigen-binding fragments derived from camelid heavy-chain Abs) directed against MIF. Of importance, these bioengineered Nbs bind both human and mouse MIFs with nanomolar affinity. NbE5 and NbE10 inhibit key MIF functions that can exacerbate septic shock, such as the tautomerase activity of MIF (by blocking catalytic pocket residues that are critical for MIF's conformation and receptor binding), the TNF-inducing potential, and the ability of MIF to antagonize glucocorticoid action. A lead NbE10, tailored to be a multivalent, half-life extended construct (NbE10-NbAlb8-NbE10), attenuated lethality in murine endotoxemia when administered via single injection, either prophylactically or therapeutically. Hence, Nbs, with their structural and pharmacologic advantages over currently available inhibitors, may be an effective, novel approach to interfere with the action of MIF in septic shock and other conditions of inflammatory end-organ damage.	[Sparkes, Amanda; De Baetselier, Patrick; Brys, Lea; Sterckx, Yann G. -J.; Schoonooghe, Steve; Muyldermans, Serge; Raes, Geert; Van Ginderachter, Jo A.; Stijlemans, Benoit] Vrije Univ Brussels, Lab Cellular & Mol Immunol, Brussels, Belgium; [Sparkes, Amanda; De Baetselier, Patrick; Brys, Lea; Schoonooghe, Steve; Raes, Geert; Van Ginderachter, Jo A.; Stijlemans, Benoit] Flanders Inst Biotechnol VIB, Myeloid Cell Immunol Lab, Ctr Inflammat Res, Brussels, Belgium; [Cabrito, Ines] Good Mfg Practices GMP Lab, Dept Biopharmaceut, Pharmaceut Prod Dev PPD Labs, Athlone, Ireland; [Cabrito, Ines; Vanlandschoot, Peter] Ablynx NV, Zwijnaarde, Belgium; [Bucala, Richard] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Vanlandschoot, Peter] N Spired, Aalter, Belgium	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Yale University	Stijlemans, B (corresponding author), Vrije Univ Brussel VIB, Pl Laan 2, B-1050 Brussels, Belgium.	benoit.stijlemans@vub.be	Sterckx, Yann G.-J./F-2269-2017; Van Ginderachter, Jo A/H-5473-2013; Muyldermans, Serge/AAC-7374-2019; Raes, Geert M/H-5185-2013; Stijlemans, Benoit/AAD-9122-2021	Sterckx, Yann G.-J./0000-0002-7420-0983; Van Ginderachter, Jo A/0000-0002-4442-7474; Muyldermans, Serge/0000-0002-3678-3575; Raes, Geert M/0000-0002-9065-1549; Stijlemans, Benoit/0000-0003-0082-9751; Schoonooghe, Steve/0000-0001-8824-0452	Interuniversity Attraction Pole Program (PAI-IAP) [P7/41]; Research Foundation-Flanders (FWO) [KaN 1515813N]; starting budget from Ablynx; Strategic Research Program (Vrije Universiteit Brussels) [SRP3]; U.S. National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110452] Funding Source: NIH RePORTER	Interuniversity Attraction Pole Program (PAI-IAP); Research Foundation-Flanders (FWO)(FWO); starting budget from Ablynx(Ablynx); Strategic Research Program (Vrije Universiteit Brussels); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Yvon Elkrim, Ella Omasta, Marie-Therese Detobel, Maria Slazak, Victor Orimoloye, Natalia Smiejkowska, Shahid Hussain, and Nadia Abou for technical and administrative assistance, as well as Dr. Alain Beschin for constructive discussions [all from the Vrije Universiteit Brussel (VUB) and the Flanders Institute for Biotechnology (VIB) Center for Inflammation Research]. This work, performed in the frame of an Interuniversity Attraction Pole Program (PAI-IAP N. P7/41; http://www.belspo.be/belspo/iap/index_en.stm), was supported by a grant from the Research Foundation-Flanders (FWO; KaN 1515813N), and a starting budget from Ablynx. B.S. was supported by the Strategic Research Program (SRP3; Vrije Universiteit Brussels). R.B. was supported by the U.S. National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Abraham E, 1999, INTENS CARE MED, V25, P556, DOI 10.1007/s001340050903; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Al-Abed Y, 2011, FUTURE MED CHEM, V3, P45, DOI 10.4155/FMC.10.281; Alampour-Rajabi S, 2015, FASEB J, V29, P4497, DOI 10.1096/fj.15-273904; Beishuizen A., 2009, J CLIN ENDOCR METAB, V86, P2811; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bozza FA, 2004, SHOCK, V22, P309, DOI 10.1097/01.shk.0000140305.01641.c8; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Bozza Marcelo T, 2012, J Parasitol Res, V2012, P413052, DOI 10.1155/2012/413052; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Caljon G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001902; Chagnon F, 2005, CIRC RES, V96, P1095, DOI 10.1161/01.RES.0000168327.22888.4d; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; De Groeve K, 2010, J NUCL MED, V51, P782, DOI 10.2967/jnumed.109.070078; Dios A, 2002, J MED CHEM, V45, P2410, DOI 10.1021/jm010534q; Emonts M, 2007, CLIN INFECT DIS, V44, P1321, DOI 10.1086/514344; Esposito S, 2017, J GLOB ANTIMICROB RE, V10, P204, DOI 10.1016/j.jgar.2017.06.013; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; Gao XM, 2011, J MOL CELL CARDIOL, V50, P991, DOI 10.1016/j.yjmcc.2010.12.022; Grieb G, 2010, DRUG NEWS PERSPECT, V23, P257, DOI 10.1358/dnp.2010.23.4.1453629; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/nnm.13.86, 10.2217/NNM.13.86]; Hoefman S, 2015, ANTIBODIES, V4, P141, DOI 10.3390/antib4030141; Jing LA, 2011, ANN CLIN LAB SCI, V41, P14; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kerschbaumer RJ, 2012, J BIOL CHEM, V287, P7446, DOI 10.1074/jbc.M111.329664; Kudrin A, 2006, J BIOL CHEM, V281, P29641, DOI 10.1074/jbc.M601103200; Lai KN, 2003, J PATHOL, V199, P496, DOI 10.1002/path.1291; Le Roy D, 1999, J IMMUNOL, V162, P7454; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Leng L, 2011, J IMMUNOL, V186, P527, DOI 10.4049/jimmunol.1001767; Luan YY, 2014, J INTERF CYTOK RES, V34, P2, DOI 10.1089/jir.2013.0042; Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y; Martin P, 2015, LEUKEMIA LYMPHOMA, V56, P3065, DOI 10.3109/10428194.2015.1028052; Maussang D, 2013, J BIOL CHEM, V288, P29562, DOI 10.1074/jbc.M113.498436; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Merk M, 2009, J IMMUNOL, V182, P6896, DOI 10.4049/jimmunol.0803710; Meza-Romero R, 2016, METAB BRAIN DIS, V31, P249, DOI 10.1007/s11011-016-9798-x; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Nee PA, 2006, EMERG MED J, V23, P713, DOI 10.1136/emj.2005.029934; Orr BA, 2003, BIOTECHNOL PROGR, V19, P631, DOI 10.1021/bp0200797; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rajasekaran D, 2016, J BIOL CHEM, V291, P15881, DOI 10.1074/jbc.M116.717751; Renner P, 2012, FASEB J, V26, P907, DOI 10.1096/fj.11-195065; Rex S, 2014, MINI-REV MED CHEM, V14, P1116; Riechmann L, 1999, J IMMUNOL METHODS, V231, P25, DOI 10.1016/S0022-1759(99)00138-6; Roger T, 2003, J ENDOTOXIN RES, V9, P119, DOI 10.1179/096805103125001513; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Saerens D, 2004, J BIOL CHEM, V279, P51965, DOI 10.1074/jbc.M409292200; Savva A, 2016, P NATL ACAD SCI USA, V113, P3597, DOI 10.1073/pnas.1520727113; Steeland S, 2015, J BIOL CHEM, V290, P4022, DOI 10.1074/jbc.M114.617787; Stijlemans B, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005862; Stijlemans B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004414; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Tarasuk M, 2014, INT J MOL MED, V33, P515, DOI 10.3892/ijmm.2014.1622; Tilstam PV, 2017, EXPERT OPIN THER TAR, V21, P671, DOI 10.1080/14728222.2017.1336227; Tohyama S, 2008, GENE THER, V15, P1513, DOI 10.1038/gt.2008.112; Tsai TL, 2014, J BIOMOL SCREEN, V19, P1116, DOI 10.1177/1087057114523317; Van Bockstaele F, 2009, CURR OPIN INVEST DR, V10, P1212; Vandenbroucke K, 2010, MUCOSAL IMMUNOL, V3, P49, DOI 10.1038/mi.2009.116; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Vosjan MJWD, 2012, MOL CANCER THER, V11, P1017, DOI 10.1158/1535-7163.MCT-11-0891; Vujicic M, 2014, EUR J PHARMACOL, V740, P683, DOI 10.1016/j.ejphar.2014.06.009; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; Zhang JB, 2004, J MOL BIOL, V335, P49, DOI 10.1016/j.jmb.2003.09.034; Zhang Y, 2011, INT IMMUNOPHARMACOL, V11, P1333, DOI 10.1016/j.intimp.2011.04.017; Zhou JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107181	74	22	23	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3411	3422		10.1096/fj.201701189R	http://dx.doi.org/10.1096/fj.201701189R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401625	Green Submitted, Green Published			2022-12-26	WOS:000432546000041
J	Visram, M; Radulovic, M; Steiner, S; Malanovic, N; Eichmann, TO; Wolinski, H; Rechberger, GN; Tehlivets, O				Visram, Myriam; Radulovic, Maja; Steiner, Sabine; Malanovic, Nermina; Eichmann, Thomas O.; Wolinski, Heimo; Rechberger, Gerald N.; Tehlivets, Oksana			Homocysteine regulates fatty acid and lipid metabolism in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLHOMOCYSTEINE-HYDROLASE; PLASMA HOMOCYSTEINE; PHOSPHATIDYLETHANOLAMINE METHYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; METHYLATION METABOLISM; DOWN-REGULATION; DEFICIENT MICE; KEY ENZYME; PHOSPHATIDYLCHOLINE; PROTEIN	S-Adenosyl-L-homocysteine hydrolase (AdoHcy hydrolase; Sah1 in yeast/AHCY in mammals) degrades AdoHcy, a by-product and strong product inhibitor of S-adenosyl-L-methionine (AdoMet)-dependent methylation reactions, to adenosine and homocysteine (Hcy). This reaction is reversible, so any elevation of Hcy levels, such as in hyperhomocysteinemia (HHcy), drives the formation of AdoHcy, with detrimental consequences for cellular methylation reactions. HHcy, a pathological condition linked to cardiovascular and neurological disorders, as well as fatty liver among others, is associated with a deregulation of lipid metabolism. Here, we developed a yeast model of HHcy to identify mechanisms that dysregulate lipid metabolism. Hcy supplementation to wildtype cells up-regulated cellular fatty acid and triacylglycerol content and induced a shift in fatty acid composition, similar to changes observed in mutants lacking Sah1. Expression of the irreversible bacterial pathway for AdoHcy degradation in yeast allowed us to dissect the impact of AdoHcy accumulation on lipid metabolism from the impact of elevated Hcy. Expression of this pathway fully suppressed the growth deficit of sah1 mutants as well as the deregulation of lipid metabolism in both the sah1 mutant and Hcy-exposed wildtype, showing that AdoHcy accumulation mediates the deregulation of lipid metabolism in response to elevated Hcy in yeast. Furthermore, Hcy supplementation in yeast led to increased resistance to cerulenin, an inhibitor of fatty acid synthase, as well as to a concomitant decline of condensing enzymes involved in very long-chain fatty acid synthesis, in line with the observed shift in fatty acid content and composition.	[Visram, Myriam; Radulovic, Maja; Steiner, Sabine; Malanovic, Nermina; Eichmann, Thomas O.; Wolinski, Heimo; Rechberger, Gerald N.; Tehlivets, Oksana] Karl Franzens Univ Graz, Inst Mol Biosci, Humboldtstr 50, A-8010 Graz, Austria; [Rechberger, Gerald N.] BioTechMed Graz, Omics Ctr Graz, A-8010 Graz, Austria	University of Graz	Tehlivets, O (corresponding author), Karl Franzens Univ Graz, Inst Mol Biosci, Humboldtstr 50, A-8010 Graz, Austria.	oksana.tehlivets@uni-graz.at	Steiner, Sabine/AAG-5804-2021; Malanovic, Nermina/ACF-9103-2022	Steiner, Sabine/0000-0002-5680-1072; Wolinski, Heimo/0000-0002-1583-6092; Malanovic, Nermina/0000-0002-2903-9369; Eichmann, Thomas O./0000-0002-8521-2795; Tehlivets, Oksana/0000-0003-1650-5014	Austrian Science Fund (FWF) [P24216, P18094]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF) Projects P24216 and P18094 (to O.T.). The authors declare that they have no conflicts of interest with the contents of this article.	Baerends RJS, 2000, J BIOL CHEM, V275, P9986, DOI 10.1074/jbc.275.14.9986; Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; Bravo E, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-60; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Clarke S, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P63; Dayal S, 2001, CIRC RES, V88, P1203, DOI 10.1161/hh1101.092180; Finkelstein JD, 2000, INT J BIOCHEM CELL B, V32, P385, DOI 10.1016/S1357-2725(99)00138-7; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Gaspar ML, 2011, J BIOL CHEM, V286, P1696, DOI 10.1074/jbc.M110.172296; GAYNOR PM, 1990, BIOCHIM BIOPHYS ACTA, V1045, P156, DOI 10.1016/0005-2760(90)90145-N; Gellekink H, 2005, CLIN CHEM, V51, P1487, DOI 10.1373/clinchem.2004.046995; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gupta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027598; Hartler J, 2011, BIOINFORMATICS, V27, P572, DOI 10.1093/bioinformatics/btq699; Henry SA, 2014, CHEM PHYS LIPIDS, V180, P23, DOI 10.1016/j.chemphyslip.2013.12.013; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HORVATH A, 1994, YEAST, V10, P1305, DOI 10.1002/yea.320101007; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ikeda K, 2011, ANAL BIOANAL CHEM, V400, P1853, DOI 10.1007/s00216-011-4703-2; Innis SM, 2003, J PEDIATR-US, V143, P351, DOI 10.1067/S0022-3476(03)00326-3; Isa Y, 2006, J NUTR SCI VITAMINOL, V52, P479, DOI 10.3177/jnsv.52.479; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Jin QR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2777; KAWAGUCHI A, 1982, J BIOCHEM-TOKYO, V92, P7, DOI 10.1093/oxfordjournals.jbchem.a133933; Kerins DM, 2001, AM J CLIN NUTR, V74, P723; Kharbanda KK, 2007, J HEPATOL, V46, P314, DOI 10.1016/j.jhep.2006.08.024; Knittelfelder OL, 2014, J CHROMATOGR B, V951, P119, DOI 10.1016/j.jchromb.2014.01.011; Leal JF, 2008, CARCINOGENESIS, V29, P2089, DOI 10.1093/carcin/bgn198; Li D, 2006, LIPIDS, V41, P85, DOI 10.1007/s11745-006-5074-x; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Liu C, 2008, J NUTR, V138, P311, DOI 10.1093/jn/138.2.311; Malanovic N, 2008, J BIOL CHEM, V283, P23989, DOI 10.1074/jbc.M800830200; Matthews RP, 2009, DEVELOPMENT, V136, P865, DOI 10.1242/dev.027565; Medici V, 2013, HEPATOLOGY, V57, P555, DOI 10.1002/hep.26047; MILLER MW, 1994, EMBO J, V13, P1806, DOI 10.1002/j.1460-2075.1994.tb06449.x; Mushegian AR, 1998, GENOME RES, V8, P590, DOI 10.1101/gr.8.6.590; Ngo S, 2014, DIABETES, V63, P2273, DOI 10.2337/db13-1640; Noga AA, 2003, J BIOL CHEM, V278, P5952, DOI 10.1074/jbc.M212194200; Ohmori O, 1996, NEUROCHEM RES, V21, P1173, DOI 10.1007/BF02532392; Pang YL, 2016, J BIOL CHEM, V291, P12336, DOI 10.1074/jbc.M115.702654; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Schalinske KL, 2012, ADV NUTR, V3, P755, DOI 10.3945/an.112.002758; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt C, 2013, J BIOL CHEM, V288, P19939, DOI 10.1074/jbc.M113.459610; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Selley ML, 2007, NEUROBIOL AGING, V28, P1834, DOI 10.1016/j.neurobiolaging.2006.08.003; SHIMIZU S, 1984, EUR J BIOCHEM, V141, P385, DOI 10.1111/j.1432-1033.1984.tb08203.x; Stead LM, 2006, AM J CLIN NUTR, V83, P5; Tehlivets O, 2004, FEBS LETT, V577, P501, DOI 10.1016/j.febslet.2004.10.057; Tehlivets O, 2013, BBA-MOL BASIS DIS, V1832, P204, DOI 10.1016/j.bbadis.2012.09.007; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Wang ZG, 2011, AM J PHYSIOL-ENDOC M, V301, pE703, DOI 10.1152/ajpendo.00050.2011; Watkins SM, 2003, J NUTR, V133, P3386, DOI 10.1093/jn/133.11.3386; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	58	17	18	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5544	5555		10.1074/jbc.M117.809236	http://dx.doi.org/10.1074/jbc.M117.809236			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29414770	hybrid, Green Published			2022-12-26	WOS:000430044100017
J	Mitchell, AC; Kannan, D; Hunter, SA; Sperberg, RAP; Chang, CH; Cochran, JR				Mitchell, Aaron C.; Kannan, Deepti; Hunter, Sean A.; Sperberg, R. Andres Parra; Chang, Cheryl H.; Cochran, Jennifer R.			Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; hepatocyte growth factor; scatter factor (HGF; SF); protease; protease inhibitor; protein engineering; Fc fusion; HAI-1; matriptase	TRANSMEMBRANE SERINE PROTEASES; YEAST SURFACE DISPLAY; PROSTATE-CANCER; CELL-SURFACE; DIRECTED EVOLUTION; BREAST-CANCER; IN-VITRO; EXPRESSION; LIBRARIES; MET	Dysregulated matriptase activity has been established as a key contributor to cancer progression through its activation of growth factors, including the hepatocyte growth factor (HGF). Despite its critical role and prevalence in many human cancers, limitations to developing an effective matriptase inhibitor include weak binding affinity, poor selectivity, and short circulating half-life. We applied rational and combinatorial approaches to engineer a potent inhibitor based on the hepatocyte growth factor activator inhibitor type-1 (HAI-1), a natural matriptase inhibitor. The first Kunitz domain (KD1) of HAI-1 has been well established as a minimal matriptase-binding and inhibition domain, whereas the second Kunitz domain (KD2) is inactive and involved in negative regulation. Here, we replaced the inactive KD2 domain of HAI-1 with an engineered chimeric variant of KD2/KD1 domains and fused the resulting construct to an antibody Fc domain to increase valency and circulating serum half-life. The final protein variant contains four stoichiometric binding sites that we showed were needed to effectively inhibit matriptase with a K-i of 70 +/- 5 pm, an increase of 120-fold compared with the natural HAI-1 inhibitor, to our knowledge making it one of the most potent matriptase inhibitors identified to date. Furthermore, the engineered inhibitor demonstrates a protease selectivity profile similar to that of wildtype KD1 but distinct from that of HAI-1. It also inhibits activation of the natural pro-HGF substrate and matriptase expressed on cancer cells with at least an order of magnitude greater efficacy than KD1.	[Mitchell, Aaron C.; Kannan, Deepti; Sperberg, R. Andres Parra; Chang, Cheryl H.; Cochran, Jennifer R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Cochran, Jennifer R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Hunter, Sean A.; Cochran, Jennifer R.] Stanford Univ, Canc Biol Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Cochran, JR (corresponding author), Stanford Univ, Shriram Bldg Rm 356,443 Via Ortega Dr, Stanford, CA 94305 USA.	jennifer.cochran@stanford.edu		CHANG, CHERYL/0000-0001-7810-0501; Kannan, Deepti/0000-0002-4416-8417; Yamada-Hunter, Sean/0000-0002-4372-6587	NIGMS, National Institutes of Health Training Grant in Biotechnology [5T32GM008412]; NCI, National Institutes of Health [R01 CA151706]; Stanford Agilent fellowship; National Institutes of Standards and Technology fellowship; Siebel Scholars graduate fellowship; National Science Foundation graduate research fellowship; Stanford graduate fellowship; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA151706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008412] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health Training Grant in Biotechnology; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stanford Agilent fellowship; National Institutes of Standards and Technology fellowship; Siebel Scholars graduate fellowship; National Science Foundation graduate research fellowship(National Science Foundation (NSF)); Stanford graduate fellowship(Stanford University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIGMS, National Institutes of Health Training Grant in Biotechnology 5T32GM008412 (to A. C. M.) and NCI, National Institutes of Health Grant R01 CA151706 (to J. R. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Stanford Agilent fellowship, National Institutes of Standards and Technology fellowship, and Siebel Scholars graduate fellowship.; Supported by a National Science Foundation graduate research fellowship and a Stanford graduate fellowship.	Antalis TM, 2010, BIOCHEM J, V428, P325, DOI 10.1042/BJ20100046; Aoki W, 2011, J BIOSCI BIOENG, V111, P16, DOI 10.1016/j.jbiosc.2010.08.006; Beaulieu A, 2013, J VIROL, V87, P4237, DOI 10.1128/JVI.03005-12; Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; Bhatt AS, 2007, P NATL ACAD SCI USA, V104, P5771, DOI 10.1073/pnas.0606514104; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Chou FP, 2013, AM J PATHOL, V183, P1306, DOI 10.1016/j.ajpath.2013.06.024; Cirino Patrick C, 2003, Methods Mol Biol, V231, P3; Colombo E, 2012, ACS MED CHEM LETT, V3, P530, DOI 10.1021/ml3000534; COPELAND RA, 2005, EVALUATION ENZYME IN, P185; Czajkowsky DM, 2012, EMBO MOL MED, V4, P1015, DOI 10.1002/emmm.201201379; Nam DH, 2016, P NATL ACAD SCI USA, V113, P14970, DOI 10.1073/pnas.1609375114; Eigenbrot C, 2010, FEBS J, V277, P2215, DOI 10.1111/j.1742-4658.2010.07638.x; Fukushima T, 2011, CANCER SCI, V102, P407, DOI 10.1111/j.1349-7006.2010.01808.x; Ganesan R, 2011, MOL CANCER RES, V9, P1175, DOI 10.1158/1541-7786.MCR-11-0004; Glotzbach B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076956; Guo JH, 2004, TRENDS BIOCHEM SCI, V29, P172, DOI 10.1016/j.tibs.2004.02.007; Hong ZB, 2016, J BIOL CHEM, V291, P14340, DOI 10.1074/jbc.M115.707240; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Hunter SA, 2016, METHOD ENZYMOL, V580, P21, DOI 10.1016/bs.mie.2016.05.002; Jones DS, 2011, P NATL ACAD SCI USA, V108, P13035, DOI 10.1073/pnas.1102561108; Kang JY, 2003, CANCER RES, V63, P1101; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kataoka H, 2010, FEBS J, V277, P2230, DOI 10.1111/j.1742-4658.2010.07640.x; Kawaguchi M, 2014, CANCERS, V6, P1890, DOI 10.3390/cancers6041890; Klokk TI, 2007, CANCER RES, V67, P5221, DOI 10.1158/0008-5472.CAN-06-4728; Kojima K, 2008, J BIOL CHEM, V283, P2478, DOI 10.1074/jbc.M709073200; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Li W, 2009, CANCER RES, V69, P8395, DOI 10.1158/0008-5472.CAN-09-1995; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; Milner JM, 2010, ARTHRITIS RHEUM-US, V62, P1955, DOI 10.1002/art.27476; Nagaike K, 2004, CANCER SCI, V95, P728, DOI 10.1111/j.1349-7006.2004.tb03253.x; Nakamura K, 2009, INT J ONCOL, V35, P239, DOI 10.3892/ijo_00000333; Owusu BY, 2016, ONCOTARGET, V7, P29492, DOI 10.18632/oncotarget.8785; Parr C, 2006, INT J CANCER, V119, P1176, DOI 10.1002/ijc.21881; Pomothy J, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6306984; Quimbar P, 2013, J BIOL CHEM, V288, P13885, DOI 10.1074/jbc.M113.460030; Rakestraw JA, 2009, BIOTECHNOL BIOENG, V103, P1192, DOI 10.1002/bit.22338; Rolland-Fourcade C, 2017, GUT, V66, P1767, DOI 10.1136/gutjnl-2016-312094; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; Sanders AJ, 2007, INT J MOL MED, V20, P613; Schneider EL, 2012, J MOL BIOL, V415, P699, DOI 10.1016/j.jmb.2011.11.036; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Szabo R, 2011, ONCOGENE, V30, P2003, DOI 10.1038/onc.2010.586; Szabo R, 2008, INT J BIOCHEM CELL B, V40, P1297, DOI 10.1016/j.biocel.2007.11.013; Tervonen TA, 2016, ONCOGENE, V35, P1832, DOI 10.1038/onc.2015.248; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; Vogel LK, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-176; Welman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034182; Wood MP, 2014, IMMUNOLOGY, V142, P474, DOI 10.1111/imm.12278; Wu SR, 2010, AM J PATHOL, V177, P3145, DOI 10.2353/ajpath.2010.100228; Wu Y, 2007, P NATL ACAD SCI USA, V104, P19784, DOI 10.1073/pnas.0708251104; Ye JJ, 2014, CANCER SCI, V105, P44, DOI 10.1111/cas.12306; Zeng L, 2005, WORLD J GASTROENTERO, V11, P6202, DOI 10.3748/wjg.v11.i39.6202; Zhao BY, 2013, J BIOL CHEM, V288, P11155, DOI 10.1074/jbc.M113.454611	60	5	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					4969	4980		10.1074/jbc.M117.815142	http://dx.doi.org/10.1074/jbc.M117.815142			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29386351	Green Published, hybrid			2022-12-26	WOS:000429409300002
J	Winter, SV; Zychlinsky, A				Winter, Sebastian Virreira; Zychlinsky, Arturo			The bacterial pigment pyocyanin inhibits the NLRP3 inflammasome through intracellular reactive oxygen and nitrogen species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA PYOCYANIN; OXIDOREDUCTASE COMPLEX-I; LUNG EPITHELIAL-CELLS; SUPEROXIDE-PRODUCTION; NEUTROPHIL APOPTOSIS; REDOX REGULATION; HOST DEFENSES; ACTIVATION; INFECTION; MEMBRANE	Inflammasomes are cytosolic complexes that mature and secrete the inflammatory cytokines interleukin 1 beta (IL-1 beta) and IL-18 and induce pyroptosis. The NLRP3 (NACHT, LRR, and PYD domains-containing protein 3) inflammasome detects many pathogen-and danger-associated molecular patterns, and reactive oxygen species (ROS)/reactive nitrogen species (RNS) have been implicated in its activation. The phenazine pyocyanin (PCN) is a virulence factor of Pseudomonas aeruginosa and generates superoxide in cells. Here we report thatPCN inhibits IL-1 beta and IL-18 release and pyroptosis upon NLRP3 inflammasome activation in macrophages by preventing speck formation and Caspase-1 maturation. Of note, PCN did not regulate the AIM2 (absent in melanoma 2) or NLRC4 inflammasomes or tumor necrosis factor (TNF) secretion. Imaging of the fluorescent glutathione redox potential sensor Grx1roGFP2 indicated thatPCNprovokes cytosolic and nuclear but not mitochondrial redox changes. PCN-induced intracellular ROS/RNS inhibited the NLRP3 inflammasome posttranslationally, and hydrogen peroxide or peroxynitrite alone were sufficient to block its activation. We propose that cytosolic ROS/RNS inhibit the NLRP3 inflammasome and that PCN's anti-inflammatory activity may help P. aeruginosa evade immune recognition.	[Winter, Sebastian Virreira; Zychlinsky, Arturo] Max Planck Inst Infect Biol, Charitepl 1, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Zychlinsky, A (corresponding author), Max Planck Inst Infect Biol, Charitepl 1, D-10117 Berlin, Germany.	zychlinsky@mpiib-berlin.mpg.de		Virreira Winter, Sebastian/0000-0002-2299-8110				Abais JM, 2015, ANTIOXID REDOX SIGN, V22, P1111, DOI 10.1089/ars.2014.5994; Ahmad IM, 2011, J TOXICOL ENV HEAL A, V74, P43, DOI 10.1080/15287394.2010.514233; Allen L, 2005, J IMMUNOL, V174, P3643, DOI 10.4049/jimmunol.174.6.3643; BARON SS, 1981, ANTIMICROB AGENTS CH, V20, P814, DOI 10.1128/AAC.20.6.814; Bednash JS, 2016, CELL MOL IMMUNOL, V13, P722, DOI 10.1038/cmi.2016.15; de Zoete M. R., 2014, COLD SPRING HARB PER, V6; Deng QC, 2016, INFECT IMMUN, V84, P56, DOI 10.1128/IAI.00945-15; Fan LF, 1999, HUM GENE THER, V10, P2273, DOI 10.1089/10430349950016924; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Gurung P, 2015, TRENDS MOL MED, V21, P193, DOI 10.1016/j.molmed.2014.11.008; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hall S, 2016, TOXINS, V8, DOI 10.3390/toxins8080236; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Hughes A. J., 2015, PSEUDOMONAS, P51; Hunter RC, 2012, AM J RESP CELL MOL, V47, P738, DOI 10.1165/rcmb.2012-0088OC; Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Lavoie EG, 2011, MICROBES INFECT, V13, P1133, DOI 10.1016/j.micinf.2011.07.011; Liu SS, 1997, BIOSCIENCE REP, V17, P259, DOI 10.1023/A:1027328510931; Lo Conte M, 2013, J BIOL CHEM, V288, P26480, DOI 10.1074/jbc.R113.467738; Manago A, 2015, ANTIOXID REDOX SIGN, V22, P1097, DOI 10.1089/ars.2014.5979; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; O'Malley YQ, 2003, AM J PHYSIOL-LUNG C, V284, pL420, DOI 10.1152/ajplung.00316.2002; Pfeiffer S, 1998, MOL PHARMACOL, V53, P795, DOI 10.1124/mol.53.4.795; Rada B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054205; Rada B, 2013, TRENDS MICROBIOL, V21, P73, DOI 10.1016/j.tim.2012.10.004; Rimessi A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7201; Rottenberg H, 2009, J BIOL CHEM, V284, P19203, DOI 10.1074/jbc.M109.017376; Schwarzer C, 2008, J BIOL CHEM, V283, P27144, DOI 10.1074/jbc.M709693200; Sorbara MT, 2011, CELL RES, V21, P558, DOI 10.1038/cr.2011.20; Spalinger MR, 2016, J CLIN INVEST, V126, P1783, DOI 10.1172/JCI83669; Stutz A, 2017, J EXP MED, V214, P1725, DOI 10.1084/jem.20160933; Tsai SJ, 2009, BIOCHEMISTRY-US, V48, P4838, DOI 10.1021/bi900166y; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Usher LR, 2002, J IMMUNOL, V168, P1861, DOI 10.4049/jimmunol.168.4.1861; Yang J, 2017, CELL MOL IMMUNOL, V14, P65, DOI 10.1038/cmi.2016.29; Yang J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00333; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111; Zhao CC, 2014, J BIOL CHEM, V289, P17020, DOI 10.1074/jbc.M114.563114; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou Y, 2015, ANTON LEEUW INT J G, V108, P163, DOI 10.1007/s10482-015-0475-6	48	12	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4893	4900		10.1074/jbc.RA117.001105	http://dx.doi.org/10.1074/jbc.RA117.001105			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29414783	Green Published, hybrid			2022-12-26	WOS:000428848300028
J	Budka, M; Deoniziak, K; Tumiel, T; Wozna, JT				Budka, Michal; Deoniziak, Krzysztof; Tumiel, Tomasz; Wozna, Joanna Teresa			Vocal individuality in drumming in great spotted woodpecker-A biological perspective and implications for conservation	PLOS ONE			English	Article							CORNCRAKE CREX-CREX; ACOUSTIC-SIGNALS; SEXUAL SELECTION; RECOGNITION; IDENTIFICATION; CALLS; SONG; VOCALIZATIONS	Animals-including conservation biologists-use acoustic signals to recognise and track individuals. The majority of research on this phenomenon has focused on sounds generated by vocal organs (e.g., larynx or syrinx). However, animals also produce sounds using other parts of the body, such as the wings, tail, legs, or bill. In this study we focused on non-syrinx vocalisation of the great spotted woodpecker, called drumming. Drumming consists of strokes of a bill on a tree in short, repeated series, and is performed by both males and females to attract mates and deter rivals. Here, we considered whether the great spotted woodpecker's drumming patterns are sex-specific and whether they enable individual identification. We recorded drumming of 41 great spotted woodpeckers (26 males, 9 females, 6 unsexed). An automatic method was used to measure the intervals between succeeding strokes and to count strokes within a drumming roll. The temporal parameters of drumming that were analysed here had lower within-than between-individual coefficients of variation. Discriminant function analyses correctly assigned 70-88% of rolls to the originating individual, but this depended on whether all individuals were analysed together or split into males and females. We found slight, but significant, differences between males and females in the length of intervals between strokes-males drummed faster than females-but no difference in the number of strokes within a roll. Our study revealed that temporal patterns of drumming in the great spotted woodpecker cannot be used for unambiguous sex determination. Instead, discrimination among individuals may be possible based on the intervals between strokes and the number of strokes within a roll. Therefore, it is possible that differences in the temporal parameters of drumming may be used by birds to identify each other, as well as by researchers to aid in census and monitoring tasks.	[Budka, Michal] Adam Mickiewicz Univ, Fac Biol, Dept Behav Ecol, Poznan, Poland; [Deoniziak, Krzysztof] Univ Bialystok, Inst Biol, Lab Insect Evolutionary Biol & Ecol, Bialystok, Poland; [Tumiel, Tomasz] Wildlife Soc Dubelt, Juszkowy Grod, Poland; [Wozna, Joanna Teresa] Poznan Univ Life Sci, Inst Zool, Poznan, Poland	Adam Mickiewicz University; University of Bialystok; Poznan University of Life Sciences	Budka, M (corresponding author), Adam Mickiewicz Univ, Fac Biol, Dept Behav Ecol, Poznan, Poland.	m.budka@amu.edu.pl	Bialas, Joanna T./ABG-1876-2021; Budka, Michał/R-5812-2019	Bialas, Joanna T./0000-0002-0683-4001; Budka, Michał/0000-0002-1244-013X; Deoniziak, Krzysztof/0000-0001-6447-6655				Amorim MCP, 2008, J FISH BIOL, V73, P1267, DOI 10.1111/j.1095-8649.2008.01974.x; Aubin T, 1998, P ROY SOC B-BIOL SCI, V265, P1665, DOI 10.1098/rspb.1998.0486; Boeckle M, 2012, CURR BIOL, V22, P801, DOI 10.1016/j.cub.2012.03.023; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Bragina E, 2013, CONDOR, V115, P501, DOI 10.1525/cond.2013.110123; Briefer E, 2008, J EXP BIOL, V211, P317, DOI 10.1242/jeb.013359; Budka M, 2015, J ORNITHOL, V156, P481, DOI 10.1007/s10336-014-1149-2; Budka M, 2013, J ORNITHOL, V154, P685, DOI 10.1007/s10336-013-0933-8; Campbell KA, 2016, J ACOUST SOC AM, V140, P1598, DOI 10.1121/1.4962281; Casteren A, 2010, J EXP BIOL, V213, P1602; CATCHPOLE CK, 1987, TRENDS ECOL EVOL, V2, P94, DOI 10.1016/0169-5347(87)90165-0; Charrier I, 2001, POLAR BIOL, V24, P378, DOI 10.1007/s003000100231; Chuang MF, 2017, ANIM BEHAV, V123, P217, DOI 10.1016/j.anbehav.2016.11.001; Delport W, 2002, IBIS, V144, P30, DOI 10.1046/j.0019-1019.2001.00019.x; Dent JM, 2015, NOTORNIS, V62, P1; Dodenhoff DJ, 2001, CONDOR, V103, P143, DOI 10.1650/0010-5422(2001)103[0143:DWDEIF]2.0.CO;2; Dooling R., 2004, NATURES MUSIC SCI BI, P209; Eberhardt LS, 1997, CONDOR, V99, P798, DOI 10.2307/1370491; Eda-Fujiwara H, 2004, ZOOL SCI, V21, P817, DOI 10.2108/zsj.21.817; Elemans CPH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9978; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Florentin J, 2016, ECOL INFORM, V35, P61, DOI 10.1016/j.ecoinf.2016.08.006; Gamba M, 2012, J ETHOL, V30, P191, DOI 10.1007/s10164-011-0291-z; Grava T, 2008, IBIS, V150, P279, DOI 10.1111/j.1474-919X.2007.00776.x; Hoodless AN, 2008, IBIS, V150, P80; Janicke T, 2007, J ORNITHOL, V148, P565, DOI 10.1007/s10336-007-0195-4; KAISER M, 1990, Beitraege zur Vogelkunde, V36, P129; Kuczynski L, 2015, ATLAS POSPOLITYCH PT, P54; Michalek KG, 2001, BEHAVIOUR, V138, P1259, DOI 10.1163/15685390152822210; Michalek Klaus G., 2003, BWP Update, V5, P101; Pasinelli G, 2006, ANN ZOOL FENN, V43, P96; Peake T. M., 2001, Animal Biodiversity and Conservation, V24, P81; Peake TM, 1998, IBIS, V140, P120, DOI 10.1111/j.1474-919X.1998.tb04548.x; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; Rebbeck M, 2001, IBIS, V143, P468, DOI 10.1111/j.1474-919X.2001.tb04948.x; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Stark RD, 1998, CONDOR, V100, P350, DOI 10.2307/1370276; Terry AMR, 2005, FRONT ZOOL, V2, P10, DOI DOI 10.1186/1742-9994-2-10; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Tremain SB, 2008, WILSON J ORNITHOL, V120, P499, DOI 10.1676/07-137.1; Vignal C, 2008, BEHAV PROCESS, V77, P191, DOI 10.1016/j.beproc.2007.09.003; Xia CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042528; Zabka H, 1980, ANN OM S, V4, P51; Zsebok S, 2017, J ORNITHOL, V158, P213, DOI 10.1007/s10336-016-1376-9	45	11	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191716	10.1371/journal.pone.0191716	http://dx.doi.org/10.1371/journal.pone.0191716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415002	gold, Green Submitted, Green Published			2022-12-26	WOS:000424325300039
J	Wu, MS; Alvarado, JJ; Augelli-Szafran, CE; Ptak, RG; Smithgall, TE				Wu, Mousheng; Alvarado, John J.; Augelli-Szafran, Corinne E.; Ptak, Roger G.; Smithgall, Thomas E.			A single beta-octyl glucoside molecule induces HIV-1 Nef dimer formation in the absence of partner protein binding	PLOS ONE			English	Article							KINASE ACTIVATION; CRYSTAL-STRUCTURE; TYROSINE KINASE; DOWN-REGULATION; SH3 DOMAIN; DIMERIZATION; FEATURES; REVEALS	The HIV-1 Nef accessory protein is essential for viral pathogenicity and AIDS progression. Nef forms complexes with multiple host cell factors to facilitate viral replication and promote immune escape of HIV-infected cells. Previous X-ray crystal structures demonstrate that Nef forms homodimers, the orientation of which are influenced by host cell binding partners. In cell-based fluorescence complementation assays, Nef forms homodimers at the plasma membrane. However, recombinant Nef proteins often exist as monomers in solution, suggesting that membrane interaction may also trigger monomer to dimer transitions. In this study, we show that monomeric Nef core proteins can be induced to form dimers in the presence of low concentrations of the non-ionic surfactant, beta-octyl glucoside (beta OG). X-ray crystallography revealed that a single beta OG molecule is present in the Nef dimer, with the 8-carbon acyl chain of the ligand binding to a hydrophobic pocket formed by the dimer interface. This Nef-beta OG dimer interface involves helix alpha B, as observed in previous dimer structures, as well as a helix formed by N-terminal residues 54 +/- 66. Nef dimer formation is stabilized in solution by the addition of beta OG, providing biochemical validation for the crystal structure. These observations together suggest that the interaction with host cell lipid mediators or other hydrophobic ligands may play a role in Nef dimerization, which has been previously linked to multiple Nef functions including host cell protein kinase activation, CD4 downregulation, and enhancement of HIV-1 replication.	[Wu, Mousheng; Augelli-Szafran, Corinne E.] Southern Res Inst, Dept Chem, Drug Discovery Div, Birmingham, AL 35205 USA; [Alvarado, John J.; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Ptak, Roger G.] Southern Res Inst, Dept Infect Dis Res, Frederick, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wu, MS (corresponding author), Southern Res Inst, Dept Chem, Drug Discovery Div, Birmingham, AL 35205 USA.; Smithgall, TE (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	mwu@southernresearch.org; tsmithga@pitt.edu			NIAID NIH HHS [R01 AI102724, R01 AI057083] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102724, R01AI057083] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarado JJ, 2014, J BIOL CHEM, V289, P28539, DOI 10.1074/jbc.M114.600031; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; Breuer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020033; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dikeakos JD, 2010, MOL BIOL CELL, V21, P3279, DOI 10.1091/mbc.E10-05-0470; Emert-Sedlak L, 2009, ACS CHEM BIOL, V4, P939, DOI 10.1021/cb900195c; Emert-Sedlak LA, 2013, CHEM BIOL, V20, P82, DOI 10.1016/j.chembiol.2012.11.005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Gerlach H, 2010, NAT CHEM BIOL, V6, P46, DOI [10.1038/NCHEMBIO.268, 10.1038/nchembio.268]; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Horenkamp FA, 2011, TRAFFIC, V12, P867, DOI 10.1111/j.1600-0854.2011.01205.x; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Joseph AM, 2005, CURR HIV RES, V3, P87, DOI 10.2174/1570162052773013; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moroco JA, 2017, J MOL BIOL IN PRESS; Mujib S, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93684; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Narute PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032561; Pereira EA, 2016, HIV 1 NEF TAKING CON; Pham TNQ, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-15; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Readinger JA, 2008, P NATL ACAD SCI USA, V105, P6684, DOI 10.1073/pnas.0709659105; Ren XF, 2014, ELIFE, V3, DOI 10.7554/eLife.01754; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Shu ST, 2017, J BIOL CHEM, V292, P2670, DOI 10.1074/jbc.M116.770016; Singh P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026629; Smithgall T. E., 2013, DRUG DISCOV TODAY TE, V10, P523; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tarafdar S, 2014, J BIOL CHEM, V289, P15718, DOI 10.1074/jbc.M114.572099; Trible RP, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-135; Veillette M, 2014, J VIROL, V88, P2633, DOI 10.1128/JVI.03230-13; Watkins RL, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0187-z; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Ye HH, 2004, BIOCHEMISTRY-US, V43, P15775, DOI 10.1021/bi048712f; Zou W, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-44	46	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192512	10.1371/journal.pone.0192512	http://dx.doi.org/10.1371/journal.pone.0192512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415006	gold, Green Published, Green Submitted			2022-12-26	WOS:000424325300083
J	Kinoshita, A; Baffa, O; Mascarenhas, S				Kinoshita, Angela; Baffa, Oswaldo; Mascarenhas, Sergio			Electron spin resonance (ESR) dose measurement in bone of Hiroshima A-bomb victim	PLOS ONE			English	Article							EPR-DOSIMETRY; TOOTH ENAMEL; RADIATION-DOSIMETRY; THERMOLUMINESCENCE; RECONSTRUCTION	Explosion of the bombs in Hiroshima and Nagasaki corresponds to the only historical moment when atomic bombs were used against civilians. This event triggered countless investigations into the effects and dosimetry of ionizing radiation. However, none of the investigations has used the victims' bones as dosimeter. Here, we assess samples of bones obtained from fatal victims of the explosion by Electron Spin Resonance (ESR). In 1973, one of the authors of the present study (SM) traveled to Japan and conducted a preliminary experiment on the victims' bone samples. The idea was to use the paramagnetism induced in bone after irradiation to measure the radiation dose. Technological advances involved in the construction of spectrometers, better knowledge of the paramagnetic center, and improvement in signal processing techniques have allowed us to resume the investigation. We obtained a reconstructed dose of 9.46 +/- 3.4 Gy from the jawbone, which was compatible with the dose distribution in different locations as measured in non-biological materials such as wall bricks and roof tiles.	[Kinoshita, Angela; Baffa, Oswaldo] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Fis, Ribeirao Preto, SP, Brazil; [Kinoshita, Angela] Univ Sagrado Coracao, Pro Reitoria Pesquisa Posgrad, Sao Paulo, Brazil; [Mascarenhas, Sergio] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Universidade do Sagrado Coracao; Universidade de Sao Paulo	Kinoshita, A (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Fis, Ribeirao Preto, SP, Brazil.; Kinoshita, A (corresponding author), Univ Sagrado Coracao, Pro Reitoria Pesquisa Posgrad, Sao Paulo, Brazil.	angelamitie@gmail.com	Filho, Oswaldo Baffa/E-3251-2012; Kinoshita, Angela/C-6946-2012	Filho, Oswaldo Baffa/0000-0002-0622-2814; Kinoshita, Angela/0000-0002-5057-1667				ARAKAWA ET, 1960, NEW ENGL J MED, V263, P488, DOI 10.1056/NEJM196009082631005; Breen SL, 1995, PHYS MED BIOL, V40, P2065, DOI 10.1088/0031-9155/40/12/005; CALLENS FJ, 1987, CALCIFIED TISSUE INT, V41, P124, DOI 10.1007/BF02563791; Chumak V, 1996, APPL RADIAT ISOTOPES, V47, P1281, DOI 10.1016/S0969-8043(96)00231-X; Clairand I, 2006, RADIAT PROT DOSIM, V119, P500, DOI 10.1093/rpd/nci516; Bruno AC, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431x20165848, 10.1590/1414-431X20165848]; De TI, 2013, APPL MAGN RESON, V44, P375, DOI 10.1007/s00723-012-0379-9; Degteva MO, 2015, RADIAT ENVIRON BIOPH, V54, P433, DOI 10.1007/s00411-015-0611-8; DESROSIERS MF, 1993, APPL RADIAT ISOTOPES, V44, P459, DOI 10.1016/0969-8043(93)90267-E; DESROSIERS MF, 1991, HEALTH PHYS, V61, P859, DOI 10.1097/00004032-199112000-00018; Egersdorfer S, 1996, APPL RADIAT ISOTOPES, V47, P1299, DOI 10.1016/S0969-8043(96)00233-3; Gritzner ML., 1987, REASSESSMENT ATOMIC, V2, P342; Herodin F, 2005, EXP HEMATOL, V33, P1071, DOI 10.1016/j.exphem.2005.04.007; HIGASHIMURA T, 1963, SCIENCE, V139, P1284, DOI 10.1126/science.139.3561.1284-a; ICHIKAWA Y, 1966, HEALTH PHYS, V12, P395, DOI 10.1097/00004032-196603000-00013; Ignatiev EA, 1999, APPL RADIAT ISOTOPES, V51, P151, DOI 10.1016/S0969-8043(98)00133-X; IKEYA M, 1984, JPN J APPL PHYS 2, V23, pL697, DOI 10.1143/JJAP.23.L697; Imanaka T, 2008, RADIAT ENVIRON BIOPH, V47, P297, DOI 10.1007/s00411-008-0176-x; JUNWANG G, 2014, PLOS ONE, V0009; Kinoshita A, 2003, HEALTH PHYS, V84, P477, DOI 10.1097/00004032-200304000-00007; Kinoshita A, 2001, APPL RADIAT ISOTOPES, V54, P269, DOI 10.1016/S0969-8043(00)00159-7; Kinoshita A, 2014, J HUM EVOL, V77, P187, DOI 10.1016/j.jhevol.2014.09.006; KOBERLE G, 1973, AN ACAD BRAS CIENC, V45, P157; Krefft K, 2014, RADIAT PROT DOSIM, V162, P38, DOI 10.1093/rpd/ncu214; MASCARENHAS S, 1973, B AM PHYS SOC, V18, P579; MASCARENHAS S, 1982, AM J PHYS ANTHROPOL, V59, P413, DOI 10.1002/ajpa.1330590411; Milton RC, 1968, TENTATIVE 1965 RAD D; Moulder JE, 2004, INT J RADIAT BIOL, V80, P3, DOI 10.1080/09553000310001642920; Nakamura N, 1998, INT J RADIAT BIOL, V73, P619, DOI 10.1080/095530098141870; Physical Measurement Laboratory, XRAY MASS ATT COEFF; Portas M, 2016, RADIAT PROT DOSIM, V171, P99, DOI 10.1093/rpd/ncw206; Schauer DA, 1996, APPL RADIAT ISOTOPES, V47, P1345, DOI 10.1016/S0969-8043(96)00203-5; Schauer DA, 2006, RADIAT MEAS, V41, pS117, DOI 10.1016/j.radmeas.2007.01.006; Shishkina EA, 2016, RADIAT ENVIRON BIOPH, V55, P477, DOI 10.1007/s00411-016-0666-1; Simon SL, 2007, RADIAT MEAS, V42, P948, DOI 10.1016/j.radmeas.2007.05.036; Skinner AR, 2000, APPL RADIAT ISOTOPES, V52, P1311, DOI 10.1016/S0969-8043(00)00089-0; Swartz HM, 2012, HEALTH PHYS, V103, P255, DOI 10.1097/HP.0b013e3182588d92; Wieser A, 2006, RADIAT PROT DOSIM, V120, P176, DOI 10.1093/rpd/nci549; Wieser A, 2000, RADIAT MEAS, V32, P549, DOI 10.1016/S1350-4487(00)00060-3; WIESER A, 1994, APPL RADIAT ISOTOPES, V45, P525, DOI 10.1016/0969-8043(94)90119-8	40	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192444	10.1371/journal.pone.0192444	http://dx.doi.org/10.1371/journal.pone.0192444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408890	Green Published, Green Submitted, gold			2022-12-26	WOS:000424302800066
J	Liu, HH; Wang, JW; Li, L; Han, CC; He, H; Xu, HY				Liu, Hehe; Wang, Jiwen; Li, Liang; Han, Chunchun; He, Hua; Xu, Hengyong			Transcriptome analysis revealed the possible regulatory pathways initiating female geese broodiness within the hypothalamic-pituitary-gonadal axis	PLOS ONE			English	Article							EXPRESSION; GENES; INVOLVEMENT; GRANULOSA; FOLLICLE; OVARY; KEGG	Geese have the strongest tendency toward broodiness among all poultry. The mechanisms initiating broodiness within the goose hypothalamic-pituitary-gonadal axis (HPGA) are still unclear. Here, we reported the transcriptome differences between laying and initial nesting within the HPGA tissues of geese. We constructed a unigene database based on HPGA tissues and identified 128,148 unigenes, 100% of which have been annotated. By using Digital Gene Expression (DGE) sequencing, we screened 19, 110, 289, and 211 differentially expressed genes (DEGs) in the hypothalamus, pituitary gland, stroma ovarii, and follicles, respectively, between laying and nesting geese. Expression changes of hypocretin (HCRT) and pro-opiomelanocortin (POMC) in the hypothalamus of nesting geese may cause appetite reduction, which is possibly the first step and a prerequisite to initiate broodiness. In addition to prolactin (PRL), follicle-stimulating hormone (FSH) and luteinizing hormone (LH), genes including oxytocin-neurophysin (OXT), chordin-like protein 1 (CHRDL1) and growth hormone (GH), expressed in the pituitary gland, are new candidate molecules that may be involved in broodiness in geese. Heme oxygenase 1 (HMOX1) in the pituitary gland, the proto-oncogene c-Fos (FOS), heat shock protein 90-alpha (HSP90AA), and cyclin-dependent kinase 1 (CDK1) in the ovary that may consolidate and transduce signals regulating the HPGA during broodiness in geese.	[Liu, Hehe; Wang, Jiwen; Li, Liang; Han, Chunchun; He, Hua; Xu, Hengyong] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Wang, JW (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Sichuan, Peoples R China.	wjw2886166@163.com	Li, Liang/AAG-7614-2020	Wang, Jiwen/0000-0001-8568-7654; Li, Liang/0000-0001-9139-5025				[Anonymous], [No title captured]; Chen F, 2014, MOL BIOL REP, V41, P2767, DOI 10.1007/s11033-014-3131-8; Chou YY, 2013, INT J GYNECOL CANCER, V23, P343, DOI 10.1097/IGC.0b013e31827eaa78; Chu SC, 2014, BRIT J PHARMACOL, V171, P3223, DOI 10.1111/bph.12667; Cyrdepauw C, 2016, MOL CELLULAR BIOL; de la Iglesia HO, 2006, ENDOCRINOLOGY, V147, P1148, DOI 10.1210/en.2005-1311; Fukunaka Y, 2007, NEUROMOL MED, V9, P292, DOI 10.1007/s12017-007-8001-2; Gajjar K, 2012, CANCER LETT, V324, P13, DOI 10.1016/j.canlet.2012.04.021; Gao GL, 2015, ANIM SCI J, V86, P800, DOI 10.1111/asj.12356; Geng AL, 2014, BRIT POULTRY SCI, V55, P264, DOI 10.1080/00071668.2013.878782; Goldman S, 2004, FRONT BIOSCI-LANDMRK, V9, P2474, DOI 10.2741/1409; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-24, 10.1186/1471-2164-15-40]; Hocking P, 2009, BIOL BREEDING POULTR, P243; Hummel S, 2004, J BIOL CHEM, V279, P23486, DOI 10.1074/jbc.M312694200; Hunt PA, 2012, P NATL ACAD SCI USA, V109, P17525, DOI 10.1073/pnas.1207854109; Jones BE, 2013, SLEEP, V36, P1769, DOI 10.5665/sleep.3188; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113211; Luan XH, 2014, MOL BIOL REP, V41, P3401, DOI 10.1007/s11033-014-3202-x; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; McGowan BM, 2008, AM J PHYSIOL-ENDOC M, V295, pE278, DOI 10.1152/ajpendo.00028.2008; Oliveira-Ferrer L, 2014, BRIT J CANCER, V110, P753, DOI 10.1038/bjc.2013.774; Qi X, 2013, PLOS ONE, V8; Qi X, 2014, PLOS ONE, V9; Shimizu T, 2009, ANIM REPROD SCI, V116, P28, DOI 10.1016/j.anireprosci.2009.01.009; SOLOFF MS, 1977, FED PROC, V36, P1861; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tanriverdi F, 2003, J ENDOCRINOL, V176, P293, DOI 10.1677/joe.0.1760293; Thakur S, 2015, J NEUROENDOCRINOL, V14, P364; Thompson IR, 2014, MOL CELL ENDOCRINOL, V385, P28, DOI 10.1016/j.mce.2013.09.012; Tsutsui K, 2010, FRONT NEUROENDOCRIN, V31, P284, DOI 10.1016/j.yfrne.2010.03.001; Vanderhyden B, 2002, FRONT BIOSCI-LANDMRK, V7, pD2006, DOI 10.2741/vander; Wagener FADTG, 2008, ARTHRITIS RHEUM, V58, P3388, DOI 10.1002/art.23970; Wang GY, 2005, J FUJIAN AGR FORESTR; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; WITKIN JW, 1994, ENDOCRINOLOGY, V135, P956, DOI 10.1210/en.135.3.956; Yen CF, 2006, POULTRY SCI, V85, P2265, DOI 10.1093/ps/85.12.2265; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhao P, 2011, HUM REPROD, V26, P695, DOI 10.1093/humrep/deq390	42	16	19	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191213	10.1371/journal.pone.0191213	http://dx.doi.org/10.1371/journal.pone.0191213			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408859	Green Published, Green Submitted, gold			2022-12-26	WOS:000424302800012
J	Sparks, ME; Bottner-Parker, KD; Gundersen-Rindal, DE; Lee, IM				Sparks, Michael E.; Bottner-Parker, Kristi D.; Gundersen-Rindal, Dawn E.; Lee, Ing-Ming			Draft genome sequence of the New Jersey aster yellows strain of 'Candidatus Phytoplasma asteris'	PLOS ONE			English	Article							PROTEIN; CLASSIFICATION; GENERATION; PREDICTION; ELEMENTS; INSECT	The NJAY (New Jersey aster yellows) strain of Candidatus Phytoplasma asteris' is a significant plant pathogen responsible for causing severe lettuce yellows in the U.S. state of New Jersey. A draft genome sequence was prepared for this organism. A total of 177,847 reads were assembled into 75 contigs > 518 bp with a total base value of 652,092 and an overall [G+C] content of 27.1%. A total of 733 protein coding genes were identified. This Whole Genome Shotgun project has been deposited at DDBJ/ENA/GenBank under the accession MAPF00000000. This draft genome was used for genome- and gene-based comparative phylogenetic analyses with other phytoplasmas, including the closely related 'Ca. Phytoplasma asteris' strain, aster yellows witches'-broom (AY-WB). NJAY and AY-WB exhibit approximately 0.5% dissimilarity at the nucleotide level among their shared genomic segments. Evidence indicated that NJAY harbors four plasmids homologous to those known to encode pathogenicity determinants in AY-WB, as well as a chromosome-encoded mobile unit. Apparent NJAY orthologs to the important AY-WB virulence factors, SAP11 and SAP54, were identified. A number of secreted proteins, both membrane-bound and soluble, were encoded, with many bearing similarity to known AY-WB effector molecules and others representing possible secreted proteins that may be novel to the NJAY lineage.	[Sparks, Michael E.; Gundersen-Rindal, Dawn E.] USDA ARS, Invas Insect Biocontrol & Behav Lab, Beltsville, MD 20705 USA; [Bottner-Parker, Kristi D.; Lee, Ing-Ming] USDA ARS, Mol Plant Pathol Lab, Beltsville, MD 20705 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Lee, IM (corresponding author), USDA ARS, Mol Plant Pathol Lab, Beltsville, MD 20705 USA.	ingming.lee@ars.usda.gov		Sparks, Michael/0000-0001-6251-8559				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen MT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-529; Bai XD, 2006, J BACTERIOL, V188, P3682, DOI 10.1128/JB.188.10.3682-3696.2006; Bai XD, 2009, MOL PLANT MICROBE IN, V22, P18, DOI 10.1094/MPMI-22-1-0018; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Chang SH, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01398-15; Chen WJ, 2014, 2014 INTERNATIONAL SYMPOSIUM ON ANTENNAS AND PROPAGATION (ISAP), P9, DOI 10.1109/ISANP.2014.7026484; Chung WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062770; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fischer A, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00297-16; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; GUNDERSEN DE, 1994, J BACTERIOL, V176, P5244, DOI 10.1128/JB.176.17.5244-5254.1994; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kakizawa S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00944-14; KUBE M, 2008, BMC GENOMICS, V9, P5040; Lee I. M., 1988, Molecular Plant-Microbe Interactions, V1, P303, DOI 10.1094/MPMI-1-303; Lee IM, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01117-15; Lee IM, 2004, INT J SYST EVOL MICR, V54, P1037, DOI 10.1099/ijs.0.02843-0; LEE IM, 1992, PHYTOPATHOLOGY, V82, P977, DOI 10.1094/Phyto-82-977; Lee IM, 1998, INT J SYST BACTERIOL, V48, P1153, DOI 10.1099/00207713-48-4-1153; LEE IM, 1983, PHYTOPATHOLOGY, V73, P1540, DOI 10.1094/Phyto-73-1540; LIN CP, 1986, PHYTOPATHOLOGY, V76, P45, DOI 10.1094/Phyto-76-45; MacLean AM, 2011, PLANT PHYSIOL, V157, P831, DOI 10.1104/pp.111.181586; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mitrovic J, 2014, J MOL MICROB BIOTECH, V24, P1, DOI 10.1159/000353904; Orlovskis Z, 2017, ANN BOT-LONDON, V119, P869, DOI 10.1093/aob/mcw213; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Porollo A, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-19; Quaglino F, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0487-4; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Saccardo F, 2012, MICROBIOL-SGM, V158, P2805, DOI 10.1099/mic.0.061432-0; The International Research Programme for Comparative Mycoplasmology Phytoplasma/Spiroplasma Working Team - Phytoplasma Taxonomy Group, 2004, International Journal of Systematic and Evolutionary Microbiology, V54, P1243, DOI 10.1099/ijs.0.02854-0; Toruno TY, 2010, MOL MICROBIOL, V77, P1406, DOI 10.1111/j.1365-2958.2010.07296.x; Tran-Nguyen LTT, 2008, J BACTERIOL, V190, P3979, DOI 10.1128/JB.01301-07; Zamorano A, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00602-16; Zhao Y, 2016, INT J SYST EVOL MICR, V66, P2121, DOI 10.1099/ijsem.0.000999; Zhu YZ, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00430-17	43	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192379	10.1371/journalpone.0192379	http://dx.doi.org/10.1371/journalpone.0192379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408883				2022-12-26	WOS:000424302800059
J	You, JC; Stephens, GS; Fu, CH; Zhang, XH; Liu, Y; Chin, J				You, Jason C.; Stephens, Gabriel S.; Fu, Chia-Hsuan; Zhang, Xiaohong; Liu, Yin; Chin, Jeannie			Genome-wide profiling reveals functional diversification of Delta FosB gene targets in the hippocampus of an Alzheimer's disease mouse model	PLOS ONE			English	Article							EPILEPTIFORM ACTIVITY; NEURONAL-ACTIVITY; EXPRESSION; INDUCTION; ASEF2; BRAIN; IDENTIFICATION; DYSFUNCTION; IMPAIRMENTS; ACTIVATION	The activity-induced transcription factor Delta FosB has been implicated in Alzheimer's disease (AD) as a critical regulator of hippocampal function and cognition downstream of seizures and network hyperexcitability. With its long half-life (> 1 week), Delta FosB is well-poised to modulate hippocampal gene expression over extended periods of time, enabling effects to persist even during seizure-free periods. However, the transcriptional mechanisms by which Delta FosB regulates hippocampal function are poorly understood due to lack of identified hippocampal gene targets. To identify putative Delta FosB gene targets, we employed high-throughput sequencing of genomic DNA bound to Delta FosB after chromatin immunoprecipitation (ChIP-sequencing). We compared ChIP-sequencing results from hippocampi of transgenic mice expressing mutant human amyloid precursor protein (APP) and nontransgenic (NTG) wild-type littermates. Surprisingly, only 52 Delta FosB gene targets were shared between NTG and APP mice; the vast majority of targets were unique to one genotype or the other. We also found a functional shift in the repertoire of Delta FosB gene targets between NTG and APP mice. A large number of targets in NTG mice are involved in neurodevelopment and/or cell morphogenesis, whereas in APP mice there is an enrichment of targets involved in regulation of membrane potential and neuronal excitability. RNA-sequencing and quantitative PCR experiments confirmed that expression of putative Delta FosB gene targets were altered in the hippocampus of APP mice. This study provides key insights into functional domains regulated by Delta FosB in the hippocampus, emphasizing remarkably different programs of gene regulation under physiological and pathological conditions.	[You, Jason C.; Zhang, Xiaohong] Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA; [You, Jason C.; Zhang, Xiaohong] Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA; [You, Jason C.; Stephens, Gabriel S.; Fu, Chia-Hsuan; Chin, Jeannie] Baylor Coll Med, Dept Neurosci, Memory & Brain Res Ctr, Houston, TX 77030 USA; [Liu, Yin] Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX USA	Jefferson University; Jefferson University; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Chin, J (corresponding author), Baylor Coll Med, Dept Neurosci, Memory & Brain Res Ctr, Houston, TX 77030 USA.	Jeannie.Chin@bcm.edu		Fu, Chia-Hsuan/0000-0002-0905-8917; Chin, Jeannie/0000-0001-9902-3744; Stephens, Gabriel/0000-0001-5665-4482	National Institute of Neurological Disorders and Stroke [NS085171, NS086965]; National Institute on Aging [AG048710]; Margaret Q. Landenberger Biomedical Research Foundation; Hassel Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085171, R01NS086965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG048710] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Margaret Q. Landenberger Biomedical Research Foundation; Hassel Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Neurological Disorders and Stroke NS085171 to JC; National Institute on Aging AG048710 to JCY; Margaret Q. Landenberger Biomedical Research Foundation research grant to JC; Hassel Family Foundation research grant to JC; National Institute of Neurological Disorders and Stroke NS086965 to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biagini G, 2005, NEUROMOL MED, V7, P325, DOI 10.1385/NMM:7:4:325; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Carle TL, 2007, EUR J NEUROSCI, V25, P3009, DOI 10.1111/j.1460-9568.2007.05575.x; Chen JS, 2000, J NEUROSCI, V20, P8965; Chen JS, 1997, J NEUROSCI, V17, P4933; Chin J, 2013, EPILEPSY BEHAV, V26, P343, DOI 10.1016/j.yebeh.2012.11.040; Corbett BF, 2017, CELL REP, V20, P344, DOI 10.1016/j.celrep.2017.06.040; Curia G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00046; de Wit J, 2013, NEURON, V79, P696, DOI 10.1016/j.neuron.2013.06.049; Diering GH, 2017, SCIENCE, V355, P511, DOI 10.1126/science.aai8355; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Dong HW, 2009, P NATL ACAD SCI USA, V106, P11794, DOI 10.1073/pnas.0812608106; Eagle AL, 2015, J NEUROSCI, V35, P13773, DOI 10.1523/JNEUROSCI.2083-15.2015; Evans JC, 2015, J BIOL CHEM, V290, P10295, DOI 10.1074/jbc.M114.605543; Giordano C, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00281; Giordano C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141221; Hall AM, 2015, J NEUROSCI, V35, P6221, DOI 10.1523/JNEUROSCI.2552-14.2015; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; Jen YHLD, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-33; Kawasaki Y, 2007, ONCOGENE, V26, P7620, DOI 10.1038/sj.onc.1210574; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Koberstein JN, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan6500; Kurushima H, 2005, CELL DEATH DIFFER, V12, P1078, DOI 10.1038/sj.cdd.4401648; Minatohara Keiichiro, 2015, Front Mol Neurosci, V8, P78, DOI 10.3389/fnmol.2015.00078; Morris TA, 2000, MOL BRAIN RES, V79, P138, DOI 10.1016/S0169-328X(00)00112-1; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nestler EJ, 2015, EUR J PHARMACOL, V753, P66, DOI [10.1016/j.ejphar.2014.1.0.034, 10.1016/j.ejphar.2014.10.034]; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Ran X, 2015, NUCLEIC ACIDS RES, V43, pD893, DOI 10.1093/nar/gku943; Renthal W, 2008, J NEUROSCI, V28, P7344, DOI 10.1523/JNEUROSCI.1043-08.2008; Ridgway LD, 2009, AM J PHYSIOL-CELL PH, V297, pC55, DOI 10.1152/ajpcell.00073.2009; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Sagara M, 2009, ONCOGENE, V28, P1357, DOI 10.1038/onc.2008.478; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Su YJ, 2017, NAT NEUROSCI, V20, P476, DOI 10.1038/nn.4494; Ulery-Reynolds PG, 2009, NEUROSCIENCE, V158, P369, DOI 10.1016/j.neuroscience.2008.10.059; Vossel KA, 2016, ANN NEUROL, V80, P858, DOI 10.1002/ana.24794; Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136; You JC, 2017, NAT MED, V23, P1377, DOI 10.1038/nm.4413; Zhang Y, 2017, NEURON, V95, P1103, DOI 10.1016/j.neuron.2017.08.010	49	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192508	10.1371/journal.pone.0192508	http://dx.doi.org/10.1371/journal.pone.0192508			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408867	Green Published, Green Submitted, gold			2022-12-26	WOS:000424302800075
J	Koizumi, K; Tayama, J; Ishioka, T; Nakamura-Thomas, H; Suzuki, M; Hara, M; Makita, S; Hamaguchi, T				Koizumi, Kohei; Tayama, Jun; Ishioka, Toshiyuki; Nakamura-Thomas, Hiromi; Suzuki, Makoto; Hara, Motohiko; Makita, Shigeru; Hamaguchi, Toyohiro			Anxiety, fatigue, and attentional bias toward threat in patients with hematopoietic tumors	PLOS ONE			English	Article							FACIAL EXPRESSION RECOGNITION; RANDOMIZED CONTROLLED-TRIAL; CANCER-PATIENTS; PSYCHOLOGICAL DISTRESS; EMOTIONAL DISORDERS; SELECTIVE ATTENTION; TERMINALLY-ILL; BREAST-CANCER; DEPRESSION; INFORMATION	Cancer patients with hematopoietic tumors exhibit particularly high rates of anxiety disorders and depression, and often develop negative affect. In addition, psychological problems experienced by cancer patients impair their quality of life. When cancer patients feel anxious, they tend to direct their attention toward stimuli associated with threat in the surrounding environment. If attentional bias occurs in patients with hematopoietic tumors, who are at particular risk of developing negative affect, resolution of the bias could be useful in alleviating their anxiety. The current study examined the association between attentional bias and negative affect in patients with hematopoietic tumors and tested the hypothesis that negative affect would be more severe in those who exhibited greater attentional bias. Twenty-seven patients with hematopoietic tumors participated in the study. Reaction time (RT) was measured as the time between the presentation of the threatening and neutral images, and the subject's button press to indicate choice (neutral expressions). Eight combinations of "threatening" expressions with high emotional valence and "neutral" expressions with low emotional valence were presented. The images used to measure attentional bias were taken from the Japanese Female Facial Expression Database and had been rated as expressive of anger, sadness, or neutrality, with predetermined emotional valence. Psychological testing was performed with the Profile of Mood States (POMS). To examine the association between attentional bias and negative affect, we calculated Spearman's rank correlation coefficients for RTs and POMS. Subjects' mean RT was 882.9 (SD = 100.9) ms, and 19 of the 27 subjects exhibited slower RTs relative to healthy individuals. RT was significantly positively correlated with Tension-Anxiety (r = .679, p < .01) and Fatigue (r = .585, p < .01) subscale scores. The results of the study suggested that attentional bias toward threatening expressions could be positively correlated with the mental intensity of anxiety and fatigue in patients with hematopoietic tumors.	[Koizumi, Kohei; Ishioka, Toshiyuki; Nakamura-Thomas, Hiromi; Suzuki, Makoto; Hamaguchi, Toyohiro] Saitama Prefectural Univ, Grad Sch Hlth Sci, Dept Occupat Therapy, Koshigaya, Saitama, Japan; [Koizumi, Kohei; Makita, Shigeru] Saitama Med Univ, Saitama Int Med Ctr, Dept Cardiac Rehabil, Hidaka, Saitama, Japan; [Tayama, Jun] Nagasaki Univ, Grad Sch Educ, Nagasaki, Japan; [Hara, Motohiko] Saitama Prefectural Univ, Sch Hlth & Social Serv, Koshigaya, Saitama, Japan	Saitama Medical University; Nagasaki University	Hamaguchi, T (corresponding author), Saitama Prefectural Univ, Grad Sch Hlth Sci, Dept Occupat Therapy, Koshigaya, Saitama, Japan.	hamaguchi-toyohiro@spu.ac.jp	Hamaguchi, Toyohiro/J-4911-2019; Hamaguchi, Toyohiro/AAG-7808-2020	Ishioka, Toshiyuki/0000-0002-3987-0383; Hamaguchi, Toyohiro/0000-0001-5645-0439; Tayama, Jun/0000-0002-4689-6880	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP15K01657]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number JP15K01657 to TH. https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-15K01657/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1997, LEARN MEMORY, V4, P291, DOI 10.1101/lm.4.3.291; AKABAYASHI A, 1991, Japanese Journal of Psychosomatic Medicine, V31, P577; Akechi T, 2006, J PAIN SYMPTOM MANAG, V31, P5, DOI 10.1016/j.jpainsymman.2005.05.016; Akechi T, 2011, PSYCHO-ONCOLOGY, V20, P497, DOI 10.1002/pon.1757; ALEXANDER PJ, 1993, ACTA ONCOL, V32, P623, DOI 10.3109/02841869309092441; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Butow P, 2015, PSYCHO-ONCOLOGY, V24, P416, DOI 10.1002/pon.3659; Cassileth BR, 2003, CANCER, V98, P2723, DOI 10.1002/cncr.11842; CHOCHINOV HM, 1994, AM J PSYCHIAT, V151, P537; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Clinton-McHarg T, 2014, J AFFECT DISORDERS, V165, P176, DOI 10.1016/j.jad.2014.04.072; Courneya KS, 2000, PSYCHO-ONCOLOGY, V9, P127, DOI 10.1002/(SICI)1099-1611(200003/04)9:2<127::AID-PON438>3.0.CO;2-L; Crombez G, 2013, PAIN, V154, P497, DOI 10.1016/j.pain.2012.11.013; Dailey MN, 2010, EMOTION, V10, P874, DOI 10.1037/a0020019; Deimling GT, 2006, PSYCHO-ONCOL, V15, P306, DOI 10.1002/pon.955; DEROGATIS LR, 1983, JAMA-J AM MED ASSOC, V249, P751, DOI 10.1001/jama.249.6.751; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Eldar S, 2012, AM J PSYCHIAT, V169, P213, DOI 10.1176/appi.ajp.2011.11060886; Erblich J, 2003, HEALTH PSYCHOL, V22, P235, DOI 10.1037/0278-6133.22.3.235; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Guidelines for Cancer Rehabilitation, 2013, THE JAPANESE ASSOCIA, P113; Hakamata Y, 2010, BIOL PSYCHIAT, V68, P982, DOI 10.1016/j.biopsych.2010.07.021; Hankin BL, 2010, J ABNORM PSYCHOL, V119, P491, DOI 10.1037/a0019609; Hirai K, 2015, EUR J ONCOL NURS, V19, P427, DOI 10.1016/j.ejon.2014.12.004; Hou R, 2008, J PSYCHOSOM RES, V65, P47, DOI 10.1016/j.jpsychores.2008.03.008; Hou RH, 2014, BEHAV RES THER, V52, P9, DOI 10.1016/j.brat.2013.10.005; Hu L, 2012, NEUROIMAGE, V62, P217, DOI 10.1016/j.neuroimage.2012.03.094; Inui K, 2006, J NEUROPHYSIOL, V96, P775, DOI 10.1152/jn.00103.2006; Kopp M, 2001, EUR J HAEMATOL, V67, P54, DOI 10.1034/j.1600-0609.2001.067001054.x; Krolak-Salmon P, 2004, NEURON, V42, P665, DOI 10.1016/S0896-6273(04)00264-8; Linden W, 2012, J AFFECT DISORDERS, V141, P343, DOI 10.1016/j.jad.2012.03.025; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; MAUNSELL E, 1992, CANCER-AM CANCER SOC, V70, P120, DOI 10.1002/1097-0142(19920701)70:1<120::AID-CNCR2820700120>3.0.CO;2-U; Mogg K, 1999, BEHAV RES THER, V37, P595, DOI 10.1016/S0005-7967(98)00158-2; Mogg K, 2002, BEHAV RES THER, V40, P1403, DOI 10.1016/S0005-7967(02)00017-7; Mohlman J, 2013, J ANXIETY DISORD, V27, P585, DOI 10.1016/j.janxdis.2013.06.005; Musa C, 2003, BEHAV RES THER, V41, P1043, DOI 10.1016/S0005-7967(02)00212-7; Nakatomi Y, 2014, J NUCL MED, V55, P945, DOI 10.2967/jnumed.113.131045; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Patel Salil H, 2005, Int J Med Sci, V2, P147; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Tashiro M, 2001, PSYCHO-ONCOL, V10, P541, DOI 10.1002/pon.548; Traeger L, 2012, J CLIN ONCOL, V30, P1197, DOI 10.1200/JCO.2011.39.5632; Valstar MF, 2012, IEEE T SYST MAN CY B, V42, P966, DOI 10.1109/TSMCB.2012.2200675; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Yokoyama K, 1990, Nihon Koshu Eisei Zasshi, V37, P913; Yokoyama K, 1990, Sangyo Igaku, V32, P354; Ziemann U, 1998, J PHYSIOL-LONDON, V511, P181, DOI 10.1111/j.1469-7793.1998.181bi.x	52	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192056	10.1371/journal.pone.0192056	http://dx.doi.org/10.1371/journal.pone.0192056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401504	Green Submitted, Green Published, gold			2022-12-26	WOS:000424101400033
J	Zhang, R; Pu, WY; Zhang, SY; Chen, L; Zhu, WP; Xiao, L; Xing, CG; Li, K				Zhang, Rong; Pu, Wangyang; Zhang, Shuyun; Chen, Li; Zhu, Weipei; Xiao, Li; Xing, Chungen; Li, Kai			Clinical value of ALU concentration and integrity index for the early diagnosis of ovarian cancer: A retrospective cohort trial	PLOS ONE			English	Article							PLASMA DNA INTEGRITY; CELL-FREE DNA; TUMOR DNA; HYPERMETHYLATION; SERUM	CA125 amounts have a large overlap in ovarian cancer and benign diseases. We conducted a retrospective cohort trial to assess the clinical value of circulating cell-free DNA concentration and integrity index for the diagnosis of ovarian cancer. A total of 150 patients were recruited. Plasma samples of 24 ovarian cancer patients, 12 benign ovarian cysts, and 12 healthy controls were assessed. By amplifying short ALU-115 repeat and long ALU-219 fragments, circulating cell-free DNA concentrations and integrity index were measured. Plasma ALU-219 fragment levels and integrity index were significantly higher in the ovarian cancer group compared with the benign disease and healthy control groups (p = 0.023 and p = 0.004, respectively). These findings indicated that plasma ALU-219 levels and integrity may have a clinical value in the early diagnosis of ovarian cancer.	[Zhang, Rong; Zhang, Shuyun; Chen, Li; Zhu, Weipei] Soochow Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Suzhou, Peoples R China; [Pu, Wangyang] Soochow Univ, Affiliated Hosp 2, Dept Oncol, Suzhou, Peoples R China; [Xiao, Li; Li, Kai] Soochow Univ, Affiliated Hosp 2, Dept Mol Med Ctr, Suzhou, Peoples R China; [Xing, Chungen] Soochow Univ, Affiliated Hosp 2, Dept Gen Surg, Suzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Li, K (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Mol Med Ctr, Suzhou, Peoples R China.; Xing, CG (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Gen Surg, Suzhou, Peoples R China.	xingcg@126.com; kaili34@yahoo.com			National Natural Science Foundation of China [81301267]; Suzhou Science and Technology Development Program [SZS201618]; research foundation of the Second Affiliated Hospital of Soochow University [SDFEYQN201302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou Science and Technology Development Program; research foundation of the Second Affiliated Hospital of Soochow University	We acknowledge the financial supports of the National Natural Science Foundation of China (No. 81301267), the Suzhou Science and Technology Development Program (SZS201618), and the research foundation of the Second Affiliated Hospital of Soochow University (SDFEYQN201302) (S4 File). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers SN, 2014, GYNECOL ONCOL, V132, P462, DOI 10.1016/j.ygyno.2013.12.024; Bai H, 2012, J CLIN ONCOL, V30, P3077, DOI 10.1200/JCO.2011.39.3744; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Chiang PW, 1999, CLIN CANCER RES, V5, P1381; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Madhavan D, 2014, BREAST CANCER RES TR, V146, P163, DOI 10.1007/s10549-014-2946-2; Mead R, 2011, BRIT J CANCER, V105, P239, DOI 10.1038/bjc.2011.230; Mirza S, 2007, LIFE SCI, V81, P280, DOI 10.1016/j.lfs.2007.05.012; Moss EL, 2005, J CLIN PATHOL, V58, P308, DOI 10.1136/jcp.2004.018077; Nawroz H, 1996, NAT MED, V2, P1035, DOI 10.1038/nm0996-1035; Pu WY, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2977-7; Salani R, 2007, CLIN CANCER RES, V13, P5805, DOI 10.1158/1078-0432.CCR-07-0853; VASIOUKHIN V, 1994, BRIT J HAEMATOL, V86, P774, DOI 10.1111/j.1365-2141.1994.tb04828.x; Wang BG, 2003, CANCER RES, V63, P3966; Zane M, 2013, BIOMED PHARMACOTHER, V67, P723, DOI 10.1016/j.biopha.2013.06.007	16	20	20	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191756	10.1371/journal.pone.0191756	http://dx.doi.org/10.1371/journal.pone.0191756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401471	gold, Green Published, Green Submitted			2022-12-26	WOS:000424101400018
J	Ebner-Karestinos, D; Flament, B; Arnould, C; Thonnard, JL; Bleyenheuft, Y				Ebner-Karestinos, Daniela; Flament, Benoit; Arnould, Carlyne; Thonnard, Jean-Louis; Bleyenheuft, Yannick			Precision grip control while walking down a step in children with unilateral cerebral palsy	PLOS ONE			English	Article							FINGERTIP FORCES; OBJECT MANIPULATION; DISCRETE MOVEMENTS; BASIC COORDINATION; MOTOR CONTROL; HABIT-ILE; HAND; MUSCLE; RELIABILITY; HEMIPLEGIA	Aim To compare grip force (GF) and load force (LF) coordination while walking down a step between children with unilateral cerebral palsy (UCP) and typically developing (TD) children. Methods Twenty-five children with UCP (age 9.3 +/- 1.7 y) and 25 TD controls (age 9.4 +/- 2.1 y) walked down a step while holding a grip-lift manipulandum. Dynamic and temporal variables were analyzed. The maximum voluntary contraction (MVC) was also assessed. Results The temporal course was perturbed mainly in the more affected hand of children with UCP when compared to TD children because the increases in GF and LF onset occurred in a reversed order. Compared with the TD controls, the children with UCP presented higher LF values on both hands and a higher GF on the less affected hand. In children with UCP, the GF to LF adaptation was adequate on the less affected hand but overestimated on the more affected hand. Furthermore, children with UCP presented a lower MVC in the more affected hand, leading to a higher percentage of MVC used during the task. Interpretation Our findings highlight an anticipatory control of precision grip during a stepping down task in children with UCP that is adequate for the less affected hand but altered for the more affected hand.	[Ebner-Karestinos, Daniela; Thonnard, Jean-Louis; Bleyenheuft, Yannick] Catholic Univ Louvain, Inst Neurosci IoNS, Brussels, Belgium; [Flament, Benoit; Arnould, Carlyne] Haute Ecole Louvain Hainaut, Phys Therapy Dept, Paramed Category, Montignies Sur Sambre, Belgium; [Flament, Benoit; Arnould, Carlyne] Haute Ecole Louvain Hainaut, Occupat Therapy Dept, Paramed Category, Montignies Sur Sambre, Belgium; [Thonnard, Jean-Louis] Clin Univ St Luc, Phys & Rehabil Med Dept, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Bleyenheuft, Y (corresponding author), Catholic Univ Louvain, Inst Neurosci IoNS, Brussels, Belgium.	yannick.bleyenheuft@uclouvain.be	Bleyenheuft, Yannick/ABA-1472-2021; Arnould, Carlyne/AAI-3111-2020	Bleyenheuft, Yannick/0000-0002-6688-932X; Ebner Karestinos, Daniela/0000-0002-5941-8706				Bernshtein NA, 1967, COORDINATION REGULAT, Vxii; Blakemore SJ, 1998, J NEUROSCI, V18, P7511; Bleyenheuft Y, 2015, NEUROREHAB NEURAL RE, V29, P645, DOI 10.1177/1545968314562109; Bleyenheuft Y, 2014, PHYS OCCUP THER PEDI, V34, P390, DOI 10.3109/01942638.2014.932884; Bleyenheuft Y, 2010, NEUROREHAB NEURAL RE, V24, P318, DOI 10.1177/1545968309353327; Bleyenheuft Y, 2009, J MOTOR BEHAV, V41, P411, DOI 10.3200/35-08-084; Ebner-Karestinos D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165549; ELIASSON AC, 1992, DEV MED CHILD NEUROL, V34, P216; ELIASSON AC, 1991, DEV MED CHILD NEUROL, V33, P661; ELIASSON AC, 1995, EXP BRAIN RES, V106, P425; Eliasson AC, 2006, PEDIATRICS, V118, pE1226, DOI 10.1542/peds.2005-2768; Eliasson AC, 2006, DEV MED CHILD NEUROL, V48, P549, DOI 10.1017/S0012162206001162; Flanagan JR, 1997, J NEUROSCI, V17, P1519; FORSSBERG H, 1991, EXP BRAIN RES, V85, P451; Forssberg H, 1999, BRAIN, V122, P1157, DOI 10.1093/brain/122.6.1157; GORDON AM, 1991, EXP BRAIN RES, V83, P477; Gordon AM, 1999, DEV MED CHILD NEUROL, V41, P176, DOI 10.1017/S0012162299000365; Gordon AM, 1999, DEV MED CHILD NEUROL, V41, P166, DOI 10.1017/S0012162299000353; Gordon AM, 2006, PEDIATR RES, V60, P587, DOI 10.1203/01.pdr.0000242370.41469.74; Graham HK, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2015.82; Gysin P, 2009, SENSORIMOTOR CONTROL, pxiv; Gysin P, 2008, J NEUROPHYSIOL, V100, P2477, DOI 10.1152/jn.90561.2008; Hogan N, 2007, EXP BRAIN RES, V181, P13, DOI 10.1007/s00221-007-0899-y; Howard IS, 2011, J NEUROPHYSIOL, V105, P1722, DOI 10.1152/jn.00780.2010; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; Maluf KS, 2005, EXP BRAIN RES, V167, P165, DOI 10.1007/s00221-005-0017-y; Meyns P, 2011, RES DEV DISABIL, V32, P1957, DOI 10.1016/j.ridd.2011.03.029; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Prabhu SB, 2011, DEV MED CHILD NEUROL, V53, P865, DOI 10.1111/j.1469-8749.2011.04061.x; Schaal S, 2004, NAT NEUROSCI, V7, P1137, DOI 10.1038/nn1322; Smits-Engelsman BCM, 2005, DEV MED CHILD NEUROL, V47, P337, DOI 10.1017/S0012162205000630; Steenbergen B, 1998, DEV MED CHILD NEUROL, V40, P108; Steenbergen B, 2008, EXP BRAIN RES, V186, P191, DOI 10.1007/s00221-007-1223-6; Steenbergen B, 2013, DEV MED CHILD NEUROL, V55, P43, DOI 10.1111/dmcn.12306; UVEBRANT P, 1988, ACTA PAEDIATR SCAND, P1; WESTLING G, 1984, EXP BRAIN RES, V53, P277; Witney AG, 2004, TRENDS NEUROSCI, V27, P637, DOI 10.1016/j.tins.2004.08.006; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X	38	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191684	10.1371/journal.pone.0191684	http://dx.doi.org/10.1371/journal.pone.0191684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390012	Green Submitted, Green Published, gold			2022-12-26	WOS:000423793400027
J	Santos, D; Ribeiro, GC; Cabral, AD; Speranca, MA				Santos, Daubian; Ribeiro, Guilherme Cunha; Cabral, Aline Diniz; Speranca, Marcia Aparecida			A non-destructive enzymatic method to extract DNA from arthropod specimens: Implications for morphological and molecular studies	PLOS ONE			English	Article								There is a growing necessity to integrate morphological and genetic studies. This paper proposes a new technique that allows DNA extraction of arthropods while still keeping intact the entire morphology of the specimens. The technique uses Proteinase K to dissolve protein tissues and preserve the chitinous exoskeleton of specimens. The method is fast, cheap, non-toxic, and allows for good morphological preparations of specimens retaining much of their tridimensional structure. The methodology works fine with specimens preserved in different kinds of media, such as for dry (pinned) specimens, and specimens preserved in Ethanol. In addition, it allows the extraction of DNA from fresh specimens, as well as from specimens preserved for a long time. The technique works well for morphological studies alone, but allows the generation of an associated genomic library at an individual-scale. Among the advantages of the new technique is the possibility of extracting DNA from the entire specimen (necessary for the study of diseases transmitted by arthropod vectors), while still keeping the morphology intact for correct taxonomic identification. In addition, in comparison with methods that extract DNA from small tissue samples (e.g., from legs or wings), the method allows for the extraction of a larger amount of DNA and is better suited for small specimens.	[Santos, Daubian; Ribeiro, Guilherme Cunha; Cabral, Aline Diniz; Speranca, Marcia Aparecida] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil	Universidade Federal do ABC (UFABC)	Speranca, MA (corresponding author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil.	marcia.speranca@ufabc.edu.br	Cabral, Aline Diniz/Q-8650-2019; Sperança, Márcia Aparecida/D-2310-2012; Santos, Daubian/GYR-2062-2022; Cabral, Aline Diniz/M-5779-2018	Cabral, Aline Diniz/0000-0002-9439-4463; Sperança, Márcia Aparecida/0000-0002-1178-3747; Santos, Daubian/0000-0003-1220-1267; Cabral, Aline Diniz/0000-0002-9439-4463	CAPES (Coordination for the Improvement of Higher Level Personnel - CAPES); Fundacao de Amparo a Pesquisa do Estado de SP (Sao Paulo Research Foundation) [2016/14514-4, 2013/26096-4]	CAPES (Coordination for the Improvement of Higher Level Personnel - CAPES); Fundacao de Amparo a Pesquisa do Estado de SP (Sao Paulo Research Foundation)	DS was financially supported by CAPES (Coordination for the Improvement of Higher Level Personnel - CAPES). MAS and ADC were financially supported by Fundacao de Amparo a Pesquisa do Estado de SP (Sao Paulo Research Foundation): grant number 2016/14514-4 and fellowship number 2013/26096-4, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bybee SM, 2010, ENTOMOLOGY, V35, P4; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Laurito M, 2013, MEM I OSWALDO CRUZ, V108, P110, DOI 10.1590/0074-0276130457; Pages N, 2009, VET PARASITOL, V165, P298, DOI 10.1016/j.vetpar.2009.07.020; Shawkey MD, 2009, J R SOC INTERFACE, V6, pS221, DOI 10.1098/rsif.2008.0459.focus; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; TAUTZ D, 1988, MOL BIOL EVOL, V5, P366; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Trewick SA, 2008, CLADISTICS, V24, P240, DOI 10.1111/j.1096-0031.2007.00174.x	10	17	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192200	10.1371/journal.pone.0192200	http://dx.doi.org/10.1371/journal.pone.0192200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390036	Green Published, gold, Green Submitted			2022-12-26	WOS:000423793400075
J	Wang, YH; Liu, SY; Dong, YM				Wang, Yahui; Liu, Siyi; Dong, Yanmei			In vitro study of dentinal tubule penetration and filling quality of bioceramic sealer	PLOS ONE			English	Article							ROOT-CANAL SEALERS; MICRO-COMPUTED TOMOGRAPHY; PHYSICAL-PROPERTIES; ENDODONTIC SEALERS; COMPACTION TECHNIQUE; MTA FILLAPEX; IROOT SP; OBTURATION; IRRIGATION; INSTRUMENTATION	This study aimed to evaluate the dentinal tubule penetration and filling quality of a bioceramic sealer (iRoot SP). Forty-two roots of extracted adult lower incisors were selected. After instrumentation with Protaper Universal to F3, 40 roots were chosen and randomly divided into 4 groups, as follows: iRoot SP single cone group, iRoot SP warm vertical group, AH Plus single cone group, and AH Plus warm vertical group. Before root canal filling, sealers were mixed with Rhodamine B dye for visualization under confocal laser scanning microscope. All samples were sectioned at 2, 4, and 6 mm to apex. Then, the percentages of void areas, gap regions, and segments of sealer that penetrated into dentinal tubules in each section were calculated. Non-parametric test was used for statistical analysis (alpha = 0.05). We found that filling techniques and types of sealer had no statistically significant effects on the occurrence of voids and gaps. The segments of iRoot SP penetrated into dentinal tubules were statistically more than that of AH Plus in both single cone and warm vertical techniques at 2 mm to apex (P < 0.05). Regardless of the filling technique used, iRoot SP can achieve comparable filling quality and better dentinal tubules penetration than AH Plus. Considering the good bioactivity of iRoot SP, it may help improve the seal of root canal system.	[Wang, Yahui; Liu, Siyi; Dong, Yanmei] Peking Univ, Sch & Hosp Stomatol, Dept Cariol & Endodontol, Beijing, Peoples R China	Peking University	Dong, YM (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Cariol & Endodontol, Beijing, Peoples R China.	kqdongyanmei@bjmu.edu.cn			National Natural Science Foundation of China [51372005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 51372005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (No. 51372005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflict of interest related to this study.	Akcay M, 2016, LASER SURG MED, V48, P70, DOI 10.1002/lsm.22446; Al-Haddad A, 2015, DENT MATER J, V34, P516, DOI 10.4012/dmj.2015-049; Amoroso-Silva PA, 2014, MICROSC RES TECHNIQ, V77, P1031, DOI 10.1002/jemt.22432; Bolles JA, 2013, J ENDODONT, V39, P708, DOI 10.1016/j.joen.2013.01.006; BRANSTETTER J, 1982, J ENDODONT, V8, P312, DOI 10.1016/S0099-2399(82)80280-X; Capar ID, 2015, DENT TRAUMATOL, V31, P302, DOI 10.1111/edt.12154; Celikten B, 2016, SCANNING, V38, P133, DOI 10.1002/sca.21249; Chang SW, 2014, J ENDODONT, V40, P1642, DOI 10.1016/j.joen.2014.04.006; Craveiro MA, 2015, J ENDODONT, V41, P836, DOI 10.1016/j.joen.2015.02.017; Candeiro GTD, 2012, J ENDODONT, V38, P842, DOI 10.1016/j.joen.2012.02.029; De-Deus G, 2017, INT ENDOD J, V50, P895, DOI 10.1111/iej.12706; De-Deus G, 2012, INT ENDOD J, V45, P642, DOI 10.1111/j.1365-2591.2012.02023.x; De -Deus G, 2017, J ENDODONT, V43, P1553, DOI 10.1016/j.joen.2017.04.027; De-Deus G, 2015, J ENDODONT, V41, P1116, DOI 10.1016/j.joen.2015.02.012; De-Deus G, 2014, J ENDODONT, V40, P1447, DOI 10.1016/j.joen.2014.02.019; De-Deus G, 2011, ORAL SURG ORAL MED O, V111, P381, DOI 10.1016/j.tripleo.2010.08.020; Desai S, 2009, J ENDODONT, V35, P475, DOI 10.1016/j.joen.2008.11.026; Du TF, 2015, J ENDODONT, V41, P1294, DOI 10.1016/j.joen.2015.04.023; Ersahan S, 2013, ACTA ODONTOL SCAND, V71, P857, DOI 10.3109/00016357.2012.734410; Fernandez R, 2016, INT ENDOD J, V49, P365, DOI 10.1111/iej.12454; Ghoneim AG, 2011, J ENDODONT, V37, P1590, DOI 10.1016/j.joen.2011.08.008; Guven EP, 2013, INT ENDOD J, V46, P1173, DOI 10.1111/iej.12115; Han L, 2013, INT ENDOD J, V46, P808, DOI 10.1111/iej.12062; Heling I, 1996, J ENDODONT, V22, P257, DOI 10.1016/S0099-2399(06)80144-5; Iglecias EF, 2017, J ENDODONT, V43, P638, DOI 10.1016/j.joen.2016.11.027; Jean-Yves Blum SE, 1997, J ENDODONT, V23, P6; KAZEMI RB, 1993, ORAL SURG ORAL MED O, V76, P766, DOI 10.1016/0030-4220(93)90050-E; Kim JA, 2017, J ENDOD; Kokkas AB, 2004, J ENDODONT, V30, P100, DOI 10.1097/00004770-200402000-00009; Leonardo MR, 2000, J ENDODONT, V26, P391, DOI 10.1097/00004770-200007000-00003; LI G, 1982, ENDODONTIC PRACTICE; McMichael GE, 2016, J ENDODONT, V42, P632, DOI 10.1016/j.joen.2015.12.012; McMichen FRS, 2003, INT ENDOD J, V36, P629, DOI 10.1046/j.1365-2591.2003.00701.x; Mjor IA, 1996, ARCH ORAL BIOL, V41, P401, DOI 10.1016/0003-9969(96)00008-8; Moon YM, 2012, J ENDODONT, V38, P531, DOI 10.1016/j.joen.2011.12.008; Mukhtar-Fayyad D, 2011, ORAL SURG ORAL MED O, V112, pE137, DOI 10.1016/j.tripleo.2011.05.042; Nirupama DN, 2014, INT J BIOMATER, V2014, DOI 10.1155/2014/383756; OGUNTEBI BR, 1994, INT ENDOD J, V27, P218, DOI 10.1111/j.1365-2591.1994.tb00257.x; Ordinola-Zapata R, 2009, ORAL SURG ORAL MED O, V108, P450, DOI 10.1016/j.tripleo.2009.04.024; Orstavik D, 2001, DENT MATER, V17, P512, DOI 10.1016/S0109-5641(01)00011-2; PETERS DD, 1986, J ENDODONT, V12, P139, DOI 10.1016/S0099-2399(86)80051-6; Qu W, 2016, J ENDODONT, V42, P1829, DOI 10.1016/j.joen.2016.08.014; Ricucci D, 1998, INT ENDOD J, V31, P384; Ricucci D, 2016, J ENDODONT, V42, P243, DOI 10.1016/j.joen.2015.11.020; Song M, 2011, J ENDODONT, V37, P1516, DOI 10.1016/j.joen.2011.06.032; Stringheta CP, 2017, J ENDODONT, V43, P2102, DOI 10.1016/j.joen.2017.07.015; van der Sluis LWM, 2007, INT ENDOD J, V40, P356, DOI 10.1111/j.1365-2591.2006.01227.x; Viapiana R, 2015, INT ENDOD J, V48, P16, DOI 10.1111/iej.12271; Wu MK, 2000, INT ENDOD J, V33, P340, DOI 10.1046/j.1365-2591.2000.00309.x; Zhang H, 2009, J ENDODONT, V35, P1051, DOI 10.1016/j.joen.2009.04.022; Zhang W, 2009, ORAL SURG ORAL MED O, V107, pE79, DOI 10.1016/j.tripleo.2009.02.024; Zhou HM, 2015, J ENDODONT, V41, P56, DOI 10.1016/j.joen.2014.09.012; Zhou HM, 2013, J ENDODONT, V39, P1281, DOI 10.1016/j.joen.2013.06.012; Zoufan K, 2011, ORAL SURG ORAL MED O, V112, P657, DOI 10.1016/j.tripleo.2011.03.050	54	43	52	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192248	10.1371/journal.pone.0192248	http://dx.doi.org/10.1371/journal.pone.0192248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390037	gold, Green Published, Green Submitted			2022-12-26	WOS:000423793400080
J	Theadom, A; Starkey, N; Barker-Collo, S; Jones, K; Ameratunga, S; Feigin, V				Theadom, Alice; Starkey, Nicola; Barker-Collo, Suzanne; Jones, Kelly; Ameratunga, Shanthi; Feigin, Valery		BIONIC4you Res Grp	Population-based cohort study of the impacts of mild traumatic brain injury in adults four years post-injury	PLOS ONE			English	Article							POST-CONCUSSION SYMPTOMS; HEAD-INJURY; HOSPITAL ANXIETY; NEW-ZEALAND; PARTICIPATION; MODERATE; QUESTIONNAIRE; PREDICTORS; DEPRESSION; VALIDITY	There is increasing evidence that some people can experience persistent symptoms for up to a year following mild TBI. However, few longitudinal studies of mild TBI exist and the longer-term impact remains unclear. The purpose of this study is to determine if there are long-term effects of mild traumatic brain injury (TBI) four-years later. Adults (aged >= 16 years) identified as part of a TBI incidence study who experienced a mild-TBI four-years ago (N = 232) were compared to age-sex matched controls (N = 232). Sociodemographic variables, prior TBI and symptoms were assessed at the time of injury. Four years post-injury participants completed the Rivermead Post-Concussion Symptom Questionnaire, Hospital Anxiety and Depression Scale, Pittsburgh Sleep Quality Index and the Participation Assessment with Recombined Tools. Analysis of covariance was used to compare differences between TBI cases four years post-injury and controls, controlling for prior TBI and depression. A multiple regression model was used to identify the predictors of increased symptoms and reduced participation. The mild-TBI sample experienced significantly increased self-reported cognitive symptoms (F = 19.90, p = < 0.01) four years post-injury than controls. There were no differences between the groups for somatic (F = 0.02, p = 0.89) or emotional symptoms (F = 0.31, p = 0.58). Additionally, the mild-TBI group reported significantly poorer community participation across all three domains: productivity (F = 199.07, p = < 0.00), social relations (F = 13.93, p = < 0.00) and getting out and about (F = 364.69, p = < 0.00) compared to controls. A regression model accounting for 41% of the variance in cognitive symptoms in TBI cases revealed a history of TBI, receiving acute medical attention and baseline cognitive symptoms, sleep quality, anxiety and depression were predictive of outcome. The results indicate that whilst somatic and emotional symptoms resolve over time, cognitive symptoms can become persistent and that mild TBI can impact longer-term community participation. Early intervention is needed to reduce the longer-term impact of cognitive symptoms and facilitate participation.	[Theadom, Alice; Jones, Kelly; Feigin, Valery] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Starkey, Nicola] Univ Waikato, Dept Psychol, Knighton Rd, Waikato, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Dept Psychol, Auckland, New Zealand; [Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand	Auckland University of Technology; University of Waikato; University of Auckland; University of Auckland	Theadom, A (corresponding author), Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand.	alice.theadom@aut.ac.nz	Starkey, Nicola/AAJ-3795-2020; Jones, Kelly/I-5199-2019; Feigin, Valery/AAF-2313-2019	Starkey, Nicola/0000-0002-4370-8186; Theadom, Alice/0000-0003-0351-6216; Feigin, Valery L./0000-0002-6372-1740	Health Research Council of New Zealand [13/408]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by Health Research Council of New Zealand 13/408 to VF.	Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hopkins W.G., 2002, SCALE MAGNITUDES EFF; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/316575; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kirsch NL, 2010, ARCH PHYS MED REHAB, V91, P35, DOI 10.1016/j.apmr.2009.09.019; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Matuseviciene G, 2016, J REHABIL MED, V48, P19, DOI 10.2340/16501977-2025; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Sveen U, 2016, DISABIL REHABIL, V38, P2296, DOI 10.3109/09638288.2015.1129445; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	55	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191655	10.1371/journal.pone.0191655	http://dx.doi.org/10.1371/journal.pone.0191655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU2GT	29385179	Green Published, Green Submitted, gold			2022-12-26	WOS:000423668400052
J	de los Rios, EA; Ruiz-Herrera, X; Tinoco-Pantoja, V; Lopez-Barrera, F; de la Escalera, GM; Clapp, C; Macotela, Y				de los Rios, Ericka A.; Ruiz-Herrera, Xarubet; Tinoco-Pantoja, Viridiana; Lopez-Barrera, Fernando; Martinez de la Escalera, Gonzalo; Clapp, Carmen; Macotela, Yazmin			Impaired prolactin actions mediate altered offspring metabolism induced by maternal high-fat feeding during lactation	FASEB JOURNAL			English	Article						nursing pups; metabolic programming; insulin resistance	RECOMBINANT HUMAN PROLACTIN; LONG-TERM CONSEQUENCES; DIET-INDUCED OBESITY; HUMAN BREAST-MILK; INSULIN SENSITIVITY; SIGNALING PATHWAYS; LEPTIN SENSITIVITY; LIPID BIOSYNTHESIS; PREVENTS OBESITY; GROWTH-HORMONE	Maternal diet during lactation affects offspring metabolic health throughout life. Prolactin (PRL) is present in high quantities in maternal milk; however, the effects of milk PRL on the offspring remain poorly characterized. In this study, we evaluated whether feeding a high-fat diet (HFD) to rats during lactation alters PRL, both in the mother's serum and in milk, and whether this factor contributes to HFD-induced metabolic dysfunction in the offspring. Maternal HFD resulted in decreased PRL levels in milk (but not in serum), reduced mammary gland (MG) PRL receptor expression, and altered MG structure and function. Offspring from HFD-fed dams had increased body weight and adiposity, and developed fatty liver, hyperinsulinemia, and insulin resistance at weaning. Increasing PRL levels in the HFD-fed mothers by subcutaneous osmotic minipumps releasing PRL normalized MG function and PRL levels in milk. Moreover, PRL treatment in HFD-fed mothers, or directly in their pups via oral PRL administration, increased liver STAT5 phosphorylation, reduced visceral adiposity, ameliorated fatty liver, and improved insulin sensitivity in offspring. Our results show that HFD impairs PRL actions during lactation to negatively affect MG physiology and directly impair offspring metabolism.	[de los Rios, Ericka A.; Ruiz-Herrera, Xarubet; Tinoco-Pantoja, Viridiana; Lopez-Barrera, Fernando; Martinez de la Escalera, Gonzalo; Clapp, Carmen; Macotela, Yazmin] Univ Nacl Autonoma Mexico, Inst Neurobiol, Campus UNAM, Juriquilla 76230, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico	Macotela, Y (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Campus UNAM, Juriquilla 76230, Queretaro, Mexico.	macotelag@unam.mx			UNAM grant UNAM-DGAPA-PAPIIT [IN203915]; Programa de Doctorado en Ciencias Biomedicas, UNAM; Consejo Nacional de Ciencia y Tecnologia (CONACYT) Fellowship [230452]	UNAM grant UNAM-DGAPA-PAPIIT; Programa de Doctorado en Ciencias Biomedicas, UNAM; Consejo Nacional de Ciencia y Tecnologia (CONACYT) Fellowship(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors thank Daniel Mondragon, Maarten Werdler, Gabriel Nava, Martin Garcia-Servin, Alejandra Castilla, and Antonio Prado [all from the Instituto de Neurobiologia, Universidad Nacional Autonoma de Mexico (UNAM)] for excellent technical assistance. The authors thank Jessica Gonzalez Norris (UNAM) for critically editing the manuscript. This study was supported by UNAM grant UNAM-DGAPA-PAPIIT IN203915 (to Y.M.) E.A.D.L.R. is a doctoral student from Programa de Doctorado en Ciencias Biomedicas, UNAM and received a Consejo Nacional de Ciencia y Tecnologia (CONACYT) Fellowship 230452. The authors declare no conflicts of interest.	Badillo-Suarez PA, 2017, J MAMMARY GLAND BIOL, V22, P171, DOI 10.1007/s10911-017-9382-y; Andreas NJ, 2015, EARLY HUM DEV, V91, P629, DOI 10.1016/j.earlhumdev.2015.08.013; Aydin S, 2008, NUTRITION, V24, P689, DOI 10.1016/j.nut.2008.03.020; Bautista CJ, 2016, BRIT J NUTR, V115, P538, DOI 10.1017/S0007114515004547; Ben-Jonathan N, 2015, ADV EXP MED BIOL, V846, P1, DOI 10.1007/978-3-319-12114-7_1; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Bonomo IT, 2008, J ENDOCRINOL, V198, P331, DOI 10.1677/JOE-07-0505; Bonomo IT, 2007, J ENDOCRINOL, V192, P339, DOI 10.1677/joe.1.06952; Brisken C, 1999, DEV BIOL, V210, P96, DOI 10.1006/dbio.1999.9271; Buonfiglio DC, 2016, SCI REP-UK, V6, DOI 10.1038/srep22421; Catli G, 2014, J CLIN RES PEDIATR E, V6, P192, DOI [10.4274/Jcrpe.1531, 10.4274/jcrpe.1531]; Chirico V, 2013, CLIN ENDOCRINOL, V79, P537, DOI 10.1111/cen.12183; Clinton SK, 1997, J NUTR, V127, P225, DOI 10.1093/jn/127.2.225; COLLET C, 1991, J MOL ENDOCRINOL, V6, P9, DOI 10.1677/jme.0.0060009; Czech MP, 2017, NAT MED, V23, P804, DOI 10.1038/nm.4350; De Luca A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168568; de Moura EG, 2009, J PHYSIOL-LONDON, V587, P4919, DOI 10.1113/jphysiol.2009.176289; DePeters EJ, 2009, J MAMMARY GLAND BIOL, V14, P397, DOI 10.1007/s10911-009-9158-0; Diau GY, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-11; Du QW, 2015, PEPTIDES, V70, P23, DOI 10.1016/j.peptides.2015.05.003; Du Y, 2012, GENE DEV, V26, P1306, DOI 10.1101/gad.191031.112; ELLIS LA, 1995, ENDOCRINOLOGY, V136, P2711, DOI 10.1210/en.136.6.2711; Ellis LA, 1996, J MAMMARY GLAND BIOL, V1, P259, DOI 10.1007/BF02018079; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Flint DJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1179, DOI 10.1152/ajpendo.00433.2004; Ganapathy S, 2009, INDIAN PEDIATR, V46, P785; Gavalda-Navarro A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13717; Gillam MP, 2011, PITUITARY, 3RD EDITION, P119, DOI 10.1016/B978-0-12-380926-1.10005-7; GONNELLA PA, 1989, J CELL PHYSIOL, V140, P138, DOI 10.1002/jcp.1041400117; GROSVENOR CE, 1993, ENDOCR REV, V14, P710, DOI 10.1210/edrv-14-6-710; GROSVENOR CE, 1976, J ENDOCRINOL, V70, P1, DOI 10.1677/joe.0.0700001; GROVE D S, 1991, Endocrine Regulations, V25, P111; Guillou A, 2015, ENDOCRINOLOGY, V156, P1924, DOI 10.1210/en.2014-1571; GUYETTE WA, 1979, CELL, V17, P1013, DOI 10.1016/0092-8674(79)90340-4; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Hara M, 1998, ANAT REC, V251, P37, DOI 10.1002/(SICI)1097-0185(199805)251:1<37::AID-AR7>3.0.CO;2-B; Heird WC, 2005, ANNU REV NUTR, V25, P549, DOI 10.1146/annurev.nutr.24.012003.132254; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hennighausen L, 1991, Biotechnology, V16, P65; Hernandez LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032598; Horta BL, 2015, ACTA PAEDIATR, V104, P30, DOI 10.1111/apa.13133; Hurley WL, 2011, NUTRIENTS, V3, P442, DOI 10.3390/nu3040442; JAGODA CA, 1991, P SOC EXP BIOL MED, V197, P431; KACSOH B, 1993, J ENDOCRINOL, V138, P243, DOI 10.1677/joe.0.1380243; Laitinen K, 2006, PEDIATR RES, V59, P723, DOI 10.1203/01.pdr.0000203158.31452.9e; Lemas DJ, 2016, AM J CLIN NUTR, V103, P1291, DOI 10.3945/ajcn.115.126375; Lemini M, 2015, AM J PHYSIOL-REG I, V308, pR792, DOI 10.1152/ajpregu.00327.2014; Liang XW, 2016, SCI REP-UK, V6, DOI 10.1038/srep34345; Masuyama H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092805; Melo AI, 2009, HORM BEHAV, V56, P281, DOI 10.1016/j.yhbeh.2009.06.005; Moretto Vera L, 2011, ISRN Obstet Gynecol, V2011, P876502, DOI 10.5402/2011/876502; Munzberg H, 2010, FORUM NUTR, V63, P123, DOI 10.1159/000264400; Musilova S, 2014, BENEF MICROBES, V5, P273, DOI 10.3920/BM2013.0080; NAGANO M, 1994, J BIOL CHEM, V269, P13337; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Nguyen DAD, 1998, J MAMMARY GLAND BIOL, V3, P233, DOI 10.1023/A:1018707309361; O'Sullivan EJ, 2015, J NUTR, V145, P2369, DOI 10.3945/jn.115.214619; Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042; Ollivier-Bousquet M, 1993, Endocr Regul, V27, P115; OPPAT CA, 1988, P SOC EXP BIOL MED, V188, P342; Pai VP, 2008, J BIOL CHEM, V283, P30901, DOI 10.1074/jbc.M802476200; Palou A, 2009, APPETITE, V52, P249, DOI 10.1016/j.appet.2008.09.013; Park S, 2011, DIABETES-METAB RES, V27, P564, DOI 10.1002/dmrr.1215; Pico C, 2007, INT J OBESITY, V31, P1199, DOI 10.1038/sj.ijo.0803585; Powe CE, 2011, PEDIATRICS, V127, pE359, DOI 10.1542/peds.2010-1627; Powe CE, 2010, CLIN ENDOCRINOL, V73, P645, DOI 10.1111/j.1365-2265.2010.03850.x; Rasmussen KM, 2007, ANNU REV NUTR, V27, P103, DOI 10.1146/annurev.nutr.27.061406.093738; Rasmussen KM, 2004, PEDIATRICS, V113, pE465, DOI 10.1542/peds.113.5.e465; ROLLS BA, 1986, PHYSIOL BEHAV, V38, P185, DOI 10.1016/0031-9384(86)90153-8; ROLLS BJ, 1980, P NUTR SOC, V39, pA51; Rudolph MC, 2011, AM J PHYSIOL-ENDOC M, V300, pE1059, DOI 10.1152/ajpendo.00083.2011; Ruiz-Herrera X, 2017, ENDOCRINOLOGY, V158, P56, DOI 10.1210/en.2016-1444; SAMPSON DA, 1984, J PEDIATR GASTR NUTR, V3, P613, DOI 10.1097/00005176-198409000-00023; Sanchez J, 2005, ENDOCRINOLOGY, V146, P2575, DOI 10.1210/en.2005-0112; Savino F, 2009, INT J PEDIATR ENDOCR, DOI 10.1155/2009/327505; Seddiki T, 2002, BIOL CELL, V94, P173, DOI 10.1016/S0248-4900(02)01188-7; SHAH GV, 1988, ENDOCRINOLOGY, V122, P1883, DOI 10.1210/endo-122-5-1883; SHYR SW, 1986, ENDOCRINOLOGY, V119, P1217, DOI 10.1210/endo-119-3-1217; Stull MA, 2007, P NATL ACAD SCI USA, V104, P16708, DOI 10.1073/pnas.0708136104; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; TANAKA T, 1980, J CLIN ENDOCR METAB, V51, P1058, DOI 10.1210/jcem-51-5-1058; Turcksin R, 2014, MATERN CHILD NUTR, V10, P166, DOI 10.1111/j.1740-8709.2012.00439.x; Velazquez-Villegas LA, 2015, BBA-BIOMEMBRANES, V1848, P1157, DOI 10.1016/j.bbamem.2015.02.011; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; VILLALBA M, 1991, ENDOCRINOLOGY, V129, P2857, DOI 10.1210/endo-129-6-2857; Vogt MC, 2014, CELL, V156, P495, DOI 10.1016/j.cell.2014.01.008; WATERS SB, 1988, AM J PHYSIOL, V255, pE567, DOI 10.1152/ajpendo.1988.255.4.E567; WHITWORTH NS, 1978, J ENDOCRINOL, V79, P191, DOI 10.1677/joe.0.0790191; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035; Young BE, 2017, EUR J CLIN NUTR, V71, P1094, DOI 10.1038/ejcn.2017.75; Yu JJ, 2013, DIABETES, V62, P3103, DOI 10.2337/db13-0182	91	12	12	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3457	3470		10.1096/fj.201701154R	http://dx.doi.org/10.1096/fj.201701154R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401632				2022-12-26	WOS:000432546000045
J	Rauf, F; Festa, F; Park, JG; Magee, M; Eaton, S; Rinaldi, C; Betanzos, CM; Gonzalez-Malerva, L; LaBaer, J				Rauf, Femina; Festa, Fernanda; Park, Jin G.; Magee, Mitchell; Eaton, Seron; Rinaldi, Capria; Betanzos, Carlos Morales; Gonzalez-Malerva, Laura; LaBaer, Joshua			Ibrutinib inhibition of ERBB4 reduces cell growth in a WNT5A-dependent manner	ONCOGENE			English	Article							BREAST-CANCER CELLS; GASTROINTESTINAL STROMAL TUMORS; OVARIAN-CANCER; THERAPEUTIC TARGET; IMATINIB MESYLATE; CATENIN PATHWAY; BTK INHIBITOR; EXPRESSION; MALIGNANCIES; MUTATIONS	Alterations in ERBB family members have been associated with many tumor malignancies. EGFR and ERBB2 have been extensively explored in clinical oncology and several drugs currently target them therapeutically. However, the significance of ERBB4 as a potential therapeutic target remains mostly unexplored, even though ERBB4 is overexpressed or mutated in many solid tumors. Using a unique functional protein microarray platform, we found that ibrutinib inhibits ERBB4 activity in the same nM range as its canonical target, BTK. Cell-based assays revealed that ibrutinib treatment inhibited cell growth and decreased phosphorylation of ERBB4 and downstream targets MEK and ERK in cancer cell lines with high levels of endogenous ERBB4. In vivo, ibrutinib-responsive mouse xenograft tumors showed decreased tumor volumes with ibrutinib treatment. Interestingly, global gene expression comparisons between responsive and non-responsive cells identified a signature featuring the WNT pathway that predicts growth responsiveness to ibrutinib. Non-responsive ERBB4-expressing cell lines featured elevated activity of the WNT pathway, through the overexpression of WNT5A. Moreover, inhibition of WNT5A expression led to an ibrutinib response in non-responsive cell lines. Our data show that inhibiting ERBB4 reduces cell growth in cells that have low WNT5A expression and reveal a link between the ERBB4 and WNT pathways.	[Rauf, Femina; Festa, Fernanda; Park, Jin G.; Magee, Mitchell; Eaton, Seron; Rinaldi, Capria; Betanzos, Carlos Morales; Gonzalez-Malerva, Laura; LaBaer, Joshua] Arizona State Univ, Virginia G Piper Biodesign Ctr Personalized Diagn, Tempe, AZ 85281 USA	Arizona State University; Arizona State University-Tempe	LaBaer, J (corresponding author), Arizona State Univ, Virginia G Piper Biodesign Ctr Personalized Diagn, Tempe, AZ 85281 USA.	jlabaer@asu.edu		Festa, Fernanda/0000-0002-2822-823X				Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Anderson KS, 2011, J PROTEOME RES, V10, P85, DOI 10.1021/pr100686b; Arend RC, 2013, GYNECOL ONCOL, V131, P772, DOI 10.1016/j.ygyno.2013.09.034; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Berglof A, 2015, SCAND J IMMUNOL, V82, P208, DOI 10.1111/sji.12333; Bian XF, 2017, J PROTEOME RES, V16, P195, DOI 10.1021/acs.jproteome.6b00354; Blanke CD, 2008, J CLIN ONCOL, V26, P620, DOI 10.1200/JCO.2007.13.4403; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Davies S, 2014, INT J GYNECOL PATHOL, V33, P402, DOI 10.1097/PGP.0000000000000081; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Gilmour LMR, 2001, CANCER RES, V61, P2169; Grabinski N, 2014, INVEST NEW DRUG, V32, P1096, DOI 10.1007/s10637-014-0141-2; Herman SEM, 2011, BLOOD, V117, P6287, DOI 10.1182/blood-2011-01-328484; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Kim JY, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2195-3; Krejci P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035826; Kurppa KJ, 2016, ONCOGENE, V35, P1283, DOI 10.1038/onc.2015.185; Liu T, 2010, MOL CELL BIOCHEM, V340, P265, DOI 10.1007/s11010-010-0426-5; Masso-Valles D, 2015, CANCER RES, V75, P1675, DOI 10.1158/0008-5472.CAN-14-2852; Mendoza-Naranjo A, 2013, EMBO MOL MED, V5, P1087, DOI 10.1002/emmm.201202343; Nakata A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13076; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Prickett TD, 2009, NAT GENET, V41, P1127, DOI 10.1038/ng.438; Rushworth SA, 2013, CELL SIGNAL, V25, P106, DOI 10.1016/j.cellsig.2012.09.008; Sagiv-Barfi I, 2015, P NATL ACAD SCI USA, V112, pE966, DOI 10.1073/pnas.1500712112; Smith MR, 2015, EXPERT OPIN PHARMACO, V16, P1879, DOI 10.1517/14656566.2015.1067302; Wang XH, 2016, MOL CANCER THER, V15, P2198, DOI 10.1158/1535-7163.MCT-15-0813; Williams CS, 2015, CARCINOGENESIS, V36, P710, DOI 10.1093/carcin/bgv049; Woyach JA, 2012, BLOOD, V120, P1175, DOI 10.1182/blood-2012-02-362624; Wu H, 2014, ACS CHEM BIOL, V9, P1086, DOI 10.1021/cb4008524	31	26	27	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	17					2237	2250		10.1038/s41388-017-0079-x	http://dx.doi.org/10.1038/s41388-017-0079-x			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GE3FW	29398709	Green Published, hybrid			2022-12-26	WOS:000431100200003
J	Saatci, O; Borgoni, S; Akbulut, O; Durmus, S; Raza, U; Eyupoglu, E; Alkan, C; Akyol, A; Kutuk, O; Wiemann, S; Sahin, O				Saatci, Ozge; Borgoni, Simone; Akbulut, Ozge; Durmus, Selvi; Raza, Umar; Eyupoglu, Erol; Alkan, Can; Akyol, Aytekin; Kutuk, Ozgur; Wiemann, Stefan; Sahin, Ozgur			Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer	ONCOGENE			English	Article							POLO-LIKE KINASE; SPINDLE-ASSEMBLY CHECKPOINT; ANTIBODY-DRUG CONJUGATE; LOW-DOSE CYTARABINE; TRASTUZUMAB EMTANSINE; TUMOR HETEROGENEITY; GENE-EXPRESSION; MITOTIC ARREST; CELLS; MECHANISMS	Trastuzumab-refractory, HER2 (human epidermal growth factor receptor 2)-positive breast cancer is commonly treated with trastuzumab emtansine (T-DM1), an antibody-drug conjugate of trastuzumab and the microtubule-targeting agent, DM1. However, drug response reduces greatly over time due to acquisition of resistance whose molecular mechanisms are mostly unknown. Here, we uncovered a novel mechanism of resistance against T-DM1 by combining whole transcriptome sequencing (RNA-Seq), proteomics and a targeted small interfering RNA (siRNA) sensitization screen for molecular level analysis of acquired and de novo T-DM1-resistant models of HER2-overexpressing breast cancer. We identified Polo-like kinase 1 (PLK1), a mitotic kinase, as a resistance mediator whose genomic as well as pharmacological inhibition restored drug sensitivity. Both acquired and de novo resistant models exhibited synergistic growth inhibition upon combination of T-DM1 with a selective PLK1 inhibitor, volasertib, at a wide concentration range of the two drugs. Mechanistically, T-DM1 sensitization upon PLK1 inhibition with volasertib was initiated by a spindle assembly checkpoint (SAC)-dependent mitotic arrest, leading to caspase activation, followed by DNA damage through CDK1-dependent phosphorylation and inactivation of Bcl-2/xL. Furthermore, we showed that Ser70 phosphorylation of Bcl-2 directly regulates apoptosis by disrupting the binding to and sequestration of the pro-apoptotic protein Bim. Importantly, T-DM1 resistance signature or PLK1 expression correlated with cell cycle progression and DNA repair, and predicted a lower sensitivity to taxane/trastuzumab combination in HER2-positive breast cancer patients. Finally, volasertib in combination with T-DM1 greatly synergized in models of T-DM1 resistance in terms of growth inhibition both in three dimensional (3D) cell culture and in vivo. Altogether, our results provide promising pre-clinical evidence for potential testing of T-DM1/volasertib combination in T-DM1 refractory HER2-positive breast cancer patients for whom there is currently no treatment available.	[Saatci, Ozge; Akbulut, Ozge; Durmus, Selvi; Raza, Umar; Eyupoglu, Erol; Sahin, Ozgur] Bilkent Univ, Dept Mol Biol & Genet, Fac Sci, TR-06800 Ankara, Turkey; [Borgoni, Simone; Wiemann, Stefan] German Canc Res Ctr, Div Mol Genome Anal, INF580, D-69120 Heidelberg, Germany; [Alkan, Can] Bilkent Univ, Dept Comp Engn, TR-06800 Ankara, Turkey; [Akyol, Aytekin] Hacettepe Univ, Dept Pathol, Sch Med, TR-06410 Ankara, Turkey; [Kutuk, Ozgur] Baskent Univ, Dept Med Genet, TR-01250 Adana, Turkey; [Saatci, Ozge; Sahin, Ozgur] Bilkent Univ, Natl Nanotechnol Res Ctr UNAM, TR-06800 Ankara, Turkey	Ihsan Dogramaci Bilkent University; Helmholtz Association; German Cancer Research Center (DKFZ); Ihsan Dogramaci Bilkent University; Hacettepe University; Baskent University; Ihsan Dogramaci Bilkent University	Saatci, O (corresponding author), Bilkent Univ, Dept Mol Biol & Genet, Fac Sci, TR-06800 Ankara, Turkey.; Saatci, O (corresponding author), Bilkent Univ, Natl Nanotechnol Res Ctr UNAM, TR-06800 Ankara, Turkey.	sahinozgur@gmail.com	Sahin, Özgür/F-4403-2014; Akbulut Çalışkan, Özge/Q-8134-2018; Akyol, Aytekin/B-6384-2009; Wiemann, Stefan/E-4424-2013; Durmus, Selvi/J-2075-2018; Alkan, Can/D-2982-2009; KUTUK, OZGUR/AAH-1671-2019	Sahin, Özgür/0000-0002-8033-7089; Akbulut Çalışkan, Özge/0000-0002-3647-1969; Akyol, Aytekin/0000-0002-4075-3475; Wiemann, Stefan/0000-0003-4683-3174; Durmus, Selvi/0000-0003-3792-1607; Alkan, Can/0000-0002-5443-0706; KUTUK, OZGUR/0000-0001-9854-7220; Borgoni, Simone/0000-0003-3833-0032; raza, umar/0000-0002-0081-6996	TUBITAK-BMBF Bilateral Grant [214Z130, 01DL16003]; EMBO Installation Grant [2791]; Genentech, USA Inc. [OR-213615]; Baskent University; The Science Academy	TUBITAK-BMBF Bilateral Grant; EMBO Installation Grant; Genentech, USA Inc.(Roche HoldingGenentech); Baskent University(Baskent University); The Science Academy	This project was supported by TUBITAK-BMBF Bilateral Grant numbers: TUBITAK, 214Z130 (to OS) and BMBF WTZ, 01DL16003 (to SW). OS further acknowledges the support from EMBO Installation Grant Number 2791. Special thanks to Genentech, USA Inc. for providing us with T-DM1 under Material Transfer Agreement with MTA number OR-213615. We thank the DKFZ Genomics and Proteomics Core Facility for providing sequencing excellent services. We also thank Deniz Atasoy and Pelin Dilsiz from Istanbul Medipol University for their help with confocal microscopy. OK acknowledges support from Baskent University and The Science Academy.	Akbani R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4887; Barok M, 2007, MOL CANCER THER, V6, P2065, DOI 10.1158/1535-7163.MCT-06-0766; Barok M, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3621; Barok M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2868; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Cheng L, 2015, CURR PHARM DESIGN, V21, P1347, DOI 10.2174/1381612820999141029162811; Daemen A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r110; DeAngelo DJ, 2015, CL LYMPH MYELOM LEUK, V15, pS194, DOI 10.1016/j.clml.2015.04.046; Degenhardt Y, 2010, CLIN CANCER RES, V16, P384, DOI 10.1158/1078-0432.CCR-09-1380; Dohner H, 2014, BLOOD, V124, P1426, DOI 10.1182/blood-2014-03-560557; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Gagliato DD, 2016, ONCOTARGET, V7, P64431, DOI 10.18632/oncotarget.7043; Gajria D, 2011, EXPERT REV ANTICANC, V11, P263, DOI 10.1586/ERA.10.226; Gleixner KV, 2010, CANCER RES, V70, P1513, DOI 10.1158/0008-5472.CAN-09-2181; Gluck S, 2012, BREAST CANCER RES TR, V132, P781, DOI 10.1007/s10549-011-1412-7; Hain KO, 2016, SCI REP-UK, V6, DOI 10.1038/srep26766; Hayashi T, 2015, J UROLOGY, V194, P1120, DOI 10.1016/j.juro.2015.05.087; Henjes F, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.16; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Koninki K, 2010, CANCER LETT, V294, P211, DOI 10.1016/j.canlet.2010.02.002; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee KS, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-4; Leow CC, 2009, MOL CANCER THER, V8, P2131, DOI 10.1158/1535-7163.MCT-08-1038; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Liu XQ, 2015, TRANSL ONCOL, V8, P185, DOI 10.1016/j.tranon.2015.03.010; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LoRusso PM, 2011, CLIN CANCER RES, V17, P6437, DOI 10.1158/1078-0432.CCR-11-0762; MAGER PP, 1981, PHARMAZIE, V36, P382; Maire V, 2013, CANCER RES, V73, P813, DOI 10.1158/0008-5472.CAN-12-2633; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; Marcotte R, 2016, CELL, V164, P293, DOI 10.1016/j.cell.2015.11.062; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Mutlu M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32541; Nicoletti R, 2015, CLIN EXP METASTAS, V32, P29, DOI 10.1007/s10585-014-9688-8; Oroudjev E, 2010, MOL CANCER THER, V9, P2700, DOI 10.1158/1535-7163.MCT-10-0645; Orth JD, 2012, MOL BIOL CELL, V23, P567, DOI 10.1091/mbc.E11-09-0781; Pathan N, 2001, NEOPLASIA, V3, P70, DOI 10.1038/sj.neo.7900131; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; RAFFO AJ, 1995, CANCER RES, V55, P4438; Rantanen S, 2001, LEUKEMIA LYMPHOMA, V42, P1089, DOI 10.3109/10428190109097729; Raza U, 2016, ONCOTARGET, V7, P49859, DOI 10.18632/oncotarget.10489; Recondo G, 2016, CANCER MANAG RES, V8, P57, DOI 10.2147/CMAR.S104447; Roden DM, 2011, CIRCULATION, V123, P1661, DOI 10.1161/CIRCULATIONAHA.109.914820; Sahin O, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-1; Sahin O, 2007, P NATL ACAD SCI USA, V104, P6579, DOI 10.1073/pnas.0606827104; Scatena CD, 1998, J BIOL CHEM, V273, P30777, DOI 10.1074/jbc.273.46.30777; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sonntag J, 2014, EXPERT REV PROTEOMIC, V11, P757, DOI 10.1586/14789450.2014.971113; Spankuch B, 2007, ONCOGENE, V26, P5793, DOI 10.1038/sj.onc.1210355; Spector NL, 2009, J CLIN ONCOL, V27, P5838, DOI 10.1200/JCO.2009.22.1507; Srivastava RK, 1999, P NATL ACAD SCI USA, V96, P3775, DOI 10.1073/pnas.96.7.3775; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tanner M, 2004, MOL CANCER THER, V3, P1585; Vu T, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00062; Trakala M, 2015, BLOOD, V126, P1707, DOI 10.1182/blood-2015-03-634402; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Turpin J, 2016, ONCOGENE, V35, P6053, DOI 10.1038/onc.2016.129; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Vogel C, 2005, J BIOL CHEM, V280, P4025, DOI 10.1074/jbc.C400545200; Wang QF, 2012, CANCER RES, V72, P4417, DOI 10.1158/0008-5472.CAN-12-1339-T; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; Wright N, 2017, FRONT BIOSCI-LANDMRK, V22, P1549, DOI 10.2741/4558; Xiao DB, 2016, MOL CELL, V64, P493, DOI 10.1016/j.molcel.2016.09.016; Yamada HY, 2006, MOL CANCER THER, V5, P2963, DOI 10.1158/1535-7163.MCT-06-0319; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yim H, 2013, ANTI-CANCER DRUG, V24, P999, DOI 10.1097/CAD.0000000000000007; Yuan JP, 2011, AM J PATHOL, V179, P2091, DOI 10.1016/j.ajpath.2011.06.031; Zitouni S, 2014, NAT REV MOL CELL BIO, V15, P433, DOI 10.1038/nrm3819	75	32	35	0	37	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	17					2251	2269		10.1038/s41388-017-0108-9	http://dx.doi.org/10.1038/s41388-017-0108-9			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GE3FW	29391599	Green Published			2022-12-26	WOS:000431100200004
J	Peng, CN; Wang, QB; Wang, SM; Wang, WS; Jiao, RM; Han, WJ; Li, FC				Peng, Chune; Wang, Qingbin; Wang, Shumin; Wang, Wenshuang; Jiao, Runmiao; Han, Wenjun; Li, Fuchuan			A chondroitin sulfate and hyaluronic acid lyase with poor activity to glucuronyl 4,6-O-disulfated N-acetylgalactosamine (E-type)-containing structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LINKAGE REGION; PROMOTES NEURITE OUTGROWTH; SIMPLEX-VIRUS INFECTIVITY; CENTRAL-NERVOUS-SYSTEM; SULFATE/DERMATAN SULFATE; MARINE BACTERIUM; DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; DEGRADES HYALURONAN; CRYSTAL-STRUCTURE	GlcUA beta 1-3GalNAc(4S,6S) (E unit)-rich domains have been shown to play key roles in various biological functions of chondroitin sulfate (CS). However, an enzyme that can specifically isolate such domains through the selective digestion of other domains in polysaccharides has not yet been reported. Here, we identified a glycosaminoglycan lyase from a marine bacterium Vibrio sp. FC509. This enzyme efficiently degraded hyaluronic acid (HA) and CS variants, but not E unit-rich CS-E, into unsaturated disaccharides; therefore, we designated this enzyme a CS-E-resisted HA/CS lyase (HCLase Er). We isolated a series of resistant oligosaccharides from the final product of a low-sulfated CS-E exhaustively digested by HCLase Er and found that the E units were dramatically accumulate in these resistant oligosaccharides. By determining the structures of several resistant tetrasaccharides, we observed that all of them possessed a Delta(4,5)HexUA alpha 1-3GalNAc(4S,6S) at their non-reducing ends, indicating that the disulfation of GalNAc abrogates HCLase Er activity on the beta 1-4 linkage between the E unit and the following disaccharide. Delta(4,5)HexUA alpha 1-3GalNAc(4S,6S)beta 1-4GlcUA beta 1-3GalNAc (4S,6S) was most strongly resistant to HCLase Er. To our knowledge, this study is the first reporting a glycosaminoglycan lyase specifically inhibited by both 4-O- and 6-O-sulfation of GalNAc. Site-directed and truncation mutagenesis experiments indicated that HCLase Er may use a general acid-base catalysis mechanism and that an extra domain (Gly(739)-Gln(796)) is critical for its activity. This enzyme will be a useful tool for structural analyses and for preparing bioactive oligosaccharides of HA and CS variants, particularly from E unit-rich CS chains.	[Li, Fuchuan] Shandong Univ, Natl Glycoengn Res Ctr, Shandong Prov Key Lab Carbohydrate Chem & Glycobi, 27 South Shanda Rd, Jinan 250100, Shandong, Peoples R China; Shandong Univ, State Key Lab Microbial Technol, 27 South Shanda Rd, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Li, FC (corresponding author), Shandong Univ, Natl Glycoengn Res Ctr, Shandong Prov Key Lab Carbohydrate Chem & Glycobi, 27 South Shanda Rd, Jinan 250100, Shandong, Peoples R China.	fuchuanli@sdu.edu.cn			National Natural Science Foundation of China [31570071, 31300664]; Science and Technology Special Project of Shandong Province [2015zdjs04002]; Science and Technology Development Project of Shandong Province [2016GGH4502]; Independent Innovation Plan of Colleges and Universities in Jinan [201401242]; Fundamental Research Funds of Shandong University [2015JC002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Special Project of Shandong Province; Science and Technology Development Project of Shandong Province; Independent Innovation Plan of Colleges and Universities in Jinan; Fundamental Research Funds of Shandong University	This work was supported by National Natural Science Foundation of China Grants 31570071 and 31300664, Science and Technology Special Project of Shandong Province Grant 2015zdjs04002, Science and Technology Development Project of Shandong Province Grant 2016GGH4502, Independent Innovation Plan of Colleges and Universities in Jinan Grant 201401242, and the Fundamental Research Funds of Shandong University Grant 2015JC002. The authors declare that they have no conflicts of interest with the contents of this article.	Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183; Basappa, 2009, GLYCOBIOLOGY, V19, P735, DOI 10.1093/glycob/cwp041; Bergefall K, 2005, J BIOL CHEM, V280, P32193, DOI 10.1074/jbc.M503645200; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Deepa SS, 2007, BIOCHEMISTRY-US, V46, P2453, DOI 10.1021/bi602374m; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Fethiere J, 1999, J MOL BIOL, V288, P635, DOI 10.1006/jmbi.1999.2698; Hamai A, 1997, J BIOL CHEM, V272, P9123; Han WJ, 2014, J BIOL CHEM, V289, P27886, DOI 10.1074/jbc.M114.590752; Hashimoto W, 2003, J BIOL CHEM, V278, P7663, DOI 10.1074/jbc.M208100200; Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254; Iida J, 1996, SEMIN CANCER BIOL, V7, P155, DOI 10.1006/scbi.1996.0021; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Izumikawa T, 2004, J BIOL CHEM, V279, P53755, DOI 10.1074/jbc.M409615200; Jinno-Oue A, 2013, AIDS RES HUM RETROV, V29, P621, DOI [10.1089/aid.2012.0156, 10.1089/AID.2012.0156]; Kato D, 2010, ANTIVIR RES, V88, P236, DOI 10.1016/j.antiviral.2010.09.002; Kim BT, 2003, J BIOL CHEM, V278, P9116, DOI 10.1074/jbc.M209344200; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Koike T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08994; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Li FC, 2010, J BIOL CHEM, V285, P27673, DOI 10.1074/jbc.M110.118703; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Mikami T, 2017, GLYCOCONJUGATE J, V34, P725, DOI 10.1007/s10719-016-9732-9; Miyata S, 2017, BBA-GEN SUBJECTS, V1861, P2420, DOI 10.1016/j.bbagen.2017.06.010; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Mizumoto S, 2013, GLYCOBIOLOGY, V23, P155, DOI 10.1093/glycob/cws137; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Pomin VH, 2015, EUR J MED CHEM, V92, P353, DOI 10.1016/j.ejmech.2015.01.002; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Sambrook J, 2001, MOL CLONING LAB MANU; Schnadelbach O, 1998, GLIA, V23, P99, DOI 10.1002/(SICI)1098-1136(199806)23:2<99::AID-GLIA2>3.0.CO;2-Z; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Smith PD, 2015, EXP NEUROL, V274, P100, DOI 10.1016/j.expneurol.2015.08.004; Sotogaku N, 2007, J NEUROCHEM, V103, P749, DOI 10.1111/j.1471-4159.2007.04849.x; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 1996, EUR J BIOCHEM, V239, P871, DOI 10.1111/j.1432-1033.1996.0871u.x; Sugahara KN, 2008, CANCER RES, V68, P7191, DOI 10.1158/0008-5472.CAN-07-6198; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Sugahara K, 2012, ADV EXP MED BIOL, V749, P33, DOI 10.1007/978-1-4614-3381-1_3; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Tully SE, 2004, J AM CHEM SOC, V126, P7736, DOI 10.1021/ja0484045; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Valcarcel J, 2017, BIOTECHNOL ADV, V35, P711, DOI 10.1016/j.biotechadv.2017.07.008; Wang WS, 2017, BIOCHEM J, V474, P3831, DOI 10.1042/BCJ20170591; Wang WS, 2015, J BIOL CHEM, V290, P7823, DOI 10.1074/jbc.M114.629154; Williams RK, 1997, J VIROL, V71, P1375, DOI 10.1128/JVI.71.2.1375-1380.1997; Yamada S, 2002, J BIOL CHEM, V277, P31877, DOI 10.1074/jbc.M205078200; YAMADA S, 1995, GLYCOBIOLOGY, V5, P335, DOI 10.1093/glycob/5.3.335; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523	55	8	9	4	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4230	4243		10.1074/jbc.RA117.001238	http://dx.doi.org/10.1074/jbc.RA117.001238			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29414785	hybrid, Green Published			2022-12-26	WOS:000428204300001
J	Gladkov, A; Grinchuk, O; Pigareva, Y; Mukhina, I; Kazantsev, V; Pimashkin, A				Gladkov, Arseniy; Grinchuk, Oleg; Pigareva, Yana; Mukhina, Irina; Kazantsev, Victor; Pimashkin, Alexey			Theta rhythm-like bidirectional cycling dynamics of living neuronal networks in vitro	PLOS ONE			English	Article							SYNCHRONIZED BURSTS; GAMMA RHYTHMS; OSCILLATIONS; INHIBITION; PATTERNS; HIPPOCAMPUS; FREQUENCY; CORTEX; PROLIFERATION; MECHANISMS	The phenomena of synchronization, rhythmogenesis and coherence observed in brain networks are believed to be a dynamic substrate for cognitive functions such as learning and memory. However, researchers are still debating whether the rhythmic activity emerges from the network morphology that developed during neurogenesis or as a result of neuronal dynamics achieved under certain conditions. In the present study, we observed self-organized spiking activity that converged to long, complex and rhythmically repeated superbursts in neural networks formed by mature hippocampal cultures with a high cellular density. The superburst lasted for tens of seconds and consisted of hundreds of short (50-100 ms) small bursts with a high spiking rate of 139.0-78.6 Hz that is associated with high-frequency oscillations in the hippocampus. In turn, the bursting frequency represents a theta rhythm (11.2-1.5 Hz). The distribution of spikes within the bursts was non-random, representing a set of well-defined spatio-temporal base patterns or motifs. The long superburst was classified into two types. Each type was associated with a unique direction of spike propagation and, hence, was encoded by a binary sequence with random switching between the two "functional" states. The precisely structured bidirectional rhythmic activity that developed in self-organizing cultured networks was quite similar to the activity observed in the in vivo experiments.	[Gladkov, Arseniy; Pigareva, Yana; Mukhina, Irina; Kazantsev, Victor; Pimashkin, Alexey] Lobachevsky State Univ Nizhni Novgorod, Lab Neuroengn, Ctr Translat Technol, Nizhnii Novgorod, Russia; [Gladkov, Arseniy; Mukhina, Irina] Nizhny Novgorod State Med Acad, Cell Technol Dept, Cent Res Lab, Nizhnii Novgorod, Russia; [Grinchuk, Oleg] Skolkovo Inst Sci & Technol, Informat Sci & Technol Dept, Moscow, Russia	Lobachevsky State University of Nizhni Novgorod; Privolzhsky Research Medical University; Skolkovo Institute of Science & Technology	Pimashkin, A (corresponding author), Lobachevsky State Univ Nizhni Novgorod, Lab Neuroengn, Ctr Translat Technol, Nizhnii Novgorod, Russia.	pimashkin@neuro.nnov.ru	Gladkov, Arseniy A/B-7451-2013; Kazantsev, Victor B/L-1424-2013; Grinchuk, Oleg/AAH-9301-2019; Mukhina, Irina/E-3257-2014; Pigareva, Yana/AAM-7211-2021	Gladkov, Arseniy A/0000-0002-1831-808X; Mukhina, Irina/0000-0002-8811-0049; Pimashkin, Alexey/0000-0001-7024-8827; Kazantsev, Viktor/0000-0002-2881-6648	Russian Science Foundation [16-19-00144]	Russian Science Foundation(Russian Science Foundation (RSF))	This research is supported by the Russian Science Foundation (No 16-19-00144).; This research was supported by the Russian Science Foundation (No 16-19-00144).	Bao WL, 2003, J NEUROPHYSIOL, V90, P333, DOI 10.1152/jn.00715.2002; Benson DL, 1998, J NEUROSCI, V18, P6892; Benson DL, 1996, J NEUROSCI, V16, P6424; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2006, RHYTHMS BRAIN; Buzsaki Gyorgy, 2012, Dialogues Clin Neurosci, V14, P345; Chen X., 2010, J NANOMATER, V2010, P1, DOI DOI 10.1016/J.JALLC0M.2010.06.029.ISSN; Chiappalone M, 2007, INT J NEURAL SYST, V17, P87, DOI 10.1142/S0129065707000968; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Colombi I, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00409; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; de Lima AD, 1999, EUR J NEUROSCI, V11, P3845, DOI 10.1046/j.1460-9568.1999.00804.x; Ferrer-Acosta Y, 2017, JOVE-J VIS EXP, DOI 10.3791/55108; Frega M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05489; Gandolfo M, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056001; Gladkov AA, 2014, VESTN LOBACHEVSKY ST, V1, P57; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; Gritsun TA, 2010, BIOL CYBERN, V102, P293, DOI 10.1007/s00422-010-0366-x; Gritsun TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043352; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Huang YT, 2012, 8 INT M SUBSTR INT M, P86; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Ide N, 2010, J NEURAL ENG, V7, P1; Idelson MS, 2010, PLOS ONE, V5, P1; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Ito D, 2010, NEUROSCIENCE, V171, P50, DOI 10.1016/j.neuroscience.2010.08.038; Ito D, 2013, BRAIN RES, V1534, P22, DOI 10.1016/j.brainres.2013.08.004; Jackson J, 2011, J NEUROSCI, V31, P12104, DOI 10.1523/JNEUROSCI.1370-11.2011; Keren H, 2016, SCI REP, V6, P1, DOI DOI 10.1038/SREP36837; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Kim JH, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/04/P04019; Kiyohara A, 2011, IEEJ T ELECTR ELECTR, V6, P163, DOI 10.1002/tee.20639; Konopacki J, 2000, ACTA NEUROBIOL EXP, V60, P67; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Koryagina EA, 2011, VESTN LOBACHEVSKY U, V2, P254; Kowalczyk T, 2001, BRAIN RES, V901, P184, DOI 10.1016/S0006-8993(01)02355-1; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Krushel LA, 1998, P NATL ACAD SCI USA, V95, P2592, DOI 10.1073/pnas.95.5.2592; le Feber J, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/3/036005; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Leondopulos SS, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026015; Madhavan R, 2007, PHYS BIOL, V4, P181, DOI 10.1088/1478-3975/4/3/005; MAEDA E, 1995, J NEUROSCI, V15, P6834; Maeda E, 1998, EUR J NEUROSCI, V10, P488, DOI 10.1046/j.1460-9568.1998.00062.x; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Mok SY, 2012, NEUROSCIENCE, V206, P17, DOI 10.1016/j.neuroscience.2012.01.009; Nakatsuji Y, 1998, GLIA, V22, P379, DOI 10.1002/(SICI)1098-1136(199804)22:4<379::AID-GLIA7>3.0.CO;2-Z; Niedringhaus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042631; Pavlov I, 2014, P NATL ACAD SCI USA, V111, P504, DOI 10.1073/pnas.1308388110; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Pimashkin A, 2016, COGN NEURODYNAMICS, V10, P287, DOI 10.1007/s11571-016-9380-6; Pimashkin A, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00046; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Raichman N, 2008, J NEUROSCI METH, V170, P96, DOI 10.1016/j.jneumeth.2007.12.020; Reimer T., 2012, J CHEM CHEM ENG, V6, P1033; ROBINSON TE, 1980, BRAIN RES REV, V2, P69, DOI 10.1016/0165-0173(80)90004-1; Shahaf G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000228; Shirokova OM, 2013, SOVREM TEHNOL MED, V5, P6; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; Stephens CL, 2012, EXP NEUROL, V234, P20, DOI 10.1016/j.expneurol.2011.12.009; Struve J, 2005, GLIA, V52, P16, DOI 10.1002/glia.20215; Sullivan D, 2011, J NEUROSCI, V31, P8605, DOI 10.1523/JNEUROSCI.0294-11.2011; Tokuda Minori, 2009, 2009 International Symposium on Micro-NanoMechatronics and Human Science (MHS), P118, DOI 10.1109/MHS.2009.5352068; Tort ABL, 2013, PROG NEUROBIOL, V100, P1, DOI 10.1016/j.pneurobio.2012.09.002; Van Pelt J, 2004, NEUROSCI LETT, V361, P86, DOI 10.1016/j.neulet.2003.12.062; Vedunova M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00149; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Wagenaar D. A., 2006, PHYS REV, V73, P1; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wagenaar DA, 2006, THESIS CALIFORNIA I; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Yamada MK, 2002, J NEUROSCI, V22, P7580; Zhao X, 2017, NEUROSCIENCE, V362, P1, DOI 10.1016/j.neuroscience.2017.08.027; Zhu G, 2010, BIOMED MICRODEVICES, V12, P153, DOI 10.1007/s10544-009-9370-0	78	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192468	10.1371/journal.pone.0192468	http://dx.doi.org/10.1371/journal.pone.0192468			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415033	Green Submitted, gold, Green Published			2022-12-26	WOS:000424325300079
J	Georgiadis, K; Wray, S; Ourselin, S; Warren, JD; Modat, M				Georgiadis, Konstantinos; Wray, Selina; Ourselin, Sebastien; Warren, Jason D.; Modat, Marc			Computational modelling of pathogenic protein spread in neurodegenerative diseases	PLOS ONE			English	Article							TAU PROPAGATION; PATHOLOGY; PATTERNS; BETA	Pathogenic protein accumulation and spread are fundamental principles of neurodegenerative diseases and ultimately account for the atrophy patterns that distinguish these diseases clinically. However, the biological mechanisms that link pathogenic proteins to specific neural network damage patterns have not been defined. We developed computational models for mechanisms of pathogenic protein accumulation, spread and toxic effects in an artificial neural network of cortical columns. By varying simulation parameters we assessed the effects of modelled mechanisms on network breakdown patterns. Our findings suggest that patterns of network breakdown and the convergence of patterns follow rules determined by particular protein parameters. These rules can account for empirical data on pathogenic protein spread in neural networks. This work provides a basis for understanding the effects of pathogenic proteins on neural circuits and predicting progression of neurodegeneration.	[Georgiadis, Konstantinos; Ourselin, Sebastien; Modat, Marc] UCL, Dept Med Phys & Biomed Engn, Ctr Med Image Comp, Translat Imaging Grp, London NW1 2HE, England; [Wray, Selina] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Ourselin, Sebastien; Warren, Jason D.; Modat, Marc] UCL, Inst Neurol, Dementia Res Ctr, London WC1N 3BG, England	University of London; University College London; University of London; University College London; University of London; University College London	Georgiadis, K (corresponding author), UCL, Dept Med Phys & Biomed Engn, Ctr Med Image Comp, Translat Imaging Grp, London NW1 2HE, England.	konstantinos.georgiadis.14@ucl.ac.uk	Wray, Selina/C-3682-2009; Ourselin, Sebastien/K-6960-2015	Wray, Selina/0000-0003-3062-7050; Ourselin, Sebastien/0000-0002-5694-5340; Georgiadis, Konstantinos/0000-0003-4460-9021; Modat, Marc/0000-0002-5277-8530; Warren, Jason/0000-0002-5405-0826	Engineering and Physical Sciences Research Council [EP/L016478/1, EP/J020990/1]; University College London Leonard Wolfson Experimental Neurology Centre [PR/ylr/18575]; National Institute for Health Research Queen Square Dementia Biomedical Research Unit, an Alzheimer's Research UK Senior Fellowship; NC3R Crack IT grant; National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL High Impact Initiative) [BW.mn.BRC10269]; Wellcome Trust Senior Clinical Fellowship [091673/Z/10/Z]; Alzheimer's Society UK [AS-PG-15-025]; Brain Research Trust; Wolfson Foundation; Alzheimer's Society; UK Medical Research Council; National Institute for Health Research University College London Hospitals Biomedical Research Centre; EPSRC [EP/L016478/1, EP/J020990/1]; UCL Leonard Wolfson Experimental Neurology Centre [PR/ylr/18575]; NIHR Queen Square Dementia Biomedical Research Unit, an ARUK Senior Fellowship; Alzheimers Research UK [ARUK-SRF2016B-2] Funding Source: researchfish; Engineering and Physical Sciences Research Council [2038134, 1676031] Funding Source: researchfish; National Centre for the Replacement [NC/C013103/1, NC/C013201/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University College London Leonard Wolfson Experimental Neurology Centre; National Institute for Health Research Queen Square Dementia Biomedical Research Unit, an Alzheimer's Research UK Senior Fellowship; NC3R Crack IT grant; National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL High Impact Initiative)(General Electric); Wellcome Trust Senior Clinical Fellowship(Wellcome Trust); Alzheimer's Society UK; Brain Research Trust; Wolfson Foundation; Alzheimer's Society; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UCL Leonard Wolfson Experimental Neurology Centre; NIHR Queen Square Dementia Biomedical Research Unit, an ARUK Senior Fellowship; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Centre for the Replacement	KG is funded by the Engineering and Physical Sciences Research Council (EP/L016478/1 - http://gow.epsrc.ac.uk/NGBOViewGrant.aspx?GrantRef=EP/L016478/1). KG and MM are supported by the University College London Leonard Wolfson Experimental Neurology Centre (PR/ylr/18575 - http://www.ucl.ac.uk/lwenc). SW is supported by the National Institute for Health Research Queen Square Dementia Biomedical Research Unit, an Alzheimers Research UK Senior Fellowship and an NC3R Crack IT grant (https://www.nc3rs.org.uk/). SO is funded by the Engineering and Physical Sciences Research Council (EP/J020990/1 - http://gow.epsrc.ac.uk/NGBOViewGrant.aspx?GrantRef=EP/J020990/1) and the National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL High Impact Initiative - BW.mn.BRC10269 - http://www.uclhospitals.brc.nihr.ac.uk/). JDW was supported by a Wellcome Trust Senior Clinical Fellowship (091673/Z/10/Z - https://wellcome.ac.uk/). MM is also funded by the Alzheimers Society UK (AS-PG-15-025 - https://www.alzheimers.org.uk/). The Dementia Research Centre is supported by the Brain Research Trust (https://brt.org.uk/), the Wolfson Foundation (http://www.wolfson.org.uk/), the Alzheimers Society (https://www.alzheimers.org.uk/) and the UK Medical Research Council (https://www.mrc.ac.uk/). This work was also funded by the Alzheimers Society (https://www.alzheimers.org.uk/) and supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre (http://www.uclhospitals.brc.nihr.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Samuel A. Neymotin and William W. Lytton for helping with the NEURON network. KG is funded by the EPSRC (EP/L016478/1). KG and MM are supported by the UCL Leonard Wolfson Experimental Neurology Centre (PR/ylr/18575) SW is supported by the NIHR Queen Square Dementia Biomedical Research Unit, an ARUK Senior Fellowship and an NC3R Crack IT grant. SO is funded by the EPSRC (EP/J020990/1) and the National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL High Impact Initiative- BW.mn.BRC10269). JDW was supported by a Wellcome Trust Senior Clinical Fellowship [091673/Z/10/Z]. MM is also funded by the Alzheimers Society UK (AS-PG-15-025). The Dementia Research Centre is supported by the Brain Research Trust, the Wolfson Foundation, the Alzheimers Society and the UK Medical Research Council. This work was also funded by the Alzheimers Society and supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre.	Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Garden GA, 2012, NEURON, V73, P886, DOI 10.1016/j.neuron.2012.02.017; Goedert M, 2016, BRAIN 2; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Hardy J, 2012, NEW ENGL J MED, V366, P2126, DOI 10.1056/NEJMcibr1202401; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Kerr CC, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00039; Kopeikina KJ, 2012, TRANSL NEUROSCI, V3, P223, DOI 10.2478/s13380-012-0032-y; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Neymotin SA, 2011, J COMPUT NEUROSCI, V30, P69, DOI 10.1007/s10827-010-0253-4; Pievani M, 2011, LANCET NEUROL, V10, P829, DOI 10.1016/S1474-4422(11)70158-2; Pooler AM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0199-x; Proctor CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073631; Raj A, 2015, CELL REP, V10, P359, DOI 10.1016/j.celrep.2014.12.034; Rowan MS, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00039; Sansom SN, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002519; Sepulcre J, 2017, JAMA NEUROLOGY; Shepherd G.M., 2003, SYNAPTIC ORG BRAIN, DOI [10.1093/acprof:oso/9780195159561.001.1, DOI 10.1093/ACPROF:OSO/9780195159561.001.1]; Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004; Utton MA, 2005, J CELL SCI, V118, P4645, DOI 10.1242/jcs.02558; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Warren JD, 2013, TRENDS NEUROSCI, V36, P561, DOI 10.1016/j.tins.2013.06.007; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Wu JW, 2016, NAT NEUROSCI, V19, P1085, DOI 10.1038/nn.4328; Young AL, 2014, BRAIN, V137, P2564, DOI 10.1093/brain/awu176; Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004	30	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192518	10.1371/journal.pone.0192518	http://dx.doi.org/10.1371/journal.pone.0192518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401516	gold, Green Published, Green Submitted			2022-12-26	WOS:000424101400064
J	Guo, SX; Huang, CC; Zhao, W; Yang, AC; Lin, CP; Nichols, T; Tsai, SJ				Guo, Shuixia; Huang, Chu-Chung; Zhao, Wei; Yang, Albert C.; Lin, Ching-Po; Nichols, Thomas; Tsai, Shih-Jen			Combining multi-modality data for searching biomarkers in schizophrenia	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; CANONICAL CORRELATION-ANALYSIS; STATE FUNCTIONAL CONNECTIVITY; IMAGING BIOMARKERS; STRUCTURAL MRI; SNP DATA; FMRI; FUSION; RISK; EEG	Identification of imaging biomarkers for schizophrenia is an important but still challenging problem. Even though considerable efforts have been made over the past decades, quantitative alterations between patients and healthy subjects have not yet provided a diagnostic measure with sufficient high sensitivity and specificity. One of the most important reasons is the lack of consistent findings, which is in part due to single-mode study, which only detects single dimensional information by each modality, and thus misses the most crucial differences between groups. Here, we hypothesize that multimodal integration of functional MRI (fMRI), structural MRI (sMRI), and diffusion tensor imaging (DTI) might yield more power for the diagnosis of schizophrenia. A novel multivariate data fusion method for combining these modalities is introduced without reducing the dimension or using the priors from 161 schizophrenia patients and 168 matched healthy controls. The multi-index feature for each ROI is constructed and summarized with Wilk's lambda by performing multivariate analysis of variance to calculate the significant difference between different groups. Our results show that, among these modalities, fMRI has the most significant featureby calculating the Jaccard similarity coefficient (0.7416) and Kappa index (0.4833). Furthermore, fusion of these modalities provides the most plentiful information and the highest predictive accuracy of 86.52%. This work indicates that multimodal integration can improve the ability of distinguishing differences between groups and might be assisting in further diagnosis of schizophrenia.	[Guo, Shuixia; Zhao, Wei] Hunan Normal Univ, Coll Math & Comp Sci, Key Lab High Performance Comp & Stochast Informat, Minist Educ China, Changsha, Hunan, Peoples R China; [Huang, Chu-Chung; Lin, Ching-Po] Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei, Taiwan; [Yang, Albert C.; Tsai, Shih-Jen] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Yang, Albert C.; Tsai, Shih-Jen] Natl Yang Ming Univ, Sch Med, Div Psychiat, Taipei, Taiwan; [Yang, Albert C.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, Boston, MA USA; [Yang, Albert C.; Lin, Ching-Po; Tsai, Shih-Jen] Natl Yang Ming Univ, Inst Brain Sci, Taipei, Taiwan; [Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Taipei, Taiwan; [Nichols, Thomas] Univ Warwick, Dept Stat, Coventry, W Midlands, England	Hunan Normal University; Ministry of Education, China; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; University of Warwick	Guo, SX (corresponding author), Hunan Normal Univ, Coll Math & Comp Sci, Key Lab High Performance Comp & Stochast Informat, Minist Educ China, Changsha, Hunan, Peoples R China.; Tsai, SJ (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.; Tsai, SJ (corresponding author), Natl Yang Ming Univ, Sch Med, Div Psychiat, Taipei, Taiwan.; Tsai, SJ (corresponding author), Natl Yang Ming Univ, Inst Brain Sci, Taipei, Taiwan.	guoshuixia75@163.com; tsai610913@gmail.com	Nichols, Thomas E./N-9902-2017; Tsai, Shih-Jen/AAK-7944-2020	Nichols, Thomas E./0000-0002-4516-5103; Tsai, Shih-Jen/0000-0002-9987-022X; Huang, Chu-Chung/0000-0002-9096-9610	National Natural Science Foundation of China (NSFC) [11671129]; Natural Science Foundation of Hunan Province [2015JJ1010]; Ministry of Science and Technology [104-2218-E-010-007-MY3, MOST 105-B-2633-400-001, MOST 106-2321-B-010-011]; National Health Research Institutes [NHRI-EX106-10611EI]; Taipei Veterans General Hospital, Taiwan [VGHUST102-G1-2-1, VGHUST103-G1- 4-1]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institutes(National Health Research Institutes, Japan); Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital)	SXG is supported by the National Natural Science Foundation of China (NSFC) grant (No. 11671129), Natural Science Foundation of Hunan Province (2015JJ1010). CPL is supported in part by funding from Ministry of Science and Technology (104-2218-E-010-007-MY3, MOST 105-B-2633-400-001, and MOST 106-2321-B-010-011) and National Health Research Institutes (zNHRI-EX106-10611EI), and Taipei Veterans General Hospital, Taiwan (grants VGHUST102-G1-2-1, and VGHUST103-G1- 4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Babiloni F, 2004, MAGN RESON IMAGING, V22, P1471, DOI 10.1016/j.mri.2004.10.007; Bartlett MS, 1938, P CAMB PHILOS SOC, V34, P33, DOI 10.1017/S0305004100019897; Calhoun VD, 2006, HUM BRAIN MAPP, V27, P47, DOI 10.1002/hbm.20166; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P1265, DOI 10.1002/hbm.20463; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Callicott JH, 2003, AM J PSYCHIAT, V160, P709, DOI 10.1176/appi.ajp.160.4.709; Camchong J, 2011, SCHIZOPHRENIA BULL, V37, P640, DOI 10.1093/schbul/sbp131; Cao HB, 2014, NEUROIMAGE, V102, P220, DOI 10.1016/j.neuroimage.2014.01.021; Carter CS, 2001, AM J PSYCHIAT, V158, P1423, DOI 10.1176/appi.ajp.158.9.1423; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cook RJ, 1998, ENCY BIOSTATISTICS; Correa NM, 2010, IEEE SIGNAL PROC MAG, V27, P39, DOI 10.1109/MSP.2010.936725; Correa NM, 2010, NEUROIMAGE, V50, P1438, DOI 10.1016/j.neuroimage.2010.01.062; Correa NM, 2009, INT CONF ACOUST SPEE, P385, DOI 10.1109/ICASSP.2009.4959601; Cox DR., 1989, ANAL BINARY DATA; Dale AM, 2001, CURR OPIN NEUROBIOL, V11, P202, DOI 10.1016/S0959-4388(00)00197-5; Fodor IK, 2002, SURVEY DIMENSION RED, DOI [10.2172/15002155, DOI 10.2172/15002155]; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Goldberg-Zimring D, 2005, J NEUROIMAGING, V15, p68S, DOI 10.1177/1051228405283363; Groves AR, 2011, NEUROIMAGE, V54, P2198, DOI 10.1016/j.neuroimage.2010.09.073; Guo S, 2016, PSYCHOL MED, V46, P2201, DOI 10.1017/S0033291716000994; Guo SX, 2014, SCHIZOPHRENIA BULL, V40, P449, DOI 10.1093/schbul/sbt163; Guo SX, 2014, HUM BRAIN MAPP, V35, P123, DOI 10.1002/hbm.22162; Guo SX, 2015, BRIT J PSYCHIAT, P1, DOI [10.1192, DOI 10.1192]; GUPTA T, 1990, INT J PROD RES, V28, P1247, DOI 10.1080/00207549008942791; Hamid JS, 2009, HUMAN GENOMICS PROTE, V1; Hamshere ML, 2012, MOL PSYCHIAT; Hanke M, 2009, NEUROINFORMATICS, V7, P37, DOI 10.1007/s12021-008-9041-y; Hasnain MK, 2001, CEREB CORTEX, V11, P702, DOI 10.1093/cercor/11.8.702; Henson RN, 2010, HUM BRAIN MAPP, V31, P1512, DOI 10.1002/hbm.20956; Hu WX, 2016, IEEE ENG MED BIO, P3310, DOI 10.1109/EMBC.2016.7591436; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Javitt DC, 2008, NAT REV DRUG DISCOV, V7, P68, DOI 10.1038/nrd2463; Karageorgiou E, 2011, NEUROINFORMATICS, V9, P321, DOI 10.1007/s12021-010-9094-6; Kim DI, 2010, NEUROINFORMATICS, V8, P213, DOI 10.1007/s12021-010-9077-7; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Lee SH, 2013, SCHIZOPHR RES, V143, P231, DOI 10.1016/j.schres.2012.11.029; Lin D, 2014, MED IMAGE ANAL, V18, P891, DOI 10.1016/j.media.2013.10.010; Liu JY, 2009, HUM BRAIN MAPP, V30, P241, DOI 10.1002/hbm.20508; McCarley RW, 2008, CLIN EEG NEUROSCI, V39, P57, DOI 10.1177/155005940803900206; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; Michael AM, 2010, NEUROIMAGE, V49, P2626, DOI 10.1016/j.neuroimage.2009.08.056; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Oertel-Knochel V, 2012, CURR TOP MED CHEM, V12, P2434, DOI 10.2174/156802612805289926; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Pettersson-Yeo W, 2013, PSYCHOL MED, V43, P2547, DOI 10.1017/S003329171300024X; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pu WD, 2014, NEUROIMAGE-CLIN, V6, P463, DOI 10.1016/j.nicl.2014.10.004; Ramnani Narender, 2002, Trends in Neurosciences, V25, P496, DOI 10.1016/S0166-2236(02)02227-0; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Schlosser R, 2003, NEUROIMAGE, V19, P751, DOI 10.1016/S1053-8119(03)00106-X; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Sui J, 2014, IEEE ENG MED BIO, P3889, DOI 10.1109/EMBC.2014.6944473; Sui J, 2012, J NEUROSCI METH, V204, P68, DOI 10.1016/j.jneumeth.2011.10.031; Sui J, 2011, NEUROIMAGE, V57, P839, DOI 10.1016/j.neuroimage.2011.05.055; Sui J, 2009, HUM BRAIN MAPP, V30, P2953, DOI 10.1002/hbm.20721; Teipel SJ, 2010, NEUROIMAGE, V49, P2021, DOI 10.1016/j.neuroimage.2009.10.067; Tregellas JR, 2014, AM J PSYCHIAT, V171, P549, DOI 10.1176/appi.ajp.2013.13070981; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; Wagner M, 2001, INT J BIOELECTROMAG, V3; Wen W, 2004, NEUROIMAGE, V22, P144, DOI 10.1016/j.neuroimage.2003.12.027; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008; Zhou YA, 2008, SCHIZOPHR RES, V100, P120, DOI 10.1016/j.schres.2007.11.039	69	14	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191202	10.1371/journal.pone.0191202	http://dx.doi.org/10.1371/journal.pone.0191202			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389986	gold, Green Published, Green Submitted			2022-12-26	WOS:000423793400013
J	Menon, M; Coghill, A; Mutyaba, I; Okuku, F; Phipps, W; Harlan, J; Orem, J; Casper, C				Menon, Manoj; Coghill, Anna; Mutyaba, Innocent; Okuku, Fred; Phipps, Warren; Harlan, John; Orem, Jackson; Casper, Corey			Whom to treat? Factors associated with chemotherapy recommendations and outcomes among patients with NHL at the Uganda Cancer Institute	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; CLINICAL-PRACTICE GUIDELINE; COLONY-STIMULATING FACTOR; SUB-SAHARAN AFRICA; ELDERLY-PATIENTS; FEBRILE NEUTROPENIA; CHOP CHEMOTHERAPY; 2010 UPDATE; MORTALITY; SURVIVAL	Introduction Cancer treatment options in sub-Saharan Africa are scarce despite an increasing burden of disease. Identification of those cancer patients who would benefit most from the limited resources available would allow broader and more effective therapy. Methods We conducted a retrospective analysis of patients over the age of 18 at the time of a pathologic diagnosis of NHL between 2003 and 2010 who were residents of Kyandondo County (Uganda) and presented to the Uganda Cancer Institute for care. Results A total of 128 patients were included in this analysis. Chemotherapy was recommended to 117 (91.4%) of the patients; the odds of recommending chemotherapy decreased for each additional month of reported symptoms prior to diagnosis. Of the 117 patients to whom chemotherapy was recommended, 111 (86.7%) patients received at least 1 cycle of chemotherapy; HIV infected patients, as well as those with a lower hemoglobin and advanced disease at the time of diagnosis were significantly less likely to complete therapy. Among the patients who initiated chemotherapy, twenty patients died prior to treatment completion (including nine who died within 30 days). Hemoglobin level at the time of presentation was the only variable associated with early mortality in the adjusted model. Conclusion In resource-poor areas, it is essential to align health care expenditures with interventions likely to provide benefit to affected populations. Targeting cancer therapy to those with a favorable chance of responding will not only save limited resources, but will also prevent harm in those patients unlikely to realize an effect of cancer-directed therapy.	[Menon, Manoj; Coghill, Anna; Phipps, Warren; Casper, Corey] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Menon, Manoj; Phipps, Warren; Harlan, John; Casper, Corey] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Mutyaba, Innocent; Okuku, Fred; Orem, Jackson] Uganda Canc Inst, Kampala, Uganda; [Mutyaba, Innocent; Okuku, Fred; Phipps, Warren; Orem, Jackson] Hutchinson Ctr Res Inst, Kampala, Uganda; [Casper, Corey] Infect Dis Res Inst, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Menon, M (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.; Menon, M (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	mmenon@fhcrc.org			AIDS Malignancy Consortium [5 K12 HL 087165, UM1 CA121947]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	AIDS Malignancy Consortium; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for MPM was provided, in part, via a Career Development in Clinical Hematology award (5 K12 HL 087165) and a fellowship from the AIDS Malignancy Consortium (UM1 CA121947). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapro MS, 2011, EUR J CANCER, V47, P8, DOI 10.1016/j.ejca.2010.10.013; Bairey O, 2006, ANN ONCOL, V17, P928, DOI 10.1093/annonc/mdl034; Bateganya MH, 2011, JAIDS-J ACQ IMM DEF, V56, P312, DOI 10.1097/QAI.0b013e31820c011a; Bates I, 2008, BJOG-INT J OBSTET GY, V115, P1331, DOI 10.1111/j.1471-0528.2008.01866.x; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Buccheri G, 1996, EUR J CANCER, V32A, P1135, DOI 10.1016/0959-8049(95)00664-8; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Coghill AE, 2013, AIDS, V27, P2933, DOI 10.1097/01.aids.0000433236.55937.cb; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Cuttner J, 2002, LEUKEMIA RES, V26, P447, DOI 10.1016/S0145-2126(01)00163-1; Ethier M-C, 2011, LACK CLARITY DEFINIT, P5080; Ferlay J, 2013, IARC CANCERBASE; Field SP, 2007, J CLIN PATHOL, V60, P1073, DOI 10.1136/jcp.2006.043505; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Garcia M, 2007, GLOBAL CANC FACTS FI; Gomez H, 1998, J CLIN ONCOL, V16, P2065, DOI 10.1200/JCO.1998.16.6.2065; Gregory SA, 2005, ANN ONCOL, V16, P1413, DOI 10.1093/annonc/mdi264; Hauser CA, 2006, SUPPORT CARE CANCER, V14, P999, DOI 10.1007/s00520-006-0079-9; Kuderer NM, 2007, J CLIN ONCOL, V25, P3158, DOI 10.1200/JCO.2006.08.8823; LISTER TA, 1989, J CLIN ONCOL, V7, P1630, DOI 10.1200/JCO.1989.7.11.1630; MALTONI M, 1995, CANCER-AM CANCER SOC, V75, P2613, DOI 10.1002/1097-0142(19950515)75:10<2613::AID-CNCR2820751032>3.0.CO;2-1; Mutyaba IOJ, 2013, J CLIN ONCOL; NCCN. National Comprehensive Cancer Network, MYEL GROWTH FACT; Neal RD, 2015, BRIT J CANCER, V112, pS92, DOI 10.1038/bjc.2015.48; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Orem Jackson, 2012, Clin Epidemiol, V4, P339, DOI 10.2147/CLEP.S35671; Pfreundschuh M, 2004, BLOOD, V104, P634, DOI 10.1182/blood-2003-06-2095; Prigerson HG, 2015, JAMA ONCOLOGY; REUBEN DB, 1988, ARCH INTERN MED, V148, P1586, DOI 10.1001/archinte.148.7.1586; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191967	10.1371/journal.pone.0191967	http://dx.doi.org/10.1371/journal.pone.0191967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389998	Green Published, gold, Green Submitted			2022-12-26	WOS:000423793400045
J	Fleet, R; Bussieres, S; Tounkara, FK; Turcotte, S; Legare, F; Plant, J; Poitras, J; Archambault, PM; Dupuis, G				Fleet, Richard; Bussieres, Sylvain; Tounkara, Fatoumata Korika; Turcotte, Stephane; Legare, France; Plant, Jeff; Poitras, Julien; Archambault, Patrick M.; Dupuis, Gilles			Rural versus urban academic hospital mortality following stroke in Canada	PLOS ONE			English	Article							PRACTICE-RECOMMENDATIONS; EMERGENCY-DEPARTMENTS; CARE; ACCESS; GUIDELINES; OUTCOMES; QUALITY; RATES	Introduction Stroke is one of the leading causes of death in Canada. While stroke care has improved dramatically over the last decade, outcomes following stroke among patients treated in rural hospitals have not yet been reported in Canada. Objectives To describe variation in 30-day post-stroke in-hospital mortality rates between rural and urban academic hospitals in Canada. We also examined 24/7 in-hospital access to CT scanners and selected services in rural hospitals. Materials and methods We included Canadian Institute for Health Information (CIHI) data on adjusted 30-day in-hospital mortality following stroke from 2007 to 2011 for all acute care hospitals in Canada excluding Quebec and the Territories. We categorized rural hospitals as those located in rural small towns providing 24/7 emergency physician coverage with inpatient beds. Urban hospitals were academic centres designated as Level 1 or 2 trauma centres. We computed descriptive data on local access to a CT scanner and other services and compared mean 30-day adjusted post-stroke mortality rates for rural and urban hospitals to the overall Canadian rate. Results A total of 286 rural hospitals (3.4 million emergency department (ED) visits/year) and 24 urban hospitals (1.5 million ED visits/year) met inclusion criteria. From 2007 to 2011, 30-day in-hospital mortality rates following stroke were significantly higher in rural than in urban hospitals and higher than the Canadian average for every year except 2008 ( rural average range = 18.26 to 21.04 and urban average range = 14.11 to 16.78). Only 11% of rural hospitals had a CT-scanner, 1% had MRI, 21% had in-hospital ICU, 94% had laboratory and 92% had basic x-ray facilities. Conclusion Rural hospitals in Canada had higher 30-day in-hospital mortality rates following stroke than urban academic hospitals and the Canadian average. Rural hospitals also have very limited local access to CT scanners and ICUs. These rural/urban discrepancies are cause for concern in the context of Canada's universal health care system.	[Fleet, Richard; Poitras, Julien; Archambault, Patrick M.] Univ Laval, Dept Family Med & Emergency Med, Quebec City, PQ, Canada; [Fleet, Richard; Bussieres, Sylvain; Tounkara, Fatoumata Korika; Poitras, Julien; Archambault, Patrick M.] Univ Laval, CHAU Hotel Dieu Levis, Res Chair Emergency Med, Levis, PQ, Canada; [Turcotte, Stephane] CHU Quebec, Populat Hlth & Practice Changing Res Grp, Res Ctr, Quebec City, PQ, Canada; [Legare, France] Univ Laval, Dept Family Med & Emergency Med, Quebec City, PQ, Canada; [Legare, France] Univ Laval, Knowledge Transfer & Hlth Technol Assessment Grp, CHU Quebec, Res Ctr, Quebec City, PQ, Canada; [Legare, France] Univ Laval, Evaluat Res Unit, Quebec City, PQ, Canada; [Plant, Jeff] Univ British Columbia, Fac Med, Penticton, BC, Canada; [Plant, Jeff] Penticton Reg Hosp, Dept Emergency Med, Penticton, BC, Canada; [Archambault, Patrick M.] Univ Laval, Dept Anesthesiol, Intens Care Div, Quebec City, PQ, Canada; [Dupuis, Gilles] Univ Quebec Montreal, Dept Psychol, Montreal, PQ, Canada	Laval University; Laval University; Laval University; Laval University; Laval University; Laval University; University of British Columbia; Laval University; University of Quebec; University of Quebec Montreal	Fleet, R (corresponding author), Univ Laval, Dept Family Med & Emergency Med, Quebec City, PQ, Canada.; Fleet, R (corresponding author), Univ Laval, CHAU Hotel Dieu Levis, Res Chair Emergency Med, Levis, PQ, Canada.	Richard.fleet@fmed.ulaval.ca		Legare, France/0000-0002-2296-6696	Research Chair Emergency Medicine Laval University - CHAU Hotel-Dieu de Levis Hospital; Hotel-Dieu de Levis Hospital Research Fund; Fonds de Recherche du Quebec - Sante	Research Chair Emergency Medicine Laval University - CHAU Hotel-Dieu de Levis Hospital; Hotel-Dieu de Levis Hospital Research Fund; Fonds de Recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec)	This research project was supported by the Research Chair Emergency Medicine Laval University - CHAU Hotel-Dieu de Levis Hospital and the Hotel-Dieu de Levis Hospital Research Fund and Fonds de Recherche du Quebec - Sante to RF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayley M, 2008, CAN MED ASSOC J, V179, P1247, DOI 10.1503/cmaj.081536; Blackwell T., 2015, NATL POST; Canada TCoFPo, 2017, RUR ROAD MAP ACT DIR; Casaubon LK, 2015, INT J STROKE, V10, P924, DOI 10.1111/ijs.12551; Coutts SB, 2015, INT J STROKE, V10, P282, DOI 10.1111/ijs.12439; du Plessis V., 2001, RURAL SMALL TOWN CAN, V3, P1; Fleet R, 2013, BMJ OPEN, V3; Fleet R, 2014, CAN J EMERG MED, V16, P437, DOI 10.2310/8000.2013.131203; Fleet R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003876; Fleet R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123746; Ginde AA, 2008, ACAD EMERG MED, V15, P780, DOI 10.1111/j.1553-2712.2008.00192.x; Hameed SM, 2010, J TRAUMA, V69, P1350, DOI 10.1097/TA.0b013e3181e751f7; Howard G, 2013, STROKE, V44, P3254, DOI 10.1161/STROKEAHA.113.002113; Indicators OE., 2015, HLTH GLANC 2011, DOI [10.1787/health_glance-2015-en, DOI 10.1787/HEALTH_GLANCE-2015-EN]; Information IfH, 30 DAY STROK IN HOSP; Joynt KE, 2011, JAMA-J AM MED ASSOC, V306, P45, DOI 10.1001/jama.2011.902; Khaliq AA, 2015, J AM COLL RADIOL, V12, P1351, DOI 10.1016/j.jacr.2015.09.008; Koifman J, 2016, J NEUROL SCI, V363, P16, DOI 10.1016/j.jns.2016.02.019; Krueger H, 2012, STROKE, V43, P2198, DOI 10.1161/STROKEAHA.111.646091; Lichtman JH, 2012, STROKE, V43, P2741, DOI 10.1161/STROKEAHA.112.665646; Paul CL, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0414-6; Rodrigues FB, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1754; RSC, 1985, CAN HLTH ACT; Statistics Canada, POP URB RUR PROV TER; Zhang XH, 2007, STROKE, V38, P3139, DOI 10.1161/STROKEAHA.107.494336	25	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191151	10.1371/journal.pone.0191151	http://dx.doi.org/10.1371/journal.pone.0191151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385173	Green Published, Green Submitted, gold			2022-12-26	WOS:000423668400034
J	Wang, QW; Su, Y; Sheng, JT; Gu, LM; Zhao, Y; Chen, XX; Chen, C; Li, WZ; Li, KS; Dai, JP				Wang, Qian-Wen; Su, Yun; Sheng, Jiang-Tao; Gu, Li-Ming; Zhao, Ying; Chen, Xiao-Xuan; Chen, Cheng; Li, Wei-Zhong; Li, Kang-Sheng; Dai, Jian-Ping			Anti-influenza A virus activity of rhein through regulating oxidative stress, TLR4, Akt, MAPK, and NF-kappa B signal pathways	PLOS ONE			English	Article							INFLUENZA-A VIRUS; ACUTE LUNG INJURY; INFECTION IN-VITRO; EPITHELIAL-CELLS; INHIBITION; MICE; INFLAMMATION; ACTIVATION; KINASE; MATRIX-METALLOPROTEINASE-9	Rhein, an anthraquinone compound existing in many traditional herbal medicines, has anti-inflammatory, antioxidant, antitumor, antiviral, hepatoprotective, and nephroprotective activities, but its anti-influenza A virus (IAV) activity is ambiguous. In the present study, through plaque inhibition assay, time-of-addition assay, antioxidant assay, qRT-PCR, ELISA, and western blotting assays, we investigated the anti-IAV effect and mechanism of action of rhein in vitro and in vivo. The results showed that rhein could significantly inhibit IAV adsorption and replication, decrease IAV-induced oxidative stress, activations of TLR4, Akt, p38, JNK MAPK, and NF-kappa B pathways, and production of inflammatory cytokines and matrix metalloproteinases in vitro. Oxidant H2O2 and agonists of TLR4, Akt, p38/JNK and IKK/NF-kappa B could significantly antagonize the inhibitory effects of rhein on IAV-induced cytopathic effect (CPE) and IAV replication. Through an in vivo test in mice, we also found that rhein could significantly improve the survival rate, lung index, pulmonary cytokines, and pulmonary histopathological changes. Rhein also significantly decreased pulmonary viral load at a high dose. In conclusion, rhein can inhibit IAV adsorption and replication, and the mechanism of action to inhibit IAV replication may be due to its ability to suppress IAV-induced oxidative stress and activations of TLR4, Akt, p38, JNK MAPK, and NF-kappa B signal pathways.	[Wang, Qian-Wen; Su, Yun; Sheng, Jiang-Tao; Gu, Li-Ming; Zhao, Ying; Chen, Xiao-Xuan; Chen, Cheng; Li, Kang-Sheng; Dai, Jian-Ping] Shantou Univ, Dept Microbiol & Immunol, Med Coll, Shantou, Guangdong, Peoples R China; [Li, Wei-Zhong] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA	Shantou University; University System of Maryland; University of Maryland College Park	Dai, JP (corresponding author), Shantou Univ, Dept Microbiol & Immunol, Med Coll, Shantou, Guangdong, Peoples R China.	daijpedu2008@163.com		Sheng, Jiangtao/0000-0003-2438-7345; Li, Weizhong/0000-0002-8602-8375; Li, Kangsheng/0000-0002-6981-9263	National Natural Science Foundation of China [81374040, 81773976]; Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases [2015014, 2015087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases	This work was supported by: 1. National Natural Science Foundation of China (No. 81374040), JPD, https://isisn.nsfc.gov.cn/eg rantweb/contract/index?dateti mestamp=1505135618010#; 2. National Natural Science Foundation of China (No. 81773976), JPD, https://is isn.nsfc.gov.cn/egrantweb/contract/index? datetimestamp=1505135618010##; 3. Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases (No. 2015014), JPD; and 4. Department of Education, Guangdong Government under the Top tier University Development Scheme for Research and Control of Infectious Diseases (No. 2015087), JPD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatore D, 2015, CELL MICROBIOL, V17, P131, DOI 10.1111/cmi.12343; Barnes Patricia M, 2004, Adv Data, P1; Bautista E, 2016, J TRACE ELEM MED BIO, V34, P62, DOI 10.1016/j.jtemb.2015.11.005; Bent S, 2008, J GEN INTERN MED, V23, P854, DOI 10.1007/s11606-008-0632-y; Cai JY, 2003, FREE RADICAL BIO MED, V34, P928, DOI 10.1016/S0891-5849(03)00023-6; Choi HJ, 2009, PHYTOMEDICINE, V16, P35, DOI 10.1016/j.phymed.2008.10.012; Cong XD, 2012, INFLAMMATION, V35, P1031, DOI 10.1007/s10753-011-9407-4; Dai JP, 2013, ANTIMICROB AGENTS CH, V57, P4433, DOI 10.1128/AAC.00759-13; Dai JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061026; Dai JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042706; Dai JP, 2009, J ORAL PATHOL MED, V38, P276, DOI 10.1111/j.1600-0714.2008.00738.x; Dai JP, 2012, J BIOMOL SCREEN, V17, P605, DOI 10.1177/1087057111435236; Denisova OV, 2014, ANTIMICROB AGENTS CH, V58, P3689, DOI 10.1128/AAC.02798-13; Egan B, 2011, FOOD FUNCT, V2, P747, DOI 10.1039/c1fo10109a; Fernand VE, 2011, CHEM-BIOL INTERACT, V192, P220, DOI 10.1016/j.cbi.2011.03.013; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Gov F., 2015, PANDEMIC FLU HIST, V2015; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Heo SK, 2010, VASC PHARMACOL, V53, P28, DOI 10.1016/j.vph.2010.03.002; Hirata N, 2014, BIOCHEM BIOPH RES CO, V450, P891, DOI 10.1016/j.bbrc.2014.06.077; Hooijmans CR, 2011, BRIT J PHARMACOL, V162, P1259, DOI 10.1111/j.1476-5381.2010.01128.x; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Karp NA, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002151; Kong MYF, 2009, INT J MED SCI, V6, P9; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Latorre E, 2014, CELL STRESS CHAPERON, V19, P289, DOI 10.1007/s12192-013-0461-8; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Legendre F, 2007, CLIN EXP RHEUMATOL, V25, P546; Lim H, 2013, J BIOL CHEM, V288, P7572, DOI 10.1074/jbc.M112.414904; Lin ML, 2009, ORAL ONCOL, V45, P531, DOI 10.1016/j.oraloncology.2008.07.012; Lin TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27768; MALTERUD KE, 1993, PHARMACOLOGY, V47, P77, DOI 10.1159/000139846; Marchant D, 2010, J VIROL, V84, P11359, DOI 10.1128/JVI.00804-10; Marjuki H, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-134; Menden H, 2013, AM J PHYSIOL-LUNG C, V304, pL445, DOI 10.1152/ajplung.00261.2012; Michaelis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019705; Muhammad S, 2016, CEREBROVASC DIS EXTR, V6, P50, DOI 10.1159/000447750; Nacken W, 2012, BIOL CHEM, V393, P525, DOI 10.1515/hsz-2011-0270; Ng HH, 2012, EXP MOL PATHOL, V92, P287, DOI 10.1016/j.yexmp.2012.03.003; Nimmerjahn F, 2004, J GEN VIROL, V85, P2347, DOI 10.1099/vir.0.79958-0; Pahwa R, 2016, METAB SYNDR RELAT D, V14, P239, DOI 10.1089/met.2016.29006.pah; Shi XL, 2010, INFLAMMATION, V33, P166, DOI 10.1007/s10753-009-9170-y; Shin N, 2015, BIOCHEM BIOPH RES CO, V459, P699, DOI 10.1016/j.bbrc.2015.03.010; Suliman HB, 2001, AM J PHYSIOL-LUNG C, V280, pL69, DOI 10.1152/ajplung.2001.280.1.L69; Sun H, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00247; Usha K, 2007, INDIAN J CLIN BIOCHE, V22, P132, DOI 10.1007/BF02913331; Vlahos R, 2014, MOL PHARMACOL, V86, P747, DOI 10.1124/mol.114.095216; Wang RK, 2015, INT J MOL SCI, V16, P22350, DOI 10.3390/ijms160922350; Wang S, 2016, J NUTR BIOCHEM, V36, P42, DOI 10.1016/j.jnutbio.2016.07.008; Yatmaz S, 2013, AM J RESP CELL MOL, V48, P17, DOI 10.1165/rcmb.2011-0345OC; Yu C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11822; Zhang CX, 2014, INT J CLIN EXP MED, V7, P4975; Zhang K, 2015, MOL MED REP, V12, P4415, DOI 10.3892/mmr.2015.3925; Zhong XF, 2012, MOL MED REP, V5, P1261, DOI 10.3892/mmr.2012.793	54	48	55	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191793	10.1371/journal.pone.0191793	http://dx.doi.org/10.1371/journal.pone.0191793			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385192	gold, Green Published, Green Submitted			2022-12-26	WOS:000423668400055
J	Haralambieva, IH; Kennedy, RB; Simon, WL; Goergen, KM; Grill, DE; Ovsyannikova, IG; Poland, GA				Haralambieva, Iana H.; Kennedy, Richard B.; Simon, Whitney L.; Goergen, Krista M.; Grill, Diane E.; Ovsyannikova, Inna G.; Poland, Gregory A.			Differential miRNA expression in B cells is associated with inter-individual differences in humoral immune response to measles vaccination	PLOS ONE			English	Article							GENETIC POLYMORPHISMS; CELLULAR-IMMUNITY; DENDRITIC CELLS; MICRORNAS; RECEPTOR; SERUM; PROTEIN; INNATE	Background MicroRNAs are important mediators of post-transcriptional regulation of gene expression through RNA degradation and translational repression, and are emerging biomarkers of immune system activation/response after vaccination. Methods We performed Next Generation Sequencing (mRNA-Seq) of intracellular miRNAs in measles virus-stimulated B and CD4(+) T cells from high and low antibody responders to measles vaccine. Negative binomial generalized estimating equation (GEE) models were used for miRNA assessment and the DIANA tool was used for gene/target prediction and pathway enrichment analysis. Results We identified a set of B cell-specific miRNAs (e.g., miR-151a-5p, miR-223, miR-29, miR-15a-5p, miR-199a-3p, miR-103a, and miR-15a/16 cluster) and biological processes/pathways, including regulation of adherens junction proteins, Fc-receptor signaling pathway, phosphatidylinositol-mediated signaling pathway, growth factor signaling pathway/pathways, transcriptional regulation, apoptosis and virus-related processes, significantly associated with neutralizing antibody titers after measles vaccination. No CD4(+) T cell-specific miRNA expression differences between high and low antibody responders were found. Conclusion Our study demonstrates that miRNA expression directly or indirectly influences humoral immunity to measles vaccination and suggests that B cell-specific miRNAs may serve as useful predictive biomarkers of vaccine humoral immune response.	[Haralambieva, Iana H.; Kennedy, Richard B.; Simon, Whitney L.; Ovsyannikova, Inna G.; Poland, Gregory A.] Mayo Clin, Vaccine Res Grp, Rochester, MN 55905 USA; [Goergen, Krista M.; Grill, Diane E.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin, Vaccine Res Grp, Rochester, MN 55905 USA.	poland.gregory@mayo.edu		Poland, Gregory/0000-0001-5057-4457; Kennedy, Rick/0000-0001-6164-4967	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI033144]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033144, R37AI048793] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI033144. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bieback K, 2002, J VIROL, V76, P8729, DOI 10.1128/JVI.76.17.8729-8736.2002; Bouche FB, 2002, VIRAL IMMUNOL, V15, P451, DOI 10.1089/088282402760312331; Bruscella P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00824; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Correia CN, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00118; de Candia P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00043; de Candia P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075348; de Vries RD, 2012, EXPERT REV VACCINES, V11, P779, DOI [10.1586/erv.12.45, 10.1586/ERV.12.45]; Ding SW, 2011, CURR OPIN VIROL, V1, P533, DOI 10.1016/j.coviro.2011.10.028; Egana-Gorrono L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106360; Fang JL, 2012, J VIROL, V86, P1010, DOI 10.1128/JVI.06169-11; Fehniger TA, 2010, GENOME RES, V20, P1590, DOI 10.1101/gr.107995.110; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Gracias DT, 2011, ADV EXP MED BIOL, V780, P15, DOI 10.1007/978-1-4419-5632-3_2; Haralambieva IH, 2017, HUM GENET, V136, P421, DOI 10.1007/s00439-017-1768-9; Haralambieva IH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160970; Haralambieva IH, 2015, TRENDS MOL MED, V21, P789, DOI 10.1016/j.molmed.2015.10.005; Haralambieva IH, 2013, EXPERT REV VACCINES, V12, P57, DOI [10.1586/erv.12.134, 10.1586/ERV.12.134]; Haralambieva IH, 2011, VACCINE, V29, P8988, DOI 10.1016/j.vaccine.2011.09.043; Haralambieva IH, 2011, VACCINE, V29, P7883, DOI 10.1016/j.vaccine.2011.08.083; Haralambieva IH, 2011, VACCINE, V29, P4485, DOI 10.1016/j.vaccine.2011.04.037; Hogg DR, 2014, BIOCHEM SOC T, V42, P1184, DOI 10.1042/BST20140055; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kelly A, 2017, ADV IMMUNOL, V134, P137, DOI 10.1016/bs.ai.2017.01.001; Kennedy RB, 2014, HUM GENET, V133, P1407, DOI 10.1007/s00439-014-1471-z; Lambert ND, 2015, J INFECT DIS, V211, P898, DOI 10.1093/infdis/jiu553; Ma Y, 2016, INT J MOL SCI, V18; Matkovich SJ, 2011, CIRC RES, V108, P18, DOI 10.1161/CIRCRESAHA.110.233528; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Ovsyannikova IG, 2016, GENES IMMUN, V17, P371, DOI 10.1038/gene.2016.34; Qi YH, 2014, VIRUSES-BASEL, V6, P1823, DOI 10.3390/v6041823; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosales C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00280; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun ZF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-423; Tambyah PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076811; Turner ML, 2011, J IMMUNOL, V187, P3911, DOI 10.4049/jimmunol.1101137; Umlauf BJ, 2012, VIRAL IMMUNOL, V25, P29, DOI 10.1089/vim.2011.0051; Verma P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01274; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Voigt EA, 2016, VACCINE, V34, P4913, DOI 10.1016/j.vaccine.2016.08.060; Xiong YZ, 2013, CLIN VACCINE IMMUNOL, V20, P1089, DOI 10.1128/CVI.00044-13; Zan H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00631; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhan YF, 2012, PROTEIN CELL, V3, P497, DOI 10.1007/s13238-012-0042-0; Zhou R, 2015, SCI REP-UK, V5, DOI 10.1038/srep17743; Zilliox MJ, 2007, CLIN VACCINE IMMUNOL, V14, P918, DOI 10.1128/CVI.00031-07; Zilliox MJ, 2006, P NATL ACAD SCI USA, V103, P3363, DOI 10.1073/pnas.0511345103	55	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191812	10.1371/journal.pone.0191812	http://dx.doi.org/10.1371/journal.pone.0191812			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381765	Green Published, Green Submitted, gold			2022-12-26	WOS:000423617800035
J	Hofstoetter, US; Freundl, B; Binder, H; Minassian, K				Hofstoetter, Ursula S.; Freundl, Brigitta; Binder, Heinrich; Minassian, Karen			Common neural structures activated by epidural and transcutaneous lumbar spinal cord stimulation: Elicitation of posterior root-muscle reflexes	PLOS ONE			English	Article							HUMAN LUMBOSACRAL CORD; TRANSCRANIAL MAGNETIC STIMULATION; DORSAL-COLUMN STIMULATION; MOTOR COMPLETE PARAPLEGIA; SOLEUS H-REFLEX; ELECTRICAL-STIMULATION; MULTIPLE-SCLEROSIS; LOWER-LIMB; INJURY; HUMANS	Epidural electrical stimulation of the lumbar spinal cord is currently regaining momentum as a neuromodulation intervention in spinal cord injury (SCI) to modify dysregulated sensorimotor functions and augment residual motor capacity. There is ample evidence that it engages spinal circuits through the electrical stimulation of large-to-medium diameter afferent fibers within lumbar and upper sacral posterior roots. Recent pilot studies suggested that the surface electrode-based method of transcutaneous spinal cord stimulation (SCS) may produce similar neuromodulatory effects as caused by epidural SCS. Neurophysiological and computer modeling studies proposed that this noninvasive technique stimulates posterior-root fibers as well, likely activating similar input structures to the spinal cord as epidural stimulation. Here, we add a yet missing piece of evidence substantiating this assumption. We conducted in-depth analyses and direct comparisons of the electromyographic (EMG) characteristics of short-latency responses in multiple leg muscles to both stimulation techniques derived from ten individuals with SCI each. Post-activation depression of responses evoked by paired pulses applied either epidurally or transcutaneously confirmed the reflex nature of the responses. The muscle responses to both techniques had the same latencies, EMG peak-to-peak amplitudes, and waveforms, except for smaller responses with shorter onset latencies in the triceps surae muscle group and shorter offsets of the responses in the biceps femoris muscle during epidural stimulation. Responses obtained in three subjects tested with both methods at different time points had near-identical waveforms per muscle group as well as same onset latencies. The present results strongly corroborate the activation of common neural input structures to the lumbar spinal cord-predominantly primary afferent fibers within multiple posterior roots-by both techniques and add to unraveling the basic mechanisms underlying electrical SCS.	[Hofstoetter, Ursula S.; Minassian, Karen] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Freundl, Brigitta; Binder, Heinrich] Otto Wagner Hosp, Maria Theresien Schloessel, Neurol Ctr, Vienna, Austria; [Minassian, Karen] Swiss Fed Inst Technol EPFL, Sch Life Sci, Ctr Neuroprosthet, Lausanne, Switzerland; [Minassian, Karen] Swiss Fed Inst Technol EPFL, Sch Life Sci, Brain Mind Inst, Lausanne, Switzerland	Medical University of Vienna; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Hofstoetter, US (corresponding author), Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria.	ursula.hofstoetter@meduniwien.ac.at		Hofstoetter, Ursula S./0000-0002-3156-6483; Minassian, Karen/0000-0003-4197-6141				Alrowayeh HN, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-65; Andrews JC, 2015, J NEUROPHYSIOL, V114, P485, DOI 10.1152/jn.01007.2014; Andrews JC, 2015, NEUROSCI LETT, V589, P144, DOI 10.1016/j.neulet.2015.01.041; Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; BAROLAT G, 1986, APPL NEUROPHYSIOL, V49, P307; Basmajian J., 1985, MUSCLES ALIVE THEIR; Bawa P, 2002, J NEUROPHYSIOL, V88, P124, DOI 10.1152/jn.2002.88.1.124; Burke D, 2016, CLIN NEUROPHYS PRACT, V1, P9, DOI 10.1016/j.cnp.2016.02.003; Calancie B, 2004, CLIN NEUROPHYSIOL, V115, P2350, DOI 10.1016/j.clinph.2004.04.028; Capogrosso M, 2016, NATURE, V539, P284, DOI 10.1038/nature20118; Capogrosso M, 2013, J NEUROSCI, V33, P19326, DOI 10.1523/JNEUROSCI.1688-13.2013; Clark DJ, 2012, J GERONTOL A-BIOL, V67, P41, DOI 10.1093/gerona/glr041; COOK AW, 1973, NEW YORK STATE J MED, V73, P2868; Cuellar CA, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00082; Danner SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147479; Danner SM, 2015, BRAIN, V138, P577, DOI 10.1093/brain/awu372; Danner SM, 2011, ARTIF ORGANS, V35, P257, DOI 10.1111/j.1525-1594.2011.01213.x; Danner SM, 2014, ENCY COMPUTATIONAL N, P1, DOI DOI 10.1007/978-1-4614-7320-6; De Luca C., 2006, ENCY MED DEVICES INS, P98; Delbono O, 1995, J MEMBRANE BIOL, V148, P211; DENOORDHOUT AM, 1988, J NEUROL NEUROSUR PS, V51, P174, DOI 10.1136/jnnp.51.2.174; Dimitrijevic M M, 1986, Cent Nerv Syst Trauma, V3, P129; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; Dy CJ, 2010, J NEUROPHYSIOL, V103, P2808, DOI 10.1152/jn.00316.2009; Estes SP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00017; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; Gad P, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00333; Gerasimenko YP, 2006, J NEUROSCI METH, V157, P253, DOI 10.1016/j.jneumeth.2006.05.004; Gerasimenko YP, 2015, J NEUROTRAUM, V32, P1968, DOI 10.1089/neu.2015.4008; Gerdle B., 1999, MODERN TECHNIQUES NE, P705, DOI DOI 10.1007/978-3-642-58552-4_26; Gildenberg PL, 2009, NEUROMODULATION, VOLS 1 AND 2, P9, DOI 10.1016/B978-0-12-374248-3.00003-3; Grahn PJ, 2017, MAYO CLIN PROC, V92, P544, DOI 10.1016/j.mayocp.2017.02.014; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Herman R, 2002, SPINAL CORD, V40, P65, DOI 10.1038/sj.sc.3101263; Hofstoetter U.S., 2014, ENCY COMPUTATIONAL N, P1, DOI DOI 10.1007/978-1-4614-7320-6; Hofstoetter US, 2008, ARTIF ORGANS, V32, P644, DOI 10.1111/j.1525-1594.2008.00616.x; Hofstoetter US, 2015, ARTIF ORGANS, V39, pE176, DOI 10.1111/aor.12615; Hofstoetter US, 2015, J NEUROPHYSIOL, V114, P400, DOI 10.1152/jn.00136.2015; Hofstoetter US, 2014, J SPINAL CORD MED, V37, P202, DOI 10.1179/2045772313Y.0000000149; Hofstoetter US, 2013, BIOMED TECH BERL, DOI DOI 10.1515/BME2013-4014; Holsheimer J, 2002, NEUROMODULATION, V5, P25, DOI 10.1046/j.1525-1403.2002._2005.x; Holsheimer J, 1998, NEUROMODULATION, V1, P57, DOI 10.1111/j.1525-1403.1998.tb00018.x; Huang H, 2006, IEEE T NEUR SYS REH, V14, P14, DOI 10.1109/TNSRE.2005.862694; HUNTER JP, 1994, J PHYSIOL-LONDON, V474, P407, DOI 10.1113/jphysiol.1994.sp020032; ILLIS LS, 1976, LANCET, V1, P1383; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Jilge B, 2004, BIOL CYBERN, V91, P359, DOI 10.1007/s00422-004-0511-5; Jilge B, 2004, EXP BRAIN RES, V154, P308, DOI 10.1007/s00221-003-1666-3; Johnson Mark, 2007, Rev Pain, V1, P7, DOI 10.1177/204946370700100103; Kirshblum S, 2014, PHYS MED REH CLIN N, V25, P505, DOI 10.1016/j.pmr.2014.04.001; Kitano K, 2009, J NEUROSCI METH, V180, P111, DOI 10.1016/j.jneumeth.2009.03.006; Krames ES, 2009, NEUROMODULATION, VOLS 1 AND 2, P3, DOI 10.1016/B978-0-12-374248-3.00002-1; Krenn M, 2015, ARTIF ORGANS, V39, P834, DOI 10.1111/aor.12616; Kumru H, 2015, MUSCLE NERVE, V52, P616, DOI 10.1002/mus.24579; Ladenbauer J, 2010, IEEE T NEUR SYS REH, V18, P637, DOI 10.1109/TNSRE.2010.2054112; Linderoth B, 1999, NEUROMODULATION, V2, P150, DOI 10.1046/j.1525-1403.1999.00150.x; Marque P, 2001, J PHYSIOL-LONDON, V536, P313, DOI 10.1111/j.1469-7793.2001.t01-1-00313.x; MEUNIER S, 1993, EXP BRAIN RES, V96, P534; Minassian K, 2007, HUM MOVEMENT SCI, V26, P275, DOI 10.1016/j.humov.2007.01.005; Minassian K, 2004, SPINAL CORD, V42, P401, DOI 10.1038/sj.sc.3101615; Minassian K., 2011, RESTORATIVE NEUROLOG, P226; Minassian K, 2005, BIOCYBERN BIOMED ENG, V25, P11; Minassian K, 2007, MUSCLE NERVE, V35, P327, DOI 10.1002/mus.20700; Minassian K, 2017, NEUROSCIENTIST, V23, P649, DOI 10.1177/1073858417699790; Minassian K, 2016, NEUROTHERAPEUTICS, V13, P284, DOI 10.1007/s13311-016-0421-y; Minassian K, 2016, CNS NEUROSCI THER, V22, P262, DOI 10.1111/cns.12530; Minassian K, 2016, NEUROREHAB NEURAL RE, V30, P233, DOI 10.1177/1545968315591706; Minassian K, 2012, CLIN NEUROL NEUROSUR, V114, P489, DOI 10.1016/j.clineuro.2012.03.013; Murg M, 2000, SPINAL CORD, V38, P394, DOI 10.1038/sj.sc.3101038; Nakazawa K, 2006, ARCH PHYS MED REHAB, V87, P71, DOI 10.1016/j.apmr.2005.08.122; PierrotDeseilligny E, 2012, CIRCUITRY OF THE HUMAN SPINAL CORD: SPINAL AND CORTICOSPINAL MECHANISMS OF MOVEMENT, P1, DOI 10.1017/CBO9781139026727; Pinter MM, 2000, SPINAL CORD, V38, P524, DOI 10.1038/sj.sc.3101040; Ranck JB, 1975, BRAIN RES, V98, P417; Rattay F, 2000, SPINAL CORD, V38, P473, DOI 10.1038/sj.sc.3101039; Rattay F, 1999, NEUROSCIENCE, V89, P335, DOI 10.1016/S0306-4522(98)00330-3; Rattay F., 2014, ENCY COMPUTATIONAL N, P1, DOI DOI 10.1007/978-1-4614-7320-6; Rejc E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14003-w; Rejc E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133998; RICHARDSON RR, 1978, SURG NEUROL, V9, P153; RICHARDSON RR, 1979, ACTA NEUROCHIR, V49, P235, DOI 10.1007/BF01808963; Roy FD, 2012, EXP BRAIN RES, V223, P281, DOI 10.1007/s00221-012-3258-6; Sayenko DG, 2014, J NEUROPHYSIOL, V111, P1088, DOI 10.1152/jn.00489.2013; SCHIEPPATI M, 1987, PROG NEUROBIOL, V28, P345, DOI 10.1016/0301-0082(87)90007-4; Schirmer CM, 2011, J NEUROSURG-SPINE, V15, P64, DOI 10.3171/2011.2.SPINE1068; SHARRARD W J, 1964, Ann R Coll Surg Engl, V35, P106; SHEALY CN, 1967, ANESTH ANAL CURR RES, V46, P489; Sherwood AM, 1996, MUSCLE NERVE, V19, P966, DOI 10.1002/(SICI)1097-4598(199608)19:8<966::AID-MUS5>3.3.CO;2-N; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; STRUIJK JJ, 1993, IEEE T BIO-MED ENG, V40, P632, DOI 10.1109/10.237693; Szava Z, 2011, TRANSCUTANEOUS ELECT; WALTZ JM, 1981, APPL NEUROPHYSIOL, V44, P244; Waltz JM, 1997, STEREOT FUNCT NEUROS, V69, P288, DOI 10.1159/000099890; Wenger N, 2016, NAT MED, V22, P138, DOI 10.1038/nm.4025; Zhu Y, 1998, ELECTROMYOGR MOTOR C, V109, P10, DOI 10.1016/S0924-980X(97)00058-1	94	77	81	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0192013	10.1371/journal.pone.0192013	http://dx.doi.org/10.1371/journal.pone.0192013			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381748	Green Published, gold, Green Submitted			2022-12-26	WOS:000423617800051
J	Wu, Q; Gao, K; Zheng, SZ; Zhu, X; Liang, YW; Pan, JM				Wu, Qiong; Gao, Kang; Zheng, Shuzhi; Zhu, Xin; Liang, Yinwen; Pan, Junmin			Calmodulin regulates a TRP channel (ADF1) and phospholipase C (PLC) to mediate elevation of cytosolic calcium during acidic stress that induces deflagellation in Chlamydomonas	FASEB JOURNAL			English	Article						cilia and flagella; NBBC; cilia motility; cilia assembly; intraflagellar transport	FLAGELLAR EXCISION; PRIMARY CILIA; 2 DISTINCT; PROTEIN; REINHARDTII; REGENERATION; BINDING; LOCALIZATION; DECILIATION; RESISTANCE	Calcium has been implicated in the motility, assembly, disassembly, and deflagellation of the eukaryotic flagellum or cilium (exchangeable terms). Calmodulin (CaM) is known to be critical for flagellar motility; however, it is unknown whether and how CaM is involved in other flagella-related activities. We have studied CaM in Chlamydomonas, a widely used organism for ciliary studies. CaM is present in the cell body and the flagellum, with enrichment in the basal body region. Loss of CaM causes shortening of the nucleus basal body connector and impairs flagellar motility and assembly but not flagellar disassembly. Moreover, the cam mutant is defective in pH shock-induced deflagellation. The mutant deflagellates, however, upon mechanical shearing and treatment with mastoparan or detergent undergo permeabilization in the presence of calcium, indicating the cam mutant is defective in elevations of cytosolic calcium induced by pH shock, rather than by the deflagellation machinery. Indeed, the cam mutant fails to produce inositol 1,4,5-trisphosphate. Biochemical and genetic analysis showed that CaM does not directly activate PLC. Furthermore, CaM interacts with ADF1, a transient receptor channel that functions in acid-induced calcium entry. Thus, CaM is a critical regulator of flagellar activities especially those involved in modulating calcium homeostasis during acidic stress.Wu, Q., Gao, K., Zheng, S., Zhu, X., Liang, Y., Pan, J. Calmodulin regulates a TRP channel (ADF1) and phospholipase C (PLC) to mediate elevation of cytosolic calcium during acidic stress that induces deflagellation in Chlamydomonas.	[Wu, Qiong; Zhu, Xin; Liang, Yinwen; Pan, Junmin] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Minist Educ,Key Lab Prot Sci, Beijing, Peoples R China; [Wu, Qiong; Pan, Junmin] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Gao, Kang; Zheng, Shuzhi] Hebei Normal Univ, Coll Life Sci, Hebei Key Lab Mol & Cellular Biol, Shijiazhuang, Hebei, Peoples R China	Tsinghua University; Qingdao National Laboratory for Marine Science & Technology; Hebei Normal University	Pan, JM (corresponding author), Tsinghua Univ, 1 Qinghuayuan,Renhuanlou 413, Beijing 100084, Peoples R China.	panjunmin@tsinghua.edu.cn	Liang, Yinwen/U-2734-2019; wu, qiong/GRY-4672-2022		Blue Life Breakthrough Program of the Laboratory for Marine Biology and Biotechnology [MS2017NO05]; Qingdao National Laboratory for Marine Science and Technology; National Natural Science Foundation of China [31330044, 31671387]; Sino-Germany Science Center [GZ990]	Blue Life Breakthrough Program of the Laboratory for Marine Biology and Biotechnology; Qingdao National Laboratory for Marine Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sino-Germany Science Center	The authors are indebted to Dr. Roger Sloboda (Dartmouth College, Hanover, NH, USA) for his critical reading and editing of this manuscript. This work was supported by the Blue Life Breakthrough Program of the Laboratory for Marine Biology and Biotechnology (Grant MS2017NO05), the Qingdao National Laboratory for Marine Science and Technology; the National Natural Science Foundation of China (Grants 31330044 and 31671387), and the Sino-Germany Science Center (Grant GZ990) to J.P.. The authors declare no conflicts of interest.	Awasthi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039258; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Braun FJ, 1999, EUR J CELL BIOL, V78, P199, DOI 10.1016/S0171-9335(99)80099-5; BROKAW CJ, 1987, J CELL BIOCHEM, V35, P175, DOI 10.1002/jcb.240350302; CHESHIRE JL, 1994, J CELL SCI, V107, P2491; CHESHIRE JL, 1991, J CELL BIOL, V115, P1651, DOI 10.1083/jcb.115.6.1651; CHEUNG WY, 1980, SCIENCE, V207, P19, DOI 10.1126/science.6243188; Craige Branch, 2013, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0341s59; DiPetrillo C, 2009, METHOD CELL BIOL, V92, P163, DOI 10.1016/S0091-679X(08)92011-2; DiPetrillo CG, 2013, METHOD ENZYMOL, V524, P37, DOI 10.1016/B978-0-12-397945-2.00003-2; Dymek EE, 2006, J CELL SCI, V119, P3107, DOI 10.1242/jcs.03028; Friedberg F, 2001, IUBMB LIFE, V51, P215; Gaillard AR, 2006, MOL BIOL CELL, V17, P2626, DOI 10.1091/mbc.E06-02-0095; Geimer S, 2005, EUKARYOT CELL, V4, P1253, DOI 10.1128/EC.4.7.1253-1263.2005; GITELMAN SE, 1980, J CELL BIOL, V87, P764, DOI 10.1083/jcb.87.3.764; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gonzalez-Ballester D, 2005, ANAL BIOCHEM, V340, P330, DOI 10.1016/j.ab.2005.01.031; Gonzalez- Ballester D., 2005, ANAL BIOCHEM, V340, P353; Heuser T, 2012, MOL BIOL CELL, V23, P3143, DOI 10.1091/mbc.E12-05-0357; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hilton LK, 2016, G3-GENES GENOM GENET, V6, P3409, DOI 10.1534/g3.116.034264; Hu ZF, 2015, CELL REP, V10, P1803, DOI 10.1016/j.celrep.2015.02.044; Iomini C, 2004, J CELL BIOL, V164, P811, DOI 10.1083/jcb.200312133; Ishii M, 2003, LIFE SCI, V74, P163, DOI 10.1016/j.lfs.2003.09.004; Ishikawa H, 2012, CURR BIOL, V22, P414, DOI 10.1016/j.cub.2012.01.031; JAMIESON GA, 1979, P NATL ACAD SCI USA, V76, P6471, DOI 10.1073/pnas.76.12.6471; JONES HP, 1980, P NATL ACAD SCI-BIOL, V77, P2772, DOI 10.1073/pnas.77.5.2772; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kader MA, 2010, PLANT SIGNAL BEHAV, V5, P233, DOI 10.4161/psb.5.3.10740; Kuin H, 2000, PLANTA, V210, P286, DOI 10.1007/PL00008136; LEFEBVRE PA, 1978, J CELL BIOL, V78, P8, DOI 10.1083/jcb.78.1.8; Leng TD, 2014, PROG NEUROBIOL, V115, P189, DOI 10.1016/j.pneurobio.2013.12.008; Levin LR, 2015, ANNU REV PHYSIOL, V77, P347, DOI 10.1146/annurev-physiol-021014-071821; Liang YW, 2016, CELL MOL LIFE SCI, V73, P1787, DOI 10.1007/s00018-016-2148-7; Liang YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069902; Meng D, 2014, J CELL SCI, V127, P281, DOI 10.1242/jcs.140723; Munnik T, 1998, BBA-LIPID LIPID MET, V1389, P222, DOI 10.1016/S0005-2760(97)00158-6; NAKAMURA S, 1987, CELL STRUCT FUNCT, V12, P369, DOI 10.1247/csf.12.369; Nakamura Y, 2017, J BIOCHEM, V161, P315, DOI 10.1093/jb/mvw094; Overgaard CE, 2009, MOL BIOL CELL, V20, P102, DOI 10.1091/mbc.E08-07-0741; Perochon A, 2011, BIOCHIMIE, V93, P2048, DOI 10.1016/j.biochi.2011.07.012; Plotnikova OV, 2012, MOL BIOL CELL, V23, P2658, DOI 10.1091/mbc.E11-12-1056; Pokotylo I, 2014, BIOCHIMIE, V96, P144, DOI 10.1016/j.biochi.2013.07.004; QUARMBY LM, 1994, J CELL BIOL, V124, P807, DOI 10.1083/jcb.124.5.807; QUARMBY LM, 1992, J CELL BIOL, V116, P737, DOI 10.1083/jcb.116.3.737; Quarmby LM, 2004, INT REV CYTOL, V233, P47, DOI 10.1016/S0074-7696(04)33002-0; RANNESTA.J, 1974, J CELL BIOL, V63, P1009, DOI 10.1083/jcb.63.3.1009; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; ROSENBAU.JL, 1969, J CELL BIOL, V41, P600, DOI 10.1083/jcb.41.2.600; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; SALISBURY JL, 1987, J CELL BIOL, V105, P1799, DOI 10.1083/jcb.105.4.1799; SALISBURY JL, 1988, J CELL BIOL, V107, P635, DOI 10.1083/jcb.107.2.635; SANDERS MA, 1989, J CELL BIOL, V108, P1751, DOI 10.1083/jcb.108.5.1751; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; Spassky N, 2017, NAT REV MOL CELL BIO, V18, P423, DOI 10.1038/nrm.2017.21; Takao D, 2016, CELL MOL LIFE SCI, V73, P119, DOI 10.1007/s00018-015-2058-0; Thompson CL, 2016, FASEB J, V30, P716, DOI 10.1096/fj.15-274944; TUCKER RW, 1979, CELL, V18, P1065, DOI 10.1016/0092-8674(79)90219-8; Tuxhorn J, 1998, CELL MOTIL CYTOSKEL, V40, P133, DOI 10.1016/j.semcdb.2008.07.005; Van Eldik L J, 1980, Ann N Y Acad Sci, V356, P36; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Vinogradova MV, 2008, J STRUCT BIOL, V163, P76, DOI 10.1016/j.jsb.2008.04.004; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; WALTER MF, 1981, EUR J CELL BIOL, V24, P97; Wheeler GL, 2008, PLANT J, V53, P401, DOI 10.1111/j.1365-313X.2007.03349.x; Wilson NF, 2004, EUKARYOT CELL, V3, P1307, DOI 10.1128/EC.3.5.1307-1319.2004; WRIGHT RL, 1985, J CELL BIOL, V101, P1903, DOI 10.1083/jcb.101.5.1903; Yang PF, 2001, J CELL BIOL, V153, P1315, DOI 10.1083/jcb.153.6.1315; YUEH YG, 1993, J CELL BIOL, V123, P869, DOI 10.1083/jcb.123.4.869; Zheng SZ, 2012, PLANT J, V69, P689, DOI 10.1111/j.1365-313X.2011.04823.x; Zhou F, 2015, CELL, V162, DOI 10.1016/j.cell.2015.06.048; Zhu X, 2017, CELL MOL LIFE SCI, V74, P3425, DOI 10.1007/s00018-017-2525-x; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697; ZIMMER WE, 1988, J BIOL CHEM, V263, P19370	76	7	7	1	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3689	3699		10.1096/fj.201701396RR	http://dx.doi.org/10.1096/fj.201701396RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29401628				2022-12-26	WOS:000435104500017
J	Yamazaki, M; Yamada, H; Munetsuna, E; Ishikawa, H; Mizuno, G; Mukuda, T; Mouri, A; Nabeshima, T; Saito, K; Suzuki, K; Hashimoto, S; Ohashi, K				Yamazaki, Mirai; Yamada, Hiroya; Munetsuna, Eiji; Ishikawa, Hiroaki; Mizuno, Genki; Mukuda, Takao; Mouri, Akihiro; Nabeshima, Toshitaka; Saito, Kuniaki; Suzuki, Koji; Hashimoto, Shuji; Ohashi, Koji			Excess maternal fructose consumption impairs hippocampal function in offspring via epigenetic modification of BDNF promoter	FASEB JOURNAL			English	Article						maternal nutrition; early-life adversity; DOHaD; cognitive function	DEPRESSIVE-LIKE BEHAVIOR; DNA METHYLATION; CARDIOVASCULAR-DISEASE; NEUROGENESIS; EXPRESSION; STRESS; BRAIN; GENE; AGE; PREGNANCY	Recent increases in fructose consumption have raised concerns about the potential adverse intergenerational effects of excess fructose intake. In the present study, we investigated whether excess maternal fructose intake affects hippocampal function in offspring. Female Sprague-Dawley rats were divided into 3 experimental groups: one group received distilled water, one group received 20% fructose water, and one group received 20% glucose water in addition to standard chow during gestation and lactation. Hippocampal function of offspring was evaluated by using novel object recognition and fear conditioning tests. Impaired cognitive performance was observed in the offspring of fructose-fed dams at postnatal d 60, potentially a result of decreased hippocampal neurogenesis. Real-time PCR analysis demonstrated that offspring from fructose-fed dams exhibited decreased brain-derived neurotrophic factor (BDNF) gene expression, whereas pyrosequencing assays revealed increased DNA methylation at the BDNF promoter. The potential association between BDNF transcription and levels of DNA methylation was confirmed on the basis of luciferase activity. Furthermore, longitudinal analysis revealed that increased methylation of the BDNF promoter region was maintained at least until rats reached maturity. These results indicate that epigenetic changes associated with BDNF may underlie hippocampal dysfunction that is induced by early-life exposure to excess maternal fructose consumption.	[Yamazaki, Mirai; Ishikawa, Hiroaki; Mizuno, Genki; Suzuki, Koji] Fujita Hlth Univ, Dept Clin Biochem, Toyoake, Aichi, Japan; [Mouri, Akihiro; Nabeshima, Toshitaka] Fujita Hlth Univ, Adv Diagnost Syst Res Lab, Toyoake, Aichi, Japan; [Saito, Kuniaki] Fujita Hlth Univ, Dept Dis Control & Prevent, Toyoake, Aichi, Japan; [Suzuki, Koji] Fujita Hlth Univ, Dept Prevent Med Sci, Sch Hlth Sci, Toyoake, Aichi, Japan; [Yamada, Hiroya; Hashimoto, Shuji] Fujita Hlth Univ, Sch Med, Dept Hyg, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi, Japan; [Munetsuna, Eiji] Fujita Hlth Univ, Dept Biochem, Sch Med, Toyoake, Aichi, Japan; [Mukuda, Takao] Tottori Univ, Fac Med, Dept Anat, Yonago, Tottori, Japan	Fujita Health University; Fujita Health University; Fujita Health University; Fujita Health University; Fujita Health University; Fujita Health University; Tottori University	Yamada, H (corresponding author), Fujita Hlth Univ, Sch Med, Dept Hyg, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi, Japan.	hyamada@fujita-hu.ac.jp		Mizuno, Genki/0000-0001-8052-5146; Suzuki, Koji/0000-0002-3235-9558	Japan Society for the Promotion of Science [JP17K07805, JP17H04252]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (JP17K07805 and JP17H04252). The authors declare no conflicts of interest.	Asghar ZA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25091; Bideskan AE, 2017, EXP TOXICOL PATHOL, V69, P329, DOI 10.1016/j.etp.2017.02.006; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Chen YJ, 2013, ADV MECH ENG, DOI 10.1155/2013/175347; Chesnokova V, 2016, BRAIN BEHAV IMMUN, V58, P1, DOI 10.1016/j.bbi.2016.01.017; Christie LA, 2012, CLIN CANCER RES, V18, P1954, DOI 10.1158/1078-0432.CCR-11-2000; Dennis KE, 2005, MOL BRAIN RES, V140, P1, DOI 10.1016/j.molbrainres.2005.06.014; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fan CN, 2016, NUTR RES, V36, P1013, DOI 10.1016/j.nutres.2016.06.005; Ghezzi AC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-3; Goran MI, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020146; HAGERMAN DD, 1952, J CLIN INVEST, V31, P911, DOI 10.1172/JCI102679; Han H, 2016, BRAIN RES BULL, V124, P269, DOI 10.1016/j.brainresbull.2016.05.011; Harrell CS, 2015, PSYCHONEUROENDOCRINO, V62, P252, DOI 10.1016/j.psyneuen.2015.08.025; Hoeijmakers L, 2015, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00103; Ibanez G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135849; Lajud N, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00003; Lajud N, 2013, HORM BEHAV, V64, P781, DOI 10.1016/j.yhbeh.2013.10.005; Laker RC, 2014, DIABETES, V63, P1605, DOI [10.2337/db14-0135, 10.2337/db13-1614]; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Mizuno G, 2017, ENDOCR RES, V42, P71, DOI 10.1080/07435800.2016.1182186; Narain A, 2016, INT J CLIN PRACT, V70, P791, DOI 10.1111/ijcp.12841; Ogden Cynthia L, 2011, NCHS Data Brief, P1; Ohashi K, 2015, BIOCHEM BIOPH RES CO, V468, P185, DOI 10.1016/j.bbrc.2015.10.134; Ohashi K, 2015, NUTR RES, V35, P259, DOI 10.1016/j.nutres.2014.11.001; OSMOND C, 1993, BRIT MED J, V307, P1519, DOI 10.1136/bmj.307.6918.1519; Painter RC, 2006, AM J CLIN NUTR, V84, P322; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rodrigo S, 2016, MOL NUTR FOOD RES, V60, P2700, DOI 10.1002/mnfr.201600193; Rutledge AC, 2007, NUTR REV, V65, pS13, DOI [10.1111/j.1753-4887.2007.tb00322.x, 10.1301/nr.2007.jun.S13-S23]; Shepherd PR, 1997, BRIT J NUTR, V78, P121, DOI 10.1079/BJN19970124; Shih YH, 2016, NEUROSCIENCE, V322, P346, DOI 10.1016/j.neuroscience.2016.02.045; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stephan BCM, 2010, J GERONTOL A-BIOL, V65, P809, DOI 10.1093/gerona/glq079; Susser E, 1998, AM J EPIDEMIOL, V147, P213; Talens RP, 2010, FASEB J, V24, P3135, DOI 10.1096/fj.09-150490; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Tozuka Y, 2010, NEUROCHEM INT, V57, P235, DOI 10.1016/j.neuint.2010.05.015; van der Borght K, 2011, REGUL PEPTIDES, V167, P26, DOI 10.1016/j.regpep.2010.11.002; Vickers MH, 2011, ENDOCRINOLOGY, V152, P1378, DOI 10.1210/en.2010-1093; Vos Miriam B, 2008, Medscape J Med, V10, P160; Wu KLH, 2016, NEUROBIOL LEARN MEM, V130, P105, DOI 10.1016/j.nlm.2016.02.004; Yamada L, 2017, J DEV ORIG HLTH DIS, V8, P30, DOI 10.1017/S2040174416000507; Yamazaki M, 2016, LIFE SCI, V149, P146, DOI 10.1016/j.lfs.2016.02.020	48	34	32	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2549	2562		10.1096/fj.201700783RR	http://dx.doi.org/10.1096/fj.201700783RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401579				2022-12-26	WOS:000432528000020
J	DePasquale, B; Cueva, CJ; Rajan, K; Escola, GS; Abbott, LF				DePasquale, Brian; Cueva, Christopher J.; Rajan, Kanaka; Escola, G. Sean; Abbott, L. F.			full-FORCE: A target-based method for training recurrent networks	PLOS ONE			English	Article							PARAMETRIC WORKING-MEMORY; NEURAL-NETWORK; MODELS; CHAOS; FRAMEWORK; PATTERNS	Trained recurrent networks are powerful tools for modeling dynamic neural computations. We present a target-based method for modifying the full connectivity matrix of a recurrent network to train it to perform tasks involving temporally complex input/output transformations. The method introduces a second network during training to provide suitable "target" dynamics useful for performing the task. Because it exploits the full recurrent connectivity, the method produces networks that perform tasks with fewer neurons and greater noise robustness than traditional least-squares (FORCE) approaches. In addition, we show how introducing additional input signals into the target-generating network, which act as task hints, greatly extends the range of tasks that can be learned and provides control over the complexity and nature of the dynamics of the trained, task-performing network.	[DePasquale, Brian; Cueva, Christopher J.; Abbott, L. F.] Columbia Univ, Dept Neurosci, Zuckerman Inst, New York, NY 10027 USA; [Rajan, Kanaka] Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; [Rajan, Kanaka] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Rajan, Kanaka] Icahn Sch Med Mt Sinai, Friedman Brain Inst, One Gustave L Levy Pl, New York, NY 10029 USA; [Escola, G. Sean] Columbia Univ, Dept Psychiat, Coll Physicians & Surg, New York, NY USA; [Abbott, L. F.] Columbia Univ, Dept Physiol & Cellular Biophys, Coll Physicians & Surg, New York, NY USA; [DePasquale, Brian] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA	Columbia University; Princeton University; Princeton University; Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; Princeton University	DePasquale, B (corresponding author), Columbia Univ, Dept Neurosci, Zuckerman Inst, New York, NY 10027 USA.; DePasquale, B (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	depasquale@princeton.edu		Rajan, Kanaka/0000-0003-2749-2917	NIH [MH093338]; Gatsby Charitable Foundation; Simons Foundation; NSF NeuroNex Award [DBI-1707398]; NSF Graduate Research Fellowship; NATIONAL EYE INSTITUTE [P30EY019007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS064929] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Foundation; Simons Foundation; NSF NeuroNex Award; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research supported by NIH grant MH093338, the Gatsby Charitable Foundation (http.//www.gatsby.org.uk/neuroscience/programmes/neuroscience-at-columbia-university-new-york), the Simons Foundation (https://www.simonsfoundation.org/collaborations/global-brain/) and NSF NeuroNex Award DBI-1707398 (LFA). BD supported by a NSF Graduate Research Fellowship (https://www.nsfgrfp.org).; We thank Raoul-Martin Memmesheimer for fruitful discussions regarding an earlier version of this work. We thank Ben Dongsung Huh for suggesting the name full-FORCE that integrates the original FORCE acronym and David Sussillo, Omri Barak and Vishwa Goudar for helpful suggestions and conversations. We also thank Eli Pollock for providing a Python implementation of our algorithm. Research supported by NIH grant MH093338, the Gatsby Charitable Foundation and the Simons Foundation. BD supported by a NSF Graduate Research Fellowship.	Abbott LF, 2016, NAT NEUROSCI, V19, P350, DOI 10.1038/nn.4241; Abu-Mostafa Y. S., 1994, Journal of Complexity, V10, P165, DOI 10.1006/jcom.1994.1007; ABUMOSTAFA YS, 1995, NEURAL COMPUT, V7, P639, DOI 10.1162/neco.1995.7.4.639; Barak O, 2013, PROG NEUROBIOL, V103, P214, DOI 10.1016/j.pneurobio.2013.02.002; BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Fisher D, 2013, NEURON, V79, P987, DOI 10.1016/j.neuron.2013.06.041; GIRKO VL, 1985, THEOR PROBAB APPL+, V29, P694, DOI 10.1137/1129095; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Haykin S, 2002, ADAPTIVE FILTER THEO; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Laje R, 2013, NAT NEUROSCI, V16, P925, DOI 10.1038/nn.3405; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee D-H, 2015, PREPRINT; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Miller P, 2003, CEREB CORTEX, V13, P1208, DOI 10.1093/cercor/bhg101; Rajan K, 2010, ADV NEURAL INFORM PR, V23; Rajan K, 2016, NEURON, V90, P128, DOI 10.1016/j.neuron.2016.02.009; Rajan K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011903; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; SOMPOLINSKY H, 1988, PHYS REV LETT, V61, P259, DOI 10.1103/PhysRevLett.61.259; Sussillo D, 2015, NAT NEUROSCI, V18, P1025, DOI 10.1038/nn.4042; Sussillo D, 2014, CURR OPIN NEUROBIOL, V25, P156, DOI 10.1016/j.conb.2014.01.008; Sussillo D, 2013, NEURAL COMPUT, V25, P626, DOI 10.1162/NECO_a_00409; Sussillo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037372; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Triefenbach F., 2010, NIPS, V23, P2307; Vincent-Lamarre P, 2016, J COMPUT NEUROSCI, V41, P305, DOI 10.1007/s10827-016-0619-3; WERBOS PJ, 1988, NEURAL NETWORKS, V1, P339, DOI 10.1016/0893-6080(88)90007-X	33	41	41	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191527	10.1371/journal.pone.0191527	http://dx.doi.org/10.1371/journal.pone.0191527			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415041	Green Published, gold, Green Submitted			2022-12-26	WOS:000424325300032
J	Fiocchi, S; Chiaramello, E; Parazzini, M; Ravazzani, P				Fiocchi, Serena; Chiaramello, Emma; Parazzini, Marta; Ravazzani, Paolo			Influence of tissue conductivity on foetal exposure to extremely low frequency magnetic fields at 50 Hz using stochastic dosimetry	PLOS ONE			English	Article							INDUCED CURRENT DENSITIES; DIELECTRIC-PROPERTIES; MATHEMATICAL-MODELS; POLYNOMIAL CHAOS; ELECTRIC-FIELDS; RISK-ASSESSMENT; POOLED ANALYSIS; PREGNANT-WOMEN; SAR; CHILDREN	Human exposure to extremely low frequency magnetic fields (ELF-MF) at 50 Hz is still a topic of great interest due to the possible correlation with childhood leukaemia. The estimation of induced electric fields in human tissues exposed to electromagnetic fields (EMFs) strictly depends on several variables which include the dielectric properties of the tissues. In this paper, the influence of the conductivity assignment to foetal tissues at different gestational ages on the estimation of the induced electric field due to ELF-MF exposure at 50 Hz has been quantified by means of a stochastic approach using polynomial chaos theory. The range of variation in conductivity values for each foetal tissue at each stage of pregnancy have been defined through three empirical approaches and the induced electric field in each tissue has been modelled through stochastic dosimetry. The main results suggest that both the peak and median induced electric fields in foetal fat vary by more than 8% at all gestational ages. On the contrary, the electric field induced in foetal brain does not seem to be significantly affected by conductivity data changes. The maximum exposure levels, in terms of the induced electric field found in each specific tissue, were found to be significantly below the basic restrictions indicated in the ICNIRP Guidelines, 2010.	[Fiocchi, Serena; Chiaramello, Emma; Parazzini, Marta; Ravazzani, Paolo] CNR, IEIIT, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Elettronica e di Ingegneria dell'Informazione e delle Telecomunicazioni (IEIIT-CNR)	Fiocchi, S (corresponding author), CNR, IEIIT, Milan, Italy.	serena.fiocchi@ieiit.cnr.it	Parazzini, Marta/J-8175-2014; Chiaramello, Emma/AAY-8463-2020; Fiocchi, Serena/AAT-5362-2021; Fiocchi, Serena/C-3475-2015	Parazzini, Marta/0000-0001-9008-7530; Chiaramello, Emma/0000-0003-2503-4779; Fiocchi, Serena/0000-0002-6568-8841; Fiocchi, Serena/0000-0002-6568-8841	French National Research Program for Environmental and Occupational Health of ANSES: Project ELFSTAT - In depth evaluation of children's exposure to ELF (40 - 800 Hz) magnetic fields and implications for health risk of new technologies [2015/1/202]	French National Research Program for Environmental and Occupational Health of ANSES: Project ELFSTAT - In depth evaluation of children's exposure to ELF (40 - 800 Hz) magnetic fields and implications for health risk of new technologies	The study is funded by the French National Research Program for Environmental and Occupational Health of ANSES (2015/1/202): Project ELFSTAT - In depth evaluation of children's exposure to ELF (40 - 800 Hz) magnetic fields and implications for health risk of new technologies, 2015-2019.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; Ahlbom A, 2000, BRIT J CANCER, V83, P692, DOI 10.1054/bjoc.2000.1376; Bellieni C V, 2012, BIOINITIATIVE REPORT, V19; Blatman G, 2011, J COMPUT PHYS, V230, P2345, DOI 10.1016/j.jcp.2010.12.021; Cech R, 2007, PHYS MED BIOL, V52, P879, DOI 10.1088/0031-9155/52/4/001; Chiaramello E, 2017, IEEE J ELECTROMAG RF, V1, P26, DOI 10.1109/JERM.2017.2727279; Christ A, 2012, BIOELECTROMAGNETICS, V33, P695, DOI 10.1002/bem.21739; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; Dimbylow P, 2005, PHYS MED BIOL, V50, P1047, DOI 10.1088/0031-9155/50/6/002; Dimbylow P, 2006, PHYS MED BIOL, V51, P2383, DOI 10.1088/0031-9155/51/10/003; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Fiocchi S, 2013, BIOELECTROMAGNETICS, V34, P443, DOI 10.1002/bem.21789; Fiocchi S, 2011, PROG BIOPHYS MOL BIO, V107, P443, DOI 10.1016/j.pbiomolbio.2011.09.019; Forbes G, 1987, HUMAN BODY COMPOSITI; FORBES RM, 1953, J BIOL CHEM, V203, P359; Gabriel C, 2006, PHYS MED BIOL, V51, P6033, DOI 10.1088/0031-9155/51/23/006; Gabriel C, 2005, BIOELECTROMAGNETICS, pS12, DOI 10.1002/bem.20147; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; Gabriel C, 2009, PHYS MED BIOL, V54, P4863, DOI 10.1088/0031-9155/54/16/002; GEISSER S, 1975, J AM STAT ASSOC, V70, P320, DOI 10.2307/2285815; Hasgall P. A., 2012, ITIS DATABASE THERMA; Int Commission Non-Ionizing, 2010, HEALTH PHYS, V99, P818, DOI 10.1097/HP.0b013e3181f06c86; Kawai H, 2006, IEICE T COMMUN, VE89B, P3401, DOI 10.1093/ietcom/e89-b.12.3401; Kheifets L, 2010, BRIT J CANCER, V103, P1128, DOI 10.1038/sj.bjc.6605838; Liorni I, 2015, INT J ENV RES PUB HE, V12, P5934, DOI 10.3390/ijerph120605934; Liorni I, 2014, BIOELECTROMAGNETICS, V35, P580, DOI 10.1002/bem.21878; Lu YJ, 1996, BIOELECTROMAGNETICS, V17, P425, DOI 10.1002/(SICI)1521-186X(1996)17:5<425::AID-BEM10>3.0.CO;2-L; Peters MJ, 2001, BIOELECTROCHEMISTRY, V53, P155, DOI 10.1016/S0302-4598(00)00117-3; Peyman A, 2009, PHYS MED BIOL, V54, P227, DOI 10.1088/0031-9155/54/2/004; Peyman A, 2012, PHYS MED BIOL, V57, P2103, DOI 10.1088/0031-9155/57/8/2103; Peyman A, 2011, PHYS MED BIOL, V56, pN93, DOI 10.1088/0031-9155/56/7/N01; Peyman A, 2011, PROG BIOPHYS MOL BIO, V107, P434, DOI 10.1016/j.pbiomolbio.2011.08.007; Preston RJ, 2004, TOXICOL APPL PHARM, V199, P132, DOI 10.1016/j.taap.2003.12.030; Repacholi M, 2005, BIOELECTROMAGNETICS, pS2, DOI 10.1002/bem.20157; SCENIHR, 2014, HLTH EFF EMF PREL OP; Schuz J, 2016, BIOELECTROMAGNETICS, V37, P183, DOI 10.1002/bem.21963; Smith S R, 1985, PHYS MED BIOL, V49, P5185; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; Soize C, 2004, SIAM J SCI COMPUT, V26, P395, DOI 10.1137/S1064827503424505; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Taub JW, 2004, LEUKEMIA LYMPHOMA, V45, P19, DOI 10.1080/1042819031000149403; Wang JQ, 2006, IEEE T ELECTROMAGN C, V48, P408, DOI 10.1109/TEMC.2006.874085; WHITE DR, 1991, BRIT J RADIOL, V64, P149, DOI 10.1259/0007-1285-64-758-149; WIDDOWSON EM, 1960, BIOCHEM J, V77, P30, DOI 10.1042/bj0770030; Wiener N, 1938, AM J MATH, V60, P897, DOI 10.2307/2371268; WOODARD HQ, 1986, BRIT J RADIOL, V59, P1209, DOI 10.1259/0007-1285-59-708-1209; World Health Organization WHO, 2007, WHO RES AG EXTR LOW; Xiu DB, 2002, SIAM J SCI COMPUT, V24, P619, DOI 10.1137/S1064827501387826; Zoppetti N, 2011, PROG BIOPHYS MOL BIO, V107, P456, DOI 10.1016/j.pbiomolbio.2011.10.003; Zupanic A, 2007, IFMBE PROC, V16, P226	50	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192131	10.1371/journal.pone.0192131	http://dx.doi.org/10.1371/journal.pone.0192131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415005	gold, Green Submitted, Green Published			2022-12-26	WOS:000424325300051
J	Castor, T; Yogev, N; Blank, T; Barwig, C; Prinz, M; Waisman, A; Bros, M; Reske-Kunz, AB				Castor, Timo; Yogev, Nir; Blank, Thomas; Barwig, Christina; Prinz, Marco; Waisman, Ari; Bros, Matthias; Reske-Kunz, Angelika B.			Inhibition of experimental autoimmune encephalomyelitis by tolerance-promoting DNA vaccination focused to dendritic cells	PLOS ONE			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NF-KAPPA-B; ANTIGEN PRESENTATION; T-CELLS; REGULATORY CYTOKINE; IMMUNE DEVIATION; GM-CSF; GENE; INDUCTION; VACCINES	In this study we analysed the effects of prophylactic biolistic DNA vaccination with plasmids encoding the encephalitogenic protein myelin oligodendrocyte glycoprotein (MOG) on the severity of a subsequently MOGp35-55-induced EAE and on the underlying immune response. We compared the outcome of vaccination with MOG-encoding plasmids alone or in combination with vectors encoding the regulatory cytokines IL-10 and TGF-beta 1, respectively. MOG expression was restricted to skin dendritic cells (DCs) by the use of the DC-specific promoter of the fascin1 gene (pFscn-MOG). For comparison, the strong and ubiquitously active CMV promoter was employed (pCMV-MOG), which allows MOG expression in all transfected cells. Expression of IL-10 and TGF-beta 1 was controlled by the CMV promoter to yield maximal synthesis (pCMV-IL10, pCMV-TGF beta). Co-application of pFscn-MOG and pCMV-IL10 significantly ameliorated EAE pathology, while vaccination with pCMV-MOG plus pCMV-IL10 did not affect EAE outcome. In contrast, vaccination with either of the two MOG-encoding plasmids in combination with pCMV-TGF beta significantly attenuated the clinical EAE symptoms. Mechanistically, we observed diminished infiltration of Th17 and Th1 cells as well as macrophages/DCs into the CNS, which correlated with decreased MOGp35-55-specific production of IL-17 and IFN-gamma by spleen cells and reduced peptidespecific T cell proliferation. Our findings suggest deletion of or anergy induction in MOG-specific CD4(+) T cells by the suppressive vaccination platform employed. MOG expression driven by the DC-specific fascin1 promoter yielded similar inhibitory effects on EAE progression as the ubiquitously active viral CMV promoter, when coapplying pCMV-TGF beta. Our finding that pCMV-IL10 promoted tolerogenic effects only, when coapplied with pFscn-MOG, but not pCMV-MOG suggests that IL-10 affected only directly transfected DCs (pFscn-MOG), but not neighbouring DCs that engulfed MOG-containing vesicles derived from transfected keratinocytes (pCMV-MOG). Thus, due to its DC-restricted expression, the fascin1 promoter might be an interesting alternative to ubiquitously expressed promoters for vaccination strategies.	[Castor, Timo; Barwig, Christina; Bros, Matthias; Reske-Kunz, Angelika B.] Univ Med Ctr, Dept Dermatol, Mainz, Germany; [Yogev, Nir; Waisman, Ari] Univ Med Ctr, Inst Mol Med, Mainz, Germany; [Blank, Thomas; Prinz, Marco] Univ Freiburg, Med Fac, Inst Neuropathol, Freiburg, Germany; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Freiburg; University of Freiburg	Reske-Kunz, AB (corresponding author), Univ Med Ctr, Dept Dermatol, Mainz, Germany.	reskekun@uni-mainz.de		Blank, Thomas/0000-0002-3969-405X	Stiftung Rheinland-Pfalz fur Innovation [15202-386261/280]	Stiftung Rheinland-Pfalz fur Innovation	This work was supported by a grant of the Stiftung Rheinland-Pfalz fur Innovation to AR-K (15202-386261/280). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; ALLEN SJ, 1993, CELL IMMUNOL, V146, P335, DOI 10.1006/cimm.1993.1031; Andersson A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003682; Becher B, 2006, J MOL MED, V84, P532, DOI 10.1007/s00109-006-0065-1; Bettelli E, 2003, J AUTOIMMUN, V20, P265, DOI 10.1016/S0896-8411(03)00048-9; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; Bourquin C, 2000, EUR J IMMUNOL, V30, P3663; Bros M, 2007, BLOOD, V109, P3820, DOI 10.1182/blood-2006-07-035576; Bros M, 2009, J IMMUNOL METHODS, V343, P13, DOI 10.1016/j.jim.2009.01.006; Brown AJ, 2015, BIOTECHNOL J, V10, P1019, DOI 10.1002/biot.201400744; Challa DK, 2016, J AUTOIMMUN, V72, P84, DOI 10.1016/j.jaut.2016.05.007; Cho JH, 2001, J IMMUNOL, V167, P5549, DOI 10.4049/jimmunol.167.10.5549; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Farooq SM, 2014, BRAIN BEHAV IMMUN, V35, P64, DOI 10.1016/j.bbi.2013.09.016; Farooq SM, 2013, CNS NEUROSCI THER, V19, P503, DOI 10.1111/cns.12087; Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334; Fissolo N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-139; Fissolo N, 2012, CLIN IMMUNOL, V142, P76, DOI 10.1016/j.clim.2010.11.011; Flanagan EP, 2016, HAND CLINIC, V133, P327, DOI 10.1016/B978-0-444-63432-0.00019-0; FORD AL, 1995, J IMMUNOL, V154, P4309; FRIEDMAN A, 1994, P NATL ACAD SCI USA, V91, P6688, DOI 10.1073/pnas.91.14.6688; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; Gandhi R, 2007, J IMMUNOL, V178, P4017, DOI 10.4049/jimmunol.178.7.4017; Gathungu G, 2013, INFLAMM BOWEL DIS, V19, P1671, DOI 10.1097/MIB.0b013e318281f506; Haase C, 2002, IMMUNOLOGY, V107, P489, DOI 10.1046/j.1365-2567.2002.01529.x; Hohn Yvonne, 2013, Methods Mol Biol, V940, P199, DOI 10.1007/978-1-62703-110-3_17; Jegou JF, 2007, MOL IMMUNOL, V44, P3691, DOI 10.1016/j.molimm.2007.04.008; Jones A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00532; Keegan BM, 2013, SEMIN NEUROL, V33, P5, DOI 10.1055/s-0033-1345709; Kelly A, 2017, ADV IMMUNOL, V134, P137, DOI 10.1016/bs.ai.2017.01.001; Korn T, 2007, J NEUROIMMUNOL, V191, P51, DOI 10.1016/j.jneuroim.2007.09.009; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lassmann H, 2017, ACTA NEUROPATHOL, V133, P223, DOI 10.1007/s00401-016-1631-4; Ludewig P, 2016, BBA-MOL BASIS DIS, V1862, P352, DOI 10.1016/j.bbadis.2015.11.003; Matsuda R, 2012, INVEST OPHTH VIS SCI, V53, P7235, DOI 10.1167/iovs.12-10587; Nadiminty N, 2006, P NATL ACAD SCI USA, V103, P7264, DOI 10.1073/pnas.0509808103; Nishinakamura H, 2007, INT IMMUNOL, V19, P609, DOI 10.1093/intimm/dxm026; Perona-Wright G, 2007, INT IMMUNOL, V19, P1123, DOI 10.1093/intimm/dxm084; Porgador A, 1998, J EXP MED, V188, P1075, DOI 10.1084/jem.188.6.1075; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Ramshaw IA, 1997, IMMUNOL CELL BIOL, V75, P409, DOI 10.1038/icb.1997.64; Ross R, 2003, GENE THER, V10, P1035, DOI 10.1038/sj.gt.3301968; Ross R, 1998, J IMMUNOL, V160, P3776; Rowin J, 2012, MUSCLE NERVE, V46, P449, DOI 10.1002/mus.23488; Scheiblhofer S, 2007, MOL IMMUNOL, V44, P1879, DOI 10.1016/j.molimm.2006.09.023; SCHEICHER C, 1992, J IMMUNOL METHODS, V154, P253, DOI 10.1016/0022-1759(92)90199-4; Song SS, 2014, INT IMMUNOPHARMACOL, V20, P117, DOI 10.1016/j.intimp.2014.02.027; Sudowe S, 2006, J ALLERGY CLIN IMMUN, V117, P196, DOI 10.1016/j.jaci.2005.08.058; Sudowe S, 2003, MOL THER, V8, P567, DOI 10.1016/S1525-0016(03)00242-9; SUDOWE S, 1995, INT IMMUNOL, V7, P1799, DOI 10.1093/intimm/7.11.1799; Sudowe S, 2009, IMMUNOLOGY, V128, pe193, DOI 10.1111/j.1365-2567.2008.02947.x; Toda M, 2000, IMMUNOLOGY, V99, P179, DOI 10.1046/j.1365-2567.2000.00935.x; Torres-Aguilar H, 2010, J IMMUNOL, V184, P1765, DOI 10.4049/jimmunol.0902133; Treacy O, 2016, METHODS MOL BIOL, V1371, P205, DOI 10.1007/978-1-4939-3139-2_13; Wahren B, 2014, VACCINES-BASEL, V2, P785, DOI 10.3390/vaccines2040785; Waisman A, 1996, NAT MED, V2, P899, DOI 10.1038/nm0896-899; Walczak A, 2004, CLIN NEUROL NEUROSUR, V106, P241, DOI 10.1016/j.clineuro.2004.02.022; Weiss R, 2002, VACCINE, V20, P3148, DOI 10.1016/S0264-410X(02)00250-5; Williams JA, 2013, VACCINES, V1, P225, DOI 10.3390/vaccines1030225; Wu GF, 2011, NEUROL CLIN, V29, P257, DOI 10.1016/j.ncl.2010.12.009	62	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191927	10.1371/journal.pone.0191927	http://dx.doi.org/10.1371/journal.pone.0191927			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408931	gold, Green Published, Green Submitted			2022-12-26	WOS:000424302800030
J	Frolich, AM; Nawka, MT; Ernst, M; Frischmuth, I; Fiehler, J; Buhk, JH				Froelich, Andreas Maximilian; Nawka, Marie Teresa; Ernst, Marielle; Frischmuth, Isabell; Fiehler, Jens; Buhk, Jan-Hendrik			Intra-aneurysmal flow disruption after implantation of the Medina (R) Embolization Device depends on aneurysm neck coverage	PLOS ONE			English	Article							INTRACRANIAL ANEURYSMS; EXPERIENCE	Background and purpose Flow disruption achieved by braided intrasaccular implants is a novel treatment strategy for cerebrovascular aneurysms. We hypothesized that the degree of intra-aneurysmal flow disruption can be quantified in vitro and is influenced by device position across the aneurysm neck. We tested this hypothesis using the Medina (R) Embolization Device (MED). Methods Ten different patient-specific elastic vascular models were manufactured. Models were connected to a pulsatile flow circuit, filled with a blood-mimicking fluid and treated by two operators using a single MED. Intra-aneurysmal flow velocity was measured using conventional and high-frequency digital subtraction angiography (HF-DSA) before and after each deployment. Aneurysm neck coverage by the implanted devices was assessed with flat detector computed tomography on a three-point Likert scale. Results A total of 80 individual MED deployments were performed by the two operators. The mean intra-aneurysmal flow velocity reduction after MED implantation was 33.6% (27.5-39.7%). No significant differences in neck coverage (p = 0.99) or flow disruption (p = 0.84) were observed between operators. The degree of flow disruption significantly correlated with neck coverage (rho = 0.42, 95% CI: 0.21-0.59, p = 0.002) as well as with neck area (rho = -0,35, 95% CI: -0.54 - -0.13, p = 0.024). On multiple regression analysis, both neck coverage and total neck area were independent predictors of flow disruption. Conclusions The degree of intra-aneurysmal flow disruption after MED implantation can be quantified in vitro and varies considerably between different aneurysms and different device configurations. Optimal device coverage across the aneurysm neck improves flow disruption and may thus contribute to aneurysm occlusion.	[Froelich, Andreas Maximilian; Nawka, Marie Teresa; Ernst, Marielle; Frischmuth, Isabell; Fiehler, Jens; Buhk, Jan-Hendrik] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Frolich, AM (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	a.froelich@gmail.com		Nawka, Marie Teresa/0000-0001-7423-9725	Philips Healthcare; Medtronic, Dublin, Ireland	Philips Healthcare; Medtronic, Dublin, Ireland(Medtronic)	The authors thank Philips Healthcare for the support and realization of the "Hermann Zeumer Research Laboratory" including a Philips Allura Clarity Angiography system. The study was supported by a research agreement with Medtronic, Dublin, Ireland which included provision of the endovascular devices used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Johanna Spallek for help in post-processing of image data. The authors also thank Philips Healthcare for the support and realization of the "Hermann Zeumer Research Laboratory" including a Philips Allura Clarity Angiography system. The devices used in this study were provided by Medtronic, Dublin, Ireland.	Bhogal P, 2017, INTERV NEURORADIOL; Bodily KD, 2011, AM J NEURORADIOL, V32, P1232, DOI 10.3174/ajnr.A2478; Cebral JR, 2017, AM J NEURORADIOL, V38, P1180, DOI 10.3174/ajnr.A5158; Cheng NS, 2008, IND ENG CHEM RES, V47, P3285, DOI 10.1021/ie071349z; Frolich AMJ, 2016, AM J NEURORADIOL, V37, P120, DOI 10.3174/ajnr.A4486; Jeon JP, 2017, CLIN NEURORADIOL, V27, P205, DOI 10.1007/s00062-015-0485-9; Jou LD, 2017, INTERV NEURORADIOL, V23, P260, DOI 10.1177/1591019917694023; Mine B, 2016, J NEUROINTERV SURG, V8, P615, DOI 10.1136/neurintsurg-2015-011644; Pereira VM, 2013, AM J NEURORADIOL, V34, P808, DOI 10.3174/ajnr.A3322; Perez MA, 2017, J NEUROINTERV SURG, V9, P77, DOI 10.1136/neurintsurg-2016-012539; Pierot L, 2012, AM J NEURORADIOL, V33, P1232, DOI 10.3174/ajnr.A3191; Sourour NA, 2017, NEUROSURGERY; Turk AS, 2016, J NEUROINTERV SURG, V8, P168, DOI 10.1136/neurintsurg-2014-011585	13	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191975	10.1371/journal.pone.0191975	http://dx.doi.org/10.1371/journal.pone.0191975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408857	Green Submitted, gold, Green Published			2022-12-26	WOS:000424302800037
J	Kent, MS; Burton, JH; Dank, G; Bannasch, DL; Rebhun, RB				Kent, Michael S.; Burton, Jenna H.; Dank, Gillian; Bannasch, Danika L.; Rebhun, Robert B.			Association of cancer-related mortality, age and gonadectomy in golden retriever dogs at a veterinary academic center (1989-2016)	PLOS ONE			English	Article							INSURED SWEDISH DOGS; EXCEPTIONAL LONGEVITY; PET DOGS; BREED; DEATH; EXPOSURE; RISK; SEX	Golden retriever dogs have been reported to have an increased prevalence of cancer compared to other breeds. There is also controversy over the effect spay or neuter status might have on longevity and the risk for developing cancer. The electronic medical records system at an academic center was searched for all dogs who had a necropsy exam from 1989-2016. 9,677 canine necropsy examinations were completed of which 655 were golden retrievers. Age was known for 652 with a median age of death 9.15 years. 424 of the 652 (65.0%) were determined to have died because of cancer. The median age for dying of a cause other than cancer was 6.93 years while those dying of cancer had a median age of 9.83 years (p<0.0001). There was no significant difference in the proportion of intact males and castrated males dying of cancer (p = 0.43) but a greater proportion of spayed females died of cancer compared to intact females (p = 0.001). Intact female dogs had shorter life spans than spayed female dogs (p<0.0001), but there were no differences between intact and castrated males. Intriguingly, being spayed or neutered did not affect the risk of a cancer related death but increasing age did. The most common histologic diagnosis found in golden retrievers dying of cancer was hemangiosarcoma (22.64%) followed by lymphoid neoplasia (18.40%). Overall golden retriever dogs have a substantial risk of cancer related mortality in a referral population and age appears to have a larger effect on cancer related mortality than reproductive status.	[Kent, Michael S.; Burton, Jenna H.; Rebhun, Robert B.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Dank, Gillian] Hebrew Univ Jerusalem, Koret Sch Vet Med, Rehovot, Israel; [Bannasch, Danika L.] Univ Calif Davis, Dept Populat Hlth & Reprod, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis; Hebrew University of Jerusalem; University of California System; University of California Davis	Kent, MS (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA.	mskent@ucdavis.edu	Bannasch, Danika/GZL-8044-2022; Burton, Jenna H/AAK-6753-2021	Burton, Jenna H/0000-0002-1895-8298; Bannasch, Danika/0000-0002-7614-7207; Rebhun, Robert/0000-0002-8047-3494; Kent, Michael/0000-0002-7703-7720	Center for Companion Animal Health, School of Veterinary Medicine, University of California [2016-70-F]; National Cancer Institute of the National Institutes of Health [K12CA138464]; NATIONAL CANCER INSTITUTE [K12CA138464, P30CA093373] Funding Source: NIH RePORTER	Center for Companion Animal Health, School of Veterinary Medicine, University of California(University of California System); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by award 2016-70-F from the Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis. http://www.vetmed.ucdavis.edu/CCAH/. JHB is supported by the National Cancer Institute of the National Institutes of Health under Award Number K12CA138464. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams VJ, 2010, J SMALL ANIM PRACT, V51, P512, DOI 10.1111/j.1748-5827.2010.00974.x; [Anonymous], 2017, SEER CANC STAT REV 1; Belanger Janelle M, 2017, Canine Genet Epidemiol, V4, P6, DOI 10.1186/s40575-017-0044-6; Boerkamp KM, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-34; Bonnett BN, 2005, ACTA VET SCAND, V46, P105, DOI 10.1186/1751-0147-46-105; BRONSON RT, 1982, AM J VET RES, V43, P2057; Cooley DM, 2003, J GERONTOL A-BIOL, V58, P1078, DOI 10.1093/gerona/58.12.B1078; Cooley DM, 2002, CANCER EPIDEM BIOMAR, V11, P1434; Craig LE, 2001, J AM ANIM HOSP ASSOC, V37, P438, DOI 10.5326/15473317-37-5-438; de la Riva GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055937; Dobson J. M., 2013, ISRN VET SCI, V2013, DOI DOI 10.1155/2013/941275); Egenvall A, 2005, ACTA VET SCAND, V46, P121, DOI 10.1186/1751-0147-46-121; Fleming JM, 2011, J VET INTERN MED, V25, P187, DOI 10.1111/j.1939-1676.2011.0695.x; Guy MK, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0230; Hart BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102241; Hoffman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061082; Inoue M, 2015, PREV VET MED, V120, P210, DOI 10.1016/j.prevetmed.2015.03.018; Kengeri SS, 2013, AGE, V35, P2503, DOI 10.1007/s11357-013-9529-8; Komazawa S, 2016, J VET MED SCI, V78, P1269, DOI 10.1292/jvms.15-0584; Kustritz MVR, 2007, JAVMA-J AM VET MED A, V231, P1665, DOI 10.2460/javma.231.11.1665; Michell AR, 1999, VET REC, V145, P625, DOI 10.1136/vr.145.22.625; O'Neill DG, 2013, VET J, V198, P638, DOI 10.1016/j.tvjl.2013.09.020; Patronek GJ, 1997, J GERONTOL A-BIOL, V52, pB171, DOI 10.1093/gerona/52A.3.B171; Priester W A, 1980, Natl Cancer Inst Monogr, P1; Proschowsky HF, 2003, PREV VET MED, V58, P63, DOI 10.1016/S0167-5877(03)00010-2; Ramos-Vara JA, 2000, VET PATHOL, V37, P597, DOI 10.1354/vp.37-6-597; Smith AN, 2014, VET CLIN N AM-SMALL, V44, P965, DOI 10.1016/j.cvsm.2014.06.003; Sturges BK, 2008, J VET INTERN MED, V22, P586, DOI 10.1111/j.1939-1676.2008.00042.x; U. S. Pet Ownership, 2017, COMM CAT SHELT POP E; Waters DJ, 2017, VET J, V224, P25, DOI 10.1016/j.tvjl.2017.05.006; Waters DJ, 2014, VET J, V200, P3, DOI 10.1016/j.tvjl.2013.11.024; Waters DJ, 2009, AGING CELL, V8, P752, DOI 10.1111/j.1474-9726.2009.00513.x; Zink MC, 2014, JAVMA-J AM VET MED A, V244, P309, DOI 10.2460/javma.244.3.309	33	26	26	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192578	10.1371/journal.pone.0192578	http://dx.doi.org/10.1371/journal.pone.0192578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408871	Green Published, gold			2022-12-26	WOS:000424302800082
J	Nemtsova, Y; Wiseman, JA; El-Banna, M; Lobel, P; Sleat, DE				Nemtsova, Yuliya; Wiseman, Jennifer A.; El-Banna, Mukarram; Lobel, Peter; Sleat, David E.			Inducible transgenic expression of tripeptidyl peptidase 1 in a mouse model of late-infantile neuronal ceroid lipofuscinosis	PLOS ONE			English	Article							IN-VIVO; SURVIVAL; CELLS; MICE; DISEASE	Late-infantile neuronal ceroid lipofuscinosis is a fatal neurodegenerative disease of children caused by mutations resulting in loss of activity of the lysosomal protease, tripeptidyl peptidase 1 (TPP1). While Tpp1-targeted mouse models of LINCL exist, the goal of this study was to create a transgenic mouse with inducible TPP1 to benchmark treatment approaches, evaluate efficacy of treatment at different stages of disease, and to provide insights into the pathobiology of disease. A construct containing a loxP-flanked stop cassette inserted between the chicken-actin promoter and a sequence encoding murine TPP1 (Tg(LSL-TPP1)) was integrated into the ROSA26 locus in mice by homologous recombination. Tested in both transfected CHO cells and in transgenic mice, the Tg(LSL-TPP1) did not express TPP1 until cre-mediated removal of the LSL cassette, which resulted in supraphysiological levels of TPP1 activity. We tested four cre/ERT2 transgenes to allow tamoxifen-inducible removal of the LSL cassette and subsequent TPP1 expression at any stage of disease. However, two of the cre/ERT2 driver transgenes had significant cre activity in the absence of tamoxifen, while cre-mediated recombination could not be induced by tamoxifen by two others. These results highlight potential problems with the use of cre/ERT2 transgenes in applications that are sensitive to low levels of basal cre expression. However, the germline-recombined mouse transgenic that constitutively overexpresses TPP1 will allow long-term evaluation of overexposure to the enzyme and in cell culture, the inducible transgene may be a useful tool in biomarker discovery projects.	[Nemtsova, Yuliya; Wiseman, Jennifer A.; El-Banna, Mukarram; Lobel, Peter; Sleat, David E.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Lobel, Peter; Sleat, David E.] Rutgers State Univ, Robert Wood Johnson Med Sch, Rutgers Biomed Hlth Sci, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Lobel, P; Sleat, DE (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.; Lobel, P; Sleat, DE (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Rutgers Biomed Hlth Sci, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA.	lobel@cabm.rutgers.edu; sleat@cabm.rutgers.edu		Sleat, David/0000-0002-5159-9928	National Institute of Neurological Disorders and Stroke; National Institutes of Health [R01NS37918]; NIH [R01NS37918];  [P30CA072720]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037918] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by National Institute of Neurological Disorders and Stroke and the National Institutes of Health grant R01NS37918 (P.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Istvan Sohar, Dr. Dieter Saur for generously providing the LSL cassette and Dr. Mantu Bhaumik of the Transgenic and Knockout Mouse Shared Resource of The Cancer Institute of New Jersey (supported by P30CA072720). This project was supported by NIH grant R01NS37918 (P.L.).	Brake Rachael L, 2004, Genet Mol Res, V3, P456; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Cabrera-Salazar MA, 2007, MOL THER, V15, P1782, DOI 10.1038/sj.mt.6300249; FRATANTONI JC, 1968, SCIENCE, V162, P570, DOI 10.1126/science.162.3853.570; Ganat YM, 2006, J NEUROSCI, V26, P8609, DOI 10.1523/JNEUROSCI.2532-06.2006; Geraets RD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176526; Goebel HH, 2011, NEURONAL CEROID LIPO, Vxiv; Kristianto J, 2017, TRANSGENIC RES, V26, P411, DOI 10.1007/s11248-017-0018-1; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; Markham A, 2017, DRUGS, V77, P1247, DOI 10.1007/s40265-017-0771-8; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Seidler B, 2008, P NATL ACAD SCI USA, V105, P10137, DOI 10.1073/pnas.0800487105; Seime T, 2015, DEV GROWTH DIFFER, V57, P10, DOI 10.1111/dgd.12184; Sleat DE, 2008, MOL GENET METAB, V94, P222, DOI 10.1016/j.ymgme.2008.01.014; Sleat DE, 2016, GENE, V593, P284, DOI 10.1016/j.gene.2016.08.031; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Sleat DE, 2004, J NEUROSCI, V24, P9117, DOI 10.1523/JNEUROSCI.2729-04.2004; Sohar I, 2000, CLIN CHEM, V46, P1005; Sondhi D, 2008, EXP NEUROL, V213, P18, DOI 10.1016/j.expneurol.2008.04.022; Wiseman JA, 2017, MOL THER-METH CLIN D, V4, P204, DOI 10.1016/j.omtm.2017.01.004; Xu S, 2011, MOL THER, V19, P1842, DOI 10.1038/mt.2011.130; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118	22	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192286	10.1371/journal.pone.0192286	http://dx.doi.org/10.1371/journal.pone.0192286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408933	gold, Green Submitted, Green Published			2022-12-26	WOS:000424302800054
J	Pal, E; Hadjadj, L; Fontanyi, Z; Monori-Kiss, A; Mezei, Z; Lippai, N; Magyar, A; Heinzlmann, A; Karvaly, G; Monos, E; Nadasy, G; Benyo, Z; Varbiro, S				Pal, Eva; Hadjadj, Leila; Fontanyi, Zoltan; Monori-Kiss, Anna; Mezei, Zsuzsanna; Lippai, Norbert; Magyar, Attila; Heinzlmann, Andrea; Karvaly, Gellert; Monos, Emil; Nadasy, Gyorgy; Benyo, Zoltan; Varbiro, Szabolcs			Vitamin D deficiency causes inward hypertrophic remodeling and alters vascular reactivity of rat cerebral arterioles	PLOS ONE			English	Article							MUSCLE-CELL PROLIFERATION; 25-HYDROXYVITAMIN D; BLOOD-PRESSURE; OXIDATIVE STRESS; NITRIC-OXIDE; RISK-FACTORS; HYPERTENSION; DISEASE; STROKE; ADOLESCENTS	Background and purpose Vitamin D deficiency (VDD) is a global health problem, which can lead to several pathophysiological consequences including cardiovascular diseases. Its impact on the cerebrovascular system is not well understood. The goal of the present work was to examine the effects of VDD on the morphological, biomechanical and functional properties of cerebral arterioles. Methods Four-week-old male Wistar rats (n = 11 per group) were either fed with vitamin D deficient diet or received conventional rat chow with per os vitamin D supplementation. Cardiovascular parameters and hormone levels (testosterone, androstenedione, progesterone and 25-hydroxyvitamin D) were measured during the study. After 8 weeks of treatment anterior cerebral artery segments were prepared and their morphological, biomechanical and functional properties were examined using pressure microangiometry. Resorcin-fuchsin and smooth muscle actin staining were used to detect elastic fiber density and smooth muscle cell counts in the vessel wall, respectively. Sections were immunostained for eNOS and COX-2 as well. Results VDD markedly increased the wall thickness, the wall-to-lumen ratio and the wall cross-sectional area of arterioles as well as the number of smooth muscle cells in the tunica media. As a consequence, tangential wall stress was significantly lower in the VDD group. In addition, VDD increased the myogenic as well as the uridine 5'-triphosphate-induced tone and impaired bradykinin-induced relaxation. Decreased eNOS and increased COX-2 expression were also observed in the endothelium of VDD animals. Conclusions VDD causes inward hypertrophic remodeling due to vascular smooth muscle cell proliferation and enhances the vessel tone probably because of increased vasoconstrictor prostanoid levels in young adult rats. In addition, the decreased eNOS expression results in endothelial dysfunction. These morphological and functional alterations can potentially compromise the cerebral circulation and lead to cerebrovascular disorders in VDD.	[Pal, Eva; Hadjadj, Leila; Monori-Kiss, Anna; Monos, Emil; Benyo, Zoltan] Semmelweis Univ, Inst Clin Expt Res, Budapest, Hungary; [Fontanyi, Zoltan; Varbiro, Szabolcs] Semmelweis Univ, Dept Obstet & Gynecol 2, Budapest, Hungary; [Mezei, Zsuzsanna; Nadasy, Gyorgy] Semmelweis Univ, Dept Physiol, Budapest, Hungary; [Lippai, Norbert] Jasz Nagykun Szolnok Cty Hetenyi Geza Hosp, Dept Pathol, Szolnok, Hungary; [Magyar, Attila; Heinzlmann, Andrea] Semmelweis Univ, Dept Anat Histol & Embryol, Budapest, Hungary; [Karvaly, Gellert] Semmelweis Univ, Dept Lab Med, Budapest, Hungary; [Karvaly, Gellert] Bion Innovat Ctr, Budapest, Hungary	Semmelweis University; Semmelweis University; Semmelweis University; Semmelweis University; Semmelweis University	Pal, E (corresponding author), Semmelweis Univ, Inst Clin Expt Res, Budapest, Hungary.	pal.eva@med.semmelweis-univ.hu		Hadjadj, Leila/0000-0001-6829-8462	Hungarian National Research, Development and Innovation Office [OTKA K-112964, OTKA K-101775, NVKP_16-1-2016-0042, ED_14-1-2014-0002]; Hungarian Society of Hypertension; Faculty of Medicine, Semmelweis University	Hungarian National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Hungarian Society of Hypertension; Faculty of Medicine, Semmelweis University	This study has been supported by the Hungarian National Research, Development and Innovation Office (http://nkfih.gov.hu/; OTKA K-112964, OTKA K-101775 and NVKP_16-1-2016-0042, to ZB; ED_14-1-2014-0002, to GK), the Hungarian Society of Hypertension (http://www.hypertension.hu/; to SzV) and by the Dean of Faculty of Medicine, Semmelweis University (http://semmelweis.hu/english/faculties/medicine/; to SzV and GyN). The funders had no role in study design data collection and analysis, decision to publish,or preparation of the manuscript.	Andersen LB, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001417; Argacha JF, 2011, J CARDIOVASC PHARM, V58, P65, DOI 10.1097/FJC.0b013e31821c832f; Balden R, 2012, ENDOCRINOLOGY, V153, P2420, DOI 10.1210/en.2011-1783; Black LJ, 2016, BRIT J NUTR, V115, P1994, DOI 10.1017/S0007114516001185; Brondum-Jacobsen P, 2013, ANN NEUROL, V73, P38, DOI 10.1002/ana.23738; Canale D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103055; Cardus A, 2006, KIDNEY INT, V69, P1377, DOI 10.1038/sj.ki.5000304; Chen SC, 2010, J STEROID BIOCHEM, V118, P135, DOI 10.1016/j.jsbmb.2009.11.002; Chowdhury R, 2012, EUR J EPIDEMIOL, V27, P581, DOI 10.1007/s10654-012-9729-z; Chung PW, 2015, STROKE, V46, P248, DOI 10.1161/STROKEAHA.114.007706; Del Gobbo LC, 2011, J NUTR, V141, P290, DOI 10.3945/jn.110.129619; Dong JH, 2013, KIDNEY INT, V84, P54, DOI 10.1038/ki.2013.12; Feletou M, 2010, ADV PHARMACOL, V60, P85, DOI [10.1016/S1054-3589(10)60006-3, 10.1016/B978-0-12-385061-4.00004-0]; Gezmish O, 2013, J CARDIOVASC TRANSL, V6, P588, DOI 10.1007/s12265-013-9475-y; Goncalves JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107228; HARDEBO JE, 1987, EUR J PHARMACOL, V144, P343, DOI 10.1016/0014-2999(87)90387-6; Hetthessy JR, 2017, PHLEBOLOGY; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hossein-nezhad A, 2013, MAYO CLIN PROC, V88, P720, DOI 10.1016/j.mayocp.2013.05.011; Husain K, 2010, AM J NEPHROL, V32, P296, DOI 10.1159/000319445; Izzard AS, 2005, J HYPERTENS, V23, P247, DOI 10.1097/00004872-200502000-00002; Kassi E, 2013, CIRCULATION, V128, P2517, DOI 10.1161/CIRCULATIONAHA.113.002654; Kojima G, 2012, STROKE, V43, P2163, DOI 10.1161/STROKEAHA.112.651752; Lacza Z, 2001, BRAIN RES, V896, P169, DOI 10.1016/S0006-8993(01)02083-2; Laursen JB, 2001, CIRCULATION, V103, P1282; Lehoux S, 2006, J INTERN MED, V259, P381, DOI 10.1111/j.1365-2796.2006.01624.x; Li XX, 2017, J NEUROL SCI, V380, P1, DOI 10.1016/j.jns.2017.06.018; Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004; Liu CQ, 2009, BIOCHEM PHARMACOL, V78, P374, DOI 10.1016/j.bcp.2009.04.022; MACCARTHY EP, 1989, HYPERTENSION, V13, P954, DOI 10.1161/01.HYP.13.6.954; Martinez-Miguel P, 2014, AM J PHYSIOL-ENDOC M, V307, pE1085, DOI 10.1152/ajpendo.00156.2014; Masszi G, 2013, LIFE SCI, V93, P133, DOI 10.1016/j.lfs.2013.05.003; Meems LMG, 2016, AM J PHYSIOL-HEART C, V311, pH1459, DOI 10.1152/ajpheart.00141.2016; Mehta V, 2017, CUREUS, V9, DOI 10.7759/cureus.1038; Menezes AR, 2014, CURR OPIN CARDIOL, V29, P571, DOI 10.1097/HCO.0000000000000108; Milazzo V, 2017, WORLD J CARDIOL, V9, P14, DOI 10.4330/wjc.v9.i1.14; Mirhosseini NZ, 2016, BRIT J NUTR, V116, P1889, DOI 10.1017/S0007114516004098; MITSUHASHI T, 1991, J CLIN INVEST, V87, P1889, DOI 10.1172/JCI115213; Molinari C, 2011, CELL PHYSIOL BIOCHEM, V27, P661, DOI 10.1159/000330075; More AS, 2014, J CARDIOVASC PHARM, V64, P209, DOI 10.1097/FJC.0000000000000105; Moretti R, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00169; Mozos I, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/109275; Muhairi SJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-33; Nascimento Fernanda A M, 2012, PLoS One, V7, pe41740, DOI 10.1371/journal.pone.0041740; Norman PE, 2014, CIRC RES, V114, P379, DOI 10.1161/CIRCRESAHA.113.301241; OSOL G, 1985, AM J PHYSIOL, V249, pH914, DOI 10.1152/ajpheart.1985.249.5.H914; Pelham CJ, 2016, J MOL CELL CARDIOL, V98, P1, DOI 10.1016/j.yjmcc.2016.06.067; Poomthavorn P, 2012, INT J OBESITY, V36, P491, DOI 10.1038/ijo.2011.260; Prabhakar P, 2015, J NEUROL SCI, V359, P108, DOI 10.1016/j.jns.2015.10.050; Rafraf M, 2014, PUBLIC HEALTH NUTR, V17, P803, DOI 10.1017/S1368980013003340; Rangan GK, 2013, AM J PHYSIOL-RENAL, V305, pF574, DOI 10.1152/ajprenal.00411.2012; Rizzoni D, 1996, HYPERTENSION, V28, P785, DOI 10.1161/01.HYP.28.5.785; Shi YJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41796; Sierra C, 2011, CURR HYPERTENS REP, V13, P200, DOI 10.1007/s11906-011-0195-x; Somjen D, 2005, CIRCULATION, V111, P1666, DOI 10.1161/01.CIR.0000160353.27927.70; Sun Q, 2012, STROKE, V43, P1470, DOI 10.1161/STROKEAHA.111.636910; Sundersingh F, 2015, BIOCHEM BIOPH RES CO, V461, P589, DOI 10.1016/j.bbrc.2015.04.069; Sung CC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/634195; Tare M, 2011, J PHYSIOL-LONDON, V589, P4777, DOI 10.1113/jphysiol.2011.214726; Turetsky A, 2015, J STROKE CEREBROVASC, V24, P1555, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.051; Wahl M., 1999, Acta Physiologica Hungarica, V86, P155; Wang HM, 2017, AGING DIS, V8, P346, DOI 10.14336/AD.2016.1021; Wu-Wong JR, 2006, ATHEROSCLEROSIS, V186, P20, DOI 10.1016/j.atherosclerosis.2005.06.046; Zittermann A, 2014, ANTICANCER RES, V34, P4641	64	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192480	10.1371/journal.pone.0192480	http://dx.doi.org/10.1371/journal.pone.0192480			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408903	gold, Green Published			2022-12-26	WOS:000424302800070
J	Afify, EAMR; Elsayed, I; Gad, MK; Mohamed, MI; Afify, AMR				Afify, Enas A. M. R.; Elsayed, Ibrahim; Gad, Mary K.; Mohamed, Magdy I.; Afify, Abd El-Moneim M. R.			Enhancement of pharmacokinetic and pharmacological behavior of ocular dorzolamide after factorial optimization of self-assembled nanostructures	PLOS ONE			English	Article							DRUG-DELIVERY; INTERFACIAL-TENSION; NANOPARTICLES; RELEASE; DESIGN; EYE; MEMBRANE; GLAUCOMA; RABBIT; PHOSPHATIDYLCHOLINE	Dorzolamide hydrochloride is frequently administered for the control of the intra-ocular pressure associated with glaucoma. The aim of this study is to develop and optimize self-assembled nanostructures of dorzolamide hydrochloride and L-alpha-Phosphatidylcholine to improve the pharmacokinetic parameters and extend the drug pharmacological action. Self-assembled nanostructures were prepared using a modified thin-film hydration technique. The formulae compositions were designed based on response surface statistical design. The prepared self-assembled nanostructures were characterized by testing their drug content, particle size, polydispersity index, zeta potential, partition coefficient, release half-life and extent. The optimized formulae having the highest drug content, zeta potential, partition coefficient, release half-life and extent with the lowest particle size and polydispersity index were subjected to further investigations including investigation of their physicochemical, morphological characteristics, in vivo pharmacokinetic and pharmacodynamic profiles. The optimized formulae were prepared at pH 8.7 (F5 and F6) and composed of L-alpha-Phosphatidylcholine and drug mixed in a ratio of 1:1 and 2:1 w/w, respectively. They showed significantly higher C-max, AUC(0)(24) and AUC(0)(infinity) at the aqueous humor with extended control over the intra-ocular pressure, when compared to the marketed product; Trusopt (R). The study introduced novel and promising self-assembled formulae able to permeate higher drug amount through the cornea and achieve sustained pharmacological effect at the site of action.	[Afify, Enas A. M. R.; Gad, Mary K.] NODCAR, Giza, Egypt; [Elsayed, Ibrahim; Mohamed, Magdy I.] Cairo Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Cairo, Egypt; [Elsayed, Ibrahim] Gulf Med Univ, Coll Pharm, Dept Pharmaceut Sci, Ajman, U Arab Emirates; [Afify, Abd El-Moneim M. R.] Cairo Univ, Fac Agr, Biochem Dept, Cairo, Egypt	National Organization for Drug Control & Research (NODCAR); Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Afify, AMR (corresponding author), Cairo Univ, Fac Agr, Biochem Dept, Cairo, Egypt.	abdelmoneimafify@yahoo.com		Elsayed, Ibrahim/0000-0001-5724-0724				Alam S, 2016, DRUG DELIV, V23, P601, DOI 10.3109/10717544.2014.923958; Asgharinezhad AA, 2016, J CHROMATOGR A, V1435, P18, DOI 10.1016/j.chroma.2016.01.027; Babazadeh A, 2017, J FUNCT FOODS, V33, P134, DOI 10.1016/j.jff.2017.03.038; Bhuiyan MHU, 2015, PROCEDIA ENGINEER, V105, P431, DOI 10.1016/j.proeng.2015.05.030; de Oliveira GGG, 2017, SAUDI PHARM J, V25, P99, DOI 10.1016/j.jsps.2016.05.001; Dinslage S, 1998, INVEST OPHTH VIS SCI, V39, P2485; Elsayed I, 2014, INT J NANOMED, V9, P2943, DOI 10.2147/IJN.S63395; GRASS GM, 1988, J PHARM SCI-US, V77, P3, DOI 10.1002/jps.2600770103; Habibi N, 2016, NANO TODAY, V11, P41, DOI 10.1016/j.nantod.2016.02.004; Hasan AA, 2014, PHARM DEV TECHNOL, V19, P748, DOI 10.3109/10837450.2013.829095; HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210; Hussain SA, 2017, IRAQI J PHARM SCI, V16, P39; Johannesson G, 2014, ACTA OPHTHALMOL, V92, P550, DOI 10.1111/aos.12334; Johnston MJW, 2006, BBA-BIOMEMBRANES, V1758, P55, DOI 10.1016/j.bbamem.2006.01.009; Khuri AI, 2010, WIRES COMPUT STAT, V2, P128, DOI 10.1002/wics.73; Lee JH, 2010, EXPERT OPIN DRUG DEL, V7, P341, DOI 10.1517/17425240903559841; Lewis RA, 2017, AM J OPHTHALMOL, V175, P137, DOI 10.1016/j.ajo.2016.11.020; Lipka E, 1999, J CONTROL RELEASE, V62, P41, DOI 10.1016/S0168-3659(99)00022-X; Loftsson T, 2012, ACTA OPHTHALMOL, V90, P603, DOI 10.1111/j.1755-3768.2011.02299.x; Mahmoud AA, 2011, INT J PHARMACEUT, V413, P229, DOI 10.1016/j.ijpharm.2011.04.031; Marques MRC, 2011, DISSOLUT TECHNOL, V18, P15, DOI 10.14227/DT180311P15; Mohamed AMI, 2014, TALANTA, V130, P495, DOI 10.1016/j.talanta.2014.06.074; Mourabet M, 2017, ARAB J CHEM, V10, pS3292, DOI 10.1016/j.arabjc.2013.12.028; Nguyen MA, 2017, EUR J PHARM SCI, V102, P1, DOI 10.1016/j.ejps.2017.02.029; Othman R, 2016, LANGMUIR, V32, P10685, DOI 10.1021/acs.langmuir.6b03178; Panda JJ, 2014, POLYM CHEM-UK, V5, P4418, DOI 10.1039/c4py00173g; Pandita A., 2013, ISRN PHARM, V2013, P10, DOI DOI 10.1155/2013/348186; Park CG, 2017, INT J PHARMACEUT, V522, P66, DOI 10.1016/j.ijpharm.2017.02.035; Petelska AD, 2002, BBA-BIOMEMBRANES, V1561, P135, DOI 10.1016/S0005-2736(01)00463-1; Petelska AD, 2000, BIOPHYS J, V78, P812, DOI 10.1016/S0006-3495(00)76638-0; Quaranta L, 2016, ADV THER, V33, P1305, DOI 10.1007/s12325-016-0358-x; Sanchez-Lopez E, 2017, EUR J PHARM BIOPHARM, V110, P70, DOI 10.1016/j.ejpb.2016.10.009; SCHOENWALD RD, 1978, J PHARM SCI-US, V67, P786, DOI 10.1002/jps.2600670614; Scozzatava A, 2014, GLAUCOMA APPL CARBON, P349; Semalty A, 2012, J INCL PHENOM MACRO, V73, P377, DOI 10.1007/s10847-011-0074-8; Semalty A, 2010, J INCL PHENOM MACRO, V67, P253, DOI 10.1007/s10847-009-9705-8; Semalty A, 2009, ACTA PHARMACEUT, V59, P335, DOI 10.2478/v10007-009-0023-x; Sharma N, 2016, ASIAN J PHARM SCI, V11, P404, DOI 10.1016/j.ajps.2015.09.004; Sigurdsson HH, 2005, J CONTROL RELEASE, V102, P255, DOI 10.1016/j.jconrel.2004.10.004; Stone Jordan S, 2015, N C Med J, V76, P211, DOI 10.18043/ncm.76.4.211; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Tita D, 2013, J THERM ANAL CALORIM, V112, P407, DOI 10.1007/s10973-013-2937-2; Tiwari M, 2017, ADV SCI LETT, V23, P1792, DOI 10.1166/asl.2017.8536; Toropainen E, 2003, EUR J PHARM SCI, V20, P99, DOI 10.1016/S0928-0987(03)00173-8; WANG W, 1991, CURR EYE RES, V10, P571, DOI 10.3109/02713689109001766; Zhang HM, 2015, SCI REP-UK, V5, DOI 10.1038/srep10099; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007; ZHU MD, 1992, AUST NZ J OPHTHALMOL, V20, P225, DOI 10.1111/j.1442-9071.1992.tb00944.x	48	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191415	10.1371/journal.pone.0191415	http://dx.doi.org/10.1371/journal.pone.0191415			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401498	Green Published, Green Submitted, gold			2022-12-26	WOS:000424101400011
J	Chen, CH; Chang, CK; Tu, CY; Liao, WC; Wu, BR; Chou, KT; Chiou, YR; Yang, SN; Zhang, G; Huang, TC				Chen, Chia-Hung; Chang, Chih-Kun; Tu, Chih-Yen; Liao, Wei-Chih; Wu, Bing-Ru; Chou, Kuei-Ting; Chiou, Yu-Rou; Yang, Shih-Neng; Zhang, Geoffrey; Huang, Tzung-Chi			Radiomic features analysis in computed tomography images of lung nodule classification	PLOS ONE			English	Article							PULMONARY NODULES; RESPONSE EVALUATION; TEXTURAL FEATURES; TUMOR RESPONSE; CANCER; CT; MANAGEMENT; DIAGNOSIS; SIZE	Purpose Radiomics, which extract large amount of quantification image features from diagnostic medical images had been widely used for prognostication, treatment response prediction and cancer detection. The treatment options for lung nodules depend on their diagnosis, benign or malignant. Conventionally, lung nodule diagnosis is based on invasive biopsy. Recently, radiomics features, a non-invasive method based on clinical images, have shown high potential in lesion classification, treatment outcome prediction. Methods Lung nodule classification using radiomics based on Computed Tomography (CT) image data was investigated and a 4-feature signature was introduced for lung nodule classification. Retrospectively, 72 patients with 75 pulmonary nodules were collected. Radiomics feature extraction was performed on non-enhanced CT images with contours which were delineated by an experienced radiation oncologist. Result Among the 750 image features in each case, 76 features were found to have significant differences between benign and malignant lesions. A radiomics signature was composed of the best 4 features which included Laws_LSL_min, Laws_SLL_energy, Laws_SSL_skewness and Laws_EEL_uniformity. The accuracy using the signature in benign or malignant classification was 84% with the sensitivity of 92.85% and the specificity of 72.73%. Conclusion The classification signature based on radiomics features demonstrated very good accuracy and high potential in clinical application.	[Chen, Chia-Hung; Tu, Chih-Yen; Liao, Wei-Chih; Wu, Bing-Ru] China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan; [Chang, Chih-Kun] Chang Bing Show Chwan Mem Hosp, Dept Med Imaging, Changhua, Taiwan; [Chou, Kuei-Ting; Yang, Shih-Neng; Huang, Tzung-Chi] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Chiou, Yu-Rou; Yang, Shih-Neng; Huang, Tzung-Chi] China Med Univ Hosp, Artificial Intelligence Ctr Med Diag, Taichung, Taiwan; [Zhang, Geoffrey] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, 12902 USF Magnolia Dr, Tampa, FL USA; [Huang, Tzung-Chi] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Bing Show Chwan Memorial Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Asia University Taiwan	Huang, TC (corresponding author), China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.; Huang, TC (corresponding author), China Med Univ Hosp, Artificial Intelligence Ctr Med Diag, Taichung, Taiwan.; Huang, TC (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.	tzungchi.huang@mail.cmu.edu.tw			Ministry of Science and Technology, Taiwan [MOST 106-2221-E-039-007]; Chang Bing Show Chwan Memorial Hospital [RD106070]; China Medical University Hospital [DMR-107-058]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Bing Show Chwan Memorial Hospital; China Medical University Hospital	This study was financially supported by Ministry of Science and Technology, Taiwan (MOST 106-2221-E-039-007; URLs: https://www.most.gov.tw/), Chang Bing Show Chwan Memorial Hospital (RD106070; URLs: https://patientsbeyondborders.com/hospital), and China Medical University Hospital (DMR-107-058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Birchard KR, 2009, CANCER-AM CANCER SOC, V115, P581, DOI 10.1002/cncr.24060; Brabender J, 2001, CLIN CANCER RES, V7, P1850; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Buckler AJ, 2011, RADIOLOGY, V258, P906, DOI 10.1148/radiol.10100799; Cebulla J, 2015, BRIT J CANCER, V112, P504, DOI 10.1038/bjc.2014.628; Cook GJR, 2014, CLIN TRANSL IMAGING, V2, P269, DOI 10.1007/s40336-014-0064-0; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; El-Baz A., 2011, LUNG IMAGING COMPUTE; Fass L, 2008, MOL ONCOL, V2, P115, DOI 10.1016/j.molonc.2008.04.001; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; He L, 2016, SCI REPORTS, V6; Kim H, 2015, INVEST RADIOL, V50, P571, DOI 10.1097/RLI.0000000000000152; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Kurland BF, 2012, MAGN RESON IMAGING, V30, P1301, DOI 10.1016/j.mri.2012.06.009; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Laws KI, 1980, TEXTURED IMAGE SEGME; Li F, 2004, RADIOLOGY, V233, P793, DOI 10.1148/radiol.2333031018; Liang M., 2012, 3D COOCCURRENCE MATR; McNitt-Gray MF, 1999, COMPUT MED IMAG GRAP, V23, P339, DOI 10.1016/S0895-6111(99)00033-6; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Oberije C, 2014, RADIOTHER ONCOL, V112, P37, DOI 10.1016/j.radonc.2014.04.012; Oliver JA, 2015, TRANSL ONCOL, V8, P524, DOI 10.1016/j.tranon.2015.11.013; Parmar C, 2015, SCI REP, P5; Parmar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102107; Shafiq-ul-Hassan M, 2017, MED PHYS, V44, P1050, DOI 10.1002/mp.12123; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Vaidya M, 2012, RADIOTHER ONCOL, V102, P239, DOI 10.1016/j.radonc.2011.10.014; Veronesi G, 2012, ANN INTERN MED, V157, P776, DOI 10.7326/0003-4819-157-11-201212040-00005; Zhao BS, 2010, CLIN CANCER RES, V16, P4647, DOI 10.1158/1078-0432.CCR-10-0125	35	87	94	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192002	10.1371/journal.pone.0192002	http://dx.doi.org/10.1371/journal.pone.0192002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401463	Green Published, Green Submitted, gold			2022-12-26	WOS:000424101400030
J	Saini, A; Rullman, E; Lilja, M; Mandic, M; Melin, M; Olsson, K; Gustafsson, T				Saini, Amarjit; Rullman, Eric; Lilja, Mats; Mandic, Mirko; Melin, Michael; Olsson, Karl; Gustafsson, Thomas			Asymmetric cellular responses in primary human myoblasts using sera of different origin and specification	PLOS ONE			English	Article							SKELETAL-MUSCLE; CELLS; EXPRESSION; CULTURE; INHIBITORS; MECHANISM; SURVIVAL; MYOTUBES; ASSAY	For successful growth and maintenance of primary myogenic cells in vitro, culture medium and addition of sera are the most important factors. At present it is not established as to what extent sera of different origin and composition, supplemented in media or serum-free media conditions influence myoblast function and responses to different stimuli. By assessing markers of proliferation, differentiation/fusion, quiescence, apoptosis and protein synthesis the aim of the current study was to elucidate how primary human myoblasts and myotubes are modulated by different commonly used serum using FCS (foetal calf serum), (CS-FCS charcoal-stripped FCS, a manufacturing process to remove hormones and growth factors from sera), HS (horse serum) as well as in serum free conditions (DMEM). To characterise the biological impact of the different serum, myoblasts were stimulated with Insulin (100 nM) and Vitamin D (100 nM; 1 alpha, 25(OH)(2)D-3, 1 alpha, 25-Dihydroxycholecalciferol, Calcitriol), two factors with characterised effects on promoting fusion and protein synthesis or quiescence, respectively in human myoblasts/myotubes. We demonstrate that sera of different origin/formulation differentially affect myoblast proliferation and myotube protein synthesis. Importantly, we showed that quantifying the extent to which Insulin effects myoblasts in vitro is highly dependent upon serum addition and which type is present in the media. Upregulation of mRNA markers for myogenic fusion, Myogenin, with Insulin stimulation, relative to DMEM, appeared dampened at varying degrees with serum addition and effects on p70S6K phosphorylation as a marker of protein synthesis could not be identified unless serum was removed from media. We propose that these asymmetric molecular and biochemical responses in human myoblasts reflect the variable composition of mitogenic and anabolic factors in each of the sera. The results have implications for both the reproducibility and interpretation of results from experimental models in myoblast cells/myotubes.	[Saini, Amarjit; Rullman, Eric; Lilja, Mats; Mandic, Mirko; Melin, Michael; Olsson, Karl; Gustafsson, Thomas] Karolinska Univ, Hosp Huddinge, Karolinska Inst, Div Clin Physiol,Dept Lab Med, Stockholm, Sweden; [Rullman, Eric; Melin, Michael] Karolinska Univ, Hosp Huddinge, Karolinska Inst, Cardiovasc Theme, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Saini, A (corresponding author), Karolinska Univ, Hosp Huddinge, Karolinska Inst, Div Clin Physiol,Dept Lab Med, Stockholm, Sweden.	amarjit.saini@ki.se	Gustafsson, Thomas/AAH-1056-2019	Gustafsson, Thomas/0000-0002-1559-4206; Lilja, Mats/0000-0003-3473-7265; Mandic, Mirko/0000-0002-7414-482X				Baker M, 2016, NATURE, V537, P433, DOI 10.1038/537433a; Baudy AR, 2009, INT IMMUNOPHARMACOL, V9, P1209, DOI 10.1016/j.intimp.2009.07.001; BERGSTROM J, 1962, SCAND J CLIN LAB INV, V14, P1; BJARE U, 1992, PHARMACOL THERAPEUT, V53, P355, DOI 10.1016/0163-7258(92)90056-6; BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623; Cho YS, 2009, ANAL BIOCHEM, V392, P110, DOI 10.1016/j.ab.2009.04.038; Cui ZY, 2009, PROTEOMICS, V9, P1274, DOI 10.1002/pmic.200800354; Gran Petra, 2011, BMC Physiology, V11, P10, DOI 10.1186/1472-6793-11-10; Gstraunthaler G, 2003, ALTEX-ALTERN TIEREXP, V20, P275; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Lawson MA, 2000, CELLS TISSUES ORGANS, V167, P130, DOI 10.1159/000016776; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; MANTON KG, 1995, NEW ENGL J MED, V333, P1232, DOI 10.1056/NEJM199511023331824; Martin NRW, 2013, BIOMATERIALS, V34, P5759, DOI 10.1016/j.biomaterials.2013.04.002; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; Middelbeek RJW, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.13; Olsson K, 2016, ENDOCRINOLOGY, V157, P98, DOI 10.1210/en.2015-1685; Owens J, 2013, IN VITRO CELL DEV-AN, V49, P695, DOI 10.1007/s11626-013-9655-8; Park YG, 2006, YONSEI MED J, V47, P179, DOI 10.3349/ymj.2006.47.2.179; PRICE PJ, 1982, IN VITRO CELL DEV B, V18, P576; Saini A, 2008, GROWTH FACTORS, V26, P239, DOI 10.1080/08977190802291634; Saini A, 2017, BIOGERONTOLOGY, V18, P109, DOI 10.1007/s10522-016-9667-3; Saini A, 2010, CELL PHYSIOL BIOCHEM, V25, P253, DOI 10.1159/000276559; Sterrenburg E, 2004, NEUROMUSCULAR DISORD, V14, P507, DOI 10.1016/j.nmd.2004.03.008; Sultan KR, 2006, AM J PHYSIOL-CELL PH, V290, pC650, DOI 10.1152/ajpcell.00163.2005; World Health Organization, 2012, GOOD HLTH ADDS LIF Y; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	27	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192384	10.1371/journal.pone.0192384	http://dx.doi.org/10.1371/journal.pone.0192384			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401478	Green Submitted, Green Published, gold			2022-12-26	WOS:000424101400057
J	Li, L; Kubasova, T; Rychlik, I; Hoerr, FJ; Rautenschlein, S				Li, Li; Kubasova, Tereza; Rychlik, Ivan; Hoerr, Frederic J.; Rautenschlein, Silke			Infectious bursal disease virus infection leads to changes in the gut associated-lymphoid tissue and the microbiota composition	PLOS ONE			English	Article							PATHOGEN-FREE CHICKENS; GOBLET CELLS; T-CELLS; IMMUNE-RESPONSES; MUCOSAL; LYMPHOCYTES; IMBALANCES; MODULATION; VACCINE; SYSTEM	Infectious bursal disease (IBD) is an acute, highly contagious and immunosuppressive poultry disease. IBD virus (IBDV) is the causative agent, which may lead to high morbidity and mortality rates in susceptible birds. IBDV-pathogenesis studies have focused mainly on primary lymphoid organs. It is not known if IBDV infection may modify the development of the gut associated lymphoid tissues (GALT) as well as the microbiota composition. The aim of the present study was to investigate the effects of IBDV-infection on the bursa of Fabricius (BF), caecal tonsils (CT) and caecum, and to determine the effects on the gut microbiota composition in the caecum. Commercial broiler chickens were inoculated with a very virulent (vv) strain of IBDV at 14 (Experiment 2) or 15 (Experiment 1) days post hatch (dph). Virus replication, lesion development, immune parameters including numbers of T and B lymphocytes, macrophages, as well as the gut microbiota composition were compared between groups. Rapid IBDV-replication was detected in the BF, CT and caecum. It was accompanied by histological lesions including an infiltration of heterophils. In addition a significant reduction in the total mucosal thickness of the caecum was observed in vvIBDV-infected birds compared to virus-free controls (P < 0.05). vvIBDV infection also led to an increase in T lymphocyte numbers and macrophages, as well as a decrease in the number of B lymphocytes in the lamina propria of the caecum, and in the caecal tonsils. Illumina sequencing analysis indicated that vvIBDV infection also induced changes in the abundance of Clostridium XIVa and Faecalibacterium over time. Overall, our results suggested that vvIBDV infection had a significant impact on the GALT and led to a modulation of gut microbiota composition, which may lead to a higher susceptibility of affected birds for pathogens invading through the gut.	[Li, Li; Rautenschlein, Silke] Univ Vet Med Hannover, Clin Poultry, Hannover, Germany; [Kubasova, Tereza; Rychlik, Ivan] Vet Res Inst, Brno, Czech Republic; [Hoerr, Frederic J.] Vet Diagnost Pathol, Ft Valley, VA USA	University of Veterinary Medicine Hannover, Foundation; Czech Veterinary Research Institute	Rautenschlein, S (corresponding author), Univ Vet Med Hannover, Clin Poultry, Hannover, Germany.	Silke.Rautenschlein@tiho-hannover.de	, Ivan/GPS-9674-2022	, Ivan/0000-0001-7995-6483	Chinese Scholar Council; AdmireVet project from the Czech Ministry of Education [CZ.1.05/2.1.00/01.0006 - ED0006/01/01]	Chinese Scholar Council; AdmireVet project from the Czech Ministry of Education	Li Li was supported by the Chinese Scholar Council and Ivan Rychlik was partially supported by AdmireVet project CZ.1.05/2.1.00/01.0006 - ED0006/01/01 from the Czech Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Veterinary Diagnostic Pathology, LLC provided support in the form of salaries for authors [FH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aricibasi M, 2010, VET IMMUNOL IMMUNOP, V135, P79, DOI 10.1016/j.vetimm.2009.11.005; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bautista DA, 2004, AVIAN DIS, V48, P361, DOI 10.1637/7130; BEFUS AD, 1980, J IMMUNOL, V125, P2626; Block H, 2007, AVIAN PATHOL, V36, P401, DOI 10.1080/03079450701589175; Boshuizen JA, 2005, VIROLOGY, V337, P210, DOI 10.1016/j.virol.2005.03.039; COSGROVE AS, 1962, AVIAN DIS, V6, P385, DOI 10.2307/1587909; De Wit J.J., 1998, POLISH VET J, V3, P19; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Dillon SM, 2014, MUCOSAL IMMUNOL, V7, P983, DOI 10.1038/mi.2013.116; Eterradossi N, 1997, ARCH VIROL, V142, P255, DOI 10.1007/s007050050075; FADLY AM, 1983, AVIAN DIS, V27, P714, DOI 10.2307/1590314; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Han ZF, 2016, DEV COMP IMMUNOL, V62, P58, DOI 10.1016/j.dci.2016.04.020; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Hoerr FJ, 2010, AVIAN DIS, V54, P2, DOI 10.1637/8909-043009-Review.1; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Humphrey S, 2014, MBIO, V5, DOI 10.1128/mBio.01364-14; Ishikawa N, 1997, GASTROENTEROLOGY, V113, P542, DOI 10.1053/gast.1997.v113.pm9247474; Jiang JQ, 2008, J VIROL, V82, P6812, DOI 10.1128/JVI.00450-08; Khan WI, 2008, PARASITOLOGY, V135, P671, DOI 10.1017/S0031182008004381; Kim IJ, 1999, AVIAN DIS, V43, P401, DOI 10.2307/1592637; LEY DH, 1983, AVIAN DIS, V27, P1060, DOI 10.2307/1590207; Liebler-Tenorio EM, 2006, VET RES, V37, P257, DOI 10.1051/vetres:2006001; Lozupone CA, 2013, CELL HOST MICROBE, V14, P329, DOI 10.1016/j.chom.2013.08.006; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; MILLER HRP, 1979, EXP PARASITOL, V47, P81, DOI 10.1016/0014-4894(79)90010-9; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Molloy MJ, 2013, CELL HOST MICROBE, V14, P318, DOI 10.1016/j.chom.2013.08.003; MULLER R, 1979, ZBL VET MED B, V26, P345; NAKAMURA K, 1990, AVIAN PATHOL, V19, P713, DOI 10.1080/03079459008418726; Noujaim JC, 2008, POULTRY SCI, V87, P927, DOI 10.3382/ps.2007-00476; OLAH I, 1979, POULTRY SCI, V58, P195, DOI 10.3382/ps.0580195; Pan D, 2014, GUT MICROBES, V5, P108, DOI 10.4161/gmic.26945; Perumbakkam S, 2014, FEMS MICROBIOL ECOL, V90, P300, DOI 10.1111/1574-6941.12392; Petkov DI, 2009, AVIAN DIS, V53, P347, DOI 10.1637/8456-082208-Reg.1; Polansky O, 2015, APPL ENVIRON MICROB; Qi XL, 2014, VACCINE, V32, P1436, DOI 10.1016/j.vaccine.2014.01.042; Rauf Abdul, 2012, Results Immunol, V2, P112, DOI 10.1016/j.rinim.2012.05.003; Rautenschlein S, 2007, VET IMMUNOL IMMUNOP, V115, P251, DOI 10.1016/j.vetimm.2006.11.002; Rehman ZU, 2016, WORLD POULTRY SCI J, V72, P805, DOI 10.1017/S0043933916000775; Robinson CM, 2014, ANNU REV VIROL, V1, P55, DOI 10.1146/annurev-virology-031413-085550; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Saif YM, 1998, POULTRY SCI, V77, P1186, DOI 10.1093/ps/77.8.1186; Schwarz A, 2011, DEV COMP IMMUNOL, V35, P774, DOI 10.1016/j.dci.2011.02.012; SHARMA JM, 2003, DIS POULTRY, P5; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; SPECIAN RD, 1991, AM J PHYSIOL, V260, pC183, DOI 10.1152/ajpcell.1991.260.2.C183; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Sun Q, 2013, AVIAN PATHOL, V42, P541, DOI 10.1080/03079457.2013.845292; Tanimura N, 1997, AVIAN DIS, V41, P638, DOI 10.2307/1592155; TANIMURA N, 1995, AVIAN DIS, V39, P9, DOI 10.2307/1591976; Thompson G, 1997, AVIAN DIS, V41, P519, DOI 10.2307/1592140; Tippenhauer M, 2013, DEV COMP IMMUNOL, V40, P1, DOI 10.1016/j.dci.2012.10.013; Toro H, 2009, AVIAN DIS, V53, P94, DOI 10.1637/8408-071408-Reg.1; Vindigni SM, 2016, THER ADV GASTROENTER, V9, P606, DOI 10.1177/1756283X16644242; Wang D, 2009, POULTRY SCI, V88, P1623, DOI 10.3382/ps.2009-00124; Wang DC, 2008, VET IMMUNOL IMMUNOP, V124, P19, DOI 10.1016/j.vetimm.2008.01.005; Wang DC, 2009, VET IMMUNOL IMMUNOP, V131, P229, DOI 10.1016/j.vetimm.2009.04.014; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Yegani M, 2008, POULTRY SCI, V87, P2052, DOI 10.3382/ps.2008-00091	65	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192066	10.1371/journal.pone.0192066	http://dx.doi.org/10.1371/journal.pone.0192066			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390031	Green Published, gold, Green Submitted			2022-12-26	WOS:000423793400061
J	Wang, RL; Li, Q; He, SA; Liu, Y; Wang, MT; Jiang, G				Wang, Rulin; Li, Qing; He, Shisong; Liu, Yuan; Wang, Mingtian; Jiang, Gan			Modeling and mapping the current and future distribution of Pseudomonas syringae pv. actinidiae under climate change in China	PLOS ONE			English	Article							BACTERIAL CANKER; SPECIES DISTRIBUTIONS; KIWIFRUIT; EPIDEMICS	Objective Bacterial canker of kiwifruit caused by Pseudomonas syringae pv. actinidiae (Psa) is a major threat to the kiwifruit industry throughout the world and accounts for substantial economic losses in China. The aim of the present study was to test and explore the possibility of using MaxEnt (maximum entropy models) to predict and analyze the future large-scale distribution of Psa in China. Method Based on the current environmental factors, three future climate scenarios, which were suggested by the fifth IPCC report, and the current distribution sites of Psa, MaxEnt combined with ArcGIS was applied to predict the potential suitable areas and the changing trend of Psa in China. The jackknife test and correlation analysis were used to choose dominant climatic factors. The receiver operating characteristic curve (ROC) drawn by MaxEnt was used to evaluate the accuracy of the simulation. Result The results showed that under current climatic conditions, the area from latitude 25 degrees to 36 degrees N and from longitude 101 E to 122 E E is the primary potential suitable area of Psa in China. The highly suitable area (with suitability between 66 and 100) was mainly concentrated in Northeast Sichuan, South Shaanxi, most of Chongqing, West Hubei and Southwest Gansu and occupied 4.94% of land in China. Under different future emission scenarios, both the areas and the centers of the suitable areas all showed differences compared with the current situation. Four climatic variables, i.e., maximum April temperature (19%), mean temperature of the coldest quarter (14%), precipitation in May (11.5%) and minimum temperature in October (10.8%), had the largest impact on the distribution of Psa. Conclusion The MaxEnt model is potentially useful for forecasting the future adaptive distribution of Psa under climate change, and it provides important guidance for comprehensive management.	[Wang, Rulin; Li, Qing] Sichuan Agr Univ, Coll Agron, Chengdu, Sichuan, Peoples R China; [Wang, Rulin; Jiang, Gan] Sichuan Prov Rural Econ Informat Ctr, Chengdu, Sichuan, Peoples R China; [He, Shisong; Liu, Yuan] Kiwifruit Inst Cangxi Country, Cangxi, Sichuan, Peoples R China; [Wang, Mingtian] Sichuan Meteorol Observ, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Li, Q (corresponding author), Sichuan Agr Univ, Coll Agron, Chengdu, Sichuan, Peoples R China.	liq8633@163.com	WANG, Rulin/AAE-6849-2019	Wang, Rulin/0000-0002-1431-0769	modern agricultural industry technology system of Sichuan innovation team; project of meteorological service for agriculture, rural areas and farmers in Sichuan	modern agricultural industry technology system of Sichuan innovation team; project of meteorological service for agriculture, rural areas and farmers in Sichuan	Our work was supported by the modern agricultural industry technology http://www.scnycxtd.com/ system of Sichuan innovation team and the project of meteorological service for agriculture, rural areas and farmers in Sichuan, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelleira A, 2014, PLANT PATHOL, V63, P691, DOI 10.1111/ppa.12125; Andolfi A, 2011, PLANT DIS, V95, P1311; Balestra GM, 1999, ACTA HORTIC, P355, DOI 10.17660/ActaHortic.1999.498.43; Bertrand R, 2012, GLOBAL CHANGE BIOL, V18, P2648, DOI 10.1111/j.1365-2486.2012.02679.x; Biber-Freudenberger L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153237; Bosso L, 2016, BIOL INVASIONS, V18, P1759, DOI 10.1007/s10530-016-1118-1; Bradie J, 2017, J BIOGEOGR, V44, P1344, DOI 10.1111/jbi.12894; Breiner FT, 2015, METHODS ECOL EVOL, V6, P1210, DOI 10.1111/2041-210X.12403; Butler MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057464; Cai Jing-yun, 2014, Jingji Dongwu Xuebao, V18, P47; Cameron A, 2014, PLANT PATHOL, V63, P1, DOI 10.1111/ppa.12066; Cao XR, 2011, PLANT PROTECTION, V37, P80; Choudhury MR, 2016, ECOL ENG, V97, P23, DOI 10.1016/j.ecoleng.2016.07.018; Cunty A, 2015, PLANT PATHOL, V64, P582, DOI 10.1111/ppa.12297; Das T, 2017, SAARC J AGR, V2, P200; David H., 2013, DIVERS DISTRIB, V1, P43; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Elad Y, 2014, J CROP IMPROV, V28, P99, DOI 10.1080/15427528.2014.865412; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fand BB, 2014, J ENVIRON BIOL, V35, P973; Fang Y., 1990, SICHUAN FRUIT SCI TE, V18, P28; Ferrante P, 2015, PLANT PATHOL, V64, P51, DOI 10.1111/ppa.12236; Ferrante P, 2010, PLANT PATHOL, V59, P954, DOI 10.1111/j.1365-3059.2010.02304.x; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Froud KJ, 2017, AUSTRALAS PLANT PATH, V46, P421, DOI 10.1007/s13313-017-0504-1; Gelviz-Gelvez SM, 2015, ECOL ENG, P302; Ghini R, 2012, TROP PLANT PATHOL, V37, P5, DOI 10.1590/S1982-56762012000100002; Ghods S, 2015, APPL ENVIRON MICROB, V81, P4026, DOI 10.1128/AEM.00194-15; Han Yangyang, 2015, Journal of Nanjing Forestry University Natural Sciences Edition, V39, P6; Hannah L, 2017, CLIMATIC CHANGE, P1; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Jiang HJ, 2016, PLOS ONE, V9; Jo WS, 2017, J KOREAN PHYS SOC, V70, P108, DOI 10.3938/jkps.70.108; Kalle R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079295; Kim GH, 2017, PLANT PATHOLOGY J, V33, P351, DOI 10.5423/PPJ.RW.01.2017.0021; Kim GH, 2016, PLANT PATHOLOGY J, V32, P545, DOI 10.5423/PPJ.OA.05.2016.0122; Koh YJ, 2002, MOL CELLS, V13, P309; Krishnan S, 2015, CLIMATIC CHANGE, V131, P259, DOI 10.1007/s10584-015-1385-3; Kumar S, 2016, J ECON ENTOMOL, V5; Leach K, 2016, ECOL MODEL, V337, P96, DOI 10.1016/j.ecolmodel.2016.06.008; Li GQ, 2012, ACTA ECOLOGICAL SINI, V16, P4827; Li M., 2002, J ANHUI AGR SCI, V30, P401; [李淼 Li Miao], 2002, [安徽农业科学, Anhui agricultural sciences], V30, P391; Li YZ, 2000, J NW FORESTRY U, V2, P53; Lopez-Martinez V, 2016, AGR FOREST ENTOMOL, V18, P409, DOI 10.1111/afe.12174; Merow C, 2014, METHODS ECOL EVOL, V5, P215, DOI 10.1111/2041-210X.12152; Moran-Ordonez A, 2017, GLOBAL ECOL BIOGEOGR, V26, P371, DOI 10.1111/geb.12545; Narouei-Khandan HA, 2016, EUR J PLANT PATHOL, V144, P655, DOI 10.1007/s10658-015-0804-7; Ortega-Huerta MA, 2008, REV MEX BIODIVERS, V79, P205; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Penado A, 2016, INSECT CONSERV DIVER, V9, P391, DOI 10.1111/icad.12190; Petersen MJ, 2013, BIOL INVASIONS, V15, P885, DOI 10.1007/s10530-012-0337-3; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Qin Z, 2015, J PLANT RES, V5, P1; QUENOUILLE MH, 1949, J ROY STAT SOC B, V11, P68; Rameshprabu N, 2015, J ENVIRON BIOL, V36, P565; Remya K, 2015, ECOL ENG, V82, P184, DOI 10.1016/j.ecoleng.2015.04.053; Renzi M, 2012, PHYTOPATHOLOGY, V102, P827, DOI 10.1094/PHYTO-02-12-0019-R; Sambaraju KR, 2012, ECOGRAPHY, V35, P211, DOI 10.1111/j.1600-0587.2011.06847.x; Sawada H, 1997, APPL ENVIRON MICROB, V63, P282, DOI 10.1128/AEM.63.1.282-288.1997; Schatz AM, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160975; Scortichini M, 2014, EUR J PLANT PATHOL, V140, P887, DOI 10.1007/s10658-014-0515-5; Serena C, 2015, PLOS ONE, V10, P2018; SERIZAWA S, 1989, Annals of the Phytopathological Society of Japan, V55, P427, DOI 10.3186/jjphytopath.55.427; Serizawa Setsuo, 1993, Annals of the Phytopathological Society of Japan, V59, P460, DOI 10.3186/jjphytopath.59.460; [邵宝林 Shao Baolin], 2016, [植物保护, Plant Protection], V42, P146; Shrestha UB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106405; Sivaraj N, 2016, MAXIMUM ENTROPY MAXE, V1, P16; Sobek-Swant S, 2012, FOREST ECOL MANAG, V281, P23, DOI 10.1016/j.foreco.2012.06.017; Testolin R, 2009, NEW ZEAL J CROP HORT, V37, P1, DOI 10.1080/01140670909510246; Thakur MP, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700866; Tondou R, 2016, J BERRY RES, V4, P1; TUKEY JW, 1958, ANN MATH STAT, V29, P614; Vanneste JL, 2013, PLANT DIS, V97, P708, DOI 10.1094/PDIS-07-12-0700-RE; Vanneste J. L., 2011, New Zealand Plant Protection, V64, P241; Vanneste JL, 2017, ANNU REV PHYTOPATHOL, V55, P377, DOI 10.1146/annurev-phyto-080516-035530; Wang WC, 2016, PLOS ONE, V9; Wilstermann A., 2017, Bulletin OEPP, V47, P255, DOI 10.1111/epp.12385; Worthington TA, 2016, ECOL MODEL, V342, P1, DOI 10.1016/j.ecolmodel.2016.09.016; [徐小彪 Xu Xiaobiao], 2003, [植物学通报, Chinese Bulletin of Botany], V20, P648; Yang XQ, 2013, ECOL ENG, V51, P83, DOI 10.1016/j.ecoleng.2012.12.004; Yi YJ, 2016, ECOL ENG, V92, P260, DOI 10.1016/j.ecoleng.2016.04.010; Yue TX, 2011, ECOL MODEL, V222, P2342, DOI 10.1016/j.ecolmodel.2010.11.026; [曾辉 Zeng Hui], 2008, [植物保护, Plant Protection], V34, P88; [张计育 Zhang Jiyu], 2014, [中国农学通报, Chinese Agricultural Science Bulletin], V30, P48; Zhang LL, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-015-5133-9; Zhang Y, 2013, BIOL DISASTER SCI, V1, P69; [赵文娟 Zhao Wenjuan], 2009, [植物保护, Plant Protection], V35, P32; Zhao ZB, 2015, CROP PROT, V75, P55, DOI 10.1016/j.cropro.2015.05.008; Ziska LH, 2011, CLIMATIC CHANGE, V105, P13, DOI 10.1007/s10584-010-9879-5	93	78	92	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192153	10.1371/journal.pone.0192153	http://dx.doi.org/10.1371/journal.pone.0192153			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389964	Green Submitted, gold, Green Published			2022-12-26	WOS:000423793400073
J	Barberia, I; Tubau, E; Matute, H; Rodriguez-Ferreiro, J				Barberia, Itxaso; Tubau, Elisabet; Matute, Helena; Rodriguez-Ferreiro, Javier			A short educational intervention diminishes causal illusions and specific paranormal beliefs in undergraduates	PLOS ONE			English	Article							CONTINGENCY JUDGMENTS; BINARY VARIABLES; DECISION-MAKING; COGNITIVE BIAS; ERRORS; SELF; PSEUDOSCIENCE; COVARIATION; PERCEPTIONS; STRATEGIES	Cognitive biases such as causal illusions have been related to paranormal and pseudoscientific beliefs and, thus, pose a real threat to the development of adequate critical thinking abilities. We aimed to reduce causal illusions in undergraduates by means of an educational intervention combining training-in-bias and training-in-rules techniques. First, participants directly experienced situations that tend to induce the Barnum effect and the confirmation bias. Thereafter, these effects were explained and examples of their influence over everyday life were provided. Compared to a control group, participants who received the intervention showed diminished causal illusions in a contingency learning task and a decrease in the precognition dimension of a paranormal belief scale. Overall, results suggest that evidence-based educational interventions like the one presented here could be used to significantly improve critical thinking skills in our students.	[Barberia, Itxaso; Tubau, Elisabet; Rodriguez-Ferreiro, Javier] Univ Barcelona, Dept Cognicio Desenvolupament & Psicol Educ, Barcelona, Spain; [Tubau, Elisabet; Rodriguez-Ferreiro, Javier] Univ Barcelona, Inst Neurociencies, Barcelona, Spain; [Matute, Helena] Univ Deusto, Dept Fundamentos & Metodos Psicol, Bilbao, Spain	University of Barcelona; University of Barcelona; University of Deusto	Rodriguez-Ferreiro, J (corresponding author), Univ Barcelona, Dept Cognicio Desenvolupament & Psicol Educ, Barcelona, Spain.; Rodriguez-Ferreiro, J (corresponding author), Univ Barcelona, Inst Neurociencies, Barcelona, Spain.	rodriguezferreiro@ub.edu	Rodríguez-Ferreiro, Javier/B-5232-2011; BARBERIA, ITXASO/L-8477-2014; Matute, Helena/A-8256-2011	Rodríguez-Ferreiro, Javier/0000-0001-9828-8302; BARBERIA, ITXASO/0000-0003-3045-2289; Matute, Helena/0000-0001-7221-1366	Agencia Estatal de Investigacion of the Spanish government [PSI2016-75776-R]; European Regional Development Fund; Programa de Millora i Innovacio Docent, PMID, Universitat de Barcelona [2015PID-UB/030]	Agencia Estatal de Investigacion of the Spanish government; European Regional Development Fund(European Commission); Programa de Millora i Innovacio Docent, PMID, Universitat de Barcelona	This study was supported by the grant PSI2016-75776-R (AEI/FEDER, UE) from Agencia Estatal de Investigacion of the Spanish government and the European Regional Development Fund to IB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was performed in the context of the teaching project 2015PID-UB/030 (Programa de Millora i Innovacio Docent, PMID, Universitat de Barcelona).	ALLAN LG, 1983, LEARN MOTIV, V14, P381, DOI 10.1016/0023-9690(83)90024-3; Allan LG, 2005, LEARN BEHAV, V33, P250; ALLAN LG, 1980, B PSYCHONOMIC SOC, V15, P147; ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441; Alter AL, 2007, J EXP PSYCHOL GEN, V136, P569, DOI 10.1037/0096-3445.136.4.569; ARKES HR, 1991, PSYCHOL BULL, V110, P486, DOI 10.1037/0033-2909.110.3.486; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Barberia I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071303; Blanco F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131378; Blanco F, 2013, LEARN BEHAV, V41, P333, DOI 10.3758/s13420-013-0108-8; Blanco F, 2011, Q J EXP PSYCHOL, V64, P1290, DOI 10.1080/17470218.2011.552727; Broockman D, 2016, SCIENCE, V352, P220, DOI 10.1126/science.aad9713; Brooks S, 2011, CLIN PSYCHOL REV, V31, P37, DOI 10.1016/j.cpr.2010.09.006; Buehner MJ, 2003, J EXP PSYCHOL LEARN, V29, P1119, DOI 10.1037/0278-7393.29.6.1119; Costa A, 2014, COGNITION, V130, P236, DOI 10.1016/j.cognition.2013.11.010; Croskerry P, 2013, NEW ENGL J MED, V368, P2445, DOI 10.1056/NEJMp1303712; De Raedt R, 2010, COGN AFFECT BEHAV NE, V10, P50, DOI 10.3758/CABN.10.1.50; Diaz-Vilela L, 2004, J PARAPSYCHOL, V68, P405; DICKSON DH, 1985, PSYCHOL REP, V57, P367, DOI 10.2466/pr0.1985.57.2.367; FORER BR, 1949, J ABNORM SOC PSYCH, V44, P118, DOI 10.1037/h0059240; Gaweda L, 2015, PSYCHIAT RES, V225, P50, DOI 10.1016/j.psychres.2014.10.006; HAMILTON DL, 1976, J EXP SOC PSYCHOL, V12, P392, DOI 10.1016/S0022-1031(76)80006-6; Hannah SD, 2009, CAN J EXP PSYCHOL, V63, P59, DOI 10.1037/a0013403; HARKNESS AR, 1985, J PERS SOC PSYCHOL, V49, P22, DOI 10.1037/0022-3514.49.1.22; Impey C, 2012, ASTRON ED REV, V11; JASP Team, 2017, JASP VERS 0 8 3 1; Keysar B, 2012, PSYCHOL SCI, V23, P661, DOI 10.1177/0956797611432178; KLAYMAN J, 1987, PSYCHOL REV, V94, P211, DOI 10.1037/0033-295X.94.2.211; Larrick R., 2004, BLACKWELL HDB JUDGME; Lilienfeld SO, 2014, PERSPECT PSYCHOL SCI, V9, P355, DOI 10.1177/1745691614535216; Lilienfeld SO, 2009, PERSPECT PSYCHOL SCI, V4, P390, DOI 10.1111/j.1745-6924.2009.01144.x; Lindeman M, 1998, SCAND J PSYCHOL, V39, P257, DOI 10.1111/1467-9450.00085; Matute H, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00888; Matute H, 2011, BRIT J PSYCHOL, V102, P392, DOI 10.1348/000712610X532210; Mellers B, 2014, PSYCHOL SCI, V25, P1106, DOI 10.1177/0956797614524255; Msetfi RM, 2005, J EXP PSYCHOL GEN, V134, P10, DOI 10.1037/0096-3445.134.1.10; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Perales JC, 2005, J EXP PSYCHOL LEARN, V31, P1105, DOI 10.1037/0278-7393.31.5.1105; Phillips N., 2017, YARRR COMPANION E BO; Phua DH, 2013, ANN ACAD MED SINGAP, V42, P33; Pronin E, 2004, PSYCHOL REV, V111, P781, DOI 10.1037/0033-295X.111.3.781; Pronin E, 2002, PERS SOC PSYCHOL B, V28, P369, DOI 10.1177/0146167202286008; R Development Core Team, 2017, R LANG ENV STAT COMP; ROTTON J, 1985, PSYCHOL BULL, V97, P286, DOI 10.1037/0033-2909.97.2.286; Schmaltz R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00336; Smedslund G, 2011, EUR J PAIN, V15, P5, DOI 10.1016/j.ejpain.2010.05.003; SNYDER CR, 1977, J CONSULT CLIN PSYCH, V45, P104, DOI 10.1037/0022-006X.45.1.104; Song HJ, 2008, SOC COGNITION, V26, P791, DOI 10.1521/soco.2008.26.6.791; SWANN WB, 1989, J PERS SOC PSYCHOL, V57, P782, DOI 10.1037/0022-3514.57.5.782; TOBACYK J, 1983, J PERS SOC PSYCHOL, V44, P1029, DOI 10.1037/0022-3514.44.5.1029; Tobacyk Jerome., 2004, INT J TRANSPERSONAL, V23, P94, DOI [DOI 10.24972/IJTS.2004.23.1.94, DOI 10.1037/T14015-000]; Wagenmakers E-J, 2017, PSYCHON B REV; WASON PC, 1960, Q J EXP PSYCHOL, V12, P129, DOI 10.1080/17470216008416717; Wasserman EA, 1996, PSYCHOL LEARN MOTIV, V34, P207, DOI 10.1016/S0079-7421(08)60562-9; White House Commission on Complementary and Alternative Medicine Policy, 2002, WHITE HOUSE COMMISSI	55	15	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191907	10.1371/journal.pone.0191907	http://dx.doi.org/10.1371/journal.pone.0191907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU2GT	29385184	Green Published, gold, Green Submitted			2022-12-26	WOS:000423668400060
J	Cannizzo, CM; Adonopulos, AA; Solly, EL; Ridiandries, A; Vanags, LZ; Mulangala, J; Yuen, SCG; Tsatralis, T; Henriquez, R; Robertson, S; Nicholls, SJ; Di Bartolo, BA; Ng, MKC; Lam, YT; Bursill, CA; Tan, JTM				Cannizzo, Carla M.; Adonopulos, Aaron A.; Solly, Emma L.; Ridiandries, Anisyah; Vanags, Laura Z.; Mulangala, Jocelyne; Yuen, Sui Ching G.; Tsatralis, Tania; Henriquez, Rodney; Robertson, Stacy; Nicholls, Stephen J.; Di Bartolo, Belinda A.; Ng, Martin K. C.; Lam, Yuen Ting; Bursill, Christina A.; Tan, Joanne T. M.			VEGFR2 is activated by high-density lipoproteins and plays a key role in the proangiogenic action of HDL in ischemia	FASEB JOURNAL			English	Article						angiogenesis; hypoxia; apoA-I	ENDOTHELIAL GROWTH-FACTOR; CORONARY HEART-DISEASE; B TYPE-I; PROGENITOR CELLS; INDUCED ANGIOGENESIS; SIGNAL PATHWAY; PROTEIN-KINASE; HYPOXIA; CHOLESTEROL; RECRUITMENT	High-density lipoproteins augment hypoxia-induced angiogenesis by inducing the key angiogenic vascular endothelial growth factor A (VEGFA) and total protein levels of its receptor 2 (VEGFR2). The activation/phosphorylation of VEGFR2 is critical for mediating downstream, angiogenic signaling events. This study aimed to determine whether reconstituted high-density lipoprotein (rHDL) activates VEGFR2 phosphorylation and the downstream signaling events and the importance of VEGFR2 in the proangiogenic effects of rHDL in hypoxia. In vitro, rHDL increased VEGFR2 activation and enhanced phosphorylation of downstream, angiogenic signaling proteins ERK1/2 and p38 MAPK in hypoxia. Incubation with a VEGFR2-neutralizing antibody attenuated rHDL-induced phosphorylation of VEGFR2, ERK1/2, p38 MAPK, and tubule formation. In a murine model of ischemia-driven neovascularization, rHDL infusions enhanced blood perfusion and augmented capillary and arteriolar density. Infusion of a VEGFR2-neutralizing antibody ablated those proangiogenic effects of rHDL. Circulating Sca1(+)/CXCR4(+) angiogenic progenitor cell levels, important for neovascularization in response to ischemia, were higher in rHDL-infused mice 3 d after ischemic induction, but that did not occur in mice that also received the VEGFR2-neutralizing antibody. In summary, VEGFR2 has a key role in the proangiogenic effects of rHDL in hypoxia/ischemia. These findings have therapeutic implications for angiogenic diseases associated with an impaired response to tissue ischemia.	[Cannizzo, Carla M.; Adonopulos, Aaron A.; Ridiandries, Anisyah; Vanags, Laura Z.; Yuen, Sui Ching G.; Tsatralis, Tania; Henriquez, Rodney; Robertson, Stacy; Ng, Martin K. C.; Lam, Yuen Ting; Bursill, Christina A.; Tan, Joanne T. M.] Heart Res Inst, Newtown, NSW, Australia; [Cannizzo, Carla M.; Adonopulos, Aaron A.; Ridiandries, Anisyah; Vanags, Laura Z.; Yuen, Sui Ching G.; Robertson, Stacy; Ng, Martin K. C.; Lam, Yuen Ting; Bursill, Christina A.; Tan, Joanne T. M.] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia; [Solly, Emma L.; Mulangala, Jocelyne; Nicholls, Stephen J.; Di Bartolo, Belinda A.; Bursill, Christina A.; Tan, Joanne T. M.] South Australian Hlth & Med Res Inst, Heart Hlth Theme, North Terrace, Adelaide, SA 5000, Australia; [Mulangala, Jocelyne; Nicholls, Stephen J.; Di Bartolo, Belinda A.; Bursill, Christina A.; Tan, Joanne T. M.] Univ Adelaide, Fac Hlth & Med Sci, Adelaide Med Sch, Adelaide, SA, Australia; [Ng, Martin K. C.] Royal Prince Alfred Hosp, Dept Cardiol, Camperdown, NSW, Australia	University of Sydney; Heart Research Institute; University of Sydney; South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; University of Sydney	Bursill, CA; Tan, JTM (corresponding author), South Australian Hlth & Med Res Inst, Heart Hlth Theme, North Terrace, Adelaide, SA 5000, Australia.	christina.bursill@sahmri.com; joanne.tan@sahmri.com	Di Bartolo, Belinda/AAF-5153-2021; Ridiandries, Anisyah/I-4360-2017; Tan, Joanne Tsui Ming/Y-4423-2019; Tan, Ming-Jen/A-3862-2011	Ridiandries, Anisyah/0000-0001-8996-6896; Tan, Joanne Tsui Ming/0000-0003-1875-4882; Henriquez, Rodney/0000-0002-2959-2260; Tan, Ming-Jen/0000-0002-3583-1723; Bursill, Christina/0000-0002-0682-8760; Nicholls, Stephen/0000-0002-9668-4368; Di Bartolo, Belinda/0000-0001-8420-0461	National Health and Medical Research Council of Australia [632512, APP1038394]; National Heart Foundation Career Development Fellowship [CR07S3331, PB12S6959]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation Career Development Fellowship(National Heart Foundation of Australia)	The authors thank Pat Pisansarakit from the Heart Research Institute (Newtown, NSW, Australia) for the maintenance of HCAECs. This work was supported by the National Health and Medical Research Council of Australia (Project Grant 632512 to M.K.C.N. and C.A.B.), and P.h.D. Scholarship (Grant APP1038394 to S.C.G.Y.); the National Heart Foundation Career Development Fellowship (Grant CR07S3331 to C.A.B.), and Ph.D. Scholarship (Grant PB12S6959 to L.Z.V.). The authors declare no conflicts of interest.	Al-Jarallah A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106487; Bocci G, 2004, CANCER RES, V64, P6616, DOI 10.1158/0008-5472.CAN-04-0401; CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; DAVIES MJ, 1993, BRIT HEART J, V69, P377; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Drew BG, 2004, P NATL ACAD SCI USA, V101, P6999, DOI 10.1073/pnas.0306266101; Endo A, 2003, J RECEPT SIG TRANSD, V23, P239, DOI 10.1081/RRS-120025567; Fang LH, 2013, NATURE, V498, P118, DOI 10.1038/nature12166; Felton-Edkins ZA, 2003, EMBO J, V22, P2422, DOI 10.1093/emboj/cdg240; Feng Y, 2008, ARTERIOSCL THROM VAS, V28, P278, DOI 10.1161/ATVBAHA.107.158741; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Ivy SP, 2009, NAT REV CLIN ONCOL, V6, P569, DOI 10.1038/nrclinonc.2009.130; Kimura T, 2010, J BIOL CHEM, V285, P4387, DOI 10.1074/jbc.M109.043869; Lam YT, 2016, ENDOCRINOLOGY, V157, P4853, DOI 10.1210/en.2016-1301; Lee RT, 1997, ARTERIOSCL THROM VAS, V17, P1859, DOI 10.1161/01.ATV.17.10.1859; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Li WL, 2011, EXP BRAIN RES, V214, P503, DOI 10.1007/s00221-011-2849-y; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Olszewska-Pazdrak B, 2009, AM J PHYSIOL-CELL PH, V296, pC1162, DOI 10.1152/ajpcell.00533.2008; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Petoumenos V, 2009, J CELL MOL MED, V13, P4623, DOI 10.1111/j.1582-4934.2008.00472.x; Prosser HCG, 2014, CARDIOVASC RES, V101, P145, DOI 10.1093/cvr/cvt234; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Simha V, 2016, DIABETES, V65, P2826, DOI 10.2337/dbi16-0039; Sontheimer DL, 2006, AM FAM PHYSICIAN, V73, P1971; Srinivasan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008283; Sumi M, 2007, ARTERIOSCL THROM VAS, V27, P813, DOI 10.1161/01.ATV.0000259299.38843.64; TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018; Tan JTM, 2016, DIABETES, V65, P3091, DOI 10.2337/db15-1668; Tan JTM, 2014, FASEB J, V28, P206, DOI 10.1096/fj.13-233874; Tso C, 2006, ARTERIOSCL THROM VAS, V26, P1144, DOI 10.1161/01.ATV.0000216600.37436.cf; van Oostrom O, 2007, ARTERIOSCL THROM VAS, V27, P1864, DOI 10.1161/ATVBAHA.107.143875; WEISWEILER P, 1987, CLIN CHIM ACTA, V169, P249, DOI 10.1016/0009-8981(87)90325-1; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zhang QH, 2010, EXP BIOL MED, V235, P1082, DOI 10.1258/ebm.2010.010060; Zhang XJ, 2011, J MOL MED, V89, P985, DOI 10.1007/s00109-011-0754-2	48	8	8	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					2911	2922		10.1096/fj.201700617R	http://dx.doi.org/10.1096/fj.201700617R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401597				2022-12-26	WOS:000432546000003
J	Garcia, LD; Sebastian-Serrano, A; Hernandez, IH; Pintor, J; Lucas, JJ; Diaz-Hernandez, M				de Diego Garcia, Laura; Sebastian-Serrano, Alvaro; Hernandez, Ivo H.; Pintor, Jesus; Lucas, Jose J.; Diaz-Hernandez, Miguel			The regulation of proteostasis in glial cells by nucleotide receptors is key in acute neuroinflammation	FASEB JOURNAL			English	Article						P2Y(2)R; Up(4)U; LPS; astrocytes; ubiquitin-proteasome system	P2Y(2) RECEPTOR; UP-REGULATION; EXTRACELLULAR NUCLEOTIDES; PROTEASOME ACTIVITY; UBIQUITIN SYSTEM; P2 RECEPTORS; MOUSE MODEL; ACTIVATION; EXPRESSION; PATHOPHYSIOLOGY	The disturbances of cellular proteostasis caused by the alteration in the ubiquitin-proteasome system (UPS) have been proposed as a common mechanism underlying several neural pathologies that involve a neuroinflammatory process. As we have previously reported that the nucleotide receptor P2Y purinoceptor 2 (P2Y(2)R) regulates the proteasomal catalytic activities, we wonder whether this receptor is involved in the UPS disturbances associated with the neuroinflammation process. With the use of mice expressing a UPS reporter [mice expressing the UPS reporter ubiquitin (G76v)-green fluorescent protein (UbGFP mice)], we found that LPS-induced acute neuroinflammation status causes a UPS impairment in astrocytes and microglial cells by a mechanism dependent on P2Y(2)R. In this line, LPS-treated double transgenic UbGFP; P2Y(2)R(-/-) mice did not present a UPS impairment in astrocytes or a social interaction deficit as severe as that observed in LPS-treated UbGFP mice. In vivo administration of selective P2Y(2)R agonist diuridine tetraphosphate reversed the UPS impairment completely in astrocytes and partially in microglial cells, promoting increased expression of the proteasomal beta 5 subunit by a mechanism dependent on the Src/PI3K/ERK pathway. Altogether, our results suggest that LPS induces unbalanced proteostasis in astrocytes by blocking P2Y(2)R. Finally, our findings point to the design of selective P2Y(2)R agonist drugs as a new therapeutic approach to treat the neuroinflammatory status.				migueldiaz@ucm.es	DE DIEGO GARCIA, LAURA/AAD-2806-2022; Lucas, Jose J./U-6543-2019; Sebastian-Serrano, Alvaro/Q-5982-2018; Hernández, Ivó H./AAB-2065-2020	DE DIEGO GARCIA, LAURA/0000-0002-1404-5803; Sebastian Serrano, Alvaro/0000-0002-9810-2165; Hernandez, Ivo H./0000-0001-9656-6508	Spanish Ministry of Science and Education [BFU2012-31195]; European Union [H2020-MSCA-ITN-2017, 766124]; Universidad Complutense of Madrid (UCM)-Santander Central Hispano Bank [911585-670]; UCM; Fundacion Banco Bilbao Vizcaya Argentaria (BBVA) grants from CiberNed-ISCIII [PI2015-2/06-3]; Mineco [SAF2015-65371-R]	Spanish Ministry of Science and Education(Spanish Government); European Union(European Commission); Universidad Complutense of Madrid (UCM)-Santander Central Hispano Bank; UCM; Fundacion Banco Bilbao Vizcaya Argentaria (BBVA) grants from CiberNed-ISCIII(BBVA Foundation); Mineco(Spanish Government)	This work was supported by funding from the Spanish Ministry of Science and Education (BFU2012-31195; European Union Project H2020-MSCA-ITN-2017, No. 766124 to M.D.-H.) and Universidad Complutense of Madrid (UCM)-Santander Central Hispano Bank (911585-670 to M.D.-H.). A.S.-S. was funded by Grant BFU2012-31195; L.D.D.-G. has a UCM pre-doctoral fellowship supervised by M.D.-H, and J.J.L. received Fundacion Banco Bilbao Vizcaya Argentaria (BBVA) grants from CiberNed-ISCIII PI2015-2/06-3 (Collaborative), and from Mineco SAF2015-65371-R. The authors declare no conflicts of interest.	Asehnoune K, 2005, CELL SIGNAL, V17, P385, DOI 10.1016/j.cellsig.2004.08.005; Bi W, 2014, NEUROIMMUNOMODULAT, V21, P331, DOI 10.1159/000357811; Boucsein C, 2003, EUR J NEUROSCI, V17, P2267, DOI 10.1046/j.1460-9568.2003.02663.x; Brehm A, 2015, SEMIN IMMUNOPATHOL, V37, P323, DOI 10.1007/s00281-015-0486-4; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; de Diego-Garcia L, 2017, BBA-MOL BASIS DIS, V1863, P43, DOI 10.1016/j.bbadis.2016.10.012; Degagne E, 2009, J IMMUNOL, V183, P4521, DOI 10.4049/jimmunol.0803977; Diaz-Hernandez M, 2006, J NEUROCHEM, V98, P1585, DOI 10.1111/j.1471-4159.2006.03968.x; Eun SY, 2014, INT IMMUNOPHARMACOL, V18, P270, DOI 10.1016/j.intimp.2013.11.026; Floreani NA, 2010, J NEUROIMMUNE PHARM, V5, P533, DOI 10.1007/s11481-010-9213-z; Garcia-Verdugo I, 2008, AM J PHYSIOL-LUNG C, V295, pL708, DOI 10.1152/ajplung.00536.2007; Glickman MH, 2005, FEBS LETT, V579, P3214, DOI 10.1016/j.febslet.2005.04.048; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Gonzalez FA, 2005, MOL NEUROBIOL, V31, P65, DOI 10.1385/MN:31:1-3:065; Guerra AN, 2003, J ENDOTOXIN RES, V9, P256, DOI 10.1179/096805103225001468; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Homolya L, 1999, J BIOL CHEM, V274, P26454, DOI 10.1074/jbc.274.37.26454; Jamart C, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-166; Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001; Kong Q, 2009, J NEUROCHEM, V109, P1300, DOI 10.1111/j.1471-4159.2009.06048.x; Kukulski F, 2010, MOL IMMUNOL, V47, P991, DOI 10.1016/j.molimm.2009.11.020; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Martinon F, 2015, NAT REV RHEUMATOL, V11, P11, DOI 10.1038/nrrheum.2014.158; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Nichols KK, 2004, EXPERT OPIN INV DRUG, V13, P47, DOI 10.1517/13543784.13.1.47; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Pintado C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-87; Pla A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.46; Rodriguez-Zayas AE, 2010, INT J DEV NEUROSCI, V28, P413, DOI 10.1016/j.ijdevneu.2010.07.001; Schrader AM, 2005, ARCH ORAL BIOL, V50, P533, DOI 10.1016/j.archoralbio.2004.11.005; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Shen JZ, 2004, MOL PHARMACOL, V66, P1265, DOI 10.1124/mol.104.002642; Shi JS, 2015, J MOL HISTOL, V46, P457, DOI 10.1007/s10735-015-9637-0; Shin JN, 2013, J BIOL CHEM, V288, P35886, DOI 10.1074/jbc.M113.514919; Sunkaria A, 2016, MOL NEUROBIOL, V53, P944, DOI 10.1007/s12035-014-9064-3; Weisman GA, 2012, MOL NEUROBIOL, V46, P96, DOI 10.1007/s12035-012-8263-z; Xiao ZL, 2012, CELL BIOL INT, V36, P625, DOI 10.1042/CBI20110111; Zhang FF, 2015, BIOCHEM BIOPH RES CO, V464, P1202, DOI 10.1016/j.bbrc.2015.07.105	40	6	6	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3020	3032		10.1096/fj.201701064RR	http://dx.doi.org/10.1096/fj.201701064RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401585				2022-12-26	WOS:000432546000011
J	Itoh, S; Mizuno, K; Aikawa, M; Aikawa, E				Itoh, Shinsuke; Mizuno, Ken; Aikawa, Masanori; Aikawa, Elena			Dimerization of sortilin regulates its trafficking to extracellular vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIOVASCULAR RISK; RECEPTOR SORTILIN; PROTEIN; RETROMER; ADHESION; DOMAIN; SORT1; ATHEROSCLEROSIS; CALCIFICATION; ADIPONECTIN	Extracellular vesicles (EVs) play a critical role in intercellular communication by transferring microRNAs, lipids, and proteins to neighboring cells. Sortilin, a sorting receptor that directs target proteins to the secretory or endocytic compartments of cells, is found in both EVs and cells. In many human diseases, including cancer and cardiovascular disorders, sortilin expression levels are atypically high. To elucidate the relationship between cardiovascular disease, particularly vascular calcification, and sortilin expression levels, we explored the trafficking of sortilin in both the intracellular and extracellular milieu. We previously demonstrated that sortilin promotes vascular calcification via its trafficking of tissue-nonspecific alkaline phosphatase to EVs. Although recent reports have noted that sortilin is regulated by multiple post-translational modifications, the precise mechanisms of sortilin trafficking still need to be determined. Here, we show that sortilin forms homodimers with an intermolecular disulfide bond at the cysteine 783 (Cys(783)) residue, and because Cys(783) can be palmitoylated, it could be shared via palmitoylation and an intermolecular disulfide bond. Formation of this intermolecular disulfide bond leads to trafficking of sortilin to EVs by preventing palmitoylation, which further promotes sortilin trafficking to the Golgi apparatus. Moreover, we found that sortilin-derived propeptide decreased sortilin homodimers within EVs. In conclusion, sortilin is transported to EVs via the formation of homodimers with an intermolecular disulfide bond, which is endogenously regulated by its own propeptide. Therefore, we propose that inhibiting dimerization of sortilin acts as a new therapeutic strategy for the treatment of EV-associated diseases, including vascular calcification and cancer.	[Itoh, Shinsuke; Mizuno, Ken; Aikawa, Masanori; Aikawa, Elena] Harvard Med Sch, Brigham & Womens Hosp, Ctr Interdisciplinary Cardiovasc Sci, Boston, MA 02115 USA; [Aikawa, Masanori; Aikawa, Elena] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Ctr Excellence Vasc Biol, Boston, MA 02115 USA; [Itoh, Shinsuke; Mizuno, Ken] Kowa Co Ltd, Tokyo New Drug Res Labs, Tokyo 1890022, Japan	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Kowa Company, Ltd.	Aikawa, E (corresponding author), Brigham & Womens Hosp, Cardiovasc Med, 3 Blackfan St,CLS 17th Floor, Boston, MA 02115 USA.	eaikawa@bwh.harvard.edu	Aikawa, Elena/L-6173-2019	Itoh, Shinsuke/0000-0001-9567-8188; Aikawa, Elena/0000-0001-7835-2135; Aikawa, Masanori/0000-0002-9275-2079	Kowa Company, Ltd., Tokyo, Japan; National Institutes of Health [R01HL 114805, R01HL 136431]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114805, R01HL136431] Funding Source: NIH RePORTER	Kowa Company, Ltd., Tokyo, Japan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a research grant from Kowa Company, Ltd., Tokyo, Japan (to M. A.). S. I. and K. M. are employees of Kowa Company, Ltd. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grants R01HL 114805 and R01HL 136431.	Andersson CH, 2016, J ALZHEIMERS DIS, V53, P1353, DOI 10.3233/JAD-160319; Beraud-Dufour S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111860; Buttenschon HN, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.167; Canuel M, 2008, BIOCHEM BIOPH RES CO, V366, P724, DOI 10.1016/j.bbrc.2007.12.015; Carlo AS, 2014, J MOL MED, V92, P905, DOI 10.1007/s00109-014-1152-3; Carlo AS, 2013, J NEUROSCI, V33, P358, DOI 10.1523/JNEUROSCI.2425-12.2013; Carrasquillo MM, 2010, AM J HUM GENET, V87, P890, DOI 10.1016/j.ajhg.2010.11.002; Dumaresq-Doiron K, 2013, BIOCHEM BIOPH RES CO, V433, P90, DOI 10.1016/j.bbrc.2013.02.059; Eggert S, 2018, CELL MOL LIFE SCI, V75, P301, DOI 10.1007/s00018-017-2625-7; Goettsch C, 2018, ARTERIOSCL THROM VAS, V38, P19, DOI 10.1161/ATVBAHA.117.310292; Goettsch C, 2017, ARTERIOSCL THROM VAS, V37, P1005, DOI 10.1161/ATVBAHA.116.308932; Goettsch C, 2016, J CLIN INVEST, V126, P1323, DOI 10.1172/JCI80851; Gustafsen C, 2014, CELL METAB, V19, P310, DOI 10.1016/j.cmet.2013.12.006; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Hutcheson JD, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.25129; Kaddai V, 2009, DIABETOLOGIA, V52, P932, DOI 10.1007/s00125-009-1273-3; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kitago Y, 2015, NAT STRUCT MOL BIOL, V22, P199, DOI 10.1038/nsmb.2954; Kjolby M, 2010, CELL METAB, V12, P213, DOI 10.1016/j.cmet.2010.08.006; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Li JB, 2014, J BIOL CHEM, V289, P22437, DOI 10.1074/jbc.M114.548933; Li WH, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0706-8; Lopez M, 1998, BLOOD, V92, P4602, DOI 10.1182/blood.V92.12.4602.424k21_4602_4611; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Massa Fabienne, 2014, Genes Cancer, V5, P240; Massa F, 2013, INT J BIOCHEM CELL B, V45, P952, DOI 10.1016/j.biocel.2013.01.020; Maurel D, 2004, ANAL BIOCHEM, V329, P253, DOI 10.1016/j.ab.2004.02.013; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; McCormick PJ, 2008, TRAFFIC, V9, P1984, DOI 10.1111/j.1600-0854.2008.00814.x; Miner JJ, 2011, J BIOL CHEM, V286, P9577, DOI 10.1074/jbc.M110.208777; Miyahara M, 2000, J BIOL CHEM, V275, P613, DOI 10.1074/jbc.275.1.613; Mortensen MB, 2014, J CLIN INVEST, V124, P5317, DOI 10.1172/JCI76002; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nyborg A. C., 2006, MOL NEURODEGENER, V13; Ogawa K, 2016, ATHEROSCLEROSIS, V249, P110, DOI 10.1016/j.atherosclerosis.2016.03.041; Pan X, 2017, MOL BIOL CELL, V28, P1667, DOI 10.1091/mbc.E16-11-0777; Patel KM, 2015, CIRC RES, V116, P789, DOI 10.1161/CIRCRESAHA.116.305811; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Roselli S, 2015, ONCOTARGET, V6, P10473, DOI 10.18632/oncotarget.3401; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Ward RJ, 2013, METHOD ENZYMOL, V521, P69, DOI 10.1016/B978-0-12-391862-8.00004-1; Westergaard UB, 2004, J BIOL CHEM, V279, P50221, DOI 10.1074/jbc.M408873200; Wilson Cornelia M, 2016, Commun Integr Biol, V9, pe1130192, DOI 10.1080/19420889.2015.1130192; Wilson CM, 2014, J CELL SCI, V127, P3983, DOI 10.1242/jcs.149336	49	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4532	4544		10.1074/jbc.RA117.000732	http://dx.doi.org/10.1074/jbc.RA117.000732			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29382723	Green Published, hybrid			2022-12-26	WOS:000428204300024
J	Kauhl, B; Maier, W; Schweikart, J; Keste, A; Moskwyn, M				Kauhl, Boris; Maier, Werner; Schweikart, Juergen; Keste, Andrea; Moskwyn, Marita			Who is where at risk for Chronic Obstructive Pulmonary Disease? A spatial epidemiological analysis of health insurance claims for COPD in Northeastern Germany	PLOS ONE			English	Article							REGIONAL DEPRIVATION; AIR-POLLUTION; SOCIOECONOMIC-STATUS; GENERAL-PRACTICE; UNITED-STATES; PREVALENCE; MORTALITY; INDEX; INEQUALITIES; DISPARITIES	Background Chronic obstructive pulmonary disease (COPD) has a high prevalence rate in Germany and a further increase is expected within the next years. Although risk factors on an individual level are widely understood, only little is known about the spatial heterogeneity and population-based risk factors of COPD. Background knowledge about broader, population-based processes could help to plan the future provision of healthcare and prevention strategies more aligned to the expected demand. The aim of this study is to analyze how the prevalence of COPD varies across northeastern Germany on the smallest spatial-scale possible and to identify the location-specific population-based risk factors using health insurance claims of the AOK Nordost. Methods To visualize the spatial distribution of COPD prevalence at the level of municipalities and urban districts, we used the conditional autoregressive Besag-York-Mollie A (BYM) model. Geographically weighted regression modelling (GWR) was applied to analyze the location-specific ecological risk factors for COPD. Results The sex-and age-adjusted prevalence of COPD was 6.5% in 2012 and varied widely across northeastern Germany. Population-based risk factors consist of the proportions of insurants aged 65 and older, insurants with migration background, household size and area deprivation. The results of the GWR model revealed that the population at risk for COPD varies considerably across northeastern Germany. Conclusion Area deprivation has a direct and an indirect influence on the prevalence of COPD. Persons ageing in socially disadvantaged areas have a higher chance of developing COPD, even when they are not necessarily directly affected by deprivation on an individual level. This underlines the importance of considering the impact of area deprivation on health for planning of healthcare. Additionally, our results reveal that in some parts of the study area, insurants with migration background and persons living in multi-persons households are at elevated risk of COPD.	[Kauhl, Boris; Keste, Andrea; Moskwyn, Marita] AOK Nordost Die Gesundheitskasse, Dept Med Care, Berlin, Germany; [Kauhl, Boris; Schweikart, Juergen] Beuth Univ Appl Sci, Dept 3, Civil Engn & Geoinformat, Berlin, Germany; [Maier, Werner] German Res Ctr Environm Hlth GmbH, Inst Hlth Econ & Hlth Care Management, Helmholtz Zentrum Munchen, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kauhl, B (corresponding author), AOK Nordost Die Gesundheitskasse, Dept Med Care, Berlin, Germany.; Kauhl, B (corresponding author), Beuth Univ Appl Sci, Dept 3, Civil Engn & Geoinformat, Berlin, Germany.	boris.kauhl@nordost.aok.de			AOK Nordost - Die Gesundheitskasse	AOK Nordost - Die Gesundheitskasse	The funder, AOK Nordost - Die Gesundheitskasse (www.nordost.aok.de), provided support in the form of salaries for authors BK, AK and MM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato F, 2009, ATMOS ENVIRON, V43, P1650, DOI 10.1016/j.atmosenv.2008.12.009; ANSELIN L., 2017, PACKAGE SPDEP; Aumann I, 2013, KLINIKARZT, V42, P168; Bevolkerungsforschung Bf, 2016, DURCHSCHN HAUSH MEHR; Blangiardo M, 2015, SPATIAL AND SPATIO-TEMPORAL BAYESIAN MODELS WITH R-INLA, P1, DOI 10.1002/9781118950203; Chan TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098170; Crighton EJ, 2015, HEALTH REP, V26, P10; Crighton EJ, 2012, CAN J PUBLIC HEALTH, V103, pE384, DOI 10.1007/BF03404447; Croft JB, 2016, CHEST, V150, P544, DOI 10.1016/j.chest.2016.05.014; Dijkstra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072730; Ford MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146085; Gebreab SY, 2012, HEALTH PLACE, V18, P1006, DOI 10.1016/j.healthplace.2012.06.006; Geldmacher H, 2008, DEUT MED WOCHENSCHR, V133, P2609, DOI 10.1055/s-0028-1105858; Geodasie BfKu, VERW EINW; Gesundheit Bf, 2012, JAHR 2012; Gingter C, 2009, FAM PRACT, V26, P3, DOI 10.1093/fampra/cmn084; Glaab T, 2006, DEUT MED WOCHENSCHR, V131, P1203, DOI 10.1055/s-2006-941752; Gollini I., 2013, ARXIV PREPRINT ARXIV; Grintsova O, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-43; Hardie JA, 2002, EUR RESPIR J, V20, P1117, DOI 10.1183/09031936.02.00023202; Havard S, 2008, SOC SCI MED, V67, P2007, DOI 10.1016/j.socscimed.2008.09.031; Heart L National, 1998, GLOB STRAT DIAGN MAN; Hoffmann F, 2012, GESUNDHEITSWESEN, V74, P291, DOI 10.1055/s-0031-1275711; Hofmeister C, 2016, GESUNDHEITSWESEN, V78, P42, DOI 10.1055/s-0034-1390421; Holt JB, 2011, INT J CHRONIC OBSTR, V6, P321, DOI 10.2147/COPD.S19945; Kanervisto M, 2011, RESP MED, V105, P1140, DOI 10.1016/j.rmed.2011.03.008; Kauhl B, 2017, BMC PUBLIC IN PRESS; Kauhl B, 2017, GESUNDHEITSWESEN; Kauhl B, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0068-2; Kauhl B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135656; KBV, 2013, NEUE BED; Kitaguchi Y, 2006, RESP MED, V100, P1742, DOI 10.1016/j.rmed.2006.02.003; Krankenkasseninfo, MITGL VERS JE KRANK; Kroll LE, 2012, BUNDESGESUNDHEITSBLA, V55, P129, DOI 10.1007/s00103-011-1403-1; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kurmi OP, 2010, THORAX, V65, P221, DOI 10.1136/thx.2009.124644; Lampert T, 2010, BUNDESGESUNDHEITSBLA, V53, P108, DOI 10.1007/s00103-009-1014-2; Lawlor DA, 2005, AM J PUBLIC HEALTH, V95, P91, DOI 10.2105/AJPH.2003.035592; Lawson AB., 2013, BAYESIAN DISEASE MAP; Lindberg A, 2006, RESP MED, V100, P264, DOI 10.1016/j.rmed.2005.04.029; LINDGREN A, 2009, INT J HEALTH GEOGR, V8; Lipton Robert, 2007, Int J Med Sci, V4, P179; Lipton Robert, 2005, COPD, V2, P435, DOI 10.1080/15412550500346543; Lokke A, 2006, THORAX, V61, P935, DOI 10.1136/thx.2006.062802; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Lu B, 2014, GEO-SPAT INF SCI, V17, P85, DOI 10.1080/10095020.2014.917453; Maier W, 2013, DIABETIC MED, V30, pE78, DOI 10.1111/dme.12062; Maier W, 2012, GESUNDHEITSWESEN, V74, P416, DOI 10.1055/s-0031-1280846; Maier W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089661; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Miravitlles M, 2009, THORAX; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; Nacul L, 2011, J PUBLIC HEALTH-UK, V33, P108, DOI 10.1093/pubmed/fdq031; Ocana-Riola R, 2008, J EPIDEMIOL COMMUN H, V62, P147, DOI 10.1136/jech.2006.053280; Olives C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060308; Ozegowski S, 2012, GESUNDHEITSWESEN, V74, P618, DOI 10.1055/s-0032-1321748; Pampalon R, 2009, CHRONIC DIS CAN, V29, P178; Pritzkuleit R, 2010, Pneumologie, V64, P535, DOI 10.1055/s-0030-1255637; Pujades-Rodriguez M, 2009, OCCUP ENVIRON MED, V66, P679, DOI 10.1136/oem.2008.043885; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Schafer T, 2013, OSTEOARTHR CARTILAGE, V21, P279, DOI 10.1016/j.joca.2012.11.006; Schikowski T, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-152; Schnee M, 2008, GESUNDHEITSMONITOR, P88; Schulz M, ZUSAMMENHANG ZWISCHE; Schulze A, 2006, BUNDES GESUNDHEITSSU; Siordia Carlos, 2012, Human Geogr, V6, P5, DOI 10.5719/hgeo.2012.62.5; Skapinakis P, 2005, BRIT J PSYCHIAT, V186, P417, DOI 10.1192/bjp.186.5.417; Song QK, 2014, INT J ENV RES PUB HE, V11, P11822, DOI 10.3390/ijerph111111822; Tanser F., 2009, INT J EPIDEMIOL; Volzke H, 2006, RAUCHEN REGIONALE UN; Welte T, 2000, EUR RESP J S31, V16, P111; Wheeler D., 2005, J GEOGRAPHICAL SYSTE, V7, P161, DOI [DOI 10.1007/S10109-005-0155-6, 10.1007/s10109-005-0155-6]; Wheeler D. C., 2013, HDB REGIONAL SCI, P1435, DOI 10.1007/978-3-642-23430-9_77; Ziegler U, 2009, GESUNDHEITSWESEN, V71, P281, DOI 10.1055/s-0028-1119384	75	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0190865	10.1371/journal.pone.0190865	http://dx.doi.org/10.1371/journal.pone.0190865			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1MC	29414997	Green Submitted, Green Published, gold			2022-12-26	WOS:000424325300011
J	Moller, P; Liu, XC; Schuster, S; Boley, D				Moeller, Philip; Liu, Xiaochen; Schuster, Stefan; Boley, Daniel			Linear programming model can explain respiration of fermentation products	PLOS ONE			English	Article							ESCHERICHIA-COLI; HUMAN BRAIN; METABOLISM; GLUCOSE; GLYCOLYSIS; EVOLUTION; PATHWAYS; LACTATE; GROWTH	Many differentiated cells rely primarily on mitochondrial oxidative phosphorylation for generating energy in the form of ATP needed for cellular metabolism. In contrast most tumor cells instead rely on aerobic glycolysis leading to lactate to about the same extent as on respiration. Warburg found that cancer cells to support oxidative phosphorylation, tend to ferment glucose or other energy source into lactate even in the presence of sufficient oxygen, which is an inefficient way to generate ATP. This effect also occurs in striated muscle cells, activated lymphocytes and microglia, endothelial cells and several mammalian cell types, a phenomenon termed the "Warburg effect". The effect is paradoxical at first glance because the ATP production rate of aerobic glycolysis is much slower than that of respiration and the energy demands are better to be met by pure oxidative phosphorylation. We tackle this question by building a minimal model including three combined reactions. The new aspect in extension to earlier models is that we take into account the possible uptake and oxidation of the fermentation products. We examine the case where the cell can allocate protein on several enzymes in a varying distribution and model this by a linear programming problem in which the objective is to maximize the ATP production rate under different combinations of constraints on enzymes. Depending on the cost of reactions and limitation of the substrates, this leads to pure respiration, pure fermentation, and a mixture of respiration and fermentation. The model predicts that fermentation products are only oxidized when glucose is scarce or its uptake is severely limited.	[Moeller, Philip; Schuster, Stefan] Friedrich Schiller Univ, Dept Bioinformat, Jena, Germany; [Liu, Xiaochen; Boley, Daniel] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Liu, Xiaochen] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	Friedrich Schiller University of Jena; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego	Boley, D (corresponding author), Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA.	boley@umn.edu		Boley, Daniel/0000-0002-2685-8449	U.S. National Science Foundation [1319749]; Deutsche Forschungsgemeinschaft [RTG 1715]; University of Jena fellowship	U.S. National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Jena fellowship	This work was supported by grant 1319749 from the U.S. National Science Foundation to D.B., by the Deutsche Forschungsgemeinschaft (RTG 1715) to P.M. and S.S. and by a University of Jena fellowship to P.M. No other external funding was received for this study. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of any funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedpour N, 1988, AM J PHYSIOL, V254, pe555; Beg QK, 2007, P NATL ACAD SCI USA, V104, P12663, DOI 10.1073/pnas.0609845104; BERTSIMAS D, 1997, ATHENA SCIENTIFIC; Bertsimas D, 1997, SD, DOI DOI 10.1073/PNAS.0609845104; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Figley CR, 2011, J NEUROSCI, V31, P4768, DOI 10.1523/JNEUROSCI.6612-10.2011; HEINRICH R, 1987, B MATH BIOL, V49, P539, DOI 10.1016/S0092-8240(87)90003-6; HTTPS, 1973, FA, P45104, DOI DOI 10.1073/PNAS.0609845104; Ide K, 2000, J PHYSIOL-LONDON, V522, P159, DOI 10.1111/j.1469-7793.2000.t01-2-00159.xm; KLAMT S, 2017, PLOS COMPUT BIOL, DOI DOI 10.1371/J0URNAL.PCBI.1005409; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; MUELLER S, 2014, JOURNAL OF THEORETIC, P95962, DOI DOI 10.1016/J.JTBI.2013.11.015; NOOR E, 2016, PLOS COMPUT BIOL, DOI DOI 10.1371/J0URNAL.PCBI.1005167; Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Rich PR, 2003, BIOCHEM SOC T, V31, P1095; RICHTER EA, 1988, AM J PHYSIOL, V254, pE555, DOI 10.1152/ajpendo.1988.254.5.E555; Rozen DE, 2000, AM NAT, V155, P24, DOI 10.1086/303299; Sajitz-Hermstein M, 2010, BIOINFORMATICS, V26, pi582, DOI 10.1093/bioinformatics/btq390; Schulz TJ, 2006, J BIOL CHEM, V281, P977, DOI 10.1074/jbc.M511064200; Schuster S., 2015, PEERJ PREPRINTS, V3, pE1609; Schuster S, 2015, BIOCHEM SOC T, V43, P1187, DOI 10.1042/BST20150153; Schuster S, 2011, BIOSYSTEMS, V105, P147, DOI 10.1016/j.biosystems.2011.05.007; Shlomi T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002018; Tournier L, 2017, J MATH BIOL, V75, P1349, DOI 10.1007/s00285-017-1118-5; Vazquez A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-58; WALEY SG, 1964, BIOCHEM J, V91, P514, DOI 10.1042/bj0910514; Warburg O, 1924, NATURWISSENSCHAFTEN, V12, P1131, DOI 10.1007/BF01504608; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wortel MT, 2014, FEBS J, V281, P1547, DOI 10.1111/febs.12722	31	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191803	10.1371/journal.pone.0191803	http://dx.doi.org/10.1371/journal.pone.0191803			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415045	Green Published, gold, Green Submitted			2022-12-26	WOS:000424325300042
J	Saavedra-Avendano, B; Schiavon, R; Sanhueza, P; Rios-Polanco, R; Garcia-Martinez, L; Darney, BG				Saavedra-Avendano, Biani; Schiavon, Raffaela; Sanhueza, Patricio; Rios-Polanco, Ranulfo; Garcia-Martinez, Laura; Darney, Blair G.			Who presents past the gestational age limit for first trimester abortion in the public sector in Mexico City?	PLOS ONE			English	Article							WOMEN; PREGNANCY; CARE; TERMINATION; SERVICES; REASONS; DELAYS	Objective To identify socio-demographic factors associated with presenting for abortion services past the gestational age (GA) limit (12 weeks), and thus not receiving services, in Mexico City's public sector first trimester abortion program. Methods We used clinical data from four high volume sites in the Interrupcion Legal de Embarazo (ILE) program, 2007-2015. We used descriptive statistics to quantify the proportion of women who did not receive an abortion due to presenting past the gestational age limit. We used multivariable logistic regression to identify associations between women's characteristics and presenting past the GA limit and calculated predicted probabilities of late presentation for key characteristics. Results Our sample included 52,391 women, 8.10% (n = 4,246) of whom did not receive abortion services due to presenting past the GA limit. Adolescents (12-17) made up 8.69% of the total sample and 13.40% of those presenting past the GA limit (p<0.05). In multivariable analyses, all age groups of adult women had significantly lower odds than adolescents of presenting past the limit (aOR = 0.77, aOR = 0.63, aOR = 0.58 and aOR = 0.37 for 19-24, 25-29, 30-39, and > = 40 years' old respectively). Women living in Mexico City and with higher levels of education had lower odds of presenting past the GA limit, and there was an educational gradient across all age groups. In the multivariable predicted probability models, adolescents at every level of education have significantly higher probabilities of not receiving an abortion due to presenting past the gestational age limit compared with adults (among women with a primary education: 11.75% adolescents vs. 9.02-4.26% across adult age groups). Conclusions Our results suggest that continued efforts are needed to educate women, especially younger and less educated women, about early pregnancy recognition. In addition, all women need information about the availability of first trimester legal abortion to ensure timely access to abortion services.	[Saavedra-Avendano, Biani; Darney, Blair G.] Natl Inst Publ Hlth INSP, Cuernavaca, Morelos, Mexico; [Schiavon, Raffaela] Int Pregnancy Advisory Serv Ipas Mexico, Mexico City, DF, Mexico; [Sanhueza, Patricio; Rios-Polanco, Ranulfo; Garcia-Martinez, Laura] Secretaria Salud Ciudad Mexico, Mexico City, DF, Mexico; [Saavedra-Avendano, Biani] Ctr Invest & Docencia Econ AC, Dept Publ Adm, Mexico City, DF, Mexico; [Darney, Blair G.] Oregon Hlth & Sci Univ, Dept Obstet & Gynaecol, Portland, OR 97201 USA	Instituto Nacional de Salud Publica; Centro de Investigacion y Docencia Economicas A.C. (CIDE); Oregon Health & Science University	Darney, BG (corresponding author), Natl Inst Publ Hlth INSP, Cuernavaca, Morelos, Mexico.; Darney, BG (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynaecol, Portland, OR 97201 USA.	bgdarney@gmail.com	Schiavon, Raffaela/AAP-4303-2020	Schiavon, Raffaela/0000-0002-6917-0986; Darney, Blair/0000-0001-8120-028X; Saavedra-Avendano, Biani/0000-0002-2080-4458	Society of Family Planning Research Fund Jr. Investigator Award [SFPRF9-JI2]; Agency for Healthcare Research and Quality [K12HS022981]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS022981] Funding Source: NIH RePORTER	Society of Family Planning Research Fund Jr. Investigator Award; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study is supported by a Society of Family Planning Research Fund Jr. Investigator Award (SFPRF9-JI2; Darney, PI), http://www.societyfp.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Darney is partially supported by grant number K12HS022981 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality.	Aggarwal P, 2013, ANN MED HEALTH SCI R, V3, P187, DOI 10.4103/2141-9248.113659; [Anonymous], 2002, CODIGO PENAL DISTRIT; Assifi AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152224; Baum S, 2015, INT J GYNECOL OBSTET, V131, P285, DOI 10.1016/j.ijgo.2015.06.036; Becker D, 2002, INT FAM PLAN PERSPEC, V28, P205, DOI 10.2307/3088223; Becker D, 2011, WOMEN HEALTH ISS, V21, pS16, DOI 10.1016/j.whi.2011.02.009; Branum AM, 2016, MATERN CHILD HLTH J; Consejo Nacional de Poblacion, AN C MET EST IND MAR; Drey EA, 2006, OBSTET GYNECOL, V107, P128, DOI 10.1097/01.AOG.0000189095.32382.d0; Finer LB, 2006, CONTRACEPTION, V74, P334, DOI 10.1016/j.contraception.2006.04.010; Foster DG, 2008, CONTRACEPTION, V77, P289, DOI 10.1016/j.contraception.2007.10.010; Grimes DA, LANCET, V368, P1908; Guttmacher Institute, 2013, MAK AB SERV ACC WAK; Hajri S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145338; Harries Jane, 2007, Reprod Health, V4, P7, DOI 10.1186/1742-4755-4-7; Harries J, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0014-y; Heredia-Pi I, 2013, SALUD PUBLICA MEXICO, V55, pS249; Hossain A, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0199-8; Ingham R, 2008, REPROD HEALTH MATTER, V16, P18, DOI 10.1016/S0968-8080(08)31375-5; Jones RK, 2013, J WOMENS HEALTH, V22, P706, DOI 10.1089/jwh.2013.4283; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Kalb MMY, 2011, STUD FAMILY PLANN, V42, P159, DOI 10.1111/j.1728-4465.2011.00277.x; Mundo-Rosas V, 2014, SALUD PUBLICA MEXICO, V56, pS12; Puri M, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0241-y; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Saavedra-Avendano B, 2016, SALUD PUBLICA MEXICO, V58; Secretaria de Salud de la Ciudad de Mexcio, INT LEG EMB MEX CIT; Silva M, 2008, AUST NZ J PUBL HEAL, V32, P519, DOI 10.1111/j.1753-6405.2008.00302.x; Sowmini CV, 2013, REPROD HEALTH MATTER, V21, P243, DOI 10.1016/S0968-8080(13)41700-7; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Upadhyay UD, 2014, AM J PUBLIC HEALTH, V104, P1687, DOI 10.2105/AJPH.2013.301378; Zyzanski SJ, 2004, ANN FAM MED, V2, P199, DOI 10.1370/afm.197	32	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192547	10.1371/journal.pone.0192547	http://dx.doi.org/10.1371/journal.pone.0192547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1MC	29414987	gold, Green Published, Green Submitted			2022-12-26	WOS:000424325300085
J	Gupta, N; Srivastava, N; Bhagyawant, SS				Gupta, Neha; Srivastava, Nidhi; Bhagyawant, Sameer S.			Vicilin-A major storage protein of mungbean exhibits antioxidative potential, antiproliferative effects and ACE inhibitory activity	PLOS ONE			English	Article							CONVERTING-ENZYME; FUNCTIONAL-PROPERTIES; BIOACTIVE PEPTIDES; FRAME PROTEIN; IN-VITRO; PLANT; PURIFICATION; HYDROLYSATE; IDENTIFICATION; ASSAY	Enzymatic hydrolysates of different food proteins demonstrate health benefits. Search for diet related food protein hydrolysates is therefore of interest within the scope of functional foods. Mungbean is one of the popular foods in India because of rich protein source. In this study, mungbean vicilin protein (MBVP) was enzymatically hydrolysed by alcalase and trypsin under optimal conditions. We have studied the antioxidant, antiproliferative and angiotensin-converting enzyme (ACE) inhibitory activities of mungbean vicilin protein hydrolysate (MBVPH) vis-a-vis alcalase-generated mungbean vicilin protein hydrolysate (AMBVPH) and trypsin-generated mungbean vicilin protein hydrolysate (TMBVPH). The results showed that MBVPH exhibited higher antioxidant potential, ACE inhibitory and antiproliferative activities than MBVP. The alcalase treated hydrolysate displayed highest ACE inhibitory activity with IC50 value of 0.32 mg protein/ml. The MBVP showed significant antiproliferative activity against both MCF-7 and MDA-MB-231 breast cancer cells at the doses between 0.2-1.0 mg/ml. The data suggested that MBVPH can be utilized as physiologically active functional foods with sufficient antihypertensive activity. The results indicate that mungbean can be utilized as a rich resource of functional foods.	[Gupta, Neha; Bhagyawant, Sameer S.] Jiwaji Univ, Sch Studies Biotechnol, Gwalior, India; [Srivastava, Nidhi] Banasthali Univ, Dept Biosci & Biotechnol, Banasthali, India	Jiwaji University Gwalior; Banasthali Vidyapith	Bhagyawant, SS (corresponding author), Jiwaji Univ, Sch Studies Biotechnol, Gwalior, India.	sameerbhagyawant@gmail.com		Bhagyawant, Sameer/0000-0002-4405-5930				Ahmad M, 2015, J FOOD SCI TECH MYS, V52, P5799, DOI 10.1007/s13197-014-1701-3; ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222; [Anonymous], 2011, CEREALS OILS; Antolovich M, 2002, ANALYST, V127, P183, DOI 10.1039/b009171p; Asoodeh A, 2012, FOOD CHEM, V131, P291, DOI 10.1016/j.foodchem.2011.08.039; Awah FM, 2010, FOOD CHEM, V119, P1409, DOI 10.1016/j.foodchem.2009.09.020; Benjamin T B, 2003, J CHEM EDUC, V80, P2; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Cancer I. A. f. R. o., 2014, WORLD CANC REPORT 20; CUSHMAN DW, 1971, BIOCHEM PHARMACOL, V20, P1637, DOI 10.1016/0006-2952(71)90292-9; DECKER EA, 1990, J AGR FOOD CHEM, V38, P674, DOI 10.1021/jf00093a019; Erdmann K, 2008, J NUTR BIOCHEM, V19, P643, DOI 10.1016/j.jnutbio.2007.11.010; ERICSON MC, 1973, PLANT PHYSIOL, V52, P98, DOI 10.1104/pp.52.2.98; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; GATEHOUSE JA, 1981, EUR J BIOCHEM, V118, P627, DOI 10.1111/j.1432-1033.1981.tb05565.x; Ghassem M, 2011, FOOD CHEM, V129, P1770, DOI 10.1016/j.foodchem.2011.06.051; Gu RZ, 2011, FOOD RES INT, V44, P1536, DOI 10.1016/j.foodres.2011.04.006; Guang C, 2009, J AGR FOOD CHEM, V57, P5113, DOI 10.1021/jf900494d; Gulcin I, 2004, PHARMACOL RES, V49, P59, DOI 10.1016/j.phrs.2003.07.012; Guo CJ, 2003, NUTR RES, V23, P1719, DOI 10.1016/j.nutres.2003.08.005; GyamfM A, 1999, GEN PHARMACOL, V32, P61; Hagerman AE, 1998, J AGR FOOD CHEM, V46, P1887, DOI 10.1021/jf970975b; Halvorsen BL, 2006, AM J CLIN NUTR, V84, P95, DOI 10.1093/ajcn/84.1.95; Hamada JS, 2000, J FOOD SCI, V65, P305, DOI 10.1111/j.1365-2621.2000.tb15998.x; HOYLE NT, 1994, J FOOD SCI, V59, P76, DOI 10.1111/j.1365-2621.1994.tb06901.x; Hyun CK, 2000, PROCESS BIOCHEM, V36, P65, DOI 10.1016/S0032-9592(00)00176-X; Intarasirisawat R, 2013, J FUNCT FOODS, V5, P1854, DOI 10.1016/j.jff.2013.09.006; Jakubczyk A, 2013, INT J FOOD SCI TECH, V48, P2363, DOI 10.1111/ijfs.12226; Jung WK, 2006, FOOD CHEM, V94, P26, DOI 10.1016/j.foodchem.2004.09.048; Kim SY, 2007, J NUTR BIOCHEM, V18, P31, DOI 10.1016/j.jnutbio.2006.02.006; KORTT AA, 1986, INT J PEPT PROT RES, V28, P613; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JK, 2009, BIORESOURCE TECHNOL, V100, P5255, DOI 10.1016/j.biortech.2009.05.057; Li GH, 2006, EUR FOOD RES TECHNOL, V222, P733, DOI 10.1007/s00217-005-0147-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Majumder K, 2011, FOOD CHEM, V126, P1614, DOI 10.1016/j.foodchem.2010.12.039; Mendoza EMT, 2001, J AGR FOOD CHEM, V49, P1552, DOI 10.1021/jf001041h; Moon JK, 2009, J AGR FOOD CHEM, V57, P1655, DOI 10.1021/jf803537k; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pahor M, 2000, DIABETES CARE, V23, P888, DOI 10.2337/diacare.23.7.888; Pellegrini N, 2003, J NUTR, V133, P2812, DOI 10.1093/jn/133.9.2812; Pownall TL, 2010, J AGR FOOD CHEM, V58, P4712, DOI 10.1021/jf904456r; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Sharma GM, 2010, J AGR FOOD CHEM, V58, P5714, DOI 10.1021/jf9036326; Tang CH, 2009, FOOD CHEM, V115, P672, DOI 10.1016/j.foodchem.2008.12.068; Tanzadehpanah H, 2016, PROCESS BIOCHEM, V51, P2067, DOI 10.1016/j.procbio.2016.09.017; Tanzadehpanah H, 2013, INNOV FOOD SCI EMERG, V18, P212, DOI 10.1016/j.ifset.2013.02.002; Tanzadehpanah H, 2012, FOOD RES INT, V49, P105, DOI 10.1016/j.foodres.2012.08.022; TSOU C S, 1979, Acta Horticulturae (Wageningen), P279; Viernes L. B. G., 2012, Journal of Biological Sciences, V12, P393; Wang FJ, 2016, EUR FOOD RES TECHNOL, V242, P911, DOI 10.1007/s00217-015-2597-5; Wang H, 2008, FOOD CHEM, V106, P888, DOI 10.1016/j.foodchem.2007.05.068; Wang WY, 2005, COMPR REV FOOD SCI F, V4, P63, DOI 10.1111/j.1541-4337.2005.tb00075.x; Wijesekara I, 2010, MAR DRUGS, V8, P1080, DOI 10.3390/md8041080; Wu H, 2008, PROCESS BIOCHEM, V43, P457, DOI 10.1016/j.procbio.2008.01.018; Wu WL, 2006, MOD FOOD SCI TECH, V22, P251; Yan QJ, 2015, FOOD CHEM, V179, P290, DOI 10.1016/j.foodchem.2015.01.137; Zheng YJ, 2017, J FUNCT FOODS, V28, P48, DOI 10.1016/j.jff.2016.11.021; Zhu KX, 2006, PROCESS BIOCHEM, V41, P1296, DOI 10.1016/j.procbio.2005.12.029	59	39	41	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191265	10.1371/journal.pone.0191265	http://dx.doi.org/10.1371/journal.pone.0191265			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408872	gold, Green Published, Green Submitted			2022-12-26	WOS:000424302800014
J	Mozo, A; Ordozgoiti, B; Gomez-Canaval, S				Mozo, Alberto; Ordozgoiti, Bruno; Gomez-Canaval, Sandra			Forecasting short-term data center network traffic load with convolutional neural networks	PLOS ONE			English	Article							WAVELET	Efficient resource management in data centers is of central importance to content service providers as 90 percent of the network traffic is expected to go through them in the coming years. In this context we propose the use of convolutional neural networks (CNNs) to forecast short-term changes in the amount of traffic crossing a data center network. This value is an indicator of virtual machine activity and can be utilized to shape the data center infrastructure accordingly. The behaviour of network traffic at the seconds scale is highly chaotic and therefore traditional time-series-analysis approaches such as ARIMA fail to obtain accurate forecasts. We show that our convolutional neural network approach can exploit the non-linear regularities of network traffic, providing significant improvements with respect to the mean absolute and standard deviation of the data, and outperforming ARIMA by an increasingly significant margin as the forecasting granularity is above the 16-second resolution. In order to increase the accuracy of the forecasting model, we exploit the architecture of the CNNs using multiresolution input distributed among separate channels of the first convolutional layer. We validate our approach with an extensive set of experiments using a data set collected at the core network of an Internet Service Provider over a period of 5 months, totalling 70 days of traffic at the one-second resolution.	[Mozo, Alberto; Ordozgoiti, Bruno; Gomez-Canaval, Sandra] Univ Politeccn Madrid, Dept Sistemas Informat, Madrid, Spain	Universidad Politecnica de Madrid	Mozo, A (corresponding author), Univ Politeccn Madrid, Dept Sistemas Informat, Madrid, Spain.	a.mozo@upm.es	Canaval, Sandra Gómez/AAM-2549-2021; VELASCO, BONIFACIO ALBERTO MOZO/AAB-1376-2019	Canaval, Sandra Gómez/0000-0002-9757-7871; VELASCO, BONIFACIO ALBERTO MOZO/0000-0001-9743-8604	European Union under the FP7 grant agreement [619633]; H grant agreement [671625]	European Union under the FP7 grant agreement; H grant agreement	The research leading to these results has received funding from the European Union under the FP7 grant agreement n. 619633 (project ONTIC, http://ict-ontic.eu) and H2020 grant agreement n. 671625 (project CogNet, http://www.cognet.5g-ppp.euf).	Abdel-Hamid O, 2012, INT CONF ACOUST SPEE, P4277, DOI 10.1109/ICASSP.2012.6288864; Brockwell P.J., 2016, INTRO TIME SERIES FO; Bui Nicola, 2015, 2015 IEEE 16th International Symposium on a World of Wireless, Mobile and Multimedia Networks (WoWMoM), P1, DOI 10.1109/WoWMoM.2015.7158161; Fang W., 2012, 2012 IEEE 9 INT C SE, P609, DOI DOI 10.1109/SCC.2012.47; Gmach Daniel, 2007, 2007 IEEE International Symposium on Workload Characterization, P171, DOI 10.1109/IISWC.2007.4362193; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Graves A, 2013, INT CONF ACOUST SPEE, P6645, DOI 10.1109/ICASSP.2013.6638947; Hinton G, 2009, SCIENCE, V1, P39, DOI DOI 10.4249/SCHOLARPEDIA.5947; Humphrey EJ, 2013, J INTELL INF SYST, V41, P461, DOI 10.1007/s10844-013-0248-5; Jiang Ming, 2009, Acta Electronica Sinica, V37, P2353; Kim Yoon, 2014, P 2014 C EMPIRICAL M, P1746, DOI [DOI 10.3115/V1/D14-1181, 10.3115/v1/D14-1181]; Kingma DP., 2014, ADAM METHOD STOCHAST; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lecun Y., 1995, HDB BRAIN THEORY NEU, DOI DOI 10.1109/IJCNN.2004.1381049; Liu H, 2013, APPL ENERG, V107, P191, DOI 10.1016/j.apenergy.2013.02.002; Lu NN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124601; Ming Mao, 2012, 2012 IEEE 5th International Conference on Cloud Computing (CLOUD), P423, DOI 10.1109/CLOUD.2012.103; Moayedi H.Z., 2008, P INT S INF TECHN, V4, P1, DOI DOI 10.1109/ITSIM.2008.4631947; Ordozgoiti B, 2017, P 25 EUR S ART NEUR; Papagiannaki K, 2003, IEEE INFOCOM SER, P1178; Piacentini M, 2011, COMPUT MANAG SCI, V8, P371, DOI 10.1007/s10287-010-0121-8; Pindoriya NM, 2008, IEEE T POWER SYST, V23, P1423, DOI 10.1109/TPWRS.2008.922251; Prevost J. J., 2011, Proceedings of the 2011 6th International Conference on System of Systems Engineering (SoSE), P276, DOI 10.1109/SYSOSE.2011.5966610; Sadek N, 2004, 2004 IEEE INTERNATIONAL CONFERENCE ON COMMUNICATIONS, VOLS 1-7, P2148, DOI 10.1109/ICC.2004.1312898; Salakhutdinov R., 2007, P 24 INT C MACH LEAR, V24, P791, DOI DOI 10.1145/1273496.1273596; Sayeed Z, 2015, 2015 IEEE 8TH INTERNATIONAL CONFERENCE ON CLOUD COMPUTING, P995, DOI 10.1109/CLOUD.2015.135; Shafie-khah M, 2011, ENERG CONVERS MANAGE, V52, P2165, DOI 10.1016/j.enconman.2010.10.047; Shafiq M. Zubair, 2011, Performance Evaluation Review, V39, P265, DOI 10.1145/2007116.2007148; Sutskever I., 2007, J MACH LEARN RES, P548; Tan ZF, 2010, APPL ENERG, V87, P3606, DOI 10.1016/j.apenergy.2010.05.012; Taylor Graham W, 2007, ADV NEURAL INFORM PR, P1345; Lora AT, 2007, IEEE T POWER SYST, V22, P1294, DOI 10.1109/TPWRS.2007.901670; Willinger W., 2000, SELF SIMILAR NETWORK, DOI 10.1002/047120644X; Yang JB, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P3995; Zaharia M., 2012, NSDI, P2; Zheng Y, 2007, INT C WEB AG INF MAN, P18; Zhou B., 2005, PROC HET NETS, P1	38	42	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191939	10.1371/journal.pone.0191939	http://dx.doi.org/10.1371/journal.pone.0191939			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408936	Green Submitted, gold, Green Published			2022-12-26	WOS:000424302800032
J	Slipher, GA; Hairston, WD; Bradford, JC; Bain, ED; Mrozek, RA				Slipher, Geoffrey A.; Hairston, W. David; Bradford, J. Cortney; Bain, Erich D.; Mrozek, Randy A.			Carbon nanofiber-filled conductive silicone elastomers as soft, dry bioelectronic interfaces	PLOS ONE			English	Article							EEG; ELECTROENCEPHALOGRAPHY	Soft and pliable conductive polymer composites hold promise for application as bioelectronic interfaces such as for electroencephalography (EEG). In clinical, laboratory, and real-world EEG there is a desire for dry, soft, and comfortable interfaces to the scalp that are capable of relaying the mu V-level scalp potentials to signal processing electronics. A key challenge is that most material approaches are sensitive to deformation-induced shifts in electrical impedance associated with decreased signal-to-noise ratio. This is a particular concern in real-world environments where human motion is present. The entire set of brain information outside of tightly controlled laboratory or clinical settings are currently unobtainable due to this challenge. Here we explore the performance of an elastomeric material solution purposefully designed for dry, soft, comfortable scalp contact electrodes for EEG that is specifically targeted to have flat electrical impedance response to deformation to enable utilization in real world environments. A conductive carbon nanofiber filled polydimethylsiloxane (CNFPDMS) elastomer was evaluated at three fill ratios (3, 4 and 7 volume percent). Electromechanical testing data is presented showing the influence of large compressive deformations on electrical impedance as well as the impact of filler loading on the elastomer stiffness. To evaluate usability for EEG, pre-recorded human EEG signals were replayed through the contact electrodes subjected to quasi-static compressive strains between zero and 35%. These tests show that conductive filler ratios well above the electrical percolation threshold are desirable in order to maximize signal-to-noise ratio and signal correlation with an ideal baseline. Increasing fill ratios yield increasingly flat electrical impedance response to large applied compressive deformations with a trade in increased material stiffness, and with nominal electrical impedance tunable over greater than 4 orders of magnitude. EEG performance was independent of filler loading above 4 vol% CNF (< 10(3) ohms).	[Slipher, Geoffrey A.] US Army, Res Lab, Vehicle Technol Directorate, Adelphi, MD 20783 USA; [Hairston, W. David; Bradford, J. Cortney] US Army, Res Lab, Human Res & Engn Directorate, Adelphi, MD 20783 USA; [Bain, Erich D.; Mrozek, Randy A.] US Army, Res Lab, Weap & Mat Res Directorate, Adelphi, MD 20783 USA	United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL)	Slipher, GA (corresponding author), US Army, Res Lab, Vehicle Technol Directorate, Adelphi, MD 20783 USA.	geoffrey.a.slipher.civ@mail.mil; william.d.hairston4.civ@mail.mil		Bain, Erich/0000-0002-2195-7798	US Army Research Lab, Center for Adaptive Soldier Technologies; US Army Research Lab [H70-HR51, DRI-13-VTD-009];  [076910227001]	US Army Research Lab, Center for Adaptive Soldier Technologies; US Army Research Lab(United States Department of DefenseUS Army Research Laboratory (ARL)); 	Funded by US Army Research Lab, Center for Adaptive Soldier Technologies. 076910227001. https://www.arl.army.mil/cast/. US Army Research Lab. H70-HR51 and DRI-13-VTD-009. https://www.arl.army.mil/www/default.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chau N, 2016, APPL PHYS LETT, V108, DOI 10.1063/1.4943628; Chi YM, 2012, IEEE T NEUR SYS REH, V20, P228, DOI 10.1109/TNSRE.2011.2174652; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Fiedler P, 2015, BRAIN TOPOGR, V28, P647, DOI 10.1007/s10548-015-0435-5; Geoffrey Slipher, 2016, STRETCHABLE CONDUCTI; GEVINS A, 1995, BIOL PSYCHOL, V40, P169, DOI 10.1016/0301-0511(95)05105-8; Hairston WD, 2015, LECT NOTES ARTIF INT, V9183, P221, DOI 10.1007/978-3-319-20816-9_22; Hairston WD, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046018; Kumar M, 2016, NANOCOMPOSITES, V2, P109, DOI 10.1080/20550324.2016.1221876; Lachaux JP, 2012, PROG NEUROBIOL, V98, P279, DOI 10.1016/j.pneurobio.2012.06.008; Lal SKL, 2002, PSYCHOPHYSIOLOGY, V39, P313, DOI 10.1017/S0048577201393095; Lance BJ, 2012, P IEEE, V100, P1585, DOI 10.1109/JPROC.2012.2184830; Lazarus N, 2015, ACS APPL MATER INTER, V7, P10080, DOI 10.1021/acsami.5b02189; Liao LD, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-5; Liao LD, 2011, SENSORS-BASEL, V11, P5819, DOI 10.3390/s110605819; Lin CT, 2011, IEEE T BIO-MED ENG, V58, P1200, DOI 10.1109/TBME.2010.2102353; Lofhede J, 2012, SENSORS-BASEL, V12, P16907, DOI 10.3390/s121216907; Lopez-Gordo MA, 2014, SENSORS-BASEL, V14, P12847, DOI 10.3390/s140712847; Mahar B, 2007, IEEE SENS J, V7, P266, DOI 10.1109/JSEN.2006.886863; Marathe AR, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00270; McDowell K, 2013, IEEE ACCESS, V1, P131, DOI 10.1109/ACCESS.2013.2260791; Moore MM, 2003, IEEE T NEUR SYS REH, V11, P162, DOI 10.1109/TNSRE.2003.814433; Mrozek RA, 2011, POLYMER, V52, P3422, DOI 10.1016/j.polymer.2011.05.021; Mullen TR, 2015, IEEE T BIO-MED ENG, V62, P2553, DOI 10.1109/TBME.2015.2481482; Ries AJ, 2014, J NEUROSCI NEUROENG, V3, P10, DOI [10.1166/jnsne.2014.1092, DOI 10.1166/JNSNE.2014.1092]; Ruffini Giulio, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1826	26	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0189415	10.1371/journal.pone.0189415	http://dx.doi.org/10.1371/journal.pone.0189415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408942	gold, Green Published, Green Submitted			2022-12-26	WOS:000424302800004
J	Tanaka, A; Fujii, Y; Kasai, N; Okajima, T; Nakashima, H				Tanaka, Aya; Fujii, Yuki; Kasai, Nahoko; Okajima, Takaharu; Nakashima, Hiroshi			Regulation of neuritogenesis in hippocampal neurons using stiffness of extracellular microenvironment	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SUBSTRATE STIFFNESS; GROWTH CONES; ACTIN ARCS; RIGIDITY; FILOPODIA; BRAIN; CELLS; MICROTUBULE; INSTABILITY	The mechanosensitivity of neurons in the central nervous system (CNS) is an interesting issue as regards understanding neuronal development and designing compliant materials as neural interfaces between neurons and external devices for treating CNS injuries and disorders. Although neurite initiation from a cell body is known to be the first step towards forming a functional nervous network during development or regeneration, less is known about how the mechanical properties of the extracellular microenvironment affect neuritogenesis. Here, we investigated the filamentous actin (F-actin) cytoskeletal structures of neurons, which are a key factor in neuritogenesis, on gel substrates with a stiffness-controlled substrate, to reveal the relationship between substrate stiffness and neuritogenesis. We found that neuritogenesis was significantly suppressed on a gel substrate with an elastic modulus higher than the stiffness of in vivo brain. Fluorescent images of the F-actin cytoskeletal structures showed that the F-actin organization depended on the substrate stiffness. Circumferential actin meshworks and arcs were formed at the edge of the cell body on the stiff gel substrates unlike with soft substrates. The suppression of F-actin cytoskeleton formation improved neuritogenesis. The results indicate that the organization of neuronal F-actin cytoskeletons is strongly regulated by the mechanical properties of the surrounding environment, and the mechanically-induced F-actin cytoskeletons regulate neuritogenesis.	[Tanaka, Aya; Kasai, Nahoko; Nakashima, Hiroshi] NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa, Japan; [Fujii, Yuki; Okajima, Takaharu] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan	Nippon Telegraph & Telephone Corporation; Hokkaido University	Tanaka, A (corresponding author), NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa, Japan.	tanaka.aya@lab.ntt.co.jp		Okajima, Takaharu/0000-0003-4230-1568; Tanaka, Aya/0000-0002-5402-752X	Nippon Telegraph and Telephone (NTT) Corporation; Japan Society for the Promotion of Science (JSPS) [16K17499]	Nippon Telegraph and Telephone (NTT) Corporation; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Nippon Telegraph and Telephone (NTT) Corporation and in part by a Grant-in-Aid for Young Scientists (B) (No. 16K17499) from the Japan Society for the Promotion of Science (JSPS) to AT. NTT supported the employer of following authors; Aya Tanaka, Nahoko Kasai, and Hiroshi Nakashima. The funder provided support in the form of salaries for these authors [AT, NK, HN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Franze K, 2013, DEVELOPMENT, V140, P3069, DOI 10.1242/dev.079145; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Hayashi S, 2015, MOL BIOL CELL, V26, P1743, DOI 10.1091/mbc.E14-08-1287; Hopkins AM, 2015, PROG NEUROBIOL, V125, P1, DOI 10.1016/j.pneurobio.2014.11.003; Kidoaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078067; Koch D, 2012, BIOPHYS J, V102, P452, DOI 10.1016/j.bpj.2011.12.025; Koser DE, 2016, NAT NEUROSCI, V19, P1592, DOI 10.1038/nn.4394; Kostic A, 2007, J CELL SCI, V120, P3895, DOI 10.1242/jcs.009852; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003; Lin YC, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041918; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Maloney JM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041923; Moeendarbary E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14787; Moshayedi P, 2014, BIOMATERIALS, V35, P3919, DOI 10.1016/j.biomaterials.2014.01.038; Moshayedi P, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194114; Mullen CA, 2015, BIOPHYS J, V108, P1604, DOI 10.1016/j.bpj.2015.02.022; Neukirchen D, 2011, J NEUROSCI, V31, P1528, DOI 10.1523/JNEUROSCI.3983-10.2011; Norman LL, 2010, CELL MOL BIOENG, V3, P398, DOI 10.1007/s12195-010-0137-8; Previtera ML, 2010, J BIOSCI BIOENG, V110, P459, DOI 10.1016/j.jbiosc.2010.04.004; Rosner H, 2007, BRAIN RES, V1176, P1, DOI 10.1016/j.brainres.2007.07.081; Saha K, 2010, BIOPHYS J, V99, pL94, DOI 10.1016/j.bpj.2010.09.045; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Tyler WJ, 2012, NAT REV NEUROSCI, V13, P867, DOI 10.1038/nrn3383; Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p	40	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191928	10.1371/journal.pone.0191928	http://dx.doi.org/10.1371/journal.pone.0191928			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408940	Green Published, Green Submitted, gold			2022-12-26	WOS:000424302800031
J	Zhang, MJ; Wang, XJ; Cui, MY; Wang, YP; Jiao, Z; Tan, ZF				Zhang, Miao; Wang, Xiaojie; Cui, Meiyan; Wang, Yanping; Jiao, Zhen; Tan, Zhongfang			Ensilage of oats and wheatgrass under natural alpine climatic conditions by indigenous lactic acid bacteria species isolated from high-cold areas	PLOS ONE			English	Article							AEROBIC STABILITY; LACTOBACILLUS-BUCHNERI; FERMENTATION QUALITY; SILAGE ADDITIVES; ACETIC-ACID; IN-VITRO; METABOLISM; BIOGAS; FRESH; STRAW	Five different species of selected broad-spectrum antibiotic lactic acid bacteria isolated from extremely high cold areas were used as starters to ferment indigenous forage oats and wheatgrass under rigid alpine climatic conditions. The five isolates were Lactobacillus plantarum QZ227, Enterococcus mundtiiQZ251, Pediococcus cellicola QZ311, Leuconostoc mesenteroides QZ1137 and Lactococcus lactis QZ613, and commercial Lactobacillus plantarum FG1 was used as the positive control and sterile water as the negative control. The minimum and maximum temperatures were -22 degrees C and 23 degrees C during the fermentation process, respectively. The pH of wheatgrass silage fermented by the QZ227 and FG1 inocula reached the expected values (<= 4.15) although the pathogens detected in the silage should be further investigated. All of the inocula additives used in this study were effective in improving the fermentation quality of oat silage as indicated by the higher content of lactic acid, lower pH values (<= 4.17) and significant inhibition of pathogens. QZ227 exhibited a fermentation ability that was comparable with the commercial inoculum FG1 for the whole process, and the deterioration rate was significantly lower than for FG1 after storage for 7 months. The pathogens Escherichia coli, mold and yeast were counted and isolated from the deteriorated silage. E. coli were the main NH3-N producer while F. fungi and yeast produced very little.	[Zhang, Miao; Wang, Xiaojie; Cui, Meiyan; Wang, Yanping; Jiao, Zhen; Tan, Zhongfang] Zhengzhou Univ, Coll Phys & Engn, Henan Key Lab Ion Beam Bioengn, Zhengzhou, Henan, Peoples R China	Zhengzhou University	Tan, ZF (corresponding author), Zhengzhou Univ, Coll Phys & Engn, Henan Key Lab Ion Beam Bioengn, Zhengzhou, Henan, Peoples R China.	tzhongfang@sina.com			National Natural Science Foundation of China [41101244]; Henan Province of China [152300410037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan Province of China	This work was supported by the National Natural Science Foundation of China (Grant No. 41101244 to ZFT), a grant (No. 152300410037) from Henan Province of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso VA, 2013, J APPL MICROBIOL, V115, P637, DOI 10.1111/jam.12178; AOAC International, 2016, OFFICIAL METHODS ANA; Balouiri M, 2016, J PHARM ANAL, V6, P71, DOI 10.1016/j.jpha.2015.11.005; Bastidas-Oyanedel JR, 2015, REV ENVIRON SCI BIO, V14, P473, DOI 10.1007/s11157-015-9369-3; Cao Y, 2011, ANIM SCI J, V82, P259, DOI 10.1111/j.1740-0929.2010.00840.x; Coelho MC, 2014, INT J FOOD MICROBIOL, V191, P53, DOI 10.1016/j.ijfoodmicro.2014.08.029; Driehuis F, 1999, J APPL MICROBIOL, V87, P583, DOI 10.1046/j.1365-2672.1999.00856.x; Elferink SJWHO, 2001, APPL ENVIRON MICROB, V67, P125, DOI 10.1128/AEM.67.1.125-132.2001; Ge J, 2015, INT J AGRIC BIOL, V17, P761, DOI 10.17957/IJAB/14.0003; Herrmann C, 2015, BIORESOURCE TECHNOL, V197, P393, DOI 10.1016/j.biortech.2015.08.114; Johnson D, 2002, NATURE, V416, P82, DOI 10.1038/416082a; Kawahata M, 2006, FEMS YEAST RES, V6, P924, DOI 10.1111/j.1567-1364.2006.00089.x; Kong X, 2017, SCI REPORTS, V6, P37224; Li XX, 2016, ANIM NUTR, V2, P229, DOI 10.1016/j.aninu.2016.04.003; Li Y., 2013, GUANGDONG TECHNOL, V20, P154; Lv H, 2014, IDENTIFICATION PRELI; Mansouri M, 2015, COMPUT ELECTRON AGR, V114, P145, DOI 10.1016/j.compag.2015.04.006; Menardo S, 2015, BIOENERG RES, V8, P1810, DOI 10.1007/s12155-015-9637-7; Ni KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121967; Ogunade IM, 2016, J DAIRY SCI, V99, P4427, DOI 10.3168/jds.2015-10766; Oliveira AS, 2017, J DAIRY SCI, V100, P4587, DOI 10.3168/jds.2016-11815; Qiu J, 2015, NATL SCI REV, V2, P489, DOI 10.1093/nsr/nwv076; Qiu J, 2008, NATURE, V454, P393, DOI 10.1038/454393a; Weghoff MC, 2015, ENVIRON MICROBIOL, V17, P670, DOI 10.1111/1462-2920.12493; Wilkinson JM, 2013, GRASS FORAGE SCI, V68, P1, DOI 10.1111/j.1365-2494.2012.00891.x; Xu ZS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14052-1; Yang YF, 2014, ISME J, V8, P430, DOI 10.1038/ismej.2013.146; Zhang M, 2017, CROP PASTURE SCI, V68, P225, DOI [10.1071/CP16324, 10.1071/cp16324]; Zhang M, 2017, ANIM SCI J, V88, P277, DOI 10.1111/asj.12632	29	10	10	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192368	10.1371/journal.pone.0192368	http://dx.doi.org/10.1371/journal.pone.0192368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408855	gold, Green Published, Green Submitted			2022-12-26	WOS:000424302800057
J	Lin, YS; Kuo, KT; Chen, SK; Huang, HS				Lin, Yi-Sian; Kuo, Kuan-Ting; Chen, Shih-Kuo; Huang, Hsien-Sung			RBFOX3/NeuN is dispensable for visual function	PLOS ONE			English	Article							MOUSE RETINA; GANGLION; DIFFERENTIATION; PROTEIN; SYSTEM; CELLS	w RBFOX3/NeuN is a neuronal splicing regulator involved in neural circuitry balance, as well as neurogenesis and synaptogenesis. Rbfox3 is expressed in neurons; however, in the retina, expression is restricted to cells in the ganglion cell layer and some cells of the inner nuclear layer. Rbfox3 is expressed in a layer-specific manner in the retina, which implies a functional role, however, the role of RBFOX3 in the retina is unknown. Rbfox3 homozygous knockout (Rbfox3(-/-)) mice exhibit deficits in visual learning; therefore, understanding the role of RBFOX3 in the retina is critical for interpreting behavioral results. We found Rbfox3 expression was developmentally regulated in the retina and specifically expressed in ganglion cells, amacrine cells and horizontal cells of the retina. We demonstrate deletion of Rbfox3 resulted in a reduction in the thickness of the inner plexiform layer of the retina, where synapses are formed. Number of ganglion cells and amacrine cells is normal with loss of Rbfox3. Innervation of retinal ganglion cells into their targeted brain regions is normal in Rbfox3(-/-)mice. Importantly, Rbfox3(-/-)mice displayed normal non-image and image forming functions. Taken together, our results suggest RBFOX3 is dispensable for visual function.	[Lin, Yi-Sian; Huang, Hsien-Sung] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei, Taiwan; [Kuo, Kuan-Ting] Natl Taiwan Univ, Coll Med, Dept Pathol, Taipei, Taiwan; [Chen, Shih-Kuo] Natl Taiwan Univ, Coll Life Sci, Dept Life Sci, Taipei, Taiwan; [Chen, Shih-Kuo; Huang, Hsien-Sung] Neurodev Club Taiwan, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Huang, HS (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei, Taiwan.; Huang, HS (corresponding author), Neurodev Club Taiwan, Taipei, Taiwan.	huang.hsiensung@gmail.com		Huang, Hsien-Sung/0000-0003-2657-3635; CHEN, SHIH-KUO/0000-0002-7921-1358	Ministry of Science and Technology, Taiwan [MOST 104-2314-B-002-078-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology, Taiwan (MOST 104-2314-B-002-078-MY3). The recipient of this funding is H-S. H. The URL of this funding agency is (https://www.most.gov.tw/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Ministry of Science and Technology, Taiwan (MOST 104-2314-B-002-078-MY3). We thank the staff of the imaging core at the First Core Labs, National Taiwan University College of Medicine, for technical assistance.	Aldiri I, 2017, NEURON, V94, P550, DOI 10.1016/j.neuron.2017.04.022; Amin N, 2016, EUR J HUM GENET, V24, P1488, DOI 10.1038/ejhg.2016.31; BLANKS JC, 1974, J COMP NEUROL, V156, P81, DOI 10.1002/cne.901560107; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Chen Y., 2016, OXIDATIVE MED CELLUL, V2016, P9, DOI DOI 10.3390/A9040070; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Duan W, 2015, MOL NEUROBIOLOGY; FISHER LJ, 1979, J COMP NEUROL, V187, P359, DOI 10.1002/cne.901870207; Kim KK, 2013, J CELL BIOL, V200, P443, DOI 10.1083/jcb.201206146; Lai D, 2013, PLOS ONE, V8; Lin YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164164; Lucas CH, 2014, NEUROSCI LETT, V558, P97, DOI 10.1016/j.neulet.2013.10.037; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Raymond ID, 2008, MOL VIS, V14, P1559; Reese BE, 2011, VISION RES, V51, P613, DOI 10.1016/j.visres.2010.07.010; Templeton JP, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-90; Utami KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090852; Wang HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17383; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zhu YL, 2013, INVEST OPHTH VIS SCI, V54, P25, DOI 10.1167/iovs.12-10861	26	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192355	10.1371/journal.pone.0192355	http://dx.doi.org/10.1371/journal.pone.0192355			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401485	Green Submitted, Green Published, gold			2022-12-26	WOS:000424101400052
J	Han, JH; Harmoney, KM; Dokmeci, E; Torrez, J; Chavez, CM; de Ortega, LC; Kuttesch, JF; Muller, M; Winter, SS				Han, Jennifer H.; Harmoney, Kathryn M.; Dokmeci, Elif; Torrez, Jacqueline; Chavez, Cathy M.; de Ortega, Loretta Cordova; Kuttesch, John F.; Muller, Martha; Winter, Stuart S.			Dynamic re-immunization of off-treatment childhood cancer survivors: An implementation feasibility study	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; STANDARD CHEMOTHERAPY; HUMORAL IMMUNITY; CHILDREN; VACCINATION; COMPLETION; THERAPY; IMMUNODEFICIENCY; REVACCINATION; ANTIBODIES	There are no universally approved re-vaccination guidelines for non-transplant pediatric cancer survivors. We hypothesized that by utilizing a response-based re-vaccination schedule, we could tailor vaccine schedules in off-treatment cancer survivors. Pre-vaccination antibody levels were obtained in 7 patients at an average of 20 days after the end of treatment date. In those without protective antibody levels, we administered vaccines 3 months after completion of treatment. Revaccinating patients 3 months after the end of treatment date resulted in protective antibody levels for most vaccines. We showed, on a preliminary basis, that vaccinating non-transplanted pediatric cancer survivors can be dynamically implemented in children with recovering immune function.	[Han, Jennifer H.; de Ortega, Loretta Cordova] Univ New Mexico, Dept Pediat, Hlth Sci Ctr, 1 Univ New Mexico, Albuquerque, NM 87131 USA; [Harmoney, Kathryn M.] Univ Iowa, Dept Pediat, Stead Family Childrens Hosp, Div Hematol Oncol, 200 Hawkins Dr, Iowa City, IA 52242 USA; [Dokmeci, Elif] Univ New Mexico, Dept Pediat, Hlth Sci Ctr, Div Allergy Immunol, 1 Univ New Mexico, Albuquerque, NM 87131 USA; [Torrez, Jacqueline; Chavez, Cathy M.; Kuttesch, John F.] Univ New Mexico, Dept Pediat, Hlth Sci Ctr, Div Hematol Oncol, 1 Univ New Mexico, Albuquerque, NM 87131 USA; [Muller, Martha] Univ New Mexico, Dept Pediat, Hlth Sci Ctr, Div Infect Dis, 1 Univ New Mexico, Albuquerque, NM 87131 USA; [Winter, Stuart S.] Childrens Hosp & Clin Minnesota, Canc & Blood Disorders Program, 2525 Chicago Ave South, Minneapolis, MN USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of Iowa; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; Children's Hospitals & Clinics of Minnesota	Han, JH (corresponding author), Univ New Mexico, Dept Pediat, Hlth Sci Ctr, 1 Univ New Mexico, Albuquerque, NM 87131 USA.; Harmoney, KM (corresponding author), Univ Iowa, Dept Pediat, Stead Family Childrens Hosp, Div Hematol Oncol, 200 Hawkins Dr, Iowa City, IA 52242 USA.	jhhan@salud.unm.edu; kathryn-harmoney@uiowa.edu						Brodtman DH, 2005, J PEDIATR-US, V146, P654, DOI 10.1016/j.jpeds.2004.12.043; Caver TE, 1998, LEUKEMIA, V12, P619, DOI 10.1038/sj.leu.2400970; DEVAAN GAM, 1982, EUR J PEDIATR, V139, P113, DOI 10.1007/BF00441492; Ercan TE, 2005, J PEDIAT HEMATOL ONC, V27, P273, DOI 10.1097/01.mph.0000163214.37147.5a; Esposito S, 2010, VACCINE, V28, P3278, DOI 10.1016/j.vaccine.2010.02.096; KOMADA Y, 1992, CANCER IMMUNOL IMMUN, V35, P271, DOI 10.1007/BF01789334; Lehrnbecher T, 2011, BRIT J HAEMATOL, V152, P754, DOI 10.1111/j.1365-2141.2010.08522.x; Ljungman P, 1999, BONE MARROW TRANSPL, V23, P635, DOI 10.1038/sj.bmt.1701641; Mackall CL, 2000, STEM CELLS, V18, P10, DOI 10.1634/stemcells.18-1-10; Nilsson A, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e91; Patel SR, 2007, CLIN INFECT DIS, V44, P635, DOI 10.1086/511636; Reinhardt D, 2003, SCAND J INFECT DIS, V35, P851, DOI 10.1080/00365540310016600; RIDGWAY D, 1991, AM J DIS CHILD, V145, P887, DOI 10.1001/archpedi.1991.02160080065022; Rubin LG, 2014, CLIN INFECT DIS, V58, pE44, DOI [10.1093/cid/cit816, 10.1093/cid/cit684]; Ruggiero A, 2011, PEDIATR BLOOD CANCER, V57, P1104, DOI 10.1002/pbc.23333; Shetty AK, 2012, OCHSNER J, V12, P228; van Tilburg CM, 2006, LEUKEMIA, V20, P1717, DOI 10.1038/sj.leu.2404326; Zignol M, 2004, CANCER-AM CANCER SOC, V101, P635, DOI 10.1002/cncr.20384	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191804	10.1371/journal.pone.0191804	http://dx.doi.org/10.1371/journal.pone.0191804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389976	gold, Green Published, Green Submitted			2022-12-26	WOS:000423793400038
J	Meza-Lopez, MM; Mooney, KA; Thompson, AL; Ho, NK; Pratt, JD				Meza-Lopez, Maria M.; Mooney, Kailen A.; Thompson, Amanda L.; Ho, Nicole K.; Pratt, Jessica D.			A test for clinal variation in Artemisia californica and associated arthropod responses to nitrogen addition	PLOS ONE			English	Article							COASTAL SAGE SCRUB; CLIMATE-CHANGE; TERRESTRIAL ECOSYSTEMS; SPECIES INTERACTIONS; SEMIARID SHRUBLANDS; ALTERED WATER; NATIVE SHRUB; N DEPOSITION; PLANT; COMMUNITY	The response of plant traits to global change is of fundamental importance to understanding anthropogenic impacts on natural systems. Nevertheless, little is known about plant genetic variation in such responses or the indirect effect of environmental change on higher trophic levels. In a three-year common garden experiment, we grew the shrub Artemisia californica from five populations sourced along a 700 km latitudinal gradient under ambient and nitrogen (N) addition (20 kg N ha(-1)) and measured plant traits and associated arthropods. N addition increased plant biomass to a similar extent among all populations. In contrast, N addition effects on most other plant traits varied among plant populations; N addition reduced specific leaf area and leaf percent N and increased carbon to nitrogen ratios in the two northern populations, but had the opposite or no effect on the three southern populations. N addition increased arthropod abundance to a similar extent among all populations in parallel with an increase in plant biomass, suggesting that N addition did not alter plant resistance to herbivores. N addition had no effect on arthropod diversity, richness, or evenness. In summary, genetic variation among A. californica populations mediated leaf-trait responses to N addition, but positive direct effects of N addition on plant biomass and indirect effects on arthropod abundance were consistent among all populations.	[Meza-Lopez, Maria M.; Mooney, Kailen A.; Thompson, Amanda L.; Ho, Nicole K.; Pratt, Jessica D.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Pratt, JD (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	jdpratt@uci.edu		Meza-Lopez, Maria/0000-0002-8120-4747	Ford Foundation Postdoctoral Fellowship; National Science Foundation [NSF-DEB-1354734, NSF-GK12 DGE-0638751]; Environmental Protection Agency [EPA-STAR FP-91724101]; UC-Irvine Graduate Division; Newkirk Center for Science Society; Orange County Association of Environmental Professionals; Newport Bay Conservancy; Lake Forest Garden Club	Ford Foundation Postdoctoral Fellowship; National Science Foundation(National Science Foundation (NSF)); Environmental Protection Agency(United States Environmental Protection Agency); UC-Irvine Graduate Division; Newkirk Center for Science Society; Orange County Association of Environmental Professionals; Newport Bay Conservancy; Lake Forest Garden Club	MMML was supported by a Ford Foundation Postdoctoral Fellowship (http://sites.nationalacademies.org/PGA/FordFellowships/index.htm). KAM received a research grant from National Science Foundation NSF-DEB-1354734 (https://www.nsf.gov/). Fellowship assistance was provided to JDP from National Science Foundation NSF-GK12 DGE-0638751 (https://www.nsf.gov), and Environmental Protection Agency EPA-STAR FP-91724101 (https://www.nsf.gov/), and the UC-Irvine Graduate Division, as well as grants from the Newkirk Center for Science & Society, Orange County Association of Environmental Professionals, Newport Bay Conservancy, and the Lake Forest Garden Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank L. Liu, A. Datu, S. Luu, C. Hertler, and D. Tran for help with field data collection. The UC Irvine Arboretum provided logistical support and space for plant propagation; Orange County Parks provided logistical support and storage space at our field site. This work was supported by grants to JDP from the Newkirk Center for Science & Society, Orange County Association of Environmental Professionals, Newport Bay Conservancy, and the Lake Forest Garden Club. MMML was supported by a Ford Foundation Postdoctoral Fellowship. A research grant to KAM was provided by NSF-DEB-1354734. Fellowship assistance to JDP was provided by NSF-GK12 DGE-0638751, EPA-STAR FP-91724101, and the UC-Irvine Graduate Division. This publication has not been formally reviewed by the EPA; the views expressed herein are solely those of the authors.	Allen EB, 1998, NITROGEN DEPOSITION, P131; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Burger JC, 2003, CONSERV BIOL, V17, P460, DOI 10.1046/j.1523-1739.2003.01325.x; Bytnerowicz A, 1996, ENVIRON POLLUT, V92, P127, DOI 10.1016/0269-7491(95)00106-9; Cleland EE, 2010, ANN NY ACAD SCI, V1195, P46, DOI 10.1111/j.1749-6632.2010.05458.x; DAVIS FW, 1994, J VEG SCI, V5, P743, DOI 10.2307/3235887; Egerton-Warburton LM, 2000, ECOL APPL, V10, P484, DOI 10.1890/1051-0761(2000)010[0484:SIAMCA]2.0.CO;2; Egerton-Warburton LM, 2007, ECOL MONOGR, V77, P527, DOI 10.1890/06-1772.1; Fenn ME, 2010, J ENVIRON MANAGE, V91, P2404, DOI 10.1016/j.jenvman.2010.07.034; Gornish ES, 2013, AM J BOT, V100, P1422, DOI 10.3732/ajb.1300046; Johnson MTJ, 2005, ECOLOGY, V86, P874, DOI 10.1890/04-1068; Kimball S, 2014, ECOL APPL, V24, P1390, DOI 10.1890/13-1313.1; Matson P, 2002, AMBIO, V31, P113, DOI 10.1639/0044-7447(2002)031[0113:TGONDC]2.0.CO;2; McCluney KE, 2012, BIOL REV, V87, P563, DOI 10.1111/j.1469-185X.2011.00209.x; Meunier CL, 2016, GLOBAL CHANGE BIOL, V22, P164, DOI 10.1111/gcb.12967; Meza-Lopez MM, 2017, PLANT ECOL, V218, P835, DOI 10.1007/s11258-017-0733-y; Muola A, 2010, J EVOLUTION BIOL, V23, P2185, DOI 10.1111/j.1420-9101.2010.02077.x; Nahum S, 2008, TREE GENET GENOMES, V4, P777, DOI 10.1007/s11295-008-0150-4; Oliver I, 1996, ECOL APPL, V6, P594, DOI 10.2307/2269394; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; Pennings SC, 2005, OIKOS, V110, P547, DOI 10.1111/j.0030-1299.2005.13792.x; Pivovaroff AL, 2016, OECOLOGIA, V181, P721, DOI 10.1007/s00442-016-3609-2; Poyry J, 2017, GLOBAL ECOL BIOGEOGR, V26, P18, DOI 10.1111/geb.12521; Pratt JD, 2017, ECOLOGY, V98, P79, DOI 10.1002/ecy.1620; Pratt JD, 2014, OIKOS, V123, P953, DOI 10.1111/oik.01156; Pratt JD, 2013, GLOBAL CHANGE BIOL, V19, P2454, DOI 10.1111/gcb.12199; Rasband WS, 1997, IMAGE J; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; SAS Institute, 2010, STAT AN SOFTW; Schwede D.B., 2014, ATMOS ENVIRON, V92, P207, DOI [DOI 10.1016/j.atmosenv.2014.04.008, 10.1016/j.atmosenv.2014.04.008]; Siguenza C, 2006, PLANT SOIL, V286, P153, DOI 10.1007/s11104-006-9034-2; Smith BM, 2009, RESTOR ECOL, V17, P12, DOI 10.1111/j.1526-100X.2007.00327.x; Thompson JD, 2007, ECOL MONOGR, V77, P421, DOI 10.1890/06-1973.1; Throop HL, 2004, ECOSYSTEMS, V7, P109, DOI 10.1007/s10021-003-0225-x; Trotter RT, 2008, ECOL ENTOMOL, V33, P1, DOI 10.1111/j.1365-2311.2007.00941.x; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Valliere JM, 2017, GLOBAL CHANGE BIOL, P1; Vourlitis GL, 2012, J ARID ENVIRON, V82, P115, DOI 10.1016/j.jaridenv.2012.02.006; Vourlitis GL, 2007, ECOSYSTEMS, V10, P263, DOI 10.1007/s10021-007-9030-2; Vourlitis GL, 2017, OECOLOGIA, V184, P267, DOI 10.1007/s00442-017-3860-1; White T.C, 2012, INADEQUATE ENV NITRO; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Wimp GM, 2007, MOL ECOL, V16, P5057, DOI 10.1111/j.1365-294X.2007.03544.x; Wolkovich EM, 2010, ECOLOGY, V91, P756, DOI 10.1890/09-0147.1	45	0	0	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191997	10.1371/journal.pone.0191997	http://dx.doi.org/10.1371/journal.pone.0191997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390030	Green Published, gold			2022-12-26	WOS:000423793400048
J	Wassmann, R; Alberto, MC; Tirol-Padre, A; Hoang, NT; Romasanta, R; Centeno, CA; Sander, BO				Wassmann, Reiner; Alberto, Ma. Carmelita; Tirol-Padre, Agnes; Nghia Trong Hoang; Romasanta, Ryan; Centeno, Caesar Arloo; Sander, Bjoern Ole			Increasing sensitivity of methane emission measurements in rice through deployment of 'closed chambers' at nighttime	PLOS ONE			English	Article							DIFFERENT GROWTH-STAGES; DIURNAL-VARIATION; EDDY COVARIANCE; ROOT EXUDATION; CH4 EMISSIONS; FIELDS; CULTIVARS; IMPACT; TEMPERATURE; TRANSPORT	This study comprises field experiments on methane emissions from rice fields conducted with an Eddy-Covariance (EC) system as well as test runs for a modified closed chamber approach based on measurements at nighttime. The EC data set covers 4 cropping seasons with highly resolved emission rates (raw data in 10 Hz frequency have been aggregated to 30-min records). The diel patterns were very pronounced in the two dry seasons with peak emissions at early afternoon and low emissions at nighttime. These diel patterns were observed at all growing stages of the dry seasons. In the two wet seasons, the diel patterns were only visible during the vegetative stages while emission rates during reproductive and ripening stages remained within a fairly steady range and did not show any diel patterns. In totality, however, the data set revealed a very strong linear relationship between nocturnal emissions (12-h periods) and the full 24-h periods resulting in an R-2-value of 0.8419 for all data points. In the second experiment, we conducted test runs for chamber measurements at nighttime with much longer deployment times (6 h) as compared to measurements at daylight (typically for 30 min). Conducting chamber measurements at nighttime excluded drastic changes of temperatures and CO2 concentrations. The data also shows that increases in CH4 concentrations remained on linear trajectory over a 6h period at night. While end CH4 concentrations were consistently >3.5 ppm, this long-term enclosure represents a very robust approach to quantify emissions as compared to assessing short-term concentration increases over time near the analytical detection limit. Finally, we have discussed the potential applications of this new approach that would allow emission measurements even when conventional (daytime) measurements will not be suitable. Nighttime chamber measurements offer an alternative to conventional (daytime) measurements if either (i) baseline emissions are at a very low level, (ii) differences of tested crop treatments or varieties are very small or (iii) the objective is to screen a large number of rice varieties for taking advantage of progress in genome sequencing.	[Wassmann, Reiner; Alberto, Ma. Carmelita; Tirol-Padre, Agnes; Romasanta, Ryan; Centeno, Caesar Arloo; Sander, Bjoern Ole] Int Rice Res Inst, Los Banos, Philippines; [Wassmann, Reiner] Karlsruhe Inst Technol, Inst Meteorol & Climate Res, Garmisch Partenkirchen, Germany; [Nghia Trong Hoang] Hue Univ Agr & Forestry, Hue City, Vietnam	CGIAR; International Rice Research Institute (IRRI); Helmholtz Association; Karlsruhe Institute of Technology; Hue University	Wassmann, R (corresponding author), Int Rice Res Inst, Los Banos, Philippines.; Wassmann, R (corresponding author), Karlsruhe Inst Technol, Inst Meteorol & Climate Res, Garmisch Partenkirchen, Germany.	r.wassmann@irri.org	Nghia, Hoang Trong/AAK-4905-2021	Nghia, Hoang Trong/0000-0002-6700-7018	CGIAR Research Program on Rice Agri-Food Systems (RICE); CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS); Climate and Clean Air Coalition to Reduce Short-lived Climate Pollutants (CCAC); Climate, Food and Farming (CLIFF) Network, an initiative of CCAFS; Climate, Food and Farming (CLIFF) Network; Climate, Food and Farming (CLIFF) Network [C-079-17]; CGIAR RICE agrifood research program [CRP 15]; Climate and Clean Air Coalition (CCAC) [DTIE16-EN050]	CGIAR Research Program on Rice Agri-Food Systems (RICE)(CGIAR); CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS)(CGIAR); Climate and Clean Air Coalition to Reduce Short-lived Climate Pollutants (CCAC); Climate, Food and Farming (CLIFF) Network, an initiative of CCAFS; Climate, Food and Farming (CLIFF) Network; Climate, Food and Farming (CLIFF) Network; CGIAR RICE agrifood research program(CGIAR); Climate and Clean Air Coalition (CCAC)	This work was funded through a grant from the Climate, Food and Farming (CLIFF) Network, implemented as part of the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS), which is carried out with support from CGIAR Fund Donors and through bilateral funding agreements (Agreement #:C-079-17). For details please visit https://ccafs.cgiar.org/donors. The views expressed in this document cannot be taken to reflect the official opinions of these organizations. This work was further supported through the CGIAR RICE agrifood research program (CRP 15). The position of B.O. Sander at IRRI was funded by the Climate and Clean Air Coalition (CCAC) to reduce short-lived climate pollutants (DTIE16-EN050).	Alberto MCR, 2014, FIELD CROP RES, V160, P12, DOI 10.1016/j.fcr.2014.02.008; Alberto MCR, 2012, FIELD CROP RES, V134, P80, DOI 10.1016/j.fcr.2012.05.002; [Anonymous], GEOPHYS RES LETT; Aulakh MS, 2001, PLANT SOIL, V230, P77, DOI 10.1023/A:1004817212321; Aulakh MS, 2000, NUTR CYCL AGROECOSYS, V58, P367, DOI 10.1023/A:1009839929441; BALDOCCHI DD, 1988, ECOLOGY, V69, P1331, DOI 10.2307/1941631; Buendia LV, 1998, CHEMOSPHERE, V36, P395, DOI 10.1016/S0045-6535(97)00283-X; ButterbachBahl K, 1997, PLANT CELL ENVIRON, V20, P1175, DOI 10.1046/j.1365-3040.1997.d01-142.x; Centeno CAR, 2017, ATMOS ENVIRON, V167, P23, DOI 10.1016/j.atmosenv.2017.08.007; Chanton JP, 1997, GLOBAL BIOGEOCHEM CY, V11, P15, DOI 10.1029/96GB03761; Das K, 2008, PHYSIOL PLANTARUM, V134, P303, DOI 10.1111/j.1399-3054.2008.01137.x; Ding A, 1999, GLOBAL BIOGEOCHEM CY, V13, P1045, DOI 10.1029/1999GB900084; Eggleston S., 2006, 2006 IPCC GUIDELINES; Gogoi N, 2008, AGRON SUSTAIN DEV, V28, P181, DOI 10.1051/agro:2008005; Gutierrez J, 2014, BIOL FERT SOILS, V50, P861, DOI 10.1007/s00374-014-0904-0; Gutierrez J, 2013, FIELD CROP RES, V146, P16, DOI 10.1016/j.fcr.2013.03.003; Hatala JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051303; Hosono T, 1997, PLANT SOIL, V191, P233, DOI 10.1023/A:1004203208686; Kljun N, 2004, BOUND-LAY METEOROL, V112, P503, DOI 10.1023/B:BOUN.0000030653.71031.96; Komiya S, 2015, INT SCHOLARLY RES NO; Kumar JIN, 2009, PADDY WATER ENVIRON, V7, P11, DOI 10.1007/s10333-008-0147-5; Lu Y, 1999, BIOGEOCHEMISTRY, V47, P203, DOI 10.1007/bf00994923; Ma K, 2010, GLOBAL CHANGE BIOL, V16, P3085, DOI 10.1111/j.1365-2486.2009.02145.x; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; Minamikawa K., 2012, GREENHOUSE GAS MEAS, V2, P118, DOI DOI 10.1080/20430779.2012.729988; Minamikawa K., 2015, GUIDELINES MEASURING; Neue H.U., 1994, NIAES SERIES, V2, P55; Qin XB, 2015, J INTEGR ENVIRON SCI, V12, P47, DOI 10.1080/1943815X.2015.1118388; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Ripp J, 1996, ANAL DETECTION LIMIT; Rolston D.E., 1986, METHODS SOIL ANAL 1; Sander B.O., 2014, GREENH GAS MEAS MANA; SAS Institute Inc, 2011, SASQC R 93 USERS GUI, P1313; Sass RL, 1991, GLOBAL BIOGEOCHEM CY, V5, P335, DOI 10.1029/91GB02586; Satpathy SN, 1997, PLANT SOIL, V195, P267, DOI 10.1023/A:1004202515767; SCHUTZ H, 1990, BIOGEOCHEMISTRY, V11, P77; SIMPSON IJ, 1995, J GEOPHYS RES-ATMOS, V100, P7283, DOI 10.1029/94JD03326; Soil Survey Staff, 2010, KEYS SOIL TAXONOMY, Veleventh; Su J, 2015, NATURE, V523, P602, DOI 10.1038/nature14673; van der Gon HACD, 2002, P NATL ACAD SCI USA, V99, P12021, DOI 10.1073/pnas.192276599; Wang B, 2000, NUTR CYCL AGROECOSYS, V58, P349, DOI 10.1023/A:1009879610785; Wassmann R, 2000, NUTR CYCL AGROECOSYS, V58, P23, DOI 10.1023/A:1009874014903; Wassmann R, 2000, NUTR CYCL AGROECOSYS, V58, P107, DOI 10.1023/A:1009838401699; Weller S, 2015, J PLANT NUTR SOIL SC, V178, P755, DOI 10.1002/jpln.201500092; Yagi K, 1997, NUTR CYCL AGROECOSYS, V49, P213, DOI 10.1023/A:1009743909716; Yang SS, 1999, AGR ECOSYST ENVIRON, V76, P75, DOI 10.1016/S0167-8809(99)00074-2; Yang W, 2008, AGRON J, V100, P1390, DOI 10.2134/agronj2007.0356; Yu LF, 2013, ENVIRON POLLUT, V181, P81, DOI 10.1016/j.envpol.2013.06.018	48	7	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191352	10.1371/journal.pone.0191352	http://dx.doi.org/10.1371/journal.pone.0191352			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390000	Green Published, gold			2022-12-26	WOS:000423793400017
J	Di Paola, N; Freire, CCD; Zanotto, PMD				Di Paola, Nicholas; de Melo Freire, Caio Cesar; de Andrade Zanotto, Paolo Marinho			Does adaptation to vertebrate codon usage relate to flavivirus emergence potential?	PLOS ONE			English	Article							WEST-NILE-VIRUS; INSECT-SPECIFIC FLAVIVIRUSES; HUMAN HOUSEKEEPING GENES; TIME RT-PCR; MOLECULAR EVOLUTION; YELLOW-FEVER; LINEAGE 2; RIG-I; HOST; BIAS	Codon adaptation index (CAI) is a measure of synonymous codon usage biases given a usage reference. Through mutation, selection, and drift, viruses can optimize their replication efficiency and produce more offspring, which could increase the chance of secondary transmission. To evaluate how higher CAI towards the host has been associated with higher viral titers, we explored temporal trends of several historic and extensively sequenced zoonotic flaviviruses and relationships within the genus itself. To showcase evolutionary and epidemiological relationships associated with silent, adaptive synonymous changes of viruses, we used codon usage tables from human housekeeping and antiviral immune genes, as well as tables from arthropod vectors and vertebrate species involved in the flavivirus maintenance cycle. We argue that temporal trends of CAI changes could lead to a better understanding of zoonotic emergences, evolutionary dynamics, and host adaptation. CAI appears to help illustrate historically relevant trends of well-characterized viruses, in different viral species and genetic diversity within a single species. CAI can be a useful tool together with in vivo and in vitro kinetics, phylodynamics, and additional functional genomics studies to better understand species trafficking and viral emergence in a new host.	[Di Paola, Nicholas; de Andrade Zanotto, Paolo Marinho] Univ Sao Paulo, Biomed Sci Inst, Dept Microbiol, Lab Mol Evolut & Bioinformat, Sao Paulo, Brazil; [de Melo Freire, Caio Cesar] UFSCar Fed Univ Sao Carlos, Dept Genet & Evolut, Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Carlos	Zanotto, PMD (corresponding author), Univ Sao Paulo, Biomed Sci Inst, Dept Microbiol, Lab Mol Evolut & Bioinformat, Sao Paulo, Brazil.	pzanotto@usp.br	de A. Zanotto, Paolo M./B-9286-2019	de A. Zanotto, Paolo M./0000-0002-8167-0625	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [441105/2016-5]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/22136-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	P.M.A.Z received funding from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, http://cnpq.br/), grant number 441105/2016-5. N.D. received funding from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, http://fapesp.br/), grant number 2013/22136-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Allison AB, 2004, EMERG INFECT DIS, V10, P2252, DOI 10.3201/eid1012.040511; Andersen KG, 2015, CELL, V162, P738, DOI 10.1016/j.cell.2015.07.020; Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; Bagnarelli P., 2011, EUROSURVEILLANCE, V2011, P16; Bahir I, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.71; Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; Bakonyi T, 2005, EMERG INFECT DIS, V11, P225, DOI 10.3201/eid1102.041028; Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005; Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372; Beck A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001910; Behura SK, 2014, MOL GENET GENOMICS, V289, P885, DOI 10.1007/s00438-014-0857-x; Behura SK, 2013, BIOL REV, V88, P49, DOI 10.1111/j.1469-185X.2012.00242.x; Behura SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043111; Billoir F, 2000, J GEN VIROL, V81, P781, DOI 10.1099/0022-1317-81-3-781; Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927; Bolling BG, 2011, AM J TROP MED HYG, V85, P169, DOI 10.4269/ajtmh.2011.10-0474; Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075; Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106; Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105; Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]; Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0; Crabtree MB, 2009, ARCH VIROL, V154, P857, DOI 10.1007/s00705-009-0373-1; Crabtree MB, 2003, ARCH VIROL, V148, P1095, DOI 10.1007/s00705-003-0019-7; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Day T, 2001, FITNESS, P1; Dobler G, 2010, VET MICROBIOL, V140, P221, DOI 10.1016/j.vetmic.2009.08.024; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupuis AP, 2003, EMERG INFECT DIS, V9, P860; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Fall G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006078; Fall G, 2014, AM J TROP MED HYG, V90, P747, DOI 10.4269/ajtmh.13-0405; Freire CCdM, 2015, SPREAD PANDEMIC ZIKA; Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867; Gould E.A, 1997, GENETIC EVOLUTION FL; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013; Hoshino K, 2012, J MED ENTOMOL, V49, P175, DOI 10.1603/ME11123; Hoshino K, 2009, VIROLOGY, V391, P119, DOI 10.1016/j.virol.2009.06.025; Jenkins GM, 2001, J MOL EVOL, V52, P383, DOI 10.1007/s002390010168; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim DY, 2009, VIROLOGY, V386, P154, DOI 10.1016/j.virol.2008.12.034; Kuno G, 2007, J MED ENTOMOL, V44, P93, DOI 10.1603/0022-2585(2007)44[93:HRSOFC]2.0.CO;2; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Labuda M, 2004, PARASITOLOGY, V129, pS221, DOI 10.1017/S0031182004005220; Li WLS, 2012, MOL BIOL EVOL, V29, P751, DOI 10.1093/molbev/msr232; LIU ZY, 2016, ELIFE, V5, DOI DOI 10.7554/ELIFE.17636; Longdon B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004395; Magassouba N, 2015, PLOS MED, V12, P1; May FJ, 2011, J VIROL, V85, P2964, DOI 10.1128/JVI.01963-10; McMullen AR, 2013, J GEN VIROL, V94, P318, DOI 10.1099/vir.0.046888-0; Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849; Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pachler K, 2014, EMERG INFECT DIS, V20, P2119, DOI 10.3201/eid2012.140921; Papa A, 2010, EUROSURVEILLANCE, V15; Papa A, 2011, EMERG INFECT DIS, V17, P920, DOI 10.3201/eid1705.101759; Petersen LR, 2001, EMERG INFECT DIS, V7, P611; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Pettersson JHO, 2014, J GEN VIROL, V95, P1969, DOI 10.1099/vir.0.065227-0; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Plowright RK, 2017, NAT REV MICROBIOL, V15, P502, DOI 10.1038/nrmicro.2017.45; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Puigbo P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-65; Saffert RT, 2006, J VIROL, V80, P3863, DOI 10.1128/JVI.80.8.3863-3871.2006; Sall AA, 2010, J VIROL, V84, P765, DOI 10.1128/JVI.01738-09; Sambri V, 2013, CLIN MICROBIOL INFEC, V19, P699, DOI 10.1111/1469-0691.12211; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Shen SH, 2015, P NATL ACAD SCI USA, V112, P4749, DOI 10.1073/pnas.1502864112; Shi M, 2016, J VIROL, V90, P659, DOI 10.1128/JVI.02036-15; Shin YC, 2015, P NATL ACAD SCI USA, V112, P14030, DOI 10.1073/pnas.1515387112; Simmen MW, 2008, GENOMICS, V92, P33, DOI 10.1016/j.ygeno.2008.03.009; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Thio CL, 2008, CLIN LIVER DIS, V12, P713, DOI 10.1016/j.cld.2008.03.002; Urrutia AO, 2001, GENETICS, V159, P1191; Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467; Vazquez A, 2012, VECTOR-BORNE ZOONOT, V12, P223, DOI 10.1089/vbz.2011.0687; Villabona-Arenas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062649; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zanotto PMD, 1999, GENETICS, V153, P1077; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548	92	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191652	10.1371/journal.pone.0191652	http://dx.doi.org/10.1371/journal.pone.0191652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385205	gold, Green Submitted, Green Published			2022-12-26	WOS:000423668400051
J	Hiwaki, O; Miyaguchi, H				Hiwaki, Osamu; Miyaguchi, Hideki			Noninvasive measurement of dynamic brain signals using light penetrating the brain	PLOS ONE			English	Article							SOMATOSENSORY-EVOKED RESPONSES; FAST OPTICAL SIGNAL; FMRI; ACTIVATION; SCATTERING; SYNCHRONY	Conventional techniques for the noninvasive measurement of brain activity involve critical limitations in spatial or temporal resolution. Here, we propose the method for noninvasive brain function measurement with high spatiotemporal resolution using optical signals. We verified that diffused near-infrared light penetrating through the upper jaw and into the skull, which we term as optoencephalography (OEG), leads to the detection of dynamic brain signals that vary concurrently with the electrophysiological neural activity. We measured the OEG signals following the stimulation of the median nerve in common marmosets. The OEG signal response was tightly coupled with the electrophysiological response represented by the somatosensory evoked potential (SSEP). The OEG measurement is also shown to offer rather clear discrimination of brain signals.	[Hiwaki, Osamu] Hiroshima City Univ, Grad Sch Informat Sci, Hiroshima, Japan; [Miyaguchi, Hideki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan	Hiroshima University	Hiwaki, O (corresponding author), Hiroshima City Univ, Grad Sch Informat Sci, Hiroshima, Japan.	hiwaki@hiroshima-cu.ac.jp	HIWAKI, OSAMU/AAI-3096-2020	Hiwaki, Osamu/0000-0003-4628-390X	CASIO Science Promotion Foundation; Hiroshima City University Grant for Special Academic Research (General Studies)	CASIO Science Promotion Foundation; Hiroshima City University Grant for Special Academic Research (General Studies)	This work was supported in part by CASIO Science Promotion Foundation, and Hiroshima City University Grant for Special Academic Research (General Studies) to OH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COHEN LB, 1968, NATURE, V218, P438, DOI 10.1038/218438a0; David O, 2002, IEEE T BIO-MED ENG, V49, P975, DOI 10.1109/TBME.2002.802013; FENG SC, 1995, APPL OPTICS, V34, P3826, DOI 10.1364/AO.34.003826; Foust AJ, 2007, NEUROSCIENCE, V145, P887, DOI 10.1016/j.neuroscience.2006.12.068; GOFF WR, 1962, ELECTROEN CLIN NEURO, V14, P697, DOI 10.1016/0013-4694(62)90084-6; Gratton G, 1997, NEUROIMAGE, V6, P168, DOI 10.1006/nimg.1997.0298; GRATTON G, 1995, PSYCHOPHYSIOLOGY, V32, P505, DOI 10.1111/j.1469-8986.1995.tb02102.x; He Bin, 2008, IEEE Rev Biomed Eng, V1, P23, DOI 10.1109/RBME.2008.2008233; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Liu JJV, 2013, NEUROIMAGE, V78, P186, DOI 10.1016/j.neuroimage.2013.03.038; Murta T, 2015, HUM BRAIN MAPP, V36, P391, DOI 10.1002/hbm.22623; Radhakrishnan H, 2009, NEUROIMAGE, V45, P410, DOI 10.1016/j.neuroimage.2008.12.014; Steinbrink J, 2005, NEUROIMAGE, V26, P996, DOI 10.1016/j.neuroimage.2005.03.006; STEPNOSKI RA, 1991, P NATL ACAD SCI USA, V88, P9382, DOI 10.1073/pnas.88.21.9382; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; Yao XC, 2005, BIOPHYS J, V88, P4170, DOI 10.1529/biophysj.104.052506	16	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0192095	10.1371/journal.pone.0192095	http://dx.doi.org/10.1371/journal.pone.0192095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385211	Green Published, gold, Green Submitted			2022-12-26	WOS:000423668400076
J	Khokhar, JS; Sareen, S; Tyagi, BS; Singh, G; Wilson, L; King, IP; Young, SD; Broadley, MR				Khokhar, Jaswant Singh; Sareen, Sindhu; Tyagi, Bhudeva Singh; Singh, Gyanendra; Wilson, Lolita; King, Ian P.; Young, Scott D.; Broadley, Martin R.			Variation in grain Zn concentration, and the grain ionome, in field-grown Indian wheat	PLOS ONE			English	Article							IRON CONCENTRATIONS; GENETIC-VARIABILITY; ZINC-DEFICIENCY; RICE GRAIN; BIOFORTIFICATION; CADMIUM; ENVIRONMENTS; FERTILIZER; CULTIVARS; NUTRITION	Wheat is an important dietary source of zinc (Zn) and other mineral elements in many countries. Dietary Zn deficiency is widespread, especially in developing countries, and breeding (genetic biofortification) through the HarvestPlus programme has recently started to deliver new wheat varieties to help alleviate this problem in South Asia. To better understand the potential of wheat to alleviate dietary Zn deficiency, this study aimed to characterise the baseline effects of genotype (G), site (E), and genotype by site interactions (GxE) on grain Zn concentration under a wide range of soil conditions in India. Field experiments were conducted on a diverse panel of 36 Indian-adapted wheat genotypes, grown on a range of soil types (pH range 4.5-9.5), in 2013-14 (five sites) and 2014-15 (six sites). Grain samples were analysed using inductively coupled plasma-mass spectrometry (ICP-MS). The mean grain Zn concentration of the genotypes ranged from 24.9-34.8 mg/kg(-1), averaged across site and year. Genotype and site effects were associated with 10% and 6% of the overall variation in grain Zn concentration, respectively. Whilst G x E interaction effects were evident across the panel, some genotypes had consistent rankings between sites and years. Grain Zn concentration correlated positively with grain concentrations of iron (Fe), sulphur (S), and eight other elements, but did not correlate negatively with grain yield, i.e. no yield dilution was observed. Despite a relatively small contribution of genotype to the overall variation in grain Zn concentration, due to experiments being conducted across many contrasting sites and two years, our data are consistent with reports that biofortifying wheat through breeding is likely to be effective at scale given that some genotypes performed consistently across diverse soil types. Notably, all soils in this study were probably Zn deficient and interactions between wheat genotypes and soil Zn availability/management (e.g. the use of Zn-containing fertilisers) need to be better-understood to improve Zn supply in food systems.	[Khokhar, Jaswant Singh; Wilson, Lolita; King, Ian P.; Young, Scott D.; Broadley, Martin R.] Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England; [Sareen, Sindhu; Tyagi, Bhudeva Singh; Singh, Gyanendra] Indian Inst Wheat & Barley Res, Karnal, Haryana, India	University of Nottingham; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research	Broadley, MR (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England.	martin.broadley@nottingham.ac.uk	Tyagi, Bhudeva/AAR-8225-2021; Broadley, Martin/AAW-4638-2021; broadley, martin r/E-9081-2011; Khokhar, Jaswant/ABG-8288-2020; Sareen, Sindhu/A-8465-2012	Broadley, Martin/0000-0003-3964-7226; broadley, martin r/0000-0003-3964-7226; Khokhar, Jaswant/0000-0003-4870-6208; Sareen, Sindhu/0000-0003-2944-0395	Biotechnological and Biological Sciences Research Council; Department of Biotechnology, Ministry of Science AMP; Technology, India under Sustainable Crop Production Research for International Development (SCPRID) [BB/J011827/1]; Biotechnological and Biological Sciences Research Council; Department of Biotechnology, Ministry of Science AMP; Technology, India under Sustainable Crop Production Research for International Development (SCPRID) [BB/J011827/1]; Biotechnology and Biological Sciences Research Council [BB/J011827/1] Funding Source: researchfish; BBSRC [BB/J011827/1] Funding Source: UKRI	Biotechnological and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department of Biotechnology, Ministry of Science AMP; Technology, India under Sustainable Crop Production Research for International Development (SCPRID); Biotechnological and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department of Biotechnology, Ministry of Science AMP; Technology, India under Sustainable Crop Production Research for International Development (SCPRID); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnological and Biological Sciences Research Council; Department of Biotechnology, Ministry of Science & Technology, India under Sustainable Crop Production Research for International Development (SCPRID) scheme award to IK (reference BB/J011827/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjos C, 2012, J GEOCHEM EXPLOR, V113, P45, DOI 10.1016/j.gexplo.2011.07.004; [Anonymous], 2016, PROGR REPORT ALL IND, P258; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Cakmak I., 2000, Food and Nutrition Bulletin, V21, P401; Cakmak I, 2008, PLANT SOIL, V302, P1, DOI 10.1007/s11104-007-9466-3; Chen XW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04992-z; de Sousa CNA, 1998, PLANT BREEDING, V117, P217, DOI 10.1111/j.1439-0523.1998.tb01929.x; Graham RD, 2001, ADV AGRON, V70, P77, DOI 10.1016/S0065-2113(01)70004-1; Graham RD, 2007, ADV AGRON, V92, P1, DOI 10.1016/S0065-2113(04)92001-9; Graham RD, 2012, ADV AGRON, V115, P1, DOI 10.1016/B978-0-12-394276-0.00001-9; Gregory PJ, 2017, GLOB FOOD SECUR-AGR, V15, P1, DOI 10.1016/j.gfs.2017.03.003; Guo J X, 2016, J AGR SCI, V154, P584; Guzman C, 2014, J CEREAL SCI, V60, P617, DOI 10.1016/j.jcs.2014.07.006; Hess SY, 2009, FOOD NUTR BULL, V30, pS60, DOI 10.1177/15648265090301S105; Hirzel J, 2017, J SOIL WATER CONSERV, V72, P77, DOI 10.2489/jswc.72.1.77; Joshi AK, 2010, FIELD CROP RES, V116, P268, DOI 10.1016/j.fcr.2010.01.004; Joy EJM, 2017, PLANT SOIL, V411, P139, DOI 10.1007/s11104-016-2961-7; Joy EJM, 2015, PLANT SOIL, V389, P1, DOI 10.1007/s11104-015-2430-8; Karami M, 2009, J AGR FOOD CHEM, V57, P10876, DOI 10.1021/jf902074f; Khokhar JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179208; King JC, 2016, J NUTR, V146, p858S, DOI 10.3945/jn.115.220079; Kumssa DB, 2015, SCI REP-UK, V5, DOI 10.1038/srep10974; Kutman UB, 2010, CEREAL CHEM, V87, P1, DOI 10.1094/CCHEM-87-1-0001; Mallikarjuna MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139067; Manickavelu A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169416; McDonald GK, 2009, P INT PLANT NUTR C 1; Monasterio Ivan, 2000, Food and Nutrition Bulletin, V21, P392; Morgounov A, 2007, EUPHYTICA, V155, P193, DOI 10.1007/s10681-006-9321-2; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Oury FX, 2006, EUR J AGRON, V25, P177, DOI 10.1016/j.eja.2006.04.011; Ozkan H, 2007, DEV PLANT BREED, V12, P455; Paltridge NG, 2012, PLANT SOIL, V361, P261, DOI 10.1007/s11104-012-1423-0; Pandey A, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3586-2; Qaswar M, 2017, SCI TOTAL ENVIRON, V605, P454, DOI 10.1016/j.scitotenv.2017.06.242; Ram H, 2016, PLANT SOIL, V403, P389, DOI 10.1007/s11104-016-2815-3; Ray P, 2013, AGROCHIMICA, V57, P347; Rengel Z, 2015, J SOIL SCI PLANT NUT, V15, P397; Salt DE, 2008, ANNU REV PLANT BIOL, V59, P709, DOI 10.1146/annurev.arplant.59.032607.092942; Sebastian A, 2014, AGRON SUSTAIN DEV, V34, P155, DOI 10.1007/s13593-013-0152-y; Shi RL, 2008, PLANT SOIL, V306, P95, DOI 10.1007/s11104-007-9483-2; Shiferaw B, 2013, FOOD SECUR, V5, P291, DOI 10.1007/s12571-013-0263-y; Simmons RW, 2003, PLANT SOIL, V257, P163, DOI 10.1023/A:1026242811667; Singh R, 2017, SCI BRIEF BIOFORTIFI; Stein AJ, 2007, PUBLIC HEALTH NUTR, V10, P492, DOI 10.1017/S1368980007223857; Swamy BPM, 2016, RICE, V9, DOI 10.1186/s12284-016-0122-5; Trethowan RM, 2005, INT WHEAT C MAR DEL; Velu G, 2014, J CEREAL SCI, V59, P365, DOI 10.1016/j.jcs.2013.09.001; Velu G, 2012, FIELD CROP RES, V137, P261, DOI 10.1016/j.fcr.2012.07.018; Velu G., 2015, ADV FOOD TECHNOLOGY, V1, P73, DOI DOI 10.17140/AFTNSOJ-1-112; Velu G, 2017, PLANT SOIL, V411, P81, DOI 10.1007/s11104-016-3025-8; Velu G, 2016, THEOR APPL GENET, V129, P1595, DOI 10.1007/s00122-016-2726-y; Wang YH, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0382-x; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; White PJ., 2013, SOIL CONDITIONS PLAN, V12, P160, DOI DOI 10.1002/9781118337295.CH6; Xing WQ, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-015-5023-3; Zhang Y, 2010, EUPHYTICA, V174, P303, DOI 10.1007/s10681-009-0082-6; Zhao FJ, 2009, J CEREAL SCI, V49, P290, DOI 10.1016/j.jcs.2008.11.007	61	33	33	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0192026	10.1371/journal.pone.0192026	http://dx.doi.org/10.1371/journal.pone.0192026			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381740	Green Submitted, Green Published, gold			2022-12-26	WOS:000423617800053
J	Narayan, E; Sawyer, G; Parisella, S				Narayan, Edward; Sawyer, Gregory; Parisella, Simone			Faecal glucocorticoid metabolites and body temperature in Australian merino ewes (Ovis aries) during summer artificial insemination (Al) program	PLOS ONE			English	Article							STRESS-LIKE CONCENTRATIONS; HEAT-STRESS; FOLLICULAR DEVELOPMENT; EMBRYO PRODUCTION; DAIRY-CATTLE; SHEEP; CORTISOL; REPRODUCTION; MORTALITY; AXIS	Reproductive wastage is a key issue for sheep producers, both regionally and globally. The reproductive output of farm animals can be influenced by physiological and environmental factors. Rapid and reliable quantification of physiological stress can provide a useful tool for designing and testing on-farm management interventions to improve farm animal welfare and productivity. In this study, we quantified physiological stress non-invasively using faecal glucocorticoid metabolites-FGMs analysis and body temperature measurements of 15 superovulated donor merino ewes (Ovis aries) during participation in artificial insemination (Al) program conducted during 2015/2016 Australian summer. We hypothesized that low percentage transferable embryos in donor merino ewes will be associated positively with higher body temperature and/or higher FGMs in these ewes. Temperature humidity index (THI) was calculated and found within high thermal stress range during the two Al trials. Overall, results showed none of the factors (ewe ID, Al trial no., THI or FGMs) were significant for reduced percentage transferrable embryos, except ewe body temperature was highly significant (p = 0.014). Within Al trial comparisons showed significant positive associations between higher FGMs and body temperature with reduced transferrable embryos. These results suggest that Australian merino ewes participating in summer Al trials can experience physiological stress. Prolonged activation of the stress endocrine response and high body temperature (e.g. ensued from heat stress) could impact on ewe reproductive output. Therefore, future research should apply minimally invasive physiological tools to gather baseline information on physiological stress in merino sheep to enable the development of new farm-friendly methods of managing stress.	[Narayan, Edward; Sawyer, Gregory] Western Sydney Univ, Sch Sci & Hlth, Locked Bag 1797, Penrith, NSW, Australia; [Narayan, Edward; Parisella, Simone] Charles Sturt Univ, Sch Anim & Vet Sci, Graham Ctr Agr Innovat, Locked Bag 588, Wagga Wagga, NSW, Australia	Western Sydney University; Charles Sturt University	Narayan, E (corresponding author), Western Sydney Univ, Sch Sci & Hlth, Locked Bag 1797, Penrith, NSW, Australia.; Narayan, E (corresponding author), Charles Sturt Univ, Sch Anim & Vet Sci, Graham Ctr Agr Innovat, Locked Bag 588, Wagga Wagga, NSW, Australia.	e.narayan@westernsydney.edu.au	Narayan, Edward/E-8238-2016	Narayan, Edward/0000-0003-2719-0900; Sawyer, Gregory/0000-0001-6340-3489	Australian Wool Education Trust; Graham Centre for Agricultural Innovation for Research Fellowship; Graham Centre for Agricultural Innovation, Charles Sturt University for Research Fellowship	Australian Wool Education Trust; Graham Centre for Agricultural Innovation for Research Fellowship; Graham Centre for Agricultural Innovation, Charles Sturt University for Research Fellowship	We thank the Australian Wool Education Trust for providing scholarships to GS and SP for their Masters research. We also thank the Graham Centre for Agricultural Innovation for Research Fellowship to EN. We thank the New South Wales Stud Merino Breeders and Australian Wool Network for cash/in-kind support. We also acknowledge the Graham Centre for Agricultural Innovation, Charles Sturt University for Research Fellowship to EN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A., 2013, HEAT STRESS ANIMAL P, P27, DOI DOI 10.1007/978-81-322-0879-2_2; Al-Katanani YM, 2002, J DAIRY SCI, V85, P390, DOI 10.3168/jds.S0022-0302(02)74086-1; Brandt Y, 2007, REPROD DOMEST ANIM, V42, P118, DOI 10.1111/j.1439-0531.2006.00698.x; Breen KM, 2006, FRONT NEUROENDOCRIN, V27, P233, DOI 10.1016/j.yfrne.2006.03.335; Chrousos GP, 2000, ENDOCR RES, V26, P513, DOI 10.3109/07435800009048562; Hernandez-Cruz BC, 2016, TROP ANIM HEALTH PRO, V48, P411, DOI 10.1007/s11250-015-0966-5; Daley CA, 2000, ANIM REPROD SCI, V59, P167, DOI 10.1016/S0378-4320(00)00141-X; Dismukes A., 2013, THESIS; Dixon AB, 2007, J ANIM SCI, V85, P1274, DOI 10.2527/jas.2006-129; Dobson H, 2012, ANIM REPROD SCI, V130, P135, DOI 10.1016/j.anireprosci.2012.01.006; DONEY JM, 1976, J AGR SCI-CAMBRIDGE, V87, P133, DOI 10.1017/S002185960002668X; DUTT R. H., 1964, INT J BIOMETEROL, V8, P47, DOI 10.1007/BF02186927; EDEY TN, 1966, J AGR SCI-CAMBRIDGE, V67, P287, DOI 10.1017/S0021859600017299; Geenty KG, 2014, ANIM PROD SCI, V54, P715, DOI 10.1071/AN11323; Hahn GL, 2003, EAAP TECH, P31; Hansen PJ, 2009, PHILOS T R SOC B, V364, P3341, DOI 10.1098/rstb.2009.0131; Hansen PJ, 2001, THERIOGENOLOGY, V55, P91, DOI 10.1016/S0093-691X(00)00448-9; Kukovics S., 2011, ARTIFICIAL INSEMINAT; Macfarlane MS, 2000, ANIM REPROD SCI, V63, P167, DOI 10.1016/S0378-4320(00)00179-2; Marai IFM, 2007, SMALL RUMINANT RES, V71, P1, DOI 10.1016/j.smallrumres.2006.10.003; Morrow CJ, 2002, GEN COMP ENDOCR, V126, P229, DOI 10.1006/gcen.2002.7797; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; Naqvi SMK, 2004, SMALL RUMINANT RES, V55, P57, DOI 10.1016/j.smallrumres.2004.02.009; Narayan E, 2017, ITAL J ANIM SCI, V16, P640, DOI 10.1080/1828051X.2017.1321972; Papargiris MM, 2011, HORM BEHAV, V60, P336, DOI 10.1016/j.yhbeh.2011.06.008; Rees A, 2016, REPROD DOMEST ANIM, V51, P392, DOI 10.1111/rda.12691; Ronchi B, 2001, LIVEST PROD SCI, V68, P231, DOI 10.1016/S0301-6226(00)00232-3; SAWYER GJ, 1979, AUST J AGR RES, V30, P1143, DOI 10.1071/AR9791143; Segnalini M, 2011, INT J BIOMETEOROL, V55, P253, DOI 10.1007/s00484-010-0331-3; Smith Sean M, 2006, Dialogues Clin Neurosci, V8, P383; Srikandakumar A, 2003, SMALL RUMINANT RES, V49, P193, DOI 10.1016/S0921-4488(03)00097-X; THWAITES C. J., 1968, Proceedings of the Australian Society of Animal Production, V7, P259; THWAITES C J, 1971, Australian Journal of Experimental Agriculture and Animal Husbandry, V11, P265, DOI 10.1071/EA9710265; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Vitali A, 2009, J DAIRY SCI, V92, P3781, DOI 10.3168/jds.2009-2127; Wagenmaker ER, 2010, BIOL REPROD, V82, P1206, DOI 10.1095/biolreprod.109.078774; Wolfenson D, 1997, ANIM REPROD SCI, V47, P9, DOI 10.1016/S0378-4320(96)01638-7; WOLFENSON D, 1995, BIOL REPROD, V52, P1106, DOI 10.1095/biolreprod52.5.1106	38	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191961	10.1371/journal.pone.0191961	http://dx.doi.org/10.1371/journal.pone.0191961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381759	Green Published, gold			2022-12-26	WOS:000423617800046
J	Villasenor-Derbez, JC; Faro, C; Wright, M; Martinez, J; Fitzgerald, S; Fulton, S; Mancha-Cisneros, MD; McDonald, G; Micheli, F; Suarez, A; Torre, J; Costello, C				Villasenor-Derbez, Juan Carlos; Faro, Caio; Wright, Melaina; Martinez, Jael; Fitzgerald, Sean; Fulton, Stuart; Mancha-Cisneros, Maria del Mar; McDonald, Gavin; Micheli, Fiorenza; Suarez, Alvin; Torre, Jorge; Costello, Christopher			A user-friendly tool to evaluate the effectiveness of no-take marine reserves	PLOS ONE			English	Article							SMALL-SCALE FISHERIES; PROTECTED AREAS; PACIFIC COAST; CONSERVATION; IMPACTS; FRAMEWORK; COMANAGEMENT; BENEFITS; HEALTH; INDEX	Marine reserves are implemented to achieve a variety of objectives, but are seldom rigorously evaluated to determine whether those objectives are met. In the rare cases when evaluations do take place, they typically focus on ecological indicators and ignore other relevant objectives such as socioeconomics and governance. And regardless of the objectives, the diversity of locations, monitoring protocols, and analysis approaches hinder the ability to compare results across case studies. Moreover, analysis and evaluation of reserves is generally conducted by outside researchers, not the reserve managers or users, plausibly thereby hindering effective local management and rapid response to change. We present a framework and tool, called "MAREA", to overcome these challenges. Its purpose is to evaluate the extent to which any given reserve has achieved its stated objectives. MAREA provides specific guidance on data collection and formatting, and then conducts rigorous causal inference analysis based on data input by the user, providing real-time outputs about the effectiveness of the reserve. MAREA's ease of use, standardization of state-of-the-art inference methods, and ability to analyze marine reserve effectiveness across ecological, socioeconomic, and governance objectives could dramatically further our understanding and support of effective marine reserve management.	[Villasenor-Derbez, Juan Carlos; Faro, Caio; Wright, Melaina; Martinez, Jael; Fitzgerald, Sean; McDonald, Gavin; Costello, Christopher] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Fulton, Stuart; Suarez, Alvin; Torre, Jorge] Comunidad & Biodiversidad AC, Calle Isla Peruano, Guaymas, Sonora, Mexico; [Mancha-Cisneros, Maria del Mar] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [McDonald, Gavin; Costello, Christopher] Univ Calif Santa Barbara, Sustainable Fisheries Grp, Santa Barbara, CA 93106 USA; [McDonald, Gavin; Costello, Christopher] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Micheli, Fiorenza] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Micheli, Fiorenza] Stanford Univ, Ctr Ocean Solut, Pacific Grove, CA 93950 USA	University of California System; University of California Santa Barbara; Arizona State University; Arizona State University-Tempe; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Stanford University; Stanford University	Villasenor-Derbez, JC (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	jvillasenor@bren.ucsb.edu	McDonald, Gavin/L-3932-2019; Fitzgerald, Sean/W-2617-2019; Villaseñor-Derbez, Juan Carlos/HGB-9506-2022	Villaseñor-Derbez, Juan Carlos/0000-0003-1245-589X; Micheli, Fiorenza/0000-0002-6865-1438; Suarez, Alvin/0000-0003-2394-2685	Latin American Fisheries Fellowship Program; Consejo Nacional de Ciencia y Tecnologia; Waitt Foundation; Walton Family Foundation; NSF-CNH program [DEB-1212124]; Marisla Foundation; Sandler Family Supporting Foundation; Packard Foundation; Nature Conservancy; World Wildlife Fund-Carlos Slim Foundation Alliance; Direct For Biological Sciences [1212124] Funding Source: National Science Foundation	Latin American Fisheries Fellowship Program; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Waitt Foundation; Walton Family Foundation; NSF-CNH program; Marisla Foundation; Sandler Family Supporting Foundation; Packard Foundation(The David & Lucile Packard Foundation); Nature Conservancy; World Wildlife Fund-Carlos Slim Foundation Alliance; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	CF and JCVD received support from the Latin American Fisheries Fellowship Program, http://www.laff.bren.ucsb.edu. JCVD received support from the Consejo Nacional de Ciencia y Tecnologia, http://www.conacyt.gob.mx. GM received financial support from Waitt Foundation, http://waittfoundation.org/. Biological data for Isla Natividad were collected with the support of the Walton Family Foundation (https://www.waltonfamilyfoundation.org/), the NSF-CNH program (grant DEB-1212124; https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=13681). Marisla Foundation (https://online.foundationsource.com/public/home/marisla), Sandler Family Supporting Foundation (http://www.sandlerfoundation.org), and Packard Foundation (https://www.packard.org). AS received support from The Nature Conservancy (https://www.nature.org) and World Wildlife Fund-Carlos Slim Foundation Alliance (https://www.worldwildlife.org: http://fundacioncarlosslim.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023601; Afflerbach JC, 2014, GLOB ECOL CONSERV, V2, P97, DOI 10.1016/j.gecco.2014.08.001; Allaire J., 2017, RMARKDOWN DYNAMIC DO; Anderson JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122809; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2014, NOM049SAGPESC; [Anonymous], 2017, EST GEOGR INF MEX; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Basurto X, 2013, GLOBAL ENVIRON CHANG, V23, P1366, DOI 10.1016/j.gloenvcha.2013.08.001; Betti F, 2017, MAR ECOL-EVOL PERSP, V38, DOI 10.1111/maec.12439; Burgess MG, 2018, MAR POLICY, V87, P331, DOI 10.1016/j.marpol.2016.12.005; Carter AB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10180-w; Chang W, 2017, SHINYDASHBOARD CREAT; Chang W, 2017, WEB APPL FRAMEWORK R; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Chirico AAD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182342; Davies TK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174758; Dowling N, 2016, ASSESSING MANAGING D; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Elfes CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092589; Espinosa-Romero MJ, 2014, MAR POLICY, V50, P290, DOI 10.1016/j.marpol.2014.07.005; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Finkbeiner EM, 2015, MAR POLICY, V51, P433, DOI 10.1016/j.marpol.2014.10.010; Friedlander AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174787; Giakoumi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08850-w; Guidetti P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091841; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178267; Halpern BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098995; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Hastings A, 2017, P NATL ACAD SCI USA, V114, P8927, DOI 10.1073/pnas.1705169114; Lester SE, 2008, MAR ECOL PROG SER, V367, P49, DOI 10.3354/meps07599; Lester SE, 2017, B MAR SCI, V93, P173, DOI 10.5343/bms.2015.1083; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; LGEEPA, 2017, LEY GEN EQ EC PROT A; Lowndes JSS, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0160; Lundquist CJ, 2005, CONSERV BIOL, V19, P1771, DOI 10.1111/j.1523-1739.2005.00279.x; Mascia MB, 2017, ANN NY ACAD SCI, V1399, P93, DOI 10.1111/nyas.13428; Mccay BJ, 2017, B MAR SCI, V93, P69, DOI 10.5343/bms.2015.1091; McCay BJ, 2014, MAR POLICY, V44, P49, DOI 10.1016/j.marpol.2013.08.001; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; Moland E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2679; Munguia-Vega A, 2015, GLOB ECOL CONSERV, V4, P264, DOI 10.1016/j.gecco.2015.07.005; OECD, 2017, INFL CPI; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Oyanedel R, 2017, B MAR SCI, V93, P155, DOI 10.5343/bms.2015.1095; Padleton LH, 2017, ICES J MARINE SCI; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Pomeroy RS, 2005, OCEAN COAST MANAGE, V48, P485, DOI 10.1016/j.ocecoaman.2005.05.004; Pomeroy RS, 2004, GUIDEBOOK NATURAL SO; Roberts CM, 2017, P NATL ACAD SCI USA, V114, P6167, DOI 10.1073/pnas.1701262114; Rodriguez Alba Garcia, 2017, Open Journal of Marine Science, V7, P379; Rossetto M, 2015, CAN J FISH AQUAT SCI, V72, P1503, DOI 10.1139/cjfas-2013-0623; Sala E, 2017, ICES J MARINE SCI; Sala E, 2016, MAR POLICY, V73, P154, DOI 10.1016/j.marpol.2016.07.032; Selig ER, 2015, ECOSYST SERV, V16, P403, DOI 10.1016/j.ecoser.2014.11.007; Soykan CU, 2015, CONSERV BIOL, V29, P775, DOI 10.1111/cobi.12445; Suman CS, 2010, MANUAL INSTRUCCION R; Szuwalski CS, 2017, P NATL ACAD SCI USA, V114, P717, DOI 10.1073/pnas.1612722114; Tennekes M., 2017, TMAP THEMATIC MAPS; Vilela T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179393; Villasenor-Derbez JC, 2017, TURFEFFECT; Woodcock P, 2017, FISH FISH, V18, P668, DOI 10.1111/faf.12196; Xie Y, 2017, GEN PURPOSE PACKAGE; Zeileis A., 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i10, DOI 10.18637/JSS.V011.I10]	66	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191821	10.1371/journal.pone.0191821	http://dx.doi.org/10.1371/journal.pone.0191821			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU1NX	29381762	Green Published, Green Submitted, gold			2022-12-26	WOS:000423617800036
J	Jin, WN; Ducruet, AF; Liu, Q; Shi, SXY; Waters, M; Zou, M; Sheth, KN; Gonzales, R; Shi, FD				Jin, Wei-Na; Ducruet, Andrew F.; Liu, Qiang; Shi, Samuel Xiang-Yu; Waters, Michael; Zou, Ming; Sheth, Kevin N.; Gonzales, Rayna; Shi, Fu-Dong			Activation of JAK/STAT3 restores NK-cell function and improves immune defense after brain ischemia	FASEB JOURNAL			English	Article						ischemic stroke; multigene signature; natural killer cell; immune suppression; poststroke infection	NATURAL-KILLER-CELLS; STROKE-INDUCED IMMUNODEPRESSION; MULTIPLE-SCLEROSIS; KYOTO ENCYCLOPEDIA; INFECTION; DEFICIENCY; INJURY; RESPONSES; GENOMES; KEGG	Stroke-induced immune suppression predisposes the host to infections and can contribute to high morbidity and mortality in stroke patients. Because ischemic stroke has a profound effect on the systemic immune response, which may explain the increased susceptibility of stroke patients to infection, an urgent need persists for a better understanding of mechanisms associated with immune suppression; new and effective treatments for stroke can then be identified. NK cells play a key role in early host defense against pathogens by killing infected cells and/or producing cytokines such as IFN-gamma. Because the phenotype and function of peripheral NK cells have been widely investigated in ischemic stroke, nCounter Inflammation Gene Array Analysis was used to build immune-related gene profiles of NK cells to comprehensively analyze the molecular signature of NK cells after ischemic brain injury. We observed distinct gene expression profiles reflecting different splenic NK-cell phenotypes and functional properties across the time course of transient middle cerebral artery occlusion (MCAO). Based on gene expression and pathway-network analysis, lower expression levels of signal transducer and activator of transcription-3 (STAT3) were observed in animals with MCAO compared with sham control animals. Genetic activation of STAT3 through the introduction of STAT3 clustered regularly interspaced short palindromic repeats (CRISPR) plasmid prevented the loss of NK-cell-derived IFN-gamma production after MCAO, together with reduced bacterial burden and mortality. Our data suggest that brain ischemia impairs NK-cell-mediated immune defense in the periphery, at least in part through the JAK-STAT3 pathway, which can be readdressed by modulating STAT3 activation status.	[Jin, Wei-Na; Shi, Fu-Dong] Capital Med Univ, Beijing Tiantan Hosp, Ctr Neuroinflammat, Beijing 100050, Peoples R China; [Jin, Wei-Na; Liu, Qiang; Zou, Ming; Shi, Fu-Dong] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China; [Jin, Wei-Na; Ducruet, Andrew F.; Liu, Qiang; Waters, Michael; Shi, Fu-Dong] St Josephs Hosp, Barrow Neurol Inst, Div Neurol & Neurosurg, Phoenix, AZ USA; [Shi, Samuel Xiang-Yu; Gonzales, Rayna] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ 85004 USA; [Sheth, Kevin N.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	Capital Medical University; Tianjin Medical University; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of Arizona; Yale University	Shi, FD (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Ctr Neuroinflammat, Beijing 100050, Peoples R China.; Gonzales, R (corresponding author), Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ 85004 USA.	rjgonzal@email.arizona.edu; fshi66@gmail.com	Liu, Qiang/HHZ-3181-2022	Gonzales, Rayna/0000-0003-1716-8988	National Science Foundation of China [91642205, 81471535, 81771274, 81471220]; U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke [R01NS092713]; American Heart Association [16SDG27250236]; National Multiple Sclerosis Society Grant [RG-1507-05318]; Arizona Alzheimer's Research Center grant; Handley Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092713] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); National Multiple Sclerosis Society Grant(National Multiple Sclerosis Society); Arizona Alzheimer's Research Center grant; Handley Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Kristofer Wood (Department of Neurology, Barrow Neurological Institute, Phoenix, AZ, USA) for editorial assistance. This work was supported by National Science Foundation of China Grants 91642205, 81471535, 81771274, 81471220; U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grant R01NS092713; American Heart Association Grant 16SDG27250236; National Multiple Sclerosis Society Grant RG-1507-05318; donor-directed funding "Handley Charitable Trust"; and an Arizona Alzheimer's Research Center grant. The authors declare no conflicts of interest.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Bolen RD, 2015, J NEUROL SCI, V352, P125, DOI 10.1016/j.jns.2015.03.037; Chamorro A, 2006, STROKE, V37, P291, DOI 10.1161/01.STR.0000200561.69611.f8; Davenport RJ, 1996, STROKE, V27, P415, DOI 10.1161/01.STR.27.3.415; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Du JL, 2014, MOL BIOSYST, V10, P2441, DOI 10.1039/c4mb00287c; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Fu Y, 2015, NAT REV NEUROL, V11, P524, DOI 10.1038/nrneurol.2015.144; Gan Y, 2014, P NATL ACAD SCI USA, V111, P2704, DOI 10.1073/pnas.1315943111; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Gross CC, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00606; Hao JW, 2010, J EXP MED, V207, P1907, DOI 10.1084/jem.20092749; Hong KS, 2008, EUR J NEUROL, V15, P1324, DOI 10.1111/j.1468-1331.2008.02310.x; Hsia HC, 2017, J LEUKOCYTE BIOL, V101, P1053, DOI 10.1189/jlb.4A1016-199RR; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Huhn MH, 2008, CELL MICROBIOL, V10, P426, DOI 10.1111/j.1462-5822.2007.01056.x; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jiang WZ, 2011, J IMMUNOL, V187, P781, DOI 10.4049/jimmunol.1100789; Jin WN, 2017, J CEREBR BLOOD F MET, V37, P2224, DOI 10.1177/0271678X17694185; Jin WN, 2016, J CEREBR BLOOD F MET, V36, P1464, DOI 10.1177/0271678X15611137; Kalra L, 2015, LANCET, V386, P1835, DOI 10.1016/S0140-6736(15)00126-9; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Klehmet J, 2009, NEUROSCIENCE, V158, P1184, DOI 10.1016/j.neuroscience.2008.07.044; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Lafargue M, 2012, FASEB J, V26, P2919, DOI 10.1096/fj.11-197384; Liu Q, 2014, NEUROSCIENCE, V256, P170, DOI 10.1016/j.neuroscience.2013.10.049; Liu Q, 2017, IMMUNITY, V46, P474, DOI 10.1016/j.immuni.2017.02.015; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Nguyen S, 2006, J NEUROIMMUNOL, V179, P117, DOI 10.1016/j.jneuroim.2006.05.028; Offner H, 2009, NEUROSCIENCE, V158, P1098, DOI 10.1016/j.neuroscience.2008.05.033; Orange JS, 2013, J ALLERGY CLIN IMMUN, V132, P515, DOI 10.1016/j.jaci.2013.07.020; Peterfalvi A, 2009, CEREBROVASC DIS, V28, P490, DOI 10.1159/000236527; Poli A, 2013, J IMMUNOL, V190, P5355, DOI 10.4049/jimmunol.1203401; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Shi FD, 2006, NAT REV IMMUNOL, V6, P751, DOI 10.1038/nri1935; Shi FD, 2011, NAT REV IMMUNOL, V11, P658, DOI 10.1038/nri3065; Tang ZW, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-26; Urra X, 2009, CURR MOL MED, V9, P195, DOI 10.2174/156652409787581574; van de Beek D, 2009, ARCH NEUROL-CHICAGO, V66, P1076, DOI 10.1001/archneurol.2009.176; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Vogelgesang A, 2008, STROKE, V39, P237, DOI 10.1161/STROKEAHA.107.493635; Wang FY, 2015, EUR J IMMUNOL, V45, P661, DOI 10.1002/eji.201444998; Wartenberg KE, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/830614; Westendorp WF, 2015, LANCET, V385, P1519, DOI 10.1016/S0140-6736(14)62456-9; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301	49	14	17	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2757	2767		10.1096/fj.201700962R	http://dx.doi.org/10.1096/fj.201700962R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401578	Green Published			2022-12-26	WOS:000432528000035
J	Park, KT; Dajkovic, A; Wissel, M; Du, SS; Lutkenhaus, J				Park, Kyung-Tae; Dajkovic, Alex; Wissel, Mark; Du, Shishen; Lutkenhaus, Joe			MinC and FtsZ mutant analysis provides insight into MinC/MinD-mediated Z ring disassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION-INHIBITION; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; STAPHYLOCOCCUS-AUREUS; SPATIAL REGULATION; SITE; POLYMERIZATION; LOCALIZATION; PROTEINS; SYSTEM	The Min system negatively regulates the position of the Z ring, which serves as a scaffold for the divisome that mediates bacterial cytokinesis. In Escherichia coli, this system consists of MinC, which antagonizes assembly of the tubulin homologue FtsZ. MinC is recruited to the membrane by MinD and induced by MinE to oscillate between the cell poles. MinC is a dimer with each monomer consisting of functionally distinct MinC(N) and MinC(C) domains, both of which contact FtsZ. According to one model, MinC(C)/MinD binding to the FtsZ tail positionsMinC(N) at the junction of two GDP-containing subunits in the filament, leading to filament breakage. Others posit that MinC sequesters FtsZ-GDP monomers or that MinC(N) caps the minus end of FtsZ polymers and that MinC(C) interferes with lateral interactions between FtsZ filaments. Here, we isolated minC mutations that impair MinC(N)function and analyzed FtsZ mutants resistant to MinC/MinD. Surprisingly, we found mutations in both minC and ftsZ that differentiate inhibition by MinC from inhibition by MinC/MinD. Analysis of these mutations suggests that inhibition of the Z ring by MinC alone is due to sequestration, whereas inhibition by MinC/MinD is not. In conclusion, our genetic and biochemical data support the model that MinC/MinD fragments FtsZ filaments	[Park, Kyung-Tae; Dajkovic, Alex; Wissel, Mark; Du, Shishen; Lutkenhaus, Joe] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Lutkenhaus, J (corresponding author), Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA.; Dajkovic, A (corresponding author), Biomillenia, 6 Rue Jean Calvin, F-75005 Paris, France.; Wissel, M (corresponding author), Viracor Eurofins Clin Diagnost, 951 NW Technol Dr, Lees Summit, MO 64086 USA.	alexdajkovic@gmail.com; MarkWissel@viracor-eurofins.com; jlutkenh@kumc.edu		Du, Shishen/0000-0002-9809-8653	National Institutes of Health [GM29764]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM29764 (to J.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An JY, 2013, J SYNCHROTRON RADIAT, V20, P984, DOI 10.1107/S0909049513022760; Arumugam S, 2014, P NATL ACAD SCI USA, V111, pE1192, DOI 10.1073/pnas.1317764111; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Bisson AW, 2015, P NATL ACAD SCI USA, V112, pE2130, DOI 10.1073/pnas.1414242112; Cho H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003304; Cho HB, 2011, P NATL ACAD SCI USA, V108, P3773, DOI 10.1073/pnas.1018674108; Cordell SC, 2003, P NATL ACAD SCI USA, V100, P7889, DOI 10.1073/pnas.1330742100; Cordell SC, 2001, EMBO J, V20, P2454, DOI 10.1093/emboj/20.10.2454; DAI K, 1991, J BACTERIOL, V173, P3500, DOI 10.1128/jb.173.11.3500-3506.1991; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; DEBOER PAJ, 1992, J BACTERIOL, V174, P63, DOI 10.1128/jb.174.1.63-70.1992; DEBOER PAJ, 1990, P NATL ACAD SCI USA, V87, P1129, DOI 10.1073/pnas.87.3.1129; Du SS, 2017, MOL MICROBIOL, V105, P177, DOI 10.1111/mmi.13696; Du SS, 2015, MOL MICROBIOL, V95, P173, DOI 10.1111/mmi.12854; Du SS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004460; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Fujita J, 2017, J STRUCT BIOL, V198, P65, DOI 10.1016/j.jsb.2017.04.008; Ghosal D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6341; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; Handler AA, 2008, MOL MICROBIOL, V68, P588, DOI 10.1111/j.1365-2958.2008.06173.x; Hernandez-Rocamora VM, 2013, J BIOL CHEM, V288, P24625, DOI 10.1074/jbc.M113.483222; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Hu ZL, 2000, J BACTERIOL, V182, P3965, DOI 10.1128/JB.182.14.3965-3971.2000; Johnson JE, 2004, J BACTERIOL, V186, P2418, DOI 10.1128/JB.186.8.2418-2429.2004; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Lutkenhaus J, 2017, SUBCELL BIOCHEM, V84, P27, DOI 10.1007/978-3-319-53047-5_2; MAGUIN E, 1986, J BACTERIOL, V166, P733, DOI 10.1128/jb.166.3.733-738.1986; Matsui T, 2012, ACTA CRYSTALLOGR D, V68, P1175, DOI 10.1107/S0907444912022640; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; MULDER E, 1992, J BACTERIOL, V174, P35, DOI 10.1128/jb.174.1.35-39.1992; Park KT, 2015, MOL MICROBIOL, V98, P895, DOI 10.1111/mmi.13164; Pichoff S, 2001, J BACTERIOL, V183, P6630, DOI 10.1128/JB.183.22.6630-6635.2001; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Schumacher MA, 2016, P NATL ACAD SCI USA, V113, P4988, DOI 10.1073/pnas.1602327113; Shen B, 2010, MOL MICROBIOL, V75, P1285, DOI 10.1111/j.1365-2958.2010.07055.x; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Zhou HJ, 2005, J BACTERIOL, V187, P2846, DOI 10.1128/JB.187.8.2846-2857.2005; Zhou HJ, 2005, J BACTERIOL, V187, P629, DOI 10.1128/JB.187.2.629-638.2005	43	11	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5834	5846		10.1074/jbc.M117.815894	http://dx.doi.org/10.1074/jbc.M117.815894			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29414773	Green Published, hybrid			2022-12-26	WOS:000430497300008
J	Shah, CA; Broglie, L; Hu, LP; Bei, L; Huang, WQ; Dressler, DB; Eklund, EA				Shah, Chirag A.; Broglie, Larisa; Hu, Liping; Bei, Ling; Huang, Weiqi; Dressler, Danielle B.; Eklund, Elizabeth A.			Stat3 and CCAAT enhancer-binding protein beta (C/ebp beta) activate Fanconi C gene transcription during emergency granulopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; BCR-ABL; ANEMIA PATHWAY; IN-VITRO; EXPRESSION; CELLS; ICSBP; LEUKEMIA; PHOSPHORYLATION; SPECIFICITY	Interferon consensus sequence-binding protein (Icsbp) is required for terminating emergency granulopoiesis, an episodic event responsible for granulocyte production in response to infections and a key component of the innate immune response. Icsbp inhibits the expression of Stat3 and C/ebp beta, transcription factors essential for initiating and sustaining granulopoiesis, and activates transcription of Fanconi C (FANCC), a DNA repair protein. In prior studies, we noted accelerated bone marrow failure in Fancc(-/-) mice undergoing multiple episodes of emergency granulopoiesis, associated with apoptosis of bone marrow cells with unrepaired DNA damage. Additionally, we found increased expression of Fanconi C and F proteins during emergency granulopoiesis. These findings suggest that Icsbp protects the bone marrow from DNA damage by increasing activity of the Fanconi DNA repair pathway, but the mechanisms for FANCC activation during initiation of emergency granulopoiesis are unclear. In this study, we observed that Stat3 and C/ebp beta activate FANCC transcription and contribute to DNA repair. Our findings indicate that FancC expression is increased during Stat3-and C/ebp beta-induced initiation of emergency granulopoiesis by these transcription factors and is maintained through termination by Icsbp. Our work reveals that Stat3-and C/ebp beta-mediated FancC expression is a critical component for initiating and sustaining key innate immune responses.	[Shah, Chirag A.; Hu, Liping; Bei, Ling; Huang, Weiqi; Dressler, Danielle B.; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60605 USA; [Shah, Chirag A.; Bei, Ling; Huang, Weiqi; Eklund, Elizabeth A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA; [Broglie, Larisa] Med Coll Wisconsin, Childrens Hosp Wisconsin, Milwaukee, WI 53213 USA	Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Children's Hospital of Wisconsin; Medical College of Wisconsin	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60605 USA.; Eklund, EA (corresponding author), Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA.	e-eklund@northwestern.edu			Department of Veterans Affairs Merit Review Grant [BX002067]; NIDDK, National Institutes of Health Grant [R01-DK098812]; NCI, National Institutes of Health Grant [R01-CA174205]; NATIONAL CANCER INSTITUTE [R01CA174205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098812, R01DK121354] Funding Source: NIH RePORTER; Veterans Affairs [I01CX001864, I01BX004635, I01BX002067] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Review Grant(US Department of Veterans Affairs); NIDDK, National Institutes of Health Grant; NCI, National Institutes of Health Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Department of Veterans Affairs Merit Review Grant BX002067; NIDDK, National Institutes of Health Grant R01-DK098812; and NCI, National Institutes of Health Grant R01-CA174205 (to E. A. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe K, 2001, ONCOGENE, V20, P3464, DOI 10.1038/sj.onc.1204461; Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; AUERBACH AD, 1991, CANCER GENET CYTOGEN, V51, P1, DOI 10.1016/0165-4608(91)90002-C; Cioc AM, 2010, AM J CLIN PATHOL, V133, P92, DOI 10.1309/AJCP7W9VMJENZOVG; Coppo P, 2003, ONCOGENE, V22, P4102, DOI 10.1038/sj.onc.1206607; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Hayashi Y, 2013, LEUKEMIA, V27, P619, DOI 10.1038/leu.2012.258; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hjort EE, 2016, ONCOTARGET, V7, P77635, DOI 10.18632/oncotarget.12749; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Howlett NG, 2005, HUM MOL GENET, V14, P693, DOI 10.1093/hmg/ddi065; Hu LP, 2016, J BIOL CHEM, V291, P4107, DOI 10.1074/jbc.M115.681361; Hu LP, 2013, J CLIN INVEST, V123, P3952, DOI 10.1172/JCI69032; Huang WQ, 2010, MOL CELL BIOL, V30, P4575, DOI 10.1128/MCB.01595-09; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Konieczna I, 2008, J CLIN INVEST, V118, P853, DOI 10.1172/JCI33742; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; LARRICK JW, 1980, J IMMUNOL, V125, P6; LORD BI, 1991, BLOOD, V77, P2154; Luedde T, 2004, HEPATOLOGY, V40, P356, DOI 10.1002/hep.20333; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Oda A, 2002, BLOOD, V99, P1850, DOI 10.1182/blood.V99.5.1850; Osada S, 1996, J BIOL CHEM, V271, P3891; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Panopoulos AD, 2006, BLOOD, V108, P3682, DOI 10.1182/blood-2006-02-003012; Resende C, 2016, GASTRIC CANCER, V19, P74, DOI 10.1007/s10120-014-0448-x; Saberwal G, 2009, J BIOL CHEM, V284, P33242, DOI 10.1074/jbc.M109.010231; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Ueda Y, 2009, J IMMUNOL, V182, P6477, DOI 10.4049/jimmunol.0803961; Wang H, 2015, J IMMUNOL, V194, P5375, DOI 10.4049/jimmunol.1401909; Wang LC, 2008, DNA REPAIR, V7, P1973, DOI 10.1016/j.dnarep.2008.08.005; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157	41	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3937	3948		10.1074/jbc.RA117.000528	http://dx.doi.org/10.1074/jbc.RA117.000528			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29382715	Green Published, hybrid			2022-12-26	WOS:000427587500008
J	Csordas, BG; Cunha, RC; Garcia, MV; da Silva, SS; Leite, FL; Andreotti, R				Csordas, Barbara Guimaraes; Cunha, Rodrigo Casquero; Garcia, Marcos Valeario; da Silva, Seargio Silva; Leite, Fabio Leivas; Andreotti, Renato			Molecular characterization of the recombinant protein RmLTI-BmCG-LTB: Protective immunity against Rhipicephalus (Boophilus) microplus	PLOS ONE			English	Article							HEAT-LABILE ENTEROTOXIN; ESCHERICHIA-COLI; B-SUBUNIT; PICHIA-PASTORIS; TICK; VACCINE; ANTIGEN; CATTLE; BM86; IMMUNOPROTECTION	The bovine tick Rhipicephalus (Boophilus) microplus is found in several tropical and subtropical regions of the world. This parasite transmits pathogens that cause disease, such as babesiosis (Babesia bovis and B. bigemina) and anaplasmosis (Anaplasma marginale). Tick infestations cause enormous livestock losses, and controlling tick infestations and the transmission of tick-borne diseases remains a challenge for the livestock industry. Because the currently available commercial vaccines offer only partial protection against R. (B.) microplus, there is a need for more efficient vaccines. Several recombinant antigens have been evaluated using different immunization strategies, and they show great promise. This work describes the construction and immunological characterization of a multi-antigen chimera composed of two R. (B.) microplus antigens (RmLTI and BmCG) and one Escherichia coli antigen (B subunit, LTB). The immunogenic regions of each antigen were selected and combined to encode a single polypeptide. The gene was cloned and expressed in E. coli. For all of the experiments, two groups (treated and control) of four Angus heifers (3-6 months old) were used. The inoculation was performed via intramuscular injection with 200 mu g of purified recombinant chimeric protein and adjuvated. The chimeric protein was recognized by specific antibodies against each subunit and by sera from cattle inoculated with the chimera. Immunization of RmLTI-BmCG-LTB cattle reduced the number of adult female ticks by 6.29% and vaccination of cattle with the chimeric antigen provided 55.6% efficacy against R. (B.) microplus infestation. The results of this study indicate that the novel chimeric protein is a potential candidate for the future development of a more effective vaccine against R. (B.) microplus.	[Csordas, Barbara Guimaraes] Univ Fed Mato Grosso do Sul, Fac Med, Programa Posgrad Doencas Infecciosas & Parasitari, Campo Grande, Mato Grosso Do, Brazil; [Cunha, Rodrigo Casquero; Leite, Fabio Leivas] Univ Fed Pelotas, Programa Posgrad Biotecnol, Pelotas, Rio Grande Do S, Brazil; [Garcia, Marcos Valeario] Fundacao Apoio Desenvolvimento Ensino Ciencia & T, Campo Grande, Mato Grosso Do, Brazil; [Garcia, Marcos Valeario; Andreotti, Renato] Embrapa Gado Corte, Dept Sanidade Anim, Lab Biol Mol Carrapato, Campo Grande, Mato Grosso Do, Brazil; [da Silva, Seargio Silva] Univ Fed Pelotas, Fac Med Vet, Lab Doencas Parasitarias, Pelotas, Rio Grande Do S, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Federal de Pelotas; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Pelotas	Andreotti, R (corresponding author), Embrapa Gado Corte, Dept Sanidade Anim, Lab Biol Mol Carrapato, Campo Grande, Mato Grosso Do, Brazil.	renato.andreotti@embrapa.br	Cunha, Rodrigo Casquero/AFZ-3898-2022; andreotti, renato/W-9503-2019	Cunha, Rodrigo Casquero/0000-0003-0145-0321; Guimaraes Csordas, Barbara/0000-0002-4493-6359; Andreotti, Renato/0000-0002-0739-2997	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Apoio ao Desenvolvimento do Ensino; Ciencia e Tecnologia do Estado de Mato Grosso do Sul (Fundect, MS)-Governo do Estado de Mato Grosso do Sul	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Desenvolvimento do Ensino; Ciencia e Tecnologia do Estado de Mato Grosso do Sul (Fundect, MS)-Governo do Estado de Mato Grosso do Sul	This study was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (Fundect, MS)-Governo do Estado de Mato Grosso do Sul. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed A, 2010, BIOCHEM ENG J, V49, P379, DOI 10.1016/j.bej.2010.01.014; Andreotti R, 2002, INT IMMUNOPHARMACOL, V2, P557, DOI 10.1016/S1567-5769(01)00203-X; Andreotti R, 2001, J PROTEIN CHEM, V20, P337, DOI 10.1023/A:1012242817869; Andreotti Renato, 2006, Rev Bras Parasitol Vet, V15, P97; Andreotti R, 2008, REV BRAS PARASITOL V, V17, P93, DOI 10.1590/S1984-29612008000200006; Andreotti R, 2012, VACCINE, V30, P6678, DOI 10.1016/j.vaccine.2012.08.066; [Anonymous], 2006, VACCINE, V24, p[5734, 5743]; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; Cunha RC, 2012, REV BRAS PARASITOL V, V21, P254, DOI 10.1590/S1984-29612012000300014; Cunha RC, 2011, REV BRAS PARASITOL V, V20, P103, DOI 10.1590/S1984-29612011000200003; DAGERT M, 1979, GENE, V6, P23, DOI 10.1016/0378-1119(79)90082-9; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Farrell MJ, 2003, J BACTERIOL, V185, P7044, DOI 10.1128/JB.185.24.7044-7052.2003; Garcia-Garcia JC, 1999, EXP APPL ACAROL, V23, P883, DOI 10.1023/A:1006270615158; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gil LAF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069692; Grassmann AA, 2012, CLIN VACCINE IMMUNOL, V19, P740, DOI 10.1128/CVI.05720-11; Jawale CV, 2014, CLIN VACCINE IMMUNOL, V21, P799, DOI 10.1128/CVI.00016-14; Kram KE, 2015, APPL ENVIRON MICROB, V81, P4442, DOI 10.1128/AEM.00722-15; Kumar B, 2016, METHODS MOL BIOL, V1404, P459, DOI 10.1007/978-1-4939-3389-1_30; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Lessard JC, 2013, METHOD ENZYMOL, V533, P181, DOI 10.1016/B978-0-12-420067-8.00011-8; Maritz-Olivier C, 2012, TICKS TICK-BORNE DIS, V3, P179, DOI 10.1016/j.ttbdis.2012.01.003; Maruyama SR, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2136-2; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Pei XL, 2011, APPL BIOCHEM BIOTECH, V165, P416, DOI 10.1007/s12010-011-9261-8; Petermann J, 2017, EXP APPL ACAROL, V72, P303, DOI 10.1007/s10493-017-0156-4; Popara M, 2013, VACCINE, V31, P4728, DOI 10.1016/j.vaccine.2013.08.031; Rocha ADR, 2008, CAN J MICROBIOL, V54, P677, DOI [10.1139/W08-056, 10.1139/w08-056]; Aguirre ADR, 2016, VET PARASITOL, V221, P30, DOI 10.1016/j.vetpar.2016.02.032; Conceicao FR, 2006, VACCINE, V24, P5734, DOI 10.1016/j.vaccine.2006.04.036; Sambrook J., 2001, MOL CLONING LAB MANU; Sugumar P, 2011, RES VET SCI, V90, P262, DOI 10.1016/j.rvsc.2010.05.037; TAMURA S, 1994, VACCINE, V12, P419, DOI 10.1016/0264-410X(94)90118-X; Tomazetto G, 2007, ENZYME MICROB TECH, V41, P821, DOI 10.1016/j.enzmictec.2007.07.006; Valdez-Cruz NA, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-18; Vargas M, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-43	38	6	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191596	10.1371/journal.pone.0191596	http://dx.doi.org/10.1371/journal.pone.0191596			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415034	Green Submitted, Green Published, gold			2022-12-26	WOS:000424325300035
J	Hodova, I; Sonnek, R; Gelnar, M; Valigurova, A				Hodova, Iveta; Sonnek, Radim; Gelnar, Milan; Valigurova, Andrea			Architecture of Paradiplozoon homoion: A diplozoid monogenean exhibiting highly-eveloped equipment for ectoparasitism	PLOS ONE			English	Article							EUDIPLOZOON-NIPPONICUM MONOGENEA; SURFACE-STRUCTURES; MEGAN MONOGENEA; TELEOST FISH; PARASITE; ULTRASTRUCTURE; SCLERITES; SYSTEM; GILLS; IDENTIFICATION	Diplozoidae (Monogenea) are blood-feeding freshwater fish gill ectoparasites with extraordinary body architecture and a unique sexual behaviour in which two larval worms fuse and transform into one functioning individual. In this study, we describe the body organisation of Paradiplozoon homoion adult stage using a combined approach of confocal laser scanning and electron microscopy, with emphasis on the forebody and hindbody. Special attention is given to structures involved in functional adaptation to ectoparasitism, i.e. host searching, attachment and feeding/metabolism. Our observations indicate clear adaptations for blood sucking, with a well-innervated mouth opening surrounded by sensory structures, prominent muscular buccal suckers and a pharynx. The buccal cavity surface is covered with numerous tegumentary digitations that increase the area in contact with host tissue and, subsequently, with its blood. The buccal suckers and the well-innervated haptor (with sclerotised clamps controlled by noticeable musculature) cooperate in attaching to and moving over the host. Putative gland cells accumulate in the region of apical circular structures, pharynx area and in the haptor middle region. Paired club-shaped sacs lying laterally to the pharynx might serve as secretory reservoirs. Furthermore, we were able to visualise the body wall musculature, including peripheral innervation, the distribution of uniciliated sensory structures essential for reception of external environmental information, and flame cells involved in excretion. Our results confirm in detail that P. homoion displays a range of sophisticated adaptations to an ectoparasitic life style, characteristic for diplozoid monogeneans.	[Hodova, Iveta; Sonnek, Radim; Gelnar, Milan; Valigurova, Andrea] Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, Brno, Czech Republic	Masaryk University Brno	Hodova, I (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, Brno, Czech Republic.	hodova@sci.muni.cz	Valigurová, Andrea/B-4522-2012	Valigurová, Andrea/0000-0001-8313-1580	Czech Science Foundation (ECIP - European Centre of lchthyoparasitology) [P505/12/G112]; Department of Botany and Zoology of the Faculty of Science at Masaryk University; ECIP (European Centre of Ichthyoparasitology)-Centre of Excellence, Czech Science Foundation [P505/12/G112]	Czech Science Foundation (ECIP - European Centre of lchthyoparasitology); Department of Botany and Zoology of the Faculty of Science at Masaryk University; ECIP (European Centre of Ichthyoparasitology)-Centre of Excellence, Czech Science Foundation	We acknowledge the financial support from Czech Science Foundation Project No. P505/12/G112 (ECIP - European Centre of lchthyoparasitology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors acknowledge support from the Department of Botany and Zoology of the Faculty of Science at Masaryk University towards the preparation of this manuscript.; The study was financially supported by ECIP (European Centre of Ichthyoparasitology)-Centre of Excellence, Czech Science Foundation Project No. P505/12/G112. All authors acknowledge support from the Department of Botany and Zoology of the Faculty of Science at Masaryk University towards the preparation of this manuscript.	Arafa SZ, 2003, ACTA PARASITOL, V48, P163; Avenant-Oldewage A, 2014, ACTA PARASITOL, V59, P247, DOI 10.2478/s11686-014-0235-1; Bombarova M, 2014, PARASITOL RES, V113, P4111, DOI 10.1007/s00436-014-4082-7; BOVET J, 1967, Bulletin de la Societe Neuchateloise des Sciences Naturelles, V90, P63; Buchmann K, 2002, INT J PARASITOL, V32, P309, DOI 10.1016/S0020-7519(01)00332-0; Civanova K, 2013, PARASITOL RES, V112, P3053, DOI 10.1007/s00436-013-3480-6; Cohen SC, 2001, MEM I OSWALDO CRUZ, V96, P555, DOI 10.1590/S0074-02762001000400019; Collins JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001009; Cooper GM, 2000, CELL MOL APPROACH; Dos Santos QM, 2015, J PARASITOL, V101, P94, DOI 10.1645/14-521.1; DUOBINISGRAY LF, 1985, P HELM SOC WASH, V52, P175; ELNAGGAR MM, 1991, INT J PARASITOL, V21, P707, DOI 10.1016/0020-7519(91)90083-J; Galli P, 2006, J PARASITOL, V92, P395, DOI 10.1645/GE-3544RN.1; Gilbert BM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177558; Goto S., 1891, J COLL SCI IMP U TOK, V4, P151; Halton DW, 1998, INT J PARASITOL, V28, P1609, DOI 10.1016/S0020-7519(98)00063-0; HALTON DW, 1979, Z PARASITENKD, V61, P1, DOI 10.1007/BF00927082; Halton DW, 2004, MICRON, V35, P361, DOI 10.1016/j.micron.2003.12.001; HIROSE H, 1987, NIPPON SUISAN GAKK, V53, P953, DOI 10.2331/suisan.53.953; Hodova I, 2010, CENT EUR J BIOL, V5, P702, DOI 10.2478/s11535-010-0040-2; Ilgova J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17598-2; Jedlickova L, 2016, PARASITOLOGY, V143, P494, DOI 10.1017/S0031182015001808; Kamegai S, 1966, MONTH REP MEGURO PAR, V83-84, P1; Kearn G. C., 1998, PARASITISM PLATYHELM; Khotenovsky IA, 1985, FAUNA USSR MONOGENEA; Konstanzova V, 2016, PARASITOL RES, V115, P1493, DOI 10.1007/s00436-015-4882-4; Konstanzova V, 2015, PARASITOL RES, V114, P1485, DOI 10.1007/s00436-015-4331-4; Konstanzova V, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2203-8; Koskova E, 2011, PARASITOL RES, V108, P935, DOI 10.1007/s00436-010-2135-0; Koskova E, 2010, PARASITOL RES, V107, P909, DOI 10.1007/s00436-010-1949-0; LANE NJ, 1988, TISSUE CELL, V20, P211, DOI 10.1016/0040-8166(88)90042-0; Lyons K.M., 1973, Advances Parasit, V11, P193, DOI 10.1016/S0065-308X(08)60187-6; LYONS KM, 1969, PARASITOLOGY, V59, P611, DOI 10.1017/S0031182000031152; Mair GR, 1998, PARASITOL TODAY, V14, P73, DOI 10.1016/S0169-4758(97)01182-4; Matejusova I, 2004, J PARASITOL, V90, P817, DOI 10.1645/GE-138R; Matejusova I, 2002, SYST PARASITOL, V53, P39, DOI 10.1023/A:1019945921143; Matejusova I, 2001, PARASITOLOGY, V123, P465, DOI 10.1017/S0031182001008617; Milne SJ, 2006, ONDERSTEPOORT J VET, V73, P149; Neves R, 2005, PARASITOL RES, V95, P43, DOI 10.1007/s00436-004-1241-2; Nordmann A., 1832, ACAD BERLIN, V2, P57; Pecinkova M, 2007, J FISH BIOL, V71, P1358, DOI 10.1111/j.1095-8649.2007.01599.x; Pecinkova M, 2007, J ZOOL, V272, P406, DOI 10.1111/j.1469-7998.2006.00284.x; Pecinkova M, 2005, DIS AQUAT ORGAN, V64, P63, DOI 10.3354/dao064063; Pecinkova M, 2007, PARASITOL INT, V56, P179, DOI 10.1016/j.parint.2007.01.010; Poddubnaya LG, 2012, SYST PARASITOL, V82, P89, DOI 10.1007/s11230-012-9359-6; POULIN R, 1998, EVOLUTIONARY ECOLOGY; RAMASAMY P, 1995, INT J PARASITOL, V25, P43, DOI 10.1016/0020-7519(94)E0039-P; RAMASAMY P, 1987, INT J PARASITOL, V17, P1187, DOI 10.1016/0020-7519(87)90171-8; Ramasamy P, 2000, PARASITOL RES, V86, P129, DOI 10.1007/s004360050022; Schabussova I, 2004, J HELMINTHOL, V78, P63, DOI 10.1079/JOH2003212; Schabussova I, 2003, HELMINTHOLOGIA, V40, P135; Smyth J.D., 1983, PHYSL TREMATODES; Sterba G., 1957, Zoologischer Anzeiger, V158, P181; Valigurova A, 2011, PARASITOL RES, V108, P383, DOI 10.1007/s00436-010-2077-6; Valverde-Islas LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014754; WILSON RA, 1974, BIOL REV, V49, P127, DOI 10.1111/j.1469-185X.1974.tb01572.x; Zeller E., 1872, Z WISS ZOOL, V22, P168; Zurawski TH, 2003, PARASITOLOGY, V126, P349, DOI 10.1017/S0031182002002871; Zurawski TH, 2003, J PARASITOL, V89, P198, DOI 10.1645/0022-3395(2003)089[0198:MEONCB]2.0.CO;2; Zurawski TH, 2001, INT J PARASITOL, V31, P783, DOI 10.1016/S0020-7519(01)00192-8	60	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192285	10.1371/journal.pone.0192285	http://dx.doi.org/10.1371/journal.pone.0192285			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414983	Green Submitted, Green Published, gold			2022-12-26	WOS:000424325300066
J	Jenkins, AR; Reid, T; du Plessis, J; Colyn, R; Benn, G; Millikin, R				Jenkins, Andrew R.; Reid, Tim; du Plessis, Johan; Colyn, Robin; Benn, Grant; Millikin, Rhonda			Combining radar and direct observation to estimate pelican collision risk at a proposed wind farm on the Cape west coast, South Africa	PLOS ONE			English	Article							BIRD MORTALITY; BEHAVIOR; AVOIDANCE; IMPACTS	Pre-construction assessments of bird collision risk at proposed wind farms are often confounded by insufficient or poor quality data describing avian flight paths through the development area. These limitations can compromise the practical value of wind farm impact studies. We used radar- and observer-based methods to quantify great white pelican flights in the vicinity of a planned wind farm on the Cape west coast, South Africa, and modelled turbine collision risk under various scenarios. Model outputs were combined with pre-existing demographic data to evaluate the possible influence of the wind farm on the pelican population, and to examine impact mitigation options. We recorded high volumes of great white pelican movement through the wind farm area, coincident with the breeding cycle of the nearby colony and associated with flights to feeding areas located about 50 km away. Pelicans were exposed to collision risk at a mean rate of 2.02 High Risk flights.h(-1). Risk was confined to daylight hours, highest during the middle of the day and in conditions of strong north-westerly winds, and 82% of High Risk flights were focused on only five of the proposed 35 turbine placements. Predicted mean mortality rates (22 fatalities.yr(-1)(1, 95% CI, 16-29, with average bird and blade speeds and 95% avoidance rates) were not sustainable, resulting in a negative population growth rate (lambda = 0.991). Models suggested that removal of the five highest risk turbines from the project, or institution of a curtailment regimen that shuts down at least these turbines at peak traffic times, could theoretically reduce impacts to manageable levels. However, in spite of the large quantities of high quality data used in our analyses, our collision risk model remains compromised by untested assumptions about pelican avoidance rates and uncertainties about the existing dynamics of the pelican population, and our findings are probably not reliable enough to ensure sustainable development.	[Jenkins, Andrew R.; du Plessis, Johan] AVISENSE Consulting, Cape Town, Western Cape, South Africa; [Jenkins, Andrew R.; Reid, Tim] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst African Ornithol, Cape Town, Western Cape, South Africa; [du Plessis, Johan; Colyn, Robin] NCC Environm Serv, Cape Town, Western Cape, South Africa; [Benn, Grant] Geocline Consulting, Cape Town, Western Cape, South Africa; [Millikin, Rhonda] EchoTrack Inc, Ottawa, ON, Canada; [Colyn, Robin] Birdlife South Africa, Johannesburg, Gauteng, South Africa	National Research Foundation - South Africa; University of Cape Town	Jenkins, AR (corresponding author), AVISENSE Consulting, Cape Town, Western Cape, South Africa.; Jenkins, AR (corresponding author), Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst African Ornithol, Cape Town, Western Cape, South Africa.	andrew@avisense.co.za			AVISENSE; NCC Environmental Services; Geocline Consulting; EchoTrack Inc.	AVISENSE; NCC Environmental Services; Geocline Consulting; EchoTrack Inc.	This study was conducted under contract to the developer of the proposed wind farm Moyeng Energy (Pty) Ltd. The developer funded all cost aspects of the project, and all the contributing authors were remunerated for the various roles they played in completing the work. However, it must be stressed that Moyeng Energy did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. AJ and JdP received funding in the form of salaries from AVISENSE. JdP received funding in the form of salary from NCC Environmental Services. GB received funding in the form of salary from Geocline Consulting. RM received funding in the form of salary from EchoTrack Inc. The specific roles of each contributing author are articulated in the 'author contributions' section.	Band W., 2007, P259; Barrios L, 2004, J APPL ECOL, V41, P72, DOI 10.1111/j.1365-2664.2004.00876.x; Beason RC, 2010, J ZOOL, V282, P157, DOI 10.1111/j.1469-7998.2010.00723.x; Bellebaum J, 2013, J NAT CONSERV, V21, P394, DOI 10.1016/j.jnc.2013.06.001; Bolker B, 2008, ECOLOGICAL MODELS DA; Breiman L, 1993, CLASSIFICATION REGRE; Carrete M, 2009, BIOL CONSERV, V142, P2954, DOI 10.1016/j.biocon.2009.07.027; Caswell H, 1989, MATRIX POPULATION MO; Crawford R. J. M., 2005, ROBERTS BIRDS SO AFR, P614; CRAWFORD RJM, 1995, S AFR J MARINE SCI, V15, P33; Crawford RJM, 2013, OSTRICH, V84, P5; de Lucas M, 2012, BIOL CONSERV, V147, P184, DOI 10.1016/j.biocon.2011.12.029; de Ponte Machado M., 2010, THESIS; Dokter AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074129; Douglas DJT, 2012, IBIS, V154, P858, DOI 10.1111/j.1474-919X.2012.01239.x; Drewitt AL, 2006, IBIS, V148, P29, DOI 10.1111/j.1474-919X.2006.00516.x; Ferrer M, J APPL ECOLOGY; Ferrer M, 2012, J APPL ECOL, V49, P38, DOI 10.1111/j.1365-2664.2011.02054.x; Hull CL, 2013, WILDLIFE SOC B, V37, P49, DOI 10.1002/wsb.254; Jenkins AR, 2015, BEST PRACTICE GUIDEL; KERLINGER P, 1985, AUK, V102, P735; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Masden EA, 2016, ENVIRON IMPACT ASSES, V56, P43, DOI 10.1016/j.eiar.2015.09.001; May RF, 2015, BIOL CONSERV, V190, P179, DOI 10.1016/j.biocon.2015.06.004; Meesters HWG, 2007, ANAL ECOLOGICAL DATA; Mentis D, 2015, RENEW ENERG, V83, P110, DOI 10.1016/j.renene.2015.03.072; Millikin RL, 2001, INT GEOSCI REMOTE SE, P2010, DOI 10.1109/IGARSS.2001.977886; Millikin RL, 2002, THESIS; Mwema Martin M., 2010, Endangered Species Research, V9, P125, DOI 10.3354/esr00243; R Core Team, 2021, R LANGUAGE ENV STAT; Rosa IMD, 2016, IBIS, V158, P28, DOI 10.1111/ibi.12333; Shannon HD, 2002, CONDOR, V104, P679, DOI 10.1650/0010-5422(2002)104[0679:AWPSFT]2.0.CO;2; Smallwood KS, 2009, J WILDLIFE MANAGE, V73, P1082, DOI 10.2193/2008-555; SNH, 2014, GUID REC BIRD SURV M; Strickland M.D., 2011, COMPREHENSIVE GUIDE; Taylor M. R., 2015, RED DATA BOOK TAJIKI; Wang SF, 2015, RENEW SUST ENERG REV, V44, P599, DOI 10.1016/j.rser.2015.01.031	37	5	5	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192515	10.1371/journal.pone.0192515	http://dx.doi.org/10.1371/journal.pone.0192515			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408877	Green Submitted, Green Published, gold			2022-12-26	WOS:000424302800077
J	Wu, JL; Lee, CH; Yang, CT; Chang, CM; Li, GA; Cheng, CK; Chen, CH; Huang, HS; Lai, YS				Wu, Jia-Lin; Lee, Chian-Her; Yang, Chan-Tsung; Chang, Chia-Ming; Li, Guoan; Cheng, Cheng-Kung; Chen, Chih-Hwa; Huang, Hsu-Shan; Lai, Yu-Shu			Novel technique for repairing posterior medial meniscus root tears using porcine knees and biomechanical study	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; PULL-OUT REPAIR; RADIAL TEARS; FOLLOW-UP; SPONTANEOUS OSTEONECROSIS; REFIXATION TECHNIQUE; PROGNOSTIC-FACTORS; AVULSION FRACTURE; CONTACT MECHANICS; HORN AVULSION	Transtibial pullout suture (TPS) repair of posterior medial meniscus root (PMMR) tears was shown to achieve good clinical outcomes. The purpose of this study was to compare biomechanically, a novel technique designed to repair PMMR tears using tendon graft (TG) and conventional TPS repair. Twelve porcine tibiae (n = 6 each) TG group: flexor digitorum profundus tendon was passed through an incision in the root area, created 5 mm postero-medially along the edge of the attachment area. TPS group: a modified Mason-Allen suture was created using no. 2 FiberWire. The tendon grafts and sutures were threaded through the bone tunnel and then fixed to the anterolateral cortex of the tibia. The two groups underwent cyclic loading followed by a load-to-failure test. Displacements of the constructs after 100, 500, and 1000 loading cycles, and the maximum load, stiffness, and elongation at failure were recorded. The TG technique had significantly lower elongation and higher stiffness compared with the TPS. The maximum load of the TG group was significantly lower than that of the TPS group. Failure modes for all specimens were caused by the suture or graft cutting through the meniscus. Lesser elongation and higher stiffness of the constructs in TG technique over those in the standard TPS technique might be beneficial for postoperative biological healing between the meniscus and tibial plateau. However, a slower rehabilitation program might be necessary due to its relatively lower maximum failure load.	[Wu, Jia-Lin; Lee, Chian-Her; Chen, Chih-Hwa] Taipei Med Univ, Coll Med, Sch Med, Dept Orthoped & Traumatol, Taipei, Taiwan; [Wu, Jia-Lin; Lee, Chian-Her; Chen, Chih-Hwa] Taipei Med Univ Hosp, Dept Orthoped, Taipei, Taiwan; [Yang, Chan-Tsung; Cheng, Cheng-Kung; Lai, Yu-Shu] Natl Yang Ming Univ, Orthopaed Devices Res Ctr, Taipei, Taiwan; [Chang, Chia-Ming; Cheng, Cheng-Kung] Natl Yang Ming Univ, Inst Biomed Engn, Taipei, Taiwan; [Li, Guoan] Massachusetts Gen Hosp, Dept Orthoped Surg, Bioengn Lab, Boston, MA 02114 USA; [Li, Guoan] Harvard Med Sch, Boston, MA USA; [Huang, Hsu-Shan] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Taipei Medical University	Lai, YS (corresponding author), Natl Yang Ming Univ, Orthopaed Devices Res Ctr, Taipei, Taiwan.; Huang, HS (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan.	huanghs99@tmu.edu.tw; uesu@ortho.ym.edu.tw		Chang, Chia-Ming/0000-0002-6073-8272; Wu, Jia-Lin/0000-0002-2843-405X; Huang, Hsu-Shan/0000-0001-8162-5608	Taipei Medical University [TMU103-AE-1-637, 106TMU-TMUH-16, TMU105-AE-1-1329, A-106-001]; Ministry of Science and Technology [105-2113-M-038-001]	Taipei Medical University; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by Taipei Medical University (TMU103-AE-1-637 and 106TMU-TMUH-16) to Jia-Lin Wu; Ministry of Science and Technology (105-2113-M-038-001) to Hsu-Shan Huang; and Taipei Medical University (TMU105-AE-1-1329, and A-106-001) to Hsu-Shan Huang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663; Alhalki MM, 1999, AM J SPORT MED, V27, P320, DOI 10.1177/03635465990270030901; Allaire R, 2008, J BONE JOINT SURG AM, V90A, P1922, DOI 10.2106/JBJS.G.00748; Bin SI, 2004, ARTHROSCOPY, V20, P373, DOI 10.1016/j.arthro.2004.01.004; Burks RT, 1997, ARTHROSCOPY, V13, P673, DOI 10.1016/S0749-8063(97)90000-1; Chen MI, 1996, ARTHROSCOPY, V12, P174, DOI 10.1016/S0749-8063(96)90007-9; Cho JH, 2012, J ORTHOP SCI, V17, P98, DOI 10.1007/s00776-011-0078-7; Choi SH, 2012, KNEE SURG SPORT TR A, V20, P2094, DOI 10.1007/s00167-011-1794-4; Chung KS, 2016, ARTHROSCOPY, V32, P1319, DOI 10.1016/j.arthro.2015.12.046; Chung KS, 2016, KNEE SURG SPORT TR A, V24, P1455, DOI 10.1007/s00167-015-3832-0; Donahue TLH, 2001, J BIOMECH ENG-T ASME, V123, P162, DOI 10.1115/1.1351889; Donahue TLH, 2003, J BIOMECH, V36, P19, DOI 10.1016/S0021-9290(02)00305-6; Feucht MJ, 2015, ARTHROSCOPY, V31, P1808, DOI 10.1016/j.arthro.2015.03.022; Feucht MJ, 2015, KNEE SURG SPORT TR A, V23, P132, DOI 10.1007/s00167-013-2656-z; Feucht MJ, 2014, AM J SPORT MED, V42, P187, DOI 10.1177/0363546513502946; Feucht MJ, 2013, AM J SPORT MED, V41, P2784, DOI 10.1177/0363546513502464; Griffith CJ, 2008, AM J SPORT MED, V36, P789, DOI 10.1177/0363546507308195; Han SB, 2010, ARTHROSCOPY, V26, P1326, DOI 10.1016/j.arthro.2010.01.032; Herbort M, 2010, AM J SPORT MED, V38, P2281, DOI 10.1177/0363546510382847; Hong Jang-Hee, 2011, Knee Surg Relat Res, V23, P164, DOI 10.5792/ksrr.2011.23.3.164; Johannsen AM, 2012, AM J SPORT MED, V40, P2342, DOI 10.1177/0363546512457642; Kim JH, 2011, ARTHROSCOPY, V27, P1644, DOI 10.1016/j.arthro.2011.06.033; Kim JG, 2013, KNEE SURG SPORT TR A, V21, P2121, DOI 10.1007/s00167-012-2182-4; Kim YM, 2013, KNEE SURG SPORT TR A, V21, P1546, DOI 10.1007/s00167-012-2131-2; Krych AJ, 2017, KNEE SURG SPORT TR A, V25, P383, DOI 10.1007/s00167-016-4359-8; LaPrade CM, 2015, AM J SPORT MED, V43, P899, DOI 10.1177/0363546514563278; LaPrade CM, 2015, AM J SPORT MED, V43, P912, DOI 10.1177/0363546514566191; LaPrade RF, 2017, AM J SPORT MED, V45, P884, DOI 10.1177/0363546516673996; Lavender CD, 2015, ARTHROSC TEC, V4, pE781, DOI 10.1016/j.eats.2015.07.028; Lee CK, 2011, KNEE SURG SPORT TR A, V19, P165, DOI 10.1007/s00167-010-1060-1; Lee Dhong Won, 2014, Knee Surg Relat Res, V26, P125, DOI 10.5792/ksrr.2014.26.3.125; Lee DW, 2013, KNEE SURG SPORT TR A, V21, P654, DOI 10.1007/s00167-012-1992-8; Lee JH, 2009, ARTHROSCOPY, V25, P951, DOI 10.1016/j.arthro.2009.03.018; Lee YHD, 2013, AM J SPORT MED, V41, P1074, DOI 10.1177/0363546513479775; Marzo JM, 2009, J AM ACAD ORTHOP SUR, V17, P276, DOI 10.5435/00124635-200905000-00002; Marzo JM, 2009, AM J SPORT MED, V37, P124, DOI 10.1177/0363546508323254; Messner K, 1998, J ANAT, V193, P161, DOI 10.1046/j.1469-7580.1998.19320161.x; Miyata K, 2000, J Orthop Sci, V5, P585; Moon HK, 2012, AM J SPORT MED, V40, P1138, DOI 10.1177/0363546511435622; Ozeki N, 2015, STEM CELLS, V33, P1927, DOI 10.1002/stem.2030; Ozeki N, 2013, ARTHRITIS RHEUM-US, V65, P2876, DOI 10.1002/art.38099; Ozkoc G, 2008, KNEE SURG SPORT TR A, V16, P849, DOI 10.1007/s00167-008-0569-z; PAGNANI M J, 1991, Arthroscopy, V7, P297, DOI 10.1016/0749-8063(91)90131-G; Poulsen MR, 2011, PHYSICIAN SPORTSMED, V39, P123, DOI 10.3810/psm.2011.02.1870; Raustol OA, 2006, ARTHROSCOPY, V22, DOI 10.1016/j.arthro.2005.12.022; Robertson DD, 2009, J BONE JOINT SURG BR, V91B, P190, DOI 10.1302/0301-620X.91B2.21097; Ropke EF, 2015, KNEE SURG SPORT TR A, V23, P45, DOI 10.1007/s00167-013-2589-6; Rosslenbroich SB, 2013, ARCH ORTHOP TRAUM SU, V133, P111, DOI 10.1007/s00402-012-1625-1; Seo HS, 2011, AM J SPORT MED, V39, P99, DOI 10.1177/0363546510382225; Seo JH, 2009, ARTHROSCOPY, V25, P1281, DOI 10.1016/j.arthro.2009.05.014; Smith GN, 2002, OSTEOARTHR CARTILAGE, V10, P321, DOI 10.1053/joca.2002.0520; Starke C, 2010, ARTHROSCOPY, V26, P358, DOI 10.1016/j.arthro.2009.08.013; Steineman BD, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117702452; STOLLER NH, 1990, J PERIODONTOL, V61, P306; Sung JH, 2013, ARTHROSCOPY, V29, P726, DOI 10.1016/j.arthro.2012.11.016; Thompson SM, 2016, AM J SPORT MED, V44, P3083, DOI 10.1177/0363546516658041; Villegas DF, 2008, ANN BIOMED ENG, V36, P123, DOI 10.1007/s10439-007-9403-x; Villegas DF, 2007, J BIOMECH, V40, P2655, DOI 10.1016/j.jbiomech.2007.01.015; Xerogeanes JW, 1998, ANN BIOMED ENG, V26, P345, DOI 10.1114/1.91	59	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192027	10.1371/journal.pone.0192027	http://dx.doi.org/10.1371/journal.pone.0192027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408892	gold, Green Published, Green Submitted			2022-12-26	WOS:000424302800040
J	Denet, E; Vasselon, V; Burdin, B; Nazaret, S; Favre-Bonte, S				Denet, Elodie; Vasselon, Valentin; Burdin, Beatrice; Nazaret, Sylvie; Favre-Bonte, Sabine			Survival and growth of Stenotrophomonas maltophilia in free-living amoebae (FLA) and bacterial virulence properties	PLOS ONE			English	Article							EFFLUX PUMP SMEDEF; MOLECULAR CHARACTERIZATION; VERMAMOEBA-VERMIFORMIS; LEGIONELLA-PNEUMOPHILA; WATER; RESISTANCE; STRAINS; INFECTION; DISEASE; BIOREMEDIATION	Stenotrophomonas maltophilia is found ubiquitously in the environment and is an important emerging nosocomial pathogen. S. maltophilia has been recently described as an Amoebae-Resistant Bacteria (ARB) that exists as part of the microbiome of various free-living amoebae (FLA) from waters. Co-culture approaches with Vermamoeba vermiformis demonstrated the ability of this bacterium to resist amoebal digestion. In the present study, we assessed the survival and growth of six environmental and one clinical S. maltophilia strains within two amoebal species: Acanthamoeba castellanii and Willaertia magna. We also evaluated bacterial virulence properties using the social amoeba Dictyostelium discoideum. A co-culture approach was carried out over 96 hours and the abundance of S. maltophilia cells was measured using quantitative PCR and culture approach. The presence of bacteria inside the amoeba was confirmed using confocal microscopy. Our results showed that some S. maltophilia strains were able to multiply within both amoebae and exhibited multiplication rates up to 17.5 and 1166 for A. castellanii and W. magna, respectively. In contrast, some strains were unable to multiply in either amoeba. Out of the six environmental S. maltophilia strains tested, one was found to be virulent. Surprisingly, this strain previously isolated from a soil amoeba, Micriamoeba, was unable to infect both amoebal species tested. We further performed an assay with a mutant strain of S. maltophilia BurA1 lacking the efflux pump ebyCAB gene and found the mutant to be more virulent and more efficient for intra-amoebal multiplication. Overall, the results obtained strongly indicated that free-living amoebae could be an important ecological niche for S. maltophilia.	[Denet, Elodie; Vasselon, Valentin; Nazaret, Sylvie; Favre-Bonte, Sabine] Univ Lyon 1, UMR CNRS 5557, UMR INRA 1418 Ecol Microbienne, Villeurbanne, France; [Burdin, Beatrice] Univ Lyon 1, Ctr Technol Microstruct, Villeurbanne, France; [Vasselon, Valentin] INRA, Ctr Alpin Rech Reseaux Troph & Ecosyst Limn, Thonon Les Bains, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE	Denet, E (corresponding author), Univ Lyon 1, UMR CNRS 5557, UMR INRA 1418 Ecol Microbienne, Villeurbanne, France.	elodie.denet@live.fr	Vasselon, Valentin/Q-7670-2019; Vasselon, Valentin/X-8504-2018	Vasselon, Valentin/0000-0001-5038-7918; Vasselon, Valentin/0000-0001-5038-7918	Centre National de la Recherche Scientifique; FR BioEnviS; Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); FR BioEnviS; Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche	The work was supported by "Centre National de la Recherche Scientifique" in order to perform experiments, and by a research program of the FR BioEnviS. E. Denet, phD Student was supported by the "Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche.	Adamek M, 2014, MICROB PATHOGENESIS, V67-68, P20, DOI 10.1016/j.micpath.2014.02.001; Adamek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027615; Albini S, 2009, SCHWEIZ ARCH TIERH, V151, P323, DOI 10.1024/0036-7281.151.7.323; Alonso A, 2004, J ANTIMICROB CHEMOTH, V53, P432, DOI 10.1093/jac/dkh074; Alonso A, 2001, ANTIMICROB AGENTS CH, V45, P1879, DOI 10.1128/AAC.45.6.1879-1881.2001; Antonioli P, 2007, APPL ENVIRON MICROB, V73, P6854, DOI 10.1128/AEM.00957-07; Berg G, 1999, J CLIN MICROBIOL, V37, P3594, DOI 10.1128/JCM.37.11.3594-3600.1999; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Cateau E, 2014, RES MICROBIOL, V165, P847, DOI 10.1016/j.resmic.2014.10.004; Chen SN, 2013, CHEMOSPHERE, V90, P1811, DOI 10.1016/j.chemosphere.2012.09.009; Corsaro D, 2013, EXP PARASITOL, V133, P383, DOI 10.1016/j.exppara.2012.12.016; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Delafont V, 2013, WATER RES, V47, P6958, DOI 10.1016/j.watres.2013.07.047; Denet E, 2017, PARASITOL RES, V116, P3151, DOI 10.1007/s00436-017-5632-6; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; Dey R, 2009, FEMS MICROBIOL LETT, V290, P10, DOI 10.1111/j.1574-6968.2008.01387.x; Dubey KK, 2012, WORLD J MICROB BIOT, V28, P1715, DOI 10.1007/s11274-011-0982-1; Dungan RS, 2003, ENVIRON MICROBIOL, V5, P287, DOI 10.1046/j.1462-2920.2003.00410.x; Dupuy M, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw022; Evstigneeva A, 2009, MICROBIOL-SGM, V155, P657, DOI 10.1099/mic.0.022970-0; Favre-Bonte S, 2003, J ANTIMICROB CHEMOTH, V52, P598, DOI 10.1093/jac/dkg397; Froquet R, 2009, NAT PROTOC, V4, P25, DOI 10.1038/nprot.2008.212; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Guimaraes AJ, 2016, MICROBIOL RES, V193, P30, DOI 10.1016/j.micres.2016.08.001; Hassanshahian M, 2013, MAR POLLUT BULL, V73, P300, DOI 10.1016/j.marpolbul.2013.05.002; Lin YT, 2015, ANTIMICROB AGENTS CH, V59, P4067, DOI 10.1128/AAC.00372-15; Loret JF, 2010, INT J HYG ENVIR HEAL, V213, P167, DOI 10.1016/j.ijheh.2010.03.004; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Moliner C, 2010, FEMS MICROBIOL REV, V34, P281, DOI [10.1111/j.1574-6976.2009.00209.x, 10.1111/j.1574-6976.2010.00209.x]; Morales-Jimenez J, 2012, MICROB ECOL, V64, P268, DOI 10.1007/s00248-011-9999-0; Ohnishi M, 2012, LETT APPL MICROBIOL, V54, P572, DOI 10.1111/j.1472-765X.2012.03246.x; Pagnier I, 2015, MICROB PATHOGENESIS, V80, P14, DOI 10.1016/j.micpath.2015.02.006; Patrizia M, 2013, ARCH MICROBIOL, V195, P89, DOI 10.1007/s00203-012-0851-9; Peralta KD, 2012, WORLD J MICROB BIOT, V28, P2003, DOI 10.1007/s11274-012-1003-8; Perez A, 2012, ANTIMICROB AGENTS CH, V56, P2084, DOI 10.1128/AAC.05509-11; Pinot C, 2011, J APPL MICROBIOL, V111, P1185, DOI 10.1111/j.1365-2672.2011.05120.x; Romanenko LA, 2008, ARCH MICROBIOL, V189, P337, DOI 10.1007/s00203-007-0324-8; Ryan RP, 2009, NAT REV MICROBIOL, V7, P514, DOI 10.1038/nrmicro2163; Siddiqui R, 2011, EXP PARASITOL, V128, P409, DOI 10.1016/j.exppara.2011.05.008; Somaraja PK, 2013, B ENVIRON CONTAM TOX, V91, P148, DOI 10.1007/s00128-013-1044-1; Steinert M, 2011, SEMIN CELL DEV BIOL, V22, P70, DOI 10.1016/j.semcdb.2010.11.003; Tacao M, 2015, MICROB DRUG RESIST, V21, P497, DOI 10.1089/mdr.2015.0072; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; Winther L, 2010, VET J, V186, P358, DOI 10.1016/j.tvjl.2009.08.026; Youenou B, 2015, GENOME BIOL EVOL, V7, P2484, DOI 10.1093/gbe/evv161; Zhang Z, 2001, PHYTOPATHOLOGY, V91, P204, DOI 10.1094/PHYTO.2001.91.2.204	46	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192308	10.1371/journal.pone.0192308	http://dx.doi.org/10.1371/journal.pone.0192308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401523	Green Published, gold, Green Submitted			2022-12-26	WOS:000424101400046
J	Maestro-Gonzalez, A; Bilbao-Leon, MC; Zuazua-Rico, D; Fernandez-Carreira, JM; Baldonedo-Cernuda, RF; Mosteiro-Diaz, MP				Maestro-Gonzalez, Alba; Cruz Bilbao-Leon, M.; Zuazua-Rico, David; Fernandez-Carreira, Jose M.; Baldonedo-Cernuda, Ricardo F.; Pilar Mosteiro-Diaz, M.			Quality of life as assessed by adults with cerebral palsy	PLOS ONE			English	Article							YOUNG-ADULTS; ROMANTIC RELATIONSHIPS; SEXUAL-ACTIVITY; HEALTH; CHILDREN; ADOLESCENTS; CLASSIFICATION; PARENTS; YOUTH	Aim We explored the quality of life of adults with cerebral palsy without an intellectual disability and the predictors of quality of life. Background Because cerebral palsy is a disease that manifests in childhood, much of the research into quality of life for those dealing with it focuses on children; there are few studies that evaluate the quality of life of adults with cerebral palsy. Therefore, it is important to consider their perceptions in order to improve their general wellbeing and self-determination. Design This was a descriptive, cross-sectional study. Method Quality of life was measured using the GENCAT Quality of Life Scale. Demographic and personal variables were also collected and examined. Participants comprised 75 adults (58.7 percent men, mean age = 40.84 years) with cerebral palsy who were members of the National Cerebral Palsy Association of Spain between 2014 and 2015. A linear multivariate model was examined as well. Results The overall mean score indicator of participants' quality of life was 103.29, which corresponds to the 56.6th percentile on the GENCAT scale. Examining the level of qualification, we found significant differences in the factors "personal development" and "self-determination," and those with a university education obtained higher scores than their less-educated counterparts. Having a partner was related to higher quality of life standard scores. After constructing a linear model, it was observed that maintaining sexual relationships was another factor that increased participants' quality of life. Conclusion This study highlights the importance of social and romantic relationships to achieve a better quality of life in adults with cerebral palsy who do not have an intellectual disability. Social integration and sexuality education programs should be developed to improve their quality of life.	[Maestro-Gonzalez, Alba; Zuazua-Rico, David; Baldonedo-Cernuda, Ricardo F.; Pilar Mosteiro-Diaz, M.] Univ Oviedo, Dept Med, Nursing Area, Oviedo, Spain; [Maestro-Gonzalez, Alba; Zuazua-Rico, David; Baldonedo-Cernuda, Ricardo F.] Hosp Univ Cent Asturias, Oviedo, Spain; [Cruz Bilbao-Leon, M.] Univ Burgos, Dept Educ Sci, Burgos, Spain; [Fernandez-Carreira, Jose M.] Hosp Publ Comarcal Jarrio, Hlth Serv Principal Asturias, Jarrio, Spain	University of Oviedo; Central University Hospital Asturias; Universidad de Burgos	Maestro-Gonzalez, A (corresponding author), Univ Oviedo, Dept Med, Nursing Area, Oviedo, Spain.; Maestro-Gonzalez, A (corresponding author), Hosp Univ Cent Asturias, Oviedo, Spain.	maestroalba@uniovi.es	Zuazua-Rico, David/HDM-2392-2022; Maestro-Gonzalez, Alba/ABH-7539-2020	Zuazua-Rico, David/0000-0002-5945-5945; Maestro-Gonzalez, Alba/0000-0002-1588-9362; Mosteiro-Diaz, Maria Pilar/0000-0002-3375-9334; Baldonedo-Cernuda, Ricardo Felipe/0000-0003-3650-7121				Alonso MA Verdugo, 2009, COMO MEJORAR CALIDAD; Andersson C, 2001, DEV MED CHILD NEUROL, V43, P76, DOI 10.1017/S0012162201; Verdugo MA, 2010, INT J CLIN HLTH PSYC, V10, P105; [Anonymous], QUALITY LIFE; Barbosa-Resende W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115643; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; BLUM RW, 1991, PEDIATRICS, V88, P280; Cans C, 2002, DEV MED CHILD NEUROL, V44, P633; Cerebral Palsy Alliance, 2017, GMFCS E R GROSS MOT; Colver A, 2015, LANCET, V385, P705, DOI 10.1016/S0140-6736(14)61229-0; Colver A, 2014, LANCET, V383, P1240, DOI 10.1016/S0140-6736(13)61835-8; Davis E, 2009, DEV MED CHILD NEUROL, V51, P193, DOI 10.1111/j.1469-8749.2008.03194.x; Donnelly C, 2008, J ADV NURS, V61, P557, DOI 10.1111/j.1365-2648.2007.04470.x; Foley KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108413; Garin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111498; Hergenroder H, 2009, DEV MED CHILD NEUROL, V51, P389, DOI 10.1111/j.1469-8749.2008.03169.x; HIROSE T, 1990, J ADV NURS, V15, P762, DOI 10.1111/j.1365-2648.1990.tb01904.x; Kearney PM, 2004, J ADV NURS, V46, P162, DOI 10.1111/j.1365-2648.2003.02976.x; Kingsnorth S, 2015, CHILD CARE HLTH DEV, V41, P374, DOI 10.1111/cch.12196; Liptak GS, 2008, CURR OPIN NEUROL, V21, P136, DOI 10.1097/WCO.0b013e3282f6a499; Little W J, 1966, Clin Orthop Relat Res, V46, P7; Monbaliu E, 2017, EUR J PAEDIATR NEURO, V21, P327, DOI 10.1016/j.ejpn.2016.09.003; Morgan PE, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0132-1; Odding E, 2006, DISABIL REHABIL, V28, P183, DOI 10.1080/09638280500158422; Opheim A, 2011, J REHABIL MED, V43, P382, DOI 10.2340/16501977-0787; Palisano RJ, 2008, DEV MED CHILD NEUROL, V50, P744, DOI 10.1111/j.1469-8749.2008.03089.x; Parkes J, 2009, J ADV NURS, V65, P2311, DOI 10.1111/j.1365-2648.2009.05089.x; Rosenbaum P, 2006, DEV MED CHILD NEUROL, V48, P4, DOI 10.1017/S001216226000028; Schalock RL, 2007, QUALITY LIFE PEOPLE; Soyupek F, 2010, DISABIL REHABIL, V32, P1109, DOI 10.3109/09638280903391120; Tadic V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146225; Tarsuslu T, 2010, DISABIL REHABIL, V32, P1658, DOI 10.3109/09638281003649904; van der Dussen L, 2001, CLIN REHABIL, V15, P84, DOI 10.1191/026921501670159475; Vitale MG, 2005, J PEDIATR ORTHOPED, V25, P792, DOI 10.1097/01.bpo.0000164870.26632.6b; Wechsler David, 2013, WAIS 4 MANUAL ADM CO; Wehmeyer M.L., 1998, TEACHING SELF DETERM; Wiegerink DJ, 2010, ARCH PHYS MED REHAB, V91, P1423, DOI 10.1016/j.apmr.2010.06.011; Wiegerink DJHG, 2008, J REHABIL MED, V40, P112, DOI 10.2340/16501977-0137; Wiegerink DJHG, 2010, DEV MED CHILD NEUROL, V52, P576, DOI 10.1111/j.1469-8749.2010.03620.x; Young NL, 2010, ARCH PHYS MED REHAB, V91, P143, DOI 10.1016/j.apmr.2009.08.152	40	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191960	10.1371/journal.pone.0191960	http://dx.doi.org/10.1371/journal.pone.0191960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401489	Green Published, Green Submitted, gold			2022-12-26	WOS:000424101400028
J	Avivi-Arber, L; Avivi, D; Perez, M; Arber, N; Shapira, S				Avivi-Arber, Limor; Avivi, Doran; Perez, Marilena; Arber, Nadir; Shapira, Shiran			Impaired bone healing at tooth extraction sites in CD24-deficient mice: A pilot study	PLOS ONE			English	Article							STEM-CELLS; COLORECTAL-CANCER; CD24; EXPRESSION; PROLIFERATION; APOPTOSIS; MODEL	Aim To use a micro-computed tomography (micro-CT) to quantify bone healing at maxillary first molar extraction sites, and test the hypothesis that bone healing is impaired in CD24-knockout mice as compared with wild-type C57BL/6J mice. Materials and methods Under ketamine-xylazine general anaesthesia, mice had either extraction of the right maxillary first molar tooth or sham operation. Mice were sacrificed 1 (n = 12/group), 2 (n = 6/group) or 4 (n = 6/group) weeks postoperatively. The right maxillae was disected. Micro-CT was used to quantify differences in bone microstructural features at extrction sites, between CD24-knockout mice and wild-type mice. Results CD24-Knockout mice displayed impaired bone healing at extraction sites that was manifested as decreased trabecular bone density, and decreased number and thickness of trabeculae. Conclusions This pilot study suggests that CD24 plays an important role in extraction socket bone healing and may be used as a novel biomarker of bone quality and potential therapeutic target to improve bone healing and density following alveolar bone injury.	[Avivi-Arber, Limor; Perez, Marilena] Univ Toronto, Fac Dent, Toronto, ON, Canada; [Avivi, Doran; Arber, Nadir; Shapira, Shiran] Tel Aviv Univ, Sackler Fac Med, Integrated Canc Prevent Ctr, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel	University of Toronto; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Avivi-Arber, L (corresponding author), Univ Toronto, Fac Dent, Toronto, ON, Canada.	Limor.avivi.arber@utoronto.ca	Avivi-Arber, Limor/C-4658-2017	Avivi-Arber, Limor/0000-0002-0567-6101; Arber, Nadir/0000-0001-5283-6991	Tel Aviv Medical Center research Grant; Tel Aviv Medical Center-research Grant	Tel Aviv Medical Center research Grant; Tel Aviv Medical Center-research Grant	This research was supported by Tel Aviv Medical Center research Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Nancy Valiquette for assisting with the micro-CT. The authors declare that they have no conflict of interests. This research was supported by Tel Aviv Medical Center-research Grant.	Aguilar P, 2016, TISSUE CELL, V48, P397, DOI 10.1016/j.tice.2016.08.008; Allegrini Sergio Jr., 2008, Roczniki Pomorskiej Akademii Medycznej w Szczecinie, V54, P70; Bakopoulou A, 2013, ARCH ORAL BIOL, V58, P1556, DOI 10.1016/j.archoralbio.2013.06.018; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chappel MS, 1996, J EXP MED, V184, P1639, DOI 10.1084/jem.184.5.1639; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Fang XF, 2010, CELL MOL IMMUNOL, V7, P100, DOI 10.1038/cmi.2009.119; Fokra A, 2016, J CANC SCI THER, V8, P135; Gracz AD, 2013, STEM CELLS, V31, P2024, DOI 10.1002/stem.1391; Guo W, 2014, IMMUN INFLAMM DIS, V2, P239, DOI 10.1002/iid3.40; Huber MB, 2011, IEEE T BIO-MED ENG, V58, P1820, DOI 10.1109/TBME.2011.2119484; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; Kristiansen G, 2004, J MOL HISTOL, V35, P255; Li O, 2004, J EXP MED, V200, P1083, DOI 10.1084/jem.20040779; Liu Y, 2009, TRENDS IMMUNOL, V30, P557, DOI 10.1016/j.it.2009.09.006; Martin W, 2009, INT J ORAL MAX IMPL, V24, P28; Naumov I, 2014, INT J CANCER, V135, P1048, DOI 10.1002/ijc.28762; Sagiv E, 2008, CANCER RES, V68, P2803, DOI 10.1158/0008-5472.CAN-07-6463; Sagiv E, 2006, GASTROENTEROLOGY, V131, P630, DOI 10.1053/j.gastro.2006.04.028; Sagiv Eyal, 2008, Expert Rev Gastroenterol Hepatol, V2, P125, DOI 10.1586/17474124.2.1.125; Salaria S, 2015, AM J CLIN PATHOL, V144, P642, DOI 10.1309/AJCPMZY5P9TWNJJV; Shapira S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139787; Shapira S, 2011, GASTROENTEROLOGY, V140, P935, DOI 10.1053/j.gastro.2010.12.004; Stroncek John D., 2008, P3; Taguchi T, 2003, J IMMUNOL, V170, P252, DOI 10.4049/jimmunol.170.1.252; Tomlin Elizabeth M, 2014, Open Dent J, V8, P66, DOI 10.2174/1874210601408010066; Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006; Vieira AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128021; Wu JY, 2012, J ENDODONT, V38, P614, DOI 10.1016/j.joen.2012.01.014; Ye P, 2006, BIOCHEM BIOPH RES CO, V349, P229, DOI 10.1016/j.bbrc.2006.08.033; Ye P, 2005, CLIN EXP IMMUNOL, V139, P328, DOI 10.1111/j.1365-2249.2005.02692.x; Ye P, 2014, J PERIODONTAL RES, V49, P253, DOI 10.1111/jre.12102; Ye P, 2011, BIOCHEM BIOPH RES CO, V412, P165, DOI 10.1016/j.bbrc.2011.07.067; Ye P, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-2	34	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191665	10.1371/journal.pone.0191665	http://dx.doi.org/10.1371/journal.pone.0191665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390019	Green Published, Green Submitted, gold			2022-12-26	WOS:000423793400026
J	Bergs, A; Schultheis, C; Fischer, E; Tsunoda, SP; Erbguth, K; Husson, SJ; Govorunova, E; Spudich, JL; Nagel, G; Gottschalk, A; Liewald, JF				Bergs, Amelie; Schultheis, Christian; Fischer, Elisabeth; Tsunoda, Satoshi P.; Erbguth, Karen; Husson, Steven J.; Govorunova, Elena; Spudich, John L.; Nagel, Georg; Gottschalk, Alexander; Liewald, Jana F.			Rhodopsin optogenetic toolbox v2.0 for light-sensitive excitation and inhibition in Caenorhabditis elegans	PLOS ONE			English	Article							ANION CHANNELRHODOPSINS; MILLISECOND-TIMESCALE; CHLORIDE CHANNEL; NEURAL ACTIVITY; OPTICAL CONTROL; IN-VIVO; BEHAVIOR; ACTIVATION; TRANSFORMATION; STIMULATION	In optogenetics, rhodopsins were established as light-driven tools to manipulate neuronal activity. However, during long-term photostimulation using channelrhodopsin (ChR), desensitization can reduce effects. Furthermore, requirement for continuous presence of the chromophore all-trans retinal (ATR) in model systems lacking sufficient endogenous concentrations limits its applicability. We tested known, and engineered and characterized new variants of de-and hyperpolarizing rhodopsins in Caenorhabditis elegans. ChR2 variants combined previously described point mutations that may synergize to enable prolonged stimulation. Following brief light pulses ChR2(C128S; H134R) induced muscle activation for minutes or even for hours ('Quint': ChR2(C128S; L132C; H134R; D156A; T159C)), thus featuring longer open state lifetime than previously described variants. Furthermore, stability after ATR removal was increased compared to the step-function opsin ChR2(C128S). The double mutants C128S; H134R and H134R; D156C enabled increased effects during repetitive stimulation. We also tested new hyperpolarizers (ACR1, ACR2, ACR1(C102A), ZipACR). Particularly ACR1 and ACR2 showed strong effects in behavioral assays and very large currents with fast kinetics. In sum, we introduce highly light-sensitive optogenetic tools, bypassing previous shortcomings, and thus constituting new tools that feature high effectiveness and fast kinetics, allowing better repetitive stimulation or investigating prolonged neuronal activity states in C. elegans and, possibly, other systems.	[Bergs, Amelie; Schultheis, Christian; Fischer, Elisabeth; Tsunoda, Satoshi P.; Erbguth, Karen; Gottschalk, Alexander; Liewald, Jana F.] Goethe Univ, Buchmann Inst Mol Life Sci, Frankfurt, Germany; [Bergs, Amelie; Schultheis, Christian; Fischer, Elisabeth; Tsunoda, Satoshi P.; Erbguth, Karen; Gottschalk, Alexander; Liewald, Jana F.] Goethe Univ, Inst Biophys Chem, Dept Biochem Chem & Pharm, Frankfurt, Germany; [Bergs, Amelie] Int Max Planck Res Sch Struct & Funct Biol Membra, Frankfurt, Germany; [Husson, Steven J.] Univ Antwerp, System Physiol & Ecotoxicol Res SPHERE, Antwerp, Belgium; [Govorunova, Elena; Spudich, John L.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA; [Nagel, Georg] Julius Maximilians Univ Wurzburg, Dept Biol, Inst Mol Plant Physiol & Biophys, Wurzburg, Germany; [Gottschalk, Alexander] Goethe Univ, CEF MC, Frankfurt, Germany; [Schultheis, Christian] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; [Fischer, Elisabeth] Univ Edinburgh, Ctr Integrat Physiol, Hugh Robson Bldg,George Sq, Edinburgh, Midlothian, Scotland; [Tsunoda, Satoshi P.] JST Presto, 4-1-8 Honcho, Kawaguchi, Saitama, Japan	Goethe University Frankfurt; Goethe University Frankfurt; University of Antwerp; University of Texas System; University of Texas Health Science Center Houston; University of Wurzburg; Goethe University Frankfurt; Boehringer Ingelheim; University of Edinburgh; Japan Science & Technology Agency (JST)	Gottschalk, A; Liewald, JF (corresponding author), Goethe Univ, Buchmann Inst Mol Life Sci, Frankfurt, Germany.; Gottschalk, A; Liewald, JF (corresponding author), Goethe Univ, Inst Biophys Chem, Dept Biochem Chem & Pharm, Frankfurt, Germany.; Gottschalk, A (corresponding author), Goethe Univ, CEF MC, Frankfurt, Germany.	a.gottschalk@em.uni-frankfurt.de; liewald@biochem.uni-frankfurt.de	Tsunoda, Satoshi/AAN-7023-2021; Gottschalk, Alexander/D-3155-2011	Gottschalk, Alexander/0000-0002-1197-6119; Govorunova, Elena/0000-0003-0522-9683; Tsunoda, Satoshi/0000-0003-3636-1521; Bergs, Amelie/0000-0002-3417-6157	Deutsche Forschungsgemeinschaft (DFG) [G01011/31/3-2, G01011/4-1/4-2 (FOR1279), SFB807, EXC115]; European Commission, FP7 [HEALTH-F2-2009-241526]; ANR-DFG [GO1011/8-1]; NIH Office of Research Infrastructure Programs [P40 OD010440]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Commission, FP7(European CommissionEuropean Commission Joint Research Centre); ANR-DFG(German Research Foundation (DFG)French National Research Agency (ANR)); NIH Office of Research Infrastructure Programs	This work was funded by the Deutsche Forschungsgemeinschaft (DFG), grants G01011/31/3-2, G01011/4-1/4-2 (FOR1279), SFB807, and EXC115 (Cluster of Excellence Frankfurt), by the European Commission, FP7/2007-2013 under grant agreement No HEALTH-F2-2009-241526 (EUTrigTreat), and by the ANR-DFG-funded project "NewOptogeneticsTools" (GO1011/8-1). Website of Deutsche Forschungsgemeinschaft: http://www.dfg.de/ Website of FP7 Health (European Commission): https://ec.europa.eu/research/fp7/index_en cfm?pg=health.; We thank Peter Hegemann for providing plasmids and for sharing information prior to publication. We thank Wagner Steuer Costa, Heike Fettermann and Mona Floret for technical assistance. We are grateful to Arunas Damijonaitis for initial work. The lin-15(n765ts-) strain was provided by the Caenorhabditis Genetics Center (CGC), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). This work was funded by the Deutsche Forschungsgemeinschaft (DFG), grants G01011/3-1/3-2, G01011/4-1/4-2 (FOR1279), SFB807, and EXC115 (Cluster of Excellence Frankfurt), by the European Commission, FP7/2007-2013 under grant agreement No HEALTH-F2-2009-241526 (EUTrigTreat), and by the ANR-DFG-funded project "NewOptogeneticsTools" (GO1011/8-1).	Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2016, P NATL ACAD SCI USA, V113, P822, DOI 10.1073/pnas.1523341113; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bruun S, 2011, FEBS LETT, V585, P3998, DOI 10.1016/j.febslet.2011.11.007; Burgess P., 2009, CONTINUOUS COVER FOR; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Chuong AS, 2014, NAT NEUROSCI, V17, P1123, DOI 10.1038/nn.3752; Costa WS, 2017, CURR BIOL, V27, P495, DOI 10.1016/j.cub.2016.12.055; Dawydow A, 2014, P NATL ACAD SCI US; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Edelstein A. D., J BIOL METHODS, V1; Erbguth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046827; FIRE A, 1986, EMBO J, V5, P2673, DOI 10.1002/j.1460-2075.1986.tb04550.x; Gao SB, 2011, P NATL ACAD SCI USA, V108, P2557, DOI 10.1073/pnas.1012346108; Govorunova EG, 2015, SCIENCE, V349, P647, DOI 10.1126/science.aaa7484; Govorunova EG, 2017, SCI REP-UK, V7, DOI 10.1038/srep43358; Govorunova EG, 2011, MBIO, V2, DOI 10.1128/mBio.00115-11; Gradmann D, 2011, BIOPHYS J, V101, P1057, DOI 10.1016/j.bpj.2011.07.040; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Gushchin I, 2015, NAT STRUCT MOL BIOL, V22, P390, DOI 10.1038/nsmb.3002; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Husson SJ, 2013, BIOL CELL, V105, P235, DOI [10.1111/boc.201200069, 10.1111/boc.201390011]; Husson SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040937; Kato HE, 2015, NATURE, V521, P48, DOI 10.1038/nature14322; Kittelmann M, 2013, P NATL ACAD SCI USA, V110, pE3007, DOI 10.1073/pnas.1305679110; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Knopfel T, 2010, J NEUROSCI, V30, P14998, DOI 10.1523/JNEUROSCI.4190-10.2010; Kocabas A, 2012, NATURE, V490, P273, DOI 10.1038/nature11431; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; LIU P, 2013, NATURE COMMUNICATION, V4; Mohammad F, 2017, NAT METHODS, V14, P271, DOI [10.1038/NMETH.4148, 10.1038/nmeth.4148]; Nagel G, 2005, BIOCHEM SOC T, V33, P863, DOI 10.1042/BST0330863; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Prigge M, 2012, J BIOL CHEM, V287, P31804, DOI 10.1074/jbc.M112.391185; Schild LC, 2015, GENETICS, V200, P1029, DOI 10.1534/genetics.115.177956; Schmitt C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043164; Schneider F, 2015, ANNU REV BIOPHYS, V44, P167, DOI 10.1146/annurev-biophys-060414-034014; Schoenenberger P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008185; Schultheis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018766; Sineshchekov OA, 2016, P NATL ACAD SCI USA, V113, pE1993, DOI 10.1073/pnas.1525269113; Sineshchekov OA, 2015, P NATL ACAD SCI USA, V112, P14236, DOI 10.1073/pnas.1513602112; Stauffer WR, 2016, CELL, V166, P1564, DOI 10.1016/j.cell.2016.08.024; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Ullrich S, 2013, BIOL CHEM, V394, P271, DOI 10.1515/hsz-2012-0256; Watanabe S, 2013, ELIFE, V2, DOI 10.7554/eLife.00723; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wietek J, 2015, SCI REP-UK, V5, DOI 10.1038/srep14807; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	59	20	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191802	10.1371/journal.pone.0191802	http://dx.doi.org/10.1371/journal.pone.0191802			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389997	Green Published, Green Submitted, gold			2022-12-26	WOS:000423793400037
J	Kawaguchi, T; Shima, T; Mizuno, M; Mitsumoto, Y; Umemura, A; Kanbara, Y; Tanaka, S; Sumida, Y; Yasui, K; Takahashi, M; Matsuo, K; Itoh, Y; Tokushige, K; Hashimoto, E; Kiyosawa, K; Kawaguchi, M; Itoh, H; Uto, H; Komorizono, Y; Shirabe, K; Takami, S; Takamura, T; Kawanaka, M; Yamada, R; Matsuda, F; Okanoue, T				Kawaguchi, Takahisa; Shima, Toshihide; Mizuno, Masayuki; Mitsumoto, Yasuhide; Umemura, Atsushi; Kanbara, Yoshihiro; Tanaka, Saiyu; Sumida, Yoshio; Yasui, Kohichiro; Takahashi, Meiko; Matsuo, Keitaro; Itoh, Yoshito; Tokushige, Katsutoshi; Hashimoto, Etsuko; Kiyosawa, Kendo; Kawaguchi, Masanori; Itoh, Hiroyuki; Uto, Hirofumi; Komorizono, Yasuji; Shirabe, Ken; Takami, Shiro; Takamura, Toshinari; Kawanaka, Miwa; Yamada, Ryo; Matsuda, Fumihiko; Okanoue, Takeshi			Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers	PLOS ONE			English	Article							CONFERS SUSCEPTIBILITY; WIDE ASSOCIATION; NATURAL-HISTORY; I148M VARIANT; PNPLA3; STEATOHEPATITIS; EXPRESSION; SEVERITY; TM6SF2	The genetic factors affecting the natural history of nonalcoholic fatty liver disease (NAFLD), including the development of nonalcoholic steatohepatitis(NASH) and NASH-derived hepatocellular carcinoma (NASH-HCC), are still unknown. In the current study, we sought to identify genetic factors related to the development of NAFLD, NASH, and NASH-HCC, and to establish risk-estimation models for them. For these purposes, 936 histologically proven NAFLD patients were recruited, and genome-wide association (GWA) studies were conducted for 902, including 476 NASH and 58 NASH-HCC patients, against 7,672 generalpopulation controls. Risk estimations for NAFLD and NASH were then performed using the SNPs identified as having significant associations in the GWA studies. We found that rs2896019 in PNPLA3 [p = 2.3x10(-31), OR (95% CI) = 1.85 (1.67 +/- 2.05)], rs1260326 in GCKR [p = 9.6x10(-10), OR (95% CI) = 1.38(1.25 +/- 1.53)], and rs4808199 in GATAD2A [p = 2.3x10(-8), OR (95% CI) = 1.37 (1.23 +/- 1.53)] were significantly associated with NAFLD. Notably, the number of risk alleles in PNPLA3 and GATAD2A was much higher in Matteoni type 4 (NASH) patients than in type 1, type 2, and type 3 NAFLD patients. In addition, we newly identified rs17007417 in DYSF [p = 5.2x10(-7), OR (95% CI) = 2.74 (1.84 +/- 4.06)] as a SNP associated with NASH-HCC. Rs641738 in TMC4, which showed association with NAFLD in patients of European descent, was not replicated in our study (p = 0.73), although the complicated LD pattern in the region suggests the necessity for further investigation. The genetic variants of PNPLA3, GCKR, and GATAD2A were then used to estimate the risk for NAFLD. The obtained Polygenic Risk Scores showed that the risk for NAFLD increased with the accumulation of risk alleles [AUC (95% CI) = 0.65 (0.63 +/- 0.67)]. Conclusions: We demonstrated that NASH is genetically and clinically different from the other NAFLD subgroups. We also established risk-estimation models for NAFLD and NASH using multiple genetic markers. These models can be used to improve the accuracy of NAFLD diagnosis and to guide treatment decisions for patients.	[Kawaguchi, Takahisa; Takahashi, Meiko; Yamada, Ryo; Matsuda, Fumihiko] Kyoto Univ, Ctr Genom Med, Grad Sch Med, Kyoto, Japan; [Shima, Toshihide; Mizuno, Masayuki; Mitsumoto, Yasuhide; Umemura, Atsushi; Okanoue, Takeshi] Saiseikai Suita Hosp, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan; [Kanbara, Yoshihiro] Saiseikai Suita Hosp, Dept Surg, Suita, Osaka, Japan; [Tanaka, Saiyu; Sumida, Yoshio] Nara Municipal Hosp, Ctr Hepatol, Nara, Japan; [Yasui, Kohichiro; Itoh, Yoshito] Kyoto Prefectural Univ Med, Dept Gastroenterol, Kyoto, Japan; [Matsuo, Keitaro] Aichi Canc Ctr, Res Inst, Div Mol & Clin Epidemiol, Nagoya, Aichi, Japan; [Tokushige, Katsutoshi; Hashimoto, Etsuko] Tokyo Womens Med Univ, Dept Internal Med & Gastroenterol, Tokyo, Japan; [Kiyosawa, Kendo] Nagano Red Cross Hosp, Dept Gastroenterol, Nagano, Japan; [Kawaguchi, Masanori] Saiseikai Wakayama Hosp, Dept Gastroenterol, Wakayama, Japan; [Itoh, Hiroyuki] Kure Saiseikai Hosp, Dept Gastroenterol, Kure, Japan; [Uto, Hirofumi] Kagoshima Univ, Digest & Life style Related Dis, Grad Sch Med & Dent Sci, Kagoshima, Japan; [Komorizono, Yasuji] Nanpuh Hosp, Dept Hepatol, Kagoshima, Japan; [Shirabe, Ken] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan; [Takami, Shiro] Otsu Municipal Hosp, Dept Gastroenterol, Otsu, Shiga, Japan; [Takamura, Toshinari] Kanazawa Univ, Dis Control & Homeostasis, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Kawanaka, Miwa] Kawasaki Med Sch, Kawasaki Hosp, Ctr Liver Dis, Okayama, Japan	Kyoto University; Kyoto Prefectural University of Medicine; Aichi Cancer Center; Tokyo Women's Medical University; Nagano Red Cross Hospital; Kagoshima University; Kyushu University; Kanazawa University; Kawasaki Medical School	Matsuda, F (corresponding author), Kyoto Univ, Ctr Genom Med, Grad Sch Med, Kyoto, Japan.; Okanoue, T (corresponding author), Saiseikai Suita Hosp, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan.	fumi@genome.med.kyoto-u.ac.jp; okanoue@suita.saiseikai.or.jp	Matsuo, Keitaro/H-6758-2019; Shima, Toshihide/AAW-9215-2020; Sumida, Yoshio/AAL-6723-2020	Matsuo, Keitaro/0000-0003-1761-6314; Shima, Toshihide/0000-0002-4120-9121; Yamada, Ryo/0000-0002-1587-630X; Umemura, Atsushi/0000-0002-7433-8501; Takahashi, Meiko/0000-0002-8344-5472; KOMORIZONO, YASUJI/0000-0002-1024-8697	Ministry of Labor and Welfare Japan [H20-Hepatitis-general-008]; Core Research of Evolutional Science & Technology (CREST), Research Program on Hepatitis from Japan Agency for Medical Research and Development, AMED	Ministry of Labor and Welfare Japan; Core Research of Evolutional Science & Technology (CREST), Research Program on Hepatitis from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was supported by the grant from Ministry of Labor and Welfare Japan [T.O., H20-Hepatitis-general-008], Core Research of Evolutional Science & Technology (CREST), Research Program on Hepatitis from Japan Agency for Medical Research and Development, AMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Anstee QM, 2016, GASTROENTEROLOGY, V150, P1728, DOI 10.1053/j.gastro.2016.01.037; Bechmann LP, 2012, HEPATOLOGY, V55, P1083, DOI 10.1002/hep.24793; Buch S, 2015, NAT GENET, V47, P1443, DOI 10.1038/ng.3417; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Higasa K, 2016, J HUM GENET, V61, P547, DOI 10.1038/jhg.2016.12; Kawaguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038322; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liu YL, 2014, J HEPATOL, V61, P75, DOI 10.1016/j.jhep.2014.02.030; Mancina RM, 2016, GASTROENTEROLOGY, V150, P1219, DOI 10.1053/j.gastro.2016.01.032; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; McPherson S, 2015, J HEPATOL, V62, P1148, DOI 10.1016/j.jhep.2014.11.034; Peter A, 2011, J CLIN ENDOCR METAB, V96, pE1126, DOI 10.1210/jc.2010-2017; Petta S, 2012, J HEPATOL, V56, P1356, DOI 10.1016/j.jhep.2012.01.007; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Sookoian S, 2015, HEPATOLOGY, V61, P515, DOI 10.1002/hep.27556; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Teo YY, 2009, GENOME RES, V19, P1849, DOI 10.1101/gr.092189.109; Ueyama M, 2016, J GASTROENTEROL, V51, P370, DOI 10.1007/s00535-015-1116-6; Valenti L, 2013, DIGEST LIVER DIS, V45, P619, DOI 10.1016/j.dld.2012.12.006; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang Z, 2011, MOL BIOL REP, V38, P1145, DOI 10.1007/s11033-010-0212-1; Yasui K, 2011, CLIN GASTROENTEROL H, V9, P428, DOI 10.1016/j.cgh.2011.01.023; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268; Zain SM, 2012, HUM GENET, V131, P1145, DOI 10.1007/s00439-012-1141-y	33	68	70	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0185490	10.1371/journal.pone.0185490	http://dx.doi.org/10.1371/journal.pone.0185490			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385134	Green Submitted, Green Published, gold			2022-12-26	WOS:000423668400002
J	Benmassaoud, A; Ghali, P; Cox, J; Wong, P; Szabo, J; Deschenes, M; Osikowicz, M; Lebouche, B; Klein, MB; Sebastiani, G				Benmassaoud, Amine; Ghali, Peter; Cox, Joseph; Wong, Philip; Szabo, Jason; Deschenes, Marc; Osikowicz, Maria; Lebouche, Bertrand; Klein, Marina B.; Sebastiani, Giada			Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; HEPATIC-FIBROSIS; ADULTS; ASSOCIATION; PREVALENCE; STEATOSIS; GUIDELINE; DIAGNOSIS	Background and aim HIV-infected individuals are at high risk of developing nonalcoholic steatohepatitis (NASH), a leading cause of end-stage liver disease in Western countries. Nonetheless, due to the invasiveness of liver biopsy, NASH remains poorly understood in HIV mono-infection. We aimed to characterize the prevalence and predictors of NASH in unselected HIV mono-infected patients by means of non-invasive diagnostic tools. Methods HIV-infected adults without significant alcohol intake or co-infection with hepatitis B or C underwent a routine screening program employing transient elastography (TE) with controlled attenuation parameter (CAP) and the serum biomarker cytokeratin-18 (CK-18). NASH was diagnosed non-invasively as the coexistence of fatty liver (CAP >= 248 dB/m) and CK-18 >246 U/L. Identified cases of NASH were offered a diagnostic liver biopsy. Predictors of NASH were determined by multivariate logistic regression analysis. Results 202 consecutive HIV mono-infected patients were included. NASH was non-invasively diagnosed in 23 cases (11.4%). Among them, 17 underwent a liver biopsy, and histology confirmed NASH in all cases. The prevalence of NASH was higher in patients with hypertriglyceridemia (17.1%), insulin resistance defined by homeostasis model for assessment of insulin resistance (HOMA-IR) (25%), those with detectable HIV viral load (42.9%) and those with elevated ALT (53.6%). After adjustment, higher HOMA-IR (adjusted odds ratio [aOR] = 1.20, 95% CI 1.01-1.43; p = 0.03) and ALT (aOR = 2.39, 95% CI 1.50-3.79; p<0.001) were independent predictors of NASH. Conclusions NASH, diagnosed by a non-invasive diagnostic approach employing CK-18 and TE with CAP, is common in unselected HIV mono-infected individuals, particularly in the presence of insulin resistance and elevated ALT.	[Benmassaoud, Amine; Ghali, Peter; Cox, Joseph; Wong, Philip; Deschenes, Marc; Sebastiani, Giada] McGill Univ, Royal Victoria Hosp, Hlth Ctr, Div Gastroenterol & Hepatol, Montreal, PQ, Canada; [Szabo, Jason; Osikowicz, Maria; Lebouche, Bertrand; Klein, Marina B.; Sebastiani, Giada] McGill Univ, Hlth Ctr, Chron Viral Illness Serv, Montreal, PQ, Canada	McGill University; Royal Victoria Hospital; McGill University	Sebastiani, G (corresponding author), McGill Univ, Royal Victoria Hosp, Hlth Ctr, Div Gastroenterol & Hepatol, Montreal, PQ, Canada.; Sebastiani, G (corresponding author), McGill Univ, Hlth Ctr, Chron Viral Illness Serv, Montreal, PQ, Canada.	giada.sebastiani@mcgill.ca	LEBOUCHE, Bertrand/AAC-6047-2022; LEBOUCHE, Bertrand/GZL-8127-2022	LEBOUCHE, Bertrand/0000-0002-1273-9393; Benmassaoud, Amine/0000-0002-0202-2276; Klein, Marina/0000-0002-3063-8430; Sebastiani, Giada/0000-0003-2655-8283; Cox, Joseph/0000-0002-7041-1556	ViiV; Merck; CIHR Canadian HIV Trials Network [CTN-PT024]; Fonds de recherche du Quebec - Sante (FRQ-S); FRQ-S	ViiV; Merck(Merck & Company); CIHR Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Sante (FRQ-S); FRQ-S	ViiV and Merck provided a grant to establish the diagnostic center for hepatic fibrosis and steatosis at McGill University Health Centre. Part of the CK-18 analysis was funded by the CIHR Canadian HIV Trials Network (CTN-PT024) and by Merck. GS and BL hold a Chercheur-Boursier career award from the Fonds de recherche du Quebec - Sante (FRQ-S). MBK holds a Chercheurs Nationaux career award from the FRQ-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Doyle MA, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1454-6; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; Guillen MA, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0046-z; Home P, 2006, DIABETIC MED, V23, P579; Hull MW, 2012, AIDS, V26, P1789, DOI 10.1097/QAD.0b013e32835612ce; Ingiliz P, 2009, HEPATOLOGY, V49, P436, DOI 10.1002/hep.22665; Karlas T, 2016, J HEPATOL; Kim D, 2013, HEPATOLOGY, V57, P1357, DOI 10.1002/hep.26156; Lemoine M, 2012, CURR OPIN INFECT DIS, V25, P10, DOI 10.1097/QCO.0b013e32834ef599; Lombardi R, 2016, DIGEST LIVER DIS, V48, P1471, DOI 10.1016/j.dld.2016.08.117; Lui G, 2016, ALIMENT PHARM THER, V44, P411, DOI 10.1111/apt.13702; Macias J, 2014, AIDS, V28, P1279, DOI 10.1097/QAD.0000000000000248; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Merchante N, 2009, GUT, V58, P1654, DOI 10.1136/gut.2009.179085; Morse CG, 2015, AIDS, V29, P2297, DOI 10.1097/QAD.0000000000000841; Morse CG, 2015, CLIN INFECT DIS, V60, P1569, DOI 10.1093/cid/civ101; Myers RP, 2012, HEPATOLOGY, V55, P199, DOI 10.1002/hep.24624; Pembroke T, 2017, J HEPATOL; Petta S, 2016, HEPATOLOGY; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; Rivero-Juarez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068953; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Rockstroh JK, 2014, CURR OPIN HIV AIDS, V9, P365, DOI 10.1097/COH.0000000000000064; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Vodkin I, 2015, ALIMENT PHARM THER, V41, P368, DOI 10.1111/apt.13052; Vuille-Lessard ELB., 2016, AIDS; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wong JB, 2000, ANN INTERN MED, V133, P665, DOI 10.7326/0003-4819-133-9-200011070-00008	35	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191985	10.1371/journal.pone.0191985	http://dx.doi.org/10.1371/journal.pone.0191985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381754	Green Published, Green Submitted, gold			2022-12-26	WOS:000423617800049
J	Devyatko, D; Pastukhov, A				Devyatko, Dina; Pastukhov, Alexander			Extrinsic grouping factors in motion-induced blindness	PLOS ONE			English	Article							PERCEPTUAL FILLING-IN; VISUAL FEATURES; COMMON REGION; PROXIMITY; SIMILARITY; DISCRIMINATION; PRINCIPLES	We investigated how various grouping factors altered subjective disappearances of the individual targets in the motion-induced blindness display. The latter relies on a moving mask to render highly salient static targets temporarily subjectively invisible. Specifically, we employed two extrinsic grouping factors, the connectedness and the common region, and examined whether their presence would make targets more resilient against the suppression. In addition, we investigated whether the presence of an illusory Kanizsa triangle would affect the suppression of the inducing Pac-Man elements. We quantified the perceptual dynamics using the proportion of the disappearance time (this indicates whether targets became more resilient against the suppression), and the proportion of simultaneous disappearance and reappearance events (characterizes the tendency for the targets to disappear or reappear as a group). We report that a single mask that encompassed all targets (a common region grouping) significantly increased the proportion of simultaneous disappearance and reappearance events, but had no effect on the proportion of the disappearance time. In contrast, a line that connected two targets significantly decreased the total invisibility time, but had no impact on the simultaneity of the disappearance and reappearance events. We found no statistically significant effect of the presence of the illusory Kanizsa triangle on either measure. Finally, we found no interaction either between the common region and the connectedness or between the common region and the presence of the illusory Kanizsa triangle. Our results indicate that extrinsic grouping factors might influence the perception differently than the intrinsic ones and highlight the importance of using several measures to characterize the perceptual dynamics, as various grouping factors might affect it differentially.	[Devyatko, Dina] Natl Res Univ, Higher Sch Econ, Lab Cognit Res, Moscow, Russia; [Devyatko, Dina] Univ Haifa, Inst Informat Proc & Decis Making, Haifa, Israel; [Pastukhov, Alexander] Univ Bamberg, Dept Gen Psychol & Methodol, Bamberg, Bavaria, Germany; [Pastukhov, Alexander] Forschungsgrp EP AEG Ergon Psychol Aesthet Gestal, Bamberg, Bavaria, Germany	HSE University (National Research University Higher School of Economics); University of Haifa; Otto Friedrich University Bamberg	Devyatko, D (corresponding author), Natl Res Univ, Higher Sch Econ, Lab Cognit Res, Moscow, Russia.; Devyatko, D (corresponding author), Univ Haifa, Inst Informat Proc & Decis Making, Haifa, Israel.	tsukit86@gmail.com	Pastukhov, Alexander/F-1399-2013	Pastukhov, Alexander/0000-0002-8738-8591				Alais D, 1999, VISION RES, V39, P4341, DOI 10.1016/S0042-6989(99)00146-7; Banica T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161177; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bonneh YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092894; Bonneh YS, 2001, NATURE, V411, P798, DOI 10.1038/35081073; Claessens PM, 2005, PERCEPT PSYCHOPHYS, V67, P1446, DOI 10.3758/BF03193649; De Weerd P, 1998, VISION RES, V38, P2721, DOI 10.1016/S0042-6989(97)00432-X; Deviatko DV, 2009, VOP PSIKHOL+, P128; Devyatko D, 2011, J RUSSIAN E EURO PSY, V49, P30, DOI [10.2753/RPO1061-0405490502, DOI 10.2753/RPO1061-0405490502]; Harris JJ, 2011, PSYCHOL SCI, V22, P399, DOI 10.1177/0956797611399293; Hsu LC, 2006, VISION RES, V46, P1973, DOI 10.1016/j.visres.2005.11.004; Kanai R, 2010, CURR BIOL, V20, P1626, DOI 10.1016/j.cub.2010.07.027; KANIZSA G, 1979, ORG VISION ESSAYS GE; Kanizsa G., 1955, RIV PSICOL; Kubovy M, 2008, PSYCHOL REV, V115, P131, DOI 10.1037/0033-295X.115.1.131; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Libedinsky C, 2011, J NEUROSCI, V31, P64, DOI 10.1523/JNEUROSCI.3620-10.2011; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Lou L, 2008, VISION RES, V48, P1514, DOI 10.1016/j.visres.2008.04.001; Luna D, 2011, PERCEPTION, V40, P1467, DOI 10.1068/p7086; Meital-Kfir N, 2016, J VISION, V16, DOI 10.1167/16.10.4; Metzger W., 2009, LAWS OF SEEING; Mitroff SR, 2004, PERCEPTION, V33, P1267, DOI 10.1068/p5341no; Mitroff SR, 2005, VISION RES, V45, P961, DOI 10.1016/j.visres.2004.09.044; Montoro P. R., 2015, SPAN J PSYCHOL, V18, P1; Morey RD, 2015, PACKAGE BAYESFACTOR; Oyama T, 1999, PERCEPTION, V28, P739, DOI 10.1068/p2799; PALMER S, 1994, PSYCHON B REV, V1, P29, DOI 10.3758/BF03200760; PALMER SE, 1992, COGNITIVE PSYCHOL, V24, P436, DOI 10.1016/0010-0285(92)90014-S; Palmer SE, 2000, PERCEPT PSYCHOPHYS, V62, P1321, DOI 10.3758/BF03212134; Palmer SE, 2007, PERCEPT PSYCHOPHYS, V69, P68, DOI 10.3758/BF03194454; Peterson MA, 2013, PERCEPTUAL ORG VISIO; Quinlan PT, 1998, PERCEPTION, V27, P417, DOI 10.1068/p270417; Quinn PC, 2008, ACTA PSYCHOL, V127, P289, DOI 10.1016/j.actpsy.2007.06.002; Quinn PC, 2005, PERCEPT PSYCHOPHYS, V67, P1171, DOI 10.3758/BF03193550; R Core Team, 2021, R LANGUAGE ENV STAT; Rock I., 1986, HDB PERCEPTION HUMAN, P1; Schwarzkopf DS, 2011, P ROY SOC B-BIOL SCI, V278, P2207, DOI 10.1098/rspb.2010.1909; Shibata M, 2010, ATTEN PERCEPT PSYCHO, V72, P387, DOI 10.3758/APP.72.2.387; Sobel KV, 2003, VISION RES, V43, P1533, DOI 10.1016/S0042-6989(03)00178-0; Vergeer MLT, 2007, PERCEPTION, V36, P1036, DOI 10.1068/p5607; von der Heydt R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01695; Wagemans J, 2012, PSYCHOL BULL, V138, P1218, DOI 10.1037/a0029334; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu CT, 2009, CURR BIOL, V19, P2003, DOI 10.1016/j.cub.2009.10.017	47	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0192133	10.1371/journal.pone.0192133	http://dx.doi.org/10.1371/journal.pone.0192133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU1NX	29381747	Green Published, Green Submitted, gold			2022-12-26	WOS:000423617800058
J	Honda, R; Kuwata, K				Honda, Ryo; Kuwata, Kazuo			Evidence for a central role of PrP helix 2 in the nucleation of amyloid fibrils	FASEB JOURNAL			English	Article						prion; protein misfolding; phi-value analysis	MOUSE PRION PROTEIN; AGGREGATION KINETIC-DATA; MAMMALIAN PRIONS; IN-VITRO; HYDROGEN/DEUTERIUM EXCHANGE; AUTOCATALYTIC GROWTH; HYDROGEN-EXCHANGE; ALPHA-HELIX; BETA; MECHANISM	Amyloid fibrils are filamentous protein aggregates associated with the pathogenesis of a wide variety of human diseases. The formation of such aggregates typically follows nucleation-dependent kinetics, wherein the assembly and structural conversion of amyloidogenic proteins into oligomeric aggregates (nuclei) is the rate-limiting step of the overall reaction. In this study, we sought to gain structural insights into the oligomeric nuclei of the human prion protein (PrP) by preparing a series of deletion mutants lacking 14-44 of the C-terminal 107 residues of PrP and examined the kinetics and thermodynamics of these mutants in amyloid formation. An analysis of the experimental data using the concepts of the phi-value analysis indicated that the helix 2 region (residues 168-196) acquires an amyloid-like -sheet during nucleation, whereas the other regions preserves a relatively disordered structure in the nuclei. This finding suggests that the helix 2 region serves as the nucleation site for the assembly of amyloid fibrils.Honda, R., Kuwata, K. Evidence for a central role of PrP helix 2 in the nucleation of amyloid fibrils.	[Honda, Ryo] Gifu Univ, Grad Sch Med, Dept Mol Pathobiochem, Gifu, Japan; [Honda, Ryo; Kuwata, Kazuo] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan; [Kuwata, Kazuo] Gifu Univ, Grad Sch Med, Dept Gene & Dev, Gifu, Japan	Gifu University; Gifu University; Gifu University	Honda, R (corresponding author), Gifu Univ, Yanagido 1-1, Gifu 5011194, Japan.	ryohonda.rh@gmail.com			Japan Society for the Promotion of Science (JSPS) [16J04145]; Japan Agency for Medical Research and Development (AMED) [17ek0109075h0003]; Japanese Ministry of Health, Labor, and Welfare Research Committee on Surveillance and Infection Control of Prion Disease	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japanese Ministry of Health, Labor, and Welfare Research Committee on Surveillance and Infection Control of Prion Disease	The authors thank Enago (www.enago.jp) for the English language review and Tatsuya Nakayama (Gifu Pharmaceutical University) for helpful discussion about chemical kinetics. This work was supported by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (KAKENHI) 16J04145 (to R.H.) and funding from the Japan Agency for Medical Research and Development (AMED; 17ek0109075h0003 to K.K.), and from the the Japanese Ministry of Health, Labor, and Welfare Research Committee on Surveillance and Infection Control of Prion Disease (to K.K.). The authors declare no conflicts of interest.	Abskharon R, 2016, SCI REP-UK, V6, DOI 10.1038/srep38877; Adachi M, 2015, J BIOL CHEM, V290, P18134, DOI 10.1074/jbc.M115.648139; Alvarez-Martinez MT, 2011, BBA-PROTEINS PROTEOM, V1814, P1305, DOI 10.1016/j.bbapap.2011.05.016; Anderson M, 2006, J MOL BIOL, V358, P580, DOI 10.1016/j.jmb.2006.02.007; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Baskakov IV, 2004, J BIOL CHEM, V279, P7671, DOI 10.1074/jbc.M310594200; Bentea L, 2017, J PHYS CHEM C, V121, P5302, DOI 10.1021/acs.jpcc.6b12021; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Buell AK, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.228101; Chakroun N, 2010, FASEB J, V24, P3222, DOI 10.1096/fj.09-153924; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Choi JK, 2016, P NATL ACAD SCI USA, V113, P13851, DOI 10.1073/pnas.1610716113; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2014, J BIOL CHEM, V289, P2643, DOI 10.1074/jbc.M113.520718; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608916; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Diaz-Espinoza R, 2012, NAT STRUCT MOL BIOL, V19, P370, DOI 10.1038/nsmb.2266; Dogan J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02076; Dutta A, 2013, FEBS LETT, V587, P2918, DOI 10.1016/j.febslet.2013.07.023; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Honda RP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00710-x; Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.3.CO;2-0; Jain S, 2011, BIOCHEMISTRY-US, V50, P1153, DOI 10.1021/bi101757x; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kim W, 2006, P NATL ACAD SCI USA, V103, P15824, DOI 10.1073/pnas.0605629103; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kurt TD, 2014, J NEUROSCI, V34, P1022, DOI 10.1523/JNEUROSCI.4636-13.2014; Kuwata K, 2003, P NATL ACAD SCI USA, V100, P14790, DOI 10.1073/pnas.2433563100; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Li L, 2000, NAT STRUCT BIOL, V7, P336; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Meisl G, 2017, CHEM SCI, V8, P7087, DOI 10.1039/c7sc01965c; Moran SD, 2014, J PHYS CHEM LETT, V5, P1984, DOI 10.1021/jz500794d; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; Morris AM, 2008, BIOCHEMISTRY-US, V47, P2413, DOI 10.1021/bi701899y; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Muramoto T, 1997, NAT MED, V3, P750, DOI 10.1038/nm0797-750; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; Naiki H, 1999, METHOD ENZYMOL, V309, P305; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nakajima K, 2016, SCI REP-UK, V6, DOI 10.1038/srep22015; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Peralvarez-Marin A, 2009, BIOPHYS J, V97, P277, DOI 10.1016/j.bpj.2009.04.017; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Risor MW, 2017, BIOPHYS J, V113, P580, DOI 10.1016/j.bpj.2017.06.030; Sabareesan AT, 2017, BIOCHEMISTRY-US, V56, P5931, DOI 10.1021/acs.biochem.7b00894; Salamat K, 2012, J BIOL CHEM, V287, P18953, DOI 10.1074/jbc.M112.341677; Sanchez IE, 2003, J MOL BIOL, V334, P1077, DOI 10.1016/j.jmb.2003.10.016; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Sarroukh R, 2013, BBA-BIOMEMBRANES, V1828, P2328, DOI 10.1016/j.bbamem.2013.04.012; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Sigurdson CJ, 2009, P NATL ACAD SCI USA, V106, P304, DOI 10.1073/pnas.0810680105; Singh J, 2016, BIOCHEMISTRY-US, V55, P459, DOI 10.1021/acs.biochem.5b01266; Singh J, 2014, J AM CHEM SOC, V136, P16704, DOI 10.1021/ja510964t; Singh J, 2013, J MOL BIOL, V425, P3510, DOI 10.1016/j.jmb.2013.06.009; Singh J, 2012, J MOL BIOL, V423, P217, DOI 10.1016/j.jmb.2012.06.040; Smirnovas V, 2016, PRION, V10, pS49; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Sun Y, 2007, J BIOL CHEM, V282, P9090, DOI 10.1074/jbc.M608623200; Szczepankiewicz O, 2015, J AM CHEM SOC, V137, P14673, DOI 10.1021/jacs.5b07849; Taylor JD, 2016, SCI REP-UK, V6, DOI 10.1038/srep24656; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Wang GZ, 2015, P NATL ACAD SCI USA, V112, P2437, DOI 10.1073/pnas.1500243112; Watzky MA, 1997, J AM CHEM SOC, V119, P10382, DOI 10.1021/ja9705102; Watzky MA, 2008, BIOCHEMISTRY-US, V47, P10790, DOI 10.1021/bi800726m; Wright CF, 2003, NAT STRUCT BIOL, V10, P658, DOI 10.1038/nsb947; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Yamaguchi K, 2012, PROTEIN SCI, V21, P38, DOI 10.1002/pro.755; Yamaguchi KI, 2008, BIOCHEMISTRY-US, V47, P13242, DOI 10.1021/bi801562w; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904	84	7	7	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3641	3652		10.1096/fj.201701183RR	http://dx.doi.org/10.1096/fj.201701183RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29401635				2022-12-26	WOS:000435104500013
J	Jia, YG; Miao, YM; Yue, MF; Shu, M; Wei, ZF; Dai, Y				Jia, Yugai; Miao, Yumeng; Yue, Mengfan; Shu, Mei; Wei, Zhifeng; Dai, Yue			Tetrandrine attenuates the bone erosion in collagen-induced arthritis rats by inhibiting osteoclastogenesis via spleen tyrosine kinase	FASEB JOURNAL			English	Article						rheumatoid arthritis; osteoclasts; NF-kappa B; NFATc1	NF-KAPPA-B; RANKL-INDUCED OSTEOCLASTOGENESIS; RECEPTOR ACTIVATOR; MEDIATED COSTIMULATION; RHEUMATOID-ARTHRITIS; SPECTROMETRY METHOD; DIFFERENTIATION; CELLS; PHOSPHORYLATION; DESTRUCTION	Tetrandrine, a bisbenzylisoquinoline alkaloid, was previously demonstrated to attenuate inflammation and cartilage destruction in the ankles of mice with collagen-induced arthritis (CIA). Here, we explored the underlying mechanism by which tetrandrine prevented arthritis-induced bone erosion by focusing on the differentiation and function of osteoclasts. We found that daily administration of tetrandrine (30 mg/kg) markedly reduced the bone damage and decreased the number of osteoclasts in CIA rats. In vitro, tetrandrine inhibited receptor activator of NF-kappa B ligand (RANKL)-induced osteoclastogenesis at the early stage and reduced the expressions of osteoclast-related marker genes. In bone marrow-derived macrophages and RAW264.7 cells, tetrandrine inhibited RANKL-induced translocation of NF-kappa B-p65 and nuclear factor of activated T cell 1 (NFATc1) through suppressing spleen tyrosine kinase (Syk)-Bruton's tyrosine kinase-PLC gamma 2-Ca2+ signaling. Of interest, tetrandrine did not affect the phosphorylation of immunoreceptor tyrosine-based activation motifs, the conventional upstream of Syk, but it inhibited the activity of Syk by enhancing its ubiquitination and degradation. The anti-osteoclastogenesis effect of tetrandrine nearly disappeared when it was used in combination with the Syk inhibitor piceatannol or in constitutively activated Syk-overexpressing cells. Taken together, tetrandrine attenuated CIA-induced bone destruction by inhibiting osteoclastogenesis through hindering the translocation of NF-kappa B-p65 and NFATc1 via reducing the activation of Syk.	[Jia, Yugai; Miao, Yumeng; Yue, Mengfan; Shu, Mei; Wei, Zhifeng; Dai, Yue] China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Wei, ZF; Dai, Y (corresponding author), China Pharmaceut Univ, 24 Tong Jia Xiang, Nanjing 210009, Jiangsu, Peoples R China.	zhifeng-wei@hotmail.com; yuedaicpu@126.com			National Natural Science Foundation of China [81373426]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (81373426) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare no conflicts of interest.	Aletaha D, 2006, ARTHRITIS RHEUM-US, V54, P2784, DOI 10.1002/art.22052; Bae JS, 2003, BIOCHEM BIOPH RES CO, V305, P1094, DOI 10.1016/S0006-291X(03)00869-6; Baek JM, 2017, MOL MED REP, V15, P784, DOI 10.3892/mmr.2016.6069; Boyce BF, 2015, ENDOCRINOL METAB, V30, P35, DOI 10.3803/EnM.2015.30.1.35; Breen ME, 2015, ACS CHEM BIOL, V10, P175, DOI 10.1021/cb5008376; Cheon YH, 2016, J BONE MINER RES, V31, P403, DOI 10.1002/jbmr.2612; Chiu YG, 2017, EXPERT OPIN BIOL TH, V17, P119, DOI 10.1080/14712598.2017.1263614; Crotti TN, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/281287; de Castro Rodrigo Orlandini, 2011, J Signal Transduct, V2011, P507291, DOI 10.1155/2011/507291; Engdahl C, 2017, J BONE MINER RES, V32, P1681, DOI 10.1002/jbmr.3158; Geahlen RL, 2014, TRENDS PHARMACOL SCI, V35, P414, DOI 10.1016/j.tips.2014.05.007; Hayer S, 2016, DIS MODEL MECH, V9, P1329, DOI 10.1242/dmm.025460; Huh JE, 2016, SCI REP-UK, V6, DOI 10.1038/srep22511; Justa-Schuch D, 2016, ELIFE, V5, DOI [10.7554/eLife.16370, 10.7554/elife.16370]; Karmakar S, 2010, RHEUM DIS CLIN N AM, V36, P385, DOI 10.1016/j.rdc.2010.03.003; Kato T, 2017, EUR J PHARMACOL, V801, P1, DOI 10.1016/j.ejphar.2017.02.048; Kavitha CV, 2014, MOL CARCINOGEN, V53, P169, DOI 10.1002/mc.21959; Kim HS, 2012, CELL SIGNAL, V24, P1306, DOI 10.1016/j.cellsig.2012.02.014; Kim J, 2013, J BONE MINER RES, V28, P2381, DOI 10.1002/jbmr.1973; Kim JY, 2015, J NAT PROD, V78, P2167, DOI 10.1021/acs.jnatprod.5b00233; Kim Jung Ha, 2016, Chonnam Med J, V52, P12, DOI 10.4068/cmj.2016.52.1.12; Kim KJ, 2015, BONE, V81, P208, DOI 10.1016/j.bone.2015.07.023; Li CH, 2011, J BONE MINER RES, V26, P644, DOI 10.1002/jbmr.242; Li SS, 2014, J CLIN INVEST, V124, P5057, DOI 10.1172/JCI71882; Liu T, 2016, ONCOTARGET, V7, P40800, DOI 10.18632/oncotarget.8315; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Park-Min KH, 2009, J IMMUNOL, V183, P2444, DOI 10.4049/jimmunol.0804165; Schiff Michael, 2015, Curr Treatm Opt Rheumatol, V1, P334, DOI 10.1007/s40674-015-0029-0; Shinohara Masahiro, 2007, Curr Osteoporos Rep, V5, P67; Song NN, 2008, J PHARMACEUT BIOMED, V48, P974, DOI 10.1016/j.jpba.2008.06.002; Takahashi T, 2012, BIOL PHARM BULL, V35, P1765, DOI 10.1248/bpb.b12-00445; Tanaka S, 2018, MOD RHEUMATOL, V28, P9, DOI 10.1080/14397595.2017.1369491; Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x; Wang XL, 2015, J SEP SCI, V38, P1286, DOI 10.1002/jssc.201401384; Wei ZL, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/147839; Xu J, 2015, MOL MED REP, V11, P865, DOI 10.3892/mmr.2014.2807; Yokota K, 2014, ARTHRITIS RHEUMATOL, V66, P121, DOI 10.1002/art.38218; Yuan XS, 2016, BIOCHEM PHARMACOL, V101, P87, DOI 10.1016/j.bcp.2015.11.025	39	29	30	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3398	3410		10.1096/fj.201701148RR	http://dx.doi.org/10.1096/fj.201701148RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401630				2022-12-26	WOS:000432546000040
J	Chen, X; Liu, ZH; Shan, ZL; Yao, WY; Gu, AH; Wen, WY				Chen, Xing; Liu, Ziheng; Shan, Zelin; Yao, Weiyi; Gu, Aihong; Wen, Wenyu			Structural determinants controlling 14-3-3 recruitment to the endocytic adaptor Numb and dissociation of the Numb center dot alpha-adaptin complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; MAMMALIAN NUMB; PHOSPHORYLATION; PROTEINS; BINDING; LOCALIZATION; DOMAIN; FATE; RECOGNITION; ACTIVATION	Traffic of cargo across membranes helps establish, maintain, and reorganize distinct cellular compartments and is fundamental to many metabolic processes. The cargo-selective endocytic adaptor Numb participates in clathrin-dependent endocytosis by attaching cargoes to the clathrin adaptor alpha-adaptin. The phosphorylation of Numb at Ser(265) and Ser(284) recruits the regulatory protein 14-3-3, accompanied by the dissociation of Numb from alpha-adaptin and Numb's translocation from the cortical membrane to the cytosol. However, the molecular mechanisms underlying the Numb-alpha-adaptin interaction and its regulation by Numb phosphorylation and 14-3-3 recruitment remain poorly understood. Here, biochemical and structural analyses of the Numb.14-3-3 complex revealed that Numb phosphorylation at both Ser(265) and Ser(284) is required for Numb's efficient interaction with 14-3-3. We also discovered that an RQFRF motif surrounding Ser(265) in Numb functions together with the canonical C-terminal DPF motif, required for Numb's interaction with alpha-adaptin, to form a stable complex with alpha-adaptin. Of note, we provide evidence that the phosphorylation-induced binding of 14-3-3 to Numb directly competes with the binding of alpha-adaptin to Numb. Our findings suggest a potential mechanism governing the dynamic assembly of Numb with alpha-adaptin or 14-3-3. This dual-site recognition of Numb by alpha-adaptin may have implications for other alpha-adaptin targets. We propose that the newly identified alpha-adaptin-binding site surrounding Ser(265) in Numb functions as a triggering mechanism for the dynamic dissociation of the Numb.alpha-adaptin complex.	Fudan Univ, Huashan Hosp, State Key Lab Med Neurobiol, Dept Neurosurg,Inst Biomed Sci, Shanghai 200032, Peoples R China; Fudan Univ, Sch Basic Med Sci, Shanghai Med Coll, Dept Syst Biol Med, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Wen, WY (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200032, Peoples R China.	wywen@fudan.edu.cn			Ministry of Science and Technology of the People's Republic of China [2014CB910201]; National Natural Science Foundation of China [31422015, 31670730, 31270778]; Shanghai Municipal Education Commission [14SG06]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by Grant 2014CB910201 from the Ministry of Science and Technology of the People's Republic of China; National Natural Science Foundation of China Grants 31422015, 31670730, and 31270778; and Shanghai Municipal Education Commission Grant 14SG06 (to W.W.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Brett TJ, 2002, STRUCTURE, V10, P797, DOI 10.1016/S0969-2126(02)00784-0; Bridges Dave, 2004, Sci STKE, V2004, pre10, DOI 10.1126/stke.2422004re10; Dho SE, 2006, MOL BIOL CELL, V17, P4142, DOI 10.1091/mbc.E06-02-0097; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Gulino A, 2010, EXP CELL RES, V316, P900, DOI 10.1016/j.yexcr.2009.11.017; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hirai M, 2017, J CLIN INVEST, V127, P569, DOI 10.1172/JCI91081; Jia M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9381; Kelly BT, 2014, SCIENCE, V345, P459, DOI 10.1126/science.1254836; Kirchhausen T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016725; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Kostelecky B, 2009, EMBO REP, V10, P983, DOI 10.1038/embor.2009.150; Ma L, 2016, DEV CELL, V37, P428, DOI 10.1016/j.devcel.2016.05.003; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Ormancey M, 2017, TRENDS PLANT SCI, V22, P263, DOI 10.1016/j.tplants.2016.11.007; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Pece S, 2011, BBA-REV CANCER, V1815, P26, DOI 10.1016/j.bbcan.2010.10.001; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Riou P, 2013, CELL, V153, P640, DOI 10.1016/j.cell.2013.03.044; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Salle J, 2017, EMBO J, V36, P1928, DOI 10.15252/embj.201695622; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Shao XM, 2016, CELL RES, V26, P593, DOI 10.1038/cr.2016.34; Siddique HR, 2015, HEPATOLOGY, V62, P1466, DOI 10.1002/hep.27987; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Stevers LM, 2016, P NATL ACAD SCI USA, V113, pE1152, DOI 10.1073/pnas.1516631113; Tokumitsu H, 2005, J BIOL CHEM, V280, P35108, DOI 10.1074/jbc.M503912200; Tokumitsu H, 2006, FEBS LETT, V580, P5797, DOI 10.1016/j.febslet.2006.09.043; Tosoni D, 2017, EMBO MOL MED, V9, P655, DOI 10.15252/emmm.201606940; Traub LM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016790; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	44	5	5	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4149	4158		10.1074/jbc.RA117.000897	http://dx.doi.org/10.1074/jbc.RA117.000897			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29382713	Green Published, hybrid			2022-12-26	WOS:000427587500025
J	Maioli, M; Basoli, V; Carta, P; Fabbri, D; Dettori, MA; Cruciani, S; Serra, PA; Delogu, G				Maioli, Margherita; Basoli, Valentina; Carta, Paola; Fabbri, Davide; Dettori, Maria Antonietta; Cruciani, Sara; Serra, Pier Andrea; Delogu, Giovanna			Synthesis of magnolol and honokiol derivatives and their effect against hepatocarcinoma cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HEPATOCELLULAR-CARCINOMA; ANTIOXIDANT ACTIVITY; SODIUM-BUTYRATE; BIPHENYL DERIVATIVES; OXIDATIVE STRESS; PEROXYL RADICALS; NATURAL-PRODUCTS; HEPG2 CELLS; APOPTOSIS	The hepatocellular carcinoma is one of the most common malignant tumour with high level of mortality rate due to its rapid progression and high resistance to conventional chemotherapies. Thus, the search for novel therapeutic leads is of global interest. Herein, a small set of derivatives of magnolol 1 and honokiol 2, the main components of Magnolia grandiflora and Magnolia obovata, were evaluated in in vitro assay using tumoral hepatocytes. The prodrug approach was applied as versatile strategy to the improve bioactivity of the compounds by careful transformation of the hydroxyl groups of magnolol 1 and honokiol 2 in suitable ester derivatives. Compounds 10 and 11 resulted to be more potent than the parental honokiol 2 at concentration down to 1 mu M with complete viability of treated fibroblast cells up to concentrations of 80 mu M. The combination of a butyrate ester and a bare phenol-OH group in the honokiol structure seemed to play a significant role in the antiproliferative activity identifying an interesting pharmacological clue against hepatocellular carcinoma.	[Maioli, Margherita; Basoli, Valentina; Cruciani, Sara] Univ Sassari, Dept Biomed Sci, Sassari, Italy; [Maioli, Margherita; Cruciani, Sara] Natl Inst Biostruct & Biosyst, Lab Mol Biol & Stem Cell Engn, Bologna, Italy; [Maioli, Margherita] CNR, Inst Neurogenet & Neuropharmacol, Cagliari, Italy; [Maioli, Margherita; Serra, Pier Andrea] Univ Sassari, Dept Biomed Sci, Ctr Dev Biol & Reprogramming CEDEBIOR, Sassari, Italy; [Basoli, Valentina] Univ Nat Resources & Life Sci Vienna, Dept Biotechnol, Vienna, Austria; [Carta, Paola; Dettori, Maria Antonietta; Delogu, Giovanna] CNR, Inst Biomol Chem, Sassari, Italy; [Serra, Pier Andrea] Univ Sassari, Dept Clin & Expt Med, Sassari, Italy	University of Sassari; Consiglio Nazionale delle Ricerche (CNR); University of Sassari; University of Natural Resources & Life Sciences, Vienna; Consiglio Nazionale delle Ricerche (CNR); University of Sassari	Delogu, G (corresponding author), CNR, Inst Biomol Chem, Sassari, Italy.	giovanna.delogu@icb.cnr.it	Basoli, Valentina/AEX-6502-2022; Cruciani, Sara/ABI-3491-2020; Carta, Paola/H-2026-2013; CARTA, PAOLA/AAT-5918-2020; fabbri, davide/AAJ-7021-2021; Dettori, Maria Antonietta/AAJ-7013-2021	Carta, Paola/0000-0001-8749-6093; CARTA, PAOLA/0000-0001-8749-6093; Dettori, Maria Antonietta/0000-0002-8776-9271; Basoli, Valentina/0000-0002-4703-7308; SERRA, Pier Andrea/0000-0003-2401-5146; FABBRI, DAVIDEGAETANO/0000-0002-3947-5164	Sardinia Region (Italy) [000411 9/2/2016]; Fondazione Sardegna (IT) [U858.2014/AI.741.MGB]; Sardinia Region (Italy); Fondazione Sardegna	Sardinia Region (Italy); Fondazione Sardegna (IT); Sardinia Region (Italy); Fondazione Sardegna(Fondazione Banco di Sardegna)	(PC) Sardinia Region (Italy) for a grant associated to the project 'Strategie di sintesi per l'accesso a nuovi lead antitumorali', Number 000411 9/2/2016. (MM) Fondazione Sardegna (IT) for the project 'Myrtus 2.0: from waste to resource (Bioactivity of myrtle by-products)', Number U858.2014/AI.741.MGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PC gratefully acknowledges the financial support from Sardinia Region (Italy) for a grant associated with the project 'Strategie di sintesi per l'accesso a nuovi lead antitumorali'. The authors acknowledge the financial support from Fondazione Sardegna for the project 'Myrtus 2.0: from waste to resource (Bioactivity of myrtle by-products)'.	Amorati R, 2003, J ORG CHEM, V68, P5198, DOI 10.1021/jo0342931; Amorati R, 2015, J ORG CHEM, V80, P10651, DOI 10.1021/acs.joc.5b01772; Appendino G, 2014, NAT PROD REP, V31, P880, DOI 10.1039/c4np00010b; Bao K, 2010, BIOORGAN MED CHEM, V18, P6708, DOI 10.1016/j.bmc.2010.07.062; Baschieri A, 2017, ORG BIOMOL CHEM, V15, P6177, DOI 10.1039/c7ob01195d; Bhattacharya A, 2010, MOL PLANT PATHOL, V11, P705, DOI [10.1111/J.1364-3703.2010.00625.X, 10.1111/j.1364-3703.2010.00625.x]; Bringmann G, 2011, CHEM REV, V111, P563, DOI 10.1021/cr100155e; Cardinali A., 2006, PHYTOCHEM ADV RES, V661, P23; Chen MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143594; Criton M, 2011, BIOL PHARM BULL, V34, P420, DOI 10.1248/bpb.34.420; Dikalov S, 2008, BIOCHEM PHARMACOL, V76, P589, DOI 10.1016/j.bcp.2008.06.012; Esatbeyoglu T, 2012, ANGEW CHEM INT EDIT, V51, P5308, DOI 10.1002/anie.201107724; Fan SL, 2014, INFLAMMATION, V37, P17, DOI 10.1007/s10753-013-9707-y; Fujisawa S, 2005, ARCH IMMUNOL THER EX, V53, P28; Hajduk PJ, 2000, J MED CHEM, V43, P3443, DOI 10.1021/jm000164q; Han LL, 2009, ENVIRON TOXICOL PHAR, V28, P97, DOI 10.1016/j.etap.2009.03.005; Jornada DH, 2016, MOLECULES, V21, DOI 10.3390/molecules21010042; Jung Roh H J, 2009, BIOMOL THER, V23, P283; Kancheva V, 2014, FOOD CHEM, V157, P263, DOI 10.1016/j.foodchem.2014.02.036; Lee YJ, 2011, PHARMACOL THERAPEUT, V130, P157, DOI 10.1016/j.pharmthera.2011.01.010; Li HM, 2011, J FLUORESC, V21, P265, DOI 10.1007/s10895-010-0714-1; Li HT, 2012, DIABETES, V61, P797, DOI 10.2337/db11-0846; Li S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4234061; Lin CJ, 2016, TOXICOL APPL PHARM, V304, P59, DOI 10.1016/j.taap.2016.05.018; Lin CJ, 2016, PHYTOMEDICINE, V23, P517, DOI 10.1016/j.phymed.2016.02.021; Lin CF, 2016, PHARM RES-DORDR, V33, P2152, DOI 10.1007/s11095-016-1953-x; Liu RX, 2017, INT J ONCOL, V51, P907, DOI 10.3892/ijo.2017.4078; Luo LX, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00199; Maioli M, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2056416; Maioli M, 2013, DRUG DES DEV THER, V7, P1063, DOI 10.2147/DDDT.S44706; Marchiani A, 2013, AMINO ACIDS, V45, P327, DOI 10.1007/s00726-013-1503-3; Mascia MP, 2012, EUR J PHARMACOL, V693, P45, DOI 10.1016/j.ejphar.2012.07.048; McKeown BT, 2014, ANTICANCER RES, V34, P6333; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; Moura FA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4047362; Olsen Sonja K, 2010, Therap Adv Gastroenterol, V3, P55, DOI 10.1177/1756283X09346669; Pandey KB, 2009, CURR NUTR FOOD SCI, V5, P249, DOI 10.2174/157340109790218058; Pant K, 2017, CHEM-BIOL INTERACT, V273, P99, DOI 10.1016/j.cbi.2017.06.001; Pant K, 2017, REDOX BIOL, V12, P340, DOI 10.1016/j.redox.2017.03.006; Park EJ, 2003, PLANTA MED, V69, P33, DOI 10.1055/s-2003-37027; Pedotti S, 2016, POLYHEDRON, V117, P80, DOI 10.1016/j.poly.2016.05.039; Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044; Rajendran P, 2012, J CELL PHYSIOL, V227, P2184, DOI 10.1002/jcp.22954; Rajgopal A, 2016, J ETHNOPHARMACOL, V193, P657, DOI 10.1016/j.jep.2016.10.016; Ran Y, 2012, MOLECULES, V17, P8091, DOI 10.3390/molecules17078091; Ruzza P, 2017, EUR J MED CHEM, V126, P1034, DOI 10.1016/j.ejmech.2016.12.028; Schuhly W, 2009, BIOORGAN MED CHEM, V17, P4459, DOI 10.1016/j.bmc.2009.05.018; Sengupta S, 2017, ONCOGENE, V36, P5709, DOI 10.1038/onc.2017.164; Shen J, 2017, CELL PHYSIOL BIOCHEM, V42, P1789, DOI 10.1159/000479458; Shen JL, 2010, MOLECULES, V15, P6452, DOI 10.3390/molecules15096452; Shen L, 2017, ONCOL LETT, V14, P4294, DOI 10.3892/ol.2017.6665; Sun LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172228; Trojan J, 2016, VISC MED, V32, P116, DOI 10.1159/000445730; Ventura C, 2004, J BIOL CHEM, V279, P23574, DOI 10.1074/jbc.M401869200; Waller LP, 2015, WORLD J HEPATOL, V7, P2648, DOI 10.4254/wjh.v7.i26.2648; Woodbury A, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00130; Xing XG, 2016, J PHYSIOL BIOCHEM, V73, P405, DOI 10.1007/s13105-017-0568-y; YAHARA S, 1991, CHEM PHARM BULL, V39, P2024, DOI 10.1248/cpb.39.2024; Yang JH, 2017, ONCOTARGET, V8, P915, DOI 10.18632/oncotarget.13687; Yeh PS, 2016, CANCER LETT, V370, P66, DOI 10.1016/j.canlet.2015.08.030; Zhang HX, 2015, INT J CLIN EXP MED, V8, P16880; Zhang YX, 2015, CARBOHYD POLYM, V133, P31, DOI 10.1016/j.carbpol.2015.06.102; Zhou MM, 2010, J CELL BIOCHEM, V109, P606, DOI 10.1002/jcb.22442	63	24	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192178	10.1371/journal.pone.0192178	http://dx.doi.org/10.1371/journal.pone.0192178			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415009	gold, Green Submitted, Green Published			2022-12-26	WOS:000424325300055
J	Gilbert, AN; DiVerdi, JA				Gilbert, Avery N.; DiVerdi, Joseph A.			Consumer perceptions of strain differences in Cannabis aroma	PLOS ONE			English	Article							SATIVA	The smell of marijuana (Cannabis sativa L.) is of interest to users, growers, plant breeders, law enforcement and, increasingly, to state-licensed retail businesses. The numerous varieties and strains of Cannabis produce strikingly different scents but to date there have been few, if any, attempts to quantify these olfactory profiles directly. Using standard sensory evaluation techniques with untrained consumers we have validated a preliminary olfactory lexicon for dried cannabis flower, and characterized the aroma profile of eleven strains sold in the legal recreational market in Colorado. We show that consumers perceive differences among strains, that the strains form distinct clusters based on odor similarity, and that strain aroma profiles are linked to perceptions of potency, price, and smoking interest.	[Gilbert, Avery N.] Headspace Sensory LLC, Ft Collins, CO 80528 USA; [DiVerdi, Joseph A.] XTR Syst LLC, Ft Collins, CO USA		Gilbert, AN (corresponding author), Headspace Sensory LLC, Ft Collins, CO 80528 USA.	avery@headspacesensory.com		Gilbert, Avery/0000-0002-8806-8557	Headspace Sensory	Headspace Sensory	This work was supported by funds provided by Headspace Sensory, LLC which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizpurua-Olaizola O, 2016, J NAT PROD, V79, P324, DOI 10.1021/acs.jnatprod.5b00949; [Anonymous], 2016, WORLD COFFEE RES SEN; Burness A., 2016, DAILY CAMERA    1105; Clarke RC, 2013, CANNABIS: EVOLUTION AND ETHNOBOTANY, P1; Dufresnes C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170522; Elinson Z., 2017, WALL STREET J; Fischedick JT, 2010, PHYTOCHEMISTRY, V71, P2058, DOI 10.1016/j.phytochem.2010.10.001; Giese MW, 2015, J AOAC INT, V98, P1503, DOI 10.5740/jaoacint.15-116; Gilbert A. N., 2008, WHAT NOSE KNOWS SCI; Gilbert AN, 2016, FOOD QUAL PREFER, V52, P203, DOI 10.1016/j.foodqual.2016.04.007; Goetzl R, 2013, AM CRIM LAW REV, V50, P607; Guerriero G, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00019, 10.3389/fpls.2016.00463]; Hazekamp A, 2012, DRUG TEST ANAL, V4, P660, DOI 10.1002/dta.407; Hillig KW, 2004, BIOCHEM SYST ECOL, V32, P875, DOI 10.1016/j.bse.2004.04.004; Mariotti KD, 2016, SCI JUSTICE, V56, P35, DOI 10.1016/j.scijus.2015.09.002; McDowell E, 2016, CHEM SENSES, V41, pE52; McPartland JM, 2000, HEMP DISEASES PESTS; Mediavilla V., 1997, Journal of the International Hemp Association, V4, P82; Mooi E, 2011, CONCISE GUIDE TO MARKET RESEARCH: THE PROCESS, DATA, AND METHODS USING IBM SPSS STATISTICS, P237, DOI 10.1007/978-3-642-12541-6_9; NOBLE AC, 1987, AM J ENOL VITICULT, V38, P143; Rahn B, 2016, CRIT REV PLANT SCI, V35, P328, DOI 10.1080/07352689.2016.1273626; Rice S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144160; Ross SA, 1996, J NAT PROD, V59, P49, DOI 10.1021/np960004a; Rothschild M, 2005, BOT J LINN SOC; Sawler J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133292; Small E, 2015, BOT REV, V81, P189, DOI 10.1007/s12229-015-9157-3; Strong E, 2015, STYLE GUIDELINES BEE; Sweeney C., 2016, N BAY BUSINESS  0613; Vandrey R, 2015, JAMA-J AM MED ASSOC, V313, P2491, DOI 10.1001/jama.2015.6613	29	20	20	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192247	10.1371/journal.pone.0192247	http://dx.doi.org/10.1371/journal.pone.0192247			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401526	Green Published, Green Submitted, gold			2022-12-26	WOS:000424101400045
J	Lopez, J; Feldman, MF				Lopez, Juvenal; Feldman, Mario F.			Expanding the molecular weaponry of bacterial species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						protein secretion; toxicity; bacteria; Pseudomonas; NAD	SECRETION SYSTEM	The type VI secretion system (T6SS) delivers toxic effectors between Gram-negative bacteria. Most antibacterial T6SS effectors are peptidoglycanases, nucleases, or lipases. In the current work, Tang et al. structurally and functionally characterize a novel family of NAD(P)(+)-hydrolyzing effectors (NADases), thus expanding the documented types of T6SS substrates. Bioinformatic identification of NADase family members putatively secreted by the bacteriolytic type VII secretion system (T7SS) of Gram-positive bacteria further points to NADases as a diverse and important class of effectors.	[Lopez, Juvenal; Feldman, Mario F.] Washington Univ, Dept Mol Microbiol, Sch Med St Louis, Campus Box 8230, St Louis, MO 63110 USA	Saint Louis University; Washington University (WUSTL)	Feldman, MF (corresponding author), Washington Univ, Dept Mol Microbiol, Sch Med St Louis, Campus Box 8230, St Louis, MO 63110 USA.	mariofeldman@wustl.edu		Lopez, Juvenal/0000-0002-3433-2412	National Institutes of Health [1R01AI125363-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125363] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work in the Feldman lab is supported by National Institutes of Health Grant 1R01AI125363-01.	Cao ZP, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.183; Cianfanelli FR, 2016, TRENDS MICROBIOL, V24, P51, DOI 10.1016/j.tim.2015.10.005; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Lazzaro M, 2017, MBIO, V8, DOI 10.1128/mBio.00559-17; Lien YW, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00254; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Tang JY, 2018, J BIOL CHEM, V293, P1504, DOI 10.1074/jbc.RA117.000178; Weber BS, 2016, MBIO, V7, DOI 10.1128/mBio.01253-16; Whitney JC, 2017, ELIFE, V6, DOI 10.7554/eLife.26938; Whitney JC, 2015, CELL, V163, P607, DOI 10.1016/j.cell.2015.09.027	10	4	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1515	1516		10.1074/jbc.H118.001463	http://dx.doi.org/10.1074/jbc.H118.001463			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29414766	Green Published, hybrid			2022-12-26	WOS:000424201700003
J	Pati, S; Peng, ZL; Wataha, K; Miyazawa, B; Potter, DR; Kozar, RA				Pati, Shibani; Peng, Zhanglong; Wataha, Katherine; Miyazawa, Byron; Potter, Daniel R.; Kozar, Rosemary A.			Lyophilized plasma attenuates vascular permeability, inflammation and lung injury in hemorrhagic shock	PLOS ONE			English	Article							FRESH-FROZEN PLASMA; TRAUMATIC BRAIN-INJURY; ENDOTHELIAL GLYCOCALYX DEGRADATION; DAMAGE CONTROL RESUSCITATION; SPRAY-DRIED PLASMA; LEUKOCYTE ADHESION; SYNDECAN 1; MODEL; SURVIVAL; COAGULOPATHY	In severe trauma and hemorrhage the early and empiric use of fresh frozen plasma (FFP) is associated with decreased morbidity and mortality. However, utilization of FFP comes with the significant burden of shipping and storage of frozen blood products. Dried or lyophilized plasma (LP) can be stored at room temperature, transported easily, reconstituted rapidly with ready availability in remote and austere environments. We have previously demonstrated that FFP mitigates the endothelial injury that ensues after hemorrhagic shock (HS). In the current study, we sought to determine whether LP has similar properties to FFP in its ability to modulate endothelial dysfunction in vitro and in vivo. Single donor LP was compared to single donor FFP using the following measures of endothelial cell (EC) function in vitro: permeability and transendothelial monolayer resistance; adherens junction preservation; and leukocyte-EC adhesion. In vivo, using a model of murine HS, LP and FFP were compared in measures of HS-induced pulmonary vascular inflammation and edema. Both in vitro and in vivo in all measures of EC function, LP demonstrated similar effects to FFP. Both FFP and LP similarly reduced EC permeability, increased transendothelial resistance, decreased leukocyte-EC binding and persevered adherens junctions. In vivo, LP and FFP both comparably reduced pulmonary injury, inflammation and vascular leak. Both FFP and LP have similar potent protective effects on the vascular endothelium in vitro and in lung function in vivo following hemorrhagic shock. These data support the further development of LP as an effective plasma product for human use after trauma and hemorrhagic shock.	[Pati, Shibani; Wataha, Katherine; Miyazawa, Byron; Potter, Daniel R.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Peng, Zhanglong] Univ Texas Hlth Sci Ctr Houston, Dept Anesthesia, Houston, TX 77030 USA; [Kozar, Rosemary A.] Univ Maryland, Sch Med, Shock Trauma Ctr, Baltimore, MD 21201 USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Health Science Center Houston; University System of Maryland; University of Maryland Baltimore	Pati, S (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	shibani.pati@ucsf.edu			National Institutes of Health [RO1GM107482]; Department of Defense [W81XWH-11-2-006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health RO1GM107482 (to RAK) and the Department of Defense W81XWH-11-2-006 (to SP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institutes of Health RO1GM107482 and the Department of Defense W81XWH-11-2-006. There are no conflicts of interest reported.	[Anonymous], 2017, SHOCK, P1; [Anonymous], 2009, SAFETY AUTOLOGOUS LY; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Chappell D, 2010, SHOCK, V34, P133, DOI 10.1097/SHK.0b013e3181cdc363; Chesebro BB, 2009, SHOCK, V32, P659, DOI 10.1097/SHK.0b013e3181a5a632; Cotton BA, 2011, ANN SURG, V254, P598, DOI 10.1097/SLA.0b013e318230089e; GIAEVER I, 1986, IEEE T BIO-MED ENG, V33, P242, DOI 10.1109/TBME.1986.325896; Hart ML, 2005, J IMMUNOL, V174, P6373, DOI 10.4049/jimmunol.174.10.6373; Haywood-Watson RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023530; Holcomb JB, 2013, JAMA SURG; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holcomb JB, 2013, HEMATOL-AM SOC HEMAT, P656, DOI 10.1182/asheducation-2013.1.656; Holcomb JB, 2011, J TRAUMA, V71, pS318, DOI 10.1097/TA.0b013e318227edbb; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Jenkins DH, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000140; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Johansson PI, 2011, BIOMED CENTRAL, V15, pR272; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kozar RA, 2015, J TRAUMA ACUTE CARE, V78, pS83, DOI 10.1097/TA.0000000000000631; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Lee TH, 2013, TRANSFUSION, V53, p72S, DOI 10.1111/trf.12039; Letourneau PA, 2011, J TISSUE SCI ENG S3; Lipowsky HH, 2012, ANN BIOMED ENG, V40, P840, DOI 10.1007/s10439-011-0427-x; Matijevic N, 2011, J TRAUMA, V70, P71, DOI 10.1097/TA.0b013e318207abec; Ostrowski SR, 2012, J TRAUMA ACUTE CARE, V73, P60, DOI 10.1097/TA.0b013e31825b5c10; Pati S, 2016, J TRAUMA ACUTE CARE, V80, P576, DOI 10.1097/TA.0000000000000961; Peng ZL, 2016, J TRAUMA ACUTE CARE, V81, pS171, DOI 10.1097/TA.0000000000001221; Peng ZL, 2013, SHOCK, V40, P195, DOI 10.1097/SHK.0b013e31829f91fc; Peng ZL, 2012, SHOCK, V38, P57, DOI 10.1097/SHK.0b013e31825a188a; Potter DR, 2015, J TRAUMA ACUTE CARE, V78, pS7, DOI 10.1097/TA.0000000000000630; Pusateri AE, 2016, TRANSFUSION, V56, pS128, DOI 10.1111/trf.13580; Query C, 2010, REPORTING SYSTEM WIS; Rahbar E, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0481-5; Sillesen M, 2013, SURGERY, V154, P197, DOI 10.1016/j.surg.2013.04.002; Spinella PC, 2008, J TRAUMA, V64, pS69, DOI 10.1097/TA.0b013e318160ba2f; Spoerke N, 2009, ARCH SURG-CHICAGO, V144, P829, DOI 10.1001/archsurg.2009.154; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Van PY, 2011, J TRAUMA, V71, P20, DOI 10.1097/TA.0b013e3182214f44; Wataha K, 2013, TRANSFUSION, V53, p80S, DOI 10.1111/trf.12040	41	37	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192363	10.1371/journal.pone.0192363	http://dx.doi.org/10.1371/journal.pone.0192363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394283	Green Published, Green Submitted, gold			2022-12-26	WOS:000424060400039
J	Wang, J; Hou, DH; Wang, QR; Kuang, WH; Zhang, L; Li, J; Shen, S; Deng, F; Wang, HL; Hu, ZH; Wang, ML				Wang, Jun; Hou, Dianhai; Wang, Qianran; Kuang, Wenhua; Zhang, Lei; Li, Jiang; Shen, Shu; Deng, Fei; Wang, Hualin; Hu, Zhihong; Wang, Manli			Genome analysis of a novel Group I alphabaculovirus obtained from Oxyplax ochracea	PLOS ONE			English	Article							PER-OS INFECTIVITY; ENVELOPE FUSION PROTEIN; EXPRESSION FACTOR GENES; NUCLEOCAPSID NUCLEOPOLYHEDROVIRUS; HOMOLOGOUS DNA; BOMBYX-MORI; BACULOVIRUS; VIRUS; IDENTIFICATION; SEQUENCE	Oxyplax ochracea (Moore) is a pest that causes severe damage to a wide range of crops, forests and fruit trees. The complete genome sequence of Oxyplax ochracea nucleopolyhedrovirus (OxocNPV) was determined using a Roche 454 pyrosequencing system. OxocNPV has a double-stranded DNA (dsDNA) genome of 113,971 bp with a G+C content of 31.1%. One hundred and twenty-four putative open reading frames (ORFs) encoding proteins of >50 amino acids in length and with minimal overlapping were predicted, which covered 92% of the whole genome. Six baculoviral typical homologous regions (hrs) were identified. Phylogenetic analysis and gene parity plot analysis showed that OxocNPV belongs to clade "a" of Group I alphabaculoviruses, and it seems to be close to the most recent common ancestor of Group I alphabaculoviruses. Three unique ORFs (with no homologs in the National Center for Biotechnology Information database) were identified. Interestingly, OxocNPV lacks three auxiliary genes (lef7, ie-2 and pcna) related to viral DNA replication and RNA transcription. In addition, OxocNPV has significantly different sequences for several genes (including ie1 and odv-e66) in comparison with those of other baculoviruses. However, three dimensional structure prediction showed that OxocNPV ODV-E66 contain the conserved catalytic residues, implying that it might possess polysaccharide lyase activity as AcMNPV ODV-E66. All these unique features suggest that OxocNPV represents a novel species of the Group I alphabaculovirus lineage.	[Wang, Jun; Hou, Dianhai; Wang, Qianran; Kuang, Wenhua; Zhang, Lei; Li, Jiang; Shen, Shu; Deng, Fei; Wang, Hualin; Hu, Zhihong; Wang, Manli] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Hou, Dianhai] Weifang Med Univ, Sch Biosci & Technol, Weifang, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Weifang Medical University	Wang, ML (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.	wangml@wh.iov.cn	Hu, Zhihong/AAS-2215-2020	Hu, Zhihong/0000-0002-1560-0928; shen, shu/0000-0002-0013-5365	National Key R&D Program of China [2017YFD0200400, 2016YFE0113500]; National Natural Science Foundation of China [31621061, 31400140]; Key Research Program of Frontier Sciences of Chinese Academy of Sciences [QYZDJ-SSW-SMC021]; Virology Key Frontier Science Program of State Key Laboratory of Virology [klv-2016-03]; National Natural Science Foundation of China	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of Frontier Sciences of Chinese Academy of Sciences; Virology Key Frontier Science Program of State Key Laboratory of Virology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Key R&D Program of China (Grants No. 2017YFD0200400 to FD and 2016YFE0113500 to ZH); the National Natural Science Foundation of China (Grant No. 31621061) to ZH; the Key Research Program of Frontier Sciences of Chinese Academy of Sciences (Grant No. QYZDJ-SSW-SMC021) to ZH, the Virology Key Frontier Science Program of State Key Laboratory of Virology (Grant No. klv-2016-03) to ZH and HW, and the National Natural Science Foundation of China (Grant No. 31400140) to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardisson-Araujo DMP, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2408-9; Ardisson-Araujo DMP, 2016, J VIROL, V90, P1668, DOI 10.1128/JVI.02491-15; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; CARSON DD, 1988, VIROLOGY, V162, P444, DOI 10.1016/0042-6822(88)90485-0; CARSON DD, 1991, VIROLOGY, V182, P279, DOI 10.1016/0042-6822(91)90671-W; Carstens EB, 2009, ARCH VIROL, V154, P1181, DOI 10.1007/s00705-009-0400-2; Chen CJ, 1997, VIROLOGY, V227, P88, DOI 10.1006/viro.1996.8341; CRAWFORD AM, 1988, J VIROL, V62, P2773, DOI 10.1128/JVI.62.8.2773-2781.1988; Fang MG, 2009, J VIROL, V83, P12569, DOI 10.1128/JVI.01141-09; Ferrelli ML, 2012, BACULOVIRAL GENOME; Gomi S, 1997, VIROLOGY, V230, P35, DOI 10.1006/viro.1997.8457; GUARINO LA, 1986, J VIROL, V60, P224, DOI 10.1128/JVI.60.1.224-229.1986; Guarino LA, 1998, J VIROL, V72, P7985, DOI 10.1128/JVI.72.10.7985-7991.1998; Guarino LA, 2002, J VIROL, V76, P12663, DOI 10.1128/JVI.76.24.12663-12675.2002; GUARINO LA, 1986, J VIROL, V60, P215, DOI 10.1128/JVI.60.1.215-223.1986; Hayakawa T, 1999, VIROLOGY, V262, P277, DOI 10.1006/viro.1999.9894; Hefferon KL, 1999, VIROLOGY, V258, P455, DOI 10.1006/viro.1999.9758; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Hilton S, 2008, ARCH VIROL, V153, P1527, DOI 10.1007/s00705-008-0148-0; Hu ZH, 1998, J GEN VIROL, V79, P2841, DOI 10.1099/0022-1317-79-11-2841; Hu ZH, 1998, VIRUS RES, V55, P71, DOI 10.1016/S0168-1702(98)00029-X; Huang GH, 2017, VIROL SIN, V32, P147, DOI 10.1007/s12250-016-3929-8; IJkel WFJ, 2000, VIROLOGY, V275, P30, DOI 10.1006/viro.2000.0483; Ishihara G, 2013, VIRUS RES, V174, P52, DOI 10.1016/j.virusres.2013.02.014; Javed MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02115-16; Garavaglia MJ, 2012, J VIROL, V86, P12069, DOI 10.1128/JVI.01873-12; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; Jehle JA, 2006, VIROLOGY, V346, P180, DOI 10.1016/j.virol.2005.10.032; Kawaguchi Y, 2013, FEBS LETT, V587, P3943, DOI 10.1016/j.febslet.2013.10.021; Ke JH, 2008, VIROLOGY, V374, P421, DOI 10.1016/j.virol.2007.12.033; Kikhno I, 2002, J GEN VIROL, V83, P3013, DOI 10.1099/0022-1317-83-12-3013; KOOL M, 1993, J GEN VIROL, V74, P2661, DOI 10.1099/0022-1317-74-12-2661; KOOL M, 1994, P NATL ACAD SCI USA, V91, P11212, DOI 10.1073/pnas.91.23.11212; Lauzon HAM, 2004, J VIROL, V78, P7023, DOI 10.1128/JVI.78.13.7023-7035.2004; Lin GY, 2002, J VIROL, V76, P5503, DOI 10.1128/JVI.76.11.5503-5514.2002; LU A, 1995, J VIROL, V69, P975, DOI 10.1128/JVI.69.2.975-982.1995; LU A, 1995, J VIROL, V69, P6265, DOI 10.1128/JVI.69.10.6265-6272.1995; Martignoni ME, 1986, CATALOG VIRAL DIS IN, P897; Mitchell JK, 2013, J VIROL, V87, P12592, DOI 10.1128/JVI.02501-13; Monsma SA, 1996, J VIROL, V70, P4607, DOI 10.1128/JVI.70.7.4607-4616.1996; MORRIS TD, 1994, VIROLOGY, V200, P360; Nie YC, 2012, J VIROL, V86, P3985, DOI 10.1128/JVI.06849-11; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; O'Reilly DR, 1997, BACULOVIRUSES; Olson VA, 2002, J VIROL, V76, P9505, DOI 10.1128/JVI.76.18.9505-9515.2002; PASSARELLI AL, 1994, J VIROL, V68, P1186, DOI 10.1128/JVI.68.2.1186-1190.1994; Peng K, 2010, J VIROL, V84, P9497, DOI 10.1128/JVI.00812-10; Possee RD, 1997, CURR OPIN BIOTECH, V8, P569, DOI 10.1016/S0958-1669(97)80030-4; Rohrmann GF, 2013, BACULOVIRUS MOL BIOL, V3rd; Sanderson MJ, 2000, SYST BIOL, V49, P671, DOI 10.1080/106351500750049761; Simon O, 2012, J INVERTEBR PATHOL, V109, P117, DOI 10.1016/j.jip.2011.10.010; Slack JM, 1997, J VIROL, V71, P9579, DOI 10.1128/JVI.71.12.9579-9587.1997; Solovyev A. V., 2009, ENTOMOFAUNA, V16, P193; Solovyev VV, 1999, NUCLEIC ACIDS RES, V27, P248, DOI 10.1093/nar/27.1.248; Sparks WO, 2011, VIROLOGY, V409, P69, DOI 10.1016/j.virol.2010.09.027; Sugiura N, 2013, GLYCOBIOLOGY, V23, P1520, DOI 10.1093/glycob/cwt082; Sugiura N, 2011, J BIOL CHEM, V286, P29026, DOI 10.1074/jbc.M111.251157; Summers MD, 2006, ADV VIRUS RES, V68, P3, DOI 10.1016/S0065-3527(06)68001-9; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang Xianchun, 1993, Virologica Sinica, V8, P158; THIEM SM, 1989, J VIROL, V63, P2008, DOI 10.1128/JVI.63.5.2008-2018.1989; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Vanarsdall AL, 2007, CURR DRUG TARGETS, V8, P1096, DOI 10.2174/138945007782151397; Wang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155134; Wang ML, 2010, J VIROL, V84, P8821, DOI 10.1128/JVI.00072-10; Xiang XW, 2011, VIRUS RES, V158, P72, DOI 10.1016/j.virusres.2011.03.012; YOO SH, 1994, VIROLOGY, V202, P746, DOI 10.1006/viro.1994.1396; Zhu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086450	68	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192279	10.1371/journal.pone.0192279	http://dx.doi.org/10.1371/journal.pone.0192279			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390020	Green Published, gold, Green Submitted			2022-12-26	WOS:000423793400086
J	Bissa, M; Forlani, G; Zanotto, C; Tosi, G; Morghen, CD; Accolla, RS; Radaelli, A				Bissa, Massimiliano; Forlani, Greta; Zanotto, Carlo; Tosi, Giovanna; Morghen, Carlo De Giuli; Accolla, Roberto S.; Radaelli, Antonia			Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-REPLICATION; INHIBITS VIRAL REPLICATION; VACCINE EFFICACY TRIAL; T-CELL RESPONSES; NEUTRALIZING ANTIBODIES; RHESUS-MONKEYS; ANTIRETROVIRAL THERAPY; ANTIVIRAL ANTIBODIES; PRIME/BOOST STRATEGY; TRANSACTIVATOR CIITA	A complete eradication of an HIV infection has never been achieved by vaccination and the search for new immunogens that can induce long-lasting protective responses is ongoing. Avipoxvirus recombinants are host-restricted for replication to avian species and they do not have the undesired side effects induced by vaccinia recombinants. In particular, Fowlpox (FP) recombinants can express transgenes over long periods and can induce protective immunity in mammals, mainly due to CD4-dependent CD8(+) T cells. In this context, the class II transactivator (CIITA) has a pivotal role in triggering the adaptive immune response through induction of the expression of class-II major histocompatibility complex molecule (MHC-II), that can present antigens to CD4(+) T helper cells. Here, we report on construction of novel FPgp and FPenv recombinants that express the highly immunogenic SIV Gag-pro and Env structural antigens. Several FP-based recombinants, with single or dual genes, were also developed that express CIITA, driven from H6 or SP promoters. These recombinants were used to infect CEF and Vero cells in vitro and determine transgene expression, which was evaluated by real-time PCR and Western blotting. Subcellular localisation of the different proteins was evaluated by confocal microscopy,whereas HLA-DR or MHC-II expression was measured by flow cytometry. Fowlpox recombinants were also used to infect syngeneic T/SA tumour cells, then injected into Balb/c mice to elicit MHC-II immune response and define the presentation of the SIV transgene products in the presence or absence of FPCIITA. Antibodies to Env were measured by ELISA. Our data show that the H6 promoter was more efficient than SP to drive CIITA expression and that CIITA can enhance the levels of the gag/pro and env gene products only when infection is performed by FP single recombinants. Also, CIITA expression is higher when carried by FP single recombinants than when combined with FPgp or FPenv constructs and can induce HLA-DR cell surface expression. However, in-vivo experiments did not show any significant increase in the humoral response. As CIITA already proved to elicit immunogenicity by improving antigen presentation, further in-vivo experiments should be performed to increase the immune responses. The use of prime/boost immunisation protocols and the oral administration route of the recombinants may enhance the immunogenicity of Env peptides presented by MHC-II and provide CD4(+) T-cell stimulation.	[Bissa, Massimiliano; Radaelli, Antonia] Univ Milan, Dept Pharmacol & Biomol Sci, Via Balzaretti 9, Milan, Italy; [Forlani, Greta; Tosi, Giovanna; Accolla, Roberto S.] Univ Insubria, Dept Expt Med, Via O Rossi 9, Varese, Italy; [Zanotto, Carlo; Morghen, Carlo De Giuli] Univ Milan, Dept Med Biotechnol & Translat Med, Via Vanvitelli 32, Milan, Italy; [Morghen, Carlo De Giuli] Catholic Univ Our Lady Good Counsel, Tirana, Albania; [Radaelli, Antonia] Univ Milan, CNR, Inst Neurosci, Cellular & Mol Pharmacol Sect, Via Vanvitelli 32, Milan, Italy; [Bissa, Massimiliano; Radaelli, Antonia] NCI, NIH, Basic Res Labs, Bethesda, MD 20892 USA	University of Milan; University of Insubria; University of Milan; Consiglio Nazionale delle Ricerche (CNR); University of Milan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Radaelli, A (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci, Via Balzaretti 9, Milan, Italy.; Radaelli, A (corresponding author), NCI, NIH, Basic Res Labs, Bethesda, MD 20892 USA.	antonia.radaelli@unimi.it	Bissa, Massimiliano/X-9135-2019	Bissa, Massimiliano/0000-0003-3455-3992	University of Insubria Intramural Grant [FAR 20142016]; European Community FP7 programme HepaVAC [A]; University of Milan, Transition Grant [18498, CUP G42I14001030001]; Intra-mural Research Support Grant [PSR2015-1716GRACA02_15_M, SIOPE B.01]; Fondazione Fratelli Confalonieri	University of Insubria Intramural Grant; European Community FP7 programme HepaVAC; University of Milan, Transition Grant; Intra-mural Research Support Grant; Fondazione Fratelli Confalonieri	This study was supported by the University of Insubria Intramural Grant FAR 20142016 to R.S. Accolla, G. Tosi and G. Forlani, and by the European Community FP7 programme HepaVAC Grant Number A (www.hepavac.eu). The study was also partially funded by the University of Milan, Transition Grant, code no. 18498, CUP G42I14001030001, and Intra-mural Research Support Grant, project PSR2015-1716GRACA02_15_M, code SIOPE B.01. M. Bissa was the recipient of a PhD Fellowship from the "Fondazione Fratelli Confalonieri". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. S. Pacchioni for her technical contributions, and Dr. Christopher P. Berrie for editorial assistance with the manuscript. M. Bissa was the recipient of a PhD Fellowship from the "Fondazione Fratelli Confalonieri".	ABIMIKU AG, 1995, NAT MED, V1, P321, DOI 10.1038/nm0495-321; Accolla RS, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00032; Accolla RS, 2002, EUR J IMMUNOL, V32, P2783, DOI 10.1002/1521-4141(2002010)32:10<2783::AID-IMMU2783>3.0.CO;2-E; ACCOLLA RS, 1986, J EXP MED, V164, P369, DOI 10.1084/jem.164.1.369; Accolla RS, 2001, TRENDS IMMUNOL, V22, P560, DOI 10.1016/S1471-4906(01)02003-8; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; BARBARO AD, 1994, J IMMUNOL, V153, P4530; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; BAXBY D, 1992, VACCINE, V10, P8, DOI 10.1016/0264-410X(92)90411-C; Bissa M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0437-9; Bissa M, 2013, VIRUS RES, V178, P374, DOI 10.1016/j.virusres.2013.09.016; Bissa M, 2013, J VIROL METHODS, V187, P172, DOI 10.1016/j.jviromet.2012.09.009; Bonsignori M, 2012, J VIROL, V86, P11521, DOI 10.1128/JVI.01023-12; Bou Nasser Eddine F, 2016, ONCOIMMUNOL, V6; Casoli C, 2004, BLOOD, V103, P995, DOI 10.1182/blood-2003-07-2503; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Clements-Mann ML, 1998, J INFECT DIS, V177, P1230, DOI 10.1086/515288; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Coupar BEH, 2006, VACCINE, V24, P1378, DOI 10.1016/j.vaccine.2005.09.044; Dale CJ, 2004, J VIROL, V78, P13819, DOI 10.1128/JVI.78.24.13819-13828.2004; De Giuli Morghen C, 2000, AIDS REV, V2, P127; De Rose R, 2005, VACCINE, V23, P1949, DOI 10.1016/j.vaccine.2004.10.012; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Dittmer U, 1999, NAT MED, V5, P189, DOI 10.1038/5550; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Forlani G, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0853-5; Forlani G, 2016, J VIROL, V90, P3708, DOI 10.1128/JVI.03000-15; Forlani G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00234; Forthal DN, 2009, CURR OPIN HIV AIDS, V4, P388, DOI 10.1097/COH.0b013e32832f0a89; Franchini Genoveffa, 2004, Expert Rev Vaccines, V3, pS75, DOI 10.1586/14760584.3.4.S75; Frangione V, 2010, INT J CANCER, V127, P1614, DOI 10.1002/ijc.25183; Gordon SN, 2012, J IMMUNOL, V188, P714, DOI 10.4049/jimmunol.1101404; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hayes P, 2013, CLIN VACCINE IMMUNOL, V20, P397, DOI 10.1128/CVI.00637-12; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; HEENEY JL, 1994, AIDS RES HUM RETROV, V10, pS117; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; JENKINS S, 1991, AIDS RES HUM RETROV, V7, P991, DOI 10.1089/aid.1991.7.991; Julg B, 2010, J VIROL, V84, P5540, DOI 10.1128/JVI.02031-09; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kawada M, 2008, J VIROL, V82, P10199, DOI 10.1128/JVI.01103-08; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kulkarni V, 2013, HUM VACC IMMUNOTHER, V9, P2081, DOI 10.4161/hv.25473; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McCoy LE, 2013, J EXP MED, V210, P209, DOI 10.1084/jem.20121827; McDermott AB, 2012, AIDS, V26, P1281, DOI 10.1097/QAD.0b013e328353bcaf; Meazza R, 2003, EUR J IMMUNOL, V33, P1183, DOI 10.1002/eji.200323712; Nacsa J, 2004, VACCINE, V22, P597, DOI 10.1016/j.vaccine.2003.08.028; Orlandi C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-106; Pacchioni S, 2010, ARCH VIROL, V155, P915, DOI 10.1007/s00705-010-0663-7; Pantaleo G, 2010, CURR OPIN HIV AIDS, V5, P391, DOI 10.1097/COH.0b013e32833d1e87; Plotkin SA, 2013, CLIN INFECT DIS, V56, P1458, DOI 10.1093/cid/cit048; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Radaelli A, 2003, VIROLOGY, V312, P181, DOI 10.1016/S0042-6822(03)00184-3; RADAELLI A, 1994, VACCINE, V12, P1101, DOI 10.1016/0264-410X(94)90180-5; Radaelli A, 2012, VIRUS RES, V170, P44, DOI 10.1016/j.virusres.2012.08.007; Raval GU, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0186-0; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robinson HL, 2013, EXPERT OPIN BIOL TH, V13, P197, DOI 10.1517/14712598.2012.743527; ROSEL JL, 1986, J VIROL, V60, P436, DOI 10.1128/JVI.60.2.436-449.1986; Sauermann U, VECTOR ORDER DETERMI; Saunders KO, 2012, AIDS, V26, P1293, DOI 10.1097/QAD.0b013e32835474d2; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Skinner MA, 2005, EXPERT REV VACCINES, V4, P63, DOI 10.1586/14760584.4.1.63; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; Stephenson KE, 2012, J VIROL, V86, P11434, DOI 10.1128/JVI.01779-12; TAYLOR J, 1988, VACCINE, V6, P497, DOI 10.1016/0264-410X(88)90100-4; Tosi G, 2011, J VIROL, V85, P10719, DOI 10.1128/JVI.00813-11; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Voss G, 1996, J VIROL, V70, P7335, DOI 10.1128/JVI.70.10.7335-7340.1996; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Whitney JB, 2004, CURR OPIN INFECT DIS, V17, P17, DOI 10.1097/00001432-200402000-00004; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Yamamoto T, 2012, J VIROL, V86, P5877, DOI 10.1128/JVI.00315-12; Yang XZ, 2006, J VIROL, V80, P11404, DOI 10.1128/JVI.01102-06; Zanotto C, 2005, VACCINE, V23, P4745, DOI 10.1016/j.vaccine.2005.05.003; Zanotto C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-190; Zanotto C, 2010, ANTIVIR RES, V88, P53, DOI 10.1016/j.antiviral.2010.07.005; Zolla-Pazner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053629; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	88	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0190869	10.1371/journal.pone.0190869	http://dx.doi.org/10.1371/journal.pone.0190869			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385169	Green Published, gold, Green Submitted			2022-12-26	WOS:000423668400027
J	Lu, CH; Chung, CH; Lee, CH; Hsieh, CH; Hung, YJ; Lin, FH; Tsao, CH; Hsieh, PS; Chien, WC				Lu, Chieh-Hua; Chung, Chi-Hsiang; Lee, Chien-Hsing; Hsieh, Chang-Hsun; Hung, Yi-Jen; Lin, Fu-Huang; Tsao, Chang-Huei; Hsieh, Po-Shiuan; Chien, Wu-Chien			Combination COX-2 inhibitor and metformin attenuate rate of joint replacement in osteoarthritis with diabetes: A nationwide, retrospective, matched-cohort study in Taiwan	PLOS ONE			English	Article							MEDICATION ADHERENCE; KNEE OSTEOARTHRITIS; HAND OSTEOARTHRITIS; INSULIN-RESISTANCE; METABOLIC SYNDROME; ASSOCIATION; OBESITY; INDIVIDUALS; PREVALENCE; PREDICTOR	Background Osteoarthritis (OA) is the most common form of arthritis associated with an increased prevalence of type 2 diabetes mellitus (T2DM), however their impact on decreasing joint replacement surgery has yet to be elucidated. This study aimed to investigate if the combination of COX-2 inhibitor and metformin therapy in OA with T2DM were associated with lower the rate of joint replacement surgery than COX-2 inhibitor alone. Methods In total, 968 subjects with OA and T2DM under COX-2 inhibitor and metformin therapy (case group) between 1 January to 31 December 2000 were selected from the National Health Insurance Research Database of Taiwan, along with 1936 patients were the 1: 2 gender-, age-, and index year-controls matched without metformin therapy (control group) in this study. Cox proportional hazards analysis was used to compare the rate of receiving joint replacement surgery during 10 years of follow-up. Results At the end of follow-up, 438 of all enrolled subjects (15.08%) had received the joint replacement surgery, including 124 in the case group (12.81%) and 314 in the control group 16.22%). The case group tended to be associated with lower rate of receiving the joint replacement surgery at the end of follow-up than the control group (p = 0.003). Cox proportional hazards regression (HR) analysis revealed that study subjects under combination therapy with metformin had lower rate of joint replacement surgery (adjusted HR 0.742 (95% CI = 0.601 +/- 0.915, p = 0.005)). In the subgroups, study subjects in the combination metformin therapy who were female, good adherence (> 80%), lived in the highest urbanization levels of residence, treatment in the hospital center and lower monthly insurance premiums were associated with a lower risk of joint replacement surgery than those without. Conclusions Patients who have OA and T2DM receiving combination COX-2 inhibitors and metformin therapy associated with lower joint replacement surgery rates than those without and this may be attributable to combination therapy much more decrease pro-inflammatory factors associated than those without metformin therapy.	[Lu, Chieh-Hua; Lee, Chien-Hsing; Hsieh, Chang-Hsun; Hung, Yi-Jen] Triserv Gen Hosp, Sch Med, Natl Def Med Ctr, Dept Internal Med,Div Endocrinol & Metab, Taipei, Taiwan; [Lu, Chieh-Hua; Hsieh, Po-Shiuan; Chien, Wu-Chien] Natl Def Med Ctr, Dept Med Res, Taipei, Taiwan; [Chung, Chi-Hsiang; Lin, Fu-Huang; Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chung, Chi-Hsiang] Taiwanese Injury Prevent & Safety Promot Assoc, Taipei, Taiwan; [Tsao, Chang-Huei] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med Res, Taipei, Taiwan; [Tsao, Chang-Huei] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan; [Hsieh, Po-Shiuan] Natl Def Med Ctr, Dept Physiol & Biophys, Taipei, Taiwan; [Hsieh, Po-Shiuan] Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center	Hsieh, PS; Chien, WC (corresponding author), Natl Def Med Ctr, Dept Med Res, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.; Hsieh, PS (corresponding author), Natl Def Med Ctr, Dept Physiol & Biophys, Taipei, Taiwan.; Hsieh, PS (corresponding author), Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan.	pshsieh@hotmail.com; chienwu@mail.ndmctsgh.edu.tw	Chung, Chi-Hsiang/AAY-3386-2021; Hsieh, Po-Shiuan/AAF-4173-2020	Hsieh, Po-Shiuan/0000-0002-3402-9851	Tri-Service General Hospital Research and Medical Affairs Bureau, Ministry of National Defense Foundation [TSGH-C104-122, MAB-105-07, TSGH-C106-002]	Tri-Service General Hospital Research and Medical Affairs Bureau, Ministry of National Defense Foundation	This study was funded by Tri-Service General Hospital Research and Medical Affairs Bureau, Ministry of National Defense Foundation (TSGH-C104-122, MAB-105-07, TSGH-C106-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; [Anonymous], ICD 9 CM ENGL CHIN D; Berenbaum F, 2012, POSTGRAD MED J, V88, P240, DOI 10.1136/pgmj.2010.146399rep; Berenbaum F, 2011, ANN RHEUM DIS, V70, P1354, DOI 10.1136/ard.2010.146399; Beswick AD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000435; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Brunton SA, 2017, J FAM PRACTICE, V66, pS46; Chamberlain JJ, 2017, ANN INTERN MED, V166, P572, DOI 10.7326/M16-2937; Chan WSH, 2010, EPMA J, V1, P563, DOI 10.1007/s13167-010-0056-8; Chang CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021368; Chang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089867; Dahaghin S, 2005, ANN RHEUM DIS, V64, P682, DOI 10.1136/ard.2004.023564; Derry S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007400.pub2; Diaz A, 2017, VACCINE, V35, P2694, DOI 10.1016/j.vaccine.2017.03.078; FELSON DT, 1988, ANN INTERN MED, V109, P18, DOI 10.7326/0003-4819-109-1-18; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; HART DJ, 1995, J RHEUMATOL, V22, P1118; Hawker GA, 2006, ARTHRITIS RHEUM, V54, P3212, DOI 10.1002/art.22146; Kim C, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5983; Laiguillon MC, 2015, OSTEOARTHR CARTILAGE, V23, P1513, DOI 10.1016/j.joca.2015.04.026; Louati K, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2015-000077; Lu CH, 2016, EUR J PHARMACOL, V789, P60, DOI 10.1016/j.ejphar.2016.07.012; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Mikyas Y, 2014, APPL HEALTH ECON HEA, V12, P267, DOI 10.1007/s40258-013-0078-1; Ministry of Interior, 2015, LIF TABL TAIW, V2016; Mobasheri Ali, 2012, Front Endocrinol (Lausanne), V3, P153, DOI 10.3389/fendo.2012.00153; Puenpatom RA, 2009, POSTGRAD MED, V121, P9, DOI 10.3810/pgm.2009.11.2073; Rau HH, 2016, COMPUT METH PROG BIO, V125, P58, DOI 10.1016/j.cmpb.2015.11.009; Schett G, 2013, DIABETES CARE, V36, P403, DOI 10.2337/dc12-0924; Schett G, 2009, ARTHRITIS RHEUM-US, V60, P2381, DOI 10.1002/art.24757; Skou ST, 2015, NEW ENGL J MED, V373, P1597, DOI 10.1056/NEJMoa1505467; Stolpe Samuel, 2016, J Manag Care Spec Pharm, V22, P1224; Sturmer T, 2001, SCAND J RHEUMATOL, V30, P169; Tzeng NS, 2016, NEUROEPIDEMIOLOGY, V47, P82, DOI 10.1159/000449166; WAINE H, 1961, Tufts Folia Med, V7, P13; Wolfe F, 2000, ARTHRITIS RHEUM-US, V43, P378, DOI 10.1002/1529-0131(200002)43:2<378::AID-ANR18>3.0.CO;2-2; Xu C, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003585; Yoshimura N, 2011, J RHEUMATOL, V38, P921, DOI 10.3899/jrheum.100569; Yusuf E, 2010, ANN RHEUM DIS, V69, P761, DOI 10.1136/ard.2008.106930	39	36	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191242	10.1371/journal.pone.0191242	http://dx.doi.org/10.1371/journal.pone.0191242			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385156	Green Submitted, Green Published, gold			2022-12-26	WOS:000423668400039
J	Yu, YL; Dai, M; Lu, A; Yu, E; Merlino, G				Yu, Yanlin; Dai, Meng; Lu, Andrew; Yu, Ellen; Merlino, Glenn			PHLPP1 mediates melanoma metastasis suppression through repressing AKT2 activation	ONCOGENE			English	Article							PROTEIN-KINASE-B; CANCER CELL MOTILITY; TUMOR-SUPPRESSOR; TYROSINE PHOSPHATASES; PROMOTES DEVELOPMENT; PROSTATE-CANCER; PTEN; PROGRESSION; EXPRESSION; SURVIVAL	PI3K/AKT pathway activation is thought to be a driving force in metastatic melanomas. Members of the pleckstrin homology (PH) domain leucine-rich repeat protein Ser/Thr specific phosphatase family (PHLPP1 and PHLPP2) can regulate AKT activation. By dephosphorylating specific serine residues in the hydrophobic motif, PHLPP1 and PHLPP2 restrain AKT signalings, thereby regulating cell proliferation and survival. We here show that PHLPP1 expression was significantly downregulated or lost and correlated with metastatic potential in melanoma. Forcing expression of either PHLPP1 or PHLPP2 in melanoma cells inhibited cell proliferation, migration, and colony formation in soft agar; but PHLPP1 had the most profound inhibitory effect on metastasis. Moreover, expression of PH mutant forms of PHLPP1 continued to inhibit metastasis, whereas a phosphatase-dead C-terminal mutant did not. The introduction of activated PHLPP1-specific targets AKT2 or AKT3 also promoted melanoma metastasis, while the non-PHLPP1 target AKT1 did not. AKT2 and AKT3 could even rescue the PHLPP1-mediated inhibition of metastasis. An AKT inhibitor blocked the activity of AKT2 and inhibited AKT2-mediated tumor growth and metastasis in a preclinical mouse model. Our data demonstrate that PHLPP1 functions as a metastasis suppressor through its phosphatase activity, and suggest that PHLPP1 represents a novel diagnostic and therapeutic marker for metastatic melanoma.	[Yu, Yanlin; Lu, Andrew; Yu, Ellen; Merlino, Glenn] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Dai, Meng] Southern Med Univ, Nanfang Hosp, Guangzhou 510515, Guangdong, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Southern Medical University - China	Yu, YL (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	YuY@mail.nih.gov			NIH intramural research program; NATIONAL CANCER INSTITUTE [ZIABC008756] Funding Source: NIH RePORTER	NIH intramural research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the funding from the NIH intramural research program. We thank Drs. Miriam Anver, Julia Zhang and Hong Sheng for assistance with tissue microarray and immunohistochemistry.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Arboleda MJ, 2003, CANCER RES, V63, P196; Bellacosa A, 2004, CANCER BIOL THER, V3, P268, DOI 10.4161/cbt.3.3.703; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Cao J, 2016, ONCOTARGET, V7, P82170, DOI 10.18632/oncotarget.10320; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Cho JH, 2015, CELL REP, V13, P898, DOI 10.1016/j.celrep.2015.09.057; Dai DL, 2005, J CLIN ONCOL, V23, P1473, DOI 10.1200/JCO.2005.07.168; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davies MA, 2009, CLIN CANCER RES, V15, P7538, DOI 10.1158/1078-0432.CCR-09-1985; Dillon RL, 2009, CANCER RES, V69, P5057, DOI 10.1158/0008-5472.CAN-08-4287; Dong L, 2014, ONCOGENE, V33, P4756, DOI 10.1038/onc.2013.420; Durban VM, 2013, J CLIN INVEST, V123, P5104, DOI 10.1172/JCI69619; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Hutchinson J, 2001, MOL CELL BIOL, V21, P2203, DOI 10.1128/MCB.21.6.2203-2212.2001; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li X, 2014, GASTROENTEROLOGY, V146, P1301, DOI 10.1053/j.gastro.2014.02.003; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Mann MB, 2015, NAT GENET, V47, P486, DOI 10.1038/ng.3275; Molina JR, 2012, ONCOGENE, V31, P1264, DOI 10.1038/onc.2011.324; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nitsche C, 2012, GASTROENTEROLOGY, V142, P377, DOI 10.1053/j.gastro.2011.10.026; O'Hayre M, 2012, LEUKEMIA, V26, P1689, DOI 10.1038/leu.2012.6; O'Neill AK, 2013, FEBS J, V280, P572, DOI 10.1111/j.1742-4658.2012.08537.x; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Qiao JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056382; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Rychahou PG, 2008, P NATL ACAD SCI USA, V105, P20315, DOI 10.1073/pnas.0810715105; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Shin SS, 2010, PIGM CELL MELANOMA R, V23, P103, DOI 10.1111/j.1755-148X.2009.00648.x; Silva JM, 2014, MOL CANCER RES, V12, P447, DOI 10.1158/1541-7786.MCR-13-0224-T; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Wang ZX, 2013, J SURG ONCOL, V108, P427, DOI 10.1002/jso.23419; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Yan J, 2004, ONCOGENE, V23, P1939, DOI 10.1038/sj.onc.1207306; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Yu YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009072; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Yu YL, 2002, CANCER RES, V62, P2951	50	14	14	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	17					2225	2236		10.1038/s41388-017-0061-7	http://dx.doi.org/10.1038/s41388-017-0061-7			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GE3FW	29391600	Green Accepted			2022-12-26	WOS:000431100200002
J	Manfre, G; Novati, A; Faccini, I; Rossetti, AC; Bosch, K; Molteni, R; Riva, MA; Van der Harst, JE; Nguyen, HP; Homberg, JR				Manfre, Giuseppe; Novati, Arianna; Faccini, Ilaria; Rossetti, Andrea C.; Bosch, Kari; Molteni, Raffaella; Riva, Marco A.; Van der Harst, Johanneke E.; Huu Phuc Nguyen; Homberg, Judith R.			BACHD rats expressing full-length mutant huntingtin exhibit differences in social behavior compared to wild-type littermates	PLOS ONE			English	Article							PREDICT-HD; DISEASE; MODEL; PLAY; ABNORMALITIES; DIAGNOSIS; DEFICITS; SYSTEM; GENE	Background Huntington disease (HD) is a devastating inherited neurodegenerative disorder characterized by progressive motor, cognitive, and psychiatric symptoms without any cure to slow down or stop the progress of the disease. The BACHD rat model for HD carrying the human full-length mutant huntingtin protein (mHTT) with 97 polyQ repeats has been recently established as a promising model which reproduces several HD-like features. While motor and cognitive functions have been characterized in BACHD rats, little is known about their social phenotype. Objective This study focuses especially on social behavior since evidence for social disturbances exists in human patients. Our objective was to compare social behavior in BACHD and wildtype (WT) rats at different ages, using two different measures of sociability. Methods Animals were tested longitudinally at the age of 2, 4 and 8 months in the social interaction test to examine different parameters of sociability. A separate cohort of 7 month old rats was tested in the three chamber social test to measure both sociability and social novelty. Gene expression analyses in 8 months old animals were performed by real time qRT-PCR to evaluate a potential involvement of D1 and D2 dopaminergic receptors and the contribution of Brain-derived neurotrophic factor (BDNF) to the observed behavioral alterations. Results In the social interaction test, BACHD rats showed age-dependent changes in behaviour when they were-re introduced to their cagemate after a 24 hours-period of individual housing. The time spent on nape attacks increased with aging. Furthermore, a significant higher level of pinning at 2 months of age was shown in the BACHD rats compared to wild-types, followed by a reduction at 4 and 8 months. On the other hand, BACHD rats exhibited a decreased active social behaviour compared to wild-types, reflected by genotype-effects on approaching, following and social nose contact. In the three chamber social test, BACHD rats seemed to show a mild deficit in preference for social novelty, but no changes in social interest. Molecular analyses revealed that BACHD animals exposed to the social interaction test displayed decreased mRNA levels of the total form of BDNF in ventral striatum and unaltered striatal expression of D1 and D2 dopamine receptors. Conclusions Taken together, these results indicate deficits in several parameters representative of sociability. Altered BDNF expression in the ventral striatum may contribute to the deficits in sociability in 8 months old BACHD rats. These data support the validity of the BACHD rat model in mimicking features of certain social deficits that could be relevant to symptoms in patients.	[Manfre, Giuseppe; Bosch, Kari; Van der Harst, Johanneke E.; Homberg, Judith R.] Radboud Univ Nijmegen, Med Ctr, Dept Cognit Neurosci, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Manfre, Giuseppe; Van der Harst, Johanneke E.] Noldus Informat Technol BV, Wageningen, Netherlands; [Manfre, Giuseppe; Novati, Arianna; Huu Phuc Nguyen] Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany; [Novati, Arianna; Huu Phuc Nguyen] Univ Tubingen, Ctr Rare Dis, Tubingen, Germany; [Faccini, Ilaria; Riva, Marco A.] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Rossetti, Andrea C.; Molteni, Raffaella] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy	Radboud University Nijmegen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Milan; University of Milan	Nguyen, HP (corresponding author), Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany.; Nguyen, HP (corresponding author), Univ Tubingen, Ctr Rare Dis, Tubingen, Germany.	hoa.nguyen@med.uni-tuebingen.de	Homberg, J.R./N-4172-2019; Homberg, Judith R/D-2473-2010; Nguyen, Huu Phuc/HDO-3462-2022; Riva, Marco Andrea/N-7418-2017; Molteni, Raffaella/Q-5011-2017	Nguyen, Huu Phuc/0000-0001-6139-788X; Riva, Marco Andrea/0000-0002-1699-5060; Molteni, Raffaella/0000-0002-5481-7572; Rossetti, Andrea Carlo/0000-0003-0320-591X	Marie Curie Initial Network (ITN) of the European Commission's 7th Framework Programme "PhenoRat" [317259]; Marie Curie Industry-Academia Partnerships and Pathways (MC-IAPP) of the European Commission's 7th Framework Program "Switch HD" [324495]	Marie Curie Initial Network (ITN) of the European Commission's 7th Framework Programme "PhenoRat"; Marie Curie Industry-Academia Partnerships and Pathways (MC-IAPP) of the European Commission's 7th Framework Program "Switch HD"	This study was supported by Marie Curie Initial Network (ITN) of the European Commission's 7th Framework Programme "PhenoRat" (FP7/2012 under grant agreement No. 317259) and the Marie Curie Industry-Academia Partnerships and Pathways (MC-IAPP) of the European Commission's 7th Framework Program "Switch HD" (FP7-PEOPLE-2012; grant agreement No. 324495). Funding was used to breed and maintain animals, acquire materials, perform experiments, analyze data and support the authors' salaries. The funders, Noldus Information Technology and QPS Austria had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided support in the form of salaries for authors [GM, AN, JVDH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section	Abada YSK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068584, 10.1371/journal.pone.0071633]; Aylward EH, 2004, NEUROLOGY, V63, P66, DOI 10.1212/01.WNL.0000132965.14653.D1; Baez-Mendoza Raymundo, 2013, FRONTIERS NEUROSCIEN, V7, P1; Cepeda C, 2014, PROG BRAIN RES, V211, P235, DOI 10.1016/B978-0-444-63425-2.00010-6; Ciamei A, 2008, NEUROBIOL LEARN MEM; Clemensson EKH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169051; Crews D, 2012, P NATL ACAD SCI USA, V109, P9143, DOI 10.1073/pnas.1118514109; Duff K, 2007, BIOL PSYCHIAT, V62, P1341, DOI 10.1016/j.biopsych.2006.11.034; Himmler BT, 2013, JOVE-J VIS EXP, DOI 10.3791/4288; Hollis F, 2015, P NATL ACAD SCI USA, V112, P15486, DOI 10.1073/pnas.1512653112; Johnson SA, 2007, BRAIN, V130, P1732, DOI 10.1093/brain/awm107; Kirkwood SC, 1999, ARCH NEUROL-CHICAGO, V56, P563, DOI 10.1001/archneur.56.5.563; Kumar A, 2015, GENE, V556, P91, DOI 10.1016/j.gene.2014.11.022; Lamirault C, 2017, NEUROPHARMACOLOGY, V123, P136, DOI 10.1016/j.neuropharm.2017.05.032; Larsen IU, 2016, PUBLIC LIB SCI, V8; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Manfre G, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00218; Manfre G, 2016, BEHAV BRAIN RES, V299, P6, DOI 10.1016/j.bbr.2015.11.007; Marder K, 2000, NEUROLOGY, V54, P452, DOI 10.1212/WNL.54.2.452; Martin P, 2007, MEASURING BEHAV INTR; Naarding P, 2009, J NEUROPSYCH CLIN N, V21, P266, DOI 10.1176/appi.neuropsych.21.3.266; Nguyen HP, 2006, HUM MOL GENET, V15, P3177, DOI 10.1093/hmg/ddl394; Oakeshott S, 2012, PLOS CURR, V4, DOI [10.1371/4f972cffe82c0, DOI 10.1371/4F972CFFE82C0]; PANKSEPP J, 1981, DEV PSYCHOBIOL, V14, P327, DOI 10.1002/dev.420140405; Paulsen JS, 2006, ARCH NEUROL-CHICAGO, V63, P883, DOI 10.1001/archneur.63.6.883; Peters SM, 2016, J NEUROSCI METH, V268, P163, DOI 10.1016/j.jneumeth.2016.02.020; Pietsch SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024601; Rossetti AC, 2016, PHARMACOL RES, V103, P1, DOI 10.1016/j.phrs.2015.10.022; Rudenko O, 2010, NEUROSCI RES, V68, P35, DOI 10.1016/j.neures.2010.05.002; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shelbourne PF, 1999, HUM MOL GENET, V8, P763, DOI 10.1093/hmg/8.5.763; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Snowden JS, 2003, NEUROPSYCHOLOGIA, V41, P688, DOI 10.1016/S0028-3932(02)00221-X; Spruijt BM, 2014, J NEUROSCI METH, V234, P2, DOI 10.1016/j.jneumeth.2014.03.001; Toth I, 2013, CELL TISSUE RES, V354, P107, DOI 10.1007/s00441-013-1636-4; Vamos M, 2007, PSYCHOSOMATICS, V48, P400, DOI 10.1176/appi.psy.48.5.400; van den Berg CL, 1999, DEV PSYCHOBIOL, V34, P129, DOI 10.1002/(SICI)1098-2302(199903)34:2<129::AID-DEV6>3.3.CO;2-C; Varlinskaya EI, 2008, BEHAV BRAIN RES, V188, P398, DOI 10.1016/j.bbr.2007.11.024; Veenema AH, 2009, PSYCHONEUROENDOCRINO, V34, P463, DOI 10.1016/j.psyneuen.2008.10.017; Wood NI, 2015, J HUNTINGTONS DIS, V4, P61, DOI 10.3233/JHD-140132; Yu-Taeger L, 2012, J NEUROSCI, V32, P15426, DOI 10.1523/JNEUROSCI.1148-12.2012; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	44	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192289	10.1371/journal.pone.0192289	http://dx.doi.org/10.1371/journal.pone.0192289			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415038	Green Published, gold			2022-12-26	WOS:000424325300067
J	Manlhiot, C; Mueller, B; O'Shea, S; Majeed, H; Bernknopf, B; Labelle, M; Westcott, KV; Bai, HM; Chahal, N; Birken, CS; Yeung, RSM; McCrindle, BW				Manlhiot, Cedric; Mueller, Brigitte; O'Shea, Sunita; Majeed, Haris; Bernknopf, Bailey; Labelle, Michael; Westcott, Katherine V.; Bai, Heming; Chahal, Nita; Birken, Catherine S.; Yeung, Rae S. M.; McCrindle, Brian W.			Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution	PLOS ONE			English	Article							CORONARY-ARTERY ANEURYSMS; TROPOSPHERIC WINDS; NATIONWIDE SURVEYS; ALLERGIC DISEASES; ASSOCIATION; JAPAN; RISK; SUSCEPTIBILITY; AGE; RUG	Background The pathogenesis of Kawasaki disease (KD) is commonly ascribed to an exaggerated immunologic response to an unidentified environmental or infectious trigger in susceptible children. A comprehensive framework linking epidemiological data and global distribution of KD has not yet been proposed. Methods and findings Patients with KD (n = 81) were enrolled within 6 weeks of diagnosis along with control subjects (n = 87). All completed an extensive epidemiological questionnaire. Geographic localization software characterized the subjects' neighborhood. KD incidence was compared to atmospheric biological particles counts and winds patterns. These data were used to create a comprehensive risk framework for KD, which we tested against published data on the global distribution. Compared to controls, patients with KD were more likely to be of Asian ancestry and were more likely to live in an environment with low exposure to environmental allergens. Higher atmospheric counts of biological particles other than fungus/spores were associated with a temporal reduction in incidence of KD. Finally, westerly winds were associated with increased fungal particles in the atmosphere and increased incidence of KD over the Greater Toronto Area. Our proposed framework was able to explain approximately 80% of the variation in the global distribution of KD. The main limitations of the study are that the majority of data used in this study are limited to the Canadian context and our proposed disease framework is theoretical and circumstantial rather than the result of a single simulation. Conclusions Our proposed etiologic framework incorporates the 1) proportion of population that are genetically susceptible; 2) modulation of risk, determined by habitual exposure to environmental allergens, seasonal variations of atmospheric biological particles and contact with infectious diseases; and 3) exposure to the putative trigger. Future modelling of individual risk and global distribution will be strengthened by taking into consideration all of these non-traditional elements.	[Manlhiot, Cedric; Mueller, Brigitte; O'Shea, Sunita; Majeed, Haris; Bernknopf, Bailey; Labelle, Michael; Westcott, Katherine V.; Bai, Heming; Chahal, Nita; McCrindle, Brian W.] Univ Toronto, Hosp Sick Children, Dept Pediat, Labatt Family Heart Ctr, Toronto, ON, Canada; [Birken, Catherine S.] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Gen Pediat, Toronto, ON, Canada; [Yeung, Rae S. M.] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Rheumatol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	McCrindle, BW (corresponding author), Univ Toronto, Hosp Sick Children, Dept Pediat, Labatt Family Heart Ctr, Toronto, ON, Canada.	brian.mccrindle@sickkids.ca	Mueller, Brigitte/E-2594-2011	Mueller, Brigitte/0000-0003-1876-4722; Yeung, Rae/0000-0003-2361-725X	CIBC Endowed Chair in Child Health Research	CIBC Endowed Chair in Child Health Research	This study was supported by the CIBC Endowed Chair in Child Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballester J, 2013, GEOPHYS RES LETT, V40, P2284, DOI 10.1002/grl.50388; Benseler SM, 2005, PEDIATRICS, V116, pE760, DOI 10.1542/peds.2005-0559; Burns JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074529; Burns JC, 2005, EPIDEMIOLOGY, V16, P220, DOI 10.1097/01.ede.0000152901.06689.d4; Carsley S, 2015, INT J EPIDEMIOL, V44, P776, DOI 10.1093/ije/dyu123; Chahal N, 2012, PEDIATR INT, V54, P383, DOI 10.1111/j.1442-200X.2012.03628.x; Chang LY, 2014, J FORMOS MED ASSOC, V113, P148, DOI 10.1016/j.jfma.2013.12.008; Crump C, 2011, J ALLERGY CLIN IMMUN, V127, P1173, DOI 10.1016/j.jaci.2011.02.023; DANIELS SR, 1991, J PEDIATR-US, V118, P485, DOI 10.1016/S0022-3476(05)82173-0; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; FATICA NS, 1989, PEDIATRICS, V84, P231; FUJITA Y, 1989, PEDIATRICS, V84, P666; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hwang CY, 2013, J PEDIATR-US, V163, P811, DOI 10.1016/j.jpeds.2013.03.068; Jorquera H, 2015, ENVIRON INT, V78, P32, DOI 10.1016/j.envint.2015.02.007; Jung CR, 2017, ENVIRON HEALTH PERSP, V125, P670, DOI 10.1289/EHP137; Kao AS, 2008, PEDIATR INFECT DIS J, V27, P981, DOI 10.1097/INF.0b013e31817acf4f; Khor CC, 2011, J MED GENET, V48, P467, DOI 10.1136/jmg.2010.086611; Maddox RA, 2015, PEDIATR INT, V57, P1116, DOI 10.1111/ped.12733; Manlhiot C, 2017, CMAJ IN PRESS; McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484; Nakamura Y, 2004, PROG PEDIATR CARDIOL, V19, P99; Nakamura Y, 2008, J EPIDEMIOL, V18, P273, DOI 10.2188/jea.JE2008030; Okubo Y, 2017, CLIN RHEUMATOL, V36, P413, DOI 10.1007/s10067-016-3512-6; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Onouchi Y, 2010, HUM MOL GENET, V19, P2898, DOI 10.1093/hmg/ddq176; Pitzer VE, 2012, P ROY SOC B-BIOL SCI, V279, P2736, DOI 10.1098/rspb.2011.2464; RAUCH AM, 1991, PEDIATRICS, V87, P663; Rigante D, 2016, IMMUNOL RES, V64, P51, DOI 10.1007/s12026-015-8679-4; Rodo X, 2016, ANN NY ACAD SCI, V1382, P84, DOI 10.1111/nyas.13201; Rodo X, 2014, P NATL ACAD SCI USA, V111, P7952, DOI 10.1073/pnas.1400380111; Rodo X, 2011, SCI REP-UK, V1, DOI 10.1038/srep00152; SANDWELL DT, 1984, J GEOPHYS RES-OCEANS, V89, P2041, DOI 10.1029/JC089iC02p02041; Sano T, 2016, PEDIATR INT, V58, P1140, DOI 10.1111/ped.12970; Singh S, 2015, ARCH DIS CHILD, V100, P1084, DOI 10.1136/archdischild-2014-307536; Sudo D, 2017, ACTA PAEDIATR, V106, P796, DOI 10.1111/apa.13773; Tsai HC, 2015, J FORMOS MED ASSOC, V114, P72, DOI 10.1016/j.jfma.2014.07.005; Tsai YJ, 2013, ALLERGY ASTHMA PROC, V34, P467, DOI 10.2500/aap.2013.34.3697; Turnier JL, 2015, PEDIATRICS, V136, pE609, DOI 10.1542/peds.2015-0950; Uehara R, 2012, J EPIDEMIOL, V22, P79, DOI 10.2188/jea.JE20110131; Wei CC, 2014, ANN EPIDEMIOL, V24, P340, DOI 10.1016/j.annepidem.2014.02.003; Wong D, 2004, CAN J CARDIOL, V20, P1147; Yorifuji T, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3919; Zeft AS, 2016, J PEDIATR-US, V177, P179, DOI 10.1016/j.jpeds.2016.06.061	45	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191087	10.1371/journal.pone.0191087	http://dx.doi.org/10.1371/journal.pone.0191087			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415012	Green Published, Green Submitted, gold			2022-12-26	WOS:000424325300014
J	Schaefer, CP; Arkwright, NB; Jacobs, LM; Jarvis, CK; Hunn, KC; Largent-Milnes, TM; Tome, ME; Davis, TP				Schaefer, Charles P.; Arkwright, Nathan B.; Jacobs, Leigh M.; Jarvis, Chelsea K.; Hunn, Kristen C.; Largent-Milnes, Tally M.; Tome, Margaret E.; Davis, Thomas P.			Chronic morphine exposure potentiates p-glycoprotein trafficking from nuclear reservoirs in cortical rat brain microvessels	PLOS ONE			English	Article							PERIPHERAL INFLAMMATORY HYPERALGESIA; OPIOID TOLERANCE; TIGHT JUNCTIONS; BARRIER; PAIN; DRUG; DELIVERY; INHIBITOR; KETAMINE; MODULATION	The rates of opioid prescription and use have continued to increase over the last few decades resulting in a greater number of opioid tolerant patients. Treatment of acute pain from surgery and injury is a clinical challenge for these patients. Several pain management strategies including prescribing increased opioids are used clinically with limited success; all currently available strategies have significant limitations. Many opioids are a substrate for p-glycoprotein (p-gp), an efflux transporter at the blood-brain barrier (BBB). Increased p-gp is associated with a decreased central nervous system uptake and analgesic efficacy of morphine. Our laboratory previously found that acute peripheral inflammatory pain (PIP) induces p-gp trafficking from the nucleus to the luminal surface of endothelial cells making up the BBB concomitant with increased p-gp activity and decreased morphine analgesic efficacy. In the current study, we tested whether PIP-induced p-gp trafficking could contribute to decreased opioid efficacy in morphine tolerant rats. A 6-day continuous dosing of morphine from osmotic minipumps was used to establish morphine tolerance in female rats. PIP induced p-gp trafficking away from nuclear stores showed a 2-fold increase in morphine tolerant rats. This observation suggests that p-gp trafficking contributes to the decreased morphine analgesic effects in morphine tolerant rats experiencing an acute pain stimulus. Attenuating p-gp trafficking during an acute pain stimulus could improve pain management by increasing the amount of opioid that could reach CNS analgesic targets and decrease the need for the dose escalation that is a serious challenge in pain management.	[Schaefer, Charles P.; Arkwright, Nathan B.; Jacobs, Leigh M.; Jarvis, Chelsea K.; Hunn, Kristen C.; Largent-Milnes, Tally M.; Tome, Margaret E.; Davis, Thomas P.] Univ Arizona, Dept Pharmacol, Tucson, AZ 85721 USA	University of Arizona	Tome, ME (corresponding author), Univ Arizona, Dept Pharmacol, Tucson, AZ 85721 USA.	mtome@email.arizona.edu			National Institutes of Health: National Institute on Drug Abuse [011271]; National Institutes of Health: National Institute of Neurological Disorders and Stroke [042652]	National Institutes of Health: National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health: National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health: National Institute on Drug Abuse (011271) (T.P.D.); National Institutes of Health: National Institute of Neurological Disorders and Stroke (042652) (T.P.D.).	Aasvang EK, 2016, ACTA ANAESTH SCAND, V60, P529, DOI 10.1111/aas.12667; Ambudkar SV, 2006, EUR J PHARM SCI, V27, P392, DOI 10.1016/j.ejps.2005.10.010; Amin ML, 2013, DRUG TARGET INSIGHT, V7, P27, DOI 10.4137/DTI.S12519; Aquilante CL, 1999, LIFE SCI, V66, pPL47; Balayssac D, 2009, NEUROSCI LETT, V465, P108, DOI 10.1016/j.neulet.2009.09.003; Bansal T, 2009, J PHARM PHARM SCI, V12, P46, DOI 10.18433/J3RC77; Barreveld AM, 2013, PAIN MED, V14, P925, DOI 10.1111/pme.12086; CAMPBELL AW, 2016, ALTERN THER HEALTH M, V22, P6; Campos CR, 2008, BRAIN RES, V1221, P6, DOI 10.1016/j.brainres.2008.05.013; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Dixon M, 2014, AM J PHYSL HEART CIR; DIXON M, 2014, SPRING CONFERENCE OF; Dumas EO, 2008, AAPS J, V10, P537, DOI 10.1208/s12248-008-9056-1; Duncan MA, 2002, J PAIN SYMPTOM MANAG, V24, P8, DOI 10.1016/S0885-3924(02)00429-3; Dyrna F, 2013, J NEUROIMMUNE PHARM, V8, P763, DOI 10.1007/s11481-013-9473-5; Faul F, BEHAV RES METHODS; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; HUBER JD, AM J PHYSL HEART CIR; HUBER JD, AM J PHYSIOL HEART C, V3, P1; Huber JD, 2002, AM J PHYSL HEART CIR, V283, pH1531; HUBER JD, AM J PHYSIOL HEART C; HUBER JD, 2002, AM J PHYSIOL HEART C; HUBER JD, 2009, AM J PHYSIOL HEART C; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; JUNCO JJ, 2013, MOL CANCER RES, V1521, P30; Kim RB, 2002, DRUG METAB REV, V34, P47, DOI 10.1081/DMR-120001389; Kobori T, 2014, DRUG METAB PHARMACOK, V29, P482, DOI 10.2133/dmpk.DMPK-14-RG-042; Letrent SP, 1999, DRUG METAB DISPOS, V27, P827; Liang XJ, 2006, CURR DRUG TARGETS, V7, P911, DOI 10.2174/138945006778019264; Lilius TO, 2015, BRIT J PHARMACOL, V172, P2799, DOI 10.1111/bph.12974; Loo TW, 2003, J BIOL CHEM, V278, P20449, DOI 10.1074/jbc.C300154200; Mahathanaruk Marchyarn, 2014, Anesthesiol Clin, V32, P923, DOI 10.1016/j.anclin.2014.08.009; McCaffrey G, 2008, J NEUROCHEM, V106, P2395, DOI 10.1111/j.1471-4159.2008.05582.x; McCaffrey G, 2012, J NEUROCHEM, V122, P962, DOI 10.1111/j.1471-4159.2012.07831.x; Miller DS, 2008, PHARMACOL REV, V60, P196, DOI 10.1124/pr.107.07109; Miller DS, 2014, CURR PHARM DESIGN, V20, P1463, DOI 10.2174/13816128113199990457; Miller DS, 2010, TRENDS PHARMACOL SCI, V31, P246, DOI 10.1016/j.tips.2010.03.003; MYERS JL, 2003, RESEARCH DESIGN AND, P2; Nelson LS, 2015, JAMA-J AM MED ASSOC, V314, P1453, DOI 10.1001/jama.2015.12397; Rathmell JP, 2006, REGION ANESTH PAIN M, V31, P1, DOI 10.1016/j.rapm.2006.05.002; Rivat C, 2005, ANESTHESIOLOGY, V102, P421; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seelbach MJ, 2007, J NEUROCHEM, V102, P1677, DOI 10.1111/j.1471-4159.2007.04644.x; Sivak L, 2017, BIOMATERIALS, V115, P65, DOI 10.1016/j.biomaterials.2016.11.013; Thomas Hilary, 2003, Cancer Control, V10, P159; Thompson SJ, 2000, ANESTHESIOLOGY, V92, P1392, DOI 10.1097/00000542-200005000-00030; Tome ME, 2016, J CEREBR BLOOD F MET, V36, P1913, DOI 10.1177/0271678X16661728; Uhelski ML, 2011, PHARMACOL BIOCHEM BE, V98, P325, DOI 10.1016/j.pbb.2011.01.012; URQUHART J, 1984, ANNU REV PHARMACOL, V24, P199; *US DEP HHS, 2016, THE OPIOID EPIDEMIC; Yousif S, 2008, J NEUROCHEM, V107, P647, DOI 10.1111/j.1471-4159.2008.05647.x; Zong J, 2003, J PHARMACOL EXP THER, V306, P556, DOI 10.1124/jpet.103.049452	52	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192340	10.1371/journal.pone.0192340	http://dx.doi.org/10.1371/journal.pone.0192340			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414996	Green Published, gold, Green Submitted			2022-12-26	WOS:000424325300072
J	Larpin, Y; Oechslin, F; Moreillon, P; Resch, G; Entenza, JM; Mancini, S				Larpin, Yu; Oechslin, Frank; Moreillon, Philippe; Resch, Gregory; Entenza, Jose Manuel; Mancini, Stefano			In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteria	PLOS ONE			English	Article							ACINETOBACTER-BAUMANNII; PSEUDOMONAS-AERUGINOSA; ANTIBACTERIAL PROPERTIES; ESCHERICHIA-COLI; RESISTANT; ENDOLYSINS; ANTIMICROBIALS; MODEL; PEPTIDES; THERAPY	The recent rise of multidrug-resistant Gram-negative bacteria represents a serious threat to public health and makes the search for novel effective alternatives to antibiotics a compelling need. Bacteriophage (Phage) lysins are enzymes that hydrolyze the cell wall of bacteria and represent a promising alternative to tackle this ever-increasing problem. Despite their use is believed to be restricted to Gram-positive bacteria, recent findings have shown that they can also be used against Gram-negative bacteria. By using a phage genome-based screening approach, we identified and characterized a novel lysin, PlyE146, encoded by an Escherichia coli prophage and with a predicted molecular mass of ca. 17 kDa. PlyE146 is composed of a C-terminal cationic peptide and a N-terminal N-acetylmuramidase domain. Histidine-tagged PlyE146 was overexpressed from a plasmid in Lactococcus lactis NZ9000 and purified by NI-NTA chromatography. PlyE146 exhibited in vitro optimal bactericidal activity against E. coli K12 (3.6 log(10) CFU/mL decrease) after 2 h of incubation at 37 degrees C at a concentration of 400 mu g/mL in the absence of NaCl and at pH 6.0. Under these conditions, PlyE146 displayed antimicrobial activity towards several other E. coli, Pseudomonas aeruginosa (3 to 3.8-log(10) CFU/mL decrease) and Acinetobacter baumannii (4.9 to >5-log(10) CFU/mL decrease) strains. Therefore, PlyE146 represents a promising therapeutic agent against E. coli, P. aeruginosa and A. baumannii infections. However, further studies are required to improve the efficacy of PlyE146 under physiological conditions.	[Larpin, Yu; Oechslin, Frank; Moreillon, Philippe; Resch, Gregory; Entenza, Jose Manuel; Mancini, Stefano] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland; [Mancini, Stefano] Univ Zurich, Inst Med Microbiol, Zurich, Switzerland	University of Lausanne; University of Zurich	Entenza, JM (corresponding author), Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland.	jose.entenza@unil.ch		resch, gregory/0000-0003-2341-4591; Larpin, Yu/0000-0002-4313-5509; Oechslin, Frank/0000-0002-8473-8795	Swiss National Science Foundation [310030-125325]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (grant 310030-125325). There was no additional external funding received for this study.	Briers Y, 2011, J APPL MICROBIOL, V110, P778, DOI 10.1111/j.1365-2672.2010.04931.x; Briers Y, 2014, MBIO, V5, DOI 10.1128/mBio.01379-14; Briers Y, 2014, ANTIMICROB AGENTS CH, V58, P3774, DOI 10.1128/AAC.02668-14; Broskey NT, 2013, J APPL PHYSIOL, V115, P765, DOI 10.1152/japplphysiol.00063.2013; Defraine V, 2016, ANTIMICROB AGENTS CH, V60, P3480, DOI 10.1128/AAC.00285-16; Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002; Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002; Huang GT, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0681-2; Jado I, 2003, J ANTIMICROB CHEMOTH, V52, P967, DOI 10.1093/jac/dkg485; Jun SY, 2013, INT J ANTIMICROB AG, V41, P156, DOI 10.1016/j.ijantimicag.2012.10.011; Junn HJ, 2005, PROTEIN EXPRES PURIF, V42, P78, DOI 10.1016/j.pep.2005.03.026; Lai MJ, 2013, INT J ANTIMICROB AG, V42, P141, DOI 10.1016/j.ijantimicag.2013.04.022; Lai MJ, 2011, APPL MICROBIOL BIOT, V90, P529, DOI 10.1007/s00253-011-3104-y; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Lood R, 2015, ANTIMICROB AGENTS CH, V59, P1983, DOI 10.1128/AAC.04641-14; Ma Q, 2017, ANTON LEEUW INT J G, V110, P347, DOI 10.1007/s10482-016-0806-2; Nelson DC, 2012, ADV VIRUS RES, V83, P299, DOI 10.1016/B978-0-12-394438-2.00007-4; Oechslin F, 2013, ANTIMICROB AGENTS CH, V57, P6276, DOI 10.1128/AAC.01701-13; Pastagia M, 2013, J MED MICROBIOL, V62, P1506, DOI 10.1099/jmm.0.061028-0; Poirel L, 2016, LANCET INFECT DIS, V16, P281, DOI 10.1016/S1473-3099(16)00006-2; Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.001; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schmelcher M, 2012, FUTURE MICROBIOL, V7, P1147, DOI [10.2217/fmb.12.97, 10.2217/FMB.12.97]; Spellberg B, 2008, LANCET INFECT DIS, V8, P211, DOI 10.1016/S1473-3099(08)70048-3; Thandar M, 2016, ANTIMICROB AGENTS CH, V60, P2671, DOI 10.1128/AAC.02972-15; Yang H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01471; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	27	52	58	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192507	10.1371/journal.pone.0192507	http://dx.doi.org/10.1371/journal.pone.0192507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408864	Green Published, Green Submitted, gold			2022-12-26	WOS:000424302800074
J	Park, SY; Kim, HI; Oh, HK; Kim, TH; Jang, HW; Chung, JH; Shin, MH; Kim, SW				Park, So Young; Kim, Hae In; Oh, Hyun-Kyung; Kim, Tae Hyuk; Jang, Hye Won; Chung, Jae Hoon; Shin, Myung-Hee; Kim, Sun Wook			Age- and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: Data from Korean National Health and Nutrition Examination Survey IV (2013-2015)	PLOS ONE			English	Article							SUBCLINICAL THYROID-DISEASE; UNITED-STATES POPULATION; SERUM TSH; URINARY IODINE; REFERENCE RANGE; FOLLOW-UP; THYROTROPIN; DYSFUNCTION; DISORDERS; EXCRETION	Background Establishment of the reference interval of thyroid-stimulating hormone (TSH) is critical in the diagnosis of thyroid dysfunction and is affected by age, gender, iodine nutrition, and ethnicity. The aim of this study was to determine the reference intervals of TSH and free thyroxin (FT4) from a large, nationwide data of Korea where iodine intake is more than adequate. Methods We analyzed data from the Korea National Health and Nutrition Examination Survey VI that measured serum TSH, FT4, and thyroid peroxidase antibody from 7,061 individuals (urinary iodine measurement in 6,565). Age-and gender-specific reference intervals were established from 95% confidence limits from the 2.5 to 97.5 percentile of TSH (log-transformed) and FT4 in reference populations. Results The geometric mean of TSH was 2.16 +/- 0.01 mIU/L, with the lowest value found in the middle aged group (2.04 +/- 0.02 mIU/L) and higher values noted in age groups of 10-19 and over 70 years (2.38 +/- 0.02 and 2.32 +/- 0.07 mIU/L, respectively). The association of TSH and age was U-shaped. The overall reference interval of TSH was 0.59-7.03 mIU/L. Mean FT4 was 1.25 +/- 0.003 ng/dL (16.09 +/- 0.039 pmol/L), and it showed a small but continuous decrease after 20 years of age (P < 0.001). There was a significant positive correlation between TSH and urine iodine concentration (r = 0.154, P < 0.001). Conclusions The reference interval of TSH in Korea, where iodine intake is above the requirement, was 0.59-7.03 mIU/L and showed U-shaped change with age, which was a similar pattern to iodine intake. The reference interval of FT4 was 0.92-1.60 ng/dL. The geometric mean and upper limit of TSH were higher than those of Western populations, reflecting the paramount importance of iodine intake on thyroid function.	[Park, So Young; Kim, Hae In; Kim, Tae Hyuk; Chung, Jae Hoon; Kim, Sun Wook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med,Thyroid Ctr, Seoul, South Korea; [Oh, Hyun-Kyung; Shin, Myung-Hee] Sungkyunkwan Univ, Sch Med, Dept Social & Prevent Med, Seoul, South Korea; [Jang, Hye Won] Sungkyunkwan Univ, Sch Med, Dept Med Educ, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU)	Kim, SW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med,Thyroid Ctr, Seoul, South Korea.; Shin, MH (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Social & Prevent Med, Seoul, South Korea.	myunghee.shin@gmail.com; swkimmd@skku.edu	Kim, Sun/GSN-4867-2022	Kim, Tae Hyuk/0000-0002-7975-2437				[Anonymous], 2003, THYROID, V13, P3; [Anonymous], 2007, ASS IOD DEF DIS MON; Aoki Y, 2007, THYROID, V17, P1211, DOI 10.1089/thy.2006.0235; Atzmon G, 2009, J CLIN ENDOCR METAB, V94, P1251, DOI 10.1210/jc.2008-2325; Biondi B, 2012, BEST PRACT RES CL EN, V26, P431, DOI 10.1016/j.beem.2011.12.004; Bjergved L, 2012, J CLIN ENDOCR METAB, V97, P4022, DOI 10.1210/jc.2012-2508; Braverman LE, 2013, WERNER INGBARS THYRO; Brown SJ, 2016, CLIN ENDOCRINOL, V85, P789, DOI 10.1111/cen.13107; Chaker L, 2016, THYROID, V26, P1195, DOI 10.1089/thy.2016.0133; Cho YY, 2016, EUR J NUTR, V55, P469, DOI 10.1007/s00394-015-0864-7; Choi HS, 2009, J KOREAN THYROID ASS, V3; Choi J, 2012, CLIN BIOCHEM, V45, P596, DOI 10.1016/j.clinbiochem.2012.02.018; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; Guan HX, 2008, CLIN ENDOCRINOL, V69, P136, DOI 10.1111/j.1365-2265.2007.03150.x; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Hansen PS, 2007, CLIN ENDOCRINOL, V66, P827, DOI 10.1111/j.1365-2265.2007.02820.x; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Ittermann T, 2015, EUR J ENDOCRINOL, V172, P261, DOI 10.1530/EJE-14-0898; Kim JY, 1998, YONSEI MED J, V39, P355, DOI 10.3349/ymj.1998.39.4.355; Kim M, 2015, KOREAN J INTERN MED, V30, P335, DOI 10.3904/kjim.2015.30.3.335; Kim YA, 2014, ENDOCRINOL METAB, V29, P20, DOI 10.3803/EnM.2014.29.1.20; Lee J, 2014, EUR J NUTR, V53, P683, DOI 10.1007/s00394-013-0558-y; LeFevre ML, 2015, ANN INTERN MED, V162, P641, DOI 10.7326/M15-0483; Li CY, 2011, ENDOCR J, V58, P995, DOI 10.1507/endocrj.K11E-101; Peeters RP, 2003, J CLIN ENDOCR METAB, V88, P2880, DOI 10.1210/jc.2002-021592; Razvi S, 2010, J CLIN PATHOL, V63, P379, DOI 10.1136/jcp.2008.057414; Samollow PB, 2004, J CLIN ENDOCR METAB, V89, P3276, DOI 10.1210/jc.2003-031706; Schalin-Jantti C, 2011, SCAND J CLIN LAB INV, V71, P344, DOI 10.3109/00365513.2011.568630; Sheehan MT, 2016, CLIN MED RES, V14, P83, DOI 10.3121/cmr.2016.1309; Sun X, 2014, ENDOCRINOL METAB, V29, P240, DOI 10.3803/EnM.2014.29.3.240; Teng WP, 2006, NEW ENGL J MED, V354, P2783, DOI 10.1056/NEJMoa054022; TIETZ NW, 1992, CLIN CHEM, V38, P1167; Volzke H, 2005, THYROID, V15, P279, DOI 10.1089/thy.2005.15.279; Yoshihara A, 2011, ENDOCR J, V58, P585, DOI 10.1507/endocrj.K11E-082	34	32	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0190738	10.1371/journal.pone.0190738	http://dx.doi.org/10.1371/journal.pone.0190738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390008	Green Published, gold, Green Submitted			2022-12-26	WOS:000423793400007
J	Kuhs, KAL; Lin, SW; Hua, X; Schiffman, M; Burk, RD; Rodriguez, AC; Herrero, R; Abnet, CC; Freedman, ND; Pinto, LA; Hamm, D; Robins, H; Hildesheim, A; Shi, JX; Safaeian, M				Kuhs, Krystle A. Lang; Lin, Shih-Wen; Hua, Xing; Schiffman, Mark; Burk, Robert D.; Rodriguez, Ana Cecilia; Herrero, Rolando; Abnet, Christian C.; Freedman, Neal D.; Pinto, Ligia A.; Hamm, David; Robins, Harlan; Hildesheim, Allan; Shi, Jianxin; Safaeian, Mahboobeh			T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INTRAEPITHELIAL NEOPLASIA; SUSCEPTIBILITY LOCI; HPV; REGRESSION; CANCER	Background It is unknown why a minority of women fail to clear human papillomavirus (HPV) and develop precancer/cancer. Differences in T-cell receptor (TCR) repertoires may identify HPV16-infected women at highest-risk for progression to cancer. We conducted a proof-of-principle study nested within the Guanacaste HPV Natural History Study to evaluate the utility of next-generation sequencing for interrogating the TCR repertoires among women who cleared and failed to clear cervical HPV16. Methods TCR repertoires of women with HPV16-related intraepithelial neoplasia grade 3 or higher (CIN3+; n = 25) were compared to women who cleared an incident HPV16 infection without developing precancer/cancer (n = 25). TCR diversity (richness and evenness) and relative abundance (RA) of gene segment (V [n = 51], D [n = 2], J [n = 13]) usage was evaluated; receiver operating curve analysis assessed the ability to differentiate case-control status. Results TCR repertoire richness was associated with CIN3+ status (P = 0.001). Relative abundance (RA) of V-gene segments was enriched for associations between cases and controls. A single V-gene (TRBV6-7) was significantly associated with CIN3+ status (RA = 0.11%, 0.16%, among cases and controls, respectively, Bonferroni P = 0.0008). The estimated area under the curve using richness and V-gene segment RA was 0.83 (95% confidence interval: 0.73 +/- 0.90). Conclusions Substantial differences in TCR repertoire among women with CIN3+ compared to women who cleared infection were observed. Impact This is the first study to use next-generation sequencing to investigate TCR repertoire in the context of HPV infection. These findings suggest that women with HPV16-associated cervical lesions have significantly different TCR repertoires from disease-free women who cleared HPV16 infection.	[Kuhs, Krystle A. Lang; Lin, Shih-Wen; Hua, Xing; Schiffman, Mark; Abnet, Christian C.; Freedman, Neal D.; Hildesheim, Allan; Shi, Jianxin; Safaeian, Mahboobeh] NCI, NIH, Bethesda, MD 20892 USA; [Kuhs, Krystle A. Lang] Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA; [Burk, Robert D.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Rodriguez, Ana Cecilia; Herrero, Rolando] Fdn INCIENSA, Proyecto Epidemiol Guanacaste, San Jose, Costa Rica; [Herrero, Rolando] Int Agcy Res Canc, Prevent & Implementat Grp, Lyon, France; [Pinto, Ligia A.] Frederick Natl Lab Canc Res, Leidos Biomed Res Inc, HPV Immunol Lab, Frederick, MD USA; [Hamm, David; Robins, Harlan] Adapt Biotechnol, Seattle, WA USA; [Robins, Harlan] Fred Hutchinson Canc Res Canc, Seattle, WA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University; Yeshiva University; Albert Einstein College of Medicine; World Health Organization; International Agency for Research on Cancer (IARC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kuhs, KAL (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.; Kuhs, KAL (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA.	Krystle.Kuhs@Vanderbilt.edu	Rodríguez, Ana/GQR-0554-2022; Schiffman, Mark/B-9766-2015; Abnet, Christian C/C-4111-2015; Freedman, Neal David/B-9741-2015	Abnet, Christian C/0000-0002-3008-7843; Freedman, Neal David/0000-0003-0074-1098	intramural research program at the National Cancer Institute, Division of Cancer Epidemiology and Genetics, Infections and Immunoepidemiology Branch; NATIONAL CANCER INSTITUTE [U01CA078527] Funding Source: NIH RePORTER	intramural research program at the National Cancer Institute, Division of Cancer Epidemiology and Genetics, Infections and Immunoepidemiology Branch; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural research program at the National Cancer Institute, Division of Cancer Epidemiology and Genetics, Infections and Immunoepidemiology Branch (Mahboobeh Safaeian). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. David Hamm and Harlan Robins have employment and stock options at Adaptive Biotechnologies. Adaptive Biotechnologies provided support in the form of salaries for authors [DH, HR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Bratti MC, 2004, REV PANAM SALUD PUBL, V15, P75; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castle PE, 2002, J MED VIROL, V68, P417, DOI 10.1002/jmv.10220; Chen D, 2013, JNCI-J NATL CANCER I, V105, P624, DOI 10.1093/jnci/djt051; Dalstein W, 2003, INT J CANCER, V106, P396, DOI 10.1002/ijc.11222; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Herrero R, 1997, Rev Panam Salud Publica, V1, P362, DOI 10.1590/S1020-49891997000500005; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Kadish AS, 2002, CANCER EPIDEM BIOMAR, V11, P483; Kojima S, 2013, AM J REPROD IMMUNOL, V69, P134, DOI 10.1111/aji.12030; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; Qu WM, 1997, J CLIN MICROBIOL, V35, P1304, DOI 10.1128/JCM.35.6.1304-1310.1997; Robins H, 2013, CURR OPIN IMMUNOL, V25, P646, DOI 10.1016/j.coi.2013.09.017; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Rodriguez AC, 2008, JNCI-J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Shi YY, 2013, NAT GENET, V45, P918, DOI 10.1038/ng.2687; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; van Steenwijk PJD, 2010, CANCER RES, V70, P2707, DOI 10.1158/0008-5472.CAN-09-4299; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0178167	10.1371/journal.pone.0178167	http://dx.doi.org/10.1371/journal.pone.0178167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385144	Green Published, gold, Green Submitted			2022-12-26	WOS:000423668400001
J	Wang, JY; Zhang, T; Lu, Y; Zhou, GY; Chen, Q; Niu, B				Wang, JianYing; Zhang, Tong; Lu, Yi; Zhou, GuangYa; Chen, Qin; Niu, Bing			Vesicular stomatitis forecasting based on Google Trends	PLOS ONE			English	Article							PREDICTION; MACHINE; ADABOOST; DISEASE; VIRUS	Background Vesicular stomatitis (VS) is an important viral disease of livestock. The main feature of VS is irregular blisters that occur on the lips, tongue, oral mucosa, hoof crown and nipple. Humans can also be infected with vesicular stomatitis and develop meningitis. This study analyses 2014 American VS outbreaks in order to accurately predict vesicular stomatitis outbreak trends. Methods American VS outbreaks data were collected from OIE. The data for VS keywords were obtained by inputting 24 disease-related keywords into Google Trends. After calculating the Pearson and Spearman correlation coefficients, it was found that there was a relationship between outbreaks and keywords derived from Google Trends. Finally, the predicted model was constructed based on qualitative classification and quantitative regression. Results For the regression model, the Pearson correlation coefficients between the predicted outbreaks and actual outbreaks are 0.953 and 0.948, respectively. For the qualitative classification model, we constructed five classification predictive models and chose the best classification predictive model as the result. The results showed, SN (sensitivity), SP (specificity) and ACC (prediction accuracy) values of the best classification predictive model are 78.52%, 72.5% and 77.14%, respectively. Conclusion This study applied Google search data to construct a qualitative classification model and a quantitative regression model. The results show that the method is effective and that these two models obtain more accurate forecast.	[Wang, JianYing; Zhang, Tong; Lu, Yi; Zhou, GuangYa; Chen, Qin; Niu, Bing] Shanghai Univ, Sch Life Sci, Shanghai Key Lab Bioenergy Crops, Shanghai, Peoples R China	Shanghai University	Chen, Q; Niu, B (corresponding author), Shanghai Univ, Sch Life Sci, Shanghai Key Lab Bioenergy Crops, Shanghai, Peoples R China.	chenqincc@staff.shu.edu.cn; bingniu@shu.edu.cn		wang, jianying/0000-0001-7137-8519	National Key Research and Development Program of China [2016YFD0501101]; High Performance Computing Center Program of Shanghai University	National Key Research and Development Program of China; High Performance Computing Center Program of Shanghai University	QC and BN are funded by The National Key Research and Development Program of China (grant no. 2016YFD0501101) and High Performance Computing Center Program of Shanghai University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrera JD, 1996, VIROLOGY, V219, P453, DOI 10.1006/viro.1996.0271; Berger Stephen A, 2005, Int J Health Geogr, V4, P10, DOI 10.1186/1476-072X-4-10; Boursalie O, 2015, PROCEDIA COMPUT SCI, V63, P384, DOI 10.1016/j.procs.2015.08.357; Burbidge R, 2001, COMPUT CHEM, V26, P5, DOI 10.1016/S0097-8485(01)00094-8; Cankurt S, 2012, COMP LINEAR REGRESSI; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; Mateus JC, 2011, MEM I OSWALDO CRUZ, V106, P107, DOI 10.1590/S0074-02762011000900014; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; Chen JinHong, 2011, Acta Academiae Medicinae Militaris Tertiae, V33, P797; Cheng CKY, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-339; Chu XL, 2004, JILIN J ANIMAL HU SB; Duffy N, 1999, GEOMETRIC APPROACH L; Dugas AF, 2013, ONLINE J PUBLIC HLTH, V8; FELDMAN S, 1972, BIOMETRICS, V28, P831, DOI 10.2307/2528766; Frank E, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P1269, DOI 10.1007/978-0-387-09823-4_66; Gao D, 2005, IEEE INT JOINT C NEU; Gluskin RT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002713; Goebel K, 2003, PROC SPIE, V5099, P39, DOI 10.1117/12.487284; Hu MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038978; Kang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055205; Kim SY, 2011, KOREAN J RADIOL, V12, P588, DOI 10.3348/kjr.2011.12.5.588; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Lee S, 1993, NEUR NETW 1993 IEEE; [李兆芹 Li Zhaoqin], 2006, [气象科学, Scientia Meteorologlca Sinica], V26, P462; Lin H, 2006, MODERN PREVENTIVE ME; Lisboa P, 2010, ADV ARTIFICIAL NEURA, V2010, P2; McCluskey BJ, 1999, J AM VET MED ASSOC, V215, P1259; Medhekar D.S., 2013, INT J ENHANCED RES S, V2; Niu B, 2017, MOL DIVERS, P1; Niu B, 2008, MOL DIVERS, V12, P41, DOI 10.1007/s11030-008-9073-0; Niu B, 2006, PROTEIN PEPTIDE LETT, V13, P489, DOI 10.2174/092986606776819619; OIE, 2020, WORLD AN HLTH INF DA; Ortiz JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018687; Peace UIO, 2008, US QUANT QUAL MOD FO; Pelat C, 2009, EMERG INFECT DIS, V15, P1327, DOI 10.3201/eid1508.090299; Reyzin L, 2006, P 23 INT C MACH LEAR; Schapire RE, 2003, LECT NOTES STAT, V171, P149, DOI 10.1007/978-0-387-21579-2_9; Seifter A, 2010, GEOSPATIAL HEALTH, V4, P135, DOI 10.4081/gh.2010.195; Tan XL L H, 2015, HUBEI J TRADITIONAL, V37, P15; USA CfFS Health P, 2008, VESICULAR STOMATITIS, V7, P205; USDA, 2016, VES STOM; Valdivia A, 2010, EUROSURVEILLANCE, V15, P2; Venkataraju KU, 2009, I S BIOMED IMAGING, P1039, DOI 10.1109/ISBI.2009.5193233; WALTON TE, 1987, AM J TROP MED HYG, V36, P166, DOI 10.4269/ajtmh.1987.36.166; Wang JJ ZY, 2016, COMPUTER APPL SOFTWA, V33, P41; Wen Han, 2016, Modern Preventive Medicine, V43, P2889; Zhang MM, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0481-y; Zhou XC, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2132132; Zhu J, 2006, STAT INTERFACE, V2, P349	49	12	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1								10.1371/journal.pone.0192141	http://dx.doi.org/10.1371/journal.pone.0192141			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385198	Green Published, gold, Green Submitted			2022-12-26	WOS:000423668400078
J	Wang, YY; Zhang, TB; Song, XX; Zhang, JP; Dang, ZH; Pei, XW; Long, Y				Wang, Yanyan; Zhang, Tianbao; Song, Xiaxia; Zhang, Jianping; Dang, Zhanhai; Pei, Xinwu; Long, Yan			Identification and functional analysis of two alternatively spliced transcripts of ABSCISIC ACID INSENSITIVE3 (ABI3) in linseed flax (Linum usitatissimum L.)	PLOS ONE			English	Article							GENE; EXPRESSION; ABA; VIVIPAROUS-1; GERMINATION; MATURATION; REGULATOR; PROMOTER; BINDING; PROTEIN	Alternative splicing is a popular phenomenon in different types of plants. It can produce alternative spliced transcripts that encode proteins with altered functions. Previous studies have shown that one transcription factor, ABSCISIC ACID INSENSITIVE3 (ABI3), which encodes an important component in abscisic acid (ABA) signaling, is subjected to alternative splicing in both mono- and dicotyledons. In the current study, we identified two homologs of ABI3 in the genome of linseed flax. We screened two alternatively spliced flax LuABI3 transcripts, LuABI3-2 and LuABI3-3, and one normal flax LuABI3 transcript, LuABI3-1. Sequence analysis revealed that one of the alternatively spliced transcripts, LuABI3-3, retained a 6 bp intron. RNA accumulation analysis showed that all three transcripts were expressed during seed development, while subcellular localization and transgene experiments showed that LuABI3-3 had no biological function. The two normal transcripts, LuABI3-1 and LuABI3-2, are the important functional isoforms in flax and play significant roles in the ABA regulatory pathway during seed development, germination, and maturation.	[Wang, Yanyan; Zhang, Tianbao; Song, Xiaxia; Pei, Xinwu; Long, Yan] Chinese Acad Agr Sci, Inst Biotechnol, MOA Key Lab Safety Assessment Mol AgriGMO, Beijing, Peoples R China; [Zhang, Jianping; Dang, Zhanhai] Gansu Acad Agr Sci, Crop Inst, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences	Pei, XW; Long, Y (corresponding author), Chinese Acad Agr Sci, Inst Biotechnol, MOA Key Lab Safety Assessment Mol AgriGMO, Beijing, Peoples R China.	peixinwu@caas.cn; longyan@caas.cn	pei, xinwu/O-7083-2019; wang, yan/GSE-6489-2022; Pei, Xinwu/AAI-1736-2019; Wang, Yin/HCI-9352-2022; wang, jing/GVT-8700-2022; wangwangwang, yuanyaun/HHN-6432-2022; Wang, Yanbo/HFZ-8018-2022; Wang, Yuan/HHC-1520-2022	Pei, Xinwu/0000-0001-7828-3037; 	National Natural Science Foundation of China [31371657]; Agricultural Science and Technology Innovation Program in China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Program in China	The work was supported by the National Natural Science Foundation of China No.31371657) and the Agricultural Science and Technology Innovation Program in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banik M, 2011, GENOME, V54, P471, DOI [10.1139/g11-013, 10.1139/G11-013]; Bies-Etheve N, 1999, PLANT MOL BIOL, V40, P1045, DOI 10.1023/A:1006252512202; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Ezcurra I, 2000, PLANT J, V24, P57, DOI 10.1046/j.1365-313x.2000.00857.x; Fan J, 2007, J EXP BOT, V58, P3811, DOI 10.1093/jxb/erm231; Fenart S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-592; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; FINKELSTEIN RR, 1985, PLANT PHYSIOL, V78, P630, DOI 10.1104/pp.78.3.630; Gagete AP, 2009, J EXP BOT, V60, P1703, DOI 10.1093/jxb/erp038; Gao DY, 2014, J INTEGR PLANT BIOL, V56, P480, DOI 10.1111/jipb.12135; Gao YF, 2013, PLANT MOL BIOL, V82, P131, DOI 10.1007/s11103-013-0044-1; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; HOECKER U, 1995, GENE DEV, V9, P2459, DOI 10.1101/gad.9.20.2459; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Kroj T, 2003, DEVELOPMENT, V130, P6065, DOI 10.1242/dev.00814; LeonKloosterziel KM, 1996, PLANT J, V10, P655, DOI 10.1046/j.1365-313X.1996.10040655.x; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Marin E, 1996, EMBO J, V15, P2331, DOI 10.1002/j.1460-2075.1996.tb00589.x; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; McKibbin RS, 2002, P NATL ACAD SCI USA, V99, P10203, DOI 10.1073/pnas.152318599; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Park J, 2011, PLANT CELL, V23, P1404, DOI 10.1105/tpc.110.080721; Reddy ASN, 2013, PLANT CELL, V25, P3657, DOI 10.1105/tpc.113.117523; Rock CD, 2000, NEW PHYTOL, V148, P357, DOI 10.1046/j.1469-8137.2000.00769.x; Shivaraj SM, 2017, SCI REP-UK, V7, DOI 10.1038/srep46137; Sugliani M, 2010, PLANT CELL, V22, P1936, DOI 10.1105/tpc.110.074674; Suzuki M, 1997, PLANT CELL, V9, P799, DOI 10.1105/tpc.9.5.799; To A, 2006, PLANT CELL, V18, P1642, DOI 10.1105/tpc.105.039925; Wang ZW, 2012, PLANT J, V72, P461, DOI 10.1111/j.1365-313X.2012.05093.x; Wu Xiao-Lu, 2010, Acta Botanica Yunnanica, V32, P141, DOI 10.3724/SP.J.1143.2010.09239; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705; Zou XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045751	33	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191910	10.1371/journal.pone.0191910	http://dx.doi.org/10.1371/journal.pone.0191910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381737	gold, Green Published, Green Submitted			2022-12-26	WOS:000423617800043
J	Guilbert, SM; Lambert, H; Rodrigue, MA; Fuchs, M; Landry, J; Lavoie, JN				Guilbert, Solenn M.; Lambert, Herman; Rodrigue, Marc-Antoine; Fuchs, Margit; Landry, Jacques; Lavoie, Josee N.			HSPB8 and BAG3 cooperate to promote spatial sequestration of ubiquitinated proteins and coordinate the cellular adaptive response to proteasome insufficiency	FASEB JOURNAL			English	Article						molecular chaperones; proteotoxic stress; p62/SQSTM1; aggresome; small HSP	HEAT-SHOCK PROTEINS; TRANSCRIPTION FACTOR NRF2; MISFOLDED PROTEINS; MYOFIBRILLAR MYOPATHY; SELECTIVE AUTOPHAGY; AGGRESOME FORMATION; KEAP1-NRF2 PATHWAY; CHAPERONE ACTIVITY; OXIDATIVE STRESS; QUALITY-CONTROL	BCL2-associated athanogene (BAG)-3 is viewed as a platform that would physically and functionally link distinct classes of molecular chaperones of the heat shock protein (HSP) family for the stabilization and clearance of damaged proteins. In this study, we show that HSPB8, a member of the small heat shock protein subfamily, cooperates with BAG3 to coordinate the sequestration of harmful proteins and the cellular adaptive response upon proteasome inhibition. Silencing of HSPB8, like depletion of BAG3, inhibited targeting of ubiquitinated proteins to the juxtanuclear aggresome, a mammalian system of spatial quality control. However, aggresome targeting was restored in BAG3-depleted cells by a mutant BAG3 defective in HSPB8 binding, uncoupling HSPB8 function from its binding to BAG3. Depletion of HSPB8 impaired formation of ubiquitinated microaggregates in an early phase and interfered with accurate modifications of the stress sensor p62/sequestosome (SQSTM)-1. This impairment correlated with decreased coupling of BAG3 to p62/SQSTM1 in response to stress, hindering Kelch-like ECH-associated protein (KEAP)-1 sequestration and stabilization of nuclear factor E2-related factor (Nrf)-2, an important arm of the antioxidant defense. Notably, the myopathy-associated mutation of BAG3 (P209L), which lies within the HSPB8-binding motif, deregulated the association between BAG3 and p62/SQSTM1 and the KEAP1-Nrf2 signaling axis. Together, our findings support a so-far-unrecognized role for the HSPB8-BAG3 connection in mounting of an efficient stress response, which may be involved in BAG3-related human diseases. -Guilbert, S. M., Lambert, H., Rodrigue, M.-A., Fuchs, M., Landry, J., Lavoie, J. N. HSPB8 and BAG3 cooperate to promote spatial sequestration of ubiquitinated proteins and coordinate the cellular adaptive response to proteasome insufficiency.	[Guilbert, Solenn M.; Lambert, Herman; Rodrigue, Marc-Antoine; Fuchs, Margit; Landry, Jacques; Lavoie, Josee N.] Univ Laval, Ctr Rech Canc, Quebec City, PQ, Canada; [Guilbert, Solenn M.; Lambert, Herman; Rodrigue, Marc-Antoine; Fuchs, Margit; Landry, Jacques; Lavoie, Josee N.] Univ Laval, Ctr Rech, CHU Quebec, Oncol, Quebec City, PQ, Canada; [Landry, Jacques; Lavoie, Josee N.] Univ Laval, Dept Biol Mol Biochim Med & Pathol, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Lavoie, JN (corresponding author), Univ Laval, St Patrick Local 3724-1,9 Rue McMahon, Quebec City, PQ G1R 3S3, Canada.	josee.lavoie@crchudequebec.ulaval.ca		Lavoie, Josee N/0000-0001-6912-1132	Canadian Institutes of Health Research Grant [7088]; Bellini Foundation; Fondazione Roby [PT67892]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Bellini Foundation; Fondazione Roby	The authors thank Dr. Arshad Desai (Ludwig Institute for Cancer Research, University of California, San Diego, San Diego, CA, USA) for contributing Flp-In-TREx HeLa cells; Dr. Sabine Elowe (Centre Hospitalier de l'Universite Laval,) for HeLa-RFP-H2B cells; Carl St-Pierre and Anne Loranger (Centre de Recherche sur le Cancer de l'Universite Laval) for assistance in microscopic analyses; and Dr. Ronald Hancock for editing the manuscript. This work was supported by Canadian Institutes of Health Research Grant 7088 to J.N.L. and J.L., and by a grant from the Bellini Foundation and Fondazione Roby (subaward to J.N.L.; PT67892). The authors declare no conflicts of interest.	Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Behl C, 2016, TRENDS PHARMACOL SCI, V37, P672, DOI 10.1016/j.tips.2016.04.007; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Ciuffa R, 2015, CELL REP, V11, P748, DOI 10.1016/j.celrep.2015.03.062; Crippa V, 2016, HUM MOL GENET, V25, P3908, DOI 10.1093/hmg/ddw232; Crippa V, 2016, SCI REP-UK, V6, DOI 10.1038/srep22827; Crippa V, 2010, HUM MOL GENET, V19, P3440, DOI 10.1093/hmg/ddq257; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Fuchs M., 2016, JOVE-J VIS EXP; Fuchs M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005582; Fuchs M, 2010, BIOCHEM J, V425, P245, DOI 10.1042/BJ20090907; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Fuse Y, 2017, MOLECULES, V22, DOI 10.3390/molecules22030436; Gallina I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7533; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Ganassi M, 2016, MOL CELL, V63, P796, DOI 10.1016/j.molcel.2016.07.021; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Guilbert S.M., 2015, BIG BOOK SMALL HEAT; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hill SM, 2017, EMBO REP, V18, P377, DOI 10.15252/embr.201643458; Horie M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144835; Houslay MD, 2010, AUTOPHAGY, V6, P1198, DOI 10.4161/auto.6.8.13479; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; JONES HW, 1971, OBSTET GYNECOL, V38, P945; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kathage B, 2017, BBA-MOL CELL RES, V1864, P62, DOI 10.1016/j.bbamcr.2016.10.007; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim HG, 2016, NUCL ENG TECHNOL, V48, P1, DOI 10.1016/j.net.2015.11.011; Kim MV, 2004, BIOCHEM BIOPH RES CO, V315, P796, DOI 10.1016/j.bbrc.2004.01.130; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Konersman CG, 2015, NEUROMUSCULAR DISORD, V25, P418, DOI 10.1016/j.nmd.2015.01.009; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lee HC, 2012, CLIN GENET, V81, P394, DOI 10.1111/j.1399-0004.2011.01659.x; Lee Y, 2017, CELL REP, V20, P1994, DOI 10.1016/j.celrep.2017.08.019; Lelouard H, 2004, J CELL BIOL, V164, P667, DOI 10.1083/jcb.200312073; Liu XD, 2012, J BIOL CHEM, V287, P19687, DOI 10.1074/jbc.M112.350934; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Merabova N, 2015, J CELL PHYSIOL, V230, P831, DOI 10.1002/jcp.24811; Miller SBM, 2015, EMBO J, V34, P778, DOI 10.15252/embj.201489524; Minoia M, 2014, AUTOPHAGY, V10, P1603, DOI 10.4161/auto.29409; Moscat J, 2012, TRENDS BIOCHEM SCI, V37, P230, DOI 10.1016/j.tibs.2012.02.008; Mymrikov EV, 2017, J BIOL CHEM, V292, P672, DOI 10.1074/jbc.M116.760413; Mymrikov EV, 2012, CELL STRESS CHAPERON, V17, P157, DOI 10.1007/s12192-011-0296-0; Naidu SD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11262-5; Odgerel Z, 2010, NEUROMUSCULAR DISORD, V20, P438, DOI 10.1016/j.nmd.2010.05.004; Rantanen K, 2013, J CELL SCI, V126, P1144, DOI 10.1242/jcs.115667; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ruparelia AA, 2014, ACTA NEUROPATHOL, V128, P821, DOI 10.1007/s00401-014-1344-5; Rusmini P, 2013, NEUROBIOL AGING, V34, P2585, DOI 10.1016/j.neurobiolaging.2013.05.026; Sala AJ, 2017, J CELL BIOL, V216, P1231, DOI 10.1083/jcb.201612111; Samarasinghe B, 2014, BIOCHEM PHARMACOL, V87, P445, DOI 10.1016/j.bcp.2013.11.014; Scior A, 2016, ESSAYS BIOCHEM, V60, P153, DOI 10.1042/EBC20160002; Selcen D, 2009, ANN NEUROL, V65, P83, DOI 10.1002/ana.21553; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Su HB, 2011, TRENDS CARDIOVAS MED, V21, P224, DOI 10.1016/j.tcm.2012.05.015; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Taniguchi K, 2016, FEBS LETT, V590, P2375, DOI 10.1002/1873-3468.12301; Ulbricht A, 2013, AUTOPHAGY, V9, P920, DOI 10.4161/auto.24213; Ulbricht A, 2013, CURR BIOL, V23, P430, DOI 10.1016/j.cub.2013.01.064; Ungelenk S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13673; Varlet AA, 2017, CELL STRESS CHAPERON, V22, P553, DOI 10.1007/s12192-017-0780-2; Wallace EWJ, 2015, CELL, V162, P1286, DOI 10.1016/j.cell.2015.08.041; Watanabe Y, 2017, AUTOPHAGY, V13, P133, DOI 10.1080/15548627.2016.1248018; Wigley WC, 1999, J CELL BIOL, V145, P481; Wolff S, 2014, CELL, V157, P52, DOI 10.1016/j.cell.2014.03.007; Xu Z, 2013, J CELL SCI, V126, P4173, DOI 10.1242/jcs.126102; Yang XD, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00402; Zhang XQ, 2011, MOL BIOL CELL, V22, P3277, DOI 10.1091/mbc.E11-05-0388	81	36	36	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3518	3535		10.1096/fj.201700558RR	http://dx.doi.org/10.1096/fj.201700558RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29405094				2022-12-26	WOS:000435104500004
J	Kim, SM; Neuendorff, N; Alaniz, RC; Sun, YX; Chapkin, RS; Earnest, DJ				Kim, Sam-Moon; Neuendorff, Nichole; Alaniz, Robert C.; Sun, Yuxiang; Chapkin, Robert S.; Earnest, David J.			Shift work cycle-induced alterations of circadian rhythms potentiate the effects of high-fat diet on inflammation and metabolism	FASEB JOURNAL			English	Article						macrophage; clock gene; cytokines; metabolic disorders; insulin resistance	RECEPTOR-GAMMA ACTIVATION; CHRONIC JET-LAG; REV-ERB-ALPHA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; INDUCIBLE 6-PHOSPHOFRUCTO-2-KINASE; OBESITY; CLOCK; MICE; MACROPHAGES	Based on genetic models with mutation or deletion of core clock genes, circadian disruption has been implicated in the pathophysiology of metabolic disorders. Thus, we examined whether circadian desynchronization in response to shift work-type schedules is sufficient to compromise metabolic homeostasis and whether inflammatory mediators provide a key link in the mechanism by which alterations of circadian timekeeping contribute to diet-induced metabolic dysregulation. In high-fat diet (HFD)-fed mice, exposure to chronic shifts of the light-dark cycle (12 h advance every 5 d): 1) disrupts photoentrainment of circadian behavior and modulates the period of spleen and macrophage clock gene rhythms; 2) potentiates HFD-induced adipose tissue infiltration and activation of proinflammatory M1 macrophages; 3) amplifies macrophage proinflammatory cytokine expression in adipose tissue and bone marrow-derived macrophages; and 4) exacerbates diet-induced increases in body weight, insulin resistance, and glucose intolerance in the absence of changes in total daily food intake. Thus, complete disruption of circadian rhythmicity or clock gene function as transcription factors is not requisite to the link between circadian and metabolic phenotypes. These findings suggest that macrophage proinflammatory activation and inflammatory signaling are key processes in the physiologic cascade by which dysregulation of circadian rhythmicity exacerbates diet-induced systemic insulin resistance and glucose intolerance.				r-chapkin@tamu.edu; dearnest@medicine.tamhsc.edu		Chapkin, Robert/0000-0002-6515-3898; Earnest, David/0000-0003-4433-6481	Center for Translational Environmental Health Research [P30ES02351]; U.S. National Institutes of Health, National Cancer Institute Outstanding Investigator Award [R35CA197707]; NATIONAL CANCER INSTITUTE [R35CA197707] Funding Source: NIH RePORTER	Center for Translational Environmental Health Research; U.S. National Institutes of Health, National Cancer Institute Outstanding Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Yang-Yi Fan (Texas A&M University) for her assistance with the FACS analysis. This study was supported by the Center for Translational Environmental Health Research (P30ES02351) and U.S. National Institutes of Health, National Cancer Institute Outstanding Investigator Award R35CA197707 (to R.S.C.). The authors declare no conflicts of interest.	Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004882; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Earnest DJ, 2016, ENDOCRINOLOGY, V157, P2836, DOI 10.1210/en.2016-1130; Farnell YF, 2011, EUR J NEUROSCI, V33, P1533, DOI 10.1111/j.1460-9568.2011.07629.x; FATOUROS M, 1995, BRIT J SURG, V82, P1675, DOI 10.1002/bjs.1800821230; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Fontaine C, 2008, MOL ENDOCRINOL, V22, P1797, DOI 10.1210/me.2007-0439; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Guo X, 2010, J BIOL CHEM, V285, P23711, DOI 10.1074/jbc.M110.123174; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Huo YQ, 2010, J BIOL CHEM, V285, P3713, DOI 10.1074/jbc.M109.058446; Iwamoto A, 2014, CHRONOBIOL INT, V31, P189, DOI 10.3109/07420528.2013.837478; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lange T, 2010, ANN NY ACAD SCI, V1193, P48, DOI 10.1111/j.1749-6632.2009.05300.x; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oike H, 2015, BIOCHEM BIOPH RES CO, V465, P556, DOI 10.1016/j.bbrc.2015.08.059; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Reddy AB, 2002, J NEUROSCI, V22, P7326; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Spengler ML, 2012, P NATL ACAD SCI USA, V109, pE2457, DOI 10.1073/pnas.1206274109; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Xu H, 2014, J BIOL CHEM, V289, P16374, DOI 10.1074/jbc.M113.539601; Yan L, 2011, NEUROSCIENCE, V183, P99, DOI 10.1016/j.neuroscience.2011.03.041; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	39	39	41	5	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3085	3095		10.1096/fj.201700784R	http://dx.doi.org/10.1096/fj.201700784R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29405095	Green Published			2022-12-26	WOS:000432546000016
J	Yang, H; Yue, HW; He, WT; Hong, JY; Jiang, LL; Hu, HY				Yang, Hui; Yue, Hong-Wei; He, Wen-Tian; Hong, Jun-Ye; Jiang, Lei-Lei; Hu, Hong-Yu			PolyQ-expanded huntingtin and ataxin-3 sequester ubiquitin adaptors hHR23B and UBQLN2 into aggregates via conjugated ubiquitin	FASEB JOURNAL			English	Article						neurodegeneration; inclusions; interaction; pathologic mechanism	PROTEIN-QUALITY CONTROL; GROUP-C PROTEIN; POLYGLUTAMINE DISEASE; ALPHA-SYNUCLEIN; NEURODEGENERATIVE DISEASES; PARKINSONS-DISEASE; NUCLEAR INCLUSIONS; NUCLEOCYTOPLASMIC TRANSPORT; DEUBIQUITINATING FUNCTION; CYTOPLASMIC INCLUSIONS	The components of ubiquitin (Ub)-proteasome system, such as Ub, Ub adaptors, or proteasome subunits, are commonly accumulated with the aggregated proteins in inclusions, but how protein aggregates sequester Ub-related proteins remains elusive. Using N-terminal huntingtin (Htt-N552) and ataxin (Atx)-3 as model proteins, we investigated the molecular mechanism underlying sequestration of Ub adaptors by polyQ-expanded proteins. We found that polyQ-expanded Htt-N552 and Atx-3 sequester endogenous Ub adaptors, human RAD23 homolog B (hHR23B) and ubiquilin (UBQLN)-2, into inclusions. This sequestration effect is dependent on the UBA domains of Ub adaptors and the conjugated Ub of the aggregated proteins. Moreover, polyQ-expanded Htt-N552 and Atx-3 reduce the protein level of xeroderma pigmentosum group C (XPC) by sequestration of hHR23B, suggesting that this process may cut down the available quantity of hHR23B and thus affect its normal function in stabilizing XPC. Our findings demonstrate that polyQ-expanded proteins sequester Ub adaptors or other Ub-related proteins into aggregates or inclusions through ubiquitination of the pathogenic proteins. This study may also provide a common mechanism for the formation of Ub-positive inclusions in cells.-Yang, H., Yue, H.-W., He, W.-T., Hong, J.-Y., Jiang, L.-L., Hu, H.-Y. PolyQ-expanded huntingtin and ataxin-3 sequester ubiquitin adaptors hHR23B and UBQLN2 into aggregates via conjugated ubiquitin.	[Yang, Hui; Yue, Hong-Wei; He, Wen-Tian; Hong, Jun-Ye; Jiang, Lei-Lei; Hu, Hong-Yu] Univ CAS, State Key Lab Mol Biol, CAS, Ctr Excellence Mol Cell Sci,SIBCB, Shanghai, Peoples R China; [Yang, Hui] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, State Key Lab Genet Engn, Shanghai, Peoples R China	Chinese Academy of Sciences; Fudan University	Hu, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	hyhu@sibcb.ac.cn	Hu, Hong-Yu/AAQ-2633-2020		National Basic Research Program of China [2012CB911003]; National Natural Science Foundation of China [31470758, 31670782]; China Postdoctoral Science Foundation [Y649S21022]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors thank Drs. J. Y. Chen and R. G. Hu (State Key Laboratory of Molecular Biology, Chinese Academy of Sciences) for technical help and valuable discussion. This work was supported by National Basic Research Program of China Grant 2012CB911003 (to H.-Y.H), National Natural Science Foundation of China Grants 31470758 (to H.-Y.H) and 31670782 (to H.-Y.H), and China Postdoctoral Science Foundation Grant Y649S21022 (to H.Y). The authors declare no conflicts of interest.	Adegbuyiro A, 2017, BIOCHEMISTRY-US, V56, P1199, DOI 10.1021/acs.biochem.6b00936; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bergink S, 2006, NEUROBIOL DIS, V23, P708, DOI 10.1016/j.nbd.2006.06.005; Blount JR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5638; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006; Che MX, 2015, FEBS LETT, V589, P1920, DOI 10.1016/j.febslet.2015.06.009; Choi YJ, 2012, MOL CELL NEUROSCI, V49, P127, DOI 10.1016/j.mcn.2011.11.003; Dantuma NP, 2009, DNA REPAIR, V8, P449, DOI 10.1016/j.dnarep.2009.01.005; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Dugger BN, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028035; Evers MM, 2014, MOL NEUROBIOL, V49, P1513, DOI 10.1007/s12035-013-8596-2; Fujita K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2828; Haacke A, 2006, HUM MOL GENET, V15, P555, DOI 10.1093/hmg/ddi472; Hjerpe R, 2016, CELL, V166, P935, DOI 10.1016/j.cell.2016.07.001; Hsu TC, 2014, HUM MOL GENET, V23, P6878, DOI 10.1093/hmg/ddu410; Janer A, 2010, HUM MOL GENET, V19, P181, DOI 10.1093/hmg/ddp478; Jiang YJ, 2011, J BIOL CHEM, V286, P25236, DOI 10.1074/jbc.M110.216333; Kumar V, 2016, EUR J MED CHEM, V124, P1105, DOI 10.1016/j.ejmech.2016.07.054; Kuusisto E, 2003, J NEUROPATH EXP NEUR, V62, P1241, DOI 10.1093/jnen/62.12.1241; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; LENNOX G, 1988, NEUROSCI LETT, V94, P211, DOI 10.1016/0304-3940(88)90297-2; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; LOWE J, 1988, J PATHOL, V155, P9, DOI 10.1002/path.1711550105; Mao Y, 2005, P NATL ACAD SCI USA, V102, P12700, DOI 10.1073/pnas.0506344102; Matos CA, 2017, CURR PHARM DESIGN, V23, P753, DOI [10.2174/1381612822666161227, 10.2174/1381612822666161227121912]; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Mori F, 2012, ACTA NEUROPATHOL, V124, P149, DOI 10.1007/s00401-012-0999-z; Nath SR, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00078; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Ochaba J, 2014, P NATL ACAD SCI USA, V111, P16889, DOI 10.1073/pnas.1420103111; Oh S, 2005, MECH AGEING DEV, V126, P1292, DOI 10.1016/j.mad.2005.07.006; Okuda Y, 2004, DNA REPAIR, V3, P1285, DOI 10.1016/j.dnarep.2004.06.010; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Pratt WB, 2015, ANNU REV PHARMACOL, V55, P353, DOI 10.1146/annurev-pharmtox-010814-124332; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rui YN, 2015, NAT CELL BIOL, V17, P262, DOI 10.1038/ncb3101; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Suhr ST, 2001, J CELL BIOL, V153, P283, DOI 10.1083/jcb.153.2.283; Tai HC, 2012, AM J PATHOL, V181, P1426, DOI 10.1016/j.ajpath.2012.06.033; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Teyssou E, 2017, NEUROBIOL AGING, V58, DOI 10.1016/j.neurobiolaging.2017.06.018; Todi SV, 2010, J BIOL CHEM, V285, P39303, DOI 10.1074/jbc.M110.181610; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Tsou WL, 2013, J BIOL CHEM, V288, P34460, DOI 10.1074/jbc.M113.513903; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; YANG H, 2014, SCI REP UK, V4; Yang H, 2016, FEBS J, V283, P3705, DOI 10.1111/febs.13722; Yang H, 2015, J BIOL CHEM, V290, P21996, DOI 10.1074/jbc.M114.631663; Yokoi M, 2017, GENE, V597, P1, DOI 10.1016/j.gene.2016.10.027; Yu A, 2014, P NATL ACAD SCI USA, V111, pE1481, DOI 10.1073/pnas.1321811111; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zeng L, 2015, NEUROBIOL DIS, V82, P281, DOI 10.1016/j.nbd.2015.06.017; Zhang YJ, 2016, NAT NEUROSCI, V19, P668, DOI 10.1038/nn.4272; Zheng QY, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00303; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	66	19	19	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					2923	2933		10.1096/fj.201700801RR	http://dx.doi.org/10.1096/fj.201700801RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401586				2022-12-26	WOS:000432546000004
J	Wetzels, SU; Eger, M; Burmester, M; Kreienbrock, L; Abdulmawjood, A; Pinior, B; Wagner, M; Breves, G; Mann, E				Wetzels, Stefanie U.; Eger, Melanie; Burmester, Marion; Kreienbrock, Lothar; Abdulmawjood, Amir; Pinior, Beate; Wagner, Martin; Breves, Gerhard; Mann, Evelyne			The application of rumen simulation technique (RUSITEC) for studying dynamics of the bacterial community and metabolome in rumen fluid and the effects of a challenge with Clostridium perfringens	PLOS ONE			English	Article							ACIDOSIS SARA ADAPTATION; MICROBIAL-POPULATIONS; VARIABLE COMPOSITION; METHANE PRODUCTION; FERMENTATION; DIVERSITY; DIETS; SPECIFICITY; MICROFLORA; SUBSTRATE	The rumen simulation technique (RUSITEC) is a well-established semicontinuous in vitro model for investigating ruminal fermentation; however, information on the stability of the ruminal bacterial microbiota and metabolome in the RUSITEC system is rarely available. The availability of high resolution methods, such as high-throughput sequencing and metabolomics improve our knowledge about the rumen microbial ecosystem and its fermentation processes. Thus, we used Illumina MiSeq 16S rRNA amplicon sequencing and a combination of direct injection mass spectrometry with a reverse-phase LC-MS/MS to evaluate the dynamics of the bacterial community and the concentration of several metabolites in a RUSITEC experiment as a function of time and in response to a challenge with a pathogenic Clostridium perfringens (C. perfringens) strain. After four days of equilibration, samples were collected on days 5, 6, 7, 10, 12 and 15 of the steady-state and experimental period. From a total of six fermenters, three non-infected fermenters were used for investigating time-dependent alterations; three fermenters were incubated with C. perfringens and compared with the non-infected vessels at days 10, 12 and 15. Along the time-line, there was no statistically significant change of the overall bacterial community, however, some phylotypes were enriched at certain time points. A decrease in Fibrobacter and Elusimicrobia over time was followed by an increase in Firmicutes and Actinobacteria. In contrast, classical fermentation measurements such as pH, redox potential, NH3-N, short chain fatty acids and the concentrations of metabolites determined by metabolomics (biogenic amines, hexoses and amino acids) remained stable throughout the experiment. In response to C. perfringens addition the concentrations of several amino acids increased. Although the overall bacterial community was not altered here either, some minor changes such as an enrichment of Synergistetes and Bacteroidetes were detectable over time. In conclusion, both, the bacterial community composition and the metabolome in the RUSITEC system were relatively stable during the experiment.	[Wetzels, Stefanie U.; Wagner, Martin; Mann, Evelyne] Univ Vet Med Vienna, Inst Milk Hyg Milk Technol & Food Sci, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Eger, Melanie; Burmester, Marion; Breves, Gerhard] Univ Vet Med Hannover, Inst Physiol, Hannover, Germany; [Kreienbrock, Lothar] Univ Vet Med Hannover, Inst Biometry Epidemiol & Informat Proc, Hannover, Germany; [Abdulmawjood, Amir] Univ Vet Med Hannover, Inst Food Qual & Food Safety, Res Ctr Emerging Infect & Zoonoses RIZ, Hannover, Germany; [Pinior, Beate] Univ Vet Med Vienna, Inst Vet Publ Hlth, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Vienna	Mann, E (corresponding author), Univ Vet Med Vienna, Inst Milk Hyg Milk Technol & Food Sci, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria.; Breves, G (corresponding author), Univ Vet Med Hannover, Inst Physiol, Hannover, Germany.	Gerhard.Breves@tiho-hannover.de; Evelyne.Mann@vetmeduni.ac.at	Selberherr, Evelyne/AAM-9702-2021; Breves, Gerhard/ABI-1315-2020; Abdulmawjood, Amir/AAL-5523-2020; Pinior, Beate/O-8547-2017; Selberherr, Evelyne/I-3795-2014	Selberherr, Evelyne/0000-0002-2253-5247; Pinior, Beate/0000-0001-8554-5963; 	Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing	This publication was supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Stephan Schmitz-Esser of the Department of Animal Science, University of Iowa for useful comments on the manuscript as well as Monika Dzieciol and Viktoria Neubauer of the Institute for Milk Hygiene, Milk Technology and Food Science of the University of Veterinary Medicine, Vienna for data submission and assistance in the laboratory. This publication was supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing.	[Anonymous], 2000, ENGLISH; [Anonymous], R LANG ENV STAT COMP; Bekele AZ, 2010, FEMS MICROBIOL LETT, V305, P49, DOI 10.1111/j.1574-6968.2010.01911.x; Belanche A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00905; Belanche A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00299; Belanche A, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv160; Boguhn J, 2008, ARCH ANIM NUTR, V62, P454, DOI 10.1080/17450390802453443; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Comtet-Marre S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00067; CZERKAWSKI JW, 1977, BRIT J NUTR, V38, P371, DOI 10.1079/BJN19770102; Duarte AC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00704; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ertl P, 2015, J DAIRY SCI, V98, P4762, DOI 10.3168/jds.2014-9063; Fasina YO, 2016, POULTRY SCI, V95, P247, DOI 10.3382/ps/pev329; Fecteau ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160353; Fohler S, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0812-6; Giraldo LA, 2007, BRIT J NUTR, V98, P753, DOI 10.1017/S0007114507744446; Goossens E, 2017, VET RES, V48, DOI 10.1186/s13567-017-0413-x; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Hook SE, 2011, FEMS MICROBIOL ECOL, V78, P275, DOI 10.1111/j.1574-6941.2011.01154.x; Hristov AN, 2001, J ANIM SCI, V79, P515; Indikova I, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01266; Kelly WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011942; Kim M, 2011, FEMS MICROBIOL ECOL, V76, P49, DOI 10.1111/j.1574-6941.2010.01029.x; Koch M, 2006, BRIT J NUTR, V96, P820, DOI 10.1017/BJN20061889; Kudva IT, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-48; Lebrun M, 2010, VET REC, V167, P13, DOI [10.1136/vr.b4859, 10.1136/vr.167.1.12]; Lengowski MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150115; Li M, 2009, J APPL MICROBIOL, V107, P1924, DOI 10.1111/j.1365-2672.2009.04376.x; Mao SY, 2013, ANAEROBE, V24, P12, DOI 10.1016/j.anaerobe.2013.08.003; Mao SY, 2016, ENVIRON MICROBIOL, V18, P525, DOI 10.1111/1462-2920.12724; Mao SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16116; Martinez ME, 2010, J DAIRY SCI, V93, P3699, DOI 10.3168/jds.2009-2934; Martinez ME, 2010, J DAIRY SCI, V93, P3684, DOI 10.3168/jds.2009-2933; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nagpal R, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0561-y; Pitta DW, 2016, ANAEROBE, V38, P50, DOI 10.1016/j.anaerobe.2015.12.003; Plaizier JC, 2017, MICROB ECOL, V74, P485, DOI 10.1007/s00248-017-0940-z; PREVOT S, 1994, ZOOL SCI, V11, P871; Riede S, 2013, ARCH ANIM NUTR, V67, P368, DOI 10.1080/1745039X.2013.830518; Saleem F, 2012, J DAIRY SCI, V95, P6606, DOI 10.3168/jds.2012-5403; Saleem F, 2013, METABOLOMICS, V9, P360, DOI 10.1007/s11306-012-0458-9; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Strobel E, 2008, ENVIRON MICROBIOL, V10, P483, DOI 10.1111/j.1462-2920.2007.01469.x; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; Tamaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025263; Weimer PJ, 2010, J DAIRY SCI, V93, P5902, DOI 10.3168/jds.2010-3500; Wetzels SU, 2017, J DAIRY SCI, V100, P1829, DOI 10.3168/jds.2016-11620; Wong MT, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00961; Zakrzewski M, 2012, J BIOTECHNOL, V158, P248, DOI 10.1016/j.jbiotec.2012.01.020; Zened A, 2013, FEMS MICROBIOL ECOL, V83, P504, DOI 10.1111/1574-6941.12011; Zhao S, 2014, LETT APPL MICROBIOL, V59, P79, DOI 10.1111/lam.12247; Ziemer CJ, 2000, ENVIRON MICROBIOL, V2, P632, DOI 10.1046/j.1462-2920.2000.00146.x	56	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192256	10.1371/journal.pone.0192256	http://dx.doi.org/10.1371/journal.pone.0192256			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415046	Green Submitted, Green Published, gold			2022-12-26	WOS:000424325300064
J	Pritchard, J; Upjohn, M; Hirson, T				Pritchard, Joy; Upjohn, Melissa; Hirson, Tamsin			Improving working equine welfare in 'hardwin' situations, where gains are difficult, expensive or marginal	PLOS ONE			English	Article							POSITIVE WELFARE; BEHAVIOR; DELPHI; HORSES; HEALTH; METHODOLOGY; COUNTRIES	Purpose Brooke is a non-government organisation with working equine welfare programmes across Africa, Asia and Latin America. In 2014, staff from ten country programmes were asked to identify 'no-win' situations (subsequently reframed as ` hard-wins') D where improving equine welfare is proving difficult, expensive and/or marginal D in order to inform strategic decisions on how to approach, manage and mitigate for such situations. Methods The Delphi-type consultation process had three phases. Round 1 posed five questions in the form of a workshop, survey and semi-structured interviews. Round 2 re-presented key themes and sense-checked initial conclusions. Round 3 reviewed the nature and prevalence of hard-win situations at an international meeting of all participants. Results Reasons given for hard-win situations included: no economic or social benefit from caring for working animals; poor resource availability; lack of empathy for working equids or their owners among wider stakeholders; deep-seated social issues, such as addiction or illegal working; areas with a high animal turnover or migratory human population; lack of community cooperation or cohesion; unsafe areas where welfare interventions cannot be adequately supported. Participants estimated the prevalence of hard-win situations as 40-70% of their work. They suggested some current ways of working that may be contributing to the problem, and opportunities to tackle hard-wins more effectively. Conclusion and animal welfare implications Respondents agreed that if equine welfare improvements are to span generations of animals, interventions cannot rely on relatively simple, technical knowledge-transfer strategies and quick-wins alone. Programmes need to be more flexible and iterative and less risk-averse in their approaches to embedding good equine welfare practices in all relevant actors. Consultation recommendations informed development of Brooke's new global strategy, a revised organisational structure and redefinition of roles and responsibilities to streamline ways to approach hard-wins in the complex environments and socio-economic contexts in which working equids are found.	[Pritchard, Joy] Animals Int Dev, Banwell, N Somerset, England; [Upjohn, Melissa] Dogs Trust, London, England; [Hirson, Tamsin] Boston Consulting Grp Inc, London, England	Boston Consulting Group (BCG)	Upjohn, M (corresponding author), Dogs Trust, London, England.	melissa.upjohn@dogstrust.org.uk						Broster CE, 2009, EQUINE VET J, V41, P474, DOI 10.2746/042516409X373907; Burford JH, 2017, EQUINE VET EDUC, V29, pS19; Collins J, 2009, VET J, V181, P63, DOI 10.1016/j.tvjl.2009.03.012; Davis R, 2015, HEALTH PSYCHOL REV, V9, P323, DOI 10.1080/17437199.2014.941722; Dijk L. van, 2010, The 6th International Colloquium on Working Equids: learning from others. Proceedings of an International Colloquium, New Delhi, India, 29 November - 2 December 2010, P51; Easterly W., 2006, WHITE MANS BURDEN; Edgar Joanne L, 2013, Animals (Basel), V3, P584, DOI 10.3390/ani3030584; Ellerman D., 2004, Review of Social Economy, V62, P149, DOI 10.1080/00346760410001684424; EWB Engineers without Borders Canada, 2010, ADM FAIL FAIL FORW P; FAOSTAT database [internet] Food and Agriculture Organisation of the United Nations, 2014, STAT DAT PROD LIV AN; Frewer LJ, 2011, TECHNOL FORECAST SOC, V78, P1514, DOI 10.1016/j.techfore.2011.05.005; Grimshaw JM, 2001, MED CARE, V39, pII2; Ireland JL, 2012, EQUINE VET J, V44, P94, DOI 10.1111/j.2042-3306.2011.00394.x; Jones H., 330 ODI; Ko M, 2014, BMJ QUAL SAF, V23, P177, DOI 10.1136/bmjqs-2013-002591; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; McInerney J., ANIMAL WELFARE EC PO; Michie S., 2011, IMPLEMENT SCI, V6; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Pritchard J., 2014, Proceedings of the 7th International Colloquium on Working Equids, Royal Holloway, University of London, UK. 1st-3rd July, 2014, P2; Pritchard JC, 2005, PREV VET MED, V69, P265, DOI 10.1016/j.prevetmed.2005.02.002; Ramalingam B., 2014, BEST PRACTICE BEST F; Ramalingam B, 285 ODI; Ruger JP, 2010, AM J PUBLIC HEALTH, V100, P41, DOI 10.2105/AJPH.2008.143651; Schon D. A., 1983, REFLECTIVE PRACTITIO, DOI [10.2307/J.CTVPBNPJG.24, DOI 10.4324/9781315237473]; Schu┬n D., 1971, STABLE STATE; Taylor D, 2006 REV UND NAT I H; Valette D., 2014, KEY FINDINGS RES ETH; Van Dijk L, 2010, SHARING LOAD GUIDE I, P139; Weary DM, 2015, ANIMALS, P1; Wentholt MTA, 2012, PREV VET MED, V103, P81, DOI 10.1016/j.prevetmed.2011.09.021; Wessells MG, 2009, AM PSYCHOL, V64, P842, DOI 10.1037/0003-066X.64.8.842; Wong S, 2009, RURAL REMOTE HEALTH, V9; Yeates JW, 2008, VET J, V175, P293, DOI 10.1016/j.tvjl.2007.05.009; Yesuf M, 2009, AM J AGR ECON, V91, P1022, DOI 10.1111/j.1467-8276.2009.01307.x	35	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191950	10.1371/journal.pone.0191950	http://dx.doi.org/10.1371/journal.pone.0191950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	29408887	gold, Green Submitted, Green Published			2022-12-26	WOS:000424302800034
J	Koparde, P; Mehta, P; Reddy, S; Ramakrishnan, U; Mukherjee, S; Robin, VV				Koparde, Pankaj; Mehta, Prachi; Reddy, Sushma; Ramakrishnan, Uma; Mukherjee, Shomita; Robin, V. V.			The critically endangered forest owlet Heteroglaux blewitti is nested within the currently recognized Athene clade: A century-old debate addressed	PLOS ONE			English	Article							BRAMA AVES STRIGIFORMES; PANDE ET-AL.; POSSIBLE HYBRID; FOSSIL OWLS; NORTHERN MAHARASHTRA; UPPER PLIOCENE; BIRDS; DIVERSIFICATION; PHYLOGENY; DISCOVERY	Range-restricted species generally have specific niche requirements and may often have unique evolutionary histories. Unfortunately, many of these species severely lack basic research, resulting in poor conservation strategies. The phylogenetic relationship of the Critically Endangered Forest Owlet Heteroglaux blewitti has been the subject of a century-old debate. The current classifications based on non-phylogenetic comparisons of morphology place the small owls of Asia into three genera, namely, Athene, Glaucidium, and Heteroglaux. Based on morphological and anatomical data, H. blewitti has been alternatively hypothesized to belong within Athene, Glaucidium, or its own monotypic genus Heteroglaux. To test these competing hypotheses, we sequenced six loci (similar to 4300 bp data) and performed phylogenetic analyses of owlets. Mitochondrial and nuclear trees were not congruent in their placement of H. blewitti. However, both mitochondrial and nuclear combined datasets showed strong statistical support with high maximum likelihood bootstrap (>/ = 90) and Bayesian posterior probability values (>/ = 0.98) for H. blewitti being nested in the currently recognized Athene group, but not sister to Indian A. brama. The divergence of H. blewitti from its sister taxa was between 4.3 and 5.7 Ma coinciding with a period of drastic climatic changes in the Indian subcontinent. This study presented the first genetic analysis of H. blewitti, a Critically Endangered species, and addressed the long debate on the relationships of the Athene-Heteroglaux-Glaucidium complex. We recommend further studies with more data and complete taxon sampling to understand the biogeography of Indian Athene species.	[Koparde, Pankaj; Mukherjee, Shomita] Salim Ali Ctr Ornithol & Nat Hist, Div Conservat Biol, Coimbatore, Tamil Nadu, India; [Koparde, Pankaj] Manipal Acad Higher Educ, Manipal, Karnataka, India; [Koparde, Pankaj; Robin, V. V.] Indian Inst Sci Educ & Res, Tirupati, Andhra Pradesh, India; [Mehta, Prachi] Wildlife Res & Conservat Soc, Pune, Maharashtra, India; [Reddy, Sushma] Loyola Univ, Chicago, IL 60611 USA; [Ramakrishnan, Uma] TIFR, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Salim Ali Center for Ornithology & Natural History (SACON); Manipal Academy of Higher Education (MAHE); Indian Institute of Science Education & Research (IISER) - Tirupati; Loyola University Chicago; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Koparde, P (corresponding author), Salim Ali Ctr Ornithol & Nat Hist, Div Conservat Biol, Coimbatore, Tamil Nadu, India.; Koparde, P (corresponding author), Manipal Acad Higher Educ, Manipal, Karnataka, India.; Koparde, P (corresponding author), Indian Inst Sci Educ & Res, Tirupati, Andhra Pradesh, India.	pankajkoparde@gmail.com	Robin, V.V./H-7299-2019; Koparde, Pankaj/H-8085-2015	Robin, V.V./0000-0003-3109-5498; Koparde, Pankaj/0000-0002-7418-8814; Reddy, Sushma/0000-0001-7263-0763; Ramakrishnan, Uma/0000-0002-5370-5966	Department of Biotechnology, Government of India [BT/PR4812/BCE/8/898/2012]; US National Science Foundation [DEB-1457624]; Direct For Biological Sciences [1457624] Funding Source: National Science Foundation	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Department of Biotechnology, Government of India (http://www.dbtindia.nic.in/) provided a research grant (file no. BT/PR4812/BCE/8/898/2012) to SM; US National Science Foundation (https://www.nsf.gov/) (DEB-1457624) provided a grant to SR for partial museum work. In both cases, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S., 1983, HDB BIRDS INDIA PAKI, V2nd; Baker ECS, 1934, NIDIFICATION BIRDS I, VIII; Barrowclough GF, 2005, MOL ECOL, V14, P1109, DOI 10.1111/j.1365-294X.2005.02465.x; Bawa KS, 2006, CURR SCI INDIA, V91, P1005; Bedetti C, 2013, PALAEONTOGR ABT A, V298, P31; Bell Christopher J., 2004, P232; Berger D. D., 1959, Bird-Banding, V30, P18, DOI 10.2307/4510726; BirdLife International, HET BLEW IUCN RED LI; Blanford WT, FAUNA BRIT INDIA INC, V3; Boev Zlatozar N., 2002, P29; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Bures S, 2002, HEREDITAS, V136, P254, DOI 10.1034/j.1601-5223.2002.1360313.x; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Claramunt S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501005; Clements JF, 2013, EBIRD CLEMENTS CHECK; del Hoyo J, 1999, HDB BIRDS WORLD VOLU, V5; Dickinson E. C., 2013, HOWARD MOORE COMPLET, V1; Dong F, 2010, MOL PHYLOGENET EVOL, V57, P1268, DOI 10.1016/j.ympev.2010.09.023; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dubois A, SYNOPSIS AVIUM NOUVE; Edwards SV, 2005, P ROY SOC B-BIOL SCI, V272, P979, DOI 10.1098/rspb.2004.3035; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; FEDUCCIA JA, 1970, WILSON BULL, V82, P332; FORD NL, 1966, CONDOR, V68, P472, DOI 10.2307/1365319; FORD NL, 1967, AUK, V84, P115, DOI 10.2307/4083261; Fregin S, 2009, MOL PHYLOGENET EVOL, V52, P866, DOI 10.1016/j.ympev.2009.04.006; Fuchs J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-197; Gill F, 2013, IOC WORLD BIRD LIST; Groth JG, 1999, MOL PHYLOGENET EVOL, V12, P115, DOI 10.1006/mpev.1998.0603; Guerra C, 2012, J ORNITHOL, V153, P347, DOI 10.1007/s10336-011-0749-3; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HAMER TE, 1994, AUK, V111, P487, DOI 10.2307/4088616; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Holmes IA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163738; Hume, 1873, STRAY FEATHERS, V1, P468; Ishtiaq Farah, 2011, Journal of Threatened Taxa, V3, P1798; Jathar Girish, 2015, Journal of the Bombay Natural History Society, V112, P55, DOI 10.17087/jbnhs/2015/v112i2/104924; Jathar Girish, 2011, Journal of Threatened Taxa, V3, P1800; Jetz W, 2014, CURR BIOL, V24, P919, DOI 10.1016/j.cub.2014.03.011; Kahindo CM, 2017, IBIS, V159, P415, DOI 10.1111/ibi.12453; Karanth KP, 2003, CURR SCI INDIA, V85, P1276; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Konig C., 1999, OWLS GUIDE OWLS WORL; Konig C, 2008, OWLS WORLD; Kurochkin EN, 2011, PALEONTOL J+, V45, P445, DOI 10.1134/S003103011104006X; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LANYON SM, 1994, EVOLUTION, V48, P679, DOI 10.1111/j.1558-5646.1994.tb01353.x; Madhusudan MD, 2006, CURR SCI INDIA, V91, P1015; Meher-Homji V.M., 1983, FEDDES REPERT, V94, P407; Mehta Prachi, 2008, BirdingASIA, V10, P77; Mlikovsky J., 1998, Buteo, V10, P5; Mlikovsky J., 2002, CENOZOIC BIRDS WOR 1; MONROE BL, 1993, WORLD CHECKLIST BIRD; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Pande Satish A., 2011, Journal of Threatened Taxa, V3, P1799; Pande Satish A., 2011, Journal of Threatened Taxa, V3, P1804; Pande Satish A., 2011, Journal of Threatened Taxa, V3, P1727; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Pavia M, 2015, ACTA PALAEONTOL POL, V60, P815, DOI 10.4202/app.00077.2014; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Primmer CR, 2002, MOL ECOL, V11, P603, DOI 10.1046/j.0962-1083.2001.01452.x; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Rasmussen PC, 2013, FORKTAIL, P78; Rasmussen Pamela C., 1999, Forktail, V15, P61; Reddy S, 2008, MOL PHYLOGENET EVOL, V47, P54, DOI 10.1016/j.ympev.2008.01.014; Reddy S, 2014, MOL PHYLOGENET EVOL, V77, P159, DOI 10.1016/j.ympev.2014.04.023; Ribeiro AM, 2011, EVOLUTION, V65, P3499, DOI 10.1111/j.1558-5646.2011.01397.x; Robin VV, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0882-6; Robin VV, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0861; Roje DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087428; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sibley CG, 1990, DISTRIBUTION TAXONOM; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TAJIMA F, 1993, GENETICS, V135, P599; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wink M., 2014, VOGELWARTE, V52, P325; Wink M, 2009, ARDEA, V97, P581, DOI 10.5253/078.097.0425; Wolters HE, 1975, VOGELARTEN ERDE; Wood JR, 2017, ZOOL J LINN SOC-LOND, V179, P907, DOI 10.1111/zoj.12483	83	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192359	10.1371/journal.pone.0192359	http://dx.doi.org/10.1371/journal.pone.0192359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401484	gold, Green Published, Green Submitted			2022-12-26	WOS:000424101400054
J	Anderson, EM; McClelland, S; Maksimova, E; Strezoska, Z; Basila, M; Briner, AE; Barrangou, R; Smith, AV				Anderson, Emily M.; McClelland, Shawn; Maksimova, Elena; Strezoska, Zaklina; Basila, Megan; Briner, Alexandra E.; Barrangou, Rodolphe; Smith, Anja van Brabant			Lactobacillus gasseri CRISPR-Cas9 characterization In Vitro reveals a flexible mode of protospacer-adjacent motif recognition	PLOS ONE			English	Article							RNA-GUIDED ENDONUCLEASE; CAS SYSTEMS; STRUCTURAL BASIS; DIVERSITY; PAM	While the CRISPR-Cas9 system from S. pyogenes is a powerful genome engineering tool, additional programmed nucleases would enable added flexibility in targeting space and multiplexing. Here, we characterized a CRISPR-Cas9 system from L. gasseri and found that it has modest activity in a cell-free lysate assay but no activity in mammalian cells even when altering promoter, position of tag sequences and NLS, and length of crRNA:tracrRNA. In the lysate assay we tested over 400 sequential crRNA target sequences and found that the Lga Cas9 PAM is NNGA/NDRA, different than NTAA predicted from the native bacterial host. In addition, we found multiple instances of consecutive crRNA target sites, indicating flexibility in either PAM sequence or distance from the crRNA target site. This work highlights the need for characterization of new CRISPR systems and highlights the non-triviality of porting them into eukaryotes as gene editing tools.	[Anderson, Emily M.; McClelland, Shawn; Maksimova, Elena; Strezoska, Zaklina; Basila, Megan; Smith, Anja van Brabant] Dharmacon, Lafayette, CO 80026 USA; [Briner, Alexandra E.; Barrangou, Rodolphe] North Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC USA	University of North Carolina; North Carolina State University	Smith, AV (corresponding author), Dharmacon, Lafayette, CO 80026 USA.	anja.smith@horizondiscovery.com	Barrangou, Rodolphe/I-2878-2014	Barrangou, Rodolphe/0000-0002-0648-3504; Crawley, Alexandra/0000-0002-3970-9506	GE Healthcare Dharmacon, Inc.; North Carolina State University	GE Healthcare Dharmacon, Inc.; North Carolina State University	"This work was funded by GE Healthcare Dharmacon, Inc. and internal funding from North Carolina State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Anderson EM, 2015, J BIOTECHNOL, V211, P56, DOI 10.1016/j.jbiotec.2015.06.427; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Briner A, 2014, MOL CELL IN PRESS; Chandrasegaran S, 2016, J MOL BIOL, V428, P963, DOI 10.1016/j.jmb.2015.10.014; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Komor AC, 2017, CELL, V169, P559, DOI 10.1016/j.cell.2017.04.005; Leenay RT, 2017, J MOL BIOL, V429, P177, DOI 10.1016/j.jmb.2016.11.024; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Liu L, 2017, MOL CELL, V65, P310, DOI 10.1016/j.molcel.2016.11.040; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sanozky-Dawes R, 2015, MICROBIOL-SGM, V161, P1752, DOI 10.1099/mic.0.000129; Scaringe SA, 2001, METHODS, V23, P206, DOI 10.1006/meth.2000.1132; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Strezoska Z, 2017, J BIOTECHNOL, V251, P189, DOI 10.1016/j.jbiotec.2017.04.017; Swarts DC, 2017, MOL CELL, V66, P221, DOI 10.1016/j.molcel.2017.03.016; Tan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168968; Wang T, 2016, COLD SPRING HARBOR P, V2016; WINCOTT F, 1995, NUCLEIC ACIDS RES, V23, P2677, DOI 10.1093/nar/23.14.2677; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	29	1	3	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192181	10.1371/journal.pone.0192181	http://dx.doi.org/10.1371/journal.pone.0192181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394276	Green Published, Green Submitted, gold			2022-12-26	WOS:000424060400029
J	Park, SH; Lee, CW; Cho, SM; Lee, H; Park, H; Lee, J; Lee, JH				Park, Sun-Ha; Lee, Chang Woo; Cho, Sung Mi; Lee, Hyoungseok; Park, Hyun; Lee, Jungeun; Lee, Jun Hyuck			Crystal structure and enzymatic properties of chalcone isomerase from the Antarctic vascular plant Deschampsia antarctica Desv.	PLOS ONE			English	Article							FLAVANONE ISOMERASE; REACTION-MECHANISM; FLAVONOIDS; BIOSYNTHESIS; PURIFICATION; REFINEMENT; FLOWERS; BINDING; STRESS; COLOR	Chalcone isomerase (CHI) is an important enzyme for flavonoid biosynthesis that catalyzes the intramolecular cyclization of chalcones into (S)-flavanones. CHIs have been classified into two types based on their substrate specificity. Type I CHIs use naringenin chalcone as a substrate and are found in most of plants besides legumes, whereas type II CHIs in leguminous plants can also utilize isoliquiritigenin. In this study, we found that the CHI from the Antarctic plant Deschampsia antarctica (DaCHI1) is of type I based on sequence homology but can use type II CHI substrates. To clarify the enzymatic mechanism of DaCHI1 at the molecular level, the crystal structures of unliganded DaCHI1 and isoliquiritigenin-bound DaCHI1 were determined at 2.7 and 2.1 angstrom resolutions, respectively. The structures revealed that isoliquiritigenin binds to the active site of DaCHI1 and induces conformational changes. Additionally, the activity assay showed that while DaCHI1 exhibits substrate preference for naringenin chalcone, it can also utilize isoliquiritigenin although the catalytic activity was relatively low. Based on these results, we propose that DaCHI1 uses various substrates to produce antioxidant flavonoids as an adaptation to oxidative stresses associated with harsh environmental conditions.	[Park, Sun-Ha; Lee, Chang Woo; Cho, Sung Mi; Lee, Hyoungseok; Park, Hyun; Lee, Jungeun; Lee, Jun Hyuck] Korea Polar Res Inst, Unit Polar Genom, Incheon, South Korea; [Lee, Chang Woo; Lee, Hyoungseok; Park, Hyun; Lee, Jungeun; Lee, Jun Hyuck] Univ Sci & Technol, Dept Polar Sci, Incheon, South Korea	Korea Polar Research Institute (KOPRI)	Lee, J; Lee, JH (corresponding author), Korea Polar Res Inst, Unit Polar Genom, Incheon, South Korea.; Lee, J; Lee, JH (corresponding author), Univ Sci & Technol, Dept Polar Sci, Incheon, South Korea.	jelee@kopri.re.kr; junhyucklee@kopri.re.kr		Lee, Hyoungseok/0000-0002-5831-6345; Cho, Sung Mi/0000-0001-5414-7727	Polar Genomics 101 Project: Genome Analysis of Polar Organisms and Establishment of Application Platform - Korea Polar Research Institute [PE18080]	Polar Genomics 101 Project: Genome Analysis of Polar Organisms and Establishment of Application Platform - Korea Polar Research Institute	This work was supported by the Polar Genomics 101 Project: Genome Analysis of Polar Organisms and Establishment of Application Platform (PE18080) funded by the Korea Polar Research Institute to HP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the staff at the X-ray crystallography core facility of the Korea Basic Science Institute (Ochang, Korea) and BL-5C of the Pohang Accelerator Laboratory (Pohang, Korea) for assistance with data collection. This work was supported by the Polar Genomics 101 Project: Genome Analysis of Polar Organisms and Establishment of Application Platform (PE18080) funded by the Korea Polar Research Institute.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BEDNAR RA, 1988, J BIOL CHEM, V263, P9582; BOLAND MJ, 1975, EUR J BIOCHEM, V50, P383, DOI 10.1111/j.1432-1033.1975.tb09814.x; Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng H, 2011, PLANT CELL REP, V30, P49, DOI 10.1007/s00299-010-0943-4; DIXON RA, 1988, PHYTOCHEMISTRY, V27, P2801, DOI 10.1016/0031-9422(88)80666-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222; FORKMANN G, 1980, BIOCHEM GENET, V18, P519, DOI 10.1007/BF00484399; Gall M, 2014, ANGEW CHEM INT EDIT, V53, P1439, DOI 10.1002/anie.201306952; GROTEWOLD E, 1994, MOL GEN GENET, V242, P1; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jez JM, 2002, BIOCHEMISTRY-US, V41, P5168, DOI 10.1021/bi0255266; Jez JM, 2002, J BIOL CHEM, V277, P1361, DOI 10.1074/jbc.M109224200; Kim S, 2004, MOL GENET GENOMICS, V272, P411, DOI 10.1007/s00438-004-1076-7; Kozlowska Aleksandra, 2014, Rocz Panstw Zakl Hig, V65, P79; Lee Eung-Ryoung, 2007, Recent Pat Biotechnol, V1, P139, DOI 10.2174/187220807780809445; Lee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092501; Lee J, 2013, PLANTA, V237, P823, DOI 10.1007/s00425-012-1797-5; MCKHANN HI, 1994, PLANT MOL BIOL, V24, P767, DOI 10.1007/BF00029858; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; MOL JNM, 1985, PHYTOCHEMISTRY, V24, P2267; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ngaki MN, 2012, NATURE, V485, P530, DOI 10.1038/nature11009; Nishihara M, 2005, FEBS LETT, V579, P6074, DOI 10.1016/j.febslet.2005.09.073; NORTH ACT, 1968, ACTA CRYSTALL A-CRYS, VA 24, P351, DOI 10.1107/S0567739468000707; Pearson AR, 2007, BIOCHEMISTRY-US, V46, P8340, DOI 10.1021/bi700086r; Qin JC, 2011, PLANTA MED, V77, P765, DOI 10.1055/s-0030-1250566; Ralston L, 2005, PLANT PHYSIOL, V137, P1375, DOI 10.1104/pp.104.054502; Shimada N, 2003, PLANT PHYSIOL, V131, P941, DOI 10.1104/pp.004820; Shoeva OY, 2014, GENE, V538, P334, DOI 10.1016/j.gene.2014.01.008; Thomsen M, 2015, ACTA CRYSTALLOGR D, V71, P907, DOI 10.1107/S1399004715001935; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walia H, 2007, PLANT MOL BIOL, V63, P609, DOI 10.1007/s11103-006-9112-0; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7; Zamora P, 2013, POLAR BIOL, V36, P1269, DOI 10.1007/s00300-013-1346-0; Zhang HC, 2009, PLANT CELL REP, V28, P1205, DOI 10.1007/s00299-009-0721-3; Zhang Y, 2012, ELECTRON J BIOTECHN, V15, DOI 10.2225/vol15-issue1-fulltext-6; Zhou B, 2007, J EXP BOT, V58, P1771, DOI 10.1093/jxb/erm036	43	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192415	10.1371/journal.pone.0192415	http://dx.doi.org/10.1371/journal.pone.0192415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394293	Green Submitted, Green Published, gold			2022-12-26	WOS:000424060400044
J	Mahmud, A; Aljunid, SM				Mahmud, Aidalina; Aljunid, Syed Mohamed			Availability and accessibility of subsidized mammogram screening program in peninsular Malaysia: A preliminary study using travel impedance approach	PLOS ONE			English	Article							HEALTH-CARE SERVICES; BREAST-CANCER; RURAL WOMEN; ACCESS; DISTANCE; POPULATION; PREDICTORS; ATTENDANCE; DIAGNOSIS; KNOWLEDGE	Access to healthcare is essential in the pursuit of universal health coverage. Components of access are availability, accessibility (spatial and non-spatial), affordability and acceptability. Measuring spatial accessibility is common approach to evaluating access to health care. This study aimed to determine the availability and spatial accessibility of subsidised mammogram screening in Peninsular Malaysia. Availability was determined from the number and distribution of facilities. Spatial accessibility was determined using the travel impedance approach to represent the revealed access as opposed to potential access measured by other spatial measurement methods. The driving distance of return trips from the respondent's residence to the facilities was determined using a mapping application. The travel expenditure was estimated by multiplying the total travel distance by a standardised travel allowance rate, plus parking fees. Respondents in this study were 344 breast cancer patients who received treatment at 4 referral hospitals between 2015 and 2016. In terms of availability, there were at least 6 major entities which provided subsidised mammogram programs. Facilities with mammogram involved with these programs were located more densely in the central and west coast region of the Peninsula. The ratio of mammogram facility to the target population of women aged 40-74 years ranged between 1: 10,000 and 1: 80,000. In terms of accessibility, of the 3.6% of the respondents had undergone mammogram screening, their mean travel distance was 53.4 km (SD = 34.5, range 8-112 km) and the mean travel expenditure was RM 38.97 (SD = 24.00, range RM7.60-78.40). Among those who did not go for mammogram screening, the estimated travel distance and expenditure had a skewed distribution with median travel distance of 22.0 km (IQR 12.0, 42.0, range 2.0-340.0) and the median travel cost of RM 17.40 (IQR 10.40, 30.00, range 3.40-240.00). Higher travel impedance was noted among those who lived in sub-urban and rural areas. In summary, availability of mammogram facilities was good in the central and west coast of the peninsula. The overall provider-to-population ratio was lower than recommended. Based on the travel impedance approach used, accessibility to subsidised mammogram screening among the respondents was good in urban areas but deprived in other areas. This study was a preliminary study with limitations. Nonetheless, the evidence suggests that actions have to be taken to improve the accessibility to opportunistic mammogram screening in Malaysia in pursuit of universal health coverage.	[Mahmud, Aidalina; Aljunid, Syed Mohamed] Univ Kebangsaan Malaysia, Int Ctr Casemix & Clin Coding, Fac Med, Kuala Lumpur, Malaysia; [Aljunid, Syed Mohamed] Kuwait Univ, Fac Publ Hlth, Hlth Sci Ctr, Dept Hlth Policy & Management, Kuwait, Kuwait	Universiti Kebangsaan Malaysia; Kuwait University	Mahmud, A (corresponding author), Univ Kebangsaan Malaysia, Int Ctr Casemix & Clin Coding, Fac Med, Kuala Lumpur, Malaysia.	aidalina75@gmail.com	Aljunid, Syed/J-6009-2014	Aljunid, Syed/0000-0002-0380-1335	Universiti kebangsaan malaysia medical centre fundamental research grant [ff-2015-308]; Medical Research Ethics Committee [NMRR-15-929-25001]; UKM Research and Ethics Committee [FF-2012-308]; Universiti Kebangsaan Malaysia Medical Center Fundamental Research Grant [ff-2015-308]	Universiti kebangsaan malaysia medical centre fundamental research grant; Medical Research Ethics Committee; UKM Research and Ethics Committee; Universiti Kebangsaan Malaysia Medical Center Fundamental Research Grant	This work was funded by the Universiti kebangsaan malaysia medical centre fundamental research grant [ff-2015-308] to SMA and AM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Director General of Health Malaysia for his permission to publish this article. This study was approved by the Medical Research Ethics Committee (NMRR-15-929-25001) and UKM Research and Ethics Committee (Research Code: FF-2012-308). This work was supported by Universiti Kebangsaan Malaysia Medical Center Fundamental Research Grant (FF-2015-308).	Abdullah NN, 2011, ASIAN PAC J CANCER P, V12, P2643; Al-Naggar RA, 2012, ASIAN PAC J CANCER P, V13, P3595, DOI 10.7314/APJCP.2012.13.8.3595; [Anonymous], GUID SUBS MAMM SCREE; [Anonymous], 2003, 3 TREAS; [Anonymous], 2011, MOHKASA441 GU NAT GU; Brustrom JE, 2001, MIL MED, V166, P347, DOI 10.1093/milmed/166.4.347; Chan P Y, 2011, Med J Malaysia, V66, P456; Dahlui M, 2011, ASIAN PAC J CANCER P, V12, P369; Dahlui M, 2013, PREV MED, V57, pS18, DOI 10.1016/j.ypmed.2012.12.010; Dahlui M, 2012, ASIAN PAC J CANCER P, V13, P3443, DOI 10.7314/APJCP.2012.13.7.3443; DeNino WF, 2010, SURG OBES RELAT DIS, V6, P597, DOI 10.1016/j.soard.2010.09.008; Department of Statistics Malaysia Official Portal, 2014, REP HOUS INC BAS AM; Engelman KK, 2002, J AM GERIATR SOC, V50, P62, DOI 10.1046/j.1532-5415.2002.50009.x; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Guagliardo Mark F, 2004, Int J Health Geogr, V3, P3; HANSEN WG, 1959, J AM I PLANNERS, V25, P73, DOI 10.1080/01944365908978307; Huang B, 2009, J RURAL HEALTH, V25, P366, DOI 10.1111/j.1748-0361.2009.00245.x; HURLEY SF, 1994, AM J PUBLIC HEALTH, V84, P1655, DOI 10.2105/AJPH.84.10.1655; Institut Kesihatan Umum, 2006, NAT HLTH MORB SURV 3; Jackson KL, 2013, DIS COLON RECTUM, V56, P367, DOI 10.1097/DCR.0b013e31827e939e; Jacoby I, 1991, J Rural Health, V7, P427; KHAN AA, 1992, SOCIO ECON PLAN SCI, V26, P275, DOI 10.1016/0038-0121(92)90004-O; Langford M, 2006, PROF GEOGR, V58, P294, DOI 10.1111/j.1467-9272.2006.00569.x; Lauzier S, 2013, JNCI-J NATL CANCER I; Lin Swu-Jane, 2004, J Med Syst, V28, P301, DOI 10.1023/B:JOMS.0000032846.20676.94; Luo W, 2003, ENVIRON PLANN B, V30, P865, DOI 10.1068/b29120; Luo Wei, 2004, J Med Syst, V28, P287, DOI 10.1023/B:JOMS.0000032845.90730.84; MANDELBLATT J, 1991, AM J PUBLIC HEALTH, V81, P646, DOI 10.2105/AJPH.81.5.646; Maxwell AJ, 2000, J MED SCREEN, V7, P114, DOI 10.1136/jms.7.2.114; McGrail MR, 2009, APPL GEOGR, V29, P533, DOI 10.1016/j.apgeog.2008.12.003; McGrail MR, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-124; Ministry of Health Malaysia, CLIN PRACT GUID MAN; Ministry of Health Malaysia, 2011, MOHKASA4411 GU MIN H; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Norlaili AA, 2013, ASIAN PAC J CANCER P, V14, P7161, DOI 10.7314/APJCP.2013.14.12.7161; Parsa P, 2010, ASIAN PAC J CANCER P, V11, P681; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Probst JC, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-40; Putthasri W, 2004, REGIONAL HLTH FORUM, V8, P84; Rahmah MA, 2013, MALAY, V519, P79; Rosmawati NHN, 2010, ASIAN PAC J CANCER P, V11, P767; Sheehan TJ, 2005, INT J HEALTH GEOGR, V9, P1; Smith RA, 2011, SALUD PUBLICA MEXICO, V53, P394; St-Jacques S, 2013, J EPIDEMIOLOGY COMMU; Subramanian P, 2013, ASIAN PAC J CANCER P, V14, P6783, DOI 10.7314/APJCP.2013.14.11.6783; Weedon-Fekjaer H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3701; Yusof A, 2014, ASIAN PAC J CANCER P, V15, P8095, DOI 10.7314/APJCP.2014.15.19.8095	47	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191764	10.1371/journal.pone.0191764	http://dx.doi.org/10.1371/journal.pone.0191764			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389972	gold, Green Submitted, Green Published			2022-12-26	WOS:000423793400032
J	Malmborg, K; Sinare, H; Kautsky, EE; Ouedraogo, I; Gordon, LJ				Malmborg, Katja; Sinare, Hanna; Kautsky, Elin Enfors; Ouedraogo, Issa; Gordon, Line J.			Mapping regional livelihood benefits from local ecosystem services assessments in rural Sahel	PLOS ONE			English	Article							REMOTE-SENSING IMAGERY; BURKINA-FASO; WEST-AFRICA; LAND-COVER; VEGETATION; CLASSIFICATION; CONSERVATION; REFLECTANCE; LANDSCAPES; TRADEOFFS	Most current approaches to landscape scale ecosystem service assessments rely on detailed secondary data. This type of data is seldom available in regions with high levels of poverty and strong local dependence on provisioning ecosystem services for livelihoods. We develop a method to extrapolate results from a previously published village scale ecosystem services assessment to a higher administrative level, relevant for land use decision making. The method combines remote sensing (using a hybrid classification method) and interviews with community members. The resulting landscape scale maps show the spatial distribution of five different livelihood benefits (nutritional diversity, income, insurance/saving, material assets and energy, and crops for consumption) that illustrate the strong multi-functionality of the Sahelian landscapes. The maps highlight the importance of a diverse set of sub-units of the landscape in supporting Sahelian livelihoods. We see a large potential in using the resulting type of livelihood benefit maps for guiding future land use decisions in the Sahel.	[Malmborg, Katja; Sinare, Hanna; Kautsky, Elin Enfors; Gordon, Line J.] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Ouedraogo, Issa] ICRASAT West & Cent Africa Reg Off, CGIAR Program Climate Change Agr & Food Secur CCA, Bamako, Mali	Stockholm University; CGIAR	Malmborg, K (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden.	katja.malmborg@su.se	Malmborg, Katja/GXG-5967-2022; BITOUN, RACHEL Elisabeth/AAC-9538-2021	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Sinare, Hanna/0000-0001-5236-9203; Malmborg, Katja/0000-0003-1660-4514; Gordon, Line/0000-0002-3520-4340	Swedish International Development Cooperation Agency; Swedish International Development Cooperation Agency [SWE-2008-148]; Vetenskapsradet [SWE-2012-115]; Targeting Agricultural Innovation and Ecosystem Service Management in the Northern Volta basin from the Innovation Fund within the CGIAR Research Program on Water, Land and Ecosystems; Swedish Foundation For Strategic Environmental Research; Ebba och Sven Schwartz Stiftelse	Swedish International Development Cooperation Agency; Swedish International Development Cooperation Agency; Vetenskapsradet(Swedish Research Council); Targeting Agricultural Innovation and Ecosystem Service Management in the Northern Volta basin from the Innovation Fund within the CGIAR Research Program on Water, Land and Ecosystems; Swedish Foundation For Strategic Environmental Research(Swedish Foundation for Strategic Research); Ebba och Sven Schwartz Stiftelse	The research was funded from the following sources: Grant to conduct fieldwork through the Minor Field Studies programme funded by the Swedish International Development Cooperation Agency (http://www.sida.se/) received by KM; Grant Adapting to changing climate in drylands: The re-greening in Sahel as a potential success case from the Swedish International Development Cooperation Agency (SWE-2008-148) and Vetenskapsradet (SWE-2012-115, http://www.vr.se/) received by LG and EEK; Grant Targeting Agricultural Innovation and Ecosystem Service Management in the Northern Volta basin from the Innovation Fund within the CGIAR Research Program on Water, Land and Ecosystems (https://wle.cgiar.org/) received by LG and EEK; Core funding to the Stockholm Resilience Centre from the Swedish Foundation For Strategic Environmental Research (http://www.mistra.org/) given to KM, HS, EEK, LG; funding from Ebba och Sven Schwartz Stiftelse (https://schwartzstiftelse.com/) received by LG; and support by funding from the Swedish International Development Cooperation Agency for the GRAID Programme at the Stockholm Resilience Centre to HS and EEK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baig MHA, 2014, REMOTE SENS LETT, V5, P423, DOI 10.1080/2150704X.2014.915434; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Benz UC, 2004, ISPRS J PHOTOGRAMM, V58, P239, DOI 10.1016/j.isprsjprs.2003.10.002; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Chan KMA, 2012, ECOL ECON, V74, P8, DOI 10.1016/j.ecolecon.2011.11.011; Crossman ND, 2013, ECOSYST SERV, V4, P4, DOI 10.1016/j.ecoser.2013.02.001; Daw TM, 2015, P NATL ACAD SCI USA, V112, P6949, DOI 10.1073/pnas.1414900112; Dawson N, 2015, ECOL ECON, V117, P62, DOI 10.1016/j.ecolecon.2015.06.018; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; Douxchamps S., 2014, WATER RESOURCES RURA, V3, P1; Douxchamps S., 2015, WATER RESOUR RURAL D, V6, P92, DOI [10.1016/j.wrr.2014.10.001, DOI 10.1016/J.WRR.2014.10.001]; Douxchamps S, 2016, REG ENVIRON CHANGE, V16, P1305, DOI 10.1007/s10113-015-0838-6; Dymond CC, 2002, REMOTE SENS ENVIRON, V80, P460, DOI 10.1016/S0034-4257(01)00324-8; Economic Commission for Latin America and the Caribbean, 2014, LCG2634P EC COMM LAT; Egoh B, 2012, INDICATORS MAPPING E; ESA, 2009, GLOBCOVER; ESRI, 2013, ARCGIS DESKT REL 10; European Space Agency, 2018, COP PROGR; EVIS, 2013, ENVI VERS 5 1; Fagerholm N, 2012, ECOL INDIC, V18, P421, DOI 10.1016/j.ecolind.2011.12.004; FAO, 2013, GREAT GREEN WALL GRE; FAO, 2013, FAO STAT YB 2013; FAO - Food and Agriculture Organization of the United Nations, 2004, SAH WEATH CROP SIT R; Friedl MA, 1997, REMOTE SENS ENVIRON, V61, P399, DOI 10.1016/S0034-4257(97)00049-7; Hagberg S., 2006, AFR TODAY, V52, P109, DOI [10.1353/at.2006.0046., DOI 10.1353/AT.2006.0046]; Holen E., 2015, USING SOIL PROPERTIE; IFAD UNEP, 2013, ROM INT FUND AGR DEV, V17, P54; IGBF, 2014, US SPEC PERM I GEOGR; INSD, 2006, MON REG NORD; INSD, 2006, MON REG CTR NORD; INSD, 2007, DIR DEM; INSD. Redensement general de la population et de l'habitation (RGPH), 2006, THEM 2 ET STRUCT POP, P1; Jose Martinez-Harms Maria, 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P17, DOI 10.1080/21513732.2012.663792; KAUFMAN YJ, 1994, IEEE T GEOSCI REMOTE, V32, P672, DOI 10.1109/36.297984; Keshtkar H. R., 2013, Desert, V17, P137; Lemoalle J, 2010, WATER INT, V35, P655, DOI 10.1080/02508060.2010.510793; MA, 2005, ECOSYSTEMS HUMAN WEL; Malinga R, 2015, ECOSYST SERV, V13, P57, DOI 10.1016/j.ecoser.2015.01.006; Malmborg K., 2015, IDENTIFYING ECOTOPES; Malmstrom CM, 2009, RESTOR ECOL, V17, P526, DOI 10.1111/j.1526-100X.2008.00411.x; Mbow C, 2013, J ARID ENVIRON, V97, P56, DOI 10.1016/j.jaridenv.2013.05.011; MYNENI RB, 1995, IEEE T GEOSCI REMOTE, V33, P481, DOI 10.1109/36.377948; NASA LP DAAC, 2011, PROD METI NASA NASA; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Niang I, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1199; Ofosu EA, 2010, PHYS CHEM EARTH, V35, P706, DOI 10.1016/j.pce.2010.07.005; Pal M, 2003, REMOTE SENS ENVIRON, V86, P554, DOI 10.1016/S0034-4257(03)00132-9; Paudyal K, 2015, ECOSYST SERV, V13, P81, DOI 10.1016/j.ecoser.2015.01.007; Peterson G, 2016, IPBES 2016 METHODOLO; Potschin M, 2013, LANDSCAPE ECOL, V28, P1053, DOI 10.1007/s10980-012-9756-x; PRUDENCIO CY, 1993, AGR ECOSYST ENVIRON, V47, P237, DOI 10.1016/0167-8809(93)90125-9; Queiroz C, 2015, AMBIO, V44, pS89, DOI 10.1007/s13280-014-0601-0; Ramirez-Gomez SOI, 2015, ECOSYST SERV, P1; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Reyers B, 2013, FRONT ECOL ENVIRON, V11, P268, DOI 10.1890/120144; Sesnie SE, 2010, INT J REMOTE SENS, V31, P2885, DOI 10.1080/01431160903140803; Sidibe A, 2005, AGR WATER MANAGE, V71, P211, DOI 10.1016/j.agwat.2004.09.002; Sinare H, 2016, ECOSYST SERV, V21, P141, DOI 10.1016/j.ecoser.2016.08.004; Sinare H, 2015, AGR ECOSYST ENVIRON, V200, P186, DOI 10.1016/j.agee.2014.11.009; Suich H, 2015, ECOSYST SERV, V12, P137, DOI 10.1016/j.ecoser.2015.02.005; Tappan G, 2007, AGR SYST, V94, P38, DOI 10.1016/j.agsy.2005.07.011; UNDP-United Nations Development Programme, 2014, HUM DEV REP SUST HUM; USGS, 2014, US GEOL SURV EARTH E; Vrebos D, 2014, ECOSYST SERV, P1; Wastfelt A, 2013, INT J APPL EARTH OBS, V23, P234, DOI 10.1016/j.jag.2012.09.006; WRI, 2005, MILLENNIUM DEV GOALS; Xie YC, 2008, J PLANT ECOL, V1, P9, DOI 10.1093/jpe/rtm005; Zheng G, 2007, J ENVIRON MANAGE, V85, P616, DOI 10.1016/j.jenvman.2006.07.015; Zizka A, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/1746-4269-11-9	69	11	12	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192019	10.1371/journal.pone.0192019	http://dx.doi.org/10.1371/journal.pone.0192019			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389965	Green Accepted, Green Published, gold			2022-12-26	WOS:000423793400051
J	van den Ham, HJ; Cooper, JD; Tomasik, J; Bahn, S; Aerts, JL; Osterhaus, ADME; Gruters, RA; Andeweg, AC				van den Ham, Henk-Jan; Cooper, Jason D.; Tomasik, Jakub; Bahn, Sabine; Aerts, Joeri L.; Osterhaus, Albert D. M. E.; Gruters, Rob A.; Andeweg, Arno C.		DC-TRN trial investigators	Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitment	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; MICROBIAL TRANSLOCATION; REPLICATION; ACTIVATION; NEF; TAT; REV; RESPONSES; THERAPY	Objectives To characterize the host response to dendritic cell-based immunotherapy and subsequent combined antiretroviral therapy (cART) interruption in HIV-1-infected individuals at the plasma protein level. Design An autologous dendritic cell (DC) therapeutic vaccine was administered to HIV-infected individuals, stable on cART. The effect of vaccination was evaluated at the plasma protein level during the period preceding cART interruption, during analytical therapy interruption and at viral reactivation. Healthy controls and post-exposure prophylactically treated healthy individuals were included as controls. Methods Plasma marker ('analyte') levels including cytokines, chemokines, growth factors, and hormones were measured in trial participants and control plasma samples using a multiplex immunoassay. Analyte levels were analysed using principle component analysis, cluster analysis and limma. Blood neutrophil counts were analysed using linear regression. Results Plasma analyte levels of HIV-infected individuals are markedly different from those of healthy controls and HIV-negative individuals receiving post-exposure prophylaxis. Viral reactivation following cART interruption also affects multiple analytes, but cART interruption itself only has only a minor effect. We find that Thyroxine-Binding Globulin (TBG) levels and late-stage neutrophil numbers correlate with the time off cART after DC vaccination. Furthermore, analysis shows that cART alters several regulators of blood glucose levels, including C-peptide, chromogranin-A and leptin. HIV reactivation is associated with the upregulation of CXCR3 ligands. Conclusions Chronic HIV infection leads to a change in multiple plasma analyte levels, as does virus reactivation after cART interruption. Furthermore, we find evidence for the involvement of TBG and neutrophils in the response to DC-vaccination in the setting of HIV-infection.	[van den Ham, Henk-Jan; Gruters, Rob A.; Andeweg, Arno C.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Cooper, Jason D.; Tomasik, Jakub; Bahn, Sabine] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [Tomasik, Jakub; Bahn, Sabine] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Aerts, Joeri L.] Vrije Univ Brussel, Dept Physiol & Immunol, Lab Mol & Cellular Therapy, Brussels, Belgium; [Osterhaus, Albert D. M. E.] Vet Univ Hannover, Res Inst Infect Dis & Zoonoses, Hannover, Germany	Erasmus University Rotterdam; Erasmus MC; University of Cambridge; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Brussel; University of Veterinary Medicine Hannover, Foundation	van den Ham, HJ (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	h.j.vandenham@erasmusmc.nl	allard, sabine/B-9248-2014; van den Ham, HJ/ABF-1071-2021; Gruters, Rob/AAM-2362-2020; Aerts, Joeri/J-6957-2014	Aerts, Joeri/0000-0002-9902-3696; Tomasik, Jakub/0000-0002-2127-4487; van den Ham, Henk-Jan/0000-0001-8582-5404	VIRGO consortium - Dutch government [FES0908]; European Union FP7 funding scheme: Marie Curie Actions Industry Academia Partnerships and Pathways [286334]; Dutch Fund for Economic Structure Reinforcement; NeuroBasic PharmaPhenomics project [0908]; Stanley Medical Research Institute (SMRI); Wetenschappelijk Fonds Willy Gepts of the UZ Brussel	VIRGO consortium - Dutch government; European Union FP7 funding scheme: Marie Curie Actions Industry Academia Partnerships and Pathways; Dutch Fund for Economic Structure Reinforcement; NeuroBasic PharmaPhenomics project; Stanley Medical Research Institute (SMRI); Wetenschappelijk Fonds Willy Gepts of the UZ Brussel	This work was supported by the VIRGO consortium that is funded by the Dutch government project number FES0908. JT was also supported through grants awarded to Psynova Neurotech Ltd. by the European Union FP7 funding scheme: Marie Curie Actions Industry Academia Partnerships and Pathways (ref. 286334, PSYCH-AID project); and by the Dutch Fund for Economic Structure Reinforcement, the NeuroBasic PharmaPhenomics project (ref. 0908). SB was also supported by a grant from the Stanley Medical Research Institute (SMRI). JLA was supported by the Wetenschappelijk Fonds Willy Gepts of the UZ Brussel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard SD, 2008, VACCINE, V26, P3735, DOI 10.1016/j.vaccine.2008.04.077; Allard SD, 2012, CLIN IMMUNOL, V142, P252, DOI 10.1016/j.clim.2011.10.010; Boulware DR, 2011, J INFECT DIS, V203, P1637, DOI 10.1093/infdis/jir134; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cameron PU, 2010, P NATL ACAD SCI USA, V107, P16934, DOI 10.1073/pnas.1002894107; Capeau J, 2012, AIDS, V26, P303, DOI 10.1097/QAD.0b013e32834e8776; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017238; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; de Goede AL, 2015, VACCINE, V33, P2922, DOI 10.1016/j.vaccine.2015.04.047; de Goede AL, 2013, AIDS, V27, P2679, DOI 10.1097/01.aids.0000433813.67662.92; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Foley JF, 2005, J IMMUNOL, V174, P4892, DOI 10.4049/jimmunol.174.8.4892; Garcia F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004682; Graziani GM, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20497; Haas A, 2011, J VIROL, V85, P12102, DOI 10.1128/JVI.05607-11; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Hoffmann CJ, 2007, CLIN INFECT DIS, V45, P488, DOI 10.1086/519978; Janssen OE, 2002, J CLIN ENDOCR METAB, V87, P1217, DOI 10.1210/jc.87.3.1217; Lane BR, 2003, VIROLOGY, V307, P122, DOI 10.1016/S0042-6822(02)00045-4; Levy Y, 2014, EUR J IMMUNOL, V44, P2802, DOI 10.1002/eji.201344433; Lian JQ, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.18892; Little R.J.A., 2002, STAT ANAL MISSING DA; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Paiardini M, 2013, IMMUNOL REV, V254, P78, DOI 10.1111/imr.12079; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Shebl FM, 2012, AIDS RES HUM RETROV, V28, P809, DOI [10.1089/aid.2011.0144, 10.1089/AID.2011.0144]; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; van de Weg CAM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002236; van den Ham HJ, 2009, RHEUMATOLOGY, V48, P899, DOI 10.1093/rheumatology/kep125; Vrisekoop N, 2015, AIDS, V29, P2071, DOI 10.1097/QAD.0000000000000822; Yang OO, 2002, J INFECT DIS, V185, P1174, DOI 10.1086/339678	33	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192278	10.1371/journal.pone.0192278	http://dx.doi.org/10.1371/journal.pone.0192278			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389978	gold, Green Published, Green Submitted			2022-12-26	WOS:000423793400085
J	del Campo, JA; Garcia-Valdecasas, M; Gil-Gomez, A; Rojas, A; Gallego, P; Ampuero, J; Gallego-Duran, R; Pastor, H; Grande, L; Padillo, FJ; Muntane, J; Romero-Gomez, M				del Campo, Jose A.; Garcia-Valdecasas, Marta; Gil-Gomez, Antonio; Rojas, Angela; Gallego, Paloma; Ampuero, Javier; Gallego-Duran, Rocio; Pastor, Helena; Grande, Lourdes; Padillo, Francisco J.; Muntane, Jordi; Romero-Gomez, Manuel			Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; LIPID-METABOLISM; INSULIN-RESISTANCE; MAMMALIAN TARGET; DOWN-REGULATION; CANCER; PATHWAY; EXPRESSION; INDUCTION; PROTECTS	Hepatitis C virus (HCV) infection has been related to increased risk of development of hepatocellular carcinoma (HCC) while metformin (M) and statins treatment seemed to protect against HCC development. In this work, we aim to identify the mechanisms by which metformin and simvastatin (S) could protect from liver cancer. Huh7.5 cells were infected with HCV particles and treated with M+S. Human primary hepatocytes were treated with M+S. Treatment with both drugs inhibited Huh7.5 cell growth and HCV infection. In non-infected cells S increased translational controlled tumor protein (TCTP) and phosphatase and tensin homolog (PTEN) proteins while M inhibited mammalian target of rapamycin (mTOR) and TCTP. Simvastatin and metformin co-administered down-regulated mTOR and TCTP, while PTEN was increased. In cells infected by HCV, mTOR, TCTP, p62 and light chain 3B II (LC3BII) were increased and PTEN was decreased. S+M treatment increased PTEN, p62 and LC3BII in Huh7.5 cells. In human primary hepatocytes, metformin treatment inhibited mTOR and PTEN, but up-regulated p62, LC3BII and Caspase 3. In conclusion, simvastatin and metformin inhibited cell growth and HCV infection in vitro. In human hepatocytes, metformin increased cell-death markers. These findings suggest that M+S treatment could be useful in therapeutic prevention of HCV-related hepatocellular carcinoma.	[del Campo, Jose A.; Gallego, Paloma; Grande, Lourdes] Valme Univ Hosp, Serv Andaluz Salud, Dept Digest Dis, Seville, Spain; [del Campo, Jose A.; Gallego, Paloma; Grande, Lourdes] Valme Univ Hosp, Serv Andaluz Salud, CIBERehd, Seville, Spain; [Garcia-Valdecasas, Marta; Gil-Gomez, Antonio; Rojas, Angela; Ampuero, Javier; Gallego-Duran, Rocio; Pastor, Helena; Romero-Gomez, Manuel] Rocio Univ Hosp, Dept Digest Dis, Biomed Inst Seville, Seville, Spain; [Garcia-Valdecasas, Marta; Gil-Gomez, Antonio; Rojas, Angela; Ampuero, Javier; Gallego-Duran, Rocio; Pastor, Helena; Romero-Gomez, Manuel] Rocio Univ Hosp, CIBERehd, Seville, Spain; [Padillo, Francisco J.; Muntane, Jordi] Rocio Univ Hosp, CSIC, Dept Gen Surg, Seville, Spain; [Padillo, Francisco J.; Muntane, Jordi] Univ Seville, Seville, Spain	Hospital Valme; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Valme; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla	del Campo, JA (corresponding author), Valme Univ Hosp, Serv Andaluz Salud, Dept Digest Dis, Seville, Spain.; del Campo, JA (corresponding author), Valme Univ Hosp, Serv Andaluz Salud, CIBERehd, Seville, Spain.	jantonio.delcampo@ciberehd.org	Padillo-Ruiz, Javier/AAF-9792-2021; Romero-Gomez, Manuel/L-8030-2014; García-Valdecasas, Marta/M-5095-2018; Ampuero, Javier/AAI-2582-2019; Gil-Gomez, Antonio/ABB-7349-2021	Padillo-Ruiz, Javier/0000-0002-1220-0822; Romero-Gomez, Manuel/0000-0001-8494-8947; García-Valdecasas, Marta/0000-0001-9920-8722; Ampuero, Javier/0000-0002-8332-2122; Gil-Gomez, Antonio/0000-0001-9622-1761; Gallego-Duran, Rocio/0000-0002-9452-1661; Del Campo, Jose A/0000-0002-6037-1028	Spanish Ministry of Economy, Innovation and Competitivity, Instituto de Salud Carlos III [PI13/01192, PI14/01349]; European Union (ERDF/ESF, "Investing in your future"); Consejeria de Salud de la Junta de Andalucia [PI-0892-2012]; Servicio Andaluz de Salud (SAS)	Spanish Ministry of Economy, Innovation and Competitivity, Instituto de Salud Carlos III; European Union (ERDF/ESF, "Investing in your future"); Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia); Servicio Andaluz de Salud (SAS)	This work was supported by the Spanish Ministry of Economy, Innovation and Competitivity, Instituto de Salud Carlos III, grant numbers PI13/01192, PI14/01349, co-funded by European Union (ERDF/ESF, Investing in your future) and Consejeria de Salud de la Junta de Andalucia (PI-0892-2012). JA Del Campo was supported by Nicolas Monardes Program from Servicio Andaluz de Salud (SAS).; This work was supported by the Spanish Ministry of Economy, Innovation and Competitivity, Instituto de Salud Carlos III, grant numbers PI13/01192, PI14/01349 co-funded by European Union (ERDF/ESF, Investing in your future) and Consejeria de Salud de la Junta de Andalucia (PI-0892-2012). JA Del Campo supported by Nicolas Monardes Program from Servicio Andaluz de Salud (SAS).	Acunzo J, 2014, CANCER TREAT REV, V40, P760, DOI 10.1016/j.ctrv.2014.02.007; Aldea M, 2014, TUMOR BIOL, V35, P5101, DOI 10.1007/s13277-014-1676-8; Amemiya F, 2008, J INFECT DIS, V197, P361, DOI 10.1086/525287; Ampuero J, 2015, WORLD J HEPATOL, V7, P1105, DOI 10.4254/wjh.v7.i8.1105; Babcook MA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.500; Babcook MA, 2014, MOL CANCER THER, V13, P2288, DOI 10.1158/1535-7163.MCT-14-0451; Bhat M, 2013, HEPATOLOGY, V58, P810, DOI 10.1002/hep.26323; Cai XB, 2013, ONCOL REP, V30, P2449, DOI 10.3892/or.2013.2718; Chan THM, 2012, HEPATOLOGY, V55, P491, DOI 10.1002/hep.24709; Cheng JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093256; del Campo JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047904; Fang ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062823; Fattovich G., 2004, GASTROENTEROLOGY; Gao TT, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0241-4; Hailfinger S, 2007, INT J CANCER, V120, P1459, DOI 10.1002/ijc.22519; Lee SK, 2011, J CELL BIOCHEM, V112, P1259, DOI 10.1002/jcb.23000; Liu HB, 2015, CANCER LETT, V359, P218, DOI 10.1016/j.canlet.2015.01.020; Ma SJ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006888; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Malki A, 2011, ONCOL RES, V19, P275, DOI 10.3727/096504011X13021877989838; Peng L, 2010, J BIOL CHEM, V285, P20870, DOI 10.1074/jbc.M110.112045; Peyrou M, 2013, J HEPATOL, V59, P420, DOI 10.1016/j.jhep.2013.04.012; Pichard Lydiane, 2006, Methods Mol Biol, V320, P283; Popescu Costin-Ioan, 2014, Biology (Basel), V3, P892, DOI 10.3390/biology3040892; Rautou PE, 2010, J HEPATOL, V53, P1123, DOI 10.1016/j.jhep.2010.07.006; Rho SB, 2011, FEBS LETT, V585, P29, DOI 10.1016/j.febslet.2010.11.014; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Roudier E, 2006, MOL CANCER THER, V5, P2706, DOI 10.1158/1535-7163.MCT-06-0352; Saito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070010; Shindoh J, 2015, WORLD J HEPATOL, V7, P70, DOI 10.4254/wjh.v7.i1.70; Simon TG, 2016, HEPATOLOGY, V64, P47, DOI 10.1002/hep.28506; Singh S, 2013, GASTROENTEROLOGY, V144, P323, DOI 10.1053/j.gastro.2012.10.005; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Song YM, 2015, AUTOPHAGY, V11, P46, DOI 10.4161/15548627.2014.984271; Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18; Takahashi A, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-53; Teresi RE, 2008, HUM MOL GENET, V17, P919, DOI 10.1093/hmg/ddm364; Tian T, 2010, ONCOL REP, V23, P1593, DOI 10.3892/or_00000800; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; Vescovo T, 2012, GASTROENTEROLOGY, V142, P644, DOI 10.1053/j.gastro.2011.11.033; Wang Z, 2014, BIOMED RES INT, V2014, P1; Xiang Y, 2015, J VIROL, V89, P6805, DOI 10.1128/JVI.00587-15; Yang D, 2013, CELL DEATH DIFFER, V20, P235, DOI 10.1038/cdd.2012.113; Zheng LY, 2012, BIOCHEM BIOPH RES CO, V420, P680, DOI 10.1016/j.bbrc.2012.03.066	45	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191805	10.1371/journal.pone.0191805	http://dx.doi.org/10.1371/journal.pone.0191805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385181	gold, Green Submitted, Green Published			2022-12-26	WOS:000423668400056
J	Leitao, TJ; Cury, JA; Tenuta, LMA				Leitao, Tarcisio Jorge; Cury, Jaime Aparecido; Andalo Tenuta, Livia Maria			Kinetics of calcium binding to dental biofilm bacteria	PLOS ONE			English	Article							PLAQUE FLUID; ENAMEL DEMINERALIZATION; STREPTOCOCCUS-MUTANS; SUCROSE EXPOSURE; FLUORIDE BINDING; CARIES; RINSE; AGGREGATION; SODIUM; CA	Dental biofilm bacteria can bind calcium ions and release them during a pH drop, which could decrease the driving force for dental demineralization (i.e. hydroxyapatite dissolution) occurring at reduced pHs. However, the kinetics of this binding and release is not completely understood. Here we validated a method to evaluate the kinetics of calcium binding and release to/from Streptococcus mutans, and estimated the importance of this reservoir as a source of ions. The kinetics of calcium binding was assessed by measuring the amount of bound calcium in S. mutans Ingbrit 1600 pellets treated with PIPES buffer, pH 7.0, containing 1 or 10 mM Ca; for the release kinetics, bacterial pellets previously treated with 1 mM or 10 mM Ca were exposed to the calcium-free or 1 mM Ca PIPES buffer, pH 7.0, for up to 60 min. Binding and release curves were constructed and parameters of kinetics were calculated. Also, calcium release was assessed by exposing pellets previously treated with calcium to a pH 5.0 buffer for 10 min. Calcium binding to bacteria was concentration-dependent and rapid, with maximum binding reached at 5 min. On the other hand, calcium release was slower, and according to the calculations, would never be complete in the groups pre-treated with 10 mM Ca. Decreasing pH from 7.0 to 5.0 caused a release of calcium able to increase the surrounding fluid calcium concentration in 2 mM. The results suggest that dental biofilm bacteria may act as a calcium reservoir, rapidly binding ions from surrounding fluids, releasing them slowly at neutral pH and promptly during a pH drop.	[Leitao, Tarcisio Jorge; Cury, Jaime Aparecido; Andalo Tenuta, Livia Maria] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, SP, Brazil; [Leitao, Tarcisio Jorge] Univ Fed Maranhao, Dept Dent 2, Sao Luis, Maranhao, Brazil; [Andalo Tenuta, Livia Maria] Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA	Universidade Estadual de Campinas; Universidade Federal do Maranhao; University of Michigan System; University of Michigan	Tenuta, LMA (corresponding author), Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, SP, Brazil.; Tenuta, LMA (corresponding author), Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA.	litenuta@umich.edu	Tenuta, Livia MA/D-2811-2012; Cury, Jaime/AAV-6647-2021; Cury, Jaime/G-3607-2012	Tenuta, Livia MA/0000-0003-4626-4477; Cury, Jaime/0000-0003-1046-5605; LEITAO, TARCISIO/0000-0003-0342-9956	FAPESP [2011/236770]; FAPESP (Sao Paulo Research Foundation) [2011/23677-0]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by FAPESP through a Master Scholarship grant (2011/236770). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank FAPESP (Sao Paulo Research Foundation) for the scholarship granted to T.J.L. (2011/23677-0).	Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; BRUDEVOLD F, 1985, J DENT RES, V64, P24, DOI 10.1177/00220345850640010401; Carey C, 1986, FACTORS RELATING DEM, P163; Correia MF, 2012, CARIES RES, V46, P408, DOI 10.1159/000339376; Cury J A, 2008, Adv Dent Res, V20, P13; Cury JA, 1997, CARIES RES, V31, P356, DOI 10.1159/000262418; Dawson R. M. C., 1991, DATA BIOCH RES, V3rd, P363; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Domon-Tawaraya H, 2013, CARIES RES, V47, P141, DOI 10.1159/000344014; KASHKET S, 1992, ARCH ORAL BIOL, V37, P187, DOI 10.1016/0003-9969(92)90088-P; Leitao TJ, 2012, BRAZ ORAL RES, V26, P100, DOI 10.1590/S1806-83242012000200003; MARGOLIS HC, 1990, J DENT RES, V69, P1337, DOI 10.1177/00220345900690062201; MARGOLIS HC, 1992, J DENT RES, V71, P1776, DOI 10.1177/00220345920710110301; MARGOLIS HC, 1994, CRIT REV ORAL BIOL M, V5, P1; Marsh PD, 2004, CARIES RES, V38, P204, DOI 10.1159/000077756; Marsh PD, 2005, J CLIN PERIODONTOL, V32, P7, DOI 10.1111/j.1600-051X.2005.00790.x; Martell AE, 1977, CRITICAL STABILITY C, V4, P1; NORRIS V, 1991, MOL MICROBIOL, V5, P775, DOI 10.1111/j.1365-2958.1991.tb00748.x; Rose RK, 1996, CARIES RES, V30, P458, DOI 10.1159/000262360; ROSE RK, 1993, J DENT RES, V72, P78, DOI 10.1177/00220345930720011201; Rose RK, 1997, ARCH ORAL BIOL, V42, P595, DOI 10.1016/S0003-9969(97)00062-9; Rose RK, 2000, BBA-GEN SUBJECTS, V1475, P76, DOI 10.1016/S0304-4165(00)00048-9; Souza JGS, 2016, CARIES RES, V50, P372, DOI 10.1159/000446407; Stephan Robert M., 1944, JOUR DENTAL RES, V23, P257, DOI 10.1177/00220345440230040401; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; TATEVOSSIAN A, 1990, J DENT RES, V69, P1309, DOI 10.1177/00220345900690061801; Tatevossian A, 1981, TOOTH SURFACE INTERA, P105; TENCATE JM, 2003, DENT CARIES DIS ITS, P49; Tenuta LMA, 2006, J DENT RES, V85, P834, DOI 10.1177/154405910608500911; Vogel GL, 2008, J DENT RES, V87, P466, DOI 10.1177/154405910808700513; Vogel GL, 2011, MONOGR ORAL SCI, V22, P146, DOI 10.1159/000325166; Vogel GL, 2000, CARIES RES, V34, P404, DOI 10.1159/000016615; VOGEL GL, 1983, CARIES RES, V17, P23, DOI 10.1159/000260645	33	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191284	10.1371/journal.pone.0191284	http://dx.doi.org/10.1371/journal.pone.0191284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385163	Green Submitted, Green Published, gold			2022-12-26	WOS:000423668400042
J	Vaccaro, G; Pelaez, JI; Gil-Montoya, JA				Vaccaro, Gustavo; Ignacio Pelaez, Jose; Antonio Gil-Montoya, Jose			A novel expert system for objective masticatory efficiency assessment	PLOS ONE			English	Article							2-COLOR CHEWING GUM; QUANTITATIVE-EVALUATION; MIXING ABILITY; PERFORMANCE; SPECIMENS	Most of the tools and diagnosis models of Masticatory Efficiency (ME) are not well documented or severely limited to simple image processing approaches. This study presents a novel expert system for ME assessment based on automatic recognition of mixture patterns of masticated two-coloured chewing gums using a combination of computational intelligence and image processing techniques. The hypotheses tested were that the proposed system could accurately relate specimens to the number of chewing cycles, and that it could identify differences between the mixture patterns of edentulous individuals prior and after complete denture treatment. This study enrolled 80 fully-dentate adults (41 females and 39 males, 25 +/- 5 years of age) as the reference population; and 40 edentulous adults (21 females and 19 males, 72 +/- 8.9 years of age) for the testing group. The system was calibrated using the features extracted from 400 samples covering 0, 10, 15, and 20 chewing cycles. The calibrated system was used to automatically analyse and classify a set of 160 specimens retrieved from individuals in the testing group in two appointments. The ME was then computed as the predicted number of chewing strokes that a healthy reference individual would need to achieve a similar degree of mixture measured against the real number of cycles applied to the specimen. The trained classifier obtained a Mathews Correlation Coefficient score of 0.97. ME measurements showed almost perfect agreement considering pre- and post-treatment appointments separately (kappa >= 0.95). Wilcoxon signed-rank test showed that a complete denture treatment for edentulous patients elicited a statistically significant increase in the ME measurements (Z = -2.31, p < 0.01). We conclude that the proposed expert system proved able and reliable to accurately identify patterns in mixture and provided useful ME measurements.	[Vaccaro, Gustavo] Granada Univ, Sch Dent, Int Postgrad Sch, Granada, Spain; [Ignacio Pelaez, Jose] Univ Malaga, Dept Languages & Comp Sci, Malaga, Spain; [Ignacio Pelaez, Jose] Univ Guayaquil, Natl Secretary Higher Educ Sci Technol & Innovat, Prometeo Project, Guayaquil, Ecuador; [Antonio Gil-Montoya, Jose] Granada Univ, Sch Dent, Gerodontol Dept, Granada, Spain	University of Granada; Universidad de Malaga; University of Granada	Vaccaro, G (corresponding author), Granada Univ, Sch Dent, Int Postgrad Sch, Granada, Spain.	fabianvaccaro@correo.ugr.es	Gil, JosÃ© Antonio/ABG-9813-2020; Vaccaro, Gustavo/AAH-6655-2021; Pelaez Sanchez, Jose Ignacio/O-9450-2016; Vaccaro, Gustavo/M-1566-2014	Gil, JosÃ© Antonio/0000-0002-8691-5003; Pelaez Sanchez, Jose Ignacio/0000-0002-2606-3849; Vaccaro, Gustavo/0000-0002-2097-2291	Secretaria Nacional de Educacion, Ciencia y Teconologia (SENESCYT) of the Government of Ecuador [0099-SPP]	Secretaria Nacional de Educacion, Ciencia y Teconologia (SENESCYT) of the Government of Ecuador	This work was funded by the Secretaria Nacional de Educacion, Ciencia y Teconologia (SENESCYT) of the Government of Ecuador, with budget allocation No. 0099-SPP, http://www.educacionsuperior.gob.ec.; We express our gratitude to the volunteers who participated in this study. Our deepest appreciation goes to the Prometeo Project of the Secretaria de EducaciOn Superior, Ciencia, Tecnologia e Innovacion (SENESCYT) of the Government of Ecuador for supporting this research work. We would also like to show our gratitude to the directive board of the Faculty of Dentistry of the University of Guayaquil for providing us with many of the necessary resources for this study.	[Anonymous], 2005, J PROSTHET DENT, V94, P10; [Anonymous], 1998, NEURAL NETWORKS COMP; Bates J F, 1976, J Oral Rehabil, V3, P57, DOI 10.1111/j.1365-2842.1976.tb00929.x; Beucher S, 1979, INT WORKSH IM PROC R; Callejon AM, 2013, INT J COMPUT INT SYS, V6, P29, DOI 10.1080/18756891.2013.754167; Cepek M, 2008, LECT NOTES COMPUT SC, V5163, P768, DOI 10.1007/978-3-540-87536-9_79; Christoudias CM, 2002, INT C PATT RECOG, P150, DOI 10.1109/ICPR.2002.1047421; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Commission Internationale de L'Eclairage, 1986, COMM INT ECL PUBL; Dai R, 2014, ORAL DIS; Gil-Montoya JA, 2008, J PUBLIC HEALTH DENT, V68, P88, DOI 10.1111/j.1752-7325.2007.00082.x; Halazonetis DJ, 2013, J ORAL REHABIL, V40, P329, DOI 10.1111/joor.12043; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Judd DB, 1940, J OPT SOC AM, V30, P2, DOI 10.1364/JOSA.30.000002; Lawrence S., 1997, AAAIIAAI, P540; Lu SY, 2017, COMPUT METH PROG BIO, V141, P1, DOI 10.1016/j.cmpb.2017.01.014; Macqueen J., 1967, P 5 BERK S MATH STAT, P281; MANLY RS, 1950, J DENT RES, V29, P448, DOI 10.1177/00220345500290040701; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Ohira A, 2012, INT J PAEDIATR DENT, V22, P146, DOI 10.1111/j.1365-263X.2011.01162.x; Prinz JF, 1999, J ORAL REHABIL, V26, P243, DOI 10.1046/j.1365-2842.1999.00362.x; Ripley B. D., 1996, PATTERN RECOGNITION; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Schimmel M, 2007, J ORAL REHABIL, V34, P671, DOI 10.1111/j.1365-2842.2007.01773.x; Schimmel M, 2015, J DENT, V43, P955, DOI 10.1016/j.jdent.2015.06.003; Suzuki K., 2013, ARTIFICIAL NEURAL NE; Vaccaro G, 2016, J ORAL REHABIL, V43, P496, DOI 10.1111/joor.12392; Vaccaro G, 2014, BIODENTAL ENGINEERING III, P221; van der Bilt A, 2011, J ORAL REHABIL, V38, P754, DOI 10.1111/j.1365-2842.2010.02197.x; van der Bilt A, 2010, J ORAL REHABIL, V37, P79, DOI 10.1111/j.1365-2842.2009.02040.x; Veredas F, 2010, IEEE T MED IMAGING, V29, P410, DOI 10.1109/TMI.2009.2033595; Vezhnevets V., 2003, P GRAPHICON, V3, P85; Wang S. H., 2016, MSC THESIS, P1; Weijenberg RAF, 2013, J ORAL REHABIL, V40, P737, DOI 10.1111/joor.12090; Yamashita S, 1999, J ORAL REHABIL, V26, P547, DOI 10.1046/j.1365-2842.1999.00446.x; Zhang YD, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0525-2; Zhang YD, 2015, INFORM SCIENCES, V322, P115, DOI 10.1016/j.ins.2015.06.017; Zhang YD, 2014, KNOWL-BASED SYST, V64, P22, DOI 10.1016/j.knosys.2014.03.015	39	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0190386	10.1371/journal.pone.0190386	http://dx.doi.org/10.1371/journal.pone.0190386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385165	Green Published, gold, Green Submitted			2022-12-26	WOS:000423668400016
J	Xu, Y; Yu, F; Li, XZ; Ma, L; Dong, D; Kou, Q; Sui, JX; Gan, ZB; Gong, L; Yang, M; Wang, YY; Sun, Y; Wang, JB; Wang, HF				Xu, Yong; Yu, Fei; Li, Xinzheng; Ma, Lin; Dong, Dong; Kou, Qi; Sui, Jixing; Gan, Zhibin; Gong, Lin; Yang, Mei; Wang, Yueyun; Sun, Yue; Wang, Jinbao; Wang, Hongfa			Spatiotemporal patterns of the macrofaunal community structure in the East China Sea, off the coast of Zhejiang, China, and the impact of the Kuroshio Branch Current	PLOS ONE			English	Article							SOUTH YELLOW SEA; MACROBENTHIC COMMUNITY; WATER MASSES; COPEPOD ASSEMBLAGES; SPATIAL VARIATIONS; DIVERSITY; DYNAMICS; ESTUARY; SHELF; NORTHEAST	The Kuroshio Current intrudes in the bottom layer of the East China Sea continental shelf from the northeast of Taiwan via two bottom branches named the Nearshore Kuroshio Branch Current (NKBC, along the 60 m isobath) and the Offshore Kuroshio Branch Current (OKBC, along the 100 m isobath). However, knowledge on the macrofaunal responses to these bottom branches is limited. This study examined the variations in the benthic macrofaunal community in a section of the East China Sea under the influence of the NKBC. Seven sites corresponding to three regions (the west, middle and east region) were sampled using an Agassiz trawl net at a monthly rate from February to November 2015 (except in August). A total of 270 macrofaunal species were collected in this study. Cluster analysis and nMDS ordination revealed three communities: the inshore, Kuroshio and offshore communities, roughly corresponding to the west, middle and east of NKBC route. Significant differences in the species composition (one-way PERMANOVA) and diversity indices (oneway ANOVA) among the regions and communities were observed, while no statistically significant difference among the months was detected. The indicator species also varied among the communities, with Sternaspis scutata and Odontamblyopus rubicundus dominating the inshore community, Camatopsis rubida, Schizaster lacunosus and Craspidaster hesperus dominating the Kuroshio community, and Portunus argentatus, Champsodon snyderi and Coelorinchus multispinulosus dominating the offshore community. Some rare species (e.g., Neobythites sivicola) may indicate the passage of the NKBC better than the indicator species. A redundancy analysis was used to describe the relationship between the macrofaunal species and environmental variables in this study. Water depth and turbidity played important roles in the distribution of the macrofauna. S. scutata and O. rubicundus were associated with high turbidity and shallow depth, while Plesionika izumiae and P. argentatus were associated with low turbidity and deep depth. This study outlines the impact of the NKBC on the distribution patterns of the macrofaunal community of the East China Sea. More studies are needed to understand the detailed interactions between macrofauna and the NKBC in the future.	[Xu, Yong; Yu, Fei; Li, Xinzheng; Ma, Lin; Dong, Dong; Kou, Qi; Sui, Jixing; Gan, Zhibin; Gong, Lin; Yang, Mei; Sun, Yue; Wang, Jinbao; Wang, Hongfa] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Xu, Yong; Yu, Fei; Li, Xinzheng; Ma, Lin; Dong, Dong; Kou, Qi; Sui, Jixing; Gan, Zhibin; Gong, Lin; Yang, Mei; Sun, Yue; Wang, Jinbao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xu, Yong; Li, Xinzheng; Ma, Lin; Dong, Dong; Kou, Qi; Sui, Jixing; Gan, Zhibin; Gong, Lin; Yang, Mei; Sun, Yue; Wang, Jinbao] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Yu, Fei] Qingdao Natl Lab Marine Sci & Technol, Lab Ocean & Climate Dynam, Qingdao, Peoples R China; [Wang, Yueyun] State Ocean Adm, Inst Oceanog 2, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Qingdao National Laboratory for Marine Science & Technology; Qingdao National Laboratory for Marine Science & Technology; State Oceanic Administration	Li, XZ (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.; Li, XZ (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Li, XZ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.	lixzh@qdio.ac.cn	Sui, Jixing/AAB-6929-2020; Wang, Yueyun/N-1496-2019	Li, Xinzheng/0000-0001-6344-6542; Wang, Yueyun/0000-0001-5709-4149	Chinese Academy of Sciences [XDA11020303, XDA11020305]; Ocean Public Welfare Scientific Research Project; State Oceanic Administration of the PRC [201505004-1]; National Natural Science Foundation of China [41176133, 41406157]; Scientific and Technological Innovation Project - Qingdao National Laboratory for Marine Science and Technology [2015ASKJ01]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ocean Public Welfare Scientific Research Project; State Oceanic Administration of the PRC; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Innovation Project - Qingdao National Laboratory for Marine Science and Technology	This research is funded by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA11020303, XDA11020305), the Ocean Public Welfare Scientific Research Project, the State Oceanic Administration of the PRC (No. 201505004-1), the National Natural Science Foundation of China (Nos. 41176133 and 41406157) and the Scientific and Technological Innovation Project Financially Supported by Qingdao National Laboratory for Marine Science and Technology (No. 2015ASKJ01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida C, 2008, ESTUAR COAST SHELF S, V80, P357, DOI 10.1016/j.ecss.2008.08.017; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Carvalho S, 2007, AQUACULTURE, V262, P227, DOI 10.1016/j.aquaculture.2006.11.028; Chang NN, 2012, CONT SHELF RES, V47, P42, DOI 10.1016/j.csr.2012.06.011; Chao M, 2012, J COASTAL RES, V28, P1008, DOI 10.2112/JCOASTRES-D-11-00194.1; Colloca F, 2003, ESTUAR COAST SHELF S, V56, P469, DOI 10.1016/S0272-7714(02)00196-8; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; [范士亮 Fan Shiliang], 2010, [海洋科学进展, Advances in Marine Science], V28, P489; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; GESAMP, 1994, ANTHR INFL SED DISCH; Gong GC, 2003, DEEP-SEA RES PT II, V50, P1219, DOI 10.1016/S0967-0645(03)00019-5; Gong GC, 1996, CONT SHELF RES, V16, P1561, DOI 10.1016/0278-4343(96)00005-2; [韩东燕 Han Dongyan], 2013, [中国水产科学, Journal of Fishery Sciences of China], V20, P148; Hwang JS, 2007, J EXP MAR BIOL ECOL, V352, P12, DOI 10.1016/j.jembe.2007.06.034; Hwang JS, 2006, J PLANKTON RES, V28, P943, DOI 10.1093/plankt/fbl031; Hwang JS, 2005, J PLANKTON RES, V27, P205, DOI 10.1093/plankt/fbh162; Legendre P., 2012, NUMERICAL ECOLOGY; Li H, 2016, DEEP-SEA RES PT II, V124, P84, DOI 10.1016/j.dsr2.2015.06.008; Lin SQ, 2016, DEEP-SEA RES PT II, V124, P93, DOI 10.1016/j.dsr2.2015.02.017; Liu Lu-San, 2002, Shengwu Duoyangxing, V10, P351; Liu R., 1986, Studia Marina Sinica, P153; Nicholls P., 2003, ARC03267 NIWA; Oksanen J., 2016, R PACKAG; Pan GL, 2012, J ZHEJIANG OCEAN U N, V31, P482; Peng SY, 2014, CHIN J OCEANOL LIMN, V32, P576, DOI 10.1007/s00343-014-3068-8; Raivo K, 2013, PHEATMAP PRETTY HEAT; Roberts DW., 2012, LABDSV ORDINATION MU; Shao K.-T, 2017, TAIWAN FISH DATABASE; Shen Wei, 2008, Marine Fisheries, V30, P319; Shuai FM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146441; Wei CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046707; Wentao Wang, 2016, Journal of Geophysical Research: Oceans, V121, P7073, DOI 10.1002/2016JC011882; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wildsmith MD, 2011, MAR POLLUT BULL, V62, P525, DOI 10.1016/j.marpolbul.2010.11.031; Xu Y, 2017, CHIN J OCEANOL LIMN, V35, P1152, DOI 10.1007/s00343-017-6085-6; Xu Y, 2016, AQUAT ECOSYST HEALTH, V19, P411, DOI 10.1080/14634988.2016.1249257; Xu Y, 2016, AQUAT ECOSYST HEALTH, V19, P92, DOI 10.1080/14634988.2016.1139429; [徐勇 Xu Yong], 2015, [中国水产科学, Journal of Fishery Sciences of China], V22, P478; Yang DZ, 2013, J MARINE SYST, V123, P1, DOI 10.1016/j.jmarsys.2013.04.002; Yang DZ, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007528; Yang DZ, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006777; Yang Junyi, 2007, Acta Ecologica Sinica, V27, P34; Yu Cun-Gen, 2010, Oceanologia et Limnologia Sinica, V41, P410; Yu Cun-Gen, 2009, Oceanologia et Limnologia Sinica, V40, P353; Zhang Bo, 2009, Yingyong Shengtai Xuebao, V20, P344; Zhang CX, 2015, J MARINE SYST, V141, P98, DOI 10.1016/j.jmarsys.2014.09.003; Zhang Heng, 2009, Yingyong Shengtai Xuebao, V20, P2519; Zhang J, 2007, PROG OCEANOGR, V74, P449, DOI 10.1016/j.pocean.2007.04.019; Zhang JL, 2016, J OCEANOGR, V72, P189, DOI 10.1007/s10872-015-0319-z; Zhang JL, 2012, CHIN J OCEANOL LIMN, V30, P248, DOI 10.1007/s00343-012-1076-0; Zhang Zhuang-li, 2009, Marine Fisheries, V31, P369; [赵瑞祥 Zhao Ruixiang], 2014, [海洋学报, Acta Oceanologica Sinica], V36, P20; Zuo T, 2006, J MARINE SYST, V59, P159, DOI 10.1016/j.jmarsys.2005.09.008	54	5	7	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0192023	10.1371/journal.pone.0192023	http://dx.doi.org/10.1371/journal.pone.0192023			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385207	Green Published, Green Submitted, gold			2022-12-26	WOS:000423668400070
J	Bedarida, T; Domingues, A; Baron, S; Ferreira, C; Vibert, F; Cottart, CH; Paul, JL; Escriou, V; Bigey, P; Gaussem, P; Leguillier, T; Nivet-Antoine, V				Bedarida, Tatiana; Domingues, Alison; Baron, Stephanie; Ferreira, Chrystophe; Vibert, Francoise; Cottart, Charles-Henry; Paul, Jean-Louis; Escriou, Virginie; Bigey, Pascal; Gaussem, Pascale; Leguillier, Teddy; Nivet-Antoine, Valerie			Reduced endothelial thioredoxin-interacting protein protects arteries from damage induced by metabolic stress in vivo	FASEB JOURNAL			English	Article						TXNIP; HP-LC diet; arterial damage; endothelial dysfunction; inflammation	SMOOTH-MUSCLE-CELLS; OXIDATIVE STRESS; INFLAMMASOME ACTIVATION; INSULIN-RESISTANCE; DISEASE; MICE; DYSFUNCTION; RESVERATROL; MOUSE; DIET	Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biologic functions, the contribution of endothelial TXNIP has not been well defined. To investigate the endothelial function of TXNIP, we generated a TXNIP knockout mouse on the Cdh5-cre background (TXNIPfl/fl cdh5(cre)). Control (TXNIPfl/fl) and TXNIPfl/fl cdh5(cre) mice were fed a high protein-low carbohydrate (HP-LC) diet for 3 mo to induce metabolic stress. We found that TXNIPfl/fl and TXNIPfl/fl cdh5(cre) mice on an HP-LC diet displayed impaired glucose tolerance and dyslipidemia concretizing the metabolic stress induced. We evaluated the impact of this metabolic stress on mice with reduced endothelial TXNIP expression with regard to arterial structure and function. TXNIPfl/fl cdh5(cre) mice on an HP-LC diet exhibited less endothelial dysfunction than littermate mice on an HP-LC diet. These mice were protected from decreased aortic medial cell content, impaired aortic distensibility, and increased plasminogen activator inhibitor 1 secretion. This protective effect came with lower oxidative stress and lower inflammation, with a reduced NLRP3 inflammasome expression, leading to a decrease in cleaved IL-1 beta. We also show the major role of TXNIP in inflammation with a knockdown model, using a TXNIP-specific, small interfering RNA included in a lipoplex. These findings demonstrate a key role for endothelial TXNIP in arterial impairments induced by metabolic stress, making endothelial TXNIP a potential therapeutic target.				valerie.nivet-antoine@parisdescartes.fr	Nivet-Antoine, Valerie/R-1981-2017; Gaussem, Pascale/AGY-9723-2022; Gaussem, P./ABA-1222-2020; Gaussem, Pascale/ABA-2228-2020; Baron, Stephanie/AAY-5703-2020	Nivet-Antoine, Valerie/0000-0003-2490-0428; Gaussem, P./0000-0002-9139-2147; Baron, Stephanie/0000-0002-0375-6968; Escriou, Virginie/0000-0001-5686-9301; Cottart, Charles-Henry/0000-0003-3776-957X; bigey, pascal/0000-0002-6795-8569; Ferreira, Chrystophe/0000-0002-1990-278X; /0000-0002-5493-455X	French Ministry of Research and Technology; INSERM; Paris Descartes University	French Ministry of Research and Technology; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris Descartes University	The authors thank the Cellular and Molecular Imaging Platform (CRP2-UMS3612CNRS-US25 INSERM-IRD) Faculte de Pharmacie, Paris Descartes University, and the Small Animals Platform of the Cochin Institute for Echo-Doppler Assessment. The authors also thank ATT Traduction Technique et Scientifique (Clermont-Ferrand, France) for language editing, Amal Zerrad-Saadi (INSERM, Unite Mixte de Recherche (UMR) S-1139, Paris, France) and Tharmarajan Ramprasath (Madurai Kamaraj University, Madurai, India) for their advice, and Antoine Giraud, Nizar Mahrouk, and Blandine Dizier (INSERM UMR S-1140, Paris, France) for their technical assistance. T.B. and A.D. were supported by funds from the French Ministry of Research and Technology. This work was funded by grants from INSERM and Paris Descartes University. The authors declare no conflicts of interest.	Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Apostolakis Stavros, 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P150, DOI 10.2174/187152508783955006; Arruda DC, 2016, METHODS MOL BIOL, V1445, P137, DOI 10.1007/978-1-4939-3718-9_8; Baron S, 2014, J GERONTOL A-BIOL, V69, P260, DOI 10.1093/gerona/glt081; Bedarida T, 2016, J GERONTOL A-BIOL, V71, P720, DOI 10.1093/gerona/glv071; Bedarida T, 2014, AM J PHYSIOL-HEART C, V307, pH649, DOI 10.1152/ajpheart.00291.2014; Bousserouel S, 2003, J LIPID RES, V44, P601, DOI 10.1194/jlr.M200092-JLR200; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Csiszar A, 2002, CIRC RES, V90, P1159, DOI 10.1161/01.RES.0000020401.61826.EA; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; DESILVA HV, 1994, J LIPID RES, V35, P1297; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Foo SY, 2009, P NATL ACAD SCI USA, V106, P15418, DOI 10.1073/pnas.0907995106; Honjo K, 2017, FASEB J, V31, P2625, DOI 10.1096/fj.201600871RR; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Ishrat T, 2015, MOL NEUROBIOL, V51, P766, DOI 10.1007/s12035-014-8766-x; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; LIBBY P, 1988, J CLIN INVEST, V81, P487, DOI 10.1172/JCI113346; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahmood DFD, 2013, ANTIOXID REDOX SIGN, V19, P1266, DOI 10.1089/ars.2012.4757; Mohamed IN, 2014, DIABETOLOGIA, V57, P413, DOI 10.1007/s00125-013-3101-z; Nivet-Antoine V, 2013, ATHEROSCLEROSIS, V227, P100, DOI 10.1016/j.atherosclerosis.2012.12.015; Nivet-Antoine V, 2010, BIOCHIMIE, V92, P1766, DOI 10.1016/j.biochi.2010.07.018; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Shah A, 2013, J BIOL CHEM, V288, P6835, DOI 10.1074/jbc.M112.419101; Spindel ON, 2012, J CLIN INVEST, V122, P30, DOI 10.1172/JCI61467; Sun D, 2004, AM J PHYSIOL-HEART C, V286, pH2249, DOI 10.1152/ajpheart.00854.2003; Ungvari Z, 2008, CIRC RES, V102, P519, DOI 10.1161/CIRCRESAHA.107.168369; Ungvari Z, 2007, AM J PHYSIOL-HEART C, V293, pH37, DOI 10.1152/ajpheart.01346.2006; Verma S, 2003, CIRCULATION, V108, P2054, DOI 10.1161/01.CIR.0000089191.72957.ED; Wang XQ, 2012, CIRC RES, V110, P560, DOI 10.1161/CIRCRESAHA.111.256362; Wu D, 2017, ARTERIOSCL THROM VAS, V37, P694, DOI 10.1161/ATVBAHA.116.307648; Yoshioka J, 2007, CIRC RES, V101, P1328, DOI 10.1161/CIRCRESAHA.106.160515; Zheng F, 2013, HEART LUNG CIRC, V22, P746, DOI 10.1016/j.hlc.2013.01.012; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zhou RH, 2012, ARTERIOSCL THROM VAS, V32, P745, DOI 10.1161/ATVBAHA.111.243121	38	10	10	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3108	3118		10.1096/fj.201700856RRR	http://dx.doi.org/10.1096/fj.201700856RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401599				2022-12-26	WOS:000432546000018
J	Kegelman, CD; Mason, DE; Dawahare, JH; Horan, DJ; Vigil, GD; Howard, SS; Robling, AG; Bellido, TM; Boerckel, JD				Kegelman, Christopher D.; Mason, Devon E.; Dawahare, James H.; Horan, Daniel J.; Vigil, Genevieve D.; Howard, Scott S.; Robling, Alexander G.; Bellido, Teresita M.; Boerckel, Joel D.			Skeletal cell YAP and TAZ combinatorially promote bone development	FASEB JOURNAL			English	Article						osteogenesis; transcriptional regulation; osteoprogenitor cells; osteoblasts	TRANSCRIPTIONAL CONTROL; TARGETED DISRUPTION; PROCOLLAGEN COL1A1; TRANSGENIC MICE; PROTEIN YAP; COMPLEX; GENE; DIFFERENTIATION; COLLAGEN; MODEL	The functions of the paralogous transcriptional coactivators Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) in bone are controversial. Each has been observed to promote or inhibit osteogenesis in vitro, with reports of both equivalent and divergent functions. Their combinatorial roles in bone physiology are unknown. We report that combinatorial YAP/TAZ deletion from skeletal lineage cells, using Osterix-Cre, caused an osteogenesis imperfecta-like phenotype with severity dependent on allele dose and greater phenotypic expressivity with homozygous TAZ vs. YAP ablation. YAP/TAZ deletion decreased bone accrual and reduced intrinsic bone material properties through impaired collagen content and organization. These structural and material defects produced spontaneous fractures, particularly in mice with homozygous TAZ deletion and caused neonatal lethality in dual homozygous knockouts. At the cellular level in vivo, YAP/TAZ ablation reduced osteoblast activity and increased osteoclast activity, in an allele dose-dependent manner, impairing bone accrual and remodeling. Transcriptionally, YAP/TAZ deletion and small-molecule inhibition of YAP/TAZ interaction with the transcriptional coeffector TEAD reduced osteogenic and collagen-related gene expression, both in vivo and in vitro. These data demonstrate that YAP and TAZ combinatorially promote bone development through regulation of osteoblast activity, matrix quality, and osteoclastic remodeling.	[Kegelman, Christopher D.; Mason, Devon E.; Boerckel, Joel D.] Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Kegelman, Christopher D.; Boerckel, Joel D.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Kegelman, Christopher D.; Mason, Devon E.; Dawahare, James H.; Boerckel, Joel D.] Univ Notre Dame, Dept Aerosp & Mech Engn, Notre Dame, IN USA; [Vigil, Genevieve D.; Howard, Scott S.] Univ Notre Dame, Dept Elect Engn, Notre Dame, IN USA; [Horan, Daniel J.; Robling, Alexander G.; Bellido, Teresita M.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA	University of Pennsylvania; University of Pennsylvania; University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University Bloomington	Boerckel, JD (corresponding author), Univ Penn, G10A Stemmler Hall,3450 Hamilton Walk, Philadelphia, PA 19104 USA.	boerckel@pennmedicine.upenn.edu	Howard, Scott S/D-2900-2011	Howard, Scott S/0000-0003-3246-6799; Mason, Devon/0000-0002-0525-6270; Vigil, Genevieve/0000-0002-7219-1526; Kegelman, Christopher/0000-0001-5359-7128	U.S. National Institutes of Health (NIH) National Center for Advancing Translational Sciences [UL1TR001108]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [T32-AR007132]; National Science Foundation [1435467]; American Heart Association [16SDG31230034]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007132] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Center for Advancing Translational Sciences; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	YAP<SUP>fl/fl</SUP>; TAZ<SUP>fl/fl</SUP> mice were provided by Eric Olson (University of Texas Southwestern Medical Center, Dallas, TX, USA); mouse husbandry and maintenance were performed by Theresa Sikorski (University of Notre Dame). 8xGTIIC luciferase and Renilla constructs were provided by Dr. Munir Tanas (University of Iowa, Iowa City, IA, USA); and 6xOSE2 and 657 bp osteocalcin promoter luciferase constructs were provided by Dr. Ling Qin (University of Pennsylvania). This project was supported in part by U.S. National Institutes of Health (NIH) National Center for Advancing Translational Sciences Grant UL1TR001108 (to J.D.B.) and NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant T32-AR007132 (to C.D.K.), by National Science Foundation Grant 1435467 (to J.D.B.), and by American Heart Association Grant 16SDG31230034 (to J.D.B.). The authors declare no conflicts of interest.	Afzal F, 2005, J CELL PHYSIOL, V204, P63, DOI 10.1002/jcp.20258; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akens MK, 2007, PHOTOCHEM PHOTOBIOL, V83, P1034, DOI 10.1111/j.1751-1097.2007.00172.x; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Byun MR, 2014, CELL DEATH DIFFER, V21, P854, DOI 10.1038/cdd.2014.8; Caroti CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13477-y; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009; CHIPMAN SD, 1993, P NATL ACAD SCI USA, V90, P1701, DOI 10.1073/pnas.90.5.1701; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Deng YJ, 2016, CELL REP, V14, P2224, DOI 10.1016/j.celrep.2016.02.021; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Forlino A, 2016, LANCET, V387, P1657, DOI 10.1016/S0140-6736(15)00728-X; Guss JD, 2017, J BONE MINER RES, V32, P1343, DOI 10.1002/jbmr.3114; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Javed A, 2010, ORAL MAXIL SURG CLIN, V22, P283, DOI 10.1016/j.coms.2010.05.001; Jepsen KJ, 2015, J BONE MINER RES, V30, P951, DOI 10.1002/jbmr.2539; Kaan HYK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02219-9; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Karystinou A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0639-9; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KHILLAN JS, 1991, J BIOL CHEM, V266, P23373; Kim KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092427; Kim M, 2015, CELL REP, V11, P270, DOI 10.1016/j.celrep.2015.03.015; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kourtis LC, 2014, ANN BIOMED ENG, V42, P1773, DOI 10.1007/s10439-014-1027-3; Li HT, 2010, AM J PATHOL, V176, P2405, DOI 10.2353/ajpath.2010.090704; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Miesfeld JB, 2015, DEVELOPMENT, V142, P3021, DOI 10.1242/dev.119008; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nadiarnykh O, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2799538; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Park HW, 2015, CELL, V162, P780, DOI 10.1016/j.cell.2015.07.013; PEREIRA R, 1993, J CLIN INVEST, V91, P709, DOI 10.1172/JCI116252; Rauch F, 2000, BONE, V26, P581, DOI 10.1016/S8756-3282(00)00269-6; RICHTER AM, 1990, J PHOTOCH PHOTOBIO B, V5, P231, DOI 10.1016/1011-1344(90)80008-L; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Schneider P, 2013, BONE, V53, P120, DOI 10.1016/j.bone.2012.11.024; Seo E, 2013, CELL REP, V3, P2075, DOI 10.1016/j.celrep.2013.05.029; Tanas MR, 2016, ONCOGENE, V35, P929, DOI 10.1038/onc.2015.148; Tang Y, 2013, DEV CELL, V25, P402, DOI 10.1016/j.devcel.2013.04.011; Vanleene M, 2012, BONE, V50, P1317, DOI 10.1016/j.bone.2012.03.007; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang L, 2015, CALCIFIED TISSUE INT, V96, P129, DOI 10.1007/s00223-014-9945-5; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056585; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang HB, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac5418; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	62	75	82	1	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2706	2721		10.1096/fj.201700872R	http://dx.doi.org/10.1096/fj.201700872R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401582	Green Published			2022-12-26	WOS:000432528000031
J	van Kruchten, A; Wilden, JJ; Niemann, S; Peters, G; Loffler, B; Ludwig, S; Ehrhardt, C				van Kruechten, Andre; Wilden, Janine J.; Niemann, Silke; Peters, Georg; Loeffler, Bettina; Ludwig, Stephan; Ehrhardt, Christina			Staphylococcus aureus triggers a shift from influenza virus-induced apoptosis to necrotic cell death	FASEB JOURNAL			English	Article						signaling; superinfection; caspase-8; accessory gene regulator locus	PANTON-VALENTINE LEUKOCIDIN; COMMUNITY-ACQUIRED PNEUMONIA; VIRULENCE DETERMINANT; COINFECTION; CLEAVAGE; INFECTION; NECROSIS; RELEASE; PROTEIN; AGR	Superinfections with Staphylococcus aureus are a major complication of influenza disease, causing excessive inflammation and tissue damage. This enhanced cell-damaging effect is also observed in superinfected tissue cultures, leading to a strong decrease in overall cell viability. In our analysis of the underlying molecular mechanisms, we observed that, despite enhanced cell damage in superinfection, S. aureus did not increase but rather inhibited influenza virus (IV)-induced apoptosis in cells on the level of procaspase-8 activation. This apparent contradiction was solved when we observed that S. aureus mediated a switch from apoptosis to necrotic cell death of IV-infected cells, a mechanism that was dependent on the bacterial accessory gene regulator (agr) locus that promotes bacterial survival and spread. This so far unknown action may be a bacterial strategy to enhance dissemination of intracellular S. aureus and may thereby contribute to increased tissue damage and severity of disease.	[van Kruechten, Andre; Wilden, Janine J.; Ludwig, Stephan; Ehrhardt, Christina] Westfaelische Wilhelms Univ WWU Munster, Inst Virol IVM, Munster, Germany; [Peters, Georg; Ludwig, Stephan; Ehrhardt, Christina] Westfaelische Wilhelms Univ WWU Munster, Cells Mot Interfaculty Ctr, Cluster Excellence EXC 1003, Munster, Germany; [van Kruechten, Andre; Niemann, Silke; Peters, Georg] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [Loeffler, Bettina] Jena Univ Hosp, Inst Med Microbiol, Jena, Germany	University of Munster; Friedrich Schiller University of Jena	Ehrhardt, C (corresponding author), Westfaelische Wilhelms Univ, Von Esmarch Str 56, D-48149 Munster, Germany.	ehrhardc@uni-muenster.de		Ludwig, Stephan/0000-0003-4490-3052	Jurgen Manchot Foundation; Deutsche Forschungsgemeinschaft [SFB 1009]; Innovative Medical Research Fund Grant [EH121307]; Interdisziplinares Zentrum fur Klinische Forschung (IZKF; Interdisciplinary Center for Clinical Research) Grant [EhC2/006/15]	Jurgen Manchot Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Innovative Medical Research Fund Grant; Interdisziplinares Zentrum fur Klinische Forschung (IZKF; Interdisciplinary Center for Clinical Research) Grant	This work was supported by the Jurgen Manchot Foundation, Deutsche Forschungsgemeinschaft Grant SFB 1009, Projects B01 and B02; Innovative Medical Research Fund Grant EH121307; and Interdisziplinares Zentrum fur Klinische Forschung (IZKF; Interdisciplinary Center for Clinical Research) Grant EhC2/006/15. The authors declare no conflicts of interest.	Aleandri M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117005; Bischoff M, 2001, J BACTERIOL, V183, P5171, DOI 10.1128/JB.183.17.5171-5179.2001; BREMELL T, 1992, INFECT IMMUN, V60, P2976, DOI 10.1128/IAI.60.7.2976-2985.1992; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Chen KS, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2172-0; Chertow DS, 2013, JAMA-J AM MED ASSOC, V309, P275, DOI 10.1001/jama.2012.194139; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Chi CY, 2014, J INFECT DIS, V209, P224, DOI 10.1093/infdis/jit445; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; George EA, 2007, CHEMBIOCHEM, V8, P847, DOI 10.1002/cbic.200700023; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Grosz M, 2014, CELL MICROBIOL, V16, P451, DOI 10.1111/cmi.12233; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; Hageman JC, 2006, EMERG INFECT DIS, V12, P894, DOI 10.3201/eid1206.051141; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hogner K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003188; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Iverson AR, 2011, J INFECT DIS, V203, P880, DOI 10.1093/infdis/jiq113; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kallen AJ, 2009, ANN EMERG MED, V53, P358, DOI 10.1016/j.annemergmed.2008.04.027; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kitur K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004820; Kobayashi SD, 2013, VIRULENCE, V4, P707, DOI 10.4161/viru.26572; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Korea CG, 2014, INFECT IMMUN, V82, P4144, DOI 10.1128/IAI.01576-14; Koziel J, 2015, J INNATE IMMUN, V7, P187, DOI 10.1159/000368048; Koziel J, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/427021; Koziel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005210; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liedmann S, 2014, J INFECT DIS, V209, P532, DOI 10.1093/infdis/jit463; Loffler B, 2013, EXPERT REV ANTI-INFE, V11, P1041, DOI 10.1586/14787210.2013.827891; LOURIA DB, 1959, J CLIN INVEST, V38, P213, DOI 10.1172/JCI103789; Mayank AK, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.360; McDanel JS, 2016, EMERG INFECT DIS, V22, P1253, DOI 10.3201/eid2207.151319; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Niemann S, 2012, J INFECT DIS, V206, P1138, DOI 10.1093/infdis/jis468; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; Otto M, 2013, INT J MED MICROBIOL, V303, P324, DOI 10.1016/j.ijmm.2013.02.007; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Rasigade JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063176; Saitoh Y, 2016, LEUKEMIA, V30, P716, DOI 10.1038/leu.2015.267; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Siegel SJ, 2014, CELL HOST MICROBE, V16, P55, DOI 10.1016/j.chom.2014.06.005; Sinha B, 2010, INT J MED MICROBIOL, V300, P170, DOI 10.1016/j.ijmm.2009.08.019; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Smith AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003238; Syed AK, 2015, INFECT IMMUN, V83, P3428, DOI 10.1128/IAI.00401-15; Tarquini F, 2014, CELL BIOCHEM FUNCT, V32, P87, DOI 10.1002/cbf.2975; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Tuchscherr L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004870; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Warnking K, 2015, CELL MICROBIOL, V17, P303, DOI 10.1111/cmi.12375; Wilson TR, 2009, CELL DEATH DIFFER, V16, P1352, DOI 10.1038/cdd.2009.76; Wurzer WJ, 2004, J BIOL CHEM, V279, P30931, DOI 10.1074/jbc.M403258200; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Yao ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140604	62	10	10	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2779	2793		10.1096/fj.201701006R	http://dx.doi.org/10.1096/fj.201701006R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401589				2022-12-26	WOS:000432528000037
J	Wong, SSW; Rani, M; Dodagatta-Marri, E; Ibrahim-Granet, O; Kishore, U; Bayry, J; Latge, JP; Sahu, A; Madan, T; Aimanianda, V				Wong, Sarah Sze Wah; Rani, Manjusha; Dodagatta-Marri, Eswari; Ibrahim-Granet, Oumaima; Kishore, Uday; Bayry, Jagadeesh; Latge, Jean-Paul; Sahu, Arvind; Madan, Taruna; Aimanianda, Vishukumar			Fungal melanin stimulates surfactant protein D-mediated opsonization of and host immune response to Aspergillus fumigatus spores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG COLLECTINS; ALVEOLAR MACROPHAGES; PNEUMOCYSTIS-CARINII; LIGAND-BINDING; LECTIN PATHWAY; SP-A; ALPHA; RECOGNITION; DEFENSE; MICE	Surfactant protein D (SP-D), a C-type lectin and pattern-recognition soluble factor, plays an important role in immune surveillance to detect and eliminate human pulmonary pathogens. SP-D has been shown to protect against infections with the most ubiquitous airborne fungal pathogen, Aspergillus fumigatus, but the fungal surface component(s) interacting with SP-D is unknown. Here, we show that SP-D binds to melanin pigment on the surface of A. fumigatus dormant spores (conidia). SP-D also exhibited an affinity to two cell-wall polysaccharides of A. fumigatus, galactomannan (GM) and galactosaminogalactan (GAG). The immunolabeling pattern of SP-D was punctate on the conidial surface and was uniform on germinating conidia, in accordance with the localization of melanin, GM, and GAG. We also found that the collagen-like domain of SP-D is involved in its interaction with melanin, whereas its carbohydrate-recognition domain recognized GM and GAG. Unlike un-opsonized conidia, SP-D-opsonized conidia were phagocytosed more efficiently and stimulated the secretion of proinflammatory cytokines by human monocyte-derived macrophages. Furthermore, SP-D-/- mice challenged intranasally with wildtype conidia or melanin ghosts (i.e. hollow melanin spheres) displayed significantly reduced proinflammatory cytokines in the lung compared with wildtype mice. In summary, SP-D binds to melanin presenton the dormant A. fumigatus conidial surface, facilitates conidial phagocytosis, and stimulates the host immune response.	[Wong, Sarah Sze Wah; Latge, Jean-Paul; Aimanianda, Vishukumar] Inst Pasteur, Unite Aspergillus, F-75015 Paris, France; [Ibrahim-Granet, Oumaima] Inst Pasteur, Unite Rech Cytokines & Inflammat, F-75015 Paris, France; [Rani, Manjusha; Madan, Taruna] ICMR Natl Inst Res Reprod Hlth, Bombay 400012, Maharashtra, India; [Dodagatta-Marri, Eswari; Kishore, Uday] Brunel Univ London, Coll Hlth & Life Sci, Uxbridge UB8 3PH, Middx, England; [Bayry, Jagadeesh] INSERM, Unite 1138, F-75006 Paris, France; [Sahu, Arvind] Natl Ctr Cell Sci, Complement Biol Lab, Pune 411007, Maharashtra, India	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Brunel University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Aimanianda, V (corresponding author), Inst Pasteur, Unite Aspergillus, F-75015 Paris, France.; Madan, T (corresponding author), ICMR Natl Inst Res Reprod Hlth, Bombay 400012, Maharashtra, India.	taruna_m@hotmail.com; vkumar@pasteur.fr	Wong, Sarah/DOH-8455-2022; Wong, Sarah/AAX-5103-2020; Aimanianda, Vishukumar/E-9204-2011; Bayry, Jagadeesh/A-6589-2011	Wong, Sarah/0000-0002-9440-1774; Aimanianda, Vishukumar/0000-0001-5813-7497; Bayry, Jagadeesh/0000-0003-0498-9808; Sahu, Arvind/0000-0003-1664-2422	ANR (L'Agence Nationale de la Recherche) France; Department of Science and Technology (DST) India	ANR (L'Agence Nationale de la Recherche) France(French National Research Agency (ANR)); Department of Science and Technology (DST) India(Department of Science & Technology (India))	This work was supported in part by the bilateral COMASPIN grant from ANR (L'Agence Nationale de la Recherche) France and the Department of Science and Technology (DST) India to (V. A., A. S., and T. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a post-doctoral fellowship from ANR (L'Agence Nationale de la Recherche) France.; Supported by a post-doctoral fellowship from the Department of Science and Technology (DST) India.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Allen MJ, 2001, INFECT IMMUN, V69, P2037, DOI 10.1128/IAI.69.4.2037-2044.2001; Alsteens D, 2013, BIOPHYS J, V105, P320, DOI 10.1016/j.bpj.2013.05.040; Bayry J, 2014, INFECT IMMUN, V82, P3141, DOI 10.1128/IAI.01726-14; Becker KL, 2016, MBIO, V7, DOI 10.1128/mBio.01823-15; Bozza S, 2009, J IMMUNOL, V183, P2407, DOI 10.4049/jimmunol.0900961; Brummer E, 2010, MED MYCOL, V48, P16, DOI 10.3109/13693780903117473; Butler MJ, 1998, CAN J MICROBIOL, V44, P1115, DOI 10.1139/cjm-44-12-1115; Cenci E, 2001, J INFECT DIS, V184, P610, DOI 10.1086/322793; Chai LYA, 2010, IMMUNOBIOLOGY, V215, P915, DOI 10.1016/j.imbio.2009.10.002; Crouch E C, 2000, Respir Res, V1, P93; Crouch EC, 2006, AM J RESP CELL MOL, V35, P84, DOI 10.1165/rcmb.2005-0462OC; Dubourdeau M, 2006, J IMMUNOL, V177, P3994, DOI 10.4049/jimmunol.177.6.3994; Eda S, 1997, BIOCHEM J, V323, P393, DOI 10.1042/bj3230393; Feofilova EP, 2010, MICROBIOLOGY+, V79, P711, DOI 10.1134/S0026261710060019; Ferguson JS, 1999, J IMMUNOL, V163, P312; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Fontaine T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002372; Gafa V, 2007, MICROBES INFECT, V9, P971, DOI 10.1016/j.micinf.2007.03.015; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gow NAR, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0035-2016; Haase G., 2004, MYCOTA, P67; Heinekamp T, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00440; Hickling TP, 2004, J LEUKOCYTE BIOL, V75, P27, DOI 10.1189/jlb.0703304; Jahn B, 2000, INFECT IMMUN, V68, P3736, DOI 10.1128/IAI.68.6.3736-3739.2000; Kay S, 2016, MOL IMMUNOL, V71, P87, DOI 10.1016/j.molimm.2016.01.002; KING RJ, 1972, AM J PHYSIOL, V223, P707, DOI 10.1152/ajplegacy.1972.223.3.707; Kingma PS, 2006, CURR OPIN PHARMACOL, V6, P277, DOI 10.1016/j.coph.2006.02.003; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kishore U, 1996, BIOCHEM J, V318, P505, DOI 10.1042/bj3180505; Kjaer TR, 2013, MOL IMMUNOL, V56, P413, DOI 10.1016/j.molimm.2013.05.007; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lawson PR, 2000, IMMUNOL REV, V173, P66, DOI 10.1034/j.1600-065X.2000.917308.x; LEE RT, 1991, J BIOL CHEM, V266, P4810; Lekkala M, 2006, INFECT IMMUN, V74, P4549, DOI 10.1128/IAI.00243-06; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Ma YJ, 2013, J INNATE IMMUN, V5, P242, DOI 10.1159/000345356; Madan T, 1997, INFECT IMMUN, V65, P3171, DOI 10.1128/IAI.65.8.3171-3179.1997; Madan T, 2001, INFECT IMMUN, V69, P2728, DOI 10.1128/IAI.69.4.2728-2731.2001; Madan T, 2010, MOL IMMUNOL, V47, P1923, DOI 10.1016/j.molimm.2010.02.027; Margalit A, 2015, FEMS MICROBIOL REV, V39, P670, DOI 10.1093/femsre/fuv018; Mehrad B, 1999, J IMMUNOL, V162, P1633; NAGAI H, 1995, J INFECT DIS, V172, P1554, DOI 10.1093/infdis/172.6.1554; Nessa K, 1997, ENVIRON RES, V75, P141, DOI 10.1006/enrs.1997.3788; Palaniyar N, 2002, J BIOL CHEM, V277, P26971, DOI 10.1074/jbc.M110080200; PERSSON A, 1990, J BIOL CHEM, V265, P5755; Pihet M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-177; Rambach G, 2015, J INFECT DIS, V212, P1140, DOI 10.1093/infdis/jiv191; Roilides E, 1999, INFECT IMMUN, V67, P3047, DOI 10.1128/IAI.67.6.3047-3050.1999; Rokade S, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12629; Saitoh M, 2000, BIOCHEMISTRY-US, V39, P1059, DOI 10.1021/bi9917939; Sano H, 2005, MOL IMMUNOL, V42, P279, DOI 10.1016/j.molimm.2004.07.014; Sebens S, 2011, J BIOL CHEM, V286, P40911, DOI 10.1074/jbc.M111.274902; Segal BH, 2006, CLIN INFECT DIS, V42, P507, DOI 10.1086/499811; Shrive AK, 2003, J MOL BIOL, V331, P509, DOI 10.1016/S0022-2836(03)00761-7; Thywissen A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00096; van Rozendaal BAWM, 2000, J INFECT DIS, V182, P917, DOI 10.1086/315799; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Vuk-Pavlovic Z, 2001, AM J RESP CELL MOL, V24, P475, DOI 10.1165/ajrcmb.24.4.3504; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; ZIMMERMAN PE, 1992, J CLIN INVEST, V89, P143, DOI 10.1172/JCI115554	61	24	25	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4901	4912		10.1074/jbc.M117.815852	http://dx.doi.org/10.1074/jbc.M117.815852			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29414772	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000428848300029
J	Hackett, JC				Hackett, John C.			Membrane-embedded substrate recognition by cytochrome P450 3A4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCELERATED MOLECULAR-DYNAMICS; ALPHA-NAPHTHOFLAVONE; LIGAND-BINDING; ACTIVE-SITE; FORCE-FIELD; HETEROTROPIC COOPERATIVITY; SCANNING MUTAGENESIS; INVIVO ACTIVATION; LIPID NANODISCS; METABOLISM	Cytochrome P450 3A4 (CYP3A4) is the dominant xenobiotic-metabolizing enzyme in the liver and intestine and is involved in the disposition of more than 50% of drugs. Because of its ability to bind multiple substrates, its reaction kinetics are complex, and its association with the microsomal membrane confounds our understanding of how this enzyme recognizes and recruits diverse substrates. Testosterone (TST) hydroxylation is the prototypical CYP3A4 reaction, displaying positive homotropic cooperativity with three binding sites. Here, exploiting the capability of accelerated molecular dynamics (aMD) to sample events in the millisecond regime, I performed >25-mu s a MD simulations in the presence of three TST molecules. These simulations identified high-occupancy surface-binding sites as well as a pathway for TST ingress into the CYP3A4 active site originating in the membrane. Adaptive biasing force analysis of the latter pathway revealed a metastable intermediate that could constitute a third binding site at high TST concentrations. Prompted by the observation that interactions between TST and the G'-helix mobilize the ligand into the active site, a free-energy analysis of TST distribution in the membrane was conducted and revealed that the depth of the G'-helix is optimal for extracting TST. In summary, these simulations confirm separate, but adjacent substrate-binding sites within the enzyme and the existence of an auxiliary TST-binding site. The broader impact of these simulations is that they support a mechanism in which cytochromes P450 directly recruit membrane-solubilized substrates.	[Hackett, John C.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Hackett, John C.] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Hackett, JC (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Goodwin Res Lab, 401 Coll St, Richmond, VA 23298 USA.	john.hackett@vcuhealth.org	Hackett, John/J-3871-2019	Hackett, John/0000-0002-4923-2668	National Institutes of Health [R01GM114168]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM114168 (to J. C. H.). The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003; Baylon JL, 2013, J AM CHEM SOC, V135, P8542, DOI 10.1021/ja4003525; Berka K, 2013, J PHYS CHEM B, V117, P11556, DOI 10.1021/jp4059559; Cameron MD, 2007, CHEM RES TOXICOL, V20, P1434, DOI 10.1021/tx7000702; Comer J, 2015, J PHYS CHEM B, V119, P1129, DOI 10.1021/jp506633n; Conner KP, 2011, ARCH BIOCHEM BIOPHYS, V507, P56, DOI 10.1016/j.abb.2010.10.006; Domanski TL, 2000, J PHARMACOL EXP THER, V293, P585; Domanski TL, 1998, ARCH BIOCHEM BIOPHYS, V350, P223, DOI 10.1006/abbi.1997.0525; Domanski TL, 2001, BIOCHEMISTRY-US, V40, P10150, DOI 10.1021/bi010758a; Frank DJ, 2011, J BIOL CHEM, V286, P5540, DOI 10.1074/jbc.M110.182055; Frank DJ, 2009, ARCH BIOCHEM BIOPHYS, V488, P146, DOI 10.1016/j.abb.2009.06.013; Giorgino T, 2014, COMPUT PHYS COMMUN, V185, P317, DOI 10.1016/j.cpc.2013.08.022; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Harlow GR, 1997, J BIOL CHEM, V272, P5396, DOI 10.1074/jbc.272.9.5396; Harlow GR, 1998, P NATL ACAD SCI USA, V95, P6636, DOI 10.1073/pnas.95.12.6636; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; Kapelyukh Y, 2008, DRUG METAB DISPOS, V36, P2136, DOI 10.1124/dmd.108.021733; Kappel K, 2015, Q REV BIOPHYS, V48, P479, DOI 10.1017/S0033583515000153; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; LASKER JM, 1984, J PHARMACOL EXP THER, V229, P162; LASKER JM, 1982, SCIENCE, V216, P1419, DOI 10.1126/science.7089530; Lonsdale R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003714; Luthra A, 2013, Methods Mol Biol, V987, P115, DOI 10.1007/978-1-62703-321-3_10; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mak PJ, 2008, BIOCHEMISTRY-US, V47, P3950, DOI 10.1021/bi800034b; Mak PJ, 2011, J AM CHEM SOC, V133, P1357, DOI 10.1021/ja105869p; McClary WD, 2016, BIOCHEMISTRY-US, V55, P6258, DOI 10.1021/acs.biochem.6b00715; Miao YL, 2016, P NATL ACAD SCI USA, V113, P12162, DOI 10.1073/pnas.1614538113; Miao YL, 2014, PHYS CHEM CHEM PHYS, V16, P6398, DOI 10.1039/c3cp53962h; Miao YL, 2013, P NATL ACAD SCI USA, V110, P10982, DOI 10.1073/pnas.1309755110; Nath A, 2007, J BIOL CHEM, V282, P28309, DOI 10.1074/jbc.M703568200; Oda Y, 2001, J PHARMACOL EXP THER, V298, P1021; Ohkubo YZ, 2012, BIOPHYS J, V102, P2130, DOI 10.1016/j.bpj.2012.03.015; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c; Ramirez CL, 2016, METHOD ENZYMOL, V578, P123, DOI 10.1016/bs.mie.2016.05.029; Rendic S, 2002, DRUG METAB REV, V34, P83, DOI 10.1081/DMR-120001392; Rendic S, 2012, CHEM RES TOXICOL, V25, P1316, DOI 10.1021/tx300132k; Roberts AG, 2007, ARCH BIOCHEM BIOPHYS, V463, P89, DOI 10.1016/j.abb.2007.03.006; SCHWAB GE, 1988, MOL PHARMACOL, V33, P493; Sevrioukova IF, 2017, P NATL ACAD SCI USA, V114, P486, DOI 10.1073/pnas.1616198114; Sevrioukova IF, 2015, BIOCHEMISTRY-US, V54, P4083, DOI 10.1021/acs.biochem.5b00510; SHOU M, 1994, BIOCHEMISTRY-US, V33, P6450, DOI 10.1021/bi00187a009; Shou M, 2001, J BIOL CHEM, V276, P2256, DOI 10.1074/jbc.M008799200; Treuheit NA, 2016, BIOCHEMISTRY-US, V55, P1058, DOI 10.1021/acs.biochem.5b01313; Ueng YF, 1997, BIOCHEMISTRY-US, V36, P370, DOI 10.1021/bi962359z; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vijayan R, 2008, BIOPHYS J, V95, pL45, DOI [10.1529/biophysj.108.140087, 10.1529/biophysj.l08.140087]; WAXMAN DJ, 1988, ARCH BIOCHEM BIOPHYS, V263, P424, DOI 10.1016/0003-9861(88)90655-8; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Woods CM, 2011, BIOCHEMISTRY-US, V50, P10041, DOI 10.1021/bi2013454; Yang J, 2012, CLIN PHARMACOL THER, V91, P442, DOI 10.1038/clpt.2011.178; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Zhao CS, 2012, BIOCHEMISTRY-US, V51, P9488, DOI 10.1021/bi301069r	58	25	25	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4037	4046		10.1074/jbc.RA117.000961	http://dx.doi.org/10.1074/jbc.RA117.000961			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29382727	Green Published, hybrid			2022-12-26	WOS:000427587500016
J	Chen, DL; Huang, HJ; Byers, DE; Shifren, A; Belikoff, B; Engle, JT; Arentson, E; Kemp, D; Phillips, S; Scherrer, DE; Fujiwara, H; Spayd, KJ; Brooks, FJ; Pierce, RA; Castro, M; Isakow, W				Chen, Delphine L.; Huang, Howard J.; Byers, Derek E.; Shifren, Adrian; Belikoff, Bryan; Engle, Jacquelyn T.; Arentson, Elizabeth; Kemp, Debra; Phillips, Sharon; Scherrer, David E.; Fujiwara, Hideji; Spayd, Katherine J.; Brooks, Frank J.; Pierce, Richard A.; Castro, Mario; Isakow, Warren			The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort study	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; OBSTRUCTIVE PULMONARY-DISEASE; BRAIN TRANSFER CONSTANTS; AIR-FLOW LIMITATION; TIME UPTAKE DATA; GRAPHICAL EVALUATION; CELL ACTIVATION; ASTHMA; INJURY; GAMMA	Background Anti-inflammatory drug development efforts for lung disease have been hampered in part by the lack of noninvasive inflammation biomarkers and the limited ability of animal models to predict efficacy in humans. We used F-18-fluorodeoxyglucose (F-18-FDG) positron emission tomography (PET) in a human model of lung inflammation to assess whether pioglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist, and zileuton, a 5-lipoxygenase inhibitor, reduce lung inflammation. Methods For this single center, single-blind, placebo-controlled cohort study, we enrolled healthy volunteers sequentially into the following treatment cohorts (N = 6 per cohort): pioglitazone plus placebo, zileuton plus placebo, or dual placebo prior to bronchoscopic endotoxin instillation. F-18-FDG uptake pre- and post-endotoxin was quantified as the Patlak graphical analysis-determined K-i (primary outcome measure). Secondary outcome measures included the mean standard uptake value (SUVmean), post-endotoxin bronchoalveolar lavage (BAL) cell counts and differentials and blood adiponectin and urinary leukotriene E-4 (LTE4) levels, determined by enzyme-linked immunosorbent assay, to verify treatment compliance. Oneor two-way analysis of variance assessed for differences among cohorts in the outcome measures (expressed as mean +/- standard deviation). Results Ten females and eight males (29 +/- 6 years of age) completed all study procedures except for one volunteer who did not complete the post-endotoxin BAL. K-i and SUVmean increased in all cohorts after endotoxin instillation (Ki increased by 0.0021 +/- 0.0019, 0.0023 +/- 0.0017, and 0.0024 +/- 0.0020 and SUVmean by 0.47 +/- 0.14, 0.55 +/- 0.15, and 0.54 +/- 0.38 in placebo, pioglitazone, and zileuton cohorts, respectively, p<0.001) with no differences among treatment cohorts (p = 0.933). Adiponectin levels increased as expected with pioglitazone treatment but not urinary LTE4 levels as expected with zileuton treatment. BAL cell counts (p = 0.442) and neutrophil percentage (p = 0.773) were similar among the treatment cohorts. Conclusions Endotoxin-induced lung inflammation in humans is not responsive to pioglitazone or zileuton, highlighting the challenge in translating anti-inflammatory drug efficacy results from murine models to humans.	[Chen, Delphine L.; Belikoff, Bryan; Engle, Jacquelyn T.; Arentson, Elizabeth; Phillips, Sharon; Spayd, Katherine J.; Brooks, Frank J.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Div Radiol Sci, St Louis, MO USA; [Chen, Delphine L.; Byers, Derek E.; Shifren, Adrian; Pierce, Richard A.; Castro, Mario; Isakow, Warren] Washington Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA; [Huang, Howard J.] Baylor Univ, Med Ctr, Annette C & Harold C Simmons Transplant Inst, Dallas, TX USA; [Kemp, Debra] Washington Univ, Sch Med, Ctr Clin Studies, St Louis, MO USA; [Scherrer, David E.] Washington Univ, Sch Med, Dept Internal Med, Cardiovasc Div, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Baylor University; Baylor University Medical Center; Washington University (WUSTL); Washington University (WUSTL)	Chen, DL (corresponding author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Div Radiol Sci, St Louis, MO USA.; Chen, DL (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA.	chend@wustl.edu	Brooks, Frank/AAM-3677-2021	Chen, Delphine/0000-0002-0150-5401	Doris Duke Clinical Scientist Development Award [2010060]; National Heart, Lung and Blood Institute [R01 HL116389]; Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences [UL1 TR000448]; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) [P30 DK020579]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002345, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the Doris Duke Clinical Scientist Development Award 2010060 to DLC (http://www.ddcf.org/what-we-fund/medical-research/goals-and-strategies/encourage-and-develop-clinical-research-careers/clinical-scientist-development-award/) as well as the National Heart, Lung and Blood Institute grant R01 HL116389 to DLC, the Washington University Institute of Clinical and Translational Sciences grant UL1 TR000448 from the National Center for Advancing Translational Sciences, and P30 DK020579 from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH.	Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Bastarache JA, 2009, DIS MODEL MECH, V2, P218, DOI 10.1242/dmm.001677; Bellani G, 2011, AM J RESP CRIT CARE, V183, P1193, DOI 10.1164/rccm.201008-1318OC; Bellani G, 2009, CRIT CARE MED, V37, P2216, DOI 10.1097/CCM.0b013e3181aab31f; Broughton KS, 1997, AM J CLIN NUTR, V65, P1011, DOI 10.1093/ajcn/65.4.1011; Chen DL, 2017, J NUCL MED, V58, P201, DOI 10.2967/jnumed.116.184796; Chen DL, 2009, AM J RESP CRIT CARE, V180, P533, DOI 10.1164/rccm.200904-0501OC; Chen DL, 2006, J APPL PHYSIOL, V100, P1602, DOI 10.1152/japplphysiol.01429.2005; Chen DL, 2004, J NUCL MED, V45, P1583; Collin M, 2004, J LEUKOCYTE BIOL, V76, P961, DOI 10.1189/jlb.0604338; de Torre C, 2006, PROTEOMICS, V6, P3949, DOI 10.1002/pmic.200500693; Di Stefano A, 1998, AM J RESP CRIT CARE, V158, P1277, DOI 10.1164/ajrccm.158.4.9802078; Franciosi LG, 2006, PULM PHARMACOL THER, V19, P189, DOI 10.1016/j.pupt.2005.05.001; Genovese S, 2013, ADV THER, V30, P190, DOI 10.1007/s12325-013-0003-x; Grommes J, 2012, EUR RESPIR J, V40, P416, DOI 10.1183/09031936.00091011; Haffner SM, 2002, CIRCULATION, V106, P679, DOI 10.1161/01.CIR.0000025403.20953.23; Hashemian SMR, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-21; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Holman BF, 2016, PHYS MED BIOL, V61, P3148, DOI 10.1088/0031-9155/61/8/3148; Huang HJ, 2015, J NUCL MED, V56, P76, DOI 10.2967/jnumed.114.146381; Ito K, 2004, EUR J CARDIO-THORAC, V25, P530, DOI 10.1016/j.ejcts.2003.12.017; Jennings JE, 2008, AM J HEMATOL, V83, P640, DOI 10.1002/ajh.21199; Jones HA, 2003, EUR RESPIR J, V21, P567, DOI 10.1183/09031936.03.00048502; Kane GC, 1996, J ALLERGY CLIN IMMUN, V97, P646, DOI 10.1016/S0091-6749(96)70310-X; Langley GR, 2016, DRUG DISCOV TODAY; Larsson BM, 2006, RESP MED, V100, P226, DOI 10.1016/j.rmed.2005.04.020; Lauredo IT, 1998, J APPL PHYSIOL, V85, P2298, DOI 10.1152/jappl.1998.85.6.2298; Lee W L, 2001, Curr Opin Crit Care, V7, P1, DOI 10.1097/00075198-200102000-00001; Levitt JE, 2016, EXPERT REV PROTEOMIC, V13, P457, DOI 10.1586/14789450.2016.1172481; LIN JH, 1995, DRUG METAB DISPOS, V23, P1008; Marder W, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000441; Martin TR, 2002, J CLIN INVEST, V110, P1603, DOI 10.1172/JCI200217302; Martinez FJ, 2011, LANCET, V378, P1027, DOI 10.1016/S0140-6736(11)61047-7; MILLER EJ, 1992, AM REV RESPIR DIS, V146, P427, DOI 10.1164/ajrccm/146.2.427; Musther H, 2014, EUR J PHARM SCI, V57, P280, DOI 10.1016/j.ejps.2013.08.018; National Institutes of Health National Heart Lung and Blood Institute, 2012, MORB MORT 2012 CHART; O'Grady NP, 2001, AM J RESP CRIT CARE, V163, P1591, DOI 10.1164/ajrccm.163.7.2009111; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Reddy RC, 2008, BLOOD, V112, P4250, DOI 10.1182/blood-2007-12-128967; Ruthman CA, 2015, THER ADV RESPIR DIS, V9, P173, DOI 10.1177/1753465815585716; Schaller G, 2008, HORM METAB RES, V40, P549, DOI 10.1055/s-2008-1076698; Sharma R, 2009, PULM PHARMACOL THER, V22, P183, DOI 10.1016/j.pupt.2008.11.011; Shaw DE, 2007, CHEST, V132, P1871, DOI 10.1378/chest.07-1047; Sidhu JS, 2003, J AM COLL CARDIOL, V42, P1757, DOI 10.1016/j.jacc.2003.04.001; Singh D, 2007, AM J RESP CRIT CARE, V176, P988, DOI 10.1164/rccm.200704-588OC; Sobrado M, 2009, J NEUROSCI, V29, P3875, DOI 10.1523/JNEUROSCI.5529-08.2009; Spencer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102190; Subramanian DR, 2012, AM J RESP CRIT CARE, V186, P1125, DOI 10.1164/rccm.201201-0051OC; Tecklenburg SL, 2007, RESP MED, V101, P1770, DOI 10.1016/j.rmed.2007.02.014; Thomson NC, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02061-2016; Vargaftig BB, 2003, AM J PHYSIOL-LUNG C, V285, pL808, DOI 10.1152/ajplung.00377.2002; Wang ACC, 2001, AM J RESP CELL MOL, V24, P688, DOI 10.1165/ajrcmb.24.6.4376; WENZEL SE, 1995, AM J RESP CRIT CARE, V152, P897, DOI 10.1164/ajrccm.152.3.7663802; Williams AE, 2014, AM J PHYSIOL-LUNG C, V306, pL217, DOI 10.1152/ajplung.00311.2013; Woodruff PG, 2001, J ALLERGY CLIN IMMUN, V108, P753, DOI 10.1067/mai.2001.119411	56	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0191783	10.1371/journal.pone.0191783	http://dx.doi.org/10.1371/journal.pone.0191783			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414995	Green Published, gold, Green Submitted			2022-12-26	WOS:000424325300040
J	Gill, MM; Mofenson, LM; Phalatse, M; Tukei, V; Guay, L; Nchephe, M				Gill, Michelle M.; Mofenson, Lynne M.; Phalatse, Mamakhetha; Tukei, Vincent; Guay, Laura; Nchephe, Matsepeli			Piloting very early infant diagnosis of HIV in Lesotho: Acceptability and feasibility among mothers, health workers and laboratory personnel	PLOS ONE			English	Article							SOUTH-AFRICA; ANTIRETROVIRAL THERAPY; MORTALITY; TRANSMISSION; INFECTION	Introduction Mortality associated with in-utero HIV infection rises rapidly within weeks after birth. Very early infant diagnosis of HIV (VEID)-testing within 2 weeks of birth-followed by immediate initiation of antiretroviral therapy has potential to avert mortality associated with in-utero transmission. However, our understanding of acceptability and feasibility of VEID is limited. Methods VEID was piloted in an observational prospective cohort of HIV-positive pregnant women and their infants in 13 Lesotho health facilities. Between March-July 2016, semi-structured interviews were conducted with HIV-positive women attending 6-week or 14-week postnatal visits and health workers (HWs) in 8 study facilities in 3 districts as well as with district and central laboratory staff. Interview themes included acceptability of birth and subsequent HIV testing and early treatment, perceived VEID challenges, and HIV birth testing procedures and how well they were performed. Results Interviews were conducted with 20 women, 18 HWs and 9 district/central laboratory staff. Nearly all mothers perceived knowing their child's HIV status at birth positively. Mothers and HWs did not indicate that birth testing affected subsequent acceptance of infant HIV testing or clinic attendance. HWs and laboratory staff reported weak follow-up systems for mothers with home deliveries, and concern regarding the increased workload associated with additional testing requirements. All groups reported turnaround time delays for EID, and that sometimes results were never received. Conclusions Women, HWs, and laboratory staff found VEID acceptable and were supportive of national implementation of birth testing. However, they identified challenges within the EID system that could be exacerbated by adding a test to the diagnostic algorithm, such as delays in receiving test results, suggesting VEID may not be feasible in certain settings. Policymakers will need to consider whether adding birth testing or strengthening the current clinic and laboratory system is the most appropriate course of action.	[Gill, Michelle M.; Mofenson, Lynne M.; Guay, Laura] Elizabeth Glaser Pediat AIDS Fdn, Project SOAR Supporting Operat AIDS Res, Washington, DC 20036 USA; [Phalatse, Mamakhetha; Nchephe, Matsepeli] Minist Hlth, Maseru, Lesotho; [Tukei, Vincent] Elizabeth Glaser Pediat AIDS Fdn, Project SOAR Supporting Operat AIDS Res, Maseru, Lesotho; [Guay, Laura] George Washington Univ, Dept Epidemiol & Biostat, Milken Inst Sch Publ Hlth, Washington, DC USA	George Washington University	Gill, MM (corresponding author), Elizabeth Glaser Pediat AIDS Fdn, Project SOAR Supporting Operat AIDS Res, Washington, DC 20036 USA.	mgill@pedaids.org	Mofenson, Lynne/P-9631-2019; Tukei, Vincent/GNH-5270-2022	Mofenson, Lynne/0000-0002-2818-9808; Tukei, Vincent Joseph/0000-0002-9525-2600	United States Agency for International Development [AID-OAA-14-00060]	United States Agency for International Development(United States Agency for International Development (USAID))	This work was supported by United States Agency for International Development: Cooperative Agreement AID-OAA-14-00060 (https://www.usaid.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 8 INT WORKSH HIV PED; Bourne DE, 2009, AIDS, V23, P101, DOI 10.1097/QAD.0b013e32831c54bd; Francke JA, 2016, J INFECT DIS, V214, P1319, DOI 10.1093/infdis/jiw379; Gous NM, 2016, JAIDS-J ACQ IMM DEF, V71, pE34, DOI 10.1097/QAI.0000000000000872; Innes S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18914; International Community of Women Living with HIV (ICW) and Global Network of People Living with HIV (GNP+), 2015, EARL INF DIAGN UND P; Lesotho Ministry of Health and ICF International, 2016, LES DEM HLTH SURV; Lilian RR, 2014, JAIDS-J ACQ IMM DEF, V67, P341, DOI 10.1097/QAI.0000000000000307; Lilian RR, 2013, PEDIATR INFECT DIS J, V32, P1080, DOI 10.1097/INF.0b013e318290622e; Loomba Foundation, 2015, GLOB WID REP 2015 GL; Magder LS, 2005, JAIDS-J ACQ IMM DEF, V38, P87, DOI 10.1097/00126334-200501010-00016; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; Maritz J, 2016, C RETR OPP INF BOST; Marston M, 2011, INT J EPIDEMIOL, V40, P385, DOI 10.1093/ije/dyq255; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Pham MD, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1588-y; Smith SJ, 2014, PAEDIATR INT CHILD H, V34, P203, DOI 10.1179/2046905514Y.0000000119; Technau K-G, 2015, C RETR OPP INF SEATT; Tiam A, 2016, 8 INT WORKSH HIV PED; UNAIDS, 2016, FAST TRACK AIDS FREE; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971	21	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0190874	10.1371/journal.pone.0190874	http://dx.doi.org/10.1371/journal.pone.0190874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415011	Green Submitted, gold, Green Published			2022-12-26	WOS:000424325300012
J	Zhai, SS; Xu, HT; Fan, CM; Yang, YJ; Hang, F; Guo, XY; Wang, HY; Duan, FJ; Yan, J				Zhai, Shanshan; Xu, Haitao; Fan, Chaomei; Yang, Yinjian; Hang, Fei; Guo, Xiying; Wang, Hongyue; Duan, Fujian; Yan, Jun			Mid-term outcomes of biventricular obstruction and left ventricular outflow tract obstruction after surgery correction in child and adolescent patients with hypertrophic cardiomyopathy	PLOS ONE			English	Article							PRESSURE-GRADIENTS; SURGICAL-TREATMENT; SEPTAL MYECTOMY; CIBENZOLINE; MANAGEMENT; DIAGNOSIS; FUTURE; DEATH	Background Data on the outcomes of hypertrophic cardiomyopathy (HCM) with biventricular obstruction are limited. Objective Our aim is to compare mid-term outcomes of biventricular outflow tract obstruction (BVOTO) HCM, left ventricular outflow tract obstruction (LVOTO) HCM and nonobstructive hypertrophic cardiomyopathy (NO-HCM) in children and adolescents who were treated with standard medication or surgical resection. Methods This retrospective study identified 21 BVOTO patients and recruited 27 LVOTO and 24 NO-HCM patients younger than 18 years presenting at our institution. The primary endpoint was all-cause death, and secondary endpoints were cardiovascular events. Results More BVOTO patients (61.9%) than LVOTO (19.2%) and NO-HCM patients (25%) exhibited New York Heart Association (NYHA) III/IV status (p < 0.01). Fourteen BVOTO and 16 LVOTO patients obtained a significant reduction of outflow tract pressure gradients after surgery (vs. preoperative baseline, p < 0.001). One of the 14 BVOTO patients died, whereas no deaths occurred among LVOTO patients. Three of 14 BVOTO surgery patients had complete heart block (CHB) and 4 had new right bundle branch block (RBBB), while no CHB or RBBB occurred in the LVOTO surgery patients. The BVOTO patients had a longer duration of aortic cross-clamping and postoperative hospital days than the LVOTO patients (p < 0.05). During a median 42-month follow-up, no deaths occurred among the remaining patients. The primary and secondary endpoint-free survival rates of the BVOTO group were comparable to those of the LVOTO and NO-HCM groups. Conclusions In children and adolescents, BVOTO patients were associated with more severe symptoms than LVOTO and NO-HCM patients; however, good mid-term outcomes similar to those of the LVOTO and NO-HCM groups can be achieved with the application of contemporary cardiovascular treatment strategies. Notably, BVOTO surgery was associated with an increased risk of CHB and RBBB compared to LVOTO surgery.	[Zhai, Shanshan; Fan, Chaomei; Yang, Yinjian; Hang, Fei; Guo, Xiying] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Minist HlthKey Lab Clinical Trial Res Cardiovascu, Beijing, Peoples R China; [Zhai, Shanshan; Xu, Haitao; Fan, Chaomei; Yang, Yinjian; Hang, Fei; Guo, Xiying; Wang, Hongyue; Duan, Fujian; Yan, Jun] Peking Union Med Coll, Beijing, Peoples R China; [Xu, Haitao; Yan, Jun] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Dept Pediat Cardiovasc Surg, Beijing, Peoples R China; [Wang, Hongyue] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Dept Pathol, Beijing, Peoples R China; [Duan, Fujian] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Dept Echocardiog, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Yan, J (corresponding author), Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Dept Pediat Cardiovasc Surg, Beijing, Peoples R China.	yanjun1112aliyun@163.com						BARR PA, 1973, BRIT HEART J, V35, P1109; BRIK H, 1978, J CLIN ULTRASOUND, V6, P121, DOI 10.1002/jcu.1870060216; Butz T, 2008, EUR J ECHOCARDIOGR, V9, P403, DOI [10.1093/ejechocard/jen153, 10.1093/ejechocard/jem074, 10.1016/j.euje.2007.02.006, 10.1093/ejechocard/jen018, 10.1093/ejechocard/jen026]; Christiaans I, 2010, EUROPACE, V12, P313, DOI 10.1093/europace/eup431; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Guo XY, 2015, CARDIOLOGY, V133, P35, DOI 10.1159/000439345; Heper G, 2010, TURK KARDIYOL DERN A, V38, P206; Hiasa G, 2002, CIRC J, V66, P1173, DOI 10.1253/circj.66.1173; Hirapur I, 2014, BMJ CASE REP, V2014; Howell N, 2015, ECHO RES PRACT, V2, pR37, DOI 10.1530/ERP-15-0005; Ishikawa T, 2010, PEDIATR CARDIOL, V31, P707, DOI 10.1007/s00246-010-9651-7; Krecki R, 2007, CIRCULATION, V116, pE551, DOI 10.1161/CIRCULATIONAHA.107.703843; Malik R, 2014, ECHOCARDIOGR-J CARD, V31, P682, DOI 10.1111/echo.12543; Maron BJ, 2014, J AM COLL CARDIOL, V64, P83, DOI 10.1016/j.jacc.2014.05.003; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2000, CIRCULATION, V102, P858; MARON BJ, 1982, CIRCULATION, V65, P7, DOI 10.1161/01.CIR.65.1.7; MARON BJ, 1993, AM J CARDIOL, V71, P1089, DOI 10.1016/0002-9149(93)90578-Z; Maron MS, 2007, AM J CARDIOL, V100, P1293, DOI 10.1016/j.amjcard.2007.05.061; McCully RB, 1996, CIRCULATION, V94, P467, DOI 10.1161/01.CIR.94.3.467; Nelson SE, 2013, TEX HEART I J, V40, P367; Ommen SR, 2008, HEART, V94, P1276, DOI 10.1136/hrt.2008.154435; Parato VM, 2016, CARDIOVASC ULTRASOUN, V14, DOI 10.1186/s12947-016-0072-5; Quintana E, 2015, EUR J CARDIO-THORAC, V47, P1006, DOI 10.1093/ejcts/ezu313; Recupero A, 2010, INT J CARDIOL, V144, pE56, DOI 10.1016/j.ijcard.2008.12.082; Schaff HV, 2012, J THORAC CARDIOV SUR, V143, P303, DOI 10.1016/j.jtcvs.2011.10.059; Shimizu M, 2003, CIRC J, V67, P855, DOI 10.1253/circj.67.855; Theodoro DA, 1996, J THORAC CARDIOV SUR, V112, P1589, DOI 10.1016/S0022-5223(96)70018-1; Valeti US, 2007, J AM COLL CARDIOL, V49, P350, DOI 10.1016/j.jacc.2006.08.055; Vriesendorp PA, 2014, JACC-HEART FAIL, V2, P630, DOI 10.1016/j.jchf.2014.06.012; Woo Anna, 2007, Heart Fail Clin, V3, P275, DOI 10.1016/j.hfc.2007.04.010	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192218	10.1371/journal.pone.0192218	http://dx.doi.org/10.1371/journal.pone.0192218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408870	gold, Green Submitted, Green Published			2022-12-26	WOS:000424302800050
J	Chandrasegaran, K; Kandregula, SR; Quader, S; Juliano, SA				Chandrasegaran, Karthikeyan; Kandregula, Samyuktha Rao; Quader, Suhel; Juliano, Steven A.			Context-dependent interactive effects of non-lethal predation on larvae impact adult longevity and body composition	PLOS ONE			English	Article							INDUCED PHENOTYPIC PLASTICITY; CONTAINER-DWELLING MOSQUITOS; AEDES-AEGYPTI DIPTERA; LIFE-HISTORY TRAITS; WATER-BORNE CUES; PREY INTERACTIONS; BEHAVIORAL-RESPONSES; FOOD AVAILABILITY; DEVELOPMENT TIME; ECOLOGICAL CONSEQUENCES	Predation impacts development, behavior and morphology of prey species thereby shaping their abundances, distribution and community structure. Non-lethal threat of predation, specifically, can have a strong influence on prey lifehistory characteristics. While investigations often focus on the impact of predation threat on prey in isolation, tests of its interactive effects with food availability and resource competition on prey survival and fitness can improve understanding of costs, benefits and trade-offs of anti-predator strategies. This study, involving Aedes aegypti mosquitoes as a model organism, investigates both simple and interactive effects of predation threat during the larval stage on survival, size at and time to maturity, stored teneral reserves of glycogen, protein and lipid in adults, and adult longevity. Our results show that development times of mosquito larvae were increased (by 14.84% in males and by 97.63% in females), and size of eclosing adults decreased (by 62.30% in males and by 58.33% in females) when exposed to lowered nutrition and elevated intraspecific competition, but that predation had no detectable effect on these simple traits. Teneral reserves of glycogen, protein and lipid and adult longevity were positively correlated with adult body size. Non-lethal predation threat had significant interactive effects with nutrition and larval competition on teneral reserves in males and adult longevity in males and females. The sexes responded differently to conditions encountered as larvae, with the larval environment affecting development and adult characteristics more acutely for females than for males. The outcome of this study shows how threat of predation on juveniles can have long-lasting effects on adults that are likely to impact mosquito population dynamics and that may impact disease transmission.	[Chandrasegaran, Karthikeyan; Kandregula, Samyuktha Rao; Quader, Suhel] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru, Karnataka, India; [Chandrasegaran, Karthikeyan; Juliano, Steven A.] Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA; [Chandrasegaran, Karthikeyan] SASTRA Univ, Thanjavur, Tamil Nadu, India; [Chandrasegaran, Karthikeyan] Indian Inst Sci, Ctr Ecol Sci, Bengaluru, Karnataka, India; [Quader, Suhel] Nat Conservat Fdn, Mysuru, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Illinois State University; Shanmugha Arts, Science, Technology & Research Academy (SASTRA); Indian Institute of Science (IISC) - Bangalore	Chandrasegaran, K (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru, Karnataka, India.; Chandrasegaran, K (corresponding author), Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA.; Chandrasegaran, K (corresponding author), SASTRA Univ, Thanjavur, Tamil Nadu, India.; Chandrasegaran, K (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bengaluru, Karnataka, India.	karthikeyanc@ncbs.res.in	Chandrasegaran, Karthikeyan/I-4037-2019	Chandrasegaran, Karthikeyan/0000-0001-8262-1510; Juliano, Steven/0000-0002-6178-4553	US-India Educational Foundation, New Delhi (India); Institute of International Education, New York (USA); Institute of International Education; School of Biological Sciences, Illinois State University; National Institute of Health [1R15AI094322-01A1]; National Centre for Biological Sciences, India	US-India Educational Foundation, New Delhi (India); Institute of International Education, New York (USA); Institute of International Education; School of Biological Sciences, Illinois State University; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centre for Biological Sciences, India	This research was supported by: Fulbright-Nehru Doctoral Research Fellowship 2014-15 from the US-India Educational Foundation, New Delhi (India) and the Institute of International Education, New York (USA) to KC; 2015 Patel Grant sponsored by the Institute of International Education to KC; R.D.Wiegel Phi Sigma Research Grant from the School of Biological Sciences, Illinois State University all to KC; by National Institute of Health grant 1R15AI094322-01A1 to SAJ; and by National Centre for Biological Sciences, India support to SQ.	ABRAMS PA, 1991, ECOLOGY, V72, P1242, DOI 10.2307/1941098; Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Agnew P, 2002, ECOL ENTOMOL, V27, P396, DOI 10.1046/j.1365-2311.2002.00430.x; Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497; Alto BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045785; Alto BW, 2005, ECOLOGY, V86, P3279, DOI 10.1890/05-0209; Altwegg R, 2003, OECOLOGIA, V136, P46, DOI 10.1007/s00442-003-1248-x; Altwegg R, 2002, ECOLOGY, V83, P2542, DOI 10.2307/3071813; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; BALL SL, 1995, FRESHWATER BIOL, V34, P1, DOI 10.1111/j.1365-2427.1995.tb00417.x; BAY EC, 1974, ANNU REV ENTOMOL, V19, P441, DOI 10.1146/annurev.en.19.010174.002301; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Bedhomme S, 2003, J EVOLUTION BIOL, V16, P721, DOI 10.1046/j.1420-9101.2003.00576.x; Belovsky GE, 2011, ECOL LETT, V14, P335, DOI 10.1111/j.1461-0248.2011.01591.x; Benard MF, 2004, ANNU REV ECOL EVOL S, V35, P651, DOI 10.1146/annurev.ecolsys.35.021004.112426; Bevins SN, 2008, BIOL INVASIONS, V10, P1109, DOI 10.1007/s10530-007-9188-8; BOOTH DJ, 1995, ECOLOGY, V76, P91, DOI 10.2307/1940634; Bradshaw WE, 1997, ECOLOGY, V78, P969, DOI 10.1890/0012-9658(1997)078[0969:HODTAP]2.0.CO;2; Bridges CM, 2002, J HERPETOL, V36, P627; Briegel H, 2003, J VECTOR ECOL, V28, P1; Briegel H, 2001, J VECTOR ECOL, V26, P21; Brown GE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2712; Carlsson N, 2004, FRESHWATER BIOL, V49, P1269, DOI 10.1111/j.1365-2427.2004.01269.x; Chandra K., 2017, ENCY DATABASE SYSTEM, P1; Chivers DP, 2001, J CHEM ECOL, V27, P45, DOI 10.1023/A:1005663815856; Christophers, 1960, AEDES AEGYPTI L YELL; Costanzo KS, 2011, ECOL ENTOMOL, V36, P605, DOI 10.1111/j.1365-2311.2011.01302.x; CROWL TA, 1990, SCIENCE, V247, P949, DOI 10.1126/science.247.4945.949; Dicke M, 2001, ANNU REV ECOL SYST, V32, P1, DOI 10.1146/annurev.ecolsys.32.081501.113951; DILL LM, 1987, CAN J ZOOL, V65, P803, DOI 10.1139/z87-128; Ferrari MCO, 2008, BEHAV ECOL SOCIOBIOL, V62, P1079, DOI 10.1007/s00265-007-0535-7; Ferrari MCO, 2007, CHEMOECOLOGY, V17, P223, DOI 10.1007/s00049-007-0380-1; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Ferrari MCO, 2005, ANIM BEHAV, V70, P777, DOI 10.1016/j.anbehav.2005.01.009; Foray V, 2012, PHYSIOL ENTOMOL, V37, P295, DOI 10.1111/j.1365-3032.2012.00831.x; GOTTHARD K, 1995, OIKOS, V74, P3, DOI 10.2307/3545669; Grill CP, 1996, J ANIM ECOL, V65, P63, DOI 10.2307/5700; HEADS PA, 1986, ECOL ENTOMOL, V11, P369, DOI 10.1111/j.1365-2311.1986.tb00315.x; Hechtel LJ, 1997, ECOLOGY, V78, P838, DOI 10.1890/0012-9658(1997)078[0838:EOAPOP]2.0.CO;2; Heithaus MR, 2008, J EXP MAR BIOL ECOL, V356, P43, DOI 10.1016/j.jembe.2007.12.013; Hermann SL, 2017, CURR OPIN INSECT SCI, V20, P54, DOI 10.1016/j.cois.2017.03.010; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Hoverman JT, 2009, FUNCT ECOL, V23, P1179, DOI 10.1111/j.1365-2435.2009.01586.x; Jourdan J, 2016, AQUAT SCI, V78, P303, DOI 10.1007/s00027-015-0432-5; Juliano SA, 2002, BEHAV ECOL, V13, P301, DOI 10.1093/beheco/13.3.301; JULIANO SA, 1992, OIKOS, V63, P465, DOI 10.2307/3544974; Juliano SA, 2014, MEM I OSWALDO CRUZ, V109, P1070, DOI 10.1590/0074-02760140455; Kaplan I, 2012, ARTHROPOD-PLANT INTE, V6, P181, DOI 10.1007/s11829-011-9175-y; Kaplan I, 2010, OIKOS, V119, P1105, DOI 10.1111/j.1600-0706.2009.18311.x; Kesavaraju B, 2004, ANN ENTOMOL SOC AM, V97, P194, DOI 10.1603/0013-8746(2004)097[0194:DBRTWC]2.0.CO;2; Kesavaraju B, 2007, ECOL ENTOMOL, V32, P262, DOI 10.1111/j.1365-2311.2006.00846.x; Kesavaraju B, 2007, ETHOLOGY, V113, P199, DOI 10.1111/j.1439-0310.2006.01317.x; Kesavaraju B, 2010, ANN ENTOMOL SOC AM, V103, P1038, DOI 10.1603/AN10007; KLECKNER CA, 1995, ECOLOGY, V76, P1242, DOI 10.2307/1940931; Knight TM, 2004, J VECTOR ECOL, V29, P277; LEA AO, 1978, PHYSIOL ENTOMOL, V3, P309, DOI 10.1111/j.1365-3032.1978.tb00164.x; LEONARD PM, 1995, ECOL ENTOMOL, V20, P125, DOI 10.1111/j.1365-2311.1995.tb00438.x; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Lind MI, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1651; Lounibos LP, 2008, J AM MOSQUITO CONTR, V24, P11, DOI 10.2987/5656.1; Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x; McCollum SA, 1997, OECOLOGIA, V109, P615, DOI 10.1007/s004420050124; Mercer DR, 2008, J MED ENTOMOL, V45, P861, DOI 10.1603/0022-2585(2008)45[861:SDILMR]2.0.CO;2; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Mostowy WM, 2004, J VECTOR ECOL, V29, P84; Muturi EJ, 2011, TROP MED INT HEALTH, V16, P955, DOI 10.1111/j.1365-3156.2011.02796.x; Naksathit AT, 1998, J AM MOSQUITO CONTR, V14, P148; Nicieza AG, 2000, OECOLOGIA, V123, P497, DOI 10.1007/s004420000343; Padmanabha H, 2012, J INSECT PHYSIOL, V58, P1597, DOI 10.1016/j.jinsphys.2012.09.015; Plaistow SJ, 2004, P ROY SOC B-BIOL SCI, V271, P919, DOI 10.1098/rspb.2004.2682; Ponlawat A, 2007, J MED ENTOMOL, V44, P422, DOI 10.1603/0022-2585(2007)44[422:AABSIM]2.0.CO;2; Ponlawat A, 2009, AM J TROP MED HYG, V80, P395, DOI 10.4269/ajtmh.2009.80.395; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Relyea RA, 2000, ECOLOGY, V81, P2278, DOI 10.1890/0012-9658(2000)081[2278:TMIEIL]2.0.CO;2; Resetarits WJ, 2001, OECOLOGIA, V129, P155, DOI 10.1007/s004420100704; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roper C, 1996, J EVOLUTION BIOL, V9, P609, DOI 10.1046/j.1420-9101.1996.9050609.x; *SAS I INC, 1989, SAS STAT USERS GUIDE, V2; Scheiner SM, 2001, DESIGN ANAL ECOLOGIC; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schoeppner NM, 2005, ECOL LETT, V8, P505, DOI 10.1111/j.1461-0248.2005.00744.x; SIH A, 1994, J FISH BIOL, V45, P111, DOI 10.1111/j.1095-8649.1994.tb01087.x; Silberbush A, 2015, ACTA TROP, V150, P196, DOI 10.1016/j.actatropica.2015.08.001; STEINWASCHER K, 1984, AM MIDL NAT, V112, P76, DOI 10.2307/2425459; Telang A, 2006, J EXP BIOL, V209, P645, DOI 10.1242/jeb.02026; Teng HJ, 2000, J MED ENTOMOL, V37, P40, DOI 10.1603/0022-2585-37.1.40; Timmermann SE, 1999, J INSECT PHYSIOL, V45, P461, DOI 10.1016/S0022-1910(98)00147-4; Van Buskirk J, 2002, AM NAT, V160, P87, DOI 10.1086/340599; Van Buskirk J, 2001, J EVOLUTION BIOL, V14, P482, DOI 10.1046/j.1420-9101.2001.00282.x; Van Buskirk J, 2000, ECOLOGY, V81, P3009, DOI 10.1890/0012-9658(2000)081[3009:PIPPIL]2.0.CO;2; van Uitregt VO, 2012, J ANIM ECOL, V81, P108, DOI 10.1111/j.1365-2656.2011.01880.x; VANHANDEL E, 1985, J AM MOSQUITO CONTR, V1, P299; VANHANDEL E, 1985, J AM MOSQUITO CONTR, V1, P302; VANHANDEL E, 1988, J AM MOSQUITO CONTR, V4, P549; VANHANDEL E, 1965, J PHYSIOL-LONDON, V181, P478, DOI 10.1113/jphysiol.1965.sp007776; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537; WERNER EE, 1986, AM NAT, V128, P319, DOI 10.1086/284565; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; WIKLUND C, 1977, OECOLOGIA, V31, P153, DOI 10.1007/BF00346917; Wisenden BD, 2000, PHILOS T ROY SOC B, V355, P1205, DOI 10.1098/rstb.2000.0668; Wormington JD, 2014, EVOL ECOL RES, V16, P223; Yoshioka M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-225; Zhou GL, 2004, INSECT BIOCHEM MOLEC, V34, P919, DOI 10.1016/j.ibmb.2004.05.009; Ziegler R, 2001, J INSECT PHYSIOL, V47, P623, DOI 10.1016/S0022-1910(00)00158-X; Zuharah WF, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev115	108	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192104	10.1371/journal.pone.0192104	http://dx.doi.org/10.1371/journal.pone.0192104			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401513	gold, Green Published, Green Submitted			2022-12-26	WOS:000424101400035
J	Hoffmans, R; Wagemakers, A; van Drunen, C; Hellings, P; Fokkens, W				Hoffmans, Ruth; Wagemakers, Alex; van Drunen, Cornelis; Hellings, Peter; Fokkens, Wytske			Acute and chronic rhinosinusitis and allergic rhinitis in relation to comorbidity, ethnicity and environment	PLOS ONE			English	Article							UPPER AIRWAY DISEASE; SOCIOECONOMIC-STATUS; OCCUPATIONAL RHINITIS; CHRONIC URTICARIA; GENERAL-PRACTICE; RISK-FACTORS; ASTHMA; PREVALENCE; POPULATION; IMPACT	Background This study was conducted to assess the effect of comorbidity, ethnicity, occupation, smoking and place of residence on allergic rhinitis (AR), acute rhinosinusitis (ARS) and chronic rhinosinusitis (CRS). Methods A GA(2) LEN (The Global Allergy and Asthma European Network) screening questionnaire was sent to a random sample of the Dutch population (n = 16700) in three different areas of the Netherlands. Results Fifty percent (8347) of the questionnaires sent were returned. A total of 29% respondents (27-31% in different areas) met the criteria for AR, 18% (17-21%) for ARS and 16% (13-18%) for CRS. Risk factors for AR were itchy rash, eczema, adverse response after taking a painkiller, asthma, CRS and ARS. Moreover, the risk of AR was twice as low for full-time housewives/househusbands than for people with jobs. The risk of ARS or CRS was significantly higher in respondents with a doctor's diagnosis of CRS, AR, itchy rash or smoking. The risk of CRS was also significantly higher in respondents with an adverse response after taking painkillers, active smoking or asthma. Caucasians are generally less likely to have AR or CRS than Latin-Americans, Hindustani and African-Creoles, and more likely to have ARS than Asian, Hindustani, Mediterranean and African-Creoles. Conclusions This study found shared and distinct risk factors for AR, ARS and CRS and therefore provides support for the belief that they have shared symptoms but are different diseases with different aetiologies.	[Hoffmans, Ruth; Wagemakers, Alex; van Drunen, Cornelis; Hellings, Peter; Fokkens, Wytske] Acad Med Ctr, Amsterdam, Netherlands; [Hellings, Peter] UZ Leuven, Leuven, Belgium	University of Amsterdam; Academic Medical Center Amsterdam; KU Leuven	Hoffmans, R (corresponding author), Acad Med Ctr, Amsterdam, Netherlands.	r.hoffmans@amc.nl	Fokkens, Wytske WJ/ABF-2185-2020; Hellings, Peter W/I-4068-2018	Hellings, Peter W/0000-0001-6898-688X; van Drunen, Cornelis M/0000-0001-5503-066X; Wagemakers, Alex/0000-0001-9632-7830				Baroody FM, 2012, OTOLARYNG HEAD NECK, V146, P880, DOI 10.1177/0194599811435972; Bauchau V, 2004, EUR RESPIR J, V24, P758, DOI 10.1183/09031936.04.00013904; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2012, J ALLERGY CLIN IMMUN, V130, P1049, DOI 10.1016/j.jaci.2012.07.053; Bousquet J, 2003, ALLERGY, P41; Buss Yiling Andrea, 2007, J Dtsch Dermatol Ges, V5, P22, DOI 10.1111/j.1610-0387.2007.06194.x; Chung SD, 2014, LARYNGOSCOPE, V124, P1536, DOI 10.1002/lary.24581; Dixon AE, 2009, CURR OPIN PULM MED, V15, P19, DOI 10.1097/MCP.0b013e32831da87e; Eriksson J, 2013, ALLERGY, V68, P347, DOI 10.1111/all.12095; Ertam I, 2007, J EUR ACAD DERMATOL, V21, P777, DOI 10.1111/j.1468-3083.2006.02083.x; Feng CH, 2012, AM J RHINOL ALLERGY, V26, P187, DOI 10.2500/ajra.2012.26.3762; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fokkens Wytske J, 2012, Rhinol Suppl, V23, P1; Giavina-Bianchi P, 2016, J ASTHMA ALLERGY, V9, P93, DOI 10.2147/JAA.S81541; GILLAM SJ, 1989, BRIT MED J, V299, P953, DOI 10.1136/bmj.299.6705.953; Hastan D, 2011, ALLERGY, V66, P1216, DOI 10.1111/j.1398-9995.2011.02646.x; Hellings PW, 2006, ALLERGY, V61, P656, DOI 10.1111/j.1398-9995.2006.01109.x; Higgins TS, 2012, CURR OPIN OTOLARYNGO, V20, P209, DOI 10.1097/MOO.0b013e3283534821; Hirsch AG, 2017, ALLERGY, V72, P274, DOI 10.1111/all.13042; Hirsch AG, 2015, ALLERGY, V70, P1613, DOI 10.1111/all.12759; Hoffmans R, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0332-8; Hoffmans R, 2011, PRIM CARE RESP J, V20, P64, DOI 10.4104/pcrj.2010.00064; Hox V, 2014, ALLERGY, V69, P282, DOI 10.1111/all.12347; Hox V, 2012, ALLERGY, V67, P560, DOI 10.1111/j.1398-9995.2011.02779.x; Hytonen M, 1997, INT ARCH OCC ENV HEA, V69, P487, DOI 10.1007/s004200050178; Jang AS, 2016, CURR OPIN ALLERGY CL, V16, P13, DOI 10.1097/ACI.0000000000000235; Katelaris CH, 2012, CLIN EXP ALLERGY, V42, P186, DOI 10.1111/j.1365-2222.2011.03891.x; Kilty SJ, 2011, RHINOLOGY, V49, P533, DOI 10.4193/Rhino10.298; Krouse JH, 2007, OTOLARYNG HEAD NECK, V136, pS75, DOI 10.1016/j.otohns.2007.02.019; Lieu JEC, 2000, ARCH OTOLARYNGOL, V126, P940, DOI 10.1001/archotol.126.8.940; Lindgren A, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-2; Montnemery P, 2003, RESP MED, V97, P970, DOI 10.1016/S0954-6111(03)00126-4; Moscato G, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-16; Moscato G, 2009, CURR OPIN ALLERGY CL, V9, P110, DOI 10.1097/ACI.0b013e328328cfe7; Nachman KE, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-25; Olivieri M, 2016, ALLERGY, V71, P859, DOI 10.1111/all.12841; Olivieri M, 2002, ALLERGY, V57, P600, DOI 10.1034/j.1398-9995.2002.23537.x; Olze H, 2011, CURR OPIN ALLERGY CL, V11, P457, DOI 10.1097/ACI.0b013e32834a9764; Ozdemir N, 2000, RESP MED, V94, P536, DOI 10.1053/rmed.1999.0728; Park DJ, 2015, ANN RHEUM DIS, V74, P569, DOI 10.1136/annrheumdis-2015-eular.2735; Philpott C, 2016, RHINOLOGY, V54, P134, DOI [10.4193/Rhin15.272, 10.4193/Rhino15.272]; Radon K, 2008, OCCUP ENVIRON MED, V65, P38, DOI 10.1136/oem.2006.031542; Salo PM, 2011, J ALLERGY CLIN IMMUN, V127, P1226, DOI 10.1016/j.jaci.2010.12.1106; Saulyte J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001611; Seidman MD, 2015, OTOLARYNG HEAD NECK, V152, P197, DOI 10.1177/0194599814562166; Smith DF, 2013, OTOLARYNG HEAD NECK, V149, P639, DOI 10.1177/0194599813498206; Soler ZM, 2012, AM J RHINOL ALLERGY, V26, P110, DOI 10.2500/ajra.2012.26.3741; Stevens WW, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-014-0487-8; Sundaresan AS, 2015, INT FORUM ALLERGY RH, V5, P996, DOI 10.1002/alr.21573; Tan BK, 2013, AM J RESP CRIT CARE, V188, P1275, DOI 10.1164/rccm.201308-1500ED; Tan T. Y., 1998, SMJ, V39, P59; Thilsing T, 2012, AM J IND MED, V55, P1037, DOI 10.1002/ajim.22074; Tomassen P, 2011, ALLERGY, V66, P556, DOI 10.1111/j.1398-9995.2010.02503.x; Wedi Bettina, 2009, Allergy Asthma Clin Immunol, V5, P10, DOI 10.1186/1710-1492-5-10	54	24	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192330	10.1371/journal.pone.0192330	http://dx.doi.org/10.1371/journal.pone.0192330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401486	Green Submitted, Green Published, gold			2022-12-26	WOS:000424101400049
J	Pigeault, R; Villa, M				Pigeault, Romain; Villa, Manon			Long-term pathogenic response to Plasmodium relictum infection in Culex pipiens mosquito	PLOS ONE			English	Article							ANOPHELES-STEPHENSI; MALARIA INFECTION; TRADE-OFFS; FECUNDITY; TRANSMISSION; MANIPULATION; REDUCTION; MORTALITY; APOPTOSIS; SURVIVAL	The transmission of Plasmodium within a vertebrate host population is strongly associated with the life history traits of its vector. Therefore the effect of malaria infection on mosquito fecundity and longevity has traditionally received a lot of attention. Several species of malaria parasites reduce mosquito fecundity, nevertheless almost all of the studies have focused only on the first gonotrophic cycle. Yet, during their lifetime, female mosquitoes go through several gonotrophic cycles, which raises the question of whether they are able to compensate the fecundity costs induced by the parasite. The impact of Plasmodium infection on female longevity is not so clear and has produced conflicting results. Here we measured the impact of Plasmodium relictum on its vector's longevity and fecundity during three consecutive gonotrophic cycles. In accordance with previous studies, we observed a negative impact of Plasmodium infection on mosquito (Culex pipiens) fecundity in the first gonotrophic cycle. Interestingly, despite having taken two subsequent uninfected blood meals, the negative impact of malaria parasite persisted. Nevertheless no impact of infection on mosquito longevity was observed. Our results are not in line with the hypothesis that the reduction of fecundity observed in infected mosquitoes is an adaptive strategy of Plasmodium to increase the longevity of its vector. We discuss the different underlying mechanisms that may explain our results.	[Pigeault, Romain] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Pigeault, Romain; Villa, Manon] Univ Montpellier, CNRS 5290, MIVEGEC, UMR IRD 224, Montpellier, France	University of Lausanne; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Pigeault, R (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.; Pigeault, R (corresponding author), Univ Montpellier, CNRS 5290, MIVEGEC, UMR IRD 224, Montpellier, France.	romain.pigeault@unil.ch		pigeault, romain/0000-0002-8011-4600				Adamo SA, 2001, ANIM BEHAV, V62, P417, DOI 10.1006/anbe.2001.1786; Ahmed AM, 2006, MICROBES INFECT, V8, P308, DOI 10.1016/j.micinf.2005.06.026; Becking LE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075996, 10.1371/journal.pone.0079276]; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Delhaye J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1905-7; Ferguson HM, 2003, PARASITOLOGY, V127, P9, DOI 10.1017/S0031182003003287; Ferguson HM, 2002, TRENDS PARASITOL, V18, P256, DOI 10.1016/S1471-4922(02)02281-X; Gray EM, 2006, PARASITOLOGY, V132, P169, DOI 10.1017/S0031182005008966; Han YS, 2002, INSECT BIOCHEM MOLEC, V32, P1311, DOI 10.1016/S0965-1748(02)00093-0; Hogg JC, 1997, PARASITOLOGY, V114, P325, DOI 10.1017/S0031182096008542; HOGG JC, 1995, MED VET ENTOMOL, V9, P176, DOI 10.1111/j.1365-2915.1995.tb00175.x; Hogg JC, 1995, PARASITOLOGY, V111, P555, DOI 10.1017/S0031182000077027; Hopwood JA, 2001, J EXP BIOL, V204, P2773; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Hurd H, 2006, PARASITOLOGY, V132, pS33, DOI 10.1017/S0031182006000849; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; HURD H, 1995, PARASITOL TODAY, V11, P411, DOI 10.1016/0169-4758(95)80021-2; Hurd H, 2001, TRENDS PARASITOL, V17, P363, DOI 10.1016/S1471-4922(01)01927-4; Hurd H., 2009, PARASITOLOGY B A, P85; Lalubin F, 2014, J ANIM ECOL, V83, P850, DOI 10.1111/1365-2656.12190; LeRoux M, 2009, TRENDS PARASITOL, V25, P474, DOI 10.1016/j.pt.2009.07.005; LI XH, 1992, MED VET ENTOMOL, V6, P57, DOI 10.1111/j.1365-2915.1992.tb00036.x; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; Oliver SV, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-390; Pigeault R, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0300; Richards SL, 2012, J VECTOR ECOL, V37, P1, DOI 10.1111/j.1948-7134.2012.00194.x; Schwartz A, 2001, TRENDS PARASITOL, V17, P189, DOI 10.1016/S1471-4922(00)01945-0; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Taylor PJ, 2001, PARASITOLOGY, V122, P491, DOI 10.1017/S0031182001007776; Valkiunas G, 2004, AVIAN MALARIA PARASI; Vezilier J, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0840; Vezilier J, 2012, P ROY SOC B-BIOL SCI, V279, P4033, DOI 10.1098/rspb.2012.1394; Vezilier J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-379; Zele F, 2012, J EVOLUTION BIOL, V25, P1243, DOI 10.1111/j.1420-9101.2012.02519.x; Zele F, 2017, PARASITOLOGY, P1	35	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192315	10.1371/journal.pone.0192315	http://dx.doi.org/10.1371/journal.pone.0192315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401525	gold, Green Published			2022-12-26	WOS:000424101400047
J	Wang, JF; Zhou, ZH; He, F; Ruan, Z; Jiang, Y; Hua, XT; Yu, YS				Wang, Jianfeng; Zhou, Zhihui; He, Fang; Ruan, Zhi; Jiang, Yan; Hua, Xiaoting; Yu, Yunsong			The role of the type VI secretion system vgrG gene in the virulence and antimicrobial resistance of Acinetobacter baumannii ATCC 19606	PLOS ONE			English	Article							CARBAPENEM RESISTANCE; ESCHERICHIA-COLI; EPITHELIAL-CELLS; OMPA	The Type VI Secretion System (T6SS) is an important virulence system that exists in many bacterial pathogens, and has emerged as a potent mediator of pathogenicity in Acinetobacter baumannii. In this study, we inactivated one of the T6SS components vgrG (valine-glycine repeat G) gene in A. baumannii ATCC 19606 and constructed a complementation strain. BEAS-2b human alveolar epithelial cells was adopted to assess bacterial adhesion, and wild female BALB/c mice were used for in vivo experiments to assess the bacterial killing ability to host. Upon deletion of the vgrG gene, increased antimicrobial resistance to ampicillin/sulbactam, but reduced resistance to chloramphenicol were observed. The vgrG mutant strain showed lower growth rate, reduced eukaryotic cell adherence and impaired lethality in mice. However, the vgrG mutant strain is not implicated in biofilm formation. Our study suggests that the Type VI Secretion System core component VgrG contributes to both virulence and antimicrobial resistance in A. baumannii ATCC 19606.	[Wang, Jianfeng] Hangzhou Normal Univ, Affiliated Hosp, Dept Resp Dis, Hangzhou, Zhejiang, Peoples R China; [Zhou, Zhihui; He, Fang; Ruan, Zhi; Jiang, Yan; Hua, Xiaoting; Yu, Yunsong] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Infect Dis, Hangzhou, Zhejiang, Peoples R China; [Zhou, Zhihui; He, Fang; Ruan, Zhi; Jiang, Yan; Hua, Xiaoting; Yu, Yunsong] Key Lab Microbial Technol & Bioinformat Zhejiang, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University; Zhejiang University	Yu, YS (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Infect Dis, Hangzhou, Zhejiang, Peoples R China.; Yu, YS (corresponding author), Key Lab Microbial Technol & Bioinformat Zhejiang, Hangzhou, Zhejiang, Peoples R China.	yvys119@zju.edu.cn	Hua, Xiaoting/B-5786-2011; Ruan, Zhi/P-3987-2015	Hua, Xiaoting/0000-0001-8215-916X; Ruan, Zhi/0000-0001-8648-4592	National Natural Science Foundation of China [81371858]; 973 Preliminary Research Program [2014CB560707]; Zhejiang Provincial Natural Science Foundation of China [LQY18H190001]; Zhejiang Provincial Medical and Health Science and Technology Plan [2017KY125]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Preliminary Research Program; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Medical and Health Science and Technology Plan	This study was supported by research grants from National Natural Science Foundation of China (81371858 to YJ), the 973 Preliminary Research Program (2014CB560707 to YY), Zhejiang Provincial Natural Science Foundation of China (LQY18H190001 to JW), and Zhejiang Provincial Medical and Health Science and Technology Plan (2017KY125 to JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamou JE, 1998, INFECT IMMUN, V66, P820, DOI 10.1128/IAI.66.2.820-822.1998; Aubert DF, 2015, MICROBIOL-SGM, V161, P2161, DOI 10.1099/mic.0.000174; Carruthers MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059388; Chatterjee S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01126; Davenport K.W., 2014, GENOME ANNOUNCEMENTS, V2; Desilets M, 2015, INFLAMMATORY BOWEL D; Eijkelkamp BA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1020; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Giannouli M, 2013, BMC INFECT DIS, V13, DOI [10.1186/1471-2334-13-470, 10.1186/1471-2334-13-282]; Hachani A, 2013, JOVE-J VIS EXP, DOI 10.3791/50103; Hu FP, 2016, CLIN MICROBIOL INFEC, V22, pS9, DOI 10.1016/j.cmi.2016.01.001; Jones C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081132; Li X M, 2016, 2016 INT C ADV MECH, V2016, P26, DOI DOI 10.1007/S10096-016-2674-0; Lin MF, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-119; Linkevicius M, 2013, J ANTIMICROB CHEMOTH, V68, P2809, DOI 10.1093/jac/dkt263; Ma JL, 2014, INFECT IMMUN, V82, P3867, DOI 10.1128/IAI.01769-14; Miyata ST, 2013, J MED MICROBIOL, V62, P663, DOI 10.1099/jmm.0.053983-0; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Pournaras S, 2017, INT J ANTIMICROB AG, V49, P749, DOI 10.1016/j.ijantimicag.2017.01.028; Repizo GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138265; Roca I, 2009, ANTIMICROB AGENTS CH, V53, P4013, DOI 10.1128/AAC.00584-09; Roussel L, 2017, BIOCHEM BIOPH RES CO, V483, P829, DOI 10.1016/j.bbrc.2017.01.009; Ruiz FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129691; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Smani Y, 2014, ANTIMICROB AGENTS CH, V58, P1806, DOI 10.1128/AAC.02101-13; Tal-Jasper R, 2016, ANTIMICROB AGENTS CH, V60, P3127, DOI 10.1128/AAC.02656-15; Tipton KA, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.418; Tucker AT, 2014, MBIO, V5, DOI 10.1128/mBio.01313-14; Weber BS, 2015, P NATL ACAD SCI USA, V112, P9442, DOI 10.1073/pnas.1502966112	29	26	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192288	10.1371/journal.pone.0192288	http://dx.doi.org/10.1371/journal.pone.0192288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394284	Green Published, Green Submitted, gold			2022-12-26	WOS:000424060400032
J	Cheng, CH; Lin, CC; Chen, HL; Lin, IT; Wu, CH; Lee, YK; Bair, MJ				Cheng, Chun-Han; Lin, Ching-Chung; Chen, Huan-Lin; Lin, I-Tsung; Wu, Chia-Hsien; Lee, Yuan-Kai; Bair, Ming-Jong			Genotype distribution and treatment response among incarcerated drug-dependent patients with chronic hepatitis C infection	PLOS ONE			English	Article							PRISON-INMATES; CLINICAL-IMPLICATIONS; MOLECULAR EPIDEMIOLOGY; VIRUS GENOTYPES; PLUS RIBAVIRIN; HCV TREATMENT; PREVALENCE; TAIWAN; POPULATION; USERS	The prevalence of hepatitis C virus (HCV) infection is disproportionately high among prisoners, especially among those who are drug-dependent. However, current screening and treatment recommendations are inconsistent for this population, and appropriate care is not reliably provided. To address these problems, the present study aimed to identify unique characteristics and clinical manifestations of incarcerated patients with HCV infection. We included incarcerated patients who received treatment with pegylated-interferon combined with ribavirin at Mackay Memorial Hospital in Taitung and were serving sentences at either the Taiyuan Skill Training Institute or the Yanwan Training Institute. HCV genotypes 1 (41.4%), 3 (25.9%), and 6 (24.1%) were the most prevalent in the incarcerated patients. During the study period, we analyzed treatment response among 58 incarcerated patients and compared obtained results with treatment response among 52 patients who were living in the community. Higher sustained virological response rate was observed among patients with incarceration and HCV genotype other than 1. The odds ratios (corresponding 95% confidence intervals) for incarceration and genotype 1 were 2.75 (1.06-7.11) and 0.37 (0.14-0.99), respectively. Better treatment compliance among incarcerated patients might partially explain these results. The results of this study suggest that treatment of prisoners with HCV infection is feasible and effective. More appropriate and timely methods are needed to prevent HCV transmission among injection drug users inside prisons.	[Cheng, Chun-Han; Chen, Huan-Lin; Lin, I-Tsung; Wu, Chia-Hsien; Lee, Yuan-Kai; Bair, Ming-Jong] Taitung Mackay Mem Hosp, Div Gastroenterol, Dept Internal Med, Taitung, Taiwan; [Cheng, Chun-Han; Lin, Ching-Chung; Chen, Huan-Lin; Lin, I-Tsung; Wu, Chia-Hsien; Lee, Yuan-Kai; Bair, Ming-Jong] Mackay Med Coll, New Taipei, Taiwan; [Lin, Ching-Chung] Mackay Mem Hosp, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Medical College; Mackay Memorial Hospital	Bair, MJ (corresponding author), Taitung Mackay Mem Hosp, Div Gastroenterol, Dept Internal Med, Taitung, Taiwan.; Bair, MJ (corresponding author), Mackay Med Coll, New Taipei, Taiwan.	a5963@mmh.org.tw		Cheng, Chun-han/0000-0002-7262-861X				Allen SA, 2003, ANN INTERN MED, V138, P187, DOI 10.7326/0003-4819-138-3-200302040-00010; Almasio PL, 2011, DIGEST LIVER DIS, V43, P589, DOI 10.1016/j.dld.2010.12.004; Boonwaat L, 2010, MED J AUSTRALIA, V192, P496, DOI 10.5694/j.1326-5377.2010.tb03605.x; Bretschneider W, 2014, J BIOETHIC INQ, V11, P319, DOI 10.1007/s11673-014-9547-y; Cheng CH, 2017, KAOHSIUNG J MED SCI, V33, P510, DOI 10.1016/j.kjms.2017.06.005; Cheng CH, 2015, KAOHSIUNG J MED SCI, V31, P597, DOI 10.1016/j.kjms.2015.09.006; Chew KW, 2009, J CLIN GASTROENTEROL, V43, P686, DOI 10.1097/MCG.0b013e31818dd94c; Falck-Ytter Y, 2002, ANN INTERN MED, V136, P288, DOI 10.7326/0003-4819-136-4-200202190-00008; Farley J, 2005, AM J PUBLIC HEALTH, V95, P1737, DOI 10.2105/AJPH.2004.056150; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hsieh MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094791; Iacomi F, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-374; Larney S, 2013, HEPATOLOGY, V58, P1215, DOI 10.1002/hep.26387; Lee CM, 2006, T ROY SOC TROP MED H, V100, P767, DOI 10.1016/j.trstmh.2005.10.008; Lee YM, 2010, J MED VIROL, V82, P57, DOI 10.1002/jmv.21658; Liu JY, 2008, CLIN INFECT DIS, V46, P1761, DOI 10.1086/587992; Macalino GE, 2004, AM J PUBLIC HEALTH, V94, P1218, DOI 10.2105/AJPH.94.7.1218; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marco A, 2013, J HEPATOL, V59, P45, DOI 10.1016/j.jhep.2013.03.008; Meyer MF, 2007, EPIDEMIOL INFECT, V135, P274, DOI 10.1017/S0950268806006820; Pena-Orellana M, 2011, J HEALTH CARE POOR U, V22, P962, DOI 10.1353/hpu.2011.0084; Rice JP, 2012, HEPATOLOGY, V56, P1252, DOI 10.1002/hep.25770; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Spaulding A, 1999, PREV MED, V28, P92, DOI 10.1006/pmed.1998.0418; Spaulding AC, 2006, ANN INTERN MED, V144, P762, DOI 10.7326/0003-4819-144-10-200605160-00010; Sterling RK, 2004, AM J GASTROENTEROL, V99, P866, DOI 10.1111/j.1572-0241.2004.30310.x; Stone J, 2017, ADDICTION, V112, P1302, DOI 10.1111/add.13783; Strock P, 2009, DIGEST DIS SCI, V54, P1325, DOI 10.1007/s10620-008-0483-8; Tan JA, 2008, HEPATOLOGY, V48, P1387, DOI 10.1002/hep.22509; Teutsch S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-633; Tyczyno M, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.14559; Thong VD, 2014, WORLD J GASTROENTERO, V20, P2927, DOI 10.3748/wjg.v20.i11.2927; Weinbaum CA, 2005, AIDS, V19, pS41, DOI 10.1097/01.aids.0000192069.95819.aa; Yu ML, 2001, J MED VIROL, V65, P58, DOI 10.1002/jmv.2001; Zampino R, 2015, WORLD J HEPATOL, V7, P2323, DOI 10.4254/wjh.v7.i21.2323	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191799	10.1371/journal.pone.0191799	http://dx.doi.org/10.1371/journal.pone.0191799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389957	Green Published, gold, Green Submitted			2022-12-26	WOS:000423793400035
J	Sena-Lopes, A; Bezerra, FSB; das Neves, RN; de Pinho, RB; Silva, MTD; Savegnago, L; Collares, T; Seixas, F; Begnini, K; Henriques, JAP; Ely, MR; Rufatto, LC; Moura, S; Barcellos, T; Padilha, F; Dellagostin, O; Borsuk, S				Sena-Lopes, Angela; Brilhante Bezerra, Francisco Silvestre; das Neves, Raquel Nascimento; de Pinho, Rodrigo Barros; de Oliveira Silva, Mara Thais; Savegnago, Lucielli; Collares, Tiago; Seixas, Fabiana; Begnini, Karine; Pegas Henriques, Joao Antonio; Ely, Mariana Roesch; Rufatto, Luciane C.; Moura, Sidnei; Barcellos, Thiago; Padilha, Francine; Dellagostin, Odir; Borsuk, Sibele			Chemical composition, immunostimulatory, cytotoxic and antiparasitic activities of the essential oil from Brazilian red propolis	PLOS ONE			English	Article							IN-VITRO; ANTIMICROBIAL ACTIVITY; BIOLOGICAL-ACTIVITY; GAS-CHROMATOGRAPHY; BOTANICAL ORIGIN; CELL-DEATH; CONSTITUENTS; ANTIOXIDANT; EXTRACT; MICE	Most studies of Brazilian red propolis have explored the composition and biological properties of its ethanolic extracts. In this work, we chemically extracted and characterized the essential oil of Brazilian red propolis (EOP) and assessed its adjuvant, antiparasitic and cytotoxic activities. The chemical composition of EOP was analyzed using gas chromatography with mass spectrometry (GC-MS). EOP was tested for in vitro activity against Trichomonas vaginalis (ATCC 30236 isolate); trophozoites were treated with different concentrations of EOP (ranging from 25 to 500 mu g/mL) in order to establish the MIC and IC50 values. A cytotoxicity assay was performed in CHO-K1 cells submitted to different EOP concentrations. BALB/c mice were used to test the adjuvant effect of EOP. The animals were divided in 3 groups and inoculated as follows: 0.4 ng/kg BW EOP (G1); 50 mu g of rCP40 protein (G2); or a combination of 0.4 ng/kg BW EOP and 50 mu g of rCP40 (G3). Total IgG, IgG1 and IgG2a levels were assessed by ELISA. The major constituent compounds of EOP were methyl eugenol (13.1%), (E)-beta-farnesene (2.50%), and d-amorphene (2.3%). Exposure to EOP inhibited the growth of T. vaginalis, with an IC50 value of 100 mu g/mL of EOP. An EOP concentration of 500 mu g/mL was able to kill 100% of the T. vaginalis trophozoites. The EOP kinetic growth curve showed a 36% decrease in trophozoite growth after a 12 h exposure to 500 mu g/mL of EOP, while complete parasite death was induced at 24 h. With regard to CHO-K1 cells, the CC50 was 266 mu g/mL, and 92% cytotoxicity was observed after exposure to 500 mu g/mL of EOP. Otherwise, a concentration of 200 mu g/mL of EOP was able to reduce parasite proliferation by 70% and was not cytotoxic to CHO-K1 cells. As an adjuvant, a synergistic effect was observed when EOP was combined with the rCP40 protein (G3) in comparison to the administration of each component alone (G1 and G2), resulting in higher concentrations of IgG, IgG1 and IgG2a. EOP is constituted by biologically active components with promising antiparasitic and immunostimulatory activities and can be investigated for the formulation of new vaccines or trichomonacidal drugs.	[Sena-Lopes, Angela; Brilhante Bezerra, Francisco Silvestre; das Neves, Raquel Nascimento; de Pinho, Rodrigo Barros; de Oliveira Silva, Mara Thais; Savegnago, Lucielli; Collares, Tiago; Seixas, Fabiana; Begnini, Karine; Dellagostin, Odir; Borsuk, Sibele] Univ Fed Pelotas UFPel, Ctr Desenvolvimento Tecnol CDTEc, Campus Capao Leao, Capao Do Leao, RS, Brazil; [Pegas Henriques, Joao Antonio; Ely, Mariana Roesch; Rufatto, Luciane C.; Moura, Sidnei; Barcellos, Thiago] Univ Caxias Sul, Inst Biotecnol, Dept Tecnol, Caxias Do Sul, RS, Brazil; [Padilha, Francine] Univ Tiradente, ITP, Aracaju, Sergipe, Brazil	Universidade Federal de Pelotas; Universidade de Caxias do Sul; Universidade Tiradentes	Borsuk, S (corresponding author), Univ Fed Pelotas UFPel, Ctr Desenvolvimento Tecnol CDTEc, Campus Capao Leao, Capao Do Leao, RS, Brazil.	sibeleborsuk@gmail.com	Collares, Tiago/K-2779-2019; da Silva, Thiago Barcellos/AAY-6367-2021; Savegnago, Lucielli/L-7287-2013; Dellagostin, Odir/C-2331-2009; Begnini, Karine Rech/J-2516-2016; Barcellos, Thiago/C-7806-2018; Roesch-Ely, Mariana/H-5981-2013; Neves, Raquel/AAV-2530-2020; Seixas, Fabiana Kommling/X-2706-2018; Bezerra, Francisco/G-2954-2012	Collares, Tiago/0000-0002-1535-3795; da Silva, Thiago Barcellos/0000-0001-9872-4602; Savegnago, Lucielli/0000-0003-0494-5610; Dellagostin, Odir/0000-0003-2803-4088; Barcellos, Thiago/0000-0001-9872-4602; Neves, Raquel/0000-0002-0153-6291; Seixas, Fabiana Kommling/0000-0003-4204-2500; Bezerra, Francisco/0000-0001-6484-143X; Rech Begnini, Karine/0000-0002-1099-3304	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) [1608/2011]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Grant #1608/2011 from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) to Joao Antonio Pegas Henriques. URL:http://www. capes.gov.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors thank the Post-Graduation Program in Pharmaceutical Sciences, UFRGS, especially T. Tasca (*) from Laboratorio de Pesquisa em Parasitologia, Faculdade de Farmacia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil, for the helping with T. vaginalis protocols assays. We are thankful for the financial support from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes), Grant #1608/2011.	Abikim G, 2011, SHIJIE HUAREN XIAOHU, V19, P1469; Alday-Provencio S, 2015, PLANTA MED, V81, P742, DOI 10.1055/s-0035-1545982; Alencar SM, 2007, J ETHNOPHARMACOL, V113, P278, DOI 10.1016/j.jep.2007.06.005; Aligiannis N, 2001, COMPOSITION ANTIMICR; Alvarez-Sanchez ME, 2017, CURR PHARM DESIGN, V23, P3359, DOI 10.2174/1381612823666170703162754; Calleja MA, 2013, BRIT J NUTR, V109, P394, DOI 10.1017/S0007114512001298; Awale S, 2008, BIOORGAN MED CHEM, V16, P181, DOI 10.1016/j.bmc.2007.10.004; Ayres DC, 2007, MEM I OSWALDO CRUZ, V102, P215, DOI 10.1590/S0074-02762007005000020; Bankova V., 1998, Journal of Essential Oil Research, V10, P693; Bankova V, 2014, CHEM CENT J, V8, DOI 10.1186/1752-153X-8-28; Begnini KR, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/639856; Bezerra GB, 2017, BIOMED PHARMACOTHER, V85, P687, DOI 10.1016/j.biopha.2016.11.080; Biscaia D, 2009, J SUPERCRIT FLUID, V51, P17, DOI 10.1016/j.supflu.2009.07.011; Boussaada O, 2008, MICROBIOL RES, V163, P87, DOI 10.1016/j.micres.2007.02.010; Bueno-Silva B, 2013, BIOFOULING, V29, P1233, DOI 10.1080/08927014.2013.834050; Bueno-Silva B, 2017, J ETHNOPHARMACOL, V207, P100, DOI 10.1016/j.jep.2017.06.015; Bueno-Silva B, 2016, PHYTOMEDICINE, V23, P1583, DOI 10.1016/j.phymed.2016.09.009; Bueno-Silva B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144954; Cavendish RL, 2015, J ETHNOPHARMACOL, V173, P127, DOI 10.1016/j.jep.2015.07.022; Cudmore SL, 2004, CLIN MICROBIOL REV, V17, P783, DOI 10.1128/CMR.17.4.783-793.2004; Frozza COD, 2017, BIOMED PHARMACOTHER, V91, P951, DOI 10.1016/j.biopha.2017.05.027; Frozza COD, 2013, FOOD CHEM TOXICOL, V52, P137, DOI 10.1016/j.fct.2012.11.013; Silva RPD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172585; DIAMOND LS, 1957, J PARASITOL, V43, P488, DOI 10.2307/3274682; do Nascimento TG, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1517-3; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Droppa-Almeida D, 2016, VACCINE, V34, P1091, DOI 10.1016/j.vaccine.2015.12.064; El Ashry ESH, 2012, VACCINE, V31, P31, DOI 10.1016/j.vaccine.2012.10.095; Fischer G., 2008, Arq. Inst. Biol., V75, P247, DOI 10.1590/1808-1657v75p2472008; Fischer G, 2010, MEM I OSWALDO CRUZ, V105, P908, DOI 10.1590/S0074-02762010000700012; Flach A, 2004, J CHEM ECOL, V30, P1045, DOI 10.1023/B:JOEC.0000028466.50392.ed; Flamini G, 2005, FOOD CHEM, V91, P63, DOI 10.1016/j.foodchem.2004.05.047; Fokialakis N, 2002, Z NATURFORSCH C, V57, P791; Freires IA, 2016, EUR J MED CHEM, V110, P267, DOI 10.1016/j.ejmech.2016.01.033; Freitas SF, 2006, PHYTOMEDICINE, V13, P170, DOI 10.1016/j.phymed.2004.07.008; Gause KT, 2017, ACS NANO, V11, P54, DOI 10.1021/acsnano.6b07343; de Mendonca ICG, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0888-9; Hubner DPG, 2016, BIOMED PHARMACOTHER, V84, P476, DOI 10.1016/j.biopha.2016.09.064; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hazzit M, 2006, J AGR FOOD CHEM, V54, P6314, DOI 10.1021/jf0606104; Hyldgaard M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00012; Ioshida MD, 2010, J ESSENT OIL BEAR PL, V13, P633, DOI 10.1080/0972060X.2010.10643873; Isidorov VA, 2003, ATMOS ENVIRON, V37, P4645, DOI 10.1016/j.atmosenv.2003.07.005; Lemberkovics Eva, 2007, Acta Pharm Hung, V77, P19; Li F, 2008, BIOORGAN MED CHEM, V16, P5434, DOI 10.1016/j.bmc.2008.04.016; Li HQ, 2013, MOLECULES, V18, P4170, DOI 10.3390/molecules18044170; Lopez BGC, 2014, FOOD CHEM, V146, P174, DOI 10.1016/j.foodchem.2013.09.063; Lopez-Anton N, 2007, APOPTOSIS, V12, P141, DOI 10.1007/s10495-006-0331-2; das Nevesa MVM, 2016, BRAZ J MICROBIOL, V47, P159, DOI 10.1016/j.bjm.2015.11.009; Oliveira AP, 2010, J VENOM ANIM TOXINS, V16, P121, DOI 10.1590/S1678-91992010005000007; Omar RMK, 2016, PHYTOCHEM ANALYSIS, V27, P107, DOI 10.1002/pca.2605; Palmer-Young EC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127296; Park YK, 2002, J AGR FOOD CHEM, V50, P2502, DOI 10.1021/jf011432b; Piccinelli AL, 2011, J AGR FOOD CHEM, V59, P6484, DOI 10.1021/jf201280z; Quijano CE, 2007, FLAVOUR FRAG J, V22, P401, DOI 10.1002/ffj.1812; Neto MSR, 2017, FOOD CHEM TOXICOL, V107, P572, DOI 10.1016/j.fct.2017.03.052; Roslindawani MN, 2016, J ANIM HEAL PROD, V4, P23; Sforcin JM, 2011, J ETHNOPHARMACOL, V133, P253, DOI 10.1016/j.jep.2010.10.032; Shellie RA, 2003, ANALYST, V128, P879, DOI 10.1039/b304371a; Silva JW, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0304-6; Correa FRS, 2017, BIOMED PHARMACOTHER, V86, P162, DOI 10.1016/j.biopha.2016.12.018; STARZYK J, 1977, ARZNEIMITTEL-FORSCH, V27, P1198; Suzuki Seiko, 2009, International Journal of Industrial Entomology, V19, P193; Trusheva B, 2006, EVID-BASED COMPL ALT, V3, P249, DOI 10.1093/ecam/nel006; Tzakou O, 2003, FLAVOUR FRAG J, V18, P2, DOI 10.1002/ffj.1132; VISHTEH A, 1986, IMMUNOPHARMACOLOGY, V12, P187, DOI 10.1016/0162-3109(86)90002-0; Wachter B, 2014, WIEN KLIN WOCHENSCHR, V126, pS32, DOI 10.1007/s00508-014-0522-8; Yanez X, 2002, MOLECULES, V7, P712, DOI 10.3390/70900712; Yayli N, 2005, PHYTOCHEMISTRY, V66, P1741, DOI 10.1016/j.phytochem.2005.04.006; ZEMEK J, 1987, FOLIA MICROBIOL, V32, P421, DOI 10.1007/BF02887573	70	31	32	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191797	10.1371/journal.pone.0191797	http://dx.doi.org/10.1371/journal.pone.0191797			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390009	gold, Green Published, Green Submitted			2022-12-26	WOS:000423793400034
J	Chuerduangphui, J; Ekalaksananan, T; Chaiyarit, P; Patarapadungkit, N; Chotiyano, A; Kongyingyoes, B; Promthet, S; Pientong, C				Chuerduangphui, Jureeporn; Ekalaksananan, Tipaya; Chaiyarit, Ponlatham; Patarapadungkit, Natcha; Chotiyano, Apinya; Kongyingyoes, Bunkerd; Promthet, Supannee; Pientong, Chamsai			Effects of arecoline on proliferation of oral squamous cell carcinoma cells by dysregulating c-Myc and miR-22, directly targeting oncostatin M	PLOS ONE			English	Article							CANCER-CELLS; ARECA NUT; IN-VITRO; CD147 EXPRESSION; EPITHELIAL-CELLS; INTERLEUKIN-6; RECEPTOR; INFLAMMATION; SUPPRESSOR; INVASION	Arecoline, the major alkaloid of areca nut, is known to induce oral carcinogenesis, however, its mechanism is still needed to elucidate. This study investigated the effects of arecoline on cell viability and cell-cycle progression of oral squamous cell carcinoma (OSCC) cells as well as a relevant cellular gene expression. The results showed that a low concentration of arecoline (0.025 mu g/ml) increased OSCC cell viability, proportion of cells in G2/M phase and cell proliferation. Simultaneously, it induced IL-6, STAT3 and c-Myc expression. Interestingly, c-myc promoter activity was also induced by arecoline. MiR-22 expression in arecoline-treated OSCC cells was suppressed and comparable to an upregulated c-Myc expression. In arecoline-treated OSCC cells, oncostatin M (OSM) expression was significantly upregulated and inversely correlated with miR-22 expression. Likewise, OSM expression and its post-transcriptional activity were significantly decreased in miR-22-transfected OSCC and 293FT cells. This result demonstrated that miR-22 directly targeted OSM. Interestingly, miR-22 played an important role as a tumor suppresser on suppressing cell proliferation, migration and cell-cycle progression of OSCC cells. This result suggested the effect of arecoline to promote cell proliferation and cell-cycle progression of OSCC cells might be involved in induction of c-Myc expression and reduction of miR-22 resulting in OSM upregulation.	[Chuerduangphui, Jureeporn; Ekalaksananan, Tipaya; Pientong, Chamsai] Khon Kaen Univ, Dept Microbiol, Fac Med, Khon Kaen, Thailand; [Chuerduangphui, Jureeporn; Ekalaksananan, Tipaya; Patarapadungkit, Natcha; Chotiyano, Apinya; Promthet, Supannee; Pientong, Chamsai] Khon Kaen Univ, HPV & EBV & Carcinogenesis Res Grp, Khon Kaen, Thailand; [Chaiyarit, Ponlatham] Khon Kaen Univ, Dept Oral Diag, Fac Dent, Khon Kaen, Thailand; [Chaiyarit, Ponlatham] Khon Kaen Univ, Res Grp Chron Inflammatory Oral Dis & Syst Dis As, Fac Dent, Khon Kaen, Thailand; [Patarapadungkit, Natcha] Khon Kaen Univ, Dept Pathol, Fac Med, Khon Kaen, Thailand; [Chotiyano, Apinya] Khon Kaen Hosp, Anat Pathol Unit, Khon Kaen, Thailand; [Kongyingyoes, Bunkerd] Khon Kaen Univ, Dept Pharmacol, Fac Med, Khon Kaen, Thailand; [Promthet, Supannee] Khon Kaen Univ, Fac Publ Hlth, Dept Epidemiol, Khon Kaen, Thailand; [Promthet, Supannee] Khon Kaen Univ, ASEAN Canc Epidemiol & Prevent Res Grp, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University	Pientong, C (corresponding author), Khon Kaen Univ, Dept Microbiol, Fac Med, Khon Kaen, Thailand.; Pientong, C (corresponding author), Khon Kaen Univ, HPV & EBV & Carcinogenesis Res Grp, Khon Kaen, Thailand.	chapie@kku.ac.th			Khon Kaen University, Thailand [592002, 601504]; Post-Doctoral Training Program from Research Affairs and Graduate School, Khon Kaen University, Thailand [58443]	Khon Kaen University, Thailand; Post-Doctoral Training Program from Research Affairs and Graduate School, Khon Kaen University, Thailand	This study was granted by Khon Kaen University, Thailand (Grant Numbers 592002 and 601504) and received scholarship under the Post-Doctoral Training Program from Research Affairs and Graduate School, Khon Kaen University, Thailand (Grant no. 58443).	Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bumrungthai S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127109; Chandak R.M., 2013, J CONT DENT, V3, P78; Cheng HL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-126; Chiang SL, 2007, TOXICOL SCI, V100, P66, DOI 10.1093/toxsci/kfm201; Chopjitt Peechanika, 2015, Asian Pac J Cancer Prev, V16, P3961; Dvorak K, 2013, WORLD J GASTROENTERO, V19, P2307, DOI 10.3748/wjg.v19.i15.2307; Fossey SL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-125; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Guo L, 2013, ONCOGENE, V32, P5272, DOI 10.1038/onc.2012.573; Hamid S, 2007, INT J MOL MED, V19, P453; Jeng JH, 2003, CARCINOGENESIS, V24, P1301, DOI 10.1093/carcin/bgg083; Junk DJ, 2014, CANCERS, V6, P741, DOI 10.3390/cancers6020741; Kan CE, 2011, CANCER RES, V71, P6930, DOI 10.1158/0008-5472.CAN-10-3860; Kong LM, 2014, CANCER RES, V74, P3764, DOI 10.1158/0008-5472.CAN-13-3555; Konttinen Y, 2001, J PATHOL, V194, P384, DOI 10.1002/1096-9896(200107)194:3<384::AID-PATH896>3.0.CO;2-8; Lacreusette A, 2008, J PATHOL, V216, P451, DOI 10.1002/path.2416; Lee CH, 2011, INT J CANCER, V129, P1741, DOI 10.1002/ijc.25809; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li N, 2011, CANCER CELL, V19, P429, DOI 10.1016/j.ccr.2011.03.018; Li QH, 2011, INT J MOL MED, V28, P101, DOI [10.3892/jimm.2011.647, 10.3892/ijmm.2011.647]; Ling B, 2012, J CANCER RES CLIN, V138, P1355, DOI 10.1007/s00432-012-1194-2; Namwat N, 2008, CHEMOTHERAPY, V54, P343, DOI 10.1159/000151541; Ouyang LM, 2006, BIOMED RES-TOKYO, V27, P197, DOI 10.2220/biomedres.27.197; Qiu KF, 2016, ARCH ORAL BIOL, V66, P92, DOI 10.1016/j.archoralbio.2016.02.013; Queen MM, 2005, CANCER RES, V65, P8896, DOI 10.1158/0008-5472.CAN-05-1734; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Tanaka M, 2004, REV PHYSIOL BIOCH P, V149, P39, DOI 10.1007/s10254-003-0013-1; Tsai YS, 2008, TOXICOLOGY, V249, P230, DOI 10.1016/j.tox.2008.05.007; Tsai YS, 2011, TOXICOL SCI, V123, P480, DOI 10.1093/toxsci/kfr182; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Van Wagoner NJ, 2000, J NEUROCHEM, V75, P563, DOI 10.1046/j.1471-4159.2000.0750563.x; West NR, 2012, ENDOCR-RELAT CANCER, V19, P181, DOI 10.1530/ERC-11-0326; Xiong JH, 2010, FEBS J, V277, P1684, DOI 10.1111/j.1742-4658.2010.07594.x; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Yang YY, 2004, JPN J CLIN ONCOL, V34, P176, DOI 10.1093/jjco/hyh037; Zhang GJ, 2012, MED ONCOL, V29, P3108, DOI 10.1007/s12032-012-0233-9	37	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0192009	10.1371/journal.pone.0192009	http://dx.doi.org/10.1371/journal.pone.0192009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385191	Green Submitted, Green Published, gold			2022-12-26	WOS:000423668400068
J	Eladak, S; Moison, D; Guerquin, MJ; Matilionyte, G; Kilcoyne, K; N'Tumba-Byn, T; Messiaen, S; Deceuninck, Y; Pozzi-Gaudin, S; Benachi, A; Livera, G; Antignac, JP; Mitchell, R; Rouiller-Fabre, V; Habert, R				Eladak, Soria; Moison, Delphine; Guerquin, Marie-Justine; Matilionyte, Gabriele; Kilcoyne, Karen; N'Tumba-Byn, Thierry; Messiaen, Sebastien; Deceuninck, Yoann; Pozzi-Gaudin, Stephanie; Benachi, Alexandra; Livera, Gabriel; Antignac, Jean-Philippe; Mitchell, Rod; Rouiller-Fabre, Virginie; Habert, Rene			Effects of environmental Bisphenol A exposures on germ cell development and Leydig cell function in the human fetal testis	PLOS ONE			English	Article							CARCINOMA IN-SITU; TRANSCRIPTION FACTOR AP-2-GAMMA; TANDEM MASS-SPECTROMETRY; SPRAGUE-DAWLEY RATS; ENDOCRINE DISRUPTORS; UTERO EXPOSURE; TESTICULAR DYSGENESIS; LACTATIONAL EXPOSURE; ANOGENITAL DISTANCE; PROGRAMMING WINDOW	Background Using an organotypic culture system termed human Fetal Testis Assay (hFeTA) we previously showed that 0.01 mu M BPA decreases basal, but not LH-stimulated, testosterone secreted by the first trimester human fetal testis. The present study was conducted to determine the potential for a long-term antiandrogenic effect of BPA using a xenograft model, and also to study the effect of BPA on germ cell development using both the hFETA and xenograft models. Methods Using the hFeTA system, first trimester testes were cultured for 3 days with 0.01 to 10 mu M BPA. For xenografts, adult castrate male nude mice were injected with hCG and grafted with first trimester testes. Host mice received 10 mu M BPA (similar to 500 mu g/kg/day) in their drinking water for 5 weeks. Plasma levels of total and unconjugated BPA were 0.10 mu M and 0.038 mu M respectively. Mice grafted with second trimester testes received 0.5 and 50 mu g/kg/day BPA by oral gavage for 5 weeks. Results With first trimester human testes, using the hFeTA model, 10 mu M BPA increased germ cell apoptosis. In xenografts, germ cell density was also reduced by BPA exposure. Importantly, BPA exposure significantly decreased the percentage of germ cells expressing the pluripotency marker AP-2 gamma, whilst the percentage of those expressing the pre-spermatogonial marker MAGE-A4 significantly increased. BPA exposure did not affect hCG-stimulated androgen production in first and second trimester xenografts as evaluated by both plasma testosterone level and seminal vesicle weight in host mice. Conclusions Exposure to BPA at environmentally relevant concentrations impairs germ cell development in first trimester human fetal testis, whilst gonadotrophin-stimulated testosterone production was unaffected in both first and second trimester testis. Studies using first trimester human fetal testis demonstrate the complementarity of the FeTA and xenograft models for determining the respective short-term and long term effects of environmental exposures.	[Eladak, Soria; Moison, Delphine; Guerquin, Marie-Justine; N'Tumba-Byn, Thierry; Messiaen, Sebastien; Livera, Gabriel; Rouiller-Fabre, Virginie; Habert, Rene] Univ Paris Diderot, Sorbonne Paris Cite, Lab Dev Gonads, Unit Genet Stabil Stem Cells & Radiat, Fontenay Aux Roses, France; [Eladak, Soria; Moison, Delphine; Guerquin, Marie-Justine; N'Tumba-Byn, Thierry; Messiaen, Sebastien; Livera, Gabriel; Rouiller-Fabre, Virginie; Habert, Rene] CEA, DSV, iRCM, SCSR,LDG, Fontenay Aux Roses, France; [Eladak, Soria; Moison, Delphine; Guerquin, Marie-Justine; N'Tumba-Byn, Thierry; Messiaen, Sebastien; Livera, Gabriel; Rouiller-Fabre, Virginie; Habert, Rene] INSERM, Unite 967, Fontenay Aux Roses, France; [Matilionyte, Gabriele; Kilcoyne, Karen; Mitchell, Rod] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Deceuninck, Yoann; Antignac, Jean-Philippe] Ecole Natl Vet Agroalimentaire & Alimentat Nantes, Lab Etud Residus & Contaminants Aliments LABERCA, Nantes, France; [Pozzi-Gaudin, Stephanie; Benachi, Alexandra] Univ Paris Sud, Hop A Beclere, Serv Gynecol Obstet & Med Reprod, Clamart, France	UDICE-French Research Universities; Universite Paris Cite; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Edinburgh; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Universite Paris Saclay	Habert, R (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Lab Dev Gonads, Unit Genet Stabil Stem Cells & Radiat, Fontenay Aux Roses, France.; Habert, R (corresponding author), CEA, DSV, iRCM, SCSR,LDG, Fontenay Aux Roses, France.; Habert, R (corresponding author), INSERM, Unite 967, Fontenay Aux Roses, France.	rene.habert@cea.fr	LIVERA, Gabriel/F-5740-2019	LIVERA, Gabriel/0000-0001-8436-4730; ANTIGNAC, Jean-Philippe/0000-0001-9512-9314; GUERQUIN, Marie-Justine/0000-0002-1752-7250				Allard P, 2010, P NATL ACAD SCI USA, V107, P20405, DOI 10.1073/pnas.1010386107; Aoki T, 2012, REPROD TOXICOL, V34, P463, DOI 10.1016/j.reprotox.2012.06.001; AUGER J, 1995, NEW ENGL J MED, V332, P281, DOI 10.1056/NEJM199502023320501; Ben Maamar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117226; Brieno-Enriquez MA, 2012, MOL HUM REPROD, V18, P171, DOI 10.1093/molehr/gar074; Chevalier N, 2015, HUM REPROD, V30, P447, DOI 10.1093/humrep/deu340; Churchwell MI, 2014, TOXICOL SCI, V139, P4, DOI 10.1093/toxsci/kfu021; Deceuninck Y, 2014, J CHROMATOGR A, V1362, P241, DOI 10.1016/j.chroma.2014.07.105; Deceuninck Y, 2015, ANAL BIOANAL CHEM, V407, P2485, DOI 10.1007/s00216-015-8469-9; Eladak S, 2015, FERTIL STERIL, V103, P11, DOI 10.1016/j.fertnstert.2014.11.005; Evtouchenko L, 1996, CELL TRANSPLANT, V5, P453, DOI 10.1016/0963-6897(96)00079-6; Fenichel P, 2012, HUM REPROD, V27, P983, DOI 10.1093/humrep/der451; Fowler PA, 2014, HUM REPROD, V29, P1471, DOI 10.1093/humrep/deu117; FUJIMOTO T, 1977, ANAT REC, V188, P315, DOI 10.1002/ar.1091880305; FUKUDA T, 1975, CELL TISSUE RES, V161, P55; Gaskell TL, 2004, BIOL REPROD, V71, P2012, DOI 10.1095/biolreprod.104.028381; GAUTIER C, 1994, MOL CELL ENDOCRINOL, V99, P55, DOI 10.1016/0303-7207(94)90146-5; Gerona RR, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0131-2; GONDOS B, 1971, AM J OBSTET GYNECOL, V110, P644, DOI 10.1016/0002-9378(71)90245-6; HABERT R, 1991, MOL CELL ENDOCRINOL, V82, P199, DOI 10.1016/0303-7207(91)90032-N; HABERT R, 1984, J STEROID BIOCHEM, V21, P193, DOI 10.1016/0022-4731(84)90383-2; Habert R, 2014, REPRODUCTION, V147, pR119, DOI 10.1530/REP-13-0497; Hoei-Hansen CE, 2004, CLIN CANCER RES, V10, P8521, DOI 10.1158/1078-0432.CCR-04-1285; Howdeshell KL, 2008, TOXICOL SCI, V102, P371, DOI 10.1093/toxsci/kfm306; Hunt PA, 2012, P NATL ACAD SCI USA, V109, P17525, DOI 10.1073/pnas.1207854109; Ikezuki Y, 2002, HUM REPROD, V17, P2839, DOI 10.1093/humrep/17.11.2839; Jin PP, 2013, J BIOMED RES, V27, P135, DOI 10.7555/JBR.27.20120076; Kabuto H, 2003, ENVIRON RES, V93, P31, DOI 10.1016/S0013-9351(03)00062-8; Kobayashi K, 2002, IND HEALTH, V40, P375, DOI 10.2486/indhealth.40.375; Lacroix MZ, 2011, TALANTA, V85, P2053, DOI 10.1016/j.talanta.2011.07.040; Lambrot R, 2006, BIOCHIMIE, V88, P1831, DOI 10.1016/j.biochi.2006.09.022; Lambrot R, 2006, J CLIN ENDOCR METAB, V91, P2696, DOI 10.1210/jc.2005-2113; LECERF L, 1993, ENDOCRINOLOGY, V133, P2313, DOI 10.1210/en.133.5.2313; Lee S, 2013, CHEMOSPHERE, V93, P434, DOI 10.1016/j.chemosphere.2013.05.029; Leridon H, 2008, HUM REPROD, V23, P1312, DOI 10.1093/humrep/den106; Li YJ, 2009, TOXICOL SCI, V108, P427, DOI 10.1093/toxsci/kfp024; Livera G, 2006, CELL TISSUE RES, V324, P507, DOI 10.1007/s00441-006-0167-7; MacLeod DJ, 2010, INT J ANDROL, V33, P279, DOI 10.1111/j.1365-2605.2009.01005.x; Main KM, 2010, BEST PRACT RES CL EN, V24, P279, DOI 10.1016/j.beem.2009.10.003; Merlet J, 2007, CELL CYCLE, V6, P2258, DOI 10.4161/cc.6.18.4654; Merlet J, 2007, P NATL ACAD SCI USA, V104, P3615, DOI 10.1073/pnas.0611421104; Miao MH, 2011, BIRTH DEFECTS RES A, V91, P867, DOI 10.1002/bdra.22845; Mitchell RT, 2012, J CLIN ENDOCR METAB, V97, pE341, DOI 10.1210/jc.2011-2411; Mitchell RT, 2008, HUM REPROD, V23, P2755, DOI 10.1093/humrep/den295; Mitchell RT, 2010, HUM REPROD, V25, P2405, DOI 10.1093/humrep/deq183; Murray TJ, 2007, REPROD TOXICOL, V23, P383, DOI 10.1016/j.reprotox.2006.10.002; N'Tumba-Byn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051579; Naik P, 2009, MUTAT RES-GEN TOX EN, V676, P106, DOI 10.1016/j.mrgentox.2009.04.010; Olaso R, 2000, J ANDROL, V21, P497, DOI 10.1002/j.1939-4640.2000.tb02114.x; Olesen IA, 2007, BEST PRACT RES CL EN, V21, P462, DOI 10.1016/j.beem.2007.04.002; Othman AI, 2016, TOXICOL IND HEALTH, V32, P1537, DOI 10.1177/0748233714561286; Pauls K, 2005, INT J CANCER, V115, P470, DOI 10.1002/ijc.20913; Pauls K, 2006, HUM REPROD, V21, P397, DOI 10.1093/humrep/dei325; Peretz J, 2014, ENVIRON HEALTH PERSP, V122, P775, DOI 10.1289/ehp.1307728; Poulain M, 2014, MOL HUM REPROD, V20, P960, DOI 10.1093/molehr/gau058; Rouiller-Fabre V, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00058; Rouiller-Fabre V, 2014, ANN ENDOCRINOL-PARIS, V75, P54, DOI 10.1016/j.ando.2014.03.010; Rouiller-Fabre V, 2009, FOLIA HISTOCHEM CYTO, V47, pS19, DOI 10.2478/v10042-009-0065-4; Salian S, 2009, LIFE SCI, V85, P742, DOI 10.1016/j.lfs.2009.10.004; Sharpe Richard M, 2008, Fertil Steril, V89, pe33, DOI 10.1016/j.fertnstert.2007.12.026; SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Skakkebaek NE, 2016, HORM RES PAEDIAT, V86, P240, DOI 10.1159/000443400; Skakkebaek NE, 2016, PHYSIOL REV, V96, P55, DOI 10.1152/physrev.00017.2015; Tanaka M, 2006, HUM EXP TOXICOL, V25, P369, DOI 10.1191/0960327106ht638oa; Tayama S, 2008, MUTAT RES-GEN TOX EN, V649, P114, DOI 10.1016/j.mrgentox.2007.08.006; Teeguarden JG, 2016, FOOD CHEM TOXICOL, V92, P129, DOI 10.1016/j.fct.2016.03.023; Thuillier R, 2009, MICROSC RES TECHNIQ, V72, P773, DOI 10.1002/jemt.20756; Tinwell H, 2002, TOXICOL SCI, V68, P339, DOI 10.1093/toxsci/68.2.339; Tyl RW, 2002, TOXICOL SCI, V68, P121, DOI 10.1093/toxsci/68.1.121; Urriola-Munoz P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113793; van den Driesche S, 2015, ENVIRON HEALTH PERSP, V123, P223, DOI 10.1289/ehp.1408248; Vandenberg Laura N., 2013, Reviews on Environmental Health, V28, P37, DOI 10.1515/reveh-2012-0034; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; vandenDriesche S, 2017, JCI INSIGHT, V359, DOI [DOI 10.1172/JCI.INSIGHT.91204, 10.1172/jci.insight.91204]; Vilela J, 2014, ANDROLOGIA, V46, P971, DOI 10.1111/and.12182; Wang Q, 2010, TOXICOL LETT, V199, P129, DOI 10.1016/j.toxlet.2010.08.014; WARTENBERG H, 1976, ANDROLOGIA, V8, P117; Watanabe S, 2003, IND HEALTH, V41, P338, DOI 10.2486/indhealth.41.338; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241; Xi W, 2012, ENVIRON SCI POLLUT R, V19, P2515, DOI 10.1007/s11356-012-0827-y; Zhang XF, 2012, MOL BIOL REP, V39, P8621, DOI 10.1007/s11033-012-1716-7	83	30	32	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191934	10.1371/journal.pone.0191934	http://dx.doi.org/10.1371/journal.pone.0191934			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385186	Green Published, gold, Green Submitted			2022-12-26	WOS:000423668400063
J	Rech, S; Pichs, YJB; Garcia-Vazquez, E				Rech, Sabine; Borrell Pichs, Yaisel J.; Garcia-Vazquez, Eva			Anthropogenic marine litter composition in coastal areas may be a predictor of potentially invasive rafting fauna	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; PLASTIC DEBRIS; BEACH; ACCUMULATION; CIRRIPEDIA; PATTERNS; BUOYS; LIFE; SIZE; BAY	Anthropogenic plastic pollution is a global problem. In the marine environment, one of its less studied effects is the transport of attached biota, which might lead to introductions of non-native species in new areas or aid in habitat expansions of invasive species. The goal of the present work was to assess if the material composition of beached anthropogenic litter is indicative of the rafting fauna in a coastal area and could thus be used as a simple and cost-efficient tool for risk assessment in the future. Beached anthropogenic litter and attached biota along the 200 km coastline of Asturias, central Bay of Biscay, Spain, were analysed. The macrobiotic community attached to fouled litter items was identified using genetic barcoding combined with visual taxonomic analysis, and compared between hard plastics, foams, other plastics and non-plastic items. On the other hand, the material composition of beached litter was analysed in a standardized area on each beach. From these two datasets, the expected frequency of several rafting taxa was calculated for the coastal area and compared to the actually observed frequencies. The results showed that plastics were the most abundant type of beached litter. Litter accumulation was likely driven by coastal sources (industry, ports) and river/sewage inputs and transported by near-shore currents. Rafting vectors were almost exclusively made up of plastics and could mainly be attributed to fishing activity and leisure/household. We identified a variety of rafting biota, including species of goose barnacles, acorn barnacles, bivalves, gastropods, polychaetes and bryozoan, and hydrozoan colonies attached to stranded litter. Several of these species were non-native and invasive, such as the giant Pacific oyster (Crassostrea gigas) and the Australian barnacle (Austrominius modestus). The composition of attached fauna varied strongly between litter items of different materials. Plastics, except for foam, had a much more diverse attached community than non-plastic materials. The predicted frequency of several taxa attached to beached litter significantly correlated with the actually observed frequencies. Therefore we suggest that the composition of stranded litter on a beach or an area could allow for predictions about the corresponding attached biotic community, including invasive species.	[Rech, Sabine; Borrell Pichs, Yaisel J.; Garcia-Vazquez, Eva] Univ Oviedo, Dept Funct Biol, Oviedo, Asturias, Spain	University of Oviedo	Rech, S (corresponding author), Univ Oviedo, Dept Funct Biol, Oviedo, Asturias, Spain.	rechsabine@uniovi.es	Rech, Sabine/ABE-1665-2020; Rech, Sabine/AAX-4368-2021; Borrell Pichs, Yaisel J./ABC-8904-2020; Garcia-Vazquez, Eva/Y-7293-2019; Borrell Pichs, Yaisel/B-2650-2009	Rech, Sabine/0000-0002-7500-6330; Borrell Pichs, Yaisel J./0000-0003-2840-4384; Borrell Pichs, Yaisel/0000-0003-2840-4384; Garcia-Vazquez, Eva/0000-0002-8429-838X	European Commission [Marie Curie ITN H2020 AQUAINVAD-ED] [642197]	European Commission [Marie Curie ITN H2020 AQUAINVAD-ED]	This work was supported by the European Commission [Marie Curie 2014 ITN H2020 AQUAINVAD-ED; grant agreement no. 642197].	Adarraga I, 2012, AQUAT INVASIONS, V7, P171, DOI 10.3391/ai.2012.7.2.003; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2007, OFF J EUR UNION, V2007, P6; [Anonymous], [No title captured]; Araujo MC, 2007, MANAG ENVIRON QUAL, V18, P6, DOI 10.1108/14777830710717677; de Araujo MCB, 2007, WASTE MANAGE, V27, P833, DOI 10.1016/j.wasman.2006.04.018; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Barnes DKA, 2003, MAR ECOL PROG SER, V262, P289, DOI 10.3354/meps262289; Barnes DKA, 2002, NATURE, V416, P808, DOI 10.1038/416808a; Bravo M, 2011, MAR ECOL PROG SER, V439, P1, DOI 10.3354/meps09344; Breves Andre, 2014, Check List, V10, P684; Browne MA, 2015, MARINE ANTHROPOGENIC LITTER, P229, DOI 10.1007/978-3-319-16510-3_9; Browne MA, 2015, ENVIRON SCI TECHNOL, V49, P7082, DOI 10.1021/es5060572; Calder DR, 2014, AQUAT INVASIONS, V9, P425, DOI 10.3391/ai.2014.9.4.02; CALDER DR, 1995, B MAR SCI, V56, P537; Astudillo JC, 2009, AQUAT BIOL, V5, P219, DOI 10.3354/ab00151; Carlton JT, 2017, SCIENCE, P357; Carson HS, 2013, MAR POLLUT BULL, V75, P126, DOI 10.1016/j.marpolbul.2013.07.054; Carson HS, 2013, MAR ENVIRON RES, V84, P76, DOI 10.1016/j.marenvres.2012.12.002; Clapp J, 2009, ENVIRON POLIT, V18, P315, DOI 10.1080/09644010902823717; Davidson TM, 2012, MAR POLLUT BULL, V64, P1821, DOI 10.1016/j.marpolbul.2012.06.005; Debrot AO, 1999, MAR POLLUT BULL, V38, P795, DOI 10.1016/S0025-326X(99)00043-0; Dell R. K., 1964, Crustaceana, V7, P79, DOI 10.1163/156854064X00308; Doughty R, 2015, TULANE ENV LAW J, V27, P277; Ebbesmeyer C., 1992, EOS T AM GEOPHYS UNI, V73, P361, DOI [10.1029/91eo10273, DOI 10.1029/91EO10273]; Ebbesmeyer CC, 2012, MAR POLLUT BULL, V65, P69, DOI 10.1016/j.marpolbul.2011.09.037; EU, 2014, OFFICIAL J EUROPEA L, V2014, P35; Farrapeira CMR, 2011, GEST COSTEIRA INTEG, V11, P85, DOI DOI 10.5894/RGCI200; Fazey FMC, 2016, MAR POLLUT BULL, V110, P371, DOI 10.1016/j.marpolbul.2016.06.039; Fazey FMC, 2016, ENVIRON POLLUT, V210, P354, DOI 10.1016/j.envpol.2016.01.026; Fine M, 2001, MAR BIOL, V138, P1195; Flor G, 1978, TRABAJOS GEOL, V10, P183; Fraser CI, 2011, P ROY SOC B-BIOL SCI, V278, P649, DOI 10.1098/rspb.2010.1117; Galgani F, 2015, MARINE ANTHROPOGENIC LITTER, P29, DOI 10.1007/978-3-319-16510-3_2; Gall SC, 2015, MAR POLLUT BULL, V92, P170, DOI 10.1016/j.marpolbul.2014.12.041; Galloway TS, 2015, MARINE ANTHROPOGENIC LITTER, P343, DOI 10.1007/978-3-319-16510-3_13; Garcia-Perez J, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-40; Garcia-Soto C, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001012; Goldstein MC, 2014, MAR BIOL, V161, P1441, DOI 10.1007/s00227-014-2432-8; Gorley C.K., 2006, GETTING STARTED PRIM; Grade A, 2016, AQUAT LIVING RESOUR, V29, DOI 10.1051/alr/2016035; GREGORY MR, 1978, NEW ZEAL J MAR FRESH, V12, P399, DOI 10.1080/00288330.1978.9515768; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hoeksema BW, 2012, MAR ECOL PROG SER, V445, P209, DOI 10.3354/meps09460; Holmes AM, 2015, J CONCHOL, V42, P41; JOKIEL PL, 1984, CORAL REEFS, V3, P113, DOI 10.1007/BF00263761; Kerckhof F, 2001, SENCK MARIT, V31, P245, DOI 10.1007/BF03043033; Kiessling T, 2015, MARINE ANTHROPOGENIC LITTER, P141, DOI 10.1007/978-3-319-16510-3_6; Kuhn S, 2015, MARINE ANTHROPOGENIC LITTER, P75, DOI 10.1007/978-3-319-16510-3_4; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lavers JL, 2016, MAR ENVIRON RES, V119, P245, DOI 10.1016/j.marenvres.2016.06.009; LavIn A, 2006, BAY BISCAY ENCOUNTER, P933; Law KL, 2017, ANNU REV MAR SCI, V9, P205, DOI 10.1146/annurev-marine-010816-060409; Lechner A, 2014, ENVIRON POLLUT, V188, P177, DOI 10.1016/j.envpol.2014.02.006; Li HX, 2016, ENVIRON POLLUT, V218, P973, DOI 10.1016/j.envpol.2016.08.047; Liu TK, 2015, MAR POLICY, V53, P123, DOI 10.1016/j.marpol.2014.12.001; Macfadyen G, 2009, UNEP REGIONAL SEAS R, V523; Marques RC, 2015, MAR BIODIVERS, V45, P333, DOI 10.1007/s12526-014-0258-8; Newman S, 2015, MARINE ANTHROPOGENIC LITTER, P367, DOI 10.1007/978-3-319-16510-3_14; NEWMAN W A, 1972, Crustaceana (Leiden), V22, P31, DOI 10.1163/156854072X00651; Nikula R, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0821; O'Riordan Ruth M., 2013, Marine Biodiversity Records, V6, pe123, DOI 10.1017/S1755267213000985; Oberbeckmann S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159289; Ordonez A, 2003, ARCH ENVIRON CON TOX, V44, P160, DOI 10.1007/s00244-002-2005-6; Pejovic I, 2016, MAR BIOL RES, V12, P168, DOI 10.1080/17451000.2015.1112016; Cabezas MP, 2013, HELGOLAND MAR RES, V67, P483, DOI 10.1007/s10152-012-0337-9; PlasticsEurope, 2016, PLAST FACTS 2016 AN, P38; Rech S, 2014, MAR POLLUT BULL, V82, P66, DOI 10.1016/j.marpolbul.2014.03.019; Rech S, 2016, MAR POLLUT BULL, V113, P40, DOI 10.1016/j.marpolbul.2016.08.032; Rees E. I. S., 2009, Marine Biodiversity Records, V2, pe25, DOI 10.1017/S1755267208000298; Rochman CM, 2013, NATURE, V494, P169, DOI 10.1038/494169a; Bastida-Zavala JR, 2017, EUR J TAXON, V344, P1, DOI 10.5852/ejt.2017.344; Ryan PG, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/8/084019; Serrano E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052739; Thiel M, 2005, OCEANOGR MAR BIOL, V42, P181, DOI DOI 10.1201/9780203507810.CH6; Vegter AC, 2014, ENDANGER SPECIES RES, V25, P225, DOI 10.3354/esr00623; Velander K, 1999, MAR POLLUT BULL, V38, P1134, DOI 10.1016/S0025-326X(99)00143-5; Whitehead TO, 2011, CRUSTACEANA, V84, P635, DOI 10.1163/001121611X574290; Williams AT, 1997, J COASTAL RES, V13, P1159; Woodall LC, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00003; WoRMS Editorial Board, 2021, WORLD REGISTER MARIN, DOI DOI 10.14284/170ATVLIZ; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	84	41	42	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191859	10.1371/journal.pone.0191859	http://dx.doi.org/10.1371/journal.pone.0191859			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385195	Green Submitted, Green Published, gold			2022-12-26	WOS:000423668400058
J	de Meireles, RC; Teixeira, JPG; Solar, R; Vasconcelos, BNF; Fernandes, RBA; Lopes, LE				de Meireles, Ricardo Camargos; Gusmao Teixeira, Joao Paulo; Solar, Ricardo; Vasconcelos, Bruno Nery F.; Fernandes, Raphael B. A.; Lopes, Leonardo Esteves			Soil attributes drive nest-site selection by the campo miner Geositta poeciloptera	PLOS ONE			English	Article							TAILED BEE-EATERS; PARTICLE COMPOSITION; CONSERVATION; PREDATION; SUCCESS; BIRDS; SIZE	Substrate type is a key-factor in nest-site selection and nest architecture of burrowing birds. However, little is known about which factors drive nest-site selection for these species, especially in the tropics. We studied the influence of soil attributes on nest-site selection by the campo miner Geositta poeciloptera, an open grassland bird that builds its nests within soil cavities. For all nests found, we measured the depth of the nest cavity and the resistance of the soil to penetration, and identified the soil horizon in which the nest was located. In soil banks with nests, we collected soil samples for granulometric analysis around each nest cavity, while in soil banks without nests we collected these samples at random points. From 43 nests found, 86% were located in the deeper soil horizons (C-horizon), and only 14% in the shallower horizons (B-horizon). Granulometric analysis showed that the C-horizons possessed a high similar granulometric composition, with high silt and low clay contents. These characteristics are associated with a low degree of structural development of the soil, which makes it easier to excavate. Contrarily, soil resistance to penetration does not seem to be an important criterion for nest site selection, although nests in more resistant the soils tend to have shallower nest cavities. Among the soil banks analyzed, 40% of those without cavities possessed a larger proportion of B-horizon relative to the C-horizon, and their texture was more clayey. On the other hand, almost all soil banks containing nest cavities had a larger C-horizon and a silty texture, indicating that soil attributes drive nest-site selection by G. poeciloptera. Thus, we conclude that the patchy distribution of G. poeciloptera can attributed to the infrequent natural exposure of the C-horizon in the tropical region, where well developed, deep and permeable soils are more common.	[de Meireles, Ricardo Camargos; Gusmao Teixeira, Joao Paulo] Univ Fed Vicosa, CCB, Posgrad Biol Anim, Campus Vicosa, Vicosa, MG, Brazil; [Solar, Ricardo] Univ Fed Minas Gerais, ICB, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Vasconcelos, Bruno Nery F.] Univ Fed Uberlandia, ICIAG, Inst Ciencias Agr, Campus Monte Carmelo, Monte Carmelo, MG, Brazil; [Fernandes, Raphael B. A.] Univ Fed Vicosa, Soil Sci Dept, Campus Vicosa, Vicosa, MG, Brazil; [Lopes, Leonardo Esteves] Univ Fed Vicosa, IBF, Lab Biol Anim, Campus Florestal, Florestal, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Minas Gerais; Universidade Federal de Uberlandia; Universidade Federal de Vicosa; Universidade Federal de Vicosa	de Meireles, RC (corresponding author), Univ Fed Vicosa, CCB, Posgrad Biol Anim, Campus Vicosa, Vicosa, MG, Brazil.	rcmeireles@hotmail.com	Meireles, Ricardo/S-1599-2019; de Castro Solar, Ricardo Ribeiro/F-2043-2010; Lopes, Leonardo Esteves/B-5726-2013; Fernandes, Raphael B. A./A-1709-2009	Meireles, Ricardo/0000-0002-4137-8005; de Castro Solar, Ricardo Ribeiro/0000-0001-5627-4017; Lopes, Leonardo Esteves/0000-0003-4014-9128; Fernandes, Raphael B. A./0000-0002-8611-1355	CNPq [476031/2013-3, 305401/2014-9]; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the CNPq under Grants number 476031/2013-3 and 305401/2014-9. RCM and JPGT received MSc fellowships from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PEDOLOGIA BASE DISTI; Azevedo L.G., 1962, ANAIS ACAD BRASILEIR, V34, P225; Beyer L. K., 1938, Wilson Bulletin, V50, P122; Birdlife International, 2017, GEOS POEC; Crawley MJ, 2012, R BOOK; de Sa A, 2012, THEOR APPL CLIMATOL, V108, P1, DOI 10.1007/s00704-011-0507-8; Embrapa, 2013, SISTEMA BRASILEIRO C, V3rd; FAO, 2015, INT SOIL CLASSIFICAT; Gee G.W., 2002, METHODS SOIL ANAL PA, V5, P255, DOI [DOI 10.2136/SSSABOOKSER5.4.C12, 10.2136/sssabookser5.4.c12]; Heneberg P, 2004, ACTA ZOOL ACAD SCI H, V50, P185; Heneberg P, 2004, BIOLOGIA, V59, P205; Heneberg P, 2003, IBIS, V145, P392, DOI 10.1046/j.1474-919X.2003.00168.x; Heneberg P, 2001, BIOLOGIA, V56, P205; Heneberg P, 2009, ECOL RES, V24, P453, DOI 10.1007/s11284-008-0520-2; Instituto Brasileiro de Geografia e Estatistica-IBGE, 2015, MAN TECN PED; Kafutshi RK, 2011, OSTRICH, V82, P243, DOI 10.2989/00306525.2011.616696; Ker J.C., 2012, PEDOLOGIA FUNDAMENTO; KERPEZ TA, 1990, CONDOR, V92, P193, DOI 10.2307/1368398; LI PJ, 1991, AUK, V108, P405; Lopes LE, 2010, BIRD CONSERV INT, V20, P84, DOI 10.1017/S0959270909990190; Machado TLSS, 2017, J NAT HIST, V51, P1; Marini MA, 2009, CONSERV BIOL, V23, P1558, DOI 10.1111/j.1523-1739.2009.01258.x; MARTIN TE, 1988, CONDOR, V90, P51, DOI 10.2307/1368432; Martin TE, 2001, ECOLOGY, V82, P175, DOI 10.2307/2680095; MMA-Ministerio do Meio Ambiente, 2014, DIARIO OFICIAL UNIAO, V245, P121; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NILSSON SG, 1984, ORNIS SCAND, V15, P167, DOI 10.2307/3675958; Oliveira Filho A. T., 1999, Cerne, V5, P51; Overbeck GE, 2015, DIVERS DISTRIB, V21, P1455, DOI 10.1111/ddi.12380; Pacheco J.F., 2008, COTINGA, V30, P16; PETERSEN ARNOLD J., 1955, WILSON BULL, V67, P235; Raats M. M., 1991, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D; Ramirez-Herranz M, 2017, PEERJ, V5, DOI 10.7717/peerj.3182; Remsen J.V. Jr, 2003, P162; RENDELL WB, 1989, CONDOR, V91, P875, DOI 10.2307/1368072; Ridgely R., 2009, FIELD GUIDE SONGBIRD; Ruiz HA, 2005, REV BRAS CIENC SOLO, V29, P297, DOI 10.1590/S0100-06832005000200015; Sandmann-Funke S., 1972, Abhandlungen Landesmus Naturk Munster, V34, P88; Sano EE, 2010, ENVIRON MONIT ASSESS, V166, P113, DOI 10.1007/s10661-009-0988-4; Santos R.D., 2015, MANUAL DESCRICAO COL; Schepps J, 1999, AUK, V116, P658, DOI 10.2307/4089327; Sick H., 1997, ORNITOLOGIA BRASILEI; Silva, 2005, 13 C BRAS ORN RES, P28; SKUTCH AF, 1948, IBIS, V90, P433, DOI 10.1111/j.1474-919X.1948.tb01705.x; Smalley I, 2013, QUATERN INT, V296, P216, DOI 10.1016/j.quaint.2012.03.059; WILLIAMS MD, 1981, IBIS, V123, P366, DOI 10.1111/j.1474-919X.1981.tb04042.x; Yuan HW, 2006, ECOL RES, V21, P510, DOI 10.1007/s11284-006-0183-9; Yuan HW, 2006, J NAT HIST, V40, P485, DOI 10.1080/00222930600681043; [No title captured]	49	5	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0192185	10.1371/journal.pone.0192185	http://dx.doi.org/10.1371/journal.pone.0192185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381768	Green Published, gold, Green Submitted			2022-12-26	WOS:000423617800063
J	Lu, ZY; Casalino-Matsuda, SM; Nair, A; Buchbinder, A; Budinger, GRS; Sporn, PHS; Gates, KL				Lu, Ziyan; Casalino-Matsuda, S. Marina; Nair, Aisha; Buchbinder, Anja; Budinger, G. R. Scott; Sporn, Peter H. S.; Gates, Khalilah L.			A role for heat shock factor 1 in hypercapnia-induced inhibition of inflammatory cytokine expression	FASEB JOURNAL			English	Article						rodent; macrophage; bacterial infections; stress response; lung	NECROSIS-FACTOR-ALPHA; MECHANICALLY VENTILATED PATIENTS; OBSTRUCTIVE PULMONARY-DISEASE; TRANSCRIPTION FACTOR; LUNG INJURY; RESPIRATORY-FAILURE; ACUTE EXACERBATIONS; HOSPITAL MORTALITY; NUCLEAR-FACTOR; IN-VITRO	Hypercapnia, elevated levels of CO2 in the blood, is a known marker for poor clinical prognosis and is associated with increased mortality in patients hospitalized with both bacterial and viral pneumonias. Although studies have established a connection between elevated CO2 levels and poor pneumonia outcomes, a mechanistic basis of this association has not yet been established. We previously reported that hypercapnia inhibits expression of key NF-B-regulated, innate immune cytokines, TNF-, and IL-6, in LPS-stimulated macrophages in vitro and in mice during Pseudomonas pneumonia. The transcription factor heat shock factor 1 (HSF1) is important in maintaining proteostasis during stress and has been shown to negatively regulate NF-B activity. In this study, we tested the hypothesis that HSF1 activation in response to hypercapnia results in attenuated NF-B-regulated gene expression. We found that hypercapnia induced the protein expression and nuclear accumulation of HSF1 in primary murine alveolar macrophages and in an alveolar macrophage cell line (MH-S). In MH-S cells treated with short interfering RNA targeting Hsf1, LPS-induced IL-6 and TNF- release were elevated during exposure to hypercapnia. Pseudomonas-infected Hsf1(+/+) (wild-type) mice, maintained in a hypercapnic environment, showed lower levels of IL-6 and TNF- in bronchoalveolar lavage fluid and IL-1 in lung tissue than did infected mice maintained in room air. In contrast, infected Hsf1(+/-) mice exposed to either hypercapnia or room air had similarly elevated levels of those cytokines. These results suggest that hypercapnia-mediated inhibition of NF-B cytokine production is dependent on HSF1 expression and/or activation.Lu, Z., Casalino-Matsuda, S. M., Nair, A., Buchbinder, A., Budinger, G. R. S., Sporn, P. H. S., Gates, K. L. A role for heat shock factor 1 in hypercapnia-induced inhibition of inflammatory cytokine expression.	[Lu, Ziyan; Casalino-Matsuda, S. Marina; Nair, Aisha; Budinger, G. R. Scott; Sporn, Peter H. S.; Gates, Khalilah L.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Nair, Aisha; Budinger, G. R. Scott; Sporn, Peter H. S.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA; [Buchbinder, Anja] Univ Giessen, Lung Ctr, Giessen, Germany; [Buchbinder, Anja] Univ Marburg, Lung Ctr, Giessen, Germany	Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Justus Liebig University Giessen; Philipps University Marburg	Gates, KL (corresponding author), Northwestern Univ, Feinberg Sch Med, 240 E Huron,McGaw M-300, Chicago, IL 60611 USA.	k-gates@northwestern.edu		Sporn, Peter/0000-0002-1006-9437	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [K01 HL108860, R01 HL131745, P01 HL071643]; NIH National Institute on Aging [P01 AG049665]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131745, R56HL131745, P01HL071643, R01HL107629, K01HL108860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG049665] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Karen Ridge and Dr. Navdeep Chandel (both from Northwestern University) for advice, reagents, and technical assistance. The authors acknowledge support from the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (Grants K01 HL108860, R01 HL131745, and P01 HL071643), and NIH National Institute on Aging (Grant P01 AG049665). The authors declare no conflicts of interest.	Akerfelt M, 2010, J BIOL CHEM, V285, P34469, DOI 10.1074/jbc.M110.157552; Budinger GRS, 2011, AM J RESP CRIT CARE, V183, P1043, DOI 10.1164/rccm.201002-0181OC; Budweiser S, 2007, CHEST, V131, P1650, DOI 10.1378/chest.06-2124; Comolli JC, 1999, INFECT IMMUN, V67, P3625, DOI 10.1128/IAI.67.7.3625-3630.1999; Cummins EP, 2010, J IMMUNOL, V185, P4439, DOI 10.4049/jimmunol.1000701; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Gally F, 2012, J INNATE IMMUN, V4, P59, DOI 10.1159/000333089; Gates KL, 2013, AM J RESP CELL MOL, V49, P821, DOI 10.1165/rcmb.2012-0487OC; Gonsalves SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015934; Gupta A, 2013, J BIOL CHEM, V288, P2756, DOI 10.1074/jbc.M112.427336; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Hagiwara S, 2007, INFLAMM RES, V56, P297, DOI 10.1007/s00011-007-6161-z; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Helenius IT, 2016, J IMMUNOL, V196, P655, DOI 10.4049/jimmunol.1501708; Helenius IT, 2009, P NATL ACAD SCI USA, V106, P18710, DOI 10.1073/pnas.0905925106; Hentze N, 2016, ELIFE, V5, DOI 10.7554/eLife.11576; Inouye S, 2007, J BIOL CHEM, V282, P33210, DOI 10.1074/jbc.M704471200; Kim HP, 2005, J IMMUNOL, V175, P2622, DOI 10.4049/jimmunol.175.4.2622; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; MacIntyre Neil, 2008, Proc Am Thorac Soc, V5, P530, DOI 10.1513/pats.200707-088ET; Mancebo J, 1998, Intensive Care Med, V24, P1339, DOI 10.1007/s001340050773; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Mohan Alladi, 2006, BMC Pulm Med, V6, P27, DOI 10.1186/1471-2466-6-27; MOSSER DD, 1990, P NATL ACAD SCI USA, V87, P3748, DOI 10.1073/pnas.87.10.3748; Murapa P, 2011, INFECT IMMUN, V79, P177, DOI 10.1128/IAI.00742-09; Murtagh P, 2009, PEDIATR PULM, V44, P450, DOI 10.1002/ppul.20984; Naidu SD, 2015, TRENDS PHARMACOL SCI, V36, P6, DOI 10.1016/j.tips.2014.10.011; Nichol AD, 2009, CRIT CARE MED, V37, P2953, DOI 10.1097/CCM.0b013e3181b028ce; Nin N, 2017, INTENS CARE MED, V43, P200, DOI 10.1007/s00134-016-4611-1; O'Croinin DF, 2008, CRIT CARE MED, V36, P2128, DOI 10.1097/CCM.0b013e31817d1b59; Sin DD, 2005, AM J MED, V118, P145, DOI 10.1016/j.amjmed.2004.10.014; Singh IS, 2002, J BIOL CHEM, V277, P4981, DOI 10.1074/jbc.M108154200; Singh IS, 2000, J BIOL CHEM, V275, P9841, DOI 10.1074/jbc.275.13.9841; Singh V, 2006, CELL CYCLE, V5, P2443, DOI 10.4161/cc.5.21.3434; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Slenter RHJ, 2013, RESPIRATION, V85, P15, DOI 10.1159/000342036; Soberanes S, 2009, J BIOL CHEM, V284, P2176, DOI 10.1074/jbc.M808844200; Song MC, 2008, J CRIT CARE, V23, P406, DOI 10.1016/j.jcrc.2007.09.007; Sun DX, 2005, J SURG RES, V129, P114, DOI 10.1016/j.jss.2005.05.028; Takii R, 2010, J IMMUNOL, V184, P1041, DOI 10.4049/jimmunol.0902579; Tiruvoipati R, 2017, CRIT CARE MED, V45, pE649, DOI 10.1097/CCM.0000000000002332; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605; Wang NZ, 2010, FASEB J, V24, P2178, DOI 10.1096/fj.09-136895; Wirth D, 2004, AM J PHYSIOL-LUNG C, V287, pL953, DOI 10.1152/ajplung.00184.2003; Xie Y, 2002, J BIOL CHEM, V277, P11802, DOI 10.1074/jbc.M109296200; Young PJ, 2014, CRIT CARE, V18, DOI 10.1186/cc13773	46	15	15	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3614	3622		10.1096/fj.201701164R	http://dx.doi.org/10.1096/fj.201701164R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29405096	Green Published			2022-12-26	WOS:000435104500011
J	Dial, AG; Rooprai, P; Lally, JS; Bujak, AL; Steinberg, GR; Ljubicic, V				Dial, Athan G.; Rooprai, Paul; Lally, James S.; Bujak, Adam L.; Steinberg, Gregory R.; Ljubicic, Vladimir			The role of AMP-activated protein kinase in the expression of the dystrophin-associated protein complex in skeletal muscle	FASEB JOURNAL			English	Article						utrophin; RNA-binding protein; fiber type; PGC-1 alpha; Duchenne muscular dystrophy	MDX MOUSE MUSCLE; GAMMA-SARCOGLYCAN GENE; NITRIC-OXIDE SYNTHASE; RNA-BINDING PROTEINS; MUSCULAR-DYSTROPHY; GLYCOPROTEIN COMPLEX; MITOCHONDRIAL BIOGENESIS; FIBER TYPES; NEUROMUSCULAR-JUNCTION; OXIDATIVE CAPACITY	Stimulation of AMPK induces the expression of dystrophin-associated protein complex (DAPC) components in skeletal muscle, whereas reductions in AMPK are associated with DAPC dysfunction. We sought to determine whether AMPK was necessary for the maintenance of DAPC expression in skeletal muscle. Fast, glycolytic extensor digitorum longus (EDL) and slow, oxidative soleus (Sol) muscles from wild-type mice and from littermates with skeletal muscle-specific knockout of the AMPK beta 1 and beta 2 subunits (AMPK beta 1 beta 2M-KO; MKO) were analyzed. DAPC mRNA and protein expression were similar between genotypes, with the exception of elevated neuronal nitric oxide synthase expression at the sarcolemma in MKO muscles. The content of transcriptional and post-transcriptional regulators of the DAPC was also not affected by the loss of AMPK. However, MyoD and myogenin expression was diminished in MKO muscles, consistent with previous reports of myopathy in these animals. Furthermore, we observed decrements in extrasynaptic utrophin expression selectively in MKO Sol muscles, likely due to the adaptive accumulation of peroxisome proliferator-activated receptor gamma coactivator-1 alpha at the sarcolemma of MKO EDL muscles. Collectively, the evidence indicates that AMPK is sufficient but not essential for the maintenance of DAPC expression in skeletal muscle, yet it is required for preserving extrasynaptic utrophin levels in slow oxidative muscles.	[Dial, Athan G.; Rooprai, Paul; Ljubicic, Vladimir] McMaster Univ, Dept Kinesiol, 1280 Main St W,e207 Ivor Wynne Ctr, Hamilton, ON L8S 4L8, Canada; [Lally, James S.; Bujak, Adam L.; Steinberg, Gregory R.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Steinberg, Gregory R.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Ljubicic, V (corresponding author), McMaster Univ, Dept Kinesiol, 1280 Main St W,e207 Ivor Wynne Ctr, Hamilton, ON L8S 4L8, Canada.	ljubicic@mcmaster.ca		Steinberg, Gregory/0000-0001-5425-8275	Canadian Institutes of Health Research; Canada Research Chairs Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs)	The authors thank Dr. David A. Hood (Muscle Health Research Centre, York University, Toronto, ON, Canada) for the gift of PGC-1 alpha knockout tissue. This work was funded by the Canadian Institutes of Health Research and the Canada Research Chairs Program. G.R.S. is the Canada Research Chair in Metabolism and Obesity, and the J. Bruce Duncan Chair in Metabolic Diseases. V.L. is the Canada Research Chair (Tier 2) in Neuromuscular Plasticity in Health and Disease. The authors declare no conflicts of interest.	Al-Rewashdy H, 2015, HUM MOL GENET, V24, P1243, DOI 10.1093/hmg/ddu535; Angus LM, 2005, AM J PHYSIOL-CELL PH, V289, pC908, DOI 10.1152/ajpcell.00196.2005; Apponi LH, 2011, TRENDS PHARMACOL SCI, V32, P652, DOI 10.1016/j.tips.2011.06.004; Augusto V, 2004, BRAZ J MORPHOL SCIS, V21, P89; Baldelli S, 2014, J CELL SCI, V127, P4813, DOI 10.1242/jcs.154229; Benziane B, 2012, J BIOL CHEM, V287, P23451, DOI 10.1074/jbc.M111.331926; Benziane B, 2009, AM J PHYSIOL-CELL PH, V297, pC1554, DOI 10.1152/ajpcell.00010.2009; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Bueno CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045699; Bujak AL, 2014, J APPL PHYSIOL, V117, P171, DOI 10.1152/japplphysiol.01101.2013; Chakkalakal JV, 2008, NUCLEIC ACIDS RES, V36, P826, DOI 10.1093/nar/gkm1107; Chakkalakal JV, 2006, HUM MOL GENET, V15, P1423, DOI 10.1093/hmg/ddl065; Chakkalakal JV, 2004, HUM MOL GENET, V13, P379, DOI 10.1093/hmg/ddh037; Chakkalakal JV, 2003, P NATL ACAD SCI USA, V100, P7791, DOI 10.1073/pnas.0932671100; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Chopard A, 2005, FASEB J, V19, P1722, DOI 10.1096/fj.04-3336fje; Chopard A, 2000, ELECTROPHORESIS, V21, P517, DOI 10.1002/(SICI)1522-2683(20000201)21:3<517::AID-ELPS517>3.0.CO;2-9; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; Delgado-Olguin P, 2008, BBA-GENE REGUL MECH, V1779, P74, DOI 10.1016/j.bbagrm.2007.09.002; Delgado-Olguin P, 2006, BBA-GENE STRUCT EXPR, V1759, P240, DOI 10.1016/j.bbaexp.2006.04.007; Dinulovic I, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0111-9; Dumont NA, 2015, NAT MED, V21, P1455, DOI 10.1038/nm.3990; Dyck DJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE340, DOI 10.1152/ajpendo.1997.272.3.E340; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Fu X, 2016, DIABETES, V65, P188, DOI 10.2337/db15-0647; Fu X, 2015, J BIOL CHEM, V290, P26445, DOI 10.1074/jbc.M115.665232; Gan ZJ, 2011, GENE DEV, V25, P2619, DOI 10.1101/gad.178434.111; Garbincius JF, 2015, P NATL ACAD SCI USA, V112, P13663, DOI 10.1073/pnas.1512991112; Gramolini AO, 2001, AM J PHYSIOL-CELL PH, V281, pC1300, DOI 10.1152/ajpcell.2001.281.4.C1300; Guiraud S, 2015, HUM MOL GENET, V24, P4212, DOI 10.1093/hmg/ddv154; Hack AA, 2000, MICROSC RES TECHNIQ, V48, P167, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<167::AID-JEMT5>3.0.CO;2-T; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hord JM, 2016, EXP GERONTOL, V83, P148, DOI 10.1016/j.exger.2016.08.006; Hudlicka O, 2011, MLTJ-MUSCLE LIGAMENT, V1, P3; Hughes DC, 2017, J GERONTOL A-BIOL, V72, P640, DOI 10.1093/gerona/glw109; Jahnke VE, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-16; Kelly SM, 2009, TRAFFIC, V10, P1199, DOI 10.1111/j.1600-0854.2009.00944.x; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KOVANEN V, 1980, ACTA PHYSIOL SCAND, V108, P173, DOI 10.1111/j.1748-1716.1980.tb06515.x; Lantier L, 2014, FASEB J, V28, P3211, DOI 10.1096/fj.14-250449; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Ljubicic V, 2014, AM J PHYSIOL-CELL PH, V307, pC66, DOI 10.1152/ajpcell.00357.2013; Ljubicic V, 2014, FASEB J, V28, P548, DOI 10.1096/fj.13-238071; Ljubicic V, 2012, AM J PHYSIOL-CELL PH, V302, pC110, DOI 10.1152/ajpcell.00183.2011; Ljubicic V, 2011, HUM MOL GENET, V20, P3478, DOI 10.1093/hmg/ddr265; Masuda A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00209; MCDONAGH PF, 1982, AM J PHYSIOL, V243, pH491, DOI 10.1152/ajpheart.1982.243.3.H491; Miura P, 2006, TRENDS MOL MED, V12, P122, DOI 10.1016/j.molmed.2006.01.002; Miura P, 2009, HUM MOL GENET, V18, P4640, DOI 10.1093/hmg/ddp431; Miyagoe-Suzuki Y, 2001, MICROSC RES TECHNIQ, V55, P164, DOI 10.1002/jemt.1167; Mounier R, 2015, TRENDS ENDOCRIN MET, V26, P275, DOI 10.1016/j.tem.2015.02.009; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nguyen T M, 1992, FEBS Lett, V313, P19; Noguchi S, 2001, FEBS LETT, V495, P77, DOI 10.1016/S0014-5793(01)02368-7; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Pavlath GK, 2010, EXP CELL RES, V316, P3067, DOI 10.1016/j.yexcr.2010.05.025; Paz I, 2014, NUCLEIC ACIDS RES, V42, pW361, DOI 10.1093/nar/gku406; Peladeau C, 2016, HUM MOL GENET, V25, P24, DOI 10.1093/hmg/ddv444; Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008; Rice KM, 2006, J GERONTOL A-BIOL, V61, P1119, DOI 10.1093/gerona/61.11.1119; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Rybakova IN, 1997, J BIOL CHEM, V272, P28771, DOI 10.1074/jbc.272.45.28771; Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SMITH D, 1989, AM J PHYSIOL, V256, pC50, DOI 10.1152/ajpcell.1989.256.1.C50; Theret M, 2017, EMBO J, V36, P1946, DOI 10.15252/embj.201695273; Thomas MM, 2014, FASEB J, V28, P2098, DOI 10.1096/fj.13-238972; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Tinsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019189; Wakabayashi-Takai E, 2001, EUR J BIOCHEM, V268, P948, DOI 10.1046/j.1432-1327.2001.01954.x; Wang W, 2002, MOL CELL BIOL, V22, P3425, DOI 10.1128/MCB.22.10.3425-3436.2002; Wilusz CJ, 2010, CELL, V143, P863, DOI 10.1016/j.cell.2010.11.041; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200	80	10	11	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					2950	2965		10.1096/fj.201700868RRR	http://dx.doi.org/10.1096/fj.201700868RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401588				2022-12-26	WOS:000432546000006
J	Griffiths, JS; Thompson, A; Stott, M; Benny, A; Lewis, NA; Taylor, PR; Forton, J; Herrick, S; Orr, SJ; McGreal, EP				Griffiths, James S.; Thompson, Aiysha; Stott, Matthew; Benny, Ankita; Lewis, Natalie A.; Taylor, Philip R.; Forton, Julian; Herrick, Sarah; Orr, Selinda J.; McGreal, Eamon P.			Differential susceptibility of Dectin-1 isoforms to functional inactivation by neutrophil and fungal proteases	FASEB JOURNAL			English	Article						elastase; C-type lectin-like receptor; cystic fibrosis; Aspergillus	C-TYPE LECTIN; IMMUNE RECOGNITION; INNATE IMMUNE; HOST-DEFENSE; ASPERGILLUS; RECEPTOR; EXPRESSION; RESPONSES; MINCLE; HYDROPHOBIN	Patients with cystic fibrosis (CF) experience chronic or recurrent bacterial and fungal lung infections. Many patients with CF cannot effectively clear Aspergillus from their lungs. This may result in IgE sensitization and the development of allergic bronchopulmonary aspergillosis, or invasive infections, such as Aspergillus bronchitis. Lung disease in patients with CF is associated with neutrophil-dominated inflammation and elevated levels of the serine protease, neutrophil elastase (NE). Various C-type lectin-like receptors (CLRs), including Dectin-1 and Dectin-2, are involved in the immune response to Aspergillus. Here, we show that purified NE cleaves Dectin-1 in an isoform-specific manner. Bronchoalveolar lavage fluid from patients with CF, which contains high NE activity, induces Dectin-1 cleavage. Similarly, filtrate from a protease-producing strain of Aspergillus fumigatus induces isoform-specific cleavage of Dectin-1. Dectin-1 knockout (KO) cells and NE-treated cells demonstrated reduced phagocytosis of zymosan, a fungal cell wall preparation. In addition, NE cleaves 2 other CLRs, Dectin-2 and Mincle, and fungal-induced cytokine production was reduced in Dectin-1 KO cells, Dectin-2 KO cells, and NE-treated cells. Thus, Dectin-1 and Dectin-2 cleavage by NE and/or A. fumigatus-derived proteases results in an aberrant antifungal immune response that likely contributes to disease pathology in patients with CF.	[Griffiths, James S.; Thompson, Aiysha; Stott, Matthew; Taylor, Philip R.; Orr, Selinda J.] Cardiff Univ, Sch Med, Div Infect & Immun, Tenovus Bldg Heath Pk, Cardiff CF14 4XN, S Glam, Wales; [Benny, Ankita; Lewis, Natalie A.] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales; [McGreal, Eamon P.] Cardiff Univ, Ctr Med Educ, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Forton, Julian] Childrens Hosp Wales, Cardiff, S Glam, Wales; [Herrick, Sarah] Univ Manchester, Fac Biol Med & Hlth, Manchester Acad Hlth Sci Ctr, Sch Biol Sci, Manchester, Lancs, England	Cardiff University; Cardiff University; Cardiff University; University of Manchester	Orr, SJ (corresponding author), Cardiff Univ, Sch Med, Div Infect & Immun, Tenovus Bldg Heath Pk, Cardiff CF14 4XN, S Glam, Wales.; McGreal, EP (corresponding author), Cardiff Univ, Ctr Med Educ, Sch Med, Cardiff CF14 4XN, S Glam, Wales.	orrs@cardiff.ac.uk	Herrick, Sarah/A-3121-2015	Herrick, Sarah/0000-0002-9085-5664; Forton, Julian/0000-0002-0580-0432; Orr, Selinda/0000-0001-8539-7825; Griffiths, James/0000-0002-7147-2465; Taylor, Philip/0000-0003-0163-1421	U.S. National Institutes of Health (NIH); National Institute of General Medical Sciences [GM62116]; Sir Henry Dale Fellowship - Wellcome Trust; Royal Society [099953/Z/12/Z]; National Institute for Social Care and Health Research Academic Health Science collaboration (Wales, United Kingdom); Wellcome Trust Investigator Award [WT107964MA]; Complement UK; Alexion Pharmaceuticals; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER; MRC [G0601617, UKDRI-3001] Funding Source: UKRI	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); National Institute for Social Care and Health Research Academic Health Science collaboration (Wales, United Kingdom); Wellcome Trust Investigator Award(Wellcome Trust); Complement UK; Alexion Pharmaceuticals; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Gordon Brown and Janet Willment [Medical Research Council (MRC) Centre for Medical Mycology, University of Aberdeen, United Kingdom] for providing the NIH3T3 cell lines that expressed human and mouse wild-type Dectin-1. A. fumigatus (CEA10 and Af293) strains were a kind gift from Dr. Paul Bowyer (University of Manchester). The authors wish to acknowledge the U.S. National Institutes of Health (NIH)-sponsored Mutant Mouse Regional Resource Center (MMRRC) National System as the source of genetically altered mice (C57BL/6-Clec4e<SUP>tm1.1Cfg</SUP>/Mmucd 031936-UCD) for use in this study. The mice were produced and deposited to the MMRRC by the Consortium for Functional Glycomics, supported by the National Institute of General Medical Sciences (Grant GM62116). S.J.O. is funded by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant 099953/Z/12/Z). J.F. is funded by a National Institute for Social Care and Health Research Academic Health Science collaboration (Wales, United Kingdom). P.R.T. is funded by a Wellcome Trust Investigator Award (WT107964MA). M.S. is funded by a Ph.D. Studentship awarded to E.P.M. by Complement UK. Funding for this Studentship was part of an unencumbered educational funding agreement between Complement UK and Alexion Pharmaceuticals. Alexion had no involvement at any stage of the project, including its design, implementation, and execution, nor were they involved in drafting or approving the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Baxter CG, 2013, J ALLERGY CLIN IMMUN, V132, P560, DOI 10.1016/j.jaci.2013.04.007; Benabid R, 2012, J BIOL CHEM, V287, P34883, DOI 10.1074/jbc.M112.361352; Bochud PY, 2008, NEW ENGL J MED, V359, P1766, DOI 10.1056/NEJMoa0802629; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Carrion SD, 2013, J IMMUNOL, V191, P2581, DOI 10.4049/jimmunol.1300748; Cunha C, 2010, BLOOD, V116, P5394, DOI 10.1182/blood-2010-04-279307; de Blic J, 2000, EUR RESPIR J, V15, P217; ELDAHR JM, 1994, AM J RESP CRIT CARE, V150, P1513, DOI 10.1164/ajrccm.150.6.7952609; Fischer M, 2017, EUR J IMMUNOL, V47, P848, DOI 10.1002/eji.201646849; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Hamon Y, 2013, INNATE IMMUN-LONDON, V19, P611, DOI 10.1177/1753425913476741; Heinsbroek SEM, 2006, J IMMUNOL, V176, P5513, DOI 10.4049/jimmunol.176.9.5513; King J, 2016, J INFECTION, V72, pS50, DOI 10.1016/j.jinf.2016.04.022; Kotecha S, 2013, BBA-MOL BASIS DIS, V1832, P2391, DOI 10.1016/j.bbadis.2013.10.002; Leal SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000976; Loures FV, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004643; Mayer-Hamblett N, 2007, AM J RESP CRIT CARE, V175, P822, DOI 10.1164/rccm.200609-1354OC; McDonald JU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045781; McGreal EP, 2010, BBA-MOL BASIS DIS, V1802, P649, DOI 10.1016/j.bbadis.2010.04.005; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Meier A, 2003, CELL MICROBIOL, V5, P561, DOI 10.1046/j.1462-5822.2003.00301.x; Patin EC, 2016, J IMMUNOL, V197, P208, DOI 10.4049/jimmunol.1501204; Plato A, 2015, SEMIN IMMUNOPATHOL, V37, P97, DOI 10.1007/s00281-014-0462-4; Rivera A, 2011, J EXP MED, V208, P369, DOI 10.1084/jem.20100906; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sainz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032273; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Sun H, 2014, IMMUNOBIOLOGY, V219, P25, DOI 10.1016/j.imbio.2013.06.013; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2005, EUR J IMMUNOL, V35, P2163, DOI 10.1002/eji.200425785; Twigg MS, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/293053; van den Berg CW, 2014, J IMMUNOL, V192, P1787, DOI 10.4049/jimmunol.1301920; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yike I, 2011, MYCOPATHOLOGIA, V171, P299, DOI 10.1007/s11046-010-9386-2; Zhao GQ, 2017, J INFECT DEV COUNTR, V11, P89, DOI 10.3855/jidc.7570	41	22	22	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3385	3397		10.1096/fj.201701145R	http://dx.doi.org/10.1096/fj.201701145R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401615	Green Accepted, Green Published			2022-12-26	WOS:000432546000039
J	Neirijnck, Y; Calvel, P; Kilcoyne, KR; Kuhne, F; Stevant, I; Griffeth, RJ; Pitetti, JL; Andric, SA; Hu, MC; Pralong, F; Smith, LB; Nef, S				Neirijnck, Yasmine; Calvel, Pierre; Kilcoyne, Karen R.; Kuehne, Francoise; Stevant, Isabelle; Griffeth, Richard J.; Pitetti, Jean-Luc; Andric, Silvana A.; Hu, Meng-Chun; Pralong, Francois; Smith, Lee B.; Nef, Serge			Insulin and IGF1 receptors are essential for the development and steroidogenic function of adult Leydig cells	FASEB JOURNAL			English	Article						IGF; steroidogenesis; progenitor Leydig cells; testis development; adrenal gland	GROWTH-FACTOR-I; PROGENITOR CELLS; TRANSGENIC MICE; ADRENAL-GLAND; MOUSE; TESTIS; DIFFERENTIATION; PROLIFERATION; EXPRESSION; MATURATION	The insulin family of growth factors (insulin, IGF1, and IGF2) are critical in sex determination, adrenal differentiation, and testicular function. Notably, the IGF system has been reported to mediate the proliferation of steroidogenic cells. However, the precise role and contribution of the membrane receptors mediating those effects, namely, insulin receptor (INSR) and type-I insulin-like growth factor receptor (IGF1R), have not, to our knowledge, been investigated. We show here that specific deletion of both Insr and Igf1r in steroidogenic cells in mice leads to severe alterations of adrenocortical and testicular development. Double-mutant mice display drastic size reduction of both adrenocortex and testes, with impaired corticosterone, testosterone, and sperm production. Detailed developmental analysis of the testes revealed that fetal Leydig cell (LC) function is normal, but there is a failure of adult LC maturation and steroidogenic function associated with accumulation of progenitor LCs (PLCs). Cell-lineage tracing revealed PLC enrichment is secondary to Insr and Igf1r deletion in differentiated adult LCs, suggesting a feedback mechanism between cells at different steps of differentiation. Taken together, these data reveal the cell-autonomous and nonautonomous roles of the IGF system for proper development and maintenance of steroidogenic lineages.	[Neirijnck, Yasmine; Calvel, Pierre; Kuehne, Francoise; Stevant, Isabelle; Griffeth, Richard J.; Pitetti, Jean-Luc; Nef, Serge] Univ Geneva, Med Sch, Dept Genet Med & Dev, Geneva, Switzerland; [Kilcoyne, Karen R.; Smith, Lee B.] Univ Edinburgh, Med Res Council, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Andric, Silvana A.] Univ Novi Sad, Fac Sci, Lab Reprod Endocrinol & Signaling, Novi Sad, Serbia; [Hu, Meng-Chun] Natl Taiwan Univ, Coll Med, Grad Inst Physiol, Taipei, Taiwan; [Pralong, Francois] Univ Hosp, Dept Internal Med, Lausanne, Switzerland; [Smith, Lee B.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia; [Calvel, Pierre] Univ Paris Saclay, AgroParisTech, INRA, GABI, Jouy En Josas, France	University of Geneva; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh; University of Novi Sad; National Taiwan University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Newcastle; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Nef, S (corresponding author), Univ Geneva, Med Sch, CMU, Dept Genet Med & Dev, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	serge.nef@unige.ch	Nef, Serge/AAV-6445-2020	Nef, Serge/0000-0001-5462-0676; Neirijnck, Yasmine/0000-0001-7236-8451; Smith, Lee/0000-0002-4103-3074; Stevant, Isabelle/0000-0002-0193-2526; Andric, Silvana/0000-0002-2908-8136	Swiss National Science Foundation [31003A_152636]; Departement de l'Instruction Publique of the State of Geneva; United Kingdom Medical Research Council (UK MRC) Programme Grant Award [MR/N002970/1]; Medical Research Council [MR/N002970/1] Funding Source: researchfish; MRC [MR/N002970/1] Funding Source: UKRI	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Departement de l'Instruction Publique of the State of Geneva; United Kingdom Medical Research Council (UK MRC) Programme Grant Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Cecile Gameiro and Gregory Schneiter (Flow Cytometry Facility, University of Geneva), as well as the teams of the Bioimaging Core Facility and the Animal Facility (Faculty of Medicine, University of Geneva). This work was supported by the Swiss National Science Foundation (Grant 31003A_152636 to S.N.); the Departement de l'Instruction Publique of the State of Geneva (to S.N.); and a United Kingdom Medical Research Council (UK MRC) Programme Grant Award (MR/N002970/1 to L.B.S. and K.R.K.). The authors declare no conflicts of interest.	Baker J, 1996, MOL ENDOCRINOL, V10, P903, DOI 10.1210/me.10.7.903; Bandiera R, 2015, MOL CELL ENDOCRINOL, V408, P145, DOI 10.1016/j.mce.2015.01.009; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Buaas FW, 2012, DEVELOPMENT, V139, P4561, DOI 10.1242/dev.087247; Chai RJ, 2012, P NATL ACAD SCI USA, V109, P8167, DOI 10.1073/pnas.1202774109; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Davidoff MS, 2004, J CELL BIOL, V167, P935, DOI 10.1083/jcb.200409107; Delacour A, 2004, MECH DEVELOP, V121, P3, DOI 10.1016/j.mod.2003.11.004; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; Efstratiadis A, 1998, INT J DEV BIOL, V42, P955; Fottner C, 1998, J ENDOCRINOL, V158, P409, DOI 10.1677/joe.0.1580409; Freedman BD, 2013, DEV CELL, V26, P666, DOI 10.1016/j.devcel.2013.07.016; Fujieda K, 2005, PEDIATR RES, V57, p62R, DOI 10.1203/01.PDR.0000159568.31749.4D; Gaysinskaya V, 2014, CYTOM PART A, V85A, P556, DOI 10.1002/cyto.a.22463; Griffeth RJ, 2014, BASIC CLIN ANDROL, V24, DOI 10.1186/2051-4190-24-12; Hu GX, 2010, J ANDROL, V31, P379, DOI 10.2164/jandrol.109.008680; Inoue M, 2016, ENDOCRINOLOGY, V157, P1222, DOI 10.1210/en.2015-1773; Jiang MH, 2014, CELL RES, V24, P1466, DOI 10.1038/cr.2014.149; KERR JB, 1987, CELL TISSUE RES, V249, P367; Kilcoyne KR, 2014, P NATL ACAD SCI USA, V111, pE1924, DOI 10.1073/pnas.1320735111; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; LIVNE I, 1992, BIOL REPROD, V47, P561, DOI 10.1095/biolreprod47.4.561; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Manna PR, 2006, MOL ENDOCRINOL, V20, P362, DOI 10.1210/me.2004-0526; MESIANO S, 1993, J CLIN ENDOCR METAB, V76, P968, DOI 10.1210/jc.76.4.968; Miyabayashi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068050; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; O'Hara L, 2015, FASEB J, V29, P894, DOI 10.1096/fj.14-255729; O'Shaughnessy PJ, 2002, J CELL SCI, V115, P3491; Pitetti JL, 2009, SEX DEV, V3, P264, DOI 10.1159/000252813; Pitetti JL, 2013, MOL ENDOCRINOL, V27, P814, DOI 10.1210/me.2012-1258; Pitetti JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003160; Potter SJ, 2016, RESULTS PROBL CELL D, V58, P101, DOI 10.1007/978-3-319-31973-5_5; Sirianni R, 2007, CANCER RES, V67, P8368, DOI 10.1158/0008-5472.CAN-06-4064; Smith LB, 2014, SEMIN CELL DEV BIOL, V30, P2, DOI 10.1016/j.semcdb.2014.02.012; Svingen T, 2013, GENE DEV, V27, P2409, DOI 10.1101/gad.228080.113; van den Driesche S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037064; Wang GM, 2004, BIOL REPROD, V70, P632, DOI 10.1095/biolreprod.103.022590; Weber MM, 1999, ENDOCRINOLOGY, V140, P1537, DOI 10.1210/en.140.4.1537; Windley SP, 2015, SEX DEV, V9, P297, DOI 10.1159/000444065; Wu HS, 2007, GENESIS, V45, P59, DOI 10.1002/dvg.20266; Xuan SH, 2002, J CLIN INVEST, V110, P1011, DOI 10.1172/JCI200215276; Yates R, 2013, CURR TOP DEV BIOL, V106, P239, DOI 10.1016/B978-0-12-416021-7.00007-9	45	25	25	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3321	3335		10.1096/fj.201700769RR	http://dx.doi.org/10.1096/fj.201700769RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401624				2022-12-26	WOS:000432546000034
J	Schur, RM; Gao, SQ; Yu, GP; Chen, Y; Maeda, A; Palczewski, K; Lu, ZR				Schur, Rebecca M.; Gao, Songqi; Yu, Guanping; Chen, Yu; Maeda, Akiko; Palczewski, Krzysztof; Lu, Zheng-Rong			New GABA modulators protect photoreceptor cells from light-induced degeneration in mouse models	FASEB JOURNAL			English	Article						anticonvulsant; GABA aminotransferase; retinal degeneration	INDUCED RETINAL DEGENERATION; GAMMA-AMINOBUTYRIC-ACID; MICROTITER PLATE ASSAY; VISUAL CYCLE MODULATOR; MACULAR DEGENERATION; VALPROIC-ACID; ANTIEPILEPTIC DRUGS; INDUCED RETINOPATHY; MEDIATED NEUROPROTECTION; EMIXUSTAT HYDROCHLORIDE	No clinically approved therapies are currently available that prevent the onset of photoreceptor death in retinal degeneration. Signaling between retinal neurons is regulated by the release and uptake of neurotransmitters, wherein GABA is the main inhibitory neurotransmitter. In this work, novel 3-chloropropiophenone derivatives and the clinical anticonvulsants tiagabine and vigabatrin were tested to modulate GABA signaling and protect against light-induced retinal degeneration. Abca4(-/-) Rdh8(-/-) mice, an accelerated model of retinal degeneration, were exposed to intense light after prophylactic injections of one of these compounds. Imaging and functional assessments of the retina indicated that these compounds successfully protected photoreceptor cells from degeneration to maintain a full-visual-field response. Furthermore, these compounds demonstrated a strong safety profile in wildtype mice and did not compromise visual function or damage the retina, despite repeated administration. These results indicate that modulating inhibitory GABA signaling can offer prophylactic protection against light-induced retinal degeneration.	[Schur, Rebecca M.; Yu, Guanping; Lu, Zheng-Rong] Case Western Reserve Univ, Case Ctr Biomol Engn, Sch Engn, Dept Biomed Engn, Cleveland, OH 44106 USA; [Gao, Songqi; Chen, Yu; Palczewski, Krzysztof] Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Maeda, Akiko] Case Western Reserve Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Lu, ZR (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Wickenden 427,Mail Stop 7207,10900 Euclid Ave, Cleveland, OH 44106 USA.	zxl125@case.edu	Schur, Rebecca/ABE-2442-2022	Lu, Zheng-Rong/0000-0001-8185-9519; Melo, Paulo A/0000-0003-1250-6933	U.S. National Institutes of Health (NIH) National Eye Institute [EY027283, EY024864]; NIH National Institute of Biomedical Imaging and Bioengineering Interdisciplinary Biomedical Training Program Grant [T32EB007509]; NATIONAL EYE INSTITUTE [R24EY024864, R24EY027283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB007509] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH National Institute of Biomedical Imaging and Bioengineering Interdisciplinary Biomedical Training Program Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors thank Dr. Timothy Kern (Department of Pharmacology, Case Western Reserve University) for valuable insights and critical discussions of this research work, Mr. Da Sun (Center for Biomolecular Engineering, Case Western Reserve University) for assistance in in vivo experiments and data analysis, and Dr. Amita Vaidya (Center for Biomolecular Engineering, Case Western Reserve University) for a critical reading of the manuscript. Z.-R.L. is the M. Frank and Margaret Domiter Rudy Professor of Biomedical Engineering, and K.P. is the John H. Hord Professor of Pharmacology. This work was supported, in part, by U.S. National Institutes of Health (NIH) National Eye Institute Grants EY027283 (to K.P.) and EY024864; and the NIH National Institute of Biomedical Imaging and Bioengineering Interdisciplinary Biomedical Training Program Grant T32EB007509 (to R.M.S.) administered by the Department of Biomedical Engineering, Case Western Reserve University. This report is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Age- Related Eye Disease Study 2 Research Group, 2013, JAMA-J AM MED ASSOC, V309, P208; Akula JD, 2015, DOC OPHTHALMOL, V131, P1, DOI 10.1007/s10633-015-9491-0; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Atlasz T, 2008, J MOL NEUROSCI, V36, P97, DOI 10.1007/s12031-008-9059-5; Bavik C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124940; Bhalla S, 2013, BRIT J OPHTHALMOL, V97, P895, DOI 10.1136/bjophthalmol-2013-303084; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P526, DOI 10.1167/iovs.09-3903; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bui BV, 2004, INVEST OPHTH VIS SCI, V45, P584, DOI 10.1167/iovs.03-0695; Cayouette M, 1998, J NEUROSCI, V18, P9282; Chen Y, 2013, J CLIN INVEST, V123, P5119, DOI 10.1172/JCI69076; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Collier RJ, 2011, INVEST OPHTH VIS SCI, V52, P8108, DOI 10.1167/iovs.10-6418; Collier RJ, 2011, INVEST OPHTH VIS SCI, V52, P2118, DOI 10.1167/iovs.10-6304; Coyner AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159776; Damico FM, 2012, ARQ BRAS OFTALMOL, V75, P71, DOI 10.1590/S0004-27492012000100016; Danciger M, 2004, MAMM GENOME, V15, P277, DOI 10.1007/s00335-003-2336-2; Duboc A, 2004, ANN NEUROL, V55, P695, DOI 10.1002/ana.20081; Dugel PU, 2015, RETINA-J RET VIT DIS, V35, P1173, DOI 10.1097/IAE.0000000000000606; EHINGER B, 1991, EXP EYE RES, V52, P17, DOI 10.1016/0014-4835(91)90124-W; Fariss RN, 2000, AM J OPHTHALMOL, V129, P215, DOI 10.1016/S0002-9394(99)00401-8; Fernandez-Sanchez L, 2015, MOLECULES, V20, P13875, DOI 10.3390/molecules200813875; Fernandez-Sanchez L, 2011, INVEST OPHTH VIS SCI, V52, P4998, DOI 10.1167/iovs.11-7496; Fletcher EL, 1997, J COMP NEUROL, V388, P1; Fletcher EL, 2000, MICROSC RES TECHNIQ, V50, P89, DOI 10.1002/1097-0029(20000715)50:2<89::AID-JEMT1>3.0.CO;2-9; Fritsche LG, 2014, ANNU REV GENOM HUM G, V15, P151, DOI 10.1146/annurev-genom-090413-025610; Froger N, 2014, PROG RETIN EYE RES, V41, P44, DOI 10.1016/j.preteyeres.2014.03.001; Hilton EJR, 2004, SEIZURE-EUR J EPILEP, V13, P113, DOI 10.1016/S1059-1311(03)00082-7; Ishikawa M, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/528940; Jaffe GJ, 2015, AM J OPHTHALMOL, V160, P1226, DOI 10.1016/j.ajo.2015.08.024; Jaiswal M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002197; Kalloniatis M, 1999, PROG RETIN EYE RES, V18, P811, DOI 10.1016/S1350-9462(98)00036-6; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kimura A, 2015, AM J PATHOL, V185, P756, DOI 10.1016/j.ajpath.2014.11.005; Kohno H, 2013, J BIOL CHEM, V288, P15326, DOI 10.1074/jbc.M112.448712; Kubota R, 2014, RETINA-J RET VIT DIS, V34, P603, DOI 10.1097/01.iae.0000434565.80060.f8; Kubota R, 2012, RETINA-J RET VIT DIS, V32, P183, DOI 10.1097/IAE.0b013e318217369e; Lenis TL, 2017, P NATL ACAD SCI USA, V114, P3987, DOI 10.1073/pnas.1620299114; Louzada PR, 2004, FASEB J, V18, P511, DOI 10.1096/fj.03-0739com; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Maeda T, 2003, J NEUROCHEM, V85, P944, DOI 10.1046/j.1471-4159.2003.01741.x; Maguire MJ, 2010, EPILEPSIA, V51, P2423, DOI 10.1111/j.1528-1167.2010.02772.x; Malmgren K, 2001, EPILEPSIA, V42, P609, DOI 10.1046/j.1528-1157.2001.28600.x; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mitton KP, 2014, MOL VIS, V20, P1527; Miya-Coreixas VS, 2013, EXP EYE RES, V115, P206, DOI 10.1016/j.exer.2013.07.026; O'Byrne CP, 2011, J MICROBIOL METH, V84, P137, DOI 10.1016/j.mimet.2010.10.017; Okada M, 2000, GRAEF ARCH CLIN EXP, V238, P998, DOI 10.1007/s004170000215; Pisani F, 2006, EXP BRAIN RES, V171, P511, DOI 10.1007/s00221-005-0298-1; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; SanGiovanni JP, 2014, CURR MOL MED, V14, P814, DOI 10.2174/1566524014666140811113606; Schur RM, 2015, INVEST OPHTH VIS SCI, V56, P4936, DOI 10.1167/iovs.15-16522; Sparrow JR, 2016, P NATL ACAD SCI USA, V113, P4564, DOI 10.1073/pnas.1600474113; Srivastava P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123896; Sun D, 2017, MOL THER-NUCL ACIDS, V7, P42, DOI 10.1016/j.omtn.2017.02.005; Tao YH, 2009, BIOORG MED CHEM LETT, V19, P731, DOI 10.1016/j.bmcl.2008.12.033; Tilz C, 2007, EUR J NEUROL, V14, P929, DOI 10.1111/j.1468-1331.2007.01524.x; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Tsukatani T, 2005, ANAL CHIM ACTA, V540, P293, DOI 10.1016/j.aca.2005.03.056; Tullis BE, 2015, INVEST OPHTH VIS SCI, V56, P4560, DOI 10.1167/iovs.15-16378; Varga B, 2011, J MOL NEUROSCI, V43, P44, DOI 10.1007/s12031-010-9406-1; Verrotti A, 2007, PEDIATR NEUROL, V36, P353, DOI 10.1016/j.pediatrneurol.2007.03.001; Wang QP, 2008, EUR J NEUROSCI, V27, P2177, DOI 10.1111/j.1460-9568.2008.06175.x; Wasowicz M, 2002, INVEST OPHTH VIS SCI, V43, P813; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Winkler BS, 1999, MOL VIS, V5; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002; Yoneda S, 2003, BRAIN RES, V967, P257, DOI 10.1016/S0006-8993(03)02270-4; Yu DY, 2004, INVEST OPHTH VIS SCI, V45, P2013, DOI 10.1167/iovs.03-0845; Zhang JY, 2015, MOL PHARMACOL, V87, P477, DOI 10.1124/mol.114.096560	73	6	6	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3289	3300		10.1096/fj.201701250R	http://dx.doi.org/10.1096/fj.201701250R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401616	Green Published			2022-12-26	WOS:000432546000032
J	Ramirez, MLG; Poreba, M; Snipas, SJ; Groborz, K; Drag, M; Salvesen, GS				Ramirez, Monica L. Gonzalez; Poreba, Marcin; Snipas, Scott J.; Groborz, Katarzyna; Drag, Marcin; Salvesen, Guy S.			Extensive peptide and natural protein substrate screens reveal that mouse caspase-11 has much narrower substrate specificity than caspase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interleukin; caspase; fluorescence; cell death; enzyme kinetics; GSDMD; proptosis	INTERLEUKIN-1-BETA CONVERTING-ENZYME; NONCANONICAL INFLAMMASOME ACTIVATION; PYROPTOTIC CELL-DEATH; GAMMA-INDUCING FACTOR; NLRP3 INFLAMMASOME; COMBINATORIAL APPROACH; CYSTEINE PROTEASE; GASDERMIN D; LPS; FAMILY	Inflammatory cell death, or pyroptosis, is triggered by pathogenic infections or events. It is executed by caspase-1 (in the canonical pyroptosis pathway) or caspase-11 (noncanonical pathway), each via production of a cell-lytic domain from the pyroptosis effector protein gasdermin D through specific and limited proteolysis. Pyroptosis is accompanied by the release of inflammatory mediators, including the proteolytically processed forms of interleukin-1 (IL-1) and IL-18. Given the similar inflammatory outcomes of the canonical and noncanonical pyroptosis pathways, we hypothesized that caspase-1 and -11 should have very similar activities and substrate specificities. To test this hypothesis, we purified recombinant murine caspases and analyzed their primary specificities by massive hybrid combinatorial substrate library (HyCoSuL) screens. We correlated the substrate preferences of each caspase with their activities on the recombinant natural substrates IL-1, IL-18, and gasdermin D. Although we identified highly selective and robust peptidyl substrates for caspase-1, we were unable to do so for caspase-11, because caspase-1 cleaved even the best caspase-11 substrates equally well. Caspase-1 rapidly processed pro-IL-1 and -18, but caspase-11 processed these two pro-ILs extremely poorly. However, both caspase-1 and -11 efficiently produced the cell-lytic domain from the gasdermin D precursor. We hypothesize that caspase-11 may have evolved a specific exosite to selectively engage pyroptosis without directly activating pro-IL-1 or -18. In summary, comparing the activities of caspase-1 and -11 in HyCoSuL screens and with three endogenous protein substrates, we conclude that caspase-11 has highly restricted substrate specificity, preferring gasdermin D over all other substrates examined.	[Ramirez, Monica L. Gonzalez; Poreba, Marcin; Snipas, Scott J.; Salvesen, Guy S.] Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, La Jolla, CA 92037 USA; [Ramirez, Monica L. Gonzalez] Sanford Burnham Prebys Med Discovery Inst, Grad Sch Biomed Sci, La Jolla, CA 92037 USA; [Groborz, Katarzyna; Drag, Marcin] Wroclaw Univ Sci & Technol, Fac Chem, Dept Bioorgan Chem, PL-50370 Wroclaw, Poland	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Wroclaw University of Science & Technology	Salvesen, GS (corresponding author), 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.	gsalvesen@sbp.edu			National Institutes of Health [R01 GM99040, P30 CA30199]; National Science Center in Poland Grant OPUS [UMO-2011/03/B/ST5/01048]; European Union's Horizon research and innovation program under Marie Sklodowska-Curie Grant [661187]; Genentech; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Center in Poland Grant OPUS; European Union's Horizon research and innovation program under Marie Sklodowska-Curie Grant; Genentech(Roche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM99040 and P30 CA30199 (to G. S. S.), National Science Center in Poland Grant OPUS, UMO-2011/03/B/ST5/01048 (to M. D.), and the European Union's Horizon 2020 research and innovation program under Marie Sklodowska-Curie Grant 661187 (to M. P.). This work was supported in part by a fellowship from Genentech. G. S. S. consults for Genentech. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003; Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Akita K, 1997, J BIOL CHEM, V272, P26595, DOI 10.1074/jbc.272.42.26595; AURON PE, 1987, J IMMUNOL, V138, P1447; Baker PJ, 2015, EUR J IMMUNOL, V45, P2918, DOI 10.1002/eji.201545655; BLACK RA, 1989, J BIOL CHEM, V264, P5323; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boucher D, 2012, P NATL ACAD SCI USA, V109, P5669, DOI 10.1073/pnas.1200934109; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Burgess RR, 2009, METHOD ENZYMOL, V463, P259, DOI 10.1016/S0076-6879(09)63017-2; Denault Jean-Bernard, 2003, Curr Protoc Protein Sci, VChapter 21, DOI 10.1002/0471140864.ps2113s30; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Drag M, 2008, IUBMB LIFE, V60, P734, DOI 10.1002/iub.113; FENTON JW, 1988, BIOCHEMISTRY-US, V27, P7106, DOI 10.1021/bi00418a066; Garcia-Calvo M, 1999, CELL DEATH DIFFER, V6, P362, DOI 10.1038/sj.cdd.4400497; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; HOWARD AD, 1991, J IMMUNOL, V147, P2964; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lechtenberg BC, 2015, ACS CHEM BIOL, V10, P945, DOI 10.1021/cb500909n; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Ng NM, 2009, BIOL CHEM, V390, P401, DOI 10.1515/BC.2009.065; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Pop C, 2008, METHOD ENZYMOL, V446, P351, DOI 10.1016/S0076-6879(08)01621-2; Poreba M, 2010, CURR MED CHEM, V17, P3968, DOI 10.2174/092986710793205381; Poreba M, 2017, NAT PROTOC, V12, P2189, DOI 10.1038/nprot.2017.091; Poreba M, 2017, SCI REP-UK, V7, DOI 10.1038/srep43135; Poreba M, 2015, CHEM REV, V115, P12546, DOI 10.1021/acs.chemrev.5b00434; Poreba M, 2014, CELL DEATH DIFFER, V21, P1482, DOI 10.1038/cdd.2014.64; Rano TA, 1997, CHEM BIOL, V4, P149, DOI 10.1016/S1074-5521(97)90258-1; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Salvesen GS, 2016, FEBS J, V283, P2577, DOI 10.1111/febs.13616; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Schmid-Burgk JL, 2015, EUR J IMMUNOL, V45, P2911, DOI 10.1002/eji.201545523; Sharma V, 2015, BIOCHEM J, V465, P163, DOI 10.1042/BJ20140809; Shen Weiping, 2005, Proteome Sci, V3, P3, DOI 10.1186/1477-5956-3-3; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; SLEATH PR, 1990, J BIOL CHEM, V265, P14526; Stennicke HR, 2000, METHOD ENZYMOL, V322, P91; Taabazuing CY, 2017, CELL CHEM BIOL, V24, P507, DOI 10.1016/j.chembiol.2017.03.009; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; THORNBERRY NA, 1995, PROTEIN SCI, V4, P3; Vigano E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9761; Yang JL, 2015, CURR OPIN IMMUNOL, V32, P78, DOI 10.1016/j.coi.2015.01.007; Zamboni DS, 2015, IMMUNOL REV, V265, P156, DOI 10.1111/imr.12291	57	52	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					7058	7067		10.1074/jbc.RA117.001329	http://dx.doi.org/10.1074/jbc.RA117.001329			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29414788	Green Published, hybrid			2022-12-26	WOS:000431487300037
J	Delgado-Calle, J; Hancock, B; Likine, EF; Sato, AY; McAndrews, K; Sanudo, C; Bruzzaniti, A; Riancho, JA; Tonra, JR; Bellido, T				Delgado-Calle, Jesus; Hancock, Benjamin; Likine, Elive F.; Sato, Amy Y.; McAndrews, Kevin; Sanudo, Carolina; Bruzzaniti, Angela; Riancho, Jose A.; Tonra, James R.; Bellido, Teresita			MMP14 is a novel target of PTH signaling in osteocytes that controls resorption by regulating soluble RANKL production	FASEB JOURNAL			English	Article						osteoclasts; osteoblasts; antiresorptive; osteoporosis	TYPE-1 MATRIX-METALLOPROTEINASE; SELECTIVE-INHIBITION; RECEPTOR ACTIVATOR; DNA METHYLATION; BONE-RESORPTION; EXPRESSION; GENE; OSTEOCLASTOGENESIS; OSTEOPROTEGERIN; OSTEOPOROSIS	Parathyroid hormone (PTH) affects the skeleton by acting on osteocytes (Ots) in bone through yet unclear mechanisms. We report that matrix metalloproteinase 14 (MMP14) expression/activity are increased in bones from mice with genetic constitutive activation (ca) of the PTH receptor 1 (PTH1R) in Ots (caPTH1R(Ot)) and in bones from mice exposed to elevated PTH levels but not in mice lacking [conditional knockout (cKO)] the PTH1R in Ots (cKOPTH1R(Ot)). Furthermore, PTH upregulates MMP14 in human bone cultures and in Ot-enriched bones from floxed control mice but not from cKOPTH1R(Ot) mice. MMP14 activity increases soluble receptor activator of NF-kappa B ligand production, which in turn, stimulates osteoclast differentiation and resorption. Pharmacologic inhibition of MMP14 activity reduced the high bone remodeling exhibited by caPTH1R(Ot) mice or induced by chronic PTH elevation and decreased bone resorption but allowed full stimulation of bone formation induced by PTH injections, thereby potentiating bone gain. Thus, MMP14 is a new member of the intricate gene network activated in Ots by PTH1R signaling that can be targeted to adjust the skeletal responses to PTH in favor of bone preservation.	[Delgado-Calle, Jesus] Indiana Univ Sch Med, Dept Med, Div Hematol Oncol, Indianapolis, IN 46202 USA; [Bellido, Teresita] Indiana Univ Sch Med, Dept Med, Div Endocrinol, Indianapolis, IN 46202 USA; [Delgado-Calle, Jesus; Hancock, Benjamin; Likine, Elive F.; Sato, Amy Y.; McAndrews, Kevin; Bellido, Teresita] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Delgado-Calle, Jesus; Bruzzaniti, Angela; Bellido, Teresita] Indiana Ctr Musculoskeletal Hlth, Indianapolis, IN USA; [Delgado-Calle, Jesus; McAndrews, Kevin; Bellido, Teresita] Richard L Roudebush Vet Affairs Med Ctr, 1481 W 10th St, Indianapolis, IN 46202 USA; [Sanudo, Carolina; Riancho, Jose A.] Univ Cantabria, Marques de Valdecilla Univ Hosp, Inst Invest Marques de Valdecilla IDIVAL, Dept Internal Med, Santander, Spain; [Bruzzaniti, Angela] Indiana Univ, Sch Dent, Dept Biomed & Appl Sci, Indianapolis, IN USA; [Tonra, James R.] Kadmon Corp, New York, NY USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Indiana University System; Indiana University-Purdue University Indianapolis	Bellido, T (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, 635 Barnhill Dr,MS5045A, Indianapolis, IN 46202 USA.; Bellido, T (corresponding author), Indiana Univ Sch Med, Dept Internal Med, 635 Barnhill Dr,MS5045A, Indianapolis, IN 46202 USA.; Bellido, T (corresponding author), Indiana Univ Sch Med, Dept Endocrinol, 635 Barnhill Dr,MS5045A, Indianapolis, IN 46202 USA.	tbellido@iupui.edu	Delgado-Calle, Jesus/AAG-1417-2020; Bruzzaniti, Angela/AAP-2225-2020	Delgado-Calle, Jesus/0000-0002-2083-2774; Sato, Amy/0000-0001-5061-1369	U.S. Department of Veterans Affairs [1 I01 BX002104-01]; U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR059357, R01-AR060332]; NIH National Heart, Lung, and Blood Institute [T35 HL1 10854-01]; American Society of Hematology; Instituto de Salud Carlos III [PI12/615]; European Union through Fonds Europeen de Developpement Economique et Regional (FEDER) funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL110854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060332, R01AR059357] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002104] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Society of Hematology; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Union through Fonds Europeen de Developpement Economique et Regional (FEDER) funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Drs. Keith Condon, Gretel Pellegrini, and Sumana Posritong and Meloney Cregor (all from Indiana University School of Medicine) for their assistance in tissue and data collection. The authors also thank Drs. David Burr and Munro Peacock (both from the Indiana University School of Medicine) for critical reading of the manuscript. This research was supported by the U.S. Department of Veterans Affairs (1 I01 BX002104-01 to T.B.); the U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grant R01-AR059357 to T.B.; R01-AR060332 to A.B.); NIH National Heart, Lung, and Blood Institute (Grant T35 HL1 10854-01); a Scholar Award from the American Society of Hematology (to J.D-C.); and a grant from Instituto de Salud Carlos III (PI12/615), cofunded by the European Union through Fonds Europeen de Developpement Economique et Regional (FEDER) funds (to J.A.R.). The KD014 neutralizing antibody was obtained under a Materials Transfer Agreement with Kadmon Corp., LLC. J.R.T. was an employee of Kadmon Corp., LCC. The remaining authors declare no conflicts of interest.	Ager EI, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv017; Allen MR, 2006, BONE, V39, P872, DOI 10.1016/j.bone.2006.04.028; Allen MR., 2007, BONEKEY OSTEOVISION, V4, P49; Aspenberg P, 2014, CURR OSTEOPOROS REP, V12, P189, DOI 10.1007/s11914-014-0200-9; Bellido T, 2013, BONE, V54, P250, DOI 10.1016/j.bone.2012.09.016; Ben-Awadh AN, 2014, ENDOCRINOLOGY, V155, P2797, DOI 10.1210/en.2014-1046; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Cappariello A, 2015, BIOMATERIALS, V46, P58, DOI 10.1016/j.biomaterials.2014.12.033; Cosman F, 2017, J BONE MINER RES, V32, P198, DOI 10.1002/jbmr.3051; Delgado-Calle J, 2017, LEUKEMIA, V31, P2686, DOI 10.1038/leu.2017.152; Delgado-Calle J, 2017, J BONE MINER RES, V32, P522, DOI 10.1002/jbmr.3011; Delgado-Calle Jesus, 2015, Curr Mol Biol Rep, V1, P157; Delgado-Calle J, 2016, CANCER RES, V76, P1089, DOI 10.1158/0008-5472.CAN-15-1703; Delgado-Calle J, 2012, J BONE MINER RES, V27, P926, DOI 10.1002/jbmr.1491; Delgado-Calle J, 2012, EPIGENETICS-US, V7, P83, DOI 10.4161/epi.7.1.18753; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Eriksen EF, 2016, BONE, V86, P139, DOI 10.1016/j.bone.2016.02.009; Galli C, 2008, ENDOCRINOLOGY, V149, P146, DOI 10.1210/en.2007-0734; Gutierrez-Fernandez A, 2015, EMBO J, V34, P1875, DOI 10.15252/embj.201490594; Hikita A, 2006, J BIOL CHEM, V281, P36846, DOI 10.1074/jbc.M606656200; Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Huang S, 2014, BONE, V60, P235, DOI 10.1016/j.bone.2013.12.023; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Kaneko K, 2016, ARTHRITIS RHEUMATOL, V68, P521, DOI 10.1002/art.39414; Leder BZ, 2016, BONE, V89, P73, DOI 10.1016/j.bone.2016.04.026; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma YFL, 2001, ENDOCRINOLOGY, V142, P4047, DOI 10.1210/en.142.9.4047; Miller PD, 2016, JAMA-J AM MED ASSOC, V316, P722, DOI 10.1001/jama.2016.11136; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; O'Brien CA, 2013, BONE, V54, P258, DOI 10.1016/j.bone.2012.08.121; O'Brien CA, 2010, BONE, V46, P911, DOI 10.1016/j.bone.2009.08.050; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Pacheco-Costa R, 2014, J BIOL CHEM, V289, P8508, DOI 10.1074/jbc.M113.529735; Pacifici R, 2016, ANN NY ACAD SCI, V1364, P11, DOI 10.1111/nyas.12969; Pacifici R, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00057; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Rozanov DV, 2004, J BIOL CHEM, V279, P50321, DOI 10.1074/jbc.M409174200; Sabbota AL, 2010, CANCER RES, V70, P5558, DOI 10.1158/0008-5472.CAN-09-4416; Sato AY, 2016, J BONE MINER RES, V31, P1791, DOI 10.1002/jbmr.2869; Saunders MM, 2010, BIOMECH MODEL MECHAN, V9, P539, DOI 10.1007/s10237-010-0195-9; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Silva BC, 2015, CURR OPIN PHARMACOL, V22, P41, DOI 10.1016/j.coph.2015.03.005; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Suvannasankha A, 2015, ONCOTARGET, V6, P19647, DOI 10.18632/oncotarget.3794; Tu XL, 2015, P NATL ACAD SCI USA, V112, pE478, DOI 10.1073/pnas.1409857112; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; Xiong J., 2017, J BONE MINER RES; Xiong JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138189; Xiong JH, 2014, BONE, V66, P146, DOI 10.1016/j.bone.2014.06.006; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	53	18	19	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2878	2890		10.1096/fj.201700919RRR	http://dx.doi.org/10.1096/fj.201700919RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401593	Green Published			2022-12-26	WOS:000432528000045
J	Sandmark, J; Dahl, G; Oster, L; Xu, BZ; Johansson, P; Akerud, T; Aagaard, A; Davidsson, P; Bigalke, JM; Winzell, MS; Rainey, GJ; Roth, RG				Sandmark, Jenny; Dahl, Goran; Oster, Linda; Xu, Bingze; Johansson, Patrik; Akerud, Tomas; Aagaard, Anna; Davidsson, Pia; Bigalke, Janna M.; Winzell, Maria Sorhede; Rainey, G. Jonah; Roth, Robert G.			Structure and biophysical characterization of the human full-length neurturin-GFRa2 complex: A role for heparan sulfate in signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; MIDBRAIN DOPAMINERGIC-NEURONS; GDNF LIGAND FAMILY; NEUROTROPHIC FACTOR; LIPID RAFTS; PARKINSONS-DISEASE; RECEPTOR COMPLEX; RET RECEPTOR; IN-VIVO; C-RET	Neurturin (NRTN) provides trophic support to neurons and is considered a therapeutic agent for neurodegenerative diseases, such as Parkinson's disease. It binds to its co-receptor GFRa2, and the resulting NRTN-GFRa2 complex activates the transmembrane receptors rearranged during transfection (RET) or the neural cell adhesion molecule (NCAM). We report the crystal structure of NRTN, alone and in complex with GFRa2. This is the first crystal structure of a GFRa with all three domains and shows that domain 1 does not interact directly with NRTN, but it may support an interaction with RET and/or NCAM, via a highly conserved surface. In addition, biophysical results show that the relative concentration of GFRa2 on cell surfaces can affect the functional affinity of NRTN through avidity effects. We have identified a heparan sulfate-binding site on NRTN and a putative binding site in GFRa2, suggesting that heparan sulfate has a role in the assembly of the signaling complex. We further show that mutant NRTN with reduced affinity for heparan sulfate may provide a route forward for delivery of NRTN with increased exposure in preclinical in vivo models and ultimately to Parkinson's patients.	[Sandmark, Jenny; Dahl, Goran; Oster, Linda; Johansson, Patrik; Akerud, Tomas; Aagaard, Anna; Bigalke, Janna M.] AstraZeneca, Dept Struct Biophys & Fragment Based Lead Generat, Discovery Sci, S-43183 Gothenburg, Sweden; [Davidsson, Pia; Winzell, Maria Sorhede] AstraZeneca, Dept Biosci Cardiovasc & Metab Dis, S-43183 Gothenburg, Sweden; [Xu, Bingze; Roth, Robert G.] AstraZeneca, Discovery Sci, IMED Biotech Unit, Dept Discovery Biol, S-43183 Gothenburg, Sweden; [Rainey, G. Jonah] MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA; [Xu, Bingze] Karolinska Inst, Div Med Inflammat Res, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Medimmune; Karolinska Institutet	Roth, RG (corresponding author), AstraZeneca, IMED Biotech Unit, Discovery Sci, Dept Discovery Biol, Pepparedsleden 1, S-43183 Molndal, Sweden.	robert.roth@astrazeneca.com						Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Alfano I, 2007, BIOCHEM J, V404, P131, DOI 10.1042/BJ20061747; Atanasova M., 2015, FASEB J S1, V29; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; Barker RA, 2015, NAT REV NEUROL, V11, P492, DOI 10.1038/nrneurol.2015.123; Barnett MW, 2002, J CELL SCI, V115, P4495, DOI 10.1242/jcs.00114; Bartus RT, 2017, NEUROBIOL DIS, V97, P169, DOI 10.1016/j.nbd.2016.03.026; Bespalov MM, 2011, J CELL BIOL, V192, P153, DOI 10.1083/jcb.201009136; Cik M, 2000, J BIOL CHEM, V275, P27505; Daramola O, 2014, BIOTECHNOL PROGR, V30, P132, DOI 10.1002/btpr.1809; Davies JA, 2003, GROWTH FACTORS, V21, P109, DOI 10.1080/08977190310001621005; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Eigenbrot C, 1997, NAT STRUCT BIOL, V4, P435, DOI 10.1038/nsb0697-435; Emmerson PJ, 2017, NAT MED, V23, P1215, DOI 10.1038/nm.4393; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fjord-Larsen L, 2005, EXP NEUROL, V195, P49, DOI 10.1016/j.expneurol.2005.03.006; Gash DM, 2005, ANN NEUROL, V58, P224, DOI 10.1002/ana.20549; Goodman KM, 2014, CELL REP, V8, P1894, DOI 10.1016/j.celrep.2014.08.040; Hamilton JF, 2001, EXP NEUROL, V168, P155, DOI 10.1006/exnr.2000.7571; Hatinen T, 2007, MOL CELL NEUROSCI, V34, P155, DOI 10.1016/j.mcn.2006.10.009; Heuckeroth RO, 1999, NEURON, V22, P253, DOI 10.1016/S0896-6273(00)81087-9; Horger BA, 1998, J NEUROSCI, V18, P4929; Hsu JY, 2017, NATURE, V550, P255, DOI 10.1038/nature24042; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirik D, 2017, NEUROBIOL DIS, V97, P179, DOI 10.1016/j.nbd.2016.09.008; Kjaer S, 2003, J BIOL CHEM, V278, P47898, DOI 10.1074/jbc.M309772200; Kjaer S, 2010, NAT STRUCT MOL BIOL, V17, P726, DOI 10.1038/nsmb.1808; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; Kulahin N, 2005, J NEUROCHEM, V95, P46, DOI 10.1111/j.1471-4159.2005.03338.x; Li L, 2017, MOL NEUROBIOL, V54, P2739, DOI 10.1007/s12035-016-9749-x; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LIN LFH, 1994, J NEUROCHEM, V63, P758; Lindahl M, 2001, J BIOL CHEM, V276, P9344, DOI 10.1074/jbc.M008279200; Marks WJ, 2010, LANCET NEUROL, V9, P1164, DOI 10.1016/S1474-4422(10)70254-4; Masure S, 2000, J BIOL CHEM, V275, P39427, DOI 10.1074/jbc.M003867200; Mauffray M, 2015, J IMMUNOL, V194, P1423, DOI 10.4049/jimmunol.1402496; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Mullican SE, 2017, NAT MED, V23, P1150, DOI 10.1038/nm.4392; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Parkash V, 2008, J BIOL CHEM, V283, P35164, DOI 10.1074/jbc.M802543200; Piltonen M, 2009, EXP NEUROL, V219, P499, DOI 10.1016/j.expneurol.2009.07.002; Rickard SM, 2003, GLYCOBIOLOGY, V13, P419, DOI 10.1093/glycob/cwg046; Runeberg-Roos P, 2016, NEUROBIOL DIS, V96, P335, DOI 10.1016/j.nbd.2016.07.008; Salvatore MF, 2006, EXP NEUROL, V202, P497, DOI 10.1016/j.expneurol.2006.07.015; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; Schlee S, 2006, NAT CHEM BIOL, V2, P636, DOI 10.1038/nchembio823; SCHLESSINGER J, 1995, CELL, V83, P357, DOI 10.1016/0092-8674(95)90112-4; Scott RP, 2001, J BIOL CHEM, V276, P1450, DOI 10.1074/jbc.M006157200; Silvian L, 2006, BIOCHEMISTRY-US, V45, P6801, DOI 10.1021/bi060035x; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sjostrand D, 2008, J BIOL CHEM, V283, P13792, DOI 10.1074/jbc.M800283200; Smith RC, 2015, EXP NEUROL, V267, P165, DOI 10.1016/j.expneurol.2015.03.002; Stewart R, 2011, PROTEIN ENG DES SEL, V24, P671, DOI 10.1093/protein/gzr015; Tanaka M, 2003, BRAIN RES PROTOC, V11, P119, DOI 10.1016/S1385-299X(03)00023-0; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trevaskis JL, 2017, DIABETES, V66, P2007, DOI 10.2337/db16-0916; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Tsui CC, 2015, J NEUROSCI, V35, P13233, DOI 10.1523/JNEUROSCI.2935-14.2015; Vance D, 2008, BIOTECHNOL BIOENG, V101, P429, DOI 10.1002/bit.22056; Vauquelin G, 2013, BRIT J PHARMACOL, V168, P1771, DOI 10.1111/bph.12106; Virtanen H, 2005, BIOCHEM J, V387, P817, DOI 10.1042/BJ20041257; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang XQ, 2006, STRUCTURE, V14, P1083, DOI 10.1016/j.str.2006.05.010; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Worby CA, 1996, J BIOL CHEM, V271, P23619, DOI 10.1074/jbc.271.39.23619; Yang LD, 2017, NAT MED, V23, P1158, DOI 10.1038/nm.4394	72	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5492	5508		10.1074/jbc.RA117.000820	http://dx.doi.org/10.1074/jbc.RA117.000820			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29414779	Green Published, hybrid			2022-12-26	WOS:000430044100013
J	Madan, E; Parker, TM; Bauer, MR; Dhiman, A; Pelham, CJ; Nagane, M; Kuppusamy, ML; Holmes, M; Holmes, TR; Shaik, K; Shee, K; Kiparoidze, S; Smith, SD; Park, YSA; Gomm, JJ; Jones, LJ; Tomas, AR; Cunha, AC; Selvendiran, K; Hansen, LA; Fersht, AR; Hideg, K; Gogna, R; Kuppusamy, P				Madan, Esha; Parker, Taylor M.; Bauer, Matthias R.; Dhiman, Alisha; Pelham, Christopher J.; Nagane, Masaki; Kuppusamy, M. Lakshmi; Holmes, Matti; Holmes, Thomas R.; Shaik, Kranti; Shee, Kevin; Kiparoidze, Salome; Smith, Sean D.; Park, Yu-Soon A.; Gomm, Jennifer J.; Jones, Louise J.; Tomas, Ana R.; Cunha, Ana C.; Selvendiran, Karuppaiyah; Hansen, Laura A.; Fersht, Alan R.; Hideg, Kalman; Gogna, Rajan; Kuppusamy, Periannan			The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE RITA; TUMOR SUPPRESSION; STAT3 INHIBITOR; MUTATIONS; BINDING; SURVIVAL; PHOSPHORYLATION; ADENOVIRUS; APOPTOSIS; GROWTH	p53 is an important tumor-suppressor protein that is mutated in more than 50% of cancers. Strategies for restoring normal p53 function are complicated by the oncogenic properties of mutant p53 and have not met with clinical success. To counteract mutant p53 activity, a variety of drugs with the potential to reconvert mutant p53 to an active wildtype form have been developed. However, these drugs are associated with various negative effects such as cellular toxicity, nonspecific binding to other proteins, and inability to induce a wildtype p53 response in cancer tissue. Here, we report on the effects of a curcumin analog, HO-3867, on p53 activity in cancer cells from different origins. We found that HO-3867 covalently binds to mutant p53, initiates a wildtype p53-like anticancer genetic response, is exclusively cytotoxic toward cancer cells, and exhibits high anticancer efficacy in tumor models. In conclusion, HO-3867 is a p53 mutant-reactivating drug with high clinical anticancer potential.	[Madan, Esha; Tomas, Ana R.; Cunha, Ana C.; Gogna, Rajan] Champalimaud Ctr Unknown, Champalimaud Res, P-1400038 Lisbon, Portugal; [Madan, Esha; Gogna, Rajan] Amity Univ, Amity Inst Mol Med & Stem Cell Res, Gautam Buddha Nagar Sect 125, Noida 201301, India; [Parker, Taylor M.] Indiana Univ Sch Med, Simon Canc Res Ctr, Dept Surg, Indianapolis, IN 46202 USA; [Bauer, Matthias R.; Fersht, Alan R.] MRC, Lab Mol Biol, Cambridge CB2 0QH, England; [Dhiman, Alisha] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Pelham, Christopher J.] St Louis Univ, Dept Physiol & Pharmacol, St Louis, MO 63104 USA; [Nagane, Masaki] Azabu Univ, Sch Vet Med, Dept Biochem, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan; [Kuppusamy, M. Lakshmi; Shee, Kevin; Kuppusamy, Periannan] Dartmouth Coll, Norris Cotton Canc Ctr, Geisel Sch Med, Dept Radiol & Med, Lebanon, NH 03756 USA; [Holmes, Matti; Holmes, Thomas R.; Shaik, Kranti; Smith, Sean D.; Park, Yu-Soon A.; Hansen, Laura A.] Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA; [Kiparoidze, Salome] Tbilisi State Med Univ, Tbilisi 0179, Georgia; [Gomm, Jennifer J.; Jones, Louise J.] Barts Canc Inst, Ctr Tumour Biol, Charterhouse Sq, London EC1M 6BQ, England; [Selvendiran, Karuppaiyah] Ohio State Univ, Coll Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Hideg, Kalman] Univ Pecs, Fac Sci, Inst Organ & Med Chem, H-7624 Pecs, Hungary	Fundacao Champalimaud; Amity University Noida; Indiana University System; Indiana University Bloomington; MRC Laboratory Molecular Biology; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Saint Louis University; Azabu University; Dartmouth College; Norris Cotton Cancer Center; Creighton University; Tbilisi State Medical University; University of London; Queen Mary University London; University System of Ohio; Ohio State University; University of Pecs	Gogna, R (corresponding author), Champalimaud Ctr Unknown, P-1400038 Lisbon, Portugal.; Kuppusamy, P (corresponding author), Dartmouth Coll, Norris Cotton Canc Ctr, Geisel Sch Med, 601 Rubin Bldg,1 Med Ctr Dr, Lebanon, NH 03756 USA.	rajan.gogna@research.fchampalimaud.org; periannan.kuppusamy@dartmouth.edu	Shee, Kevin/V-6803-2019; Smith, Sean/GYJ-6782-2022; Dhiman, Alisha/ABY-2171-2022; Fersht, Alan R/B-2189-2008; Nagane, Masaki/K-3431-2013	Shee, Kevin/0000-0001-5378-7650; Dhiman, Alisha/0000-0002-4395-9292; GOGNA, RAJAN/0000-0001-7304-7692; MADAN, ESHA/0000-0002-4941-0612; Nagane, Masaki/0000-0002-3408-7656; Bauer, Matthias/0000-0003-4015-6483; Cunha, Ana/0000-0001-9382-6511	Hungarian National, Research, Development and Innovation Office [OTKA 104956]; Swiss Cancer Leagu [LB692]; Seeds of Science; Winthrop P. Rockefeller Cancer Institute; Creighton University; MRC [MC_EX_G0901534] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA016058, F30CA216966] Funding Source: NIH RePORTER; Medical Research Council [MC_EX_G0901534] Funding Source: researchfish	Hungarian National, Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Swiss Cancer Leagu; Seeds of Science; Winthrop P. Rockefeller Cancer Institute; Creighton University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a research grant (OTKA 104956) from the Hungarian National, Research, Development and Innovation Office (to K.H.) and by the Swiss Cancer League, LB692, Seeds of Science, the Winthrop P. Rockefeller Cancer Institute, and Creighton University startup funds (to R.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahrendt SA, 2003, J NATL CANCER I, V95, P961, DOI 10.1093/jnci/95.13.961; Bauer MR, 2016, P NATL ACAD SCI USA, V113, pE5271, DOI 10.1073/pnas.1610421113; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Brazdova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059567; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Chan WM, 2004, MOL CELL BIOL, V24, P3536, DOI 10.1128/MCB.24.8.3536-3551.2004; Coates AS, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3348; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Gogna R, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.15; Gogna R, 2013, EMBO MOL MED, V5, P1662, DOI 10.1002/emmm.201202055; Gogna R, 2012, J BIOL CHEM, V287, P2907, DOI 10.1074/jbc.M111.317354; Hadjal Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.246; Hiraki M, 2015, CHEM BIOL, V22, P1206, DOI 10.1016/j.chembiol.2015.07.016; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Hu Y, 2017, FUEL CELLS, V17, P3, DOI 10.1002/fuce.201600172; Hu Y, 2017, ANTI-CANCER DRUG, V28, P392, DOI 10.1097/CAD.0000000000000470; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Jackson JG, 2006, CANCER RES, V66, P8356, DOI 10.1158/0008-5472.CAN-06-1752; Jordan JJ, 2010, MOL CANCER RES, V8, P701, DOI 10.1158/1541-7786.MCR-09-0442; Kamada R, 2011, J BIOL CHEM, V286, P252, DOI 10.1074/jbc.M110.174698; Kirn D, 2001, GENE THER, V8, P89, DOI 10.1038/sj.gt.3301377; Krajewski M, 2005, NAT MED, V11, P1135, DOI 10.1038/nm1105-1135; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lehmann BD, 2012, J CLIN ONCOL, V30, P3648, DOI 10.1200/JCO.2012.44.0412; Lehmann S, 2012, J CLIN ONCOL, V30, P3633, DOI 10.1200/JCO.2011.40.7783; Liang YY, 2009, INT J ONCOL, V35, P1015, DOI 10.3892/ijo_00000416; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Madan E, 2012, BRIT J CANCER, V107, P516, DOI 10.1038/bjc.2012.260; Madan E, 2013, MOL CELL BIOL, V33, P1285, DOI 10.1128/MCB.06798-11; Madan E, 2012, BIOCHEM J, V443, P811, DOI 10.1042/BJ20111627; Madan E, 2011, ONCOTARGET, V2, P948; Makower D, 2003, CLIN CANCER RES, V9, P693; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Peraud A, 2002, CLIN CANCER RES, V8, P1117; Rath KS, 2014, CANCER RES, V74, P2316, DOI 10.1158/0008-5472.CAN-13-2433; Rippin TM, 2002, ONCOGENE, V21, P2119, DOI 10.1038/sj.onc.1205362; Selivanova G, 2007, ONCOGENE, V26, P2243, DOI 10.1038/sj.onc.1210295; Selvendiran K, 2010, MOL CANCER RES, V8, P1188, DOI 10.1158/1541-7786.MCR-10-0201; Selvendiran K, 2010, MOL CANCER THER, V9, P1169, DOI 10.1158/1535-7163.MCT-09-1207; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Staab A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-213; Swisher SG, 1999, J NATL CANCER I, V91, P763, DOI 10.1093/jnci/91.9.763; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Tierney BJ, 2012, CANCER BIOL THER, V13, P766, DOI 10.4161/cbt.20559; Timofeev O, 2013, CELL REP, V3, P1512, DOI 10.1016/j.celrep.2013.04.008; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Trbusek M, 2011, J CLIN ONCOL, V29, P2703, DOI 10.1200/JCO.2011.34.7872; Turin I., 2014, MED SCI, V2, P70, DOI DOI 10.3390/medsci2020070; VOJTESEK B, 1995, ONCOGENE, V10, P389; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Walerych D, 2009, ONCOGENE, V28, P4284, DOI 10.1038/onc.2009.281; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Wilcken R, 2012, J AM CHEM SOC, V134, P6810, DOI 10.1021/ja301056a; Wischhusen J, 2003, ONCOGENE, V22, P8233, DOI 10.1038/sj.onc.1207198; Yang P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02246; Yu X, 2012, CANCER CELL, V21, P614, DOI 10.1016/j.ccr.2012.03.042	63	30	30	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4262	4276		10.1074/jbc.RA117.000950	http://dx.doi.org/10.1074/jbc.RA117.000950			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29382728	Green Published, hybrid			2022-12-26	WOS:000428204300003
J	de Oliveira, SA; de Oliveira, CMG; Maleita, CMN; Silva, MDA; Abrantes, IMD; Wilcken, SRS				de Oliveira, Samara Azevedo; Goncalves de Oliveira, Claudio Marcelo; Nobre Maleita, Carla Maria; Silva, Maria de Fatima A.; de Oliveira Abrantes, Isabel Maria; Wilcken, Silvia Renata S.			First report of Meloidogyne graminis on golf courses turfgrass in Brazil	PLOS ONE			English	Article							ROOT-KNOT NEMATODE; ORNAMENTAL PLANTS; SPP.; IDENTIFICATION; HETERODERIDAE; TYLENCHIDA; DIVERSITY; OLIVE; PCR	Plant-parasitic nematodes of the genus Meloidogyne, known as root-knot nematodes (RKN), have an important economic impact on golf course turfgrasses. The most prevalent RKN species associated with grasses are M. chitwoodi, M. graminicola, M. graminis, M. incognita, M. marylandi, M. microtyla, M. minor, M. naasi and M. sasseri. In 2010, slight thickening of the roots and RKN females with unusual features were observed in turfgrass roots on golf courses in Araras, Sao Paulo state, Brazil. This population (MgARA) was maintained in the lab and studied including morphological, morphometrical, biochemical and molecular markers. Morphology and morphometry were variable and not useful for identification, although perineal pattern morphology showed highly similarity with M. graminis description. Concerning to biochemical characterisation, the esterase phenotype Mg1, characterised by a very slow and fainter band, was detected in some protein homogenates. Regarding to molecular analysis, D2-D3 region of 28S rDNA gene and cytochrome oxidase subunit II region from mitochondrial DNA were amplified by PCR and sequenced. Phylogenetic analysis revealed that the Brazilian isolate, found associated with turfgrass, grouped with M. graminis isolates (98-99% bootstrap; variation of 8-11 and 0-24 bp, respectively), close to M. marylandi, supporting its identification as M. graminis. This is the first report of M. graminis on golf courses in Brazil.	[de Oliveira, Samara Azevedo; Silva, Maria de Fatima A.; Wilcken, Silvia Renata S.] Univ Estadual Paulista, Fac Ciencias Agron, Campus Botucatu,Rua Jose Barbosa Barros, Botucatu, SP, Brazil; [Goncalves de Oliveira, Claudio Marcelo] Inst Biol, Lab Nematol, Campinas, SP, Brazil; [Nobre Maleita, Carla Maria] UC, Chem Engn Dept, CIEPQPF Chem Proc Engn & Forest Prod Res Ctr, Rua Silvio Lima,Polo 2, Coimbra, Portugal; [Nobre Maleita, Carla Maria; de Oliveira Abrantes, Isabel Maria] UC, Dept Life Sci, CFE, Coimbra, Portugal	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Coimbra; Universidade de Coimbra	de Oliveira, SA (corresponding author), Univ Estadual Paulista, Fac Ciencias Agron, Campus Botucatu,Rua Jose Barbosa Barros, Botucatu, SP, Brazil.	samaranematologia@gmail.com	Wilcken, Silvia Renata S/H-3877-2012; Maleita, Carla Maria Nobre/AAA-1852-2021; Abrantes, Isabel/CAG-1426-2022	Wilcken, Silvia Renata S/0000-0002-9306-0197; Abrantes, Isabel/0000-0002-8761-2151	CNPq (National Counsel of Technological and Scientific Development) [134753/2013-5]; CFE through the Programa Operacional Factores de Competitividade (COMPETE, Portugal); IATV through the Programa Operacional Factores de Competitividade (COMPETE, Portugal); CIEPQPF through the Programa Operacional Factores de Competitividade (COMPETE, Portugal); FEDER funds through the Programa Operacional Factores de Competitividade (COMPETE, Portugal); FCT (Fundacao para a Ciencia e a Tecnologia, Portugal) [UID/BIA/04004/2013, PEst-C/EQB/UI0102/2013, FCOMP-01-0124-FEDER-027960]; FCT - Ministerio da Educacao e Ciencia national funding [SFRH/BPD/85736/2012]; FCT - European Social Funds through Programa Operacional Capital Humano [SFRH/BPD/85736/2012]	CNPq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CFE through the Programa Operacional Factores de Competitividade (COMPETE, Portugal); IATV through the Programa Operacional Factores de Competitividade (COMPETE, Portugal); CIEPQPF through the Programa Operacional Factores de Competitividade (COMPETE, Portugal); FEDER funds through the Programa Operacional Factores de Competitividade (COMPETE, Portugal); FCT (Fundacao para a Ciencia e a Tecnologia, Portugal)(Portuguese Foundation for Science and Technology); FCT - Ministerio da Educacao e Ciencia national funding; FCT - European Social Funds through Programa Operacional Capital Humano	Samara A. de Oliveira thanks the CNPq (National Counsel of Technological and Scientific Development, cnpq.br) for the scholarship, process number: 134753/2013-5. This research was also supported by CFE, IATV, CIEPQPF and FEDER funds through the Programa Operacional Factores de Competitividade (COMPETE, Portugal) and by FCT (Fundacao para a Ciencia e a Tecnologia, Portugal), under contracts: UID/BIA/04004/2013, PEst-C/EQB/UI0102/2013 and FCOMP-01-0124-FEDER-027960. Carla Maleita (SFRH/BPD/85736/2012) acknowledge FCT for granted fellowships, financed by Ministerio da Educacao e Ciencia national funding and by the European Social Funds through Programa Operacional Capital Humano.	ABRANTES IMD, 1991, J NEMATOL, V23, P210; Al-Banna L, 2004, J NEMATOL, V36, P142; Blok Vivian C., 2009, P98, DOI 10.1079/9781845934927.0098; Brito JA, 2010, NEMATROPICA, V40, P87; Carneiro RMDG, 2004, NEMATOLOGY, V6, P287, DOI 10.1163/1568541041217942; Carneiro RMDG, 2000, NEMATOLOGY, V2, P645, DOI 10.1163/156854100509510; Castillo P, 2003, PHYTOPATHOLOGY, V93, P1093, DOI 10.1094/PHYTO.2003.93.9.1093; COOLEN W. A., 1972, Ghent; Crow WT, 2014, J NEMATOL, V46, P8; Dias-Arieira Claudia R., 2007, Nematologia Brasileira, V31, P46; Entwistle K., 2003, ROOT KNOT NEMATODE I, P21; Ferraz LCCB, 1995, MANUAL FITOPATOLOGIA, V1, P168; Fleming CC, 2008, AGRIFOOD BIOSCIENCE, V55; Godoy LJG, 2005, THESIS; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Jepson S.B., 1987, IDENTIFICATION ROOT; Khan MR, 2014, ROOT KNOT NEMATODES, P78; McClure MA, 2012, PLANT DIS, V96, P635, DOI 10.1094/PDIS-09-11-0808; Mitkowski N., 2001, ROOT KNOT NEMATODES, V10; Negretti RRD, 2013, THESIS; Oliveira C. M. G., 2009, NEMATOLOGIA BRASILEI, V33, P218; Oliveira Claudio M. G., 2011, Nematologia Brasileira, V35, P36; OLIVEIRA CMG, 2012, TECNICAS DIAGNOSTICO, V1, P103; Perichi Guillermo, 2006, Fitopatologia Venezolana, V19, P17; Perry RN, 2010, ROOT-KNOT NEMATODES, P1; Pires AC, 2010, BIOTA NEOTROP, V10, P339, DOI 10.1590/S1676-06032010000200035; POWERS TO, 1993, J NEMATOL, V25, P1; SLEDGE EB, 1964, P HELM SOC WASH, V31, P83; Stanton J, 1997, FUND APPL NEMATOL, V20, P261; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAYLOR DP, 1974, NEMATOLOGICA, V20, P268, DOI 10.1163/187529274X00285; Wesemael WML, 2011, NEMATOLOGY, V13, P3, DOI 10.1163/138855410X526831; Ye WM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143556; Zeng YS, 2012, J NEMATOL, V44, P337; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhuo Kan, 2011, Acta Prataculturae Sinica, V20, P253	37	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192397	10.1371/journal.pone.0192397	http://dx.doi.org/10.1371/journal.pone.0192397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415001	Green Published, Green Submitted, gold			2022-12-26	WOS:000424325300075
J	Bryan, MA; Giordano, D; Draves, KE; Green, R; Gale, M; Clark, EA				Bryan, Marianne A.; Giordano, Daniela; Draves, Kevin E.; Green, Richard; Gale, Michael, Jr.; Clark, Edward A.			Splenic macrophages are required for protective innate immunity against West Nile virus	PLOS ONE			English	Article							SUBCAPSULAR SINUS MACROPHAGES; CD8-ALPHA(+) DENDRITIC CELLS; ALPHA/BETA-INTERFERON; T-CELLS; NATURAL-KILLER; UNITED-STATES; DENGUE-VIRUS; INFECTION; ACTIVATION; ENCEPHALITIS	Although the spleen is a major site for West Nile virus (WNV) replication and spread, relatively little is known about which innate cells in the spleen replicate WNV, control viral dissemination, and/or prime innate and adaptive immune responses. Here we tested if splenic macrophages (M Phi s) were necessary for control of WNV infection. We selectively depleted splenic M Phi s, but not draining lymph node M Phi s, by injecting mice intravenously with clodronate liposomes several days prior to infecting them with WNV. Mice missing splenic M Phi s succumbed to WNV infection after an increased and accelerated spread of virus to the spleen and the brain. WNV-specific Ab and CTL responses were normal in splenic M Phi-depleted mice; however, numbers of NK cells and CD4 and CD8 T cells were significantly increased in the brains of infected mice. Splenic M Phi deficiency led to increased WNV in other splenic innate immune cells including CD11b(-) DCs, newly formed MFs and monocytes. Unlike other splenic myeloid subsets, splenic MFs express high levels of mRNAs encoding the complement protein C1q, the apoptotic cell clearance protein Mertk, the IL-18 cytokine and the Fc gamma R1 receptor. Splenic M Phi-deficient mice may be highly susceptible to WNV infection in part to a deficiency in C1q, Mertk, IL-18 or Caspase 12 expression.	[Bryan, Marianne A.; Giordano, Daniela; Draves, Kevin E.; Green, Richard; Gale, Michael, Jr.; Clark, Edward A.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Giordano, Daniela; Draves, Kevin E.; Green, Richard; Gale, Michael, Jr.; Clark, Edward A.] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Clark, EA (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.; Clark, EA (corresponding author), Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.	eaclark@uw.edu		Green, Richard/0000-0001-8851-7204; Giordano, Daniela/0000-0001-8362-7017	NIAID [U19 AI83019, RO1 AI104002, R01 AI52203]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100625, U19AI083019, R01AI052203] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported in part by grants from NIAID including U19 AI83019 and RO1 AI104002 (MG) and R01 AI52203 (EAC).; This research was supported in part by grants from NIAID (U19 AI83019, RO1 AI104002, and R01 AI52203). M.A.B. and E.A.C. designed and coordinated the study with feedback from D. G.; M.A.B. and K.E.D. performed experiments and analyzed data; K.E.D. bred and prepared mice used for experiments; M.G. provided virus and key methods and edited the manuscript; M.A.B., D.G. and E.A.C. wrote and edited initial drafts of the manuscript. All authors contributed to the interpretation and conclusions presented in the manuscript.	Amanna IJ, 2014, EXPERT REV VACCINES, V13, P589, DOI 10.1586/14760584.2014.906309; Ashhurst TM, 2013, INDIAN J MED RES, V138, P632; Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416; Beasley DWC, 2013, ANTIVIR RES, V99, P1, DOI 10.1016/j.antiviral.2013.04.015; Beaulieu AM, 2015, ADV EXP MED BIOL, V850, P81, DOI 10.1007/978-3-319-15774-0_7; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; BenNathan D, 1996, ARCH VIROL, V141, P459, DOI 10.1007/BF01718310; Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568; Buiting AMJ, 1996, SCAND J IMMUNOL, V43, P398, DOI 10.1046/j.1365-3083.1996.d01-54.x; CARDOSA MJ, 1986, J VIROL, V57, P952, DOI 10.1128/JVI.57.3.952-959.1986; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Chen ST, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002655; Cyster JG, 2010, IMMUNOL CELL BIOL, V88, P617, DOI 10.1038/icb.2010.74; Daffis S, 2009, J INNATE IMMUN, V1, P435, DOI 10.1159/000226248; Diamond MS, 2009, ANTIVIR RES, V83, P214, DOI 10.1016/j.antiviral.2009.05.006; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13; Franca RFO, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0628-1; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Giordano D, 2011, J LEUKOCYTE BIOL, V89, P443, DOI 10.1189/jlb.0610329; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Gray EE, 2012, J INNATE IMMUN, V4, P424, DOI 10.1159/000337007; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06; Lazear HM, 2015, CURR OPIN VIROL, V11, P1, DOI 10.1016/j.coviro.2014.12.001; Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304; Linke S, 2007, J VIROL METHODS, V146, P355, DOI 10.1016/j.jviromet.2007.05.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5; Ma DY, 2015, CURR OPIN VIROL, V12, P26, DOI 10.1016/j.coviro.2015.02.005; Ma DY, 2013, J VIROL, V87, P3361, DOI 10.1128/JVI.02368-12; Martinez-Pomares L, 2012, TRENDS IMMUNOL, V33, P66, DOI 10.1016/j.it.2011.11.001; Mehlhop E, 2006, J EXP MED, V203, P1371, DOI 10.1084/jem.20052388; Mehlhop E, 2009, VIROLOGY, V393, P11, DOI 10.1016/j.virol.2009.08.019; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Murray KO, 2013, EMERG INFECT DIS, V19, P1836, DOI 10.3201/eid1911.130768; National Research Council, 1996, GUIDE CARE USE LAB A, V7th ed., P140, DOI [10.17226/5140, DOI 10.17226/5140]; Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042; Pinto AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004086; Prestwood TR, 2012, J VIROL, V86, P12138, DOI 10.1128/JVI.00375-12; Purtha WE, 2008, J VIROL, V82, P10964, DOI 10.1128/JVI.01646-08; Purtha WE, 2007, EUR J IMMUNOL, V37, P1845, DOI 10.1002/eji.200737192; Rawle DJ, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0279-3; Roehrig JT, 2013, VIRUSES-BASEL, V5, P3088, DOI 10.3390/v5123088; Rojas JM, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/6104054; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Seiler P, 1997, EUR J IMMUNOL, V27, P2626, DOI 10.1002/eji.1830271023; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Silva MC, 2007, J VIROL, V81, P13640, DOI 10.1128/JVI.00857-07; Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003168; Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950; Suthar MS, 2012, J VIROL, V86, P7704, DOI 10.1128/JVI.00401-12; Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757; Szretter KJ, 2010, J VIROL, V84, P12125, DOI 10.1128/JVI.01026-10; Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012; Waithman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066136; Wang PX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049720; Wang PH, 2010, NAT IMMUNOL, V11, P912, DOI 10.1038/ni.1933; Wang T, 2013, VIRUSES-BASEL, V5, P2298, DOI 10.3390/v5092298; Winkelmann ER, 2014, VIROLOGY, V450, P278, DOI 10.1016/j.virol.2013.12.021	67	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191690	10.1371/journal.pone.0191690	http://dx.doi.org/10.1371/journal.pone.0191690			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408905	Green Published, Green Submitted, gold			2022-12-26	WOS:000424302800023
J	Choong, TSY; Yeoh, CM; Phuah, ET; Siew, WL; Lee, YY; Tang, TK; Abdullah, L				Choong, Thomas Shean Yaw; Yeoh, Chiou Moi; Phuah, Eng-Tong; Siew, Wai-Lin; Lee, Yee-Ying; Tang, Teck-Kim; Abdullah, Luqman Chuah			Kinetic study of lipase-catalyzed glycerolysis of palm olein using Lipozyme TLIM in solvent-free system	PLOS ONE			English	Article							ENZYMATIC GLYCEROLYSIS; IMMOBILIZED LIPASE; PARTIAL HYDROLYSIS; MONOACYLGLYCEROL PRODUCTION; DIACYLGLYCEROL; OIL; ESTERIFICATION; TRIACYLGLYCEROL; MECHANISM; MODEL	Diacylglycerol (DAG) and monoacylglycerol (MAG) are two natural occurring minor components found in most edible fats and oils. These compounds have gained increasing market demand owing to their unique physicochemical properties. Enzymatic glycerolysis in solvent-free system might be a promising approach in producing DAG and MAG-enriched oil. Understanding on glycerolysis mechanism is therefore of great importance for process simulation and optimization. In this study, a commercial immobilized lipase (Lipozyme TL IM) was used to catalyze the glycerolysis reaction. The kinetics of enzymatic glycerolysis reaction between triacylglycerol (TAG) and glycerol (G) were modeled using rate equation with unsteady-state assumption. Ternary complex, ping-pong bi-bi and complex ping-pong bi-bi models were proposed and compared in this study. The reaction rate constants were determined using non-linear regression and sum of square errors (SSE) were minimized. Present work revealed satisfactory agreement between experimental data and the result generated by complex ping-pong bi-bi model as compared to other models. The proposed kinetic model would facilitate understanding on enzymatic glycerolysis for DAG and MAG production and design optimization of a pilot-scale reactor.	[Choong, Thomas Shean Yaw; Yeoh, Chiou Moi; Abdullah, Luqman Chuah] Univ Putra Malaysia, Fac Engn, Dept Chem & Environm Engn, Serdang, Selangor, Malaysia; [Choong, Thomas Shean Yaw] Univ Putra Malaysia, INTROP, Serdang, Selangor, Malaysia; [Phuah, Eng-Tong] Univ Tunku Abdul Rahman, Dept Agr & Food Sci, Fac Sci, Kampar, Perak, Malaysia; [Siew, Wai-Lin] Malaysian Palm Oil Board, Persiaran Inst, Kajang, Selangor, Malaysia; [Tang, Teck-Kim] Univ Putra Malaysia, Inst Biosci, Serdang, Selangor, Malaysia; [Lee, Yee-Ying] Monash Univ Malaysia, Sch Sci, Bandar Sunway, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Tunku Abdul Rahman (UTAR); Malaysian Palm Oil Board; Universiti Putra Malaysia; Monash University; Monash University Sunway	Choong, TSY (corresponding author), Univ Putra Malaysia, Fac Engn, Dept Chem & Environm Engn, Serdang, Selangor, Malaysia.; Choong, TSY (corresponding author), Univ Putra Malaysia, INTROP, Serdang, Selangor, Malaysia.	csthomas@upm.edu.my	Phuah, Eng-Tong/AFV-5125-2022; Abdullah, Luqman Chuah/L-8915-2016; Phuah, Eng-Tong/S-9977-2017	Phuah, Eng-Tong/0000-0002-0334-2335; Abdullah, Luqman Chuah/0000-0003-4785-9296; Phuah, Eng-Tong/0000-0002-0334-2335; LEE, YEE YING/0000-0002-4586-5978				Al-Zuhair S, 2003, PROCESS BIOCHEM, V38, P1155, DOI 10.1016/S0032-9592(02)00279-0; BERGER M, 1992, J AM OIL CHEM SOC, V69, P955, DOI 10.1007/BF02541057; Cheirsilp B, 2007, BIOCHEM ENG J, V35, P71, DOI 10.1016/j.bej.2006.12.024; Cheong LZ, 2007, FOOD CHEM, V105, P1614, DOI 10.1016/j.foodchem.2007.03.070; Chew YH, 2008, BIOCHEM ENG J, V39, P516, DOI 10.1016/j.bej.2007.10.019; Coteron A, 1998, J AM OIL CHEM SOC, V75, P657, DOI 10.1007/s11746-998-0080-1; Damstrup ML, 2006, J AGR FOOD CHEM, V54, P7113, DOI 10.1021/jf061365r; Ferreira-Dias S, 2001, J MOL CATAL B-ENZYM, V11, P699, DOI 10.1016/S1381-1177(00)00079-5; Fureby AM, 1997, ENZYME MICROB TECH, V20, P198, DOI 10.1016/S0141-0229(96)00133-0; Garcia HS, 1995, FOOD RES INT, V28, P605, DOI 10.1016/0963-9969(95)00051-8; Garcia T, 1996, CHEM ENG SCI, V51, P2841, DOI 10.1016/0009-2509(96)00162-5; Garcia T, 1999, ENZYME MICROB TECH, V25, P584, DOI 10.1016/S0141-0229(99)00082-4; Garcia T, 2000, CHEM ENG SCI, V55, P1411, DOI 10.1016/S0009-2509(99)00425-X; GHAZALI HM, 1995, J AM OIL CHEM SOC, V72, P633, DOI 10.1007/BF02635647; Kaewthong W, 2005, PROCESS BIOCHEM, V40, P1525, DOI 10.1016/j.procbio.2003.12.002; Kristensen JB, 2005, J AM OIL CHEM SOC, V82, P329, DOI 10.1007/s11746-005-1074-5; Maki KC, 2002, AM J CLIN NUTR, V76, P1230, DOI 10.1093/ajcn/76.6.1230; Nagao T, 2000, J NUTR, V130, P792, DOI 10.1093/jn/130.4.792; Nakajima Y, 2004, J AM OIL CHEM SOC, V81, P907, DOI 10.1007/s11746-004-1000-x; Voll FAP, 2012, APPL BIOCHEM BIOTECH, V168, P1121, DOI 10.1007/s12010-012-9846-x; Phuah ET, 2012, J MOL CATAL B-ENZYM, V78, P91, DOI 10.1016/j.molcatb.2012.03.009; Plou FJ, 1996, ENZYME MICROB TECH, V18, P66, DOI 10.1016/0141-0229(96)00054-3; Rosu R, 1999, J AM OIL CHEM SOC, V76, P839, DOI 10.1007/s11746-999-0074-7; Rudkowska I, 2005, OBES RES, V13, P1864, DOI 10.1038/oby.2005.229; SONNTAG NOV, 1982, J AM OIL CHEM SOC, V59, pA795, DOI 10.1007/BF02634442; SWE PZ, 1995, J AM OIL CHEM SOC, V72, P343, DOI 10.1007/BF02541094; Tan TW, 2005, BIOCHEM ENG J, V25, P39, DOI 10.1016/j.bej.2005.03.009; Valerio A, 2009, J AGR FOOD CHEM, V57, P8350, DOI 10.1021/jf901771m; YAMANE T, 1994, J AM OIL CHEM SOC, V71, P339, DOI 10.1007/BF02638064; Yeoh CM, 2009, EUR J LIPID SCI TECH, V111, P599, DOI 10.1002/ejlt.200800265	30	11	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192375	10.1371/journal.pone.0192375	http://dx.doi.org/10.1371/journal.pone.0192375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401481	gold, Green Published, Green Submitted			2022-12-26	WOS:000424101400056
J	Salazar, JCS; Bieng, MAN; Melgarejo, LM; Di Rienzo, JA; Casanoves, F				Suarez Salazar, Juan Carlos; Ngo Bieng, Marie Ange; Marina Melgarejo, Luz; Di Rienzo, Julio A.; Casanoves, Fernando			First typology of cacao (Theobroma cacao L.) systems in Colombian Amazonia, based on tree species richness, canopy structure and light availability	PLOS ONE			English	Article							COCOA-BASED AGROFORESTRY; FOREST; CONSERVATION; DIVERSITY; BIODIVERSITY; VEGETATION; PACKAGE; REGION	Aim and background We present a typology of cacao agroforest systems in Colombian Amazonia. These systems had yet to be described in the literature, especially their potential in terms of biodiversity conservation. The systems studied are located in a post-conflict area, and a deforestation front in Colombian Amazonia. Cacao cropping systems are of key importance in Colombia: cacao plays a prime role in post conflict resolution, as cacao is a legal crop to replace illegal crops; cacao agroforests are expected to be a sustainable practice, promoting forest-friendly land use. Material and methods We worked in 50 x 2000 m(2) agroforest plots, in Colombian Amazonia. A cluster analysis was used to build a typology based on 28 variables characterised in each plot, and related to diversity, composition, spatial structure and light availability for the cacao trees. We included variables related to light availability to evaluate the amount of transmitted radiation to the cacao trees in each type, and its suitability for cacao ecophysiological development. Main results We identified 4 types of cacao agroforests based on differences concerning tree species diversity and the impact of canopy spatial structure on light availability for the cacao trees in the understorey. We found 127 tree species in the dataset, with some exclusive species in each type. We also found that 3 out of the 4 types identified displayed an erosion of tree species diversity. This reduction in shade tree species may have been linked to the desire to reduce shade, but we also found that all the types described were compatible with good ecophysiological development of the cacao trees. Main conclusions and prospects Cacao agroforest systems may actually be achieving biodiversity conservation goals in Colombian Amazonia. One challenging prospect will be to monitor and encourage the conservation of tree species diversity in cacao agroforest systems during the development of these cropping systems, as a form of forest-friendly management enhancing sustainable peace building in Colombia.	[Suarez Salazar, Juan Carlos] Univ Amazonia, Fac Ingn, Campus Porvenir Calle 17 Diagonal 17 Con Carrera, Florencia, Caqueta, Colombia; [Suarez Salazar, Juan Carlos; Marina Melgarejo, Luz] Univ Nacl Colombia, Fac Ciencias, Dept Biol, Lab Fisiol & Bioquim Vegetal, Bogota, Colombia; [Ngo Bieng, Marie Ange] CIRAD, UR Forets & Soc, CIRAD Campus Int Baillarguet, Montpellier 5, France; [Ngo Bieng, Marie Ange; Casanoves, Fernando] CATIE, CATIE Ctr Agron Trop Invest & Ensenanaza, Turrialba, Cartago, Costa Rica; [Di Rienzo, Julio A.] Univ Nacl Cordoba, Fac Ciencias Agr, Av Valparaiso S-N,Ciudad Univ, Cordoba, Argentina	Universidad Nacional de Colombia; CIRAD; CATIE - Centro Agronomico Tropical de Investigacion y Ensenanza; National University of Cordoba	Bieng, MAN (corresponding author), CIRAD, UR Forets & Soc, CIRAD Campus Int Baillarguet, Montpellier 5, France.; Bieng, MAN (corresponding author), CATIE, CATIE Ctr Agron Trop Invest & Ensenanaza, Turrialba, Cartago, Costa Rica.	marie-ange.ngo_bieng@cirad.fr	Melgarejo, Luz/AAZ-5918-2020; suárez salazar, juan carlos/GXH-2202-2022; Casanoves, Fernando/I-3588-2016	Casanoves, Fernando/0000-0001-8765-9382; Melgarejo, Luz Marina/0000-0003-3148-1911; Suarez Salazar, Juan Carlos/0000-0001-5928-1837	COLCIENCIAS; IDB funds; Doctoral School of the University of Amazonia	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); IDB funds; Doctoral School of the University of Amazonia	This work was developed with the financial collaboration of COLCIENCIAS, with IDB funds and within the framework of the "Caracterizacion y tipificacion de plantaciones tradicionales de Theobroma cacao L to Juan Carlos Suarez Salazar. como estrategia de diseno e implementacion de arreglos agroforestales en el Bajo Caguan (Cartagena del Chaira)" Project, implemented by the University of Amazonia, with special contract of cooperation 590 for the year 2012, and with funds from the Doctoral School of the University of Amazonia, by means of the "Prodesarrollo de la Universidad de la Amazonia" Law No 1301 dated 2009 to Juan Carlos Suarez Salazar.	Almeida AAF, 2014, PHOTOSYNTHETICA, V52, P16, DOI 10.1007/s11099-013-0048-8; Asase A, 2010, AFR J ECOL, V48, P338, DOI 10.1111/j.1365-2028.2009.01112.x; Avila-Lovera E, 2016, EXP AGR, V52, P137, DOI 10.1017/S0014479714000593; Baptiste B, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0102; Bharathi S, 2017, J FORESTRY RES, V28, P357, DOI 10.1007/s11676-016-0328-9; Bieng MAN, 2013, BASIC APPL ECOL, V14, P329, DOI 10.1016/j.baae.2013.03.003; Bisseleua HBD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056115; Charbonnier F, 2013, AGR FOREST METEOROL, V181, P152, DOI 10.1016/j.agrformet.2013.07.010; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Colwell RK, 2014, ECOGRAPHY, V37, P609, DOI 10.1111/ecog.00814; Deheuvels O, 2012, AGR ECOSYST ENVIRON, V149, P181, DOI 10.1016/j.agee.2011.03.003; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; FEDECACAO, 2017, FED NAC CAC; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Gao LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070739; Gidoin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109405; Gidoin C, 2014, PHYTOPATHOLOGY, V104, P275, DOI 10.1094/PHYTO-07-13-0216-R; Harja D., 2008, SPATIALLY EXPLICIT I; ICCO (International Cocoa Organization), 2015, Q B COCOA STAT, VXL; Johns ND, 1999, ENVIRON MANAGE, V23, P31, DOI 10.1007/s002679900166; Kessler M, 2005, BIODIVERS CONSERV, V14, P547, DOI 10.1007/s10531-004-3914-7; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Mariscal MJ, 2004, ECOSYSTEMS, V7, P454, DOI 10.1007/s10021-004-0137-4; Mbolo MMA, 2016, AGROFOREST SYST, V90, P577, DOI 10.1007/s10457-016-9945-8; Moguel P, 1999, CONSERV BIOL, V13, P11, DOI 10.1046/j.1523-1739.1999.97153.x; Oke DO, 2007, AGR ECOSYST ENVIRON, V122, P305, DOI 10.1016/j.agee.2007.01.022; Rangel JOC, 2011, PLANT BIOSYST, V145, P186, DOI 10.1080/11263504.2011.602727; Phillips-Mora W, 2007, PLANT PATHOL, V56, P911, DOI 10.1111/j.1365-3059.2007.01646.x; Quesada F., 2007, SHADEMOTION 3 0 SOFT; Rice RA, 2000, AMBIO, V29, P167, DOI 10.1579/0044-7447-29.3.167; Robledo, 2017, INFOSTAT VERSION; Rosalien EJ, 2017, ECOL ECON, V140, P136, DOI 10.1016/j.ecolecon.2017.04.019; Sambuichi RHR, 2012, BIODIVERS CONSERV, V21, P1055, DOI 10.1007/s10531-012-0240-3; Sanchez-Cuervo AM, 2013, ECOSYSTEMS, V16, P1052, DOI 10.1007/s10021-013-9667-y; Sierra D.C., 2016, CACAO COMO PRODUCTO; Somarriba E., 2013, Forests, Trees and Livelihoods, V22, P51, DOI 10.1080/14728028.2013.770316; Somarriba E, 2012, MAINSTREAMING AGRO F; Sonwa DJ, 2007, BIODIVERS CONSERV, V16, P2385, DOI 10.1007/s10531-007-9187-1; Sonwa DJ, 2017, AGROFOREST SYST, V91, P451, DOI 10.1007/s10457-016-9942-y; Steffan-Dewenter I, 2007, P NATL ACAD SCI USA, V104, P4973, DOI 10.1073/pnas.0608409104; Team RDC, 2016, R LANG ENV STAT COMP; Tomassone R, 1993, BIOMETRIE MODELISATI; Tondoh JE, 2015, GLOB ECOL CONSERV, V3, P575, DOI 10.1016/j.gecco.2015.02.007; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; Zhang DS, 2014, FIELD CROP RES, V169, P132, DOI 10.1016/j.fcr.2014.09.001; Zuidema PA, 2005, AGR SYST, V84, P195, DOI 10.1016/j.agsy.2004.06.015	46	12	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191003	10.1371/journal.pone.0191003	http://dx.doi.org/10.1371/journal.pone.0191003			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401499	gold, Green Published			2022-12-26	WOS:000424101400009
J	Hassani, A; Corboy, JR; Al-Salami, S; Khan, G				Hassani, Asma; Corboy, John R.; Al-Salami, Suhail; Khan, Gulfaraz			Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells	PLOS ONE			English	Article							HERPES-SIMPLEX VIRUS; MENINGEAL INFLAMMATION; EBV PERSISTENCE; INFECTED-CELLS; LATENT INFECTION; IMMUNE-RESPONSE; T-CELLS; EXPRESSION; PATHOLOGY; DISEASE	Multiple sclerosis (MS) is a chronic neuroinflammatory condition of the central nervous system (CNS). It is a major cause of neurological disability in young adults, particularly women. What triggers the destruction of myelin sheaths covering nerve fibres is unknown. Both genetic and infectious agents have been implicated. Of the infectious agents, Epstein-Barr virus (EBV), a common herpesvirus, has the strongest epidemiological and serological evidence. However, the presence of EBV in the CNS and demonstration of the underlying mechanism(s) linking EBV to the pathogenesis of MS remain to be elucidated. We aimed at understanding the contribution of EBV infection in the pathology of MS. We examined 1055 specimens (440 DNA samples and 615 brain tissues) from 101 MS and 21 non-MS cases for the presence of EBV using PCR and EBER-in situ hybridization (EBER-ISH). EBV was detected by PCR and/or EBER-ISH in 91/101 (90%) of MS cases compared to only 5/21 (24%) of non-MS cases with other neuropathologies. None of the samples were PCR positive for other common herpesviruses (HSV-1, CMV, HHV-6). By quantitative PCR, EBV viral load in MS brain was mainly low to moderate in most cases. However, in 18/101 (18%) of MS cases, widespread but scattered presence of EBV infected cells was noted in the affected tissues by EBER-ISH. Immunohistochemical analysis of EBV gene expression in the 18 heavily infected cases, revealed that the EBV latent protein EBNA1, and to a lesser extent the early lytic protein BZLF1 were expressed. Furthermore, using double-staining we how for the first time that astrocytes and microglia, in addition to B-cells can also be infected. To the best of our knowledge, this is the most comprehensive study demonstrating that EBV is present and transcriptionally active in the brain of most cases of MS and supports a role for the virus in MS pathogenesis. Further studies are required to address the mechanism of EBV involvement in MS pathology.	[Hassani, Asma; Khan, Gulfaraz] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, Tawam Hosp Campus, Al Ain, U Arab Emirates; [Corboy, John R.] Univ Colorado, Rocky Mt MS Ctr, Sch Med, Dept Neurol, Aurora, CO USA; [Al-Salami, Suhail] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Pathol, Tawam Hosp Campus, Al Ain, U Arab Emirates	United Arab Emirates University; University of Colorado System; University of Colorado Anschutz Medical Campus; United Arab Emirates University	Khan, G (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, Tawam Hosp Campus, Al Ain, U Arab Emirates.	g_khan@uaeu.ac.ae	Corboy, John/GVT-2436-2022; Khan, Gulfaraz/AAC-2859-2022	Khan, Gulfaraz/0000-0001-6836-1783; Al-Salam, Suhail/0000-0003-0109-5964; Hassani, Asma/0000-0001-7792-2140	UAE University [31R090, 31M263]	UAE University	The work in GK laboratory is supported by grants from UAE University (31R090, 31M263).	Ahmed W, 2015, J GEN VIROL, V96, P3646, DOI 10.1099/jgv.0.000313; Ahmed W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099163; Al-Salam S, 2011, INT J PEDIATR OTORHI, V75, P1160, DOI 10.1016/j.ijporl.2011.06.012; Aloisi F, 2010, BRAIN, V133, DOI 10.1093/brain/awq223; Sousa ADA, 2016, ANN CLIN TRANSL NEUR, V3, P422, DOI 10.1002/acn3.310; Angelini DF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003220; Ascherio A, 2000, EPIDEMIOLOGY, V11, P220, DOI 10.1097/00001648-200003000-00023; Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Belbasis L, 2015, LANCET NEUROL, V14, P263, DOI 10.1016/S1474-4422(14)70267-4; Bezold G, 2001, FERTIL STERIL, V76, P416, DOI 10.1016/S0015-0282(01)01920-3; Brooks JM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005549; Browne P, 2014, NEUROLOGY, V83, P1022, DOI 10.1212/WNL.0000000000000768; Choi SR, 2012, BRAIN, V135, P2925, DOI 10.1093/brain/aws189; COATES PJ, 1991, J CLIN PATHOL, V44, P115, DOI 10.1136/jcp.44.2.115; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dobson Ruth, 2017, Neurol Neuroimmunol Neuroinflamm, V4, pe318, DOI 10.1212/NXI.0000000000000318; Dooley MM, 2016, J NEUROIMMUNOL, V299, P147, DOI 10.1016/j.jneuroim.2016.08.016; Dunham J, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2017.1; Fan H, 2001, Methods Mol Med, V49, P301, DOI 10.1385/1-59259-081-0:301; Fanaian NK, 2009, PEDIATR DEVEL PATHOL, V12, P195, DOI 10.2350/07-07-0316.1; Farrell RA, 2009, NEUROLOGY, V73, P32, DOI 10.1212/WNL.0b013e3181aa29fe; Gulley ML, 2008, J MOL DIAGN, V10, P279, DOI 10.2353/jmoldx.2008.080023; Hassani A, 2015, EXP MOL PATHOL, V99, P558, DOI 10.1016/j.yexmp.2015.09.013; Hemmer B, 2015, LANCET NEUROL, V14, P406, DOI 10.1016/S1474-4422(14)70305-9; HILTON DA, 1994, J NEUROL NEUROSUR PS, V57, P975, DOI 10.1136/jnnp.57.8.975; Hollsberg P, 2003, CLIN EXP IMMUNOL, V132, P137, DOI 10.1046/j.1365-2249.2003.02114.x; Howell OW, 2015, NEUROPATH APPL NEURO, V41, P798, DOI 10.1111/nan.12199; Howell OW, 2011, BRAIN, V134, P2755, DOI 10.1093/brain/awr182; Hudnall SD, 2005, MODERN PATHOL, V18, P519, DOI 10.1038/modpathol.3800369; Iwakiri D, 2009, J EXP MED, V206, P2091, DOI 10.1084/jem.20081761; Izawa K, 2017, J EXP MED, V214, P73, DOI 10.1084/jem.20160784; Jilek S, 2012, J IMMUNOL, V188, P4671, DOI 10.4049/jimmunol.1103100; Kalla M, 2012, EUR J CELL BIOL, V91, P65, DOI 10.1016/j.ejcb.2011.01.014; Kalla M, 2010, P NATL ACAD SCI USA, V107, P850, DOI 10.1073/pnas.0911948107; KESSLER HH, 1994, J CLIN MICROBIOL, V32, P1881, DOI 10.1128/JCM.32.8.1881-1886.1994; KHAN G, 1992, AM J PATHOL, V140, P757; Khan G, 1996, IMMUNITY, V5, P173, DOI 10.1016/S1074-7613(00)80493-8; Khan G, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0260-1; Khan G, 2011, EXP MOL PATHOL, V91, P466, DOI 10.1016/j.yexmp.2011.04.018; Khan Gulfaraz, 2009, V511, P311, DOI 10.1007/978-1-59745-447-6_13; Kieff E, 2007, FIELDS VIROLOGY, P2603; Kooi EJ, 2009, J NEUROPATH EXP NEUR, V68, P1021, DOI 10.1097/NEN.0b013e3181b4bf8f; Krumbholz M, 2005, J EXP MED, V201, P195, DOI 10.1084/jem.20041674; Lassmann H, 2011, BRAIN, V134, P2772, DOI 10.1093/brain/awr197; Latham LB, 2016, ACTA NEUROL SCAND, V133, P17, DOI 10.1111/ane.12417; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Levin LI, 2010, ANN NEUROL, V67, P824, DOI 10.1002/ana.21978; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; LINDBERG C, 1991, NEUROEPIDEMIOLOGY, V10, P62, DOI 10.1159/000110248; Lunemann JD, 2010, ANN NEUROL, V67, P159, DOI 10.1002/ana.21886; Macsween KF, 2003, LANCET INFECT DIS, V3, P131, DOI 10.1016/S1473-3099(03)00543-7; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Magliozzi R, 2013, J NEUROPATH EXP NEUR, V72, P29, DOI 10.1097/NEN.0b013e31827bfc62; Mameli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044991; Miller E, 2012, ADV EXP MED BIOL, V724, P222, DOI 10.1007/978-1-4614-0653-2_17; Mostafa A, 2017, J MED VIROL, V89, P1309, DOI 10.1002/jmv.24774; Nielsen TR, 2007, ARCH NEUROL-CHICAGO, V64, P72, DOI 10.1001/archneur.64.1.72; Opsahl ML, 2007, J NEUROL, V254, P425, DOI 10.1007/s00415-006-0316-7; Peferoen LAN, 2010, BRAIN, V133, DOI 10.1093/brain/awp296; Pikor NB, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00657; Price AM, 2014, ADV VIRUS RES, V88, P279, DOI 10.1016/B978-0-12-800098-4.00006-4; Ryan JL, 2004, J MOL DIAGN, V6, P378, DOI 10.1016/S1525-1578(10)60535-1; Sanders VJ, 1996, ARCH NEUROL-CHICAGO, V53, P125, DOI 10.1001/archneur.1996.00550020029012; Sanders VJ, 1996, J NEUROVIROL, V2, P249, DOI 10.3109/13550289609146888; Sargsyan SA, 2010, NEUROLOGY, V74, P1127, DOI 10.1212/WNL.0b013e3181d865a1; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030; Serafini B, 2013, BRAIN, V136, DOI 10.1093/brain/aws315; Serafini B, 2010, J NEUROPATH EXP NEUR, V69, P677, DOI 10.1097/NEN.0b013e3181e332ec; Shi SR, 2001, J HISTOCHEM CYTOCHEM, V49, P931, DOI 10.1177/002215540104900801; Sundstrom P, 2004, NEUROLOGY, V62, P2277, DOI 10.1212/01.WNL.0000130496.51156.D7; Thorley-Lawson DA, 2015, CURR TOP MICROBIOL, V390, P151, DOI 10.1007/978-3-319-22822-8_8; Torkildsen O, 2010, BRAIN PATHOL, V20, P720, DOI 10.1111/j.1750-3639.2009.00343.x; Tzartos JS, 2012, NEUROLOGY, V78, P15, DOI 10.1212/WNL.0b013e31823ed057; Wen WR, 2007, J VIROL, V81, P1037, DOI 10.1128/JVI.01416-06; Willis SN, 2009, BRAIN, V132, P3318, DOI 10.1093/brain/awp200; Wilms T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184201	78	61	63	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192109	10.1371/journal.pone.0192109	http://dx.doi.org/10.1371/journal.pone.0192109			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394264	Green Submitted, Green Published, gold			2022-12-26	WOS:000424060400026
J	Shang, HM; Zhou, HZ; Yang, JY; Li, R; Song, H; Wu, HX				Shang, Hong-Mei; Zhou, Hai-Zhu; Yang, Jun-Yan; Li, Ran; Song, Hui; Wu, Hong-Xin			In vitro and in vivo antioxidant activities of inulin	PLOS ONE			English	Article							LAYING PERFORMANCE; LIPID-METABOLISM; EGG QUALITY; POLYSACCHARIDE; MICROFLORA; FRUCTANS; SUPPLEMENTATION; CAPACITY; REDUCE	This study was designed to investigate the in vitro and in vivo antioxidant activities of inulin. The in vitro assays demonstrated that the antioxidant activities of inulin, including the DPPH radical scavenging activity, ABTS scavenging activity and ferric reducing power, were weak and significantly lower than those of Vitamin C (P < 0.05). The influence of dietary supplementation with inulin on the antioxidant status of laying hens was evaluated with in vivo antioxidant assays. The results indicated that inulin supplementation quadratically improved the egg production rate of the laying hens (P < 0.01). The antioxidant enzyme activities in the serum, including SOD, CAT, and GSH-Px, and the total antioxidant capacity increased quadratically as inulin levels increased (P < 0.001). The levels of MDA in the serum decreased quadratically as inulin levels increased (P < 0.001). These findings suggest that inulin has the potential to improve the antioxidant status of laying hens.	[Shang, Hong-Mei; Zhou, Hai-Zhu; Yang, Jun-Yan; Li, Ran] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China; [Shang, Hong-Mei] Jilin Agr Univ, Key Lab Anim Nutr & Feed Sci Jilin Prov, Changchun, Jilin, Peoples R China; [Song, Hui] Jilin Agr Univ, Sch Life Sci, Changchun, Jilin, Peoples R China; [Wu, Hong-Xin] Grassland Res Inst CAAS, Hohhot, Neimenggu, Peoples R China	Jilin Agricultural University; Jilin Agricultural University; Jilin Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS	Song, H (corresponding author), Jilin Agr Univ, Sch Life Sci, Changchun, Jilin, Peoples R China.	songhuinongda@163.com	Shang, Hongmei/HDL-7105-2022	Shang, Hongmei/0000-0002-0961-491X	National Natural Science Foundation of China [31601972]; China Postdoctoral Science Foundation [2017M621224]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (31601972 to HMS) and Project funded by China Postdoctoral Science Foundation (2017M621224 to HMS).; This work was supported by the National Natural Science Foundation of China (No. 31601972) and the Project funded by China Postdoctoral Science Foundation (No. 2017M621224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apolinario AC, 2014, CARBOHYD POLYM, V101, P368, DOI 10.1016/j.carbpol.2013.09.081; Gargari BP, 2013, DIABETES METAB J, V37, P140, DOI 10.4093/dmj.2013.37.2.140; Giannenas I, 2010, RES VET SCI, V89, P78, DOI 10.1016/j.rvsc.2010.02.003; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; HE G, 2002, J ANIM SCI, V80, P81; Hu YX, 2014, INT J BIOL MACROMOL, V70, P44, DOI 10.1016/j.ijbiomac.2014.06.024; Jing YS, 2015, J AGR FOOD CHEM, V63, P3464, DOI 10.1021/jf505915t; Liu HN, 2014, POULTRY SCI, V93, P347, DOI 10.3382/ps.2013-03225; Liu J, 2015, INT J BIOL MACROMOL, V72, P1479, DOI 10.1016/j.ijbiomac.2014.09.066; Liu W, 2014, INT J BIOL MACROMOL, V65, P446, DOI 10.1016/j.ijbiomac.2014.01.062; Luo AX, 2011, MOLECULES, V16, P1579, DOI 10.3390/molecules16021579; MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407; Mudannayake DC, 2015, J FOOD SCI, V80, pC950, DOI 10.1111/1750-3841.12857; Mujahid A, 2007, POULTRY SCI, V86, P364, DOI 10.1093/ps/86.2.364; Munjal U, 2009, BRIT J NUTR, V102, P663, DOI 10.1017/S0007114509274770; Muriel P, 2008, J APPL TOXICOL, V28, P93, DOI 10.1002/jat.1310; Nabizadeh A, 2012, J ANIM FEED SCI, V21, P725, DOI 10.22358/jafs/66144/2012; National Reasearch Council, 1994, NUTR REQ POULTR, V9th; Pasqualetti V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098031; Petkova N., 2015, ACTA SCI NATURALIS, V1, P225, DOI DOI 10.1177/1934578X1701200207; Petrovsky N, 2015, VACCINE, V33, P5920, DOI 10.1016/j.vaccine.2015.09.030; Pool-Zobel B, 2002, BRIT J NUTR, V87, pS273, DOI 10.1079/BJN/2002548; Qi XL, 2011, ARCH ANIM NUTR, V65, P354, DOI 10.1080/1745039X.2011.617546; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Roberfroid MB, 2002, BRIT J NUTR, V87, pS139, DOI 10.1079/BJN/2002529; Russo I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032841; Shang HM, 2010, BRIT POULTRY SCI, V51, P791, DOI 10.1080/00071668.2010.531005; Shang HM, 2016, J SCI FOOD AGR, V96, P215, DOI 10.1002/jsfa.7084; SHIMADA K, 1992, J AGR FOOD CHEM, V40, P945, DOI 10.1021/jf00018a005; Shoaib M, 2016, CARBOHYD POLYM, V147, P444, DOI 10.1016/j.carbpol.2016.04.020; Tiengtam N, 2015, ANIM FEED SCI TECH, V207, P120, DOI 10.1016/j.anifeedsci.2015.05.008; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vassilev D, 2016, J RENEW MATER, V4, P24, DOI 10.7569/JRM.2015.634125; Wang J, 2011, CARBOHYD POLYM, V86, P1192, DOI 10.1016/j.carbpol.2011.06.014; Wang JQ, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5692852; Wu LC, 2006, FOOD CHEM, V95, P319, DOI 10.1016/j.foodchem.2005.01.002; Zhang Y, 2010, EUR FOOD RES TECHNOL, V231, P151, DOI 10.1007/s00217-010-1255-1; Zhao X, 2011, POULTRY SCI, V90, P1720, DOI 10.3382/ps.2010-01280; Zuo ZY, 2012, J APPL POULTRY RES, V21, P243, DOI 10.3382/japr.2011-00351	39	51	56	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192273	10.1371/journal.pone.0192273	http://dx.doi.org/10.1371/journal.pone.0192273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394273	Green Published, gold, Green Submitted			2022-12-26	WOS:000424060400031
J	Aibekova, L; Foley, B; Hortelano, G; Raees, M; Abdraimov, S; Toichuev, R; Ali, S				Aibekova, Lazzat; Foley, Brian; Hortelano, Gonzalo; Raees, Muhammad; Abdraimov, Sabit; Toichuev, Rakhmanbek; Ali, Syed			Molecular epidemiology of HIV-1 subtype A in former Soviet Union countries	PLOS ONE			English	Article							EASTERN-EUROPE; KAZAKSTAN; TYPE-1; PETERSBURG; UZBEKISTAN; OUTBREAK; VARIANT	While in other parts of the world it is on decline, incidence of HIV infection continues to rise in the former Soviet Union (FSU) countries. The present study was conducted to investigate the patterns and modes of HIV transmission in FSU countries. We performed phylogenetic analysis of publicly available 2705 HIV-1 subtype A pol sequences from thirteen FSU countries: Armenia, Azerbaijan, Belarus, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Moldova, Russia, Ukraine and Uzbekistan. Our analysis showed that the clusters from FSU countries were intermixed, indicating a possible role of transmigration in HIV transmission. Injection drug use was found to be the most frequent mode of transmission, while the clusters from PWID and heterosexual transmission were intermixed, indicating bridging of HIV infection across populations. To control the expanding HIV epidemic in this region, harm reduction strategies should be focused on three modes of transmission, namely, cross-border migration, injection drug use and heterosexual.	[Aibekova, Lazzat; Hortelano, Gonzalo] Nazarbayev Univ, Sch Sci & Technol, Dept Biol Sci, Astana, Kazakhstan; [Foley, Brian] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM USA; [Raees, Muhammad] Vanderbilt Univ, Med Ctr, Monroe Carell Jr Childrens Hosp, Div Pediat Cardiac Surg, Nashville, TN USA; [Abdraimov, Sabit] Ctr Dis Control & Prevent AIDS, Astana, Kazakhstan; [Toichuev, Rakhmanbek] Natl Acad Sci Kyrgyz Republ, Osh, Kyrgyzstan; [Ali, Syed] Nazarbayev Univ, Nazarbayev Sch Med, Dept Biomed Sci, Astana, Kazakhstan	Nazarbayev University; United States Department of Energy (DOE); Los Alamos National Laboratory; Vanderbilt University; National Academy of Sciences of the Kyrgyz Republic (NAS KR); Nazarbayev University	Ali, S (corresponding author), Nazarbayev Univ, Nazarbayev Sch Med, Dept Biomed Sci, Astana, Kazakhstan.	syed.ali@nu.edu.kz	Foley, Brian T/N-4527-2018	Foley, Brian T/0000-0002-1086-0296; Toichuev, R.M./0000-0002-5978-6058				Abidi SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093415; Aldridge RW, 2016, LANCET INFECT DIS, V16, P962, DOI 10.1016/S1473-3099(16)00072-4; AVERT, 2016, HIV AIDS RUSS; Bobkov AF, 2004, AIDS RES HUM RETROV, V20, P1134, DOI 10.1089/aid.2004.20.1134; Bobkova M, 2013, AIDS REV, V15, P204; Carr JK, 2005, JAIDS-J ACQ IMM DEF, V39, P570; Choudinovskikh O, WP306; DeHovitz J, 2014, CURR HIV-AIDS REP, V11, P168, DOI 10.1007/s11904-014-0202-3; Diez-Fuertes F, 2015, INFECT GENET EVOL, V33, P197, DOI 10.1016/j.meegid.2015.05.003; Dukhovlinova E, 2015, AIDS RES HUM RETROV, V31, P608, DOI [10.1089/aid.2014.0150, 10.1089/AID.2014.0150]; ECDPC, 2013, MON IMPL DUBL DECL P; El-Bassel N, 2011, AM J PUBLIC HEALTH, V101, P1075, DOI 10.2105/AJPH.2010.300085; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; Kurbanov F, 2003, AIDS RES HUM RETROV, V19, P731, DOI 10.1089/088922203769232520; Laga V, 2015, CURR HIV RES, V13, P219, DOI 10.2174/1570162X13666150407142834; Lapovok I. A., 2015, Voprosy Virusologii, V60, P29; Lie AL, 2012, EFFECTS INT EMIGRATI; PEPFAR, 2013, CENTR AS REG OP PLAN; Prague Process, 2013, OV MIGR PROF LIGHT; Registry-Migration, 2015, GBIF ORG SENCK CEDAM; Rhodes T, 1999, ADDICTION, V94, P1323, DOI 10.1046/j.1360-0443.1999.94913235.x; Saad MD, 2006, AIDS RES HUM RETROV, V22, P796, DOI 10.1089/aid.2006.22.796; Sharma S, 2015, J HEPATOL, V63, P515, DOI 10.1016/j.jhep.2015.04.026; Thomson MM, 2009, JAIDS-J ACQ IMM DEF, V51, P332, DOI 10.1097/QAI.0b013e31819c1757; UNAIDS, 2015, AIDS RESP PROGR REP; UNESCO, 2005, HIV AIDS CAUC REG SO; UNODC, 2003, GLOBAL ILL DRUG TREN	27	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191891	10.1371/journal.pone.0191891	http://dx.doi.org/10.1371/journal.pone.0191891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29389951	Green Published, Green Submitted, gold			2022-12-26	WOS:000423793400041
J	Blamires, SJ; Nobbs, M; Martens, PJ; Tso, IM; Chuang, WT; Chang, CK; Sheu, HS				Blamires, Sean J.; Nobbs, Madeleine; Martens, Penny J.; Tso, I-Min; Chuang, Wei-Tsung; Chang, Chung-Kai; Sheu, Hwo-Shuenn			Multiscale mechanisms of nutritionally induced property variation in spider silks	PLOS ONE			English	Article							X-RAY-SCATTERING; SOLID-STATE NMR; DRAGLINE SILK; AMPULLATE SILK; THIN-FILMS; FIBERS; EVOLUTION; PROTEINS; PROLINE; GENES	Variability in spider major ampullate (MA) silk properties at different scales has proven difficult to determine and remains an obstacle to the development of synthetic fibers mimicking MA silk performance. A multitude of techniques may be used to measure multiscale aspects of silk properties. Here we fed five species of Araneoid spider solutions that either contained protein or were protein deprived and performed silk tensile tests, small and wide-angle Xray scattering (SAXS/WAXS), amino acid composition analyses, and silk gene expression analyses, to resolve persistent questions about how nutrient deprivation induces variations in MA silk mechanical properties across scales. Our analyses found that the properties of each spider's silk varied differently in response to variations in their protein intake. We found changes in the crystalline and non-crystalline nanostructures to play specific roles in inducing the property variations we found. Across treatment MaSp expression patterns differed in each of the five species. We found that in most species MaSp expression and amino acid composition variations did not conform with our predictions based on a traditional MaSp expression model. In general, changes to the silk's alanine and proline compositions influenced the alignment of the proteins within the silk's amorphous region, which influenced silk extensibility and toughness. Variations in structural alignment in the crystalline and non-crystalline regions influenced ultimate strength independent of genetic expression. Our study provides the deepest insights thus far into the mechanisms of how MA silk properties vary from gene expression to nanostructure formations to fiber mechanics. Such knowledge is imperative for promoting the production of synthetic silk fibers.	[Blamires, Sean J.; Nobbs, Madeleine] Univ New South Wales, Sch Biol Earth & Environm Sci D26, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Martens, Penny J.] Univ New South Wales, Grad Sch Biomed Engn, Samuels Bldg F25, Sydney, NSW, Australia; [Tso, I-Min] Tunghai Univ, Dept Life Sci, Taichung, Taiwan; [Chuang, Wei-Tsung; Chang, Chung-Kai; Sheu, Hwo-Shuenn] Natl Synchrotron Radiat Res Ctr, Hsinchu, Taiwan	University of New South Wales Sydney; University of New South Wales Sydney; Tunghai University; National Synchrotron Radiation Research Center	Blamires, SJ (corresponding author), Univ New South Wales, Sch Biol Earth & Environm Sci D26, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	s.blamires@unsw.edu.au	Blamires, Sean/F-4402-2016	Blamires, Sean/0000-0001-5953-3723; Martens, Penny/0000-0003-3098-1420	Australian Research Council [DE140101281]; UNSW Biological Earth and Environmental Sciences; Taiwan National Science Council [NSC-102-2311-B-029-001-MY3, NSC-102-2811-B-029-001]	Australian Research Council(Australian Research Council); UNSW Biological Earth and Environmental Sciences; Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	Research was supported by an Australian Research Council (Discovery Early Career Researcher Award DE140101281) and UNSW Biological Earth and Environmental Sciences grant to S.J.B., and Taiwan National Science Council grants (NSC-102-2311-B-029-001-MY3 and NSC-102-2811-B-029-001) to I.M.T.	Alsop D, 2007, REG INTEGR COMP PHYS, V294, pR711 ; An B, 2011, BIOMACROMOLECULES, V12, P2375, DOI 10.1021/bm200463e; dos Santos-Pinto JRA, 2016, J PROTEOME RES, V15, P1179, DOI 10.1021/acs.jproteome.5b01056; Asakura T, 2013, PROG NUCL MAG RES SP, V69, P23, DOI 10.1016/j.pnmrs.2012.08.001; Ayoub NA, 2008, MOL BIOL EVOL, V25, P277, DOI 10.1093/molbev/msm246; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Babb PL, 2017, NAT GENET, V49, P895, DOI 10.1038/ng.3852; Balta-Calleja FJ, 1989, XRAY SCATTERING SYNT, V8; Benamu M, 2017, CHEMOSPHERE, V181, P241, DOI 10.1016/j.chemosphere.2017.04.079; Blackledge TA, 2005, ZOOLOGY, V108, P41, DOI 10.1016/j.zool.2004.11.001; Blamires SJ, 2010, J EXP BIOL, V213, P3906, DOI 10.1242/jeb.046730; Blamires SJ, 2017, ANNU REV ENTOMOL, V62, P443, DOI 10.1146/annurev-ento-031616-035615; Blamires SJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081294; Blamires SJ, 2015, BIOMACROMOLECULES, V16, P1218, DOI 10.1021/acs.biomac.5b00006; Blamires SJ, 2013, BIOMACROMOLECULES, V14, P3484, DOI 10.1021/bm400803z; Blamires SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031626; Boutry C, 2013, J EXP BIOL, V216, P3606, DOI 10.1242/jeb.084236; Boutry C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022467; Bram A, 1997, J APPL CRYSTALLOGR, V30, P390, DOI 10.1107/S0021889896012344; Breslauer DN, 2009, BIOMACROMOLECULES, V10, P49, DOI 10.1021/bm800752x; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Cetinkaya M, 2011, BIOPHYS J, V100, P1298, DOI 10.1016/j.bpj.2010.12.3712; Chaw RC, 2015, J PROTEOME RES, V14, P4223, DOI 10.1021/acs.jproteome.5b00353; Chung H, 2012, CURR OPIN BIOTECH, V23, P957, DOI 10.1016/j.copbio.2012.03.013; Cranford SW, 2012, NATURE, V482, P72, DOI 10.1038/nature10739; Creager MS, 2010, BIOMACROMOLECULES, V11, P2039, DOI 10.1021/bm100399x; Dicko C, 2004, BIOMACROMOLECULES, V5, P2105, DOI 10.1021/bm034486y; Du N, 2011, ADV FUNCT MATER, V21, P772, DOI 10.1002/adfm.201001397; Fallon A, 1987, APPL HPLC BIOCH; Fluidigm Corporation, 2017, REAL TIME PCR USERS; Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102; Garb JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-243; Garrido MA, 2002, POLYMER, V43, P4495, DOI 10.1016/S0032-3861(02)00254-9; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Giesa T, 2016, BIOMACROMOLECULES, V17, P427, DOI 10.1021/acs.biomac.5b01246; Glisovic A, 2008, MACROMOLECULES, V41, P390, DOI 10.1021/ma070528p; Grubb DT, 1997, MACROMOLECULES, V30, P2860, DOI 10.1021/ma961293c; Guan ZB, 2007, POLYM INT, V56, P467, DOI 10.1002/pi.2245; Guinier, 1963, XRAY DIFFRACTION CRY, DOI DOI 10.1002/bip.10163; Heim M, 2009, ANGEW CHEM INT EDIT, V48, P3584, DOI 10.1002/anie.200803341; Holmes KC, 1966, USE XRAY DIFFRACTION; Hsia Y, 2011, METAL, CERAMIC AND POLYMERIC COMPOSITES FOR VARIOUS USES, P303; Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jeffrey F, 2011, JOVE-J VIS EXP, V47, pe2382; Jeng US, 2010, J APPL CRYSTALLOGR, V43, P110, DOI 10.1107/S0021889809043271; Jenkins JE, 2013, BIOMACROMOLECULES, V14, P3472, DOI 10.1021/bm400791u; Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]; Kim S, 2008, MACROMOLECULES, V41, P3401, DOI 10.1021/ma800584t; Koch MHJ, 2008, ANNU REP PROG CHEM C, V104, P35, DOI 10.1039/b703892p; Lane AK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-846; Larracas C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091537; Lawrence BA, 2004, BIOMACROMOLECULES, V5, P689, DOI 10.1021/bm0342640; Lefevre T, 2007, BIOMACROMOLECULES, V8, P2342, DOI 10.1021/bm7005517; Liao CP, 2009, BEHAV ECOL, V20, P1194, DOI 10.1093/beheco/arp119; Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g; Madurga R, 2015, SCI REP-UK, V5, DOI 10.1038/srep14820; Morrison DF, 1983, APPL LINEAR STAT MET; Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w; Parkhe AD, 1997, J MOL RECOGNIT, V10, P1, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<1::AID-JMR338>3.0.CO;2-7; Podorov SG, 2006, J APPL CRYSTALLOGR, V39, P652, DOI 10.1107/S0021889806025696; QAIGEN, 2012, ONESTEP DT PCR HDB; Riekel C, 2001, NATURWISSENSCHAFTEN, V88, P67, DOI 10.1007/s001140000197; Rising A, 2015, NAT CHEM BIOL, V11, P309, DOI [10.1038/nchembio.1789, 10.1038/NCHEMBIO.1789]; Rousseau ME, 2004, BIOMACROMOLECULES, V5, P2247, DOI 10.1021/bm049717V; Sampath S, 2012, SOFT MATTER, V8, P6713, DOI 10.1039/c2sm25373a; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi XY, 2014, CHEM COMMUN, V50, P4856, DOI 10.1039/c4cc00971a; SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060; Srinivasachary, 2007, THEOR APPL GENET, V115, P489, DOI 10.1007/s00122-007-0582-5; Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; Tokareva O, 2013, MICROB BIOTECHNOL, V6, P651, DOI 10.1111/1751-7915.12081; Vollrath F, 2013, MRS BULL, V38, P73, DOI 10.1557/mrs.2012.314; Vollrath F, 2011, SOFT MATTER, V7, P9595, DOI 10.1039/c1sm05812f; WARWICKER JO, 1960, J MOL BIOL, V2, P350, DOI 10.1016/S0022-2836(60)80046-0; WUTZ C, 1995, REV SCI INSTRUM, V66, P1303, DOI 10.1063/1.1145959; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Yang Z, 1997, MACROMOLECULES, V30, P8254, DOI 10.1021/ma970548z; Zondlo NJ, 2013, ACCOUNTS CHEM RES, V46, P1039, DOI 10.1021/ar300087y	81	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192005	10.1371/journal.pone.0192005	http://dx.doi.org/10.1371/journal.pone.0192005			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390013	Green Submitted, Green Published, gold			2022-12-26	WOS:000423793400049
J	Mulye, M; Zapata, B; Gilk, SD				Mulye, Minal; Zapata, Brianne; Gilk, Stacey D.			Altering lipid droplet homeostasis affects Coxiella burnetii intracellular growth	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; DIFFERENTIATION-RELATED PROTEIN; ADIPOSE TRIGLYCERIDE LIPASE; SMALL-MOLECULE INHIBITORS; FOAM CELL-FORMATION; MYCOBACTERIUM-LEPRAE; Q-FEVER; CHLAMYDIA-TRACHOMATIS; SCHWANN-CELLS; HOST-CELLS	Coxiella burnetii is an obligate intracellular bacterial pathogen and a causative agent of culture-negative endocarditis. While C. burnetii initially infects alveolar macrophages, it has also been found in lipid droplet (LD)-containing foamy macrophages in the cardiac valves of endocarditis patients. In addition, transcriptional studies of C. burnetii-infected macrophages reported differential regulation of the LD coat protein-encoding gene perilipin 2 (plin-2). To further investigate the relationship between LDs and C. burnetii, we compared LD numbers using fluorescence microscopy in mock-infected and C. burnetii-infected alveolar macrophages. On average, C. burnetii-infected macrophages contained twice as many LDs as mock-infected macrophages. LD numbers increased as early as 24 hours post-infection, an effect reversed by blocking C. burnetii protein synthesis. The observed LD accumulation was dependent on the C. burnetii Type 4B Secretion System (T4BSS), a major virulence factor that manipulates host cellular processes by secreting bacterial effector proteins into the host cell cytoplasm. To determine the importance of LDs during C. burnetii infection, we manipulated LD homeostasis and assessed C. burnetii intracellular growth. Surprisingly, blocking LD formation with the pharmacological inhibitors triacsin C or T863, or knocking out acyl-CoA transferase-1 (acat-1) in alveolar macrophages, increased C. burnetii growth at least 2-fold. Conversely, preventing LD lipolysis by inhibiting adipose triglyceride lipase (ATGL) with atglistatin almost completely blocked bacterial growth, suggesting LD breakdown is essential for C. burnetii. Together these data suggest that maintenance of LD homeostasis, possibly via the C. burnetii T4BSS, is critical for bacterial growth.	[Mulye, Minal; Zapata, Brianne; Gilk, Stacey D.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Zapata, Brianne] Calif State Univ Dominguez Hills, Dept Biol, Carson, CA 90747 USA; [Mulye, Minal] Marian Univ, Coll Osteopath Med, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; California State University System; California State University Dominguez Hills	Gilk, SD (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	sgilk@iu.edu		Gilk, Stacey/0000-0002-0835-057X	National Institutes of Health [AI21786, 5R25GM07592]; American Heart Association [16POST27250157]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI121786] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institutes of Health (AI21786; S.D.G.), American Heart Association (16POST27250157; M.M.) and National Institutes of Health (5R25GM07592; B.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo-Santos T, 2014, J INFECT DIS, V210, P1951, DOI 10.1093/infdis/jiu299; Barisch C, 2017, BIOCHIMIE, V141, P54, DOI 10.1016/j.biochi.2017.06.001; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; Bozza PT, 1996, P NATL ACAD SCI USA, V93, P11091, DOI 10.1073/pnas.93.20.11091; BROUQUI P, 1994, AM J MED, V97, P451, DOI 10.1016/0002-9343(94)90325-5; Cao F, 2007, INFECT IMMUN, V75, P753, DOI 10.1128/IAI.01386-06; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Charron AJ, 2002, J CELL SCI, V115, P3049; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Cockrell DC, 2008, J MICROBIOL METH, V72, P321, DOI 10.1016/j.mimet.2007.12.015; Coleman SA, 2004, J BACTERIOL, V186, P7344, DOI 10.1128/JB.186.21.7344-7352.2004; D'Avila H, 2008, CELL MICROBIOL, V10, P2589, DOI 10.1111/j.1462-5822.2008.01233.x; D'Avila H, 2006, J IMMUNOL, V176, P3087, DOI 10.4049/jimmunol.176.5.3087; D'Avila H, 2011, J INFECT DIS, V204, P951, DOI 10.1093/infdis/jir432; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; DVORAK AM, 1983, J IMMUNOL, V131, P2965; Filipe A, 2015, TRENDS MOL MED, V21, P34, DOI 10.1016/j.molmed.2014.11.003; Graham JG, 2013, CELL MICROBIOL, V15, P1012, DOI 10.1111/cmi.12096; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Herker E, 2012, J BIOL CHEM, V287, P2280, DOI 10.1074/jbc.R111.300202; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; IZZO AA, 1993, CLIN EXP IMMUNOL, V94, P507, DOI 10.1111/j.1365-2249.1993.tb08226.x; Justis AV, 2016, CELLULAR MICROBIOLOG; KOSTER FT, 1985, J IMMUNOL, V135, P1067; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Lecoeur H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002276; Long AP, 2012, TRAFFIC, V13, P705, DOI 10.1111/j.1600-0854.2012.01339.x; Mahapatra S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-244; Manna PR, 2013, J BIOL CHEM, V288, P8505, DOI 10.1074/jbc.M112.417873; Martinez E, 2016, P NATL ACAD SCI USA, V113, pE3260, DOI 10.1073/pnas.1522811113; Mattos KA, 2011, J IMMUNOL, V187, P2548, DOI 10.4049/jimmunol.1101344; Mattos KA, 2011, CELL MICROBIOL, V13, P259, DOI 10.1111/j.1462-5822.2010.01533.x; Mattos KA, 2010, J LEUKOCYTE BIOL, V87, P371, DOI 10.1189/jlb.0609433; Mayer N, 2013, NAT CHEM BIOL, V9, P785, DOI [10.1038/NCHEMBIO.1359, 10.1038/nchembio.1359]; McDonough JA, 2013, MBIO, V4, DOI 10.1128/mBio.00606-12; Melo RCN, 2016, EXP CELL RES, V340, P193, DOI 10.1016/j.yexcr.2015.10.028; Nawabi P, 2008, MOL MICROBIOL, V68, P173, DOI 10.1111/j.1365-2958.2008.06142.x; Newton HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054566; Ogawa M, 2014, MICROBES INFECT, V16, P962, DOI 10.1016/j.micinf.2014.09.004; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Paul A, 2008, CIRC RES, V102, P1492, DOI 10.1161/CIRCRESAHA.107.168070; Pol A, 2014, J CELL BIOL, V204, P635, DOI 10.1083/jcb.201311051; Pulido-Mendez M., 2006, Journal of Submicroscopic Cytology and Pathology, V38, P143; Rabhi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148640; Ren Q, 2003, ANN NY ACAD SCI, V990, P701, DOI 10.1111/j.1749-6632.2003.tb07447.x; Rudel LL, 2001, CURR OPIN LIPIDOL, V12, P121, DOI 10.1097/00041433-200104000-00005; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Sandoz KM, 2014, ANTIMICROB AGENTS CH, V58, P3860, DOI 10.1128/AAC.02064-13; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shannon JG, 2009, IMMUNOL RES, V43, P138, DOI 10.1007/s12026-008-8059-4; Soltysiak KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136699; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Toledo DAM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160433; VAUGHAN M, 1964, J BIOL CHEM, V239, P401; Vieira-de-Abreu A, 2011, AM J RESP CELL MOL, V44, P509, DOI 10.1165/rcmb.2010-0004OC; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; WELLER PF, 1991, AM J PATHOL, V138, P141; Welte MA, 2007, TRENDS CELL BIOL, V17, P363, DOI 10.1016/j.tcb.2007.06.004; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	61	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192215	10.1371/journal.pone.0192215	http://dx.doi.org/10.1371/journal.pone.0192215			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390006	Green Published, Green Submitted, gold			2022-12-26	WOS:000423793400076
J	Ramirez-Carvajal, L; Pauszek, SJ; Ahmed, Z; Farooq, U; Naeem, K; Shabman, RS; Stockwell, TB; Rodriguez, LL				Ramirez-Carvajal, Lisbeth; Pauszek, Steven J.; Ahmed, Zaheer; Farooq, Umer; Naeem, Khalid; Shabman, Reed S.; Stockwell, Timothy B.; Rodriguez, Luis L.			Genetic stability of foot-and-mouth disease virus during long-term infections in natural hosts	PLOS ONE			English	Article							BUFFALO SYNCERUS CAFFER; AFRICAN BUFFALO; PHYLOGENETIC ANALYSIS; RAPID DETECTION; SEROTYPE; CATTLE; PAKISTAN; FMDV; DATAMONKEY; SELECTION	Foot-and-mouth disease (FMD) is a severe infection caused by a picornavirus that affects livestock and wildlife. Persistence in ruminants is a well-documented feature of Foot-and-mouth disease virus (FMDV) pathogenesis and a major concern for disease control. Persistently infected animals harbor virus for extended periods, providing a unique opportunity to study within-host virus evolution. This study investigated the genetic dynamics of FMDV during persistent infections of naturally infected Asian buffalo. Using next-generation sequencing (NGS) we obtained 21 near complete FMDV genome sequences from 12 sub-clinically infected buffalo over a period of one year. Four animals yielded only one virus isolate and one yielded two isolates of different serotype suggesting a serial infection. Seven persistently infected animals yielded more than one virus of the same serotype showing a long-term intra-host viral genetic divergence at the consensus level of less than 2.5%. Quasi-species analysis showed few nucleotide variants and non-synonymous substitutions of progeny virus despite intra-host persistence of up to 152 days. Phylogenetic analyses of serotype Asia-1 VP1 sequences clustered all viruses from persistent animals with Group VII viruses circulating in Pakistan in 2011, but distinct from those circulating on 2008-2009. Furthermore, signature amino acid (aa) substitutions were found in the antigenically relevant VP1 of persistent viruses compared with viruses from 2008-2009. Intra-host purifying selective pressure was observed, with few codons in structural proteins undergoing positive selection. However, FMD persistent viruses did not show a clear pattern of antigenic selection. Our findings provide insight into the evolutionary dynamics of FMDV populations within naturally occurring subclinical and persistent infections that may have implications to vaccination strategies in the region.	[Ramirez-Carvajal, Lisbeth; Pauszek, Steven J.; Ahmed, Zaheer; Rodriguez, Luis L.] ARS, Foreign Anim Dis Res Unit, Plum Isl Anim Dis Ctr, Orient, NY 11957 USA; [Ramirez-Carvajal, Lisbeth; Ahmed, Zaheer] Oak Ridge Inst Sci & Educ, Oak Ridge, TN 37830 USA; [Ahmed, Zaheer] Anim Plant Hlth Inspect Serv, Foreign Anim Dis Diagnost Lab, Plum Isl Anim Dis Ctr, Orient, NY USA; [Farooq, Umer; Naeem, Khalid] Natl Agr Res Ctr, Anim Hlth Program, Islamabad, Pakistan; [Shabman, Reed S.; Stockwell, Timothy B.] J Craig Venter Inst, Rockville, MD USA; [Ramirez-Carvajal, Lisbeth] Univ Costa Rica, Serv Nacl Salud Anim, San Pedro Montes De Oca, San Jose, Costa Rica; [Ramirez-Carvajal, Lisbeth] Univ Costa Rica, Inst Hlth Res INISA, San Pedro Montes De Oca, San Jose, Costa Rica; [Stockwell, Timothy B.] Natl Biodef Anal & Countermeasures Ctr, Ft Detrick, MD USA	Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; National Agricultural Research Council - Pakistan; J. Craig Venter Institute; Universidad Costa Rica; Universidad Costa Rica	Ramirez-Carvajal, L; Rodriguez, LL (corresponding author), ARS, Foreign Anim Dis Res Unit, Plum Isl Anim Dis Ctr, Orient, NY 11957 USA.; Ramirez-Carvajal, L (corresponding author), Oak Ridge Inst Sci & Educ, Oak Ridge, TN 37830 USA.; Ramirez-Carvajal, L (corresponding author), Univ Costa Rica, Serv Nacl Salud Anim, San Pedro Montes De Oca, San Jose, Costa Rica.; Ramirez-Carvajal, L (corresponding author), Univ Costa Rica, Inst Hlth Res INISA, San Pedro Montes De Oca, San Jose, Costa Rica.	lizramirez@gmail.com; luis.rodriguez@ars.usda.gov		Stockwell, Timothy/0000-0002-3595-4539; Ahmed, Zaheer/0000-0001-9622-7418	USDA-ARS; Science and Technology Directorate of the U.S. Department of Homeland Security [HSHQDC-12-X-00060]; Plum Island Animal Disease Center Research Participation Program fellowship; ARS-USDA CRIS Project [1940-32000-061-00D]; US Department of State, BEP program [58-1940-7-161-F]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Science and Technology Directorate of the U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); Plum Island Animal Disease Center Research Participation Program fellowship; ARS-USDA CRIS Project; US Department of State, BEP program	This research was funded in part by ARS-USDA CRIS Project 1940-32000-061-00D. Additional funding came from the US Department of State, BEP program, under agreement 58-1940-7-161-F to the NARC in Pakistan. Part of the work was also funded through an interagency agreement between USDA-ARS and the Science and Technology Directorate of the U.S. Department of Homeland Security under Award Number HSHQDC-12-X-00060. ZA and LR were recipients of a Plum Island Animal Disease Center Research Participation Program fellowship, administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the U.S. Department of Energy (DOE) and the U.S. Department of Agriculture (USDA). All opinions expressed in this paper are the authors' and do not necessarily reflect the policies and views of the USDA, DOE, ORAU/ORISE.; The authors thank Elias Torres-Arroyo, Lauro Velazquez, and Devendra Rai for technical assistance with data analysis. Also we thank Vinita Puri, for help with sample processing during NGS library preparation. This research was funded in part by ARS-USDA CRIS Project 1940-32000-061-00D. Additional funding came from the US Department of State, BEP program, under agreement 58-1940-7-161-F to the NARC in Pakistan. Part of the work was also funded through an interagency agreement between USDA-ARS and the Science and Technology Directorate of the U.S. Department of Homeland Security under Award Number HSHQDC-12-X-00060. ZA and LRC were supported by the Plum Island Animal Disease Center Research Participation Program fellowship, administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the U.S. Department of Energy (DOE) and the U.S. Department of Agriculture (USDA). All opinions expressed in this paper are the authors' and do not necessarily reflect the policies and views of the USDA, DOE, ORAU/ORISE. Sample collection was done by field NARC veterinarians in Pakistan Project following IACUC protocol: 209.04-15-R. Finally, we thank Costa Rica's National Center for High Technology for access to their supercomputer Kabre for data analysis.	Abdul-Hamid NF, 2011, VIRUS GENES, V43, P41, DOI 10.1007/s11262-011-0599-3; Abubakar Muhammad, 2012, Virologica Sinica, V27, P320, DOI 10.1007/s12250-012-3271-8; Aftabuddin M, 2007, BIOPHYS J, V93, P225, DOI 10.1529/biophysj.106.098004; AFZAL H, 1965, B OFF INT EPIZOOT, V65, P101; Ahmed Z, 2017, TRANSBOUND EMERG DIS; ANSELL DM, 1994, EPIDEMIOL INFECT, V112, P213, DOI 10.1017/S0950268800057587; BACHRACH HL, 1968, ANNU REV MICROBIOL, V22, P201, DOI 10.1146/annurev.mi.22.100168.001221; Bari FD, 2014, VACCINE, V32, P5794, DOI 10.1016/j.vaccine.2014.08.033; Brito BP, 2013, TRANSBOUND EMERG DIS, V60, P516, DOI 10.1111/j.1865-1682.2012.01366.x; Callahan JD, 2002, J AM VET MED ASSOC, V220, P1636, DOI 10.2460/javma.2002.220.1636; Cedillo-Barron L, 2003, VACCINE, V21, P4261, DOI 10.1016/S0264-410X(03)00453-5; Cooke JN, 2008, INFECT GENET EVOL, V8, P855, DOI 10.1016/j.meegid.2008.08.004; Cottam EM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000050; DAWE PS, 1994, VET REC, V134, P230, DOI 10.1136/vr.134.10.230; DAWE PS, 1994, VET REC, V134, P211, DOI 10.1136/vr.134.9.211; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; DUTTA PK, 1983, VET REC, V113, P134, DOI 10.1136/vr.113.6.134; Eschbaumer M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162750; Farooq U, 2016, ASIAN BIOMED, V10, P123, DOI 10.5372/1905-7415.1002.472; FOX G, 1989, J GEN VIROL, V70, P625, DOI 10.1099/0022-1317-70-3-625; Freimanis GL, 2016, REV SCI TECH OIE, V35, P175, DOI 10.20506/rst.35.1.2426; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Haydon DT, 2001, GENETICS, V157, P7; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Horsington J, 2007, VIRUS RES, V125, P114, DOI 10.1016/j.virusres.2006.12.008; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jamal SM, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-116; Jamal SM, 2011, INFECT GENET EVOL, V11, P2049, DOI 10.1016/j.meegid.2011.09.015; Jamal SM, 2011, J GEN VIROL, V92, P2849, DOI 10.1099/vir.0.035626-0; Jamal SM, 2010, ARCH VIROL, V155, P1487, DOI 10.1007/s00705-010-0732-y; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Kanwal S., 2014, PAK BR J VIROL, V1, P21; Knight-Jones TJD, 2014, VACCINE, V32, P1848, DOI 10.1016/j.vaccine.2014.01.071; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LaRocco M, 2013, J CLIN MICROBIOL, V51, P1714, DOI 10.1128/JCM.03370-12; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Logan G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-828; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Maree F, 2016, J VIROL, V90, P5132, DOI 10.1128/JVI.00166-16; Mason PW, 2003, VIRUS RES, V91, P9, DOI 10.1016/S0168-1702(02)00257-5; Mohapatra JK, 2008, VIRUS RES, V136, P16, DOI 10.1016/j.virusres.2008.04.010; Morelli MJ, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-12; Moser LA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00039-15; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Parthiban ABR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128815; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Poon AFY, 2009, METHODS MOL BIOL, V537, P163, DOI 10.1007/978-1-59745-251-9_8; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Rodriguez LL, 2009, VACCINE, V27, pD90, DOI 10.1016/j.vaccine.2009.08.039; Samuel Karlin, 1986, EVOLUTIONARY PROCESS; Stenfeldt C, 2016, J VIROL, V90, P6344, DOI 10.1128/JVI.00388-16; Stenfeldt C, 2013, VET MICROBIOL, V162, P330, DOI 10.1016/j.vetmic.2012.09.008; Subramaniam S, 2013, VET MICROBIOL, V167, P280, DOI 10.1016/j.vetmic.2013.08.023; Ullah A, 2016, TRANSBOUND EMERG DIS; Valarcher JF, 2009, EMERG INFECT DIS, V15, P1046, DOI 10.3201/eid1507.081621; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]	61	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0190977	10.1371/journal.pone.0190977	http://dx.doi.org/10.1371/journal.pone.0190977			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390015	Green Published, gold, Green Submitted			2022-12-26	WOS:000423793400011
J	Dickel, F; Munch, D; Amdam, GV; Mappes, J; Freitak, D				Dickel, Franziska; Munch, Daniel; Amdam, Gro Vang; Mappes, Johanna; Freitak, Dalial			Increased survival of honeybees in the laboratory after simultaneous exposure to low doses of pesticides and bacteria	PLOS ONE			English	Article							APIS-MELLIFERA L; NEONICOTINOID INSECTICIDES; DROSOPHILA-MELANOGASTER; LEARNING PERFORMANCES; CALORIC RESTRICTION; FORAGING BEHAVIOR; BEES; HORMESIS; STRESS; DELTAMETHRIN	Recent studies of honeybees and bumblebees have examined combinatory effects of different stressors, as insect pollinators are naturally exposed to multiple stressors. At the same time the potential influences of simultaneously occurring agricultural agents on insect pollinator health remain largely unknown. Due to different farming methods, and the drift of applied agents and manure, pollinators are most probably exposed to insecticides but also bacteria from organic fertilizers at the same time. We orally exposed honeybee workers to sub-lethal doses of the insecticide thiacloprid and two strains of the bacterium Enterococcus faecalis, which can occur in manure from farming animals. Our results show that under laboratory conditions the bees simultaneously exposed to the a bacterium and the pesticide thiacloprid thiacloprid had significant higher survival rates 11 days post exposure than the controls, which surprisingly showed the lowest survival. Bees that were exposed to diet containing thiacloprid showed decreased food intake. General antibacterial activity is increased by the insecticide and the bacteria, resulting in a higher immune response observed in treated individuals compared to control individuals. We thus propose that caloric restriction through behavioural and physiological adaptations may have mediated an improved survival and stress resistance in our tests. However, the decreased food consumption could in long-term also result in possible negative effects at colony level. Our study does not show an additive negative impact of sub-lethal insecticide and bacteria doses, when tested under laboratory conditions. In contrast, we report seemingly beneficial effects of simultaneous exposure of bees to agricultural agents, which might demonstrate a surprising biological capacity for coping with stressors, possibly through hormetic regulation.	[Dickel, Franziska; Mappes, Johanna] Univ Jyvaskyla, Ctr Excellence Biol Interact, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Munch, Daniel; Amdam, Gro Vang] Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway; [Amdam, Gro Vang] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Freitak, Dalial] Univ Helsinki, Ctr Excellence Biol Interact, Dept Biosci, Helsinki, Finland	University of Jyvaskyla; Norwegian University of Life Sciences; Arizona State University; Arizona State University-Tempe; University of Helsinki	Dickel, F (corresponding author), Univ Jyvaskyla, Ctr Excellence Biol Interact, Dept Biol & Environm Sci, Jyvaskyla, Finland.	franziska.dickel@jyu.fi	Mappes, Johanna/AAZ-3627-2021		Suomen Kulttuurirahasto; Research Council of Norway [213976]; Centre of Excellence in Biological Interactions [SA-252411]	Suomen Kulttuurirahasto(Finnish Cultural Foundation); Research Council of Norway(Research Council of Norway); Centre of Excellence in Biological Interactions	This work was supported by Suomen Kulttuurirahasto, https://skr.fi/en, F. Dickel; Research Council of Norway, http://www.forskningsradet.no, #213976, G.V. Amdam; Centre of Excellence in Biological Interactions, http://www.aka.fi/en/research-and-science-policy/centres-of-excellence/, project number SA-252411, J. Mappes, F. Dickel, D. Freitak. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Shaara HF, 2014, VET MED-CZECH, V59, P1, DOI 10.17221/7240-VETMED; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Alavanja Michael C. R., 2009, Reviews on Environmental Health, V24, P303; Ardia DR, 2012, FUNCT ECOL, V26, P732, DOI 10.1111/j.1365-2435.2012.01989.x; Aufauvre J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00326; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Belzunces LP, 2012, APIDOLOGIE, V43, P348, DOI 10.1007/s13592-012-0134-0; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; Bose R., 2014, TARGETED DELIVERY PE, DOI [10.1007/978-81-322-1689-6, DOI 10.1007/978-81-322-1689-6]; BotIas C, 2016, SCI TOTAL ENV; Botias C., 2015, ENV SCI TECHNOL; Audisio MC, 2011, MICROBIOL RES, V166, P1, DOI 10.1016/j.micres.2010.01.003; Christe P, 2003, ECOL LETT, V6, P19, DOI 10.1046/j.1461-0248.2003.00395.x; Connolly Christopher N, 2013, Commun Integr Biol, V6, pe25074, DOI 10.4161/cib.25074; Coors A, 2008, J APPL ECOL, V45, P1820, DOI 10.1111/j.1365-2664.2008.01566.x; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Cutler GC, 2015, PEST MANAG SCI, V71, P1368, DOI 10.1002/ps.4042; Cutler GC, 2013, DOSE-RESPONSE, V11, P154, DOI 10.2203/dose-response.12-008.Cutler; Damalas CA, 2011, INT J ENV RES PUB HE, V8, P1402, DOI 10.3390/ijerph8051402; David A, 2016, ENVIRON INT, V88, P169, DOI 10.1016/j.envint.2015.12.011; de Franca S. M., 2017, BIOL CONTROL PEST VE; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Dei A, 2015, HOMEOPATHY, V104, P116, DOI 10.1016/j.homp.2015.02.008; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Doublet V, 2014, ENV MICROBIOL; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; EFSA, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4419; European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3295; Fairbrother A, 2014, ENVIRON TOXICOL CHEM, V33, P719, DOI 10.1002/etc.2527; Fauser-Misslin A, 2014, J APPL ECOL, V51, P450, DOI 10.1111/1365-2664.12188; Freitak D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-56; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gaspar F, 2009, MICROBIOL-SGM, V155, P3564, DOI 10.1099/mic.0.030775-0; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Godfray HCJ, 2015, P R SOC B; Goulson D, 2015, SCIENCEXPRESS; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; Hatjina F, 2013, APIDOLOGIE, V44, P467, DOI 10.1007/s13592-013-0199-4; Henry M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2110; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hole DG, 2005, BIOL CONSERVATION; Hroncova Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118707; Huang SK, 2014, J ECON ENTOMOL, V107, P54, DOI 10.1603/EC13213; Jones A, 2014, PEST MANAG SCI; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; King AM, 2015, ANNU REV ENTOMOL, V60, P59, DOI 10.1146/annurev-ento-011613-162107; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Krautz R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00342; La Rosa SL, 2015, INFECT IMMUN, V83, P2156, DOI 10.1128/IAI.02801-14; Le Bourg E, 2011, EXP GERONTOL, V46, P345, DOI 10.1016/j.exger.2010.08.003; Lebreton F., 2014, ENTEROCOCCI COMMENSA; Lundin O, 2015, PLOS ONE, P10; Lundin O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136928; Maglioni S, 2014, EXP GERONTOL, V56, P89, DOI 10.1016/j.exger.2014.03.026; MARTIN JD, 1972, APPL MICROBIOL, V24, P575, DOI 10.1128/AEM.24.4.575-580.1972; Mason KL, 2011, MBIO, V2, DOI 10.1128/mBio.00065-11; Masoro Edward J., 2007, V35, P1; Mattson MP, 2008, AGEING RES REV, V7, P43, DOI 10.1016/j.arr.2007.08.004; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Mikonranta L, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-23; Moret Y, 2001, NATURE; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Ollerton J, 2014, SCIENCE, V346, P1360, DOI 10.1126/science.1257259; Park SY, 2007, INFECT IMMUN, V75, P1861, DOI 10.1128/IAI.01473-06; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Pimentel D, 2005, BIOSCIENCE, V55, P573, DOI 10.1641/0006-3568(2005)055[0573:EEAECO]2.0.CO;2; Pohorecka K, 2012, J APIC SCI, V56, P115, DOI 10.2478/v10289-012-0029-3; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Rolff J., 2009, INSECT INFECT IMMUNI; Rose T, 2016, POLICY ANLAYSIS PAPE; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schreinemachers P, 2012, FOOD POLICY; Schubert, 2011, PFLANZENERNAHRUNG GR; Seufert V, 2012, NATURE, V485, P229, DOI 10.1038/nature11069; Shen Y, 2014, J INSECT PHYSL; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Simon-Delso N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03467-5; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Siva-Jothy MT, 2002, PHYSIOL ENTOMOL, V27, P206, DOI 10.1046/j.1365-3032.2002.00286.x; Sming MA, 2006, AGR SCI CHINA; Soupir ML, 2006, WATER AIR SOIL POLL, V169, P125, DOI 10.1007/s11270-006-1808-x; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Tan K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102725; Tosi S, 2018, SCI TOTAL ENV; Tosi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01361-8; Tosi S, 2016, J INSECT PHYSIOL, V93-94, P56, DOI 10.1016/j.jinsphys.2016.08.010; Turturro A, 2000, HUM EXP TOXICOL, V19, P320, DOI 10.1191/096032700678815981; Vahjen W, 2017, BENEF MICROBES, V8, P779, DOI 10.3920/BM2017.0040; VANDAME R, 1995, ENVIRON TOXICOL CHEM, V14, P855, DOI 10.1002/etc.5620140517; Vandame R, 1998, NEUROSCI LETT; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Vilmos P, 1998, IMMUNOL LETT, V62, P59, DOI 10.1016/S0165-2478(98)00023-6; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Wu JY, 2012, J INVERTEBR PATHOL, V109, P326, DOI 10.1016/j.jip.2012.01.005; Wu SC, 2012, CELL HOST MICROBE, V11, P410, DOI 10.1016/j.chom.2012.03.004; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547	106	20	20	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191256	10.1371/journal.pone.0191256	http://dx.doi.org/10.1371/journal.pone.0191256			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385177	Green Published, gold, Green Submitted			2022-12-26	WOS:000423668400041
J	Gao, ZL; Wang, YH				Gao, Zilin; Wang, Yinhe			The structural balance analysis of complex dynamical networks based on nodes' dynamical couplings	PLOS ONE			English	Article							HEIDER BALANCE; DECENTRALIZED CONTROL; SOCIAL NETWORKS; SYNCHRONIZATION; MODEL; OSCILLATIONS; DELAYS	The nodes and their connection relationships are the two main bodies for dynamic complex networks. In existing theoretical researches, the phenomena of stabilization and synchronization for complex dynamical networks are generally regarded as the dynamic characteristic behaviors of the nodes, which are mainly caused by coupling effect of connection relationships between nodes. However, the connection relationships between nodes are also one main body of a time-varying dynamic complex network, and thus they may evolve with time and maybe show certain characteristic phenomena. For example, the structural balance in the social networks and the synaptic facilitation in the biological neural networks. Therefore, it is important to investigate theoretically the reasons in dynamics for the occurrence. Especially, from the angle of large-scale systems, how the dynamic behaviors of nodes (such as the individuals, neurons) contribute to the connection relationships is one of worthy research directions. In this paper, according to the structural balance theory of triad proposed by F. Heider, we mainly focus on the connection relationships body, which is regarded as one of the two subsystems (another is the nodes body), and try to find the dynamic mechanism of the structural balance with the internal state behaviors of the nodes. By using the Riccati linear matrix differential equation as the dynamic model of connection relationships subsystem, it is proved under some mathematic conditions that the connection relationships subsystem is asymptotical structural balance via the effects of the coupling roles with the internal state of nodes. Finally, the simulation example is given to show the validity of the method in this paper.	[Gao, Zilin; Wang, Yinhe] Guangdong Univ Technol, Sch Automat, Guangzhou, Guangdong, Peoples R China; [Gao, Zilin] Chongqing Three Gorges Univ, Sch Comp Sci & Engn, Chongqing, Peoples R China	Guangdong University of Technology; Chongqing Three Gorges University	Gao, ZL (corresponding author), Guangdong Univ Technol, Sch Automat, Guangzhou, Guangdong, Peoples R China.; Gao, ZL (corresponding author), Chongqing Three Gorges Univ, Sch Comp Sci & Engn, Chongqing, Peoples R China.	gaozilin321@163.com		Gao, Zilin/0000-0001-6214-3312	National Science Foundation of China [61673120, 61273219]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20134420110003]; Scientific and Technological Research Program of Chongqing Municipal Education Commission [KJ1710244, KJ1710257, KJ1601003, KJ1603303, KJ1401029]; National Science Foundation Scientists of China [2015M582616]; Chongqing Basic and Advanced Technology Research Project [cstc2014jcyjA1316]; Youth Scientific Project of Chongqing Three Gorges University [14QN30, 15QN09]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Scientific and Technological Research Program of Chongqing Municipal Education Commission; National Science Foundation Scientists of China; Chongqing Basic and Advanced Technology Research Project; Youth Scientific Project of Chongqing Three Gorges University	This work was supported by the National Science Foundation of China (61673120, 61273219), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20134420110003), the Scientific and Technological Research Program of Chongqing Municipal Education Commission (KJ1710244, KJ1710257, KJ1601003, KJ1603303, KJ1401029), the National Science Foundation Scientists of China (2015M582616), the Chongqing Basic and Advanced Technology Research Project (cstc2014jcyjA1316), and the Youth Scientific Project of Chongqing Three Gorges University (14QN30,15QN09).; This work was supported by the National Science Foundation of China (61673120, 61273219), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20134420110003), the Scientific and Technological Research Program of Chongqing Municipal Education Commission (KJ1710244, KJ1710257, KJ1601003, KJ1603303, KJ1401029), the National Science Foundation Scientists of China (2015M582616), the Chongqing Basic and Advanced Technology Research Project (cstc2014jcyjA1316), and the Youth Scientific Project of Chongqing Three Gorges University(14QN30,15QN09).	Al Zhour Z., 2012, INTELL CONTROL AUTOM, V3, P176, DOI DOI 10.4236/ICA.2012.32020; Antal T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036121; Antal T, 2006, PHYSICA D, V224, P130, DOI 10.1016/j.physd.2006.09.028; Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; BARNETT S, 1973, SIAM J APPL MATH, V24, P1, DOI 10.1137/0124001; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Botts EA, 2013, GLOBAL ECOL BIOGEOGR, V22, P567, DOI 10.1111/geb.12027; CARTWRIGHT D, 1956, PSYCHOL REV, V63, P277, DOI 10.1037/h0046049; Duan ZS, 2008, AUTOMATICA, V44, P1028, DOI 10.1016/j.automatica.2007.08.005; Fan YQ, 2013, APPL MATH COMPUT, V219, P6719, DOI 10.1016/j.amc.2013.01.013; Fort H, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/05/P05005; Gawronski P, 2005, ACTA PHYS POL B, V36, P2549; Gawronski P, 2015, ACTA PHYS POL B, V46, P911, DOI 10.5506/APhysPolB.46.911; Gopalsamy K, 1997, IEEE T NEURAL NETWOR, V8, P341, DOI 10.1109/72.557672; Hassanibesheli F, 2017, PHYSICA A, V468, P334, DOI 10.1016/j.physa.2016.10.091; Heider F, 1946, J PSYCHOL, V21, P107, DOI 10.1080/00223980.1946.9917275; Hu QY, 2012, NONLINEAR DYNAM, V69, P1813, DOI 10.1007/s11071-012-0388-0; Ilany A, 2013, ANIM BEHAV, V85, P1397, DOI 10.1016/j.anbehav.2013.03.032; Krawczyk MJ, 2015, PHYSICA A, V439, P66, DOI 10.1016/j.physa.2015.07.027; Kulakowski K, 2005, INT J MOD PHYS C, V16, P707, DOI 10.1142/S012918310500742X; Kulakowski P., 2005, PHYSICS, V779, P93; Liu C, 2007, PHYSICA A, V386, P531, DOI 10.1016/j.physa.2007.08.006; Lu JH, 2004, PHYSICA A, V334, P281, DOI 10.1016/j.physa.2003.10.052; Marvel SA, 2011, P NATL ACAD SCI USA, V108, P1771, DOI 10.1073/pnas.1013213108; Marvel SA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.198701; Park MJ, 2012, APPL MATH COMPUT, V218, P11634, DOI 10.1016/j.amc.2012.05.046; Pattison P, 2002, SOCIOL METHODOL, V32, P301, DOI 10.1111/1467-9531.00119; SANDELL NR, 1978, IEEE T AUTOMAT CONTR, V23, P108, DOI 10.1109/TAC.1978.1101704; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Traag VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060063; Traub RD, 2000, EUR J NEUROSCI, V12, P4093, DOI 10.1046/j.1460-9568.2000.00300.x; Wang YH, 2012, IEEE T CIRCUITS-I, V59, P1786, DOI 10.1109/TCSI.2011.2180439; Wen S, 2008, PHYS LETT A, V372, P6340, DOI 10.1016/j.physleta.2008.08.059; Wongkaew S, 2015, EUR PHYS J-SPEC TOP, V224, P3325, DOI 10.1140/epjst/e2015-50087-9; Zhang LL, 2015, APPL MATH COMPUT, V259, P510, DOI 10.1016/j.amc.2014.12.034; Zhao J, 2012, IEEE T AUTOMAT CONTR, V57, P2656, DOI 10.1109/TAC.2012.2190206; Zhou J, 2006, IEEE T AUTOMAT CONTR, V51, P652, DOI 10.1109/TAC.2006.872760	37	23	23	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191941	10.1371/journal.pone.0191941	http://dx.doi.org/10.1371/journal.pone.0191941			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385183	Green Published, gold, Green Submitted			2022-12-26	WOS:000423668400064
J	Hamad, I; Abou Abdallah, R; Ravaux, I; Mokhtari, S; Tissot-Dupont, H; Michelle, C; Stein, A; Lagier, JC; Raoult, D; Bittar, F				Hamad, Ibrahim; Abou Abdallah, Rita; Ravaux, Isabelle; Mokhtari, Saadia; Tissot-Dupont, Herve; Michelle, Caroline; Stein, Andreas; Lagier, Jean-Christophe; Raoult, Didier; Bittar, Fadi			Metabarcoding analysis of eukaryotic microbiota in the gut of HIV-infected patients	PLOS ONE			English	Article							HUMAN GASTROINTESTINAL-TRACT; INTESTINAL PARASITES; FUNGAL COMMUNITY; DNA EXTRACTION; DIVERSITY; PCR; MICROSPORIDIOSIS; SENSITIVITY; SAMPLES; REGION	Research on the relationship between changes in the gut microbiota and human disease, including AIDS, is a growing field. However, studies on the eukaryotic component of the intestinal microbiota have just begun and have not yet been conducted in HIV-infected patients. Moreover, eukaryotic community profiling is influenced by the use of different methodologies at each step of culture-independent techniques. Herein, initially, four DNA extraction protocols were compared to test the efficiency of each method in recovering eukaryotic DNA from fecal samples. Our results revealed that recovering eukaryotic components from fecal samples differs significantly among DNA extraction methods. Subsequently, the composition of the intestinal eukaryotic microbiota was evaluated in HIV-infected patients and healthy volunteers through clone sequencing, high-throughput sequencing of nuclear ribosomal internal transcribed spacers 1 (ITS1) and 2 (ITS2) amplicons and real-time PCRs. Our results revealed that not only richness (Chao-1 index) and alpha diversity (Shannon diversity) differ between HIV-infected patients and healthy volunteers, depending on the molecular strategy used, but also the global eukaryotic community composition, with little overlapping taxa found between techniques. Moreover, our results based on cloning libraries and ITS1/ITS2 metabarcoding sequencing showed significant differences in fungal composition between HIV-infected patients and healthy volunteers, but without distinct clusters separating the two groups. Malassezia restricta was significantly more prevalent in fecal samples of HIV-infected patients, according to cloning libraries, whereas operational taxonomic units (OTUs) belonging to Candida albicans and Candida tropicalis were significantly more abundant in fecal samples of HIV-infected patients compared to healthy subjects in both ITS subregions. Finally, real-time PCR showed the presence of Microsporidia, Giardia lamblia, Blastocystis and Hymenolepis diminuta in different proportions in fecal samples from HIV patients as compared to healthy individuals. Our work revealed that the use of different sequencing approaches can impact the perceived eukaryotic diversity results of the human gut. We also provide a more comprehensive view of the eukaryotic community in the gut of HIV-infected patients through the complementarity of the different molecular techniques used. Combining these various methodologies may provide a gold standard for a more complete characterization of the eukaryotic microbiome in future studies.	[Hamad, Ibrahim; Abou Abdallah, Rita; Tissot-Dupont, Herve; Michelle, Caroline; Lagier, Jean-Christophe; Raoult, Didier; Bittar, Fadi] Aix Marseille Univ, IHU Mediterranee Infect, AP HM, CNRS 7278,IRD 198,Inserm 1095,URMITE, Marseille, France; [Hamad, Ibrahim] Charmo Univ, Charmo Res Ctr, Chamchamal Sulaimani, Iraq; [Ravaux, Isabelle; Stein, Andreas] CHU Concept, Serv Malad Infect & Trop, IHU Mediterranee Infect, Marseille, France; [Mokhtari, Saadia] CHU Nord, AP HM, Pole Infect, IHU Mediterranee Infect, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Bittar, F (corresponding author), Aix Marseille Univ, IHU Mediterranee Infect, AP HM, CNRS 7278,IRD 198,Inserm 1095,URMITE, Marseille, France.	fadi.bittar@univ-amu.fr	Bittar, Fadi/F-2037-2018; RAOULT, Didier/A-8434-2008; Lagier, Jean-Christophe/AAY-3837-2021	Bittar, Fadi/0000-0003-4052-344X; RAOULT, Didier/0000-0002-0633-5974; Lagier, Jean-Christophe/0000-0003-0771-8245; Michelle, Caroline/0000-0002-9235-074X				Adamska M, 2010, PARASITE, V17, P299, DOI 10.1051/parasite/2010174299; Agholi M, 2013, AIDS RES HUM RETROV, V29, P35, DOI [10.1089/aid.2012.0119, 10.1089/AID.2012.0119]; Ampel NM, 1996, EMERG INFECT DIS, V2, P109, DOI 10.3201/eid0202.960205; Angelakis E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26276; Balint M, 2014, ECOL EVOL, V4, P2642, DOI 10.1002/ece3.1107; BARBER GR, 1993, AM J MED, V95, P365, DOI 10.1016/0002-9343(93)90304-8; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Bengtsson-Palme J, 2013, METHODS ECOL EVOL, V4, P914, DOI 10.1111/2041-210X.12073; Chen Y., 2010, DIAGN MICROBIOL INFE, V70, P492; Cui LJ, 2013, GENOME MED, V5, DOI 10.1186/gm467; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; de Repentigny L, 2004, CLIN MICROBIOL REV, V17, P729, DOI 10.1128/CMR.17.4.729-759.2004; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Escobar-Zepeda A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00348; Esebelahie NO, 2013, LIBYAN J MED, V8, DOI 10.3402/ljm.v8i0.20322; Frykman PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124172; Girma M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-100; Gouba N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106994; Gouba Nina, 2014, BMC Res Notes, V7, P33, DOI 10.1186/1756-0500-7-33; Gouba N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059474; Hallen-Adams HE, 2015, FUNGAL ECOL, V15, P9, DOI 10.1016/j.funeco.2015.01.006; Hamad I, 2016, PARASITE IMMUNOL, V38, P12, DOI 10.1111/pim.12284; HAMAD I, 2014, SCI REP UK, V4; Hamad I, 2014, SCI REP-UK, V4, DOI 10.1038/srep04478; Hamad I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040888; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hoarau G, 2016, MBIO, V7, DOI [10.1128/mBio.01250-16, 10.1128/mbio.01250-16]; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019; Huang L, 2009, RESPIROLOGY, V14, P474, DOI 10.1111/j.1440-1843.2009.01534.x; Hugerth LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095567; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jagielski T, 2014, BMC DERMATOL, V14, DOI 10.1186/1471-5945-14-3; Kumar S S, 2002, Indian J Med Microbiol, V20, P88; LaTuga MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027858; Lehman LG, 2013, J INFECT DEV COUNTR, V7, P137, DOI 10.3855/jidc.2757; Li QR, 2012, HUM PATHOL, V43, P1273, DOI 10.1016/j.humpath.2011.09.017; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Luan CG, 2015, SCI REP-UK, V5, DOI 10.1038/srep07980; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Mathur MK, 2013, J GLOB INFECT DIS, V5, P164, DOI 10.4103/0974-777X.122012; Monard C, 2013, FEMS MICROBIOL ECOL, V84, P165, DOI 10.1111/1574-6941.12046; Moran P, 2005, EXP PARASITOL, V110, P331, DOI 10.1016/j.exppara.2005.03.023; Murphy SC, 2011, J MOL DIAGN, V13, P359, DOI 10.1016/j.jmoldx.2011.01.007; Nam YD, 2008, J MICROBIOL, V46, P491, DOI 10.1007/s12275-008-0199-7; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; Nowrousian M, 2010, EUKARYOT CELL, V9, P1300, DOI 10.1128/EC.00123-10; OBERLE AD, 1981, AM J CLIN PATHOL, V76, P112; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; Ott SJ, 2008, SCAND J GASTROENTERO, V43, P831, DOI 10.1080/00365520801935434; Paulos S, 2016, J MICROBIOL METH, V127, P68, DOI 10.1016/j.mimet.2016.05.020; Porter TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035749; Raccurt CP, 2008, AM J TROP MED HYG, V79, P579, DOI 10.4269/ajtmh.2008.79.579; Roka M, 2012, SCI TOTAL ENVIRON, V432, P404, DOI 10.1016/j.scitotenv.2012.06.023; Samie A, 2007, T ROY SOC TROP MED H, V101, P547, DOI 10.1016/j.trstmh.2007.02.005; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Suhr MJ, 2015, MYCOLOGIA, V107, P1057, DOI 10.3852/15-147; Tian LG, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-36; Tonge DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093849; Tragiannidis A, 2010, MYCOSES, V53, P187, DOI 10.1111/j.1439-0507.2009.01814.x; Villar Cristina Cunha, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000835; World Health Organization, 2015, HIV AIDS; Wumba R, 2010, PARASITE, V17, P321, DOI 10.1051/parasite/2010174321; Wumba R, 2012, INT J GEN MED, V5, P603, DOI 10.2147/IJGM.S32344; Yongabi KA, 2009, AFR J MICROBIOL RES, V3, P133	67	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191913	10.1371/journal.pone.0191913	http://dx.doi.org/10.1371/journal.pone.0191913			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385188	gold, Green Published, Green Submitted			2022-12-26	WOS:000423668400062
J	Deckmann, K; Rafiq, A; Erdmann, C; Illig, C; Durschnabel, M; Wess, J; Weidner, W; Bschleipfer, T; Kummer, W				Deckmann, Klaus; Rafiq, Amir; Erdmann, Christian; Illig, Christian; Durschnabel, Melanie; Wess, Juergen; Weidner, Wolfgang; Bschleipfer, Thomas; Kummer, Wolfgang			Muscarinic receptors 2 and 5 regulate bitter response of urethral brush cells via negative feedback	FASEB JOURNAL			English	Article						chemosensory cells; cholinergic; cystometry; overactive bladder syndrome	KNOCKOUT MICE; ACETYLCHOLINE-RECEPTOR; URINARY-BLADDER; OVERACTIVE BLADDER; SPINAL-CORD; GUINEA-PIG; RELEASE; SUBTYPES; RAT; LACKING	We have recently identified a cholinergic chemosensory cell in the urethral epithelium, urethral brush cell (UBC), that, upon stimulation with bitter or bacterial substances, initiates a reflex detrusor activation. Here, we elucidated cholinergic mechanisms that modulate UBC responsiveness. We analyzed muscarinic acetylcholine receptor (M1-5 mAChR) expression by using RT-PCR in UBCs, recorded [Ca2+](i) responses to a bitter stimulus in isolated UBCs of wild-type and mAChR-deficient mice, and performed cystometry in all involved strains. The bitter response of UBCs was enhanced by global cholinergic and selective M2 inhibition, diminished by positive allosteric modulation of M5, and unaffected by Ml, M3, and M4 mAChR inhibitors. This effect was not observed in M2 and M5 mAChR-deficient mice. In cystometry, M5 mAChR-deficient mice demonstrated signs of detrusor overactivity. In conclusion, M2 and M5 mAChRs attenuate the bitter response of UBC via a cholinergic negative autocrine feedback mechanism. Cystometry suggests that dysfunction, particularly of the M5 receptor, may lead to such symptoms as bladder overactivity.	[Deckmann, Klaus; Rafiq, Amir; Kummer, Wolfgang] Justus Liebig Univ Giessen, Inst Anat & Cell Biol, Aulweg 123, D-35385 Giessen, Germany; [Erdmann, Christian; Illig, Christian; Durschnabel, Melanie; Weidner, Wolfgang] Justus Liebig Univ Giessen, Dept Urol Pediat Urol & Androl, Giessen, Germany; [Wess, Juergen] NIDDK, Mol Signaling Sect, Lab Bioorgan Chem, Bethesda, MD USA; [Bschleipfer, Thomas] Nordoberpfalz AG, Weiden Hosp Clin, Clin Urol Androl & Pediat Urol, Weiden, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Deckmann, K (corresponding author), Justus Liebig Univ Giessen, Inst Anat & Cell Biol, Aulweg 123, D-35385 Giessen, Germany.	klaus.deckmann@anatomie.med.uni-giessen.de		Kummer, Wolfgang/0000-0002-3946-0683	Hessian State Offensive for the Development of Scientific and Economic Excellence (LOEWE) (Non-neuronal Cholinergic Systems, Project A5; University Hospital of Giessen and Marburg (UKGM)-Justus-Liebig-University (JLU)-Cooperation Grant [7/2016]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075020] Funding Source: NIH RePORTER	Hessian State Offensive for the Development of Scientific and Economic Excellence (LOEWE) (Non-neuronal Cholinergic Systems, Project A5; University Hospital of Giessen and Marburg (UKGM)-Justus-Liebig-University (JLU)-Cooperation Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank M. Bodenbenner and K. Michael (Institute for Anatomy and Cell Biology, Justus-Liebig-University Giessen) for skillful technical assistance. This work was supported by the Hessian State Offensive for the Development of Scientific and Economic Excellence (LOEWE) (Non-neuronal Cholinergic Systems, Project A5; to W.K. and T.B.) and a University Hospital of Giessen and Marburg (UKGM)-Justus-Liebig-University (JLU)-Cooperation Grant (7/2016 GI to K.D.). The authors declare no conflicts of interest.	Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Andersson KE, 2011, NEUROUROL URODYNAM, V30, P636, DOI 10.1002/nau.21108; BOGNAR IT, 1990, N-S ARCH PHARMACOL, V341, P279; Bschleipfer T, 2015, J UROLOGY, V193, P345, DOI 10.1016/j.juro.2014.08.098; Bschleipfer T, 2012, LIFE SCI, V91, P1082, DOI 10.1016/j.lfs.2012.04.007; Chen SR, 2014, J BIOL CHEM, V289, P14321, DOI 10.1074/jbc.M114.550384; Chen SR, 2010, J BIOL CHEM, V285, P40427, DOI 10.1074/jbc.M110.176966; Chess-Williams R., 2002, Autonomic & Autacoid Pharmacology, V22, P133, DOI 10.1046/j.1474-8673.2002.00258.x; Daly DM, 2010, EUR UROL, V58, P22, DOI 10.1016/j.eururo.2009.12.030; Dando R, 2012, J PHYSIOL-LONDON, V590, P3009, DOI 10.1113/jphysiol.2012.232009; Deckmann K, 2015, INT IMMUNOPHARMACOL, V29, P51, DOI 10.1016/j.intimp.2015.05.038; Deckmann K, 2014, P NATL ACAD SCI USA, V111, P8287, DOI 10.1073/pnas.1402436111; Ehlert FJ, 2005, J PHARMACOL EXP THER, V313, P368, DOI 10.1124/jpet.104.077909; Fisahn A, 2002, NEURON, V33, P615, DOI 10.1016/S0896-6273(02)00587-1; Foster DJ, 2014, J NEUROSCI, V34, P3253, DOI 10.1523/JNEUROSCI.4896-13.2014; FRYER AD, 1984, BRIT J PHARMACOL, V83, P973, DOI 10.1111/j.1476-5381.1984.tb16539.x; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P1692, DOI 10.1073/pnas.96.4.1692; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P10483, DOI 10.1073/pnas.96.18.10483; Groen J, 2016, EUR UROL, V69, P324, DOI 10.1016/j.eururo.2015.07.071; Igawa Y, 2004, J UROLOGY, V172, P2460, DOI 10.1097/01.ju.0000138054.77785.4a; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Ito Y, 2009, BRIT J PHARMACOL, V156, P1147, DOI 10.1111/j.1476-5381.2009.00113.x; KILBINGER H, 1991, BRIT J PHARMACOL, V103, P1757, DOI 10.1111/j.1476-5381.1991.tb09859.x; Kummer W, 2017, CURR OPIN UROL, V27, P85, DOI 10.1097/MOU.0000000000000361; Matsui M, 2002, J NEUROSCI, V22, P10627; Milsom I, 2001, BJU INT, V87, P760, DOI 10.1046/j.1464-410x.2001.02228.x; Mohr F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141136; Mori Y, 2016, PFLUG ARCH EUR J PHY, V468, P2053, DOI 10.1007/s00424-016-1879-5; Nandigama R, 2010, NEUROSCIENCE, V168, P842, DOI 10.1016/j.neuroscience.2010.04.012; Oliveira L, 2002, EUR J NEUROSCI, V15, P1728, DOI 10.1046/j.1460-9568.2002.02020.x; Sculptoreanu A, 2001, NEUROCHEM RES, V26, P933, DOI 10.1023/A:1012332500946; Struckmann N, 2003, MOL PHARMACOL, V64, P1444, DOI 10.1124/mol.64.6.1444; Takeuchi T, 2008, NEUROSCIENCE, V156, P381, DOI 10.1016/j.neuroscience.2008.07.056; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; WESSLER I, 1990, N-S ARCH PHARMACOL, V341, P510; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604; Yamada M, 2001, P NATL ACAD SCI USA, V98, P14096, DOI 10.1073/pnas.251542998; Zhou H, 2002, N-S ARCH PHARMACOL, V365, P112, DOI 10.1007/s00210-001-0517-7	38	5	5	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					2903	2910		10.1096/fj.201700582R	http://dx.doi.org/10.1096/fj.201700582R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401598	Green Published			2022-12-26	WOS:000432546000002
J	Jackson, KC; Tarpey, MD; Valencia, AP; Inigo, MR; Pratt, SJ; Patteson, DJ; McClung, JM; Lovering, RM; Thomson, DM; Spangenburg, EE				Jackson, Kathryn C.; Tarpey, Michael D.; Valencia, Ana P.; Inigo, Melissa R.; Pratt, Stephen J.; Patteson, Daniel J.; McClung, Joseph M.; Lovering, Richard M.; Thomson, David M.; Spangenburg, Espen E.			Induced Cre-mediated knockdown of Brca1 in skeletal muscle reduces mitochondrial respiration and prevents glucose intolerance in adult mice on a high-fat diet	FASEB JOURNAL			English	Article						metabolism; disease; breast; cancer	CELLS	The breast cancer type 1 susceptibility protein (Brca1) is a regulator of DNA repair in mammary gland cells; however, recent cell culture evidence suggests that Brca1 influences other processes, including those in nonmammary cells. In this study, we sought to determine whether Brca1 is necessary for metabolic regulation of skeletal muscle using a . novel in vivo mouse model. We developed an inducible skeletal muscle-specific Brca1-knockout (BRCA1KO(smi)) model to test whether Brca1 expression is necessary for maintenance of metabolic function of skeletal muscle when exposed to a high-fat diet (HFD). Our data demonstrated that deletion of Brca1 prevented HFD-induced alterations in glucose and insulin tolerance. Irrespective of diet, BRCA1KO(smi) mice exhibited significantly lower ADP-stimulated complex I mitochondrial respiration rates compared to age-matched wild-type (WT) mice. The data show that Brca1 has the ability to localize to the mitochondria in skeletal muscle and that BRCA1KO(smi) mice exhibit higher whole-body CO2 production, respiratory exchange ratio, and energy expenditure, compared with the WT mice. Our results demonstrate that loss of Brca1 in skeletal muscle leads to dysregulated metabolic function, characterized by decreased mitochondrial respiration. Thus, any condition that results in loss of Brca1 function could induce metabolic imbalance in skeletal muscle.				spangenburge14@ecu.edu		Inigo, Melissa Mae/0000-0003-0298-6611; , Stephen/0000-0003-3627-7258	U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases [R21AR059913, RO1AR066660, R01AR059179, R21AR067872]; NIH National Heart, Lung, and Blood Institute [RO1HL125695]; NIH National Institute on Aging [T32 AG000268]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR067872, R01AR066660, R01AR059179, R21AR059913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000268] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Tom Greene (East Carolina University, Greenville, NC, USA) for technical assistance; BRCA1 plasmids were kind gift of Dr. B. Henderson (Westmead Institute for Cancer Research, Sydney, NSW Australia), and Dr. John McCarthy (University of Kentucky, Lexington, KY, USA) for numerous helpful discussions concerning animal breeding. This work was funded U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants R21AR059913, RO1AR066660, R01AR059179, and R21AR067872 (to R.M.L.); NIH National Heart, Lung, and Blood Institute Grant RO1HL125695 (to J.M.M.); and NIH National Institute on Aging Grant T32 AG000268 (to K.C.J. and A.P.V.). The authors declare no conflicts of interest.	Coene ED, 2005, MOL BIOL CELL, V16, P997, DOI 10.1091/mbc.E04-10-0895; DiFranco Marino, 2009, J Vis Exp, DOI 10.3791/1520; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Garcia-Cazarin M. L., 2011, JOVE-J VIS EXP, V49; Gilliam LAA, 2012, J PHARMACOL EXP THER, V342, P631, DOI 10.1124/jpet.112.192146; Henderson BR, 2005, BIOESSAYS, V27, P884, DOI 10.1002/bies.20277; Jackson KC, 2014, J LIPID RES, V55, P668, DOI 10.1194/jlr.M043851; Lovren F, 2014, J THORAC CARDIOV SUR, V147, P1946, DOI 10.1016/j.jtcvs.2013.09.060; Maniccia AW, 2009, J CELL PHYSIOL, V219, P634, DOI 10.1002/jcp.21708; MARQUIS ST, 1995, NAT GENET, V11, P17, DOI 10.1038/ng0995-17; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; Pao GM, 2014, P NATL ACAD SCI USA, V111, pE1240, DOI 10.1073/pnas.1400783111; Privat M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102438; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Singh KK, 2013, J THORAC CARDIOV SUR, V146, P702, DOI 10.1016/j.jtcvs.2012.12.046; Spangenburg EE, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/598358; StoneO MR, 2007, J CELL SCI, V120, P3999, DOI 10.1242/jcs.009241; Suberbielle E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9897; Thompson ME, 2010, FEBS J, V277, P3072, DOI 10.1111/j.1742-4658.2010.07733.x; Wall CE, 2015, P NATL ACAD SCI USA, V112, P8714, DOI 10.1073/pnas.1509930112; White AT, 2015, MOL METAB, V4, P569, DOI 10.1016/j.molmet.2015.05.001; Wohlers LM, 2011, J CELL BIOCHEM, V112, P3675, DOI 10.1002/jcb.23302; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743	23	13	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3070	3084		10.1096/fj.201700464R	http://dx.doi.org/10.1096/fj.201700464R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401626	Green Submitted, Green Published			2022-12-26	WOS:000432546000015
J	Witkowski, A; Chan, GKL; Boatz, JC; Li, NJ; Inoue, AP; Wong, JC; van der Wel, PCA; Cavigiolio, G				Witkowski, Andrzej; Chan, Gary K. L.; Boatz, Jennifer C.; Li, Nancy J.; Inoue, Ayuka P.; Wong, Jaclyn C.; van der Wel, Patrick C. A.; Cavigiolio, Giorgio			Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation	FASEB JOURNAL			English	Article						self-association; protein structure; solid-state NMR; myeloperoxidase; cholesterol efflux	ABCA1-DEPENDENT CHOLESTEROL TRANSPORT; NLRP3 INFLAMMASOME ACTIVATION; HUMAN ATHEROSCLEROTIC LESIONS; HIGH-DENSITY-LIPOPROTEINS; SITE-SPECIFIC OXIDATION; ANGLE-SPINNING NMR; MASS-SPECTROMETRY; STERILE INFLAMMATION; SELF-ASSOCIATION; FIBRIL FORMATION	-Apolipoprotein A-I (apoA-I) shares with other exchangeable apolipoproteins a high level of structural plasticity. In the lipid-free state, the apolipoprotein amphipathic a-helices interact intra- and intermolecularly, providing structural stabilization by self-association. We have reported that lipid-free apoA-I becomes amyloidogenic upon physiologically relevant (myeloperoxidase-mediated) Met oxidation. In this study, we established that Met oxidation promotes amyloidogenesis by reducing the stability of apoA-I monomers and irreversibly disrupting selfassociation. The oxidized apoA-I monomers also exhibited increased cellular cholesterol release capacity and stronger association with macrophages, compared to nonoxidized apoA-I. Of physiologic relevance, preformed oxidized apoAI amyloid fibrils induced amyloid formation in nonoxidized apoA-I. This process was enhanced when self-association of nonoxidized apoA-I was disrupted by thermal treatment. Solid state NMR analysis revealed that aggregates formed by seeded nonoxidized apoA-I were structurally similar to those formed by the oxidized protein, featuring a beta-structure-rich amyloid fold alongside a-helices retained from the native state. In atherosclerotic lesions, the conditions that promote apoA-I amyloid formation are readily available: myeloperoxidase, active oxygen species, low pH, and high concentration of lipid-free apoA-I. Our results suggest that even partial Met oxidation of apoA-I can nucleate amyloidogenesis, thus sequestering and inactivating otherwise antiatherogenic and HDL-forming apoA-I.	[Witkowski, Andrzej; Chan, Gary K. L.; Li, Nancy J.; Inoue, Ayuka P.; Wong, Jaclyn C.; Cavigiolio, Giorgio] CHORI, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA; [Boatz, Jennifer C.; van der Wel, Patrick C. A.] Univ Pittsburgh, Dept Struct Biol, Pittsburgh, PA USA	Children's Hospital Oakland Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cavigiolio, G (corresponding author), CHORI, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	gcavigiolio@chori.org	van der Wel, Patrick C.A./B-1428-2009	van der Wel, Patrick C.A./0000-0002-5390-3321; Boatz, Jennifer C/0000-0002-8240-5778; Witkowski, Andrzej/0000-0002-0442-4586; Li, Nancy Jingyi/0000-0001-8533-7304; Cavigiolio, Giorgio/0000-0002-1622-0628	U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute Grant [R01HL113059]; NIH National Institute of General Medical Sciences [R01GM112678, T32 GM088119]; Office of the Director of the NIH [1S10OD018070]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088119, R01GM112678] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018070] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute Grant; NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of the Director of the NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dr. Gordon L. Watson [Children's Hospital Oakland Research Institute (CHORI)] for contributing the wild-type mice for bone marrow extraction and Dorothy Tabron (CHORI) for taking care of the animals and extracting the bone marrow. The CD36-KO mice were generously provided by Prof. Andreas Stahl (University of California at Berkeley, Berkeley, CA, USA). The authors are also grateful to Prof. Shinji Yokoyama and Prof. Rui Lu (Nutritional Health Science Research Center, Chubu University, Kasugai, Japan) for assistance in troubleshooting the cellular cholesterol release protocol and to Dr. Trudy M. Forte (CHORI) and Dr. Shobini Jayaraman (Boston University School of Medicine. Boston, MA, USA) for useful discussions. This work was supported in whole or part by U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute Grant R01HL113059 (to G.C)., and NIH National Institute of General Medical Sciences Grants R01GM112678 (to P.C.A.V.D.W.) and T32 GM088119 (to J.C.B.). The Agilent 6490 triple quadrupole mass spectrometer was purchased through Grant 1S10OD018070, from the Office of the Director of the NIH. The article's content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Audet A, 2012, HISTOPATHOLOGY, V61, P610, DOI 10.1111/j.1365-2559.2012.04265.x; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Berisha SZ, 2015, J LIPID RES, V56, P653, DOI 10.1194/jlr.M056754; Boatz JC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15137; Brouillette CG, 2005, BIOCHEMISTRY-US, V44, P16413, DOI 10.1021/bi051018v; Brubaker G, 2006, BBA-MOL CELL BIOL L, V1761, P64, DOI 10.1016/j.bbalip.2006.01.007; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Chan GKL, 2015, J BIOL CHEM, V290, P10958, DOI 10.1074/jbc.M114.630442; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; COHEN JS, 1979, J BIOCHEM BIOPH METH, V1, P145, DOI 10.1016/0165-022X(79)90033-2; CORNWELL GG, 1983, AM J MED, V75, P618, DOI 10.1016/0002-9343(83)90443-6; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiDonato JA, 2014, J BIOL CHEM, V289, P10276, DOI 10.1074/jbc.M114.556506; DiDonato JA, 2013, CIRCULATION, V128, P1644, DOI 10.1161/CIRCULATIONAHA.113.002624; Dunstan DE, 2009, PROTEIN ENG DES SEL, V22, P741, DOI 10.1093/protein/gzp059; Ekstrand M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130898; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fritzsching KJ, 2016, J BIOMOL NMR, V64, P115, DOI 10.1007/s10858-016-0013-5; Harris RK, 2008, MAGN RESON CHEM, V46, P582, DOI 10.1002/mrc.2225; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Hewing B, 2014, ARTERIOSCL THROM VAS, V34, P779, DOI 10.1161/ATVBAHA.113.303044; Hoofnagle AN, 2012, CLIN CHEM, V58, P777, DOI 10.1373/clinchem.2011.173856; Hoop CL, 2014, BIOCHEMISTRY-US, V53, P6653, DOI 10.1021/bi501010q; HOROWITZ BS, 1993, J CLIN INVEST, V91, P1743, DOI 10.1172/JCI116384; Howlett GJ, 2006, CURR OPIN LIPIDOL, V17, P541, DOI 10.1097/01.mol.0000245260.63505.4f; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Jahangiri A, 2005, J LIPID RES, V46, P896, DOI 10.1194/jlr.M400212-JLR200; Jayaraman S, 2011, J BIOL CHEM, V286, P35610, DOI 10.1074/jbc.M111.262485; Kee P, 2002, ARTERIOSCL THROM VAS, V22, P1912, DOI 10.1161/01.ATV.0000038485.94020.7F; Kerschen P, 2016, CURR TREAT OPTION NE, V18, DOI 10.1007/s11940-016-0436-z; King VL, 2011, CURR OPIN LIPIDOL, V22, P302, DOI 10.1097/MOL.0b013e3283488c39; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kristen AV, 2010, CARDIOVASC PATHOL, V19, P228, DOI 10.1016/j.carpath.2009.04.005; Larsson A, 2011, AMYLOID, V18, P229, DOI 10.3109/13506129.2011.630761; Lau D, 2006, PHARMACOL THERAPEUT, V111, P16, DOI 10.1016/j.pharmthera.2005.06.023; Lee CC, 2007, BIOPHYS J, V92, P3448, DOI 10.1529/biophysj.106.098608; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Li J, 2011, J BIOL CHEM, V286, P28988, DOI 10.1074/jbc.M111.261750; Lin HK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15462; Liu WW, 2014, INFLAMM RES, V63, P33, DOI 10.1007/s00011-013-0667-3; Loavenbruck AJ, 2012, MUSCLE NERVE, V46, P817, DOI 10.1002/mus.23415; MacLean B, 2010, ANAL CHEM, V82, P10116, DOI 10.1021/ac102179j; Mandal A, 2017, J BIOMOL NMR, V67, P165, DOI 10.1007/s10858-017-0089-6; Mandal A, 2015, BIOPHYS J, V109, P1873, DOI 10.1016/j.bpj.2015.09.016; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Medeiros LA, 2004, J BIOL CHEM, V279, P10643, DOI 10.1074/jbc.M311735200; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Melchior JT, 2017, NAT STRUCT MOL BIOL, V24, P1093, DOI 10.1038/nsmb.3501; MUCCHIANO G, 1992, AM J PATHOL, V140, P871; Mucchiano GI, 2001, J PATHOL, V193, P270, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S; Mucchiano GI, 2001, AM J CLIN PATHOL, V115, P298; Murphy C, 2011, AMYLOID, V18, P219, DOI 10.3109/13506129.2011.574354082; Nagata KO, 2013, P NATL ACAD SCI USA, V110, P5034, DOI 10.1073/pnas.1220703110; Nanjee MN, 1996, ARTERIOSCL THROM VAS, V16, P1203, DOI 10.1161/01.ATV.16.9.1203; Nanjee MN, 2000, CLIN CHEM, V46, P207; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Oorni K, 2015, J LIPID RES, V56, P203, DOI 10.1194/jlr.R050252; Panzenbock U, 2000, J BIOL CHEM, V275, P19536, DOI 10.1074/jbc.M000458200; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Rios FJ, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/198193; Rios FJO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036632; Rocken C, 2006, ARTERIOSCL THROM VAS, V26, P676, DOI 10.1161/01.ATV.0000201930.10103.be; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Roijers RB, 2011, AM J PATHOL, V178, P2879, DOI 10.1016/j.ajpath.2011.02.004; Ruberg FL, 2012, CIRCULATION, V126, P1286, DOI 10.1161/CIRCULATIONAHA.111.078915; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; Sankaranarayanan S, 2011, J LIPID RES, V52, P2332, DOI 10.1194/jlr.D018051; Sasahara K, 2008, BIOCHEMISTRY-US, V47, P2650, DOI 10.1021/bi701968g; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2008, METHOD ENZYMOL, V440, P33, DOI 10.1016/S0076-6879(07)00803-8; Shao BH, 2014, CIRC RES, V114, P1733, DOI 10.1161/CIRCRESAHA.114.303454; Shao BH, 2012, J BIOL CHEM, V287, P6375, DOI 10.1074/jbc.M111.337345; Shao BH, 2012, BBA-MOL CELL BIOL L, V1821, P490, DOI 10.1016/j.bbalip.2011.11.011; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Shen Y, 2010, J BIOMOL NMR, V48, P13, DOI 10.1007/s10858-010-9433-9; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P2759, DOI 10.1021/bi047717+; Skvortsov AN, 2003, RUSS J ORG CHEM+, V39, P170, DOI 10.1023/A:1025523832425; Solomon A, 2006, ARTHRITIS RHEUM, V54, P3545, DOI 10.1002/art.22201; Sormanni P, 2015, J MOL BIOL, V427, P478, DOI 10.1016/j.jmb.2014.09.026; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Townsend D, 2017, BIOCHEMISTRY-US, V56, P1632, DOI 10.1021/acs.biochem.6b01120; Tubb MR, 2009, J LIPID RES, V50, P1497, DOI 10.1194/jlr.D900003-JLR200; van der Wel PCA, 2017, SOLID STATE NUCL MAG, V88, P1, DOI 10.1016/j.ssnmr.2017.10.001; Varsano N, 2015, J AM CHEM SOC, V137, P1601, DOI 10.1021/ja511642t; VITELLO LB, 1976, J BIOL CHEM, V251, P1131; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Westermark GT, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a024323; WESTERMARK P, 1995, AM J PATHOL, V147, P1186; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhao L, 2013, BIOCHEMISTRY-US, V52, P1913, DOI 10.1021/bi301313b; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	112	17	17	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3149	3165		10.1096/fj.201701127R	http://dx.doi.org/10.1096/fj.201701127R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401604	Green Published			2022-12-26	WOS:000432546000021
J	Celik, H; Sciandra, M; Flashner, B; Gelmez, E; Kayrakilogiu, N; Allegakoen, DV; Petro, JR; Conn, EJ; Hour, S; Han, J; Oktay, L; Tiwari, PB; Hayran, M; Harris, BT; Manara, MC; Toretsky, JA; Scotlandi, K; Uren, A				Celik, Haydar; Sciandra, Marika; Flashner, Bess; Gelmez, Elif; Kayrakilogiu, Neslihan; Allegakoen, David V.; Petro, Jeff R.; Conn, Erin J.; Hour, Sarah; Han, Jenny; Oktay, Lalehan; Tiwari, Purushottam B.; Hayran, Mutlu; Harris, Brent T.; Manara, Maria Cristina; Toretsky, Jeffrey A.; Scotlandi, Katia; Uren, Aykut			Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99	ONCOGENE			English	Article							MIC2 EXPRESSION; CELL; TUMORS; GENE; OSTEOSARCOMA; ENGAGEMENT; MIGRATION; CANCER; FAMILY; IDENTIFICATION	Ewing sarcoma (ES) is an aggressive bone and soft tissue malignancy that predominantly affects children and adolescents. CD99 is a cell surface protein that is highly expressed on ES cells and is required to maintain their malignancy. We screened small molecule libraries for binding to extracellular domain of recombinant CD99 and subsequent inhibition of ES cell growth. We identified two structurally similar FDA-approved compounds, clofarabine and cladribine that selectively inhibited the growth of ES cells in a panel of 14 ES vs. 28 non-ES cell lines. Both drugs inhibited CD99 dimerization and its interaction with downstream signaling components. A membrane-impermeable analog of clofarabine showed similar cytotoxicity in culture, suggesting that it can function through inhibiting CD99 independent of DNA metabolism. Both drugs drastically inhibited anchorage-independent growth of ES cells, but clofarabine was more effective in inhibiting growth of three different ES xenografts. Our findings provide a novel molecular mechanism for clofarabine that involves direct binding to a cell surface receptor CD99 and inhibiting its biological activities.	[Celik, Haydar; Flashner, Bess; Gelmez, Elif; Kayrakilogiu, Neslihan; Allegakoen, David V.; Petro, Jeff R.; Conn, Erin J.; Hour, Sarah; Han, Jenny; Oktay, Lalehan; Tiwari, Purushottam B.; Toretsky, Jeffrey A.; Uren, Aykut] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Sciandra, Marika; Manara, Maria Cristina; Scotlandi, Katia] Rizzoli Orthopaed Inst, Expt Oncol Lab, CRS Dev Biomol Therapies, Bologna, Italy; [Sciandra, Marika; Manara, Maria Cristina; Scotlandi, Katia] Rizzoli Orthopaed Inst, RIT Dept, STB, PROMETEO Lab, Bologna, Italy; [Hayran, Mutlu] Hacettepe Univ, Canc Inst, Dept Prevent Oncol, Ankara, Turkey; [Harris, Brent T.] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20007 USA	Georgetown University; IRCCS Istituto Ortopedico Rizzoli; IRCCS Istituto Ortopedico Rizzoli; Hacettepe University; Georgetown University	Uren, A (corresponding author), Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA.; Scotlandi, K (corresponding author), Rizzoli Orthopaed Inst, Expt Oncol Lab, CRS Dev Biomol Therapies, Bologna, Italy.; Scotlandi, K (corresponding author), Rizzoli Orthopaed Inst, RIT Dept, STB, PROMETEO Lab, Bologna, Italy.	katia.scotlandi@ior.it; au26@georgetown.edu	Sciandra, Marika/C-8724-2018; Manara, Maria Cristina/K-3366-2018; Scotlandi, Katia/J-9009-2016	Sciandra, Marika/0000-0001-7147-6960; Manara, Maria Cristina/0000-0001-5686-720X; Scotlandi, Katia/0000-0001-6114-9499; Celik, Haydar/0000-0003-4314-8438	Children's Cancer Foundation; Hyundai Hope on Wheels; Alan B. Slifka Foundation; Italian Association for Cancer Research [AIRC_IG14049]; National Cancer Institute [P30CA51008]	Children's Cancer Foundation; Hyundai Hope on Wheels; Alan B. Slifka Foundation; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the funds from the Children's Cancer Foundation (to A. Uren), Hyundai Hope on Wheels (to A. Uren), the Alan B. Slifka Foundation (to A. Uren and K. Scotlandi) and the Italian Association for Cancer Research (AIRC_IG14049 to K. Scotlandi). The authors thank the Animal Models Shared Resource, Tissue Culture Shared Resource, Histopathology and Tissue Shared Resource and the Biacore Molecular Interaction Shared Resource at the Lombardi Comprehensive Cancer Center (Georgetown University), which are supported by a grant P30CA51008 from the National Cancer Institute.	AMBROS IM, 1991, CANCER, V67, P1886, DOI 10.1002/1097-0142(19910401)67:7<1886::AID-CNCR2820670712>3.0.CO;2-U; Arndt CAS, 1999, NEW ENGL J MED, V341, P342, DOI 10.1056/NEJM199907293410507; AUBRIT F, 1989, EUR J IMMUNOL, V19, P1431, DOI 10.1002/eji.1830190813; BERNARD A, 1988, J IMMUNOL, V140, P1802; Bixel G, 2004, BLOOD, V104, P3205, DOI 10.1182/blood-2004-03-1184; Bonate PL, 2006, NAT REV DRUG DISCOV, V5, P855, DOI 10.1038/nrd2055; Brohl AS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004475; CCEDILELIK H, 2015, MOL CELL BIOL, V35, P3145, DOI DOI 10.1128/MCB.00332-15; Choi G, 2007, EXP MOL MED, V39, P746, DOI 10.1038/emm.2007.81; Chung SS, 2014, BLOOD, V124, P3760; Chung SS, 2013, BLOOD, V122; Chung SS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2025; Cox CV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165210; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dworzak MN, 1999, BRIT J HAEMATOL, V105, P690, DOI 10.1046/j.1365-2141.1999.01426.x; DWORZAK MN, 1994, BLOOD, V83, P415, DOI 10.1182/blood.V83.2.415.bloodjournal832415; ELLIS NA, 1994, NAT GENET, V8, P285, DOI 10.1038/ng1194-285; FELLINGER EJ, 1991, AM J PATHOL, V139, P317; Franzetti GA, 2013, ONCOGENE, V32, P3915, DOI 10.1038/onc.2012.403; Gaspar N, 2015, J CLIN ONCOL, V33, P3036, DOI 10.1200/JCO.2014.59.5256; GELIN C, 1989, EMBO J, V8, P3253, DOI 10.1002/j.1460-2075.1989.tb08485.x; Gellini M, 2013, CURR PHARM BIOTECHNO, V14, P449, DOI 10.2174/1389201011314040011; Giovannoni G, 2010, NEW ENGL J MED, V362, P416, DOI 10.1056/NEJMoa0902533; Gollnest T, 2016, ANGEW CHEM INT EDIT, V55, P5255, DOI 10.1002/anie.201511808; Gollnest T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9716; Guerzoni C, 2015, CLIN CANCER RES, V21, P146, DOI 10.1158/1078-0432.CCR-14-0492; Halliday BE, 1998, DIAGN CYTOPATHOL, V19, P410, DOI 10.1002/(SICI)1097-0339(199812)19:6<410::AID-DC2>3.0.CO;2-Z; Hu-Lieskovan S, 2005, CANCER RES, V65, P4633, DOI 10.1158/0008-5472.CAN-04-2857; Husak Z, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.164; Husak Z, 2010, J LEUKOCYTE BIOL, V88, P405, DOI 10.1189/jlb.0210097; KAWASAKI H, 1993, BLOOD, V81, P597; Khoury JD, 2005, ADV ANAT PATHOL, V12, P212, DOI 10.1097/01.pap.0000175114.55541.52; Kim HJ, 2004, IMMUNOL LETT, V95, P155, DOI 10.1016/j.imlet.2004.07.001; KOVAR H, 1990, ONCOGENE, V5, P1067; Kovar Heinrich, 1998, Current Opinion in Oncology, V10, P334, DOI 10.1097/00001622-199807000-00010; Kovar H, 2016, ONCOTARGET, V7, P8613, DOI 10.18632/oncotarget.6937; Kreppel M, 2006, ONCOGENE, V25, P2795, DOI 10.1038/sj.onc.1209300; Lawlor Elizabeth R., 2015, Critical Reviews in Oncogenesis, V20, P155, DOI 10.1615/CritRevOncog.2015013553; Lee CS, 1996, PEDIATR PATHOL LAB M, V16, P379, DOI 10.1080/15513819609168678; Longhi A, 2012, CANCER-AM CANCER SOC, V118, P5050, DOI 10.1002/cncr.27493; Lucas DR, 2001, AM J CLIN PATHOL, V115, P11; Manara MC, 2006, MOL BIOL CELL, V17, P1910, DOI 10.1091/mbc.E05-10-0971; Mi-Kyung L, 2008, J MICROBIOL BIOTECHN, V18, P472; Miyagawa Y, 2008, MOL CELL BIOL, V28, P2125, DOI 10.1128/MCB.00740-07; Moricoli D, 2016, APPL MICROBIOL BIOT, V100, P3949, DOI 10.1007/s00253-015-7226-5; PERLMAN EJ, 1994, HUM PATHOL, V25, P304, DOI 10.1016/0046-8177(94)90203-8; Rocchi A, 2010, J CLIN INVEST, V120, P668, DOI 10.1172/JCI36667; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scotlandi K, 2000, CANCER RES, V60, P5134; Scotlandi K, 2006, EUR J CANCER, V42, P91, DOI 10.1016/j.ejca.2005.09.015; Sigal DS, 2010, BLOOD, V116, P2884, DOI 10.1182/blood-2010-02-246140; Sohn HW, 1998, AM J PATHOL, V153, P1937, DOI 10.1016/S0002-9440(10)65707-0; Suh YH, 2003, GENE, V307, P63, DOI 10.1016/S0378-1119(03)00401-3; Ventura S, 2016, ONCOGENE, V35, P3944, DOI 10.1038/onc.2015.463; Watson RL, 2015, J EXP MED, V212, P1021, DOI 10.1084/jem.20150354; WEIDNER N, 1994, AM J SURG PATHOL, V18, P486, DOI 10.1097/00000478-199405000-00008; Winger RC, 2016, J IMMUNOL, V196, P1443, DOI 10.4049/jimmunol.1501634; Zucchini C, 2014, ONCOGENE, V33, P1912, DOI 10.1038/onc.2013.152	59	15	17	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2018	37	16					2181	2196		10.1038/s41388-017-0080-4	http://dx.doi.org/10.1038/s41388-017-0080-4			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GD5ZV	29382926				2022-12-26	WOS:000430589000008
J	Jung, TW; Kim, HC; Abd El-Aty, AM; Jeong, JH				Jung, Tae Woo; Kim, Hyoung-Chun; Abd El-Aty, A. M.; Jeong, Ji Hoon			Maresin 1 attenuates NAFLD by suppression of endoplasmic reticulum stress via AMPK-SERCA2b pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; HEPATIC STEATOSIS; ER STRESS; INSULIN SENSITIVITY; LIPID-ACCUMULATION; INHIBITS INSULIN; ADIPOSE-TISSUE; UP-REGULATION; CELL-DEATH; ACTIVATION	Maresin 1 (MAR1), which is derived from docosahexaenoic acid biosynthesized by macrophages, has been reported to improve insulin resistance. Recently, it has been documented that MAR1 could ameliorate inflammation and insulin resistance in obese mice. These findings led us to investigate the effects of MAR1 on hepatic lipid metabolism. We found that MAR1 could stimulate AMP-activated protein kinase (AMPK), thereby augmenting sarcoendoplasmic reticulum Ca2+-ATPase 2b (SERCA2b) expression. This stimulation suppressed lipid accumulation by attenuating the endoplasmic reticulum (ER) stress in hepatocytes under hyperlipidemic conditions. Attenuation was mitigated by knockdown of AMPK or thapsigargin, a SERCA2b inhibitor. We also demonstrated that MAR1 administration resulted in increased hepatic AMPK phosphorylation and Serca2b mRNA expression, whereas hepatic ER stress was reduced in high-fat diet (HFD)-fed mice. Moreover, MAR1 treatment suppressed hepatic lipid synthesis, thereby attenuating hepatic steatosis in HFD-fed mice. In conclusion, our results suggest that MAR1 ameliorates hepatic steatosis via AMPK/SERCA2b-mediated suppression of ER stress. Therefore, MAR1 may be an effective therapeutic strategy for treating non-alcoholic fatty liver disease (NAFLD) via regulation of ER stress-induced hepatic lipogenesis.	[Jung, Tae Woo] Seoul Natl Univ, Bundang Hosp, Res Adm Team, Gyeonggi 13620, South Korea; [Kim, Hyoung-Chun] Kangwon Natl Univ, Coll Pharm, Neuropsychopharmacol & Toxicol Program, Chunchon 24341, South Korea; [Abd El-Aty, A. M.] Cairo Univ, Dept Pharmacol, Fac Vet Med, Giza 12211, Egypt; [Jeong, Ji Hoon] Chung Ang Univ, Dept Pharmacol, Coll Med, Seoul 06974, South Korea; [Abd El-Aty, A. M.] Ataturk Univ, Med Fac, Dept Med Pharmacol, TR-25240 Erzurum, Turkey	Seoul National University (SNU); Kangwon National University; Egyptian Knowledge Bank (EKB); Cairo University; Chung Ang University; Chung Ang University Hospital; Ataturk University	Jeong, JH (corresponding author), Chung Ang Univ, Dept Pharmacol, Coll Med, 221 Heuksuk Dong, Seoul 156756, South Korea.	jhjeong3@cau.ac.kr	El-Aty, A. M. Abd/H-8216-2018	El-Aty, A. M. Abd/0000-0001-6596-7907	Basic Science Research Program through National Research Foundation of Korea - Korean Ministry of Education [2017R1D1A1B03028892]	Basic Science Research Program through National Research Foundation of Korea - Korean Ministry of Education	This work was supported by the Basic Science Research Program through National Research Foundation of Korea Grant 2017R1D1A1B03028892 funded by the Korean Ministry of Education. The authors declare that they have no conflicts of interest with the contents of this article.	Ashby MC, 2001, SEMIN CELL DEV BIOL, V12, P11, DOI 10.1006/scdb.2000.0212; Bai YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100864; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Deng X, 2015, BBA-MOL CELL BIOL L, V1851, P1521, DOI 10.1016/j.bbalip.2015.08.007; Dong YZ, 2010, DIABETES, V59, P1386, DOI 10.2337/db09-1637; Fang DL, 2013, MOL CELL BIOCHEM, V381, P127, DOI 10.1007/s11010-013-1694-7; Figueras M, 2011, OBESITY, V19, P362, DOI 10.1038/oby.2010.194; Flamment M, 2010, CURR OPIN LIPIDOL, V21, P239, DOI 10.1097/MOL.0b013e3283395e5c; Ford RJ, 2015, BIOCHEM J, V468, P125, DOI 10.1042/BJ20150125; Glimcher LH, 2009, ANN NY ACAD SCI, V1173, pE2, DOI 10.1111/j.1749-6632.2009.04956.x; Gonzalez-Periz A, 2006, FASEB J, V20, P2537, DOI 10.1096/fj.06-6250fje; Haas MJ, 2016, FREE RADICAL BIO MED, V99, P1, DOI 10.1016/j.freeradbiomed.2016.07.020; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jung TW, 2015, MOL CELL ENDOCRINOL, V417, P131, DOI 10.1016/j.mce.2015.09.027; Jung TW, 2013, BIOCHEM PHARMACOL, V86, P960, DOI 10.1016/j.bcp.2013.07.034; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kopach O, 2016, CELL CALCIUM, V59, P251, DOI 10.1016/j.ceca.2016.02.014; Lee YH, 2016, INT J OBESITY, V40, P356, DOI 10.1038/ijo.2015.173; Li HL, 2014, BBA-MOL BASIS DIS, V1842, P1844, DOI 10.1016/j.bbadis.2014.07.002; Li RD, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9203716; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Martinez-Fernandez L, 2017, FASEB J, V31, P2135, DOI 10.1096/fj.201600859R; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Moura-Assis A, 2018, J NUTR BIOCHEM, V53, P9, DOI 10.1016/j.jnutbio.2017.09.015; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park SW, 2010, P NATL ACAD SCI USA, V107, P19320, DOI 10.1073/pnas.1012044107; Peraldi P, 1996, J BIOL CHEM, V271, P13018, DOI 10.1074/jbc.271.22.13018; Rius B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00257; Sehgal P, 2017, J BIOL CHEM, V292, P19656, DOI 10.1074/jbc.M117.796920; Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Smith BK, 2016, AM J PHYSIOL-ENDOC M, V311, pE730, DOI 10.1152/ajpendo.00225.2016; Vangheluwe P, 2005, CELL CALCIUM, V38, P291, DOI 10.1016/j.ceca.2005.06.033; Wang YZ, 2017, P NATL ACAD SCI USA, V114, pE1500, DOI 10.1073/pnas.1612991114; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhang J, 2014, AM J PHYSIOL-CELL PH, V306, pC279, DOI 10.1152/ajpcell.00117.2013	45	46	47	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3981	3988		10.1074/jbc.RA117.000885	http://dx.doi.org/10.1074/jbc.RA117.000885			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29414781	Green Published, hybrid			2022-12-26	WOS:000427587500011
J	Cheng, L; Wong, LJ; Yan, NH; Han, RC; Yu, HH; Guo, CY; Batsuuri, K; Zinzuwadia, A; Guan, R; Cho, KS; Chen, DF				Cheng, Lin; Wong, Lucy J.; Yan, Naihong; Han, Richard C.; Yu, Honghua; Guo, Chenying; Batsuuri, Khulan; Zinzuwadia, Aniket; Guan, Ryan; Cho, Kin-Sang; Chen, Dong Feng			Ezh2 does not mediate retinal ganglion cell homeostasis or their susceptibility to injury	PLOS ONE			English	Article							DOMAIN FACTOR BRN-3B; EPIGENETIC MECHANISMS; GENE-EXPRESSION; RNA-SEQ; INTRAOCULAR-PRESSURE; COMPETENCE STATE; MATH5; GLAUCOMA; METHYLATION; ROLES	Epigenetic predisposition is thought to critically contribute to adult-onset disorders, such as retinal neurodegeneration. The histone methyltransferase, enhancer of zeste homolog 2 (Ezh2), is transiently expressed in the perinatal retina, particularly enriched in retinal ganglion cells (RGCs). We previously showed that embryonic deletion of Ezh2 from retinal progenitors led to progressive photoreceptor degeneration throughout life, demonstrating a role for embryonic predisposition of Ezh2-mediated repressive mark in maintaining the survival and function of photoreceptors in the adult. Enrichment of Ezh2 in RGCs leads to the question if Ezh2 also mediates gene expression and function in postnatal RGCs, and if its deficiency changes RGC susceptibility to cell death under injury or disease in the adult. To test this, we generated mice carrying targeted deletion of Ezh2 from RGC progenitors driven by Math5-Cre (mKO). mKO mice showed no detectable defect in RGC development, survival, or cell homeostasis as determined by physiological analysis, live imaging, histology, and immunohistochemistry. Moreover, RGCs of Ezh2 deficient mice revealed similar susceptibility against glaucomatous and acute optic nerve trauma-induced neurodegeneration compared to littermate floxed or wild-type control mice. In agreement with the above findings, analysis of RNA sequencing of RGCs purified from Ezh2 deficient mice revealed few gene changes that were related to RGC development, survival and function. These results, together with our previous report, support a cell lineage-specific mechanism of Ezh2-mediated gene repression, especially those critically involved in cellular function and homeostasis.	[Cheng, Lin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Cheng, Lin; Wong, Lucy J.; Yan, Naihong; Han, Richard C.; Yu, Honghua; Guo, Chenying; Batsuuri, Khulan; Zinzuwadia, Aniket; Guan, Ryan; Cho, Kin-Sang; Chen, Dong Feng] Harvard Med Sch, Massachusetts Eye & Ear, Schepens Eye Res Inst, Dept Ophthalmol, Boston, MA 02115 USA; [Wong, Lucy J.] Univ Freiburg, Fac Med, Med Ctr, Eye Ctr, Freiburg, Germany; [Yan, Naihong] Sichuan Univ, West China Hosp, Dept Ophthalmol & Ophthalm Labs, State Key Lab Biotherapy & Canc Ctr, Chengdu, Sichuan, Peoples R China	Sun Yat Sen University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; University of Freiburg; Sichuan University	Chen, DF (corresponding author), Harvard Med Sch, Massachusetts Eye & Ear, Schepens Eye Res Inst, Dept Ophthalmol, Boston, MA 02115 USA.	dongfeng_chen@meei.harvard.edu		Cheng, Lin/0000-0002-4960-8186; Cho, Kin-Sang/0000-0003-4285-615X; Kessler, Lucy Joanne/0000-0002-5322-9875	NIH/NEI [R41 EY025913, R01EY025259]; Curing Kids Fund; Core Grant for Vision Research from NIH/NEI [P30EY03790]; Postdoctoral Foundation [2015M580758]; Natural Science Foundation of Guangdong Province [2016A030310201]; Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE [P30EY003790, R01EY025259] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Curing Kids Fund; Core Grant for Vision Research from NIH/NEI; Postdoctoral Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by funding from the NIH/NEI (R41 EY025913 and R01EY025259) and Curing Kids Fund to D.F.C.; the Core Grant for Vision Research from NIH/NEI to the Schepens Eye Research Institute (P30EY03790), and the Postdoctoral Foundation to L. C. (No. 2015M580758), the Natural Science Foundation of Guangdong Province (2016A030310201) to L.C and Massachusetts Lions Eye Research Fund to DFC. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	ANDERS S, 2010, GENOME BIOL, V11; Barth P. G., 2016, NEUROPATHOL APPL NEU; Brown NL, 2001, DEVELOPMENT, V128, P2497; Brzezinski JA, 2012, DEV BIOL, V365, P395, DOI 10.1016/j.ydbio.2012.03.006; Camp AS, 2011, INVEST OPHTH VIS SCI, V52, P5226, DOI 10.1167/iovs.10-6307; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chen HH, 2011, INVEST OPHTH VIS SCI, V52, P36, DOI 10.1167/iovs.09-5115; Chen SD, 2015, ASIA-PAC J OPHTHALMO, V4, P236, DOI 10.1097/APO.0000000000000122; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; Chou RH, 2011, AM J TRANSL RES, V3, P243; Delgado-Olguin P, 2012, NAT GENET, V44, P343, DOI 10.1038/ng.1068; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Feng L, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-36; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Gregory MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017659; He SK, 2013, MOL VIS, V19, P665; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hufnagel RB, 2007, MOL CELL NEUROSCI, V36, P435, DOI 10.1016/j.mcn.2007.08.006; Iida A, 2015, DEV NEUROBIOL, V75, P947, DOI 10.1002/dneu.22261; Jiao JW, 2005, EMBO J, V24, P1068, DOI 10.1038/sj.emboj.7600589; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Lange CA, 2012, OPHTHALMOLOGY, V119, P1924, DOI 10.1016/j.ophtha.2012.03.037; Le TT, 2006, DEV BIOL, V295, P764, DOI 10.1016/j.ydbio.2006.03.055; Li JL, 2013, NAT NEUROSCI, V16, P1745, DOI 10.1038/nn.3564; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Mu XQ, 2005, DEV BIOL, V280, P467, DOI 10.1016/j.ydbio.2005.01.028; Mu XQ, 2004, SEMIN CELL DEV BIOL, V15, P115, DOI 10.1016/j.semcdb.2003.09.009; Nakano N, 2011, OPHTHALMOLOGY, V118, P2414, DOI 10.1016/j.ophtha.2011.06.015; Pelzel HR, 2012, INVEST OPHTH VIS SCI, V53, P1428, DOI 10.1167/iovs.11-8872; Pelzel HR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-62; Pennington KL, 2015, J EXP NEUROSCI, V9, P51, DOI 10.4137/JEN.S25513; Prasov L, 2012, DEV BIOL, V368, P214, DOI 10.1016/j.ydbio.2012.05.005; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Rao RC, 2010, INVEST OPHTH VIS SCI, V51, P6784, DOI 10.1167/iovs.09-4730; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Saeki T, 2008, CURR EYE RES, V33, P247, DOI 10.1080/02713680801919716; Sato S, 2007, GENESIS, V45, P502, DOI 10.1002/dvg.20318; Shen XT, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0124-15.2016; Strouthidis NG, 2010, INVEST OPHTH VIS SCI, V51, P1464, DOI 10.1167/iovs.09-3984; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Ueno K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29264; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Vogel T, 2006, DEV DYNAM, V235, P2574, DOI 10.1002/dvdy.20876; Vu THK, 2012, ASIA-PAC J OPHTHALMO, V1, P303, DOI 10.1097/APO.0b013e31826f57a3; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wiggs JL, 2012, INVEST OPHTH VIS SCI, V53, P2467, DOI 10.1167/iovs.12-9483e; Yan NH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33887; Yang Q, 2012, INVEST OPHTH VIS SCI, V53, P3733, DOI 10.1167/iovs.12-9814; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; Zhang JM, 2015, DEV BIOL, V403, P128, DOI 10.1016/j.ydbio.2015.05.010	57	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191853	10.1371/journal.pone.0191853	http://dx.doi.org/10.1371/journal.pone.0191853			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408885	gold, Green Published, Green Submitted			2022-12-26	WOS:000424302800026
J	Hu, WJ; Pan, XL; Li, FF; Dong, WB				Hu, Wenjin; Pan, Xinli; Li, Fengfeng; Dong, Wubei			UPLC-QTOF-MS metabolomics analysis revealed the contributions of metabolites to the pathogenesis of Rhizoctonia solani strain AG-1-IA	PLOS ONE			English	Article							SYSTEMIC WOUND RESPONSE; CHAIN FATTY-ACID; DEFENSE RESPONSES; ARABIDOPSIS-THALIANA; ANTIOXIDANT ACTIVITY; MASS-SPECTROMETRY; TRANSGENIC MAIZE; STRESS; IDENTIFICATION; BIOSYNTHESIS	To explore the pathogenesis of Rhizoctonia solani and its phytotoxin phenylacetic acid (PAA) on maize leaves and sheaths, treated leaf and sheath tissues were analyzed and interpreted by ultra-performance liquid chromatography-mass spectrometry combined with chemometrics. The PAA treatment had similar effects to those of R. solani on maize leaves regarding the metabolism of traumatin, phytosphingosine, vitexin 2'' O-beta-D-glucoside, rutin and DIBOA-glucoside, which were up-regulated, while the synthesis of OPC-8:0 and 12-OPDA, precursors for the synthesis of jasmonic acid, a plant defense signaling molecule, was down-regulated under both treatments. However, there were also discrepancies in the influences exhibited by R. solani and PAA as the metabolic concentration of zeaxanthin diglucoside in the R. solani infected leaf group decreased. Conversely, in the PAA-treated leaf group, the synthesis of zeaxanthin diglucoside was enhanced. Moreover, although the synthesis of 12 metabolites were suppressed in both the R. solani- and PAA-treated leaf tissues, the inhibitory effect of R. solani was stronger than that of PAA. An increased expression of quercitrin and quercetin 3-O-glucoside was observed in maize sheaths treated by R. solani, while their concentrations were not changed significantly in the PAA-treated sheaths. Furthermore, a significant decrease in the concentration of L-Glutamate, which plays important roles in plant resistance to necrotrophic pathogens, only occurred in the R. solani-treated sheath tissues. The differentiated metabolite levels may be the partial reason of why maize sheaths were more susceptible to R. solani than leaves and may explain the underlying mechanisms of R. solani pathogenesis.	[Hu, Wenjin; Li, Fengfeng; Dong, Wubei] Huazhong Agr Univ, Dept Plant Pathol, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Hu, Wenjin; Li, Fengfeng; Dong, Wubei] Huazhong Agr Univ, Key Lab Crop Dis Monitoring & Safety Control Hube, Wuhan, Hubei, Peoples R China; [Pan, Xinli] Tech Univ Dortmund, Dept Biochem & Chem Engn, Dortmund, Germany	Huazhong Agricultural University; Huazhong Agricultural University; Dortmund University of Technology	Dong, WB (corresponding author), Huazhong Agr Univ, Dept Plant Pathol, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China.; Dong, WB (corresponding author), Huazhong Agr Univ, Key Lab Crop Dis Monitoring & Safety Control Hube, Wuhan, Hubei, Peoples R China.	dwb@mail.hzau.edu.cn		Dong, Wubei/0000-0001-8513-8751	National Major Project for Transgenic Organism Breeding [2016ZX08003-001]; Hubei Provincial Technology Innovation Program [2016ABA093]	National Major Project for Transgenic Organism Breeding; Hubei Provincial Technology Innovation Program	This work was supported by the National Major Project for Transgenic Organism Breeding (2016ZX08003-001) and the Hubei Provincial Technology Innovation Program (2016ABA093).	Ahmad S, 2011, PLANT PHYSIOL, V157, P317, DOI 10.1104/pp.111.180224; Aliferis KA, 2010, METABOLOMICS, V6, P96, DOI 10.1007/s11306-009-0180-4; Aliferis KA, 2013, METABOLOMICS, V9, pS159, DOI 10.1007/s11306-011-0340-1; AOKI H, 1963, NATURE, V200, P575, DOI 10.1038/200575a0; Bartz FE, 2012, MYCOLOGIA, V104, P793, DOI 10.3852/11-084; Bernardes-de-Assis J, 2009, PHYTOPATHOLOGY, V99, P1090, DOI 10.1094/PHYTO-99-9-1090; Betsiashvili M, 2015, J EXP BOT, V66, P571, DOI 10.1093/jxb/eru379; Brauc S, 2011, J PLANT PHYSIOL, V168, P1813, DOI 10.1016/j.jplph.2011.05.012; Broyart C, 2010, PHYTOCHEM ANALYSIS, V21, P102, DOI 10.1002/pca.1177; Castro C, 2008, J EXP BOT, V59, P3913, DOI 10.1093/jxb/ern239; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Ding XP, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00830; Dulermo T, 2009, PLANT SIGNAL BEHAV, V4, P859, DOI 10.4161/psb.4.9.9397; Frank T, 2012, J AGR FOOD CHEM, V60, P3005, DOI 10.1021/jf204167t; Gao J, 2014, MOL BIOL REP, V41, P2471, DOI 10.1007/s11033-014-3103-z; Gavaghan CL, 2011, PHYTOCHEM ANALYSIS, V22, P214, DOI 10.1002/pca.1268; Grassmann J, 2002, PLANT PHYSIOL BIOCH, V40, P471, DOI 10.1016/S0981-9428(02)01395-5; Guo R, 2007, J PHARMACEUT BIOMED, V43, P1580, DOI 10.1016/j.jpba.2006.11.029; Hassan S, 2012, J EXP BOT, V63, P3429, DOI 10.1093/jxb/err430; Havaux M, 1998, TRENDS PLANT SCI, V3, P147, DOI 10.1016/S1360-1385(98)01200-X; Howe GA, 2002, CURR OPIN PLANT BIOL, V5, P230, DOI 10.1016/S1369-5266(02)00250-9; Hu WJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177464; Huan JJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02303; Jayasinghe CK, 2004, MYCOPATHOLOGIA, V157, P73, DOI 10.1023/B:MYCO.0000012210.64378.97; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; KLINGNER A, 1995, PHYTOCHEMISTRY, V38, P53, DOI 10.1016/0031-9422(94)00538-5; Kuhl C, 2012, ANAL CHEM, V84, P283, DOI 10.1021/ac202450g; Kuhnen S, 2010, J AGR FOOD CHEM, V58, P2194, DOI 10.1021/jf9037776; Li L, 2002, P NATL ACAD SCI USA, V99, P6416, DOI 10.1073/pnas.072072599; Li X, 2011, AGR SYST, V104, P348, DOI 10.1016/j.agsy.2010.12.006; Li YH, 2007, P NATL ACAD SCI USA, V104, P18339, DOI 10.1073/pnas.0706984104; LIM BP, 1992, BIOCHIM BIOPHYS ACTA, V1126, P178; Maddox CE, 2010, CURR MICROBIOL, V60, P53, DOI 10.1007/s00284-009-9501-0; Magnin-Robert M, 2015, PLANT PHYSIOL, V169, P2255, DOI 10.1104/pp.15.01126; Makoi J.H., 2007, AFR J BIOTECHNOL, V6; Manetti C, 2004, PHYTOCHEMISTRY, V65, P3187, DOI 10.1016/j.phytochem.2004.10.015; Manetti C, 2006, J EXP BOT, V57, P2613, DOI 10.1093/jxb/erl025; Navarre DA, 1999, PLANT CELL, V11, P237; Ndakidemi PA, 2003, FUNCT PLANT BIOL, V30, P729, DOI 10.1071/FP03042; Neal AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035498; Niemeyer HM, 2009, J AGR FOOD CHEM, V57, P1677, DOI 10.1021/jf8034034; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Parvez MM, 2004, BIOCHEM SYST ECOL, V32, P631, DOI 10.1016/j.bse.2003.12.002; Pietryczuk A, 2011, PLANT GROWTH REGUL, V65, P279, DOI 10.1007/s10725-011-9599-5; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Raffaele S, 2009, PLANT SIGNAL BEHAV, V4, P94, DOI 10.4161/psb.4.2.7580; Robert CAM, 2012, ECOL LETT, V15, P55, DOI 10.1111/j.1461-0248.2011.01708.x; Ruttkies C, 2016, J CHEMINFORMATICS, V8, DOI 10.1186/s13321-016-0115-9; Seifi HS, 2013, MOL PLANT MICROBE IN, V26, P475, DOI 10.1094/MPMI-07-12-0176-CR; SIEDOW JN, 1991, ANNU REV PLANT PHYS, V42, P145, DOI 10.1146/annurev.pp.42.060191.001045; Skogerson K, 2010, J AGR FOOD CHEM, V58, P3600, DOI 10.1021/jf903705y; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Strack D, 2006, NEW PHYTOL, V172, P22, DOI 10.1111/j.1469-8137.2006.01837.x; Strassner J, 2002, PLANT J, V32, P585, DOI 10.1046/j.1365-313X.2002.01449.x; Suzuki K, 2007, PLANT SCI, V173, P291, DOI 10.1016/j.plantsci.2007.06.002; Taguri T, 2006, BIOL PHARM BULL, V29, P2226, DOI 10.1248/bpb.29.2226; Thevenot EA, 2015, J PROTEOME RES, V14, P3322, DOI 10.1021/acs.jproteome.5b00354; van der Luit AH, 2000, PLANT PHYSIOL, V123, P1507, DOI 10.1104/pp.123.4.1507; Vidhyasekaran P, 1997, PHYTOPATHOLOGY, V87, P1258, DOI 10.1094/PHYTO.1997.87.12.1258; Wen WW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4438; Witt S, 2012, MOL PLANT, V5, P401, DOI 10.1093/mp/ssr102; Yamaguchi T, 2005, PLANT CELL PHYSIOL, V46, P579, DOI 10.1093/pcp/pci065; Yang W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146910; Yuan JS, 2008, TRENDS PLANT SCI, V13, P421, DOI 10.1016/j.tplants.2008.06.001; Zabela MD, 2002, MOL PLANT MICROBE IN, V15, P808, DOI 10.1094/MPMI.2002.15.8.808; Zhang ZhiMing, 2012, African Journal of Biotechnology, V11, P2827	66	10	13	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192486	10.1371/journal.pone.0192486	http://dx.doi.org/10.1371/journal.pone.0192486			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408919	Green Published, gold, Green Submitted			2022-12-26	WOS:000424302800071
J	Kuo, SY; Lin, YC; Lai, YC; Liao, JT; Hsu, YH; Huang, HC; Hu, CC				Kuo, Song-Yi; Lin, Yuan-Chuen; Lai, Yi-Chin; Liao, Jia-Teh; Hsu, Yau-Heiu; Huang, Hsiou-Chen; Hu, Chung-Chi			Production of fluorescent antibody-labeling proteins in plants using a viral vector and the application in the detection of Acidovorax citrulli and Bamboo mosaic virus	PLOS ONE			English	Article							AVENAE SUBSP CITRULLI; CELL-TO-CELL; CLEAVAGE ACTIVITIES; FUSION PROTEIN; COAT PROTEIN; EXPRESSION; BINDING; CONSTRUCTION; APHTHOVIRUS; MOVEMENT	Serological methods are relatively convenient and simple for the detection of pathogens for front-line workers. On-site visualization of the test results plays a pivotal role in the process. However, an efficient, universal labeling agent for antibodies is needed for the development of efficient serological detection tools. In this study, a Bamboo mosaic virus (BaMV)-based viral vector was employed to express recombinant proteins, collectively designated GfED, consisting of Staphylococcus aureus Protein A domain ED (SpaED) fused to either the N- or C-terminal of an improved green florescent protein (GFP) with or without the coat protein (CP) of BaMV, efficiently in Chenopodium quinoa. The GfED in crude leaf extracts could specifically attach to IgG molecules of rabbits and mice, effectively labeling IgG with GFP, emitting green light at 506 nm when excited at 450 nm using simple, handheld equipment. To demonstrate the applicability of GfED in serological assays, we have developed a fluorescent dot blot assay for the rapid detection of Acidovorax citrulli (Ac), a bacterial pathogen of cucurbits, and BaMV, a viral pathogen of bamboos. By using the crude extracts of inoculated C. quinoa leaves expressing GfED as an IgG-labeling agent, the pathogens were easily and quickly detected through uncomplicated operations using simple equipment, with results observable by the naked eye. Examination using fluorescent microscopy and transmission electron microscopy revealed that the GfED subunits may assemble into virus-like particles, which were further involved in the formation of aggregates of GfED-anti-body-antigen complexes with the potential for fluorescence signal enhancement. The results suggested that plant-expressed GfED may serve as a promising alternative of IgG-labeling agent for current serological assays.	[Kuo, Song-Yi; Lin, Yuan-Chuen; Lai, Yi-Chin; Liao, Jia-Teh; Hsu, Yau-Heiu; Huang, Hsiou-Chen; Hu, Chung-Chi] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung, Taiwan	National Chung Hsing University	Hsu, YH; Huang, HC; Hu, CC (corresponding author), Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung, Taiwan.	yhhsu@dragon.nchu.edu.tw; hchuang@dragon.nchu.edu.tw; cchu@dragon.nchu.edu.tw			Ministry of Science and Technology, Taiwan [NSC 102-2811-B-005-038]; Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Executive Yuan, Taiwan [100AS-1.1.12-BQ-B1(Z), 101AS-10.3.1-BQ-B2(Z), 102AS-10.2.5-BQ-B2(Z)]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Executive Yuan, Taiwan	This study was supported by Post-doctoral grant NSC 102-2811-B-005-038 to YCL from Ministry of Science and Technology, Taiwan, and grants 100AS-1.1.12-BQ-B1(Z), 101AS-10.3.1-BQ-B2(Z), and 102AS-10.2.5-BQ-B2(Z) to HCH and CCH from Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Executive Yuan, Taiwan.	Aoki T, 2000, BIOSCI BIOTECH BIOCH, V64, P1547, DOI 10.1271/bbb.64.1547; Aoki T, 1996, FEBS LETT, V384, P193, DOI 10.1016/0014-5793(96)00289-X; Arai R, 1998, J FERMENT BIOENG, V86, P440, DOI 10.1016/S0922-338X(98)80148-7; Buchwalow IB, 2010, IMMUNOHISTOCHEMISTRY: BASICS AND METHODS, P1, DOI 10.1007/978-3-642-04609-4; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Cava F, 2008, ENVIRON MICROBIOL, V10, P605, DOI 10.1111/j.1462-2920.2007.01482.x; Chang KC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00870; Chen TH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00788; Chen TH, 2012, VIRUS RES, V166, P109, DOI 10.1016/j.virusres.2012.02.021; Cruz SS, 1998, PLANT CELL, V10, P495, DOI 10.1105/tpc.10.4.495; Deng WL, 2010, PLANT DIS, V94, P1065, DOI 10.1094/PDIS-94-8-1065A; Dickmeis C, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00189; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Donnelly MLL, 1997, J GEN VIROL, V78, P13, DOI 10.1099/0022-1317-78-1-13; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; Fang Y, 2015, BIOSENSORS-BASEL, V5, P537, DOI 10.3390/bios5030537; Gecchele E, 2015, JOVE-J VIS EXP, DOI 10.3791/52459; Gleba Y, 2007, CURR OPIN BIOTECH, V18, P134, DOI 10.1016/j.copbio.2007.03.002; Gleba YY, 2014, CURR TOP MICROBIOL, V375, P155, DOI 10.1007/82_2013_352; Huang Z, 2006, VACCINE, V24, P2506, DOI 10.1016/j.vaccine.2005.12.024; Hung CJ, 2014, MOL PLANT MICROBE IN, V27, P1211, DOI 10.1094/MPMI-04-14-0112-R; Jansson B, 1998, FEMS IMMUNOL MED MIC, V20, P69, DOI 10.1016/S0928-8244(97)00108-9; JENDEBERG L, 1995, J MOL RECOGNIT, V8, P270, DOI 10.1002/jmr.300080405; KING EO, 1954, J LAB CLIN MED, V44, P301; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LATIN RX, 1995, PLANT DIS, V79, P761, DOI 10.1094/PD-79-0761; Lee CC, 2011, J VIROL, V85, P12022, DOI 10.1128/JVI.05595-11; Lico C, 2008, J CELL PHYSIOL, V216, P366, DOI 10.1002/jcp.21423; LIN NS, 1991, PHYTOPATHOLOGY, V81, P1551, DOI 10.1094/Phyto-81-1551; LIN NS, 1993, PLANT DIS, V77, P448, DOI 10.1094/PD-77-0448; Maniatis T., 1982, MOL CLONING; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Merlin M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/136419; MOKS T, 1986, EUR J BIOCHEM, V156, P637, DOI 10.1111/j.1432-1033.1986.tb09625.x; Muthamilselvan T, 2016, PLANT BIOTECHNOL J, V14, P231, DOI 10.1111/pbi.12377; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; Ogi H, 2007, BIOSENS BIOELECTRON, V22, P3238, DOI 10.1016/j.bios.2007.03.003; Prachayasittikul V, 2005, EXCLI J, V4, P91; Santi L, 2008, VACCINE, V26, P1846, DOI 10.1016/j.vaccine.2008.01.053; Savary S, 2012, FOOD SECUR, V4, P519, DOI 10.1007/s12571-012-0200-5; SCHAAD NW, 1978, INT J SYST BACTERIOL, V28, P117, DOI 10.1099/00207713-28-1-117; SHUTTLEWORTH HL, 1987, GENE, V58, P283, DOI 10.1016/0378-1119(87)90383-0; Starovasnik MA, 1999, PROTEIN SCI, V8, P1423, DOI 10.1110/ps.8.7.1423; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Vira S, 2010, ANAL BIOCHEM, V402, P146, DOI 10.1016/j.ab.2010.03.036; WILLEMS A, 1992, INT J SYST BACTERIOL, V42, P107, DOI 10.1099/00207713-42-1-107; Yang CD, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-62	48	9	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192455	10.1371/journal.pone.0192455	http://dx.doi.org/10.1371/journal.pone.0192455			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408944	gold, Green Published, Green Submitted			2022-12-26	WOS:000424302800068
J	Xia, KL				Xia, Kelin			Sequence-based multiscale modeling for high-throughput chromosome conformation capture (Hi-C) data analysis	PLOS ONE			English	Article							TOPOLOGICAL DOMAINS; FUNCTIONAL-ORGANIZATION; GENOME; PRINCIPLES; IDENTIFICATION; SHAPE	In this paper, we introduce sequence-based multiscale modeling for biomolecular data analysis. We employ spectral clustering method in our modeling and reveal the difference between sequence-based global scale clustering and local scale clustering. Essentially, two types of distances, i.e., Euclidean (or spatial) distance and genomic (or sequential) distance, can be used in data clustering. Clusters from sequence-based global scale models optimize spatial distances, meaning spatially adjacent loci are more likely to be assigned into the same cluster. Sequence-based local scale models, on the other hand, result in clusters that optimize genomic distances. That is to say, in these models, sequentially adjoining loci tend to be cluster together. We propose two sequence-based multiscale models (SeqMMs) for the study of chromosome hierarchical structures, including genomic compartments and topological associated domains (TADs). We find that genomic compartments are determined only by global scale information in the Hi-C data. The removal of all the local interactions within a band region as large as 10 Mb in genomic distance has almost no significant influence on the final compartment results. Further, in TAD analysis, we find that when the sequential scale is small, a tiny variation of diagonal band region in a contact map will result in a great change in the predicted TAD boundaries. When the scale value is larger than a threshold value, the TAD boundaries become very consistent. This threshold value is highly related to TAD sizes. By the comparison of our results with those previously obtained using a spectral clustering model, we find that our method is more robust and reliable. Finally, we demonstrate that almost all TAD boundaries from both clustering methods are local minimum of a TAD summation function.	[Xia, Kelin] Nanyang Technol Univ, Sch Phys & Math Sci, Div Math Sci, Singapore 637371, Singapore; [Xia, Kelin] Nanyang Technol Univ, Sch Biol Sci, Singapore 637371, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Xia, KL (corresponding author), Nanyang Technol Univ, Sch Phys & Math Sci, Div Math Sci, Singapore 637371, Singapore.; Xia, KL (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637371, Singapore.	xiakelin@ntu.edu.sg	XIA, KELIN/AAF-7490-2020; XIA, KELIN/I-7880-2016	XIA, KELIN/0000-0003-4183-0943; XIA, KELIN/0000-0003-4183-0943	Nanyang Technological University Startup Grant [M4081842.110]; Singapore Ministry of Education Academic Research Fund Tier 1 [M401110000]	Nanyang Technological University Startup Grant(Nanyang Technological University); Singapore Ministry of Education Academic Research Fund Tier 1(Ministry of Education, Singapore)	This work was supported by Nanyang Technological University (http://www.ntu.edu.sg/) Startup Grant M4081842.110 and Singapore Ministry of Education (https://www.moe.gov.sg/) Academic Research Fund Tier 1 M401110000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The author would like to thank Amartya Sanyal for valuable discussions. This work was supported in part by Nanyang Technological University Startup Grant M4081842.110 and Singapore Ministry of Education Academic Research fund Tier 1 M401110000.	Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Bonev B, 2016, NAT REV GENET, V17, P661, DOI 10.1038/nrg.2016.112; Cang Z. X., 2017, INT J NUMERICAL METH; Cang ZX, 2017, BIOINFORMATICS, V33, P3549, DOI 10.1093/bioinformatics/btx460; Cang ZX, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005690; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Chen HM, 2015, P NATL ACAD SCI USA, V112, P8002, DOI 10.1073/pnas.1505822112; Chen J, 2016, BIOINFORMATICS, V32, P2151, DOI 10.1093/bioinformatics/btw221; Chung F., 1997, SPECTRAL GRAPH THEOR; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dryden NH, 2014, GENOME RES, V24, P1854, DOI 10.1101/gr.175034.114; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Feng X, 2012, INT J NUMER METH BIO, V28, P1198, DOI 10.1002/cnm.2532; Filippova D, 2014, ALGORITHM MOL BIOL, V9, DOI 10.1186/1748-7188-9-14; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Hu M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002893; Imakaev MV, 2015, FEBS LETT, V589, P3031, DOI 10.1016/j.febslet.2015.09.004; Le Dily F, 2014, GENE DEV, V28, P2151, DOI 10.1101/gad.241422.114; Lesne A, 2014, NAT METHODS, V11, P1141, DOI [10.1038/nmeth.3104, 10.1038/NMETH.3104]; Levy-Leduc C, 2014, BIOINFORMATICS, V30, pI386, DOI 10.1093/bioinformatics/btu443; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lu MY, 2005, BIOPHYS J, V89, P2395, DOI 10.1529/biophysj.105.065904; Ming D, 2002, P NATL ACAD SCI USA, V99, P8620, DOI 10.1073/pnas.082148899; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Opron K, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4882258; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sanyal A, 2011, CURR OPIN CELL BIOL, V23, P325, DOI 10.1016/j.ceb.2011.03.009; Schmitt AD, 2016, NAT REV MOL CELL BIO, V17, P743, DOI 10.1038/nrm.2016.104; Schoenfelder S, 2015, GENOME RES, V25, P582, DOI 10.1101/gr.185272.114; Segal MR, 2014, BIOSTATISTICS, V15, P442, DOI 10.1093/biostatistics/kxu003; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Tama F, 2006, ANNU REV BIOPH BIOM, V35, P115, DOI 10.1146/annurev.biophys.35.040405.102010; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wei, 2016, ARXIV161201735; Xia KL, 2018, PHYS CHEM CHEM PHYS, V20, P658, DOI 10.1039/c7cp07177a; Xia K, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4931733; Xia KL, 2015, J COMPUT BIOL, V22, P887, DOI 10.1089/cmb.2015.0104; Xia KL, 2015, J COMPUT CHEM, V36, P1502, DOI 10.1002/jcc.23953; Xia KL, 2014, INT J NUMER METH BIO, V30, P814, DOI 10.1002/cnm.2655; Xia K, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4830404; Xia KL, 2014, J COMPUT PHYS, V257, P912, DOI 10.1016/j.jcp.2013.09.034; Zhang B, 2015, P NATL ACAD SCI USA, V112, P6062, DOI 10.1073/pnas.1506257112; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716; Zhang ZZ, 2013, J COMPUT BIOL, V20, P831, DOI 10.1089/cmb.2013.0076; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	54	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191899	10.1371/journal.pone.0191899	http://dx.doi.org/10.1371/journal.pone.0191899			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408904	gold, Green Published, Green Submitted			2022-12-26	WOS:000424302800028
J	Gong, JH; Zheng, YB; Wang, Y; Sheng, WJ; Li, Y; Liu, XJ; Si, SY; Shao, RG; Zhen, YS				Gong, Jianhua; Zheng, Yanbo; Wang, Ying; Sheng, Weijin; Li, Yi; Liu, Xiujun; Si, Shuyi; Shao, Rongguang; Zhen, Yongsu			A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway	PLOS ONE			English	Article							ATM PROTEIN-KINASE; BIOLOGICAL EVALUATION; ATAXIA-TELANGIECTASIA; CHECKPOINT CONTROL; CARCINOMA-CELLS; DERIVATIVES; CHK2; INHIBITORS; DESIGN; P53	Through cell-based screening models, we have identified a new compound IMB5043, a thiophenylated pyridazinone, which exerted cytotoxicity against cancer cells. In the present study, we evaluated its antitumor efficacy and the possible mechanism. By MTT assay, IMB5043 inhibited the proliferation of various human cancer cells lines, especially hepatocarcinoma SMMC-7721 cells. IMB5043 blocked cell cycle with G2/M arrest, induced cell apoptosis, and inhibited the migration and invasion of SMMC-7721 cells. As verified by comet assay and gamma-H2AX foci formation, IMB5043 caused DNA damage and activated ATM, Chk2 and p53 through phosphorylation. As shown by Gene microarray analysis, the differentially expressed genes in SMMC-7721 cells treated with IMB5043 were highly related to cell death and apoptosis. IMB5043 suppressed the growth of hepatocarcinoma SMMC-7721 xenograft in athymic mice. By histopathological examination, no lesions were found in bone marrow and various organs of the treated mice. Our findings reveal that IMB5043 as an active compound consisting of both pyridazinone and thiophene moieties exerts antitumor efficacy through activation of ATM-Chk2 pathway. IMB5043 may serve as a promising leading compound for the development of antitumor drugs.	[Liu, Xiujun; Si, Shuyi; Shao, Rongguang; Zhen, Yongsu] Chinese Acad Med Sci, Inst Med Biotechnol, Dept Oncol, Beijing, Peoples R China; Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhen, YS (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Dept Oncol, Beijing, Peoples R China.	zhenys@imb.pumc.edu.cn	Gong, Jian-Hua/L-5284-2019		Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences [2017-I2M-1-010]	Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences	This work was supported by grants from Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences [2017-I2M-1-010].	Akhtar W, 2017, MINI REV MED CHEM, V17; Akhtar W, 2016, EUR J MED CHEM, V123, P256, DOI 10.1016/j.ejmech.2016.07.061; Ambrose M, 2013, BLOOD, V121, P4036, DOI 10.1182/blood-2012-09-456897; Annovazzi L, 2017, CANCERS, V9, DOI 10.3390/cancers9060057; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Brooke DG, 2014, BIOORGAN MED CHEM, V22, P1029, DOI 10.1016/j.bmc.2013.12.041; Coutts AS, 2009, P NATL ACAD SCI USA, V106, P19872, DOI 10.1073/pnas.0906785106; Dai XY, 2012, CELL PHYSIOL BIOCHEM, V29, P281, DOI 10.1159/000337609; Dalvie DK, 2002, CHEM RES TOXICOL, V15, P269, DOI 10.1021/tx015574b; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; Dorsch D, 2015, BIOORG MED CHEM LETT, V25, P1597, DOI 10.1016/j.bmcl.2015.02.002; Forsch RA, 2002, BIOORGAN MED CHEM, V10, P2067, DOI 10.1016/S0968-0896(02)00018-4; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Ghorab MM, 2014, ACTA PHARMACEUT, V64, P419, DOI 10.2478/acph-2014-0035; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Jaballah MY, 2017, DRUG RES, V67, P138, DOI 10.1055/s-0042-119992; Jerome KD, 2010, BIOORG MED CHEM LETT, V20, P3146, DOI 10.1016/j.bmcl.2010.03.088; Kim EY, 2016, ARCH PHARM RES, V39, P453, DOI 10.1007/s12272-015-0703-7; Lin HL, 2011, DRUG METAB DISPOS, V39, P345, DOI 10.1124/dmd.110.034074; Lu D, 2017, ACS MED CHEM LETT, V8, P830, DOI 10.1021/acsmedchemlett.7b00172; Marechal A., 2013, COLD SPRING HARB PER, V5; McGowan CH, 2002, CELL CYCLE, V1, P401, DOI 10.4161/cc.1.6.264; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Panathur N, 2016, MED CHEM RES, V25, P135, DOI 10.1007/s00044-015-1473-y; Pommier Y, 2006, CLIN CANCER RES, V12, P2657, DOI 10.1158/1078-0432.CCR-06-0743; Rakesh KS, 2015, MED CHEM, V11, P462, DOI 10.2174/1573406411666141210141918; Romagnoli R, 2013, J MED CHEM, V56, P2606, DOI 10.1021/jm400043d; Saad HA, 2011, MOLECULES, V16, P4937, DOI 10.3390/molecules16064937; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Singh J, 2017, FUTURE MED CHEM, V9, P95, DOI 10.4155/fmc-2016-0194; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Wang J, 2015, BIOORG MED CHEM LETT, V25, P2340, DOI 10.1016/j.bmcl.2015.04.013; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Zhou SG, 2014, EUR J MED CHEM, V83, P581, DOI 10.1016/j.ejmech.2014.06.068; Zuco V, 2010, CANCER LETT, V292, P186, DOI 10.1016/j.canlet.2009.12.001	38	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191984	10.1371/journal.pone.0191984	http://dx.doi.org/10.1371/journal.pone.0191984			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394294	Green Published, gold, Green Submitted			2022-12-26	WOS:000424060400022
J	Hernan, AE; Mahoney, JM; Curry, W; Richard, G; Lucas, MM; Massey, A; Holmes, GL; Scott, RC				Hernan, Amanda E.; Mahoney, J. Matthew; Curry, Willie; Richard, Greg; Lucas, Marcella M.; Massey, Andrew; Holmes, Gregory L.; Scott, Rod C.			Environmental enrichment normalizes hippocampal timing coding in a malformed hippocampus	PLOS ONE			English	Article							NEURONAL MIGRATION DISORDERS; PLACE CELLS; METHYLAZOXYMETHANOL ACETATE; CORTICAL DYSPLASIA; TEMPORAL SEQUENCES; PHASE PRECESSION; ANIMAL-MODEL; RAT; INTERNEURONS; COMPRESSION	Neurodevelopmental insults leading to malformations of cortical development (MCD) are a common cause of psychiatric disorders, learning impairments and epilepsy. In the methylazoxymethanol (MAM) model of MCDs, animals have impairments in spatial cognition that, remarkably, are improved by post-weaning environmental enrichment (EE). To establish how EE impacts network-level mechanisms of spatial cognition, hippocampal in vivo single unit recordings were performed in freely moving animals in an open arena. We took a generalized linear modeling approach to extract fine spike timing (FST) characteristics and related these to place cell fidelity used as a surrogate of spatial cognition. We find that MAM disrupts FST and place-modulated rate coding in hippocampal CA1 and that EE improves many FST parameters towards normal. Moreover, FST parameters predict spatial coherence of neurons, suggesting that mechanisms determining altered FST are responsible for impaired cognition in MCDs. This suggests that FST parameters could represent a therapeutic target to improve cognition even in the context of a brain that develops with a structural abnormality.	[Hernan, Amanda E.; Mahoney, J. Matthew; Curry, Willie; Richard, Greg; Massey, Andrew; Holmes, Gregory L.; Scott, Rod C.] Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA; [Lucas, Marcella M.] Geisel Sch Med Dartmouth, Dept Neurol, Lebanon, NH USA; [Scott, Rod C.] UCL, Inst Child Hlth, London, England	University of Vermont; Dartmouth College; University of London; University College London	Hernan, AE; Scott, RC (corresponding author), Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA.; Scott, RC (corresponding author), UCL, Inst Child Hlth, London, England.	Amanda.Hernan@uvm.edu; Rodney.Scott@uvm.edu		Hernan, Amanda/0000-0003-4931-3481; Scott, Rod/0000-0002-8944-928X	NIH [7R01NS075249-04]; National Institutes of Health - National Institute of Neurological Disease and Stroke [7R01NS075249-04]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075249] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health - National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health - National Institute of Neurological Disease and Stroke, 7R01NS075249-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by NIH grant 7R01NS075249-04 awarded to RCS. The authors declare no conflicts of interest.	Amilhon B, 2015, NEURON, V86, P1277, DOI 10.1016/j.neuron.2015.05.027; Baraban SC, 1995, EPILEPSY RES, V22, P145, DOI 10.1016/0920-1211(95)00045-3; Buzsaki G., 2002, NEURON; Calcagnotto ME, 2005, J NEUROSCI, V25, P9649, DOI 10.1523/JNEUROSCI.2687-05.2005; Casanova MF, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-67; Cascella NG, 2009, NEUROSCI RES, V63, P227, DOI 10.1016/j.neures.2009.01.002; Chadwick A, 2015, ELIFE, V4, DOI 10.7554/eLife.03542; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Fiore M, 2004, NEUROREPORT, V15, P1791, DOI 10.1097/01.wnr.0000135934.03635.6a; Germano IM, 1998, J NEUROSCI RES, V51, P473, DOI 10.1002/(SICI)1097-4547(19980215)51:4<473::AID-JNR7>3.0.CO;2-9; Germano IM, 1996, EPILEPSIA, V37, P902, DOI 10.1111/j.1528-1157.1996.tb00044.x; Hradetzky E, 2012, NEUROPSYCHOPHARMACOL, V37, P364, DOI 10.1038/npp.2011.219; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Jenks KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084492; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kuo MF, 2014, NEUROIMAGE, V85, P948, DOI 10.1016/j.neuroimage.2013.05.117; KUZNIECKY R, 1993, NEUROLOGY, V43, P681, DOI 10.1212/WNL.43.4.681; Lenck-Santini PP, 2008, J NEUROSCI, V28, P5053, DOI 10.1523/JNEUROSCI.5024-07.2008; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Lucas MM, 2011, BRAIN, V134, P1684, DOI 10.1093/brain/awr087; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; MULLER RU, 1987, J NEUROSCI, V7, P1951; Park IM, 2014, NAT NEUROSCI, V17, P1395, DOI 10.1038/nn.3800; Penschuck S, 2006, EUR J NEUROSCI, V23, P279, DOI 10.1111/j.1460-9568.2005.04536.x; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Piontkewitz Y, 2011, BIOL PSYCHIAT, V70, P842, DOI 10.1016/j.biopsych.2011.06.007; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Snyder MA, 2013, NEUROPSYCHOPHARMACOL, V38, P328, DOI 10.1038/npp.2012.180; Yamada S, 2007, K MEANS ADVANTAGES C	32	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191488	10.1371/journal.pone.0191488	http://dx.doi.org/10.1371/journal.pone.0191488			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394267	Green Submitted, Green Published, gold			2022-12-26	WOS:000424060400012
J	Mayaphi, SH; Martin, DJ; Olorunju, SAS; Williams, BG; Quinn, TC; Stoltz, AC				Mayaphi, Simnikiwe H.; Martin, Desmond J.; Olorunju, Steve A. S.; Williams, Brian G.; Quinn, Thomas C.; Stoltz, Anton C.			High risk exposure to HIV among sexually active individuals who tested negative on rapid HIV Tests in the Tshwane District of South Africa-The importance of behavioural prevention measures	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; HETEROSEXUAL TRANSMISSION; DRUG-RESISTANCE; INFECTION; PREVALENCE; THAILAND; COHORT; UGANDA; PARTNERSHIPS	Objective To assess the prevalence of HIV risk behaviour among sexually active HIV sero-negative individuals in the Tshwane district of South Africa (SA). Methods Demographic and HIV risk behaviour data were collected on a questionnaire from participants of a cross-sectional study that screened for early HIV infection using pooled nucleic acid amplification testing (NAAT). The study enrolled individuals who tested negative on rapid HIV tests performed at five HIV counseling and testing (HCT) clinics, which included four antenatal clinics and one general HCT clinic. Results The study enrolled 9547 predominantly black participants (96.6%) with a median age of 27 years (interquartile range [IQR]: 23-31). There were 1661 non-pregnant and 7886 pregnant participants largely enrolled from the general and antenatal HCT clinics, respectively. NAAT detected HIV infection in 61 participants (0.6%; 95% confidence interval [CI]: 0.4-0.8) in the whole study. A high proportion of study participants, 62.8% and 63.0%, were unaware of their partner's HIV status; and also had high prevalence, 88.5% and 99.5%, of recent unprotected sex in the general and pregnant population, respectively. Consistent use of condoms was associated with protection against HIV infection in the general population. Trends of higher odds for HIV infection were observed with most demographic and HIV risk factors at univariate analysis, however, multivariate analysis did not show statistical significance for almost all these factors. A significantly lower risk of HIV infection was observed in circumcised men (p < 0.001). Conclusions These data show that a large segment of sexually active people in the Tshwane district of SA have high risk exposure to HIV. The detection of newly diagnosed HIV infections in all study clinics reflects a wide distribution of individuals who are capable of sustaining HIV transmission in the setting where HIV risk behaviour is highly prevalent. A questionnaire that captures HIV risk behaviour would be useful during HIV counselling and testing to ensure that there is a systematic way of identifying HIV risk factors and that counselling is optimised for each individual. HIV risk behaviour surveillance could be used to inform relevant HIV prevention interventions that could be implemented at a community or population level.	[Mayaphi, Simnikiwe H.; Martin, Desmond J.] Univ Pretoria, Dept Med Virol, City Of Tshwane, South Africa; [Mayaphi, Simnikiwe H.] NHLS TAD, City Of Tshwane, South Africa; [Martin, Desmond J.] Toga Labs, Johannesburg, South Africa; [Olorunju, Steve A. S.] MRC, Biostat Unit, City Of Tshwane, South Africa; [Williams, Brian G.] South African Ctr Epidemiol Modelling & Anal, Stellenbosch, South Africa; [Quinn, Thomas C.] NIAID, Div Intramural Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Quinn, Thomas C.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Stoltz, Anton C.] Univ Pretoria, Dept Internal Med, Div Infect Dis, City Of Tshwane, South Africa	University of Pretoria; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; University of Pretoria	Mayaphi, SH (corresponding author), NHLS TAD, City Of Tshwane, South Africa.	sim.mayaphi@up.ac.za		Mayaphi, Simnikiwe/0000-0002-5453-4353	NHLS Research Trust fund; University of Pretoria; MRC - SIR grant; Discovery Foundation grant; Division of Intramural Research, NIAID, NIH; Toga Laboratories; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000361] Funding Source: NIH RePORTER	NHLS Research Trust fund; University of Pretoria; MRC - SIR grant; Discovery Foundation grant; Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Toga Laboratories; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NHLS Research Trust fund - SHM & DJM, University of Pretoria research assistant grant - SHM, MRC - SIR grant - SHM, Discovery Foundation grant - SHM, and The Division of Intramural Research, NIAID, NIH - TCQ. Prof Desmond J. Martin [DJM] is an employee of a commercial company, Toga Laboratories. The Toga Laboratories provided support in the form of salaries for [DJM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkus JE, 2016, JAIDS-J ACQ IMM DEF, V72, P333, DOI 10.1097/QAI.0000000000000974; Bekker LG, 2014, ANTIVIR THER, V19, P105, DOI 10.3851/IMP2905; Chomba E, 2008, JAIDS-J ACQ IMM DEF, V47, P108, DOI 10.1097/QAI.0b013e31815b2d67; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen M, 2000, AM J PUBLIC HEALTH, V90, P560, DOI 10.2105/AJPH.90.4.560; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Gregson J, 2016, LANCET INFECT DIS, V16, P565, DOI 10.1016/S1473-3099(15)00536-8; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Kagaayi J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092015; Kaiser R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017842; Kalichman SC, 2007, SEX TRANSM INFECT, V83, P371, DOI 10.1136/sti.2006.023630; Kalichman SC, 2007, AM J DRUG ALCOHOL AB, V33, P687, DOI 10.1080/00952990701522716; Karita E, 2016, JAIDS-J ACQ IMM DEF, V73, pE51, DOI 10.1097/QAI.0000000000001138; Kaul R, 2008, J REPROD IMMUNOL, V77, P32, DOI 10.1016/j.jri.2007.02.002; Kirungi WL, 2006, SEX TRANSM INFECT, V82, pI36, DOI 10.1136/sti.2005.017111; Lagarde E, 2001, AIDS, V15, P877, DOI 10.1097/00002030-200105040-00008; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; Manasa J, 2012, AIDS RES HUM RETROV, V28, P558, DOI [10.1089/aid.2011.0284, 10.1089/AID.2011.0284]; Mayaphi SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164943; Mohlabane N, 2015, J PSYCHOL, V6, P19; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Nelson KE, 1996, NEW ENGL J MED, V335, P297, DOI 10.1056/NEJM199608013350501; Onoya D, 2016, PUBLIC HEALTH, V136, P152, DOI 10.1016/j.puhe.2016.03.029; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; Pandey A, 2008, AIDS, V22, pS81, DOI 10.1097/01.aids.0000343766.00573.15; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; Population Reference Bereau, 2016, WORLD POP DAT SHEET; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Punyacharoensin N, 2009, AIDS, V23, P1143, DOI 10.1097/QAD.0b013e32832baa1c; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rosenberg NE, 2016, SEX TRANSM INFECT, V92, P579, DOI 10.1136/sextrans-2016-052651; Shafer LA, 2008, AIDS, V22, P1641, DOI 10.1097/QAD.0b013e32830a7502; Shisana O, 2004, SAMJ S AFR MED J, V94, P537; Shisana O., 2014, AFRICAN NATL HIV P; Statistics SA, 2015, MIDY POP EST; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Strode A, 2010, SAMJ S AFR MED J, V100, P247, DOI 10.7196/SAMJ.3609; Talu A, 2010, INT J DRUG POLICY, V21, P56, DOI 10.1016/j.drugpo.2009.02.007; UNAIDS, 2016, GLOB AIDS UPD; van Griensven F, 2013, AIDS, V27, P825, DOI 10.1097/QAD.0b013e32835c546e; Weiss HA, 2010, AIDS, V24, pS61, DOI 10.1097/01.aids.0000390708.66136.f4; Yuntadilok N, 2014, AIDS BEHAV, V18, pS42, DOI 10.1007/s10461-013-0522-0	42	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192357	10.1371/journal.pone.0192357	http://dx.doi.org/10.1371/journal.pone.0192357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU7VI	29394288	Green Published, gold, Green Submitted			2022-12-26	WOS:000424060400037
J	Cheng, YT; Imanirad, P; Jutooru, I; Hedrick, E; Jin, UH; Hoffman, AR; de Araujo, JL; Morpurgo, B; Golovko, A; Safe, S				Cheng, Yating; Imanirad, Parisa; Jutooru, Indira; Hedrick, Erik; Jin, Un-Ho; Hoffman, Aline Rodrigues; de Araujo, Jeann Leal; Morpurgo, Benjamin; Golovko, Andrei; Safe, Stephen			Role of metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) in pancreatic cancer	PLOS ONE			English	Article							NONCODING RNA MALAT1; TUMOR-GROWTH; LNCRNA MALAT1; POOR-PROGNOSIS; NUCLEAR SPECKLES; REGULATORY ROLE; STEM-CELLS; KAPPA-B; GENE; EXPRESSION	Metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) is a long non-coding RNA (lncRNA) that is a negative prognostic factor for patients with pancreatic cancer and several other tumors. In this study, we show that knockdown of MALAT-1 in Panc1 and other pancreatic cancer cell lines decreases cell proliferation, survival and migration. We previously observed similar results for the lncRNAs HOTTIP and HOTAIR in Panc1 cells; however, RNAseq comparison of genes regulated by MALAT-1 shows minimal overlap with HOTTIP/HOTAIR-regulated genes. Analysis of changes in gene expression after MALAT-1 knockdown shows that this lncRNA represses several tumor suppressor-like genes including N-myc downregulated gene-1 (NDRG-1), a tumor suppressor in pancreatic cancer that is also corepressed by EZH2 (a PRC2 complex member). We also observed that Specificity proteins Sp1, Sp3 and Sp4 are overexpressed in Panc1 cells and Sp knockdown or treatment with small molecules that decrease Sp proteins expression also decrease MALAT-1 expression. We also generated Kras-overexpressing p53L/L;LSL-Kras(G12D)L/+; p48Cre+/-(p53 (L/L)/Kras(G12D)) and p53L/+;LSLKras(G12D)L/+;p48Cre+/-(p53L/+/Kras(G12D)) mice which are p53 homo-and heterozygous, respectively. These mice rapidly develop pancreatic ductal adenocarcinoma-like tumors and were crossed with MALAT-1(-/-) mice. We observed that the loss of one or two MALAT-1 alleles in these Ras overexpressing mice does not significantly affect the time to death; however, the loss of MALAT-1 in the p53(-/+) (heterozygote) mice slightly increases their lifespan.	[Cheng, Yating; Imanirad, Parisa; Jutooru, Indira; Hedrick, Erik; Jin, Un-Ho; Safe, Stephen] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Hoffman, Aline Rodrigues; de Araujo, Jeann Leal] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX USA; [Morpurgo, Benjamin; Golovko, Andrei] Texas A&M Univ, Texas A&M Inst Genom Med, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Safe, S (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA.	ssafe@cvm.tamu.edu	de Araujo, Jeann Leal/S-5955-2019	de Araujo, Jeann Leal/0000-0001-8688-9864	National Institute of Environmental Health Sciences [P30-E5023512]; Texas AgriLife Research	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Texas AgriLife Research	This work was supported by the National Institute of Environmental Health Sciences [P30-E5023512] (SS) and Texas AgriLife Research (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B. D., 2015, CANC RES; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Angst E, 2011, SURGERY, V149, P614, DOI 10.1016/j.surg.2010.11.002; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Cheng YT, 2015, ONCOTARGET, V6, P10840, DOI 10.18632/oncotarget.3450; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Fan Y, 2014, CLIN CANCER RES, V20, P1531, DOI 10.1158/1078-0432.CCR-13-1455; Guerra C, 2013, MOL ONCOL, V7, P232, DOI 10.1016/j.molonc.2013.02.002; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Han YH, 2013, UROLOGY, V81, DOI 10.1016/j.urology.2012.08.044; Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108; Hedrick E, 2016, ONCOTARGET, DOI 10.18632/oncotarget.7925; Hirata H, 2015, CANCER RES, V75, P1322, DOI 10.1158/0008-5472.CAN-14-2931; Hogan B, 1994, MANIPULATING MOUSE E; Hosoi F, 2009, CANCER RES, V69, P4983, DOI 10.1158/0008-5472.CAN-08-4882; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Ji Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078700; Jiao F, 2015, INT J MOL SCI, V16, P6677, DOI 10.3390/ijms16046677; Jiao F, 2014, ONCOL REP, V32, P2485, DOI 10.3892/or.2014.3518; Jutooru I, 2014, MOL CELL BIOL, V34, P2382, DOI 10.1128/MCB.01602-13; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Jutooru I, 2010, MOL PHARMACOL, V78, P226, DOI 10.1124/mol.110.064451; Kim K, 2012, ONCOGENE; Li BZ, 2014, J BIOL CHEM, V289, P29365, DOI 10.1074/jbc.M114.572693; Li L, 2016, MOL CANCER THER, V15, P2232, DOI 10.1158/1535-7163.MCT-16-0008; Li SF, 2015, J CANCER RES CLIN, V141, P1909, DOI 10.1007/s00432-015-1951-0; Liby KT, 2010, CANCER PREV RES, V3, P1427, DOI 10.1158/1940-6207.CAPR-10-0197; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Lin R, 2011, FEBS LETT, V585, P671, DOI 10.1016/j.febslet.2011.01.030; Liu JH, 2014, ASIAN PAC J CANCER P, V15, P2971, DOI 10.7314/APJCP.2014.15.7.2971; Ma KX, 2015, TUMOR BIOL, V36, P3355, DOI 10.1007/s13277-014-2969-7; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Miyagawa R, 2012, RNA, V18, P738, DOI 10.1261/rna.028639.111; Nakagawa S, 2012, RNA, V18, P1487, DOI 10.1261/rna.033217.112; Okugawa Y, 2014, CARCINOGENESIS, V35, P2731, DOI 10.1093/carcin/bgu200; Pang EJ, 2015, TUMOR BIOL, V36, P2403, DOI 10.1007/s13277-014-2850-8; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Shen LQ, 2015, J NEURO-ONCOL, V121, P101, DOI 10.1007/s11060-014-1613-0; Tano K, 2010, FEBS LETT, V584, P4575, DOI 10.1016/j.febslet.2010.10.008; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; West JA, 2014, MOL CELL, V55, P791, DOI 10.1016/j.molcel.2014.07.012; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhao Y, 2014, CANCER RES, V74, P5103, DOI 10.1158/0008-5472.CAN-14-0427; Zheng HT, 2014, INT J CLIN EXP PATHO, V7, P3174; Zong XY, 2011, RNA BIOL, V8, P968, DOI 10.4161/rna.8.6.17606	50	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192264	10.1371/journal.pone.0192264	http://dx.doi.org/10.1371/journal.pone.0192264			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389953	gold, Green Published, Green Submitted			2022-12-26	WOS:000423793400084
J	Conrad, KA; Rodriguez, R; Salcedo, EC; Rauceo, JM				Conrad, Karen A.; Rodriguez, Ronald; Salcedo, Eugenia C.; Rauceo, Jason M.			The Candida albicans stress response gene Stomatin-Like Protein 3 is implicated in ROS-induced apoptotic-like death of yeast phase cells	PLOS ONE			English	Article							HUMAN FUNGAL PATHOGEN; IDENTIFICATION; VISUALIZATION; DISRUPTION; EXPRESSION; FLOTILLIN; SEQUENCE; SKO1	The ubiquitous presence of SPFH (Stomatin, Prohibitin, Flotillin, HflK/HflC) proteins in all domains of life suggests that their function would be conserved. However, SPFH functions are diverse with organism-specific attributes. SPFH proteins play critical roles in physiological processes such as mechanosensation and respiration. Here, we characterize the stomatin ORF19.7296/SLP3 in the opportunistic human pathogen Candida albicans. Consistent with the localization of stomatin proteins, a Slp3p-Yfp fusion protein formed visible puncta along the plasma membrane. We also visualized Slp3p within the vacuolar lumen. Slp3p primary sequence analyses identified four putative S-palmitoylation sites, which may facilitate membrane localization and are conserved features of stomatins. Plasma membrane insertion sequences are present in mammalian and nematode SPFH proteins, but are absent in Slp3p. Strikingly, Slp3p was present in yeast cells, but was absent in hyphal cells, thus categorizing it as a yeast-phase specific protein. Slp3p membrane fluorescence significantly increased in response to cellular stress caused by plasma membrane, cell wall, oxidative, or osmotic perturbants, implicating SLP3 as a general stress-response gene. A slp3 Delta/Delta homozygous null mutant had no detected phenotype when slp3 Delta/Delta mutants were grown in the presence of a variety of stress agents. Also, we did not observe a defect in ion accumulation, filamentation, endocytosis, vacuolar structure and function, cell wall structure, or cytoskeletal structure. However, SLP3 over-expression triggered apoptotic-like death following prolonged exposure to oxidative stress or when cells were induced to form hyphae. Our findings reveal the cellular localization of Slp3p, and for the first time associate Slp3p function with the oxidative stress response.	[Conrad, Karen A.; Rodriguez, Ronald; Salcedo, Eugenia C.; Rauceo, Jason M.] CUNY, John Jay Coll, Dept Sci, New York, NY 10021 USA; [Rodriguez, Ronald] Univ Calif Berkeley, Grad Grp Microbiol, Berkeley, CA 94720 USA; [Salcedo, Eugenia C.] Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94143 USA	City University of New York (CUNY) System; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Rauceo, JM (corresponding author), CUNY, John Jay Coll, Dept Sci, New York, NY 10021 USA.	jrauceo@jjay.cuny.edu			National Institute of General Medical Sciences [SC3GM111133]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM111133] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institute of General Medical Sciences (http://www.nigms.nih.gov/), grant number SC3GM111133 to JMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Armstrong J, 2010, TRENDS CELL BIOL, V20, P580, DOI 10.1016/j.tcb.2010.06.010; Bartolome A, 2016, APMIS, V124, P271, DOI 10.1111/apm.12505; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Cabezon V, 2009, PROTEOMICS, V9, P4770, DOI 10.1002/pmic.200800988; Chaillot J, 2015, ANTIMICROB AGENTS CH, V59, P4584, DOI 10.1128/AAC.00551-15; Chen TW, 2016, CELL BIOL INT, V40, P926, DOI 10.1002/cbin.10636; Christie DA, 2011, MOL CELL BIOL, V31, P3845, DOI 10.1128/MCB.05393-11; Dantas AD, 2015, BIOMOLECULES, V5, P142, DOI 10.3390/biom5010142; David C., 2005, STRATHERN METHODS IN; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Dempwolff F, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006116; Dunkel N, 2014, MICROBIOL-SGM, V160, P1599, DOI 10.1099/mic.0.078238-0; Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Gerami-Nejad M, 2001, YEAST, V18, P859, DOI 10.1002/yea.738; Hao BH, 2013, ANTIMICROB AGENTS CH, V57, P326, DOI 10.1128/AAC.01366-12; HIEBLDIRSCHMIED CM, 1991, BIOCHIM BIOPHYS ACTA, V1065, P195, DOI 10.1016/0005-2736(91)90230-6; HIEBLDIRSCHMIED CM, 1991, BIOCHIM BIOPHYS ACTA, V1090, P123, DOI 10.1016/0167-4781(91)90047-P; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Kaloriti D, 2014, MBIO, V5, DOI 10.1128/mBio.01334-14; Khamooshi K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-56; Lapatsina L, 2012, EUR J CELL BIOL, V91, P240, DOI 10.1016/j.ejcb.2011.01.018; Leach MD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11704; Lee JH, 2017, FASEB J, V31, P47, DOI 10.1096/fj.201600643R; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; Magee PT, 2003, INFECT IMMUN, V71, P2299, DOI 10.1128/IAI.71.5.2299-2309.2003; Mairhofer M, 2009, J BIOL CHEM, V284, P29218, DOI 10.1074/jbc.M109.014993; Marotta DH, 2013, GENOMICS, V102, P363, DOI 10.1016/j.ygeno.2013.06.002; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Nobile CJ, 2008, CELL MICROBIOL, V10, P2180, DOI 10.1111/j.1462-5822.2008.01198.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Osman C, 2007, MOL BIOL CELL, V18, P627, DOI 10.1091/mbc.E06-09-0839; Rauceo JM, 2008, MOL BIOL CELL, V19, P2741, DOI 10.1091/mbc.E08-02-0191; Reuter AT, 2013, EUKARYOT CELL, V12, P529, DOI 10.1128/EC.00324-12; Richards A, 2012, J MICROBIOL METH, V91, P155, DOI 10.1016/j.mimet.2012.08.002; Rivera-Milla E, 2006, CELL MOL LIFE SCI, V63, P343, DOI 10.1007/s00018-005-5434-3; Rungaldier S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178646; Rungaldier S, 2013, BBA-BIOMEMBRANES, V1828, P956, DOI 10.1016/j.bbamem.2012.11.030; Skrzypek MS, 2017, NUCLEIC ACIDS RES, V45, pD592, DOI 10.1093/nar/gkw924; Snyers L, 1998, J BIOL CHEM, V273, P17221, DOI 10.1074/jbc.273.27.17221; STEWART GW, 1992, BLOOD, V79, P1593, DOI 10.1182/blood.V79.6.1593.bloodjournal7961593; Takeshita N, 2012, MOL MICROBIOL, V83, P1136, DOI 10.1111/j.1365-2958.2012.07996.x; Thuaud F, 2013, CHEM BIOL, V20, P316, DOI 10.1016/j.chembiol.2013.02.006; Umlauf E, 2006, J BIOL CHEM, V281, P23349, DOI 10.1074/jbc.M513720200; Vasicek EM, 2014, ANTIMICROB AGENTS CH, V58, P6807, DOI 10.1128/AAC.00064-14; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wai T, 2016, EMBO REP, V17, P1844, DOI 10.15252/embr.201642698; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Wetzel C, 2017, NAT NEUROSCI, V20, P209, DOI 10.1038/nn.4454; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Yu QL, 2015, CHEM-BIOL INTERACT, V227, P1, DOI 10.1016/j.cbi.2014.12.014	54	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192250	10.1371/journal.pone.0192250	http://dx.doi.org/10.1371/journal.pone.0192250			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389961	gold, Green Published			2022-12-26	WOS:000423793400082
J	Dromard, CR; Bouchon-Navaro, Y; Cordonnier, S; Guene, M; Harmelin-Vivien, M; Bouchon, C				Dromard, Charlotte R.; Bouchon-Navaro, Yolande; Cordonnier, Sebastien; Guene, Mathilde; Harmelin-Vivien, Mireille; Bouchon, Claude			Different transfer pathways of an organochlorine pesticide across marine tropical food webs assessed with stable isotope analysis	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; DIPHENYL ETHERS PBDES; FRENCH-WEST-INDIES; TROPHIC TRANSFER; CHLORDECONE EXPOSURE; NITROGEN ISOTOPES; RISK-ASSESSMENT; TRACE-METALS; BIOMAGNIFICATION; BIOACCUMULATION	Chlordecone is a persistent organochlorine pesticide used in the banana fields of the French West Indies from 1972 to 1993. Three marine habitats (mangroves, seagrass beds and coral reefs) of two study sites located downstream contaminated rivers were chosen to evaluate the level of contamination of marine food webs. On each habitat, the food chain collected included suspended organic matter, primary producers (macroalgae, algal turf, seagrass), zooplankton, symbiotic organisms (corals, sea anemones), primary consumers (herbivores, suspension feeders, biofilm feeders), omnivores and detritivores (lobsters, fish), secondary consumers (carnivores 1: invertebrate feeders, planktivores) and tertiary consumers (carnivores 2: invertebrate and fish feeders, piscivores). Log-linear regressions of the concentrations of chlordecone versus nitrogen isotopic ratios (delta(15) N) were used to assess the bioaccumulation of chlordecone along trophic food webs. At each site, bioconcentration and bioamplification take part on the transfer of chlordecone in marine organisms. In mangroves (i.e. close to the source of pollution), lower trophic magnification factors (TMF) indicated that bioconcentration prevailed over bioamplification phenomenon. The opposite phenomenon appeared on coral reefs in which bioconcentration processes were less important and bioamplification pathway became dominant. Far from the source of pollution, molecules of chlordecone seemed to be transfered to organisms mostly via trophic interactions rather than water contact.	[Dromard, Charlotte R.; Bouchon-Navaro, Yolande; Cordonnier, Sebastien; Guene, Mathilde; Bouchon, Claude] Univ Antilles, UMR BOREA, CNRS MNHN UPMC UCBN IRD UA 7208 207, Lab Excellence CORAIL, Pointe a Pitre, Guadeloupe, France; [Harmelin-Vivien, Mireille] Aix Marseille Univ, CNRS IRD UM 110, Inst Mediterraneen Oceanol MIO, Marseille, France	UDICE-French Research Universities; Sorbonne Universite; Universite des Antilles; UDICE-French Research Universities; Aix-Marseille Universite	Dromard, CR (corresponding author), Univ Antilles, UMR BOREA, CNRS MNHN UPMC UCBN IRD UA 7208 207, Lab Excellence CORAIL, Pointe a Pitre, Guadeloupe, France.	charlotte.dromard@univ-antilles.fr		Dromard, Charlotte R./0000-0003-2463-5687	LABEX CORAIL; Contrat de Recherche Developpement Chlohal 2	LABEX CORAIL; Contrat de Recherche Developpement Chlohal 2	This study was funded by the LABEX CORAIL (stable isotope analyses) and by the "Contrat de Recherche Developpement Chlohal 2" coordinated by the Prefecture of Martinique Island (chlordecone analyses) to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell L, 1998, CAN J FISH AQUAT SCI, V55, P1114, DOI 10.1139/cjfas-55-5-1114; Bayen S, 2005, CHEMOSPHERE, V61, P303, DOI 10.1016/j.chemosphere.2005.02.097; Bertrand J, 2013, RESULTATS CAMPAGNES; Borga K, 2001, ENVIRON POLLUT, V113, P187, DOI 10.1016/S0269-7491(00)00171-8; Bouchon C, 2003, NIVEAU CONTAMINATION; Bouchon C, 2007, CONTAMINATION PESTIC; Bouchon C, 2016, ENVIRON SCI POLLUT R, V23, P61, DOI 10.1007/s11356-015-5682-1; BROMAN D, 1992, ENVIRON TOXICOL CHEM, V11, P331; CABANA G, 1994, NATURE, V372, P255, DOI 10.1038/372255a0; Cabidoche YM, 2009, ENVIRON POLLUT, V157, P1697, DOI 10.1016/j.envpol.2008.12.015; Cabidoche YM., 2011, INNOV AGRON, V16, P117; Cattan P, 2006, SOIL TILL RES, V86, P38, DOI 10.1016/j.still.2005.02.002; Charlotte DR, 2016, MAR POLLUT BULL, V107, P102, DOI 10.1016/j.marpolbul.2016.04.012; Coat S, 2006, AQUAT LIVING RESOUR, V19, P181, DOI 10.1051/alr:2006016; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Dietz R, 2000, SCI TOTAL ENVIRON, V245, P221, DOI 10.1016/S0048-9697(99)00447-7; Dromard C. R., 2017, ENVIRON SCI POLLUT R, P1; Dromard CR, 2016, ENVIRON SCI POLLUT R, V23, P73, DOI 10.1007/s11356-015-4732-z; EPSTEIN SS, 1978, SCI TOTAL ENVIRON, V9, P1, DOI 10.1016/0048-9697(78)90002-5; EVANS MS, 1991, ARCH ENVIRON CON TOX, V20, P87, DOI 10.1007/BF01065333; Fernandez A, 2007, MAR POLLUT BULL, V54, P1681, DOI 10.1016/j.marpolbul.2007.08.007; FISHER DJ, 1983, AQUAT TOXICOL, V4, P219, DOI 10.1016/0166-445X(83)90019-X; Fisk AT, 2001, ENVIRON SCI TECHNOL, V35, P732, DOI 10.1021/es001459w; GLYNN PW, 1995, MAR POLLUT BULL, V30, P397, DOI 10.1016/0025-326X(94)00206-O; Harmelin-Vivien M, 2012, MAR POLLUT BULL, V64, P974, DOI 10.1016/j.marpolbul.2012.02.014; HAWKER DW, 1985, CHEMOSPHERE, V14, P1835, DOI 10.1016/0045-6535(85)90126-2; Haynes D, 2000, MAR POLLUT BULL, V41, P267, DOI 10.1016/S0025-326X(00)00134-X; Haynes D, 2000, MAR POLLUT BULL, V41, P288, DOI 10.1016/S0025-326X(00)00127-2; Hoekstra PF, 2003, ENVIRON POLLUT, V124, P509, DOI 10.1016/S0269-7491(02)00482-7; HUFF JE, 1978, J ENVIRON PATHOL TOX, V1, P377; Jarman WM, 1996, ENVIRON SCI TECHNOL, V30, P654, DOI 10.1021/es950392n; Joly PB, 1968, RECONSTRUCTION CHRON; Kay SH, 1984, POTENTIAL BIOMAGNIFI; Kidd KA, 2001, ENVIRON SCI TECHNOL, V35, P14, DOI 10.1021/es001119a; Kiriluk RM, 1995, CAN J FISH AQUAT SCI, V52, P2660, DOI 10.1139/f95-855; Kucklick JR, 1996, ENVIRON TOXICOL CHEM, V15, P1388, DOI [10.1897/1551-5028(1996)015&lt;1388:ODITPF&gt;2.3.CO;2, 10.1002/etc.5620150819]; LEBLANC GA, 1995, ENVIRON SCI TECHNOL, V29, P154, DOI 10.1021/es00001a020; Liang Y, 1999, WATER RES, V33, P1337, DOI 10.1016/S0043-1354(98)00353-4; LOGANATHAN BG, 1994, AMBIO, V23, P187; Luellen DR, 2006, SCI TOTAL ENVIRON, V358, P286, DOI 10.1016/j.scitotenv.2005.08.046; Ma XD, 2013, MAR POLLUT BULL, V74, P110, DOI 10.1016/j.marpolbul.2013.07.020; Mancinelli G, 2015, ESTUAR COAST SHELF S, V156, P195, DOI 10.1016/j.ecss.2014.11.030; Mizukawa K, 2009, MAR POLLUT BULL, V58, P1217, DOI 10.1016/j.marpolbul.2009.03.008; Multigner L, 2016, ENVIRON SCI POLLUT R, V23, P3, DOI 10.1007/s11356-015-4621-5; Multigner L, 2010, J CLIN ONCOL, V28, P3457, DOI 10.1200/JCO.2009.27.2153; Paez-Osuna F, 2002, MAR POLLUT BULL, V44, P1303, DOI 10.1016/S0025-326X(02)00172-8; Russell RW, 1999, ENVIRON TOXICOL CHEM, V18, P1250, DOI [10.1002/etc.5620180626, 10.1897/1551-5028(1999)018&lt;1250:ROCAEF&gt;2.3.CO;2]; Salvat B, 2016, ENVIRON SCI POLLUT R, V23, P49, DOI 10.1007/s11356-015-4395-9; Schaffelke B, 2005, MAR POLLUT BULL, V51, P279, DOI 10.1016/j.marpolbul.2004.10.025; Simcock A, 2016, 1 GLOBAL INTEGRATED, P1; Strandberg B, 1998, SCI TOTAL ENVIRON, V217, P143, DOI 10.1016/S0048-9697(98)00173-9; Sun YX, 2015, MAR POLLUT BULL, V99, P150, DOI 10.1016/j.marpolbul.2015.07.041; THOMANN RV, 1984, ENVIRON SCI TECHNOL, V18, P65, DOI 10.1021/es00120a003; Vallack HW, 1998, ENVIRON TOXICOL PHAR, V6, P143, DOI 10.1016/S1382-6689(98)00036-2; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6	55	18	18	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191335	10.1371/journal.pone.0191335	http://dx.doi.org/10.1371/journal.pone.0191335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390017	Green Submitted, Green Published, gold			2022-12-26	WOS:000423793400016
J	Okhovat, MA; Ziari, K; Ranjbaran, R; Nikouyan, N				Okhovat, Mohammad Ali; Ziari, Katayoun; Ranjbaran, Reza; Nikouyan, Negin			The effect of histone deacetylase inhibitors on AHSP expression	PLOS ONE			English	Article							HEMOGLOBIN-STABILIZING PROTEIN; KRUPPEL-LIKE FACTOR; HOMOZYGOUS BETA-THALASSEMIA; GLOBIN MESSENGER-RNA; CHAIN FATTY-ACIDS; FACTOR EKLF GENE; ALPHA-HEMOGLOBIN; GAMMA-GLOBIN; ERYTHROPOIESIS; INDUCTION	Alpha-hemoglobin stabilizing protein (AHSP) is a molecular chaperone that can reduce the damage caused by excess free alpha-globin to erythroid cells in patients with impaired beta-globin chain synthesis. We assessed the effect of sodium phenylbutyrate and sodium valproate, two histone deacetylase inhibitors (HDIs) that are being studied for the treatment of hemoglobinopathies, on the expression of AHSP, BCL11A (all isoforms), gamma-globin genes (HBG1/2), and some related transcription factors including GATA1, NFE2, EKLF, KLF4, and STAT3. For this purpose, the K562 cell line was cultured for 2, 4, and 6 days in the presence and absence of sodium phenylbutyrate and sodium valproate. Relative real-time qRT-PCR analysis of mRNA levels was performed to determine the effects of the two compounds on gene expression. Expression of all target mRNAs increased significantly (p < 0.05), except for the expression of BCL11A, which was down-regulated (p < 0.05) in the cells treated with both compounds relative to the levels measured for untreated cells. The findings indicated that sodium valproate had a more considerable effect than sodium phenylbutyrate (p < 0.0005) on BCL11A repression and the up-regulation of other studied genes. gamma-Globin and AHSP gene expression continuously increased during the culture period in the treated cells, with the highest gene expression observed for 1 mM sodium valproate after 6 days. Both compounds repressed the expression of BCL11A (-XL, -L, -S) and up-regulated GATA1, NFE2, EKLF, KLF4, STAT3, AHSP, and gamma-globin genes expression. Moreover, sodium valproate showed a stronger effect on repressing BCL11A and escalating the expression of other target genes. The findings of this in vitro experiment could be considered in selecting drugs for clinical use in patients with beta-hemoglobinopathies.	[Okhovat, Mohammad Ali; Ranjbaran, Reza; Nikouyan, Negin] Shiraz Univ Med Sci, Sch Paramed Sci, Diagnost Lab Sci & Technol Res Ctr, Shiraz, Iran; [Ziari, Katayoun] AJA Univ Med Sci, Besat Hosp, Dept Pathol, Tehran, Iran	Shiraz University of Medical Science	Okhovat, MA (corresponding author), Shiraz Univ Med Sci, Sch Paramed Sci, Diagnost Lab Sci & Technol Res Ctr, Shiraz, Iran.; Ziari, K (corresponding author), AJA Univ Med Sci, Besat Hosp, Dept Pathol, Tehran, Iran.	Okhovat.Clinicallab@gmail.com; Dr.Katayoun.Ziari@gmail.com	Okhovat, Mohammad Ali/B-9586-2014; Ranjbaran, Reza/AAA-5838-2020; Ranjbaran, Reza/AGM-4558-2022; ziari, Katayoun/ABG-1108-2021	Okhovat, Mohammad Ali/0000-0003-2137-1428; Ranjbaran, Reza/0000-0002-8890-0999; Nikouyan, Negin/0000-0003-3588-2448				Anderson KP, 1998, J BIOL CHEM, V273, P14347, DOI 10.1074/jbc.273.23.14347; Borgna-Pignatti C, 2007, BRIT J HAEMATOL, V138, P291, DOI 10.1111/j.1365-2141.2007.06654.x; Cao C, 2014, SCI CHINA LIFE SCI, V57, P488, DOI 10.1007/s11427-014-4652-z; Chen ZY, 2009, BLOOD CELL MOL DIS, V42, P144, DOI 10.1016/j.bcmd.2008.12.003; Chenais B, 1997, LEUKEMIA, V11, P1575, DOI 10.1038/sj.leu.2400755; COLLINS AF, 1994, BLOOD, V84, P1690; COLLINS AF, 1995, BLOOD, V85, P43, DOI 10.1182/blood.V85.1.43.bloodjournal85143; CROSSLEY M, 1994, J BIOL CHEM, V269, P15440; Dempsey NJ, 2003, BLOOD, V102, P4214, DOI 10.1182/blood-2002-12-3766; dos Santos CO, 2008, AM J HEMATOL, V83, P103, DOI 10.1002/ajh.21041; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; Galanello R, 2003, BLOOD, p1881a; Gallagher PG, 2005, J BIOL CHEM, V280, P39016, DOI 10.1074/jbc.M506062200; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Jalali Far Mohammad Ali, 2016, Int J Hematol Oncol Stem Cell Res, V10, P37; Kalra IS, 2011, BRIT J HAEMATOL, V154, P248, DOI 10.1111/j.1365-2141.2011.08710.x; Keys JR, 2007, BRIT J HAEMATOL, V136, P150, DOI 10.1111/j.1365-2141.2006.06381.x; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kim YW, 2011, NUCLEIC ACIDS RES, V39, P6944, DOI 10.1093/nar/gkr253; Lai MI, 2006, BRIT J HAEMATOL, V133, P675, DOI 10.1111/j.1365-2141.2006.06075.x; LIAKOPOULOU E, 1995, BLOOD, V86, P3227; Lim WF, 2012, BLOOD CELL MOL DIS, V48, P17, DOI 10.1016/j.bcmd.2011.10.002; PERRINE SP, 1987, BIOCHEM BIOPH RES CO, V148, P694, DOI 10.1016/0006-291X(87)90932-6; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pilon AM, 2006, MOL CELL BIOL, V26, P4368, DOI 10.1128/MCB.02216-05; Platt OS, 2008, NEW ENGL J MED, V358, P1362, DOI 10.1056/NEJMct0708272; Ranjbaran R, 2014, ANN CLIN LAB SCI, V44, P189; Reich S, 2000, BLOOD, V96, P3357, DOI 10.1182/blood.V96.10.3357.h8003357_3357_3363; Ronzoni L, 2014, BRIT J HAEMATOL, V165, P714, DOI 10.1111/bjh.12814; Sankaran VG, 2011, HEMATOL-AM SOC HEMAT, P459, DOI 10.1182/asheducation-2011.1.459; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Sedgewick AE, 2008, BLOOD CELL MOL DIS, V41, P255, DOI 10.1016/j.bcmd.2008.06.007; Selby R, 1997, VALPROIC ACID AUGMEN; SHER GD, 1995, NEW ENGL J MED, V332, P1606, DOI 10.1056/NEJM199506153322404; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; Steliou K, 2012, BIORESEARCH OPEN ACC, V1, P192, DOI 10.1089/biores.2012.0223; Tallack MR, 2013, CURR OPIN HEMATOL, V20, P193, DOI 10.1097/MOH.0b013e32835f59ba; Testa U, 2009, ANN HEMATOL, V88, P505, DOI 10.1007/s00277-008-0637-y; Weinberg RS, 2005, BLOOD, V105, P1807, DOI 10.1182/blood-2004-02-0454; Weiss MJ, 2005, ANN NY ACAD SCI, V1054, P103, DOI 10.1196/annals.1345.013; Witt O, 2002, AM J HEMATOL, V71, P45, DOI 10.1002/ajh.10161; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; Zhao Guo-wei, 2010, Chinese Medical Sciences Journal, V25, P193, DOI 10.1016/S1001-9294(11)60001-1; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	45	5	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0189267	10.1371/journal.pone.0189267	http://dx.doi.org/10.1371/journal.pone.0189267			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389946	Green Published, Green Submitted, gold			2022-12-26	WOS:000423793400003
J	Sinko, K; Jagsch, R; Drog, C; Mosgoeller, W; Wutzl, A; Millesi, G; Klug, C				Sinko, Klaus; Jagsch, Reinhold; Drog, Claudio; Mosgoeller, Wilhelm; Wutzl, Arno; Millesi, Gabriele; Klug, Clemens			Facial esthetics and the assignment of personality traits before and after orthognathic surgery rated on video clips	PLOS ONE			English	Article							1ST IMPRESSIONS; ATTRACTIVENESS; FACE	Typically, before and after surgical correction faces are assessed on still images by surgeons, orthodontists, the patients, and family members. We hypothesized that judgment of faces in motion and by naive raters may closer reflect the impact on patients' real life, and the treatment impact on e.g. career chances. Therefore we assessed faces from dysgnathic patients (Class II, III and Laterognathia) on video clips. Class I faces served as anchor and controls. Each patient's face was assessed twice before and after treatment in changing sequence, by 155 naive raters with similar age to the patients. The raters provided independent estimates on aesthetic trait pairs like ugly/beautiful, and personality trait pairs like dominant /flexible. Furthermore the perception of attractiveness, intelligence, health, the persons' erotic aura, faithfulness, and five additional items were rated. We estimated the significance of the perceived treatment related differences and the respective effect size by general linear models for repeated measures. The obtained results were comparable to our previous rating on still images. There was an overall trend, that faces in video clips are rated along common stereotypes to a lesser extent than photographs. We observed significant class differences and treatment related changes of most aesthetic traits (e.g. beauty, attractiveness), these were comparable to intelligence, erotic aura and to some extend healthy appearance. While some personality traits (e.g. faithfulness) did not differ between the classes and between baseline and after treatment, we found that the intervention significantly and effectively altered the perception of the personality trait self-confidence. The effect size was highest in Class III patients, smallest in Class II patients, and in between for patients with Laterognathia. All dysgnathic patients benefitted from orthognathic surgery. We conclude that motion can mitigate marked stereotypes but does not entirely offset the mostly negative perception of dysgnathic faces.	[Sinko, Klaus; Wutzl, Arno; Millesi, Gabriele; Klug, Clemens] Med Univ Vienna, Clin Craniomaxillofacial & Oral Surg, Vienna, Austria; [Jagsch, Reinhold] Univ Vienna, Dept Psychol, Clin Psychol & Hlth Psychol, Vienna, Austria; [Drog, Claudio] Med Univ Vienna, Univ Clin Dent, Vienna, Austria; [Mosgoeller, Wilhelm] Med Univ Vienna, Inst Canc Res, Vienna, Austria	Medical University of Vienna; University of Vienna; Medical University of Vienna; Medical University of Vienna	Sinko, K (corresponding author), Med Univ Vienna, Clin Craniomaxillofacial & Oral Surg, Vienna, Austria.	klaus.sinko@meduniwien.ac.at		Jagsch, Reinhold/0000-0002-3864-6048; Klug, Clemens/0000-0001-7307-6397				Cellerino A, 2003, J Endocrinol Invest, V26, P45; Cunningham SJ, 1996, BRIT J ORAL MAX SURG, V34, P210, DOI 10.1016/S0266-4356(96)90271-5; Dayan S, 2004, AESTHET PLAST SURG, V28, P301, DOI 10.1007/s00266-004-1017-1; DESMIT A, 1984, AM J ORTHOD DENTOFAC, V86, P67, DOI 10.1016/0002-9416(84)90278-1; DION K, 1972, J PERS SOC PSYCHOL, V24, P285, DOI 10.1037/h0033731; Honn M, 2008, J OROFAC ORTHOP, V69, P20, DOI 10.1007/s00056-008-0735-4; Honn Mirjam, 2005, J Orofac Orthop, V66, P187, DOI 10.1007/s00056-005-0445-0; Islam S, 2017, J PLAST RECONSTR AES, V70, P931, DOI 10.1016/j.bjps.2017.03.012; Johnston C, 2005, EUR J ORTHODONT, V27, P129, DOI 10.1093/ejo/cjh093; Johnston P, 2013, CORTEX, V49, P2462, DOI 10.1016/j.cortex.2013.01.002; Kessler H., 2011, PSYCHOSOCIAL MED, V8; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Little AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002106; Livingston RW, 2009, PSYCHOL SCI, V20, P1229, DOI 10.1111/j.1467-9280.2009.02431.x; Michiels G, 1994, Int J Adult Orthodon Orthognath Surg, V9, P95; O'Toole AJ, 2011, VISION RES, V51, P74, DOI 10.1016/j.visres.2010.09.035; Rhodes G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026653; Rubenstein AJ, 2005, PSYCHOL SCI, V16, P759, DOI 10.1111/j.1467-9280.2005.01610.x; Sinko K, 2012, INT J ORAL MAX SURG, V41, P469, DOI 10.1016/j.ijom.2011.10.026; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x	20	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191718	10.1371/journal.pone.0191718	http://dx.doi.org/10.1371/journal.pone.0191718			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU3ZZ	29390018	Green Submitted, gold, Green Published			2022-12-26	WOS:000423793400029
J	Teuschl, Y; Trapl, M; Ratajczak, P; Matz, K; Dachenhausen, A; Brainin, M				Teuschl, Yvonne; Trapl, Michaela; Ratajczak, Paulina; Matz, Karl; Dachenhausen, Alexandra; Brainin, Michael			Systematic dysphagia screening and dietary modifications to reduce stroke-associated pneumonia rates in a stroke-unit	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; GUGGING SWALLOWING SCREEN; RESPIRATORY-INFECTIONS; OUTCOMES; RISK; INTERVENTION; PREDICTORS; ASPIRATION; MANAGEMENT; DIAGNOSIS	Background and purpose While formal screening for dysphagia following acute stroke is strongly recommended, there is little evidence on how multi-consistency screening and dietary modifications affect the rate of stroke-associated pneumonia (SAP). This observational study reports which factors affect formal screening on a stroke-unit and how dietary recommendations relate to SAP. Method Analyses from a database including 1394 patients admitted with acute stroke at our stroke-unit in Austria between 2012 and 2014. Dietary modifications were performed following the recommendations from the Gugging Swallowing Screen (GUSS). Patients evaluated with GUSS were compared to the unscreened patients. Results Overall, 993 (71.2%) patients were screened with GUSS; of these 50 (5.0%) developed SAP. In the 401 unscreened patients, the SAP rate was similar: 22 (5.5%). Multivariable analysis showed that either mild to very mild strokes or very severe strokes were less likely to undergo formal screening. Older age, pre-existing disability, history of hypertension, atrial fibrillation, stroke severity, cardiological and neurological complications, nasogastric tubes, and intubation were significant markers for SAP. Out of 216 patients, 30 (13.9%) developed SAP in spite of receiving nil per mouth (NPO). Conclusion The routine use of GUSS is less often applied in either mild strokes or very severe strokes. While most patients with high risk of SAP were identified by GUSS and assigned to NPO, dietary modifications could not prevent SAP in 1 of 7 cases. Other causes of SAP such as silent aspiration, bacteraemia or central breathing disturbances should be considered.	[Teuschl, Yvonne; Ratajczak, Paulina; Matz, Karl; Dachenhausen, Alexandra; Brainin, Michael] Danube Univ Krems, Dept Clin Neurosci & Prevent Med, Krems, Austria; [Trapl, Michaela; Matz, Karl] Univ Hosp Tulln, Dept Neurol, Tulln, Austria; [Matz, Karl] Karl Landsteiner Univ Hlth Sci, Krems, Austria	Danube University Krems	Brainin, M (corresponding author), Danube Univ Krems, Dept Clin Neurosci & Prevent Med, Krems, Austria.	michael.brainin@donau-uni.ac.at		Matz, Karl/0000-0002-2851-9897; Trapl-Grundschober, Michaela/0000-0003-3740-9136; Teuschl, Yvonne/0000-0002-1755-7943				Al-Khaled M, 2016, CEREBROVASC DIS, V42, P81, DOI 10.1159/000445299; Aoki S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154608; Arnold M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148424; Baijens LWJ, 2016, CLIN INTERV AGING, V11, P1403, DOI 10.2147/CIA.S107750; Bray BD, 2017, J NEUROL NEUROSUR PS, V88, P25, DOI 10.1136/jnnp-2016-313356; Brogan E, 2014, DYSPHAGIA, V29, P340, DOI 10.1007/s00455-013-9514-5; Carnaby G, 2006, LANCET NEUROL, V5, P31, DOI 10.1016/S1474-4422(05)70252-0; Cichero JAY, 2017, DYSPHAGIA, V32, P293, DOI 10.1007/s00455-016-9758-y; de Lima Alvarenga EH, 2017, EUR ARCH OTORHINOLAR; Ferrari J, 2010, NEUROLOGY, V74, P136, DOI 10.1212/WNL.0b013e3181c9188b; Finlayson O, 2011, NEUROLOGY, V77, P1338, DOI 10.1212/WNL.0b013e31823152b1; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hinchey JA, 2005, STROKE, V36, P1972, DOI 10.1161/01.STR.0000177529.86868.8d; Joundi RA, 2017, STROKE, V48, P900, DOI 10.1161/STROKEAHA.116.015332; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; Kishore AK, 2015, STROKE, V46, P1202, DOI 10.1161/STROKEAHA.114.007843; Lakshminarayan K, 2010, STROKE, V41, P2849, DOI 10.1161/STROKEAHA.110.597039; Langdon PC, 2009, NEUROEPIDEMIOLOGY, V32, P107, DOI 10.1159/000177036; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Masrur S, 2013, J STROKE CEREBROVASC, V22, pE301, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.013; Paciaroni M, 2004, EUR NEUROL, V51, P162, DOI 10.1159/000077663; Palli C, 2017, STROKE, V48, P2583, DOI 10.1161/STROKEAHA.117.018157; Smith CJ, 2015, STROKE, V46, P2335, DOI 10.1161/STROKEAHA.115.009617; Smith CJ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001307; Smithard DG, 2007, AGE AGEING, V36, P90, DOI 10.1093/ageing/afl149; Teuschl Y, 2013, STROKE, V44, P1070, DOI 10.1161/STROKEAHA.111.676114; Titsworth WL, 2013, STROKE, V44, P3154, DOI 10.1161/STROKEAHA.111.000204; Trapl M, 2017, EUR J NEUROL, V24, pE34, DOI 10.1111/ene.13298; Trapl M, 2007, STROKE, V38, P2948, DOI 10.1161/STROKEAHA.107.483933; Warnecke T, 2017, EUR J NEUROL, V24, P594, DOI 10.1111/ene.13251; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110	31	21	30	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192142	10.1371/journal.pone.0192142	http://dx.doi.org/10.1371/journal.pone.0192142			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389984	gold, Green Published, Green Submitted			2022-12-26	WOS:000423793400070
J	Mintz, M; Khair, S; Grewal, S; LaComb, JF; Park, J; Channer, B; Rajapakse, R; Bucobo, JC; Buscaglia, JM; Monzur, F; Chawla, A; Yang, J; Robertson, CE; Frank, DN; Li, E				Mintz, Michael; Khair, Shanawaj; Grewal, Suman; LaComb, Joseph F.; Park, Jiyhe; Channer, Breana; Rajapakse, Ramona; Bucobo, Juan Carlos; Buscaglia, Jonathan M.; Monzur, Farah; Chawla, Anupama; Yang, Jie; Robertson, Charlie E.; Frank, Daniel N.; Li, Ellen			Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; COLONOSCOPY; MANAGEMENT; SIGNATURES; DIVERSITY; ALIGNMENT	Background Studies of colonoscopic fecal microbiota transplant (FMT) in patients with recurrent CDI, indicate that this is a very effective treatment for preventing further relapses. In order to provide this service at Stony Brook University Hospital, we initiated an open-label prospective study of single colonoscopic FMT among patients with >= 2 recurrences of CDI, with the intention of monitoring microbial composition in the recipient before and after FMT, as compared with their respective donor. We also initiated a concurrent open label prospective trial of single colonoscopic FMT of patients with ulcerative colitis (UC) not responsive to therapy, after obtaining an IND permit (IND 15642). To characterize how FMT alters the fecal microbiota in patients with recurrent Clostridia difficile infections (CDI) and/or UC, we report the results of a pilot microbiome analysis of 11 recipients with a history of 2 or more recurrences of C. difficile infections without inflammatory bowel disease (CDI-only), 3 UC recipients with recurrent C. difficile infections (CDI + UC), and 5 UC recipients without a history of C. difficile infections (UC-only). Method V3V4 Illumina 16S ribosomal RNA (rRNA) gene sequencing was performed on the pre-FMT, 1-week post-FMT, and 3-months post-FMT recipient fecal samples along with those collected from the healthy donors. Fitted linear mixed models were used to examine the effects of Group (CDI-only, CDI + UC, UC-only), timing of FMT (Donor, pre-FMT, 1-week post-FMT, 3-months post-FMT) and first order Group*FMT interactions on the diversity and composition of fecal microbiota. Pairwise comparisons were then carried out on the recipient vs. donor and between the pre-FMT, 1-week post-FMT, and 3-months post-FMT recipient samples within each group. Results Significant effects of FMT on overall microbiota composition (e.g., beta diversity) were observed for the CDI-only and CDI + UC groups. Marked decreases in the relative abundances of the strictly anaerobic Bacteroidetes phylum, and two Firmicutes sub-phyla associated with butyrate production (Ruminococcaceae and Lachnospiraceae) were observed between the CDI-only and CDI + UC recipient groups. There were corresponding increases in the microaerophilic Proteobacteria phylum and the Firmicutes/Bacilli group in the CDI-only and CDI + UC recipient groups. At a more granular level, significant effects of FMT were observed for 81 genus-level operational taxonomic units (OTUs) in at least one of the three recipient groups (p<0.00016 with Bonferroni correction). Pairwise comparisons of the estimated pre-FMT recipient/donor relative abundance ratios identified 6 Gammaproteobacteria OTUs, including the Escherichia-Shigella genus, and 2 Fusobacteria OTUs with significantly increased relative abundance in the pre-FMT samples of all three recipient groups (FDR < 0.05), however the magnitude of the fold change was much larger in the CDI-only and CDI + UC recipients than in the UC-only recipients. Depletion of butyrate producing OTUs, such as Faecalibacterium, in the CDI-only and CDI + UC recipients, were restored after FMT. Conclusion The results from this pilot study suggest that the microbial imbalances in the CDI + UC recipients more closely resemble those of the CDI-only recipients than the UC-only recipients.	[Mintz, Michael; Khair, Shanawaj; Grewal, Suman; LaComb, Joseph F.; Channer, Breana; Rajapakse, Ramona; Bucobo, Juan Carlos; Buscaglia, Jonathan M.; Monzur, Farah; Li, Ellen] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Park, Jiyhe] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Chawla, Anupama] SUNY Stony Brook, Dept Pediat, Stony Brook, NY 11794 USA; [Yang, Jie] SUNY Stony Brook, Dept Family Populat & Prevent Med, Stony Brook, NY 11794 USA; [Robertson, Charlie E.; Frank, Daniel N.] Univ Colorado Denver, Dept Med, Aurora, CO USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Li, E (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	ellen.li@stonybrookmedicine.edu		Khair, shanawaj/0000-0001-7902-5689; Yang, Jie/0000-0003-3469-5931; LaComb, Joseph/0000-0002-2981-1072	Simons Foundation [1130410 1 7408]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	Simons Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Simons Foundation (1130410 1 7408) to EL (https://www.simonsfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Bakken JS, 2011, CLIN GASTROENTEROL H, V9, P1044, DOI 10.1016/j.cgh.2011.08.014; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Fuentes S, 2017, ISME J, V11, P1877, DOI 10.1038/ismej.2017.44; Garey KW, 2008, J HOSP INFECT, V70, P298, DOI 10.1016/j.jhin.2008.08.012; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Hourigan SK, 2015, ALIMENT PHARM THER, V42, P741, DOI 10.1111/apt.13326; Hughes ER, 2017, CELL HOST MICROBE, V21, P208, DOI 10.1016/j.chom.2017.01.005; Johnson S, 2009, J INFECTION, V58, P403, DOI 10.1016/j.jinf.2009.03.010; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Khanna S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0269-3; Koroleva EP, 2015, J IMMUNOL METHODS, V421, P61, DOI 10.1016/j.jim.2015.02.003; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Li E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026284; Lopez-Siles M, 2017, ISME J, V11, P841, DOI 10.1038/ismej.2016.176; Mattila E, 2012, GASTROENTEROLOGY, V142, P490, DOI 10.1053/j.gastro.2011.11.037; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; Nelson RL, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004610.pub5; Olsen MA, 2015, CLIN MICROBIOL INFEC, V21, P164, DOI 10.1016/j.cmi.2014.08.017; Paine ER, 2014, GASTROENTEROL REP, V2, P161, DOI 10.1093/gastro/gou028; Petersen AM, 2015, SCAND J GASTROENTERO, V50, P1199, DOI 10.3109/00365521.2015.1028993; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rao K, 2016, INFLAMM BOWEL DIS, V22, P1744, DOI 10.1097/MIB.0000000000000793; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Rossen NG, 2015, GASTROENTEROLOGY, V149, P110, DOI 10.1053/j.gastro.2015.03.045; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Son JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137725; Song Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0081330, 10.1371/journal.pone.0075729]; Staley C, 2016, MBIO, V7, DOI 10.1128/mBio.01965-16; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Yoon SS, 2010, J CLIN GASTROENTEROL, V44, P562, DOI 10.1097/MCG.0b013e3181dac035	39	18	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0190997	10.1371/journal.pone.0190997	http://dx.doi.org/10.1371/journal.pone.0190997			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385143	Green Submitted, gold, Green Published			2022-12-26	WOS:000423668400029
J	Mupfumi, L; Moyo, S; Molebatsi, K; Thami, PK; Anderson, M; Mogashoa, T; Iketleng, T; Makhema, J; Marlink, R; Kasvosve, I; Essex, M; Musonda, RM; Gaseitsiwe, S				Mupfumi, Lucy; Moyo, Sikhulile; Molebatsi, Kesaobaka; Thami, Prisca K.; Anderson, Motswedi; Mogashoa, Tuelo; Iketleng, Thato; Makhema, Joseph; Marlink, Ric; Kasvosve, Ishmael; Essex, Max; Musonda, Rosemary M.; Gaseitsiwe, Simani			Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT PROGRAMS; RISK-FACTORS; EARLY MORTALITY; HIGH-INCOME; MYCOBACTERIUM-TUBERCULOSIS; SOUTH-AFRICA; ADULTS; INITIATION; RATES; TERM	Background There is a high burden of tuberculosis (TB) in HIV antiretroviral programmes in Africa. However, few studies have looked at predictors of incident TB while on Truvada-based combination antiretroviral therapy (cART) regimens. Methods We estimated TB incidence among individuals enrolled into an observational cohort evaluating the efficacy and tolerability of Truvada-based cART in Gaborone, Botswana between 2008 and 2011. We used Cox proportional hazards regressions to determine predictors of incident TB. Results Of 300 participants enrolled, 45 (15%) had a diagnosis of TB at baseline. During 428 person-years (py) of follow-up, the incidence rate of TB was 3.04/100py (95% CI, 1.695.06), with 60% of the cases occurring within 3 months of ART initiation. Incident cases had low baseline CD4+ T cell counts (153cells/mm(3) [Q1, Q3: 82, 242]; p = 0.69) and hemoglobin levels (9.2g/dl [Q1, Q3: 8.5,10.1]; p<0.01). In univariate analysis, low BMI (HR = 0.73; 95% CI 0.580.91; p = 0.01) and hemoglobin levels <8 g/dl (HR = 10.84; 95%CI: 2.9940.06; p<0.01) were risk factors for TB. Time to incident TB diagnosis was significantly reduced in patients with poor immunological recovery (p = 0.04). There was no association between baseline viral load and risk of TB (HR = 1.75; 95%CI: 0.704.37). Conclusion Low hemoglobin levels prior to initiation of ART are significant predictors of incident tuberculosis. Therefore, there is potential utility of iron biomarkers to identify patients at risk of TB prior to initiation on ART. Furthermore, additional strategies are required for patients with poor immunological recovery to reduce excess risk of TB while on ART.	[Mupfumi, Lucy; Moyo, Sikhulile; Thami, Prisca K.; Anderson, Motswedi; Mogashoa, Tuelo; Iketleng, Thato; Makhema, Joseph; Marlink, Ric; Essex, Max; Musonda, Rosemary M.; Gaseitsiwe, Simani] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Mupfumi, Lucy; Mogashoa, Tuelo; Kasvosve, Ishmael] Univ Botswana, Sch Allied Hlth Profess, Dept Med Lab Sci, Gaborone, Botswana; [Moyo, Sikhulile; Makhema, Joseph; Marlink, Ric; Essex, Max; Musonda, Rosemary M.; Gaseitsiwe, Simani] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Molebatsi, Kesaobaka] Univ Botswana, Dept Stat, Gaborone, Botswana; [Thami, Prisca K.; Anderson, Motswedi] Univ Botswana, Dept Biol Sci, Gaborone, Botswana; [Iketleng, Thato] Univ KwaZulu Natal, Coll Hlth Sci, Durban, South Africa; [Marlink, Ric] Rutgers State Univ, Rutgers Global Hlth Inst, Robert Wood Johnson Med Sch, New Brunswick, NJ USA	Botswana-Harvard AIDS Institute Partnership; University of Botswana; Harvard University; Harvard T.H. Chan School of Public Health; University of Botswana; University of Botswana; University of Kwazulu Natal; Rutgers State University New Brunswick; Rutgers State University Medical Center	Mupfumi, L (corresponding author), Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana.; Mupfumi, L (corresponding author), Univ Botswana, Sch Allied Hlth Profess, Dept Med Lab Sci, Gaborone, Botswana.	lmupfumi@bhp.org.bw	Moyo, Sikhulile/E-1464-2015	Moyo, Sikhulile/0000-0003-3821-4592; Iketleng, Thato/0000-0002-5725-295X; Mupfumi, Lucy/0000-0002-2290-2481; Kasvosve, Ishmael/0000-0002-2046-545X; Mogashoa, Tuelo/0000-0003-4156-8746; THAMI, PRISCA/0000-0002-4550-2560	Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [DEL-15-006]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107752/Z/15/Z]; UK government; SANTHE; ACHAP; Government of Botswana; Bill AMP; Melinda Gates Foundation; MSD/Merck Company Foundation; Fogarty International Center, of the National Institutes of Health [D43 TWO10543]; National Institute of Mental Health, of the National Institutes of Health [D43 TWO10543]; FOGARTY INTERNATIONAL CENTER [D43TW009610, D43TW010543] Funding Source: NIH RePORTER	Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); UK government; SANTHE; ACHAP; Government of Botswana; Bill AMP; Melinda Gates Foundation(CGIAR); MSD/Merck Company Foundation; Fogarty International Center, of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Mental Health, of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported through the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [grant # DEL-15-006]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [grant # 107752/Z/15/Z] and the UK government. The views expressed in this publication are those of the author(s) and not necessarily those of MS, NEPAD Agency, Wellcome Trust or the UK government. LM, KM, PT, TM& SG received funding from SANTHE. The Bomolemo study was funded by ACHAP, a country-led, public private development partnership between the Government of Botswana, the Bill & Melinda Gates Foundation, and the MSD/Merck Company Foundation. SM was supported by the Fogarty International Center and National Institute of Mental Health, of the National Institutes of Health under Award Number D43 TWO10543. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2016, ORAL DIS, V22, P53, DOI 10.1111/odi.12390; Alemu YM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009058; Anderson M, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw140; Auld AF, 2013, PLOS ONE, P8; Benova L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035948; Bisson GP, 2015, CURR HIV-AIDS REP, V12, P107, DOI 10.1007/s11904-015-0256-x; Brennan AT, 2016, INT J TUBERC LUNG D, V20, P1040, DOI 10.5588/ijtld.15.0488; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Chang CA, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv154; del Amo J, 2012, CLIN INFECT DIS, V54, P1364, DOI 10.1093/cid/cis203; Dhasmana DJ, 2008, DRUGS, V68, P191, DOI 10.2165/00003495-200868020-00004; Diedrich CR, 2016, J INFECT DIS, V214, P1309, DOI 10.1093/infdis/jiw313; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Gaardbo JC, 2008, CLIN EXP IMMUNOL, V154, P80, DOI 10.1111/j.1365-2249.2008.03725.x; Gaardbo JC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/670957; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Gupta RK, 2015, LANCET HIV, V2, pE243, DOI 10.1016/S2352-3018(15)00063-6; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Hermans SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010527; Karim SSA, 2011, LANCET, V378, pE23, DOI 10.1016/S0140-6736(11)61136-7; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Kerkhoff AD, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0320-9; Kufa T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1598-8; Lawn SD, 2005, CLIN INFECT DIS, V41, P1783, DOI 10.1086/498308; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2005, AM J RESP CRIT CARE, V172, P1348, DOI 10.1164/ajrccm.172.10.1348; Lawn SD, 2005, CLIN INFECT DIS, V41, P1683, DOI 10.1086/498030; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2008, LANCET, V372, P287, DOI 10.1016/S0140-6736(08)61101-0; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2006, SAMJ S AFR MED J, V96, P502; Lawn SD, 2011, AIDS, V25, P1554, DOI 10.1097/QAD.0b013e328348fb61; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Liu EJ, 2015, AIDS, V29, P1391, DOI 10.1097/QAD.0000000000000705; Middelkoop K, 2011, JAIDS-J ACQ IMM DEF, V56, P263, DOI 10.1097/QAI.0b013e31820413b3; Minchella PA, 2014, INT J TUBERC LUNG D, V18, P1337, DOI 10.5588/ijtld.14.0143; Minchella PA, 2015, CLIN INFECT DIS, V60, P764, DOI 10.1093/cid/ciu945; Mupfumi L, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu038; Pathmanathan I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173309; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; Rangaka MX, 2013, LANCET INFECT DIS, V13, P825, DOI 10.1016/S1473-3099(13)70218-4; Ravimohan S, 2013, J INFECT DIS, V208, P1784, DOI 10.1093/infdis/jit368; Samandari T, 2015, AIDS, V29, P351, DOI 10.1097/QAD.0000000000000535; Sumner T, 2016, AIDS, V30, P1279, DOI 10.1097/QAD.0000000000001078; Theron G, 2014, LANCET INFECT DIS, V14, P527, DOI 10.1016/S1473-3099(13)70360-8; Thobakgale C, 2017, JAIDS-J ACQ IMM DEF, V74, P213, DOI 10.1097/QAI.0000000000001181; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; Van Tieu H, 2009, AIDS RES HUM RETROV, V25, P1083, DOI 10.1089/aid.2009.0055; Visser ME, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003650.pub4; Wood R, 2007, AM J RESP CRIT CARE, P175	52	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0192030	10.1371/journal.pone.0192030	http://dx.doi.org/10.1371/journal.pone.0192030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385208	Green Published, Green Submitted, gold			2022-12-26	WOS:000423668400071
J	Li, F; Xu, RJ; Low, BE; Lin, CL; Garcia-Barros, M; Schrandt, J; Mileva, I; Snider, A; Luo, CK; Jiang, XC; Li, MS; Hannun, YA; Obeid, LM; Wiles, MV; Mao, CG				Li, Fang; Xu, Ruijuan; Low, Benjamin E.; Lin, Chih-Li; Garcia-Barros, Monica; Schrandt, Jennifer; Mileva, Izolda; Snider, Ashley; Luo, Catherine K.; Jiang, Xian-Cheng; Li, Ming-Song; Hannun, Yusuf A.; Obeid, Lina M.; Wiles, Michael V.; Mao, Cungui			Alkaline ceramidase 2 is essential for the homeostasis of plasma sphingoid bases and their phosphates	FASEB JOURNAL			English	Article						sphingosine-1-phosphate; sphingolipid; plasma; hematopoietic cell; erythrocyte	VASCULAR DEVELOPMENT; DIHYDROSPHINGOSINE 1-PHOSPHATE; FUNCTIONAL-CHARACTERIZATION; LYMPHOCYTE EGRESS; MOLECULAR-CLONING; SPHINGOSINE-1-PHOSPHATE; RECEPTOR; MICE; KINASE; GENE	Sphingosine-1-phosphate (S1P) plays important roles in cardiovascular development and immunity. S1P is abundant in plasma because erythrocytes-the major source of S1P-lack any S1P-degrading activity; however, much remains unclear about the source of the plasma S1P precursor, sphingosine (SPH), derived mainly from the hydrolysis of ceramides by the action of ceramidases that are encoded by 5 distinct genes, acid ceramidase 1 (ASAH1)/Asah1, ASAH2/Asah2, alkaline ceramidase 1 (ACER1)/Acerl, ACER2/Acer2, and ACER3/Acer3, in humans/ mice. Previous studies have reported that knocking out Asahl or Asah2 failed to reduce plasma SPH and S1P levels in mice. In this study, we show that knocking out Acerl or Acer3 also failed to reduce the blood levels of SPH or S1P in mice. In contrast, knocking out Acer2 from either whole body or the hematopoietic lineage markedly decreased the blood levels of SPH and S1P in mice. Of interest, knocking out Acer2 from whole-body or the hematopoietic lineage also markedly decreased the levels of dihydrosphingosine (dhSPH) and dihydrosphingosine-1-phosphate (dhS1P) in blood. Taken together, these results suggest that ACER2 plays a key role in the maintenance of high plasma levels of sphingoid base-1-phosphates-S1P and dhS1P-by controlling the generation of sphingoid bases-SPH and dhSPH-in hematopoietic cells.				Michael.Wiles@jax.org; cungui.mao@stonybrook.edu	xu, rui/GRX-5734-2022	Luo, Catherine K/0000-0002-2646-9566; wiles, michael/0000-0002-3620-8386	U.S. National Institutes of Health, National Cancer Institute [R01-CA163825, P01-CA097132]; Sphingolipid Animal Cancer Pathobiology Shared Resource Core; NATIONAL CANCER INSTITUTE [P01CA097132, R01CA163825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM130878, R35GM118128] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sphingolipid Animal Cancer Pathobiology Shared Resource Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Peter M. Kutny (Genetic Engineering Technologies, The Jackson Laboratory) for assistance with microinjections, Cindy Avery at the Jackson Laboratory for animal maintenance and genotyping, and Ping Ji (State University of New York at Stony Brook) for assistance with histological analysis. The authors also thank Dr. Ye Chen (Southern Medical University) for assistance with animal studies. This work was supported, in whole or in part, by U.S. National Institutes of Health, National Cancer Institute Grants R01-CA163825 (to C.M.) and P01-CA097132 (to Y.A.H. and C.M.). This work was also supported by the Sphingolipid Animal Cancer Pathobiology Shared Resource Core. The authors declare no conflicts of interest.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Barth BM, 2013, ACS NANO, V7, P2132, DOI 10.1021/nn304862b; Bu S, 2008, J BIOL CHEM, V283, P19593, DOI 10.1074/jbc.M802417200; Callihan P, 2012, NEUROPHARMACOLOGY, V62, P988, DOI 10.1016/j.neuropharm.2011.10.005; Chun J, 2010, PHARMACOL REV, V62, P579, DOI 10.1124/pr.110.003111; Coant Nicolas, 2017, Advances in Biological Regulation, V63, P122, DOI 10.1016/j.jbior.2016.10.002; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cui YZ, 2002, BONE MARROW TRANSPL, V30, P843, DOI 10.1038/sj.bmt.1703766; Cutignano A, 2010, PROSTAG OTH LIPID M, V93, P25, DOI 10.1016/j.prostaglandins.2010.06.001; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Dworski S, 2017, BBA-MOL BASIS DIS, V1863, P386, DOI 10.1016/j.bbadis.2016.11.031; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gazit SL, 2016, CIRC RES, V119, pE110, DOI 10.1161/CIRCRESAHA.116.308929; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Lin CL, 2017, STEM CELL REP, V9, P1488, DOI 10.1016/j.stemcr.2017.09.015; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Low BE, 2016, METHODS MOL BIOL, V1438, P19, DOI 10.1007/978-1-4939-3661-8_2; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Mendelson K, 2014, DEVELOPMENT, V141, P5, DOI 10.1242/dev.094805; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Moritz E, 2017, CLIN CHIM ACTA, V468, P25, DOI 10.1016/j.cca.2017.01.029; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Onuma T, 2017, THROMB RES, V156, P91, DOI 10.1016/j.thromres.2017.06.001; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Pyne NJ, 2017, MOLECULES, V22, DOI 10.3390/molecules22030344; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rosen H, 2003, IMMUNOL REV, V195, P160, DOI 10.1034/j.1600-065X.2003.00068.x; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Snider AJ, 2012, PROSTAG OTH LIPID M, V99, P124, DOI 10.1016/j.prostaglandins.2012.08.003; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Veret J, 2013, BBA-MOL CELL BIOL L, V1831, P251, DOI 10.1016/j.bbalip.2012.10.003; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Wang K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005591; Wang Yiming, 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P126; Xiang YQ, 2014, J CLIN INVEST, V124, P4823, DOI 10.1172/JCI77685; Xu RJ, 2010, FASEB J, V24, P2507, DOI 10.1096/fj.09-153635; Zhou JH, 1998, BIOCHEM BIOPH RES CO, V242, P502, DOI 10.1006/bbrc.1997.7993	46	24	24	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3058	3069		10.1096/fj.201700445RR	http://dx.doi.org/10.1096/fj.201700445RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401619	Green Published			2022-12-26	WOS:000432546000014
J	Wijesekara, N; Goncalves, RA; Ahrens, R; De Felice, FG; Fraser, PE				Wijesekara, Nadeeja; Goncalves, Rafaella Araujo; Ahrens, Rosemary; De Felice, Fernanda G.; Fraser, Paul E.			Tau ablation in mice leads to pancreatic beta cell dysfunction and glucose intolerance	FASEB JOURNAL			English	Article						insulin; MAPT; islets; Alzheimer's disease	ALZHEIMERS-DISEASE; AMYLOID-BETA; INSULIN-SECRETION; TRANSGENIC MICE; PROTEIN-TAU; MICROTUBULES; NEURODEGENERATION; HYPERGLYCEMIA; EXPRESSION; ISOFORMS	The microtubule-associated protein tau is highly expressed in pancreatic islets. Abnormally phosphorylated tau aggregates assemble into neurofibrillary tangles linked to Alzheimer's disease pathology and has also been found in islets of patients with type 2 diabetes. However, the significance of tau in islet function remains relatively unexplored. Therefore, we investigated the role of tau on beta cell function and glucose homeostasis using tau knockout (tauKO) mice. TauKO mice were hyperglycemic and glucose intolerant at an early age. Islet insulin content was reduced and proinsulin levels were significantly elevated in tauKO mice, resulting in impaired glucose-stimulated insulin secretion. Loss of tau also resulted in increased epididymal fat mass and leptin levels, reduced glucose production, and insulin resistance at later ages, leading to complete onset of diabetes. Transgenic expression of human tau in islets was unable to rescue those defects in glucose regulation, indicating structural and/or functional differences between mouse and human tau. Cumulatively, these results suggest an important role for tau in the proper maintenance of pancreatic beta cell function and glucose homeostasis.	[Wijesekara, Nadeeja; Goncalves, Rafaella Araujo; Ahrens, Rosemary; Fraser, Paul E.] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,60 Leonard Ave, Toronto, ON M5T 2S8, Canada; [Goncalves, Rafaella Araujo; De Felice, Fernanda G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo Meis, Rio De Janeiro, Brazil; [De Felice, Fernanda G.] Queens Univ, Ctr Neurosci Studies, Dept Biomed & Mol Sci, Kingston, ON, Canada	Krembil Research Institute; University of Toronto; University of Toronto; Universidade Federal do Rio de Janeiro; Queens University - Canada	Wijesekara, N (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,60 Leonard Ave, Toronto, ON M5T 2S8, Canada.	nadeeja.wijesekara@utoronto.ca	Wijesekara, Nadeeja/AAW-7230-2021	Araujo Goncalves da Silva, Rafaella/0000-0001-5334-0816	Diabetes Canada; Brazilian funding agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); International Union of Biochemistry and Molecular Biology (IUBMB); International Society for Neurochemistry (ISN); Canadian Institutes of Health Research (CIHR) [MOP-115056]	Diabetes Canada; Brazilian funding agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); International Union of Biochemistry and Molecular Biology (IUBMB); International Society for Neurochemistry (ISN); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	N.W. was supported by a postdoctoral fellowship from Diabetes Canada. R.A.G. was supported by a predoctoral fellowship from the Brazilian funding agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and by research fellowships from the International Union of Biochemistry and Molecular Biology (IUBMB) and the International Society for Neurochemistry (ISN). This study was operationally funded by the Canadian Institutes of Health Research (CIHR) Grant MOP-115056 to P.E.F. The authors declare no conflicts of interest.	Allen B, 2002, J NEUROSCI, V22, P9340; Amitani M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00051; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Bharadwaj P, 2017, J ALZHEIMERS DIS, V59, P421, DOI 10.3233/JAD-161192; BOYD AE, 1982, J CELL BIOL, V92, P425, DOI 10.1083/jcb.92.2.425; BRION JP, 1993, J NEUROCHEM, V61, P2071, DOI 10.1111/j.1471-4159.1993.tb07444.x; Chuang CC, 2007, ENDOCRINOLOGY, V148, P4267, DOI 10.1210/en.2007-0179; Dawson HN, 2001, J CELL SCI, V114, P1179; Easom RA, 1999, DIABETES, V48, P675, DOI 10.2337/diabetes.48.4.675; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gu YJ, 1996, J NEUROCHEM, V67, P1235; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Ke Yazi D, 2012, Int J Alzheimers Dis, V2012, P873270, DOI 10.1155/2012/873270; Lei P, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-29; Liu C., 2013, ABSTR APPL ANAL, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0084849; Maj M, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1964634; Maj M, 2010, J ENDOCRINOL, V205, P25, DOI 10.1677/JOE-09-0341; MALAISSELAGAE F, 1979, J CLIN INVEST, V63, P1284, DOI 10.1172/JCI109423; Marciniak E, 2017, J EXP MED, V214, P2257, DOI 10.1084/jem.20161731; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Medina M, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020021; Miklossy J, 2010, NEUROBIOL AGING, V31, P1503, DOI 10.1016/j.neurobiolaging.2008.08.019; Murakami T, 2006, AM J PATHOL, V169, P1365, DOI 10.2353/ajpath.2006.051250; Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004; Stuart AAV, 2012, J CLIN ENDOCR METAB, V97, P463, DOI 10.1210/jc.2011-1858; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Wijesekara N, 2017, FASEB J, V31, P5409, DOI 10.1096/fj.201700431R; Yang Y, 2013, NEUROSCIENCE, V250, P140, DOI 10.1016/j.neuroscience.2013.07.009; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008; Zhu XD, 2015, DEV CELL, V34, P656, DOI 10.1016/j.devcel.2015.08.020; Zierath JR, 2003, BEST PRACT RES CL EN, V17, P385, DOI 10.1016/S1521-690X(03)00040-X	36	28	29	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3166	3173		10.1096/fj.201701352	http://dx.doi.org/10.1096/fj.201701352			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401605				2022-12-26	WOS:000432546000022
J	Hu, K; Jastrab, JB; Zhang, SS; Kovach, A; Zhao, GP; Darwin, KH; Li, HL				Hu, Kuan; Jastrab, Jordan B.; Zhang, Susan; Kovach, Amanda; Zhao, Gongpu; Darwin, K. Heran; Li, Huilin			Proteasome substrate capture and gate opening by the accessory factor PafE from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; COMPLEX; SYSTEM; ACTIVATION; MECHANISMS; INSIGHTS; BINDING	In all domains of life, proteasomes are gated, chambered proteases that require opening by activators to facilitate protein degradation. Twelve proteasome accessory factor E (PafE) monomers assemble into a single dodecameric ring that promotes proteolysis required for the full virulence of the human bacterial pathogen Mycobacterium tuberculosis. Whereas the best characterized proteasome activators use ATP to deliver proteins into a proteasome, PafE does not require ATP. Here, to unravel the mechanism of PafE-mediated protein targeting and proteasome activation, we studied the interactions of PafE with native substrates, including a newly identified proteasome substrate, the ParA-like protein, Rv3213c, and with proteasome core particles. We characterized the function of a highly conserved feature in bacterial proteasome activator proteins: a glycine-glutamine-tyrosine-leucine (GQYL) motif at their C termini that is essential for stimulating proteolysis. Using cryoelectron microscopy (cryo-EM), we found that the GQYL motif of PafE interacts with specific residues in the alpha subunits of the proteasome core particle to trigger gate opening and degradation. Finally, we also found that PafE rings have 40-angstrom openings lined with hydrophobic residues that form a chamber for capturing substrates before they are degraded, suggesting PafE has a previously unrecognized chaperone activity. In summary, we have identified the interactions between PafE and the proteasome core particle that cause conformational changes leading to the opening of the proteasome gate and have uncovered a mechanism of PafE-mediated substrate degradation. Collectively, our results provide detailed insights into the mechanism of ATP-independent proteasome degradation in bacteria.	[Hu, Kuan; Kovach, Amanda; Zhao, Gongpu; Li, Huilin] Van Andel Res Inst, Cryo EM Struct Biol Lab, Grand Rapids, MI 49503 USA; [Jastrab, Jordan B.; Zhang, Susan; Darwin, K. Heran] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Van Andel Institute; New York University	Li, HL (corresponding author), 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	Heran.Darwin@med.nyu.edu; Huilin.Li@vai.org		Darwin, K Heran/0000-0002-5043-7548; Li, Huilin/0000-0001-8085-8928	National Institutes of Health [AI070285, AI088075, T32 AI007180, F30 AI110067]; Van Andel Research Institute; Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F30AI110067, T32AI007180, R01AI088075, R01AI070285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Van Andel Research Institute; Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants AI070285 (to H. L.), AI088075 (to K. H. D.), and T32 AI007180 and F30 AI110067 (to J. B. J.), and the Van Andel Research Institute (to H. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by an Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bai L, 2016, P NATL ACAD SCI USA, V113, pE1983, DOI 10.1073/pnas.1512094113; Becker SH, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00036-16; Bolten M, 2016, STRUCTURE, V24, P2138, DOI 10.1016/j.str.2016.10.008; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Darwin KH, 2005, MOL MICROBIOL, V55, P561, DOI 10.1111/j.1365-2958.2004.04403.x; Das Gupta T, 2008, MICROBIOL-SGM, V154, P484, DOI 10.1099/mic.0.2007/012294-0; Delley CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114348; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Festa RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008589; Finley D, 2016, TRENDS BIOCHEM SCI, V41, P77, DOI 10.1016/j.tibs.2015.10.009; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Hu GQ, 2006, MOL MICROBIOL, V59, P1417, DOI 10.1111/j.1365-2958.2005.05036.x; Huang XL, 2016, NAT STRUCT MOL BIOL, V23, P778, DOI 10.1038/nsmb.3273; Huber EM, 2017, STRUCTURE, V25, P1473, DOI 10.1016/j.str.2017.07.013; Iwanczyk J, 2006, J MOL BIOL, V363, P648, DOI 10.1016/j.jmb.2006.08.010; Jastrab J. B., 2017, J BACTERIOL, V199; Jastrab JB, 2015, ANNU REV MICROBIOL, V69, P109, DOI 10.1146/annurev-micro-091014-104201; Jastrab JB, 2015, P NATL ACAD SCI USA, V112, pE1763, DOI 10.1073/pnas.1423319112; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Knowlton JR, 1997, NATURE, V390, P639, DOI 10.1038/37670; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/NMETH.2727, 10.1038/nmeth.2727]; Li DY, 2010, EMBO J, V29, P2037, DOI 10.1038/emboj.2010.95; Lin G, 2006, MOL MICROBIOL, V59, P1405, DOI 10.1111/j.1365-2958.2005.05035.x; Mierzejewska J, 2012, PLASMID, V67, P1, DOI 10.1016/j.plasmid.2011.08.003; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Samanovic MI, 2016, TRENDS MICROBIOL, V24, P26, DOI 10.1016/j.tim.2015.10.001; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Wang T, 2010, NAT STRUCT MOL BIOL, V17, P1352, DOI 10.1038/nsmb.1918; Watrous J, 2010, MOL BIOSYST, V6, P376, DOI 10.1039/b916104j; Wehmer M, 2017, P NATL ACAD SCI USA, V114, P1305, DOI 10.1073/pnas.1621129114; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Wu YJ, 2017, MOL MICROBIOL, V105, P227, DOI 10.1111/mmi.13695; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	40	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4713	4723		10.1074/jbc.RA117.001471	http://dx.doi.org/10.1074/jbc.RA117.001471			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29414791	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000428848300014
J	Stepanov, A; Karelina, T; Markevich, N; Demin, O; Nicholas, T				Stepanov, Alexander; Karelina, Tatiana; Markevich, Nikolai; Demin, Oleg; Nicholas, Timothy			A mathematical model of multisite phosphorylation of tau protein	PLOS ONE			English	Article							SITE-SPECIFIC PHOSPHORYLATION; ALZHEIMERS; DEPHOSPHORYLATION; SPECTROSCOPY; TRUNCATION; GSK-3-BETA; TOXICITY; PP2A	Abnormal tau metabolism followed by formation of tau deposits causes a number of neurodegenerative diseases called tauopathies including Alzheimer's disease. Hyperphosphorylation of tau protein precedes tau aggregation and is a topic of interest for the development of pharmacological interventions to prevent pathology progression at early stages. The development of a mathematical model of multisite phosphorylation of tau would be helpful for searching for the targets of pharmacological interventions and candidates for biomarkers of pathology progression. In the present study, we for the first time developed a model of multisite phosphorylation of tau protein and elucidated the relative contribution of kinases to phosphorylation of distinct sites. The model describes phosphorylation of tau or PKA-prephosphorylated tau by GSK3 beta and CDK5 and dephosphorylation by PP2A, accurately reproducing the data for short-term kinetics of tau (de)phosphorylation. Our results suggest that kinase inhibition may more specifically prevent tau hyperphosphorylation, e.g., on PHF sites, which are key biomarkers of pathological changes in Alzheimer's disease. The main features of our model are partial phosphorylation of tau residues and merging of random and sequential mechanisms of multisite phosphorylation within the framework of the probability-based approach assuming independent phosphorylation events.	[Stepanov, Alexander; Karelina, Tatiana; Markevich, Nikolai; Demin, Oleg] InSysBio, Moscow, Russia; [Nicholas, Timothy] Pfizer Global R&D, Groton, CT USA; [Markevich, Nikolai] RAS, Inst Theoret & Expt Biophys, Pushchino, Russia	Pfizer; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics	Stepanov, A (corresponding author), InSysBio, Moscow, Russia.	stepanov@insysbio.com	Stepanov, Alexander/V-7287-2019; markevich, nikolai i/J-9564-2014; Stepanov, Alexander/GQY-8569-2022	Stepanov, Alexander/0000-0002-9113-9440; Stepanov, Alexander/0000-0002-9113-9440				Amniai L, 2011, BIOCHEM BIOPH RES CO, V412, P743, DOI 10.1016/j.bbrc.2011.08.046; Ben Bouallegue F, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0260-z; Billingsley ML, 1997, BIOCHEM J, V323, P577, DOI 10.1042/bj3230577; Borisov NM, 2005, BIOPHYS J, V89, P951, DOI 10.1529/biophysj.105.060533; Buus S, 2012, MOL CELL PROTEOMICS, V11, P1790, DOI 10.1074/mcp.M112.020800; Chu DD, 2016, J ALZHEIMERS DIS, V49, P365, DOI 10.3233/JAD-150497; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; Cummings Jeffrey, 2016, Alzheimers Dement (N Y), V2, P222, DOI 10.1016/j.trci.2016.07.001; Danos V, 2004, THEOR COMPUT SCI, V325, P69, DOI 10.1016/j.tcs.2004.03.065; Danos V, 2007, LECT NOTES COMPUT SC, V4703, P17; Ding HP, 2006, J BIOL CHEM, V281, P19107, DOI 10.1074/jbc.M511697200; Faeder JR, 2005, SYSTEMS BIOL, V2, P5, DOI 10.1049/sb:20045031; Flores-Rodriguez P, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00033; Gizzatkulov NM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-109; Godemann R, 1999, FEBS LETT, V454, P157, DOI 10.1016/S0014-5793(99)00741-3; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Ittner A, 2016, SCIENCE, V354, P904, DOI 10.1126/science.aah6205; Jin NN, 2017, FEBS LETT, V591, P1053, DOI 10.1002/1873-3468.12617; Kawakami F, 2013, FEBS J, P1; Khanna MR, 2016, ALZHEIMERS DEMENT, V12, P1051, DOI 10.1016/j.jalz.2016.06.006; Kiris E, 2011, J BIOL CHEM, V286, P14257, DOI 10.1074/jbc.M111.219311; Kolobkov D, 2016, J BIOPHARM STAT, V26, P742, DOI 10.1080/10543406.2015.1052818; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Landrieu I, 2010, BIOCHEM SOC T, V38, P1006, DOI 10.1042/BST0381006; Lasagna-Reeves CA, 2016, NEURON, V92, P407, DOI 10.1016/j.neuron.2016.09.022; Leroy A, 2010, J BIOL CHEM, V285, P33435, DOI 10.1074/jbc.M110.149419; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu F, 2006, FEBS LETT, V580, P6269, DOI 10.1016/j.febslet.2006.10.033; Lovestone S, 2015, J ALZHEIMERS DIS, V45, P75, DOI 10.3233/JAD-141959; Medina Miguel, 2011, Int J Alzheimers Dis, V2011, P479249, DOI 10.4061/2011/479249; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Povellato G, 2014, BIOL OPEN, V3, P1, DOI 10.1242/bio.20136692; Salazar C, 2009, FEBS J, V276, P3177, DOI 10.1111/j.1742-4658.2009.07027.x; Sengupta A, 1997, MOL CELL BIOCHEM, V167, P99, DOI 10.1023/A:1006883924775; Struyfs H, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00138; Suwanmajo T, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1405; Suwanmajo T, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0742; Wang YX, 2015, NEUROBIOL AGING, V36, P188, DOI 10.1016/j.neurobiolaging.2014.07.035; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Yao XQ, 2011, BIOCHEM J, V437, P335, DOI 10.1042/BJ20110347	40	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192519	10.1371/journal.pone.0192519	http://dx.doi.org/10.1371/journal.pone.0192519			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408874	gold, Green Published, Green Submitted			2022-12-26	WOS:000424302800078
J	Sandlund, L; Kongshaug, H; Horsberg, TE; Male, R; Nilsen, F; Dalvin, S				Sandlund, Liv; Kongshaug, Heidi; Horsberg, Tor Einar; Male, Rune; Nilsen, Frank; Dalvin, Sussie			Identification and characterisation of the ecdysone biosynthetic genes neverland, disembodied and shade in the salmon louse Lepeophtheirus salmonis (Copepoda, Caligidae)	PLOS ONE			English	Article							ECDYSTEROID BIOSYNTHESIS; MOLECULAR CHARACTERIZATION; RECEPTOR; REPRODUCTION; EXPRESSION; REGULATOR; EVOLUTION; PATHWAYS; ENZYMES; PROTEIN	The salmon louse is a marine ectoparasitic copepod on salmonid fishes. Its lifecycle consists of eight developmental stages, each separated by a molt. In crustaceans and insects, molting and reproduction is controlled by circulating steroid hormones such as 20-hydroxyecdysone. Steroid hormones are synthesized from cholesterol through catalytic reactions involving a 7,8-dehydrogenase Neverland and several cytochrome P450 genes collectively called the Halloween genes. In this study, we have isolated and identified orthologs of never-land, disembodied and shade in the salmon louse (Lepeophtheirus salmonis) genome. Tissue-specific expression analysis show that the genes are expressed in intestine and reproductive tissue. In addition, levels of the steroid hormones ecdysone, 20-hydroxyecdysone and ponasterone A were measured during the reproductive stage of adult females and in early life stages.	[Sandlund, Liv; Kongshaug, Heidi; Male, Rune; Nilsen, Frank] Univ Bergen, Dept Biol Sci, Sea Lice Res Ctr, Bergen, Norway; [Sandlund, Liv; Dalvin, Sussie] Inst Marine Res, Sea Lice Res Ctr, Bergen, Norway; [Horsberg, Tor Einar] Norwegian Univ Life Sci, Sea Lice Res Ctr, Oslo, Norway	University of Bergen; Institute of Marine Research - Norway; Norwegian University of Life Sciences	Dalvin, S (corresponding author), Inst Marine Res, Sea Lice Res Ctr, Bergen, Norway.	sussie.dalvin@hi.no	Dalvin, Sussie/AAL-6893-2021	Dalvin, Sussie/0000-0002-6092-4710	Research Council of Norway, SFI-Sea Lice Research Centre [203513/O30]	Research Council of Norway, SFI-Sea Lice Research Centre(Research Council of Norway)	The research has been funded by the Research Council of Norway, SFI-Sea Lice Research Centre, Grant Number 203513/O30. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright LJ, 1991, CAN J ZOOL, V69; Asazuma H, 2009, ARCH INSECT BIOCHEM, V72, P220, DOI 10.1002/arch.20335; Baldwin WS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-169; Dalvin S, 2011, DIS AQUAT ORGAN, V94, P211, DOI 10.3354/dao02331; Dalvin S, 2009, INT J PARASITOL, V39, P1407, DOI 10.1016/j.ijpara.2009.04.004; Edvardsen RB, 2014, MAR GENOMICS; Eichner C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1277-y; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; Frost P, 2003, VET PARASITOL, V118, P169, DOI 10.1016/j.vetpar.2003.09.020; Gilbert LI, 2005, VITAM HORM, V73, P31, DOI 10.1016/S0083-6729(05)73002-8; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; GOAD LJ, 1981, PURE APPL CHEM, V53, P837, DOI 10.1351/pac198153040837; GOHAR M, 1984, REPROD NUTR DEV, V24, P137, DOI 10.1051/rnd:19840205; GRIENEISEN ML, 1994, INSECT BIOCHEM MOLEC, V24, P115, DOI 10.1016/0965-1748(94)90078-7; Hamre LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073539; Hamre LA, 2009, PARASITOL INT, V58, P451, DOI 10.1016/j.parint.2009.08.009; Hansen BH, 2008, GEN COMP ENDOCR, V158, P115, DOI 10.1016/j.ygcen.2008.05.013; Hopkins PM, 2009, CRUSTACEAN ECDYSTERI, P73; Iga M, 2012, BIOL PHARM BULL, V35, P838, DOI 10.1248/bpb.35.838; Iga M, 2010, PEPTIDES, V31, P456, DOI 10.1016/j.peptides.2009.08.002; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Kvamme BO, 2004, INT J PARASITOL, V34, P823, DOI 10.1016/j.ijpara.2004.02.004; LACHAISE F, 1993, J CRUSTACEAN BIOL, V13, P198, DOI 10.2307/1548970; Lafont R, 2007, ECOTOXICOLOGY, V16, P109, DOI 10.1007/s10646-006-0113-1; Martin-Creuzburg D, 2007, GEN COMP ENDOCR, V151, P66, DOI 10.1016/j.ygcen.2006.11.015; Mykles DL, 2011, J STEROID BIOCHEM, V127, P8; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Pike AW, ADV PARASITOL, V44, P233; REES HH, 1995, EUR J ENTOMOL, V92, P9; Rewitz KF, 2006, INSECT BIOCHEM MOLEC, V36, P188, DOI 10.1016/j.ibmb.2005.12.002; Rewitz KF, 2007, INSECT BIOCHEM MOLEC, V37, P741, DOI 10.1016/j.ibmb.2007.02.012; Rewitz KF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-60; Ritchie G, 1996, J CRUSTACEAN BIOL, V16, P330, DOI 10.2307/1548891; Sandlund L, 2016, MOL BIOCHEM PARASIT, V208, P65, DOI 10.1016/j.molbiopara.2016.06.007; Sandlund L, 2015, INT J PARASITOL, V45, P175, DOI 10.1016/j.ijpara.2014.10.003; Schram Thomas A., 1993, P30; Skern-Mauritzen R, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-32; Spaziani E, 1999, AM ZOOL, V39, P496; Styrishave B, 2008, J MAR BIOL ASSOC UK, V88, P575, DOI [10.1017/S0025315408000878, 10.1017/S0025315408000879]; Subramoniam T, 2000, COMP BIOCHEM PHYS C, V125, P135, DOI 10.1016/S0742-8413(99)00098-5; Sumiya E, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0060-2; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384	46	13	13	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191995	10.1371/journal.pone.0191995	http://dx.doi.org/10.1371/journal.pone.0191995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401467	Green Published, gold, Green Submitted			2022-12-26	WOS:000424101400029
J	Suzuki, Y; Uchida, K; Takemura, T; Sekine, M; Tamura, T; Furukawa, A; Hebisawa, A; Sakakibara, Y; Awano, N; Amano, T; Kobayashi, D; Negi, M; Kakegawa, T; Wada, Y; Ito, T; Suzuki, T; Akashi, T; Eishi, Y				Suzuki, Yoshimi; Uchida, Keisuke; Takemura, Tamiko; Sekine, Masaki; Tamura, Tomoki; Furukawa, Asuka; Hebisawa, Akira; Sakakibara, Yumi; Awano, Nobuyasu; Amano, Tomonari; Kobayashi, Daisuke; Negi, Mariko; Kakegawa, Tomoya; Wada, Yuriko; Ito, Takashi; Suzuki, Takashige; Akashi, Takumi; Eishi, Yoshinobu			Propionibacterium acnes-derived insoluble immune complexes in sinus macrophages of lymph nodes affected by sarcoidosis	PLOS ONE			English	Article							JAPANESE PATIENTS; DNA; MYCOBACTERIAL; CELLS; LOCALIZATION; PROTEIN; TH1	Background Propionibacterium acnes is thought to be a causative agent of sarcoidosis. Patients with sarcoidosis have circulating immune complexes. We attempted to detect P. acnes-derived immune complexes in sarcoid lesions. Methods We evaluated formalin-fixed and paraffin-embedded lymph node samples from 38 sarcoidosis patients and 90 non-sarcoidosis patients (27 patients with necrotizing lymphadenitis, 28 patients with reactive lymphadenitis, 16 patients with colon cancer, 19 patients with gastric cancer) by immunohistochemistry using anti-human immunoglobulins (IgG, IgA, and IgM) and complement (C1q and C3c) antibodies, and a P. acnes-specific monoclonal antibody (PAB antibody) that reacts with the membrane-bound lipoteichoic acid of P. acnes. Results Small round bodies (SRBs) bound to IgA, IgM, or IgG were detected in sinus macrophages, in 32 (84%), 32 (84%), or 11 (29%) sarcoid samples, respectively, and in 19 (21%), 26 (29%), or no (0%) control samples, respectively. Some of these insoluble immune complexes (IICs) also bound to C1q and C3c. We developed a microwave treatment followed by brief trypsin digestion (MT treatment) to detect PAB-reactive SRBs bound to immunoglobulins (IIC-forming P. acnes). MT treatment revealed abundant IIC-forming P. acnes in most (89%) of the sarcoid samples and sparse distribution in some (20%) of the control samples with lymphadenitis, but no IIC-forming P. acnes was detected in control samples without inflammation. IIC-forming P. acnes were mostly bound to both IgA and IgM. The PAB-reactive antigen and immunoglobulins were both located at the peripheral rim of the IIC-forming P. acnes. Conventional electron microscopy identified many SRBs (0.5-2.0 mu m diameter) in sinus macrophages of sarcoid lymph nodes with many IIC-forming P. acnes, some of which were in phagolysosomes with a degraded and lamellar appearance. Conclusions P. acnes-derived IICs in sinus macrophages were frequent and abundant in sarcoid lymph nodes, suggesting a potential etiologic link between sarcoidosis and this commensal bacterium.	[Suzuki, Yoshimi; Furukawa, Asuka; Kobayashi, Daisuke; Negi, Mariko; Kakegawa, Tomoya; Wada, Yuriko; Ito, Takashi; Suzuki, Takashige; Eishi, Yoshinobu] Tokyo Med & Dent Univ, Grad Sch, Dept Human Pathol, Bunkyo Ku, Tokyo, Japan; [Suzuki, Yoshimi; Furukawa, Asuka; Kobayashi, Daisuke; Negi, Mariko; Kakegawa, Tomoya; Wada, Yuriko; Ito, Takashi; Suzuki, Takashige; Eishi, Yoshinobu] Tokyo Med & Dent Univ, Fac Med, Bunkyo Ku, Tokyo, Japan; [Uchida, Keisuke; Sekine, Masaki; Tamura, Tomoki; Akashi, Takumi] Tokyo Med & Dent Univ Hosp, Div Surg Pathol, Bunkyo Ku, Tokyo, Japan; [Takemura, Tamiko] Japanese Red Cross Med Ctr, Div Pathol, Shibuya Ku, Tokyo, Japan; [Hebisawa, Akira] Tokyo Natl Hosp, Natl Hosp Org, Clin Res Ctr, Tokyo, Japan; [Hebisawa, Akira] Tokyo Natl Hosp, Natl Hosp Org, Pathol Div, Tokyo, Japan; [Sakakibara, Yumi] Tokyo Med & Dent Univ, Grad Sch, Dept Resp Med, Bunkyo Ku, Tokyo, Japan; [Sakakibara, Yumi] Tokyo Med & Dent Univ, Fac Med, Bunkyo Ku, Tokyo, Japan; [Awano, Nobuyasu] Japanese Red Cross Med Ctr, Clin Resp Med, Shibuya Ku, Tokyo, Japan; [Amano, Tomonari] Tokyo Kita Med Ctr, Div Pathol, Kita Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japanese Red Cross Medical Center; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japanese Red Cross Medical Center	Eishi, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Human Pathol, Bunkyo Ku, Tokyo, Japan.; Eishi, Y (corresponding author), Tokyo Med & Dent Univ, Fac Med, Bunkyo Ku, Tokyo, Japan.	eishi.path@tmd.ac.jp	AWANO, Nobuyasu/GXG-4375-2022	AWANO, Nobuyasu/0000-0002-1438-4880				ABE C, 1984, ZBL BAKT-INT J MED M, V256, P541, DOI 10.1016/S0174-3031(84)80032-3; CARR I, 1980, VIRCHOWS ARCH B, V32, P147, DOI 10.1007/BF02889023; Celada LJ, 2015, CLIN CHEST MED, V36, P561, DOI 10.1016/j.ccm.2015.08.001; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; DANIELE RP, 1978, CHEST, V74, P261, DOI 10.1378/chest.74.3.261; de Brouwer B, 2015, SARCOIDOSIS VASC DIF, V32, P271; Ebe Y, 2000, SARCOIDOSIS VASC DIF, V17, P256; Eishi Y, 2002, J CLIN MICROBIOL, V40, P198, DOI 10.1128/JCM.40.1.198-204.2002; Eishi Y., 1988, SARCOIDOSIS, P143; Eishi Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/935289; Fagan PK, 2001, INFECT IMMUN, V69, P4851, DOI 10.1128/IAI.69.8.4851-4857.2001; Furusawa H, 2012, RESPIR INVESTIG, V50, P104, DOI 10.1016/j.resinv.2012.07.001; GUPTA RC, 1977, AM REV RESPIR DIS, V116, P261; HEDFORS E, 1974, CLIN EXP IMMUNOL, V16, P493; HOMMA JY, 1978, JPN J EXP MED, V48, P251; Hunninghake G W, 1999, Sarcoidosis Vasc Diffuse Lung Dis, V16, P149; Iida T, 2013, MYCOBACT DIS OMICS I, P4; Ishige I, 1999, LANCET, V354, P120, DOI 10.1016/S0140-6736(98)12310-3; Ishige I, 2005, SARCOIDOSIS VASC DIF, V22, P33; JAMES DG, 1975, AM J MED, V59, P388, DOI 10.1016/0002-9343(75)90397-6; Kwak JW, 1996, J IMMUNOL METHODS, V191, P49, DOI 10.1016/0022-1759(95)00287-1; Markova N, 2015, HUM VACC IMMUNOTHER, V11, P1192, DOI 10.1080/21645515.2015.1016682; MCIJOHNSON N, 1980, THORAX, V35, P286; Michailova L, 2005, INT J TUBERC LUNG D, V9, P907; Moscovic E A, 1978, Pathol Annu, V13 Pt 2, P69; NAKATA Y, 1986, ACTA MED OKAYAMA, V40, P257; Negi M, 2012, MODERN PATHOL, V25, P1284, DOI 10.1038/modpathol.2012.80; OKABE T, 1981, AM REV RESPIR DIS, V124, P608; Schupp JC, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0070-7; Sell S, 1987, GRANULOMATOUS REACTI, P529; Tanabe T, 2006, BBA-MOL BASIS DIS, V1762, P794, DOI 10.1016/j.bbadis.2006.07.006; VERRIERJONES J, 1976, ANN NY ACAD SCI, V278, P212, DOI 10.1111/j.1749-6632.1976.tb47032.x; Yamada T, 2002, J PATHOL, V198, P541, DOI 10.1002/path.1243; Yorozu P, 2015, RESPIR INVESTIG, V53, P161, DOI 10.1016/j.resinv.2015.02.005; Zhou Y, 2015, CLIN EXP IMMUNOL, V181, P511, DOI 10.1111/cei.12650	35	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192408	10.1371/journal.pone.0192408	http://dx.doi.org/10.1371/journal.pone.0192408			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401490	Green Published, Green Submitted, gold			2022-12-26	WOS:000424101400060
J	Zahn, K; Linseisen, J; Heier, M; Peters, A; Thorand, B; Nairz, F; Meisinger, C				Zahn, Karl; Linseisen, Jakob; Heier, Margit; Peters, Annette; Thorand, Barbara; Nairz, Franziska; Meisinger, Christa			Body fat distribution and risk of incident ischemic stroke in men and women aged 50 to 74 years from the general population. The KORA Augsburg cohort study	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; CORONARY-HEART-DISEASE; MASS INDEX; MYOCARDIAL-INFARCTION; MILLION PARTICIPANTS; CARDIOVASCULAR RISK; OBESITY; METAANALYSIS; PREDICTORS; ADIPOSITY	Background It remains controversial whether measures of general or abdominal adiposity are better risk predictors for ischemic stroke. Furthermore, so far it is unclear whether body fat mass index (BFMI) and fat free mass index (FFMI) are risk predictors for ischemic stroke. This study examined the sex-specific relevance of body mass index (BMI), BROCA Index, waist circumference (WC), waist-height ratio (WHtR), BFMI and FFMI for the development of ischemic stroke in a Caucasian population. Material and methods The prospective population-based cohort study was based on 1917 men and 1832 women (aged 50 to 74 years) who participated in the third (1994/95) or fourth (1999/2001) MONICA/KORA Augsburg survey. Subjects were free of stroke at baseline. Standardized anthropometric and bioelectric impedance measurements were obtained at baseline. Hazard ratios (HR) were estimated from Cox proportional hazard models. Results During a median follow-up of 9.3 years 128 ischemic strokes occurred in men and 81 in women, respectively. Coded as quartiles WC and WHtR were significantly associated with incident stroke in multivariable analyses in women (comparing the 4th vs. the bottom quartile), but none of the adiposity measures was significantly associated with incident stroke in multivariable adjusted analyses in men. When anthropometric measures were used as continuous variables, these findings were confirmed. After multivariable adjustment the associations between obesity measures and incident ischemic stroke were statistically significant only for WC (HR 1.39, 95% CI 1.12-1.72) and WHtR in women (HR 1.39, 95% CI 1.12-1.73) per increase of 1 standard deviation. In both sexes the measures BFMI and FFMI were no independent predictors for incident ischemic stroke. Conclusions Abdominal obesity measures are independent predictors of incident ischemic stroke in women but not in men from the general adult population. Thus, it may be of particular importance for women to prevent central obesity in order to reduce their risk of ischemic stroke.	[Zahn, Karl; Linseisen, Jakob; Heier, Margit; Peters, Annette; Thorand, Barbara; Nairz, Franziska; Meisinger, Christa] German Res Ctr Environm Hlth, Inst Epidemiol 2, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Zahn, Karl] Inst Med Informat Biometry & Epidemiol IBE, Munich, Germany; [Linseisen, Jakob; Meisinger, Christa] Ludwig Maximilians Univ Munchen, UNIKA T, Chair Epidemiol, Augsburg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Zahn, K (corresponding author), German Res Ctr Environm Hlth, Inst Epidemiol 2, Helmholtz Zentrum Munchen, Neuherberg, Germany.; Zahn, K (corresponding author), Inst Med Informat Biometry & Epidemiol IBE, Munich, Germany.	zahnaugsburg@aol.com	Meisinger, Christine/B-5358-2014; Linseisen, Jakob/B-5353-2014; Peters, Annette/A-6117-2011; Heier, Margit/AAT-5280-2020; Thorand, Barbara/B-5349-2014	Linseisen, Jakob/0000-0002-9386-382X; Peters, Annette/0000-0001-6645-0985; Thorand, Barbara/0000-0002-8416-6440	Helmholtz Zentrum Munchen; German Research Center for Environmental Health (GmbH) - German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; Munich Center of Health Science (MC Health); Ludwig-Maximilians-Universitat Munchen as part of LMUinnovativ	Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health (GmbH) - German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; Munich Center of Health Science (MC Health); Ludwig-Maximilians-Universitat Munchen as part of LMUinnovativ	The KORA research platform (KORA, Cooperative Health Research in the Region of Augsburg) and the KORA Augsburg studies are financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH), which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Science (MC Health), Ludwig-Maximilians-Universitat Munchen as part of LMUinnovativ. This research was a master's thesis of Karl Zahn and was not supported by a grant.	Abete I, 2015, EUR J NUTR, V54, P365, DOI 10.1007/s00394-014-0716-x; [Anonymous], 2005, BIOELECTRICAL IMPEDA; Blaak E, 2001, CURR OPIN CLIN NUTR, V4, P499, DOI 10.1097/00075197-200111000-00006; Bodenant M, 2011, STROKE, V42, P2872, DOI 10.1161/STROKEAHA.111.614099; Dhaliwal SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094560; Eknoyan G, 2008, NEPHROL DIAL TRANSPL, V23, P47, DOI 10.1093/ndt/gfm517; Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P230, DOI 10.1159/000441106; Franco-Villoria M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008922; Gelber RP, 2008, J AM COLL CARDIOL, V52, P605, DOI 10.1016/j.jacc.2008.03.066; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Heitmann BL, 2004, OBES RES, V12, P482, DOI 10.1038/oby.2004.54; Ibrahim-Verbaas CA, 2014, STROKE, V45, P403, DOI 10.1161/STROKEAHA.113.003044; Caceres DI, 2014, NUTR HOSP, V30, P1359, DOI 10.3305/nh.2014.30.6.7934; Kafri MW, 2014, EUR J CLIN NUTR, V68, P677, DOI 10.1038/ejcn.2013.266; Kizer JR, 2011, AM J EPIDEMIOL, V173, P10, DOI 10.1093/aje/kwq311; Kurth T, 2005, CIRCULATION, V111, P1992, DOI 10.1161/01.CIR.0000161822.83163.B6; Kyle UG, 2003, NUTRITION, V19, P597, DOI 10.1016/S0899-9007(03)00061-3; Kyle UG, 2001, NUTRITION, V17, P248, DOI 10.1016/S0899-9007(00)00553-0; Lau DCW, 2005, AM J PHYSIOL-HEART C, V288, pH2031, DOI 10.1152/ajpheart.01058.2004; Lew J, 2017, CIRCULATION, V135, P544, DOI 10.1161/CIRCULATIONAHA.116.023005; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS13, DOI 10.1055/s-2005-858234; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Mastaglia SR, 2012, J CLIN DENSITOM, V15, P159, DOI 10.1016/j.jocd.2011.12.006; Meisinger C, 2016, GESUNDHEITSWESEN, V78, P84, DOI 10.1055/s-0041-110916; Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.82; Myint PK, 2014, HEART, V100, P1613, DOI 10.1136/heartjnl-2014-305816; Neuhauser HK, 2015, BLOOD PRESS MONIT, V20, P39, DOI 10.1097/MBP.0000000000000081; R Core Team, 2018, R LANG ENV STAT COMP; Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C; Strazzullo P, 2010, STROKE, V41, pE418, DOI 10.1161/STROKEAHA.109.576967; Twig G, 2016, NEW ENGL J MED, V374, P2430, DOI 10.1056/NEJMoa1503840; Walker SP, 1996, AM J EPIDEMIOL, V144, P1143, DOI 10.1093/oxfordjournals.aje.a008892; Wang AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061665; WELIN L, 1987, NEW ENGL J MED, V317, P521, DOI 10.1056/NEJM198708273170901; Wiklund P, 2008, J CLIN ENDOCR METAB, V93, P4360, DOI 10.1210/jc.2008-0804; Winter Y, 2008, STROKE, V39, P3145, DOI 10.1161/STROKEAHA.108.523001; Winter Y, 2016, J STROKE CEREBROVASC, V25, P1141, DOI 10.1016/j.jstrokecerebrovasdis.2015.12.026; Yatsuya H, 2010, CIRC-CARDIOVASC QUAL, V3, P498, DOI 10.1161/CIRCOUTCOMES.109.908517; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhang XL, 2009, STROKE, V40, P1098, DOI 10.1161/STROKEAHA.108.539692	40	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191630	10.1371/journal.pone.0191630	http://dx.doi.org/10.1371/journal.pone.0191630			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401461	Green Published, gold, Green Submitted			2022-12-26	WOS:000424101400016
J	Hadweh, P; Chaitoglou, I; Gravato-Nobre, MJ; Ligoxygakis, P; Mosialos, G; Hatzivassiliou, E				Hadweh, Paul; Chaitoglou, Iro; Gravato-Nobre, Maria Joao; Ligoxygakis, Petros; Mosialos, George; Hatzivassiliou, Eudoxia			Functional analysis of the C-elegans cyld-1 gene reveals extensive similarity with its human homolog	PLOS ONE			English	Article							NF-KAPPA-B; CYLD USP; PATHWAY; EXPRESSION; RECEPTOR	The human cylindromatosis tumor suppressor (HsCyld) has attracted extensive attention due to its association with the development of multiple types of cancer. HsCyld encodes a deubiquitinating enzyme (HsCYLD) with a broad range of functions that include the regulation of several cell growth, differentiation and death pathways. HsCyld is an evolutionarily conserved gene. Homologs of HsCyld have been identified in simple model organisms such as Drosophila melanogaster and Caenorhabditis elegans (C. elegans) which offer extensive possibilities for functional analyses. In the present report we have investigated and compared the functional properties of HsCYLD and its C. elegans homolog (CeCYLD). As expected from the mammalian CYLD expression pattern, the CeCyld promoter is active in multiple tissues with certain gastrointestinal epithelia and neuronal cells showing the most prominent activity. CeCYLD is a functional deubiquitinating enzyme with similar specificity to HsCYLD towards K63-and M1-linked polyubiquiting chains. CeCYLD was capable of suppressing the TRAF2-mediated activation of NF-kappaB and AP1 similarly to HsCYLD. Finally, CeCYLD could suppress the induction of TNF-dependent gene expression in mammalian cells similarly to HsCYLD. Our results demonstrate extensively overlapping functions between the HsCYLD and CeCYLD, which establish the C. elegans protein as a valuable model for the elucidation of the complex activity of the human tumor suppressor protein.	[Hadweh, Paul; Chaitoglou, Iro; Mosialos, George] Aristotle Univ Thessaloniki, Sch Biol, Thessaloniki, Macedonia, Greece; [Gravato-Nobre, Maria Joao; Ligoxygakis, Petros] Univ Oxford, Dept Biochem, South Parks Rd, Oxford, England; [Hatzivassiliou, Eudoxia] Aristotle Univ Thessaloniki, Sch Hlth Sci, Dept Med, Thessaloniki, Macedonia, Greece	Aristotle University of Thessaloniki; University of Oxford; Aristotle University of Thessaloniki	Mosialos, G (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, Thessaloniki, Macedonia, Greece.; Hatzivassiliou, E (corresponding author), Aristotle Univ Thessaloniki, Sch Hlth Sci, Dept Med, Thessaloniki, Macedonia, Greece.	gmosialo@bio.auth.gr; eudoxiah@auth.gr		Mosialos, George/0000-0002-5342-4873; Hadweh, Paul/0000-0001-8418-9987	Greek State Scholarship Foundation (IKY FELLOWSHIPS OF EXCELLENCE FOR POSTGRADUATE STUDIES IN GREECE-SIEMENS PROGRAM); Bodossaki Foundation; IKY FELLOWSHIPS OF EXCELLENCE FOR POSTGRADUATE STUDIES IN GREECE-SIEMENS PROGRAM	Greek State Scholarship Foundation (IKY FELLOWSHIPS OF EXCELLENCE FOR POSTGRADUATE STUDIES IN GREECE-SIEMENS PROGRAM); Bodossaki Foundation; IKY FELLOWSHIPS OF EXCELLENCE FOR POSTGRADUATE STUDIES IN GREECE-SIEMENS PROGRAM	Funded by Greek State Scholarship Foundation (IKY FELLOWSHIPS OF EXCELLENCE FOR POSTGRADUATE STUDIES IN GREECE-SIEMENS PROGRAM) PH and Bodossaki Foundation to GM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Catherine Chourlia and Kyriaki Driva for assistance and reagents. This study was supported by an IKY FELLOWSHIPS OF EXCELLENCE FOR POSTGRADUATE STUDIES IN GREECE-SIEMENS PROGRAM to PH. The authors gratefully acknowledge the support provided by the Bodossaki Foundation for the acquisition of imaging equipment that was used in this study.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Devergne O, 1996, MOL CELL BIOL, V16, P7098; Fernandez-Majada V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12508; Gilmore TD, 2012, IMMUNOL REV, V246, P14, DOI 10.1111/j.1600-065X.2012.01096.x; Gravato-Nobre MJ, 2008, DEV DYNAM, V237, P3762, DOI 10.1002/dvdy.21792; Hatzivassiliou E, 1997, BIOCHEMISTRY-US, V36, P9221, DOI 10.1021/bi963145k; Hayashi M, 2014, BREAST CANCER RES TR, V143, P447, DOI 10.1007/s10549-013-2824-3; Hellerbrand C, 2007, CARCINOGENESIS, V28, P21, DOI 10.1093/carcin/bgl081; Kawasaki M, 1999, EMBO J, V18, P3604, DOI 10.1093/emboj/18.13.3604; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Rajan N, 2015, LANCET ONCOL, V16, pE460, DOI 10.1016/S1470-2045(15)00245-4; Sato Y, 2015, NAT STRUCT MOL BIOL, V22, P222, DOI 10.1038/nsmb.2970; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Tsichritzis T, 2007, DEVELOPMENT, V134, P2605, DOI 10.1242/dev.02859; Xue L, 2007, DEV CELL, V13, P446, DOI 10.1016/j.devcel.2007.07.012; Yang YF, 2016, J CELL SCI, V129, P2289, DOI 10.1242/jcs.183319	22	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191864	10.1371/journal.pone.0191864	http://dx.doi.org/10.1371/journal.pone.0191864			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394249	Green Published, gold, Green Submitted			2022-12-26	WOS:000424060400019
J	Huang, YP; Yang, HJ; Qi, XM; Malekian, R; Pfeiffer, O; Li, ZX				Huang, Yaping; Yang, Haijun; Qi, Xuemei; Malekian, Reza; Pfeiffer, Olivia; Li, Zhixiong			A novel selection method of seismic attributes based on gray relational degree and support vector machine	PLOS ONE			English	Article								The selection of seismic attributes is a key process in reservoir prediction because the prediction accuracy relies on the reliability and credibility of the seismic attributes. However, effective selection method for useful seismic attributes is still a challenge. This paper presents a novel selection method of seismic attributes for reservoir prediction based on the gray relational degree (GRD) and support vector machine (SVM). The proposed method has a two-hierarchical structure. In the first hierarchy, the primary selection of seismic attributes is achieved by calculating the GRD between seismic attributes and reservoir parameters, and the GRD between the seismic attributes. The principle of the primary selection is that these seismic attributes with higher GRD to the reservoir parameters will have smaller GRD between themselves as compared to those with lower GRD to the reservoir parameters. Then the SVM is employed in the second hierarchy to perform an interactive error verification using training samples for the purpose of determining the final seismic attributes. A real-world case study was conducted to evaluate the proposed GRD-SVM method. Reliable seismic attributes were selected to predict the coalbed methane (CBM) content in southern Qinshui basin, China. In the analysis, the instantaneous amplitude, instantaneous bandwidth, instantaneous frequency, and minimum negative curvature were selected, and the predicted CBM content was fundamentally consistent with the measured CBM content. This real-world case study demonstrates that the proposed method is able to effectively select seismic attributes, and improve the prediction accuracy. Thus, the proposed GRD-SVM method can be used for the selection of seismic attributes in practice.	[Huang, Yaping; Qi, Xuemei] China Univ Min & Technol, Sch Resources & Geosci, Xuzhou, Peoples R China; [Huang, Yaping] China Univ Min & Technol, Key Lab Coal Methane & Fire Control, Minist Educ, Xuzhou, Peoples R China; [Yang, Haijun] Tarim Oilfield Co, Inst China Petr, Korla, Xinjiang, Peoples R China; [Malekian, Reza] Univ Pretoria, Dept Elect Elect & Comp Engn, Pretoria, South Africa; [Pfeiffer, Olivia] Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA; [Li, Zhixiong] China Univ Min & Technol, Sch Mechatron Engn, Xuzhou, Peoples R China; [Li, Zhixiong] Univ Wollongong, Sch Mech Mat Mechatron & Biomed Engn, Wollongong, NSW, Australia	China University of Mining & Technology; China University of Mining & Technology; University of Pretoria; University of Massachusetts System; University of Massachusetts Amherst; China University of Mining & Technology; University of Wollongong	Li, ZX (corresponding author), China Univ Min & Technol, Sch Mechatron Engn, Xuzhou, Peoples R China.; Li, ZX (corresponding author), Univ Wollongong, Sch Mech Mat Mechatron & Biomed Engn, Wollongong, NSW, Australia.	zhixiong.li@ieee.org	Li, Zhixiong/G-8418-2018	Li, Zhixiong/0000-0002-7265-0008	Natural Science Foundation of China [41704104]; Chinese Postdoctoral Science Foundation [2014M551703]; Fundamental Research Funds for the Central Universities [2012QNA62]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); UOW; Institute of China Petroleum Tarim Oilfield Company	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); UOW; Institute of China Petroleum Tarim Oilfield Company	We acknowledge the financial support provided by the Natural Science Foundation of China (Grant No. 41704104), the Chinese Postdoctoral Science Foundation (Grant No. 2014M551703), the Fundamental Research Funds for the Central Universities (Grant No. 2012QNA62), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) to YH. VC fellowship of UOW to ZL. The Institute of China Petroleum Tarim Oilfield Company provided support in the form of salaries for author Haijun Yang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We acknowledge the financial support provided by the Natural Science Foundation of China (Grant No. 41704104), the Chinese Postdoctoral Science Foundation (Grant No. 2014M551703), the Fundamental Research Funds for the Central Universities (Grant No. 2012QNA62), a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and VC fellowship of UOW. The Institute of China Petroleum Tarim Oilfield Company provided support in the form of salaries for author Haijun Yang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ahmed OA, 2010, GEOPHYSICS, V75, pP1, DOI 10.1190/1.3298443; Bahorich M, 1995, LEADING EDGE, V14, P1053, DOI [10.1190/1.1437077, DOI 10.1190/1.1437077]; Barnes AE, 2007, GEOPHYSICS, V72, pP33, DOI 10.1190/1.2716717; Chen XP, 2013, CHINESE J GEOPHYS-CH, V56, P2837, DOI 10.6038/cjg20130832; Chen XP, 2013, GEOPHYSICS, V78, pD237, DOI 10.1190/GEO2012-0352.1; Chopra S, 2005, GEOPHYSICS, V70, p3SO, DOI 10.1190/1.2098670; Chopra S, 2007, EXPLORATION, P1; Deng J, 2004, PRESS; Dorrington KP, 2004, GEOPHYSICS, V69, P212, DOI 10.1190/1.1649389; Fomel S, 2007, GEOPHYSICS, V72, pA29, DOI 10.1190/1.2437573; Fu DJ, 2006, GEOPHYSICS, V71, pB151, DOI 10.1190/1.2335636; Fu X, 2006, COALBED GAS GEOLOGY; Galvis I.S., 2017, LEADING EDGE, V36, P239, DOI [10.1190/tle36030239.1, DOI 10.1190/TLE36030239.1]; Gao J, 2006, APPL GEOPHYS, V3, P243; Gholami A, 2017, J PETROL SCI ENG, V152, P238, DOI 10.1016/j.petrol.2017.03.013; Hampson DP, 2001, GEOPHYSICS, V66, P220, DOI 10.1190/1.1444899; Iturraran-Viveros U, 2012, J APPL GEOPHYS, V76, P1, DOI 10.1016/j.jappgeo.2011.10.012; Jiang Y, 2016, MEASUREMENT SCI TECH, V27; Kalkomey C.T., 1997, LEAD EDGE, V16, P247, DOI DOI 10.1190/1.1437610; Li Z, 2018, RELIAB ENG SYST SAFE, DOI DOI 10.1016/j.jfluidstructs.2017.12.019; Li ZX, 2018, RENEW ENERG, V116, P55, DOI 10.1016/j.renene.2016.12.013; Qi XM, 2012, APPL GEOPHYS, V9, P80, DOI 10.1007/s11770-012-0317-5; TANER MT, 1979, GEOPHYSICS, V44, P1041, DOI 10.1190/1.1440994; Torrado L, 2014, GEOPHYSICS, V79, pB221, DOI 10.1190/GEO2013-0429.1; Vapnik V., 2013, NATURE STAT LAERNING; Wang ZG, 2015, GEOPHYSICS, V80, pB35, DOI 10.1190/GEO2014-0362.1; Zhang C, 2010, SEG DENVER 2010 ANNU, P1586	27	10	10	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0192407	10.1371/journal.pone.0192407	http://dx.doi.org/10.1371/journal.pone.0192407			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394297	Green Published, gold, Green Submitted			2022-12-26	WOS:000424060400043
J	Silva, DAS; Tremblay, MS; de Souza, MDM; Mooney, M; Naghavi, M; Malta, DC				Santos Silva, Diego Augusto; Tremblay, Mark Stephen; Marinho de Souza, Maria de Fatima; Mooney, Meghan; Naghavi, Mohsen; Malta, Deborah Carvalho			Mortality and years of life lost by colorectal cancer attributable to physical inactivity in Brazil (1990-2015): Findings from the Global Burden of Disease Study	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; ASSOCIATION; TIME; RISK; ADULTS	Introduction The aims of this study were to estimate all-cause and cause-specific mortality and years of life lost, investigated by disability-adjusted life-years (DALYs), due to colorectal cancer attributable to physical inactivity in Brazil and in the states; to analyze the temporal trend of these estimates over 25 years (1990-2015) compared with global estimates and according to the socioeconomic status of states of Brazil. Methods Databases from the Global Burden of Disease Study (GBD) for Brazil, Brazilian states and global information were used. It was estimated the total number and the age-standardized rates of deaths and DALYs for colorectal cancer attributable to physical inactivity in the years 1990 and 2015. We used the Socioeconomic Development Index (SDI). Results Physical inactivity was responsible for a substantial number of deaths (1990: 1,302; 2015: 119,351) and DALYs (1990: 31,121; 2015: 87,116) due to colorectal cancer in Brazil. From 1990 to 2015, the mortality and DALYs due to colorectal cancer attributable to physical inactivity increased in Brazil (0.6% and 0.6%, respectively) and decreased around the world (-0.8% and -1.1%, respectively). The Brazilian states with better socioeconomic indicators had higher rates of mortality and morbidity by colorectal cancer due to physical inactivity (p<0.01). Physical inactivity was responsible for deaths and DALYs due to colorectal cancer in Brazil. Conclusions Over 25 years, the Brazilian population showed more worrisome results than around the world. Actions to combat physical inactivity and greater cancer screening and treatment are urgent in the Brazilian states.	[Santos Silva, Diego Augusto] Univ Fed Santa Catarina, Res Ctr Kinanthropometry & Human Performance, Florianopolis, SC, Brazil; [Tremblay, Mark Stephen] Eastern Ontario Res Inst, Childrens Hosp, Ottawa, ON, Canada; [Marinho de Souza, Maria de Fatima] Minist Hlth, Dept Surveillance Noncommunicable Dis & Injuries, Brasilia, DF, Brazil; [Mooney, Meghan; Naghavi, Mohsen] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Malta, Deborah Carvalho] Univ Fed Minas Gerais, Dept Maternal & Child Nursing & Publ Hlth, Sch Nursing, Belo Horizonte, MG, Brazil	Universidade Federal de Santa Catarina (UFSC); University of Ottawa; Children's Hospital of Eastern Ontario; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Universidade Federal de Minas Gerais	Silva, DAS (corresponding author), Univ Fed Santa Catarina, Res Ctr Kinanthropometry & Human Performance, Florianopolis, SC, Brazil.	diegoaugustoss@yahoo.com.br	Marinho, Fatima/ABC-8725-2021; Tremblay, Mark/ABI-5477-2020; Tremblay, Mark/AAF-2981-2019; Silva, Diego/GRF-5446-2022; Marinho, Fatima/AFJ-2948-2022; Silva, Diego Augusto Santos/AAB-9249-2020; Marinho, Fatima/AAF-4556-2022; Malta, Deborah Carvalho/L-2491-2019	Marinho, Fatima/0000-0003-3287-9163; Silva, Diego Augusto Santos/0000-0002-0489-7906; Marinho, Fatima/0000-0003-3287-9163; Malta, Deborah Carvalho/0000-0002-8214-5734	National Council for Scientific and Technological Development from Brazil; Ministry of Health from Brazil [25000192049/2014-14]	National Council for Scientific and Technological Development from Brazil; Ministry of Health from Brazil	The author (DASS and DCM) thanks the National Council for Scientific and Technological Development from Brazil for the research grant (PQ). Bill & Melinda Gates Foundation (GBD Global) and Ministry of Health from Brazil (GBD 2015 Brazil-states; Process No. 25000192049/2014-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breen N, 2017, CANCER CAUSE CONTROL, V28, P117, DOI 10.1007/s10552-016-0842-2; Del Duca GF, 2013, CAD SAUDE PUBLICA, V29, P2119, DOI 10.1590/0102-311X00130412; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Farris MS, 2015, CANCER EPIDEM BIOMAR, V24, P1462, DOI 10.1158/1055-9965.EPI-15-0301; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Fitzmaurice C, 2018, INT J PUBLIC HEALTH, V63, P151, DOI 10.1007/s00038-017-0999-9; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Friedenreich CM, J MOL MED IN PRESS; Guerra Maximiliano Ribeiro, 2017, Rev. bras. epidemiol., V20, P102, DOI 10.1590/1980-5497201700050009; Ishitani Lenice Harumi, 2017, Rev. bras. epidemiol., V20, P34, DOI 10.1590/1980-5497201700050004; Kerr J, 2017, LANCET ONCOL, V18, pE457, DOI 10.1016/S1470-2045(17)30411-4; Kyu HH, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3857; Malta D, 2015, REV BRASILEIRA ATIVI, V20, P141, DOI [10.1590/S1415-790X2011000500006, DOI 10.12820/rbafs.v.20n2p141]; Malta Deborah Carvalho, 2017, Rev. bras. epidemiol., V20, P217, DOI 10.1590/1980-5497201700050018; Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548; Murray, 2002, SUMMARY MEASURES POP, P205; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Quadrilatero J, 2003, J SPORT MED PHYS FIT, V43, P121; Queiroz Bernardo Lanza, 2017, Rev. bras. epidemiol., V20, P21, DOI 10.1590/1980-5497201700050003; Schwarz E, 2012, REV SAUDE PUBL, V46, P108, DOI 10.1590/S0034-89102012005000061; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Souza Maria de Fatima Marinho de, 2017, Rev Bras Epidemiol, V20Suppl 01, P1, DOI 10.1590/1980-5497201700050001; Stopa SR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051000074, 10.1590/s1518-8787.2017051000074]; Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da; United Nations Department of Economic and Social Affairs Population Division, 2015, ESAPWP241 UN, DOI DOI 10.1017/CBO9781107415324.004; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; World Health Organization, 2013, GLOBAL ACTION PLAN F	28	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0190943	10.1371/journal.pone.0190943	http://dx.doi.org/10.1371/journal.pone.0190943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390002	gold, Green Submitted, Green Published			2022-12-26	WOS:000423793400010
J	Verma, S; Goyal, S; Kumari, A; Singh, A; Jamal, S; Grover, A				Verma, Sharad; Goyal, Sukriti; Kumari, Anchala; Singh, Aditi; Jamal, Salma; Grover, Abhinav			Structural investigations on mechanism of lapatinib resistance caused by HER-2 mutants	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; MOLECULAR-DYNAMICS SIMULATION; GENE AMPLIFICATION; KINASE DOMAIN; MYCOBACTERIUM-TUBERCULOSIS; SOMATIC MUTATIONS; PROTEIN; ERBB2; TRASTUZUMAB; EFFICACY	HER-2 belongs to the human epidermal growth factor receptor (HER) family. Via different signal transduction pathways, HER-2 regulates normal cell proliferation, survival, and differentiation. Recently, it was reported that MCF10A, BT474, and MDA-MB-231 cells bearing the HER2 K753E mutation were resistant to lapatinib. Present study revealed that HER-2 mutant K753E showed some contrasting behaviour as compared to wild, L768S and V773L HER-2 in complex with lapatinib while similar to previously known lapatinib resistant L755S HER-2 mutant. Lapatinib showed stable but reverse orientation in binding site of K753E and the highest binding energy among studied HER2-lapatinib complexes but slightly lesser than L755S mutant. Results indicate that K753E has similar profile as L755S mutant for lapatinib. The interacting residues were also found different from other three studied forms as revealed by free energy decomposition and ligplot analysis.	[Verma, Sharad; Kumari, Anchala; Singh, Aditi; Grover, Abhinav] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi, India; [Goyal, Sukriti; Jamal, Salma] Banasthali Univ, Dept Biosci & Biotechnol, Tonk, Rajasthan, India; [Kumari, Anchala; Singh, Aditi] TERI Sch Adv Studies, Dept Biotechnol, New Delhi, India	Jawaharlal Nehru University, New Delhi; Banasthali Vidyapith; TERI University	Grover, A (corresponding author), Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi, India.	abhinavgr@gmail.com	Kumari, Anchala/AAX-5951-2021	verma, sharad/0000-0002-9261-6878; Singh, Aditi/0000-0001-7438-2863	Department of Health Research (DHR); DST PURSE Grant from Jawaharlal Nehru University; Department of Health Research (DHR), India; Council of Scientific and Industrial Research (CSIR), India	Department of Health Research (DHR); DST PURSE Grant from Jawaharlal Nehru University; Department of Health Research (DHR), India; Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This study was funded in part by DST PURSE Grant from Jawaharlal Nehru University in the form of support for the article's publication fee. SG received support from from the Department of Health Research (DHR), India, in the form of the Young Scientist Fellowship. SV received support from the Council of Scientific and Industrial Research (CSIR), India, in the form of a Senior Research Associateship (pool scientist scheme). No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AG is thankful to Jawaharlal Nehru University for usage of all computational facilities. AG is grateful to University Grants Commission, India for the Faculty Recharge position. SV is thankful of Council of Scientific and Industrial Research (CSIR), India for providing senior research associateship (pool scientist scheme). SG acknowledges Young Scientist fellowship from Department of Health Research (DHR).	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amadei A, 1996, J BIOMOL STRUCT DYN, V13, P615, DOI 10.1080/07391102.1996.10508874; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Esteva FJ, 2010, NAT REV CLIN ONCOL, V7, P98, DOI 10.1038/nrclinonc.2009.216; Gilmer TM, 2008, CANCER RES, V68, P571, DOI 10.1158/0008-5472.CAN-07-2404; Gupta A, 2015, J RECEPT SIG TRANSD, V35, P626, DOI 10.3109/10799893.2015.1041645; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Iqbal N, 2014, MOL BIOL INT, V2014; Kaburagi M, 2016, POLYM J, V48, P189, DOI 10.1038/pj.2015.82; Kancha RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026760; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; MacFarlane RJ, 2011, EXPERT OPIN DRUG SAF, V10, P109, DOI 10.1517/14740338.2011.533168; Minami Y, 2007, ONCOGENE, V26, P5023, DOI 10.1038/sj.onc.1210292; Nagpal N, 2016, J RECEPT SIG TRANSD, P1; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Pandey B, 2016, GENE, V581, P31, DOI 10.1016/j.gene.2016.01.024; Pandey V, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0563-7; Patel K, 2015, COMPUT BIOL CHEM, V59, P37, DOI 10.1016/j.compbiolchem.2015.09.006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sasaki H, 2006, INT J CANCER, V118, P180, DOI 10.1002/ijc.21301; Seidman AD, 2001, J CLIN ONCOL, V19, P2587, DOI 10.1200/JCO.2001.19.10.2587; Shen HJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002851; Singh B, 2015, J PHYS CHEM B, V119, P392, DOI 10.1021/jp5079554; Sinha S, 2016, J BIOMOL STRUCT DYN, P1; Slamon D., 1987, SCIENCE, P235; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Sun ZJ, 2015, J CELL MOL MED, V19, P2691, DOI 10.1111/jcmm.12662; Suzuki M, 2015, LUNG CANCER, V87, P14, DOI 10.1016/j.lungcan.2014.10.014; Telesco SE, 2009, BIOPHYS J, V96, P2321, DOI 10.1016/j.bpj.2008.12.3912; Tournier AL, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.208106; Trowe T, 2008, CLIN CANCER RES, V14, P2465, DOI 10.1158/1078-0432.CCR-07-4367; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; vanAalten DMF, 1995, PROTEIN ENG, V8, P1129; Verma S, 2016, J BIOMOL STRUCT DYN, P1; Verma S, 2016, J MOL GRAPH MODEL, V67, P94, DOI 10.1016/j.jmgm.2016.05.007; Verma S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149014; Verma S, 2012, J MOL GRAPH MODEL, V37, P27, DOI 10.1016/j.jmgm.2012.04.004; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Wang L, 2015, RSC ADV, V5, P66391, DOI 10.1039/c5ra12328c; Wang YC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3067; Yan M, 2014, CANCER TREAT REV, V40, P770, DOI 10.1016/j.ctrv.2014.02.008; Zabransky DJ, 2015, P NATL ACAD SCI USA, V112, pE6205, DOI 10.1073/pnas.1516853112; Zuo WJ, 2016, CLIN CANCER RES, V22, P4859, DOI 10.1158/1078-0432.CCR-15-3036	49	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0190942	10.1371/journal.pone.0190942	http://dx.doi.org/10.1371/journal.pone.0190942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389942	gold, Green Published, Green Submitted			2022-12-26	WOS:000423793400009
J	Shim, SH; Lim, MC; Kim, HJ; Lee, M; Nam, EJ; Lee, JY; Lee, YY; Lee, KB; Park, JY; Kim, YH; Ki, KD; Song, YJ; Chung, HH; Kim, S; Lee, JW; Kim, JW; Bae, DS; Lee, JM				Shim, Seung-Hyuk; Lim, Myong Cheol; Kim, Hyun Jung; Lee, Maria; Nam, Eun Ji; Lee, Jung Yun; Lee, Yoo-Young; Lee, Kwang Beom; Park, Jeong Yeol; Kim, Yun Hwan; Ki, Kyung Do; Song, Yong Jung; Chung, Hyun Hoon; Kim, Sunghoon; Lee, Jeong-won; Kim, Jae-Weon; Bae, Duk-Soo; Lee, Jong-Min			Can simple trachelectomy or conization show comparable survival rate compared with radical trachelectomy in IA1 cervical cancer patients with lymphovascular space invasion who wish to save fertility? A systematic review and guideline recommendation	PLOS ONE			English	Review							PARAMETRIAL INVOLVEMENT; VAGINAL TRACHELECTOMY; SPARING SURGERY; STAGE; CARCINOMA; WOMEN; RISK; PRESERVATION; MANAGEMENT; OPTION	Objective This study aims to analyze the published literatures on the effect of less radical fertility-preserving procedures, such as conization or simple trachelectomy, on oncological outcomes in IA1 cervical cancer patients with lymphovascular space invasion (LVSI) through a systematic-review. Methods The EMBASE and MEDLINE databases and Cochrane Library were searched for published studies reporting the oncological outcomes of conization/simple trachelectomy in these patients, through April 2017. The endpoints were recurrence and mortality rates. Data were presented as per the Meta-analysis Of Observational Studies in Epidemiology checklist. Practice guidelines were generated via the Grading of Recommendation, Assessment, Development and Evaluation system. Results From 6,755 records, 94 full-texts articles were reviewed for eligibility, and five studies were included in this systematic review. All included studies were nonrandomized studies: two case-control studies comparing conization (n = 14) with hysterectomy (n = 24), and the other three were interrupted time series including conization (n = 20) and simple vaginal trachelectomy (n = 59). During the median follow-up duration of 43 months, no recurrence was reported in both conization and simple trachelectomy groups in IA1 patients with LVSI. From three studies reporting the fertility outcomes, the rates of pregnancy, live birth, preterm delivery, and second-trimester miscarriage were 73% (35/48), 64% (32/50), 10% (5/48), and 6% (3/48), respectively. Conclusion Results suggest that simple trachelectomy or conization could be performed for IA1 cervical cancer patients with LVSI who want to preserve fertility, although these results are only based on a small number of nonrandomized studies (recommendation grade 2 = weak; evidence level D = very low). Further randomized trials with long-term study period are needed to address this issue.	[Shim, Seung-Hyuk] Konkuk Univ, Dept Obstet & Gynecol, Sch Med, Seoul, South Korea; [Lim, Myong Cheol] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Ctr Uterine Canc, Canc Healthcare Res Branch, Goyang Si Gyeonggi Do, South Korea; [Lim, Myong Cheol] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Populat Hlth, Ctr Clin Trials,Res Inst & Hosp, Goyang Si Gyeonggi Do, South Korea; [Kim, Hyun Jung] Korea Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Lee, Maria; Chung, Hyun Hoon; Kim, Jae-Weon] Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Nam, Eun Ji; Lee, Jung Yun; Kim, Sunghoon] Yonsei Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Lee, Yoo-Young] Univ Toronto, Univ Hlth Network, Div Gynecol Oncol, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Lee, Kwang Beom] Gachon Univ, Gil Med Ctr, Coll Med, Dept Obstet & Gynecol, Incheon, South Korea; [Park, Jeong Yeol] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Yun Hwan] Ewha Womans Univ, Sch Med, Mokdong Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Ki, Kyung Do; Lee, Jong-Min] Kyung Hee Univ, Coll Med, Kyung Hee Univ Hosp Gangdong, Dept Obstet & Gynecol, Seoul, South Korea; [Song, Yong Jung] Pusan Natl Univ, Dept Obstet & Gynecol, Sch Med, Pusan, South Korea; [Lee, Jeong-won; Bae, Duk-Soo] Sungkyunkwan Univ, Dept Obstet & Gynecol, Samsung Med Ctr, Sch Med, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Yonsei University; Yonsei University Health System; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Gachon University; University of Ulsan; Asan Medical Center; Ewha Womans University; Kyung Hee University; Kyung Hee University Hospital; Pusan National University; Pusan National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, JM (corresponding author), Kyung Hee Univ, Coll Med, Kyung Hee Univ Hosp Gangdong, Dept Obstet & Gynecol, Seoul, South Korea.	kgo02@hanmail.net	Dangal, Ganesh/O-1989-2017; lee, jw/O-6237-2014; Lee, Maria/AAQ-2558-2020	Dangal, Ganesh/0000-0002-5834-5525; Kim, Jae-Weon/0000-0003-1835-9436; Lee, Jung-Yun/0000-0001-7948-1350; Ki, Kyung-Do/0000-0002-1060-2297; Lee, Maria/0000-0002-8017-3176; kim, sunghoon/0000-0002-1570-3230; Kim, Sunghoon/0000-0002-1645-7473; Nam, Eun Ji/0000-0003-0189-3560; Shim, Seung-Hyuk/0000-0001-8043-2257	Konkuk University Medical Center Research Grant	Konkuk University Medical Center Research Grant	This work was supported by the Konkuk University Medical Center Research Grant 2017.	Albrechtsen S, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1343; Anderson M. D., CONS SURG WOM CERV C; Andikyan V, 2014, INT J GYNECOL CANCER, V24, P113, DOI 10.1097/IGC.0000000000000034; Aziz O, 2006, ANN SURG ONCOL, V13, P413, DOI 10.1245/ASO.2006.05.045; Baiocchi G, 2017, GYNECOL ONCOL; Bekkers RLM, 2002, INT J GYNECOL CANCER, V12, P485, DOI 10.1046/j.1525-1438.2002.01131.x; Bentivegna E, 2016, LANCET ONCOL, V17, pE240, DOI 10.1016/S1470-2045(16)30032-8; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Bratila E, 2016, INDIAN J SURG, V78, P265, DOI 10.1007/s12262-015-1351-3; Colombo N, 2012, ANN ONCOL, V23, P27, DOI 10.1093/annonc/mds268; Covens A, 2002, GYNECOL ONCOL, V84, P145, DOI 10.1006/gyno.2001.6493; Dargent D, 2000, CANCER, V88, P1877, DOI 10.1002/(SICI)1097-0142(20000415)88:8<1877::AID-CNCR17>3.3.CO;2-N; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Frumovitz M, 2009, OBSTET GYNECOL, V114, P93, DOI 10.1097/AOG.0b013e3181ab474d; Kardakis Spyridon, 2012, ISRN Oncol, V2012, P817065, DOI 10.5402/2012/817065; KINNEY WK, 1995, GYNECOL ONCOL, V57, P3, DOI 10.1006/gyno.1995.1091; Lee SW, 2009, ACTA OBSTET GYN SCAN, V88, P209, DOI 10.1080/00016340802596009; Lim MC, 2017, J GYNECOL ONCOL, V28, DOI 10.3802/jgo.2017.28.e22; Lim MC, 2013, J GYNECOL ONCOL, V24, P298, DOI 10.3802/jgo.2013.24.4.298; Min KJ, 2015, J GYNECOL ONCOL, V26, P232, DOI 10.3802/jgo.2015.26.3.232; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nagase S, 2010, INT J CLIN ONCOL, V15, P117, DOI 10.1007/s10147-010-0061-x; Park Y, 2015, EPIDEMIOL HEALTH, V37, DOI 10.4178/epih/e2015024; Plante M, 2017, INT J GYNECOL CANCER, V27, P1021, DOI 10.1097/IGC.0000000000000989; Ramirez PT, 2014, GYNECOL ONCOL, V132, P254, DOI 10.1016/j.ygyno.2013.09.004; Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576; Ribeiro RB, 2012, ACTA OTORRINOLAR ESP, V63, P292, DOI 10.1016/j.otorri.2012.02.012; Rob L, 2007, INT J GYNECOL CANCER, V17, P304, DOI 10.1111/j.1525-1438.2007.00758.x; Rob L, 2008, GYNECOL ONCOL, V111, pS116, DOI 10.1016/j.ygyno.2008.07.021; Rob L, 2011, LANCET ONCOL, V12, P192, DOI 10.1016/S1470-2045(10)70084-X; Schneider A, 2012, INT J GYNECOL CANCER, V22, P659, DOI 10.1097/IGC.0b013e3182466a0e; Seol HJ, 2014, J GYNECOL ONCOL, V25, P70, DOI 10.3802/jgo.2014.25.1.70; Smith AL, 2010, GYNECOL ONCOL, V119, P183, DOI 10.1016/j.ygyno.2010.07.015; Stegeman M, 2007, GYNECOL ONCOL, V105, P475, DOI 10.1016/j.ygyno.2007.01.016; Strnad P, 2008, GYNECOL ONCOL, V109, P280, DOI 10.1016/j.ygyno.2008.02.004; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tong S, 2008, OBSTET GYNECOL, V111, P710, DOI 10.1097/AOG.0b013e318163747c; Wells G SB, 2013, NEWCASTLE OTTAWA SCA; Willows Karla, 2016, Gynecol Oncol Res Pract, V3, P9; Winter WE, 2002, OBSTET GYNECOL, V100, P671, DOI 10.1016/S0029-7844(02)02171-3; Wright JD, 2007, CANCER-AM CANCER SOC, V110, P1281, DOI 10.1002/cncr.22899; Zhang Q, 2017, ONCOTARGET	42	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0189847	10.1371/journal.pone.0189847	http://dx.doi.org/10.1371/journal.pone.0189847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385139	gold, Green Published			2022-12-26	WOS:000423668400010
J	Singer, W; Kasini, K; Manthey, M; Eckert, P; Armbruster, P; Vogt, MA; Jaumann, M; Dotta, M; Yamahara, K; Harasztosi, C; Zimmermann, U; Knipper, M; Ruttiger, L				Singer, Wibke; Kasini, Kamyar; Manthey, Marie; Eckert, Philipp; Armbruster, Philipp; Vogt, Miriam Annika; Jaumann, Mirko; Dotta, Michela; Yamahara, Kohei; Harasztosi, Csaba; Zimmermann, Ulrike; Knipper, Marlies; Ruettiger, Lukas			The glucocorticoid antagonist mifepristone attenuates sound-induced long-term deficits in auditory nerve response and central auditory processing in female rats	FASEB JOURNAL			English	Article						glucocorticoid receptors; mineralocorticoid receptors; hidden hearing loss; synaptic ribbon; auditory trauma	SENSORINEURAL HEARING-LOSS; TRAUMATIC BRAIN-INJURY; OUTER HAIR-CELLS; RESTRAINT STRESS; ACOUSTIC TRAUMA; GUINEA-PIG; MINERALOCORTICOID RECEPTOR; COCHLEAR SYNAPTOPATHY; INTRATYMPANIC DEXAMETHASONE; INNER-EAR	Systemic corticosteroids have been the mainstay of treatment for various hearing disorders for more than 30 yr. Accordingly, numerous studies have described glucocorticoids (GCs) and stressors to be protective in the auditory organ against damage associated with a variety of health conditions, including noise exposure. Conversely, stressors are also predictive risk factors for hearing disorders. How both of these contrasting stress actions are linked has remained elusive. Here, we demonstrate that higher corticosterone levels during acoustic trauma in female rats is highly correlated with a decline of auditory fiber responses in high-frequency cochlear regions, and that hearing thresholds and the outer hair cell functions (distortion products of otoacoustic emissions) are left unaffected. Moreover, when GC receptor (GR) or mineralocorticoid receptor (MR) activation was antagonized by mifepristone or spironolactone, respectively, GR, but not MR, inhibition significantly and permanently attenuated trauma-induced effects on auditory fiber responses, including inner hair cell ribbon loss and related reductions of early and late auditory brainstem responses. These findings strongly imply that higher corticosterone stress levels profoundly impair auditory nerve processing, which may influence central auditory acuity. These changes are likely GR mediated as they are prevented by mifepristone.	[Singer, Wibke; Kasini, Kamyar; Manthey, Marie; Eckert, Philipp; Armbruster, Philipp; Vogt, Miriam Annika; Jaumann, Mirko; Dotta, Michela; Yamahara, Kohei; Zimmermann, Ulrike; Knipper, Marlies; Ruettiger, Lukas] Univ Tubingen, Tubingen Hearing Res Ctr, Dept Otolaryngol, Mol Physiol Hearing, Tubingen, Germany; [Harasztosi, Csaba] Univ Tubingen, Tubingen Hearing Res Ctr, Dept Otolaryngol, Sect Physiol Acoust & Commun, Tubingen, Germany; [Yamahara, Kohei] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Kyoto University	Knipper, M (corresponding author), Univ Tubingen, Dept Otolaryngol, Tubingen Hearing Res Ctr, Elfriede Aulhorn Str 5, D-72076 Tubingen, Germany.	marlies.knipper@uni-tuebingen.de	åå, å·å/AAC-7392-2019	åå, å·å/0000-0002-3281-7547; Vogt, Miriam Annika/0000-0002-3400-5067	Deutsche Forschungsgemeinschaft [DFG-Kni-316-10-1, SPP 1608 RU 316/12-1, KN 316/12-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Grants DFG-Kni-316-10-1, SPP 1608 RU 316/12-1, and KN 316/12-1). The authors thank Michael Paolillo (Interfaculty Institute of Biochemistry, University of Tubingen) for reading the manuscript. The authors declare no conflicts of interest.	Adamec R, 2007, BEHAV BRAIN RES, V179, P192, DOI 10.1016/j.bbr.2007.02.001; Perez MA, 2013, NEUROSCIENCE, V246, P94, DOI 10.1016/j.neuroscience.2013.04.044; Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; Bharadwaj HM, 2015, J NEUROSCI, V35, P2161, DOI 10.1523/JNEUROSCI.3915-14.2015; Boudaba C, 2006, AM J PHYSIOL-REG I, V291, pR102, DOI 10.1152/ajpregu.00795.2005; Buran BN, 2010, J NEUROSCI, V30, P7587, DOI 10.1523/JNEUROSCI.0389-10.2010; Burkard R., 2007, AUDITORY EVOKED POTE, P229; Canlon B, 2007, HEARING RES, V226, P61, DOI 10.1016/j.heares.2006.05.009; Chavez CM, 2009, NEUROBIOL LEARN MEM, V91, P382, DOI 10.1016/j.nlm.2008.10.010; Dagnino-Subiabre A, 2009, BEHAV BRAIN RES, V203, P88, DOI 10.1016/j.bbr.2009.04.024; DALLOS P, 1978, J NEUROPHYSIOL, V41, P365, DOI 10.1152/jn.1978.41.2.365; de Kloet ER, 2013, EUR J PHARMACOL, V719, P53, DOI 10.1016/j.ejphar.2013.04.053; de Kloet ER, 2014, ENDOCRINOLOGY, V155, P2754, DOI 10.1210/en.2014-1048; El Sabbagh NG, 2017, LARYNGOSCOPE, V127, P1897, DOI 10.1002/lary.26394; El-Badry MM, 2007, BRAIN RES, V1134, P122, DOI 10.1016/j.brainres.2006.11.078; Engel J, 2006, NEUROSCIENCE, V143, P837, DOI 10.1016/j.neuroscience.2006.08.060; Felmingham KL, 2012, BIOL PSYCHOL, V90, P224, DOI 10.1016/j.biopsycho.2012.03.011; Fetoni AR, 2016, FREE RADICAL BIO MED, V101, P211, DOI 10.1016/j.freeradbiomed.2016.10.014; Fox LC, 2016, BEHAV BRAIN RES, V312, P362, DOI 10.1016/j.bbr.2016.06.048; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; Griesbach GS, 2012, NEUROSCIENCE, V210, P393, DOI 10.1016/j.neuroscience.2012.03.005; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Hickox AE, 2017, HEARING RES, V349, P164, DOI 10.1016/j.heares.2016.12.010; Hobson CE, 2016, CURR OPIN OTOLARYNGO, V24, P407, DOI 10.1097/MOO.0000000000000288; Howland RH, 2013, J PSYCHOSOC NURS MEN, V51, P11, DOI 10.3928/02793695-20121219-01; Jaumann M, 2012, NAT MED, V18, P252, DOI 10.1038/nm.2634; Jia H, 2016, NEUROSCIENCE, V316, P261, DOI 10.1016/j.neuroscience.2015.12.031; Joels M, 2017, J ENDOCRINOL, V234, pT49, DOI 10.1530/JOE-16-0660; JOHNSON DH, 1976, BIOPHYS J, V16, P719, DOI 10.1016/S0006-3495(76)85724-4; Karst H, 2010, P NATL ACAD SCI USA, V107, P14449, DOI 10.1073/pnas.0914381107; Kil SH, 2013, HEARING RES, V299, P63, DOI 10.1016/j.heares.2013.01.020; Kobel M, 2017, HEARING RES, V349, P148, DOI 10.1016/j.heares.2016.12.008; KORTE SM, 1995, PSYCHONEUROENDOCRINO, V20, P385, DOI 10.1016/0306-4530(94)00069-7; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kurabi A, 2017, HEARING RES, V349, P129, DOI 10.1016/j.heares.2016.11.013; Lee HY, 2017, EUR ARCH OTO-RHINO-L, V274, P143, DOI 10.1007/s00405-016-4276-y; Ma LL, 2017, STRESS, V20, P312, DOI 10.1080/10253890.2017.1323861; Marcon S, 2008, HEARING RES, V237, P76, DOI 10.1016/j.heares.2007.12.011; McLean WJ, 2009, JARO-J ASSOC RES OTO, V10, P37, DOI 10.1007/s10162-008-0152-9; Melcher JR, 1996, HEARING RES, V93, P52, DOI 10.1016/0378-5955(95)00200-6; Meltser I, 2011, HEARING RES, V281, P47, DOI 10.1016/j.heares.2011.06.003; Muller M, 2017, HNO, V65, pS59, DOI 10.1007/s00106-016-0266-z; MULLER M, 1991, HEARING RES, V57, P63, DOI 10.1016/0378-5955(91)90075-K; Niedermeier K, 2012, ACTA OTO-LARYNGOL, V132, P1252, DOI 10.3109/00016489.2012.701017; O'Byrne PM, 1998, J ALLERGY CLIN IMMUN, V102, P879, DOI 10.1016/S0091-6749(98)70322-7; O'Leary SJ, 2013, HEARING RES, V298, P27, DOI 10.1016/j.heares.2013.01.012; Oitzl MS, 2010, NEUROSCI BIOBEHAV R, V34, P853, DOI 10.1016/j.neubiorev.2009.07.006; Plontke SK, 2014, OTOL NEUROTOL, V35, P1168, DOI 10.1097/MAO.0000000000000434; RAREY KE, 1995, HEARING RES, V82, P135, DOI 10.1016/0378-5955(94)00171-L; Ruttiger L, 2017, ORL J OTO-RHINO-LARY, V79, P93, DOI 10.1159/000455705; Ruttiger L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057247; Safieddine S, 2012, ANNU REV NEUROSCI, V35, P509, DOI 10.1146/annurev-neuro-061010-113705; Schmiedt RA, 1996, J NEUROPHYSIOL, V76, P2799, DOI 10.1152/jn.1996.76.4.2799; Sergeyenko Y, 2013, J NEUROSCI, V33, P13686, DOI 10.1523/JNEUROSCI.1783-13.2013; Sha SH, 2017, EXPERT OPIN INV DRUG, V26, P85, DOI 10.1080/13543784.2017.1269171; Shera CA, 1999, J ACOUST SOC AM, V105, P782, DOI 10.1121/1.426948; Singer W, 2016, METHODS MOL BIOL, V1427, P263, DOI 10.1007/978-1-4939-3615-1_15; Singer W, 2013, MOL NEUROBIOL, V47, P261, DOI 10.1007/s12035-012-8372-8; Tahera Y, 2006, J NEUROSCI RES, V83, P1066, DOI 10.1002/jnr.20795; Tahera Y, 2007, NEUROBIOL DIS, V25, P189, DOI 10.1016/j.nbd.2006.09.004; Tahera Y, 2006, ENDOCRINOLOGY, V147, P4430, DOI 10.1210/en.2006-0260; Terakado M, 2011, HEARING RES, V280, P148, DOI 10.1016/j.heares.2011.05.006; Trune DR, 2012, ANAT REC, V295, P1928, DOI 10.1002/ar.22576; Trune DR, 2006, HEARING RES, V212, P22, DOI 10.1016/j.heares.2005.10.006; Tsigos C, 2000, ENDOTEXT; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028; Wang Y, 2002, HEARING RES, V165, P96, DOI 10.1016/S0378-5955(02)00289-7; Yao XF, 1996, ACTA OTO-LARYNGOL, V116, P493, DOI 10.3109/00016489609137879; Yoshida N, 2000, HEARING RES, V148, P213, DOI 10.1016/S0378-5955(00)00161-1; Yoshida N, 1999, HEARING RES, V131, P29, DOI 10.1016/S0378-5955(99)00008-8	70	21	21	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3005	3019		10.1096/fj.201701041RRR	http://dx.doi.org/10.1096/fj.201701041RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401591				2022-12-26	WOS:000432546000010
J	Naing, SH; Kalyoncu, S; Smalley, DM; Kim, H; Tao, XJ; George, JB; Jonke, AP; Oliver, RC; Urban, VS; Torres, MP; Lieberman, RL				Naing, Swe-Htet; Kalyoncu, Sibel; Smalley, David M.; Kim, Hyojung; Tao, Xingjian; George, Josh B.; Jonke, Alex P.; Oliver, Ryan C.; Urban, Volker S.; Torres, Matthew P.; Lieberman, Raquel L.			Both positional and chemical variables control in vitro proteolytic cleavage of a presenilin ortholog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; SIGNAL PEPTIDE PEPTIDASE; FAMILIAL ALZHEIMERS-DISEASE; CARBOXYL TERMINAL FRAGMENT; GAMMA-SECRETASE CLEAVAGE; INTRAMEMBRANE PROTEOLYSIS; TRANSMEMBRANE DOMAIN; SUBSTRATE-SPECIFICITY; ASPARTIC PROTEASES; HELIX PROPENSITY	Mechanistic details of intramembrane aspartyl protease (IAP) chemistry, which is central to many biological and pathogenic processes, remain largely obscure. Here, we investigated the in vitro kinetics of a microbial intramembrane aspartyl protease (mIAP) fortuitously acting on the renin substrate angiotensinogen and the C-terminal transmembrane segment of amyloid precursor protein (C100), which is cleaved by the presenilin subunit of gamma-secretase, an Alzheimer disease (AD)-associated IAP. mIAP variants with substitutions in active-site and putative substrate-gating residues generally exhibit impaired, but not abolished, activity toward angiotensinogen and retain the predominant cleavage site (His-Thr). The aromatic ring, but not the hydroxyl substituent, within Tyr of the catalytic Tyr-Asp (YD) motif plays a catalytic role, and the hydrolysis reaction incorporates bulk water as in soluble aspartyl proteases. mIAP hydrolyzes the transmembrane region of C100 at two major presenilin cleavage sites, one corresponding to the AD-associated A beta 42 peptide (Ala-Thr) and the other to the non-pathogenic A beta 48 (Thr-Leu). For the former site, we observed more favorable kinetics in lipid bilayer-mimicking bicelles than in detergent solution, indicating that substrate-lipid and substrate-enzyme interactions both contribute to catalytic rates. High-resolution MS analyses across four substrates support a preference for threonine at the scissile bond. However, results from threonine-scanning mutagenesis of angiotensinogen demonstrate a competing positional preference for cleavage. Our results indicate that IAP cleavage is controlled by both positional and chemical factors, opening up new avenues for selective IAP inhibition for therapeutic interventions.	[Naing, Swe-Htet; Kalyoncu, Sibel; Kim, Hyojung; Tao, Xingjian; George, Josh B.; Lieberman, Raquel L.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Smalley, David M.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Kim, Hyojung; Jonke, Alex P.; Torres, Matthew P.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Oliver, Ryan C.; Urban, Volker S.] Oak Ridge Natl Lab, Neutron Scattering Div, Oak Ridge, TN 37831 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; United States Department of Energy (DOE); Oak Ridge National Laboratory	Lieberman, RL (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	raquel.lieberman@chemistry.gatech.edu	Urban, Volker S/N-5361-2015; Kalyoncu, Sibel/H-3225-2019	Urban, Volker S/0000-0002-7962-3408; Kalyoncu, Sibel/0000-0003-2264-0757; Torres, Matthew/0000-0001-7296-4536; Oliver, Ryan/0000-0003-4489-0861	National Science Foundation [MCB 0845445]; National Institutes of Health [R01GM112662, R01GM118744]; College of Sciences at Georgia Tech; Office of Biological and Environmental Research; Scientific User Facilities Division, Office of Basic Energy Sciences of the United States Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112662, R01GM118744] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Sciences at Georgia Tech; Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scientific User Facilities Division, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Science Foundation Grant MCB 0845445 (to R. L. L.) and National Institutes of Health Grants R01GM112662 and R01GM118744 (to M. P. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a travel grant from the College of Sciences at Georgia Tech to collect data at ORNL.; Supported by the Office of Biological and Environmental Research and by the Scientific User Facilities Division, Office of Basic Energy Sciences of the United States Department of Energy.	Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008; Bolduc DM, 2016, ELIFE, V5, DOI 10.7554/eLife.17578; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; Dang SY, 2015, P NATL ACAD SCI USA, V112, P3344, DOI 10.1073/pnas.1502150112; De Jonghe C, 1999, NEUROBIOL DIS, V6, P280, DOI 10.1006/nbdi.1999.0247; Deatherage CL, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602794; Dunn BM, 2002, CHEM REV, V102, P4431, DOI 10.1021/cr010167q; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fluhrer R, 2008, J BIOL CHEM, V283, P30121, DOI 10.1074/jbc.M806092200; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HOLZMAN TF, 1991, J PROTEIN CHEM, V10, P553, DOI 10.1007/BF01025483; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Ikeuchi T, 2003, J BIOL CHEM, V278, P7751, DOI 10.1074/jbc.C200711200; Kamp F, 2015, BIOPHYS J, V108, P1229, DOI 10.1016/j.bpj.2014.12.045; Khelashvili G, 2010, J PHYS CHEM B, V114, P12046, DOI 10.1021/jp106373r; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kroos L, 2013, BBA-BIOMEMBRANES, V1828, P2873, DOI 10.1016/j.bbamem.2013.03.032; Langosch D, 2015, TRENDS BIOCHEM SCI, V40, P318, DOI 10.1016/j.tibs.2015.04.001; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Maulik M, 2013, MOL NEUROBIOL, V47, P37, DOI 10.1007/s12035-012-8337-y; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Morishima-Kawashima M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00463; Naing SH, 2015, ACS CHEM BIOL, V10, P2166, DOI 10.1021/acschembio.5b00305; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pester O, 2013, J AM CHEM SOC, V135, P1317, DOI 10.1021/ja3112093; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Song YL, 2013, BIOCHEMISTRY-US, V52, P5051, DOI 10.1021/bi400735x; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Szaruga M, 2017, CELL, V170, P443, DOI 10.1016/j.cell.2017.07.004; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Takeo K, 2014, P NATL ACAD SCI USA, V111, P10544, DOI 10.1073/pnas.1402171111; Theron LW, 2014, APPL MICROBIOL BIOT, V98, P8853, DOI 10.1007/s00253-014-6035-6; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tong BCK, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf1371; Torres-Arancivia C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013072; Ujwal R, 2011, METHODS, V55, P337, DOI 10.1016/j.ymeth.2011.09.020; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2002, CURR OPIN GENET DEV, V12, P512, DOI 10.1016/S0959-437X(02)00334-9; Veugelen S, 2016, NEURON, V90, P410, DOI 10.1016/j.neuron.2016.03.010; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Voss M, 2013, BBA-BIOMEMBRANES, V1828, P2828, DOI 10.1016/j.bbamem.2013.03.033; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2013, BBA-BIOMEMBRANES, V1828, P2886, DOI 10.1016/j.bbamem.2013.04.015; Wood WG, 2014, J NEUROCHEM, V129, P559, DOI 10.1111/jnc.12637; YEAGLE PL, 1991, BIOCHIMIE, V73, P1303, DOI 10.1016/0300-9084(91)90093-G; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200	72	10	10	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4653	4663		10.1074/jbc.RA117.001436	http://dx.doi.org/10.1074/jbc.RA117.001436			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29382721	Green Published, hybrid			2022-12-26	WOS:000428848300008
J	Boscolo-Rizzo, P; Zorzi, M; Del Mistro, A; Da Mosto, MC; Tirelli, G; Buzzoni, C; Rugge, M; Polesel, J; Guzzinati, S				Boscolo-Rizzo, Paolo; Zorzi, Manuel; Del Mistro, Annarosa; Da Mosto, Maria Cristina; Tirelli, Giancarlo; Buzzoni, Carlotta; Rugge, Massimo; Polesel, Jerry; Guzzinati, Stefano		AIRTUM Working Grp	The evolution of the epidemiological landscape of head and neck cancer in Italy: Is there evidence for an increase in the incidence of potentially HPV-related carcinomas?	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; ALCOHOL-DRINKING; UNITED-STATES; LARYNGEAL-CANCER; INCIDENCE TRENDS; SEXUAL-BEHAVIOR; UNKNOWN PRIMARY; ORAL-CAVITY	The current study aimed to investigate the incidence and survival patterns of HNSCCs arising from different anatomic sites, potentially related (the oropharynx) or unrelated (the oral cavity, the larynx/hypopharynx) to HPV, to provide clues on possible growing impact of HPV in the epidemiology of HNSCC in Italy. Epidemiological data were retrieved from ten long-term Cancer Registries covering a population of 7.8 million inhabitants. Trends were described by means of the estimated annual percent change (APC) stratified by age and gender, and compared between HPV-related and HPV-unrelated anatomical sites. The data regarding 28,295 HNSCCs diagnosed in Italy between 1988 and 2012 were analyzed. In males, the incidence rate (IR) of cancers arising from sites unrelated to HPV infection significantly decreased in all age groups (APC:-3.31 for larynx/hypopharynx; APC:-1.77 for oral cavity), whereas stable IR were observed for cancers arising from sites related to HPV infection. In females, IR for cancers from HPV-related sites increased significantly over the observed period; the largest increment was noted in those over 60 (APC: 2.92%) who also showed a significantly lower number of HNSCCs from the larynx/hypopharynx (APC:-0.84) and a significantly higher number of oral cavity tumors (APC = 2.15). The five-year relative survival remained largely unchanged in the patients with laryngeal/hypopharyngeal SCC and, conversely, significantly improved in the patients with SCC at HPV-related sites. The trends observed suggest a potential increasing impact of HPV infection on the epidemiology of HNSCC in Italy, but to a lesser extent and with a different pattern from that observed in other Western countries.	[Boscolo-Rizzo, Paolo; Da Mosto, Maria Cristina] Univ Padua, Reg Ctr Head & Neck Canc, Dept Neurosci, Treviso, Italy; [Zorzi, Manuel; Rugge, Massimo; Guzzinati, Stefano] Veneto Tumor Registry, Padua, Italy; [Del Mistro, Annarosa] Veneto Inst Oncol IOV IRCCS, Padua, Italy; [Tirelli, Giancarlo] Univ Trieste, Hosp Cattinara, Head & Neck Dept, Trieste, Italy; [Buzzoni, Carlotta] AIRTUM Database, Florence, Italy; [Buzzoni, Carlotta] Canc Prevent & Res Inst ISPO, Clin & Descript Epidemiol Unit, Tuscany Canc Registry, Florence, Italy; [Rugge, Massimo] Univ Padua, Dept Med, Surg Pathol Unit, Padua, Italy; [Polesel, Jerry] CRO Aviano Natl Canc Inst, Unit Canc Epidemiol, Aviano, Italy	University of Padua; Azienda Zero; IRCCS Istituto Oncologico Veneto (IOV); University of Trieste; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Padua; IRCCS Aviano (CRO)	Guzzinati, S (corresponding author), Veneto Tumor Registry, Padua, Italy.	stefano.guzzinati@regione.veneto.it	Boscolo-Rizzo, Paolo/AAI-5666-2021; Polesel, Jerry/AAA-5750-2019; tirelli, giancarlo/G-3118-2012	Boscolo-Rizzo, Paolo/0000-0002-4635-7959; Polesel, Jerry/0000-0001-9381-1520; tirelli, giancarlo/0000-0002-7871-2011; RUGGE, MASSIMO/0000-0002-0679-0563; guzzinati, stefano/0000-0002-4908-5506				Agalliu I, 2016, JAMA ONCOL; Anantharaman D, 2017, INT J CANCER, V140, P1968, DOI 10.1002/ijc.30608; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Baboci L, 2016, PAPILLOMAVIRUS RES, V2, P133, DOI 10.1016/j.pvr.2016.07.002; Bagnardi V, 2001, BRIT J CANCER, V85, P1700, DOI 10.1054/bjoc.2001.2140; Blomberg M, 2011, INT J CANCER, V129, P733, DOI 10.1002/ijc.25699; Boscolo-Rizzo P, 2015, CLIN EXP METASTAS, V32, P835, DOI 10.1007/s10585-015-9744-z; Bossi P, 2014, ANN ONCOL, V25, P694, DOI 10.1093/annonc/mdu004; Braakhuis BJM, 2009, ORAL ONCOL, V45, pE85, DOI 10.1016/j.oraloncology.2009.03.010; Castellsague X, 2017, RECENT RESULTS CANC, V206, P27, DOI 10.1007/978-3-319-43580-0_2; Castellsague X, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv403; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chiesi A, 1999, RECENT SOCIAL TRENDS; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; D'Souza G, 2016, ORAL ONCOL, V62, P20, DOI 10.1016/j.oraloncology.2016.09.005; de Martel C, 2017, INT J CANCER, V141, P664, DOI 10.1002/ijc.30716; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Forte T, 2012, CANCER CAUSE CONTROL, V23, P1343, DOI 10.1007/s10552-012-0013-z; Gallus S, 2003, CANCER EPIDEM BIOMAR, V12, P514; Gallus S, 2011, PREV MED, V52, P434, DOI 10.1016/j.ypmed.2011.03.011; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Halec G, 2013, BRIT J CANCER, V109, P172, DOI 10.1038/bjc.2013.296; Hocking JS, 2011, BRIT J CANCER, V104, P886, DOI 10.1038/sj.bjc.6606091; Hussein AA, 2017, EUR J CANCER, V82, P115, DOI 10.1016/j.ejca.2017.05.026; Hwang TZ, 2015, INT J CANCER, V137, P395, DOI 10.1002/ijc.29330; Islami F, 2010, ORAL ONCOL, V46, P802, DOI 10.1016/j.oraloncology.2010.07.015; Jehannin-Ligier K, 2017, INT J CANCER, V140, P2032, DOI 10.1002/ijc.30631; Lubin JH, 2010, AM J EPIDEMIOL, V171, P1250, DOI 10.1093/aje/kwq088; Lugo A, 2017, TUMORI J, V103, P353, DOI 10.5301/tj.5000644; Mehanna H, 2013, HEAD NECK-J SCI SPEC, V35, P747, DOI 10.1002/hed.22015; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Pulte D, 2010, ONCOLOGIST, V15, P994, DOI 10.1634/theoncologist.2009-0289; Rettig E, 2015, EXPERT REV ANTICANC, V15, P35, DOI 10.1586/14737140.2015.957189; Schroeder L, 2017, EUR J CANCER, V74, P73, DOI 10.1016/j.ejca.2016.12.020; Tramacere I, 2010, ORAL ONCOL, V46, P497, DOI 10.1016/j.oraloncology.2010.03.024; TURNER CF, 1995, SEX TRANSM DIS, V22, P173, DOI 10.1097/00007435-199505000-00009; Underwood JM, 2015, J COMMUN HEALTH, V40, P414, DOI 10.1007/s10900-014-9951-6; van Monsjou HS, 2015, ORAL ONCOL, V51, P901, DOI 10.1016/j.oraloncology.2015.06.011; Viarisio D, 2016, CANCER RES, V76, P4216, DOI 10.1158/0008-5472.CAN-16-0370; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Znaor A, 2003, INT J CANCER, V105, P681, DOI 10.1002/ijc.11114	44	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192621	10.1371/journal.pone.0192621	http://dx.doi.org/10.1371/journal.pone.0192621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415020	Green Published, Green Submitted, gold			2022-12-26	WOS:000424325300090
J	de la Fuente, C; Pinkham, C; Dabbagh, D; Beitzel, B; Garrison, A; Palacios, G; Hodge, KA; Petricoin, EF; Schmaljohn, C; Campbell, CE; Narayanan, A; Kehn-Hall, K				de la Fuente, Cynthia; Pinkham, Chelsea; Dabbagh, Deemah; Beitzel, Brett; Garrison, Aura; Palacios, Gustavo; Hodge, Kimberley Alex; Petricoin, Emanuel F.; Schmaljohn, Connie; Campbell, Catherine E.; Narayanan, Aarthi; Kehn-Hall, Kylene			Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection	PLOS ONE			English	Article							NSS PROTEIN; TRANSCRIPTION FACTOR; POTENTIAL MECHANISM; GENE-EXPRESSION; DOWN-REGULATION; GROWTH; RECEPTOR; BINDING; PHOSPHORYLATION; GLYCOPROTEIN	Rift Valley fever virus (RVFV) infects both ruminants and humans leading to a wide variance of pathologies dependent on host background and age. Utilizing a targeted reverse phase protein array (RPPA) to define changes in signaling cascades after in vitro infection of human cells with virulent and attenuated RVFV strains, we observed high phosphorylation of Smad transcription factors. This evolutionarily conserved family is phosphorylated by and transduces the activation of TGF-beta superfamily receptors. Moreover, we observed that phosphorylation of Smad proteins required active RVFV replication and loss of NSs impaired this activation, further corroborating the RPPA results. Gene promoter analysis of transcripts altered after RVFV infection identified 913 genes that contained a Smad-response element. Functional annotation of these potential Smad-regulated genes clustered in axonal guidance, hepatic fibrosis and cell signaling pathways involved in cellular adhesion/migration, calcium influx, and cytoskeletal reorganization. Furthermore, chromatin immunoprecipitation confirmed the presence of a Smad complex on the interleukin 1 receptor type 2 (IL1R2) promoter, which acts as a decoy receptor for IL-1 activation.	[de la Fuente, Cynthia; Pinkham, Chelsea; Dabbagh, Deemah; Narayanan, Aarthi; Kehn-Hall, Kylene] George Mason Univ, Natl Ctr Biodef & Infect Dis, Sch Syst Biol, Manassas, VA 22030 USA; [Beitzel, Brett; Garrison, Aura; Palacios, Gustavo; Schmaljohn, Connie] United States Army Med Res Inst Infect Dis, Frederick, MD USA; [Hodge, Kimberley Alex; Petricoin, Emanuel F.] George Mason Univ, Ctr Appl Prote & Mol Med, Sch Syst Biol, Manassas, VA USA; [Campbell, Catherine E.] DCE Consulting, Vienna, VA USA	George Mason University; George Mason University	Kehn-Hall, K (corresponding author), George Mason Univ, Natl Ctr Biodef & Infect Dis, Sch Syst Biol, Manassas, VA 22030 USA.	kkehnhal@gmu.edu	Kehn-Hall, Kylene/I-5752-2013; Palacios, Gustavo/I-7773-2015; Garrison, Aura/O-4123-2019	Palacios, Gustavo/0000-0001-5062-1938; Garrison, Aura/0000-0003-3034-6400; Beitzel, Brett/0000-0002-3798-6411	Defense Threat Reduction Agency (DTRA) grant [HDTRA1-13-1-0006]; DTRA grant [HDTRA1-13-1-0006]	Defense Threat Reduction Agency (DTRA) grant; DTRA grant	This work was funded through a Defense Threat Reduction Agency (DTRA) grant HDTRA1-13-1-0006 to KK and AN. DTRA does not have any role in the design of the study and collection, analysis, and interpretation of data and nor in writing the manuscript. DCE Consulting provided bioinformatics analysis for this study as a subcontract award as part of DTRA grant HDTRA1-13-1-0006. The specific roles of these authors are articulated in the 'author contributions' section.	Adams MJ, 2017, ARCH VIROL, V162, P2505, DOI 10.1007/s00705-017-3358-5; Argentou N, 2016, INFLAMM RES, V65, P355, DOI 10.1007/s00011-016-0921-6; Arnulf B, 2002, BLOOD, V100, P4129, DOI 10.1182/blood-2001-12-0372; Austin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036327; Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065; Baer A, 2012, J BIOL CHEM, V287, P7399, DOI 10.1074/jbc.M111.296608; Benedict A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00676; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Blanchette F, 1997, J CLIN INVEST, V99, P1974, DOI 10.1172/JCI119365; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Bouloy Michele, 2010, Open Virol J, V4, P8, DOI 10.2174/1874357901004020008; BROWN JL, 1981, INFECT IMMUN, V33, P848, DOI 10.1128/IAI.33.3.848-853.1981; Bruice P. Y, 2004, ORGANIC CHEM; CAPLEN H, 1985, J GEN VIROL, V66, P2271, DOI 10.1099/0022-1317-66-10-2271; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Contreras X, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-37; Copeland AM, 2015, VIROLOGY, V486, P88, DOI 10.1016/j.virol.2015.09.003; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; Cyr N, 2015, P NATL ACAD SCI USA, V112, P6021, DOI 10.1073/pnas.1503688112; Dasgupta A, 2004, MOL CELL, V13, P456, DOI 10.1016/S1097-2765(04)00092-9; DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; Espina V, 2003, PROTEOMICS, V3, P2091, DOI 10.1002/pmic.200300592; Fang XJ, 1999, ONCOGENE, V18, P6635, DOI 10.1038/sj.onc.1203076; Filone CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015483; Gaudreault NN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00664; GENTRY LE, 1990, BIOCHEMISTRY-US, V29, P6851, DOI 10.1021/bi00481a014; Gravina GL, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-46; Habjan M, 2008, J GEN VIROL, V89, P2157, DOI 10.1099/vir.0.2008/002097-0; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Hata A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022061; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hill C. S., 2016, COLD SPRING HARB PER, V8; Igumenova TI, 2015, BIOCHEMISTRY-US, V54, P4953, DOI 10.1021/acs.biochem.5b00565; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2012, ANTIVIR RES, V95, P293, DOI 10.1016/j.antiviral.2012.06.001; Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493; Ikegami T, 2009, ANN NY ACAD SCI, V1171, pE75, DOI 10.1111/j.1749-6632.2009.05054.x; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; Kainulainen M, 2014, J VIROL, V88, P3464, DOI 10.1128/JVI.02914-13; Kalveram B, 2011, JOVE-J VIS EXP, DOI 10.3791/3400; Kalveram B, 2011, J VIROL, V85, P6234, DOI 10.1128/JVI.02255-10; Konig R, 2015, CURR OPIN MICROBIOL, V26, P79, DOI 10.1016/j.mib.2015.06.001; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; KUBINYI H, 1979, FARMACO-ED SCI, V34, P248; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Leach NR, 2010, VIROLOGY, V406, P127, DOI 10.1016/j.virol.2010.07.002; Lee DK, 2001, GENE DEV, V15, P455, DOI 10.1101/gad.856201; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Li QS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004163; Linthicum KJ, 2016, ANNU REV ENTOMOL, V61, P395, DOI 10.1146/annurev-ento-010715-023819; Liu XJ, 1998, CANCER RES, V58, P4752; Lokugamage N, 2012, J VIROL, V86, P13566, DOI 10.1128/JVI.02081-12; Ly HJ, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0573-8; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McElroy AK, 2012, VIROLOGY, V422, P6, DOI 10.1016/j.virol.2011.09.023; MEEGAN JM, 1979, VET REC, V105, P124, DOI 10.1136/vr.105.6.124; Morikawa M, 2016, COLD SPRING HARB PER, V8; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Munger JS, 1997, KIDNEY INT, V51, P1376, DOI 10.1038/ki.1997.188; Murata T, 2005, VIROLOGY, V331, P407, DOI 10.1016/j.virol.2004.10.036; Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200; Palomo J, 2015, CYTOKINE, V76, P25, DOI 10.1016/j.cyto.2015.06.017; Pasquato A, 2006, J BIOL CHEM, V281, P23471, DOI 10.1074/jbc.M513675200; Pin E, 2014, CURR PROTOC PROTEIN, V75; Pinkham C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14800-3; Pinkham C, 2016, VIROLOGY, V496, P175, DOI 10.1016/j.virol.2016.06.004; Pokharel SM, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00174; Popova TG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013805; Rolin AI, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.81; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Shafagati N, 2016, VIRULENCE, V7, P756, DOI 10.1080/21505594.2016.1185585; Sieczkarski SB, 2003, J VIROL, V77, P460, DOI 10.1128/JVI.77.1.460-469.2003; Signore M, 2017, METHODS MOL BIOL, V1606, P51, DOI 10.1007/978-1-4939-6990-6_4; SMITH H, 1980, SCAND J INFECT DIS, P119; TENDIJKE P, 1990, MOL CELL BIOL, V10, P4473, DOI 10.1128/MCB.10.9.4473; Terasaki K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005047; Theodorescu D, 1991, GROWTH FACTORS, V5, DOI 10.3109/08977199109000294; Tiwari R, 2011, VIROLOGY, V413, P60, DOI 10.1016/j.virol.2011.02.002; Urata S, 2011, J VIROL, V85, P795, DOI 10.1128/JVI.02019-10; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wang Y, 2017, ONCOL REP, V37, P3520, DOI 10.3892/or.2017.5618; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Wu Q, 2017, AM J PHYSL LUNG CELL; Xiao Y, 2008, VIROLOGY, V372, P384, DOI 10.1016/j.virol.2007.10.036; Xu PL, 2014, MOL CELL, V56, P723, DOI 10.1016/j.molcel.2014.11.027; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang F, 2017, GASTROENTEROLOGY, V152, P257, DOI 10.1053/j.gastro.2016.09.033	98	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191983	10.1371/journal.pone.0191983	http://dx.doi.org/10.1371/journal.pone.0191983			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408900	Green Published, Green Submitted, gold			2022-12-26	WOS:000424302800038
J	Kimura-Suda, H; Takahata, M; Ito, T; Shimizu, T; Kanazawa, K; Ota, M; Iwasaki, N				Kimura-Suda, Hiromi; Takahata, Masahiko; Ito, Teppei; Shimizu, Tomohiro; Kanazawa, Kyosuke; Ota, Masahiro; Iwasaki, Norimasa			Quick and easy sample preparation without resin embedding for the bone quality assessment of fresh calcified bone using fourier transform infrared imaging	PLOS ONE			English	Article							COLLAGEN FIBER ORIENTATION; KIDNEY-DISEASE; SPECTROSCOPY; MICROSPECTROSCOPY; TISSUES; RATS; PROTEIN	Fourier transform infrared (FTIR) imaging is a powerful tool for the assessment of bone quality; however, it requires the preparation of thin bone sections. Conventional poly(methyl methacrylate) (PMMA) embedding for the preparation of sections takes more than two weeks and causes denaturation of the bone. Development of a quick and easy sample preparation technique without denaturation is needed for accurate clinical evaluation of fresh calcified bone using FTIR imaging. Frozen sectioning allows the quick and easy preparation of thin sections without denaturation, but it requires a substrate with good chemical resistance and improved heat shock resistance. Polypropylene (PP) film afforded both good chemical resistance and greater heat shock resistance, and the 4-mu m-thick PP film coated with glue was thin enough for the IR beam to pass through it, while the optical anisotropy of infrared bands overlapping with PO43- band was negligible. The bone quality of femoral thin sections prepared by the conventional PMMA embedding and sectioning procedure (RESIN-S) or the newly developed frozen sectioning procedure (FROZEN-S) was evaluated by FTIR imaging. The mineral-to-matrix ratio and crystallinity in the RESIN-S sections were higher than those in the FROZEN-S sections, whereas the carbonate-to-phosphate ratio in the RESIN-S sections was lower than that in the FROZEN-S sections. In RESIN-S, the increased mineral-to-matrix ratio could be caused by dehydration, and the increased crystallinity and decreased carbonate-to-phosphate ratio might be consequence of dissolution of bone mineral during PMMA embedding. Therefore, the combined use of PP film coated with glue and the frozen sectioning procedure without denaturation appears well suited to the assessment of the bone quality of fresh calcified bone using FTIR imaging.	[Kimura-Suda, Hiromi; Ito, Teppei; Kanazawa, Kyosuke] Chitose Inst Sci & Technol, Grad Sch Photon Sci, Chitose, Hokkaido, Japan; [Takahata, Masahiko; Shimizu, Tomohiro; Ota, Masahiro; Iwasaki, Norimasa] Hokkaido Univ, Sch Med, Dept Orthoped Surg, Sapporo, Hokkaido, Japan	Hokkaido University	Kimura-Suda, H (corresponding author), Chitose Inst Sci & Technol, Grad Sch Photon Sci, Chitose, Hokkaido, Japan.	kimurasu@photon.chitose.ac.jp	Takahata, Masahiko/E-1929-2012; kimura-suda, Hiromi/ABA-9749-2020	Takahata, Masahiko/0000-0002-2436-2175; kimura-suda, Hiromi/0000-0002-4335-9027	KAKENHI [25462357, 24591237, 16K10916]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI) C. Award Number: 25462357 Recipient: Masahiko Takahata; and a Grant-in-Aid for Scientific Research (KAKENHI) C. Award Number: 24591237, 16K10916 Recipient: Hiromi Kimura-Suda.	Acerbo AS, 2012, ANAL CHEM, V84, P3607, DOI 10.1021/ac203375d; Aparicio S, 2002, CALCIFIED TISSUE INT, V70, P422, DOI 10.1007/s00223-001-1016-z; Bairi VG, 2016, SPECTROCHIM ACTA B, V116, P21, DOI 10.1016/j.sab.2015.11.008; BOSKEY AL, 1982, CALCIFIED TISSUE INT, V34, P328, DOI 10.1007/BF02411262; BOUCEK RJ, 1979, BIOCHEM J, V177, P853, DOI 10.1042/bj1770853; Burr DB, 2014, BASIC AND APPLIED BONE BIOLOGY, P3, DOI 10.1016/B978-0-12-416015-6.00001-0; Farlay D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028736; Farlay D, 2010, J BONE MINER METAB, V28, P433, DOI 10.1007/s00774-009-0146-7; Gadeleta SJ, 2000, BONE, V27, P541, DOI 10.1016/S8756-3282(00)00362-8; Hanifi A, 2013, ANAL CHIM ACTA, V779, P41, DOI 10.1016/j.aca.2013.03.053; Ito T, 2015, MOL CRYST LIQ CRYST, V622, P114, DOI 10.1080/15421406.2015.1097011; Kimura-Suda H, 2012, MOL CRYST LIQ CRYST, V566, P75, DOI 10.1080/15421406.2012.701831; Kimura-Suda H, 2017, J ORAL BIOSCI, V59, P142, DOI 10.1016/j.job.2017.04.002; Kimura-Suda H, 2015, E-J SURF SCI NANOTEC, V13, P244, DOI 10.1380/ejssnt.2015.244; Kimura-Suda H, 2013, J ORAL BIOSCI, V55, P61, DOI 10.1016/j.job.2013.04.006; LEES S, 1981, CALCIFIED TISSUE INT, V33, P83, DOI 10.1007/BF02409417; LEES S, 1981, CALCIFIED TISSUE INT, V33, P591, DOI 10.1007/BF02409497; McElderry JDP, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3574525; Miller LM, 2013, BBA-BIOMEMBRANES, V1828, P2339, DOI 10.1016/j.bbamem.2013.01.014; MORRIS MD, 2009, INFRARED RAMAN SPECT, P149; Nicholson CL, 2012, ANAL CHEM, V84, P3369, DOI 10.1021/ac300123r; PLESHKO NL, 1992, J HISTOCHEM CYTOCHEM, V40, P1413, DOI 10.1177/40.9.1506677; PLESHKO NL, 1992, CALCIFIED TISSUE INT, V51, P72, DOI 10.1007/BF00296221; Rehman I., 2012, FT IR RAMAN CHARACTE, P213; Rehman IU, 2012, CHEM STRUCTURAL ANAL, P189; REY C, 1991, CALCIFIED TISSUE INT, V49, P383, DOI 10.1007/BF02555847; Wopenka B, 2005, MAT SCI ENG C-BIO S, V25, P131, DOI 10.1016/j.msec.2005.01.008; Yeni YN, 2006, CALCIFIED TISSUE INT, V78, P363, DOI 10.1007/s00223-005-0301-7	28	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0189650	10.1371/journal.pone.0189650	http://dx.doi.org/10.1371/journal.pone.0189650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408856	Green Submitted, Green Published, gold			2022-12-26	WOS:000424302800005
J	Mui, AM; Yang, V; Aung, MH; Fu, JM; Adekunle, AN; Prall, BC; Sidhu, CS; Park, HN; Boatright, JH; Iuvone, PM; Pardue, MT				Mui, Amanda M.; Yang, Victoria; Aung, Moe H.; Fu, Jieming; Adekunle, Adewumi N.; Prall, Brian C.; Sidhu, Curran S.; Park, Han Na; Boatright, Jeffrey H.; Iuvone, P. Michael; Pardue, Machelle T.			Daily visual stimulation in the critical period enhances multiple aspects of vision through BDNF-mediated pathways in the mouse retina	PLOS ONE			English	Article							INNER PLEXIFORM LAYER; NEUROTROPHIC FACTOR; GANGLION-CELLS; MESSENGER-RNA; RAT RETINA; A-WAVE; MICE; EXPERIENCE; SYSTEM; ELECTRORETINOGRAM	Visual experience during the critical period modulates visual development such that deprivation causes visual impairments while stimulation induces enhancements. This study aimed to determine whether visual stimulation in the form of daily optomotor response (OMR) testing during the mouse critical period (1) improves aspects of visual function, (2) involves retinal mechanisms and (3) is mediated by brain derived neurotrophic factor (BDNF) and dopamine (DA) signaling pathways. We tested spatial frequency thresholds in C57BLI6J mice daily from postnatal days 16 to 23 (P16 to P23) using OMR testing. Daily OMR-treated mice were compared to littermate controls that were placed in the OMR chamber without moving gratings. Contrast sensitivity thresholds, electroretinograms (ERGs), visual evoked potentials, and pattern ERGs were acquired at P21. To determine the role of BDNF signaling, a TrkB receptor antagonist (ANA-12) was systemically injected 2 hours prior to OMR testing in another cohort of mice. BDNF immunohistochemistry was performed on retina and brain sections. Retinal DA levels were measured using high-performance liquid chromatography. Daily OMR testing enhanced spatial frequency thresholds and contrast sensitivity compared to controls. OMR-treated mice also had improved rod-driven ERG oscillatory potential response times, greater BDNF immunoreactivity in the retinal ganglion cell layer, and increased retinal DA content compared to controls. VEPs and pattern ERGs were unchanged. Systemic delivery of ANA-12 attenuated OMR-induced visual enhancements. Daily OMR testing during the critical period leads to general visual function improvements accompanied by increased DA and BDNF in the retina, with this process being requisitely mediated by TrkB activation. These results suggest that novel combination therapies involving visual stimulation and using both behavioral and molecular approaches may benefit degenerative retinal diseases or amblyopia.	[Mui, Amanda M.; Adekunle, Adewumi N.; Prall, Brian C.; Sidhu, Curran S.; Park, Han Na; Boatright, Jeffrey H.; Iuvone, P. Michael; Pardue, Machelle T.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Mui, Amanda M.; Yang, Victoria; Fu, Jieming; Adekunle, Adewumi N.; Prall, Brian C.; Park, Han Na; Boatright, Jeffrey H.; Pardue, Machelle T.] Atlanta VA Med Ctr, Ctr Visual & Neurocognit Rehabil, Decatur, GA 30033 USA; [Yang, Victoria; Fu, Jieming; Pardue, Machelle T.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Aung, Moe H.; Prall, Brian C.; Iuvone, P. Michael; Pardue, Machelle T.] Emory Univ, Neurosci Program, Atlanta, GA 30322 USA; [Iuvone, P. Michael] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; University System of Georgia; Georgia Institute of Technology; Emory University; Emory University	Pardue, MT (corresponding author), Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA.; Pardue, MT (corresponding author), Atlanta VA Med Ctr, Ctr Visual & Neurocognit Rehabil, Decatur, GA 30033 USA.; Pardue, MT (corresponding author), Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.; Pardue, MT (corresponding author), Emory Univ, Neurosci Program, Atlanta, GA 30322 USA.	machelle.pardue@bme.gatech.edu	Pardue, Machelle T/N-9795-2013		Rehabilitation Research and Development Service at the Department of Veterans Affairs; Research Career Scientist Award; Research to Prevent Blindness Departmental Award; Katz Foundation;  [NEI R01 EY016435];  [R01 EY014026];  [R01 EY004864];  [P30 EY006030]; NATIONAL EYE INSTITUTE [R01EY021592, R01EY014026, R01EY004864, P30EY006360, R01EY016435] Funding Source: NIH RePORTER	Rehabilitation Research and Development Service at the Department of Veterans Affairs(US Department of Veterans Affairs); Research Career Scientist Award(US Department of Veterans Affairs); Research to Prevent Blindness Departmental Award(Research to Prevent Blindness (RPB)); Katz Foundation; ; ; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Rehabilitation Research and Development Service at the Department of Veterans Affairs, Research Career Scientist Award to MTP; Research to Prevent Blindness Departmental Award to Emory Ophthalmology; the Katz Foundation to JHB; and NEI R01 EY016435, R01 EY014026, R01 EY004864, and P30 EY006030.	Aung MH, 2013, INVEST OPHTH VIS SCI, V54, P1370, DOI 10.1167/iovs.12-10927; BODISWOLLNER I, 1990, TRENDS NEUROSCI, V13, P296, DOI 10.1016/0166-2236(90)90113-O; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; Cazorla M, 2011, J CLIN INVEST, V121, P1846, DOI 10.1172/JCI43992; Chou T-H, 2014, VISUAL NEUROSCI, P2469; Chrysostomou V, 2013, INVEST OPHTH VIS SCI, V54, P4691, DOI 10.1167/iovs.13-12415; Dhande OS, 2013, J NEUROSCI, V33, P17797, DOI 10.1523/JNEUROSCI.2778-13.2013; Di Marco S, 2009, J NEUROSCI, V29, P13691, DOI 10.1523/JNEUROSCI.3854-09.2009; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; FISHER LJ, 1979, J EMBRYOL EXP MORPH, V54, P219; Franklin BJ, 2007, MOUSE BRAIN STEROTAX; Fujieda H, 2008, EXP EYE RES, V86, P335, DOI 10.1016/j.exer.2007.11.005; Giovannelli A, 2008, BIOCHEM BIOPH RES CO, V365, P349, DOI 10.1016/j.bbrc.2007.10.204; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hanif AM, 2015, INVEST OPHTH VIS SCI, V56, P6839, DOI 10.1167/iovs.15-16792; HOOD DC, 1990, INVEST OPHTH VIS SCI, V31, P2070; Hwang CK, 2013, J NEUROSCI, V33, P14989, DOI 10.1523/JNEUROSCI.2039-13.2013; Jackson CR, 2012, J NEUROSCI, V32, P9359, DOI 10.1523/JNEUROSCI.0711-12.2012; KAWATO M, 1992, TRENDS NEUROSCI, V15, P445, DOI 10.1016/0166-2236(92)90008-V; Kretschmer F, 2017, J NEUROPHYSIOL, V118, P300, DOI 10.1152/jn.00055.2017; Lawson EC, 2014, J NEUROSCI, V34, P2406, DOI 10.1523/JNEUROSCI.2062-13.2014; Liu BH, 2016, NATURE, V538, P383, DOI 10.1038/nature19818; Lunghi C, 2013, J VISION, V13, DOI 10.1167/13.6.1; Mocko JA, 2011, INVEST OPHTH VIS SCI, V52, P4223, DOI 10.1167/iovs.10-6750; Neal M, 2003, INVEST OPHTH VIS SCI, V44, P791, DOI 10.1167/iovs.02-0557; OYSTER CW, 1980, J COMP NEUROL, V190, P49, DOI 10.1002/cne.901900105; Pardue Machelle T., 2001, Documenta Ophthalmologica, V103, P155, DOI 10.1023/A:1012202410144; PENN RD, 1969, NATURE, V223, P201, DOI 10.1038/223201a0; Pollock GS, 2001, J NEUROSCI, V21, P3923, DOI 10.1523/JNEUROSCI.21-11-03923.2001; Porciatti V, 2007, DOC OPHTHALMOL, V115, P145, DOI 10.1007/s10633-007-9059-8; Pozdeyev N, 2008, EUR J NEUROSCI, V27, P2691, DOI 10.1111/j.1460-9568.2008.06224.x; Prusky GT, 2008, J NEUROSCI, V28, P9817, DOI 10.1523/JNEUROSCI.1940-08.2008; Prusky GT, 2006, J NEUROSCI, V26, P11554, DOI 10.1523/JNEUROSCI.3396-06.2006; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; Prusky GT, 2000, BEHAV BRAIN RES, V114, P11, DOI 10.1016/S0166-4328(00)00186-8; Robson JG, 1998, DOC OPHTHALMOL, V95, P187, DOI 10.1023/A:1001891904176; Schmucker C, 2005, INVEST OPHTH VIS SCI, V46, P398, DOI 10.1167/iovs.04-0959; Seki M, 2003, INVEST OPHTH VIS SCI, V44, P3211, DOI 10.1167/iovs.02-1089; SOSULA L, 1971, J COMP NEUROL, V141, P427, DOI 10.1002/cne.901410403; Spaeth AM, 2012, AM J PHYSIOL-ENDOC M, V302, pE1252, DOI 10.1152/ajpendo.00025.2012; STAFFORD CA, 1984, OPHTHAL PHYSL OPT, V4, P95, DOI 10.1016/0275-5408(84)90059-0; Sun LO, 2015, NEURON, V86, P971, DOI 10.1016/j.neuron.2015.03.064; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tian N, 2001, NEURON, V32, P439, DOI 10.1016/S0896-6273(01)00470-6; Tian N, 2008, J PHYSIOL-LONDON, V586, P4347, DOI 10.1113/jphysiol.2008.159202; Tschetter WW, 2013, J NEUROSCI, V33, P5362, DOI 10.1523/JNEUROSCI.5229-12.2013; Tschetter WW, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00044; Turner PV, 2005, COMPARATIVE MED, V55, P175; Vassoler FM, 2013, NAT NEUROSCI, V16, P42, DOI 10.1038/nn.3280; Viswanathan S, 1999, INVEST OPHTH VIS SCI, V40, P1124; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Xu HP, 2007, J COMP NEUROL, V503, P244, DOI 10.1002/cne.21379	53	12	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192435	10.1371/journal.pone.0192435	http://dx.doi.org/10.1371/journal.pone.0192435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408880	Green Submitted, Green Published, gold			2022-12-26	WOS:000424302800065
J	Ooka, M; Abe, T; Cho, K; Koike, K; Takeda, S; Hirota, K				Ooka, Masato; Abe, Takuya; Cho, Kosai; Koike, Kaoru; Takeda, Shunichi; Hirota, Kouji			Chromatin remodeler ALC1 prevents replication-fork collapse by slowing fork progression	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; FACILITATE HOMOLOGOUS RECOMBINATION; TOPOISOMERASE-I INHIBITORS; DNA-POLYMERASE DELTA; POLY(ADP-RIBOSE) POLYMERASE; ATAXIA-TELANGIECTASIA; TRANSLESION SYNTHESIS; EXCISION-REPAIR; CELLS; ACTIVATION	ALC1 (amplified in liver cancer 1), an SNF2 superfamily chromatin-remodeling factor also known as CHD1 L (chromodomain helicase/ATPase DNA binding protein 1-like), is implicated in base-excision repair, where PARP (Poly(ADP-ribose) polymerase) mediated Poly (ADP-ribose) signaling facilitates the recruitment of this protein to damage sites. We here demonstrate the critical role played by ALC1 in the regulation of replication-fork progression in cleaved template strands. To analyze the role played by ALC1 as well as its functional relationship with PARP1, we generated ALC1(-/-), PARP1(-/-), and ALC1(-/-)/PARP1(-/-) cells from chicken DT40 cells. We then exposed these cells to camptothecin (CPT), a topoisomerase I poison that generates single-strand breaks and causes the collapse of replication forks. The ALC1(-/-) and PARP1(-/-) cells exhibited both higher sensitivity to CPT and an increased number of chromosome aberrations, compared with wild-type cells. Moreover, phenotypes were very similar across all three mutants, indicating that the role played by ALC1 in CPT tolerance is dependent upon the PARP pathway. Remarkably, inactivation of ALC1 resulted in a failure to slow replication-fork progression after CPT exposure, indicating that ALC1 regulates replication-fork progression at DNA-damage sites. We disrupted ATPase activity by inserting the E165Q mutation into the ALC1 gene, and found that the resulting ALC1(-/E/65Q) cells displayed a CPT sensitivity indistinguishable from that of the null-mutant cells. This observation suggests that ALC1 contributes to cellular tolerance to CPT, possibly as a chromatin remodeler. This idea is supported by the fact that CPT exposure induced chromatin relaxation in the vicinity of newly synthesized DNA in wild-type but not in ALC1(-/-) cells. This implies a previously unappreciated role for ALC1 in DNA replication, in which ALC1 may regulate replication-fork slowing at CPT-induced DNA-damage sites.	[Ooka, Masato; Abe, Takuya; Hirota, Kouji] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Chem, 1-1 Minami Osawa, Hachioji, Tokyo, Japan; [Cho, Kosai; Takeda, Shunichi; Hirota, Kouji] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto, Japan; [Cho, Kosai; Koike, Kaoru] Kyoto Univ, Grad Sch Med, Dept Primary Care & Emergency Med, Sakyo Ku, Kyoto, Japan	Tokyo Metropolitan University; Kyoto University; Kyoto University	Hirota, K (corresponding author), Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Chem, 1-1 Minami Osawa, Hachioji, Tokyo, Japan.; Takeda, S; Hirota, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto, Japan.	stakeda@rg.med.kyoto-u.ac.jp; khirota@tmu.ac.jp	Ooka, Masato/HHN-0222-2022	Ooka, Masato/0000-0002-2729-2619; Takeda, Shunichi/0000-0002-7924-7991; Hirota, Kouji/0000-0003-1676-979X	JSPS KAKENHI [JP16K12598, JP16H02957, JP16H01314, JP16H06306]; JSPS Core-to-Core Program (A) Advanced Research Networks; Takeda Science Foundation; Yamada Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Core-to-Core Program (A) Advanced Research Networks; Takeda Science Foundation(Takeda Science Foundation (TSF)); Yamada Science Foundation	This work was supported by the JSPS KAKENHI Grant Number (JP16K12598, JP16H02957 and JP16H01314 to KH, and JP16H06306 to ST), the JSPS Core-to-Core Program (A) Advanced Research Networks (to ST), the Takeda Science Foundation and Yamada Science Foundation (to KH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Asada R, 2015, MOL CELL BIOL, V35, P847, DOI 10.1128/MCB.00924-14; Ball LG, 2005, ACTA PHARMACOL SIN, V26, P897, DOI 10.1111/j.1745-7254.2005.00165.x; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Croset A, 2013, NUCLEIC ACIDS RES, V41, P7344, DOI 10.1093/nar/gkt522; D'Silva I, 1999, BBA-PROTEIN STRUCT M, V1430, P119, DOI 10.1016/S0167-4838(98)00278-7; Das BB, 2014, NUCLEIC ACIDS RES, V42, P4435, DOI 10.1093/nar/gku088; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Gottschalk AJ, 2012, J BIOL CHEM, P287; Gupte R, 2017, GENE DEV, V31, P101, DOI 10.1101/gad.291518.116; Hanzlikova H, 2016, NUCL ACIDS RES; Henry-Mowatt J, 2003, MOL CELL, V11, P1109, DOI 10.1016/S1097-2765(03)00132-1; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Hirota K, 2008, MOL BIOL CELL, V19, P1162, DOI 10.1091/mbc.E07-04-0377; Hirota K, 2016, NUCLEIC ACIDS RES, V44, P7242, DOI 10.1093/nar/gkw439; Hirota K, 2015, NUCLEIC ACIDS RES, V43, P1671, DOI 10.1093/nar/gkv023; HOLM C, 1989, CANCER RES, V49, P6365; HSIANG YH, 1989, CANCER RES, V49, P5077; Hu JC, 2017, J BIOL CHEM, V292, P15588, DOI 10.1074/jbc.R117.807453; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kobayashi S, 2015, ONCOGENE, V34, P4403, DOI 10.1038/onc.2014.371; Ma NF, 2008, HEPATOLOGY, V47, P503, DOI 10.1002/hep.22072; Mu QJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143030; Ooka M, 2016, CHEMOSPHERE, V164, P106, DOI 10.1016/j.chemosphere.2016.08.092; Pines A, 2012, J CELL BIOL, V199, P235, DOI 10.1083/jcb.201112132; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Sellou H, 2016, MOL BIOL CELL, V27, P3791, DOI 10.1091/mbc.E16-05-0269; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; Sugimura K, 2008, J CELL BIOL, V183, P1203, DOI 10.1083/jcb.200806068; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Tsuda M, PLOS ONE IN PRESS; Tsuda M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188320; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099	43	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0192421	10.1371/journal.pone.0192421	http://dx.doi.org/10.1371/journal.pone.0192421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1EC	29408941	gold, Green Submitted, Green Published			2022-12-26	WOS:000424302800063
J	Shi, JY; Jie-Ni; Zhuang, LF; Zhang, XM; Fan, LF; Lai, HC				Shi, Jun-Yu; Jie-Ni; Zhuang, Long-fei; Zhang, Xiao-Meng; Fan, Lin-Feng; Lai, Hong-Chang			Peri-implant conditions and marginal bone loss around cemented and screw-retained single implant crowns in posterior regions: A retrospective cohort study with up to 4 years follow-up	PLOS ONE			English	Article							COMPLICATION RATES; SUPPORTED RECONSTRUCTIONS; PROSTHESIS; RETENTION; SURVIVAL; METAANALYSIS; ASSOCIATION; DISEASES; OUTCOMES	The aim of the present study was to identify the peri-implant conditions (bleeding on probing (BOP), pocket probing depth (PPD), modified plaque index (mPI)) and marginal bone loss (MBL, marginal bone level change between follow-up and occlusal loading) around cemented and screw-retained posterior single crowns on tissue-level implants. The study was a retrospective cohort study with up to 4 years (mean 2.5 years) follow-up. Patients with either cemented or screw-retained crowns in posterior regions were included. Implant survival, technical complications, BOP, PPD, mPI, MBL, biologic complications (peri-implant mocositis and peri-implantitis) were evaluated. Mann-Whitney U test was used to test the difference between the screw-retained group (SG) and cemented group (CG). 176 patients (SG: 94, CG: 82) were included. The implant survival rates were 100% in SG and 98.8% in CG. Prosthetic screw loosening was found in 8 restorations (8.7%) at follow-up visit. Peri-implant mucositis rate was significantly higher in the SG group (42.1%) than that in the CG group (32.2%) (P = 0.04). Six patients (6.38%) in the screw-retained group and 5 patients (6.10%) in the cemented group were diagnosed with peri-implantitis, the difference did not reach statistical significance (P>0.05). No significant difference of PPD, mPI and MBL were found between two groups (P = 0.11, 0.13 and 0.08, respectively). High implant survival rates were achieved in both groups. Cemented single crowns on tissue-level implants showed comparable peri-implant conditions in comparison with two-piece screw-retained crowns. Well-designed prospective cohort or randomized controlled clinical trials with longer follow-up are needed to confirm the result.	[Shi, Jun-Yu; Jie-Ni; Zhang, Xiao-Meng; Lai, Hong-Chang] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Dent Implantat,Shanghai Key Lab Stomatol, Shanghai, Peoples R China; [Zhuang, Long-fei] Shanghai Adore Dent Care, Shanghai, Peoples R China; [Fan, Lin-Feng] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Radiol,Shanghai Key Lab Stomatol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lai, HC (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Dent Implantat,Shanghai Key Lab Stomatol, Shanghai, Peoples R China.; Fan, LF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Radiol,Shanghai Key Lab Stomatol, Shanghai, Peoples R China.	fanlinfeng0419@163.com; lhc9@hotmail.com		Shi, Jun-Yu/0000-0002-8241-2572	National Natural Science Foundation of China [81500892]; Shanghai Summit & Plateau Disciplines	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Summit & Plateau Disciplines	The study was funded by National Natural Science Foundation of China (81500892) and Shanghai Summit & Plateau Disciplines to Junyu Shi.	Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11; Lemos CAA, 2016, J PROSTHET DENT, V115, P419, DOI 10.1016/j.prosdent.2015.08.026; Boitelle P, 2014, J ORAL REHABIL, V41, P853, DOI 10.1111/joor.12205; Dalago HR, 2017, CLIN ORAL IMPLAN RES, V28, P144, DOI 10.1111/clr.12772; Gu YX, 2016, CLIN ORAL IMPLAN RES, V27, P120, DOI 10.1111/clr.12547; Jung RE, 2008, CLIN ORAL IMPLAN RES, V19, P119, DOI 10.1111/j.1600-0501.2007.01453.x; Korsch M, 2015, QUINTESSENCE INT, V46, P583, DOI 10.3290/j.qi.a34077; Kotsakis G, 2015, J PERIODONTOL, P1; Kotsakis G, 2016, J PERIODONTOL, V87, P999, DOI 10.1902/jop.2016.160236; Kotsakis GA, 2016, J PERIODONTOL, V87, P212, DOI 10.1902/jop.2015.150450; Lee JH, 2016, J ADV PROSTHODONT, V8, P150, DOI 10.4047/jap.2016.8.2.150; Linkevicius T, 2013, CLIN ORAL IMPLAN RES, V24, P1179, DOI 10.1111/j.1600-0501.2012.02570.x; Linkevicius T, 2013, CLIN ORAL IMPLAN RES, V24, P71, DOI 10.1111/j.1600-0501.2012.02453.x; Millen C, 2015, INT J ORAL MAX IMPL, V30, P110, DOI 10.11607/jomi.3607; Pesce P, 2015, J PROSTHET DENT, V114, P346, DOI 10.1016/j.prosdent.2015.04.002; Pjetursson BE, 2014, INT J ORAL MAX IMPL, V29, P308, DOI 10.11607/jomi.2014suppl.g5.2; Rismanchian M, 2012, J ORAL IMPLANTOL, V38, P677, DOI 10.1563/AAID-JOI-D-11-00167; Sailer I, 2012, CLIN ORAL IMPLAN RES, V23, P163, DOI 10.1111/j.1600-0501.2012.02538.x; Sgolastra F, 2015, CLIN ORAL IMPLAN RES, V26, pe8, DOI 10.1111/clr.12319; Sherif S, 2014, J PROSTHODONT, V23, P1, DOI 10.1111/jopr.12128; Squier RS, 2001, INT J ORAL MAX IMPL, V16, P793; Weber HP, 2007, INT J ORAL MAX IMPL, V22, P140; Wittneben JG, 2014, INT J ORAL MAX IMPL, V29, P84, DOI 10.11607/jomi.2014suppl.g2.1; Zhao X, 2016, CLIN ORAL IMPLAN RES, V27, P106, DOI 10.1111/clr.12540	24	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0191717	10.1371/journal.pone.0191717	http://dx.doi.org/10.1371/journal.pone.0191717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401469	Green Published, gold, Green Submitted			2022-12-26	WOS:000424101400017
J	Omelchenko, A; Firestein, BL				Omelchenko, Anton; Firestein, Bonnie L.			Lipids and phosphates at odds in synaptic depression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							KINASE ANCHORING PROTEIN; PLASTICITY	Long-term depression (LTD) is a reduction in the efficacy of neuronal synapses, but the molecular basis of LTD signaling and how these signals lead to phenotypic outcomes, such as the shrinkage of synaptic regions, is not clear. In a new report, Woolfrey et al. use chemically-induced LTD and a multitude of in vitro biochemical assays to provide evidence that synaptic removal of the scaffolding protein AKAP79/150 promotes LTD-induced spine shrinkage. The further identification of CaMKII, a kinase primarily associated with long-term potentiation (LTP), as a requirement for AKAP79/150 removal, uncovers unexpected interplay between different post-translational modifications and points to a new model of LTD.	[Omelchenko, Anton; Firestein, Bonnie L.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Firestein, BL (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA.	firestein@biology.rutgers.edu		Firestein, Bonnie/0000-0002-1679-3565; Omelchenko, Anton/0000-0001-7396-2815	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008339] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM008339] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Coultrap SJ, 2014, CELL REP, V6, P431, DOI 10.1016/j.celrep.2014.01.005; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Jurado S, 2010, NAT NEUROSCI, V13, P1053, DOI 10.1038/nn.2613; Keith DJ, 2012, J NEUROSCI, V32, P7119, DOI 10.1523/JNEUROSCI.0784-12.2012; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Woolfrey KM, 2018, J BIOL CHEM, V293, P1551, DOI 10.1074/jbc.M117.813808	8	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1568	1569		10.1074/jbc.H117.813808	http://dx.doi.org/10.1074/jbc.H117.813808			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29414768	hybrid, Green Published			2022-12-26	WOS:000424201700009
J	Ather, JL; Poynter, ME				Ather, Jennifer L.; Poynter, Matthew E.			Serum amyloid A3 is required for normal weight and immunometabolic function in mice	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; REGULATORY T-CELLS; HEPATITIS-C VIRUS; ADIPOSE-TISSUE; MACROPHAGE POLARIZATION; ALLERGIC SENSITIZATION; OBESITY; POPULATION; METABOLISM; MECHANISMS	Serum amyloid A (SAA) is an apolipoprotein that is robustly upregulated in numerous inflammatory diseases and has been implicated as a candidate pro-inflammatory mediator. However, studies comparing endogenous SAAs and recombinant forms of the acute phase protein have generated conflicting data on the function of SAA in immunity. We generated SAA3 knockout mice to evaluate the contribution of SAA3 to immune-mediated disease, and found that mice lacking SAA3 develop adult-onset obesity and metabolic dysfunction along with defects in innate immune development. Mice that lack SAA3 gain more weight, exhibit increased visceral adipose deposition, and develop hepatic steatosis compared to wild-type littermates. Leukocytes from the adipose tissue of SAA3(-/-) mice express a pro-inflammatory phenotype, and bone marrow derived dendritic cells from mice lacking SAA3 secrete increased levels of IL-1 beta, IL-6, IL-23, and TNF alpha in response to LPS compared to cells from wild-type mice. Finally, BMDC lacking SAA3 demonstrate an impaired endotoxin tolerance response and inhibited responses to retinoic acid. Our findings indicate that endogenous SAA3 modulates metabolic and immune homeostasis.	[Ather, Jennifer L.; Poynter, Matthew E.] Univ Vermont, Dept Med, Vermont Lung Ctr, Div Pulm Dis & Crit Care, Burlington, VT 05405 USA	University of Vermont	Poynter, ME (corresponding author), Univ Vermont, Dept Med, Vermont Lung Ctr, Div Pulm Dis & Crit Care, Burlington, VT 05405 USA.	Matthew.Poynter@uvm.edu			National Institutes of Health [R01 HL107291, R01 HL133920]; Flight Attendant Medical Research Institute (FAMRI) [CIA 113045]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107291, R01HL133920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute (FAMRI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grants R01 HL107291 and R01 HL133920 from the National Institutes of Health, and a Clinical Innovator award from the Flight Attendant Medical Research Institute (FAMRI) grant CIA 113045 to MEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artl A, 2000, ARTERIOSCL THROM VAS, V20, P763, DOI 10.1161/01.ATV.20.3.763; Ather JL, 2011, J IMMUNOL, V187, P64, DOI 10.4049/jimmunol.1100500; Bakdash G, 2015, MUCOSAL IMMUNOL, V8, P265, DOI 10.1038/mi.2014.64; Bevelander M, 2007, J IMMUNOL, V179, P3680, DOI 10.4049/jimmunol.179.6.3680; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Boutens L, 2016, DIABETOLOGIA, V59, P879, DOI 10.1007/s00125-016-3904-9; Brun PJ, 2013, BIOFACTORS, V39, P151, DOI 10.1002/biof.1056; Cai ZH, 2007, J VIROL, V81, P6128, DOI 10.1128/JVI.02627-06; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; Christenson K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00092; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; den Hartigh LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108564; Derebe MG, 2014, ELIFE, V3, DOI 10.7554/eLife.03206; Dullaart RPF, 2013, OBESITY, V21, P361, DOI 10.1002/oby.20058; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Golay A, 2005, BEST PRACT RES CL EN, V19, P649, DOI 10.1016/j.beem.2005.07.010; Hari-Dass R, 2005, J BIOL CHEM, V280, P18562, DOI 10.1074/jbc.M500490200; Hawkesworth S, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.24; He RL, 2009, BLOOD, V113, P429, DOI 10.1182/blood-2008-03-139923; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kotsis V, 2010, HYPERTENS RES, V33, P386, DOI 10.1038/hr.2010.9; Lavie M, 2006, HEPATOLOGY, V44, P1626, DOI 10.1002/hep.21406; Lee WJ, 2015, DIABETES, V64, P2836, DOI 10.2337/db14-1668; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mathis D, 2011, NAT REV IMMUNOL, V11, P81, DOI 10.1038/nri2922; Misse D, 2007, J IMMUNOL, V178, P407, DOI 10.4049/jimmunol.178.1.407; Norata GD, 2015, IMMUNITY, V43, P421, DOI 10.1016/j.immuni.2015.08.023; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Poynter ME, 2012, PULM PHARMACOL THER, V25, P438, DOI 10.1016/j.pupt.2012.04.005; RAMADORI G, 1985, J IMMUNOL, V135, P3645; Reigstad CS, 2010, GUT MICROBES, V1, P55, DOI 10.4161/gmic.1.1.10514; Reigstad CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005842; Shah C, 2006, BLOOD, V108, P1751, DOI 10.1182/blood-2005-11-011932; STEEL DM, 1993, GENOMICS, V16, P447, DOI 10.1006/geno.1993.1209; Tannock LR, 2017, J LIPID RES; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Wang B, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.36; Wang B, 2017, EBIOMEDICINE, V18, P288, DOI 10.1016/j.ebiom.2017.03.041; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Williams LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106159; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215	45	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192352	10.1371/journal.pone.0192352	http://dx.doi.org/10.1371/journal.pone.0192352			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390039	Green Published, gold, Green Submitted			2022-12-26	WOS:000423793400090
J	Beaver, JM; Lai, YH; Rolle, SJ; Weng, LW; Greenberg, MM; Liu, Y				Beaver, Jill M.; Lai, Yanhao; Rolle, Shantell J.; Weng, Liwei; Greenberg, Marc M.; Liu, Yuan			An oxidized abasic lesion inhibits base excision repair leading to DNA strand breaks in a trinucleotide repeat tract	PLOS ONE			English	Article							POLYMERASE-BETA; GENETIC INSTABILITY; PHOSPHATE LYASE; HUMAN-DISEASE; EXPANSION; DAMAGE; MECHANISM; SITE; DEOXYRIBOSE; 8-OXO-7,8-DIHYDROGUANINE	Oxidative DNA damage and base excision repair (BER) play important roles in modulating trinucleotide repeat (TNR) instability that is associated with human neurodegenerative diseases and cancer. We have reported that BER of base lesions can lead to TNR instability. However, it is unknown if modifications of the sugar in an abasic lesion modulate TNR instability. In this study, we characterized the effects of the oxidized sugar, 5'-(2-phosphoryl-1,4-dioxobutane)(DOB) in CAG repeat tracts on the activities of key BER enzymes, as well as on repeat instability. We found that DOB crosslinked with DNA polymerase beta and inhibited its synthesis activity in CAG repeat tracts. Surprisingly, we found that DOB also formed cross-links with DNA ligase I and inhibited its ligation activity, thereby reducing the efficiency of BER. This subsequently resulted in the accumulation of DNA strand breaks in a CAG repeat tract. Our study provides important new insights into the adverse effects of an oxidized abasic lesion on BER and suggests a potential alternate repair pathway through which an oxidized abasic lesion may modulate TNR instability.	[Beaver, Jill M.; Liu, Yuan] Florida Int Univ, Biochem PhD Program, Miami, FL 33199 USA; [Lai, Yanhao; Rolle, Shantell J.; Liu, Yuan] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Weng, Liwei; Greenberg, Marc M.] Johns Hopkins Univ, Dept Chem, Charles & 34Th St, Baltimore, MD 21218 USA; [Liu, Yuan] Florida Int Univ, Sch Integrated Sci & Humanities, Biomol Sci Inst, Miami, FL 33199 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University; Johns Hopkins University; State University System of Florida; Florida International University	Liu, Y (corresponding author), Florida Int Univ, Biochem PhD Program, Miami, FL 33199 USA.; Liu, Y (corresponding author), Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA.; Liu, Y (corresponding author), Florida Int Univ, Sch Integrated Sci & Humanities, Biomol Sci Inst, Miami, FL 33199 USA.	yualiu@fiu.edu	Lai, Yanhao/AAD-3392-2019		National Institutes of Health [R01ES023569]; Florida International University RISE Fellowship; National Institute of General Medical Sciences [GM-063028]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063028] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida International University RISE Fellowship; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health [R01ES023569 to Y. Liu], Florida International University RISE Fellowship [to J.M.B.], and National Institute of General Medical Sciences [GM-063028 to M.M.G.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; National Institutes of Health [R01ES023569 to Y.Liu]. Florida International University RISE Fellowship [to J.M.B.]. National Institute of General Medical Sciences [GM-063028 to M.M.G.]	Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beaver JM, 2015, NUCLEIC ACIDS RES, V43, P5948, DOI 10.1093/nar/gkv530; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Chen BZ, 2004, CHEM RES TOXICOL, V17, P1406, DOI 10.1021/tx049818e; Cilli P, 2016, NUCLEIC ACIDS RES, V44, P5190, DOI 10.1093/nar/gkw170; Derevyanko AG, 2012, BIOCHEMISTRY-MOSCOW+, V77, P270, DOI 10.1134/S0006297912030054; GOLDBERG IH, 1991, ACCOUNTS CHEM RES, V24, P191, DOI 10.1021/ar00007a001; Goula AV, 2012, BIOCHEMISTRY-US, V51, P3919, DOI 10.1021/bi300410d; Goula AV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000749; Greenberg MM, 2014, CURR OPIN CHEM BIOL, V21, P48, DOI 10.1016/j.cbpa.2014.03.018; Guan LR, 2010, BIOCHEMISTRY-US, V49, P9904, DOI 10.1021/bi101533a; Guan LR, 2010, J AM CHEM SOC, V132, P5004, DOI 10.1021/ja101372c; Guan LR, 2009, J AM CHEM SOC, V131, P15225, DOI 10.1021/ja9061695; Hashimoto M, 2001, J AM CHEM SOC, V123, P3161, DOI 10.1021/ja003354z; Jacobs AC, 2011, BIOCHEMISTRY-US, V50, P136, DOI 10.1021/bi1017667; Jarem DA, 2011, DNA REPAIR, V10, P887, DOI 10.1016/j.dnarep.2011.06.003; Jarem DA, 2009, BIOCHEMISTRY-US, V48, P6655, DOI 10.1021/bi9007403; Kodama T, 2005, J ORG CHEM, V70, P9916, DOI 10.1021/jo051666k; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Lai YH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12465; Lai YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093464; Lai YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056960; Liu Y, 2012, TRENDS BIOCHEM SCI, V37, P162, DOI 10.1016/j.tibs.2011.12.002; Liu Y, 2009, J BIOL CHEM, V284, P28352, DOI 10.1074/jbc.M109.050286; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; McMurray CT, 1999, P NATL ACAD SCI USA, V96, P1823, DOI 10.1073/pnas.96.5.1823; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; Pitie M, 2010, CHEM REV, V110, P1018, DOI 10.1021/cr900247m; Prasad R, 1998, J BIOL CHEM, V273, P11121, DOI 10.1074/jbc.273.18.11121; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Tarantino ME, 2015, J BIOL CHEM, V290, P21154, DOI 10.1074/jbc.M115.666438; TOMKINSON AE, 1991, P NATL ACAD SCI USA, V88, P400, DOI 10.1073/pnas.88.2.400; Usdin K, 2015, CRIT REV BIOCHEM MOL, V50, P142, DOI 10.3109/10409238.2014.999192; Volle CB, 2012, BIOCHEMISTRY-US, V51, P52, DOI 10.1021/bi201552s; Wang GL, 2014, DNA REPAIR, V19, P143, DOI 10.1016/j.dnarep.2014.03.017; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wells RD, 1996, J BIOL CHEM, V271, P2875, DOI 10.1074/jbc.271.6.2875; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; Xu M, 2014, NUCLEIC ACIDS RES, V42, P13749, DOI 10.1093/nar/gku1239; Xu M, 2014, NUCLEIC ACIDS RES, V42, P3675, DOI 10.1093/nar/gkt1372; Xu Meng, 2013, Nucleic Acids Res, V41, P1684, DOI 10.1093/nar/gks1306	44	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192148	10.1371/journal.pone.0192148	http://dx.doi.org/10.1371/journal.pone.0192148			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389977	gold, Green Published, Green Submitted			2022-12-26	WOS:000423793400072
J	Kohl, C; Tachedjian, M; Todd, S; Monaghan, P; Boyd, V; Marsh, GA; Crameri, G; Field, H; Kurth, A; Smith, I; Wang, LF				Kohl, Claudia; Tachedjian, Mary; Todd, Shawn; Monaghan, Paul; Boyd, Victoria; Marsh, Glenn A.; Crameri, Gary; Field, Hume; Kurth, Andreas; Smith, Ina; Wang, Lin-Fa			Hervey virus: Study on co-circulation with Henipaviruses in Pteropid bats within their distribution range from Australia to Africa	PLOS ONE			English	Article							LENGTH GENOME SEQUENCE; FRUIT BATS; RESERVOIR HOSTS; TIOMAN VIRUS; HENDRA VIRUS; FLYING-FOXES; PARAMYXOVIRUSES; PIGS; REPRODUCTION; MULTIPLE	In 2011, an unusually large number of independent Hendra virus outbreaks were recorded on horse properties in Queensland and New South Wales, Australia. Urine from bat colonies adjacent to the outbreak sites were sampled and screened for Hendra and other viruses. Several novel paramyxoviruses were also isolated at different locations. Here one of the novel viruses, named Hervey virus (HerPV), is fully characterized by genome sequencing, annotation, phylogeny and in vitro host range, and its serological cross-reactivity and neutralization patterns are examined. HerPV may have ecological and spatial and temporal patterns similar to Hendra virus and could serve as a sentinel virus for the surveillance of this highly pathogenic virus. The suitability of HerPV as potential sentinel virus is further assessed by determining the serological prevalence of HerPV antibodies in fruit-eating bats from Australia, Indonesia, Papua New Guinea, Tanzania and the Gulf of Guinea, indicating the presence of similar viruses in regions beyond the Australian border.	[Kohl, Claudia; Kurth, Andreas] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Seestr 10, Berlin, Germany; [Tachedjian, Mary; Todd, Shawn; Monaghan, Paul; Boyd, Victoria; Marsh, Glenn A.; Crameri, Gary; Smith, Ina; Wang, Lin-Fa] CSIRO Hlth & Biosecur, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Field, Hume] Queensland Ctr Emerging Infect Dis, Dept Agr & Fisheries, Brisbane, Qld, Australia; [Field, Hume] EcoHlth Alliance, New York, NY USA; [Wang, Lin-Fa] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore	Robert Koch Institute; Commonwealth Scientific & Industrial Research Organisation (CSIRO); EcoHealth Alliance; National University of Singapore	Smith, I; Wang, LF (corresponding author), CSIRO Hlth & Biosecur, Australian Anim Hlth Lab, Geelong, Vic, Australia.; Wang, LF (corresponding author), Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.	Ina.Smith@csiro.au; linfa.wang@duke-nus.edu.sg	wang, lin/HHM-2225-2022; Smith, Ina/H-7225-2013; wang, lili/HDL-7210-2022; wang, lin/GSE-3040-2022; Marsh, Glenn A/A-5418-2013; Tachedjian, Mary/H-4572-2013	Smith, Ina/0000-0001-5807-3737; Marsh, Glenn A/0000-0002-3469-1837; Tachedjian, Mary/0000-0002-8936-6564; Wang, Lin-Fa/0000-0003-2752-0535	CSIRO appropriation funds, a German-Australian Mobility Call Grant [RI 17.5, BMBF 01DR14007]; Australian Queensland through a National Hendra Virus Research Program Grant [NHeVRP_05]; New South Wales Governments through a National Hendra Virus Research Program Grant [NHeVRP_05]; National Research Foundation in Singapore [NRF2012NRF-CRP001-056]; Konrad Adenauer Foundation	CSIRO appropriation funds, a German-Australian Mobility Call Grant; Australian Queensland through a National Hendra Virus Research Program Grant; New South Wales Governments through a National Hendra Virus Research Program Grant; National Research Foundation in Singapore(National Research Foundation, Singapore); Konrad Adenauer Foundation	This research was partially funded by CSIRO appropriation funds, a German-Australian Mobility Call Grant (RI 17.5 and BMBF 01DR14007) to L-FW and CK; and the Australian Queensland and New South Wales Governments through a National Hendra Virus Research Program Grant (NHeVRP_05) to HF. L-FW is supported in part by a National Research Foundation grant (NRF2012NRF-CRP001-056) in Singapore. CK was supported as a visiting scientist at AAHL in 2012 by a fellowship from the Konrad Adenauer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Ursula Erikli for copy-editing and Annika Brinkmann for technical assistance. We thank Andrew Breed, Andrew Cunningham, Alison Peel, Craig Smith and James Wood for providing the bat serum samples for our previous collaborative studies. We thank the CSIRO AAHL Hendra virus response team (Michelle Baker, Kate Baker, Jennifer Barr, Amy Burroughs, Bronwyn Clayton, Johanna Dups, Reuben Klein, Huajun Zhang, Peng Zhou) and the staff of Biosecurity Queensland, Department of Agriculture and Fisheries (Craig Smith, Carol de Jong, Deb Melville and Alice Broos), for assistance in collecting urine samples during the Hendra virus outbreaks of 2011. This research was partially funded by CSIRO appropriation funds, a German-Australian Mobility Call Grant (RI 17.5 and BMBF 01DR14007) to L-FW and CK; and the Australian Queensland and New South Wales Governments through a National Hendra Virus Research Program Grant (NHeVRP_05) to HF. L-FW is supported in part by a National Research Foundation grant (NRF2012NRF-CRP001-056) in Singapore. CK was supported as a visiting scientist at AAHL in 2012 by a fellowship from the Konrad Adenauer Foundation.	Baker KS, 2012, J GEN VIROL, V93, P850, DOI 10.1099/vir.0.039339-0; Baker KS, 2014, J ANIM ECOL, V83, P415, DOI 10.1111/1365-2656.12153; Baker KS, 2013, J VIROL, V87, P1348, DOI 10.1128/JVI.01202-12; Barr J, 2015, J GEN VIROL, V96, P24, DOI 10.1099/vir.0.068106-0; Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; Bowden TR, 2012, J GEN VIROL, V93, P1007, DOI 10.1099/vir.0.038448-0; Breed AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061316; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chen LH, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau021; Chua KB, 2002, ARCH VIROL, V147, P1323, DOI 10.1007/s00705-002-0815-5; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Edson D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125881; Fauquet CM, 2001, ARCH VIROL, V146, P189, DOI 10.1007/s007050170203; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Klose SM, 2006, J COMP PHYSIOL A, V192, P341, DOI 10.1007/s00359-005-0067-4; Kurth A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038688; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Marsh GA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002836; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Smith I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025275; Streicker DG, 2012, P ROY SOC B-BIOL SCI, V279, P3384, DOI 10.1098/rspb.2012.0538; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; Wang LF, 2007, ARCH VIROL, V152, P1259, DOI 10.1007/s00705-007-0959-4; Weiss S, 2012, EMERG INFECT DIS, V18, P1536, DOI 10.3201/eid1809.111607; Yaiw KC, 2008, J VIROL, V82, P565, DOI 10.1128/JVI.01660-07	37	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0191933	10.1371/journal.pone.0191933	http://dx.doi.org/10.1371/journal.pone.0191933			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29390028	Green Published, Green Submitted, gold			2022-12-26	WOS:000423793400043
J	Loft, ND; Skov, L; Rasmussen, MK; Gniadecki, R; Dam, TN; Brandslund, I; Hoffmann, HJ; Andersen, MR; Dessau, RB; Bergmann, AC; Andersen, NM; Abildtoft, MK; Andersen, PS; Hetland, ML; Glintborg, B; Bank, S; Vogel, U; Andersen, V				Loft, Nikolai Dyrberg; Skov, Lone; Rasmussen, Mads Kirchheiner; Gniadecki, Robert; Dam, Tomas Norman; Brandslund, Ivan; Hoffmann, Hans Jurgen; Andersen, Malene Rohr; Dessau, Ram Benny; Bergmann, Ann Christina; Andersen, Niels Moller; Abildtoft, Mikkel Kramme; Andersen, Paal Skytt; Hetland, Merete Lund; Glintborg, Bente; Bank, Steffen; Vogel, Ulla; Andersen, Vibeke			Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis	PLOS ONE			English	Article							FACTOR-ALPHA GENE; NF-KAPPA-B; SUSCEPTIBILITY LOCI; IL23R GENES; EARLY-ONSET; NSAID USE; RISK; IL12B; DISEASE; VULGARIS	Background Psoriasis (PsO) is a chronic inflammatory disease with predominantly cutaneous manifestations. Approximately one third of patients with PsO develop psoriatic arthritis (PsA), whereas the remaining proportion of patients has isolated cutaneous psoriasis (PsC). These two phenotypes share common immunology, but with different heredity that might in part be explained by genetic variables. Methods Using a candidate gene approach, we studied 53 single nucleotide polymorphisms (SNPs) in 37 genes that regulate inflammation. In total, we assessed 480 patients with PsO from DERMBIO, of whom 151 had PsC for 10 years or more (PsC10), 459 patients with PsA from DANBIO, and 795 healthy controls. Using logistic regression analysis, crude and adjusted for age and gender, we assessed associations between genetic variants and PsO, PsC10, and PsA, as well as associations between genetic variants and development of PsA in PsO. Results Eleven polymorphisms in 10 genes were nominally associated with PsO and/or PsC and/or PsA (P < 0.05). After correction for multiple testing with a false discovery rate of 5%, two SNPs remained significant: TNF (rs361525) was associated with PsO, PsC10, and PsA; and IL12B (rs6887695) was associated with PsO. Conclusion Among a cohort of Danish patients with moderate-to-severe psoriasis, two SNPs in the IL12B and TNF genes were associated with susceptibility of psoriasis. None of the SNPs were specifically associated with isolated cutaneous psoriasis or psoriatic arthritis.	[Loft, Nikolai Dyrberg; Skov, Lone] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Dermatol & Allergy, Hellerup, Denmark; [Rasmussen, Mads Kirchheiner] Aarhus Univ Hosp, Dept Dermatol, Aarhus, Denmark; [Gniadecki, Robert] Bispebjerg Hosp, Dept Dermatol, Copenhagen, Denmark; [Dam, Tomas Norman] Dermatol Clin, Nykoebing Falster, Denmark; [Brandslund, Ivan] Lillebaelt Hosp, Dept Clin Immunol & Biochem, Vejle, Denmark; [Hoffmann, Hans Jurgen] Aarhus Univ, Inst Clin Med, Aarhus, Denmark; [Hoffmann, Hans Jurgen] Aarhus Univ Hosp, Dept Resp Dis & Allergy B, Aarhus, Denmark; [Andersen, Malene Rohr] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Clin Biochem, Hellerup, Denmark; [Dessau, Ram Benny] Slagelse Hosp, Dept Clin Microbiol, Slagelse, Denmark; [Bergmann, Ann Christina; Andersen, Niels Moller; Bank, Steffen; Andersen, Vibeke] Hosp Southern Jutland, Focused Res Unit Mol Diagnost & Clin Res, IRS Ctr Soenderjylland, Aabenraa, Denmark; [Abildtoft, Mikkel Kramme] Zitelab Aps, Copenhagen, Denmark; [Andersen, Paal Skytt] Serum Inst, Dept Microbiol & Infect Control, Copenhagen, Denmark; [Hetland, Merete Lund] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Hetland, Merete Lund; Glintborg, Bente] Rigshosp, Ctr Head & Orthopaed, Ctr Rheumatol & Spine Dis, DANBIO Registry, Glostrup, Denmark; [Hetland, Merete Lund; Glintborg, Bente] Rigshosp, Ctr Head & Orthopaed, Ctr Rheumatol & Spine Dis, Copenhagen Ctr Arthrit Res COPECARE, Glostrup, Denmark; [Glintborg, Bente] Herlev & Gentofte Hosp, Dept Rheumatol, Hellerup, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Andersen, Vibeke] Univ Southern Denmark, Inst Mol Med, Odense, Denmark; [Andersen, Vibeke] Univ Southern Denmark, OPEN Odense Patient Data Explorat Network, Odense, Denmark	University of Copenhagen; Aarhus University; University of Copenhagen; Bispebjerg Hospital; Aarhus University; Aarhus University; University of Copenhagen; Statens Serum Institut; University of Copenhagen; Rigshospitalet; Rigshospitalet; National Research Centre for the Working Environment; University of Southern Denmark; University of Southern Denmark	Loft, ND (corresponding author), Univ Copenhagen, Herlev & Gentofte Hosp, Dept Dermatol & Allergy, Hellerup, Denmark.	nikolai.dyrberg.loft@regionh.dk	Skov, Lone/W-3575-2018; Hetland, Merete L/AAE-5297-2019; Glintborg, Bente/W-6374-2019; Hoffman, Hans Jurgen/I-6969-2018; Vogel, Ulla B/I-5048-2012; Andersen, Vibeke/I-7932-2012; Vogel, Ulla/ABC-2212-2020; Gniadecki, Robert/A-5696-2010; Andersen, Paal Skytt/H-2087-2015	Hetland, Merete L/0000-0003-4229-6818; Glintborg, Bente/0000-0002-8931-8482; Hoffman, Hans Jurgen/0000-0002-6743-7931; Vogel, Ulla B/0000-0001-6807-1524; Andersen, Vibeke/0000-0002-0127-2863; Vogel, Ulla/0000-0001-6807-1524; Gniadecki, Robert/0000-0002-2310-8300; Rasmussen, Mads Kirchheiner/0000-0001-8242-9377; Andersen, Paal Skytt/0000-0001-5656-0427; Skov, Lone/0000-0002-4784-9680; Dessau, Ram/0000-0002-1497-6309; Loft, Nikolai Dyrberg/0000-0002-2950-3280; Brandslund, Ivan/0000-0002-4203-5442	Psoriasisforeningen; Robert Wehnerts og Kirsten Wehnerts Fonden; Knud og Edith Eriksens Mindefond; Gigtforeningen [A2037, A3570]; DERMBIO; Novo Nordisk Foundation [NNF150C0017622]; Novo Nordisk Foundation	Psoriasisforeningen; Robert Wehnerts og Kirsten Wehnerts Fonden; Knud og Edith Eriksens Mindefond; Gigtforeningen; DERMBIO; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The work was funded by Psoriasisforeningen, Robert Wehnerts og Kirsten Wehnerts Fonden, Knud og Edith Eriksens Mindefond, Gigtforeningen (A2037, A3570), DERMBIO, and the Novo Nordisk Foundation (NNF150C0017622). The Novo Nordisk Foundation provided support in form of a scholarship for author NDL, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The rest of the Funders supported the study with funding for collection and analysis of biological material. MKA is employed by Zitelap Aps. Zitelap Aps provided support in the form of salary for author MKA and is responsible for management of the DERMBIO and DANBIO databases, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Baliwag J, 2015, CYTOKINE, V73, P342, DOI 10.1016/j.cyto.2014.12.014; Bank S, 2014, PHARMACOGENOMICS J, V14, P526, DOI 10.1038/tpj.2014.19; Bank S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098815; Bank S, 2013, GENET TEST MOL BIOMA, V17, P501, DOI 10.1089/gtmb.2012.0429; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bowes J, 2015, ANN RHEUM DIS, V74, P1882, DOI 10.1136/annrheumdis-2014-207187; Bowes J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7046; Bowes J, 2012, ANN RHEUM DIS, V71, P313, DOI 10.1136/ard.2011.154690; Bowes J, 2011, ANN RHEUM DIS, V70, P1016, DOI 10.1136/ard.2010.143123; Budu-Aggrey A, 2016, ANN RHEUM DIS, V75, P1417, DOI 10.1136/annrheumdis-2016-209290; Butt C, 2006, J RHEUMATOL, V33, P1631; Cardili RN, 2016, INT J DERMATOL, V55, pE16, DOI 10.1111/ijd.12894; Chandran V, 2014, RHEUMATOLOGY, V53, P233, DOI 10.1093/rheumatology/ket296; De Simone C, 2015, J EUR ACAD DERMATOL, V29, P1786, DOI 10.1111/jdv.13024; Duffin KC, 2009, J INVEST DERMATOL, V129, P2777, DOI 10.1038/jid.2009.169; Eder L, 2012, ANN RHEUM DIS, V71, P50, DOI 10.1136/ard.2011.155044; Eder L, 2011, ANN RHEUM DIS, V70, P1594, DOI 10.1136/ard.2010.147421; Eiris N, 2014, J DERMATOL SCI, V75, P167, DOI 10.1016/j.jdermsci.2014.05.010; Eiris N, 2012, CYTOKINE, V60, P27, DOI 10.1016/j.cyto.2012.05.030; Ernst A, 2007, SCAND J GASTROENTERO, V42, P1445, DOI 10.1080/00365520701427102; Eskandari-Nasab E, 2013, SCAND J IMMUNOL, V78, P85, DOI 10.1111/sji.12054; Filer C, 2008, ARTHRITIS RHEUM-US, V58, P3705, DOI 10.1002/art.24128; Gladman DD, 2011, ANN RHEUM DIS, V70, P2152, DOI 10.1136/ard.2011.150938; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Goldminz AM, 2013, J DERMATOL SCI, V69, P89, DOI 10.1016/j.jdermsci.2012.11.002; Haroon M, 2015, ANN RHEUM DIS, V74, P1045, DOI 10.1136/annrheumdis-2013-204858; Huffmeier U, 2009, J INVEST DERMATOL, V129, P355, DOI 10.1038/jid.2008.233; Ibfelt EH, 2016, CLIN EPIDEMIOL, V8, P737, DOI 10.2147/CLEP.S99490; Isssik S, 308G A 238G A POL TN; Jia Y, 2013, CLIN EXP DERMATOL, V38, P836, DOI 10.1111/ced.12136; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kaluza W, 2000, J INVEST DERMATOL, V114, P1180, DOI 10.1046/j.1523-1747.2000.00001.x; Lee YH, 2013, IMMUNOL INVEST, V42, P726, DOI 10.3109/08820139.2013.810241; Loft ND, 2017, PHARMACOGENOMICS J; Mossner R, 2004, ARCH DERMATOL RES, V296, P1, DOI 10.1007/s00403-004-0463-6; Nair RP, 2008, J INVEST DERMATOL, V128, P1653, DOI 10.1038/sj.jid.5701255; Nair RP, 2010, ARCH DERMATOL RES, V302, P139, DOI 10.1007/s00403-009-0986-y; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nedoszytko B, 2007, BRIT J DERMATOL, V157, P165, DOI 10.1111/j.1365-2133.2007.07993.x; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Oka A, 2013, IMMUNOGENETICS, V65, P823, DOI 10.1007/s00251-013-0721-x; Okada Y, 2014, AM J HUM GENET, V95, P162, DOI 10.1016/j.ajhg.2014.07.002; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Petersen RK, 2012, CANCER LETT, V315, P59, DOI 10.1016/j.canlet.2011.10.009; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rajesh D, 2017, INT J DERMATOL, V56, P307, DOI 10.1111/ijd.13482; Reich K, 2007, ARTHRITIS RHEUM, V56, P2056, DOI 10.1002/art.22590; Sakkas LI, 2017, AUTOIMMUN REV, V16, P10, DOI 10.1016/j.autrev.2016.09.015; Smith RL, 2008, J INVEST DERMATOL, V128, P1325, DOI 10.1038/sj.jid.5701140; Sode J, 2016, PHARMACOGENOMICS J; Sode J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139781; Sode J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100361; Soto-Sanchez J, 2010, CYTOKINE, V50, P114, DOI 10.1016/j.cyto.2010.01.006; Stuart PE, 2015, AM J HUM GENET, V97, P816, DOI 10.1016/j.ajhg.2015.10.019; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Theander E, 2014, ANN RHEUM DIS, V73, P407, DOI 10.1136/annrheumdis-2012-201972; Vogel U, 2007, MUTAT RES-FUND MOL M, V624, P88, DOI 10.1016/j.mrfmmm.2007.04.006; Vogel U, 2007, CARCINOGENESIS, V28, P427, DOI 10.1093/carcin/bgl170; Wang XB, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000613; Winchester R, 2012, ARTHRITIS RHEUM-US, V64, P1134, DOI 10.1002/art.33415; Yang Q, 2013, BRIT J DERMATOL, V168, P1060, DOI 10.1111/bjd.12142; Zachariae H, 2003, AM J CLIN DERMATOL, V4, P441, DOI 10.2165/00128071-200304070-00001; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]; Zhu KJ, 2013, RHEUMATOL INT, V33, P1785, DOI 10.1007/s00296-012-2637-4; Zhu KJ, 2012, INFLAMM RES, V61, P1149, DOI 10.1007/s00011-012-0509-8; Zhuang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068827	66	28	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192010	10.1371/journal.pone.0192010	http://dx.doi.org/10.1371/journal.pone.0192010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389950	Green Published, Green Submitted, gold			2022-12-26	WOS:000423793400050
J	Manderstedt, E; Lind-Hallden, C; Lethagen, S; Hallden, C				Manderstedt, Eric; Lind-Hallden, Christina; Lethagen, Stefan; Hallden, Christer			Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patients	PLOS ONE			English	Article							LINKAGE; ASSOCIATION; CONTRIBUTES; VARIANTS; SIGN	von Willebrand factor (VWF) levels in healthy individuals and in patients with type 1 von Willebrand disease (VWD) are influenced by genetic variation in several genes, e.g. VWF, ABO, STXBP5 and CLEC4M. This study aims to screen comprehensively for CLEC4M variants and investigate their association with type 1 VWD in the Swedish population. In order to screen for CLEC4M variants, the CLEC4M gene region was re-sequenced and the polymorphic neck region was genotyped in 106 type 1 VWD patients from unrelated type 1 VWD families. Single nucleotide variants (SNV) and variable number tandem repeat (VNTR) allele and genotype frequencies were then compared with 294 individuals from the 1000Genomes project and 436 Swedish control individuals. Re-sequencing identified a total of 42 SNVs. Rare variants showed no accumulation in type 1 VWD patients and are not thought to contribute substantially to type 1 VWD. The only missense mutation (rs2277998, NP_001138379.1: p.Asp224Asn) had a higher frequency in type 1 VWD patients than in controls (4.9%). The VNTR genotypes 57 and 67 were observed at higher frequencies than expected in type 1 VWD patients (6.4% and 6.2%) and showed an increase in patients compared with controls (7.4% and 3.1%). Strong linkage disequilibrium in the CLEC4M region makes it difficult to distinguish between the effect of the missense mutation and the VNTR genotypes. In conclusion, heterozygous VNTR genotypes 57 and 67 of CLEC4M were highly enriched and are the most likely mechanism through which CLEC4M contributes to disease in the Swedish type 1 VWD population.	[Manderstedt, Eric; Lind-Hallden, Christina; Hallden, Christer] Kristianstad Univ, Biomed, Kristianstad, Sweden; [Lethagen, Stefan] Univ Copenhagen, Copenhagen, Denmark; [Lethagen, Stefan] Sobi, Stockholm, Sweden; [Lethagen, Stefan] Lund Univ, Lund, Sweden	Kristianstad University; University of Copenhagen; Swedish Orphan Biovitrum; Lund University	Manderstedt, E (corresponding author), Kristianstad Univ, Biomed, Kristianstad, Sweden.	eric.manderstedt@hkr.se		Manderstedt, Eric/0000-0002-8984-9697	Sobi	Sobi	Stefan Lethagen [SL] is employed by and receive salary from Sobi. The funder provided support in the form of salary for author [SL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the author contributions section.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Antoni G, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-102; Barreiro LB, 2005, AM J HUM GENET, V77, P869, DOI 10.1086/497613; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boily-Larouche G, 2007, HUM IMMUNOL, V68, P523, DOI 10.1016/j.humimm.2007.02.002; Casari C., 2013, J THROMB HAEMOST, V11, P1538; Chan VSF, 2006, NAT GENET, V38, P38, DOI 10.1038/ng1698; Desch KC, 2013, P NATL ACAD SCI USA, V110, P588, DOI 10.1073/pnas.1219885110; Flood VH, 2016, BLOOD, V127, P2481, DOI 10.1182/blood-2015-10-673681; Goodeve AC, 2010, BLOOD REV, V24, P123, DOI 10.1016/j.blre.2010.03.003; Guo Y, 2006, J BIOL CHEM, V281, P16794, DOI 10.1074/jbc.M602430200; Hallden C, 2012, J THROMB HAEMOST, V10, P2503, DOI 10.1111/jth.12010; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lanke E, 2005, J THROMB HAEMOST, V3, P2656, DOI 10.1111/j.1538-7836.2005.01631.x; Leckband DE, 2011, BIOCHEMISTRY-US, V50, P6125, DOI 10.1021/bi2003444; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042972; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030268; Lillicrap D, 2013, HEMATOL-AM SOC HEMAT, P254, DOI 10.1182/asheducation-2013.1.254; Liu Huanliang, 2005, Methods Mol Biol, V304, P471; Manderstedt E, TH OPEN; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rastegarlari G, 2012, BLOOD, V119, P2126, DOI 10.1182/blood-2011-08-373605; Rydz N, 2013, BLOOD, V121, P5228, DOI 10.1182/blood-2012-10-457507; Sanders YV, 2015, J THROMB HAEMOST, V13, P956, DOI 10.1111/jth.12927; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Tang NLS, 2007, NAT GENET, V39, P690, DOI 10.1038/ng0607-692; van Loon JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040624; Zhi LT, 2007, NAT GENET, V39, P691, DOI [10.1038/ng0607-692, 10.1038/ng0607-691]; Zhu DY, 2010, BIOCHEM BIOPH RES CO, V393, P598, DOI 10.1016/j.bbrc.2010.02.021	30	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192024	10.1371/journal.pone.0192024	http://dx.doi.org/10.1371/journal.pone.0192024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389944	Green Submitted, Green Published, gold			2022-12-26	WOS:000423793400052
J	Mizuno, M; Sasaki, T; Kobayashi, M; Haneda, T; Masubuchi, T				Mizuno, Mariko; Sasaki, Takeshi; Kobayashi, Mari; Haneda, Takayuki; Masubuchi, Takahito			Mitochondrial DNA reveals secondary contact in Japanese harbour seals, the southernmost population in the western Pacific	PLOS ONE			English	Article							SALMON ONCORHYNCHUS-KETA; CHUM SALMON; GENETIC-VARIATION; PHOCA-VITULINA; PATTERNS; SUBSTRUCTURE; WASHINGTON; DIVERSITY; RICHARDSI; SEQUENCES	In this study, we used relatively large number of samples (n = 178) and control region of mtDNA (454bp) to clearify the divergence history of Japanese harbour seals (Phoca vitulina stejnegeri) and phylogenetic relationship between the seals in Japan and other countries. Our results suggested that Japanese harbour seals possibly consisted of more than two lineages and secondary contact of populations after a long isolation. Furthermore, one of the lineage was made only by Japanese harbour seals (Group P1). The proportion of Group P1 was the highest at the South West and gradually decreased towards the North East of Hokkaido, Japan. On the other hand, the haplotypes do not belonged to Group P1 showed close relationship to the seals in the North Pacific. Based on the fossil record of harbour seal in Japan and the range of sea ice during the Last Glacial Maximum (LGM), Group P1 might have entered Japan before the LGM and became isolated due to the geographical boundary, and gradually extended its range from the South West towards the North East of Hokkaido after the disappearance of the sea ice, while the seals which are not in Group P1 immigrated into Japan from the North Pacific.	[Mizuno, Mariko; Kobayashi, Mari; Haneda, Takayuki; Masubuchi, Takahito] Tokyo Univ Agr, Grad Sch Bioind, Abashiri, Hokkaido, Japan; [Mizuno, Mariko; Kobayashi, Mari; Haneda, Takayuki; Masubuchi, Takahito] Inc Non Profit Org, Marine Wildlife Ctr Japan, Abashiri, Hokkaido, Japan; [Sasaki, Takeshi] Tokyo Univ Agr, Grad Sch Human & Anim Plant Relationships, Atsugi, Kanagawa, Japan	Tokyo University of Agriculture; Tokyo University of Agriculture	Kobayashi, M (corresponding author), Tokyo Univ Agr, Grad Sch Bioind, Abashiri, Hokkaido, Japan.; Kobayashi, M (corresponding author), Inc Non Profit Org, Marine Wildlife Ctr Japan, Abashiri, Hokkaido, Japan.	m3kobaya@bioindustry.nodai.ac.jp			Environment Research and Technology Development Fund (ERTDF) [4-1301]; Inui Memorial Trust for Research on Animal Science, Japan [2014]	Environment Research and Technology Development Fund (ERTDF); Inui Memorial Trust for Research on Animal Science, Japan	MK received Grant No:4-1301 from The Environment Research and Technology Development Fund (ERTDF), http://www.env.go.jp/policy/kenkyu/suishin/english/kadai/index_2015html. MM received Grant No:2014 from The Inui Memorial Trust for Research on Animal Science, Japan, http://www.jwrc.or.jp/shintaku/5.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2007, AQUACULTURE, V272, pS239, DOI 10.1016/j.aquaculture.2007.07.019; Andersen LW, 2011, BIOL J LINN SOC, V102, P420, DOI 10.1111/j.1095-8312.2010.01577.x; Baker AR, 2005, J MAMMAL, V86, P1075, DOI 10.1644/04-MAMM-A-113R1.1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beacham TD, 2009, FISHERY B; Burg TM, 1999, CAN J ZOOL, V77, P930, DOI 10.1139/cjz-77-6-930; Canino MF, 2010, MOL ECOL, V19, P4339, DOI 10.1111/j.1365-294X.2010.04815.x; Cronin MA, 1996, J MAMMAL, V77, P546, DOI 10.2307/1382828; EXCOFFIER L, 1992, GENETICS, V131, P479; Flagstad O, 2003, EVOLUTION, V57, P658; Green M.R., 2012, MOL CLONING LAB MANU; Hasegawa Y, 1988, MEM NATL SCI MUSEUM, V21, P36; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Higdon JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-216; Holder K, 1999, EVOLUTION, V53, P1936, DOI 10.1111/j.1558-5646.1999.tb04574.x; Huber HR, 2010, CAN J ZOOL, V88, P280, DOI 10.1139/Z09-141; Kobayashi M., 2009, WILD MAMMALS JAPAN, P272; Lamont MM, 1996, MAR MAMMAL SCI, V12, P402, DOI 10.1111/j.1748-7692.1996.tb00592.x; MANN DH, 1994, QUATERNARY RES, V42, P136, DOI 10.1006/qres.1994.1063; Miyazaki Shigeo, 1994, Island Arc, V3, P361, DOI 10.1111/j.1440-1738.1994.tb00120.x; Nakagawa E, 2010, ZOOL SCI, V27, P263, DOI 10.2108/zsj.27.263; Ono Y, 1984, GEOGRAPHICAL REV J B, V57, P87; PELTIER WR, 1994, SCIENCE, V265, P195, DOI 10.1126/science.265.5169.195; Sato SP, 2001, ZOOL SCI, V18, P99, DOI 10.2108/zsj.18.99; Seeb LW, 1999, T AM FISH SOC, V128, P58, DOI 10.1577/1548-8659(1999)128&lt;0058:HGHICS&gt;2.0.CO;2; SLADE RW, 1994, MOL BIOL EVOL, V11, P341; Stanley HF, 1996, MOL BIOL EVOL, V13, P368, DOI 10.1093/oxfordjournals.molbev.a025596; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAYLOR EB, 1994, CAN J FISH AQUAT SCI, V51, P1430, DOI 10.1139/f94-143; Waite JN, 2011, MOL ECOL RESOUR, V11, P166, DOI 10.1111/j.1755-0998.2010.02874.x; Webber MA., 1993, FAO SPECIES IDENTIFI; Westlake RL, 2002, J MAMMAL, V83, P1111, DOI 10.1644/1545-1542(2002)083<1111:MSAPOG>2.0.CO;2; Yoon M, 2008, J FISH BIOL, V73, P1256, DOI 10.1111/j.1095-8649.2008.01995.x	34	8	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191329	10.1371/journal.pone.0191329	http://dx.doi.org/10.1371/journal.pone.0191329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385193	Green Published, Green Submitted, gold			2022-12-26	WOS:000423668400044
J	Yu, DY; Yang, SE; Miller, BR; Wisinski, JA; Sherman, DS; Brinkman, JA; Tomasiewicz, JL; Cummings, NE; Kimple, ME; Cryns, VL; Lamming, DW				Yu, Deyang; Yang, Shany E.; Miller, Blake R.; Wisinski, Jaclyn A.; Sherman, Dawn S.; Brinkman, Jacqueline A.; Tomasiewicz, Jay L.; Cummings, Nicole E.; Kimple, Michelle E.; Cryns, Vincent L.; Lamming, Dudley W.			Short-term methionine deprivation improves metabolic health via sexually dimorphic, mTORC1-independent mechanisms	FASEB JOURNAL			English	Article						Fgf21; amino acids; diabetes; obesity; dietary protein	GROWTH-FACTOR 21; FAT VEGAN DIET; ADIPOSE-TISSUE; LIFE-SPAN; LIPID-METABOLISM; CLINICAL-TRIAL; AMINO-ACIDS; INSULIN SENSITIVITY; PROTEIN RESTRICTION; STRESS RESISTANCE	Obesity and diabetes are major challenges to global health, and there is an urgent need for interventions that promote weight loss. Dietary restriction of methionine promotes leanness and improves metabolic health in mice and humans. However, poor long-term adherence to this diet limits its translational potential. In this study, we develop a short-term methionine deprivation (MD) regimen that preferentially reduces fat mass, restoring normal body weight and glycemic control to diet-induced obese mice of both sexes. The benefits of MD do not accrue from calorie restriction, but instead result from increased energy expenditure. MD promotes increased energy expenditure in a sex-specific manner, inducing the fibroblast growth factor (Fgf)-21-uncoupling protein (Ucp)-1 axis only in males. Methionine is an agonist of the protein kinase mechanistic target of rapamycin complex (mTORC)-1, which has been proposed to play a key role in the metabolic response to amino acid-restricted diets. In our study, we used a mouse model of constitutive hepatic mTORC1 activity and demonstrate that suppression of hepatic mTORC1 signaling is not required for the metabolic effects of MD. Our study sheds new light on the mechanisms by which dietary methionine regulates metabolic health and demonstrates the translational potential of MD for the treatment of obesity and type 2 diabetes.	[Yu, Deyang; Yang, Shany E.; Miller, Blake R.; Wisinski, Jaclyn A.; Sherman, Dawn S.; Brinkman, Jacqueline A.; Cummings, Nicole E.; Kimple, Michelle E.; Cryns, Vincent L.; Lamming, Dudley W.] Univ Wisconsin, Div Endocrinol Diabet & Metab, Dept Med, Madison, WI 53705 USA; [Yu, Deyang; Cryns, Vincent L.; Lamming, Dudley W.] Univ Wisconsin, Mol & Environm Toxicol Program, Madison, WI 53705 USA; [Cummings, Nicole E.; Kimple, Michelle E.; Lamming, Dudley W.] Univ Wisconsin, Endocrinol & Reprod Physiol Grad Training Program, Madison, WI 53705 USA; [Yu, Deyang; Yang, Shany E.; Miller, Blake R.; Wisinski, Jaclyn A.; Sherman, Dawn S.; Brinkman, Jacqueline A.; Tomasiewicz, Jay L.; Cummings, Nicole E.; Kimple, Michelle E.; Lamming, Dudley W.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Wisinski, Jaclyn A.] Univ Wisconsin, Dept Biol, La Crosse, WI 54601 USA; [Cryns, Vincent L.; Lamming, Dudley W.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin System; University of Wisconsin Madison	Lamming, DW (corresponding author), Univ Wisconsin, 2500 Overlook Terrace,VAH C3127 Res 151, Madison, WI 53705 USA.	dlamming@medicine.wisc.edu	Lamming, Dudley/O-7191-2015	Lamming, Dudley/0000-0002-0079-4467; Yang, Shany/0000-0003-3890-7671; Richardson, Nicole/0000-0002-2772-3060	U.S. National Institutes of Health (NIH) National Institute on Aging (NIA) [AG041765, AG050135, AG051974, AG056771]; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant [DK102598]; New Investigator Program Award from the Wisconsin Partnership Program; Collaborative Health Sciences Program Award from the Wisconsin Partnership Program; V Foundation for Cancer Research; Glenn Foundation Award for Research in the Biological Mechanisms of Aging; startup funds from the UW-Madison School of Medicine and Public Health; UW-Madison Department of Medicine; American Federation for Aging Research (AFAR) grant; American Heart Association [17PRE33410983]; training grant from the NIH/NIDDK [DK007665]; training grant from the UW Institute on Aging [NIA T32 AG000213]; UWCCC Support Grant from the NIH National Cancer Institute [P30 CA014520]; William S. Middleton Memorial Veterans Hospital; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102598, P30DK020579, T32DK007665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG041765, R56AG056771, K99AG041765, T32AG000213, R21AG051974, R21AG050135, R01AG056771] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Aging (NIA); NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant; New Investigator Program Award from the Wisconsin Partnership Program; Collaborative Health Sciences Program Award from the Wisconsin Partnership Program; V Foundation for Cancer Research; Glenn Foundation Award for Research in the Biological Mechanisms of Aging; startup funds from the UW-Madison School of Medicine and Public Health; UW-Madison Department of Medicine; American Federation for Aging Research (AFAR) grant; American Heart Association(American Heart Association); training grant from the NIH/NIDDK; training grant from the UW Institute on Aging; UWCCC Support Grant from the NIH National Cancer Institute; William S. Middleton Memorial Veterans Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Ildiko Kasza and Dr. Caroline Alexander (both from the McArdle Laboratory for Cancer Research, Madison, WI, USA) for assistance in establishing the lipid droplet quantification protocol and advice regarding the collection and analysis of adipose tissue; all members of the D.W.L., M.E.K., and V.L.C. laboratories, and Dr. Dawn Davis, Dr. Matthew Merrins and their laboratories for their assistance and insight [University of Wisconsin-Madison (UW-Madison)]; and Dr. Tina Herfel (Envigo, Madison, WI, USA) for assistance with the formulation of the amino acid-defined diets. This research was supported, in part, by the U.S. National Institutes of Health (NIH) National Institute on Aging (NIA) Grants AG041765, AG050135, AG051974, and AG056771 (to D.W.L.); NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant DK102598 (to M.E.K.); a New Investigator Program Award from the Wisconsin Partnership Program (to D.W.L.); a Collaborative Health Sciences Program Award from the Wisconsin Partnership Program (to V.L.C.), the V Foundation for Cancer Research (to V.L.C.); a Glenn Foundation Award for Research in the Biological Mechanisms of Aging (to D.W.L.); and startup funds from the UW-Madison School of Medicine and Public Health and the UW-Madison Department of Medicine (to V.L.C. and D.W.L.). This research was conducted while D.W.L. was an American Federation for Aging Research (AFAR) grant recipient. D.Y. was supported in part by a fellowship from the American Heart Association (17PRE33410983); J.A.W. was supported by a training grant from the NIH/NIDDK (DK007665); N.E.C. was supported by a training grant from the UW Institute on Aging (NIA T32 AG000213). The UW Carbone Cancer Center (UWCCC) Experimental Pathology Laboratory is supported by UWCCC Support Grant P30 CA014520 from the NIH National Cancer Institute. This work was supported using facilities and resources from the William S. Middleton Memorial Veterans Hospital. This work does not represent the views of the Department of Veterans Affairs or the United States Government. The authors declare no conflicts of interest.	Ables GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051357; Apelo SIA, 2016, AGING CELL, V15, P28, DOI 10.1111/acel.12405; Baar EL, 2016, AGING CELL, V15, P155, DOI 10.1111/acel.12425; Barnard ND, 2006, DIABETES CARE, V29, P1777, DOI 10.2337/dc06-0606; Barnard ND, 2009, J AM DIET ASSOC, V109, P263, DOI 10.1016/j.jada.2008.10.049; Barnard ND, 2009, AM J CLIN NUTR, V89, pS1588, DOI 10.3945/ajcn.2009.26736H; Brown-Borg HM, 2017, AGEING RES REV, V39, P87, DOI 10.1016/j.arr.2016.08.007; Caballero F, 2010, J BIOL CHEM, V285, P18528, DOI 10.1074/jbc.M109.099333; Centers for Disease Control, 2020, NATL DIABETES STAT R; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; Cummings N. E., 2017, J PHYSL; Cummings NE, 2017, MOL CELL ENDOCRINOL, V455, P13, DOI 10.1016/j.mce.2016.11.014; Douris N, 2015, ENDOCRINOLOGY, V156, P2470, DOI 10.1210/en.2014-2001; Durando X, 2008, NUTR CANCER, V60, P23, DOI 10.1080/01635580701525877; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fontana L, 2016, CELL REP, V16, P520, DOI 10.1016/j.celrep.2016.05.092; Fothergill E, 2016, OBESITY, V24, P1612, DOI 10.1002/oby.21538; Goberdhan DCI, 2016, CELL METAB, V23, P580, DOI 10.1016/j.cmet.2016.03.013; Gong Q, 2016, HEPATOLOGY, V64, P425, DOI 10.1002/hep.28523; Gu X, 2017, SCIENCE, V358, P813, DOI 10.1126/science.aao3265; Harputlugil E, 2014, CELL REP, V8, P1160, DOI 10.1016/j.celrep.2014.07.018; Hasek BE, 2013, DIABETES, V62, P3362, DOI 10.2337/db13-0501; Hill CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07498-w; Keipert S, 2017, CELL METAB, V26, P437, DOI 10.1016/j.cmet.2017.07.016; Kwon DH, 2012, J NUTR BIOCHEM, V23, P791, DOI 10.1016/j.jnutbio.2011.04.002; Lamming DW, 2014, AGING CELL, V13, P911, DOI 10.1111/acel.12256; Lee YM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155918; Lees EK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10381-3; Lees EK, 2014, AGING CELL, V13, P817, DOI 10.1111/acel.12238; Leib DE, 2015, CELL REP, V13, P1081, DOI 10.1016/j.celrep.2015.09.055; Malloy VL, 2013, METABOLISM, V62, P1651, DOI 10.1016/j.metabol.2013.06.012; McCarty MF, 2009, MED HYPOTHESES, V72, P125, DOI 10.1016/j.mehy.2008.07.044; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Neuman JC, 2014, JOVE-J VIS EXP, DOI 10.3791/50374; ORENTREICH N, 1993, J NUTR, V123, P269; Orgeron ML, 2014, PROG MOL BIOL TRANSL, V121, P351, DOI 10.1016/B978-0-12-800101-1.00011-9; Owen BM, 2014, CELL METAB, V20, P670, DOI 10.1016/j.cmet.2014.07.012; Perrone CE, 2012, J NUTRIGENET NUTRIGE, V5, P132, DOI 10.1159/000339347; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Pettit AP, 2017, J NUTR, V147, P1031, DOI 10.3945/jn.116.246710; Plaisance EP, 2011, J CLIN ENDOCR METAB, V96, pE836, DOI 10.1210/jc.2010-2493; Plaisance EP, 2010, AM J PHYSIOL-REG I, V299, pR740, DOI 10.1152/ajpregu.00838.2009; Schmidt JA, 2016, EUR J CLIN NUTR, V70, P306, DOI 10.1038/ejcn.2015.144; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Stone KP, 2015, OBESITY, V23, P1836, DOI 10.1002/oby.21177; Stone KP, 2014, DIABETES, V63, P3721, DOI 10.2337/db14-0464; Thivat E, 2009, ANTICANCER RES, V29, P5235; Truchan NA, 2015, ISLETS, V7, DOI 10.1080/19382014.2015.1076607; Wanders D, 2017, DIABETES, V66, P858, DOI 10.2337/db16-1212; Wanders D, 2016, DIABETES, V65, P1499, DOI 10.2337/db15-1324; Wanders D, 2015, BIOFACTORS, V41, P391, DOI 10.1002/biof.1240; Wolfson RL, 2017, CELL METAB, V26, P301, DOI 10.1016/j.cmet.2017.07.001	52	41	41	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3471	3482		10.1096/fj.201701211R	http://dx.doi.org/10.1096/fj.201701211R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401631	Green Published			2022-12-26	WOS:000432546000046
J	Zhang, Y; Liu, YF; Wu, LH; Fan, C; Wang, ZW; Zhang, XL; Alachkar, A; Liang, XM; Civelli, O				Zhang, Yan; Liu, Yanfang; Wu, Lehao; Fan, Chao; Wang, Zhiwei; Zhang, Xiuli; Alachkar, Amal; Liang, Xinmiao; Civelli, Olivier			Receptor-specific crosstalk between prostanoid E receptor 3 and bombesin receptor subtype 3	FASEB JOURNAL			English	Article						BRS-3 receptor; EP3 receptor; PGE2; toad skin	HORMONE SECRETAGOGUE RECEPTOR; PROTEIN-COUPLED-RECEPTORS; HAMSTER OVARY CELLS; LUNG-CANCER CELLS; AGONIST; ADENOSINE; BRS-3; MICE; ACTIVATION; MECHANISM	Bombesin receptor subtype 3 (BRS-3) is a GPCR that is expressed in the CNS, peripheral tissues, and tumors. Our understanding of BRS-3's role in physiology and pathophysiology is limited because its natural ligand is unknown. In an attempt to identify this ligand, we screened toad skin (Bufo bufo gargarizans Cantor) extracts and identified prostaglandins as putative ligands. In BRS-3-transfected human embryonic kidney (HEK) cells, we found that prostaglandins, with prostaglandin E2 (PGE2) being the most potent, fulfill the pharmacologic criteria of affinity, selectivity, and specificity to be considered as agonists to the BRS-3 receptor. However, PGE2 is unable to activate BRS-3 in different cellular environments. We speculated that EP receptors might be the cause of this cellular selectivity, and we found that EP3 is the receptor primarily responsible for the differential PGE2 effect. Consequently, we reconstituted the HEK environment in Chinese hamster ovary (CHO) cells and found that BRS-3 and EP3 interact to potentiate PGE2 signaling. This potentiating effect is receptor specific, and it occurs only when BRS-3 is paired to EP3. Our study represents an example of functional crosstalk between two distantly related GPCRs and may be of clinical importance for BRS-3-targeted therapies.	[Zhang, Yan; Wu, Lehao; Fan, Chao] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai, Peoples R China; [Liu, Yanfang; Zhang, Xiuli; Liang, Xinmiao] Chinese Acad Sci, Dalian Inst Chem Phys, Key Lab Nat Med Liaoning Prov, Key Lab Separat Sci Analyt Chem, Dalian 116023, Peoples R China; [Wang, Zhiwei; Alachkar, Amal; Civelli, Olivier] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; University of California System; University of California Irvine	Liang, XM (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, Key Lab Nat Med Liaoning Prov, Key Lab Separat Sci Analyt Chem, Dalian 116023, Peoples R China.; Civelli, O (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.	liangxm@dicp.ac.cn; ocivelli@uci.edu	Civelli, Olivier/A-8392-2012	Wu, Lehao/0000-0003-0127-2609	U.S. National Institutes of Health (NIH) National Institute on Drug Abuse [DA024746]; Eric L. and Lila D. Nelson Chair in Neuropharmacology; National Natural Science Foundation of China Key Program [21135005, 81402806]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024746] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Drug Abuse; Eric L. and Lila D. Nelson Chair in Neuropharmacology; National Natural Science Foundation of China Key Program(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by U.S. National Institutes of Health (NIH) National Institute on Drug Abuse Grant DA024746, and the Eric L. and Lila D. Nelson Chair in Neuropharmacology (to O.C.). This work was also supported by the National Natural Science Foundation of China Key Program 21135005 (to X.L.), and Grant 81402806 (to Y.Z.). The authors declare no conflicts of interest.	ANASTASI A, 1971, EXPERIENTIA, V27, P166, DOI 10.1007/BF02145873; Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Carreira MC, 2006, J ENDOCRINOL, V191, P147, DOI 10.1677/joe.1.06714; Civelli O, 2001, TRENDS NEUROSCI, V24, P230, DOI 10.1016/S0166-2236(00)01763-X; FATHI Z, 1993, J BIOL CHEM, V268, P5979; Feng Y, 2011, ENDOCRINOLOGY, V152, P4106, DOI 10.1210/en.2011-1440; Gbahou F, 2010, J PHARMACOL EXP THER, V333, P51, DOI 10.1124/jpet.109.162131; Guan XM, 2011, J PHARMACOL EXP THER, V336, P356, DOI 10.1124/jpet.110.174763; Guan XM, 2010, CELL METAB, V11, P101, DOI 10.1016/j.cmet.2009.12.008; Hermansson NO, 2007, ACTA PHYSIOL, V190, P77, DOI 10.1111/j.1365-201X.2007.01691.x; Hou X, 2006, LUNG CANCER, V54, P143, DOI 10.1016/j.lungcan.2006.08.005; Insel PA, 2005, BIOCHEM SOC T, V33, P1131, DOI 10.1042/BST0331131; IRIE A, 1994, BIOCHEM BIOPH RES CO, V204, P303, DOI 10.1006/bbrc.1994.2460; Jensen RT, 2008, PHARMACOL REV, V60, P1, DOI 10.1124/pr.107.07108; Johansson S, 2005, BIOCHEM PHARMACOL, V70, P598, DOI 10.1016/j.bcp.2005.05.023; Jugus MJ, 2009, BRIT J PHARMACOL, V158, P372, DOI 10.1111/j.1476-5381.2009.00275.x; Kiriyama M, 1997, BRIT J PHARMACOL, V122, P217, DOI 10.1038/sj.bjp.0701367; Ladenheim EE, 2008, ENDOCRINOLOGY, V149, P971, DOI 10.1210/en.2007-1319; Lateef DM, 2016, AM J PHYSIOL-HEART C, V310, pH891, DOI 10.1152/ajpheart.00963.2015; Lateef DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142637; Mo CH, 2017, J MOL ENDOCRINOL, V59, P61, DOI [10.1530/JME-17-0020, 10.1530/jme-17-0020]; OhkiHamazaki H, 1997, NATURE, V390, P165, DOI 10.1038/36568; Olmo IG, 2016, MOL PHARMACOL, V90, P609, DOI 10.1124/mol.116.104372; Pera T, 2014, CURR OPIN PHARMACOL, V16, P72, DOI 10.1016/j.coph.2014.03.005; Porcher C, 2005, CELL TISSUE RES, V320, P21, DOI 10.1007/s00441-004-1032-1; Quitterer U, 1999, P NATL ACAD SCI USA, V96, P10626, DOI 10.1073/pnas.96.19.10626; Reitman ML, 2012, J CLIN PHARMACOL, V52, P1306, DOI 10.1177/0091270011419854; Rives ML, 2009, EMBO J, V28, P2195, DOI 10.1038/emboj.2009.177; Rozenfeld R, 2011, EMBO J, V30, P2350, DOI 10.1038/emboj.2011.139; Sabourin T, 2002, MOL PHARMACOL, V61, P546, DOI 10.1124/mol.61.3.546; Sano H, 2004, GENOMICS, V84, P139, DOI 10.1016/j.ygeno.2004.01.008; Smith RG, 2000, BIOCHEM BIOPH RES CO, V276, P1306, DOI 10.1006/bbrc.2000.3610; TAKANO S, 1978, PROSTAGLANDINS, V15, P485, DOI 10.1016/0090-6980(78)90132-6; Tan YR, 2006, PEPTIDES, V27, P1852, DOI 10.1016/j.peptides.2005.12.012; ToiScott M, 1996, LUNG CANCER-J IASLC, V15, P341, DOI 10.1016/0169-5002(95)00597-8; Tullin S, 2000, ENDOCRINOLOGY, V141, P3397, DOI 10.1210/en.141.9.3397; Xiao CY, 2016, TRENDS ENDOCRIN MET, V27, P603, DOI 10.1016/j.tem.2016.03.003; Yamada K, 2002, MOL PSYCHIATR, V7, P113, DOI 10.1038/sj/mp/4000974; Zhang L, 2009, BIOCHEM BIOPH RES CO, V387, P283, DOI 10.1016/j.bbrc.2009.07.006; Zhang Y, 2014, CURR BIOL, V24, P117, DOI 10.1016/j.cub.2013.11.039; Zhou B, 2015, EVID-BASED COMPL ALT, V2015	41	6	6	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3184	3192		10.1096/fj.201700337RR	http://dx.doi.org/10.1096/fj.201700337RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401613	Green Published			2022-12-26	WOS:000432546000024
J	Partovi, SE; Mus, F; Gutknecht, AE; Martinez, HA; Tripet, BP; Lange, BM; DuBois, JL; Peters, JW				Partovi, Sarah E.; Mus, Florence; Gutknecht, Andrew E.; Martinez, Hunter A.; Tripet, Brian P.; Lange, Bernd Markus; DuBois, Jennifer L.; Peters, John W.			Coenzyme M biosynthesis in bacteria involves phosphate elimination by a functionally distinct member of the aspartase/fumarase superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosynthesis; enzyme purification; bacteria; bacterial metabolism; NMR; MS; coenzyme M	XANTHOBACTER STRAIN PY2; M 2-MERCAPTOETHANESULFONIC ACID; SITE-DIRECTED MUTAGENESIS; ASPARTATE AMMONIA-LYASE; ADENYLOSUCCINATE LYASE; ESCHERICHIA-COLI; ARGININOSUCCINATE LYASE; ALKALINE-PHOSPHATASE; PHOSPHOSULFOLACTATE SYNTHASE; METHANOBACTERIUM-RUMINANTIUM	For nearly 30 years, coenzyme M (CoM) was assumed to be present solely in methanogenic archaea. In the late 1990s, CoM was reported to play a role in bacterial propene metabolism, but no biosynthetic pathway for CoM has yet been identified in bacteria. Here, using bioinformatics and proteomic approaches in the metabolically versatile bacterium Xanthobacter autotrophicus Py2, we identified four putative CoM biosynthetic enzymes encoded by the xcbB1, C1, D1, and E1 genes. Only XcbB1 was homologous to a known CoM biosynthetic enzyme (ComA), indicating that CoM biosynthesis in bacteria involves enzymes different from those in archaea. We verified that the ComA homolog produces phosphosulfolactate from phosphoenolpyruvate (PEP), demonstrating that bacterial CoM biosynthesis is initiated similarly as the phosphoenolpyruvate-dependent methanogenic archaeal pathway. The bioinformatics analysis revealed that XcbC1 and D1 are members of the aspartase/fumarase superfamily (AFS) and that XcbE1 is a pyridoxal 5-phosphate-containing enzyme with homology to d-cysteine desulfhydrases. Known AFS members catalyze -elimination reactions of succinyl-containing substrates, yielding fumarate as the common unsaturated elimination product. Unexpectedly, we found that XcbC1 catalyzes -elimination on phosphosulfolactate, yielding inorganic phosphate and a novel metabolite, sulfoacrylic acid. Phosphate-releasing -elimination reactions are unprecedented among the AFS, indicating that XcbC1 is an unusual phosphatase. Direct demonstration of phosphosulfolactate synthase activity for XcbB1 and phosphate -elimination activity for XcbC1 strengthened their hypothetical assignment to a CoM biosynthetic pathway and suggested functions also for XcbD1 and E1. Our results represent a critical first step toward elucidating the CoM pathway in bacteria.	[Partovi, Sarah E.; Gutknecht, Andrew E.; Martinez, Hunter A.; Tripet, Brian P.; DuBois, Jennifer L.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Mus, Florence; Lange, Bernd Markus; Peters, John W.] Washington State Univ, Inst Biol Chem, 287 Clark Hall,100 Dairy Rd, Pullman, WA 99164 USA; [Lange, Bernd Markus] Washington State Univ, MJ Murdock Metabol Lab, Pullman, WA 99164 USA	Montana State University System; Montana State University Bozeman; Washington State University; Washington State University	Peters, JW (corresponding author), Washington State Univ, Inst Biol Chem, 287 Clark Hall,100 Dairy Rd, Pullman, WA 99164 USA.	jw.peters@wsu.edu		Mus, Florence/0000-0002-1655-1267	National Institutes of Health Shared Instrumentation Grant Program [1S10RR13878, 1S10RR026659]; National Science Foundation MRI Program [DBI-1532078]; Murdock Charitable Trust; Montana State University's Vice President for Research Economic Development's office; NIGMS, National Institutes of Health [P20GM103474]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103474] Funding Source: NIH RePORTER	National Institutes of Health Shared Instrumentation Grant Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation MRI Program(National Science Foundation (NSF)); Murdock Charitable Trust; Montana State University's Vice President for Research Economic Development's office; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support for the NMR instrument console upgrades and Montana State University's NMR Center has been provided by the National Institutes of Health Shared Instrumentation Grant Program (1S10RR13878 and 1S10RR026659), the National Science Foundation MRI Program (DBI-1532078), the Murdock Charitable Trust, and Montana State University's Vice President for Research Economic Development's office. The Proteomics, Metabolomics, and Mass Spectrometry facility at Montana State University received support from the Murdock Charitable Trust and NIGMS, National Institutes of Health (P20GM103474). We thank Dr. George Gauss for technical support and helpful suggestions. We also thank Garrett Moraski and Dr. Robert White for insightful advice.	Allen JR, 1999, P NATL ACAD SCI USA, V96, P8432, DOI 10.1073/pnas.96.15.8432; Allen JR, 1999, BIOCHEMISTRY-US, V38, P247, DOI 10.1021/bi982114h; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; BALCH WE, 1979, J BACTERIOL, V137, P256, DOI 10.1128/JB.137.1.256-263.1979; Banerjee S, 2014, FEBS J, V281, P1642, DOI 10.1111/febs.12730; BESSEY OA, 1946, J BIOL CHEM, V164, P321; Bhaumik P, 2004, ACTA CRYSTALLOGR D, V60, P1964, DOI 10.1107/S0907444904021912; Broberg CA, 2010, ARCH MICROBIOL, V192, P945, DOI 10.1007/s00203-010-0623-3; Brosius JL, 2002, BIOCHEMISTRY-US, V41, P2217, DOI 10.1021/bi011998t; Bull H, 2002, J CLIN PATHOL-MOL PA, V55, P65; Bulusu V, 2009, BBA-PROTEINS PROTEOM, V1794, P642, DOI 10.1016/j.bbapap.2008.11.021; Clark DD, 2000, BIOCHEMISTRY-US, V39, P1294, DOI 10.1021/bi992282p; Coleman NV, 2002, APPL ENVIRON MICROB, V68, P6162, DOI 10.1128/AEM.68.12.6162-6171.2002; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; ENSIGN SA, 1992, APPL ENVIRON MICROB, V58, P3038, DOI 10.1128/AEM.58.9.3038-3046.1992; Ensign SA, 2001, BIOCHEMISTRY-US, V40, P5845, DOI 10.1021/bi015523d; FARRELL K, 1987, BIOCHEM J, V242, P261, DOI 10.1042/bj2420261; Fibriansah G, 2011, BIOCHEMISTRY-US, V50, P6053, DOI 10.1021/bi200497y; Fiske CH, 1925, J BIOL CHEM, V66, P375; Fyfe PK, 2010, ACTA CRYSTALLOGR D, V66, P881, DOI 10.1107/S0907444910020081; GARRARD LJ, 1985, J BIOL CHEM, V260, P5548; Graham DE, 2009, BIOCHEM J, V424, P467, DOI 10.1042/BJ20090999; Graham DE, 2002, J BIOL CHEM, V277, P13421, DOI 10.1074/jbc.M201011200; Graham DE, 2001, EUR J BIOCHEM, V268, P5176, DOI 10.1046/j.0014-2956.2001.02451.x; Graupner M, 2000, J BACTERIOL, V182, P3688, DOI 10.1128/JB.182.13.3688-3692.2000; Graupner M, 2000, J BACTERIOL, V182, P4862, DOI 10.1128/JB.182.17.4862-4867.2000; Ke ZH, 2011, J AM CHEM SOC, V133, P11103, DOI 10.1021/ja204378q; KELLER JW, 1990, J BIOL CHEM, V265, P5531; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; Kofoed MA, 2011, J BACTERIOL, V193, P4904, DOI 10.1128/JB.05231-11; Kozlov G, 2009, ACTA CRYSTALLOGR F, V65, P857, DOI 10.1107/S1744309109029674; Krishnakumar AM, 2008, MICROBIOL MOL BIOL R, V72, P445, DOI 10.1128/MMBR.00005-08; Krum JG, 2002, BIOCHEMISTRY-US, V41, P5005, DOI 10.1021/bi0255221; Krum JG, 2001, J BACTERIOL, V183, P2172, DOI 10.1128/JB.183.7.2172-2177.2001; Krum JG, 2000, J BACTERIOL, V182, P2629, DOI 10.1128/JB.182.9.2629-2634.2000; Lee TT, 1999, BIOCHEMISTRY-US, V38, P22, DOI 10.1021/bi982299s; Liu XK, 2016, APPL ENVIRON MICROB, V82, P3269, DOI 10.1128/AEM.00673-16; Mattes TE, 2005, ARCH MICROBIOL, V183, P95, DOI 10.1007/s00203-004-0749-2; MCBRIDE BC, 1971, BIOCHEMISTRY-US, V10, P2317; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; PALMER RE, 1985, J CHEM EDUC, V62, P898, DOI 10.1021/ed062p898; Pandey AS, 2011, FEBS LETT, V585, P459, DOI 10.1016/j.febslet.2010.12.035; PATEJUNAS G, 1995, EXP EYE RES, V61, P151, DOI 10.1016/S0014-4835(05)80034-X; Paul A, 2013, ACTA CRYSTALLOGR F, V69, P1422, DOI 10.1107/S1744309113031138; Sampaleanu LM, 2004, BIOCHEM J, V384, P437, DOI 10.1042/BJ20040656; Sampaleanu LM, 2001, BIOCHEMISTRY-US, V40, P2732, DOI 10.1021/bi002272k; Sharma U, 2014, INDIAN J CLIN BIOCHE, V29, P269, DOI 10.1007/s12291-013-0408-y; SIMOPOULOS TT, 1994, BIOCHEMISTRY-US, V33, P10375, DOI 10.1021/bi00200a018; Small FJ, 1997, J BIOL CHEM, V272, P24913, DOI 10.1074/jbc.272.40.24913; SMALL FJ, 1995, APPL ENVIRON MICROB, V61, P1507, DOI 10.1128/AEM.61.4.1507-1513.1995; Soutourina J, 2001, J BIOL CHEM, V276, P40864, DOI 10.1074/jbc.M102375200; Stec B, 2000, J MOL BIOL, V299, P1303, DOI 10.1006/jmbi.2000.3799; Tabaldi LA, 2007, ENVIRON EXP BOT, V59, P43, DOI 10.1016/j.envexpbot.2005.10.009; TAYLOR CD, 1974, J BACTERIOL, V120, P974, DOI 10.1128/JB.120.2.974-975.1974; Todorovic B, 2008, PLANTA, V229, P193, DOI 10.1007/s00425-008-0820-3; Toney MD, 2005, ARCH BIOCHEM BIOPHYS, V433, P279, DOI 10.1016/j.abb.2004.09.037; Toth EA, 2000, STRUCT FOLD DES, V8, P163, DOI 10.1016/S0969-2126(00)00092-7; Tsai M, 2007, J MOL BIOL, V370, P541, DOI 10.1016/j.jmb.2007.04.052; VANGINKEL CG, 1987, APPL ENVIRON MICROB, V53, P2903, DOI 10.1128/AEM.53.12.2903-2907.1987; Veetil VP, 2012, BIOCHEMISTRY-US, V51, P4237, DOI 10.1021/bi300430j; Veetil VP, 2009, FEBS J, V276, P2994, DOI 10.1111/j.1742-4658.2009.07015.x; Viola RE, 2000, ADV ENZYMOL RAMB, V74, P295; VISHNIAC W, 1957, BACTERIOL REV, V21, P195, DOI 10.1128/MMBR.21.3.195-213.1957; WATANABE Y, 1956, J BIOCHEM-TOKYO, V43, P283, DOI 10.1093/oxfordjournals.jbchem.a126629; Westphal A. H., 2013, EUR J BIOCHEM, V257, P160; WHITE RH, 1988, BIOCHEMISTRY-US, V27, P7458, DOI 10.1021/bi00419a043; WHITE RH, 1986, BIOCHEMISTRY-US, V25, P5304, DOI 10.1021/bi00366a047; WHITE RH, 1985, BIOCHEMISTRY-US, V24, P6487, DOI 10.1021/bi00344a027; WIEGANT WM, 1980, J GEN MICROBIOL, V120, P325; Wise EL, 2003, J BIOL CHEM, V278, P45858, DOI 10.1074/jbc.M307486200; Wolfe R. S., 1990, MOL BASIS BACTERIAL, P1; WOODS SA, 1988, BIOCHIM BIOPHYS ACTA, V954, P14, DOI 10.1016/0167-4838(88)90050-7; Yang J, 2004, BIOCHEMISTRY-US, V43, P10424, DOI 10.1021/bi036205c; YOON MY, 1995, ARCH BIOCHEM BIOPHYS, V320, P115, DOI 10.1006/abbi.1995.1348; Zhu YQ, 2007, MOL CELL, V28, P899, DOI 10.1016/j.molcel.2007.11.011	75	7	8	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5236	5246		10.1074/jbc.RA117.001234	http://dx.doi.org/10.1074/jbc.RA117.001234			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29414784	Green Published, hybrid			2022-12-26	WOS:000429409300028
J	Su, ZH; Zhang, YQ; Liao, BJ; Zhong, XF; Chen, X; Wang, HT; Guo, YP; Shan, YL; Wang, LH; Pan, GJ				Su, Zhenghui; Zhang, Yanqi; Liao, Baojian; Zhong, Xiaofen; Chen, Xin; Wang, Haitao; Guo, Yiping; Shan, Yongli; Wang, Lihui; Pan, Guangjin			Antagonism between the transcription factors NANOG and OTX2 specifies rostral or caudal cell fate during neural patterning transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; VERTEBRATE NERVOUS-SYSTEM; HUMAN ES; SUBTYPE SPECIFICATION; PLURIPOTENCY; DIFFERENTIATION; PROGENITORS; INDUCTION; NEURONS; INHIBITION	During neurogenesis, neural patterning is a critical step during which neural progenitor cells differentiate into neurons with distinct functions. However, the molecular determinants that regulate neural patterning remain poorly understood. Here we optimized the "dual SMAD inhibition" method to specifically promote differentiation of human pluripotent stem cells (hPSCs) into forebrain and hindbrain neural progenitor cells along the rostral-caudal axis. We report that neural patterning determination occurs at the very early stage in this differentiation. Undifferentiated hPSCs expressed basal levels of the transcription factor orthodenticle homeobox 2 (OTX2) that dominantly drove hPSCs into the "default" rostral fate at the beginning of differentiation. Inhibition of glycogen synthase kinase 3 beta (GSK3 beta) through CHIR99021 application sustained transient expression of the transcription factor NANOG at early differentiation stages through Wnt signaling. Wnt signaling and NANOG antagonized OTX2 and, in the later stages of differentiation, switched the default rostral cell fate to the caudal one. Our findings have uncovered a mutual antagonism between NANOG and OTX2 underlying cell fate decisions during neural patterning, critical for the regulation of early neural development in humans.	[Su, Zhenghui; Wang, Haitao] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Su, Zhenghui; Zhang, Yanqi; Liao, Baojian; Zhong, Xiaofen; Guo, Yiping; Shan, Yongli; Pan, Guangjin] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Su, Zhenghui; Liao, Baojian; Pan, Guangjin] Hefei Inst Stem Cell & Regenerat Med, Hefei 230088, Anhui, Peoples R China; [Chen, Xin] Guangdong Univ Technol, Sch Automat, Guangzhou 510006, Guangdong, Peoples R China; [Wang, Lihui] Jinan Univ, Med Coll, Dept Pathol, Guangzhou 510632, Guangdong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Guangdong University of Technology; Jinan University	Pan, GJ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, 190 Kaiyuan Ave,Sci Pk, Guangzhou 510530, Guangdong, Peoples R China.	pan_guangjin@gibh.ac.cn	Su, Zhenghui/ABB-9503-2021; Liao, Baojian/AAI-6286-2021; Wang, Haitao/GYV-1262-2022	Wang, Haitao/0000-0002-2436-113X; Pan, Guangjin/0000-0002-2378-7198; Zhang, Yanqi/0000-0001-6896-8657	National Key Research and Development Program of China, Stem Cell and Translational Research [2017YFA0102601]; Frontier and Key Technology Innovation Special Grants from the Department of Science and Technology of Guangdong Province [2014B020225006, 2014B020225002, 2014B050504008, 2015B020228003, 2016B030230002, 2016B030229008]; Natural Science Foundation of Guangdong Province, China [2016A030313167]; National Basic Research Program of China, 973 Program of China [2015CB964901]; National Natural Science Foundation of China [31371514, 31421004]; Cooperation Grants of the Natural Science Foundation of Guangdong Province [2014A030313801, 2014A030312012, 2015A030310229]; Science and Information Technology of Guangzhou Key Project [201508020258, 201506010092, 2015A030310254]; Youth Innovation Promotion Association of the Chinese Academy of Sciences [2015293]; "Hundred Talents Program" of the Chinese Academy of Science; Science and Technology Planning Project of Guangdong Province, China [2014B030301058]; Guangdong Province Special Program for Elite Scientists in Science and Technology Innovation [2014TQ01R746, 2015TX01R203]	National Key Research and Development Program of China, Stem Cell and Translational Research; Frontier and Key Technology Innovation Special Grants from the Department of Science and Technology of Guangdong Province; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); National Basic Research Program of China, 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cooperation Grants of the Natural Science Foundation of Guangdong Province; Science and Information Technology of Guangzhou Key Project; Youth Innovation Promotion Association of the Chinese Academy of Sciences; "Hundred Talents Program" of the Chinese Academy of Science(Chinese Academy of Sciences); Science and Technology Planning Project of Guangdong Province, China; Guangdong Province Special Program for Elite Scientists in Science and Technology Innovation	This work was supported by the National Key Research and Development Program of China, Stem Cell and Translational Research (2017YFA0102601); Frontier and Key Technology Innovation Special Grants from the Department of Science and Technology of Guangdong Province (2014B020225006, 2014B020225002, 2014B050504008, 2015B020228003, 2016B030230002, and 2016B030229008); the Natural Science Foundation of Guangdong Province, China (2016A030313167); the National Basic Research Program of China, 973 Program of China (2015CB964901); the National Natural Science Foundation of China (31371514 and 31421004); Cooperation Grants of the Natural Science Foundation of Guangdong Province (2014A030313801, 2014A030312012, and 2015A030310229); Science and Information Technology of Guangzhou Key Project (201508020258, 201506010092, and 2015A030310254); the Youth Innovation Promotion Association of the Chinese Academy of Sciences (2015293); the "Hundred Talents Program" of the Chinese Academy of Science (to X.Z.); the Science and Technology Planning Project of Guangdong Province, China (2014B030301058); and the Guangdong Province Special Program for Elite Scientists in Science and Technology Innovation (2014TQ01R746 to B.L. and 2015TX01R203 to G.P.). The authors declare that they have no conflicts of interest with the contents of this article.	Acampora D, 2016, CELL REP, V15, P2651, DOI 10.1016/j.celrep.2016.05.041; Andoniadou CL, 2013, CELL MOL LIFE SCI, V70, P3739, DOI 10.1007/s00018-013-1269-5; Becker CG, 2015, DEVELOPMENT, V142, P811, DOI 10.1242/dev.121053; Bier E, 2015, SCIENCE, V348, DOI 10.1126/science.aaa5838; Carletti B, 2008, NEUROSCIENTIST, V14, P91, DOI 10.1177/1073858407304629; Caronia-Brown G, 2016, NEURAL DEV, V11, DOI 10.1186/s13064-016-0065-y; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Du ZW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7626; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Funa NS, 2015, CELL STEM CELL, V16, P639, DOI 10.1016/j.stem.2015.03.008; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Henrique D, 2015, DEVELOPMENT, V142, P2864, DOI 10.1242/dev.119768; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kelava I, 2016, CELL STEM CELL, V18, P736, DOI 10.1016/j.stem.2016.05.022; Kicheva A, 2015, TRENDS CELL BIOL, V25, P579, DOI 10.1016/j.tcb.2015.07.006; Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877; LaVaute TM, 2009, STEM CELLS, V27, P1741, DOI 10.1002/stem.99; Leung AW, 2016, DEVELOPMENT, V143, P398, DOI 10.1242/dev.130849; Li JYH, 2001, DEVELOPMENT, V128, P4979; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Lupo G, 2014, CELL MOL LIFE SCI, V71, P2917, DOI 10.1007/s00018-014-1596-1; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Maury Y, 2015, NAT BIOTECHNOL, V33, P89, DOI 10.1038/nbt.3049; Osorno R, 2012, DEVELOPMENT, V139, P2288, DOI 10.1242/dev.078071; Ozair MZ, 2013, STEM CELLS, V31, P35, DOI 10.1002/stem.1246; Pere EM, 2014, EXP CELL RES, V321, P25, DOI 10.1016/j.yexcr.2013.11.018; Sanchez-Arrones L, 2009, DEV BIOL, V335, P43, DOI 10.1016/j.ydbio.2009.08.012; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Stern CD, 2006, INT J DEV BIOL, V50, P3, DOI 10.1387/ijdb.052095cs; Sunmonu NA, 2011, DEVELOPMENT, V138, P725, DOI 10.1242/dev.055665; Surmacz B, 2012, STEM CELLS, V30, P1875, DOI 10.1002/stem.1166; Tao YL, 2016, CELL STEM CELL, V19, P573, DOI 10.1016/j.stem.2016.10.015; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Xue YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070573; Yaguchi J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006001; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang SC, 2006, BRAIN PATHOL, V16, P132, DOI 10.1111/j.1750-3639.2006.00008.x; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhou SL, 2016, DIFFERENTIATION, V92, P183, DOI 10.1016/j.diff.2016.06.002; Zirra A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/8291260	56	8	9	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4445	4455		10.1074/jbc.M117.815449	http://dx.doi.org/10.1074/jbc.M117.815449			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29386354	Green Published, hybrid			2022-12-26	WOS:000428204300016
J	Lei, L; Bandola-Simon, J; Roche, PA				Lei, Lei; Bandola-Simon, Joanna; Roche, Paul A.			Ubiquitin-conjugating enzyme E2 D1 (Ube2D1) mediates lysine-independent ubiquitination of the E3 ubiquitin ligase March-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; DENDRITIC CELLS; ANTIGEN PRESENTATION; DOWN-REGULATION; PROTEIN; DEGRADATION; UBIQUITYLATION; ACTIVATION; MECHANISMS; RESIDUES	March-I is a membrane-bound E3 ubiquitin ligase belonging to the membrane-associated RING-CH (March) family. March-I ubiquitinates and down-regulates the expression of major histocompatibility complex (MHC) class II and cluster of differentiation 86 (CD86) in antigen-presenting cells. March-I expression is regulated both transcriptionally and posttranslationally, and it has been reported that March-I is ubiquitinated and that this ubiquitination contributes to March-I turnover. However, the molecular mechanism regulating March-I ubiquitination and the importance of March-I's E3 ligase activity for March-I ubiquitination are not fully understood. Here we confirmed that, although March-I is ubiquitinated, it is not ubiquitinated on a lysine residue, as a lysine-less March-I variant was ubiquitinated similarly as wildtype March-I. We found that March-I E3 ligase activity is not required for its ubiquitination and does not regulate March-I protein expression, suggesting that March-I does not undergo autoubiquitination. Knocking down ubiquitin- conjugating enzyme E2 D1 (Ube2D1) impaired March-I ubiquitination, increased March-I expression, and enhanced March-I-dependent down-regulation of MHC-II proteins. Taken together, our results suggest that March-I undergoes lysine-independent ubiquitination by an as yet unidentified E3 ubiquitin ligase that, together with Ube2D1, regulates March-I expression.	[Lei, Lei; Bandola-Simon, Joanna; Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Roche, PA (corresponding author), NIH, Bldg 10,Rm 3N103, Bethesda, MD 20892 USA.	paul.roche@nih.gov		Roche, Paul/0000-0002-8949-9172	Intramural Research Program of the National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC009404, ZIABC011033] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baravalle G, 2011, J IMMUNOL, V187, P2966, DOI 10.4049/jimmunol.1101643; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bourgeois-Daigneault MC, 2013, J CELL SCI, V126, P989, DOI 10.1242/jcs.117804; Bourgeois-Daigneault MC, 2012, J IMMUNOL, V188, P4959, DOI 10.4049/jimmunol.1102708; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Callis Judy, 2014, Arabidopsis Book, V12, pe0174, DOI 10.1199/tab.0174; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Furuta K, 2013, P NATL ACAD SCI USA, V110, P20188, DOI 10.1073/pnas.1312994110; Jabbour M, 2009, J IMMUNOL, V183, P6500, DOI 10.4049/jimmunol.0901521; Khandelwal S, 2010, J BIOL CHEM, V285, P35303, DOI 10.1074/jbc.M110.147793; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; McDowell GS, 2013, INT J BIOCHEM CELL B, V45, P1833, DOI 10.1016/j.biocel.2013.05.026; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Mittal SK, 2015, J BIOL CHEM, V290, P27158, DOI 10.1074/jbc.M115.682708; Nathan JA, 2008, TRAFFIC, V9, P1130, DOI 10.1111/j.1600-0854.2008.00747.x; Oh J, 2013, J EXP MED, V210, P1069, DOI 10.1084/jem.20122695; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Walseng E, 2010, J BIOL CHEM, V285, P41749, DOI 10.1074/jbc.M110.157586; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780	31	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3904	3912		10.1074/jbc.RA117.001322	http://dx.doi.org/10.1074/jbc.RA117.001322			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29414787	Green Published, hybrid			2022-12-26	WOS:000427587500005
J	Carranza, S; Xipell, M; Tarroso, P; Gardner, A; Arnold, EN; Robinson, MD; Simo-Riudalbas, M; Vasconcelos, R; de Pous, P; Amat, F; Smid, J; Sindaco, R; Metallinou, M; Els, J; Pleguezuelos, JM; Machado, L; Donaire, D; Martinez, G; Garcia-Porta, J; Mazuch, T; Wilms, T; Gebhart, J; Aznar, J; Gallego, J; Zwanzig, BM; Fernandez-Guiberteau, D; Papenfuss, T; Al Saadi, S; Alghafri, A; Khalifa, S; Al Farqani, H; Bilal, SB; Alazri, IS; Al Adhoobi, AS; Al Omairi, ZS; Al Shariani, M; Al Kiyumi, A; Al Sariri, T; Al Shukaili, AS; Al Akhzami, SN				Carranza, Salvador; Xipell, Meritxell; Tarroso, Pedro; Gardner, Andrew; Arnold, Edwin Nicholas; Robinson, Michael D.; Simo-Riudalbas, Marc; Vasconcelos, Raquel; de Pous, Philip; Amat, Felix; Smid, Jiri; Sindaco, Roberto; Metallinou, Margarita; Els, Johannes; Manuel Pleguezuelos, Juan; Machado, Luis; Donaire, David; Martinez, Gabriel; Garcia-Porta, Joan; Mazuch, Tomas; Wilms, Thomas; Gebhart, Juergen; Aznar, Javier; Gallego, Javier; Zwanzig, Bernd-Michael; Fernandez-Guiberteau, Daniel; Papenfuss, Theodore; Al Saadi, Saleh; Alghafri, Ali; Khalifa, Sultan; Al Farqani, Hamed; Bilal, Salim Bait; Alazri, Iman Sulaiman; Al Adhoobi, Aziza Saud; Al Omairi, Zeyana Salim; Al Shariani, Mohammed; Al Kiyumi, Ali; Al Sariri, Thuraya; Al Shukaili, Ahmed Said; Al Akhzami, Suleiman Nasser			Diversity, distribution and conservation of the terrestrial reptiles of Oman (Sauropsida, Squamata)	PLOS ONE			English	Article							SULTANATE-OF-OMAN; PRISTURUS-RUPESTRIS; NORTH-AFRICA; BIOGEOGRAPHY; GEKKONIDAE; TAXONOMY; SYSTEMATICS; LIZARDS; ARABIA; BIODIVERSITY	In the present work, we use an exceptional database including 5,359 records of 101 species of Oman's terrestrial reptiles together with spatial tools to infer the spatial patterns of species richness and endemicity, to infer the habitat preference of each species and to better define conservation priorities, with especial focus on the effectiveness of the protected areas in preserving this unique arid fauna. Our results indicate that the sampling effort is not only remarkable from a taxonomic point of view, with multiple observations for most species, but also for the spatial coverage achieved. The observations are distributed almost continuously across the two-dimensional climatic space of Oman defined by the mean annual temperature and the total annual precipitation and across the Principal Component Analysis (PCA) of the multivariate climatic space and are well represented within 17 out of the 20 climatic clusters grouping 10% of the explained climatic variance defined by PC1 and PC2. Species richness is highest in the Hajar and Dhofar Mountains, two of the most biodiverse areas of the Arabian Peninsula, and endemic species richness is greatest in the Jebel Akhdar, the highest part of the Hajar Mountains. Oman's 22 protected areas cover only 3.91% of the country, including within their limits 63.37% of terrestrial reptiles and 50% of all endemics. Our analyses show that large areas of the climatic space of Oman lie outside protected areas and that seven of the 20 climatic clusters are not protected at all. The results of the gap analysis indicate that most of the species are below the conservation target of 17% or even the less restrictive 12% of their total area within a protected area in order to be considered adequately protected. Therefore, an evaluation of the coverage of the current network of protected areas and the identification of priority protected areas for reptiles using reserve design algorithms are urgently needed. Our study also shows that more than half of the species are still pending of a definitive evaluation by the International Union for Conservation of Nature (IUCN).	[Carranza, Salvador; Xipell, Meritxell; Tarroso, Pedro; Simo-Riudalbas, Marc; Vasconcelos, Raquel; de Pous, Philip; Metallinou, Margarita; Machado, Luis; Garcia-Porta, Joan] Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Passeig Maritim de la Barceloneta, Barcelona, Spain; [Tarroso, Pedro; Vasconcelos, Raquel; Machado, Luis] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, InBio Lab Associado, CIBIO, Vairao, Portugal; [Gardner, Andrew] Univ Western Australia, Sch Mol Sci, Crawley, WA, Australia; [Arnold, Edwin Nicholas] Nat Hist Museum, Dept Zool, London, England; [Robinson, Michael D.] Sultan Qaboos Univ, Coll Sci, Dept Biol, Al Khod Muscat, Oman; [Amat, Felix] Museu Granollers Ciencies Nat, Area Herpetol, Palaudaries, Granollers, Spain; [Smid, Jiri] Natl Museum, Dept Zool, Prague, Czech Republic; [Sindaco, Roberto] Museo Civ Storia Nat, Carmagnola, TO, Italy; [Els, Johannes] Environm & Protected Areas Author, Breeding Ctr Endangered Arabian Wildlife, Sharjah, U Arab Emirates; [Manuel Pleguezuelos, Juan] Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain; [Machado, Luis] Univ Porto, Fac Ciencias, Dept Biol, Oporto, Portugal; [Donaire, David] Asociac Herpetol Fretum Gaditanum, Mar Egeo, Jerez De La Fra, Spain; [Wilms, Thomas] Allwetterzoo Munster, Munster, Germany; [Fernandez-Guiberteau, Daniel] Escola Nat Parets, C Galende, Parets Del Vall, Spain; [Papenfuss, Theodore] Univ Calif Berkeley, Museum Vertebrate Zool, Dept Integrat Biol, Berkeley, CA 94720 USA; [Al Saadi, Saleh; Alghafri, Ali; Khalifa, Sultan; Al Farqani, Hamed; Bilal, Salim Bait; Alazri, Iman Sulaiman; Al Adhoobi, Aziza Saud; Al Omairi, Zeyana Salim; Al Shariani, Mohammed; Al Kiyumi, Ali; Al Sariri, Thuraya; Al Shukaili, Ahmed Said; Al Akhzami, Suleiman Nasser] Minist Environm & Climate Affairs, Muscat, Oman	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Universidade do Porto; University of Western Australia; Natural History Museum London; Sultan Qaboos University; National Museum; University of Granada; Universidade do Porto; University of California System; University of California Berkeley	Carranza, S (corresponding author), Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Passeig Maritim de la Barceloneta, Barcelona, Spain.	salvador.carranza@ibe.upf-csic.es	Smid, Jiri/N-1616-2013; Machado, Luis/D-2732-2015; Tarroso, Pedro/I-3023-2012; Carranza, Salvador/A-2126-2012; Vasconcelos, Raquel/H-5524-2012; Garcia-Porta, Joan/AAA-8771-2020	Smid, Jiri/0000-0002-0309-209X; Machado, Luis/0000-0002-8637-5043; Tarroso, Pedro/0000-0002-2694-1170; Carranza, Salvador/0000-0002-5378-3008; Vasconcelos, Raquel/0000-0002-4717-9429; Al Adhoobi, Aziza S/0000-0002-7326-8011; Sindaco, Roberto/0000-0002-2590-9603; Els, Johannes/0000-0002-5614-1887; Garcia-Porta, Joan/0000-0003-4032-9495	Ministerio de Economia y Competitividad, Spain (FEDER) [CGL2012-36970, CGL2015-70390-P]; project Field study for the conservation of reptiles in Oman, Ministry of Environment and Climate Affairs, Oman [22412027]; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya [2014-SGR-1532]; FPI grant from the Ministerio de Economia y Competitividad, Spain [BES-2013-064248]; Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BPD/79913/2011, SFRH/BPD/93473/2013, SFRH/BD/89820/2012]; Programa Operacional Potencial Humano (POPH) - Quadro de Referencia Estrategico Nacional (QREN) from the European Social Fund; Portuguese Ministerio da Educacao e Ciencia	Ministerio de Economia y Competitividad, Spain (FEDER)(Spanish Government); project Field study for the conservation of reptiles in Oman, Ministry of Environment and Climate Affairs, Oman; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya); FPI grant from the Ministerio de Economia y Competitividad, Spain; Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional Potencial Humano (POPH) - Quadro de Referencia Estrategico Nacional (QREN) from the European Social Fund; Portuguese Ministerio da Educacao e Ciencia(Portuguese Foundation for Science and Technology)	This work was funded by grants CGL2012-36970, CGL2015-70390-P from the Ministerio de Economia y Competitividad, Spain (cofunded by FEDER) to SC, the project Field study for the conservation of reptiles in Oman, Ministry of Environment and Climate Affairs, Oman (Ref: 22412027) to SC and grant 2014-SGR-1532 from the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya to SC. MSR is funded by a FPI grant from the Ministerio de Economia y Competitividad, Spain (BES-2013-064248); RV, PT and LM were funded by Fundacao para a Ciencia e Tecnologia (FCT) through post-doc grants (SFRH/BPD/79913/2011) to RV, (SFRH/BPD/93473/2013) to PT and PhD grant (SFRH/BD/89820/2012) to LM, financed by Programa Operacional Potencial Humano (POPH) - Quadro de Referencia Estrategico Nacional (QREN) from the European Social Fund and Portuguese Ministerio da Educacao e Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold E.N., 1986, Fauna of Saudi Arabia, V8, P385; Arnold E.N., 1982, Fauna of Saudi Arabia, V4, P468; Arnold E.N., 1986, Fauna of Saudi Arabia, V8, P352; Arnold EN, 2009, ZOOTAXA, P1; Arnold E.N., 1980, Fauna of Saudi Arabia, V2, P368; ARNOLD E N, 1972, Zoologische Mededelingen (Leiden), V47, P111; Arnold E. N., 1980, J OMAN STUDIES SPECI, P273; Arnold E.N., 1977, J OMAN STUDIES SPECI, V1, P81; Arnold E. Nicholas, 1994, Fauna of Saudi Arabia, V14, P424; Arnold EN, 1977, J OMAN STUD SPEC REP, V1, P59; Badiane A, 2014, ZOOTAXA, V3835, P33, DOI 10.11646/zootaxa.3835.1.2; Becker R, 1988, COMPUTER SCI SERIES; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Brito JC, 2016, DIVERS DISTRIB, V22, P371, DOI 10.1111/ddi.12416; Brito JC, 2014, BIOL REV, V89, P215, DOI 10.1111/brv.12049; Buttiker W., 1980, Journal of Oman Studies Special Report, P217; Camargo A, 2010, MOL ECOL, V19, P3250, DOI 10.1111/j.1365-294X.2010.04722.x; Cantu C, 2004, BIOL CONSERV, V115, P411, DOI 10.1016/S0006-3207(03)00158-7; Carranza S., 2003, Systematics and Biodiversity, V1, P275, DOI 10.1017/S1477200003001099; Carranza S, 2000, P ROY SOC B-BIOL SCI, V267, P637, DOI 10.1098/rspb.2000.1050; Carranza S, 2014, THE TREE OF LIFE, P530; Carranza S, 2016, PEERJ, V4, DOI 10.7717/peerj.2371; Carranza S, 2012, ZOOTAXA, P1; Convention on Biological Diversity, 2010, STRAT PLAN BIOD 2011; Cox N., 2012, CONSERVATION STATUS; de Pous P, 2016, J ZOOL SYST EVOL RES, V54, P67, DOI 10.1111/jzs.12107; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; Edgell HS., 2006, ARABINA DESERTS NATU; Eriksen J, 2013, OFFICIAL LIST BIRDS; Funk VA, 2002, SYST BIOL, V51, P235, DOI 10.1080/10635150252899743; Gallagher M.D., 1980, Journal of Oman Studies Special Report, P347; Garcia-Porta J, 2017, J BIOGEOGR, V44, P1694, DOI 10.1111/jbi.12929; GARDNER AS, 1994, J HERPETOL, V28, P141, DOI 10.2307/1564612; Gardner AS., 2013, AMPHIBIANS REPTILES; Gasperetti J., 1988, Fauna of Saudi Arabia, V9, P169; GITTLEMAN JL, 1991, NATURE, V351, P524, DOI 10.1038/351524a0; Greathead DJ, 1980, J OMAN STUDIES SPECI, V2, P233; Grieco C., 2013, MONOGRAFIE SOC HERPE, VI, DOI DOI 10.1146/annurev.ecolsys.34.012103.144032; Harrison D.L., 1980, Journal of Oman Studies Special Report, P387; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoogstraal H., 1980, Journal of Oman Studies Special Report, P265; Khuroo AA, 2007, J NAT CONSERV, V15, P256, DOI 10.1016/j.jnc.2007.07.003; Kwarteng AY, 2009, INT J CLIMATOL, V29, P605, DOI 10.1002/joc.1727; Larsen T.B., 1980, Journal of Oman Studies Special Report, P153; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Mandaville J., 1977, PLANTS J OMAN STUDIE, V1, P229; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; McNeely Jeffrey A., 2002, Journal for Nature Conservation (Jena), V10, P145, DOI 10.1078/1617-1381-00015; Meiri S, 2016, BIOL CONSERV, V204, P6, DOI 10.1016/j.biocon.2016.03.009; Metallinou Margarita, 2014, Biodivers Data J, pe4011, DOI 10.3897/BDJ.2.e4011; Metallinou M, 2015, MOL PHYLOGENET EVOL, V85, P208, DOI 10.1016/j.ympev.2015.02.010; Metallinou M, 2013, ZOOTAXA, V 3745, P449, DOI 10.11646/zootaxa.3745.4.3; Morrison WR, 2009, BIOL CONSERV, V142, P3201, DOI 10.1016/j.biocon.2009.07.019; Murrell P., 2005, R GRAPHICS; Pincheira-Donoso D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059741; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Roll U, 2017, NAT ECOL EVOL, V1, P1677, DOI 10.1038/s41559-017-0332-2; Russello MA, 2005, BIOL LETT-UK, V1, P287, DOI 10.1098/rsbl.2005.0317; Sale JB, 1980, J OMAN STUDIES SPECI, V2, P17; Simo-Riudalbas M, SYST BIODIVERS; Simo-Riudalbas M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180397; Sindaco R, 2008, MONOGRAFIE SOC HERPE; Smid J, 2015, ZOOTAXA, V4033, P380, DOI 10.11646/zootaxa.4033.3.4; Smid J, 2015, SYST BIODIVERS, V13, P346, DOI 10.1080/14772000.2014.996264; Smid Jiri, 2010, Herpetology Notes, V3, P329; Tamar K, 2016, MOL PHYLOGENET EVOL, V97, P55, DOI 10.1016/j.ympev.2015.12.021; Uetz P., 2020, REPTILE DATABASE; Vasconcelos R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149985; Vasconcelos R, 2014, ZOOTAXA, V3835, P501, DOI 10.11646/zootaxa.3835.4.4; Vasconcelos R, 2012, BIOL CONSERV, V153, P276, DOI 10.1016/j.biocon.2012.04.020; Wallach V., 2014, SNAKES WORLD CATALOG; Waterston A.R., 1980, Journal of Oman Studies Special Report, P149; Wiens JJ, 2013, EVOLUTION, V67, P1715, DOI 10.1111/evo.12053; Wilson DE, 2005, MAMMAL SPECIES WORLD, V2, P745; Wiltshire E.P., 1980, Journal of Oman Studies Special Report, P187; Wright R. Gerald, 1996, P3; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	78	25	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0190389	10.1371/journal.pone.0190389	http://dx.doi.org/10.1371/journal.pone.0190389			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29414999	Green Submitted, Green Published, gold			2022-12-26	WOS:000424325300007
J	Sriver, RL; Lempert, RJ; Wikman-Svahn, P; Keller, K				Sriver, Ryan L.; Lempert, Robert J.; Wikman-Svahn, Per; Keller, Klaus			Characterizing uncertain sea-level rise projections to support investment decisions	PLOS ONE			English	Article							CLIMATE-CHANGE UNCERTAINTIES; ICE-SHEET; EXPERT JUDGMENT; FLOOD RISK; MANAGEMENT; IMPACTS; ADAPTATION	Many institutions worldwide are considering how to include uncertainty about future changes in sea-levels and storm surges into their investment decisions regarding large capital infrastructures. Here we examine how to characterize deeply uncertain climate change projections to support such decisions using Robust Decision Making analysis. We address questions regarding how to confront the potential for future changes in low probability but large impact flooding events due to changes in sea-levels and storm surges. Such extreme events can affect investments in infrastructure but have proved difficult to consider in such decisions because of the deep uncertainty surrounding them. This study utilizes Robust Decision Making methods to address two questions applied to investment decisions at the Port of Los Angeles: (1) Under what future conditions would a Port of Los Angeles decision to harden its facilities against extreme flood scenarios at the next upgrade pass a cost-benefit test, and (2) Do sea-level rise projections and other information suggest such conditions are sufficiently likely to justify such an investment? We also compare and contrast the Robust Decision Making methods with a full probabilistic analysis. These two analysis frameworks result in similar investment recommendations for different idealized future sea-level projections, but provide different information to decision makers and envision different types of engagement with stakeholders. In particular, the full probabilistic analysis begins by aggregating the best scientific information into a single set of joint probability distributions, while the Robust Decision Making analysis identifies scenarios where a decision to invest in near-term response to extreme sea-level rise passes a cost-benefit test, and then assembles scientific information of differing levels of confidence to help decision makers judge whether or not these scenarios are sufficiently likely to justify making such investments. Results highlight the highly-localized and context dependent nature of applying Robust Decision Making methods to inform investment decisions.	[Sriver, Ryan L.] Univ Illinois, Dept Atmospher Sci, Urbana, IL 61801 USA; [Lempert, Robert J.] RAND Corp, Santa Monica, CA USA; [Wikman-Svahn, Per; Keller, Klaus] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Keller, Klaus] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Keller, Klaus] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA; [Wikman-Svahn, Per] Royal Inst Technol, Dept Philosophy & Hist, Stockholm, Sweden	University of Illinois System; University of Illinois Urbana-Champaign; RAND Corporation; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Carnegie Mellon University; Royal Institute of Technology	Sriver, RL (corresponding author), Univ Illinois, Dept Atmospher Sci, Urbana, IL 61801 USA.	rsriver@illinois.edu	Keller, Klaus/A-6742-2013		National Science Foundation [SES-0345925]; Department of Energy sponsored Program on Integrated Assessment Model Development, Diagnostics and Inter-Model Comparisons (PIAMDDI); Network for Sustainable Climate Risk Management (SCRiM) under NSF cooperative agreement [GEO-1240507]; Penn State Center for Climate Risk Management; Directorate For Geosciences [1240507] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Department of Energy sponsored Program on Integrated Assessment Model Development, Diagnostics and Inter-Model Comparisons (PIAMDDI); Network for Sustainable Climate Risk Management (SCRiM) under NSF cooperative agreement; Penn State Center for Climate Risk Management; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was partially supported by the National Science Foundation through (Grant SES-0345925), as well as the Department of Energy sponsored Program on Integrated Assessment Model Development, Diagnostics and Inter-Model Comparisons (PIAMDDI), the Network for Sustainable Climate Risk Management (SCRiM) under NSF cooperative agreement GEO-1240507, and the Penn State Center for Climate Risk Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; Allison I, 2009, ANTARCT SCI, V21, P413, DOI 10.1017/S0954102009990137; Anthoff D, 2010, MITIG ADAPT STRAT GL, V15, P321, DOI 10.1007/s11027-010-9220-7; Applegate PJ, 2012, CRYOSPHERE, V6, P589, DOI 10.5194/tc-6-589-2012; Bakker AMR, 2017, CLIMATIC CHANGE, V140, P339, DOI 10.1007/s10584-016-1864-1; Bakker AMR, SEA LEVEL PROJECTION; Bamber JL, 2013, NAT CLIM CHANGE, V3, P424, DOI [10.1038/nclimate1778, 10.1038/NCLIMATE1778]; Bromirski PD, 2003, J CLIMATE, V16, P982, DOI 10.1175/1520-0442(2003)016<0982:SVATCC>2.0.CO;2; Bromirski PD, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006759; Brown C, 2012, EOS T AGU, V93, P401, DOI DOI 10.1029/2012EO410001; Bryant BP, 2010, TECHNOL FORECAST SOC, V77, P34, DOI 10.1016/j.techfore.2009.08.002; Buchanan MK, 2016, CLIMATIC CHANGE, V137, P347, DOI 10.1007/s10584-016-1664-7; Bursztyn D, 2006, J STAT PLAN INFER, V136, P1103, DOI 10.1016/j.jspi.2004.08.007; Caldwell P.C., 2015, SEA LEVEL MEASURED T; Carter TR, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P133; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Cayan DR, 2016, CREATING PROBABILIST; Church JA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024826; Church JA, 2006, AUST METEOROL MAG, V55, P253; Church JA, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1137; Church JA, 2013, SCIENCE, V342, P1445, DOI 10.1126/science.342.6165.1445-a; Church JA, 2011, OCEANOGRAPHY, V24, P130, DOI 10.5670/oceanog.2011.33; Church JA, 2008, SUSTAIN SCI, V3, P9, DOI 10.1007/s11625-008-0042-4; CO-CAT, 2010, STATE OF CALIFORNIA; Dalal S, 2013, ENVIRON MODELL SOFTW, V48, P49, DOI 10.1016/j.envsoft.2013.05.013; DeConto RM, 2016, NATURE, V531, P591, DOI 10.1038/nature17145; Dessai S, 2007, GLOBAL ENVIRON CHANG, V17, P59, DOI 10.1016/j.gloenvcha.2006.11.005; Diaz D, 2016, AM ECON REV, V106, P607, DOI 10.1257/aer.p20161103; DOUGLAS BC, 1992, J GEOPHYS RES-OCEANS, V97, P12699, DOI 10.1029/92JC01133; Gilboa I, 2008, J ECON PERSPECT, V22, P173, DOI 10.1257/jep.22.3.173; Gilboa I, 2009, ECON PHILOS, V25, P285, DOI 10.1017/S0266267109990241; Giuliani M, 2014, WATER RESOUR RES, V50, P3355, DOI 10.1002/2013WR014700; Goes M, 2011, CLIMATIC CHANGE, V109, P719, DOI 10.1007/s10584-010-9961-z; Griggs G., 2017, RISING SEAS CALIFORN; Grinsted A, 2010, CLIM DYNAM, V34, P461, DOI 10.1007/s00382-008-0507-2; Grinsted A, 2013, P NATL ACAD SCI USA, V110, P5369, DOI 10.1073/pnas.1209980110; Hall JW, 2012, RISK ANAL, V32, P1657, DOI 10.1111/j.1539-6924.2012.01802.x; Hanson S, 2011, CLIMATIC CHANGE, V104, P89, DOI 10.1007/s10584-010-9977-4; Hay CC, 2015, NATURE, V517, P481, DOI 10.1038/nature14093; Hinkel J, 2013, CLIMATIC CHANGE, V117, P783, DOI 10.1007/s10584-012-0564-8; Hogan E, 2017, WATER-SUI, V9, DOI 10.3390/w9070483; Holgate S, 2007, SCIENCE, V317, DOI 10.1126/science.1140942; HOSKING JRM, 1990, J ROY STAT SOC B MET, V52, P105; Hunter JR, 2013, OCEAN ENG, V71, P17, DOI 10.1016/j.oceaneng.2012.12.041; Hunter J, 2012, CLIMATIC CHANGE, V113, P239, DOI 10.1007/s10584-011-0332-1; Irvine PJ, 2012, NAT CLIM CHANGE, V2, P97, DOI [10.1038/nclimate1351, 10.1038/NCLIMATE1351]; Jevrejeva S, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/104008; Jevrejeva S, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003229; Jevrejeva S, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033611; Jonkman SN, 2008, RISK ANAL, V28, P1357, DOI 10.1111/j.1539-6924.2008.01103.x; Jonkman SN, 2013, J COASTAL RES, V29, P1212, DOI 10.2112/JCOASTRES-D-12-00230.1; Kalra N., 2014, 6906 WORLD BANK, DOI DOI 10.1596/1813-9450-6906; Keller K., 2015, OXFORD HDB MACROECON; Keller K, 2008, CLIMATIC CHANGE, V91, P5, DOI 10.1007/s10584-006-9114-6; Kemp AC, 2011, P NATL ACAD SCI USA, V108, P11017, DOI 10.1073/pnas.1015619108; Knutti R, 2010, J CLIMATE, V23, P2739, DOI 10.1175/2009JCLI3361.1; Kopp RE, 2014, EARTHS FUTURE, V2, P383, DOI 10.1002/2014EF000239; Kunreuther H, 2013, NAT CLIM CHANGE, V3, P447, DOI [10.1038/NCLIMATE1740, 10.1038/nclimate1740]; Le Bars D, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa6512; Le Cozannet G, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa5528; Lempert R, 2004, CLIMATIC CHANGE, V65, P1, DOI 10.1023/B:CLIM.0000037561.75281.b3; Lempert R, 2012, CHARACTERIZING UNCER; Lempert R.J., 2003, SHAPING NEXT 100 YEA; Lempert RJ, 2002, P NATL ACAD SCI USA, V99, P7309, DOI 10.1073/pnas.082081699; Lempert RJ, 2005, GOVT UNCERTAIN WORLD; Lempert RJ, 2014, J BENEFIT-COST ANAL, V5, P487, DOI 10.1515/jbca-2014-9006; Levermann A, 2014, EARTH SYST DYNAM, V5, P271, DOI 10.5194/esd-5-271-2014; Little CM, 2013, NAT CLIM CHANGE, V3, P654, DOI [10.1038/NCLIMATE1845, 10.1038/nclimate1845]; Mastrandrea M.D., 2010, GUIDANCE NOTE LEAD A; McInerney D, 2012, CLIMATIC CHANGE, V112, P547, DOI 10.1007/s10584-011-0377-1; Meehl G.A., 2007, GLOBAL CLIMATE PROJE; Mendez FJ, 2007, J ATMOS OCEAN TECH, V24, P894, DOI 10.1175/JTECH2009.1; Menendez M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005997; Miller KG, 2013, EARTHS FUTURE, V1, P3, DOI 10.1002/2013EF000135; Milne GA, 2009, NAT GEOSCI, V2, P471, DOI 10.1038/ngeo544; Moore JC, 2013, REV GEOPHYS, V51, P484, DOI 10.1002/rog.20015; Morgan MG, 2014, P NATL ACAD SCI USA, V111, P7176, DOI 10.1073/pnas.1319946111; Morgan MG., 1992, UNCERTAINTY GUIDE DE; Mudersbach C, 2010, J FLOOD RISK MANAG, V3, P52, DOI 10.1111/j.1753-318X.2009.01054.x; National Research Council, 2009, INF DEC CHANG CLIM; Nicholls RJ, 2014, WIRES CLIM CHANGE, V5, P129, DOI 10.1002/wcc.253; Nicholls RJ, 2011, PHILOS T R SOC A, V369, P161, DOI 10.1098/rsta.2010.029; Oppenheimer M, 2008, CLIMATIC CHANGE, V89, P155, DOI 10.1007/s10584-008-9405-1; Oppenheimer M, 2016, SCIENCE, V354, P1375, DOI 10.1126/science.aak9460; Oppenheimer M, 2016, NAT CLIM CHANGE, V6, P445, DOI 10.1038/NCLIMATE2959; Pardaens AK, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047678; Parris A, 2018, CPO1 NOAA OAR; PateCornell ME, 1996, RELIAB ENG SYST SAFE, V54, P95, DOI 10.1016/S0951-8320(96)00067-1; Pfeffer WT, 2008, SCIENCE, V321, P1340, DOI 10.1126/science.1159099; Pfeffer WT, 2011, OCEANOGRAPHY, V24, P94, DOI 10.5670/oceanog.2011.30; Pollard D, 2015, EARTH PLANET SC LETT, V412, P112, DOI 10.1016/j.epsl.2014.12.035; Pollard D, 2010, CLIMATIC CHANGE, V100, P173, DOI 10.1007/s10584-010-9830-9; Purvis MJ, 2008, COAST ENG, V55, P1062, DOI 10.1016/j.coastaleng.2008.04.008; Rahmstorf S., 2010, NAT CLIM CHANGE, V1004, P44, DOI [DOI 10.1038/CLIMATE.2010.29, 10.1038/climate.2010.29]; Rahmstorf S, 2012, CLIM DYNAM, V39, P861, DOI 10.1007/s00382-011-1226-7; Ranger N, 2010, ADAPTATION IN THE UK; Ranger N, 2013, EURO J DECIS PROCESS, V1, P233, DOI 10.1007/s40070-013-0014-5; Reeder T., 2011, DO YOU ADAPT UNCERTA; Ritz C, 2015, NATURE, V528, P115, DOI 10.1038/nature16147; Rosenzweig C, 2011, CLIMATIC CHANGE, V106, P93, DOI 10.1007/s10584-010-0002-8; Rosenzweig C, 2010, ANN NY ACAD SCI, V1196, P13, DOI 10.1111/j.1749-6632.2009.05306.x; Ruckert KL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170052; Siddall M, 2010, J QUATERNARY SCI, V25, P19, DOI 10.1002/jqs.1270; Sriver RL, 2012, CLIMATIC CHANGE, V115, P893, DOI 10.1007/s10584-012-0610-6; Sweet W., 2017, NOAA TECHNICAL REPOR, DOI 10.7289/v5/tr-nos-coops-083; Titus JG, 1996, CLIMATIC CHANGE, V33, P151, DOI 10.1007/BF00140246; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; VANDANTZIG D, 1956, ECONOMETRICA, V24, P276, DOI 10.2307/1911632; von Storch H, 2008, OCEAN DYNAM, V58, P227, DOI 10.1007/s10236-008-0142-9; Vrijling JK, 2001, RELIAB ENG SYST SAFE, V74, P337, DOI 10.1016/S0951-8320(01)00082-5; Walker W. E., 2013, ENCY OPERATIONS RES, DOI [10.1007/978-1-4419-1153-7_1140, DOI 10.1007/978-1-4419-1153-7_1140]; Walsh KJE, 2004, J COASTAL RES, V20, P586, DOI 10.2112/1551-5036(2004)020[0586:USLRPF]2.0.CO;2; Willis JK, 2012, SCIENCE, V336, P550, DOI 10.1126/science.1220366; Wong TE, IMPACTS ANTARCTIC FA; Wong TE, 2017, CLIMATIC CHANGE, V144, P347, DOI 10.1007/s10584-017-2039-4; Woodworth PL, 2009, INT J CLIMATOL, V29, P777, DOI 10.1002/joc.1771; Woodworth PL, 2004, J CLIMATE, V17, P1190, DOI 10.1175/1520-0442(2004)017&lt;1190:EFSCIE&gt;2.0.CO;2	118	26	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0190641	10.1371/journal.pone.0190641	http://dx.doi.org/10.1371/journal.pone.0190641			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1MC	29414978	Green Published, gold, Green Submitted			2022-12-26	WOS:000424325300009
J	Andrade, ACD; Mingoti, SA; Fernandes, AP; de Andrade, RG; Friche, AAD; Xavier, CC; Proietti, FA; Diez-Roux, AV; Caiaffa, WT				de Souza Andrade, Amanda Cristina; Mingoti, Sueli Aparecida; Fernandes, Amanda Paula; de Andrade, Roseli Gomes; de Lima Friche, Amelia Augusta; Xavier, Cesar Coelho; Proietti, Fernando Augusto; Diez-Roux, Ana V.; Caiaffa, Waleska Teixeira			Neighborhood-based physical activity differences: Evaluation of the effect of health promotion program	PLOS ONE			English	Article							PROPENSITY SCORE METHODS; ACTIVITY INTERVENTIONS; LATIN-AMERICA; BRAZIL; ADULTS; PARTICIPATION; RECIFE	Introduction The practice of physical activity is an important factor in the prevention of health problems. However, a small portion of the population is physically active. Recent reviews show that physical activity classes in community settings have the potential to increase population levels of physical activity and reduce health inequalities. Objective To evaluate the effect of the Academias da Cidade Program in Belo Horizonte on the practice of physical activity in leisure time (PALT) by non-users living near the program centers. Methods We conducted a home-based health survey in Belo Horizonte (2008 +/- 2009) with 1,581 adults who were non-users of the program and who lived within a 1,500-meter radius of one active program center (exposed group) and two nonoperational centers with sites reserved for their construction (unexposed group). We collected data on PALT levels (>= 150 minutes/week), which was measured with the Physical Activity International Questionnaire and analyzed with binary logistic regression using the Generalized Estimating Equations method. The propensity score was used as an adjustment variable to control the potential confusion in the measures of effect of exposure studied. Results The overall prevalence of the PALT was 26.5% in the exposed group and 22.7% in the unexposed group. The exposed group was more likely to be active in leisure time (OR = 1.05; CI 95%: 1.01 +/- 1.10). When considering the interaction between exposed group and distance, individuals in the exposed group who lived less than 500 meters from the program center were more likely to be active in leisure time (OR = 1.18, CI 95%: 1.03 +/- 1.35) compared to their counterparts. Conclusion Promoting physical activity in the community can favorably affect PALT levels among residents, especially those living closest to intervention centers. We believe the Academias da Cidade Program is a promising strategy to facilitate the access to appropriate spaces for the practice of physical activity and contribute to increase the levels physical activity within populations.	[de Souza Andrade, Amanda Cristina; Fernandes, Amanda Paula; de Andrade, Roseli Gomes; de Lima Friche, Amelia Augusta; Caiaffa, Waleska Teixeira] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil; [de Souza Andrade, Amanda Cristina; Mingoti, Sueli Aparecida; Fernandes, Amanda Paula; de Andrade, Roseli Gomes; de Lima Friche, Amelia Augusta; Xavier, Cesar Coelho; Proietti, Fernando Augusto; Caiaffa, Waleska Teixeira] Belo Horizonte Observ Urban Hlth, Belo Horizonte, MG, Brazil; [Mingoti, Sueli Aparecida] Univ Fed Minas Gerais, Inst Exact Sci, Belo Horizonte, MG, Brazil; [Xavier, Cesar Coelho; Proietti, Fernando Augusto] Fac Hlth & Human Ecol, Vespasiano, Brazil; [Diez-Roux, Ana V.] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Drexel University	Andrade, ACD (corresponding author), Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.; Andrade, ACD (corresponding author), Belo Horizonte Observ Urban Hlth, Belo Horizonte, MG, Brazil.	amandasouza_est@yahoo.com.br	Andrade, Roseli/GVS-7908-2022; Friche, Amelia A L/F-6114-2015; Mingoti, Sueli Aparecida/A-2967-2015	Cristina de Souza Andrade, Amanda/0000-0002-3366-4423	National Health Fund of the Ministry of Health; Fapemig; CNPq; NIH / Fogarty International Center; CAPES	National Health Fund of the Ministry of Health; Fapemig(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIH / Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the National Health Fund of the Ministry of Health, Fapemig, CNPq, NIH / Fogarty International Center. The CAPES for a research scholarship to ACSA and APE. CNPq for a research productivity scholarship to the researcher WTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Basu S, 2017, ANNU REV PUBL HEALTH, V38, P351, DOI 10.1146/annurev-publhealth-031816-044208; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Brasil. Ministerio da Saude, 2011, AV AT FIS BRAS, P125; Caiaffa W. T., 2010, Urban health: global perspectives, P437; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Moraes José Rodrigo de, 2011, Rev. bras. epidemiol., V14, P589, DOI 10.1590/S1415-790X2011000400006; Dias MAS, 2010, DESAFIOS INOVACOES G, P63; Fernandes AP, 2015, CAD SAUDE PUBLICA, V31, pS195, DOI 10.1590/0102-311X00104514; Friche AAL., 2015, SAUDE URBANA BELO HO; Hallal PC, 2010, J PHYS ACT HEALTH, V7, pS213, DOI 10.1123/jpah.7.s2.s213; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Heath GW, 2012, LANCET, V380, P272, DOI 10.1016/S0140-6736(12)60816-2; Hino Adriano Akira Ferreira, 2010, Rev. bras. cineantropom. desempenho hum., V12, P387, DOI 10.5007/1980-0037.2010V12N5P387; Hoehner CM, 2008, AM J PREV MED, V34, P224, DOI 10.1016/j.amepre.2007.11.016; Hoehner CM, 2013, AM J PREV MED, V44, pE31, DOI 10.1016/j.amepre.2012.10.026; Hoehner CM, 2005, AM J PREV MED, V28, P105, DOI 10.1016/j.amepre.2004.10.023; Humpel N, 2002, AM J PREV MED, V22, P188, DOI 10.1016/S0749-3797(01)00426-3; IBGE ( Instituto Brasileiro de Geografia e Estatistica), 2011, SIN CENS DEM 2010; Malta D.C., 2014, REV BRAS ATIVIDADE F, V19, P286, DOI DOI 10.12820/RBAFS.V.19N3P286; Mendonca BC, 2010, J PHYS ACT HEALTH, V7, pS223, DOI 10.1123/jpah.7.s2.s223; Pazin J, 2016, HEALTH PLACE, V39, P18, DOI 10.1016/j.healthplace.2016.02.005; Reis RS, 2014, MED SCI SPORT EXER, V46, P92, DOI 10.1249/MSS.0b013e3182a365ae; Ribeiro Manoel Carlos Sampaio de Almeida, 2016, Cad. Metrop., V18, P401, DOI 10.1590/2236-9996.2016-3605; Rydin Y, 2012, LANCET, V379, P2079, DOI 10.1016/S0140-6736(12)60435-8; Silva I, 2015, REV BRAS AT FIS SAUD, V20, P286; Simoes EJ, 2017, PREV MED, V103, pS66, DOI 10.1016/j.ypmed.2016.09.032; Simoes EJ, 2009, AM J PUBLIC HEALTH, V99, P68, DOI 10.2105/AJPH.2008.141978; WHO, 2006, PROM PHYS ACT ACT LI; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	31	7	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0192115	10.1371/journal.pone.0192115	http://dx.doi.org/10.1371/journal.pone.0192115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU8KH	29401506	Green Submitted, Green Published, gold			2022-12-26	WOS:000424101400036
J	Inomata, T; Konno, S; Nagai, K; Suzuki, M; Nishimura, M				Inomata, Takashi; Konno, Satoshi; Nagai, Katsura; Suzuki, Masaru; Nishimura, Masaharu			Neutrophil predominance in bronchoalveolar lavage fluid is associated with disease severity and progression of HRCT findings in pulmonary Mycobacterium avium infection	PLOS ONE			English	Article							CYSTIC-FIBROSIS; PREVALENCE; CELLS	Pulmonary Mycobacterium avium complex (MAC) infection is increasing in prevalence worldwide even in immunocompetent individuals. Despite its variable clinical course, the clinical and immunological factors associated with radiographical severity and progression are not largely unknown. We aimed to study the association between the inflammatory cell and cytokine profiles at the local infected site, and the radiological severity and/or progression of pulmonary MAC infection. In this retrospective cohort study, 22 healthy subjects and 37 consecutive patients who were diagnosed as having pulmonary MAC infection by positive cultures of bronchoalveolar lavage (BAL) fluids were enrolled. The 37 patients were divided into 2 groups based on the predominant BAL inflammatory cell type: the lymphocyte-dominant (LD) group and neutrophil-dominant (ND) groups. The high-resolution computed tomography score in both the lavaged segment and whole lung and cytokines profiles were compared between the 2 groups. The clinical course after the BAL procedure was also compared between the 2 groups. Both the segment and whole lung scores in the ND group were significantly higher than the LD group (P < 0.001). Levels of IL-8 in the BAL fluids were significantly higher in the ND group compared to the LD group (P = 0.01). In contrast, levels of IL-22 were significantly lower in the ND group compared to the LD group (P < 0.001). The prevalence of patients who showed deterioration of the disease was significantly higher in the ND group (83.3%) than the LD group (12.5%) (P < 0.01). Neutrophil-predominant inflammatory response at the infected site is associated with the radiographical severity and progression of pulmonary MAC infection.	[Inomata, Takashi; Konno, Satoshi; Nagai, Katsura; Suzuki, Masaru; Nishimura, Masaharu] Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido, Japan	Hokkaido University	Konno, S (corresponding author), Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido, Japan.	satkonno@med.hokudai.ac.jp	Suzuki, Masaru/H-2087-2012; Nishimura, Masaharu/A-4062-2012	Suzuki, Masaru/0000-0002-2124-6793; Nishimura, Masaharu/0000-0002-6456-4361				BHALLA M, 1991, RADIOLOGY, V179, P783, DOI 10.1148/radiology.179.3.2027992; Cassidy PM, 2009, CLIN INFECT DIS, V49, pE124, DOI 10.1086/648443; Condos R, 1998, AM J RESP CRIT CARE, V157, P729, DOI 10.1164/ajrccm.157.3.9705044; Donohue MJ, 2016, ANN AM THORAC SOC, V13, P2143, DOI 10.1513/AnnalsATS.201605-353OC; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Fowler SJ, 2006, EUR RESPIR J, V28, P1204, DOI 10.1183/09031936.06.00149805; GREENING AP, 1985, THORAX, V40, P278, DOI 10.1136/thx.40.4.278; Grenier P, 1993, J Thorac Imaging, V8, P213, DOI 10.1097/00005382-199322000-00006; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hayashi M, 2012, AM J RESP CRIT CARE, V185, P575, DOI 10.1164/rccm.201107-1203OC; Helbich TH, 1999, RADIOLOGY, V213, P537, DOI 10.1148/radiology.213.2.r99nv04537; HOLLAND SM, 1994, NEW ENGL J MED, V330, P1348, DOI 10.1056/NEJM199405123301904; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; Hwang JA, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00537-2016; Ide S, 2015, PLOS ONE, V28; Jasenosky LD, 2015, IMMUNOL REV, V264, P74, DOI 10.1111/imr.12274; Justa S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093279; Kondratieva E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010515; Mabuchi T, 2012, J DERMATOL SCI, V65, P4, DOI 10.1016/j.jdermsci.2011.11.007; Morimoto Kozo, 2014, Ann Am Thorac Soc, V11, P1, DOI 10.1513/AnnalsATS.201303-067OC; Odajima N, 2010, HUM PATHOL, V41, P935, DOI 10.1016/j.humpath.2009.12.009; Sakai S, 2014, CURR OPIN IMMUNOL, V29, P137, DOI 10.1016/j.coi.2014.06.003; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Shigemura M, 2010, LUNG, V188, P151, DOI 10.1007/s00408-009-9218-7; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Stern AS, 1996, LIFE SCI, V58, P639, DOI 10.1016/0024-3205(95)02247-3; Wu J, 2014, PLOS ONE, V16; Yamazaki Y, 1999, AM J RESP CRIT CARE, V160, P1851, DOI 10.1164/ajrccm.160.6.9902019; Yamazaki Y, 1998, EUR RESPIR J, V11, P1227, DOI 10.1183/09031936.98.11061227	29	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2018	13	2							e0190189	10.1371/journal.pone.0190189	http://dx.doi.org/10.1371/journal.pone.0190189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8KH	29401501	Green Submitted, gold, Green Published			2022-12-26	WOS:000424101400003
J	Gutierrez, S; Diago, MAP; Fernandez-Novales, J; Tardaguila, J				Gutierrez, Salvador; Diago, Maria A. P.; Fernandez-Novales, Juan; Tardaguila, Javier			Vineyard water status assessment using on-the-go thermal imaging and machine learning	PLOS ONE			English	Article							STOMATAL RESPONSE; STRESS INDEX; GRAPEVINE; IMAGERY; THERMOGRAPHY; VARIABILITY; PHYSIOLOGY; ENSEMBLE; CLOSURE; FOREST	The high impact of irrigation in crop quality and yield in grapevine makes the development of plant water status monitoring systems an essential issue in the context of sustainable viticulture. This study presents an on-the-go approach for the estimation of vineyard water status using thermal imaging and machine learning. The experiments were conducted during seven different weeks from July to September in season 2016. A thermal camera was embedded on an all-terrain vehicle moving at 5 km/h to take on-the-go thermal images of the vineyard canopy at 1.2 m of distance and 1.0 m from the ground. The two sides of the canopy were measured for the development of side-specific and global models. Stem water potential was acquired and used as reference method. Additionally, reference temperatures T-dry and T-wet were determined for the calculation of two thermal indices: the crop water stress index (CWSI) and the Jones index (I-g). Prediction models were built with and without considering the reference temperatures as input of the training algorithms. When using the reference temperatures, the best models casted determination coefficients R-2 of 0.61 and 0.58 for cross validation and prediction (RMSE values of 0.190 MPa and 0.204 MPa), respectively. Nevertheless, when the reference temperatures were not considered in the training of the models, their performance statistics responded in the same way, returning R-2 values up to 0.62 and 0.65 for cross validation and prediction (RMSE values of 0.190 MPa and 0.184 MPa), respectively. The outcomes provided by the machine learning algorithms support the use of thermal imaging for fast, reliable estimation of a vineyard water status, even suppressing the necessity of supervised acquisition of reference temperatures. The new developed on-the-go method can be very useful in the grape and wine industry for assessing and mapping vineyard water status.	[Gutierrez, Salvador; Diago, Maria A. P.; Fernandez-Novales, Juan; Tardaguila, Javier] Univ La Rioja, Inst Ciencias Vid & Vino, CSIC, Gobierno La Rioja, Ctra Burgos Km 6, Logrono 26007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-CAR-UR - Instituto de Ciencias de la Vid y del Vino (ICVV); Universidad de La Rioja	Tardaguila, J (corresponding author), Univ La Rioja, Inst Ciencias Vid & Vino, CSIC, Gobierno La Rioja, Ctra Burgos Km 6, Logrono 26007, Spain.	javier.tardaguila@unirioja.es	Tardaguila, Javier/K-3512-2012; Fernández-Novales, Juan/K-7123-2015; Diago, Maria P/R-9547-2018; Novales, Juan Fernández/ABG-2333-2021; Gutiérrez, Salvador/T-7637-2019; Gutiérrez, Salvador/GLV-0302-2022	Tardaguila, Javier/0000-0002-6639-8723; Fernández-Novales, Juan/0000-0001-9973-2604; Diago, Maria P/0000-0003-4049-0879; Novales, Juan Fernández/0000-0001-9973-2604; Gutiérrez, Salvador/0000-0002-8205-9772; 	FP7 ERA-net project; CORE Organic Plus; European Commission; Formacion para el Personal Investigador grant by Universidad de La Rioja, Gobierno de La Rioja [299/2016]; Spanish Ministry of Economy, Industry and Competitiveness (MINECO); Ramon y Cajal grant [RYC-2015-18429]; FPI grant by Universidad de La Rioja, Gobierno de La Rioja [299/2016]	FP7 ERA-net project; CORE Organic Plus; European Commission(European CommissionEuropean Commission Joint Research Centre); Formacion para el Personal Investigador grant by Universidad de La Rioja, Gobierno de La Rioja; Spanish Ministry of Economy, Industry and Competitiveness (MINECO)(Spanish Government); Ramon y Cajal grant(Spanish Government); FPI grant by Universidad de La Rioja, Gobierno de La Rioja	This work is part of the RESOLVE project, for which the authors acknowledge the financial support provided by transnational funding bodies, being partners of the FP7 ERA-net project, CORE Organic Plus, and the cofund from the European Commission. Salvador Gutierrez would like to acknowledge the research founding Formacion para el Personal Investigador grant 299/2016 by Universidad de La Rioja, Gobierno de La Rioja. Dr. Maria P. Diago is funded by the Spanish Ministry of Economy, Industry and Competitiveness (MINECO) with a Ramon y Cajal grant RYC-2015-18429.; The authors acknowledge Carlos Poblete for his support in the design of the experimental layout and Daniel Sepulveda and Marjolaine Chatin for their help with the measurement of the stem water potential. Special thanks to Luis Angel Garcia for his support and to Bodegas Vivanco, for providing the vineyard to conduct the study. This work is part of the RESOLVE project, for which the authors acknowledge the financial support provided by transnational funding bodies, being partners of the FP7 ERA-net project, CORE Organic Plus, and the cofund from the European Commission. Salvador Gutierrez would like to acknowledge the research founding FPI grant 299/2016 by Universidad de La Rioja, Gobierno de La Rioja. Dr. Maria P. Diago is funded by the Spanish Ministry of Economy, Industry and Competitiveness (MINECO) with a Ramon y Cajal grant RYC-2015-18429.	Acevedo-Opazo C, 2008, PRECIS AGRIC, V9, P285, DOI 10.1007/s11119-008-9073-1; Acevedo-Opazo C, 2010, PRECIS AGRIC, V11, P358, DOI 10.1007/s11119-010-9164-7; Baluja J, 2012, IRRIGATION SCI, V30, P511, DOI 10.1007/s00271-012-0382-9; Bellvert J, 2016, AUST J GRAPE WINE R, V22, P307, DOI 10.1111/ajgw.12173; Bellvert J, 2015, IRRIGATION SCI, V33, P81, DOI 10.1007/s00271-014-0456-y; Bellvert J, 2014, PRECIS AGRIC, V15, P361, DOI 10.1007/s11119-013-9334-5; Brillante L, 2016, PRECIS AGRIC, V17, P637, DOI 10.1007/s11119-016-9441-1; Brillante L, 2016, FRONT PLANT SCI, P7; Brillante L, 2015, COMPUT ELECTRON AGR, V117, P186, DOI 10.1016/j.compag.2015.07.017; Cohen Y, 2015, PRECIS AGRIC, V16, P311, DOI 10.1007/s11119-014-9378-1; Cohen Y, 2016, PRECIS AGRIC, P1; Costa JM, 2010, USE THERMAL IMAGING; Costa JM, 2012, FUNCT PLANT BIOL, V39, P179, DOI 10.1071/FP11156; De Bei R, 2011, AUST J GRAPE WINE R, V17, P62, DOI 10.1111/j.1755-0238.2010.00117.x; Diago MP, 2017, AUST J GRAPE WINE R, V23, P409, DOI 10.1111/ajgw.12283; Fernaandez-Novales J, 2017, BIOSYSTEMS ENG; Fernandez JE, 2014, AGR WATER MANAGE, V142, P99, DOI 10.1016/j.agwat.2014.04.017; Fuentes S, 2012, IRRIGATION SCI, V30, P523, DOI 10.1007/s00271-012-0375-8; Grant OM, 2016, J HORTIC SCI BIOTECH, V91, P43, DOI 10.1080/14620316.2015.1110991; Grant OM, 2007, J EXP BOT, V58, P815, DOI 10.1093/jxb/erl153; Grant OM, 2006, PHYSIOL PLANTARUM, V127, P507, DOI 10.1111/j.1399-3054.2006.00686.x; Gutierrez S, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16020236; Gutierrez S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143197; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Han J, 2012, MOR KAUF D, P1; HARRISONMURRAY RS, 1991, J HORTIC SCI, V66, P141, DOI 10.1080/00221589.1991.11516136; Hinkelmann K., 2007, DESIGN ANAL EXPT INT; IDSO SB, 1981, AGR METEOROL, V24, P45, DOI 10.1016/0002-1571(81)90032-7; Intrigliolo D, 2009, 6 INT S IRR HORT CRO, V889, P99; Jones H. G., 1992, Plants and microclimate: a quantitative approach to environmental plant physiology.; Jones Hamlyn G., 2003, Journal of Agricultural Meteorology, V59, P205, DOI 10.2480/agrmet.59.205; Jones HG, 1999, AGR FOREST METEOROL, V95, P139, DOI 10.1016/S0168-1923(99)00030-1; Jones HG, 2004, J EXP BOT, V55, P2427, DOI 10.1093/jxb/erh213; Jones HG, 2002, J EXP BOT, V53, P2249, DOI 10.1093/jxb/erf083; Keller M, 2010, SCIENCE OF GRAPEVINES: ANATOMY AND PHYSIOLOGY, P1; Meron M, 2010, PRECIS AGRIC, V11, P148, DOI 10.1007/s11119-009-9153-x; Costa JM, 2013, J EXP BOT, V64, P3937, DOI 10.1093/jxb/ert029; Moller M, 2007, J EXP BOT, V58, P827, DOI 10.1093/jxb/erl115; Murray F., 1967, J APPL METEOROL CLIM, V6, P203, DOI [10.1175/1520-0450(1967)0062.0.CO;2, DOI 10.1175/1520-0450(1967)0062.0.CO;2]; Pou A, 2014, AGR WATER MANAGE, V134, P60, DOI 10.1016/j.agwat.2013.11.010; Prieto JA, 2010, J INT SCI VIGNE VIN, V44, P9; Rodriguez JJ, 2006, IEEE T PATTERN ANAL, V28, P1619, DOI 10.1109/TPAMI.2006.211; Santos AO, 2009, SCI AGR, V66, P287, DOI 10.1590/S0103-90162009000300001; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; Schultz HR, 2010, AUST J GRAPE WINE R, V16, P4, DOI 10.1111/j.1755-0238.2009.00074.x; Sepulveda-Reyes D, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8100822; Soar CJ, 2006, AUST J GRAPE WINE R, V12, P2, DOI 10.1111/j.1755-0238.2006.tb00038.x; Tardaguila J, 2017, J SCI FOOD AGR, V97, P3772, DOI 10.1002/jsfa.8241; Witten IH, 2011, MOR KAUF D, P1	49	39	39	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192037	10.1371/journal.pone.0192037	http://dx.doi.org/10.1371/journal.pone.0192037			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389982	Green Published, gold			2022-12-26	WOS:000423793400055
J	Legault, R; Zogg, GP; Travis, SE				Legault, Rene, II; Zogg, Gregory P.; Travis, Steven E.			Competitive interactions between native Spartina alterniflora and non-native Phragmites australis depend on nutrient loading and temperature	PLOS ONE			English	Article							COMMON REED; INVASIVE PLANTS; DIVERSITY; NITROGEN; GROWTH; EXPANSION; SALINITY; LINEAGES; WETLANDS; MARSHES	We explored the nature and impact of competitive interactions between the salt marsh foundational plant Spartina alterniflora and invasive Phragmites australis in New England under varying levels of anthropogenic influence from nutrient loading and temperature warming. Plants were grown with and without competition in mesocosms over a four-month growing season. Mesocosms were split evenly among three levels of nutrient additions and two temperatures varying by an average of similar to 3 degrees C, manipulated using small greenhouses. We measured aboveground productivity as total biomass, numbers of new stems, and mean stem height. Nutrient enrichment increased all growth parameters, while competition generally reduced aboveground biomass and the production of new stems in both species. Most importantly, smooth cordgrass suffered no negative consequences of competition when no nutrients were added and temperature was elevated. The results of this study suggest that minimizing nutrient loading into coastal marshes could be an important factor in slowing the spread of common reed into the low marsh zone of New England salt marshes as global temperatures continue to warm.	[Legault, Rene, II; Zogg, Gregory P.; Travis, Steven E.] Univ New England, Dept Biol, Biddeford, ME 04005 USA; [Legault, Rene, II] Rhode Isl Dept Environm Management, Off Water Resources, Providence, RI USA	University of New England - Maine	Travis, SE (corresponding author), Univ New England, Dept Biol, Biddeford, ME 04005 USA.	stravis@une.edu		Travis, Steven/0000-0001-9338-8953	Maine Association of Wetland Scientists; New England Estuarine Research Society	Maine Association of Wetland Scientists; New England Estuarine Research Society	This study was supported by grants from the Maine Association of Wetland Scientists and the New England Estuarine Research Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsberry L, 2000, ECOL APPL, V10, P1110, DOI 10.1890/1051-0761(2000)010[1110:CIATEO]2.0.CO;2; Bernal B, 2017, GLOBAL CHANGE BIOL, V23, P2104, DOI 10.1111/gcb.13539; Bertness MD, 2002, P NATL ACAD SCI USA, V99, P1395, DOI 10.1073/pnas.022447299; Tho BT, 2016, BIOL INVASIONS, V18, P2563, DOI 10.1007/s10530-016-1158-6; Burdick DM, 2001, ENVIRON EXP BOT, V46, P247, DOI 10.1016/S0098-8472(01)00099-5; Busso CA, 2013, INTERCIENCIA, V38, P95; Caplan JS, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu020; Chambers RM, 2003, ESTUARIES, V26, P398, DOI 10.1007/BF02823716; Crosby SC, 2017, ESTUAR COAST, V40, P213, DOI 10.1007/s12237-016-0142-9; Deegan LA, 2012, NATURE, V490, P388, DOI 10.1038/nature11533; Douhovnikoff V, 2014, AM J BOT, V101, P1577, DOI 10.3732/ajb.1400177; Eller F, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01833; Farnsworth EJ, 2003, WETLANDS, V23, P750, DOI 10.1672/0277-5212(2003)023[0750:CEOFWP]2.0.CO;2; Gedan KB, 2011, MAR ECOL PROG SER, V434, P229, DOI 10.3354/meps09084; Gornish ES, 2013, AM J BOT, V100, P1422, DOI 10.3732/ajb.1300046; Hanson A, 2016, ESTUAR COAST, V39, P1376, DOI 10.1007/s12237-016-0090-4; Hazelton Eric L G, 2014, AoB Plants, V6, DOI 10.1093/aobpla/plu001; Holdredge C, 2011, BIOL INVASIONS, V13, P423, DOI 10.1007/s10530-010-9836-2; Holdredge C, 2010, OIKOS, V119, P1776, DOI 10.1111/j.1600-0706.2010.18647.x; Johnson DS, 2016, ECOL APPL, V26, P2647, DOI 10.1002/eap.1402; Kettenring KM, 2012, BIOL INVASIONS, V14, P2489, DOI 10.1007/s10530-012-0246-5; King RS, 2007, ESTUAR COAST, V30, P469, DOI 10.1007/BF02819393; Kirwan ML, 2011, BIOGEOSCIENCES, V8, P987, DOI 10.5194/bg-8-987-2011; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Kirwan ML, 2009, GLOBAL CHANGE BIOL, V15, P1982, DOI 10.1111/j.1365-2486.2008.01834.x; Martin LJ, 2013, ESTUAR COAST, V36, P626, DOI 10.1007/s12237-013-9593-4; McCormick MK, 2010, J ECOL, V98, P1369, DOI 10.1111/j.1365-2745.2010.01712.x; Medeiros DL, 2013, WETLANDS, V33, P421, DOI 10.1007/s13157-013-0400-6; Meyer L., 2014, CLIMATE CHANGE 2014; Minchinton TE, 2003, ECOL APPL, V13, P1400, DOI 10.1890/02-5136; Moore GE, 2012, NORTHEAST NAT, V19, P611, DOI 10.1656/045.019.0406; Mozdzer TJ, 2011, MAR ECOL PROG SER, V433, P43, DOI 10.3354/meps09117; Mozdzer TJ, 2016, BIOL INVASIONS, V18, P2619, DOI 10.1007/s10530-016-1156-8; Mozdzer TJ, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt048; Mozdzer TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042794; Mozdzer TJ, 2010, ESTUAR COAST, V33, P784, DOI 10.1007/s12237-009-9254-9; Mozdzer TJ, 2010, J ECOL, V98, P451, DOI 10.1111/j.1365-2745.2009.01625.x; Mykleby Philip M., 2015, Great Plains Research, V25, P63; Peter CR, 2010, ESTUAR COAST, V33, P1225, DOI 10.1007/s12237-010-9328-8; Price AL, 2014, WETLANDS, V34, P369, DOI 10.1007/s13157-013-0504-z; Ravit B, 2007, WETLANDS, V27, P915, DOI 10.1672/0277-5212(2007)27[915:TEODAN]2.0.CO;2; Rickey MA, 2004, J APPL ECOL, V41, P888, DOI 10.1111/j.0021-8901.2004.00948.x; Saltonstall K, 2002, P NATL ACAD SCI USA, V99, P2445, DOI 10.1073/pnas.032477999; Saltonstall K, 2007, AQUAT BOT, V86, P331, DOI 10.1016/j.aquabot.2006.12.003; Sciance MB, 2016, BIOL INVASIONS, V18, P2661, DOI 10.1007/s10530-016-1136-z; Siemann E, 2007, GLOBAL CHANGE BIOL, V13, P2184, DOI 10.1111/j.1365-2486.2007.01425.x; Silliman BR, 2004, CONSERV BIOL, V18, P1424, DOI 10.1111/j.1523-1739.2004.00112.x; Slater MA, 2017, AQUAT BOT, V136, P220, DOI 10.1016/j.aquabot.2016.10.006; Travis SE, 2005, J ECOL, V93, P417, DOI 10.1111/j.0022-0477.2005.00985.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vasquez EA, 2006, AM J BOT, V93, P1784, DOI 10.3732/ajb.93.12.1784; Watson EB, 2017, ESTUAR COAST, V40, P617, DOI [10.1007/s12237-016-0166-1, 10.1007/s12237-016-0069-1]; Windham L, 2001, WETLANDS, V21, P179, DOI 10.1672/0277-5212(2001)021[0179:COBPAD]2.0.CO;2; Zedler JB, 2004, CRIT REV PLANT SCI, V23, P431, DOI 10.1080/07352680490514673	54	13	13	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2018	13	2							e0192234	10.1371/journal.pone.0192234	http://dx.doi.org/10.1371/journal.pone.0192234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU3ZZ	29389960	Green Published, Green Submitted, gold			2022-12-26	WOS:000423793400079
J	Gonzalez, CR; Isla, MLM; Vitullo, AD				Gonzalez, Candela R.; Muscarsel Isla, Maria L.; Vitullo, Alfredo D.			The balance between apoptosis and autophagy regulates testis regression and recrudescence in the seasonal-breeding South American plains vizcacha, Lagostomus maximus	PLOS ONE			English	Article							SEMINIFEROUS EPITHELIUM; TESTICULAR REGRESSION; CELL APOPTOSIS; PROLIFERATION; HAMSTERS; PHOTOPERIOD; MECHANISMS; EPIDIDYMIS; RECEPTORS; CYCLE	Mammalian testis undergoes deep changes in their architecture and function during photo-regression conditions in seasonal breeders. Particularly, the testicular mechanisms that regulate the transition between the active (functional) and inactive (regression) stage vary between species. The aim of the present study was to analyze the incidence of proliferation, apoptosis and autophagy in the testicular seminiferous ephitelium of a seasonal breeder, Lagostomus maximus, during the annual reproductive cycle. We observed that proliferating spermatogonia increased from the active testis until reaching the maximum peak in the activating testis. During the annual reproductive cycle, the quantity of apoptotic-TUNEL positive spermatogonia and meiotic germ cells was constant and this might be regulated by the members of the BCL2 family. Only in the activating testis, apoptosis of germ cells was almost undetectable. The analysis of the autophagic-related proteins BECN1 and LC3 showed their localization in Leydig cells and the germ cells in the active and activating testis. In the inactive testis, BECN1 and LC3 ceased to be immunolocalized within the seminiferous tubules and the mRNA expression of both regulators decreased. Moreover, the expression of BECN1 and LC3 and also the apoptotic index were up regulated in testicular cultures subjected to nutritional stress. These results suggest a possible interaction between apoptosis and autophagy in the active and activating testis (characterized by high metabolic requirement and nutrient), where autophagy could promote survival over cell death. In the inactive testis, the absence of autophagic-related proteins might explain the massive loss of germ cells, suggesting that autophagy plays new and key role in the alterations of the seminiferous epithelium during photoregression.	[Gonzalez, Candela R.; Muscarsel Isla, Maria L.; Vitullo, Alfredo D.] Univ Maimonides, Ctr Estudios Biomed Biotecnol Ambientales & Diagn, Buenos Aires, DF, Argentina; [Gonzalez, Candela R.; Vitullo, Alfredo D.] Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Gonzalez, CR (corresponding author), Univ Maimonides, Ctr Estudios Biomed Biotecnol Ambientales & Diagn, Buenos Aires, DF, Argentina.; Gonzalez, CR (corresponding author), Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.	gonzalez.candela@maimonides.edu	Vitullo, Alfredo/F-9744-2015	Vitullo, Alfredo/0000-0002-4833-5147	Fundacion Cientifica Felipe Fiorellino	Fundacion Cientifica Felipe Fiorellino	This work was supported by Fundacion Cientifica Felipe Fiorellino.	Aguilera-Merlo C, 2005, ANAT REC PART A, V282A, P83, DOI 10.1002/ar.a.20144; BARTKE A, 1987, J STEROID BIOCHEM, V27, P581, DOI 10.1016/0022-4731(87)90357-8; BLOTTNER S, 1995, THERIOGENOLOGY, V44, P321, DOI 10.1016/0093-691X(95)00187-D; Blottner S, 2007, CELL TISSUE RES, V327, P615, DOI 10.1007/s00441-006-0328-8; Dadhich RK, 2010, BIOL REPROD, V83, P83, DOI 10.1095/biolreprod.109.080135; FUENTES LB, 1991, BIOL REPROD, V45, P493, DOI 10.1095/biolreprod45.3.493; FURUTA I, 1994, BIOL REPROD, V51, P1315, DOI 10.1095/biolreprod51.6.1315; Gonzalez CR, 2012, ZYGOTE, V20, P219, DOI 10.1017/S0967199411000128; Hale AN, 2013, AUTOPHAGY, V9, P951, DOI 10.4161/auto.24273; Hikim APS, 1999, REV REPROD, V4, P38; Jezek D, 2013, NORMAL MORPHOLOGY PA; Jimenez R, 2015, SEX DEV, V9, P205, DOI 10.1159/000439039; Kierzenbaum AL, 2006, SPERMATOGENESIS HIST; KLEMCKE HG, 1990, BIOL REPROD, V43, P162, DOI 10.1095/biolreprod43.1.162; Leal MC, 2006, BIOL REPROD, V74, P616, DOI 10.1095/biolreprod.105.048074; Liu M., 2016, IEEE T SMART GRID, VPP, P1, DOI DOI 10.1093/acrefore/9780190228613.013.162; Lowe JS, 2015, STEVENS LOWE HUMAN H, P319; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Marino G, 2004, CELL MOL LIFE SCI, V61, P1439, DOI 10.1007/s00018-004-4012-4; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Merlo CA, 2005, BIOCELL, V29, P243; Morales E, 2002, INT J ANDROL, V25, P281, DOI 10.1046/j.1365-2605.2002.00363.x; Morales E, 2007, J ANDROL, V28, P123, DOI 10.2164/jandrol.106.000778; Pastor LM, 2011, REPROD DOMEST ANIM, V46, P155, DOI 10.1111/j.1439-0531.2009.01573.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rodrigues P, 2009, REPRODUCTION, V137, P709, DOI 10.1530/REP-08-0203; Roulet V, 2006, HUM REPROD, V21, P1564, DOI 10.1093/humrep/del018; Sasso-Cerri E, 2006, J ANAT, V209, P21, DOI 10.1111/j.1469-7580.2006.00582.x; Shen HM, 2011, AUTOPHAGY, V7, P457, DOI 10.4161/auto.7.5.14226; STEGER RW, 1991, BIOL REPROD, V44, P76, DOI 10.1095/biolreprod44.1.76; Strbenc M, 2003, ANAT HISTOL EMBRYOL, V32, P48, DOI 10.1046/j.1439-0264.2003.00437.x; Young KA, 2001, REPRODUCTION, V122, P677, DOI 10.1530/rep.0.1220677; Young KA, 2000, BIOL REPROD, V62, P347, DOI 10.1095/biolreprod62.2.347; Young KA, 1999, ENDOCRINOLOGY, V140, P3133, DOI 10.1210/en.140.7.3133; Zhang M, 2012, PLOS ONE, V7, P1	35	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0191126	10.1371/journal.pone.0191126	http://dx.doi.org/10.1371/journal.pone.0191126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385162	Green Published, gold, Green Submitted			2022-12-26	WOS:000423668400033
J	Sun, WP; Yao, SH; Tang, JL; Liu, S; Chen, J; Deng, DQ; Zeng, CP				Sun, Weiping; Yao, Sihong; Tang, Jielong; Liu, Shuai; Chen, Juan; Deng, Daqing; Zeng, Chunping			Integrative analysis of super enhancer SNPs for type 2 diabetes	PLOS ONE			English	Article							FATTY LIVER-DISEASE; SKELETAL-MUSCLE CELLS; INSULIN-RESISTANCE; TRANSCRIPTION FACTORS; AORTIC STIFFNESS; DOWN-REGULATION; ADIPOSE-TISSUE; PPAR-GAMMA; ASSOCIATION; TCF7L2	Clinical studies in type 2 diabetes (T2D) primarily focused on the single nucleotide polymor-phisms (SNPs) located in protein-coding regions. Recently, the SNPs located in noncoding regions have also been recognized to play an important role in disease susceptibility. The super enhancer is a cluster of transcriptional enhancers located in noncoding regions. It plays a critical role in cell-type specific gene expression. However, the exact mechanism of the super enhancer SNPs for T2D remains unclear. In this study, we integrated genomewide association studies (GWASs) and T2D cell/tissue-specific histone modification ChIP-seq data to identify T2D-associated SNPs in super enhancer, followed by comprehensive bioinformatics analyses to further explore the functional importance of these SNPs. We identified several interesting T2D super enhancer SNPs. Interesting, most of them were clustered within the same or neighboring super enhancers. A number of SNPs are involved in chromatin interactive regulation and/or potentially influence the binding affinity of transcription factors. Gene Ontology (GO) analysis showed a significant enrichment in several well-known signaling pathways and regulatory process, e.g. WNT signaling pathway, which plays a key role in T2D metabolism. Our results highlighted the potential functional importance of T2D super enhancer SNPs, which may yield novel insights into the pathogenesis of T2D.	[Sun, Weiping; Chen, Juan; Deng, Daqing] First Peoples Hosp Xiangtan City, Dept Geriatr, Xiangtan, Peoples R China; [Yao, Sihong] Jishou Univ, Sch Med, Dept Clin Med, Jishou, Peoples R China; [Tang, Jielong; Liu, Shuai; Zeng, Chunping] Guangzhou Med Univ, Affiliated Hosp 5, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China	Jishou University; Guangzhou Medical University	Zeng, CP (corresponding author), Guangzhou Med Univ, Affiliated Hosp 5, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China.	zcp193@163.com			technological innovation project of Foshan City [2017AG100102]; medical technology research fund of Guangdong province [A2017575]	technological innovation project of Foshan City; medical technology research fund of Guangdong province	This study was partially supported or benefited by grants from technological innovation project of Foshan City (2017AG100102), and medical technology research fund of Guangdong province (A2017575).	Almgren P, 2011, DIABETOLOGIA, V54, P2811, DOI 10.1007/s00125-011-2267-5; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cardoso CRL, 2013, DIABETES CARE, V36, P3772, DOI 10.2337/dc13-0506; Cauchi S, 2006, DIABETES, V55, P2903, DOI 10.2337/db06-0474; Choi SS, 2016, DIABETES, V65, P829, DOI 10.2337/db15-1382; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cunha DA, 2009, DIABETES, V58, P2851, DOI 10.2337/db09-0685; Cusi K, 2010, CURR DIABETES REP, V10, P306, DOI 10.1007/s11892-010-0122-6; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Dietze D, 2002, DIABETES, V51, P2369, DOI 10.2337/diabetes.51.8.2369; Dworacki G, 2015, IMMUNOLOGY, V146, P456, DOI 10.1111/imm.12522; Ehnert S, 2015, EXP CELL RES, V332, P247, DOI 10.1016/j.yexcr.2014.12.011; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Golbidi S, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00136; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Guo LY, 2016, NUCLEIC ACIDS RES, V44, pD888, DOI 10.1093/nar/gkv1107; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huang PX, 2010, ANNU REV PHYSIOL, V72, P247, DOI 10.1146/annurev-physiol-021909-135917; Iguchi H, 2007, J BIOL CHEM, V282, P19052, DOI 10.1074/jbc.M700460200; Imamura M, 2012, HUM MOL GENET, V21, P3042, DOI 10.1093/hmg/dds113; Jackson S, 2000, DIABETES, V49, P1169, DOI 10.2337/diabetes.49.7.1169; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jin T, 2008, MOL ENDOCRINOL, V22, P2383, DOI 10.1210/me.2008-0135; Karoli Ritu, 2014, Indian J Endocrinol Metab, V18, P552, DOI 10.4103/2230-8210.137518; Kebapci N, 2007, NEUROUROL URODYNAM, V26, P814, DOI 10.1002/nau.20422; Khan IU, 2008, ANTI-CANCER AGENT ME, V8, P186; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kohlgruber A, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0670-x; Korf ESC, 2006, DIABETES CARE, V29, P2268, DOI 10.2337/dc06-0243; Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4; Kumar NP, 2015, IMMUNOLOGY, V144, P677, DOI 10.1111/imm.12421; Kumar S, 2017, NUCLEIC ACIDS RES, V45, pD139, DOI 10.1093/nar/gkw1064; Leite NC, 2009, LIVER INT, V29, P113, DOI 10.1111/j.1478-3231.2008.01718.x; Lekva T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136892; Li MLJ, 2013, NUCLEIC ACIDS RES, V41, pW150, DOI 10.1093/nar/gkt456; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Mansour AS, 2013, J HYPERTENS, V31, P1584, DOI 10.1097/HJH.0b013e3283613074; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McLaughlin T, 2014, ARTERIOSCL THROM VAS, V34, P2637, DOI 10.1161/ATVBAHA.114.304636; Miyake K, 2008, J HUM GENET, V53, P174, DOI 10.1007/s10038-007-0231-5; Moran C, 2013, DIABETES CARE, V36, P4036, DOI 10.2337/dc13-0143; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Santos FRM, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-55; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Reimann F, 2016, DIABETOLOGIA, V59, P229, DOI 10.1007/s00125-015-3825-z; Saddik Basema, 2015, Online J Public Health Inform, V7, pe214, DOI 10.5210/ojphi.v7i2.6011; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Scott LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11764; Seeley RJ, 2016, NAT MED, V22, P709, DOI 10.1038/nm.4137; Shaw-Smith C, 2014, DIABETES, V63, P2888, DOI 10.2337/db14-0061; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Siti SD, 2012, BLOOD, V120, P1281; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; Wang QJ, 2015, APMIS, V123, P146, DOI 10.1111/apm.12330; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Werman A, 1997, J BIOL CHEM, V272, P20230, DOI 10.1074/jbc.272.32.20230; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Willemsen G, 2015, TWIN RES HUM GENET, V18, P762, DOI 10.1017/thg.2015.83; Xia C, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/6494795; Yang Y, 2015, GENET MOL RES, V14, P10064, DOI 10.4238/2015.August.21.13; Yekutieli D, 1999, J STAT PLAN INFER, V82, P171, DOI 10.1016/S0378-3758(99)00041-5; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou JB, 2015, PEERJ, V3, DOI 10.7717/peerj.1304	71	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0192105	10.1371/journal.pone.0192105	http://dx.doi.org/10.1371/journal.pone.0192105			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385209	Green Submitted, Green Published, gold			2022-12-26	WOS:000423668400077
J	Biniaminov, N; Bandt, S; Roth, A; Haertel, S; Neumann, R; Bub, A				Biniaminov, Nathalie; Bandt, Susanne; Roth, Alexander; Haertel, Sascha; Neumann, Rainer; Bub, Achim			Irisin, physical activity and fitness status in healthy humans: No association under resting conditions in a cross-sectional study	PLOS ONE			English	Article							FNDC5 GENE-EXPRESSION; HUMAN SKELETAL-MUSCLE; ADIPOSE-TISSUE; CIRCULATING IRISIN; METABOLIC SYNDROME; BROWN-FAT; INSULIN-RESISTANCE; DIABETES-MELLITUS; SECRETORY ORGAN; EXERCISE	Regular physical activity and physical fitness are closely related to a positive health status in humans. In this context, the muscle becomes more important due to its function as an endocrine organ. Muscle tissue secretes "myokines" in response to physical activity and it is speculated that these myokines are involved in physical activity induced positive health effects. Recently, the newly discovered myokine Irisin thought to be secreted by the muscle in response to physical activity and might be related to the health inducing effect by inducing browning of white adipose tissue. Speculating that myokines at least partly mediate exercise related health effects one would assume that regular physical activity and physical fitness are associated with resting Irisin concentrations in healthy humans. To investigate the association between resting Irisin concentration and either short-term physical activity, habitual physical activity, or physical fitness, data of 300 healthy participants from the cross-sectional KarMeN-study were analyzed. By applying different activity measurements we determined short-term and habitual physical activity, as well as physical fitness. Fasting serum samples were collected to determine resting Irisin concentrations by Enzyme-linked Immunosorbent Assay. Multivariate linear regression analysis served to investigate associations of the individual physical activity parameters with Irisin concentrations. Therefore, lean body mass and total fat mass (both determined by dual-energy X-ray absorptiometry) as well as age and parameters of glucose metabolism were included as confounders in multivariate linear regression analysis. Results showed that Irisin serum concentrations were not related to measures of physical activity and physical fitness in healthy humans under resting conditions, irrespective of the applied methods. Therefore we assume that if physical activity related effects are partly induced by myokines, permanently increased Irisin serum concentration may not be necessary to induce health-related exercise effects.	[Biniaminov, Nathalie; Haertel, Sascha; Neumann, Rainer; Bub, Achim] Karlsruhe Inst Technol, Inst Sports & Sports Sci, Karlsruhe, Germany; [Bandt, Susanne; Roth, Alexander; Bub, Achim] Fed Res Inst Nutr & Food, Max Rubner Inst, Dept Physiol & Biochem Nutr, Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Bub, A (corresponding author), Karlsruhe Inst Technol, Inst Sports & Sports Sci, Karlsruhe, Germany.; Bub, A (corresponding author), Fed Res Inst Nutr & Food, Max Rubner Inst, Dept Physiol & Biochem Nutr, Karlsruhe, Germany.	Achim.Bub@kit.edu			German Federal Ministry of Food and Agriculture (BMEL)	German Federal Ministry of Food and Agriculture (BMEL)	The work was supported by the German Federal Ministry of Food and Agriculture (BMEL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Al-Daghri NM, 2015, EUR J CLIN INVEST, V45, P775, DOI 10.1111/eci.12468; Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Anastasilakis AD, 2014, J CLIN ENDOCR METAB, V99, P3247, DOI 10.1210/jc.2014-1367; Bishop-Bailey D, 2013, BRIT J PHARMACOL, V170, P1153, DOI 10.1111/bph.12399; Bluher S, 2014, OBESITY, V22, P1701, DOI 10.1002/oby.20739; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bub A, 2016, JMIR RES PROTOC, V5, P225, DOI 10.2196/resprot.5792; Castillo-Quan JI, 2012, DIS MODEL MECH, V5, P293, DOI 10.1242/dmm.009894; Catoire M, 2015, FASEB J, V29, P1615, DOI 10.1096/fj.14-263699; Choi YK, 2013, DIABETES RES CLIN PR, V100, P96, DOI 10.1016/j.diabres.2013.01.007; Cinti S, 2012, DIS MODEL MECH, V5, P588, DOI 10.1242/dmm.009662; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Daskalopoulou SS, 2014, EUR J ENDOCRINOL, V171, P343, DOI 10.1530/EJE-14-0204; Fletcher GF, 2013, CIRCULATION, V128, P873, DOI 10.1161/CIR.0b013e31829b5b44; Hecksteden A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-235; Hew-Butler T, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12262; Huh JY, 2015, J CLIN ENDOCR METAB, V100, pE453, DOI 10.1210/jc.2014-2416; Huh JY, 2014, J CLIN ENDOCR METAB, V99, pE2154, DOI 10.1210/jc.2014-1437; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Kerstholt N, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0035-x; Kraemer RR, 2014, HORM METAB RES, V46, P150, DOI 10.1055/s-0033-1355381; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Laaksonen DE, 2002, DIABETES CARE, V25, P1612, DOI 10.2337/diacare.25.9.1612; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009; Loffler D, 2015, J CLIN ENDOCR METAB, V100, P1289, DOI 10.1210/jc.2014-2932; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Miyamoto-Mikami E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120354; Moraes C, 2013, HORM METAB RES, V45, P900, DOI 10.1055/s-0033-1354402; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Nygaard H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121367; Palacios-Gonzalez B, 2015, OBESITY, V23, P729, DOI 10.1002/oby.21029; Pedersen BK, 2013, COMPR PHYSIOL, V3, P1337, DOI 10.1002/cphy.c120033; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2009, J PHYSIOL-LONDON, V587, P5559, DOI 10.1113/jphysiol.2009.179515; Pedersen BK, 2003, J MUSCLE RES CELL M, V24, P113, DOI 10.1023/A:1026070911202; Pekkala S, 2013, J PHYSIOL-LONDON, V591, P5393, DOI 10.1113/jphysiol.2013.263707; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Roecker K, 2003, INT J SPORTS MED, V24, P173, DOI 10.1055/s-2003-39087; Shoukry A, 2016, IUBMB LIFE, V68, P544, DOI 10.1002/iub.1511; Tsuchiya Y, 2014, TOHOKU J EXP MED, V233, P135, DOI 10.1620/tjem.233.135; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Yang XL, 2003, OBES RES, V11, P1182, DOI 10.1038/oby.2003.163	47	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0189254	10.1371/journal.pone.0189254	http://dx.doi.org/10.1371/journal.pone.0189254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381744	gold, Green Published, Green Submitted			2022-12-26	WOS:000423617800003
J	Lin, CY; Lin, LY				Lin, Chih-Ying; Lin, Lih-Yuan			The conserved basic residues and the charged amino acid residues at the alpha-helix of the zinc finger motif regulate the nuclear transport activity of triple C2H2 zinc finger proteins	PLOS ONE			English	Article							DNA-BINDING DOMAIN; KRUPPEL-LIKE FACTOR; LOCALIZATION SIGNAL; TRANSCRIPTION FACTORS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ZIF268-DNA COMPLEXES; IMPORTIN ALPHA; RECOGNITION; SEQUENCE	Zinc finger (ZF) motifs on proteins are frequently recognized as a structure for DNA binding. Accumulated reports indicate that ZF motifs contain nuclear localization signal (NLS) to facilitate the transport of ZF proteins into nucleus. We investigated the critical factors that facilitate the nuclear transport of triple C2H2 ZF proteins. Three conserved basic residues (hot spots) were identified among the ZF sequences of triple C2H2 ZF proteins that reportedly have NLS function. Additional basic residues can be found on the a-helix of the ZFs. Using the ZF domain (ZFD) of Egr-1 as a template, various mutants were constructed and expressed in cells. The nuclear transport activity of various mutants was estimated by analyzing the proportion of protein localized in the nucleus. Mutation at any hot spot of the Egr-1 ZFs reduced the nuclear transport activity. Changes of the basic residues at the a-helical region of the second ZF (ZF2) of the Egr-1 ZFD abolished the NLS activity. Flowever, this activity can be restored by substituting the acidic residues at the homologous positions of ZF1 or ZF3 with basic residues. The restored activity dropped again when the hot spots at ZF1 or the basic residues in the a-helix of ZF3 were mutated. The variations in nuclear transport activity are linked directly to the binding activity of the ZF proteins with importins. This study was extended to other triple C2H2 ZF proteins. SP1 and KLF families, similar to Egr-1, have charged amino acid residues at the second (alpha 2) and the third (alpha 3) positions of the alpha-helix. Replacing the amino acids at alpha 2 and alpha 3 with acidic residues reduced the NLS activity of the SP1 and KLF6 ZFD. The reduced activity can be restored by substituting the alpha 3 with histidine at any SP1 and KLF6 ZFD. The results show again the interchangeable role of ZFs and charge residues in the alpha-helix in regulating the NLS activity of triple C2H2 ZF proteins.	[Lin, Lih-Yuan] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University	Lin, LY (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.	lylin@life.nthu.edu.tw		Lin, Lih-Yuan/0000-0001-9827-3434	Ministry of Science and Technology [NSC99-2627-B007-002, MOST103-2622-S007-001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by grants NSC99-2627-B007-002 and MOST103-2622-S007-001 from the Ministry of Science and Technology (https://www.most.gov.tw/). L-Y Lin received all of the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bernard D, 2013, J BIOMOL NMR, V57, P103, DOI 10.1007/s10858-013-9770-6; Bouhouche N, 2000, TRENDS MICROBIOL, V8, P77, DOI 10.1016/S0966-842X(99)01679-0; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V51, P9, DOI 10.1007/s12013-008-9007-6; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Chapman NR, 2000, J BIOL CHEM, V275, P4719, DOI 10.1074/jbc.275.7.4719; Choi S, 2014, ACTA CRYSTALLOGR D, V70, P1050, DOI 10.1107/S1399004714000972; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Depping R, 2012, CELL PHYSIOL BIOCHEM, V29, P223, DOI 10.1159/000337603; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Elrod-Erickson M, 1998, STRUCTURE, V6, P451, DOI 10.1016/S0969-2126(98)00047-1; Fernandez-Martinez J, 2003, J MOL BIOL, V334, P667, DOI 10.1016/j.jmb.2003.09.072; Gaj T, 2014, ACS CHEM BIOL, V9, P1662, DOI 10.1021/cb500282g; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Gersbach CA, 2014, ACCOUNTS CHEM RES, V47, P2309, DOI 10.1021/ar500039w; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Gupta A, 2014, NUCLEIC ACIDS RES, V42, P4800, DOI 10.1093/nar/gku132; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hatayama M, 2008, HUM MOL GENET, V17, P3459, DOI 10.1093/hmg/ddn239; Huang SM, 2007, BIOCHEM J, V402, P359, DOI 10.1042/BJ20061295; Ito T, 2010, BIOCHEM BIOPH RES CO, V403, P161, DOI 10.1016/j.bbrc.2010.10.036; Ito T, 2009, BIOCHEM BIOPH RES CO, V380, P28, DOI 10.1016/j.bbrc.2008.12.165; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Kim MS, 2017, MOL CELLS, V40, P533, DOI 10.14348/molcells.2017.0139; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Laity JH, 2000, J MOL BIOL, V295, P719, DOI 10.1006/jmbi.1999.3406; LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871; Li JX, 2013, MITOCHONDR DNA, V24, P8, DOI 10.3109/19401736.2012.710225; Lu H, 2011, J BIOL CHEM, V286, P20335, DOI 10.1074/jbc.M110.215632; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; MATHENY C, 1994, J BIOL CHEM, V269, P8176; Mehta TS, 2009, CELL RES, V19, P1098, DOI 10.1038/cr.2009.64; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Mingot JM, 2009, J CELL SCI, V122, P1452, DOI 10.1242/jcs.041749; Oka S, 2004, BIOCHEMISTRY-US, V43, P16027, DOI 10.1021/bi048438p; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Peisach E, 2003, J MOL BIOL, V330, P1, DOI 10.1016/S0022-2836(03)00572-2; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Quadrini KJ, 2002, J BIOL CHEM, V277, P32243, DOI 10.1074/jbc.M205677200; Rodriguez E., 2010, PLOS ONE, V5; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Saijou E, 2007, J BIOL CHEM, V282, P32327, DOI 10.1074/jbc.M706793200; SANCHEZGARCIA I, 1994, TRENDS GENET, V10, P315, DOI 10.1016/0168-9525(94)90034-5; SETO E, 1993, NATURE, V365, P462, DOI 10.1038/365462a0; Stubbs L, 2011, SUBCELL BIOCHEM, V52, P75, DOI 10.1007/978-90-481-9069-0_4; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Yasuharaa N, 2009, SEMIN CELL DEV BIOL, V20, P590, DOI 10.1016/j.semcdb.2009.05.003; Yoneda Y, 2000, GENES CELLS, V5, P777, DOI 10.1046/j.1365-2443.2000.00366.x	61	5	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0191971	10.1371/journal.pone.0191971	http://dx.doi.org/10.1371/journal.pone.0191971			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381770	Green Published, gold, Green Submitted			2022-12-26	WOS:000423617800047
J	Sundaramoorthy, J; Park, GT; Mukaiyama, K; Tsukamoto, C; Chang, JH; Lee, JD; Kim, JH; Seo, HS; Song, JT				Sundaramoorthy, Jagadeesh; Park, Gyu Tae; Mukaiyama, Kyosuke; Tsukamoto, Chigen; Chang, Jeong Ho; Lee, Jeong-Dong; Kim, Jeong Hoe; Seo, Hak Soo; Song, Jong Tae			Molecular elucidation of a new allelic variation at the Sg-5 gene associated with the absence of group A saponins in wild soybean	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; MAX L. MERRILL; GLYCINE-SOJA; TRITERPENOID SAPONINS; CRYSTAL-STRUCTURES; PLANT SAPONINS; SEED; PROTEIN; IDENTIFICATION; BIOSYNTHESIS	In soybean, triterpenoid saponin is one of the major secondary metabolites and is further classified into group A and DDMP saponins. Although they have known health benefits for humans and animals, acetylation of group A saponins causes bitterness and gives an astringent taste to soy products. Therefore, several studies are being conducted to eliminate acetylated group A saponins. Previous studies have isolated and characterized the Sg-5 (Glyma. 15g243300) gene, which encodes the cytochrome P450 72A69 enzyme and is responsible for soyasapogenol A biosynthesis. In this study, we elucidated the molecular identity of a novel mutant of Glycine soja, 'CWS5095'. Phenotypic analysis using TLC and LC-PDA/MS/MS showed that the mutant 'CWS5095' did not produce any group A saponins. Segregation analysis showed that the absence of group A saponins is controlled by a single recessive allele. The locus was mapped on chromosome 15 (4.3 Mb) between Affx-89193969 and Affx-89134397 where the previously identified Glyma. 15g243300 gene is positioned. Sequence analysis of the coding region for the Glyma. 15g243300 gene revealed the presence of four SNPs in 'CWS5095' compared to the control lines. One of these four SNPs (G1127A) leads to the amino acid change Arg376Lys in the EXXR motif, which is invariably conserved among the CYP450 superfamily proteins. Co-segregation analysis showed that the missense mutation (Arg376Lys) was tightly linked with the absence of group A saponins in 'CWS5095'. Even though Arg and Lys have similar chemical features, the 3D modelled protein structure indicates that the replacement of Arg with Lys may cause a loss-of-function of the Sg-5 protein by inhibiting the stable binding of a heme cofactor to the CYP72A69 apoenzyme.	[Sundaramoorthy, Jagadeesh; Park, Gyu Tae; Lee, Jeong-Dong; Song, Jong Tae] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea; [Mukaiyama, Kyosuke; Tsukamoto, Chigen] Iwate Univ, Fac Agr, Morioka, Iwate, Japan; [Chang, Jeong Ho] Kyungpook Natl Univ, Dept Biol Educ, Daegu, South Korea; [Lee, Jeong-Dong] Kyungpook Natl Univ, Dept Biol, Daegu, South Korea; [Seo, Hak Soo] Seoul Natl Univ, Dept Plant Sci, Seoul, South Korea	Kyungpook National University; Iwate University; Kyungpook National University; Kyungpook National University; Seoul National University (SNU)	Song, JT (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea.	jtsong68@knu.ac.kr	; Sundaramoorthy, Jagadeesh/O-4027-2017	Song, Jong Tae/0000-0002-2052-6582; Sundaramoorthy, Jagadeesh/0000-0002-0748-5800	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2016R1D1A1B01007409]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) fund by the Ministry of Education (No. NRF-2016R1D1A1B01007409) to JTS.	ABE I, 1993, CHEM REV, V93, P2189, DOI 10.1021/cr00022a009; Bak Soren, 2011, Arabidopsis Book, V9, pe0144, DOI 10.1199/tab.0144; Biazzi E, 2015, MOL PLANT, V8, P1493, DOI 10.1016/j.molp.2015.06.003; CHEN S, 1992, J BIOL CHEM, V267, P22587; Dorner ME, 2015, PROTEIN SCI, V24, P1495, DOI 10.1002/pro.2737; Doyle J. J., 1987, PHYTOCHEM B, P11; Fenwick G.R., 1991, TOXIC SUBSTANCES CRO, P285, DOI DOI 10.1533/9781845698454.285; Fukushima EO, 2013, PLANT CELL PHYSIOL, V54, P740, DOI 10.1093/pcp/pct015; Graham SE, 1999, ARCH BIOCHEM BIOPHYS, V369, P24, DOI 10.1006/abbi.1999.1350; Hagely KB, 2013, J AGR FOOD CHEM, V61, P1105, DOI 10.1021/jf303985q; Hamberger B, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0426; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; Hatae T, 1996, FEBS LETT, V389, P268, DOI 10.1016/0014-5793(96)00600-X; Higashimoto Y, 2005, J BIOL CHEM, V280, P729, DOI 10.1074/jbc.M406203200; JOFUKU KD, 1989, PLANT CELL, V1, P427, DOI 10.1105/tpc.1.4.427; Kahn RA, 2000, RECENT ADV PHYTOCHEM, V34, P151, DOI 10.1016/S0079-9920(00)80007-6; Karu N, 2007, J AGR FOOD CHEM, V55, P2824, DOI 10.1021/jf0628025; Kato S., 2007, Bulletin of the National Agricultural Research Center for Tohoku Region, P29; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kikuchi A, 1999, BREEDING SCI, V49, P167, DOI 10.1270/jsbbs.49.167; Kim HY, 2004, CANCER LETT, V210, P1, DOI 10.1016/j.canlet.2004.01.009; Kim SL, 2006, J AGR FOOD CHEM, V54, P10003, DOI 10.1021/jf062275p; KONOSHIMA T, 1992, J NAT PROD, V55, P1776, DOI 10.1021/np50090a011; Krishnamurthy P, 2014, GENET RESOUR CROP EV, V61, P1121, DOI 10.1007/s10722-014-0095-4; Krishnamurthy P, 2012, CHROMATOGRAPHIA, V75, P1445, DOI 10.1007/s10337-012-2340-3; KUDOU S, 1992, BIOSCI BIOTECH BIOCH, V56, P142, DOI 10.1271/bbb.56.142; Moses T, 2014, CRIT REV BIOCHEM MOL, V49, P439, DOI 10.3109/10409238.2014.953628; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; OKUBO K, 1994, ACS SYM SER, V546, P330; OKUBO K, 1992, BIOSCI BIOTECH BIOCH, V56, P99, DOI 10.1271/bbb.56.99; Panneerselvam K, 2013, PLANT BREEDING, V132, P121, DOI 10.1111/pbr.12016; Paquette SM, 2000, DNA CELL BIOL, V19, P307, DOI 10.1089/10445490050021221; Patil G., 2017, INT J PLANT GENOMICS, V2017; Qiu D, 2015, THEOR APPL GENET, V128, P2167, DOI 10.1007/s00122-015-2575-0; Reinprecht Y, 2011, THEOR APPL GENET, V122, P1247, DOI 10.1007/s00122-011-1528-5; Rupasinghe HPV, 2003, J AGR FOOD CHEM, V51, P5888, DOI 10.1021/jf0343736; Sasama H, 2010, ACS SYM SER, V1059, P91; Sawai S, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00025; Sayama T, 2012, PLANT CELL, V24, P2123, DOI 10.1105/tpc.111.095174; Seki H, 2011, PLANT CELL, V23, P4112, DOI 10.1105/tpc.110.082685; Sello MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11572; Sezutsu H, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0428; Shibuya M, 2006, FEBS J, V273, P948, DOI 10.1111/j.1742-4658.2006.05120.x; Shibuya M, 2010, FEBS LETT, V584, P2258, DOI 10.1016/j.febslet.2010.03.037; SHIMIZU T, 1991, J BIOL CHEM, V266, P3372; SHIMOYAMADA M, 1991, AGR BIOL CHEM TOKYO, V55, P1403, DOI 10.1080/00021369.1991.10870766; SHIMOYAMADA M, 1990, AGR BIOL CHEM TOKYO, V54, P77, DOI 10.1080/00021369.1990.10869887; Shin JH, 2012, THEOR APPL GENET, V124, P613, DOI 10.1007/s00122-011-1733-2; SHIRAIWA M, 1990, AGR BIOL CHEM TOKYO, V54, P1347, DOI 10.1080/00021369.1990.10870134; SHIRAIWA M, 1991, AGR BIOL CHEM TOKYO, V55, P323, DOI 10.1080/00021369.1991.10870575; Sirim D, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-34; Sparg SG, 2004, J ETHNOPHARMACOL, V94, P219, DOI 10.1016/j.jep.2004.05.016; SUGANO M, 1990, J NUTR, V120, P977, DOI 10.1093/jn/120.9.977; Syed K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095616; Szakiel Anna, 2005, Phytochemistry Reviews, V4, P151, DOI 10.1007/s11101-005-4053-9; Takada Y, 2013, THEOR APPL GENET, V126, P721, DOI 10.1007/s00122-012-2013-5; Takada Y, 2011, BREEDING SCI, V61, P639, DOI 10.1270/jsbbs.61.639; Takada Y, 2010, BREEDING SCI, V60, P3, DOI 10.1270/jsbbs.60.3; TSUKAMOTO C, 1993, PHYTOCHEMISTRY, V34, P1351, DOI 10.1016/0031-9422(91)80028-Y; Vincken JP, 2007, PHYTOCHEMISTRY, V68, P275, DOI 10.1016/j.phytochem.2006.10.008; Wang KJ, 2004, GENOME, V47, P9, DOI [10.1139/g03-087, 10.1139/G03-087]; WANG WH, 1994, P NATL ACAD SCI USA, V91, P5828, DOI 10.1073/pnas.91.13.5828; Werck-Reichhart Daniele, 2002, Arabidopsis Book, V1, pe0028, DOI 10.1199/tab.0028; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Yano R, 2017, PLANT J, V89, P527, DOI 10.1111/tpj.13403; Yoshiki Y, 1996, PLANT SCI, V116, P125, DOI 10.1016/0168-9452(96)04375-0; Zhao LX, 2012, J BIOL CHEM, V287, P1054, DOI 10.1074/jbc.M111.264481	67	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2018	13	1							e0192150	10.1371/journal.pone.0192150	http://dx.doi.org/10.1371/journal.pone.0192150			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU1NX	29381775	gold, Green Submitted, Green Published			2022-12-26	WOS:000423617800059
J	Mediero, A; Wilder, T; Shah, L; Cronstein, BN				Mediero, Aranzazu; Wilder, Tuere; Shah, Lopa; Cronstein, Bruce N.			Adenosine A(2A) receptor (A2AR) stimulation modulates expression of semaphorins 4D and 3A, regulators of bone homeostasis	FASEB JOURNAL			English	Article						Sema4D; Sema3A; cell communication; RhoA; beta-catenin	B NUCLEAR TRANSLOCATION; OSTEOCLAST FORMATION; A(2B) RECEPTORS; AXON GUIDANCE; DIFFERENTIATION; CELLS; ACTIVATION; MODEL; INNERVATION; SUPPRESSION	The axonal guidance proteins semaphorin (Sema)4D and Sema3A play important roles in communication between osteoclasts and osteoblasts. As stimulation of adenosine A(2A) receptors (A2AR) regulates both osteoclast and osteoblast function, we asked whether A2AR regulates both osteoclast and osteoblast expression of Semas. In vivo bone formation and Sema3A/PlexinA1/Neuropilin-1, Sema4D/PlexinB1 protein expression were studied in a murine model of wear particle-induced osteolysis. Osteoclast/osteoblast differentiation were studied in vitro as the number of tartrate-resistant acid phosphatase(+)/Alizarin Red(+) cells after challenge with CGS21680 (A2AR agonist, 1 mu M) or ZM241385 (A2AR antagonist, 1 mu M), with or without Sema4D or Sema3A (10 ng/ml). Sema3A/PlexinA1/Neuropilin-1, Sema4D/PlexinB1, and receptor activator of NF-kappa B ligand/osteoprotegerin (RANKL/OPG) expression was studied by RT-PCR and Western blot. beta-Catenin activation and cytoskeleton changes were studied by fluorescence microscopy and Western blot. In mice with wear particles implanted over the calvaria, CGS21680 treatment increased bone formation in vivo, reduced Sema4D, and increased Sema3A expression compared with mice with wear particle-induced osteolysis treated with vehicle alone. During osteoclast differentiation, CGS21680 abrogated RANKL-induced Sema4D mRNA expression (1.3 +/- 0.3- vs. 2.5 +/- 0.1-fold change, P < 0.001, n = 4). PlexinA1, but not Neuropilin-1, mRNA was enhanced by CGS21680 treatment. CGS21680 enhanced Sema3A mRNA expression during osteoblast differentiation (8.7 +/- 0.2-fold increase, P < 0.001, n = 4); PlexinB1 mRNA was increased 2-fold during osteoblast differentiation and was not altered by CGS21680. Similar changes were observed at the protein level. CGS21680 decreased RANKL, increased OPG, and increased total/nuclear beta-catenin expression in osteoblasts. Sema4D increased Ras homolog gene family, member A phosphorylation and focal adhesion kinase activation in osteoclast precursors, and CGS21680 abrogated these effects. In summary, A2AR activation diminishes secretion of Sema4D by osteoclasts, inhibits Sema4D-mediated osteoclast activation, and enhances secretion of Sema3A by osteoblasts, increasing osteoblast differentiation and diminishing inflammatory osteolysis.-Mediero, A., Wilder, T., Shah, L., Cronstein, B. N. Adenosine A(2A) receptor (A2AR) stimulation modulates expression of semaphorins 4D and 3A, regulators of bone homeostasis.	[Mediero, Aranzazu; Wilder, Tuere; Shah, Lopa; Cronstein, Bruce N.] NYU, Dept Med, Div Translat Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Mediero, Aranzazu] Univ Autonoma Madrid, Inst Invest Sanitaria, Fdn Jimenez Diaz, Bone & Joint Res Unit, Madrid, Spain	New York University; NYU Langone Medical Center; Autonomous University of Madrid; Fundacion Jimenez Diaz	Cronstein, BN (corresponding author), NYU, Sch Med, Dept Med, Div Translat Med, 550 First Ave,MSB251, New York, NY 10016 USA.	bruce.cronstein@nyumc.org	Mediero, Aranzazu/AAA-8362-2020; Cronstein, Bruce N/D-4678-2011	Cronstein, Bruce N/0000-0002-4295-7383; Mediero, Aranzazu/0000-0002-5368-574X	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR68593, AR56672]; New York University-Health and Hospitals Corporation Clinical and Translational Science Institute [U54TR001364]; New York University Caregiver Intervention Center Support Grant [9NIH/NCI 5 P30CA16087-310]; Instituto de Salud Carlos III [CP15/00053]; Fondo Europeo de Desarrollo Regional (FEDER); Spanish Instituto de Salud Carlos III [PI16/00991]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068593, R01AR056672, R56AR056672] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); New York University-Health and Hospitals Corporation Clinical and Translational Science Institute; New York University Caregiver Intervention Center Support Grant; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Spanish Instituto de Salud Carlos III(Instituto de Salud Carlos III); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grants AR68593 and AR56672), the New York University-Health and Hospitals Corporation Clinical and Translational Science Institute (Grant U54TR001364), and a New York University Caregiver Intervention Center Support Grant (9NIH/NCI 5 P30CA16087-310). A.M. is funded by Instituto de Salud Carlos III through the Miguel Servet Program (CP15/00053), and cofunded by Fondo Europeo de Desarrollo Regional (FEDER) with a research grant from the Spanish Instituto de Salud Carlos III (PI16/00991). A.M. and B.N.C. have filed a patent on use of A2AR agonists to prevent prosthesis loosening (pending), and a separate patent on use of A2AR agonists and agents that increase adenosine levels to promote bone formation/regeneration. B.N.C. is a consultant for Bristol-Myers Squibb, AstraZeneca, Novartis, and CanFite Biopharmaceuticals and has stock in CanFite Biopharmaceuticals. The remaining authors declare no conflicts of interest.	BJURHOLM A, 1991, INT ORTHOP, V15, P325; Boyce BF, 2013, J DENT RES, V92, P860, DOI 10.1177/0022034513500306; Chitu V, 2005, MOL BIOL CELL, V16, P2947, DOI 10.1091/mbc.e04-10-0914; Dacquin R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026627; Edwards Claire M, 2008, Int J Med Sci, V5, P263; Fang KX, 2016, MOL MED REP, V14, P2449, DOI 10.3892/mmr.2016.5568; Fang KX, 2014, INT J NANOMED, V9, P4649, DOI 10.2147/IJN.S68895; Fukuda T, 2013, NATURE, V497, P490, DOI 10.1038/nature12115; Gharibi B, 2011, J BONE MINER RES, V26, P2112, DOI 10.1002/jbmr.424; Gomez C, 2005, DEV DYNAM, V234, P393, DOI 10.1002/dvdy.20512; Harmatys KM, 2013, MOL PHARMACEUT, V10, P4263, DOI 10.1021/mp400357v; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; He WJ, 2013, FASEB J, V27, P3446, DOI 10.1096/fj.13-231233; HOHMANN EL, 1986, SCIENCE, V232, P868, DOI 10.1126/science.3518059; Kang SJ, 2013, SEMIN CELL DEV BIOL, V24, P163, DOI 10.1016/j.semcdb.2012.09.008; Katebi M, 2009, J LEUKOCYTE BIOL, V85, P438, DOI 10.1189/jlb.0908520; Kikutani H, 2007, ADV IMMUNOL, V93, P121, DOI 10.1016/S0065-2776(06)93003-X; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kular J, 2012, CLIN BIOCHEM, V45, P863, DOI 10.1016/j.clinbiochem.2012.03.021; Li YF, 2017, J BIOMED MATER RES B, V105, P2060, DOI 10.1002/jbm.b.33730; LIU X, 2016, STEM CELLS INT, V2016, DOI DOI 10.1155/2016/2545214; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; Mediero A, 2015, J BONE MINER RES, V30, P837, DOI 10.1002/jbmr.2421; Mediero A, 2015, FASEB J, V29, P1577, DOI 10.1096/fj.14-265066; Mediero A, 2014, FASEB J, V28, P4901, DOI 10.1096/fj.14-255703; Mediero A, 2013, BRIT J PHARMACOL, V169, P1372, DOI 10.1111/bph.12227; Mediero A, 2013, TRENDS ENDOCRIN MET, V24, P290, DOI 10.1016/j.tem.2013.02.001; Mediero A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003393; Mediero A, 2012, AM J PATHOL, V180, P775, DOI 10.1016/j.ajpath.2011.10.017; Negishi-Koga Takako, 2012, Bonekey Rep, V1, P183, DOI 10.1038/bonekey.2012.183; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Nogi T, 2010, NATURE, V467, P1123, DOI 10.1038/nature09473; Perez-Aso M, 2013, PURINERG SIGNAL, V9, P573, DOI 10.1007/s11302-013-9368-1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Saad S, 2016, ACTA BIOMATER, V30, P311, DOI 10.1016/j.actbio.2015.11.025; Shaikh G, 2016, BRIT J PHARMACOL, V173, P3279, DOI 10.1111/bph.13615; Shaikh G, 2016, PURINERG SIGNAL, V12, P191, DOI 10.1007/s11302-016-9498-3; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; Sims NA, 2012, CURR OSTEOPOROS REP, V10, P109, DOI 10.1007/s11914-012-0096-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Togari A, 2000, BRAIN RES, V878, P204, DOI 10.1016/S0006-8993(00)02700-1; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Xu R, 2014, CELL ADHES MIGR, V8, P5, DOI 10.4161/cam.27752; Yang YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150151; Yasuda H, 1999, BONE, V25, P109, DOI 10.1016/S8756-3282(99)00121-0; Yoshida Y, 2015, ARTHRITIS RHEUMATOL, V67, P1481, DOI 10.1002/art.39086; Zhang Y, 2014, J DENT RES, V93, P1095, DOI 10.1177/0022034514552676; Zhang YY, 2015, INT J CLIN EXP MED, V8, P16352; Zhang YF, 2015, J BONE MINER RES, V30, P286, DOI 10.1002/jbmr.2322	50	21	22	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3487	3501		10.1096/fj.201700217R	http://dx.doi.org/10.1096/fj.201700217R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29394106	Green Published			2022-12-26	WOS:000435104500002
J	He, SR; Wang, CS; Du, XJ; Chen, YN; Zhao, JM; Tian, BL; Lu, HM; Zhang, Y; Liu, JP; Yang, G; Li, L; Li, HX; Cheng, JQ; Lu, YR				He, Sirong; Wang, Chengshi; Du, Xiaojiong; Chen, Younan; Zhao, Jiuming; Tian, Bole; Lu, Huimin; Zhang, Yi; Liu, Jingping; Yang, Guang; Li, Lan; Li, Hongxia; Cheng, Jingqiu; Lu, Yanrong			MSCs promote the development and improve the function of neonatal porcine islet grafts	FASEB JOURNAL			English	Article						neonatal porcine islets; MSCs; development; proliferation; islet xenotransplantation	MESENCHYMAL STEM-CELLS; PANCREATIC BETA-CELLS; INSULIN-PRODUCING CELLS; BONE-MARROW; IN-VITRO; ENDOCRINE PANCREAS; RHESUS-MONKEYS; TRANSPLANTATION; GROWTH; DIFFERENTIATION	Deficient insulin secretion caused by immaturity is the predominant disadvantage of neonatal porcine islets (NPIs) when they serve as a source for islet xenotransplantation. We hypothesize that the transplantation of NPIs with a combination of mesenchymal stem cells (MSCs) can accelerate NPI maturation and improve the engraftment and function of NPIs. After indirect coculturing with monkey MSCs over 21 d, insulin secretion and the expression of regulatory genes relevant to development were assessed in NPIs. NPIs alone or in combination with allogeneic MSCs were intraportally transplanted into diabetic monkeys. Glycemic control was monitored, and graft function was evaluated. Our results suggest that MSCs benefit both the development and proliferation of NPIs in the coexisting systems in vitro and in vivo. These effects are dependent on platelet-derived growth factor receptor-alpha and are relevant to the inhibition of downstream target Notch1 signaling and the activation of PI3K/protein kinase B signaling.	[He, Sirong; Wang, Chengshi; Chen, Younan; Zhao, Jiuming; Liu, Jingping; Yang, Guang; Li, Lan; Cheng, Jingqiu; Lu, Yanrong] Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Lab Transplant Engn & Immunol, 1 Keyuan 4th Rd,Gao Peng Ave, Chengdu 610041, Sichuan, Peoples R China; [Tian, Bole; Lu, Huimin; Zhang, Yi] Sichuan Univ, West China Hosp, Dept Pancreat Surg, Chengdu, Sichuan, Peoples R China; [He, Sirong] Chongqing Med Univ, Coll Basic Med, Dept Immunol, Chongqing, Peoples R China; [Li, Hongxia] Natl Ctr Safety Evaluat Tradit Chinese Med, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Chongqing Medical University	Cheng, JQ; Lu, YR (corresponding author), Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Lab Transplant Engn & Immunol, 1 Keyuan 4th Rd,Gao Peng Ave, Chengdu 610041, Sichuan, Peoples R China.	jqcheng@scu.edu.cn; luyanrong@scu.edu.cn	Liu, Jingping/P-8908-2019; wang, chengshi/AAX-4864-2021	wang, chengshi/0000-0002-0650-4109	Key Program of the Natural Science Foundation of China [30930088]; Natural Science Foundation of China [30872382, 81500590]; National Program for High Technology Research and Development of China [2012AA020702]	Key Program of the Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for High Technology Research and Development of China(National High Technology Research and Development Program of China)	This work was supported by the Key Program of the Natural Science Foundation of China (Grant 30930088), the Program of the Natural Science Foundation of China (30872382 and 81500590), and the National Program for High Technology Research and Development of China (2012AA020702). The authors declare no conflicts of interest.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Berman DM, 2010, DIABETES, V59, P2558, DOI 10.2337/db10-0136; Blyszczuk P, 2003, P NATL ACAD SCI USA, V100, P998, DOI 10.1073/pnas.0237371100; Burlacu A, 2013, STEM CELLS DEV, V22, P643, DOI 10.1089/scd.2012.0273; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Deng YB, 2005, CHINESE MED J-PEKING, V118, P1533; Ding YC, 2009, DIABETES, V58, P1797, DOI 10.2337/db09-0317; Du AP, 2009, DIABETES, V58, P2059, DOI 10.2337/db08-0987; Duprez IR, 2011, UPSALA J MED SCI, V116, P8, DOI 10.3109/03009734.2010.524320; Fiaschi-Taesch NM, 2008, DIABETES, V57, P2745, DOI 10.2337/db08-1085; Figliuzzi Marina, 2014, World J Stem Cells, V6, P163, DOI 10.4252/wjsc.v6.i2.163; Gao K, 2008, TRANSPL P, V40, P634, DOI 10.1016/j.transproceed.2008.01.053; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Hanley SC, 2011, J ENDOCRINOL, V211, P231, DOI 10.1530/JOE-11-0213; He SR, 2013, EXP BIOL MED, V238, P385, DOI 10.1177/1535370213477974; Heinis M, 2010, HORM RES PAEDIAT, V74, P77, DOI 10.1159/000314894; Jin S, 2008, CIRC RES, V102, P1483, DOI 10.1161/CIRCRESAHA.107.167965; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Korbutt GS, 2009, XENOTRANSPLANTATION, V16, P223, DOI 10.1111/j.1399-3089.2009.00542.x; Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649; Krishnamurthy M, 2011, ENDOCRINOLOGY, V152, P424, DOI 10.1210/en.2010-0877; Li HT, 2012, BIOCHEM BIOPH RES CO, V420, P793, DOI 10.1016/j.bbrc.2012.03.076; Lu YR, 2010, CELL BIOCHEM FUNCT, V28, P637, DOI 10.1002/cbf.1701; MacKenzie DA, 2003, TRANSPLANTATION, V76, P887, DOI 10.1097/01.TP.0000087114.18315.17; Moriscot C, 2005, STEM CELLS, V23, P594, DOI 10.1634/stemcells.2004-0123; Mundra V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077591; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Park KS, 2010, TRANSPLANTATION, V89, P509, DOI 10.1097/TP.0b013e3181c7dc99; Rutter W J, 1978, Symp Soc Dev Biol, P205; Servitja JM, 2004, DIABETOLOGIA, V47, P597, DOI 10.1007/s00125-004-1368-9; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Thompson P, 2011, AM J TRANSPLANT, V11, P2593, DOI 10.1111/j.1600-6143.2011.03720.x; Tsaniras SC, 2010, J ENDOCRINOL, V206, P13, DOI 10.1677/JOE-10-0073; Wang ZW, 2007, CANCER RES, V67, P11377, DOI 10.1158/0008-5472.CAN-07-2803; Weir G C, 1997, Ann Transplant, V2, P63; Wu H, 2011, MOL PHARMACEUT, V8, P1458, DOI 10.1021/mp200135e; Yang KM, 2014, ROM J MORPHOL EMBRYO, V55, P305; Yang YG, 2007, NAT REV IMMUNOL, V7, P519, DOI 10.1038/nri2099; You H, 2009, ENDOCRINOLOGY, V150, P5455, DOI 10.1210/en.2009-0468; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhang S, 2012, J AM ASSOC LAB ANIM, V51, P842	45	11	12	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3242	3253		10.1096/fj.201700991R	http://dx.doi.org/10.1096/fj.201700991R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401607				2022-12-26	WOS:000432546000028
J	Wan, M; Tang, X; Rekha, RS; Muvva, SSVJR; Brighenti, S; Agerberth, B; Haeggstrom, JZ				Wan, Min; Tang, Xiao; Rekha, Rokeya Sultana; Muvva, S. S. V. Jagadeeswara Rao; Brighenti, Susanna; Agerberth, Birgitta; Haeggstrom, Jesper Z.			Prostaglandin E-2 suppresses hCAP18/LL-37 expression in human macrophages via EP2/EP4: implications for treatment of Mycobacterium tuberculosis infection	FASEB JOURNAL			English	Article						eicosanoids; cathelicidin; innate immunity; vitamin D-3; cAMP	VITAMIN-D-RECEPTOR; ANTIMICROBIAL PEPTIDES; CATHELICIDIN LL-37; INNATE IMMUNITY; CUTTING EDGE; I INTERFERON; CAMP; GENE; PROTEIN; AUTOREGULATION	Prostaglandin (PG)E-2 is an arachidonic acid-derived lipid mediator that plays an important role in inflammation and immunity. In this study, we demonstrate that PGE(2) suppresses basal and 1,25-dihydroxy vitamin D-3 (VD3)-induced expression of hCAP18/LL-37 via E prostanoid (EP)(2) and EP4 receptors. In humans, VD3 upregulates vitamin D receptor (VDR) expression and promotes transcription of the cathelicidin hCAP18/LL-37 gene, whereas PGE(2) counteracts this effect. We find that PGE(2) induces the cAMP/PKA-signaling pathway and enhances the expression of the inhibitory transcription factor cAMP-responsive modulator/inducible cAMP early repressor, which prevents VDR expression and induction of hCAP18/LL-37 in human macrophages. The negative regulation by PGE(2) was evident in M1- and M2-polarized human macrophages, although PGE(2) displayed more profound inhibitory effects in M2 cells. PGE(2) impaired VD3-induced expression of cathelicidin and concomitant activation of autophagy during Mycobacterium tuberculosis (Mtb) infection and facilitated intracellular Mtb growth in human macrophages. An EP4 agonist also significantly promoted Mtb survival in human macrophages. Our results indicate that PGE(2) inhibits hCAP18/LL-37 expression, especially VD3-induced cathelicidin and autophagy, which may reduce host defense against Mtb. Accordingly, antagonists of EP4 may constitute a novel adjunctive therapy in Mtb infection.	[Wan, Min; Tang, Xiao; Haeggstrom, Jesper Z.] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, Stockholm, Sweden; [Rekha, Rokeya Sultana; Agerberth, Birgitta] Karolinska Univ Hosp, Dept Lab Med, Stockholm, Sweden; [Muvva, S. S. V. Jagadeeswara Rao; Brighenti, Susanna] Karolinska Univ Hosp, Ctr Infect Med, Stockholm, Sweden; [Wan, Min] Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Wan, M (corresponding author), Karolinska Univ Hosp, Stockholm, Sweden.; Wan, M (corresponding author), Karolinska Inst, Alfred Nobels Alle 8, S-14186 Stockholm, Sweden.	min.wan@ki.se	Brighenti, Susanna/AAA-2255-2022	Brighenti, Susanna/0000-0001-8540-153X	Swedish Research Council [10350, 2016-01496]; Swedish Research Council (Linneus Grant CERIC); NovoNordisk Foundation [NNF15CC0018346, NNF15CC0018486]; Clas Groschinskys memorial foundation; Eva and Oscar Ahrens Foundation; Lars Hierta Memorial Foundation; China Scholarship Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council (Linneus Grant CERIC)(Swedish Research Council); NovoNordisk Foundation(Novo Nordisk Foundation); Clas Groschinskys memorial foundation; Eva and Oscar Ahrens Foundation; Lars Hierta Memorial Foundation; China Scholarship Council(China Scholarship Council)	The authors thank Devaraj Basavarajappa (Karolinska Insitutet) for generating and sharing mPGES knockdown cells; Gudmundur H. Gudmundsson (University of Iceland, Reykjavik, Iceland), Martin Rottenberg (Karolinska Institutet), Yu Gao (Karolinska Institutet), and Rubhana Raqib (International Center for Diarrheal Disease Research, Dhaka, Bangladesh) for scientific discussions; and Peter Bergman (Karolinska Institutet) for critically reading the manuscript and advice. This study was supported by the Swedish Research Council (Grants 10350 and 2016-01496, and Linneus Grant CERIC), the NovoNordisk Foundation (Grant NNF15CC0018346 and NNF15CC0018486), the Clas Groschinskys memorial foundation, the Eva and Oscar Ahrens Foundation, and the Lars Hierta Memorial Foundation. X.T. is supported by a Ph.D. stipend from the China Scholarship Council. M.W. and X.T. are co-first authors. The authors declare no conflicts of interest.	Agard M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00045; Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; Byrne ST, 2007, J ANTIMICROB CHEMOTH, V59, P313, DOI 10.1093/jac/dkl486; Chakraborty K, 2008, CELL MICROBIOL, V10, P2520, DOI 10.1111/j.1462-5822.2008.01227.x; Chakraborty K, 2009, J BIOL CHEM, V284, P21810, DOI 10.1074/jbc.M109.001180; Chen JJ, 2015, IEEE INT CONF COMM, P1, DOI 10.1109/ICCW.2015.7247066; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Coulombe F, 2014, IMMUNITY, V40, P554, DOI 10.1016/j.immuni.2014.02.013; Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Gupta S, 2017, J PATHOL, V242, P52, DOI 10.1002/path.4878; Hirata T, 2012, ADV IMMUNOL, V116, P143, DOI 10.1016/B978-0-12-394300-2.00005-3; Kahlenberg JM, 2013, J IMMUNOL, V191, P4895, DOI 10.4049/jimmunol.1302005; Kai-Larsen Y, 2008, FRONT BIOSCI, V13, P3760, DOI 10.2741/2964; Katzenback Barbara A., 2015, Biology-Basel, V4, P607, DOI 10.3390/biology4040607; Kaul V, 2012, J INFECT DIS, V206, P1816, DOI 10.1093/infdis/jis609; Konya V, 2013, PHARMACOL THERAPEUT, V138, P485, DOI 10.1016/j.pharmthera.2013.03.006; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Martineau AR, 2007, J IMMUNOL, V178, P7190, DOI 10.4049/jimmunol.178.11.7190; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Nakao K, 2007, J PHARMACOL EXP THER, V322, P686, DOI 10.1124/jpet.107.122010; O'Brien AJ, 2014, NAT MED, V20, P522, DOI 10.1038/nm.3516; Peres-Buzalaf C, 2011, PROSTAG LEUKOTR ESS, V85, P75, DOI 10.1016/j.plefa.2011.04.024; Pike JW, 2010, ENDOCRIN METAB CLIN, V39, P255, DOI 10.1016/j.ecl.2010.02.007; Rekha RS, 2015, AUTOPHAGY, V11, P1688, DOI 10.1080/15548627.2015.1075110; Sassone-Corsi P., 2012, COLD SPRING HARB PER, V4; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Schmidt M, 2013, PHARMACOL REV, V65, P670, DOI 10.1124/pr.110.003707; Silva JP, 2016, BIOTECHNOL ADV, V34, P924, DOI 10.1016/j.biotechadv.2016.05.007; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Valdez PA, 2012, IMMUNITY, V36, P668, DOI 10.1016/j.immuni.2012.02.013; Vilaplana C, 2013, J INFECT DIS, V208, P199, DOI 10.1093/infdis/jit152; Wan M, 2007, FASEB J, V21, P2897, DOI 10.1096/fj.06-7974com; Wan M, 2014, FASEB J, V28, P3456, DOI 10.1096/fj.14-251306; Wan M, 2011, FASEB J, V25, P1697, DOI 10.1096/fj.10-175687; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Zaslona Z, 2012, BLOOD, V119, P2358, DOI 10.1182/blood-2011-08-374207; Zella LA, 2007, J STEROID BIOCHEM, V103, P435, DOI 10.1016/j.jsbmb.2006.12.019; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	45	23	24	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2827	2840		10.1096/fj.201701308	http://dx.doi.org/10.1096/fj.201701308			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401596				2022-12-26	WOS:000432528000041
J	Li, XY; Liu, LJ; Yang, HJ; Li, Y				Li, Xiaoyu; Liu, Lijuan; Yang, Huijin; Li, Yan			Relationships between carbon fluxes and environmental factors in a drip-irrigated, film-mulched cotton field in arid region	PLOS ONE			English	Article							WATER-USE EFFICIENCY; NET ECOSYSTEM EXCHANGE; STAND-SCALE TRANSPIRATION; VAPOR-PRESSURE DEFICIT; JARVIS-STEWART MODEL; PLASTIC FILM; EDDY COVARIANCE; DIOXIDE EXCHANGE; CO2 FLUXES; INTERANNUAL VARIATIONS	Environmental factors and human activities play important roles in carbon fixation and emissions generated from croplands. Eddy covariance measurements in a drip-irrigated, film-mulched cotton field were used to analyze the relationships between carbon fluxes and environmental factors in Wulanwusu, northern Xinjiang, an arid region of Northwest China. Our results showed that the cumulative net carbon flux (NEE) was -304.8 g Cm-2 (a strong sink) over the whole cotton growing season in 2012, which was more than that in cotton cropland without plastic film mulching and drip-irrigation. Moreover, when time is scaled up from a half-hour to a month, the correlations of gross primary production (GPP) to air temperature (T-air), net solar radiation (R-n) and soil water content (SWC) gradually become stronger due to ecosystem resistance and resilience as well as the protection of plastic film mulching. The GPP is more strongly correlated with R-n than T-air at time scales from minutes to days, while it reverses at time scales from days to weeks. This outcome is largely determined by the biochemical characteristics of photosynthesis. SWC and vapor pressure deficit (VPD) at all time scales are weakly correlated with GPP because plastic film mulching and regularly drip-irrigation allow soil to maintain sufficient water.	[Li, Xiaoyu; Liu, Lijuan; Li, Yan] Zhejiang A&F Univ, State Key Lab Subtrop Silviculture, Linan, Peoples R China; [Li, Xiaoyu] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Xinjiang, Peoples R China; [Yang, Huijin] Wuhan Univ, Sch Remote Sensing & Informat Engn, Wuhan, Hubei, Peoples R China	Zhejiang A&F University; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Wuhan University	Li, Y (corresponding author), Zhejiang A&F Univ, State Key Lab Subtrop Silviculture, Linan, Peoples R China.	liyan2016@zafu.edu.cn	yang, huijin/AAK-9960-2021		973 Program of China [2014CB954204]; National Natural Science Foundation of China [31470708, U1503182, 41501205, 41271202]	973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work received financial support from the 973 Program of China (No. 2014CB954204), National Natural Science Foundation of China (No. 31470708, U1503182, 41501205 & 41271202).	An TT, 2015, SOIL BIOL BIOCHEM, V80, P53, DOI 10.1016/j.soilbio.2014.09.024; ANTONIA RA, 1993, EXP FLUIDS, V14, P203; Aubinet M, 2000, ADV ECOL RES, V30, P113, DOI 10.1016/S0065-2504(08)60018-5; Bai J, 2015, J ARID LAND, V7, P272, DOI 10.1007/s40333-014-0012-x; Baker JT, 2009, AGRON J, V101, P52, DOI 10.2134/agronj2008.0007x; Baldocchi D, 1998, AGR FOREST METEOROL, V90, P1, DOI 10.1016/S0168-1923(97)00072-5; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Baldocchi DD, 2003, GLOBAL CHANGE BIOL, V9, P479, DOI 10.1046/j.1365-2486.2003.00629.x; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Berger S, 2013, AGR ECOSYST ENVIRON, V167, P43, DOI 10.1016/j.agee.2013.01.010; Bergeron O, 2007, GLOBAL CHANGE BIOL, V13, P89, DOI 10.1111/j.1365-2486.2006.01281.x; Beringer J, 2013, AGR FOREST METEOROL, V182, P239, DOI 10.1016/j.agrformet.2013.06.008; Beziat P, 2009, AGR FOREST METEOROL, V149, P1628, DOI 10.1016/j.agrformet.2009.05.004; Bristow KL, 1996, THEOR APPL CLIMATOL, V54, P85, DOI 10.1007/BF00863561; Broeckx LS, 2014, GCB BIOENERGY, V6, P473, DOI 10.1111/gcbb.12087; Burba G, 2006, 27 C AGR FOR MET; Cai WW, 2014, J GEOPHYS RES-BIOGEO, V119, P110, DOI 10.1002/2013JG002456; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Conaty WC, 2014, FUNCT PLANT BIOL, V41, P535, DOI 10.1071/FP13223; Cuello JP, 2015, APPL SOIL ECOL, V91, P48, DOI 10.1016/j.apsoil.2015.02.007; De Luca V, 2000, J AGR ENG RES, V77, P93, DOI 10.1006/jaer.2000.0565; Flanagan LB, 2002, GLOBAL CHANGE BIOL, V8, P599, DOI 10.1046/j.1365-2486.2002.00491.x; Ge ZM, 2011, AGR FOREST METEOROL, V151, P191, DOI 10.1016/j.agrformet.2010.10.003; Giasson MA, 2006, AGR FOREST METEOROL, V140, P23, DOI 10.1016/j.agrformet.2006.08.001; Goulden ML, 1996, GLOBAL CHANGE BIOL, V2, P169, DOI 10.1111/j.1365-2486.1996.tb00070.x; Hollings S., 1985, RESILENCE ECOSYSTEMS; Jaksic V, 2006, AGR FOREST METEOROL, V139, P323, DOI 10.1016/j.agrformet.2006.07.009; Kolari P, 2004, GLOBAL CHANGE BIOL, V10, P1106, DOI 10.1111/j.1529-8817.2003.00797.x; Lei HM, 2010, GLOBAL CHANGE BIOL, V16, P2944, DOI 10.1111/j.1365-2486.2009.02136.x; Li J., 2014, THESIS; Li SX, 2013, AGR WATER MANAGE, V116, P39, DOI 10.1016/j.agwat.2012.10.004; Li YS, 2007, SOIL TILL RES, V93, P370, DOI 10.1016/j.still.2006.05.010; Li Z, 2014, J AGR SCI-CAMBRIDGE, V152, P534, DOI 10.1017/S0021859613000701; Li Z, 2005, SCI CHINA SER D, V34, P46; Li ZG, 2011, PEDOSPHERE, V21, P178, DOI 10.1016/S1002-0160(11)60116-1; Liao Y, 2004, AGR SCI CHINA, V4, P865; Ling HB, 2013, QUATERN INT, V286, P116, DOI 10.1016/j.quaint.2012.07.027; Liu CA, 2013, EUR J SOIL BIOL, V57, P9, DOI 10.1016/j.ejsobi.2013.03.007; [刘贤赵 Liu Xianzhao1], 2014, [地球科学进展, Advance in Earth Sciences], V29, P216; Liu Y, 2010, ACTA AGR SCAND B-S P, V60, P245, DOI 10.1080/09064710902878121; Miller AE, 2002, OECOLOGIA, V130, P609, DOI 10.1007/s00442-001-0838-8; Niu SL, 2011, GLOBAL CHANGE BIOL, V17, P3102, DOI 10.1111/j.1365-2486.2011.02459.x; Oelbermann M, 2004, AGR ECOSYST ENVIRON, V104, P359, DOI 10.1016/j.agee.2004.04.001; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Saigusa N, 2008, AGR FOREST METEOROL, V148, P700, DOI 10.1016/j.agrformet.2007.12.006; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Tong XJ, 2014, J HYDROL, V512, P221, DOI 10.1016/j.jhydrol.2014.02.042; Tubiello FN, 1999, AGRON J, V91, P247, DOI 10.2134/agronj1999.00021962009100020012x; Velasco E, 2005, ATMOS ENVIRON, V39, P7433, DOI 10.1016/j.atmosenv.2005.08.038; Vourlitis GL, 2000, ECOL APPL, V10, P60, DOI 10.1890/1051-0761(2000)010[0060:PMFSPM]2.0.CO;2; Wang GS, 2016, AGR WATER MANAGE, V163, P403, DOI 10.1016/j.agwat.2015.10.012; Wang Yu-Hui, 2014, Chinese Journal of Plant Ecology, V38, P795, DOI 10.3724/SP.J.1258.2014.00075; Watson R.T., 1996, CLIMATE CHANGE 1995; Watson R. T., 1990, GREENHOUSE GASES AER; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Whitley R, 2008, PLANT SOIL, V305, P35, DOI 10.1007/s11104-007-9399-x; Whitley R, 2013, HYDROL PROCESS, V27, P1133, DOI 10.1002/hyp.9280; Whitley R, 2009, J HYDROL, V373, P256, DOI 10.1016/j.jhydrol.2009.04.036; Whitley RJ, 2011, GLOBAL CHANGE BIOL, V17, P3130, DOI 10.1111/j.1365-2486.2011.02425.x; Williams M, 1998, PLANT CELL ENVIRON, V21, P953, DOI 10.1046/j.1365-3040.1998.00339.x; Wilson K, 2002, AGR FOREST METEOROL, V113, P223, DOI 10.1016/S0168-1923(02)00109-0; Wu J, 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1007/S40515-014-0013-4; Wu YH, 1996, AGR FOREST METEOROL, V81, P299, DOI 10.1016/0168-1923(95)02320-8; Xue QW, 2004, ENVIRON EXP BOT, V51, P167, DOI 10.1016/j.envexpbot.2003.09.003; Yang QD, 2012, J HYDROL, V452, P102, DOI 10.1016/j.jhydrol.2012.05.041; Yoshimoto M, 2005, AGR FOREST METEOROL, V133, P226, DOI 10.1016/j.agrformet.2005.09.010; Zhang F, 2015, ARID LAND RES MANAG, V29, P432, DOI 10.1080/15324982.2015.1018456; Zhang QQ, 2012, ENVIRON EARTH SCI, V66, P683, DOI 10.1007/s12665-011-1276-5; Zhang SL, 2011, SOIL TILL RES, V112, P92, DOI 10.1016/j.still.2010.11.006; Zhou LM, 2015, SOIL TILL RES, V150, P21, DOI 10.1016/j.still.2015.01.006; Zhou LM, 2012, FIELD CROP RES, V126, P181, DOI 10.1016/j.fcr.2011.10.010; Zhou SQ, 2012, HYDROL PROCESS, V26, P1169, DOI 10.1002/hyp.8208; Zhu ZL, 2006, SCI CHINA SER D, V49, P36, DOI 10.1007/s11430-006-8036-5	73	12	13	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2018	13	2							e0192467	10.1371/journal.pone.0192467	http://dx.doi.org/10.1371/journal.pone.0192467			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1MC	29415018	Green Submitted, Green Published, gold			2022-12-26	WOS:000424325300078
J	Zahr, NM				Zahr, Natalie M.			Peripheral TNF alpha elevations in abstinent alcoholics are associated with hepatitis C infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TUMOR-NECROSIS-FACTOR; HIV-ASSOCIATED DEMENTIA; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; BRAIN-SLICE CULTURES; USE DISORDERS; LIVER-FIBROSIS; CHEMOATTRACTANT PROTEIN-1; ANTIRETROVIRAL THERAPY	Substantial evidence supports the view that inflammatory processes contribute to brain alterations in HIV infection. Mechanisms recently proposed to underlie neuropathology in Alcohol Use Disorder (AUD) include elevations in peripheral cytokines that sensitize the brain to the damaging effects of alcohol. This study included 4 groups: healthy controls, individuals with AUD (abstinent from alcohol at examination), those infected with HIV, and those comorbid for HIV and AUD. The aim was to determine whether inflammatory cytokines are elevated in AUD as they are in HIV infection. Cytokines showing group differences included interferon gamma-induced protein 10 (IP-10) and tumor necrosis factor alpha (TNF alpha). Follow-up t-tests revealed that TNF alpha and IP-10 were higher in AUD than controls but only in AUD patients who were seropositive for Hepatitis C virus (HCV). Specificity of TNF alpha and IP-10 elevations to HCV infection status was provided by correlations between cytokine levels and HCV viral load and indices of liver integrity including albumin/globulin ratio, fibrosis scores, and AST/platelet count ratio. Because TNF alpha levels were mediated by HCV infection, this study provides no evidence for elevations in peripheral cytokines in "uncomplicated", abstinent alcoholics, independent of liver disease or HCV infection. Nonetheless, these results corroborate evidence for elevations in IP-10 and TNF alpha in HIV and for IP-10 levels in HIV+HCV co-infection.	[Zahr, Natalie M.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Zahr, Natalie M.] SRI Int, Neurosci Dept, Menlo Pk, CA 94025 USA	Stanford University; SRI International	Zahr, NM (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.; Zahr, NM (corresponding author), SRI Int, Neurosci Dept, Menlo Pk, CA 94025 USA.	nzahr@stanford.edu	Zahr, Natalie/W-5292-2019; Zahr, Natalie/L-7692-2016	Zahr, Natalie/0000-0002-3346-4894	National Institute of Alcohol Abuse and Alcoholism (NIAAA) [U01 AA017347, U01 AA013521, K05 AA017168, R01 AA005965, R37 AA010723]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA005965, U01AA017347, U01AA013521] Funding Source: NIH RePORTER	National Institute of Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported with grant funding from the National Institute of Alcohol Abuse and Alcoholism (NIAAA) including U01 AA017347, U01 AA013521, K05 AA017168, R01 AA005965, R37 AA010723. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afford SC, 1998, J PATHOL, V186, P82, DOI 10.1002/(SICI)1096-9896(199809)186:1<82::AID-PATH151>3.0.CO;2-D; Agrawal RG, 2011, BRAIN BEHAV IMMUN, V25, pS165, DOI 10.1016/j.bbi.2011.03.002; Alfonso-Loeches S, 2012, GLIA, V60, P948, DOI 10.1002/glia.22327; Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Andersson J, 1998, AIDS, V12, pF123, DOI 10.1097/00002030-199811000-00004; Auguet T, 2010, ALCOHOL, V44, P211, DOI 10.1016/j.alcohol.2010.02.007; Augustynska B, 2015, ACTA BIOCHIM POL, V62, P63, DOI 10.18388/abp.2014_772; Tran BX, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-27; Bagyinszky E, 2017, J NEUROL SCI, V376, P242, DOI 10.1016/j.jns.2017.03.031; Bajo M, 2015, BRAIN BEHAV IMMUN, V45, P189, DOI 10.1016/j.bbi.2014.11.011; Bajo M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00049; Banerjee A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140498; Barve S, 2010, ALCOHOL RES HEALTH, V33, P229; Bautista AP, 1997, HEPATOLOGY, V25, P335, DOI 10.1002/hep.510250214; Baxter-Potter LN, 2017, NEUROSCIENCE, V346, P238, DOI 10.1016/j.neuroscience.2017.01.015; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Beech RD, 2012, ALCOHOL CLIN EXP RES, V36, P1487, DOI 10.1111/j.1530-0277.2012.01775.x; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Blednov YA, 2005, BEHAV BRAIN RES, V165, P110, DOI 10.1016/j.bbr.2005.06.026; Blednov YA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00129; Blednov YA, 2012, ADDICT BIOL, V17, P108, DOI 10.1111/j.1369-1600.2010.00284.x; Bonacini M, 2011, ANN HEPATOL, V10, P502, DOI 10.1016/S1665-2681(19)31519-4; Braithwaite RS, 2007, AIDS CARE, V19, P459, DOI 10.1080/09540120601095734; Catalfamo M, 2012, CYTOKINE GROWTH F R, V23, P207, DOI 10.1016/j.cytogfr.2012.05.007; Cohen RA, 2011, J NEUROIMMUNOL, V233, P204, DOI 10.1016/j.jneuroim.2010.11.006; Conigliaro J, 2006, MED CARE, V44, pS1, DOI 10.1097/01.mlr.0000223659.36369.cf; Cook RL, 2001, J GEN INTERN MED, V16, P83, DOI 10.1111/j.1525-1497.2001.00122.x; Correia S, 2013, J NEUROIMMUNOL, V265, P117, DOI 10.1016/j.jneuroim.2013.09.005; Corrigan F, 2015, BRAIN BEHAV IMMUN, V45, P245, DOI 10.1016/j.bbi.2014.12.019; Cosenza MA, 2002, BRAIN PATHOL, V12, P442, DOI 10.1111/j.1750-3639.2002.tb00461.x; Crews FT., 2017, NEUROPHARMACOLOGY; Crews F, 2006, ALCOHOL CLIN EXP RES, V30, P1938, DOI 10.1111/j.1530-0277.2006.00239.x; Crews FT, 2013, BIOL PSYCHIAT, V73, P602, DOI 10.1016/j.biopsych.2012.09.030; Cui SQ, 2015, BRAZ J MED BIOL RES, V48, P515, DOI 10.1590/1414-431X20144250; Daniluk J, 2001, ALCOHOL, V23, P29, DOI 10.1016/S0741-8329(00)00134-8; Davis RL, 2004, NEUROSCI LETT, V371, P128, DOI 10.1016/j.neulet.2004.08.051; de Timary P, 2017, NEUROPHARMACOLOGY; El Serafy MA, 2017, ARAB J GASTROENTEROL, V18, P51, DOI 10.1016/j.ajg.2017.05.005; ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766; Fernandez-Lizarbe S, 2009, J IMMUNOL, V183, P4733, DOI 10.4049/jimmunol.0803590; First M. B., 1998, STRUCTURED CLIN INTE; Fischer-Smith T, 2004, AM J PATHOL, V164, P2089, DOI 10.1016/S0002-9440(10)63767-4; Flatscher-Bader T, 2005, J NEUROCHEM, V93, P359, DOI 10.1111/j.1471-4159.2004.03021.x; Fouad SA, 2012, WORLD J GASTROENTERO, V18, P2988, DOI 10.3748/wjg.v18.i23.2988; Franchi S, 2010, INT J IMMUNOPATH PH, V23, P847, DOI 10.1177/039463201002300320; Freeman K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-97; Fuller BE, 2009, CURR OPIN PSYCHIATR, V22, P401, DOI 10.1097/YCO.0b013e32832cadb9; Fuster D, 2014, AIDS, V28, P1059, DOI 10.1097/QAD.0000000000000184; Fuster D, 2013, AIDS RES HUM RETROV, V29, P1110, DOI [10.1089/aid.2012.0348, 10.1089/AID.2012.0348]; Garcia-Valdecasas-Campelo E, 2007, ALCOHOL ALCOHOLISM, V42, P533, DOI 10.1093/alcalc/agm065; Gaydos J, 2016, AM J PHYSIOL-LUNG C, V310, pL507, DOI 10.1152/ajplung.00242.2015; Gendelman HE, 1997, AIDS, V11, pS35; GENDELMAN HE, 1994, RES IMMUNOL, V145, P679, DOI 10.1016/S0923-2494(05)80054-9; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; Gonzalez-Quintela A, 2000, CYTOKINE, V12, P1437, DOI 10.1006/cyto.2000.0715; Gonzalez-Quintela A, 2008, ALCOHOL, V42, P513, DOI 10.1016/j.alcohol.2008.04.008; Gonzalez-Reimers E, 2012, ALCOHOL ALCOHOLISM, V47, P390, DOI 10.1093/alcalc/ags041; Gonzalez-Reimers E, 2011, ALCOHOL ALCOHOLISM, V46, P529, DOI 10.1093/alcalc/agr064; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Graham CS, 2007, J INFECT DIS, V195, P847, DOI 10.1086/511990; Grovit-Ferbas K, 2010, IMMUNOL RES, V48, P40, DOI 10.1007/s12026-010-8166-x; HAASE AT, 1986, MICROB PATHOGENESIS, V1, P1, DOI 10.1016/0882-4010(86)90026-4; Hajarizadeh B, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0482-x; Harper KM, 2015, ALCOHOL CLIN EXP RES, V39, P2375, DOI 10.1111/acer.12898; Harris RA, 2017, J NEUROSCI, V37, P1139, DOI 10.1523/JNEUROSCI.2002-16.2016; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; Heberlein A, 2014, ALCOHOL, V48, P671, DOI 10.1016/j.alcohol.2014.08.003; HILL DB, 1993, HEPATOLOGY, V18, P576, DOI 10.1016/0270-9139(93)90358-T; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Hoyt LR, 2017, REDOX BIOL, V12, P883, DOI 10.1016/j.redox.2017.04.020; Irwin M, 2004, BRAIN BEHAV IMMUN, V18, P349, DOI 10.1016/j.bbi.2004.02.001; Jaatinen P, 2003, ALCOHOL, V29, P91, DOI 10.1016/S0741-8329(03)00002-8; Jiao YM, 2012, VIRAL IMMUNOL, V25, P333, DOI 10.1089/vim.2012.0011; June HL, 2015, NEUROPSYCHOPHARMACOL, V40, P1549, DOI 10.1038/npp.2015.4; Karlsson C, 2016, ADDICTION BIOL; Karnofsky DA, 1949, EVALUATION CHEMOTHER, P191; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Keating SM, 2011, AIDS, V25, P1823, DOI 10.1097/QAD.0b013e3283489d1f; Kebir O, 2011, EUR ADDICT RES, V17, P146, DOI 10.1159/000324849; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Knapp DJ, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6030025; Kramer-Hammerle S, 2005, VIRUS RES, V111, P194, DOI 10.1016/j.virusres.2005.04.009; LAHDEVIRTA J, 1988, AM J MED, V85, P289, DOI 10.1016/0002-9343(88)90576-1; Lane BR, 2003, VIROLOGY, V307, P122, DOI 10.1016/S0042-6822(02)00045-4; Langford D, 2001, BRAIN PATHOL, V11, P306; Laso FJ, 1998, J HEPATOL, V28, P771, DOI 10.1016/S0168-8278(98)80226-2; Leclercq S, 2014, BIOL PSYCHIAT, V76, P725, DOI 10.1016/j.biopsych.2014.02.003; Leclercq S, 2012, BRAIN BEHAV IMMUN, V26, P911, DOI 10.1016/j.bbi.2012.04.001; Lee CH, 2013, CLIN MOL HEPATOL, V19, P376, DOI 10.3350/cmh.2013.19.4.376; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Lippai D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070945; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; Liu JA, 2011, P NATL ACAD SCI USA, V108, P4465, DOI 10.1073/pnas.1019020108; Maes M, 1998, PSYCHIAT RES, V78, P151, DOI 10.1016/S0165-1781(98)00010-9; Manzardo AM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040472; Marcondes MCG, 2008, ALCOHOL CLIN EXP RES, V32, P1583, DOI 10.1111/j.1530-0277.2008.00730.x; Marcos M, 2009, AM J EPIDEMIOL, V170, P948, DOI 10.1093/aje/kwp236; Marshall SA, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6020016; Masliah E, 2000, AIDS, V14, P69, DOI 10.1097/00002030-200001070-00008; Matta B, 2016, CURR HIV-AIDS REP, V13, P279, DOI 10.1007/s11904-016-0329-5; Mattis S, 1998, DEMENTIA RATING SCAL; Mayfield J, 2013, CURR OPIN NEUROBIOL, V23, P513, DOI 10.1016/j.conb.2013.01.024; Miguez MJ, 2003, ADDICT BIOL, V8, P33, DOI 10.1080/1355621031000069855; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Molina PE, 2006, ALCOHOL CLIN EXP RES, V30, P2065, DOI 10.1111/j.1530-0277.2006.00252.x; Neupane SP, 2014, CNS NEUROSCI THER, V20, P898, DOI 10.1111/cns.12303; Neupane SP, 2015, ALCOHOL, V49, P471, DOI 10.1016/j.alcohol.2015.01.012; Neupane SP, 2015, ALCOHOL CLIN EXP RES, V39, P514, DOI 10.1111/acer.12651; Okvist A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000930; Pascual M, 2016, ADDICTION BIOL; Pastor IJ, 2005, ALCOHOL CLIN EXP RES, V29, P1928, DOI 10.1097/01.alc.0000187595.19324.ca; Pastor L, 2017, CLIN INFECT DIS, V65, P1670, DOI 10.1093/cid/cix600; Pedersen KK, 2013, JAIDS-J ACQ IMM DEF, V63, P272, DOI 10.1097/QAI.0b013e318289bced; PELUSO R, 1985, VIROLOGY, V147, P231, DOI 10.1016/0042-6822(85)90246-6; Peters L, 2010, CURR OPIN HIV AIDS, V5, P517, DOI 10.1097/COH.0b013e32833e3ee6; Petry NM, 1999, INT J STD AIDS, V10, P561, DOI 10.1258/0956462991914654; Ploquin MJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005774; PULLIAM L, 1991, J CLIN INVEST, V87, P503, DOI 10.1172/JCI115024; Qin L, 2012, J NEUROINFLAMM, V9; Qin LY, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-10; Qu J, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-15; Reiberger T, 2008, ANTIVIR THER, V13, P969; Rezai-Zadeh K, 2009, J NEUROIMMUNE PHARM, V4, P462, DOI 10.1007/s11481-009-9166-2; Roe B, 2007, J INFECT DIS, V196, P1053, DOI 10.1086/520935; Ryan LA, 2001, J INFECT DIS, V184, P699, DOI 10.1086/323036; Samet JH, 2007, PANMINERVA MED, V49, P67; Samet JH, 2004, AIDS RES HUM RETROV, V20, P151, DOI 10.1089/088922204773004860; Scherzer R, 2017, AIDS, V31, P71, DOI 10.1097/QAD.0000000000001278; Schneider R, 2017, NEUROCHEM RES, V42, P2135, DOI 10.1007/s11064-017-2218-8; Serretti A, 2006, NEUROSCI LETT, V406, P107, DOI 10.1016/j.neulet.2006.07.003; Sevigny JJ, 2004, NEUROLOGY, V63, P2084, DOI 10.1212/01.WNL.0000145763.68284.15; SHERON N, 1991, CLIN EXP IMMUNOL, V84, P449; Skinner H., 1982, DEV VALIDATION LIFET; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; Soboka Matiwos, 2014, BMC Res Notes, V7, P828, DOI 10.1186/1756-0500-7-828; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; SULTANA C, 2013, HEPAT MON, V13; Swardfager W, 2016, NEUROSCI BIOBEHAV R, V64, P148, DOI 10.1016/j.neubiorev.2016.02.017; Tandon R, 2014, AIDS RES HUM RETROV, V30, P654, DOI [10.1089/aid.2014.0004, 10.1089/AID.2014.0004]; Tate JP, 2013, AIDS, V27, P563, DOI 10.1097/QAD.0b013e32835b8c7f; Thandassery RB, 2016, J CLIN GASTROENTEROL, V50, P518, DOI 10.1097/MCG.0000000000000489; Trepanier MO, 2016, MOL PSYCHIATR, V21, P1009, DOI 10.1038/mp.2016.90; Umhau JC, 2014, ALCOHOL CLIN EXP RES, V38, P1301, DOI 10.1111/acer.12367; Vaidya SA, 2014, J INFECT DIS, V210, P1042, DOI 10.1093/infdis/jiu206; Valenta JP, 2016, ALCOHOL CLIN EXP RES, V40, P187, DOI 10.1111/acer.12928; Viana MSVB, 2009, ANN HEPATOL, V8, P26, DOI 10.1016/S1665-2681(19)31807-1; VAZEUX R, 1987, AM J PATHOL, V126, P403; Vetreno RP, 2013, NEUROBIOL DIS, V59, P52, DOI 10.1016/j.nbd.2013.07.002; VONSYDOW M, 1991, AIDS RES HUM RETROV, V7, P375, DOI 10.1089/aid.1991.7.375; Ward RJ, 2009, J NEUROCHEM, V111, P1119, DOI 10.1111/j.1471-4159.2009.06389.x; Wechsler D., 2001, WECHSLER TEST ADULT; Weiss JM, 1999, J IMMUNOL, V163, P2953; Wiley CA, 2003, BRAIN PATHOL, V13, P415; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; Wiley CA, 2003, BRAIN PATHOLOGY ZURI, V13, P6; Wu Y, 2012, BRIT J PHARMACOL, V165, P1319, DOI 10.1111/j.1476-5381.2011.01572.x; Yamauchi M, 2001, ALCOHOL CLIN EXP RES, V25, p7S, DOI 10.1111/j.1530-0277.2001.tb02409.x; ZANGERLE R, 1994, IMMUNOL LETT, V41, P229, DOI 10.1016/0165-2478(94)90138-4; Zeremski M, 2007, JAIDS-J ACQ IMM DEF, V45, P262; Zink MC, 2001, J INFECT DIS, V184, P1015, DOI 10.1086/323478; Zou J, 2010, ALCOHOL CLIN EXP RES, V34, P777, DOI 10.1111/j.1530-0277.2010.01150.x; Zou JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087915; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014	164	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2018	13	2							e0191586	10.1371/journal.pone.0191586	http://dx.doi.org/10.1371/journal.pone.0191586			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FV1EC	29408932	Green Published, gold, Green Submitted			2022-12-26	WOS:000424302800022
J	Farah, G; Siwek, D; Cummings, P				Farah, George; Siwek, Donald; Cummings, Peter			Tau accumulations in the brains of woodpeckers	PLOS ONE			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; DISEASE; NEUROPATHOLOGY; DIAGNOSIS; INJURY	Woodpeckers experience forces up to 1200-1400 g while pecking. It is assumed due to evolutionary adaptations, the woodpecker is immune to brain injury. This assumption has led to the use of the woodpecker as a model in the development of sports safety equipment such as football helmets. However, it is unknown at this time if the woodpecker brain develops neuro-trauma in relation to the high g-forces experienced during pecking. The brains of 10 ethanol preserved woodpeckers and 5 ethanol preserved red-winged black bird experimental controls were examined using Gallyas silver stain and anti-phospho-tau. The results demonstrated perivascular and white matter tract silver-positive deposits in eight out of the 10 woodpecker brains. The tau positive accumulations were seen in white matter tracts in 2 of the 3 woodpeckers examined. No staining was identified in control birds. The negative staining of controls birds contrasted with the diffuse positive staining woodpecker sections suggest the possibility that pecking may induce the accumulation of tau in the woodpecker brain. Further research is needed to better understand the relationship.	[Farah, George; Siwek, Donald; Cummings, Peter] Boston Univ, Dept Anat & Neurobiol, Sch Med, Boston, MA 02118 USA	Boston University	Cummings, P (corresponding author), Boston Univ, Dept Anat & Neurobiol, Sch Med, Boston, MA 02118 USA.	pmc@bu.edu			Department of Anatomy and Neurobiology at the Boston University School of Medicine; Boston University School of Medicine's Department of Anatomy and Neurobiology Vesalius Grant	Department of Anatomy and Neurobiology at the Boston University School of Medicine; Boston University School of Medicine's Department of Anatomy and Neurobiology Vesalius Grant	Boston University School of Medicine's Department of Anatomy and Neurobiology Vesalius Grant was the source of funding for this project (to George Farah). With this grant, we were able to purchase laboratory materials such as antibodies and various chemicals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the two museums who believed in our project and generously donated the preserved museum specimens to our project. A large debt of gratitude to the Field Museum of Chicago, IL and its Ornithology Department for donating specimens: 379007, 379008, 379005, 379006, 379009, 291433, 291434, 291435, and 238695. Secondly, to the Harvard Museum of Natural History at Harvard University in Cambridge, MA. We would like to thank Dr. Scott Edwards and Mr. Jeremiah Trimble from the Ornithology Department at the Harvard Museum of Comparative Zoology for their enthusiasm and generous specimen donation for this project. Without both museums' help, we would not have been able to complete this project. Another thanks to the Department of Anatomy and Neurobiology at the Boston University School of Medicine for funding this project. We would also like to thank Dr. Brian Le for his editorial contribution to the production of this manuscript. Finally, Mr. Farah and Dr. Cummings would like to dedicate this manuscript to Dr. Donald Siwek who suddenly passed away during the writing of this manuscript. His wealth of knowledge and mentorship was unbounded and will be dearly missed.	[Anonymous], 2017, TRAUM BRAIN INJ RES; [Anonymous], 2017, IHC STAIN PROT PAR F; Bailes JE, 2007, J ATHL TRAINING, V42, P126; BUEE L, 1994, ACTA NEUROPATHOL, V87, P469; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Kingsbury MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020720; MAY PRA, 1976, LANCET, V1, P454; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mehta P.S., 2016, SAE TECH PAP, DOI [10.4271/2016-01-0396, DOI 10.4271/2016-01-0396]; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Rubenstein R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0435-7; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Uchihara T, 2007, ACTA NEUROPATHOL, V113, P483, DOI 10.1007/s00401-007-0200-2	15	14	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191526	10.1371/journal.pone.0191526	http://dx.doi.org/10.1371/journal.pone.0191526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	29394252	Green Published, Green Submitted, gold			2022-12-26	WOS:000424060400013
J	Hubscher, CH; Herrity, AN; Williams, CS; Montgomery, LR; Willhite, AM; Angeli, CA; Harkema, SJ				Hubscher, Charles H.; Herrity, April N.; Williams, Carolyn S.; Montgomery, Lynnette R.; Willhite, Andrea M.; Angeli, Claudia A.; Harkema, Susan J.			Improvements in bladder, bowel and sexual outcomes following task-specific locomotor training in human spinal cord injury	PLOS ONE			English	Article							URINARY-TRACT DYSFUNCTION; AUTONOMIC DYSREFLEXIA; SACRAL NEUROMODULATION; MOTONEURON PROPERTIES; ANTIDIURETIC-HORMONE; VOLUNTARY MOVEMENTS; NOCTURNAL POLYURIA; NEUROGENIC BLADDER; PERIPHERAL CONTROL; PHYSICAL-ACTIVITY	Objective Locomotor training (LT) as a therapeutic intervention following spinal cord injury (SCI) is an effective rehabilitation strategy for improving motor outcomes, but its impact on non-locomotor functions is unknown. Given recent results of our labs' pre-clinical animal SCI LT studies and existing overlap of lumbosacral spinal circuitries controlling pelvic-visceral and locomotor functions, we addressed whether LT can improve bladder, bowel and sexual function in humans at chronic SCI time-points (> two years post-injury). Study design Prospective cohort study; pilot trial with small sample size. Methods Eight SCI research participants who were undergoing 80 daily one- hour sessions of LT on a treadmill using body-weight support, or one- hour of LT and stand training on alternate days, as part of another research study conducted at the Kentucky Spinal Cord Injury Research Center, University of Louisville, were enrolled in this pilot trial. Urodynamic assessments were performed and International Data Set questionnaire forms completed for bladder, bowel and sexual functions at pre-and post-training time points. Four usual care (nontrained; regular at-home routine) research participants were also enrolled in this study and had the same assessments collected twice, at least 3 months apart. Results Filling cystometry documented significant increases in bladder capacity, voiding efficiency and detrusor contraction time as well as significant decreases in voiding pressure post- training relative to baseline. Questionnaires revealed a decrease in the frequency of nocturia and urinary incontinence for several research participants as well as a significant decrease in time required for defecation and a significant increase in sexual desire post-training. No significant differences were found for usual care research participants. Conclusions These results suggest that an appropriate level of sensory information provided to the spinal cord, generated through task-specific stepping and/or loading, can positively benefit the neural circuitries controlling urogenital and bowel functions.	[Hubscher, Charles H.; Montgomery, Lynnette R.] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Hubscher, Charles H.; Herrity, April N.; Montgomery, Lynnette R.; Willhite, Andrea M.; Angeli, Claudia A.; Harkema, Susan J.] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; [Herrity, April N.; Willhite, Andrea M.; Harkema, Susan J.] Univ Louisville, Dept Neurol Surg, Louisville, KY 40292 USA; [Williams, Carolyn S.] Univ Louisville, Dept Urol, Louisville, KY 40292 USA; [Angeli, Claudia A.; Harkema, Susan J.] Frazier Rehabil Inst, Louisville, KY USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Hubscher, CH (corresponding author), Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.; Hubscher, CH (corresponding author), Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA.	chhubs01@louisville.edu		Hubscher, Charles/0000-0002-6678-750X; Angeli, Claudia/0000-0003-4127-7121; Reis, AlessanRSS/0000-0001-8486-7469	NICHHD [R01HD080205]; Christopher & Dana Reeve Foundation; Craig H. Neilsen Foundation; NIH/NCRR [8P30GM103507]; Leona M. and Harry B. Helmsley Charitable Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD080205] Funding Source: NIH RePORTER	NICHHD; Christopher & Dana Reeve Foundation; Craig H. Neilsen Foundation; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Leona M. and Harry B. Helmsley Charitable Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by the NICHHD (R01HD080205) to Charles Hubscher, and the Leona M. and Harry B. Helmsley Charitable Trust, the Christopher & Dana Reeve Foundation, and the Craig H. Neilsen Foundation. This project utilized KSCIRC Neuroscience Core facilities supported by NIH/NCRR P30 (8P30GM103507) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported by the NICHHD (R01HD080205), and the Leona M. and Harry B. Helmsley Charitable Trust, the Christopher & Dana Reeve Foundation, and the Craig H. Neilsen Foundation. This project utilized KSCIRC Neuroscience Core facilities supported by NIH/NCRR P30 (8P30GM103507) grant. No competing financial interests exist.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Alexander MS, 2011, SPINAL CORD, V49, P795, DOI 10.1038/sc.2010.192; Alexander MS, 2011, SPINAL CORD, V49, P787, DOI 10.1038/sc.2011.7; Alexander MS, 2009, J SPINAL CORD MED, V32, P226, DOI 10.1080/10790268.2009.11760777; Anderson KD, 2007, SPINAL CORD, V45, P328, DOI 10.1038/sj.sc.3101977; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; ANDERSSON O, 1983, ACTA PHYSIOL SCAND, V118, P229, DOI 10.1111/j.1748-1716.1983.tb07267.x; ANDERSSON O, 1981, ACTA PHYSIOL SCAND, V113, P89, DOI 10.1111/j.1748-1716.1981.tb06867.x; Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; Antunes-Rodrigues J, 2004, PHYSIOL REV, V84, P169, DOI 10.1152/physrev.00017.2003; BARBEAU H, 1987, BRAIN RES, V412, P84, DOI 10.1016/0006-8993(87)91442-9; Beaumont E, 2008, NEUROSCI RES, V62, P147, DOI 10.1016/j.neures.2008.07.003; Behrman AL, 2005, PHYS THER, V85, P1356, DOI 10.1093/ptj/85.12.1356; Benevento BT, 2002, PHYS THER, V82, P601, DOI 10.1093/ptj/82.6.601; Beres-Jones JA, 2004, BRAIN, V127, P2232, DOI 10.1093/brain/awh252; Beres-Jones JA, 2003, EXP BRAIN RES, V149, P222, DOI 10.1007/s00221-002-1349-5; Biering-Sorensen F, 2008, SPINAL CORD, V46, P513, DOI 10.1038/sj.sc.3102174; Biering-Sorensen F, 2008, SPINAL CORD, V46, P325, DOI 10.1038/sj.sc.3102145; Blaivas J. G., 1982, NEUROUROL URODYNAM, V1, P51, DOI [10.1002/nau.1930010104, DOI 10.1002/NAU.1930010104]; BODNER DR, 1987, J UROLOGY, V138, P310, DOI 10.1016/S0022-5347(17)43130-2; BRINDLEY GS, 1994, PARAPLEGIA, V32, P795, DOI 10.1038/sc.1994.126; Button DC, 2008, J PHYSIOL-LONDON, V586, P529, DOI 10.1113/jphysiol.2007.141499; Colombo G, 1998, ANN NY ACAD SCI, V860, P536, DOI 10.1111/j.1749-6632.1998.tb09097.x; Consortium for Spinal Cord Medicine, 2002, J Spinal Cord Med, V25 Suppl 1, pS67; CONVERTINO VA, 1980, J APPL PHYSIOL, V48, P665, DOI 10.1152/jappl.1980.48.4.665; CONWAY BA, 1987, EXP BRAIN RES, V68, P643; COPE TC, 1986, J NEUROPHYSIOL, V55, P1202, DOI 10.1152/jn.1986.55.6.1202; COURTOIS FJ, 1993, PARAPLEGIA, V31, P771, DOI 10.1038/sc.1993.120; Creasey GH, 2001, ARCH PHYS MED REHAB, V82, P1512, DOI 10.1053/apmr.2001.25911; Cruz F, 2011, EUR UROL, V60, P742, DOI 10.1016/j.eururo.2011.07.002; de Leon RD, 1998, J NEUROPHYSIOL, V79, P1329, DOI 10.1152/jn.1998.79.3.1329; De Looze DA, 1998, DIS COLON RECTUM, V41, P778, DOI 10.1007/BF02236269; DENNY-BROWN D., 1933, BRAIN, V56, P397, DOI 10.1093/brain/56.4.397; Dietz V, 2004, J APPL PHYSIOL, V96, P1954, DOI 10.1152/japplphysiol.00942.2003; Dietz V, 1997, TRENDS NEUROSCI, V20, P346; DIETZ V, 1987, J PHYSIOL-LONDON, V386, P149, DOI 10.1113/jphysiol.1987.sp016527; DIETZ V, 1995, ANN NEUROL, V37, P574, DOI 10.1002/ana.410370506; DIETZ V, 1994, LANCET, V344, P1260, DOI 10.1016/S0140-6736(94)90751-X; Dietz V, 1998, SPINAL CORD, V36, P380, DOI 10.1038/sj.sc.3100590; Ditunno PL, 2008, SPINAL CORD, V46, P500, DOI 10.1038/sj.sc.3102172; DUYSENS J, 1980, BRAIN RES, V187, P321, DOI 10.1016/0006-8993(80)90206-1; Dy CJ, 2010, J NEUROPHYSIOL, V103, P2808, DOI 10.1152/jn.00316.2009; Edgerton V R, 1991, J Am Paraplegia Soc, V14, P150; Fajardo NR, 2003, AM J GASTROENTEROL, V98, P128; Ferris DP, 2004, SPINAL CORD, V42, P14, DOI 10.1038/sj.sc.3101542; Fode M, 2012, ASIAN J ANDROL, V14, P61, DOI 10.1038/aja.2011.70; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P269, DOI 10.1111/j.1748-1716.1980.tb06533.x; Gammie A, 2014, NEUROUROL URODYNAM, V33, P370, DOI 10.1002/nau.22546; Gardiner PF, 2006, EXERC SPORT SCI REV, V34, P54, DOI 10.1249/00003677-200604000-00003; Ginsberg D, 2012, J UROLOGY, V187, P2131, DOI 10.1016/j.juro.2012.01.125; Glickman S, 1996, LANCET, V347, P1651, DOI 10.1016/S0140-6736(96)91487-7; Grillner S, 1988, Adv Neurol, V47, P425; GRILLNER S, 1979, EXP BRAIN RES, V34, P241; GRILLNER S, 1978, BRAIN RES, V146, P269, DOI 10.1016/0006-8993(78)90973-3; GRILLNER S, 1995, TRENDS NEUROSCI, V18, P270, DOI 10.1016/0166-2236(95)93914-J; Groen J, 2016, EUR UROL, V69, P324, DOI 10.1016/j.eururo.2015.07.071; Han TR, 1998, SPINAL CORD, V36, P485, DOI 10.1038/sj.sc.3100616; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; Harkema SJ, 2001, NEUROSCIENTIST, V7, P455, DOI 10.1177/107385840100700514; Harkema SJ, 2008, BRAIN RES REV, V57, P255, DOI 10.1016/j.brainresrev.2007.07.012; Harkema SJ, 2012, ARCH PHYS MED REHAB, V93, P1588, DOI 10.1016/j.apmr.2012.04.032; Harkema SJ, 2012, ARCH PHYS MED REHAB, V93, P1508, DOI 10.1016/j.apmr.2011.01.024; Herrity AN, 2015, AM J PHYSIOL-REG I, V308, pR1021, DOI 10.1152/ajpregu.00445.2014; Herrity AN, 2014, J COMP NEUROL, V522, P3667, DOI 10.1002/cne.23629; Hew-Butler T, 2010, BRIT J SPORT MED, V44, P710, DOI 10.1136/bjsm.2008.051771; Hubscher CH, 2016, AM J PHYSIOL-RENAL, V310, pF1258, DOI 10.1152/ajprenal.00557.2015; Ide M, 2001, SPINAL CORD, V39, P387, DOI 10.1038/sj.sc.3101171; Jamil F, 2001, SPINAL CORD, V39, P355, DOI 10.1038/sj.sc.3101132; Jayaraman A, 2008, J SPINAL CORD MED, V31, P185, DOI 10.1080/10790268.2008.11760710; JOLESZ FA, 1982, SCIENCE, V216, P1243, DOI 10.1126/science.7200635; Kessler TM, 2010, EUR UROL, V58, P865, DOI 10.1016/j.eururo.2010.09.024; Kilinc S, 1999, SPINAL CORD, V37, P332, DOI 10.1038/sj.sc.3100814; Komisaruk BR, 2004, BRAIN RES, V1024, P77, DOI 10.1016/j.brainres.2004.07.029; Komisaruk BR, 1997, ARCH NEUROL-CHICAGO, V54, P1513, DOI 10.1001/archneur.1997.00550240063014; KOONER JS, 1988, PARAPLEGIA, V26, P233, DOI 10.1038/sc.1988.36; Krassioukov A, 2009, ARCH PHYS MED REHAB, V90, P682, DOI 10.1016/j.apmr.2008.10.017; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; Krhut J, 2015, NEUROUROL URODYN; Krogh K, 2009, SPINAL CORD, V47, P235, DOI 10.1038/sc.2008.103; Krogh K, 2009, SPINAL CORD, V47, P230, DOI 10.1038/sc.2008.102; KRUSE MN, 1995, J AUTONOM NERV SYST, V54, P215, DOI 10.1016/0165-1838(95)00011-L; Laessoe L, 2003, J UROLOGY, V169, P2216, DOI 10.1097/01.ju.0000058770.15127.d6; Lane TM, 2000, BJU INT, V86, P942, DOI 10.1046/j.1464-410x.2000.00947.x; Liu N, 2013, SPINAL CORD, V51, P863, DOI 10.1038/sc.2013.113; Lombardi G, 2009, SPINAL CORD, V47, P486, DOI 10.1038/sc.2008.172; LOVELY RG, 1986, EXP NEUROL, V92, P421, DOI 10.1016/0014-4886(86)90094-4; Lukacz ES, 2011, INT J CLIN PRACT, V65, P1026, DOI 10.1111/j.1742-1241.2011.02763.x; Lynch AC, 2001, SPINAL CORD, V39, P193, DOI 10.1038/sj.sc.3101119; Maegele M, 2002, J NEUROTRAUM, V19, P1217, DOI 10.1089/08977150260338010; MAI J, 1976, ACTA NEUROL SCAND, V53, P395, DOI 10.1111/j.1600-0404.1976.tb04358.x; Maio G, 2010, J SEX MED, V7, P2201, DOI 10.1111/j.1743-6109.2010.01783.x; Marino RJ., 2003, J SPINAL CORD MED S1, V26, pS50, DOI [10.1080/10790268.2003.11754575, DOI 10.1080/10790268.2003.11754575]; MATHIAS CJ, 1986, BRIT MED J, V293, P353, DOI 10.1136/bmj.293.6543.353; Mcgee MJ, 2015, J SPINAL CORD MED, V38, P135, DOI 10.1179/2045772314Y.0000000299; MCGUIRE EJ, 1981, J UROLOGY, V126, P205, DOI 10.1016/S0022-5347(17)54449-3; Milligan J, 2012, CAN FAM PHYSICIAN, V58, P831; Miranda EP, 2016, ARCH PHYS MED REHAB, V97, P947, DOI 10.1016/j.apmr.2016.01.005; Monti PR, 1997, UROLOGY, V49, P112, DOI 10.1016/S0090-4295(96)00503-1; National Spinal Cord Injury Statistical Center, 2013, J Spinal Cord Med, V36, P1, DOI 10.1179/1079026813Z.000000000136; Panicker JN, 2010, CLIN REHABIL, V24, P579, DOI 10.1177/0269215509353252; PEDERSEN E, 1986, J NEUROL NEUROSUR PS, V49, P273, DOI 10.1136/jnnp.49.3.273; Piatt JA, 2016, J SPINAL CORD MED, V39, P693, DOI 10.1080/10790268.2015.1123845; Reitz A, 2004, INT J IMPOT RES, V16, P167, DOI 10.1038/sj.ijir.3901193; Rejc E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133998; Rosen RC, 2006, UROLOGY, V68, P6, DOI 10.1016/j.urology.2006.05.046; Rosier Peter F, 2013, F1000Prime Rep, V5, P8, DOI 10.12703/P5-8; SATO A, 1977, NEUROSCIENCE, V2, P111, DOI 10.1016/0306-4522(77)90072-0; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; SHERWOOD AM, 1992, J NEUROL SCI, V110, P90, DOI 10.1016/0022-510X(92)90014-C; Lara LAS, 2015, J SEX MED, V12, P1584, DOI 10.1111/jsm.12909; Sipski ML, 2001, ANN NEUROL, V49, P35, DOI 10.1002/1531-8249(200101)49:1<35::AID-ANA8>3.0.CO;2-J; Steadman CJ., 2016, CURR SEX HLTH REP, V8, P106, DOI [10.1007/s11930-016-0067-0, DOI 10.1007/S11930-016-0067-0]; STEERS WD, 1991, J CLIN INVEST, V88, P1709, DOI 10.1172/JCI115488; Suh DD, 2003, UROLOGY, V61, P184, DOI 10.1016/S0090-4295(02)02112-X; Szollar SM, 1997, ARCH PHYS MED REHAB, V78, P455, DOI 10.1016/S0003-9993(97)90155-6; Trimble M H, 2001, J Spinal Cord Med, V24, P74; Valles M, 2009, DIS COLON RECTUM, V52, P1589, DOI 10.1007/DCR.0b013e3181a873f3; WADE CE, 1984, MED SCI SPORT EXER, V16, P506, DOI 10.1249/00005768-198410000-00015; WADE CE, 1980, J APPL PHYSIOL, V49, P930, DOI 10.1152/jappl.1980.49.6.930; Ward PJ, 2014, J NEUROTRAUM, V31, P819, DOI 10.1089/neu.2013.3082; Ward PJ, 2012, J NEUROTRAUM, V29, P2490, DOI 10.1089/neu.2012.2402; Waring WP, 2010, J SPINAL CORD MED, V33, P346, DOI 10.1080/10790268.2010.11689712; Winchester P, 2005, NEUROREHAB NEURAL RE, V19, P313, DOI 10.1177/1545968305281515; Winters JC, 2012, J UROLOGY, V188, P2464, DOI 10.1016/j.juro.2012.09.081; Wyndaele JJ, 1998, J UROLOGY, V160, P479, DOI 10.1016/S0022-5347(01)62929-X; YAVETZ H, 1994, HUM REPROD, V9, P381, DOI 10.1093/oxfordjournals.humrep.a138513	126	67	66	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0190998	10.1371/journal.pone.0190998	http://dx.doi.org/10.1371/journal.pone.0190998			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	29385166	Green Published, gold, Green Submitted			2022-12-26	WOS:000423668400030
